Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353492	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1493	"liver: 1224.7"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 1548.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	51000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.1	1224.7	0.1	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	2.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.9	0.3	0.8	0.0	0.1	0.1	0.7	1.3	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.4	0.0	0.6	0.2	0.0	0.0	0.9	0.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	10.2	12.8	14.1	0.7	50.2	8.8	2.2	16.2	12.0	3.4	52.0	64.3	0.7	27.1	10.6	22.0	2.1	1.0	71.2	0.0	7.9	0.9	0.6	5.0	52.6	10.9	1.2	56.2	2.2	9.2	15.6	20.3	5.1	2.1	17.7	10.8	43.2	1548.5	25.1	8.4	1.7	0.1	20.3	110.9	66.0	2.1	1.2	49.4	115.6	0.0	60.8	3.1	15.5	0.0	8.7	5.4	0.0	1.2	94.4	11.1	0.0	2.0	15.0	5.5	26.3	29.2	43.8	4.1	7.9	1.5	3.7	1.9	52.6	0.7	0.2	0.6
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822621-8887001	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 556.3;vagina: 204.8"	"Cell type enriched"	"Detected in some"	6	"Squamous epithelial cells: 127.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 10.9;hTCEpi: 5.5;SK-BR-3: 13.9"					"Low region specificity"	"Detected in many"			"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	NA	NA		10000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.2	0.1	2.1	0.0	2.1	0.2	4.1	0.8	2.4	116.5	0.6	0.1	0.0	0.5	0.4	556.3	0.7	0.2	0.4	2.0	2.2	0.1	0.3	0.1	0.2	1.8	3.1	0.4	0.2	0.8	1.4	0.7	1.3	0.6	0.0	0.7	99.0	0.0	0.3	72.0	0.1	0.1	1.7	0.1	0.7	5.0	4.3	3.0	0.1	0.0	51.5	1.1	204.8	1.5	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.5	10.9	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	13.9	0.0	1.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	2.1	2.1	0.8	2.4	2.0	2.2	1.8	3.1	1.3	1.7	4.3	1.5	0.0	0.0	0.0	20.2	0.0	0.4	0.5	1.0	1.8	0.7	0.3	0.1	0.7	0.0	2.2	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.4	4.4	0.9	0.3	0.0	0.0	4.9	0.0	0.5	0.4	0.0	11.9	0.0	0.8	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.3	0.0	0.4	0.3	1.0	0.4	127.6	12.6	0.1	0.1	1.9	0.0	8.2
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123713-138132390	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"stomach 1: 23.6"	"Group enriched"	"Detected in some"	25	"Cholangiocytes: 4.3;Gastric mucus-secreting cells: 16.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	2.7	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.2	0.4	0.1	3.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	17.0	36.3	12.3	13.8	15.0	19.1	17.1	15.2	15.6	20.3	15.1	19.1	12.3	19.1	7.2	19.3	19.9	9.4	22.7	12.9	13.7	21.7	24.6	14.0	17.6	14.3	14.1	19.2	23.9	18.0	24.8	17.4	14.8	18.4	15.1	12.3	18.5	11.7	22.6	17.3	17.7	16.8	13.7	22.2	21.6	27.3	14.0	25.2	19.4	18.5	21.6	17.8	17.9	17.2	26.1	77.3	63.2	38.0	28.6	32.2	38.9	29.8	31.3	72.6	42.1	54.0	56.7	62.2	47.4	37.3	41.9	37.6	106.4	78.8	42.1	41.0	68.1	49.7	29.9	40.7	26.4	45.5	37.9	28.1	39.4	48.9	44.6	40.4	56.6	56.2	67.6	70.6	30.4	72.8	71.2	46.1	40.0	27.7	53.1	72.1	39.3	69.4	38.2	17.5	32.8	41.3	20.2	46.9	21.0	40.2	61.2	38.8	25.5	34.9	51.1	27.4	32.9	32.5	43.5	54.7	25.6	39.6	40.5	1.0	17.7	10.7	18.4	20.2	20.8	20.0	15.9	16.8	18.8	21.8	21.7	21.4	1.1	10.5	22.5	22.6	17.4	15.2	12.3	15.0	15.2	15.6	12.9	13.7	14.3	14.1	14.8	13.7	14.0	17.2	11.7	12.8	7.8	17.9	15.1	7.4	19.0	26.2	10.2	11.8	13.2	13.0	8.2	17.2	15.4	14.7	16.7	58.4	13.7	9.3	13.7	20.4	12.5	11.9	12.9	11.7	8.4	41.2	7.3	18.3	49.5	14.9	13.3	8.9	8.2	13.1	11.0	12.0	28.5	1.7	6.6	13.1	18.3	12.4	9.3	26.2	17.7	10.6	10.6	5.6	11.6	18.0	15.5	6.6	11.4	8.9	11.0	12.8	20.8	8.1	11.2	18.5	12.6	15.5	19.7	11.0	39.7	34.2	40.5	13.1	7.4	36.5	11.4	14.9	17.2	13.0
AACS	"ACSF1, FLJ12389, SUR-5"	ENSG00000081760	"Acetoacetyl-CoA synthetase"	Q86V21	12	125065434-125143333	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.1;Excitatory neurons: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058815	Approved		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA058815: AB_2683826"	"unprognostic (1.28e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-3)"	"unprognostic (6.60e-6)"	"unprognostic (3.03e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.80e-2)"	31.7	7.8	6.4	5.6	8.2	3.7	43.4	2.8	11.0	14.6	3.2	12.7	17.9	6.3	8.7	30.9	8.5	7.6	7.4	9.1	3.7	10.3	3.9	6.2	5.8	6.1	3.1	6.0	12.8	9.6	8.5	6.1	6.0	8.6	11.3	6.2	48.2	7.5	5.5	40.4	10.4	5.8	2.4	5.2	16.9	13.5	5.0	10.4	10.0	7.6	10.2	6.1	14.3	6.5	26.8	26.2	11.2	15.3	40.3	26.1	18.7	21.2	20.1	24.6	21.8	34.0	17.4	16.5	21.3	25.7	10.6	28.4	21.0	22.8	13.2	17.8	19.2	13.1	16.9	26.2	33.5	9.4	12.8	29.1	18.2	21.0	21.0	30.8	18.1	9.5	9.4	9.9	15.9	49.1	10.8	12.7	14.2	28.0	30.4	2.1	28.2	23.0	25.0	40.2	29.7	8.6	22.4	35.0	16.6	10.8	26.2	20.7	17.4	11.8	18.7	13.4	16.4	22.0	13.6	18.0	14.8	15.4	13.2	7.7	2.1	5.9	3.3	0.6	4.4	2.4	3.1	2.5	2.4	1.2	4.4	3.0	0.3	5.4	0.7	9.9	2.1	3.4	6.4	8.2	2.8	11.0	9.1	3.7	6.1	3.1	6.0	2.4	5.0	6.5	4.2	6.4	17.3	16.3	4.5	16.6	5.6	14.1	9.1	20.9	23.6	16.9	9.4	17.2	12.0	5.5	27.1	2.1	6.5	14.0	7.9	11.0	67.1	6.3	15.3	6.5	25.2	0.8	59.4	10.7	8.7	11.8	13.3	12.3	2.5	13.1	2.2	4.2	4.8	6.7	28.6	22.0	16.2	4.1	9.0	22.5	9.3	3.9	5.4	5.6	5.4	5.6	5.2	12.1	12.5	9.9	7.4	5.3	12.1	8.2	10.7	6.5	5.7	21.8	0.0	8.6	7.7	22.0	5.3	25.3	28.1	2.5	8.1	20.8	15.8	5.6
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814073-151828488	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 224.9;intestine: 241.7;liver: 946.7"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 687.7;Proximal enterocytes: 460.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002911	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	8.2	224.9	0.0	0.4	0.0	0.0	5.0	0.0	0.1	0.1	0.2	0.3	220.9	0.2	0.0	2.7	0.6	27.4	0.7	0.0	0.0	0.2	946.7	9.1	0.3	0.0	0.1	0.1	36.7	0.0	0.0	1.5	0.0	0.1	0.2	0.0	1.3	0.0	0.0	13.8	241.7	0.0	0.0	0.2	52.3	0.8	0.1	0.4	0.3	0.0	2.5	0.7	0.4	0.0	0.0	9.5	0.0	0.0	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.6	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	1.0	0.4	0.1	0.3	1.7	0.0	1.7	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.0	0.9	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.5	0.0	14.3	0.0	0.7	0.3	0.0	4.4	0.0	0.0	0.0	0.0	1.1	71.4	8.7	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	1.8	0.1	0.7	0.0	2.7	0.0	51.9	0.0	39.3	53.5	0.2	0.0	0.0	5.0	687.7	0.2	0.0	0.0	9.6	0.0	14.8	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	10.0	0.0	0.1	0.2	460.5	0.0	2.9	0.0	0.0	0.0	3.4	0.0	0.1	1.4	3.4	0.3	0.7	0.3	18.4	0.2
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 67.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.3	2.8	6.2	1.9	6.8	0.3	4.7	3.8	9.8	9.8	11.3	6.2	1.6	10.5	5.9	2.6	6.3	3.9	2.7	6.5	6.7	6.8	67.1	4.9	0.7	5.8	5.6	4.7	5.6	6.0	6.1	1.9	6.5	14.4	5.0	11.8	1.7	5.3	4.0	1.4	2.3	7.3	4.8	1.7	3.6	8.2	6.1	1.5	7.5	2.4	0.8	6.4	5.7	8.7	3.5	8.5	25.0	0.0	4.9	18.9	9.0	8.7	4.2	4.9	5.0	8.4	1.0	0.1	1.4	9.8	6.5	2.9	11.3	4.1	3.4	0.0	9.7	0.0	10.0	14.0	3.9	0.1	3.8	7.7	2.5	4.0	5.1	13.5	4.7	11.4	1.5	0.1	19.0	8.9	4.3	0.1	19.0	9.6	7.6	0.0	7.8	0.0	4.4	15.3	20.1	23.5	7.0	1.7	8.5	8.0	0.1	1.7	3.2	12.5	13.4	14.3	13.9	0.1	0.0	0.1	12.5	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.8	3.8	9.8	6.5	6.7	5.8	5.6	6.5	4.8	6.1	8.7	0.9	0.0	5.9	22.2	0.3	0.9	2.8	0.9	6.2	6.0	3.9	1.0	1.2	1.5	2.1	0.0	2.1	2.8	0.0	0.7	0.0	1.6	0.5	3.7	7.4	0.7	6.7	0.0	15.4	2.2	71.3	3.2	3.1	6.0	0.0	6.2	0.7	29.3	1.6	0.0	13.6	2.8	0.0	0.3	0.9	1.4	1.2	0.4	1.8	5.6	0.0	2.7	0.0	17.6	14.0	1.1	1.6	2.2	0.0	4.0	0.2	8.4	8.5	9.1	6.6	3.9	4.2	14.5	27.1	3.0	0.4	5.6	0.3	3.3	3.1	1.8
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67200667-67255195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (1.53e-1)"	15.1	19.1	10.5	19.2	13.3	19.8	22.5	7.2	14.5	17.9	12.7	27.8	15.8	14.8	25.9	20.5	16.5	18.5	15.8	12.9	15.7	27.4	18.1	15.6	19.9	9.8	11.5	8.0	17.0	35.2	19.0	15.8	11.5	18.8	33.8	22.1	15.4	20.5	32.8	12.9	19.5	21.2	9.5	15.4	23.9	21.9	15.7	29.9	33.0	23.0	25.9	27.5	13.2	12.2	49.7	89.9	63.2	64.8	60.0	49.3	31.1	51.4	74.7	60.6	68.7	66.8	52.9	48.1	51.1	52.9	74.4	98.2	129.9	59.4	62.9	65.0	62.0	46.2	63.2	26.8	66.0	78.8	51.2	48.6	80.6	45.8	94.3	41.0	47.8	59.7	96.5	63.7	60.2	61.3	47.6	32.7	53.1	61.7	31.5	53.1	81.1	57.7	55.9	116.1	89.7	57.3	60.7	44.0	75.7	54.7	71.5	59.2	51.7	54.2	64.5	50.0	73.0	33.7	119.3	69.2	52.7	71.8	55.4	56.4	27.0	28.2	31.3	35.4	36.2	22.0	28.2	29.7	33.2	17.3	23.7	25.0	14.6	42.7	38.1	25.4	37.3	30.2	10.5	13.3	7.2	14.5	12.9	15.7	9.8	11.5	11.5	9.5	15.7	12.2	10.8	3.2	7.7	26.1	19.0	12.0	18.8	19.4	15.9	13.4	17.8	10.3	12.9	4.3	19.0	27.6	27.1	16.3	8.8	33.4	17.6	28.6	14.6	14.5	11.6	12.0	15.7	10.9	45.4	31.2	14.8	14.1	22.4	18.0	10.8	8.2	8.2	12.7	17.0	18.5	33.1	17.3	14.2	15.5	8.4	8.6	7.8	11.6	7.2	30.0	21.3	14.4	16.5	26.2	31.9	25.3	20.9	11.3	15.5	22.9	15.3	19.1	20.5	19.4	13.1	10.5	10.2	43.0	33.8	17.6	13.8	16.6	17.8	25.3	15.7	24.5
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 656.7"	"Cell type enhanced"	"Detected in all"		"Theca cells: 385.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 143.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 280.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	75.8	180.9	30.1	13.0	35.8	21.0	62.5	35.2	42.6	51.0	31.4	66.6	37.4	41.4	27.9	24.6	47.5	23.4	178.9	30.5	31.7	56.0	57.9	46.9	13.8	37.2	34.4	56.7	34.4	27.4	28.6	21.7	35.9	46.0	29.2	20.1	36.6	34.6	656.7	55.4	47.5	40.2	31.9	31.7	62.4	42.2	34.3	23.7	42.2	173.0	13.6	48.1	42.7	42.7	30.3	24.3	37.2	26.5	106.0	73.3	10.0	49.2	33.4	43.8	54.1	280.1	44.6	20.3	46.5	83.0	43.2	16.9	56.4	32.9	51.9	47.1	45.3	19.5	43.5	52.4	52.2	11.2	17.1	98.3	22.2	46.0	24.2	40.2	131.3	27.0	23.1	32.0	93.2	35.6	23.8	44.3	17.3	84.5	41.4	22.3	63.6	19.6	58.2	18.1	13.1	49.2	62.4	26.7	36.0	55.1	41.2	21.1	138.2	45.5	24.7	87.5	16.5	34.2	58.4	37.8	17.7	18.0	26.2	143.1	28.9	33.3	14.6	17.7	18.8	18.3	28.4	24.2	32.6	25.2	24.8	18.4	16.9	35.9	17.5	33.8	47.3	16.3	30.1	35.8	35.2	42.6	30.5	31.7	37.2	34.4	35.9	31.9	34.3	42.7	68.4	83.3	25.4	19.6	10.0	64.2	82.7	51.0	24.5	10.0	58.7	67.2	114.1	62.9	42.5	79.1	4.2	29.1	11.8	70.2	144.8	60.0	100.1	37.7	27.8	55.7	22.7	19.1	6.9	73.1	43.1	64.5	39.3	35.8	41.2	53.4	93.9	122.2	46.9	11.8	8.9	48.7	44.7	29.9	35.9	36.3	68.3	22.5	83.6	8.4	56.2	101.3	16.5	18.1	24.8	70.2	132.2	64.3	10.2	46.6	160.3	200.8	50.1	13.9	46.0	53.5	65.8	154.0	85.4	29.2	100.7	15.7	14.8	385.5	61.0	71.2
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264129-218270178	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	66.5	66.4	65.0	46.2	66.1	27.5	65.2	67.1	80.1	62.6	63.2	76.3	62.8	61.7	43.8	75.1	60.8	56.1	65.4	65.7	67.2	60.2	77.5	46.6	47.8	69.2	66.6	79.8	70.7	72.7	62.1	54.9	66.4	58.0	58.0	38.4	66.9	58.7	90.4	76.6	61.7	50.7	67.5	53.0	86.9	53.8	67.1	54.0	66.6	62.0	52.6	70.0	57.4	70.3	126.1	104.6	75.1	102.2	111.9	75.7	146.0	89.6	136.3	167.1	124.5	226.2	100.1	64.6	121.8	112.6	158.8	94.3	150.7	133.4	129.3	103.5	200.9	147.4	108.2	237.4	158.9	139.3	92.4	97.8	152.7	172.2	149.7	99.7	97.6	124.3	202.6	82.4	108.9	198.0	112.4	234.9	121.0	182.4	75.4	90.6	97.5	105.8	100.3	160.5	96.2	92.9	59.4	128.7	134.7	119.1	99.1	104.6	84.7	110.2	82.3	81.2	106.8	105.7	198.1	108.4	111.0	88.6	77.4	75.9	166.2	60.3	101.1	209.2	105.1	100.3	90.1	94.9	191.4	105.7	111.1	100.7	26.2	114.9	210.6	114.1	109.3	179.4	65.0	66.1	67.1	80.1	65.7	67.2	69.2	66.6	66.4	67.5	67.1	70.3	57.8	41.7	35.2	11.4	50.4	90.5	86.1	122.9	66.0	47.7	50.7	45.2	35.5	41.5	74.0	42.3	12.5	160.0	42.2	74.3	103.7	95.7	3.5	33.5	46.4	50.6	75.5	34.0	11.5	95.4	130.3	63.4	80.5	38.2	34.8	57.6	42.5	46.2	91.9	63.9	12.9	89.9	93.6	37.0	65.3	8.8	83.3	38.5	62.2	5.6	64.8	80.2	41.2	8.0	10.5	86.6	72.0	74.9	51.2	116.0	99.5	85.3	47.4	37.1	65.7	38.4	86.5	72.0	53.3	70.2	97.3	202.6	44.4	62.5	103.5	119.9
AAR2	"bA234K24.2, C20orf4"	ENSG00000131043	"AAR2 splicing factor"	Q9Y312	20	36236131-36270918	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034220, HPA048645"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034220: AB_1564205, HPA048645: AB_2680475"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.54e-3)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.09e-2)"	"unprognostic (6.84e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	22.3	26.8	14.5	14.3	15.8	22.3	21.6	15.8	15.5	19.8	19.1	27.5	15.1	25.6	25.0	17.8	23.2	16.5	18.8	14.3	14.7	20.9	23.5	19.2	17.5	15.9	15.2	22.6	18.6	25.5	10.0	17.5	15.9	19.9	17.3	7.5	18.1	21.1	23.4	25.9	18.9	27.9	15.5	18.1	23.0	16.4	15.4	26.2	17.9	20.7	19.9	25.8	16.2	17.2	26.9	30.7	28.8	33.2	48.9	32.4	22.9	25.4	33.7	58.1	45.7	69.2	35.0	18.2	35.6	36.9	44.8	36.6	46.6	48.2	35.8	17.0	28.2	57.9	19.3	43.3	36.9	39.5	27.9	39.6	68.7	41.5	31.5	29.4	36.3	36.0	36.8	34.3	32.4	32.0	56.0	48.9	25.1	39.1	49.5	30.7	48.3	42.4	33.0	19.6	33.2	36.1	37.8	100.7	32.8	26.2	57.1	42.8	26.6	54.9	34.3	33.0	32.2	31.1	42.3	34.6	39.9	26.3	29.7	60.6	46.2	41.6	43.0	49.4	43.2	32.5	40.0	41.4	49.1	35.5	50.0	43.0	8.9	58.4	58.1	39.8	50.2	57.4	14.5	15.8	15.8	15.5	14.3	14.7	15.9	15.2	15.9	15.5	15.4	17.2	11.7	6.4	12.5	4.6	10.8	5.7	10.6	11.8	6.8	4.4	10.3	9.5	6.8	11.5	8.4	9.2	8.4	21.3	10.9	7.1	11.7	19.7	2.8	6.9	8.9	11.9	11.4	14.7	6.3	21.0	14.3	12.7	6.6	6.6	15.9	10.8	11.4	11.8	15.0	15.2	7.1	10.5	12.2	15.0	2.5	3.1	11.1	8.5	10.6	3.7	12.3	6.1	14.4	5.0	9.9	17.3	7.6	15.1	7.5	11.3	8.4	8.0	11.1	3.5	6.6	9.8	13.9	17.0	14.5	9.0	7.5	18.6	7.9	15.3	8.7	8.9
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44298731-44313347	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	4.7	5.2	6.5	5.6	6.2	5.4	4.9	9.4	6.7	7.6	6.7	5.8	6.5	6.1	3.2	9.2	6.4	4.6	6.0	6.8	5.1	5.7	6.9	4.3	6.0	6.1	5.8	8.3	6.5	5.9	6.3	4.1	6.4	7.0	4.1	5.4	6.2	4.3	4.8	7.2	7.9	4.1	5.4	7.2	5.4	3.7	6.0	6.2	6.2	3.3	5.3	5.6	7.4	6.7	14.6	9.9	13.9	23.8	8.1	7.2	18.3	10.9	5.7	11.2	10.6	11.4	7.1	16.3	16.2	4.8	12.2	10.0	14.7	16.0	4.7	10.9	23.7	18.9	10.6	14.5	4.8	17.9	16.0	5.9	9.8	9.0	10.2	7.3	9.5	21.8	21.0	15.4	6.2	16.0	14.2	15.9	9.9	40.3	9.8	16.4	8.7	10.4	6.7	12.7	32.0	11.4	9.4	10.9	15.5	9.7	9.9	21.6	8.4	12.1	13.5	7.6	13.9	8.8	8.7	16.5	6.8	15.9	22.1	2.2	1.1	0.1	1.3	1.3	2.1	1.5	1.9	1.7	1.0	2.9	1.8	1.7	0.2	1.9	1.4	1.3	1.2	1.3	6.5	6.2	9.4	6.7	6.8	5.1	6.1	5.8	6.4	5.4	6.0	6.7	2.6	6.4	3.3	5.2	3.7	0.6	2.1	1.9	4.0	6.6	2.8	2.7	3.5	5.7	2.8	0.0	12.5	5.0	4.9	3.0	0.0	2.3	10.1	3.5	5.4	3.0	0.0	8.2	5.5	0.4	5.0	3.4	5.1	6.2	0.0	5.9	3.9	2.5	3.3	0.0	9.0	2.2	2.0	2.8	1.8	1.0	4.7	2.5	0.0	1.9	3.9	2.0	4.1	3.0	3.6	1.4	0.7	4.5	6.9	1.6	6.3	1.0	3.0	7.1	0.0	4.7	2.8	4.3	6.1	4.4	0.4	5.3	4.1	4.5	3.7	1.6
AARSD1	MGC2744	ENSG00000266967	"Alanyl-tRNA synthetase domain containing 1"	Q9BTE6	17	42950526-42964498	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.2;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021408, HPA022869, HPA023714"	Supported		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (2.85e-3)"	"unprognostic (9.78e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.69e-3)"	18.2	19.6	18.1	13.7	20.2	16.5	20.3	17.9	21.4	19.9	17.2	20.4	12.8	20.7	21.1	18.6	20.3	13.5	34.4	19.5	19.8	20.5	24.4	13.7	17.4	19.3	18.1	26.0	25.5	24.7	20.5	14.6	19.7	18.1	17.4	13.5	20.5	18.4	68.9	15.6	13.7	23.2	17.7	14.2	20.5	72.3	18.8	19.3	21.4	60.5	20.7	19.6	17.6	20.3	38.7	52.4	39.6	39.8	47.0	44.8	30.5	41.2	34.5	46.9	31.1	45.8	32.0	104.3	2.0	43.2	28.7	32.1	55.2	62.2	53.7	35.1	43.7	41.4	57.6	25.3	61.6	81.6	22.2	40.8	33.1	32.6	81.5	32.2	38.3	46.4	76.3	21.3	45.0	22.0	81.8	58.3	27.6	53.5	26.3	53.3	80.8	107.0	46.7	35.8	51.1	32.0	20.0	20.5	54.0	43.0	54.8	68.4	37.3	48.4	43.4	24.9	58.6	33.6	46.3	64.7	31.7	50.1	52.7	4.1	19.0	1.5	20.5	27.3	27.1	27.2	21.4	24.4	29.9	31.2	26.9	26.3	0.6	25.4	24.5	33.3	22.6	17.8	18.1	20.2	17.9	21.4	19.5	19.8	19.3	18.1	19.7	17.7	18.8	20.3	6.3	12.8	8.2	0.0	22.6	8.3	11.7	10.6	26.2	22.1	8.4	8.0	0.7	4.3	13.2	14.7	33.3	8.7	6.9	11.9	3.9	7.2	68.2	7.5	7.0	7.1	12.0	14.7	0.0	6.1	8.7	12.4	12.8	5.3	5.1	11.1	7.5	4.2	5.0	15.2	0.0	6.7	22.4	4.1	6.4	26.9	13.1	6.8	3.6	0.0	6.1	5.5	17.5	0.0	0.0	4.3	4.5	10.9	21.7	9.6	4.5	4.9	9.6	16.2	0.0	7.2	15.0	44.5	21.4	17.4	4.5	2.7	17.7	13.7	10.0	6.7
AASDH	"ACSF4, LYS2, NRPS998"	ENSG00000157426	"Aminoadipate-semialdehyde dehydrogenase"	Q4L235	4	56338287-56387508	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036472, HPA036473"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA036472: AB_2675142, HPA036473: AB_10673656"	"unprognostic (1.95e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.85e-3)"	4.3	4.9	3.9	4.7	4.6	4.5	8.4	6.1	4.2	5.8	4.0	4.5	4.5	6.4	8.1	4.6	7.0	4.4	3.7	3.6	4.2	6.7	6.5	4.5	6.4	4.5	4.5	8.4	3.8	7.2	4.2	5.0	4.6	6.4	5.8	11.8	5.6	5.4	4.2	7.1	4.2	5.7	4.1	5.9	4.7	5.0	4.3	6.2	7.1	4.2	6.7	4.3	4.3	5.3	5.0	3.3	8.6	6.6	12.8	14.7	5.3	6.2	7.5	6.3	5.4	3.8	10.2	10.9	5.7	6.8	4.8	3.1	6.3	6.3	7.0	4.4	6.3	5.1	6.3	4.9	11.4	9.4	3.7	8.5	10.2	6.7	10.0	9.1	9.8	6.9	11.9	5.4	7.2	4.9	11.1	7.8	4.8	9.1	4.8	8.2	4.2	5.1	9.0	4.2	5.7	5.5	7.1	11.2	7.2	8.1	8.9	6.0	6.7	4.2	5.6	4.4	4.5	4.3	3.6	7.1	6.6	8.4	4.6	0.0	2.0	1.6	2.8	2.5	3.7	2.4	2.8	2.4	2.2	3.0	4.0	3.0	0.4	2.8	1.6	1.9	2.9	1.3	3.9	4.6	6.1	4.2	3.6	4.2	4.5	4.5	4.6	4.1	4.3	5.3	14.1	6.4	16.2	59.4	17.3	10.1	13.9	26.0	13.6	38.7	21.7	21.2	10.1	14.3	17.3	18.4	27.1	40.7	22.8	9.4	25.4	9.9	26.0	22.0	28.6	13.9	12.1	24.0	26.9	7.6	19.4	17.9	14.8	21.0	20.3	26.4	19.6	21.9	15.4	35.3	36.7	14.7	22.4	17.6	8.7	5.2	16.8	12.6	10.6	19.7	21.5	31.3	20.6	36.2	39.1	6.0	13.4	18.0	9.9	14.2	8.0	29.2	11.2	56.4	6.6	22.5	11.9	43.3	35.0	13.6	15.6	23.9	16.5	23.8	15.9	8.1
AASDHPPT	"AASD-PPT, ACPS, CGI-80, LYS5"	ENSG00000149313	"Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"	Q9NRN7	11	106075501-106098699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026687	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA026687: AB_1844414"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.04e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-1)"	16.9	23.5	28.7	18.4	30.7	15.8	21.2	28.1	47.9	17.6	20.9	13.6	13.6	20.3	25.8	21.1	20.6	13.4	27.7	32.1	32.5	34.1	33.6	15.4	22.6	27.5	26.6	20.9	33.3	20.1	11.4	27.9	27.5	18.9	14.0	32.3	24.5	17.1	32.8	17.1	11.9	18.3	29.9	17.3	13.5	37.5	28.2	21.3	22.1	32.4	23.9	18.4	11.6	32.6	29.6	28.2	84.7	63.5	41.4	54.6	34.3	43.1	36.7	58.7	45.0	61.2	53.3	91.4	98.2	28.2	57.2	37.8	77.0	57.6	59.0	55.8	39.3	84.6	19.5	45.0	64.3	73.5	35.2	53.8	72.8	47.0	63.8	40.5	49.6	39.8	95.2	22.2	57.6	16.7	79.8	63.6	36.9	40.2	39.4	55.7	81.3	103.7	70.4	32.5	63.0	58.3	47.5	45.8	43.6	49.1	60.2	50.0	41.9	49.7	47.6	35.3	45.6	30.7	53.7	90.0	22.4	100.0	57.9	63.2	21.6	23.9	20.6	27.9	29.2	26.7	23.9	22.7	21.8	20.8	27.4	26.4	6.9	31.9	28.1	19.2	30.6	18.2	28.7	30.7	28.1	47.9	32.1	32.5	27.5	26.6	27.5	29.9	28.2	32.6	32.4	32.1	31.7	18.3	33.8	20.0	28.2	39.4	56.3	35.0	23.4	31.9	24.1	34.3	29.8	18.4	2.1	78.4	27.7	7.3	39.2	33.5	388.5	31.6	42.2	23.9	18.6	47.9	36.0	24.3	63.8	33.9	23.4	29.4	29.8	41.9	17.2	36.5	39.0	21.9	34.8	12.6	30.5	24.9	13.0	70.2	32.3	27.9	32.0	15.0	29.9	67.4	19.6	32.6	43.4	22.6	10.2	26.7	45.1	23.5	11.1	81.4	47.6	20.0	13.1	30.8	38.2	47.8	37.5	46.2	24.4	39.4	33.1	62.9	13.5	19.6
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948925-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	29.8	24.4	22.2	26.3	25.6	34.7	26.6	23.6	24.9	24.6	19.8	28.3	18.5	25.6	17.5	24.4	24.7	15.4	26.1	21.0	23.2	22.1	22.5	23.4	34.1	24.0	23.4	29.5	37.5	20.3	15.9	23.2	24.5	20.3	24.0	17.3	21.0	24.1	40.8	37.1	24.2	24.5	22.8	27.1	30.0	22.9	23.5	35.3	20.4	14.2	39.2	31.2	23.4	26.8	107.2	174.2	37.0	73.8	49.3	57.0	67.3	61.2	50.4	76.0	67.3	120.3	74.3	178.2	79.5	60.5	123.4	89.9	141.8	80.0	102.6	83.4	97.3	77.1	65.6	85.8	59.4	121.9	73.4	49.5	138.7	98.4	88.4	68.2	56.6	92.3	114.4	51.7	68.6	81.6	162.4	105.0	46.0	62.8	63.3	104.0	96.7	105.6	62.6	93.7	79.0	33.8	90.9	40.8	95.5	79.6	69.6	72.3	50.4	58.1	96.2	122.5	211.9	61.3	83.1	124.2	72.2	101.9	107.1	48.9	55.2	90.2	60.0	74.0	59.6	46.8	53.9	64.0	51.0	51.0	48.1	47.7	67.5	58.1	77.7	45.5	75.7	57.2	22.2	25.6	23.6	24.9	21.0	23.2	24.0	23.4	24.5	22.8	23.5	26.8	24.5	22.4	34.6	25.1	41.2	43.7	46.3	39.7	29.6	13.4	14.7	13.1	17.8	32.9	37.8	25.8	22.9	72.9	48.5	26.4	9.8	41.6	32.0	23.4	22.9	30.1	16.1	33.7	28.5	48.1	59.8	30.3	23.0	22.0	47.5	37.4	14.6	16.9	46.8	18.5	24.6	26.4	6.1	33.9	30.3	62.0	23.6	33.4	28.4	30.0	54.9	34.3	53.5	29.1	57.7	51.1	26.3	23.3	38.4	52.1	48.8	52.0	31.1	24.0	32.9	32.3	39.0	52.5	40.8	28.2	43.9	163.9	44.3	27.4	31.9	43.6
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81110487-81166221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 184.7"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 243.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 60.1;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	3.3	4.2	35.4	3.1	79.2	3.7	2.3	43.4	82.0	2.8	0.0	7.7	30.9	0.9	0.5	1.8	2.8	2.7	3.9	30.6	30.8	1.0	0.9	9.5	0.9	99.2	67.9	0.9	20.6	3.0	17.3	2.0	63.4	5.2	0.5	2.1	5.9	3.3	0.6	4.5	23.7	0.8	38.8	9.7	5.8	0.7	78.4	0.1	2.9	1.0	0.2	2.8	4.2	184.7	0.3	0.5	0.7	4.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	60.1	0.2	0.0	0.3	0.0	0.0	1.2	0.6	0.0	0.0	0.0	2.0	2.2	3.2	2.8	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	6.6	0.0	0.2	0.7	0.6	0.3	2.1	4.1	0.6	0.0	0.2	4.5	17.1	0.2	0.4	2.3	0.2	1.1	2.2	2.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	35.4	79.2	43.4	82.0	30.6	30.8	99.2	67.9	63.4	38.8	78.4	184.7	6.3	32.1	20.3	17.0	0.3	0.3	1.0	1.9	0.6	43.0	1.3	5.1	2.2	2.8	0.1	0.0	4.2	0.1	0.5	6.8	0.0	0.6	0.0	0.4	0.2	1.8	1.8	0.0	34.6	1.8	0.1	0.5	7.1	0.6	6.3	2.0	1.1	0.1	2.1	21.9	36.0	4.6	0.0	2.8	0.4	0.0	1.5	8.2	5.4	2.8	1.5	9.6	4.1	21.1	243.2	1.1	4.2	2.6	0.1	0.9	34.1	0.9	0.0	4.4	0.0	4.3	0.8	0.4	0.5	0.0	0.3	2.3	1.4	0.4	7.0	0.2
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781006-104928155	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 13.1;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 34.1;U-87 MG: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	24.7	36.5	12.0	11.0	29.1	20.7	13.3	14.4	12.5	7.4	4.1	16.3	4.5	5.6	8.2	4.9	8.0	15.0	4.6	10.4	13.7	7.2	38.7	12.3	8.9	19.5	26.2	8.9	4.0	1.8	2.5	22.7	19.0	4.1	9.9	3.7	5.7	5.0	10.9	13.4	8.1	7.6	16.4	7.1	6.7	3.6	27.3	11.0	5.1	3.4	5.4	19.7	7.6	20.7	0.0	5.6	4.6	0.0	13.1	4.9	4.1	5.9	22.6	1.9	2.1	0.8	0.8	8.2	6.4	5.9	21.7	0.0	2.5	0.3	1.7	0.0	0.0	0.9	1.9	20.3	23.5	0.0	13.8	34.1	1.5	22.7	0.4	21.6	2.2	0.7	0.0	20.2	0.5	0.8	5.2	11.1	6.5	1.2	1.7	0.1	0.0	0.4	3.7	3.9	0.7	0.2	6.2	1.0	1.2	8.7	0.1	4.1	2.1	6.0	0.4	8.0	6.5	7.9	4.0	4.8	79.0	0.0	0.1	2.4	0.8	13.1	0.1	1.0	0.2	1.2	0.3	0.0	0.2	1.5	0.6	0.0	10.6	0.1	1.7	0.1	0.1	0.2	12.0	29.1	14.4	12.5	10.4	13.7	19.5	26.2	19.0	16.4	27.3	20.7	35.8	105.8	9.3	71.5	21.1	29.7	5.9	6.3	61.5	18.4	4.6	7.0	8.9	22.8	11.7	11.0	47.9	31.1	2.4	8.4	0.0	4.5	1.9	17.1	76.0	18.7	9.1	1.3	8.1	1.5	6.9	44.0	14.3	29.4	46.9	3.6	31.4	175.5	75.0	0.0	22.5	2.2	8.2	169.1	109.5	2.5	31.1	74.8	26.6	38.4	6.4	0.5	0.0	57.8	7.7	4.9	5.0	28.2	2.2	2.6	0.1	18.0	8.4	6.7	46.0	24.3	23.4	1.0	1.8	17.1	19.5	8.9	6.5	39.5	3.2	13.3
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 231.0;Excitatory neurons: 91.9;Fibroblasts: 64.3;Inhibitory neurons: 112.4;Late spermatids: 93.1;Microglial cells: 187.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.3;HUVEC TERT2: 1.3;RT4: 1.3;U-2197: 2.1"									HPA014535	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	8.7	1.7	2.2	0.0	3.1	0.0	10.4	4.8	6.6	4.1	2.4	2.8	1.1	3.2	2.6	2.7	12.7	3.5	7.2	2.9	2.3	1.8	4.5	3.0	0.6	4.0	2.3	18.3	2.7	0.4	2.6	0.2	4.7	2.2	4.0	3.4	5.6	0.6	6.4	4.6	3.0	1.9	1.6	1.1	2.4	3.5	3.8	0.8	5.5	2.3	0.7	3.2	4.2	3.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	1.3	0.2	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	4.8	6.6	2.9	2.3	4.0	2.3	4.7	1.6	3.8	3.8	4.3	0.0	3.2	2.6	0.3	1.0	0.5	1.1	1.2	6.7	1.8	2.3	3.9	1.5	0.2	0.0	25.0	0.0	1.2	6.9	0.0	0.6	231.0	2.1	0.7	1.9	4.9	0.0	91.9	0.2	0.0	64.3	2.0	3.3	0.0	6.9	0.4	1.8	0.1	0.0	112.4	3.7	0.0	0.0	3.3	93.1	51.0	1.0	1.8	187.4	1.6	1.9	4.1	26.2	13.5	0.4	0.4	11.7	0.7	0.3	5.6	0.5	3.1	9.0	0.0	6.1	4.5	8.1	2.6	1.1	0.4	0.0	0.6	18.9	0.7	0.5
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"brain: 543.0"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.0	6.0	90.2	4.2	269.7	6.7	6.3	194.3	189.0	5.9	0.0	7.9	3.0	4.3	4.5	3.3	6.2	5.9	9.1	92.4	101.3	7.1	7.4	6.2	4.6	284.9	211.4	3.2	9.3	13.4	23.4	3.1	255.1	7.1	2.2	2.7	8.4	4.7	7.3	6.6	6.5	2.4	135.7	9.5	11.6	2.9	204.9	2.9	15.2	3.5	1.8	5.6	5.3	543.0	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	90.2	269.7	194.3	189.0	92.4	101.3	284.9	211.4	255.1	135.7	204.9	543.0	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992834-94121148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"choroid plexus: 144.6;retina: 461.0"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	6	"hippocampal formation: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.5	0.0	0.4	0.1	0.3	0.0	0.8	1.1	0.7	0.5	144.6	0.2	2.5	0.1	8.4	0.2	0.4	0.1	0.2	9.3	0.1	8.7	0.9	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.1	0.6	0.2	0.2	0.1	461.0	0.0	1.4	0.1	2.1	2.9	0.0	0.1	0.1	0.1	1.0	1.4	0.3	0.4	0.0	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	6.8	0.3	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.3	0.7	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.9	0.5	0.0	1.2	0.0	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	3.0	0.1	3.1	0.3	0.0	0.1	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.7	9.3	0.1	0.4	0.5	0.2	0.1	1.4	0.4	1.2	0.0	1.1	1.3	0.0	0.1	0.2	1.7	0.0	27.9	0.5	1.3	1.1	0.0	1.8	7.3	450.4	0.3	0.0	0.0	0.0	0.0	8.8	0.3	0.1	3.1	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.9	0.0	0.2	1.4	0.3	0.1	10.1	0.6	16.2	0.0	0.3	0.0	21.9	0.0	0.0	0.0	19.7	0.0	37.3	0.0	0.5	0.0	0.0	0.0	0.4	0.0	2.6	1.3	0.4	2.3	482.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.7
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	7.6	7.7	4.0	2.9	4.2	6.4	12.2	25.9	9.8	7.9	10.2	9.4	9.5	5.4	7.0	7.0	6.1	4.2	4.7	5.4	9.9	7.0	21.4	3.9	3.4	6.6	3.8	5.7	17.9	11.4	12.5	3.4	7.3	6.0	10.0	27.3	6.7	6.3	33.4	23.6	13.6	3.1	5.3	3.9	8.6	9.1	7.0	5.8	7.4	13.8	3.9	3.5	6.9	6.8	5.1	2.3	1.8	2.8	8.7	6.3	0.6	5.1	5.6	5.3	7.8	0.7	1.8	0.0	2.7	4.5	4.2	7.3	1.2	4.3	5.9	0.1	3.4	0.0	6.0	3.4	11.6	0.0	3.1	6.2	5.2	2.2	6.0	1.1	11.7	1.8	0.0	1.9	0.5	4.3	3.2	0.0	1.8	1.9	3.4	0.4	0.1	0.4	1.0	8.3	10.0	1.5	18.6	8.4	5.0	1.6	8.7	3.2	8.6	6.0	1.7	5.6	1.1	10.3	0.3	0.4	2.4	0.0	5.5	0.3	0.3	2.1	1.3	0.0	1.8	1.1	1.7	1.5	0.2	2.3	0.9	1.4	0.9	1.5	0.0	1.8	1.2	0.6	4.0	4.2	25.9	9.8	5.4	9.9	6.6	3.8	7.3	5.3	7.0	6.8	17.7	19.2	20.3	14.4	12.5	65.4	34.9	35.1	31.3	122.3	33.9	42.8	26.4	30.0	27.8	38.6	116.7	17.3	17.7	126.7	5.9	15.6	18.9	38.6	17.4	18.3	112.7	8.4	143.1	9.8	6.0	33.1	32.6	61.8	14.0	90.3	17.2	94.4	7.4	106.0	184.6	73.7	32.6	3.7	24.4	14.4	63.6	7.0	101.4	20.6	29.9	45.6	11.3	79.9	105.3	9.3	45.6	45.9	23.4	32.1	151.1	9.4	66.0	113.4	92.1	28.7	30.3	200.8	78.1	33.8	53.6	23.7	18.2	80.7	30.4	41.8
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867289-68955392	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 231.5;Granulosa cells: 117.3;Leydig cells: 502.6;Microglial cells: 162.1;Oligodendrocytes: 406.6;Skeletal myocytes: 216.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 31.9;ASC TERT1: 69.6;HSkMC: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	39.1	30.5	12.6	2.8	28.1	0.0	21.3	21.0	18.3	10.0	9.6	16.4	6.2	11.9	15.6	7.6	23.7	16.9	42.1	13.6	16.1	9.5	33.7	18.2	1.1	28.2	19.8	51.5	5.7	3.8	11.1	9.0	29.0	9.5	16.9	9.2	14.8	8.6	12.3	6.2	11.8	6.6	20.7	12.4	14.3	19.5	18.4	4.5	17.0	26.7	3.0	16.3	14.6	58.1	0.0	0.0	3.9	0.0	31.9	69.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	12.0	0.0	0.0	53.5	0.0	0.8	0.0	0.4	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	28.1	21.0	18.3	13.6	16.1	28.2	19.8	29.0	20.7	18.4	58.1	22.6	51.3	1.1	0.7	0.0	6.0	1.8	0.0	2.8	5.0	0.7	1.0	18.8	0.0	4.3	0.0	2.1	0.2	0.3	0.0	0.0	0.0	4.8	0.4	14.0	6.8	0.0	0.0	0.5	0.0	0.1	231.5	3.1	0.3	1.3	117.3	5.7	48.1	1.1	5.0	0.6	0.0	0.0	1.9	9.4	19.4	502.6	2.6	1.8	162.1	0.0	100.3	0.0	0.5	406.6	0.0	0.0	70.3	1.9	0.4	0.0	0.1	0.0	3.3	39.5	216.6	44.5	5.1	1.7	2.5	4.7	0.3	2.1	60.9	0.0	0.4
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69060949	"Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 55.5;Fibroblasts: 86.6;Inhibitory neurons: 73.2;Leydig cells: 96.3;Microglial cells: 227.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 21.8;ASC TERT1: 47.7;HSkMC: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	33.7	4.1	2.8	1.4	5.1	1.8	22.3	7.7	8.0	14.7	6.3	12.4	1.8	11.2	8.9	4.8	20.6	8.2	22.6	3.0	1.4	2.7	11.9	8.8	2.3	3.1	1.2	27.4	3.5	2.3	4.9	1.2	4.5	3.3	4.0	8.4	9.0	2.8	13.1	9.2	6.6	6.6	1.2	1.6	7.8	5.2	3.5	2.5	11.1	10.6	1.1	10.9	12.7	7.7	0.2	0.4	0.8	0.8	21.8	47.7	0.6	0.4	0.4	0.0	0.4	0.5	0.5	0.6	0.2	0.8	0.3	0.5	0.4	0.7	0.2	0.3	0.4	0.6	2.4	0.6	2.3	0.9	1.3	17.0	0.5	3.6	0.3	0.9	4.8	0.6	0.8	1.3	0.1	0.3	0.3	2.1	0.3	0.2	0.4	2.2	0.1	0.3	0.3	1.9	0.7	0.6	0.5	0.3	0.3	0.4	0.4	0.8	2.0	1.3	0.5	2.3	0.5	1.0	0.5	0.4	0.4	0.5	2.4	0.5	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.0	0.1	0.0	0.0	2.8	5.1	7.7	8.0	3.0	1.4	3.1	1.2	4.5	1.2	3.5	7.7	7.4	0.0	1.5	2.6	0.5	1.8	0.3	0.1	1.2	3.9	0.7	0.8	3.9	1.5	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.1	1.3	0.4	2.1	2.6	0.0	0.0	55.5	0.0	0.0	86.6	2.0	1.4	0.0	2.2	18.5	11.4	0.3	0.0	73.2	0.1	0.0	1.3	5.1	3.6	96.3	4.9	0.0	227.7	0.0	7.9	1.0	6.0	10.9	0.2	0.0	15.4	0.2	0.1	0.3	0.0	1.7	5.6	13.1	26.3	7.1	1.3	0.8	1.3	1.6	0.0	0.5	26.3	0.1	0.3
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558707	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HL-60: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	8.9	6.0	4.7	8.9	4.8	60.1	7.9	6.6	6.4	6.8	5.0	11.1	17.2	6.9	4.6	8.3	7.9	6.7	7.9	4.4	4.5	9.8	19.0	8.8	11.0	4.8	4.7	5.5	7.3	9.4	3.4	11.3	4.6	8.4	11.3	6.4	6.7	7.3	12.9	8.1	13.9	9.2	4.3	8.6	10.1	3.8	5.2	8.2	7.5	10.9	9.6	8.5	6.3	5.7	25.1	14.6	11.9	9.8	19.9	17.1	51.6	22.5	16.8	20.0	18.1	15.1	18.7	27.3	20.1	20.7	8.2	21.1	25.8	18.6	20.1	18.7	32.5	30.0	12.2	19.3	14.2	101.9	16.1	11.8	15.7	12.2	14.1	12.1	21.9	47.9	65.2	61.0	20.8	7.9	26.1	57.9	15.9	28.8	12.3	23.4	23.5	29.0	16.2	15.9	8.8	13.3	17.6	19.4	28.6	7.3	15.0	35.0	17.0	21.5	13.5	13.5	31.2	14.9	11.9	23.7	11.3	17.5	13.8	0.5	0.6	0.8	0.7	0.8	1.0	0.5	0.9	1.1	0.8	0.6	0.8	1.0	0.1	0.4	0.6	0.9	0.8	0.3	4.7	4.8	6.6	6.4	4.4	4.5	4.8	4.7	4.6	4.3	5.2	5.7	6.9	9.6	2.0	16.0	3.8	3.2	2.7	4.3	3.4	6.8	6.4	4.2	11.5	5.7	5.5	0.0	12.5	6.5	7.9	13.5	1.9	4.6	0.2	6.3	8.7	6.5	10.2	170.0	21.9	5.3	10.4	5.0	6.1	6.0	5.7	3.5	8.6	19.2	9.1	10.1	27.3	10.6	2.0	13.3	6.6	0.5	5.0	8.3	8.8	10.3	16.8	3.6	4.1	31.2	30.3	4.7	8.8	4.5	5.5	8.4	13.5	4.9	12.1	4.8	6.6	5.4	6.8	4.2	4.5	8.3	5.1	3.6	5.9	2.8	11.5	3.7
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168915498-169031324	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 80.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;RT4: 1.6;TIME: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.5	0.0	0.3	0.1	0.3	0.0	0.6	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	80.8	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	6.2	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.4	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.2	0.2	1.0	0.6	0.5	0.3	0.2	0.3	0.0	41.7	44.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	19.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	16.5	0.1	0.0	1.8	0.0	2.7	0.8	0.0	0.0	6.6	0.0	0.0	24.0	0.0	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.1	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.6
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051048-75156732	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	12.6	13.5	5.0	7.7	5.9	11.1	11.8	8.2	7.6	11.4	9.8	13.8	16.0	10.9	5.0	11.6	11.2	7.4	22.0	5.5	6.1	10.1	14.8	9.8	12.0	6.4	6.0	12.3	9.6	11.0	8.6	7.5	6.2	8.5	9.6	9.8	10.0	6.9	31.4	12.9	11.8	8.8	6.1	10.9	12.3	4.1	5.4	14.0	9.5	22.2	11.1	10.5	10.9	6.8	17.0	16.2	12.2	20.9	14.1	25.5	7.0	8.9	14.6	12.3	22.4	18.5	24.5	25.8	22.8	9.2	21.2	18.8	25.6	18.5	12.0	26.0	33.2	16.8	29.2	17.3	8.2	24.7	13.7	15.9	16.3	12.8	16.7	21.3	23.1	26.2	18.9	31.1	9.8	10.5	24.4	26.1	26.8	26.3	30.5	21.4	26.9	30.5	12.7	13.2	17.7	14.1	27.4	23.5	17.8	20.0	10.2	22.9	10.3	11.3	22.9	23.2	12.4	10.1	27.5	21.2	10.1	35.8	9.4	9.6	26.9	10.0	15.7	25.6	16.6	24.7	16.7	16.7	29.0	28.2	28.7	21.1	2.4	17.5	20.4	18.2	27.2	19.2	5.0	5.9	8.2	7.6	5.5	6.1	6.4	6.0	6.2	6.1	5.4	6.8	12.0	9.6	10.4	48.0	26.6	15.8	14.5	16.0	19.9	10.9	10.9	9.9	46.8	14.3	14.2	11.0	6.2	23.0	19.0	8.2	11.7	17.5	0.4	8.4	12.8	11.9	13.8	26.9	37.9	13.5	11.6	13.9	9.7	10.1	22.2	20.6	9.3	11.8	20.1	25.2	39.0	10.5	8.2	26.1	16.7	0.8	14.6	19.2	10.6	45.0	22.9	12.4	6.2	43.7	46.6	11.6	7.9	13.2	14.3	10.6	15.9	19.9	10.7	7.9	32.9	19.6	13.8	5.5	10.9	16.1	16.1	22.3	14.5	19.2	17.9	11.9
ABCB8	"EST328128, M-ABC1, MABC1, MITOSUR"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	10.3	20.4	9.3	8.4	10.3	8.1	8.6	9.7	13.7	16.6	11.3	12.1	10.9	14.9	7.9	18.3	11.0	6.0	13.2	9.5	8.6	15.0	22.3	10.8	7.5	11.5	10.3	11.6	10.0	11.5	19.6	8.4	12.2	11.0	5.3	8.7	8.9	6.6	7.9	10.6	11.3	7.1	8.3	11.2	12.2	12.4	11.1	7.2	15.6	5.8	6.2	8.9	10.6	14.3	26.1	40.1	10.1	32.3	15.8	9.2	20.0	13.6	13.8	20.6	21.9	16.1	42.7	13.8	17.7	14.4	25.2	27.1	15.0	28.1	9.3	17.2	16.5	10.9	16.2	19.7	10.3	8.5	25.9	15.7	20.8	25.1	10.3	7.8	21.4	29.5	57.8	18.3	16.1	58.4	32.3	15.9	6.9	19.6	45.8	14.8	6.4	49.0	14.2	10.9	9.8	19.6	14.5	40.4	13.0	7.9	15.6	11.0	13.3	19.3	5.1	14.1	20.6	18.7	9.8	9.8	27.6	19.9	20.2	11.8	3.2	2.5	4.9	4.7	3.4	2.8	3.4	3.9	4.3	2.1	3.1	4.4	0.7	3.0	3.3	7.1	3.8	2.8	9.3	10.3	9.7	13.7	9.5	8.6	11.5	10.3	12.2	8.3	11.1	14.3	7.3	12.8	1.1	16.6	12.1	3.7	6.6	10.6	6.2	24.9	6.4	4.7	7.0	7.2	7.2	11.0	37.5	36.2	12.0	28.5	3.9	15.9	3.1	14.8	12.8	4.8	0.0	13.7	15.9	20.0	22.5	9.8	36.7	12.1	49.6	57.8	6.1	25.2	28.0	30.3	17.8	14.0	18.3	6.0	3.9	2.8	6.5	8.2	8.8	2.8	9.7	9.0	17.5	7.1	11.8	21.5	8.5	12.4	22.9	7.0	20.6	14.3	8.8	36.6	26.3	8.9	9.5	9.9	13.5	12.0	7.4	81.8	11.3	28.1	18.7	7.6
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;testis: 17.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.3;Inhibitory neurons: 41.7;Plasma cells: 92.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6;memory B-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"GAMG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.0	3.1	11.9	1.6	10.4	3.4	3.9	19.7	20.4	3.1	0.0	2.4	2.7	3.0	4.9	2.9	2.9	2.5	4.9	8.2	7.5	3.6	1.2	1.6	1.6	7.3	9.1	4.0	3.2	2.8	11.6	1.8	6.0	3.5	2.1	7.3	5.6	2.8	1.6	3.3	3.4	2.0	2.1	3.6	3.4	17.8	16.0	1.3	3.0	1.2	1.9	1.9	3.1	10.6	4.7	8.6	4.7	4.5	2.0	3.8	2.2	3.0	4.3	5.1	3.2	3.7	5.3	5.2	3.4	2.8	25.9	4.3	3.5	7.2	2.0	1.0	7.0	22.9	7.7	5.9	2.2	1.1	9.0	5.3	2.8	7.5	2.3	12.5	5.7	5.1	4.6	3.8	2.9	10.6	1.7	2.2	1.5	5.0	8.4	6.4	1.3	5.0	2.6	3.1	5.0	1.5	1.5	10.7	10.7	1.8	12.6	1.6	2.5	3.6	12.2	11.5	8.8	12.3	7.4	1.5	6.3	2.5	20.2	2.6	0.3	0.3	0.3	0.1	0.8	2.5	0.3	0.3	0.2	0.5	0.6	0.6	0.7	0.2	0.1	0.1	0.2	0.8	11.9	10.4	19.7	20.4	8.2	7.5	7.3	9.1	6.0	2.1	16.0	10.6	9.7	6.4	4.6	13.4	15.9	3.2	2.8	1.5	8.6	10.7	3.9	5.0	2.0	0.0	2.5	3.7	14.6	5.2	3.4	1.9	0.0	3.8	8.9	2.6	2.6	4.0	1.2	2.1	46.3	1.5	1.8	2.0	4.1	5.6	2.5	3.0	2.9	1.2	1.1	6.7	41.7	1.1	0.0	1.0	2.1	23.2	2.8	1.8	5.4	7.5	0.3	20.0	2.1	4.0	18.1	2.5	0.1	2.6	92.2	2.1	4.1	0.9	0.7	5.3	6.6	2.1	3.7	9.6	3.5	3.3	3.1	1.4	3.9	2.9	2.6	1.8
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	10.4	11.6	0.3	4.0	0.2	3.6	8.6	0.3	0.7	10.4	4.1	16.1	1.1	11.0	0.1	22.8	7.0	3.1	11.2	0.3	0.5	8.0	2.3	15.5	4.4	1.1	0.8	8.9	8.9	3.6	7.2	2.0	0.7	15.2	0.7	0.4	9.2	0.9	21.2	9.7	12.4	6.3	0.5	15.7	15.0	13.1	0.6	4.3	21.0	0.1	1.1	15.4	12.8	0.9	4.3	43.7	0.3	11.7	3.2	4.5	0.5	15.4	19.0	13.1	13.8	6.7	34.8	7.0	79.6	29.6	11.0	12.1	3.4	12.4	4.6	22.2	4.4	16.4	22.0	16.3	25.1	5.9	39.5	15.0	9.0	1.1	2.3	3.8	10.2	28.6	17.8	6.8	0.5	5.4	12.0	0.9	3.5	1.8	8.2	41.9	7.8	5.3	0.7	15.2	6.4	11.8	18.9	17.8	3.6	11.9	6.2	0.8	3.5	0.4	2.0	11.4	11.9	13.5	7.4	3.3	6.6	0.6	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.5	1.1	0.8	0.7	0.5	0.6	0.9	8.6	25.6	5.6	10.7	13.1	8.8	8.5	18.2	9.6	3.1	4.4	3.7	6.0	4.3	14.4	5.5	22.9	0.9	9.8	2.7	3.9	9.1	11.0	15.7	12.9	8.6	18.6	16.0	26.6	6.2	3.2	12.3	49.5	17.8	22.1	16.8	8.6	0.4	8.5	5.0	38.5	6.6	14.2	21.4	9.1	14.3	7.5	12.2	3.6	11.2	10.5	1.2	5.2	12.1	15.9	11.2	4.5	6.8	15.7	18.7	0.5	1.1	9.9	8.8	0.0	6.4	5.1	4.9	6.6	18.1	5.1	0.5	17.4	37.1	3.7	11.6
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	17.7	18.0	8.2	17.9	7.5	8.9	19.6	24.2	14.4	16.6	12.7	9.4	13.2	8.3	16.3	11.8	6.8	12.4	17.5	17.0	15.5	10.1	10.8	8.7	17.0	17.0	17.6	19.5	5.0	19.6	7.7	17.3	17.3	7.6	4.5	12.7	7.6	7.8	11.0	13.0	8.6	15.7	15.5	13.5	9.2	17.6	8.3	12.8	3.4	7.4	16.2	13.8	17.3	13.3	6.7	8.7	19.9	18.8	12.0	9.0	13.7	9.6	10.1	8.6	14.9	5.6	2.8	15.9	16.7	7.9	16.5	5.8	10.6	7.2	17.1	11.7	9.5	8.4	29.8	11.5	13.2	13.7	20.9	13.9	13.5	7.4	10.0	13.8	8.9	11.3	14.9	12.1	13.1	7.8	20.3	5.6	32.1	8.0	3.9	2.3	9.8	11.7	21.6	12.1	9.8	8.1	11.5	10.2	7.6	11.3	12.8	14.4	12.4	4.2	11.6	16.6	13.3	6.2	6.9	5.8	9.4	5.9	5.0	1.9	2.2	2.9	0.6	1.3	1.0	2.2	2.6	1.1	0.9	1.2	1.8	0.7	1.3	1.5	0.8	2.8	1.8	18.0	17.9	19.6	24.2	17.5	17.0	17.0	17.0	17.3	15.7	17.6	17.3	4.6	3.2	5.6	15.7	5.6	1.1	5.9	6.7	10.2	9.3	3.2	3.8	2.5	4.3	3.4	0.0	10.4	7.1	6.6	5.4	1.9	4.5	1.3	4.9	5.5	5.1	7.8	1.7	16.0	3.3	6.0	4.1	15.3	4.9	6.3	11.8	6.1	2.0	6.9	11.8	14.9	3.6	4.1	4.1	3.3	0.8	7.5	5.2	3.6	9.4	3.4	2.1	13.4	13.6	11.1	4.7	6.1	6.0	7.1	2.1	5.4	3.4	9.9	5.6	0.0	3.3	3.7	2.2	4.5	4.7	1.8	4.4	7.9	14.4	5.4	2.8
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48081006-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.4;Excitatory neurons: 5.1;Late spermatids: 2.2;Spermatocytes: 6.0;Theca cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043100	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692253	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.1;liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.1;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.1	59.1	0.1	3.4	1.8	0.8	4.2	0.2	0.7	2.1	0.0	18.9	12.0	1.1	1.8	7.5	1.0	11.9	0.9	0.3	0.3	8.0	50.4	4.8	1.9	5.9	0.8	0.7	22.6	0.8	0.8	1.1	3.5	5.9	8.7	0.4	7.0	5.5	0.2	7.1	11.9	1.3	1.7	3.4	17.1	1.0	2.5	0.3	5.5	0.0	1.7	6.3	3.6	2.4	5.7	79.4	0.0	0.3	4.4	6.9	0.1	10.4	13.1	0.7	0.7	4.2	60.6	0.0	8.0	20.6	14.5	14.5	0.0	1.0	1.0	0.0	0.0	1.7	36.9	24.2	17.2	0.0	0.0	7.5	5.6	2.9	6.2	8.5	1.4	0.0	0.2	0.0	8.0	18.9	0.0	0.0	0.1	89.7	10.1	0.1	0.0	0.3	33.4	34.2	0.1	0.6	19.2	3.1	0.0	0.1	2.6	0.0	17.3	0.5	3.4	0.2	8.5	0.1	0.0	0.0	8.2	0.0	0.9	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.3	6.4	0.1	0.5	5.4	0.1	1.8	0.2	0.7	0.3	0.3	5.9	0.8	3.5	1.7	2.5	2.4	0.7	19.2	5.5	0.0	1.8	9.4	122.2	47.1	42.7	1.6	1.9	6.9	3.1	231.6	19.5	14.7	0.0	0.4	0.0	265.1	5.9	100.1	82.9	5.9	8.8	2.7	23.5	0.0	4.3	106.1	3.7	3.6	271.7	30.5	0.0	3.1	3.9	192.9	26.1	1.7	0.9	96.2	12.2	33.0	11.4	118.6	9.0	31.6	3.6	2.8	8.7	2.9	1.0	0.5	0.5	105.9	194.7	3.0	2.1	104.6	57.2	10.8	2.7	0.3	0.0	1.9	5.6	0.9	0.8	12.7	10.5	1.0	2.6	0.1	111.0	118.4
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724856-153744755	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 36.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035214	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA035214: "	"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	14.6	33.3	3.1	5.4	3.9	4.7	12.5	3.4	3.8	7.5	2.2	14.7	10.6	33.2	1.7	3.7	9.3	3.4	11.9	2.9	3.4	7.0	13.3	7.6	3.9	4.4	3.6	5.4	11.9	2.1	10.0	4.7	4.8	9.9	1.8	0.5	6.2	5.6	20.5	4.4	17.4	4.8	3.1	13.8	7.2	19.0	5.5	4.3	6.0	4.6	1.7	11.9	6.1	4.2	13.2	4.0	2.6	11.2	7.4	3.2	34.3	6.3	6.8	4.2	7.4	2.6	7.1	3.5	69.7	8.6	11.3	1.7	1.6	1.4	0.5	11.8	2.1	10.3	42.1	34.1	9.8	6.4	22.4	6.2	1.7	4.8	0.4	4.4	6.7	4.7	6.0	12.4	5.9	4.7	4.5	6.1	3.3	3.2	50.0	7.8	6.2	5.7	3.2	1.4	2.8	11.5	16.4	49.2	26.4	3.0	3.7	10.8	7.9	5.5	7.4	14.3	7.0	12.2	5.7	8.4	6.9	21.7	7.8	0.4	3.2	2.5	0.8	3.0	4.0	1.0	1.0	1.2	2.7	0.7	1.1	0.8	1.7	0.7	2.8	1.7	0.3	2.5	3.1	3.9	3.4	3.8	2.9	3.4	4.4	3.6	4.8	3.1	5.5	4.2	5.0	0.0	1.1	3.6	3.8	3.2	1.6	1.6	0.6	2.2	2.7	2.8	2.4	2.8	2.2	3.7	2.1	12.2	4.8	9.5	0.0	3.8	0.7	2.0	3.5	3.4	6.0	3.6	0.5	6.9	19.5	4.5	3.6	4.0	0.0	6.9	5.7	6.8	12.6	8.4	0.9	5.0	2.0	15.9	8.4	2.7	4.1	12.3	1.8	0.0	5.9	2.4	0.0	0.0	1.2	5.0	2.1	5.7	2.4	0.8	39.2	2.8	1.2	0.7	6.6	2.3	2.8	3.8	4.8	0.8	1.3	27.4	4.0	7.8	5.5	1.4
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418389-94518666	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA		12000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	16.8	18.7	19.8	16.2	23.2	25.1	32.8	22.7	24.3	22.4	22.6	44.6	44.5	14.7	21.2	26.7	16.7	26.8	26.0	18.7	21.8	59.4	126.6	23.3	13.3	22.1	21.2	10.1	28.6	29.6	13.3	14.4	22.7	21.5	40.2	26.3	17.5	27.0	23.5	35.5	46.1	17.7	23.7	11.0	43.5	16.3	21.4	47.5	27.5	29.8	21.2	22.9	16.2	27.3	81.5	37.6	37.8	36.1	28.3	31.0	55.8	41.4	32.0	46.8	51.5	117.5	25.0	49.8	52.1	52.8	50.0	58.2	43.7	53.7	64.9	40.1	36.9	56.7	52.3	102.5	27.5	51.2	17.0	26.2	29.6	54.2	20.8	30.2	29.0	47.0	25.8	29.2	48.6	11.4	86.4	26.8	43.7	61.7	50.7	48.0	78.4	19.4	45.6	122.2	28.5	46.7	71.5	75.2	55.7	28.4	27.7	41.8	28.9	34.5	49.5	61.3	55.9	16.5	16.5	48.4	27.1	25.6	16.4	0.4	3.8	2.9	4.2	4.3	4.0	1.8	3.8	4.9	5.9	1.8	4.5	4.4	0.9	5.9	3.8	1.5	4.6	3.3	19.8	23.2	22.7	24.3	18.7	21.8	22.1	21.2	22.7	23.7	21.4	27.3	16.9	35.3	48.8	64.3	10.2	23.3	16.2	32.8	14.8	27.5	43.7	21.1	39.1	58.6	43.2	42.3	22.9	25.0	12.3	72.1	23.5	22.8	9.0	37.5	16.8	16.4	39.7	8.4	32.7	44.5	12.0	18.3	37.8	30.6	27.9	19.1	18.2	108.9	11.0	33.7	47.5	37.5	26.4	21.9	7.4	8.2	13.7	15.0	16.0	40.3	15.1	78.4	11.3	67.3	96.5	37.5	33.0	24.5	15.4	20.4	75.7	72.3	49.8	26.3	19.7	19.0	17.7	14.5	23.2	21.0	34.0	15.3	15.4	16.7	39.5	32.5
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285269-74303055	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	6.6	4.7	3.0	3.9	3.4	4.6	6.4	4.0	5.4	5.8	2.9	5.4	8.8	4.9	2.1	4.8	8.5	7.7	6.0	3.0	3.3	5.4	7.7	5.8	6.6	4.2	3.4	6.9	6.0	3.8	3.9	7.4	3.7	3.6	4.0	3.3	4.0	3.5	3.9	4.1	8.7	5.2	2.8	6.2	4.5	3.4	3.6	5.5	7.2	2.0	3.8	4.5	4.3	4.5	2.6	3.1	7.9	6.2	6.4	4.3	9.8	3.9	5.6	5.8	6.0	6.5	13.7	4.3	7.4	5.9	3.2	9.2	6.0	5.4	3.0	3.9	3.8	2.3	5.1	5.2	2.1	2.9	4.4	10.4	2.4	4.1	2.8	3.0	9.9	5.4	4.3	1.9	4.5	4.3	7.1	5.6	3.0	5.0	5.9	9.7	11.4	6.3	8.6	8.5	3.7	7.3	5.4	5.3	5.5	3.7	12.3	1.7	9.7	3.6	7.0	3.2	2.5	4.4	4.5	3.3	5.1	4.3	4.5	6.0	1.3	1.8	2.6	1.2	1.7	1.9	2.2	2.9	2.1	1.8	1.2	1.8	1.1	2.6	1.0	4.0	5.2	1.4	3.0	3.4	4.0	5.4	3.0	3.3	4.2	3.4	3.7	2.8	3.6	4.5	50.0	28.9	18.6	32.3	16.7	15.6	14.8	23.0	12.0	46.5	21.4	14.2	9.7	34.3	21.2	20.2	64.6	51.6	28.9	31.4	9.8	25.3	10.3	27.9	23.5	50.2	12.0	9.9	29.6	11.3	19.9	23.0	13.7	20.1	20.3	43.2	44.6	23.3	51.1	32.0	34.7	15.7	18.3	24.8	27.1	7.7	40.4	19.5	21.4	20.6	22.8	36.4	32.0	23.6	38.1	17.9	19.4	25.2	13.3	12.6	60.1	23.9	19.5	55.5	32.9	23.3	19.1	35.8	27.2	10.6	10.7	28.5	23.4	27.9	22.9	16.7
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151211484-151227205	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA		51000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	19.0	18.8	16.1	11.1	16.2	7.6	14.8	15.1	19.5	13.8	14.2	18.8	6.0	16.6	12.1	19.2	14.4	8.9	27.9	16.0	16.7	20.2	12.3	14.6	11.6	18.0	16.5	15.0	15.0	14.3	17.0	10.3	17.3	16.1	10.8	10.8	14.2	10.2	61.2	16.3	13.4	14.1	16.2	15.6	16.6	18.7	16.5	11.5	13.8	20.2	15.2	19.5	13.9	16.9	33.0	50.3	18.8	66.0	36.6	31.1	25.1	40.6	33.0	49.9	42.1	47.9	22.1	57.4	34.3	42.8	40.9	25.2	58.9	47.8	49.5	28.1	48.8	23.1	26.3	27.4	43.3	58.0	35.7	42.3	39.6	54.6	34.4	21.2	40.7	32.5	68.4	22.9	43.2	80.1	60.4	70.3	46.8	37.6	54.5	40.3	30.1	50.5	35.4	24.0	32.9	31.0	39.5	37.5	26.8	19.5	16.2	29.0	40.7	31.7	12.8	39.6	61.7	46.9	54.5	42.7	43.5	56.4	60.3	7.9	11.3	3.8	13.8	13.3	19.5	11.9	14.2	13.7	13.1	13.1	13.3	13.8	1.6	14.5	15.1	9.8	15.8	14.7	16.1	16.2	15.1	19.5	16.0	16.7	18.0	16.5	17.3	16.2	16.5	16.9	4.7	0.0	0.5	10.1	15.9	27.1	25.9	22.5	14.2	17.4	0.3	0.6	23.5	7.2	9.5	0.0	8.4	29.5	10.0	28.4	0.0	0.0	47.0	0.1	0.1	12.8	6.7	18.3	12.6	0.0	28.8	13.8	16.3	0.0	10.2	0.0	12.5	12.9	20.7	10.1	12.6	9.1	12.2	10.4	11.5	55.9	10.5	6.7	19.6	7.5	6.2	14.1	14.4	7.1	10.4	0.0	18.9	14.7	14.0	29.8	15.7	0.0	6.6	16.9	13.1	25.7	15.1	31.0	12.4	21.5	25.1	32.3	10.9	0.1	15.1	19.6
ABCF2-H2BE1		ENSG00000285292	"ABCF2-H2BE1 readthrough"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol		NA	NA		51000	"Cluster 16: MAIT-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		12.0	8.1	1.1	11.1	1.6	5.5	9.0	2.1	6.2	7.4	2.9	9.5	6.7	8.4	2.9	10.1	9.0	7.6	9.8	1.5	2.0	9.7	7.4	8.6	11.4	1.5	1.6	6.0	4.6	13.9		8.3	2.3	7.2	10.3	10.0	5.4	9.5	30.7	9.0	5.7	11.9	1.9	9.5	6.0	6.8	2.1	10.2	9.5	20.9	13.8	14.4		2.8	45.0	54.8	27.0	71.0	38.7	38.6	22.4	57.1	38.5	43.7	45.1	40.5	33.8	66.4	44.1	59.7	61.1	34.7	57.9	55.3	61.0	29.9	31.8	37.1	30.6	26.6	57.8	76.5	25.8	40.8	40.8	72.5	50.5	28.6	55.4	35.8	89.1	28.4	57.6	68.1	88.9	23.1	36.5	58.4	50.1	36.5	34.6	68.3	21.9	33.8	21.9	34.8	59.5	44.0	30.3	25.1	21.2	33.9	47.5	33.4	11.4	45.2	73.6	41.6	47.5	64.7	55.4	64.7	49.0	22.5	21.3	6.0	22.5	19.1	45.7	17.5	27.9	26.3	24.8	19.9	24.8	24.3	1.6	25.5	18.5	15.4	30.2	30.3	1.1	1.6	2.1	6.2	1.5	2.0	1.5	1.6	2.3	1.9	2.1	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins, Transporters"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	16.1	56.1	10.9	13.3	10.9	16.8	15.8	11.8	13.4	18.2	9.6	15.5	15.7	15.5	12.3	20.0	17.0	12.7	28.5	10.9	12.7	19.2	22.7	14.4	17.0	13.9	12.3	20.0	23.6	43.5	21.0	16.4	12.8	16.2	13.6	14.2	26.9	19.6	46.8	19.6	16.3	12.4	9.2	17.8	17.5	16.5	12.4	14.6	17.9	41.3	16.1	17.1	17.6	11.6	49.9	30.2	16.9	32.8	48.1	26.9	33.3	35.2	39.1	46.7	36.5	52.0	19.3	29.8	69.5	38.1	54.9	46.4	26.5	37.1	24.1	38.4	25.5	25.7	26.6	30.8	40.4	29.2	25.2	39.7	33.5	33.1	32.7	27.4	33.8	25.7	24.1	34.9	33.5	60.0	28.7	18.8	25.7	51.1	41.2	28.5	28.1	50.4	25.4	29.6	29.1	16.9	36.5	69.1	33.8	18.3	93.7	25.3	33.5	24.9	27.1	39.5	53.1	39.2	40.5	38.2	38.8	28.7	31.3	8.1	29.1	22.7	32.9	30.4	34.7	23.6	29.0	27.5	25.6	23.8	36.0	29.5	14.6	24.0	32.4	15.8	27.2	37.2	10.9	10.9	11.8	13.4	10.9	12.7	13.9	12.3	12.8	9.2	12.4	11.6	10.2	9.6	2.0	6.2	17.4	14.5	10.0	29.8	9.6	16.7	10.8	6.7	11.6	17.2	19.7	14.7	14.6	36.9	16.2	19.8	29.4	22.5	9.5	11.2	12.0	11.6	11.4	8.6	7.1	22.4	25.5	12.5	13.3	12.0	9.5	16.0	16.8	20.0	21.6	20.2	9.9	13.4	30.5	9.4	6.9	10.2	12.5	12.9	16.0	3.7	22.8	14.7	17.5	6.6	7.3	20.5	9.8	11.7	19.4	9.0	28.6	37.3	14.4	22.3	6.6	11.9	9.5	12.8	17.1	14.5	10.2	43.8	16.6	18.1	14.7	11.7
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 88.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6"	"Cancer enhanced"	"Detected in many"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.3	4.0	30.8	1.0	29.1	2.3	4.0	30.0	33.1	22.1	17.4	15.7	48.2	23.1	6.8	2.3	9.8	5.1	2.9	25.4	32.3	3.5	36.0	5.1	1.2	40.1	31.3	8.3	0.8	4.4	8.9	11.7	40.1	7.1	13.9	2.5	5.0	33.8	0.3	0.6	88.3	19.8	31.1	1.4	1.9	3.0	40.0	1.3	6.4	0.9	2.0	2.3	4.0	31.9	1.7	43.5	11.9	0.0	0.4	0.0	75.8	1.9	1.3	2.1	3.5	9.8	0.5	0.0	0.4	0.3	5.4	13.2	0.4	1.2	3.1	13.2	1.9	0.6	0.3	13.0	0.0	0.6	0.1	0.2	5.1	4.8	0.3	1.2	4.1	1.0	1.1	0.0	1.3	26.2	6.3	0.2	4.1	58.6	0.0	3.2	0.0	38.9	0.1	9.5	0.2	0.5	8.9	0.9	1.2	26.1	0.3	0.1	0.0	1.7	1.6	0.4	0.2	11.9	4.7	0.0	3.1	0.0	1.8	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.0	1.1	0.1	0.2	0.8	0.2	30.8	29.1	30.0	33.1	25.4	32.3	40.1	31.3	40.1	31.1	40.0	31.9	9.4	3.2	1.1	3.9	0.9	3.8	0.3	0.0	0.0	0.4	24.3	1.9	1.6	1.5	0.2	0.0	0.0	16.8	0.6	106.7	1.9	0.0	3.3	0.4	3.8	45.8	3.0	20.6	1.1	0.2	81.7	2.4	0.5	0.5	5.7	0.2	31.4	23.4	137.4	0.0	0.7	12.0	0.0	1.3	2.5	1.2	1.2	2.8	5.4	185.5	0.1	0.7	2.1	11.1	0.9	0.1	44.3	0.4	2.0	0.2	216.6	7.6	0.8	0.9	0.0	0.4	4.3	1.0	4.3	1.1	0.4	37.6	1.0	4.3	6.1	0.2
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149052-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 52.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 58.4;Inhibitory neurons: 9.8;Rod photoreceptor cells: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.9;HAP1: 1.0;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057635	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.3	0.4	4.0	0.1	4.4	0.0	0.1	7.5	11.3	0.4	0.0	0.3	0.2	0.5	0.3	0.9	0.2	0.3	0.8	4.2	5.8	0.4	0.1	0.1	0.0	6.9	3.9	0.1	0.3	1.8	0.3	0.1	6.8	0.3	0.1	52.0	0.2	0.6	0.1	0.3	0.2	0.4	1.5	0.1	0.2	5.8	6.2	2.9	0.8	0.2	0.5	0.1	0.6	5.6	0.1	0.4	0.4	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.1	1.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.4	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.4	7.5	11.3	4.2	5.8	6.9	3.9	6.8	1.5	6.2	5.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.9	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	6.7	9.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.3	2.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABHD1	"FLJ36128, LABH1"	ENSG00000143994	"Abhydrolase domain containing 1"	Q96SE0	2	27123789-27130812	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 21.6"	"Group enriched"	"Detected in many"	9	"Early spermatids: 295.1;Late spermatids: 1030.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.5;T-47d: 3.3;U-266/70: 3.0;U-266/84: 2.8"					"Low region specificity"	"Detected in all"			HPA044390	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044390: AB_10959380"	"unprognostic (1.20e-3)"	"unprognostic (6.07e-3)"	"unprognostic (7.71e-4)"	"unprognostic (1.63e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.09e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.09e-2)"	"unprognostic (7.97e-2)"	1.2	0.6	0.8	0.1	0.7	0.0	0.5	1.5	1.1	0.1	0.3	0.1	0.0	0.3	0.4	0.1	0.2	0.2	0.5	0.7	0.8	0.3	3.3	0.1	0.2	0.9	0.7	0.4	0.1	0.4	0.2	0.0	0.9	0.7	0.0	0.4	1.5	0.2	1.9	0.0	0.1	0.3	0.9	0.1	0.2	21.6	0.9	0.0	0.4	1.7	0.1	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	3.0	2.8	0.0	0.1	0.1	0.1	0.0	0.2	0.8	0.6	0.0	0.2	0.5	0.3	0.3	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.7	1.5	1.1	0.7	0.8	0.9	0.7	0.9	0.9	0.9	0.9	0.8	0.0	0.0	4.9	1.0	0.0	3.3	0.0	2.8	5.1	1.9	2.8	3.1	1.5	0.0	0.0	8.4	0.2	0.9	0.2	0.0	0.3	295.1	0.4	0.6	1.9	0.0	3.2	0.6	0.2	0.0	1.3	0.0	0.5	1.3	1.6	2.5	3.9	0.1	0.0	0.8	0.2	0.0	0.3	0.3	1030.5	6.5	1.2	0.0	1.9	0.5	8.1	3.1	2.0	2.2	0.0	0.0	5.7	0.5	3.6	0.2	3.0	0.7	4.9	0.0	2.4	1.2	70.5	3.9	0.3	0.3	0.0	1.8	0.3	0.2	2.2
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10, depalmitoylase"	Q9NUJ1	3	111979010-111993368	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		71000	"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	11.0	21.9	23.0	10.6	25.3	10.9	15.0	24.5	29.3	11.3	22.9	14.1	11.7	11.1	50.8	8.2	14.9	10.1	25.0	23.9	24.6	49.4	34.4	10.1	17.9	23.5	23.2	19.8	13.7	16.7	27.9	10.8	23.7	20.4	14.7	27.0	25.5	13.7	14.1	10.0	10.3	10.0	24.4	14.6	14.9	16.4	26.3	21.8	31.1	19.6	16.2	9.5	8.3	25.3	40.2	34.1	36.4	12.0	20.5	27.5	19.8	41.4	21.5	33.0	31.7	35.3	22.4	36.0	22.6	17.2	22.7	21.6	16.3	23.0	44.9	12.1	20.6	29.7	15.4	30.7	16.3	60.3	30.4	16.9	16.7	17.0	42.4	22.7	35.9	42.1	13.9	14.9	36.7	13.7	56.9	27.9	23.7	43.8	53.2	50.9	23.4	16.7	34.6	17.1	24.6	17.9	33.2	23.7	39.8	14.3	26.8	21.8	20.6	19.7	25.3	14.4	21.7	23.6	9.0	61.4	20.1	32.4	21.5	29.4	16.5	25.2	9.8	21.6	16.8	26.2	12.2	11.3	28.1	21.6	15.4	13.9	2.5	11.4	17.3	17.8	13.2	16.1	23.0	25.3	24.5	29.3	23.9	24.6	23.5	23.2	23.7	24.4	26.3	25.3	9.1	0.0	7.2	11.1	19.7	7.0	10.2	12.1	14.2	21.8	12.7	10.9	26.1	7.2	12.4	11.0	8.4	19.2	16.1	7.0	35.2	5.2	1.0	11.1	10.3	8.8	12.1	24.2	16.0	7.8	14.9	12.3	12.8	6.8	9.5	9.5	10.0	26.2	14.1	42.1	16.2	13.4	6.1	19.5	7.0	3.0	10.5	11.0	10.6	15.0	10.7	20.4	12.3	14.6	15.6	5.4	4.0	7.5	25.0	5.1	7.0	42.5	19.5	16.2	0.0	7.9	8.9	29.7	37.0	13.6	8.2	5.5	14.6	19.2	12.1	4.5
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.9;Urothelial cells: 241.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 92.6;SK-BR-3: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria		NA	NA		31000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA024042: AB_1844445, HPA049641: AB_2680838"	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	7.5	13.5	9.3	5.6	9.8	4.5	12.2	10.6	11.3	9.3	16.4	31.3	15.9	7.2	5.8	13.6	13.8	8.6	21.6	9.1	9.9	29.4	9.5	9.5	4.0	11.4	11.1	3.9	25.7	12.9	16.4	7.6	11.0	23.2	17.4	3.0	21.3	8.2	11.3	13.3	19.8	3.5	10.4	8.1	9.0	7.2	12.3	3.3	28.1	10.3	5.4	8.5	6.9	10.4	46.9	10.7	7.1	16.4	3.7	5.0	39.7	21.1	8.9	12.7	14.9	13.1	51.4	22.2	6.2	9.0	17.3	20.2	3.2	12.1	8.8	8.2	15.4	10.8	6.7	8.3	6.5	11.8	11.4	4.6	5.0	16.4	7.6	4.6	9.2	7.4	15.1	11.8	12.0	92.6	9.2	14.9	8.3	29.5	39.1	5.0	11.4	41.0	29.7	21.8	18.3	7.6	17.1	113.0	7.1	5.1	36.8	7.8	9.1	10.8	10.2	46.5	22.2	7.3	4.2	14.8	17.3	11.2	20.3	10.2	19.1	19.3	8.2	32.7	6.8	10.1	9.1	8.7	19.4	12.7	8.4	5.9	15.2	14.9	33.5	9.2	6.3	11.9	9.3	9.8	10.6	11.3	9.1	9.9	11.4	11.1	11.0	10.4	12.3	10.4	7.9	44.8	15.7	3.3	10.6	5.5	60.3	39.8	10.2	16.6	43.1	21.7	16.9	54.3	60.7	57.0	4.2	86.3	8.7	156.9	72.4	52.1	1.2	98.9	17.3	9.7	62.6	9.4	5.8	40.8	120.1	9.9	35.7	98.1	15.2	6.3	4.6	8.7	28.0	5.0	4.0	106.8	95.6	11.3	10.5	2.3	9.0	13.7	14.2	4.7	10.4	26.6	14.4	3.0	3.7	38.2	151.7	3.4	10.5	53.1	128.2	55.3	127.6	15.2	0.0	10.3	14.4	6.8	7.1	23.3	6.3	127.7	9.6	22.1	128.9	241.3
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12, lysophospholipase"	Q8N2K0	20	25294742-25390835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 315.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	29.5	33.0	55.7	27.4	67.3	26.5	26.9	70.0	64.7	32.1	35.9	37.0	47.0	25.3	133.1	50.0	24.8	33.4	30.5	77.3	58.2	45.5	29.8	32.6	30.8	70.9	64.6	30.6	117.8	55.3	42.1	29.6	73.3	35.5	36.4	30.8	36.9	39.9	13.3	52.4	52.8	23.6	66.0	22.0	55.0	19.2	71.8	23.4	80.8	14.8	41.5	37.2	35.1	96.9	67.2	148.3	41.6	50.9	79.6	47.1	93.3	97.0	84.5	73.7	84.6	90.1	93.0	21.8	53.3	77.0	155.1	116.5	44.4	56.8	62.8	22.7	41.9	33.3	46.8	128.4	59.3	33.3	71.6	58.7	42.0	85.4	44.1	95.7	33.2	37.8	25.8	315.3	72.8	142.5	51.8	31.0	29.4	77.8	96.8	39.2	95.3	195.0	43.4	145.7	46.6	39.7	75.4	198.9	133.8	72.3	67.4	47.6	44.6	98.3	63.0	57.1	54.0	38.8	36.1	33.4	61.8	38.7	57.3	15.8	18.8	17.3	9.9	17.0	7.5	3.8	10.2	13.7	17.9	5.1	8.9	8.9	3.6	15.4	17.7	17.0	10.4	8.6	55.7	67.3	70.0	64.7	77.3	58.2	70.9	64.6	73.3	66.0	71.8	96.9	20.7	6.4	6.5	19.2	13.8	17.7	32.0	9.8	19.4	34.5	19.6	19.7	16.6	30.0	13.7	27.6	10.4	91.6	22.2	97.0	27.4	33.7	53.0	24.9	18.1	17.5	34.0	14.5	37.7	34.3	95.2	22.9	35.2	28.3	10.2	26.9	15.0	19.5	114.1	42.1	46.0	28.9	20.3	37.8	43.8	107.1	16.1	62.4	33.8	42.2	58.7	44.1	23.7	50.8	67.5	22.9	77.7	20.7	39.3	31.6	126.7	24.6	13.1	23.3	26.3	13.8	19.5	19.9	37.7	27.2	18.3	130.8	18.0	19.6	33.3	35.2
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872053-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 6.8;retina: 15.6;skin 1: 10.5"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 188.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.0;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"thalamus: 2.1"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	0.5	0.0	2.7	0.1	6.5	1.6	1.3	0.0	2.6	0.0	0.9	0.7	0.0	0.3	0.0	0.2	1.0	0.1	0.1	1.4	1.7	0.2	0.0	0.3	0.1	0.2	5.0	0.0	0.0	0.2	0.1	0.1	1.4	0.0	1.0	15.6	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.6	6.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.7	6.5	0.0	2.6	1.4	1.7	0.2	5.0	1.4	0.0	6.8	1.0	2.4	0.0	0.0	0.3	0.1	0.4	0.1	1.5	0.0	3.4	0.1	0.1	1.9	0.0	5.0	1.8	2.1	0.1	0.0	2.2	0.0	0.0	7.7	2.5	0.2	0.7	0.0	0.0	9.9	0.0	0.0	0.7	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.1	0.0	0.0	5.8	1.2	0.1	0.0	0.0	0.0	188.1	0.0	1.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	26.4	18.1	0.0	0.1	1.2	0.3	0.2	0.0	1.4	0.3	0.1	0.0	1.8	0.2
ABHD13	"bA153I24.2, BEM46L1, C13orf6, FLJ14906"	ENSG00000139826	"Abhydrolase domain containing 13"	Q7L211	13	108218392-108234243	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032143, HPA032144"	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"HPA032143: AB_2674178, HPA032144: AB_10602304"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.62e-2)"	7.0	5.3	3.7	7.0	4.0	16.3	7.3	5.9	5.3	6.2	7.0	6.5	7.0	6.3	10.2	5.6	4.3	6.4	4.3	4.1	3.2	6.1	10.4	6.9	8.3	3.3	3.3	5.2	4.7	5.7	3.8	8.4	3.2	6.2	7.3	6.4	4.6	5.6	4.2	4.3	7.4	6.8	3.2	7.8	6.8	3.8	3.4	9.3	7.6	6.4	7.1	7.5	4.3	3.9	9.8	4.0	10.5	5.9	8.0	9.5	5.1	9.5	9.5	8.2	9.7	6.2	9.1	8.2	9.7	7.4	8.1	8.8	7.9	11.0	13.0	11.1	6.9	10.1	5.7	6.1	8.0	21.1	12.0	9.8	10.3	6.4	8.3	7.7	9.8	11.2	5.5	4.5	8.5	4.1	10.3	8.8	5.0	14.5	4.7	8.7	7.5	4.8	11.5	8.7	7.9	9.9	5.0	8.3	10.6	9.3	7.7	19.3	10.2	5.8	6.0	6.8	6.5	8.8	7.4	9.0	13.7	13.0	10.7	7.7	8.2	16.0	5.9	7.6	8.8	6.8	8.0	7.2	7.2	6.0	7.6	6.3	9.0	9.5	7.2	5.3	8.4	8.6	3.7	4.0	5.9	5.3	4.1	3.2	3.3	3.3	3.2	3.2	3.4	3.9	17.6	22.4	16.6	8.1	24.5	44.4	21.4	33.3	15.9	12.8	16.8	10.8	7.2	27.1	22.2	11.0	0.0	20.9	23.7	14.7	9.8	19.1	24.8	12.3	13.4	18.2	30.5	16.2	21.4	21.0	15.4	19.9	19.9	14.4	14.0	9.5	19.6	29.5	19.5	18.5	17.4	11.6	44.7	21.5	40.1	18.2	15.5	24.6	26.6	15.0	25.8	12.6	19.6	16.1	15.2	20.8	14.3	17.3	10.2	20.7	16.4	11.5	18.4	12.2	19.7	15.1	18.2	22.9	12.3	21.1	51.1	21.3	28.4	12.5	12.1	26.3
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 124.3;Rod photoreceptor cells: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles		NA	NA		420000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038153: AB_2675868, HPA056913: AB_2683275"	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	23.5	48.6	65.2	8.3	64.5	13.5	18.4	72.3	78.0	25.1	67.6	18.1	10.6	15.0	28.3	8.4	24.2	12.1	36.1	64.8	69.3	35.3	26.1	14.3	11.4	59.6	60.0	27.1	26.6	27.1	49.6	8.9	59.7	19.0	6.9	43.5	23.2	14.5	34.8	7.6	12.9	7.5	59.2	14.6	17.7	13.2	69.4	11.5	32.8	39.1	8.4	19.4	16.7	59.8	6.9	12.9	8.2	24.7	79.8	39.9	4.5	9.0	14.8	10.6	14.3	14.8	27.0	7.8	6.0	22.4	12.1	6.2	9.0	10.0	3.4	25.1	10.0	22.7	37.4	50.0	22.4	31.4	29.0	37.9	6.6	9.0	4.6	23.7	13.8	14.6	9.3	25.4	16.8	7.8	14.5	31.8	4.7	32.4	30.4	10.3	4.2	73.9	20.7	10.6	16.8	26.1	22.5	4.7	13.5	1.7	7.1	33.7	8.2	9.6	10.4	23.4	10.7	37.0	37.4	6.6	18.1	49.6	14.1	6.9	20.3	15.2	94.0	12.7	96.5	49.0	80.9	83.5	36.2	41.5	73.7	79.0	2.1	45.5	8.6	46.0	88.4	54.9	65.2	64.5	72.3	78.0	64.8	69.3	59.6	60.0	59.7	59.2	69.4	59.8	15.9	6.4	21.7	0.0	20.2	9.7	25.1	29.0	4.0	90.8	21.0	22.9	24.3	20.0	20.8	33.1	25.0	10.3	29.6	7.1	33.2	15.5	4.7	23.5	18.0	14.1	40.2	2.5	0.0	12.4	15.3	36.9	4.6	14.9	15.2	12.8	17.2	16.2	29.3	58.9	0.0	14.0	24.4	14.2	18.5	24.9	88.0	14.6	12.4	0.0	7.4	59.9	41.2	0.0	0.0	17.1	5.6	33.1	16.3	17.0	13.8	124.3	29.5	115.2	19.7	24.7	16.8	18.2	57.8	1.8	5.5	4.9	28.9	20.6	15.3	19.5
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.8;Collecting duct cells: 5.5;Distal tubular cells: 3.9;Proximal tubular cells: 16.8;Theca cells: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"			"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	0.5	0.8	0.1	0.1	0.1	0.0	0.4	0.6	0.4	0.2	0.2	0.2	0.0	0.6	0.0	0.2	0.5	0.1	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.2	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	0.2	0.2	0.0	0.2	0.2	0.4	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.4	0.5	1.2	0.9	0.8	0.6	0.7	1.1	1.0	0.5	0.7	1.0	0.0	1.1	0.6	0.6	1.0	0.5	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.2	1.4	0.0	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.2	3.2	0.0	0.0	1.8	5.5	0.0	0.0	0.9	0.1	3.9	1.5	0.0	0.4	1.4	0.6	0.0	0.8	1.0	1.2	0.0	1.0	2.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.5	1.2	2.0	0.0	0.0	0.0	0.0	0.2	16.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	6.3	0.0	0.0
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 313.2;Proximal tubular cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 190.8"	"Low region specificity"	"Detected in all"							"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2100000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	69.2	81.9	21.3	26.1	22.3	37.4	66.0	21.4	25.3	49.7	29.9	60.0	81.5	39.3	44.7	46.1	58.3	35.2	31.0	20.2	21.4	97.3	155.6	37.8	48.3	22.2	22.2	51.2	65.2	51.3	36.5	15.4	22.7	48.5	55.3	40.4	64.8	36.6	25.1	42.7	74.8	26.9	22.4	47.1	51.0	9.6	22.9	39.0	57.1	22.6	43.1	47.9	42.9	22.3	37.6	32.9	2.7	37.3	100.6	91.3	9.2	14.5	18.4	27.2	32.5	25.3	72.6	41.7	11.4	54.2	12.6	18.5	23.5	22.2	21.0	57.6	27.2	66.6	30.6	106.6	55.3	37.8	64.9	115.1	74.4	27.8	36.9	41.9	34.0	64.2	39.1	66.8	55.8	40.5	16.8	29.9	3.5	43.6	88.5	42.1	5.2	190.8	51.8	16.7	15.2	16.6	37.3	68.0	121.8	5.7	97.7	25.8	31.5	13.8	64.8	32.3	8.7	82.1	41.6	17.4	30.4	118.9	24.8	41.7	24.3	10.9	42.2	19.9	63.3	58.3	53.0	52.0	38.1	42.9	52.4	49.2	1.9	24.5	12.9	28.4	42.4	37.5	21.3	22.3	21.4	25.3	20.2	21.4	22.2	22.2	22.7	22.4	22.9	22.3	40.4	6.4	26.2	7.8	69.4	30.2	62.4	68.5	38.1	12.7	88.1	81.0	4.7	72.9	28.7	69.9	14.6	16.7	50.7	79.6	146.8	34.8	1.4	19.6	22.4	36.8	75.9	41.2	10.1	46.8	19.0	43.4	35.2	20.9	50.8	14.8	39.7	122.1	55.4	8.4	10.8	97.1	42.7	60.7	36.3	2.4	65.0	39.0	55.2	14.0	37.7	14.8	50.4	4.5	9.4	30.0	74.5	46.6	37.4	39.6	313.2	265.3	25.2	39.9	39.5	34.7	35.6	0.4	3.9	57.1	30.4	11.8	63.9	47.7	127.9	64.4
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567037	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 79.4;Hepatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;MAIT T-cell: 6.6;NK-cell: 10.8;plasmacytoid DC: 23.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	19.2	3.8	3.6	6.2	4.0	8.2	10.6	3.8	3.3	4.6	3.8	7.3	11.2	4.5	3.3	4.7	4.7	5.2	4.9	3.1	4.1	8.9	26.2	6.0	9.1	4.9	4.2	2.9	8.1	7.9	9.1	4.5	4.7	4.7	6.5	1.6	5.1	3.8	2.6	4.6	11.2	4.0	4.2	9.9	8.3	1.8	4.3	4.6	5.8	3.8	8.1	5.6	4.6	4.9	5.8	22.1	2.7	7.7	29.0	12.6	11.3	7.8	8.6	7.6	6.9	5.1	2.9	8.6	5.6	8.4	13.4	15.6	9.7	3.3	4.2	26.5	7.3	3.5	11.0	6.5	8.8	9.0	15.4	9.4	8.9	7.3	1.4	5.6	5.6	5.0	4.6	8.0	4.1	7.8	8.5	10.4	0.6	19.5	6.5	19.7	10.5	20.0	13.7	8.8	1.9	3.1	11.7	5.2	3.1	2.9	13.2	20.5	6.9	4.4	5.5	11.1	7.0	13.3	9.6	4.4	8.8	5.6	9.6	18.3	0.6	2.8	2.6	0.3	6.6	1.4	1.4	2.2	1.5	2.5	0.4	1.3	0.6	10.8	0.2	23.6	1.2	1.1	3.6	4.0	3.8	3.3	3.1	4.1	4.9	4.2	4.7	4.2	4.3	4.9	2.4	3.2	4.1	2.6	11.7	1.3	1.1	2.5	2.2	0.1	3.8	2.4	3.0	2.8	4.3	7.3	0.0	1.5	79.4	12.0	0.0	3.0	0.3	4.7	3.1	2.9	7.2	7.0	0.3	7.6	1.4	4.0	2.0	5.1	2.5	2.9	4.2	30.2	7.2	1.7	0.5	6.1	2.0	6.7	8.4	0.7	4.7	9.5	5.4	2.8	5.6	1.1	15.5	0.5	1.2	5.6	2.5	4.5	5.2	1.5	17.7	5.6	5.2	0.9	0.0	3.5	1.9	0.8	0.6	2.0	2.4	0.3	11.8	4.5	7.4	1.2
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.9"	"Group enriched"	"Detected in some"	77	"Early spermatids: 131.8;Late spermatids: 270.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.0;PC-3: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059272, HPA075886"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA059272: AB_2683963, HPA075886: "																		2.1	1.5	2.2	2.5	1.6	1.0	0.1	1.7	3.0	0.2	0.8	0.8	1.8	1.0	0.0	0.4	0.2	0.4	1.0	1.7	2.1	1.0	0.3	1.0	1.7	2.0	2.2	0.9	2.1	0.0	0.1	0.6	2.3	1.3	0.0	0.3	1.6	0.0	1.6	1.1	1.6	0.0	1.3	3.6	2.3	15.9	4.6	0.0	0.4	0.0	0.0	0.1	0.2	2.1	4.9	3.2	0.6	1.2	0.0	0.0	7.2	5.7	0.0	0.1	0.0	16.0	6.3	4.5	4.6	0.0	1.4	12.6	0.0	0.0	0.0	3.1	3.8	2.9	6.7	11.8	0.0	1.7	7.9	0.0	0.0	0.0	0.0	0.3	0.0	3.4	5.6	5.2	0.0	8.5	2.7	4.8	1.3	0.6	18.8	5.8	0.7	1.7	0.0	3.3	2.2	1.9	5.4	3.1	0.8	0.2	6.3	0.8	1.9	3.3	5.8	1.7	2.4	4.2	2.6	2.9	2.4	1.8	2.4	0.1	0.7	2.7	0.7	0.4	0.4	0.3	0.2	0.5	0.6	0.6	0.5	0.4	0.2	0.2	0.3	0.6	0.8	0.8	2.2	1.6	1.7	3.0	1.7	2.1	2.0	2.2	2.3	1.3	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	270.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A, depalmitoylase"	Q96GS6	19	1876810-1885496	"Enzymes, Predicted intracellular proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 338.2;NK-cells: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	49.8	51.5	61.3	8.8	50.0	13.4	44.1	53.0	104.9	43.9	16.0	50.3	13.6	46.5	2.1	63.6	42.3	4.1	79.9	70.8	36.6	47.3	42.9	52.7	10.7	66.9	54.2	41.7	42.9	7.5	45.1	11.6	60.6	52.5	2.0	1.9	40.4	8.2	56.9	73.3	41.8	3.2	56.3	69.3	45.4	33.4	61.4	8.6	43.0	10.7	3.9	45.3	45.9	56.9	43.0	14.7	6.0	16.7	7.8	9.6	32.5	28.6	8.8	8.4	7.7	7.4	7.5	21.1	11.3	8.3	1.9	26.9	3.0	11.8	1.2	48.9	61.8	15.9	6.7	19.2	10.7	16.4	50.9	10.5	8.8	4.9	3.4	5.5	16.2	20.6	27.6	23.9	6.1	24.1	28.3	31.0	31.2	8.3	32.3	32.8	14.3	32.0	5.9	9.4	19.4	43.9	14.8	16.0	29.8	2.4	16.6	28.3	31.3	9.4	21.4	38.1	28.3	90.8	58.8	18.2	20.6	21.0	15.5	1.6	1.0	4.2	5.2	0.6	3.8	3.7	2.3	3.5	1.0	1.4	2.5	2.7	1.1	3.1	0.6	1.0	2.4	0.9	61.3	50.0	53.0	104.9	70.8	36.6	66.9	54.2	60.6	56.3	61.4	56.9	125.3	3.2	5.8	13.4	35.6	32.2	21.5	10.4	12.5	41.2	43.9	35.6	4.0	24.3	12.1	14.7	39.6	77.8	338.2	61.8	9.8	31.0	6.4	28.4	43.7	67.6	30.5	22.3	12.8	37.8	43.2	29.8	29.6	37.8	10.2	31.6	65.0	21.5	66.3	55.5	12.5	34.9	12.2	36.1	28.7	6.4	30.1	42.8	26.6	19.7	35.0	66.0	383.1	5.0	63.1	42.7	31.9	36.5	58.7	25.9	38.6	19.5	7.5	35.5	13.1	31.0	44.1	16.3	20.7	21.2	45.9	65.7	117.1	66.1	34.0	32.3
ABHD17B	"C9orf77, CGI-67, FAM108B1"	ENSG00000107362	"Abhydrolase domain containing 17B, depalmitoylase"	Q5VST6	9	71862452-71911193	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047862	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA047862: AB_10959595"	"unprognostic (7.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.03e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.53e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (4.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.34e-2)"	8.3	7.2	14.5	6.9	25.7	19.1	7.9	18.9	21.3	9.3	7.7	10.4	16.0	9.2	4.1	16.0	8.6	8.2	6.8	14.8	17.3	11.7	12.3	8.8	10.9	19.0	19.6	7.0	6.1	10.4	5.9	7.2	19.2	9.2	10.0	25.5	10.7	4.3	16.4	12.1	13.4	8.5	19.2	8.4	7.4	11.6	18.6	33.1	8.0	10.2	10.1	12.9	10.8	42.4	11.2	11.6	26.7	15.0	12.8	8.6	19.0	12.1	14.8	11.5	9.4	3.8	7.4	25.1	10.0	9.3	9.8	22.5	27.5	8.9	12.5	13.7	11.8	15.3	19.4	11.8	8.9	18.6	24.2	10.5	11.7	10.5	9.4	10.2	14.5	48.2	12.4	13.0	9.4	6.0	50.6	14.9	36.1	15.9	13.9	63.3	19.0	0.2	12.6	25.5	15.9	17.5	12.3	14.3	11.0	19.2	4.8	14.5	11.7	10.5	12.4	19.5	9.9	11.0	14.8	21.0	8.7	13.4	5.1	3.5	1.9	1.9	1.3	0.6	1.2	1.9	1.7	1.9	2.2	4.2	1.3	1.9	1.2	3.2	0.6	2.6	2.5	0.8	14.5	25.7	18.9	21.3	14.8	17.3	19.0	19.6	19.2	19.2	18.6	42.4	16.1	6.4	6.3	17.6	20.2	17.1	29.4	7.4	12.0	16.9	9.7	7.2	8.8	7.2	10.1	5.5	12.5	10.7	33.0	31.5	11.7	8.7	25.0	20.9	12.4	11.7	8.9	7.4	30.8	5.7	8.2	7.6	16.8	13.0	17.2	7.8	12.1	9.4	6.1	5.0	29.1	32.8	6.1	7.7	16.6	9.6	11.5	11.1	5.4	11.2	8.8	27.5	19.6	37.7	136.7	4.6	19.5	10.5	11.4	20.5	21.8	10.7	17.2	57.8	0.0	24.7	13.7	32.2	18.5	15.2	9.8	7.3	20.0	5.3	13.1	54.2
ABHD17C	FAM108C1	ENSG00000136379	"Abhydrolase domain containing 17C, depalmitoylase"	Q6PCB6	15	80679684-80755621	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 65.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 201.4;Intestinal goblet cells: 103.7;Urothelial cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 127.1;RT4: 102.6;SK-MEL-30: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048890	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048890: AB_2680546"	"unprognostic (3.60e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.08e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.89e-3)"	2.5	4.7	17.6	10.3	17.7	5.9	11.7	14.3	18.4	19.3	13.6	65.3	23.3	6.1	2.1	46.5	10.9	6.3	4.2	19.2	16.3	15.6	5.6	19.5	7.2	16.4	16.2	2.0	7.9	7.0	6.0	4.7	14.5	18.1	56.2	16.8	23.6	3.4	1.8	18.7	30.6	5.5	17.0	8.1	36.0	5.2	18.2	5.6	8.0	2.8	23.0	28.7	21.3	16.2	26.4	24.7	15.7	19.8	5.7	11.6	26.8	24.9	93.0	20.7	20.0	20.6	57.7	8.7	9.9	26.4	14.7	52.7	44.1	23.0	18.5	62.0	25.0	0.1	17.7	22.1	9.9	8.0	12.3	24.9	27.1	15.0	7.4	17.9	22.6	9.1	0.2	10.8	12.1	73.3	0.7	0.8	23.3	127.1	9.2	17.4	13.4	24.5	17.0	102.6	13.9	5.7	19.8	33.7	119.9	6.8	16.8	13.5	7.7	12.8	10.5	14.1	22.4	0.8	0.3	8.6	8.3	71.6	14.3	0.0	0.0	0.0	0.7	0.0	0.5	0.3	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	17.6	17.7	14.3	18.4	19.2	16.3	16.4	16.2	14.5	17.0	18.2	16.2	2.0	12.8	12.5	32.3	1.4	7.1	13.2	14.3	9.6	4.8	15.7	9.4	5.3	17.2	11.1	7.3	8.4	2.2	2.8	201.4	45.0	6.5	0.3	13.4	7.8	6.9	14.5	0.8	18.4	8.9	5.8	3.1	39.8	35.4	0.0	3.0	6.4	6.0	1.1	10.1	20.1	103.7	10.2	1.3	1.5	0.7	1.2	5.9	8.8	6.5	1.4	4.8	0.0	12.1	3.1	28.1	58.6	0.0	2.4	34.5	46.3	5.6	10.5	22.4	0.0	1.0	2.0	0.7	6.0	19.3	22.7	1.0	2.6	19.6	53.2	86.1
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	4.3	4.2	2.4	5.3	3.0	5.8	4.0	6.5	3.3	4.3	2.0	5.3	7.1	4.0	4.2	4.0	4.5	2.4	13.5	2.5	3.7	4.6	8.4	3.9	5.8	2.4	2.2	5.1	8.9	3.3	5.2	2.9	2.6	3.6	5.1	5.4	4.8	2.2	10.9	5.5	7.0	3.2	1.8	4.8	4.6	1.9	2.9	5.9	4.8	11.7	4.9	4.1	4.1	3.2	4.2	3.5	4.1	5.3	3.2	4.4	6.1	4.0	3.2	3.5	4.6	7.8	7.7	11.1	6.5	2.0	3.3	4.0	8.7	4.7	3.8	9.2	2.8	8.2	5.1	6.7	4.4	13.9	10.1	3.4	3.2	3.7	2.4	4.1	6.3	8.4	13.8	8.0	3.3	7.4	18.7	6.8	4.3	8.7	3.1	10.2	1.4	7.2	5.2	4.2	9.4	3.4	4.1	6.8	4.1	5.8	6.0	5.7	5.4	2.3	3.1	5.7	4.0	14.8	15.4	13.2	4.0	14.7	3.7	13.6	5.7	8.7	5.0	5.0	3.9	6.3	6.3	6.0	4.7	7.8	7.2	7.1	12.1	4.5	3.7	7.8	7.2	2.9	2.4	3.0	6.5	3.3	2.5	3.7	2.4	2.2	2.6	1.8	2.9	3.2	8.4	6.4	15.4	0.0	17.6	0.0	8.7	0.0	17.1	13.5	5.9	3.7	0.0	8.6	5.6	7.3	20.9	5.5	13.5	7.9	0.0	5.1	3.5	6.3	5.7	6.9	6.1	27.3	0.0	7.3	4.7	4.8	23.4	8.2	1.3	10.6	11.4	23.4	7.8	18.5	0.0	9.6	0.0	17.6	0.0	1.6	6.2	12.9	0.0	0.0	15.9	5.1	12.3	0.0	0.0	7.5	5.6	5.7	21.3	10.2	13.9	8.5	3.6	19.8	13.1	8.0	4.2	9.2	4.8	12.0	0.0	9.2	14.5	7.8	8.4	9.4
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3, phospholipase"	Q8WU67	18	21650901-21704780	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.7;Paneth cells: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 209.6;RPMI-8226: 233.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	17.1	7.3	13.3	25.2	13.8	17.6	15.7	16.8	21.9	12.6	23.2	63.5	44.1	8.1	9.1	18.1	12.0	20.8	7.5	13.2	14.0	14.5	39.3	15.7	29.8	14.2	15.6	12.5	12.3	16.0	11.4	19.8	16.2	11.1	65.7	5.8	14.5	6.2	14.4	6.3	56.3	9.7	13.2	24.0	35.6	6.3	16.2	21.4	22.9	7.9	25.8	15.3	12.8	15.9	29.0	20.6	19.8	12.7	12.3	8.2	0.1	18.6	7.6	13.1	17.6	21.6	29.1	82.3	33.2	6.2	58.6	93.6	32.5	15.3	18.1	52.1	21.9	9.0	35.7	37.5	18.7	39.6	28.9	7.3	17.7	19.2	8.8	6.5	8.7	28.0	23.4	47.9	11.6	11.7	38.5	43.6	9.7	92.1	47.8	209.6	15.0	233.5	36.4	27.6	16.6	7.5	42.5	37.6	11.2	21.3	11.7	68.9	6.9	12.7	18.2	22.6	29.3	53.1	37.5	84.9	16.1	50.9	29.4	89.3	24.7	29.3	25.3	44.4	19.8	16.2	22.7	24.8	15.2	12.6	18.2	23.2	81.6	18.6	61.8	10.2	44.9	24.3	13.3	13.8	16.8	21.9	13.2	14.0	14.2	15.6	16.2	13.2	16.2	15.9	8.4	9.6	9.3	42.4	22.8	33.4	40.8	21.6	18.2	14.3	12.9	6.2	4.6	40.0	25.4	3.7	47.9	30.6	24.4	187.7	1.9	52.9	4.1	32.6	9.9	9.5	36.4	10.3	27.2	27.5	22.7	10.6	32.1	49.4	11.4	1.2	10.4	31.6	68.5	0.0	30.9	57.9	52.9	31.9	47.2	1.5	7.5	26.4	32.0	33.7	29.6	7.8	26.8	17.1	10.7	51.1	126.6	6.4	45.5	32.0	93.8	8.8	40.8	15.7	13.1	6.8	13.2	4.1	9.7	22.4	15.2	94.3	38.3	5.4	36.8	36.8
ABHD4	FLJ12816	ENSG00000100439	"Abhydrolase domain containing 4, N-acyl phospholipase B"	Q8TB40	14	22598237-22613215	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 35.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 35.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 121.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000600	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA000600: AB_1078081"	"unprognostic (5.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.03e-2)"	22.8	28.7	21.6	7.3	23.6	12.6	17.5	22.3	22.4	25.9	27.7	19.2	15.0	26.3	27.4	38.3	15.4	24.7	20.5	21.0	24.5	25.3	22.6	17.6	8.0	27.8	24.5	15.9	14.5	22.8	12.8	17.9	23.3	19.3	13.8	21.7	16.5	33.7	25.5	18.9	17.9	24.5	22.5	14.8	24.9	36.8	24.2	10.1	21.6	27.2	14.8	24.8	26.2	26.0	23.4	38.5	15.5	14.2	121.8	44.0	14.9	10.3	52.2	25.3	46.8	23.5	36.4	2.2	26.7	45.2	27.2	44.5	9.9	26.6	20.6	17.3	3.5	8.7	28.1	77.9	55.6	1.4	30.3	56.1	20.6	33.2	28.2	52.7	26.4	16.0	6.5	41.1	23.5	12.8	0.7	1.3	18.8	94.4	27.7	6.5	13.8	9.8	29.6	24.6	1.0	3.1	69.1	24.3	27.2	30.6	9.5	2.6	18.8	11.0	14.9	18.0	4.1	44.1	25.3	0.8	8.2	1.8	8.9	35.4	6.3	10.2	8.2	4.7	6.8	5.5	5.4	5.5	4.2	3.1	1.7	3.5	25.7	7.3	4.6	0.6	3.4	5.6	21.6	23.6	22.3	22.4	21.0	24.5	27.8	24.5	23.3	22.5	24.2	26.0	5.0	12.8	5.6	2.6	4.7	3.2	7.0	5.2	7.4	3.5	6.2	6.6	6.7	11.5	3.4	3.7	4.2	6.1	4.8	9.8	9.8	13.3	3.1	8.3	6.0	6.5	6.0	4.4	1.1	11.7	2.3	5.2	16.3	12.5	5.1	5.2	9.3	10.3	7.8	8.4	1.2	6.8	4.1	6.9	1.7	4.7	5.6	4.6	1.8	1.0	9.4	6.9	5.2	4.0	3.7	9.8	9.3	8.2	12.4	9.5	13.3	4.7	2.6	3.2	6.6	3.1	6.0	0.7	0.5	13.2	2.7	26.8	5.0	9.7	3.3	11.7
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 146.2;Horizontal cells: 72.3;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 53.9;U-266/70: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: AB_2683638"	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	7.4	26.0	32.3	3.9	37.2	4.5	8.8	20.6	57.8	12.0	14.3	16.7	2.7	11.5	1.7	5.7	11.2	2.9	12.4	36.3	23.8	11.6	28.2	9.6	4.5	19.2	26.5	14.2	11.6	8.9	24.6	5.6	19.5	14.6	0.6	6.1	10.5	6.7	13.8	11.3	7.8	2.7	16.1	11.4	11.1	45.7	30.0	4.7	12.1	3.9	2.2	10.2	8.8	27.0	22.5	6.4	3.2	12.6	4.1	1.4	34.2	4.5	6.0	4.8	6.1	5.6	15.0	1.6	6.1	3.5	7.4	3.1	3.2	7.8	1.0	26.6	21.1	7.3	9.6	9.7	13.4	0.5	9.9	3.8	4.7	8.2	1.0	7.4	3.5	12.5	6.6	12.4	1.9	1.2	9.0	1.3	6.0	3.8	53.9	13.3	9.9	6.5	4.3	2.1	3.9	21.3	10.0	3.3	14.6	2.8	13.6	12.6	2.1	4.4	9.6	22.7	8.1	40.6	33.0	7.9	14.9	8.7	4.1	0.0	2.4	3.0	1.1	1.9	0.7	0.3	1.6	0.9	2.9	0.5	1.3	1.2	1.3	1.7	1.9	1.3	1.2	1.0	32.3	37.2	20.6	57.8	36.3	23.8	19.2	26.5	19.5	16.1	30.0	27.0	5.9	0.0	1.3	20.9	5.0	3.8	4.7	8.0	8.6	56.9	9.6	14.4	2.0	7.2	4.8	7.3	18.8	20.6	4.0	0.8	7.9	13.1	146.2	3.0	3.7	4.3	7.2	0.8	22.7	8.5	9.0	7.7	2.6	2.5	4.5	12.3	4.2	13.5	22.5	72.3	19.4	3.3	12.2	8.1	6.9	314.2	12.5	11.1	1.8	8.4	18.4	36.1	7.2	2.5	1.4	8.4	4.3	25.6	9.2	6.3	0.4	9.7	1.7	38.2	6.6	13.6	5.6	64.3	1.5	3.0	4.1	24.8	4.8	10.8	1.3	4.3
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 278.2;Suprabasal keratinocytes: 270.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA068407"	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"CAB008375: AB_592744, HPA068407: AB_2685983"	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	28.9	16.2	28.5	35.0	29.2	83.8	29.8	28.3	38.9	30.4	20.9	32.0	32.4	23.6	19.2	53.0	23.8	24.9	16.3	37.4	28.8	27.6	24.9	28.1	48.1	24.7	26.8	26.6	19.9	20.1	12.9	28.3	25.4	20.8	33.0	18.9	32.9	19.1	20.0	42.9	34.1	23.8	26.2	32.3	31.8	14.2	28.0	44.5	22.6	19.6	53.7	34.7	36.5	27.1	55.0	28.6	21.1	21.9	34.4	39.5	34.1	50.9	31.2	35.0	37.5	33.7	61.7	101.1	23.2	51.7	23.0	57.7	28.0	37.0	41.0	65.2	24.2	44.5	18.0	29.0	23.6	23.2	43.9	28.1	54.6	35.3	21.8	41.5	43.7	33.5	30.7	67.2	40.5	25.4	49.8	26.0	18.8	37.5	13.5	51.4	41.2	69.2	48.0	22.9	17.1	18.5	41.3	44.5	46.8	29.4	27.7	35.5	50.6	27.3	33.2	34.4	25.5	15.0	24.0	108.7	38.7	61.1	17.4	77.3	35.5	91.4	42.1	43.2	40.8	57.2	40.9	48.5	39.4	47.7	37.7	41.7	64.3	35.8	45.4	34.1	76.5	57.2	28.5	29.2	28.3	38.9	37.4	28.8	24.7	26.8	25.4	26.2	28.0	27.1	44.4	41.7	37.7	278.2	89.3	246.2	127.9	74.0	123.5	9.6	40.5	26.5	23.2	38.6	73.5	25.8	2.1	36.4	75.7	69.7	13.7	56.3	11.3	72.1	41.3	41.9	44.9	43.8	81.6	52.1	46.9	45.9	42.3	111.5	57.7	22.3	32.9	25.6	75.8	16.8	133.7	54.9	83.4	80.5	116.3	5.7	22.1	92.1	92.5	106.8	89.8	48.2	73.2	128.7	47.4	82.2	52.1	22.2	56.8	132.5	52.7	39.0	86.2	10.0	32.9	29.8	40.3	14.7	10.8	109.6	270.6	77.2	71.0	27.2	41.3	195.4
ABI2	"ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2"	ENSG00000138443	"Abl interactor 2"	Q9NYB9	2	203328280-203447728	"Predicted intracellular proteins"	"Host-virus interaction, Neurogenesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070567	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA070567: AB_2686281"	"unprognostic (5.26e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	10.5	13.2	31.0	9.5	41.9	3.3	15.2	22.9	38.4	19.0	10.0	18.7	5.7	28.0	18.7	11.9	22.5	13.4	32.7	40.4	33.0	20.9	7.4	16.1	8.2	16.3	24.1	27.9	7.5	20.4	20.5	19.4	17.3	18.7	10.7	30.0	8.6	23.0	7.4	7.6	8.9	25.2	21.3	12.9	9.3	27.5	36.0	22.2	26.5	15.8	8.7	14.6	11.9	22.5	19.3	29.4	102.5	64.4	23.9	40.5	22.6	33.0	29.0	27.9	32.2	27.3	35.5	0.0	22.0	39.0	38.8	20.9	47.1	34.6	54.8	9.5	27.4	47.9	30.9	21.4	36.3	20.6	21.1	28.8	16.5	51.2	39.5	80.5	52.6	54.1	34.7	41.8	49.7	35.0	52.8	20.4	53.5	18.2	64.8	34.5	51.4	3.5	29.3	19.6	43.2	55.3	6.2	19.2	37.4	76.8	25.0	23.9	39.9	50.4	43.0	27.8	36.2	29.3	28.7	26.6	54.7	8.5	33.2	0.2	1.4	0.0	3.3	1.6	3.6	1.4	3.7	3.7	4.0	1.3	4.4	3.9	0.2	3.9	3.8	12.7	4.4	3.2	31.0	41.9	22.9	38.4	40.4	33.0	16.3	24.1	17.3	21.3	36.0	22.5	39.7	54.5	26.5	123.4	14.7	30.1	55.7	37.7	34.1	111.9	39.5	38.7	56.7	28.6	32.8	53.3	162.6	23.7	33.1	10.1	33.2	24.3	128.2	62.3	68.4	43.6	49.2	30.3	201.3	13.1	15.7	54.1	25.0	72.3	15.8	100.0	65.7	12.3	16.7	102.6	128.6	10.9	20.3	11.4	62.3	81.6	46.6	22.1	49.8	57.1	18.6	67.6	26.8	114.1	94.2	15.5	19.4	63.2	18.3	44.2	11.1	38.5	83.1	89.6	26.3	70.5	67.9	89.0	52.4	22.0	26.1	19.7	21.7	69.9	17.0	37.5
ABI3	"NESH, SSH3BP3"	ENSG00000108798	"ABI family member 3"	Q9P2A4	17	49210411-49223225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.7;Kupffer cells: 130.7;Macrophages: 71.4;monocytes: 66.0;NK-cells: 249.3;T-cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 735.0;non-classical monocyte: 788.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 49.9;HDLM-2: 28.8;HUVEC TERT2: 76.0;RH-30: 18.6;TIME: 59.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017345, HPA064805"	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA017345: AB_2669592, HPA064805: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.18e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.40e-1)"	10.2	8.1	7.5	21.9	8.8	6.4	8.1	10.6	11.2	6.9	6.9	7.7	10.9	7.3	1.9	5.1	7.4	7.6	12.8	8.2	13.0	10.6	7.0	17.3	30.1	20.5	12.4	3.0	4.1	3.6	4.2	6.3	15.4	8.0	7.4	0.7	4.5	3.6	3.8	4.6	18.1	8.0	15.5	69.5	8.4	1.2	14.1	10.0	8.9	6.8	28.6	7.8	6.2	17.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	1.9	3.1	5.2	0.4	0.0	49.9	0.6	0.1	0.0	0.0	0.0	0.0	4.9	28.8	0.0	0.2	0.2	0.0	0.0	0.5	0.2	0.1	0.0	1.4	0.1	0.0	76.0	2.7	0.0	0.0	0.5	0.0	10.1	7.3	3.2	0.0	0.0	8.2	18.6	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.4	59.3	0.1	11.2	0.0	0.0	0.6	2.6	8.4	0.0	0.5	0.1	1.4	117.2	3.2	290.2	735.0	141.2	36.1	51.8	189.2	248.5	27.3	31.4	141.0	17.9	110.8	788.6	9.8	33.5	234.0	7.5	8.8	10.6	11.2	8.2	13.0	20.5	12.4	15.4	15.5	14.1	17.2	25.5	0.0	6.4	1.0	20.5	1.9	0.1	0.0	0.0	0.0	0.8	1.8	1.5	2.8	0.0	0.0	0.0	0.3	82.7	0.2	50.9	0.1	0.4	0.1	0.3	39.4	1.2	6.9	0.2	0.2	0.5	2.4	2.6	0.2	7.0	0.1	39.7	1.6	45.7	0.0	0.2	0.0	0.0	130.7	21.4	0.7	0.3	71.4	1.8	2.8	66.0	0.1	249.3	0.0	0.0	0.0	0.0	0.0	14.7	0.2	0.0	0.4	0.7	0.4	0.0	0.8	2.1	0.2	0.4	0.0	4.3	0.3	58.0	0.5	0.1	0.2
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713016-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 71.2;Oligodendrocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	50.9	30.7	27.4	25.3	38.9	23.4	45.8	33.6	31.4	60.5	40.4	96.4	23.1	63.0	11.6	33.8	55.6	35.7	36.1	26.6	28.3	23.1	17.5	37.3	16.3	39.3	38.5	56.0	24.9	32.5	34.9	26.5	35.8	43.5	26.7	14.2	32.4	33.6	29.4	36.3	45.2	41.2	31.3	23.3	51.6	20.1	34.9	22.4	46.7	30.8	15.4	79.3	42.7	41.3	22.5	48.3	53.6	62.9	76.5	93.3	18.8	38.8	60.4	44.8	38.1	36.4	28.3	32.3	22.3	52.0	47.6	42.5	23.5	36.0	30.7	20.6	16.3	23.7	84.1	33.4	51.8	36.5	32.3	68.8	37.2	80.6	50.0	64.1	61.0	47.9	135.8	26.5	54.9	42.0	49.2	30.5	57.9	34.3	33.8	55.9	67.9	35.9	45.0	25.7	47.9	60.1	66.1	23.5	29.2	31.0	46.2	33.1	71.1	170.7	44.1	66.3	62.6	8.4	20.3	47.9	72.1	27.6	55.1	0.0	0.7	0.3	0.6	0.4	0.8	1.3	0.6	0.6	0.7	0.4	0.6	0.5	0.0	0.8	1.9	1.0	0.3	0.6	27.4	38.9	33.6	31.4	26.6	28.3	39.3	38.5	35.8	31.3	34.9	41.3	16.2	9.6	13.6	54.9	4.7	9.2	7.3	9.8	5.2	8.2	11.6	10.2	6.2	7.2	7.2	14.7	12.5	13.6	12.1	21.2	1.9	14.4	5.9	8.6	29.7	18.1	22.1	4.6	52.5	11.1	4.3	36.7	5.6	12.4	2.5	22.1	20.3	15.9	16.6	10.1	63.7	17.5	6.1	16.4	11.7	8.8	28.0	10.2	5.4	71.2	6.6	19.2	6.2	66.9	116.0	17.9	18.3	25.6	5.6	8.6	11.6	10.3	7.8	9.1	19.7	29.5	19.8	16.9	16.5	6.6	6.8	15.2	7.9	20.1	21.4	7.2
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099330-179229684	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8;Langerhans cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 73.5;TIME: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	9.3	3.2	5.9	4.9	6.7	2.7	5.7	6.1	6.1	5.4	2.0	4.6	2.8	3.7	2.7	2.5	3.2	11.8	3.9	7.4	5.0	3.6	2.7	6.5	2.7	3.8	4.4	3.5	5.7	4.2	3.8	4.1	3.9	3.5	3.3	9.2	3.5	2.6	3.1	4.2	3.2	4.5	3.0	2.7	3.7	4.4	5.6	4.1	3.8	4.2	2.5	6.4	4.0	4.8	24.2	13.1	8.7	5.8	7.3	16.8	5.3	26.3	21.6	31.9	23.1	9.9	7.2	13.7	18.9	19.2	21.7	11.0	12.6	9.1	44.6	8.5	11.4	6.7	12.4	4.9	13.3	7.5	2.1	15.6	11.6	45.3	73.5	13.9	36.2	7.0	16.1	3.8	42.6	6.5	5.9	4.0	8.3	5.0	4.3	8.6	14.4	6.5	10.8	4.0	5.2	11.9	22.0	7.0	53.8	13.2	6.2	6.4	70.7	33.3	24.5	15.7	42.8	7.0	9.3	14.1	15.6	4.0	32.4	1.4	0.3	0.0	0.5	0.1	0.2	0.5	0.3	0.3	0.2	0.7	0.4	0.5	0.6	0.5	0.1	0.5	0.2	0.1	5.9	6.7	6.1	6.1	7.4	5.0	3.8	4.4	3.9	3.0	5.6	4.8	33.5	22.4	24.0	44.1	14.4	46.9	43.6	16.3	12.5	40.0	18.7	9.5	8.9	22.8	10.8	11.0	166.8	9.3	7.7	15.5	11.7	14.3	15.6	12.3	23.4	67.2	27.0	9.9	81.6	13.9	8.2	67.6	10.2	21.5	17.1	19.5	31.1	15.3	22.9	25.2	62.0	11.0	10.2	34.9	188.1	32.2	15.2	67.7	69.4	45.0	13.9	11.3	8.2	72.4	57.1	45.5	16.0	13.5	10.3	42.6	9.9	9.4	11.0	35.7	6.6	32.3	30.5	17.8	30.5	11.5	38.4	10.4	12.4	11.6	14.9	25.3
ABLIM1	"ABLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114768061	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 875.6;Cardiomyocytes: 592.5;Peritubular cells: 413.0;Squamous epithelial cells: 481.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 139.1"	"Group enriched"	"Detected in many"	7	"B-cells: 52.2;NK-cells: 63.6;T-cells: 139.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 164.1;OE19: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol		NA	NA		6000	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	73.3	93.4	71.0	35.7	67.6	13.6	54.8	277.3	59.4	44.4	76.2	46.7	37.3	37.3	26.7	205.6	51.3	33.5	268.6	58.5	78.3	54.7	28.3	54.5	50.0	90.5	65.1	233.6	32.1	42.3	22.0	31.5	74.9	24.0	57.8	110.1	98.2	26.5	75.1	97.5	34.2	29.3	85.2	20.1	120.7	41.3	67.0	56.8	112.9	111.6	89.1	42.0	89.4	73.2	48.2	34.7	120.2	27.2	1.1	0.4	1.5	9.6	3.2	2.4	6.7	49.0	76.7	61.8	128.7	11.1	18.1	101.4	41.1	66.2	3.1	21.2	35.5	0.5	96.0	128.8	0.5	24.6	0.4	1.5	164.1	18.1	52.1	50.3	47.5	21.4	0.2	93.3	0.5	17.5	5.0	10.8	47.0	159.5	38.4	2.1	29.3	80.3	38.4	105.6	41.7	51.4	40.4	59.2	21.0	60.0	30.7	0.3	32.1	0.1	43.1	1.1	18.3	0.5	0.3	140.0	2.3	54.0	0.9	11.9	0.2	0.8	28.6	0.2	55.5	40.9	53.9	32.8	0.4	52.2	139.1	91.0	2.4	63.6	0.3	0.4	33.7	48.1	71.0	67.6	277.3	59.4	58.5	78.3	90.5	65.1	74.9	85.2	67.0	73.2	218.9	317.3	36.0	875.6	47.1	86.8	42.2	35.7	306.2	54.5	27.6	29.5	592.5	51.5	97.1	53.3	18.8	1.5	43.2	59.8	35.2	37.8	110.7	88.4	32.7	107.3	16.8	7.4	236.0	54.5	0.8	126.1	225.3	30.9	1.3	119.6	55.6	51.4	0.6	58.9	326.0	101.7	16.2	1.3	18.4	133.7	227.7	9.4	21.4	213.6	4.3	54.7	27.8	50.3	9.2	59.6	34.7	413.0	22.7	49.8	46.7	42.1	79.3	96.7	0.0	155.8	22.0	3.9	4.7	481.0	189.4	0.7	62.8	53.6	51.4	164.0
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 204.8;tongue: 73.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 93.2;Inhibitory neurons: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	7.3	4.0	2.7	1.6	11.0	0.1	5.1	0.0	9.9	2.5	0.0	2.3	0.5	1.2	0.7	13.1	1.8	1.3	7.1	2.7	10.4	7.0	0.9	3.3	1.0	1.4	0.0	0.6	3.4	1.3	6.8	0.6	1.1	1.5	1.7	5.0	5.4	0.5	204.8	6.9	1.6	1.9	0.0	20.5	1.4	1.0	1.4	1.7	3.0	73.5	2.2	1.9	4.1	0.0	1.1	0.0	0.2	1.6	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.5	3.1	0.3	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.7	2.1	0.1	0.0	1.2	2.9	0.9	0.2	1.0	0.7	0.2	0.0	13.8	1.0	5.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.7	11.0	0.0	9.9	2.7	10.4	1.4	0.0	1.1	0.0	1.4	0.0	4.4	0.0	1.1	9.4	0.5	2.5	0.1	0.1	0.6	6.4	0.4	0.3	4.7	1.5	0.3	3.7	0.0	0.0	0.6	7.9	0.0	3.5	2.2	5.2	0.7	3.5	10.7	0.0	93.2	4.3	0.6	0.9	2.6	0.2	2.5	0.5	0.7	0.4	0.1	11.8	67.6	3.8	0.0	0.6	0.7	5.1	0.0	0.3	0.0	2.8	0.0	3.1	0.0	16.1	17.6	3.5	5.1	3.8	0.1	0.3	14.3	0.6	1.7	3.2	6.6	7.0	3.5	0.2	2.0	2.0	6.3	0.0	0.7	4.0	5.8	0.3
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
ABR	MDB	ENSG00000159842	"ABR activator of RhoGEF and GTPase"	Q12979	17	1003518-1229738	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.7;Late spermatids: 164.0;Microglial cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.3;hTERT-RPE1: 38.6;LHCN-M2: 24.6;RPMI-8226: 21.5;TIME: 41.3;U-251 MG: 42.0;U-698: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	22.7	21.7	4.5	5.5	3.1	1.3	20.0	1.2	6.0	27.0	0.0	58.9	1.9	28.5	0.1	42.0	22.9	0.6	40.5	5.1	1.7	9.7	3.0	28.5	1.0	4.2	5.0	14.7	8.6	1.2	22.4	1.6	7.3	18.2	7.0	1.2	28.1	0.4	9.0	25.0	40.5	8.1	6.9	21.0	19.5	13.9	6.7	4.8	10.5	0.0	5.7	22.0	24.7	12.3	1.0	1.3	0.3	0.1	1.3	0.2	1.7	0.2	0.3	0.1	0.0	0.6	0.0	31.3	0.7	0.3	1.7	0.1	4.0	0.1	0.9	11.8	14.5	0.0	0.4	0.1	0.8	2.7	9.5	0.4	0.0	0.3	12.7	38.6	0.0	0.0	0.1	0.0	24.6	1.2	0.1	3.4	0.2	0.7	0.2	0.2	0.0	21.5	0.2	0.4	0.3	0.6	0.1	0.0	1.8	0.1	11.5	3.0	41.3	0.3	0.4	3.0	42.0	0.1	0.6	29.5	1.9	5.1	0.8	9.0	0.2	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.5	0.0	4.5	3.1	1.2	6.0	5.1	1.7	4.2	5.0	7.3	6.9	6.7	12.3	20.0	32.1	24.6	171.7	9.6	17.1	18.2	19.0	11.4	75.5	11.3	8.3	23.7	22.8	21.0	1.8	2.1	2.4	13.3	61.0	0.0	17.7	37.0	14.3	6.1	22.1	15.0	2.5	80.5	6.3	3.0	13.7	18.8	9.7	19.6	16.3	18.2	0.6	30.4	11.8	67.6	37.2	16.2	31.9	49.4	164.0	13.7	31.0	19.6	146.1	25.5	25.8	34.0	41.7	5.2	48.3	38.4	9.4	4.2	21.8	36.8	7.9	26.7	20.0	39.5	19.9	25.3	2.7	8.3	22.3	16.9	2.2	15.5	0.6	53.2	25.1
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"HPA037654: AB_2675588"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	4.4	3.9	2.9	3.9	2.0	7.9	3.8	7.7	3.0	5.1	12.0	3.3	3.7	6.4	2.1	5.2	4.8	5.7	3.7	2.4	1.4	4.1	2.2	3.8	8.0	2.2	2.2	14.8	3.4	2.2	1.1	2.9	2.4	2.7	2.8	3.6	3.5	2.2	6.4	5.7	3.1	2.9	0.5	4.1	3.6	10.8	2.6	4.8	7.4	2.0	3.8	3.8	3.5	5.1	5.6	3.4	6.8	8.2	6.1	25.2	3.6	4.1	5.1	1.9	2.9	7.6	9.0	22.1	3.3	4.3	4.2	2.9	3.7	2.9	3.5	8.8	2.4	12.9	4.6	9.1	4.9	15.3	11.1	10.9	2.5	2.7	2.4	10.2	8.7	12.9	36.7	13.2	4.7	3.7	17.2	5.6	11.5	6.3	5.0	9.3	7.6	5.5	4.2	4.6	6.3	5.1	5.3	2.2	9.6	5.5	6.3	6.3	11.5	7.4	7.6	7.4	6.0	11.5	8.4	16.1	6.7	12.8	5.3	4.0	2.5	2.1	2.0	2.3	2.6	2.1	3.5	2.4	1.9	3.3	5.4	4.2	3.2	5.0	2.3	1.5	3.2	1.9	2.9	2.0	7.7	3.0	2.4	1.4	2.2	2.2	2.4	0.5	2.6	5.1	14.3	16.0	12.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	13.0	0.0	0.0	8.6	12.9	0.0	5.2	8.8	0.0	43.0	9.2	0.0	11.9	20.7	5.7	0.0	0.0	0.0	6.5	6.9	9.1	0.0	5.9	6.3	12.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	1.7	0.0	0.0	30.1	21.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	2.9	6.2	26.8	0.0	0.0
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801819-124836667	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Collecting duct cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	9.1	10.5	8.0	10.3	8.3	12.3	12.2	8.0	9.9	8.8	6.6	9.9	10.2	9.4	9.3	9.8	9.0	8.2	10.0	8.4	8.6	12.3	13.7	9.3	12.5	7.8	8.4	10.4	8.3	12.7	3.9	10.3	8.5	9.5	10.3	5.3	8.5	8.8	19.0	11.6	10.8	10.5	7.7	10.0	9.5	6.7	8.2	12.9	12.7	16.2	13.3	9.7	6.8	7.9	22.2	14.9	15.7	21.6	19.9	19.6	13.5	22.4	35.1	26.2	24.1	12.1	20.9	24.7	18.6	24.4	14.2	24.4	25.0	21.0	27.5	21.6	17.2	18.8	11.8	15.0	25.4	32.6	18.9	21.6	25.1	25.8	46.4	28.3	20.1	21.7	20.0	16.6	21.6	14.5	25.1	29.1	13.5	20.0	13.8	20.0	16.6	15.1	19.5	11.1	10.8	19.8	17.9	17.0	24.4	15.8	14.0	22.2	17.4	14.0	11.2	16.5	27.1	17.2	17.1	23.6	18.3	15.9	10.1	22.8	10.5	9.8	7.6	14.5	10.5	10.5	8.8	10.6	12.9	11.6	9.3	10.3	4.1	7.7	11.8	8.7	11.4	7.0	8.0	8.3	8.0	9.9	8.4	8.6	7.8	8.4	8.5	7.7	8.2	7.9	15.1	25.6	14.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.4	10.3	0.0	0.0	6.2	23.9	0.0	16.9	7.0	0.0	17.6	13.7	0.0	11.1	15.6	6.3	0.0	0.0	0.0	12.5	13.0	5.5	0.0	12.3	12.6	12.4	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	20.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	1.6	0.0	0.0	18.6	12.4	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	16.0	4.3	13.5	0.0	0.0
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680926	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 822.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 822.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	38.4	18.7	30.6	18.8	35.8	51.1	33.4	38.0	42.4	42.0	28.9	38.9	12.3	29.7	5.3	13.4	37.2	18.1	40.5	32.7	25.9	25.5	17.3	32.0	22.0	28.7	27.2	30.3	17.7	9.0	31.4	12.2	27.1	31.0	4.6	8.7	24.5	13.6	44.7	24.9	31.8	7.6	24.7	89.7	27.5	8.1	29.1	21.5	21.8	26.2	7.4	32.9	31.2	30.7	4.3	10.7	0.9	2.0	10.0	8.7	7.8	6.8	12.2	4.5	6.5	0.3	8.9	1.9	11.9	5.1	6.0	2.2	0.2	5.1	1.0	20.7	2.5	3.1	19.4	2.5	7.5	0.5	9.5	12.0	5.6	4.5	1.5	15.2	4.8	8.3	0.1	13.5	4.9	6.6	4.9	13.4	0.9	4.9	11.7	3.0	5.6	13.8	6.7	3.3	9.5	6.0	4.8	6.6	25.0	2.6	1.4	3.7	9.1	4.8	4.0	8.5	2.3	11.5	3.8	0.6	11.1	4.0	7.8	40.7	64.5	161.8	17.0	48.2	16.6	17.8	19.0	17.1	28.6	21.1	16.6	14.3	822.3	25.2	44.5	18.1	46.3	46.2	30.6	35.8	38.0	42.4	32.7	25.9	28.7	27.2	27.1	24.7	29.1	30.7	45.3	19.2	13.0	10.7	31.7	11.7	15.6	14.2	7.4	10.4	9.9	15.6	8.1	22.8	5.3	7.3	18.8	8.1	34.2	11.3	15.6	15.1	0.5	9.9	11.1	20.8	23.9	58.7	26.1	16.8	22.3	21.0	23.0	10.1	14.7	10.1	27.5	8.9	21.3	3.3	12.2	15.0	12.2	64.7	16.4	1.7	33.8	37.4	10.6	18.7	74.3	18.0	35.0	6.6	12.8	25.9	21.4	22.6	25.2	12.8	26.3	23.0	6.9	31.1	65.7	16.1	36.8	1.0	8.6	4.2	9.2	15.9	38.6	10.6	10.3	11.8
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150987-34358010	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"eosinophil: 5.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	2.3	13.0	7.9	2.0	12.6	2.5	2.0	18.1	6.7	8.1	1.2	3.4	8.8	6.1	4.4	4.1	4.6	2.1	12.8	5.3	8.5	9.4	11.6	2.9	2.1	24.1	16.3	2.5	2.3	0.5	3.5	3.2	16.7	4.9	2.5	2.6	6.7	4.3	16.9	6.8	7.0	2.5	12.7	0.9	2.5	2.7	15.9	2.4	2.0	7.2	2.0	3.6	5.6	20.3	5.6	16.2	6.4	1.8	1.7	0.1	6.4	3.2	2.5	2.8	5.3	4.0	4.0	0.2	5.3	4.1	16.5	10.5	3.6	3.7	2.3	0.2	8.8	0.1	9.8	17.4	1.0	8.9	1.2	0.9	2.0	5.6	2.4	10.1	0.0	0.7	1.9	0.5	1.8	13.8	0.3	10.7	8.0	8.1	8.8	1.7	3.8	6.3	10.0	13.0	8.1	6.6	8.1	24.6	6.5	4.2	5.3	3.8	0.9	3.1	0.5	9.8	5.8	0.9	0.4	0.1	7.1	2.5	9.7	0.0	0.1	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	7.9	12.6	18.1	6.7	5.3	8.5	24.1	16.3	16.7	12.7	15.9	20.3	0.7	0.0	2.3	18.9	1.1	4.7	3.2	1.3	1.2	2.1	3.0	3.3	10.0	2.8	1.1	12.9	0.0	2.7	2.5	12.2	5.9	4.6	1.2	3.4	4.5	0.9	7.2	0.0	4.0	4.5	1.1	5.8	4.6	10.7	1.3	0.3	0.0	6.8	0.8	0.0	8.9	2.3	4.1	0.8	6.1	0.3	1.2	1.2	1.8	6.5	9.3	7.5	0.0	50.3	126.2	10.5	9.1	6.0	2.1	9.3	15.5	2.0	0.3	0.6	0.0	4.3	2.4	0.5	1.1	1.0	4.8	28.3	2.9	0.4	2.9	7.5
AC000120.3		ENSG00000285953	"Novel protein"		7	92131774-92245924	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;granulocytes: 1.3"					"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA049606	Uncertain		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA049606: AB_2680832"																		2.1	1.0	0.5	1.1	1.0	0.4	2.0	1.8	0.9	3.6	0.0	1.0	0.4	1.8	0.0	1.2	2.1	1.6	1.4	0.1	0.9	2.5	2.1	2.1	1.7	0.8	0.7	2.6	1.4	3.2		2.9	0.8	1.5	1.3	2.2	0.9	2.0	3.2	0.2	1.1	1.7	0.5	0.7	0.4	5.9	0.5	1.8	2.5	3.7	2.5	1.2		2.0	3.2	2.7	4.2	2.8	4.3	9.2	4.3	5.2	4.9	7.8	7.8	2.2	4.4	5.7	3.2	4.1	4.4	2.6	6.4	5.0	10.9	3.9	3.1	4.9	4.3	1.3	4.2	6.9	2.9	2.1	3.9	5.7	6.7	2.8	5.4	3.3	12.8	3.7	6.0	1.8	4.4	1.1	3.6	4.3	5.0	2.5	7.0	4.8	1.9	2.3	3.3	2.3	8.0	3.0	3.1	8.4	2.9	2.4	2.0	2.6	3.0	7.1	2.5	2.1	3.9	7.6	2.9	3.0	4.6	0.0	0.1	0.2	0.1	0.1	0.5	0.5	0.2	0.2	0.4	0.2	0.3	0.3	0.0	0.3	0.1	0.2	0.2	0.3	0.5	1.0	1.8	0.9	0.1	0.9	0.8	0.7	0.8	0.5	0.5	2.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004556.3		ENSG00000276345	"39S ribosomal protein L23, mitochondrial"		Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 24.0"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7"									HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"		"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"																		3.8	0.0	2.5	4.0	3.0	0.0	19.4	2.8	3.2	0.0	2.6	10.3	0.1	5.0	14.3	0.0	4.9	5.9	24.0	2.4	2.7	6.7	8.5	1.6	0.0	3.1	3.7	6.3	6.8	0.0		2.1	3.4	5.0	0.0	1.2	7.5	0.3	14.5	5.1	9.9	0.5	2.4	4.1	5.0	2.4	2.8	9.9	2.6	0.0	0.1	4.5		2.8	0.2	0.0	0.1	0.1	0.0	0.0	42.0	27.8	43.4	46.5	33.2	94.7	0.8	0.1	0.1	0.0	0.0	0.6	0.7	0.3	18.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	51.1	0.0	31.4	48.3	75.5	42.5	0.4	0.4	85.4	160.6	0.0	0.2	141.1	0.5	22.8	0.2	44.0	27.1	0.2	0.6	0.0	0.2	0.1	0.0	70.4	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.1	0.8	0.3	113.7	12.3	3.4	2.2	1.7	6.2	1.4	1.7	2.5	3.5	3.0	2.0	2.6	2.9	1.0	2.1	2.8	2.8	4.0	2.1	2.5	3.0	2.8	3.2	2.4	2.7	3.1	3.7	3.4	2.4	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
AC004691.2		ENSG00000250424	"Novel protein, MINDY4 and AQP1 readthrough"		7	30852273-30923812	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019206, HPA030130"	Approved		Approved	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA019206: AB_1844965, HPA030130: AB_10601565"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"			"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.72e-4)"		"unprognostic (5.13e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.76e-1)"		"unprognostic (2.49e-1)"	"unprognostic (3.71e-2)"	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.3	0.0	0.5	0.4	0.4	0.4	0.2	0.6	0.9	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004922.1		ENSG00000284292	"Novel protein, ARPC1A and ARPC1B readthrough"		7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Club cells: 2.5;Exocrine glandular cells: 1.5;granulocytes: 1.3;Pancreatic endocrine cells: 1.1"					"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		1.5	1.2	0.1	0.9	0.1	0.5	1.2	0.1	0.3	1.1	0.0	1.4	0.9	0.9	0.0	1.3	1.0	0.1	1.0	0.2	0.1	1.0	1.2	1.8	0.8	0.5	0.2	0.8	0.9	0.1	0.8	0.2	0.3	0.9	0.0	0.0	1.2	0.0	0.4	0.7	1.9	0.2	0.1	2.9	1.2	0.5	0.2	0.2	1.2	0.0	0.1	1.2	1.0	0.0	1.9	2.1	0.4	0.2	0.3	1.0	2.5	1.6	0.7	0.9	1.0	4.1	3.5	2.5	4.8	1.5	1.7	1.6	0.1	1.1	0.2	1.0	1.7	1.2	1.3	0.9	0.2	1.4	1.4	1.4	0.7	1.3	0.6	0.3	1.0	0.8	1.6	2.2	1.0	5.1	3.8	0.1	0.7	0.7	2.8	1.4	0.3	0.7	0.2	1.0	0.4	0.3	1.3	2.7	6.0	0.3	0.8	0.7	2.0	3.3	1.3	3.6	2.4	0.0	1.0	2.4	1.7	2.5	3.5	11.8	20.7	23.7	8.7	20.4	6.2	9.3	8.5	8.7	16.6	11.1	7.1	6.9	16.9	7.1	18.7	11.2	16.5	31.5	0.1	0.1	0.1	0.3	0.2	0.1	0.5	0.2	0.3	0.1	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.5	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC004997.1		ENSG00000248751	"Novel protein"		22	30285238-30299482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.3;Karpas-707: 1.0;LHCN-M2: 1.0"									HPA073183	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"		"Cluster 2: Karpas-707 - Immune response"				"HPA073183: "	"unprognostic (2.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.83e-5)"	"unprognostic (7.90e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.02e-2)"	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.1	0.3	0.1	0.1	0.0	0.3	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.4	0.5	0.4	0.1	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.6	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005154.5		ENSG00000281039	"Novel protein"		7	30497077-30550761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.4"									HPA020735	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA020735: AB_1845754"	"unprognostic (1.15e-2)"	"unprognostic (5.67e-3)"			"unprognostic (1.07e-2)"			"unprognostic (8.33e-2)"	"unprognostic (3.92e-2)"		"unprognostic (6.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.37e-4)"		"unprognostic (2.55e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.50e-4)"	12.8	9.2	19.6	6.9	19.0	28.7	9.6	17.0	26.7	3.8	20.7	8.1	10.9	8.3	24.9	2.8	6.1	7.6	4.4	18.3	19.1	4.4	6.2	12.8	14.0	16.8	17.8	9.2	2.6	7.7	3.1	6.2	16.8	7.8	8.6	20.6	7.0	8.4	10.9	15.2	6.8	5.3	16.1	12.3	8.9	5.2	18.2	8.9	8.3	4.0	11.4	5.8	0.6	19.4	2.0	0.0	7.4	7.5	5.1	11.7	2.8	5.0	5.4	2.8	2.0	1.2	0.7	2.6	1.5	4.1	3.6	5.4	1.0	2.3	2.8	3.3	1.4	2.6	6.2	2.4	4.7	5.9	11.6	8.0	7.0	2.1	4.1	5.8	2.8	5.7	2.2	12.0	4.3	0.4	2.3	7.6	1.6	1.2	0.7	2.2	0.5	4.7	4.5	3.3	1.7	2.7	2.6	1.6	3.6	8.6	4.0	8.2	2.8	2.0	1.5	2.0	1.1	21.4	5.2	2.5	3.5	7.2	6.3	0.0	0.2	0.4	0.5	0.1	0.1	0.0	0.1	0.4	0.4	0.3	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.0	19.6	19.0	17.0	26.7	18.3	19.1	16.8	17.8	16.8	16.1	18.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005324.2		ENSG00000251537	"Novel tripartite motif-containing 16 (TRIM16) and CMT1A duplicated region transcript 1 (CDRT1) protein"		17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.1;HaCaT: 2.1;HeLa: 1.1"									"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"		Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005697.1		ENSG00000266202	"Novel protein"		17	27798806-27893365	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"pancreas: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA023051	Uncertain					NA	NA				"Cluster 50: Non-specific - Ribosome"		"Cluster 11: Alveolar cells - Smell perception"			"HPA023051: AB_10602333"													"unprognostic (1.92e-2)"					0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC005726.1		ENSG00000258472	"Novel protein"		17	28455752-28614185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.2;Club cells: 5.6;granulocytes: 6.3;Proximal tubular cells: 20.4;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA					"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.6	13.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.4	0.0	0.0	5.6	3.7	0.0	1.7	0.5	0.0	1.9	1.2	0.0	1.7	2.4	1.4	0.0	0.0	0.0	2.0	0.8	1.6	0.0	3.2	6.3	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	20.4	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	1.1	1.2	0.0	0.0
AC005833.1		ENSG00000255639	"Novel protein"		12	4649101-4774184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 23.1;tongue: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA012638, HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Mitochondria"		"HPA012638: AB_2294503, HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-2)"			"unprognostic (5.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.10e-1)"			"unprognostic (1.31e-1)"	"unprognostic (6.29e-3)"		"unprognostic (2.94e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.16e-1)"	2.1	1.3	1.1	3.8	1.4	2.0	2.6	1.3	1.6	1.9	0.9	14.6	14.2	1.2	1.0	2.2	1.7	1.3	7.0	1.2	1.3	6.8	6.4	1.4	1.7	1.3	1.3	1.0	0.5	7.0		1.9	1.4	1.8	23.1	0.7	2.5	2.4	2.2	1.0	14.5	3.2	1.3	1.3	2.6	3.4	1.3	2.9	1.6	18.4	3.4	2.8		1.5	4.4	7.0	5.1	3.4	3.4	3.5	11.8	3.7	5.2	10.4	8.6	13.6	7.6	8.8	1.0	5.7	6.5	6.0	9.3	6.4	11.9	8.9	5.0	10.0	7.4	8.9	7.1	9.6	3.0	5.0	6.0	5.6	10.2	4.0	10.6	5.9	7.0	19.9	7.8	5.0	3.6	3.3	16.5	10.2	2.2	6.5	9.6	6.0	8.6	8.2	2.7	2.3	5.3	9.5	4.6	11.7	1.8	3.0	5.1	4.7	9.5	2.5	8.3	1.3	4.6	10.6	3.5	4.5	4.5	3.6	7.4	2.6	5.2	7.4	5.9	6.0	4.9	5.7	9.6	3.9	4.1	4.0	0.3	5.6	6.9	8.7	6.7	14.7	1.1	1.4	1.3	1.6	1.2	1.3	1.3	1.3	1.4	1.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC006538.2		ENSG00000267001	"Novel protein"		19	2717769-2740048	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA058526	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"				"HPA058526: AB_2683743"																		5.0	0.0	0.4	0.7	0.4	1.3	1.0	0.2	1.4	1.1	0.3	2.7	2.6	0.7	0.0	0.2	1.2	0.3	0.2	0.5	0.5	1.2	1.8	1.6	0.7	0.4	0.3	0.0	0.0	2.6	0.0	0.3	0.4	1.4	0.6	0.1	2.2	2.3	6.5	1.2	0.7	2.4	0.5	1.2	1.8	2.8	0.5	0.9	0.1	2.9	0.3	0.9	0.0	0.6	9.8	13.0	2.3	0.0	10.4	11.1	7.1	7.1	5.2	6.2	11.4	12.7	0.7	7.7	8.6	6.0	4.8	3.6	0.0	3.1	0.0	0.0	9.3	24.6	9.1	17.4	22.0	6.4	3.4	6.0	7.2	11.5	0.4	1.8	2.7	8.5	23.5	4.1	1.7	11.7	3.2	3.4	2.1	1.3	16.2	3.9	2.2	7.9	0.0	5.9	3.6	6.1	10.1	1.8	9.5	0.0	3.2	17.8	1.9	1.6	2.8	11.2	8.2	11.6	16.4	5.0	1.0	26.0	1.7	7.1	8.8	12.5	8.0	8.0	7.9	7.7	7.4	7.6	12.5	6.9	5.5	6.7	3.1	6.5	8.5	15.0	4.5	7.4	0.4	0.4	0.2	1.4	0.5	0.5	0.4	0.3	0.4	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC007325.2		ENSG00000277196	"Proline dehydrogenase 1, mitochondrial"		Unmapped	138082-161852	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"brain: 113.8;choroid plexus: 218.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.9;Distal tubular cells: 7.9;Endometrial ciliated cells: 2.5;Proximal enterocytes: 5.6;Squamous epithelial cells: 2.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"OE19: 345.1;RPTEC TERT1: 183.1"									HPA020361	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"																		2.2	0.6	83.9	0.8	83.5	0.7	3.3	75.2	113.8	1.0	218.6	1.1	28.9	0.5	0.1	6.8	1.4	0.4	9.5	90.0	76.6	12.3	6.0	18.8	1.0	87.3	82.6	0.0	0.1	0.1		0.9	72.0	0.9	1.4	1.9	0.7	2.4	10.2	32.6	33.2	0.2	74.5	0.7	0.8	1.9	85.0	5.6	4.5	24.0	6.4	1.9		72.3	0.0	8.3	0.3	2.5	5.0	0.0	1.6	0.0	0.0	0.0	0.0	5.3	1.8	0.0	0.5	0.0	0.2	10.0	18.8	0.5	0.0	0.0	0.7	0.0	0.2	0.9	3.6	0.0	0.1	0.4	18.5	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.5	0.2	0.0	17.5	345.1	0.0	0.1	0.1	0.0	183.1	0.7	0.4	0.5	0.0	6.9	1.5	18.8	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.9	83.5	75.2	113.8	90.0	76.6	87.3	82.6	72.0	74.5	85.0	72.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.2	0.1
AC008162.2		ENSG00000278646	"Novel protein similar to cancer/testis antigen family 47, member A12 (CT47A12)"		X	120877496-120878924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	7	"testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-266/70: 3.8"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008397.2		ENSG00000285188	"Novel protein"		19	18207961-18255419	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"stomach 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.0;Alveolar cells type 1: 9.6;Alveolar cells type 2: 10.6;Breast glandular cells: 2.2;Breast myoepithelial cells: 4.6"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.1	0.0	1.8	0.1	2.3	0.0	0.0	1.2	2.3	0.3	1.2	1.2	0.8	0.7	1.9	0.1	0.7	0.3	0.5	2.1	1.5	0.4	0.0	1.2	0.0	1.3	1.5	0.2	0.4	0.0		0.6	1.4	0.2	1.0	0.0	0.0	0.7	2.4	0.0	0.5	0.5	1.3	0.4	3.6	0.3	1.6	0.0	0.0	2.6	0.0	0.1		1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.3	1.2	2.3	2.1	1.5	1.3	1.5	1.4	1.3	1.6	1.6	2.0	9.6	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC008687.1		ENSG00000267335	"Novel protein"		19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"pituitary gland: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.6;HMC-1: 4.4;U-138 MG: 1.6;U-251 MG: 6.0"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA038925: AB_2676272"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	17.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.6	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.6	1.3	0.3	6.0	0.3	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AC008695.1		ENSG00000273217	"Novel protein"		5	131425891-131796983	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 8.2"	"Cell line enhanced"	"Detected in single"		"A549: 2.5"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	1.9	2.5	0.3	4.4	1.1	2.7	3.0	0.3	1.5	8.2	3.9	0.5	1.9	0.7	0.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC008758.5		ENSG00000268870	"Novel zinc finger protein"		19	12391949-12441082	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 4.4;RT4: 4.9"									"HPA003150, HPA018683"	Uncertain		Uncertain	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 30: Non-specific - Translation"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"		Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"																		0.6	0.1	0.2	0.6	0.3	0.2	0.8	0.5	0.6	0.4	0.3	0.8	0.5	0.6	0.2	0.0	0.3	0.1	0.0	0.1	0.3	0.6	0.6	0.4	0.6	0.3	0.2	0.6	0.2	0.6	0.0	0.8	0.5	0.5	0.8	0.5	0.4	0.4	0.7	0.2	0.3	0.2	0.3	0.6	0.7	0.6	0.3	0.9	0.5	0.0	0.5	0.2	0.1	0.4	1.6	0.0	1.1	1.8	0.1	0.2	2.9	1.2	0.2	0.1	0.5	1.7	0.0	1.4	2.6	0.7	0.6	0.5	0.0	0.4	0.5	0.0	0.9	2.3	0.0	3.2	0.0	2.1	3.1	0.0	0.8	1.1	0.0	0.0	1.0	1.7	1.5	0.0	0.2	0.3	3.3	0.5	1.1	1.9	0.3	0.5	4.4	0.0	0.3	4.9	0.2	0.9	1.1	0.6	0.0	1.6	2.1	2.5	0.3	1.2	0.7	2.5	0.5	0.2	1.5	1.6	0.5	0.9	1.2	0.3	0.5	0.4	0.8	0.1	1.4	1.5	1.6	1.3	0.9	0.9	1.4	0.3	0.2	0.7	0.1	0.2	1.1	0.6	0.2	0.3	0.5	0.6	0.1	0.3	0.3	0.2	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008770.2		ENSG00000267179	"Novel protein"		19	11925075-11979290	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"									HPA047845	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.46e-3)"	"unprognostic (9.75e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.3	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.6	0.1	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.3	0.4	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.7	0.2	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.1	0.5	0.5	0.1	0.5	0.0	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.4	0.2	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC008770.4		ENSG00000286098	"Zinc finger protein 844"		19	11987641-12078106	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046982	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"		"Cluster 29: U-266 - Adaptive immune response"				"HPA046982: AB_10964399"																		0.9	1.0	0.2	1.4	0.3	3.7	2.2	1.2	0.5	1.1	0.7	1.3	0.8	1.4	0.7	1.1	1.5	0.4	1.2	0.3	0.5	2.2	0.7	0.8	1.4	0.5	0.5	3.6	0.9	3.8		0.9	0.5	1.9	2.0	4.2	1.0	1.8	1.7	0.0	1.0	1.2	0.3	1.3	1.0	2.0	0.4	2.1	3.4	3.0	1.2	0.8		0.6	0.7	0.0	1.6	1.9	1.6	1.2	1.2	1.1	0.4	0.6	1.0	1.9	0.4	2.5	2.0	0.6	1.5	0.5	0.1	0.5	0.5	0.4	0.5	3.0	0.1	0.1	1.4	1.1	3.3	1.1	0.2	1.1	0.1	0.9	0.6	2.8	0.3	0.0	1.6	0.1	3.9	1.5	1.7	0.0	0.4	1.3	2.5	2.0	0.7	0.1	1.7	1.5	0.0	0.5	1.6	1.5	0.7	1.5	0.4	0.4	1.2	2.3	2.0	3.6	4.4	2.6	0.0	1.4	0.3	2.3	1.3	3.4	1.3	1.8	1.2	2.1	1.2	1.2	1.8	1.4	2.5	1.8	1.8	2.2	1.6	2.0	1.2	0.9	0.2	0.3	1.2	0.5	0.3	0.5	0.5	0.5	0.5	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008982.1		ENSG00000268083	"Novel protein"		19	38817471-38840178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.1"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"NB-4: 26.4"									"HPA002907, HPA051748"	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA002907: AB_1847964, HPA051748: AB_2681588"																	"unprognostic (1.36e-2)"	0.6	0.2	0.4	0.1	0.4	1.0	0.2	0.4	2.1	0.2	0.4	0.7	0.5	0.3	0.0	0.2	0.1	0.0	0.4	0.4	0.4	0.3	0.2	0.5	0.3	0.4	0.4	0.2	0.3	0.0	0.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	1.4	0.3	0.3	0.0	0.4	0.2	0.2	0.3	0.4	0.0	0.2	0.4	0.0	0.1	0.2	0.4	1.5	0.0	0.2	0.3	0.1	0.1	1.8	0.5	0.0	0.6	0.1	0.8	0.1	0.2	1.2	0.1	0.1	0.8	0.0	0.0	0.2	1.5	0.5	1.0	0.0	0.0	0.1	0.5	1.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.9	1.3	26.4	1.9	0.0	0.0	1.6	0.8	0.7	0.3	0.3	0.7	2.9	0.0	0.0	6.0	0.0	0.5	3.0	0.0	0.1	2.7	1.6	2.1	1.3	1.0	2.2	0.1	0.8	0.1	0.5	0.7	0.7	0.6	0.5	1.0	0.4	0.7	0.7	0.6	0.5	0.6	0.8	0.0	0.8	0.3	1.5	0.9	0.7	0.4	0.4	0.4	2.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC009163.5		ENSG00000261717	"Novel TMEM170A-CFDP1 readthrough protein"		16	75412684-75464706	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 4.8;skeletal muscle: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"white matter: 4.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.3;REH: 9.0;U-698: 28.4"					"Low region specificity"	"Detected in all"			HPA041316	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"				"HPA041316: AB_10794371"					"unprognostic (1.57e-1)"													0.6	0.1	0.5	0.0	0.8	0.6	0.0	0.6	1.0	0.1	0.1	1.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.0	1.4	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.1	0.4	0.2	0.7	0.8	0.1	0.1	0.0	0.1	0.0	0.0	4.8	3.0	0.3	1.0	0.0	0.0	0.0	5.9	5.0	0.8	0.0	0.1	1.5	1.3	1.2	9.3	0.0	0.0	1.0	0.0	1.2	0.0	3.8	2.1	0.8	0.7	2.1	0.0	3.0	2.4	0.3	0.3	0.0	0.3	0.0	0.0	0.9	1.9	0.0	0.0	3.6	1.0	1.0	1.2	0.0	1.6	9.0	1.4	3.2	0.0	1.8	1.1	0.9	1.5	0.0	0.7	0.4	0.7	0.4	0.7	0.0	6.4	0.5	1.5	2.6	6.0	28.4	0.8	0.3	0.6	8.5	17.5	32.0	10.4	22.2	15.1	18.1	9.5	11.9	18.6	18.6	10.7	9.8	18.0	10.5	17.0	15.9	11.6	13.3	0.5	0.8	0.6	1.0	0.4	0.1	1.4	0.4	1.1	0.1	0.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010132.3		ENSG00000256646	"Novel PSMA2 and C7orf25 readthrough"		7	42909273-42932214	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.3;Club cells: 1.8;granulocytes: 2.5;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA008188	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"			"Cluster 11: Alveolar cells - Smell perception"			"HPA008188: AB_1855819"	"unprognostic (1.73e-1)"	"unprognostic (3.83e-4)"	"unprognostic (3.10e-1)"		"unprognostic (6.63e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.59e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	4.5	0.9	2.1	0.6	1.1	0.7	0.9	0.9	0.9	1.0	1.1	0.6	0.6	0.3	0.9	1.0	0.9	1.2	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
AC010319.2		ENSG00000269035	"Novel protein"		19	17436611-17460804	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041580	Approved		Uncertain	"Nuclear membrane"		NA	NA							"Nuclear membrane"		"HPA041580: AB_10795700"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010422.5		ENSG00000269590	"Novel protein"		19	12664828-12669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.2;lymphoid tissue: 1.4;skeletal muscle: 1.3"	"Cell type enhanced"	"Detected in single"		"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 10.8;RT4: 5.5"									HPA065685	Uncertain		Approved	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Endoplasmic reticulum"		"HPA065685: AB_2685531"																		0.1	0.8	0.0	0.4	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.7	1.4	0.1	0.1	0.5	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	2.4	0.0	0.3	0.7	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.6	0.0	0.3	0.7	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.9	0.1	0.0	0.0	0.1	0.3	2.7	0.0	10.8	2.8	0.3	0.7	0.0	0.0	1.0	0.0	0.0	0.9	5.5	1.6	1.3	0.0	1.3	0.3	0.0	1.7	0.5	0.0	3.7	0.1	1.4	1.7	1.7	2.5	1.3	3.4	0.6	1.5	0.9	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010522.1		ENSG00000268750	"Novel protein"		19	57819719-57858941	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.8"									HPA056213	Uncertain					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056213: AB_2683069"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-1)"	1.8	1.3	1.2	1.4	1.0	3.0	1.8	2.2	1.3	2.3	4.6	2.3	4.2	2.1	0.0	1.5	1.7	1.2	1.7	0.9	1.0	1.3	1.9	1.9	1.5	0.9	2.0	2.6	3.6	0.7	3.1	1.3	1.7	2.6	1.1	1.0	3.0	0.4	2.2	1.6	2.0	1.1	0.1	2.3	3.0	1.0	1.1	1.2	1.9	0.6	1.0	1.9	2.0	2.6	4.4	5.4	1.4	4.5	0.4	1.9	3.6	5.4	0.1	1.3	1.3	9.7	1.3	6.2	2.9	1.7	2.0	3.3	2.4	2.1	1.3	6.3	26.8	7.5	16.0	7.4	1.8	4.1	4.0	3.6	1.3	2.9	1.9	1.4	1.0	5.6	8.3	6.6	0.1	5.7	3.5	2.0	0.9	0.8	13.7	5.5	3.1	7.8	1.0	16.9	5.0	3.4	1.1	5.0	2.2	1.1	4.3	3.2	2.5	5.5	3.0	2.4	5.2	11.5	12.2	8.4	3.3	4.4	4.0	0.0	0.7	0.0	1.8	0.9	2.3	2.8	2.0	1.7	1.2	2.2	2.5	2.2	0.0	1.2	1.1	5.1	0.5	0.9	1.2	1.0	2.2	1.3	0.9	1.0	0.9	2.0	1.7	0.1	1.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010531.1		ENSG00000131152	"Novel protein"		16	87302876-87334273	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.7;U-266/70: 3.4"									HPA040850	Approved					NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"				"HPA040850: AB_10794882"	"unprognostic (1.44e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.21e-3)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.72e-3)"	0.9	0.5	0.5	0.0	0.4	0.3	0.7	2.1	0.8	0.6	0.0	0.7	0.6	0.5	0.0	0.7	0.7	0.2	0.7	0.9	0.3	0.4	1.5	0.3	0.5	0.5	0.3	0.6	0.9	0.2	1.2	0.3	0.3	0.5	0.0	0.1	0.4	0.1	3.9	0.4	0.5	0.1	0.2	0.2	0.6	0.6	0.4	0.1	0.4	0.3	0.2	0.7	0.7	0.4	0.5	0.2	0.1	0.0	1.9	0.8	0.1	0.1	0.0	0.3	0.1	0.6	0.0	1.6	0.3	1.7	0.0	1.6	0.4	0.0	0.2	0.3	1.3	2.7	0.1	1.8	0.9	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.8	0.4	2.4	0.3	0.0	0.6	0.9	2.0	0.5	0.5	0.3	0.8	0.1	1.7	0.0	0.0	1.3	0.3	0.8	0.2	0.6	0.1	0.2	0.0	0.0	1.1	0.1	0.0	0.3	3.4	1.2	1.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	2.1	0.8	0.9	0.3	0.5	0.3	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011005.1		ENSG00000230626	"Novel protein similar to mitogen-activated protein kinase kinase 2 MAP2K2"		7	129126518-129130793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"testis: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051993	Uncertain		Approved	Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"			Cytosol		"HPA051993: AB_2681685"	"unprognostic (2.03e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.36e-5)"	"unprognostic (3.43e-2)"	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.3	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.4	0.4	0.4	0.0	0.0	0.3	0.4	3.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011455.2		ENSG00000269547	"Novel protein"		19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.0"									"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 6: T47d - Mammary gland"		"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011462.1		ENSG00000255730	"Novel protein"		19	41350853-41425001	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.7;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA036640	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"		"Cluster 60: Granulocytes - Receptor signaling"			"HPA036640: AB_10671964"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"		"unprognostic (2.65e-1)"		"unprognostic (3.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-8)"	"unprognostic (8.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.97e-2)"	7.8	14.0	0.0	0.0	0.1	0.8	8.0	0.0	0.5	10.0	0.0	8.1	0.0	6.5	0.1	16.9	7.8	0.1	18.5	0.0	0.3	12.6	20.1	8.4	0.0	0.0	0.1	8.2	13.2	0.0	8.9	0.0	0.0	8.5	0.0	0.0	9.3	0.0	11.8	14.6	6.5	0.0	0.0	10.0	7.9	12.6	0.1	0.0	10.1	0.0	0.1	8.7	11.8	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	0.2	0.8	0.0	0.0	0.3	0.2	0.8	0.0	0.2	0.1	2.4	0.1	0.3	0.2	0.2	0.8	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC012184.2		ENSG00000260537	"Novel protein, DDX19B and DDX19A readthrough"		16	70299194-70372582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 34.2;U-698: 35.1"									"HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA046380: AB_2679645, HPA066668: "																		3.3	1.8	0.0	4.3	0.0	4.5	1.3	0.0	0.2	0.5	0.0	3.1	4.0	0.5	0.0	4.0	0.5	2.8	4.6	0.0	0.0	2.3	1.9	1.2	4.0	0.0	0.0	0.2	6.3	1.5	0.0	1.2	0.0	0.9	2.6	0.7	2.1	0.2	6.0	3.8	2.8	1.0	0.0	1.1	3.0	0.0	0.0	1.3	3.1	2.1	5.8	4.3	0.7	0.0	2.2	7.6	5.5	14.4	0.0	6.4	12.7	6.6	7.9	11.8	12.6	14.0	19.2	13.1	8.7	6.4	1.4	7.2	0.0	5.0	6.6	3.9	9.6	8.7	4.5	0.9	7.3	12.2	6.2	4.3	1.1	11.5	0.0	2.3	7.7	3.3	5.3	3.5	4.8	4.8	0.1	0.0	6.7	0.6	1.8	34.2	2.7	22.9	3.6	9.2	7.3	8.1	18.1	3.2	3.2	0.9	5.4	3.0	7.8	8.1	7.6	3.2	4.8	11.0	8.0	35.1	1.0	9.0	13.8	22.4	16.1	11.6	15.5	19.8	12.8	10.4	13.3	15.3	18.2	11.5	11.3	11.3	2.2	15.9	14.8	3.8	22.1	14.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.6		ENSG00000288607	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	34	"brain: 3.4;choroid plexus: 3.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.7	0.0	0.0	0.9	1.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	0.9	1.3	1.1	1.1	3.4	3.2	2.7	1.8	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.7		ENSG00000288631	"Elongin A3"	Q8NG57	18	47028202-47029842	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"brain: 3.9;choroid plexus: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.8	0.0	0.0	1.5	1.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	3.9	3.8	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.8	1.5	1.8	1.6	1.9	3.9	3.8	2.7	1.1	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC013477.1		ENSG00000288637	"Novel protein"		4	153152435-153415081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 2.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;AN3-CA: 1.0;CACO-2: 1.1;RPTEC TERT1: 1.4;SH-SY5Y: 1.0"									"HPA035853, HPA035854, HPA043499"	Uncertain		Approved	Centrosome		NA	NA					"Cluster 35: RPTEC-TERT1 - Kidney processes"		Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659, HPA043499: AB_2732506"																		0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.3	1.8	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.7	1.4	0.1	0.0	0.0	0.0	2.1	1.0	0.1	0.8	0.0		0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	1.5	0.0	0.5	0.0	0.0	0.1		2.7	0.1	0.0	1.0	1.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	1.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.3	1.8	0.7	1.4	2.1	1.0	1.0	0.5	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC013489.1		ENSG00000173867	"Novel transcript"		15	88459501-88546585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (3.32e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	0.4	0.4	0.6	0.2	0.6	0.4	1.1	0.7	0.7	0.4	0.9	0.5	0.3	2.2	1.0	0.3	1.0	0.5	0.8	0.5	0.9	0.7	0.8	0.5	0.4	0.6	0.6	2.2	1.0	0.7		0.5	0.7	0.6	0.6	1.3	0.4	0.7	1.4	0.3	0.4	0.9	0.6	0.7	0.4	0.4	0.7	0.5	0.7	1.2	0.5	0.3		0.8	0.3	0.6	0.5	0.8	1.2	0.6	0.6	1.0	0.7	1.0	0.7	0.6	1.1	0.9	0.7	1.2	0.7	0.6	2.1	0.6	0.9	0.3	1.0	1.0	0.5	0.8	0.4	0.8	0.7	1.0	1.1	0.7	0.8	0.4	0.5	1.2	1.0	0.9	0.1	0.4	1.0	0.5	0.6	0.7	0.2	0.4	0.7	1.2	0.6	0.8	0.6	0.4	0.9	0.4	1.4	1.0	0.7	1.5	0.8	0.7	0.5	0.9	0.9	0.5	0.9	0.6	0.9	0.7	0.5	0.0	0.5	0.3	0.7	0.9	0.8	0.9	0.9	0.8	0.8	0.7	1.0	1.1	0.0	0.9	0.6	0.6	0.8	0.9	0.6	0.6	0.7	0.7	0.5	0.9	0.6	0.6	0.7	0.6	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC018630.2		ENSG00000275778	"PRH1-PRR4 readthrough"		12	10845849-11171600	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"Alveolar cells type 1: 3.2;Club cells: 1.8;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;GAMG: 2.3;HDLM-2: 2.5;HSkMC: 1.1;MCF7: 1.2;RPMI-8226: 2.0"									HPA042133	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"		"Cluster 44: HDLM-2 - Immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA042133: AB_10793979"	"unprognostic (8.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.45e-3)"	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.4	0.1	0.4	0.3	0.5	0.2		0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.3		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.5	1.4	0.0	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.2	0.9	0.3	1.3	0.8	1.3	1.8	0.6	1.3	2.0	1.1	0.0	1.9	0.6	1.9	1.1	0.5	0.1	0.1	0.1	0.5	0.1	0.4	0.1	0.4	0.1	0.3	0.2	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
AC018755.2		ENSG00000268500	"Novel transcript, sense intronic to AC018755.18"		19	51612091-51646889	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lymphoid tissue: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 5.0"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 180.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 180.3;monocytes: 70.1"	"Group enriched"	"Detected in some"	10	"HMC-1: 78.0;U-937: 33.2"									HPA009085	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA009085: AB_1079965"																		1.4	0.4	0.1	7.2	0.2	26.1	0.1	0.3	5.0	0.3	0.3	0.3	0.8	0.1	0.0	1.0	0.2	1.0	0.3	0.1	0.4	0.1	0.2	1.3	2.9	0.7	0.4	0.0	0.2	0.1	0.0	0.5	1.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.5	0.4	4.0	0.4	0.1	0.7	0.6	0.0	0.1	0.5	1.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.6	78.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	33.2	0.1	11.2	32.4	1.0	0.1	32.3	0.0	2.0	0.0	0.0	22.8	2.7	0.0	0.0	180.3	0.8	70.1	4.9	0.0	17.3	0.1	0.2	0.3	5.0	0.1	0.4	0.7	0.4	1.6	0.4	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC019117.1		ENSG00000283321	"Novel protein"		7	17299295-17467234	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"cervix: 8.4;urinary bladder: 15.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 1.1;Early spermatids: 2.1;Endometrial ciliated cells: 1.4;Late spermatids: 1.2;Theca cells: 1.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 55.3"									HPA029722	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA029722: AB_10599189"																		0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.0	0.1	8.4	0.0	0.1	0.3	1.6	0.4	0.2	2.0	0.8	0.0	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.3	0.7	0.9	0.3	0.0	0.5	0.1	0.4	0.0	0.2	1.1	0.4	0.1	0.1	0.1	0.0	0.1	15.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	11.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0
AC020907.6		ENSG00000285526	"Novel protein"		19	35106510-35124297	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 3.3;choroid plexus: 3.1;salivary gland: 7.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.9;Club cells: 1.3;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SCLC-21H: 6.2;WM-115: 8.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"spinal cord: 3.8"	HPA010856	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA					"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"																		0.0	0.0	2.4	0.0	3.1	0.0	0.4	2.7	3.2	1.4	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	2.4	0.0	0.1	0.0	0.0	2.9	2.7	0.0	1.8	0.0		0.2	2.6	0.3	0.0	0.2	7.3	0.1	0.0	1.6	0.0	0.0	2.3	0.0	0.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0		3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	2.7	3.2	2.2	2.4	2.9	2.7	2.6	2.3	2.6	3.3	0.0	6.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC020909.1		ENSG00000142539	"Novel protein"		19	50415799-50428409	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	16	"B-cells: 1.1;dendritic cells: 2.0"	"Cell line enhanced"	"Detected in some"		"REH: 3.0;U-2 OS: 1.1;U-266/70: 1.5;U-698: 2.4"									HPA018523	Uncertain					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"				"HPA018523: AB_1857443"																		0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.5	0.3	2.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC022150.4		ENSG00000269825	"Novel zinc finger protein"		19	52650447-52690533	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 15.0"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 15: RT4 - Unknown function"		"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (2.33e-3)"	"unprognostic (9.06e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.55e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-3)"	"unprognostic (3.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.89e-1)"	1.1	1.1	1.7	2.0	4.9	3.1	1.6	5.2	2.1	1.0	2.2	0.7	0.8	1.4	2.1	1.1	0.8	1.6	0.8	1.1	2.1	1.4	0.3	1.2	1.6	3.8	2.4	1.2	1.1	1.2		2.8	4.0	1.4	0.9	3.1	0.9	2.0	0.5	2.1	0.6	1.2	2.5	1.8	1.3	1.8	2.6	2.1	1.5	0.6	1.9	1.1		3.2	5.0	0.0	2.6	6.4	0.6	1.4	6.1	5.1	3.0	3.7	4.5	4.3	2.9	4.1	1.4	2.8	2.5	1.8	4.6	2.4	5.7	0.1	0.4	2.5	14.3	0.8	0.5	3.1	4.0	1.6	0.3	5.4	6.4	1.2	4.0	4.4	4.5	1.7	3.5	2.1	4.4	2.3	1.6	0.0	7.1	6.9	4.7	2.2	2.4	15.0	2.9	1.8	6.4	2.7	0.5	6.4	7.3	2.1	5.7	9.6	4.2	1.8	7.8	0.1	3.0	5.7	0.1	1.5	5.1	0.8	0.3	0.2	0.7	0.3	0.5	0.5	0.5	0.8	0.2	0.5	0.5	0.7	0.7	0.9	0.3	0.4	0.5	0.3	1.7	4.9	5.2	2.1	1.1	2.1	3.8	2.4	4.0	2.5	2.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC022414.1		ENSG00000284762	"Phosphodiesterase 8B"		5	77086732-77427124	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"thyroid gland: 12.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.4;HeLa: 5.3;SCLC-21H: 2.5"									HPA036912	Supported					NA	NA					"Cluster 20: HeLa - Mitochondria"				"HPA036912: AB_10670377"																		1.6	0.8	0.9	0.2	2.0	0.0	0.5	0.4	1.3	1.3	0.1	0.2	0.1	2.1	1.9	0.2	3.6	0.7	1.8	1.2	3.0	1.2	0.4	0.6	0.1	1.5	1.2	1.6	1.1	0.9		1.4	1.7	1.3	0.4	2.7	0.4	1.9	0.1	0.0	0.1	2.5	0.7	0.2	0.8	0.7	1.7	0.2	12.5	0.2	0.4	0.2		2.8	0.1	2.4	0.3	1.0	1.7	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.2	0.0	0.7	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.6	0.2	5.3	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.8	0.4	0.0	0.6	0.0	0.1	0.7	0.2	0.0	0.2	0.0	2.5	0.6	1.9	1.5	0.5	0.2	1.5	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.4	0.6	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.4	1.3	1.2	3.0	1.5	1.2	1.7	0.7	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC023055.1		ENSG00000257390	"Novel protein"		12	55757275-55827546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	9	"testis: 8.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 6.3;granulocytes: 2.5;Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.0"									"HPA017653, HPA030902, HPA030903"	Uncertain		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (8.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-5)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-3)"	0.4	0.1	0.0	0.1	0.2	0.5	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	0.0	0.1	0.3	0.0	0.0	0.3	0.2	0.3	0.9	0.1	0.1	0.2	0.2	0.4	0.0	0.0	0.1	0.2	8.9	0.7	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	1.2	1.7	1.1	0.0	1.3	0.8	0.6	0.1	0.5	0.5	0.4	1.3	0.2	0.7	0.4	0.7	1.0	1.2	0.5	0.0	1.2	0.9	0.3	0.5	0.5	1.4	1.0	0.2	0.0	0.5	0.2	0.0	0.1	0.7	0.6	0.0	0.2	0.0	0.7	1.0	1.9	1.4	0.0	1.1	1.4	0.8	0.7	0.6	1.6	0.5	0.5	2.1	3.0	0.5	0.4	0.4	0.0	0.0	0.1	0.2	0.3	0.0	1.1	0.9	0.3	0.2	0.2	1.2	0.4	1.4	1.1	0.8	0.7	1.9	1.3	0.7	1.1	1.3	0.9	1.3	0.2	1.8	2.0	0.6	1.8	1.4	0.0	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.7	0.3	0.1	6.4	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	2.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
AC024598.1		ENSG00000285837	"Novel protein"		10	62374192-62672011	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"gallbladder: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;TIME: 2.5"									HPA052446	Uncertain		Approved	Vesicles,Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"		"Vesicles, Centrosome"		"HPA052446: AB_2681836"																		0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.7	0.1	0.4	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC037459.1		ENSG00000248235	"Novel protein"		8	22589274-22602084	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.9;U-2 OS: 1.9;U-2197: 3.7;U-87 MG: 2.0"									HPA024667	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"				"HPA024667: AB_1845783"	"unprognostic (3.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.64e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.23e-3)"	0.7	0.4	0.3	0.8	0.3	0.0	0.2	0.8	0.8	0.6	0.4	0.5	0.4	0.5	0.0	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.2	0.7	0.7	0.7	0.4	0.4	0.0	0.0	0.1	0.3	0.7	0.3	0.0	0.0	0.8	0.0	1.4	0.7	1.7	0.3	0.3	2.6	0.5	0.0	0.4	0.2	0.2	0.1	0.0	0.3	0.5	0.6	0.1	0.7	0.3	1.6	0.0	1.5	0.2	1.0	1.3	0.5	1.1	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.2	0.3	0.0	0.5	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.7	0.9	1.5	0.1	0.6	0.3	0.0	0.9	1.9	3.7	0.1	0.0	0.0	0.1	2.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.8	0.8	0.2	0.3	0.7	0.4	0.7	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC068580.4		ENSG00000250644	"Novel protein"		11	1734821-1763954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	4	"adrenal gland: 202.9;liver: 54.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.7;granulocytes: 1.3;Macrophages: 1.7;Respiratory ciliated cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 241.6;hTERT-RPE1: 212.9;U-87 MG: 63.6"									HPA003001	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA003001: AB_1078404"	"unprognostic (5.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-6)"	"unprognostic (1.77e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.35e-2)"	"unprognostic (5.79e-5)"	"unprognostic (7.47e-2)"	9.3	202.9	14.8	2.2	17.0	13.3	7.7	16.4	24.0	4.6	4.5	4.3	2.8	3.9	6.7	6.9	3.2	9.9	3.7	12.8	15.3	20.7	54.0	11.5	1.9	20.7	13.2	2.5	3.2	0.8	2.4	7.0	19.9	7.6	2.2	2.2	14.1	15.1	20.6	15.3	6.6	1.3	12.3	30.1	4.5	8.5	14.4	1.1	1.6	3.2	2.9	15.9	11.1	22.7	1.2	9.0	0.5	1.8	4.2	2.3	2.5	3.2	4.2	0.9	1.1	2.2	241.6	0.5	4.1	13.4	8.3	18.5	0.4	0.3	0.3	1.1	4.6	1.7	1.3	0.9	4.2	2.5	5.0	9.6	2.7	1.1	1.7	212.9	0.6	0.9	0.3	4.0	22.9	23.1	0.0	3.2	1.1	10.9	1.6	0.5	3.6	2.1	10.0	11.3	0.9	49.2	1.6	18.8	32.6	0.6	41.4	1.1	5.9	12.2	1.8	2.8	4.3	10.9	25.8	0.5	63.6	2.2	10.2	1.3	5.9	1.7	1.5	2.5	1.1	0.3	0.7	1.0	1.6	0.1	1.1	1.6	5.8	7.0	3.4	3.0	0.9	5.0	14.8	17.0	16.4	24.0	12.8	15.3	20.7	13.2	19.9	12.3	14.4	22.7	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0
AC068631.2		ENSG00000283149	"Novel protein"		3	186581995-186597103	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010814	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA010814: AB_1078691"																		9.2	10.1	5.2	11.6	5.4	9.8	7.9	5.4	15.4	6.7	4.9	18.2	12.1	5.9	13.9	8.6	5.9	7.6	13.4	5.2	5.2	14.7	32.7	9.7	4.5	5.2	5.3	6.0	22.7	7.9	8.3	6.0	5.4	8.6	5.9	8.9	9.2	4.2	4.6	6.5	9.9	3.0	4.9	13.4	10.6	8.5	5.2	6.0	18.6	0.0	5.2	7.6	6.8	5.1	36.3	28.9	35.7	42.8	29.6	12.9	9.3	71.3	16.4	25.1	16.4	102.9	15.0	21.6	82.1	46.3	40.5	24.3	31.8	25.1	22.6	18.7	0.0	23.6	52.7	102.2	22.7	46.0	11.6	14.0	8.0	32.0	50.5	21.3	13.4	10.6	12.8	81.1	10.7	83.7	23.7	2.0	9.7	93.6	0.0	14.2	37.2	26.9	12.4	69.5	0.3	0.6	30.9	62.2	18.4	35.9	40.0	57.9	7.3	17.9	21.3	13.0	62.9	31.5	88.4	66.5	26.3	33.7	35.2	7.5	6.4	8.6	10.3	8.6	7.0	7.8	6.4	8.8	9.9	4.8	4.2	8.3	1.6	10.2	7.2	15.3	8.4	7.3	5.2	5.4	5.4	15.4	5.2	5.2	5.2	5.3	5.4	4.9	5.2	5.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC068775.1		ENSG00000255641	"Novel protein"		12	10412312-10436001	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 5.1;choroid plexus: 2.5;lymphoid tissue: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 134.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 134.8"	"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;HeLa: 8.6;HSkMC: 1.5;SuSa: 3.4"									HPA062570	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"			"HPA062570: AB_2684795"					"unprognostic (6.09e-2)"													0.4	0.1	3.5	0.3	3.4	1.7	0.2	3.1	5.1	0.1	2.5	0.6	0.3	0.4	0.0	0.1	0.2	0.1	0.2	3.7	3.6	0.1	0.4	1.0	0.8	3.8	3.5	0.1	0.1	0.0	0.0	0.1	3.8	0.2	0.4	0.1	0.4	0.0	0.0	0.0	0.8	0.1	3.4	5.0	0.4	0.2	3.8	0.6	0.2	0.0	0.4	0.2	0.2	4.2	0.0	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	8.6	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	17.2	0.0	0.1	0.0	0.0	15.0	0.0	0.0	0.1	20.8	0.8	134.8	0.0	0.1	0.0	8.4	3.5	3.4	3.1	5.1	3.7	3.6	3.8	3.5	3.8	3.4	3.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
AC069444.2		ENSG00000285585	"Novel protein"		3	119703076-119807570	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 9.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074084	Uncertain					NA	NA						"Cluster 49: Ciliated cells - Cilium organization"			"HPA074084: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC073896.1		ENSG00000144785	"Novel protein"		12	56285916-56316059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"pancreas: 18.8;salivary gland: 19.4"	"Cell type enhanced"	"Detected in single"		"Club cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038466, HPA068007"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centriolar satellite"		"HPA038466: AB_10672646, HPA068007: "	"unprognostic (3.07e-2)"	"unprognostic (9.89e-3)"	"unprognostic (8.23e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.63e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.26e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.93e-1)"	7.0	5.7	1.5	3.5	1.5	5.1	3.9	1.5	5.3	1.7	2.6	8.9	9.8	1.2	0.3	3.0	3.3	5.9	1.4	1.7	1.2	3.0	4.7	1.8	2.2	1.6	1.4	3.7	18.8	3.7	0.3	4.4	1.6	2.5	0.3	0.7	19.4	6.6	1.5	1.0	5.6	0.9	1.3	4.2	7.0	2.0	1.6	3.3	3.3	1.4	0.9	2.6	0.3	2.2	22.0	38.1	5.4	23.4	17.4	12.6	37.7	42.5	42.1	33.2	23.4	43.2	22.7	15.8	61.9	17.7	18.8	49.0	9.9	15.3	3.8	30.6	18.4	0.8	22.8	42.6	37.6	15.5	45.4	24.5	23.3	18.3	1.1	19.8	29.0	43.8	19.2	18.5	5.1	36.9	11.0	24.7	37.5	19.1	97.7	50.3	21.2	29.2	0.3	3.4	30.6	29.1	26.1	25.8	26.9	0.6	20.9	84.8	20.6	30.1	15.6	18.8	37.4	29.4	62.0	17.1	41.4	27.0	41.3	31.5	41.3	19.4	40.8	36.4	41.6	65.1	35.5	43.2	50.3	51.9	40.9	38.7	6.9	41.7	22.1	59.5	39.6	70.1	1.5	1.5	1.5	5.3	1.7	1.2	1.6	1.4	1.6	1.3	1.6	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
AC087721.2		ENSG00000285920	"Novel protein"		15	41284007-41380996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA042904, HPA074847"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"																		0.8	1.5	0.3	1.8	0.2	2.9	1.3	2.1	1.0	1.0	0.1	1.8	1.7	0.9	0.3	1.6	0.7	1.1	0.8	0.1	0.3	1.1	1.7	1.0	2.4	0.4	0.6	1.5	0.6	0.9		1.3	0.5	0.7	1.9	1.8	0.6	1.1	3.1	1.0	1.4	1.1	0.2	1.6	1.2	2.9	0.6	2.6	0.7	1.9	2.5	1.5		0.4	3.7	1.2	6.6	5.5	2.5	3.7	3.4	3.8	2.9	4.8	4.7	2.0	4.1	2.8	4.0	2.2	4.4	8.7	10.1	5.3	4.1	7.2	3.6	9.4	3.8	3.6	2.0	14.2	8.2	2.1	3.3	3.3	8.8	1.9	4.7	10.6	8.7	11.0	4.3	1.8	5.5	4.5	6.9	9.2	5.5	7.6	5.0	4.3	4.6	4.0	6.6	6.0	6.6	3.9	2.6	7.0	6.6	8.5	4.3	2.8	5.5	3.2	5.8	5.6	10.7	9.4	2.4	8.7	5.6	0.1	0.4	1.0	0.2	0.4	0.3	0.4	0.5	0.4	0.6	0.3	0.2	0.2	0.1	0.3	0.5	0.9	0.9	0.5	0.3	0.2	2.1	1.0	0.1	0.3	0.4	0.6	0.5	0.2	0.6	0.4	0.0	6.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
AC090373.2		ENSG00000288616	"Elongin A3 family member D"	A6NLF2	18	46962768-46964408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	37	"brain: 3.4;choroid plexus: 4.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	3.4	1.9	0.0	0.0	0.0		0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.2	1.4	1.0	0.9	3.4	1.9	2.4	0.8	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC090527.2		ENSG00000260170	"Novel protein"		15	45587351-45676314	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;THP-1: 1.1"									HPA041589	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"		"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041589: AB_2677565"					"unprognostic (5.93e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.03e-2)"						"unprognostic (1.54e-1)"				0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.2	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.3	0.2	2.2	1.7	0.9	0.8	0.8	1.0	0.7	0.7	0.3	0.0	1.3	1.6	0.4	6.2	0.0	0.9	0.5	1.2	0.4	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC091959.1		ENSG00000275740	"Novel readthrough transcript"		5	146203550-146339251	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (6.42e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.05e-2)"		"unprognostic (4.95e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.12e-2)"	0.5	0.5	0.2	1.4	0.6	2.4	0.5	1.9	0.8	1.0	0.8	0.6	1.5	0.5	0.0	1.2	1.0	0.4	0.6	0.4	1.0	0.5	0.4	0.7	1.3	0.4	0.3	1.3	0.7	0.9	0.0	0.9	0.3	0.5	0.7	0.7	0.9	0.6	0.6	0.3	1.1	1.0	0.0	0.7	0.9	6.7	0.6	1.8	1.5	0.7	1.2	0.8	0.1	0.8	7.2	11.4	5.6	5.5	1.7	1.7	5.0	8.9	5.4	10.4	10.7	12.4	5.9	8.6	5.3	4.8	6.6	5.5	8.2	7.9	8.9	16.0	4.5	10.0	5.5	1.3	1.2	12.0	9.5	2.4	1.0	9.9	6.1	1.7	3.3	3.2	13.1	5.4	3.3	3.7	9.6	0.0	5.1	3.2	7.4	9.6	10.8	4.8	0.7	9.2	5.6	3.9	12.9	2.9	4.0	1.9	9.3	1.7	6.8	5.8	6.7	6.9	8.9	6.4	14.9	13.4	6.3	6.9	6.6	18.2	7.0	14.5	10.4	7.2	11.6	10.3	9.5	8.2	7.5	12.2	10.0	9.9	10.3	10.4	12.0	10.2	9.3	7.8	0.2	0.6	1.9	0.8	0.4	1.0	0.4	0.3	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AC092143.1		ENSG00000198211	"Novel protein (MC1R-TUBB3 readthrough)"		16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	12	"testis: 6.6"	"Cell type enriched"	"Detected in single"	15	"Fibroblasts: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 10.7"									"CAB011512, HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092647.5		ENSG00000249773	"Novel zinc finger protein 713 (ZNF713) and mitochondrial ribosomal protein S17 (MRPS17) protein"		7	55887277-55955239	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"testis: 2.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA047159	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047159: AB_2679961"	"unprognostic (1.54e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.02e-2)"		"unprognostic (3.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.67e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	0.3	0.2	1.0	0.2	1.2	0.7	0.8	1.0	1.1	0.5	0.5	0.3	0.3	0.8	0.2	0.3	0.8	0.2	0.4	0.8	1.3	0.5	0.2	0.4	0.0	1.3	1.1	0.4	0.5	0.5	0.9	0.3	1.2	0.4	0.2	0.7	0.3	0.4	0.3	0.3	0.4	0.4	0.9	0.2	0.6	2.8	1.5	0.8	0.5	0.3	0.3	0.3	0.3	1.6	5.2	0.2	3.4	3.7	0.4	0.1	1.2	0.8	0.1	0.5	0.3	0.1	1.9	2.3	1.6	0.2	2.5	0.7	1.7	1.1	0.3	1.4	1.7	0.8	2.0	0.5	0.5	1.7	0.9	0.3	0.8	0.3	1.0	0.8	0.8	1.4	1.4	0.7	0.4	0.5	2.1	0.7	3.0	1.0	1.0	2.0	0.8	0.4	1.8	0.4	2.7	3.2	3.3	0.9	0.2	1.5	3.1	1.1	0.7	0.1	4.7	0.3	1.8	1.2	1.4	1.9	0.8	0.9	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	1.2	1.0	1.1	0.8	1.3	1.3	1.1	1.2	0.9	1.5	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0
AC092718.2		ENSG00000260643	"Novel protein"		16	81053587-81096296	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 13.4"									HPA041368	Approved		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"		Vesicles		"HPA041368: AB_10804001"	"unprognostic (3.87e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.56e-3)"	"unprognostic (3.03e-1)"	4.4	2.9	12.8	1.1	14.6	0.5	3.5	12.7	15.5	3.1	12.8	2.5	0.3	2.5	5.0	1.7	4.8	1.3	4.8	13.5	13.6	6.5	9.6	2.6	0.9	13.8	14.4	3.2	2.9	3.2	8.1	2.8	13.8	4.5	0.8	5.7	2.6	1.7	6.4	1.2	1.4	1.6	12.1	1.3	2.2	6.2	14.0	1.3	14.2	2.9	0.6	3.6	2.7	14.1	4.1	3.1	4.8	3.4	11.1	3.9	5.0	2.1	0.9	1.8	0.3	0.3	4.7	0.6	4.1	0.9	4.1	3.3	3.0	1.3	2.7	1.4	5.3	0.7	1.5	3.1	3.9	3.0	2.6	4.7	5.9	2.8	2.6	5.3	1.9	5.9	3.6	0.3	2.5	4.5	4.1	13.4	2.3	3.2	1.7	11.7	1.0	1.9	7.3	1.6	3.8	3.7	2.4	1.0	4.1	5.1	1.1	4.7	2.1	0.8	1.7	2.2	1.7	2.6	3.3	5.4	2.4	2.1	2.0	0.9	0.4	0.3	1.2	0.3	1.3	1.6	0.8	0.4	1.1	1.5	1.2	0.7	0.3	1.7	0.4	1.8	0.2	1.0	12.8	14.6	12.7	15.5	13.5	13.6	13.8	14.4	13.8	12.1	14.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092718.7		ENSG00000284512	"Novel protein"		16	81022316-81096284	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 6.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											HPA041368	Uncertain		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"		Vesicles		"HPA041368: AB_10804001"																		0.1	0.2	2.7	0.3	3.5	1.1	0.2	2.9	3.5	0.2	2.1	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	2.4	2.5	0.2	0.2	0.1	0.2	2.9	3.0	0.3	0.2	0.3	0.3	0.2	2.8	1.3	0.0	0.7	0.1	0.1	0.1	0.2	0.1	0.0	2.7	0.1	0.1	6.5	2.8	0.0	0.5	0.0	0.0	0.1	0.1	3.9	0.4	0.2	0.6	0.5	0.1	0.0	0.5	0.8	0.1	0.1	0.0	0.4	0.6	0.6	0.3	0.2	0.3	0.9	0.0	0.0	0.1	0.1	0.4	0.3	1.0	0.6	0.0	0.6	1.1	0.2	0.0	0.1	0.0	0.3	0.0	0.7	0.3	1.0	0.0	1.3	0.6	1.4	0.6	0.2	0.4	0.5	0.4	0.1	0.0	0.3	0.9	0.2	0.6	0.3	0.1	0.3	0.4	0.2	0.1	0.5	0.6	0.4	0.3	0.5	0.3	1.2	0.2	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.3	0.1	2.7	3.5	2.9	3.5	2.4	2.5	2.9	3.0	2.8	2.7	2.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093155.3		ENSG00000267561	"Novel protein"		1	86993009-87169204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.3"	"Cell type enriched"	"Detected in single"	6	"granulocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.4;HEL: 14.7;HMC-1: 17.9;THP-1: 12.7"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	19.3	1.8	2.6	3.1	3.2	0.3	7.0	1.5	5.0	4.4	1.8	3.7	2.4	2.6	2.2	3.2	1.5	4.8	8.4	2.7	1.8	1.9	1.7	5.5	2.2	1.7	1.9	6.8	1.1	0.8	0.0	5.9	1.7	0.8	3.3	0.3	2.9	2.4	1.3	0.4	3.1	4.5	1.8	2.7	1.2	3.8	1.8	1.1	1.9	3.6	1.0	4.6	0.0	2.1	0.0	0.1	0.9	2.2	2.5	9.4	0.3	0.0	0.1	0.0	0.4	0.7	0.9	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.4	0.1	0.5	14.7	0.4	0.1	0.1	0.3	17.9	1.6	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	1.2	0.0	0.2	0.3	0.0	0.4	0.4	0.2	0.4	0.3	0.0	0.5	0.9	0.2	12.7	0.0	0.3	0.7	0.1	1.5	1.0	4.0	0.0	0.7	0.1	0.4	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	3.2	1.5	5.0	2.7	1.8	1.7	1.9	1.7	1.8	1.8	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC093525.2		ENSG00000260272	"Novel protein"		16	2496032-2520218	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.1;Club cells: 17.3;granulocytes: 17.7;Macrophages: 7.7;Respiratory ciliated cells: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;RPMI-8226: 1.1;SCLC-21H: 1.0;SH-SY5Y: 1.3"									HPA044712	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"			"HPA044712: AB_10795619"	"unprognostic (4.12e-1)"	"unprognostic (9.64e-2)"			"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.13e-2)"		"unprognostic (9.83e-2)"	"unprognostic (5.98e-3)"	0.4	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.0	0.3	0.0	0.0	3.0	0.2	0.7	0.0	0.1	0.0	0.1	0.4	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.7	0.1	0.3	0.0	0.0	0.3	0.1	0.0	1.1	0.1	0.0	1.0	1.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.4	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0
AC093827.5		ENSG00000285458	"Novel protein"		4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 3.1;Distal tubular cells: 5.9;Respiratory ciliated cells: 8.0"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.1"									HPA057434	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Focal adhesion sites"	Cytosol	"HPA057434: AB_2683438"																		1.3	1.2	2.2	0.7	2.5	1.1	1.9	3.6	3.3	1.2	1.3	0.9	1.0	1.1	2.0	1.3	1.0	0.8	2.7	2.6	2.2	1.7	0.7	1.0	0.5	2.0	2.0	1.1	0.9	1.6		0.9	2.1	1.4	1.2	2.0	1.4	0.9	3.4	2.8	1.0	1.0	1.0	0.9	1.3	1.9	2.1	0.6	2.2	3.7	0.4	0.9		3.6	1.6	1.0	0.4	0.7	1.5	1.3	0.6	1.5	1.6	0.5	0.7	0.7	2.6	0.2	1.3	1.0	1.2	1.1	0.7	0.9	0.6	1.2	0.6	1.2	1.3	0.7	0.8	2.1	0.8	0.9	2.3	0.5	1.7	0.8	0.4	0.6	0.9	5.1	0.3	0.5	0.9	0.7	1.0	1.6	0.5	1.6	0.6	1.3	1.5	1.1	0.5	0.8	1.1	1.0	1.3	0.7	2.0	1.3	0.6	1.1	1.5	0.5	0.7	2.3	1.1	2.3	0.9	1.0	0.6	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.2	0.3	0.3	0.3	0.3	0.6	0.4	0.4	0.2	0.5	0.1	0.1	2.2	2.5	3.6	3.3	2.6	2.2	2.0	2.0	2.1	1.0	2.1	3.6	0.7	12.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.0	1.1	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0
AC093899.2		ENSG00000251569	"Novel protein"		2	169479480-169525922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"retina: 18.5;testis: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HSkMC: 3.0;LHCN-M2: 5.4;SK-MEL-30: 2.5"									HPA046125	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA046125: AB_2679549"																		0.6	0.1	0.4	0.1	0.4	0.0	1.6	0.4	1.3	0.7	0.4	0.3	0.1	1.4	1.3	0.3	1.8	1.8	1.4	0.4	0.4	1.0	0.1	0.9	0.3	0.5	0.5	1.2	0.4	1.0	0.5	0.4	0.5	1.7	0.7	18.5	0.4	1.3	2.6	0.2	0.1	1.0	0.4	0.6	0.4	8.8	0.4	0.6	1.8	2.4	0.6	0.8	0.1	0.4	0.0	0.0	1.0	0.1	0.8	4.6	0.0	1.0	0.6	0.9	0.5	0.0	0.0	0.0	0.2	1.1	1.2	0.0	0.7	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.1	0.5	0.0	3.0	0.5	1.2	0.4	1.1	1.5	0.9	0.3	0.0	5.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.7	0.1	0.3	0.0	2.5	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.4	0.4	0.5	0.5	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC097634.4		ENSG00000285708	"Novel protein"		3	70959226-71754229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"basal ganglia: 102.6"					HPA003876	Uncertain		Approved	Nucleoplasm		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA003876: AB_1078907"																		0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC099489.1		ENSG00000188897	"Novel lipoprotein amino terminal region containing protein"		16	11359845-11527245	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 5.3;Glandular and luminal cells: 2.3;granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;HDLM-2: 3.4;U-266/70: 1.7"					"Not detected"	"Not detected"			HPA042154	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA042154: AB_2677877"	"unprognostic (4.69e-2)"	"unprognostic (3.80e-2)"	"unprognostic (7.24e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.91e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.04e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.72e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.33e-5)"	2.2	0.5	0.7	3.7	0.6	1.5	0.9	0.8	1.7	1.7	0.6	0.8	0.1	0.9	0.3	0.5	3.4	0.5	1.4	0.6	0.4	2.2	2.3	5.2	0.8	0.6	0.5	0.7	0.8	0.5	1.0	0.3	1.0	1.9	0.1	0.2	3.0	0.4	2.4	3.6	1.0	0.1	0.4	18.6	1.2	4.8	0.5	0.2	0.9	0.4	0.3	1.6	1.1	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.1	1.0	0.3	0.0	0.0	0.2	0.1	1.1	0.0	0.2	0.3	0.2	0.0	0.4	0.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.8	1.7	0.6	0.4	0.6	0.5	1.0	0.4	0.5	0.9	0.4	9.6	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	1.6	0.9	0.3	0.0	0.0	0.0	0.2	0.1	0.5	0.0	2.3	3.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0
AC104389.6		ENSG00000284931	"Novel protein"		11	5248270-5254783	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	24	"placenta: 4358.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 7590.9"									HPA043234	Uncertain					NA	NA					"Cluster 36: HEL - Hemostasis"				"HPA043234: AB_2678378"																		0.7	2.9	0.4	0.0	0.4	184.3	3.3	0.4	2.0	0.0	0.5	0.1	0.1	0.1	0.4	0.8	1.1	6.7	0.0	0.4	0.5	0.3	2.3	0.7	0.0	0.7	0.4	0.3	2.9	0.6		4358.4	0.9	0.5	0.2	0.0	0.7	0.1	5.1	0.0	0.2	1.8	0.7	0.0	0.0	0.2	0.5	3.9	0.4	5.3	0.0	0.2		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7590.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1682.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.4	0.4	0.4	2.0	0.4	0.5	0.7	0.4	0.9	0.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC109583.1		ENSG00000206549	"Novel protein identical to PRSS50"		3	46712115-46812574	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 4.8;thyroid gland: 6.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040768	Supported					NA	NA				"Cluster 51: Non-specific - Unknown function"					"HPA040768: AB_2677126"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.32e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.66e-3)"	0.2	0.3	0.1	0.0	0.1	0.0	0.7	0.7	0.2	1.7	0.5	0.5	0.1	0.7	3.0	0.1	1.0	0.0	1.5	0.0	0.4	1.6	0.8	0.3	0.0	0.3	0.3	0.7	1.5	1.8	4.6	0.0	0.3	1.5	0.0	0.1	0.8	0.7	4.8	0.2	0.2	0.1	0.2	0.1	0.3	1.8	0.3	0.0	6.0	0.2	0.0	0.6	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.2	0.0	0.4	0.3	0.3	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC116366.1		ENSG00000283782	"Novel protein"		5	132410832-132646079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.0;Breast glandular cells: 6.0;Endometrial ciliated cells: 11.7;Endometrial stromal cells: 10.9;Glandular and luminal cells: 22.2"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052291	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"		"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA052291: AB_2681786"																		4.0	3.4	2.5	3.6	2.4	2.0	4.1	3.3	2.9	4.3	2.7	3.7	4.9	3.1	3.3	2.0	3.8	3.5	3.6	2.5	3.3	4.2	4.7	4.4	4.7	3.1	3.0	6.2	1.1	4.3		2.6	3.1	3.8	4.0	2.2	2.8	4.3	3.8	1.8	4.0	3.0	3.2	4.7	3.9	1.9	2.9	6.2	3.2	5.8	5.0	2.8		3.0	3.7	0.2	0.9	2.2	8.0	7.0	5.3	4.0	3.1	6.0	5.7	0.2	7.9	3.7	2.3	3.9	10.2	2.4	2.5	0.9	3.1	7.3	1.2	4.4	0.9	0.5	12.6	2.3	3.1	4.9	1.3	4.1	4.5	6.7	4.7	4.0	0.5	8.6	6.7	0.1	8.6	3.0	1.6	2.2	1.3	7.9	3.2	11.4	1.4	0.3	1.9	1.4	2.0	1.6	3.2	2.6	0.2	3.7	4.4	2.9	1.9	2.0	2.0	12.5	6.7	3.0	3.6	9.0	1.5	2.7	1.1	4.4	4.7	1.9	2.7	3.0	2.6	3.5	0.6	2.9	2.9	3.4	2.7	3.4	1.9	2.0	3.3	2.2	2.5	2.4	3.3	2.9	2.5	3.3	3.1	3.0	3.1	3.2	2.9	3.0	9.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.7	0.0	11.7	10.9	3.1	0.0	0.0	0.0	0.5	0.0	2.5	0.0	22.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0
AC126283.1		ENSG00000285330	"Novel protein"		4	109713916-109801999	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 1.5;Collecting duct cells: 3.7;Endometrial ciliated cells: 3.4"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 38.1;HDLM-2: 7.8;Hep G2: 8.4;RPTEC TERT1: 11.2"									"HPA001143, HPA024061, HPA035909"	Uncertain					NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074"																		1.5	3.5	0.3	3.4	0.3	0.1	1.5	0.3	0.8	1.9	0.5	1.6	6.2	2.1	0.0	3.4	2.1	3.1	4.1	0.3	0.4	3.6	9.7	2.3	1.8	0.8	0.2	3.2	9.0	1.2		3.6	0.4	2.1	2.1	3.5	2.5	1.2	3.4	0.7	5.3	2.1	0.4	2.4	2.3	1.4	0.3	1.3	1.9	4.1	1.5	4.1		0.6	0.0	1.0	0.0	0.3	0.2	0.4	0.0	1.5	2.9	0.0	0.3	0.2	38.1	0.2	6.5	0.7	0.6	0.1	0.2	0.1	0.0	7.8	0.7	0.1	0.5	8.4	5.8	0.4	0.0	6.0	0.0	0.0	0.1	1.9	4.8	0.1	0.5	2.5	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.3	0.2	11.2	1.1	0.2	0.3	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.1	6.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.8	0.3	0.4	0.8	0.2	0.4	0.4	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0
AC127029.3		ENSG00000285947	"Novel protein"		17	63917203-63931385	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 14.0;naive B-cell: 18.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 18.4"	"Cell line enhanced"	"Detected in single"		"U-698: 2.2"									"HPA009178, HPA043715"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA009178: AB_1078483, HPA043715: AB_2678632"																		0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	2.2	0.4	14.0	0.7	0.3	0.5	18.4	0.4	0.2	0.0	0.5	3.8	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC131160.1		ENSG00000283765	"Presenilin associated rhomboid like"		3	183815568-183884889	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 9.2;skeletal muscle: 5.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 15.8"									HPA019545	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019545: AB_1855796"																		0.5	0.5	5.0	0.4	7.2	0.5	0.3	7.7	9.2	0.2	3.1	0.5	0.1	0.1	0.0	0.6	0.2	0.0	0.6	5.0	5.7	0.2	0.2	0.3	0.2	7.0	6.6	0.3	2.0	0.4	0.1	0.2	6.7	0.2	0.5	1.0	0.3	0.4	5.5	0.6	0.3	0.4	5.2	0.2	0.4	1.3	6.1	1.7	0.3	1.6	0.2	0.4	0.2	8.3	1.0	0.4	1.3	0.4	0.3	0.3	0.1	0.9	0.4	1.3	0.5	3.3	0.1	1.1	0.3	0.8	1.7	0.0	4.2	0.8	2.1	1.4	1.5	1.6	0.9	0.8	0.0	1.0	0.3	0.6	0.6	1.0	0.0	0.8	0.0	2.7	0.3	1.1	2.0	2.5	3.1	0.7	3.2	0.0	0.5	2.2	1.1	2.1	0.3	1.6	2.3	1.4	0.7	1.2	1.4	0.2	15.8	0.2	0.0	0.1	1.6	0.3	1.5	2.0	2.6	2.1	0.5	2.2	0.6	0.0	0.2	0.6	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.1	5.0	7.2	7.7	9.2	5.0	5.7	7.0	6.6	6.7	5.2	6.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC134669.1		ENSG00000265118	"Novel protein"		17	31305213-31318831	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 4.9;lymphoid tissue: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 220.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.6;HMC-1: 3.4;MOLT-4: 7.1;RPMI-8226: 5.5"									HPA045033	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA045033: AB_2679191"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"		"unprognostic (5.88e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.45e-5)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"		1.2	0.2	0.7	3.6	1.8	2.0	0.4	1.3	1.8	0.2	0.8	0.5	0.8	0.2	0.0	0.5	0.5	1.1	0.2	0.8	1.7	0.0	0.3	1.3	2.3	3.1	1.9	0.1	0.2	0.2	0.1	1.2	2.5	0.1	0.7	0.2	0.3	0.4	0.5	0.4	0.7	0.8	2.1	1.9	1.5	0.6	1.8	8.4	0.1	0.2	3.1	0.6	0.1	4.9	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.3	0.6	0.4	0.9	0.0	0.0	0.7	0.0	0.3	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	1.3	3.4	0.8	0.0	0.0	1.5	0.4	0.0	1.4	0.0	3.1	1.3	0.0	7.1	0.6	0.0	0.0	0.0	2.0	0.4	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.2	1.6	0.6	0.1	0.8	0.8	3.1	0.0	2.4	0.2	1.1	0.7	8.5	94.4	8.5	31.0	41.4	28.2	35.0	35.2	32.3	54.9	22.5	35.3	31.9	220.3	19.0	43.9	18.7	48.6	96.4	0.7	1.8	1.3	1.8	0.8	1.7	3.1	1.9	2.5	2.1	1.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
AC134980.2		ENSG00000285472	"Novel protein"		15	22015233-22095857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	48	"testis: 4.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Approved	Centrosome		NA	NA							Centrosome		"HPA057442: AB_2683442"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC135050.2		ENSG00000255439	"Novel protein, VKORC1 and PRSS53 readthrough"		16	31083439-31094956	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"skin 1: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 5.2;NB-4: 6.8;RPMI-8226: 8.7;U-266/70: 5.7"									HPA042720	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.84e-8)"	"unprognostic (4.96e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.29e-4)"	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.3	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	1.1	0.4	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.9	0.4	0.0	0.4	1.0	1.2	0.3	5.2	0.3	0.0	0.2	0.2	0.3	3.4	1.8	0.1	0.0	0.2	0.0	0.1	0.0	1.3	2.7	0.8	0.3	0.2	0.0	0.5	1.1	0.3	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.7	0.1	0.4	0.8	6.8	0.1	0.0	1.5	3.4	0.3	8.7	0.0	0.3	2.1	2.6	1.2	0.4	1.0	0.0	0.0	0.2	1.3	0.5	0.0	1.6	0.5	5.7	0.7	0.6	1.2	0.9	0.2	0.6	0.7	2.5	2.0	0.8	2.7	2.1	2.1	2.8	0.9	1.6	1.3	1.9	0.9	0.9	1.8	1.6	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC136352.3		ENSG00000277666			Unmapped	100123-101141	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA003342	Uncertain					NA	NA									"HPA003342: AB_1078588"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138696.1		ENSG00000264668	"Novel protein"		8	143247110-143276403	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;MOLT-4: 1.2"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"		"Cluster 34: Mesenchymal cell lines - ECM organization"		"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.1	0.5	0.3	0.0	0.4	0.1	0.6	0.0	0.1	0.7	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.4	0.4	0.6	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.3	1.7	0.1	0.1	0.5	1.1	0.6	0.2	0.0	0.7	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.2	0.3	0.4	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.1	0.3	0.6	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	1.1	0.0	0.8	0.2	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138811.2		ENSG00000260342	"Novel protein"		16	18788063-18801519	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 14.8"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.6;Club cells: 2.5;Endothelial cells: 2.0;granulocytes: 2.5;Macrophages: 1.8;Respiratory ciliated cells: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 52.4;HDLM-2: 69.2"									HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (1.03e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.18e-4)"	"unprognostic (2.92e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.95e-2)"	0.7	0.8	1.3	1.4	3.4	0.9	0.6	0.6	5.1	0.5	0.8	3.7	0.0	0.4	0.4	0.8	0.3	0.4	0.5	2.2	1.5	1.0	1.0	0.4	0.6	4.5	1.3	0.3	2.3	2.7	0.2	0.4	3.8	0.2	0.7	1.0	0.4	0.7	3.9	0.3	1.1	1.2	1.9	1.0	1.4	14.8	2.0	1.6	0.3	0.5	0.7	0.5	0.3	2.4	17.7	2.6	4.1	19.8	1.6	0.6	0.6	24.8	1.7	2.8	3.6	15.8	11.4	5.3	52.4	6.5	6.4	21.3	9.8	4.1	8.1	69.2	3.1	5.8	8.5	4.7	0.0	27.9	10.9	1.6	0.9	9.3	0.0	2.5	1.7	3.3	11.5	16.2	3.0	0.0	7.9	0.7	1.3	1.7	0.6	32.8	7.4	2.0	2.0	12.9	10.5	1.1	29.5	5.2	2.2	2.3	3.4	0.7	20.9	8.9	14.7	9.4	22.3	4.3	34.2	11.9	12.2	3.9	20.3	116.7	76.9	48.7	128.7	56.2	98.7	89.9	99.2	122.2	76.2	94.1	84.6	92.2	61.5	120.7	76.0	162.2	159.6	188.5	1.3	3.4	0.6	5.1	2.2	1.5	4.5	1.3	3.8	1.9	2.0	2.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0
AC138894.1		ENSG00000261832	"Novel protein"		16	28456371-28492098	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.3;Distal tubular cells: 1.9;Respiratory ciliated cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053611	Uncertain		Approved	Nucleoplasm		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.93e-3)"	"unprognostic (8.88e-3)"	"unprognostic (4.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.82e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.3	6.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.6	0.0	0.0	0.9	0.1	0.0	1.9	0.4	0.0	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	1.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0
AC138969.1		ENSG00000183889	"Novel member of the nuclear pore complex interacting protein NPIP gene family"		16	16317444-16350590	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.6;Club cells: 4.3;granulocytes: 8.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 234.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.91e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.45e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.04e-6)"	"unprognostic (6.04e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.22e-3)"	97.7	91.8	210.7	20.9	215.1	43.4	93.2	264.9	292.8	115.3	185.9	152.7	18.7	108.3	87.1	88.8	130.4	52.5	101.0	212.4	210.2	76.7	99.9	89.4	35.2	217.5	201.8	171.4	117.5	41.9	232.0	21.5	218.9	122.2	55.9	63.7	69.1	44.0	121.5	116.4	87.3	63.1	186.1	96.8	92.5	116.9	203.7	37.2	105.5	49.6	41.8	116.6	103.2	214.5	30.3	20.9	57.7	54.3	80.8	75.8	40.6	61.1	30.1	31.8	41.7	14.6	18.0	24.5	55.3	67.3	25.5	53.1	36.9	25.4	47.7	9.9	34.8	58.3	167.0	99.7	83.0	37.1	234.1	70.8	158.4	49.6	82.6	61.3	20.7	45.3	21.6	81.4	47.0	50.8	59.2	135.2	26.7	27.9	14.5	69.9	23.8	25.0	50.5	100.5	36.0	36.7	29.8	44.2	107.5	41.6	47.2	108.9	14.1	49.0	29.3	30.3	23.2	36.7	73.4	49.3	28.2	39.2	25.8	0.0	0.2	0.1	0.7	0.0	0.2	1.3	0.6	0.7	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.4	0.2	210.7	215.1	264.9	292.8	212.4	210.2	217.5	201.8	218.9	186.1	203.7	214.5	0.4	3.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	4.3	0.0	0.0	0.8	0.4	0.0	0.0	1.0	0.0	0.9	1.3	1.6	0.0	0.0	0.0	1.3	0.6	1.3	0.0	0.7	8.8	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0
AC139530.2		ENSG00000262660	"Novel protein"		17	81703371-81720539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"intestine: 2.4;skeletal muscle: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;Karpas-707: 6.8;MOLT-4: 18.0;SK-BR-3: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043, HPA023048"	Approved		Supported	Mitochondria		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950"		"unprognostic (2.36e-3)"					"unprognostic (1.17e-1)"		"unprognostic (2.87e-1)"								"unprognostic (3.83e-1)"	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.3	0.6	1.6	5.5	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.3	0.5	0.9	0.3	0.0	1.6	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.5	0.6	0.2	0.1	0.0	6.8	0.0	0.8	18.0	0.8	1.0	0.7	0.0	3.9	0.6	1.4	0.0	0.0	3.3	1.5	0.0	6.6	1.8	0.4	3.2	1.5	0.0	0.5	1.1	1.1	1.8	0.6	0.0	0.7	1.4	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC144573.1		ENSG00000285880	"ADRB3-GOT1L1 readthrough"		8	37934340-37965953	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA061969	Uncertain					NA	NA									"HPA061969: AB_2732674"																		0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0		0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC171558.1		ENSG00000274792	"Olfactory receptor 4N4-like"		Unmapped	386278-387620	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"Early spermatids: 6.9;Late spermatids: 16.6"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome		NA	NA						"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"HPA057442: AB_2683442"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC171558.3		ENSG00000275249			Unmapped	372322-373405	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain					NA	NA									"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC213203.1		ENSG00000268674		P0DMU3	Unmapped	35407-35916	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in single"	5	"brain: 1.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"				"Intermediate filaments"		"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3		0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.8	0.3	0.1	0.2	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC240274.1		ENSG00000271254	"Neuroblastoma breakpoint family member 1"		Unmapped	4612-29626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 186.6"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"		"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		12.0	29.1	16.1	10.4	19.5	9.4	10.9	19.5	17.7	12.7	14.0	21.1	17.0	18.1	13.3	9.6	18.6	12.4	7.9	14.7	18.3	14.9	8.2	12.8	6.6	22.2	19.7	29.6	5.7	18.0		14.6	21.7	11.6	21.8	13.8	11.2	9.2	10.9	11.8	25.0	16.4	18.3	12.9	8.5	40.6	20.5	6.8	12.0	6.8	7.4	8.5		23.5	25.6	33.3	36.9	26.2	12.1	13.2	8.4	37.6	22.7	34.4	28.8	12.2	9.7	20.0	2.9	34.8	11.9	14.0	14.3	7.0	46.2	13.4	29.2	5.4	19.6	16.7	16.4	17.5	11.4	8.7	10.0	19.6	15.6	22.3	9.8	32.6	24.4	6.7	13.5	35.0	21.5	7.5	5.8	3.6	79.2	38.4	23.5	2.9	8.3	14.0	27.3	44.2	37.2	31.0	16.0	10.8	28.1	5.2	13.3	21.2	21.5	53.0	17.1	7.8	28.3	16.1	5.2	26.3	7.6	1.5	0.8	1.1	0.6	0.8	1.1	0.6	0.4	0.4	0.3	0.9	0.6	0.7	0.7	2.3	0.6	0.5	0.0	0.4	16.1	19.5	19.5	17.7	14.7	18.3	22.2	19.7	21.7	18.3	20.5	23.5	2.5	22.4	11.6	0.0	1.4	0.0	1.6	0.0	6.8	2.0	4.3	4.8	0.0	1.5	4.3	0.0	4.2	9.5	0.7	12.9	1.9	2.5	46.1	2.1	3.6	4.4	0.0	5.2	0.0	2.7	12.8	6.4	3.6	1.6	15.2	14.3	2.5	2.7	6.9	0.0	0.0	4.3	0.0	4.2	0.0	11.0	16.8	5.2	0.0	0.0	4.0	2.4	2.1	0.0	0.0	2.8	3.4	18.4	0.6	0.9	5.7	1.6	10.9	1.4	6.6	6.1	2.3	186.6	46.2	5.9	0.0	2.6	1.6	33.3	3.6	0.9
AC242842.3		ENSG00000286185	"Novel protein, identical to neuroblastoma breakpoint family, member 19 NBPF19"		1	149390623-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA							Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC245033.1		ENSG00000260836	"Novel protein"		15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 32.1;Alveolar cells type 2: 45.1;Club cells: 8.6;granulocytes: 12.6;Respiratory ciliated cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-2197: 12.6"									HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA					"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: AB_2682686"									"unprognostic (2.91e-2)"									0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.4	0.4	12.6	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.6	0.2	0.1	0.3	0.4	0.5	0.2	0.3	0.3	0.0	32.1	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
AC253536.7		ENSG00000285762	"Novel protein, AP000351.4-DDT readtrhough"		22	23971378-23980469	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 15.4;Club cells: 4.3;granulocytes: 3.8;Respiratory ciliated cells: 3.6"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.1;HaCaT: 1.0;hTERT-RPE1: 2.2;RH-30: 1.2"									"HPA049871, HPA074115"	Uncertain		Approved	Mitochondria		NA	NA					"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA049871: AB_2680926, HPA074115: "																		0.1	0.3	0.1	0.3	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.3	0.3	0.1	0.0	0.3	0.2	0.0	0.4	0.4	0.1	0.5	0.0		0.4	0.3	0.0	0.0	0.2	0.8	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.1		0.5	0.2	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.1	0.4	0.4	0.3	0.0	0.3	0.5	0.0	6.4	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 212.6;liver: 659.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 224.0;SK-BR-3: 342.9"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	42.8	54.1	47.5	24.0	54.4	44.7	41.2	54.3	49.5	28.3	42.3	56.9	101.0	20.8	44.6	56.7	19.4	29.8	84.8	44.6	48.7	212.6	659.3	34.9	26.1	54.2	50.4	20.9	59.3	47.9	24.8	17.2	53.0	55.1	51.2	4.9	38.9	25.3	48.2	30.7	89.5	18.7	50.9	41.3	42.1	15.5	53.6	28.0	32.1	53.8	30.0	43.7	33.5	54.9	35.5	39.8	13.0	40.7	55.6	32.2	44.6	32.2	47.0	36.3	34.5	52.8	38.8	21.1	22.6	52.0	17.4	24.5	34.9	54.0	20.0	31.0	37.2	27.0	35.4	155.5	35.3	63.3	59.8	59.0	39.3	31.2	22.5	23.9	49.9	49.7	26.2	24.2	41.3	49.2	60.3	45.3	13.3	224.0	47.0	13.9	25.0	34.3	103.4	110.4	10.9	16.5	31.7	342.9	23.7	18.0	35.1	48.9	36.8	21.9	21.1	43.2	44.2	31.9	21.7	16.1	34.8	54.4	34.7	79.9	114.4	130.4	48.8	159.1	41.2	33.9	45.7	47.4	178.1	36.0	45.2	42.5	76.3	71.9	187.7	104.5	77.2	82.1	47.5	54.4	54.3	49.5	44.6	48.7	54.2	50.4	53.0	50.9	53.6	54.9	30.7	41.7	38.7	50.6	45.6	33.3	56.5	57.6	40.9	36.9	48.7	37.1	3.2	98.7	44.3	66.2	14.6	91.6	61.7	356.8	166.3	98.0	4.5	40.7	38.6	25.4	55.1	40.4	25.6	78.4	64.5	34.4	76.5	39.1	19.0	32.5	37.1	686.0	81.7	8.4	24.7	73.1	48.8	93.5	86.8	9.6	35.8	83.2	58.7	14.0	89.5	43.1	53.5	12.5	30.9	100.9	270.6	33.1	44.5	60.6	441.1	721.8	26.3	16.7	32.9	28.5	27.4	19.8	11.7	48.1	35.5	99.3	44.4	186.7	84.3	87.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084992-37406836	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 138.1;Excitatory neurons: 230.7;Inhibitory neurons: 197.8;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA		110000	"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	16.2	25.4	10.8	3.7	10.8	4.9	22.2	9.0	15.8	11.5	11.3	14.4	5.2	12.1	13.8	25.2	10.8	4.8	7.7	9.5	11.2	13.6	23.3	13.3	2.0	11.1	9.9	11.3	10.5	10.9	19.2	3.8	11.1	26.2	6.4	8.0	14.6	9.6	15.1	15.4	9.6	8.0	8.6	7.3	12.6	16.4	10.3	3.7	8.9	3.6	5.5	19.9	14.6	12.3	34.7	7.0	39.8	42.6	54.7	53.2	13.9	15.2	21.3	15.9	27.5	27.4	5.9	5.0	12.0	24.3	39.4	33.9	7.5	51.1	23.7	13.6	23.2	27.3	15.5	28.0	9.2	14.8	5.3	43.4	29.0	40.2	30.0	18.8	27.5	25.1	66.5	3.2	2.1	27.3	16.3	22.8	30.4	21.5	22.1	24.1	25.3	6.4	36.1	38.5	45.0	17.0	27.8	12.3	12.7	34.8	24.9	16.8	23.8	12.7	20.6	17.3	3.9	8.7	11.5	42.0	11.7	12.3	17.2	0.5	0.8	0.1	0.6	1.3	0.6	0.7	0.7	0.7	1.0	1.1	1.1	0.8	0.3	0.6	0.8	0.7	1.0	0.6	10.8	10.8	9.0	15.8	9.5	11.2	11.1	9.9	11.1	8.6	10.3	12.3	6.8	32.1	51.7	138.1	8.0	11.6	20.8	14.8	22.2	17.2	17.3	11.7	8.0	2.8	16.5	11.0	27.1	16.0	7.0	5.3	9.8	6.7	66.3	19.1	15.6	8.3	9.0	10.7	230.7	8.3	7.6	10.4	15.8	15.9	7.0	19.5	6.4	17.3	5.8	23.5	197.8	7.3	14.2	3.8	4.3	51.2	9.9	6.1	10.6	58.1	4.3	18.2	4.1	181.0	186.9	7.2	6.4	15.8	9.3	22.8	4.8	7.0	10.5	11.8	6.6	10.0	7.8	20.8	20.5	27.8	15.9	16.3	6.4	43.2	10.0	22.0
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 183.3;skeletal muscle: 173.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.7;Astrocytes: 136.8;Hepatocytes: 216.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.5"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 222.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006554	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	183.3	19.8	19.6	3.3	21.7	3.6	100.5	7.6	11.4	12.9	26.9	37.2	8.4	12.0	3.5	10.6	12.1	10.9	35.4	10.1	11.2	12.6	54.3	6.7	3.8	12.7	19.4	14.3	19.2	17.9	11.2	2.5	11.6	11.8	8.2	1.7	12.5	11.7	173.2	9.5	15.5	9.4	6.7	7.8	18.6	4.9	19.1	4.5	18.1	61.5	3.0	23.0	11.5	13.2	0.9	5.7	3.6	6.9	222.6	1.7	2.6	0.9	1.5	1.0	0.6	4.1	1.1	2.9	1.6	1.2	2.4	4.8	3.0	1.5	0.6	3.8	5.3	6.6	6.2	4.3	1.0	5.7	1.6	2.6	1.5	2.3	0.6	1.7	0.5	4.9	0.7	0.3	0.7	1.7	4.1	5.3	3.9	0.4	12.4	2.2	4.8	1.5	1.8	2.0	2.3	5.4	5.9	2.8	3.4	1.5	2.6	5.9	0.4	2.2	1.3	2.5	1.9	8.8	5.3	4.0	5.3	4.5	1.7	4.6	0.4	17.5	1.1	0.1	0.6	2.2	1.0	0.3	0.2	3.0	1.8	0.9	0.7	0.1	0.2	0.3	0.6	0.1	19.6	21.7	7.6	11.4	10.1	11.2	12.7	19.4	11.6	6.7	19.1	13.2	128.7	6.4	1.1	136.8	3.7	2.3	2.6	1.0	3.4	3.1	32.5	5.0	35.3	25.8	1.7	23.9	0.0	0.6	2.4	13.9	1.9	2.1	34.3	3.3	3.4	26.0	10.2	25.7	5.1	4.0	0.5	16.0	18.3	1.3	1.3	20.0	41.4	216.5	1.7	23.5	6.4	9.6	0.0	12.6	2.4	36.4	29.2	3.7	5.4	28.1	1.2	5.2	2.1	29.7	25.8	2.7	7.3	50.4	2.5	0.9	17.9	6.5	2.3	4.1	6.6	29.3	12.0	2.3	3.0	2.5	1.6	0.1	3.5	21.8	11.8	1.1
ACAD10	MGC5601	ENSG00000111271	"Acyl-CoA dehydrogenase family member 10"	Q6JQN1	12	111686053-111757107	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA067222	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"			"HPA067222: AB_2685805"	"unprognostic (8.45e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.21e-2)"	"prognostic favorable (3.71e-6)"	"unprognostic (2.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.87e-2)"	7.5	14.7	4.1	6.6	5.6	9.1	8.2	6.7	5.5	8.2	11.4	13.4	16.0	7.6	10.8	9.0	9.8	7.9	15.1	5.0	4.5	19.3	22.7	6.3	8.7	5.2	4.7	10.3	13.4	18.7	12.1	7.5	5.7	9.7	11.1	9.1	10.6	8.0	13.0	11.9	14.8	7.8	3.7	9.3	12.5	7.7	5.3	10.0	12.9	9.0	8.6	8.5	8.3	8.6	6.8	18.7	7.9	10.3	12.2	15.9	14.2	6.0	9.5	6.5	5.0	6.9	11.2	5.0	6.3	7.0	6.1	15.8	7.4	6.4	3.4	11.8	10.4	8.0	13.7	9.1	12.4	6.7	10.0	18.3	11.5	9.4	9.3	13.7	7.3	11.6	5.6	10.1	5.9	9.5	8.1	10.6	12.4	9.7	12.7	8.7	4.0	14.3	12.6	15.1	7.5	12.0	7.0	12.5	19.1	10.6	28.7	13.0	4.5	5.9	4.5	9.3	5.8	12.8	6.4	8.6	8.8	9.4	9.2	6.9	6.2	3.6	3.6	6.9	3.9	4.0	3.6	3.6	6.1	3.3	3.5	3.5	6.7	4.8	8.6	3.5	5.0	3.6	4.1	5.6	6.7	5.5	5.0	4.5	5.2	4.7	5.7	3.7	5.3	8.6	3.7	6.4	11.6	19.6	7.2	1.9	3.4	5.6	5.7	11.7	5.5	5.5	17.1	7.2	5.7	3.7	25.0	9.4	5.2	9.3	0.0	5.0	12.2	5.7	5.6	5.1	11.4	1.3	11.8	4.7	5.2	4.1	14.3	5.1	2.5	15.0	5.0	14.8	5.7	10.1	14.7	10.6	4.1	6.7	2.3	8.7	5.9	5.8	1.8	9.4	8.0	7.0	3.1	14.1	22.9	3.7	7.8	3.0	5.4	3.4	17.1	12.1	6.1	23.7	0.0	5.5	5.5	11.3	11.7	4.5	2.8	5.6	4.8	10.2	12.9	2.1
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660082	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.4;liver: 103.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	16.2	7.6	8.6	2.8	11.3	7.8	6.1	9.3	13.3	8.5	23.3	7.7	17.0	8.0	6.7	4.0	8.5	4.0	15.4	8.8	9.0	64.4	103.6	5.8	3.3	10.2	9.9	9.9	8.2	8.8	9.8	9.8	10.0	6.6	3.4	11.7	5.7	6.0	4.3	6.3	15.8	6.4	9.6	4.3	4.8	8.2	10.3	4.6	6.4	2.0	3.2	5.5	6.5	11.5	5.8	5.2	10.5	13.6	23.2	17.9	10.5	13.6	21.0	8.0	10.5	19.3	2.1	3.9	7.6	7.7	9.0	4.3	8.0	11.9	12.7	6.7	5.6	4.3	5.5	18.1	23.0	4.7	4.1	12.2	8.9	11.0	27.2	18.6	7.9	5.0	2.3	8.2	11.2	7.8	3.0	3.2	6.2	2.8	5.2	3.3	8.4	6.4	18.0	3.8	4.1	6.7	10.5	5.0	28.5	10.9	10.5	3.4	6.5	6.3	3.9	3.6	4.8	6.7	2.3	4.0	8.4	1.6	5.2	0.0	0.2	0.0	0.6	0.4	0.5	0.6	0.6	0.3	0.2	0.6	1.4	0.7	0.0	0.9	0.3	0.9	0.3	0.2	8.6	11.3	9.3	13.3	8.8	9.0	10.2	9.9	10.0	9.6	10.3	11.5	1.4	6.4	3.2	0.0	2.1	0.1	0.2	0.7	2.8	0.9	0.6	0.4	0.0	0.0	0.8	0.0	0.0	4.2	0.8	0.4	0.0	0.8	0.6	1.5	2.0	1.0	4.8	5.7	0.0	1.1	0.9	1.6	0.0	0.8	1.3	1.5	0.4	3.9	0.7	0.0	0.0	0.5	0.0	0.8	0.2	0.2	0.6	0.8	0.0	0.0	2.3	0.6	4.1	0.0	0.0	0.4	0.2	0.7	7.6	0.2	4.4	1.6	1.0	2.9	0.0	0.9	1.1	0.1	0.3	0.9	0.3	9.7	2.2	1.1	0.7	0.1
ACAD8		ENSG00000151498	"Acyl-CoA dehydrogenase family member 8"	Q9UKU7	11	134253548-134265855	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism, Transcription, Transcription regulation"	"Activator, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040689, HPA043903"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA040689: AB_2677080, HPA043903: AB_2678724"	"unprognostic (5.00e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.62e-4)"	"unprognostic (7.57e-3)"	"unprognostic (9.83e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.42e-10)"	"unprognostic (1.08e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.03e-2)"	11.0	18.1	13.9	3.5	14.2	6.8	11.3	14.3	15.4	7.5	18.7	11.6	11.3	6.3	12.6	9.6	9.4	5.2	27.2	14.7	14.3	31.6	24.8	7.8	5.0	14.3	14.1	6.9	16.7	12.4	6.5	4.8	13.8	20.5	10.9	5.0	12.6	7.5	32.5	14.3	8.4	8.3	14.5	8.6	12.6	6.3	14.8	8.5	27.7	39.2	8.9	8.4	6.9	14.8	5.9	5.9	11.8	17.6	20.2	11.5	13.5	11.3	14.0	14.7	10.3	16.2	10.8	14.2	21.1	11.7	15.5	6.0	14.6	14.3	10.2	13.0	4.7	29.4	5.8	11.3	17.0	16.5	18.3	13.8	4.4	14.8	4.5	13.3	16.3	20.8	13.8	7.0	12.4	7.5	12.2	18.1	17.0	49.8	9.7	9.8	11.9	8.5	20.1	17.5	3.7	11.7	19.5	14.8	7.3	11.9	31.0	15.0	11.3	7.1	7.5	6.2	11.2	7.8	3.8	12.7	7.2	15.4	11.2	36.2	13.4	23.1	11.8	13.5	11.5	11.6	11.1	11.7	12.7	9.2	13.0	11.7	12.1	31.5	12.9	10.8	15.1	12.3	13.9	14.2	14.3	15.4	14.7	14.3	14.3	14.1	13.8	14.5	14.8	14.8	11.7	3.2	12.2	15.3	8.8	6.0	4.7	23.5	7.4	11.2	17.5	11.9	24.6	4.3	19.7	18.4	14.6	19.7	14.0	20.0	52.8	12.1	5.3	8.2	11.8	9.7	3.6	12.0	21.5	11.9	10.6	9.8	10.2	8.5	3.8	15.7	10.8	36.7	12.9	15.2	16.0	14.3	48.8	14.2	6.9	6.1	11.5	10.0	28.4	13.1	12.7	11.8	9.2	12.1	15.8	12.6	15.8	10.1	14.6	5.9	17.4	59.8	20.1	17.1	6.6	8.7	9.6	22.4	17.3	10.9	7.7	8.3	10.5	36.0	14.9	5.3
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128924003	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	16.7	20.5	9.0	6.1	8.5	4.7	14.5	9.6	10.2	14.4	9.1	13.6	9.0	14.6	7.7	23.2	12.9	7.3	21.9	8.3	8.7	15.6	20.6	11.0	6.6	8.2	8.7	12.9	14.4	27.7	14.6	8.4	8.4	12.1	9.4	4.1	14.2	12.0	30.4	48.0	11.2	11.1	7.4	12.2	15.9	12.5	8.7	12.1	13.6	28.7	11.2	12.9	14.5	9.0	46.2	22.6	18.0	12.6	28.7	20.7	17.5	22.4	26.2	43.6	36.8	33.3	27.1	33.3	21.1	29.5	29.0	35.5	33.8	45.9	32.8	21.2	23.1	29.3	46.8	24.4	21.6	23.9	10.6	22.5	16.8	23.6	26.7	25.1	35.8	25.2	14.4	11.4	29.5	46.5	36.7	19.0	9.9	49.3	33.8	25.5	17.4	35.1	30.9	25.1	19.0	11.6	37.0	32.9	23.2	17.4	44.5	54.8	18.2	13.2	13.4	14.2	20.3	14.5	5.8	28.3	28.3	21.4	22.7	2.4	15.1	4.9	8.3	18.3	7.8	8.1	7.6	7.3	17.5	5.4	6.2	8.0	0.7	6.8	25.2	9.9	8.3	12.1	9.0	8.5	9.6	10.2	8.3	8.7	8.2	8.7	8.4	7.4	8.7	9.0	10.4	16.0	21.7	13.1	9.3	6.2	11.4	16.7	8.6	14.1	11.9	9.5	30.5	15.7	14.8	14.7	10.4	26.2	10.5	11.7	21.5	20.6	20.2	10.4	11.5	11.2	5.4	14.3	14.3	17.8	18.8	12.9	16.8	12.9	16.5	12.0	15.7	26.7	31.5	10.1	17.7	7.4	16.2	9.5	4.0	17.3	10.2	10.8	16.0	7.5	13.4	15.0	12.3	6.0	12.2	14.1	8.7	14.7	9.5	8.1	9.4	26.3	12.0	11.9	13.1	12.7	14.9	22.6	9.6	13.5	14.2	30.6	8.2	18.1	14.3	8.4
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187126-210225447	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.0;pancreas: 28.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported				NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"			"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	11.9	1.1	0.8	0.1	0.8	0.0	8.0	0.7	1.1	3.4	0.9	0.5	0.0	0.7	1.1	0.5	4.0	0.6	3.1	0.7	1.2	19.8	28.0	10.1	0.0	0.8	0.8	12.7	28.4	4.5	2.9	1.0	0.8	20.6	0.1	0.0	6.8	4.8	9.5	2.8	0.4	0.1	0.8	0.0	5.6	3.1	0.7	1.5	23.7	5.0	0.0	1.0	3.8	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.6	0.5	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.1	0.7	1.2	0.8	0.8	0.8	0.8	0.7	0.9	0.2	28.9	70.9	1.0	0.0	0.6	1.4	1.1	1.2	0.2	1.3	0.5	1.1	8.6	7.6	22.0	2.1	8.8	0.0	0.0	15.6	4.0	85.6	7.1	0.4	0.2	0.0	0.0	0.2	11.9	0.3	4.9	3.6	5.9	2.5	0.8	0.7	23.0	0.5	0.0	13.3	0.0	0.0	0.3	0.4	69.4	46.9	0.4	0.0	4.7	0.0	0.2	0.0	7.5	0.3	3.9	0.0	46.6	0.0	8.2	0.0	31.5	2.4	0.2	0.0	7.6	13.7	0.7	0.7	0.7	1.0	6.3	0.4	0.1	0.0	0.7
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225266	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 850.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		98000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	197.9	405.2	120.1	78.7	131.0	103.5	142.9	128.4	126.7	110.5	170.6	157.3	306.2	98.5	44.4	181.0	94.0	92.6	576.8	117.8	125.0	215.3	517.4	106.7	52.0	127.5	125.3	80.9	236.5	159.6	189.6	112.0	124.8	133.2	131.6	34.9	158.5	113.9	850.4	135.7	270.6	110.6	118.2	132.2	186.4	75.9	132.0	83.4	159.3	817.1	82.9	137.1	115.3	122.7	193.7	162.5	65.8	92.4	271.2	99.2	135.9	156.5	169.0	136.9	84.5	67.2	155.3	90.4	109.0	260.0	49.7	147.9	43.8	135.5	119.6	295.9	47.1	50.6	120.9	101.1	131.2	49.0	129.5	112.5	122.0	114.7	178.5	212.6	124.8	111.3	73.3	110.2	222.7	65.3	49.6	68.4	34.3	178.4	91.9	70.4	78.3	227.2	305.1	155.0	19.1	47.3	206.8	224.8	110.8	60.6	102.8	74.9	151.5	127.5	101.6	75.9	149.9	104.5	59.1	5.2	230.7	85.7	94.9	24.2	96.1	121.3	39.1	57.8	35.7	25.2	32.5	43.8	99.9	24.6	23.7	29.1	20.2	37.8	39.3	80.4	31.8	79.4	120.1	131.0	128.4	126.7	117.8	125.0	127.5	125.3	124.8	118.2	132.0	122.7	109.9	60.9	81.9	143.3	72.3	87.3	336.0	322.4	91.6	42.0	157.7	104.5	451.4	138.7	206.7	202.3	62.6	482.9	87.7	484.2	185.9	310.8	133.0	87.2	52.7	77.4	179.3	65.2	40.9	77.0	197.8	118.6	406.7	88.5	88.4	121.1	53.6	365.4	182.4	33.7	33.4	251.8	233.9	67.9	94.6	249.9	124.5	101.5	81.8	34.7	274.9	40.7	73.2	23.1	24.5	106.1	388.9	132.8	172.3	369.0	489.8	345.8	144.1	41.3	105.2	88.3	147.4	114.3	47.8	113.8	87.5	663.3	75.5	169.2	316.8	367.5
ACAN	"AGC1, CSPG1, CSPGCP, MSK16"	ENSG00000157766	Aggrecan	P16112	15	88803436-88875353	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.5;seminal vesicle: 3.1"	"Group enriched"	"Detected in some"	15	"Extravillous trophoblasts: 127.1;Granulosa cells: 132.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"WM-115: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016377, HPA038241, HPA038242"	Enhanced				"Secreted to extracellular matrix"	NA	NA		17000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910"	"unprognostic (2.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.27e-2)"	1.2	0.2	0.6	0.9	1.0	0.1	0.1	2.2	1.6	0.9	0.1	0.3	0.1	0.4	0.2	0.1	0.2	0.7	0.5	0.7	6.5	0.7	0.1	0.7	0.1	2.1	1.6	0.4	0.2	0.1	0.4	0.2	1.5	0.5	0.3	0.1	0.1	3.1	0.2	0.2	0.1	0.5	1.3	0.2	0.2	1.4	1.5	0.0	0.3	0.0	0.0	0.8	0.7	1.4	0.0	0.0	0.0	0.0	0.8	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	2.2	1.6	0.7	6.5	2.1	1.6	1.5	1.3	1.5	1.4	0.1	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	1.2	0.0	127.1	0.7	0.0	0.4	1.3	132.4	0.0	0.0	2.5	0.0	4.5	0.0	0.0	0.0	0.5	2.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	8.4	2.3	6.3	0.0	0.4	3.6	0.1	1.8	0.0	0.4
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 3430.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	5.6	1.1	0.4	18.9	0.5	41.0	2.1	0.5	0.8	2.3	0.5	7.4	4.1	1.5	0.3	4.2	4.0	3.6	2.1	0.3	0.4	4.6	5.2	16.1	39.5	0.6	0.5	0.9	1.2	0.1	1.3	0.5	0.6	3.8	2.1	0.2	3.6	0.4	0.9	2.5	43.3	0.9	0.5	96.0	5.0	0.8	0.8	25.8	5.2	0.8	22.6	4.3	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	23.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	8.8	0.1	0.0	0.1	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	29.4	0.0	0.0	14.5	37.9	0.4	0.0	0.0	15.1	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.1	0.0	0.0	9.1	8.2	10.9	0.1	24.9	0.0	28.8	7.9	30.8	29.6	2.4	33.3	20.2	31.5	32.1	13.7	21.3	26.7	27.5	22.6	32.5	0.4	17.3	39.0	22.3	0.4	0.5	0.5	0.8	0.3	0.4	0.6	0.5	0.6	0.5	0.8	0.6	3.8	9.6	5.5	1.6	150.9	8.3	7.6	25.1	2.8	15.8	7.0	8.1	32.9	7.2	12.3	5.5	18.8	3.9	160.7	2.0	7.9	3.9	498.1	8.3	5.4	5.0	3.6	22.9	0.3	3.7	3.2	8.0	5.6	3.4	40.5	1.8	7.1	5.3	7.5	0.0	1.9	2.7	8.2	26.2	39.5	3430.7	20.2	27.9	24.9	2.8	38.3	11.7	332.7	0.5	1.0	5.5	0.0	15.4	68.0	4.6	1.3	3.8	44.6	20.4	19.7	7.5	8.1	15.6	10.5	1.5	7.4	4.4	268.3	0.9	1.6	3.5
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274745-195443044	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 215.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	15.9	10.2	10.7	22.2	10.3	39.6	13.5	21.4	14.5	14.3	1.8	17.0	14.0	14.4	10.9	21.7	12.2	14.2	8.3	14.1	6.4	10.3	11.8	15.7	26.9	2.5	4.2	19.0	9.0	13.2	8.5	15.5	6.1	10.7	17.3	29.4	9.5	10.4	5.3	15.5	15.3	14.5	3.3	23.6	14.0	15.1	5.0	21.0	21.7	9.7	27.9	13.5	11.5	7.7	34.6	13.5	21.5	21.1	34.3	41.9	31.6	28.0	37.2	20.5	21.4	18.5	19.8	38.7	65.7	25.8	20.0	21.6	16.5	14.0	29.4	43.4	9.7	38.5	14.2	7.6	33.5	52.5	26.7	32.3	24.0	20.4	46.1	17.6	22.7	21.4	19.1	37.0	30.3	20.3	33.7	19.1	13.0	19.8	18.1	39.7	24.8	27.8	14.1	32.2	23.8	11.5	30.7	27.4	32.9	18.2	51.7	30.6	40.3	25.9	14.7	34.6	32.7	21.8	50.2	84.0	19.1	56.2	27.5	62.8	55.2	55.3	27.5	49.0	21.2	39.3	26.1	21.3	32.9	45.6	22.0	22.4	215.8	17.6	59.0	34.4	26.2	25.4	10.7	10.3	21.4	14.5	14.1	6.4	2.5	4.2	6.1	3.3	5.0	7.7	110.7	44.8	40.9	103.8	103.1	44.5	28.8	45.1	88.2	58.7	43.1	50.3	17.9	22.8	43.4	31.3	77.2	20.2	101.9	75.8	19.6	24.1	11.1	49.7	60.4	74.1	51.6	50.1	141.2	24.3	22.2	62.2	44.4	49.7	39.9	33.5	57.5	32.5	65.4	121.1	143.1	44.4	22.4	115.7	67.5	9.7	46.6	110.8	35.6	143.4	122.3	29.1	68.0	132.7	130.1	31.7	70.7	37.6	67.6	41.5	39.3	28.6	45.1	92.6	59.2	43.8	61.4	39.6	26.7	143.7	51.7	29.0	85.1	43.0	37.6	38.6
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292390-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.3;Cone photoreceptor cells: 104.3;Rod photoreceptor cells: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	14.1	17.1	40.9	2.9	48.0	9.0	10.1	46.1	62.4	23.0	27.9	21.2	6.0	16.3	2.5	32.4	14.2	3.5	26.7	47.7	32.9	17.3	20.6	12.8	3.1	35.1	33.6	16.4	13.3	2.7	40.2	2.9	34.0	17.3	2.1	12.1	14.5	5.0	17.4	33.5	13.7	3.7	35.0	16.3	16.4	6.5	41.7	4.8	10.7	5.7	2.3	19.6	25.3	43.9	9.7	10.5	5.2	8.5	11.8	8.1	5.2	23.7	7.6	6.7	5.0	13.2	8.1	10.5	12.1	13.2	6.7	22.0	4.7	6.3	1.7	11.8	21.1	4.5	43.7	25.2	8.3	9.1	10.8	6.0	5.0	5.7	3.5	6.4	3.2	12.7	12.5	14.2	7.6	12.9	19.1	13.9	5.1	12.8	24.6	18.7	10.9	40.7	4.1	5.1	36.4	25.9	14.1	9.2	22.8	4.4	9.4	7.1	10.7	12.4	8.9	10.3	8.4	11.5	8.6	9.0	17.0	23.6	5.5	0.0	0.2	0.3	0.2	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.1	40.9	48.0	46.1	62.4	47.7	32.9	35.1	33.6	34.0	35.0	41.7	43.9	10.0	0.0	4.7	20.5	11.0	32.1	5.8	7.0	12.5	148.3	15.4	11.9	23.4	14.3	5.6	1.8	104.3	9.0	9.3	22.2	3.9	9.4	3.5	4.3	18.3	8.8	32.3	12.6	48.2	5.1	8.8	16.0	39.3	8.0	0.0	8.2	13.2	17.3	7.2	53.8	31.7	14.4	8.2	17.9	15.5	9.0	15.2	11.2	8.8	15.0	11.9	18.9	12.3	80.9	44.4	12.7	13.7	13.2	11.1	6.1	12.6	7.8	6.9	201.6	6.6	12.9	15.2	3.9	15.2	23.5	34.2	10.1	10.4	12.2	16.8	9.9
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186741	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Approved		Supported	"Golgi apparatus"		NA	NA		29000	"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	21.6	16.9	11.6	20.4	12.4	25.9	24.4	13.1	13.0	27.6	16.6	23.2	17.5	22.8	20.6	30.8	17.8	23.5	21.4	10.9	13.7	20.2	24.3	22.4	21.3	12.6	13.9	23.2	22.7	28.0	14.6	31.7	12.9	22.8	25.4	16.1	24.1	16.4	21.5	19.3	17.5	21.7	13.1	17.8	31.7	18.8	13.1	18.0	28.8	20.3	25.7	26.9	20.2	13.5	43.7	29.3	24.3	15.1	73.6	65.4	47.2	53.7	55.7	31.5	40.3	38.0	53.2	46.3	48.0	69.7	28.5	33.5	34.6	35.2	43.9	19.4	40.4	22.5	30.3	34.8	47.2	36.5	26.7	48.7	46.0	39.1	51.1	44.7	36.6	22.2	42.6	32.0	51.3	22.1	27.2	28.5	36.1	72.5	38.0	25.0	53.3	47.1	29.4	39.2	27.6	39.8	47.8	52.7	53.0	34.0	54.2	41.5	46.2	31.4	22.0	76.7	51.5	60.4	67.4	57.3	37.3	24.2	52.8	2.1	1.4	1.4	0.9	1.8	1.6	5.0	1.3	0.9	1.0	4.4	1.4	1.3	1.5	1.0	1.5	1.4	1.7	0.7	11.6	12.4	13.1	13.0	10.9	13.7	12.6	13.9	12.9	13.1	13.1	13.5	53.5	67.3	41.5	14.0	50.4	52.0	63.4	17.9	38.7	35.1	50.6	37.2	35.7	27.1	37.9	35.0	56.3	45.3	44.2	46.1	15.6	25.0	24.0	56.6	84.0	47.6	43.5	10.7	29.8	34.7	60.7	55.8	50.4	85.8	24.6	29.8	28.2	52.0	37.9	26.9	31.3	71.9	28.5	25.1	51.0	7.3	40.7	39.4	49.8	20.6	18.0	52.1	18.6	27.6	29.2	39.0	28.4	32.7	87.3	61.7	26.7	32.1	26.9	39.4	32.9	46.6	51.4	72.1	55.8	46.7	77.7	62.4	34.0	33.1	35.6	98.3
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	11.1	17.2	14.4	6.3	14.1	4.1	12.9	13.9	16.6	19.1	13.1	21.2	29.9	14.4	4.0	7.1	22.3	6.6	11.8	13.4	13.9	24.6	93.0	9.6	9.9	14.2	14.0	19.3	20.0	14.5	15.8	4.3	13.4	21.6	5.7	10.3	14.1	12.2	6.8	9.0	25.9	5.7	14.5	16.2	14.7	4.2	14.2	5.4	21.1	5.1	6.4	15.7	13.6	13.2	7.9	15.4	1.9	4.2	3.5	6.4	5.1	2.9	6.1	4.7	9.2	6.0	10.8	8.4	7.4	4.3	2.8	7.3	2.6	4.8	1.9	12.2	5.9	4.2	11.3	12.0	7.5	1.6	11.1	6.4	4.6	1.7	2.4	16.1	4.6	7.7	2.7	13.1	2.3	5.3	6.0	2.1	0.3	8.3	4.2	4.8	0.5	18.8	11.8	5.1	3.1	1.4	2.1	3.1	8.9	1.0	20.1	3.0	1.7	1.2	3.6	1.8	1.8	20.4	5.9	2.6	6.8	2.1	2.0	4.4	2.3	3.5	2.9	2.6	3.2	3.7	3.4	3.2	2.0	5.0	3.7	4.3	0.5	4.0	1.7	1.3	4.3	3.2	14.4	14.1	13.9	16.6	13.4	13.9	14.2	14.0	13.4	14.5	14.2	13.2	5.7	3.2	3.0	12.4	7.8	1.9	5.9	3.9	2.8	16.6	7.4	6.9	9.7	14.3	2.6	3.7	22.9	6.3	5.9	9.6	7.9	7.3	1.4	2.0	2.7	5.3	6.0	2.1	7.2	7.1	1.3	7.3	4.6	3.6	8.2	7.4	5.0	21.8	5.3	11.8	8.5	7.8	6.1	1.9	2.6	5.0	6.8	3.1	3.6	2.8	4.5	14.7	5.2	4.5	1.9	5.6	12.5	7.5	5.2	3.1	56.8	25.6	2.6	16.8	6.6	8.7	7.7	2.5	5.2	3.1	1.8	6.3	6.4	4.4	9.1	2.8
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27168135-27243046	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Transport"		Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	14.6	25.1	31.0	13.5	37.0	18.2	12.3	36.2	37.1	13.2	24.2	20.3	39.8	9.4	9.7	12.0	12.0	15.4	40.4	27.6	33.1	37.3	73.8	14.7	14.7	37.2	34.0	9.9	11.1	31.2	6.4	13.4	38.1	15.2	20.9	36.2	10.3	11.4	31.0	17.3	39.2	8.8	36.7	14.7	21.0	19.3	36.1	12.2	27.8	36.6	12.7	13.5	7.5	38.8	25.8	76.5	17.1	18.0	19.1	17.3	20.1	32.3	12.1	28.1	33.5	19.4	39.9	10.7	27.0	22.4	23.4	21.1	23.2	16.3	23.0	26.2	23.9	16.5	23.1	15.2	20.6	11.0	20.9	16.7	17.7	23.5	12.8	24.9	20.5	16.7	13.6	19.5	35.7	20.0	21.1	9.4	13.1	35.2	10.0	17.4	42.5	20.2	44.1	22.4	21.3	45.5	35.4	38.3	17.9	18.9	18.8	11.5	30.4	27.2	15.2	43.7	25.9	19.4	28.1	20.7	27.4	24.6	12.0	12.5	13.0	10.2	15.3	12.7	15.2	6.4	7.5	12.4	13.0	7.0	5.0	11.0	11.1	10.3	15.1	8.5	7.4	8.0	31.0	37.0	36.2	37.1	27.6	33.1	37.2	34.0	38.1	36.7	36.1	38.8	23.3	25.6	29.9	17.9	16.0	9.7	4.1	14.5	7.4	30.8	14.5	10.8	83.0	15.7	25.2	31.3	25.0	9.6	27.4	22.4	33.2	22.1	43.1	33.7	20.2	18.7	10.2	8.6	20.6	16.2	12.6	16.4	19.4	41.1	12.6	11.5	12.8	56.9	19.0	23.5	26.9	30.4	10.2	25.5	12.5	16.9	16.4	22.4	21.4	15.9	22.4	47.7	29.9	17.6	24.8	17.8	26.1	16.6	14.2	11.7	64.4	48.2	32.7	47.2	19.7	20.9	16.1	41.0	8.3	16.5	15.5	10.4	22.3	27.1	26.5	9.2
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	19.5	19.0	11.5	15.0	11.3	25.9	18.4	14.9	13.8	20.5	10.7	21.1	15.2	21.5	15.1	15.1	17.7	17.7	22.3	10.6	12.3	17.7	15.5	15.2	19.0	10.7	10.5	24.7	19.5	25.0	14.4	28.2	10.7	16.4	13.6	7.2	17.3	17.4	24.0	20.7	13.8	18.5	10.3	17.8	15.4	33.0	11.1	20.5	20.0	20.6	18.1	19.5	17.3	13.5	69.4	56.4	47.6	33.2	33.9	57.4	91.1	31.3	69.7	57.6	52.0	80.1	52.8	60.0	62.2	35.3	27.5	47.0	36.2	62.7	38.3	44.5	56.8	48.3	51.9	48.2	82.2	85.5	41.2	51.1	89.5	35.9	59.0	52.4	66.2	49.9	74.5	48.9	48.4	70.7	68.1	84.1	47.8	53.2	20.3	67.3	38.0	119.4	51.4	40.8	68.0	86.0	44.4	74.6	44.9	48.6	75.6	65.4	50.4	40.8	45.3	49.5	71.0	88.1	55.7	137.4	43.4	50.7	47.7	3.1	13.1	4.4	13.6	20.0	15.4	18.1	11.6	11.8	22.0	11.6	13.9	16.3	0.9	27.3	16.3	17.7	11.7	12.2	11.5	11.3	14.9	13.8	10.6	12.3	10.7	10.5	10.7	10.3	11.1	13.5	31.5	32.1	33.0	60.4	32.7	21.3	29.9	38.7	42.7	64.2	23.6	33.3	42.3	21.5	35.4	16.5	39.6	165.0	38.7	3.8	41.1	43.7	106.9	22.2	38.0	31.9	19.4	25.0	124.9	41.6	41.7	35.6	19.9	23.3	20.2	52.2	23.9	13.4	44.6	52.2	118.1	15.7	34.6	17.8	18.6	59.2	51.3	25.0	37.4	60.9	30.0	37.8	26.8	98.0	109.3	36.2	12.9	50.8	48.4	27.2	19.6	51.2	27.4	6.6	59.2	38.4	53.4	143.6	64.6	40.5	22.4	84.4	29.4	63.2	19.2	24.8
ACCS	"ACS, PHACS"	ENSG00000110455	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive)"	Q96QU6	11	44065925-44084237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018873, HPA021654"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA018873: AB_1855273, HPA021654: AB_1855274"	"unprognostic (3.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.86e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (6.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.92e-2)"	11.4	17.0	1.8	3.7	1.5	10.0	11.2	1.5	2.0	11.1	7.2	8.3	5.4	14.2	8.1	5.5	15.4	10.1	5.8	1.9	2.2	10.4	18.9	9.7	5.5	2.0	1.8	9.8	11.0	2.8	11.0	2.6	1.8	10.9	6.9	1.0	10.3	6.3	3.1	7.8	10.3	6.3	1.5	14.0	10.4	6.5	2.3	4.1	12.7	2.4	6.4	9.1	8.3	2.0	4.0	8.8	0.0	1.0	2.3	4.1	0.0	2.1	2.7	1.9	2.0	0.7	5.6	1.5	1.6	4.7	0.0	6.7	2.4	0.5	1.0	0.5	2.6	6.3	3.3	0.1	4.4	0.0	0.0	4.6	8.2	2.4	1.1	2.6	3.5	0.0	5.0	0.0	5.8	3.0	0.0	2.5	3.4	5.1	1.3	5.5	0.0	0.0	4.8	2.6	1.1	3.5	2.1	1.1	2.5	2.2	8.6	3.8	3.8	2.2	2.3	3.5	1.1	0.0	0.0	0.2	5.3	0.0	2.3	0.9	3.1	5.6	0.8	3.1	0.7	1.1	0.7	1.3	4.4	1.4	1.1	0.7	0.0	0.9	2.5	3.3	1.2	2.0	1.8	1.5	1.5	2.0	1.9	2.2	2.0	1.8	1.8	1.5	2.3	2.0	12.2	12.8	22.7	11.8	4.6	2.7	2.7	4.0	6.8	1.9	8.6	10.2	4.0	7.2	8.9	9.2	0.0	3.1	4.0	6.4	0.0	2.3	2.1	8.6	3.9	7.0	7.2	3.4	3.4	4.2	0.4	6.9	13.7	5.0	9.5	11.0	8.2	9.7	6.1	0.0	3.3	8.2	4.1	7.0	5.5	4.4	9.6	9.0	0.0	5.6	9.4	2.6	7.2	4.5	6.6	2.9	8.0	7.5	2.5	2.1	16.6	6.5	7.4	1.0	0.0	3.7	4.7	0.7	2.4	2.4	2.3	1.9	3.3	9.2	6.4	2.1
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA049411: AB_2680752, HPA057660: AB_2683493"	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	13.0	9.9	14.2	7.3	14.4	10.1	12.9	14.4	17.7	17.1	12.0	14.8	4.2	16.4	4.0	9.1	15.6	5.2	11.2	14.6	14.2	10.8	6.7	9.9	10.1	14.6	14.2	19.9	12.4	6.3	13.7	4.7	15.0	12.2	2.3	2.7	9.4	6.3	9.8	11.4	12.1	4.6	14.1	14.9	11.2	23.7	14.6	5.5	10.0	3.2	5.6	15.5	12.2	14.6	42.1	32.3	18.4	19.2	8.3	5.8	39.5	17.1	11.3	25.0	30.3	42.0	20.3	11.6	19.4	9.4	22.5	32.7	11.3	32.8	8.2	12.6	37.4	24.9	13.4	42.4	5.8	32.5	37.6	8.3	10.0	33.7	17.7	9.4	15.9	34.3	15.7	8.1	12.6	45.2	31.8	31.8	23.5	16.3	21.5	44.1	19.8	48.0	10.5	16.6	26.3	23.1	64.0	6.7	14.5	5.3	15.8	17.9	13.8	26.6	22.4	31.9	26.1	21.7	28.6	35.9	24.7	20.5	23.3	34.5	18.2	22.8	40.2	22.2	34.1	46.4	36.7	34.8	21.0	37.7	28.5	30.3	25.9	43.5	25.8	22.9	39.5	24.7	14.2	14.4	14.4	17.7	14.6	14.2	14.6	14.2	15.0	14.1	14.6	14.6	19.4	6.4	11.9	5.5	22.3	14.4	15.9	22.6	21.6	14.7	13.7	16.0	2.8	8.6	12.6	11.0	4.2	25.1	22.5	5.5	9.8	21.3	59.3	6.6	7.7	15.4	12.5	11.6	6.2	19.6	22.8	14.1	9.7	6.8	27.9	13.6	12.8	4.7	15.5	13.5	6.1	6.4	6.1	7.6	20.6	71.4	15.2	13.4	23.2	4.7	19.3	14.3	30.9	4.0	3.6	18.4	9.2	11.7	17.0	9.9	10.2	13.2	16.1	10.8	6.6	11.8	14.8	58.1	24.1	7.1	9.7	11.4	27.0	6.9	9.0	10.0
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 265.1;testis: 101.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC TERT1: 63.3;HUVEC TERT2: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	13.4	4.9	1.7	4.8	8.1	0.1	8.1	0.2	2.5	18.1	0.5	11.2	176.4	8.1	3.5	4.1	6.3	8.2	10.4	1.3	1.0	10.8	1.9	49.0	4.9	1.3	0.9	1.9	6.2	18.7	9.2	11.6	1.3	8.9	6.1	0.4	7.6	23.8	16.1	3.8	265.1	9.6	0.8	2.8	8.3	101.9	2.0	0.8	19.2	10.0	2.1	5.5	3.8	1.1	0.0	0.0	0.0	0.0	2.6	63.3	0.6	2.4	4.7	0.0	0.0	0.9	5.1	1.3	1.8	11.4	0.1	0.0	3.1	0.0	0.0	0.0	1.4	6.6	0.0	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	1.2	33.8	0.0	5.8	0.0	0.1	1.1	0.0	1.4	0.4	11.7	0.7	0.1	0.5	0.9	0.0	0.0	8.2	5.6	0.0	0.0	0.0	1.3	2.9	0.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	8.1	0.2	2.5	1.3	1.0	1.3	0.9	1.3	0.8	2.0	1.1	50.0	0.0	3.3	0.0	0.5	1.5	2.6	0.1	1.2	4.0	3.6	1.9	2.1	1.5	0.7	0.0	0.0	0.1	0.3	11.9	0.0	5.9	543.6	10.8	8.0	34.7	18.0	0.0	4.7	0.4	0.1	11.5	2.0	36.3	7.0	24.1	3.6	0.8	4.2	0.0	1.8	39.8	0.0	33.7	3.5	1322.9	4.4	13.6	3.6	4.7	0.0	1.8	0.0	1.0	0.2	0.7	40.9	2.6	0.1	4.2	1172.8	21.7	0.0	1.1	0.0	2.0	4.2	13.5	6.4	0.2	0.1	0.1	2.2	0.3	26.2	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860859-77026797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070087	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	10.9	3.0	6.2	4.8	8.5	3.0	5.4	8.5	9.3	5.2	4.0	6.4	6.2	4.2	3.1	6.9	4.1	3.2	3.4	6.3	8.5	4.7	2.5	8.0	4.2	8.6	7.1	2.3	2.9	3.5	2.1	6.2	9.5	4.1	5.5	2.3	4.2	2.3	1.6	2.9	4.6	3.9	8.4	5.6	3.4	6.0	7.3	2.2	3.3	1.2	3.8	4.5	4.4	12.0	7.3	7.7	6.4	7.6	29.2	14.0	5.7	11.2	10.7	8.2	9.2	6.0	7.3	6.4	8.4	8.0	10.3	12.9	10.9	10.6	10.0	8.6	4.3	9.0	4.8	3.6	8.1	9.3	15.0	6.3	5.0	11.8	10.9	4.8	16.8	5.8	6.1	4.2	9.9	5.9	0.7	6.2	3.6	19.3	8.8	4.3	22.8	5.0	6.8	7.2	2.2	5.5	13.9	12.6	3.5	4.9	10.7	5.1	22.2	8.2	6.4	23.3	8.3	3.1	7.1	8.6	5.1	4.7	8.9	0.1	4.3	2.5	0.7	3.1	0.8	1.2	0.5	0.9	4.6	0.4	0.3	0.4	0.9	0.2	2.4	1.5	1.2	1.6	6.2	8.5	8.5	9.3	6.3	8.5	8.6	7.1	9.5	8.4	7.3	12.0	32.4	41.7	35.0	52.9	11.5	31.9	21.4	17.0	33.0	18.8	11.3	11.0	7.5	11.5	27.6	9.2	10.4	13.6	11.3	54.6	7.9	15.5	66.8	6.3	29.0	29.4	2.4	13.5	65.0	17.6	7.5	17.0	26.0	11.5	83.5	30.9	27.8	10.0	44.4	43.7	71.9	30.5	18.3	64.1	67.1	31.7	20.2	64.0	17.8	61.8	40.0	11.3	12.3	159.3	335.1	18.6	37.9	25.9	8.6	15.6	20.0	15.3	12.3	10.0	6.6	17.0	21.0	69.8	25.9	26.3	16.8	26.8	15.2	7.2	20.1	24.1
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"Blood group antigen, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 320.5;breast: 278.2"	"Group enriched"	"Detected in many"	5	"Adipocytes: 383.6;Endothelial cells: 523.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 44.4;HSkMC: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (8.74e-3)"	"prognostic favorable (2.52e-5)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.84e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.30e-2)"	320.5	13.4	17.7	42.0	21.8	14.5	278.2	34.6	25.5	141.7	21.6	67.0	15.3	125.0	21.5	63.6	121.2	59.2	42.2	18.4	18.6	34.5	1.8	146.8	49.3	21.4	17.7	21.4	15.8	9.7	11.6	10.4	23.2	72.9	19.4	23.7	61.3	24.5	51.7	85.3	60.9	107.7	24.9	82.1	57.0	8.6	17.0	33.2	47.7	30.2	40.8	112.4	113.1	22.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	44.4	0.0	0.0	5.5	0.0	0.0	30.7	0.0	0.0	3.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	21.8	34.6	25.5	18.4	18.6	21.4	17.7	23.2	24.9	17.0	22.0	383.6	6.4	10.8	1.6	1.0	0.0	1.7	0.0	2.8	78.4	3.6	3.7	15.1	0.0	1.8	0.0	2.1	0.4	0.8	0.0	0.0	0.0	2.2	0.4	1.0	523.8	0.0	81.3	3.6	9.8	0.2	18.9	0.0	0.4	5.1	0.0	7.5	0.0	1.1	6.7	3.2	0.0	0.0	0.8	0.0	3.7	1.2	2.2	0.0	1.0	0.0	5.9	0.0	0.5	0.3	0.0	0.0	0.4	0.1	2.2	0.0	0.1	0.7	3.7	0.0	3.9	4.5	0.2	0.5	4.0	0.0	0.1	1.1	0.1	0.0	2.3
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 9.4;placenta: 16.0"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 33.0;Extravillous trophoblasts: 106.2;Syncytiotrophoblasts: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.9;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 51.2;HEL: 17.1;SK-BR-3: 28.0;U-937: 10.7"	"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.9;cerebral cortex: 4.9;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	6.7	1.0	1.5	1.0	1.0	0.7	2.8	1.5	1.3	1.7	0.9	1.9	0.9	0.9	2.8	1.6	2.3	1.3	1.3	1.0	0.5	1.5	9.4	1.6	1.1	1.4	1.4	0.4	0.9	0.4	0.5	16.0	1.3	0.6	2.1	0.7	2.2	0.4	0.6	2.6	1.1	1.1	0.6	0.7	1.1	0.8	1.1	0.4	2.9	0.9	2.1	1.8	2.3	1.3	0.1	0.0	0.2	0.4	2.4	0.2	51.2	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.1	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	17.1	0.4	3.1	0.1	0.2	1.9	0.5	0.5	0.0	0.1	0.0	0.1	0.5	2.2	0.4	0.3	0.3	0.0	0.2	0.1	0.7	0.2	0.1	0.0	0.1	0.7	7.5	0.3	0.1	1.3	28.0	0.1	2.9	2.8	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	10.7	0.1	0.4	0.1	3.9	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.4	1.1	0.3	0.1	0.0	0.1	1.5	1.0	1.5	1.3	1.0	0.5	1.4	1.4	1.3	0.6	1.1	1.3	1.0	0.0	0.0	9.8	0.1	0.1	0.1	0.3	0.0	0.7	1.2	0.3	0.8	1.5	3.3	0.0	2.1	33.0	0.3	3.0	1.9	0.1	3.0	3.7	0.8	3.3	1.8	0.0	2.0	0.0	106.2	2.1	0.0	5.9	2.5	2.5	4.6	7.0	5.3	1.7	1.2	0.6	0.0	0.6	0.4	1.8	0.3	0.4	0.0	5.6	0.1	2.6	0.0	1.0	4.5	0.8	0.5	1.2	0.1	0.4	1.6	0.5	3.4	1.0	0.0	0.4	0.3	4.8	5.4	0.0	0.0	73.6	0.5	0.5	1.1	0.6
ACKR3	"CMKOR1, CXCR7, GPR159, RDC1"	ENSG00000144476	"Atypical chemokine receptor 3"	P25106	2	236567787-236582354	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 39.6;Endothelial cells: 59.8;Fibroblasts: 171.2;Smooth muscle cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"NK-cells: 4.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 103.7;MCF7: 80.0;RT4: 312.3;SiHa: 97.0;U-2197: 328.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032003, HPA049718"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"HPA032003: AB_2674107, HPA049718: AB_2680859"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-3)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (9.71e-2)"	"unprognostic (8.57e-3)"	"prognostic unfavorable (2.93e-4)"	116.2	5.2	13.0	14.3	13.5	3.5	70.4	13.1	15.6	29.2	18.3	38.7	11.8	17.3	10.5	25.0	33.7	30.8	68.5	13.7	18.9	11.3	28.3	26.3	10.5	22.3	16.0	15.9	37.9	5.0	24.4	123.3	14.4	20.1	24.7	1.7	21.4	16.8	35.4	38.1	34.1	24.2	14.3	56.0	27.9	14.6	14.5	6.4	58.1	37.9	5.6	107.0	38.2	13.6	0.0	0.1	6.3	0.0	10.5	0.2	44.9	2.6	1.4	2.3	4.6	0.5	0.1	0.0	5.1	0.2	16.9	68.0	0.2	24.0	0.4	0.1	0.0	0.1	103.7	0.2	0.1	0.2	0.1	3.2	61.0	0.3	0.0	15.4	11.2	0.3	1.2	0.1	0.0	80.0	0.2	0.2	11.0	0.0	0.7	0.1	7.6	0.8	0.0	312.3	0.4	0.1	97.0	0.5	0.0	23.9	0.0	0.3	0.0	0.8	23.3	328.5	0.1	1.4	0.0	0.1	1.2	6.6	0.5	0.0	0.1	0.0	2.5	0.2	3.8	0.3	1.3	3.2	0.1	0.6	1.1	1.5	0.0	4.7	0.4	0.0	2.0	0.5	13.0	13.5	13.1	15.6	13.7	18.9	22.3	16.0	14.4	14.3	14.5	13.6	33.2	9.6	4.8	20.5	1.1	22.0	0.2	39.6	1.2	1.7	0.2	1.0	9.1	0.0	24.8	0.0	0.0	0.1	0.7	1.0	0.0	0.2	0.9	13.5	24.2	59.8	0.0	0.0	0.7	10.4	0.8	171.2	1.1	24.8	6.3	6.3	33.5	2.5	0.8	0.0	2.3	0.1	6.1	4.1	10.1	0.4	1.5	6.9	1.8	12.2	0.8	0.1	1.0	1.0	0.1	1.3	5.3	1.2	0.5	0.5	3.3	0.9	5.8	0.1	0.0	35.7	37.1	0.2	0.3	1.1	15.9	0.3	1.5	1.1	0.2	2.6
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 141.1;liver: 162.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.1	0.2	0.0	0.3	141.1	162.5	0.1	0.3	0.8	0.2	0.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.8	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
ACOD1	"CAD, IRG1"	ENSG00000102794	"Aconitate decarboxylase 1"	A6NK06	13	76948511-76958638	"Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA040143	Uncertain					NA	NA				"Cluster 16: Immune cells - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA040143: AB_10793916"	"unprognostic (2.39e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.37e-1)"			"unprognostic (3.54e-2)"		"unprognostic (3.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.30e-2)"			"unprognostic (1.64e-5)"	"unprognostic (7.70e-2)"	"unprognostic (3.68e-2)"		"unprognostic (6.51e-3)"	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537143-73543796	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Cardiomyocytes: 51.5;Excitatory neurons: 13.8;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 30.5;T-47d: 49.8"									HPA043705	Approved		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	15.1	12.9	10.4	3.6	10.2	2.4	13.0	9.3	11.3	5.7	8.4	12.9	10.8	13.2	11.6	3.4	7.3	3.5	18.6	10.1	9.7	25.9	44.4	7.3	2.3	9.2	10.1	3.5	3.0	2.2	2.0	2.9	9.6	5.6	5.4	2.9	5.1	9.3	19.6	8.9	11.8	20.9	9.5	2.6	6.4	4.2	11.1	2.5	3.6	29.3	2.1	9.5	4.0	9.6	10.7	9.0	3.3	0.7	15.2	9.1	0.1	2.9	8.5	7.0	12.6	3.9	6.9	0.0	0.4	5.8	0.9	6.0	0.0	1.4	3.4	4.5	2.8	4.6	2.8	30.5	14.4	0.1	5.1	12.0	0.6	5.6	0.0	0.7	3.2	0.0	0.0	0.0	5.5	4.7	0.6	1.0	3.4	1.4	4.9	9.5	6.8	0.2	6.9	8.7	4.9	6.4	9.0	20.2	12.2	0.9	49.8	9.9	4.2	5.2	7.5	4.2	0.7	0.1	0.0	2.6	6.2	0.0	6.8	0.7	0.9	0.7	4.1	1.1	3.5	2.6	3.9	3.4	3.8	1.9	3.5	3.9	0.1	3.5	1.1	2.2	5.1	2.6	10.4	10.2	9.3	11.3	10.1	9.7	9.2	10.1	9.6	9.5	11.1	9.6	0.2	0.0	3.2	10.7	0.0	0.0	0.1	0.6	1.8	0.0	0.4	0.4	51.5	0.0	0.4	0.0	0.0	0.7	1.3	0.2	0.0	0.4	0.6	0.3	0.3	0.7	0.0	2.7	13.8	8.0	0.3	2.6	0.0	0.3	0.0	0.1	0.0	1.1	0.9	0.0	12.0	0.0	2.0	0.3	0.0	0.0	0.0	0.5	1.8	3.7	0.0	0.0	0.0	8.5	15.1	2.6	0.0	0.4	0.3	0.0	0.0	3.7	0.3	0.0	0.0	0.0	3.6	0.1	0.2	0.6	0.0	0.8	0.2	0.0	0.2	0.0
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 44.4;intestine: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Distal enterocytes: 71.3;Late spermatids: 150.6;Proximal enterocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 18.9;OE19: 27.3;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.4	3.4	4.6	2.4	5.9	3.7	1.1	7.0	5.2	3.8	44.4	13.8	36.0	2.6	3.1	15.9	3.0	2.4	30.4	5.4	4.9	16.3	1.2	1.9	1.7	7.1	12.3	5.2	3.1	21.2	8.0	1.5	6.1	3.5	11.6	7.9	9.4	3.4	9.2	2.8	29.3	2.5	3.6	1.5	11.1	2.5	7.6	0.6	10.1	10.6	3.3	6.5	6.3	3.9	6.7	4.2	2.0	1.2	0.8	1.9	3.4	3.7	0.2	1.1	0.8	6.4	16.9	1.4	5.6	3.0	4.0	18.9	0.8	3.3	0.6	3.9	1.4	16.0	6.2	2.7	0.3	1.8	2.1	2.0	3.7	0.4	1.6	1.7	3.4	1.1	0.9	1.9	4.0	2.0	0.7	2.4	3.3	27.3	0.9	1.2	11.1	1.5	0.7	40.1	4.2	4.2	1.8	1.2	0.8	6.8	1.6	5.1	3.5	2.5	2.4	1.7	1.4	1.9	1.0	1.5	1.2	11.7	1.3	1.1	0.6	4.6	0.3	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.4	1.3	0.4	0.5	0.4	0.3	0.3	4.6	5.9	7.0	5.2	5.4	4.9	7.1	12.3	6.1	3.6	7.6	3.9	0.5	0.0	7.8	134.8	1.4	4.8	16.6	7.3	2.8	46.4	3.4	0.9	24.7	10.0	7.2	25.8	0.0	2.0	0.2	71.3	11.7	4.4	22.6	11.4	1.7	2.1	47.5	3.0	11.7	2.6	6.2	3.5	33.6	14.1	15.2	3.3	3.9	0.4	8.3	15.2	6.0	38.8	10.2	8.0	7.4	150.6	13.7	6.1	8.8	10.3	2.9	46.4	0.0	19.6	3.9	4.7	37.0	17.7	0.5	6.6	106.1	48.0	8.5	5.3	0.0	19.1	2.5	0.6	1.0	5.3	2.8	2.5	1.2	16.4	44.8	26.3
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 847.1;Proximal tubular cells: 525.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	6.3	6.1	7.2	4.8	7.5	3.4	3.8	7.9	7.3	3.4	6.0	9.1	6.5	3.1	3.7	3.4	3.6	4.9	12.0	6.6	7.8	19.2	30.6	4.6	5.2	7.2	7.8	3.9	6.6	7.2	5.1	3.0	7.4	6.5	7.4	9.6	5.0	3.3	12.2	5.5	6.1	3.1	7.1	4.8	5.5	7.0	8.2	5.1	5.7	10.3	3.4	3.5	3.1	7.4	5.9	7.6	7.6	13.6	10.5	13.1	4.2	4.8	5.8	3.5	5.4	10.1	7.5	11.1	16.2	5.5	18.4	6.4	6.7	9.7	5.4	17.4	6.2	10.4	7.7	7.0	5.3	6.7	4.6	7.6	9.4	4.7	9.0	8.5	8.3	11.3	17.0	5.7	7.0	6.1	12.1	12.9	5.1	11.7	5.9	10.4	6.6	14.0	11.7	5.4	15.0	5.2	5.7	19.1	14.1	8.8	13.2	5.5	9.7	6.2	3.5	1.7	4.6	10.7	29.3	11.1	6.5	23.8	19.1	4.8	5.3	3.6	4.4	5.7	6.1	6.9	4.9	5.0	4.7	4.9	5.7	5.1	6.2	4.6	5.8	3.7	5.3	4.8	7.2	7.5	7.9	7.3	6.6	7.8	7.2	7.8	7.4	7.1	8.2	7.4	27.9	67.3	41.7	19.6	19.7	17.2	26.6	66.4	18.8	18.7	29.4	32.3	94.6	45.8	46.9	31.3	16.7	56.8	22.6	88.4	158.5	43.2	847.1	34.0	31.3	24.0	54.7	37.2	12.1	40.2	31.1	26.2	23.9	31.8	14.5	30.3	21.4	215.5	86.7	5.0	14.3	85.8	67.1	24.5	23.7	131.5	19.6	35.0	26.6	14.0	68.9	41.7	18.6	15.6	18.7	29.2	130.7	24.0	25.4	23.2	47.1	525.2	56.8	31.8	26.3	50.6	64.2	117.1	27.3	19.5	23.4	40.0	20.5	43.4	69.4	28.6
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591873-73595766	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;liver: 16.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 26.4;Proximal tubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.6;MCF7: 14.1;SK-BR-3: 27.9;T-47d: 69.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	4.9	1.4	3.7	1.1	3.7	0.6	4.6	4.2	4.3	3.9	2.4	3.0	4.3	0.8	2.6	1.5	0.9	0.9	0.9	3.6	2.9	15.0	16.8	3.6	1.3	3.1	2.7	0.9	1.5	1.0	0.4	1.8	3.3	1.4	3.4	0.8	1.7	1.8	0.6	0.6	3.3	1.5	2.5	1.5	2.0	2.2	2.9	1.0	1.3	0.6	1.3	1.2	0.9	3.2	10.7	2.9	0.3	0.1	1.3	0.6	0.0	0.6	0.0	0.7	1.2	0.3	17.6	0.0	0.6	1.0	0.0	1.1	0.0	0.1	0.1	5.8	0.1	0.0	3.5	0.0	2.0	0.0	9.5	0.8	1.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.6	14.1	0.3	1.9	0.9	3.7	2.8	0.0	0.0	0.0	0.4	5.2	1.5	0.3	6.9	27.9	2.1	0.1	69.7	10.5	0.2	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.5	0.0	1.4	14.7	0.6	7.3	2.1	6.9	8.4	0.4	3.3	4.0	8.5	0.0	7.2	0.2	0.9	7.2	5.3	3.7	3.7	4.2	4.3	3.6	2.9	3.1	2.7	3.3	2.5	2.9	3.2	0.4	0.0	2.7	1.0	1.0	0.3	1.1	3.8	1.2	0.2	5.5	4.2	1.7	7.2	2.8	11.0	0.0	15.9	3.6	8.3	15.6	4.2	1.8	4.1	1.1	0.5	0.0	0.0	1.4	9.2	13.8	1.5	3.1	5.6	5.7	4.1	0.0	26.4	11.2	1.7	0.8	3.2	8.2	3.0	0.3	5.3	0.3	2.1	0.0	1.9	1.0	0.7	11.3	0.5	0.3	6.2	2.6	0.4	1.5	1.1	15.7	59.8	2.9	0.5	0.0	1.5	1.1	3.2	15.8	2.6	0.3	4.5	5.1	0.4	2.6	1.3
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;kidney: 3.7;liver: 3.1;skeletal muscle: 4.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.3;Excitatory neurons: 2.7;Hepatocytes: 3.4;Inhibitory neurons: 2.8;Proximal tubular cells: 5.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"T-47d: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058258	Uncertain					NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	1.7	0.6	0.8	0.1	1.3	0.0	0.1	5.0	2.5	0.0	2.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.8	1.2	0.0	3.7	3.1	0.1	0.1	0.6	0.3	0.5	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.2	0.0	4.0	0.0	0.1	0.0	0.4	0.2	0.0	0.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	1.8	0.1	0.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	5.0	2.5	1.2	0.0	0.6	0.3	1.0	0.4	0.5	0.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857405	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	8.3	31.7	27.8	8.6	29.8	18.1	7.6	28.2	35.2	9.3	24.3	18.5	21.1	8.5	11.0	17.5	10.7	9.2	28.1	29.8	28.6	21.3	26.0	11.0	12.6	27.0	28.5	8.0	15.6	15.1	15.4	7.1	28.7	12.7	12.8	9.2	12.8	5.9	28.7	17.0	20.5	6.4	26.0	12.3	21.3	20.2	28.7	13.1	11.4	17.8	9.7	11.0	10.4	28.1	16.8	20.2	6.8	13.4	18.3	11.0	11.7	11.1	9.5	15.1	13.7	29.2	22.7	20.8	48.2	16.3	35.4	32.3	13.0	27.8	6.6	15.5	22.3	21.2	25.1	28.5	16.9	19.9	19.3	12.9	21.3	15.1	10.9	22.6	9.4	23.6	18.8	24.2	11.0	47.4	28.7	27.0	11.8	32.4	52.2	14.0	12.2	37.6	16.5	19.1	23.1	10.8	24.9	61.7	39.5	10.6	34.4	48.8	11.6	37.9	8.5	19.5	18.9	20.7	33.8	14.0	46.3	21.2	20.8	34.3	34.3	43.6	24.8	34.6	21.8	27.5	23.2	21.9	36.7	27.9	20.0	21.6	25.0	16.3	34.2	23.3	31.9	26.7	27.8	29.8	28.2	35.2	29.8	28.6	27.0	28.5	28.7	26.0	28.7	28.1	8.2	35.3	14.1	5.9	17.9	6.1	12.3	21.9	8.6	19.2	9.8	10.9	9.3	11.5	17.7	12.9	16.7	34.2	11.8	104.2	64.6	21.6	38.5	14.2	10.4	10.9	19.2	17.0	12.3	21.0	20.9	11.4	19.9	14.0	14.0	27.6	11.4	25.5	27.8	8.4	12.0	37.3	10.2	18.6	7.1	90.3	9.9	17.5	10.6	3.7	27.5	17.8	34.0	5.0	9.6	21.6	68.4	8.6	21.3	11.3	105.4	81.5	27.1	22.8	13.1	5.8	12.8	27.0	10.2	16.1	8.0	19.4	13.9	37.6	30.3	16.0
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23701055-23766475	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7600	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	24.1	18.8	8.0	19.5	7.5	15.8	19.8	7.5	9.5	17.7	10.3	22.0	15.5	22.5	8.4	12.1	17.3	13.6	49.3	7.2	9.1	15.5	14.5	26.1	12.7	8.0	7.5	15.1	14.0	11.7	8.8	17.8	8.6	16.1	16.4	9.6	18.6	22.1	27.6	12.5	15.8	32.3	6.9	18.4	17.7	6.2	8.5	6.3	17.4	14.2	12.5	21.3	14.7	7.5	81.5	54.0	23.1	51.4	37.2	42.0	11.7	62.7	54.3	60.7	58.4	48.5	71.4	4.1	39.1	70.5	81.8	48.3	29.6	79.9	84.2	18.8	44.6	27.4	55.0	35.6	49.9	10.8	33.3	37.5	53.6	71.5	80.5	39.6	90.3	0.6	17.7	26.7	66.7	28.4	15.2	26.1	33.9	31.8	65.3	15.7	87.6	34.4	72.8	29.8	4.5	22.1	68.4	28.3	41.6	85.5	31.9	14.0	84.7	50.7	33.8	73.3	34.7	6.4	16.1	0.5	37.4	10.5	43.6	24.7	30.2	22.2	10.2	43.5	14.1	11.1	12.6	11.3	32.4	9.9	4.0	9.4	15.8	12.3	56.2	5.4	20.8	18.6	8.0	7.5	7.5	9.5	7.2	9.1	8.0	7.5	8.6	6.9	8.5	7.5	34.6	48.1	27.3	12.1	23.0	20.1	45.9	51.8	7.4	5.3	5.6	6.7	44.3	18.6	36.8	16.5	25.0	4.0	21.5	9.7	5.9	59.6	0.8	20.8	22.9	38.7	2.4	11.2	6.1	52.5	11.4	33.4	16.8	21.6	37.3	14.8	32.9	11.8	42.4	5.0	8.6	10.3	16.2	37.1	95.4	0.4	18.0	57.3	33.8	13.1	192.3	11.9	19.6	4.5	3.1	83.4	15.0	25.6	27.7	52.4	14.6	30.3	38.0	9.9	26.3	35.2	65.1	1.6	10.4	3.5	10.7	3.0	21.2	30.4	11.2	38.2
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979177	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 191.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 199.8;Hepatocytes: 287.4;Proximal enterocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 77.2;neutrophil: 113.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 113.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 96.9;RT4: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		96000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	37.8	18.1	16.1	10.6	18.2	8.8	17.1	17.4	15.1	11.0	21.3	40.9	62.5	9.3	9.8	30.4	9.9	14.9	23.0	14.3	17.5	40.3	191.5	13.6	6.2	16.6	17.9	9.5	39.7	18.8	12.6	17.3	15.9	18.4	27.1	16.1	15.4	11.8	30.1	24.8	51.4	11.1	17.5	10.5	27.4	9.3	20.6	8.3	17.0	29.2	12.1	19.5	12.7	18.9	16.3	24.5	7.2	9.9	34.0	14.4	96.9	11.8	11.3	12.9	14.8	16.4	24.0	9.1	14.0	17.9	12.5	9.9	28.7	12.4	19.2	10.0	9.5	10.9	13.1	47.2	19.4	9.7	7.8	24.0	9.4	15.7	9.2	13.1	32.3	13.6	12.3	8.9	14.0	45.3	26.3	7.0	4.9	36.8	19.8	13.4	21.3	10.2	20.7	129.1	8.7	12.6	30.6	46.5	11.4	21.2	32.6	11.3	20.9	18.2	13.4	15.2	11.5	14.4	11.0	4.0	10.0	9.7	11.4	77.2	18.3	5.2	6.9	14.2	8.2	5.4	6.6	8.8	10.3	4.5	7.2	7.1	113.7	7.2	9.4	9.4	9.3	8.0	16.1	18.2	17.4	15.1	14.3	17.5	16.6	17.9	15.9	17.5	20.6	18.9	28.0	28.9	25.0	25.1	10.8	13.5	15.9	26.1	21.1	27.4	19.4	13.5	47.4	51.5	23.4	23.9	22.9	37.7	12.1	199.8	21.5	22.9	11.6	18.1	16.7	18.8	34.4	21.5	17.8	40.6	46.5	19.8	88.7	24.1	17.1	21.4	21.8	287.4	25.4	18.5	18.8	44.5	24.4	35.4	14.1	7.1	29.8	23.7	14.2	15.0	36.3	61.9	9.2	22.1	18.2	34.2	100.0	47.0	18.3	24.0	238.7	107.8	17.4	28.4	0.0	18.4	17.2	5.5	11.0	28.5	30.3	43.2	13.2	17.1	41.9	31.7
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Supported	Peroxisomes		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	7.7	8.8	5.8	6.4	5.2	4.4	12.2	3.8	7.2	9.5	5.9	8.4	8.9	5.6	4.3	26.6	6.6	5.9	16.2	5.3	4.9	6.5	14.9	7.2	6.6	5.9	4.6	7.5	12.0	7.1	4.5	8.4	4.7	10.5	6.3	3.8	15.4	8.4	6.4	12.5	8.9	11.4	4.2	5.3	10.1	2.9	5.0	4.6	8.5	5.6	8.5	10.1	13.7	7.1	8.9	9.6	10.5	14.1	11.0	18.7	17.2	11.1	15.1	18.5	16.1	4.8	11.7	11.9	11.7	22.8	25.0	5.4	4.6	14.4	14.3	4.1	4.5	5.2	8.2	14.8	18.3	10.7	9.4	18.9	12.1	16.7	6.5	13.3	22.1	13.1	7.0	10.6	16.1	8.2	11.4	15.6	5.9	11.3	16.4	11.8	17.3	14.3	11.2	12.4	5.1	11.7	14.2	7.2	7.3	8.6	7.2	14.9	21.7	18.2	5.9	7.5	11.8	7.9	5.6	5.4	23.2	13.1	11.8	0.1	13.2	3.3	6.1	15.2	6.3	5.4	7.1	7.8	17.8	4.9	6.5	6.7	3.1	9.5	14.4	21.4	10.4	9.4	5.8	5.2	3.8	7.2	5.3	4.9	5.9	4.6	4.7	4.2	5.0	7.1	6.2	6.4	5.9	14.7	4.8	4.5	7.6	12.3	8.6	8.2	11.6	7.6	9.4	10.0	9.8	11.0	33.3	23.9	7.7	10.9	3.9	17.3	4.4	13.1	4.2	5.6	1.8	3.0	13.2	13.7	9.3	6.6	10.2	10.0	0.0	21.7	4.6	14.2	10.2	1.7	14.2	4.9	14.2	4.1	4.4	3.3	6.8	5.3	5.4	6.5	7.6	3.8	2.1	12.5	14.5	16.9	7.4	11.3	5.6	9.1	18.3	8.2	11.2	18.6	0.0	3.8	6.9	2.4	2.3	14.1	5.8	74.6	6.0	6.0	7.5	11.4
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368298	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3643.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.7"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	480000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	3.1	5.4	0.9	7.3	1.3	17.5	3.4	0.9	0.9	6.3	1.2	3.6	3.1	1.4	17.2	47.7	2.2	1.5	0.6	1.2	1.5	28.9	1.4	4.5	1.9	1.5	1.3	1.1	2.7	3.9	0.5	10.8	1.5	3643.7	6.5	0.4	10.6	0.8	0.2	27.0	3.4	1.8	1.0	1.8	3.2	2.4	1.0	1.0	2.4	0.2	6.5	1.8	12.1	1.7	0.5	0.1	0.0	0.0	0.2	0.9	11.7	0.3	17.7	0.1	0.0	0.4	0.4	10.6	0.8	0.0	0.1	4.8	0.0	0.1	0.0	0.1	0.5	2.0	0.4	0.2	0.2	7.3	0.1	1.1	1.6	0.1	0.0	0.2	0.0	0.0	0.1	2.7	0.2	0.1	0.0	13.5	0.7	22.3	2.1	0.1	0.0	58.0	5.0	6.5	0.0	4.1	0.1	2.0	0.6	1.7	0.3	6.5	0.0	0.1	0.1	2.5	0.1	0.8	0.4	17.2	14.9	12.7	0.2	0.1	30.2	139.7	0.2	26.9	0.2	0.7	0.0	0.0	35.3	0.0	0.0	0.0	26.4	2.6	25.8	2.4	0.0	10.1	0.9	1.3	0.9	0.9	1.2	1.5	1.5	1.3	1.5	1.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 108.9;RPTEC TERT1: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000	"Cluster 35: T-regs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.3	13.6	6.2	4.2	6.3	5.0	17.8	5.6	6.6	11.8	7.9	11.4	7.4	8.3	16.2	7.8	12.7	6.8	8.4	5.9	6.3	17.5	13.2	7.3	3.9	6.3	6.9	9.3	11.0	21.9	15.2	4.2	6.2	12.6	9.7	3.6	10.4	11.2	6.7	9.3	8.8	6.0	6.0	6.0	12.4	5.7	6.1	7.9	15.2	6.0	6.9	11.2	6.7	5.7	21.1	8.5	7.1	12.7	4.5	4.3	20.2	4.8	14.8	14.8	17.5	10.2	31.9	6.1	17.4	10.4	11.4	35.6	9.6	32.0	15.4	8.2	16.1	21.9	11.8	19.4	13.2	3.9	0.8	6.3	23.3	7.7	15.4	17.6	15.2	30.2	10.5	3.4	17.0	15.8	16.5	10.0	17.0	108.9	62.9	11.7	6.1	70.9	119.7	41.3	5.8	7.1	17.5	12.5	36.5	15.9	20.3	6.0	10.7	4.6	8.6	0.9	15.1	13.4	21.3	2.8	8.7	0.3	25.8	0.1	2.3	13.4	4.6	0.8	7.9	2.6	7.5	6.1	5.4	2.8	8.2	7.0	3.5	0.3	0.3	3.4	14.8	2.7	6.2	6.3	5.6	6.6	5.9	6.3	6.3	6.9	6.2	6.0	6.1	5.7	2.1	19.2	13.9	74.4	2.9	1.1	6.1	7.4	7.4	3.1	6.3	6.3	7.0	10.0	6.7	16.5	0.0	19.7	7.0	3.7	17.6	7.5	6.0	9.1	2.3	2.4	9.1	4.2	14.2	15.3	7.2	2.4	10.7	9.4	1.3	15.2	5.3	10.9	4.6	0.0	20.6	8.5	8.2	4.8	6.7	1.5	5.9	2.9	3.6	15.0	3.4	8.8	4.1	18.1	10.4	18.7	5.4	4.1	3.8	4.9	6.3	14.4	11.9	1.1	13.1	5.7	7.7	7.5	4.7	9.1	1.3	8.1	9.6	7.3	8.5	5.8
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.6;lymphoid tissue: 2.6;skin 1: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 33.3;U-87 MG: 45.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.0	0.0	1.7	0.0	3.3	0.0	0.2	6.6	2.7	0.7	0.8	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	2.0	2.2	0.0	0.0	0.0	0.0	3.9	3.7	0.0	0.0	0.3	0.0	0.0	3.8	0.3	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	2.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	2.6	0.1	0.6	4.1	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.4	5.2	0.0	0.0	0.0	33.3	0.3	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.5	0.3	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.1	1.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	6.6	2.7	2.0	2.2	3.9	3.7	3.8	2.0	3.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745339	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 86.7"	"Group enriched"	"Detected in some"	33	"Early spermatids: 492.2;Late spermatids: 134.8;Spermatocytes: 216.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA048687	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA048687: AB_2680494"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	2.6	0.2	0.4	0.0	0.5	0.0	2.0	0.4	0.5	0.8	2.6	0.5	0.1	1.1	0.7	0.4	1.1	0.2	1.0	0.4	0.3	0.9	0.8	2.0	0.0	0.3	0.3	0.3	0.2	0.0	0.5	0.1	0.5	0.6	0.0	0.1	0.6	0.2	0.8	0.8	0.5	0.2	0.4	3.0	0.3	86.7	0.4	0.0	0.6	0.0	0.0	0.6	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.4	8.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	492.2	0.4	0.1	4.7	3.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.5	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	134.8	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	2.6	0.0	0.0	1.2	0.4	0.0	0.0	6.6	0.3	0.1	216.9	2.5	0.3	0.0	0.0	0.0	0.1	1.5	0.2
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647433	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"testis: 283.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1097.8;Late spermatids: 723.5;Macrophages: 220.0;Spermatocytes: 387.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.5;intermediate monocyte: 15.8;myeloid DC: 17.7;non-classical monocyte: 31.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 17.7;monocytes: 31.0"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;HMC-1: 6.7;U-266/70: 15.0;U-266/84: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted in male reproductive system"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	2.2	0.9	0.9	3.8	1.3	10.7	1.1	1.9	1.4	1.9	1.1	2.9	8.4	1.4	14.2	0.9	2.1	4.1	0.6	0.9	1.0	1.8	2.2	2.8	5.5	1.3	1.2	0.7	2.9	0.3	0.9	2.3	1.3	2.0	2.1	1.8	1.3	1.1	0.4	1.7	8.1	2.1	1.1	9.2	1.9	283.5	1.2	3.0	13.8	0.4	3.6	2.4	0.9	1.5	0.2	0.1	0.8	2.5	0.8	1.2	1.3	0.0	0.0	0.1	0.1	0.0	1.8	0.3	0.8	0.2	0.1	0.0	0.4	0.0	0.2	0.8	0.0	5.3	0.6	0.0	1.8	0.1	6.7	0.1	3.3	0.9	0.1	0.6	0.6	1.7	3.5	0.0	0.1	0.3	0.2	1.9	1.5	4.3	0.0	0.3	0.1	0.3	0.5	0.1	1.0	0.3	0.0	0.7	1.1	1.2	0.0	1.9	0.7	0.1	0.8	0.5	0.0	15.0	10.5	0.5	0.5	2.0	0.0	1.5	12.5	1.2	0.2	15.8	0.0	1.3	0.0	0.0	17.7	1.9	0.2	0.1	2.6	0.7	31.0	4.5	0.0	10.6	0.9	1.3	1.9	1.4	0.9	1.0	1.3	1.2	1.3	1.1	1.2	1.5	0.3	0.0	1.3	0.7	1.5	0.1	0.1	0.0	1.2	1.7	0.5	0.5	1.0	0.0	0.1	0.0	0.0	0.1	1.9	0.9	0.0	0.2	1097.8	0.7	0.5	1.5	0.0	5.7	0.2	0.5	0.3	0.5	0.0	0.8	6.3	0.4	1.8	0.3	9.8	0.0	0.3	0.8	0.0	20.5	3.4	723.5	8.1	220.0	0.0	1.0	7.6	1.1	10.3	0.0	0.4	0.1	1.6	4.5	0.5	0.0	7.6	1.1	0.2	1.3	6.6	0.3	0.2	387.5	7.5	0.3	0.0	0.1	1.0	0.4	1.1	0.1
ACRV1	"D11S4365, SP-10, SPACA2"	ENSG00000134940	"Acrosomal vesicle protein 1"	P26436	11	125671522-125680874	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 116.7"	"Group enriched"	"Detected in some"	48	"Early spermatids: 904.8;Late spermatids: 278.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 5.0;HEL: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038718, HPA038719"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA038718: AB_2676171, HPA038719: AB_10670787"	"unprognostic (3.58e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.39e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.80e-8)"	"unprognostic (5.26e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.75e-1)"	0.0	0.0	1.8	0.1	1.9	0.2	0.1	1.3	2.0	0.0	1.2	0.1	0.1	0.1	3.5	0.0	0.1	0.0	0.0	1.7	1.6	0.0	0.0	0.0	0.4	1.5	1.5	0.0	0.0	0.0	0.2	0.1	1.6	0.2	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.2	1.6	0.0	0.0	116.7	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.3	1.2	5.0	3.2	0.0	0.0	1.0	1.5	0.0	0.1	0.0	1.8	1.7	2.7	0.6	0.0	0.7	0.4	0.0	0.0	0.3	1.9	0.9	5.0	0.6	0.9	0.1	2.5	1.1	0.0	0.0	0.0	0.2	0.2	0.0	0.8	1.4	2.0	0.4	0.7	2.7	3.4	1.1	0.5	1.0	2.3	1.2	0.5	0.0	0.5	0.6	0.8	0.6	0.1	0.1	0.9	0.9	0.6	0.5	1.7	1.1	0.2	0.3	0.9	1.2	1.3	0.2	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	1.9	1.3	2.0	1.7	1.6	1.5	1.5	1.6	1.6	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	904.8	0.8	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	278.8	6.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;skin 1: 14.3"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 158.0"	"Cancer enriched"	"Detected in some"	4	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SK-MEL-30: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	0.1	5.5	23.0	0.4	42.6	2.4	1.6	30.5	24.0	0.5	0.0	1.1	0.4	0.2	0.7	0.3	2.8	0.2	0.8	19.6	35.9	0.5	0.4	0.5	0.4	46.0	39.9	0.3	0.2	0.0	0.5	0.1	47.7	0.8	0.1	0.6	0.3	0.2	0.2	14.3	0.5	0.2	45.8	0.3	0.3	3.7	36.6	3.4	0.2	0.0	0.1	0.3	0.5	56.6	0.3	0.0	0.6	0.9	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.5	0.3	0.6	0.3	0.0	0.2	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.4	0.0	0.1	0.2	0.5	3.1	0.2	0.1	0.1	0.4	0.2	0.0	0.4	0.2	0.3	0.1	0.4	1.5	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.3	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	23.0	42.6	30.5	24.0	19.6	35.9	46.0	39.9	47.7	45.8	36.6	56.6	0.1	0.0	2.0	158.0	0.6	1.1	0.6	0.3	0.6	1.9	0.2	0.1	3.0	0.0	2.7	0.0	4.2	0.2	0.5	0.3	0.0	0.0	1.8	4.4	0.3	0.2	0.0	4.6	0.7	0.0	0.2	0.7	0.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.7	0.3	4.0	1.8	2.8	0.1	0.2	1.0	7.5	26.9	0.2	0.0	0.0	0.9	0.3	0.1	0.2	19.1	3.3	0.0	0.3	1.0	2.0	10.0	0.4	0.6	0.4	0.5	1.6	0.1	0.7
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	89	"testis: 129.3"	"Group enriched"	"Detected in some"	75	"Early spermatids: 533.6;Late spermatids: 1782.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.1	0.0	0.2	0.0	0.2	0.0	0.2	1.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	129.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.2	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	533.6	0.0	0.1	0.6	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1782.3	11.8	0.8	0.0	1.9	0.0	0.0	0.0	1.5	3.1	0.0	0.0	7.2	0.0	0.0	0.0	1.9	0.0	0.0	6.6	0.0	0.1	15.4	9.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 142.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 97.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Uncertain	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Microtubules, Cytosol"		"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.41e-4)"	24.8	71.9	7.6	5.7	8.5	3.3	21.0	7.7	10.1	18.9	8.6	26.9	22.1	6.7	15.8	7.7	9.7	10.8	25.9	7.1	7.0	142.1	36.4	17.8	8.5	8.5	7.3	19.3	6.8	9.9	2.9	15.4	8.0	15.0	17.5	1.1	15.8	16.0	41.3	22.5	20.2	5.4	8.2	8.4	18.8	4.9	7.9	5.6	42.5	25.8	8.2	17.8	13.4	7.7	24.8	8.1	6.6	15.8	68.1	12.1	38.1	5.9	8.6	12.6	24.5	32.1	47.2	15.7	12.6	7.3	11.5	14.7	4.7	29.2	15.3	19.5	11.2	27.3	3.9	58.5	11.4	3.3	24.3	54.9	44.4	15.8	2.1	45.4	17.4	20.3	3.2	8.8	13.7	31.3	8.8	11.1	1.1	47.5	11.9	20.6	4.8	41.2	4.2	97.2	21.6	11.3	11.8	17.3	12.3	13.7	15.5	22.8	12.7	22.5	6.8	3.5	1.9	15.4	3.1	8.2	9.3	17.1	1.4	0.0	2.9	15.3	2.0	7.7	1.7	8.6	1.5	2.1	16.1	2.0	0.7	0.9	0.5	1.6	7.0	6.3	5.5	2.7	7.6	8.5	7.7	10.1	7.1	7.0	8.5	7.3	8.0	8.2	7.9	7.7	3.2	28.9	24.3	27.1	7.3	6.0	23.3	17.0	25.0	0.0	20.8	16.0	25.9	11.5	19.9	3.7	0.0	85.8	1.7	59.5	11.7	13.5	0.4	4.9	3.5	4.9	10.2	1.3	0.3	4.3	11.7	6.5	21.9	7.7	22.2	24.5	4.2	44.4	21.9	0.0	0.3	20.6	2.0	9.8	11.0	1.6	26.8	11.0	3.6	17.8	12.7	6.1	5.2	3.5	0.5	5.7	53.1	14.3	2.6	3.5	78.2	128.4	14.6	0.2	0.0	2.7	5.9	0.2	2.2	5.4	7.0	81.0	4.1	12.1	25.8	14.0
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 770.4;liver: 1319.0;skeletal muscle: 731.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 355.8;Hepatocytes: 1170.0;Late spermatids: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 475.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 475.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1124.0;ASC TERT1: 275.2;HSkMC: 609.5;RPTEC TERT1: 358.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011317, HPA011964"	Enhanced		Uncertain	Vesicles		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA011316: AB_1844536, HPA011317: , HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	770.4	43.3	32.5	94.8	43.9	337.9	316.7	45.2	70.2	62.1	60.7	34.0	32.4	41.6	78.2	66.0	50.6	36.2	172.7	34.4	39.1	218.7	1319.0	173.7	20.7	63.2	44.4	15.5	49.3	57.0	39.6	30.0	56.2	91.3	16.3	28.4	84.2	30.1	731.8	173.0	34.5	42.8	45.2	132.8	54.2	41.9	63.2	12.2	51.3	442.0	24.7	73.2	57.7	70.8	51.6	15.9	9.7	24.6	1124.0	275.2	8.3	29.1	13.8	16.1	11.2	3.9	14.0	22.2	3.0	32.8	38.4	29.7	43.1	17.8	13.3	107.1	17.7	16.6	13.1	40.5	183.4	41.9	37.2	609.5	140.7	13.6	67.1	27.6	21.1	3.6	7.5	59.4	77.0	26.9	3.1	55.1	2.0	32.5	23.3	8.0	8.6	27.0	358.4	135.9	36.3	35.1	25.4	70.8	86.5	3.9	26.9	39.8	25.1	13.8	16.8	34.5	8.7	24.5	13.5	8.9	45.6	56.3	22.4	16.5	54.7	17.7	3.3	30.9	2.8	3.3	2.3	1.5	13.1	3.4	2.5	2.2	475.2	4.4	23.0	2.4	4.9	20.8	32.5	43.9	45.2	70.2	34.4	39.1	63.2	44.4	56.2	45.2	63.2	70.8	7.5	25.6	121.0	6.5	15.7	21.0	16.0	14.0	5.2	6.6	49.7	10.3	119.1	25.8	33.5	31.3	18.8	10.2	7.1	4.3	93.9	4.6	355.8	9.8	25.0	9.8	0.0	34.1	15.2	12.8	2.2	19.4	36.2	24.6	24.1	1.5	18.2	1170.0	41.8	3.3	22.8	4.7	85.5	140.7	14.6	456.6	19.3	170.1	32.0	6.5	40.5	3.1	1.0	8.5	89.8	8.6	1.6	16.6	8.6	51.3	1.5	111.1	26.8	11.4	13.1	11.1	12.4	10.5	16.7	26.4	41.1	3.4	10.6	1.8	3.2	23.1
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860942-222944639	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 172.1"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 523.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 410.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	25.2	19.8	22.2	17.5	24.7	27.7	90.8	21.9	29.5	18.4	8.8	27.0	22.2	12.6	24.8	36.1	11.0	16.7	14.8	22.9	26.7	24.3	30.9	20.6	12.3	20.9	26.0	10.8	16.7	172.1	10.0	28.0	22.4	66.1	25.5	32.2	45.4	16.2	25.3	14.9	16.0	14.5	27.5	10.5	50.6	23.3	35.3	19.8	23.8	15.2	14.2	33.5	20.6	24.5	49.7	77.0	118.3	121.9	42.1	121.3	35.0	61.0	159.5	70.5	139.8	75.0	126.4	24.0	33.8	51.9	147.2	143.9	20.4	121.3	76.0	44.0	50.1	55.8	52.2	68.0	91.0	36.2	26.6	60.0	180.7	120.0	163.6	34.7	65.6	39.8	109.6	83.1	78.1	104.8	70.4	42.5	59.9	102.9	42.4	40.0	85.4	39.7	80.8	198.2	57.3	49.3	36.0	79.5	410.5	67.5	49.8	64.8	58.0	43.9	76.2	41.5	41.0	30.0	17.2	81.3	40.7	26.0	140.0	10.7	14.0	20.0	18.0	16.0	17.5	10.5	11.2	13.6	15.2	11.1	16.0	14.9	15.6	16.6	17.2	20.8	9.5	17.5	22.2	24.7	21.9	29.5	22.9	26.7	20.9	26.0	22.4	27.5	35.3	24.5	73.1	35.3	70.8	110.4	29.6	46.5	101.8	97.5	55.2	101.9	89.9	62.9	57.2	28.6	93.8	36.8	77.2	43.7	45.0	46.6	7.9	32.7	59.2	68.9	39.6	41.4	20.9	35.8	91.0	31.1	10.7	56.6	81.1	100.7	27.3	25.3	32.2	52.7	37.4	523.3	124.2	36.0	99.7	49.0	62.7	27.1	26.1	75.3	48.0	69.3	32.1	184.7	20.6	149.3	120.1	37.3	41.3	35.7	24.6	109.4	17.5	14.6	80.3	55.6	46.0	52.8	68.2	49.7	45.3	108.6	48.7	60.6	32.4	52.0	50.7	117.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		16000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	44.2	40.6	11.9	38.8	14.1	16.2	19.8	13.2	14.8	48.2	5.6	12.7	15.4	19.2	17.7	15.8	13.4	29.2	29.4	16.5	23.7	46.4	13.9	39.0	24.6	17.6	20.8	14.9	11.9	19.8	9.2	21.4	21.3	13.4	13.6	24.7	10.6	15.2	42.6	9.9	13.4	22.0	13.7	22.2	19.3	26.8	14.6	20.3	18.6	16.9	18.5	68.0	10.6	18.9	67.3	21.3	24.2	28.3	97.8	61.6	20.3	94.0	107.6	91.0	97.4	21.1	45.0	46.2	35.4	71.7	100.9	19.4	22.4	92.0	143.0	15.7	23.3	181.4	26.6	223.3	44.8	44.8	360.0	51.4	36.7	103.6	74.0	50.2	71.8	25.5	5.6	54.2	100.7	4.7	40.7	60.7	31.6	15.2	37.2	26.4	45.4	39.6	136.3	20.9	15.2	12.3	109.3	0.4	63.2	49.0	1.9	45.8	128.5	81.1	22.6	129.3	85.9	28.1	31.7	41.2	139.7	97.8	52.2	32.5	10.9	35.0	4.2	15.5	3.2	3.3	3.9	3.5	10.6	3.1	3.0	3.8	29.6	4.0	19.4	4.0	6.7	6.5	11.9	14.1	13.2	14.8	16.5	23.7	17.6	20.8	21.3	13.7	14.6	18.9	27.9	76.9	184.3	29.0	19.5	22.3	25.7	20.0	81.4	44.2	7.3	8.1	37.2	15.7	40.1	73.5	2.1	7.3	18.3	0.8	50.9	27.7	1.4	79.5	27.0	29.8	7.7	26.1	76.7	25.4	36.9	46.0	7.1	208.8	633.8	151.6	18.2	44.2	23.9	6.7	78.3	5.7	2.0	64.9	59.1	4.9	5.6	67.8	16.0	57.1	70.4	10.9	8.2	71.4	116.4	32.3	3.0	10.1	36.1	19.4	0.7	12.4	12.2	16.7	0.0	20.0	27.9	3.7	5.3	10.1	8.1	31.6	25.2	34.9	2.7	18.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 7.6;U-937: 6.2"									HPA040470	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.2	4.2	14.8	1.4	18.3	22.6	0.2	26.3	32.0	0.1	1.2	0.5	4.7	0.1	0.5	0.3	0.2	0.3	1.4	18.6	12.8	1.9	2.0	0.3	2.4	22.2	18.2	0.0	1.1	11.3	4.2	0.6	18.9	0.3	0.3	45.8	0.3	18.0	2.3	0.1	2.4	0.1	13.8	1.1	0.6	20.7	25.0	0.6	0.4	1.4	1.0	0.2	0.1	14.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	6.2	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.7	1.6	0.0	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.3	14.8	18.3	26.3	32.0	18.6	12.8	22.2	18.2	18.9	13.8	25.0	14.3	0.6	25.6	29.2	229.2	1.4	1.9	1.5	0.0	2.2	65.2	2.1	0.4	0.0	1.5	16.1	1.8	229.4	0.3	3.3	0.6	7.9	0.6	43.7	0.3	0.1	3.9	2.4	110.5	70.6	0.2	0.1	4.2	0.0	0.2	10.1	0.2	1.8	8.4	0.1	21.9	110.6	1.8	0.0	1.0	15.9	7.9	0.3	6.4	0.0	15.9	0.9	24.5	0.0	41.7	9.8	0.3	1.6	1.9	0.8	1.1	1.8	0.4	8.1	130.0	0.0	2.3	1.1	45.3	1.7	0.1	1.3	0.3	15.3	0.1	0.4	1.3
ACSM1	"BUCS1, MACS1"	ENSG00000166743	"Acyl-CoA synthetase medium chain family member 1"	Q08AH1	16	20623237-20698890	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"breast: 225.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.2;Late spermatids: 23.2;Theca cells: 8.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 14.7;prostate cancer: 36.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 15.6"	"Not detected"	"Not detected"							HPA046291	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 5: Breast - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA046291: AB_10960704"	"unprognostic (1.08e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	0.4	0.5	0.3	0.0	0.4	3.6	225.3	0.4	0.4	2.0	0.2	1.0	0.5	2.1	0.4	0.4	2.2	0.4	0.5	0.3	0.4	1.1	10.7	0.5	0.3	0.4	0.3	2.5	1.6	0.9	0.1	0.0	0.5	3.7	0.6	0.1	1.8	0.6	0.3	2.0	0.7	0.8	0.3	0.5	2.2	4.4	0.4	0.4	0.5	0.2	0.2	1.0	1.4	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.1	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.1	0.0	0.0	0.3	1.0	0.6	2.6	1.2	1.2	0.0	2.5	2.4	1.0	5.7	1.4	0.0	0.0	0.2	0.2	1.6	1.9	4.2	13.2	1.4	0.2	1.5	1.2	1.3	0.8	2.3	0.1	0.7	2.0	0.8	0.0	2.8	3.6	1.3	0.2	0.0	0.7	2.9	0.0	0.3	2.8	23.2	4.4	0.6	0.0	0.0	1.7	0.0	0.0	1.0	1.3	1.2	3.7	7.2	0.0	2.5	0.6	1.4	3.7	0.0	0.0	0.1	0.2	0.8	0.2	1.1	1.6	0.1	0.3	8.4	2.5	1.4
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487669	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1182	"kidney: 277.2;liver: 363.3"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 708.7;Proximal tubular cells: 372.5"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favorable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	277.2	363.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	4.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	21.5	0.0	7.3	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	2.7	0.0	13.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	708.7	0.0	0.0	0.2	0.0	0.0	18.3	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	372.5	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.0	0.1	0.3	1.7	0.0	0.0	0.1
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	173	"kidney: 414.1;liver: 523.5"	"Group enriched"	"Detected in some"	20	"Hepatocytes: 1036.1;Proximal tubular cells: 441.9"	"Group enriched"	"Detected in some"	449	"liver cancer: 30.9;renal cancer: 17.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;Hep G2: 5.5;U-937: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favorable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.4	0.5	0.4	0.0	1.0	0.2	0.3	2.7	1.6	0.1	0.1	0.8	0.3	0.3	0.3	0.3	0.4	0.5	0.6	0.6	0.8	414.1	523.5	0.4	0.2	0.7	0.5	0.4	0.2	0.2	0.1	0.1	0.7	0.2	0.0	0.5	0.1	0.0	0.9	0.8	0.1	0.1	0.1	0.3	0.6	0.9	0.4	0.1	1.0	0.0	0.1	0.0	0.1	0.8	0.5	0.0	2.9	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.7	0.5	0.0	1.4	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.4	0.1	0.7	5.5	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.5	0.0	0.0	0.4	0.3	0.5	0.6	0.7	0.0	0.0	0.6	0.1	0.0	0.1	0.9	0.5	1.4	0.0	0.5	0.1	1.1	0.2	0.0	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.0	2.7	1.6	0.6	0.8	0.7	0.5	0.7	0.1	0.4	0.8	0.5	0.0	0.0	0.0	6.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	7.3	0.0	0.0	0.0	0.2	35.2	0.1	0.8	0.0	0.0	2.2	1.8	24.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.7	1036.1	0.1	0.0	0.0	0.0	0.0	23.2	0.4	0.7	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	441.9	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	2.7	0.1	0.0	0.0
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 85.1;liver: 178.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 446.7;Hepatic stellate cells: 100.6;Proximal tubular cells: 136.0;Theca cells: 208.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 95.1;HMC-1: 381.7;K-562: 285.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	4.5	3.2	1.7	2.4	1.6	15.3	60.2	2.1	3.1	10.3	1.9	26.4	7.7	19.9	5.7	3.2	26.8	10.4	8.6	1.7	0.8	85.1	178.5	8.1	3.1	3.1	2.7	74.8	30.4	15.2	0.9	2.5	2.5	22.0	25.6	1.0	4.8	6.9	0.8	4.3	8.2	5.1	1.0	1.9	28.1	5.9	2.2	2.8	2.8	1.0	2.9	4.9	5.2	5.3	1.0	12.4	2.3	0.7	3.9	2.3	1.5	0.2	1.3	0.3	1.0	1.0	18.2	1.6	20.1	0.4	0.7	1.6	0.2	2.1	1.6	4.5	6.6	95.1	0.2	7.7	1.3	10.9	381.7	3.7	2.2	0.5	1.4	1.9	0.2	0.7	285.1	15.3	0.1	1.5	0.7	3.5	0.7	14.5	3.8	3.1	0.1	20.3	18.3	1.1	0.8	0.7	0.4	5.4	0.3	0.8	6.1	0.9	1.3	1.2	1.2	0.9	0.7	21.9	18.6	1.2	1.2	7.5	0.5	2.6	2.0	23.5	3.6	1.2	4.2	1.6	4.5	3.3	0.2	2.8	6.9	8.2	0.5	2.3	4.0	2.3	5.6	2.9	1.7	1.6	2.1	3.1	1.7	0.8	3.1	2.7	2.5	1.0	2.2	5.3	0.3	3.2	31.3	1.0	16.5	2.8	34.6	1.5	8.0	0.0	6.3	6.1	3.2	20.0	1.7	12.9	0.0	19.1	1.5	7.0	84.1	84.8	25.0	14.0	4.3	3.4	2.4	25.4	0.3	12.5	2.1	23.7	8.6	32.8	0.0	446.7	100.6	38.2	3.2	0.0	0.3	11.8	0.0	5.4	1.7	12.3	27.7	3.4	0.0	0.0	3.1	0.0	4.1	0.0	0.1	8.9	20.3	12.8	1.0	14.5	4.7	136.0	1.5	0.0	0.0	0.4	52.7	6.9	2.2	3.8	1.8	19.2	4.3	208.3	23.0	11.3
ACSM4		ENSG00000215009	"Acyl-CoA synthetase medium chain family member 4"	P0C7M7	12	7304284-7328724	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.4;Excitatory neurons: 1.2;Inhibitory neurons: 1.1;Spermatogonia: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;Karpas-707: 1.1;NB-4: 1.8;SH-SY5Y: 2.0;U-87 MG: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049895	Uncertain					NA	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA049895: AB_2680940"	"unprognostic (9.50e-5)"	"unprognostic (5.45e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.06e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.31e-3)"	"unprognostic (3.85e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.45e-9)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.73e-1)"	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	2.0	0.3	0.5	0.0	0.0	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 276.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.5	2.5	7.1	0.6	5.2	0.6	10.7	4.7	5.0	2.8	3.0	3.7	0.8	1.2	7.1	1.0	1.7	2.3	3.3	5.5	7.9	25.4	276.6	2.1	1.9	6.3	6.8	0.8	0.6	1.0	0.5	1.4	6.8	0.6	1.2	0.5	0.9	0.9	13.9	2.3	1.9	1.0	6.7	4.6	3.4	0.9	8.2	0.7	4.2	1.7	0.7	1.1	2.2	8.2	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	7.1	5.2	4.7	5.0	5.5	7.9	6.3	6.8	6.8	6.7	8.2	8.2	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.6;pancreas: 4.0;skin 1: 1.9;stomach 1: 1.9;urinary bladder: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.0;Cone photoreceptor cells: 2.1;Early spermatids: 2.4;Excitatory neurons: 3.8;Inhibitory neurons: 3.4;Oligodendrocytes: 2.1;Rod photoreceptor cells: 5.3"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"RT4: 3.7"									HPA044593	Uncertain					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.71e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.9	0.1	0.1	3.6	0.4	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	2.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.4	0.6	1.2	0.6	0.0	0.0	3.8	0.0	0.0	0.1	1.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	12.8	9.5	65.0	15.5	70.2	33.4	14.1	55.8	66.9	16.1	124.7	28.1	49.3	16.1	19.7	14.3	18.8	15.0	91.3	64.5	55.7	49.9	13.9	20.2	25.5	57.9	65.0	22.6	57.4	34.0	11.3	118.4	53.8	29.1	20.6	4.0	39.8	12.0	44.6	18.0	46.8	13.1	53.4	33.6	62.9	38.6	67.7	30.9	29.8	41.4	21.3	15.7	14.5	60.8	0.1	11.8	3.4	0.0	10.6	4.0	0.2	1.3	5.1	5.0	3.3	12.0	1.6	21.0	2.0	4.8	21.5	5.9	17.1	2.6	1.0	0.0	1.6	36.0	0.2	50.3	11.1	8.5	0.4	7.0	8.6	0.5	0.0	0.0	10.9	51.2	1.9	39.0	0.4	1.3	49.6	14.6	0.2	64.6	18.9	38.2	1.1	75.1	7.3	9.4	8.3	0.2	2.3	4.6	33.5	0.2	22.5	19.1	1.7	0.1	0.1	0.1	0.6	26.7	1.9	0.0	0.5	51.5	13.0	5.6	2.8	7.2	4.2	5.1	3.3	4.0	2.7	3.6	3.5	5.1	2.3	3.5	0.5	10.2	3.4	2.1	2.7	2.3	65.0	70.2	55.8	66.9	64.5	55.7	57.9	65.0	53.8	53.4	67.7	60.8	10.8	12.8	15.1	300.4	29.8	5.2	6.7	3.1	5.2	2.2	15.1	8.0	73.0	45.8	7.7	11.0	0.0	329.7	26.4	27.2	76.3	6.5	87.7	14.3	5.0	9.7	0.0	42.9	0.9	7.7	10.9	14.0	26.5	7.2	5.7	20.4	9.3	6.2	53.2	0.0	1.8	28.5	10.2	11.2	8.8	16.2	34.5	12.0	7.2	41.2	12.3	14.8	25.7	32.2	31.4	1.9	15.8	32.4	42.2	14.0	90.6	16.7	13.8	1.0	19.7	8.8	12.0	1.1	2.0	9.5	4.3	419.5	22.6	60.2	23.4	4.1
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 117.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 137.7;Hepatocytes: 138.9;Intestinal goblet cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.6;granulocytes: 34.3;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved					NA	NA		16000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	69.3	23.7	4.0	10.7	9.3	7.5	27.2	6.8	7.8	15.1	6.0	54.6	64.2	13.7	34.3	18.6	22.1	10.7	49.8	3.3	6.4	22.0	46.9	23.2	4.0	12.1	5.9	13.0	14.8	19.6	3.8	17.2	12.7	12.2	32.9	5.3	38.1	16.2	117.3	17.1	46.8	11.3	5.1	8.1	37.7	10.6	7.2	4.0	9.6	99.2	7.0	9.3	11.9	16.3	32.8	11.6	17.1	10.7	69.5	59.1	25.5	14.5	32.4	13.9	21.7	27.3	40.6	0.1	18.6	24.1	50.2	26.0	20.1	132.4	9.5	0.1	7.1	37.2	6.6	18.5	46.2	6.6	28.1	50.3	34.2	24.8	34.5	27.8	27.7	4.2	22.0	7.1	15.8	13.3	2.4	18.8	3.3	27.6	44.1	15.9	20.3	83.4	62.5	9.0	2.9	14.5	24.7	49.1	32.1	21.2	19.6	24.4	23.5	12.3	7.8	12.4	7.9	24.0	19.7	9.1	32.3	9.3	9.1	34.3	21.8	6.6	1.2	13.3	1.2	0.7	3.0	1.3	22.6	1.1	5.3	2.9	12.2	0.7	6.4	4.2	2.0	9.2	4.0	9.3	6.8	7.8	3.3	6.4	12.1	5.9	12.7	5.1	7.2	16.3	8.8	12.8	41.1	17.6	4.2	7.8	9.4	13.5	10.2	6.4	27.6	10.9	82.2	20.0	16.6	11.0	6.2	15.5	3.7	137.7	11.7	20.8	9.0	8.0	8.2	13.5	7.8	29.0	18.5	33.7	11.2	11.4	58.1	13.0	9.5	35.3	13.6	138.9	16.4	8.4	18.2	100.6	18.3	17.9	13.9	7.2	11.5	15.6	14.2	17.8	19.4	9.1	1.0	5.5	86.5	23.4	66.4	4.5	14.6	11.2	70.4	60.5	7.6	4.1	13.1	7.2	9.8	32.1	20.3	12.3	10.9	20.9	5.1	7.8	75.1	13.0
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 133409.0"	"Group enriched"	"Detected in some"	36	"Cardiomyocytes: 1901.9;Skeletal myocytes: 1541.2"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	22	"BEWO: 469.2"	"Low region specificity"	"Detected in all"							"CAB000045, HPA041264, HPA041271"	Enhanced					NA	NA		2800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	15.3	3.8	1.2	1.6	1.2	0.3	19.8	1.8	2.8	1.2	0.4	8.8	0.3	3.0	0.0	604.6	0.6	1.6	6656.6	1.2	3.5	2.6	7.3	7.6	2.2	0.9	1.1	4.6	7.3	0.0	4.7	1.2	0.8	164.8	0.0	0.1	591.0	0.7	133409.0	36.0	5.3	66.3	0.7	3.0	5.1	2.5	1.4	3.1	14.5	20867.7	0.9	3.0	5.4	1.0	0.2	0.2	0.1	0.4	0.0	0.1	469.2	0.0	0.0	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.4	0.2	0.5	21.5	0.0	0.5	0.7	20.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.2	4.3	0.1	0.0	0.3	0.4	0.6	0.3	0.2	0.5	0.5	0.6	1.0	0.3	0.3	0.6	0.3	18.3	16.5	34.2	11.5	25.4	8.4	6.7	9.4	11.2	23.6	6.4	7.2	11.5	18.8	8.2	24.1	7.5	15.7	45.4	1.2	1.2	1.8	2.8	1.2	3.5	0.9	1.1	0.8	0.7	1.4	1.0	0.2	0.0	0.0	0.3	0.1	0.5	0.4	0.8	0.0	0.8	0.3	2.2	1901.9	0.0	0.1	0.0	4.2	1.7	0.0	0.0	0.0	1.9	0.4	0.1	0.4	38.1	0.0	0.0	0.6	0.0	3.3	43.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	2.1	0.3	0.0	9.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1541.2	46.6	1.1	0.2	0.7	0.4	0.3	8.2	0.1	0.1	0.2
ACTA2	ACTSA	ENSG00000107796	"Actin alpha 2, smooth muscle"	P62736	10	88935074-88991339	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 101.0"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	1035.2	241.6	54.0	728.1	61.4	3.9	838.4	52.7	121.1	2000.3	61.4	2755.1	248.9	6678.8	1360.1	1509.9	3104.3	906.1	1069.2	53.4	54.6	312.2	161.8	732.8	173.7	59.0	55.9	798.0	91.4	80.6	60.8	771.3	55.3	2642.8	866.4	8.2	414.7	5920.3	202.1	355.7	701.6	8099.9	54.1	452.1	1427.1	263.9	56.1	56.5	312.0	214.0	48.4	3002.5	1367.0	52.9	3.9	19.0	49.3	102.7	198.1	390.6	9.5	109.8	136.8	11.9	45.4	0.0	8.8	7.2	11.5	641.1	8.6	1.4	1.8	25.4	11.3	60.6	11.3	0.4	5.6	119.3	625.8	0.8	3.2	345.1	44.9	73.9	28.5	743.4	11.3	3.0	0.0	7.1	128.8	10.8	1.0	28.3	2.5	0.2	1.2	1.4	0.2	4.6	27.1	5.0	0.7	7.6	10.2	7.9	1.0	296.8	32.4	1.0	27.9	24.0	4.0	30.2	9.3	21.1	1.6	0.6	29.6	10.2	26.1	28.1	12.3	17.5	17.6	8.7	13.8	6.0	14.1	19.8	10.8	1.8	1.5	10.7	11.1	4.0	14.2	0.4	58.7	10.7	54.0	61.4	52.7	121.1	53.4	54.6	59.0	55.9	55.3	54.1	56.1	52.9	65.4	9.6	6.1	5.5	4.4	43.2	23.4	16.5	22.8	1.1	22.7	1007.7	25.1	2.8	5.2	0.0	6.2	16.3	7.3	1.9	1.9	1.8	11.1	11.1	225.4	41.1	0.0	4.0	3.6	0.9	16.8	316.3	10.7	8.2	5.7	448.9	474.0	4.6	37.7	0.0	1.1	2.7	4.1	5.4	67.6	48.8	141.4	12.6	55.2	61.8	4.2	13.4	4.1	1.0	0.3	2.0	3.0	5290.7	3.7	17.5	3.4	9.5	10.9	1.4	3030.6	72.0	2394.6	4.0	13.8	11.1	40.5	23.7	16.5	36.0	5.7	10.4
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5526409-5563902	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 22882.9;Pancreatic endocrine cells: 14370.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA		5800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	2558.1	1235.8	2143.2	4250.8	2321.0	3598.4	2009.8	2400.1	2776.1	2274.6	2183.3	6581.2	1659.0	5033.9	1630.3	2928.9	2943.6	1772.1	817.6	2355.6	2315.8	1313.6	1759.9	2876.0	4394.2	2654.8	2338.9	1711.5	761.9	838.5	731.4	1817.2	2569.2	2027.1	2338.4	488.2	1470.2	2943.2	465.1	1541.7	2825.9	5736.8	2457.9	3009.5	2869.7	558.3	2483.4	3278.4	1317.9	524.0	4602.3	3720.8	2223.5	3045.4	7791.1	5198.8	5604.1	4658.2	2321.1	3120.3	6654.3	6049.6	4853.2	6209.7	4619.4	8249.5	4361.9	4522.7	4557.0	9445.4	4904.8	4820.3	3279.5	9453.9	4507.4	5324.6	1668.7	3974.3	4579.6	4520.6	3538.8	4733.2	9853.8	4098.5	2786.7	6863.0	1738.0	4128.6	5073.2	3561.3	2189.7	3513.0	6603.4	7531.9	4055.1	13162.1	6813.7	2468.5	3490.8	5658.6	3351.4	3419.7	5904.6	3175.8	1633.1	2746.9	5754.7	5822.1	2400.3	5088.3	5859.7	5314.8	7975.3	10437.4	7019.9	7000.1	8802.8	1902.3	2442.5	5082.1	5772.0	6622.6	12412.7	14674.1	18104.2	29636.6	10647.1	19648.6	8327.7	5139.6	7639.4	9512.9	19292.5	4844.1	5592.0	7894.3	18040.6	6233.1	22870.8	7122.2	11463.2	37406.8	2143.2	2321.0	2400.1	2776.1	2355.6	2315.8	2654.8	2338.9	2569.2	2457.9	2483.4	3045.4	2775.4	1150.6	680.4	142.4	4118.9	5737.0	9776.6	5792.0	3110.2	146.7	1564.0	2047.2	145.3	1080.9	2763.3	2144.5	85.5	3647.7	3989.3	3419.3	2277.4	6508.8	101.3	1422.1	2344.0	2768.4	1451.5	3170.9	129.3	6365.4	12480.2	2958.5	3136.1	2041.6	1539.9	2372.0	2163.5	2590.6	13977.7	269.2	101.3	2006.7	3694.5	7392.0	11420.0	199.7	1766.7	8486.4	2995.4	259.5	22882.9	1654.4	5237.9	116.1	302.2	14370.0	2899.8	2680.3	3040.4	4764.9	4968.2	2149.2	1453.8	146.7	3287.0	1398.2	5423.9	133.8	381.9	4376.1	4722.2	3257.7	5961.7	1688.9	1966.6	6941.4
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin beta like 2"	Q562R1	5	57480018-57482811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.1;Club cells: 1.0;Ductal cells: 1.7;Early spermatids: 2.4;Exocrine glandular cells: 1.1;Pancreatic endocrine cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.3;RPTEC TERT1: 1.6;SiHa: 2.9;U-2 OS: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain					NA	NA		830000000			"Cluster 38: EFO-21 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	1.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	2.4	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin alpha cardiac muscle 1"	P68032	15	34790230-34795549	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"heart muscle: 11410.0"	"Cell type enriched"	"Detected in some"	30	"Cardiomyocytes: 9746.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037330, HPA041264, HPA041271"	Enhanced					NA	NA		2400000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (9.32e-4)"	51.1	1.8	1.9	24.7	1.7	0.0	11.9	2.1	2.6	8.6	1.3	4.0	0.8	6.9	1.1	22.8	1.6	11.8	11410.0	1.9	2.8	1.5	0.6	3.9	2.6	2.7	2.8	3.2	12.9	1.0	2.2	8.9	3.0	73.0	3.6	31.6	11.5	538.1	135.2	4.6	0.6	8.8	1.4	1.3	9.3	0.5	4.0	11.3	2.4	195.0	0.2	439.6	16.1	1.5	0.0	0.2	0.1	0.0	0.2	3.3	0.2	2.2	0.7	5.2	1.3	0.0	0.0	0.0	1.3	1131.8	0.2	0.0	0.4	0.0	1.3	0.0	0.0	0.1	23.9	0.0	0.1	1.4	0.0	457.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	4544.5	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2053.3	0.0	0.0	0.0	0.1	0.1	4.0	0.0	0.0	31.2	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	2.1	2.6	1.9	2.8	2.7	2.8	3.0	1.4	4.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	11.9	0.1	0.0	9746.1	0.0	0.0	0.0	20.9	0.1	0.0	0.0	1.9	0.0	5.0	0.0	0.1	69.2	0.0	0.0	0.2	0.2	4.3	315.2	0.0	0.0	0.0	0.1	0.4	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	63.4	86.5	1.0	0.7	0.0	0.4	0.3	0.1	0.1	0.0	0.0
ACTG1	"ACTG, DFNA20, DFNA26"	ENSG00000184009	"Actin gamma 1"	P63261	17	81509413-81523847	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 9107.1;Exocrine glandular cells: 8305.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041264, HPA041271"	Approved					NA	NA		4900000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (3.95e-2)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-3)"	1548.5	950.4	523.3	1325.4	549.3	1130.2	1158.2	582.8	628.6	1634.2	506.2	1258.5	994.5	1629.9	558.1	2422.2	1315.8	1179.5	666.3	548.5	677.3	905.8	762.8	1516.1	1696.9	652.8	592.5	2046.6	1693.4	608.2	824.5	922.4	629.8	723.8	662.3	293.9	1291.3	643.0	358.4	1455.8	1026.3	739.2	589.8	1034.8	1385.5	438.5	611.8	1347.8	1252.2	270.9	1292.7	1540.3	1571.3	709.7	3652.9	4010.4	4601.5	2275.7	813.0	2758.2	1601.3	4193.6	3154.7	3546.5	2675.5	3699.5	1690.3	2114.0	2566.1	4263.6	2867.3	2049.5	1722.7	3395.6	1727.7	3745.8	2549.8	1724.3	1784.6	3515.1	2165.8	1909.2	2003.4	3599.7	1366.0	3586.4	938.0	4516.4	5237.2	1343.4	331.2	2723.2	3288.0	2677.4	6305.5	2235.8	1970.8	2272.7	2122.3	3520.6	1537.3	1716.3	3385.4	2838.3	1234.4	1284.1	4804.4	969.0	5127.0	1530.7	2192.3	1908.9	5402.3	4755.5	1993.3	2802.6	7012.2	908.3	791.7	1505.4	3808.4	1910.5	2940.1	4240.1	1897.3	3013.3	2108.9	2333.9	2026.4	1297.8	1892.2	2024.3	3012.5	939.2	1391.8	1827.7	1532.7	1355.2	2939.2	1616.5	2980.5	5301.8	523.3	549.3	582.8	628.6	548.5	677.3	652.8	592.5	629.8	589.8	611.8	709.7	1602.0	974.4	558.2	107.1	1285.4	5276.1	9107.1	3827.4	2541.1	493.3	1477.5	1943.4	233.6	825.0	1924.3	1140.3	244.0	2002.6	1886.0	2460.0	1058.5	4368.6	293.0	1028.0	1501.0	1664.2	1914.5	567.0	59.0	8305.0	4361.7	1595.3	2440.4	1433.3	588.7	3067.7	1031.6	517.1	3219.5	267.5	65.7	2206.9	1957.2	1426.0	1807.7	258.5	1718.6	1840.3	1398.1	70.3	4004.3	3402.9	1971.2	78.4	111.9	7194.7	2426.5	1363.9	1369.6	3987.9	1673.2	566.6	950.0	571.1	1360.8	873.0	2277.1	756.5	995.7	3085.9	5371.9	2827.2	1823.7	2394.4	2187.5	6279.2
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin gamma 2, smooth muscle"	P63267	2	73892314-73919865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8846.3;seminal vesicle: 6238.4;smooth muscle: 8607.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 394.2;Smooth muscle cells: 287.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"T-reg: 8.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 63.8;BJ hTERT+: 53.5;BJ hTERT+ SV40 Large T+: 214.8;HHSteC: 55.1;SuSa: 52.5;U-251 MG: 229.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 11.8;spinal cord: 4.7"	"HPA041264, HPA041271"	Supported					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	189.6	37.1	2.8	724.8	3.9	0.0	138.2	2.8	10.0	494.7	4.8	8846.3	392.1	3622.6	124.6	1954.7	857.3	330.4	30.4	2.9	2.9	11.3	10.8	137.5	6.8	3.4	3.1	88.5	8.1	0.9	6.1	96.4	3.1	2250.2	1179.0	0.0	75.1	6238.4	16.3	91.8	1353.8	8607.9	2.9	16.6	2099.7	4.8	3.1	2.8	33.8	6.9	1.2	2914.5	667.3	2.8	0.7	0.3	20.5	0.3	0.0	0.0	63.8	13.5	53.5	214.8	38.6	6.7	0.0	0.3	0.9	0.0	0.4	0.1	36.9	0.0	28.3	0.1	0.0	0.0	2.9	0.5	55.1	0.2	0.6	0.5	0.3	29.0	0.0	1.5	0.0	0.2	0.0	0.0	0.5	0.0	2.9	7.9	0.2	0.0	0.1	0.2	0.4	3.1	0.5	13.6	0.6	2.3	0.3	2.8	1.2	52.5	0.0	0.3	0.0	1.1	2.3	2.5	229.9	0.1	0.3	0.8	0.7	1.0	0.9	0.2	0.5	0.3	0.2	0.3	0.1	0.1	0.8	0.3	0.4	0.1	0.4	0.5	0.1	0.2	0.4	0.1	8.6	2.4	2.8	3.9	2.8	10.0	2.9	2.9	3.4	3.1	3.1	2.9	3.1	2.8	3.5	0.0	0.5	0.0	0.4	4.5	2.7	0.5	0.6	0.0	9.8	394.2	14.6	0.0	0.1	0.0	0.0	7.4	0.7	0.0	0.0	0.0	5.8	2.8	1.5	3.1	0.0	0.0	0.1	0.0	36.8	74.1	0.0	4.8	0.0	1.0	22.9	0.3	5.4	0.0	0.1	0.0	0.0	0.0	10.4	26.6	0.3	1.0	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	10.8	0.0	0.4	0.8	0.0	6.6	1.8	287.8	0.2	3.2	0.4	7.7	6.4	1.7	8.4	0.0	3.7
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656448	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;pituitary gland: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	76	"SCLC-21H: 28.5;SH-SY5Y: 28.7"	"Low region specificity"	"Detected in all"							HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	0.0	1.8	13.8	0.0	14.5	0.0	0.0	9.4	20.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	8.5	0.0	0.0	0.0	0.0	4.4	1.8	0.0	0.8	0.1	15.3	0.0	4.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.5	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.5	9.4	20.7	14.9	8.5	4.4	1.8	4.3	1.7	3.9	11.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	19.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	1.2	0.0	3.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ACTL7A		ENSG00000187003	"Actin like 7A"	Q9Y615	9	108862266-108863756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1049	"testis: 230.2"	"Group enriched"	"Detected in some"	128	"Early spermatids: 1406.2;Late spermatids: 4717.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021624	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA021624: AB_1844549"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1406.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4717.1	20.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	23.8	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTL7B	Tact1	ENSG00000148156	"Actin like 7B"	Q9Y614	9	108854588-108855986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1099	"testis: 118.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1697.8;Late spermatids: 449.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA021803, HPA024664"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA021803: AB_1844551, HPA024664: AB_1844552"					"unprognostic (7.64e-2)"	"unprognostic (1.62e-1)"								"unprognostic (3.09e-1)"	"unprognostic (3.83e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1697.8	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	449.1	9.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	54.6	4.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1
ACTL9	MGC33407	ENSG00000181786	"Actin like 9"	Q8TC94	19	8697400-8698795	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1118	"testis: 111.7"	"Group enriched"	"Detected in some"	178	"Early spermatids: 979.9;Late spermatids: 2374.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019231, HPA026693"	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA019231: AB_1853883, HPA026693: AB_1853884"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	979.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2374.9	6.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 524.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 364.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		210000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	117.4	40.7	27.3	149.5	55.8	149.3	103.5	0.1	32.0	118.4	20.1	449.8	49.8	313.1	60.3	154.4	152.1	143.9	121.4	29.7	14.7	46.7	61.8	100.0	47.5	24.5	11.0	61.8	46.8	9.1	27.3	96.1	7.3	174.3	109.0	28.2	116.4	295.1	21.7	59.3	106.9	524.5	4.2	55.9	171.7	21.2	32.9	32.6	35.0	13.3	50.7	305.9	83.3	28.8	871.9	262.3	158.6	121.4	275.2	180.5	592.4	749.3	712.0	770.0	571.1	211.8	196.6	0.7	256.5	744.7	310.4	370.9	126.8	790.3	965.2	4.6	38.5	118.2	133.5	179.0	494.0	85.4	14.3	231.7	152.1	479.8	540.3	551.6	428.6	48.2	56.9	1.4	612.0	246.9	10.1	181.1	124.7	217.9	198.1	59.3	294.1	32.6	292.0	225.6	57.0	68.7	649.9	96.8	177.1	474.8	146.0	170.9	546.0	1085.2	432.8	126.9	662.5	113.8	47.8	3.9	314.4	115.7	584.4	64.6	67.5	137.1	5.7	28.8	7.1	0.1	22.7	12.4	45.5	0.2	103.9	92.2	364.2	4.5	8.9	2.0	9.6	89.2	27.3	55.8	0.1	32.0	29.7	14.7	24.5	11.0	7.3	4.2	32.9	28.8	44.7	38.5	25.1	19.6	4.0	119.3	154.9	137.4	82.0	74.7	88.6	157.6	60.3	51.5	36.0	42.3	246.0	155.3	3.0	17.2	3.9	186.8	34.0	65.8	112.8	135.5	38.5	21.9	102.7	144.9	351.8	88.9	34.1	90.2	7.6	15.9	129.5	96.6	79.5	18.5	29.7	57.3	59.0	100.9	82.1	10.7	35.8	96.4	30.2	34.7	105.1	6.0	4.1	9.0	4.3	203.7	28.0	245.6	0.6	132.6	2.4	15.3	47.8	80.8	177.5	30.0	270.6	19.4	18.4	51.8	59.8	66.9	22.7	20.9	47.0	67.1
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ACTN3		ENSG00000248746	"Actinin alpha 3"	Q08043	11	66546395-66563334	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	72	"skeletal muscle: 1670.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HDLM-2: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA006035	Uncertain		Uncertain	"Actin filaments"		NA	NA		11000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.2	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.1	1670.4	0.1	0.1	0.0	0.0	0.1	0.1	4.0	0.0	0.0	0.3	23.3	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.2	1.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731589	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 626.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 947.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		71000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	176.5	160.8	22.9	63.9	42.0	74.2	151.4	42.9	42.2	165.2	58.5	168.5	128.7	269.4	11.8	232.8	163.2	46.8	89.0	19.5	27.8	166.7	85.0	174.7	37.5	45.9	42.4	102.5	90.6	42.2	80.0	85.7	44.8	115.6	42.2	26.0	148.1	59.0	52.2	183.4	150.3	73.1	30.2	118.1	120.9	23.6	38.1	18.5	105.4	18.8	24.2	150.2	181.3	63.4	364.6	947.0	92.9	48.6	37.7	50.6	237.2	198.7	162.5	178.8	143.9	335.9	265.1	99.0	409.1	260.6	117.4	185.1	57.4	203.8	38.3	238.3	69.5	139.7	356.1	240.4	103.4	101.7	145.2	95.3	63.4	157.5	79.6	146.9	116.4	26.3	165.0	71.8	127.5	221.2	27.2	44.1	78.4	197.8	177.3	89.5	109.4	43.8	174.6	396.3	83.0	49.8	366.3	210.5	94.7	64.0	94.5	78.8	309.7	249.3	138.7	135.3	476.1	44.1	84.5	67.8	231.7	90.6	476.7	7.6	8.1	17.8	13.2	7.7	9.8	3.2	5.7	13.2	7.0	3.0	0.9	4.4	16.9	24.8	6.7	10.8	9.5	10.6	22.9	42.0	42.9	42.2	19.5	27.8	45.9	42.4	44.8	30.2	38.1	63.4	315.2	179.5	120.0	21.5	45.8	234.8	266.4	155.1	153.7	25.6	134.0	148.1	9.2	143.0	119.4	152.6	14.6	123.7	150.7	626.1	19.6	413.5	2.5	272.0	145.7	206.2	162.0	59.3	46.0	419.3	256.7	77.3	219.7	346.4	73.5	75.9	130.6	108.5	72.6	23.5	22.6	365.5	73.2	65.9	103.7	4.5	41.3	75.4	46.2	48.7	162.2	122.4	120.5	35.2	83.6	532.3	425.2	71.5	91.2	322.1	315.5	104.0	122.1	32.3	190.7	97.2	251.0	36.2	23.7	189.3	202.7	168.0	119.4	115.3	280.6	284.7
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"Actin related protein 1A"	P61163	10	102461881-102502712	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules		NA	NA		560000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules		"CAB037193: AB_258253, HPA047443: AB_2680049"	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	59.4	58.8	98.3	39.4	100.6	36.8	51.5	101.9	108.4	50.9	78.4	90.0	37.8	61.8	37.5	61.6	47.4	36.1	93.0	101.9	108.0	49.0	40.4	58.5	33.7	116.3	105.9	36.9	41.9	56.5	54.7	45.3	116.9	53.0	41.7	41.9	46.4	51.9	174.3	65.1	49.1	69.0	97.4	48.7	56.2	40.4	104.0	56.8	41.2	127.0	42.2	74.8	51.2	104.4	80.5	95.8	113.5	117.1	138.0	109.2	45.5	100.3	177.3	154.4	142.4	52.7	63.3	54.4	75.2	149.5	76.2	78.3	109.9	123.7	106.5	70.7	75.8	72.9	53.4	77.9	99.6	56.9	65.0	112.4	89.6	141.2	100.7	155.7	201.6	88.7	60.5	53.5	154.6	67.1	103.5	97.9	45.4	62.5	86.2	78.5	146.0	35.0	125.2	43.9	40.5	88.8	60.1	35.4	75.1	98.3	130.0	38.9	147.0	74.7	71.5	83.6	102.1	54.0	58.8	63.3	78.7	98.3	45.9	32.2	40.7	44.3	31.1	51.8	25.5	18.8	22.0	30.4	40.6	17.6	18.0	20.7	31.2	23.9	57.0	20.8	33.6	39.2	98.3	100.6	101.9	108.4	101.9	108.0	116.3	105.9	116.9	97.4	104.0	104.4	40.0	57.7	41.0	10.1	23.4	33.8	24.0	42.3	13.1	26.6	22.1	17.1	51.6	14.3	34.8	27.6	16.7	54.9	23.8	52.4	54.8	75.5	53.0	15.3	21.0	45.2	39.6	45.9	14.9	77.5	63.3	36.9	23.4	19.3	32.3	27.3	34.6	24.1	73.9	26.9	15.5	24.4	46.8	37.6	38.2	53.9	33.2	44.5	51.6	5.6	70.3	31.5	38.1	10.1	15.3	92.0	36.8	36.1	30.0	26.7	40.9	45.6	26.5	24.5	46.0	17.1	48.5	61.9	14.0	27.3	32.4	104.7	28.2	32.9	24.2	26.6
ACTR2	ARP2	ENSG00000138071	"Actin related protein 2"	P61160	2	65227788-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol		NA	NA		35000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	113.0	70.7	39.9	216.2	48.3	160.5	77.0	42.2	54.7	81.4	38.3	142.4	104.8	70.1	64.5	111.0	53.7	90.9	64.9	51.4	47.2	85.6	108.9	115.9	246.4	43.6	41.4	43.9	61.7	61.9	25.0	109.6	42.9	71.7	139.1	70.2	64.9	64.1	60.4	69.4	118.2	104.4	48.0	172.0	107.3	46.2	45.5	182.2	73.1	64.9	256.3	128.6	46.0	61.1	267.3	221.2	205.5	224.5	218.8	296.1	213.2	367.3	284.1	280.0	193.6	249.3	214.2	590.6	181.8	406.9	174.3	196.8	179.8	258.3	459.4	337.2	150.8	652.1	147.6	235.9	248.0	619.8	731.6	256.5	201.6	312.2	297.7	228.6	356.6	202.0	282.1	209.2	480.0	198.2	325.4	330.6	173.2	245.7	157.5	347.9	266.0	248.6	328.7	341.7	105.2	171.6	239.0	273.5	262.0	186.9	167.6	417.4	467.9	306.5	184.8	202.8	408.9	158.0	155.2	824.1	264.4	598.7	353.9	325.4	182.4	220.6	104.3	241.4	111.8	97.1	91.1	98.6	213.1	80.4	70.3	99.2	258.2	104.1	273.3	79.3	113.9	344.5	39.9	48.3	42.2	54.7	51.4	47.2	43.6	41.4	42.9	48.0	45.5	61.1	187.1	86.6	112.7	32.3	202.4	74.7	88.0	93.0	70.0	81.8	75.8	57.1	76.3	51.5	93.2	97.5	66.7	81.8	257.9	280.5	50.9	100.5	37.5	114.5	131.4	131.0	110.8	89.8	152.6	129.0	138.6	96.0	105.0	163.2	191.1	77.8	113.6	102.9	277.7	104.3	106.0	166.5	85.5	450.1	311.8	92.5	65.3	352.0	88.9	97.4	378.9	87.9	207.0	38.7	68.9	164.4	195.3	74.4	119.7	114.9	131.1	89.0	127.7	82.4	124.9	63.3	122.8	31.4	41.8	102.5	90.6	124.4	203.2	74.2	172.8	181.7
ACTR3	ARP3	ENSG00000115091	"Actin related protein 3"	P61158	2	113890063-113962596	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005085, HPA047016, HPA051683"	Approved					NA	NA		25000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB005085: AB_2289106, HPA047016: AB_2679903, HPA051683: AB_2681573"	"unprognostic (7.28e-2)"	"prognostic unfavorable (6.52e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.44e-1)"	97.5	125.3	29.9	229.7	36.4	216.5	64.5	37.6	41.0	62.7	52.4	129.3	107.4	78.1	47.2	167.1	58.1	84.4	71.7	48.0	41.9	79.4	89.9	97.9	291.2	46.4	38.2	46.4	64.3	54.7	23.1	101.4	41.7	71.3	125.1	31.7	64.3	83.6	47.8	77.7	119.0	137.0	36.2	155.8	113.1	84.8	39.0	185.8	67.3	49.8	331.3	153.6	67.1	46.7	377.8	179.1	249.4	170.6	178.0	251.7	259.9	518.7	395.0	369.7	349.1	379.9	233.6	538.7	590.6	487.9	497.1	200.0	262.3	286.5	486.7	806.2	135.6	502.7	210.2	296.2	314.8	474.0	879.1	227.1	220.8	484.9	316.5	216.1	348.6	207.1	273.9	393.8	493.1	153.2	429.7	204.5	187.2	254.8	297.5	328.8	246.8	273.4	381.0	348.9	124.0	124.1	263.0	269.7	330.6	188.7	112.7	387.7	514.6	440.9	288.3	205.6	451.5	208.5	446.5	635.4	385.5	304.2	417.7	753.0	478.9	1048.4	464.4	728.1	381.6	455.9	424.6	460.6	634.4	385.0	371.4	437.9	777.1	479.9	887.7	191.4	587.0	1265.4	29.9	36.4	37.6	41.0	48.0	41.9	46.4	38.2	41.7	36.2	39.0	46.7	113.7	89.8	64.1	26.4	254.0	331.9	369.7	139.1	93.9	32.0	57.5	48.9	68.5	57.2	125.4	68.0	8.4	144.6	196.5	164.4	129.1	220.8	113.6	109.2	100.8	138.9	85.3	154.8	40.1	154.8	316.6	101.4	122.9	171.0	267.5	88.4	81.0	72.9	339.2	38.7	40.4	120.2	105.8	201.4	413.7	108.3	45.4	288.1	112.1	69.3	316.5	46.7	286.3	58.3	67.6	177.0	168.1	73.0	158.7	181.7	103.3	132.4	117.7	19.5	65.7	58.5	194.1	207.1	74.7	173.4	353.8	205.6	264.4	242.2	120.3	314.1
ACTR3B	"ARP11, ARP3beta"	ENSG00000133627	"Actin related protein 3B"	Q9P1U1	7	152759749-152855378	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 58.1;Breast myoepithelial cells: 64.8;Excitatory neurons: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047016, HPA051683"	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA047016: AB_2679903, HPA051683: AB_2681573"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.34e-3)"	"unprognostic (5.89e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.11e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (1.66e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.48e-2)"	5.0	6.9	12.1	3.2	19.9	3.4	6.2	8.5	19.1	5.2	1.6	3.5	3.5	4.6	6.8	3.4	6.9	2.3	5.5	22.7	12.6	7.5	9.2	4.0	3.9	6.1	4.2	6.0	8.7	8.7	15.0	3.0	3.8	4.5	3.5	16.3	12.5	4.0	11.2	6.8	3.5	2.7	3.1	3.7	4.5	13.9	11.5	4.3	4.5	5.2	3.9	4.9	4.2	14.7	21.0	9.8	18.4	23.0	5.4	6.8	15.2	10.8	6.9	4.4	4.4	12.1	12.1	17.8	8.1	7.1	8.1	7.5	17.0	5.1	5.3	6.6	9.0	7.2	6.9	11.5	5.8	10.0	2.8	3.4	6.2	2.6	6.5	3.0	5.7	7.2	38.0	0.3	9.6	21.8	14.6	19.5	39.8	20.5	11.0	11.7	7.1	14.1	7.3	11.7	36.0	30.4	13.8	10.7	9.6	6.8	11.0	7.8	3.4	4.4	1.1	5.7	9.6	15.3	17.7	12.3	8.8	14.0	9.4	0.0	0.3	0.0	0.8	0.2	1.0	0.7	0.9	1.7	0.8	0.9	1.8	1.0	0.1	1.2	0.1	0.4	1.4	1.2	12.1	19.9	8.5	19.1	22.7	12.6	6.1	4.2	3.8	3.1	11.5	14.7	3.4	6.4	1.1	24.2	5.3	2.7	4.8	2.8	4.0	19.4	58.1	64.8	4.4	5.7	3.0	3.7	22.9	8.5	7.9	1.3	31.3	5.3	29.1	5.7	5.0	4.8	10.8	5.5	64.1	5.7	7.7	4.3	8.2	3.7	4.5	5.2	2.5	7.8	3.1	15.2	49.2	3.9	8.2	2.8	3.1	41.1	42.9	9.3	48.0	11.2	3.5	34.0	3.1	30.7	26.1	5.1	3.0	54.2	2.8	17.1	1.7	6.5	6.0	21.9	6.6	20.4	4.4	28.5	27.5	3.7	1.6	12.4	4.3	7.3	3.3	6.0
ACTR5	"Arp5, FLJ12785, INO80M"	ENSG00000101442	"Actin related protein 5"	Q9H9F9	20	38748460-38772520	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042676	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042676: AB_2678110"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.33e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (2.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.95e-2)"	6.6	4.5	5.3	5.5	5.5	10.3	6.5	5.3	5.8	8.3	4.1	6.0	4.9	6.5	3.9	7.5	6.8	3.2	4.7	5.2	4.8	5.4	6.7	5.4	8.0	4.9	4.7	8.9	6.3	3.7	5.8	3.5	4.8	6.2	4.9	6.0	5.7	3.7	7.1	8.9	7.3	4.5	4.4	8.7	5.4	12.8	4.9	5.4	5.6	2.8	6.6	6.4	7.5	6.6	8.8	12.3	8.4	6.8	4.7	4.6	11.3	4.6	4.6	9.2	6.8	33.5	12.1	18.2	8.2	4.5	17.8	13.9	14.6	13.1	8.9	5.3	7.6	13.7	7.6	19.8	6.4	9.5	11.3	4.2	19.0	9.5	7.3	3.9	9.2	8.5	12.8	13.8	6.0	9.4	19.7	12.9	6.8	20.5	24.1	12.5	15.8	10.7	7.9	5.9	8.4	13.6	17.8	22.3	10.9	8.5	13.8	6.9	5.9	13.7	12.3	12.7	9.7	10.1	12.2	14.7	8.3	9.1	7.8	1.6	7.7	5.0	12.1	10.1	11.4	9.8	9.2	9.0	10.9	9.7	7.2	7.8	1.0	9.4	6.3	6.8	7.7	6.6	5.3	5.5	5.3	5.8	5.2	4.8	4.9	4.7	4.8	4.4	4.9	6.6	4.9	3.2	6.3	4.6	6.9	3.7	3.3	5.0	8.6	4.2	3.0	3.2	2.2	4.3	4.7	1.8	4.2	4.3	10.8	3.5	1.9	5.5	6.2	2.3	3.7	4.5	7.8	7.0	6.7	5.5	6.1	4.3	4.1	2.6	0.0	4.2	5.7	3.6	4.3	1.7	8.6	4.9	2.0	1.9	3.5	1.4	3.7	3.8	5.4	8.4	3.5	3.2	5.2	6.0	9.5	3.5	3.1	6.0	5.8	2.3	2.3	3.2	2.2	5.1	0.0	3.5	4.8	24.4	15.6	4.5	3.7	1.9	8.6	3.8	4.1	1.6
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"Actin related protein 6"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	15.0	16.7	17.6	12.8	17.7	7.4	28.9	18.2	24.5	13.9	17.9	14.6	15.2	15.2	18.1	13.8	14.2	10.3	17.5	18.2	19.8	22.1	19.6	12.2	20.8	18.0	18.6	17.9	5.0	20.8	4.5	17.0	19.1	16.8	15.3	20.6	15.3	15.9	14.3	13.6	14.4	14.4	18.3	16.1	10.6	21.3	17.7	20.4	16.3	15.8	19.2	17.1	4.5	20.8	60.2	23.5	27.1	35.9	22.4	28.3	63.3	26.0	22.6	25.0	18.2	15.2	17.8	32.9	24.7	19.5	18.8	23.0	36.5	22.5	34.3	48.9	33.8	22.8	22.2	17.7	23.6	33.7	17.7	17.4	27.7	20.2	25.8	38.5	28.9	38.0	36.9	10.5	29.2	15.5	33.7	50.8	31.6	22.5	34.2	27.0	27.3	41.4	27.3	35.8	24.8	47.0	35.3	62.5	36.5	22.4	40.6	39.5	18.8	18.4	12.3	20.5	23.7	23.6	55.6	42.8	12.1	21.2	21.7	5.7	6.4	10.0	15.2	11.5	19.3	12.6	17.9	20.3	8.2	12.1	19.4	19.6	3.0	19.4	13.2	12.0	20.5	12.1	17.6	17.7	18.2	24.5	18.2	19.8	18.0	18.6	19.1	18.3	17.7	20.8	33.5	16.0	17.7	6.5	25.8	22.9	36.2	72.4	29.6	32.7	26.5	23.9	34.8	8.6	38.1	23.9	18.8	55.6	36.9	9.9	46.9	21.4	135.2	56.8	27.7	20.7	12.5	21.7	20.9	12.0	68.4	25.0	12.2	28.9	33.0	19.1	16.1	16.4	23.7	33.7	23.2	11.3	73.2	19.1	13.4	34.3	20.2	17.5	32.0	13.1	19.5	27.0	25.7	17.1	17.4	13.2	10.0	22.6	19.7	24.7	11.7	67.9	67.9	32.8	32.9	27.8	36.8	80.8	19.9	23.8	19.7	96.0	36.6	23.8	13.3	33.8
ACTRT1	"AIP1, ARIP1, Arp-T1, KIAA0705"	ENSG00000123165	"Actin related protein T1"	Q8TDG2	X	128050962-128052398	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 4.1"	"Group enriched"	"Detected in some"	79	"Early spermatids: 28.7;Late spermatids: 82.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003119	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA003119: AB_1078219"															"unprognostic (3.68e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTRT2	"Arp-T2, ARPM2, FLJ25424"	ENSG00000169717	"Actin related protein T2"	Q8TDY3	1	3021467-3022903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1104	"testis: 155.3"	"Group enriched"	"Detected in some"	112	"Early spermatids: 1270.8;Late spermatids: 3615.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006480, HPA025079"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA006480: AB_1845047, HPA025079: AB_1845048"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1270.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3615.6	10.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	21.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 47.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 1021.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.1;HSkMC: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA035817: AB_10671938, HPA035818: AB_2674801"	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.6	0.9	1.7	0.7	2.1	0.4	1.1	2.6	4.5	1.4	2.0	0.9	1.1	1.1	0.8	1.0	2.0	0.9	1.2	2.2	2.0	2.4	2.7	1.1	0.8	2.1	3.5	1.6	0.6	1.2	1.3	1.0	2.2	1.2	0.8	0.8	0.6	1.9	0.7	0.4	0.8	1.6	1.8	0.4	1.2	47.5	2.5	0.8	1.5	0.7	0.9	1.7	0.7	2.6	4.0	2.5	0.2	1.1	18.1	5.5	0.0	4.7	3.0	3.1	2.6	0.0	5.2	0.0	6.5	5.9	2.0	2.5	1.5	2.5	3.3	2.9	1.7	9.3	1.9	0.5	3.0	1.1	0.9	11.8	0.6	3.8	0.7	2.0	5.8	0.9	0.0	0.0	5.7	2.0	0.2	0.1	4.5	3.5	5.3	0.6	0.0	0.1	3.3	1.0	3.1	2.1	5.9	1.4	0.1	0.6	2.5	4.1	2.4	0.0	0.0	2.5	0.0	0.4	0.2	0.2	1.1	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.7	2.1	2.6	4.5	2.2	2.0	2.1	3.5	2.2	1.8	2.5	2.6	0.9	0.0	1.5	0.3	0.1	0.4	1.3	1.6	1.2	1.6	0.4	0.4	0.7	0.0	2.0	0.0	2.1	1.7	0.1	0.2	1.9	2.3	1021.8	1.1	0.6	1.8	0.0	0.4	0.2	2.1	1.3	1.7	0.5	0.9	1.3	1.3	2.2	2.1	1.5	3.3	0.2	1.3	0.0	0.8	0.7	161.0	9.6	2.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.1	5.7	0.2	0.7	0.5	2.8	2.1	1.3	13.1	1.1	1.4	24.6	4.6	1.2	0.0	0.8	1.3	3.8	1.2	0.4
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157876330	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	20.8	10.4	17.3	12.9	12.7	1.8	18.8	14.0	15.4	28.1	17.4	16.5	10.9	24.4	32.7	11.3	17.0	24.2	19.7	26.3	12.8	26.4	22.7	17.5	8.8	13.7	12.9	21.2	10.0	8.5	10.9	17.6	13.7	15.1	12.6	6.3	18.8	15.3	21.5	13.9	10.5	34.5	12.6	8.3	14.7	5.2	16.3	7.5	40.5	13.3	8.2	20.9	15.5	11.8	6.1	13.1	14.4	18.5	65.0	70.6	18.9	43.4	71.3	33.7	36.1	10.1	13.4	0.2	18.2	45.6	32.3	16.9	10.5	22.5	36.8	43.0	8.7	25.7	7.2	14.4	54.7	2.0	28.5	89.5	41.4	69.8	84.2	42.8	38.7	6.7	9.5	6.7	45.2	11.1	0.4	0.4	21.4	8.7	21.7	4.1	19.6	5.7	45.4	24.5	12.4	14.9	17.0	9.7	64.5	22.2	5.3	7.0	54.0	50.9	16.8	25.3	17.1	4.7	3.5	0.3	52.2	1.6	58.1	2.9	1.7	0.1	0.5	1.0	0.7	0.8	4.9	1.3	1.3	0.2	1.6	0.7	0.2	1.2	1.4	1.4	6.6	1.1	17.3	12.7	14.0	15.4	26.3	12.8	13.7	12.9	13.7	12.6	16.3	11.8	9.6	9.6	9.0	22.9	1.8	9.8	7.7	12.6	12.5	10.4	8.0	9.8	12.7	11.5	12.4	7.3	0.0	8.4	1.1	4.8	5.9	9.9	1.0	5.9	12.9	17.3	4.2	1.7	34.0	17.8	5.3	20.3	8.2	6.5	5.1	4.2	18.2	13.3	7.0	3.3	34.2	4.5	24.4	13.0	8.7	2.0	20.2	7.6	3.6	106.8	5.5	6.6	2.1	42.3	22.9	17.2	4.1	15.8	6.4	13.0	3.7	15.5	13.6	2.1	13.1	16.3	19.3	0.4	2.7	4.0	7.5	10.5	4.3	3.5	4.3	8.8
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951699-51997078	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	16.5	10.3	20.7	10.0	20.8	13.5	13.2	13.6	23.4	13.9	9.1	24.6	28.2	8.8	18.0	20.9	15.3	12.2	10.1	21.5	13.3	34.3	29.9	14.7	6.4	12.5	13.9	9.4	40.7	52.7	14.7	11.1	13.1	14.0	24.4	17.4	32.8	15.3	13.1	45.6	26.1	8.1	9.5	8.8	24.9	15.7	16.1	7.6	11.4	8.8	7.4	12.6	18.8	18.3	11.4	24.3	18.6	10.3	20.9	16.2	10.5	12.6	14.2	13.1	9.9	49.5	17.1	5.0	17.2	13.8	14.6	19.6	17.8	15.2	13.5	7.3	21.0	12.3	5.9	15.6	23.8	19.9	43.8	32.0	19.4	14.8	18.6	13.9	18.7	17.7	13.3	14.9	11.8	23.2	19.1	17.2	18.0	24.0	8.5	10.2	14.4	6.4	37.2	17.0	23.5	19.5	13.6	19.2	9.0	13.1	21.1	12.8	12.0	9.0	13.6	10.2	6.1	9.0	6.8	6.7	9.7	9.4	11.8	2.5	1.2	3.9	0.3	1.8	0.5	0.0	0.3	0.3	0.7	0.2	0.8	0.4	1.0	0.0	2.2	0.3	0.5	0.3	20.7	20.8	13.6	23.4	21.5	13.3	12.5	13.9	13.1	9.5	16.1	18.3	8.0	3.2	13.4	8.1	2.9	18.6	10.1	9.2	23.3	45.3	11.3	8.6	5.9	17.2	12.0	25.8	29.2	0.7	2.0	49.7	3.9	17.7	2.9	12.3	8.1	10.9	24.6	0.8	34.8	14.4	0.8	12.6	19.9	9.0	11.4	9.4	17.9	24.4	4.0	37.0	30.2	28.7	2.0	16.7	5.3	8.4	9.9	10.0	7.2	9.4	10.1	8.8	1.0	21.6	11.3	13.3	22.1	9.4	2.3	15.1	31.8	17.0	15.8	24.5	6.6	17.5	12.2	3.8	16.5	17.7	25.3	0.5	4.6	5.6	24.7	15.5
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157628864	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 31.3;brain: 10.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.2;Leydig cells: 31.7;Oligodendrocytes: 55.8;Proximal enterocytes: 17.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 10.9;HDLM-2: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.7"	"HPA007982, HPA011933"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	31.3	2.5	3.2	0.6	6.3	0.1	6.2	1.3	3.5	0.5	0.0	4.1	4.1	0.1	0.3	0.2	0.1	0.3	0.4	6.4	10.2	0.4	2.2	0.2	0.5	1.4	1.9	3.6	1.5	0.0	2.2	0.1	1.3	0.2	3.0	0.4	0.8	0.3	0.8	0.3	3.4	0.2	0.9	0.1	2.1	0.4	6.6	0.2	0.2	0.3	0.3	0.1	0.2	3.8	1.5	0.0	0.0	0.1	10.9	0.3	0.2	0.3	0.3	0.1	0.3	1.7	0.2	0.0	0.1	0.9	0.7	0.0	0.1	0.0	0.2	5.1	0.7	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.6	1.9	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.2	6.3	1.3	3.5	6.4	10.2	1.4	1.9	1.3	0.9	6.6	3.8	0.5	0.0	1.1	14.7	1.4	0.6	0.7	0.9	1.8	0.8	0.9	0.3	1.9	0.0	0.9	0.0	0.0	0.2	0.3	14.3	0.0	0.2	1.9	0.4	4.9	0.7	7.8	0.0	26.2	0.2	0.8	0.9	2.6	0.5	0.0	0.4	1.1	5.9	0.1	0.0	11.0	9.2	2.0	0.0	1.3	2.9	31.7	0.1	3.6	3.7	4.3	1.8	0.0	3.5	55.8	0.4	7.6	9.1	2.9	1.8	17.7	1.1	0.2	0.3	0.0	0.6	0.8	0.4	2.4	0.7	1.4	0.3	2.5	0.4	13.5	0.5
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Inhibitory neurons: 63.4;Oligodendrocyte precursor cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.3;RH-30: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	7.3	4.0	6.2	4.6	7.4	3.3	7.0	10.8	6.4	5.4	1.0	6.3	7.7	5.2	6.6	7.2	4.5	7.7	3.7	7.5	7.5	5.6	7.4	4.6	3.1	2.6	4.5	4.5	4.4	4.3	3.9	7.7	3.9	6.8	6.5	8.3	7.5	5.2	17.5	19.5	9.3	7.0	3.8	4.0	6.8	6.4	8.6	2.3	6.7	6.3	3.9	7.4	7.4	4.6	1.8	2.1	13.2	5.0	7.3	4.7	5.4	4.1	5.0	6.9	12.0	5.8	8.1	0.1	3.6	6.7	2.5	6.2	12.0	6.1	8.8	1.4	7.3	0.9	3.6	10.2	26.3	1.0	0.9	8.1	7.3	4.5	8.9	5.2	5.3	1.6	2.0	3.5	4.7	4.8	0.4	0.8	14.9	5.5	3.6	0.2	23.3	1.3	5.6	11.5	13.0	7.3	3.5	4.2	5.4	5.6	2.5	1.4	4.1	6.4	7.5	6.1	2.9	1.0	0.3	2.4	3.9	0.5	5.2	0.2	1.7	0.2	0.6	2.0	0.2	0.1	2.4	1.1	1.3	0.3	1.5	0.3	0.0	4.8	2.0	1.7	0.2	0.7	6.2	7.4	10.8	6.4	7.5	7.5	2.6	4.5	3.9	3.8	8.6	4.6	13.7	6.4	7.0	26.8	1.5	29.7	6.9	9.5	13.1	15.4	6.8	12.4	7.9	17.2	10.7	7.3	14.6	4.9	6.0	16.5	1.9	6.3	5.3	6.4	12.2	11.9	9.0	0.0	62.5	6.3	2.5	17.4	6.6	5.7	0.0	2.2	11.7	12.1	5.4	11.8	63.4	12.9	8.2	7.3	18.9	2.1	9.9	5.7	10.6	33.7	7.2	3.3	6.2	84.9	34.1	7.6	10.0	11.3	5.2	7.7	23.7	5.8	10.2	9.4	32.9	8.3	10.9	18.2	14.1	14.4	29.8	5.3	5.9	2.9	11.7	11.8
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453890-38493142	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025115, HPA040384"	Approved					NA	No				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"CAB025115: , HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	1.1	2.8	3.2	0.6	3.2	0.2	1.7	5.2	2.8	1.9	1.0	1.5	0.9	1.7	1.7	0.7	1.9	0.6	1.4	2.6	3.0	1.8	2.2	1.3	0.7	2.6	3.2	2.9	2.5	3.3	2.0	2.5	2.6	1.3	1.1	6.5	1.7	1.3	6.0	0.7	1.1	0.9	2.3	1.0	1.5	2.5	2.9	4.1	1.6	2.8	0.6	1.4	1.4	3.6	1.1	1.8	20.9	1.8	0.8	0.5	11.2	0.4	0.7	0.4	0.9	3.1	1.4	0.1	1.6	0.5	0.6	1.3	8.1	1.3	1.1	3.2	5.2	5.6	3.5	4.6	1.0	4.0	2.0	0.8	1.2	0.6	2.3	1.3	1.4	8.0	9.4	1.8	0.4	1.7	6.9	2.5	25.9	1.1	0.9	2.2	7.0	1.4	1.3	2.6	4.9	8.5	0.6	3.2	3.0	14.7	1.7	5.2	1.2	0.7	3.3	0.5	1.8	5.0	7.3	1.2	0.7	3.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.2	5.2	2.8	2.6	3.0	2.6	3.2	2.6	2.3	2.9	3.6	7.0	6.4	6.1	9.4	0.7	4.0	4.6	2.1	4.0	23.0	5.2	5.0	15.0	2.8	3.6	0.0	22.9	8.5	1.3	3.1	0.0	3.6	11.3	8.7	7.0	7.5	7.2	0.4	12.6	3.8	7.6	3.8	2.6	5.3	1.3	17.9	7.9	8.7	2.6	21.9	17.0	4.1	0.0	2.2	6.4	15.8	11.8	2.4	7.2	5.6	0.7	7.6	0.0	15.1	17.2	3.2	5.3	7.9	1.4	5.2	4.8	3.1	7.1	25.4	0.0	9.7	7.7	11.4	17.9	1.8	4.0	6.2	2.6	7.4	4.4	3.9
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 96.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.3;Distal enterocytes: 182.7;Endothelial cells: 84.7;Fibroblasts: 56.0;Hepatic stellate cells: 60.3;Paneth cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 1.5;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	19	"dendritic cells: 2.1;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 61.4;ASC TERT1: 42.1;EFO-21: 61.0;HUVEC TERT2: 200.0;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	49.2	12.1	17.1	20.1	14.5	0.6	38.4	15.5	14.9	35.9	10.5	39.2	10.2	28.1	4.3	11.4	32.7	14.3	38.5	13.3	14.6	29.8	3.3	96.3	15.1	17.8	16.7	4.8	12.0	23.6	6.2	83.8	18.7	17.7	28.4	0.7	11.8	13.3	18.2	18.5	28.5	16.2	14.0	29.2	19.1	1.7	22.0	4.6	29.2	15.7	6.1	25.1	25.6	15.0	0.0	0.7	0.4	0.0	61.4	42.1	0.1	3.0	5.6	0.1	0.3	0.3	0.4	0.1	61.0	24.0	0.2	0.0	0.0	0.0	0.1	0.1	2.1	1.4	0.0	0.0	9.0	0.0	1.3	16.8	0.1	0.4	0.0	0.0	200.0	0.0	0.2	0.1	1.1	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.4	0.0	4.1	161.2	0.0	0.4	0.7	0.0	0.0	0.1	0.2	0.3	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.1	14.5	15.5	14.9	13.3	14.6	17.8	16.7	18.7	14.0	22.0	15.0	107.3	3.2	7.9	0.0	0.6	5.2	0.3	0.0	0.6	0.4	1.0	1.3	4.0	0.0	1.3	0.0	0.0	0.6	0.3	182.7	0.0	4.0	0.0	1.4	19.9	84.7	5.4	0.0	0.1	1.4	36.9	56.0	0.5	0.7	0.0	0.0	60.3	0.1	12.0	0.0	0.0	26.4	0.0	30.9	12.4	1.2	11.8	7.8	5.4	25.3	9.9	2.0	0.0	1.0	0.1	0.0	74.7	3.4	0.1	0.6	4.5	0.0	2.8	0.4	39.5	32.9	18.2	0.1	0.8	0.6	5.4	2.6	1.2	0.6	49.3	1.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.4;tongue: 163.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	19.5	42.8	64.9	5.4	72.9	7.1	15.7	74.8	85.4	10.6	61.5	14.3	7.4	11.5	12.8	10.4	11.6	8.5	63.4	63.9	72.8	14.5	28.0	10.6	10.9	69.5	68.8	9.3	12.7	13.6	26.2	6.5	70.3	14.4	5.3	24.1	15.2	9.2	207.4	9.9	9.0	7.9	70.4	12.7	12.9	10.2	70.4	10.7	12.6	163.2	8.4	14.0	10.7	76.9	11.7	5.9	6.0	4.4	23.7	17.3	3.7	11.5	9.7	8.3	7.3	1.5	7.1	21.5	33.0	12.6	7.8	8.5	3.3	10.8	7.4	14.4	13.1	13.4	6.3	16.3	8.5	12.7	6.3	13.6	19.3	5.6	9.5	15.2	3.9	9.8	5.5	11.5	17.9	7.6	7.5	17.0	5.9	8.4	6.7	5.4	4.7	12.2	18.8	10.6	17.6	10.0	17.4	10.0	5.7	1.9	3.4	13.2	10.9	11.5	10.6	3.5	11.1	21.4	12.5	10.2	16.3	24.3	12.4	41.2	14.0	26.1	16.9	13.0	15.4	29.0	16.6	16.1	20.3	26.9	20.1	16.4	11.5	18.6	13.5	33.4	16.3	11.3	64.9	72.9	74.8	85.4	63.9	72.8	69.5	68.8	70.3	70.4	70.4	76.9	21.7	16.0	17.9	84.9	30.6	20.5	41.9	52.8	18.8	15.5	49.7	65.7	162.6	34.3	32.0	18.4	10.4	13.6	27.9	24.5	62.6	24.3	86.8	29.5	23.6	23.1	30.6	14.5	158.8	38.1	6.1	21.0	26.0	19.5	19.7	17.6	30.7	74.2	31.9	28.6	134.1	21.9	36.7	40.0	28.5	64.7	13.4	25.4	23.2	59.0	26.1	90.1	24.7	67.8	180.1	29.9	18.8	30.9	36.4	27.4	29.1	55.6	32.2	31.6	52.6	30.8	30.0	22.9	9.8	28.9	21.3	10.3	22.7	29.7	18.6	45.0
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 507.2;lymphoid tissue: 259.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5"	"Group enriched"	"Detected in many"	5	"JURKAT: 570.9;MOLT-4: 1915.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	16.6	6.3	6.9	18.5	8.2	20.2	10.9	6.8	9.4	7.3	5.6	5.7	507.2	3.8	1.7	9.0	5.6	9.2	17.8	6.9	7.0	3.3	4.4	6.2	33.4	7.2	8.2	2.1	5.3	1.5	1.3	4.6	7.2	4.3	3.6	0.3	4.7	2.8	5.3	6.0	17.9	5.7	6.1	17.5	46.0	2.4	8.7	259.0	5.8	6.4	26.4	9.3	5.4	8.8	14.0	37.7	19.2	13.2	35.6	48.7	30.5	13.7	7.8	13.2	9.3	17.5	14.8	38.4	15.8	17.9	24.7	2.2	13.2	55.1	7.3	2.9	17.2	7.8	6.6	13.5	15.0	6.3	20.3	234.3	23.2	5.1	9.0	12.6	50.3	570.9	20.4	30.7	6.0	33.1	1915.5	28.9	5.2	17.2	13.5	102.3	25.8	95.0	2.3	0.0	0.7	9.3	20.2	4.4	24.2	24.0	4.5	19.1	16.9	10.1	18.6	20.5	2.8	40.1	27.3	82.3	3.5	32.5	9.0	0.5	9.8	1.2	43.3	168.5	27.8	7.5	35.5	51.0	35.2	7.6	27.3	38.6	2.5	94.5	362.8	218.6	29.8	57.4	6.9	8.2	6.8	9.4	6.9	7.0	7.2	8.2	7.2	6.1	8.7	8.8	18.2	0.0	1.9	2.9	13.5	12.9	3.4	10.0	13.6	0.0	2.7	3.2	2.1	0.0	4.8	1.8	0.0	2.9	76.4	0.8	0.0	3.7	0.4	0.7	9.1	17.0	0.0	10.7	0.2	19.7	128.2	19.7	14.8	0.8	0.0	3.5	7.1	3.6	28.5	0.0	0.2	1.5	10.2	20.8	25.5	1.8	42.3	27.6	8.8	3.7	37.4	3.8	56.7	0.5	9.4	10.7	0.3	2.6	31.4	6.0	0.7	3.0	2.4	0.0	13.1	1.9	14.1	0.3	6.2	12.9	13.9	3.7	30.9	6.8	4.9	2.7
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17258235	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 106.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	14.0	11.3	8.3	39.4	9.9	22.8	17.6	10.6	7.9	22.0	20.5	28.3	18.1	19.9	2.7	12.0	51.5	32.1	39.6	7.8	10.9	14.5	21.1	54.9	47.3	16.3	11.4	12.1	13.9	5.4	22.5	15.2	14.7	15.4	34.3	11.0	15.6	17.1	3.4	4.7	26.1	23.4	13.7	106.3	19.6	18.4	12.9	53.7	16.9	4.3	60.7	34.7	6.5	21.1	0.0	0.0	6.4	0.0	0.2	0.8	0.3	2.3	0.1	0.0	0.0	0.0	23.7	6.0	21.4	7.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.0	0.3	0.3	11.3	0.1	0.0	0.1	0.1	24.0	9.0	0.1	44.9	0.9	0.0	38.9	1.1	17.8	0.0	0.1	1.2	0.0	6.5	0.0	9.3	10.9	0.1	0.1	0.0	0.0	19.1	0.2	9.7	3.0	0.1	0.2	0.0	0.0	23.8	2.3	1.7	0.0	39.6	0.0	17.5	212.9	11.3	34.6	204.9	26.8	25.8	27.4	34.1	139.1	19.7	31.6	32.4	10.5	44.9	176.1	57.4	17.2	170.7	8.3	9.9	10.6	7.9	7.8	10.9	16.3	11.4	14.7	13.7	12.9	21.1	8.7	0.0	16.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	11.2	5.5	0.0	0.4	13.7	0.0	7.9	1.7	0.0	27.6	6.6	2.2	0.0	0.0	0.0	5.2	0.9	2.1	0.0	22.0	5.1	12.6	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	12.4	0.0	0.0	3.1	15.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	8.2	3.1	0.0	0.0
ADAD2	"FLJ00337, TENRL"	ENSG00000140955	"Adenosine deaminase domain containing 2"	Q8NCV1	16	84191138-84197168	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 64.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 80.0;Late spermatids: 26.2;Spermatocytes: 111.8;Spermatogonia: 29.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079443	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA079443: "	"unprognostic (5.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.47e-2)"	0.7	0.3	0.5	0.0	0.5	0.0	0.5	0.0	1.5	0.4	0.0	0.2	0.0	0.5	0.0	0.7	0.1	0.1	0.5	2.5	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.1	3.6	0.2	64.7	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.5	2.5	0.1	0.0	0.1	0.0	0.1	0.1	0.5	3.9	0.0	0.0	0.0	0.3	0.8	3.1	0.6	1.2	0.0	0.1	0.3	0.9	0.0	0.6	0.0	0.0	0.1	0.0	0.0	5.9	0.0	80.0	0.1	0.1	2.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.3	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	26.2	1.5	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	111.8	29.2	7.8	1.8	0.0	0.1	0.2	0.0	3.8
ADAL		ENSG00000168803	"Adenosine deaminase like"	Q6DHV7	15	43330672-43354569	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 81.3;Rod photoreceptor cells: 84.8;Spermatocytes: 99.5;Spermatogonia: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039879, HPA048175, HPA058795"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Vesicles"	"HPA039879: , HPA048175: AB_2680298, HPA058795: "	"unprognostic (1.65e-2)"	"unprognostic (1.53e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (7.64e-9)"	"unprognostic (2.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.44e-2)"	6.2	6.6	6.7	4.2	7.1	4.4	5.9	7.6	9.6	3.6	10.2	5.7	5.8	4.3	8.4	4.1	3.3	3.8	20.9	6.3	7.4	11.9	8.2	3.5	4.8	6.7	7.2	3.6	3.6	10.4	6.1	2.7	7.0	6.2	4.8	21.2	4.2	6.4	20.4	2.6	4.6	4.7	6.9	3.8	4.0	11.1	7.1	5.4	10.9	23.4	4.8	4.6	3.0	7.4	6.8	3.4	13.3	15.1	5.5	7.1	6.3	8.1	8.2	12.6	19.3	14.2	3.5	8.0	13.0	8.9	16.7	7.5	0.0	5.7	10.8	8.5	8.0	19.0	23.1	12.0	6.9	0.0	14.8	9.1	10.3	8.5	8.7	8.1	2.7	19.4	21.1	16.2	13.2	4.6	12.3	9.7	5.5	7.8	4.6	15.9	19.9	12.7	11.0	4.1	16.3	11.6	13.1	11.7	12.4	7.2	12.5	12.5	3.7	21.9	10.6	16.6	16.5	16.6	29.9	3.4	12.2	21.2	18.1	5.9	1.4	3.8	2.4	2.0	1.8	2.0	2.2	1.9	2.0	1.6	2.3	2.9	1.1	2.3	1.9	2.9	4.5	1.3	6.7	7.1	7.6	9.6	6.3	7.4	6.7	7.2	7.0	6.9	7.1	7.4	5.9	9.6	10.3	32.7	10.0	7.0	7.4	9.3	7.4	40.7	9.2	9.9	51.2	10.0	6.9	18.4	81.3	7.1	13.3	7.0	58.7	8.9	17.6	10.6	10.3	8.2	7.7	19.1	24.4	8.5	7.0	10.4	5.1	6.8	7.6	15.7	11.0	30.8	8.9	42.1	26.7	7.2	10.2	8.8	7.0	12.7	9.6	8.9	8.8	10.3	5.4	35.5	24.7	19.1	18.3	5.7	1.3	8.6	6.9	7.1	13.0	29.0	10.9	84.8	6.6	11.6	7.3	99.5	82.5	8.8	4.4	2.6	7.0	12.6	11.6	4.4
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44758988-44781846	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 36.6;heart muscle: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 11.8;Cardiomyocytes: 18.0;Excitatory neurons: 47.1;Horizontal cells: 23.5;Inhibitory neurons: 23.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEK 293: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced					NA	NA		23000		"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074550: AB_2732259"	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	0.5	0.2	11.9	0.0	16.6	0.2	0.6	23.9	36.6	1.6	0.0	2.5	0.1	3.2	0.2	0.5	1.6	0.4	11.1	18.4	3.5	0.3	0.2	0.3	0.1	9.4	6.0	1.4	0.2	0.0	1.8	0.0	10.2	1.4	0.0	2.7	0.3	0.8	0.2	1.0	0.6	1.0	0.3	0.2	0.8	4.1	14.0	0.3	0.3	0.0	0.0	0.9	0.9	17.8	0.0	1.3	0.5	4.4	0.2	0.0	0.3	0.1	0.0	1.2	0.3	0.7	0.2	0.1	0.3	0.0	1.9	0.0	3.3	0.0	0.4	1.4	19.7	0.1	0.4	0.3	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.3	0.1	4.2	0.0	2.3	0.7	1.5	1.2	2.7	0.0	0.3	0.0	0.1	3.2	1.7	0.0	0.1	1.0	0.3	1.3	0.7	0.0	0.5	1.4	1.5	0.4	0.7	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.9	16.6	23.9	36.6	18.4	3.5	9.4	6.0	10.2	0.3	14.0	17.8	0.2	0.0	0.0	10.7	0.1	0.0	0.2	0.2	0.0	11.8	0.3	0.3	18.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.2	1.4	0.4	0.0	0.0	47.1	0.0	0.0	1.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	23.5	23.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.7	0.0	2.2	1.0	3.0	4.2	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.1	3.5	0.0	0.3	1.3	0.7	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 166.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"MAIT T-cell: 6.1"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	11.4	0.1	2.0	6.0	4.0	0.1	4.6	1.6	2.1	18.2	3.5	0.4	0.2	6.3	0.0	0.4	0.2	11.8	0.7	1.0	2.5	1.0	0.2	1.3	3.2	6.0	2.7	8.8	0.5	0.1	1.1	166.5	3.1	0.3	0.6	0.3	1.1	0.0	0.1	0.4	0.5	4.3	1.8	1.6	0.5	0.9	10.4	1.8	0.3	0.0	3.5	11.6	0.5	3.0	16.8	2.5	6.5	0.1	18.7	38.3	0.0	42.7	3.5	14.2	35.5	0.0	0.0	0.0	0.0	154.2	30.0	0.0	0.2	1.4	15.5	1.9	0.6	0.2	25.1	0.0	2.9	0.0	33.2	47.0	0.0	94.3	2.9	27.1	0.0	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	4.8	4.4	0.4	44.1	0.5	28.4	5.0	0.0	0.7	2.5	0.1	0.1	0.0	50.9	16.9	93.2	86.2	0.0	0.5	0.0	70.7	0.1	32.3	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	2.0	4.0	1.6	2.1	1.0	2.5	6.0	2.7	3.1	1.8	10.4	3.0	0.5	0.0	1.9	22.5	0.3	1.5	0.4	3.0	0.0	2.1	1.7	3.6	2.3	0.0	0.5	0.0	102.2	14.0	0.5	0.7	0.0	8.0	10.9	10.7	16.6	1.6	0.0	0.0	7.4	1.1	400.8	34.5	0.5	1.8	49.5	7.8	2.5	0.2	15.5	6.7	19.0	1.0	4.1	0.6	3.1	1.7	16.8	0.8	1.8	14.0	9.0	3.3	1.0	99.0	52.2	2.2	0.1	0.7	0.3	1.0	0.7	0.4	6.5	30.5	0.0	5.1	13.4	6.0	5.0	0.0	0.6	129.2	4.7	28.1	0.9	0.5
ADAM15	MDC15	ENSG00000143537	"ADAM metallopeptidase domain 15"	Q13444	1	155050566-155062775	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.5;Extravillous trophoblasts: 172.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 26.5;myeloid DC: 64.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 64.0;monocytes: 39.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 329.5;RPMI-8226: 361.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011633, HPA072878"	Uncertain		Uncertain	Vesicles		NA	NA		640000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA011633: AB_1844574, HPA072878: "	"unprognostic (6.35e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (5.83e-5)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.64e-9)"	"unprognostic (3.35e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.40e-2)"	70.1	18.5	12.5	21.4	16.0	34.1	64.7	16.9	13.9	40.3	7.1	38.3	16.4	42.5	7.6	79.1	41.5	21.6	63.1	10.5	13.8	32.4	15.1	50.0	10.0	20.2	15.1	25.5	25.5	30.0	14.1	39.1	16.8	40.0	23.8	3.4	45.3	16.7	22.7	107.9	31.3	38.6	17.3	28.8	44.2	4.9	17.1	7.3	31.6	32.4	13.6	38.9	57.3	18.0	112.0	35.0	7.0	153.2	54.9	45.6	66.3	48.2	60.9	60.1	40.5	25.9	63.3	30.9	210.7	63.5	26.7	135.9	34.5	147.9	15.8	14.3	44.9	7.6	63.1	25.3	95.5	63.4	7.9	48.7	153.8	60.5	86.6	82.6	274.7	9.3	11.9	124.8	45.2	64.7	0.5	47.1	21.6	193.4	329.5	10.0	20.5	361.8	43.7	29.7	20.8	44.7	105.2	131.2	41.8	10.7	194.8	38.9	205.1	58.6	24.6	58.9	54.1	13.9	11.7	13.7	42.7	47.6	65.4	0.0	39.1	0.8	9.5	26.5	6.5	2.0	4.7	5.6	64.0	2.1	2.0	2.5	1.4	1.6	6.2	5.3	8.9	22.8	12.5	16.0	16.9	13.9	10.5	13.8	20.2	15.1	16.8	17.3	17.1	18.0	164.5	3.2	6.7	8.8	6.6	48.9	30.4	81.6	47.8	9.7	34.6	20.7	11.5	35.8	38.3	9.2	29.2	13.0	8.1	100.4	0.0	33.4	1.7	13.3	9.2	120.8	12.7	4.6	8.1	25.5	172.4	19.8	85.6	15.4	1.3	8.5	62.2	19.9	31.7	6.7	9.8	80.7	18.3	65.0	43.6	1.3	17.4	27.2	14.2	15.9	28.8	8.8	13.4	9.0	16.8	42.1	50.9	18.0	8.0	55.2	47.4	2.6	22.9	17.0	13.1	15.7	14.5	0.8	6.4	91.2	57.1	17.8	8.6	2.7	76.9	40.0
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAM2	"CT15, FTNB, PH-30b, PH30"	ENSG00000104755	"ADAM metallopeptidase domain 2"	Q99965	8	39743735-39838289	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	129	"testis: 38.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 28.2;Spermatocytes: 96.8"	"Cancer enriched"	"Detected in single"	5	"prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022390, HPA024621, HPA026581"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577"				"unprognostic (4.74e-2)"								"unprognostic (1.67e-3)"					"unprognostic (3.82e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.8	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ADAM20		ENSG00000134007	"ADAM metallopeptidase domain 20"	O43506	14	70522358-70535015	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.6;testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 30.0;Early spermatids: 55.5;Excitatory neurons: 45.4;Inhibitory neurons: 37.4;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 23.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA059377	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA059377: AB_2683997"	"unprognostic (4.13e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.52e-3)"	0.1	0.0	0.8	0.0	0.6	0.0	0.1	1.6	1.3	0.2	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	1.6	1.3	0.5	0.5	0.2	0.3	0.1	0.0	0.5	0.5	0.2	0.0	0.0	30.0	0.0	0.3	0.1	0.1	0.0	4.1	0.3	0.3	0.5	0.0	0.1	0.0	4.2	0.1	0.3	0.2	0.0	0.3	55.5	0.2	0.2	0.4	0.0	0.0	45.4	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	3.3	37.4	0.0	0.0	0.0	0.0	8.2	0.3	0.1	0.0	12.2	0.1	0.3	0.0	23.1	23.9	0.2	0.0	0.7	0.1	0.5	0.0	0.0	0.4	3.5	0.0	0.5	0.3	5.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6
ADAM21	ADAM31	ENSG00000139985	"ADAM metallopeptidase domain 21"	Q9UKJ8	14	70417107-70460427	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 69.5;Late spermatids: 131.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.3;U-251 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059016	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA059016: AB_2683882"	"unprognostic (7.85e-2)"	"unprognostic (7.67e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.72e-1)"	0.1	0.4	0.4	0.1	0.4	0.0	0.1	0.0	0.9	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	8.6	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.5	0.1	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.7	0.0	0.3	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.5	0.1	0.1	0.5	0.2	1.3	0.0	0.1	1.3	0.1	0.7	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	69.5	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	131.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.1	2.4	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443532-206621127	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;parathyroid gland: 82.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 410.0;Inhibitory neurons: 236.6;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"memory CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 54.4;RH-30: 63.8;RPMI-8226: 172.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Secreted in brain"	NA	NA		890000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	1.7	7.5	14.3	2.4	20.6	2.0	1.1	3.5	45.7	3.2	0.0	3.0	1.5	2.2	3.8	4.0	0.8	4.2	30.7	20.6	9.6	0.9	0.3	1.5	2.1	13.9	10.2	2.0	1.2	82.9	6.4	0.2	12.9	1.7	2.2	17.4	1.5	2.4	11.1	1.1	3.2	4.5	1.6	0.8	1.6	8.0	17.4	4.9	1.0	8.7	2.7	3.0	4.1	24.0	0.1	0.9	22.3	0.0	11.9	17.2	0.9	2.4	2.9	3.2	0.6	26.8	0.5	3.3	0.0	3.8	39.5	33.9	14.5	0.7	0.3	13.2	12.4	0.0	2.1	0.3	11.4	0.3	1.4	6.5	0.1	0.1	0.0	54.4	39.4	1.2	0.0	0.1	8.2	0.4	0.3	0.0	43.9	0.4	4.6	0.1	63.8	172.6	0.0	16.6	17.4	7.0	0.0	0.0	12.9	10.9	0.1	0.0	34.3	11.1	10.2	6.0	5.3	45.2	0.1	0.0	21.1	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	20.6	3.5	45.7	20.6	9.6	13.9	10.2	12.9	1.6	17.4	24.0	1.6	0.0	0.0	41.8	0.4	0.4	0.9	0.1	0.6	39.3	0.0	0.1	62.8	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	0.0	17.6	0.3	7.7	2.7	1.8	0.0	410.0	0.0	0.0	4.3	0.0	0.2	0.0	15.0	0.0	0.1	0.0	3.3	236.6	0.0	0.0	0.0	0.3	57.7	0.6	0.1	3.6	10.3	0.0	4.1	0.0	127.2	22.3	0.1	1.1	3.0	0.0	0.5	0.0	0.0	0.7	6.8	0.0	14.2	2.2	5.1	4.7	1.5	0.4	0.1	2.0	45.2	0.0	0.1
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAM30	svph4	ENSG00000134249	"ADAM metallopeptidase domain 30"	Q9UKF2	1	119893533-119896515	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	259	"testis: 25.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 77.4;Spermatocytes: 60.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026080	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026080: AB_1844581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.8	0.0	60.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ADAM32		ENSG00000197140	"ADAM metallopeptidase domain 32"	Q8TC27	8	39106990-39284917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 27.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA044156, HPA062151"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA044156: AB_10796798, HPA062151: AB_2684699"	"unprognostic (2.13e-1)"	"unprognostic (6.92e-2)"	"unprognostic (4.63e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-7)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.34e-3)"	"unprognostic (7.82e-2)"	1.0	1.0	1.0	0.2	0.9	0.4	1.0	3.2	1.5	0.6	0.0	0.5	0.0	0.4	0.6	0.2	0.5	0.4	0.7	0.9	1.3	0.2	0.0	0.3	0.1	0.1	0.5	0.6	1.8	0.0	0.4	0.1	0.4	0.6	0.4	0.9	0.5	0.3	0.2	0.7	0.2	0.1	0.1	0.7	0.3	27.4	1.0	0.0	0.3	0.1	0.1	0.5	0.4	1.3	0.2	0.4	0.0	0.2	0.6	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.9	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.2	0.5	1.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	1.0	0.9	3.2	1.5	0.9	1.3	0.1	0.5	0.4	0.1	1.0	1.3	1.0	0.0	0.0	11.8	0.0	0.9	1.1	0.7	0.6	8.2	2.5	2.3	1.7	1.5	0.4	1.8	18.8	0.3	0.1	0.4	0.0	0.4	189.0	5.7	3.6	1.0	4.2	0.0	37.3	1.3	0.2	2.4	0.0	9.8	0.0	3.3	0.7	0.4	0.5	0.0	29.8	1.1	0.0	0.0	1.0	50.5	2.8	0.6	0.0	9.4	0.1	1.0	0.0	18.6	17.6	2.8	0.1	3.0	0.1	1.7	0.0	0.2	1.4	3.8	0.0	3.4	0.9	99.9	2.9	0.5	0.0	0.1	0.2	3.7	1.4	1.5
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 280.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 40.8;Fibroblasts: 45.2;Leydig cells: 22.7;Microglial cells: 18.7;Smooth muscle cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.4;ASC TERT1: 104.9;BJ: 38.5;BJ hTERT+: 64.7;fHDF/TERT166: 38.9;U-2197: 50.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	53.3	3.8	7.8	10.5	8.5	0.1	47.4	5.8	12.3	280.4	8.4	157.2	11.0	151.8	19.0	31.6	106.9	32.8	26.7	6.7	9.3	3.9	2.0	18.0	6.2	16.0	8.0	58.7	6.0	0.5	6.9	12.7	16.4	87.0	12.1	1.0	19.6	57.5	9.1	22.0	43.4	53.0	5.9	8.3	44.8	22.5	6.9	0.9	18.4	14.1	2.2	125.4	159.0	6.2	0.0	0.0	0.2	0.0	82.4	104.9	0.2	38.5	64.7	11.2	21.3	0.1	0.0	0.0	0.2	38.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	13.0	0.0	0.0	18.2	0.0	4.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	2.8	0.2	2.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	0.0	0.2	0.0	50.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	8.5	5.8	12.3	6.7	9.3	16.0	8.0	16.4	5.9	6.9	6.2	3.9	0.0	0.0	7.2	0.1	5.5	0.1	0.0	0.6	0.0	0.3	0.3	3.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.5	1.8	40.8	2.4	0.0	0.0	1.3	0.0	0.1	45.2	2.6	1.2	0.0	3.1	1.8	0.0	0.5	0.0	11.4	0.0	0.0	0.3	8.8	0.8	22.7	0.8	3.6	18.7	0.0	2.2	0.0	8.0	0.1	0.0	0.0	10.1	0.0	0.2	0.0	0.9	0.0	0.1	6.6	6.8	17.1	0.7	0.5	0.3	3.1	0.5	0.7	0.0	0.0	0.1
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	237	"epididymis: 3726.4"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 128.3"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"BEWO: 2.4;NB-4: 6.1;RPMI-8226: 1.7;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008879	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3726.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.8	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	16.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.6;lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 21.2"	"Group enriched"	"Detected in many"	5	"basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.0"	"Cell line enhanced"	"Detected in many"		"A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	5.6	2.4	2.1	22.1	2.3	68.6	2.7	1.4	21.2	4.2	1.7	3.6	5.8	2.2	2.1	3.5	6.0	5.1	2.5	1.8	1.8	4.7	8.4	21.5	11.6	3.2	1.9	3.0	4.3	0.3	3.6	3.1	4.4	4.5	1.6	1.5	4.2	1.1	1.2	3.2	11.3	2.1	1.6	48.5	11.5	2.6	5.9	4.0	3.8	1.7	8.2	11.9	3.2	3.4	60.0	1.7	0.5	0.9	0.4	0.1	81.8	0.7	1.4	0.3	0.4	4.6	70.4	1.0	1.7	0.1	0.5	69.8	0.2	11.9	0.1	45.9	1.0	0.8	0.5	0.0	0.7	3.6	15.9	0.2	1.1	0.6	1.0	3.7	0.1	0.5	3.2	2.4	0.0	4.8	0.2	20.2	0.3	7.1	1.7	0.4	0.7	6.6	0.8	1.4	0.1	0.8	0.4	0.2	1.0	1.1	1.0	2.0	1.7	0.0	1.5	0.6	1.0	3.4	2.2	0.6	34.5	2.0	0.2	107.4	24.8	259.0	22.2	9.2	15.9	10.2	14.8	21.4	37.2	5.6	5.6	8.2	139.4	24.7	9.4	0.7	16.9	25.2	2.1	2.3	1.4	21.2	1.8	1.8	3.2	1.9	4.4	1.6	5.9	3.4	1.3	3.2	10.5	3.3	23.2	7.8	6.6	14.3	0.0	4.3	2.2	1.8	2.4	2.8	9.5	0.0	8.4	7.7	54.7	0.3	1.9	3.1	1.0	1.5	0.9	1.7	0.0	5.7	3.5	2.7	96.4	2.4	6.1	2.1	12.6	1.1	2.5	2.4	23.3	0.0	3.0	0.6	2.0	8.8	124.9	0.4	0.9	33.9	7.2	0.0	81.3	0.2	82.4	2.0	2.9	39.1	0.1	0.0	20.7	11.0	0.3	0.5	10.0	5.1	0.0	0.8	1.0	1.5	0.8	0.6	6.5	20.0	39.4	0.2	0.5	42.5
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS10	ADAM-TS10	ENSG00000142303	"ADAM metallopeptidase with thrombospondin type 1 motif 10"	Q9H324	19	8580240-8610735	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.3;Excitatory neurons: 21.4;Inhibitory neurons: 19.9;Microglial cells: 30.9;Skeletal myocytes: 15.9;Smooth muscle cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.2;hTERT-RPE1: 7.5;NB-4: 37.0;REH: 9.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			HPA040223	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA040223: AB_10795376"	"unprognostic (2.60e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.91e-4)"	"unprognostic (4.98e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (6.86e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-2)"	15.9	8.2	7.1	2.3	7.3	1.8	9.5	5.0	11.9	13.0	5.8	7.3	0.8	12.7	0.7	4.1	10.2	1.9	8.5	7.6	8.7	6.9	6.3	8.2	3.2	7.1	6.8	8.3	7.8	0.8	4.1	1.7	6.7	8.4	0.5	0.4	4.1	1.5	2.8	8.8	6.3	1.5	6.0	5.4	3.8	2.4	8.1	1.4	6.2	0.8	1.3	5.7	8.7	6.5	0.0	4.6	2.5	0.0	0.4	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.2	1.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	7.2	0.0	0.3	0.0	0.1	1.8	0.0	0.0	0.0	7.5	0.1	0.3	0.1	0.0	0.0	0.0	0.3	37.0	1.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.2	0.1	0.4	2.0	3.1	4.4	2.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	7.3	5.0	11.9	7.6	8.7	7.1	6.8	6.7	6.0	8.1	6.5	5.6	0.0	0.0	18.3	0.3	1.7	0.6	0.1	0.0	1.5	1.2	1.5	1.3	5.7	0.1	0.0	0.0	0.1	6.9	0.0	0.0	8.8	5.1	0.4	7.4	5.8	0.0	1.3	21.4	0.5	0.0	6.4	1.1	0.4	0.0	1.8	6.8	2.0	0.9	0.0	19.9	0.3	0.0	2.7	6.0	2.4	7.5	3.3	0.0	30.9	0.6	0.8	11.3	9.5	1.2	0.9	0.0	6.0	1.3	0.2	0.0	0.1	0.0	0.2	6.6	15.9	15.0	0.1	0.4	0.1	0.9	0.4	3.2	0.6	0.1	0.3
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892019	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	9.0	5.2	0.9	1.6	0.7	0.0	7.8	0.5	0.4	2.7	1.7	2.5	0.5	3.8	0.5	0.9	3.2	4.0	1.6	0.2	0.4	1.3	1.4	5.6	0.9	1.2	0.9	2.7	0.6	0.5	0.6	3.9	1.0	1.3	1.0	0.7	0.9	1.4	0.8	1.5	1.1	6.5	1.5	0.5	1.2	2.0	1.3	0.3	1.9	0.7	0.6	2.2	2.0	3.3	28.7	0.9	25.5	0.0	35.9	17.2	0.0	13.3	33.1	16.8	19.5	0.0	0.0	0.0	0.0	9.0	29.1	0.8	0.7	16.7	24.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	13.8	0.0	47.4	12.2	88.0	0.0	0.0	0.0	0.1	26.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	29.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	28.0	36.2	0.3	7.9	4.4	3.5	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	0.4	0.2	0.4	1.2	0.9	1.0	1.5	1.3	3.3	6.4	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.0	0.1	1.5	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.9	1.2	25.2	2.1	0.0	0.0	3.0	0.2	0.4	22.9	0.0	0.6	0.0	3.3	11.4	0.2	0.6	0.0	6.2	0.0	0.0	0.3	2.1	3.0	22.1	0.2	7.2	73.1	0.0	5.3	0.0	0.5	7.8	0.1	0.0	17.7	0.0	0.1	0.0	2.4	0.7	0.2	52.6	1.7	19.1	0.4	4.7	0.1	0.9	0.8	0.3	55.4	0.0	0.1
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	120000000	"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	2.5	2.8	6.9	0.5	7.3	0.6	2.8	7.6	10.0	5.0	5.3	4.3	3.2	4.2	2.9	2.4	5.7	1.2	6.0	7.1	6.2	9.6	63.8	2.8	0.9	7.0	6.7	6.7	6.2	1.5	12.5	0.8	7.1	6.4	0.9	1.1	2.5	1.4	4.3	2.6	4.4	0.6	6.3	2.6	9.8	13.5	7.2	0.8	6.1	1.4	0.5	4.4	3.1	7.1	0.0	0.8	1.9	2.6	1.5	1.3	0.8	0.7	0.5	0.2	0.3	0.3	2.1	0.2	0.9	0.4	0.6	0.3	0.1	0.4	0.1	1.2	1.7	0.2	0.9	0.4	1.1	0.0	0.7	3.6	0.9	0.2	0.7	1.2	0.1	1.3	0.0	0.8	0.3	3.3	0.0	0.9	2.0	1.1	1.1	0.2	0.2	0.9	0.8	0.8	1.3	4.0	1.4	0.6	1.2	3.9	3.7	0.4	0.5	1.5	0.8	0.9	0.0	1.7	0.3	0.3	1.1	0.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.3	7.6	10.0	7.1	6.2	7.0	6.7	7.1	6.3	7.2	7.1	0.9	0.0	2.0	16.0	1.2	0.3	0.3	0.9	0.0	1.7	1.4	1.9	4.2	4.3	2.4	0.0	0.0	0.2	0.2	1.0	1.9	0.6	19.3	3.6	1.6	0.9	1.2	0.0	12.4	0.4	0.3	1.5	4.6	3.3	0.0	3.0	5.0	1.6	0.2	3.3	12.4	1.3	0.0	0.6	0.0	13.6	0.9	0.3	0.0	7.5	0.0	1.7	0.0	2.0	5.5	0.3	3.0	1.5	0.4	0.4	1.5	0.9	0.7	1.8	0.0	0.4	0.7	6.0	3.9	0.3	0.4	0.1	0.5	1.7	0.9	0.3
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 26.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 8.6;Cardiomyocytes: 11.0;Endometrial stromal cells: 15.6;Fibroblasts: 9.6;Gastric mucus-secreting cells: 8.2;Glandular and luminal cells: 7.5;Granulosa cells: 6.8;Skeletal myocytes: 6.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 72.0;ASC TERT1: 43.0;EFO-21: 36.6;hTERT-RPE1: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	26.4	1.2	0.4	1.7	0.5	0.0	15.3	0.4	0.8	3.4	1.7	3.2	0.5	4.3	1.3	3.7	9.8	2.3	14.5	0.4	0.9	11.0	0.4	7.2	1.1	4.4	0.6	2.7	1.4	0.4	1.3	16.9	1.5	1.9	1.9	0.2	1.3	1.1	1.8	5.0	3.6	4.6	1.0	2.3	5.5	0.9	1.2	1.1	7.0	1.0	0.3	8.8	2.6	1.0	0.0	2.6	1.6	0.8	72.0	43.0	0.0	2.7	5.2	1.0	0.2	0.5	1.2	0.0	36.6	0.2	2.6	7.0	0.6	0.7	0.2	0.0	1.7	0.0	3.3	0.0	0.7	0.0	0.0	14.1	0.0	0.6	0.1	19.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	8.1	1.3	0.0	5.7	0.0	4.1	0.0	0.1	0.1	0.6	0.0	12.1	0.0	0.0	5.2	3.9	0.0	0.0	0.6	8.5	7.0	3.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.8	0.4	0.9	4.4	0.6	1.5	1.0	1.2	1.0	8.6	0.0	0.0	0.3	0.2	0.5	0.1	3.5	0.0	1.3	5.6	2.7	11.0	0.0	0.5	1.8	0.0	0.6	0.0	1.0	0.0	0.0	0.0	4.4	15.6	1.7	0.0	0.0	0.4	0.8	0.6	9.6	8.2	7.5	0.0	6.8	0.4	0.1	0.9	0.0	1.6	0.5	2.0	0.0	0.3	0.0	5.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.9	0.7	0.0	0.0	0.1	1.0	0.5	0.0	0.0	6.9	3.6	0.2	0.3	0.0	0.3	0.8	0.1	0.0	1.8	0.1
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435034	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;placenta: 20.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 36.8;Granulosa cells: 15.0;Muller glia cells: 13.7;Oligodendrocytes: 16.9;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;HUVEC TERT2: 8.0;SuSa: 10.6;TIME: 2.5;U-87 MG: 4.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.3"	"Low region specificity"	"Detected in all"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	3.1	0.1	1.3	0.3	3.0	0.0	2.9	11.0	2.5	1.2	0.5	0.0	0.1	0.8	0.0	0.1	0.2	0.6	0.0	1.8	2.7	0.2	0.0	0.1	0.1	4.3	2.4	0.1	0.3	0.0	0.8	20.6	3.7	0.4	0.0	2.0	1.3	0.1	0.6	0.1	0.0	0.6	1.7	0.0	0.0	0.2	2.4	0.9	0.0	0.0	0.0	0.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.6	0.0	0.5	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.0	11.0	2.5	1.8	2.7	4.3	2.4	3.7	1.7	2.4	5.9	36.8	0.0	0.0	4.6	0.1	0.1	0.1	0.0	0.0	1.8	1.5	4.3	0.6	0.0	0.0	1.8	2.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.3	0.0	15.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.1	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	10	"brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.6	1.0	0.0	3.3	0.0	0.0	0.0	1.5	10.2	0.1	0.2	0.1	9.8	0.0	0.2	0.2	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.7	0.0	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	5.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	1.5	0.8	0.2	0.0	0.5	0.0	0.0	0.3	0.6	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110853-179345461	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2000000		"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	36.9	10.9	0.8	2.4	4.2	0.3	22.7	0.9	3.5	20.6	0.9	10.5	1.4	21.7	0.5	5.5	15.5	6.1	22.3	0.5	0.9	7.5	15.8	29.6	1.8	4.5	3.3	12.1	5.8	0.4	15.1	9.7	4.2	9.0	1.4	0.2	5.3	1.8	2.9	9.4	11.6	9.1	0.2	38.4	9.3	3.9	2.5	0.4	6.8	0.8	0.6	15.0	16.7	2.2	0.0	0.0	0.1	0.7	36.0	35.8	0.0	31.4	5.4	11.5	12.4	0.1	0.0	0.0	0.2	39.3	0.7	0.1	1.8	0.0	5.1	0.0	1.5	0.0	0.1	2.3	115.5	0.0	0.0	94.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.9	1.2	0.1	0.0	0.4	1.9	0.0	10.7	0.0	19.1	3.0	24.5	0.0	0.3	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.8	4.2	0.9	3.5	0.5	0.9	4.5	3.3	4.2	0.2	2.5	2.2	3.3	0.0	1.1	1.6	0.1	2.2	0.4	0.0	2.2	0.3	0.2	5.2	1.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.9	32.2	1.4	0.0	0.0	17.9	0.0	0.3	30.7	0.0	0.8	1.3	6.5	17.2	0.5	5.1	0.0	8.5	0.0	0.0	71.4	4.4	3.4	5.0	10.4	0.0	4.7	0.3	0.1	0.0	3.0	2.4	0.5	0.0	12.8	0.1	0.4	0.0	0.2	0.0	0.0	26.3	4.7	20.4	2.1	4.8	0.2	2.7	0.0	0.4	0.6	0.0	0.1
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43552203	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 5.1;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"medulla oblongata: 2.8;pons: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.6;NB-4: 1.6;NTERA-2: 2.8;SuSa: 2.2;U-266/70: 4.0;U-266/84: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.1	0.0	0.0	1.6	2.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.8	0.1	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569221	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 8.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Excitatory neurons: 50.2;Leydig cells: 19.9;Rod photoreceptor cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;AN3-CA: 7.8;HEL: 14.1;K-562: 12.3;SH-SY5Y: 7.0;U-2 OS: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	2.3	0.8	0.5	1.0	2.5	0.8	3.2	0.0	1.5	0.4	0.1	0.3	0.1	1.9	1.7	0.2	2.9	0.6	0.9	1.5	0.6	0.9	0.2	1.1	0.8	0.0	0.2	2.0	0.3	2.7	0.2	0.7	0.1	0.7	0.3	8.4	0.4	1.1	0.2	0.4	0.2	1.7	0.0	0.7	0.5	1.9	0.1	0.6	1.2	0.3	0.3	1.3	0.4	0.4	0.0	0.0	13.2	7.8	0.1	0.3	0.1	0.7	2.1	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.8	0.0	1.8	0.0	1.8	14.1	0.9	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.3	0.0	0.0	12.3	0.0	0.0	0.0	1.3	0.0	2.2	0.0	4.0	0.0	2.6	0.0	4.6	0.0	0.5	7.0	0.0	0.6	0.2	1.4	0.1	0.2	0.1	5.6	8.5	0.0	0.7	0.0	0.0	0.0	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	1.5	1.5	0.6	0.0	0.2	0.1	0.0	0.1	0.4	1.8	0.0	3.4	7.5	0.0	0.5	0.9	0.0	0.0	0.9	0.8	3.2	1.2	1.5	1.3	1.8	14.6	0.0	0.0	0.0	0.0	0.0	4.1	2.2	5.1	3.7	0.0	2.5	50.2	0.0	0.3	3.3	0.0	0.7	1.3	1.9	3.9	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.7	1.9	19.9	0.3	0.0	1.0	0.0	1.8	0.0	7.1	1.3	0.0	0.0	4.5	0.0	1.1	0.0	0.3	0.5	12.9	0.0	0.3	1.2	1.2	0.8	0.3	0.0	0.0	0.0	2.8	0.0	0.1
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917922-26967088	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 26.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 38.2;Endometrial stromal cells: 72.1;Fibroblasts: 88.6;Leydig cells: 62.7;Skeletal myocytes: 110.2;Smooth muscle cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.6;ASC TERT1: 13.9;fHDF/TERT166: 11.9;RH-30: 33.1;U-87 MG: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		28000		"Cluster 5: Breast - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655"	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.15e-1)"	17.5	0.8	0.3	1.0	0.6	0.0	10.8	3.3	0.3	8.8	2.6	2.7	0.8	12.5	2.4	1.6	4.2	1.6	3.3	0.5	0.9	2.5	1.4	1.0	0.6	1.4	0.9	16.6	0.4	1.5	0.4	26.2	0.9	3.0	1.3	0.6	2.0	1.8	2.0	4.2	3.4	7.5	1.5	7.7	2.2	0.8	0.4	0.3	6.8	3.7	0.1	4.2	3.6	1.2	0.0	0.0	0.0	0.0	31.6	13.9	0.0	1.7	0.2	1.4	0.6	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	2.3	0.0	1.3	0.0	0.3	0.0	3.5	0.1	0.0	8.0	0.0	1.1	0.2	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.1	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.3	0.4	1.9	0.9	0.0	0.0	0.0	13.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.3	0.3	0.5	0.9	1.4	0.9	0.9	1.5	0.4	1.2	24.3	0.0	0.5	0.3	0.1	2.9	0.2	0.4	0.0	9.8	1.5	38.2	2.7	0.0	0.6	3.7	0.0	1.1	0.3	0.0	0.0	0.0	6.4	2.0	72.1	10.6	1.8	0.0	0.5	0.2	1.6	88.6	0.0	1.3	0.0	3.0	3.3	0.0	1.9	0.0	11.6	0.0	0.0	0.0	4.6	1.0	62.7	1.4	3.6	3.7	4.0	0.1	0.0	12.5	0.2	0.0	0.0	9.1	0.0	0.3	0.0	2.2	0.0	0.2	13.1	110.2	44.9	0.3	0.9	0.4	3.0	2.7	0.8	20.0	0.0	0.1
ADAMTS6	ADAM-TS6	ENSG00000049192	"ADAM metallopeptidase with thrombospondin type 1 motif 6"	Q9UKP5	5	65148738-65481920	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.6;Inhibitory neurons: 63.6;Microglial cells: 31.9;Oligodendrocyte precursor cells: 139.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 12.6;HBF TERT88: 13.4;hTEC/SVTERT24-B: 12.6;hTERT-HME1: 14.9;TIME: 14.5;U-2197: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043441	Enhanced				"Secreted to extracellular matrix"	NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043441: AB_2678484"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-6)"	"unprognostic (3.23e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.02e-4)"	"unprognostic (4.18e-3)"	0.5	0.1	0.2	0.6	0.2	0.0	0.3	0.2	0.3	0.3	0.5	0.3	0.1	1.1	0.7	0.2	0.6	1.4	0.3	0.2	0.6	0.2	0.0	0.5	0.4	0.3	0.4	0.3	0.0	0.0	0.1	1.9	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.6	0.6	0.3	0.7	0.3	0.5	0.3	0.2	0.1	0.1	0.3	0.7	0.3	0.2	2.7	0.0	0.6	0.6	0.0	2.0	0.0	12.6	7.4	7.7	9.0	0.0	0.3	0.0	0.1	4.8	5.3	0.5	0.1	2.4	13.4	2.0	0.0	0.2	5.1	0.3	0.4	0.0	0.7	0.9	0.0	12.6	14.9	3.7	6.9	1.3	0.0	0.0	4.8	0.0	0.7	0.0	0.1	0.3	0.1	0.4	2.6	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	1.6	0.0	0.1	14.5	3.0	4.5	16.2	10.2	0.1	0.0	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.4	2.1	0.1	0.2	0.0	1.3	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.3	0.4	0.3	0.3	0.3	0.2	11.3	0.0	0.0	4.9	16.1	0.3	0.0	0.6	0.6	13.9	0.3	0.5	1.8	1.5	0.1	3.7	0.0	34.6	3.2	0.2	0.0	1.4	15.2	8.5	7.4	13.3	0.0	0.0	16.7	0.0	4.7	5.5	0.0	25.7	1.3	18.7	8.9	0.3	2.4	0.0	63.6	0.5	2.0	0.3	1.0	8.0	12.2	3.2	0.0	31.9	0.3	17.4	1.0	139.7	2.1	2.6	0.0	18.0	2.5	0.1	0.1	1.0	0.1	1.1	6.6	5.1	10.5	6.1	8.9	0.3	0.0	14.2	5.1	2.2	0.6	0.0
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 30.6"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.6	5.3	0.5	1.8	0.4	0.1	3.8	0.3	0.5	6.0	0.6	4.2	1.1	7.2	0.1	0.9	2.2	2.3	30.6	0.4	0.5	2.2	1.1	6.3	0.9	0.5	0.5	6.1	0.5	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.4	1.1	1.8	2.6	1.4	0.2	5.2	2.2	4.1	0.7	0.1	2.1	0.5	0.2	3.0	2.5	0.6	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.5	0.4	0.5	0.5	0.5	0.4	0.2	0.7	0.6	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404923-130428609	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066349	Approved				"Secreted to extracellular matrix"	NA	NA		3600000		"Cluster 19: Lung - Lung function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	1.8	0.1	1.5	10.1	2.7	0.0	0.7	0.0	3.7	2.0	0.0	7.0	1.1	3.0	1.0	3.0	2.1	1.6	2.3	3.5	0.0	0.5	0.0	27.6	0.1	0.7	0.1	0.4	0.7	0.0	0.2	2.6	0.2	2.7	0.5	0.0	0.5	4.9	0.5	0.3	2.1	4.2	0.1	0.4	5.3	0.3	1.0	0.0	0.2	0.5	0.0	4.2	0.9	1.8	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	0.0	3.7	3.5	0.0	0.7	0.1	0.2	0.1	1.0	1.8	1.3	0.0	0.6	1.0	0.0	0.4	0.4	0.1	0.0	2.4	2.3	3.9	9.1	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	14.5	30.9	0.6	0.0	0.0	7.4	0.0	0.0	6.6	0.0	37.7	1.3	1.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.7	0.5	0.0	0.1	1.8	2.8	0.0	0.1	1.0	0.5	5.9	0.0	0.0	1.5	0.0	0.5	0.0	0.1	2.6	0.2	0.0	26.9	5.7	0.1	0.3	0.1	0.1	0.0	0.6	0.1	0.0	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 13.3"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.6"	"Region enhanced"	"Detected in many"		"thalamus: 9.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 118.3;HSkMC: 61.2;hTEC/SVTERT24-B: 64.3;hTERT-RPE1: 55.8;LHCN-M2: 64.3;TIME: 207.9;U-138 MG: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		28000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	3.9	5.5	1.0	1.9	0.9	0.0	2.4	1.7	1.1	3.8	0.0	3.0	1.8	13.3	1.1	5.4	4.0	4.9	1.0	3.6	1.8	2.1	0.9	1.2	0.8	2.1	3.3	1.5	1.4	0.2	1.8	0.6	0.5	8.1	2.9	0.4	1.3	1.6	0.4	0.9	1.8	11.2	1.4	0.7	5.1	1.0	9.6	0.5	0.9	0.8	0.9	2.6	2.0	1.0	6.4	0.5	1.2	0.0	17.5	118.3	0.0	3.6	16.3	14.8	33.3	0.0	0.1	0.1	0.1	44.1	5.5	0.0	6.6	1.1	41.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	61.2	0.0	64.3	0.2	55.8	27.1	0.0	0.1	0.3	64.3	0.0	0.2	0.1	5.6	0.0	0.3	0.0	10.1	0.2	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	207.9	96.9	2.5	2.6	15.8	0.0	0.0	0.0	31.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.7	1.1	3.6	1.8	2.1	3.3	0.5	1.4	9.6	1.0	1.6	0.0	0.0	5.2	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.4	1.4	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.0	0.1	7.2	0.3	1.1	8.9	0.0	0.0	245.4	0.0	0.0	15.1	0.5	0.5	0.0	0.1	1.1	0.0	0.1	0.0	39.5	0.4	0.0	0.0	0.8	2.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	9.0	5.7	0.0	0.4	1.2	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.1	1.2	2.9	1.6	0.1	0.1	0.1	0.0	0.1	1.7	0.1
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.2;liver: 35.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		170000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.7	28.5	6.8	1.0	7.3	0.1	1.5	12.0	10.1	2.3	1.4	2.7	1.4	3.1	3.1	1.8	3.1	2.5	73.2	5.8	7.9	25.9	35.8	23.2	3.4	19.3	11.1	4.9	7.1	1.2	15.9	1.5	20.8	8.4	0.3	0.3	3.4	2.2	4.3	0.8	3.2	0.9	8.5	6.4	2.3	3.1	9.3	0.6	12.1	0.5	0.6	5.3	1.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.5	0.0	1.1	0.7	10.1	0.0	0.0	1.4	30.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.3	12.0	10.1	5.8	7.9	19.3	11.1	20.8	8.5	9.3	7.6	1.4	0.0	0.5	4.9	0.1	0.1	0.1	0.0	0.0	4.2	0.0	0.1	2.3	0.0	0.0	1.8	0.0	0.1	0.0	1.4	5.9	0.2	0.1	0.1	0.1	5.7	5.3	0.0	5.0	0.0	0.1	8.5	0.0	0.0	0.0	0.1	4.6	0.9	0.3	0.0	3.8	0.4	0.0	0.3	0.8	1.1	4.7	0.6	0.0	12.2	0.0	0.4	0.0	2.5	4.0	0.2	0.5	3.0	0.0	0.2	0.0	0.7	0.0	0.2	6.6	1.1	1.6	0.1	0.8	0.4	0.3	0.0	0.6	0.7	1.1	0.2
ADAMTSL3	"KIAA1233, punctin-2"	ENSG00000156218	"ADAMTS like 3"	P82987	15	83654088-84039842	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034773, HPA034774"	Uncertain		Uncertain	Vesicles	"Secreted in other tissues"	NA	NA		270000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034773: AB_10601965, HPA034774: AB_2674326"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (5.92e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.00e-3)"	"unprognostic (4.62e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.95e-5)"	6.3	4.2	1.1	1.0	1.7	0.0	1.7	1.4	1.0	3.1	4.4	10.6	1.4	6.9	1.5	3.3	4.4	1.1	10.7	1.1	1.1	3.3	10.4	7.4	1.1	1.4	1.5	1.2	7.3	0.8	1.4	10.4	1.7	6.6	3.2	0.3	2.4	7.1	2.6	1.4	1.8	4.7	1.5	1.9	4.6	2.7	1.1	1.0	2.6	4.8	0.5	5.2	2.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	14.0	0.0	0.0	0.0	0.2	0.2	0.0	1.3	0.0	0.0	13.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.4	1.0	1.1	1.1	1.4	1.5	1.7	1.5	1.1	3.0	8.7	141.1	111.8	86.5	0.1	7.0	5.2	1.7	0.6	0.2	0.2	0.3	9.4	0.0	61.7	1.8	0.0	0.1	0.8	0.0	0.0	0.5	14.9	0.6	0.4	10.6	0.0	0.0	31.3	2.4	0.2	29.0	1.5	1.2	63.1	0.1	1.1	10.2	0.2	6.7	91.6	0.0	0.0	0.6	0.5	16.9	49.4	5.9	0.0	5.6	0.0	0.1	1.0	4.5	75.2	1.0	0.0	17.0	0.4	2.4	0.0	0.6	56.4	0.2	26.3	13.0	8.3	2.1	2.8	0.6	1.1	0.1	5.0	0.4	0.0	2.3
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.1"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	32.0	5.1	1.1	14.9	1.0	4.2	24.7	0.8	11.1	22.9	7.9	19.3	3.6	20.0	1.6	33.3	29.2	7.7	22.3	0.8	1.4	6.4	17.3	26.1	1.8	4.4	2.8	17.1	3.0	0.5	3.0	62.9	2.9	9.0	3.8	0.6	11.8	3.4	37.7	11.8	13.7	11.4	1.2	5.4	17.2	2.4	3.6	0.8	6.1	47.9	1.2	32.8	23.3	1.5	22.0	0.6	0.3	3.9	19.1	92.0	200.3	20.8	18.0	12.1	7.0	1.8	8.5	0.2	4.3	14.4	0.2	11.0	0.8	3.2	4.9	1.7	0.4	6.2	2.6	8.9	15.3	0.3	3.0	43.8	0.9	3.0	6.8	10.3	0.1	0.0	67.7	0.7	2.2	0.5	0.0	1.1	3.5	0.6	0.7	0.0	0.0	0.1	2.1	0.8	0.1	0.6	6.7	15.9	0.1	10.0	4.5	11.5	3.8	0.7	5.5	8.6	0.3	1.9	0.6	4.5	0.8	4.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.3	1.1	1.0	0.8	11.1	0.8	1.4	4.4	2.8	2.9	1.2	3.6	1.5	2.8	0.0	1.5	1.0	0.5	2.4	2.3	0.2	0.6	1.7	1.3	1.8	2.2	10.0	0.6	0.0	0.0	146.7	1.0	0.2	0.0	1.7	0.6	2.6	36.9	5.3	0.0	0.0	0.3	0.6	46.4	34.5	0.0	5.4	2.5	0.9	1.8	10.6	34.0	0.0	0.1	0.2	0.0	24.0	12.5	0.7	30.1	20.0	3.6	0.0	23.1	1.4	1.0	0.0	0.0	12.3	0.1	3.4	3.2	2.2	0.0	0.2	0.9	2.2	0.0	14.3	3.8	0.1	1.6	5.5	2.8	99.5	1.7	0.5	0.3	2.5
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897900-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;intestine: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 15.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	4.9	3.8	51.2	11.2	55.8	9.8	3.4	57.3	73.6	4.1	11.2	43.2	19.7	6.0	0.6	9.0	8.8	6.0	8.1	59.4	42.9	22.3	3.6	10.4	3.8	63.5	63.1	1.5	13.3	6.1	4.7	2.7	56.9	6.6	22.8	1.6	4.6	2.9	0.7	3.9	26.8	8.3	48.7	17.2	19.6	1.1	55.4	0.9	7.6	0.5	2.1	8.9	3.8	85.9	108.1	4.0	0.1	3.7	1.4	0.2	1.1	3.6	0.1	0.7	0.1	43.1	74.1	0.2	10.3	0.5	0.2	44.5	5.9	8.1	0.5	0.6	4.7	0.0	6.0	25.4	1.7	0.7	71.0	1.8	21.4	0.2	0.0	0.1	0.0	3.1	0.4	0.0	0.0	33.2	0.1	30.1	3.2	191.5	0.0	14.4	0.2	0.4	4.7	25.0	3.1	1.0	3.3	1.3	0.5	0.4	25.9	122.6	0.6	0.8	2.8	0.1	0.3	0.0	0.2	0.0	0.2	22.3	3.3	1.0	6.5	3.3	6.0	7.3	2.8	1.1	1.6	5.5	5.1	0.9	0.5	2.6	3.1	1.6	11.7	0.3	0.8	4.0	51.2	55.8	57.3	73.6	59.4	42.9	63.5	63.1	56.9	48.7	55.4	85.9	0.4	0.0	10.3	2.9	3.6	1.0	2.9	3.3	2.8	4.7	2.5	1.5	8.5	7.2	2.9	7.3	0.0	0.3	19.4	97.7	9.8	3.9	0.2	8.6	0.9	0.5	16.2	0.0	13.2	4.6	0.9	1.5	17.9	7.6	7.0	1.3	0.0	0.6	12.2	0.0	12.6	42.5	4.1	23.0	15.7	0.4	0.0	22.1	10.6	2.8	13.2	1.3	15.5	3.0	43.6	17.5	64.4	0.0	2.6	3.0	48.5	7.1	8.2	1.1	0.0	0.1	1.9	0.3	1.2	1.1	1.3	0.7	9.0	0.0	50.6	5.5
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADAT1		ENSG00000065457	"Adenosine deaminase tRNA specific 1"	Q9BUB4	16	75596868-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 101.9;Late spermatids: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	13.8	16.4	11.0	9.5	11.1	7.8	14.1	11.5	15.1	12.0	10.5	11.6	5.1	14.0	12.7	11.7	11.8	6.6	11.5	10.8	10.5	19.8	18.5	12.8	10.8	11.5	11.2	10.3	12.6	14.6	14.2	7.3	11.7	15.3	9.1	9.6	12.1	8.6	9.5	14.1	14.0	6.0	10.6	20.4	12.0	26.9	11.5	11.8	14.8	5.2	8.7	13.1	11.6	13.0	14.7	23.1	15.0	15.5	26.4	20.3	11.5	20.2	21.0	26.1	17.7	15.4	22.4	15.7	19.8	20.6	14.0	17.6	16.4	25.0	24.6	11.7	8.6	8.8	16.0	13.3	21.2	19.6	19.6	21.7	23.8	42.7	32.1	7.5	23.1	24.7	13.7	7.6	21.2	35.9	18.8	14.3	12.2	19.8	10.7	23.6	12.1	21.5	24.6	22.0	18.1	18.6	47.8	12.2	11.2	15.0	24.6	9.3	16.3	32.4	14.6	17.1	16.9	15.1	24.3	58.9	16.3	15.6	28.5	8.5	4.3	11.5	8.5	6.4	11.3	7.9	7.3	11.3	5.8	7.3	4.5	6.3	4.9	10.8	9.9	4.6	9.0	6.2	11.0	11.1	11.5	15.1	10.8	10.5	11.5	11.2	11.7	10.6	11.5	13.0	9.9	9.6	5.8	2.3	11.6	4.6	5.9	5.7	6.8	13.5	10.7	6.6	5.6	11.5	6.6	7.3	27.1	11.8	9.8	6.8	17.6	8.6	101.9	11.8	8.2	11.9	14.4	16.0	6.0	7.6	8.9	6.4	8.6	10.5	8.2	12.6	6.1	10.5	10.3	13.5	6.4	4.7	10.2	14.4	10.6	213.0	9.9	10.2	3.6	2.8	12.8	7.8	15.5	3.0	8.0	9.8	3.3	7.9	8.1	8.3	6.9	11.3	9.9	21.6	6.6	6.8	7.0	17.5	13.4	8.4	5.4	9.7	14.8	12.9	9.1	7.6
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
ADAT3	TAD3	ENSG00000213638	"Adenosine deaminase tRNA specific 3"		19	1905399-1913447	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Gastric mucus-secreting cells: 8.2;Squamous epithelial cells: 13.7;Suprabasal keratinocytes: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058899	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA058899: AB_2683847"	"unprognostic (1.79e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.43e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.55e-3)"	3.3	4.6	1.6	0.8	3.1	0.7	3.1	2.8	2.6	4.2	1.2	7.7	7.5	3.5	0.2	10.6	3.7	0.2	2.8	1.1	1.4	7.9	5.4	3.7	0.5	5.6	3.1	3.1	6.3	0.1	3.3	0.2	4.0	6.4	0.7	0.0	8.1	0.4	1.9	13.9	6.6	0.1	3.1	6.1	4.7	2.9	3.3	0.1	4.5	0.2	0.3	2.8	5.3	6.1	4.9	1.2	0.7	1.0	0.4	0.0	5.9	1.7	0.3	0.6	0.9	1.9	1.5	2.8	0.7	0.2	0.3	3.1	0.2	0.2	0.0	6.9	12.5	0.7	3.7	2.5	0.2	1.3	8.8	0.0	0.2	0.8	0.0	0.1	0.6	0.8	8.1	1.5	0.4	1.0	2.3	4.2	6.5	0.2	8.4	7.6	1.1	4.8	0.7	1.2	2.6	6.4	2.1	5.0	2.5	0.3	3.9	1.0	1.6	0.6	2.8	2.4	3.7	2.7	2.6	2.5	0.5	1.3	1.6	0.2	1.2	0.0	1.3	0.7	1.4	0.9	2.0	2.3	1.7	2.5	1.4	2.3	0.3	4.1	1.1	13.2	2.6	0.8	1.6	3.1	2.8	2.6	1.1	1.4	5.6	3.1	4.0	3.1	3.3	6.1	1.1	0.0	1.5	0.0	2.9	6.1	1.0	1.0	9.1	0.0	4.0	1.8	0.6	1.5	0.5	0.0	0.0	1.8	5.5	4.1	1.9	1.5	0.1	6.3	1.2	1.4	1.2	0.4	0.0	0.7	2.4	1.6	8.2	3.1	0.0	0.5	2.2	0.8	1.8	0.0	0.0	1.1	0.0	1.4	3.1	0.6	0.0	2.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	4.3	0.7	6.4	0.3	4.2	4.0	2.3	0.0	0.0	0.8	1.2	0.8	3.1	13.7	11.1	4.5	3.6	0.8	1.7	1.2
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800109-77935014	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9;Oligodendrocytes: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Uncertain	Nucleoplasm	"Secreted - unknown location"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051012: AB_2681310, HPA055014: AB_2682672"	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic favorable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	4.4	8.1	7.3	3.7	7.8	5.3	4.2	7.3	10.3	4.3	8.2	6.7	7.4	4.8	5.1	6.1	4.4	3.8	9.0	7.8	7.2	7.0	8.6	4.0	4.1	7.8	7.4	4.7	6.7	6.5	8.3	5.1	8.2	6.5	5.8	3.8	6.7	5.4	8.9	6.3	5.6	6.4	7.1	7.3	6.1	4.6	7.9	5.2	5.9	5.2	4.8	5.1	4.0	10.2	5.5	9.1	4.4	17.4	13.0	6.5	6.2	5.7	7.9	4.5	5.6	4.7	12.4	12.0	8.5	9.5	7.5	10.2	27.0	9.3	2.9	6.3	9.1	2.8	4.9	7.5	12.2	4.5	6.6	7.7	16.2	1.9	5.7	4.4	7.1	10.1	11.4	7.4	5.9	24.5	5.8	7.6	9.6	17.5	10.2	9.1	0.7	9.0	6.6	13.9	10.4	6.0	10.6	14.7	5.9	6.8	20.9	9.4	6.8	4.6	3.4	8.9	4.6	6.4	7.7	6.3	6.6	7.7	5.8	1.3	4.0	1.4	4.2	6.0	2.9	1.4	1.6	2.4	7.4	3.0	1.9	3.4	0.3	3.2	2.5	5.5	3.1	2.5	7.3	7.8	7.3	10.3	7.8	7.2	7.8	7.4	8.2	7.1	7.9	10.2	1.9	0.0	3.7	10.1	1.8	0.9	1.8	3.9	2.8	5.9	2.9	3.0	5.7	4.3	2.8	0.0	20.9	8.2	4.2	4.0	3.9	4.4	1.5	2.0	2.4	1.4	1.8	2.1	10.3	5.1	4.2	2.4	6.6	2.4	1.3	5.0	1.8	6.6	9.6	8.4	11.7	4.0	4.1	4.4	1.5	0.8	1.5	5.1	0.0	5.6	2.5	4.0	3.1	11.6	29.0	2.8	1.3	1.9	3.2	1.5	3.0	3.8	2.4	9.3	0.0	2.1	1.6	1.8	9.9	4.3	1.4	5.3	2.2	4.6	5.4	1.2
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140672945-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	10.4	9.1	23.7	10.2	25.1	8.8	11.3	24.6	25.9	11.9	16.5	13.4	7.4	9.7	8.9	17.5	16.0	8.3	10.7	24.3	24.2	12.4	13.3	10.8	14.8	29.1	25.6	11.8	14.4	19.5	12.8	11.2	25.9	13.2	10.9	6.3	15.6	10.7	14.1	26.3	11.0	9.0	26.3	12.2	13.1	6.5	26.4	12.4	12.8	8.4	14.1	11.9	13.7	30.2	32.6	23.2	5.6	24.9	19.3	21.5	31.7	16.5	20.0	17.2	11.2	21.7	22.5	42.4	24.0	11.7	39.4	26.3	27.5	19.0	5.1	31.3	26.1	9.2	8.8	11.1	26.5	6.2	21.8	17.7	56.8	9.9	13.5	17.3	14.8	30.9	16.1	20.9	6.1	41.0	46.4	15.3	8.2	27.0	23.1	36.3	0.3	21.0	9.9	34.9	20.6	14.5	22.7	32.7	23.3	10.1	29.2	12.2	15.6	21.3	7.3	35.0	32.0	14.2	23.2	32.4	31.3	23.9	25.7	0.0	3.0	3.0	4.2	4.1	4.0	7.0	3.8	4.3	4.8	3.0	5.8	3.7	0.1	4.4	2.6	10.1	5.4	2.0	23.7	25.1	24.6	25.9	24.3	24.2	29.1	25.6	25.9	26.3	26.4	30.2	9.0	9.6	3.6	2.3	9.8	12.4	21.3	4.4	5.7	11.4	15.3	11.7	6.4	7.2	3.5	9.2	0.0	32.9	17.8	15.0	5.9	6.3	37.9	5.6	3.4	8.8	16.8	12.2	6.5	7.5	20.2	6.2	5.1	9.3	11.4	98.0	7.1	9.9	31.5	11.8	6.7	13.5	6.1	11.4	16.1	16.4	3.4	14.3	3.6	6.5	8.4	13.3	9.2	8.0	10.8	6.1	15.8	13.5	5.1	19.6	8.3	5.7	4.8	5.9	0.0	9.5	7.2	7.0	6.4	7.3	13.9	33.8	9.6	14.9	14.0	21.2
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 61.7;Theca cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	3.1	9.1	1.3	1.5	1.3	0.9	3.4	1.1	2.6	4.5	0.9	6.7	4.8	3.7	0.2	6.4	3.7	0.5	4.1	1.4	1.1	4.3	6.4	2.8	1.1	1.4	1.1	4.5	5.0	0.8	3.5	0.6	1.3	4.1	0.7	0.5	4.1	0.8	4.0	5.2	8.4	0.4	0.9	5.7	4.4	6.7	1.2	1.1	3.6	0.7	0.5	4.0	4.2	1.2	2.5	3.1	0.7	2.1	0.5	0.5	3.7	2.2	1.2	1.8	0.7	3.6	2.7	1.1	1.5	0.5	0.6	3.2	0.1	2.2	0.1	2.8	1.0	2.9	2.6	3.9	1.6	0.7	2.2	1.0	1.4	0.6	0.7	0.9	1.2	2.1	1.9	1.9	0.9	6.9	2.2	2.9	0.4	2.3	2.3	2.8	1.0	2.0	1.2	2.3	0.4	1.1	3.1	2.4	1.8	0.5	2.1	1.9	0.8	0.8	3.2	2.2	1.5	0.9	0.3	1.0	1.9	2.5	1.3	0.9	2.0	1.2	1.1	2.7	1.3	0.9	1.3	0.8	3.2	2.7	1.3	0.7	0.4	1.0	2.7	2.0	2.1	1.3	1.3	1.3	1.1	2.6	1.4	1.1	1.4	1.1	1.3	0.9	1.2	1.2	5.8	3.2	1.7	4.9	6.5	4.1	3.3	10.2	2.2	10.3	5.0	6.1	2.3	7.2	6.9	5.5	16.7	4.3	6.6	33.5	3.9	9.3	8.2	3.7	4.2	5.0	8.4	3.0	7.6	7.1	11.2	4.5	20.4	4.8	8.9	16.2	2.5	8.2	8.0	3.3	8.3	31.2	12.2	5.5	4.3	11.3	5.9	5.0	3.6	2.8	9.1	6.4	7.2	4.0	2.4	9.5	16.8	7.2	3.7	2.7	61.7	6.9	9.5	16.3	13.1	2.5	4.4	26.5	19.2	4.7	5.1	2.5	4.8	42.3	25.4	3.1
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.7;liver: 19.2;retina: 53.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 521.3;Excitatory neurons: 147.2;Inhibitory neurons: 117.9;Rod photoreceptor cells: 174.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;SH-SY5Y: 25.5;SK-MEL-30: 30.1;WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	1.9	1.8	13.7	0.3	22.4	0.0	4.7	15.4	33.7	5.3	0.0	0.4	0.2	1.8	0.5	0.6	2.0	0.6	2.9	31.9	0.0	1.9	19.2	0.6	0.4	1.2	0.9	0.9	3.3	1.9	2.6	0.4	1.1	2.8	0.4	53.0	0.3	1.2	7.7	0.4	0.3	0.9	0.0	1.7	1.1	2.8	4.0	0.3	2.4	8.5	0.3	0.8	1.3	24.5	0.8	5.9	2.1	3.2	4.1	0.1	4.0	0.2	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	5.8	1.9	3.8	0.3	0.1	10.7	2.7	0.0	0.0	0.6	0.0	0.2	0.1	4.9	2.8	0.5	22.2	0.0	0.1	8.6	0.3	7.0	0.3	7.1	0.0	0.0	8.3	5.1	0.0	0.0	0.0	11.7	0.0	5.7	13.4	25.5	2.1	0.0	30.1	3.1	2.0	3.5	0.0	0.6	4.2	0.5	3.6	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	22.4	15.4	33.7	31.9	0.0	1.2	0.9	1.1	0.0	4.0	24.5	3.5	0.0	0.0	30.7	0.3	0.3	0.6	0.0	0.0	43.8	10.6	5.7	11.4	2.8	0.0	0.0	521.3	0.1	0.3	0.5	1.9	0.0	2.9	1.0	23.1	10.8	31.2	0.0	147.2	0.9	0.2	4.2	0.0	0.7	0.0	0.2	15.7	52.3	0.3	42.1	117.9	1.0	2.0	3.2	0.4	0.7	1.8	0.2	3.6	17.8	0.0	13.8	0.0	63.3	4.0	0.5	0.1	7.5	0.1	2.6	0.0	0.4	0.0	174.4	0.0	2.3	8.8	0.5	6.8	0.1	0.1	0.0	0.6	0.6	0.6	0.3
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809386-167914215	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 6.1;testis: 17.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 87.5;Late spermatids: 85.4"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"T-47d: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015243, HPA017749"	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"			"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.2	1.3	0.0	1.2	0.0	1.0	2.6	2.4	0.2	0.7	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.2	1.4	0.7	0.4	6.1	0.2	0.0	0.6	0.8	0.1	0.4	0.0	0.1	0.1	0.7	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.3	17.6	1.2	0.1	0.1	0.0	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.6	2.4	1.4	0.7	0.6	0.8	0.7	0.6	1.2	1.7	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	87.5	0.3	0.2	0.1	0.0	0.0	9.9	0.0	0.7	0.3	0.0	0.1	0.0	0.9	0.7	7.6	0.1	0.0	7.6	0.0	0.0	0.0	0.4	85.4	0.6	0.1	0.0	1.0	0.0	0.0	0.0	3.5	3.6	0.0	0.0	0.4	0.0	0.2	1.1	0.2	0.0	0.0	0.0	0.2	0.4	11.3	0.6	0.1	0.4	1.8	0.0	0.8	0.2	0.2
ADCY2	"AC2, HBAC2, KIAA1060"	ENSG00000078295	"Adenylate cyclase 2"	Q08462	5	7396138-7830081	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 50.8;skeletal muscle: 68.3;tongue: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 647.1;Excitatory neurons: 406.6;Horizontal cells: 201.9;Inhibitory neurons: 423.9;Oligodendrocyte precursor cells: 181.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 5.6;NTERA-2: 4.3;SK-MEL-30: 4.6;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031482, HPA038015, HPA038483"	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799"	"unprognostic (6.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.03e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.09e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.92e-3)"	1.4	2.2	32.3	0.3	39.1	0.1	1.8	25.9	39.9	4.5	8.0	3.2	0.9	3.2	0.6	3.0	3.0	1.1	0.4	38.2	37.6	0.2	0.0	0.3	0.0	43.4	44.1	3.9	0.8	0.4	6.3	0.8	34.1	5.2	0.5	7.0	1.8	3.9	68.3	5.4	1.1	3.3	50.8	0.2	1.6	2.7	33.8	0.2	0.4	30.8	0.1	1.9	3.1	37.8	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	3.8	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.3	39.1	25.9	39.9	38.2	37.6	43.4	44.1	34.1	50.8	33.8	37.8	0.3	3.2	2.7	647.1	0.1	5.9	0.7	0.1	0.0	26.8	1.5	1.5	2.2	1.5	2.6	0.0	68.8	0.6	0.2	0.2	0.0	0.6	3.2	0.2	1.6	1.3	12.6	0.0	406.6	0.5	0.3	3.5	0.0	0.2	1.3	3.2	0.4	0.2	0.2	201.9	423.9	1.2	0.0	0.0	5.0	4.9	4.4	0.9	40.9	20.6	0.0	2.0	0.0	181.5	10.6	3.6	7.6	1.9	0.0	8.0	0.2	0.2	5.3	4.9	0.0	11.9	0.9	1.2	1.7	0.0	4.7	0.8	0.7	0.3	0.4	1.4
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24920237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	94.4	17.3	43.5	17.3	55.1	17.7	74.6	36.7	50.1	66.7	28.4	27.5	10.9	56.4	20.5	30.4	62.1	23.0	36.6	43.3	43.4	25.9	6.6	42.5	18.9	41.6	43.8	71.9	15.7	17.0	41.7	83.6	41.1	40.6	15.8	4.2	21.6	33.0	15.2	38.4	34.4	35.3	36.9	30.4	25.0	9.8	50.6	11.4	36.8	20.4	18.1	36.4	48.9	44.9	76.5	40.4	17.2	28.3	84.5	75.4	29.6	32.3	65.9	37.1	37.8	38.6	25.1	26.0	6.2	53.2	51.0	54.5	43.1	54.5	24.0	58.4	55.8	43.0	40.0	1.7	64.0	24.0	24.6	55.7	47.5	36.6	50.8	23.6	33.8	27.9	15.5	49.2	19.3	43.6	17.9	2.1	14.9	39.9	24.4	38.8	75.3	59.5	15.5	38.7	31.6	19.1	45.8	54.2	30.2	13.0	13.5	22.5	33.5	59.7	34.2	39.1	54.1	42.4	101.6	113.6	18.7	39.2	31.4	2.6	1.5	0.0	0.4	1.6	0.3	5.5	0.9	0.5	9.5	6.0	0.7	0.5	0.0	1.2	0.4	9.0	3.4	1.0	43.5	55.1	36.7	50.1	43.3	43.4	41.6	43.8	41.1	36.9	50.6	44.9	14.6	0.0	1.8	17.0	8.2	11.0	4.2	4.1	5.2	3.0	18.6	8.0	2.8	0.0	1.3	1.8	0.0	1.0	5.2	5.0	0.0	0.9	0.3	1.9	42.2	10.6	1.2	5.2	40.1	0.0	2.1	25.5	2.0	2.2	18.4	3.7	5.0	0.3	12.6	0.0	36.8	6.0	2.0	5.4	6.9	3.9	58.4	10.1	7.2	21.5	4.0	1.6	0.0	15.1	33.2	1.0	5.8	29.3	4.9	11.2	8.3	0.2	1.1	2.2	111.7	6.5	62.8	0.4	2.4	4.4	11.8	1.2	7.2	92.9	12.1	3.9
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449090	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;heart muscle: 105.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 388.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 155.9"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	18.9	3.3	25.5	4.9	97.7	0.0	10.6	13.9	43.9	9.8	0.0	35.1	5.2	14.7	5.7	18.8	12.7	10.0	105.2	25.8	15.9	12.8	3.3	4.1	2.3	20.5	18.3	13.2	7.5	0.8	14.3	6.1	17.4	19.8	5.6	4.5	4.0	21.5	2.7	2.6	13.0	18.2	10.8	6.5	21.2	8.2	34.4	1.3	1.9	5.8	3.0	23.2	7.8	30.1	0.0	0.6	1.3	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.2	2.3	0.5	0.6	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	15.5	0.0	0.0	0.8	0.0	0.1	0.0	0.3	2.7	5.2	0.5	1.8	1.6	0.0	0.5	0.1	1.7	0.0	0.1	0.0	0.1	1.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	97.7	13.9	43.9	25.8	15.9	20.5	18.3	17.4	10.8	34.4	30.1	0.3	0.0	0.0	8.1	0.1	0.3	0.1	0.2	0.0	21.8	0.4	5.8	75.5	8.6	0.0	7.3	0.0	1.4	0.0	2.6	0.0	15.9	0.9	1.5	7.1	1.8	0.0	0.0	34.0	6.9	4.0	5.2	0.0	4.0	0.0	4.6	3.9	0.1	0.3	0.0	44.0	0.3	0.0	0.0	0.3	3.0	20.5	0.1	0.0	6.5	1.0	1.0	0.0	19.1	89.7	0.4	59.6	73.7	0.0	0.1	0.3	0.8	0.0	2.2	65.7	0.6	21.4	0.8	6.3	0.2	0.9	12.4	0.2	1.0	2.0	0.1
ADCY6	AC6	ENSG00000174233	"Adenylate cyclase 6"	O43306	12	48766194-48789089	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018365	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB018365: AB_2257941"	"unprognostic (1.18e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.48e-2)"	43.2	15.0	8.9	6.1	7.9	1.3	23.7	5.0	9.2	19.3	10.3	26.3	18.7	20.7	19.0	10.3	17.1	13.9	57.2	8.0	11.2	21.1	9.6	13.5	3.9	5.5	5.4	22.3	22.3	20.7	14.6	14.5	6.6	16.3	20.3	5.7	33.5	16.5	12.1	15.3	21.4	13.6	1.9	4.8	25.1	4.0	14.4	2.8	17.9	12.7	3.2	12.3	12.8	6.4	14.0	25.9	30.2	18.9	32.0	15.9	32.0	16.7	17.1	19.8	13.8	45.7	45.3	0.0	37.2	15.3	8.2	10.9	9.2	11.6	7.9	0.1	13.4	12.5	37.8	8.4	17.6	0.0	10.1	20.0	13.6	17.1	6.5	37.9	18.7	0.8	1.7	4.5	15.6	23.1	0.0	0.5	10.3	21.6	12.3	4.6	11.4	7.7	23.4	41.5	4.5	18.4	17.2	68.0	15.2	13.3	53.3	3.5	21.1	18.3	13.1	9.7	7.4	7.0	3.7	0.4	16.9	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	7.9	5.0	9.2	8.0	11.2	5.5	5.4	6.6	1.9	14.4	6.4	11.6	0.0	6.4	18.3	0.6	2.7	3.3	7.5	4.0	10.1	22.7	15.0	8.2	7.2	9.8	18.4	20.9	7.4	0.4	38.8	0.0	5.8	0.8	6.8	8.0	8.1	8.4	0.0	17.5	4.0	2.7	7.6	14.3	11.3	1.3	14.6	5.0	7.7	2.5	10.1	18.8	24.9	8.2	0.6	2.8	1.1	11.5	0.7	7.2	7.5	0.6	3.4	0.0	15.1	7.0	9.5	30.3	9.4	0.3	6.3	26.0	2.8	5.8	9.3	19.7	9.5	26.6	1.9	1.7	3.6	2.0	5.1	0.8	13.9	23.7	9.3
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.8;granulocytes: 50.6;Kupffer cells: 65.1;Langerhans cells: 48.0;Macrophages: 45.4;Microglial cells: 52.5;monocytes: 42.4;NK-cells: 76.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 81.0;HMC-1: 194.6;RPMI-8226: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	8.1	3.9	6.8	23.9	7.3	24.7	5.6	7.8	8.8	3.9	6.9	8.2	4.1	3.7	2.3	14.3	7.6	12.4	5.5	6.2	10.6	1.6	3.8	23.3	27.1	14.4	11.4	19.4	2.0	1.6	2.0	14.5	12.8	2.7	8.8	0.8	4.0	2.1	2.2	13.7	8.6	7.8	10.9	29.7	7.8	1.9	12.9	19.3	2.4	3.5	24.5	7.6	4.7	19.1	16.3	18.5	0.7	2.6	1.9	24.0	1.7	9.7	4.5	8.1	7.0	23.4	28.4	4.2	25.4	41.0	0.5	50.5	22.3	10.0	8.9	50.7	6.9	81.0	18.4	5.8	20.6	10.6	194.6	12.0	8.5	5.7	8.3	4.4	2.3	17.7	30.4	7.9	10.5	9.2	5.8	34.9	3.5	8.4	31.1	5.7	7.1	100.6	5.0	1.1	4.0	9.8	5.4	2.0	4.8	4.4	0.1	38.7	17.6	0.9	25.5	2.9	3.6	0.3	0.6	8.5	9.3	32.6	3.4	9.2	7.6	2.8	6.9	10.7	5.1	2.8	2.9	5.2	12.2	3.3	2.5	3.6	4.1	9.5	18.1	6.8	4.4	5.6	6.8	7.3	7.8	8.8	6.2	10.6	14.4	11.4	12.8	10.9	12.9	19.1	1.4	19.2	35.9	2.0	15.4	3.7	0.4	0.6	1.2	1.2	1.3	2.8	1.0	0.0	7.9	0.0	6.2	11.6	42.8	3.3	0.0	1.9	1.5	6.7	6.5	1.9	0.0	12.4	6.4	0.2	1.8	9.2	3.6	13.6	50.6	4.7	1.4	0.5	35.2	0.0	3.8	0.7	0.0	65.1	48.0	1.3	0.6	45.4	5.4	52.5	42.4	0.5	76.2	3.5	0.7	4.2	10.4	1.2	15.6	0.5	0.1	0.2	1.0	0.8	6.6	28.3	2.2	0.0	1.5	7.2	4.0	4.0	26.6	16.0	2.3	1.3
ADCY8	"AC8, ADCY3, HBAC1"	ENSG00000155897	"Adenylate cyclase 8"	P40145	8	130780301-131040909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 29.4;epididymis: 22.8"	"Group enriched"	"Detected in some"	5	"Astrocytes: 151.8;Inhibitory neurons: 250.9;Oligodendrocyte precursor cells: 138.7"	"Group enriched"	"Detected in some"	5	"glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;GAMG: 8.2;U-138 MG: 17.6;U-87 MG: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018652, HPA024291"	Supported					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB018652: AB_633654, HPA024291: AB_1844597"	"unprognostic (5.59e-3)"				"unprognostic (3.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"		0.0	0.0	17.0	0.0	13.4	0.0	0.5	19.7	9.6	0.4	1.7	0.0	0.0	0.0	22.8	0.0	3.9	0.0	0.0	11.9	14.0	0.2	0.0	1.2	0.0	17.2	22.6	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	3.1	1.1	1.4	0.1	2.1	0.0	0.5	25.9	0.0	0.1	0.5	29.4	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.1	1.3	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.6	0.4	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	13.4	19.7	9.6	11.9	14.0	17.2	22.6	15.2	25.9	29.4	23.3	0.0	0.0	1.5	151.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.1	0.0	138.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116442	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.4;skeletal muscle: 52.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.3;Inhibitory neurons: 72.7;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	6.9	5.6	5.1	4.4	7.6	1.5	6.1	3.2	7.5	8.2	45.4	8.2	8.2	8.0	2.4	8.4	9.2	6.9	14.9	10.7	0.0	9.4	11.9	14.0	1.9	3.0	0.6	11.2	15.8	9.1	5.1	9.9	0.9	4.4	6.8	2.9	11.9	5.8	52.9	5.9	9.6	7.9	0.1	4.4	6.4	4.0	1.3	2.1	18.8	28.6	2.6	9.7	6.1	5.2	8.5	12.9	3.8	7.0	13.3	16.0	5.6	14.5	15.1	8.0	6.3	10.6	7.2	0.0	21.8	40.1	4.8	8.0	14.9	9.1	5.4	10.4	14.3	0.3	29.4	20.3	14.2	1.1	6.4	17.1	13.6	9.3	4.9	6.6	5.4	2.7	4.7	0.0	8.3	15.3	0.1	4.4	6.9	3.6	6.9	13.3	18.0	0.4	2.9	2.3	8.7	3.8	11.3	13.2	9.6	4.2	33.5	15.0	4.9	15.8	4.3	15.6	6.4	3.2	2.1	1.7	3.4	4.4	6.3	0.8	0.3	0.2	0.4	0.3	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.3	5.1	7.6	3.2	7.5	10.7	0.0	3.0	0.6	0.9	0.1	1.3	5.2	7.0	12.8	12.8	33.3	1.0	6.4	1.1	3.9	5.2	10.6	4.2	3.7	17.3	22.8	7.1	12.9	12.5	1.8	5.8	19.5	0.0	4.5	0.8	6.1	10.5	6.3	1.2	0.4	95.3	5.3	1.8	8.1	1.5	5.7	0.0	15.3	8.2	19.9	1.5	1.7	72.7	7.6	2.0	4.7	2.0	2.2	8.4	3.3	7.2	31.9	2.6	5.5	4.1	42.3	12.5	3.5	4.3	7.5	2.5	1.1	15.0	5.6	9.5	14.9	0.0	9.4	12.5	1.1	5.0	0.9	3.8	1.0	3.4	4.8	7.2	1.3
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904871-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 13.4;granulocytes: 43.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065887	Supported	Supported			"Secreted in other tissues"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	1.8	0.2	1.9	10.9	2.6	0.0	1.3	0.3	2.9	2.1	0.0	1.8	0.1	3.0	0.0	1.3	0.4	7.1	0.5	2.7	21.7	0.5	0.2	1.6	1.0	31.9	6.8	0.1	4.8	0.2	3.5	0.1	13.7	1.4	1.1	0.3	1.9	0.5	0.2	0.7	1.3	1.0	5.4	0.1	1.5	2.5	17.7	0.4	0.2	0.0	1.0	2.3	1.3	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.3	2.9	2.7	21.7	31.9	6.8	13.7	5.4	17.7	2.0	0.2	3.2	0.6	0.3	0.0	0.6	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	13.4	0.0	0.0	2.4	0.0	0.0	43.1	0.0	0.4	0.0	0.1	0.0	0.5	0.0	4.1	0.0	0.9	1.5	0.3	0.2	0.0	1.9	0.0	0.2	0.0	0.5	1.1	2.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.6	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.2
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052308-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 57.1;Inhibitory neurons: 45.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	7.4	11.4	91.8	2.3	79.8	0.0	4.0	53.4	57.6	13.1	3.5	7.1	0.8	5.3	1.5	2.9	29.5	1.3	3.8	69.7	106.5	0.1	0.2	0.8	0.1	96.0	102.7	1.8	1.6	1.6	9.8	0.0	88.9	1.8	1.3	2.7	2.2	3.2	1.3	1.1	2.2	3.7	67.9	0.5	3.5	1.6	148.0	0.8	2.1	8.0	0.8	1.8	4.3	43.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	7.4	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.6	0.8	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	79.8	53.4	57.6	69.7	106.5	96.0	102.7	88.9	67.9	148.0	43.7	4.2	0.0	0.0	57.1	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.7	0.0	0.0	10.8	0.0	0.0	4.6	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.7	0.9	11.5	0.0	1.8	2.8	0.0	0.0	0.0	11.6	1.5	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	5.8	0.3	1.5	0.0	0.3	0.0	0.2	0.1	0.0	0.1
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 66.5;brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4"	"Group enriched"	"Detected in many"	5	"glioma: 5.2;testis cancer: 11.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.2;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.8	1.7	19.5	1.9	21.0	66.5	0.9	14.6	52.8	0.7	0.0	0.9	0.1	0.5	0.3	1.4	0.7	0.3	0.9	18.7	10.8	0.4	0.2	0.9	2.5	14.0	0.2	0.2	1.7	0.2	4.0	0.7	9.5	0.5	0.3	16.0	0.2	0.2	0.8	0.3	0.9	1.0	0.0	1.2	0.3	2.8	0.9	0.7	1.4	1.0	2.2	0.5	0.6	9.6	17.6	20.5	0.8	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	2.7	12.3	0.0	33.9	0.0	0.0	0.1	20.1	1.7	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	8.0	0.0	33.1	46.5	0.0	0.0	0.1	0.2	1.6	86.7	0.0	0.4	0.0	0.5	41.7	5.7	0.0	42.8	19.3	21.6	0.1	0.1	9.4	0.1	10.7	0.8	0.2	0.9	0.0	47.1	14.1	17.0	0.0	0.7	7.1	7.9	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.0	1.7	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.3	19.5	21.0	14.6	52.8	18.7	10.8	14.0	0.2	9.5	0.0	0.9	9.6	2.8	0.0	0.5	1.0	4.2	0.1	0.3	0.0	0.0	23.3	0.2	0.0	2.5	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.1	31.7	0.1	0.2	3.9	0.0	74.1	70.1	1.1	0.2	1.0	1.1	0.1	0.0	0.0	2.9	0.0	0.2	139.7	51.8	0.0	0.0	1.0	0.4	62.4	0.9	0.6	1.8	2.8	0.8	0.8	0.0	17.6	1.8	0.3	0.0	0.7	0.1	0.6	0.0	0.0	0.0	8.7	0.0	0.6	0.3	3.5	6.8	0.0	0.1	0.3	0.5	1.5	0.0	1.3
ADD3	ADDL	ENSG00000148700	"Adducin 3"	Q9UEY8	10	109996368-110135565	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 449.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.2;ASC TERT1: 292.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009797, HPA035696"	Supported		Supported	"Plasma membrane"		NA	NA		260000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB009797: AB_2223583, HPA035696: AB_2674740"	"unprognostic (2.66e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.42e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.37e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.92e-2)"	57.7	21.7	105.6	38.8	97.2	37.5	89.4	88.6	129.3	57.6	65.9	58.2	71.9	24.9	62.4	39.0	47.6	72.0	59.9	113.3	108.1	102.7	27.8	38.4	70.9	107.3	94.8	46.4	67.9	18.8	25.3	36.6	102.0	32.7	66.0	99.4	59.1	31.8	9.6	33.6	85.4	23.9	105.2	40.0	63.7	51.5	95.6	87.4	87.7	25.6	65.4	42.3	40.1	122.4	29.2	6.0	41.7	19.8	313.2	292.1	17.7	41.2	110.9	25.4	49.9	60.3	90.6	89.9	45.2	63.9	26.4	10.0	37.3	27.1	39.5	9.0	46.5	8.8	28.5	45.9	35.5	30.5	66.0	142.5	12.9	63.3	2.6	96.4	37.8	109.9	23.5	48.7	46.7	0.8	32.3	31.0	25.8	69.2	15.3	27.7	58.2	4.8	65.7	14.2	6.1	67.9	27.6	8.9	66.5	62.2	10.7	11.4	9.5	16.0	42.0	33.5	9.1	68.9	31.5	82.7	47.8	16.2	27.7	139.5	29.6	98.0	68.8	26.5	55.7	51.4	72.9	59.1	24.8	42.9	83.2	67.6	47.1	73.4	32.6	16.3	73.3	94.9	105.6	97.2	88.6	129.3	113.3	108.1	107.3	94.8	102.0	105.2	95.6	122.4	67.3	22.4	52.9	449.2	110.6	55.7	35.9	77.4	38.7	26.8	56.0	34.4	128.2	74.4	85.5	36.8	60.5	55.6	112.7	125.2	60.7	27.2	51.4	70.3	76.0	77.7	102.4	32.6	83.4	61.1	12.1	182.4	100.9	56.0	26.0	18.8	126.7	12.2	25.7	116.1	141.1	71.6	48.8	88.5	41.1	25.7	226.5	66.3	58.7	70.3	65.3	339.0	151.4	236.8	279.6	59.8	167.1	251.3	68.4	38.4	135.2	162.2	151.9	121.7	65.7	27.6	36.2	122.7	62.1	53.2	50.6	22.3	111.5	30.9	166.7	98.6
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598967-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 6.0;fallopian tube: 7.5;testis: 26.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HDLM-2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.3	0.1	0.4	6.0	0.3	0.0	0.1	0.2	0.0	7.5	0.0	0.0	0.8	0.8	0.0	0.0	1.4	0.0	5.5	3.8	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	26.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	0.1	0.8	0.8	5.5	3.8	2.4	3.0	1.0	1.0	0.0	3.2	1.5	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	9.5	0.0	4.2	0.0	0.0	0.4	0.0	0.0	305.4	57.1	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	2.0	0.0	1.9	74.8	2.8	0.4	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.3	2.6	0.0	0.1	0.0	0.1	92.5	0.1	0.0	0.0	0.9	68.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	0.0
ADGRA1	"GPR123, KIAA1828"	ENSG00000197177	"Adhesion G protein-coupled receptor A1"	Q86SQ6	10	133070929-133131675	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	13	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"RH-30: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042773	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042773: AB_10794764"		"unprognostic (8.31e-2)"			"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.29e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.66e-1)"			0.0	3.8	16.3	0.0	14.2	0.0	0.0	3.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	18.8	15.2	0.4	0.2	0.1	0.0	9.8	18.5	0.0	0.1	0.0	2.8	0.0	10.9	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.7	38.4	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	14.2	3.3	27.5	18.8	15.2	9.8	18.5	10.9	4.2	38.4	15.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.5	0.0	2.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	29.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRA2	"DKFZp434C211, DKFZp434J0911, FLJ14390, GPR124, KIAA1531, TEM5"	ENSG00000020181	"Adhesion G protein-coupled receptor A2"	Q96PE1	8	37784191-37844896	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.6;Endometrial stromal cells: 49.4;Fibroblasts: 36.4;Hepatic stellate cells: 31.4;Leydig cells: 56.5;Microglial cells: 24.4;Muller glia cells: 25.0;Peritubular cells: 41.8;Sertoli cells: 46.0;Smooth muscle cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 83.6;ASC TERT1: 64.8;BJ hTERT+: 75.2;fHDF/TERT166: 77.6;HSkMC: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012393	Uncertain					NA	NA		270000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA012393: AB_1849256"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.18e-7)"	"unprognostic (2.65e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.60e-3)"	29.1	4.8	10.0	12.2	8.6	2.0	26.4	8.7	10.1	59.8	5.9	24.1	7.7	45.1	18.2	24.8	43.8	26.2	17.6	9.8	6.5	9.6	4.3	16.2	7.7	7.7	8.3	35.9	5.5	2.2	10.0	48.7	7.8	44.4	8.2	6.7	9.0	54.9	6.6	13.1	12.8	27.8	7.0	11.9	12.3	3.5	11.2	5.2	11.3	8.3	5.6	39.6	32.0	6.6	0.2	2.3	0.3	4.7	83.6	64.8	0.6	38.5	75.2	4.6	12.4	0.5	0.2	0.0	6.9	77.6	3.1	0.9	3.5	0.2	1.5	1.6	1.8	0.2	2.2	0.2	38.1	0.0	0.0	39.4	0.4	3.4	0.8	3.3	22.3	3.0	0.2	0.7	1.2	1.2	0.1	8.0	3.5	0.0	0.6	6.5	4.2	0.4	0.0	0.1	0.3	18.1	1.0	0.2	5.7	17.7	0.2	16.9	18.2	7.6	9.6	11.2	3.5	6.2	0.5	0.1	1.0	20.3	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.6	8.7	10.1	9.8	6.5	7.7	8.3	7.8	7.0	11.2	6.6	30.6	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	1.0	1.0	1.1	1.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.9	0.1	0.2	1.5	49.4	17.8	0.0	0.0	7.8	1.6	0.6	36.4	0.0	2.2	0.0	0.1	31.4	0.1	2.1	0.0	7.8	0.2	0.0	1.6	0.0	3.1	56.5	1.5	0.0	24.4	1.0	25.0	1.0	3.0	0.8	0.3	0.1	41.8	0.1	0.3	0.0	0.0	0.0	0.7	46.0	5.5	36.0	0.3	0.8	0.5	0.0	2.3	0.4	2.6	0.3	0.2
ADGRA3	"FLJ38547, GPR125, PGR21"	ENSG00000152990	"Adhesion G protein-coupled receptor A3"	Q8IWK6	4	22345071-22516066	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 221.7;Hepatocytes: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008904	Uncertain				"Intracellular and membrane"	NA	NA		280000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA008904: AB_1849258"	"unprognostic (3.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-3)"	8.1	9.5	22.9	3.7	21.5	1.9	10.9	21.6	19.2	10.9	43.8	17.1	7.2	15.1	9.6	5.2	21.6	7.6	10.8	21.8	27.2	10.4	58.3	5.0	1.2	24.5	34.7	8.9	12.5	12.2	7.3	9.2	24.2	12.0	17.1	5.9	8.2	11.5	17.6	4.4	7.0	14.0	26.8	2.7	9.6	6.8	25.6	5.1	25.1	11.4	2.6	5.7	4.9	24.1	19.6	14.4	36.5	30.6	29.0	13.0	32.7	23.5	25.7	15.5	8.4	16.5	38.1	3.0	11.7	11.2	21.5	21.1	23.2	33.4	22.1	0.0	16.3	1.7	11.3	37.0	9.7	17.1	0.0	12.3	40.9	10.1	17.5	29.5	23.7	12.2	17.9	0.6	26.1	8.7	15.3	0.5	40.3	18.3	14.6	70.7	74.6	4.9	18.8	19.9	27.1	31.3	9.8	0.8	16.7	25.1	10.1	14.8	0.5	23.2	16.6	10.6	22.4	2.7	0.0	0.1	12.7	12.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.9	21.5	21.6	19.2	21.8	27.2	24.5	34.7	24.2	26.8	25.6	24.1	2.4	3.2	4.1	221.7	1.1	0.0	13.4	0.0	11.4	11.8	12.0	14.6	14.5	21.5	5.0	16.5	20.9	21.8	2.3	18.8	0.0	18.4	7.9	50.1	23.2	3.1	12.2	9.1	12.3	11.8	7.9	10.2	10.2	41.4	0.0	28.5	6.1	120.4	3.4	0.0	18.9	18.8	0.0	5.4	0.0	7.4	9.6	1.8	0.0	9.4	0.4	6.2	0.0	54.3	3.5	20.3	12.2	9.8	0.2	21.0	10.6	5.4	2.2	13.5	0.0	25.7	8.0	1.3	7.2	2.5	0.0	7.3	1.3	11.7	22.2	11.1
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.5;Cardiomyocytes: 47.0;Early spermatids: 16.2;Endometrial stromal cells: 50.2;Fibroblasts: 32.7;Late spermatids: 21.4;Leydig cells: 13.7;Microglial cells: 25.3;Peritubular cells: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.0;intermediate monocyte: 2.3;myeloid DC: 1.1;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;fHDF/TERT166: 4.7;HeLa: 7.6;HHSteC: 4.9;HMC-1: 13.0;U-2 OS: 6.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.1"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	26.4	1.9	1.9	1.3	2.0	0.3	10.3	1.2	2.5	20.6	1.0	10.6	1.9	15.4	7.3	6.9	17.7	12.9	62.4	1.4	3.2	3.4	10.3	35.6	0.4	2.0	2.6	17.9	12.0	0.3	6.3	25.7	2.2	15.3	1.8	0.8	2.9	1.0	7.3	7.0	12.1	7.1	2.0	2.3	20.7	7.5	3.6	0.4	11.2	8.5	1.0	40.3	16.3	1.7	0.0	0.7	0.0	2.0	0.0	0.0	0.1	4.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	4.9	0.0	13.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.8	0.0	0.1	0.2	2.1	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.4	6.1	1.5	0.1	0.1	1.7	0.8	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	1.9	2.0	1.2	2.5	1.4	3.2	2.0	2.6	2.2	2.0	3.6	1.7	2.0	22.4	30.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	47.0	0.0	5.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	16.2	1.3	50.2	3.4	0.0	0.0	1.1	0.4	0.6	32.7	0.5	1.0	1.3	0.3	1.8	3.6	2.3	0.0	1.4	0.0	0.0	1.5	0.0	21.4	13.7	1.5	0.0	25.3	3.5	0.0	0.0	0.0	0.1	0.3	0.0	15.8	0.0	0.0	0.0	0.1	2.2	0.7	6.6	2.2	3.5	4.3	6.5	0.1	0.0	1.0	0.6	0.2	0.1	0.3
ADGRE1	"EMR1, TM7LN3"	ENSG00000174837	"Adhesion G protein-coupled receptor E1"	Q14246	19	6887566-6940459	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.8;lymphoid tissue: 14.8"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 31.5;Macrophages: 13.2;monocytes: 13.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 166.4;eosinophil: 324.9"	"Group enriched"	"Detected in many"	18	"granulocytes: 324.9;monocytes: 105.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.9;BJ hTERT+: 10.5;GAMG: 10.9;HDLM-2: 26.5;HMC-1: 18.1;Karpas-707: 22.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA052809	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA052809: AB_2681959"	"unprognostic (2.06e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.93e-5)"	"unprognostic (6.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-7)"	"unprognostic (6.69e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.35e-1)"	1.9	0.1	0.3	7.3	0.3	6.8	0.2	0.2	0.7	0.1	0.4	0.9	2.9	0.2	1.1	0.1	0.2	1.0	0.2	0.2	0.7	0.3	2.6	4.6	1.5	1.3	0.9	0.0	0.1	0.2	0.1	1.3	0.7	0.2	0.7	0.0	0.2	0.1	0.1	0.0	2.9	1.9	0.5	14.8	1.0	0.9	0.3	3.4	0.1	0.1	1.5	4.0	0.0	0.9	2.8	7.9	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	10.9	0.0	0.0	0.0	0.0	26.5	0.0	0.1	0.0	0.0	0.0	0.6	18.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	22.3	0.0	0.2	0.7	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	0.3	0.4	0.2	1.1	4.2	0.1	5.1	5.2	0.0	166.4	21.1	324.9	0.1	58.6	0.3	0.1	7.2	0.9	12.0	0.1	8.9	0.6	7.9	0.9	105.0	0.5	2.2	10.0	0.3	0.3	0.2	0.7	0.2	0.7	1.3	0.9	0.7	0.5	0.3	0.9	0.0	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.8	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.3	1.8	0.0	0.6	0.0	0.0	31.5	0.0	0.4	0.0	13.2	0.0	0.0	13.2	0.0	1.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	1.3	0.0	0.0	0.1	0.8	0.1	0.0	0.1
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.1;lymphoid tissue: 6.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.4;Astrocytes: 2.0;Excitatory neurons: 1.9;granulocytes: 2.5;Inhibitory neurons: 2.4;Macrophages: 8.0;Microglial cells: 3.7;monocytes: 3.2;Oligodendrocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 281.6;eosinophil: 509.0;neutrophil: 489.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 509.0"	"Cell line enriched"	"Detected in some"	36	"HMC-1: 43.3"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.2	0.1	0.0	6.1	0.0	3.1	0.0	0.0	0.5	0.2	0.0	0.4	1.6	0.1	0.0	0.3	0.3	1.0	0.1	0.0	0.0	0.1	0.6	2.5	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.2	0.2	0.5	0.0	1.8	0.0	0.0	0.0	2.3	0.7	0.0	5.9	0.5	0.1	0.1	0.4	0.1	1.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	281.6	21.8	509.0	0.0	52.9	0.1	0.6	0.2	0.0	5.3	0.1	0.1	0.1	489.4	0.0	61.3	0.3	0.1	7.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	8.0	0.0	3.7	3.2	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 211.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 245.4;Kupffer cells: 111.1;Macrophages: 131.6;NK-cells: 160.6;Plasma cells: 141.5;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	2400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	45.6	21.4	4.7	79.5	7.6	211.6	21.5	7.8	6.3	60.9	4.0	52.7	43.6	143.6	7.0	15.1	48.9	33.2	30.4	4.8	6.0	28.0	19.9	80.2	58.2	9.6	7.4	14.6	31.4	6.1	7.5	32.7	8.4	17.0	29.7	0.4	22.1	10.4	29.5	14.9	51.0	75.3	6.6	145.0	40.5	3.4	9.0	32.5	21.3	13.5	32.0	42.2	29.3	12.1	118.1	81.9	0.8	77.2	33.3	54.1	12.2	79.6	127.0	56.0	61.0	23.5	115.9	13.5	78.5	103.1	79.6	27.2	21.0	38.8	25.0	73.4	23.7	26.4	113.0	10.4	41.0	57.4	117.3	23.9	1.0	57.1	19.4	18.2	5.6	22.7	35.0	101.9	61.9	26.6	3.7	76.3	2.3	92.7	100.4	7.8	33.7	61.8	18.7	10.4	1.0	2.8	45.4	64.1	57.9	1.8	16.7	52.3	14.0	19.0	31.1	79.5	133.2	0.2	0.4	1.1	67.6	100.4	72.0	371.6	158.5	772.8	187.5	281.4	123.9	28.5	94.2	129.6	102.6	18.5	65.5	91.9	623.2	179.2	352.9	48.4	70.6	242.4	4.7	7.6	7.8	6.3	4.8	6.0	9.6	7.4	8.4	6.6	9.0	12.1	10.0	35.3	93.1	1.3	88.6	0.0	8.5	0.0	2.2	0.5	7.2	6.7	3.7	12.8	17.3	0.0	0.0	4.1	245.4	25.8	0.0	18.1	0.1	16.1	26.9	13.1	4.9	25.7	1.4	22.5	46.3	20.0	49.5	13.3	77.0	1.4	23.9	2.9	50.8	0.0	1.8	25.9	0.0	111.1	0.0	1.4	6.5	131.6	0.0	6.5	55.3	2.6	160.6	2.0	11.2	21.2	30.6	4.9	141.5	12.8	17.8	0.9	27.7	1.5	26.3	34.6	23.1	0.5	5.3	3.2	0.0	7.9	184.3	3.7	29.1	17.6
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997708-47042350	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 17.5;kidney: 20.3;urinary bladder: 42.6"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 108.5;Pancreatic endocrine cells: 98.9;Urothelial cells: 363.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.2;CAPAN-2: 113.3;HaCaT: 25.3;PC-3: 36.6;RPTEC TERT1: 50.9;RT4: 132.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038438	Approved				"Secreted - unknown location"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	3.4	0.0	0.3	0.0	0.2	0.1	17.5	0.8	6.1	0.0	0.0	0.0	20.3	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.0	0.1	0.0	3.2	1.7	0.0	0.0	3.2	0.0	0.0	0.0	1.4	0.6	0.0	0.1	6.2	0.0	5.9	42.6	6.4	0.0	31.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.3	0.0	2.0	0.0	0.0	25.3	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	36.6	0.0	0.0	0.0	50.9	132.6	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	21.8	0.0	0.1	0.0	25.4	0.0	0.6	0.0	5.5	1.9	0.7	12.8	13.6	108.5	0.0	0.0	0.0	1.5	23.5	30.8	0.0	7.0	5.0	0.7	0.0	0.0	0.1	18.9	0.1	0.8	3.6	46.9	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	0.0	0.0	0.0	39.1	1.2	0.7	14.6	0.0	0.0	0.2	1.1	0.0	0.2	2.6	0.0	0.1	1.0	0.1	0.2	363.7
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.0;skin 1: 2.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Early spermatids: 1.0;Endometrial ciliated cells: 1.6;Excitatory neurons: 1.2;Glandular and luminal cells: 1.3;Squamous epithelial cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA035507	Uncertain					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 44: Endometrium - Transcription"			"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.6	0.1	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.3;skin 1: 38.8"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Pancreatic endocrine cells: 20.5;Prostatic glandular cells: 6.0;Squamous epithelial cells: 14.4;Syncytiotrophoblasts: 7.3;Urothelial cells: 20.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.2"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;HBEC3-KT: 21.0;hTCEpi: 31.8;OE19: 18.4;U-87 MG: 26.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.2	0.7	0.0	0.2	0.0	0.0	2.2	0.4	0.1	4.7	0.0	1.2	0.0	0.3	0.0	18.3	1.1	0.7	0.6	0.0	1.9	0.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	2.0	0.0	0.2	1.5	0.0	2.4	0.0	0.6	38.8	0.2	0.1	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.9	4.1	4.3	9.6	0.0	8.9	1.2	0.0	0.0	0.0	0.0	1.0	0.0	5.1	0.1	0.0	2.4	0.0	0.0	0.0	0.0	8.2	13.2	0.0	21.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	31.8	0.4	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	18.4	1.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.0	0.8	0.1	1.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	4.4	0.0	3.5	0.7	1.6	0.3	0.2	0.0	0.0	0.6	3.4	15.1	0.4	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.5	0.0	0.0	6.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	14.4	0.0	7.3	0.0	0.0	0.1	20.5
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 216.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 160.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 160.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	50.9	13.2	79.6	12.7	67.7	19.6	50.5	46.9	115.2	36.3	0.0	36.7	26.1	19.7	84.2	46.7	52.2	69.6	36.8	68.7	71.5	158.9	4.2	37.3	5.2	64.6	76.2	5.3	59.8	28.4	17.7	101.3	73.9	31.7	33.4	6.6	92.2	57.5	15.7	87.5	19.3	19.8	54.8	12.3	47.9	45.4	92.5	28.9	216.3	16.9	15.6	37.1	37.8	51.6	41.8	47.1	12.0	0.6	0.0	0.1	127.7	8.5	3.9	14.4	2.6	34.7	218.4	0.2	110.5	8.2	196.1	149.1	0.0	103.4	5.1	1.6	0.0	5.1	56.0	39.3	0.3	0.4	2.1	2.4	143.8	24.5	10.2	15.8	118.1	1.0	0.1	1.2	3.2	51.4	107.3	0.8	1.7	143.3	42.6	3.8	1.4	30.8	209.4	134.9	38.2	1.2	2.0	277.7	297.8	8.4	123.8	0.8	241.4	25.6	38.0	1.5	96.2	0.2	2.1	0.6	200.5	0.7	62.9	2.9	0.8	0.2	160.3	0.5	1.9	0.3	10.5	62.6	0.2	0.1	5.3	45.2	3.3	30.6	0.7	0.3	0.2	37.1	79.6	67.7	46.9	115.2	68.7	71.5	64.6	76.2	73.9	54.8	92.5	51.6	107.7	9.6	11.9	113.9	3.7	0.0	24.1	0.0	11.4	0.9	29.6	27.2	4.3	15.7	21.7	79.1	0.0	222.5	120.4	17.7	27.4	33.9	74.0	24.6	4.3	53.9	20.6	17.7	3.5	170.7	25.1	4.7	29.0	45.2	5.1	88.2	30.0	0.5	22.8	0.0	4.9	23.2	0.0	3.5	0.0	31.3	3.1	6.1	0.0	41.2	1.1	4.8	208.1	85.5	1.3	101.1	12.3	0.0	19.1	15.2	5.6	132.6	16.8	0.5	0.0	1.6	7.1	2.7	0.9	23.0	0.0	186.5	35.1	0.4	24.6	19.5
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668277-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 147.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 10.6"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 142.3;neutrophil: 169.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 169.8"	"Group enriched"	"Detected in some"	6	"NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040469	Uncertain					NA	NA		1200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA040469: AB_10794032"	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	8.5	0.3	0.1	14.6	0.2	147.0	1.7	0.1	10.6	1.1	0.3	1.6	2.2	1.0	0.0	1.0	4.3	2.3	1.2	0.1	0.1	0.8	2.3	12.0	0.3	0.2	0.2	0.4	0.7	0.0	0.2	1.7	2.0	0.6	1.4	0.0	0.4	0.1	0.3	0.7	3.4	2.6	0.1	29.4	1.3	0.3	0.4	0.6	3.2	2.8	0.4	3.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	75.5	0.0	142.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	36.4	0.1	0.0	0.0	0.9	0.1	0.2	0.1	10.6	0.1	0.1	0.2	0.2	2.0	0.1	0.4	0.1	1.0	9.6	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	1.8	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.6	0.5	0.2	2.8	0.0	5.3	0.1	0.0	0.1	0.9	0.0	0.4	2.5	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.2	1.5	0.0	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.1	4.2	0.0	0.0	0.1
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416890	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.0;intestine: 2.5;retina: 1.2"	"Group enriched"	"Detected in some"	10	"Horizontal cells: 42.1;Paneth cells: 47.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA035324	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 62: Horizontal cells - Visual perception"			"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.2	0.3	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.1	0.1	2.9	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542643-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 3.9;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 32.0;Microglial cells: 11.2;NK-cells: 43.3;Plasma cells: 16.4;T-cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 125.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 39.4;OE19: 13.2;RPMI-8226: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.3	0.3	0.3	5.0	0.2	1.4	0.7	0.2	0.2	0.2	0.1	1.7	3.7	0.3	0.1	0.6	0.5	0.1	0.0	0.3	0.4	0.0	0.2	0.9	10.5	0.8	0.4	0.0	0.0	0.1	0.2	0.0	0.6	0.3	1.3	0.0	1.3	0.3	0.1	0.1	3.9	0.3	0.6	5.8	0.4	0.4	0.4	1.6	0.3	0.0	10.5	1.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	3.6	3.6	13.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.1	125.9	33.3	0.1	16.9	12.0	4.8	19.1	2.4	8.6	1.2	11.2	0.5	29.9	0.1	68.8	0.2	9.0	0.3	0.2	0.2	0.2	0.3	0.4	0.8	0.4	0.6	0.6	0.4	0.3	0.3	0.0	1.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.6	0.0	0.3	0.0	3.2	0.0	11.2	1.7	0.0	43.3	0.0	0.3	0.0	0.0	0.0	16.4	0.1	2.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	7.1	0.0	0.7	0.0
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADGRL1	"CIRL1, KIAA0821, LEC2, LPHN1"	ENSG00000072071	"Adhesion G protein-coupled receptor L1"	O94910	19	14147743-14206187	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.2;Excitatory neurons: 52.8;Horizontal cells: 35.3;Inhibitory neurons: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.8;HMC-1: 25.6;SCLC-21H: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037974	Uncertain					NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA037974: AB_10675623"	"unprognostic (5.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.52e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (7.65e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.18e-1)"	10.7	5.3	19.3	2.3	17.4	1.3	11.1	8.9	28.0	17.9	0.0	20.2	3.9	22.7	2.4	8.5	15.6	2.6	13.6	21.4	3.4	13.0	1.3	9.8	1.8	6.7	6.3	9.3	9.1	8.8	26.1	2.3	3.1	11.6	2.2	6.6	9.6	4.6	1.6	12.0	11.7	4.9	0.8	6.4	14.3	10.1	11.1	2.9	16.1	0.6	1.1	12.1	10.0	15.1	11.7	4.4	10.0	35.8	2.6	0.7	3.5	0.8	1.2	1.1	0.7	3.9	4.0	0.9	11.9	1.3	2.3	0.7	12.1	3.4	0.3	1.7	10.3	2.1	2.0	0.6	5.9	0.7	25.6	2.1	3.1	0.3	0.5	1.8	1.0	11.3	10.4	1.1	0.1	19.7	1.0	1.1	14.9	6.3	8.6	5.7	1.2	13.0	1.9	3.6	27.4	7.0	2.1	14.3	5.0	3.5	14.2	5.4	1.4	9.2	14.0	2.5	3.3	2.8	2.5	15.9	2.7	13.5	3.4	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.1	0.2	0.1	0.0	19.3	17.4	8.9	28.0	21.4	3.4	6.7	6.3	3.1	0.8	11.1	15.1	6.7	0.0	4.5	29.4	0.7	0.0	3.0	0.0	9.1	64.2	13.0	9.4	8.8	1.5	1.8	7.3	10.4	0.4	4.9	4.9	0.0	3.2	0.9	4.1	10.0	7.6	7.3	6.6	52.8	3.2	0.4	6.6	8.6	4.9	5.1	5.9	8.2	0.2	0.9	35.3	46.2	4.3	0.0	1.9	0.0	2.6	9.3	1.2	0.0	6.5	1.1	31.8	11.3	33.7	22.7	2.1	9.1	16.1	1.6	4.5	7.2	0.8	0.0	23.2	19.7	1.2	5.4	2.3	19.1	6.2	0.0	0.3	3.1	6.2	6.5	1.6
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"adrenal gland: 533.0"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	533.0	36.9	0.0	47.8	0.6	3.6	12.7	40.3	0.9	22.4	1.0	0.3	0.1	0.7	2.4	0.2	12.3	0.2	39.1	11.6	21.5	42.3	2.1	0.0	9.4	12.8	0.2	1.5	0.8	15.1	4.1	9.4	1.3	1.0	18.2	2.3	0.2	0.2	2.1	0.5	0.0	7.3	0.3	1.1	1.4	18.3	0.8	17.5	0.0	0.4	10.4	1.9	26.1	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.9	47.8	12.7	40.3	39.1	11.6	9.4	12.8	9.4	7.3	18.3	26.1	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 196.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	196.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.2	0.0	0.0	38.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
ADHFE1	FLJ32430	ENSG00000147576	"Alcohol dehydrogenase iron containing 1"	Q8IWW8	8	66432492-66468907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 31.2;skeletal muscle: 29.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cardiomyocytes: 41.6;Syncytiotrophoblasts: 116.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;RPTEC TERT1: 1.5"					"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	7.0	2.3	8.7	0.3	8.5	0.0	3.9	7.2	11.7	2.3	10.4	3.9	0.6	2.0	1.3	1.3	5.6	0.7	24.5	8.2	8.2	6.6	31.2	2.1	0.3	8.3	8.5	5.1	9.4	5.0	2.6	1.1	8.1	5.2	0.7	1.5	2.3	1.5	29.2	1.1	2.5	0.2	7.8	1.8	11.0	1.7	8.7	0.3	2.7	31.3	0.3	4.4	1.8	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	8.7	8.5	7.2	11.7	8.2	8.2	8.3	8.5	8.1	7.8	8.7	8.5	1.5	9.6	20.1	76.4	1.8	1.0	4.1	2.7	3.4	1.7	4.6	4.6	41.6	14.3	9.6	9.2	10.4	8.8	6.5	1.0	11.7	1.5	0.5	2.5	1.6	3.3	3.6	2.5	8.3	0.6	0.9	5.3	8.6	2.5	8.8	6.1	6.1	27.1	2.5	0.0	13.2	2.0	4.1	2.1	2.8	1.6	23.9	2.1	0.0	14.0	2.0	7.6	6.2	21.6	19.2	0.9	5.8	27.1	3.0	3.5	4.1	14.8	14.3	8.5	0.0	7.8	5.2	0.5	0.6	1.9	1.0	116.4	10.0	2.5	2.4	2.5
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497366-3519531	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 590.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	55.1	76.9	31.1	28.0	32.6	31.7	50.4	31.7	42.1	54.2	43.3	58.3	105.2	45.6	43.3	48.2	45.2	66.7	146.4	32.0	31.0	200.2	590.7	44.6	30.1	33.0	32.2	50.0	34.9	49.6	33.5	41.3	33.6	101.1	52.3	17.1	53.6	55.9	121.1	35.7	68.9	37.9	31.6	57.2	82.4	16.7	31.6	26.9	36.5	56.0	34.5	57.9	36.5	34.7	46.5	64.5	55.9	50.2	187.5	85.0	91.9	95.6	124.1	102.7	74.5	86.9	59.2	22.1	143.4	109.5	21.4	45.1	62.9	49.0	59.2	39.5	131.4	67.6	42.2	184.1	165.4	71.2	151.3	91.4	72.3	55.0	63.7	45.3	75.8	36.1	51.8	45.3	87.4	137.8	25.6	147.1	44.4	131.9	86.4	27.1	31.3	128.2	90.2	83.3	57.0	54.0	53.0	75.0	37.2	36.8	55.6	95.5	54.1	75.9	29.0	35.9	56.6	35.4	91.6	88.7	58.6	115.5	41.0	87.6	134.3	336.9	28.5	126.5	31.8	66.8	67.4	26.7	127.7	53.4	79.3	25.6	59.4	54.5	117.4	186.3	67.4	189.0	31.1	32.6	31.7	42.1	32.0	31.0	33.0	32.2	33.6	31.6	31.6	34.7	44.8	67.3	111.1	25.1	73.1	76.0	154.5	107.8	92.2	9.2	103.0	88.9	275.8	338.8	109.5	152.6	14.6	395.0	80.6	140.1	888.3	157.2	8.8	65.9	116.3	61.6	57.2	123.1	9.4	87.2	247.1	129.1	66.3	116.3	41.8	75.1	207.8	1234.6	263.2	8.4	15.0	146.1	236.0	168.8	67.6	23.8	137.0	90.0	204.5	7.5	108.2	197.2	40.2	5.5	19.0	79.7	272.5	210.3	97.4	143.6	409.8	1546.8	38.0	15.3	164.3	45.5	109.3	5.3	11.3	113.6	76.9	381.4	53.0	120.8	147.2	156.9
ADIG	"MGC39724, RP5-1100H13.2, SMAF1"	ENSG00000182035	Adipogenin	Q0VDE8	20	38581195-38588463	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"testis: 53.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 1714.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041124	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA041124: AB_10795534"					"unprognostic (2.97e-2)"		"unprognostic (7.69e-3)"					"unprognostic (2.27e-1)"	"unprognostic (4.52e-3)"			"unprognostic (1.34e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.5	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	409.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1714.0	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.0	6.6	0.0	0.0	5.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 898.8;breast: 248.9"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			898.8	8.9	0.1	2.4	0.1	0.2	248.9	0.2	0.1	0.0	0.0	7.7	0.1	0.1	0.0	1.2	0.1	7.6	6.5	0.0	0.0	0.8	0.1	0.1	1.3	0.1	0.0	0.0	6.2	0.1	0.1	0.0	0.1	0.3	6.1	0.1	18.8	0.0	2.3	6.6	8.5	1.2	0.0	0.0	3.9	0.1	0.1	2.2	2.9	20.2	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIPOR2	"ACDCR2, PAQR2"	ENSG00000006831	"Adiponectin receptor 2"	Q86V24	12	1688574-1788674	"Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 321.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043737	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA043737: AB_10964205"	"unprognostic (1.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.85e-2)"	55.1	72.3	36.6	10.6	49.8	9.6	44.2	46.4	48.7	25.8	28.3	32.2	22.2	24.4	8.1	45.2	23.3	9.7	33.3	35.3	40.6	22.4	79.6	44.6	9.8	50.9	46.9	25.1	31.1	16.9	26.1	13.0	49.5	20.7	17.7	13.1	22.2	11.9	42.9	31.9	32.7	12.0	41.6	19.9	44.7	27.7	44.5	12.8	28.0	19.9	12.6	21.4	29.3	67.0	34.3	28.0	23.1	21.4	21.4	25.6	30.9	24.6	28.4	31.5	44.5	42.1	51.6	24.1	7.8	23.0	56.7	26.1	34.7	35.8	44.9	62.7	28.7	47.3	22.7	30.3	21.2	36.1	29.3	22.6	35.5	39.8	45.6	28.7	23.1	25.8	31.7	50.9	23.7	48.8	23.6	32.8	46.3	28.4	14.8	19.5	43.7	18.3	31.4	19.9	6.9	16.4	22.7	43.8	51.5	39.7	24.6	46.5	23.2	17.8	37.5	28.6	36.2	12.3	16.5	39.5	21.7	32.3	24.7	0.7	0.7	1.8	0.9	0.7	0.7	0.5	0.5	0.8	0.5	0.5	0.6	0.7	0.9	0.6	0.6	0.9	0.7	0.3	36.6	49.8	46.4	48.7	35.3	40.6	50.9	46.9	49.5	41.6	44.5	67.0	81.5	12.8	32.4	39.2	21.8	23.7	25.0	26.6	22.8	11.3	29.9	20.3	22.3	31.5	36.6	14.7	18.8	13.9	32.4	91.4	11.7	22.6	56.3	17.8	15.4	41.1	37.5	38.1	35.7	31.4	42.2	21.1	61.7	30.2	36.3	28.8	28.9	113.4	18.2	18.5	41.3	49.0	32.6	27.3	18.9	77.0	15.8	32.6	26.6	124.6	27.0	32.5	27.8	32.2	321.0	39.6	49.4	22.6	30.2	27.8	41.5	10.8	21.7	16.0	6.6	21.3	25.7	45.0	42.2	29.7	34.4	29.3	26.1	39.6	33.5	29.8
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151202-74709963	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 151.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 245.3;Inhibitory neurons: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		920000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	23.9	15.5	13.0	16.9	18.7	28.6	27.4	13.5	17.7	17.5	11.6	17.9	16.9	10.8	16.5	47.3	16.5	11.4	27.2	13.9	15.2	35.8	151.2	24.4	22.8	14.0	15.0	8.3	18.8	44.2	14.9	26.6	16.5	14.9	19.5	16.1	20.0	16.0	41.5	33.9	12.4	14.8	14.2	15.0	12.1	15.5	14.1	27.0	38.2	47.1	34.5	24.5	24.7	15.8	177.3	37.4	37.2	50.5	37.1	54.7	88.2	140.8	105.4	103.8	114.5	114.0	172.6	86.3	34.2	57.7	51.3	151.1	44.1	150.1	167.0	59.1	51.3	55.6	59.8	122.8	41.7	87.6	22.5	51.1	95.5	77.4	191.7	79.0	91.2	38.7	41.8	28.4	78.8	101.7	102.5	129.0	9.9	80.0	276.3	100.6	63.7	69.4	117.1	92.7	29.5	33.8	63.6	239.7	49.5	34.7	159.7	69.3	82.8	34.3	67.0	93.2	123.0	40.5	48.3	98.1	65.0	127.6	22.1	2.3	34.2	4.1	12.9	65.5	29.9	103.7	28.2	24.1	83.1	155.0	21.3	19.2	11.1	20.7	80.4	57.6	55.7	36.3	13.0	18.7	13.5	17.7	13.9	15.2	14.0	15.0	16.5	14.2	14.1	15.8	9.8	83.3	75.8	136.5	84.2	94.2	73.5	102.0	105.9	16.3	26.2	26.0	67.8	38.6	72.4	31.3	56.3	136.7	25.9	11.0	92.0	83.2	80.7	40.6	18.8	14.9	10.8	27.7	245.3	67.5	139.5	27.0	23.0	55.6	21.5	9.7	17.2	130.1	39.3	11.8	287.7	12.1	44.7	25.2	50.0	26.9	16.8	33.7	48.0	198.6	44.1	14.1	11.3	140.8	165.4	62.7	10.4	12.0	39.1	92.1	5.0	64.5	33.5	25.0	6.6	20.4	26.0	17.4	14.3	96.7	97.0	107.3	32.7	17.0	20.5	66.3
ADM	AM	ENSG00000148926	Adrenomedullin	P35318	11	10305073-10307397	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 340.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 590.8;Extravillous trophoblasts: 1217.1;Syncytiotrophoblasts: 1084.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"neutrophil: 242.2"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 242.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 684.6;fHDF/TERT166: 357.4;HSkMC: 410.9;U-138 MG: 390.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016075, HPA068955"	Approved				"Secreted to blood"	NA	NA	31000	340000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB016075: AB_628693, HPA068955: "	"unprognostic (1.67e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (9.70e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.62e-2)"	340.2	29.9	12.9	32.2	18.3	43.9	195.9	28.1	15.2	162.1	17.9	60.6	8.0	20.3	3.1	84.6	71.0	30.0	153.3	10.6	15.5	123.8	90.5	157.6	17.1	19.7	18.0	33.1	24.6	23.5	43.3	102.8	16.5	26.8	11.4	16.7	52.7	1.6	79.3	169.8	49.5	7.6	16.8	34.5	55.5	4.9	21.6	4.1	52.7	14.3	3.5	85.1	224.3	18.6	35.4	29.2	33.8	9.8	684.6	306.7	51.8	263.6	263.9	260.5	175.7	142.4	43.9	0.1	11.7	357.4	136.9	51.0	9.5	40.6	191.9	0.7	13.9	1.1	16.1	18.0	88.0	1.6	1.1	410.9	34.7	30.8	44.6	89.9	60.4	0.5	0.4	0.7	64.3	1.2	0.2	10.6	65.7	8.4	13.6	1.0	1.1	54.5	16.7	48.6	1.1	3.2	101.0	23.7	0.6	36.4	31.4	0.3	17.9	390.0	5.5	233.2	37.9	2.7	29.5	10.5	112.0	0.2	117.0	0.0	7.0	0.0	0.0	7.7	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.1	242.2	0.0	13.6	0.0	0.3	1.9	12.9	18.3	28.1	15.2	10.6	15.5	19.7	18.0	16.5	16.8	21.6	18.6	347.7	9.6	12.3	17.0	14.2	192.1	590.8	194.4	182.1	2.7	28.0	46.9	104.6	18.6	136.2	3.7	8.4	134.6	9.1	266.7	15.6	135.7	0.5	80.8	58.1	99.1	67.5	4.0	0.4	30.5	1217.1	202.8	55.0	210.9	9.5	30.1	95.7	18.6	71.4	3.3	3.0	127.6	181.0	69.6	57.7	2.6	132.7	107.9	40.9	6.5	8.1	4.9	1.0	1.5	0.1	61.7	298.3	19.2	20.0	218.9	14.0	60.1	38.7	15.3	0.0	73.3	76.5	5.1	4.9	182.3	125.6	1084.8	14.7	8.1	55.5	224.5
ADNP	"ADNP1, KIAA0784"	ENSG00000101126	"Activity dependent neuroprotector homeobox"	Q9H2P0	20	50888916-50931437	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006371	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006371: AB_1078105"	"unprognostic (3.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.68e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-1)"	21.1	22.3	31.9	20.2	33.1	25.3	32.6	37.5	40.0	26.6	30.6	23.3	20.1	31.4	42.1	23.9	29.4	22.3	19.4	32.1	32.7	24.9	25.4	24.0	28.9	30.8	31.7	39.3	21.8	36.1	20.5	25.3	30.7	28.6	24.1	43.6	21.9	29.9	35.7	27.9	22.8	29.7	31.2	25.0	26.7	36.6	35.1	44.8	29.6	28.4	35.6	26.7	23.9	36.9	51.2	50.9	103.2	53.7	51.3	47.3	38.8	41.2	48.1	79.0	55.8	80.4	42.3	74.0	51.7	52.9	41.9	62.1	86.6	85.1	89.5	32.6	30.8	54.2	58.1	64.0	48.9	87.7	41.2	47.1	101.3	47.8	85.7	61.2	56.7	46.2	66.7	47.2	51.6	61.6	76.4	61.4	45.5	52.7	42.8	76.2	54.4	55.5	50.9	77.2	81.2	61.9	92.7	138.0	73.6	65.8	62.7	82.5	44.7	68.6	69.4	49.0	45.8	36.3	39.2	104.0	42.2	50.5	47.3	38.5	23.8	22.3	40.5	37.4	42.7	26.0	44.6	36.9	28.3	29.8	43.8	58.4	12.3	31.4	52.8	58.2	32.8	22.5	31.9	33.1	37.5	40.0	32.1	32.7	30.8	31.7	30.7	31.2	35.1	36.9	45.5	9.6	24.4	85.5	31.1	60.0	32.9	22.9	26.7	41.3	46.9	39.2	38.0	38.6	26.4	14.7	25.0	31.4	55.4	25.6	17.6	22.2	26.3	50.0	59.9	33.4	37.1	26.9	75.6	21.9	20.3	32.8	25.0	61.3	17.2	72.5	27.1	29.5	22.5	38.7	93.5	29.3	18.3	27.4	41.0	38.8	31.4	28.9	40.9	77.8	26.7	25.0	20.6	124.1	122.7	28.5	21.1	39.9	27.0	36.1	22.1	23.2	22.0	37.1	39.5	45.9	41.2	27.9	35.2	31.2	52.0	22.2	36.6	42.8	33.7	39.8
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109262-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (9.90e-4)"	"unprognostic (5.19e-2)"	8.0	6.2	17.3	6.6	13.1	41.3	8.1	7.3	31.2	6.0	9.9	7.2	9.1	7.4	10.8	8.6	6.6	7.5	8.0	10.2	9.1	6.7	7.9	7.5	7.2	15.4	10.1	8.0	8.2	9.6	6.9	6.7	14.0	6.8	6.6	12.4	6.4	6.3	2.7	12.7	6.6	7.8	9.4	6.5	7.8	22.0	18.0	9.4	8.4	4.5	7.1	7.7	6.9	15.6	23.1	17.8	36.2	27.0	8.1	11.4	27.0	16.3	18.6	19.2	23.8	16.9	11.5	0.2	6.2	13.3	23.6	20.8	35.4	21.1	20.2	21.0	17.8	32.3	12.8	18.5	14.8	47.5	34.5	11.9	19.6	19.7	26.1	12.8	19.4	36.1	31.8	33.3	11.4	16.4	43.8	9.9	24.9	10.3	20.6	16.6	40.5	16.4	11.6	30.3	24.7	31.8	18.4	18.1	13.0	17.6	17.8	36.0	13.3	22.6	56.6	9.5	18.4	11.7	23.1	46.8	15.1	19.8	15.7	0.0	0.4	0.2	1.2	0.7	0.8	0.8	1.5	1.0	0.2	0.3	0.8	1.4	0.6	0.6	1.2	0.8	0.8	0.5	17.3	13.1	7.3	31.2	10.2	9.1	15.4	10.1	14.0	9.4	18.0	15.6	17.0	19.2	20.9	21.9	10.2	39.5	24.4	11.7	16.5	20.3	17.0	11.9	16.6	10.0	12.6	3.7	27.1	10.1	15.5	17.4	0.0	7.9	9.9	15.8	14.2	14.5	22.2	22.3	22.7	10.9	8.3	15.9	13.3	31.2	12.0	13.6	15.4	19.5	9.9	25.2	25.2	18.9	14.2	10.6	13.8	8.2	7.5	14.6	14.2	11.2	5.5	9.7	3.1	17.1	36.8	11.5	15.9	11.7	9.7	21.7	10.6	7.2	10.2	30.2	0.0	15.6	14.5	45.4	38.3	23.7	43.2	9.7	15.5	17.8	13.6	32.2
ADO	"C10orf22, FLJ14547"	ENSG00000181915	"2-aminoethanethiol dioxygenase"	Q96SZ5	10	62804720-62808479	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 186.2;Late spermatids: 317.6;Spermatocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039194, HPA040437"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA039194: AB_10794994, HPA040437: AB_10795633"	"unprognostic (4.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (4.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.64e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.59e-2)"	8.9	8.4	12.8	7.6	17.8	5.1	9.2	20.5	17.0	8.4	7.5	7.2	7.0	8.7	13.1	6.7	7.0	7.4	14.5	11.8	14.6	11.3	7.4	7.7	10.0	19.7	17.7	10.5	7.9	12.4	4.0	7.2	18.3	9.7	6.3	10.5	6.4	8.8	11.7	6.1	6.5	9.3	19.0	8.5	7.4	37.6	16.3	8.9	11.9	17.4	9.9	8.6	4.9	28.0	14.3	10.3	20.1	33.2	21.6	16.3	11.9	17.3	20.5	18.2	19.7	16.2	11.2	13.3	8.9	17.8	14.4	21.6	21.0	13.3	19.3	18.3	15.8	9.1	10.8	13.7	22.3	31.3	22.8	14.0	25.3	19.1	30.7	27.8	14.0	17.3	16.8	12.5	24.4	13.6	20.5	30.5	18.7	13.7	99.1	23.9	16.1	8.2	17.6	9.0	20.9	34.3	17.4	23.8	36.4	16.1	15.5	21.5	12.1	18.3	18.9	15.0	29.0	22.8	44.8	21.1	22.2	32.8	12.0	0.8	0.8	0.2	0.4	1.3	0.8	1.3	0.5	0.6	0.9	0.8	0.4	0.8	0.0	0.8	0.9	0.6	0.3	0.4	12.8	17.8	20.5	17.0	11.8	14.6	19.7	17.7	18.3	19.0	16.3	28.0	7.6	9.6	7.3	3.9	7.2	15.9	11.9	4.3	9.6	23.4	9.9	7.1	32.2	5.7	4.3	14.7	6.2	9.1	8.5	5.3	19.6	6.6	186.2	2.7	13.2	9.0	4.9	4.0	9.5	5.3	7.9	11.5	8.2	4.4	2.5	9.2	10.8	3.7	12.7	32.0	7.8	6.8	0.0	11.9	13.3	317.6	10.5	10.9	12.4	3.7	11.3	12.5	7.2	6.0	22.4	7.5	3.4	26.7	3.2	12.1	4.8	15.8	5.6	17.7	13.1	13.0	11.7	90.5	8.4	9.4	21.7	3.8	8.9	12.5	8.4	10.8
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;brain: 101.4;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	6	"B-cells: 5.8;monocytes: 10.9;Plasma cells: 11.8;T-cells: 3.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"basal ganglia: 101.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;Karpas-707: 52.8;RPMI-8226: 41.1;SK-BR-3: 74.0;U-266/70: 52.8;U-266/84: 74.4;U-698: 55.0"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.8"	"Region enriched"	"Detected in many"	50	"basal ganglia: 142.2"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	3.4	5.4	12.3	13.5	101.4	40.6	2.5	10.8	19.2	4.0	8.0	4.1	6.6	2.9	1.6	2.0	3.7	3.0	13.5	11.6	10.0	17.5	14.5	14.6	20.5	10.2	10.4	3.9	2.3	0.2	6.7	1.8	10.4	5.5	1.0	2.1	3.2	1.7	2.5	1.6	7.0	0.9	9.9	15.2	4.0	3.1	19.9	54.1	4.3	1.4	10.4	5.3	3.4	9.7	0.5	0.9	1.0	0.3	0.4	0.3	1.0	0.7	23.2	1.3	2.4	4.5	0.3	39.3	2.6	0.7	2.4	1.0	2.4	0.0	0.0	4.7	6.6	0.7	0.2	5.6	0.4	0.8	18.7	0.2	0.2	7.2	0.0	0.5	8.2	5.8	0.3	52.8	0.0	0.7	14.0	4.2	1.6	5.0	0.1	0.6	1.7	41.1	0.1	0.3	3.9	21.6	1.1	74.0	0.3	1.1	0.8	3.7	0.5	2.2	3.7	0.5	0.4	52.8	74.4	55.0	11.5	13.6	0.3	9.6	2.1	11.6	20.0	6.5	46.9	21.9	37.4	39.2	2.6	38.3	51.5	42.4	32.6	6.3	23.1	2.9	54.0	27.1	12.3	101.4	10.8	19.2	11.6	10.0	10.2	10.4	10.4	9.9	19.9	9.7	0.0	0.0	0.5	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 140.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		66000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Centrosome		"HPA045194: AB_10964638, HPA058525: AB_2683742"	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.22e-4)"	"prognostic unfavorable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	10.1	7.5	2.7	15.3	2.8	23.7	8.7	3.3	3.8	7.3	9.7	10.3	8.0	5.4	12.1	7.5	9.5	7.0	5.3	2.9	4.9	11.7	10.8	17.0	13.5	4.4	4.4	5.9	7.8	6.6	3.8	16.5	5.0	12.1	11.8	4.3	9.6	5.3	4.7	7.1	8.6	7.8	3.8	13.6	9.8	7.2	3.9	15.3	9.2	5.3	16.4	13.7	5.9	4.9	18.5	37.8	19.8	23.5	43.8	33.2	26.6	52.7	51.0	54.0	74.4	21.5	47.6	34.7	38.3	33.1	53.6	49.0	56.6	27.7	40.2	34.5	38.8	26.0	9.9	20.3	28.2	60.3	37.3	36.2	15.7	28.6	26.4	26.4	31.8	26.7	27.7	57.6	33.1	11.6	18.8	27.0	29.6	36.7	17.6	21.9	32.3	48.5	27.9	21.3	14.3	14.7	48.2	19.7	26.3	30.8	18.9	71.9	26.4	27.0	22.4	103.2	48.5	57.8	119.3	34.6	47.2	58.4	45.7	56.8	69.2	51.6	22.4	48.4	27.9	30.4	20.6	22.8	72.5	26.7	17.7	20.2	27.2	32.0	41.5	55.4	17.9	59.6	2.7	2.8	3.3	3.8	2.9	4.9	4.4	4.4	5.0	3.8	3.9	4.9	19.3	19.2	34.3	22.5	61.7	15.3	20.9	22.7	17.1	15.6	20.1	14.7	3.9	8.6	23.8	20.2	14.6	38.2	75.6	15.1	7.9	25.8	14.9	18.2	22.6	20.2	7.8	10.5	13.0	17.4	62.0	27.4	23.4	17.5	48.9	31.6	21.4	23.9	80.4	15.2	17.5	17.0	24.4	101.3	51.6	6.4	21.8	68.5	26.6	31.9	140.6	11.7	42.2	13.0	22.1	22.3	16.9	15.4	34.9	34.4	15.6	10.7	24.8	24.4	19.7	19.2	16.4	24.4	31.3	11.8	18.2	41.7	36.0	22.9	20.9	31.2
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	10.6	6.2	3.0	7.3	3.3	3.4	7.9	3.3	4.2	6.9	9.2	5.5	2.3	6.0	4.9	4.0	4.2	6.9	8.5	2.9	3.5	4.9	3.1	13.5	11.0	4.6	3.4	1.9	6.7	8.0	2.0	11.3	4.4	6.1	4.1	6.6	5.1	9.3	11.8	2.6	5.4	9.2	4.2	11.9	3.9	2.4	4.6	5.9	5.8	9.9	13.0	6.5	3.4	4.9	2.4	3.0	0.7	0.0	2.4	2.7	0.0	2.1	0.4	1.8	2.3	0.9	2.0	0.6	0.9	3.2	0.1	0.2	2.0	0.0	1.7	23.9	0.2	17.1	0.4	0.0	3.9	0.1	18.5	4.0	0.1	0.9	0.1	0.8	7.3	0.0	1.6	25.3	11.0	0.7	0.0	4.1	6.9	0.2	5.8	0.0	8.2	1.1	1.0	0.9	0.5	0.1	0.0	0.1	6.4	1.0	4.4	10.6	6.0	0.0	1.1	4.6	0.4	24.5	5.8	0.1	3.0	0.0	4.6	13.9	18.7	19.1	0.8	17.2	0.8	11.0	1.9	1.7	11.2	6.8	0.2	0.7	0.6	5.3	13.9	9.8	14.3	7.5	3.0	3.3	3.3	4.2	2.9	3.5	4.6	3.4	4.4	4.2	4.6	4.9	12.6	9.6	8.6	0.3	5.0	0.8	0.7	0.4	0.0	0.5	1.5	1.9	4.7	2.8	2.7	3.7	4.2	5.8	5.0	0.3	1.9	3.6	0.7	0.2	0.9	9.9	0.0	2.7	0.1	3.2	3.8	2.1	2.6	0.5	10.8	2.5	7.1	1.6	9.4	0.0	0.2	0.2	2.0	12.2	11.1	0.5	0.3	14.8	1.8	4.7	10.2	0.8	4.1	0.0	0.6	2.1	0.5	3.0	3.9	0.7	0.0	1.3	2.1	4.3	0.0	3.6	3.9	0.4	0.6	0.1	0.9	11.8	1.2	0.7	0.2	0.2
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 384.9;skeletal muscle: 332.6;tongue: 243.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 148.6;Skeletal myocytes: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 37.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.3"					"HPA066478, HPA072123"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA066478: AB_2685673, HPA072123: "	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	3.0	3.9	3.0	0.8	3.1	0.5	3.5	1.9	6.2	1.9	5.8	3.1	4.3	1.7	1.0	7.9	8.2	3.3	384.9	3.3	2.8	1.3	2.2	1.3	0.8	3.6	2.7	2.1	6.7	0.7	4.1	1.9	3.5	4.3	2.5	1.1	8.7	0.8	332.6	4.2	4.1	0.9	1.9	1.4	6.4	2.7	4.2	1.5	1.2	243.0	0.4	1.7	1.5	4.7	5.9	13.9	1.4	4.3	4.3	6.9	3.8	2.3	1.0	0.7	0.5	3.9	14.3	2.1	8.1	2.5	4.0	3.2	5.4	0.3	0.6	2.1	2.3	6.1	3.3	1.1	1.4	0.4	2.5	2.4	3.3	4.5	0.6	0.6	0.1	5.1	1.8	0.6	5.7	12.9	1.0	3.6	3.1	15.3	7.3	9.4	3.6	5.5	1.5	0.6	20.8	4.8	1.5	6.8	1.8	1.6	37.7	0.8	0.5	0.2	2.6	6.3	0.8	2.1	1.8	6.9	4.1	1.1	3.0	0.1	0.2	0.0	0.0	0.3	0.4	0.4	0.1	0.5	0.6	0.1	0.3	0.3	0.3	0.2	0.3	0.1	0.3	0.2	3.0	3.1	1.9	6.2	3.3	2.8	3.6	2.7	3.5	1.9	4.2	4.7	1.3	0.0	4.6	4.9	0.5	1.3	2.3	1.0	2.8	1.6	5.5	5.2	148.6	0.0	3.0	0.0	0.0	3.6	0.4	3.2	0.0	3.6	1.4	16.6	8.1	2.8	4.2	0.0	5.4	3.2	2.5	6.8	2.6	12.4	0.0	0.6	1.1	1.0	0.6	1.7	4.0	4.8	0.0	0.6	0.3	3.8	0.0	1.3	1.8	1.0	0.1	2.6	0.0	1.5	2.3	1.2	7.4	1.5	0.1	2.0	7.8	0.5	5.9	1.7	0.0	53.7	2.8	1.8	2.7	2.0	2.6	2.5	0.8	4.2	3.2	3.2
ADPRM	"C17orf48, MDS006"	ENSG00000170222	"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent"	Q3LIE5	17	10697594-10711558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023265, HPA023820"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA023265: AB_1845590, HPA023820: AB_1845591"	"unprognostic (7.58e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.38e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.97e-2)"	6.7	4.6	1.9	4.9	2.2	6.6	6.6	2.0	2.3	6.8	1.7	5.1	3.1	6.4	3.7	4.4	4.8	4.7	3.6	1.9	2.1	4.5	6.8	3.9	6.9	1.9	1.8	7.8	6.9	3.1	3.9	2.6	1.9	7.7	3.2	9.9	4.7	3.5	9.2	5.4	6.0	2.8	2.0	5.8	7.9	4.0	2.2	7.0	6.5	6.4	5.6	4.8	5.2	2.4	3.8	2.8	3.9	5.0	8.8	11.1	1.9	7.2	7.7	5.2	7.5	1.5	1.7	7.1	3.3	7.5	2.2	3.0	1.8	5.2	6.4	4.4	5.4	3.5	2.9	4.3	14.7	2.6	4.3	13.7	7.5	5.6	7.8	8.0	9.6	7.8	3.4	0.6	6.8	1.1	2.8	4.5	4.2	2.5	1.5	3.1	2.7	1.9	9.1	2.5	0.7	5.2	3.5	1.3	8.2	4.7	3.6	5.0	9.8	2.9	2.3	3.6	4.2	1.6	1.1	1.1	6.9	3.6	6.1	2.6	2.5	4.7	2.4	2.6	3.5	5.9	6.2	4.1	3.1	7.2	13.0	8.5	2.3	4.1	2.3	1.7	5.9	3.9	1.9	2.2	2.0	2.3	1.9	2.1	1.9	1.8	1.9	2.0	2.2	2.4	5.8	3.2	2.0	6.5	17.6	5.2	11.7	17.4	8.0	11.7	5.9	6.0	2.7	4.3	8.9	1.8	18.8	7.2	6.4	3.8	3.9	8.4	10.2	1.9	3.9	5.7	4.8	6.7	6.0	8.3	7.3	6.6	4.6	2.4	14.0	4.4	7.1	9.8	6.7	3.3	6.9	7.5	2.0	9.5	5.1	5.2	15.8	6.0	10.6	1.9	11.1	13.5	6.2	8.0	8.1	8.1	4.6	8.2	3.6	12.7	14.9	8.5	4.1	34.3	6.6	6.6	14.0	12.5	10.2	4.4	4.7	8.2	13.0	4.4	5.6	11.4
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6;liver: 60.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	21.8	0.5	13.3	1.1	11.1	0.0	3.6	3.0	22.6	0.7	0.0	1.4	0.9	1.4	0.6	0.8	0.2	0.3	7.6	42.6	20.8	0.7	60.1	3.9	1.7	9.3	4.9	0.9	0.0	0.0	0.1	0.0	9.5	12.4	0.5	0.3	6.2	13.5	0.2	0.6	1.1	2.9	1.5	9.2	0.9	0.1	4.2	0.1	0.1	1.4	0.4	0.4	0.3	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	11.1	3.0	22.6	42.6	20.8	9.3	4.9	9.5	1.5	4.2	6.9	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	16.2	0.0	0.0	123.2	0.0	0.0	0.0	0.5	28.3	0.6	0.0	0.0	9.4	0.0	0.0	0.0	114.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220630-4249287	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.6;cervix: 7.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 1.2;Excitatory neurons: 2.1;Inhibitory neurons: 2.4;Oligodendrocyte precursor cells: 1.0;Smooth muscle cells: 2.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 7.5;CAPAN-2: 3.3;fHDF/TERT166: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038789	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA038789: AB_10673475"	"unprognostic (5.37e-2)"	"unprognostic (4.65e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.75e-11)"	"unprognostic (7.83e-3)"	"unprognostic (1.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.82e-4)"	"unprognostic (4.41e-3)"	"unprognostic (8.37e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.71e-7)"	"unprognostic (5.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.32e-5)"	1.2	0.4	5.0	0.0	0.6	0.0	0.8	0.3	4.8	7.2	0.0	2.0	0.0	3.5	0.3	0.2	2.0	0.2	0.3	7.5	4.2	0.3	0.1	2.3	0.0	2.7	4.9	0.6	0.3	0.2	0.0	0.1	2.4	3.4	0.1	0.0	0.2	1.7	0.5	0.4	0.2	0.3	1.3	1.4	1.6	0.7	9.6	0.0	0.8	0.4	0.0	2.4	2.9	1.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	7.5	1.3	0.4	0.1	0.3	3.3	0.0	0.0	4.4	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.3	4.8	7.5	4.2	2.7	4.9	2.4	1.3	9.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 1.0"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in some"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	6.4	2.1	1.5	0.3	1.7	0.8	3.0	1.4	2.7	1.5	4.9	2.3	0.3	1.9	3.8	0.7	3.0	0.6	10.1	1.2	1.4	5.1	7.0	0.5	0.2	1.8	1.6	1.7	0.8	0.5	0.5	0.8	1.7	1.4	0.3	0.0	2.2	1.5	6.4	1.9	2.6	0.7	1.3	8.6	2.2	1.6	2.6	0.2	1.3	5.0	0.1	2.5	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	2.7	1.2	1.4	1.8	1.6	1.7	1.3	2.6	2.4	2.9	0.0	0.0	0.0	0.9	1.1	0.7	0.7	0.6	0.0	0.9	0.9	2.5	0.0	1.5	1.8	0.0	0.8	2.9	0.1	0.0	0.2	0.0	2.2	1.0	2.4	2.4	0.0	0.0	0.6	0.2	1.0	1.1	9.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.2	0.0	0.3	8.0	0.0	1.8	5.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.4	0.7	0.0	0.1	1.4	0.0	32.9	0.7	13.3	0.0	0.3	0.6	1.4	0.4	2.8	0.1	0.1	0.3
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 84.9;endometrium 1: 57.6"	"Cell type enriched"	"Detected in some"	5	"Endometrial stromal cells: 135.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 22.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 34.3"	HPA057688	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	17.9	3.7	7.6	0.5	22.3	0.0	8.2	3.7	8.8	84.9	3.2	3.1	0.4	57.6	2.2	2.0	22.7	0.4	7.6	6.8	5.5	32.9	0.6	4.1	0.7	5.4	5.7	8.3	3.8	0.2	4.8	3.6	7.1	22.4	0.2	0.8	1.2	18.6	3.5	7.4	3.2	2.1	3.8	22.0	2.4	3.7	8.6	0.4	1.4	1.8	0.1	4.2	14.1	6.4	0.0	4.6	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.1	0.0	2.4	1.4	0.0	2.3	0.4	0.8	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	13.3	0.6	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	21.9	0.0	0.0	7.4	8.6	0.0	0.0	6.8	0.0	0.0	0.4	8.0	9.7	3.0	0.0	0.1	1.9	7.0	0.1	0.0	0.0	5.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	22.3	3.7	8.8	6.8	5.5	5.4	5.7	7.1	3.8	8.6	6.4	26.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.2	1.7	0.8	0.9	1.0	2.8	0.0	12.9	0.0	0.9	0.1	0.1	3.9	0.4	0.0	4.7	135.9	5.4	0.0	0.0	1.2	0.0	0.2	1.4	0.0	2.4	0.0	10.7	1.1	0.0	0.3	3.3	0.6	0.2	0.0	0.0	0.7	0.4	1.5	0.6	0.0	1.0	0.0	5.8	0.0	0.0	0.2	0.1	0.0	3.8	0.0	0.3	0.0	2.4	0.0	0.1	0.0	0.9	5.8	0.1	1.6	0.0	0.0	1.6	0.6	0.0	0.1	0.2
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114043866-114046904	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.7;lung: 13.1;placenta: 29.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 85.7;Cytotrophoblasts: 84.5;Sertoli cells: 52.6;Syncytiotrophoblasts: 38.4"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;PC-3: 2.6;THP-1: 4.5;TIME: 5.8;U-937: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067972	Enhanced					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067972: AB_2685936"	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.0	0.2	5.5	0.3	10.3	0.5	2.3	0.7	12.0	0.1	0.2	3.1	0.9	0.1	0.1	0.9	0.1	0.1	23.7	6.8	3.3	1.1	1.4	13.1	0.2	1.8	3.1	0.0	1.3	0.8	0.8	29.1	2.4	4.4	0.6	2.1	5.4	0.1	2.3	0.4	1.9	0.1	0.9	1.5	0.7	0.5	5.0	0.1	0.6	0.0	0.3	0.7	0.1	7.8	1.4	0.8	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.3	1.0	0.2	0.2	0.0	0.4	0.3	0.1	0.1	0.1	7.1	0.4	0.3	0.1	0.1	0.0	0.2	0.4	0.0	0.7	0.0	1.3	0.1	0.1	1.0	0.0	0.1	0.1	0.8	1.1	0.9	0.3	0.2	2.6	0.2	0.2	0.1	0.0	1.1	0.1	0.2	0.0	0.5	0.0	0.3	0.2	4.5	5.8	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	3.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	0.7	12.0	6.8	3.3	1.8	3.1	2.4	0.9	5.0	7.8	1.1	19.2	7.8	15.0	0.5	1.0	3.9	0.8	1.2	21.8	1.0	0.5	85.7	2.8	9.8	0.0	0.0	84.5	3.0	0.1	1.9	0.1	0.1	0.4	0.6	11.3	0.0	0.0	12.8	0.2	5.2	5.3	0.0	0.3	0.0	0.0	0.4	0.2	4.4	13.5	2.5	3.3	2.0	2.2	1.6	0.2	0.0	2.8	1.8	7.5	0.6	0.7	3.1	1.0	0.3	0.1	1.4	0.4	1.2	6.1	0.8	0.0	12.1	1.7	52.6	0.4	8.2	0.5	0.2	0.1	0.0	38.4	4.8	0.0	0.6	3.9
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148826611-148828623	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.1;Basal keratinocytes: 387.5;Basal respiratory cells: 146.6;Squamous epithelial cells: 276.0;Suprabasal keratinocytes: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 72.4;hTERT-HME1: 74.1;PC-3: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	19.5	1.6	4.5	3.2	4.7	12.5	18.7	5.1	4.4	13.5	1.8	2.3	1.9	2.3	1.7	15.1	4.1	3.8	6.7	5.3	4.2	1.1	14.2	19.5	4.1	6.0	5.6	0.9	1.2	2.2	0.3	9.9	6.2	9.0	2.8	0.6	4.2	1.5	11.7	21.8	2.1	3.7	6.2	7.9	7.5	0.5	7.1	2.7	1.0	8.6	6.0	6.8	7.2	7.6	23.3	0.1	0.1	0.0	0.8	0.2	0.0	4.3	13.2	6.0	6.7	0.0	9.7	0.1	6.1	1.3	21.5	20.0	0.0	27.9	6.9	0.0	0.6	0.0	5.1	0.0	0.6	0.1	11.0	0.1	72.4	2.0	74.1	5.0	2.8	0.0	0.1	8.3	16.0	0.0	0.0	12.9	0.4	0.2	31.2	6.7	4.1	13.0	3.2	5.8	0.1	0.1	5.4	0.4	2.0	2.5	0.0	7.0	12.3	0.0	5.0	7.2	3.5	1.9	0.0	0.2	0.0	15.1	2.6	16.5	21.8	67.8	151.4	37.1	112.3	21.5	34.3	93.0	24.7	15.6	5.8	53.3	35.4	37.2	53.3	28.4	2.3	53.4	4.5	4.7	5.1	4.4	5.3	4.2	6.0	5.6	6.2	6.2	7.1	7.6	196.1	112.2	31.6	1.6	16.5	387.5	36.6	146.6	127.5	0.5	23.3	15.2	18.6	0.0	67.4	0.0	0.0	0.4	59.2	3.7	0.0	2.4	0.5	3.2	0.5	40.3	3.0	1.3	0.0	0.2	0.3	6.2	35.7	3.0	118.6	0.1	6.8	14.1	17.7	0.0	0.0	3.1	16.2	20.8	54.9	0.7	0.0	21.1	30.2	15.9	4.0	4.1	90.6	0.0	0.1	8.6	0.1	0.0	23.2	23.5	0.1	0.1	27.8	5.0	0.0	19.8	9.6	0.7	0.1	276.0	245.4	0.5	40.1	0.1	3.5	61.5
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962990-37966599	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;ovary: 11.7"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 2.8;Hofbauer cells: 1.1;Langerhans cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"medulla oblongata: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA061969	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"		"Cluster 33: Fibroblasts - ECM organization"			"HPA061969: AB_2732674"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.14e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.10e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.06e-3)"	0.3	0.0	1.2	0.4	1.1	0.2	0.3	0.5	0.9	0.4	1.5	2.1	0.2	0.7	1.1	0.1	4.1	1.7	0.0	0.9	0.7	0.0	0.0	0.1	0.1	8.1	2.7	11.7	0.0	0.0	0.0	2.9	3.1	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.4	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	4.6	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	0.9	0.9	0.7	8.1	2.7	3.1	0.4	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 369.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1655.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 727.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	76.9	92.7	44.9	53.4	45.6	78.0	68.3	48.7	63.7	57.8	38.1	78.7	52.0	80.6	14.6	99.0	58.4	33.5	109.0	44.0	48.4	65.1	119.5	67.3	54.2	52.0	45.7	44.5	83.2	23.5	52.6	39.6	51.0	59.5	16.1	11.9	61.3	35.1	369.5	93.9	63.4	23.3	44.4	83.2	68.6	128.5	47.3	38.9	51.7	66.9	29.7	73.0	64.4	46.4	219.9	241.8	66.8	142.6	62.5	45.8	178.1	138.9	95.4	260.1	104.0	727.1	227.8	117.4	250.3	82.1	148.3	243.6	84.3	209.9	79.8	136.7	170.1	284.4	177.4	392.0	105.6	149.3	261.1	57.0	126.3	170.9	67.7	43.4	101.4	113.0	211.4	125.6	61.7	296.1	187.5	290.8	225.1	106.6	354.0	149.2	115.5	186.7	71.3	163.9	118.5	146.5	151.5	241.7	174.0	44.9	168.1	163.3	149.4	258.5	274.4	252.4	289.1	261.5	223.4	158.6	272.6	148.7	192.3	195.4	208.7	233.5	200.4	262.1	179.9	260.2	180.8	192.9	219.2	265.2	132.4	151.4	200.2	184.8	227.8	205.6	265.8	260.8	44.9	45.6	48.7	63.7	44.0	48.4	52.0	45.7	51.0	44.4	47.3	46.4	91.4	35.3	25.2	7.5	91.3	148.2	115.6	275.4	98.4	34.7	62.0	62.0	19.4	52.9	119.3	66.2	18.8	230.4	83.3	156.4	115.4	186.9	359.1	61.7	43.9	105.6	57.8	74.3	5.2	211.3	173.6	73.3	51.0	56.9	42.5	55.8	87.1	101.7	150.2	33.7	4.9	87.1	156.6	77.6	154.2	1655.0	72.4	89.8	97.8	3.7	126.5	73.0	83.4	4.0	8.5	247.5	129.7	86.9	118.2	145.7	118.6	139.0	96.2	31.7	65.7	49.9	177.0	135.2	204.2	108.0	148.0	423.0	86.1	57.5	95.2	144.6
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
ADSS1	"ADSSL1, FLJ38602"	ENSG00000185100	"Adenylosuccinate synthase 1"	Q8N142	14	104724229-104747325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 1273.1;tongue: 609.8"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052621	Enhanced					NA	NA		290000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052621: "	"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	8.1	5.1	3.8	1.0	6.8	0.9	4.4	6.6	5.6	4.1	7.6	3.0	2.7	3.3	4.5	18.5	6.5	5.7	100.2	3.7	6.7	14.8	28.8	3.1	1.1	6.0	6.0	2.7	7.9	7.3	10.0	7.3	6.1	7.6	1.4	10.1	10.7	4.0	1273.1	5.5	2.8	2.3	5.2	2.0	6.5	18.5	5.5	1.0	7.4	609.8	0.8	6.5	5.4	7.7	0.1	3.2	2.4	7.1	1.7	1.1	0.8	0.9	1.3	0.2	0.7	0.2	2.5	0.0	15.2	0.8	0.5	1.3	0.2	0.5	0.6	1.0	0.5	0.1	7.9	1.1	1.8	0.0	6.0	3.2	2.3	0.0	2.6	2.7	0.4	0.3	2.9	0.1	1.2	14.2	0.0	0.7	2.1	23.2	1.3	0.2	0.3	0.9	0.5	1.7	2.0	4.2	23.1	1.0	3.3	1.8	7.1	2.1	0.8	0.1	0.6	1.6	0.1	4.4	3.5	0.0	2.2	1.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.8	6.8	6.6	5.6	3.7	6.7	6.0	6.0	6.1	5.2	5.5	7.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0
ADSS2	ADSS	ENSG00000035687	"Adenylosuccinate synthase 2"	P30520	1	244408494-244451909	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		690000	"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.8	20.5	17.8	28.1	22.0	43.9	34.6	21.7	26.7	25.9	17.0	28.7	28.7	23.4	29.8	32.6	23.9	21.0	8.9	19.2	21.1	32.9	24.3	25.3	31.9	21.9	19.6	21.7	19.8	27.6	14.5	28.6	23.1	25.3	29.8	11.4	22.8	25.6	10.8	33.2	27.1	25.2	19.6	23.7	35.0	70.3	20.9	33.8	34.9	8.4	34.9	36.2	21.5	28.7	89.9	48.6	41.6	36.9	47.6	67.8	76.2	88.5	74.4	62.3	47.0	64.6	84.5	79.7	57.1	68.9	26.6	66.1	45.9	58.0	69.5	59.6	81.0	53.1	47.8	49.3	57.1	127.1	65.6	46.8	68.5	58.1	58.3	72.1	225.6	43.3	94.0	57.7	62.7	21.6	82.3	85.0	110.5	85.0	53.1	74.9	39.4	86.5	103.8	55.2	56.2	49.2	75.2	69.0	91.4	43.9	48.0	66.7	99.4	57.1	31.3	67.0	93.7	69.1	97.2	60.0	47.2	146.8	86.3	48.3	22.8	20.0	20.4	29.9	22.0	15.3	18.6	17.8	20.1	12.3	15.6	17.9	17.5	23.6	33.6	7.9	22.3	18.8	17.8	22.0	21.7	26.7	19.2	21.1	21.9	19.6	23.1	19.6	20.9	28.7	26.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	49.3	59.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	97.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	54.0	11.0	0.0	0.0	0.0
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.5;parathyroid gland: 92.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 116.4;Distal tubular cells: 52.8;Early spermatids: 141.6;Late spermatids: 168.0;Paneth cells: 87.0;Proximal enterocytes: 127.0;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 14.8;T-reg: 13.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 93.9;RPMI-8226: 41.2;TIME: 57.7;U-138 MG: 42.4;U-266/84: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.5	0.2	1.9	14.2	2.1	1.1	3.3	0.6	2.2	0.4	35.2	80.7	82.4	0.3	13.7	1.5	0.6	1.6	0.3	2.0	0.0	9.8	1.4	11.1	9.4	0.1	0.1	0.2	0.8	92.9	0.0	2.4	0.1	0.4	58.5	0.6	0.8	24.4	1.0	18.9	98.5	2.6	0.1	1.3	38.2	22.6	0.4	2.6	0.5	0.1	12.7	10.2	0.3	1.1	4.1	0.0	0.0	0.0	0.5	0.9	0.1	1.5	0.8	1.0	0.7	3.6	1.9	0.1	1.7	0.7	2.4	1.9	0.0	11.2	1.4	0.1	0.0	0.3	0.8	0.1	0.3	0.1	0.2	0.0	20.4	10.4	23.6	17.5	93.9	0.7	23.0	0.0	3.1	0.1	0.2	0.6	0.3	0.1	5.8	0.0	0.3	41.2	1.7	0.2	0.1	0.2	1.5	0.0	0.8	2.8	0.0	0.8	57.7	42.4	2.0	0.7	2.6	1.2	47.1	0.0	7.9	1.3	0.2	2.7	0.0	0.0	0.0	0.3	2.6	0.2	3.7	0.3	0.1	0.2	14.8	1.3	0.3	0.1	0.2	0.2	13.5	1.7	1.9	2.1	0.6	2.2	2.0	0.0	0.1	0.1	0.1	0.1	0.4	1.1	0.2	0.0	1.1	0.7	4.0	5.1	0.3	3.9	0.6	0.0	0.1	1.9	0.1	0.0	2.6	5.5	0.0	0.2	0.1	116.4	52.8	0.7	141.6	0.2	0.0	0.3	5.4	2.7	13.1	2.4	0.2	1.1	32.1	0.1	5.7	0.0	0.0	0.2	11.4	0.0	0.4	40.7	2.0	0.8	1.5	168.0	1.8	3.1	1.8	0.0	27.9	0.0	1.0	1.0	0.1	7.9	87.0	0.7	7.8	0.6	127.0	0.7	0.8	0.0	0.0	0.2	1.2	1.6	0.7	0.4	5.7	0.1	6.2	0.0	52.3	0.5
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	19.0	27.2	9.9	20.0	11.6	20.5	23.5	13.0	16.5	25.8	12.5	18.8	16.3	34.0	20.2	35.1	28.0	21.8	17.8	17.7	7.2	27.8	20.3	20.7	27.7	1.9	6.7	35.1	17.5	29.9	8.9	44.1	2.0	24.8	20.6	27.7	19.3	30.7	13.6	29.4	16.7	31.1	0.3	23.1	16.1	20.8	11.8	29.2	30.8	19.8	32.3	25.0	18.2	14.7	32.4	42.4	42.6	20.1	31.1	38.6	95.2	29.9	34.1	43.5	45.7	48.0	54.5	51.0	24.3	41.4	27.6	38.0	93.7	34.6	69.1	149.4	30.6	46.7	60.8	30.0	36.4	60.1	30.8	36.2	36.3	35.6	52.8	52.0	35.6	34.8	25.2	1.4	41.2	38.5	63.0	71.7	82.6	26.6	18.9	50.3	82.3	35.9	32.2	68.2	10.0	23.4	60.6	25.7	29.8	91.3	32.8	35.0	40.5	40.7	30.9	12.8	44.9	14.0	24.9	106.0	30.3	25.1	29.2	4.3	2.5	2.5	4.2	2.7	4.4	2.2	4.4	3.6	2.0	2.8	3.7	5.8	2.7	6.0	2.2	2.6	4.5	1.2	9.9	11.6	13.0	16.5	17.7	7.2	1.9	6.7	2.0	0.3	11.8	14.7	23.9	25.6	14.3	31.6	20.5	75.2	25.1	15.5	53.5	29.8	22.0	13.3	22.1	12.8	24.2	12.9	43.8	60.3	24.3	9.5	17.6	12.3	1.3	31.1	31.5	22.2	22.7	11.6	57.2	12.2	24.8	28.3	14.3	28.8	27.8	17.7	14.3	12.9	15.4	52.2	59.4	11.2	4.1	17.0	47.9	2.3	24.5	17.8	28.4	30.0	17.7	21.5	14.4	42.3	51.6	11.5	10.3	29.0	18.3	24.5	9.0	18.3	26.1	16.1	19.7	46.7	40.1	16.2	26.3	51.0	76.0	83.0	28.1	34.2	10.7	28.2
AF196969.1		ENSG00000286268	"Novel protein"		X	48521806-48545469	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-2197: 2.5"									HPA003130	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"		"Cluster 18: U-2197 - ECM organization"		"Endoplasmic reticulum"		"HPA003130: AB_1078717"																		0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.2	0.0	0.2	0.0	0.3	2.5	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AF241726.1		ENSG00000250349	"Novel proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1) and tetraspanin 7 (TSPAN7) protein"		X	37349330-38687674	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	5	"brain: 3.1;skeletal muscle: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;JURKAT: 1.4;RPTEC TERT1: 2.1"									HPA003140	Uncertain					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA003140: AB_1078454"																		0.6	0.2	0.7	0.0	1.4	0.0	0.0	2.1	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.1	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.1	0.0	4.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.1	0.0	3.1	1.1	0.2	0.2	0.1	0.4	0.2	0.0	0.2	0.6	0.1	0.3	1.4	0.2	0.0	0.9	0.2	0.1	0.1	1.2	0.7	0.1	0.3	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.7	0.4	0.2	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	2.1	0.9	0.8	0.8	1.9	1.2	1.9	1.9	1.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.5;Extravillous trophoblasts: 116.3;Inhibitory neurons: 117.2;Late spermatids: 373.8;Oligodendrocyte precursor cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"TIME: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	12.6	3.1	7.0	8.7	5.8	0.7	9.7	4.5	6.9	8.7	2.9	17.6	5.6	15.4	2.0	11.0	8.5	9.4	10.8	5.8	4.5	4.9	1.2	8.5	4.4	3.7	2.7	7.1	3.8	14.7	7.9	12.6	2.8	7.7	9.8	3.4	8.6	10.2	3.5	5.3	7.7	15.4	3.4	4.0	6.7	22.0	3.5	3.1	7.4	2.4	4.8	14.2	8.3	3.5	31.9	23.2	16.2	12.9	15.4	27.8	21.3	46.4	68.1	43.6	40.0	7.4	7.2	0.1	15.2	75.5	72.3	15.1	8.6	18.7	28.6	0.9	5.7	0.0	33.2	4.5	43.0	0.0	0.4	17.2	13.8	54.4	35.5	72.2	53.0	4.8	0.7	6.8	23.0	10.3	0.6	0.0	7.0	13.2	44.3	0.0	12.1	1.5	4.7	4.1	31.8	53.0	15.9	10.9	12.4	21.4	4.1	0.3	126.7	53.0	11.8	69.6	23.0	0.0	0.2	0.0	18.9	0.1	61.9	0.0	0.4	2.9	0.4	0.1	0.5	0.0	0.6	0.6	0.0	0.0	1.2	0.5	1.0	0.0	0.0	0.0	0.5	0.7	7.0	5.8	4.5	6.9	5.8	4.5	3.7	2.7	2.8	3.4	3.5	3.5	22.5	6.4	2.0	4.6	0.2	2.9	9.7	16.2	7.4	1.2	10.2	8.9	5.9	10.0	12.7	11.0	4.2	5.6	2.3	14.8	0.0	19.2	170.5	7.5	17.6	20.1	14.5	0.0	24.7	7.7	116.3	21.1	11.2	8.8	0.0	4.4	14.3	0.0	8.5	0.0	117.2	20.6	0.0	0.3	3.6	373.8	11.1	6.0	1.8	30.9	0.6	10.2	0.0	125.2	5.4	29.9	8.6	12.4	0.6	13.5	6.4	4.2	6.4	0.7	6.6	8.0	13.4	12.5	10.0	6.2	4.3	8.8	7.3	2.6	13.9	9.9
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 64.5;parathyroid gland: 68.7;thyroid gland: 82.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7"	"Low region specificity"	"Detected in all"							HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	7.6	2.4	15.7	4.2	12.9	0.1	10.2	21.5	13.1	21.8	5.9	13.0	3.9	23.9	13.2	9.3	22.9	4.5	4.7	11.8	12.4	17.6	1.7	5.3	4.3	12.9	12.8	15.1	11.9	68.7	2.4	18.4	13.6	13.1	5.1	3.7	6.9	23.9	3.0	9.8	6.4	18.9	13.6	64.5	5.9	1.4	13.3	13.5	82.2	4.4	7.6	5.9	14.7	13.5	74.4	10.8	10.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	77.4	0.1	56.4	0.6	1.1	98.7	0.2	27.2	0.2	1.5	0.1	0.0	0.7	0.0	3.0	0.0	2.7	0.0	28.9	8.1	7.1	0.3	0.3	2.8	0.0	0.2	0.0	3.1	1.9	0.1	0.5	2.0	0.5	0.9	0.8	51.3	59.7	0.6	0.3	0.5	2.3	1.7	2.9	16.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.6	1.1	1.2	0.0	1.6	0.3	0.9	0.1	0.4	0.0	0.1	1.8	0.6	15.7	12.9	21.5	13.1	11.8	12.4	12.9	12.8	13.6	13.6	13.3	13.5	14.6	0.0	0.0	0.7	1.2	12.4	7.3	3.1	5.2	0.8	1.8	5.3	2.2	0.0	1.8	40.5	0.0	1.5	2.4	8.1	0.0	0.6	1.0	5.3	7.4	14.5	0.0	0.8	6.5	14.3	1.2	10.7	3.1	9.5	0.0	0.3	13.2	0.0	0.5	1.7	10.1	1.8	0.0	0.0	3.7	3.0	3.1	0.5	5.4	34.7	0.6	3.2	0.0	122.6	0.6	23.2	1.7	1.9	0.1	3.7	2.2	0.4	1.5	0.6	19.7	21.4	24.7	0.0	0.8	2.3	6.8	0.3	3.4	2.4	2.2	4.3
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500617-149000663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.0;brain: 24.6;epididymis: 11.9;placenta: 14.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 22.9;Excitatory neurons: 29.7;Granulosa cells: 24.6;Inhibitory neurons: 140.2;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.0;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 74.2;HL-60: 31.7;U-698: 106.4;U-937: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	0.9	0.2	7.3	1.6	8.4	12.0	0.5	18.7	19.0	3.5	0.0	0.2	0.0	0.5	11.9	0.2	0.1	2.2	0.6	24.6	10.2	0.2	0.1	2.0	5.4	4.1	4.2	0.9	0.1	0.0	3.5	14.7	5.4	0.6	0.1	8.2	0.3	1.5	0.0	0.6	0.1	0.1	5.4	0.4	0.1	2.1	9.6	5.3	0.4	0.0	6.2	0.3	0.2	1.8	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.2	0.1	4.3	0.0	0.0	9.9	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	31.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.0	2.2	0.0	4.2	9.6	2.7	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	1.3	4.1	0.0	0.9	0.0	3.4	0.4	0.3	106.4	0.0	22.9	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.4	18.7	19.0	24.6	10.2	4.1	4.2	5.4	5.4	9.6	1.8	0.2	0.0	0.0	2.3	0.1	0.4	0.0	0.1	0.0	4.7	0.0	0.3	1.5	0.0	0.0	0.0	22.9	0.2	0.0	0.0	0.0	0.5	8.9	1.8	0.3	0.1	0.0	2.5	29.7	0.0	0.2	1.0	0.0	3.4	5.7	24.6	0.0	0.0	0.1	1.7	140.2	0.0	0.0	0.0	0.8	6.4	7.8	0.3	0.0	4.7	0.8	1.3	0.0	38.2	3.3	0.0	0.0	17.7	0.6	0.2	0.0	0.6	0.0	15.3	6.6	0.1	1.4	0.3	0.2	0.0	0.0	0.3	0.2	2.0	0.0	0.0
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.3	1.6	3.1	6.2	3.9	11.2	11.6	17.4	13.2	3.5	0.0	5.1	1.1	7.7	0.8	3.5	4.5	2.2	4.3	9.7	5.0	1.4	1.7	6.5	14.2	2.2	0.0	6.3	0.4	0.1	4.4	6.2	1.8	16.2	2.2	4.2	1.9	2.5	0.7	0.9	6.0	5.9	0.0	7.3	4.6	5.4	0.0	7.7	1.2	0.7	12.2	6.7	2.2	9.8	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	3.1	3.9	17.4	13.2	9.7	5.0	2.2	0.0	1.8	0.0	0.0	9.8	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
AFF4	"AF5Q31, MCEF"	ENSG00000072364	"AF4/FMR2 family member 4"	Q9UHB7	5	132875395-132963634	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023690, HPA029634"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA023690: AB_1844633, HPA029634: AB_2673129"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.69e-1)"	21.4	28.2	10.9	16.9	13.3	43.4	22.8	20.2	15.3	20.3	9.9	18.5	14.4	26.7	18.2	26.8	16.4	26.0	16.5	11.3	18.7	24.3	21.1	19.7	15.4	11.5	16.1	28.9	24.9	36.3	19.5	20.5	10.6	25.1	17.6	47.3	19.1	21.3	25.4	18.5	15.0	23.6	7.8	16.8	25.1	18.0	19.0	19.0	33.2	25.6	17.1	23.1	19.3	15.6	42.5	33.5	45.2	50.3	34.1	40.9	35.3	44.8	47.9	40.4	51.2	49.8	27.2	21.5	51.7	59.2	49.0	20.8	36.8	55.5	67.3	15.4	23.7	26.6	44.6	17.8	43.6	9.4	26.5	48.2	36.2	70.2	70.7	43.5	39.4	19.2	19.4	17.7	51.2	16.0	26.1	10.0	17.4	12.6	13.6	17.3	44.1	8.1	35.0	58.8	35.2	37.0	50.9	12.3	50.4	62.0	26.2	15.0	55.9	48.3	40.8	43.0	48.2	24.3	45.3	19.3	45.2	17.2	33.7	13.0	1.8	3.2	4.0	1.5	3.0	6.2	3.7	2.8	2.2	6.3	3.8	3.3	4.1	3.0	4.1	4.1	1.9	1.3	10.9	13.3	20.2	15.3	11.3	18.7	11.5	16.1	10.6	7.8	19.0	15.6	134.3	80.1	43.9	62.3	98.7	79.7	79.8	52.0	140.0	74.8	94.1	76.7	65.2	57.2	70.8	58.8	158.4	36.4	75.9	69.9	7.9	51.1	244.1	136.4	147.8	79.3	97.6	29.2	99.5	46.2	47.8	98.0	197.2	229.0	43.1	222.1	54.3	25.2	41.9	79.1	85.1	59.1	50.8	62.3	123.7	200.5	69.3	100.9	69.4	60.9	41.6	61.9	39.1	73.9	106.0	75.8	65.5	67.4	93.0	97.3	56.1	35.7	53.2	135.1	78.9	126.5	103.8	34.2	21.5	130.6	86.5	69.9	68.9	89.6	47.2	120.0
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 961.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	79.7	961.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 118.3;Proximal tubular cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.4;intermediate monocyte: 16.7;memory B-cell: 5.4;myeloid DC: 7.6;non-classical monocyte: 11.0;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in all"	5	"B-cells: 5.4;dendritic cells: 7.6;monocytes: 16.7"	"Cell line enhanced"	"Detected in all"		"Hep G2: 186.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	14.6	7.6	52.8	11.7	76.1	10.8	65.5	67.3	66.2	15.2	35.5	15.8	17.9	15.3	13.9	18.7	22.9	19.0	22.5	52.6	60.5	88.8	173.2	27.1	12.0	74.4	71.3	31.9	59.3	9.1	9.1	26.7	66.8	28.3	18.8	4.0	38.7	18.4	19.2	32.9	15.5	13.4	56.6	14.6	22.1	13.2	68.6	8.9	15.0	14.4	13.4	13.2	19.0	114.8	21.3	29.4	25.4	23.3	27.9	32.5	13.7	29.8	16.8	20.4	24.5	31.5	17.2	65.8	19.2	22.8	11.9	17.8	43.5	26.0	28.5	41.9	34.6	53.2	35.2	186.5	24.4	44.4	26.2	43.8	26.9	23.9	31.0	33.5	38.8	19.6	54.7	22.4	16.0	20.9	34.0	67.2	20.9	51.1	49.8	38.3	25.9	79.2	27.9	19.3	56.2	41.5	25.5	75.5	24.4	25.1	22.8	42.3	19.3	31.2	20.5	19.9	21.4	33.8	24.2	68.0	25.7	21.5	8.2	1.7	6.4	0.8	0.7	16.7	1.2	5.4	1.1	1.2	7.6	2.1	0.6	0.6	1.8	1.9	11.0	5.1	1.1	1.8	52.8	76.1	67.3	66.2	52.6	60.5	74.4	71.3	66.8	56.6	68.6	114.8	17.9	16.0	16.0	0.7	9.7	26.4	19.8	11.5	79.6	1.2	44.7	34.3	13.2	58.6	12.1	64.4	4.2	12.9	2.1	15.1	17.6	11.5	0.2	21.3	14.5	16.7	13.1	11.3	7.7	8.5	11.2	18.6	23.9	23.8	2.5	9.5	17.9	118.3	10.1	1.7	4.0	26.8	10.2	20.9	20.7	2.7	22.4	21.9	30.2	6.5	8.8	1.6	2.1	3.0	74.2	7.8	27.6	21.8	25.4	15.7	17.8	105.8	14.7	1.7	0.0	15.2	18.1	1.5	13.3	52.1	41.1	11.5	4.3	21.6	30.6	14.5
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.37e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.83e-4)"	15.9	20.2	24.6	21.1	24.9	21.3	32.4	31.2	38.4	22.5	28.3	30.5	23.1	18.8	43.7	29.6	22.9	21.9	12.0	25.3	25.6	56.1	33.6	21.9	37.2	24.6	24.6	19.3	31.6	38.0	25.1	15.0	24.5	34.5	33.7	36.8	28.9	18.6	15.4	33.2	24.5	17.3	24.8	26.4	33.7	24.6	25.4	29.3	25.3	12.9	41.4	25.5	22.4	26.2	29.8	19.3	14.1	17.1	17.8	15.1	23.4	16.7	24.9	26.9	20.1	22.4	21.9	43.9	16.0	20.7	31.1	23.5	24.6	23.3	34.8	42.8	13.5	21.0	12.0	26.5	18.8	40.5	34.5	7.5	48.6	17.4	39.6	19.8	21.4	21.8	16.0	38.7	16.8	16.9	21.9	49.1	13.0	55.9	14.3	17.7	22.6	28.8	48.9	31.5	25.9	13.1	17.7	39.9	35.7	18.0	24.0	30.6	18.5	20.0	23.0	17.0	18.8	43.3	27.8	66.7	15.1	45.3	22.6	40.5	9.3	16.6	7.4	9.3	8.7	21.8	9.3	9.1	12.2	20.3	8.8	6.9	16.3	7.1	14.7	15.8	12.8	5.9	24.6	24.9	31.2	38.4	25.3	25.6	24.6	24.6	24.5	24.8	25.4	26.2	24.6	25.6	39.7	43.1	75.4	122.6	29.6	21.5	55.8	24.2	43.8	23.0	16.0	40.0	33.6	20.2	20.9	13.8	40.5	60.7	37.2	25.5	34.8	44.6	17.8	27.1	46.6	52.0	72.1	25.7	12.4	23.6	35.2	55.9	46.9	17.8	17.5	36.8	20.8	37.0	62.9	40.3	20.3	45.2	77.9	55.1	15.8	52.1	23.2	65.6	60.8	35.0	26.8	52.3	67.0	27.3	43.0	20.7	60.5	42.6	29.0	70.5	40.2	32.9	26.3	25.3	21.2	43.1	21.9	59.0	123.5	27.2	36.5	10.2	40.3	46.1
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430774-177442437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 77.5;Karpas-707: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		36000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	9.4	13.3	8.1	9.1	10.4	15.4	21.1	9.8	12.0	9.2	16.2	13.1	9.6	8.6	30.2	15.9	8.4	13.1	7.5	8.4	9.9	15.3	18.7	11.6	12.2	11.4	9.1	10.2	15.1	17.1	6.1	8.4	11.4	11.8	13.1	6.6	14.9	9.8	9.0	20.6	12.4	9.5	9.5	10.3	16.2	13.2	8.6	11.1	15.8	5.8	15.6	10.9	8.2	13.7	5.4	11.9	13.3	18.8	14.9	13.2	9.0	39.5	77.5	20.1	24.8	6.2	26.2	26.9	7.2	30.0	9.7	6.5	11.3	13.0	39.4	17.3	7.5	11.2	11.9	17.3	10.0	19.6	7.4	9.6	22.5	14.7	6.5	18.0	18.7	11.4	10.3	111.6	8.0	14.6	15.9	12.0	5.2	10.5	12.2	5.0	5.4	4.0	20.5	12.9	7.3	16.4	11.9	10.3	32.2	9.9	23.3	39.8	6.1	13.9	12.3	6.6	15.2	21.2	17.4	14.0	22.3	22.0	16.0	26.4	15.3	23.9	15.6	27.5	17.9	13.9	16.6	18.8	14.8	12.9	14.8	21.3	3.3	12.7	35.8	15.8	17.8	15.1	8.1	10.4	9.8	12.0	8.4	9.9	11.4	9.1	11.4	9.5	8.6	13.7	12.6	12.8	13.5	2.6	20.5	24.0	17.4	26.9	12.5	3.9	19.8	16.9	7.5	15.7	21.7	14.7	2.1	26.3	17.6	8.4	5.9	28.2	13.6	8.9	8.5	10.9	5.4	7.8	3.7	31.3	32.0	16.0	13.7	12.5	14.0	13.9	8.2	23.5	23.1	6.7	2.3	18.2	14.2	15.4	23.3	9.2	11.1	15.9	39.2	2.8	23.8	19.1	11.3	3.5	19.3	21.4	9.1	9.8	48.8	13.4	15.1	22.1	10.5	4.8	0.0	8.4	14.1	35.8	36.6	23.7	27.3	22.7	22.5	14.1	13.6	17.7
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGAP3	CENTG3	ENSG00000133612	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 3"	Q96P47	7	151085831-151144436	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012883	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA012883: AB_1846533"	"unprognostic (3.63e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (4.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.50e-3)"	46.7	42.9	104.5	14.7	112.6	7.1	47.2	60.6	186.6	79.5	38.1	54.8	17.7	57.6	11.1	64.6	55.2	15.4	50.5	120.6	72.0	34.9	53.7	72.5	13.0	90.8	74.1	71.9	56.7	24.2	100.5	19.0	86.5	64.8	7.9	12.4	45.5	18.3	46.1	69.9	38.6	14.7	56.0	37.8	41.9	20.0	82.7	5.4	47.5	13.8	8.4	54.8	66.0	111.2	44.1	34.8	30.7	67.6	28.5	22.7	47.2	33.9	31.9	26.0	22.8	34.1	44.9	0.9	42.7	19.8	31.8	60.8	21.8	47.7	8.3	51.4	67.6	39.4	38.0	46.8	40.0	26.7	15.5	22.9	58.2	21.1	22.1	41.3	39.0	16.7	71.8	31.0	15.4	115.6	11.2	123.6	57.5	34.9	38.4	27.6	21.2	62.4	32.7	106.4	91.5	76.4	26.0	8.1	83.9	21.5	22.5	40.3	37.8	35.1	11.7	43.3	42.3	39.5	19.0	0.6	69.3	45.1	44.8	0.0	2.7	0.2	0.9	1.8	0.7	1.9	1.3	1.6	1.2	0.2	0.9	0.5	0.2	2.0	0.5	0.0	0.2	1.5	104.5	112.6	60.6	186.6	120.6	72.0	90.8	74.1	86.5	56.0	82.7	111.2	24.3	28.9	25.3	24.2	2.4	21.3	14.1	17.7	22.8	53.7	14.7	23.4	21.5	10.0	16.8	3.7	8.4	8.8	6.4	16.2	0.0	5.8	0.4	13.5	19.4	21.9	7.2	1.3	45.4	10.5	1.6	16.0	7.7	15.6	17.2	34.6	13.9	19.0	19.5	57.2	38.0	11.1	8.2	17.9	47.5	2.8	11.8	24.1	12.4	26.2	8.9	13.2	1.0	16.6	38.5	21.6	3.2	11.7	5.5	14.8	17.8	6.5	11.8	15.1	13.1	12.3	9.8	0.7	13.6	22.6	18.6	3.1	6.6	20.2	11.8	11.7
AGAP4	"AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2"	ENSG00000188234	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 4"	Q96P64	10	45825613-45853875	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 141.3;Late spermatids: 52.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 21.6"									HPA042490	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042490: AB_2678022"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.10e-4)"	"unprognostic (4.13e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.76e-5)"	"unprognostic (7.49e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.28e-4)"	5.0	6.8	11.9	5.1	12.2	5.9	5.3	14.6	13.7	7.5	11.2	6.0	7.5	5.0	5.8	4.9	6.1	3.0	6.0	12.0	11.8	8.9	9.3	5.1	7.1	11.5	11.0	7.3	7.4	2.5	9.0	3.6	11.7	9.1	3.7	9.8	4.6	4.2	7.2	9.6	6.8	2.7	10.4	10.2	5.8	7.1	12.1	5.3	6.3	2.8	3.5	5.8	5.9	12.9	2.8	3.2	9.3	5.6	3.8	4.5	7.0	3.2	3.0	3.4	3.5	7.3	7.3	4.1	4.7	2.6	1.9	7.8	1.8	4.5	2.4	5.2	5.8	0.3	8.1	9.2	3.7	4.8	3.1	3.0	3.9	3.9	4.1	2.6	1.8	8.5	6.1	4.8	1.9	4.5	4.0	21.6	4.3	2.7	1.2	5.7	3.1	4.5	3.3	3.5	6.5	5.3	1.5	5.7	5.5	4.8	5.1	5.8	5.3	1.5	4.4	3.3	6.8	8.5	5.0	3.6	3.1	6.9	1.7	2.0	0.2	0.7	0.4	0.2	0.3	0.1	0.1	0.4	0.3	0.5	0.2	0.2	1.0	0.4	0.1	0.3	0.1	0.1	11.9	12.2	14.6	13.7	12.0	11.8	11.5	11.0	11.7	10.4	12.1	12.9	5.4	19.2	8.2	6.2	2.4	0.4	1.6	0.1	0.0	4.2	4.3	4.7	5.2	5.7	5.1	1.8	10.4	4.6	4.3	4.7	0.0	2.0	141.3	4.2	2.7	4.4	1.2	2.1	15.1	1.8	1.4	2.9	10.2	3.0	12.7	6.5	5.7	2.5	2.3	0.0	14.3	4.9	2.0	4.1	0.6	52.9	2.1	2.6	0.0	2.8	4.4	1.8	3.1	8.0	9.9	1.5	1.0	5.3	2.9	2.8	5.5	1.0	6.4	5.5	6.6	3.3	4.8	6.6	5.3	2.1	0.1	1.9	3.4	3.9	5.6	2.1
AGAP5	"CTGLF2, Em:AC073389.1"	ENSG00000172650	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 5"	A6NIR3	10	73674287-73697881	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 79.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA042490	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042490: AB_2678022"	"unprognostic (1.84e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.04e-3)"	"unprognostic (4.33e-3)"	"unprognostic (5.83e-5)"	"unprognostic (3.33e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.17e-2)"	3.2	5.1	2.7	3.8	3.1	3.2	4.3	4.2	3.7	3.9	4.4	3.5	3.5	3.3	4.2	3.2	3.3	2.6	5.5	2.7	3.2	4.4	6.9	3.6	4.4	3.0	2.8	4.8	9.9	1.9	4.7	2.6	3.2	4.7	3.1	5.3	6.3	2.5	8.7	6.5	4.0	2.2	2.1	5.0	4.3	8.4	3.4	3.1	4.0	2.1	2.8	3.3	3.5	4.6	2.4	2.9	3.8	4.2	3.0	2.3	5.7	2.9	2.1	2.0	1.7	3.9	3.3	2.9	2.4	2.3	0.8	5.9	2.8	2.4	1.3	3.4	3.3	2.3	6.7	4.5	2.5	5.9	3.7	2.4	2.6	2.3	6.2	5.2	1.6	4.2	3.0	5.8	1.8	2.3	2.3	7.7	1.1	2.6	7.9	3.1	1.6	2.2	2.0	2.3	1.7	1.5	1.7	6.2	3.5	2.7	3.5	4.7	2.9	2.5	3.4	2.5	3.8	6.9	3.7	1.7	2.6	6.7	1.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.7	3.1	4.2	3.7	2.7	3.2	3.0	2.8	3.2	2.1	3.4	4.6	2.1	0.0	9.0	4.2	1.5	1.9	0.3	0.8	0.0	2.4	2.4	1.7	0.0	1.5	3.7	3.7	6.2	1.7	2.1	1.0	0.0	1.6	79.9	2.6	2.3	2.1	0.0	2.7	6.4	2.2	0.7	1.7	4.6	1.5	3.8	2.5	3.9	3.5	1.5	3.3	6.3	2.0	0.0	1.3	2.2	18.9	1.2	1.9	1.8	1.9	2.4	1.7	2.1	4.5	8.4	2.7	0.5	3.8	1.6	1.1	3.2	0.6	6.6	2.7	0.0	0.9	0.9	4.2	2.4	0.9	1.3	0.7	1.8	1.3	2.1	0.7
AGAP6	"bA324H6.1, CTGLF3"	ENSG00000204149	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 6"	Q5VW22	10	49982190-50011654	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.8;Late spermatids: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 9.0"									HPA042490	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042490: AB_2678022"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.34e-2)"	"unprognostic (7.48e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.93e-3)"	"prognostic unfavorable (9.70e-10)"	"unprognostic (8.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.83e-7)"	20.3	21.7	1.9	1.1	2.0	0.4	20.2	2.3	2.7	23.6	2.7	23.8	1.4	18.6	0.2	16.0	20.7	0.3	17.4	1.8	1.7	28.8	38.7	22.6	2.3	1.8	1.7	22.6	31.4	0.4	38.6	0.8	1.8	28.4	1.0	0.7	18.5	1.3	20.1	18.9	24.0	1.1	1.5	35.0	20.8	29.3	1.9	3.2	29.0	0.6	0.7	19.2	19.5	2.1	1.0	1.4	0.8	2.1	2.7	1.5	1.8	3.0	0.5	1.0	1.6	2.9	1.1	2.3	1.0	0.6	0.6	1.5	1.0	1.0	1.4	1.4	4.3	3.8	3.0	1.2	1.2	3.1	4.6	1.8	3.4	1.2	3.7	1.6	1.2	2.3	3.9	3.1	1.8	1.4	3.5	9.0	0.6	0.8	3.6	2.6	0.9	1.2	2.0	2.3	2.1	2.6	0.7	2.3	1.1	0.7	1.8	1.6	3.1	1.4	1.4	0.4	2.4	4.9	2.1	1.5	0.3	3.3	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	2.0	2.3	2.7	1.8	1.7	1.8	1.7	1.8	1.5	1.9	2.1	6.0	19.2	10.9	19.2	2.9	3.3	1.8	1.3	1.2	6.2	5.6	7.4	8.3	2.8	7.8	0.0	4.2	2.6	6.0	4.5	0.0	2.4	84.8	4.3	5.0	5.8	7.3	2.5	22.6	2.5	1.5	3.9	6.6	5.1	7.6	5.1	5.0	5.4	2.2	3.3	17.8	6.4	0.0	5.0	1.5	44.0	5.6	4.5	0.0	10.3	5.1	2.8	3.1	14.6	17.4	2.6	3.3	4.5	6.2	3.2	4.0	0.7	7.5	7.0	0.0	4.3	4.8	10.7	7.8	1.3	5.3	1.4	5.9	3.8	8.4	2.0
AGAP9	"bA301J7.2, CTGLF6, FLJ00312"	ENSG00000204172	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 9"	Q5VTM2	10	47501854-47523638	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA042490	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042490: AB_2678022"	"unprognostic (6.26e-2)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (9.98e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.89e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (9.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.70e-3)"	"prognostic favorable (7.04e-4)"	12.7	14.5	7.8	5.2	8.6	8.5	14.4	9.7	9.4	17.9	9.4	14.1	15.6	12.2	6.7	13.5	14.9	5.6	13.0	7.7	8.1	22.1	39.8	12.2	5.4	8.7	8.4	18.6	32.1	3.0	26.1	2.3	9.0	18.0	3.4	11.9	14.2	4.7	9.9	19.7	19.2	3.5	7.1	14.6	18.4	27.3	9.0	4.9	19.8	2.3	3.2	12.3	14.8	10.0	4.4	6.6	5.7	5.8	5.1	4.2	6.8	4.2	1.9	2.0	1.5	7.9	6.9	0.9	5.2	2.9	1.2	12.9	2.3	3.0	1.5	8.5	12.4	2.5	2.6	9.4	4.5	9.3	7.4	2.9	5.8	5.1	14.2	2.2	1.0	0.5	4.0	3.5	1.3	7.3	1.6	11.9	3.1	3.2	1.3	3.4	3.2	2.8	4.1	5.0	0.7	4.1	3.4	7.0	0.9	5.4	9.3	5.1	5.3	4.3	7.1	5.0	7.8	4.8	3.7	4.3	4.3	9.7	1.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.8	8.6	9.7	9.4	7.7	8.1	8.7	8.4	9.0	7.1	9.0	10.0	3.8	3.2	9.9	0.0	1.6	0.0	1.6	0.0	2.8	6.6	5.3	5.0	1.6	7.2	3.1	11.0	18.8	3.1	3.0	0.2	1.9	1.8	109.7	12.3	4.7	2.7	1.2	2.7	0.0	2.2	0.7	3.6	20.4	4.1	7.6	7.1	2.2	7.2	2.1	11.8	0.0	1.5	0.0	3.0	0.0	21.5	3.4	3.3	0.0	0.0	1.7	4.3	1.0	0.0	0.0	6.0	0.8	6.0	2.1	2.6	6.7	1.0	6.6	8.7	0.0	3.2	2.9	12.4	4.8	1.8	0.0	1.0	2.3	4.0	2.0	1.8
AGBL2	"CCP2, FLJ23598"	ENSG00000165923	"ATP/GTP binding protein like 2"	Q5U5Z8	11	47659591-47715389	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.7;testis: 12.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.5;Endometrial ciliated cells: 25.7;Respiratory ciliated cells: 77.2;Spermatocytes: 19.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;T-47d: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007718	Uncertain					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA007718: AB_1078110"	"unprognostic (3.44e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.33e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (9.83e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.24e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-3)"	0.3	1.3	0.3	0.4	0.2	0.2	0.5	0.7	0.3	1.4	2.6	0.8	0.3	0.6	1.1	0.4	7.7	0.2	0.2	0.3	0.4	1.6	3.0	1.6	0.5	1.2	1.8	1.3	0.8	0.3	1.7	0.2	0.8	1.2	0.2	0.3	0.5	0.4	0.0	0.4	1.2	0.1	1.0	0.9	0.6	12.5	0.2	0.7	1.5	0.0	0.4	1.1	0.6	0.4	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.3	0.2	0.6	0.2	2.3	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.3	0.7	0.1	0.1	1.1	0.8	0.3	0.0	0.3	0.6	0.2	0.3	0.2	0.2	0.0	0.8	0.1	0.5	0.3	0.9	0.5	0.2	0.0	0.1	0.0	0.6	0.0	0.2	0.3	1.0	0.8	0.1	0.2	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.3	0.0	0.5	0.4	0.4	0.1	0.3	0.0	0.3	0.5	0.1	0.3	0.2	0.7	0.3	0.3	0.4	1.2	1.8	0.8	1.0	0.2	0.4	0.1	0.0	2.7	2.6	1.3	0.1	1.3	2.6	2.2	0.1	0.9	0.6	0.6	0.0	6.5	7.3	0.0	0.4	0.5	0.7	0.0	0.4	37.5	25.7	1.3	0.1	1.2	0.8	0.6	0.0	0.3	1.2	1.5	0.9	0.0	0.8	0.4	0.8	0.1	0.0	0.6	0.5	2.0	0.6	0.0	8.2	0.3	0.3	0.0	1.0	1.0	0.7	0.0	1.0	0.5	0.3	0.6	1.5	0.4	0.4	2.4	0.2	77.2	0.5	0.0	0.3	1.1	19.3	1.8	0.6	0.0	0.4	1.3	1.3	0.9	0.5
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.5;Excitatory neurons: 40.7;Inhibitory neurons: 34.2;Oligodendrocytes: 37.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5"	"Low region specificity"	"Detected in all"							"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	1.0	0.9	1.0	2.3	1.3	2.2	2.3	2.0	3.0	0.8	1.2	1.2	0.8	2.9	7.9	0.1	1.8	0.7	0.8	1.0	1.9	1.7	0.6	1.8	2.3	1.3	1.2	3.5	2.3	0.4	0.3	0.9	1.1	1.9	1.5	1.3	2.5	2.1	2.4	2.5	2.0	1.6	1.3	3.8	2.5	5.1	1.7	0.9	2.8	0.8	0.9	0.3	0.2	1.8	1.7	0.9	2.2	0.5	0.6	0.8	1.3	0.4	0.0	0.3	0.5	3.0	1.9	2.7	0.8	0.0	0.9	1.8	0.8	0.3	0.0	2.2	5.5	2.3	4.0	3.0	0.0	1.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	3.0	1.7	1.5	0.3	1.5	0.6	0.9	1.9	0.2	0.2	1.6	0.1	0.8	1.5	0.3	1.3	1.4	0.3	0.0	0.2	0.0	1.2	2.3	0.0	0.2	0.5	0.3	1.0	3.3	1.1	1.3	1.1	2.8	2.7	0.0	0.1	0.1	0.8	0.0	0.7	0.8	0.4	0.9	0.2	0.7	0.7	1.7	0.2	0.9	0.0	0.6	0.6	0.6	1.0	1.3	2.0	3.0	1.0	1.9	1.3	1.2	1.1	1.3	1.7	1.8	6.7	3.2	0.6	18.3	3.5	1.3	0.9	1.2	2.8	5.1	2.2	2.2	2.1	4.3	2.0	9.2	2.1	0.3	0.9	0.6	7.9	4.6	70.5	6.6	1.8	4.8	3.0	3.0	40.7	2.9	0.4	2.8	4.6	2.6	1.3	3.2	5.0	1.9	0.5	3.3	34.2	0.4	0.0	1.3	0.7	11.8	3.4	0.8	5.4	22.5	6.9	2.8	1.0	16.6	37.3	1.7	0.1	2.2	6.1	1.3	0.4	7.6	6.4	3.3	0.0	2.0	4.1	21.4	6.3	1.2	0.3	0.1	2.0	2.4	0.5	1.0
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532854-50023954	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.4;retina: 5.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 1232.8;Inhibitory neurons: 630.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;SCLC-21H: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037994	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	0.4	1.5	2.0	0.1	2.4	0.2	0.4	0.0	5.4	0.2	2.3	0.1	0.0	0.2	0.8	0.1	2.8	0.1	1.4	2.0	0.0	3.9	1.6	0.4	0.1	0.0	0.5	0.3	0.8	2.4	2.4	0.9	0.2	0.1	0.1	5.9	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.3	0.2	2.4	0.1	0.4	1.1	0.1	0.1	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.0	2.4	0.0	5.4	2.0	0.0	0.0	0.5	0.2	0.0	0.1	0.8	0.2	0.0	0.0	166.2	0.0	0.3	1.0	0.3	0.0	4.0	0.4	1.1	2.2	0.0	0.9	3.7	85.5	0.2	0.0	0.4	1.9	0.1	12.6	10.7	0.1	0.4	6.0	0.0	1232.8	0.2	0.1	0.5	0.0	0.2	0.0	0.2	0.4	0.1	0.1	5.0	630.3	0.5	2.0	0.0	0.0	9.1	0.3	0.0	0.0	40.3	0.0	2.4	0.0	142.2	19.2	0.0	0.1	0.7	0.0	0.3	0.0	4.4	10.5	22.6	0.0	0.7	0.3	19.9	10.4	0.0	0.0	0.1	0.0	0.4	0.1	0.2
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561217	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles		NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (7.31e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	69.4	39.4	30.4	48.4	31.6	155.5	51.1	29.3	36.0	25.3	23.8	32.2	43.4	25.7	20.1	47.2	27.3	38.9	36.2	32.4	27.0	36.9	36.2	54.6	47.1	34.6	29.0	26.1	35.0	41.6	17.9	75.8	33.4	21.0	33.0	47.7	27.9	23.4	33.9	36.3	36.2	39.3	33.6	46.5	33.2	92.8	34.5	48.6	34.3	38.6	53.3	65.7	32.2	47.3	60.5	97.9	50.8	49.6	84.8	62.1	191.6	78.4	74.6	92.0	81.2	77.4	67.6	42.7	58.3	86.8	123.8	62.2	87.9	101.7	118.6	72.3	48.9	94.1	80.8	144.3	90.9	64.7	57.0	38.3	106.4	116.7	109.5	70.3	93.7	43.3	100.3	112.0	111.8	85.8	77.8	58.0	79.3	80.4	50.4	70.8	83.6	30.3	91.7	81.5	47.0	36.7	64.1	82.5	74.7	87.6	35.3	72.4	92.7	78.8	63.0	114.7	70.0	64.5	46.9	59.6	85.6	54.4	92.5	4.1	5.3	1.9	1.6	4.3	3.2	2.0	1.8	1.5	3.3	3.5	1.5	2.8	5.6	1.1	4.2	2.3	2.3	1.6	30.4	31.6	29.3	36.0	32.4	27.0	34.6	29.0	33.4	33.6	34.5	47.3	36.6	25.6	23.6	45.7	27.2	33.1	37.5	18.0	18.2	37.7	29.3	22.1	23.3	17.2	19.6	22.0	25.0	31.0	26.5	28.2	15.6	17.5	162.3	32.7	34.9	29.1	34.1	13.3	114.2	21.5	17.5	26.8	39.8	65.8	12.7	30.4	23.6	22.9	24.1	43.7	74.9	20.4	12.2	92.8	33.6	333.2	15.5	67.3	19.6	119.9	48.4	43.3	19.6	109.6	116.0	32.6	18.0	11.7	22.7	39.4	31.3	27.4	15.5	35.4	19.7	83.8	21.7	72.6	18.4	25.0	32.1	39.7	24.0	20.6	22.2	57.9
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539203-100568220	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"salivary gland: 289.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatic stellate cells: 57.5;Hepatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	12.8	35.6	16.7	5.1	20.1	5.0	11.2	10.8	15.8	11.6	6.8	18.9	10.3	21.9	5.3	30.8	16.4	11.1	9.8	22.0	14.7	14.0	53.9	7.8	9.0	19.4	12.0	30.2	18.8	7.4	17.7	2.2	14.1	13.3	9.9	2.2	289.4	13.4	6.2	26.0	13.4	7.6	11.1	29.1	13.5	12.1	15.5	4.4	10.7	5.6	6.4	11.7	12.5	12.3	10.8	17.2	2.2	5.1	15.1	7.8	3.0	5.1	13.6	7.9	8.2	15.1	9.6	6.8	16.5	6.0	34.8	8.8	2.4	5.2	3.5	24.1	6.7	2.1	8.3	33.1	6.1	2.2	11.7	13.0	3.9	6.4	7.1	4.9	21.6	4.4	6.4	9.2	6.5	9.5	8.8	8.0	1.5	30.0	7.1	4.3	2.5	6.1	4.6	5.7	3.1	3.8	9.9	14.0	4.6	3.4	4.0	3.0	5.5	9.8	6.7	24.5	5.4	5.6	31.4	2.6	7.4	6.5	5.7	2.2	0.0	2.2	1.7	0.2	1.5	0.3	1.7	2.0	0.1	0.6	0.5	0.7	0.4	0.5	0.0	0.4	1.4	0.6	16.7	20.1	10.8	15.8	22.0	14.7	19.4	12.0	14.1	11.1	15.5	12.3	16.9	0.0	3.9	15.0	3.2	2.0	7.4	2.3	8.6	1.6	4.3	3.6	9.1	34.3	3.1	25.8	2.1	1.8	4.9	25.8	11.7	13.4	1.7	2.8	3.2	13.4	26.5	5.9	6.2	11.6	1.6	3.6	10.2	4.2	2.5	7.2	57.5	37.0	1.5	3.3	4.8	12.0	2.0	5.4	3.1	2.3	5.6	1.3	3.6	3.7	7.1	4.0	7.2	3.0	2.5	7.2	9.6	9.1	7.3	3.6	11.1	2.8	1.0	1.7	13.1	1.5	5.6	14.5	14.5	9.2	5.4	0.8	12.6	6.8	15.2	6.9
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551278-141655244	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.4;Inhibitory neurons: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 97.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	10.1	14.7	9.4	8.5	10.9	5.6	11.9	8.3	12.8	11.5	10.2	11.8	5.9	11.7	14.5	12.2	12.2	7.8	30.4	11.1	10.8	15.7	14.1	11.6	12.1	8.0	8.8	11.3	10.1	21.5	13.7	10.0	9.0	12.8	13.1	12.7	13.7	11.4	8.6	9.6	12.0	15.4	8.2	16.6	12.2	6.6	10.0	14.0	12.7	10.0	14.7	10.8	11.5	9.0	23.7	25.6	26.7	21.8	21.2	29.4	16.2	23.5	29.3	44.5	50.9	24.7	18.3	26.3	24.0	26.8	40.5	18.7	41.6	32.8	51.0	33.8	32.7	26.1	10.7	18.7	34.1	15.6	12.5	29.9	26.9	36.3	33.1	19.8	34.1	32.3	36.3	36.9	25.3	24.6	47.3	9.1	25.6	19.9	32.4	29.2	4.2	80.1	33.1	20.8	23.3	29.6	24.6	29.7	27.1	26.1	16.3	20.2	19.5	18.9	14.1	23.8	38.1	29.5	31.9	14.4	30.7	9.1	50.4	0.4	7.1	1.2	22.1	13.9	15.3	10.8	17.3	26.0	16.2	6.5	12.8	23.5	1.2	97.3	8.2	6.3	18.9	15.7	9.4	10.9	8.3	12.8	11.1	10.8	8.0	8.8	9.0	8.2	10.0	9.0	8.4	0.0	6.0	22.5	11.4	3.1	5.6	7.9	5.2	11.8	5.5	5.1	18.1	2.8	6.6	12.9	8.4	15.7	15.8	3.0	9.8	6.6	9.9	7.4	9.0	7.5	0.0	11.8	43.4	6.9	8.2	7.7	10.7	6.6	8.2	9.9	4.2	4.1	7.0	15.2	43.0	3.9	12.2	5.1	4.9	12.0	6.8	5.6	7.2	26.2	12.4	11.2	27.8	38.7	37.9	6.1	2.1	10.5	22.1	2.9	2.4	8.2	7.6	17.4	0.0	6.2	8.0	6.2	4.9	11.3	2.7	9.2	15.0	14.2	5.6	3.8
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 133.9;liver: 62.1;skeletal muscle: 34.2"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.6	1.5	0.5	1.1	9.2	17.9	0.5	0.3	0.5	0.3	0.5	0.1	1.1	1.3	133.9	62.1	0.2	4.0	0.7	0.6	0.1	0.6	2.2	0.3	0.2	0.8	0.5	6.8	0.4	4.6	0.1	34.2	0.4	13.4	0.7	0.4	1.6	1.8	0.7	0.9	2.1	0.5	6.1	4.1	0.8	0.1	1.2	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.6	1.5	1.1	1.3	0.7	0.6	0.8	0.4	0.9	1.2	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute RISC catalytic component 2"	Q9UKV8	8	140520156-140635633	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		65000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	7.8	4.1	6.9	6.2	11.5	11.3	5.9	12.4	9.2	6.9	2.4	8.6	3.2	7.7	5.9	6.3	8.3	5.1	7.3	5.7	11.4	5.9	3.8	9.1	6.1	14.0	10.1	9.5	5.0	7.0	8.0	5.8	11.3	5.8	4.0	6.8	4.8	4.6	17.5	8.5	6.2	5.2	5.9	5.2	6.6	3.3	10.8	7.6	6.3	9.1	5.4	6.6	6.7	19.2	18.9	15.2	15.3	17.6	9.9	11.5	12.9	11.6	8.4	5.1	6.3	17.0	5.5	21.5	14.1	11.3	5.5	12.4	26.2	12.5	11.3	12.2	13.7	25.2	28.7	11.0	8.9	10.5	8.2	7.9	11.0	14.1	14.6	7.0	12.0	13.4	26.9	13.2	16.8	28.5	18.2	8.3	11.4	12.9	26.3	18.5	12.9	9.7	6.5	19.3	18.0	13.0	18.1	6.1	12.8	15.7	15.7	15.1	16.9	8.8	24.5	14.0	18.9	11.5	4.0	14.7	6.5	18.7	13.2	0.7	0.8	0.2	0.8	0.7	0.9	0.4	0.8	0.7	0.7	0.7	0.8	0.8	2.2	0.8	0.8	0.5	0.7	0.6	6.9	11.5	12.4	9.2	5.7	11.4	14.0	10.1	11.3	5.9	10.8	19.2	30.8	22.4	25.1	50.3	40.7	21.9	74.8	5.7	17.6	26.5	34.5	24.5	22.2	8.6	22.6	14.7	43.8	46.5	63.1	14.8	7.9	25.6	21.2	73.1	54.3	37.8	24.2	122.9	32.6	18.2	21.5	44.3	28.5	129.4	17.1	31.6	27.5	14.6	14.9	42.1	36.4	19.1	2.0	26.0	48.5	14.9	37.3	53.0	5.4	32.8	36.0	26.1	32.0	51.3	83.2	37.9	18.6	46.3	46.6	115.0	12.7	9.4	15.4	29.7	32.9	65.9	44.5	3.1	4.0	31.8	23.9	79.1	49.1	12.0	19.3	100.1
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute RISC component 4"	Q9HCK5	1	35808016-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 60.6;Inhibitory neurons: 72.0;Microglial cells: 63.7;Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	8.8	4.9	7.2	8.8	7.1	20.4	7.7	8.6	7.9	8.4	8.6	9.6	4.7	8.9	6.6	7.3	7.2	6.2	9.9	6.8	6.8	5.0	7.5	11.4	7.0	7.4	7.1	7.0	8.6	6.5	5.8	8.9	7.4	8.1	6.4	18.1	8.4	6.1	13.3	20.1	7.8	9.8	6.8	14.2	9.7	7.3	7.3	7.3	5.5	11.8	6.8	8.2	8.5	7.6	6.0	1.5	11.3	6.5	5.8	6.6	5.7	4.5	4.4	4.6	5.3	0.8	9.0	9.6	6.0	6.6	4.7	2.4	4.9	3.6	4.3	10.7	4.5	4.9	4.2	2.8	5.5	5.6	7.2	4.3	7.6	2.5	3.8	8.8	7.9	11.5	3.7	3.7	6.2	0.9	9.1	6.2	3.7	3.8	2.7	9.0	10.1	1.2	4.5	7.4	5.0	7.3	4.1	3.7	12.7	9.6	3.0	24.6	9.5	3.5	1.7	3.6	3.4	5.4	1.8	1.4	4.3	7.0	3.2	1.3	2.7	3.0	0.8	1.5	1.4	0.6	0.7	1.1	2.0	0.4	0.3	0.4	7.5	0.6	1.4	0.4	0.2	0.8	7.2	7.1	8.6	7.9	6.8	6.8	7.4	7.1	7.4	6.8	7.3	7.6	16.4	19.2	21.7	54.9	6.7	9.8	4.7	5.4	9.6	28.2	8.5	7.1	21.8	12.8	9.2	11.0	22.9	4.2	17.9	5.5	1.9	5.6	2.0	12.7	9.4	11.6	12.6	5.0	60.6	5.6	4.7	7.2	10.7	10.9	2.5	11.4	22.1	11.5	13.5	6.7	72.0	8.4	2.0	42.3	10.0	1.6	5.0	28.9	3.6	63.7	33.6	6.5	6.2	87.4	54.8	14.4	11.7	5.7	4.3	9.0	10.0	1.5	10.3	32.2	19.7	6.8	8.5	11.3	1.6	5.9	12.8	4.1	10.3	3.6	5.7	6.7
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	46.6	60.3	3.0	5.9	7.2	6.6	42.6	2.5	47.1	58.2	2.9	61.3	28.2	64.3	42.9	33.9	56.5	18.9	66.9	4.0	25.5	61.6	60.2	44.2	10.9	3.8	9.5	67.2	37.5	9.3	53.8	15.9	4.4	53.2	20.1	12.5	34.1	0.0	67.7	35.1	53.0	1.5	2.5	39.8	58.4	79.3	3.3	18.4	54.1	33.5	12.5	58.2	42.7	4.7	0.0	0.4	51.2	0.3	127.5	85.2	49.4	0.0	0.0	0.0	0.0	104.5	0.0	0.0	46.1	128.0	36.4	13.4	108.5	39.4	0.0	0.4	83.6	0.0	0.0	111.7	0.0	0.0	101.5	51.0	47.6	0.0	46.0	105.9	31.6	86.7	78.5	66.0	109.2	28.8	0.4	26.8	0.0	0.1	18.0	0.6	0.0	0.5	32.8	0.0	0.0	0.1	51.3	16.1	70.4	51.6	63.4	0.0	25.9	0.0	20.3	0.0	0.2	45.9	41.1	18.0	64.3	0.1	0.3	3.4	5.6	12.4	7.6	8.2	7.4	5.3	5.0	8.6	9.3	5.0	4.3	6.4	9.4	8.7	5.8	11.6	7.2	6.9	3.0	7.2	2.5	47.1	4.0	25.5	3.8	9.5	4.4	2.5	3.3	4.7	32.1	16.0	18.6	11.1	14.3	9.1	14.0	20.6	16.5	26.1	26.2	21.6	4.0	14.3	12.0	36.8	12.5	35.2	24.5	28.7	5.9	17.9	63.9	14.1	24.9	21.3	29.4	12.0	13.8	14.3	29.9	19.6	16.3	11.4	12.7	22.7	27.1	31.2	24.7	32.0	17.7	24.3	18.3	22.3	20.6	91.7	13.4	24.9	8.8	11.2	13.0	38.5	21.6	10.1	14.8	17.0	22.3	21.4	16.9	10.2	73.6	29.4	12.9	17.9	0.0	18.3	22.9	44.8	22.1	9.5	3.7	15.3	13.8	21.5	20.8	12.1
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687457	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 369.3;liver: 445.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 688.9;Late spermatids: 387.3;Paneth cells: 670.7;Proximal enterocytes: 1298.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 186.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019544	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	369.3	38.3	11.4	11.8	9.3	34.2	259.9	8.8	15.9	32.1	13.5	83.2	111.4	26.4	9.6	85.6	29.7	15.7	84.9	9.4	12.6	80.2	445.0	60.9	9.2	11.8	12.3	17.7	129.6	18.4	41.5	8.0	11.3	34.3	12.2	0.9	48.1	12.8	37.4	51.1	119.4	6.7	11.4	39.2	52.0	24.1	13.9	5.5	46.9	10.0	5.3	35.5	36.6	9.6	55.0	75.2	8.9	41.4	63.3	19.8	37.3	35.5	28.5	24.1	18.5	86.0	105.7	17.8	77.8	21.0	38.6	145.1	12.7	22.2	2.8	186.9	57.3	26.5	30.3	19.2	42.6	28.1	62.1	19.0	30.9	20.9	11.0	20.9	12.5	23.6	32.7	2.9	10.4	98.5	1.9	87.4	22.5	101.0	135.0	41.0	31.3	100.3	28.5	33.9	19.5	31.4	45.8	47.6	60.3	6.8	30.6	109.3	24.7	31.5	32.1	10.4	23.0	4.4	0.4	11.8	0.4	59.7	32.1	20.1	88.8	111.8	6.8	83.5	6.5	12.8	5.8	7.9	47.8	22.7	4.6	5.5	61.1	7.2	75.7	65.6	8.1	35.2	11.4	9.3	8.8	15.9	9.4	12.6	11.8	12.3	11.3	11.4	13.9	9.6	25.9	16.0	64.4	0.7	20.2	45.2	60.0	64.0	22.8	3.5	23.4	22.4	39.6	87.2	45.3	73.5	0.0	7.3	30.8	688.9	54.8	155.2	136.4	50.4	17.4	27.9	35.8	8.0	1.9	219.5	37.1	30.1	81.6	63.8	13.4	31.4	31.1	228.0	131.2	40.4	2.6	197.3	126.1	53.4	57.4	387.3	26.8	57.6	136.9	4.7	48.8	14.6	23.7	0.0	0.3	169.5	670.7	20.3	13.4	93.5	1298.3	41.9	46.3	3.8	46.0	15.3	29.8	1.8	27.2	47.5	81.3	6.8	26.6	16.4	207.7	196.2
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129967-161274061	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 51.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 407.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;HEL: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	4.8	2.1	14.7	1.8	30.5	5.2	4.5	24.6	22.5	7.2	5.6	6.4	1.2	7.8	2.2	3.7	6.1	4.2	2.6	14.9	22.7	6.0	0.8	6.7	0.9	47.1	26.3	7.4	2.1	0.3	11.4	8.7	34.3	3.6	2.1	2.2	2.7	2.4	1.0	2.3	2.6	4.7	25.5	4.6	2.3	2.8	28.6	1.3	4.1	1.0	1.0	3.0	5.0	51.3	0.5	1.0	25.5	5.1	4.7	9.5	1.1	0.9	0.3	1.9	3.2	1.5	4.6	0.7	1.8	4.2	11.8	0.5	4.8	4.0	1.8	2.9	8.1	19.4	4.9	0.1	3.7	0.2	2.8	11.4	1.9	5.0	2.7	9.1	6.1	3.1	9.8	8.9	2.4	0.0	1.4	2.2	6.2	0.0	9.7	0.0	1.1	0.5	5.6	0.4	14.8	5.6	4.0	2.1	1.1	9.9	1.1	1.2	6.8	2.6	3.3	1.8	4.4	0.7	1.0	0.0	9.9	1.0	1.6	0.0	1.8	0.0	3.4	1.5	1.1	0.2	1.6	2.1	1.0	0.5	0.8	1.2	0.3	2.9	1.3	0.8	1.7	1.3	14.7	30.5	24.6	22.5	14.9	22.7	47.1	26.3	34.3	25.5	28.6	51.3	12.0	3.2	5.5	7.5	4.5	3.2	5.5	9.7	6.2	2.4	3.5	2.7	5.6	5.7	6.9	5.5	0.0	20.3	31.1	6.1	0.0	5.2	52.1	23.8	12.5	13.5	1.8	31.5	87.9	8.2	12.0	17.8	4.6	5.1	11.4	20.6	10.4	0.2	18.2	0.0	95.8	0.7	10.2	7.2	16.4	72.8	5.9	17.0	3.6	23.4	9.4	4.0	9.2	56.3	407.6	5.5	18.7	8.6	15.7	1.3	0.0	0.6	21.4	1.2	19.7	5.3	6.9	4.9	2.8	1.1	2.6	22.2	14.1	3.7	1.4	3.6
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708642-6761503	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.4	11.8	6.7	2.9	6.8	2.3	4.9	7.2	8.3	6.5	6.1	8.0	3.1	6.6	7.9	8.5	7.4	1.8	3.4	6.6	7.4	7.2	10.0	4.5	4.1	7.8	7.4	5.8	6.4	3.3	10.3	4.1	7.6	6.0	4.2	5.2	5.0	5.6	11.3	3.5	6.7	2.9	7.6	4.8	6.9	22.5	7.1	4.7	4.0	2.7	3.7	4.7	5.8	8.7	8.5	7.0	15.3	6.8	3.4	5.2	9.4	4.3	4.6	7.9	7.0	4.6	7.3	21.8	3.2	3.3	10.8	11.0	9.5	9.5	11.2	4.6	6.6	27.4	7.0	10.5	9.1	12.4	10.0	7.6	10.0	6.7	9.8	8.2	13.6	9.5	19.9	10.7	11.4	6.3	23.5	20.1	20.4	13.6	5.8	15.0	15.0	8.2	7.9	13.1	24.4	14.8	4.1	7.9	9.4	8.1	3.6	20.5	5.5	10.8	5.4	4.4	12.4	4.0	12.8	11.3	7.3	13.8	12.9	1.8	1.9	1.2	0.7	2.4	1.6	4.4	1.3	1.4	1.2	5.1	0.9	1.1	0.2	2.7	2.2	4.4	1.2	1.4	6.7	6.8	7.2	8.3	6.6	7.4	7.8	7.4	7.6	7.6	7.1	8.7	15.7	3.2	4.4	58.8	46.5	9.1	18.8	14.2	19.4	7.8	14.2	10.5	5.8	11.5	9.0	7.3	2.1	9.4	23.5	17.4	3.9	11.2	40.0	30.0	27.9	22.3	22.1	50.0	45.0	10.0	14.2	10.4	27.0	83.6	18.9	10.6	10.4	41.9	12.2	6.7	46.8	10.1	14.2	16.0	4.6	34.7	15.8	12.6	7.2	33.7	7.5	42.3	6.2	56.8	60.2	10.2	16.0	15.4	22.3	30.4	9.8	22.5	14.6	9.8	6.6	14.0	24.7	26.2	10.9	30.9	10.4	18.5	17.4	15.0	25.2	11.9
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392746-177567024	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		69000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	14.3	9.2	4.4	15.6	6.9	19.6	13.9	7.1	6.9	14.3	4.6	20.1	11.1	14.6	6.5	12.7	9.8	11.3	10.4	4.7	6.6	18.1	19.3	13.7	11.9	8.9	7.0	7.8	11.4	18.5	3.4	13.2	8.2	7.0	21.9	6.4	8.3	8.8	11.7	4.5	13.1	21.1	7.8	8.7	9.9	16.3	6.3	16.1	12.6	12.6	12.8	14.6	5.2	11.9	43.1	36.3	23.3	19.0	32.2	33.2	33.3	29.6	21.9	34.5	34.8	70.6	34.0	58.5	59.5	45.0	46.3	47.5	64.4	45.1	47.8	51.4	16.7	77.6	56.5	75.8	31.9	82.3	63.5	28.6	28.7	58.6	44.6	33.3	75.3	42.1	44.9	26.3	45.7	0.1	59.9	22.4	33.3	42.7	30.9	47.0	65.1	32.7	60.0	65.0	22.0	31.3	66.2	5.8	43.0	58.1	0.4	35.4	70.0	29.4	61.9	26.8	64.2	28.7	59.0	23.6	29.4	43.1	11.8	2.6	3.3	5.8	1.9	4.0	2.9	1.7	3.0	2.4	3.6	1.1	2.7	1.6	1.5	2.8	3.6	0.1	4.3	2.2	4.4	6.9	7.1	6.9	4.7	6.6	8.9	7.0	8.2	7.8	6.3	11.9	20.2	16.0	13.1	29.4	10.7	10.8	6.5	15.5	12.0	11.5	19.2	6.7	20.0	20.0	13.0	14.7	2.1	14.1	15.5	25.6	13.7	20.9	262.2	25.2	17.2	14.0	19.8	20.8	53.0	23.2	20.6	23.0	18.8	25.4	64.1	16.6	11.7	31.0	31.8	15.2	61.7	30.4	16.2	30.0	31.8	41.4	14.6	28.7	14.2	56.2	36.0	12.0	21.6	45.8	83.8	23.9	17.4	13.9	14.1	3.8	15.3	46.5	21.6	7.6	6.6	16.8	16.4	41.7	22.2	16.2	9.8	7.0	19.0	22.7	26.0	6.1
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 638.7;intestine: 1224.0;stomach 1: 1402.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.7	0.0	66.6	0.0	0.0	72.3	0.2	0.5	638.7	0.0	768.1	486.0	14.1	389.1	16.2	306.4	275.8	0.2	0.1	0.0	11.2	0.9	50.7	0.6	0.0	0.1	0.3	22.1	0.1	31.4	1.6	0.0	227.3	1224.0	0.0	475.3	181.0	0.2	2.5	379.2	45.2	0.0	0.9	1402.3	0.9	0.0	1.7	7.4	0.1	7.2	160.8	4.0	0.1	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859412-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 225.2;intestine: 237.6;lung: 152.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"OE19: 109.8;T-47d: 339.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 4.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		67000		"Cluster 9: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.1	0.0	11.0	0.0	0.0	69.6	0.0	0.2	25.0	0.1	219.9	167.2	8.7	0.0	1.5	225.2	48.3	0.1	0.1	0.4	2.5	0.3	152.7	0.2	2.0	3.4	0.3	10.7	0.0	21.2	0.8	1.0	4.8	214.9	0.0	30.9	0.8	0.0	1.5	237.6	8.7	0.7	0.3	99.9	0.2	0.2	0.0	7.3	0.0	0.8	27.6	0.2	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	109.8	0.0	0.0	0.0	2.3	8.1	0.0	1.3	0.4	0.0	0.6	0.0	0.0	339.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	2.0	3.4	1.0	0.7	0.2	0.5	0.7	333.3	408.1	0.3	1.4	2.7	12.5	108.5	0.0	0.0	105.1	51.9	0.1	31.5	319.9	29.5	0.0	3.4	0.7	380.0	1.9	30.4	0.0	861.1	7.4	1.9	112.7	0.0	0.2	71.4	3.3	5.3	71.4	39.2	20.8	0.0	0.0	0.0	0.5	0.0	0.2	701.9	134.3	0.0	0.3	0.0	0.3	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	16.6	744.5	0.0	0.4	7.1	1051.2	0.0	1771.2	0.0	0.0	0.0	27.9	0.0	0.1	0.0	9.8	2.2	4.1	0.0	495.4	117.9
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483547	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 122.5;epididymis: 37.1"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 3.9;Hofbauer cells: 8.8;Leydig cells: 3.1;Macrophages: 4.5;Peritubular cells: 2.6;Theca cells: 5.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	60	"hypothalamus: 122.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.2"	"Region enriched"	"Detected in single"	16	"hypothalamus: 16.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	HPA041017	Enhanced	Supported			"Secreted in brain"	NA	NA	255000		"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.0	12.4	1.2	0.2	1.0	0.2	0.0	0.8	2.0	0.0	1.6	0.1	0.0	0.0	37.1	0.0	0.0	0.0	0.1	1.0	122.5	1.0	0.1	3.7	0.4	1.7	1.1	0.1	0.0	0.2	0.7	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.3	0.0	0.3	0.5	0.3	0.4	2.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.1	0.1	0.0	1.6	0.5	0.9	1.1	0.3	0.7	0.2	0.3	0.7	0.4	0.6	0.6	0.2	0.0	0.4	0.5	0.3	0.4	1.2	1.0	0.8	2.0	1.0	122.5	1.7	1.1	1.0	0.3	2.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.6	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.6	0.0	0.4	3.1	4.5	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	5.0	0.0	0.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1603.7"	"Group enriched"	"Detected in many"	9	"Cholangiocytes: 985.1;Hepatocytes: 2244.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 646.2;THP-1: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	11.7	14.6	252.9	2.6	259.8	0.4	4.4	267.5	243.6	9.7	138.2	5.6	2.5	3.2	1.9	2.6	6.0	92.7	154.7	236.0	242.1	52.5	1603.7	5.1	1.0	352.4	314.4	3.5	7.9	6.0	25.8	0.7	304.9	16.3	3.6	26.4	4.9	2.2	43.6	2.0	9.7	5.8	340.5	1.3	4.9	4.1	273.5	1.7	13.2	25.8	0.1	7.0	4.5	322.4	0.2	0.4	0.2	0.2	15.6	0.0	0.9	0.6	0.2	0.0	0.0	80.6	0.1	0.3	0.7	0.2	0.7	0.7	0.0	0.0	0.0	11.4	0.2	0.2	0.3	646.2	1.9	1.0	0.5	26.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	5.5	0.7	0.0	0.2	0.6	0.6	0.1	0.2	0.3	2.4	0.1	0.1	0.3	0.9	0.6	0.4	0.1	5.5	0.1	0.0	243.6	0.1	0.4	1.3	0.4	1.2	3.5	47.0	0.4	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.9	259.8	267.5	243.6	236.0	242.1	352.4	314.4	304.9	340.5	273.5	322.4	0.8	0.0	1.7	140.0	11.3	0.6	1.1	0.0	0.0	4.7	0.8	0.3	60.0	985.1	0.6	3.7	35.5	0.1	0.0	0.0	25.4	169.8	62.2	0.3	0.4	5.5	0.0	50.8	0.3	10.0	0.2	27.2	0.5	0.1	0.0	0.0	39.3	2244.9	2.1	3.3	1.5	1.1	0.0	56.9	0.4	48.5	4.1	0.9	8.8	5.6	0.6	75.1	0.0	3.5	6.8	13.7	1.2	3.4	0.0	26.2	24.2	146.9	0.1	49.8	13.1	7.2	94.1	0.4	0.4	0.0	0.0	0.7	3.9	0.0	0.4	1.9
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.1;brain: 73.4;retina: 46.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.7;Inhibitory neurons: 163.0;Oligodendrocytes: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	8.4	5.5	31.1	9.5	44.3	60.1	6.2	23.2	36.3	4.7	0.0	5.1	3.7	4.9	3.9	5.3	4.6	5.3	12.2	20.1	30.3	6.9	4.6	14.4	9.4	30.5	28.6	3.6	6.7	7.5	5.3	6.1	31.5	4.7	5.8	46.5	4.1	3.0	16.5	6.2	5.1	6.5	32.0	14.8	5.5	14.1	34.3	12.4	5.8	20.5	8.4	5.7	4.3	73.4	5.1	9.6	27.9	11.1	5.6	6.0	10.6	7.4	6.4	7.4	8.4	5.2	8.6	31.3	6.2	7.7	13.2	2.9	13.0	9.4	6.9	33.6	11.8	5.3	11.5	9.3	11.8	24.5	6.2	5.8	10.8	7.0	23.5	4.8	11.9	15.9	6.7	24.5	3.3	8.0	19.3	14.5	19.3	18.1	6.8	17.3	10.2	9.8	12.8	5.4	33.5	23.7	8.4	9.1	15.4	26.1	3.5	7.8	12.0	4.8	8.5	30.4	8.9	16.7	14.8	14.3	10.1	23.5	9.8	37.4	14.4	12.7	9.0	8.4	8.8	2.3	4.4	7.0	15.6	1.7	3.7	7.0	21.2	6.8	6.7	2.5	5.1	9.6	31.1	44.3	23.2	36.3	20.1	30.3	30.5	28.6	31.5	32.0	34.3	73.4	22.3	64.1	12.8	46.0	14.3	7.9	2.6	2.9	8.0	38.0	4.7	4.8	48.3	0.0	13.8	3.7	102.2	4.1	41.8	4.3	7.9	5.7	52.5	29.3	8.6	12.0	7.7	16.8	176.7	4.0	4.3	6.9	9.2	22.0	27.1	9.2	8.2	3.7	8.1	35.3	163.0	5.6	6.1	35.4	24.1	53.9	1.8	42.8	3.6	61.8	46.6	16.7	47.4	82.9	463.5	5.1	1.2	2.6	26.2	3.8	3.2	9.8	14.7	59.1	13.1	9.3	10.4	46.6	29.2	9.2	10.7	2.9	26.3	6.4	4.7	2.3
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 96.6;placenta: 141.6"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"	"Region enhanced"	"Detected in some"		"midbrain: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2"					"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	65.9	38.2	0.3	1.8	0.7	0.0	39.9	0.2	0.4	3.4	0.4	21.1	0.8	3.5	2.7	2.8	9.8	6.2	10.9	0.4	1.4	18.4	96.6	10.4	0.7	2.1	8.1	3.8	3.5	2.8	3.8	141.6	0.9	5.3	4.4	0.9	4.7	4.2	11.6	15.8	4.3	4.6	0.2	9.1	6.5	2.2	0.7	3.0	14.2	13.8	0.2	14.6	6.1	0.2	0.0	1.0	0.8	0.0	176.8	24.4	0.0	0.2	3.9	34.8	20.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.2	0.0	3.4	1.8	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.4	0.4	1.4	2.1	8.1	0.9	0.2	0.7	0.2	20.5	0.0	0.6	0.0	0.0	3.4	0.2	0.0	0.0	0.0	1.3	0.9	6.3	2.8	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.8	0.0	0.3	3.8	23.5	0.0	0.1	7.6	0.3	53.1	0.5	0.0	0.0	0.0	17.5	30.9	0.7	0.0	0.0	0.2	0.0	0.3	3.5	1.7	145.1	0.5	1.8	2.8	0.0	5.7	0.0	0.0	0.1	0.5	0.0	7.5	0.4	1.1	0.0	0.1	0.0	0.1	144.7	7.6	71.2	0.0	1.8	0.3	1.7	0.3	0.5	0.3	0.0	0.1
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"kidney: 207.9;liver: 123.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 105.9;Proximal tubular cells: 359.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		13000		"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	207.9	123.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	2.8	0.0	9.2	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	105.9	0.0	0.0	0.2	0.6	0.0	2.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.2	0.4	0.0	0.0	6.7	359.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984765-110023742	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 328.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA		160000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	68.0	66.1	222.3	33.5	271.0	14.7	51.4	244.2	238.0	66.5	175.2	52.1	126.8	54.3	91.8	47.9	72.9	65.2	38.2	183.8	300.2	102.1	69.2	44.6	31.5	337.1	292.5	53.0	73.3	178.5	51.4	56.3	271.6	44.2	51.6	68.8	50.9	64.1	91.8	38.5	64.1	57.3	310.0	34.6	56.3	28.3	299.6	32.2	75.3	44.6	37.5	49.3	39.9	295.6	100.9	83.4	77.3	80.5	182.8	106.8	127.2	78.1	87.7	72.2	70.7	65.3	56.4	42.5	64.9	115.5	55.0	63.0	69.2	89.1	95.0	355.3	59.8	70.8	106.5	69.5	188.4	61.1	47.7	109.7	55.2	90.0	131.0	175.5	92.2	70.7	51.8	84.1	75.7	80.1	51.3	30.2	91.5	140.6	64.1	54.9	161.1	47.7	157.7	99.8	75.4	49.1	121.1	142.9	165.2	116.8	76.5	60.3	80.3	69.3	67.3	82.8	70.4	68.8	30.5	36.0	142.2	65.7	145.1	3.9	5.0	4.6	2.2	5.4	2.3	3.9	2.3	3.1	3.5	4.4	2.4	2.3	4.7	2.5	3.8	3.2	5.0	2.2	222.3	271.0	244.2	238.0	183.8	300.2	337.1	292.5	271.6	310.0	299.6	295.6	67.3	35.3	74.8	328.1	30.1	89.2	100.1	61.7	47.8	62.3	105.9	71.2	49.8	85.8	68.0	117.7	223.1	80.7	29.4	72.0	125.2	142.2	41.6	226.2	69.1	59.0	85.5	42.0	48.7	110.5	50.4	107.4	69.8	181.1	31.7	81.1	61.8	158.2	42.8	63.9	50.4	71.1	65.1	75.8	67.7	29.6	93.5	62.2	62.2	53.4	57.2	99.9	19.6	60.8	53.2	100.8	38.5	81.6	27.0	108.1	134.3	143.6	83.5	105.7	46.0	87.9	105.7	31.6	13.1	75.6	108.4	100.3	26.8	61.4	78.9	134.2
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 31.3"	"Low region specificity"	"Detected in all"							"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	12.3	24.3	10.6	3.8	8.4	2.5	12.6	12.5	11.3	23.5	0.0	16.2	2.6	26.8	2.2	35.8	19.5	3.4	18.2	9.1	8.1	11.5	7.6	12.0	3.2	5.5	9.2	22.7	8.5	2.0	18.7	4.6	3.8	12.0	1.1	2.7	16.8	6.9	30.3	31.2	7.8	5.2	3.2	16.6	11.3	9.7	9.0	6.3	20.9	15.5	2.0	15.2	24.2	5.1	10.5	9.5	13.0	6.9	4.1	6.7	13.2	9.6	6.8	6.5	5.3	3.7	9.5	1.6	6.9	6.5	3.9	10.3	1.4	12.5	1.9	3.9	5.0	8.3	9.0	5.0	3.8	2.2	4.1	6.3	5.0	4.6	2.9	6.7	3.4	4.8	10.0	1.1	11.1	5.1	7.2	11.8	9.5	2.6	11.5	31.3	15.7	0.8	4.4	1.4	22.3	8.6	6.8	10.8	2.7	4.4	5.3	1.9	6.6	11.2	9.2	8.4	3.0	3.3	2.4	1.6	9.5	6.5	6.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	10.6	8.4	12.5	11.3	9.1	8.1	5.5	9.2	3.8	3.2	9.0	5.1	20.3	6.4	5.2	39.2	5.8	49.5	9.1	25.3	41.5	33.4	37.9	44.4	14.5	4.3	14.4	18.4	0.0	11.5	23.0	10.3	3.9	10.4	0.8	13.2	33.0	19.7	9.7	3.4	26.4	13.7	4.3	24.5	15.8	14.1	0.0	5.5	17.2	11.7	14.2	35.3	19.9	5.5	6.1	3.5	24.8	4.1	51.9	5.8	16.0	16.9	3.6	12.8	14.4	21.6	8.1	16.2	4.5	63.6	5.6	11.6	4.3	4.3	17.7	2.0	39.5	46.2	20.9	4.6	6.8	61.6	56.1	5.6	10.5	67.5	6.6	13.6
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283407-135498434	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"	"Developmental protein"	"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 1121.7;Excitatory neurons: 633.2;Inhibitory neurons: 655.2;Rod photoreceptor cells: 1631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Approved	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Centrosome		"HPA031698: AB_2673997, HPA046684: AB_2679752"	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	5.8	9.4	6.2	2.8	4.9	1.7	5.8	12.6	10.6	8.0	5.7	7.0	1.9	7.8	6.1	3.8	8.6	3.2	5.9	4.1	16.4	5.5	5.3	6.4	1.9	5.9	9.2	10.6	9.1	7.0	29.6	3.3	4.8	9.3	3.9	27.2	6.6	5.7	5.5	4.5	4.8	5.0	2.2	2.8	7.0	13.3	19.5	3.6	7.2	3.4	1.9	7.0	6.2	12.7	4.8	6.7	7.9	8.8	11.6	15.0	3.0	9.3	11.7	8.3	14.5	1.7	3.4	6.8	4.6	9.1	8.4	3.2	6.3	1.7	12.5	6.2	6.3	2.5	15.0	4.2	6.0	14.5	2.8	6.2	3.4	12.7	5.1	15.3	8.8	8.1	14.8	0.6	14.0	4.4	4.4	1.7	5.9	2.8	4.9	6.8	4.3	2.7	3.4	3.0	12.2	6.5	12.2	3.9	5.6	5.3	3.2	7.1	6.9	6.9	8.7	11.3	8.2	6.7	11.0	3.5	8.5	2.3	12.7	11.1	2.5	0.1	6.0	0.8	3.4	11.5	5.7	6.0	3.6	14.1	4.3	5.6	0.2	6.4	0.8	21.9	3.3	0.9	6.2	4.9	12.6	10.6	4.1	16.4	5.9	9.2	4.8	2.2	19.5	12.7	32.7	38.5	93.8	162.6	35.6	28.7	38.2	11.2	37.0	296.1	41.1	38.6	26.7	25.8	35.1	58.8	1121.7	25.8	64.0	43.9	13.7	29.5	327.4	92.7	65.1	43.8	101.8	10.7	633.2	44.4	18.2	66.8	61.7	50.7	58.3	49.8	21.0	17.5	13.3	329.7	655.2	52.4	24.4	6.5	19.3	375.4	67.7	20.7	32.0	89.9	9.0	93.4	11.3	171.9	272.1	22.5	43.1	65.1	36.6	30.5	7.1	13.6	65.2	1631.4	52.6	81.6	37.6	137.4	127.1	18.1	22.6	28.6	38.6	52.8	42.5	24.9
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 395.4"	"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		10000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	243.1	27.9	62.6	43.4	50.2	44.1	190.3	33.7	45.4	183.3	61.0	276.2	49.0	183.3	51.7	248.2	145.5	74.8	115.1	65.0	98.0	59.7	60.1	144.1	36.7	76.2	48.3	125.8	30.3	26.3	16.9	97.3	62.9	88.5	96.6	10.1	127.5	105.7	188.5	334.7	136.6	113.1	60.8	59.5	133.5	18.0	49.0	27.9	64.9	172.2	63.7	142.0	213.3	78.4	188.2	107.9	9.8	44.1	421.8	561.4	70.3	166.0	201.4	103.0	57.4	93.7	64.9	0.2	61.7	554.5	79.8	244.1	41.2	203.7	130.7	154.2	7.3	22.6	173.4	27.9	80.8	31.5	142.2	204.2	233.0	202.4	183.6	131.5	215.4	2.7	21.8	138.8	211.7	72.1	0.4	60.7	3.0	59.6	171.7	0.4	45.1	113.9	227.1	120.2	0.3	9.2	167.5	69.3	69.0	198.8	133.7	28.4	582.1	182.4	119.8	229.8	74.4	25.0	5.4	0.6	138.2	10.1	60.9	44.1	75.6	0.3	38.7	45.0	25.8	20.0	24.8	31.7	73.8	16.1	3.2	17.3	1.1	31.5	37.8	20.2	21.5	36.8	62.6	50.2	33.7	45.4	65.0	98.0	76.2	48.3	62.9	60.8	49.0	78.4	413.1	439.1	106.3	49.3	171.4	479.4	133.8	285.0	253.2	1.4	173.0	226.8	199.9	195.9	224.1	193.1	0.0	110.8	194.3	400.8	13.7	99.6	10.6	188.5	195.0	282.5	47.6	43.7	0.9	64.1	145.6	312.9	538.2	351.2	238.9	4.3	201.4	88.5	79.4	1.7	0.8	164.8	138.4	329.8	458.3	33.2	451.4	292.3	318.4	43.1	284.8	30.7	138.0	0.5	0.4	262.5	195.5	466.0	329.0	202.4	262.3	6.8	149.3	1.2	177.5	349.5	244.4	3.1	8.1	596.4	610.3	102.2	256.5	3.0	101.8	198.0
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978374	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 305.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0"	"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		40000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	30.4	2.3	9.8	2.4	9.9	0.0	16.4	9.3	15.9	84.5	4.6	105.3	1.4	64.3	2.9	114.1	29.2	5.1	4.5	9.7	16.0	3.5	6.2	5.1	0.1	38.1	15.3	3.5	1.6	0.7	3.4	1.8	40.8	18.6	8.6	19.0	24.0	28.6	3.6	305.9	20.2	31.6	12.4	0.9	25.2	7.7	18.1	0.4	2.8	4.5	4.7	49.4	86.6	18.5	2.9	107.6	0.1	6.0	120.0	135.1	0.2	10.5	22.3	3.8	1.9	0.3	38.9	0.1	14.5	82.9	85.3	62.9	0.3	124.9	1.7	0.0	0.4	0.0	67.5	0.5	11.0	0.0	3.8	17.6	308.7	12.1	130.3	52.3	54.7	0.0	0.0	0.2	62.8	8.0	0.0	0.0	0.3	9.5	42.9	0.3	5.7	0.1	84.4	0.0	0.6	0.6	46.2	0.1	2.3	2.8	6.0	0.0	138.4	29.3	17.9	33.8	9.9	0.0	0.0	0.0	88.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.8	9.9	9.3	15.9	9.7	16.0	38.1	15.3	40.8	12.4	18.1	18.5	3.8	12.8	1.1	0.3	0.0	114.3	4.9	83.8	13.1	8.9	2.2	1.3	1.5	0.0	38.2	1.8	2.1	0.2	0.3	0.4	0.0	11.9	24.2	16.0	10.5	13.0	0.0	0.0	8.2	8.7	0.5	31.9	0.0	18.9	17.1	0.1	3.6	2.1	1.0	60.6	5.1	0.0	61.1	0.3	12.7	3.1	0.6	0.7	32.0	3.7	0.0	3.2	0.0	1.5	3.3	68.2	0.0	0.4	0.0	4.5	0.0	0.3	66.8	13.9	0.0	13.1	8.6	0.4	4.3	63.7	164.7	0.1	0.9	0.1	0.2	6.2
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 262.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.0;hTERT-HME1: 73.8;OE19: 61.2;RT4: 63.2"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	22.3	15.0	1.4	25.8	2.7	44.1	19.5	1.4	2.8	14.5	2.3	13.7	16.4	8.8	7.0	17.4	10.5	33.7	9.5	1.9	1.3	7.1	45.0	37.6	15.4	5.4	1.9	6.9	5.8	6.6	3.0	17.7	3.9	11.0	16.3	4.0	10.5	11.2	2.2	22.0	14.5	15.2	2.8	18.7	25.2	2.9	2.7	9.7	12.7	6.5	19.8	49.5	15.0	5.8	8.2	6.6	2.6	0.0	19.2	13.1	1.2	16.5	23.9	7.5	10.8	8.2	17.5	0.0	5.0	24.4	29.7	21.8	1.6	15.1	19.7	0.4	3.6	4.8	8.1	7.3	35.5	8.1	11.5	18.1	71.0	28.8	73.8	33.8	25.3	0.0	0.7	0.2	34.3	4.2	0.0	12.6	2.1	61.2	10.3	0.0	0.0	0.3	23.5	63.2	2.4	0.0	12.4	13.0	12.5	19.0	9.4	2.7	4.3	3.1	0.1	40.7	0.0	3.3	0.1	0.0	51.6	30.6	51.9	0.8	5.6	4.2	0.5	2.6	0.7	0.6	1.7	1.0	6.9	0.7	0.9	0.7	0.6	2.1	1.0	1.6	2.1	1.7	1.4	2.7	1.4	2.8	1.9	1.3	5.4	1.9	3.9	2.8	2.7	5.8	78.3	150.6	76.2	1.6	15.2	75.3	47.6	67.9	104.2	37.0	23.4	30.0	14.7	34.3	84.9	7.3	8.4	3.3	13.6	23.9	0.0	19.3	6.2	39.1	8.4	78.1	5.4	8.6	18.0	15.7	1.8	57.0	56.1	78.8	133.1	0.6	52.1	48.3	24.4	43.7	39.2	12.9	30.5	88.4	262.6	3.2	3.7	107.1	71.2	8.4	70.1	0.9	5.2	1.5	40.6	33.3	19.8	2.6	16.7	48.6	9.9	6.8	51.3	6.1	6.6	14.8	37.8	2.8	2.2	38.3	89.2	21.5	54.7	3.3	19.3	116.1
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469472	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 345.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	70.9	99.1	134.7	51.8	136.1	51.0	55.4	142.0	345.7	63.9	135.3	82.4	44.8	80.1	72.3	72.6	120.9	39.4	116.7	134.9	139.1	73.2	71.8	60.8	71.6	141.8	139.3	69.8	50.3	65.5	66.7	76.5	144.0	64.4	71.8	39.1	56.7	70.3	140.2	59.8	54.9	85.0	139.4	55.7	61.9	99.4	142.5	65.2	47.1	118.3	91.4	76.9	61.1	156.2	185.0	356.7	103.1	131.9	159.1	110.3	175.1	131.2	111.6	223.0	165.3	277.0	163.4	361.3	103.0	145.1	258.4	204.7	386.2	186.5	231.8	131.8	207.5	156.1	181.6	343.3	113.7	102.6	230.8	98.3	244.9	150.7	72.2	133.1	209.9	225.3	205.5	115.6	138.5	522.6	278.6	207.8	170.6	347.7	372.9	210.2	110.3	178.1	178.2	187.1	155.0	161.4	119.2	302.9	115.8	154.4	174.4	152.6	100.3	115.3	162.1	126.2	198.7	103.7	241.6	273.8	169.1	211.3	131.1	82.7	51.5	67.9	66.4	74.0	76.9	81.0	59.8	68.0	67.2	63.7	69.0	70.6	39.8	88.7	92.5	66.4	77.2	52.2	134.7	136.1	142.0	345.7	134.9	139.1	141.8	139.3	144.0	139.4	142.5	156.2	46.6	35.3	21.6	10.1	59.4	156.0	208.2	82.8	74.0	36.0	49.9	46.6	92.2	42.9	57.0	27.6	85.5	153.4	66.8	60.0	74.3	74.2	40.6	112.6	60.8	54.9	78.3	55.8	14.6	48.8	113.3	68.3	25.5	59.6	76.2	55.2	28.9	41.0	93.5	18.5	14.7	70.5	65.1	26.7	117.5	34.2	67.7	52.6	90.7	12.2	58.5	46.6	61.8	10.1	23.6	67.8	65.6	66.5	54.1	145.4	56.4	87.0	132.2	54.1	98.6	46.9	135.0	92.0	57.3	67.7	140.1	136.7	92.3	86.0	85.2	120.1
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5817.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
AHSP	"EDRF, ERAF"	ENSG00000169877	"Alpha hemoglobin stabilizing protein"	Q9NZD4	16	31527900-31528803	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	62	"bone marrow: 1669.9"	"Cell type enriched"	"Detected in some"	296	"Erythroid cells: 8721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 3.0;K-562: 1.5"					"Low region specificity"	"Detected in some"			HPA040940	Enhanced					NA	NA		5300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA040940: AB_10796231"		"unprognostic (3.00e-1)"			"unprognostic (2.01e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.53e-1)"		"unprognostic (3.10e-1)"	"unprognostic (2.16e-1)"		"unprognostic (3.70e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-2)"		1.3	0.1	0.6	0.2	0.6	1669.9	0.4	0.6	2.6	0.4	0.6	0.1	0.0	0.1	0.0	0.2	0.2	0.0	1.5	0.6	0.5	1.9	4.7	4.5	0.2	0.7	0.7	0.2	0.3	0.1	1.4	27.1	0.7	0.1	0.3	0.0	0.5	0.0	0.2	1.4	0.1	0.0	0.6	23.7	0.2	4.1	0.6	2.9	0.7	8.9	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.6	0.6	0.6	2.6	0.6	0.5	0.7	0.7	0.7	0.6	0.6	0.8	0.1	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.6	0.0	8721.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	2.9	4.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	29.4	0.3	2.8	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.1
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.4;kidney: 313.2;lymphoid tissue: 206.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	44.7	4.8	165.6	4.7	199.6	2.3	39.9	179.6	284.4	20.2	101.5	7.2	1.3	13.5	9.3	105.8	10.8	8.3	41.8	145.4	160.9	313.2	1.6	12.2	1.9	209.2	204.2	5.1	6.5	80.6	18.2	23.8	196.2	6.6	5.7	6.9	32.1	36.6	14.6	15.9	7.9	10.0	172.9	206.8	9.0	6.5	188.0	3.9	91.9	21.9	5.8	9.2	35.3	225.1	0.5	2.2	140.3	24.1	0.0	0.0	59.5	0.0	0.3	0.1	0.3	26.8	11.3	0.0	63.5	0.0	3.0	13.5	21.2	1.5	0.8	0.3	30.0	15.7	7.4	51.4	0.3	0.1	7.6	1.2	6.6	0.5	0.7	0.4	6.7	39.3	10.6	0.1	0.0	96.7	9.3	1.9	106.7	9.0	10.1	0.2	1.9	39.6	299.9	8.5	54.3	8.7	7.4	60.0	20.4	82.7	57.6	0.9	0.9	3.8	10.2	0.5	30.8	0.4	0.5	0.4	6.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	165.6	199.6	179.6	284.4	145.4	160.9	209.2	204.2	196.2	172.9	188.0	225.1	122.9	0.0	0.0	5.9	2.8	4.1	2.1	1.5	1.2	0.1	45.0	29.5	6.6	0.0	3.5	356.8	0.0	4.5	1.3	0.8	289.5	1.5	1.0	4.1	3.5	35.0	3.6	0.0	0.3	0.8	383.2	15.5	0.5	15.0	0.0	10.1	33.5	0.0	7.0	0.0	0.3	2.1	2.0	0.3	2.0	3.5	37.6	2.3	67.6	21.5	0.0	15.1	0.0	8.0	36.3	2.9	0.3	59.0	0.0	7.7	0.0	201.5	0.6	0.2	0.0	3.3	10.3	0.2	5.3	4.4	2.4	21.1	1.7	29.9	1.3	2.0
AIFM1	"AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130124666-130165879	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.4;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	21.0	65.2	10.5	17.6	11.2	11.8	17.8	11.9	12.8	15.7	24.7	34.3	52.9	15.3	8.9	20.8	22.1	10.1	107.7	10.9	11.6	97.3	110.6	13.9	16.2	11.3	11.0	11.9	27.8	29.7	16.2	10.3	11.4	14.8	15.9	8.5	18.6	7.6	68.9	15.2	29.9	10.1	11.2	20.3	41.2	30.3	12.1	18.5	14.7	25.2	11.0	18.4	13.4	11.6	52.8	95.4	22.6	85.2	24.1	14.6	50.0	28.6	19.0	33.5	25.2	55.8	36.4	105.0	113.3	17.5	39.3	47.2	61.3	33.3	12.7	48.2	73.4	61.6	59.1	68.9	34.0	51.5	63.5	26.1	21.7	34.5	22.0	12.1	27.2	83.4	62.6	50.7	13.1	96.7	57.6	74.5	24.4	53.6	65.1	55.6	31.7	132.7	60.8	36.6	46.0	28.2	35.5	68.0	67.5	13.2	46.0	40.8	31.7	20.5	20.4	63.9	58.7	24.2	45.0	47.5	25.3	86.4	33.4	4.1	21.0	14.1	11.8	26.6	13.1	14.6	12.8	14.6	31.7	10.3	12.7	12.6	2.4	20.7	24.8	14.7	17.9	12.4	10.5	11.2	11.9	12.8	10.9	11.6	11.3	11.0	11.4	11.2	12.1	11.6	12.6	16.0	20.1	17.0	17.1	8.7	8.2	25.0	9.1	19.3	13.0	8.3	165.4	22.8	21.2	40.5	22.9	58.0	14.2	31.6	92.0	24.9	1.8	36.7	17.3	11.5	9.6	26.3	10.8	20.5	29.0	16.4	27.0	50.4	10.8	33.1	14.3	92.3	38.0	15.2	12.1	24.0	34.6	14.4	7.4	4.9	17.4	16.8	10.6	8.4	16.6	17.2	20.6	8.0	19.6	18.0	18.9	17.3	19.2	7.9	45.6	326.1	21.3	48.1	6.6	11.3	39.3	10.2	32.0	17.1	6.8	39.7	15.8	45.9	37.2	9.8
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 173.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	39.6	13.5	7.5	6.3	8.1	1.9	31.2	7.3	8.0	6.9	8.6	12.9	9.3	7.8	9.0	13.3	6.8	5.0	17.0	6.9	7.7	10.4	21.9	9.3	5.1	8.2	7.3	7.9	5.0	3.2	5.6	4.1	6.9	9.9	7.1	2.4	7.6	7.7	9.8	5.6	11.5	5.0	6.2	7.7	9.9	3.9	8.3	2.4	14.6	7.3	3.6	12.0	6.3	6.5	26.5	45.2	1.1	11.3	26.2	9.8	0.3	10.4	25.5	21.0	23.6	35.3	49.8	3.8	25.8	14.5	27.5	27.9	12.7	3.8	5.9	50.8	1.9	0.2	27.3	173.3	56.1	0.3	6.4	13.3	8.4	33.8	7.2	13.2	9.5	1.7	20.5	21.9	11.0	33.5	1.2	1.3	4.5	21.2	14.6	0.8	4.2	12.4	11.4	19.2	3.6	0.8	19.1	16.6	29.8	1.8	0.7	7.2	12.0	0.5	25.3	15.6	30.8	16.2	32.7	7.3	14.0	0.9	13.9	1.0	0.5	0.5	1.8	0.5	1.5	1.7	0.6	1.5	0.4	1.5	0.8	1.3	0.5	4.0	0.5	0.2	1.3	0.7	7.5	8.1	7.3	8.0	6.9	7.7	8.2	7.3	6.9	6.2	8.3	6.5	11.6	6.4	14.1	7.2	5.0	2.3	15.0	8.4	2.8	5.7	5.5	4.7	13.8	8.6	10.5	18.4	0.0	13.9	1.4	53.1	3.9	40.7	24.1	6.0	7.7	4.8	12.0	7.0	8.2	21.9	3.0	11.2	14.3	6.2	11.4	22.3	1.8	25.0	10.2	1.7	5.2	7.1	14.2	3.3	3.3	47.0	5.3	6.7	8.8	4.7	34.4	4.8	1.0	5.5	3.5	40.8	22.7	4.5	17.0	14.6	28.7	22.6	9.5	2.1	19.7	11.8	12.8	6.2	3.9	5.1	1.4	18.6	3.8	8.8	13.7	20.4
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 50.3"	"Group enriched"	"Detected in some"	4	"B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	1.2	0.6	0.9	21.6	0.6	1.2	0.9	0.9	0.9	0.6	8.1	2.4	1.8	0.4	0.3	1.6	0.4	2.3	0.3	0.8	0.6	0.5	1.7	1.7	50.3	1.3	0.9	0.2	0.4	0.0	9.8	0.9	1.1	0.9	2.2	0.4	1.3	0.1	0.3	0.6	15.5	0.8	0.8	24.9	3.2	2.5	0.8	4.1	0.7	1.0	49.4	14.0	0.5	0.7	15.8	0.0	0.9	0.0	0.0	12.5	0.0	0.0	1.6	1.1	1.0	0.0	0.0	94.6	0.1	0.0	0.1	0.1	0.0	0.0	1.0	132.5	0.0	3.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	50.4	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	0.0	8.9	0.0	8.3	8.6	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	17.9	0.3	41.7	34.2	0.8	38.6	3.4	6.7	20.7	8.2	0.0	2.0	7.0	5.4	143.8	5.3	3.5	4.2	63.7	0.5	1.3	16.3	0.0	8.2	0.0	11.9	5.0	0.9	0.6	0.9	0.9	0.8	0.6	1.3	0.9	1.1	0.8	0.8	0.7	0.4	0.0	0.0	0.0	64.2	0.0	0.1	0.2	0.0	0.7	0.1	0.3	0.3	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.4	0.0	0.0	3.2	1.9	33.3	0.3	3.2	3.6	0.0	4.0	0.3	0.0	0.5	0.0	0.1	0.1	0.7	40.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.7	0.4	1.4	0.0	0.0	10.0	0.0	0.0	0.4
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349456	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000	35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	32.5	33.4	23.3	31.4	25.9	60.1	44.4	25.8	32.9	32.2	25.2	42.1	39.9	34.5	35.1	37.7	32.1	32.1	34.4	23.2	25.0	40.3	35.8	29.0	38.6	25.8	25.7	42.3	32.4	37.8	25.6	30.1	25.7	33.1	41.6	36.0	35.0	35.1	65.3	29.4	37.8	32.3	24.3	33.5	34.8	23.5	24.8	35.4	38.9	50.4	39.2	40.9	30.7	27.8	66.7	46.1	47.3	60.3	51.0	78.0	68.1	80.8	69.7	73.9	87.7	81.9	97.8	109.4	61.6	79.6	50.5	61.4	69.6	86.6	98.8	62.1	47.4	64.2	63.8	134.0	101.3	147.4	75.4	62.9	100.2	74.5	117.5	56.3	64.3	68.2	120.8	58.0	82.4	58.5	99.2	78.2	51.4	94.6	46.5	81.1	86.3	101.5	94.7	60.5	72.9	56.9	52.7	158.1	86.4	61.7	75.2	107.8	50.5	87.9	73.1	66.1	105.9	71.5	98.9	110.0	74.6	112.7	97.0	60.6	54.7	55.0	42.9	61.8	51.7	57.4	54.0	43.9	58.5	55.8	55.8	51.0	7.7	51.9	73.4	74.7	72.2	34.9	23.3	25.9	25.8	32.9	23.2	25.0	25.8	25.7	25.7	24.3	24.8	27.8	87.4	70.5	55.2	18.6	72.7	50.2	147.0	166.1	50.7	49.7	71.3	87.8	95.4	82.9	130.2	66.2	35.5	124.5	58.1	83.3	156.5	121.1	79.0	75.4	83.8	60.8	73.8	66.7	17.3	126.6	144.8	66.0	48.9	130.8	79.3	64.2	61.4	109.8	109.6	25.2	20.4	144.4	116.0	90.1	53.3	19.4	99.1	68.8	32.0	16.9	117.2	56.0	74.2	24.6	38.3	118.3	93.7	85.4	40.9	141.8	146.8	166.1	105.6	45.5	59.2	77.5	128.4	127.2	74.3	66.4	50.2	150.9	68.9	74.3	142.2	173.1
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.9;tongue: 102.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	19.2	21.0	13.6	14.3	15.1	12.4	17.3	15.6	17.0	11.0	12.8	25.8	47.7	16.7	16.7	22.0	14.4	8.8	45.3	15.4	14.6	25.7	33.8	12.6	14.3	14.9	14.5	7.4	17.0	28.7	7.8	13.4	14.7	11.9	24.4	11.9	16.4	15.2	154.9	21.6	27.8	19.3	15.2	13.0	14.6	44.1	15.1	15.4	25.8	102.5	19.5	17.0	13.7	16.2	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.6	15.1	15.6	17.0	15.4	14.6	14.9	14.5	14.7	15.2	15.1	16.2	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
AIP	"ARA9, FKBP16, FKBP37, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483026-67491103	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055"	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	62.9	58.1	72.5	47.4	77.6	40.4	58.5	74.7	82.4	84.5	66.7	78.4	33.7	71.0	32.4	38.9	66.9	39.4	72.1	70.3	74.3	68.0	51.6	62.3	89.5	75.9	72.7	77.9	48.8	35.4	51.1	33.5	74.6	60.8	20.1	22.9	40.6	36.0	46.4	39.5	64.7	28.8	71.8	85.1	57.0	29.7	73.1	78.7	63.6	45.8	49.1	73.1	62.6	80.4	80.8	91.1	51.6	49.9	64.8	64.2	39.3	49.7	61.2	83.6	60.9	143.7	77.9	142.2	118.1	55.3	63.5	63.9	59.2	51.9	32.1	209.3	63.5	86.5	98.7	87.0	67.1	87.5	145.1	77.8	48.3	74.6	48.4	81.4	43.0	138.6	50.0	83.6	55.5	153.7	187.7	214.6	49.0	122.0	115.7	82.2	78.5	126.5	59.5	47.2	81.4	81.3	64.4	45.5	204.3	19.9	60.9	87.2	71.5	73.4	71.1	108.9	46.3	67.4	99.8	112.7	100.4	67.4	57.7	192.5	117.9	135.6	194.3	144.6	212.0	241.6	227.4	227.6	179.8	221.5	203.4	194.7	78.2	165.3	175.0	207.9	352.4	182.4	72.5	77.6	74.7	82.4	70.3	74.3	75.9	72.7	74.6	71.8	73.1	80.4	57.2	32.1	25.6	6.8	69.4	30.3	35.8	54.2	31.9	36.8	24.6	33.1	23.1	30.0	33.7	49.7	4.2	56.4	61.9	50.1	82.2	46.8	25.3	12.7	31.0	54.0	31.8	22.5	4.0	42.2	63.5	51.0	23.4	18.0	77.3	51.7	45.7	23.3	66.7	37.0	4.9	34.7	48.8	65.0	54.6	14.2	53.1	56.1	56.9	5.6	72.5	49.6	76.2	5.0	10.5	41.2	53.5	35.3	50.2	42.7	86.1	98.3	17.4	29.4	39.5	36.4	86.5	21.7	28.4	19.4	21.2	59.5	90.6	42.0	25.4	52.2
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1012	"retina: 836.0"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.0	0.0	0.2	0.1	0.3	0.7	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	836.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	2.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.3	0.1	0.8	0.2	0.1	0.3	0.0	0.3	0.6	0.0	3.2	1.1	0.0	0.0	0.8	1.0	0.0	0.0	139.2	0.1	0.0	0.6	0.0	1.4	0.0	412.8	0.1	0.1	0.2	0.0	0.0	7.8	0.4	0.2	8.5	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.1	1.4	0.0	0.1	65.6	0.2	0.2	0.0	0.3	1.1	1.3	0.0	0.3	1.8	0.0	0.0	256.1	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1926.4	0.0	1.8	0.3	0.4	0.2	0.0	0.4	0.3	0.4	0.1	0.0	1.7
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7;pituitary gland: 19.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;dendritic cells: 5.2;Granulosa cells: 4.9;Theca cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	2.4	3.1	14.7	1.0	15.6	1.2	1.7	26.7	17.0	3.8	0.0	17.4	2.1	4.7	0.2	3.2	4.1	0.4	5.3	18.3	1.8	3.6	4.9	2.2	0.5	6.2	2.9	1.4	7.4	0.8	19.9	0.6	2.8	7.7	0.8	0.8	2.3	1.3	3.1	2.6	5.7	0.5	0.0	5.0	5.9	6.4	3.4	0.3	3.2	0.5	0.3	9.3	3.6	4.7	3.0	2.3	0.3	0.9	0.4	0.3	3.7	2.3	0.4	0.3	0.1	0.8	1.5	1.8	1.9	0.6	0.7	3.2	0.3	0.9	0.0	4.6	1.7	0.4	5.2	0.7	1.2	1.1	3.2	0.7	1.1	0.3	0.2	1.8	0.2	0.8	2.8	1.1	0.5	3.3	0.3	3.6	0.9	2.4	3.0	2.2	0.7	5.9	0.7	0.5	5.6	2.0	1.5	5.8	3.3	0.4	4.6	2.2	2.4	3.8	2.6	1.3	1.4	5.0	3.7	0.6	6.6	3.6	0.9	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.5	1.1	0.0	0.2	14.7	15.6	26.7	17.0	18.3	1.8	6.2	2.9	2.8	0.0	3.4	4.7	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	5.5	0.0	0.6	5.2	0.0	0.0	1.8	0.0	0.8	1.1	0.2	0.0	0.0	0.0	0.5	0.9	0.4	0.0	1.8	1.3	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.0	2.3	0.0	0.0
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971177-22982551	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 61.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 217.0;hTCEpi: 222.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	4.8	3.0	2.3	1.4	1.8	0.5	6.7	2.0	2.2	14.4	9.2	3.2	1.5	12.1	8.5	18.3	7.5	4.9	6.3	2.2	1.5	17.7	43.4	15.2	2.6	2.5	2.1	12.2	11.6	7.2	2.0	19.3	1.6	10.6	2.5	3.7	8.2	15.9	1.9	61.7	1.9	8.4	2.2	3.8	4.2	5.5	1.9	8.2	10.9	2.3	5.5	7.6	15.5	2.7	46.9	54.1	71.0	27.6	6.8	12.2	57.4	44.9	58.5	102.6	91.4	116.0	47.3	1.2	45.5	92.9	70.8	146.2	54.9	217.0	124.6	4.5	5.0	3.5	90.8	131.4	78.9	4.9	3.1	38.9	222.3	42.9	164.3	72.7	40.0	8.3	1.9	2.8	96.2	37.3	4.5	5.7	4.5	86.6	73.9	12.7	59.0	1.2	103.9	71.3	0.2	6.2	135.5	39.4	8.8	57.4	55.3	4.5	36.1	44.2	88.4	7.3	43.6	0.4	1.3	0.5	7.0	4.2	20.6	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.2	0.5	0.5	0.2	0.2	0.0	0.1	2.3	1.8	2.0	2.2	2.2	1.5	2.5	2.1	1.6	2.2	1.9	2.7	2.1	19.2	6.4	0.7	0.0	47.5	13.0	27.6	35.3	0.1	3.7	9.7	4.5	20.0	10.2	7.3	0.0	10.0	0.1	0.3	5.9	14.3	5.8	13.0	2.5	4.0	0.0	0.0	0.0	14.9	9.8	3.4	0.0	4.4	0.0	12.8	2.5	17.1	1.7	0.0	0.0	0.4	2.0	0.0	2.2	5.0	3.7	0.6	3.6	0.0	0.0	8.1	0.0	0.5	0.0	33.8	0.1	0.7	1.2	34.2	0.3	21.0	8.3	0.2	32.9	2.7	14.0	7.0	2.7	14.2	49.6	4.0	0.5	1.6	0.8	18.0
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866486-127877675	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1346.2;tongue: 783.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		24000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	28.5	34.5	81.3	11.5	79.2	28.4	17.0	87.9	95.1	37.5	145.8	33.8	17.9	14.3	28.5	32.0	342.2	22.5	270.0	79.5	88.5	31.4	26.5	74.6	5.0	97.4	99.8	45.0	14.9	47.0	33.8	7.6	99.0	17.1	39.5	29.0	33.1	35.9	1346.2	14.2	12.1	21.9	105.0	20.8	23.9	63.1	89.4	3.9	34.8	783.3	12.6	19.7	19.4	97.2	56.7	23.6	30.1	40.4	71.2	142.9	27.4	38.3	38.2	66.7	40.4	18.0	34.9	1.5	40.8	79.4	44.1	79.2	0.3	43.1	26.6	9.0	26.1	8.3	65.2	31.6	40.1	0.0	1.0	110.9	81.8	49.9	35.5	36.8	90.3	0.8	33.7	2.3	76.7	53.5	0.1	1.1	10.6	139.7	74.2	1.3	30.0	12.6	44.8	4.1	48.3	30.4	101.0	57.4	29.8	15.3	45.8	33.3	75.9	45.9	18.8	163.8	37.3	3.5	0.6	0.2	57.7	0.3	32.4	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.2	0.1	0.9	0.0	0.3	81.3	79.2	87.9	95.1	79.5	88.5	97.4	99.8	99.0	105.0	89.4	97.2	12.8	41.7	148.1	25.8	2.6	26.4	17.2	84.5	6.2	54.6	11.5	7.9	49.7	28.6	79.4	7.3	16.7	7.5	5.7	210.1	17.6	116.7	281.3	7.3	8.0	39.8	106.3	97.0	11.1	60.9	46.8	37.3	46.4	4.8	1.3	2.7	49.2	77.3	59.3	48.8	12.0	62.7	120.1	3.7	22.3	1031.8	226.5	7.9	83.6	2.8	2.3	287.6	10.3	4.5	9.7	57.2	132.7	386.3	4.2	14.4	22.8	8.2	186.5	69.5	26.3	107.2	56.4	20.2	16.7	33.6	28.4	13.5	7.1	83.4	65.5	25.3
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 440.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	85.3	88.6	39.9	76.9	45.0	74.3	80.4	44.1	49.0	79.6	49.8	117.2	140.0	58.6	52.1	108.5	65.3	49.0	114.1	38.8	43.8	181.6	172.9	59.3	73.3	48.5	42.8	59.9	78.9	123.6	49.4	68.4	50.4	63.2	114.0	51.0	81.1	55.5	154.2	74.4	139.4	68.1	44.0	57.2	92.7	54.8	44.3	85.9	86.6	122.9	113.4	84.2	76.9	49.3	339.1	153.4	131.6	149.7	94.9	116.6	132.8	185.0	143.5	267.7	280.2	283.2	311.9	602.1	218.4	139.8	204.2	235.4	312.5	327.0	276.6	261.6	229.3	396.2	270.0	219.9	218.2	712.5	222.2	118.1	238.2	232.7	471.2	163.3	190.2	245.7	436.9	230.4	165.0	174.2	273.0	392.8	181.2	337.4	222.4	314.7	222.2	415.6	286.2	205.1	190.8	114.8	205.4	235.0	584.8	151.4	194.5	517.2	138.9	165.5	194.3	259.4	357.5	238.0	324.7	565.7	232.4	664.6	195.5	49.2	158.8	198.0	77.1	145.5	81.8	122.3	72.7	74.0	195.8	105.8	72.9	67.9	42.1	115.3	130.4	154.2	96.8	188.1	39.9	45.0	44.1	49.0	38.8	43.8	48.5	42.8	50.4	44.0	44.3	49.3	60.5	51.3	79.0	19.6	44.0	125.2	101.4	228.1	63.7	21.1	66.5	72.6	106.9	71.4	142.8	112.2	83.4	158.0	37.0	109.6	256.3	120.2	108.3	50.0	42.1	70.7	50.4	50.9	16.2	123.7	164.6	58.0	66.3	47.0	40.0	38.8	41.4	135.5	96.1	8.4	19.7	84.7	89.5	44.8	60.1	42.8	46.9	48.4	87.2	12.2	67.3	22.1	48.4	14.1	22.0	110.5	67.2	44.0	55.7	109.0	236.9	440.0	67.0	41.8	52.6	34.1	108.4	91.0	31.6	88.6	122.7	216.6	40.7	72.2	122.6	120.5
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709556-4742043	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 242.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 485.4;HEL: 273.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063324	Enhanced		Supported	Mitochondria		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	75.5	62.9	30.1	23.7	36.9	20.1	39.7	33.5	34.9	41.0	56.2	67.4	68.3	41.9	31.2	61.2	34.4	35.9	100.6	27.0	40.6	101.4	199.9	34.9	29.6	32.8	38.1	47.8	38.9	66.8	22.2	35.1	33.7	49.2	59.6	16.8	38.7	42.6	242.8	47.4	62.5	41.7	33.5	33.0	69.5	11.2	37.9	35.1	49.9	159.6	34.4	48.7	39.7	36.5	44.1	30.7	55.5	22.6	75.3	55.5	4.9	60.4	116.1	30.4	45.5	5.7	43.6	39.5	20.4	63.5	16.6	29.3	40.8	48.0	51.2	485.4	37.1	273.3	56.1	91.3	58.5	28.7	14.1	87.9	41.4	26.4	36.0	70.4	91.2	38.2	22.1	49.6	91.8	22.5	27.5	65.6	53.3	77.1	15.4	38.2	21.1	19.2	82.1	55.7	98.3	63.6	65.7	18.5	35.1	53.7	26.5	53.2	65.9	25.7	28.8	70.1	43.6	15.5	10.5	50.3	46.9	19.9	18.9	13.3	10.2	32.2	27.6	8.1	25.5	12.1	21.6	25.7	19.6	12.3	28.4	29.2	2.8	27.4	6.5	26.3	31.8	21.1	30.1	36.9	33.5	34.9	27.0	40.6	32.8	38.1	33.7	33.5	37.9	36.5	58.3	57.7	80.3	78.0	34.0	74.2	76.4	87.4	84.2	10.7	58.8	28.3	182.9	68.6	71.0	66.2	22.9	95.5	34.6	129.9	258.2	84.8	3.7	40.7	30.6	65.7	109.6	68.1	23.4	69.6	17.0	83.4	87.1	37.8	46.2	75.8	79.2	305.6	47.5	15.2	55.8	104.2	73.2	46.9	41.4	4.5	108.7	34.7	74.7	22.5	40.9	28.2	33.0	44.7	87.0	67.3	78.7	149.7	62.8	166.7	111.8	183.5	52.8	11.0	105.2	76.0	60.8	6.4	14.1	152.5	104.4	214.0	36.4	68.5	145.5	151.6
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 183.5;liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 242.6;Proximal tubular cells: 595.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	Yes		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	24.7	1.9	19.5	6.6	21.0	4.9	26.6	17.8	20.8	6.1	17.5	19.7	4.3	7.0	4.2	23.4	7.6	13.7	51.7	21.4	21.2	183.5	104.0	2.8	1.6	19.0	22.8	4.6	1.2	18.3	4.7	8.3	22.8	16.2	14.0	21.9	9.6	12.7	1.7	27.4	6.6	21.4	18.5	1.2	15.0	11.3	22.7	5.7	2.5	38.8	3.3	19.1	11.8	21.1	73.2	5.0	5.6	23.9	51.6	48.7	12.0	12.1	15.0	25.6	70.8	108.1	8.6	39.1	31.0	19.0	32.1	46.1	18.8	89.9	101.9	33.0	21.5	37.9	21.9	208.6	2.5	29.9	4.6	27.2	49.6	25.1	73.0	42.2	0.9	12.2	48.0	0.6	39.6	31.2	1.1	1.3	24.6	1.0	42.5	0.2	41.0	7.1	37.8	3.2	20.5	15.4	21.6	1.5	16.7	25.8	29.7	12.9	4.2	42.4	36.2	3.3	20.9	39.5	18.8	2.1	68.7	10.9	2.5	0.9	3.1	0.0	0.1	0.6	0.2	0.2	0.1	0.2	2.7	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.0	0.8	19.5	21.0	17.8	20.8	21.4	21.2	19.0	22.8	22.8	18.5	22.7	21.1	11.2	0.0	0.5	51.2	4.7	49.7	23.6	44.2	63.7	24.5	48.9	44.7	105.7	52.9	14.3	31.3	2.1	2.2	0.6	15.8	56.7	18.6	3.4	30.1	8.2	19.6	5.4	13.9	17.1	12.1	21.1	11.4	27.5	52.2	0.0	36.4	11.7	242.6	3.3	16.8	7.7	8.7	24.4	7.8	9.2	5.8	4.1	6.9	24.9	3.7	5.7	32.7	0.0	9.5	2.5	31.9	4.3	9.4	0.4	38.7	18.8	595.5	12.3	6.5	6.6	5.6	18.8	1.8	9.5	43.1	74.3	4.9	3.6	0.7	23.1	20.4
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282019-77559966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 121.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.5;Excitatory neurons: 403.7;Inhibitory neurons: 167.3;Oligodendrocytes: 706.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 13.6;naive CD4 T-cell: 16.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 13.6;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;BJ: 67.8;fHDF/TERT166: 77.5;LHCN-M2: 189.9;U-2 OS: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.0	1.6	75.9	1.5	101.2	3.9	18.9	19.4	115.0	1.3	0.8	2.6	1.0	0.7	0.6	1.0	1.0	1.0	1.0	121.0	31.5	1.4	0.1	0.4	2.3	27.2	30.2	0.5	1.6	0.7	3.4	1.2	25.6	2.3	1.0	3.0	3.0	2.1	0.3	2.0	1.0	0.8	31.0	2.1	2.4	9.4	31.7	0.8	1.1	0.8	1.5	0.7	0.7	81.1	0.2	3.6	2.9	0.1	34.8	93.7	1.2	67.8	14.4	10.8	4.6	0.5	1.7	0.6	0.5	77.5	4.4	0.4	0.2	0.0	5.5	2.6	0.7	0.5	1.2	0.4	1.8	0.6	0.2	11.6	0.5	2.1	4.3	37.9	31.5	0.3	0.9	0.7	189.9	0.7	0.0	0.6	3.9	18.4	24.5	1.7	7.1	1.6	29.3	1.1	15.3	3.5	0.2	0.2	4.4	0.3	0.3	0.5	7.9	26.1	58.4	1.6	2.2	15.2	14.7	0.3	5.2	3.5	9.8	1.2	0.8	0.1	3.8	0.2	0.5	0.9	3.6	1.9	13.6	0.9	16.3	9.1	0.6	0.2	0.2	1.5	1.7	2.3	75.9	101.2	19.4	115.0	121.0	31.5	27.2	30.2	25.6	31.0	31.7	81.1	0.7	0.0	0.0	10.7	0.4	0.3	0.4	0.0	1.2	1.3	54.0	27.3	1.1	0.0	0.0	1.8	0.0	1.9	5.6	0.3	7.9	0.3	150.5	1.1	0.1	1.3	12.0	0.8	403.7	0.6	56.3	1.5	1.1	1.7	0.0	0.0	0.4	0.0	2.4	13.5	167.3	0.3	0.0	0.0	0.6	29.2	1.2	0.4	3.6	41.2	1.9	0.0	47.4	60.8	706.6	0.1	1.1	0.7	0.1	2.9	0.0	7.8	0.0	0.3	0.0	1.2	6.3	10.2	91.0	0.0	0.3	2.9	4.2	0.1	0.2	0.1
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 185.9;Late spermatids: 275.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	46.0	58.0	18.7	12.5	19.6	11.6	40.0	20.6	27.1	26.1	19.8	40.8	15.2	32.4	21.6	29.7	29.6	7.7	48.4	19.8	20.3	54.9	46.6	29.5	13.0	19.7	20.1	32.6	35.8	11.6	28.6	12.1	19.5	32.9	12.6	23.2	30.9	8.3	79.8	20.6	30.1	9.5	18.7	28.0	36.4	43.3	19.5	13.3	33.0	23.3	12.5	35.5	28.0	20.7	40.3	18.8	28.0	42.6	43.6	26.3	51.1	59.3	18.6	23.8	30.7	56.0	35.5	82.1	54.9	23.4	62.2	14.0	37.2	23.3	40.0	33.1	15.7	40.7	47.8	44.9	33.0	49.5	17.1	14.0	33.3	23.0	37.0	25.0	14.8	45.8	36.6	29.3	28.6	42.1	50.2	31.4	25.0	17.9	10.5	55.8	34.5	44.5	40.3	31.3	14.4	13.3	28.2	26.4	44.6	21.3	25.1	54.7	29.5	20.4	34.6	41.4	47.6	33.1	74.4	75.3	29.8	69.3	28.9	25.2	16.8	20.1	19.2	22.1	20.3	29.8	22.8	24.9	24.8	26.1	24.5	26.3	2.7	24.1	21.0	29.9	25.8	13.3	18.7	19.6	20.6	27.1	19.8	20.3	19.7	20.1	19.5	18.7	19.5	20.7	51.5	22.4	30.0	14.0	33.9	0.0	95.7	0.0	33.6	19.8	57.3	86.6	55.6	18.6	16.7	23.9	10.4	86.7	27.2	16.8	185.9	75.6	174.9	36.4	34.6	38.6	9.7	29.2	14.8	78.5	95.1	47.3	16.8	30.2	21.5	31.7	30.7	42.5	71.3	20.2	15.4	21.3	0.0	30.6	0.0	275.9	33.5	32.2	0.0	6.5	42.4	58.7	34.0	13.0	17.0	59.1	25.5	32.0	29.4	116.6	48.6	149.8	18.2	29.3	52.6	40.9	50.0	56.5	37.9	24.3	0.0	66.2	27.6	44.7	32.9	88.1
AK7	"CFAP75, FAP75, FLJ32864"	ENSG00000140057	"Adenylate kinase 7"	Q96M32	14	96392128-96489427	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.3"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003543	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003543: AB_1078117"	"unprognostic (4.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (3.18e-4)"	"unprognostic (4.98e-5)"	"unprognostic (8.41e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.25e-3)"	0.7	2.6	2.0	0.6	3.1	1.5	1.4	1.1	1.7	1.7	13.2	2.1	1.9	2.1	3.9	1.5	24.3	2.6	0.7	2.2	5.2	4.5	1.6	4.2	0.6	6.9	9.4	0.4	2.2	6.9	5.1	0.5	5.6	0.9	1.6	3.0	1.0	1.3	0.3	6.1	1.2	1.1	4.4	3.3	2.8	7.6	5.0	0.5	2.7	0.0	0.4	0.5	1.0	4.2	0.2	4.9	2.0	1.5	0.8	2.6	17.0	0.3	0.6	0.3	0.3	0.5	15.1	0.4	0.3	0.0	0.3	1.9	4.7	0.2	0.1	2.2	0.4	0.4	2.4	0.2	0.8	0.1	0.3	0.2	0.6	2.5	0.1	0.8	0.2	1.4	0.2	0.3	0.3	49.5	0.3	0.3	0.8	2.2	1.0	35.2	0.3	0.4	7.6	0.3	3.1	6.7	1.9	0.6	0.1	1.8	4.2	0.2	0.1	0.4	0.2	0.6	0.2	0.6	2.3	0.2	0.2	0.0	0.7	9.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.1	2.0	3.1	1.1	1.7	2.2	5.2	6.9	9.4	5.6	4.4	5.0	4.2	1.6	6.4	4.1	0.7	0.8	1.8	0.9	3.6	1.8	0.2	0.9	0.3	0.4	4.3	12.3	7.3	2.1	0.7	0.1	1.4	3.9	3.2	18.7	97.9	1.7	1.9	1.2	6.9	2.0	1.1	1.7	0.8	5.1	11.6	0.0	0.1	0.7	2.4	0.2	0.0	2.4	0.3	4.1	0.3	0.4	4.1	0.0	0.5	1.8	0.0	0.0	0.6	0.0	0.5	3.7	0.5	0.1	0.0	0.0	0.5	1.0	3.4	137.1	1.8	0.0	0.4	1.6	25.4	9.1	0.7	3.0	2.9	0.2	1.5	1.2	0.6
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.3;fallopian tube: 25.8;testis: 15.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 102.3;Endometrial ciliated cells: 26.1;Late spermatids: 134.1;monocytes: 49.2;Respiratory ciliated cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 6.2;naive B-cell: 4.9;NK-cell: 3.1"	"Group enriched"	"Detected in many"	30	"B-cells: 6.2;NK-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.1;RPTEC TERT1: 3.6;T-47d: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 3: Monocytes - Immune response regulation"			"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.7	1.2	2.2	0.5	2.5	0.1	1.0	1.7	2.3	2.5	5.6	0.5	0.0	1.3	19.3	0.9	25.8	1.3	0.2	2.5	3.1	2.3	0.1	2.1	0.6	4.2	6.8	1.6	0.7	3.1	1.8	0.4	4.5	0.9	0.3	2.7	1.7	2.7	0.0	1.6	0.1	0.7	3.7	0.1	0.8	15.9	3.3	1.5	4.7	0.2	4.3	0.5	0.5	2.5	1.1	0.7	0.3	1.6	0.2	0.4	0.3	0.1	0.1	0.1	0.0	0.3	1.2	0.0	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	1.0	0.5	0.3	0.4	0.4	0.0	0.8	0.0	0.0	0.3	3.1	0.7	0.3	0.1	0.4	0.5	0.0	0.0	0.0	3.6	0.0	0.6	0.6	1.5	0.0	0.2	0.3	2.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	4.9	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.1	2.2	2.5	1.7	2.3	2.5	3.1	4.2	6.8	4.5	3.7	3.3	2.5	0.2	3.2	1.7	9.4	1.5	0.5	0.5	3.9	0.6	0.3	0.8	0.5	1.2	0.0	3.4	3.7	0.0	0.4	0.1	0.3	0.0	2.8	102.3	26.1	1.1	1.1	0.0	0.4	4.9	0.5	0.3	0.8	0.0	1.3	0.0	0.4	0.7	0.0	1.7	0.0	5.1	0.9	2.0	0.3	0.3	134.1	6.2	1.8	1.8	0.0	49.2	0.8	0.0	4.5	5.0	1.2	0.3	4.1	0.0	0.6	0.0	6.0	36.7	1.8	0.0	0.8	2.7	24.3	5.6	0.4	1.6	0.4	0.2	1.0	0.5	0.7
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
AKAIN1	C18orf42	ENSG00000231824	"A-kinase anchor inhibitor 1"	P0CW23	18	5142911-5197503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.2;brain: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA049365	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"					"HPA049365: AB_2680729"					"unprognostic (4.86e-1)"						"unprognostic (1.49e-3)"				"unprognostic (7.05e-2)"			0.0	10.2	2.5	0.0	1.1	0.0	0.0	22.9	14.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	1.2	0.2	1.1	0.0	0.0	3.7	2.6	0.1	0.7	0.7	2.4	0.0	2.9	0.0	0.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.8	5.9	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	1.1	22.9	14.7	11.3	1.2	3.7	2.6	2.9	1.3	5.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121346	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.8"	"Group enriched"	"Detected in all"	9	"Early spermatids: 584.7;Late spermatids: 2219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	40.6	15.5	31.6	17.8	35.2	6.9	35.2	29.1	35.2	23.7	17.2	76.1	54.8	24.5	19.7	36.4	31.5	18.0	82.6	28.5	26.5	26.2	49.9	19.6	10.8	26.7	27.1	20.0	22.2	48.1	17.1	7.1	26.9	34.7	48.9	34.7	33.6	24.8	207.8	27.3	55.8	26.3	21.9	11.3	55.4	112.9	29.8	11.4	36.3	137.9	9.5	46.8	25.5	28.0	46.1	54.3	80.7	27.5	18.2	12.8	46.8	19.0	18.3	24.2	16.8	61.2	42.2	74.1	52.3	14.5	26.5	74.6	50.1	44.4	24.7	40.6	63.5	63.1	51.4	118.1	19.4	59.9	23.8	11.7	41.8	26.2	39.2	14.4	25.7	22.9	42.3	28.6	14.8	39.8	76.1	24.1	28.7	97.9	61.7	58.2	32.8	61.0	17.1	61.9	58.9	40.3	15.8	45.1	23.9	16.6	31.4	61.4	18.8	24.3	24.2	28.3	45.0	28.9	36.9	55.8	14.0	47.5	19.7	1.6	1.0	0.4	2.6	2.0	2.3	1.8	2.0	2.1	2.3	1.2	4.0	2.1	0.1	3.3	0.5	4.0	1.7	1.3	31.6	35.2	29.1	35.2	28.5	26.5	26.7	27.1	26.9	21.9	29.8	28.0	34.5	35.3	49.9	26.4	16.6	22.6	23.5	11.9	32.5	33.0	29.4	42.3	154.9	28.6	32.1	5.5	47.9	21.5	10.6	89.1	1.9	16.3	584.7	16.8	12.6	16.4	45.9	12.6	14.9	16.3	13.8	12.2	54.0	37.8	3.8	21.0	11.4	60.2	9.5	37.0	26.3	86.6	8.2	9.0	9.5	2219.5	19.6	10.9	7.2	4.7	8.7	8.2	3.1	10.6	9.6	12.7	68.5	13.9	13.2	32.3	65.6	7.4	6.5	77.1	46.0	17.9	54.4	18.3	14.9	44.9	19.7	6.8	11.5	13.3	117.6	17.0
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	11.4	13.3	10.5	12.3	12.4	10.6	12.3	11.4	13.6	11.5	15.1	11.4	9.5	12.4	8.8	10.6	10.4	10.7	7.4	11.3	11.6	13.1	8.1	11.0	16.0	9.9	10.7	13.5	8.4	15.1	7.5	12.2	10.6	10.9	11.6	15.3	9.8	11.7	7.2	9.5	10.1	13.3	10.4	14.9	11.1	14.2	13.8	14.1	15.1	9.4	12.5	11.3	10.2	14.7	18.1	21.3	13.9	9.7	18.0	22.5	25.7	20.6	21.9	22.4	26.7	23.2	10.6	15.4	13.6	16.4	19.4	18.8	18.1	17.2	30.4	12.8	15.4	13.2	20.2	11.4	17.0	9.7	20.7	19.1	21.1	20.5	25.1	25.0	18.3	18.5	8.6	7.5	23.6	13.1	18.1	14.3	9.1	25.1	7.2	11.8	45.5	8.1	18.7	11.3	4.7	14.1	23.6	11.0	19.7	84.8	26.7	10.7	16.1	17.2	14.2	14.8	19.3	9.3	10.7	18.8	22.8	11.5	17.0	4.9	9.7	12.6	8.6	14.4	8.0	8.4	8.4	9.4	8.5	9.2	10.0	8.9	33.8	7.6	13.9	6.3	7.1	4.3	10.5	12.4	11.4	13.6	11.3	11.6	9.9	10.7	10.6	10.4	13.8	14.7	13.4	3.2	12.3	71.2	24.4	7.0	9.7	8.9	10.2	24.6	11.1	9.0	8.4	21.5	11.9	5.5	16.7	14.9	16.8	15.8	1.9	9.9	12.8	11.0	14.8	12.6	7.2	15.2	55.1	7.2	11.1	11.7	14.8	10.8	10.1	18.0	16.8	13.6	16.5	33.7	54.6	9.9	12.2	35.1	10.5	13.9	15.2	21.4	5.4	61.8	32.3	11.7	25.7	51.8	78.5	7.9	15.2	13.9	11.2	15.6	14.6	5.7	15.3	23.2	19.7	10.5	11.2	23.1	23.6	11.0	7.7	14.0	19.0	15.6	11.8	12.1
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272152-42323261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane, Cytosol"		"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	12.6	13.9	14.2	11.5	27.3	3.7	11.6	10.9	19.9	16.6	0.0	10.0	7.5	13.5	15.4	10.6	10.4	10.2	11.6	22.7	12.7	13.3	10.7	10.9	15.8	8.7	15.3	14.7	6.9	11.7	9.3	7.7	8.5	11.3	10.5	32.5	8.0	12.3	5.6	9.9	8.4	12.2	11.5	13.3	10.4	20.6	16.4	13.2	14.0	10.9	13.8	10.4	8.6	18.9	15.2	15.3	18.4	11.0	23.6	28.7	8.0	20.2	16.7	11.9	11.1	16.9	12.4	31.2	7.6	22.7	12.5	17.7	16.1	16.9	22.7	33.4	7.5	8.8	10.6	8.4	18.5	22.2	20.8	21.2	17.0	24.4	21.2	17.5	17.8	15.5	29.5	12.3	24.3	11.4	13.0	7.2	10.9	22.3	7.1	10.7	12.9	15.1	11.9	11.1	7.8	11.3	15.5	10.1	7.1	8.5	8.7	11.8	24.8	20.1	10.4	30.7	15.4	4.7	6.3	15.8	25.7	11.1	14.4	1.7	0.3	0.4	0.5	0.3	0.7	0.9	0.8	0.5	0.3	1.1	0.6	0.6	0.1	1.6	0.5	0.5	1.0	0.2	14.2	27.3	10.9	19.9	22.7	12.7	8.7	15.3	8.5	11.5	16.4	18.9	41.9	25.6	30.5	58.8	42.8	12.2	13.7	15.4	14.8	67.3	20.4	14.6	44.9	12.8	32.6	29.5	37.5	4.4	21.2	12.9	1.9	12.7	14.0	24.3	33.1	25.5	21.0	16.6	105.4	9.5	3.8	27.5	24.5	25.7	34.2	25.9	29.3	22.6	12.5	42.1	105.4	14.9	20.3	24.8	21.6	14.6	21.8	25.0	8.8	46.9	21.6	69.8	16.5	69.9	91.3	12.7	15.4	33.4	27.0	12.2	9.4	20.5	33.1	38.3	19.7	33.9	27.1	49.2	32.8	20.6	16.9	2.5	25.4	28.3	12.3	13.4
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	105.6	16.0	13.8	17.1	16.6	2.2	59.7	99.7	57.5	19.8	4.5	60.1	8.6	31.1	9.3	18.6	31.2	31.5	51.8	14.7	66.8	35.8	30.6	44.3	6.9	67.0	35.3	87.8	10.8	1.6	23.3	38.3	74.7	23.1	13.2	109.4	6.5	20.8	11.9	9.4	24.9	42.9	10.9	14.3	25.6	100.0	39.4	5.9	22.1	14.5	3.4	33.0	21.2	24.3	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.6	99.7	57.5	14.7	66.8	67.0	35.3	74.7	10.9	39.4	24.3	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 161.8"	"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol		NA	NA		14000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	37.7	18.9	10.0	38.7	9.2	56.1	32.1	1.7	9.3	28.5	66.1	25.9	16.7	83.0	20.7	25.6	22.7	44.6	66.6	11.0	17.7	14.4	22.2	54.1	47.6	16.7	17.6	26.7	54.5	11.8	18.5	26.0	13.9	20.3	21.3	8.3	23.9	23.5	83.9	24.7	32.5	40.3	9.7	38.3	34.4	20.0	15.0	46.3	32.7	60.3	46.5	32.9	26.7	16.3	13.2	29.0	20.8	7.8	31.3	34.6	11.2	10.6	23.5	9.4	9.0	11.3	11.0	62.0	14.6	19.2	23.8	26.5	23.9	9.9	9.0	45.2	11.0	83.8	20.0	8.6	17.3	17.2	161.8	25.6	25.5	11.6	39.8	10.6	25.2	22.4	5.5	29.6	14.7	6.3	24.7	12.8	13.5	22.8	11.5	16.7	20.6	23.5	15.3	27.0	13.1	23.4	27.9	8.3	14.5	22.7	6.0	14.3	30.2	11.4	7.8	6.7	10.7	46.1	30.1	48.9	6.8	55.2	9.0	282.9	66.0	181.4	122.2	54.9	68.3	74.9	81.6	93.3	38.8	68.8	68.2	75.5	104.3	108.2	77.5	100.6	73.2	48.0	10.0	9.2	1.7	9.3	11.0	17.7	16.7	17.6	13.9	9.7	15.0	16.3	110.5	125.0	431.2	88.2	186.8	75.7	105.2	29.1	57.5	18.6	50.2	39.9	215.2	91.5	71.6	40.5	41.7	36.7	336.8	143.3	5.9	83.4	258.9	155.6	327.0	121.5	63.5	37.0	51.2	69.6	27.6	119.6	170.2	323.6	279.5	65.6	75.7	53.7	79.2	13.5	13.0	57.8	36.7	147.1	276.3	166.3	77.6	257.9	99.6	290.4	197.3	45.8	252.4	123.6	13.2	101.2	118.7	63.6	205.8	77.0	68.6	10.5	60.1	17.9	85.5	139.6	117.4	23.3	37.2	77.6	79.0	23.4	269.7	30.5	61.7	179.6
AKAP14	AKAP28	ENSG00000186471	"A-kinase anchoring protein 14"	Q86UN6	X	119895837-119920716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 44.0;testis: 83.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 485.6;Late spermatids: 1648.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.6;SCLC-21H: 2.4;SuSa: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA060999	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA060999: AB_2684407"	"unprognostic (1.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.68e-2)"		"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.80e-1)"	0.0	0.0	1.0	0.0	1.0	0.2	0.1	1.0	0.8	1.2	16.1	0.1	0.3	0.7	0.1	0.0	44.0	0.0	0.0	1.4	2.2	0.0	0.1	3.2	0.0	3.4	3.7	0.1	0.0	0.0	0.7	0.0	2.5	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.4	0.0	1.4	0.0	0.0	83.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.0	0.8	1.4	2.2	3.4	3.7	2.5	1.4	3.7	1.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	18.7	0.0	0.5	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	485.6	133.5	1.1	0.3	0.0	0.0	0.6	0.0	0.3	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	22.4	0.0	0.0	1648.3	2.5	0.8	0.0	1.0	0.0	0.2	0.0	1.5	0.2	0.0	0.1	7.2	0.0	0.0	0.1	0.1	224.1	0.1	13.1	0.0	4.9	14.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591604-1602520	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.5"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: AB_2681314"	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favorable (1.11e-5)"	35.2	46.9	13.7	33.8	15.0	44.6	37.3	12.3	15.2	45.6	15.1	38.6	30.9	35.2	20.1	38.5	39.5	16.5	34.9	13.0	11.9	39.3	70.1	51.5	36.0	16.4	14.1	73.0	66.4	12.6	46.6	17.3	13.5	50.7	9.9	7.5	41.5	15.9	17.4	35.6	49.4	7.6	12.1	83.0	41.3	31.8	16.3	27.2	62.7	9.2	20.1	32.2	38.0	20.3	23.8	29.8	23.4	26.5	11.3	14.4	57.1	25.1	10.2	19.8	16.6	33.3	21.3	35.5	15.8	12.6	27.9	20.4	14.3	12.6	11.8	29.3	49.2	44.3	32.6	31.3	24.1	17.3	71.3	12.8	22.8	14.8	16.4	23.6	13.8	17.7	28.2	21.8	11.7	15.6	38.5	74.4	35.0	5.5	25.6	28.9	27.9	30.0	13.2	16.3	26.1	38.1	19.7	31.5	31.5	19.2	20.6	31.3	26.9	30.8	14.0	26.9	22.1	93.7	17.0	49.1	12.5	27.7	8.4	4.5	0.5	0.9	0.3	0.2	0.4	0.9	0.4	0.7	0.3	0.5	0.3	0.3	1.9	0.7	0.4	0.8	0.2	0.2	13.7	15.0	12.3	15.2	13.0	11.9	16.4	14.1	13.5	12.1	16.3	20.3	41.2	25.6	25.3	1.3	53.5	44.4	36.1	10.6	36.5	24.1	41.5	29.8	12.0	12.8	19.4	12.9	10.4	25.1	67.0	39.9	13.7	21.2	52.1	29.6	32.7	35.1	22.6	14.5	0.8	15.5	32.4	31.5	39.3	41.1	25.4	49.8	32.2	21.3	22.8	16.8	0.8	38.7	12.2	25.7	54.5	18.9	38.8	37.4	40.9	0.0	38.0	21.5	54.6	2.0	2.7	24.4	35.9	31.6	65.0	41.9	22.6	7.9	14.4	15.4	0.0	28.4	23.2	20.6	27.6	31.7	47.2	72.7	51.1	131.7	28.6	46.2
AKAP3	"AKAP110, CT82, FSP95, SOB1"	ENSG00000111254	"A-kinase anchoring protein 3"	O75969	12	4615508-4649051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"testis: 100.0"	"Group enriched"	"Detected in some"	19	"Early spermatids: 818.1;Late spermatids: 356.6"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.3;NTERA-2: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039765, HPA073296"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"			"HPA039765: AB_10795113, HPA073296: "	"unprognostic (2.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.07e-6)"	"unprognostic (3.22e-3)"	"unprognostic (3.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	0.4	0.8	1.6	0.7	2.7	0.0	0.9	2.5	1.9	0.5	1.5	0.6	0.9	0.6	2.7	0.5	2.3	0.3	4.2	1.7	2.1	2.2	1.0	0.8	0.5	2.4	2.2	0.9	2.0	0.8	1.0	0.7	2.5	0.9	0.5	0.5	1.5	0.6	0.7	0.7	0.6	0.7	2.2	0.6	0.7	100.0	2.2	0.9	1.6	0.5	0.6	0.4	0.3	3.1	0.0	0.3	1.0	0.2	2.7	0.2	0.6	0.3	0.3	0.3	0.9	0.1	2.0	0.2	0.0	0.6	2.0	0.0	1.5	0.0	0.4	1.5	1.8	0.2	0.0	0.3	0.1	0.2	0.5	0.5	0.4	0.6	0.7	0.2	0.3	3.3	0.8	2.1	0.7	0.3	0.3	0.0	4.0	0.3	0.1	0.5	0.1	0.3	1.1	0.1	0.3	0.1	0.2	0.2	0.9	2.7	0.0	0.0	0.1	0.1	0.3	0.7	0.1	0.9	1.3	0.4	1.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.5	0.7	0.0	0.5	0.0	0.0	0.0	0.1	1.6	2.7	2.5	1.9	1.7	2.1	2.4	2.2	2.5	2.2	2.2	3.1	0.1	0.0	0.5	3.9	0.4	0.0	0.2	0.2	0.0	0.2	0.5	0.6	23.7	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.3	818.1	1.4	0.1	0.5	0.0	0.0	0.7	0.4	0.3	1.7	1.5	0.3	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.7	2.0	0.0	0.0	356.6	3.7	0.4	0.0	1.9	0.0	0.7	0.0	1.5	6.3	0.1	0.0	2.2	0.5	0.2	0.5	1.5	2.4	0.3	6.6	0.4	0.4	29.6	5.8	0.5	0.0	0.3	0.2	0.1	0.4	0.2
AKAP4	"AKAP82, CT99, Fsc1, hAKAP82, HI, p82"	ENSG00000147081	"A-kinase anchoring protein 4"	Q5JQC9	X	50190777-50201007	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1023	"testis: 195.7"	"Group enriched"	"Detected in some"	137	"Early spermatids: 778.9;Late spermatids: 2587.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005949, HPA020046"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA005949: AB_1078120, HPA020046: AB_1844693"			"unprognostic (2.94e-2)"											"unprognostic (1.86e-2)"	"unprognostic (2.47e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	195.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	778.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2587.5	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	12.2	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;intestine: 3.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7"	"Immune cell enriched"	"Detected in single"	8	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9"	"Group enriched"	"Detected in all"	5	"amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8"	"Group enriched"	"Detected in all"	5	"amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.3	0.3	5.3	1.4	13.5	0.6	0.5	0.0	8.5	0.4	0.0	3.7	0.5	1.3	0.1	0.5	0.5	0.9	0.2	7.7	0.0	1.3	0.8	1.8	1.9	0.0	0.1	0.4	0.2	0.4	1.0	1.1	0.0	0.4	3.8	0.6	0.3	0.4	0.2	0.5	1.4	1.3	0.0	1.2	0.5	0.3	0.0	0.9	0.5	0.0	1.6	0.6	0.3	0.3	1.3	1.0	1.3	0.8	0.4	0.1	4.2	0.9	0.4	1.2	1.5	10.9	3.3	1.0	2.0	0.7	0.1	0.4	2.8	0.2	1.1	2.0	2.4	3.3	2.0	0.9	0.1	0.4	0.4	0.4	0.1	0.8	0.0	2.1	0.4	2.4	0.4	0.7	0.7	0.8	2.7	0.2	1.0	0.1	0.5	3.3	0.5	0.2	1.9	1.2	3.3	1.4	1.1	0.1	0.2	3.8	1.0	0.2	0.6	1.4	4.2	0.1	1.7	2.2	2.6	2.4	0.9	0.4	0.2	3.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	5.3	13.5	0.0	8.5	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	6.4	2.4	1.6	2.8	0.9	1.3	0.5	1.2	7.4	1.8	1.4	1.6	1.5	0.2	0.0	8.4	0.6	15.6	5.1	0.0	0.6	2.6	0.5	1.4	1.9	0.0	2.7	17.2	0.2	1.9	2.1	0.5	1.0	67.6	0.9	0.4	0.7	0.5	8.4	5.5	28.7	0.0	0.3	2.9	0.9	0.0	1.2	1.8	0.0	0.3	0.9	16.5	3.0	1.6	0.8	2.2	0.0	6.4	1.2	0.8	1.4	0.2	7.7	0.0	2.2	0.8	0.5	4.9	0.1	0.9	0.7	12.4	0.3	6.2	0.9
AKAP6	"ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6"	ENSG00000151320	"A-kinase anchoring protein 6"	Q13023	14	32329298-32837684	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;heart muscle: 54.6;skeletal muscle: 47.5;tongue: 50.7"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 601.6;Inhibitory neurons: 663.1;Oligodendrocyte precursor cells: 412.7;Oligodendrocytes: 1162.5"	"Cancer enhanced"	"Detected in many"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001983, HPA048741"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001983: , HPA048741: AB_2680506"	"unprognostic (1.99e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.81e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.54e-1)"	"unprognostic (3.33e-16)"	"unprognostic (8.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.79e-3)"	1.6	5.6	21.0	2.5	31.4	0.5	4.6	20.3	24.6	1.6	0.0	5.5	1.8	3.9	5.6	5.4	2.9	3.7	54.6	16.9	36.7	2.9	2.1	2.3	0.8	52.0	34.9	2.5	0.8	3.5	3.6	4.5	51.9	2.0	2.2	13.6	2.6	1.2	47.5	1.2	2.4	7.7	22.4	0.8	2.0	5.9	34.8	0.9	4.8	50.7	0.7	4.2	1.5	59.8	0.3	0.8	1.0	0.9	0.2	1.7	0.2	1.3	3.6	0.2	0.4	1.1	1.0	1.4	0.9	15.8	0.6	0.8	1.2	1.4	0.5	1.3	1.0	1.3	1.5	1.1	0.5	0.1	0.3	1.8	1.3	0.0	0.4	0.6	0.1	2.1	0.3	4.1	1.1	0.8	0.7	0.2	0.2	1.1	1.1	0.7	4.9	0.6	0.4	1.2	5.2	4.2	1.1	0.7	3.2	0.7	2.9	0.1	0.3	0.2	0.8	0.8	0.5	2.5	2.4	0.6	1.5	0.1	5.4	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	3.5	0.4	0.6	0.5	0.1	0.1	0.4	0.0	0.3	21.0	31.4	20.3	24.6	16.9	36.7	52.0	34.9	51.9	22.4	34.8	59.8	0.6	6.4	2.7	111.3	2.2	2.3	2.9	1.0	5.2	49.2	8.7	3.0	108.0	0.0	4.9	1.8	50.1	0.8	0.1	1.1	0.0	0.8	32.4	6.7	0.4	1.7	1.2	0.0	601.6	0.5	0.3	6.3	0.0	1.4	1.3	0.6	1.1	2.7	1.2	26.9	663.1	0.6	4.1	0.6	1.6	13.7	14.6	1.1	7.2	23.4	0.7	2.5	0.0	412.7	1162.5	0.3	0.1	33.1	2.0	1.1	1.9	1.5	23.6	21.5	19.7	25.8	14.3	25.9	1.3	1.1	1.6	0.4	0.6	3.4	0.9	0.9
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135467-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	9.0	56.6	15.8	6.4	16.3	10.9	6.7	17.7	20.7	8.1	11.5	19.1	29.8	6.4	5.7	4.2	6.8	9.9	6.7	16.0	16.7	8.1	24.4	6.6	11.2	15.3	16.2	9.8	42.0	4.0	4.3	4.0	15.3	14.0	18.9	7.6	4.6	6.4	15.9	2.8	16.5	5.9	16.7	9.6	5.3	8.8	17.0	11.9	5.9	14.4	7.6	8.7	5.6	15.8	1.2	2.1	7.8	3.8	4.4	9.0	5.4	3.3	5.3	5.5	7.3	2.8	2.2	0.1	6.1	5.7	4.1	0.1	2.3	3.6	4.0	0.0	3.3	8.0	2.7	12.2	6.1	0.4	2.5	7.8	2.4	3.6	4.6	5.1	5.8	4.6	1.4	11.7	5.3	2.1	3.6	2.1	27.2	0.8	2.9	7.3	5.1	0.1	23.5	27.2	0.1	2.7	4.5	0.4	11.1	4.5	1.8	17.1	2.1	2.5	3.5	7.5	8.3	10.5	0.1	2.0	6.3	8.1	5.9	15.2	1.9	0.3	8.1	3.8	12.8	3.7	11.1	11.0	2.4	5.5	17.6	11.0	0.5	4.4	4.7	0.1	4.3	6.0	15.8	16.3	17.7	20.7	16.0	16.7	15.3	16.2	15.3	16.7	17.0	15.8	11.7	19.2	9.1	88.8	16.4	6.2	6.5	0.8	6.8	22.3	10.1	13.2	10.4	177.3	1.6	5.5	16.7	8.2	18.0	22.1	19.6	35.7	8.2	31.6	13.4	6.5	1.2	63.8	44.7	4.2	10.2	7.4	6.1	35.6	10.8	22.9	9.7	39.9	8.6	8.4	79.1	14.8	10.2	20.8	9.9	2.7	8.4	12.9	1.8	68.4	9.8	38.2	25.7	123.6	62.7	2.2	33.2	5.7	3.4	8.2	13.6	26.5	1.4	13.2	0.0	12.6	6.9	4.6	10.0	7.0	4.1	4.7	23.9	26.0	22.0	4.9
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379815	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	13.6	10.4	0.1	1.5	0.1	3.1	12.3	0.2	1.0	10.2	0.1	11.7	5.4	12.3	0.0	11.6	11.0	0.0	10.0	0.1	0.1	8.8	12.5	10.3	0.3	0.1	0.1	10.9	10.5	1.5	7.5	0.4	0.1	9.5	0.1	0.3	11.2	1.1	23.0	14.6	12.8	0.4	0.0	13.3	10.7	7.4	0.1	1.8	10.1	2.5	0.2	10.7	10.2	0.1	18.2	12.2	8.4	5.6	2.6	2.3	12.2	10.1	7.1	7.2	7.2	19.4	10.6	19.9	10.2	8.9	6.8	8.5	5.1	12.3	0.4	17.9	12.8	21.1	11.7	18.8	4.3	28.0	8.0	4.5	2.7	7.8	0.0	0.6	7.3	11.5	15.1	6.4	2.3	23.7	15.1	5.7	17.8	9.7	15.8	12.1	12.3	16.8	0.0	22.5	10.5	11.4	13.0	9.9	8.9	1.5	4.3	2.2	18.8	12.4	10.1	7.0	21.0	12.9	12.8	21.0	9.8	10.4	11.5	0.0	4.4	0.9	4.4	4.6	4.7	3.8	4.0	4.8	6.5	4.2	2.9	3.6	0.3	4.1	6.3	4.4	5.6	3.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	25.6	12.8	28.1	17.0	24.6	19.2	21.0	14.5	19.9	14.7	16.0	14.7	18.0	10.0	22.3	12.9	27.1	30.0	25.9	26.0	5.9	18.9	3.6	22.8	24.1	20.9	10.8	28.2	14.4	21.6	23.9	17.6	20.9	39.9	30.4	14.3	10.4	13.8	13.1	21.9	14.0	21.9	2.0	13.5	16.1	2.7	19.0	19.8	12.4	10.3	21.3	16.5	12.3	12.1	15.3	18.6	13.1	13.9	25.6	16.7	14.8	9.7	22.1	19.5	6.6	26.3	22.5	19.6	23.2	21.3	16.1	40.2	25.6	15.4	22.6	20.9
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380050-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	27.2	32.8	25.1	4.0	25.5	32.3	26.9	26.0	32.2	34.8	21.8	32.7	2.5	23.5	11.9	23.4	31.8	7.5	41.5	24.4	25.3	29.3	28.8	33.5	9.4	24.1	24.4	36.2	22.5	11.1	40.4	9.3	24.7	32.3	5.8	37.4	23.2	6.3	60.5	34.5	24.0	6.4	25.0	31.5	24.7	48.8	25.8	20.6	33.9	24.1	10.8	26.8	28.1	26.1	25.4	25.8	32.3	17.2	32.3	34.0	18.8	21.0	25.1	34.0	30.9	41.5	35.2	23.2	38.8	23.4	31.8	29.9	51.2	28.3	29.8	39.8	44.2	40.3	21.9	34.0	57.3	38.8	26.6	29.6	52.0	27.2	35.3	31.3	25.4	38.0	51.3	41.9	21.3	34.3	39.0	32.6	31.9	32.0	41.9	46.6	22.8	25.2	28.7	8.5	37.2	23.5	26.2	28.3	37.5	42.4	20.8	42.2	30.4	20.5	15.4	34.4	36.7	60.1	48.0	49.5	19.2	39.8	23.5	0.1	1.8	1.7	0.9	0.8	1.8	1.7	0.8	1.0	1.5	2.3	1.3	1.2	3.5	0.5	1.0	1.4	2.8	0.8	25.1	25.5	26.0	32.2	24.4	25.3	24.1	24.4	24.7	25.0	25.8	26.1	34.7	6.4	15.9	55.5	39.1	31.6	48.2	22.6	26.2	60.9	34.6	29.3	7.7	17.2	30.0	35.0	77.2	35.6	47.3	22.5	25.4	32.6	34.6	52.7	33.7	29.8	25.6	114.9	59.1	31.8	28.6	26.0	50.0	42.6	13.9	69.6	17.5	17.0	16.3	79.1	45.1	22.0	26.4	18.6	32.8	9.9	26.4	31.3	26.6	19.7	24.0	42.0	30.9	29.7	38.5	32.5	19.9	29.3	38.2	33.2	13.6	17.3	32.1	83.2	26.3	27.8	45.2	83.3	63.9	26.4	39.2	62.4	44.0	60.2	18.3	40.2
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940840-92110673	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	7.1	8.3	8.6	6.2	9.0	8.6	11.0	15.3	14.1	6.5	15.5	16.0	16.5	6.4	3.9	7.9	8.4	10.4	6.5	8.6	11.0	13.2	16.2	7.8	5.8	8.8	9.6	11.9	9.5	12.7	8.6	5.4	9.0	7.5	14.6	31.4	9.6	3.8	16.2	6.8	18.6	4.0	7.7	5.0	9.4	4.1	11.9	9.3	9.3	10.0	5.3	5.5	7.2	9.7	11.7	8.1	9.6	5.8	11.6	11.3	6.2	8.7	6.3	4.9	5.9	10.3	8.0	9.2	12.5	7.3	7.5	8.3	10.5	5.6	9.2	9.8	8.2	10.9	11.6	7.3	4.0	18.5	9.6	6.2	6.2	9.1	8.8	7.7	10.3	10.6	19.3	13.0	7.4	14.1	10.4	7.0	8.3	6.5	8.4	7.6	18.2	6.2	4.9	11.5	13.3	11.0	19.0	16.9	10.1	11.1	5.1	9.8	17.5	9.5	11.2	14.5	12.6	7.3	13.0	13.6	6.2	7.8	9.4	1.1	0.6	0.9	1.3	0.6	0.9	1.9	1.1	1.1	0.4	1.6	1.2	1.0	0.7	1.2	0.6	3.2	1.0	0.2	8.6	9.0	15.3	14.1	8.6	11.0	8.8	9.6	9.0	7.7	11.9	9.7	123.3	525.6	357.0	141.3	143.3	103.5	126.5	112.6	170.8	273.5	165.4	150.9	253.2	297.4	208.4	176.6	2230.9	141.4	201.5	293.4	101.8	131.0	22.5	392.3	157.7	115.9	185.1	129.4	142.6	92.6	81.9	123.5	152.9	185.0	136.6	386.1	98.2	153.5	57.2	360.1	182.6	350.8	136.3	78.3	88.4	17.5	173.4	101.6	58.7	115.2	121.5	155.7	119.4	169.9	187.1	102.4	218.9	135.8	193.5	91.4	298.5	47.2	506.3	1279.6	138.1	206.1	116.1	83.0	129.0	87.3	111.8	333.8	145.7	135.8	171.4	97.6
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991276-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 1546.1;Late spermatids: 1455.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	46.0	29.9	37.5	33.5	41.3	77.2	23.1	41.8	43.8	21.9	41.3	35.1	24.2	28.7	42.3	29.2	25.0	41.8	38.5	38.6	47.4	42.9	53.2	30.0	42.3	45.9	45.1	19.6	27.7	43.2	40.0	26.5	47.2	36.3	36.2	37.5	24.4	35.8	30.1	17.3	26.8	41.9	42.4	31.7	33.3	83.2	49.8	41.5	36.1	30.4	42.1	41.2	18.6	48.1	61.4	28.0	117.3	96.9	56.3	66.2	83.8	70.0	73.1	69.2	70.1	73.2	49.5	48.3	63.3	67.1	49.6	41.8	114.7	62.8	110.8	72.2	58.3	142.7	41.6	92.5	74.2	137.5	75.3	68.5	80.5	90.4	73.6	61.6	64.9	61.8	99.0	46.6	87.8	25.2	58.5	60.2	248.2	45.9	47.1	92.4	85.4	48.2	77.7	73.9	81.3	55.2	77.8	41.4	160.1	182.8	37.9	70.6	58.3	42.3	68.4	46.2	72.1	67.1	92.5	102.6	72.7	80.4	73.3	35.7	39.3	83.7	33.4	33.9	50.6	33.7	54.4	51.7	55.4	30.2	63.3	42.0	102.8	72.0	38.8	41.7	54.7	53.1	37.5	41.3	41.8	43.8	38.6	47.4	45.9	45.1	47.2	42.4	49.8	48.1	48.5	64.1	43.9	25.1	83.8	137.9	77.1	34.0	56.9	48.1	69.0	48.6	45.1	31.5	40.1	38.6	47.9	72.9	111.6	48.6	93.9	45.6	1546.1	108.2	56.7	43.5	94.8	57.9	32.9	40.5	76.9	49.9	37.2	93.9	47.6	55.1	35.0	37.3	45.5	55.5	26.6	49.6	36.7	39.9	109.9	1455.5	44.1	65.2	42.7	16.9	85.1	52.1	42.2	23.6	73.2	50.5	37.2	45.5	53.2	67.8	23.9	41.8	38.9	45.0	52.6	61.3	77.5	77.3	103.9	43.4	138.5	167.5	99.9	34.0	41.8	81.4
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 3039.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	65.1	3039.1	83.1	38.4	89.3	21.9	52.3	91.8	97.4	41.4	80.9	40.1	20.5	42.4	44.0	28.2	38.7	40.2	208.2	84.1	92.5	218.0	19.3	55.0	74.6	101.6	96.9	60.5	34.4	111.2	76.5	203.7	104.9	34.4	30.9	36.5	41.9	332.7	330.0	26.6	50.8	39.6	91.4	62.8	51.4	44.9	88.7	54.9	44.3	396.9	62.5	67.3	35.0	101.4	184.2	1667.3	186.5	261.4	785.9	212.3	494.6	177.2	3096.2	259.3	335.0	75.8	170.6	0.0	79.2	301.5	1143.3	78.6	204.0	175.3	206.6	65.2	168.2	93.4	225.0	230.1	1117.9	0.1	0.8	196.9	133.4	367.6	98.3	252.8	370.3	181.1	0.1	62.4	292.4	3.5	283.3	131.0	309.2	13.9	1.8	292.9	116.5	138.8	1447.8	915.5	137.1	301.6	1261.5	1.5	134.3	121.3	0.6	140.6	289.6	254.5	116.0	22.7	195.6	168.2	196.9	470.0	1343.5	0.7	153.0	125.7	106.4	5.6	147.6	72.3	135.2	133.0	124.7	144.5	145.3	121.7	162.9	156.7	8.5	119.7	39.2	20.4	94.9	230.2	83.1	89.3	91.8	97.4	84.1	92.5	101.6	96.9	104.9	91.4	88.7	101.4	34.1	12.8	19.4	9.1	50.3	20.6	55.3	66.1	20.5	36.2	11.7	27.9	202.4	25.8	26.4	649.2	8.4	1105.1	35.1	2.3	164.4	112.7	5.0	6.1	20.9	50.9	31.0	20.2	10.5	41.5	1284.9	100.3	20.4	5.9	53.8	59.8	82.1	2.6	394.1	72.3	18.7	15.1	697.8	172.8	53.9	14.5	79.2	127.7	30.2	14.0	76.3	49.3	66.9	5.5	12.4	51.0	4.5	77.5	72.6	25.6	0.3	60.2	24.9	24.1	59.2	98.9	54.5	22.6	100.2	10.5	11.6	2022.4	49.9	70.5	6.7	54.2
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 224.5;intestine: 614.8;stomach 1: 432.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	7.9	0.0	0.2	0.4	0.3	0.1	73.9	0.0	73.4	614.8	0.5	0.1	224.5	0.9	176.1	0.2	0.1	0.1	12.2	40.0	0.4	0.3	0.0	0.0	0.2	0.7	0.0	4.8	0.1	0.1	1.3	45.6	0.1	32.4	0.2	3.7	7.7	354.8	3.2	0.1	0.1	432.5	0.6	0.0	5.5	0.6	5.9	7.7	65.8	145.6	0.2	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549110-134579875	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"breast: 166.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Fibroblasts: 2.9;Late spermatids: 3.6;Skeletal myocytes: 12.5;Syncytiotrophoblasts: 10.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 15.8;HDLM-2: 12.8;Hep G2: 11.2;SK-BR-3: 5.1;U-87 MG: 6.7"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	0.4	0.1	0.4	0.2	1.4	0.0	166.7	0.3	0.5	1.1	0.0	0.8	14.0	0.0	0.2	3.2	0.0	5.2	0.1	0.4	1.1	0.1	2.1	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.6	0.3	1.8	0.0	7.8	1.1	4.5	0.0	0.7	0.0	12.0	0.5	1.4	0.2	0.1	18.8	0.3	0.9	2.6	1.5	0.1	15.8	0.1	0.0	0.6	0.5	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.8	0.0	0.1	0.2	11.2	0.0	0.2	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.2	3.1	0.4	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.1	0.0	0.1	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.5	0.4	1.1	0.6	1.1	0.6	0.7	1.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.1	0.0	0.7	0.0	0.3	10.4	0.1	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 623.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	185.7	14.3	12.3	13.5	16.5	5.8	116.2	16.0	11.5	12.9	6.9	23.2	25.3	6.6	6.6	103.9	11.5	65.7	135.5	10.9	18.7	45.4	623.2	28.9	4.7	22.1	18.4	15.5	23.3	0.8	9.7	1.7	23.2	17.3	12.2	11.5	73.7	12.5	120.4	35.3	23.4	8.7	19.6	4.1	142.9	13.0	22.2	4.6	46.7	27.3	7.8	71.1	31.3	20.3	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.3	16.5	16.0	11.5	10.9	18.7	22.1	18.4	23.2	19.6	22.2	20.3	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
AKR1E2	"AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 19.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 153.8;Late spermatids: 174.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 12.3;RT4: 10.4;U-2197: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	2.0	0.8	1.7	0.7	1.8	2.1	3.1	1.5	2.3	1.8	0.0	1.3	1.4	1.1	0.9	1.4	1.0	1.3	1.9	2.0	2.4	0.9	0.5	2.0	0.8	1.6	2.0	0.7	2.1	1.0	0.5	1.8	2.7	0.9	1.2	3.5	1.1	1.8	1.5	1.2	1.0	2.1	0.5	1.2	1.5	19.0	1.6	0.7	3.3	0.8	0.5	1.1	1.3	1.6	0.5	5.9	2.2	1.0	0.0	0.0	0.1	2.3	0.2	0.1	0.1	9.0	0.8	0.0	0.0	6.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	1.1	6.2	1.1	0.0	0.0	6.5	12.3	5.6	0.0	0.0	5.4	0.7	0.0	2.2	6.9	4.4	0.0	0.0	0.0	1.6	10.4	0.0	4.8	8.2	2.4	4.7	2.4	4.6	2.6	4.1	0.0	2.0	19.5	0.0	2.8	0.0	0.0	0.1	0.0	1.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	1.8	1.5	2.3	2.0	2.4	1.6	2.0	2.7	0.5	1.6	1.6	0.9	0.0	0.0	1.6	0.2	0.0	0.1	0.5	0.6	0.2	1.1	0.6	0.8	0.0	0.6	1.8	0.0	0.1	0.1	0.0	0.0	0.3	153.8	0.5	0.7	1.4	0.0	1.3	7.1	0.0	0.0	2.2	0.0	0.6	0.0	0.6	2.2	0.0	1.2	1.7	8.9	0.1	0.0	0.6	0.6	174.2	2.8	0.8	3.6	5.6	0.6	0.3	0.0	9.0	0.0	0.1	0.1	1.5	0.0	0.2	0.0	0.5	0.3	1.2	0.0	0.8	1.2	32.0	10.0	0.7	0.1	0.0	0.2	0.2	0.1	0.5
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 711.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		950000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	33.3	67.9	45.3	17.5	48.0	25.0	33.8	47.4	44.2	57.2	66.2	46.4	81.1	34.7	22.4	47.8	48.4	29.1	39.1	45.9	46.1	76.7	62.7	24.6	25.3	48.8	49.4	45.7	47.9	32.7	32.6	19.0	44.9	31.6	27.5	16.0	31.4	27.7	55.4	37.1	56.8	22.6	49.2	28.3	42.7	33.1	48.2	31.3	28.6	39.6	20.5	29.6	38.5	54.1	65.3	40.2	43.3	40.2	67.0	64.7	28.8	47.6	57.6	65.0	58.2	51.5	53.6	46.8	49.6	64.2	36.6	50.8	48.7	71.5	30.5	37.5	77.4	29.4	37.5	83.3	51.9	32.9	22.9	64.8	55.5	50.0	30.6	61.5	55.8	60.2	43.6	42.6	67.7	64.9	64.2	31.9	12.4	90.8	50.1	66.7	54.0	83.2	64.2	28.3	80.9	30.2	51.8	46.1	84.6	24.6	91.9	112.7	44.2	40.6	42.7	44.0	36.2	51.4	34.8	57.9	87.6	74.4	58.5	0.7	82.2	40.6	61.4	69.7	71.7	63.8	54.4	54.2	113.5	57.6	61.7	54.1	9.5	69.4	54.1	98.8	78.9	73.7	45.3	48.0	47.4	44.2	45.9	46.1	48.8	49.4	44.9	49.2	48.2	54.1	47.6	16.0	22.3	15.3	42.6	24.3	73.2	56.4	37.5	33.1	94.6	98.8	27.7	98.7	31.7	77.3	6.2	167.5	52.8	95.0	254.3	64.0	94.6	85.8	35.8	35.3	99.7	33.4	8.6	36.2	99.8	67.9	44.9	33.4	10.2	62.5	43.2	90.6	104.6	21.9	7.5	97.9	46.8	58.4	34.2	57.6	77.3	47.6	53.4	5.6	64.6	128.7	63.8	5.5	9.2	39.4	131.5	67.7	36.3	39.3	273.8	711.5	61.0	30.1	46.0	57.8	54.4	56.3	24.9	76.0	34.1	102.6	40.4	88.4	136.4	62.3
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	39.0	54.0	35.6	14.2	37.9	14.3	34.9	37.2	41.0	33.1	28.6	40.3	21.8	39.1	14.3	53.2	32.6	12.4	47.1	34.7	36.6	36.2	65.9	25.6	8.7	40.5	41.4	33.1	39.2	24.4	34.2	16.7	40.5	35.0	14.1	6.6	32.8	20.0	118.3	54.0	29.3	17.6	33.9	24.6	40.5	24.0	39.5	8.2	31.4	45.4	9.7	38.5	33.2	39.4	70.9	83.8	24.1	56.0	50.2	53.4	42.5	62.2	69.4	57.4	49.4	45.7	46.0	14.1	31.1	70.6	43.5	47.9	41.9	70.5	33.5	32.2	116.6	17.0	48.2	43.5	44.6	14.9	26.8	65.9	64.0	62.3	70.2	43.0	53.9	16.8	57.0	18.2	52.5	49.5	14.0	36.7	63.0	85.7	120.9	17.1	33.8	43.2	57.9	49.3	56.2	65.4	53.2	93.7	39.9	28.1	49.1	28.9	52.5	118.1	61.7	34.2	62.1	26.4	69.8	15.2	68.4	27.2	57.5	0.1	1.1	0.9	0.7	1.4	0.4	0.4	0.5	0.7	0.8	0.7	0.4	0.7	1.7	0.7	1.6	1.2	1.0	0.6	35.6	37.9	37.2	41.0	34.7	36.6	40.5	41.4	40.5	33.9	39.5	39.4	20.7	0.0	3.3	7.2	15.1	14.7	22.9	33.8	18.8	12.6	31.2	22.6	6.2	27.1	15.5	11.0	2.1	64.0	10.7	56.1	45.0	36.8	24.8	18.2	22.9	20.6	30.0	42.5	4.1	40.2	52.3	23.5	32.1	25.3	4.5	18.6	17.9	42.8	31.1	10.1	4.9	38.8	30.5	20.7	22.8	10.8	23.9	16.6	12.4	4.7	26.9	32.9	15.5	2.5	8.1	34.5	32.9	28.6	17.1	43.3	57.1	55.8	7.2	11.7	26.3	23.7	25.3	12.3	19.3	32.1	20.0	130.0	9.4	26.5	38.1	31.3
AKT2	PKBβ	ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	62.8	40.0	31.7	37.3	31.3	48.4	38.6	58.3	40.0	49.8	55.1	42.3	24.5	43.5	49.4	42.5	46.1	25.1	40.8	31.5	24.5	52.2	59.2	30.7	38.1	32.0	26.0	53.9	41.9	58.5	47.8	27.6	26.3	41.2	23.3	41.2	32.5	45.0	101.3	39.4	35.6	34.2	22.1	38.1	33.1	29.7	28.0	53.4	100.1	118.7	37.0	39.8	41.5	35.2	66.2	160.1	63.1	61.5	72.0	88.9	32.5	41.7	63.5	87.6	77.9	71.8	60.8	67.4	36.8	96.3	37.2	28.2	66.8	90.0	56.1	62.5	74.3	43.4	116.5	44.7	45.8	50.7	50.5	82.7	53.6	58.6	56.4	71.9	19.0	73.0	57.3	67.5	49.8	54.6	81.1	24.7	31.7	73.7	41.5	54.2	32.1	48.5	68.3	105.7	82.7	49.8	43.3	75.0	35.0	62.5	59.8	64.9	18.8	52.7	51.5	47.3	67.6	61.5	59.0	56.4	52.6	59.7	44.3	5.7	2.6	2.1	2.2	1.2	2.2	1.9	1.8	1.5	1.7	2.9	1.7	2.6	4.0	1.7	1.6	4.9	1.6	1.7	31.7	31.3	58.3	40.0	31.5	24.5	32.0	26.0	26.3	22.1	28.0	35.2	18.1	16.0	15.9	51.2	33.0	23.8	23.9	20.9	26.2	67.6	25.3	23.9	31.2	30.0	18.1	60.7	41.7	31.3	26.0	23.7	21.5	19.7	5.5	26.2	26.7	17.4	19.2	19.1	30.4	30.4	25.2	27.9	20.9	25.8	14.0	44.2	13.9	87.5	22.3	60.6	25.3	20.1	22.4	23.2	17.5	10.5	42.9	20.0	23.2	23.4	21.7	46.2	50.4	41.7	40.6	24.8	16.9	26.7	30.4	29.7	21.8	24.8	24.9	97.4	19.7	29.3	25.0	14.8	15.6	31.1	27.4	38.7	23.1	56.9	23.3	29.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	19.3	9.7	13.4	6.0	17.0	3.8	15.5	59.9	36.6	20.0	0.0	24.5	2.6	22.7	8.6	5.9	20.3	8.2	11.8	22.8	5.6	11.2	4.7	15.3	5.9	1.2	3.9	26.4	4.5	7.4	13.9	13.1	7.4	15.8	4.9	17.0	5.1	15.6	5.9	6.3	11.8	15.7	0.8	8.1	10.2	9.7	20.3	7.0	14.4	11.5	4.6	18.8	14.8	31.1	30.8	7.2	31.0	0.4	16.9	20.6	13.9	20.8	22.5	11.8	12.9	1.1	13.9	0.5	3.0	28.9	12.1	1.2	16.3	8.5	18.9	9.0	15.3	1.0	1.0	0.3	11.7	0.6	6.5	11.3	0.3	15.5	16.9	30.3	30.2	7.2	0.5	1.1	9.0	0.9	7.6	3.3	14.4	0.3	5.1	4.2	19.7	0.6	4.8	4.1	31.4	41.9	1.3	0.5	40.1	19.1	1.9	21.5	25.6	22.7	17.7	1.1	19.5	4.6	4.6	7.1	19.4	5.2	25.3	1.3	0.8	0.1	0.6	0.1	1.1	0.6	0.6	0.6	0.3	0.8	0.6	0.7	0.7	1.4	0.3	0.5	0.1	0.3	13.4	17.0	59.9	36.6	22.8	5.6	1.2	3.9	7.4	0.8	20.3	31.1	65.4	3.2	2.2	457.4	22.2	2.4	15.0	1.3	17.1	43.6	6.1	5.1	5.4	4.3	2.7	27.6	33.3	11.0	24.4	0.0	0.0	11.6	82.8	1.7	35.5	43.7	0.0	5.0	756.1	1.7	8.0	27.9	2.6	1.1	5.1	29.7	48.2	0.6	2.9	42.1	514.5	0.0	2.0	10.5	12.5	72.8	27.4	9.5	7.2	414.1	8.6	20.1	19.6	633.3	475.9	0.7	0.0	35.3	14.4	27.0	0.0	6.9	0.3	35.0	19.7	40.1	35.6	15.0	14.6	1.7	1.7	12.4	27.8	8.3	0.0	12.2
AKTIP	"FLJ13258, FTS"	ENSG00000166971	"AKT interacting protein"	Q9H8T0	16	53491040-53504411	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 168.3;Late spermatids: 325.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041794, HPA046300"	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041794: AB_2677677, HPA046300: AB_2679619"	"unprognostic (2.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"prognostic favorable (1.18e-14)"	"unprognostic (2.39e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.31e-1)"	29.3	20.5	46.9	15.7	48.9	32.1	24.7	47.8	55.7	24.5	42.0	30.2	15.5	22.3	31.6	33.2	21.4	17.4	55.3	50.9	47.2	37.1	31.8	24.4	22.5	51.5	46.9	30.4	17.3	44.9	29.0	30.2	52.8	24.7	17.8	76.9	20.5	31.0	134.9	26.9	20.0	25.7	47.6	15.5	21.2	44.0	47.5	13.2	31.7	81.4	24.2	25.1	26.1	48.9	40.2	25.7	17.2	22.7	22.8	17.2	50.5	24.7	18.6	21.5	5.3	35.0	20.6	6.6	14.9	25.4	16.2	34.0	14.9	20.0	28.8	9.7	23.6	1.9	13.6	28.1	29.6	9.2	17.1	14.6	55.1	21.4	18.4	31.2	37.1	13.4	3.6	14.1	19.2	31.2	8.0	13.7	11.9	19.2	24.6	9.6	28.5	30.3	28.4	33.2	13.5	16.8	14.9	52.4	22.4	22.9	46.7	5.7	35.2	23.1	25.1	15.2	24.4	20.6	19.6	13.5	24.9	8.1	15.0	22.3	4.5	11.0	32.4	3.4	19.5	9.1	31.1	33.9	2.0	13.7	47.7	39.3	29.3	27.1	3.4	3.0	46.4	19.1	46.9	48.9	47.8	55.7	50.9	47.2	51.5	46.9	52.8	47.6	47.5	48.9	41.9	25.6	15.4	11.8	9.3	7.0	15.1	29.0	5.7	28.4	17.9	11.9	32.2	17.2	25.4	23.9	16.7	80.3	13.6	15.0	82.2	29.8	168.3	11.2	7.1	22.2	6.0	3.6	19.4	20.5	44.3	16.4	8.2	12.9	3.8	9.6	26.0	26.3	13.3	21.9	20.2	6.5	44.7	7.0	5.6	325.9	14.0	6.2	23.2	7.5	8.0	58.8	28.8	8.5	21.5	20.6	6.0	38.4	12.2	15.0	36.2	38.2	22.0	27.3	6.6	22.1	22.2	16.1	40.4	11.2	12.8	77.3	28.7	8.4	11.5	19.0
AL021546.1		ENSG00000111780	"Novel protein"		12	120438198-120460006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.9;HEK 293: 11.5;U-266/84: 10.4"									HPA062394	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA062394: AB_2684749"		"unprognostic (3.79e-2)"			"unprognostic (1.74e-1)"	"unprognostic (2.79e-1)"		"unprognostic (2.90e-1)"		"unprognostic (1.71e-1)"		"unprognostic (1.33e-1)"	"unprognostic (9.54e-4)"	"unprognostic (2.04e-1)"				0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.4	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.4	2.0	2.6	0.0	0.6	0.0	0.0	0.0	1.8	0.3	0.5	0.0	8.9	0.0	0.5	3.2	0.0	0.8	0.9	0.0	0.5	0.0	1.6	11.5	0.7	0.0	0.0	0.0	4.1	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.9	0.2	0.0	0.0	3.2	0.4	0.2	0.0	4.6	1.8	1.2	1.0	0.0	0.0	4.5	0.3	2.9	0.7	0.0	0.0	0.8	0.4	2.4	1.5	0.4	0.0	1.2	0.9	10.4	3.8	0.6	1.3	0.0	1.6	6.1	5.6	5.0	8.9	5.6	4.9	3.0	5.7	11.0	3.8	3.3	3.1	1.3	2.2	6.9	7.9	5.4	4.2	0.1	0.3	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL022318.4		ENSG00000284554	"Novel protein"		22	39014363-39033276	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	5	"lymphoid tissue: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"									HPA055116	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"				"HPA055116: AB_2682701"																		0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.1	1.1	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.1	2.5	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	2.5	2.0	1.3	2.8	2.3	3.6	0.1	2.8	1.5	1.5	0.0	0.6	1.8	1.0	2.8	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.4	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL031777.2		ENSG00000282988	"Novel protein"		6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.1;Extravillous trophoblasts: 6.7;Hofbauer cells: 9.1;Syncytiotrophoblasts: 20.7"					"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 30.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in some"		"K-562: 6.9;SiHa: 7.7;T-47d: 4.6;U-2 OS: 5.1;U-266/70: 9.3;U-266/84: 5.6"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA041189: AB_2677357"																		0.6	0.3	0.5	0.2	0.6	1.5	1.1	1.3	1.2	2.0	1.6	0.7	0.3	0.1	0.0	3.4	0.4	0.1	0.4	0.6	0.5	0.8	1.9	2.2	0.3	1.2	0.8	0.4	0.1	0.1	0.3	0.3	1.1	2.5	0.3	0.1	0.5	0.0	0.0	0.8	0.6	0.1	1.0	2.0	0.5	0.7	1.0	0.8	0.4	0.0	0.1	0.4	2.4	1.4	0.2	0.7	0.2	0.7	1.5	0.1	0.5	0.6	0.1	1.2	0.4	0.2	0.5	0.1	2.0	0.1	0.5	1.4	0.1	0.0	0.2	2.6	0.2	0.4	2.1	0.3	0.1	0.1	0.9	1.0	0.0	0.1	0.3	0.2	0.0	0.6	6.9	1.5	0.0	1.0	0.1	0.4	0.2	2.6	1.6	0.2	0.1	3.0	0.0	0.0	0.6	0.2	7.7	0.5	0.3	0.3	4.6	0.0	0.0	0.7	5.1	0.0	0.0	9.3	5.6	0.7	0.0	1.9	0.7	16.9	0.6	5.1	1.6	0.7	3.6	2.1	0.8	1.1	2.3	4.7	0.8	0.5	30.6	0.9	1.5	5.2	2.3	1.1	0.5	0.6	1.3	1.2	0.6	0.5	1.2	0.8	1.1	1.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0
AL035078.4		ENSG00000285283	"Novel protein"		11	31812391-32104665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 8.8;lymphoid tissue: 5.7;retina: 7.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 224.4;RH-30: 110.7;RT4: 139.0;TIME: 116.0"									HPA038474	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"		"HPA038474: AB_10672595"																		1.3	0.0	0.4	5.7	0.7	0.5	0.0	2.5	1.4	0.3	0.0	8.8	0.0	2.3	0.1	2.2	0.7	0.0	0.0	0.4	1.3	0.3	1.6	1.0	0.0	1.5	1.2	1.1	0.0	0.0		0.4	1.1	0.2	0.2	7.4	0.0	0.0	4.1	0.0	1.5	0.2	1.0	0.2	2.1	0.5	0.8	0.3	0.0	0.0	0.5	0.1		1.6	14.7	33.3	4.9	22.6	2.8	0.0	0.6	224.4	40.6	18.6	9.5	11.2	25.0	0.0	46.0	12.7	14.3	7.1	21.8	12.1	14.7	13.1	0.8	13.4	24.1	0.0	0.0	11.3	1.8	0.0	0.0	23.7	6.4	3.8	4.4	0.1	3.7	13.5	0.0	0.2	13.8	0.0	2.6	0.0	0.3	8.7	110.7	2.7	0.0	139.0	12.9	3.7	36.6	1.4	16.3	0.0	13.9	0.5	116.0	62.2	27.3	30.4	64.6	0.0	0.1	0.6	74.6	2.9	24.7	0.0	0.8	0.0	0.3	0.4	0.4	0.2	0.0	0.2	1.0	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.4	0.4	0.7	2.5	1.4	0.4	1.3	1.5	1.2	1.1	1.0	0.8	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL049629.2		ENSG00000284969	"Novel protein"		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		2.5	0.7	1.5	2.3	1.4	1.5	1.1	1.5	1.6	0.5	2.5	0.7	1.4	1.3	1.8	1.2	0.6	2.1	1.1	1.4	1.7	1.6	0.8	1.7	0.3	1.8	2.0	0.6	0.7	1.0		1.5	1.8	0.5	0.7	0.6	2.4	0.7	3.5	0.3	0.3	0.6	1.8	0.5	2.9	1.1	1.8	0.2	0.8	1.1	1.4	2.3		2.1	1.3	3.3	0.2	2.4	3.4	7.9	0.1	18.5	8.4	2.3	2.2	0.1	9.6	0.0	2.3	12.5	1.1	2.2	0.3	42.8	4.0	2.0	0.4	0.3	7.1	0.8	0.8	0.4	1.2	3.0	2.7	1.0	14.7	1.9	55.1	0.3	0.5	7.4	15.4	1.0	1.8	0.8	0.5	1.3	24.8	0.4	1.5	1.3	4.9	2.2	0.0	0.3	2.0	3.4	7.3	0.2	1.0	0.0	66.2	7.0	2.7	57.6	7.4	3.8	3.7	0.3	16.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	1.4	1.5	1.6	1.4	1.7	1.8	2.0	1.8	1.8	1.8	2.1	0.5	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.7	0.2	2.1	0.0	0.0	0.0	14.4	0.0	0.2	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
AL121899.2		ENSG00000286022	"Novel protein"		20	2207328-2341059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"esophagus: 3.1;fallopian tube: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.0"									HPA004728	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"		"Cluster 38: EFO-21 - Unknown function"				"HPA004728: AB_1080360"																		0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.2	0.3	0.1	0.2	0.1	0.1	3.1	3.4	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.7	0.8	0.0	0.1	0.0		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0		0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.7	0.8	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL121900.1		ENSG00000284776	"Novel protein"		20	18567453-18744216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"		"Cluster 30: Epithelial cell lines - Translation"		"Nucleoli, Cytosol"		"HPA040981: AB_10673268"																		11.6	14.9	16.3	13.1	15.8	15.3	17.0	15.4	18.3	10.5	13.3	13.1	10.4	12.7	12.8	13.2	11.2	7.9	11.1	16.2	20.1	19.7	8.1	12.4	13.0	16.7	16.0	15.3	19.0	22.9		11.1	17.4	9.9	14.5	28.2	9.7	10.4	21.9	9.9	8.5	11.8	17.6	12.4	12.5	14.7	17.7	8.5	21.6	17.9	17.0	14.7		19.4	58.0	57.7	65.1	58.3	23.6	55.4	27.8	50.7	50.0	43.6	35.0	39.8	46.0	0.9	33.2	50.6	53.1	32.6	49.7	119.3	68.9	26.6	25.9	65.1	15.8	57.9	72.3	57.9	37.8	32.9	89.5	44.8	154.1	33.8	72.2	10.2	34.6	70.7	59.4	66.0	12.8	55.3	53.3	40.1	93.8	0.6	87.1	51.6	57.1	33.8	82.0	57.5	25.4	69.0	120.5	32.8	42.9	33.6	61.1	55.3	26.1	63.7	69.7	54.8	69.5	31.1	37.8	51.4	45.6	57.6	20.5	15.8	29.8	30.5	30.5	30.5	29.9	29.6	40.1	26.1	20.7	21.9	24.3	25.6	31.3	9.0	24.5	19.2	16.3	15.8	15.4	18.3	16.2	20.1	16.7	16.0	17.4	17.6	17.7	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132671.2		ENSG00000282218	"Novel protein, GOPC-ROS1 readthrough"		6	117318211-117573571	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Alveolar cells type 2: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"U-138 MG: 8.9"	"Low region specificity"	"Detected in all"							HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA					"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132780.3		ENSG00000259132	"Novel protein"		14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.9;MCF7: 23.7"									HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA029803: AB_10601428"																		3.0	4.8	9.5	2.8	9.6	4.7	2.5	9.1	13.9	4.0	9.0	5.6	3.9	2.6	6.8	4.2	4.7	4.2	8.1	9.6	9.4	7.7	6.9	4.0	6.4	10.1	9.4	6.9	12.8	2.3	3.1	2.8	9.9	4.7	4.0	2.0	3.7	2.1	5.8	6.1	4.2	1.8	9.5	10.2	5.4	3.4	9.8	4.7	3.4	1.5	2.6	3.5	3.0	10.2	4.0	13.0	4.4	0.8	7.1	7.1	6.1	0.0	5.6	3.7	4.1	2.9	0.0	0.0	1.9	9.4	1.3	0.6	2.9	3.9	2.1	0.0	1.6	0.0	7.7	38.9	4.1	4.2	0.1	4.3	8.1	3.5	8.3	8.5	6.9	12.7	0.0	5.6	3.4	23.7	6.2	16.8	2.2	6.4	5.1	5.7	3.9	4.4	14.1	10.8	4.4	1.9	0.0	2.8	1.4	4.7	4.6	7.9	0.1	5.4	2.6	0.6	4.4	4.7	9.4	7.1	0.4	1.7	3.1	0.3	2.8	1.2	1.7	2.5	0.6	1.6	1.0	1.0	2.8	2.3	1.8	1.0	5.8	0.5	1.6	1.4	2.4	1.5	9.5	9.6	9.1	13.9	9.6	9.4	10.1	9.4	9.9	9.5	9.8	10.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL133500.1		ENSG00000285547	"Novel protein"		X	72301691-72572843	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	6	"epididymis: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;SH-SY5Y: 1.4"									"HPA048560, HPA049051"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA048560: AB_2680442, HPA049051: AB_2680612"																		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2		0.0	0.1	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.1	0.1	0.5	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL136295.1		ENSG00000254692	"Novel protein"		14	24189157-24213473	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.4;granulocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 8.1"									HPA059249	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"		"HPA059249: AB_2683959"						"unprognostic (3.45e-2)"												1.7	3.0	0.6	2.1	0.7	2.0	0.8	0.7	1.5	1.2	0.5	1.3	2.5	1.0	0.2	0.8	1.1	0.4	1.7	0.6	0.8	1.7	0.8	1.1	1.4	0.8	0.6	0.9	1.4	0.5	0.5	0.7	0.7	0.8	0.9	1.3	0.8	0.6	1.9	1.3	2.2	0.6	0.5	0.8	1.3	1.0	0.8	1.6	0.8	0.0	0.4	0.8	0.7	0.7	1.5	1.4	2.4	0.9	2.2	1.3	1.9	1.4	2.0	1.0	2.2	1.0	5.1	1.5	0.2	1.8	2.9	1.5	1.5	0.8	3.2	2.4	0.0	0.9	0.8	1.2	0.4	4.3	2.5	0.5	0.8	1.2	0.0	3.5	0.7	1.3	0.1	4.3	1.7	1.2	1.1	0.0	2.1	0.7	0.0	1.7	1.9	0.0	1.9	1.1	0.2	1.0	8.1	2.7	3.4	2.8	2.0	3.4	4.4	0.2	1.0	1.3	2.1	3.4	2.6	3.6	0.5	0.9	0.8	0.0	0.1	0.5	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.1	0.6	0.7	0.7	1.5	0.6	0.8	0.8	0.6	0.7	0.5	0.8	0.7	0.0	6.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AL139011.2		ENSG00000258465	"Novel protein"		1	160216800-160285130	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Group enriched"	"Detected in some"	10	"Alveolar cells type 2: 2.6;Club cells: 1.8;granulocytes: 5.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Immune cell enriched"	"Detected in single"	9	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA044837	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 60: Granulocytes - Receptor signaling"			"HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	0.1	0.0	0.1	0.0	0.2	0.0	0.0	1.2	0.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0
AL139260.3		ENSG00000274944	"Novel protein"		1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.7;Endometrial ciliated cells: 1.3;Glandular and luminal cells: 2.1;Respiratory ciliated cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.4	2.0	0.0	0.9	0.0	0.4	0.4	0.0	0.9	0.5	0.0	2.7	1.7	0.3	0.0	2.7	0.7	0.2	0.4	0.0	0.0	1.1	1.8	0.4	2.5	0.0	0.0	0.4	0.5	0.0	0.9	0.6	0.0	0.7	1.6	0.0	2.4	0.0	0.3	1.5	1.2	0.0	0.0	1.2	1.6	5.1	0.0	0.4	0.6	0.0	0.5	0.9	1.0	0.0	16.7	1.3	3.7	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	8.0	17.5	2.8	14.5	0.0	0.3	11.1	0.0	0.0	0.0	9.2	2.3	1.4	2.7	2.2	0.0	19.3	5.4	0.0	0.0	0.8	0.5	1.2	0.9	0.0	6.4	4.7	1.1	4.1	8.7	20.6	7.7	8.5	9.8	9.8	7.7	17.9	0.0	8.6	7.0	3.6	9.2	7.5	2.1	3.1	5.0	6.1	6.8	2.2	7.6	7.7	16.0	1.8	17.3	12.9	8.2	7.5	2.2	0.0	0.4	0.0	0.0	0.5	0.2	1.2	0.0	0.1	1.7	1.3	0.1	0.0	0.9	0.0	1.4	3.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AL139300.1		ENSG00000256500	"Novel protein"		14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.7;tongue: 16.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044617, HPA052450"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													4.3	2.6	0.9	2.9	1.0	0.8	1.3	0.9	5.2	1.2	0.2	1.4	0.0	0.8	0.2	1.6	0.9	0.1	12.8	1.4	1.6	0.5	0.5	1.0	1.6	1.0	1.7	1.0	2.5	7.5	3.8	0.1	1.6	1.4	0.0	3.5	1.6	1.1	31.7	0.6	0.7	3.1	0.7	0.4	0.7	9.4	1.1	2.9	0.1	16.5	1.7	3.4	0.5	1.2	8.1	15.9	18.5	0.6	8.2	7.8	5.6	25.7	19.7	29.3	17.0	9.5	12.1	22.0	17.2	19.2	19.3	5.5	12.4	13.3	17.4	6.7	0.0	8.7	6.1	8.7	9.7	10.8	3.4	8.6	0.6	13.5	11.0	14.5	15.2	13.7	11.6	3.4	21.4	15.4	18.9	1.2	12.1	19.5	13.9	7.7	12.1	11.4	13.6	9.0	22.1	12.2	14.6	5.7	12.1	6.2	13.0	6.6	8.4	11.3	9.2	16.9	10.4	6.4	8.6	25.6	19.6	3.4	9.8	0.2	0.8	1.1	0.5	1.3	0.7	0.3	0.7	0.9	0.4	1.3	1.0	0.4	0.7	0.6	1.6	1.5	1.4	0.3	0.9	1.0	0.9	5.2	1.4	1.6	1.0	1.7	1.6	0.7	1.1	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL157392.5		ENSG00000282246	"Novel protein"		10	13610047-13655929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.8;Collecting duct cells: 3.7;granulocytes: 2.5"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA047950	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"			"HPA047950: AB_2680221"																		3.4	1.6	3.9	3.6	3.7	5.1	4.3	4.4	5.8	1.5	3.2	2.4	4.7	2.6	6.7	1.4	1.6	2.2	1.7	3.7	3.4	1.6	1.7	2.3	5.6	3.4	3.4	2.1	3.3	1.6	0.0	2.4	3.5	2.8	3.5	9.8	5.6	2.1	3.5	12.0	3.4	1.3	2.8	5.3	4.2	5.7	3.7	4.2	2.5	0.5	3.3	2.1	0.0	3.7	1.6	2.1	7.7	1.7	1.6	0.5	4.7	2.5	0.1	1.0	1.1	3.5	2.8	0.6	1.8	1.2	0.7	4.5	1.4	1.8	1.0	1.3	2.7	0.8	4.9	4.4	1.4	1.4	2.6	1.1	4.2	0.4	0.4	6.6	0.4	5.7	2.7	2.4	0.5	1.8	2.3	3.9	0.5	3.2	1.5	0.9	1.3	0.7	1.1	0.9	1.2	1.2	1.0	2.4	2.1	4.8	2.2	1.9	7.0	4.3	1.5	3.6	2.1	2.7	1.8	0.8	1.7	2.4	4.1	1.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.5	0.0	1.6	0.0	0.0	0.2	3.9	3.7	4.4	5.8	3.7	3.4	3.4	3.4	3.5	2.8	3.7	3.7	0.7	9.6	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	1.8	3.7	0.0	0.5	0.6	0.0	0.0	0.6	0.0	1.1	1.0	0.6	0.0	0.0	0.0	0.5	0.5	0.3	0.0	1.7	2.5	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.9	0.9	0.0	0.0
AL162231.1		ENSG00000187186	"Uncharacterized LOC730098"		9	34664163-34666112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 292.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 24.5;Breast myoepithelial cells: 36.4;Collecting duct cells: 36.8;Distal tubular cells: 25.4;Proximal tubular cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 18.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 51.4"									HPA069617	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Endoplasmic reticulum"	"HPA069617: AB_2686161"	"unprognostic (8.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.00e-2)"	6.0	9.8	49.0	2.9	53.7	2.6	7.8	48.5	76.1	9.3	42.3	9.9	3.9	10.4	19.4	2.4	8.3	2.8	27.8	49.4	50.0	14.6	6.7	5.1	1.9	48.4	46.8	14.0	8.8	6.4	60.6	3.1	48.6	11.7	1.4	6.5	7.3	2.5	36.7	4.6	4.3	2.4	47.8	2.6	6.3	292.4	52.6	2.1	13.6	22.2	0.7	8.0	5.9	49.8	0.6	10.1	9.1	11.9	7.4	3.6	8.2	8.0	2.4	4.9	5.7	1.7	4.0	0.0	1.0	5.4	9.8	2.5	5.9	2.8	0.9	22.1	1.1	0.0	51.4	3.0	1.8	4.5	7.4	3.9	3.1	3.0	3.0	6.8	1.4	12.3	5.5	12.3	3.7	0.0	1.0	4.5	7.7	9.1	2.6	0.0	8.7	1.6	9.3	0.0	9.4	15.2	5.5	1.8	14.0	5.1	4.6	12.5	1.8	17.3	24.0	5.5	1.9	13.1	4.7	1.9	21.4	2.5	24.3	18.2	2.4	2.6	1.8	1.4	1.6	4.4	2.1	0.9	0.8	1.3	2.6	1.3	3.4	4.1	0.8	11.7	2.1	1.3	49.0	53.7	48.5	76.1	49.4	50.0	48.4	46.8	48.6	47.8	52.6	49.8	1.6	9.6	7.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	24.5	36.4	0.0	0.0	2.5	36.8	0.0	13.7	0.4	0.0	25.4	16.2	0.0	7.3	10.4	0.7	0.0	0.0	0.0	10.7	12.1	6.6	0.0	6.0	2.5	5.4	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	37.1	3.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	7.1	1.0	4.0	0.0	0.0
AL162417.1		ENSG00000285245	"Novel protein"		9	133098121-133163914	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in single"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;REH: 1.1;TIME: 1.1"									HPA025961	Uncertain		Uncertain	Nucleoplasm		NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"		Nucleoplasm		"HPA025961: AB_2671795"																		0.1	0.2	0.0	0.2	0.2	0.4	0.0	0.4	0.3	0.1	0.8	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.7	0.8	1.0	0.6	0.2		0.1	0.8	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.5	0.3	0.1	0.1	0.0	0.7	0.0	0.1	0.6	0.0	0.3		0.3	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.6	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.1	0.3	0.7	0.8	0.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL353671.1		ENSG00000288684	"Novel protein"		9	32455323-32552603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in some"											"HPA047193, HPA073217"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 36: HEL - Hemostasis"		"Plasma membrane, Cytosol"		"HPA047193: AB_2679978, HPA073217: "																		0.7	0.1	0.5	0.3	0.5	0.2	0.2	0.4	0.5	0.4	0.5	0.3	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.9	0.1	0.0	0.8		0.1	0.9	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.8	0.5	0.1	0.5	0.1	0.2		0.9	0.3	0.5	0.6	0.1	0.8	0.7	0.2	1.4	0.7	0.7	1.4	0.7	0.0	0.4	0.2	0.6	0.9	0.1	0.2	0.7	0.0	1.3	0.4	1.8	0.7	0.0	0.4	0.8	0.1	0.7	0.5	0.6	1.0	0.8	1.1	1.3	0.2	0.1	0.7	0.0	0.3	0.7	0.3	0.9	0.1	1.4	0.3	0.1	0.3	0.7	0.6	1.4	0.5	0.2	0.2	0.1	0.1	0.0	0.5	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.4	0.2	0.0	1.7	0.4	1.6	0.5	0.4	0.3	0.5	0.5	0.6	0.3	0.3	0.6	0.5	5.4	0.4	0.3	0.1	0.8	0.3	0.5	0.5	0.4	0.5	0.3	0.6	0.9	0.9	0.9	0.5	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL357075.4		ENSG00000288520	"Novel protein"	G9CGD6	6	154159828-154510114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0"									"HPA028708, HPA028710, HPA049651"	Uncertain		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442, HPA049651: AB_2680841"																		0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.4	0.5	0.5	0.3	0.5	0.7	0.1	1.0	0.4	0.3	0.2	0.0	0.2	0.8	0.6	0.2	0.0	0.3	0.2	0.5	1.4	0.0		0.5	0.3	0.4	0.3	0.1	0.0	0.3	0.0	0.0	0.6	0.6	0.3	0.5	0.3	0.6	0.2	0.0	0.2	0.0	0.4	0.5		0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL358113.1		ENSG00000285130	"Novel protein"		9	69035747-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;Endometrial ciliated cells: 3.8;Glandular and luminal cells: 3.8;Respiratory ciliated cells: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.6	0.0		0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0		0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.7	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.8	0.5	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.8	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
AL365214.2		ENSG00000281613	"Novel ret finger protein-like 4B"		6	112236806-112350094	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"RPTEC TERT1: 3.4"									HPA059324	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA059324: "																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL441992.2		ENSG00000286112	"Kynurenine aminotransferase 1"		9	128819663-128881931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 1.9"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"											"HPA021176, HPA021177, HPA027736"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"		"Cluster 16: U-266 - Nucleosome"		Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"																		0.3	0.1	0.6	0.2	0.7	0.5	0.2	1.5	1.9	0.2	0.5	0.2	0.2	0.3	0.5	0.2	0.3	0.2	0.1	0.6	0.3	0.1	0.3	0.1	0.3	0.4	0.3	0.3	0.2	0.1		0.3	0.4	0.3	0.1	1.1	0.2	0.4	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.3	0.5	0.3	0.1	0.4	0.2	0.2		1.3	0.4	1.5	1.0	0.6	1.2	0.4	1.2	1.0	0.1	0.7	0.6	1.1	0.4	1.1	0.5	0.6	0.7	1.2	0.6	1.1	0.1	0.9	1.3	1.0	1.4	0.8	0.2	0.9	0.4	0.4	0.5	0.9	0.4	0.7	0.3	1.0	1.6	0.2	0.2	0.5	0.9	0.7	0.9	1.3	1.1	1.2	1.1	0.3	0.2	0.3	0.6	1.0	0.9	0.0	0.2	0.7	0.2	0.3	1.0	0.7	0.6	0.3	0.7	1.2	2.6	0.9	0.3	0.7	0.3	0.8	0.9	0.2	1.0	0.3	0.9	1.4	0.7	0.7	0.7	1.1	0.8	0.8	0.6	1.3	0.5	1.9	0.8	0.5	0.6	0.7	1.5	1.9	0.6	0.3	0.4	0.3	0.4	0.2	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512785.2		ENSG00000254706	"Novel protein"		1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.6;HEL: 12.0"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	1.1	0.6	0.5	0.3	1.2	1.2	1.8	2.3	0.6	1.9	3.5	2.1	2.1	0.9	0.0	1.0	1.2	2.4	0.7	0.6	1.4	1.2	2.7	1.0	0.2	3.8	1.6	0.3	3.2	1.0	0.4	0.7	2.5	1.1	0.5	0.0	5.0	3.9	0.2	1.1	1.4	0.7	2.6	0.1	2.1	1.5	1.4	0.2	0.1	0.2	0.1	0.7	0.3	4.1	7.6	0.0	4.0	4.4	0.2	0.0	0.0	0.8	0.5	0.4	0.0	1.7	2.6	0.0	5.8	0.0	1.5	3.0	0.4	0.5	0.0	0.1	3.9	12.0	0.0	2.8	0.1	0.2	0.0	0.8	0.2	0.0	0.5	0.7	1.5	0.9	1.2	0.2	0.2	2.7	0.4	0.0	3.5	2.1	3.0	0.3	0.1	0.0	1.4	2.7	1.7	1.9	2.6	0.4	1.9	0.5	4.3	0.0	2.1	0.1	1.0	0.1	1.8	5.8	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.3	0.6	0.6	1.4	3.8	1.6	2.5	2.6	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL589987.1		ENSG00000230707	"Novel protein (LOC389895)"		X	140091415-140092911	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.3;brain: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"endometrial cancer: 2.0;glioma: 1.0;ovarian cancer: 0.9;testis cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HAP1: 2.1;NTERA-2: 1.7;U-251 MG: 2.2"									HPA041568	Uncertain					NA	NA					"Cluster 12: NES - Nervous system development"				"HPA041568: AB_10796677"				"unprognostic (1.27e-1)"	"unprognostic (3.32e-2)"					"unprognostic (2.17e-1)"		"unprognostic (4.08e-2)"			"unprognostic (5.26e-1)"	"unprognostic (1.28e-2)"		0.1	6.3	2.8	0.1	3.2	0.0	0.0	2.5	3.7	0.9	1.3	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	3.1	2.6	0.0	0.0	0.0	0.0	2.6	2.4	0.3	0.0	0.1		0.0	2.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.2	0.0	1.3	2.6	0.0	0.1	0.0	0.0	0.0		2.5	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.2	2.5	3.7	3.1	2.6	2.6	2.4	2.4	2.6	2.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL592183.1		ENSG00000273748			Unmapped	54224-83311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.4;Ionocytes: 42.7;Langerhans cells: 34.4"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 103.6"					"Low region specificity"	"Detected in all"			HPA049380	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049380: AB_2680736"																		33.2	24.0	7.9	24.4	13.5	27.7	30.0	17.6	22.3	21.4	8.4	28.3	32.5	55.2	69.3	32.3	22.3	70.8	30.7	9.5	16.5	37.4	21.6	13.2	69.3	9.8	9.5	30.7	24.3	15.1		26.4	12.3	22.6	25.8	49.2	30.2	32.8	20.5	39.0	21.5	20.2	8.8	26.5	29.0	15.3	9.4	18.5	49.1	6.8	42.7	18.9		16.7	60.5	5.9	1.2	33.2	36.7	44.3	7.3	43.9	35.0	23.8	39.4	2.9	44.2	35.5	17.4	11.2	21.1	31.7	8.9	0.9	28.5	73.5	30.9	31.7	10.4	15.5	0.9	47.7	47.9	49.5	5.0	9.2	21.5	60.4	15.2	28.5	64.8	103.6	15.6	2.0	34.3	27.9	4.8	5.0	3.8	46.7	6.6	18.9	31.7	27.8	4.9	45.7	3.4	14.0	5.5	13.6	10.0	30.9	15.5	7.4	3.5	5.5	8.2	56.7	91.6	19.1	42.8	8.7	11.9	9.2	2.5	7.3	3.5	3.0	4.9	8.1	4.7	4.6	2.7	6.8	5.7	5.7	2.4	4.8	5.2	4.2	4.8	3.4	7.9	13.5	17.6	22.3	9.5	16.5	9.8	9.5	12.3	8.8	9.4	16.7	3.0	6.4	9.5	0.0	5.6	14.8	20.0	37.4	0.6	2.5	3.5	8.4	0.0	5.7	16.9	3.7	2.1	2.2	1.7	0.7	7.9	4.0	0.2	2.1	1.9	7.4	1.2	4.8	0.0	1.3	0.7	5.6	0.0	1.2	16.4	1.7	6.4	1.8	2.5	0.0	0.0	3.4	42.7	12.9	34.4	0.5	5.0	4.1	17.8	0.0	2.8	5.0	1.0	0.0	0.0	2.2	1.3	7.2	2.0	4.8	1.5	3.3	18.2	5.2	13.1	7.8	6.7	0.3	1.6	1.1	12.4	1.9	8.2	1.0	3.4	11.9
AL645922.1		ENSG00000244255	"Novel complement component 2 (C2) and complement factor B (CFB) protein"		6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"liver: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;Club cells: 3.1;Fibroblasts: 1.2;Respiratory ciliated cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL645941.2		ENSG00000248993	"Novel  protein"		6	32937364-32953122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012298	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"			"Cluster 11: Alveolar cells - Smell perception"			"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"		0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL662899.2		ENSG00000263020	"Novel protein"		6	31666102-31673546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Low region specificity"	"Detected in all"			"HPA005944, HPA048307"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA005944: AB_1847290, HPA048307: AB_2680348"	"unprognostic (7.19e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	7.9	7.0	0.0	0.0	0.0	10.4	7.5	0.1	0.1	8.7	0.0	8.5	0.0	6.2	0.1	8.0	8.7	0.1	7.4	0.0	0.1	7.5	8.2	7.5	0.1	0.0	0.0	9.3	7.0	0.0	6.3	0.0	0.1	8.7	0.1	0.2	6.2	0.0	5.7	13.9	10.7	0.0	0.0	15.1	7.6	7.3	0.0	0.0	7.2	0.3	0.0	6.6	6.4	0.0	0.4	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.6	0.3	0.5	0.9	0.5	0.1	1.5	1.7	0.4	1.2	1.2	0.3	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.6	0.2	0.4	1.1	1.2	0.1	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	1.4	0.4	0.3	0.1	0.0	0.3	0.3	0.1	0.7	1.6	0.0	0.0	0.0	0.3	1.4	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL669918.1		ENSG00000250264	"Novel protein, TAP2-HLA-DOB readthrough"		6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9;HDLM-2: 11.5;HEL: 9.8;U-698: 10.0"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	1.7	1.0	0.4	11.8	0.4	1.4	1.0	0.7	0.5	1.5	0.1	1.6	2.0	1.4	0.0	1.4	1.1	0.6	0.6	0.5	0.5	0.6	0.5	1.9	5.9	0.6	0.4	0.6	0.4	0.4	1.5	0.2	0.6	0.7	1.0	0.0	2.8	0.0	0.4	1.0	5.0	0.4	0.8	7.0	4.4	0.6	0.6	0.7	1.1	0.0	1.3	1.1	1.2	0.9	2.4	2.9	0.0	0.8	1.6	1.8	0.6	0.7	0.3	0.0	0.7	0.0	3.3	19.9	1.7	0.4	0.2	6.2	2.1	2.8	0.7	11.5	0.4	9.8	2.8	0.3	0.5	0.0	1.3	0.0	0.9	0.6	0.2	0.0	0.0	2.1	3.8	2.4	0.1	0.7	1.6	1.1	0.3	0.0	3.8	4.0	0.6	6.3	0.1	0.0	0.3	0.4	2.2	6.1	1.6	0.0	4.6	1.0	0.0	1.4	2.0	0.5	1.0	1.8	4.7	10.0	1.0	4.2	0.4	0.7	1.8	3.7	1.5	1.7	1.9	4.5	1.6	2.2	3.4	4.5	1.2	2.6	4.1	1.3	3.0	3.1	2.5	3.3	0.4	0.4	0.7	0.5	0.5	0.5	0.6	0.4	0.6	0.8	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
AL772284.1		ENSG00000277535	"Novel cancer/testis antigen family protein"		X	119073226-119076373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	26	"testis: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Approved	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386312-113401290	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 209.8"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 147.8;Granulosa cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced		Approved	Cytosol		NA	NA		44000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	54.7	153.9	73.5	16.8	82.7	82.2	23.2	75.2	84.7	18.4	53.6	25.7	29.5	16.3	26.6	35.0	15.6	27.4	51.9	66.0	74.5	73.2	209.8	20.6	15.6	85.4	83.5	28.9	46.5	73.2	15.9	24.9	84.5	34.1	24.5	19.0	98.6	24.2	28.8	38.9	26.6	17.6	80.1	13.6	50.4	13.1	81.1	20.3	25.9	23.9	18.7	18.4	19.3	83.7	8.1	14.8	11.0	15.7	71.2	48.4	67.8	21.9	35.4	13.7	17.2	19.2	16.7	11.7	12.7	30.3	11.0	29.1	8.1	14.6	8.3	29.5	10.2	22.0	18.2	26.2	16.4	21.2	19.0	41.2	10.8	12.7	5.5	53.9	27.1	18.6	8.9	16.5	23.7	61.8	23.8	21.2	5.4	57.9	27.4	19.5	18.7	19.8	21.4	16.6	10.2	9.4	27.2	32.5	20.1	19.2	34.1	23.7	30.7	12.5	9.3	25.1	12.4	23.8	26.0	9.8	34.1	18.9	13.6	10.2	13.7	23.6	11.3	15.5	6.0	6.8	9.3	6.0	14.6	10.2	8.7	9.9	6.2	6.9	17.4	6.0	10.8	9.7	73.5	82.7	75.2	84.7	66.0	74.5	85.4	83.5	84.5	80.1	81.1	83.7	7.2	16.0	15.6	18.6	10.4	7.0	8.9	7.1	8.0	12.9	16.7	11.6	50.3	25.8	12.0	14.7	27.1	48.2	7.4	27.7	13.7	20.3	5.4	17.7	9.2	11.5	9.1	147.8	10.0	26.3	23.2	10.2	15.3	27.7	14.5	86.5	11.0	70.0	17.0	5.0	10.7	12.5	10.2	15.1	6.4	10.8	11.8	12.4	12.4	9.4	12.4	6.4	8.2	7.1	20.0	15.0	35.3	14.7	11.0	7.6	32.6	59.0	10.6	15.7	6.6	8.9	24.6	6.8	9.5	22.6	9.1	11.4	8.8	11.7	16.7	9.2
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453225-49471050	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved					NA	NA		600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	18.5	14.1	3.0	9.7	3.4	10.0	14.5	3.5	3.8	17.7	3.6	13.9	13.9	15.9	0.8	15.5	12.9	3.5	8.5	2.9	3.3	14.1	17.1	11.7	10.4	4.5	3.8	11.3	18.6	3.8	7.5	5.0	3.6	10.3	2.3	1.0	10.8	4.9	7.0	16.2	19.1	3.2	3.9	28.3	14.1	5.2	4.2	4.9	12.4	1.8	4.9	12.9	13.8	4.0	24.6	32.7	7.8	18.4	3.5	2.3	26.3	15.5	4.9	11.8	12.1	17.1	9.3	36.8	24.9	2.1	2.8	16.7	3.1	8.9	1.5	23.3	19.0	28.7	13.1	24.6	5.1	17.6	61.3	4.3	5.0	5.7	4.6	2.4	7.7	12.5	20.7	37.3	3.1	24.8	12.8	51.9	17.1	10.6	0.0	21.8	11.1	28.1	5.7	28.7	14.1	16.1	13.9	15.4	13.4	1.9	14.0	20.3	17.4	17.4	11.3	8.0	17.4	31.4	38.2	10.7	4.3	24.9	12.6	11.2	10.9	18.6	9.3	26.0	9.8	17.1	9.1	10.1	16.4	17.1	8.4	8.8	1.8	8.6	29.8	17.4	7.9	8.1	3.0	3.4	3.5	3.8	2.9	3.3	4.5	3.8	3.6	3.9	4.2	4.0	22.3	6.4	11.5	1.0	27.2	9.9	28.6	19.2	21.1	9.2	10.8	8.6	4.0	12.8	15.5	11.0	8.4	33.7	19.5	27.6	5.9	22.0	1.5	6.3	6.3	16.9	13.1	20.0	1.3	24.5	28.7	16.3	21.4	8.0	17.2	12.9	15.4	17.4	46.2	1.7	1.2	16.6	20.3	29.9	14.7	2.9	28.0	20.2	16.0	3.7	31.4	6.4	15.5	1.5	4.2	14.0	26.0	8.2	17.6	9.1	43.8	22.9	24.3	7.0	19.7	7.2	15.8	3.6	13.1	19.7	10.5	40.4	13.8	27.6	23.7	28.3
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH1A2	RALDH2	ENSG00000128918	"Aldehyde dehydrogenase 1 family member A2"	O94788	15	57953424-58497866	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 82.2;fallopian tube: 74.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 115.7;Endometrial stromal cells: 142.2;Late spermatids: 48.7;Microglial cells: 42.2;Spermatocytes: 78.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 13.1;hippocampal formation: 8.4"	"Immune cell enriched"	"Detected in some"	15	"neutrophil: 32.6"	"Lineage enriched"	"Detected in single"	62	"granulocytes: 32.6"	"Group enriched"	"Detected in some"	5	"AN3-CA: 402.4;HEK 293: 128.8;JURKAT: 387.2;K-562: 316.2;MOLT-4: 408.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010022	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA010022: AB_1844723"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.80e-3)"	21.3	3.9	1.9	2.9	1.4	4.0	5.9	2.1	13.1	52.3	3.4	1.7	0.7	82.2	7.8	2.4	74.5	24.0	28.4	8.4	0.9	19.5	2.6	7.8	0.6	1.7	1.6	24.0	3.2	29.8	14.6	5.2	1.9	21.0	0.7	6.0	2.0	53.3	10.7	1.7	1.3	31.9	1.8	4.3	0.7	57.6	2.5	2.8	1.4	3.0	0.4	4.0	12.9	1.1	1.2	0.0	0.0	402.4	0.0	0.0	0.1	0.0	5.7	0.6	1.3	0.0	0.3	0.4	3.9	0.0	0.1	1.0	11.8	0.0	0.7	0.0	128.8	0.0	2.7	0.7	0.3	0.0	3.0	2.3	0.0	0.0	0.0	0.0	21.4	387.2	316.2	0.0	0.0	0.0	408.5	0.1	0.7	11.2	19.6	0.0	0.8	0.0	70.7	2.0	0.8	0.1	0.4	0.4	1.9	0.4	0.2	0.1	0.9	0.3	1.0	3.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.3	0.0	0.0	0.0	1.9	1.4	2.1	13.1	8.4	0.9	1.7	1.6	1.9	1.8	2.5	1.1	13.1	6.4	13.9	0.0	0.0	0.6	1.9	0.2	0.0	1.1	1.1	0.9	2.4	20.0	3.4	7.3	0.0	0.3	0.1	5.2	13.7	11.6	115.7	6.8	142.2	7.6	0.0	0.0	5.8	0.4	0.3	17.6	0.0	3.6	1.3	0.3	10.8	17.4	2.2	0.0	9.6	0.1	0.0	1.6	0.8	48.7	5.3	3.0	1.8	42.2	0.7	10.1	0.0	0.0	1.2	0.7	0.3	5.3	0.0	1.3	0.3	0.3	1.4	0.3	0.0	8.3	3.3	78.9	14.7	0.2	0.4	0.5	1.0	0.1	0.7	1.3
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 134.5;urinary bladder: 125.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 80.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"olfactory bulb: 4.5;spinal cord: 15.8"	"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	83.7	11.4	3.0	41.5	2.7	0.6	30.5	4.7	5.2	37.1	16.2	16.6	15.0	8.2	30.3	28.7	24.9	17.0	12.4	3.1	1.9	8.2	5.3	9.8	3.0	4.8	3.4	6.1	15.0	9.0	7.5	8.4	2.6	134.5	8.9	0.3	93.7	49.3	5.9	3.9	25.2	40.8	2.8	3.1	12.8	16.6	3.3	1.6	2.5	6.9	15.7	125.1	22.3	3.9	363.3	43.5	0.6	0.7	75.0	32.8	1.4	3.2	3.2	1.9	0.8	1.0	285.8	2.6	4.7	97.1	55.7	441.7	8.8	1096.9	6.7	0.1	2.0	1.7	20.1	0.3	25.5	1.4	1.9	23.5	29.8	24.4	4.5	347.7	4.0	0.0	0.7	2.4	1.8	3.8	0.2	1.2	9.0	9.6	316.3	0.7	4.2	2.3	0.2	283.6	0.3	25.4	113.9	94.9	33.3	3.6	9.3	3.2	58.3	0.3	1.0	619.0	14.2	0.7	3.4	1.5	484.7	0.2	516.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.7	4.7	5.2	3.1	1.9	4.8	3.4	2.6	2.8	3.3	3.9	10.0	16.0	6.3	0.3	0.5	0.6	175.4	70.5	4.6	0.0	64.6	18.9	2.0	1.5	141.6	103.0	0.0	9.6	0.9	1.0	3.9	70.5	1.2	20.6	247.9	11.6	3.5	0.0	2.9	1.4	0.5	48.9	1.1	11.7	5.7	0.0	1.8	0.1	1.2	0.0	2.3	2.1	30.5	0.0	1.3	8.5	194.5	3.3	0.0	1.0	0.6	0.0	0.0	36.7	4.6	29.4	0.0	135.4	0.0	580.3	0.1	0.7	78.7	0.0	13.1	20.4	11.5	0.5	0.9	2.9	1.6	4.9	2.0	1.5	0.8	468.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105107643	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 40.7;salivary gland: 13.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.1;Inhibitory neurons: 24.0;Oligodendrocyte precursor cells: 25.1;Plasma cells: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.8;ASC TERT1: 85.2;fHDF/TERT166: 102.4;HHSteC: 55.6;HSkMC: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No				"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	3.7	0.6	1.3	3.1	1.2	0.6	2.3	2.3	1.6	5.3	0.7	2.2	2.6	2.0	1.0	1.3	1.5	2.8	1.9	1.1	1.6	0.4	0.2	1.8	1.0	1.4	1.3	0.6	40.7	0.6	1.3	1.1	1.5	3.6	2.3	0.7	13.0	4.6	0.8	1.0	1.4	4.2	1.8	0.7	3.3	1.1	1.6	0.5	2.1	1.2	1.7	3.4	1.5	2.5	13.0	1.3	0.7	27.3	62.8	85.2	1.6	40.8	26.0	5.2	13.5	1.6	0.0	0.0	1.6	102.4	0.2	0.1	0.1	1.0	6.5	0.0	0.3	0.8	0.1	3.4	55.6	5.3	0.1	69.7	3.1	13.6	25.2	0.0	3.0	0.2	2.1	37.7	10.6	0.0	0.0	0.3	1.6	0.0	0.3	0.0	0.1	4.3	0.0	0.0	9.4	4.5	0.0	8.3	20.5	0.4	6.0	44.0	0.3	3.9	3.8	0.0	2.2	45.5	12.8	0.1	16.2	19.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.2	2.3	1.6	1.1	1.6	1.4	1.3	1.5	1.8	1.6	2.5	1.4	0.0	0.6	3.3	2.6	0.5	0.1	0.7	0.0	1.7	0.3	1.1	1.6	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.3	4.1	0.7	8.5	0.9	0.0	0.0	23.1	9.8	0.6	10.5	1.5	1.6	0.0	0.1	1.1	0.0	0.4	5.0	24.0	0.0	0.0	0.6	1.7	5.9	3.7	1.0	5.4	1.0	4.0	1.3	0.0	25.1	8.5	3.7	0.0	6.8	14.6	0.4	0.0	0.1	0.2	0.8	0.0	3.6	8.4	1.7	0.1	0.0	0.6	0.3	0.9	0.1	0.1	0.2
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 857.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.0;myeloid DC: 213.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.2;monocytes: 212.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved					NA	NA		2200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	303.8	102.4	139.7	39.8	146.1	29.2	77.2	136.5	163.5	25.0	123.3	73.3	73.7	30.1	21.3	73.6	32.3	37.4	111.3	132.2	139.7	177.7	857.7	111.6	18.7	140.7	144.9	42.0	23.3	2.6	23.3	7.0	141.1	34.6	72.3	29.2	32.4	29.5	130.8	127.9	74.8	30.2	143.0	20.6	101.5	13.0	151.8	27.1	30.8	165.7	52.9	50.0	29.0	144.5	8.8	13.1	18.7	31.9	86.8	13.0	60.9	9.3	16.8	4.3	3.1	23.5	12.1	0.5	45.3	20.8	11.9	16.2	0.1	4.6	2.7	0.6	6.1	0.7	8.4	64.7	97.0	0.9	0.9	23.9	22.6	14.8	0.3	17.7	26.9	0.9	17.9	3.0	4.1	0.5	1.0	23.4	24.8	152.2	2.1	0.6	0.4	1.9	31.4	0.6	7.5	23.1	22.8	201.0	0.2	33.7	20.3	92.1	1.1	0.4	16.5	0.6	0.4	5.5	3.0	25.7	22.0	0.8	0.4	6.5	212.0	51.1	0.7	93.0	0.9	6.2	0.3	0.7	213.2	5.2	0.7	0.5	10.7	3.4	25.4	70.6	0.5	123.5	139.7	146.1	136.5	163.5	132.2	139.7	140.7	144.9	141.1	143.0	151.8	144.5	27.7	147.4	242.7	51.2	22.6	60.0	205.2	311.1	80.8	78.7	35.0	23.7	378.9	165.8	243.1	66.2	18.8	62.4	48.6	260.3	399.2	127.5	4.3	27.8	24.5	66.2	55.2	42.1	11.7	218.0	127.5	103.1	200.3	47.7	30.9	29.0	139.6	857.0	129.2	35.3	18.2	231.0	101.7	278.5	124.1	10.6	79.9	189.3	35.6	26.2	940.8	130.2	8.2	14.1	6.8	130.2	366.5	149.0	12.5	84.4	384.3	882.0	89.4	42.6	46.0	46.0	67.6	3.0	3.9	105.1	124.7	42.1	13.1	81.0	272.6	150.4
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 115.4;Alveolar cells type 2: 58.4;Endometrial ciliated cells: 54.5;Kupffer cells: 59.0;Respiratory ciliated cells: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 163.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 67.5;granulocytes: 163.2;monocytes: 125.8"	"Cell line enhanced"	"Detected in many"		"A549: 154.4;CAPAN-2: 154.9;RPMI-8226: 85.9;U-87 MG: 89.1"	"Low region specificity"	"Detected in all"							HPA038525	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	12.7	26.7	2.9	10.6	4.5	46.5	5.5	5.1	4.2	11.4	8.9	9.8	23.4	6.4	0.9	13.9	39.6	8.8	4.0	2.5	3.8	16.3	4.1	44.4	5.6	6.0	5.6	3.6	8.0	0.6	7.7	11.7	4.9	4.7	6.5	0.5	11.1	4.1	2.0	5.7	18.0	5.6	4.5	20.0	20.7	2.1	5.4	1.3	2.5	1.7	2.6	10.8	8.9	6.2	11.4	154.4	1.1	3.3	9.9	31.0	26.8	15.1	24.8	10.9	5.3	5.7	154.9	0.7	26.9	35.9	15.3	12.9	0.3	2.1	2.7	0.4	0.9	1.6	64.3	13.4	61.0	9.1	0.5	22.5	6.8	5.4	14.6	24.6	0.6	0.8	0.4	27.3	17.8	9.5	0.9	9.0	1.2	76.1	9.2	3.7	5.9	85.9	17.9	1.5	1.8	0.8	35.7	29.7	15.2	0.8	34.3	19.7	16.2	15.7	21.3	76.2	5.3	0.4	3.0	0.2	89.1	24.5	7.4	47.6	91.0	163.2	0.2	125.8	0.3	0.4	0.2	0.2	67.5	0.5	0.2	0.1	26.6	11.8	118.1	7.0	0.1	47.7	2.9	4.5	5.1	4.2	2.5	3.8	6.0	5.6	4.9	4.5	5.4	6.2	0.4	115.4	58.4	1.0	1.4	2.2	2.7	8.4	1.2	0.5	1.7	1.3	3.1	20.0	53.6	5.5	0.0	0.8	2.9	6.6	0.0	7.4	21.6	54.5	9.2	1.8	2.4	7.8	0.2	2.5	8.2	6.5	12.8	5.1	25.2	2.0	1.4	2.3	34.0	3.3	0.1	9.0	12.2	59.0	10.6	10.0	1.8	33.1	3.6	1.9	30.9	2.1	1.0	0.5	5.7	19.3	7.5	1.5	1.3	3.1	36.2	30.1	211.6	0.4	0.0	6.9	6.5	0.4	0.4	1.0	1.0	0.7	2.2	0.0	9.8	6.2
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662160-67681224	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 73.0;esophagus: 152.2;skin 1: 123.0;vagina: 41.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 26.2;Endometrial ciliated cells: 12.6;Glandular and luminal cells: 28.1;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 14.8;Syncytiotrophoblasts: 14.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 71.9;SK-BR-3: 70.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045132	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.3	0.0	0.1	0.1	0.0	0.2	73.0	0.0	0.0	14.4	0.0	0.1	0.1	0.8	6.8	152.2	4.6	0.3	0.1	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.3	5.2	0.1	3.2	0.0	3.3	0.1	0.5	17.3	4.8	0.3	123.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	2.4	0.0	0.0	21.1	8.3	41.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	7.9	0.0	0.0	0.1	0.0	1.3	3.5	3.3	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.9	6.8	0.0	0.1	9.0	0.0	0.0	0.0	1.9	0.0	13.0	0.0	0.1	0.0	70.7	0.1	0.4	15.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	1.7	1.2	4.9	1.2	0.0	26.2	7.2	0.4	0.0	7.3	5.5	0.0	10.6	0.2	0.0	1.9	1.1	0.0	12.6	2.6	0.2	0.0	0.0	0.1	0.2	10.6	0.2	0.0	28.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	53.3	14.8	14.6	0.2	0.0	0.0	7.6
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056847-74084492	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 379.1;liver: 367.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 43.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.2"	"Cell line enhanced"	"Detected in all"		"T-47d: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	38.7	14.7	58.6	4.8	66.0	3.3	14.4	58.8	59.3	17.3	61.4	15.2	26.6	11.4	9.8	9.8	12.8	9.4	40.3	51.0	54.0	379.1	367.1	9.4	5.1	63.3	54.0	28.3	23.4	37.0	6.6	7.6	55.6	25.4	15.8	15.2	19.8	16.1	27.5	6.2	23.4	9.0	56.4	5.4	24.0	17.1	69.8	5.7	28.3	34.8	5.3	11.4	7.0	62.6	8.9	7.8	11.0	23.5	39.3	19.2	17.5	6.3	11.8	6.8	11.5	17.3	10.2	10.5	13.6	13.5	5.3	4.8	24.9	7.0	14.5	9.5	3.5	5.1	8.0	19.2	45.0	2.7	2.4	28.2	12.0	8.7	20.7	17.0	12.0	23.7	8.1	14.7	4.6	36.2	7.6	4.0	8.7	32.6	5.2	15.1	11.2	14.6	9.2	5.8	4.4	7.0	21.0	21.9	5.7	18.0	57.5	9.6	3.8	7.4	9.0	11.7	2.4	9.3	18.9	10.2	9.9	3.2	7.3	29.1	6.2	43.2	6.9	4.8	10.6	7.2	7.8	8.4	9.2	6.1	9.9	7.0	2.4	9.7	4.2	5.3	6.1	4.9	58.6	66.0	58.8	59.3	51.0	54.0	63.3	54.0	55.6	56.4	69.8	62.6	15.4	38.5	60.4	24.5	11.8	9.2	26.8	10.0	20.5	20.6	28.4	18.9	81.4	67.2	22.9	66.2	4.2	31.0	7.1	18.9	201.5	11.6	23.4	26.2	27.5	27.0	16.9	28.6	5.5	3.1	14.8	25.9	34.7	90.2	7.6	27.1	87.4	523.6	17.7	11.8	10.0	39.3	8.2	26.5	8.9	19.0	28.9	13.4	24.9	1.9	15.8	98.5	9.2	12.5	23.4	4.1	16.3	48.2	8.0	27.6	55.3	962.4	15.4	17.0	13.1	25.6	16.9	11.0	4.2	25.2	7.4	30.6	11.0	10.2	35.7	17.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 311.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	119.2	105.5	49.6	29.8	51.0	24.8	76.8	49.3	60.3	51.5	62.5	45.7	54.8	38.6	93.4	105.6	50.2	32.0	48.2	47.4	57.5	142.4	206.5	38.5	40.3	50.5	52.1	53.6	44.0	81.9	39.9	38.0	51.4	65.3	50.6	46.4	104.1	45.6	93.6	54.7	48.6	42.0	50.7	37.9	39.5	63.4	49.3	39.0	123.0	56.4	60.1	39.4	43.9	55.6	55.7	53.5	48.7	44.1	152.1	132.8	40.7	71.9	101.5	70.8	61.0	33.4	40.7	0.1	67.1	64.8	34.9	42.8	40.0	70.3	83.0	25.9	50.6	35.3	34.7	36.5	78.2	56.0	36.1	86.0	34.8	75.2	62.5	97.8	62.2	45.9	56.9	48.4	111.7	33.4	37.6	57.6	71.3	145.1	64.7	31.7	62.0	74.3	92.5	52.0	57.7	39.8	51.4	57.1	67.4	65.6	108.8	84.0	61.9	42.5	41.5	52.4	37.1	44.7	62.5	54.8	47.9	52.6	41.7	61.8	35.2	50.9	45.5	37.7	48.8	49.9	43.8	49.6	34.5	46.8	43.8	50.4	51.3	43.0	45.3	21.6	69.8	45.6	49.6	51.0	49.3	60.3	47.4	57.5	50.5	52.1	51.4	50.7	49.3	55.6	56.2	16.0	47.6	12.7	43.3	32.6	43.3	43.8	68.3	25.0	83.0	54.6	46.5	55.8	36.8	51.5	22.9	48.5	39.3	43.9	97.8	42.9	45.4	27.7	39.1	49.4	55.8	28.2	5.6	37.0	76.4	60.6	36.2	20.4	38.0	60.9	59.3	158.8	61.9	13.5	8.3	56.9	32.6	59.1	24.9	39.8	95.4	43.8	56.9	6.5	34.6	311.5	39.1	12.1	12.2	32.2	33.1	115.5	34.8	39.6	80.3	204.4	59.4	28.9	26.3	32.5	40.1	85.6	49.9	123.8	51.9	38.2	43.7	148.4	63.6	28.3
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 26754.8;tongue: 9180.4"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004177, CAB006252"	Supported		Approved	Cytosol		NA	NA		640000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	569.3	696.4	616.8	443.1	697.4	732.5	512.6	617.3	719.7	566.0	617.0	774.1	517.9	533.7	201.0	1302.0	449.7	420.5	2286.1	731.9	652.0	709.0	217.1	425.6	358.2	762.3	654.0	510.4	390.5	943.1	525.1	351.4	763.9	457.7	400.1	465.2	904.9	597.6	26754.8	643.4	488.3	465.2	545.5	417.5	595.0	138.7	657.8	280.9	454.5	9180.4	478.3	761.8	740.3	558.7	2206.1	1620.4	477.9	1542.8	714.6	808.5	1520.8	1297.9	1336.2	1291.6	1603.0	1158.1	1643.6	1487.6	2072.2	1318.6	708.6	1632.6	966.8	2829.1	939.3	658.5	1272.9	1219.3	1202.7	2591.1	1112.5	1793.8	1251.3	1115.7	979.6	1455.4	968.9	2119.7	965.4	686.9	1070.0	951.1	1393.4	3136.7	1100.2	1477.0	1192.8	848.1	1346.6	1613.9	765.2	3353.2	1629.4	1230.5	950.7	668.5	808.6	3368.5	1213.9	591.2	1433.0	1194.7	1162.5	1892.3	750.3	1046.7	1430.0	1861.5	1387.3	1369.3	3524.5	1715.9	1532.9	2050.6	2694.7	2081.7	1008.7	2466.5	1138.1	908.5	1091.7	1047.0	2182.7	877.9	1027.4	996.9	2531.7	819.9	2780.2	824.0	1476.3	4372.2	616.8	697.4	617.3	719.7	731.9	652.0	762.3	654.0	763.9	545.5	657.8	558.7	17.0	12.8	32.4	83.2	281.2	792.0	716.4	3267.9	784.8	387.4	34.4	21.6	1968.4	273.1	1385.1	42.3	118.9	1194.1	107.9	1834.8	111.6	120.9	258.8	15.8	11.8	261.1	323.9	215.8	66.2	76.2	2322.1	329.7	513.3	16.1	196.5	18.7	289.5	102.0	1181.9	733.6	70.0	755.1	1265.4	632.2	715.4	1152.4	380.8	388.8	924.9	50.6	417.7	662.1	328.5	40.2	60.8	126.2	1497.1	405.1	409.4	676.9	1755.7	75.8	700.9	298.9	486.4	680.9	572.9	25.8	123.6	1174.6	684.5	1361.3	294.3	15.2	937.7	1146.2
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5736.6;kidney: 7181.0;liver: 11160.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.3	1.4	0.4	17.0	0.7	0.0	0.7	1.0	2.3	0.2	0.0	30.1	4073.8	2.8	1.0	0.7	0.4	176.9	1.0	2.4	0.0	7181.0	11160.8	0.5	4.9	0.0	0.0	0.5	292.7	0.0	5.6	0.4	0.0	2.1	5.6	0.3	0.3	0.0	0.4	0.5	5736.6	7.0	0.0	2.0	34.3	1.1	0.0	0.7	0.3	0.0	0.8	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033923-5087379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.3	19.6	6.2	12.8	6.6	7.7	9.9	6.1	7.9	12.4	12.7	18.8	15.8	11.0	14.5	11.2	12.4	9.8	8.3	6.5	6.6	12.6	21.0	9.3	12.4	6.3	6.0	8.8	26.8	17.5	10.9	9.5	6.9	10.5	16.3	6.8	18.8	10.6	7.4	8.8	13.1	12.0	5.8	15.0	19.6	20.8	6.5	12.0	11.6	5.5	12.1	12.4	8.3	6.8	24.0	53.7	10.8	25.5	40.7	24.2	26.4	50.6	50.6	46.9	46.4	44.8	72.4	44.4	43.1	48.0	20.7	58.2	30.1	36.2	31.6	42.0	43.3	20.7	40.1	87.1	33.4	37.6	37.3	29.7	26.9	36.2	23.0	18.5	28.7	32.2	29.5	44.7	34.5	50.1	28.9	40.7	51.2	31.7	33.6	48.8	16.0	124.9	28.3	18.7	20.7	21.7	49.3	67.8	27.4	14.3	45.1	29.2	29.8	22.5	25.6	134.7	40.1	39.8	59.3	30.2	20.5	39.8	38.1	11.5	79.9	28.8	87.2	80.6	77.1	72.9	74.9	86.3	86.7	73.9	66.7	75.0	4.3	79.8	80.0	75.6	81.1	126.6	6.2	6.6	6.1	7.9	6.5	6.6	6.3	6.0	6.9	5.8	6.5	6.8	4.6	16.0	6.1	4.2	11.2	2.4	3.4	15.7	5.2	7.4	6.8	6.0	0.7	8.6	14.3	7.3	12.5	16.2	7.2	8.5	3.9	19.5	10.7	5.4	8.1	8.7	13.3	12.0	4.0	28.3	18.7	9.3	13.7	5.5	1.3	8.1	8.6	17.7	21.7	3.3	4.6	21.0	8.2	10.6	2.4	25.5	9.6	7.6	10.6	1.0	9.3	7.5	9.2	3.5	3.4	21.6	11.1	6.8	22.7	4.5	11.8	10.4	11.7	6.3	6.6	5.4	7.1	28.0	16.0	7.7	1.6	8.5	8.6	13.8	18.0	4.4
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10 alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022468-34029694	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	2.3	2.6	1.3	2.7	1.5	4.1	2.8	1.7	1.1	1.9	0.9	2.3	1.6	2.2	2.7	2.1	3.4	1.8	1.0	0.8	1.5	1.9	2.9	1.8	3.7	1.9	1.2	2.3	1.5	2.3	0.6	2.3	1.6	2.6	1.9	3.3	1.5	1.9	0.9	1.9	1.8	2.1	1.6	2.9	2.0	2.6	1.3	3.6	2.8	1.3	2.9	1.3	0.9	2.2	5.3	5.8	4.0	7.0	4.6	4.3	14.0	5.1	4.7	5.4	9.8	8.8	12.6	10.3	7.3	2.6	8.2	7.8	7.9	6.8	7.9	13.0	7.2	9.2	6.7	3.9	1.8	11.4	8.1	4.0	3.6	11.3	9.3	2.6	3.7	8.1	13.9	13.6	5.5	6.8	8.4	6.3	15.1	3.2	7.7	6.5	14.8	8.3	3.2	7.8	3.8	3.0	9.4	3.8	5.6	11.7	8.6	3.2	7.5	7.4	10.7	11.3	6.5	7.4	14.7	17.3	5.0	4.8	6.2	0.0	1.0	1.7	0.6	0.4	0.9	0.8	0.9	0.4	0.6	0.8	1.1	1.3	0.1	0.8	0.5	0.7	1.2	0.5	1.3	1.5	1.7	1.1	0.8	1.5	1.9	1.2	1.6	1.6	1.3	2.2	3.0	6.4	0.5	1.3	5.1	1.5	3.0	4.3	2.8	4.6	2.0	1.7	0.8	2.8	5.1	5.5	4.2	6.8	3.5	1.4	1.9	2.4	1.0	3.1	2.8	2.3	1.2	7.0	1.5	3.8	5.5	2.7	3.1	2.2	1.3	3.6	0.7	2.9	3.3	1.7	1.8	1.7	2.0	2.8	1.9	0.3	1.5	2.2	0.0	1.9	3.3	3.4	1.0	2.5	1.8	3.3	0.6	1.2	4.0	0.8	1.2	1.3	3.9	4.2	0.0	2.5	2.0	12.4	5.8	4.3	2.7	3.1	3.2	2.6	1.9	1.8
ALG10B	KCR1	ENSG00000175548	"ALG10 alpha-1,2-glucosyltransferase B"	Q5I7T1	12	38316762-38329721	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	2.9	3.5	2.1	3.0	2.3	4.3	5.2	3.1	2.5	2.8	1.8	2.1	2.4	3.7	3.7	1.8	3.4	2.6	2.2	1.8	2.0	3.3	3.7	2.5	4.6	2.5	2.3	5.0	2.9	3.7	1.1	5.0	2.6	3.4	2.6	9.1	2.8	2.2	1.5	4.3	2.6	2.5	2.6	4.6	3.7	2.6	2.2	4.0	4.2	2.4	3.7	1.5	1.4	3.1	5.1	4.6	6.1	6.2	3.0	5.5	6.3	4.0	2.0	5.3	4.6	1.7	15.2	8.0	7.2	2.3	4.1	5.3	5.7	4.4	7.6	5.2	6.8	8.4	8.4	3.5	3.5	11.3	6.1	3.1	5.7	7.5	5.5	4.7	4.2	10.4	9.6	4.6	4.8	3.9	7.5	8.9	7.8	0.5	4.6	2.5	13.2	6.3	4.4	6.4	1.8	6.3	7.1	2.3	5.0	6.6	10.6	4.6	3.3	5.5	6.6	4.9	5.2	3.6	10.1	12.5	4.7	7.7	7.3	0.3	0.4	0.6	0.3	0.5	0.5	0.4	0.3	0.4	0.3	1.3	0.5	0.7	0.1	0.4	0.4	0.7	1.2	0.3	2.1	2.3	3.1	2.5	1.8	2.0	2.5	2.3	2.6	2.6	2.2	3.1	7.1	6.4	13.9	9.1	2.6	2.0	3.4	3.3	4.0	14.9	5.0	3.8	3.9	0.0	7.0	3.7	33.3	16.1	2.1	0.9	7.9	4.3	0.3	6.5	6.2	5.7	0.0	2.5	4.8	5.8	9.6	4.8	2.0	4.6	1.3	9.5	6.8	7.1	4.8	10.1	5.7	1.9	4.1	1.6	2.0	1.8	4.1	3.1	1.8	10.3	2.5	8.0	1.0	9.0	9.1	4.5	2.0	5.7	1.6	2.0	2.6	2.6	5.2	14.5	6.6	6.5	3.2	10.7	4.7	3.1	1.8	8.1	3.0	4.6	2.3	2.3
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11 alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012391-52079232	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	10.1	9.5	7.4	8.3	8.4	4.1	12.1	9.5	9.7	12.1	1.9	11.0	10.1	11.0	9.4	7.5	10.8	8.9	10.4	7.5	4.8	14.6	19.2	9.1	8.1	4.8	4.0	11.6	8.6	17.2	2.4	12.7	4.6	12.1	11.8	9.0	10.9	10.9	6.5	7.2	9.7	11.4	2.9	10.1	11.6	6.2	4.7	9.5	16.8	8.8	8.6	8.7	2.5	9.6	6.7	10.5	17.8	15.2	18.6	13.3	14.2	17.7	16.3	12.9	10.3	8.5	14.5	16.2	4.2	18.4	15.8	15.3	18.2	12.0	17.0	16.7	12.9	31.0	8.8	11.4	14.1	28.3	31.0	12.9	17.8	10.1	18.4	14.1	11.5	18.5	17.8	10.4	19.4	5.7	14.7	9.7	19.2	28.8	7.5	15.2	11.9	8.9	16.7	10.8	6.9	15.2	11.9	17.1	11.9	15.0	11.9	20.8	17.8	10.4	11.5	13.6	11.8	9.1	13.5	17.7	6.4	11.7	18.0	13.2	5.4	7.2	7.7	4.5	7.6	5.1	7.0	6.6	6.9	7.1	8.9	8.9	2.2	7.3	12.0	9.8	7.2	4.9	7.4	8.4	9.5	9.7	7.5	4.8	4.8	4.0	4.6	2.9	4.7	9.6	5.3	19.2	8.2	5.5	7.1	2.4	3.2	7.8	8.0	6.8	4.2	3.2	7.5	5.7	9.3	3.7	6.2	3.4	6.2	2.1	1.9	2.9	0.9	5.1	7.3	5.2	3.0	12.6	9.3	2.2	3.9	8.2	9.7	5.4	3.8	6.5	6.1	4.0	2.5	5.0	8.1	2.7	6.1	2.2	3.1	0.5	3.4	3.5	1.8	5.6	2.6	2.8	11.3	13.0	8.9	2.7	1.7	1.2	14.0	2.6	3.5	1.7	13.5	7.5	0.0	4.2	6.4	4.8	3.5	7.8	2.4	4.8	7.2	3.7	2.1	4.0
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12 alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	6.3	8.0	3.5	7.3	4.5	5.9	6.4	6.2	4.7	7.6	4.9	8.8	11.1	8.3	6.5	8.0	7.6	6.6	8.3	3.9	2.6	10.3	14.5	7.0	5.6	4.5	4.3	7.1	11.4	11.8	6.6	5.4	4.7	9.1	4.1	3.0	12.0	5.6	6.1	7.2	8.9	4.4	3.3	7.2	10.3	4.5	4.9	6.5	11.7	4.5	4.8	7.7	6.8	8.4	8.6	8.5	8.8	14.7	16.4	7.6	9.8	8.8	7.9	10.2	8.2	14.0	12.0	4.6	7.8	7.8	11.1	15.2	10.7	10.4	5.0	7.3	15.9	4.2	14.7	14.1	18.6	10.6	8.9	11.6	10.5	9.9	14.3	11.2	9.9	10.3	5.3	11.2	5.4	19.6	10.4	8.6	8.4	11.3	7.7	17.2	11.0	12.1	10.6	9.6	5.9	9.6	14.0	26.3	11.4	11.7	10.8	9.4	7.7	11.2	8.5	7.9	6.8	9.8	4.9	6.1	12.5	8.0	10.9	21.4	8.7	7.7	11.5	8.5	11.7	4.8	8.9	11.4	7.6	6.4	7.3	8.6	7.1	16.9	10.1	7.7	12.8	8.1	3.5	4.5	6.2	4.7	3.9	2.6	4.5	4.3	4.7	3.3	4.9	8.4	6.8	9.6	3.1	21.5	10.2	4.1	10.2	12.1	9.1	5.2	11.1	10.2	1.2	8.6	10.3	18.4	2.1	20.5	8.5	16.6	3.9	15.9	6.9	6.6	8.0	8.1	6.7	7.4	23.2	13.5	22.4	10.6	11.7	9.2	8.2	7.0	5.3	15.0	18.6	3.3	30.4	12.9	12.2	9.2	5.3	4.3	8.7	8.7	10.6	9.4	9.0	2.9	18.6	17.6	40.4	10.3	9.7	8.2	15.6	11.3	18.8	6.8	5.6	5.2	0.0	8.5	7.7	12.9	9.1	10.4	6.0	26.3	11.9	8.3	16.3	9.1
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13 UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	15.1	17.9	10.5	18.8	11.7	16.6	18.3	11.5	19.0	17.2	12.3	18.2	13.7	16.1	20.5	14.7	15.4	16.4	13.2	10.2	13.8	21.0	23.8	13.8	23.4	12.6	12.1	15.8	14.7	23.4	17.9	14.1	13.3	17.7	19.4	11.8	15.6	13.4	9.2	19.4	17.3	17.5	11.4	18.5	15.5	17.4	11.8	17.3	18.2	9.9	20.1	21.3	14.7	16.6	22.3	24.4	21.8	13.8	13.8	19.6	12.3	17.7	18.3	22.4	27.5	24.9	23.1	19.5	33.0	24.7	46.5	12.6	26.1	12.5	23.5	14.4	17.6	10.7	26.1	28.4	20.3	19.5	40.5	23.6	22.8	18.0	38.6	23.3	24.8	21.8	23.9	53.5	22.5	55.8	16.4	17.6	19.9	66.3	33.6	12.8	13.9	26.7	36.6	34.0	13.1	19.1	25.2	15.2	16.3	21.7	13.6	18.5	16.7	19.2	9.7	24.9	34.4	25.8	47.1	31.5	20.5	25.5	15.2	39.5	15.8	16.6	9.5	16.3	9.3	10.6	10.6	9.2	18.5	12.1	13.0	10.8	3.0	4.6	12.9	9.5	14.6	9.6	10.5	11.7	11.5	19.0	10.2	13.8	12.6	12.1	13.3	11.4	11.8	16.6	50.9	16.0	30.8	33.6	127.9	35.2	65.8	53.5	33.6	15.1	33.9	31.6	18.7	22.8	36.0	18.4	10.4	27.3	73.9	39.2	45.0	37.4	21.1	48.2	31.1	37.4	26.5	27.1	64.7	52.1	39.1	34.6	37.2	47.9	109.8	15.7	28.2	28.4	42.5	11.8	57.4	49.0	46.8	39.2	52.3	9.4	21.5	56.1	28.4	83.4	41.8	16.0	29.9	41.7	77.5	58.0	55.6	16.1	60.4	46.9	38.5	55.5	35.3	16.5	26.3	38.7	46.2	32.6	22.4	26.5	35.4	48.7	71.1	28.8	32.8	64.6
ALG14	MGC19780	ENSG00000172339	"ALG14 UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974405-95072951	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	1.2	2.5	1.5	0.8	1.7	0.9	1.3	2.2	1.9	1.0	1.7	1.6	1.8	0.8	2.3	1.0	0.8	1.2	0.9	1.6	1.4	1.5	2.1	0.7	0.8	1.7	1.4	0.9	1.8	1.6	1.0	0.8	1.5	0.9	1.7	1.4	1.8	0.8	1.5	0.9	1.3	0.8	1.2	0.8	1.1	1.1	1.7	0.7	1.7	0.5	0.8	0.9	0.7	2.2	2.5	1.6	1.3	1.2	1.0	1.7	1.1	1.8	1.9	1.8	1.5	1.8	0.8	1.3	1.8	2.2	2.2	1.7	1.5	1.7	2.2	2.8	2.5	0.7	1.6	2.9	1.6	1.7	0.4	1.9	1.7	1.4	1.3	1.4	1.6	1.7	1.4	1.6	1.8	1.2	1.9	1.1	0.8	2.5	2.2	1.2	2.6	1.4	2.1	1.4	1.1	1.5	1.0	3.4	3.2	0.9	1.5	1.5	1.2	1.1	1.3	2.0	3.9	1.0	1.0	1.1	0.8	0.8	0.9	1.3	1.0	0.3	0.8	1.3	0.7	1.6	0.9	1.0	1.5	1.4	0.8	0.9	0.8	0.9	0.6	1.9	1.3	0.6	1.5	1.7	2.2	1.9	1.6	1.4	1.7	1.4	1.5	1.2	1.7	2.2	11.8	0.0	12.2	14.0	13.1	11.7	11.4	30.5	19.4	16.9	13.8	15.2	7.7	10.0	20.3	16.5	6.2	34.6	10.5	25.7	19.6	24.9	10.0	12.2	19.6	10.1	4.2	13.0	24.6	53.7	25.9	18.9	11.2	13.3	1.3	14.7	11.7	32.4	18.9	8.4	22.4	12.9	18.3	8.4	8.9	8.4	14.3	8.6	32.0	14.0	10.3	30.9	3.1	14.6	35.4	23.6	22.6	10.1	41.6	8.9	22.1	40.0	12.7	14.4	32.9	17.1	15.2	36.1	23.0	19.0	8.7	25.2	5.6	39.9	26.9	12.9
ALG1L	ALG1L1	ENSG00000189366	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 10.8;urinary bladder: 9.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7"									HPA036108	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favorable (6.24e-4)"	0.5	1.1	2.5	1.1	2.7	0.3	1.4	2.0	3.0	1.6	1.4	1.4	0.4	1.4	10.8	1.6	2.2	0.8	0.7	2.4	2.6	1.7	1.4	1.0	0.4	2.5	2.4	2.3	1.3	0.6	1.8	1.5	2.5	1.8	0.8	0.6	1.9	0.9	6.7	5.8	0.5	0.5	2.1	0.3	1.5	1.2	2.4	1.1	1.6	2.6	2.7	9.4	1.5	2.5	1.1	0.8	0.4	0.0	0.0	0.2	1.8	0.1	0.0	0.2	0.4	15.9	14.3	4.4	6.8	0.0	0.3	15.2	0.4	0.0	0.8	0.6	3.6	0.8	2.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	4.1	1.2	1.4	0.0	30.1	1.0	0.3	6.4	19.1	3.8	0.1	0.1	7.4	0.0	0.9	2.4	0.9	0.5	0.2	0.7	3.2	19.7	0.4	0.3	0.2	2.2	0.2	0.1	10.9	1.7	5.9	0.2	0.0	1.0	2.5	0.0	0.1	2.0	0.1	1.1	1.6	1.0	2.2	0.0	0.9	1.2	0.7	0.4	3.2	0.0	1.3	2.7	0.9	2.5	2.7	2.0	3.0	2.4	2.6	2.5	2.4	2.5	2.1	2.4	2.5	0.2	0.0	0.5	0.3	0.7	3.3	1.7	33.6	0.6	0.3	2.1	2.4	0.0	0.0	15.2	1.8	0.0	3.5	0.5	0.3	1.9	0.4	1.7	10.5	0.8	0.3	1.8	0.0	1.2	0.4	2.0	1.1	0.0	0.4	1.3	1.4	0.0	0.1	0.3	0.0	1.7	0.2	12.2	0.0	1.2	1.8	1.8	0.1	1.8	0.0	0.2	1.5	2.1	1.0	0.6	0.6	1.4	3.0	0.4	0.5	0.0	1.0	46.0	0.0	0.0	2.7	2.6	1.4	1.6	0.3	5.1	1.4	0.5	2.4	0.4	8.2
ALG1L2		ENSG00000251287	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.4;retina: 2.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 6.0;Erythroid cells: 6.1;Granulosa cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.5	0.1	0.3	0.0	1.4	0.3	0.2	0.2	0.0	0.5	0.7	1.2	0.0	2.6	0.7	1.7	0.0	6.0	0.0	0.0	1.7	1.4	1.7	0.4	0.0	0.6	1.8	4.2	0.3	0.9	0.8	1.9	0.2	0.4	0.7	3.0	0.9	0.0	6.1	0.8	0.0	0.3	1.7	1.5	0.9	0.0	16.7	0.7	0.4	0.2	5.0	0.6	1.4	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.3	3.2	0.0	0.5	0.8	0.0	0.0	2.6	1.1	3.3	1.2	1.1	0.7	3.0	0.0	3.3	2.2	1.3	0.2	0.5	0.0	0.0	1.5	1.5	1.5	1.7
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2 alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216425-99221942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Approved	"Golgi apparatus"		NA	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	17.7	38.2	13.4	19.4	14.6	23.0	27.1	16.6	18.4	35.1	19.8	24.9	21.9	23.8	74.0	15.1	29.5	26.2	13.4	14.5	15.0	34.3	47.4	24.3	20.8	14.7	16.1	30.2	42.0	37.0	21.8	29.9	15.1	32.8	27.3	15.0	37.9	34.5	15.3	17.9	20.5	24.2	14.8	17.9	25.0	19.2	14.7	16.7	42.3	13.5	27.5	31.7	10.9	16.9	22.9	28.7	22.7	34.4	82.6	52.7	42.0	46.7	75.3	45.6	39.3	34.9	31.2	24.6	18.8	54.3	60.0	85.3	37.9	49.1	45.7	35.2	16.2	14.4	23.7	54.0	99.7	28.2	26.2	61.9	65.2	37.7	72.8	45.8	52.3	15.1	23.2	56.2	44.7	47.8	12.9	29.8	27.6	75.0	39.6	14.0	43.4	38.1	65.2	31.1	22.5	19.3	33.5	63.8	61.6	33.5	24.4	23.3	38.8	31.4	27.9	40.9	28.6	45.8	28.0	10.5	58.6	20.5	16.3	38.7	35.5	22.0	33.7	28.2	49.2	30.8	32.0	33.9	45.1	26.3	27.7	27.4	9.3	38.0	28.4	79.9	38.3	36.0	13.4	14.6	16.6	18.4	14.5	15.0	14.7	16.1	15.1	14.8	14.7	16.9	12.6	12.8	22.9	6.8	22.1	23.3	26.8	56.2	10.2	11.3	22.6	16.6	6.9	32.9	35.8	23.9	2.1	50.3	30.2	20.0	21.5	36.1	28.7	16.9	30.9	19.8	12.5	12.0	8.1	35.2	34.2	30.4	15.3	26.4	7.6	14.1	21.8	55.5	28.1	10.1	8.3	26.3	38.7	25.8	45.4	20.3	26.8	23.0	21.4	10.3	64.2	15.5	15.5	9.5	9.7	31.9	16.0	25.2	47.0	37.3	18.7	36.6	33.1	8.3	6.6	17.2	18.2	22.6	24.6	15.0	23.7	89.2	16.6	25.6	20.8	31.3
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3 alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (1.58e-5)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	22.0	32.6	9.3	15.0	9.3	15.7	19.7	10.8	11.1	18.1	13.9	23.8	16.9	17.5	12.5	30.5	15.1	11.6	19.6	8.8	9.7	18.7	58.0	18.1	13.0	10.6	10.1	12.7	37.1	23.1	14.6	19.6	11.2	19.8	18.3	6.0	26.8	13.7	30.2	24.9	20.4	16.4	10.0	20.8	23.1	25.7	10.7	12.2	18.4	14.8	14.1	22.5	19.8	10.3	77.2	67.6	18.0	59.5	70.2	39.4	59.3	40.6	46.0	54.9	47.3	102.8	50.9	67.6	108.4	50.8	112.0	90.8	64.1	90.0	34.5	49.0	76.7	60.8	49.3	84.7	64.3	99.5	52.4	47.0	74.7	64.8	90.9	29.4	30.0	46.0	60.7	132.6	36.1	95.8	48.5	83.1	55.9	153.3	85.8	49.9	27.5	269.7	63.2	25.7	44.3	36.7	37.6	147.0	67.5	21.8	140.2	54.8	24.3	57.2	36.0	51.2	88.4	72.3	137.8	71.3	51.5	129.2	52.9	0.6	60.9	14.6	35.8	61.1	40.5	31.6	38.3	36.8	71.4	30.8	33.9	33.2	2.0	48.9	51.3	65.3	44.6	41.7	9.3	9.3	10.8	11.1	8.8	9.7	10.6	10.1	11.2	10.0	10.7	10.3	14.2	6.4	18.1	4.6	24.5	25.0	28.3	61.0	26.2	10.4	24.1	20.8	11.7	21.5	43.0	20.2	10.4	79.2	21.0	24.9	7.9	62.3	95.7	9.1	17.7	18.7	14.5	24.4	5.6	63.1	100.4	22.3	25.0	13.5	12.7	16.3	12.5	51.7	69.8	8.4	5.9	33.3	50.8	24.9	15.5	211.5	12.5	25.8	21.4	7.5	21.2	13.7	16.5	7.1	6.3	44.6	22.0	15.1	63.8	47.2	39.4	31.8	16.7	13.0	19.7	9.0	34.6	29.7	34.3	39.4	27.0	65.8	17.6	23.1	45.6	29.1
ALG5	bA421P11.2	ENSG00000120697	"ALG5 dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949738-37000763	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	29.1	32.3	12.1	19.6	13.3	26.9	41.6	13.4	25.7	34.2	14.9	36.0	27.1	23.5	77.9	21.7	23.3	23.2	18.5	12.4	13.7	41.2	61.9	24.5	20.7	13.5	13.1	20.6	90.1	40.2	18.7	25.4	14.0	26.5	46.4	11.2	51.9	30.9	18.5	20.9	27.6	23.4	13.6	23.6	36.6	15.2	12.6	22.7	54.9	10.5	28.9	30.5	21.6	14.8	24.3	35.0	31.5	29.4	95.1	61.8	22.5	63.9	81.1	63.7	53.7	71.0	84.1	35.2	25.9	45.7	55.0	57.5	41.9	55.0	62.6	37.4	77.7	77.2	27.5	40.1	85.1	69.6	43.7	62.7	88.8	49.4	60.6	41.5	47.7	43.9	39.8	49.7	59.9	45.6	47.4	59.8	29.1	188.2	27.5	54.3	30.4	102.5	71.5	49.8	25.2	45.5	29.2	62.8	34.2	25.4	34.4	79.1	36.1	32.7	20.4	37.2	45.8	35.8	28.8	37.4	51.2	41.9	57.1	59.1	55.7	26.2	53.4	62.3	54.4	44.1	49.1	55.6	57.1	40.2	46.4	47.2	5.8	54.7	53.0	109.0	65.7	69.2	12.1	13.3	13.4	25.7	12.4	13.7	13.5	13.1	14.0	13.6	12.6	14.8	52.0	51.3	51.9	11.1	51.5	34.7	45.9	142.9	27.3	19.8	50.2	42.5	14.2	61.5	86.0	53.3	10.4	81.4	49.4	28.9	23.5	93.5	33.7	31.5	44.1	45.5	36.1	25.9	19.5	140.2	74.4	46.0	32.1	40.1	29.2	25.9	37.9	77.3	69.7	11.8	22.4	76.3	111.9	37.1	52.1	25.8	40.0	39.4	80.0	14.0	45.2	36.6	25.7	18.1	30.6	85.9	50.9	38.4	166.6	56.4	51.4	62.7	43.8	25.2	46.0	34.4	70.7	57.6	23.7	33.6	30.3	81.3	43.0	58.5	62.2	50.7
ALG6		ENSG00000088035	"ALG6 alpha-1,3-glucosyltransferase"	Q9Y672	1	63367575-63438553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	3.5	4.5	1.1	1.1	1.3	1.4	3.4	1.9	1.4	3.7	1.0	3.8	1.1	2.9	1.4	6.1	3.0	0.8	2.1	1.1	1.2	3.0	4.6	2.7	1.9	1.1	1.2	3.2	3.3	1.4	2.0	1.0	1.1	3.1	1.2	1.2	4.3	0.6	2.8	5.1	4.4	0.6	1.1	5.2	3.2	2.2	1.1	2.0	3.1	0.1	1.6	3.1	4.2	1.4	0.5	1.3	1.3	1.2	1.8	1.3	2.6	0.9	0.2	0.3	0.3	2.0	0.6	2.7	1.4	0.7	1.5	1.0	2.0	1.0	1.4	2.4	4.2	2.2	1.5	2.4	0.6	2.8	2.4	0.9	0.6	0.9	0.6	0.7	2.0	2.3	2.2	1.3	1.0	2.5	1.7	2.4	7.6	1.3	2.3	1.8	1.6	2.1	1.6	2.2	1.5	0.8	2.3	3.2	2.3	2.9	0.9	2.1	0.9	0.6	0.6	1.8	1.5	1.7	1.7	1.7	1.2	3.3	2.4	1.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.6	0.5	0.1	0.4	0.3	0.2	0.3	0.2	1.1	1.3	1.9	1.4	1.1	1.2	1.1	1.2	1.1	1.1	1.1	1.4	9.8	9.6	4.8	9.8	12.1	11.0	8.5	24.6	15.4	6.3	8.5	5.5	3.1	12.8	22.1	3.7	4.2	42.1	10.2	6.1	1.9	12.4	2.4	11.2	7.0	8.7	4.2	9.0	19.1	8.9	28.5	8.6	11.2	10.0	8.9	12.2	8.2	11.5	15.5	6.7	19.4	7.8	22.4	7.1	8.8	2.0	6.8	9.1	16.0	4.7	4.8	5.5	13.4	19.1	16.8	6.0	3.6	4.9	11.4	4.9	8.2	7.3	11.7	5.4	6.6	4.5	6.6	16.2	15.3	18.3	11.1	26.8	15.1	10.0	11.5	7.4
ALG8	MGC2840	ENSG00000159063	"ALG8 alpha-1,3-glucosyltransferase"	Q9BVK2	11	78095244-78139660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	22.8	33.0	12.7	13.4	14.3	9.2	25.6	13.9	16.4	18.7	15.4	17.5	13.3	15.9	33.2	19.0	18.8	12.0	17.9	12.9	13.3	24.9	47.1	15.0	14.6	14.1	13.1	22.1	23.8	23.7	19.8	18.7	13.8	19.1	21.8	10.4	21.7	18.0	12.1	16.6	15.5	16.4	13.5	18.3	20.2	43.5	13.1	17.8	22.4	8.9	19.8	18.4	16.0	15.2	27.8	74.4	62.8	56.6	63.7	42.5	37.6	38.6	57.8	68.6	67.4	127.9	102.0	61.4	74.5	51.5	92.3	86.5	87.0	56.5	111.9	46.3	50.8	74.3	56.5	62.2	38.9	71.8	39.6	34.4	36.4	81.8	37.9	37.5	50.3	58.0	98.2	65.8	97.7	38.6	53.3	61.9	81.9	200.5	38.1	63.6	32.6	168.3	70.0	40.4	20.2	44.8	62.0	102.2	29.4	65.6	106.5	50.8	32.0	43.5	50.6	102.5	35.1	46.6	88.0	80.3	26.7	71.4	84.4	1.2	30.0	5.4	25.1	34.5	29.1	37.2	25.5	25.7	34.2	31.3	29.7	26.2	2.6	29.1	39.9	33.1	22.5	27.6	12.7	14.3	13.9	16.4	12.9	13.3	14.1	13.1	13.8	13.5	13.1	15.2	11.9	12.8	11.6	12.4	21.0	10.5	23.3	49.6	26.2	14.7	18.3	16.3	6.9	20.0	35.2	20.2	18.8	53.8	9.1	7.0	5.9	24.4	18.9	11.0	16.9	17.2	7.8	9.9	21.3	25.4	59.5	19.4	11.7	13.8	11.4	36.4	9.3	40.2	31.4	16.8	18.0	15.9	32.6	17.0	10.8	14.0	18.0	15.3	26.6	12.2	12.3	8.2	21.6	13.0	20.7	17.7	6.4	15.8	43.1	16.9	7.7	15.8	21.7	13.5	0.0	14.2	19.6	105.0	37.8	20.9	8.9	32.7	15.2	16.9	16.8	15.2
ALG9	DIBD1	ENSG00000086848	"ALG9 alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	14.0	9.7	6.3	8.6	7.1	7.8	12.4	8.2	7.8	12.9	6.3	10.9	12.1	11.5	10.9	11.4	9.2	7.9	10.1	6.3	6.6	9.5	13.4	9.6	6.6	6.5	6.8	12.5	19.7	12.7	10.0	9.6	6.7	9.6	10.3	12.0	17.5	11.3	9.1	15.2	10.2	11.1	5.6	8.4	12.0	13.6	6.1	9.8	12.3	8.3	9.2	11.3	11.1	6.4	16.6	16.5	30.7	31.1	19.0	18.0	23.7	20.5	16.5	16.4	17.9	28.7	27.4	27.1	28.7	23.8	21.4	29.8	16.6	25.4	23.4	20.2	12.2	19.7	8.6	21.2	22.0	22.2	13.6	15.5	17.2	17.7	17.8	24.2	16.2	20.2	20.3	41.0	28.4	12.5	22.2	20.3	10.7	23.3	15.9	20.4	26.9	51.5	18.5	13.7	15.0	25.4	18.0	28.0	11.4	21.6	29.0	9.3	16.9	35.0	25.2	17.1	22.6	13.3	10.2	24.4	15.1	27.4	24.7	4.5	3.1	3.8	4.0	4.5	4.7	4.0	4.1	4.6	5.2	3.1	5.8	3.6	1.1	4.2	4.0	5.6	4.5	3.3	6.3	7.1	8.2	7.8	6.3	6.6	6.5	6.8	6.7	5.6	6.1	6.4	3.2	0.0	4.4	21.5	5.9	2.0	1.5	3.2	9.6	8.9	3.8	3.4	5.6	1.5	3.9	7.3	8.4	3.5	4.6	3.2	3.9	7.5	5.1	2.0	5.2	4.1	4.2	6.3	26.6	7.1	12.6	4.7	4.6	3.8	0.0	5.5	2.2	6.8	3.2	15.2	31.8	4.0	4.1	1.9	1.9	4.3	4.7	3.5	0.0	12.2	3.1	4.9	3.1	21.1	31.8	6.5	2.9	3.8	22.8	1.3	4.6	2.3	2.2	9.7	6.6	3.5	5.4	4.2	5.7	8.6	1.6	9.0	5.8	2.5	4.4	0.8
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.4	0.0	0.1	0.7	2.8	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	3.9	0.0	0.0	0.1	0.0	4.4	6.8	0.0	0.0	0.0	1.3	0.0	10.9	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.9	0.0	0.1	1.2	2.7	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.7	2.8	1.5	3.9	4.4	6.8	10.9	2.9	2.7	2.1	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565430	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 2.4;thyroid gland: 2.4"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 5.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	1.2	0.0	1.1	0.6	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.4	0.1	0.1	0.0	2.4	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.5	0.1	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708023	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	2.7	2.7	2.8	1.8	3.2	1.2	3.5	3.9	3.5	3.4	2.7	2.8	2.5	2.3	2.1	2.6	2.9	2.2	4.1	3.0	3.5	3.0	3.6	2.2	3.5	2.8	3.2	2.9	2.6	3.3	1.5	3.9	2.9	3.1	3.4	2.9	2.1	3.1	5.7	2.6	2.1	2.9	3.0	2.3	2.5	3.0	3.2	4.4	3.1	7.4	4.1	3.1	2.2	3.3	5.2	7.5	6.0	4.1	6.3	6.8	7.4	5.3	6.8	11.3	12.7	7.7	3.1	7.9	2.9	4.8	5.3	4.5	13.2	5.7	13.2	5.4	5.1	4.2	4.0	6.4	8.9	4.5	2.6	5.8	9.2	6.6	10.5	5.0	9.4	6.1	6.6	4.4	6.1	8.1	6.0	5.7	6.6	7.7	9.6	6.0	6.0	5.3	6.4	4.5	7.6	5.7	4.3	4.5	5.7	4.9	10.9	4.5	4.3	4.7	4.7	5.2	4.3	5.4	9.4	7.6	3.2	6.3	4.7	10.7	3.0	1.4	2.9	3.5	2.4	3.4	2.7	2.8	3.0	2.7	2.8	2.2	0.8	3.6	2.4	1.6	3.3	2.2	2.8	3.2	3.9	3.5	3.0	3.5	2.8	3.2	2.9	3.0	3.2	3.3	6.5	0.0	3.9	13.1	7.3	8.4	5.7	6.2	6.8	4.1	5.4	4.4	7.5	1.5	4.5	1.8	2.1	9.9	3.5	4.2	9.8	6.2	4.8	4.4	4.5	5.7	2.4	4.2	15.9	7.0	8.8	5.5	2.6	3.8	9.5	6.1	2.2	3.9	7.6	0.0	15.8	4.9	6.1	5.2	5.0	4.2	6.5	7.7	5.4	5.6	6.6	7.8	4.1	16.1	19.4	6.8	1.5	5.3	4.9	4.5	7.0	6.5	5.5	5.3	6.6	4.2	5.6	21.1	15.9	4.4	5.4	12.2	5.6	5.1	4.8	3.7
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	22.1	14.7	17.0	13.1	18.8	8.5	22.3	17.9	18.5	19.9	15.0	16.7	7.9	21.6	9.3	18.0	20.4	8.2	14.6	17.1	18.1	15.2	31.8	12.3	16.8	18.5	18.3	21.8	19.1	6.1	9.8	7.2	18.6	15.4	9.1	4.5	15.6	11.3	25.3	27.7	15.0	13.8	17.7	15.1	16.8	11.3	18.1	11.3	15.1	12.1	14.0	19.1	18.6	20.8	35.1	58.6	33.0	74.1	22.7	30.3	52.2	22.9	15.2	23.7	26.7	62.3	24.6	53.5	22.1	13.3	11.1	25.1	55.9	23.0	13.8	48.0	50.0	26.8	35.3	57.9	30.1	37.2	23.9	31.4	48.9	22.2	56.5	28.7	9.1	50.5	40.3	31.0	16.3	61.6	34.8	74.5	45.6	36.6	59.1	30.4	32.0	57.7	31.5	48.1	33.8	58.0	24.2	77.4	50.9	12.3	47.5	22.1	9.6	26.0	28.5	25.0	34.1	43.1	54.6	119.2	22.4	31.8	42.7	2.9	8.1	1.4	12.4	11.2	21.8	27.4	18.4	17.5	8.5	27.6	27.1	16.2	1.5	16.7	7.6	21.6	15.8	10.4	17.0	18.8	17.9	18.5	17.1	18.1	18.5	18.3	18.6	17.7	18.1	20.8	23.7	9.6	6.3	4.2	15.9	50.9	52.2	19.4	42.1	3.6	25.2	44.3	6.2	12.8	16.3	9.2	2.1	17.5	12.5	3.1	15.6	26.5	12.2	7.2	27.9	17.3	8.4	10.9	3.5	24.0	25.0	20.6	14.3	8.6	6.3	9.5	6.1	21.4	9.8	5.0	3.6	11.6	18.3	8.2	11.7	5.4	26.8	6.8	26.6	3.7	4.9	11.2	7.2	6.0	7.6	24.1	5.1	17.3	13.1	46.7	7.4	20.2	10.0	7.4	0.0	44.5	26.0	7.9	32.0	35.9	60.0	5.1	12.6	24.5	14.8	25.3
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase"	Q96Q83	11	43880811-43920274	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 90.9;Late spermatids: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	20.6	15.7	14.6	9.1	16.0	7.9	20.6	18.3	20.9	21.3	15.7	18.3	10.9	20.5	24.7	18.5	19.5	9.2	15.3	15.3	15.4	16.7	18.5	13.2	13.8	15.5	15.2	22.9	23.6	16.9	18.2	7.3	15.3	21.9	12.8	17.0	19.3	13.5	35.2	23.4	15.9	13.6	15.3	19.6	20.0	20.4	15.2	15.9	15.3	25.8	14.6	19.2	19.9	17.6	15.8	26.0	10.7	0.0	20.3	26.1	0.0	19.5	42.0	36.9	34.7	10.7	12.0	2.6	12.2	28.7	20.5	21.3	14.6	32.3	33.1	0.0	49.6	23.7	17.1	27.4	51.9	44.5	30.5	27.8	55.7	17.0	81.4	15.2	26.5	44.7	33.9	25.9	18.3	18.4	38.6	21.9	20.6	16.2	38.5	11.6	23.8	30.3	21.3	23.2	20.3	16.1	15.7	22.6	37.1	9.7	32.9	26.3	20.6	21.6	12.5	35.7	28.0	23.1	25.1	26.3	31.3	18.3	17.6	34.4	16.4	9.4	19.8	18.4	19.3	18.6	20.9	18.2	23.5	21.8	24.8	22.9	2.9	24.6	29.4	20.9	21.3	17.4	14.6	16.0	18.3	20.9	15.3	15.4	15.5	15.2	15.3	15.3	15.2	17.6	12.0	16.0	10.9	15.0	12.6	10.3	8.8	16.5	10.8	11.5	10.9	12.8	6.8	14.3	13.3	16.5	4.2	3.4	13.7	9.8	31.3	24.6	90.9	6.3	7.3	14.6	9.5	9.9	15.8	32.6	4.6	14.0	10.2	4.8	7.6	12.5	13.2	12.9	19.0	10.1	15.8	11.3	6.1	11.2	7.0	103.3	16.1	13.1	17.8	3.7	14.1	20.4	22.6	13.0	16.1	27.7	8.6	10.5	12.4	9.3	15.5	17.1	14.0	13.0	6.6	9.9	15.3	29.3	12.6	20.6	7.1	2.2	12.7	15.7	12.5	8.3
ALKBH4	FLJ20013	ENSG00000160993	"AlkB homolog 4, lysine demethylase"	Q9NXW9	7	102456238-102464863	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051422	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051422: AB_2681480"	"unprognostic (1.18e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.83e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.20e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.44e-2)"	3.4	5.2	8.3	2.9	9.0	5.0	3.6	10.0	9.4	4.3	7.6	3.9	3.9	4.6	3.5	4.2	3.8	2.3	4.2	8.7	8.8	5.0	4.9	2.7	4.3	8.5	8.5	4.0	5.0	6.9	5.1	2.9	8.8	4.1	2.6	2.3	5.0	3.2	4.3	4.9	5.0	2.9	8.6	7.1	4.3	2.7	8.9	4.4	5.8	4.3	3.3	3.7	3.8	9.2	5.4	7.2	5.9	13.9	4.0	4.5	6.5	4.0	6.9	8.4	7.9	8.2	7.1	6.3	6.6	5.7	7.4	4.3	7.6	5.6	6.2	6.3	15.9	6.3	3.3	6.0	6.2	5.6	5.9	6.8	7.6	6.5	2.9	7.2	5.5	10.1	11.2	7.5	5.2	19.6	15.7	17.5	9.0	10.2	10.9	9.3	6.2	11.2	7.0	5.8	7.3	10.9	5.0	15.1	5.6	7.4	6.3	6.6	1.8	8.9	10.2	13.8	8.8	10.2	8.4	11.7	5.2	7.6	9.4	3.7	5.4	3.0	6.1	4.8	6.4	5.2	4.7	8.0	5.4	4.6	4.7	6.1	1.6	9.2	9.8	6.9	4.9	3.4	8.3	9.0	10.0	9.4	8.7	8.8	8.5	8.5	8.8	8.6	8.9	9.2	10.2	6.4	5.8	2.3	7.0	8.3	4.3	12.9	5.2	16.6	8.1	11.7	2.2	11.5	5.9	9.2	4.2	25.6	9.2	7.3	25.4	16.3	1.3	6.8	12.2	10.5	6.1	19.6	5.2	14.9	15.4	10.8	7.7	10.0	3.8	11.7	10.4	9.1	15.3	28.6	6.2	8.1	10.2	12.0	5.8	1.9	14.0	7.2	3.6	2.8	14.6	13.4	25.7	2.0	4.5	11.8	10.6	21.4	8.3	6.3	12.0	18.8	4.6	10.2	0.0	7.6	9.5	11.9	16.9	9.5	7.4	11.1	8.7	17.7	10.1	1.8
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	33.4	40.1	23.7	21.4	21.8	32.6	29.2	18.1	23.5	34.2	17.8	51.1	22.3	45.3	5.2	25.9	43.1	21.6	68.6	20.4	23.4	29.9	33.6	28.8	25.1	23.2	23.7	33.5	36.0	26.6	39.8	17.4	29.5	31.7	10.6	26.5	36.4	25.1	236.6	28.1	31.0	22.0	19.3	26.8	33.6	51.3	26.7	22.2	29.8	98.7	15.8	43.0	29.6	27.4	90.3	86.4	27.8	47.0	37.0	25.0	30.1	41.1	41.8	56.8	51.5	96.1	19.9	53.9	65.4	35.9	29.4	56.2	40.9	33.6	26.8	71.3	74.0	35.4	47.7	41.8	32.5	27.4	53.0	24.3	23.1	41.8	24.7	33.9	31.8	35.3	45.0	20.4	29.8	60.6	60.1	28.6	24.9	28.3	44.4	57.6	56.0	89.0	14.4	31.0	32.5	47.6	44.8	27.2	41.7	90.9	31.4	20.9	38.3	55.8	44.1	87.8	78.0	32.0	25.1	32.2	100.6	38.8	39.0	3.6	7.4	20.4	13.0	7.8	11.9	6.8	13.3	16.1	9.0	10.0	9.5	9.5	4.3	7.2	11.6	5.7	7.4	6.7	23.7	21.8	18.1	23.5	20.4	23.4	23.2	23.7	29.5	19.3	26.7	27.4	37.2	35.3	33.3	17.9	41.1	64.6	29.0	26.8	19.4	80.3	48.7	40.3	93.5	28.6	24.4	27.6	39.6	33.0	59.0	44.9	84.1	27.4	58.9	53.9	36.5	36.6	60.9	24.0	17.0	31.4	44.8	42.4	18.3	36.7	40.7	25.2	35.7	65.2	33.5	119.5	18.1	45.0	22.4	45.3	56.9	42.5	41.0	36.4	49.8	7.5	36.3	76.3	57.7	9.0	24.0	32.8	38.7	51.9	21.1	35.3	47.6	115.2	46.4	58.9	19.7	39.4	47.3	118.7	117.3	20.3	56.0	31.5	48.3	32.7	39.1	28.6
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	5.4	8.4	9.3	3.1	8.3	3.3	5.3	9.7	12.4	6.6	6.9	9.8	2.9	7.6	2.3	7.6	6.7	2.1	6.8	9.3	12.3	7.2	11.5	5.5	4.3	15.7	10.3	5.6	4.4	4.7	9.9	2.7	15.0	7.6	1.9	2.7	6.1	4.0	6.4	6.3	7.3	3.7	8.3	7.9	7.8	4.5	12.7	4.1	6.6	3.9	3.8	7.9	6.0	10.6	12.5	13.1	4.9	7.2	7.4	4.5	8.2	12.1	8.0	13.9	14.0	5.4	6.4	10.8	18.8	6.7	7.2	4.9	5.1	14.0	7.2	17.2	9.4	6.2	5.1	5.9	8.4	5.4	18.3	6.8	9.9	11.5	3.9	4.8	9.5	16.2	9.9	8.0	7.5	13.1	13.1	7.0	3.8	12.8	8.3	8.4	6.7	7.9	10.3	5.5	5.9	6.0	8.2	9.8	10.8	6.8	7.8	12.1	4.1	7.2	10.5	16.6	12.0	14.9	9.6	7.8	15.5	6.1	7.8	58.5	18.2	47.8	26.2	26.0	20.4	32.9	23.8	25.4	16.0	24.6	20.2	19.3	16.0	28.8	20.7	22.7	34.4	16.0	9.3	8.3	9.7	12.4	9.3	12.3	15.7	10.3	15.0	8.3	12.7	10.6	6.1	3.2	1.7	6.8	16.5	6.8	11.1	4.5	9.1	5.6	8.0	6.5	2.0	10.0	3.3	18.4	0.0	17.7	13.1	9.5	5.9	10.4	7.6	6.8	5.0	5.9	13.1	14.5	8.1	9.2	15.8	8.1	14.3	6.3	0.0	7.1	7.9	12.7	11.0	10.1	7.2	11.9	2.0	5.3	7.7	5.4	11.1	9.1	8.8	3.7	15.2	5.5	23.7	2.0	6.5	13.3	13.6	4.5	12.1	7.1	7.8	11.8	2.3	3.3	6.6	4.1	10.1	3.6	2.4	8.7	5.1	19.0	15.5	6.4	9.5	9.5
ALKBH7	"MGC10974, SPATA11"	ENSG00000125652	"AlkB homolog 7"	Q9BT30	19	6372794-6375250	"Predicted intracellular proteins"	Necrosis	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 517.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 3004.6;Late spermatids: 8717.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008539, HPA039571, HPA039872"	Approved		Supported	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710"	"unprognostic (5.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (7.83e-6)"	"unprognostic (7.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	48.9	64.5	59.8	19.2	62.3	31.1	51.3	65.7	74.2	54.6	69.5	72.5	65.8	48.4	14.6	66.1	55.4	19.2	157.2	56.6	61.3	86.0	152.9	40.4	26.9	64.0	61.3	68.8	112.3	44.9	67.5	14.3	61.0	70.1	20.0	15.8	65.2	30.5	154.4	61.0	61.5	12.8	63.6	46.6	68.4	517.8	61.6	28.1	73.0	67.4	15.9	52.1	51.6	68.5	28.9	25.2	21.4	37.1	11.8	32.7	30.9	20.5	18.0	18.1	19.1	44.0	18.3	42.1	68.4	26.2	12.8	22.1	9.6	17.1	3.5	40.9	38.9	24.5	17.6	41.4	34.5	12.4	31.3	37.6	33.8	15.7	12.3	17.5	22.5	40.7	26.2	80.0	13.9	58.3	63.5	42.6	30.8	33.9	106.1	46.6	13.4	84.2	20.4	22.1	30.3	46.3	13.8	36.1	76.4	10.1	41.0	44.7	20.3	18.0	25.0	66.9	20.1	129.2	98.1	27.7	33.9	41.9	15.9	38.3	106.4	17.3	52.7	91.6	72.9	113.4	91.4	72.5	127.6	103.0	137.4	111.1	64.4	66.1	72.0	143.9	85.7	91.5	59.8	62.3	65.7	74.2	56.6	61.3	64.0	61.3	61.0	63.6	61.6	68.5	84.8	60.9	74.4	3.3	109.0	83.7	154.4	129.1	160.5	93.1	221.6	335.4	106.3	112.9	83.9	66.2	66.7	97.6	79.3	516.1	313.1	110.1	3004.6	76.1	73.0	84.8	220.4	54.0	2.4	245.2	149.6	88.0	77.5	85.1	66.0	108.3	113.2	302.0	196.8	42.1	3.5	400.4	71.2	168.6	96.2	8717.7	103.2	128.6	133.4	1.9	192.6	166.1	69.0	3.0	9.3	116.0	528.2	88.8	121.0	121.1	856.4	433.6	52.7	152.4	92.1	97.2	104.1	1180.3	76.7	171.2	100.6	108.9	87.4	143.4	410.5	215.6
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
ALMS1	KIAA0328	ENSG00000116127	"ALMS1 centrosome and basal body associated protein"	Q8TCU4	2	73385758-73625166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Cone-rod dystrophy, Deafness, Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.4;Excitatory neurons: 64.9;Late spermatids: 86.6;Oligodendrocytes: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RH-30: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035277, HPA043200"	Enhanced		Approved	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles, Centrosome"	Cytosol	"HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	2.6	2.4	5.3	2.4	6.8	5.5	4.3	16.0	5.2	4.1	4.5	3.1	2.3	4.5	4.7	1.9	6.4	2.5	1.6	5.3	4.8	3.5	2.4	3.1	3.2	6.8	6.4	9.8	4.5	4.8	1.7	2.7	6.0	3.5	3.0	10.4	2.9	3.6	0.8	2.9	1.9	3.6	5.1	2.4	2.9	22.2	5.7	8.7	4.6	3.1	2.9	2.6	1.5	7.8	14.3	4.6	9.0	8.2	6.2	5.8	6.7	4.8	5.0	6.2	4.8	4.8	1.5	13.8	3.3	6.7	8.0	6.5	12.3	4.2	8.3	6.7	4.1	7.9	4.4	10.2	4.1	10.9	3.8	4.5	3.7	7.6	3.9	3.9	6.3	9.3	7.4	4.9	7.1	7.0	10.2	14.3	10.6	5.7	3.9	10.8	32.5	5.1	4.1	3.7	7.1	10.0	9.1	1.5	5.2	7.5	1.7	2.5	5.4	8.2	8.3	7.1	11.7	6.6	4.0	10.4	3.7	8.2	4.0	0.2	0.0	0.5	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.2	0.1	0.3	0.2	0.0	5.3	6.8	16.0	5.2	5.3	4.8	6.8	6.4	6.0	5.1	5.7	7.8	7.3	6.4	10.3	48.3	5.6	2.4	3.1	2.6	6.8	23.3	4.7	4.8	7.2	7.2	9.1	11.0	25.0	3.3	12.8	4.4	0.0	4.7	68.4	30.6	13.2	8.0	7.3	15.4	64.9	3.7	2.7	8.9	10.7	9.3	5.1	21.8	4.6	2.2	3.3	21.9	55.8	5.2	0.0	3.1	2.7	86.6	8.1	6.3	3.6	31.9	5.3	9.2	5.2	54.3	92.7	3.4	1.3	9.1	10.2	3.2	4.0	1.7	25.2	39.7	6.6	14.8	9.5	30.6	26.7	6.9	3.3	1.9	7.8	11.5	5.3	2.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630919-4642294	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.2;fallopian tube: 12.7"	"Group enriched"	"Detected in some"	5	"Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.6"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	193	"eosinophil: 602.9"	"Lineage enriched"	"Detected in many"	193	"granulocytes: 602.9"	"Group enriched"	"Detected in some"	7	"HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	37.2	0.0	0.6	1.6	2.0	0.5	3.2	0.0	1.3	0.5	0.0	1.6	1.9	0.0	0.4	0.8	12.7	0.6	2.9	0.5	0.5	0.0	0.1	6.6	1.9	0.3	0.2	0.1	0.0	0.0	3.0	0.1	0.3	0.2	1.0	0.0	0.2	0.3	0.0	2.2	3.3	0.6	0.1	1.4	1.0	1.8	0.4	0.8	0.0	0.0	0.6	1.1	0.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	14.7	0.0	0.3	1.1	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	602.9	0.0	0.2	0.2	0.1	0.0	0.1	3.1	0.2	0.0	0.1	0.9	0.0	0.1	2.7	0.1	0.4	0.6	2.0	0.0	1.3	0.5	0.5	0.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	1.1	0.0	0.2	1.5	0.0	13.0	0.0	0.0	1.1	0.1	0.9	11.5	60.3	0.0	0.0	1.8	1.3	0.0	0.0	0.0	19.2	3.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	3.6	0.0	0.1	1.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	4.1	0.0	72.2	2.5	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	191.8	0.0	0.0	0.1	3.9	1.2	1.2	0.0	0.9	7.4	0.3	0.0	0.0	0.3
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase type B"	O15296	17	8039034-8049134	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 111.7;prostate: 73.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 75.8;Basal respiratory cells: 22.0;Kupffer cells: 42.2;monocytes: 87.9;Prostatic glandular cells: 25.6;Squamous epithelial cells: 44.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.9;myeloid DC: 4.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 4.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.7;HSkMC: 16.6;hTCEpi: 35.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	2.2	1.7	0.7	1.3	0.7	0.4	111.7	0.6	2.5	12.0	0.5	2.3	0.1	1.1	0.9	39.1	1.6	0.7	0.7	0.7	0.8	0.5	0.4	24.5	2.9	1.8	0.9	0.7	1.4	0.2	0.5	1.2	1.6	73.1	0.3	0.3	3.7	0.1	0.3	36.9	3.7	0.1	0.9	3.8	4.4	0.5	0.9	0.7	1.9	0.1	7.6	1.7	33.4	1.9	0.1	0.0	0.0	0.1	0.5	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	16.6	35.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.9	0.7	0.7	0.6	2.5	0.7	0.8	1.8	0.9	1.6	0.9	0.9	1.9	1.4	0.0	75.8	0.0	0.3	3.1	0.6	22.0	7.4	0.0	19.8	12.3	0.3	1.5	8.2	0.0	0.0	0.2	0.2	0.2	0.0	0.1	1.3	0.0	0.8	0.4	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.2	1.3	0.0	0.7	0.3	4.2	0.0	0.0	0.0	2.0	42.2	1.1	0.8	0.0	15.4	5.4	0.0	87.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	25.6	0.0	0.0	2.2	0.0	0.0	0.1	1.3	0.6	0.8	44.4	1.1	0.8	0.0	0.0	0.0	2.2
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 487.2;lung: 183.3;lymphoid tissue: 138.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6"	"Cancer enhanced"	"Detected in all"		"glioma: 49.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3555.3;granulocytes: 9703.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	51.6	36.1	10.8	100.6	11.6	487.2	25.7	12.5	18.1	18.8	13.4	22.8	21.6	17.4	7.1	21.8	24.5	40.0	12.4	10.2	15.7	13.3	19.7	183.3	77.2	21.0	15.6	10.6	14.1	9.6	6.1	37.2	21.1	13.2	21.4	3.7	19.9	15.5	3.8	7.4	28.3	42.6	16.6	138.5	20.0	4.3	17.7	93.2	9.1	24.7	108.2	65.6	11.9	31.3	0.6	0.8	1.2	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	1.3	7.1	156.3	2.2	0.0	5.2	1.2	0.0	4.6	0.1	658.4	0.0	18.7	0.3	1.0	0.7	352.3	1072.9	0.8	0.2	0.1	37.9	8.1	1.4	33.3	0.1	3.2	1.9	0.1	19.8	12.7	0.0	0.0	0.2	3.2	3.9	12.4	1.4	0.3	10.2	0.1	0.2	0.3	0.9	2.3	0.0	434.2	1.1	0.0	3.2	0.3	2.6	66.2	0.5	103.8	1.0	321.1	1.4	9703.9	322.4	4033.4	546.0	17.2	808.3	477.9	536.4	449.0	198.5	489.2	271.6	260.7	4968.7	98.0	12.4	3555.3	843.9	775.2	10.8	11.6	12.5	18.1	10.2	15.7	21.0	15.6	21.1	16.6	17.7	31.3	3.5	41.7	102.0	0.0	117.6	23.7	2.6	1.8	1.2	0.0	3.3	9.1	4.1	10.0	23.7	0.0	0.0	3.1	691.3	4.0	15.6	2.3	5.6	14.3	0.7	17.2	26.4	27.1	0.4	1.0	4.0	11.2	21.4	0.7	609.1	1.9	7.1	1.8	492.2	0.0	0.4	2.0	4.1	144.3	335.4	4.5	4.7	637.0	42.7	13.1	217.1	0.1	280.2	0.5	0.3	6.4	3.1	4.1	31.1	1.5	7.3	2.0	11.1	0.1	32.9	4.4	4.0	0.4	1.1	1.7	24.7	4.9	368.6	0.0	2.0	1.4
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 56.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.0	0.0	0.5	0.0	0.3	0.0	1.6	1.9	2.1	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.4	0.2	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.1	56.2	0.0	0.0	0.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.2	0.0	1.8	0.5	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.1	0.5	0.2	0.2	0.1	2.9	0.4	0.8	10.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.1	13.7	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.4	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.9	2.1	0.7	0.4	0.8	0.7	0.7	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	2.1	1.2	0.0	0.0	0.6	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.1	0.1	0.2	0.0	0.0	1.2	0.9	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	1.7	0.3	1.8	1.1	0.0	0.0	0.0	0.6
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 141.2"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	141.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	128.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442621	"Enzymes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	4.8	5.3	1.7	4.4	2.0	10.7	5.1	1.9	2.7	5.4	3.2	4.3	2.4	3.7	3.7	4.4	5.3	4.2	3.1	4.5	1.6	7.2	4.5	5.1	5.4	1.4	1.1	5.4	3.5	4.2	2.5	3.6	1.8	4.9	4.2	2.1	5.4	3.1	1.8	6.9	5.0	4.2	0.5	8.7	4.0	2.1	1.8	5.2	4.2	2.3	6.1	6.0	4.4	2.5	1.6	5.0	1.5	0.3	6.4	10.1	2.1	1.7	3.6	2.6	3.3	0.5	7.8	5.3	3.3	3.3	5.2	1.0	1.7	3.2	3.7	6.7	1.9	3.6	2.0	0.4	10.1	2.2	2.0	12.8	8.3	3.7	7.8	5.7	0.9	2.7	0.9	9.1	5.0	3.1	1.3	2.0	0.3	3.7	1.2	0.6	1.1	1.6	3.9	1.8	0.5	0.8	1.7	6.4	2.8	0.2	2.9	4.1	1.8	2.3	2.0	3.8	1.3	2.2	0.7	4.5	5.8	5.3	2.1	1.6	3.7	1.7	0.2	4.7	0.6	0.9	0.6	0.1	3.7	0.9	0.8	0.6	18.7	0.4	2.2	0.5	0.0	1.4	1.7	2.0	1.9	2.7	4.5	1.6	1.4	1.1	1.8	0.5	1.8	2.5	10.8	12.8	26.8	11.4	7.3	2.9	10.9	11.5	12.5	0.5	8.7	10.7	4.0	4.3	15.5	5.5	0.0	4.9	2.9	10.0	0.0	8.0	11.1	12.0	13.7	8.2	1.2	5.0	5.9	6.7	3.0	9.6	16.3	10.9	6.3	10.9	7.1	7.4	10.1	0.0	1.2	8.6	8.2	13.5	4.6	2.6	3.7	18.7	7.2	73.1	16.1	10.7	1.0	0.5	0.7	7.1	9.0	7.5	2.4	8.8	8.0	5.3	25.7	0.2	6.6	8.4	10.8	0.9	0.7	10.3	4.5	7.3	4.0	7.0	6.4	12.4
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58629091	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 41.9;skeletal muscle: 38.3;tongue: 33.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 120.4;Cone photoreceptor cells: 47.9;Early spermatids: 15.9;Late spermatids: 24.3;monocytes: 18.1"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 51.2;BJ hTERT+: 31.0;fHDF/TERT166: 46.6;U-138 MG: 25.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.9	41.9	0.4	0.0	9.2	4.5	0.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.2	2.1	0.3	0.0	38.3	0.5	1.0	0.1	0.0	0.5	1.7	1.1	0.0	3.5	0.0	33.2	4.4	1.5	0.0	0.0	0.0	13.7	0.9	0.0	0.4	3.4	0.3	51.2	31.0	21.2	18.1	3.4	0.0	0.0	5.2	46.6	2.9	0.0	0.0	0.0	21.5	11.5	0.0	0.0	4.4	1.8	2.7	0.0	0.0	3.0	0.0	6.4	0.2	0.7	0.0	0.0	0.0	0.4	13.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	25.3	11.2	3.5	8.7	20.9	19.2	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.1	4.8	120.4	0.0	0.0	0.0	47.9	0.0	0.1	0.0	1.9	1.5	15.9	0.0	2.3	0.9	0.0	0.0	1.0	0.7	0.0	8.9	0.0	0.1	0.0	4.0	0.4	3.0	0.7	1.7	0.7	0.0	0.0	0.3	3.0	24.3	0.3	2.4	0.0	0.0	18.1	2.6	0.0	0.0	0.8	0.2	2.3	0.0	0.6	0.0	0.3	13.6	0.0	0.9	0.0	3.8	1.7	1.1	0.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84817356-84873479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 62.7;skeletal muscle: 195.8;tongue: 59.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	12.5	9.6	1.2	0.9	1.6	0.1	4.4	1.0	2.2	2.2	9.3	7.5	0.6	1.5	5.4	3.0	1.7	1.8	62.7	1.3	3.8	13.5	5.9	5.5	0.6	2.2	3.4	0.8	7.7	11.2	26.1	2.5	4.5	2.4	0.8	2.5	2.6	1.3	195.8	1.0	2.1	3.1	1.6	0.5	5.2	0.9	3.9	0.6	3.6	59.1	0.4	3.6	1.4	1.1	1.8	0.1	0.1	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.1	10.7	1.7	1.8	0.3	0.0	0.2	0.0	0.1	1.3	0.2	0.0	0.0	0.1	15.5	0.1	0.0	0.1	21.2	0.9	0.0	0.2	12.9	0.3	0.1	0.0	37.7	0.2	0.0	4.0	0.0	0.2	0.0	2.0	0.1	1.9	0.1	9.6	0.3	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.0	2.2	1.3	3.8	2.2	3.4	4.5	1.6	3.9	1.1	3.3	6.4	2.7	2.6	0.2	0.9	0.1	0.6	1.2	4.1	1.3	0.8	64.1	17.2	2.4	9.2	16.7	0.3	0.2	0.5	0.0	2.9	0.3	11.5	1.0	8.7	9.1	0.0	3.0	20.5	0.7	3.8	0.5	8.9	1.3	8.7	1.8	1.7	10.2	0.0	3.4	0.3	0.0	0.3	12.0	0.0	0.0	5.2	3.6	9.4	4.7	1.0	1.0	0.5	0.3	10.4	1.2	0.0	1.5	0.7	0.1	2.2	4.2	3.4	0.0	51.9	8.4	0.5	3.2	0.2	0.1	0.7	0.5	0.2	0.3	1.6
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALPP	"PALP, PLAP"	ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378724-232382889	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 17.8;placenta: 34.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 381.0;SiHa: 103.6"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	42.9	0.0	0.1	0.0	0.1	381.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	103.6	35.3	0.0	3.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	6.7	0.1	0.2	0.0	0.0
ALS2	ALS2CR6	ENSG00000003393	"Alsin Rho guanine nucleotide exchange factor ALS2"	Q96Q42	2	201700267-201782112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 91.8;granulocytes: 46.9;Inhibitory neurons: 66.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 26.4"	"Group enriched"	"Detected in many"	5	"basophil: 23.0;eosinophil: 6.8"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in all"		"HMC-1: 50.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	7.3	5.5	2.6	2.6	3.1	5.6	6.8	26.4	4.2	6.4	4.5	6.6	3.2	6.6	7.8	4.8	6.4	3.8	13.7	3.4	1.6	8.0	14.5	6.7	2.8	0.9	1.0	6.0	5.7	4.3	10.0	3.5	1.7	6.1	3.4	5.4	5.4	1.6	13.5	7.1	6.6	4.8	0.3	5.3	6.8	5.3	1.4	2.4	6.3	5.9	2.8	6.2	5.7	2.6	6.5	6.7	7.1	5.6	7.0	5.1	7.2	8.6	10.4	14.0	13.2	5.8	8.4	1.2	3.8	11.7	6.1	3.7	4.6	10.6	18.0	3.5	4.8	15.3	6.2	5.2	8.1	16.4	50.4	9.8	4.1	11.5	14.0	5.7	10.0	8.6	9.8	5.7	9.6	7.5	6.7	20.3	9.2	4.6	5.3	5.4	7.7	4.2	9.8	8.8	3.4	7.8	6.4	7.1	9.2	14.3	5.4	7.2	7.9	11.6	7.2	3.5	6.2	7.1	9.2	4.5	8.5	3.4	7.2	23.0	0.9	6.8	1.6	1.7	1.9	1.2	1.3	1.3	1.4	1.0	1.5	1.5	0.9	3.0	1.2	0.8	2.1	0.8	2.6	3.1	26.4	4.2	3.4	1.6	0.9	1.0	1.7	0.3	1.4	2.6	7.6	12.8	16.7	28.7	2.8	5.4	3.8	4.4	3.4	15.1	5.4	4.3	32.3	8.6	4.3	9.2	29.2	5.7	3.7	3.6	0.0	6.9	16.5	14.0	6.8	10.4	4.8	12.0	91.8	3.3	3.2	6.9	9.7	6.8	46.9	10.1	13.2	20.3	5.9	8.4	66.6	6.9	2.0	3.2	3.0	6.5	7.8	4.8	0.0	27.2	3.1	5.9	4.1	36.2	44.0	6.1	3.9	8.2	2.3	4.4	7.8	6.1	17.5	15.4	0.0	9.3	8.4	7.3	5.6	4.6	6.0	6.7	3.9	5.2	4.7	3.7
ALS2CL	"DKFZp686I0110, FLJ36525, RN49018"	ENSG00000178038	"ALS2 C-terminal like"	Q60I27	3	46668995-46693704	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.5;kidney: 30.7;skin 1: 32.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Gastric mucus-secreting cells: 41.3;Respiratory ciliated cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 31.6;HaCaT: 17.1;HBEC3-KT: 33.1;hTCEpi: 20.9;RT4: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB046465, HPA048301"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB046465: AB_10638285, HPA048301: AB_2680346"	"unprognostic (6.38e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.45e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.14e-3)"	4.7	2.2	0.8	1.6	0.9	0.8	5.1	1.8	2.0	10.1	0.5	5.6	3.5	2.2	0.1	37.5	4.4	2.7	10.1	0.6	0.8	30.7	7.2	10.8	1.7	1.5	0.6	1.8	5.8	0.5	4.3	1.3	1.4	4.5	1.0	0.0	11.0	2.2	5.3	32.3	4.7	0.8	0.5	6.5	3.5	0.8	0.6	1.1	15.6	1.9	1.4	4.8	19.5	0.6	9.8	2.2	0.0	0.0	0.0	0.0	0.1	0.7	1.1	0.0	0.3	0.1	31.6	0.0	8.9	0.8	0.5	17.1	0.0	33.1	0.1	0.1	0.0	0.8	3.7	0.0	0.3	0.0	0.0	0.0	20.9	0.0	3.2	0.2	0.9	2.0	0.0	0.2	0.0	0.9	0.0	0.1	0.3	4.7	1.9	0.1	0.0	12.0	7.7	15.8	0.3	0.2	12.6	9.7	0.0	0.5	2.2	0.2	6.6	0.1	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.9	1.8	2.0	0.6	0.8	1.5	0.6	1.4	0.5	0.6	0.6	17.5	73.7	15.3	2.3	0.5	15.2	8.4	21.8	12.0	0.3	4.7	5.5	10.2	18.6	29.9	11.0	0.0	1.5	0.1	29.0	0.0	10.1	0.6	5.1	1.8	13.1	0.0	0.0	8.0	13.5	7.3	4.5	41.3	5.5	1.3	0.1	7.1	7.6	2.7	0.0	2.9	6.4	24.4	0.3	4.1	0.2	0.3	1.4	1.8	10.3	0.8	0.1	0.0	0.0	0.3	26.3	12.0	0.0	0.1	17.7	5.9	0.4	46.9	0.1	19.7	5.6	8.5	1.3	2.7	22.3	16.3	2.1	1.3	0.3	11.8	27.7
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.9;kidney: 6.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.7	3.9	0.0	2.3	0.0	0.0	0.2	0.3	6.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.8	0.0	0.4	0.3	0.2	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887835-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"bone marrow: 148.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	39.0	30.0	19.2	50.2	19.6	148.9	34.9	20.2	22.9	33.1	17.7	37.4	32.9	35.1	17.1	57.6	31.3	19.6	37.8	19.8	20.0	37.7	29.6	36.0	62.4	19.6	20.7	32.4	26.9	21.3	28.9	32.1	20.9	30.0	24.3	9.4	30.3	15.9	61.5	45.7	34.5	21.1	20.9	44.7	31.6	72.7	19.8	65.7	30.6	21.2	48.8	35.7	36.4	22.1	263.7	237.8	165.5	164.6	34.4	44.8	213.8	130.0	68.0	257.0	161.0	269.4	173.7	291.4	100.8	104.9	155.6	150.5	241.9	137.5	111.7	111.8	425.9	210.8	151.2	295.1	68.6	341.4	183.0	46.1	61.8	155.3	62.0	37.8	155.5	204.6	275.9	175.2	97.2	279.8	721.2	587.2	231.3	152.0	254.2	472.3	206.1	155.1	54.1	152.1	229.8	299.0	123.9	304.8	110.4	89.9	222.1	343.3	103.9	275.1	270.9	130.0	443.2	201.8	107.3	377.6	143.7	217.0	238.2	0.3	1.1	0.1	1.5	1.2	1.0	1.0	1.1	1.0	1.2	1.2	0.3	0.8	0.2	0.9	1.1	2.2	0.6	0.6	19.2	19.6	20.2	22.9	19.8	20.0	19.6	20.7	20.9	20.9	19.8	22.1	68.4	0.0	16.0	1.3	22.9	34.9	22.9	7.5	9.1	11.0	24.7	32.5	13.0	11.5	8.4	20.2	0.0	9.8	59.0	16.1	1.9	5.2	2.3	52.9	49.0	23.4	12.6	43.3	1.7	8.4	23.1	24.9	17.3	53.7	15.2	39.1	8.9	14.8	17.9	5.0	1.7	24.3	6.1	13.9	33.8	3.2	3.4	31.3	14.2	3.7	12.7	21.5	8.2	2.5	5.0	10.5	10.1	4.1	46.4	33.1	7.4	4.3	8.4	7.6	0.0	27.9	30.6	16.5	8.8	22.6	43.0	16.6	27.6	38.2	21.9	31.6
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 10947.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.7	0.2	0.1	0.0	0.1	0.0	6.4	0.3	0.4	0.2	0.3	0.3	2.3	0.1	0.4	0.3	0.4	160.4	0.5	0.1	0.1	11.0	10947.9	0.3	0.0	0.1	0.1	0.2	125.3	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.3	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
AMBRA1	"DCAF3, FLJ20294, KIAA1736, WDR94"	ENSG00000110497	"Autophagy and beclin 1 regulator 1"	Q9C0C7	11	46396414-46594125	"Predicted intracellular proteins"	"Autophagy, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 65.6;Excitatory neurons: 101.4;Inhibitory neurons: 101.9;Microglial cells: 84.3;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017825, HPA038535"	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Mitochondria	"CAB017825: , HPA038535: AB_2676068"	"unprognostic (1.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.98e-2)"	10.2	16.4	7.5	6.7	9.1	11.6	10.5	7.8	9.1	10.4	7.4	10.1	10.0	11.7	5.8	10.6	10.1	6.4	8.4	7.9	6.4	8.2	9.1	8.6	8.2	6.6	6.1	11.6	8.3	12.3	9.2	7.6	7.3	9.8	7.0	7.8	10.6	7.6	13.0	17.4	9.8	8.8	5.4	10.3	9.7	12.6	8.4	13.5	9.4	8.3	8.1	9.4	10.0	10.8	8.7	23.0	15.5	16.8	16.1	12.0	9.6	8.5	16.1	13.6	14.1	17.4	14.8	17.5	8.5	15.1	16.1	15.4	7.9	15.0	10.0	15.3	25.5	11.9	14.6	22.5	10.5	17.3	14.6	16.7	11.6	8.6	16.3	14.8	14.3	14.9	20.8	11.7	10.2	21.4	22.2	12.2	26.1	19.6	12.4	21.5	21.3	9.7	13.1	15.4	12.5	13.9	14.7	16.6	15.6	10.1	17.2	11.6	15.2	12.5	11.1	14.6	12.8	13.2	11.3	18.1	11.1	9.6	11.3	11.8	2.2	1.7	2.6	1.1	2.2	2.4	1.9	2.0	2.0	2.1	1.9	1.7	2.5	1.4	1.9	2.1	3.2	1.9	7.5	9.1	7.8	9.1	7.9	6.4	6.6	6.1	7.3	5.4	8.4	10.8	5.1	3.2	5.6	65.6	7.2	4.1	2.5	3.4	4.0	6.6	5.1	5.2	8.2	4.3	4.3	0.0	2.1	4.0	5.9	16.0	0.0	6.9	13.8	5.2	5.3	4.7	9.6	10.3	101.4	9.3	2.1	6.7	13.7	8.3	4.5	8.8	3.6	4.1	5.2	5.0	101.9	9.7	2.0	3.5	2.3	6.7	5.3	4.8	5.4	84.3	3.1	3.2	6.2	84.9	136.4	8.4	7.5	7.9	6.6	3.5	8.2	3.2	4.4	5.7	13.1	4.2	5.8	2.1	2.1	7.4	4.5	6.8	6.4	7.9	6.4	4.2
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110898879	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 202.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 70.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	31.8	28.3	35.0	34.7	44.9	89.9	33.9	39.6	56.1	32.8	32.0	36.9	29.2	35.5	25.7	56.0	25.6	33.3	40.2	37.5	38.2	48.6	33.6	33.4	39.9	45.6	38.5	30.0	39.7	40.3	26.0	59.9	42.2	202.9	36.5	35.9	37.4	34.5	26.7	26.9	26.5	35.4	45.5	27.3	31.2	31.9	37.6	40.5	46.2	50.2	50.3	37.4	25.8	67.1	85.8	57.4	68.6	130.6	101.1	63.9	89.8	119.9	131.8	91.4	106.7	92.2	52.3	149.7	56.7	76.7	97.0	57.4	163.9	108.6	125.1	88.5	94.6	155.4	47.5	96.5	60.2	135.7	88.9	43.4	98.0	63.4	126.4	31.8	81.0	75.4	118.2	126.8	156.3	51.8	181.9	103.3	84.7	84.1	51.9	98.5	68.9	89.3	103.9	112.9	87.4	62.2	73.2	91.7	110.7	55.5	59.5	114.9	53.8	60.5	45.7	325.0	131.5	34.4	59.7	152.8	69.6	106.7	79.4	42.9	23.9	37.7	17.4	28.9	20.2	14.5	17.4	20.3	31.5	14.8	20.4	20.8	102.6	15.5	37.3	13.9	22.5	17.0	35.0	44.9	39.6	56.1	37.5	38.2	45.6	38.5	42.2	45.5	37.6	67.1	169.5	38.5	92.5	23.2	164.8	315.3	241.5	49.5	262.4	101.4	178.5	151.1	95.7	125.8	82.7	55.2	60.5	44.5	208.7	144.1	146.8	67.2	31.8	145.0	106.2	104.4	124.4	184.1	39.2	70.0	152.0	132.1	96.4	214.8	93.9	36.9	53.6	59.3	77.0	77.4	37.9	108.2	28.5	109.1	244.2	53.6	43.8	176.7	131.6	23.4	92.0	303.7	60.8	36.7	111.6	87.6	95.9	50.0	118.9	379.4	66.2	89.9	29.3	105.6	19.7	170.5	124.9	93.0	76.7	246.4	288.1	54.6	184.6	45.7	128.8	147.7
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.7	20.2	2.7	5.6	3.4	5.5	13.7	2.4	4.8	12.9	2.8	12.6	9.1	12.2	0.7	10.6	10.8	4.3	7.0	3.3	2.0	18.7	13.8	12.2	7.9	3.4	3.1	9.3	8.2	3.1	8.5	4.5	2.8	10.8	0.8	0.4	13.7	3.2	8.8	15.4	17.3	1.4	2.4	26.1	9.9	37.0	4.2	3.7	12.1	1.3	1.9	10.9	9.8	4.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	2.7	3.4	2.4	4.8	3.3	2.0	3.4	3.1	2.8	2.4	4.2	4.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205708	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 15.3"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	1.1	1.4	1.6	1.3	1.5	1.2	1.3	1.8	1.6	1.9	0.1	1.5	1.5	1.9	4.0	2.8	2.2	1.0	1.3	1.0	1.6	1.8	2.1	1.2	1.2	1.5	1.4	6.3	2.0	1.6	0.7	0.8	1.5	1.7	1.3	1.3	2.2	2.2	4.1	2.2	1.3	2.8	0.7	1.3	1.6	0.4	1.9	1.6	1.4	15.3	1.6	1.3	1.3	1.0	3.1	2.2	5.8	4.6	2.2	2.1	4.7	1.4	1.2	2.1	1.3	7.3	1.1	5.9	1.8	3.0	1.6	4.3	12.5	4.1	2.0	2.5	2.5	3.7	4.9	4.9	1.6	7.7	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.6	5.6	5.9	1.1	3.7	5.2	4.0	15.6	4.0	4.4	11.7	9.4	4.3	0.9	1.0	2.6	3.9	3.7	5.0	1.9	4.8	1.6	2.1	0.8	2.5	5.8	6.7	1.9	3.0	2.2	4.4	1.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	1.5	1.8	1.6	1.0	1.6	1.5	1.4	1.5	0.7	1.9	1.0	0.9	0.0	0.0	1.0	1.5	2.2	0.6	0.9	2.8	5.0	1.7	1.5	2.6	4.3	0.3	0.0	2.1	1.1	3.4	1.1	0.0	1.2	0.1	3.3	2.6	1.5	1.2	0.8	0.8	1.6	0.8	1.8	3.6	2.0	0.0	3.9	1.4	2.6	0.4	0.0	1.3	1.0	0.0	1.0	0.3	0.2	2.5	0.5	1.8	1.0	1.2	0.2	0.0	1.0	0.6	0.7	0.5	4.1	2.4	1.2	0.8	0.8	0.0	1.0	6.6	2.3	4.4	0.0	0.2	3.6	2.6	0.7	0.9	6.4	1.6	0.7
AMER2	"FAM123A, FLJ25477"	ENSG00000165566	"APC membrane recruitment protein 2"	Q8N7J2	13	25161679-25172288	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 114.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 99.3;Bipolar cells: 105.5;Cone photoreceptor cells: 81.3;Horizontal cells: 153.1;Muller glia cells: 313.0;Oligodendrocytes: 337.1;Rod photoreceptor cells: 112.1"	"Cancer enriched"	"Detected in single"	24	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 3.3;SCLC-21H: 2.3;SuSa: 2.3;U-266/70: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039458	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA039458: AB_10795677"	"unprognostic (1.69e-2)"	"unprognostic (4.13e-2)"		"unprognostic (7.43e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.00e-3)"		"unprognostic (5.00e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.90e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.34e-1)"		0.2	0.1	36.7	0.0	72.0	0.0	0.0	37.9	52.2	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	41.2	37.7	0.0	0.0	0.1	0.0	58.9	49.1	0.0	0.0	0.0	4.1	0.0	41.9	0.1	0.0	25.8	0.0	0.2	0.2	0.1	0.0	0.0	36.8	0.0	0.0	1.2	49.1	0.0	0.0	0.0	0.0	0.0	0.0	114.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	72.0	37.9	52.2	41.2	37.7	58.9	49.1	41.9	36.8	49.1	114.8	0.0	0.0	0.0	99.3	0.1	0.1	0.0	0.0	0.0	105.5	0.1	0.1	1.1	0.0	0.0	0.0	81.3	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.6	0.8	0.0	0.0	21.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	153.1	24.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.8	4.7	0.0	313.0	0.0	28.6	337.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	112.1	0.0	0.2	0.0	2.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425545	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5;Hepatocytes: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	29.6	53.1	49.7	22.8	58.0	36.9	27.5	56.6	48.0	34.4	78.5	29.1	47.5	33.6	51.5	44.2	31.7	29.2	32.1	50.2	56.7	64.8	75.4	27.1	40.2	62.1	58.4	40.1	29.2	70.6	24.2	41.0	62.6	28.0	25.0	57.6	25.6	37.4	159.4	24.9	36.0	33.9	65.3	26.9	24.6	83.7	57.2	20.6	33.8	56.5	43.5	25.8	29.4	75.7	55.5	75.2	32.4	59.2	98.2	54.7	28.4	56.8	71.2	77.0	60.1	66.4	49.4	142.0	65.3	79.1	45.2	50.3	49.9	45.1	72.9	31.7	51.2	40.9	29.2	73.4	85.7	33.2	45.6	64.1	64.3	61.7	73.1	53.6	45.6	41.0	45.7	18.8	56.9	33.7	50.7	35.8	15.3	28.2	51.1	57.0	64.8	53.6	47.9	57.0	32.2	24.6	135.6	47.3	45.5	30.3	142.3	35.0	59.4	72.3	39.4	36.9	39.7	40.7	38.5	75.8	52.7	23.4	33.7	37.1	10.0	14.4	7.9	12.5	11.2	21.7	9.9	8.3	9.9	17.9	10.1	10.9	12.5	14.2	17.9	13.2	11.4	5.5	49.7	58.0	56.6	48.0	50.2	56.7	62.1	58.4	62.6	65.3	57.2	75.7	25.7	9.6	9.0	23.8	34.0	25.7	18.1	11.0	10.8	17.7	58.9	23.0	19.9	28.6	11.7	99.3	39.6	27.5	17.4	53.6	25.4	20.8	154.5	16.4	26.4	23.5	24.7	29.0	20.5	43.0	6.8	31.9	8.6	32.4	8.8	31.8	38.9	166.4	17.0	32.0	23.7	23.6	12.2	69.1	33.2	118.7	41.0	25.5	30.2	23.4	25.5	50.1	10.3	27.6	31.5	35.6	25.3	34.3	12.0	36.0	53.4	54.3	9.2	43.3	13.1	29.4	24.1	30.5	11.7	12.0	20.9	24.4	17.1	34.1	22.9	29.7
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504178-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	3.8	10.7	12.7	2.7	13.8	0.4	3.2	11.7	20.0	3.6	8.2	6.9	2.1	4.3	11.7	2.8	3.3	2.8	8.6	14.3	12.6	5.2	2.8	4.6	4.1	11.5	10.7	8.8	6.8	12.4	7.4	1.9	12.5	6.3	2.4	23.4	7.6	7.7	19.3	2.4	3.8	4.5	7.9	3.3	4.6	2.9	12.6	2.7	6.5	11.9	3.3	3.9	2.8	11.8	2.3	1.1	2.4	8.3	3.0	1.3	2.9	3.6	2.0	4.4	2.1	0.5	0.1	0.1	1.0	2.5	1.0	1.2	6.5	0.2	3.7	0.9	0.5	0.0	1.6	0.7	2.5	1.9	4.6	0.6	2.8	1.5	0.0	0.4	1.1	1.3	1.9	0.0	0.1	4.1	0.4	3.9	1.3	2.0	2.5	0.6	0.0	0.3	5.1	1.1	8.1	2.7	0.9	11.0	3.2	1.0	3.2	2.8	1.0	0.1	4.8	3.0	1.5	0.2	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.9	1.1	0.0	0.0	2.3	1.7	0.0	0.9	0.0	0.0	0.7	0.4	12.7	13.8	11.7	20.0	14.3	12.6	11.5	10.7	12.5	7.9	12.6	11.8	0.6	3.2	2.0	5.9	0.2	0.6	0.4	0.3	0.6	33.6	2.4	1.4	8.9	1.5	0.3	3.7	4.2	1.3	0.6	1.5	0.0	1.2	0.0	0.4	0.4	1.6	4.8	0.0	9.6	0.9	0.2	1.9	0.0	0.7	0.0	1.4	1.1	1.0	0.2	5.0	15.9	1.0	2.0	0.6	0.0	0.1	2.1	0.2	0.0	2.8	0.8	6.7	0.0	3.0	2.1	0.8	1.6	5.7	0.1	1.1	2.3	0.8	0.1	9.4	0.0	4.3	1.5	1.2	1.4	0.2	0.4	0.3	1.8	0.9	1.5	0.3
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079959	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		390000	"Cluster 32: T-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	10.8	19.8	4.5	7.0	4.9	3.5	22.8	3.6	5.4	20.3	2.3	39.4	3.3	30.7	7.9	4.0	36.4	19.3	5.6	3.2	8.8	7.7	4.6	20.0	12.4	9.1	37.9	28.7	3.6	6.4	5.3	13.2	19.6	11.3	9.0	25.7	4.5	11.0	1.1	4.4	12.6	34.3	4.3	17.4	5.5	10.7	13.1	2.8	4.2	2.2	7.6	22.6	14.3	3.9	44.4	105.5	6.3	0.2	2.5	0.2	17.2	14.8	39.3	4.7	3.8	0.3	192.0	0.0	47.6	183.2	117.0	64.8	0.0	117.6	5.5	8.6	0.7	0.0	11.0	0.1	3.8	1.2	1.7	0.9	20.1	122.6	59.5	312.2	15.0	0.9	8.5	0.0	179.2	2.1	3.6	0.1	4.5	21.2	27.1	0.3	46.5	0.1	52.3	251.9	18.8	0.0	76.2	9.0	0.5	3.4	11.2	1.0	4.1	2.6	149.9	1.7	121.3	1.9	0.4	0.2	10.0	3.4	2.8	0.0	0.1	0.0	4.4	0.2	6.0	3.7	6.8	6.9	0.7	1.6	15.3	12.1	0.1	8.6	0.0	8.8	4.4	4.7	4.5	4.9	3.6	5.4	3.2	8.8	9.1	37.9	19.6	4.3	13.1	3.9	7.2	9.6	3.1	1.0	3.6	2.4	13.1	39.4	15.4	62.6	10.8	37.7	1.6	1.5	4.9	1.8	0.0	1.0	12.4	0.4	1.9	5.3	1.4	31.5	6.0	12.7	60.4	5.7	2.6	19.3	28.1	11.1	0.5	72.8	7.0	76.8	32.2	1.2	4.8	0.0	0.2	3.1	2.0	3.5	1.1	2.3	2.5	7.2	1.8	1.9	5.3	15.6	2.1	0.0	0.1	40.4	1.5	0.7	3.8	10.7	0.0	0.1	2.9	4.9	0.0	3.2	27.7	0.7	2.4	2.5	0.4	8.5	7.6	12.8	0.3	33.9
AMMECR1		ENSG00000101935	"AMMECR nuclear protein 1"	Q9Y4X0	X	110194186-110440318	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	3.6	2.9	1.7	3.7	1.7	13.4	3.4	1.8	2.0	2.9	8.5	3.7	3.1	2.3	2.1	7.9	3.3	2.3	1.1	1.5	1.7	3.4	3.3	2.8	4.2	1.3	1.3	5.5	2.0	2.2	2.0	7.0	1.2	2.2	3.9	14.5	2.8	1.9	1.3	7.4	3.3	2.9	1.0	3.7	3.7	1.6	1.7	4.5	2.4	1.7	5.7	4.8	4.5	1.5	20.3	9.8	7.1	3.4	7.9	11.8	7.8	13.8	12.3	11.1	16.2	15.9	14.4	12.0	6.4	18.4	9.0	9.5	22.7	15.7	11.3	8.4	10.1	16.7	21.7	3.3	19.9	13.5	6.7	6.6	27.3	12.7	22.6	6.0	8.9	5.9	47.1	34.8	8.5	17.2	6.5	4.8	32.6	17.4	19.1	13.7	7.6	21.2	18.8	16.8	11.3	5.3	23.2	22.7	19.9	8.5	5.6	13.3	4.1	7.6	4.6	22.8	12.6	7.1	8.6	18.9	11.6	27.5	25.9	0.6	0.9	0.8	1.6	0.6	2.1	1.6	3.2	2.6	1.5	2.2	2.1	1.9	0.4	0.6	2.7	0.6	2.3	1.0	1.7	1.7	1.8	2.0	1.5	1.7	1.3	1.3	1.2	1.0	1.7	1.5	4.4	0.0	9.8	17.9	11.5	9.6	3.9	10.5	5.7	35.3	7.5	4.4	4.2	8.6	8.9	3.7	52.1	27.2	9.5	8.9	23.5	9.2	0.5	10.5	7.7	9.6	15.0	83.1	92.8	12.0	9.9	12.8	13.7	13.4	2.5	14.4	19.6	8.4	7.1	1.7	108.7	11.2	12.2	7.6	3.1	2.1	12.8	7.3	3.6	21.5	9.4	7.1	14.4	35.7	19.2	11.5	3.7	17.3	8.0	9.1	10.3	10.2	10.4	87.3	13.1	6.7	8.4	2.2	6.9	17.4	26.7	86.5	13.0	34.7	10.5	15.7
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	12.4	10.1	3.1	3.4	3.3	2.4	10.9	3.2	3.8	12.1	2.6	9.9	4.5	12.1	2.4	10.0	11.5	5.0	9.4	3.2	3.4	9.2	12.7	8.9	3.7	3.4	3.3	10.8	10.5	8.5	7.2	7.4	3.3	9.7	4.6	2.3	8.9	5.7	8.3	11.4	9.4	7.3	2.9	10.1	9.6	12.7	3.8	5.4	9.0	7.9	5.1	9.4	11.4	3.2	8.0	5.6	16.4	12.3	15.7	12.0	11.1	10.0	14.4	13.6	14.6	15.0	7.4	6.5	6.6	18.2	6.0	7.7	17.2	10.5	17.9	13.1	9.8	5.7	5.4	11.2	18.3	9.7	9.6	15.6	21.9	18.8	18.4	12.6	19.1	9.5	8.3	5.4	14.6	4.7	10.3	2.7	11.3	9.7	14.1	11.0	15.7	4.7	10.1	3.7	11.0	11.9	12.9	16.2	27.0	14.1	7.0	8.6	13.4	16.6	9.0	5.4	8.5	5.6	11.1	7.6	7.7	7.7	12.5	0.5	1.2	3.8	1.5	1.3	2.0	1.4	1.6	1.5	1.7	1.6	1.4	1.1	1.8	1.6	1.6	1.8	1.4	1.3	3.1	3.3	3.2	3.8	3.2	3.4	3.4	3.3	3.3	2.9	3.8	3.2	9.8	19.2	8.1	5.9	7.2	18.0	8.6	4.8	9.6	5.3	14.5	9.7	12.0	10.0	9.2	3.7	6.2	5.9	7.1	8.6	0.0	6.2	11.4	11.8	27.0	10.4	5.4	5.0	10.4	5.8	7.7	11.1	10.2	12.6	7.0	10.2	8.2	16.2	4.6	1.7	9.2	9.4	2.0	7.5	6.6	15.1	6.8	5.8	5.4	8.4	4.4	4.2	3.1	7.5	10.8	9.2	6.7	8.2	12.2	14.8	5.5	4.6	14.7	6.0	0.0	15.4	11.8	6.6	9.8	13.2	15.8	7.7	7.0	6.4	9.3	13.9
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922663-102933596	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Protein transport, Transport"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 83.5;kidney: 39.8;liver: 37.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 672.6;Intestinal goblet cells: 283.9;Paneth cells: 724.4;Proximal enterocytes: 2014.8;Proximal tubular cells: 348.9;Undifferentiated cells: 272.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.1;Hep G2: 9.9;U-698: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA000817	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	1.4	0.0	0.1	1.1	0.2	0.1	0.5	0.1	0.2	1.5	0.0	33.0	43.5	0.1	0.0	5.6	1.1	1.9	0.0	0.2	0.1	39.8	37.8	1.7	0.1	0.3	0.1	0.1	0.7	0.0	0.5	0.0	0.3	0.7	3.0	0.0	1.2	0.0	0.0	2.3	83.5	0.1	0.1	0.5	8.0	0.8	0.1	0.1	0.8	0.0	0.0	0.3	2.5	0.3	0.3	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	9.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.7	1.2	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.7	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.3	0.2	9.6	0.5	0.7	18.0	13.4	23.4	1.3	12.0	3.3	13.1	2.0	1.5	140.2	6.1	20.2	0.0	2.7	4.7	672.6	33.2	1.8	4.8	8.2	1.1	0.6	19.2	0.8	0.1	0.7	4.1	0.9	61.7	10.5	4.5	1.9	0.4	52.6	0.6	1.7	0.1	283.9	6.1	1.6	2.3	6.3	0.6	3.1	7.2	0.0	0.1	0.2	1.0	0.0	0.1	11.1	724.4	0.7	4.5	28.1	2014.8	348.9	4.5	1.2	0.0	0.5	0.9	21.2	25.7	17.1	20.9	1.4	5.2	0.4	272.4	65.7
AMN1		ENSG00000151743	"Antagonist of mitotic exit network 1 homolog"	Q8IY45	12	31671142-31729121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 384.0;Late spermatids: 156.1;Spermatocytes: 232.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046157, HPA062290"	Approved		Approved	Centrosome		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA046157: AB_10965846, HPA062290: AB_2684739"	"unprognostic (2.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.60e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	6.2	10.8	28.1	6.9	29.1	3.4	9.6	25.2	36.4	9.8	18.1	6.0	4.0	11.6	8.4	6.2	18.7	7.5	11.7	30.5	26.9	12.0	6.2	6.9	12.8	25.1	25.1	17.2	8.7	13.7	12.5	5.6	24.8	9.3	4.3	46.0	6.8	7.7	18.4	6.2	6.0	7.5	25.7	10.2	9.4	56.7	26.5	19.5	8.5	20.0	10.2	8.9	6.8	33.1	5.4	11.6	8.5	0.7	8.5	10.8	5.2	5.7	8.2	3.7	7.1	6.0	19.8	2.6	11.9	4.8	28.1	2.8	4.3	6.4	7.6	4.6	5.4	9.7	3.9	8.7	15.4	5.0	4.8	7.1	10.5	6.3	8.9	28.4	21.4	13.9	8.4	8.0	14.3	3.3	2.9	4.0	12.5	11.2	5.1	4.2	14.7	4.5	8.7	11.9	14.7	11.2	7.3	1.5	11.7	19.3	16.9	5.6	11.5	6.1	5.1	5.2	9.9	9.1	9.5	9.0	8.2	4.5	11.9	8.2	5.0	6.4	7.4	3.7	7.5	22.1	7.7	7.9	4.0	19.3	16.9	10.5	51.8	9.4	3.2	12.4	12.8	5.9	28.1	29.1	25.2	36.4	30.5	26.9	25.1	25.1	24.8	25.7	26.5	33.1	13.2	6.4	2.7	25.5	25.7	9.3	25.6	35.3	12.5	11.7	10.5	6.7	4.0	7.2	22.3	16.5	27.1	7.1	3.1	2.1	27.4	10.5	384.0	20.0	4.7	11.5	14.4	1.7	48.6	7.2	5.3	7.7	7.1	12.1	7.6	8.1	11.4	3.2	9.0	30.3	58.5	1.9	42.7	6.0	6.8	156.1	10.2	7.7	16.0	13.1	4.1	15.9	11.3	22.1	67.3	11.1	1.0	13.5	5.4	16.9	2.0	11.4	22.9	43.2	0.0	6.1	11.2	232.9	31.1	6.9	12.6	7.3	9.5	10.8	2.1	32.3
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 145.6;tongue: 53.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	4.3	1.6	29.0	1.3	24.7	0.3	6.5	23.4	21.9	9.2	0.6	3.5	2.9	4.9	145.6	4.0	12.2	2.8	4.0	23.7	31.6	10.4	2.1	2.7	0.8	32.8	34.4	5.7	2.3	14.3	7.2	20.7	24.1	6.3	4.3	1.7	6.9	25.7	39.0	2.3	3.7	3.2	20.6	1.5	3.0	2.3	36.4	4.4	3.8	53.5	1.0	2.8	4.1	18.2	4.3	0.0	22.5	1.0	0.5	0.5	8.8	0.7	0.0	0.0	0.0	10.5	0.8	0.5	4.7	3.5	0.0	8.4	25.1	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.0	1.1	0.2	0.0	5.1	0.6	4.9	0.2	0.4	0.0	0.0	0.6	0.4	6.8	0.3	10.5	21.2	0.1	8.4	6.6	0.1	11.2	11.0	0.0	8.0	0.1	0.0	9.8	34.9	0.8	0.2	0.1	2.9	6.8	0.0	9.4	0.7	0.0	0.0	1.0	0.1	6.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	29.0	24.7	23.4	21.9	23.7	31.6	32.8	34.4	24.1	20.6	36.4	18.2	2.2	3.2	2.0	57.5	0.9	1.8	2.7	2.5	2.8	1.1	9.7	6.9	2.0	1.5	7.2	29.5	0.0	46.2	1.1	4.9	1.9	5.1	0.2	7.2	6.3	3.7	15.8	0.4	8.9	1.9	3.8	7.2	4.1	7.1	0.0	1.5	4.2	4.0	6.2	0.0	2.0	7.2	6.1	1.6	2.1	0.5	6.8	1.0	3.6	17.8	1.7	4.9	4.1	2.0	3.5	3.2	5.6	6.4	0.0	6.6	4.7	16.8	10.1	0.5	6.6	3.9	4.0	0.4	3.2	3.0	1.1	15.9	0.9	0.8	7.3	2.5
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876748	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 111.4;WM-115: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		59000	"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	15.4	10.3	15.1	7.6	9.8	1.7	15.0	7.8	7.2	11.7	8.7	36.5	4.5	14.2	5.9	30.4	13.3	13.3	19.1	12.2	12.4	6.4	7.8	15.8	3.5	12.0	28.8	4.8	15.6	13.8	14.1	24.1	13.2	32.4	7.3	6.6	10.9	23.1	112.0	21.7	8.4	20.5	7.3	9.2	12.4	11.7	30.4	27.9	9.7	71.7	9.7	27.5	14.0	6.2	57.1	16.0	41.9	0.0	44.1	38.1	19.9	31.0	53.7	13.9	16.2	29.7	1.5	2.7	14.9	42.2	11.4	72.4	20.1	111.4	14.6	4.6	15.4	30.7	16.2	0.1	10.2	6.8	0.2	22.7	67.3	47.7	78.9	35.9	29.3	11.9	79.0	2.9	33.1	16.6	21.3	4.1	6.3	0.1	10.5	0.0	76.2	4.9	19.4	23.6	31.7	38.3	2.0	42.4	11.2	28.1	2.2	9.6	27.1	38.0	27.6	0.8	21.6	1.5	0.0	16.0	10.6	0.1	105.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	15.1	9.8	7.8	7.2	12.2	12.4	12.0	28.8	13.2	7.3	30.4	6.2	28.4	35.3	35.0	17.0	0.8	35.4	19.7	11.7	29.0	4.7	6.9	14.9	51.0	10.0	10.1	7.3	4.2	30.1	1.0	0.0	0.0	17.3	127.0	22.3	12.7	31.1	0.0	6.3	26.8	17.0	15.6	30.9	0.5	27.4	2.5	4.9	36.4	17.0	4.9	15.2	61.3	0.0	4.1	4.0	10.0	62.9	8.1	3.2	10.6	46.9	1.4	14.4	0.0	20.6	1.4	10.8	0.0	12.4	0.7	19.4	0.0	4.0	4.2	1.1	13.1	32.7	30.2	16.7	11.4	21.7	26.9	27.9	1.4	3.4	0.0	8.4
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 559.2;tongue: 211.4"	"Group enriched"	"Detected in some"	6	"Plasma cells: 43.8;Skeletal myocytes: 13.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"U-266/70: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA		38000	"Cluster 37: B-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	0.1	0.1	0.0	0.5	0.0	0.3	3.0	0.0	0.0	0.2	0.0	5.6	16.4	0.2	0.0	5.8	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.0	3.5	5.5	0.0	4.4	0.9	559.2	0.0	7.5	0.1	0.0	1.6	3.7	0.1	0.0	0.4	0.1	211.4	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.9	0.0	0.0	0.0	3.0	4.2	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631420	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.9;pituitary gland: 21.3;retina: 65.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.2;Cone photoreceptor cells: 87.6;Excitatory neurons: 228.2;Inhibitory neurons: 198.4;Oligodendrocyte precursor cells: 96.5;Rod photoreceptor cells: 59.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 64.6;ASC TERT1: 37.8;BJ hTERT+ SV40 Large T+: 25.4;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 44.8;HBF TERT88: 23.1;U-138 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	6.5	1.3	19.2	1.5	21.9	0.0	5.9	7.2	48.9	5.8	0.0	3.7	0.5	4.0	3.4	3.2	4.7	3.0	5.4	27.3	28.8	2.6	0.4	1.0	0.4	11.2	0.8	0.9	1.8	0.3	21.3	0.0	10.9	1.4	1.4	65.9	2.5	2.9	3.6	1.3	1.8	3.8	7.9	1.9	2.8	2.5	5.4	0.7	1.7	9.6	0.2	2.4	2.9	17.5	0.0	0.0	16.7	0.0	64.6	37.8	0.0	2.4	0.0	25.4	29.9	0.0	0.0	0.0	0.0	4.8	44.8	0.0	0.0	0.0	23.1	0.0	2.0	0.2	0.0	0.0	0.0	0.3	0.1	22.4	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.5	0.1	0.3	0.0	0.3	8.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	4.9	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	24.6	17.1	8.8	9.8	0.1	0.3	0.0	16.8	0.3	22.6	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.4	0.0	0.0	19.2	21.9	7.2	48.9	27.3	28.8	11.2	0.8	10.9	7.9	5.4	17.5	0.8	0.0	0.0	22.5	0.6	0.3	0.1	0.0	0.0	72.2	3.1	2.2	7.9	0.0	0.0	0.0	87.6	0.0	0.3	0.0	1.9	0.3	9.9	0.4	3.2	1.1	0.0	0.0	228.2	0.0	0.0	8.6	0.0	0.3	0.0	0.2	3.9	0.1	0.1	1.7	198.4	0.0	0.0	13.0	1.1	15.0	2.8	0.7	0.0	22.5	0.5	7.6	3.1	96.5	5.5	0.1	0.0	4.9	0.1	0.0	0.0	0.0	0.0	59.4	6.6	8.3	8.4	4.7	2.8	0.0	0.3	0.0	0.6	2.0	0.0	0.0
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518569-70532743	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 28.3;salivary gland: 6.8;stomach 1: 7.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 14.0;Ionocytes: 4.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 16.7;hTERT-RPE1: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.3	0.0	0.0	28.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.7	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	23.7	0.1	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.5	14.0	0.0	0.0	0.1	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2
AMY1A	AMY1	ENSG00000237763	"Amylase alpha 1A"	P04745	1	103655290-103664554	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	290	"salivary gland: 22089.3"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		70000000		"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 49: Ciliated cells - Cilium organization"			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.8	6.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22089.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.2	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5
AMY1B	AMY1	ENSG00000174876	"Amylase alpha 1B"	P04745	1	103687415-103696680	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	53	"salivary gland: 4607.5"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 19.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		70000000		"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	86.5	0.0	0.0	0.0	0.1	0.0	0.6	56.3	0.0	0.9	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.4	32.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4607.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	1.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
AMY1C	AMY1	ENSG00000187733	"Amylase alpha 1C"	P04745	1	103750406-103758690	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	7	"pancreas: 125.9;salivary gland: 199.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 36.2;Respiratory ciliated cells: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		70000000		"Cluster 25: Pancreas - Digestion"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.3	125.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.8	0.0	4.6	10.8	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AMY2A	AMY2	ENSG00000243480	"Amylase alpha 2A"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1983	"pancreas: 148689.6"	"Cell type enriched"	"Detected in some"	114	"Exocrine glandular cells: 1016.0"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		6.0	1.3	1.2	2.8	1.3	0.3	3.9	0.7	1.4	3.3	0.6	1.7	22.5	2.9	0.1	2.3	0.8	0.0	26.6	1.2	0.9	1.5	4.7	1.0	5.4	0.8	0.9	74.9	148689.6	0.1	1.5	8.3	0.8	2.1	0.0	0.6	30.0	0.0	1.5	1.4	10.7	0.0	0.7	1.7	2.2	1.2	0.9	0.0	1.1	0.0	0.0	0.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.7	1.4	1.2	0.9	0.8	0.9	0.8	0.7	0.9	1.0	0.1	0.0	0.0	2.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.0	0.2	0.0	0.0	1.3	1016.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6
AMY2B	AMY2	ENSG00000240038	"Amylase alpha 2B"	P19961	1	103553815-103579534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	122	"pancreas: 31246.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 61.2;Exocrine glandular cells: 148.0;Inhibitory neurons: 48.4;Oligodendrocytes: 41.8"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.8;EFO-21: 10.3"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		77000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	35.4	24.8	29.5	11.2	34.8	13.4	34.9	39.9	38.6	40.8	19.7	33.0	16.5	22.7	20.2	13.1	50.3	14.1	40.9	27.9	29.5	59.4	39.0	30.2	20.0	27.7	29.1	40.0	31246.7	14.9	36.8	6.9	27.1	35.3	11.9	69.8	256.2	14.6	63.7	42.6	31.7	9.8	26.3	34.8	18.1	5.2	30.6	12.6	63.5	25.2	13.8	29.3	25.8	30.0	0.0	0.5	1.1	0.0	5.6	9.8	1.1	0.8	0.8	0.6	1.5	0.0	0.2	1.0	10.3	0.3	0.0	1.2	0.1	1.3	1.4	1.3	1.6	1.9	4.5	0.8	0.8	2.5	2.6	6.7	6.7	0.8	1.2	1.8	0.2	3.0	0.0	3.2	0.9	0.0	1.9	0.5	0.1	0.1	1.4	0.5	0.0	4.7	5.7	2.0	2.8	0.6	2.4	1.1	0.8	1.8	0.1	1.4	0.8	0.3	0.9	0.5	0.7	3.5	0.1	0.3	1.9	1.8	0.2	0.0	5.0	1.0	0.4	2.5	0.3	1.0	0.1	0.2	1.6	0.9	0.6	0.2	1.2	0.1	2.2	0.5	0.2	1.2	29.5	34.8	39.9	38.6	27.9	29.5	27.7	29.1	27.1	26.3	30.6	30.0	2.8	12.8	20.1	56.2	3.2	4.7	4.2	1.4	0.6	11.7	2.9	2.7	7.2	2.8	11.2	1.8	33.3	0.4	2.4	3.6	0.0	1.3	7.3	1.1	0.6	2.7	4.9	1.3	61.2	148.0	0.4	3.2	2.0	0.7	3.8	0.5	2.2	6.5	1.6	10.1	48.4	2.5	0.0	9.4	3.5	2.7	2.5	3.4	5.4	11.2	4.0	3.1	2.1	22.1	41.8	1.3	2.7	1.9	1.4	1.5	4.3	0.8	14.6	15.4	0.0	1.0	2.5	1.5	0.9	0.4	3.0	0.3	1.7	0.4	2.2	1.6
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 7.5"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;MCF7: 7.5;SK-BR-3: 5.2;T-47d: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	7.4	0.2	7.5	0.4	0.1	3.4	5.1	0.9	0.0	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.1	3.6	1.9	0.0	0.8	0.5	0.2	3.6	3.7	0.2	0.1	0.0	0.6	0.8	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.6	0.4	0.0	0.6	6.1	0.0	0.0	0.0	0.3	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.0	2.3	3.4	1.6	2.2	0.0	1.0	0.6	0.2	2.2	0.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.5	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	5.2	0.0	0.1	27.7	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.2	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.4	7.5	3.4	5.1	3.6	1.9	3.6	3.7	2.1	0.6	6.1	1.7	0.1	0.0	0.5	14.4	0.9	0.0	0.1	0.0	0.0	0.8	0.3	0.3	3.3	0.0	0.0	0.0	4.2	0.3	1.6	0.0	0.0	0.0	18.8	0.5	1.6	0.4	0.0	0.0	6.1	0.0	9.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	10.6	0.2	0.0	0.0	1.9	9.9	0.0	1.7	1.8	5.6	0.0	0.0	0.0	104.5	20.7	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68205481-68257712	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	52.3	51.8	54.5	32.6	66.4	36.4	45.0	57.1	87.2	41.2	50.0	57.8	26.2	44.5	53.4	38.4	52.5	37.9	77.0	59.5	56.6	59.2	38.1	32.9	54.0	58.8	56.7	48.7	45.3	64.4	59.1	29.5	58.0	41.6	32.9	78.5	40.0	51.2	95.6	43.1	36.9	41.7	55.3	43.3	39.7	194.4	60.0	53.2	53.3	86.8	51.7	48.5	36.5	61.4	94.6	98.9	87.5	72.9	65.6	113.4	140.0	71.0	88.3	116.1	93.7	42.3	60.4	142.6	74.9	104.8	107.0	46.0	68.6	198.5	154.0	50.2	67.7	52.8	38.6	83.1	124.9	49.8	86.9	96.9	213.9	107.5	206.2	113.0	118.9	121.7	54.6	86.5	150.9	67.3	110.2	45.4	43.5	51.1	98.5	41.3	238.9	106.7	71.2	50.1	85.7	67.2	64.8	125.5	130.9	184.6	100.7	33.5	65.2	143.8	72.0	55.8	74.8	121.9	121.9	255.7	105.1	69.0	79.1	76.6	25.2	35.3	34.8	30.3	46.2	30.7	43.2	46.0	30.3	41.3	37.8	40.4	45.1	63.7	40.9	28.1	58.3	36.9	54.5	66.4	57.1	87.2	59.5	56.6	58.8	56.7	58.0	55.3	60.0	61.4	18.5	12.8	15.6	477.3	38.7	18.6	31.6	58.4	30.1	13.8	29.7	34.3	81.4	21.5	32.8	23.9	8.4	64.0	58.0	9.4	109.5	28.8	736.8	28.4	17.2	24.4	21.1	21.0	36.4	26.0	66.9	28.2	14.8	18.5	34.1	28.9	21.4	15.5	41.8	18.5	30.0	16.7	40.7	26.1	71.0	1665.0	36.1	39.0	56.9	27.2	46.4	65.7	69.0	56.8	47.7	25.4	10.8	32.7	46.2	17.7	15.2	69.0	61.8	12.8	19.7	26.5	26.8	274.4	59.4	26.4	22.6	34.2	49.3	26.1	15.1	24.5
ANAPC1	"APC1, MCPR, TSG24"	ENSG00000153107	"Anaphase promoting complex subunit 1"	Q9H1A4	2	111611639-111884690	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Cancer-related genes, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036329, HPA036330, HPA042998"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Vesicles		"HPA036329: AB_10670714, HPA036330: AB_2675065, HPA042998: AB_2678263"	"unprognostic (1.74e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.49e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	6.4	4.8	4.1	9.5	5.1	8.3	9.2	4.8	5.1	6.9	9.8	9.9	8.3	8.0	4.9	8.1	7.8	5.8	5.8	4.7	3.6	6.2	5.6	5.4	12.1	4.1	4.1	8.4	6.3	10.4	4.6	7.7	5.1	6.4	10.5	7.9	5.4	6.2	12.2	6.8	6.5	7.6	3.7	7.8	6.6	10.2	4.0	12.6	6.3	9.4	12.4	8.4	5.8	5.2	42.4	31.0	33.1	23.9	14.9	18.4	32.6	25.0	18.8	30.3	26.5	60.4	26.6	72.7	19.9	23.0	36.0	35.4	51.0	28.4	40.4	31.7	31.9	81.6	27.6	37.1	14.3	85.0	27.4	13.8	14.3	44.9	40.8	15.4	29.5	34.9	75.8	30.8	21.5	20.2	51.9	25.5	50.3	18.3	26.1	51.1	39.4	41.1	19.1	41.6	26.2	16.0	26.2	23.9	22.8	21.8	14.1	30.1	20.9	26.5	28.5	21.7	26.9	23.0	52.5	67.1	21.5	36.9	21.9	0.0	2.1	0.6	4.2	2.2	6.1	4.0	3.8	3.6	3.9	3.1	5.4	5.2	0.4	4.8	1.9	1.8	1.8	3.3	4.1	5.1	4.8	5.1	4.7	3.6	4.1	4.1	5.1	3.7	4.0	5.2	14.5	3.2	8.2	17.0	20.3	14.3	20.5	7.6	22.2	11.2	12.1	11.8	7.5	8.6	6.0	3.7	14.6	12.2	25.4	7.2	5.9	5.9	6.6	13.5	13.4	11.0	11.4	17.9	32.5	5.9	12.7	12.0	12.2	11.7	8.2	19.2	8.6	12.8	9.0	20.2	32.6	11.1	14.2	8.4	11.8	8.6	10.2	12.2	7.2	12.2	8.8	7.7	13.4	21.6	31.3	7.1	5.4	9.4	14.4	24.6	5.6	8.8	8.2	16.0	13.1	15.9	11.5	17.3	21.0	18.0	20.2	6.7	21.2	12.2	14.5	23.4
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	11.4	9.4	7.7	6.1	8.2	10.1	14.3	9.6	11.2	11.0	7.9	9.1	4.4	11.6	13.3	7.7	10.7	7.7	13.9	7.9	8.5	12.9	13.6	9.8	10.3	8.3	8.9	11.9	7.5	9.0	7.5	12.3	8.3	8.9	9.8	9.2	8.1	9.2	14.9	8.2	6.6	11.8	8.5	8.4	7.4	19.0	8.4	13.8	11.8	15.1	10.7	11.0	9.0	9.1	14.3	7.8	20.0	7.8	19.5	21.2	13.0	17.1	16.9	21.6	15.7	18.9	18.6	19.6	11.1	11.8	15.6	8.4	17.6	22.6	23.1	19.0	14.0	12.1	6.0	15.6	24.5	23.9	13.7	17.2	15.9	17.7	28.8	18.0	17.1	23.0	32.2	28.2	22.8	10.3	40.5	29.1	14.1	17.0	15.7	20.5	15.5	11.8	24.1	9.0	14.0	10.4	11.1	10.4	23.1	18.6	9.4	19.7	15.6	14.7	8.9	13.7	21.7	22.3	25.2	31.3	19.2	30.2	18.7	25.5	7.8	9.7	13.0	10.3	13.4	15.1	13.5	13.2	11.5	12.4	13.4	13.7	2.2	16.4	9.6	15.6	18.1	7.4	7.7	8.2	9.6	11.2	7.9	8.5	8.3	8.9	8.3	8.5	8.4	9.1	30.7	12.8	17.0	31.3	16.7	16.3	22.0	61.6	10.8	9.9	16.9	26.0	14.8	4.3	34.3	14.7	0.0	38.9	20.2	7.6	46.9	25.8	83.3	26.4	21.0	22.2	3.0	8.6	61.2	26.1	35.8	20.7	9.2	15.6	26.0	15.3	19.6	15.6	35.1	5.0	58.0	13.0	40.7	12.7	18.2	22.8	33.8	17.6	10.6	36.5	27.8	19.0	22.6	55.8	62.3	27.3	15.5	27.1	10.5	26.9	14.3	49.8	27.6	9.8	32.9	21.0	36.2	126.8	41.5	14.2	19.9	29.6	19.5	26.1	13.7	29.4
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1161.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	112.1	120.5	104.8	52.1	108.6	109.3	103.4	110.9	149.5	85.9	100.7	126.0	61.0	86.4	39.0	125.8	80.3	58.0	231.3	106.4	106.8	127.3	185.7	89.3	73.0	110.0	105.1	76.4	108.1	59.0	92.0	54.8	105.0	105.7	27.3	19.3	117.6	42.0	272.8	99.7	83.4	36.5	110.4	86.7	117.9	189.7	113.0	50.1	90.6	126.5	34.0	95.9	94.7	118.1	262.4	605.0	139.0	209.7	118.7	132.8	164.3	123.4	100.6	111.4	127.1	248.6	226.9	82.1	133.3	114.4	121.8	148.9	58.1	166.4	40.5	122.5	437.1	126.8	257.9	379.0	131.3	95.3	103.6	145.6	151.8	120.4	98.2	73.4	184.9	111.9	173.7	233.8	120.8	474.1	225.5	150.6	131.2	259.2	448.7	92.3	136.2	168.0	104.9	229.3	175.8	282.6	133.5	205.7	253.8	96.7	254.1	222.7	108.4	215.0	169.5	229.4	234.1	110.5	52.1	107.0	228.7	144.5	177.7	495.1	419.8	418.8	229.7	359.9	218.7	309.0	232.0	252.9	348.0	296.2	223.0	212.3	212.1	258.5	345.4	581.1	297.9	506.0	104.8	108.6	110.9	149.5	106.4	106.8	110.0	105.1	105.0	110.4	113.0	118.1	137.2	128.2	157.2	11.4	110.5	148.6	215.0	406.1	145.7	59.5	272.5	332.7	360.2	201.6	272.3	198.6	20.9	467.8	119.5	239.6	522.3	260.6	451.9	157.0	151.3	152.9	190.3	201.6	9.8	337.7	524.6	182.9	124.4	169.5	108.3	158.3	159.2	496.4	448.2	33.7	10.2	272.6	319.4	174.6	194.3	1161.0	181.7	170.1	261.5	13.1	251.4	227.7	176.1	7.1	17.0	324.3	274.0	164.7	226.8	334.2	290.7	548.0	199.8	78.9	105.2	115.9	245.0	435.8	252.5	257.4	186.7	508.7	117.3	156.0	271.4	307.0
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 463.7;Proximal tubular cells: 373.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	56.7	73.3	54.1	29.0	56.1	30.0	65.9	58.0	68.6	49.1	74.4	44.6	35.2	46.8	114.4	35.1	48.2	48.0	98.5	56.8	63.4	121.2	86.8	45.4	38.8	60.3	58.6	52.2	50.1	77.2	63.7	51.1	62.3	60.0	45.8	62.6	53.7	54.4	87.1	38.1	33.8	48.1	58.0	40.1	54.3	29.3	57.2	35.7	95.6	67.9	36.6	51.3	33.3	58.3	91.9	56.2	87.4	74.9	144.7	191.6	67.5	116.0	106.4	83.4	77.9	70.6	52.9	61.9	244.8	172.2	100.1	53.0	82.6	83.6	119.9	31.7	37.7	63.3	43.2	119.3	104.6	104.2	43.5	127.7	90.3	83.5	155.1	93.4	130.9	59.3	85.9	51.2	266.9	117.3	53.5	103.1	59.8	157.7	54.5	42.6	68.5	113.7	165.3	56.0	35.4	58.0	103.2	37.8	107.4	92.8	94.2	101.6	91.9	115.2	47.0	164.1	52.2	56.2	65.6	127.3	71.4	57.4	100.9	112.9	96.6	86.5	52.7	108.2	69.7	86.1	78.7	69.9	91.8	68.9	94.2	80.7	236.4	67.6	111.4	70.1	72.9	84.8	54.1	56.1	58.0	68.6	56.8	63.4	60.3	58.6	62.3	58.0	57.2	58.3	46.6	35.3	47.0	3.6	41.7	42.1	47.6	72.2	47.8	41.0	60.8	49.9	112.8	67.2	41.7	84.6	12.5	95.8	26.8	22.1	463.7	51.5	42.5	38.1	39.5	51.8	40.8	26.3	7.0	53.8	96.6	57.2	38.2	28.9	18.9	34.5	53.6	64.5	78.7	20.2	8.3	40.6	77.3	71.3	48.8	104.6	50.7	43.8	97.8	6.5	33.4	85.0	42.2	4.0	6.3	39.5	42.6	44.0	46.0	74.7	54.6	373.4	49.3	38.3	19.7	26.6	58.5	46.2	64.2	44.3	50.6	70.3	35.4	59.5	35.4	52.9
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	28.9	44.2	47.0	30.0	47.5	95.9	30.0	47.8	61.1	24.3	45.8	67.1	30.7	43.4	38.3	53.2	30.4	18.3	62.2	47.2	47.7	48.8	44.0	30.0	43.5	46.4	46.8	22.4	39.2	25.4	32.8	19.2	47.2	52.0	40.6	42.8	39.9	38.8	95.2	39.6	40.1	31.9	46.4	41.2	46.5	72.0	46.3	72.6	44.7	64.3	44.3	41.6	29.5	49.0	74.0	109.4	87.5	55.8	25.5	41.2	41.4	77.1	70.1	121.3	80.2	128.8	78.4	98.8	72.9	110.3	59.0	122.6	133.4	144.0	113.9	64.0	63.3	113.1	124.9	84.5	30.2	110.8	101.3	43.2	56.2	68.9	91.6	45.4	80.7	136.7	83.3	66.6	80.0	127.2	214.5	102.9	70.9	155.3	62.3	89.6	217.4	67.2	106.1	50.5	61.9	53.8	79.0	76.5	127.0	46.8	89.6	58.6	73.4	55.5	72.9	110.5	82.8	68.0	71.5	125.3	34.0	87.8	31.7	29.7	168.5	136.3	73.3	114.2	78.0	94.5	93.4	86.3	148.8	71.4	110.9	101.5	68.4	72.4	107.4	119.1	153.0	124.1	47.0	47.5	47.8	61.1	47.2	47.7	46.4	46.8	47.2	46.4	46.3	49.0	20.1	16.0	16.5	2.9	36.1	41.8	71.2	83.5	44.3	32.9	43.2	55.6	3.9	12.8	50.6	23.9	27.1	84.7	40.5	82.9	123.3	49.4	15.4	38.8	21.3	22.8	49.6	34.1	7.1	102.7	78.8	18.3	36.7	27.8	30.4	27.2	15.0	44.1	82.8	13.5	7.3	66.2	61.1	48.5	47.5	13.4	6.8	48.0	26.6	1.0	58.8	44.1	36.0	5.5	5.2	53.1	61.4	23.0	47.1	43.8	56.2	123.6	45.6	43.3	19.7	16.0	35.3	115.9	139.9	53.8	41.1	46.7	41.1	32.3	71.5	61.7
ANAPC16	"APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728"	ENSG00000166295	"Anaphase promoting complex subunit 16"	Q96DE5	10	72216000-72235860	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 93.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037815	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA037815: AB_10672288"	"unprognostic (2.87e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.75e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	20.5	25.2	12.4	15.0	13.4	14.1	21.9	16.6	15.2	19.7	15.5	23.6	15.7	18.2	22.3	14.9	23.5	12.6	43.6	12.5	12.8	24.2	27.2	18.9	25.4	13.6	12.8	24.3	33.7	33.1	15.9	11.9	13.4	21.5	17.9	20.6	32.3	21.8	62.7	15.0	19.6	17.8	12.4	22.7	25.8	8.4	13.1	32.3	23.5	43.2	25.7	19.5	15.1	14.6	24.9	12.1	12.1	14.3	33.0	15.7	9.3	8.5	17.3	11.7	11.0	14.6	31.1	24.3	13.6	12.7	14.1	19.0	10.9	21.9	11.0	29.0	18.0	12.5	10.6	14.4	39.6	21.0	14.7	20.5	93.9	10.6	34.8	25.8	14.3	35.1	18.4	28.1	13.6	15.0	17.9	21.1	9.3	18.2	6.8	10.2	10.8	24.2	29.4	10.4	17.4	16.0	14.8	37.9	29.5	15.2	12.2	21.9	18.6	5.9	13.8	9.5	13.1	28.6	26.8	25.1	16.4	40.3	7.0	41.1	21.5	38.8	31.4	23.1	35.2	60.5	35.2	31.3	18.1	66.1	48.6	38.6	19.7	34.4	24.9	45.7	34.7	36.3	12.4	13.4	16.6	15.2	12.5	12.8	13.6	12.8	13.4	12.4	13.1	14.6	191.0	157.0	209.5	41.8	303.7	111.7	246.7	322.0	150.8	81.0	288.6	316.5	435.4	280.2	234.9	222.5	37.5	198.4	240.1	166.8	684.8	239.8	91.9	188.9	98.9	179.8	161.8	155.0	47.8	291.9	191.2	142.0	108.1	145.9	202.0	110.1	203.1	481.3	226.5	33.7	57.2	258.0	254.3	310.0	111.9	53.4	233.6	160.4	193.9	36.5	322.4	192.4	363.5	43.2	75.9	196.9	239.9	250.1	208.2	218.1	262.6	548.7	217.0	144.5	230.1	162.0	219.9	158.7	126.2	189.9	140.9	149.3	268.6	145.6	214.1	240.9
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
ANAPC4	APC4	ENSG00000053900	"Anaphase promoting complex subunit 4"	Q9UJX5	4	25377263-25418498	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 266.1;Glandular and luminal cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032519, HPA038395, HPA038396"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Intermediate filaments"		"CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356"	"unprognostic (1.36e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (5.73e-7)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.18e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (1.12e-6)"	13.4	15.7	14.1	15.6	15.0	18.5	15.8	14.5	19.1	23.5	15.1	15.6	11.8	26.7	18.1	13.5	35.1	11.8	11.6	14.6	14.1	15.1	13.0	13.8	20.6	14.1	13.9	18.6	15.8	15.5	12.9	15.5	14.1	16.6	16.7	16.6	12.9	21.2	13.8	14.7	15.8	13.9	14.3	19.2	14.1	10.8	14.7	16.1	13.7	8.5	18.3	18.8	14.3	16.7	21.5	12.4	21.4	22.4	22.0	24.4	30.5	25.0	18.5	23.2	22.3	20.0	33.4	34.9	13.1	21.4	29.5	16.9	22.9	21.1	26.5	12.5	17.5	33.9	23.2	18.9	14.8	26.7	26.6	18.9	15.6	20.5	12.4	16.4	20.4	30.4	49.7	10.2	29.8	16.7	34.6	43.5	29.7	18.9	15.2	24.4	35.7	25.7	19.6	23.0	23.8	14.3	18.7	11.0	16.1	21.8	16.4	28.3	20.9	19.7	12.4	15.3	29.1	13.4	25.3	33.3	21.4	37.6	19.0	2.4	7.4	14.9	9.6	8.8	13.1	8.6	8.7	11.4	6.5	6.9	7.7	9.8	3.0	10.3	12.5	4.2	11.6	6.4	14.1	15.0	14.5	19.1	14.6	14.1	14.1	13.9	14.1	14.3	14.7	16.7	11.1	9.6	14.5	26.8	15.2	12.9	16.5	13.1	14.2	12.9	7.6	7.5	14.0	14.3	17.2	7.3	10.4	56.9	17.5	8.9	5.9	10.3	4.3	266.1	20.6	11.1	12.6	10.3	28.8	12.0	14.2	16.3	17.3	79.0	25.3	15.3	15.0	7.1	17.5	21.9	38.4	8.4	10.2	13.7	8.0	3.4	10.2	13.7	17.8	18.7	15.0	12.2	16.5	34.2	49.0	8.9	6.5	15.1	19.5	4.9	9.8	7.0	45.9	13.9	19.7	15.7	16.3	13.4	15.4	13.0	9.2	23.8	19.7	12.7	11.8	7.8
ANAPC5	APC5	ENSG00000089053	"Anaphase promoting complex subunit 5"	Q9UJX4	12	121308245-121399896	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039457, HPA039801"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA039457: AB_10795676, HPA039801: AB_2676687"	"unprognostic (3.41e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-3)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (2.01e-9)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.28e-1)"	47.8	48.9	32.2	38.7	38.0	55.0	49.6	34.6	39.8	48.6	36.0	42.7	36.3	45.7	41.6	43.5	53.7	33.0	40.9	33.0	32.3	38.1	52.1	34.4	56.9	34.0	34.3	41.9	76.3	41.4	50.2	35.8	37.3	37.1	47.4	17.6	51.7	37.3	90.5	48.5	42.1	42.2	34.6	50.8	52.6	28.3	33.6	61.9	43.9	61.1	64.7	41.3	39.5	47.3	92.0	123.5	56.4	38.9	98.1	108.1	97.7	86.8	100.2	100.6	89.8	101.9	46.7	124.1	85.0	128.2	40.5	76.7	131.5	86.6	79.8	105.9	139.1	113.7	74.0	114.1	106.5	167.8	108.5	108.3	80.5	101.3	82.6	93.0	129.2	107.0	144.6	74.2	81.4	130.1	141.9	161.6	89.8	91.4	132.1	126.2	82.1	162.6	73.0	92.9	71.1	70.5	127.7	54.2	87.5	63.8	128.9	157.8	80.5	67.1	47.7	43.3	71.5	92.1	97.6	143.1	88.3	123.7	84.0	51.2	67.2	59.9	52.1	71.0	66.2	64.5	60.8	66.3	80.0	52.9	60.1	57.4	15.6	79.0	63.5	52.4	86.1	99.4	32.2	38.0	34.6	39.8	33.0	32.3	34.0	34.3	37.3	34.6	33.6	47.3	60.3	41.7	64.8	34.6	85.6	65.6	65.0	61.3	68.9	61.7	60.3	55.2	48.0	44.3	68.2	55.2	56.3	90.5	81.4	45.8	70.5	61.0	22.4	72.9	74.8	60.2	85.1	89.6	56.8	88.3	105.2	71.9	58.6	41.5	68.4	76.9	46.8	62.7	55.1	77.4	57.6	55.9	63.1	54.1	50.4	36.6	80.2	78.0	48.0	30.0	94.4	43.2	141.1	45.8	184.3	68.7	42.7	63.6	151.2	53.2	61.3	75.9	93.8	59.7	52.6	59.9	65.0	54.1	89.2	75.5	64.8	82.0	79.6	103.6	71.2	53.3
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786009-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	11.3	18.5	18.3	11.8	19.7	6.8	12.7	16.7	21.2	12.8	15.6	10.0	9.2	14.8	23.8	7.0	12.2	11.4	15.7	19.2	21.1	11.6	19.3	14.0	12.2	22.5	19.6	19.3	50.8	17.2	21.1	10.4	21.5	9.3	10.9	26.4	15.8	8.4	12.2	6.4	10.3	12.3	18.1	29.3	15.8	52.4	20.1	8.1	13.7	9.8	10.9	9.5	8.5	23.8	13.1	14.0	15.2	13.6	12.2	11.1	14.1	7.7	11.0	7.8	9.9	13.5	18.2	23.8	11.1	6.7	10.6	16.2	14.6	13.7	13.1	10.1	13.1	14.8	9.7	10.3	7.9	7.8	8.7	11.8	16.8	7.3	14.5	11.3	20.0	24.8	14.5	6.2	8.2	25.3	14.0	11.6	17.5	20.7	18.4	17.0	10.4	14.1	11.8	18.4	21.5	9.6	11.6	15.8	7.1	13.8	31.1	8.4	9.6	9.1	8.0	6.9	6.4	15.9	12.9	14.7	7.7	13.7	11.8	0.8	4.8	1.6	5.9	5.5	7.2	6.8	5.3	5.6	7.5	5.5	7.5	5.6	1.4	5.5	7.1	4.9	4.5	5.9	18.3	19.7	16.7	21.2	19.2	21.1	22.5	19.6	21.5	18.1	20.1	23.8	7.4	6.4	10.5	17.6	4.7	1.1	1.8	1.5	2.2	2.4	5.7	5.0	6.7	5.7	2.2	3.7	10.4	1.5	1.5	2.1	0.0	3.3	64.3	3.7	3.9	10.0	4.2	4.2	18.3	3.2	2.8	4.3	1.5	3.3	1.3	15.9	7.1	9.5	7.2	0.0	19.7	4.4	4.1	5.7	2.0	75.1	2.1	5.5	1.8	23.4	1.4	4.9	1.0	64.8	30.2	2.5	1.0	4.9	8.9	3.4	1.7	1.3	1.4	8.9	6.6	5.1	2.4	15.9	4.9	2.8	0.4	1.2	3.0	12.9	4.6	1.5
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015867	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	7.5	6.6	13.1	6.9	14.9	6.4	10.4	11.1	14.7	7.9	9.2	6.6	5.2	8.6	8.1	5.9	7.4	6.1	5.8	12.8	11.1	7.7	8.0	6.6	10.5	10.6	10.8	10.8	6.7	7.8	6.2	6.5	10.1	8.2	6.4	9.2	6.0	6.2	7.3	9.1	7.2	7.1	10.1	9.8	6.3	5.5	13.1	10.2	8.1	7.1	9.2	7.1	6.3	11.6	12.2	9.6	15.2	13.2	11.5	16.8	13.6	9.8	16.3	15.4	15.3	6.3	8.9	11.8	8.8	9.7	8.5	9.4	17.8	9.4	15.5	22.3	10.6	11.9	7.4	6.3	12.5	11.8	13.6	10.4	11.9	12.1	12.2	13.1	13.2	10.4	13.9	11.8	18.0	4.0	13.6	7.9	36.4	6.6	6.8	6.9	27.4	12.4	12.1	8.2	7.5	21.7	11.9	15.7	18.3	16.2	12.2	8.6	9.8	12.7	6.7	15.7	15.1	8.6	8.9	7.9	14.2	8.7	11.9	6.6	4.4	5.9	5.1	4.3	6.5	5.7	6.4	5.4	5.5	3.5	6.7	5.7	2.7	10.9	3.5	3.3	8.9	5.2	13.1	14.9	11.1	14.7	12.8	11.1	10.6	10.8	10.1	10.1	13.1	11.6	23.1	48.1	9.8	26.8	23.8	6.9	8.5	11.7	12.5	21.2	14.6	10.2	15.2	17.2	14.5	12.9	10.4	14.8	26.2	7.6	11.7	10.3	1.5	11.3	19.8	15.9	6.7	18.1	33.2	10.5	15.0	18.0	14.3	11.7	17.1	28.8	16.1	12.5	11.8	28.6	26.3	8.4	14.2	20.4	10.5	2.6	15.5	17.1	3.6	30.0	17.3	11.6	16.5	30.2	49.3	10.2	6.4	13.9	24.2	10.8	10.7	16.9	22.5	17.8	19.7	21.7	16.1	9.5	16.6	12.7	7.0	10.9	25.8	17.9	8.0	7.4
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 33.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 5.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	NA	NA	32000000	110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	25.1	5.6	3.2	2.6	4.5	0.7	4.6	4.5	2.2	5.8	2.5	3.4	2.3	3.5	4.8	3.5	3.0	13.2	4.8	4.5	6.1	11.1	2.1	21.7	1.4	8.0	3.5	9.5	1.6	1.2	5.8	20.5	4.8	17.7	3.3	0.6	12.0	33.5	23.4	1.2	2.6	3.3	4.8	11.0	4.0	2.3	2.1	2.1	3.5	7.0	1.0	3.9	3.7	11.9	0.0	2.4	9.3	5.3	87.9	30.2	6.6	30.0	25.8	8.1	11.9	6.2	0.1	0.0	0.1	16.0	0.0	0.0	4.2	0.1	10.5	0.0	1.4	53.1	0.6	0.0	24.5	0.7	0.0	145.5	0.0	4.9	0.6	7.5	0.6	0.0	28.2	5.1	10.9	0.0	1.1	7.9	9.6	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.1	4.2	1.1	0.6	0.0	11.6	2.2	0.0	0.3	70.5	0.9	2.5	0.7	0.2	3.2	0.0	9.7	1.1	47.5	0.1	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.6	3.2	4.5	4.5	2.2	4.5	6.1	8.0	3.5	4.8	4.8	2.1	11.9	9.0	0.0	2.3	60.4	0.0	0.6	10.1	0.4	5.2	0.9	0.5	2.8	3.3	0.0	2.2	7.3	0.0	5.2	0.0	0.0	1.9	0.3	8.1	0.7	9.1	5.6	0.0	10.1	6.5	0.0	7.6	20.4	1.5	1.9	0.0	0.0	3.3	0.1	0.5	0.0	37.6	0.0	2.0	0.3	1.0	2.4	2.5	2.9	0.0	6.5	1.5	0.5	0.0	3.0	0.6	0.0	0.0	3.8	1.1	1.2	0.0	2.8	0.8	0.0	6.6	3.5	48.6	1.6	5.4	4.0	0.1	2.7	0.8	1.7	0.1	1.2
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 12.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	110000	"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.7	0.5	5.6	3.8	5.0	0.4	9.9	6.3	9.0	6.2	2.6	2.9	1.2	4.3	1.1	2.2	4.2	4.9	7.3	4.9	6.3	5.4	2.7	4.6	6.8	12.3	5.8	2.5	0.8	2.3	0.8	11.3	12.3	3.3	1.8	1.6	2.5	2.7	4.0	3.1	2.5	6.8	7.7	0.5	1.8	0.9	7.6	6.4	8.2	2.0	2.8	10.6	3.2	7.5	0.1	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	4.7	0.4	0.1	0.9	0.0	17.9	39.9	0.0	0.0	0.0	0.1	62.6	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.8	0.0	0.0	0.1	0.3	0.1	0.1	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	22.7	1.7	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.1	5.6	5.0	6.3	9.0	4.9	6.3	12.3	5.8	12.3	7.7	7.6	7.5	81.7	9.6	0.0	5.2	7.8	8.2	2.7	2.5	1.8	9.3	1.5	1.4	2.8	2.8	1.6	0.0	29.2	1.8	3.6	0.6	0.0	1.3	3.2	4.2	5.4	182.2	13.8	1.3	17.0	0.5	1.5	6.3	1.5	5.9	4.5	2.0	30.4	0.9	0.6	38.7	16.1	1.7	0.0	2.5	10.9	5.0	43.5	2.7	16.0	26.2	2.4	2.9	7.2	24.6	11.3	1.3	1.2	3.8	0.9	9.9	2.6	1.0	1.4	12.5	0.0	8.1	79.8	1.6	1.6	0.3	8.0	30.6	5.5	2.9	1.3	4.7
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869900-916334	"Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;breast: 6.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 52.9;Late spermatids: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	41	"ASC diff: 33.7;BEWO: 48.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	7.2	0.3	0.3	0.1	0.3	0.0	6.6	0.2	0.3	3.8	0.1	0.3	0.1	3.3	2.1	0.2	3.3	0.3	0.2	0.2	0.4	0.2	0.2	1.2	0.1	0.3	0.3	3.9	0.1	0.1	0.0	0.0	0.4	0.5	0.1	0.1	0.3	0.4	0.0	1.4	0.3	1.1	0.2	0.0	0.3	0.6	0.4	0.2	1.7	0.6	0.0	1.0	2.2	0.3	0.2	0.0	0.0	0.0	33.7	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.3	0.3	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	52.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.3	17.0	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.9	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849535-178871077	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 133.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 81.7;Leydig cells: 425.9;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"ASC diff: 149.9;ASC TERT1: 60.1;HHSteC: 64.9;HSkMC: 147.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"	NA	NA		380000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	56.6	45.1	2.0	10.5	2.7	0.9	26.9	2.3	2.7	21.3	1.5	56.7	9.6	69.2	14.0	33.8	59.0	27.9	22.8	2.9	1.9	17.5	23.9	12.6	3.5	2.1	1.5	68.2	21.9	1.1	2.1	133.8	1.4	12.3	27.5	9.6	36.3	9.5	30.3	9.0	26.7	65.5	2.2	10.9	21.6	15.6	1.7	8.6	41.1	57.3	6.9	23.9	17.1	2.3	0.2	0.0	4.0	0.0	149.9	60.1	0.0	0.1	0.0	0.4	0.8	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	64.9	0.0	0.1	147.5	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	2.7	2.3	2.7	2.9	1.9	2.1	1.5	1.4	2.2	1.7	2.3	16.5	0.0	0.0	9.4	1.3	3.7	0.0	0.0	1.2	2.3	0.8	0.5	3.7	41.5	0.0	1.8	6.2	0.6	0.1	0.0	1.9	2.4	1.4	3.3	40.3	4.1	0.0	0.0	14.8	0.4	0.4	81.7	1.1	5.5	0.0	1.6	8.9	1.0	1.4	0.0	14.9	0.0	0.0	0.0	4.6	10.6	425.9	0.8	3.6	8.4	0.0	31.6	0.0	21.6	0.7	0.0	5.0	212.1	0.4	0.1	0.1	0.1	0.7	10.9	39.5	10.0	51.8	0.8	0.6	0.2	3.7	1.4	0.5	2.7	0.0	0.1
ANGPTL2	"ARP2, HARP"	ENSG00000136859	"Angiopoietin like 2"	Q9UKU9	9	127087348-127122635	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 47.4;Endothelial cells: 34.6;Fibroblasts: 99.7;Oligodendrocyte precursor cells: 35.2;Skeletal myocytes: 39.3;Smooth muscle cells: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 140.4;ASC TERT1: 94.9;BJ hTERT+: 205.9;HSkMC: 98.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040933, HPA041299"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	2510000	2200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA040933: AB_10795530, HPA041299: AB_10794552"	"unprognostic (5.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.07e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.15e-2)"	109.5	11.5	6.1	33.5	12.9	0.2	71.2	15.1	8.6	67.7	12.4	76.5	15.1	72.9	13.7	21.7	31.4	67.0	69.2	6.9	9.4	13.4	14.8	22.5	8.1	12.0	12.4	44.2	5.5	4.1	3.4	21.4	11.7	24.7	17.9	0.9	18.0	27.1	57.6	29.2	27.8	63.4	9.9	49.2	28.9	4.4	12.6	4.7	15.7	36.6	8.9	59.4	49.1	15.4	0.0	0.0	17.4	0.0	140.4	94.9	9.4	8.1	205.9	9.2	8.5	0.0	0.0	0.0	7.0	21.4	1.8	0.1	1.7	0.0	4.8	0.1	0.0	0.0	0.1	0.5	30.3	0.1	0.0	98.2	0.0	20.0	0.0	28.7	27.6	2.3	0.0	0.1	6.3	0.0	0.2	4.3	18.4	0.0	1.0	16.5	27.3	1.6	2.2	0.0	9.3	10.1	0.0	0.0	0.0	3.3	0.0	0.0	8.8	35.5	4.5	50.4	0.0	0.0	0.1	0.0	37.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	12.9	15.1	8.6	6.9	9.4	12.0	12.4	11.7	9.9	12.6	15.4	47.4	9.6	2.4	1.0	0.1	14.3	7.0	0.2	3.4	14.4	0.6	6.6	16.6	0.0	0.1	0.0	2.1	1.0	0.5	0.1	0.0	0.2	1.6	1.4	20.2	34.6	0.0	0.0	0.6	0.0	0.8	99.7	1.1	1.0	0.0	2.9	5.0	0.0	1.4	0.0	1.5	0.0	0.0	0.0	17.4	1.5	20.8	0.8	7.2	1.9	0.0	1.9	0.0	35.2	19.2	1.2	0.0	6.4	0.0	1.7	0.0	2.4	1.6	0.8	0.0	39.3	43.5	1.0	0.0	1.4	11.1	2.6	1.7	1.1	0.0	0.6
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 675.7"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 567.6;Proximal tubular cells: 272.5"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	120000000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	53.0	675.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	11.5	0.0	5.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.1	0.1	0.7	0.0	16.0	0.1	0.2	0.1	0.0	2.6	0.3	0.0	0.0	9.7	567.6	0.1	0.0	0.1	0.0	0.0	16.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374370	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 195.8;breast: 165.0;liver: 183.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 318.9;Hepatocytes: 148.4;Pancreatic endocrine cells: 230.4;Proximal enterocytes: 146.3;Skeletal myocytes: 198.3"	"Cancer enriched"	"Detected in all"	4	"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.6;HBEC3-KT: 226.5;LHCN-M2: 60.9;TIME: 114.6;U-138 MG: 65.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	3100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	195.8	23.0	25.2	15.4	31.8	1.4	165.0	26.2	32.6	18.8	14.0	25.6	11.5	6.8	0.1	41.2	7.9	9.4	45.4	27.7	27.0	51.9	183.7	46.6	2.0	30.1	37.6	9.1	70.8	1.0	16.1	18.3	27.2	30.4	0.9	3.2	19.1	2.6	24.8	30.2	28.0	6.0	27.3	13.1	21.7	6.7	33.8	0.7	34.1	6.2	2.8	26.6	32.1	33.7	0.1	2.2	1.2	3.3	54.6	12.0	0.7	4.4	0.5	0.7	0.2	0.0	20.9	0.2	30.6	8.8	4.5	3.0	0.0	226.5	0.4	1.9	0.4	0.3	0.9	0.9	1.2	0.1	0.2	5.6	1.0	34.0	0.7	6.2	17.4	0.6	1.1	0.5	60.9	1.8	0.2	2.1	0.3	0.0	1.8	1.3	0.1	1.0	11.1	4.0	0.2	0.5	26.2	2.7	4.3	1.5	6.8	0.4	114.6	65.1	0.3	33.3	0.0	0.3	0.1	0.2	44.9	0.0	12.4	3.3	0.1	0.4	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.3	0.0	0.1	0.2	0.1	25.2	31.8	26.2	32.6	27.7	27.0	30.1	37.6	27.2	27.3	33.8	33.7	53.5	38.5	5.8	128.0	1.2	14.0	39.8	318.9	17.1	0.2	71.8	49.0	5.3	1.5	85.7	14.7	0.0	7.4	2.5	17.1	0.0	107.1	0.7	4.2	6.9	28.9	0.0	0.0	0.4	18.0	111.2	89.1	46.9	13.8	2.5	1.5	17.9	148.4	8.3	0.0	0.6	14.2	16.2	1.6	10.3	2.2	88.0	5.0	8.8	2.8	2.0	2.7	0.0	1.0	4.5	230.4	8.4	131.7	1.0	38.3	146.3	4.5	19.0	0.1	32.9	198.3	121.5	0.0	3.1	21.8	11.5	40.1	2.3	20.7	6.7	77.7
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"ovary: 22.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 19.4;Langerhans cells: 11.3;Leydig cells: 27.7;Melanocytes: 7.2;Peritubular cells: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 2.7"					"Region enhanced"	"Detected in some"		"spinal cord: 3.3"	HPA038516	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	4.3	0.2	0.1	0.0	0.2	0.0	5.5	0.2	0.4	0.2	0.4	0.3	0.1	0.0	4.4	0.2	0.3	0.2	2.7	0.2	0.2	0.0	0.0	0.9	0.1	0.2	0.1	22.4	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.4	0.2	0.4	2.4	0.2	0.0	0.2	0.0	0.1	1.6	0.1	0.0	0.7	1.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	2.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.3	0.0	6.2	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.9	0.6	0.8	0.0	0.0	2.7	0.0	0.1	19.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	11.3	0.8	27.7	0.1	7.2	4.7	0.0	0.2	0.0	1.0	0.2	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.2	1.0	0.2	0.2	0.0	5.5	0.1	0.5	5.7	0.0	0.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 50.3;SK-BR-3: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	6.3	6.7	45.5	6.5	86.5	2.1	21.5	144.9	82.3	12.0	0.0	26.0	39.3	23.0	125.2	16.9	19.1	21.5	81.1	60.8	86.1	95.4	16.6	24.6	6.1	82.7	61.3	11.6	11.2	131.8	14.5	15.6	97.0	20.0	20.9	123.2	42.6	40.5	80.5	39.9	27.2	13.2	21.2	10.8	15.5	8.0	87.3	9.1	41.6	94.1	7.4	10.8	14.1	114.4	8.7	4.9	30.3	0.4	0.0	1.8	23.3	0.6	0.4	0.1	0.6	22.2	16.6	0.5	9.8	0.6	0.9	12.1	16.4	14.9	0.5	0.5	11.0	0.2	9.7	0.1	6.2	0.1	0.4	14.6	9.3	7.8	0.4	26.1	3.6	0.0	4.3	20.6	6.9	29.0	0.2	1.0	13.8	23.3	26.6	0.1	21.7	4.3	5.4	50.3	15.6	2.8	0.6	49.4	0.0	33.6	28.7	0.1	10.0	0.9	2.9	13.3	1.5	0.9	0.2	0.2	5.5	0.2	18.9	1.6	0.2	0.5	2.7	0.2	2.4	4.1	4.6	1.5	0.1	1.1	5.0	1.2	0.7	1.5	0.3	2.5	0.8	1.0	45.5	86.5	144.9	82.3	60.8	86.1	82.7	61.3	97.0	21.2	87.3	114.4	0.9	44.8	174.3	20.2	14.5	19.1	21.9	17.8	38.7	490.2	26.8	20.6	189.3	12.8	42.5	53.3	225.2	38.8	3.4	62.9	19.6	10.6	28.3	139.8	26.2	3.9	30.6	0.0	859.2	8.6	9.9	13.2	15.8	153.3	12.6	66.9	7.9	0.5	4.7	43.7	881.3	12.1	14.2	4.8	1.4	11.5	28.0	3.3	8.8	23.4	4.4	41.4	0.0	592.6	1579.5	4.8	41.8	5.7	3.4	12.2	62.5	51.3	66.7	216.6	0.0	30.2	11.7	1.1	2.3	35.9	18.2	25.0	18.5	4.5	17.8	18.4
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.9;Early spermatids: 88.8;Inhibitory neurons: 60.6;Oligodendrocyte precursor cells: 87.0;Oligodendrocytes: 80.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.2	0.3	0.2	0.4	1.0	0.3	0.2	1.4	0.2	0.2	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.4	0.3	0.5	0.3	0.3	0.3	0.5	0.6	0.1	0.3	0.3	0.5	0.4	0.6	0.5	0.2	0.1	0.3	0.3	0.2	0.2	0.4	0.5	5.8	0.3	0.1	0.5	0.0	0.3	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.6	10.5	3.2	8.2	82.9	13.4	1.3	7.2	2.5	5.2	12.6	4.1	3.8	4.7	4.3	2.8	11.0	14.6	1.2	8.1	3.3	1.9	3.3	88.8	2.8	8.4	8.9	0.0	10.1	46.0	4.3	1.1	9.7	13.3	2.8	0.0	8.4	7.1	2.4	2.4	3.3	60.6	5.7	2.0	1.9	4.9	46.1	21.8	5.6	7.2	47.8	3.4	6.1	13.4	87.0	80.5	4.5	5.6	13.9	5.1	4.1	4.8	2.7	1.5	46.2	6.6	15.8	8.4	20.3	11.1	5.2	1.3	0.1	9.6	4.8	4.2	4.1
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 13.8"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.6	9.0	5.1	2.6	4.5	2.7	1.5	2.0	5.4	2.3	0.1	1.3	1.2	2.2	1.9	3.6	4.0	2.9	2.2	3.8	2.5	0.8	0.4	2.6	4.8	4.7	2.7	3.8	4.4	4.4	1.2	1.6	2.2	2.3	0.4	2.8	2.4	2.1	1.2	3.3	1.8	1.6	2.1	10.7	1.7	3.6	3.5	0.8	2.6	0.1	1.3	3.0	2.0	2.5	1.2	3.7	1.6	1.6	2.7	2.1	6.9	1.6	4.4	1.7	2.5	2.1	1.7	1.6	1.9	3.8	1.4	1.3	3.7	0.3	1.4	0.7	1.1	1.5	4.6	1.5	2.0	1.2	2.5	1.6	0.5	1.1	0.6	0.9	1.2	1.7	0.3	24.1	0.5	3.5	0.6	2.6	2.2	0.6	1.7	0.8	1.0	12.1	0.2	17.7	3.2	4.5	1.0	1.2	1.8	1.5	1.2	1.5	1.8	3.2	3.3	2.8	1.6	6.4	25.4	1.2	3.6	3.0	1.0	0.5	0.4	0.0	1.0	0.9	0.3	0.4	0.5	1.4	0.7	0.3	0.3	0.4	0.7	3.1	0.9	0.0	2.1	0.4	5.1	4.5	2.0	5.4	3.8	2.5	4.7	2.7	2.2	2.1	3.5	2.5	8.0	0.0	1.3	209.6	1.5	5.6	4.2	1.1	4.0	11.2	0.7	1.0	1.4	1.5	1.3	0.0	12.5	3.1	3.8	0.1	0.0	0.9	1.1	1.7	9.6	12.7	1.2	0.0	37.7	2.3	5.6	6.5	0.0	3.6	5.7	1.1	5.3	0.0	5.4	3.3	24.6	0.0	2.0	6.0	25.4	4.1	61.8	7.1	10.6	19.7	1.1	28.9	5.2	30.2	10.7	2.8	0.1	78.6	6.2	2.7	0.0	0.3	0.2	8.2	13.1	11.8	7.1	2.6	1.3	0.8	3.7	2.2	3.0	3.3	0.1	5.2
ANKDD1B		ENSG00000189045	"Ankyrin repeat and death domain containing 1B"	A6NHY2	5	75611182-75681773	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Endometrial ciliated cells: 13.6;Gastric mucus-secreting cells: 8.6;Intestinal goblet cells: 8.4;Proximal tubular cells: 8.4;Respiratory ciliated cells: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;PC-3: 1.0;RPMI-8226: 1.5;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059722	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA059722: AB_2684112"	"unprognostic (5.11e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.30e-7)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	0.1	0.4	1.0	1.0	1.9	0.1	0.9	1.2	1.3	0.4	3.3	3.4	0.1	0.6	0.6	0.1	4.3	0.5	0.2	1.2	1.3	3.6	0.1	1.0	0.5	1.8	2.2	0.1	0.7	0.7	0.2	0.5	1.2	0.8	3.3	0.2	0.1	0.1	0.0	1.7	0.9	0.2	1.7	0.3	1.9	0.6	1.9	0.2	0.3	0.0	0.5	0.2	0.2	1.4	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	1.5	2.6	0.2	0.3	0.6	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	1.0	1.9	1.2	1.3	1.2	1.3	1.8	2.2	1.2	1.7	1.9	1.4	0.3	0.0	2.4	2.0	0.6	0.5	0.7	1.4	0.0	0.0	1.0	0.6	0.4	0.0	2.5	3.7	0.0	2.5	0.3	2.9	9.8	1.0	0.6	13.6	0.6	1.1	0.0	0.8	6.8	1.0	0.5	0.2	8.6	0.6	0.0	0.5	2.2	0.1	0.4	0.0	4.9	8.4	0.0	0.8	0.7	0.2	2.1	1.3	1.8	3.7	0.1	0.0	2.1	2.0	3.5	0.4	1.4	1.5	0.1	0.5	0.0	8.4	23.4	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.6	0.5	0.8	2.1	4.3	0.2
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.0;testis: 14.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 323.1;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.11e-1)"	2.4	1.4	1.1	1.5	1.1	0.6	3.1	2.7	1.4	2.2	2.8	2.5	2.5	1.0	1.0	2.5	4.0	2.2	1.0	0.9	1.7	2.5	4.0	1.7	1.2	1.4	1.3	2.2	14.0	4.3	2.2	0.7	1.4	1.9	2.3	5.3	2.6	2.1	0.6	2.8	2.4	0.7	0.9	1.2	3.7	14.6	1.6	1.7	5.7	0.6	1.8	1.6	1.3	0.9	9.0	8.7	0.9	2.1	2.2	1.5	5.9	1.3	0.1	1.6	0.8	5.1	7.2	0.1	2.4	0.3	9.7	7.1	2.3	9.0	1.9	0.0	1.4	1.1	2.2	5.3	1.0	0.9	0.2	3.9	9.8	1.5	1.4	4.0	1.4	3.2	3.4	6.1	0.4	2.4	1.4	0.0	4.4	11.2	2.4	0.0	0.1	5.6	5.3	5.5	6.5	3.1	3.8	8.7	0.0	3.2	7.2	0.8	0.9	1.1	1.4	0.1	1.4	7.0	14.2	1.3	2.4	0.4	1.2	0.0	0.0	0.0	0.7	0.0	1.1	0.5	0.7	0.5	0.0	0.4	1.0	0.6	0.1	0.5	0.0	0.5	0.7	0.2	1.1	1.1	2.7	1.4	0.9	1.7	1.4	1.3	1.4	0.9	1.6	0.9	0.5	3.2	6.7	1.3	2.0	0.3	2.3	1.6	3.4	1.7	3.4	1.8	1.8	2.8	2.0	7.3	0.0	2.2	1.2	2.7	1.9	4.5	323.1	6.7	1.0	1.8	5.3	0.4	1.1	6.3	2.0	0.9	10.7	2.8	1.3	0.7	0.7	9.1	1.3	3.3	2.8	3.8	2.0	0.3	0.6	383.0	3.4	1.4	0.0	1.0	0.0	0.8	3.1	0.5	0.4	5.3	4.2	4.1	4.8	1.9	3.3	2.8	16.2	4.9	0.0	0.7	0.3	5.1	3.4	8.6	0.3	1.5	2.6	1.1	3.7	1.5
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;cervix: 9.2;fallopian tube: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 138.4;Excitatory neurons: 27.2;Inhibitory neurons: 86.6;Oligodendrocyte precursor cells: 70.9;Respiratory ciliated cells: 31.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.8;MOLT-4: 15.4;T-47d: 5.0;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	0.7	0.2	5.3	0.0	3.6	0.0	0.3	3.6	1.8	9.2	0.6	0.1	0.1	0.1	0.9	0.2	5.3	0.2	0.0	3.1	8.4	0.1	0.0	0.7	0.0	7.5	11.3	0.0	0.0	0.0	0.3	0.8	6.2	0.2	0.1	0.2	0.2	0.1	0.0	2.2	0.1	0.0	7.7	0.0	0.3	1.7	9.7	0.6	0.1	0.0	0.0	1.0	0.9	3.0	0.0	0.0	0.1	0.0	1.1	0.1	0.3	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.4	15.4	0.0	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.3	4.8	0.0	1.3	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.6	3.6	1.8	3.1	8.4	7.5	11.3	6.2	7.7	9.7	3.0	0.0	0.0	1.1	138.4	0.0	0.5	0.1	0.6	0.0	0.0	0.3	0.1	0.6	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	18.7	16.9	1.2	0.3	0.0	0.0	27.2	0.0	0.9	1.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	86.6	2.4	0.0	0.0	0.7	8.6	0.6	0.0	1.8	11.2	0.0	0.3	0.0	70.9	3.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	31.0	0.1	6.6	0.0	0.5	6.4	2.7	0.0	0.4	2.9	0.0	0.0	0.1	1.4
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163821-4263995	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567"	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	13.8	16.1	18.9	13.5	25.4	16.4	12.5	23.4	19.0	15.2	15.1	25.8	11.4	18.0	10.6	13.6	15.1	11.9	11.4	17.8	23.9	11.3	13.9	15.3	14.0	27.5	23.6	19.9	9.6	19.0	12.3	14.2	25.4	12.1	13.9	13.1	13.7	12.2	14.1	19.8	13.7	14.8	25.8	15.0	13.0	5.9	22.9	20.3	14.4	11.4	12.8	14.6	13.9	28.1	20.6	47.2	31.5	21.3	41.7	31.6	20.5	22.5	23.4	35.5	35.2	21.0	13.7	17.8	18.0	34.1	19.0	32.0	29.3	24.0	31.2	9.7	29.7	17.6	34.0	19.6	23.2	10.6	20.4	33.3	24.8	25.5	18.7	19.0	21.3	17.2	17.3	16.7	24.5	16.0	15.9	11.3	13.3	16.0	16.4	23.9	21.0	9.9	18.5	27.7	10.5	16.4	31.9	15.1	20.2	24.3	17.5	13.7	27.3	22.5	11.7	31.0	30.3	5.5	4.6	5.9	27.5	21.1	27.5	1.0	3.9	1.7	2.7	6.4	2.5	0.9	1.8	1.9	2.7	0.9	1.8	1.7	1.6	1.0	7.3	1.1	1.7	2.2	18.9	25.4	23.4	19.0	17.8	23.9	27.5	23.6	25.4	25.8	22.9	28.1	14.5	28.9	24.6	43.1	8.7	12.4	8.9	12.7	13.1	24.1	12.2	13.2	4.6	8.6	13.6	18.4	29.2	11.2	15.1	13.8	1.9	9.8	4.3	13.9	20.0	15.1	12.1	6.3	59.9	9.7	9.8	15.2	18.8	12.5	3.8	21.1	24.7	19.7	20.2	26.9	60.5	10.9	6.1	24.4	7.6	3.8	14.6	19.1	17.8	39.4	18.8	9.8	19.6	36.7	46.4	13.2	6.4	19.2	7.4	15.4	11.4	7.6	22.4	30.2	6.6	25.5	11.9	12.9	12.8	17.2	11.6	6.2	15.5	16.6	12.5	14.5
ANKHD1	"FLJ10042, FLJ11979, FLJ14127, FLJ20288, KIAA1085, MASK, MASK1"	ENSG00000131503	"Ankyrin repeat and KH domain containing 1"	Q8IWZ3	5	140401814-140539856	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008718	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA008718: AB_1078162"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.05e-2)"	39.3	43.3	24.4	37.0	30.2	74.1	39.6	34.2	41.0	47.2	30.9	40.4	31.7	41.3	48.3	44.6	41.3	24.9	36.0	24.4	25.4	36.7	54.3	40.3	41.3	27.7	28.0	52.3	60.6	37.9	42.4	28.5	28.5	37.0	33.2	40.4	42.4	27.7	71.4	50.7	46.3	26.1	24.7	48.4	41.8	30.7	28.5	48.8	46.8	27.9	41.4	36.3	43.9	36.4	58.6	56.5	69.8	95.9	44.3	42.8	74.0	32.4	35.1	45.0	56.0	138.1	51.6	86.5	50.6	29.8	91.6	58.5	67.4	63.4	58.2	65.3	65.1	67.8	77.7	77.3	43.8	132.6	64.3	37.5	41.7	61.9	75.5	31.0	49.3	61.5	69.4	91.5	34.6	62.6	70.4	70.6	42.5	36.7	56.9	89.3	87.1	60.6	23.8	74.2	58.5	40.7	73.1	74.6	75.4	33.6	77.3	69.5	46.4	48.8	28.3	49.5	53.8	83.6	88.5	108.3	38.0	85.3	35.2	25.2	8.2	10.4	10.5	6.3	9.3	10.5	10.6	10.9	7.2	9.2	9.4	9.7	17.9	15.6	8.8	11.3	7.8	3.4	24.4	30.2	34.2	41.0	24.4	25.4	27.7	28.0	28.5	24.7	28.5	36.4	13.0	12.8	45.5	0.0	34.7	18.6	18.6	7.2	44.9	13.6	9.0	7.5	5.4	18.6	20.5	9.2	16.7	12.0	17.7	10.7	3.9	11.8	13.2	7.9	8.0	13.5	4.2	21.0	0.0	19.2	13.5	13.7	27.5	11.7	12.7	8.3	15.0	10.9	13.0	11.8	0.0	10.1	8.2	19.8	20.8	4.2	10.8	19.7	17.8	0.0	18.5	8.4	11.3	0.0	0.0	13.8	12.1	9.1	41.6	14.0	12.5	5.2	16.3	13.2	19.7	15.3	12.9	31.6	31.6	39.2	21.6	30.8	31.2	6.5	11.8	21.5
ANKHD1-EIF4EBP3	MASK-BP3	ENSG00000254996	"ANKHD1-EIF4EBP3 readthrough"		5	140401908-140549569	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.3;Club cells: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA008718	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA008718: AB_1078162"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.10e-3)"	"unprognostic (4.84e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.53e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.60e-2)"	9.7	14.7	3.9	6.5	4.0	5.7	10.5	4.1	4.5	9.0	7.8	11.8	7.4	8.2	19.6	14.9	7.9	6.4	8.2	3.4	5.1	10.4	9.6	11.1	9.1	4.5	4.1	8.9	16.4	21.2	10.1	7.0	4.2	12.1	11.9	11.9	12.2	9.3	10.5	15.1	11.7	7.3	3.5	15.7	11.7	11.4	4.7	14.4	10.1	8.2	13.4	10.0	10.5	4.0	8.8	12.0	21.1	17.9	27.5	15.4	14.0	5.9	11.8	12.9	16.3	19.9	13.8	16.8	5.3	11.0	24.7	10.8	17.5	16.2	16.3	14.6	7.9	9.0	16.7	18.0	15.7	10.6	11.3	10.8	27.9	16.8	17.0	13.7	17.9	5.6	5.9	5.0	12.5	7.2	13.4	5.4	8.7	8.7	6.1	12.7	10.1	12.6	19.6	16.2	8.3	6.8	15.7	13.7	5.2	11.9	17.8	8.5	9.6	10.9	6.1	7.2	10.7	12.1	7.1	9.7	7.6	8.2	13.5	1.1	0.7	0.9	1.0	1.0	0.7	1.3	1.2	1.2	1.4	1.1	1.0	1.4	1.6	0.7	0.9	1.2	0.4	1.0	3.9	4.0	4.1	4.5	3.4	5.1	4.5	4.1	4.2	3.5	4.7	4.0	1.3	6.4	27.3	3.6	0.9	0.9	0.4	0.3	1.8	0.8	1.2	0.6	1.1	2.8	14.6	1.8	0.0	0.4	2.0	0.5	0.0	0.6	0.3	1.0	1.1	1.6	1.2	1.3	6.1	0.2	0.1	3.2	4.1	1.5	1.3	0.9	0.7	1.8	0.4	0.0	5.8	0.3	0.0	0.6	0.4	0.0	0.0	2.6	1.8	2.8	1.2	0.4	1.0	5.0	4.1	0.7	0.2	0.0	2.0	0.9	0.7	0.2	7.1	0.9	0.0	2.0	1.1	0.5	0.2	4.4	2.4	0.8	1.6	0.9	0.6	0.8
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92245974-92401383	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 182.5;Inhibitory neurons: 218.0;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 590.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: AB_2670819"	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	12.6	10.6	28.4	10.0	56.8	6.9	12.3	21.2	42.0	12.6	0.0	12.9	11.1	12.0	15.9	11.8	9.8	14.9	10.2	19.0	54.6	25.6	10.6	11.0	13.2	32.9	32.4	12.6	12.2	23.9	7.5	12.7	34.5	10.0	12.8	9.9	13.9	11.2	7.7	14.4	12.0	13.6	14.0	12.4	11.7	20.8	36.3	14.5	17.2	9.9	11.7	13.2	9.0	85.5	35.7	20.9	18.7	27.3	32.0	34.9	19.2	27.1	30.0	25.4	34.0	15.8	52.0	20.0	23.4	39.7	66.8	16.5	16.5	28.1	38.0	35.1	14.0	13.1	23.7	12.1	22.0	18.8	26.5	23.1	22.8	31.0	38.2	34.6	28.7	17.4	16.9	41.8	30.0	27.5	39.6	17.0	19.6	23.9	23.7	14.6	22.8	21.9	26.6	30.7	25.5	29.4	39.2	41.8	22.4	34.8	17.5	10.2	26.2	48.5	40.2	55.3	27.8	26.7	52.3	25.4	27.7	21.9	56.2	1.4	0.4	1.2	0.9	0.7	0.7	1.7	0.9	1.3	0.4	2.0	0.7	1.0	0.2	1.2	0.6	1.6	1.9	0.4	28.4	56.8	21.2	42.0	19.0	54.6	32.9	32.4	34.5	14.0	36.3	85.5	24.1	25.6	30.4	97.6	21.8	18.6	17.5	16.4	13.1	20.8	25.6	20.2	33.4	24.3	22.3	27.6	18.8	13.4	27.8	20.7	1.9	21.5	52.8	21.5	37.2	22.4	41.9	8.8	182.5	19.2	25.2	25.9	14.3	27.0	26.6	47.4	27.8	15.1	13.5	30.3	218.0	24.8	10.2	22.2	16.1	61.1	33.2	20.4	17.8	87.1	20.6	27.3	34.0	176.5	590.8	33.5	11.8	40.6	23.4	26.5	20.8	37.3	18.8	16.2	19.7	34.8	26.1	70.9	50.4	20.3	22.7	14.0	22.7	31.2	21.7	21.9
ANKK1	X-kinase	ENSG00000170209	"Ankyrin repeat and kinase domain containing 1"	Q8NFD2	11	113387779-113400416	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 7.2;Club cells: 2.4;Ionocytes: 6.1;Respiratory ciliated cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.1;RT4: 1.0"	"Not detected"	"Not detected"							HPA012813	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA012813: AB_1844832"	"unprognostic (5.63e-3)"	"unprognostic (6.67e-3)"	"unprognostic (5.09e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.56e-4)"	"unprognostic (7.02e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.39e-6)"	"unprognostic (3.17e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.65e-2)"	0.2	0.5	0.6	0.2	2.7	0.1	0.7	0.5	1.0	1.1	2.0	0.3	0.1	0.4	0.3	0.5	2.0	0.0	0.1	0.4	0.7	0.4	0.3	0.6	0.4	1.0	3.1	0.7	0.3	0.1	3.0	0.0	0.7	1.5	0.0	0.6	1.3	0.3	0.3	3.5	0.6	0.0	0.7	0.8	0.2	1.0	1.1	0.1	0.7	0.0	0.2	0.4	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.5	1.0	0.4	0.7	1.0	3.1	0.7	0.7	1.1	0.7	0.2	0.0	0.5	1.6	0.2	0.6	0.8	7.2	0.0	1.2	0.3	1.1	0.4	0.0	2.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	1.9	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	0.2	0.2	6.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.5	1.1	0.0	1.1	0.0	0.0	0.5	0.0	0.0	6.0	0.9	0.0	1.3	0.4	0.1	0.1	0.0	0.6	0.0	0.5	0.2	0.0	0.5
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.6;brain: 8.8"	"Cell type enriched"	"Detected in some"	10	"Erythroid cells: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.7	0.9	4.5	2.3	2.7	25.6	0.6	8.8	5.5	0.7	0.6	0.5	0.9	1.0	1.2	0.7	0.6	0.7	1.0	3.2	2.3	0.4	0.6	0.8	4.1	1.6	1.4	1.5	1.7	0.4	0.5	1.2	1.7	0.7	0.5	3.6	1.5	0.6	0.3	2.4	0.8	0.8	0.4	2.2	0.8	1.5	3.3	1.3	0.9	0.5	3.1	0.7	0.4	2.7	0.9	0.8	3.7	1.7	0.4	0.6	3.2	1.1	0.3	0.6	0.6	17.1	1.5	77.2	0.7	0.5	0.6	1.5	28.4	0.4	0.6	22.3	3.4	29.1	13.1	0.6	0.3	34.6	12.5	0.3	1.0	2.7	0.2	0.9	0.6	6.4	4.2	9.2	0.4	0.9	24.2	41.7	10.2	0.3	2.6	17.3	1.0	8.7	0.4	1.7	1.2	7.1	6.8	0.9	0.7	1.5	0.6	20.1	1.4	1.0	1.2	1.4	1.0	1.3	0.9	27.8	0.7	57.2	1.3	0.9	0.9	0.6	0.5	1.9	0.3	1.6	0.4	0.5	1.1	0.9	0.5	0.4	1.5	0.3	1.4	0.9	0.4	0.6	4.5	2.7	8.8	5.5	3.2	2.3	1.6	1.4	1.7	0.4	3.3	2.7	0.4	0.0	0.5	0.7	1.1	0.8	0.8	0.3	0.0	1.9	0.5	0.6	0.8	0.0	0.1	0.0	0.0	1.6	0.4	0.4	0.0	0.2	0.3	0.2	0.4	0.4	0.0	70.7	1.4	0.2	0.7	0.6	0.0	0.8	1.3	1.1	0.0	0.1	0.8	0.0	1.6	0.5	0.0	0.9	1.3	0.0	1.8	1.1	0.0	1.0	3.0	0.5	1.0	1.0	1.6	0.3	0.1	1.5	0.9	0.5	0.0	0.1	0.9	1.5	6.6	0.6	0.4	0.5	1.0	0.0	0.4	0.4	0.5	0.3	0.3	0.2
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761832	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 215.7;Urothelial cells: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	30.0	37.6	12.4	27.0	13.3	38.4	27.8	15.2	16.6	25.4	21.9	23.8	17.8	24.9	19.0	33.6	25.2	17.4	22.0	13.8	14.1	21.8	22.9	31.3	31.6	12.3	12.4	27.1	24.6	17.9	23.1	20.4	12.3	23.9	16.1	12.3	26.1	15.6	29.3	36.9	33.3	21.9	12.0	37.9	24.1	55.7	14.3	26.2	23.3	18.3	31.2	25.0	27.6	13.2	50.7	46.4	47.3	29.5	26.9	42.1	59.1	60.2	44.7	59.0	45.0	53.2	33.6	39.5	30.7	53.1	39.5	59.2	41.8	54.8	56.2	17.0	51.6	50.1	84.0	25.2	29.9	54.6	34.0	39.1	54.9	56.2	41.3	108.8	42.8	32.0	46.1	15.1	61.2	36.4	51.1	89.4	40.1	24.8	43.9	58.0	31.1	16.7	42.6	64.9	57.9	35.6	77.7	32.4	27.1	44.1	56.9	39.1	61.5	70.5	50.9	38.0	68.1	27.9	29.5	47.9	54.7	35.8	40.5	0.9	1.2	4.4	1.8	1.1	2.4	2.7	2.6	2.8	1.7	2.8	2.4	2.0	0.7	2.7	1.3	1.7	2.6	0.7	12.4	13.3	15.2	16.6	13.8	14.1	12.3	12.4	12.3	12.0	14.3	13.2	38.0	73.7	31.2	18.3	43.2	67.3	92.0	38.2	32.5	32.3	31.2	27.1	24.6	27.1	51.3	31.3	45.9	29.2	41.1	33.8	1.9	33.2	109.1	58.6	52.4	36.3	20.8	23.1	21.0	32.7	35.5	35.7	35.2	119.2	18.4	38.3	22.9	12.9	20.1	32.0	17.8	18.0	24.4	19.7	47.6	24.5	25.1	35.5	33.8	16.9	40.6	21.9	47.4	18.1	18.4	101.9	24.8	28.2	47.6	116.9	18.8	8.5	32.3	39.7	26.3	39.2	40.5	215.7	61.8	44.8	72.9	36.5	44.7	31.6	24.0	168.7
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.20e-4)"	4.9	4.4	6.4	5.7	7.6	12.5	6.3	6.0	7.3	7.5	6.1	6.0	6.5	5.4	8.7	5.8	24.6	4.7	3.4	5.4	4.9	5.0	6.2	6.9	9.0	8.1	12.3	7.4	8.6	6.2	4.5	3.9	8.0	6.6	5.5	3.8	5.1	5.2	3.5	8.2	7.2	3.0	8.0	8.2	9.6	67.9	7.1	7.1	6.5	2.1	6.7	5.7	6.4	11.1	7.0	15.2	3.2	6.0	2.9	4.1	13.4	3.3	5.0	2.7	3.6	4.9	14.2	7.0	0.6	3.7	4.1	7.6	6.2	7.8	3.2	12.9	5.2	13.9	8.6	13.0	2.4	7.8	12.8	6.6	18.7	2.5	17.7	8.2	2.8	11.0	13.2	8.8	4.6	6.7	7.2	12.8	2.7	12.1	9.0	20.1	9.8	11.1	4.1	15.0	7.5	5.6	2.7	7.2	10.0	3.9	6.2	11.9	3.6	10.0	3.3	4.0	5.9	20.0	5.5	7.0	5.7	11.8	7.9	0.0	2.1	4.5	4.6	1.8	2.7	2.8	2.8	2.9	2.7	4.1	4.1	3.0	0.9	1.3	2.3	1.8	0.9	2.4	6.4	7.6	6.0	7.3	5.4	4.9	8.1	12.3	8.0	8.0	7.1	11.1	3.0	0.0	8.1	23.8	7.2	0.9	1.8	5.3	13.1	3.5	4.3	3.7	2.2	1.5	10.1	3.7	4.2	3.0	8.1	4.8	1.9	2.7	187.5	40.8	3.6	3.5	4.2	6.5	17.0	4.3	1.7	2.8	16.8	4.5	5.7	4.8	2.9	6.4	2.7	3.3	25.4	4.5	6.1	7.6	2.0	213.1	4.1	6.7	0.0	38.4	5.5	2.6	7.2	21.1	42.9	3.2	2.2	3.0	3.4	2.8	5.7	2.9	62.6	4.0	0.0	2.2	3.5	28.8	8.9	5.0	2.3	2.9	8.6	2.9	4.7	2.0
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552190-73565667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	7.8	11.3	4.6	5.7	5.1	14.0	10.1	5.7	5.4	9.4	5.2	8.9	9.6	12.4	13.1	7.5	11.4	9.7	8.2	4.2	5.1	5.9	10.8	7.0	9.9	5.0	4.9	14.1	8.3	8.0	7.5	10.0	5.3	12.4	10.4	9.9	10.9	8.4	7.6	9.1	9.6	8.3	5.1	8.8	10.0	6.7	5.2	10.0	14.3	6.6	8.1	7.4	7.7	6.2	6.6	4.5	6.6	7.5	12.3	19.3	20.6	9.0	13.2	7.6	11.0	1.4	9.4	6.2	7.0	8.8	7.3	4.5	3.1	15.4	10.9	11.9	5.5	5.4	3.6	6.5	9.6	3.1	9.3	19.8	21.0	9.1	9.2	13.6	8.7	6.7	5.3	9.9	8.6	3.8	5.6	8.5	3.9	2.5	3.7	3.5	7.1	8.7	5.6	8.2	9.0	6.9	6.9	5.3	11.0	10.2	8.2	5.0	11.2	3.0	3.4	4.9	6.3	19.7	15.1	5.3	7.5	5.1	8.8	19.9	5.1	11.2	7.6	4.5	9.3	9.9	8.9	10.7	4.6	8.0	13.3	12.4	8.4	7.3	7.8	5.3	11.5	6.8	4.6	5.1	5.7	5.4	4.2	5.1	5.0	4.9	5.3	5.1	5.2	6.2	10.7	3.2	11.5	10.4	23.5	15.8	30.1	29.8	26.2	26.2	20.7	15.9	8.9	31.5	22.7	18.4	10.4	26.3	27.1	16.0	27.4	14.1	1.3	18.1	11.0	12.8	24.1	21.5	10.0	16.6	22.2	13.8	10.7	13.4	19.0	18.8	15.7	23.8	10.5	23.5	12.9	22.6	36.7	18.5	6.7	2.2	32.6	11.1	12.4	16.9	15.1	16.2	17.5	21.1	22.3	16.9	20.0	29.0	14.6	25.7	21.5	18.0	21.4	21.2	26.3	11.3	17.8	25.6	15.9	16.0	12.4	48.8	20.4	16.3	17.0	36.8
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921087	"Metabolic proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"heart muscle: 6540.8"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 13820.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	0.9	0.7	0.0	0.4	0.0	0.0	1.8	0.2	0.3	0.6	0.6	0.7	0.0	0.4	0.0	0.6	0.1	1.3	6540.8	0.0	0.2	0.7	1.6	48.6	2.5	0.0	0.2	0.7	4.8	0.2	1.1	4.2	0.0	6.8	0.0	0.0	8.7	0.1	571.0	2.3	0.6	2.1	0.0	0.5	1.0	0.9	0.8	1.5	1.7	20.5	0.0	1.2	0.5	0.1	37.2	10.8	6.6	0.3	5.8	6.7	0.5	21.5	2.2	6.0	10.8	474.5	17.9	0.3	1248.9	1.8	48.5	13.3	2.3	3.1	15.7	1.4	1.2	0.2	2.9	148.5	27.7	0.0	0.0	44.2	0.1	9.5	21.6	679.8	437.8	0.0	0.3	0.0	1573.6	0.4	0.0	0.0	1.3	2.7	0.3	0.0	104.3	0.0	3.9	0.5	0.1	0.0	0.3	0.4	1.2	469.1	0.3	1.9	2206.7	4.1	163.9	3.2	175.0	0.0	1.2	3.0	0.9	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	913.5	42.0	0.0	0.0	0.0	3.5	18.5	0.0	0.0	0.0	0.0	13820.4	7.2	6.6	0.0	0.0	0.6	0.0	0.0	0.0	66.3	5.7	9.4	0.2	83.6	0.0	0.0	0.0	0.2	0.2	243.5	0.0	4.6	3.8	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.0	0.0	74.5	100.9	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1
ANKRD10	FLJ20093	ENSG00000088448	"Ankyrin repeat domain 10"	Q9NXR5	13	110878540-110915069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034211, HPA038878, HPA038879"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253"	"unprognostic (3.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.97e-3)"	"unprognostic (9.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.25e-6)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.41e-6)"	78.2	60.3	61.9	42.2	69.8	88.7	75.6	65.9	85.2	109.1	71.4	97.2	43.8	87.4	89.9	37.6	90.7	53.5	74.3	62.6	68.8	93.9	84.1	91.7	63.3	72.5	65.8	99.6	94.9	25.5	97.5	36.4	75.5	108.1	50.2	77.6	70.3	42.4	176.6	48.9	88.1	49.0	66.3	138.9	75.0	40.8	67.7	52.4	82.1	73.4	50.4	79.2	68.3	80.1	36.1	29.6	66.7	56.2	50.2	48.4	29.6	24.0	50.0	23.5	28.9	31.0	68.8	49.5	51.1	18.2	38.2	81.1	29.2	22.6	31.7	119.1	43.2	59.0	73.3	64.9	20.0	85.9	49.4	46.2	33.7	16.5	24.4	49.1	32.1	48.8	26.4	33.1	64.2	10.8	49.9	95.3	37.0	79.1	18.3	76.0	24.5	49.6	64.9	39.4	53.2	39.7	18.2	31.7	39.9	49.7	22.7	108.0	28.0	27.6	23.0	13.7	24.7	40.8	46.9	28.9	51.7	41.5	44.2	39.0	25.8	22.7	30.4	21.1	26.3	42.9	29.2	25.3	33.8	44.7	30.9	33.7	16.1	31.8	22.3	31.5	39.9	26.8	61.9	69.8	65.9	85.2	62.6	68.8	72.5	65.8	75.5	66.3	67.7	80.1	77.6	16.0	65.4	83.6	69.3	94.3	39.0	25.9	129.1	33.3	72.2	55.0	32.0	45.8	45.3	38.6	54.2	45.1	54.4	43.4	19.6	52.1	8.5	59.0	79.2	83.3	41.9	30.3	118.7	49.2	51.8	78.3	51.5	105.4	30.4	65.3	40.7	48.8	46.6	32.0	105.8	55.2	57.0	46.5	99.7	7.3	39.1	60.4	72.9	145.2	44.7	28.6	35.0	158.3	203.6	38.7	46.2	51.6	58.5	62.5	40.9	45.1	40.8	55.4	52.6	105.6	88.8	28.0	23.6	44.3	77.7	38.9	58.9	44.9	59.6	53.2
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267630-89490561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	21.1	33.1	26.0	29.3	53.9	14.5	23.2	39.1	18.0	18.7	17.6	21.4	22.0	12.8	22.5	18.4	18.6	22.3	36.8	22.1	15.7	12.2	18.9	26.3	29.8	25.7	29.2	26.6	24.7	24.1	17.9	25.3	16.1	13.6	14.1	20.1	17.0	24.8	35.0	21.0	14.5	19.2	26.6	21.7	18.4	26.7	24.9	19.4	15.0	19.0	19.3	16.5	28.8	55.5	67.9	66.8	51.5	40.3	41.4	64.5	61.7	41.1	36.5	25.8	79.7	57.8	51.0	41.6	44.9	41.1	54.6	46.0	56.8	41.2	25.5	55.3	40.3	49.3	64.7	60.8	30.0	44.0	46.4	56.4	47.9	61.5	52.8	44.4	84.1	88.4	39.6	46.5	52.5	50.1	75.2	58.8	28.7	61.9	101.6	77.0	43.3	38.0	45.7	39.1	47.9	89.0	18.5	65.1	33.9	43.3	46.6	83.2	76.4	71.4	42.9	68.7	71.5	27.1	62.9	61.6	48.6	42.2	7.6	2.9	3.0	2.7	3.1	3.1	2.6	3.1	3.3	1.6	3.0	2.7	2.4	8.5	7.1	5.1	5.4	3.3	1.5	33.1	29.3	23.2	39.1	36.8	22.1	29.8	25.7	25.3	19.2	26.7	28.8	133.0	131.4	103.0	94.7	136.3	116.5	150.3	49.5	91.6	181.3	57.4	65.8	233.3	84.4	52.5	71.7	158.4	42.7	203.7	109.7	31.3	80.1	118.5	200.9	162.6	135.4	106.9	58.5	122.1	72.7	36.3	118.2	96.8	312.8	55.7	164.5	80.7	69.4	48.4	156.5	97.7	89.8	30.5	63.5	117.9	39.5	103.8	112.0	48.0	119.0	110.9	83.1	146.2	117.1	110.0	122.4	66.9	106.1	143.3	147.6	64.6	35.1	45.6	112.9	39.5	148.3	126.3	92.2	98.9	102.6	122.2	38.7	133.8	137.4	87.3	179.0
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	15.8	9.3	17.1	20.5	21.4	20.5	13.7	59.9	26.0	11.1	2.2	13.0	12.9	11.8	9.5	14.4	6.2	14.6	11.9	13.9	18.4	13.0	13.8	11.5	22.4	11.2	13.4	14.1	11.9	10.5	5.9	14.1	13.2	12.2	12.0	29.8	12.3	10.6	26.7	20.2	13.4	9.1	10.4	19.9	14.5	27.7	15.8	11.4	16.4	12.3	18.5	13.5	8.0	32.3	10.1	6.7	9.0	6.0	14.2	14.5	7.3	15.3	14.2	5.4	7.4	6.1	7.6	13.9	8.7	10.6	16.4	9.1	6.8	6.0	14.5	14.8	8.1	6.4	4.7	9.0	10.5	15.0	19.7	7.6	13.1	7.7	12.4	12.2	9.2	8.0	14.7	106.4	13.2	5.7	10.1	10.2	3.4	24.7	6.8	9.0	12.6	51.1	7.1	15.8	20.9	7.7	15.0	7.4	11.1	8.0	9.2	12.4	19.9	39.5	18.1	32.1	14.4	30.8	52.0	25.9	19.4	7.9	15.2	102.0	26.4	85.1	42.4	24.1	47.9	63.6	54.9	42.0	19.2	56.2	55.9	43.4	157.3	30.4	37.2	60.6	44.0	18.3	17.1	21.4	59.9	26.0	13.9	18.4	11.2	13.4	13.2	10.4	15.8	32.3	235.1	278.9	261.5	198.5	246.9	108.2	205.9	83.3	116.7	301.0	87.5	108.5	138.6	94.4	137.7	68.0	523.3	46.3	267.2	163.1	19.6	99.7	204.9	144.3	91.9	136.8	92.7	90.7	172.1	83.5	41.1	126.8	64.2	292.9	187.2	76.3	121.7	74.0	67.8	286.0	218.1	90.4	107.8	99.7	126.2	230.9	134.8	149.3	90.7	161.1	178.2	125.5	244.1	184.5	347.4	93.0	147.1	141.4	210.1	196.8	126.1	37.0	88.5	315.4	111.7	173.2	150.0	239.5	152.8	70.9	96.0	78.1	298.3	63.0	71.0	170.7
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 160.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 205.4;HBF TERT88: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"	13.2	10.9	6.3	36.5	10.0	36.0	16.4	8.8	8.1	14.1	6.1	21.8	14.3	11.9	6.6	31.7	12.3	22.9	10.7	7.1	7.4	17.6	15.3	26.9	54.0	8.4	8.7	16.3	12.3	17.4	4.6	24.4	9.0	17.9	22.4	8.7	27.5	24.6	6.9	22.6	17.6	24.4	7.5	32.8	17.1	60.9	8.4	27.9	28.2	8.7	66.7	25.9	13.2	15.0	163.7	7.3	16.9	15.6	25.4	25.1	20.8	160.9	150.5	149.8	79.3	21.2	10.3	107.8	12.4	205.4	18.7	19.0	21.7	24.0	200.3	122.3	19.2	39.9	15.6	17.4	22.2	46.8	46.2	21.9	24.9	63.8	36.5	37.3	23.0	24.9	31.6	17.2	66.5	5.8	41.3	19.5	9.3	11.7	34.1	35.8	47.3	42.7	21.2	20.7	34.7	16.5	29.6	57.0	19.5	11.4	26.0	38.5	29.2	111.6	20.0	62.2	87.4	36.8	23.3	144.1	54.3	31.7	16.5	1.5	1.2	5.6	0.5	2.5	1.5	2.0	1.3	0.6	1.5	1.2	0.7	1.0	3.5	0.9	1.1	1.0	0.6	0.7	6.3	10.0	8.8	8.1	7.1	7.4	8.4	8.7	9.0	7.5	8.4	15.0	15.7	48.1	32.5	13.4	75.5	29.3	18.7	11.0	15.4	24.4	23.1	16.9	13.0	28.6	30.5	57.0	14.6	16.9	31.2	30.3	21.5	29.2	104.7	22.0	12.3	14.9	18.7	19.4	15.9	17.6	21.0	15.5	16.3	29.5	13.3	18.5	15.7	17.3	15.4	25.2	26.9	9.4	4.1	37.1	26.9	160.4	11.8	33.7	14.2	16.9	34.2	9.7	21.6	17.6	46.0	20.8	12.5	21.8	33.0	16.2	16.0	9.8	37.6	14.2	32.9	50.3	18.0	71.1	15.0	23.9	37.8	37.6	31.8	16.9	17.0	25.7
ANKRD13B	FLJ25555	ENSG00000198720	"Ankyrin repeat domain 13B"	Q86YJ7	17	29589769-29614761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4;Endometrial stromal cells: 24.2;Excitatory neurons: 19.4;Horizontal cells: 16.8;Late spermatids: 44.7;Oligodendrocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 52.0;SH-SY5Y: 57.6;SK-BR-3: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051886, HPA063748"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA051886: AB_2681652, HPA063748: AB_2685112"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (7.58e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (9.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.36e-3)"	12.0	3.7	12.5	1.7	14.3	0.7	7.5	11.9	15.9	16.3	0.0	10.2	0.8	13.6	0.8	6.5	12.0	3.7	10.3	13.9	6.2	2.8	1.2	5.5	1.6	13.4	9.4	15.1	3.7	1.6	14.6	0.9	10.4	7.7	0.6	2.0	4.3	1.8	9.6	7.5	4.5	2.9	7.2	2.6	4.9	18.9	10.8	0.9	5.8	1.3	0.3	10.0	11.6	22.9	6.6	11.5	13.3	35.4	8.2	8.0	5.1	2.0	1.2	1.4	2.7	6.1	1.4	7.4	6.4	2.8	4.9	24.3	7.2	7.8	0.2	14.8	23.5	2.3	22.3	5.3	3.5	2.4	4.6	7.9	10.2	2.2	5.8	6.4	10.1	12.8	6.0	6.1	1.9	5.9	16.0	7.5	11.4	6.8	9.7	33.4	9.5	23.4	3.0	2.2	52.0	57.6	3.9	48.0	4.3	1.2	7.4	4.4	6.7	7.4	7.2	5.2	7.2	11.4	15.7	9.2	5.2	12.1	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.3	11.9	15.9	13.9	6.2	13.4	9.4	10.4	7.2	10.8	22.9	2.6	0.0	0.0	6.8	0.1	1.7	1.0	0.7	3.4	4.5	1.8	2.7	2.3	0.0	0.4	0.0	2.1	0.1	0.6	0.6	1.9	1.6	27.4	0.9	24.2	2.4	3.0	1.7	19.4	0.6	0.2	5.5	2.6	1.0	0.0	3.8	1.4	0.6	0.1	16.8	14.6	0.8	0.0	0.3	1.6	44.7	14.6	0.3	0.0	0.0	0.0	1.8	0.0	11.1	17.8	0.5	0.0	7.5	0.5	3.2	0.1	0.2	0.0	5.2	0.0	2.4	2.5	6.0	4.7	2.6	1.7	0.1	0.7	1.0	1.1	1.5
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67289300-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.9;SK-MEL-30: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	12.0	14.7	13.3	6.8	14.3	0.3	11.4	10.9	20.7	19.5	10.8	13.8	3.1	12.5	2.9	24.4	15.3	7.9	12.0	16.5	12.9	16.2	8.9	13.8	15.0	13.8	11.7	14.1	9.5	6.0	28.9	5.2	15.1	23.8	2.3	2.0	14.4	7.3	3.7	15.0	13.8	6.5	10.2	39.2	12.8	12.1	15.8	10.0	11.2	3.8	5.7	17.5	20.5	19.6	9.7	7.2	5.8	12.3	10.9	10.1	3.8	7.0	8.4	7.2	5.6	6.4	10.1	11.6	12.4	5.6	10.7	12.4	4.5	8.6	1.0	19.9	5.3	11.6	11.3	4.3	16.8	14.0	27.8	10.4	11.8	6.2	6.8	14.1	9.5	9.2	6.3	12.4	8.0	14.1	18.0	63.9	2.5	19.8	10.1	28.5	4.9	9.9	13.6	6.0	6.0	9.8	7.0	16.7	57.0	4.5	14.3	33.1	7.7	7.1	6.1	7.9	8.2	9.8	9.4	5.6	17.4	21.4	8.2	6.6	0.6	5.7	2.0	2.1	1.3	0.8	1.5	2.8	1.2	0.5	0.5	3.2	1.9	3.1	1.4	1.8	1.6	1.2	13.3	14.3	10.9	20.7	16.5	12.9	13.8	11.7	15.1	10.2	15.8	19.6	23.2	0.0	18.8	18.9	22.2	14.1	11.7	15.4	17.6	61.1	21.5	20.8	7.0	8.6	14.5	16.5	75.0	8.3	73.6	7.5	1.9	8.3	18.0	27.7	19.7	17.9	10.8	8.2	29.8	6.9	9.0	15.7	20.4	18.0	25.3	25.7	22.1	3.0	20.0	42.1	29.7	7.9	18.3	52.0	21.4	6.0	22.1	45.8	12.4	18.7	49.7	20.8	49.4	17.6	18.4	9.9	4.6	17.0	30.7	19.9	2.3	2.6	30.4	51.7	13.1	13.6	18.5	3.1	8.1	19.3	25.1	7.5	49.9	28.9	8.4	19.8
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861616-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 26.9;Inhibitory neurons: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	3.8	4.0	5.5	2.3	5.5	1.9	4.1	5.6	7.9	6.3	3.1	3.7	3.2	5.1	4.9	3.7	5.8	2.5	3.3	5.2	4.2	3.5	4.1	3.0	3.1	5.0	4.5	6.2	4.1	5.7	3.9	1.7	5.2	4.1	2.5	4.4	4.0	3.1	3.9	6.7	3.2	3.2	4.0	3.2	6.6	8.7	4.8	3.8	3.7	2.6	3.3	4.3	4.4	5.6	8.3	9.8	4.5	9.2	4.6	3.4	6.6	2.5	1.9	4.4	3.8	12.1	4.3	8.8	3.5	4.2	1.6	8.5	5.5	6.4	2.0	3.1	8.6	5.5	4.8	11.1	5.9	3.4	3.8	5.3	4.8	4.0	3.1	3.5	4.9	9.0	7.5	2.6	3.1	11.5	12.7	5.8	3.7	11.2	6.9	9.6	2.9	18.1	5.0	5.3	2.7	6.0	5.2	6.4	6.0	3.6	8.9	6.9	3.2	2.6	3.4	5.8	3.5	14.7	7.1	5.8	5.4	3.3	2.9	0.3	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.4	0.1	0.5	0.2	0.1	5.5	5.5	5.6	7.9	5.2	4.2	5.0	4.5	5.2	4.0	4.8	5.6	5.3	3.2	1.3	14.7	5.9	4.7	7.8	1.4	4.6	14.1	7.0	6.0	2.8	10.0	1.8	3.7	6.2	4.7	3.0	2.4	13.7	2.1	8.4	7.8	9.8	4.2	4.2	5.5	25.1	2.2	3.6	10.2	4.1	4.4	0.0	13.0	3.3	3.8	3.3	26.9	28.4	3.1	0.0	1.0	3.3	14.6	5.6	3.2	3.6	5.6	3.6	8.8	1.0	12.5	16.2	1.0	1.3	3.8	11.3	7.3	5.2	8.3	1.0	14.4	0.0	8.5	4.5	13.0	7.8	6.5	5.7	1.5	3.5	10.5	5.2	3.7
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 18.2;brain: 21.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.3;Excitatory neurons: 24.8;Inhibitory neurons: 26.8;Oligodendrocytes: 118.1;Rod photoreceptor cells: 31.2;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 17.9"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.0	0.1	3.0	0.3	9.1	18.2	0.4	3.6	3.7	0.4	0.0	0.5	0.3	0.2	0.2	0.8	0.5	0.4	0.6	3.1	5.1	0.9	0.7	0.3	0.2	12.6	6.0	0.0	2.2	0.6	1.0	0.1	14.3	0.9	0.7	5.0	0.4	0.1	0.0	1.3	0.7	0.2	5.1	0.1	1.0	7.2	8.4	0.3	2.2	0.0	0.1	0.2	0.4	21.9	4.8	3.7	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.9	0.0	0.0	0.9	3.5	3.4	0.0	0.0	5.2	0.0	5.6	2.9	0.0	17.9	0.5	0.0	2.3	0.0	3.1	1.7	0.0	7.2	1.7	0.4	0.3	4.6	0.1	0.9	3.7	6.2	2.1	0.0	6.5	6.8	2.1	2.0	1.5	3.0	2.4	0.5	0.2	7.1	2.6	8.3	4.5	0.0	1.3	0.1	0.0	0.3	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	9.1	3.6	3.7	3.1	5.1	12.6	6.0	14.3	5.1	8.4	21.9	0.1	0.0	1.5	1.0	0.1	0.6	2.0	1.5	3.4	3.8	2.3	2.4	9.4	1.5	3.7	1.8	2.1	0.0	0.1	0.8	1.9	5.4	8.0	33.3	1.7	0.2	4.2	0.0	24.8	2.4	0.9	0.2	7.7	19.2	0.0	14.7	0.0	0.5	0.1	0.0	26.8	3.3	2.0	0.0	0.3	2.2	0.6	0.2	0.0	1.0	0.4	9.2	0.0	18.1	118.1	3.9	2.6	0.4	0.1	1.9	1.6	0.3	11.0	31.2	0.0	0.0	0.3	53.5	4.3	3.8	1.7	0.0	1.4	0.3	2.3	1.4
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 34.5;choroid plexus: 10.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 27.5"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	0.4	0.2	16.8	0.0	17.5	0.1	0.1	34.5	30.1	0.2	10.6	0.0	0.0	0.1	0.1	1.9	0.2	0.4	0.0	18.2	13.6	0.0	0.0	0.1	0.1	22.3	15.7	0.0	0.0	0.0	0.4	0.2	21.4	1.2	0.0	1.9	0.1	0.0	0.7	2.2	0.0	0.0	12.7	0.3	0.0	3.9	14.5	0.0	0.2	0.1	0.1	0.7	0.9	17.0	10.0	8.8	0.6	0.1	0.2	1.5	0.9	2.1	2.1	2.7	2.9	2.1	0.2	0.2	0.4	0.3	2.9	2.2	5.9	2.1	3.6	0.1	5.2	10.2	13.1	1.5	0.0	3.5	0.6	0.8	3.6	3.7	9.3	0.7	5.0	0.0	5.5	0.5	3.0	1.7	0.0	27.5	9.1	0.2	4.8	0.0	13.0	2.0	1.6	2.4	0.3	8.5	4.2	0.3	0.4	5.5	7.5	13.4	4.6	1.5	5.8	4.4	3.9	1.5	0.8	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	17.5	34.5	30.1	18.2	13.6	22.3	15.7	21.4	12.7	14.5	17.0	0.0	0.0	0.0	0.7	0.0	2.0	5.4	2.9	1.2	8.5	0.5	0.9	3.1	4.3	2.8	1.8	0.0	0.0	0.0	0.6	0.0	0.8	34.4	12.1	0.2	0.3	0.0	0.0	13.8	0.5	0.4	0.1	0.0	4.0	0.0	12.1	0.4	0.1	0.2	0.0	9.0	2.0	4.1	0.0	0.3	3.7	0.6	0.2	0.0	1.9	0.0	22.3	0.0	4.0	0.8	0.4	1.7	0.7	0.0	2.5	0.3	0.1	9.8	5.5	0.0	0.5	0.5	41.4	2.1	6.2	3.3	0.0	0.2	0.0	1.3	3.9
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	63	"heart muscle: 437.1;skeletal muscle: 981.2;tongue: 823.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 218.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9;testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA		110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	0.4	0.8	2.5	0.1	2.3	0.0	0.5	2.5	3.7	0.2	2.0	0.3	0.0	0.3	0.3	1.0	0.1	0.3	437.1	2.5	2.7	11.8	0.3	0.8	0.2	2.5	2.4	0.1	0.9	0.0	0.6	0.0	2.5	2.9	0.0	0.3	3.4	0.9	981.2	2.7	0.2	0.2	1.9	0.1	0.2	0.5	2.7	0.0	0.5	823.8	0.1	0.1	0.4	2.5	17.6	5.4	0.0	0.0	0.2	0.0	0.4	0.9	0.0	7.3	4.7	0.3	5.3	0.0	0.6	0.2	0.4	13.0	0.0	4.7	5.0	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.8	2.1	4.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.4	0.8	0.0	0.0	0.0	4.4	0.0	0.4	2.1	0.3	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.5	3.7	2.5	2.7	2.5	2.4	2.5	1.9	2.7	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.7	1.7	1.2	0.0	0.2	0.4	218.3	2.8	0.2	3.7	0.0	0.2	0.0	0.0	31.3	1.2	0.6	0.1	0.3	1.6	0.0	0.0	1.3	0.2	0.4	1.0	0.0	0.1	0.0	0.7	0.4	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.5	0.4	0.9	0.0	1.9	0.0	0.1	0.0	19.1	0.0	0.1	0.0	13.6	1.1	2.5	3.5	0.6	0.3	0.3	0.2	0.1	0.0	0.5
ANKRD20A1	"ANKRD20A, DKFZp434A171"	ENSG00000260691	"Ankyrin repeat domain 20 family member A1"	Q5TYW2	9	67832765-67920552	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;testis: 4.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.8;Excitatory neurons: 14.8;Inhibitory neurons: 9.0;Oligodendrocyte precursor cells: 12.5;Spermatocytes: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 8.7;U-266/70: 8.7;U-266/84: 5.6"									"HPA043239, HPA046346, HPA046695, HPA047112, HPA047167, HPA047766, HPA049923, HPA051288, HPA051753"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA043239: , HPA046346: AB_2679631, HPA046695: , HPA047112: , HPA047167: , HPA047766: , HPA049923: AB_2680954, HPA051288: AB_2681421, HPA051753: AB_2681592"	"unprognostic (4.92e-1)"	"unprognostic (4.31e-3)"			"unprognostic (3.97e-1)"			"unprognostic (2.30e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"		0.4	0.2	0.8	0.1	2.6	0.5	0.4	0.1	3.3	0.3	0.0	0.4	0.1	0.2	0.3	0.8	0.4	0.2	0.9	1.3	0.2	0.3	0.2	0.5	0.1	0.4	0.1	0.2	1.0	0.2	0.7	0.0	0.7	0.4	0.7	0.8	0.4	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.1	4.4	0.4	0.3	0.4	0.0	0.0	0.1	0.4	2.9	0.2	0.2	1.3	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.3	0.5	0.9	0.3	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.2	0.3	1.4	0.3	8.7	0.0	0.0	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.3	0.4	0.8	8.7	5.6	0.0	0.3	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	2.6	0.1	3.3	1.3	0.2	0.4	0.1	0.7	0.1	0.4	2.9	0.0	3.2	2.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.3	1.2	0.2	0.0	0.8	0.0	0.0	14.8	1.8	0.0	0.3	1.5	0.1	1.3	0.5	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.6	0.0	0.0	12.5	0.3	0.5	2.5	0.0	0.0	0.0	1.8	0.0	2.2	0.0	0.0	0.0	0.2	10.3	1.9	0.7	0.0	0.0	0.4	0.0	1.3	0.1
ANKRD20A2P	ANKRD20A2	ENSG00000183148	"Ankyrin repeat domain 20 family member A2, pseudogene"	Q5SQ80	9	40223285-40266845	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 2.6;testis: 3.3"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 10.5"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.24e-3)"									"unprognostic (9.19e-2)"				0.3	0.1	0.5	0.0	2.6	0.0	0.3	0.0	1.9	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.2	0.0	1.0	1.0	0.2	0.1	0.1	0.8	0.0	0.7	0.7	0.1	0.9	0.0	0.5	0.0	1.0	0.2	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.0	0.4	0.3	0.1	3.3	1.5	0.1	0.3	0.0	0.0	0.0	0.4	1.8	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	10.5	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	1.9	1.0	0.2	0.7	0.7	1.0	0.4	1.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ANKRD20A3P	ANKRD20A3	ENSG00000276203	"Ankyrin repeat domain 20 family member A3, pseudogene"	Q5VUR7	9	66106815-66179474	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"testis: 2.0"	"Cell type enriched"	"Detected in single"	15	"Cardiomyocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 9.5;U-266/84: 3.7"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.27e-2)"													0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A4P	ANKRD20A4	ENSG00000172014	"Ankyrin repeat domain 20 family member A4, pseudogene"	Q4UJ75	9	64369394-64413142	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.6"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.0;Karpas-707: 1.4"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"	"unprognostic (3.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (2.56e-1)"		"unprognostic (9.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.84e-2)"	0.5	0.2	0.4	0.1	0.7	1.1	0.2	0.7	1.6	0.2	0.0	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.4	0.3	0.3	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.6	0.1	0.2	0.3	0.5	0.1	0.4	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	0.3	0.5	0.5	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.6	0.1	0.0	0.2	0.5	0.4	0.1	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.9	1.0	1.4	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.7	0.7	1.6	0.3	0.3	0.3	0.1	0.5	0.0	0.5	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88819896-88851844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.8;skin 1: 30.9;stomach 1: 46.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 37.2;Distal enterocytes: 38.2;Gastric mucus-secreting cells: 49.5;Paneth cells: 51.5;Squamous epithelial cells: 35.8;Suprabasal keratinocytes: 102.9;Urothelial cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	14	"granulocytes: 6.4;monocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"A-431: 8.6;CAPAN-2: 26.1;HL-60: 9.4;NB-4: 8.7;OE19: 20.9;RT4: 16.4;T-47d: 12.2;U-937: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favorable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.2	0.3	0.6	9.5	0.7	5.4	2.6	0.5	0.9	7.6	0.4	7.2	2.7	0.2	0.3	33.8	0.3	3.2	0.1	0.5	0.7	4.7	2.0	1.5	4.2	1.3	0.8	0.3	12.9	0.8	0.3	0.2	1.1	2.5	7.1	0.1	4.9	0.1	0.1	30.9	2.1	1.6	0.6	6.4	46.3	0.1	0.7	5.5	0.1	0.0	7.8	4.8	13.9	0.9	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.0	0.0	6.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.6	8.7	0.0	20.9	0.1	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	1.3	0.0	0.0	12.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.9	0.0	0.0	2.1	1.1	0.0	3.1	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	6.4	0.2	0.6	0.2	0.0	0.6	0.6	0.7	0.5	0.9	0.5	0.7	1.3	0.8	1.1	0.6	0.7	0.9	0.0	0.0	3.7	0.0	1.0	37.2	18.6	7.6	1.8	0.0	1.5	0.9	0.2	5.7	4.5	7.3	0.0	0.0	0.0	38.2	0.0	3.2	0.0	0.9	0.5	0.3	1.8	0.4	0.0	5.9	0.0	0.6	49.5	4.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	14.9	16.2	9.3	3.1	0.2	0.3	8.5	1.8	0.0	2.2	0.0	0.0	0.0	0.0	5.7	51.5	0.0	0.2	10.1	0.6	0.0	1.7	0.0	0.0	0.1	0.3	0.1	0.2	35.8	102.9	0.0	0.8	0.1	25.7	30.3
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"skeletal muscle: 1438.6;tongue: 448.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Karpas-707: 38.5"	"Low region specificity"	"Detected in many"							HPA036201	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.8	0.9	1.6	0.4	2.1	0.7	1.2	2.2	2.1	1.4	0.6	1.3	0.8	1.8	0.0	6.0	2.5	0.2	24.2	1.5	1.4	0.7	2.2	1.0	0.6	2.5	1.6	1.7	1.6	0.3	10.4	0.2	1.8	5.3	0.1	0.1	18.5	0.3	1438.6	2.5	1.3	0.2	1.5	2.3	0.7	0.7	1.9	0.6	1.1	448.6	0.4	1.2	1.1	2.3	0.5	0.7	0.4	0.8	0.0	0.2	1.1	0.3	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.3	0.3	0.2	1.1	1.0	0.5	0.8	0.2	0.1	0.8	1.8	0.3	0.3	0.6	0.0	0.2	0.1	1.5	0.9	38.5	0.3	0.9	0.5	0.8	0.4	0.1	0.3	1.4	0.0	5.0	0.2	0.9	1.4	0.2	0.3	0.7	0.0	0.2	1.1	0.0	0.3	0.5	0.6	0.7	0.1	1.7	0.7	0.3	0.4	1.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	2.1	2.2	2.1	1.5	1.4	2.5	1.6	1.8	1.5	1.9	2.3	1.1	0.0	1.1	2.0	0.5	0.8	0.5	0.4	0.6	2.6	0.8	2.3	5.0	0.0	1.5	0.0	2.1	0.4	2.1	0.9	0.0	0.3	3.3	1.3	1.9	0.8	0.0	0.4	2.8	1.1	0.2	1.3	0.5	0.7	1.3	1.1	1.4	1.2	0.2	1.7	2.7	1.0	0.0	0.6	0.3	1.8	1.5	0.6	0.0	1.0	0.2	1.1	1.0	0.5	2.9	0.1	0.3	3.0	0.4	0.3	0.6	0.2	7.4	5.2	0.0	6.1	1.6	1.3	0.4	0.4	1.3	0.3	1.1	0.7	0.9	0.2
ANKRD24	KIAA1981	ENSG00000089847	"Ankyrin repeat domain 24"	Q8TF21	19	4183354-4224814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3;testis: 14.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 24.7;Extravillous trophoblasts: 19.1;Inhibitory neurons: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.9;U-266/70: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041534, HPA048498"	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Microtubules, Cytosol"		"HPA041534: AB_2677537, HPA048498: AB_2680420"	"unprognostic (3.70e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.23e-9)"	"unprognostic (7.03e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-4)"	1.1	3.7	6.8	0.3	11.0	0.5	0.9	4.2	20.3	1.3	0.0	1.3	0.8	0.8	0.8	0.5	1.4	0.5	0.6	10.9	4.1	3.1	10.7	1.0	0.4	2.6	4.0	2.0	3.9	0.6	6.5	0.8	2.4	4.1	0.3	2.7	0.9	0.6	1.2	0.6	1.4	0.2	1.5	1.5	1.8	14.0	5.8	0.4	2.8	0.4	0.1	1.0	0.7	10.8	0.1	0.2	0.0	0.1	2.7	0.2	2.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.2	0.1	0.1	0.4	0.0	2.2	0.3	0.0	0.1	0.1	1.5	0.1	0.3	1.5	0.1	0.2	0.7	0.4	0.1	1.7	0.1	4.9	0.0	0.7	0.0	0.1	2.1	0.6	0.6	0.3	0.0	0.4	0.0	0.2	0.8	0.1	0.1	0.1	0.3	0.5	0.6	0.4	0.0	0.1	1.0	0.8	0.0	16.2	1.5	0.1	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	11.0	4.2	20.3	10.9	4.1	2.6	4.0	2.4	1.5	5.8	10.8	0.1	0.0	1.9	12.1	0.5	0.0	0.2	0.1	0.0	1.2	0.4	0.4	0.9	1.5	1.4	0.0	4.2	0.3	0.0	0.3	0.0	0.1	0.4	0.6	0.2	0.2	3.6	0.0	24.7	0.0	19.1	0.2	1.5	0.4	0.0	0.2	0.7	0.9	0.4	0.0	14.4	0.7	0.0	0.8	0.0	1.7	0.0	0.3	0.0	1.0	0.0	0.9	0.0	3.5	4.4	0.0	0.3	0.0	0.2	0.2	0.5	0.8	0.3	1.2	0.0	0.4	0.2	1.0	2.9	0.2	0.0	1.1	0.2	0.4	0.2	0.2
ANKRD26	"KIAA1074, THC2"	ENSG00000107890	"Ankyrin repeat domain 26"	Q9UPS8	10	26973793-27100494	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA040654, HPA041460"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA040654: AB_10795370, HPA041460: AB_10795120"	"unprognostic (1.92e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.99e-1)"	2.3	2.6	4.7	1.6	5.4	1.5	3.8	5.9	8.6	3.9	5.0	2.5	1.7	3.3	3.0	2.0	3.0	2.0	4.1	4.4	4.0	2.7	2.8	1.9	3.5	4.7	3.8	4.0	2.6	4.0	4.6	3.2	2.7	2.6	2.8	10.0	2.3	2.5	6.7	2.5	2.0	2.5	2.8	2.5	2.2	4.0	4.9	3.1	2.7	7.5	2.2	2.2	2.7	5.8	7.7	5.4	9.8	3.7	6.1	6.7	3.4	10.1	3.7	9.2	8.5	5.2	5.1	17.9	3.1	4.7	6.5	8.1	9.6	4.7	11.0	7.4	7.2	1.1	7.9	7.9	4.5	4.5	1.2	4.7	2.9	9.5	3.2	7.5	8.4	5.5	14.8	4.8	9.3	4.3	5.5	2.8	3.9	2.8	3.5	6.6	13.8	4.3	5.7	3.1	8.5	4.7	9.6	2.0	8.1	7.1	8.5	3.1	7.6	7.7	5.2	9.9	5.7	1.9	2.6	11.7	7.3	9.9	3.5	1.0	0.2	0.2	0.2	0.1	0.7	1.2	0.4	0.4	0.3	0.6	1.6	0.5	0.1	1.6	0.1	2.1	0.4	0.2	4.7	5.4	5.9	8.6	4.4	4.0	4.7	3.8	2.7	2.8	4.9	5.8	19.5	22.4	28.8	130.6	14.3	4.2	7.6	9.0	8.6	77.8	13.5	17.7	70.9	7.2	19.4	3.7	200.1	24.8	8.6	8.3	5.9	14.5	19.0	47.7	38.6	20.4	20.9	6.3	136.8	13.1	13.1	21.3	8.2	16.5	5.1	43.5	13.6	8.3	11.9	79.1	185.9	9.3	10.2	5.7	5.4	6.4	30.4	11.8	3.6	45.0	12.4	45.0	18.6	87.0	67.2	11.3	4.2	27.1	7.8	5.3	12.1	5.6	49.5	117.9	32.9	30.1	15.6	60.7	57.2	8.9	8.0	13.7	12.9	46.1	14.6	5.0
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597006-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042769	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Vesicles	Cytosol	"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	8.9	7.4	10.8	8.9	12.9	10.4	8.7	12.1	12.6	10.3	21.5	17.2	7.6	10.0	8.8	14.3	8.0	7.7	9.6	11.8	9.8	9.7	4.4	10.3	11.1	12.0	12.9	8.3	7.2	9.3	6.8	13.6	12.4	12.3	11.9	11.7	9.7	13.5	20.7	12.4	10.7	11.6	8.9	9.0	11.0	17.3	12.1	16.7	13.3	10.8	11.5	16.9	11.1	11.8	32.0	36.0	11.5	20.8	23.5	18.0	28.1	18.0	18.0	19.4	25.4	28.8	19.0	34.7	16.5	23.0	20.4	19.4	29.6	22.3	32.0	47.3	15.1	137.9	13.7	23.9	29.4	53.5	47.6	13.1	28.8	20.9	33.8	13.5	19.7	25.3	37.5	76.3	15.1	31.5	20.8	46.2	6.0	40.2	13.8	30.6	15.6	12.7	15.6	30.5	21.3	8.6	17.6	29.6	21.0	15.2	12.4	25.7	18.5	21.1	22.4	19.6	28.0	19.7	12.7	23.8	21.0	51.8	13.8	36.5	11.1	28.5	13.9	15.7	17.5	7.5	14.3	15.6	12.6	6.9	10.9	11.7	9.0	30.6	13.3	6.2	13.2	13.3	10.8	12.9	12.1	12.6	11.8	9.8	12.0	12.9	12.4	8.9	12.1	11.8	6.8	16.0	9.4	18.3	10.0	15.6	5.5	5.6	14.2	9.4	9.0	5.1	9.2	7.2	5.7	9.2	20.9	14.9	9.7	9.3	0.0	3.3	5.1	7.5	9.4	7.1	9.1	26.5	35.5	5.9	10.6	7.6	5.6	11.6	12.0	10.1	4.6	4.8	8.4	11.8	16.3	9.6	8.2	12.0	12.1	16.2	10.8	8.7	16.0	12.2	6.0	5.8	9.2	11.1	18.7	7.1	10.3	9.4	8.0	10.0	10.8	7.7	7.1	14.7	0.0	6.8	9.3	4.1	17.1	14.7	15.5	15.2	14.0	7.2	8.9	8.4
ANKRD29	FLJ25053	ENSG00000154065	"Ankyrin repeat domain 29"	Q8N6D5	18	23598926-23662911	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 163.8;Alveolar cells type 1: 218.0;Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.7;BJ hTERT+: 16.6;hTCEpi: 16.2;PC-3: 15.5;U-2197: 20.5;U-87 MG: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041272, HPA049419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA041272: AB_2677387, HPA049419: AB_2680757"	"unprognostic (4.52e-3)"	"unprognostic (8.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (1.92e-5)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.98e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.54e-1)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.10e-2)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.64e-5)"	17.8	7.2	14.1	3.6	6.4	0.2	15.8	9.1	13.5	12.9	10.7	4.7	1.5	15.7	5.3	9.4	13.8	5.6	6.8	13.5	10.4	3.6	1.9	31.3	20.1	11.6	14.8	14.5	1.0	24.8	8.1	0.1	11.5	8.3	2.2	4.9	7.5	8.8	4.4	4.4	6.6	11.7	6.8	2.6	15.1	3.7	9.4	3.8	3.3	3.9	14.3	6.6	13.0	10.1	2.4	6.7	0.0	0.0	1.6	16.7	0.1	6.6	16.6	2.6	3.3	3.0	0.6	0.0	0.9	3.2	12.9	3.4	0.0	8.7	0.6	0.2	5.9	0.0	4.3	0.2	0.3	0.0	0.5	4.4	16.2	2.6	4.4	2.4	1.7	0.0	0.0	0.4	4.4	0.7	0.0	0.0	1.2	5.7	15.5	0.0	0.4	1.5	4.1	2.4	1.0	8.0	1.7	0.3	0.1	0.3	1.9	0.1	3.9	0.4	2.3	20.5	6.0	0.0	0.0	0.0	21.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.1	6.4	9.1	13.5	13.5	10.4	11.6	14.8	11.5	6.8	9.4	10.1	163.8	218.0	38.7	27.4	0.2	5.1	10.1	5.0	5.2	6.0	5.1	16.6	9.7	8.6	6.3	1.8	66.7	0.0	1.1	0.3	5.9	2.5	40.0	10.2	18.7	39.0	1.8	0.4	22.1	1.1	0.0	6.6	25.5	0.8	3.8	9.7	15.4	0.9	2.3	42.1	27.6	1.7	0.0	0.8	3.3	25.2	7.2	3.6	7.2	22.5	0.2	1.3	0.0	8.5	1.3	11.4	1.2	20.3	1.5	5.1	11.5	10.1	1.6	4.3	13.1	12.1	40.6	2.3	2.6	20.1	2.8	0.0	0.8	21.5	2.5	3.6
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14854038	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.2"	"Group enriched"	"Detected in some"	8	"Early spermatids: 13.1;Excitatory neurons: 32.6;Inhibitory neurons: 39.3;Late spermatids: 13.9;Spermatocytes: 23.7"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 63.1"									"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA060455: AB_2684282, HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.1	0.1	0.2	0.0	0.4	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.7	0.0	1.1	4.4	0.3	63.1	0.0	6.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.4	0.4	0.4	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.0	0.0	2.8	1.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.9	0.0	13.1	0.7	0.1	0.2	1.8	0.0	32.6	0.0	0.4	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.1	0.0	39.3	1.6	0.0	0.3	0.0	13.9	0.9	0.2	0.0	1.0	0.0	0.0	0.0	2.5	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	23.7	1.7	0.0	0.3	0.5	0.1	0.0	1.1	0.3
ANKRD31	FLJ40191	ENSG00000145700	"Ankyrin repeat domain 31"	Q8N7Z5	5	75068275-75236911	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 4.9"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 148.9;Spermatogonia: 37.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038028, HPA057566"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Nucleoli, Vesicles"	"HPA038028: AB_10672615, HPA057566: AB_2683470"	"unprognostic (1.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	4.9	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.1	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.5	5.2	0.4	0.4	0.4	0.5	0.6	3.3	0.8	1.1	1.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.3	3.6	2.8	0.8	0.1	0.0	0.8	5.8	0.2	0.6	0.4	4.1	0.4	12.0	0.5	0.4	0.0	0.1	1.7	5.4	0.0	0.0	0.0	0.0	4.7	1.5	0.1	0.0	1.0	0.1	1.3	0.0	3.0	5.6	0.1	0.1	0.4	1.3	0.0	0.1	0.3	1.2	2.2	13.1	0.6	0.4	148.9	37.7	0.4	0.1	0.3	1.1	0.7	0.1	0.2
ANKRD33	"C12orf7, DKFZp686O1689, PANKY"	ENSG00000167612	"Ankyrin repeat domain 33"	Q7Z3H0	12	51888009-51891727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 18.3"	"Group enriched"	"Detected in some"	17	"Cone photoreceptor cells: 166.8;Rod photoreceptor cells: 166.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058753	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA058753: AB_2683808"			"unprognostic (4.42e-2)"	"unprognostic (2.13e-5)"	"unprognostic (8.25e-4)"	"unprognostic (2.37e-1)"	"unprognostic (3.25e-5)"	"unprognostic (2.42e-1)"		"unprognostic (4.07e-1)"	"unprognostic (6.21e-2)"		"unprognostic (5.51e-10)"	"unprognostic (4.41e-3)"	"unprognostic (5.56e-2)"		"unprognostic (2.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.4	0.0	0.0	0.0	166.8	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0
ANKRD33B		ENSG00000164236	"Ankyrin repeat domain 33B"	A6NCL7	5	10564070-10657816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.5;retina: 50.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 350.3;Excitatory neurons: 110.4;Rod photoreceptor cells: 73.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HDLM-2: 47.0;HMC-1: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 7.7;basal ganglia: 16.2;cerebral cortex: 19.6;hippocampal formation: 16.0;olfactory bulb: 10.0"	HPA056974	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA056974: AB_2683295"	"unprognostic (6.19e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.16e-5)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.47e-2)"	2.7	0.1	5.0	2.2	6.3	9.1	1.7	0.0	12.9	2.2	0.1	2.1	0.4	4.9	0.5	1.9	3.4	0.9	4.3	20.5	0.0	5.9	0.4	1.7	3.5	0.0	0.1	0.4	1.5	0.3	0.5	2.1	0.0	1.8	1.0	50.8	0.8	2.4	4.4	6.9	2.4	3.8	0.0	7.2	1.7	1.0	0.5	7.0	0.4	8.4	4.4	3.0	3.2	4.3	4.3	6.3	0.4	0.5	14.3	6.7	18.5	1.2	2.1	2.5	2.9	7.8	3.4	23.7	20.7	4.0	3.0	4.3	2.1	2.1	2.8	47.0	1.4	9.3	5.7	0.0	6.5	7.1	29.8	3.3	1.6	1.3	8.3	0.6	3.1	1.7	2.1	11.1	0.6	0.0	0.3	8.6	4.9	0.0	1.9	1.9	4.7	0.8	8.3	3.0	0.1	0.2	0.1	0.4	0.7	15.5	0.0	8.8	9.0	1.4	9.0	7.5	2.3	12.9	15.3	2.0	0.4	11.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	6.3	0.0	12.9	20.5	0.0	0.0	0.1	0.0	0.0	0.5	4.3	1.6	12.8	1.5	9.8	14.4	0.4	2.5	0.0	2.2	26.5	0.6	0.4	5.6	4.3	0.6	3.7	350.3	1.6	0.7	0.0	1.9	1.7	6.5	14.2	20.7	2.4	0.0	2.1	110.4	0.2	0.8	8.6	0.5	24.2	0.0	0.0	3.3	0.0	0.2	6.7	24.5	0.0	0.0	0.0	0.8	0.6	1.5	4.3	1.8	6.5	15.4	10.2	0.0	5.5	1.5	0.2	0.0	0.0	30.8	7.3	0.0	18.4	0.0	73.4	0.0	7.8	6.0	0.1	3.3	6.3	1.1	0.5	2.9	2.8	0.0	2.0
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959441-145964575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 6.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.7;Excitatory neurons: 6.1;Inhibitory neurons: 5.8;Microglial cells: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.7;U-266/84: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.6	0.7	3.8	1.2	5.9	0.2	0.6	4.8	14.1	0.8	0.0	1.1	0.9	1.6	0.6	0.6	1.0	0.6	1.4	6.0	1.6	0.5	0.5	0.6	0.9	0.9	1.1	1.2	0.3	0.9	2.9	0.2	0.9	1.2	0.2	3.4	1.0	1.1	6.4	0.4	1.1	0.8	0.0	1.0	0.8	0.4	3.2	0.4	0.6	2.6	0.9	1.1	0.8	5.0	1.2	0.6	0.6	2.0	2.8	2.2	0.3	2.2	4.3	0.5	1.3	0.2	0.6	2.4	0.2	2.9	1.1	0.5	0.9	0.6	0.3	5.0	1.4	0.1	1.8	0.0	0.4	0.3	1.9	2.0	0.2	1.8	2.0	3.0	0.7	1.9	1.2	5.3	3.3	2.2	1.0	0.7	0.2	0.1	2.5	0.2	0.5	10.7	0.9	0.0	2.8	2.0	0.4	0.1	1.3	0.2	3.0	0.3	0.7	5.1	3.5	4.4	1.1	3.6	7.5	0.3	5.0	1.9	0.4	0.0	0.0	0.2	1.1	0.1	0.8	0.5	0.5	0.6	0.1	0.6	0.7	1.1	0.1	0.1	0.0	0.0	0.6	0.3	3.8	5.9	4.8	14.1	6.0	1.6	0.9	1.1	0.9	0.0	3.2	5.0	0.4	0.0	0.0	0.3	1.4	0.3	0.4	0.3	1.2	9.7	0.6	0.6	3.0	0.0	0.2	0.0	0.0	0.0	1.0	0.3	1.9	0.3	0.8	0.2	0.6	0.8	0.0	0.0	6.1	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.4	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.0	3.7	0.2	2.1	1.0	2.0	1.3	0.1	0.3	1.5	0.1	0.3	0.0	0.5	0.0	2.1	0.0	0.6	0.9	0.7	0.4	0.6	0.1	0.1	1.4	0.7	0.1	0.1
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.0;Collecting duct cells: 3.7;Enteroendocrine cells: 1.8;Inhibitory neurons: 6.0;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"thalamus: 40.7"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.0	0.0	2.8	0.4	15.8	1.7	0.0	3.4	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.4	0.7	0.0	0.1	0.9	4.0	2.4	0.0	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.2	40.7	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	97.9	0.1	0.3	0.4	0.0	0.3	0.0	0.1	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	2.8	15.8	3.4	3.6	1.1	7.4	4.0	2.4	2.0	1.6	40.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	6.0	0.0	0.0	1.2	0.0	0.7	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 60.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	4.0	1.3	8.2	1.1	7.9	0.3	4.6	7.6	9.7	20.6	6.4	6.0	0.5	5.8	1.4	24.7	6.6	1.3	2.9	7.5	8.6	0.8	2.5	2.3	0.4	8.7	9.5	4.4	0.7	0.0	2.0	0.1	8.5	6.6	0.8	1.3	11.4	2.7	8.2	60.8	2.5	2.1	8.4	0.5	3.9	1.6	9.0	0.5	1.7	3.8	6.7	7.3	20.6	7.6	0.1	0.0	0.0	0.0	2.2	9.6	0.2	1.4	3.6	0.4	1.2	0.4	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.1	2.9	0.1	3.3	0.4	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.2	0.0	0.0	3.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.5	0.0	0.0	2.1	0.0	0.7	0.8	0.1	0.0	0.3	1.1	0.3	0.0	0.2	0.7	0.1	0.7	0.2	0.5	0.7	0.7	8.2	7.9	7.6	9.7	7.5	8.6	8.7	9.5	8.5	8.4	9.0	7.6	1.6	0.0	0.0	6.8	0.3	4.6	16.8	10.2	0.0	1.1	6.3	13.5	1.5	2.8	9.5	1.8	0.0	0.1	2.2	0.0	0.0	0.0	3.5	56.4	10.9	1.3	0.0	2.7	5.6	0.4	0.1	31.2	0.5	17.2	19.1	0.0	2.2	13.9	11.0	0.0	2.1	0.0	14.2	1.2	4.6	5.9	36.4	1.1	5.4	1.0	1.1	57.7	5.2	3.0	0.6	0.1	0.0	50.8	0.4	5.3	0.0	0.1	9.8	2.7	0.0	29.5	6.4	0.1	1.0	10.4	12.4	0.3	5.5	1.1	0.0	13.6
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 93.7"	"Cell type enhanced"	"Detected in all"		"Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	16.9	10.3	30.7	4.3	31.7	3.3	13.4	32.2	58.7	36.6	45.2	11.2	7.8	6.1	3.7	69.5	11.7	6.7	27.4	31.5	31.9	14.3	26.2	9.9	4.1	33.7	32.9	29.1	17.5	1.4	21.8	15.1	32.1	35.2	9.5	93.7	31.2	5.7	30.2	14.9	6.4	4.4	33.9	7.1	9.0	11.2	34.7	5.1	23.9	13.3	7.5	10.8	29.6	32.4	12.6	1.6	1.1	5.4	7.4	4.5	4.9	4.8	3.7	3.7	6.8	2.9	3.4	4.3	2.4	8.4	6.4	4.3	6.5	6.2	4.2	12.4	0.7	2.8	5.8	8.3	3.3	2.4	7.6	1.2	6.4	3.0	3.6	23.8	3.9	2.9	5.0	8.2	9.4	2.6	2.6	12.1	1.7	1.1	8.3	0.5	1.5	13.4	4.5	1.1	7.2	12.9	3.7	4.1	14.4	4.6	4.1	2.3	5.1	6.6	5.0	4.2	5.1	13.3	5.2	2.2	20.9	2.8	6.9	0.5	3.3	8.3	4.1	3.2	3.9	6.8	3.6	6.7	2.0	6.9	2.4	3.4	1.2	3.9	3.3	3.4	4.5	2.5	30.7	31.7	32.2	58.7	31.5	31.9	33.7	32.9	32.1	33.9	34.7	32.4	39.3	22.4	28.7	9.1	104.2	59.4	41.8	197.9	42.7	29.9	66.9	92.3	1.8	11.5	257.6	9.2	29.2	25.0	69.8	93.8	25.4	25.2	6.2	271.9	18.9	44.7	119.9	8.4	8.0	23.3	43.0	28.6	142.2	96.5	61.7	7.7	12.1	25.8	15.4	10.1	7.9	186.6	89.5	8.1	170.2	3.2	9.3	53.3	142.3	12.2	17.7	99.8	1.0	4.0	4.6	32.3	53.3	11.7	223.5	38.5	60.9	31.5	263.3	115.2	6.6	27.3	38.7	32.1	28.4	54.0	48.2	84.4	65.8	7.4	50.8	20.2
ANKRD39	MGC41816	ENSG00000213337	"Ankyrin repeat domain 39"	Q53RE8	2	96836611-96858016	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 263.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042678	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA042678: AB_10794532"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (9.53e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.12e-3)"	"prognostic favorable (6.12e-5)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (6.78e-9)"	"unprognostic (3.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.21e-4)"	6.8	14.1	13.1	7.2	13.4	10.5	7.3	15.9	18.7	6.9	8.9	11.0	8.3	10.2	2.9	7.5	10.2	5.9	14.9	13.2	13.2	7.9	14.8	6.2	11.0	13.0	12.5	6.6	8.3	12.3	16.0	5.5	13.4	8.2	4.0	5.3	7.4	6.8	7.9	8.7	7.4	6.2	12.3	9.7	8.3	4.1	12.5	7.4	5.8	4.5	6.5	8.5	6.8	14.5	24.0	15.7	8.8	19.2	2.9	5.7	21.1	18.1	8.4	22.5	17.3	38.8	9.9	15.2	26.4	13.2	17.7	10.3	11.2	17.3	5.0	17.6	34.1	11.0	14.4	53.5	14.8	24.9	25.6	11.0	10.2	20.5	7.9	8.4	16.3	31.1	23.5	263.1	8.4	37.9	23.3	19.5	11.1	8.1	35.8	17.8	6.2	85.3	11.8	12.3	20.3	13.3	13.1	30.6	23.7	8.0	9.3	13.5	8.2	14.0	13.8	16.0	32.5	13.4	16.2	25.3	14.0	28.5	14.9	20.1	16.0	13.4	44.4	20.8	37.7	41.6	43.6	39.3	16.6	33.2	24.0	29.2	8.3	37.6	23.5	70.4	71.0	21.1	13.1	13.4	15.9	18.7	13.2	13.2	13.0	12.5	13.4	12.3	12.5	14.5	14.0	6.4	8.9	2.6	16.9	9.4	17.2	25.7	9.1	25.2	14.9	23.2	19.5	18.6	17.6	9.2	4.2	44.9	28.1	15.1	25.4	28.8	6.1	18.1	18.7	12.9	18.6	13.5	4.6	32.0	38.6	14.9	11.7	11.8	12.7	12.7	10.8	32.0	31.6	33.7	5.3	19.9	18.3	11.1	10.4	2.9	12.5	13.8	28.4	1.0	9.3	15.9	37.0	4.5	5.9	41.3	11.3	14.7	26.2	12.5	23.4	29.4	35.0	29.8	26.3	24.9	18.8	13.6	14.3	18.9	17.8	21.6	24.4	33.5	16.9	15.7
ANKRD40	MGC15396	ENSG00000154945	"Ankyrin repeat domain 40"	Q6AI12	17	50693198-50707914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021668, HPA021759, HPA074884"	Uncertain		Approved	"Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center, Cytosol"	"HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: "	"unprognostic (2.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	42.8	19.7	126.7	15.5	163.3	7.8	25.7	130.4	159.3	20.6	63.4	32.0	11.8	23.8	13.7	18.4	19.4	16.2	27.6	98.5	115.4	17.8	17.8	22.5	16.6	150.3	152.4	20.6	19.4	26.9	10.8	23.1	142.2	18.3	16.3	20.7	15.0	24.7	107.0	14.4	16.3	27.9	141.3	20.5	18.7	10.3	135.2	16.9	16.9	84.0	14.4	25.3	16.9	164.8	41.1	38.6	34.2	34.6	48.2	39.8	29.9	36.2	39.5	41.3	38.7	82.6	20.5	43.3	49.2	46.4	44.3	22.8	49.3	29.4	66.8	40.0	31.7	59.1	25.1	40.7	26.4	41.6	24.0	34.3	29.5	40.3	50.1	30.2	32.9	35.1	34.0	42.3	34.4	32.0	52.2	15.1	38.0	33.0	36.1	35.2	61.9	30.8	32.5	34.8	18.1	50.5	20.2	27.2	39.6	59.1	31.4	27.4	40.4	55.8	44.1	29.2	46.7	44.3	43.4	38.3	30.6	15.9	46.4	7.4	7.0	3.1	10.9	11.2	12.5	9.8	12.0	12.3	7.1	9.2	11.1	13.4	1.8	10.7	12.3	14.2	9.3	4.6	126.7	163.3	130.4	159.3	98.5	115.4	150.3	152.4	142.2	141.3	135.2	164.8	39.0	16.0	11.4	11.4	13.9	45.0	24.2	6.1	11.4	14.3	19.8	11.7	31.7	12.8	4.9	18.4	4.2	14.9	19.9	13.5	27.4	16.6	1.8	10.4	20.3	31.4	6.0	7.4	16.0	17.5	18.9	19.6	5.6	16.1	9.5	14.3	32.9	21.9	19.0	35.3	15.6	12.3	6.1	32.4	25.1	3.1	34.2	16.3	26.6	11.2	13.2	19.6	8.2	12.1	32.2	19.9	8.4	37.6	4.5	30.5	9.6	24.8	5.0	12.0	46.0	39.1	27.3	17.5	21.1	10.4	33.2	10.7	15.7	9.7	12.8	24.1
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193712-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.2	13.3	8.0	5.2	8.9	9.0	6.0	4.3	11.8	7.4	15.8	5.8	5.2	6.0	19.7	4.8	15.8	7.6	5.3	11.6	14.3	11.1	4.7	6.6	3.8	10.0	9.2	8.7	5.9	12.3	13.1	3.9	7.9	7.2	4.2	17.8	6.0	7.4	2.7	5.5	4.9	5.3	7.6	4.5	6.2	37.2	10.7	2.8	11.8	2.2	4.1	7.3	5.5	8.2	5.6	9.7	4.7	9.5	14.3	15.0	4.1	11.4	8.8	6.7	4.1	5.9	6.8	2.2	14.1	10.3	13.4	11.9	5.0	7.8	5.5	3.2	3.7	4.0	14.5	4.0	10.0	11.6	9.0	8.9	8.8	17.0	8.9	12.3	7.0	4.0	12.0	2.0	9.8	7.9	1.7	12.2	3.9	8.8	6.1	2.7	6.5	2.8	21.8	6.6	3.7	4.9	14.9	9.2	2.9	6.1	13.9	6.2	10.2	10.2	7.1	37.1	5.4	2.9	7.1	4.5	7.9	6.7	4.3	5.7	2.6	3.2	2.9	3.0	1.9	5.0	2.5	2.9	3.5	3.8	1.2	2.0	2.0	4.4	8.0	1.4	1.1	1.7	8.0	8.9	4.3	11.8	11.6	14.3	10.0	9.2	7.9	7.6	10.7	8.2	7.6	9.6	16.0	7.5	8.5	11.2	21.5	6.5	4.0	3.9	11.9	9.8	7.8	8.6	8.0	7.3	39.6	3.1	7.1	5.2	9.8	7.7	170.5	53.1	21.9	8.5	3.0	2.1	33.3	6.7	3.3	13.0	7.7	15.4	13.9	7.8	9.3	4.8	5.0	1.7	27.3	3.1	12.2	7.2	9.9	63.2	8.7	8.8	7.2	7.5	7.3	7.4	2.1	4.5	2.9	5.7	4.9	10.5	4.7	10.6	5.8	14.8	61.6	22.4	13.1	16.6	9.0	55.5	17.3	4.7	15.3	5.5	9.1	14.5	3.9	11.5
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 153.3;Microglial cells: 390.7;NK-cells: 146.2;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 199.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.4;HMC-1: 33.8;Karpas-707: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nuclear speckles"	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"	5.8	6.4	8.0	24.6	10.8	17.4	4.1	8.9	9.3	8.1	5.7	5.8	3.8	4.9	2.8	3.2	3.8	8.4	4.2	6.8	10.4	3.3	4.9	11.6	36.5	12.7	10.8	3.2	3.7	4.1	3.9	7.6	13.2	4.4	5.5	3.3	4.0	5.0	2.2	3.6	11.5	6.1	10.0	23.0	6.8	5.7	11.7	28.3	3.2	2.2	33.2	6.8	6.2	14.6	1.9	1.1	2.8	2.9	6.2	2.5	0.6	4.1	1.8	2.1	1.9	0.7	1.0	15.4	1.9	3.5	3.9	0.2	1.0	0.8	1.7	46.4	3.7	0.5	5.6	0.3	0.4	11.4	33.8	1.3	0.5	2.1	0.1	3.1	2.9	3.8	2.6	25.1	3.2	2.6	5.4	9.7	0.4	0.6	2.8	9.7	3.1	20.3	5.4	1.4	2.8	12.2	1.4	1.0	12.0	2.1	1.5	11.0	15.0	7.1	4.2	2.2	3.0	6.2	8.0	19.6	5.0	14.0	4.5	55.0	19.6	45.3	24.5	19.5	23.3	23.5	18.2	21.3	19.2	28.6	20.9	25.2	68.7	25.0	25.2	12.6	19.0	15.1	8.0	10.8	8.9	9.3	6.8	10.4	12.7	10.8	13.2	10.0	11.7	14.6	8.4	16.0	23.9	79.7	153.3	3.4	4.5	0.4	2.2	9.9	4.4	3.9	9.3	20.0	8.0	11.0	4.2	5.9	90.6	0.6	1.9	4.0	14.0	10.7	6.7	10.2	2.4	12.8	32.6	4.6	0.8	9.7	8.2	15.5	53.8	4.8	49.2	8.9	18.5	3.3	126.4	1.9	0.0	64.2	34.9	17.5	15.5	72.5	37.4	390.7	84.1	8.0	146.2	174.9	199.5	5.0	2.6	17.7	70.4	3.9	2.9	1.5	10.6	10.4	19.7	15.5	16.4	2.9	3.4	5.2	3.7	1.4	123.0	4.3	1.8	4.9
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173608336-173669851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 6.7;choroid plexus: 14.3;fallopian tube: 12.7;parathyroid gland: 9.3;testis: 11.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7"									"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.2	0.6	2.8	0.0	5.4	0.2	0.1	1.9	2.5	1.3	14.3	0.2	0.0	1.6	0.7	0.0	12.7	0.3	0.4	4.3	2.8	1.3	0.0	1.2	0.0	5.2	6.7	0.7	0.3	9.3	1.8	0.0	3.9	0.8	0.1	2.6	0.0	0.3	0.2	0.0	0.0	1.1	3.3	0.4	0.1	11.0	3.8	0.2	0.5	0.0	0.0	0.1	0.1	4.0	0.0	0.0	5.5	0.0	0.0	0.3	0.1	0.0	2.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	5.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	5.4	1.9	2.5	4.3	2.8	5.2	6.7	3.9	3.3	3.8	4.0	0.2	0.0	1.7	12.4	0.0	0.3	0.3	1.1	0.0	0.7	0.1	0.4	0.9	0.0	1.5	5.5	37.5	0.2	0.0	0.3	1.9	0.6	48.8	23.7	1.3	1.3	0.0	0.0	4.6	0.5	0.3	0.4	0.0	0.6	0.0	1.1	3.3	0.0	0.1	0.0	4.1	0.0	6.1	0.0	0.0	16.8	1.8	0.2	0.0	2.8	0.0	3.3	0.0	0.5	3.2	0.1	0.0	0.4	0.0	0.2	0.0	0.4	31.8	1.7	0.0	0.1	0.8	54.9	7.9	0.0	0.0	0.1	0.0	5.5	0.4	0.1
ANKRD46		ENSG00000186106	"Ankyrin repeat domain 46"	Q86W74	8	100509752-100559784	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013758	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA013758: AB_10962626"	"unprognostic (3.71e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-3)"	19.2	38.7	29.1	8.4	30.2	2.2	14.6	25.1	33.6	15.1	15.6	9.2	10.2	12.7	16.3	12.7	11.4	7.7	20.1	30.1	25.8	32.7	41.6	10.7	9.9	22.3	22.2	22.6	18.5	16.1	10.3	20.8	24.4	13.5	9.1	35.2	17.1	13.2	62.2	11.2	11.0	12.4	24.9	11.1	11.6	8.3	24.0	15.4	20.0	36.2	10.9	9.5	9.9	28.7	10.0	12.2	17.9	10.1	13.6	8.0	20.0	12.8	5.8	9.6	8.1	17.8	5.9	31.2	23.3	4.4	3.1	7.5	18.5	9.5	10.1	11.2	16.3	39.0	6.4	14.1	7.7	9.3	4.7	5.8	17.1	6.1	10.2	10.3	11.9	21.4	20.8	9.9	9.3	11.4	43.3	16.8	13.1	25.6	9.0	33.1	6.0	21.0	14.1	10.6	19.8	20.1	5.5	9.9	8.5	21.5	14.8	15.7	9.0	4.4	4.9	6.5	5.1	23.0	23.8	25.7	4.8	29.6	7.2	16.4	7.3	7.6	14.4	3.7	17.1	12.7	13.5	12.4	9.6	11.1	17.5	15.2	1.8	16.9	6.8	8.8	13.8	10.9	29.1	30.2	25.1	33.6	30.1	25.8	22.3	22.2	24.4	24.9	24.0	28.7	11.5	6.4	3.9	17.9	14.2	10.8	11.3	9.0	19.4	30.1	10.7	7.4	13.1	12.8	4.8	22.0	18.8	32.1	12.2	5.7	29.4	8.3	1.2	4.6	6.7	12.5	7.3	12.2	41.5	6.0	14.1	11.9	9.7	4.7	4.5	13.8	21.8	34.6	11.4	67.3	36.9	7.6	2.0	6.7	9.3	2.2	21.1	4.0	10.6	24.4	8.1	46.4	10.3	24.1	23.4	3.3	9.1	26.4	13.8	10.5	20.3	61.8	6.5	31.5	26.3	15.1	12.8	14.4	17.2	13.9	14.2	23.4	9.3	11.9	8.5	9.6
ANKRD49	"FGIF, FLJ20189, GBIF"	ENSG00000168876	"Ankyrin repeat domain 49"	Q8WVL7	11	94493979-94499578	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040273, HPA048137"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA040273: AB_10674991, HPA048137: AB_2680279"	"unprognostic (1.52e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.46e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (6.32e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.40e-2)"	"prognostic favorable (6.16e-4)"	7.8	6.8	8.3	12.7	8.9	25.2	13.1	11.1	11.4	9.7	8.2	10.8	11.4	10.4	18.3	9.5	8.5	8.4	5.3	8.3	8.4	7.8	8.6	7.5	20.8	8.2	7.7	12.6	13.4	9.3	8.9	12.1	8.0	10.9	13.6	11.8	10.7	10.8	5.8	10.2	16.2	8.8	7.8	15.6	12.7	5.4	9.3	17.1	14.2	7.3	20.8	7.9	8.5	9.5	8.9	4.4	11.0	9.4	10.2	12.0	13.5	13.3	12.0	14.9	17.1	20.7	18.4	23.4	20.9	8.5	12.5	20.5	14.0	9.8	12.2	17.9	12.1	18.9	16.8	7.8	11.1	17.8	15.8	9.1	23.1	10.7	14.9	10.4	11.3	20.9	18.4	14.4	9.4	6.1	19.8	32.8	6.3	17.5	9.8	14.9	11.3	12.0	12.9	9.2	10.5	10.9	10.2	9.8	8.7	18.4	18.0	12.9	7.5	13.0	9.3	13.8	7.2	7.6	20.0	24.6	4.4	21.8	7.4	77.8	23.1	23.9	21.9	19.5	23.7	34.1	23.4	19.4	18.4	28.8	28.4	25.9	42.7	27.2	15.8	30.5	31.4	17.8	8.3	8.9	11.1	11.4	8.3	8.4	8.2	7.7	8.0	7.8	9.3	9.5	20.5	12.8	9.3	11.1	43.2	5.6	10.0	15.1	14.2	16.3	14.0	11.3	9.1	24.3	15.4	25.8	14.6	31.1	36.1	27.8	21.5	20.3	10.1	11.9	18.1	15.4	13.3	40.0	11.1	23.0	13.8	16.5	27.0	15.1	21.5	18.7	16.4	18.8	14.3	11.8	9.5	23.6	8.2	28.5	8.4	3.7	35.8	18.5	10.6	8.4	28.1	21.8	57.7	5.5	12.7	22.8	35.2	23.7	28.0	11.3	45.3	19.3	8.1	14.4	26.3	11.3	18.4	21.0	19.9	11.6	6.8	28.0	36.5	9.8	22.0	5.8
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664048-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	6.0	2.6	3.2	4.2	4.5	4.5	5.7	1.3	3.1	11.4	2.6	4.7	3.1	7.6	2.5	6.4	2.8	8.5	5.0	3.7	6.2	4.4	5.8	9.6	2.3	4.3	4.2	6.5	3.3	5.7	1.0	14.8	3.8	8.9	5.6	1.8	3.9	6.2	1.4	11.0	3.9	8.9	2.1	3.1	7.4	15.1	7.2	4.6	7.4	3.6	1.9	14.2	5.6	2.0	6.3	11.6	32.0	14.9	25.0	15.8	3.2	15.9	13.4	8.1	5.2	5.0	8.1	0.0	4.8	22.8	7.3	5.7	21.3	12.3	14.1	0.0	4.6	5.3	15.3	5.0	17.8	8.8	6.6	16.0	16.4	12.8	56.8	15.2	58.2	5.7	9.6	11.0	15.5	14.3	11.1	3.2	6.7	9.2	16.9	9.0	9.9	1.4	10.2	25.7	9.2	11.5	11.0	6.9	12.9	13.3	7.4	7.4	147.7	17.1	13.3	8.5	13.8	8.0	0.1	2.1	7.8	3.7	20.0	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.0	0.1	3.2	4.5	1.3	3.1	3.7	6.2	4.3	4.2	3.8	2.1	7.2	2.0	18.3	32.1	24.6	10.7	0.9	40.4	21.7	17.9	24.5	2.8	12.2	7.1	9.0	12.8	12.5	5.5	0.0	2.9	2.7	7.3	0.0	9.3	41.0	6.6	14.2	21.5	8.4	5.0	15.1	20.1	29.0	16.5	11.7	7.7	5.1	20.4	29.6	8.8	5.3	21.9	42.2	3.7	18.3	13.4	13.0	55.6	6.8	12.6	10.6	30.9	12.8	2.7	0.0	30.7	13.4	15.1	2.8	12.0	0.6	11.7	3.7	4.7	11.0	0.9	0.0	10.9	17.5	17.2	11.2	33.0	30.7	4.1	1.2	33.7	5.3	18.0
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	8.4	21.5	10.9	9.8	11.3	9.6	8.7	9.3	12.9	11.9	4.9	12.3	8.4	12.4	5.7	10.5	11.0	6.1	12.9	9.6	13.3	11.6	7.9	9.4	9.2	17.7	16.2	12.9	12.9	19.8	13.2	7.1	21.4	11.2	8.1	9.6	10.9	7.9	25.0	11.2	12.8	11.0	9.2	10.9	10.5	7.4	15.4	8.8	11.2	17.0	9.6	12.0	9.8	10.3	24.7	58.5	25.9	47.4	20.7	16.2	18.2	48.1	20.9	42.1	18.9	39.0	13.4	26.1	29.9	47.3	14.8	31.5	29.0	21.0	24.2	25.3	29.1	46.9	38.6	15.0	14.3	37.3	26.2	16.7	23.2	39.0	19.7	30.9	24.8	21.1	19.6	13.8	40.1	34.2	30.0	12.3	10.9	16.1	27.4	23.4	17.8	10.4	27.7	30.0	19.6	17.8	52.2	33.1	18.9	19.9	26.5	14.3	34.4	43.4	38.1	24.7	30.4	12.7	18.0	12.4	45.0	12.2	29.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	11.3	9.3	12.9	9.6	13.3	17.7	16.2	21.4	9.2	15.4	10.3	4.1	6.4	5.3	9.1	7.8	11.2	3.6	8.4	10.2	5.0	9.1	6.9	6.7	4.3	4.3	12.9	27.1	5.8	7.9	12.6	0.0	10.4	0.5	5.8	9.7	5.7	9.6	5.5	12.8	9.5	7.4	5.4	8.2	9.0	1.3	8.6	6.8	6.5	7.0	8.4	12.5	6.6	20.3	7.1	7.5	1.1	6.2	4.8	10.6	7.5	4.6	3.4	7.2	7.5	8.4	15.7	7.0	4.9	8.7	5.7	9.2	6.4	4.2	6.0	0.0	5.6	7.6	6.4	8.8	10.0	10.9	3.7	6.0	5.5	8.9	4.4
ANKRD53	"FLJ12056, FLJ36160"	ENSG00000144031	"Ankyrin repeat domain 53"	Q8N9V6	2	70978380-70985499	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.5"	"Group enriched"	"Detected in many"	21	"Early spermatids: 158.6;Late spermatids: 481.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;HHSteC: 1.6;HSkMC: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049574	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049574: AB_2680819"	"unprognostic (6.11e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	7.5	1.7	0.3	0.6	0.2	0.3	6.1	1.5	0.5	1.8	0.0	1.9	0.7	1.8	0.4	0.7	3.0	0.7	1.3	0.3	0.2	0.8	0.6	1.3	0.3	0.8	0.4	4.1	8.2	0.3	3.2	0.3	0.2	2.0	0.2	6.1	4.5	0.6	0.4	0.8	1.7	0.6	0.3	0.8	2.0	27.5	0.1	0.1	3.1	0.3	0.3	1.6	1.6	0.2	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.4	0.4	0.4	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	1.6	0.0	0.4	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.3	0.2	1.5	0.5	0.3	0.2	0.8	0.4	0.2	0.3	0.1	0.2	1.1	0.0	0.0	0.3	1.1	0.1	1.4	0.5	4.6	1.3	0.3	1.3	0.4	1.5	0.1	0.0	2.1	0.1	1.0	0.0	0.0	1.2	158.6	4.3	0.5	0.7	0.0	0.4	0.4	0.4	1.0	1.9	1.1	2.2	0.0	0.4	1.1	0.2	0.0	1.7	1.2	0.0	0.0	0.0	0.4	481.3	3.4	0.4	0.0	0.0	0.0	4.1	0.0	1.5	0.3	0.5	0.0	3.0	11.7	0.7	0.1	1.5	0.6	15.1	6.6	2.8	1.5	1.5	1.7	0.6	0.0	0.3	0.4	0.1	0.1	0.1
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	8.6	18.7	22.4	5.9	20.8	6.9	9.1	22.6	23.3	13.0	28.7	16.4	7.1	12.9	7.8	14.0	23.8	6.3	12.4	23.0	26.2	14.9	15.6	8.4	6.4	22.6	24.7	17.8	18.1	11.7	19.2	5.4	21.6	13.7	6.6	6.3	13.9	11.0	12.6	11.3	8.9	9.5	22.0	9.2	10.9	30.9	26.1	10.4	13.8	8.7	7.2	14.0	10.9	20.3	18.5	18.6	15.4	23.0	19.9	11.3	8.1	24.8	19.2	41.1	25.2	11.8	7.3	17.8	10.1	16.5	13.3	16.4	19.5	14.1	19.9	14.2	39.5	9.3	17.3	28.3	17.7	17.8	20.8	10.1	14.2	22.6	13.3	10.3	25.5	13.1	11.9	12.7	19.1	19.8	17.6	21.1	4.4	24.5	16.5	20.2	18.3	11.3	23.2	6.4	26.4	14.1	20.7	18.8	30.8	7.0	19.3	28.0	15.1	24.5	25.6	12.9	18.6	13.3	11.7	14.3	20.1	15.1	17.9	3.5	4.5	2.2	5.4	5.5	5.4	3.9	5.1	4.0	5.7	5.2	5.3	2.6	2.7	10.2	9.3	5.3	2.4	3.3	22.4	20.8	22.6	23.3	23.0	26.2	22.6	24.7	21.6	22.0	26.1	20.3	8.4	12.8	14.5	11.8	14.4	15.8	11.0	12.4	12.0	18.3	16.9	15.6	8.1	24.3	12.2	18.4	29.2	20.9	14.0	19.9	39.2	17.1	6.4	47.8	12.6	10.9	9.0	12.8	9.4	14.7	17.7	12.3	12.2	8.5	9.5	23.3	13.6	12.0	13.2	26.9	9.4	14.3	12.2	12.5	10.7	7.7	18.0	8.8	10.6	2.8	9.2	18.5	17.5	13.6	8.6	11.3	15.3	21.4	8.4	11.4	19.2	22.0	48.2	23.2	6.6	13.1	13.4	65.6	42.1	12.7	17.6	16.8	13.3	25.4	20.7	9.9
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099680-56233330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.3;liver: 3.1;lymphoid tissue: 3.6;testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8"	"Group enriched"	"Detected in many"	74	"granulocytes: 22.9;T-cells: 19.8"	"Group enriched"	"Detected in some"	6	"HEL: 34.4;HMC-1: 17.1;NB-4: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.4	0.1	2.2	0.7	3.0	0.7	0.1	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.9	8.3	0.4	3.1	0.3	3.6	4.1	4.6	0.1	0.0	0.0	0.2	0.6	5.2	0.0	0.2	0.4	1.0	0.0	0.0	0.4	1.3	0.1	3.3	1.6	0.3	9.8	7.8	3.2	0.2	0.0	2.0	0.3	0.1	0.9	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.2	1.3	0.0	1.6	17.1	0.0	0.1	0.0	0.0	0.1	4.2	0.1	2.9	1.1	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.7	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.0	0.4	22.9	0.2	20.7	0.1	0.1	0.0	0.0	4.3	0.0	0.1	0.0	19.8	0.8	2.0	0.0	0.1	0.0	1.0	2.8	2.2	3.0	0.0	2.4	0.9	8.3	4.1	4.6	5.2	3.3	7.8	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	161.3	0.4	0.8	2.2	0.0	0.0	1.3	0.2	0.3	0.6	0.5	7.5	2.5	0.1	41.7	0.6	0.7	0.0	103.5	0.0	0.0	3.2	1.9	29.1	0.6	1.4	1.8	1.0	0.9	0.9	3.1	18.6	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	59.3	0.6	0.0	0.0	1.2	3.9	0.5	0.0	0.2
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433152-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.3;Granulosa cells: 53.9;Inhibitory neurons: 54.3;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BEWO: 44.9;HAP1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310"	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.5	1.8	15.3	2.6	16.5	1.4	3.6	24.7	14.8	5.0	10.5	2.8	0.7	5.2	1.8	4.1	9.1	4.7	7.8	13.6	17.6	4.9	4.1	4.9	2.3	11.2	9.7	12.8	3.8	6.5	3.4	3.7	9.5	2.6	0.9	3.0	5.1	1.7	3.8	1.6	1.5	4.0	8.8	1.8	2.2	5.3	26.7	3.8	4.7	3.1	1.7	3.5	2.8	6.7	0.0	2.0	15.1	6.6	0.1	0.7	44.9	0.2	0.2	0.1	1.0	0.5	1.2	0.0	1.5	0.0	7.0	0.0	15.2	8.2	0.6	0.1	10.0	5.5	0.0	0.5	0.2	0.0	2.0	1.0	2.3	0.0	0.0	0.0	1.6	1.4	0.4	3.6	0.0	1.9	0.2	0.6	4.4	0.6	1.5	5.7	0.0	0.0	2.9	8.0	9.5	3.6	1.2	10.7	4.6	9.0	3.1	3.5	0.0	2.3	0.9	0.2	1.3	0.5	0.1	0.0	0.4	0.0	1.8	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	15.3	16.5	24.7	14.8	13.6	17.6	11.2	9.7	9.5	8.8	26.7	6.7	6.8	16.0	19.4	35.3	1.6	0.9	5.6	4.7	10.2	0.9	4.4	4.6	5.7	11.5	6.4	1.8	12.5	3.6	1.3	0.1	11.7	5.9	2.6	12.0	2.9	5.7	1.8	1.7	23.8	11.2	10.8	7.2	5.6	3.9	10.8	53.9	5.0	2.8	2.6	0.0	54.3	0.0	8.2	2.6	2.1	6.1	9.6	2.5	3.6	25.3	2.9	7.2	3.1	32.6	6.6	5.1	0.1	27.8	4.0	2.5	0.0	4.1	8.2	1.7	6.6	3.4	5.2	5.3	5.3	4.3	1.1	1.9	1.5	4.3	0.0	4.9
ANKRD60	"bA196N14.3, C20orf86"	ENSG00000124227	"Ankyrin repeat domain 60"	Q9BZ19	20	58218495-58228653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.6"	"Group enriched"	"Detected in some"	25	"Early spermatids: 3.7;Late spermatids: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060561	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA060561: AB_2684318"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.9	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036552	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"bone marrow: 6.1;testis: 5.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 58.5;Late spermatids: 23.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.4	0.4	0.2	0.6	0.3	6.1	0.5	1.2	0.4	0.4	0.8	0.4	0.5	0.4	0.0	0.3	0.4	0.2	0.4	0.1	0.4	0.2	0.4	0.4	0.8	0.4	0.3	0.5	0.7	0.0	0.4	0.4	0.6	0.3	0.0	0.7	0.6	0.0	0.5	1.2	0.6	0.1	0.1	0.7	0.6	5.6	0.5	0.1	0.6	0.2	0.0	0.3	0.4	1.1	1.4	3.4	1.2	1.7	0.2	0.1	1.6	0.9	0.2	0.3	0.3	1.7	3.5	0.7	0.3	0.1	1.6	1.3	0.6	0.0	0.3	0.2	0.4	1.0	9.3	0.2	0.1	1.0	1.5	0.2	0.7	0.3	0.6	0.8	0.3	1.1	1.2	1.0	0.4	2.3	0.2	1.1	0.6	0.3	0.4	1.0	0.3	0.2	0.3	1.7	0.8	1.5	0.9	1.0	0.1	1.7	1.7	0.6	0.7	1.4	2.9	1.7	1.0	0.9	1.1	0.5	0.4	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.4	0.1	0.4	0.4	0.3	0.6	0.1	0.5	1.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	58.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.9	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.7	0.0	0.0	0.4	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.0;Glandular and luminal cells: 88.4;Respiratory ciliated cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"myeloid DC: 3.5;plasmacytoid DC: 7.8"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 7.8"	"Group enriched"	"Detected in some"	8	"Hep G2: 35.9;RT4: 34.5;SCLC-21H: 46.3"	"Not detected"	"Not detected"							HPA065720	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	6.0	1.0	24.6	3.2	29.5	0.2	10.3	25.6	25.9	8.8	18.5	14.2	2.3	7.6	5.9	15.6	36.7	2.9	4.1	22.0	25.2	6.0	1.5	11.2	9.1	31.0	28.5	8.5	15.2	1.4	2.3	6.9	29.4	19.9	1.7	2.5	16.1	21.9	3.1	7.0	6.3	4.0	24.0	1.6	9.9	7.3	25.7	7.8	4.3	3.3	7.2	21.1	9.4	34.8	1.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.9	0.0	4.5	0.3	4.3	0.0	0.5	0.4	0.0	0.0	35.9	0.8	0.1	0.0	0.4	5.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	0.1	0.0	0.3	4.6	0.0	0.0	34.5	46.3	0.5	0.2	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.2	24.6	29.5	25.6	25.9	22.0	25.2	31.0	28.5	29.4	24.0	25.7	34.8	11.8	22.4	29.0	5.5	0.1	2.2	12.9	14.1	13.1	8.5	5.9	32.5	0.7	14.3	20.1	1.8	0.0	26.0	0.0	0.0	9.8	19.0	0.0	65.0	20.5	11.7	1.8	2.7	4.4	30.7	0.8	13.3	3.1	88.4	8.8	2.9	1.4	0.8	2.2	8.4	2.0	0.0	14.2	1.0	3.3	0.9	20.8	1.5	3.6	1.0	1.2	16.6	0.0	3.5	20.5	11.0	0.1	29.0	0.1	6.3	0.0	0.5	51.8	3.1	0.0	25.7	3.6	0.3	0.3	10.7	3.1	16.8	1.1	0.7	0.0	10.8
ANKRD9		ENSG00000156381	"Ankyrin repeat domain 9"	Q96BM1	14	102501767-102509799	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 112.0;skeletal muscle: 154.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 198.8;Early spermatids: 161.0;Erythroid cells: 146.5;Proximal enterocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055985	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055985: AB_2682996"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.17e-7)"	"unprognostic (3.89e-1)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.15e-1)"	12.1	21.1	29.0	3.0	20.8	18.1	10.4	22.2	43.1	10.5	27.4	30.7	50.3	7.6	1.9	19.5	6.9	4.6	112.0	19.0	17.5	24.2	16.0	15.9	0.8	36.4	24.3	10.2	11.4	8.8	7.4	5.0	27.4	20.1	10.0	2.4	26.1	4.1	154.7	25.6	32.7	2.4	27.4	9.2	22.5	40.6	37.3	0.4	11.2	26.4	1.7	12.9	15.0	15.3	16.0	7.5	13.3	12.6	13.6	5.6	20.8	18.7	7.0	8.3	8.1	1.9	10.5	0.0	20.5	5.2	9.2	25.8	6.5	3.8	4.2	11.3	26.7	4.2	14.7	3.6	7.0	1.5	13.5	2.8	22.6	4.5	4.5	5.4	3.6	2.1	8.2	1.4	4.0	14.0	2.2	4.4	6.3	24.6	33.5	21.5	12.5	1.0	8.5	16.2	10.8	11.5	13.3	8.6	24.4	7.8	13.1	6.0	8.3	8.4	10.9	41.4	14.7	11.9	6.9	0.5	9.9	2.9	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	29.0	20.8	22.2	43.1	19.0	17.5	36.4	24.3	27.4	27.4	37.3	15.3	10.8	19.2	4.5	41.4	2.7	13.0	37.5	1.5	6.8	11.0	32.3	22.5	40.3	15.7	5.0	14.7	2.1	9.7	30.4	198.8	92.0	3.9	161.0	11.4	6.4	9.8	16.7	146.5	12.6	4.8	30.5	13.5	34.7	21.5	31.8	20.1	8.6	11.8	29.5	16.8	14.1	42.5	2.0	7.5	7.8	23.9	5.6	25.4	10.6	5.6	0.7	16.8	2.1	4.0	3.4	5.3	73.7	9.8	10.2	37.8	129.2	16.7	1.1	7.7	13.1	26.8	10.8	6.6	6.7	14.1	20.2	18.3	9.3	18.3	56.7	54.8
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889255-35091406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Inhibitory neurons: 160.5;Microglial cells: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	15.0	19.1	15.2	8.0	13.9	5.7	15.0	16.4	15.8	10.9	13.8	29.0	10.5	10.7	7.4	15.4	20.1	10.0	18.6	12.7	13.4	13.1	10.7	18.8	9.3	15.6	17.0	17.4	9.4	16.4	8.4	27.8	17.4	11.7	9.0	22.9	9.2	15.4	20.1	15.6	14.3	14.3	14.0	23.0	14.8	16.5	22.1	7.6	13.8	9.5	5.7	27.2	13.1	11.9	15.4	7.3	14.8	14.2	6.5	6.4	22.3	6.0	6.7	7.2	8.7	18.4	9.7	10.4	10.0	6.4	13.1	15.7	17.4	17.6	8.3	8.0	21.9	7.3	9.2	13.7	4.0	11.8	6.7	7.4	14.9	9.3	12.3	7.7	15.9	10.7	12.6	4.4	6.4	10.0	7.4	12.8	10.7	20.3	8.4	8.9	8.3	10.6	14.5	27.9	58.5	14.8	10.3	14.1	43.7	18.1	11.1	13.0	13.9	7.3	9.2	7.6	8.9	6.7	10.9	5.5	5.6	16.8	20.3	0.0	0.6	0.5	0.2	0.9	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.2	1.1	0.2	1.5	1.1	0.3	0.4	15.2	13.9	16.4	15.8	12.7	13.4	15.6	17.0	17.4	14.0	22.1	11.9	48.2	80.1	11.4	54.2	4.4	12.1	9.1	4.2	4.0	28.8	11.3	14.4	25.3	11.5	8.3	12.9	64.6	8.9	5.5	17.2	0.0	7.3	12.7	32.1	7.4	31.7	13.2	5.7	94.0	5.9	7.5	10.0	13.3	35.6	2.5	17.2	47.5	6.6	11.9	8.4	160.5	11.0	18.3	29.2	10.9	11.3	12.8	18.9	5.4	168.6	8.1	21.7	10.3	90.5	75.9	10.2	7.6	30.1	6.4	13.3	10.0	7.0	29.0	45.4	19.7	10.3	13.5	6.9	5.9	8.5	20.5	12.4	4.8	5.9	9.2	14.9
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 77.0;skeletal muscle: 34.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 2224.0;Inhibitory neurons: 1545.5;Oligodendrocyte precursor cells: 1318.0;Oligodendrocytes: 1000.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;ASC TERT1: 5.8;SCLC-21H: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078230	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	1.6	3.6	36.2	0.7	50.4	0.1	2.7	40.2	77.0	2.9	0.0	4.0	0.5	2.3	1.4	2.9	3.6	1.2	1.4	51.8	5.2	4.6	1.1	1.0	0.6	0.0	7.9	8.9	1.1	0.8	10.1	1.8	2.0	3.1	1.0	6.2	3.1	2.7	34.2	1.0	1.1	2.3	0.4	1.1	1.4	7.6	13.8	1.0	5.6	1.8	0.3	2.1	1.7	71.6	0.2	2.2	10.3	2.4	4.0	5.8	0.5	0.0	1.1	0.7	0.8	0.2	0.7	0.8	0.4	1.5	3.1	0.4	0.1	0.0	0.2	1.2	0.7	0.1	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.7	0.1	0.6	0.4	0.5	2.9	0.0	1.9	0.7	0.0	0.2	0.1	0.0	11.1	1.1	0.9	3.2	1.2	0.8	3.7	0.1	0.1	0.9	0.9	0.6	0.6	0.0	0.7	0.5	0.9	0.2	0.9	3.7	0.6	1.1	0.7	1.0	1.1	0.9	1.3	0.7	0.6	0.9	1.0	1.0	1.9	1.5	1.6	1.2	4.3	0.6	36.2	50.4	40.2	77.0	51.8	5.2	0.0	7.9	2.0	0.4	13.8	71.6	0.5	3.2	3.9	228.8	0.8	1.1	1.1	0.2	4.6	32.9	6.3	2.4	2.4	0.0	1.3	9.2	18.8	0.4	0.5	0.0	0.0	0.5	142.2	2.6	0.8	0.8	0.0	0.0	2224.0	0.0	0.3	5.7	1.1	0.9	1.3	0.3	0.4	0.5	0.6	30.3	1545.5	0.0	0.0	0.0	1.9	92.0	1.2	0.4	5.4	84.3	0.2	1.7	1.0	1318.0	1000.1	0.0	1.1	6.0	0.3	0.5	0.0	5.0	3.1	3.4	6.6	12.1	1.8	31.8	3.9	2.6	1.4	0.8	2.1	0.5	0.1	0.6
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	5.1	4.9	5.5	2.4	5.6	1.9	4.6	6.1	7.9	7.3	5.3	8.7	2.6	6.3	1.5	3.9	6.8	2.9	4.9	5.3	5.7	7.9	5.0	4.6	3.0	5.4	5.4	8.7	5.5	2.8	7.2	2.4	5.7	6.9	1.2	2.5	6.5	4.0	6.5	4.3	4.1	2.8	5.1	4.3	4.9	5.0	5.5	2.0	6.2	3.3	2.0	6.9	5.7	6.0	2.5	29.4	3.7	8.3	7.1	5.8	8.6	11.0	8.9	10.0	8.9	15.3	6.1	5.5	13.4	7.4	3.9	4.9	8.2	6.0	4.4	7.2	15.6	5.2	14.6	3.8	7.7	2.8	4.3	3.7	6.2	9.6	9.2	6.0	1.9	3.6	12.4	1.7	5.9	9.3	5.5	10.3	10.0	3.7	5.4	8.6	9.3	10.0	7.6	3.1	12.1	11.6	5.7	8.3	4.7	2.1	8.2	3.6	3.4	7.3	9.9	13.7	5.7	8.6	16.4	8.6	4.0	2.8	8.5	0.0	0.4	0.0	0.8	0.5	1.2	1.2	1.0	0.7	0.8	1.3	1.5	0.9	0.0	0.6	0.6	2.2	0.7	0.5	5.5	5.6	6.1	7.9	5.3	5.7	5.4	5.4	5.7	5.1	5.5	6.0	9.0	6.4	14.3	18.3	9.9	7.6	13.2	12.9	8.0	42.9	11.6	11.0	4.9	14.3	11.7	22.0	110.5	12.6	9.9	9.8	19.6	16.5	6.1	10.1	15.1	9.4	9.0	5.5	28.8	8.6	8.5	13.1	13.7	6.8	0.0	21.4	14.6	8.1	8.1	50.5	27.7	13.6	14.2	4.4	4.3	6.4	27.1	4.9	10.6	6.5	12.5	12.5	20.6	17.1	21.2	13.3	13.3	28.2	7.5	16.1	8.8	16.1	15.1	92.2	6.6	13.8	12.3	29.1	25.4	6.0	9.7	6.7	10.6	19.1	12.8	6.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Inhibitory neurons: 48.6;Oligodendrocytes: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.7	4.8	8.0	3.2	8.8	1.5	4.7	14.3	10.0	9.5	7.6	10.5	4.2	8.9	4.9	8.7	10.2	3.3	3.9	8.1	7.7	9.4	2.7	6.6	2.4	12.5	8.9	10.3	12.8	5.5	4.8	2.0	12.4	5.5	4.9	2.2	5.4	2.3	3.7	5.3	7.7	4.9	8.2	3.2	11.5	5.7	10.1	2.6	13.6	1.0	2.9	8.7	5.2	9.7	8.2	12.3	10.9	19.3	9.0	7.3	7.4	5.9	10.0	6.5	7.7	6.7	5.8	15.2	4.4	8.4	9.2	23.9	8.1	9.9	3.4	21.2	8.3	3.6	7.7	2.9	8.8	2.0	2.3	8.9	12.0	8.7	8.9	7.9	7.4	13.8	26.0	3.5	5.0	13.5	0.9	3.9	17.3	36.3	12.2	10.2	26.8	1.2	11.7	5.1	7.1	8.1	2.5	14.2	6.7	8.8	0.0	4.1	7.6	6.5	7.2	18.4	5.8	6.8	12.1	2.4	9.4	6.8	9.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	8.8	14.3	10.0	8.1	7.7	12.5	8.9	12.4	8.2	10.1	9.7	3.5	6.4	10.5	16.0	2.4	1.8	0.9	8.2	5.2	12.0	1.5	2.2	4.4	10.0	7.7	12.9	8.4	3.1	1.5	5.1	3.9	4.2	3.0	3.7	5.3	3.2	4.9	0.8	52.8	8.9	2.7	4.9	7.7	3.9	1.3	6.2	1.8	1.7	1.9	0.0	48.6	7.1	0.0	1.3	0.9	5.8	2.8	0.9	0.0	9.4	0.7	1.9	2.1	14.1	54.2	9.3	3.1	4.5	1.4	3.9	4.8	5.9	11.1	0.8	0.0	2.7	3.2	3.8	5.9	5.6	1.1	1.1	2.4	6.2	10.4	2.9
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;choroid plexus: 6.9;fallopian tube: 5.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 124.3;Respiratory ciliated cells: 118.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053749	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.1	0.6	0.3	0.0	0.3	0.3	0.6	6.9	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	0.7	0.5	0.0	0.0	1.1	0.0	2.9	5.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.3	0.7	0.5	2.9	5.1	2.5	1.4	0.3	1.3	0.0	0.0	1.7	0.3	0.0	0.5	0.8	7.3	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	124.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	10.2	1.6	0.3	5.4	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	118.9	0.0	0.0	0.2	1.4	4.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.7
ANKZF1	"FLJ10415, Vms1, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1"	Q9H8Y5	2	219229783-219236679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	9.1	9.2	7.8	8.8	8.6	7.8	10.8	9.9	9.8	13.8	9.6	13.1	9.6	10.1	3.2	15.2	13.5	6.1	14.1	7.9	8.0	13.9	14.4	10.7	13.7	10.1	8.5	16.0	15.6	6.4	12.5	5.9	9.3	15.1	5.2	8.2	15.3	5.6	16.9	17.3	15.2	4.6	7.9	18.1	14.2	7.9	8.7	11.9	11.9	8.1	8.3	12.4	15.0	10.5	31.6	6.1	8.1	11.8	10.6	8.8	32.5	10.1	10.0	13.6	17.2	14.9	13.2	6.6	18.0	4.3	15.3	22.7	10.5	17.5	10.0	13.9	11.0	14.6	19.1	13.9	10.6	9.6	13.7	8.9	33.1	10.1	15.9	22.6	9.4	17.0	24.8	14.9	6.9	13.6	14.1	24.1	13.5	13.7	10.9	14.3	9.9	21.4	7.6	7.9	10.3	10.5	11.9	23.9	19.8	19.5	6.4	23.7	10.3	11.4	8.7	10.1	13.3	31.6	19.9	12.9	19.4	13.8	5.1	9.9	9.1	11.0	16.1	9.0	17.4	13.0	16.3	16.2	9.4	13.3	19.0	18.0	12.3	24.4	14.0	9.8	17.1	13.6	7.8	8.6	9.9	9.8	7.9	8.0	10.1	8.5	9.3	7.9	8.7	10.5	10.2	16.0	17.2	24.2	28.0	9.3	14.5	28.9	9.6	39.8	14.4	13.6	9.2	11.5	24.8	12.9	31.3	10.5	32.7	17.3	13.7	20.5	4.4	28.2	9.7	11.8	9.6	19.6	19.0	12.6	27.2	8.9	17.9	13.0	21.6	21.4	8.6	13.1	7.7	32.0	21.0	19.1	20.3	8.2	5.3	4.0	23.9	10.9	10.6	6.5	15.6	18.0	43.3	13.6	25.3	14.2	16.0	16.6	17.7	13.6	25.2	16.5	65.1	55.4	6.6	13.2	12.8	10.1	17.0	8.3	9.9	11.6	30.0	21.3	17.6	11.1
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	26.6	14.1	17.6	15.1	18.6	33.0	21.8	23.9	20.9	22.3	18.4	39.4	61.1	21.6	13.6	25.3	13.9	19.4	12.7	18.1	21.1	29.9	14.1	16.9	7.6	22.7	22.9	13.9	15.2	23.7	13.9	18.1	23.2	14.2	33.7	10.1	28.6	20.2	15.5	32.0	54.7	28.0	19.6	9.1	13.5	13.0	19.8	7.1	24.5	11.6	9.7	18.1	21.5	24.1	30.6	23.6	26.1	27.4	101.1	53.5	31.2	87.7	141.1	42.0	54.4	16.2	27.5	3.1	27.4	114.8	43.1	16.3	20.6	47.0	52.6	33.6	14.2	39.4	28.7	17.7	43.9	7.2	31.1	50.5	36.3	53.6	71.8	79.4	100.3	18.7	30.8	24.9	95.2	20.8	7.8	5.2	31.3	23.7	28.6	6.3	18.7	10.2	85.5	31.4	6.4	19.4	34.4	27.0	19.8	45.3	59.5	14.5	84.7	66.2	24.4	70.2	40.7	15.7	22.9	1.1	60.2	14.6	44.2	7.4	19.0	1.4	6.7	11.1	3.8	2.7	4.6	4.5	13.1	2.5	3.9	6.0	32.8	9.7	12.7	2.3	5.4	7.0	17.6	18.6	23.9	20.9	18.1	21.1	22.7	22.9	23.2	19.6	19.8	24.1	24.3	6.4	3.2	70.2	4.1	5.6	5.8	6.9	8.0	8.0	18.2	8.4	5.2	8.6	13.2	14.7	0.0	14.4	3.7	38.5	123.3	21.6	2.9	11.8	23.6	17.8	9.6	11.8	77.4	17.8	19.5	10.6	10.2	31.2	2.5	6.8	23.6	10.7	11.6	10.1	97.9	23.8	10.2	9.6	5.3	5.2	5.6	9.1	14.2	69.3	9.2	17.1	5.2	71.4	46.4	11.7	22.1	10.1	2.6	4.4	58.4	19.0	4.0	3.6	6.6	19.1	15.7	17.1	23.6	8.7	6.1	17.1	5.8	6.2	26.9	4.8
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 226.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	8.8	0.3	3.8	0.4	4.4	0.0	6.6	2.2	3.3	4.3	5.0	1.9	0.7	1.8	1.4	1.7	3.2	1.1	8.0	2.5	2.4	1.2	0.2	7.2	0.1	3.2	3.2	1.5	0.9	1.3	0.6	4.1	3.4	2.5	0.6	226.0	1.3	1.0	2.0	1.1	1.7	1.5	3.0	3.4	2.2	10.1	3.9	0.3	2.4	4.4	0.2	2.4	3.5	2.8	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	4.4	2.2	3.3	2.5	2.4	3.2	3.2	3.4	3.0	3.9	2.8	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26188842-26663289	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 59.2;epididymis: 57.4"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 201.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 59.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 158.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 180.1"	HPA041629	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	3.0	0.8	4.3	0.1	59.2	0.0	0.5	0.0	11.8	0.5	0.0	0.2	0.1	0.1	57.4	0.0	0.2	1.8	0.3	7.7	0.0	1.0	1.1	0.4	0.0	1.1	0.1	0.1	0.3	0.1	0.3	0.0	1.9	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.9	0.3	0.1	1.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.4	0.0	1.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.3	0.0	0.4	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	59.2	0.0	11.8	7.7	0.0	1.1	0.1	1.9	0.0	0.3	1.7	1.0	0.0	2.0	3.3	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.0	0.9	0.0	0.2	0.0	14.6	0.2	0.0	0.0	0.0	0.1	12.0	0.5	0.0	0.4	0.0	0.0	201.9	0.0	0.3	0.5	0.0	0.3	0.0	0.0	1.8	0.7	0.0	8.4	4.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	38.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	2.3	0.0	0.0	4.7	3.8	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ANO4	"FLJ34221, FLJ34272, FLJ35277, TMEM16D"	ENSG00000151572	"Anoctamin 4"	Q32M45	12	100717526-101128641	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.0;brain: 11.3;cervix: 7.6;ovary: 7.7;seminal vesicle: 8.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 536.3;Oligodendrocyte precursor cells: 276.9;Oligodendrocytes: 814.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 20.0;LHCN-M2: 9.5;SK-MEL-30: 15.5;TIME: 31.8;WM-115: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053412	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053412: AB_2682140"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.54e-2)"	"prognostic favorable (5.48e-5)"	"unprognostic (1.16e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.41e-1)"	0.2	12.0	5.1	0.0	10.4	0.0	0.1	2.3	6.8	7.6	0.0	0.1	0.3	4.4	0.3	0.0	0.2	0.0	0.1	5.3	5.8	0.1	0.0	0.0	0.0	6.6	7.1	7.7	0.5	0.1	0.8	0.1	5.7	4.8	0.1	0.8	2.0	8.1	0.0	0.0	0.2	0.5	2.6	0.0	0.0	1.0	9.5	0.7	0.1	0.0	0.4	0.7	0.3	11.3	0.0	0.0	2.2	0.0	1.1	1.4	0.0	7.0	6.2	5.7	2.8	0.0	0.0	0.0	0.0	20.0	0.0	0.3	7.2	5.9	5.3	0.0	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.5	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	15.5	7.6	0.0	0.0	31.8	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	10.4	2.3	6.8	5.3	5.8	6.6	7.1	5.7	2.6	9.5	11.3	0.3	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.1	5.7	0.3	7.8	0.1	4.2	0.0	124.9	0.4	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	536.3	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.0	6.5	0.0	0.0	0.0	276.9	814.1	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.2	0.6	0.6	1.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	21799934-22283357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 24.9;parathyroid gland: 17.0;skeletal muscle: 65.5;tongue: 50.4"	"Group enriched"	"Detected in many"	7	"Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain					NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favorable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	0.9	4.5	1.9	0.8	3.0	0.0	0.7	0.1	8.9	1.6	3.0	2.6	3.3	1.5	1.3	2.0	0.8	1.7	24.9	4.0	2.2	3.6	2.1	1.2	0.2	2.7	2.1	0.5	3.9	17.0	3.4	0.0	2.2	4.2	3.3	2.1	2.6	4.1	65.5	0.1	2.5	2.7	0.4	0.7	3.0	1.8	2.4	0.2	4.7	50.4	0.3	2.0	0.3	3.4	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.4	2.5	0.0	0.0	0.0	0.0	3.5	2.6	0.0	0.0	0.0	0.0	3.2	0.1	2.7	2.6	0.0	0.0	0.0	2.1	2.1	1.9	0.0	0.0	1.9	0.0	0.0	2.0	3.7	0.0	2.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.1	8.9	4.0	2.2	2.7	2.1	2.2	0.4	2.4	3.4	0.4	0.0	5.9	67.9	0.6	0.3	0.3	0.0	0.0	6.7	2.2	0.6	86.2	1.5	0.0	1.8	0.0	0.1	0.0	7.8	1.9	1.3	5.8	0.4	0.2	3.2	5.4	0.4	166.6	2.7	0.0	3.0	1.5	0.3	0.0	3.0	2.5	5.1	0.5	1.7	136.4	7.1	0.0	0.6	1.4	2.9	0.0	1.6	1.8	14.0	1.9	2.8	0.0	81.4	4.2	1.0	4.4	1.2	0.0	1.4	2.7	3.3	0.7	0.8	0.0	8.1	2.4	11.0	0.9	0.1	0.1	0.0	0.2	1.6	4.6	0.2
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;prostate: 69.6;stomach 1: 28.1"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.2;Hep G2: 2.3;OE19: 2.5"	"Low region specificity"	"Detected in many"							HPA078464	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.3	0.3	0.2	1.0	0.7	3.6	0.2	0.2	1.0	0.3	0.0	16.3	10.7	0.5	0.0	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.0	1.2	0.2	0.5	0.4	0.0	0.2	0.1	0.4	69.6	10.1	0.0	4.9	0.2	0.0	0.2	14.7	0.1	0.3	0.3	28.1	0.2	0.8	0.0	0.2	0.0	0.0	0.2	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.2	1.0	0.2	0.2	1.2	0.2	0.4	0.3	0.8	1.6	1.2	0.0	0.0	1.6	0.7	0.3	0.8	0.8	1.2	0.2	1.9	2.7	1.6	0.0	0.2	0.0	0.0	0.6	0.1	2.6	0.0	2.7	0.1	0.8	0.7	2.1	3.0	0.0	4.8	4.2	5.6	2.0	80.0	1.9	0.0	12.4	2.9	3.9	1.5	0.0	2.7	53.4	0.0	1.3	0.0	0.0	3.4	0.7	1.8	7.5	0.0	1.4	0.0	1.0	6.9	6.4	1.9	2.2	0.5	11.9	3.6	2.8	0.0	0.6	0.0	0.8	1.0	0.1	1.7	0.1	0.0	0.7	0.3	2.6	2.4	0.8
ANO8	"KIAA1623, TMEM16H"	ENSG00000074855	"Anoctamin 8"	Q9HCE9	19	17323223-17334855	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.1;Inhibitory neurons: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049206	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA049206: AB_2680675"	"unprognostic (5.12e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.59e-2)"	6.2	21.0	11.1	4.6	9.9	2.6	6.7	10.0	14.6	5.0	2.8	4.7	4.4	3.8	1.1	11.6	4.9	5.3	5.3	10.6	9.6	7.6	7.1	6.4	4.4	13.2	12.1	3.8	6.9	6.6	4.5	3.4	12.3	4.8	2.3	4.1	7.7	2.7	8.4	18.4	4.7	2.8	11.2	5.5	8.2	3.1	12.7	5.2	6.0	4.9	2.8	3.5	6.4	9.4	6.3	5.5	14.8	16.8	4.4	3.1	24.5	6.3	3.6	3.2	3.6	2.4	13.2	0.5	6.5	6.2	4.5	5.7	3.1	5.1	1.9	27.8	7.6	4.2	18.0	3.7	2.2	0.9	6.9	3.5	4.7	4.2	3.0	8.2	2.4	9.9	3.1	6.2	2.1	4.8	5.6	1.6	8.4	7.1	21.9	9.2	3.1	7.5	5.3	10.3	5.4	17.8	6.8	6.4	5.2	5.4	9.2	2.8	2.5	7.4	4.1	22.9	6.9	10.7	9.2	1.0	11.7	7.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	11.1	9.9	10.0	14.6	10.6	9.6	13.2	12.1	12.3	11.2	12.7	9.4	4.4	6.4	1.7	73.1	1.0	0.9	0.4	0.7	2.2	5.2	10.3	9.9	2.4	1.5	1.1	0.0	4.2	3.9	3.4	2.1	0.0	1.8	0.2	2.3	1.6	1.4	0.0	0.4	12.6	1.6	8.7	1.6	10.2	4.6	5.7	5.9	1.1	3.5	1.7	1.7	19.3	2.4	2.0	1.9	1.4	0.3	2.1	2.2	0.0	9.4	0.8	2.5	0.0	12.5	7.8	1.8	0.3	0.7	3.0	0.8	2.3	0.9	0.7	2.7	0.0	1.5	2.4	0.3	0.8	2.1	1.4	2.6	2.2	4.7	2.2	0.8
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.2;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	48	"B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"	0.7	0.1	0.0	7.0	0.0	2.2	1.7	0.0	0.0	1.1	0.2	16.0	34.2	0.5	7.0	6.3	1.2	2.0	0.1	0.0	0.0	3.7	0.3	2.9	12.0	0.0	0.0	0.1	6.5	0.7	1.3	0.1	0.0	2.9	9.1	0.0	3.0	0.7	0.0	27.8	30.0	0.8	0.0	4.7	7.0	0.2	0.0	9.0	2.4	0.1	8.7	2.4	3.4	0.0	2.7	0.6	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	3.1	29.5	1.9	1.4	0.0	0.1	16.8	0.0	7.0	0.0	2.1	0.0	0.0	0.6	5.1	0.0	0.4	0.0	0.0	5.6	0.0	1.2	0.1	0.0	4.5	0.1	1.9	0.0	3.8	0.5	0.1	0.0	6.0	0.0	0.1	0.0	20.6	5.1	4.4	1.6	0.0	0.3	7.3	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.5	2.1	6.5	3.3	0.0	0.8	3.7	2.8	0.0	4.1	0.0	0.0	8.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.7	0.3	9.1	5.2	4.6	15.3	6.2	0.0	5.5	3.9	2.4	8.6	9.1	3.7	0.0	0.3	3.0	81.0	0.0	10.5	0.8	4.9	1.0	0.8	15.5	0.0	0.3	6.5	3.7	0.6	29.0	11.0	0.0	0.0	0.7	0.3	0.4	0.0	0.2	50.5	14.2	0.3	1.9	0.1	0.0	1.2	3.6	0.0	1.3	0.0	0.0	0.0	0.0	9.0	50.5	0.0	5.0	2.7	87.7	3.7	9.2	0.0	0.0	0.1	1.0	0.2	0.2	7.0	6.3	0.1	12.8	0.0	45.2	5.7
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983341-98015943	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		570000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	144.0	77.1	134.8	124.0	155.9	365.7	138.6	134.0	187.6	161.6	112.0	145.5	95.1	116.2	104.7	140.9	127.2	60.4	92.3	113.7	150.0	100.2	103.5	122.4	222.6	171.4	149.8	168.5	156.4	68.7	68.1	110.5	158.5	98.6	118.7	46.2	110.6	71.4	109.6	148.0	127.3	78.0	155.6	123.8	131.9	59.6	142.6	271.5	96.9	50.6	248.4	132.5	146.6	173.4	659.7	347.4	378.6	318.4	208.1	365.2	344.4	332.6	292.4	349.2	291.9	438.3	313.1	798.2	194.2	224.6	266.3	423.9	516.1	375.2	397.1	523.0	290.9	692.4	289.1	478.4	266.9	1201.9	386.8	278.7	268.8	280.9	574.0	283.2	307.9	701.5	1359.2	548.8	272.6	875.7	913.5	1062.0	148.2	638.8	341.2	537.8	589.5	381.7	228.8	269.9	304.2	265.8	390.4	376.2	364.5	185.3	213.2	444.0	377.0	226.5	367.3	288.3	355.5	493.2	601.3	469.1	209.7	472.7	432.1	91.3	83.6	118.8	65.2	95.5	89.3	106.1	122.5	92.8	100.5	93.0	143.8	112.1	34.2	74.1	149.7	96.4	162.5	85.3	134.8	155.9	134.0	187.6	113.7	150.0	171.4	149.8	158.5	155.6	142.6	173.4	127.9	86.6	101.8	7.8	227.7	180.7	201.3	180.0	208.9	61.1	100.4	126.0	85.8	112.9	120.7	75.4	25.0	345.5	159.5	159.1	97.8	144.9	114.9	73.8	176.3	146.9	149.9	709.4	5.8	171.6	537.9	121.9	123.3	117.5	119.7	247.9	159.5	96.6	284.7	119.5	6.2	242.2	75.3	310.6	152.0	95.2	146.3	222.5	128.1	14.0	263.5	68.9	149.3	8.0	18.8	137.1	151.1	145.2	266.5	260.6	177.7	101.9	56.3	42.1	151.2	113.4	189.4	204.3	339.0	243.0	154.1	333.1	217.6	188.9	302.7	234.1
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472559-48473622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Smooth muscle cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: AB_2684947, HPA067561: AB_2685861"		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		280000	"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	20.0	30.4	36.1	38.9	37.8	75.7	18.1	54.9	45.0	20.5	30.4	19.9	22.5	26.3	34.4	18.7	21.2	20.2	35.1	32.8	39.9	30.8	29.0	23.0	71.0	43.5	41.5	23.3	8.9	33.1	16.4	21.6	40.5	16.2	18.2	98.6	12.9	24.5	49.8	21.6	25.7	21.0	39.7	33.1	17.3	10.3	40.7	88.2	30.5	26.0	62.2	21.8	16.2	35.6	224.0	141.7	289.7	144.0	22.3	32.7	109.8	117.7	66.6	111.8	106.0	105.6	154.0	405.1	101.8	68.3	66.3	76.6	164.9	73.6	158.4	466.1	101.3	280.7	175.6	153.2	21.1	572.0	136.6	26.8	11.9	104.1	95.4	54.8	84.6	193.3	274.8	231.2	103.6	232.3	231.5	148.3	292.5	72.9	64.8	245.4	161.2	214.1	80.2	88.8	94.5	161.2	245.4	39.6	70.7	127.5	105.3	287.7	87.4	56.7	158.4	59.1	239.1	297.6	325.6	388.7	64.5	403.6	105.5	56.6	20.8	35.9	35.0	15.6	53.2	54.5	46.4	38.5	17.4	39.5	32.6	40.7	14.7	31.5	20.3	12.2	56.2	36.5	36.1	37.8	54.9	45.0	32.8	39.9	43.5	41.5	40.5	39.7	40.7	35.6	48.7	12.8	84.0	16.3	88.9	97.3	37.6	36.8	40.5	117.5	33.8	37.7	99.9	24.3	32.8	73.5	33.3	58.4	98.2	12.1	86.1	36.4	1.4	52.5	64.0	52.3	14.4	222.5	7.9	26.5	133.1	57.6	20.9	41.9	63.3	28.4	39.7	59.0	52.3	63.9	9.9	19.9	28.5	48.0	108.9	1.9	30.4	54.3	67.6	6.5	57.0	134.3	60.8	3.0	6.6	27.0	14.2	33.4	116.3	21.6	20.4	58.6	59.6	135.1	26.3	56.8	75.1	12.4	22.7	55.2	98.5	40.6	108.9	27.9	37.8	25.8
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
ANTKMT	"C16orf24, FAM173A, MGC2494"	ENSG00000103254	"Adenine nucleotide translocase lysine methyltransferase"	Q9BQD7	16	720581-722590	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Cytotrophoblasts: 46.0;dendritic cells: 14.9;Extravillous trophoblasts: 37.4;Hofbauer cells: 88.4;Syncytiotrophoblasts: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046262	Approved		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046262: AB_10963070"	"unprognostic (3.94e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.28e-2)"	"unprognostic (3.60e-3)"	14.8	22.6	23.2	4.1	23.5	3.7	13.0	22.9	38.1	11.6	21.3	18.9	9.9	14.0	0.3	14.8	11.4	1.0	26.1	22.8	22.4	30.5	37.5	13.0	3.6	26.7	24.9	8.4	23.2	3.0	27.9	2.2	22.5	16.1	1.0	1.8	13.8	3.4	21.5	10.5	18.1	1.3	23.1	23.1	20.9	23.5	23.6	2.7	17.4	3.3	1.5	15.5	11.1	25.3	15.9	10.5	1.7	5.2	0.4	0.8	24.7	14.9	3.3	3.2	3.5	9.4	13.0	21.0	24.2	1.6	5.2	24.7	1.7	5.6	0.8	44.5	27.1	8.4	10.4	10.1	4.1	15.4	10.9	2.0	4.2	1.3	3.3	6.0	1.2	12.8	18.3	8.5	2.5	22.8	1.9	32.6	7.8	7.8	31.8	8.3	5.0	37.3	7.8	4.5	7.8	21.6	7.4	12.2	24.6	1.1	12.5	12.6	12.1	2.6	23.2	8.7	10.3	74.0	36.0	23.1	6.2	9.8	7.1	0.1	11.5	9.6	12.0	7.2	25.0	17.5	8.7	19.6	7.3	21.4	9.0	26.7	1.3	11.6	8.2	10.0	23.3	6.9	23.2	23.5	22.9	38.1	22.8	22.4	26.7	24.9	22.5	23.1	23.6	25.3	7.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	46.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	37.4	8.3	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	25.6	1.5	0.0	0.0	0.0
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092537-168187736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 486.3"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 284.8;PC-3: 125.5;RT4: 172.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	19.6	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	486.3	0.9	0.0	0.0	0.0	0.0	0.0	89.6	0.1	0.0	0.0	4.6	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.4	0.1	9.7	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	284.8	125.5	0.0	0.6	0.0	0.0	172.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.5	0.0	0.5	15.5	0.0	0.4	0.1	0.0	0.2	7.2	3.2	0.0	2.1	0.0	0.0	0.1	0.0	21.1	11.0	0.1	0.1	0.3	0.0	2.7	0.2	172.6	0.0	0.4	667.7	0.1	0.0	0.0	1.8	72.6	0.0	0.0	0.2	0.5	0.0	2.8	0.0	0.8	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	315.0	1.1	0.0	1.4	0.6	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	14.7
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 144.3;intestine: 293.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.0	1.1	1.6	2.6	0.0	0.4	2.6	2.2	0.4	1.1	21.6	293.6	1.5	2.2	0.2	58.4	144.3	0.1	1.1	1.5	7.0	20.2	0.2	0.2	4.1	2.9	0.4	0.4	0.0	0.0	0.0	3.3	0.5	36.1	4.3	0.1	24.3	0.0	0.1	219.5	2.9	3.3	0.0	0.8	4.2	2.1	0.1	0.0	0.0	0.0	0.5	0.1	5.3	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	2.6	2.2	1.1	1.5	4.1	2.9	3.3	3.3	2.1	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 337.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	320	"neutrophil: 207.7"	"Lineage enriched"	"Detected in single"	327	"granulocytes: 207.7"	"Cell line enhanced"	"Detected in many"		"A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"		NA	NA		6400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	52.9	3.1	16.5	22.7	17.3	337.7	43.8	14.5	28.2	19.6	11.7	27.7	15.8	12.5	3.7	55.2	16.8	17.3	51.2	14.2	21.6	24.9	3.9	144.4	2.4	19.9	16.1	2.5	32.7	34.0	5.9	81.5	20.8	68.0	26.7	1.6	119.5	12.9	28.3	10.0	13.3	20.1	14.6	21.6	90.5	1.9	19.9	7.1	83.7	36.7	12.7	10.2	15.6	14.7	419.5	77.7	1.3	0.9	1.0	0.9	0.6	4.9	0.4	11.0	10.9	403.5	563.7	0.1	334.7	14.4	0.4	161.6	0.1	300.0	16.0	1.4	3.3	36.4	142.0	23.9	45.9	5.9	0.2	2.4	262.6	4.1	566.3	60.1	118.9	9.0	0.7	0.3	1.9	15.9	1.7	0.2	13.0	502.1	55.4	0.0	0.8	0.0	477.8	45.2	0.3	0.3	235.5	58.2	16.6	186.1	9.9	4.3	153.2	0.6	52.6	0.2	93.0	3.1	5.1	2.2	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	207.7	0.1	0.6	0.1	0.0	2.9	16.5	17.3	14.5	28.2	14.2	21.6	19.9	16.1	20.8	14.6	19.9	14.7	322.7	589.7	47.3	0.0	1.1	24.9	81.8	144.9	1.8	0.2	27.6	85.9	8.6	55.8	175.2	38.6	0.0	212.6	1.0	35.4	17.6	434.5	1.1	33.7	4.4	84.6	5.4	3.2	0.9	305.3	106.2	16.9	99.9	58.1	5.1	0.1	23.2	0.6	18.9	0.0	0.3	33.4	122.1	0.3	0.3	0.3	3.1	6.9	5.4	42.2	21.0	1.2	0.0	1.0	0.6	754.2	61.6	0.4	0.6	158.6	11.5	5.5	89.6	0.4	0.0	7.6	18.7	1.1	0.6	21.9	6.7	62.8	2.3	1.3	29.7	46.7
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827112	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 569.9;pancreas: 356.8"	"Cell type enhanced"	"Detected in all"		"Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		550000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	48.2	21.6	14.5	33.6	15.4	30.8	45.9	14.9	18.9	62.4	52.4	101.7	271.3	50.9	30.3	43.0	68.6	569.9	26.1	14.4	15.2	104.0	120.9	81.6	21.1	15.6	15.1	38.8	356.8	78.0	11.9	52.7	15.8	46.3	92.3	30.0	39.2	52.1	17.2	61.0	232.4	52.0	15.7	24.2	108.2	9.7	15.2	23.0	43.6	20.4	24.0	61.3	50.2	16.6	69.6	249.4	3.4	31.0	185.0	158.3	11.3	66.0	101.5	27.1	38.0	37.9	121.7	22.8	414.2	109.5	78.9	104.7	23.8	108.1	27.6	65.2	20.3	35.0	20.5	456.9	131.2	12.5	43.0	95.9	104.8	36.5	87.3	62.9	71.1	11.0	2.0	20.1	74.7	63.8	18.3	22.8	6.1	280.0	34.3	19.4	6.8	28.3	623.2	99.1	5.1	22.9	72.9	99.5	103.8	35.6	33.3	156.3	100.9	49.2	23.8	65.5	37.7	8.2	9.7	1.3	75.8	59.7	34.1	80.4	34.7	29.6	23.1	42.5	17.5	40.6	11.7	17.5	50.6	46.7	2.0	12.5	4.9	9.5	58.7	15.5	14.5	24.2	14.5	15.4	14.9	18.9	14.4	15.2	15.6	15.1	15.8	15.7	15.2	16.6	66.4	205.1	154.8	47.3	27.3	74.2	98.5	148.2	68.9	8.2	36.8	36.4	10.6	2344.8	139.4	84.6	6.2	86.4	27.2	315.1	221.1	1469.8	14.6	257.9	79.0	49.1	18.6	12.6	29.9	344.4	370.1	103.6	196.7	488.8	111.5	24.3	33.9	68.5	227.6	8.4	17.7	193.8	240.1	46.1	80.4	11.2	64.7	54.5	92.5	63.7	87.2	48.7	45.3	17.6	106.0	245.7	268.6	92.2	6.9	55.6	657.1	400.4	230.2	59.9	6.6	27.6	64.6	15.8	3.7	61.3	79.6	439.6	32.5	19.1	174.1	96.9
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		5000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	490.6	286.5	111.7	241.7	126.3	96.2	314.0	136.9	144.7	429.1	137.7	181.9	96.5	288.7	162.6	135.1	225.0	273.1	213.9	106.4	134.7	216.2	149.5	299.0	136.2	151.2	129.6	224.7	162.9	133.7	176.7	466.0	150.4	211.7	155.5	78.1	273.8	250.5	85.2	132.5	130.9	370.3	134.3	175.7	186.0	110.4	154.3	63.3	182.9	114.8	135.2	298.1	178.6	157.3	463.5	339.6	438.0	256.1	2094.3	1645.5	503.4	1582.7	1464.9	841.3	744.8	246.2	200.6	35.7	282.9	2224.8	581.7	165.4	287.3	727.6	762.2	335.1	171.2	105.0	281.6	647.4	1213.9	221.1	178.3	945.5	344.7	705.1	665.9	927.4	1120.9	25.2	106.0	271.8	2133.5	306.7	225.5	75.1	231.9	417.7	718.5	8.2	1014.5	72.6	1368.9	66.3	117.1	141.4	579.7	227.6	1515.2	872.3	201.5	261.2	830.6	1322.1	632.1	955.2	478.0	240.8	308.6	76.0	847.8	123.5	1586.2	122.2	725.8	359.9	104.8	830.5	136.0	127.3	158.8	131.9	745.6	89.5	51.3	74.6	157.9	48.4	798.0	91.2	289.9	773.3	111.7	126.3	136.9	144.7	106.4	134.7	151.2	129.6	150.4	134.3	154.3	157.3	286.5	243.6	233.9	13.7	85.0	199.3	266.4	395.9	76.2	6.8	101.6	107.4	88.3	265.9	257.2	132.4	25.0	1156.8	53.2	15.6	297.4	703.5	16.2	239.7	318.1	287.7	48.6	29.0	15.4	338.2	1125.1	564.7	91.3	312.6	148.7	177.5	186.4	54.8	753.2	13.5	7.1	110.9	187.2	446.5	705.1	41.4	379.9	544.0	352.2	45.0	412.5	161.4	13.4	23.1	26.8	501.1	31.2	366.3	203.1	473.8	15.3	194.3	268.9	30.0	295.9	443.1	377.2	15.9	28.6	101.1	140.8	1140.8	122.0	185.7	43.2	188.2
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
ANXA7	ANX7	ENSG00000138279	"Annexin A7"	P20073	10	73375101-73414076	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 693.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004312, HPA064290"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		290000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"CAB004312: AB_626681, HPA064290: AB_2685233"	"unprognostic (1.48e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.06e-2)"	79.0	72.1	60.1	58.6	61.1	85.2	75.5	55.9	67.8	69.9	57.1	64.3	39.4	57.6	80.5	69.3	57.0	51.8	113.4	62.6	64.8	116.4	126.0	60.4	60.8	55.4	57.0	67.1	55.9	240.7	55.6	57.2	58.1	69.2	74.4	32.3	70.2	70.6	200.1	61.2	44.9	68.4	60.8	53.4	51.7	26.3	62.5	55.4	83.1	139.6	84.1	75.2	57.4	63.9	143.4	101.4	38.8	95.3	148.9	145.2	84.3	93.2	244.7	119.9	100.6	149.2	164.8	56.6	92.2	177.2	78.8	116.9	73.2	110.9	118.1	140.8	54.5	80.4	46.5	133.9	130.6	115.7	35.4	90.8	105.7	149.2	265.1	104.7	108.0	60.8	106.2	156.4	154.4	114.5	66.1	74.4	43.5	85.1	693.9	53.9	110.1	103.4	209.3	86.5	30.9	42.8	105.1	239.4	90.3	54.3	149.7	61.0	100.8	48.5	87.9	148.1	122.5	100.5	153.2	79.5	114.4	147.4	38.4	188.6	98.1	129.8	57.5	74.9	78.9	96.5	88.8	72.2	101.3	75.1	80.0	71.4	98.0	97.2	77.5	43.2	127.8	137.2	60.1	61.1	55.9	67.8	62.6	64.8	55.4	57.0	58.1	60.8	62.5	63.9	85.0	67.3	61.8	24.8	68.4	86.2	137.9	189.8	40.9	33.0	56.7	40.9	131.9	62.9	120.6	93.8	14.6	210.6	61.2	76.2	193.7	167.2	9.7	82.9	43.8	82.4	191.8	119.3	44.8	150.9	112.0	85.3	51.5	60.4	108.3	69.0	56.4	122.7	119.9	10.1	50.7	82.8	193.3	83.0	87.3	6.5	137.0	91.4	85.4	15.0	301.5	66.4	36.0	26.7	46.2	133.1	47.5	174.5	73.0	125.3	57.9	262.8	161.1	26.3	26.3	82.1	92.9	24.0	42.3	72.5	92.5	177.3	78.4	46.9	76.9	146.1
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982249-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.5;Collecting duct cells: 12.9;Ductal cells: 21.2;Hepatocytes: 17.4;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;granulocytes: 1.0;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.6;Hep G2: 42.3;MCF7: 59.2;OE19: 47.8;T-47d: 139.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	3.2	3.7	2.6	2.6	7.1	2.4	6.9	6.1	3.5	2.2	3.3	2.1	4.6	6.4	5.9	26.2	4.7	9.2	6.0	1.7	3.5	22.0	29.9	3.1	2.3	9.0	6.7	4.7	35.8	19.2	1.2	1.0	7.9	2.4	0.3	7.2	7.5	21.2	3.8	32.4	4.2	2.9	4.5	2.8	4.2	3.8	5.3	0.5	25.0	0.2	23.2	6.3	6.0	12.1	11.7	2.8	4.2	4.4	0.0	0.0	11.4	1.0	0.8	0.1	0.0	33.9	40.6	0.4	2.5	0.0	1.3	6.8	0.0	0.8	0.1	3.9	4.4	6.1	4.7	42.3	0.0	2.4	2.6	0.0	0.3	0.1	0.2	9.5	0.0	1.8	3.0	13.2	0.1	59.2	0.5	3.2	1.1	47.8	0.8	2.8	0.6	15.0	0.1	17.0	6.4	3.6	2.6	28.8	1.7	2.3	139.9	3.7	4.7	0.9	1.3	0.7	0.8	4.0	13.0	18.8	6.2	4.2	3.3	0.0	1.2	0.7	0.0	0.7	0.3	0.2	0.1	0.2	1.6	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.4	2.6	7.1	6.1	3.5	1.7	3.5	9.0	6.7	7.9	4.5	5.3	12.1	0.1	0.0	1.1	0.3	0.2	0.1	0.4	0.8	0.0	0.0	4.5	2.5	0.4	61.5	4.5	12.9	0.0	2.0	0.1	0.0	3.9	21.2	1.5	1.3	0.8	0.1	0.0	0.0	0.2	7.5	0.3	0.6	0.0	1.6	1.3	0.0	0.0	17.4	2.2	0.0	0.2	0.0	0.0	0.6	0.4	0.9	1.5	1.4	1.8	0.0	0.2	0.0	0.0	1.0	0.5	2.9	0.1	1.2	0.0	0.3	0.3	44.6	2.5	0.0	0.0	0.1	0.3	4.9	0.2	0.3	0.0	1.5	0.2	0.0	0.3	5.4
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	7.5	5.1	2.4	33.7	2.2	43.3	3.8	2.1	3.1	5.7	4.7	10.4	9.5	2.8	1.5	3.3	3.5	15.6	2.0	2.1	3.6	1.9	13.2	12.7	35.1	6.6	5.1	2.6	1.5	1.5	0.9	11.2	5.7	2.5	13.3	0.8	3.7	2.8	0.5	0.8	12.1	9.3	4.0	64.9	7.0	1.3	5.1	13.9	1.8	0.9	15.1	13.9	1.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	26.5	0.1	0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	1.8	298.5	97.8	43.6	251.9	9.0	2.6	2.2	30.7	183.1	0.3	4.8	37.3	97.9	106.8	113.2	2.7	0.7	207.3	2.4	2.2	2.1	3.1	2.1	3.6	6.6	5.1	5.7	4.0	5.1	8.6	1.3	0.0	9.6	1.3	3.6	0.8	0.1	0.0	0.0	1.1	0.6	1.7	0.5	1.5	2.5	0.0	0.0	0.2	77.9	9.2	1.9	0.3	0.6	0.4	0.3	1.4	15.5	16.0	12.4	0.0	0.2	3.1	2.6	0.4	5.1	0.7	2.5	0.9	32.8	0.0	8.1	0.3	0.0	119.7	20.3	1.2	0.0	77.1	0.0	233.3	67.5	2.8	90.6	12.1	38.6	0.0	3.8	0.4	13.6	0.1	0.3	0.5	0.7	0.3	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	54.1	0.6	0.9	0.2
AOC1	"ABP, ABP1, DAO"	ENSG00000002726	"Amine oxidase copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 227.2;kidney: 136.5;placenta: 496.7"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 272.2;Distal enterocytes: 517.5;Paneth cells: 532.1;Proximal enterocytes: 957.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"eosinophil: 31.2"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.5;HaCaT: 6.2;NB-4: 6.4;RPMI-8226: 7.7;THP-1: 27.1"					"Low region specificity"	"Detected in many"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		2500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.7	0.1	0.3	13.0	0.2	1.9	0.2	0.3	0.3	7.2	0.4	142.2	184.0	2.1	1.9	3.3	0.1	1.8	0.7	0.3	0.2	136.5	5.8	0.6	1.3	0.5	0.5	0.3	1.4	0.0	0.0	496.7	0.5	6.1	94.1	0.1	0.6	1.0	0.1	1.4	227.2	3.4	0.3	0.5	18.0	2.1	0.6	2.1	0.2	0.0	3.8	0.8	0.4	0.5	0.0	0.1	0.1	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	3.2	20.5	0.0	2.7	0.0	1.7	6.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.1	6.4	0.2	1.9	0.0	0.0	0.0	7.7	0.3	0.2	2.2	2.5	0.1	0.9	0.0	0.3	0.8	27.1	0.6	0.2	0.1	0.6	0.0	0.2	0.1	0.1	0.2	1.0	0.1	0.2	0.1	31.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.3	0.3	0.2	0.5	0.5	0.5	0.3	0.6	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.8	272.2	0.0	2.1	0.0	517.5	15.6	0.0	7.1	1.9	0.5	0.4	43.3	0.0	0.1	3.3	63.4	0.5	13.7	4.8	5.7	0.0	0.0	0.0	2.8	0.0	0.1	129.7	2.0	0.0	1.7	18.4	0.0	1.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	3.7	532.1	0.0	0.0	0.7	957.9	145.2	0.2	0.0	0.0	0.0	0.3	3.7	1.3	0.0	0.1	3.4	0.9	0.0	117.9	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase copper containing 2"	O75106	17	42844580-42850707	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 29.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	5.8	1.1	1.9	0.6	2.1	0.9	2.6	1.9	3.2	1.3	0.6	1.3	0.3	1.0	0.5	0.7	1.6	0.7	0.7	2.4	1.9	1.2	3.4	2.3	0.5	2.0	1.6	1.1	0.7	0.2	2.0	0.4	2.0	1.5	0.2	1.5	0.6	0.5	1.6	1.3	0.8	0.6	1.1	1.6	0.8	4.8	2.0	0.3	0.9	0.6	0.6	1.8	1.2	1.9	0.2	2.3	0.5	2.5	11.2	1.1	6.0	0.8	0.7	1.6	2.2	1.8	0.2	0.9	1.1	0.2	0.7	1.0	2.2	0.6	3.2	2.0	6.0	0.3	1.3	1.9	0.7	0.3	2.2	1.7	2.0	1.5	2.3	0.4	0.4	3.1	0.6	2.1	0.4	0.3	0.5	0.9	0.8	0.2	0.7	1.1	2.3	1.9	0.3	3.6	0.8	0.5	0.1	0.8	3.4	4.6	0.4	0.2	0.4	1.5	3.2	2.0	1.0	4.6	4.9	0.9	0.4	2.2	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.9	2.1	1.9	3.2	2.4	1.9	2.0	1.6	2.0	1.1	2.0	1.9	1.1	0.0	0.5	1.6	0.3	1.0	0.5	0.1	0.0	0.5	0.9	0.9	0.4	0.0	0.7	0.0	2.1	0.1	0.4	0.0	0.0	0.3	29.5	1.4	0.7	1.4	0.0	0.0	1.8	0.4	0.1	0.2	0.0	2.8	0.0	0.5	0.4	0.7	0.1	0.0	1.2	0.2	0.0	0.3	0.6	5.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	1.2	0.1	0.2	0.4	0.8	0.0	0.5	1.0	2.3	2.1	0.4	1.6	0.0	0.2	0.4	0.2	0.6
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AOPEP	"AP-O, APO, C90RF3, C9orf3, FLJ14675"	ENSG00000148120	"Aminopeptidase O (putative)"	Q8N6M6	9	94726604-95087159	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 148.2;Cytotrophoblasts: 65.9;Extravillous trophoblasts: 43.7;Syncytiotrophoblasts: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	5.6	6.6	11.8	4.9	20.4	2.2	7.0	16.9	16.3	8.1	23.8	6.9	4.3	18.5	8.3	16.9	10.3	12.1	29.4	15.9	15.5	7.2	7.6	10.4	2.2	23.0	15.7	8.1	11.2	16.3	5.7	24.3	20.7	14.3	5.8	4.7	12.2	15.2	30.5	38.6	5.0	15.8	11.1	5.0	5.7	6.0	15.4	2.6	11.2	15.3	5.6	7.7	6.8	40.5	6.8	27.6	3.3	5.3	3.4	3.8	12.4	6.4	3.0	6.3	4.1	6.3	8.7	2.1	5.3	9.8	8.7	24.8	5.7	6.1	3.4	13.2	4.9	2.0	30.1	5.8	6.1	1.8	1.4	4.4	23.7	5.5	4.1	17.7	3.5	3.3	3.4	3.0	11.4	10.1	2.8	2.3	4.4	7.8	10.7	4.2	9.4	2.7	11.0	6.4	6.6	9.7	11.2	9.4	2.5	8.5	10.8	1.5	2.7	2.9	2.8	10.8	3.4	2.5	3.6	1.0	9.8	1.7	4.8	0.0	1.4	0.9	1.4	1.0	0.8	0.9	1.1	1.2	2.2	2.2	0.8	1.0	0.5	1.4	0.7	2.1	0.8	0.7	11.8	20.4	16.9	16.3	15.9	15.5	23.0	15.7	20.7	11.1	15.4	40.5	20.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.2	0.0	0.0	0.0	0.0	65.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	43.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	88.2	0.2	0.0	0.0	0.0
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
AP000311.1		ENSG00000249209	"Novel protein similar to ATP synthase delta (OSCP) subunit domain"		21	33584687-33931607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	6	"T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 5.7"									HPA039558	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA039558: AB_2676570"												"unprognostic (4.72e-1)"						0.4	0.3	0.7	0.6	0.9	0.1	0.2	0.6	1.2	0.1	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.3	0.9	1.0	0.6	0.3	0.4	0.4	1.1	0.9	0.8	0.3	0.0	0.2	0.0	0.9	0.9	0.4	0.5	0.1	0.7	0.0	0.8	0.3	0.4	0.0	0.5	0.2	0.5	0.9	0.7	0.4	0.3	1.0	0.1	0.1	0.0	1.0	2.6	0.2	0.6	0.2	0.3	0.0	1.0	0.3	0.5	0.3	0.2	3.7	1.4	0.3	2.2	0.1	0.5	1.5	1.2	1.5	0.0	1.7	3.3	1.2	0.7	0.4	0.5	1.1	0.7	0.4	0.0	0.5	0.5	0.1	0.1	2.4	1.8	3.2	0.6	0.7	1.7	0.5	3.3	5.0	2.9	2.2	0.5	1.3	0.1	1.2	2.5	0.1	2.8	1.3	0.4	2.8	1.7	1.6	0.3	0.3	5.7	0.9	0.2	1.5	1.7	0.8	1.8	0.9	0.0	1.7	1.4	1.2	5.8	1.0	7.8	2.0	8.2	8.6	1.6	2.2	7.2	7.2	0.8	1.0	1.1	1.7	12.8	3.9	0.7	0.9	0.6	1.2	1.0	0.6	0.9	0.8	0.9	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
AP000350.4		ENSG00000251357	"Novel protein"		22	23862188-23895223	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 78.1;Club cells: 43.0;Fibroblasts: 25.6;granulocytes: 54.2;Melanocytes: 33.8;Respiratory ciliated cells: 44.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.1;SK-MEL-30: 1.6;THP-1: 1.5"									HPA042960	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"		"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA042960: AB_2678241"																		0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	1.1	1.0	0.0	0.5	1.6	0.1	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.8	0.0	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	78.1	0.0	0.2	16.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	54.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.2	0.0	15.5	0.0	0.0	3.3	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	14.5	0.0	9.0	0.0	0.5	0.0
AP000721.1		ENSG00000256100	"Novel transcript"		11	63974620-63988346	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.2;Club cells: 3.7;Respiratory ciliated cells: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055942	Uncertain					NA	NA						"Cluster 11: Alveolar cells - Smell perception"			"HPA055942: AB_2682979"		"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.96e-2)"	"unprognostic (3.95e-1)"					"unprognostic (2.67e-1)"			"unprognostic (7.06e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AP000781.2		ENSG00000254979	"Novel protein"		11	57387365-57424059	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 13.3;liver: 7.2;placenta: 7.1"	"Cell type enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.5"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 186.9"									HPA038515	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA038515: AB_10675800"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.55e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-10)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.10e-1)"	6.1	0.2	0.0	0.6	0.0	13.3	2.6	0.0	0.3	0.6	0.0	0.5	0.7	0.4	0.0	1.1	0.2	1.1	0.6	0.0	0.0	0.5	7.2	1.0	1.0	0.0	0.0	0.3	2.9	0.0	0.2	7.1	0.0	0.3	0.4	0.0	1.4	0.0	1.0	5.4	0.5	0.3	0.0	0.5	0.3	0.1	0.0	0.4	1.2	0.1	0.9	1.0	0.6	0.0	0.7	0.0	0.1	0.0	0.0	0.9	0.8	0.0	0.3	0.2	0.6	0.0	0.2	0.8	0.0	0.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	4.2	0.0	0.0	0.8	28.6	186.9	1.7	0.0	0.6	0.0	0.0	0.4	0.7	0.4	1.6	0.0	0.0	1.1	9.1	0.3	0.0	0.0	4.0	0.0	8.7	0.2	0.0	1.0	0.3	0.2	0.4	2.9	0.0	0.0	0.9	0.1	0.2	0.5	3.3	0.0	0.3	0.0	1.0	0.9	1.1	1.3	3.5	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP000812.4		ENSG00000284922	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q8WZ04	11	72080331-72110782	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 14.1;testis: 9.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0"									HPA039949	Approved		Uncertain	Microtubules		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"		Microtubules		"HPA039949: AB_10960708"																		0.1	0.0	0.4	0.0	0.5	0.0	0.2	0.6	1.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	14.1	0.0	0.0	0.3	0.6	0.4	0.2	0.6	0.0	0.4	0.4	0.2	0.0	0.5		0.0	0.4	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.3	0.2	0.0	9.5	0.4	0.0	0.1	0.0	0.0	0.1		0.6	0.2	0.1	0.0	0.2	0.7	0.2	0.1	0.4	0.5	0.3	1.2	0.2	0.2	0.0	0.1	2.9	0.5	0.6	0.4	2.9	0.3	1.2	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.8	0.0	1.3	0.4	0.1	0.1	0.6	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.0	0.0	0.6	0.5	0.2	0.9	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.9	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.8	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP001267.5		ENSG00000285827	"Novel protein"		11	118401602-118482737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 24.1;Club cells: 14.9;granulocytes: 20.2;Respiratory ciliated cells: 13.8"					"Region enhanced"	"Detected in many"		"cerebellum: 3.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044629	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA044629: AB_2679028"																		1.2	1.2	0.7	1.5	0.9	7.2	1.3	3.8	1.3	0.8	0.4	1.3	1.8	0.8	1.1	0.6	0.8	0.7	1.2	0.7	1.4	1.2	1.2	0.9	2.4	0.2	0.1	0.8	0.8	1.6		0.7	0.2	1.4	1.2	1.5	1.4	0.8	1.5	0.5	1.8	0.8	0.0	1.0	1.4	0.7	0.2	2.6	1.1	1.8	1.3	1.0		1.6	3.1	0.7	2.0	2.7	0.9	0.8	3.8	1.5	1.2	1.9	1.9	3.3	2.5	2.6	3.6	1.9	4.0	2.4	2.8	2.4	2.8	4.0	1.8	4.3	1.2	1.6	1.8	2.9	3.0	1.4	1.3	2.3	3.0	1.2	2.4	6.1	3.4	6.7	1.7	2.4	4.5	5.7	1.7	5.5	2.6	3.9	2.2	3.4	3.4	1.2	3.3	2.3	2.4	1.2	1.5	3.0	1.9	1.5	1.3	2.0	4.2	1.1	1.9	1.7	1.6	5.2	0.7	3.1	1.0	5.5	5.1	6.0	4.9	4.2	4.1	6.1	4.4	4.0	5.0	5.1	4.2	4.0	4.1	3.7	4.0	7.2	5.8	10.6	0.7	0.9	3.8	1.3	0.7	1.4	0.2	0.1	0.2	0.0	0.2	1.6	0.0	16.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
AP001273.2		ENSG00000284057	"Novel protein, C11orf54-MED17 readthrough"		11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"kidney: 9.5"	"Cell type enriched"	"Detected in single"	7	"Respiratory ciliated cells: 4.4"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		1.3	2.1	0.6	2.1	0.5	0.0	1.1	0.5	1.0	1.5	0.3	1.8	4.9	1.2	0.4	0.3	1.4	1.9	1.5	0.4	0.6	9.5	4.6	1.1	0.8	0.6	0.5	2.3	0.3	2.0	0.5	1.7	0.7	2.3	1.6	1.4	1.6	1.0	1.1	1.6	3.3	0.5	0.5	0.7	1.8	1.3	0.5	1.6	1.5	1.8	1.2	0.9	0.2	0.7	0.6	0.0	3.3	0.6	1.9	0.0	1.9	0.0	1.0	0.7	1.3	0.6	1.4	2.2	4.0	2.5	1.0	2.2	4.0	0.9	0.4	3.3	0.3	0.7	1.4	0.0	1.4	0.0	0.7	1.4	0.6	0.0	1.5	2.9	1.0	1.7	1.3	0.5	3.9	0.0	2.6	2.2	1.4	6.0	0.1	0.8	2.3	1.3	3.5	0.0	0.7	0.3	2.1	2.4	4.9	2.8	2.5	0.9	2.8	0.3	0.8	0.4	1.3	0.6	1.3	2.9	0.2	1.8	1.3	1.9	1.2	1.8	1.1	1.2	1.3	1.0	1.1	1.4	1.5	0.4	1.1	1.4	1.8	1.2	1.4	0.8	2.1	1.2	0.6	0.5	0.5	1.0	0.4	0.6	0.6	0.5	0.7	0.5	0.5	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP001781.2		ENSG00000258529	"Novel protein"		11	111786286-111879425	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;HeLa: 3.0"									HPA038575	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA038575: AB_10672718"																		0.6	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.6	0.0	0.0	0.7	0.7	0.4	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.2	0.7	0.0	0.2	0.1	0.3	0.3	1.1	0.1	0.4	0.2	0.2	0.4	0.0	0.0	0.1	0.1	0.0	0.5	0.5	0.0	0.7	0.1	0.8	0.0	0.1	0.0	2.8	0.0	0.1	0.5	0.0	0.8	1.0	0.0	0.0	0.6	0.2	0.0	1.7	3.0	0.2	0.0	0.0	0.3	1.0	1.0	0.7	1.5	0.4	0.0	1.0	0.1	1.0	0.0	0.0	0.6	1.3	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.9	0.0	0.0	0.7	0.0	0.1	0.0	0.6	0.6	0.0	1.2	0.3	0.5	0.1	0.8	0.7	2.1	0.3	1.5	0.2	0.3	0.5	0.5	1.2	0.6	0.8	0.5	0.7	0.7	0.6	0.6	1.3	0.6	0.0	0.7	0.5	0.7	0.2	1.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP002495.1		ENSG00000254469	"XRCC1 N-terminal domain containing 1-like"	Q6ZNB5	11	71865504-71928665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	1.9	2.1	1.9	2.2	2.8	4.7	3.2	4.3	2.6	2.8	2.8	2.2	2.6	3.7	5.3	2.6	2.4	2.1	2.1	1.7	2.2	2.9	2.2	1.8	4.2	2.5	1.5	4.6	3.1	2.9	2.5	2.0	2.4	3.1	3.5	7.3	2.2	2.8	1.6	4.2	2.6	2.4	0.6	2.9	2.4	3.3	2.8	3.2	3.2	1.5	3.4	2.3	2.2	5.0	2.6	6.2	4.7	4.5	1.8	1.6	3.1	2.9	2.3	3.1	3.0	6.5	6.4	5.8	2.6	2.0	3.9	8.4	4.9	3.3	3.2	8.4	4.5	9.4	7.7	4.2	1.1	4.2	3.1	2.2	1.6	5.2	3.6	2.6	4.9	8.0	6.3	7.6	3.0	4.9	4.8	3.5	4.9	9.6	4.5	3.6	16.3	4.0	3.5	3.1	6.9	6.6	4.6	4.1	9.2	3.3	5.1	2.3	4.6	2.5	4.1	4.9	1.9	5.5	8.4	7.0	4.0	4.6	3.7	2.7	1.9	1.7	2.9	3.0	1.7	2.5	5.1	3.8	2.2	3.3	4.8	4.1	2.0	1.2	1.9	4.8	4.9	1.9	1.9	2.8	4.3	2.6	1.7	2.2	2.5	1.5	2.4	0.6	2.8	5.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0
AP002748.5		ENSG00000256349	"Novel protein"		11	66509079-66533613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.9;choroid plexus: 1.9;retina: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 9.7;THP-1: 2.8"									HPA058283	Uncertain		Approved	Midbody		Yes	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"		Midbody		"HPA058283: AB_2683667"																		0.0	0.1	2.1	0.0	2.2	0.0	0.2	1.9	2.9	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	2.3	0.4	0.2	0.2	0.2	2.3	2.1	0.0	0.9	0.2	0.0	0.2	2.3	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.6	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	1.1	0.1	0.0	1.3	0.1	0.4	0.0	0.6	0.3	0.6	9.7	0.8	0.0	0.8	0.0	0.0	0.7	1.4	0.2	0.1	0.2	0.5	0.4	0.2	0.9	2.8	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	2.2	1.9	2.9	2.0	2.3	2.3	2.1	2.3	2.3	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP003108.2		ENSG00000256591	"Novel transcript"		11	61429220-61485822	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 1.4;Endometrial stromal cells: 1.5;Glandular and luminal cells: 1.4;Granulosa cells: 3.4;Respiratory ciliated cells: 1.5;Theca cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 28.0"					"Low region specificity"	"Detected in all"			HPA039732	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"HPA039732: AB_10962868"	"unprognostic (1.23e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-7)"	"unprognostic (5.74e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-3)"	5.1	4.7	2.7	4.0	3.1	8.7	4.0	3.0	3.9	5.9	2.6	2.7	2.2	3.6	3.1	3.4	3.2	4.8	7.0	3.1	3.4	3.6	2.4	3.8	4.6	3.2	3.3	2.1	2.0	2.3	1.3	3.1	3.3	3.3	3.3	1.0	2.6	2.7	1.8	1.7	2.6	4.2	3.0	4.4	3.4	2.9	3.2	7.7	5.1	5.9	4.8	5.4	1.9	3.1	6.8	3.3	3.8	6.1	9.7	8.1	2.0	8.9	7.6	6.6	6.2	2.6	4.5	7.1	14.5	8.3	5.5	3.0	4.5	6.3	3.9	6.3	5.3	5.4	0.9	0.9	11.4	4.2	2.0	15.6	3.8	9.8	7.8	4.2	16.7	9.2	5.8	6.0	10.9	5.3	14.1	4.0	8.5	5.8	4.5	8.4	5.8	8.6	4.4	5.4	3.0	3.8	3.7	3.5	12.6	2.5	4.9	4.8	28.0	8.4	4.7	4.5	5.0	2.2	9.5	4.8	7.2	5.5	6.3	5.9	8.0	8.4	11.6	7.3	14.6	5.9	11.5	11.8	6.3	6.8	13.2	12.3	11.2	7.4	6.8	6.8	12.9	10.2	2.7	3.1	3.0	3.9	3.1	3.4	3.2	3.3	3.3	3.0	3.2	3.1	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.6	3.7	0.0	0.3	1.4	0.0	0.0	0.2	0.0	0.7	1.5	0.6	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.4	1.3	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.6	1.5	0.0	0.0
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231740-112273110	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: AB_2683610"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favorable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favorable (7.79e-4)"	9.0	15.7	6.4	12.6	7.6	3.7	16.9	9.4	9.7	8.4	5.7	18.0	22.2	11.3	8.2	13.3	6.5	12.8	7.9	8.7	8.4	22.1	20.5	9.1	12.1	6.2	7.2	11.6	8.3	40.9	4.8	12.0	6.5	9.0	16.3	7.6	12.1	10.0	7.4	14.2	23.8	9.8	5.9	13.2	13.0	14.5	7.6	10.9	10.8	7.5	12.1	13.0	9.9	7.9	20.7	10.1	24.5	23.8	20.7	15.2	22.3	18.9	45.9	13.6	16.2	10.0	39.0	46.0	15.3	12.7	16.2	9.2	24.4	14.5	23.2	53.1	13.3	15.5	13.6	32.8	31.9	38.0	23.9	16.9	32.3	11.9	33.7	11.1	21.2	24.2	16.7	38.5	13.5	19.6	34.7	23.5	18.2	47.0	10.8	30.0	26.2	23.5	26.4	14.5	24.5	32.1	12.7	45.2	34.5	12.2	14.9	12.8	19.0	18.1	23.1	27.4	15.2	34.5	68.0	56.2	19.0	14.4	16.3	6.7	7.4	2.6	4.0	10.0	5.6	6.8	6.3	6.4	9.5	5.9	8.5	8.9	1.1	9.0	8.4	4.4	7.5	5.2	6.4	7.6	9.4	9.7	8.7	8.4	6.2	7.2	6.5	5.9	7.6	7.9	21.3	9.6	19.5	9.4	12.9	21.0	8.9	7.0	22.2	8.9	34.2	22.7	20.5	17.2	14.9	16.5	2.1	5.5	14.5	38.4	11.7	9.8	91.7	21.3	17.2	17.7	31.7	6.3	24.8	10.1	3.8	15.2	18.3	29.5	6.3	8.2	9.3	27.3	15.7	10.1	20.6	16.0	6.1	20.1	16.5	59.9	4.7	17.4	23.2	15.0	12.0	12.3	1.0	13.6	16.3	12.7	24.0	10.1	6.8	13.1	24.9	28.6	16.0	8.0	0.0	16.0	20.4	9.6	12.2	28.2	31.3	3.1	12.5	15.2	20.8	14.7
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 subunit gamma 1"	O43747	16	71729000-71809201	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		62000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	19.0	25.7	15.4	23.4	16.4	76.7	24.8	19.6	20.8	20.3	26.9	23.6	22.6	17.8	25.5	26.7	18.0	18.9	13.6	16.8	14.9	36.4	33.2	21.4	24.6	14.4	14.5	15.3	24.2	40.4	16.8	17.5	15.8	22.5	25.7	52.8	22.6	16.3	28.2	26.6	23.6	16.1	13.5	22.4	29.3	30.7	15.6	24.9	24.0	36.5	30.4	20.6	18.4	24.3	43.9	62.4	46.3	48.1	48.2	45.4	41.0	44.6	42.1	56.8	54.5	64.3	47.1	55.0	41.9	60.4	41.5	55.4	62.7	49.3	74.4	21.6	33.8	36.2	31.7	46.5	28.9	44.7	114.1	39.1	33.4	76.0	46.9	36.1	50.2	35.8	47.8	23.0	56.1	80.0	39.2	35.3	43.7	34.6	26.8	62.9	37.3	59.3	53.7	49.3	42.5	25.5	55.7	34.8	24.5	46.6	61.0	33.7	60.2	49.4	37.9	27.3	32.9	35.1	50.2	109.2	40.3	34.4	43.3	5.7	6.9	10.0	6.7	7.6	6.8	5.4	5.9	7.5	7.5	5.7	4.6	5.8	14.9	6.7	6.4	5.2	6.6	4.2	15.4	16.4	19.6	20.8	16.8	14.9	14.4	14.5	15.8	13.5	15.6	24.3	32.6	32.1	31.1	42.4	34.2	28.8	27.4	17.3	22.8	26.8	47.6	25.4	13.4	35.8	25.2	36.8	73.0	14.4	40.6	39.3	19.6	21.1	268.8	55.8	37.9	26.0	23.4	9.9	54.2	21.8	13.3	24.0	46.4	84.8	21.0	26.2	21.4	58.5	16.7	30.3	59.0	25.7	12.2	30.4	27.2	130.7	17.7	32.4	23.2	36.5	25.1	16.4	24.7	53.8	79.2	30.5	24.2	19.9	30.6	36.9	30.5	46.4	31.7	66.6	19.7	33.0	26.4	35.8	37.1	32.4	38.6	24.5	33.4	23.0	26.4	47.8
AP1G2	G2AD	ENSG00000213983	"Adaptor related protein complex 1 subunit gamma 2"	O75843	14	23559565-23568070	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 108.3;RT4: 151.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004106	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004106: AB_1078172"	"unprognostic (1.94e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.85e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-3)"	15.3	18.0	31.3	23.3	35.5	30.5	20.0	34.0	40.5	22.5	27.8	27.2	28.7	11.7	14.3	35.5	19.8	18.2	6.1	32.8	30.7	26.7	15.1	18.9	39.1	29.7	28.7	23.0	36.2	24.9	67.4	12.9	29.9	33.8	23.0	9.8	29.7	15.9	2.2	45.2	37.5	10.3	27.5	45.7	35.2	7.5	30.2	30.1	27.2	1.6	42.9	26.3	26.2	30.1	29.1	30.4	0.8	3.1	4.5	7.2	45.5	3.5	8.3	10.3	13.5	28.6	64.8	53.8	15.6	2.8	0.1	53.5	16.2	45.4	7.0	30.0	9.2	20.8	14.5	67.7	16.9	31.6	108.3	20.9	66.0	7.0	24.1	11.2	6.1	37.5	9.2	22.3	4.4	70.8	26.3	28.8	6.9	59.2	11.1	38.9	0.2	16.7	41.3	151.2	8.2	11.5	15.0	68.0	5.6	17.9	40.4	7.8	5.3	2.7	20.2	2.6	0.2	16.2	9.2	21.3	1.2	21.3	3.3	40.6	25.4	43.8	29.5	35.2	28.0	30.7	31.5	31.5	42.5	28.1	25.4	24.8	10.2	38.7	37.0	22.2	42.2	35.6	31.3	35.5	34.0	40.5	32.8	30.7	29.7	28.7	29.9	27.5	30.2	30.1	9.1	19.2	21.7	6.2	31.4	13.5	18.9	33.1	29.0	31.1	23.7	21.8	0.5	17.2	38.2	12.9	2.1	22.8	23.7	38.7	5.9	30.4	1.1	9.7	4.7	9.7	32.4	9.9	21.5	29.4	24.1	7.1	64.2	15.6	31.7	22.0	6.4	2.5	15.2	72.3	15.7	29.4	42.7	15.2	21.0	1.2	9.3	15.1	10.6	6.5	27.5	8.6	12.3	4.0	4.7	26.6	53.1	6.0	14.0	11.0	33.1	9.6	24.3	6.2	0.0	1.6	5.0	5.8	3.9	16.4	9.8	24.5	30.9	13.9	34.6	23.3
AP1M1	"AP47, CLAPM2"	ENSG00000072958	"Adaptor related protein complex 1 subunit mu 1"	Q9BXS5	19	16197854-16245906	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045256	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA045256: AB_10960697"	"unprognostic (5.10e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.56e-1)"	49.5	47.2	30.1	30.7	31.0	58.5	37.9	22.3	36.3	32.2	22.0	37.7	32.1	38.8	9.2	29.6	29.8	21.4	39.9	33.0	31.0	39.6	81.0	31.9	36.9	26.6	30.0	31.7	18.8	20.1	24.0	27.5	33.5	25.3	12.6	17.3	21.6	24.8	44.4	30.8	31.0	35.4	23.1	37.6	27.3	60.8	25.0	37.8	23.7	29.0	28.2	38.3	29.1	25.9	63.3	70.2	69.3	65.3	82.7	80.9	39.1	69.6	74.1	99.5	103.3	83.9	48.6	49.8	78.7	76.6	64.4	35.1	54.2	56.9	111.3	85.5	122.3	80.9	63.4	114.6	67.1	91.5	96.9	83.5	42.2	89.2	59.8	65.4	95.6	69.8	40.3	98.0	109.5	75.8	131.2	55.4	56.9	22.3	162.7	87.9	56.7	67.3	54.9	45.2	44.4	99.4	56.8	34.4	64.0	36.9	41.0	73.1	83.1	111.8	45.6	151.7	134.3	104.6	141.6	54.9	125.5	112.8	88.7	89.4	142.3	243.9	104.8	180.7	105.6	99.8	103.4	111.2	121.6	92.3	115.1	147.0	101.8	133.1	235.7	131.2	161.8	174.3	30.1	31.0	22.3	36.3	33.0	31.0	26.6	30.0	33.5	23.1	25.0	25.9	17.4	41.7	31.2	12.7	30.6	4.6	7.4	13.2	11.4	35.4	11.3	10.9	17.9	14.3	15.2	12.9	20.9	32.1	30.5	8.3	15.6	21.1	32.5	10.6	27.2	22.7	19.8	21.7	11.8	18.2	40.4	28.1	8.6	14.8	27.1	19.0	21.8	41.9	42.6	42.1	11.7	7.3	6.1	36.0	13.3	92.1	23.0	30.2	10.6	5.6	34.9	18.3	38.1	4.5	12.8	31.2	5.9	19.9	24.5	6.2	25.1	23.6	13.9	40.2	0.0	26.1	22.8	61.9	23.3	12.6	7.1	17.5	32.9	17.7	9.0	4.6
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 subunit sigma 2"	P56377	X	15825806-15854931	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 663.3"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 221.1;monocytes: 326.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 298.0;SK-MEL-30: 442.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	28.3	21.4	24.6	36.7	28.4	38.3	15.0	32.0	36.9	31.6	27.3	42.1	11.9	52.2	663.3	21.4	13.5	20.1	74.8	25.1	48.0	13.1	15.9	25.8	33.2	42.7	35.8	8.8	7.8	16.7	19.4	42.0	47.0	11.6	22.0	43.7	9.5	30.5	70.1	14.0	20.1	76.3	34.4	43.0	19.5	23.4	29.6	28.7	12.5	93.7	28.8	26.1	12.7	33.8	12.0	14.2	130.1	78.4	29.5	19.1	5.0	47.1	22.7	31.1	41.1	9.6	11.1	22.6	183.0	72.6	50.4	16.1	31.7	10.8	57.0	30.1	64.9	15.3	16.7	14.7	24.2	63.1	16.9	12.2	11.2	36.0	33.1	50.4	78.1	19.1	14.3	298.0	72.4	8.7	12.9	39.5	171.0	6.4	42.5	29.5	116.7	50.6	37.4	2.5	14.8	69.2	18.4	4.8	442.2	84.1	52.7	69.2	43.9	67.8	21.2	92.5	41.9	25.5	58.7	37.3	33.6	28.0	159.7	50.9	326.8	34.6	21.1	325.0	24.8	30.8	25.5	20.6	221.1	28.0	18.5	18.1	52.8	27.9	175.4	82.2	38.1	228.0	24.6	28.4	32.0	36.9	25.1	48.0	42.7	35.8	47.0	34.4	29.6	33.8	130.8	3.2	13.1	37.2	77.0	55.2	12.7	9.1	8.6	34.7	12.0	11.4	195.6	12.8	3.2	9.2	12.5	5.3	114.2	9.2	33.2	13.7	5.1	50.4	32.6	166.3	26.9	32.6	15.1	6.4	18.9	38.0	7.7	78.0	78.6	15.6	147.4	8.6	259.8	11.8	73.2	8.4	12.2	392.6	609.2	17.5	17.4	362.7	149.4	31.9	630.0	21.1	62.8	19.1	85.0	10.3	14.0	7.2	26.0	19.0	6.5	9.0	1.6	39.3	39.5	26.7	39.1	55.7	28.8	10.6	51.6	5.6	58.3	4.0	8.5	6.7
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 subunit sigma 3"	Q96PC3	2	223751686-223838027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 52.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Cytotrophoblasts: 48.2;Pancreatic endocrine cells: 44.2;Urothelial cells: 69.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.9;dendritic cells: 4.0;granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 151.1;RPTEC TERT1: 56.8;RT4: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066782	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	0.7	0.8	3.4	3.3	3.2	4.0	2.1	3.9	3.5	2.2	0.5	2.7	5.3	0.9	52.8	4.8	2.3	5.2	0.5	2.8	3.0	5.6	1.4	4.7	4.2	2.0	1.6	0.5	2.4	3.8	1.1	6.6	1.5	2.9	2.6	5.7	1.6	5.4	0.9	1.9	5.0	0.7	1.1	2.8	9.8	0.9	3.2	1.6	14.4	0.3	5.2	8.1	1.2	2.1	28.7	17.7	2.4	12.0	1.5	0.6	13.5	11.5	2.4	4.9	4.2	151.1	21.8	11.0	8.0	1.7	5.8	43.8	6.4	30.3	6.8	15.3	8.9	1.2	33.7	15.7	0.6	3.4	1.3	0.6	31.2	9.1	30.1	11.2	3.4	5.8	1.8	2.9	2.9	12.3	0.6	0.9	3.8	32.8	15.5	4.3	0.1	4.5	56.8	52.1	7.4	2.1	5.4	11.8	3.8	6.1	5.0	6.3	2.0	1.6	4.6	3.1	9.2	10.2	9.0	28.2	4.4	2.0	6.0	4.9	0.5	0.3	0.6	0.4	0.5	4.9	0.4	0.4	1.2	2.7	0.4	0.5	1.8	0.6	0.2	4.0	1.0	0.4	3.4	3.2	3.9	3.5	2.8	3.0	2.0	1.6	1.5	1.1	3.2	2.1	0.4	35.3	6.7	8.8	24.2	4.2	32.6	15.3	4.0	3.3	4.3	1.8	1.7	0.0	15.8	11.0	64.6	48.2	13.6	3.6	9.8	17.5	0.2	8.1	2.1	2.1	2.4	0.0	19.3	18.1	3.4	3.5	11.7	26.1	3.8	0.8	0.7	0.4	4.7	6.7	9.6	3.6	16.2	1.6	38.1	0.0	0.3	7.5	3.6	4.7	7.4	1.9	6.2	10.6	4.0	44.2	4.6	0.0	10.7	26.6	5.4	4.5	10.3	5.9	0.0	1.1	1.8	0.3	1.9	6.3	4.1	13.1	6.9	1.0	4.7	69.6
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 subunit alpha 1"	O95782	19	49767001-49807114	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 165.0;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.5"	"Lineage enriched"	"Detected in all"	4	"monocytes: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles		NA	NA		61000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	47.0	87.4	37.4	25.2	47.9	54.4	41.2	20.6	49.2	48.1	9.0	42.2	24.7	56.6	7.4	46.5	48.2	19.6	52.2	44.2	31.8	33.3	51.1	37.2	19.5	45.8	31.4	57.1	33.8	13.9	34.3	31.4	45.3	33.0	9.9	13.9	28.9	18.6	89.6	54.2	34.0	21.4	17.8	47.6	36.3	88.8	50.0	15.4	30.5	26.9	13.2	46.0	43.6	35.8	70.9	100.3	33.8	78.7	59.5	72.2	69.0	82.0	55.3	49.7	51.8	52.0	43.5	31.5	30.6	85.2	41.9	62.8	25.7	59.0	21.1	50.1	58.4	46.6	66.1	56.8	65.3	37.7	75.0	113.6	42.3	55.4	28.7	44.2	59.5	51.3	118.5	42.7	47.6	55.8	41.6	50.2	34.6	66.6	101.8	46.6	79.7	40.4	29.6	88.1	25.7	34.7	90.1	61.1	34.3	36.1	52.1	52.9	82.9	128.4	70.6	54.6	59.3	63.1	83.5	33.1	90.5	54.8	55.1	0.3	5.3	3.4	2.0	12.8	1.4	1.2	1.2	1.2	4.6	1.0	0.9	1.3	4.0	2.3	20.5	1.4	1.6	4.8	37.4	47.9	20.6	49.2	44.2	31.8	45.8	31.4	45.3	17.8	50.0	35.8	22.9	0.0	2.3	19.6	18.5	13.8	19.0	18.5	14.8	45.1	26.7	19.0	2.9	14.3	11.7	14.7	43.8	90.8	21.8	39.1	11.7	16.1	129.9	23.0	57.1	22.4	2.4	106.5	24.2	29.4	35.3	36.0	22.4	16.0	8.9	33.2	39.3	36.6	31.3	50.5	25.5	17.4	8.2	56.2	21.3	165.0	53.4	34.0	19.6	14.0	40.4	31.5	63.8	14.1	21.8	27.3	19.0	61.7	28.1	16.3	41.2	50.4	14.9	30.2	59.2	23.2	28.5	54.7	59.2	22.1	13.9	241.6	23.2	48.6	23.9	24.3
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 subunit alpha 2"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		10000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	20.1	18.0	3.5	1.3	5.1	4.5	16.6	10.8	9.9	20.3	1.4	23.0	5.4	17.9	1.5	12.7	18.1	2.0	19.1	5.5	3.5	34.4	29.9	18.9	3.2	0.9	2.1	17.5	25.3	3.7	25.6	5.2	3.0	20.3	4.9	5.8	14.6	4.0	14.1	14.5	19.6	5.6	0.0	57.6	20.6	15.5	3.3	3.8	13.9	1.6	2.5	19.0	15.7	1.4	7.5	2.9	3.7	10.7	13.8	14.2	9.1	10.2	3.3	6.0	4.9	1.3	7.3	7.4	8.7	12.3	5.7	8.9	8.9	5.6	3.9	5.5	23.2	2.1	10.4	3.9	5.3	2.8	4.9	16.8	6.1	3.1	6.1	14.8	8.5	5.0	5.9	4.7	6.3	0.4	2.6	3.2	2.0	9.1	17.9	4.2	2.6	8.1	9.2	6.2	12.3	10.0	11.4	9.2	1.7	6.3	5.4	0.8	13.3	1.9	2.3	2.8	5.2	4.3	3.9	5.3	4.0	3.7	3.1	1.5	1.7	1.5	1.1	1.7	0.5	0.5	1.1	0.6	1.4	1.0	1.1	1.2	2.1	1.1	1.4	1.3	2.1	0.6	3.5	5.1	10.8	9.9	5.5	3.5	0.9	2.1	3.0	0.0	3.3	1.4	38.1	38.5	21.8	29.4	14.3	14.3	12.4	13.3	7.4	50.9	27.2	23.0	12.9	21.5	15.9	62.5	60.5	42.1	17.3	45.3	39.2	37.5	46.7	64.0	44.6	36.6	35.2	27.1	37.2	18.0	45.2	28.7	16.3	86.7	27.3	31.0	80.3	59.8	82.8	101.0	36.4	32.3	18.3	104.7	26.9	28.3	34.5	51.8	8.8	41.2	31.2	30.4	39.1	23.1	21.9	25.8	24.2	27.8	13.6	16.9	43.5	70.4	23.5	69.2	26.3	20.7	22.6	72.7	28.0	11.2	11.4	28.5	19.7	30.5	37.0	11.5
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 subunit beta 1"	P63010	17	35578046-35726413	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 503.9;Late spermatids: 739.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		380000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	46.4	42.4	77.0	38.2	87.8	49.2	58.3	69.9	88.7	54.1	76.6	67.6	33.5	41.7	70.7	25.1	46.7	42.3	67.6	92.1	83.5	69.0	35.0	53.4	38.6	69.8	78.6	57.2	33.2	126.4	55.0	66.8	76.8	40.9	84.0	76.1	41.9	50.1	57.5	29.9	38.8	56.0	80.3	42.0	48.4	93.5	78.7	59.7	65.1	61.0	45.5	46.8	34.4	95.0	188.8	233.9	113.7	132.0	184.4	202.8	51.6	94.3	138.9	131.0	141.1	129.0	154.6	90.5	81.1	175.3	168.8	173.2	162.5	264.8	190.8	108.6	147.0	117.7	161.8	71.0	104.7	119.3	80.8	128.9	104.3	134.5	209.3	151.2	211.4	111.8	190.6	126.9	206.9	36.9	113.7	58.7	94.2	98.9	164.5	94.3	165.1	64.7	166.2	108.3	94.4	114.1	114.5	39.6	126.9	273.3	161.5	78.5	211.5	99.3	93.4	109.8	142.1	53.0	106.1	84.7	124.1	86.9	112.5	19.6	11.8	16.7	16.0	15.3	16.9	12.1	13.9	14.3	10.7	11.9	6.3	8.0	13.3	9.6	16.8	10.7	20.5	11.0	77.0	87.8	69.9	88.7	92.1	83.5	69.8	78.6	76.8	80.3	78.7	95.0	76.5	16.0	17.0	49.3	45.9	31.1	26.3	57.4	70.6	67.6	88.9	50.9	62.5	68.6	37.4	112.2	56.3	29.7	70.7	97.4	117.4	105.0	503.9	74.5	83.7	56.8	71.3	214.7	105.5	120.2	42.8	47.1	36.2	85.4	41.2	46.5	79.9	64.5	44.1	69.0	109.8	79.4	28.5	54.3	25.9	739.2	58.7	37.2	16.0	60.0	47.3	52.6	74.2	81.4	89.0	177.9	46.6	68.4	32.1	37.4	39.4	102.5	30.4	40.9	59.2	25.3	37.6	258.8	60.0	19.6	14.6	32.8	49.2	37.3	89.8	29.1
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 subunit mu 1"	Q96CW1	3	184174689-184184091	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		7500	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	191.8	364.2	233.5	164.7	250.3	231.3	164.6	211.3	257.3	222.8	196.3	232.4	167.5	216.4	104.2	218.1	178.6	166.5	366.2	261.1	249.0	196.0	140.9	180.0	148.2	234.8	211.1	198.6	106.4	224.8	224.9	243.3	248.9	183.2	141.1	230.4	167.2	231.8	181.2	157.2	156.2	243.7	200.9	162.5	156.3	106.4	235.4	158.4	148.0	194.0	157.6	223.7	192.4	225.6	436.3	327.5	275.7	311.8	432.1	450.8	284.3	714.3	412.5	788.5	550.5	355.1	309.9	198.2	851.3	1076.1	516.1	480.0	376.3	482.9	647.1	409.8	470.4	512.2	365.8	317.9	508.9	254.8	311.5	577.0	269.4	501.1	318.5	711.0	595.3	258.3	250.0	377.1	750.1	993.6	330.1	151.2	674.1	388.1	484.7	302.7	351.5	393.7	489.7	389.3	292.0	212.6	561.3	696.4	335.1	427.5	934.4	305.7	645.0	497.1	400.1	492.4	960.2	336.9	318.7	441.6	937.1	369.9	331.7	194.4	294.8	244.9	137.5	238.8	136.2	114.3	127.6	134.0	268.7	112.7	107.7	111.8	127.7	170.2	206.8	134.1	185.4	441.0	233.5	250.3	211.3	257.3	261.1	249.0	234.8	211.1	248.9	200.9	235.4	225.6	146.8	54.5	50.7	41.4	84.8	124.9	177.2	275.1	97.9	174.2	108.0	98.2	195.9	112.9	133.5	114.0	70.9	400.9	117.3	155.9	375.6	243.7	326.6	69.3	131.2	172.2	140.8	277.8	62.0	161.3	327.1	161.5	71.4	78.5	149.1	173.6	182.4	78.0	576.9	277.6	63.4	119.0	201.4	137.1	162.9	347.8	164.7	185.1	199.3	34.7	369.4	199.4	130.7	26.2	46.1	232.1	153.1	214.8	100.2	138.8	253.8	290.7	58.3	125.9	197.2	106.9	278.0	83.3	101.7	128.5	126.6	513.6	102.6	278.1	154.1	185.1
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 subunit beta 2"	Q13367	15	82659281-82710112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7;pituitary gland: 18.8;retina: 33.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	0.7	4.5	15.3	0.9	18.6	1.1	1.4	15.5	20.7	0.9	0.0	1.1	0.7	1.1	2.3	0.7	0.9	0.4	0.2	19.6	5.5	0.6	0.2	0.3	0.5	15.6	5.4	1.2	2.1	12.7	18.8	0.6	13.2	1.4	0.6	33.0	0.9	1.4	0.3	0.9	0.9	1.3	1.1	0.7	1.1	6.2	4.7	1.0	2.1	0.4	1.3	0.8	0.6	11.3	0.2	0.4	9.5	3.2	1.6	0.2	5.7	0.5	0.0	0.8	0.2	0.4	0.4	0.8	4.9	0.2	1.8	0.9	1.0	0.0	0.2	3.2	0.7	0.3	0.4	0.2	0.3	0.4	1.8	1.0	1.1	0.1	0.7	0.1	0.0	2.8	1.0	0.7	0.1	2.5	0.3	0.5	9.5	0.1	0.1	0.3	0.0	0.2	0.0	17.3	29.0	17.5	3.2	1.4	2.4	1.0	0.2	1.9	0.2	0.3	0.9	0.4	1.3	1.6	8.8	0.7	2.2	0.5	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.2	0.9	0.1	0.1	0.4	0.0	0.1	15.3	18.6	15.5	20.7	19.6	5.5	15.6	5.4	13.2	1.1	4.7	11.3	0.1	0.0	1.1	20.9	0.1	0.4	2.1	0.6	1.2	18.4	1.5	2.3	0.8	0.0	0.1	0.0	27.1	0.1	0.2	0.1	0.0	0.2	8.0	0.2	0.6	0.1	13.9	0.0	61.7	0.4	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	13.5	56.9	0.5	6.1	0.0	0.6	5.4	0.9	0.1	0.0	4.7	0.0	4.1	0.0	44.7	22.8	0.0	0.1	0.4	1.2	0.7	0.0	0.4	0.0	58.6	0.0	1.3	0.7	9.8	3.1	0.7	0.1	0.0	0.1	0.2	0.0	0.6
AP3M1		ENSG00000185009	"Adaptor related protein complex 3 subunit mu 1"	Q9Y2T2	10	74120255-74150842	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045591, HPA048380"	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA045591: AB_2679377, HPA048380: AB_2680379"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.43e-2)"	24.6	23.3	9.8	22.6	11.2	16.3	22.5	13.2	13.6	21.3	11.9	21.8	20.7	23.2	16.5	25.6	20.0	18.0	21.5	9.9	13.6	19.7	27.1	19.2	25.6	12.8	15.1	20.0	24.1	36.0	9.0	32.4	13.6	26.1	27.5	17.6	19.0	22.7	14.3	17.3	19.1	29.0	12.3	21.8	20.4	17.6	11.2	30.5	24.5	20.6	32.8	25.7	14.5	14.5	51.8	52.3	64.8	74.3	41.9	56.3	44.1	50.9	65.1	61.1	67.8	60.1	45.9	52.2	34.0	49.2	35.2	55.0	76.7	48.3	74.6	51.8	55.4	43.6	39.4	35.8	34.9	72.9	43.5	40.0	27.5	52.7	43.6	66.9	81.8	43.5	84.9	63.2	55.2	28.2	70.0	34.0	28.2	56.6	266.0	61.9	52.4	41.7	46.1	40.4	30.5	47.5	40.2	102.5	57.3	52.5	97.6	41.3	60.5	31.0	44.5	40.1	60.4	33.3	62.2	75.0	51.1	80.7	31.3	38.1	22.5	16.9	20.5	24.4	23.6	19.9	18.1	21.5	24.5	18.6	18.9	20.1	13.8	23.5	29.3	15.6	19.3	23.2	9.8	11.2	13.2	13.6	9.9	13.6	12.8	15.1	13.6	12.3	11.2	14.5	11.5	28.9	12.1	8.8	19.7	11.0	13.3	10.6	18.8	8.2	17.8	12.2	8.6	11.5	17.3	11.0	33.3	38.3	27.8	15.4	7.9	14.1	2.0	16.8	15.1	15.9	12.0	12.4	16.7	15.7	16.8	15.3	18.3	23.6	12.7	20.9	14.3	19.5	21.1	21.9	15.2	17.6	8.2	19.8	8.2	2.0	17.4	17.4	10.6	8.4	23.1	17.3	17.5	18.6	13.7	15.8	10.2	13.9	18.6	13.6	12.3	10.6	5.8	14.5	19.7	12.7	19.4	19.9	14.7	23.6	13.5	34.2	19.2	20.1	15.4	12.9
AP3M2	"AP47B, CLA20"	ENSG00000070718	"Adaptor related protein complex 3 subunit mu 2"	P53677	8	42152946-42171673	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014876, HPA045591, HPA048380"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"CAB014876: , HPA045591: AB_2679377, HPA048380: AB_2680379"	"unprognostic (5.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.32e-1)"	"unprognostic (8.04e-2)"	"prognostic favorable (2.38e-4)"	9.1	11.3	26.0	8.0	27.0	11.2	8.8	18.5	27.4	9.2	14.4	8.5	7.2	10.5	13.0	7.0	16.4	10.5	14.1	27.9	25.7	12.4	4.6	12.7	12.4	22.9	21.4	9.5	6.5	22.7	13.3	20.6	24.2	10.3	8.7	41.9	6.2	11.5	8.9	12.6	7.8	9.9	20.8	10.4	7.0	23.6	26.9	8.3	13.5	10.6	10.4	9.9	8.1	21.2	20.6	20.8	18.2	21.4	16.2	15.9	4.0	23.5	23.3	22.0	25.7	11.7	24.4	12.3	14.7	13.5	24.8	23.9	28.6	14.8	28.4	17.0	26.9	23.4	17.8	8.1	14.7	10.1	13.4	14.5	25.1	24.0	13.6	30.5	15.0	35.1	28.5	11.3	20.2	9.7	30.0	11.9	20.4	25.0	14.5	28.6	34.7	13.2	16.8	24.0	25.9	18.6	14.4	7.2	26.1	18.8	21.2	6.4	9.6	13.4	19.2	20.0	10.9	9.6	19.5	11.2	18.8	1.4	37.8	2.9	1.9	1.5	7.5	2.7	9.7	4.7	15.5	8.1	4.2	3.0	14.4	5.7	2.3	7.7	2.8	6.8	5.9	5.0	26.0	27.0	18.5	27.4	27.9	25.7	22.9	21.4	24.2	20.8	26.9	21.2	16.2	12.8	3.3	16.6	13.6	17.5	20.3	8.0	9.1	35.9	6.9	7.4	17.0	1.5	9.3	14.7	39.6	7.0	21.3	2.6	5.9	12.9	59.8	15.7	11.6	18.1	3.0	10.8	26.2	7.4	4.8	11.5	6.6	11.1	3.8	12.1	18.5	4.3	6.6	35.3	33.6	3.0	16.2	2.1	10.1	70.1	5.3	6.5	37.4	14.0	13.5	19.6	11.3	15.1	16.0	16.3	1.8	9.1	17.1	8.9	0.9	6.8	18.8	37.1	19.7	8.1	15.0	26.8	45.0	6.6	19.7	2.9	41.5	11.0	4.3	15.4
AP3S1	CLAPS3	ENSG00000177879	"Adaptor related protein complex 3 subunit sigma 1"	Q92572	5	115841592-115914081	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA049270: AB_2680696"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (2.73e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-1)"	63.1	44.5	57.0	38.7	59.7	133.3	60.1	55.2	84.5	70.1	54.6	53.7	61.9	55.1	113.6	65.8	46.1	49.2	52.6	61.5	60.7	37.4	74.7	38.1	64.6	62.3	60.3	69.6	63.2	24.9	19.7	60.1	62.8	43.6	60.1	34.0	59.4	85.6	21.9	60.7	81.5	64.1	59.1	39.0	37.7	57.3	58.4	41.1	49.3	34.4	61.1	60.2	25.4	59.5	134.3	44.8	95.2	63.4	257.4	369.1	89.2	142.6	132.4	94.1	152.0	98.9	121.4	107.5	68.4	162.8	115.4	38.1	58.8	230.4	157.6	320.3	114.4	45.1	43.8	146.2	139.8	76.2	84.6	168.6	177.9	100.2	112.1	123.5	109.4	122.1	47.1	80.9	150.3	49.9	87.3	129.0	71.1	65.5	74.4	85.0	141.9	172.0	123.2	58.8	35.1	53.8	222.8	42.7	146.3	86.2	70.3	116.1	115.4	173.1	116.5	127.1	113.4	71.6	47.3	91.8	129.9	144.2	73.5	81.9	70.7	174.8	37.6	79.2	63.7	67.1	47.1	52.3	54.5	47.3	39.9	41.6	110.0	48.3	75.8	94.8	60.3	70.6	57.0	59.7	55.2	84.5	61.5	60.7	62.3	60.3	62.8	59.1	58.4	59.5	75.6	22.4	21.9	31.3	90.1	203.0	92.8	308.5	95.0	68.0	72.9	59.3	26.4	67.2	115.0	46.0	25.0	74.1	95.0	129.7	70.5	93.6	130.2	37.8	62.1	73.9	76.1	31.7	83.1	86.5	309.4	158.3	43.8	35.1	83.6	39.6	81.8	87.2	152.6	26.9	61.2	131.5	105.8	111.7	185.7	217.4	173.1	88.4	115.6	68.4	103.9	19.6	74.2	46.3	49.9	111.4	105.5	111.3	103.6	118.3	361.1	156.7	59.8	77.7	32.9	48.2	118.0	108.8	104.7	131.5	227.9	128.7	79.0	60.7	74.9	112.5
AP3S2	sigma3b	ENSG00000157823	"Adaptor related protein complex 3 subunit sigma 2"	P59780	15	89830599-89894638	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA049270: AB_2680696"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (5.55e-16)"	"unprognostic (7.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.67e-3)"	24.2	20.3	15.1	11.2	15.8	10.4	19.4	14.9	18.1	17.3	13.3	19.3	10.9	13.0	16.3	20.7	17.3	17.5	30.7	15.0	17.0	36.5	40.5	16.3	12.9	16.0	18.4	20.0	19.0	32.6	9.0	18.5	18.4	15.3	19.2	44.0	13.5	21.4	44.8	8.7	10.2	18.0	15.0	12.6	10.0	12.5	16.7	20.1	26.2	45.2	17.7	15.3	6.8	16.7	13.5	60.6	33.4	35.6	66.7	45.6	28.0	58.8	75.2	74.3	59.7	26.0	34.8	12.1	51.3	39.1	48.9	31.0	57.4	33.1	58.3	51.2	29.0	37.3	25.4	33.6	28.1	16.1	22.3	30.9	40.4	20.7	41.6	40.6	38.8	30.8	29.1	32.8	48.0	27.7	27.6	8.7	37.2	68.5	11.6	15.9	33.8	25.0	42.1	35.9	25.5	22.3	69.4	43.1	40.4	69.8	26.9	14.1	16.3	40.0	19.2	62.1	19.6	28.3	94.5	28.9	35.8	18.7	24.1	6.3	16.6	7.8	5.0	15.4	7.8	4.5	7.2	7.4	11.6	6.3	5.7	4.0	16.1	8.3	19.9	7.4	8.4	10.6	15.1	15.8	14.9	18.1	15.0	17.0	16.0	18.4	18.4	15.0	16.7	16.7	5.9	12.8	15.4	0.0	5.9	3.3	4.0	6.0	5.2	22.0	8.0	5.7	18.2	10.0	11.2	5.5	35.5	8.9	6.1	34.4	9.8	13.4	3.1	5.9	10.8	7.2	14.4	5.0	0.0	16.1	4.2	9.0	8.2	7.1	8.2	15.4	8.9	17.0	6.4	18.5	0.0	11.4	2.0	12.0	6.4	3.2	7.2	9.7	8.8	0.0	16.9	17.3	9.2	0.0	0.0	13.4	16.4	7.5	8.6	5.8	15.8	13.7	9.8	30.6	0.0	6.1	6.0	11.6	8.3	6.1	2.8	6.4	6.2	28.5	15.2	4.2
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
AP4M1	"MU-4, MU-ARP2, SPG50"	ENSG00000221838	"Adaptor related protein complex 4 subunit mu 1"	O00189	7	100101549-100110345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 95.9;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066774	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA066774: AB_2685718"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (1.58e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	8.4	7.3	9.9	4.7	9.9	4.9	9.6	9.6	12.1	11.4	10.0	15.2	12.5	15.7	6.1	10.3	12.4	8.5	9.8	9.9	10.0	10.3	4.7	8.8	6.3	11.2	10.5	9.3	12.3	7.7	15.4	5.6	10.7	12.3	6.2	6.4	10.1	11.0	10.7	11.7	9.9	8.0	10.0	7.2	12.8	32.6	10.9	6.1	10.9	5.5	4.6	12.4	10.3	10.1	9.3	13.0	13.9	35.4	7.8	17.8	15.8	5.5	9.6	7.1	8.9	10.6	23.7	11.1	25.2	13.4	10.2	9.9	6.1	12.0	3.9	8.9	8.6	6.2	12.7	9.4	16.2	7.2	10.9	15.1	20.5	20.7	12.5	13.7	23.5	14.3	11.9	8.4	24.6	28.7	25.9	14.1	10.9	8.4	13.3	21.8	7.0	13.9	18.0	11.9	24.2	21.1	14.0	40.9	11.9	7.9	18.6	14.0	26.0	21.2	16.9	19.8	9.4	6.2	6.8	16.8	17.7	8.3	18.8	4.3	6.3	9.1	4.5	7.9	4.1	5.3	4.0	5.1	8.7	3.4	1.8	3.2	2.1	3.2	10.8	5.3	4.5	4.3	9.9	9.9	9.6	12.1	9.9	10.0	11.2	10.5	10.7	10.0	10.9	10.1	12.6	16.0	4.6	20.5	10.4	9.4	17.3	17.7	9.1	17.7	14.2	17.8	3.2	20.0	13.3	16.5	52.1	14.7	6.8	17.7	7.9	24.4	69.3	20.3	14.6	12.5	12.1	8.2	9.5	19.0	18.1	12.4	14.8	11.2	3.8	22.8	13.2	3.3	9.9	6.7	7.0	15.6	12.2	7.3	7.7	95.9	14.6	6.9	14.2	10.3	14.5	21.0	8.2	6.0	8.1	19.6	17.7	12.8	5.9	13.7	21.9	11.1	29.5	67.9	13.1	15.3	12.4	84.7	39.5	8.8	8.4	14.0	8.2	16.0	14.2	11.2
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 subunit sigma 1"	Q9Y587	14	31025106-31130996	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.8	6.3	9.8	6.6	10.6	6.0	5.7	14.1	12.8	6.5	5.6	8.6	3.9	7.7	7.0	4.9	7.3	5.4	8.7	9.5	10.2	7.8	6.2	5.4	8.1	6.3	6.5	10.7	7.9	6.5	8.5	6.7	6.1	6.2	4.1	11.9	5.2	6.7	12.6	4.6	4.4	7.9	5.4	8.0	4.3	18.4	9.0	6.6	8.8	7.2	7.7	6.2	4.8	10.1	9.0	12.6	11.0	3.2	4.4	7.9	8.5	6.0	10.4	9.6	9.5	12.2	14.5	10.6	5.5	7.3	7.2	9.7	7.6	9.4	15.9	9.1	4.4	16.4	5.5	19.0	9.5	14.1	9.2	6.3	5.9	9.6	12.0	6.4	11.7	8.0	8.4	7.0	10.3	12.5	9.7	7.8	13.1	10.5	10.9	10.3	9.8	1.4	10.5	12.4	6.1	6.1	10.7	5.1	16.3	7.3	10.8	6.5	8.8	7.3	6.5	5.0	5.2	8.6	17.0	15.9	4.2	4.4	5.7	3.4	1.3	2.4	2.5	3.5	3.7	3.3	3.8	3.0	1.2	3.4	3.7	4.5	2.6	5.8	2.8	3.3	6.6	1.7	9.8	10.6	14.1	12.8	9.5	10.2	6.3	6.5	6.1	5.4	9.0	10.1	7.1	9.6	7.7	10.7	8.1	3.4	6.5	6.5	1.2	12.1	4.0	4.3	16.5	4.3	3.1	5.5	31.3	9.1	7.6	3.9	5.9	7.6	21.9	5.2	8.8	6.7	6.0	3.8	29.4	4.8	5.3	6.2	7.1	5.8	7.6	7.8	10.8	4.0	7.4	6.7	24.9	3.8	4.1	5.4	4.1	17.0	6.8	6.0	3.6	12.2	7.5	9.3	5.2	25.1	16.4	2.8	6.2	8.6	4.2	4.0	5.0	7.7	8.1	24.4	6.6	8.5	8.1	36.0	8.3	3.0	2.8	11.5	7.3	8.2	4.0	5.2
AP5B1	"AP-5, DKFZp761E198, PP1030"	ENSG00000254470	"Adaptor related protein complex 5 subunit beta 1"	Q2VPB7	11	65773898-65780976	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 44.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065739, HPA067880"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Golgi apparatus"	"HPA065739: AB_2685550, HPA067880: AB_2685914"	"unprognostic (3.64e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.67e-1)"	8.3	4.8	3.2	6.9	2.6	44.0	6.6	5.8	3.6	5.4	1.3	6.0	5.7	7.1	2.0	10.2	5.2	3.1	5.0	3.6	1.2	5.7	5.8	8.7	4.7	3.9	1.5	2.9	10.3	6.4	3.5	3.8	3.0	5.0	3.0	2.5	7.0	4.5	9.6	9.1	6.8	3.2	1.1	10.0	6.0	2.5	1.8	4.8	4.9	3.4	4.3	6.6	5.1	1.6	12.8	9.8	2.8	14.3	8.6	4.1	16.4	5.3	6.2	6.1	4.7	7.7	6.0	7.8	9.4	6.3	12.4	15.8	8.7	4.3	2.9	12.1	10.1	7.0	12.0	3.8	5.8	9.9	13.3	7.0	10.1	4.0	2.9	6.0	5.2	13.6	15.6	9.7	3.6	9.2	5.5	10.5	4.6	4.4	10.1	17.3	0.5	16.8	5.9	15.8	2.7	5.4	4.1	2.6	26.0	3.7	4.4	14.1	7.6	10.2	8.6	13.6	6.0	10.0	11.2	8.1	7.5	8.5	10.5	1.1	1.7	0.6	0.5	1.0	0.2	0.3	0.2	0.2	0.5	0.3	0.3	0.2	25.0	0.4	1.3	0.3	0.2	0.8	3.2	2.6	5.8	3.6	3.6	1.2	3.9	1.5	3.0	1.1	1.8	1.6	2.0	0.0	8.8	6.2	3.9	2.4	12.3	4.3	7.4	5.0	4.2	2.0	1.6	2.8	3.7	7.3	14.6	7.6	5.9	12.8	1.9	8.9	1.4	6.3	2.9	3.0	3.0	0.0	3.6	13.6	18.2	2.9	6.6	10.7	2.5	5.3	1.4	7.1	14.0	11.8	3.2	3.8	6.1	12.4	2.1	0.7	0.6	11.6	7.2	3.7	17.8	3.0	6.2	1.0	2.2	9.4	6.9	3.8	3.6	5.6	10.1	8.8	2.9	8.0	0.0	3.7	3.0	0.6	4.7	6.0	2.3	34.9	4.3	2.0	4.5	10.0
AP5M1	"C14orf108, FLJ10813, mu5, MuD, MUDENG"	ENSG00000053770	"Adaptor related protein complex 5 subunit mu 1"	Q9H0R1	14	57268924-57298742	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055768, HPA057098"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA055768: AB_2682913, HPA057098: AB_2683335"	"unprognostic (7.95e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.11e-14)"	"unprognostic (6.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	11.5	12.1	6.5	13.2	8.7	15.4	13.8	11.9	10.2	14.3	20.1	25.7	28.8	11.7	15.3	16.3	9.8	12.1	16.5	7.2	13.5	28.5	21.1	11.7	17.0	13.2	9.0	8.3	10.0	31.5	6.6	11.0	12.1	12.3	29.5	22.5	16.7	12.6	15.5	11.2	25.2	14.0	9.0	14.4	14.9	10.5	10.0	22.2	18.4	28.3	22.8	13.3	7.5	11.0	19.0	16.1	22.3	21.5	20.2	22.6	17.8	21.0	20.7	18.5	24.5	16.1	27.8	26.7	20.4	20.7	16.5	27.6	32.1	18.5	27.8	27.9	9.4	14.8	15.3	18.7	14.0	44.9	23.6	20.9	23.8	17.6	13.3	19.2	21.0	23.2	18.4	17.6	29.8	16.6	41.6	11.2	16.9	34.6	22.4	27.9	29.4	20.3	42.7	44.1	36.4	20.0	24.3	38.9	16.3	21.8	23.8	20.4	13.5	26.3	24.9	13.9	12.0	9.7	15.9	24.1	23.2	21.1	19.8	20.5	17.8	36.4	19.1	15.4	20.8	22.8	21.0	22.0	24.9	15.9	21.4	22.9	14.9	28.6	15.3	13.2	25.6	17.9	6.5	8.7	11.9	10.2	7.2	13.5	13.2	9.0	12.1	9.0	10.0	11.0	15.4	32.1	13.1	19.2	30.7	20.1	18.8	30.5	21.6	21.0	17.8	11.6	32.6	17.2	25.3	23.9	39.6	21.5	22.6	40.6	86.1	20.9	115.1	11.5	12.9	19.0	29.9	23.4	42.3	16.2	18.9	17.0	29.0	13.1	17.7	13.4	18.9	31.1	24.5	35.3	45.6	29.0	44.7	25.6	11.5	88.1	17.7	17.9	21.4	21.5	32.1	19.3	34.0	19.1	31.0	16.6	23.7	20.3	26.8	19.9	44.8	74.4	16.2	31.3	19.7	12.7	13.4	31.5	10.7	37.8	21.5	19.3	22.3	17.2	39.6	23.7
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.5	7.1	5.5	7.7	7.4	5.8	6.4	8.2	4.8	8.1	6.2	6.3	5.7	3.0	7.4	4.7	4.6	11.3	7.3	6.7	9.4	14.6	5.4	5.5	6.8	6.5	5.8	7.5	7.8	7.5	5.4	6.5	6.9	4.4	3.4	8.7	3.6	19.2	5.3	6.4	3.9	6.3	8.2	6.4	11.2	6.6	4.3	9.4	10.0	3.8	5.4	5.1	6.5	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	7.1	7.7	6.4	8.2	7.3	6.7	6.8	6.5	6.5	6.3	6.6	6.5	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 subunit zeta 1"	O43299	7	4775615-4794397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	14.8	18.5	7.0	0.7	7.1	1.5	11.8	7.3	10.0	12.4	5.8	13.2	1.1	13.4	1.0	11.0	11.0	0.8	7.7	6.9	5.7	9.2	9.2	12.9	1.8	8.3	6.5	11.8	9.9	0.7	9.8	1.1	7.4	11.7	0.4	0.6	12.4	0.7	8.5	21.8	15.5	0.4	5.9	22.9	12.0	8.6	7.4	0.9	11.2	0.2	0.6	13.4	10.9	7.3	2.8	4.2	0.7	2.4	1.0	0.9	4.3	1.3	1.9	2.0	1.7	5.2	3.5	1.6	1.8	0.9	5.1	5.4	0.7	0.5	0.6	1.8	3.5	2.4	4.5	4.6	3.0	2.5	5.1	2.2	1.6	1.8	1.3	0.7	0.5	2.2	3.4	1.1	1.2	7.7	0.3	15.0	5.9	0.3	4.3	2.9	2.6	4.8	1.0	4.4	1.7	3.0	1.8	8.7	6.4	0.5	6.4	8.9	3.8	2.3	4.4	6.5	1.7	8.5	7.4	2.3	1.7	5.6	3.6	1.9	2.3	2.9	2.4	2.8	1.4	1.9	1.8	2.4	1.2	1.8	2.5	2.2	2.2	2.4	2.5	2.4	1.8	1.3	7.0	7.1	7.3	10.0	6.9	5.7	8.3	6.5	7.4	5.9	7.4	7.3	12.4	9.6	15.0	7.5	18.2	6.9	2.9	8.8	8.0	10.5	5.7	5.8	4.3	15.7	6.6	11.0	4.2	11.5	20.3	20.1	0.0	14.1	2.2	9.9	10.1	11.6	12.0	5.0	12.4	13.6	7.7	9.9	21.4	16.4	17.1	14.3	12.5	8.1	28.7	18.5	10.7	15.1	10.2	12.3	10.7	1.5	13.4	16.3	14.2	13.1	23.4	8.2	21.6	10.6	12.6	20.6	15.9	10.9	19.8	4.9	14.7	6.8	8.3	9.4	0.0	5.8	9.5	8.1	10.8	7.6	11.1	16.6	15.6	12.6	14.1	3.8
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
APBA3	"mint3, X11L2"	ENSG00000011132	"Amyloid beta precursor protein binding family A member 3"	O96018	19	3750772-3761692	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045577	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA045577: AB_10964881"	"unprognostic (3.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (6.64e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.83e-4)"	6.7	6.7	3.1	3.5	4.0	2.0	7.1	3.8	5.3	8.0	2.8	8.0	3.5	7.9	0.1	7.5	6.9	1.1	7.6	2.9	3.2	8.3	10.3	6.7	3.7	4.4	3.7	9.4	7.9	1.5	7.1	2.0	4.1	7.5	0.6	0.4	8.4	2.5	15.4	7.5	8.4	1.4	3.4	11.2	8.3	3.2	3.7	2.8	8.3	2.7	1.9	7.5	6.8	5.6	8.0	6.0	1.3	2.3	2.4	1.8	6.4	5.1	3.0	2.7	3.7	5.8	2.7	5.4	4.4	2.0	6.3	3.8	1.4	4.3	0.6	20.5	4.5	3.1	4.9	4.6	8.1	1.9	11.2	3.6	5.3	3.4	2.2	2.2	3.7	5.5	5.2	8.4	1.2	4.7	6.1	7.8	3.5	2.6	8.9	6.3	2.6	8.9	1.9	5.0	4.6	4.8	3.2	4.6	7.9	0.8	2.0	4.6	6.4	4.5	4.6	7.9	6.3	17.0	6.8	4.9	4.1	6.2	4.8	11.3	7.3	11.4	13.0	5.6	11.9	9.5	12.9	12.9	8.3	11.6	8.2	10.0	10.2	6.9	5.1	7.8	19.8	8.4	3.1	4.0	3.8	5.3	2.9	3.2	4.4	3.7	4.1	3.4	3.7	5.6	4.9	6.4	5.6	2.9	12.1	4.2	6.5	18.1	4.0	3.9	7.0	6.2	4.7	4.3	7.9	7.3	8.4	10.6	9.0	8.0	7.9	14.2	0.9	2.9	4.8	6.4	4.8	1.3	3.4	9.0	10.0	7.6	13.3	5.4	2.5	5.4	5.3	8.2	8.6	3.3	3.2	9.1	10.2	6.7	9.3	0.5	6.2	5.9	5.4	1.0	16.4	3.3	13.4	3.0	5.2	12.6	5.8	3.0	13.4	9.3	19.5	11.3	3.8	6.4	6.6	4.0	5.1	2.5	6.2	7.7	7.5	15.3	12.4	3.5	7.5	6.4
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 85.6"	"Lineage enriched"	"Detected in all"	5	"T-cells: 85.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	18.1	23.8	101.7	11.9	119.4	2.7	18.0	116.6	121.1	39.5	65.1	43.3	7.0	43.5	4.3	14.9	38.3	11.4	42.0	123.3	105.3	21.5	3.8	22.5	13.9	123.9	106.0	39.2	16.3	21.4	61.3	8.6	135.0	23.7	4.7	23.3	13.4	25.9	42.3	12.2	19.2	33.2	109.4	13.8	19.4	12.7	112.1	28.9	19.1	54.0	11.1	31.2	23.5	152.9	0.0	14.9	50.6	22.8	26.7	27.4	0.2	24.6	41.7	41.2	51.4	26.4	10.3	0.0	3.6	44.3	36.9	0.5	44.4	7.5	19.4	27.8	33.7	0.3	9.3	0.9	19.3	0.2	9.9	24.8	1.9	19.4	2.9	35.3	51.7	1.2	1.1	0.7	15.3	0.5	0.5	0.1	18.3	0.8	15.5	0.2	2.0	0.2	1.7	0.2	68.1	37.6	3.6	3.0	15.9	15.2	2.1	3.4	22.8	4.2	24.8	27.5	5.0	13.8	6.8	2.0	21.1	0.0	14.3	8.4	1.7	0.3	23.2	1.5	25.2	6.7	32.5	30.2	1.7	16.2	85.6	51.7	1.6	16.5	0.6	0.3	48.7	29.9	101.7	119.4	116.6	121.1	123.3	105.3	123.9	106.0	135.0	109.4	112.1	152.9	9.6	19.2	5.4	22.9	7.5	5.0	12.1	3.6	12.0	45.8	6.6	5.7	50.5	11.5	5.4	5.5	22.9	0.4	4.6	1.1	25.4	18.2	5.6	7.6	9.5	13.9	19.3	4.0	47.1	4.2	0.7	15.2	4.6	2.3	1.3	10.8	15.7	3.3	1.2	40.4	44.8	1.2	0.0	1.9	4.0	13.1	9.6	1.8	8.8	7.5	3.2	24.7	9.2	49.3	102.3	8.0	1.7	19.2	1.4	8.3	0.4	21.6	17.3	20.1	6.6	10.0	17.3	6.9	13.7	3.2	2.8	0.8	20.1	7.0	1.3	5.4
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438341-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 182.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	30.7	4.7	7.0	47.8	8.0	45.5	14.5	10.4	7.6	3.5	5.7	6.1	7.1	2.2	1.6	3.4	5.9	11.6	5.7	7.6	10.4	5.0	38.3	15.5	50.0	16.4	12.5	1.5	4.3	1.6	2.8	8.8	18.0	2.6	6.7	0.6	5.1	2.1	1.4	3.4	17.8	7.5	16.0	56.6	9.2	0.8	15.5	145.4	3.5	2.7	44.3	10.5	3.6	27.3	0.1	1.8	0.0	0.0	12.8	21.2	11.3	37.0	7.2	20.8	19.8	0.0	0.0	101.0	0.5	24.9	22.2	0.1	0.0	0.0	28.6	0.0	0.0	73.3	0.2	0.0	0.0	13.9	0.1	30.3	0.0	0.7	0.0	2.6	0.0	40.5	0.1	62.0	0.0	0.0	87.7	19.5	0.1	7.9	0.0	195.4	0.1	72.4	5.8	0.0	0.1	0.0	3.4	0.3	0.1	0.3	0.1	47.6	0.1	0.0	0.5	6.8	0.1	16.8	0.0	204.7	16.9	71.0	0.0	81.5	23.8	58.5	30.2	23.6	24.9	32.6	25.8	25.9	15.4	39.5	29.3	28.8	182.9	19.1	38.9	50.3	27.2	13.4	7.0	8.0	10.4	7.6	7.6	10.4	16.4	12.5	18.0	16.0	15.5	27.3	3.2	0.0	25.3	1.6	88.2	1.1	0.1	0.1	0.6	0.1	1.6	3.2	1.0	8.6	2.6	3.7	0.0	2.2	149.1	0.1	0.0	3.9	0.4	0.7	12.8	4.7	0.0	28.2	1.1	0.0	20.7	15.0	3.6	0.4	23.4	0.1	6.8	28.9	59.9	0.0	2.9	0.2	0.0	117.7	18.4	0.3	0.0	93.4	3.6	381.3	65.2	0.0	134.9	4.0	1.5	0.1	0.1	0.0	41.7	0.1	0.0	5.1	3.7	0.2	0.0	0.9	11.3	0.1	1.1	0.4	0.1	1.4	125.9	0.4	0.1	0.1
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 586.1;Oligodendrocytes: 803.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"naive B-cell: 5.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 138.7;TIME: 192.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	41.6	9.1	23.1	5.4	42.3	8.6	25.1	38.1	24.5	16.1	3.7	13.9	8.3	14.0	5.9	8.9	13.1	16.1	21.5	20.6	30.6	16.5	14.7	18.6	7.4	42.9	39.6	32.1	10.8	8.5	8.5	17.6	39.5	8.7	7.7	15.7	8.6	9.8	28.7	12.6	7.0	14.9	25.2	14.8	11.3	8.5	36.7	13.2	33.6	21.7	5.6	10.7	13.1	72.9	19.4	9.4	20.6	28.8	64.9	50.7	45.2	38.5	45.8	14.0	24.5	34.1	40.2	33.9	20.7	16.5	44.5	5.6	36.5	49.4	25.0	1.1	7.3	0.4	23.5	21.1	65.0	19.2	1.1	76.7	24.6	42.5	43.0	58.2	138.7	19.0	1.1	0.7	86.1	16.3	6.3	3.6	17.1	9.8	17.9	50.9	58.6	38.4	19.9	8.9	27.2	15.4	11.7	6.6	6.9	23.7	17.2	2.2	192.3	20.1	59.5	13.8	61.1	8.1	18.5	41.2	20.7	30.8	24.6	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	23.1	42.3	38.1	24.5	20.6	30.6	42.9	39.6	39.5	25.2	36.7	72.9	58.8	80.1	14.5	46.7	5.0	10.7	3.8	10.4	7.4	7.6	25.5	13.6	22.5	12.8	6.3	9.2	6.2	14.4	0.5	5.2	7.9	3.8	14.5	5.6	32.8	39.4	3.0	5.3	121.3	6.4	2.8	25.2	12.8	7.5	1.3	13.5	47.2	13.8	3.2	62.2	171.3	4.0	16.2	4.0	6.7	23.1	35.8	2.5	7.2	164.9	0.1	9.3	0.0	586.1	803.4	6.2	6.7	37.2	0.2	2.7	5.5	6.3	4.0	7.6	59.2	43.2	51.4	3.8	10.8	7.3	11.9	6.0	1.2	24.0	7.4	3.6
APBB3	FE65L2	ENSG00000113108	"Amyloid beta precursor protein binding family B member 3"	O95704	5	140558268-140564781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 63.1;Late spermatids: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005571, HPA076196"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments, Cytosol"		"HPA005571: AB_1844912, HPA076196: "	"unprognostic (7.63e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.67e-2)"	2.2	3.9	7.2	0.0	7.6	0.7	2.3	7.3	10.1	2.0	3.7	2.0	0.2	2.5	1.5	1.5	2.6	0.5	2.3	8.1	9.6	2.5	3.1	1.4	0.5	8.2	6.0	2.5	2.6	1.6	9.9	1.4	8.8	1.9	0.7	6.4	2.5	1.7	2.3	2.0	2.1	0.9	4.9	2.2	2.6	8.5	7.2	0.6	3.1	1.2	0.7	2.2	1.8	5.9	0.4	0.4	0.2	2.0	0.0	0.8	3.3	1.0	1.2	1.3	2.6	1.0	1.1	1.3	2.0	1.7	0.8	0.7	0.0	1.4	0.4	1.6	0.6	0.6	4.0	0.1	2.2	0.7	0.8	5.0	0.6	1.2	1.0	0.3	0.8	3.6	0.1	4.4	1.5	0.9	0.2	1.3	0.8	0.5	2.5	0.3	0.4	1.1	1.2	1.0	6.4	3.0	2.8	0.9	3.7	0.2	2.7	2.8	0.7	0.3	0.6	0.0	0.2	1.7	1.3	0.1	0.8	0.4	0.5	5.6	0.7	0.0	0.7	1.8	0.4	0.2	0.4	0.6	0.6	0.6	0.3	0.6	1.9	0.4	0.3	1.0	0.5	0.6	7.2	7.6	7.3	10.1	8.1	9.6	8.2	6.0	8.8	4.9	7.2	5.9	8.3	3.2	9.3	25.8	6.8	2.8	3.4	5.7	4.0	29.4	9.4	8.3	2.1	14.3	10.1	5.5	0.0	11.7	6.3	5.4	5.9	3.9	63.1	3.9	6.8	6.1	5.4	5.2	13.1	1.5	11.9	7.8	15.3	5.3	10.8	6.2	7.1	17.0	14.5	18.5	13.5	2.8	14.2	18.0	14.2	43.6	5.6	13.8	7.2	8.4	12.6	13.5	5.2	8.5	15.6	2.4	3.7	4.9	3.9	2.3	8.6	3.3	5.6	16.5	0.0	6.4	7.2	19.2	6.9	2.9	2.8	11.8	5.2	4.9	3.6	3.1
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515399	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 19.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.1;Breast myoepithelial cells: 7.7;Fibroblasts: 3.6;Oligodendrocyte precursor cells: 6.0;Skeletal myocytes: 8.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 94.5;hTEC/SVTERT24-B: 32.7;HUVEC TERT2: 33.6;TIME: 56.1;U-87 MG: 36.5"					"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria		No	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.4	0.4	0.2	0.2	0.0	0.0	4.8	0.5	0.1	1.7	0.0	1.0	0.1	1.8	0.0	0.5	0.0	0.7	1.4	0.1	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.5	0.6	0.0	19.2	1.3	0.6	0.8	0.4	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	16.8	0.1	1.9	1.4	0.0	5.6	0.0	0.0	94.5	0.5	1.1	0.0	3.3	3.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.6	0.0	32.7	0.5	6.8	33.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	56.1	12.6	0.9	0.0	16.5	0.0	0.0	0.0	36.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.1	0.0	0.3	0.4	0.0	0.0	9.1	7.7	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.7	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	6.0	0.5	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	8.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3629.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	47.7	0.2	0.0	0.0	1.3	3629.2	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APH1A	"APH-1A, CGI-78"	ENSG00000117362	"Aph-1 homolog A, gamma-secretase subunit"	Q96BI3	1	150265399-150269580	"Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037272	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"			"CAB037272: AB_476776"	"unprognostic (1.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.87e-1)"	73.5	93.9	59.3	60.5	63.4	78.7	97.8	60.8	60.7	79.6	58.3	100.6	82.2	60.5	84.0	118.6	83.2	69.0	71.0	55.3	59.1	78.6	132.2	83.6	80.7	67.2	62.3	88.6	92.2	110.3	56.5	72.4	62.2	62.0	95.4	24.4	92.7	68.1	58.8	120.6	80.4	54.8	65.7	99.2	95.7	34.8	64.7	72.9	95.7	63.2	90.7	77.8	84.0	63.4	226.4	95.6	113.7	175.8	140.3	115.0	148.3	82.8	171.4	183.7	190.9	78.2	251.5	125.3	116.9	146.2	90.9	180.2	98.8	143.6	127.2	114.0	122.8	93.2	61.3	101.7	173.6	173.1	136.4	145.0	198.7	124.5	147.6	132.7	201.8	128.3	104.1	208.4	119.0	280.7	118.8	101.5	127.5	163.7	158.0	135.9	116.0	203.8	136.1	151.9	93.2	210.7	81.9	133.8	172.0	105.6	174.5	303.8	115.5	104.8	99.4	102.8	147.1	297.0	263.0	113.0	89.4	180.6	116.7	9.7	10.6	8.2	11.1	9.4	11.8	8.6	7.6	7.4	9.9	6.8	7.0	8.4	9.7	12.1	10.5	9.3	3.8	9.9	59.3	63.4	60.8	60.7	55.3	59.1	67.2	62.3	62.2	65.7	64.7	63.4	80.6	22.4	25.5	15.3	91.9	65.8	86.2	107.1	74.6	23.3	92.9	72.6	24.0	70.1	56.1	82.8	8.4	132.8	77.4	110.9	33.2	131.6	7.1	26.3	40.6	77.4	75.6	44.2	6.8	157.2	143.9	60.3	50.0	49.7	35.5	74.9	71.7	68.2	159.8	37.0	7.9	107.4	71.2	125.1	95.0	7.7	60.3	88.7	62.2	12.2	119.2	59.6	113.3	13.0	10.7	140.4	84.7	40.6	84.6	102.8	81.7	49.7	22.1	17.5	26.3	57.1	38.8	17.2	16.4	83.7	81.8	165.4	71.4	62.4	114.0	122.0
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	37.6	33.1	29.2	43.4	31.1	35.3	45.7	38.5	37.4	39.3	25.9	44.3	42.8	42.1	34.5	44.6	36.6	32.4	28.2	32.0	30.6	49.1	57.7	34.8	53.5	29.2	28.5	35.1	45.9	46.6	19.0	29.9	30.8	40.4	46.6	44.1	39.0	39.5	37.1	40.0	45.5	46.6	32.8	40.3	41.1	26.8	29.9	62.1	51.4	35.9	57.2	44.2	27.6	38.6	90.2	93.0	119.4	75.2	82.7	82.4	82.9	83.8	89.4	116.3	110.2	69.4	38.8	106.4	67.2	90.2	86.9	107.7	143.2	99.7	160.6	122.4	134.9	96.5	53.0	60.8	74.8	165.6	88.9	64.2	104.6	59.0	102.9	72.4	98.9	65.8	160.3	93.9	82.1	57.0	141.2	71.1	214.6	111.1	86.0	145.2	126.3	85.3	89.5	103.8	95.5	64.2	100.7	88.7	81.4	88.4	109.1	76.6	86.5	102.0	78.3	139.8	144.5	77.5	122.7	172.1	88.8	95.0	62.3	61.3	47.3	51.5	66.5	64.5	75.1	61.7	64.8	69.3	62.1	60.4	66.3	68.7	9.9	116.3	67.3	40.0	61.4	88.4	29.2	31.1	38.5	37.4	32.0	30.6	29.2	28.5	30.8	32.8	29.9	38.6	26.4	16.0	27.3	30.0	35.9	43.8	16.6	21.6	47.3	23.8	27.8	17.8	14.4	31.5	28.0	20.2	10.4	30.4	31.8	20.1	31.3	21.3	13.6	23.5	25.8	26.2	24.0	48.0	40.2	19.7	30.4	28.3	35.2	28.2	32.3	25.9	22.1	48.0	26.3	28.6	33.5	27.5	12.2	33.6	28.8	6.5	18.6	30.0	32.0	27.2	41.7	21.1	17.5	25.1	45.4	24.9	19.8	20.3	44.2	24.0	29.4	37.3	20.8	19.0	6.6	28.9	31.1	28.4	26.6	43.1	51.9	38.9	33.8	26.6	31.4	19.2
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		52000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	30.4	25.4	14.7	20.7	17.1	14.4	20.7	17.3	17.1	18.0	14.2	19.9	13.6	15.0	15.0	13.8	17.2	18.5	20.0	13.9	16.3	27.0	19.4	21.2	20.2	18.7	16.4	12.3	17.2	15.8	9.1	13.3	18.4	16.8	19.5	16.8	31.7	23.6	65.6	10.0	16.3	12.3	17.1	15.5	18.8	10.7	16.0	31.3	24.6	38.3	16.3	19.1	9.6	20.9	25.1	27.3	33.5	8.3	27.7	26.8	14.5	36.8	38.0	38.9	44.4	15.6	21.3	77.1	21.7	15.5	40.3	28.8	56.1	24.9	53.3	49.9	56.3	39.5	27.8	42.6	41.2	111.3	28.9	23.6	20.6	22.1	40.7	19.1	29.8	49.8	94.2	45.2	27.6	24.2	59.7	57.7	25.1	39.6	61.7	36.4	89.1	29.6	46.8	36.3	28.5	13.6	45.0	37.2	50.2	17.4	38.9	34.3	24.1	29.2	26.9	68.1	9.0	43.9	36.1	89.4	32.2	27.3	37.2	11.3	27.3	25.4	17.2	30.0	21.3	24.5	21.1	18.8	42.7	24.3	21.4	18.3	6.7	31.4	36.8	27.2	27.2	18.4	14.7	17.1	17.3	17.1	13.9	16.3	18.7	16.4	18.4	17.1	16.0	20.9	24.7	35.3	30.1	42.4	27.9	25.0	37.5	62.7	19.4	28.8	73.8	36.2	23.1	37.1	63.0	18.4	4.2	37.2	25.5	49.5	187.9	30.2	8.0	33.4	23.9	22.8	35.5	42.5	28.4	32.4	23.4	24.4	29.6	24.8	20.3	22.0	21.0	26.0	76.5	18.5	35.2	41.3	87.5	47.1	31.8	8.3	23.9	47.6	21.4	17.8	59.4	23.1	25.7	51.3	108.8	25.4	28.4	24.8	44.2	33.0	35.0	101.7	56.8	21.6	39.5	37.8	30.1	32.4	22.3	31.4	26.3	26.4	25.8	27.1	50.1	50.4
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467572-68655862	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 103.7;Late spermatids: 164.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	1.2	1.1	2.0	0.8	3.2	0.7	1.4	0.1	2.2	1.1	0.0	1.1	0.6	1.3	1.0	1.5	0.5	1.0	0.9	2.7	1.9	0.9	1.5	0.9	1.2	0.7	2.2	0.9	0.6	0.9	0.4	1.8	1.0	1.1	0.8	0.4	1.1	1.3	1.1	2.3	0.5	1.1	0.9	0.8	0.7	1.0	1.5	0.8	1.1	1.3	1.2	1.0	1.4	3.2	1.8	0.3	1.7	1.8	3.4	4.4	1.0	1.7	3.6	1.1	1.4	0.7	1.1	3.4	1.1	1.7	2.2	0.5	0.3	2.7	2.7	2.9	0.4	2.5	0.1	0.4	1.5	0.8	2.4	2.4	2.2	1.7	2.5	2.2	0.8	1.7	0.2	2.8	1.2	0.2	1.3	3.1	1.1	1.8	0.9	1.5	0.6	1.6	2.4	1.0	0.4	1.1	1.8	0.0	1.7	2.6	0.0	0.6	1.2	3.4	0.6	1.5	1.3	2.0	0.9	2.4	1.5	0.8	2.0	7.0	0.5	1.9	0.4	0.7	0.6	0.6	0.8	0.7	0.8	0.5	0.8	0.4	0.0	1.0	0.6	0.7	1.4	0.5	2.0	3.2	0.1	2.2	2.7	1.9	0.7	2.2	1.0	0.9	1.5	3.2	3.6	3.2	2.6	14.0	3.1	2.4	2.4	4.4	8.0	0.5	2.4	3.6	3.5	0.0	2.9	0.0	2.1	6.3	2.6	0.3	0.0	3.5	103.7	1.4	4.0	3.1	3.5	3.4	21.8	1.9	2.2	3.2	4.6	1.7	0.0	3.9	2.2	1.2	2.2	3.3	3.2	0.7	2.0	1.9	2.6	164.1	4.4	2.3	0.0	9.4	4.2	0.5	3.1	22.6	29.0	1.4	0.5	1.9	6.4	2.8	0.2	2.2	1.3	0.2	0.0	4.8	4.7	7.7	4.8	5.0	3.3	4.9	1.8	2.2	0.7	1.5
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237235	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 268.8;lymphoid tissue: 101.0;placenta: 88.1"	"Group enriched"	"Detected in some"	7	"Adipocytes: 67.6;Endothelial cells: 98.5"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AF22: 4.9;HEL: 4.3;K-562: 1.3;NTERA-2: 1.8;SuSa: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025842	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	17.3	3.7	47.1	9.4	46.3	0.1	10.6	52.0	45.7	2.3	22.7	5.4	4.5	3.5	0.3	4.1	1.2	13.0	23.7	48.3	130.5	5.7	18.5	8.1	9.6	268.8	97.4	0.7	2.0	2.9	2.4	88.1	92.2	1.0	6.0	0.0	3.5	1.9	15.2	7.1	4.2	9.9	99.9	101.0	3.2	1.4	92.7	4.1	9.5	10.8	4.2	6.2	1.7	122.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	46.3	52.0	45.7	48.3	130.5	268.8	97.4	92.2	99.9	92.7	122.4	67.6	0.0	0.0	6.5	0.6	2.3	0.1	0.0	0.0	0.0	0.5	0.6	3.2	1.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.3	0.3	98.5	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.5	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	2.6	0.2	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.7	0.0	0.0	0.3	3.1	0.1	0.2	2.7	0.0	0.1
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APLP2	"APPH, APPL2"	ENSG00000084234	"Amyloid beta precursor like protein 2"	Q06481	11	130068147-130144811	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 249.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039319	Approved		Approved	Vesicles		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA039319: AB_10673141"	"unprognostic (2.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.33e-9)"	"unprognostic (3.20e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.42e-2)"	217.2	130.2	125.6	144.0	126.0	196.5	192.3	164.7	157.9	170.4	252.6	209.9	272.4	176.6	138.6	134.2	167.6	201.8	271.6	131.0	153.2	359.9	334.8	391.4	77.5	130.9	137.5	180.8	136.0	291.5	87.1	324.8	133.1	287.7	176.7	540.8	135.3	291.0	65.9	113.3	226.6	211.5	135.4	95.7	149.7	54.9	157.9	81.5	607.8	85.2	56.8	199.1	129.6	152.8	216.7	170.3	307.1	281.2	1259.7	847.8	393.7	598.6	741.1	294.2	251.8	1300.5	1541.3	107.9	1515.3	1422.2	322.4	540.4	229.1	567.6	168.0	165.6	206.4	180.9	116.7	502.9	191.9	556.7	363.8	566.4	367.8	244.5	469.5	1520.2	912.7	34.1	180.7	228.9	495.2	205.7	26.9	245.3	182.8	256.8	301.1	70.0	69.8	105.5	758.9	589.6	109.9	239.0	706.9	368.0	92.0	535.8	582.2	489.5	1567.6	314.1	211.7	496.8	281.9	33.8	50.6	245.5	347.0	487.7	221.0	55.1	249.3	65.3	17.9	122.2	13.5	16.3	12.7	17.0	110.1	44.8	9.4	12.6	160.8	15.6	94.6	10.5	20.0	149.5	125.6	126.0	164.7	157.9	131.0	153.2	130.9	137.5	133.1	135.4	157.9	152.8	239.6	942.3	550.3	37.9	74.4	106.7	175.4	497.0	78.6	967.9	252.9	183.1	262.0	254.5	460.6	404.6	706.8	798.1	72.0	354.2	52.8	305.5	13.6	211.0	191.3	220.3	92.8	156.3	99.0	107.1	130.3	253.5	86.6	432.8	103.5	109.6	127.1	498.2	652.4	240.6	133.5	159.8	463.9	287.6	214.3	13.8	167.4	405.5	96.0	54.4	293.1	396.1	56.7	45.8	31.6	276.5	220.7	214.4	45.5	190.1	352.0	244.9	258.3	729.0	190.7	148.9	207.7	182.8	240.4	81.6	109.4	927.3	58.8	165.9	161.5	215.4
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992751	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 314.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 325.4;Hepatocytes: 251.1;Syncytiotrophoblasts: 751.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 680.7;NK-cells: 343.8;T-cells: 367.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Approved		Approved	"Plasma membrane"		NA	NA		130000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: AB_2685328"	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	168.0	44.6	59.2	47.2	60.1	187.4	84.6	76.0	65.4	41.8	62.2	46.5	32.7	46.8	106.3	26.7	46.0	43.1	37.5	64.1	72.6	50.5	314.0	53.2	44.0	61.4	62.8	40.8	45.2	83.4	78.7	80.2	68.6	44.2	42.9	32.0	40.1	47.9	39.5	55.8	34.7	49.2	60.5	66.6	38.5	54.2	69.7	42.4	209.1	24.4	34.1	51.8	29.5	68.8	110.6	191.3	90.0	139.5	175.3	97.5	94.4	141.8	153.4	133.3	137.4	113.7	189.3	45.9	161.1	170.6	232.1	198.1	85.0	165.1	149.1	62.3	69.7	51.2	66.0	226.9	140.9	99.5	115.4	134.3	226.9	154.9	107.0	173.8	192.5	73.4	61.5	195.8	128.6	168.1	68.9	108.2	59.3	166.6	172.1	56.3	312.8	96.3	140.2	98.9	150.6	59.4	146.9	240.5	157.1	92.0	87.6	78.8	173.7	156.9	140.6	134.7	209.5	113.0	134.3	50.9	83.1	148.0	151.9	61.8	99.3	198.9	367.9	98.6	228.8	36.4	100.8	268.2	102.1	37.4	78.6	202.2	680.7	343.8	71.3	50.7	75.0	363.3	59.2	60.1	76.0	65.4	64.1	72.6	61.4	62.8	68.6	60.5	69.7	68.8	28.5	19.2	32.7	25.8	22.2	24.3	46.7	77.6	17.1	51.4	48.1	32.1	17.5	34.3	39.7	49.7	10.4	325.4	163.2	18.9	17.6	72.0	22.9	18.0	26.3	42.4	18.0	33.6	24.0	45.4	50.6	40.6	15.3	23.8	36.1	68.6	41.4	251.1	95.9	16.8	25.4	19.4	85.5	50.0	94.8	32.5	65.0	59.5	46.2	42.2	105.1	35.0	222.5	19.6	15.9	40.8	25.4	82.0	54.9	34.1	20.8	13.2	24.5	22.5	39.5	36.9	33.2	97.1	90.1	16.7	20.0	751.1	96.7	38.3	28.0	28.1
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19248.5"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	3.2	1.4	1.2	3.6	1.2	0.0	2.1	1.1	1.4	0.8	0.8	7.4	1709.3	3.5	0.4	1.1	6.1	1.7	67.2	1.0	1.1	3.7	19248.5	2.7	3.2	1.1	1.1	23.1	2.5	0.0	4.2	1.6	1.1	1.1	0.2	0.1	0.7	1.0	0.8	1.0	4053.7	2.1	1.1	9.0	14.6	384.5	1.2	0.9	3.7	0.2	0.1	0.5	1.5	1.2	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.2	1.2	1.1	1.4	1.0	1.1	1.1	1.1	1.1	1.1	1.2	1.2	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1388	"liver: 36012.6"	"Cell type enriched"	"Detected in some"	75	"Hepatocytes: 50065.8"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 16822.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	92000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	3.8	1.1	0.7	0.7	0.6	25.9	1.8	0.5	1.4	0.9	1.0	0.7	0.0	0.7	0.1	1.0	1.9	0.0	2.0	0.6	0.8	9.5	36012.6	2.1	0.3	1.1	0.8	0.7	2.0	0.0	1.2	1.3	1.1	0.6	0.5	0.0	0.6	0.0	0.6	0.9	0.9	0.0	0.8	7.7	1.9	1.2	0.7	0.4	0.8	0.0	0.3	0.4	0.8	1.0	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1814.4	0.0	3.6	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	5.8	10.0	16822.4	0.0	19.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.7	0.7	1.5	0.0	1.1	1.3	14.6	0.3	0.0	11.3	0.8	0.0	7.8	0.0	0.2	5.2	0.1	0.0	4.1	0.0	0.1	0.0	0.0	3.8	0.0	5.2	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.6	0.5	1.4	0.6	0.8	1.1	0.8	1.1	0.8	0.7	1.0	0.0	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	480.4	0.0	0.0	0.0	0.8	0.0	0.1	1.9	0.0	1.7	0.0	0.0	22.5	0.0	323.6	0.0	0.6	6.4	0.2	0.0	0.0	0.0	0.0	425.9	50065.8	4.7	0.0	0.0	0.2	0.0	665.8	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	5.6	26.0	0.0	0.0	0.0
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823304	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 3112.4"	"Cell type enriched"	"Detected in some"	44	"Proximal enterocytes: 10311.5"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	74000000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.3	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	2204.9	1.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	257.2	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3112.4	3.0	0.0	0.1	4.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	77.5	0.0	0.0	0.0	234.3	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.5	0.0	0.0	0.0	10311.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	87.7	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053202-41064891	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 203.7;skeletal muscle: 853.2;tongue: 288.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Cardiomyocytes: 103.5;Early spermatids: 25.7;Exocrine glandular cells: 21.8;Extravillous trophoblasts: 18.1;Late spermatids: 25.1;Skeletal myocytes: 36.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7;pancreatic cancer: 4.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014252, HPA017957"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	0.2	0.8	0.3	0.3	0.9	1.1	0.3	0.4	0.7	0.0	0.2	0.8	1.4	0.1	0.0	12.0	0.1	0.1	203.7	0.2	0.4	0.4	0.1	0.5	0.3	1.0	0.6	0.1	12.7	0.0	0.1	0.7	0.8	7.7	0.1	5.7	12.7	0.0	853.2	1.1	1.2	2.1	0.5	0.2	12.6	2.7	0.7	10.9	0.3	288.0	0.0	0.3	0.1	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.1	0.3	0.1	0.1	0.0	0.8	0.6	1.3	1.6	0.5	1.4	2.1	1.5	1.7	0.4	1.9	1.6	1.8	0.6	0.6	0.9	2.2	1.6	0.1	0.3	0.9	0.4	0.7	0.2	0.4	1.0	0.6	0.8	0.5	0.7	1.7	0.0	0.0	0.0	1.0	0.0	0.3	0.7	1.0	0.0	15.8	0.0	0.0	103.5	0.0	0.0	0.0	2.1	1.6	0.1	0.0	0.0	8.0	25.7	0.0	0.0	1.2	0.0	0.0	0.5	21.8	18.1	2.3	8.6	0.1	0.0	0.0	0.0	0.0	0.4	1.7	0.5	0.1	0.0	0.3	0.3	25.1	0.3	0.1	1.8	0.0	0.0	0.9	0.0	2.0	3.7	2.2	0.0	0.0	0.0	0.0	0.5	2.0	0.0	3.1	0.0	36.7	2.0	1.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 93.9;lymphoid tissue: 48.3;urinary bladder: 24.4"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	20.9	0.5	93.9	0.8	0.7	1.1	2.2	0.8	1.5	1.4	0.4	0.3	12.2	4.2	6.3	1.4	0.9	0.5	0.7	2.0	13.4	1.1	0.6	0.4	0.2	1.5	0.4	0.3	3.5	0.7	0.4	0.6	0.2	6.7	0.3	0.5	0.6	0.8	1.7	0.3	48.3	1.1	0.2	0.5	2.4	1.0	3.7	21.1	24.4	10.3	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.7	1.1	0.9	0.5	0.6	0.4	0.7	0.3	0.5	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014257-39020352	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	12.3	36.2	3.1	31.1	3.2	31.4	12.3	3.1	4.0	23.1	3.5	20.2	14.0	22.6	51.7	22.7	56.0	18.4	24.0	3.0	3.5	6.0	7.0	20.6	57.8	5.0	3.6	38.2	5.1	10.5	3.8	11.6	5.1	25.9	33.1	3.4	22.1	36.1	2.7	19.8	17.4	30.8	4.5	36.5	18.1	29.4	3.9	25.2	15.2	11.3	67.8	27.6	17.3	6.5	39.4	38.1	6.3	73.9	40.2	82.6	32.4	28.3	54.9	41.0	54.5	36.8	43.7	115.5	18.6	56.1	26.2	39.4	6.5	120.2	39.5	44.3	32.0	111.8	1.6	30.6	43.5	73.4	107.1	90.5	68.1	54.0	13.3	20.4	23.0	0.9	69.9	142.3	83.0	0.4	29.6	39.8	9.8	0.5	82.8	51.1	16.9	96.6	27.2	51.4	1.9	4.9	40.9	0.2	21.7	15.9	0.2	26.8	11.9	21.8	37.1	11.9	12.4	38.6	42.7	9.5	66.9	47.1	58.8	86.6	104.4	277.0	309.1	220.6	212.6	241.6	164.7	276.9	106.9	249.1	54.0	196.9	14.1	196.9	247.8	86.9	168.9	173.6	3.1	3.2	3.1	4.0	3.0	3.5	5.0	3.6	5.1	4.5	3.9	6.5	3.3	3.2	16.2	0.0	68.8	25.2	45.4	44.1	24.5	0.2	16.4	8.9	23.0	28.6	18.4	7.3	0.0	4.3	60.2	56.6	0.0	31.6	3.2	11.0	16.4	9.6	26.4	57.2	0.0	1.3	1.4	26.5	5.6	15.6	57.0	78.6	30.0	1.2	61.9	0.0	0.0	17.8	28.5	49.0	37.3	9.3	57.8	34.2	44.4	0.0	65.1	24.4	117.4	0.5	0.0	11.5	16.6	38.0	55.4	18.9	3.2	1.3	13.6	0.8	26.3	11.9	20.1	1.5	1.5	9.7	16.3	1.9	67.7	53.5	18.8	41.9
APOBEC3D	"APOBEC3DE, APOBEC3E, ARP6"	ENSG00000243811	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3D"	Q96AK3	22	39021113-39033277	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 6.7;NK-cells: 9.2;Plasma cells: 6.4;T-cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.8;Karpas-707: 46.7"									HPA055116	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA055116: AB_2682701"	"prognostic favorable (2.51e-5)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.69e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (4.76e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (3.01e-4)"	1.7	2.2	1.2	8.6	1.2	2.5	1.8	1.5	1.2	3.5	1.1	3.5	3.8	3.3	3.0	1.7	5.2	4.1	1.2	1.0	0.9	1.6	1.2	3.3	15.3	1.6	1.2	4.1	0.5	1.1	0.9	2.2	1.3	2.6	4.3	0.3	2.8	2.3	0.9	1.4	5.3	2.4	1.3	12.0	5.3	2.4	1.1	7.7	1.9	1.2	13.8	4.6	2.7	1.4	0.5	0.0	0.3	2.1	3.1	5.5	1.9	0.3	3.3	3.9	4.4	0.9	5.3	6.1	0.9	4.4	2.5	0.6	0.3	0.0	1.4	11.1	1.2	10.7	0.1	0.0	8.3	1.5	11.8	3.6	0.5	6.3	0.0	0.0	2.9	9.0	2.7	46.7	0.2	0.0	5.2	3.4	0.8	0.0	0.5	4.3	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.1	1.7	1.4	0.1	0.5	1.1	0.1	1.2	0.6	0.0	3.2	3.9	0.8	1.6	3.3	1.5	4.8	1.3	3.5	8.0	3.5	5.2	6.7	5.8	7.3	0.8	6.8	2.7	3.6	1.7	4.9	6.5	5.4	5.8	3.4	1.2	1.2	1.5	1.2	1.0	0.9	1.6	1.2	1.3	1.3	1.1	1.4	0.9	3.2	0.5	0.0	6.7	1.0	1.5	0.9	0.0	0.2	0.3	0.6	0.4	5.7	1.1	1.8	0.0	1.3	3.8	3.0	0.0	0.2	0.5	1.0	0.8	1.9	1.8	1.7	0.0	0.2	0.7	1.8	2.6	0.6	0.0	1.1	2.5	0.2	2.5	0.0	0.0	3.6	0.0	3.4	1.0	0.0	3.1	1.1	3.6	2.8	1.2	0.3	9.2	0.5	0.0	0.2	0.1	1.9	6.4	1.4	1.3	0.3	2.7	0.5	0.0	0.9	1.4	0.2	0.4	0.2	0.9	0.5	8.7	0.8	2.1	2.6
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077067-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	5.5	8.1	3.3	21.7	3.2	15.9	8.6	3.4	4.6	7.7	2.9	7.6	5.5	10.3	10.4	6.1	21.1	11.1	4.3	3.0	4.0	4.1	5.7	14.5	45.9	3.9	3.7	22.7	1.7	4.8	3.5	5.0	3.9	7.8	9.4	1.4	8.5	22.4	1.2	1.6	9.6	9.6	4.0	28.2	10.0	20.1	3.4	25.9	5.8	2.7	35.1	15.7	6.4	4.5	4.5	0.1	0.0	0.0	5.0	9.7	0.3	1.0	16.8	19.9	30.0	1.6	22.6	38.3	0.5	7.3	11.6	0.1	0.2	1.3	6.0	31.8	0.1	23.1	0.0	0.2	21.8	7.1	10.1	14.3	0.5	10.9	2.4	0.0	2.4	1.2	1.9	44.2	3.1	0.0	7.6	7.7	0.6	0.0	1.7	15.3	0.0	25.8	0.0	19.6	0.0	0.0	0.5	0.0	2.0	1.7	0.0	13.2	0.0	2.8	0.2	0.0	0.0	0.0	3.5	0.5	3.2	6.9	5.0	30.7	42.3	28.7	363.8	98.1	207.6	84.9	108.8	281.7	52.4	66.1	34.3	160.2	34.8	232.2	123.0	28.1	92.3	297.8	3.3	3.2	3.4	4.6	3.0	4.0	3.9	3.7	3.9	4.0	3.4	4.5	8.4	3.2	8.9	1.0	55.7	1.8	15.5	27.0	4.6	0.4	3.0	6.6	3.7	7.2	14.4	0.0	2.1	3.9	145.4	0.6	5.9	11.7	47.2	5.7	6.4	8.9	6.0	8.6	0.1	2.3	1.1	10.0	2.0	3.9	12.6	62.5	11.4	0.9	30.6	0.0	0.1	1.9	10.2	20.4	9.8	13.7	19.0	21.3	7.2	3.7	69.1	8.1	251.3	0.5	0.0	2.2	1.8	9.1	69.5	16.0	0.1	2.1	12.1	1.2	19.7	4.7	10.1	1.3	1.6	2.0	1.3	1.0	120.5	20.3	1.5	18.0
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	0.7	0.8	0.3	2.3	0.5	3.6	0.6	1.0	0.7	0.7	0.0	1.8	0.5	0.8	3.6	1.1	1.3	1.6	0.5	0.3	0.3	0.8	0.6	2.4	3.8	0.7	0.4	0.5	0.3	0.6	0.7	1.0	0.6	0.7	3.3	0.6	0.9	1.5	0.6	0.5	1.2	1.2	0.2	3.1	0.9	1.6	0.5	2.9	0.7	0.0	2.1	1.4	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.2	0.0	0.0	0.2	2.8	1.0	0.3	0.0	0.1	0.0	0.6	0.0	2.7	0.3	0.7	0.1	0.0	0.2	0.0	2.0	1.8	1.6	0.2	0.2	0.2	0.0	0.1	0.0	6.9	0.9	0.9	1.4	0.2	0.0	0.0	0.0	1.6	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	4.8	0.7	0.2	0.2	1.2	0.1	0.1	0.3	0.0	23.2	0.5	9.4	1.4	12.1	19.4	0.2	0.4	0.6	8.9	0.0	19.7	1.6	0.0	11.9	4.7	0.3	0.5	1.0	0.7	0.3	0.3	0.7	0.4	0.6	0.2	0.5	0.5	0.4	0.0	4.2	0.0	1.6	0.1	0.6	0.9	1.2	0.0	0.2	0.3	0.1	0.0	2.4	0.0	0.0	6.6	9.6	0.1	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.6	0.1	0.5	0.1	3.8	0.1	0.4	0.2	4.9	0.0	0.2	0.0	2.0	1.0	0.6	0.5	0.0	1.0	0.0	0.0	10.5	0.0	6.2	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.9	0.1	0.2	0.2	0.0	1.5	20.8	0.0	0.0	0.5
APOBR	"APOB100R, APOB48R"	ENSG00000184730	"Apolipoprotein B receptor"	Q0VD83	16	28494643-28498970	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 34.9;intestine: 26.3;lung: 11.6;lymphoid tissue: 36.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 149.9;granulocytes: 39.3;Intestinal goblet cells: 47.5;NK-cells: 65.9;Paneth cells: 84.8;Undifferentiated cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 41.6;HMC-1: 124.8;NB-4: 35.7;THP-1: 25.8;U-937: 30.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041667, HPA042093"	Enhanced					NA	NA		700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041667: AB_10793972, HPA042093: AB_10795393"	"unprognostic (3.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.19e-3)"	"prognostic favorable (3.26e-4)"	"unprognostic (5.48e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.60e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-2)"	3.3	2.0	0.9	20.0	0.9	34.9	1.6	1.1	2.0	1.3	0.9	26.3	6.1	1.1	1.4	1.6	2.4	2.8	1.3	0.9	1.7	1.1	2.7	11.6	6.7	2.3	1.3	0.4	1.3	0.6	0.7	2.7	1.8	1.8	16.1	0.1	2.1	3.5	1.1	3.1	9.4	2.7	1.5	36.6	4.1	1.3	2.6	3.7	1.2	1.1	3.8	4.8	1.1	2.2	0.1	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	41.6	0.3	0.5	0.0	15.4	124.8	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.3	0.7	0.0	1.2	1.5	35.7	0.0	0.0	0.0	0.9	0.1	0.0	0.0	1.9	0.0	0.0	0.1	1.1	0.1	0.1	1.4	25.8	0.1	0.0	0.0	0.1	0.0	0.7	0.3	1.5	0.1	30.8	0.1	10.5	5.8	16.5	2.4	2.9	2.3	0.0	1.3	2.4	5.0	0.1	0.3	1.2	17.1	7.3	2.6	0.9	0.4	2.3	0.9	0.9	1.1	2.0	0.9	1.7	2.3	1.3	1.8	1.5	2.6	2.2	0.3	3.2	7.7	0.0	2.2	0.8	0.2	0.1	0.0	0.0	2.2	0.6	0.6	0.0	2.7	3.7	0.0	2.1	21.9	149.9	0.0	0.0	0.1	0.2	0.2	0.7	9.1	6.5	0.0	0.2	14.6	1.0	1.1	0.2	39.3	0.1	0.7	0.6	32.3	0.0	0.0	47.5	0.0	30.1	32.5	0.4	0.3	33.9	1.8	1.9	34.8	0.0	65.9	0.0	0.1	0.0	84.8	0.0	5.7	0.1	6.5	0.1	0.8	0.0	6.6	0.0	0.4	0.4	0.3	0.0	0.3	5.9	16.0	0.0	49.3	0.4
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16232.1"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	59.2	1998.1	90.3	28.1	133.0	52.2	87.1	83.3	338.1	29.0	73.6	29.1	13.1	11.0	42.0	5.9	21.2	31.0	10.9	75.3	109.8	14.6	16232.1	289.9	140.1	133.2	152.8	56.4	21.4	16.3	23.6	41.7	121.9	14.4	16.7	15.1	35.5	2.2	22.2	73.1	49.1	4.0	92.7	254.9	22.7	18.7	139.2	37.4	36.3	6.1	33.9	23.5	11.3	169.4	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	90.3	133.0	83.3	338.1	75.3	109.8	133.2	152.8	121.9	92.7	139.2	169.4	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"liver: 9641.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.2	5.4	49.5	1.7	55.2	1.1	5.3	55.1	116.2	4.5	44.7	4.3	41.4	1.2	4.8	2.4	4.3	3.7	0.8	50.7	69.2	16.3	9641.4	34.9	15.8	65.3	64.9	0.4	2.2	6.6	3.0	2.9	74.3	1.3	4.4	2.8	2.4	2.1	1.9	4.3	65.6	0.7	63.3	3.9	2.7	1.1	59.9	3.2	0.9	0.7	9.9	2.2	0.8	75.0	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	49.5	55.2	55.1	116.2	50.7	69.2	65.3	64.9	74.3	63.3	59.9	75.0	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942237-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"liver: 629.1"	"Cell type enriched"	"Detected in single"	37	"Hepatocytes: 3.8"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Region enhanced"	"Detected in single"		"white matter: 3.0"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.4;TIME: 1.2"	"Not detected"	"Not detected"							HPA062671	Approved				"Secreted to blood"	NA	NA	1000000000	980000000	"Cluster 6: Non-specific - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.2	0.3	0.4	0.0	0.8	0.5	0.2	0.5	0.9	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.3	0.2	0.2	0.5	0.0	629.1	0.2	0.1	0.5	0.4	0.3	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.1	1.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.1	0.5	0.3	2.4	0.0	0.3	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.0	0.1	0.1	0.4	0.0	0.0	0.4	0.8	0.5	0.9	0.2	0.5	0.5	0.4	0.4	0.3	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOC4-APOC2		ENSG00000224916	"APOC4-APOC2 readthrough (NMD candidate)"		19	44942238-44949565	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	1258	"liver: 2221.0"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 147.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 9.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"THP-1: 4.2"									HPA055877	Supported					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA055877: AB_2682953"	"unprognostic (1.45e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.68e-2)"	0.1	0.4	0.7	0.0	0.6	0.0	0.2	0.7	0.8	0.2	0.6	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.6	0.6	0.8	2221.0	1.7	0.0	0.7	0.7	0.0	0.3	0.0	0.8	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.1	0.4	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.7	0.8	0.6	0.6	0.7	0.7	0.8	0.7	0.9	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	147.1	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568705-195584033	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 5037.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 4485.3;Leydig cells: 2077.4;Melanocytes: 1028.1;Peritubular cells: 994.5"	"Cancer enriched"	"Detected in all"	4	"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"memory B-cell: 5.0"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.0"	"Group enriched"	"Detected in many"	6	"ASC diff: 3507.4;ASC TERT1: 1918.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	90000000000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	2071.8	84.8	949.6	13.9	1157.3	0.9	5037.8	1174.9	1364.1	620.2	1370.1	144.7	56.0	496.7	155.7	160.0	750.6	213.3	1007.8	952.8	1010.4	49.7	7.1	183.5	24.6	1148.3	1040.5	131.2	212.4	61.9	192.2	350.5	1122.0	419.8	57.2	0.8	1272.3	183.8	1154.9	970.1	88.4	96.2	1027.5	8.2	402.6	75.7	1070.2	113.5	828.8	625.3	20.8	434.4	591.7	1347.6	0.0	2.2	0.5	0.7	3507.4	1918.1	6.1	31.3	7.6	0.1	0.2	222.4	0.4	0.4	0.9	1.8	0.0	0.9	0.4	10.5	0.3	0.3	2.4	0.3	0.2	0.1	12.5	0.3	0.5	91.4	21.0	0.2	17.0	0.3	4.3	0.2	0.2	0.9	5.3	1.3	0.1	0.7	0.5	38.9	0.5	0.1	0.0	0.6	0.0	2.8	0.7	0.5	0.0	34.8	31.8	1.3	67.2	0.1	0.4	0.5	1.4	0.4	0.1	0.2	0.3	9.2	1.0	0.4	420.3	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	949.6	1157.3	1174.9	1364.1	952.8	1010.4	1148.3	1040.5	1122.0	1027.5	1070.2	1347.6	543.2	0.0	11.0	2.9	7.5	145.0	16.0	25.4	46.7	0.0	121.6	138.7	26.9	1.5	81.8	5.5	0.0	5.4	15.9	1.4	0.0	0.4	9.7	16.3	393.7	114.1	46.3	0.0	3.3	0.0	4.2	4485.3	7.7	7.0	0.0	0.0	21.4	0.0	13.3	0.0	2.1	0.7	10.2	0.3	193.2	51.0	2077.4	31.8	1028.1	279.2	1.0	0.0	0.0	300.6	221.5	2.3	0.3	994.5	19.2	25.7	0.0	0.2	128.9	0.0	19.7	100.3	210.7	10.5	4.0	24.1	102.6	5.9	23.5	7.0	0.6	47.3
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905791-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 3453.9;liver: 6592.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 9363.4;Hofbauer cells: 6072.6;Muller glia cells: 9454.8;Peritubular cells: 4958.2;Proximal tubular cells: 8155.9;Theca cells: 7201.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1867.0;CACO-2: 466.1;Hep G2: 935.3;HSkMC: 1374.2;SK-MEL-30: 1956.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	29000000000		"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	522.1	3453.9	813.4	92.8	1164.2	66.5	325.1	775.0	943.2	271.2	329.2	130.9	40.3	81.5	20.0	37.2	72.2	100.2	176.3	606.1	841.6	1066.0	6592.5	258.8	352.2	1016.0	1037.0	508.2	41.9	34.5	110.9	102.2	1106.9	45.4	22.9	87.6	80.5	10.8	31.1	381.2	165.9	12.6	823.2	620.3	83.3	140.5	962.6	57.8	146.4	10.4	46.1	93.4	135.5	964.4	3.2	5.2	9.5	2.6	1867.0	76.3	69.4	1.5	4.3	8.4	1.4	466.1	2.8	2.0	9.9	0.3	9.1	6.4	12.6	2.1	0.7	1.7	4.0	3.3	1.7	935.3	192.4	6.8	2.3	1374.2	2.5	14.8	1.3	15.6	1.0	0.7	124.9	2.8	1.2	3.3	1.9	2.5	243.2	3.0	1.3	2.6	8.0	1.8	2.8	0.9	5.6	2.4	4.5	1.4	1956.0	131.6	165.3	52.8	3.3	13.2	3.1	1.4	1.6	5.9	8.6	3.8	5.9	4.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	813.4	1164.2	775.0	943.2	606.1	841.6	1016.0	1037.0	1106.9	823.2	962.6	964.4	136.7	0.0	8.2	444.0	66.1	935.2	12.3	18.3	67.7	81.7	86.7	565.8	2.2	450.4	5.2	228.1	41.7	46.3	6.0	2.2	682.9	1.8	73.6	33.8	936.6	140.2	0.0	331.6	1.1	0.7	43.8	860.7	3.6	22.9	174.4	103.6	208.9	9363.4	6072.6	38.7	2.1	0.6	4.1	718.0	292.6	355.3	2629.4	940.6	2481.3	60.9	70.3	9454.8	0.0	12.1	2.2	0.6	0.3	4958.2	7.2	15.0	0.2	8155.9	1.0	311.4	223.5	2958.4	345.5	14.8	12.8	15.1	1684.9	74.3	60.6	7201.0	1.7	4.7
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
APOL2	APOL-II	ENSG00000128335	"Apolipoprotein L2"	Q9BQE5	22	36226209-36239954	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 80.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001078, CAB026695"	Supported					NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"CAB026695: , HPA001078: AB_10602432"	"unprognostic (4.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.26e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (5.06e-6)"	42.0	23.4	36.5	43.6	38.3	13.0	37.4	37.0	49.7	36.8	34.9	28.8	41.8	33.1	17.8	18.4	30.2	42.1	40.0	38.6	43.2	52.6	65.4	44.8	42.5	52.0	41.6	19.5	15.3	19.7	47.3	22.3	52.3	34.2	26.5	12.2	25.0	28.3	28.0	16.2	32.3	35.8	42.1	46.6	38.3	6.8	38.2	29.6	19.4	18.3	30.4	59.5	26.1	38.2	24.0	18.7	17.0	12.7	63.6	49.1	31.7	32.1	73.4	84.1	113.3	7.1	19.2	29.3	52.4	57.2	52.0	11.1	18.3	25.4	41.6	98.0	21.3	13.4	39.9	33.5	107.3	29.0	25.2	62.4	17.0	59.2	15.5	35.2	55.8	16.4	24.8	79.1	53.2	9.4	29.8	13.2	6.3	8.6	16.4	30.3	21.6	17.3	85.6	63.3	30.2	8.5	21.8	40.7	18.4	11.5	12.8	4.1	54.8	50.6	25.1	10.6	17.9	47.6	25.8	9.1	43.7	15.0	19.6	31.1	22.8	16.8	39.7	46.6	36.3	16.3	28.6	33.2	16.5	10.3	16.2	27.1	116.5	28.4	34.0	10.2	29.2	14.3	36.5	38.3	37.0	49.7	38.6	43.2	52.0	41.6	52.3	42.1	38.2	38.2	14.8	35.3	16.8	8.5	12.5	6.0	8.0	21.4	0.6	5.0	7.5	5.0	24.3	21.5	20.1	12.9	0.0	16.6	17.1	31.8	17.6	42.6	0.2	53.0	21.1	21.2	4.8	8.6	18.1	62.9	10.7	19.5	21.4	80.2	2.5	8.3	18.9	65.4	24.2	6.7	9.3	12.0	22.4	20.9	13.0	1.9	16.8	15.0	8.8	7.5	26.6	9.3	25.7	12.1	4.8	68.1	14.5	20.7	17.9	28.4	33.1	25.6	15.6	5.1	0.0	23.9	12.4	0.4	0.2	2.8	6.7	15.2	19.1	10.4	8.0	19.4
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 32.7;Enteroendocrine cells: 14.9;Glandular and luminal cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.7;HDLM-2: 109.9;HSkMC: 16.1;K-562: 23.7;SCLC-21H: 47.9"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	13.5	1.0	0.8	6.0	0.8	1.5	14.7	0.9	2.2	4.6	0.5	3.3	4.8	3.9	1.6	4.3	5.9	6.3	5.3	0.9	1.6	8.1	2.0	12.8	4.7	2.5	1.3	3.9	1.0	0.3	9.4	3.3	1.9	14.7	3.4	0.1	5.8	3.4	1.1	4.1	3.8	2.4	1.0	3.2	4.9	0.7	1.1	2.9	3.2	1.3	1.8	12.1	3.6	0.8	0.0	0.0	0.0	0.0	0.2	2.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	109.9	0.0	5.7	0.0	0.0	0.1	0.0	0.2	16.1	0.0	0.0	0.0	0.0	0.8	0.0	23.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	47.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.8	0.8	0.9	2.2	0.9	1.6	2.5	1.3	1.9	1.0	1.1	0.8	7.0	0.0	6.7	0.3	0.2	1.3	0.7	1.5	0.0	0.3	4.6	2.2	1.1	1.5	3.4	0.0	0.0	0.5	0.1	0.0	3.9	0.2	0.0	32.7	12.4	6.6	14.9	4.2	0.0	0.7	1.0	10.4	0.0	52.6	2.5	0.0	2.5	0.4	2.3	1.7	0.1	0.8	0.0	6.2	6.5	0.0	2.8	8.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	1.2	0.2	0.3	4.2	0.0	0.0	9.0	1.9	0.0	0.0	0.0	1.1	6.2	1.3	0.5	0.4	1.9
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648446-35668404	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.9;NK-cells: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	23.4	7.3	4.1	15.8	4.3	16.1	10.0	3.4	4.0	6.8	3.3	13.2	19.2	5.5	5.5	5.9	6.6	9.1	4.2	3.9	5.1	6.4	46.5	15.5	15.5	8.7	5.0	12.2	2.9	2.6	2.4	7.8	5.8	7.9	11.8	2.6	14.0	5.1	3.1	4.5	19.7	7.4	6.7	18.2	14.0	2.3	4.9	10.1	8.5	3.9	10.4	13.2	3.7	5.4	12.8	4.1	0.3	1.5	30.1	15.0	17.3	5.3	14.2	17.3	21.7	2.0	14.2	17.7	2.6	14.0	12.6	16.2	0.1	8.6	4.5	33.6	0.1	7.4	2.6	4.0	23.7	10.4	12.4	19.3	5.7	5.9	3.3	3.9	3.6	8.0	0.8	31.2	3.2	1.3	14.6	3.2	0.5	0.9	5.3	6.1	6.8	8.7	7.6	28.9	0.4	0.2	8.5	7.2	10.0	1.1	1.2	12.1	3.9	4.3	2.6	3.0	2.8	16.4	14.2	1.7	8.1	16.2	6.1	7.5	4.8	2.6	7.3	7.6	6.1	1.0	4.8	5.8	2.4	0.7	4.6	5.3	7.5	5.0	8.5	0.3	5.5	4.2	4.1	4.3	3.4	4.0	3.9	5.1	8.7	5.0	5.8	6.7	4.9	5.4	58.6	70.5	34.3	6.8	15.7	8.0	10.8	14.7	13.6	0.2	16.8	10.8	7.3	34.3	38.6	12.9	0.0	8.3	79.1	101.1	9.8	33.6	10.5	18.4	48.9	33.4	47.3	11.6	0.2	41.9	35.6	33.4	41.8	17.2	36.8	12.2	39.3	135.9	34.9	0.0	1.3	55.3	20.3	58.1	19.9	7.4	26.1	50.5	8.8	17.8	68.5	3.8	126.7	9.5	2.1	45.7	43.7	18.8	51.0	43.2	88.6	31.6	47.4	0.0	0.0	25.3	22.0	0.5	0.2	15.6	5.3	2.5	67.7	6.0	35.9	62.0
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 124.5"	"Cell type enriched"	"Detected in many"	4	"Adipocytes: 781.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 24.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 5.7;olfactory bulb: 20.1"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	124.5	15.6	35.2	15.4	28.7	0.3	90.6	29.8	41.8	43.8	22.5	12.4	3.9	15.7	2.3	35.3	30.5	34.4	55.8	26.9	30.7	20.0	17.7	17.1	5.6	37.6	34.0	6.9	24.0	28.0	10.5	86.6	38.1	12.8	12.0	5.8	10.3	5.6	34.3	18.4	10.7	52.5	30.3	6.1	12.1	3.0	43.6	10.6	64.8	28.8	3.3	28.3	18.1	29.3	6.4	0.2	36.7	1.2	1.1	2.1	0.3	6.0	9.9	6.0	8.7	2.4	6.5	2.0	0.5	2.3	2.1	2.0	1.4	0.3	10.1	19.3	1.4	0.5	2.0	0.0	2.2	1.0	0.6	1.4	1.7	2.1	4.7	15.1	4.6	3.5	0.5	2.5	3.1	1.3	1.0	1.1	0.2	1.5	1.1	2.9	0.8	0.9	0.7	0.6	3.1	3.4	5.7	0.5	13.6	0.6	0.2	3.1	5.6	1.3	2.0	8.1	5.5	1.8	0.9	1.4	2.0	4.0	6.9	2.2	0.3	0.2	0.3	0.1	0.4	1.0	0.7	0.5	0.2	0.8	0.5	0.3	1.6	0.3	0.2	0.6	1.1	0.1	35.2	28.7	29.8	41.8	26.9	30.7	37.6	34.0	38.1	30.3	43.6	29.3	781.6	6.4	5.3	17.3	15.9	18.1	2.5	1.4	6.8	4.4	5.4	5.8	11.9	4.3	5.9	0.0	4.2	2.9	13.3	5.3	0.0	1.1	2.9	0.7	7.2	169.4	3.6	18.9	5.3	0.4	1.4	25.0	1.1	1.3	7.6	5.8	62.4	3.8	6.6	3.3	7.0	6.3	2.0	14.2	27.1	2.1	4.4	6.6	28.4	32.8	5.9	39.6	29.9	5.0	28.5	1.2	0.6	0.4	5.7	2.9	2.3	0.5	5.4	4.8	111.7	17.5	193.5	5.5	1.0	2.3	15.5	1.0	18.3	1.1	9.3	3.7
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 390.7"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.9	5.3	0.6	0.1	0.6	2.5	5.2	1.0	0.9	3.7	0.5	3.8	0.6	3.9	1.0	4.1	4.1	0.5	3.5	0.6	0.7	93.7	390.7	2.6	0.6	0.7	0.7	6.2	6.0	0.7	4.7	0.1	0.7	3.8	0.4	0.4	3.5	0.5	7.2	6.4	9.0	0.4	0.7	4.1	5.3	16.0	0.6	1.2	5.5	0.6	1.1	3.3	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.6	0.6	1.0	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
APOO	"FAM121B, MGC4825, Mic23, MIC26, MICOS26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907938	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	9.0	23.7	55.8	9.0	58.0	7.9	13.3	58.1	76.3	13.1	67.8	17.3	14.4	10.6	19.6	12.6	20.8	9.3	65.1	57.9	58.4	46.5	18.2	8.6	11.7	58.8	57.0	9.4	14.2	62.0	29.2	10.9	57.3	13.7	18.8	52.8	19.7	15.0	45.9	7.7	12.0	12.0	57.0	8.4	17.7	16.8	56.8	14.0	20.3	73.2	11.6	11.2	8.1	57.1	36.5	32.7	53.9	37.8	8.8	19.9	8.3	17.9	21.9	37.4	38.8	19.3	17.0	31.5	21.9	16.5	48.5	29.3	68.5	35.7	41.2	33.4	48.7	15.9	28.6	31.1	20.8	40.9	17.1	22.2	20.7	41.2	30.4	20.1	26.6	38.8	22.9	33.2	35.1	34.6	41.2	43.0	49.2	47.5	52.7	31.5	26.6	75.6	74.1	18.4	36.4	26.5	39.0	36.7	39.7	52.4	63.6	17.9	6.5	23.9	14.6	86.6	27.9	26.3	50.5	28.7	38.5	19.8	35.8	14.8	4.8	1.4	12.6	15.9	16.6	10.8	13.7	12.5	14.0	10.2	10.9	10.7	3.0	10.3	16.0	16.6	14.0	7.7	55.8	58.0	58.1	76.3	57.9	58.4	58.8	57.0	57.3	57.0	56.8	57.1	7.4	16.0	11.5	61.7	11.8	14.0	17.0	74.3	11.4	20.4	14.3	17.0	61.8	21.5	28.3	23.9	14.6	17.2	11.3	12.8	180.0	28.4	25.9	56.0	13.0	10.1	7.2	20.8	61.4	16.0	8.9	11.7	13.3	24.4	3.8	14.2	7.9	13.9	22.7	20.2	76.5	17.0	44.7	14.6	12.0	15.7	11.5	9.9	28.4	74.0	34.2	50.0	8.2	43.7	76.5	10.2	20.0	15.8	14.8	14.1	24.0	80.6	106.9	32.4	6.6	10.8	22.3	26.1	53.2	18.9	7.0	12.4	9.5	17.0	22.3	16.8
APOOL	"AAIR8193, CXorf33, FAM121A, Mic27, MICOS27, UNQ8193"	ENSG00000155008	"Apolipoprotein O like"	Q6UXV4	X	85003877-85093316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000612	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA000612: AB_1078594"	"prognostic unfavorable (2.68e-5)"	"unprognostic (2.72e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (4.27e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.77e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.35e-12)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.11e-2)"	"unprognostic (7.51e-2)"	5.9	6.5	2.8	3.7	3.2	3.7	6.6	3.6	5.2	4.3	5.4	5.9	5.9	4.4	4.7	6.2	5.1	4.0	11.5	4.2	3.9	11.2	14.5	4.3	3.3	4.5	4.3	4.1	6.0	11.6	3.2	4.1	4.6	5.9	6.5	6.8	5.8	4.4	17.8	6.7	4.6	5.9	2.9	3.5	6.8	2.2	4.6	3.6	8.3	17.9	3.5	4.2	4.0	4.3	11.4	6.5	6.0	8.2	16.9	11.7	6.4	7.4	6.9	6.2	6.0	7.0	6.3	8.3	6.9	8.4	11.7	8.8	18.3	7.0	9.3	8.4	8.0	8.8	10.2	7.2	11.0	17.5	9.1	11.8	11.8	10.4	18.4	7.2	8.8	10.7	15.2	10.7	10.8	6.1	7.2	7.1	4.9	6.8	12.1	7.9	14.6	8.6	7.8	8.3	0.6	9.8	14.1	12.7	8.8	6.4	7.7	8.3	9.2	8.5	8.3	17.5	8.6	6.9	24.4	7.1	10.9	12.4	7.3	2.4	2.0	0.6	1.9	2.8	1.7	2.1	1.7	1.4	2.1	1.9	2.1	2.0	0.4	1.2	2.5	2.6	1.0	1.0	2.8	3.2	3.6	5.2	4.2	3.9	4.5	4.3	4.6	2.9	4.6	4.3	16.7	16.0	19.1	25.8	10.7	5.6	13.3	5.3	6.2	26.7	16.8	11.9	45.4	15.7	7.7	20.2	14.6	15.3	9.3	10.6	13.7	18.1	0.2	17.0	15.4	13.0	37.1	14.9	32.3	14.0	11.3	13.9	17.3	17.4	21.5	18.3	15.0	51.6	12.0	21.9	26.2	15.3	4.1	15.2	2.3	0.8	13.7	11.4	0.0	21.5	9.5	13.6	8.2	30.2	36.2	17.5	14.6	15.4	8.7	19.6	15.6	43.7	7.6	16.8	19.7	19.3	16.9	3.1	8.2	11.5	3.4	19.4	6.6	16.8	15.4	17.8
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 870.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 38.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		26000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	249.9	498.0	413.0	157.4	457.6	134.4	447.5	413.1	572.4	264.2	396.8	357.2	226.4	281.1	293.3	178.6	308.1	350.8	389.0	456.2	405.3	532.5	298.2	279.4	78.9	425.0	481.9	306.2	323.5	278.6	155.4	451.9	448.7	260.6	328.5	209.3	270.7	343.6	107.5	218.6	200.3	379.9	419.7	154.4	213.5	165.6	426.4	159.2	469.9	176.0	78.2	304.9	151.7	523.5	388.7	489.9	538.4	448.5	707.7	869.8	559.8	757.1	1029.2	386.6	449.3	286.4	941.0	0.9	848.3	614.8	505.1	255.6	326.4	921.6	324.4	14.7	253.1	0.8	275.6	204.1	688.0	372.0	19.6	790.4	990.7	456.8	823.0	1584.3	1750.7	158.6	0.8	39.0	614.5	433.1	6.5	4.0	416.2	644.9	418.6	241.2	505.2	325.3	1283.3	270.1	267.3	385.6	824.0	549.0	393.4	720.0	482.4	400.1	1837.1	850.8	350.2	310.4	371.6	232.3	3.1	4.8	690.4	1.6	836.3	1.1	7.5	0.0	0.2	2.2	0.3	0.8	2.2	0.7	5.6	2.2	2.3	0.6	1.5	0.5	1.6	38.1	0.6	3.3	413.0	457.6	413.1	572.4	456.2	405.3	425.0	481.9	448.7	419.7	426.4	523.5	330.2	109.0	39.6	70.5	47.6	181.6	215.6	449.0	306.7	45.2	280.3	199.6	143.2	296.0	214.0	502.1	29.2	472.6	180.7	395.2	56.7	398.7	46.1	78.8	162.2	416.0	162.6	29.2	481.6	180.4	141.2	309.5	164.7	110.7	8.2	100.3	539.7	125.7	76.3	84.1	525.5	303.1	256.3	61.6	79.9	61.8	242.6	69.9	161.9	189.3	89.9	329.9	4.1	423.2	870.8	205.4	223.1	296.8	24.0	187.5	95.2	165.8	164.7	24.5	118.3	336.5	198.5	38.3	86.9	85.9	106.1	552.1	27.0	111.4	283.5	133.6
APPBP2	"Hs.84084, KIAA0228, PAT1"	ENSG00000062725	"Amyloid beta precursor protein binding protein 2"	Q92624	17	60443158-60526242	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 110.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066852, HPA078370"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA066852: , HPA078370: "	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (7.67e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.90e-3)"	"unprognostic (6.87e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.36e-2)"	14.9	11.2	13.6	10.2	15.3	4.1	11.3	14.9	15.4	11.7	11.9	10.4	7.3	12.8	9.5	10.3	10.0	11.6	7.0	12.0	14.1	13.1	11.0	9.5	8.7	12.6	13.6	19.6	11.5	14.4	8.0	12.2	13.8	13.7	9.1	17.3	8.5	10.1	9.4	8.7	7.2	11.8	14.6	12.0	10.8	23.5	14.4	10.3	12.8	9.8	8.2	10.0	8.8	22.0	16.5	21.9	22.6	19.0	23.7	24.7	12.6	25.4	17.5	13.9	17.6	10.7	14.0	17.0	41.7	21.4	24.0	13.8	16.2	8.8	24.4	15.3	12.4	21.6	20.1	22.5	25.2	18.1	23.1	24.4	11.4	14.6	14.1	21.6	21.9	10.5	16.5	19.3	20.4	110.4	25.5	9.2	5.0	17.9	9.7	16.8	37.8	20.0	21.5	26.7	24.6	21.0	22.0	3.7	18.2	12.5	30.4	12.3	28.4	31.1	37.6	21.7	19.5	20.5	70.8	14.3	20.6	10.5	22.4	13.8	9.5	12.0	7.4	7.1	8.4	7.2	8.7	8.2	9.3	9.7	11.8	8.9	11.9	12.5	12.2	5.6	9.3	7.5	13.6	15.3	14.9	15.4	12.0	14.1	12.6	13.6	13.8	14.6	14.4	22.0	32.8	28.9	24.0	55.5	20.9	18.0	15.6	18.6	21.6	59.4	18.8	15.0	27.3	20.0	20.8	14.7	18.8	27.4	24.0	17.0	19.6	19.7	391.3	21.3	33.6	29.3	33.0	5.9	57.8	16.6	8.9	30.1	13.7	27.3	22.9	40.6	40.0	21.7	19.8	37.0	65.4	22.1	20.3	19.4	14.9	126.2	35.4	17.7	17.8	44.0	22.5	44.4	16.5	55.8	132.0	16.9	13.2	39.1	17.1	24.7	15.9	30.2	19.5	34.9	39.5	32.1	31.6	56.3	33.3	15.3	18.5	63.2	20.8	42.0	20.4	18.1
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227726-57278105	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 28.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011138	Approved		Approved	"Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	No		10000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Plasma membrane"	"Actin filaments, Cytosol"	"HPA011138: AB_1844959"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	15.6	11.6	9.5	14.8	9.7	15.1	18.9	12.9	11.3	17.1	6.8	14.2	12.6	17.1	10.6	16.9	11.7	13.0	24.7	9.7	11.3	16.5	12.9	13.6	16.7	9.8	10.1	22.7	29.6	25.1	7.8	14.3	10.1	15.0	14.0	13.5	15.2	14.4	44.2	20.1	14.6	15.3	10.4	15.8	15.2	8.0	10.2	18.9	19.8	26.6	19.6	13.4	11.9	10.7	30.2	12.9	12.2	45.4	21.2	29.7	26.2	15.5	9.5	15.4	17.8	14.9	17.5	47.3	6.2	24.6	24.7	5.9	33.7	27.3	26.6	36.1	15.0	27.6	19.5	16.1	22.7	59.6	19.1	21.8	24.3	19.3	21.3	31.3	25.3	30.2	9.0	30.0	17.8	10.4	48.7	15.4	19.5	21.6	21.7	1.7	49.1	26.1	27.7	16.7	12.5	26.5	21.1	32.3	21.0	16.7	15.7	39.6	23.4	25.1	17.5	37.4	29.9	27.0	41.8	33.2	27.4	29.1	17.1	2.0	5.3	3.8	3.7	4.5	4.9	17.9	3.8	3.3	10.9	28.3	3.3	2.5	1.4	7.4	3.6	18.0	1.9	2.7	9.5	9.7	12.9	11.3	9.7	11.3	9.8	10.1	10.1	10.4	10.2	10.7	82.9	51.3	45.5	19.6	106.6	52.9	47.3	46.9	83.6	40.5	67.2	92.8	100.1	47.1	47.4	42.3	31.3	46.9	70.9	29.0	58.7	58.6	42.5	35.4	92.8	66.2	45.6	20.0	49.7	60.3	44.7	68.6	40.2	59.4	23.4	60.8	40.0	44.1	52.2	52.2	50.4	36.2	42.7	68.6	50.6	22.1	73.0	71.0	19.6	33.7	87.8	56.6	56.7	43.2	62.2	51.7	25.5	76.0	62.8	38.7	41.0	58.8	18.1	55.4	52.6	94.3	61.2	64.9	44.2	105.7	69.6	28.0	45.4	73.7	49.1	25.8
APPL2	"DIP13B, FLJ10659"	ENSG00000136044	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2"	Q8NEU8	12	105173297-105236203	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 171.2;Microglial cells: 112.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 177.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039688, HPA043925"	Approved					NA	NA		45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039688: AB_2676626, HPA043925: AB_2678733"	"unprognostic (3.46e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.32e-2)"	34.1	29.2	33.1	18.5	35.9	37.0	35.2	41.0	35.5	33.0	29.8	54.1	38.8	26.3	19.0	23.4	20.7	34.4	16.3	30.6	34.6	20.7	16.1	18.4	22.7	36.5	34.4	28.8	23.8	23.2	19.7	23.1	37.7	38.8	54.7	33.5	22.2	26.9	14.5	66.6	57.6	22.1	33.0	22.9	31.7	36.6	36.5	20.0	16.2	12.8	17.7	16.6	27.8	38.6	15.5	23.2	37.8	22.9	111.9	80.5	27.6	114.4	110.1	40.0	24.3	27.7	11.8	13.5	21.6	177.9	15.3	18.1	19.2	24.6	49.0	6.8	16.6	7.4	11.4	12.4	18.1	5.5	7.4	42.6	22.9	31.6	35.4	77.4	17.2	18.2	8.4	17.5	90.9	20.9	10.6	17.6	27.8	33.1	33.1	8.3	24.9	25.3	33.4	31.9	25.7	48.1	38.4	17.0	19.3	26.6	28.3	10.1	16.7	61.7	14.8	30.4	19.4	15.9	13.7	9.9	39.6	7.3	34.4	0.2	4.7	10.7	1.6	3.7	1.3	0.4	0.6	0.9	3.2	2.8	0.9	1.4	21.1	4.6	6.2	1.0	2.3	1.7	33.1	35.9	41.0	35.5	30.6	34.6	36.5	34.4	37.7	33.0	36.5	38.6	16.0	19.2	13.2	95.3	6.1	12.7	13.0	6.5	12.0	30.6	18.0	14.1	13.2	28.6	10.6	11.0	10.4	19.9	12.1	171.2	5.9	24.2	6.8	33.8	23.0	15.7	30.0	2.5	50.2	18.9	19.0	22.8	15.8	20.7	8.2	46.0	16.4	6.5	30.3	10.1	51.8	40.0	12.2	23.3	8.3	8.6	23.6	18.9	16.0	112.4	10.3	39.9	10.3	91.5	75.1	26.4	38.1	21.8	6.0	29.4	101.5	16.6	56.2	16.2	19.7	18.9	13.2	15.6	23.7	14.3	19.0	23.1	8.0	25.0	17.5	14.2
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911853-30925517	"Blood group antigen proteins, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 727.9;Alveolar cells type 2: 231.8;Cholangiocytes: 358.9;Endothelial cells: 606.7;Hepatic stellate cells: 325.6;Proximal tubular cells: 319.7"	"Cancer enhanced"	"Detected in all"		"glioma: 336.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.7;HeLa: 12.5;SH-SY5Y: 14.7;U-2 OS: 14.9;WM-115: 76.4"					"Group enriched"	"Detected in some"	6	"medulla oblongata: 5.5;spinal cord: 22.0"	"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		49000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	385.9	30.5	86.5	29.3	149.4	50.7	250.3	106.2	79.1	148.9	277.7	97.7	51.0	160.8	41.7	143.5	165.8	162.3	206.8	141.0	124.4	522.9	12.9	413.9	45.5	512.3	181.1	28.1	257.6	48.2	15.2	36.9	199.5	83.8	32.6	0.7	114.0	84.4	199.0	112.6	90.8	142.4	357.3	12.6	80.4	7.8	138.8	39.0	113.2	388.6	34.2	138.5	143.2	432.4	0.1	0.5	0.3	0.6	0.3	1.3	0.7	2.4	0.5	0.0	0.0	0.2	0.8	0.1	34.7	1.9	0.1	0.4	0.0	0.0	0.0	0.3	0.3	0.5	12.5	0.0	0.3	0.3	0.1	4.9	0.1	0.3	0.0	0.1	5.1	0.1	2.3	0.1	0.0	0.0	0.0	0.9	0.7	1.0	0.0	0.0	8.9	0.3	0.9	0.0	0.3	14.7	1.9	1.2	0.0	4.6	0.3	0.1	0.0	0.0	14.9	1.1	0.5	0.8	0.6	0.6	0.0	0.1	76.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	149.4	106.2	79.1	141.0	124.4	512.3	181.1	199.5	357.3	138.8	432.4	727.9	179.5	231.8	75.7	3.6	91.5	1.2	0.3	5.2	0.7	11.5	29.0	78.0	358.9	3.9	31.3	8.4	3.4	3.7	3.7	29.4	53.3	2.3	2.5	1.2	606.7	7.3	86.9	3.5	2.5	4.8	67.6	0.0	0.9	1.3	0.5	325.6	2.0	3.7	0.0	1.0	28.6	0.0	5.1	107.7	2.1	1.2	6.0	88.9	0.0	1.6	0.4	0.0	0.5	0.2	2.4	14.5	3.4	3.7	1.2	90.6	319.7	6.2	0.4	13.1	23.1	42.3	0.3	1.5	2.6	78.7	7.3	8.1	4.7	67.8	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 68.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Erythroid cells: 1.3;granulocytes: 5.7;Hepatic stellate cells: 1.4;Macrophages: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.0;HMC-1: 7.1;K-562: 21.0;SH-SY5Y: 4.8"					"Not detected"	"Not detected"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	68.5	0.0	0.1	0.1	4.6	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.7	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.1	5.7	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.1
AQP12A	AQP12	ENSG00000184945	"Aquaporin 12A"	Q8IXF9	2	240691851-240698483	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	332	"pancreas: 129.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.5;Paneth cells: 1.2;Proximal enterocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA042216	Supported					NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 45: Enterocytes - Digestion"			"HPA042216: AB_2677905"			"unprognostic (9.82e-2)"							"unprognostic (1.63e-2)"	"unprognostic (9.48e-2)"			"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	129.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP12B	INSSA3	ENSG00000185176	"Aquaporin 12B"	A6NM10	2	240676418-240682906	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	334	"pancreas: 209.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported					NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 45: Enterocytes - Digestion"			"HPA042216: AB_2677905"			"unprognostic (1.30e-1)"							"unprognostic (2.87e-2)"	"unprognostic (1.68e-1)"			"unprognostic (3.41e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	209.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 386.9;seminal vesicle: 212.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	1.5	0.0	0.0	386.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	212.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852043-26865771	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 440.5;lung: 114.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 1102.6;Alveolar cells type 2: 342.3;Astrocytes: 487.7;Muller glia cells: 227.2"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPTEC TERT1: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		0.1	0.1	272.7	0.0	298.7	0.0	0.3	282.0	246.3	0.6	62.9	0.3	0.0	0.0	0.8	0.9	1.1	0.1	2.8	283.6	440.5	2.3	0.9	114.8	0.3	250.5	351.2	2.5	0.2	2.2	3.7	0.0	333.3	0.4	0.0	60.2	0.7	0.2	60.1	0.1	0.1	0.0	333.0	0.5	11.4	0.5	387.1	0.2	14.7	20.9	0.1	0.1	0.1	376.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.7	298.7	282.0	246.3	283.6	440.5	250.5	351.2	333.3	333.0	387.1	376.0	0.0	1102.6	342.3	487.7	0.0	0.0	0.8	0.6	0.0	3.1	0.8	0.9	13.9	4.3	76.6	3.7	6.2	0.0	0.0	0.1	3.9	0.3	0.0	0.7	0.1	1.8	0.0	0.0	3.0	0.0	0.0	0.8	0.0	0.0	3.8	0.0	0.0	0.5	0.0	1.7	1.1	0.0	0.0	0.0	0.3	0.0	5.0	0.8	0.0	9.4	0.0	227.2	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.1	9.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	2.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 622.6;testis: 222.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	2.9	0.8	2.7	0.1	3.7	0.2	17.1	3.3	2.7	12.9	1.5	0.4	15.3	2.7	0.2	16.5	0.7	2.8	4.0	2.4	2.9	1.9	0.1	7.6	0.0	3.3	3.9	0.2	2.0	3.0	1.2	0.0	3.1	1.3	0.0	1.0	622.6	1.0	0.2	112.7	0.1	0.3	2.6	0.4	52.3	222.0	3.8	0.0	1.6	0.0	0.1	0.3	0.4	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.7	3.3	2.7	2.4	2.9	3.3	3.9	3.1	2.6	3.8	2.6	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 52.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.2;Cardiomyocytes: 8.3;Collecting duct cells: 5.5;Ionocytes: 2.0"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"	"Region enriched"	"Detected in some"	7	"cerebellum: 21.0"	"Not detected"	"Not detected"			HPA015278	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	2.8	0.1	4.1	0.0	0.1	5.6	2.6	0.3	1.6	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	2.7	2.5	52.7	0.3	0.1	0.0	4.9	4.6	0.0	0.1	0.2	0.2	0.0	5.2	0.2	0.0	0.2	1.0	0.2	0.0	0.3	0.2	0.1	3.4	0.0	0.4	2.4	6.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	1.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	5.6	2.6	2.7	2.5	4.9	4.6	5.2	3.4	6.1	3.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.6	0.0	0.1	0.4	0.3	8.3	0.0	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.6	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228932	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	641	"intestine: 330.0;pancreas: 1280.1"	"Group enriched"	"Detected in some"	45	"Distal enterocytes: 1005.1;Paneth cells: 379.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.4;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.3	0.2	0.6	0.4	0.7	0.4	0.3	0.7	0.8	0.5	0.3	330.0	0.2	0.5	0.0	0.1	0.3	0.0	0.2	0.7	0.5	0.2	0.7	0.1	0.0	0.4	0.4	0.6	1280.1	0.0	0.1	0.1	0.4	0.3	160.3	0.1	0.1	0.3	0.1	0.4	0.2	1.2	0.4	0.1	0.8	0.5	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.8	0.7	0.5	0.4	0.4	0.4	0.4	0.6	0.6	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1005.1	0.0	0.1	1.4	0.2	1.3	0.1	13.1	0.0	0.8	11.0	0.1	0.0	0.0	0.3	8.9	0.4	0.0	0.0	0.1	1.7	0.6	15.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	379.5	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.4	1.7	0.2	12.9	0.1
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 702.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 313.9;Macrophages: 82.1"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Immune cell enriched"	"Detected in many"	20	"neutrophil: 1161.4"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 1161.4"	"Cell line enriched"	"Detected in some"	29	"U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA074762, CAB075684"	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	18.2	0.8	0.8	72.9	0.9	67.5	2.4	0.9	14.4	1.3	0.8	0.9	0.2	1.2	43.4	1.2	7.1	5.3	1.7	3.2	0.5	0.9	702.7	22.2	0.6	0.7	1.0	0.5	1.6	5.6	0.3	6.2	4.0	0.9	0.3	0.4	1.1	0.7	0.5	22.0	0.9	6.4	0.6	42.7	1.5	0.3	6.9	1.8	0.6	7.5	0.8	32.6	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.2	58.4	1.2	0.1	17.5	0.1	0.5	0.1	0.0	1.8	0.1	0.1	0.0	1161.4	0.3	23.0	0.6	0.3	18.9	0.8	0.9	0.9	14.4	3.2	0.5	0.7	1.0	4.0	0.6	6.9	0.8	0.7	0.0	12.2	0.3	2.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	5.7	3.1	0.0	0.0	0.3	0.5	0.0	0.0	0.1	2.1	0.3	0.1	0.7	0.0	13.9	2.4	0.2	0.9	1.9	0.0	1.8	7.6	0.0	7.9	313.9	40.8	0.0	0.8	0.0	0.0	28.5	6.2	1.9	0.3	82.1	0.0	0.0	18.9	0.0	1.0	0.5	0.2	0.5	0.0	0.0	0.7	0.2	0.0	0.3	1.5	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.8	1.5	0.0	0.0	0.1
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544021-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 93.7;Granulosa cells: 104.8;Hepatocytes: 269.2;Leydig cells: 77.9;Peritubular cells: 86.5;Skeletal myocytes: 75.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.6;prostate cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;BJ hTERT+: 10.3;HAP1: 14.9;LHCN-M2: 16.1;RH-30: 23.6;T-47d: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000001, HPA004733, CAB065764"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	6.7	1.0	1.1	0.5	1.3	0.0	8.7	1.7	1.1	23.6	0.2	2.0	0.2	18.6	16.1	1.2	20.7	2.0	5.8	1.0	3.5	3.6	38.2	1.5	0.3	3.5	2.6	14.6	0.8	0.1	1.9	0.1	2.7	16.5	0.6	0.2	1.4	18.2	13.9	5.2	0.9	9.5	2.1	1.3	1.5	3.9	4.8	2.7	2.1	6.1	0.5	3.5	12.9	2.0	0.0	4.8	13.3	0.0	0.0	0.0	0.0	7.3	10.3	0.3	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	14.9	0.0	0.0	0.0	2.4	0.0	1.5	0.0	0.8	0.0	0.0	5.5	0.0	1.8	0.0	0.0	3.9	0.1	4.6	2.2	16.1	1.5	0.0	0.0	5.4	0.0	0.0	0.0	23.6	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	10.9	7.6	0.3	0.3	2.2	0.0	3.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.7	1.1	1.0	3.5	3.5	2.6	2.7	2.1	4.8	2.0	3.1	0.0	5.0	28.4	0.4	9.7	17.8	0.2	15.9	0.7	93.7	33.7	37.4	14.3	10.7	3.7	0.0	3.5	14.0	0.0	1.9	11.3	1.1	2.9	49.1	10.5	0.0	5.3	7.7	0.0	0.2	39.4	0.0	5.8	1.3	104.8	36.0	269.2	0.8	0.0	17.8	0.3	0.0	2.2	4.2	4.4	77.9	3.3	10.6	1.0	1.7	0.2	0.0	26.7	0.2	0.6	0.0	86.5	0.0	36.5	0.6	27.7	3.6	0.3	65.7	75.0	20.8	0.8	3.3	12.7	16.1	1.0	1.7	37.8	0.2	22.0
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561205-47571908	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066326	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	37.7	41.7	17.8	36.9	20.8	102.3	36.2	19.2	21.1	34.8	22.6	40.9	37.8	36.6	21.2	32.2	35.0	32.5	50.8	17.1	18.0	44.6	55.7	39.4	40.4	22.8	20.5	39.5	59.1	51.8	27.7	31.3	20.1	40.9	33.3	15.4	45.1	34.6	136.3	36.0	39.7	31.3	18.8	46.1	46.7	12.0	21.0	38.0	39.4	85.6	31.5	36.1	30.8	20.4	49.1	69.5	29.2	46.9	43.5	34.2	39.0	40.3	42.3	58.6	54.1	57.2	58.6	29.0	32.4	54.6	49.2	67.3	51.8	56.3	34.3	53.5	61.9	29.4	74.4	30.6	61.4	58.3	85.1	45.0	56.0	56.2	49.6	39.2	45.9	36.0	55.2	55.7	40.5	83.3	42.6	64.0	41.8	41.2	77.8	39.2	38.0	65.5	34.4	46.7	32.8	25.0	43.7	39.7	24.5	47.0	74.9	43.3	44.2	38.0	42.5	76.2	41.4	71.1	49.2	22.5	50.8	65.3	31.1	48.3	47.8	61.3	44.1	57.8	40.3	32.6	38.4	40.9	55.2	37.3	33.5	40.5	37.8	38.7	67.9	40.4	41.6	50.8	17.8	20.8	19.2	21.1	17.1	18.0	22.8	20.5	20.1	18.8	21.0	20.4	13.3	16.0	29.2	7.5	25.8	15.7	25.0	29.0	18.2	5.3	15.0	9.8	25.1	34.3	22.0	18.4	10.4	33.0	26.3	43.8	23.5	29.3	1.3	11.4	10.8	17.5	31.8	22.3	5.0	34.3	30.4	16.9	39.3	15.6	16.5	13.6	24.3	42.6	28.0	13.5	5.5	35.9	40.7	26.4	21.6	4.3	17.4	25.8	33.8	4.7	43.7	18.4	32.0	8.5	8.9	26.2	41.5	17.7	27.9	20.3	44.6	27.1	11.5	9.0	19.7	15.9	18.0	8.2	10.5	17.7	16.2	44.6	26.5	12.5	32.3	24.6
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		36000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	41.5	63.5	40.0	58.6	48.6	97.5	33.4	37.9	50.4	44.1	62.9	35.5	29.6	38.9	14.0	37.7	48.3	44.2	42.9	42.2	38.5	47.8	40.2	71.8	53.4	50.6	42.3	49.4	37.1	20.4	48.9	35.5	45.9	44.9	18.2	8.6	33.3	25.7	20.1	47.1	43.3	28.7	40.1	117.5	31.3	16.4	50.8	32.2	46.6	20.1	25.2	39.7	37.5	56.8	19.7	41.9	15.2	18.5	63.4	42.9	23.1	26.2	46.5	29.8	29.3	56.0	50.8	42.9	51.3	44.4	40.7	64.5	23.2	64.4	12.5	50.9	28.4	36.6	40.3	81.9	43.7	25.1	98.7	47.5	65.4	48.7	23.4	36.2	33.2	31.3	31.5	17.4	13.9	40.3	38.9	89.3	9.5	35.1	25.9	36.8	23.2	21.3	27.5	61.1	15.7	32.0	19.1	27.9	84.8	19.5	25.1	56.8	37.5	41.0	28.5	42.8	16.4	27.4	14.3	23.0	21.8	37.4	22.3	19.3	24.8	30.7	8.9	39.4	5.2	6.6	5.9	6.8	15.9	4.7	4.5	5.4	50.8	13.4	51.3	5.3	6.7	17.6	40.0	48.6	37.9	50.4	42.2	38.5	50.6	42.3	45.9	40.1	50.8	56.8	8.9	28.9	32.3	33.6	16.1	7.4	7.5	14.3	15.4	4.3	8.7	7.9	2.6	7.2	9.0	16.5	33.3	9.2	18.3	16.5	9.8	13.5	50.1	14.1	11.7	7.8	23.3	9.9	7.7	7.5	8.9	22.4	16.3	9.1	10.8	36.9	9.7	10.8	43.0	0.0	7.0	12.8	12.2	45.6	25.1	6.4	20.8	57.3	8.8	30.0	29.0	7.4	21.6	17.6	31.5	12.1	10.9	15.1	12.3	4.8	20.9	5.3	20.2	2.8	0.0	8.6	8.8	0.4	2.8	10.8	5.4	4.9	12.4	10.5	15.1	7.4
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244514	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.9;brain: 92.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 285.4;Late spermatids: 167.5;Oligodendrocytes: 781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.7;hTCEpi: 12.7;MOLT-4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	4.5	2.2	28.9	10.0	70.4	39.9	5.1	19.9	39.5	3.5	0.0	5.3	8.9	3.3	3.8	13.1	3.3	9.3	1.5	24.5	21.5	3.7	9.4	13.4	15.7	34.1	38.8	1.5	7.0	5.4	2.9	3.5	32.6	2.2	5.6	1.4	4.6	2.9	0.7	16.1	8.9	4.3	18.3	11.5	6.1	6.2	32.1	24.6	23.2	0.8	11.0	9.9	6.3	92.8	8.6	0.7	0.8	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	4.2	13.7	4.1	3.2	0.4	0.0	3.2	1.3	6.7	0.0	0.0	7.6	0.1	2.9	0.2	1.6	5.5	0.0	0.4	12.7	0.0	2.7	4.9	0.0	11.1	0.2	0.7	0.0	3.6	12.8	4.5	1.0	6.0	2.6	6.5	0.0	4.7	9.3	8.7	7.3	0.0	0.4	2.1	2.7	0.4	5.6	1.6	0.0	2.3	7.5	0.0	1.1	0.0	0.0	8.0	0.9	6.1	1.9	0.0	0.5	0.0	3.8	1.8	3.5	1.8	2.1	2.7	0.3	0.9	0.7	1.9	0.4	6.7	4.7	1.2	1.1	0.6	28.9	70.4	19.9	39.5	24.5	21.5	34.1	38.8	32.6	18.3	32.1	92.8	18.6	153.8	23.3	285.4	46.1	39.1	32.9	13.5	21.6	0.8	11.2	7.0	2.1	17.2	33.2	7.3	0.0	0.2	100.4	15.5	7.9	7.9	123.6	31.4	3.0	15.8	3.0	8.6	140.8	10.0	0.4	9.4	20.4	50.0	9.5	5.9	3.3	4.2	8.7	0.0	29.9	11.3	6.1	33.2	24.9	167.5	2.8	35.1	5.4	40.3	26.7	5.4	95.8	161.4	781.2	21.5	23.3	0.7	43.0	30.0	17.4	5.8	18.0	1.2	0.0	8.1	3.6	4.2	3.0	37.0	67.5	0.8	90.7	0.1	6.9	44.1
ARAP3	"CENTD3, DRAG1, FLJ21065"	ENSG00000120318	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3"	Q8WWN8	5	141653401-141682230	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Endothelial cells: 28.3;Hepatic stellate cells: 28.5;Horizontal cells: 38.7;Microglial cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.3;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.4;HUVEC TERT2: 74.3;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042887	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042887: AB_10796681"	"unprognostic (1.98e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.77e-3)"	"unprognostic (9.76e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.98e-2)"	11.4	4.1	4.6	5.4	4.7	6.2	10.1	5.2	5.4	9.5	1.5	4.5	3.2	7.5	5.4	3.2	7.8	6.7	14.1	3.3	2.9	7.8	2.1	15.8	2.3	4.1	4.4	3.7	2.5	5.3	5.1	11.9	4.4	7.4	2.6	3.9	3.9	5.8	7.0	2.6	4.6	5.9	3.1	7.3	4.3	1.6	6.3	0.7	8.5	9.2	1.2	7.8	7.3	2.9	11.9	7.5	29.4	0.0	1.8	4.5	0.3	7.0	7.9	7.2	9.2	4.7	0.9	0.1	39.4	2.6	11.7	12.8	5.0	16.8	5.5	0.2	2.1	11.0	12.6	0.1	8.2	0.9	0.4	8.3	7.6	3.9	8.9	20.1	74.3	0.0	0.8	0.1	1.0	0.3	0.0	9.5	17.4	3.9	9.4	0.2	2.3	0.0	0.8	5.4	0.5	24.7	15.1	0.8	12.7	10.6	0.4	2.8	53.3	4.8	10.8	1.3	14.7	0.0	0.1	0.1	12.4	12.6	24.3	0.3	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.1	0.2	4.6	4.7	5.2	5.4	3.3	2.9	4.1	4.4	4.4	3.1	6.3	2.9	33.2	3.2	8.6	0.3	0.3	0.5	1.7	3.1	0.0	6.1	0.9	2.2	5.2	0.0	2.6	1.8	0.0	0.1	1.6	1.3	0.0	1.2	0.0	0.7	2.3	28.3	0.0	0.0	2.4	0.7	0.1	2.2	1.1	1.2	1.3	0.0	28.5	0.3	1.3	38.7	3.2	1.3	2.0	4.4	2.1	0.6	0.3	2.2	0.0	15.0	2.7	3.6	2.1	1.5	0.1	4.6	1.8	1.5	1.6	2.8	0.0	0.1	0.9	0.9	0.0	1.2	3.3	0.5	0.9	0.8	0.4	0.1	1.5	0.4	2.7	3.6
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		140000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	75.4	67.7	47.5	53.8	51.0	30.4	67.5	52.0	60.5	78.0	61.2	65.0	59.2	69.2	111.1	72.5	60.5	51.6	75.6	46.8	50.9	58.3	91.6	62.6	53.2	51.2	51.3	65.5	119.7	61.9	88.7	54.7	51.1	68.8	67.1	39.2	79.6	64.5	51.1	60.9	64.9	71.0	50.0	57.9	71.8	46.2	50.5	58.8	65.2	55.0	62.2	66.4	60.9	57.2	90.9	72.6	135.3	98.9	174.0	172.7	66.6	244.8	208.5	102.4	120.7	239.4	116.6	96.4	199.7	275.7	148.0	123.7	160.5	139.5	151.5	128.0	66.3	211.6	56.7	151.4	197.1	140.4	121.8	157.8	117.6	175.0	168.7	149.3	162.2	95.0	106.8	139.2	201.3	157.0	123.2	130.8	85.3	207.7	92.4	107.9	134.2	147.4	137.3	107.0	88.3	86.6	130.2	129.0	70.1	132.5	155.9	111.4	144.0	129.4	65.1	118.4	109.5	79.9	78.5	147.6	74.3	122.6	161.4	118.1	49.8	50.7	52.7	59.8	69.0	39.5	51.7	51.3	54.0	35.4	48.0	44.7	41.5	64.5	64.5	44.9	53.9	55.8	47.5	51.0	52.0	60.5	46.8	50.9	51.2	51.3	51.1	50.0	50.5	57.2	43.6	35.3	47.9	12.4	32.2	31.6	38.5	31.5	23.9	22.4	39.4	27.9	46.5	24.3	41.9	31.3	4.2	17.2	45.6	68.4	9.8	34.3	11.1	38.4	72.2	43.1	40.2	14.9	15.4	37.8	36.1	44.9	39.3	50.4	39.3	31.9	31.4	55.7	30.3	18.5	17.7	80.2	22.4	36.0	37.6	8.5	48.1	35.3	23.2	11.2	49.0	17.3	26.8	17.1	20.2	46.9	35.8	41.3	68.3	51.5	56.2	30.5	46.2	13.6	19.7	52.7	45.7	44.8	47.6	30.4	34.7	30.2	38.4	43.9	42.6	51.6
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445136-74455005	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.9;placenta: 328.8;urinary bladder: 145.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 67.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 11.8;NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in many"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	48.1	4.6	0.1	36.7	0.1	129.9	61.6	0.1	0.8	19.2	1.8	18.7	3.3	3.7	0.2	43.4	13.2	74.1	20.5	0.3	0.1	2.5	4.0	36.1	1.9	0.3	0.2	12.4	4.5	1.5	9.5	328.8	0.8	6.5	18.9	0.1	11.7	0.7	18.4	15.3	10.2	6.5	0.2	10.0	20.2	9.3	0.4	7.1	5.4	0.8	3.0	145.6	13.8	0.4	15.9	107.3	0.0	0.0	0.9	1.4	0.0	3.2	5.0	0.7	2.9	379.0	59.8	0.0	8.0	0.0	0.0	17.4	0.1	648.1	6.5	0.1	0.0	0.4	2.8	18.0	191.9	2.3	0.4	5.9	644.0	37.8	1365.7	0.9	0.2	0.4	1.6	0.7	14.4	416.8	0.2	0.0	0.0	78.6	42.8	0.0	0.1	0.1	36.4	2.9	0.5	0.2	22.2	1.2	0.0	0.4	11.6	0.1	1.0	0.0	15.3	5.3	0.1	0.9	0.0	0.1	0.0	0.0	1.7	11.0	0.0	11.8	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.3	0.2	0.0	0.1	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.3	0.2	0.8	0.2	0.4	0.4	670.0	198.7	301.9	0.0	190.7	1119.1	1254.3	73.0	303.9	0.0	801.5	460.2	49.0	62.9	183.9	51.5	0.0	1.8	836.1	878.0	0.0	61.8	70.4	167.7	12.3	32.2	41.6	18.5	0.0	10.2	1.5	80.8	254.9	193.1	680.5	0.9	10.8	4.2	32.2	0.0	0.5	393.5	8.2	250.4	196.4	12.1	0.3	1271.1	33.8	0.0	1.7	0.8	20.6	0.0	0.0	497.1	909.8	1.2	352.1	115.3	55.7	0.7	53.3	0.2	19.7	10.3	20.2	68.3	51.1	194.5	342.4	1.1	473.6	1.2	308.9	2102.9
AREL1	"FIEL1, KIAA0317"	ENSG00000119682	"Apoptosis resistant E3 ubiquitin protein ligase 1"	O15033	14	74653437-74713117	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051306	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA051306: AB_2681433"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.58e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (4.67e-6)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.18e-2)"	6.2	6.9	4.3	10.4	4.7	16.9	6.7	3.1	4.8	7.8	3.3	10.4	11.8	6.5	7.1	10.0	10.4	6.7	10.6	6.7	5.0	14.6	5.3	9.0	10.0	3.1	4.1	6.8	9.5	15.4	4.5	8.3	2.6	8.4	12.3	13.3	9.7	7.7	9.9	7.8	12.7	8.4	3.7	8.5	9.8	17.1	5.6	13.1	15.5	13.1	13.3	10.0	5.6	3.5	19.2	24.6	25.1	23.6	21.3	14.1	19.3	20.7	23.5	25.2	25.1	19.2	22.2	16.4	10.8	26.6	22.9	25.3	26.9	23.2	32.4	30.4	12.7	25.5	14.5	13.7	14.2	18.5	23.9	18.4	15.8	18.6	20.0	31.6	25.0	23.5	20.3	17.1	32.9	25.8	19.2	7.8	15.4	26.0	24.2	19.5	28.4	10.2	20.5	42.6	24.6	33.0	18.1	23.9	13.4	16.6	21.0	18.5	34.6	23.8	28.5	14.3	24.3	22.6	32.8	32.2	28.8	14.0	18.8	2.2	3.5	7.1	4.6	5.1	3.3	2.1	2.8	4.2	4.5	1.4	2.9	2.6	6.8	3.4	2.7	2.1	2.6	3.4	4.3	4.7	3.1	4.8	6.7	5.0	3.1	4.1	2.6	3.7	5.6	3.5	3.7	12.8	4.6	23.2	6.5	3.6	3.4	6.0	7.4	12.3	7.0	3.7	11.1	5.7	7.5	11.0	27.1	4.2	11.2	18.3	1.9	6.6	3.1	7.2	7.1	5.0	14.9	21.0	24.8	9.2	3.3	4.6	12.8	10.5	1.3	10.3	6.4	12.9	8.0	16.8	24.1	11.6	8.2	15.0	5.3	4.6	8.7	9.6	5.4	23.4	13.9	5.2	11.3	22.6	32.5	11.2	6.5	6.8	9.1	6.8	11.8	5.1	7.3	11.7	0.0	4.4	4.9	6.7	11.1	10.5	3.3	5.9	8.4	6.4	11.5	6.3
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	268.3	282.5	213.8	176.7	222.5	426.9	241.9	188.1	261.9	249.1	215.1	259.8	242.6	266.6	193.1	304.7	247.5	189.2	340.0	242.7	231.3	257.0	324.7	298.2	185.0	200.6	201.6	237.3	327.6	296.9	299.1	276.9	207.6	244.0	177.3	96.7	355.2	203.9	330.9	237.3	240.8	176.2	196.6	251.4	265.6	193.9	218.9	184.4	240.3	206.4	154.7	229.0	233.1	206.4	476.6	321.6	257.4	257.9	289.9	362.6	425.7	409.5	433.0	444.3	386.8	383.6	442.7	239.9	428.8	438.3	204.6	298.8	316.4	399.4	219.4	355.3	506.8	234.3	209.8	386.6	559.5	342.1	333.8	350.4	476.7	408.6	427.0	374.1	443.3	267.0	456.0	533.3	431.4	341.8	350.0	495.9	331.7	656.7	643.0	279.0	228.1	750.6	315.1	242.1	362.6	320.0	265.9	790.0	466.8	87.8	543.9	681.0	406.0	324.6	256.5	479.4	626.8	498.5	301.0	331.1	445.9	285.0	670.6	1003.7	556.5	625.5	387.3	527.8	472.4	276.7	328.0	359.8	423.6	261.3	253.2	280.8	863.6	345.5	528.2	571.4	417.9	1082.4	213.8	222.5	188.1	261.9	242.7	231.3	200.6	201.6	207.6	196.6	218.9	206.4	276.9	173.1	185.2	25.8	205.1	262.6	281.7	248.0	104.2	114.3	209.1	172.0	139.8	125.8	208.1	115.8	45.9	373.7	267.8	487.8	230.9	422.7	236.3	164.6	218.7	247.2	230.1	173.8	42.3	404.5	565.8	227.3	142.8	240.8	198.3	128.8	152.4	124.8	409.4	158.2	41.1	436.9	213.6	198.8	256.2	429.9	229.2	300.1	300.6	35.6	356.0	162.2	214.2	30.7	40.7	400.2	407.2	227.2	282.8	344.6	370.1	173.3	180.7	80.2	230.1	149.6	416.0	321.1	155.7	158.3	286.0	676.7	224.9	174.6	335.2	370.0
ARF6		ENSG00000165527	"ADP ribosylation factor 6"	P62330	14	49893082-49897054	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 716.1;Suprabasal keratinocytes: 673.3;Urothelial cells: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002778, CAB079914"	Approved		Supported	Cytosol		NA	NA		310000	"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002778: , CAB079914: AB_2539861"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.49e-2)"	32.1	25.3	13.4	43.6	14.2	83.1	32.6	15.2	15.3	35.7	16.3	53.4	46.4	21.7	26.6	108.2	28.3	32.8	18.3	11.8	14.3	29.7	46.1	31.5	62.0	14.7	14.3	15.3	24.7	20.4	12.6	36.3	15.4	32.2	51.0	13.2	36.3	19.2	26.1	66.0	51.2	23.8	15.6	49.6	46.7	15.8	15.9	45.2	21.1	17.1	66.7	46.8	55.7	15.6	141.5	58.2	38.4	44.8	51.5	68.4	78.3	86.5	62.6	60.3	62.2	42.6	96.2	91.3	43.7	72.7	46.3	101.7	43.7	69.3	71.3	181.4	34.9	47.2	30.6	38.3	58.1	87.2	60.7	53.7	81.5	48.9	93.7	72.1	67.6	58.3	45.9	176.9	84.7	101.5	77.7	76.5	42.0	75.9	82.8	59.4	50.1	53.9	157.6	112.9	56.4	37.4	68.9	102.3	89.0	46.5	78.0	70.0	90.0	111.9	57.4	66.7	66.1	94.3	104.4	68.6	40.1	50.9	81.3	34.2	20.7	21.1	34.7	33.0	37.6	33.5	33.7	35.3	23.9	26.6	23.0	29.6	14.7	29.1	31.4	15.8	36.2	23.4	13.4	14.2	15.2	15.3	11.8	14.3	14.7	14.3	15.4	15.6	15.9	15.6	102.9	51.3	29.9	2.9	233.7	599.8	529.1	47.9	231.6	22.9	154.4	80.1	18.5	127.2	47.6	101.2	2.1	152.7	298.8	276.0	158.5	125.4	5.8	95.6	98.5	117.1	99.3	140.1	5.3	80.0	208.1	94.9	115.7	143.7	79.9	40.3	108.5	143.3	168.0	33.7	5.9	167.0	20.3	195.6	716.1	8.3	33.5	184.5	304.1	15.0	204.9	42.2	192.6	6.0	8.9	130.4	161.6	32.7	182.4	443.4	190.8	166.5	30.3	21.6	46.0	68.8	90.7	62.7	48.7	361.4	673.3	202.9	311.0	52.6	182.5	703.8
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289790	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	Cytosol	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.9	16.7	13.1	15.5	14.3	12.1	13.0	13.1	20.6	19.1	8.4	19.1	13.1	20.8	8.6	15.8	16.1	16.8	14.1	14.4	11.0	15.9	17.8	16.1	16.1	14.1	12.0	17.7	28.3	11.8	63.9	15.4	14.2	20.1	9.5	11.7	18.4	13.4	14.1	19.1	18.1	12.5	9.1	20.5	18.5	24.2	12.5	14.2	17.9	7.5	11.3	16.5	14.9	15.9	32.6	60.2	25.6	30.6	30.3	32.5	51.2	46.4	36.5	90.7	45.5	145.2	35.2	24.5	41.7	55.4	41.5	43.2	23.5	73.8	28.5	15.8	26.7	19.4	64.7	128.4	46.2	28.8	38.4	28.5	46.9	44.0	24.9	30.5	32.9	25.5	34.9	27.8	25.1	53.2	52.9	28.0	34.5	34.3	51.9	29.7	36.8	23.6	22.3	38.8	27.3	29.9	55.1	58.7	59.2	20.7	42.8	36.4	42.8	56.0	77.3	35.0	37.6	28.4	20.2	26.5	56.9	20.0	35.3	4.8	5.7	6.4	5.6	7.1	6.4	3.0	3.1	5.3	5.7	4.2	3.0	3.0	2.4	4.7	9.5	4.2	4.1	6.0	13.1	14.3	13.1	20.6	14.4	11.0	14.1	12.0	14.2	9.1	12.5	15.9	12.6	22.4	30.7	34.9	11.2	10.1	6.0	8.6	4.0	26.6	17.6	14.4	12.4	11.5	14.4	12.9	33.3	12.5	15.4	37.6	9.8	12.2	15.9	11.0	17.1	14.2	24.5	9.5	14.5	15.4	24.9	16.3	50.4	14.9	15.9	30.6	13.6	23.3	14.9	21.9	14.9	40.4	2.0	14.4	11.5	23.3	12.5	13.5	12.4	5.6	12.3	11.8	15.5	18.6	24.8	28.2	18.3	9.8	17.8	11.6	17.4	11.5	18.8	20.1	6.6	11.1	14.9	21.3	7.4	6.7	8.5	15.2	10.3	16.8	24.0	9.2
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favorable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	38.0	51.4	62.1	36.3	63.9	82.2	41.7	63.2	68.3	42.3	57.2	49.4	40.0	43.3	35.5	60.8	49.3	32.1	58.7	62.5	60.1	47.6	76.8	40.7	51.9	65.1	61.8	44.6	69.7	48.2	38.7	39.9	61.8	51.4	39.4	38.9	56.1	41.7	115.9	78.7	43.8	38.8	60.6	51.2	55.7	30.7	63.1	49.8	47.4	81.4	50.5	44.7	43.3	70.3	55.7	36.4	54.9	43.3	45.9	37.3	51.6	51.2	48.1	64.1	48.4	41.3	45.3	91.3	32.4	58.7	40.8	82.3	47.2	74.6	40.3	45.0	46.1	77.6	85.5	50.8	53.7	107.0	84.4	56.7	82.3	33.3	71.1	46.1	60.4	65.6	111.8	67.8	58.5	102.5	50.8	87.8	43.6	98.3	48.4	78.8	94.8	116.8	60.3	79.3	53.0	47.0	58.7	81.7	38.8	26.1	126.8	78.8	48.7	55.2	43.3	50.5	68.6	58.6	60.7	78.3	38.6	81.2	56.4	108.5	69.1	92.8	74.0	77.3	66.6	59.0	57.1	66.2	65.9	63.1	63.0	63.4	41.8	69.2	98.4	35.4	71.8	108.1	62.1	63.9	63.2	68.3	62.5	60.1	65.1	61.8	61.8	60.6	63.1	70.3	23.8	35.3	45.9	25.1	46.5	22.2	31.4	22.1	29.6	73.6	30.9	25.8	13.0	20.0	41.2	31.3	114.7	64.3	40.7	38.6	25.4	38.7	2.7	20.3	26.4	29.8	45.4	47.1	16.2	36.6	47.1	29.7	34.1	27.0	60.8	44.9	31.1	44.0	36.8	74.0	15.1	35.0	38.7	33.6	25.4	6.6	34.2	28.6	28.4	15.9	58.1	51.1	71.1	13.0	23.7	39.2	45.0	26.4	31.7	26.4	41.0	26.3	34.1	115.4	39.5	33.0	28.0	24.7	35.9	30.3	26.7	91.8	43.7	40.3	36.3	34.0
ARFGAP3	ARFGAP1	ENSG00000242247	"ADP ribosylation factor GTPase activating protein 3"	Q9NP61	22	42796502-42858106	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000638	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Golgi apparatus"	"HPA000638: AB_1078188"	"unprognostic (3.29e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (8.97e-6)"	"unprognostic (5.83e-2)"	"unprognostic (8.85e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.65e-4)"	"unprognostic (1.73e-1)"	30.1	88.9	16.5	34.1	17.4	47.8	30.9	19.5	20.4	56.1	23.2	26.9	36.5	32.2	53.3	22.1	22.9	36.6	23.6	17.9	20.6	53.2	49.2	32.3	28.1	20.5	18.7	20.7	85.8	38.0	38.1	34.8	20.3	64.7	30.6	35.5	68.5	40.2	31.3	20.7	51.1	30.8	19.0	26.0	43.2	49.5	19.6	25.9	61.3	21.8	32.6	45.2	23.4	21.0	59.6	19.3	41.1	24.7	57.2	94.1	17.3	111.8	76.4	50.5	60.9	23.5	32.8	30.1	24.5	102.9	41.8	14.4	18.7	33.0	54.7	18.5	25.4	35.7	27.6	37.4	79.6	31.9	53.2	42.0	57.6	42.6	75.9	71.9	52.4	27.4	16.1	132.0	89.6	15.7	49.4	17.5	6.7	32.7	23.2	31.1	92.3	38.3	80.7	27.5	14.6	9.0	54.3	21.5	46.0	30.6	22.7	24.4	67.0	58.7	42.5	52.1	30.7	94.7	48.2	33.1	41.9	34.0	46.7	86.2	33.2	36.8	45.1	44.4	58.8	27.1	29.7	39.8	32.5	26.1	19.2	27.2	50.8	49.4	50.9	53.1	28.8	30.1	16.5	17.4	19.5	20.4	17.9	20.6	20.5	18.7	20.3	19.0	19.6	21.0	40.8	38.5	54.8	27.4	41.7	26.6	86.9	43.0	19.9	42.8	43.1	29.5	26.5	37.1	62.1	57.0	18.8	18.8	67.3	36.4	66.5	65.9	19.1	60.5	89.9	42.4	49.1	17.5	26.1	64.3	23.7	58.1	30.1	96.3	65.9	28.4	30.4	37.3	28.7	33.7	28.8	53.0	46.8	21.7	89.3	15.0	48.1	68.2	69.4	35.6	33.7	40.5	38.1	43.7	40.0	83.0	15.6	45.5	110.0	121.5	70.9	62.9	65.5	33.7	39.5	80.0	65.5	178.7	67.6	14.6	26.7	59.9	49.6	39.0	22.7	86.7
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343781	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavorable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	11.4	10.3	5.6	14.6	5.3	27.5	13.6	8.2	6.8	14.2	10.1	19.2	16.9	10.5	11.0	15.2	11.8	12.5	9.6	4.6	5.5	22.8	15.2	13.8	15.4	6.2	6.5	10.3	17.5	28.0	5.4	14.4	6.7	13.0	17.2	36.5	14.8	12.1	12.8	13.7	17.5	10.8	5.2	13.8	19.6	28.3	6.4	22.2	22.4	14.0	17.2	19.7	7.9	7.3	31.8	20.4	19.3	7.3	21.9	29.8	22.5	21.4	24.3	21.7	22.0	12.6	30.0	23.9	8.9	27.6	26.2	22.2	23.5	30.4	26.6	28.3	16.0	40.2	12.0	13.5	18.6	20.9	37.3	18.4	21.6	19.2	31.8	22.3	31.5	24.6	24.5	25.3	25.5	7.2	48.1	9.7	42.5	34.5	18.5	22.4	13.9	4.8	35.8	58.2	7.6	14.9	14.1	33.9	19.5	29.5	58.5	18.3	38.6	14.4	19.3	19.5	16.4	20.4	22.6	17.5	23.6	20.8	14.2	6.1	1.6	4.3	2.8	2.3	3.6	1.2	1.8	2.3	1.6	1.3	3.0	2.6	5.1	2.5	0.9	2.2	3.9	0.9	5.6	5.3	8.2	6.8	4.6	5.5	6.2	6.5	6.7	5.2	6.4	7.3	38.5	44.8	23.1	73.1	32.7	23.7	34.0	23.8	19.9	36.8	32.7	18.9	33.1	18.6	31.9	38.6	139.7	20.0	47.0	43.2	11.7	29.7	25.4	42.5	34.7	28.5	29.4	16.2	119.0	25.6	15.4	22.9	57.6	53.0	15.2	40.0	23.2	19.6	15.8	43.7	146.3	27.9	14.2	31.3	20.4	36.0	40.0	35.2	17.8	105.9	47.1	22.9	46.4	151.8	126.6	40.1	25.7	30.1	29.8	38.2	30.8	24.7	33.9	100.8	6.6	23.6	26.5	69.4	50.7	26.0	29.5	24.9	42.4	32.1	28.0	60.4
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921711-49036693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 81.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 102.6;Inhibitory neurons: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	9.1	20.2	2.8	8.7	4.1	10.4	15.8	1.9	5.8	11.5	7.9	14.2	13.7	9.0	5.9	11.0	7.5	8.5	13.4	4.5	3.9	15.3	12.4	7.8	9.8	2.6	3.2	7.7	19.2	81.5	8.7	9.2	3.5	10.6	15.7	6.8	11.0	9.7	11.8	11.1	10.9	9.5	1.9	10.4	16.2	13.6	3.5	11.3	23.8	18.2	14.2	11.1	8.2	5.0	18.3	16.5	8.9	5.1	18.0	14.8	21.8	15.5	19.5	36.6	19.0	37.1	19.8	25.5	22.1	19.7	33.8	21.0	18.6	23.6	33.8	9.0	7.6	17.5	17.9	25.4	19.7	22.6	19.7	15.0	21.6	23.9	27.6	12.7	28.4	11.7	15.0	22.3	20.8	6.3	13.0	6.8	8.3	20.5	17.4	14.0	25.5	30.3	13.6	23.4	7.1	9.0	42.6	66.0	23.4	10.3	26.6	18.6	34.5	35.6	16.5	18.2	13.1	35.9	35.0	18.7	23.4	10.7	11.6	1.1	0.6	0.2	0.5	0.4	0.6	0.5	0.5	0.4	0.7	0.9	0.8	0.7	0.3	0.3	0.3	0.9	0.1	0.3	2.8	4.1	1.9	5.8	4.5	3.9	2.6	3.2	3.5	1.9	3.5	5.0	16.6	19.2	26.0	37.2	21.2	11.3	12.2	11.0	11.4	15.3	27.7	14.7	40.7	17.2	20.0	11.0	14.6	10.5	14.7	30.4	1.9	10.9	16.6	19.5	17.1	19.5	12.5	14.3	102.6	13.3	10.0	12.6	16.3	24.7	15.2	11.0	20.7	27.8	10.8	11.8	96.7	23.3	8.2	15.7	13.9	24.6	10.2	17.8	10.6	60.9	15.6	5.4	10.3	43.2	57.0	15.5	21.6	11.3	29.0	24.1	18.6	11.5	17.2	16.1	6.6	14.2	12.5	32.6	20.4	17.5	15.5	30.0	13.2	16.6	21.0	21.2
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161939-138344663	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;salivary gland: 18.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036350: AB_10672084"	"prognostic unfavorable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.2	3.8	13.4	0.7	16.4	0.4	7.9	20.1	17.7	5.0	0.0	4.2	2.2	0.7	0.9	0.4	2.2	1.7	1.0	16.7	13.0	2.1	0.1	6.4	0.2	11.1	17.7	0.1	8.7	15.8	7.0	1.4	14.4	12.0	4.8	2.8	18.0	1.0	0.2	1.2	1.9	0.7	7.5	0.4	10.0	0.6	15.2	0.1	1.9	0.7	0.2	3.4	0.4	28.4	8.0	3.1	0.0	0.6	0.0	0.0	4.7	0.3	0.2	0.2	0.0	0.1	0.4	0.0	3.1	0.3	2.7	2.6	3.8	2.0	0.0	0.0	4.9	0.0	1.5	0.9	0.0	3.0	0.0	0.0	0.9	0.0	0.9	3.5	4.1	2.7	0.0	4.9	0.0	14.8	0.0	0.0	2.7	8.5	3.4	0.6	13.4	2.6	2.6	19.4	6.9	0.0	7.8	22.2	0.9	0.3	4.4	0.0	0.4	0.2	2.2	0.0	7.9	1.7	6.7	0.0	3.2	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.4	20.1	17.7	16.7	13.0	11.1	17.7	14.4	7.5	15.2	28.4	9.4	16.0	114.6	34.3	0.5	0.0	18.8	0.0	6.2	19.0	39.9	12.6	6.4	14.3	44.6	3.7	0.0	16.5	0.8	2.5	3.9	11.4	83.0	8.6	1.4	11.9	66.7	2.7	200.9	24.7	2.4	4.1	41.3	17.7	2.5	0.1	8.2	0.3	1.4	11.8	207.8	44.2	0.0	0.0	0.0	22.0	0.0	0.5	0.0	36.5	2.0	0.9	0.0	173.9	378.1	14.2	8.4	0.0	0.9	67.6	2.5	0.3	37.2	3.3	0.0	3.5	0.9	4.1	1.1	3.0	0.0	6.2	0.8	0.1	13.2	42.7
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	16.8	14.8	7.9	15.8	8.7	3.7	23.4	9.9	10.8	22.5	9.9	28.1	23.2	21.7	20.5	20.9	18.5	19.9	10.2	7.3	9.3	19.8	15.4	16.8	15.1	9.3	8.0	17.6	10.5	22.4	10.5	18.0	9.5	21.1	27.8	20.2	13.7	17.2	6.6	17.3	21.3	19.8	9.4	18.3	22.7	12.1	8.3	12.0	20.1	10.4	14.8	23.5	15.2	11.4	25.8	18.4	25.1	25.7	37.2	37.9	30.6	29.5	40.5	28.7	26.9	21.3	51.3	20.6	9.9	40.5	22.7	18.1	26.3	29.1	35.3	16.9	16.2	20.0	18.0	20.5	26.1	38.2	41.7	26.6	30.9	24.8	23.8	30.7	26.4	11.8	23.5	43.3	39.8	28.6	22.7	19.8	21.8	29.9	18.5	12.6	14.7	19.2	50.7	32.1	32.8	26.0	22.1	40.7	30.2	23.5	37.7	19.6	17.3	27.8	20.1	26.8	21.4	48.2	42.8	28.1	35.3	38.2	40.0	31.5	27.3	42.2	14.5	31.1	14.6	19.0	11.2	12.2	24.8	17.7	8.7	11.8	81.6	29.1	30.7	3.1	18.5	18.7	7.9	8.7	9.9	10.8	7.3	9.3	9.3	8.0	9.5	9.4	8.3	11.4	28.5	6.4	31.8	40.5	20.3	29.6	18.4	30.7	34.1	17.2	26.2	19.7	10.2	20.0	29.1	38.6	0.0	28.6	15.6	40.9	27.4	27.4	46.3	42.2	33.0	23.8	38.9	12.0	44.5	18.3	27.0	28.8	40.2	50.7	22.8	14.2	17.2	19.8	22.1	18.5	42.8	39.1	34.6	23.8	18.0	21.6	22.4	24.5	21.4	89.9	19.5	35.9	23.7	76.4	75.6	24.4	28.2	21.8	11.8	23.6	23.8	34.2	31.9	24.2	32.9	20.6	27.8	31.7	29.5	31.9	34.0	43.9	17.7	89.2	31.7	30.3
ARFIP2	POR1	ENSG00000132254	"ADP ribosylation factor interacting protein 2"	P53365	11	6474683-6481479	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032985, HPA038156"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"CAB032985: AB_2058811, HPA038156: AB_10697243"	"unprognostic (2.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.48e-3)"	19.8	29.3	31.7	18.6	32.3	22.8	50.7	32.5	35.2	36.3	36.2	36.8	32.9	27.2	34.0	31.4	39.3	23.9	17.9	32.1	31.4	27.0	34.6	24.4	22.4	31.2	31.4	29.4	49.4	46.4	40.7	29.7	31.9	46.6	48.1	28.3	57.7	28.2	15.2	32.8	30.7	27.4	30.9	20.7	50.4	18.3	31.8	25.7	36.9	16.1	32.0	29.2	24.4	33.1	50.4	64.8	38.9	38.5	59.1	53.9	56.1	40.3	107.0	86.2	101.8	62.1	80.3	39.9	16.5	79.3	49.8	68.0	49.4	84.1	70.0	30.9	86.5	22.3	87.7	60.4	71.3	36.2	42.8	60.0	65.7	43.0	98.3	64.2	55.9	38.3	35.3	45.0	55.8	98.9	41.9	41.6	67.2	119.0	71.9	31.7	22.6	37.1	61.9	50.4	50.8	63.2	48.7	204.9	25.9	36.3	86.9	33.0	36.8	35.4	35.7	39.1	30.3	67.3	32.5	24.3	65.4	22.0	43.9	13.0	15.6	9.9	17.9	10.9	17.8	12.1	16.7	14.5	21.3	13.8	16.7	17.1	6.1	21.1	6.7	16.6	18.9	13.9	31.7	32.3	32.5	35.2	32.1	31.4	31.2	31.4	31.9	30.9	31.8	33.1	14.8	6.4	6.4	4.6	20.7	28.0	49.3	48.9	16.5	32.6	59.8	45.1	4.3	40.0	30.5	12.9	29.2	80.1	24.3	56.0	58.7	62.7	31.7	28.1	20.1	19.6	63.0	21.8	8.4	85.4	65.8	23.1	62.2	37.2	31.8	30.3	20.3	21.1	28.1	21.9	7.8	126.6	32.6	10.1	16.4	43.3	20.5	14.4	24.9	5.6	25.2	35.4	18.6	6.6	7.6	59.9	63.4	24.5	28.0	73.3	65.2	34.4	34.7	32.3	26.3	21.6	23.3	41.0	26.2	26.2	32.1	112.5	16.9	40.9	52.6	64.7
ARFRP1	"ARL18, ARP, Arp1"	ENSG00000101246	"ADP ribosylation factor related protein 1"	Q13795	20	63698642-63708025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047028, HPA050634"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA047028: AB_2679908, HPA050634: AB_2681196"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.39e-1)"	26.8	27.8	23.4	14.0	23.4	10.0	25.0	22.8	29.1	31.8	22.4	29.3	18.9	29.3	5.3	36.2	27.9	8.8	41.0	22.7	22.7	34.1	36.5	26.0	17.8	23.1	23.2	29.3	24.4	12.6	25.1	11.6	23.1	32.4	8.4	5.5	22.4	16.0	31.8	22.9	27.2	10.1	22.7	42.0	24.6	20.1	24.5	17.7	25.6	15.5	11.2	29.5	28.3	23.9	26.5	31.9	10.1	10.6	10.0	10.8	14.6	31.8	21.1	67.7	24.6	60.0	22.4	32.4	21.6	18.8	27.3	35.8	11.0	35.5	11.9	11.3	16.5	23.8	36.1	52.2	34.7	27.3	21.5	15.1	45.2	17.8	21.6	17.9	25.1	30.5	36.0	24.1	16.9	14.9	54.0	37.7	15.8	19.5	46.7	42.3	14.0	33.4	14.5	21.7	16.9	17.3	32.3	46.5	11.4	6.1	20.5	34.8	20.0	39.6	15.9	14.9	32.6	24.9	11.1	25.1	26.5	17.9	22.8	44.3	30.9	23.5	41.5	31.6	34.7	32.6	37.5	39.8	28.3	33.7	46.8	41.5	15.7	37.6	34.7	49.2	32.3	36.5	23.4	23.4	22.8	29.1	22.7	22.7	23.1	23.2	23.1	22.7	24.5	23.9	40.7	12.8	11.9	12.4	25.9	13.9	25.5	26.1	19.4	44.6	20.8	28.7	34.0	8.6	15.8	25.8	20.9	42.2	28.0	48.9	39.2	31.2	12.8	13.5	27.0	34.3	26.4	25.7	10.6	20.4	25.5	31.6	18.3	10.7	24.7	28.4	24.3	18.4	36.9	37.0	10.6	31.6	18.3	20.7	15.3	10.5	23.9	24.1	24.9	5.6	41.0	40.8	29.9	4.0	11.9	51.6	34.6	29.7	23.4	22.9	52.4	33.4	12.3	42.3	19.7	21.8	35.1	44.5	32.7	22.4	14.2	30.2	30.7	35.7	33.1	17.0
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619920-67651708	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 220.0;prostate: 108.5;thyroid gland: 105.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	2.8	7.3	5.6	2.9	6.1	0.5	4.8	6.9	13.9	17.0	7.9	2.7	3.7	7.0	3.6	16.3	1.8	9.3	3.4	6.3	11.6	64.0	3.8	3.8	0.5	6.4	7.7	18.7	5.0	220.0	45.6	8.8	9.2	108.5	1.4	22.3	17.0	5.8	35.7	2.1	15.3	3.7	5.1	0.9	3.2	3.4	6.5	3.0	105.0	52.6	1.7	17.8	9.9	5.6	8.9	1.5	14.4	9.4	2.1	0.1	20.1	6.7	17.4	20.6	34.5	36.3	4.5	14.6	1.9	4.3	9.4	2.1	58.2	26.8	24.9	0.7	14.6	6.7	2.6	41.9	6.2	1.8	37.8	1.1	33.6	10.2	49.7	1.6	35.4	37.7	19.4	0.1	1.4	4.4	2.5	1.4	27.2	4.0	0.5	0.8	2.0	16.8	16.8	14.3	31.5	12.2	4.2	4.2	6.4	32.9	15.1	1.2	7.3	6.4	15.9	0.7	5.0	1.3	2.4	4.9	12.8	7.5	10.9	0.1	0.4	0.7	0.3	0.1	0.1	0.2	0.1	0.3	0.5	0.7	0.2	0.2	0.6	0.1	0.4	0.0	0.9	1.0	5.6	6.1	6.9	13.9	6.3	11.6	6.4	7.7	9.2	5.1	6.5	5.6	3.9	0.0	5.8	5.5	8.4	8.8	190.1	17.0	7.4	5.2	41.6	28.7	6.3	4.3	20.3	165.5	10.4	86.5	14.6	9.0	37.2	8.4	16.5	75.1	18.7	5.9	36.8	8.8	20.3	3.3	6.2	5.6	37.8	145.2	7.0	23.9	2.9	1.3	14.7	10.1	41.8	24.5	12.2	0.6	3.6	3.2	0.3	9.3	10.6	7.5	0.9	40.5	1.0	9.0	9.2	5.0	5.0	0.4	5.7	95.4	72.8	220.9	3.0	17.6	6.6	6.2	8.9	8.4	3.4	9.7	5.4	601.3	15.1	2.2	8.7	165.2
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121567949-121590622	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.4"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5"	"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.7"									HPA043049	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043049: AB_2678288"															"unprognostic (6.00e-2)"			0.1	0.2	0.7	0.3	0.7	1.2	0.3	2.4	1.1	0.0	0.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.4	0.7	0.2	0.2	0.4	0.1	0.0	0.2	0.7	0.2	0.2	0.6	0.4	0.1	0.5	0.8	0.3	0.1	0.0	0.3	0.4	0.3	0.6	0.1	0.3	0.1	0.3	0.1	0.0	1.9	0.1	0.2	0.3	0.3	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.3	0.4	0.6	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.2	0.3	0.3	0.6	0.3	0.1	0.5	0.9	0.1	0.5	0.1	0.1	0.2	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.5	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.5	0.3	0.3	0.2	1.7	0.1	0.3	0.2	0.2	0.4	0.4	0.3	0.4	0.1	0.5	0.2	0.4	0.3	0.3	0.2	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.8	0.6	0.3	0.4	0.2	0.1	0.7	0.7	2.4	1.1	0.8	0.4	0.7	0.2	0.7	0.0	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568137	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	35.0	25.5	17.9	4.5	18.4	11.0	36.3	19.5	25.2	43.7	13.5	41.2	3.5	43.1	6.2	30.8	47.0	2.9	31.1	17.8	16.4	28.2	22.9	46.3	6.7	15.2	15.6	50.4	29.3	3.7	34.1	6.1	15.3	34.7	4.7	8.6	35.1	4.5	28.4	32.1	42.6	6.3	15.3	40.8	38.2	23.7	16.2	7.0	36.3	7.5	5.7	35.6	37.6	18.2	10.5	9.4	26.0	6.4	9.0	4.6	9.1	10.2	6.5	9.1	6.6	16.8	8.3	21.5	6.1	9.2	8.4	6.9	17.4	9.9	11.4	24.5	12.3	18.8	9.2	11.6	9.3	36.0	8.2	5.0	6.8	6.9	7.2	9.2	8.1	13.0	13.4	11.4	11.4	7.7	16.4	13.9	18.6	23.6	4.0	17.3	19.7	8.9	10.6	7.3	7.0	13.8	9.9	12.7	6.1	17.6	5.8	27.0	9.2	7.5	6.2	5.9	10.0	11.1	14.2	27.4	10.6	15.6	6.7	44.6	24.2	17.2	15.4	17.7	14.1	30.2	13.5	12.1	17.1	32.4	15.3	14.6	45.7	18.8	14.8	34.2	15.7	12.8	17.9	18.4	19.5	25.2	17.8	16.4	15.2	15.6	15.3	15.3	16.2	18.2	342.0	141.1	230.6	198.8	242.0	261.7	268.5	179.3	186.1	222.7	153.9	104.0	88.3	90.1	204.9	114.0	135.5	141.9	329.3	195.3	99.7	120.7	42.0	201.2	308.3	298.1	187.7	160.3	208.8	113.2	137.7	204.7	355.7	290.6	168.7	331.2	280.2	81.5	101.3	304.5	155.6	218.5	148.5	90.7	186.2	34.0	255.1	142.1	128.1	161.1	182.1	223.3	301.8	200.6	367.2	145.0	173.8	217.7	194.9	251.0	153.7	58.6	190.7	271.2	216.9	179.6	196.8	199.8	125.9	164.1	262.3	185.2	257.8	280.7	193.1	316.0
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700619	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Approved	Vesicles		NA	NA		11000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	84.5	49.2	40.9	38.0	48.3	33.4	61.8	33.4	46.1	71.3	31.2	62.8	25.7	93.7	21.5	75.0	68.4	50.7	112.3	39.1	41.0	41.5	46.2	38.4	30.7	45.7	43.2	46.4	36.5	24.7	36.8	39.0	39.0	64.9	32.6	9.6	46.1	62.6	30.0	65.3	46.7	80.6	38.0	58.4	49.0	15.8	49.8	23.2	44.6	20.5	34.6	107.9	63.4	57.4	23.0	56.7	27.9	39.8	135.4	99.6	32.9	50.3	50.7	45.3	41.2	34.2	29.5	33.1	26.7	102.3	40.7	55.8	22.4	76.0	33.5	23.3	24.6	36.8	27.7	40.4	44.5	31.3	52.3	131.9	46.7	34.5	42.9	46.8	39.1	27.1	24.3	30.3	55.9	82.6	21.2	30.9	72.1	78.5	29.4	25.0	39.9	49.3	42.3	85.2	10.0	31.6	45.8	69.8	19.1	40.1	88.0	35.4	49.1	82.1	25.5	98.7	51.0	32.0	38.2	24.8	77.4	52.0	39.3	27.6	33.0	33.1	26.7	56.9	19.3	14.3	20.8	22.8	32.3	14.7	17.9	20.8	37.3	23.7	72.0	34.1	27.4	24.9	40.9	48.3	33.4	46.1	39.1	41.0	45.7	43.2	39.0	38.0	49.8	57.4	25.2	19.2	18.7	16.6	18.3	8.5	13.4	24.6	10.8	11.9	22.3	24.6	50.2	10.0	18.1	29.5	27.1	25.1	35.2	35.2	3.9	22.2	0.4	17.9	26.9	19.6	19.4	15.3	13.0	27.9	31.0	29.2	31.6	27.6	19.6	21.3	25.7	32.1	30.4	16.8	15.3	36.0	14.2	30.7	8.4	1.7	23.6	19.1	8.8	11.2	28.2	11.0	36.0	23.1	92.3	27.3	19.2	35.3	10.1	11.4	22.4	13.3	10.9	14.2	59.2	28.0	55.9	3.1	3.5	24.7	13.1	16.6	19.9	9.4	21.5	18.7
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639941	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.7	0.9	2.0	7.9	2.5	24.2	1.7	2.1	2.1	1.5	1.2	7.5	6.1	1.5	1.0	5.3	0.8	1.7	0.7	1.7	1.9	0.6	1.3	1.7	13.5	2.6	3.0	0.6	2.6	1.2	0.7	4.3	2.6	0.6	8.8	0.5	1.2	0.5	0.9	4.4	7.6	4.8	2.5	2.8	3.6	8.6	2.2	26.1	1.3	0.4	14.3	2.8	1.9	3.0	80.8	69.4	73.1	46.2	5.0	13.0	39.6	78.5	50.2	80.0	63.3	52.2	41.5	43.5	23.7	49.9	91.3	56.9	55.3	43.8	110.9	83.5	27.4	132.6	68.9	33.5	2.0	103.8	55.5	4.3	5.5	61.6	50.9	15.2	61.5	94.4	101.0	112.7	95.3	31.7	58.6	39.7	44.6	71.6	44.5	67.8	141.7	38.2	28.4	41.6	64.7	44.5	72.9	46.2	17.6	37.6	63.6	115.8	35.3	102.5	74.1	42.0	87.2	38.3	63.7	123.7	44.4	129.1	91.8	0.1	0.3	0.8	0.5	0.5	0.2	0.3	1.0	0.9	0.4	0.2	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	2.0	2.5	2.1	2.1	1.7	1.9	2.6	3.0	2.6	2.5	2.2	3.0	0.7	0.0	2.3	0.3	4.6	4.8	1.1	2.4	2.2	0.2	1.3	1.7	0.9	4.3	1.9	1.8	0.0	9.8	2.9	6.2	0.0	0.8	4.7	3.8	2.6	2.0	0.0	38.7	1.0	0.8	23.7	3.5	8.6	2.8	0.0	21.1	1.8	2.1	9.5	0.0	0.6	7.8	0.0	6.5	4.2	5.0	0.6	3.5	0.0	1.0	3.9	0.1	2.1	0.5	1.4	0.5	2.9	0.4	18.6	1.4	1.1	0.4	1.4	1.0	6.6	1.4	3.3	24.7	22.6	10.5	2.3	3.1	5.4	2.0	14.1	2.1
ARHGAP11B	"B'-T, FAM7B1"	ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30649529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6;lymphoid tissue: 1.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.6;Erythroid cells: 37.4;Late spermatids: 21.7;Muller glia cells: 17.3"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 8.9;Karpas-707: 7.1"									HPA064479	Uncertain		Uncertain	Vesicles		NA	NA					"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA064479: AB_2685272"																		0.2	0.0	0.0	0.8	0.2	2.6	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.2	0.0	0.0	0.1		0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.2	0.2	0.3	0.1	1.4	0.1	0.0	0.8	0.1		0.1	1.2	1.0	2.8	1.3	0.0	0.4	0.8	3.2	0.9	1.6	1.8	0.6	1.8	1.5	0.1	0.2	0.9	1.4	1.6	0.6	1.3	3.0	3.9	3.1	8.9	0.2	0.0	2.8	1.8	0.1	0.0	0.4	0.2	0.5	0.9	1.9	0.8	7.1	1.7	1.0	1.0	2.8	0.8	0.7	1.2	1.9	3.2	0.8	0.7	1.3	1.5	0.8	1.9	0.7	0.4	0.7	1.5	1.4	1.0	2.6	1.7	0.5	0.8	1.4	0.5	3.1	0.4	3.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.0	1.5	1.0	6.1	2.0	1.0	2.8	1.8	3.2	0.6	0.3	0.7	0.0	0.6	1.8	6.2	0.0	5.1	7.0	0.0	0.4	22.6	0.4	1.3	1.1	0.0	37.4	0.4	0.6	0.0	2.3	15.3	0.7	1.3	6.9	4.2	0.8	0.0	3.3	0.2	8.3	2.0	7.9	3.1	21.7	2.1	3.3	0.0	1.0	4.8	17.3	4.1	0.0	0.7	0.4	2.5	1.2	12.6	1.0	1.6	0.6	1.2	2.3	0.0	1.3	1.5	15.5	12.9	6.9	1.4	0.0	5.8	1.2	12.1	0.9
ARHGAP12	"FLJ10971, FLJ20737, FLJ21785"	ENSG00000165322	"Rho GTPase activating protein 12"	Q8IWW6	10	31805398-31928876	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000412	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000412: AB_10964051"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.88e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.48e-3)"	8.6	12.5	9.3	8.5	13.0	4.2	16.4	18.5	7.6	13.2	15.8	15.7	15.4	9.3	10.8	9.3	7.8	15.2	11.8	8.0	15.7	14.6	16.3	12.3	7.2	22.1	17.8	14.9	21.3	19.5	6.6	10.8	20.5	11.6	14.7	17.8	16.6	8.0	7.9	8.1	15.8	8.0	17.9	17.8	29.4	6.6	15.0	5.9	16.1	9.6	8.0	10.8	6.9	27.0	23.3	30.8	18.8	16.6	28.0	31.3	12.4	14.4	19.3	11.0	16.1	16.5	56.6	6.8	8.6	23.6	18.9	13.1	9.1	16.6	19.3	3.0	8.8	1.3	5.5	31.5	17.7	1.2	1.3	19.9	14.0	16.7	12.0	18.2	11.7	6.3	14.0	2.1	25.1	16.5	4.4	2.5	6.6	31.0	4.7	6.0	22.1	5.7	19.7	22.2	10.2	9.8	7.4	7.1	37.0	16.9	4.8	4.7	17.3	12.6	18.8	29.2	11.0	2.0	2.7	7.5	18.9	9.4	16.4	0.0	1.2	0.0	3.0	2.7	2.4	2.5	2.5	3.3	0.7	2.2	3.1	3.2	1.7	4.2	2.5	1.0	3.1	1.6	9.3	13.0	18.5	7.6	8.0	15.7	22.1	17.8	20.5	17.9	15.0	27.0	19.0	48.1	45.3	54.5	17.8	24.6	14.9	17.1	37.5	14.5	34.2	19.3	33.5	34.3	29.4	22.0	29.2	9.1	20.0	32.9	11.7	28.5	1.3	21.2	24.2	14.9	33.0	3.8	39.1	29.6	5.4	34.0	69.8	28.6	3.8	24.5	13.6	19.4	19.2	58.9	103.2	38.1	8.2	18.7	12.6	3.3	18.0	13.4	21.4	156.4	6.5	20.7	22.6	94.0	81.5	34.3	28.3	22.2	12.9	22.1	26.9	21.3	27.1	25.1	13.1	49.5	17.8	12.6	24.5	16.5	20.6	9.7	17.3	37.4	24.1	22.9
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919389-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041703, HPA075891"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA041703: AB_10794304, HPA075891: "	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.76e-4)"	46.0	40.5	8.2	15.2	9.8	9.2	37.2	9.2	10.2	29.9	9.6	32.7	11.3	28.9	7.9	33.6	28.6	11.9	48.1	7.9	9.2	25.9	22.9	31.8	24.9	10.6	9.5	24.8	24.1	9.3	30.3	15.3	10.4	23.6	12.2	2.3	21.3	7.9	41.0	34.3	39.2	11.6	8.7	66.8	28.9	25.5	9.7	12.0	28.2	11.1	20.9	25.6	29.8	11.6	28.5	16.7	21.9	23.1	22.0	23.0	23.7	18.1	19.3	20.9	20.4	25.9	11.5	13.0	12.0	36.4	19.9	7.7	21.8	12.8	22.2	20.0	26.1	10.8	37.8	43.3	25.0	15.5	10.7	29.4	7.7	22.6	16.3	15.0	35.7	11.7	14.3	0.0	23.6	20.8	14.3	19.8	25.2	8.1	13.7	68.1	17.9	5.2	25.9	6.4	14.6	14.5	18.6	20.5	8.2	17.5	11.1	40.2	46.7	15.5	11.9	35.6	15.1	13.0	17.3	7.5	19.1	22.6	14.1	5.6	9.7	9.0	6.3	17.5	5.7	25.3	5.5	6.3	14.6	22.8	6.2	6.1	4.8	6.2	15.8	25.9	8.0	8.1	8.2	9.8	9.2	10.2	7.9	9.2	10.6	9.5	10.4	8.7	9.7	11.6	33.8	9.6	11.0	26.8	46.3	14.5	6.8	8.9	14.2	6.4	11.0	9.7	24.9	7.2	9.1	5.5	10.4	11.1	36.3	49.5	3.9	13.3	6.3	30.6	21.8	32.3	21.0	16.2	28.8	16.0	18.9	16.0	15.3	66.4	7.0	16.9	26.7	6.8	27.1	10.1	33.0	21.8	8.2	30.3	21.7	10.8	13.4	25.2	16.0	59.0	22.8	6.4	14.4	40.2	68.9	17.6	27.2	11.7	11.5	11.1	35.4	5.0	8.5	7.5	26.3	15.5	43.8	7.0	11.7	24.7	24.0	15.7	21.1	15.9	19.7	12.2
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710177	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 395.8;LHCN-M2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	20.5	37.2	3.4	13.0	2.5	4.3	13.4	2.4	2.8	14.9	15.1	14.8	24.8	6.7	20.2	6.0	28.3	15.4	6.0	2.9	4.1	28.4	6.3	28.7	9.4	4.7	5.7	6.0	33.2	14.2	6.7	20.8	4.3	9.9	15.0	2.6	14.6	8.4	10.6	4.0	27.3	10.6	3.5	9.0	27.9	8.3	6.4	6.1	23.0	13.0	7.9	12.6	4.1	3.7	8.6	18.8	1.9	2.6	17.8	25.0	15.1	64.0	48.8	27.7	18.5	10.0	14.1	7.1	30.6	43.2	8.8	11.0	13.4	20.9	51.3	7.0	5.7	46.7	13.8	57.3	25.4	6.9	395.8	15.9	3.2	50.4	44.7	57.8	79.8	0.0	25.3	17.4	113.1	2.3	0.1	6.8	2.0	16.0	4.5	0.3	8.5	13.7	84.6	4.8	0.0	0.1	5.3	8.8	32.3	9.3	9.7	8.1	61.6	28.8	4.1	2.3	51.8	7.8	6.0	4.8	9.7	12.7	40.9	12.0	5.1	13.5	4.9	5.8	3.1	2.9	2.5	5.5	4.8	1.7	0.4	2.6	3.9	2.5	3.2	11.8	2.8	6.0	3.4	2.5	2.4	2.8	2.9	4.1	4.7	5.7	4.3	3.5	6.4	3.7	139.5	57.7	33.3	1.6	13.0	13.0	17.7	15.7	10.8	0.7	53.4	14.7	4.1	17.2	39.5	38.6	2.1	92.7	31.0	19.0	150.6	48.2	20.7	176.1	5.8	89.2	13.1	10.9	16.8	120.5	24.9	45.3	63.2	35.7	253.6	34.7	11.0	5.0	110.4	0.0	23.1	22.1	63.1	48.4	112.4	21.2	3.7	163.9	7.2	43.1	23.9	16.4	28.8	12.5	2.2	102.4	25.0	1.2	26.4	18.5	69.8	31.7	265.3	0.9	26.3	38.9	32.5	10.6	1.1	11.2	12.9	212.3	35.9	69.1	31.3	19.1
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	3.2	2.1	2.4	7.1	3.9	18.8	7.6	2.9	2.0	3.7	0.6	4.3	3.6	5.5	2.6	4.0	4.7	3.4	3.3	1.6	3.2	3.9	2.4	4.7	13.3	4.3	3.2	9.3	1.6	5.5	0.5	5.3	4.4	3.6	4.5	3.2	3.2	3.0	1.8	3.6	5.3	4.5	3.3	7.9	3.6	18.5	2.9	21.3	3.2	4.2	13.2	2.9	2.0	5.9	18.5	6.0	31.9	56.0	2.1	8.3	9.8	9.0	9.1	13.9	9.9	11.2	16.1	40.9	7.4	6.2	8.3	12.3	27.1	11.2	17.8	20.4	14.7	27.0	7.8	7.8	2.1	42.1	27.8	4.2	3.9	9.8	22.3	4.7	19.6	57.3	27.1	21.0	12.1	8.9	39.3	9.1	16.9	12.2	5.5	45.5	27.1	11.4	4.2	7.8	2.5	14.5	6.7	3.1	14.5	11.9	19.4	22.2	9.1	5.7	6.8	8.9	23.6	18.6	20.7	54.3	7.0	48.7	6.4	21.5	7.2	11.1	5.0	6.8	4.7	5.5	4.9	4.7	5.4	5.3	5.6	5.0	15.8	4.4	6.1	3.0	6.3	5.5	2.4	3.9	2.9	2.0	1.6	3.2	4.3	3.2	4.4	3.3	2.9	5.9	5.8	3.2	3.2	0.0	4.1	0.9	1.4	2.8	3.4	2.8	3.6	8.8	1.9	2.8	1.6	0.0	0.0	2.0	3.6	2.2	0.0	1.3	9.1	2.4	2.6	5.4	0.0	6.7	0.0	1.6	3.5	3.9	1.5	3.6	5.1	5.6	11.7	2.6	3.5	6.7	0.0	1.9	2.0	9.3	1.9	6.3	3.4	6.1	1.8	0.0	5.4	1.7	5.2	0.0	0.0	1.4	2.9	4.1	5.8	2.6	2.6	0.7	4.8	1.3	0.0	3.1	2.2	13.7	10.4	5.3	2.4	1.0	3.5	3.4	3.5	1.6
ARHGAP20	KIAA1391	ENSG00000137727	"Rho GTPase activating protein 20"	Q9P2F6	11	110577042-110713189	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.0;Excitatory neurons: 97.9;Inhibitory neurons: 159.9;Leydig cells: 48.7;Oligodendrocyte precursor cells: 90.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.6;ASC TERT1: 8.2;HHSteC: 5.5;SiHa: 7.2;U-2197: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038458, HPA038459, HPA076303"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792"	"unprognostic (1.69e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.84e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.21e-3)"	"unprognostic (4.10e-2)"	8.9	2.3	3.8	1.3	4.1	0.0	4.5	1.8	3.5	4.4	0.3	1.9	0.8	4.4	3.6	2.2	3.1	2.2	0.4	3.5	2.5	0.3	1.7	4.1	1.2	0.5	0.7	1.2	0.2	0.8	0.9	1.7	0.5	3.9	2.8	1.1	1.3	8.8	0.9	1.0	1.5	3.3	1.2	1.3	1.8	8.3	2.0	0.4	4.8	1.3	0.8	3.2	2.2	0.8	0.0	0.0	0.0	0.0	24.6	8.2	0.0	1.1	3.3	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.3	0.0	5.5	0.0	0.0	3.0	0.0	0.0	0.0	0.1	2.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.3	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.4	0.0	0.1	0.0	2.1	0.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.1	1.8	3.5	3.5	2.5	0.5	0.7	0.5	1.2	2.0	0.8	1.7	0.0	2.3	5.2	1.7	0.8	4.9	1.1	10.2	9.9	0.5	6.0	0.9	1.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	13.1	1.7	78.0	4.3	0.0	0.0	97.9	0.4	0.1	15.1	0.0	1.2	1.3	1.1	9.7	2.0	0.2	3.3	159.9	0.2	0.0	0.8	1.6	4.6	48.7	2.1	3.6	22.5	0.0	0.7	0.0	90.0	3.2	0.7	0.0	36.5	1.2	1.9	0.0	0.0	0.0	1.4	0.0	2.3	4.6	11.8	11.7	1.6	0.4	0.7	0.5	3.6	0.0	0.8
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723887	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 111.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	28.4	18.0	44.3	10.3	77.7	7.2	16.1	56.7	58.1	19.7	0.0	16.6	12.9	19.9	8.6	10.8	17.5	17.9	21.2	49.1	48.3	11.0	13.1	21.7	5.3	76.3	63.1	31.9	14.9	14.6	12.1	16.6	66.7	10.8	18.5	41.3	24.5	11.5	17.7	6.8	16.3	17.8	48.4	8.9	27.1	14.6	58.0	11.4	12.8	23.0	6.0	13.8	9.0	111.2	59.0	25.1	60.9	52.3	42.2	59.1	21.6	41.6	26.6	24.5	34.0	18.4	36.8	10.9	14.0	64.3	37.7	38.1	31.6	40.4	35.9	38.0	20.5	64.9	54.7	13.8	25.5	0.0	9.9	24.4	45.0	32.1	34.4	36.9	42.3	16.1	27.9	96.3	50.0	11.6	30.2	2.3	9.7	20.8	13.6	7.0	21.4	6.2	17.2	10.2	10.5	10.9	27.9	16.0	32.6	18.1	16.3	9.1	47.8	35.3	22.7	40.0	30.6	11.0	20.3	7.8	36.2	11.4	24.7	0.9	0.2	0.4	0.1	0.4	0.1	0.0	0.2	0.3	0.3	0.0	0.6	0.3	0.0	0.2	0.2	0.4	0.4	0.2	44.3	77.7	56.7	58.1	49.1	48.3	76.3	63.1	66.7	48.4	58.0	111.2	47.9	86.6	33.1	246.8	6.5	29.6	13.2	23.6	14.8	144.0	17.5	26.0	37.4	24.3	45.0	5.5	68.8	23.8	6.9	44.6	1.9	21.4	5.0	36.2	148.7	34.9	16.2	15.2	266.5	27.6	21.0	73.0	82.0	54.2	17.1	135.8	26.0	20.9	14.6	132.9	153.8	28.3	14.2	32.8	31.8	8.3	92.9	38.9	19.6	171.4	11.0	194.0	2.1	336.7	827.4	37.1	34.6	59.5	15.2	27.4	21.9	6.5	30.3	53.5	26.3	60.4	43.2	27.4	35.6	18.1	20.2	12.6	11.8	62.2	29.0	29.5
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446036-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	1.9	12.0	3.0	15.7	1.4	1.6	17.6	14.5	1.6	7.7	2.0	0.6	1.1	0.7	1.4	1.8	1.8	4.4	11.9	12.7	1.3	0.8	2.0	2.7	22.6	17.0	4.8	1.7	0.9	2.0	0.8	20.1	3.3	1.0	0.4	2.0	1.1	1.9	2.2	1.6	1.4	16.9	2.8	1.2	4.8	17.0	2.8	6.6	1.6	2.2	2.1	2.2	22.2	6.2	1.4	0.4	0.0	5.1	20.8	4.3	31.9	15.1	3.0	4.1	7.0	0.9	0.0	1.2	13.1	2.1	12.4	0.4	11.2	5.4	0.6	11.5	18.2	0.2	0.1	2.7	2.0	2.0	5.0	11.2	37.1	3.0	68.8	20.6	0.0	17.4	3.0	64.8	0.2	0.2	0.1	7.2	0.0	0.5	0.1	0.0	7.9	6.5	0.7	1.1	6.4	1.5	0.1	0.6	0.6	0.4	0.3	66.2	30.1	0.4	3.8	23.8	0.0	0.0	0.0	82.5	0.3	4.9	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.0	15.7	17.6	14.5	11.9	12.7	22.6	17.0	20.1	16.9	17.0	22.2	0.9	0.0	1.7	4.2	2.9	3.4	4.1	6.8	4.6	1.1	0.8	3.0	2.9	1.5	2.9	0.0	2.1	11.6	3.2	0.2	0.0	2.8	53.6	0.7	1.6	2.4	0.0	10.9	51.7	4.4	0.7	6.5	0.5	1.0	0.0	4.4	1.8	0.0	10.3	0.0	29.8	0.3	2.0	7.6	14.2	122.7	2.8	15.6	1.8	227.7	14.8	1.8	0.0	141.8	200.8	2.5	0.0	6.0	0.5	1.9	0.0	0.2	3.8	1.4	0.0	1.6	4.2	1.6	4.3	0.4	0.6	1.0	0.7	10.6	0.1	0.6
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 296.7;RT4: 115.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	25.6	13.8	36.2	8.3	66.2	10.7	18.8	47.2	54.6	25.9	5.5	22.8	3.0	28.4	3.7	60.8	18.4	7.8	27.3	34.4	37.5	11.8	2.9	28.0	4.1	63.7	59.6	18.1	3.5	3.1	6.2	19.4	54.1	19.9	2.8	8.5	12.8	12.5	10.6	61.1	10.4	11.6	43.0	30.7	13.4	16.1	66.1	5.4	9.5	5.8	11.0	36.3	29.5	97.8	32.5	17.2	15.2	5.1	9.5	31.1	19.6	44.8	49.5	37.7	21.8	56.8	55.1	0.7	35.2	102.5	18.7	296.7	1.7	62.3	26.6	3.5	3.3	0.0	55.1	0.4	47.2	3.0	0.3	18.8	11.8	27.7	17.3	31.0	39.4	6.0	0.6	8.3	21.6	0.0	10.2	6.3	9.0	1.2	6.3	17.0	33.0	10.4	16.0	115.7	3.7	8.8	26.9	0.1	0.3	21.2	6.7	7.9	57.7	62.6	22.9	12.9	12.1	6.5	7.3	1.9	16.3	8.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	66.2	47.2	54.6	34.4	37.5	63.7	59.6	54.1	43.0	66.1	97.8	27.2	12.8	1.5	23.8	0.7	9.9	17.5	10.6	9.1	59.4	1.7	3.9	20.4	1.5	13.2	3.7	0.0	27.0	0.2	0.1	0.0	2.9	7.6	8.5	10.0	34.9	0.0	4.0	9.3	1.4	3.1	11.6	3.1	5.7	0.0	4.9	46.1	0.5	5.1	26.9	16.2	0.4	2.0	2.5	4.2	21.0	9.0	1.2	1.8	9.4	0.2	9.6	0.0	20.1	129.2	7.0	0.1	7.2	1.7	15.4	0.0	0.2	8.3	3.4	0.0	10.9	7.6	13.5	2.7	27.5	25.9	16.6	1.8	1.3	0.3	42.2
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 237.3;Excitatory neurons: 611.6;Inhibitory neurons: 261.5;Late spermatids: 153.3;Microglial cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"neutrophil: 24.7;NK-cell: 9.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.7;NK-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA035106: AB_2674465, HPA035107: AB_10669855"	"prognostic favorable (2.05e-4)"	"prognostic favorable (1.36e-4)"	"prognostic favorable (6.95e-4)"	"prognostic favorable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.88e-6)"	11.0	4.5	10.9	17.7	6.5	36.4	11.3	19.3	17.0	11.9	0.6	12.9	12.0	7.7	9.1	6.4	15.5	14.2	15.0	10.8	3.4	8.9	6.8	19.0	6.4	0.5	2.7	3.0	4.9	3.9	12.2	20.9	0.3	7.4	12.7	17.2	12.8	4.2	12.6	7.4	11.3	9.7	2.3	16.7	15.2	15.4	10.1	13.8	8.3	10.5	12.2	12.2	5.8	9.9	16.4	29.1	8.0	7.6	12.3	12.7	12.4	2.2	2.4	7.6	12.1	44.9	33.0	2.0	16.1	4.9	21.5	7.5	4.1	15.3	8.7	33.8	4.6	0.1	5.3	26.9	7.8	22.6	2.9	4.7	23.0	12.8	31.0	5.6	10.2	9.9	0.6	85.4	2.4	2.3	12.9	9.2	4.3	23.2	7.7	5.2	12.5	36.5	20.4	25.6	3.4	4.7	3.8	4.4	7.1	6.5	2.4	6.2	21.0	4.1	5.8	0.4	8.1	4.0	14.0	0.4	10.7	21.3	5.6	4.0	3.9	2.3	3.8	2.5	1.7	0.5	0.8	2.4	3.0	0.4	0.3	1.1	24.7	9.8	1.6	0.7	0.3	1.8	10.9	6.5	19.3	17.0	10.8	3.4	0.5	2.7	0.3	2.3	10.1	9.9	39.4	16.0	22.5	237.3	5.8	6.9	13.8	13.2	5.7	15.9	20.7	17.0	37.6	21.5	14.1	0.0	8.4	1.3	41.6	38.7	0.0	17.9	77.2	17.9	4.0	32.5	3.6	11.8	611.6	21.1	0.6	13.6	39.8	55.6	26.6	6.4	40.0	6.5	26.4	75.7	261.5	26.4	0.0	48.0	44.9	153.3	6.5	51.6	10.6	326.0	47.3	7.5	40.2	30.7	29.8	21.1	27.8	14.3	14.5	29.3	27.9	5.8	16.1	52.6	46.0	27.6	17.7	2.6	8.7	7.5	5.5	1.9	29.3	50.5	26.8	36.2
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.1;Paneth cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;OE19: 20.5;RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	16.2	7.3	4.3	8.6	6.7	11.6	15.8	4.0	4.8	27.1	3.1	39.6	10.5	8.7	1.7	98.0	11.7	3.2	22.7	3.7	4.0	20.4	6.5	28.4	9.1	5.4	4.5	3.6	7.7	3.1	10.4	4.0	4.7	17.0	8.9	0.5	37.7	1.5	4.4	27.3	51.6	2.4	4.4	63.0	12.7	8.9	5.5	6.3	16.7	1.8	6.7	17.6	44.2	4.3	6.1	6.0	0.1	1.7	0.8	0.4	16.7	0.0	0.3	0.4	0.1	5.3	11.9	5.5	11.4	0.4	2.6	3.8	0.8	1.1	0.2	11.3	3.7	0.3	2.7	3.5	0.1	0.0	15.7	0.8	4.7	0.0	1.7	0.5	3.6	5.9	1.5	9.8	0.5	4.2	5.3	1.9	0.3	20.5	4.9	4.4	0.2	1.9	3.9	26.1	0.8	0.5	0.7	5.0	0.3	2.0	3.9	10.2	5.6	0.0	1.4	0.1	0.5	12.0	8.4	1.2	0.3	1.5	0.1	1.0	5.2	4.4	2.4	8.6	1.5	3.6	1.5	2.7	4.3	2.7	1.2	1.3	10.0	1.8	11.4	7.2	2.1	4.0	4.3	6.7	4.0	4.8	3.7	4.0	5.4	4.5	4.7	4.4	5.5	4.3	19.9	6.4	17.8	2.9	23.1	10.3	15.2	9.3	2.8	3.3	11.4	7.4	10.6	15.7	13.0	18.4	4.2	7.7	38.0	99.1	3.9	6.0	1.1	11.0	2.5	20.8	19.2	1.7	3.6	3.4	11.5	3.1	31.6	18.4	4.5	0.5	17.5	2.1	15.0	1.7	8.8	34.2	10.2	47.1	13.4	1.1	0.3	33.1	7.2	19.7	26.0	1.6	23.7	3.0	2.5	19.1	79.6	0.0	15.9	28.3	57.0	6.4	11.7	1.6	0.0	3.0	2.9	6.7	2.0	9.7	8.7	14.1	14.2	1.0	43.4	57.4
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729716-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 25.9;testis: 77.5"	"Group enriched"	"Detected in many"	14	"Early spermatids: 536.8;Late spermatids: 488.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AF22: 30.4;CACO-2: 32.8;SuSa: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	4.7	1.9	1.1	1.7	1.2	0.8	2.7	1.7	1.6	8.6	0.8	1.9	1.7	2.9	8.7	1.9	3.1	6.6	2.0	1.5	1.6	8.4	0.9	4.6	1.7	0.4	0.2	10.4	3.8	3.0	0.8	25.9	0.5	3.9	2.3	1.4	0.8	2.2	4.9	2.1	1.8	1.4	0.1	12.6	2.1	77.5	1.1	3.8	2.9	1.6	0.9	5.4	3.0	0.8	0.2	0.2	30.4	3.1	6.3	10.5	4.9	2.2	5.1	2.5	5.3	32.8	0.2	0.2	1.0	0.4	1.7	1.4	0.1	0.8	3.7	1.0	1.8	0.1	2.9	0.2	1.1	0.1	0.1	12.6	0.6	2.7	0.2	0.3	7.8	0.5	0.8	2.5	4.1	0.5	0.5	0.3	9.6	0.4	1.4	0.1	2.7	0.2	0.0	2.9	2.9	11.9	0.1	2.8	0.5	22.6	0.2	0.1	1.3	0.5	13.1	10.1	0.4	0.2	0.1	0.1	5.0	0.3	1.1	0.7	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	3.0	0.1	0.0	0.2	0.0	0.0	1.1	1.2	1.7	1.6	1.5	1.6	0.4	0.2	0.5	0.1	1.1	0.8	8.3	0.0	1.9	6.2	0.1	1.9	1.3	0.2	0.0	1.5	0.9	0.5	1.8	0.0	0.7	1.8	20.9	14.9	0.0	0.0	0.0	1.1	536.8	0.5	14.6	7.9	0.0	0.0	7.1	2.7	2.7	16.1	0.0	0.4	0.0	25.8	4.2	0.2	2.1	0.0	34.4	0.1	0.0	0.3	0.4	488.0	18.3	0.5	0.0	12.2	0.0	0.2	0.0	24.6	3.6	0.7	0.0	14.3	0.1	4.7	0.0	3.8	0.0	0.8	0.0	11.0	5.4	14.3	3.7	0.8	1.4	6.6	0.3	23.7	0.0	1.3
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.6;lymphoid tissue: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 71.6;dendritic cells: 103.4;Kupffer cells: 77.8;Macrophages: 79.1;monocytes: 133.0;NK-cells: 268.8;T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 118.2;HL-60: 92.5;HMC-1: 123.4;Karpas-707: 93.1;MOLT-4: 75.8;THP-1: 90.9;U-266/70: 138.6;U-266/84: 97.7;U-698: 97.9;U-937: 72.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	12.1	4.9	3.1	55.9	3.6	57.6	5.3	3.7	4.3	3.4	3.3	8.1	9.5	2.9	2.8	14.1	4.5	10.2	2.8	2.9	3.6	3.4	6.6	25.2	77.0	6.1	4.5	2.0	2.4	1.4	1.8	7.0	5.4	3.4	8.4	0.6	6.4	2.3	2.6	19.8	23.9	8.0	5.0	75.5	11.6	2.3	6.3	63.7	2.9	2.7	61.2	13.8	6.5	6.8	0.8	0.1	0.2	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.3	1.2	118.2	0.6	0.0	0.1	2.3	0.0	0.0	0.2	55.3	0.2	39.7	0.2	0.0	0.0	92.5	123.4	0.0	1.2	0.1	0.0	0.1	0.0	56.8	0.3	93.1	0.0	1.0	75.8	21.3	0.1	0.7	0.1	46.8	0.6	1.6	0.0	1.0	0.7	0.3	0.2	0.7	0.2	0.7	0.8	90.9	0.9	0.1	0.7	0.2	0.5	138.6	97.7	97.9	0.4	72.3	0.1	7.1	29.6	33.1	32.9	32.2	25.1	11.9	21.9	27.1	21.8	12.6	17.9	25.0	48.5	19.3	46.4	15.0	23.8	33.5	3.1	3.6	3.7	4.3	2.9	3.6	6.1	4.5	5.4	5.0	6.3	6.8	1.5	3.2	20.5	0.3	71.6	5.6	3.3	6.8	0.0	0.5	5.2	2.9	1.3	2.8	13.8	0.0	4.2	0.6	103.4	0.5	0.0	3.4	2.2	6.6	1.2	2.3	0.0	14.5	0.3	6.0	1.9	1.9	3.1	13.7	68.3	0.0	6.1	1.7	55.5	0.0	0.3	0.4	8.2	77.8	44.6	0.7	0.3	79.1	5.4	14.0	133.0	0.1	268.8	0.5	1.2	12.5	0.2	0.0	49.8	5.4	0.0	0.5	15.3	3.0	0.0	1.0	1.9	0.1	0.1	9.9	24.6	4.5	105.1	0.2	0.5	16.7
ARHGAP31	CDGAP	ENSG00000031081	"Rho GTPase activating protein 31"	Q2M1Z3	3	119294383-119420714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 47.8;Astrocytes: 123.1;Endothelial cells: 46.9;Langerhans cells: 54.1;Microglial cells: 125.5;Oligodendrocyte precursor cells: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 6.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 35.0;TIME: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036380	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA036380: AB_10673129"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.18e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (3.57e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-3)"	17.0	2.1	8.3	7.6	9.3	0.8	9.0	10.1	8.3	6.0	1.1	5.4	3.0	6.2	3.1	5.9	5.1	8.6	13.0	8.3	8.9	4.9	3.6	19.5	5.6	11.6	10.4	6.1	2.9	4.0	2.1	11.2	9.4	3.0	5.4	1.5	2.8	3.4	4.2	6.4	4.7	11.8	9.0	7.1	3.2	1.3	10.8	6.9	12.7	9.2	6.8	8.1	3.8	9.9	0.4	2.5	6.2	12.2	3.5	2.9	1.9	7.5	8.6	5.8	4.2	0.1	0.5	0.1	8.7	19.5	10.0	0.2	5.9	1.9	6.7	11.0	0.8	1.7	0.8	0.0	5.8	0.4	7.0	7.8	0.2	15.1	1.7	4.5	35.0	1.2	0.0	3.0	13.1	0.2	0.1	0.3	2.1	0.0	7.6	0.0	2.9	0.0	1.7	0.0	0.0	22.7	3.8	0.0	15.6	3.3	0.7	0.6	38.5	16.0	6.4	2.0	5.9	5.1	5.6	6.2	10.9	5.6	16.4	0.0	2.6	0.0	0.4	2.8	0.8	1.6	0.3	0.5	6.0	0.6	0.3	0.2	0.0	1.1	1.1	5.2	0.8	1.2	8.3	9.3	10.1	8.3	8.3	8.9	11.6	10.4	9.4	9.0	10.8	9.9	47.8	19.2	24.6	123.1	7.3	5.2	0.7	3.1	1.8	0.6	0.5	1.7	16.0	1.5	3.1	0.0	0.0	1.2	9.8	0.2	0.0	2.1	0.4	0.4	2.1	46.9	0.0	7.4	3.4	2.0	10.3	7.3	0.0	0.4	9.5	8.4	30.7	0.6	10.1	0.0	18.4	3.9	0.0	14.5	54.1	0.7	2.8	16.7	10.6	125.5	13.8	3.9	4.1	159.8	0.9	1.9	0.3	2.6	4.9	1.1	0.0	2.1	1.4	0.4	0.0	2.5	11.3	0.3	0.7	1.3	5.1	1.0	3.7	3.3	0.4	0.7
ARHGAP32	"GC-GAP, GRIT, KIAA0712, MGC1892, RICS"	ENSG00000134909	"Rho GTPase activating protein 32"	A7KAX9	11	128965060-129279324	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038382, HPA038389, HPA061505"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544"	"unprognostic (1.17e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (1.47e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.64e-2)"	4.7	7.5	2.6	3.4	8.2	2.1	10.3	0.0	26.6	11.9	0.0	14.1	21.1	8.1	9.0	26.3	13.3	7.6	4.3	15.1	0.0	7.0	5.0	5.8	1.6	0.0	0.0	10.9	15.2	10.7	6.1	8.6	0.0	6.4	15.8	33.5	15.8	4.2	7.6	20.1	20.6	5.9	0.0	3.0	12.0	10.7	0.0	10.5	3.8	4.3	6.9	9.4	17.1	5.1	12.2	6.4	19.7	0.1	6.3	6.3	14.2	4.5	6.3	2.8	3.4	14.9	24.7	0.1	6.7	8.7	14.1	27.2	9.0	11.4	5.4	0.0	3.1	0.2	3.4	5.6	3.1	0.0	0.0	6.1	14.4	2.7	16.3	6.2	3.5	10.2	0.6	0.2	4.9	9.5	10.2	0.2	5.4	36.6	6.8	24.9	5.9	2.5	3.0	39.5	19.3	7.9	6.8	42.3	8.0	7.5	21.9	3.9	6.6	9.9	5.2	5.9	8.9	0.3	0.0	0.1	4.3	27.4	6.4	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.1	2.6	8.2	0.0	26.6	15.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	6.4	16.8	240.6	3.4	18.2	12.7	29.1	16.5	31.6	36.5	17.1	4.3	14.3	46.6	11.0	123.0	23.1	4.8	48.7	1.9	8.3	19.0	27.7	10.0	5.6	40.7	2.5	403.4	27.2	4.2	14.1	35.2	25.4	1.3	9.8	5.0	16.2	6.5	18.5	239.7	61.9	20.3	4.1	4.2	12.3	6.8	5.7	16.0	103.0	2.9	113.6	0.0	170.9	95.0	24.5	44.2	13.2	1.5	22.7	52.7	9.9	61.6	37.9	19.7	19.4	9.5	8.6	9.6	55.4	31.1	28.5	2.0	4.0	54.0	59.5
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.4;Cone photoreceptor cells: 25.0;Horizontal cells: 20.2;Oligodendrocytes: 22.7;Rod photoreceptor cells: 33.7;Spermatocytes: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	7.7	8.7	24.3	4.2	28.8	20.5	10.9	14.3	39.1	20.4	8.2	11.2	4.0	13.9	1.3	8.1	17.1	2.8	6.9	30.0	21.0	10.1	5.6	6.8	5.8	19.9	16.5	26.9	11.9	4.2	33.6	1.6	18.0	12.5	1.3	9.9	7.4	3.3	3.4	9.8	9.2	2.0	15.2	11.1	10.4	39.6	19.5	11.7	18.0	1.3	2.2	9.4	13.7	22.1	9.0	5.6	15.5	11.7	0.6	1.5	1.2	7.2	0.9	2.7	1.9	2.3	6.6	5.2	2.6	2.1	2.3	2.4	1.9	2.0	1.0	16.4	3.6	7.6	8.6	2.1	0.7	2.7	58.1	2.2	0.4	2.1	0.8	2.2	1.6	20.4	3.7	22.1	2.4	6.8	18.8	7.4	3.5	3.4	2.5	25.4	2.5	2.5	1.2	1.4	15.4	9.4	3.2	5.7	1.1	1.9	8.3	7.5	3.1	11.0	10.6	5.8	8.5	19.5	4.0	5.2	4.0	8.9	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	28.8	14.3	39.1	30.0	21.0	19.9	16.5	18.0	15.2	19.5	22.1	2.7	0.0	1.1	7.8	1.0	1.7	1.0	1.0	4.6	27.4	4.8	4.7	2.3	2.8	2.7	1.8	25.0	0.7	5.1	1.4	0.0	0.4	11.4	6.1	4.8	1.6	3.5	6.5	12.1	0.7	1.0	3.5	3.6	2.5	5.1	7.3	1.1	1.5	1.2	20.2	11.3	2.3	2.0	0.8	1.9	8.9	4.1	0.7	0.0	1.9	0.2	7.3	0.0	19.1	22.7	0.7	0.6	3.0	2.2	0.6	0.3	0.2	4.2	33.7	0.0	4.6	3.1	22.2	6.2	4.2	1.7	0.4	3.6	7.2	2.8	0.6
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46860997-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 186.4;Late spermatids: 651.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142"	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	13.6	10.1	35.7	8.0	31.5	5.3	16.1	16.8	31.1	12.9	9.2	14.8	12.9	12.8	10.6	15.7	12.8	9.1	25.8	37.0	27.3	19.1	22.3	14.9	8.7	26.0	32.3	17.3	13.6	31.3	14.1	7.8	34.5	13.4	12.3	16.6	15.7	15.7	29.4	11.6	16.3	12.9	19.8	8.8	10.9	40.3	33.3	10.8	20.2	24.2	9.0	13.1	9.0	25.1	52.0	56.7	37.9	34.0	33.9	27.9	6.4	27.3	38.7	27.1	31.0	30.6	18.0	27.4	19.1	112.0	41.2	30.8	34.8	35.3	36.9	19.3	14.7	37.2	40.1	24.1	31.7	22.3	30.4	28.3	35.1	30.6	32.5	37.9	24.7	18.2	25.2	9.9	31.4	30.3	21.8	35.4	19.9	37.4	20.8	24.1	26.0	8.5	23.0	100.0	37.9	36.1	50.5	47.5	20.0	23.4	44.6	27.1	31.3	23.9	18.9	26.2	33.0	10.1	19.6	21.7	53.6	22.8	59.7	0.3	0.2	0.2	0.6	0.2	0.6	0.1	0.6	0.7	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.3	35.7	31.5	16.8	31.1	37.0	27.3	26.0	32.3	34.5	19.8	33.3	25.1	15.7	44.8	38.4	47.7	8.6	15.2	13.9	20.1	19.4	31.9	35.2	23.0	58.2	27.1	21.4	25.8	25.0	3.7	14.8	61.0	7.9	14.6	186.4	17.8	19.0	19.5	31.2	16.6	42.4	20.0	1.0	19.1	19.9	34.1	9.5	30.9	27.8	89.7	15.0	69.0	48.8	18.5	14.2	19.5	7.8	651.3	23.3	11.0	21.4	32.8	14.2	28.2	18.6	37.2	58.2	20.9	21.4	25.6	6.7	23.3	44.5	22.6	10.4	22.0	19.7	22.6	24.9	45.9	23.5	24.4	16.6	1.6	16.1	29.5	25.7	17.0
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 119.1;lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000301, HPA001012, HPA001083"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	20.0	12.5	5.2	52.2	5.4	119.1	13.4	6.9	6.5	9.9	15.0	18.6	14.2	9.7	3.1	7.0	12.9	14.4	10.3	5.7	6.3	22.6	8.6	36.2	73.8	10.9	8.3	5.4	5.9	1.7	8.6	21.2	9.3	11.1	6.9	1.2	9.2	3.8	4.3	5.0	49.7	6.5	8.2	120.9	12.6	7.2	8.5	42.7	10.9	1.5	33.7	11.6	9.2	10.0	1.5	0.6	1.0	5.9	0.2	0.0	2.5	1.0	0.4	0.1	0.2	0.4	42.8	103.0	5.9	0.1	0.8	1.2	4.6	0.2	0.0	27.8	3.4	44.4	0.5	1.7	3.6	76.7	59.7	0.2	0.4	0.0	0.3	0.5	9.1	22.4	0.5	90.8	0.5	4.6	93.0	1.5	3.7	0.4	0.3	44.6	12.0	180.7	0.4	0.7	8.4	12.1	0.9	2.1	0.9	1.2	19.0	83.7	1.9	0.3	1.3	0.9	0.5	60.1	55.8	90.4	0.7	79.9	0.2	10.9	26.1	35.4	26.2	42.4	18.6	18.0	18.8	21.1	25.5	16.9	17.4	17.4	22.4	16.0	59.4	31.6	23.5	26.1	5.2	5.4	6.9	6.5	5.7	6.3	10.9	8.3	9.3	8.2	8.5	10.0	16.0	9.6	22.7	2.6	65.3	3.4	0.6	0.2	0.0	13.7	2.4	6.1	48.3	1.5	2.7	18.4	4.2	1.9	70.0	9.5	5.9	0.9	0.1	2.4	1.4	13.0	4.8	11.3	2.1	0.6	1.9	3.5	7.1	1.5	34.2	7.7	4.2	0.5	86.6	3.3	1.4	6.6	0.0	77.2	31.5	0.2	0.9	76.0	10.6	19.7	42.5	1.9	70.0	2.0	0.7	0.2	0.5	0.0	32.9	0.5	3.0	0.8	8.7	4.6	0.0	7.1	2.6	0.7	5.2	1.6	1.7	1.4	69.5	1.1	5.0	0.4
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"breast: 32.4;epididymis: 35.7;esophagus: 28.7;skin 1: 45.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.1	0.0	0.3	0.0	1.3	0.0	32.4	0.1	0.6	3.2	0.2	0.0	1.7	0.7	35.7	28.7	0.1	0.1	0.0	0.2	0.3	5.6	0.1	0.8	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	0.8	4.6	0.0	0.0	3.6	7.9	0.4	45.3	0.0	0.0	0.2	0.0	4.6	2.7	0.6	0.0	0.9	0.0	3.7	3.2	7.4	0.2	4.5	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.1	0.2	0.9	0.0	3.6	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.7	0.0	1.6	15.4	0.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.6	0.2	0.3	0.3	1.8	0.8	0.2	0.6	0.2	0.1	0.0	1.5	0.7	0.0	0.3	0.0	1.8	0.0	0.0	14.7	8.6	0.1	0.0	4.3	3.7	0.0	0.0	0.2	0.0	0.0	0.0	7.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	A6NI28	11	100687288-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.8;Early spermatids: 74.7;Oligodendrocyte precursor cells: 226.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.2;RH-30: 20.4;RT4: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: AB_2684308"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	6.6	2.9	5.7	3.8	6.7	1.2	3.7	5.9	6.7	6.4	7.9	6.7	7.7	5.8	3.1	3.2	3.4	6.7	4.7	5.3	8.0	9.2	10.1	6.2	4.6	6.9	7.1	3.1	1.2	5.6	1.3	15.1	6.8	2.8	6.1	31.6	3.1	2.8	3.3	3.1	7.9	4.2	6.7	4.6	9.4	2.1	7.3	9.3	8.1	5.1	2.9	5.3	1.7	7.3	0.6	4.6	5.0	0.1	2.7	4.7	4.0	0.7	1.1	1.2	2.7	6.3	30.2	0.9	8.3	2.1	5.5	9.4	2.8	1.6	1.2	0.0	2.7	15.3	13.0	2.1	5.2	0.1	0.1	3.6	2.8	5.3	0.9	2.9	1.9	3.9	0.5	0.0	4.2	0.9	1.8	0.0	6.8	7.5	6.7	5.4	20.4	0.5	6.8	21.1	3.4	1.8	10.9	0.4	8.0	10.6	1.0	1.8	4.0	4.1	5.3	4.6	2.3	4.6	0.0	6.2	4.1	3.3	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	5.7	6.7	5.9	6.7	5.3	8.0	6.9	7.1	6.8	6.7	7.3	7.3	8.7	48.1	5.3	102.8	3.7	2.4	6.5	1.5	2.2	3.1	2.9	4.6	6.8	14.3	13.4	3.7	25.0	0.7	3.4	22.2	1.9	4.5	74.7	16.0	19.6	6.1	1.8	3.6	2.4	3.9	2.1	12.6	16.3	18.1	0.0	21.8	6.8	6.3	1.6	1.7	47.7	3.6	2.0	0.3	1.2	38.9	1.2	1.4	10.6	39.4	0.0	32.2	0.0	226.2	0.5	10.0	12.1	2.6	5.6	14.6	7.9	19.8	11.8	62.0	39.5	4.5	38.6	3.6	2.3	2.3	3.4	6.4	0.6	6.2	4.7	18.3
ARHGAP44	"KIAA0672, RICH-2, RICH2"	ENSG00000006740	"Rho GTPase activating protein 44"	Q17R89	17	12789498-12991643	"Predicted intracellular proteins"	Exocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 205.3;Horizontal cells: 178.4;Inhibitory neurons: 189.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.5;JURKAT: 5.9;SK-BR-3: 7.2;SuSa: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038814	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038814: AB_10673295"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.98e-1)"	"unprognostic (9.58e-2)"	4.4	1.7	14.7	2.2	12.6	0.0	2.0	2.8	35.2	2.7	0.0	15.3	7.2	2.9	3.1	0.8	9.8	5.4	4.2	19.2	5.7	2.5	0.6	12.0	1.5	11.5	6.7	4.0	3.6	17.4	8.1	9.4	9.1	3.1	12.0	7.0	5.7	4.0	2.3	1.4	7.5	3.0	0.5	0.7	3.3	2.7	15.2	0.7	6.4	2.5	1.6	2.1	2.2	19.3	0.3	1.5	1.2	0.9	0.1	0.6	4.0	0.6	4.8	0.2	0.5	0.6	0.2	3.8	0.4	1.6	2.4	0.5	2.6	0.0	0.1	0.0	9.5	0.0	1.4	1.5	0.1	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.0	5.9	0.2	0.0	0.0	4.7	0.4	0.0	3.7	2.1	0.2	3.4	0.0	0.9	0.0	1.3	3.8	0.2	0.2	7.2	0.0	12.1	0.8	1.4	0.0	3.7	1.9	1.3	0.0	0.0	0.0	0.4	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	12.6	2.8	35.2	19.2	5.7	11.5	6.7	9.1	0.5	15.2	19.3	1.4	12.8	12.8	25.8	2.4	2.7	4.8	2.1	1.8	23.1	3.2	2.7	8.7	15.7	2.3	9.2	2.1	2.1	0.2	32.4	0.0	4.8	14.3	8.9	2.2	2.8	12.0	0.8	205.3	4.6	1.2	6.3	3.1	4.2	0.0	5.4	4.6	0.6	0.6	178.4	189.4	15.4	2.0	0.6	1.2	3.4	4.4	0.3	1.8	10.3	0.1	5.4	1.0	38.7	19.0	3.4	14.3	10.9	1.2	4.2	7.4	0.6	8.6	14.7	19.7	3.8	12.4	0.8	7.1	1.6	1.6	0.8	0.9	2.5	32.8	3.2
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	11.2	5.5	3.6	43.1	3.4	68.3	5.5	4.4	7.5	4.2	5.1	12.4	7.2	3.5	0.5	5.5	6.7	5.0	4.4	3.3	4.4	7.8	7.4	39.5	58.4	9.1	5.4	2.0	2.7	0.8	4.5	6.0	6.9	5.9	2.6	8.7	6.4	1.5	2.1	3.9	53.2	2.2	7.6	106.1	10.9	3.5	8.1	32.9	9.0	0.8	18.6	6.6	5.5	11.4	11.2	2.1	0.1	12.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	29.2	13.9	73.7	3.0	0.0	0.4	9.6	2.1	0.6	0.0	54.7	1.0	10.1	22.6	3.5	0.4	48.6	56.2	0.0	2.9	0.1	0.0	0.0	0.1	46.8	6.8	100.4	0.0	0.6	54.5	43.4	7.6	1.9	5.4	52.0	0.3	74.7	0.0	0.2	0.6	0.2	16.8	0.0	4.5	0.7	3.5	92.3	4.8	0.2	1.9	0.2	0.3	130.8	60.2	58.8	0.3	72.1	5.4	6.7	24.4	25.3	45.7	21.2	38.8	15.9	52.2	54.1	22.5	18.3	68.9	53.6	37.0	28.0	20.9	13.3	43.5	59.8	3.6	3.4	4.4	7.5	3.3	4.4	9.1	5.4	6.9	7.6	8.1	11.4	2.0	48.1	8.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	15.2	11.0	0.0	0.0	1.8	11.0	0.0	40.1	62.7	0.0	0.0	2.6	0.0	4.5	0.7	1.6	0.0	0.0	0.0	3.8	56.6	1.3	0.0	3.5	3.8	0.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	72.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	15.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	75.5	30.2	0.1	0.0	0.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11117651-11665920	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 44.3;Microglial cells: 127.4;Oligodendrocyte precursor cells: 60.3;Prostatic glandular cells: 54.4;Sertoli cells: 46.0;Skeletal myocytes: 62.3;Smooth muscle cells: 44.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;ASC TERT1: 34.2;HEL: 36.4;HMC-1: 24.7;HSkMC: 33.8;K-562: 26.5;RT4: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		350000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	10.8	1.1	9.0	1.7	5.1	0.7	5.6	2.0	4.2	7.6	3.2	13.9	2.1	10.5	8.2	3.8	8.4	4.2	4.0	5.0	5.8	6.5	0.9	9.6	1.2	3.2	4.0	16.4	1.9	1.2	3.2	7.0	3.2	27.6	3.9	1.0	2.6	30.9	9.6	2.5	4.7	12.9	2.6	5.9	4.1	1.9	6.1	1.0	25.4	8.1	0.8	10.4	5.7	3.8	0.0	0.0	2.4	0.0	26.2	34.2	0.6	0.4	0.6	1.4	0.9	0.4	0.0	0.0	0.0	5.0	0.0	0.1	0.9	0.0	1.2	0.6	0.5	36.4	0.4	0.0	9.7	0.1	24.7	33.8	0.0	2.5	0.1	3.1	0.7	0.1	26.5	12.3	1.5	0.0	0.0	0.2	0.7	0.2	0.4	0.1	11.6	15.7	8.3	20.3	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.4	0.3	1.6	0.7	7.1	0.2	0.7	0.0	0.0	0.5	0.2	4.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	9.0	5.1	2.0	4.2	5.0	5.8	3.2	4.0	3.2	2.6	6.1	3.8	9.6	0.0	1.7	10.4	5.3	2.0	16.9	0.3	2.8	4.3	2.3	3.3	4.7	0.0	2.6	33.1	0.0	0.6	0.4	0.0	25.4	0.0	0.1	0.1	5.1	9.2	1.2	2.1	5.5	1.1	0.7	29.1	3.6	0.2	40.0	3.0	8.2	0.0	4.9	0.0	44.3	0.4	0.0	2.2	18.9	0.9	16.1	29.1	5.4	127.4	3.4	7.2	0.0	60.3	3.5	0.7	0.0	10.1	4.9	54.4	0.0	7.4	5.6	0.7	46.0	62.3	44.4	0.2	0.4	4.5	1.7	0.0	1.2	2.1	0.0	22.3
ARHGAP8	"BPGAP1, FLJ20185"	ENSG00000241484	"Rho GTPase activating protein 8"	P85298	22	44752558-44862788	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 20.5;Cytotrophoblasts: 26.9;Ductal cells: 25.6;Pancreatic endocrine cells: 30.5;Urothelial cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.9;BEWO: 47.5;CACO-2: 30.9;HEK 293: 43.6;MCF7: 44.9;SK-BR-3: 40.1"	"Not detected"	"Not detected"							HPA069694	Approved					NA	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA069694: AB_2686173"	"unprognostic (4.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.78e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.65e-6)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-2)"	1.0	0.4	0.4	1.2	0.2	0.6	9.5	1.1	1.0	3.0	4.2	10.0	1.7	1.6	11.4	7.5	6.8	4.3	0.1	0.4	0.1	28.1	1.1	4.4	0.7	0.2	0.1	0.3	10.3	5.6	6.4	7.4	0.4	13.5	7.1	0.3	23.2	8.3	0.1	2.0	3.6	0.3	0.1	9.0	6.5	3.3	0.4	0.5	17.5	0.0	1.1	2.0	2.9	0.2	26.9	0.4	0.4	0.2	0.0	0.4	47.5	0.2	3.1	0.0	0.2	30.9	13.5	0.2	1.6	0.0	0.4	19.1	8.5	21.9	0.2	0.1	43.6	0.0	0.9	0.4	0.1	0.1	0.4	0.2	9.3	0.2	0.4	0.6	0.1	0.5	0.9	0.7	0.1	44.9	0.1	0.2	6.7	19.3	0.0	0.0	0.1	0.4	11.6	17.9	2.7	0.1	0.0	40.1	0.9	9.9	17.5	0.3	0.4	0.0	1.5	0.1	0.2	3.9	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.2	1.1	1.0	0.4	0.1	0.2	0.1	0.4	0.1	0.4	0.2	0.1	3.2	12.5	0.0	0.5	0.6	20.5	5.9	3.4	0.4	8.9	2.4	0.8	4.3	9.1	18.4	4.2	26.9	0.7	8.6	0.0	25.6	2.3	4.1	1.0	1.1	7.2	0.0	0.0	10.8	2.1	1.3	7.1	12.3	0.0	0.5	0.4	0.0	3.3	0.0	0.0	11.7	12.2	1.0	0.4	3.2	0.3	0.6	0.0	0.0	0.1	0.7	5.2	0.0	0.0	30.5	12.1	0.4	0.6	20.0	1.2	2.0	4.1	0.7	0.0	1.7	0.7	0.1	3.9	6.0	0.3	7.0	1.0	6.9	17.0	20.8
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol		NA	NA		21000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	274.5	196.2	116.6	154.7	122.9	219.4	227.6	92.6	173.4	215.5	64.6	215.7	177.7	222.0	23.8	265.1	191.2	64.3	181.1	122.2	141.1	236.2	220.7	266.1	116.9	136.3	148.9	174.8	195.2	69.6	187.3	101.9	158.2	206.0	52.9	14.6	180.0	78.7	131.9	198.6	225.6	72.4	105.0	243.9	194.3	92.0	131.4	83.4	173.4	32.8	66.9	203.4	212.2	112.9	472.6	455.1	146.6	233.1	131.8	162.9	167.2	396.0	251.3	292.1	216.0	229.0	173.7	249.4	164.9	299.8	254.9	252.3	160.3	302.6	120.7	192.3	422.2	266.3	267.7	303.0	270.6	418.3	367.4	211.1	137.0	213.5	180.5	147.7	450.1	204.1	221.5	334.8	235.8	285.4	611.3	432.9	173.0	159.8	405.3	274.2	185.4	200.6	193.7	289.5	193.0	568.8	208.5	522.2	386.9	105.3	247.5	335.7	499.7	575.1	494.2	539.3	681.4	292.8	164.9	256.5	497.7	249.9	399.8	39.5	47.9	87.5	64.3	72.5	60.8	35.8	53.6	62.5	47.9	27.4	34.5	42.1	30.2	45.2	101.9	55.3	55.4	60.4	116.6	122.9	92.6	173.4	122.2	141.1	136.3	148.9	158.2	105.0	131.4	112.9	146.0	38.5	59.1	14.0	152.2	127.2	201.5	173.0	63.2	18.3	78.8	65.4	2.9	62.9	86.7	79.1	10.4	130.1	164.6	289.7	135.0	234.2	8.3	66.4	97.5	134.6	134.6	34.9	13.9	265.0	263.4	98.2	120.8	124.1	118.6	76.4	112.1	82.7	243.2	52.2	10.4	173.7	101.7	167.1	157.8	19.5	86.6	167.4	193.9	15.0	243.9	82.6	187.4	9.5	17.5	424.5	286.3	74.1	171.3	183.5	300.7	157.5	46.0	11.9	118.3	70.6	121.4	38.9	44.1	88.5	116.1	221.9	169.3	78.6	156.2	222.2
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942031-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 1579.9;lymphoid tissue: 1075.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	188.8	74.1	48.7	521.0	51.2	1579.9	170.4	56.0	77.6	85.4	57.9	112.9	79.6	68.0	48.4	82.9	85.3	165.9	110.7	49.4	56.4	95.9	139.0	280.3	905.3	68.5	65.4	27.6	32.2	54.1	35.4	143.8	68.4	68.8	142.4	5.3	122.3	66.3	56.3	74.2	201.6	144.3	61.8	592.6	108.1	19.5	65.6	1075.8	110.6	79.0	1036.8	290.4	67.4	79.6	147.8	5.5	5.8	327.3	23.7	17.6	2.1	6.0	1.8	2.3	1.6	19.3	156.9	1210.9	74.3	28.0	1.9	171.1	0.0	270.8	17.9	2.3	0.0	1636.5	3.5	0.7	5.2	1927.3	2070.0	2.5	37.5	0.8	24.2	5.6	929.0	1421.7	8.7	454.5	28.8	0.8	2313.6	1382.4	7.1	3.3	1.7	1912.5	21.3	540.3	52.7	845.5	1.3	1.4	1.8	205.7	2.5	14.1	10.9	1385.1	1171.8	4.6	11.5	2.2	36.2	74.5	13.0	1750.9	5.3	1339.7	2.4	5890.8	2659.3	6464.2	2731.2	3085.1	2695.1	2676.3	3099.3	3090.3	2210.1	2532.9	2986.0	3120.5	5422.5	2408.4	3802.9	955.6	5589.7	9860.2	48.7	51.2	56.0	77.6	49.4	56.4	68.5	65.4	68.4	61.8	65.6	79.6	189.6	60.9	143.0	0.7	575.2	68.2	51.9	11.1	5.7	0.6	99.7	64.5	14.0	11.5	79.5	58.8	0.0	89.6	703.8	5.3	17.6	21.9	1.5	3.2	6.1	175.6	1.2	182.1	0.7	342.7	667.6	47.3	42.3	3.6	700.2	0.4	342.3	11.1	915.2	0.0	0.2	2.2	8.2	742.6	487.7	4.1	53.4	672.9	90.7	26.2	451.3	3.3	999.0	0.5	0.1	53.5	16.3	58.6	292.5	6.9	0.2	9.2	39.0	1.2	243.3	10.3	187.9	1.2	2.3	5.5	56.1	68.0	895.2	14.9	6.7	94.7
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883173-41930150	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	50.2	20.9	17.1	79.1	21.8	113.5	39.9	19.1	21.9	37.2	17.8	37.5	26.8	33.4	3.6	34.1	36.4	23.5	26.2	16.1	18.2	31.9	30.0	67.7	127.5	24.1	20.2	32.9	27.4	12.6	25.9	18.3	22.0	32.1	10.4	5.6	28.8	11.8	15.4	37.6	87.1	13.4	19.0	168.4	34.9	10.9	21.4	96.5	36.7	8.9	48.9	33.9	33.2	27.9	58.8	69.9	15.8	19.9	21.9	22.9	18.4	30.1	45.7	37.4	32.8	21.5	49.2	77.9	54.6	27.8	19.8	33.8	20.3	46.9	11.8	74.1	23.6	63.1	30.6	28.4	31.9	68.4	100.8	27.8	30.5	36.3	23.5	19.9	36.2	68.2	25.5	46.7	21.8	40.4	48.0	52.9	17.9	46.4	54.0	71.8	29.7	46.3	23.2	31.8	10.3	43.8	42.3	18.7	36.0	8.1	21.9	114.4	49.6	49.7	33.2	26.8	47.7	63.0	43.2	68.4	40.5	107.6	80.2	10.4	20.5	29.2	47.0	39.5	37.2	20.1	35.6	49.4	21.5	19.5	36.1	39.4	27.4	32.1	57.5	11.3	38.7	36.4	17.1	21.8	19.1	21.9	16.1	18.2	24.1	20.2	22.0	19.0	21.4	27.9	46.6	6.4	22.0	35.3	97.3	14.5	13.9	15.0	20.5	18.7	13.1	12.4	4.2	8.6	8.8	7.3	27.1	13.3	156.2	21.7	3.9	23.6	1.4	12.2	16.7	29.0	21.7	23.8	8.0	24.9	22.8	17.7	56.6	16.8	31.7	19.3	26.7	9.3	38.2	11.8	7.9	29.2	16.2	52.5	31.9	1.8	19.3	58.9	19.6	18.7	39.0	8.8	187.4	13.6	27.6	55.9	22.7	16.6	66.4	15.7	10.1	7.3	6.3	19.1	26.3	17.6	17.3	7.3	10.1	17.3	14.8	10.1	159.0	20.4	26.4	11.1
ARHGEF10	"Gef10, KIAA0294"	ENSG00000104728	"Rho guanine nucleotide exchange factor 10"	O15013	8	1823926-1958641	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 158.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024649	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA024649: AB_1845002"	"unprognostic (2.51e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.46e-2)"	19.2	10.1	9.3	2.3	9.9	0.4	15.2	9.3	9.6	14.7	9.3	19.1	0.5	18.7	2.7	5.5	15.0	1.9	18.3	9.0	8.9	12.4	3.4	27.9	1.6	9.7	9.8	13.5	6.6	1.1	7.3	3.0	10.3	12.8	1.6	1.9	12.1	3.1	4.0	13.3	9.3	4.7	8.8	6.9	14.2	24.3	9.1	2.1	12.9	1.1	1.1	12.3	13.4	11.7	7.1	7.6	7.7	4.0	6.8	7.4	1.9	9.4	6.9	6.5	7.8	2.5	3.2	0.0	1.0	11.7	11.1	5.3	8.4	10.9	8.8	0.0	3.0	3.2	8.6	0.0	6.0	0.0	2.1	6.5	6.2	7.7	6.1	10.0	11.8	2.5	3.1	0.0	8.0	3.8	5.8	1.1	6.6	5.3	4.2	0.3	8.6	0.0	6.2	2.7	1.5	1.6	5.7	0.2	5.3	9.4	3.1	2.1	13.2	5.9	3.8	0.1	8.4	0.0	2.9	0.1	6.0	8.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	9.9	9.3	9.6	9.0	8.9	9.7	9.8	10.3	8.8	9.1	11.7	11.7	3.2	4.1	90.1	0.9	38.4	13.4	8.1	5.7	7.7	7.8	6.3	13.3	15.7	5.0	7.3	10.4	0.6	2.6	1.4	0.0	7.5	17.8	3.3	11.4	27.7	1.2	3.6	17.3	2.0	1.6	30.0	4.1	6.9	0.0	11.3	13.9	1.2	1.7	21.9	16.3	4.5	8.2	1.6	9.4	20.5	35.1	2.1	23.2	50.6	0.3	10.1	4.1	69.9	158.9	12.4	0.3	26.4	2.3	22.6	0.7	0.8	2.8	9.2	0.0	22.6	14.2	54.9	38.3	1.4	15.2	0.3	2.1	7.7	2.4	6.3
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539698-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	41	"classical monocyte: 18.8;intermediate monocyte: 18.0;myeloid DC: 13.4;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	48	"dendritic cells: 13.4;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	22.2	10.5	11.9	11.4	10.9	1.7	16.5	38.7	11.4	24.2	13.8	29.4	15.9	16.2	4.6	28.1	16.0	11.9	30.2	10.3	12.2	32.5	87.5	13.0	4.5	19.4	18.5	10.4	43.9	17.0	7.9	5.9	19.4	18.4	12.9	4.0	25.9	19.5	66.2	40.9	21.7	8.7	10.9	9.7	20.8	3.7	17.7	1.6	18.0	35.5	4.3	24.6	21.7	9.3	8.0	9.1	11.3	3.9	19.1	6.3	7.6	5.4	10.6	6.3	5.3	9.5	23.6	0.0	9.8	10.2	8.8	6.0	1.6	2.9	1.2	0.2	2.9	0.0	9.5	26.9	4.2	0.0	0.0	8.5	5.5	3.9	1.1	12.7	1.2	0.0	0.0	0.2	17.8	7.7	0.0	0.2	4.9	12.2	0.0	0.0	4.5	3.0	13.4	16.4	16.5	12.2	4.2	2.9	12.3	3.2	11.0	9.5	0.0	5.5	6.5	6.5	2.3	0.0	2.5	0.0	8.5	0.2	3.0	0.0	18.8	0.0	0.0	18.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	7.6	11.9	10.9	38.7	11.4	10.3	12.2	19.4	18.5	19.4	10.9	17.7	9.3	1.3	3.2	7.4	82.6	1.0	5.7	5.3	7.2	5.2	16.1	13.7	12.3	36.4	20.0	13.9	31.3	2.1	0.7	0.1	41.6	9.8	19.8	15.9	3.4	4.2	2.1	37.8	2.7	16.7	20.3	0.6	8.5	17.9	6.5	0.0	3.9	2.5	43.7	26.0	10.1	23.8	45.5	8.2	8.6	26.4	8.9	5.0	18.6	3.6	19.7	9.6	14.6	0.0	24.6	7.1	11.7	24.9	6.8	0.2	5.9	13.6	18.3	9.4	5.4	13.1	10.8	18.3	11.9	1.6	8.0	8.7	1.0	0.6	0.3	46.1	12.1
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045742	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Cone photoreceptor cells: 93.8;Excitatory neurons: 102.4;Inhibitory neurons: 122.5;Oligodendrocyte precursor cells: 78.4;Rod photoreceptor cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	10.9	10.9	10.3	9.5	8.6	4.3	8.1	4.1	22.6	10.0	0.8	12.3	13.1	12.0	9.6	11.5	10.3	10.2	12.1	9.4	10.2	7.2	6.3	11.4	5.3	12.7	11.1	13.2	9.9	25.0	12.2	11.1	12.0	9.2	11.2	17.6	8.6	11.6	12.3	10.0	14.9	13.3	4.0	9.3	10.7	19.2	16.9	3.6	13.0	11.2	5.7	10.4	8.1	11.1	13.5	26.6	22.0	16.9	28.5	14.6	25.0	13.4	19.4	20.0	14.6	17.9	14.0	1.8	22.6	23.0	15.3	14.4	15.0	13.5	10.8	19.6	9.3	6.7	15.9	11.5	16.4	13.7	23.0	22.7	14.4	18.3	14.2	14.9	14.5	5.7	11.1	1.2	13.3	17.4	3.5	7.2	27.6	21.0	16.0	0.5	10.9	7.4	9.5	21.9	4.2	25.1	28.3	22.6	23.3	18.8	20.3	30.3	22.4	20.6	12.9	18.3	13.7	18.7	12.2	1.3	13.1	1.8	69.7	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.9	0.0	0.4	0.0	0.0	0.2	10.3	8.6	4.1	22.6	9.4	10.2	12.7	11.1	12.0	4.0	16.9	11.1	6.2	3.2	4.2	68.6	0.5	1.1	2.8	0.4	0.0	48.0	5.0	5.8	15.3	7.2	1.6	1.8	93.8	1.8	0.0	26.0	1.9	1.1	8.6	7.7	10.9	5.0	5.4	0.4	102.4	1.6	0.6	5.5	10.2	7.8	8.9	6.6	5.3	5.2	4.0	21.9	122.5	7.3	0.0	8.8	3.9	10.5	4.7	7.1	1.8	37.5	6.8	9.7	0.0	78.4	47.2	1.2	10.8	4.5	2.9	4.0	10.6	1.3	1.4	58.7	0.0	6.7	6.9	3.1	4.8	1.8	2.0	1.5	0.9	9.2	9.8	3.3
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336413-120489937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	25.6	30.6	27.2	14.3	26.9	11.4	31.9	26.8	32.1	32.9	26.4	27.6	25.0	27.8	25.4	27.6	29.3	28.4	40.3	30.9	23.0	67.4	66.4	36.7	11.9	17.8	25.6	25.2	26.1	68.4	14.6	42.9	17.3	26.5	29.1	47.7	25.0	30.9	32.2	49.5	25.5	30.3	20.1	21.5	32.2	9.7	35.9	13.5	51.5	31.8	18.7	28.7	22.0	19.3	38.1	31.6	41.9	39.8	55.0	54.5	16.7	43.8	49.8	26.1	33.1	37.5	27.2	3.2	51.7	79.8	46.6	27.5	54.1	56.0	51.3	31.1	25.8	61.8	34.0	29.2	49.2	0.1	43.7	52.4	39.7	57.8	63.8	58.0	80.7	32.7	52.4	122.5	67.0	26.6	0.1	0.1	11.4	49.3	26.1	13.4	47.4	11.9	65.1	66.1	30.0	36.4	61.5	51.0	16.2	25.0	43.1	5.1	80.1	57.2	24.2	37.6	32.4	35.1	15.4	20.2	23.6	7.9	44.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	27.2	26.9	26.8	32.1	30.9	23.0	17.8	25.6	17.3	20.1	35.9	19.3	86.2	73.7	88.4	274.9	8.6	90.5	69.1	47.2	42.1	134.6	55.1	26.9	87.6	68.6	57.8	97.5	185.6	16.7	11.5	59.7	35.2	45.6	6.4	61.4	55.7	94.0	37.8	69.7	239.0	50.9	10.4	44.0	34.7	140.3	11.4	44.9	85.6	118.3	7.3	90.9	192.4	39.6	18.3	31.2	25.6	14.8	29.8	18.2	51.6	118.0	8.7	41.0	13.4	143.2	55.0	53.5	52.1	33.4	9.3	85.6	48.1	76.3	48.7	80.9	26.3	58.4	60.3	16.3	13.8	55.3	85.1	28.7	16.1	43.1	41.3	99.1
ARHGEF16	"GEF16, NBR"	ENSG00000130762	"Rho guanine nucleotide exchange factor 16"	Q5VV41	1	3454665-3481113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.1;Extravillous trophoblasts: 55.6;Gastric mucus-secreting cells: 67.2;Intestinal goblet cells: 49.6;Paneth cells: 68.2;Proximal enterocytes: 72.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.4;MCF7: 32.4;OE19: 38.2;SK-BR-3: 34.9"	"Region enhanced"	"Detected in many"		"olfactory bulb: 4.7"	"Low region specificity"	"Detected in many"			HPA010609	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010609: AB_1845004"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (1.24e-10)"	"unprognostic (6.46e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.29e-2)"	3.8	0.5	1.4	2.7	2.0	0.0	4.8	3.0	2.0	3.5	5.2	19.7	44.0	1.1	2.7	17.9	2.5	11.1	1.0	1.1	4.0	17.7	6.5	3.3	0.2	5.3	2.6	1.3	11.1	8.0	11.4	5.0	5.1	9.4	11.9	2.7	17.0	5.7	1.4	5.9	34.2	0.5	2.6	0.8	28.1	3.2	3.3	0.4	10.0	1.5	2.0	5.0	9.0	3.3	18.3	6.8	1.8	0.2	0.0	0.0	12.6	0.3	0.4	0.5	1.4	20.7	56.4	0.0	13.5	0.1	3.4	18.8	3.0	12.1	0.1	0.0	6.3	0.0	8.8	16.2	0.6	0.0	0.1	0.3	11.4	1.2	0.6	1.2	0.1	0.3	2.3	0.0	0.1	32.4	0.0	0.4	13.8	38.2	0.4	0.0	0.0	2.7	14.2	9.1	9.8	1.8	3.6	34.9	0.8	7.1	15.7	0.6	0.0	0.2	4.0	0.3	0.4	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.0	3.0	2.0	1.1	4.0	5.3	2.6	5.1	2.6	3.3	3.3	0.6	9.6	5.4	2.0	0.5	3.2	15.0	9.1	14.2	1.1	8.1	4.6	1.6	12.8	11.7	16.5	6.2	3.2	0.1	101.1	15.6	16.5	0.1	4.3	0.8	0.8	10.2	0.0	0.4	12.7	55.6	0.8	67.2	9.9	0.0	17.3	0.4	4.3	1.2	3.3	0.5	49.6	20.3	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.6	36.7	0.0	0.5	5.2	28.6	68.2	0.0	2.8	3.6	72.1	11.5	6.5	8.8	0.0	0.0	3.0	0.3	3.9	12.2	1.0	6.7	0.5	2.0	40.0	13.3
ARHGEF17	"KIAA0337, p164-RhoGEF, TEM4"	ENSG00000110237	"Rho guanine nucleotide exchange factor 17"	Q96PE2	11	73308276-73369388	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Endometrial stromal cells: 40.5;Sertoli cells: 85.5;Smooth muscle cells: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007991	Uncertain		Approved	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007991: AB_1845005"	"unprognostic (2.36e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.27e-5)"	"unprognostic (6.96e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-3)"	"unprognostic (7.12e-3)"	"unprognostic (6.85e-3)"	"unprognostic (3.42e-3)"	32.8	12.2	32.7	9.1	39.5	3.3	24.1	24.1	45.7	37.0	15.3	38.2	5.5	39.9	15.2	10.0	30.5	17.6	34.5	29.6	33.7	24.9	5.4	31.2	5.9	38.2	31.6	24.2	8.2	19.1	15.3	23.6	37.6	25.4	5.3	7.2	11.7	27.3	11.5	10.7	16.4	22.6	21.3	12.8	19.8	7.1	36.9	3.1	36.0	12.2	2.7	26.9	20.2	28.8	9.6	11.4	24.1	28.4	18.7	15.7	14.8	26.6	38.2	25.9	16.5	30.2	8.2	0.0	18.2	50.7	11.8	14.5	8.1	10.8	10.8	16.9	2.4	0.0	21.0	11.9	21.6	0.8	0.5	27.1	12.2	15.6	9.3	16.9	19.4	1.2	0.9	0.2	14.6	13.7	0.3	17.4	3.2	6.4	2.4	4.0	27.3	0.6	16.5	6.7	15.8	12.1	22.6	26.4	31.3	22.0	43.8	8.2	12.9	12.5	25.5	5.3	8.6	1.6	0.3	0.1	4.4	1.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.7	39.5	24.1	45.7	29.6	33.7	38.2	31.6	37.6	21.3	36.9	28.8	13.9	16.0	16.3	38.5	0.2	3.4	2.4	6.0	5.7	12.6	11.1	12.3	25.5	8.6	7.4	7.3	0.0	7.2	0.1	1.5	0.0	6.4	1.1	10.5	40.5	10.9	1.2	1.3	29.5	0.7	5.3	10.7	2.6	8.9	0.0	13.7	10.8	0.6	2.0	23.5	24.8	0.7	0.0	0.3	4.2	2.0	10.8	1.4	1.8	8.4	1.1	11.1	0.0	10.6	2.0	2.4	0.4	20.3	1.6	4.1	0.0	4.3	5.4	2.3	85.5	5.2	67.5	1.6	8.3	1.1	2.7	6.2	0.6	2.0	1.0	1.5
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF, p114RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7348937-7472485	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.0;Excitatory neurons: 22.2;Inhibitory neurons: 18.0;Microglial cells: 14.0;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042689, HPA049151, HPA071867"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042689: AB_10794385, HPA049151: AB_2680654, HPA071867: AB_2686466"	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"	8.2	15.9	10.4	20.0	13.3	27.1	8.1	9.7	12.1	12.2	7.0	22.1	13.3	16.8	3.1	19.9	9.7	10.7	7.1	9.8	8.8	24.1	13.1	14.6	29.8	12.1	13.0	10.1	21.0	11.2	15.8	7.8	10.8	14.2	7.7	5.0	11.0	7.3	5.3	13.8	31.1	13.9	9.5	35.9	22.6	8.9	12.2	33.1	10.8	3.0	17.5	14.0	12.1	15.3	31.2	17.9	10.2	13.9	9.4	7.8	30.8	13.4	12.9	20.5	20.8	24.5	17.4	62.9	29.4	15.2	15.3	24.6	12.7	29.7	11.8	37.6	16.1	15.5	11.7	16.4	22.1	31.2	30.4	12.8	20.2	19.7	16.3	10.1	11.2	20.2	13.4	14.7	21.3	11.0	36.0	26.8	16.0	16.9	29.2	42.2	17.6	17.2	9.0	34.6	9.8	13.7	16.4	16.1	18.8	9.6	17.4	36.4	21.9	16.8	20.1	25.9	17.2	35.6	23.2	40.2	16.7	27.5	15.1	6.4	3.7	23.0	3.9	4.5	4.0	8.8	5.3	4.3	2.3	12.4	5.4	4.1	12.5	0.9	6.9	2.8	3.9	3.5	10.4	13.3	9.7	12.1	9.8	8.8	12.1	13.0	10.8	9.5	12.2	15.3	0.2	0.0	1.1	17.0	2.2	2.9	0.0	6.5	2.8	0.2	0.4	0.1	0.2	0.0	4.3	0.0	4.2	0.1	0.3	0.5	0.0	0.3	0.1	2.4	0.8	0.5	1.8	3.0	22.2	0.4	0.1	1.1	6.1	2.9	0.0	0.5	0.0	0.0	0.2	0.0	18.0	0.0	4.1	0.3	2.1	0.1	0.0	1.6	1.8	14.0	0.7	0.0	0.0	18.1	30.5	0.6	2.3	0.0	4.3	0.0	0.7	0.1	9.3	0.4	0.0	0.1	1.2	0.0	0.0	3.9	3.8	0.0	1.6	0.0	0.0	0.3
ARHGEF2	"GEF-H1, GEFH1, KIAA0651, Lfc, LFP40, P40"	ENSG00000116584	"Rho/Rac guanine nucleotide exchange factor 2"	Q92974	1	155946851-156007070	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Mitosis, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043437	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA043437: AB_2678481"	"unprognostic (2.27e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.20e-6)"	"unprognostic (5.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.85e-3)"	"unprognostic (7.98e-2)"	48.9	12.3	52.6	39.2	80.8	64.0	40.8	69.0	77.8	38.8	18.7	47.3	18.8	37.0	15.2	25.8	42.1	31.1	42.8	55.5	56.2	35.7	13.2	89.9	48.4	85.9	75.9	28.1	15.1	18.5	16.8	32.1	84.1	27.3	28.8	11.1	25.0	15.1	17.8	17.9	45.4	29.9	60.9	69.9	39.9	33.9	77.2	38.6	46.7	16.8	32.6	37.8	31.4	130.6	32.0	25.7	44.0	30.3	41.4	51.9	45.3	69.9	89.4	67.2	71.5	23.3	23.6	79.4	41.9	53.8	35.4	45.7	26.7	22.2	50.9	32.5	22.9	105.1	40.9	14.0	162.4	138.6	87.8	61.1	90.4	100.2	122.1	50.7	55.7	60.5	59.2	94.2	96.2	17.7	70.2	187.2	48.8	53.4	17.0	75.5	61.3	135.9	28.3	19.0	72.1	33.1	30.1	43.6	246.1	43.6	45.0	188.7	73.6	57.7	32.7	50.9	89.8	155.7	171.1	55.6	82.4	68.7	144.6	15.1	20.6	17.1	15.7	18.1	10.8	14.6	9.9	11.3	18.2	13.1	9.6	11.0	31.7	11.0	21.9	8.7	9.9	28.2	52.6	80.8	69.0	77.8	55.5	56.2	85.9	75.9	84.1	60.9	77.2	130.6	26.4	38.5	73.4	2.9	43.9	15.2	28.1	12.6	10.8	54.1	15.7	12.3	6.2	10.0	12.0	16.5	2.1	3.5	32.1	21.1	7.9	15.5	52.9	6.6	10.2	32.3	30.5	48.6	30.8	5.3	22.8	24.8	59.1	13.3	27.9	8.9	23.2	1.0	29.7	1.7	17.0	20.9	16.2	49.0	67.8	16.1	11.5	46.0	24.9	20.6	82.9	12.9	48.4	22.1	105.5	16.5	22.5	10.1	20.0	16.7	9.8	2.2	13.0	3.3	59.2	32.9	30.8	3.1	4.1	11.7	13.8	3.4	29.7	2.1	14.2	40.2
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57617245	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 151.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.8;Leydig cells: 24.8;Peritubular cells: 45.9;Sertoli cells: 26.3;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 59.1;RH-30: 129.7;SH-SY5Y: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	34.4	12.0	30.7	10.7	38.7	0.1	29.1	38.5	72.1	64.5	12.6	151.2	10.3	92.8	44.3	29.6	85.5	23.6	24.6	72.0	21.7	17.7	5.0	21.7	6.2	20.6	21.1	58.2	8.5	9.4	26.4	9.4	20.8	60.6	19.5	13.2	13.9	80.4	11.4	12.0	34.4	68.8	17.3	20.1	45.0	10.6	22.5	2.1	14.1	13.8	4.9	84.3	51.4	40.5	0.8	8.9	41.6	26.1	0.1	0.0	3.3	12.7	37.4	16.5	20.2	5.2	8.1	3.5	10.7	23.4	7.7	0.4	16.2	0.7	13.9	11.7	13.9	7.4	6.1	11.4	11.6	0.2	19.2	11.5	3.5	7.5	1.1	59.1	6.5	2.0	15.5	16.0	12.2	3.0	2.7	0.3	26.5	0.4	0.4	0.0	129.7	0.7	0.7	0.7	24.1	58.7	2.4	1.2	4.8	14.8	4.3	8.9	0.0	14.8	14.0	9.7	4.7	33.5	5.4	0.1	12.4	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	38.7	38.5	72.1	72.0	21.7	20.6	21.1	20.8	17.3	22.5	40.5	5.6	0.0	0.0	8.5	0.0	2.0	1.8	0.2	4.6	17.7	1.8	8.6	11.6	0.0	0.6	0.0	2.1	0.2	0.6	0.0	0.0	0.5	0.2	1.1	20.8	4.4	0.0	0.0	15.3	1.4	0.5	12.6	0.5	0.6	0.0	2.6	6.8	0.0	0.5	8.4	8.5	0.0	0.0	0.0	1.7	1.5	24.8	0.2	0.0	8.4	0.0	5.4	2.1	3.0	1.6	0.3	0.0	45.9	0.3	0.8	0.0	0.4	0.0	2.8	26.3	6.3	38.9	1.4	1.4	0.9	1.1	0.3	0.5	9.6	0.0	0.4
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 339.7;Astrocytes: 248.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	8.0	2.1	5.8	1.8	5.7	0.3	6.0	4.1	5.3	5.0	7.7	18.3	7.3	4.3	1.2	7.4	6.2	5.5	3.2	4.6	5.0	1.7	15.5	16.3	0.3	5.9	7.3	3.9	6.0	9.9	1.7	3.4	5.8	3.4	2.6	7.1	3.1	4.8	0.4	6.2	6.6	7.1	5.4	0.8	8.7	5.1	6.1	0.8	3.1	1.4	0.9	5.1	6.4	4.8	8.5	3.7	10.6	6.8	5.1	1.4	0.3	0.3	0.0	3.1	4.3	6.5	0.8	5.0	0.5	0.6	4.9	8.9	6.7	4.4	3.9	0.0	8.8	0.1	2.6	1.5	4.7	1.6	0.2	1.3	0.4	4.0	0.5	1.8	0.6	5.4	0.0	0.0	2.0	8.1	2.0	0.1	6.7	2.4	3.0	0.0	12.9	0.0	0.7	4.1	3.2	1.1	1.7	14.4	1.5	4.6	10.1	0.5	0.0	1.1	5.3	0.1	26.6	4.5	0.7	0.0	2.5	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	4.1	5.3	4.6	5.0	5.9	7.3	5.8	5.4	6.1	4.8	5.0	339.7	26.8	248.8	1.7	19.5	9.0	2.7	17.6	11.6	54.2	6.6	1.8	20.0	10.8	3.7	4.2	1.8	4.3	1.5	0.0	2.2	11.9	4.7	4.5	4.3	0.0	2.7	4.2	2.5	1.1	12.0	14.3	2.1	5.1	3.6	8.6	60.8	0.6	5.0	10.1	7.9	6.1	2.5	3.4	3.4	10.5	1.3	3.6	7.5	2.7	58.1	12.3	41.7	5.1	2.0	6.9	18.8	0.7	7.5	21.4	0.1	14.9	47.8	0.0	14.1	3.7	4.7	37.0	11.7	23.7	6.2	4.7	2.5	8.1	5.7
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.1;Granulosa cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.98e-4)"	4.8	23.9	4.5	1.1	4.7	0.0	7.5	0.4	5.1	3.9	0.0	3.3	3.2	4.1	2.5	6.4	9.8	5.3	1.9	5.0	4.3	31.5	6.4	7.3	0.4	1.6	2.0	19.0	20.7	1.2	6.0	0.5	3.2	5.0	3.7	6.0	19.2	3.6	0.9	14.8	2.5	3.5	1.4	2.8	21.8	1.5	3.2	4.0	13.6	0.9	2.9	3.7	6.6	2.8	30.1	21.0	0.1	2.6	2.6	3.6	0.0	10.8	21.5	13.5	13.3	6.3	12.8	0.1	22.5	3.7	30.4	10.0	1.4	17.4	20.2	0.2	3.1	0.6	3.3	27.2	20.9	0.0	0.0	3.3	7.0	21.0	97.8	25.2	44.4	0.6	0.0	0.0	92.2	2.8	0.0	0.0	0.2	7.9	8.5	0.0	5.5	3.7	36.4	18.0	2.0	3.9	5.3	0.8	0.6	0.0	4.6	0.1	59.8	6.6	9.2	0.5	10.3	1.1	0.0	0.2	10.1	1.4	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	4.7	0.4	5.1	5.0	4.3	1.6	2.0	3.2	1.4	3.2	2.8	9.1	28.9	16.4	3.9	0.2	25.7	14.1	14.1	40.5	4.9	7.5	11.0	2.0	24.3	15.5	31.3	0.0	0.3	2.1	3.7	15.6	13.0	9.6	32.7	1.7	12.8	11.4	2.7	73.1	11.3	0.3	3.1	35.7	12.6	1.3	83.2	2.2	7.3	0.3	13.5	34.5	10.7	40.7	0.3	0.9	2.6	10.2	3.3	1.8	32.8	0.6	26.8	1.0	34.7	15.2	26.3	4.6	5.7	1.2	16.0	3.9	26.7	50.4	1.6	6.6	0.5	7.0	1.0	1.3	20.4	25.6	0.1	1.2	32.3	6.7	17.3
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;NK-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 88.8;RPMI-8226: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	16.8	43.2	11.2	20.6	14.8	9.8	13.8	14.4	17.4	16.0	30.9	14.3	6.4	38.0	12.5	19.0	23.2	22.3	12.7	25.9	10.8	25.3	5.2	24.8	29.3	11.2	9.1	20.6	29.1	52.3	21.6	21.3	10.7	14.8	13.5	8.2	21.5	15.3	8.0	12.6	9.6	34.5	7.6	21.5	15.8	14.3	11.6	36.1	14.2	8.5	28.7	17.2	11.6	12.8	24.2	8.4	1.2	7.7	2.7	2.2	16.5	2.6	2.2	2.6	3.4	4.1	22.3	12.6	2.5	4.7	25.3	12.1	7.2	30.8	3.0	18.4	3.5	10.3	5.2	88.8	6.6	0.0	10.9	9.7	19.9	2.3	3.5	23.6	25.5	13.3	2.9	27.2	5.9	3.7	34.8	1.3	2.3	19.5	12.9	0.2	9.2	92.2	19.8	13.2	1.4	3.8	15.3	11.2	6.9	8.5	2.9	10.6	11.8	1.3	6.0	5.4	4.0	35.0	14.2	45.1	21.7	12.2	10.9	20.6	23.0	3.7	96.1	25.5	72.5	26.0	73.6	85.0	13.9	16.9	59.3	73.5	8.3	39.7	32.2	5.9	67.4	76.0	11.2	14.8	14.4	17.4	25.9	10.8	11.2	9.1	10.7	7.6	11.6	12.8	22.7	16.0	22.4	30.0	24.2	11.1	8.6	16.3	32.5	9.5	7.6	9.9	9.8	2.8	12.6	23.9	4.2	11.4	57.5	4.8	11.7	11.0	22.6	10.1	7.0	40.3	9.6	14.1	157.8	10.2	7.9	13.5	36.2	16.5	13.9	4.8	22.9	0.1	7.6	0.0	70.8	1.3	2.0	38.1	8.2	14.1	17.7	18.7	10.6	63.7	19.9	9.0	137.0	68.3	80.0	7.5	1.4	24.0	22.1	11.2	0.2	7.3	9.5	1.2	0.0	8.0	4.4	3.3	2.6	37.9	14.9	11.9	64.3	3.2	3.2	13.4
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889875-38975454	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 15.2;Late spermatids: 26.8;Spermatocytes: 34.7;Spermatogonia: 35.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	4	"BEWO: 5.6;HeLa: 2.6;SiHa: 7.2"	"Region enriched"	"Detected in many"	32	"cerebellum: 280.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 23.1"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.4	2.1	4.9	0.6	5.2	0.0	0.9	22.6	5.8	1.5	4.4	1.0	0.1	1.5	2.6	0.4	1.4	0.8	0.5	4.9	4.1	0.9	0.2	0.7	0.3	4.1	5.4	3.5	0.4	0.7	3.4	0.5	4.0	0.9	0.3	4.0	0.5	0.7	0.3	0.8	0.4	0.5	3.1	0.3	0.5	5.7	7.2	0.1	1.1	0.0	0.2	0.7	0.7	5.0	0.2	0.0	0.2	0.1	0.1	0.1	5.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	2.6	0.1	0.4	0.2	0.1	0.5	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.3	0.2	7.2	0.3	0.0	0.6	0.0	0.2	0.4	0.1	0.9	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.9	5.2	22.6	5.8	4.9	4.1	4.1	5.4	4.0	3.1	7.2	5.0	0.4	0.0	1.5	7.8	0.1	0.0	0.1	0.0	0.6	2.5	0.3	0.6	0.8	1.5	0.6	0.0	0.0	1.1	0.0	0.1	0.0	0.1	34.8	1.8	1.2	0.4	0.0	2.7	15.2	0.0	1.9	1.2	0.0	0.2	0.0	1.4	0.0	0.2	1.0	0.0	11.4	0.4	0.0	0.0	0.0	26.8	1.2	0.2	0.0	1.9	0.1	3.6	0.0	5.5	3.4	0.0	0.0	3.4	0.0	0.1	0.0	0.4	3.9	2.9	0.0	0.3	1.5	34.7	35.6	0.1	0.1	0.5	0.0	2.0	0.1	0.2
ARHGEF35	"ARHGEF5L, CTAGE4, FLJ43692"	ENSG00000213214	"Rho guanine nucleotide exchange factor 35"	A5YM69	7	144186083-144195833	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 107.0;Urothelial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.9;HBEC3-KT: 21.8;hTCEpi: 33.7;OE19: 32.2;RPTEC TERT1: 46.4;WM-115: 23.5"									"HPA044188, HPA045619, HPA045699"	Supported					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.97e-2)"	2.5	0.9	0.4	2.1	0.5	1.1	14.5	0.4	0.4	5.5	2.7	11.0	12.2	2.3	3.9	16.5	5.8	5.0	1.8	0.3	0.4	11.1	5.4	3.5	1.3	0.6	0.7	1.6	7.5	7.2	3.4	3.8	0.6	5.6	14.3	1.0	10.4	4.1	0.2	17.9	8.6	1.1	0.6	1.6	10.5	0.6	0.6	1.3	20.5	0.7	3.4	5.7	7.0	0.4	39.9	0.8	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.2	13.0	13.6	0.0	0.0	1.6	3.3	11.0	0.0	21.8	0.4	0.1	0.0	0.0	2.7	0.0	3.6	0.0	0.0	3.4	33.7	0.2	8.1	2.9	0.1	0.0	0.0	0.0	1.4	6.9	0.0	0.0	4.4	32.2	3.7	0.1	0.0	0.0	46.4	9.8	0.0	0.0	8.0	14.8	3.5	2.3	18.1	0.8	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.4	0.4	0.3	0.4	0.6	0.7	0.6	0.6	0.6	0.4	3.3	9.6	11.5	0.0	2.5	46.5	107.0	27.0	18.2	0.8	29.9	32.5	1.0	35.8	32.6	62.5	16.7	49.0	1.5	46.4	17.6	44.4	4.3	46.1	5.9	2.0	19.2	0.0	0.0	29.7	72.2	3.9	18.8	49.9	0.0	2.9	1.1	19.4	5.3	0.0	0.0	24.8	12.2	1.3	3.2	1.4	4.7	1.4	16.0	0.0	0.0	3.9	0.0	0.0	0.0	43.8	46.1	3.0	3.1	27.4	56.6	28.8	17.1	5.6	0.0	1.0	4.3	0.8	2.1	21.5	47.0	59.9	2.5	1.7	23.6	91.8
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8;Oligodendrocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 9.3;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.9;HaCaT: 26.1;hTCEpi: 33.8"	"Region enhanced"	"Detected in many"		"cerebellum: 10.4"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA043885: AB_2678715, HPA053487: AB_2682167"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	4.2	3.8	26.9	2.2	38.9	5.2	24.5	33.3	33.8	5.5	34.0	20.8	6.8	7.4	13.6	14.0	10.6	6.3	12.1	23.4	28.6	9.1	2.5	6.4	1.5	41.1	35.9	3.8	10.7	28.1	6.7	3.2	39.5	23.3	7.5	14.4	39.9	35.4	20.4	45.1	7.4	10.2	32.5	1.4	23.3	5.5	35.3	1.6	2.9	10.5	4.8	10.6	8.9	51.3	4.4	1.7	1.2	5.1	0.3	0.6	3.0	0.5	0.9	0.8	0.8	0.0	5.6	0.6	13.9	0.6	1.5	26.1	0.4	2.6	1.6	1.1	1.3	0.4	2.9	0.3	1.0	0.0	0.8	0.7	33.8	2.6	3.3	2.7	4.2	1.8	0.6	1.1	0.0	0.6	0.8	0.8	0.3	10.7	3.1	0.5	0.6	0.0	5.7	2.1	2.1	5.0	3.2	0.3	0.5	0.6	7.7	0.1	3.4	0.3	0.9	0.1	0.7	0.7	1.6	0.5	1.0	0.1	3.6	9.3	0.5	0.3	0.2	0.8	0.3	0.1	0.1	0.2	0.2	0.4	0.5	0.4	3.0	0.2	0.3	0.7	0.1	0.0	26.9	38.9	33.3	33.8	23.4	28.6	41.1	35.9	39.5	32.5	35.3	51.3	9.2	0.0	4.5	5.9	2.8	6.8	9.6	10.4	0.6	4.6	32.7	24.4	15.8	17.2	16.5	9.2	4.2	6.2	4.6	18.2	0.0	3.7	5.3	9.4	2.0	7.4	11.4	14.3	5.1	4.9	1.4	2.7	9.7	9.9	7.0	1.7	6.8	3.2	3.1	5.0	7.5	9.6	8.2	2.5	3.3	1.5	1.8	2.9	3.6	12.2	3.9	36.8	7.2	2.0	62.3	5.1	10.1	10.5	2.0	10.5	15.9	1.4	17.8	7.6	6.6	5.7	4.5	16.0	5.7	4.8	9.7	4.5	3.3	1.5	10.5	5.7
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 7.8;pancreas: 6.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	7.8	0.0	0.0	2.5	0.0	2.6	1.9	0.2	5.5	0.1	0.6	3.2	0.0	0.0	0.0	3.9	0.1	3.6	0.0	0.0	0.0	0.0	6.5	0.0	2.0	0.0	0.0	5.7	4.2	0.0	4.9	0.4	0.3	0.5	2.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	48.5	0.0	0.2	0.0	1.1	1.1	0.0	0.0	17.9	6.1	1.8	4.3	12.6	12.9	0.0	0.2	0.2	9.8	9.8	6.8	1.9	12.6	0.5	0.3	8.4	0.0	0.3	5.8	0.1	0.3	9.2	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	14.8	10.2	0.0	0.2	0.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	2.4	6.4	0.0	0.1	9.4	4.8	0.5	31.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.8
ARHGEF39	"C9orf100, FLJ14642"	ENSG00000137135	"Rho guanine nucleotide exchange factor 39"	Q8N4T4	9	35658875-35675866	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.2;Erythroid cells: 16.6;Extravillous trophoblasts: 19.5;Late spermatids: 36.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.7"	"Low region specificity"	"Detected in all"			HPA061299	Uncertain					NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA061299: AB_2684473"	"unprognostic (2.93e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (9.75e-2)"	"unprognostic (6.04e-9)"	"unprognostic (3.31e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.46e-1)"	2.9	1.8	0.1	1.6	0.1	1.8	2.2	0.9	0.2	1.8	0.2	4.0	2.1	2.4	0.1	1.5	2.0	0.8	2.2	0.1	0.1	1.2	1.2	1.7	2.0	0.1	0.0	1.1	1.7	0.0	0.9	0.7	0.1	2.5	1.1	1.5	1.0	0.2	0.7	1.3	2.3	0.3	0.0	2.0	3.0	1.1	0.2	1.6	1.2	0.0	1.3	3.0	1.7	0.2	5.2	7.7	7.4	3.6	0.0	0.2	4.9	3.7	1.4	3.3	2.9	8.7	4.0	3.2	2.2	0.5	4.6	3.8	3.7	2.2	1.3	9.5	5.8	5.1	11.3	3.3	0.0	4.3	7.5	0.2	0.2	1.6	0.9	1.0	1.2	4.6	3.6	2.9	1.4	2.6	1.1	2.4	4.7	3.7	2.5	4.4	5.7	1.9	1.2	2.2	5.2	2.1	1.9	4.1	1.0	3.0	6.1	2.5	0.7	2.3	7.4	2.7	2.7	2.8	3.7	1.4	1.4	2.3	5.1	0.3	0.2	0.2	0.5	0.1	0.7	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.2	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.0	2.1	2.7	1.4	1.6	0.6	2.1	1.6	3.4	1.4	1.5	1.0	1.8	0.0	8.1	3.6	1.7	0.0	1.0	98.2	0.6	1.6	1.3	3.5	16.6	0.4	0.8	19.5	2.0	14.8	1.1	0.0	4.1	1.8	0.5	5.3	0.0	0.5	4.1	0.0	2.5	5.0	36.1	0.9	2.0	5.4	0.0	0.4	1.6	3.1	0.5	0.3	0.5	0.3	0.4	2.6	1.2	1.5	0.3	1.2	2.4	0.0	2.6	3.3	3.3	5.4	3.5	2.0	1.9	3.1	0.5	6.9	0.8
ARHGEF4	"ASEF, KIAA1112, STM6"	ENSG00000136002	"Rho guanine nucleotide exchange factor 4"	Q9NR80	2	130836914-131047263	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.3;skin 1: 39.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 333.3;Excitatory neurons: 83.0;Inhibitory neurons: 83.5;Oligodendrocyte precursor cells: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.0;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 39.9;hTCEpi: 78.9;REH: 20.3;SCLC-21H: 52.9"									HPA018267	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018267: AB_1845006"	"unprognostic (2.30e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (3.93e-3)"	"unprognostic (9.71e-3)"	5.6	5.0	53.1	1.0	56.8	0.0	2.1	32.5	67.3	11.2	27.3	7.0	0.2	2.9	1.6	34.0	8.4	2.9	1.4	63.1	38.1	0.4	0.9	3.1	0.3	44.4	39.7	7.8	17.9	2.5	15.4	0.2	39.9	5.2	0.8	10.2	5.7	9.3	9.0	39.8	1.3	4.1	41.5	0.2	3.1	5.2	44.6	1.8	6.1	2.6	2.5	4.5	19.9	46.0	4.8	2.0	0.9	16.6	0.1	0.0	0.4	5.3	0.3	0.3	0.2	0.9	1.5	0.0	0.5	2.1	3.6	39.9	2.4	10.5	0.0	0.0	2.2	0.0	7.0	0.0	0.6	0.0	0.1	0.0	78.9	1.2	5.8	0.1	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	5.8	0.7	7.2	20.3	0.2	0.8	3.2	0.1	52.9	7.0	0.8	8.3	0.6	1.6	0.5	0.5	0.0	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.5	0.0	0.0	0.5	1.4	0.0	0.0	0.0	1.0	0.5	0.1	53.1	56.8	32.5	67.3	63.1	38.1	44.4	39.7	39.9	41.5	44.6	46.0	0.1	25.6	0.0	333.3	0.0	17.3	1.2	4.8	15.4	18.8	0.9	5.5	3.2	1.5	2.9	0.0	37.5	1.0	2.9	0.3	0.0	0.8	10.9	7.5	1.0	0.5	0.0	2.7	83.0	0.0	0.3	3.5	2.6	5.4	0.0	3.1	0.7	0.4	0.4	28.6	83.5	0.9	0.0	0.6	2.4	8.2	5.0	0.3	5.4	11.2	0.7	3.7	0.0	143.7	28.3	1.5	0.0	10.9	0.0	1.2	0.3	0.9	6.6	13.9	0.0	3.1	1.1	1.1	4.2	17.4	19.9	0.3	0.8	0.4	0.4	0.8
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070273-21090248	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	21.0	47.2	9.6	5.3	11.1	1.6	18.5	10.0	9.2	24.8	6.2	14.5	3.7	18.9	12.2	3.5	13.2	14.8	12.3	8.9	11.1	10.1	26.9	14.2	2.3	13.5	10.5	19.3	24.0	10.7	9.0	6.5	10.5	12.3	6.2	2.8	20.2	18.6	10.5	7.4	7.9	9.7	10.1	27.8	9.5	4.3	12.1	3.1	15.8	6.1	1.7	13.8	13.3	12.1	3.3	2.9	30.8	5.8	24.5	37.1	1.1	11.4	28.1	12.1	9.4	1.4	7.5	0.0	1.8	20.9	12.2	5.0	2.6	3.7	4.3	6.6	1.1	4.6	3.4	9.0	3.5	3.0	16.5	15.5	2.4	10.3	3.1	22.6	0.0	0.0	1.4	1.3	9.6	0.3	0.0	8.6	8.1	0.8	0.5	1.0	23.2	1.4	7.6	4.1	0.7	11.6	6.4	0.6	8.9	6.0	2.7	10.1	5.9	25.4	17.5	11.9	5.9	2.6	0.0	0.0	8.8	4.2	7.5	0.0	1.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.4	9.6	11.1	10.0	9.2	8.9	11.1	13.5	10.5	10.5	10.1	12.1	12.1	12.7	6.4	5.0	32.0	2.5	4.8	8.0	5.8	1.8	9.2	6.6	11.3	13.4	47.1	3.2	14.7	0.0	1.4	0.5	10.0	19.6	21.2	1.0	17.6	13.1	11.0	7.8	1.7	0.3	10.2	0.9	20.4	18.3	3.5	38.0	11.6	8.2	31.5	14.1	5.0	6.2	9.1	4.1	46.9	14.6	2.3	24.2	22.0	23.2	17.8	23.6	24.6	1.0	21.1	8.9	16.4	6.6	24.0	3.1	6.3	1.0	7.1	1.7	6.8	26.3	18.6	21.9	3.1	2.8	0.6	4.4	1.2	3.5	14.6	18.7	6.1
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 47.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.7;Glandular and luminal cells: 47.4;Paneth cells: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 29.4;CAPAN-2: 21.9;HaCaT: 16.7;hTCEpi: 18.0;RPTEC TERT1: 17.5;WM-115: 17.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	5.1	2.6	1.8	1.6	2.4	2.4	12.3	1.5	1.7	11.5	5.7	16.4	10.1	3.4	6.9	36.6	4.7	4.7	3.5	0.9	1.8	20.9	14.4	8.4	2.2	2.1	2.7	5.6	19.0	7.3	9.5	3.2	1.8	14.7	5.6	1.8	18.1	2.0	0.7	47.1	13.1	1.2	1.3	3.8	13.8	2.0	2.0	1.8	24.0	0.2	3.1	5.3	17.6	1.4	29.4	3.3	0.0	0.0	0.0	0.0	8.7	3.8	2.3	1.5	1.9	11.5	21.9	0.1	10.3	0.9	0.3	16.7	0.0	10.6	1.5	0.1	3.8	0.0	4.2	0.8	3.1	0.0	0.0	5.5	18.0	0.7	9.9	4.8	0.1	0.0	0.0	0.0	1.5	9.7	0.1	0.0	4.5	7.9	5.2	1.1	0.0	0.4	17.5	1.3	0.1	0.1	11.5	13.4	5.1	2.3	6.8	0.3	0.2	0.5	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.0	17.7	0.0	0.0	0.0	0.3	0.0	0.4	0.8	0.8	0.7	0.0	0.9	0.9	0.2	0.3	0.0	0.0	0.0	1.5	0.1	1.8	2.4	1.5	1.7	0.9	1.8	2.1	2.7	1.8	1.3	2.0	1.4	3.0	6.4	14.8	0.3	2.3	18.5	37.3	9.4	26.2	0.0	17.5	18.7	1.4	11.5	12.1	22.0	4.2	11.8	1.4	61.7	5.9	14.8	2.3	28.9	5.5	1.6	9.6	2.7	0.0	16.5	15.2	3.6	37.2	47.4	0.0	4.0	1.8	7.5	1.8	0.0	0.0	24.0	6.1	0.3	1.9	0.6	1.5	1.2	5.4	0.0	0.0	2.7	0.0	0.5	0.1	27.7	53.7	1.5	3.1	14.3	42.0	5.4	13.5	3.1	0.0	1.1	1.8	0.7	1.5	28.7	16.8	14.2	2.5	1.1	23.5	33.6
ARHGEF6	"alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136780932	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	44.0	16.2	23.4	30.5	24.4	31.4	23.5	25.0	19.5	10.7	11.6	13.2	7.5	12.9	5.3	7.6	7.0	17.3	32.9	25.2	26.9	6.7	8.5	25.6	41.8	26.8	29.2	16.5	3.9	10.3	6.2	46.9	27.8	7.8	11.1	4.6	8.7	8.8	68.7	6.2	14.4	16.6	29.0	39.4	12.3	3.8	26.5	51.4	5.6	54.7	39.6	14.3	8.7	30.1	1.1	0.0	5.1	0.0	11.2	28.5	0.1	1.6	9.5	1.5	8.2	0.0	0.0	5.5	2.3	8.0	7.8	0.8	6.1	0.0	1.5	28.1	2.0	117.6	0.1	0.0	4.2	153.7	532.0	30.9	0.1	5.4	0.1	10.1	3.0	152.7	0.5	22.1	20.4	0.2	70.6	88.4	4.9	0.0	2.3	26.6	37.2	0.1	1.6	29.5	0.3	6.7	0.2	1.2	4.0	2.6	3.5	61.2	0.5	7.6	1.2	9.3	7.2	3.6	0.1	57.3	35.1	158.2	10.1	57.2	16.4	71.3	13.8	18.9	16.0	6.2	15.4	11.3	19.1	5.4	13.7	12.3	9.1	12.4	16.1	6.0	21.5	15.3	23.4	24.4	25.0	19.5	25.2	26.9	26.8	29.2	27.8	29.0	26.5	30.1	18.1	6.4	8.9	57.1	22.4	1.1	0.9	0.8	1.2	0.8	16.1	10.8	60.0	0.0	2.4	1.8	0.0	0.3	23.6	0.1	1.9	0.6	12.0	0.9	2.4	13.2	0.0	11.3	20.6	1.8	0.4	10.7	5.6	1.6	193.9	128.2	12.5	2.5	15.2	13.5	21.6	0.4	0.0	46.5	25.1	35.8	14.9	40.3	3.6	77.8	36.1	4.7	36.0	48.2	4.3	0.7	0.0	14.7	12.8	0.4	0.0	0.2	2.2	0.3	13.1	33.5	18.5	0.7	0.7	0.6	1.7	0.4	40.5	30.1	0.1	0.7
ARHGEF7	"BETA-PIX, COOL1, DKFZp686C12170, DKFZp761K1021, KIAA0142, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB"	ENSG00000102606	"Rho guanine nucleotide exchange factor 7"	Q14155	13	111114559-111305737	"Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.1;Inhibitory neurons: 189.9;Oligodendrocyte precursor cells: 169.4;Oligodendrocytes: 269.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004744	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA004744: AB_1845332"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.40e-3)"	56.7	26.7	38.6	27.9	39.7	37.9	50.9	45.7	47.1	35.7	15.8	29.3	27.5	29.6	21.7	26.1	28.3	28.1	43.4	44.2	25.7	30.6	31.8	40.8	36.9	24.7	28.5	35.1	26.2	20.4	32.1	45.7	26.7	37.6	29.2	28.4	27.4	18.1	50.8	47.3	31.2	23.7	17.9	46.8	27.7	28.6	32.6	65.4	36.0	33.7	33.3	27.3	32.8	57.4	46.2	24.2	52.1	25.7	39.5	54.6	33.8	35.3	31.4	29.0	35.5	29.3	32.0	77.2	35.7	28.5	34.9	38.5	26.5	24.7	32.9	37.2	33.4	54.5	45.7	19.6	21.3	59.7	31.0	39.1	30.0	23.9	29.6	28.4	79.7	77.1	33.2	13.8	25.7	18.1	54.7	36.2	31.5	65.1	15.0	50.8	27.1	15.9	17.3	32.4	36.3	53.4	25.2	37.0	23.3	37.8	33.1	52.5	78.4	19.4	22.3	18.4	22.2	31.6	29.7	91.4	44.6	27.5	26.4	29.7	5.5	6.2	7.0	6.2	10.2	9.9	6.5	6.1	6.1	9.1	8.0	6.0	4.3	12.0	8.1	6.6	8.4	6.1	38.6	39.7	45.7	47.1	44.2	25.7	24.7	28.5	26.7	17.9	32.6	57.4	128.2	9.6	19.1	78.0	32.8	15.9	9.8	8.5	25.6	35.8	21.2	16.8	26.8	10.0	15.6	16.5	18.8	18.4	29.6	24.7	1.9	11.7	79.7	13.6	26.7	49.6	13.2	13.7	280.1	8.5	15.5	21.2	23.4	26.8	8.2	18.6	40.0	17.6	12.9	60.6	189.9	22.8	20.3	16.4	19.8	64.1	17.4	19.6	24.9	71.2	15.7	20.3	20.6	169.4	269.4	14.6	19.1	18.0	30.3	19.3	19.8	6.9	14.3	28.7	65.7	24.5	78.0	31.2	23.9	20.0	23.0	18.3	29.3	17.3	18.9	16.2
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 88.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 184.3;Cone photoreceptor cells: 233.5;Rod photoreceptor cells: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035419: AB_10669859, HPA055291: AB_2682774"	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	7.7	15.6	32.6	6.4	39.3	4.1	10.6	5.1	51.0	8.4	5.2	13.6	15.8	9.3	7.1	11.2	7.7	8.0	35.9	46.2	36.6	13.2	5.6	6.3	6.3	13.1	14.3	16.2	5.2	15.0	15.7	5.8	14.3	13.8	14.3	88.1	6.3	14.6	5.9	9.1	13.4	17.2	10.0	6.9	8.9	2.8	26.7	9.5	8.2	8.9	7.3	14.3	6.5	27.2	6.3	9.7	20.2	10.3	7.6	11.1	1.2	12.3	11.8	12.8	9.8	0.6	6.8	14.1	8.7	8.0	10.8	0.2	8.4	14.5	15.1	18.5	6.6	13.7	4.5	0.6	4.5	6.7	4.2	12.2	6.9	5.9	18.5	11.9	7.1	14.8	1.5	20.8	14.0	10.0	12.6	3.3	16.4	6.2	12.1	22.9	48.2	13.5	7.8	6.0	0.1	5.1	5.6	9.8	6.7	8.4	7.5	8.9	3.4	7.1	6.4	34.6	5.1	7.8	6.5	10.2	8.7	10.7	5.1	0.8	1.4	1.3	4.5	2.0	3.2	2.2	2.7	3.1	2.2	2.9	3.3	2.9	1.1	8.4	1.4	1.8	2.6	1.9	32.6	39.3	5.1	51.0	46.2	36.6	13.1	14.3	14.3	10.0	26.7	27.2	9.2	9.6	11.4	59.4	20.3	5.7	6.5	8.7	12.5	184.3	26.0	17.4	45.9	7.2	10.0	11.0	233.5	5.0	19.4	18.2	13.7	6.3	2.0	6.5	9.8	10.8	20.9	3.8	105.9	8.8	1.4	11.8	24.5	6.0	14.5	20.0	11.7	10.7	10.5	82.4	90.5	16.0	12.2	5.7	6.3	6.2	15.5	8.2	14.2	33.7	3.8	29.9	34.0	89.0	50.5	7.9	14.5	15.4	12.4	4.3	19.1	17.3	9.3	320.8	0.0	12.7	22.0	1.9	3.4	11.2	6.0	4.4	21.8	39.6	21.8	6.1
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782104	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	16.4	16.3	10.1	22.7	9.4	37.0	16.4	12.9	24.3	16.2	0.0	18.0	15.4	20.4	15.8	22.2	18.3	14.0	17.4	6.3	35.8	13.3	16.8	16.8	25.8	20.8	6.8	20.8	23.2	19.3	14.3	18.6	9.9	15.1	15.3	20.1	19.3	14.4	21.6	20.5	20.3	17.5	3.0	24.3	19.5	16.7	17.9	46.4	22.6	17.6	23.7	18.4	17.8	9.0	53.2	49.5	68.6	71.5	19.6	18.5	32.3	24.4	21.1	32.7	23.0	36.3	34.1	74.3	20.7	31.8	20.7	31.6	60.3	26.9	37.9	92.7	22.6	63.6	33.0	24.7	16.1	95.2	19.6	21.7	18.8	38.7	27.5	18.2	28.6	52.5	77.7	81.1	21.5	25.1	80.1	36.8	72.4	34.5	22.9	82.2	45.3	42.1	20.3	35.3	62.9	50.7	42.7	35.7	29.0	37.8	10.6	53.4	50.6	34.9	33.5	32.4	39.9	38.0	54.9	34.1	21.2	59.8	31.5	0.2	1.5	1.5	1.6	1.2	2.1	1.8	1.3	2.1	1.4	1.6	1.7	1.9	3.3	2.1	1.3	2.4	0.7	1.9	10.1	9.4	12.9	24.3	6.3	35.8	20.8	6.8	9.9	3.0	17.9	9.0	49.9	60.9	40.4	99.9	66.6	73.4	21.0	32.5	90.0	68.0	77.2	61.5	33.0	38.6	35.9	38.6	52.1	36.5	56.1	46.5	1.9	35.3	23.3	48.8	59.3	46.3	47.5	56.6	47.1	37.6	40.2	35.9	35.7	72.3	61.2	68.4	49.6	65.6	51.0	74.0	59.8	50.2	28.5	89.0	47.5	9.0	38.5	73.2	40.9	89.9	86.4	30.8	53.5	78.9	116.1	49.7	36.4	41.8	48.5	50.0	32.4	16.7	36.1	42.3	52.6	38.2	47.3	44.1	52.2	101.8	94.3	36.7	57.0	45.8	52.1	43.2
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156776020-157210779	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	15.2	12.0	14.6	14.5	13.4	28.7	15.6	29.0	16.0	19.0	2.2	15.9	14.2	17.0	11.3	15.7	18.6	14.4	14.4	20.4	10.1	13.2	9.7	14.6	18.2	13.4	10.9	27.5	17.1	28.2	12.2	11.7	11.1	14.6	12.1	11.7	20.4	12.7	33.6	23.2	15.3	15.8	7.3	18.4	12.5	9.8	12.5	25.4	22.0	25.4	18.8	17.4	17.4	17.2	13.0	19.4	29.6	41.2	24.7	21.5	20.4	14.6	18.6	18.1	18.0	17.7	20.0	43.0	8.1	23.9	22.4	16.5	25.2	23.3	18.1	40.4	18.1	30.6	19.6	22.1	17.1	25.3	21.8	25.5	18.4	27.1	24.6	20.4	25.6	26.8	35.8	32.3	13.2	15.9	29.1	30.5	15.3	18.3	10.5	66.3	12.7	22.9	12.7	24.3	28.0	34.7	28.3	29.4	15.8	15.7	19.6	40.2	26.4	23.4	23.6	22.0	27.5	21.8	18.2	52.7	19.7	30.3	32.0	5.0	2.3	2.3	4.1	1.9	3.7	5.3	3.5	2.8	1.8	6.9	2.9	4.1	4.2	2.4	2.1	9.4	3.7	1.2	14.6	13.4	29.0	16.0	20.4	10.1	13.4	10.9	11.1	7.3	12.5	17.2	85.7	48.1	51.8	282.7	83.3	47.5	22.3	22.3	41.5	36.0	70.9	44.4	36.9	27.1	32.6	126.9	29.2	14.7	103.7	21.8	7.9	40.8	15.0	70.8	124.5	43.9	40.8	37.8	404.3	34.5	7.5	49.9	31.1	78.0	38.7	137.1	33.9	27.3	14.1	47.1	475.4	33.7	20.3	32.6	36.1	19.4	56.8	49.1	30.2	327.0	59.4	21.9	24.7	417.7	503.7	46.6	26.9	62.8	70.2	28.1	26.8	18.4	29.5	29.6	46.0	43.1	56.7	8.0	12.2	39.7	55.7	17.5	51.9	72.9	36.3	27.1
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 23.4;testis: 17.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 191.8;Extravillous trophoblasts: 492.4;Langerhans cells: 163.7;Syncytiotrophoblasts: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 206.5;CACO-2: 72.3;Hep G2: 65.8;K-562: 95.6;THP-1: 66.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	3.4	1.8	2.3	4.9	1.6	10.3	2.2	3.4	3.8	2.5	2.7	2.4	3.2	2.2	0.7	3.0	2.3	0.8	1.9	1.9	1.2	3.9	2.1	4.4	3.5	2.0	1.6	1.2	3.1	2.1	3.3	23.4	2.1	1.9	1.2	0.8	2.0	0.7	1.7	3.1	3.6	1.3	1.7	6.6	2.6	17.0	2.2	2.5	1.6	1.1	2.7	2.2	3.0	1.8	3.8	5.0	17.2	4.3	7.2	5.4	206.5	16.5	10.7	8.8	5.8	72.3	0.6	1.6	3.8	5.6	2.2	1.5	7.0	3.9	3.8	22.5	5.0	7.2	6.5	65.8	3.1	25.1	17.8	7.7	5.5	5.5	1.4	1.4	2.9	5.7	95.6	20.3	2.6	5.8	9.8	28.5	16.6	2.6	1.0	21.9	5.4	13.9	1.1	3.7	8.3	15.8	5.3	4.3	3.1	37.7	7.6	66.7	4.9	5.8	7.8	8.4	1.9	47.0	45.3	12.5	3.8	14.5	4.0	0.7	1.6	1.1	0.3	1.4	0.3	0.9	0.2	0.3	1.0	0.6	0.3	0.1	4.1	1.3	2.1	6.4	0.2	0.7	2.3	1.6	3.4	3.8	1.9	1.2	2.0	1.6	2.1	1.7	2.2	1.8	4.7	6.4	2.8	2.9	30.2	14.8	8.0	8.9	9.6	8.4	7.4	7.5	8.0	0.0	2.4	14.7	8.4	191.8	56.0	4.0	9.8	5.7	41.3	14.8	19.0	14.1	46.9	9.9	8.5	3.3	492.4	18.9	5.1	15.2	3.8	11.4	11.4	7.6	98.2	6.7	8.0	11.3	4.1	41.0	163.7	4.7	7.2	41.0	16.0	24.4	60.4	2.2	13.4	6.6	2.7	14.3	0.3	6.4	50.9	6.9	10.8	5.7	1.1	4.4	0.0	3.2	10.5	2.9	9.9	8.1	15.3	518.3	10.7	8.2	5.5	2.1
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.8	2.4	3.1	6.1	2.4	24.6	2.6	5.2	3.4	3.3	6.6	4.9	4.4	2.3	1.9	6.2	2.5	2.4	2.3	3.3	4.4	3.6	4.0	7.3	7.2	2.9	3.4	1.5	5.7	1.7	6.2	15.7	2.9	4.6	4.0	18.7	3.8	1.7	3.4	3.2	7.0	1.6	2.3	9.5	7.1	22.1	3.7	6.0	3.8	2.2	6.3	3.2	3.9	2.8	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	3.1	2.4	5.2	3.4	3.3	4.4	2.9	3.4	2.9	2.3	3.7	2.8	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 486.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	11.3	10.9	9.6	14.1	11.2	33.0	13.5	12.8	13.0	15.0	7.8	10.2	8.1	15.9	14.4	9.8	10.9	13.2	7.4	8.4	9.5	10.6	11.9	12.0	21.0	10.4	10.5	17.2	11.4	13.6	10.9	12.7	10.8	14.3	9.1	14.6	11.5	10.8	9.0	9.0	10.3	10.2	9.9	18.4	13.2	17.1	9.6	21.4	16.9	9.8	17.0	12.9	10.6	13.0	15.8	10.5	18.0	16.5	15.3	15.5	17.5	17.6	15.1	11.3	10.9	12.2	16.9	18.1	19.9	12.0	8.7	13.4	16.4	7.4	17.8	23.5	17.3	14.7	14.7	10.9	11.9	15.8	21.0	10.8	10.4	13.5	12.7	16.1	18.2	11.4	19.3	25.4	11.9	7.5	21.9	15.3	18.9	12.1	8.2	9.4	13.4	15.3	14.1	13.2	15.9	22.4	22.1	20.3	18.3	6.2	19.1	27.4	21.6	14.4	11.5	18.2	17.7	25.1	22.1	18.2	9.8	11.9	19.4	61.7	13.7	41.1	29.9	15.0	27.5	32.2	31.6	26.0	13.8	34.0	31.2	26.7	72.5	33.8	25.6	23.6	28.3	12.6	9.6	11.2	12.8	13.0	8.4	9.5	10.4	10.5	10.8	9.9	9.6	13.0	156.8	102.5	106.8	107.7	150.1	124.3	83.8	61.2	103.0	125.5	86.2	78.5	77.4	47.1	91.7	31.3	120.9	64.0	218.9	47.9	19.6	76.4	334.7	119.3	127.9	128.9	90.1	45.2	157.0	47.9	70.2	101.6	59.1	169.2	110.1	78.0	67.8	27.6	44.4	112.7	158.4	53.2	65.1	61.2	127.6	486.5	101.2	97.3	83.6	107.7	122.8	67.7	204.9	144.8	304.2	68.6	57.3	77.5	104.1	108.7	48.3	20.6	82.3	150.7	46.0	130.2	121.4	236.7	161.9	66.5	106.4	156.7	209.8	84.8	44.7	149.6
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474330-72602987	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.8;testis: 42.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003295	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003295: AB_1845017"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	8.5	7.9	2.5	10.1	3.9	16.5	6.0	7.0	5.8	6.4	7.1	8.2	9.5	7.5	3.2	6.8	5.4	4.4	11.4	4.4	4.0	5.2	6.2	7.3	4.9	3.4	2.7	9.0	6.6	3.9	5.9	6.5	3.6	5.8	3.3	10.4	4.3	4.8	47.8	7.6	7.4	6.3	3.0	6.0	6.3	42.5	3.8	3.9	5.0	8.5	4.1	7.6	6.5	4.3	17.6	18.0	17.5	10.2	8.9	6.2	20.6	19.3	7.0	8.6	5.9	18.3	14.6	17.2	28.4	8.3	30.3	24.8	18.1	10.1	4.8	30.6	12.4	13.0	22.5	12.4	6.3	19.6	14.4	7.4	3.4	9.5	12.2	8.2	6.4	12.4	13.8	19.7	8.5	11.5	18.9	7.5	18.9	6.3	6.5	21.4	21.3	9.8	4.8	29.0	16.3	18.4	25.1	11.2	31.4	23.0	9.0	22.0	16.7	14.1	19.6	54.8	27.4	20.7	45.2	20.6	9.2	17.5	15.2	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.3	0.3	0.2	0.6	0.4	0.4	1.0	0.6	0.2	0.3	0.8	0.1	2.5	3.9	7.0	5.8	4.4	4.0	3.4	2.7	3.6	3.0	3.8	4.3	79.5	19.2	37.7	88.5	64.0	66.3	52.7	13.3	76.2	63.3	74.9	53.3	46.9	30.0	25.7	18.4	91.8	18.4	83.3	32.9	3.9	18.4	110.3	108.7	84.8	50.7	46.5	24.8	141.6	18.9	21.8	43.3	63.7	148.4	43.2	43.7	40.0	28.5	19.0	62.2	152.0	31.2	8.2	30.5	42.1	55.4	28.6	67.5	16.0	104.0	24.2	25.7	27.8	129.7	135.1	24.7	19.1	27.4	60.9	55.8	20.8	13.9	33.0	58.8	19.7	96.8	59.9	45.3	32.1	68.8	59.8	40.8	68.3	36.8	27.0	63.7
ARL1	ARFL1	ENSG00000120805	"ADP ribosylation factor like GTPase 1"	P40616	12	101393116-101407772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062656, HPA073012"	Approved		Supported	"Golgi apparatus"		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA062656: AB_2684821, HPA073012: AB_2686564"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.41e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.46e-2)"	46.4	66.0	25.3	40.0	27.0	16.5	62.5	26.6	31.6	86.5	41.8	56.6	48.0	51.3	71.2	49.1	50.1	43.6	65.5	27.1	33.6	76.6	68.6	36.6	33.2	30.1	29.3	65.2	44.6	92.6	59.1	51.5	31.9	73.4	60.5	48.7	73.9	69.1	51.9	27.8	43.2	59.7	28.5	28.9	57.5	32.8	28.0	32.8	84.7	56.7	48.7	53.0	35.9	27.7	64.9	61.2	58.8	51.6	162.0	161.5	77.8	129.2	155.2	85.9	81.9	71.4	46.9	58.4	77.3	150.7	76.4	44.3	67.1	88.6	98.0	47.0	51.5	54.9	32.9	110.7	120.2	63.7	40.2	97.7	77.1	85.6	135.7	146.1	93.1	39.7	74.1	33.5	113.3	76.1	55.4	63.4	56.6	93.9	82.5	40.8	58.8	67.1	130.5	128.6	38.8	25.5	62.1	80.5	104.2	82.6	136.0	43.5	70.4	65.1	37.3	88.5	56.4	55.5	59.5	58.9	93.3	47.4	71.5	50.4	25.3	18.2	21.8	30.7	32.5	30.1	25.8	28.4	32.8	28.8	25.6	20.1	2.5	23.7	34.2	39.6	34.1	24.6	25.3	27.0	26.6	31.6	27.1	33.6	30.1	29.3	31.9	28.5	28.0	27.7	57.0	41.7	46.7	13.4	39.4	51.2	71.4	175.5	38.7	42.1	65.1	64.4	75.2	41.5	119.1	69.9	18.8	102.6	30.5	42.3	125.2	97.0	90.2	54.8	68.4	44.6	47.5	24.6	14.5	64.3	119.4	88.4	36.2	60.6	37.4	37.4	36.8	50.2	65.8	32.0	19.5	125.6	75.3	27.7	31.9	31.8	78.6	31.6	55.2	6.5	39.6	81.9	25.7	12.5	15.8	62.1	52.2	71.1	79.3	117.2	70.4	131.3	100.0	48.9	46.0	51.2	75.7	134.6	86.1	46.2	55.4	135.3	28.8	54.6	65.7	100.1
ARL10	ARL10A	ENSG00000175414	"ADP ribosylation factor like GTPase 10"	Q8N8L6	5	176365487-176401865	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.0;Oligodendrocyte precursor cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047044	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA047044: AB_2679915"	"unprognostic (2.50e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.33e-2)"	3.1	1.5	5.5	2.4	5.9	4.1	2.7	7.0	7.1	6.4	1.3	5.7	1.2	4.6	2.8	4.4	3.4	3.6	4.3	5.2	6.0	2.5	1.3	2.5	3.1	2.1	2.4	7.5	1.9	2.2	3.9	3.0	2.3	3.9	1.2	5.3	1.9	3.0	6.7	14.2	3.2	3.3	0.6	2.8	2.5	2.0	8.5	1.8	1.8	1.8	2.3	4.5	5.2	4.7	0.4	0.1	13.5	6.3	7.1	8.6	0.7	4.0	1.7	5.4	5.7	0.4	1.0	1.4	0.8	7.1	0.3	9.0	0.1	1.1	8.1	0.1	5.5	1.2	13.1	1.4	4.3	0.2	1.6	5.1	0.5	7.0	0.0	2.9	9.0	2.6	0.4	1.3	7.3	8.4	2.4	0.3	2.4	1.0	1.5	4.0	3.3	2.6	3.3	4.7	12.5	13.3	3.2	1.8	2.6	5.9	0.4	1.6	6.9	5.1	4.2	3.7	0.7	0.5	3.7	0.4	4.1	0.2	1.7	0.2	0.0	0.0	0.3	0.1	0.5	1.6	1.1	0.7	0.1	1.2	0.7	0.7	0.2	1.5	0.1	0.6	0.5	0.1	5.5	5.9	7.0	7.1	5.2	6.0	2.1	2.4	2.3	0.6	8.5	4.7	2.7	3.2	22.0	15.0	4.5	4.0	4.3	3.8	2.8	13.1	2.1	2.0	11.1	1.5	7.1	7.3	6.2	0.5	1.0	0.6	0.0	2.0	0.8	1.2	8.7	5.6	0.0	0.0	17.5	0.2	0.7	8.5	2.0	2.4	17.1	11.7	4.2	0.6	1.2	20.2	18.2	0.4	4.1	1.9	3.1	0.5	6.5	2.9	3.6	7.5	0.9	3.6	6.2	26.2	20.3	0.9	0.0	7.2	2.9	6.5	0.4	2.0	5.5	4.5	0.0	8.1	7.6	1.5	1.1	6.2	7.5	0.4	3.9	1.9	0.3	2.9
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628507-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 38.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Intermediate filaments, Cytosol"		"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	0.8	0.8	0.5	3.9	0.5	3.5	0.7	0.6	0.7	0.6	0.8	1.0	1.2	0.2	0.2	1.0	0.3	1.1	0.4	0.4	0.6	0.1	0.6	2.2	6.9	1.0	0.7	0.2	0.1	0.3	0.3	1.9	0.8	0.2	1.5	0.1	0.6	0.2	0.3	0.6	1.9	0.7	0.7	4.8	0.6	0.3	1.0	3.7	0.4	0.4	3.9	1.3	0.8	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	0.0	5.2	10.7	0.1	0.1	0.0	0.0	0.0	0.4	5.1	0.3	0.1	0.0	1.3	4.9	11.1	0.1	0.0	0.0	5.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	3.5	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.6	0.0	6.3	0.0	21.8	15.3	16.3	0.1	17.9	0.2	7.9	0.3	0.3	8.1	10.1	0.8	0.4	38.0	0.8	13.4	8.6	0.3	4.4	0.5	0.5	0.6	0.7	0.4	0.6	1.0	0.7	0.8	0.7	1.0	1.2	0.9	0.0	1.1	0.0	18.2	0.3	0.3	0.2	1.2	0.7	1.0	0.9	0.6	2.8	0.0	0.0	0.0	4.7	3.4	1.7	0.0	0.0	1.7	0.1	0.1	1.2	1.2	6.9	0.0	0.0	5.1	0.3	0.0	0.1	7.6	0.0	1.8	0.6	31.3	0.0	0.0	3.4	0.0	34.8	3.5	1.3	0.3	18.2	0.0	3.7	19.2	0.3	1.0	0.0	0.1	0.1	10.2	0.0	2.9	0.1	4.2	0.1	2.3	0.5	0.0	0.3	0.2	1.5	0.3	4.1	0.0	1.5	1.2	0.5	3.1	0.4
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 5.1"	"Group enriched"	"Detected in some"	29	"Early spermatids: 69.8;Late spermatids: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037377, HPA037378"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA037377: AB_2675442, HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.1	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	55.5	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARL13B	"ARL2L1, DKFZp761H079, JBTS8"	ENSG00000169379	"ADP ribosylation factor like GTPase 13B"	Q3SXY8	3	93980139-94055678	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 18.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Rod photoreceptor cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048926	Approved		Uncertain	Microtubules,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Cytosol	"HPA048926: AB_2680559"	"unprognostic (2.29e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.50e-2)"	3.4	2.5	1.3	2.9	1.6	0.8	2.3	1.2	2.5	4.1	8.7	1.9	0.8	4.6	1.0	3.3	4.1	4.0	2.0	1.2	1.1	3.6	2.6	4.1	2.1	1.5	1.8	3.2	1.5	3.6	2.0	2.7	1.6	2.0	1.4	18.2	1.5	2.6	0.7	1.4	1.9	4.2	1.5	2.9	1.6	3.5	1.2	2.5	4.3	1.7	1.7	3.1	1.7	2.0	8.3	12.5	7.9	4.3	13.3	3.5	3.6	7.8	4.8	11.8	15.9	8.0	4.4	5.9	11.3	6.9	7.1	5.1	7.2	5.3	16.2	10.5	6.4	12.7	5.6	5.4	6.0	15.2	6.9	5.2	2.1	12.3	19.0	4.5	4.0	8.7	12.5	7.3	6.7	3.1	12.3	1.2	2.9	4.3	7.5	7.2	25.8	2.0	5.7	1.2	18.0	4.6	15.9	0.9	9.4	2.9	2.1	3.5	7.7	11.6	11.0	6.8	9.6	1.8	2.0	11.7	8.5	8.8	8.5	6.4	3.4	2.9	3.7	4.2	3.8	3.9	3.3	3.0	3.0	3.4	3.3	3.1	2.0	4.3	4.8	4.8	2.9	1.8	1.3	1.6	1.2	2.5	1.2	1.1	1.5	1.8	1.6	1.5	1.2	2.0	27.2	93.0	39.6	31.6	11.3	46.8	28.1	8.6	10.2	19.0	11.0	16.8	8.1	12.8	19.7	1.8	41.7	1.9	7.1	1.3	15.6	17.1	14.8	30.1	25.2	31.7	22.1	6.5	58.4	11.8	6.3	48.5	10.2	11.2	45.6	9.2	17.5	7.7	12.1	15.2	41.5	3.1	12.2	7.0	21.6	6.4	23.9	10.7	16.0	38.4	6.0	26.9	6.2	29.7	49.8	11.4	3.8	25.6	8.0	13.9	1.8	18.7	71.9	102.0	6.6	59.4	33.8	43.1	14.5	12.7	58.7	0.8	13.2	16.5	3.1	10.6
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323104-30338223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	13.9	22.5	13.5	13.2	15.6	8.0	20.0	15.9	17.3	17.0	14.9	11.8	9.5	18.9	23.2	11.6	16.4	13.1	22.9	15.7	14.2	17.4	19.7	10.9	22.5	12.4	13.3	20.5	12.9	26.1	12.0	11.5	12.1	19.7	10.8	15.9	19.1	19.9	20.6	12.6	9.7	14.5	13.9	20.8	15.7	14.6	13.3	15.6	24.7	20.8	21.4	14.5	8.1	13.8	10.8	15.4	16.9	14.8	27.1	29.2	8.5	20.8	26.0	18.4	20.2	8.5	4.1	43.8	13.9	15.0	20.5	17.8	24.8	17.5	25.9	35.2	30.7	13.3	12.0	15.0	42.6	24.0	14.7	30.5	34.7	8.7	32.8	26.7	20.6	17.9	21.4	23.2	32.5	10.4	21.9	19.6	19.6	24.1	21.3	18.8	41.2	18.0	24.7	14.8	19.2	20.4	16.2	21.4	25.8	15.0	22.8	13.4	18.1	20.8	11.2	41.7	20.1	36.0	21.9	28.5	20.0	14.8	20.4	12.7	19.2	6.4	23.3	20.0	55.5	35.9	28.2	25.9	26.3	28.9	25.7	25.0	3.5	52.9	15.5	18.9	20.3	23.1	13.5	15.6	15.9	17.3	15.7	14.2	12.4	13.3	12.1	13.9	13.3	13.8	27.3	28.9	33.6	14.4	39.7	12.4	46.6	35.1	8.0	34.0	19.9	30.4	68.1	24.3	23.8	25.8	14.6	19.1	29.2	5.9	76.3	27.3	130.1	25.8	41.0	29.2	14.5	13.2	31.1	22.5	12.7	33.4	12.8	19.0	27.8	33.5	15.4	29.8	25.7	32.0	26.4	11.7	32.6	27.1	29.3	66.3	27.4	28.4	26.6	18.7	45.4	36.1	38.1	27.6	19.9	21.9	8.4	25.2	25.4	46.0	9.4	42.1	27.5	32.4	13.1	33.1	29.8	111.4	37.6	13.8	11.1	11.1	29.6	33.0	12.6	28.4
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883942-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 441.6;Inhibitory neurons: 285.2;Microglial cells: 408.5;Oligodendrocyte precursor cells: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: AB_2685131"	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	14.0	12.5	6.6	5.6	7.5	1.9	13.0	5.6	10.0	17.7	7.2	10.6	11.9	16.0	7.6	9.8	8.2	14.5	14.0	8.5	7.1	17.9	9.8	7.6	6.3	5.8	6.2	5.7	5.0	3.2	8.5	22.3	6.0	10.0	10.9	7.6	10.5	6.8	3.3	11.3	9.9	16.6	6.1	8.2	8.3	9.3	6.8	10.6	8.4	11.7	8.0	13.6	8.8	6.2	3.2	5.5	8.5	15.6	7.0	7.8	11.8	10.2	15.1	9.4	20.7	21.1	8.0	32.0	14.9	9.1	11.0	7.7	13.2	14.1	12.4	3.2	13.9	36.9	7.1	2.8	2.5	4.5	43.8	10.0	10.1	15.8	9.5	14.2	20.8	7.0	32.4	5.3	6.5	7.7	7.5	4.3	3.0	1.6	3.9	6.2	10.4	0.8	12.8	30.3	11.3	7.1	13.1	6.7	7.9	15.6	8.6	4.7	11.4	5.7	9.6	5.4	6.7	1.8	1.7	34.8	9.9	10.6	9.5	1.1	1.8	2.2	1.3	1.4	0.7	1.0	0.9	0.9	2.4	0.7	0.9	0.7	3.5	0.7	1.2	0.3	2.3	1.2	6.6	7.5	5.6	10.0	8.5	7.1	5.8	6.2	6.0	6.1	6.8	6.2	44.5	3.2	7.7	33.6	6.5	9.7	7.9	5.8	8.0	5.1	4.8	5.8	7.5	5.7	4.5	12.9	14.6	52.5	5.2	7.5	21.5	3.2	3.4	4.1	6.9	35.1	20.9	8.6	441.6	4.9	4.9	8.5	6.6	5.1	2.5	3.2	26.0	4.9	8.4	1.7	285.2	7.6	18.3	8.7	8.7	1.5	4.4	12.5	1.8	408.5	5.0	3.2	6.2	184.5	104.7	6.9	7.6	3.8	4.7	5.4	5.7	10.0	3.9	3.0	6.6	3.6	5.3	1.0	3.5	5.9	10.1	42.7	8.9	24.4	7.1	8.4
ARL16		ENSG00000214087	"ADP ribosylation factor like GTPase 16"		17	81681187-81683797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043711	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043711: AB_10964639"	"unprognostic (1.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	27.1	23.6	23.2	7.5	24.9	13.2	26.7	23.3	27.2	28.7	20.9	27.7	8.4	25.3	17.9	22.0	23.2	13.4	23.2	25.5	22.4	39.4	20.1	18.3	13.5	22.0	22.2	27.2	22.0	18.2	18.9	17.8	21.9	25.7	8.3	13.8	21.0	14.2	23.6	24.6	16.9	11.1	23.5	19.1	21.9	25.3	22.7	16.2	22.6	18.9	10.8	26.6	24.7	24.1	23.2	36.0	39.6	46.4	18.7	24.3	22.6	46.3	43.3	55.0	42.5	42.9	23.7	22.4	28.5	43.1	39.7	21.3	32.6	33.9	32.6	19.9	58.0	24.9	29.5	20.0	52.7	54.8	18.9	29.5	19.1	42.0	40.8	39.8	35.2	28.6	19.7	19.2	36.3	21.5	52.0	57.5	32.4	27.7	43.4	57.7	37.6	15.2	40.2	30.1	71.5	72.5	30.5	18.5	48.5	33.0	24.9	49.2	40.2	74.9	38.5	40.4	56.1	28.0	12.8	43.7	44.7	29.5	42.3	41.8	27.0	27.6	21.1	25.3	25.8	43.2	19.9	19.5	23.4	52.4	31.9	24.2	15.1	41.9	21.3	32.1	20.3	22.5	23.2	24.9	23.3	27.2	25.5	22.4	22.0	22.2	21.9	23.5	22.7	24.1	39.1	25.6	30.9	6.2	32.7	37.7	28.7	64.2	36.5	37.1	47.9	61.1	20.1	38.6	48.4	44.1	31.3	64.6	41.8	49.2	60.7	48.4	10.4	44.0	31.1	35.4	36.1	21.5	13.4	44.5	47.5	38.5	60.1	35.1	21.5	44.2	29.3	21.2	35.0	21.9	10.6	37.5	42.7	20.0	34.9	8.8	40.7	26.1	33.8	7.5	41.1	43.3	43.3	14.1	11.3	43.9	39.7	44.0	29.4	38.8	60.7	86.1	40.9	38.9	52.6	22.4	41.7	66.5	50.3	34.7	34.7	38.6	33.8	54.7	45.4	31.4
ARL17A	"ARF1P2, ARL17P1"	ENSG00000185829	"ADP ribosylation factor like GTPase 17A"	Q8IVW1	17	46516702-46579691	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 54.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA046814	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA046814: AB_2679821"	"unprognostic (8.57e-4)"	"unprognostic (7.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.57e-5)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-2)"	7.6	7.0	4.1	8.1	4.6	8.1	8.8	15.3	6.9	15.0	4.8	9.9	3.6	9.6	10.2	8.8	11.5	3.2	7.5	5.3	4.9	7.2	5.8	9.1	9.5	4.7	4.3	12.8	9.5	6.5	13.4	4.0	5.8	11.5	6.7	14.7	11.4	4.9	10.5	11.2	9.4	6.2	2.2	9.8	9.1	7.1	6.5	5.7	11.7	3.5	7.3	9.5	12.0	8.1	4.6	5.4	9.5	8.2	3.8	4.6	4.2	5.8	2.1	2.8	3.6	12.5	6.9	16.3	4.1	2.7	9.1	7.0	5.1	3.7	5.9	13.8	17.5	5.5	23.0	10.3	2.4	8.5	6.1	4.1	7.1	3.7	4.9	6.0	5.4	10.3	7.2	8.9	5.0	1.9	10.5	10.1	4.2	2.0	3.4	14.7	14.1	4.3	3.2	6.8	7.1	4.6	4.1	2.0	1.8	5.4	12.2	7.4	9.3	16.2	8.6	5.2	4.2	10.9	14.8	5.4	4.1	9.9	5.5	4.1	1.6	1.2	3.1	1.2	1.8	2.4	2.2	2.6	1.4	3.4	2.2	2.8	1.4	3.0	1.6	3.2	2.1	0.7	4.1	4.6	15.3	6.9	5.3	4.9	4.7	4.3	5.8	2.2	6.5	8.1	5.8	22.4	11.8	17.6	10.7	6.0	8.7	9.7	8.0	19.1	7.3	5.5	8.3	4.3	8.1	16.5	54.2	6.4	11.1	5.3	9.8	6.7	8.6	4.2	7.6	5.8	6.7	2.1	24.5	2.6	4.2	6.5	2.6	5.3	6.3	15.2	9.7	4.3	6.4	15.2	26.5	7.9	10.2	9.0	6.9	5.4	13.1	6.0	3.6	14.0	14.2	5.9	2.1	29.7	36.4	3.2	4.6	9.1	3.5	4.9	5.6	6.3	10.6	30.3	13.1	11.1	7.0	12.2	6.1	2.9	8.4	3.6	9.6	9.4	9.1	7.5
ARL17B	ARL17	ENSG00000228696	"ADP ribosylation factor like GTPase 17B"	Q8IVW1	17	46274784-46361797	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 63.3;Excitatory neurons: 107.1;Inhibitory neurons: 96.0;Microglial cells: 62.8;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 54.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.4;U-266/84: 21.2"									HPA046814	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA046814: AB_2679821"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.83e-2)"	3.9	5.5	3.8	4.1	4.3	5.7	5.2	12.1	5.2	5.7	3.3	6.1	0.6	5.8	2.8	5.1	4.5	0.9	4.6	4.4	3.5	3.3	4.2	3.5	4.7	3.8	3.4	5.9	3.8	4.4	4.4	1.7	4.0	4.8	3.5	9.2	3.8	2.8	7.4	5.4	3.5	4.7	2.4	3.4	4.0	4.5	4.5	4.3	5.3	5.9	4.0	5.1	4.7	5.9	2.3	0.6	6.4	2.5	2.2	1.4	0.9	2.1	1.0	0.9	2.3	10.2	3.1	14.3	1.6	0.7	13.4	0.9	2.2	0.2	1.6	7.2	16.7	1.9	18.4	10.9	2.9	3.1	1.5	0.8	6.4	1.4	0.7	1.9	3.4	5.4	1.0	3.1	6.3	1.0	2.8	2.8	3.5	0.6	1.0	8.2	11.6	5.4	0.2	5.0	2.5	1.4	2.3	1.5	0.3	2.6	2.0	9.6	6.5	8.9	10.1	1.5	1.4	10.2	21.2	1.3	2.2	7.6	3.3	17.3	4.7	1.5	4.3	2.3	3.6	4.5	5.3	4.8	3.5	8.9	7.1	6.9	2.9	6.8	2.5	7.7	3.2	2.7	3.8	4.3	12.1	5.2	4.4	3.5	3.8	3.4	4.0	2.4	4.5	5.9	4.6	6.4	2.2	63.3	4.6	5.0	2.2	3.7	0.6	7.8	3.9	3.9	4.8	1.5	4.9	3.7	10.4	2.9	4.5	1.3	3.9	1.8	4.3	3.9	6.4	3.5	3.5	0.8	107.1	2.9	1.6	4.4	0.5	3.5	3.8	8.9	2.5	0.6	1.6	8.4	96.0	1.0	4.1	2.2	4.0	3.6	5.0	2.7	3.6	62.8	3.8	4.5	4.1	56.3	54.2	1.6	0.5	6.0	1.5	2.8	1.2	1.7	4.1	12.6	19.7	4.3	4.7	9.5	4.4	0.6	4.0	0.8	4.0	4.4	1.9	11.2
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014160-65022184	"FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	124.8	93.7	161.5	40.6	190.2	51.3	112.0	172.4	200.2	106.3	132.3	123.1	52.7	121.2	28.2	67.2	94.6	48.0	169.1	157.0	168.7	138.5	22.5	90.4	37.7	171.5	167.9	95.7	75.3	65.3	68.5	56.1	167.2	84.7	32.9	43.5	67.9	66.6	214.2	95.8	73.4	60.9	171.4	63.4	85.2	116.1	167.4	33.5	85.7	158.1	29.0	112.2	93.5	184.4	162.0	257.0	76.5	115.8	207.4	156.5	70.5	82.5	181.7	111.2	109.1	72.8	110.0	62.1	144.5	112.7	168.1	101.4	82.9	140.0	53.1	65.5	130.6	61.9	109.2	111.9	157.8	77.9	54.9	123.7	114.6	92.6	204.4	160.5	150.4	74.0	152.8	110.1	76.4	194.1	63.1	174.5	120.3	77.7	208.6	33.4	81.6	152.9	120.9	70.6	143.3	79.3	66.4	67.6	225.8	74.4	72.3	94.3	109.2	205.9	68.6	164.7	82.1	37.9	57.6	38.5	97.2	112.5	171.3	46.5	78.2	72.5	120.4	80.2	130.9	163.1	110.0	116.9	101.7	149.0	123.5	137.2	10.2	83.3	48.2	140.1	79.0	136.9	161.5	190.2	172.4	200.2	157.0	168.7	171.5	167.9	167.2	171.4	167.4	184.4	179.1	22.4	43.6	0.0	42.7	81.4	94.4	118.4	63.7	70.2	66.8	83.9	103.2	51.5	66.4	82.8	29.2	179.7	40.0	110.0	268.0	142.0	430.8	42.2	59.0	148.0	83.3	69.4	0.0	76.0	193.5	107.0	29.6	50.7	95.7	71.5	137.4	19.7	98.3	69.0	0.0	68.4	83.4	49.7	73.5	1125.1	71.7	49.5	177.9	0.0	100.6	208.4	55.6	0.0	0.0	68.3	115.7	71.1	16.5	79.9	162.4	505.5	47.0	48.9	65.7	74.2	109.7	126.5	79.4	56.3	82.8	107.3	40.0	65.7	98.0	75.9
ARL2BP	"BART, BART1, RP66"	ENSG00000102931	"ADP ribosylation factor like GTPase 2 binding protein"	Q9Y2Y0	16	57245259-57253635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 264.6;Late spermatids: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043066, HPA048440"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043066: AB_2678302, HPA048440: AB_2680393"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.78e-2)"	48.5	42.6	49.8	30.1	51.6	35.7	37.4	51.1	58.1	35.5	51.9	36.0	20.8	45.0	34.8	49.6	44.1	36.2	54.4	51.5	52.2	44.0	32.7	44.5	37.7	50.1	51.9	50.6	29.6	48.0	27.6	37.4	51.6	34.9	36.0	37.2	25.4	46.0	31.8	31.3	24.8	59.3	51.1	49.4	27.5	57.1	51.6	44.8	29.9	46.1	46.3	39.9	29.9	52.1	74.2	49.4	93.3	48.7	82.6	106.0	23.2	91.2	105.4	104.2	65.9	37.4	28.9	61.9	104.0	126.3	48.8	48.5	60.3	74.0	97.8	28.5	57.8	54.9	36.3	64.2	112.3	50.8	113.6	91.6	94.8	75.4	103.3	77.4	127.5	46.7	42.5	23.3	73.0	28.7	52.3	63.9	32.7	25.7	98.7	71.3	91.7	120.8	113.8	26.4	29.2	61.1	140.1	66.1	82.8	58.1	48.8	66.6	114.6	61.2	37.8	53.3	70.8	58.8	49.6	58.9	79.8	33.2	60.2	35.5	46.1	27.3	40.5	45.3	42.3	37.6	36.7	44.1	56.5	29.8	49.5	42.0	7.6	63.6	51.3	16.3	33.7	55.1	49.8	51.6	51.1	58.1	51.5	52.2	50.1	51.9	51.6	51.1	51.6	52.1	60.3	51.3	27.4	9.8	47.0	36.7	43.3	57.0	42.7	44.4	30.6	27.8	0.2	40.0	28.7	36.8	4.2	51.0	50.5	23.4	76.3	46.2	264.6	49.2	57.8	63.7	26.4	105.7	20.6	58.0	30.2	66.6	30.1	58.7	74.3	105.7	62.8	34.3	63.3	55.5	22.5	21.5	46.8	52.8	36.5	503.7	82.3	42.2	48.0	7.5	71.2	66.0	66.9	42.7	33.9	44.6	18.5	109.1	50.3	24.0	23.2	65.8	32.9	38.0	13.1	39.7	45.5	122.2	51.8	66.8	37.1	22.3	60.8	170.2	23.6	22.6
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 96.3"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 289.1;Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.1	8.9	20.2	4.2	21.3	1.7	8.1	20.8	25.1	12.4	19.1	11.3	4.2	11.5	10.6	4.6	15.2	5.2	13.5	20.8	19.5	15.4	5.2	8.3	3.6	19.3	19.1	16.8	6.4	19.8	21.0	4.9	19.7	8.7	4.6	96.3	6.3	9.0	5.6	7.2	6.1	8.7	18.5	4.5	8.8	11.0	20.5	5.7	11.4	5.9	4.7	9.8	8.3	19.5	14.7	25.0	33.6	24.7	15.2	22.7	5.9	11.4	17.3	13.6	14.7	8.7	7.4	6.1	10.8	18.5	16.4	10.7	12.7	15.3	16.9	16.1	13.4	9.9	16.9	8.3	16.4	4.6	9.5	11.5	12.6	18.8	11.0	36.1	15.8	12.0	4.5	6.0	23.0	15.1	9.5	7.3	13.0	9.2	9.8	7.9	24.8	5.4	18.1	7.7	11.8	25.7	8.7	1.8	14.1	18.5	45.1	4.6	9.1	9.2	12.9	18.9	16.0	4.2	8.9	11.3	24.4	13.6	8.1	2.0	7.2	2.6	3.7	6.1	9.4	4.5	6.5	5.5	7.1	3.9	3.9	4.7	13.4	4.4	5.4	5.2	4.9	5.4	20.2	21.3	20.8	25.1	20.8	19.5	19.3	19.1	19.7	18.5	20.5	19.5	46.0	54.5	39.3	47.7	16.7	32.1	70.4	144.3	29.0	167.6	48.2	57.5	135.5	31.5	85.8	62.5	116.7	45.5	12.1	9.4	234.8	70.7	46.5	250.5	85.2	41.6	74.8	9.4	30.8	43.6	37.8	61.7	19.4	84.6	33.0	94.1	43.9	25.5	64.7	97.6	37.6	31.6	73.2	16.4	33.6	25.8	60.6	26.8	76.5	13.1	67.3	289.1	13.4	31.7	23.4	31.1	13.5	104.2	18.6	54.2	23.1	225.8	268.3	318.6	26.3	50.8	122.0	145.6	43.4	11.9	31.7	32.3	20.8	58.6	25.4	50.5
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497081	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	15.1	10.6	15.4	31.7	14.6	65.0	17.3	17.8	18.6	11.4	45.3	9.1	6.6	5.8	9.5	23.2	11.9	31.8	5.1	13.1	21.9	12.2	12.8	16.1	55.3	21.9	17.1	2.1	5.5	10.8	7.4	16.5	21.3	10.3	11.2	9.7	21.6	5.4	1.5	24.1	13.2	5.9	12.8	51.0	13.6	1.2	18.5	74.0	3.7	1.7	32.1	25.5	18.0	13.8	32.3	97.4	12.0	1.6	10.4	3.0	31.6	3.2	13.8	3.8	6.6	45.4	60.4	0.1	8.0	7.7	109.0	23.5	12.0	66.4	4.1	30.4	4.2	0.0	0.6	0.6	10.7	0.1	2.8	6.4	42.2	36.6	21.2	149.4	6.4	78.4	0.4	102.4	16.4	4.4	93.7	0.3	12.6	22.5	21.9	0.3	54.1	18.0	284.8	35.2	44.1	8.1	1.1	7.1	4.7	18.2	0.9	1.9	14.8	60.0	23.2	168.2	61.6	51.1	19.7	1.6	101.9	0.1	32.0	79.8	1.2	27.4	86.7	1.6	85.6	18.1	60.0	69.5	10.3	18.3	53.5	59.1	2.2	61.2	0.9	55.2	83.8	30.0	15.4	14.6	17.8	18.6	13.1	21.9	21.9	17.1	21.3	12.8	18.5	13.8	12.3	73.7	15.9	8.8	63.6	124.8	120.7	18.4	145.1	156.6	40.4	64.6	10.9	67.2	27.0	14.7	8.4	30.0	610.9	2.3	0.0	19.6	7.8	73.9	19.2	23.4	1.8	6.1	15.5	5.7	5.4	23.7	19.9	186.3	27.8	1.1	11.0	3.4	31.4	107.7	103.0	2.5	0.0	208.4	474.5	6.5	0.3	182.1	42.7	6.5	41.8	32.2	437.7	6.0	2.5	16.5	0.1	0.0	132.6	60.4	0.1	0.9	4.7	13.1	0.0	7.0	19.3	0.7	1.9	65.4	42.9	14.6	349.8	0.4	1.2	46.6
ARL4D	ARF4L	ENSG00000175906	"ADP ribosylation factor like GTPase 4D"	P49703	17	43398993-43401137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 32.3;naive B-cell: 36.1"	"Lineage enriched"	"Detected in all"	4	"B-cells: 36.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;hTCEpi: 76.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4"	HPA060379	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	"Golgi apparatus"	"HPA060379: AB_2684269"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-2)"	"prognostic favorable (1.16e-5)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (9.25e-4)"	21.0	4.3	7.9	2.2	8.7	0.9	7.2	9.1	11.6	29.3	12.6	27.9	2.0	20.2	4.7	82.2	22.1	7.3	12.7	8.1	7.1	30.5	56.4	16.2	1.6	5.6	5.7	9.7	2.2	8.1	21.6	7.7	5.7	11.0	3.5	85.1	16.9	15.2	1.9	44.9	6.0	14.8	5.4	16.7	7.6	32.1	5.7	1.6	38.3	3.4	3.0	28.5	39.5	9.3	8.7	10.9	6.7	5.2	12.5	17.2	3.1	21.0	21.5	14.6	18.8	9.7	37.7	0.1	10.3	22.6	10.0	23.4	4.5	32.0	10.0	1.9	7.5	0.7	8.7	22.5	57.1	2.4	2.1	19.2	76.1	21.3	45.8	13.2	6.3	2.3	1.4	0.4	14.3	0.5	5.4	5.0	7.1	0.8	10.1	9.1	1.5	1.0	24.9	18.8	7.9	5.6	16.5	0.4	15.8	14.4	30.6	8.5	1.3	21.0	6.7	27.2	6.4	2.1	1.1	0.0	25.8	1.9	7.1	0.1	2.8	2.1	5.1	4.3	3.2	32.3	4.2	4.7	8.4	36.1	4.6	5.2	0.0	2.1	1.4	2.5	1.0	4.6	7.9	8.7	9.1	11.6	8.1	7.1	5.6	5.7	5.7	5.4	5.7	9.3	28.8	0.0	1.7	0.7	37.9	224.3	41.4	142.2	132.1	155.5	35.3	60.6	12.7	5.7	49.5	132.4	116.7	39.9	37.4	1.5	76.3	2.3	220.8	55.5	33.3	32.2	11.9	4.0	9.1	1.8	24.1	52.3	5.6	69.6	0.0	20.7	22.9	29.7	8.1	16.8	9.3	5.4	26.4	4.1	77.9	55.3	15.8	16.6	26.6	1.0	1.4	70.1	2.1	2.5	1.3	3.7	0.9	22.6	1.4	9.5	0.3	17.6	7.6	259.6	13.1	11.1	45.1	25.0	9.2	223.4	254.6	105.5	31.7	19.3	4.6	78.1
ARL5A	ARL5	ENSG00000162980	"ADP ribosylation factor like GTPase 5A"	Q9Y689	2	151788984-151828492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 88.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 88.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027002	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA027002: AB_10601685"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.59e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.55e-1)"	20.4	20.9	13.1	13.1	14.9	11.8	19.7	17.1	12.4	14.7	12.1	17.6	22.1	14.1	7.3	23.9	14.6	17.2	35.8	12.8	18.5	25.1	22.4	20.0	20.3	18.5	14.7	15.3	15.9	17.9	7.5	23.6	17.3	17.2	16.6	17.6	15.5	13.6	32.5	28.8	20.5	18.0	17.7	14.6	17.7	6.3	14.4	17.5	29.6	36.5	24.6	18.3	11.2	18.8	20.2	20.2	29.0	25.7	20.9	35.6	39.1	34.7	26.8	24.8	30.0	59.5	24.7	66.9	36.4	37.2	18.6	12.8	34.6	26.7	40.0	40.4	31.6	73.6	21.9	77.8	28.8	74.0	39.5	27.9	39.3	34.0	36.4	33.3	34.7	41.1	55.7	78.0	26.5	23.4	63.1	29.3	36.8	24.7	21.5	28.5	40.1	27.6	35.7	33.6	13.0	27.0	21.1	21.8	29.5	34.3	17.0	44.0	28.5	19.6	24.1	18.8	37.7	39.3	47.6	64.6	34.7	50.4	34.7	88.3	7.9	8.9	6.9	6.1	6.5	11.0	6.1	8.6	11.2	15.2	6.6	5.1	3.8	7.4	4.7	6.7	7.9	4.5	13.1	14.9	17.1	12.4	12.8	18.5	18.5	14.7	17.3	17.7	14.4	18.8	18.1	57.7	38.6	28.7	104.3	138.7	122.6	120.7	64.3	62.6	24.4	12.6	109.8	91.5	60.6	14.7	14.6	84.3	46.2	44.3	45.0	55.3	11.9	15.3	17.2	62.9	75.6	66.3	29.8	59.9	153.1	79.6	51.5	12.1	48.2	17.9	77.8	76.6	128.0	116.1	31.9	64.3	126.1	135.8	154.7	13.8	74.6	82.9	81.8	51.5	97.5	64.1	132.8	34.7	23.8	52.6	44.1	82.4	160.7	167.4	166.8	42.9	60.3	61.9	72.3	85.9	60.4	72.6	65.0	103.9	163.7	143.0	63.6	9.2	72.7	135.9
ARL5B	ARL8	ENSG00000165997	"ADP ribosylation factor like GTPase 5B"	Q96KC2	10	18659431-18681639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 314.7;Langerhans cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027002	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA027002: AB_10601685"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.86e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	11.1	20.8	3.2	7.8	3.5	19.6	6.5	6.0	5.6	8.1	4.5	7.5	9.3	9.3	3.7	8.5	4.7	14.1	6.8	3.6	4.0	5.7	29.8	9.7	7.1	3.4	3.9	7.9	9.0	6.1	6.8	13.1	3.6	6.3	8.4	5.7	7.2	3.6	4.3	6.6	10.0	6.7	4.0	5.6	6.4	5.7	3.9	13.5	8.2	6.2	7.1	12.6	5.9	4.3	14.8	8.1	36.5	14.2	10.4	11.9	22.1	12.5	6.0	11.8	19.9	26.7	12.4	18.3	5.0	6.5	7.6	14.2	25.5	9.1	15.0	5.9	19.5	18.4	9.5	38.2	26.7	8.8	10.3	11.9	12.4	11.3	12.3	11.5	18.7	13.8	23.7	19.0	9.4	7.0	21.1	6.4	25.2	15.4	3.5	26.1	23.8	12.0	10.5	12.7	4.7	30.4	9.6	10.0	17.9	27.9	5.9	10.1	12.7	6.7	20.5	12.9	10.6	10.1	13.8	24.9	6.7	7.3	6.2	1.2	0.7	0.5	0.5	0.8	0.7	0.5	0.5	0.6	0.9	0.5	0.8	0.6	0.9	1.0	0.5	0.5	0.7	0.5	3.2	3.5	6.0	5.6	3.6	4.0	3.4	3.9	3.6	4.0	3.9	4.3	70.1	38.5	26.0	10.4	36.1	152.3	76.0	42.9	122.9	9.9	84.3	50.4	16.7	21.5	36.9	9.2	6.2	26.7	53.5	96.8	5.9	25.9	74.5	117.1	52.1	54.5	65.4	16.4	12.4	15.8	39.1	44.9	72.9	314.7	101.1	26.6	15.7	44.8	13.4	10.1	12.1	65.2	14.2	25.3	304.3	15.8	6.8	94.1	58.7	12.2	8.0	9.1	7.2	19.1	14.7	20.8	81.6	5.7	49.0	63.8	58.5	8.1	34.5	7.4	6.6	41.9	50.8	27.8	15.5	134.6	167.1	43.2	47.1	21.5	43.5	153.1
ARL5C	ARL12	ENSG00000141748	"ADP ribosylation factor like GTPase 5C"	A6NH57	17	39156894-39167484	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"lymphoid tissue: 3.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 3.1;dendritic cells: 1.4;Microglial cells: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA069849	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 56: Bipolar cells - Visual perception"			"HPA069849: AB_2686213"	"unprognostic (2.57e-1)"				"unprognostic (2.34e-1)"								"unprognostic (1.60e-7)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ARL6	"BBS3, RP55"	ENSG00000113966	"ADP ribosylation factor like GTPase 6"	Q9H0F7	3	97764521-97801229	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 55.0;Inhibitory neurons: 51.5;Rod photoreceptor cells: 57.4;Spermatocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019361	Approved		Approved	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA019361: AB_1845028"	"unprognostic (1.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.88e-2)"	"unprognostic (5.55e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (9.49e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.97e-1)"	3.6	5.2	4.1	2.2	4.8	0.8	3.3	4.2	5.2	3.4	3.8	2.4	1.5	4.4	3.9	3.0	7.2	3.7	3.6	5.7	4.9	7.5	2.6	5.0	2.5	3.5	3.7	3.5	2.9	12.8	4.1	2.8	3.7	3.9	2.5	46.3	5.8	3.5	1.6	3.1	1.8	4.2	3.9	3.0	2.8	6.6	3.8	2.3	5.5	2.2	2.2	3.2	2.1	3.7	10.1	5.2	4.9	4.1	11.5	7.6	1.3	6.2	5.5	5.6	6.7	2.2	3.6	5.8	6.1	3.1	8.5	4.6	6.1	6.8	10.4	6.3	3.7	1.5	3.9	2.2	5.4	7.6	3.5	4.1	4.9	7.4	1.7	4.5	6.1	7.0	1.8	1.1	8.1	3.1	4.1	3.2	6.1	4.9	7.5	1.9	5.9	4.0	6.5	2.8	26.0	14.4	5.4	3.4	11.2	3.1	4.3	2.4	5.3	5.2	4.7	4.5	8.7	4.2	5.3	6.4	9.5	4.0	6.4	0.2	0.2	0.1	1.0	0.4	2.1	0.8	0.9	1.1	0.4	1.6	1.6	1.3	0.0	1.8	0.5	0.4	1.7	0.7	4.1	4.8	4.2	5.2	5.7	4.9	3.5	3.7	3.7	3.9	3.8	3.7	3.2	3.2	3.6	31.6	2.2	3.2	3.2	4.8	5.2	12.7	3.2	3.0	2.4	1.5	5.0	9.2	27.1	1.2	0.8	0.6	3.9	3.4	25.7	20.3	4.4	3.7	2.4	2.1	55.0	2.5	2.3	5.1	4.6	2.2	0.0	2.4	4.6	2.9	1.8	5.0	51.5	1.0	6.1	1.3	1.1	5.6	4.1	1.5	1.8	15.0	0.4	8.2	2.1	15.1	27.6	1.7	2.0	4.1	3.7	1.3	0.2	10.1	27.2	57.4	6.6	3.3	4.6	39.6	6.7	4.4	2.0	0.7	2.7	4.6	1.3	2.0
ARL6IP1	"AIP1, ARL6IP, ARMER, KIAA0069, SPG61"	ENSG00000170540	"ADP ribosylation factor like GTPase 6 interacting protein 1"	Q15041	16	18791669-18801572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (2.42e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.32e-3)"	"unprognostic (5.36e-3)"	142.0	171.3	206.4	77.7	217.3	209.7	112.9	200.6	282.2	79.2	182.4	140.9	138.8	70.8	122.9	70.0	86.6	131.9	32.1	227.7	209.2	150.1	359.6	79.6	132.6	192.0	197.8	101.6	81.7	180.6	40.7	90.3	200.0	75.9	123.4	316.0	84.3	70.4	23.1	66.1	123.4	69.1	185.0	72.8	125.8	129.9	200.5	158.5	112.5	51.5	113.4	132.5	47.4	197.6	375.3	334.6	417.8	331.6	146.7	93.5	373.2	208.9	196.9	311.0	246.7	205.7	851.1	315.7	388.4	198.0	209.2	388.9	303.7	144.2	359.1	421.2	137.1	227.9	192.5	549.1	116.4	329.9	232.0	78.6	137.7	216.2	224.0	229.1	316.1	180.5	251.0	318.5	607.6	331.4	229.9	238.3	520.0	311.7	109.8	387.9	535.9	266.0	337.8	206.1	255.2	287.5	466.5	279.8	204.5	280.1	576.1	315.9	189.2	204.2	192.9	147.1	384.1	109.5	209.5	383.2	182.8	215.6	405.5	211.4	125.2	84.2	179.4	119.5	167.0	163.2	159.0	199.1	127.4	160.7	137.9	166.4	105.9	179.2	133.3	221.6	281.5	295.0	206.4	217.3	200.6	282.2	227.7	209.2	192.0	197.8	200.0	185.0	200.5	197.6	306.4	67.3	51.0	56.8	170.6	372.6	241.4	170.1	309.6	189.2	256.5	216.8	30.6	361.8	128.7	286.9	131.3	296.7	164.6	269.0	174.1	398.2	74.6	93.3	61.7	188.1	145.9	503.8	70.4	203.1	385.4	150.4	257.9	158.3	135.8	198.0	275.5	457.4	253.9	89.2	94.2	234.6	229.9	275.8	424.6	42.7	84.8	205.8	200.9	39.4	267.3	318.5	142.2	57.3	50.3	271.0	288.5	110.9	107.5	219.4	217.0	189.1	126.6	218.0	92.1	125.6	118.6	193.6	56.6	295.2	326.5	326.6	186.9	53.1	319.7	323.8
ARL6IP4	"SFRS20, SR-25, SRp25, SRrp37"	ENSG00000182196	"ADP ribosylation factor like GTPase 6 interacting protein 4"	Q66PJ3	12	122980060-122982913	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052098	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA052098: AB_2681724"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.04e-3)"	"unprognostic (6.48e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.03e-5)"	"unprognostic (4.01e-2)"	"unprognostic (8.41e-8)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.43e-2)"	"prognostic favorable (1.08e-4)"	134.0	168.4	158.3	88.5	152.0	162.6	130.6	147.5	178.3	135.7	143.1	177.2	108.8	117.1	63.7	118.3	120.5	74.9	190.3	148.9	151.2	159.1	207.4	106.9	117.9	157.2	157.9	142.4	192.6	109.3	120.4	67.3	156.4	131.4	59.2	44.1	151.8	92.6	373.4	118.0	116.0	64.1	149.0	135.5	161.1	91.3	158.1	100.6	114.8	174.0	82.5	145.8	117.5	161.1	233.9	248.5	160.3	108.3	110.3	144.7	125.7	131.0	156.0	192.5	145.4	123.9	96.2	220.5	160.3	166.8	90.1	120.3	129.1	212.6	85.2	197.1	134.8	367.3	227.3	246.5	211.4	202.8	155.6	151.0	168.3	148.4	193.7	210.1	214.8	174.6	166.4	104.3	156.2	274.1	237.5	367.4	126.5	140.1	156.0	178.1	175.9	262.6	168.2	195.1	155.1	185.2	123.7	204.3	314.5	69.6	268.4	259.5	194.5	110.7	202.4	106.6	166.1	221.6	115.0	255.4	159.9	233.8	141.6	182.2	250.1	266.6	194.6	327.5	209.3	241.1	231.4	217.0	315.8	233.8	219.7	198.4	68.5	216.9	385.2	215.0	272.3	298.5	158.3	152.0	147.5	178.3	148.9	151.2	157.2	157.9	156.4	149.0	158.1	161.1	239.4	93.0	127.9	33.6	228.0	204.4	313.8	271.4	156.5	111.1	309.0	379.5	0.0	207.3	146.2	211.5	43.8	282.2	262.0	361.9	516.5	306.3	200.5	141.3	168.6	218.7	223.3	147.5	27.1	635.5	261.0	197.4	171.8	112.1	167.1	273.3	240.2	465.6	386.5	97.6	26.5	332.6	170.9	401.4	412.8	380.8	222.4	270.7	377.1	23.4	477.6	231.0	324.4	18.6	26.4	395.6	332.8	180.9	241.6	337.3	706.6	814.9	135.8	125.5	177.5	215.3	242.7	189.1	164.2	188.8	203.3	240.2	228.5	353.8	331.7	370.1
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084937-69106092	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	157.7	130.6	91.0	109.9	95.9	67.8	139.7	100.6	156.0	123.0	83.1	87.3	59.1	72.8	104.4	78.3	90.5	102.1	216.3	91.1	105.6	88.5	80.3	125.5	138.3	100.6	93.4	74.2	55.3	83.4	47.6	88.8	106.8	129.6	85.2	135.0	159.6	90.5	183.2	48.5	66.1	100.4	104.1	100.3	72.5	34.9	98.3	92.3	71.2	186.8	130.0	111.8	61.0	113.3	86.9	59.0	71.1	52.8	361.4	335.2	89.7	87.9	196.5	66.7	77.4	30.1	205.9	17.0	28.9	151.1	124.8	67.0	59.2	100.8	57.0	339.5	55.2	59.6	91.1	45.8	92.9	51.4	280.5	243.6	177.5	61.5	77.3	235.0	206.0	55.7	26.6	156.7	163.6	50.3	56.0	67.0	18.5	200.2	55.1	48.6	65.0	159.1	330.5	143.1	17.8	47.0	87.0	93.5	119.5	69.7	61.7	80.2	203.7	44.1	34.8	112.5	96.1	139.4	208.5	31.7	146.0	126.0	72.8	697.4	388.2	650.2	332.4	357.6	257.1	397.7	462.4	427.6	275.7	336.1	391.2	409.5	162.0	298.4	315.1	176.0	530.4	933.9	91.0	95.9	100.6	156.0	91.1	105.6	100.6	93.4	106.8	104.1	98.3	113.3	101.1	176.3	132.0	34.6	183.6	72.8	70.6	275.5	108.7	201.9	214.9	174.5	422.0	95.8	185.0	93.8	187.7	305.8	212.7	146.7	25.4	281.4	20.8	144.9	79.5	121.4	42.0	89.8	45.9	214.4	379.2	254.8	64.2	233.4	336.6	75.7	150.3	72.5	292.0	122.8	70.7	57.1	270.6	260.0	402.1	18.9	207.2	275.4	272.1	35.6	476.6	235.7	272.9	49.8	97.0	244.2	95.7	261.8	93.4	93.6	91.7	77.8	155.0	272.4	190.7	190.3	125.4	7.3	4.3	207.8	73.9	178.4	292.2	133.6	77.8	94.0
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152762396	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 214.0;eosinophil: 161.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 214.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	5.1	3.9	3.0	1.8	4.0	8.3	4.7	3.2	3.0	4.4	2.2	3.7	2.4	4.2	1.2	6.0	3.8	1.2	2.7	2.6	3.1	2.5	1.9	4.0	3.4	3.9	3.3	5.0	2.7	1.1	3.1	4.4	4.3	3.1	1.9	3.2	3.9	1.8	3.5	7.1	3.5	1.6	3.6	4.4	3.1	5.3	3.3	3.9	3.2	2.0	2.4	4.2	5.5	5.3	9.6	6.2	13.7	3.9	4.1	4.6	19.7	11.6	4.9	9.6	12.2	14.2	13.3	17.2	10.6	5.2	4.3	10.7	8.1	5.7	10.4	26.1	15.1	14.2	5.3	13.0	4.5	12.1	12.4	3.3	6.5	10.6	8.9	3.4	7.5	11.9	14.9	10.6	7.8	7.1	12.1	12.6	13.3	3.2	12.7	13.0	13.4	13.9	4.5	7.2	11.6	12.0	10.4	1.1	9.7	4.7	4.7	7.9	10.0	14.4	9.9	10.2	10.3	9.9	10.3	13.1	6.8	10.4	12.3	214.0	9.1	161.8	13.2	10.2	13.2	20.3	13.3	13.5	10.9	18.4	13.6	11.4	24.8	9.7	12.8	24.8	19.7	13.2	3.0	4.0	3.2	3.0	2.6	3.1	3.9	3.3	4.3	3.6	3.3	5.3	34.3	16.0	10.0	30.7	41.9	106.6	48.5	74.0	50.7	6.3	20.3	14.9	4.3	17.2	29.9	11.0	4.2	155.7	42.4	14.1	17.6	24.9	14.1	17.7	20.0	31.3	13.8	81.0	21.0	18.6	136.2	27.9	30.1	25.0	27.3	19.4	28.5	5.9	39.8	8.4	23.8	22.2	38.7	24.2	57.2	24.2	19.6	33.6	46.2	30.9	46.2	19.8	32.0	38.7	56.8	22.5	18.6	17.0	33.8	40.3	16.3	8.8	29.2	15.8	32.9	22.2	24.9	24.4	30.0	43.4	106.6	108.4	45.2	27.9	24.5	51.3
ARL8A	"ARL10B, FLJ45195, Gie2"	ENSG00000143862	"ADP ribosylation factor like GTPase 8A"	Q96BM9	1	202133404-202144743	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038759, HPA040515, HPA045924"	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"			"HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500"	"unprognostic (1.20e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (5.15e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-2)"	41.7	40.1	61.4	25.0	83.4	70.0	37.5	82.0	78.9	37.9	36.1	36.0	21.6	35.0	16.8	32.4	34.3	21.5	43.9	67.4	70.7	34.6	45.1	46.1	21.3	89.7	81.1	35.3	28.3	26.2	31.7	31.1	82.3	29.7	10.9	18.7	30.8	19.6	46.4	37.2	26.4	21.7	72.1	38.4	32.0	19.5	78.2	18.1	32.3	26.0	13.3	31.4	33.8	103.2	24.2	25.6	26.2	31.9	23.1	19.9	11.3	28.1	36.6	31.3	24.1	9.2	18.7	23.3	18.1	29.2	29.2	34.0	17.6	19.4	10.0	45.7	24.7	14.1	13.2	9.6	45.8	28.6	63.8	21.8	50.4	27.4	23.6	32.9	32.2	23.3	13.6	34.7	22.3	26.4	20.0	39.3	37.4	8.3	8.9	19.2	22.9	20.5	29.5	20.4	24.2	62.8	22.9	73.8	46.2	32.7	34.2	31.6	38.7	25.1	22.8	43.4	24.1	54.0	54.6	19.3	20.4	15.1	21.4	3.5	2.1	7.3	1.5	2.1	1.1	1.1	1.3	1.2	1.5	1.5	0.7	0.9	5.2	0.7	2.0	2.7	1.5	0.9	61.4	83.4	82.0	78.9	67.4	70.7	89.7	81.1	82.3	72.1	78.2	103.2	45.4	19.2	10.2	17.0	16.6	41.3	24.0	12.1	7.4	36.0	39.0	33.5	2.5	22.8	13.2	11.0	14.6	33.3	37.1	11.3	5.9	38.9	0.4	20.7	28.2	26.0	20.5	7.0	17.8	29.3	14.7	25.7	14.3	26.8	19.0	26.0	20.7	39.8	57.2	53.8	18.6	14.7	14.2	57.8	51.0	2.1	33.5	45.7	32.0	6.5	35.4	47.1	18.6	13.0	82.8	50.3	21.1	27.4	14.5	31.8	16.6	27.1	10.7	23.1	26.3	22.8	28.6	1.3	5.2	13.4	51.7	76.1	21.4	16.5	10.1	37.2
ARL8B	"ARL10C, FLJ10702, Gie1"	ENSG00000134108	"ADP ribosylation factor like GTPase 8B"	Q9NVJ2	3	5122249-5180911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038759, HPA040515, HPA045924"	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.84e-6)"	"unprognostic (5.90e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-2)"	41.7	51.1	53.6	36.1	58.4	59.7	42.4	55.4	73.2	39.5	38.3	33.8	30.7	45.1	39.8	65.8	31.1	38.7	55.2	59.7	58.6	53.8	43.9	43.6	38.7	57.2	54.3	38.9	27.5	48.1	0.1	49.8	59.2	45.0	34.8	34.3	28.6	41.8	50.7	54.8	34.3	47.0	60.3	33.9	34.1	32.2	59.5	35.8	62.1	59.9	47.5	49.7	0.3	61.7	49.5	44.1	38.5	20.7	118.4	103.8	71.7	67.8	75.5	64.0	75.8	33.6	44.9	52.6	29.4	65.7	141.4	30.6	61.9	60.1	73.2	58.3	35.8	86.2	34.3	48.4	162.5	73.9	97.0	96.7	179.5	80.9	56.2	67.4	72.2	47.2	76.6	55.0	96.2	45.1	63.0	56.1	36.2	44.6	65.2	43.5	52.2	46.7	63.9	73.8	22.1	41.9	57.7	112.5	96.2	42.7	66.0	219.7	61.6	66.5	55.8	91.9	62.3	50.8	88.0	143.9	94.4	102.7	54.9	42.9	37.8	24.5	18.8	33.0	22.4	19.8	19.6	18.8	31.7	16.7	20.0	20.0	17.0	22.1	27.4	14.2	20.3	27.7	53.6	58.4	55.4	73.2	59.7	58.6	57.2	54.3	59.2	60.3	59.5	61.7	35.8	80.1	63.7	52.9	42.9	128.1	60.5	40.4	74.6	23.3	44.4	31.4	55.6	31.5	45.2	35.0	10.4	42.4	30.4	38.9	19.6	37.2	33.7	45.9	39.8	35.9	13.1	35.1	61.6	37.6	80.1	48.7	33.6	88.5	56.4	25.3	19.2	42.4	97.8	8.4	68.3	19.5	24.4	68.3	249.6	42.0	23.0	109.3	55.2	47.8	103.3	37.2	23.7	47.7	86.0	61.5	26.7	33.8	45.4	71.5	23.2	46.1	40.6	22.7	72.3	31.7	45.7	34.5	24.0	109.5	164.7	173.1	36.8	23.8	16.6	123.3
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56524959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.9"	"Group enriched"	"Detected in many"	17	"Early spermatids: 100.7;Late spermatids: 292.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.8;REH: 7.5;SCLC-21H: 7.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	0.2	1.1	1.2	0.2	1.3	2.2	0.8	1.4	1.6	1.5	4.2	1.2	0.3	1.4	0.4	0.5	0.5	1.0	0.2	1.1	1.4	0.2	0.1	0.2	0.2	2.2	1.4	1.4	0.1	0.1	1.2	0.0	1.3	1.0	0.2	0.4	0.8	1.6	0.2	2.1	0.5	1.7	1.0	0.1	0.4	12.9	1.5	0.4	0.4	0.0	0.2	0.6	1.9	1.3	0.0	0.1	0.3	0.2	0.6	1.7	0.0	0.6	0.3	1.3	1.2	0.1	0.5	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.3	2.8	0.4	1.2	0.1	0.4	1.3	0.0	0.0	0.3	1.1	0.0	0.1	0.0	1.6	0.0	0.8	7.5	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.2	1.3	1.4	1.6	1.1	1.4	2.2	1.4	1.3	1.0	1.5	1.3	0.4	0.0	1.1	0.3	0.0	6.0	1.3	3.6	1.8	0.1	2.6	2.5	0.1	1.5	0.3	1.8	0.0	0.1	0.1	0.0	0.0	0.6	100.7	2.5	2.0	0.7	0.0	0.0	3.3	0.2	0.1	3.0	0.0	2.9	0.0	2.0	0.4	0.0	0.1	0.0	2.4	0.8	0.0	0.8	0.3	292.4	1.5	0.2	5.4	0.0	0.0	0.9	0.0	3.0	1.7	0.8	0.1	1.2	0.0	1.6	0.1	0.7	0.4	0.1	0.0	1.3	0.9	11.5	1.2	0.0	1.6	0.0	0.2	1.6	0.6	0.3
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602458-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavorable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.6	15.4	19.0	13.5	23.8	13.1	18.4	21.0	29.0	15.2	16.4	16.4	15.6	18.6	16.4	16.8	13.2	11.9	21.6	19.7	21.7	22.0	23.2	12.4	19.3	19.8	20.9	18.8	14.9	21.0	9.0	15.0	20.4	17.8	16.6	12.5	15.7	16.9	19.2	11.5	13.7	21.6	20.4	13.9	13.6	9.4	20.8	22.3	14.7	24.6	20.3	16.8	10.8	25.6	51.3	35.6	34.2	32.0	33.1	30.1	24.8	44.7	33.2	46.5	34.2	26.5	40.3	79.0	11.2	41.0	50.7	33.4	61.9	35.9	62.9	45.0	31.7	61.3	20.6	38.9	44.1	23.4	32.0	27.8	40.9	38.3	52.5	36.6	48.5	55.3	64.5	54.7	50.6	32.9	86.9	30.7	35.7	63.6	38.9	49.9	42.6	27.9	37.2	23.8	25.3	27.3	28.5	35.4	44.3	34.6	56.9	27.2	28.5	43.8	32.1	33.8	42.5	40.3	45.2	53.2	41.5	42.8	43.7	36.3	5.6	7.4	8.3	9.3	11.4	9.8	9.9	10.2	7.2	6.9	9.9	10.1	0.7	11.5	9.2	6.4	11.4	6.5	19.0	23.8	21.0	29.0	19.7	21.7	19.8	20.9	20.4	20.4	20.8	25.6	26.6	41.7	27.7	16.0	33.0	15.8	12.1	17.5	19.4	23.7	20.7	19.4	33.4	18.6	24.5	16.5	22.9	35.0	32.9	14.4	54.8	28.3	10.4	15.9	26.9	23.7	23.4	62.7	23.9	28.1	43.9	24.4	20.4	15.3	10.8	31.5	21.4	25.6	25.0	20.2	22.7	17.0	24.4	18.9	12.6	5.7	26.1	20.6	21.4	19.7	31.6	47.3	24.7	15.1	47.7	28.0	13.0	33.4	27.2	18.9	19.9	47.7	17.6	21.9	6.6	29.0	32.2	50.7	24.5	29.9	18.5	37.6	28.0	28.1	23.4	9.1
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099759	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	20.9	22.8	11.2	9.3	11.9	7.2	18.1	10.5	12.7	22.3	12.2	19.4	9.8	17.8	17.0	21.0	18.6	11.3	16.6	11.4	11.9	24.0	24.4	15.5	10.8	10.7	11.4	24.4	24.4	17.2	11.9	10.9	11.4	18.0	12.7	13.8	16.4	15.7	18.4	25.8	12.1	14.4	13.7	12.3	19.8	12.2	11.6	13.6	17.6	8.6	11.5	21.3	19.5	15.9	30.1	25.5	16.1	28.8	30.0	28.4	15.1	19.3	22.2	14.7	17.4	13.7	34.8	57.3	42.4	18.0	43.4	25.6	20.9	23.3	20.9	19.2	22.3	19.4	10.9	7.8	31.9	55.8	21.3	19.3	40.4	18.8	30.2	45.7	33.6	29.6	45.9	32.8	26.5	58.8	38.8	43.9	36.2	54.5	26.8	22.9	15.5	69.2	37.7	20.8	16.3	25.1	30.3	43.8	35.3	26.9	17.6	26.9	23.4	22.9	23.6	52.0	31.8	47.8	77.6	42.9	25.5	50.1	30.2	0.0	2.3	3.8	1.4	3.1	2.2	2.2	2.2	2.2	3.4	3.0	2.3	2.4	0.5	2.1	1.6	3.1	2.4	1.1	11.2	11.9	10.5	12.7	11.4	11.9	10.7	11.4	11.4	13.7	11.6	15.9	30.1	25.6	17.9	12.1	31.8	78.8	60.2	7.9	54.7	24.4	53.3	56.1	17.4	34.3	12.4	27.6	14.6	45.3	41.1	17.6	66.5	19.7	12.6	31.4	32.3	28.4	15.0	51.5	20.7	15.5	52.2	35.4	33.6	23.8	17.2	37.9	30.4	37.6	46.7	8.4	18.5	32.6	6.1	38.8	39.5	8.3	33.8	32.7	46.2	14.0	28.7	38.3	25.7	20.6	44.0	23.2	20.5	34.3	41.9	87.1	21.9	97.4	10.5	28.6	32.9	28.6	37.5	15.6	35.1	67.2	104.3	45.0	31.4	31.9	41.3	71.9
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 64.2"	"Group enriched"	"Detected in some"	96	"Early spermatids: 503.3;Late spermatids: 1116.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;HSkMC: 6.1;MOLT-4: 4.8;U-698: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	1.6	1.7	4.4	0.6	4.4	0.9	1.5	4.0	5.3	2.5	5.1	1.5	0.0	1.7	5.8	0.8	2.8	0.7	0.7	4.3	4.5	1.5	4.5	1.2	1.3	4.6	5.1	3.0	1.3	0.5	11.2	0.2	4.6	3.6	0.3	1.3	0.6	0.8	1.9	1.1	1.7	0.7	4.3	2.8	1.2	64.2	4.3	3.0	2.4	0.5	0.7	1.1	1.7	4.5	0.0	0.3	2.1	2.7	4.9	2.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	1.2	0.6	0.3	0.1	0.0	2.4	0.0	0.0	6.1	1.5	0.1	0.9	2.5	0.5	2.0	0.0	3.2	0.8	0.3	4.8	0.6	0.4	0.0	0.1	2.2	0.0	0.0	0.5	0.0	0.6	2.0	0.0	0.0	0.4	1.0	1.4	0.2	0.0	0.4	0.2	0.1	0.0	0.7	0.2	5.4	0.2	2.8	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.2	0.9	0.0	0.0	0.0	0.8	0.0	0.1	4.4	4.4	4.0	5.3	4.3	4.5	4.6	5.1	4.6	4.3	4.3	4.5	0.8	0.0	0.0	4.6	0.1	0.9	1.9	0.2	1.2	0.0	0.3	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	503.3	0.4	0.4	0.8	0.0	0.4	0.3	0.0	0.0	0.6	0.0	0.3	0.0	2.4	0.4	2.8	0.0	0.0	0.5	0.2	0.0	1.2	0.8	1116.3	8.4	1.3	0.0	0.0	0.1	0.8	0.0	0.5	0.3	0.0	0.0	4.1	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.5	0.4	8.1	6.0	0.7	0.1	0.0	0.3	0.2	0.2	0.4
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	5.3	3.8	3.8	3.9	7.8	8.8	7.0	0.9	6.8	6.6	31.8	2.9	1.8	7.5	7.6	3.4	20.4	5.2	9.3	3.0	2.3	3.6	2.6	8.6	4.2	2.7	5.9	5.4	2.4	9.4	6.7	6.9	1.2	3.9	4.6	26.7	3.4	4.7	4.0	5.2	3.4	4.1	1.1	5.9	5.0	33.4	7.6	3.8	10.6	1.3	4.2	2.4	2.7	3.6	3.5	2.1	10.1	6.5	4.9	5.9	2.2	2.1	2.9	5.3	7.0	3.2	3.0	5.5	2.6	3.4	8.1	3.0	5.6	4.2	9.1	1.5	4.9	5.1	5.2	3.4	2.6	8.0	2.2	6.8	5.8	6.1	1.7	7.1	5.0	16.6	2.2	8.4	5.5	2.7	7.0	7.3	3.2	3.4	2.6	7.8	8.3	4.3	4.9	4.1	14.0	5.2	7.3	1.8	5.1	5.6	3.7	4.1	2.5	4.4	2.3	3.8	2.9	3.8	5.5	4.7	7.6	5.5	5.6	3.7	2.1	0.6	2.0	3.0	1.8	0.8	1.5	2.2	1.7	1.9	0.9	2.2	6.0	2.9	2.4	2.8	4.7	1.0	3.8	7.8	0.9	6.8	3.0	2.3	2.7	5.9	1.2	1.1	7.6	3.6	2.0	9.6	3.7	80.0	3.4	1.0	1.1	1.9	0.6	2.0	1.2	1.5	6.8	1.5	10.9	0.0	0.0	1.5	2.9	0.3	0.0	1.2	117.7	33.0	2.7	2.2	1.8	2.1	86.1	1.0	2.1	3.0	1.5	1.8	0.0	2.8	0.7	0.3	3.9	1.7	69.3	0.4	4.1	4.4	0.4	145.3	6.8	3.1	5.4	11.2	0.5	1.7	3.1	35.7	24.4	0.7	0.0	10.1	5.9	0.6	0.4	1.8	61.8	4.9	0.0	4.2	4.2	41.5	6.3	1.9	1.4	0.5	5.1	2.5	0.6	0.7
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 12.9;choroid plexus: 34.5;fallopian tube: 44.6;testis: 33.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 4.0;ovarian cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"CAPAN-2: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037823, HPA037824"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.0	0.0	3.3	0.0	3.9	0.0	0.0	2.4	1.5	1.3	34.5	0.0	0.0	1.5	0.1	0.1	44.6	0.0	0.1	3.0	3.7	0.4	0.0	3.5	0.0	11.4	12.9	0.0	0.3	0.0	1.3	0.0	8.5	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	33.6	4.6	0.1	0.3	0.1	0.0	0.0	0.0	8.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	3.9	2.4	1.5	3.0	3.7	11.4	12.9	8.5	7.7	4.6	8.3	0.0	0.0	1.1	8.1	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.1	0.3	0.0	22.4	0.0	6.2	0.0	0.1	0.0	0.0	0.4	364.4	169.1	1.4	0.8	0.0	0.0	9.1	0.0	0.0	0.4	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	12.2	0.0	0.0	90.1	3.4	1.5	0.0	2.8	0.0	0.0	0.0	1.5	9.0	0.0	0.0	3.8	0.0	0.3	0.0	1.5	204.6	1.1	0.0	0.0	3.0	70.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ARMC4	"CILD23, DKFZP434P1735, FLJ10376, FLJ10817, gudu"	ENSG00000169126	"Armadillo repeat containing 4"	Q5T2S8	10	27775186-27999079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.1;testis: 40.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 277.5;Endometrial ciliated cells: 45.3;Late spermatids: 85.1;Respiratory ciliated cells: 128.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.8;BJ: 8.2;fHDF/TERT166: 9.4;RH-30: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037829	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037829: AB_10670960"	"unprognostic (1.03e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	0.3	0.9	1.4	0.3	1.4	0.6	0.2	0.9	1.7	1.2	9.5	1.0	0.2	1.0	0.6	0.4	23.1	0.3	0.2	1.3	1.8	0.3	0.7	2.6	0.1	4.5	4.7	1.6	0.0	0.3	3.2	0.0	3.5	2.4	0.3	0.3	0.0	1.8	0.1	0.1	0.2	0.5	3.5	0.2	0.3	40.7	1.4	0.6	0.4	0.0	0.0	0.6	0.3	2.8	0.1	0.2	7.8	0.0	0.0	0.0	0.1	8.2	2.7	6.0	3.6	0.0	0.3	0.1	0.0	9.4	1.8	0.0	1.2	0.6	4.7	0.3	4.9	0.0	4.6	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	2.2	2.2	1.8	0.0	0.0	1.3	0.0	4.9	0.6	6.8	0.0	5.4	0.1	25.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.7	1.7	1.0	0.0	3.6	0.4	4.3	0.2	0.0	0.1	1.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.9	1.7	1.3	1.8	4.5	4.7	3.5	3.5	1.4	2.8	0.2	3.2	3.9	8.8	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.4	2.7	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.5	45.3	0.9	0.6	0.0	0.0	2.2	0.4	0.0	1.1	0.0	0.7	0.0	1.1	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.3	85.1	1.2	0.3	0.0	5.6	0.0	0.0	0.0	7.1	0.3	0.0	1.1	1.9	0.0	0.1	0.0	0.1	128.4	0.0	0.0	0.2	1.4	32.4	2.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	6.3	7.9	9.0	3.4	9.2	21.4	4.3	8.9	11.7	6.0	7.0	5.8	4.6	6.9	0.9	9.9	5.6	2.0	6.5	9.2	8.1	8.7	24.6	4.6	3.2	12.3	9.4	6.8	6.4	3.0	9.0	2.1	12.4	7.7	0.9	2.4	5.3	2.2	16.0	8.5	7.0	1.7	9.1	8.8	6.8	6.8	9.2	2.9	9.7	3.9	1.3	5.6	6.6	10.5	5.0	7.6	3.3	4.8	2.0	1.5	8.4	6.5	2.8	3.6	3.0	7.2	5.0	4.9	13.3	3.5	3.6	7.5	3.9	5.7	0.7	6.8	9.9	2.2	12.4	16.7	4.0	14.9	14.3	3.7	6.3	3.6	1.0	4.2	5.5	8.0	11.2	11.5	2.5	12.2	5.6	59.5	5.3	2.2	5.0	10.0	4.7	18.2	2.9	5.6	10.7	9.4	5.9	7.8	4.6	2.0	5.1	17.6	10.9	7.8	5.7	3.2	5.4	10.4	9.8	3.0	5.1	12.2	5.7	2.9	2.3	0.7	3.2	1.1	2.7	2.7	2.5	2.6	3.0	2.2	2.2	2.6	1.3	7.1	1.3	7.2	3.2	2.6	9.0	9.2	8.9	11.7	9.2	8.1	12.3	9.4	12.4	9.1	9.2	10.5	8.7	6.4	14.3	4.2	6.2	6.5	9.2	8.7	9.1	6.0	6.3	5.0	5.8	11.5	8.2	0.0	6.2	7.5	7.6	11.1	3.9	5.0	1.2	5.2	8.6	10.8	7.8	8.2	4.3	4.4	5.4	6.1	6.6	7.6	9.5	6.7	8.9	28.7	6.1	13.5	4.0	8.7	6.1	3.7	4.0	0.6	4.4	6.7	1.8	2.8	3.9	7.2	6.2	2.0	4.6	4.4	3.8	5.7	8.0	6.9	9.2	4.6	3.4	5.9	0.0	8.7	6.6	5.5	8.0	9.6	6.3	11.5	7.6	6.1	7.7	6.1
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 110.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA041420: AB_2677469, HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	11.9	16.6	20.4	11.4	20.4	16.7	11.7	21.6	27.8	13.9	19.8	12.4	10.0	14.7	6.1	18.7	11.7	6.9	17.9	21.2	21.7	16.9	110.5	11.9	15.8	22.9	21.2	12.0	11.2	11.9	17.8	8.8	22.7	15.6	8.9	7.7	13.3	8.0	21.3	12.7	12.3	9.1	19.5	17.8	12.3	24.0	20.3	23.2	19.4	18.2	12.4	14.4	12.6	20.8	64.1	42.8	30.7	38.0	14.5	24.7	39.7	40.3	23.5	64.5	47.7	59.8	56.0	96.3	63.8	34.1	23.8	31.8	73.7	47.8	35.5	20.4	104.0	48.5	39.0	49.0	32.0	87.1	54.3	31.2	44.9	44.0	30.7	14.5	41.6	56.3	86.4	36.0	36.0	78.0	93.2	70.5	71.5	71.9	86.8	76.3	27.7	68.9	31.9	42.6	70.5	30.6	32.4	41.1	33.9	20.7	35.0	54.1	27.2	33.0	28.8	47.3	83.8	27.5	53.2	93.2	27.3	117.1	44.0	10.6	19.0	5.3	22.1	20.3	16.6	13.4	12.0	19.3	28.3	15.1	15.7	18.0	3.8	30.6	16.7	18.2	23.4	18.3	20.4	20.4	21.6	27.8	21.2	21.7	22.9	21.2	22.7	19.5	20.3	20.8	7.1	0.0	5.9	4.6	10.7	6.6	6.8	9.2	9.1	14.1	11.5	11.4	5.9	17.2	8.9	12.9	12.5	20.5	21.3	12.3	7.9	16.0	25.5	6.3	11.8	10.2	15.0	13.7	4.0	10.7	20.3	10.7	12.2	9.6	1.3	11.1	8.2	52.4	20.7	5.0	5.0	10.9	6.1	15.6	6.0	47.9	10.2	9.2	5.4	0.0	14.9	16.4	20.6	5.0	5.5	10.8	10.8	8.2	10.3	12.4	10.4	12.3	4.5	17.9	13.1	7.4	9.1	22.0	31.0	10.0	10.1	13.0	10.3	16.5	17.3	5.5
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA024229: AB_2059152, HPA053076: AB_2682036"	"unprognostic (1.35e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.4	6.7	7.3	5.8	7.5	4.1	7.4	12.7	9.0	7.7	7.7	12.4	9.6	7.0	4.8	11.2	6.6	4.7	8.8	7.6	7.7	39.5	13.2	12.3	7.0	7.3	7.1	5.2	7.0	6.6	7.0	5.8	7.6	11.8	6.9	2.7	8.9	6.4	5.5	12.0	11.9	4.0	7.0	14.0	11.4	7.3	7.9	8.2	9.9	3.9	6.4	8.7	9.3	7.9	15.2	30.2	8.9	8.5	7.0	4.3	9.4	8.3	9.0	15.9	14.3	25.3	14.7	9.0	10.8	7.7	8.7	12.4	14.6	6.1	7.6	8.7	23.2	17.5	13.4	15.9	15.5	13.5	16.1	5.6	11.4	10.0	5.8	7.7	14.6	14.5	15.8	17.6	5.3	21.7	25.9	14.8	4.5	32.8	22.6	14.6	18.0	16.8	35.6	27.4	8.3	11.9	15.6	15.7	18.6	15.2	18.4	12.9	11.3	16.1	14.9	6.4	13.1	14.7	5.5	12.7	7.2	9.6	11.8	31.7	13.7	28.5	18.0	9.9	15.8	13.4	12.9	15.1	12.7	10.0	9.8	14.9	18.6	15.7	7.9	11.1	20.8	11.7	7.3	7.5	12.7	9.0	7.6	7.7	7.3	7.1	7.6	7.0	7.9	7.9	6.6	12.8	8.8	1.3	10.4	4.6	2.8	5.8	2.2	6.0	6.0	5.1	2.5	7.2	5.2	22.0	0.0	14.1	10.1	28.6	35.2	8.7	6.2	4.6	3.0	9.0	6.0	1.7	3.0	9.4	8.3	4.1	8.6	5.1	10.8	4.4	14.3	4.6	15.2	0.0	2.9	9.8	6.1	7.5	3.3	12.2	5.3	9.7	12.4	1.9	13.9	3.3	11.3	2.5	1.8	11.3	27.1	3.8	6.4	4.8	15.8	15.4	7.2	3.4	19.7	2.2	4.6	3.8	5.9	4.4	4.5	4.9	8.7	6.6	12.4	3.8
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	20.8	14.3	14.6	18.0	16.6	60.6	16.4	41.2	18.5	14.7	25.6	16.8	12.0	17.6	12.2	21.0	15.7	15.3	17.4	13.3	16.9	18.9	16.9	16.3	21.2	16.0	15.8	16.0	14.2	21.3	12.3	19.8	17.5	16.5	18.3	26.2	12.5	17.5	38.7	12.8	13.5	24.4	15.9	15.9	15.4	18.4	16.7	22.2	21.3	34.8	22.9	22.2	13.4	19.4	46.2	22.0	28.5	23.2	35.2	30.7	37.9	34.8	33.4	46.7	45.3	34.3	23.7	43.2	35.0	30.2	54.6	23.5	37.1	33.9	57.4	29.3	25.7	77.2	14.3	23.9	44.3	60.6	82.5	46.2	21.2	30.0	42.9	25.4	37.0	37.0	29.3	23.8	58.6	40.5	42.7	28.6	39.2	34.8	19.1	33.0	45.7	34.6	30.7	42.3	33.0	24.0	50.0	17.2	29.1	36.8	33.8	31.6	40.4	24.8	20.2	33.1	25.9	45.0	37.5	65.2	22.4	28.4	25.2	79.7	39.7	74.8	38.6	43.5	44.6	48.8	35.2	41.1	45.9	43.3	41.1	40.6	27.9	48.8	46.0	20.3	50.4	37.4	14.6	16.6	41.2	18.5	13.3	16.9	16.0	15.8	17.5	15.9	16.7	19.4	25.0	28.9	14.1	56.2	38.2	31.0	31.9	29.0	25.0	34.9	17.7	14.9	23.1	24.3	27.2	12.9	33.3	29.9	35.6	25.1	11.7	20.2	7.3	16.2	22.3	23.4	23.4	59.6	101.9	14.6	27.6	23.4	31.1	19.5	35.4	24.1	24.3	24.6	22.5	43.7	93.6	16.9	30.5	32.7	39.2	7.3	30.4	35.2	19.6	70.3	27.2	25.0	39.1	128.2	120.8	14.8	17.2	22.2	26.8	28.1	17.0	26.1	17.4	47.0	13.1	30.2	31.5	43.4	32.2	22.3	28.4	34.1	30.9	19.6	17.4	28.3
ARMC9	"ARM, FLJ12584, KIAA1868, KU-MEL-1"	ENSG00000135931	"Armadillo repeat containing 9"	Q7Z3E5	2	231198546-231376848	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 48.6;retina: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 310.6;Excitatory neurons: 112.5;monocytes: 116.4;Rod photoreceptor cells: 202.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 15.5"	"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 275.2;SK-MEL-30: 222.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019041, HPA026671"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA019041: AB_1845035, HPA026671: AB_1845036"	"unprognostic (2.90e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.20e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.66e-5)"	2.3	15.0	4.0	5.4	5.3	1.9	3.3	1.1	15.5	5.6	48.6	14.7	1.7	19.5	5.6	4.2	8.7	7.7	2.3	5.9	1.9	5.2	0.8	7.1	1.6	0.4	2.4	9.4	3.7	10.8	11.1	5.7	0.1	5.5	5.2	71.5	3.2	6.6	1.0	2.6	6.5	23.5	0.0	1.1	8.9	9.4	0.2	3.0	7.6	1.1	2.1	6.8	2.7	1.7	21.2	10.8	20.3	15.1	14.5	23.7	8.3	23.3	275.2	28.6	35.8	3.1	10.3	2.7	11.0	68.3	46.6	12.2	24.8	22.7	25.0	1.7	15.2	1.5	14.0	11.6	41.3	5.0	5.1	63.8	8.8	38.3	13.7	73.3	21.7	12.2	4.7	0.6	46.0	29.9	6.3	6.9	44.4	7.7	12.0	7.8	18.2	0.3	30.6	6.9	15.6	32.2	9.3	25.2	222.7	17.8	9.7	5.4	22.6	17.6	10.9	10.0	10.4	24.8	6.2	1.3	33.9	1.0	17.7	1.1	0.2	0.3	0.2	0.1	0.1	0.6	0.2	0.3	0.2	0.3	0.3	0.3	0.5	2.6	0.2	0.3	0.2	0.2	4.0	5.3	1.1	15.5	5.9	1.9	0.4	2.4	0.1	0.0	0.2	1.7	1.3	3.2	36.1	25.8	1.4	1.8	5.6	6.8	1.2	24.0	5.1	5.7	3.3	2.8	7.5	3.7	310.6	4.8	0.1	4.0	1.9	7.3	69.5	25.1	22.3	4.9	7.8	1.3	112.5	17.3	3.0	7.2	3.6	4.1	3.8	6.6	2.5	1.0	10.6	1.7	62.7	6.0	0.0	0.3	2.4	23.8	14.0	6.6	19.6	17.8	116.4	16.7	1.0	25.6	14.1	11.5	1.8	21.4	1.1	1.9	0.7	5.1	31.3	202.4	6.6	5.3	6.4	36.7	15.7	0.6	0.9	2.2	1.3	6.3	10.0	2.1
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	34.9	58.9	30.8	24.4	33.0	14.7	32.2	35.4	35.7	45.0	27.6	31.5	20.2	40.9	105.3	18.1	27.7	34.0	51.0	34.1	38.7	37.2	24.6	29.5	21.8	34.5	33.7	38.3	57.4	103.6	47.7	45.4	34.8	44.5	21.8	19.0	59.6	46.7	30.7	11.9	21.5	36.3	35.4	41.3	29.7	12.9	35.5	20.1	49.9	63.6	21.5	31.9	22.5	37.7	26.4	18.8	48.8	23.9	109.4	118.3	10.0	56.5	54.3	23.2	68.3	20.7	21.5	9.5	31.7	64.7	50.8	5.0	34.9	20.2	28.7	21.6	23.2	18.7	64.9	30.2	85.2	18.2	41.5	67.0	27.4	30.9	30.3	65.1	47.6	11.6	15.2	78.9	67.4	10.9	15.0	0.8	24.4	49.5	4.3	19.1	62.2	8.9	36.0	10.1	22.1	18.9	28.3	1.5	63.9	67.7	19.2	19.0	67.5	29.8	18.9	70.8	11.2	69.7	20.9	0.1	50.4	14.5	25.5	43.6	15.3	13.6	14.6	15.8	18.3	15.0	14.0	12.4	15.8	9.8	15.2	10.6	5.6	13.7	16.8	25.8	9.0	14.4	30.8	33.0	35.4	35.7	34.1	38.7	34.5	33.7	34.8	35.4	35.5	37.7	67.4	44.8	36.1	16.3	61.1	37.9	81.2	40.6	42.7	63.1	70.9	42.3	114.6	50.1	48.4	75.4	58.4	55.3	61.1	20.4	37.2	53.9	0.6	42.2	80.9	69.2	82.4	25.6	35.9	30.6	27.4	85.8	33.1	78.8	79.1	45.5	58.2	48.6	50.7	62.2	41.8	67.6	40.7	52.5	84.9	2.8	64.7	72.3	97.8	18.7	27.2	86.6	34.0	28.6	31.0	30.6	22.1	72.6	122.6	75.2	20.1	43.1	25.1	13.3	32.9	57.1	73.2	2.5	0.4	24.6	21.5	114.9	58.0	70.2	32.1	81.2
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing X-linked 4"	Q5H9R4	X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Excitatory neurons: 59.1;Inhibitory neurons: 87.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favorable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	2.1	4.0	1.8	1.1	2.1	0.7	2.7	1.4	2.0	2.8	0.0	2.5	0.9	3.6	2.5	1.0	3.0	1.3	1.8	2.0	3.0	2.4	1.0	1.8	0.9	1.8	2.1	7.1	2.0	4.5	4.5	1.7	2.1	3.6	1.6	1.6	1.9	4.7	1.9	2.1	2.1	2.6	1.1	1.7	1.8	0.9	2.2	0.9	2.7	1.0	0.8	2.3	1.8	2.3	2.4	0.6	7.9	0.0	3.7	3.9	0.8	5.5	4.3	4.4	8.5	1.9	0.7	0.0	2.1	8.2	0.1	0.9	0.0	0.1	7.2	0.0	0.9	0.6	2.5	0.0	2.2	0.0	3.0	2.4	0.4	9.6	0.0	0.0	7.8	0.0	0.0	0.7	2.0	0.0	0.3	0.3	5.8	0.8	0.0	0.4	6.5	0.0	1.1	1.4	5.3	4.9	0.8	0.0	3.0	1.3	0.6	1.2	2.9	2.0	1.2	6.1	0.0	0.0	0.0	0.0	3.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.4	2.0	2.0	3.0	1.8	2.1	2.1	1.1	2.2	2.3	8.7	3.2	6.8	66.6	2.2	2.4	7.7	1.7	5.7	24.5	9.1	7.1	10.5	2.8	7.9	27.6	8.4	1.7	2.6	2.3	17.6	2.7	0.2	5.6	8.9	8.0	3.0	1.3	59.1	2.3	0.7	11.0	2.0	8.3	3.8	13.3	5.3	2.5	2.3	23.5	87.5	2.3	6.1	3.8	5.1	0.7	10.5	2.4	17.8	63.7	2.8	11.6	4.1	78.4	75.6	2.0	3.9	12.4	2.2	5.3	4.7	4.8	9.8	7.8	0.0	8.1	10.9	1.3	1.3	1.8	3.4	1.5	2.2	8.4	4.0	4.5
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.2	11.0	10.4	8.8	10.6	10.3	17.8	10.0	11.5	13.7	6.9	12.8	10.8	15.2	15.5	11.0	15.0	10.0	10.7	11.4	9.3	12.6	11.3	11.2	10.4	7.7	7.0	20.3	14.7	19.9	7.2	8.4	7.6	20.6	15.3	10.6	15.7	13.5	9.3	11.2	12.3	13.9	7.3	8.0	13.5	5.4	9.6	16.2	19.5	10.1	13.3	11.2	6.5	11.4	17.8	15.7	36.4	19.4	15.9	17.8	20.4	17.1	13.1	19.5	34.5	18.7	21.5	0.0	20.3	17.2	22.3	15.1	32.8	16.3	22.1	0.0	13.1	17.9	19.2	15.6	20.6	32.7	20.0	22.3	20.7	16.9	20.3	15.5	20.0	0.0	17.6	0.1	26.3	15.8	23.3	3.9	16.4	30.3	29.5	22.7	88.9	0.1	14.5	24.2	17.1	15.4	30.5	15.7	24.7	10.4	10.8	15.4	20.3	14.5	12.8	16.5	12.3	0.0	13.0	0.0	11.4	32.7	37.8	0.1	11.8	3.2	13.9	12.3	13.3	12.5	12.8	10.9	11.3	6.4	17.8	14.0	1.0	9.3	7.8	10.0	9.7	11.1	10.4	10.6	10.0	11.5	11.4	9.3	7.7	7.0	7.6	7.3	9.6	11.4	6.9	6.4	6.9	0.0	9.0	5.6	11.7	8.0	19.4	16.5	8.9	7.7	4.4	7.2	10.3	9.2	20.9	5.7	9.2	6.8	21.5	10.0	0.3	5.9	8.3	9.6	9.6	3.4	0.0	9.7	2.6	9.9	10.7	5.7	1.3	7.8	5.7	9.6	6.0	1.7	0.0	9.8	4.1	7.2	3.5	0.5	8.4	6.6	8.8	0.0	4.6	6.5	10.3	0.0	0.0	9.3	3.8	6.0	12.0	9.3	9.6	10.6	13.7	20.8	0.0	6.7	7.8	3.0	5.3	14.5	5.7	3.7	9.5	7.5	9.7	11.1
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: AB_2678277, HPA048125: AB_2680275"	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	9.4	14.6	11.8	9.6	12.1	8.2	11.7	13.0	13.8	14.2	11.9	11.1	6.2	15.8	22.7	9.3	12.6	10.5	15.3	11.7	12.7	13.0	7.6	9.6	12.8	13.9	12.6	19.1	17.4	26.3	17.1	15.7	13.5	13.7	8.1	5.3	24.5	18.3	6.7	10.7	9.0	14.8	12.9	19.2	9.5	4.4	12.4	13.8	14.2	8.3	13.8	11.2	11.3	14.6	13.7	15.7	24.2	13.8	48.4	28.6	4.8	28.0	27.0	24.5	47.5	9.4	12.8	14.4	28.0	26.4	25.5	13.9	23.8	11.3	19.1	12.6	14.4	13.5	22.6	12.8	22.2	13.4	16.4	17.9	11.3	15.1	7.8	34.3	25.4	7.4	11.3	18.0	37.3	33.0	19.8	0.2	17.5	17.7	3.1	20.0	32.5	5.5	17.7	1.8	13.3	12.5	16.4	0.1	21.0	18.3	11.4	6.4	19.8	29.7	13.4	41.8	6.6	22.1	12.6	0.0	8.9	3.5	9.9	11.3	3.7	6.1	5.8	6.7	7.5	13.2	6.1	6.4	7.6	9.0	7.3	6.9	0.4	8.3	5.1	13.2	3.6	6.2	11.8	12.1	13.0	13.8	11.7	12.7	13.9	12.6	13.5	12.9	12.4	14.6	23.9	9.6	9.1	5.2	28.5	13.4	14.4	28.3	26.2	5.5	39.3	44.4	9.7	14.3	16.3	31.3	16.7	37.8	40.6	2.2	23.5	44.2	0.6	21.9	23.7	27.2	16.4	13.0	1.9	27.7	17.3	24.6	19.9	38.0	14.5	30.2	25.4	15.7	67.9	10.1	3.3	14.2	16.2	29.0	32.3	2.2	18.6	40.8	37.4	5.6	28.5	30.3	36.0	8.5	4.9	26.5	11.2	19.9	23.8	18.3	7.6	25.0	5.5	4.6	26.3	13.1	22.4	2.6	2.3	32.7	16.1	34.5	26.0	29.5	11.7	20.8
ARMH1	"C1orf228, MGC33556, NCRNA00082, p40"	ENSG00000198520	"Armadillo like helical domain containing 1"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.2;testis: 11.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favorable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.4	1.1	1.7	0.2	2.2	2.2	0.7	1.1	2.6	0.8	4.5	0.5	0.2	1.7	3.5	0.5	8.2	0.7	0.2	2.3	1.3	0.9	4.2	1.0	0.6	2.6	4.0	2.6	0.5	1.9	3.3	0.3	2.1	0.8	0.3	4.2	0.7	0.6	0.1	0.8	0.3	0.3	1.8	0.3	0.7	11.7	1.9	0.4	0.6	0.0	0.3	0.3	0.3	2.2	0.2	0.3	1.8	0.1	0.5	2.1	0.5	0.0	0.2	0.5	0.3	0.4	3.8	0.2	0.2	0.8	0.9	0.5	0.0	0.0	0.0	1.0	0.2	0.9	2.6	0.6	0.2	6.9	4.1	1.7	0.2	0.7	0.0	1.3	0.2	0.3	0.1	0.7	0.2	0.0	4.9	7.5	0.1	0.5	0.0	2.7	0.1	2.2	0.7	0.0	1.2	0.8	0.0	1.2	0.9	1.2	0.3	3.6	0.0	0.3	0.3	0.3	0.0	0.3	0.1	0.2	0.3	9.9	0.4	8.7	2.1	6.1	0.2	0.7	0.1	0.6	1.1	0.8	1.0	0.9	1.6	1.5	1.0	0.4	0.0	4.8	0.0	1.4	1.7	2.2	1.1	2.6	2.3	1.3	2.6	4.0	2.1	1.8	1.9	2.2	0.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	3.7	0.0	0.4	1.3	0.0	1.9	0.7	0.0	13.1	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.7	0.0	6.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	5.2	0.9	0.0	0.0
ARMH3	"C10orf76, FLJ13114"	ENSG00000120029	"Armadillo like helical domain containing 3"	Q5T2E6	10	101845599-102056193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050913, HPA053580"	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA050913: AB_2681270, HPA053580: AB_2682198"	"unprognostic (5.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.55e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.87e-2)"	10.4	9.1	5.9	12.0	7.6	21.8	9.9	10.2	7.3	11.2	8.0	12.5	12.8	10.5	9.4	14.3	10.5	9.2	16.6	5.7	7.3	10.0	12.0	11.8	12.7	7.1	8.2	11.2	10.1	16.4	7.9	11.0	6.1	10.8	13.2	16.3	9.5	10.5	19.7	12.2	12.2	12.9	6.0	13.6	10.3	8.9	6.7	13.1	10.0	19.8	13.3	10.8	10.1	7.9	23.2	17.7	15.5	19.1	12.9	17.3	13.9	20.3	24.0	20.0	16.9	12.2	18.6	17.0	13.5	22.9	14.5	17.7	20.4	22.4	18.3	17.9	18.9	30.3	15.9	14.6	15.2	21.3	26.4	16.0	17.7	22.6	19.9	23.4	15.3	15.3	0.9	15.9	16.6	14.4	16.5	13.8	8.5	18.8	11.6	16.0	28.1	11.0	16.4	18.6	7.3	12.1	15.8	10.9	21.0	15.8	28.8	12.4	15.1	10.5	17.1	9.8	14.7	15.4	17.0	17.1	16.9	23.7	7.9	19.4	7.3	7.4	5.9	8.7	5.5	6.1	6.2	4.5	7.7	7.0	4.8	4.9	1.9	5.2	10.7	7.4	6.0	4.7	5.9	7.6	10.2	7.3	5.7	7.3	7.1	8.2	6.1	6.0	6.7	7.9	8.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	7.4	6.0	0.0	0.0	0.0	0.0	0.0	11.2	10.5	0.0	1.9	7.8	0.0	6.9	6.8	1.9	0.0	0.0	0.0	9.7	14.8	2.7	0.0	7.7	0.0	11.5	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	16.3	3.9	5.7	0.0	0.0
ARMH4	"C14orf37, UT2"	ENSG00000139971	"Armadillo like helical domain containing 4"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;kidney: 8.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		1800000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	1.2	2.5	2.3	0.6	3.6	0.7	0.8	8.5	3.5	1.8	0.0	0.7	0.5	3.0	1.8	0.8	2.1	1.8	3.1	2.6	2.1	8.3	0.8	0.7	0.4	11.5	5.1	4.3	1.0	3.6	1.3	0.4	12.8	1.6	1.0	1.2	0.7	1.4	0.2	1.0	0.7	2.3	1.0	0.5	1.4	2.2	1.6	0.2	1.5	1.9	0.3	1.2	0.9	0.7	0.0	0.0	9.7	6.1	4.7	1.7	0.0	1.9	1.5	0.3	0.3	0.5	0.1	0.0	0.6	10.8	1.2	0.0	2.9	0.0	0.4	0.1	1.0	0.0	0.0	0.5	0.2	0.0	4.8	1.8	0.0	0.2	0.2	2.7	0.5	0.8	0.1	0.3	1.2	0.3	0.0	0.0	4.5	0.0	2.0	1.4	0.3	2.5	3.9	0.3	1.1	0.0	0.1	0.0	0.3	2.7	0.2	0.2	0.1	1.3	3.5	0.5	2.6	0.3	0.2	0.0	3.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	8.5	3.5	2.6	2.1	11.5	5.1	12.8	1.0	1.6	0.7	15.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	12.9	0.0	0.2	0.7	0.0	0.0	2.1	0.0	10.2	7.7	2.3	0.0	0.0	0.0	1.3	0.4	3.0	0.0	2.4	0.0	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3	44.5	0.0	0.0
ARMS2	"ARMD8, LOC387715"	ENSG00000254636	"Age-related maculopathy susceptibility 2"	P0C7Q2	10	122454653-122457352	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 16.9;Late spermatids: 59.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067225	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA067225: AB_2685806"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"		"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.49e-2)"		"unprognostic (1.98e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.60e-2)"	"unprognostic (5.29e-5)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.25e-2)"	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.2	1.3	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.6	0.4	0.4	0.1	0.2	0.0	0.0	0.3	0.4	0.7	0.0	0.0	0.4	1.3	0.4	0.1	0.0	0.5	0.8	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.1	2.9	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.3	0.4	0.4	0.3	0.4	0.4	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	16.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	59.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	8.6	0.0	0.0	0.0	0.0
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809713-150876708	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 397.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	25.8	20.4	9.6	18.1	9.6	17.1	22.7	16.2	12.2	31.8	16.5	19.5	15.0	27.4	14.8	19.2	25.0	20.5	20.7	8.9	10.7	17.8	42.9	24.7	17.5	10.4	9.5	37.7	28.6	19.6	12.5	31.2	10.2	16.3	21.2	39.1	15.5	17.6	32.3	23.9	17.0	29.0	8.0	19.5	19.0	17.3	10.9	20.4	19.6	28.1	22.4	21.3	24.0	11.2	17.1	17.2	25.6	19.5	53.4	50.9	34.2	19.0	36.9	25.2	22.7	15.1	17.0	18.3	16.5	34.0	12.4	19.1	24.2	21.3	21.9	29.3	13.8	21.4	28.7	17.6	31.0	26.4	24.7	39.9	20.0	30.7	26.9	30.6	31.3	24.4	27.9	34.9	26.3	33.8	21.1	15.0	21.2	30.9	13.0	26.1	30.8	25.5	20.6	17.4	17.6	25.1	36.6	25.3	15.2	34.4	32.6	59.4	22.6	20.9	18.8	16.8	16.8	39.8	30.8	397.5	25.5	0.9	14.4	46.6	23.6	21.2	12.1	21.6	11.1	8.7	10.0	11.7	18.7	8.7	9.5	9.8	11.9	12.0	23.4	7.8	11.1	16.2	9.6	9.6	16.2	12.2	8.9	10.7	10.4	9.5	10.2	8.0	10.9	11.2	14.8	12.8	10.3	28.1	14.9	14.1	9.9	11.0	8.0	23.6	10.2	6.9	12.8	24.3	11.6	11.0	54.2	24.5	12.6	13.3	3.9	11.2	5.0	10.3	23.3	14.8	20.4	16.6	41.6	9.7	37.1	25.4	8.6	20.6	3.8	17.1	30.0	47.7	20.3	6.7	47.5	16.5	8.2	39.1	20.1	4.3	32.3	20.0	10.6	39.4	27.9	7.9	13.4	41.7	50.9	9.6	8.1	32.7	13.0	8.8	10.1	13.1	9.7	38.3	13.1	17.0	19.4	18.4	16.7	11.0	15.3	29.6	12.7	20.7	9.0	10.0
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597933	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 128.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	2.2	2.1	94.4	2.1	100.6	0.4	1.4	47.8	111.7	5.6	29.8	5.8	1.7	5.9	8.2	2.0	5.3	2.5	4.1	128.0	64.2	21.7	0.4	5.0	2.3	61.8	70.5	10.7	3.4	6.4	11.5	1.1	53.6	5.5	2.1	8.1	1.2	5.0	9.7	2.1	2.7	3.9	60.2	3.5	4.1	9.9	84.0	2.2	7.0	6.0	3.0	4.3	2.0	66.7	0.4	16.1	28.4	0.0	0.1	3.6	0.1	12.2	17.3	13.9	28.2	0.0	0.0	0.0	3.0	14.7	7.2	0.4	10.5	0.6	17.7	0.0	2.9	0.5	0.0	1.0	0.9	0.0	7.2	13.2	0.5	6.1	0.3	29.7	0.0	0.0	0.0	0.1	26.0	14.0	0.0	0.0	5.7	0.0	0.2	0.0	0.3	0.0	6.0	20.5	14.9	20.6	1.5	0.2	30.8	1.8	0.6	0.0	0.0	22.2	4.4	0.6	14.7	0.0	0.0	0.0	8.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	100.6	47.8	111.7	128.0	64.2	61.8	70.5	53.6	60.2	84.0	66.7	0.1	0.0	2.3	209.6	0.0	1.3	1.2	1.5	4.0	17.0	3.2	3.4	7.6	2.8	4.7	3.7	8.4	0.2	0.1	0.2	13.7	6.0	36.7	8.5	2.7	1.8	22.9	0.0	204.7	0.2	3.6	2.7	3.1	4.4	2.5	5.7	0.4	0.0	0.2	1.7	301.5	2.6	8.2	0.0	1.6	39.8	0.6	0.4	7.2	98.4	0.1	5.9	2.1	232.7	136.9	2.4	2.3	3.0	0.0	2.2	0.3	1.0	1.6	9.3	6.6	2.6	2.5	2.1	3.0	0.5	0.3	2.7	0.6	1.9	1.3	1.4
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 63.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	15.0	13.3	3.2	5.1	4.8	7.4	14.1	4.8	8.3	10.5	3.2	12.4	5.2	11.6	1.6	10.5	11.5	4.0	9.5	5.5	1.9	7.2	19.4	15.0	5.8	1.6	2.6	19.7	10.3	1.5	12.3	4.4	2.2	8.5	4.1	23.4	12.7	3.4	27.0	17.6	12.4	5.6	1.9	11.6	10.9	10.9	4.4	14.1	18.9	8.2	6.4	9.3	11.5	7.4	8.2	9.0	7.5	4.0	15.0	9.0	5.7	9.5	8.1	8.6	9.7	3.7	10.9	0.1	2.6	5.2	10.4	3.4	5.3	10.3	7.7	13.6	6.3	3.9	6.6	1.8	23.7	1.8	16.2	10.1	21.3	3.7	14.1	5.9	6.2	12.6	2.5	14.9	6.9	4.7	4.7	0.9	1.6	5.4	4.3	5.1	11.4	3.4	5.7	1.8	1.2	12.2	6.1	0.7	7.6	7.1	5.7	7.0	11.5	6.2	6.8	20.3	5.5	4.1	12.0	0.0	6.4	4.1	8.3	4.3	8.3	17.9	18.1	9.0	25.2	2.6	16.8	15.6	8.4	3.1	9.4	11.1	24.5	14.1	8.9	1.1	11.1	10.7	3.2	4.8	4.8	8.3	5.5	1.9	1.6	2.6	2.2	1.9	4.4	7.4	4.9	25.6	21.0	49.9	9.0	30.8	13.4	7.3	10.2	28.3	6.1	5.0	8.8	10.0	11.1	1.8	16.7	17.6	34.8	8.6	17.6	6.8	1.5	6.1	14.2	6.6	1.2	3.0	63.6	6.4	2.2	10.3	11.7	12.9	2.5	6.9	10.8	22.9	8.2	30.3	30.5	4.6	4.1	14.0	12.3	4.2	12.8	11.9	3.6	18.7	13.1	18.8	32.0	34.2	11.9	8.3	9.3	19.9	11.5	8.0	13.5	11.3	5.3	30.9	13.1	6.6	10.7	4.7	5.4	9.4	32.4	6.3	33.0	4.7	4.5	12.0
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.1;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.9;U-2197: 159.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.0	1.0	1.3	10.0	6.4	2.3	2.1	0.0	3.6	5.8	0.0	2.5	2.8	1.2	0.2	28.1	0.9	3.6	0.8	2.8	1.6	1.1	4.7	2.3	5.2	0.0	0.5	0.2	1.3	1.5	0.8	2.8	0.0	1.1	3.2	0.4	7.2	0.6	0.2	7.6	2.6	4.6	0.0	1.0	10.9	2.7	0.6	4.4	0.6	0.8	22.2	14.7	11.9	2.2	76.0	19.2	4.2	1.6	3.6	11.0	58.3	26.3	34.5	16.8	26.2	18.2	57.4	0.6	14.4	12.6	51.9	30.6	12.3	92.1	42.7	121.9	15.7	14.6	11.7	15.2	4.8	29.6	6.1	4.0	8.1	58.8	45.6	28.9	80.0	17.7	7.5	29.8	19.6	9.2	16.2	16.2	32.1	25.7	65.8	29.8	68.2	4.7	14.1	42.8	13.6	2.2	13.5	2.1	0.4	10.0	2.9	9.7	54.6	54.2	31.4	159.5	110.0	4.4	8.4	0.1	46.5	23.5	10.9	1.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	1.3	6.4	0.0	3.6	2.8	1.6	0.0	0.5	0.0	0.0	0.6	2.2	2.1	3.2	1.3	1.3	0.4	0.8	45.6	8.6	1.2	0.9	1.6	0.8	0.9	11.5	7.5	9.2	0.0	1.9	0.3	1.5	0.0	22.1	3.8	7.9	0.7	6.9	1.2	3.4	78.8	27.4	4.0	3.2	28.1	11.8	0.0	5.3	2.5	3.5	1.4	0.0	24.8	3.3	2.0	2.5	5.4	4.4	0.0	2.9	1.8	7.5	15.7	0.0	0.0	8.5	2.3	86.9	1.4	0.0	3.4	109.0	1.7	0.6	2.7	0.1	0.0	1.7	3.6	3.1	4.7	6.6	2.3	4.2	1.3	0.2	2.1	128.2
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325898-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		760000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	74.4	82.9	61.6	39.7	63.3	40.4	63.2	60.1	71.9	69.8	71.9	80.7	92.8	60.1	80.9	124.6	75.5	53.3	121.7	78.7	73.9	65.9	77.4	62.2	41.9	64.6	67.7	81.5	63.8	65.4	62.1	54.3	71.7	56.9	78.2	33.0	66.6	55.5	48.0	84.5	84.9	57.2	60.8	52.7	99.1	42.4	68.4	39.2	78.8	47.1	44.9	61.6	74.9	62.9	265.3	144.3	155.1	73.6	144.2	242.4	133.5	185.5	216.1	185.5	184.4	164.4	301.7	92.3	270.5	226.7	273.8	110.6	208.0	270.8	221.5	46.7	186.4	49.7	99.9	137.1	156.1	59.2	63.7	227.6	149.1	237.8	252.0	220.0	310.8	75.9	125.9	105.6	289.8	398.6	99.4	78.5	150.5	295.3	326.1	58.1	107.8	113.9	142.0	162.7	161.7	138.3	180.9	260.2	255.9	264.2	130.2	88.4	239.3	239.0	211.0	424.7	302.1	39.6	80.0	130.7	206.6	130.1	320.2	111.7	49.9	88.8	24.2	80.8	19.3	30.8	23.1	31.5	43.0	28.8	30.0	22.6	63.7	30.7	86.1	31.9	33.5	26.9	61.6	63.3	60.1	71.9	78.7	73.9	64.6	67.7	71.7	60.8	68.4	62.9	124.3	51.3	55.5	20.9	45.2	41.4	139.5	249.1	54.7	38.0	107.2	131.6	46.7	95.8	130.1	58.8	18.8	189.6	27.3	196.2	135.0	213.6	32.1	55.0	43.7	96.4	74.2	68.8	31.6	276.9	345.8	70.6	140.2	57.4	13.3	141.4	135.0	75.8	84.6	33.7	28.0	209.4	132.2	77.5	26.1	24.6	66.8	56.0	80.0	26.2	68.6	79.8	42.2	19.1	28.4	442.5	191.6	67.4	52.4	151.5	295.7	155.5	102.2	40.1	184.1	59.1	188.4	171.6	130.0	88.9	47.9	129.7	29.8	87.7	166.3	280.7
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394816	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 317.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 899.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Enhanced		Supported	Vesicles,Cytosol		NA	NA		13000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	132.2	71.6	19.6	173.3	20.4	209.8	99.1	20.5	25.9	71.7	23.9	104.4	106.6	71.0	14.2	51.6	73.9	48.9	70.1	18.2	21.7	84.4	81.7	169.5	202.1	28.9	23.5	30.1	51.4	14.3	52.4	66.4	26.8	67.4	32.5	1.1	72.4	30.1	18.6	43.2	160.2	39.4	27.3	317.3	66.2	20.4	33.3	62.2	90.1	19.5	95.5	85.1	57.5	28.4	124.3	219.3	16.1	47.5	62.9	225.0	167.9	165.8	170.5	68.7	60.5	146.3	477.8	215.4	308.2	188.5	146.9	93.1	22.4	152.5	27.5	175.5	59.9	157.0	61.6	98.4	179.7	159.5	515.8	125.7	77.3	96.2	94.3	134.6	181.5	113.3	177.9	508.0	100.2	574.5	158.8	332.5	59.6	148.9	435.5	139.5	14.6	536.2	141.2	59.7	13.2	42.1	116.4	506.3	899.5	54.4	119.7	322.4	262.0	190.1	155.8	339.0	216.6	91.4	190.1	263.5	189.9	411.0	350.4	1026.1	2400.1	1973.2	770.3	2458.8	723.9	786.7	883.0	857.2	2054.4	699.1	510.2	680.0	1963.4	633.5	2382.6	1172.9	1315.9	4198.2	19.6	20.4	20.5	25.9	18.2	21.7	28.9	23.5	26.8	27.3	33.3	28.4	182.2	41.7	86.6	1.0	279.2	60.5	141.3	587.9	58.1	9.6	50.8	34.3	9.1	107.2	260.2	130.6	8.4	588.4	416.3	264.9	25.4	407.1	3.2	37.7	37.2	265.5	112.7	84.9	3.2	414.5	948.7	99.7	62.7	41.3	192.2	31.0	226.3	54.5	1088.1	1.7	2.3	97.6	203.4	1035.5	422.8	8.4	37.3	789.1	179.7	28.1	1029.7	21.4	498.5	0.5	1.6	405.1	268.7	18.0	154.0	132.4	516.0	110.9	214.0	14.7	92.1	29.5	238.5	2.7	15.5	26.3	37.1	303.2	324.4	20.4	161.1	187.6
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434823-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm		NA	NA		3800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	196.5	205.3	160.2	365.7	167.7	774.3	213.5	160.2	228.2	205.5	165.9	324.0	259.5	151.6	298.3	367.1	162.2	253.1	153.0	167.3	171.5	241.6	262.4	264.7	578.8	172.9	166.9	107.2	171.6	174.8	163.6	276.6	170.8	166.9	344.1	60.4	205.0	152.1	106.7	156.5	258.2	206.6	169.4	366.3	263.3	106.9	165.1	343.3	184.2	102.5	573.7	355.8	206.5	180.5	452.0	360.8	307.0	196.4	318.3	600.2	411.5	476.0	550.1	594.6	578.6	392.9	350.1	654.7	359.3	559.7	354.4	340.1	343.9	520.7	647.7	377.7	415.6	562.1	146.6	385.1	519.7	565.6	842.4	422.6	555.3	375.3	347.8	736.2	756.3	434.5	366.2	170.3	746.3	365.6	661.6	1390.3	302.7	525.8	428.6	510.9	181.5	559.4	1050.5	581.0	346.6	342.2	334.0	464.7	427.1	453.8	757.8	933.8	630.0	350.5	195.7	312.9	349.9	332.7	507.0	914.8	458.0	568.1	425.1	1313.6	1022.6	1660.3	352.4	1182.3	322.2	692.3	361.1	398.7	987.2	604.5	267.0	349.5	1607.5	418.3	1417.4	632.7	619.8	1547.5	160.2	167.7	160.2	228.2	167.3	171.5	172.9	166.9	170.8	169.4	165.1	180.5	316.2	189.1	239.5	16.6	619.4	159.5	315.8	810.1	145.1	36.1	222.3	252.2	52.2	208.8	555.8	268.5	12.5	538.2	582.4	473.2	579.2	636.3	131.2	373.6	241.1	269.0	274.1	244.0	32.4	535.1	824.0	199.0	190.6	459.6	491.8	245.8	227.7	165.5	1432.0	53.8	25.1	538.9	537.1	918.9	781.2	45.3	172.4	935.9	240.1	45.9	1221.8	184.1	545.8	23.6	41.6	630.2	665.2	157.6	352.5	313.5	422.2	777.0	407.3	35.6	249.8	108.4	329.6	209.8	200.1	365.5	171.9	721.6	462.6	323.3	401.1	629.3
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635783	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	86.1	49.2	17.4	148.2	22.5	69.1	48.8	23.7	23.8	46.5	13.0	104.7	99.5	69.5	15.7	77.8	52.0	52.9	35.7	20.0	22.3	39.0	64.3	103.1	158.9	35.2	22.8	30.6	51.7	29.9	19.7	108.2	29.7	46.0	68.9	8.0	45.9	35.9	18.7	42.6	117.4	78.9	24.0	120.8	88.6	38.4	24.1	130.5	46.0	22.5	131.3	75.9	51.8	37.8	313.4	167.7	141.0	98.1	114.0	161.5	338.7	419.7	317.9	176.3	143.0	150.9	215.9	284.9	463.9	241.7	114.6	211.2	101.1	141.6	93.9	413.6	87.1	172.9	212.6	132.6	185.2	254.8	325.0	197.6	148.2	215.7	170.3	201.2	213.7	196.1	133.3	229.1	233.9	125.6	238.5	67.9	133.7	238.5	63.0	219.2	126.3	278.6	97.3	158.7	61.1	164.7	435.8	186.1	167.3	147.1	185.2	222.5	480.9	259.0	134.5	293.8	410.1	270.1	321.8	196.2	204.5	179.6	204.6	1221.0	987.7	1563.7	395.7	1110.1	315.7	338.3	382.3	407.1	838.9	339.7	409.4	415.4	1852.1	392.6	1267.7	394.3	512.4	1913.3	17.4	22.5	23.7	23.8	20.0	22.3	35.2	22.8	29.7	24.0	24.1	37.8	148.7	375.0	188.9	8.1	163.3	249.1	178.3	275.9	91.0	34.2	79.9	118.9	30.2	150.2	197.6	82.8	14.6	475.1	227.4	283.5	166.3	344.3	35.5	78.8	211.4	186.7	202.0	90.0	21.6	280.2	734.2	166.2	87.1	119.8	258.8	147.7	181.7	87.4	608.5	38.7	13.8	146.6	238.0	556.3	740.8	24.2	125.9	558.5	254.3	20.6	635.1	56.7	423.3	7.5	51.5	381.6	234.5	183.6	132.1	182.6	213.6	152.0	95.2	25.4	243.3	83.9	286.8	151.9	137.3	161.5	244.9	199.5	234.4	144.4	155.4	234.6
ARPC5L	"ARC16-2, MGC3038"	ENSG00000136950	"Actin related protein 2/3 complex subunit 5 like"	Q9BPX5	9	124862130-124877733	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 576.3;Late spermatids: 975.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 415.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022013	Approved					NA	NA		97000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"			"HPA022013: AB_1845045"	"unprognostic (2.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.48e-2)"	"unprognostic (9.37e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.58e-1)"	40.1	60.3	47.3	27.6	50.6	51.9	32.7	46.2	57.5	29.7	41.9	38.6	25.5	23.8	22.7	90.7	21.0	19.3	63.0	51.7	49.2	59.0	59.6	47.6	44.6	47.2	47.3	15.1	28.4	22.7	44.1	24.2	47.8	27.8	26.1	14.4	37.3	16.9	70.4	69.8	34.4	18.1	45.6	57.7	43.6	79.1	48.9	24.4	27.8	41.5	48.4	34.0	46.5	50.0	86.2	45.5	38.3	44.9	31.6	45.6	93.5	87.5	48.1	65.9	46.0	94.2	72.9	78.3	51.4	53.5	48.4	124.2	60.4	77.2	62.1	86.8	47.1	41.3	109.5	55.7	50.6	90.8	50.6	35.6	91.1	58.6	63.8	40.4	76.5	47.4	112.0	209.3	69.8	125.3	52.3	86.8	90.1	134.8	114.3	83.2	66.3	228.1	64.2	59.9	56.0	45.3	58.6	74.6	75.5	41.9	105.4	89.0	85.0	55.1	64.7	81.9	123.3	138.0	415.8	103.7	65.3	69.0	53.2	10.2	15.5	20.7	73.3	13.7	71.7	67.3	43.3	77.5	27.1	64.6	31.8	50.3	8.7	86.5	16.1	54.4	54.8	24.3	47.3	50.6	46.2	57.5	51.7	49.2	47.2	47.3	47.8	45.6	48.9	50.0	79.4	57.7	64.4	5.2	98.7	354.2	149.9	135.5	101.3	25.6	92.5	79.4	80.5	71.4	90.8	68.0	2.1	152.2	143.9	104.9	131.0	126.9	576.3	79.8	38.4	119.5	65.7	37.6	17.4	164.6	163.9	49.0	69.8	78.7	37.4	42.6	75.0	83.5	95.2	25.2	10.9	83.8	101.7	32.1	147.3	975.1	41.3	48.9	90.7	5.6	55.7	72.3	267.7	6.0	9.9	270.2	92.5	48.5	150.8	182.0	77.2	98.2	77.5	25.6	26.3	31.3	71.1	246.1	124.3	156.4	418.5	213.7	137.2	66.5	99.9	267.8
ARPIN	"C15orf38, MGC61550"	ENSG00000242498	"Actin related protein 2/3 complex inhibitor"	Q7Z6K5	15	89895006-89912952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 5.3;intermediate monocyte: 2.9;myeloid DC: 4.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.5;monocytes: 5.3"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA040513, HPA047173, HPA052278"	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA040513: AB_2677015, HPA047173: AB_2679969, HPA052278: AB_2681783"	"unprognostic (2.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.62e-3)"	10.6	4.7	9.3	7.0	10.1	0.9	8.4	11.2	8.5	11.4	5.4	15.0	14.5	11.9	13.9	10.3	11.5	8.1	8.1	8.1	9.7	7.5	5.2	11.9	4.6	10.8	9.3	14.7	40.0	12.9	5.0	8.6	9.7	12.6	16.7	9.5	9.0	11.3	9.5	12.2	16.9	11.5	9.3	7.7	8.0	6.0	10.5	3.3	8.7	8.1	5.4	9.5	10.7	10.4	13.9	18.5	18.6	12.3	10.9	14.9	3.5	12.8	9.5	8.5	9.6	2.6	18.8	0.1	6.3	11.6	3.4	6.4	0.1	12.6	7.6	0.1	4.6	0.1	22.1	3.5	7.2	0.1	1.2	9.7	12.2	10.2	2.1	6.5	14.9	0.1	0.1	0.6	11.1	2.8	0.0	0.3	7.5	11.6	2.1	0.0	0.5	0.1	4.5	13.2	0.6	6.1	28.1	11.4	14.5	9.9	22.4	3.8	10.3	15.8	17.6	20.3	6.4	0.3	0.1	0.2	13.1	0.1	5.9	0.5	5.3	0.1	0.1	2.9	0.3	0.1	0.1	0.0	4.5	0.2	0.1	0.1	0.7	0.2	0.4	0.3	0.0	1.3	9.3	10.1	11.2	8.5	8.1	9.7	10.8	9.3	9.7	9.3	10.5	10.4	14.8	25.6	21.0	0.0	1.0	0.0	16.2	0.0	11.4	9.5	11.1	10.3	10.2	22.8	8.1	16.5	12.5	16.1	0.3	19.0	3.9	10.0	33.3	13.0	11.8	13.2	12.2	1.7	0.0	15.8	17.5	13.6	9.2	10.9	6.3	15.7	13.2	13.4	24.4	5.0	0.0	18.3	0.0	26.6	0.0	109.0	15.2	18.5	0.0	0.0	23.0	14.0	0.0	0.0	0.0	12.8	23.8	17.0	0.2	12.5	50.6	19.2	5.1	15.4	13.1	18.3	11.9	20.2	5.7	18.2	0.0	6.7	0.8	6.4	20.6	12.1
ARPIN-AP3S2	C15orf38-AP3S2	ENSG00000250021	"ARPIN-AP3S2 readthrough"		15	89834308-89912882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040513, HPA047173, HPA049270, HPA052278"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"		Vesicles		"HPA040513: AB_2677015, HPA047173: AB_2679969, HPA049270: AB_2680696, HPA052278: AB_2681783"	"unprognostic (1.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-2)"	12.3	12.8	12.4	7.9	14.1	5.9	11.5	14.5	13.3	9.2	10.7	14.6	10.4	9.1	11.4	12.8	9.1	8.1	19.4	11.2	14.2	13.9	23.4	10.2	5.8	14.6	15.1	10.6	20.3	10.9	10.2	9.3	15.0	11.0	15.0	10.9	10.3	8.7	22.0	10.3	9.6	9.4	13.2	9.5	9.4	12.0	15.0	9.0	11.2	15.2	8.0	11.0	10.0	14.9	11.7	25.0	19.5	26.1	27.7	12.5	13.9	20.3	22.8	25.5	25.5	8.1	26.8	6.2	20.8	17.1	21.6	14.2	15.9	17.8	17.2	12.6	14.7	8.6	11.2	18.4	16.1	4.2	6.6	15.2	14.7	15.1	15.2	13.8	23.0	7.5	8.3	14.4	19.8	16.6	6.4	7.0	20.2	29.7	6.0	5.0	7.7	4.1	24.4	13.3	6.1	9.9	36.3	35.2	27.9	25.1	23.3	8.9	11.8	22.6	16.8	31.4	13.0	4.6	13.0	6.6	19.1	5.6	17.0	13.1	26.7	11.8	6.8	23.1	9.1	7.2	8.4	7.5	20.0	6.8	6.2	6.2	18.7	10.9	16.8	8.4	9.3	16.9	12.4	14.1	14.5	13.3	11.2	14.2	14.6	15.1	15.0	13.2	15.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARPP19	"ARPP-16, ARPP-19, ARPP16, ENSAL"	ENSG00000128989	"CAMP regulated phosphoprotein 19"	P56211	15	52547045-52569883	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 268.9"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3587.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056851	Approved					NA	NA		270000	"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA056851: AB_2683255"	"unprognostic (2.83e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.27e-1)"	61.2	51.7	109.3	38.6	268.9	103.3	46.2	99.6	166.2	38.1	56.0	39.6	28.9	47.9	36.3	52.1	33.4	39.2	81.4	154.5	113.0	56.4	42.2	45.1	48.4	116.4	100.4	46.2	46.3	109.2	38.7	57.0	106.1	39.5	35.8	57.4	31.7	40.9	240.3	32.1	30.6	58.0	117.5	43.7	38.6	84.6	107.0	52.9	57.4	170.6	51.7	55.4	30.1	140.2	115.1	126.3	178.2	81.3	69.8	77.6	91.7	103.8	88.7	75.9	76.9	111.7	56.6	120.2	110.3	75.0	110.3	100.4	126.1	116.7	98.2	412.3	59.9	138.0	126.0	99.9	59.4	131.8	99.3	74.0	116.1	78.5	128.2	90.0	119.8	115.3	86.2	224.4	113.9	129.0	126.4	51.6	110.1	81.0	63.8	134.1	102.6	243.3	108.2	146.7	179.4	145.2	76.6	99.2	102.6	194.4	99.2	89.0	109.4	120.3	86.1	87.0	151.1	104.4	289.8	154.8	84.9	116.8	116.7	53.5	38.5	88.1	47.7	44.5	47.4	69.9	50.0	57.4	32.5	50.8	47.9	53.1	63.8	65.6	55.6	41.5	80.2	53.9	109.3	268.9	99.6	166.2	154.5	113.0	116.4	100.4	106.1	117.5	107.0	140.2	90.8	64.1	59.4	33.6	93.9	215.7	190.7	142.2	55.8	54.3	107.3	72.5	156.5	61.5	96.1	62.5	20.9	75.7	100.3	46.2	135.0	88.9	743.5	66.3	60.4	83.0	84.6	63.3	133.2	67.9	94.2	73.7	43.3	104.4	62.1	58.5	80.7	93.1	72.3	85.8	33.9	45.6	81.4	81.7	211.9	3587.2	70.8	73.4	165.4	32.8	144.5	105.5	65.9	24.6	54.3	117.0	38.1	108.3	94.8	174.0	37.0	129.4	62.7	59.4	72.3	78.7	131.1	154.9	196.1	82.0	222.8	87.7	95.0	40.3	43.4	262.9
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 260.8;lymphoid tissue: 170.1;skeletal muscle: 85.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 260.8"	"Immune cell enriched"	"Detected in single"	30	"plasmacytoid DC: 10.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 10.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 254.3"	HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		0.2	0.2	34.8	0.4	260.8	4.5	0.1	85.2	69.9	0.0	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.2	48.5	15.7	1.1	2.3	0.1	0.1	14.3	7.8	0.0	0.1	0.0	12.6	0.0	15.6	1.1	0.4	2.9	2.1	0.2	85.6	0.2	0.3	0.0	0.0	0.2	0.2	0.0	9.1	170.1	0.5	48.6	0.4	0.0	0.0	44.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.6	0.0	5.2	0.0	0.0	0.0	0.6	0.0	111.4	0.0	0.2	2.6	0.0	68.4	0.0	0.1	0.0	2.7	37.3	20.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	34.8	260.8	85.2	69.9	48.5	15.7	14.3	7.8	15.6	0.0	9.1	44.5	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	861.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	108.2	0.0	0.0	0.0	0.0	3.5	0.3	0.1	0.0	21.5	0.1	0.0	0.0	624.8	85.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.5	0.0	21.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ARR3	ARRX	ENSG00000120500	"Arrestin 3"	P36575	X	70268305-70281840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	170	"retina: 392.2"	"Cell type enriched"	"Detected in some"	8	"Cone photoreceptor cells: 1538.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA063129	Enhanced		Approved	"Golgi apparatus"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA063129: AB_2732696"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.77e-7)"	"unprognostic (8.64e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.43e-1)"	0.2	0.3	0.1	0.5	0.2	0.5	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.3	0.0	0.2	0.1	0.4	0.4	0.1	0.1	0.1	0.0	0.2	0.9	0.4	0.3	0.3	0.4	0.0	0.0	0.3	0.3	0.3	0.2	392.2	0.3	0.0	0.3	2.3	0.9	0.0	0.1	0.5	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.2	1.2	0.8	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.2	0.4	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.1	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.1	2.2	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.7	0.0	0.1	0.9	0.5	0.7	0.5	0.0	0.5	0.3	0.3	0.5	0.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.3	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.3	0.0	0.0	0.0	1538.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.2	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	172.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ARRDC1	MGC40555	ENSG00000197070	"Arrestin domain containing 1"	Q8N5I2	9	137605685-137615360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 204.5;T-47d: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044345	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044345: AB_10965181"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.03e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (8.01e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.52e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (5.01e-3)"	"unprognostic (1.51e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.11e-3)"	19.8	25.2	8.7	9.1	8.8	23.3	28.3	7.4	15.1	23.7	11.4	39.0	22.7	13.1	3.2	60.4	21.5	4.6	23.9	9.4	8.0	35.7	42.9	35.2	11.0	9.3	8.3	10.3	42.9	9.5	30.8	7.8	9.2	43.4	5.3	3.1	51.9	11.2	13.6	37.2	43.8	2.5	8.2	54.6	53.7	21.0	8.5	8.3	31.7	4.0	4.9	23.6	35.9	8.4	39.4	25.4	2.4	8.3	3.9	4.2	38.7	10.2	8.8	5.5	4.2	21.4	53.1	9.5	25.7	7.2	10.5	79.5	2.8	32.9	0.9	8.9	15.6	6.4	23.1	19.4	9.3	11.2	15.4	1.7	49.2	4.9	20.4	7.4	7.9	14.7	13.8	5.6	2.4	204.5	13.6	72.0	5.1	43.9	31.6	16.3	4.2	43.1	20.4	29.2	10.3	7.8	7.1	83.0	11.4	2.5	89.9	26.5	18.8	3.2	4.7	21.8	8.8	11.1	9.0	8.3	8.5	24.9	3.7	108.7	99.2	214.7	35.7	132.5	26.4	23.3	32.7	32.8	121.8	39.9	28.9	28.4	92.9	28.3	122.3	46.1	49.7	56.1	8.7	8.8	7.4	15.1	9.4	8.0	9.3	8.3	9.2	8.2	8.5	8.4	39.4	19.2	22.3	11.1	29.2	17.0	58.5	78.0	29.0	7.2	52.5	35.3	5.4	45.8	67.1	58.8	62.6	85.4	43.1	71.7	37.2	50.2	12.1	30.9	8.2	22.5	17.4	11.1	10.6	46.0	41.8	10.1	85.6	32.9	18.4	22.1	23.2	23.7	48.1	3.3	6.1	56.1	57.0	54.0	29.8	14.8	10.8	41.3	7.2	16.9	57.0	10.7	46.4	2.5	3.5	69.1	72.8	10.5	20.6	58.6	81.6	27.4	53.9	46.0	0.0	4.1	13.7	21.3	13.7	33.7	21.3	73.3	38.8	6.7	47.1	69.0
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	65.8	10.7	50.9	23.7	61.3	80.0	49.8	52.9	67.2	31.7	34.2	30.8	12.2	22.8	7.7	22.1	27.7	22.8	34.4	43.2	48.4	32.9	20.4	75.0	38.7	64.7	61.1	13.7	16.5	71.6	17.2	14.4	58.0	33.6	12.1	1.3	44.2	18.8	204.8	30.7	43.4	11.1	50.4	58.4	27.7	5.2	53.1	24.8	44.0	49.3	35.0	32.6	32.0	81.3	12.1	21.2	0.4	10.6	8.5	7.8	8.4	6.8	19.3	5.6	5.5	4.8	22.9	22.1	18.9	5.8	9.1	7.9	8.4	6.2	4.4	14.5	12.3	16.8	18.0	6.8	7.8	12.9	24.0	8.4	9.6	6.5	9.9	10.5	9.6	13.9	19.7	0.6	5.4	18.4	9.8	35.6	2.7	26.4	34.9	57.7	0.2	16.8	8.1	11.0	5.0	5.2	11.1	11.0	11.5	1.7	6.7	32.5	21.1	9.7	7.5	32.9	8.6	1.6	0.1	24.8	15.5	48.6	7.7	3.7	5.8	3.6	3.6	4.8	2.5	3.4	6.1	4.6	3.0	5.3	14.1	7.5	2.3	6.6	5.7	1.8	5.1	4.4	50.9	61.3	52.9	67.2	43.2	48.4	64.7	61.1	58.0	50.4	53.1	81.3	114.2	16.0	15.5	1.6	80.3	6.4	19.8	14.0	13.1	0.4	16.7	11.0	7.3	64.3	15.8	9.2	0.0	0.7	47.7	12.7	1.9	10.8	0.8	10.7	13.0	29.9	18.5	44.6	3.8	6.2	7.8	9.2	23.4	29.8	26.6	3.3	17.2	7.0	17.9	0.0	0.5	12.3	16.2	31.0	58.7	1.2	4.7	50.3	5.4	9.4	14.5	1.1	13.4	0.5	20.0	15.4	9.4	7.5	13.6	24.9	3.5	0.5	15.9	0.4	13.1	14.0	15.9	0.5	3.9	7.6	7.1	1.2	38.6	5.0	5.6	26.7
ARRDC4	FLJ36045	ENSG00000140450	"Arrestin domain containing 4"	Q8NCT1	15	97960703-97973833	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 105.7;Paneth cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.1;classical monocyte: 2.5;eosinophil: 1.5;intermediate monocyte: 1.7;myeloid DC: 1.1;neutrophil: 1.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.5;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"BJ: 103.2;HSkMC: 55.8;hTCEpi: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039934, HPA042109"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Vesicles	"HPA039934: , HPA042109: AB_10795606"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-3)"	"unprognostic (4.49e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.77e-2)"	12.5	12.2	21.6	16.5	24.6	11.5	19.8	24.1	22.4	16.2	16.9	43.9	15.8	14.6	15.6	10.0	14.5	17.2	12.1	30.5	39.1	25.1	30.2	19.8	7.5	76.6	24.1	7.3	34.7	6.3	8.9	18.3	73.9	10.9	23.0	4.5	8.1	16.4	14.8	35.5	22.6	18.1	45.9	8.0	26.9	14.7	20.5	5.7	17.3	9.6	5.1	14.9	10.8	82.8	5.8	0.2	0.8	15.0	6.6	47.7	0.0	103.2	45.8	13.5	6.0	6.2	3.6	0.0	14.2	4.8	1.2	6.0	3.7	36.0	21.6	0.0	9.6	10.1	1.9	4.1	2.6	7.0	15.2	55.8	86.9	15.4	17.9	18.8	0.7	2.9	14.4	0.0	4.9	19.2	1.2	5.8	3.0	17.4	2.1	0.1	0.9	0.2	26.3	12.7	5.0	8.8	15.7	5.7	29.5	3.1	2.1	10.6	0.1	4.0	2.9	21.2	5.0	0.0	0.0	0.2	8.7	1.2	10.6	1.1	2.5	1.5	0.0	1.7	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.4	21.6	24.6	24.1	22.4	30.5	39.1	76.6	24.1	73.9	45.9	20.5	82.8	5.7	3.2	10.4	19.9	4.0	25.4	3.1	11.0	23.9	1.6	14.4	8.3	12.9	8.6	9.4	22.0	6.2	0.3	1.4	105.7	7.9	2.7	4.5	21.5	17.6	5.9	38.3	4.4	8.1	8.2	0.2	12.3	15.8	18.0	23.5	1.4	6.4	17.1	21.5	0.0	6.0	29.5	10.2	23.9	10.5	10.9	5.0	19.7	24.9	3.7	13.4	0.7	3.1	38.7	3.4	12.0	82.4	8.2	0.2	12.2	30.2	3.1	15.6	3.5	0.0	7.8	12.5	2.0	12.6	11.8	31.1	0.7	1.3	17.5	31.3	12.2
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	28.8	25.1	14.4	15.6	18.0	18.4	27.2	16.8	21.8	21.3	27.5	31.3	30.8	22.4	8.6	28.1	25.1	15.7	33.0	14.9	15.2	31.4	42.8	29.1	19.8	20.0	15.9	11.3	46.7	11.7	34.7	10.9	19.1	28.9	8.2	4.4	39.6	16.2	25.3	17.5	33.8	6.5	16.3	44.5	30.3	54.0	19.4	9.8	32.3	5.1	9.5	23.9	24.7	21.0	8.5	11.0	5.3	10.9	41.8	21.8	13.5	13.0	15.9	5.7	9.3	3.3	12.9	5.3	8.2	22.9	10.8	12.8	1.2	12.3	1.0	2.7	8.0	3.4	14.3	12.5	28.3	5.2	32.7	26.0	24.4	9.5	6.3	19.9	12.8	11.5	3.5	80.4	12.1	9.6	4.6	5.8	1.7	9.0	11.2	4.0	0.4	26.7	9.9	13.5	2.5	8.2	18.2	17.2	10.1	5.1	7.7	6.6	22.1	3.8	15.1	14.9	4.1	18.4	1.9	4.5	11.7	4.3	13.6	10.4	27.7	36.1	17.3	33.3	15.1	10.4	12.4	14.2	22.7	12.5	7.3	10.0	60.4	8.9	43.2	32.1	18.2	16.3	14.4	18.0	16.8	21.8	14.9	15.2	20.0	15.9	19.1	16.3	19.4	21.0	22.8	6.4	12.9	24.5	22.2	4.7	14.0	23.8	18.8	5.3	18.9	13.1	8.0	27.1	15.5	12.9	4.2	11.5	14.0	85.4	1.9	29.4	62.4	24.4	10.3	13.4	36.7	9.7	9.4	21.3	19.9	19.6	41.3	21.3	6.3	15.3	8.2	28.6	36.8	6.7	8.6	30.6	14.2	29.0	9.5	127.5	10.8	29.2	17.8	10.3	28.7	10.3	8.2	8.0	11.9	24.2	75.2	6.0	132.0	10.8	93.9	22.7	21.2	7.2	0.0	6.6	9.9	48.3	4.1	18.3	5.5	13.3	17.2	7.2	25.0	16.1
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 25.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	6.9	4.5	3.9	8.1	3.9	8.1	2.6	3.1	4.6	5.3	4.2	5.5	3.1	6.4	3.5	4.8	2.9	7.3	8.3	4.7	3.6	21.3	7.6	7.0	5.4	4.6	5.3	2.2	4.6	6.6	2.5	11.5	4.0	5.0	8.2	6.7	3.1	6.6	3.8	2.1	3.6	14.1	4.3	5.2	3.9	2.6	5.2	2.6	4.2	4.3	4.8	8.0	2.3	5.0	5.0	11.3	18.6	6.3	41.9	16.4	16.7	29.2	23.0	18.9	23.0	9.9	8.4	6.5	31.5	25.5	29.0	3.9	7.0	7.4	18.5	55.6	6.2	9.2	11.2	40.1	9.7	10.5	10.4	19.4	2.4	19.7	6.5	15.6	22.4	3.9	2.0	12.9	19.6	9.2	5.8	19.3	5.6	1.1	6.7	7.7	10.9	5.9	12.0	6.2	6.8	15.9	20.3	6.2	12.1	12.7	6.9	26.2	16.2	17.5	10.4	7.6	26.4	14.8	28.0	7.2	21.6	21.4	40.3	19.0	8.3	25.6	1.0	6.7	0.6	2.0	0.4	0.4	7.8	1.3	0.3	0.5	4.6	0.2	5.6	5.7	0.7	2.7	3.9	3.9	3.1	4.6	4.7	3.6	4.6	5.3	4.0	4.3	5.2	5.0	3.9	0.0	2.0	40.8	5.1	0.8	1.4	1.3	0.6	3.7	1.6	1.0	7.2	1.5	0.7	3.7	6.2	2.2	5.5	1.4	3.9	3.7	0.5	1.9	7.2	4.5	1.2	16.2	37.4	9.2	5.1	6.6	2.6	9.0	0.0	6.3	13.6	3.8	16.7	6.7	42.5	6.0	0.0	25.2	14.3	0.5	4.4	15.9	14.2	40.3	16.1	3.6	2.1	71.4	56.2	4.0	3.0	3.8	8.1	2.2	0.5	18.8	2.5	2.7	6.6	5.0	4.4	2.2	3.1	0.7	1.3	2.6	3.4	1.6	2.2	1.3
ARSD		ENSG00000006756	"Arylsulfatase D"	P51689	X	2903972-2929349	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.2;EFO-21: 24.5"									"HPA004694, HPA063835"	Approved		Approved	"Vesicles,Lipid droplets"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA004694: AB_1078221, HPA063835: AB_2685132"	"unprognostic (3.92e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (5.90e-3)"	"unprognostic (6.32e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.18e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.11e-3)"	8.4	7.8	4.3	6.1	4.1	4.9	23.6	4.2	4.5	23.9	10.7	20.5	21.0	11.2	15.9	10.0	28.0	11.4	4.8	4.1	5.1	38.9	40.0	16.8	3.6	6.3	5.7	18.7	32.4	12.7	4.2	8.6	5.4	19.3	14.8	1.7	17.5	13.3	1.7	7.3	15.4	7.6	5.6	7.2	30.4	3.8	4.6	2.8	21.1	3.2	4.2	11.7	8.4	5.0	6.9	12.0	3.2	15.4	13.6	7.7	0.1	3.9	7.1	1.7	1.1	0.7	23.2	0.0	24.5	7.9	18.1	0.0	0.6	2.0	1.6	0.2	0.0	0.0	0.0	4.0	7.5	0.0	9.1	12.3	6.3	3.4	3.6	11.1	11.5	0.0	0.0	0.1	7.6	16.9	0.1	1.7	2.7	21.3	5.0	2.9	0.0	0.2	12.3	0.1	0.0	8.5	5.4	6.3	4.1	8.5	17.1	13.1	10.6	0.0	0.5	1.2	1.8	0.1	0.0	0.0	11.1	8.2	8.8	1.5	5.8	4.1	1.7	5.0	0.6	1.3	0.8	1.4	4.4	0.8	0.2	0.9	1.0	2.0	2.0	3.0	0.3	2.5	4.3	4.1	4.2	4.5	4.1	5.1	6.3	5.7	5.4	5.6	4.6	5.0	13.4	19.2	36.4	9.8	4.5	5.0	13.9	11.3	10.8	4.9	45.0	30.9	5.6	74.4	23.1	44.1	0.0	19.1	8.6	44.3	19.6	35.1	0.7	68.6	19.6	13.8	67.9	3.4	0.9	53.9	25.0	7.9	31.6	67.8	16.5	66.8	11.7	109.9	18.5	0.0	1.7	56.2	10.2	17.8	6.4	1.4	6.2	16.1	14.2	6.5	23.1	5.8	11.3	3.5	1.5	47.4	47.9	6.8	1.6	18.1	53.1	23.4	25.8	0.9	6.6	15.1	10.7	1.3	3.9	16.2	7.2	26.0	4.3	38.3	60.9	16.4
ARSG	KIAA1001	ENSG00000141337	"Arylsulfatase G"	Q96EG1	17	68259182-68422731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 30.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;NK-cells: 42.2;Rod photoreceptor cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023245, HPA023285"	Enhanced				"Intracellular and membrane"	NA	NA		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA023245: AB_1845056, HPA023285: AB_1845057"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.11e-7)"	"unprognostic (4.24e-3)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.87e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.49e-1)"	2.6	4.6	1.5	2.9	2.0	3.4	5.5	6.6	2.0	3.5	8.6	2.2	1.1	3.8	30.2	4.4	6.6	2.1	4.9	1.1	2.9	3.0	2.5	2.4	3.9	2.5	3.6	6.2	2.3	1.2	5.3	2.6	3.6	2.0	1.1	7.8	3.3	5.5	3.7	4.5	1.9	2.1	0.7	4.9	2.6	2.1	2.1	2.5	7.5	3.0	3.6	2.0	2.0	1.4	1.4	1.7	1.3	2.1	7.0	4.3	5.7	1.9	5.7	2.7	1.3	0.7	3.2	3.3	4.8	2.5	1.1	0.2	2.2	0.7	1.0	4.8	2.0	1.8	1.8	5.4	5.7	5.1	3.6	1.6	1.3	0.7	2.8	7.2	3.1	5.0	1.0	9.5	1.2	6.2	5.9	4.1	2.0	0.6	1.6	0.2	1.0	8.8	4.1	0.9	7.0	0.6	2.3	5.5	12.1	2.7	13.5	6.1	3.3	4.2	0.4	1.6	0.7	10.5	5.8	5.0	3.3	6.4	1.6	7.1	8.5	6.5	6.3	6.1	4.4	4.0	4.2	6.0	7.7	2.2	4.2	6.0	12.8	4.3	5.2	1.2	4.7	5.4	1.5	2.0	6.6	2.0	1.1	2.9	2.5	3.6	3.6	0.7	2.1	1.4	4.9	3.2	2.7	11.8	7.7	4.0	5.0	4.7	0.0	23.8	9.2	3.8	2.7	8.6	4.8	12.9	54.2	8.1	11.2	3.6	9.8	3.2	0.4	8.7	9.2	8.6	1.8	5.3	18.8	4.7	23.8	24.3	2.6	11.7	3.8	6.4	17.5	3.0	9.2	26.9	26.0	5.2	0.0	6.9	10.7	1.3	13.4	8.4	23.2	12.2	16.0	9.4	42.2	7.1	2.7	2.3	10.9	23.0	11.1	10.0	2.4	12.8	4.3	59.6	6.6	8.7	5.5	1.4	3.6	6.0	3.8	16.8	13.6	9.3	2.3	8.8
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: AB_2675995"	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.19e-4)"	1.2	0.3	1.6	2.3	2.6	0.6	0.4	2.5	2.1	2.7	0.7	1.6	0.6	3.1	0.6	1.8	2.1	1.1	1.3	1.4	1.8	0.7	0.4	4.5	0.3	3.6	2.4	0.4	0.4	0.6	1.0	2.8	3.9	1.7	0.4	0.4	0.5	0.8	0.8	4.8	0.7	2.8	2.6	0.8	0.8	0.4	2.8	0.3	0.2	0.5	0.4	3.8	2.7	5.5	1.0	3.8	1.1	0.0	0.0	0.8	0.0	8.1	12.1	15.7	11.5	1.1	1.8	0.0	3.1	11.5	1.3	31.4	0.2	5.3	5.6	0.0	0.1	0.0	0.4	19.9	1.5	0.0	0.0	0.8	3.4	30.9	0.9	10.7	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.2	0.0	6.7	0.9	1.3	11.2	0.0	0.0	0.0	0.3	10.2	0.3	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.6	2.5	2.1	1.4	1.8	3.6	2.4	3.9	2.6	2.8	5.5	0.1	0.0	0.0	0.3	0.0	12.1	0.0	2.4	0.0	0.1	0.1	0.4	1.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	1.1	10.8	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.1	0.0	0.8	0.2	0.6	0.0	21.4	0.0	0.0	3.9	0.0	0.0	2.5	0.4	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.3	0.0	1.8	6.6	0.1	0.9	0.9	4.7	1.4	1.1	0.0	0.0	0.0
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	1.8	1.3	1.5	1.3	1.1	0.0	1.0	5.0	1.4	4.5	0.2	2.4	0.6	2.0	0.9	3.1	2.8	3.6	2.5	1.2	0.9	2.7	1.7	3.3	0.6	0.9	1.1	2.0	1.1	3.0	0.7	4.3	0.7	3.9	3.3	0.6	5.8	2.2	0.2	0.7	0.7	2.2	0.6	0.2	3.5	0.1	1.9	1.5	0.7	0.6	0.3	3.8	2.1	1.1	2.7	5.3	0.6	0.0	10.1	20.5	0.0	46.4	35.5	29.0	11.3	1.3	3.4	0.0	5.7	22.6	10.3	5.0	0.2	11.7	36.2	0.0	2.1	0.0	4.2	0.0	30.6	0.0	0.0	12.7	11.5	19.7	40.0	20.5	42.2	0.0	0.0	0.0	42.8	0.4	0.0	0.0	1.5	0.0	8.4	0.0	5.1	0.0	38.0	0.0	0.0	1.7	3.1	0.5	2.2	7.5	0.2	0.0	53.6	33.3	8.7	5.0	22.3	0.0	0.0	0.0	16.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	5.0	1.4	1.2	0.9	0.9	1.1	0.7	0.6	1.9	1.1	0.7	35.3	9.8	44.1	0.2	2.9	60.3	23.7	15.9	0.2	4.7	2.9	1.3	11.5	10.8	25.8	0.0	0.3	0.1	7.0	0.0	9.2	0.0	6.2	21.1	4.3	23.4	0.0	27.1	0.9	0.2	13.6	4.6	8.2	0.0	0.0	4.2	1.2	0.5	1.7	1.5	17.3	16.2	0.3	1.6	0.3	2.5	0.3	3.6	7.5	0.0	6.8	1.0	3.0	0.5	5.2	5.0	1.5	0.0	49.6	0.1	4.1	4.6	0.2	0.0	8.6	10.5	0.1	0.3	16.9	1.1	0.4	0.6	3.3	4.1	25.6
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555101-95605102	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 19.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	3.0	3.7	2.1	2.2	2.3	2.3	3.3	2.8	3.0	3.8	2.1	2.7	2.2	3.6	4.2	2.9	3.2	3.1	2.6	2.4	2.1	5.4	3.7	2.9	2.7	1.9	1.9	5.8	4.9	19.1	2.6	5.5	2.3	4.9	2.5	3.6	2.8	4.9	2.3	3.3	2.2	3.0	1.7	2.4	4.2	1.6	2.6	3.7	5.0	2.7	2.0	3.2	3.3	2.2	5.1	3.2	6.6	6.6	32.4	16.8	9.5	15.9	9.2	6.1	12.4	3.9	7.8	6.9	8.1	5.5	10.9	4.6	5.8	10.1	13.3	7.4	8.5	5.5	7.7	6.7	9.4	3.1	4.4	12.4	8.9	9.2	5.9	12.8	10.0	9.3	5.6	7.4	13.7	2.5	8.5	5.9	8.6	1.6	15.3	5.2	10.6	11.0	14.1	1.2	4.7	4.8	9.7	3.1	10.0	9.1	8.9	3.2	18.1	9.6	7.8	15.0	9.9	6.2	11.2	8.4	9.6	8.0	36.5	12.9	1.1	2.1	4.0	1.2	4.7	4.9	4.7	5.4	0.6	5.0	7.0	5.2	0.9	3.3	0.7	2.2	3.9	1.8	2.1	2.3	2.8	3.0	2.4	2.1	1.9	1.9	2.3	1.7	2.6	2.2	6.8	3.2	2.2	9.1	6.6	4.5	6.8	7.4	5.7	7.3	4.4	7.2	4.6	1.5	3.7	7.3	12.5	11.8	6.6	1.9	3.9	4.1	9.2	7.1	10.3	6.2	3.0	10.1	11.0	2.5	47.4	13.6	2.0	5.7	22.9	8.1	6.8	16.5	4.6	10.1	9.7	2.0	10.2	3.2	5.4	2.9	10.8	4.9	5.4	7.5	5.1	12.7	14.4	7.1	10.0	2.6	3.2	11.7	7.1	3.9	3.2	4.8	6.8	10.4	0.0	10.2	10.9	7.4	8.6	5.1	7.0	5.1	9.8	11.8	3.4	2.1
ARSL	"ARSE, CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase L"	P51690	X	2934521-2968475	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 86.3;pancreas: 105.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 34.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.4	0.7	2.6	2.2	2.7	0.3	1.1	2.1	2.8	1.7	4.5	20.8	17.9	3.2	2.2	0.4	4.1	8.2	1.0	2.8	2.6	36.6	86.3	2.7	0.1	2.8	2.8	7.1	105.2	0.0	0.7	0.7	2.9	0.5	16.7	0.3	1.3	2.9	0.2	0.2	13.6	1.9	2.4	0.0	2.9	0.4	2.6	0.0	0.2	0.3	0.1	0.5	1.6	2.3	4.5	68.9	8.2	0.0	3.3	4.0	1.3	3.9	6.4	4.0	4.0	42.7	0.0	0.0	13.7	0.1	30.8	0.0	0.0	0.9	2.3	0.0	4.5	0.0	0.0	64.1	1.8	0.0	0.1	9.6	0.0	3.8	0.0	7.3	3.8	0.0	0.0	0.1	10.5	0.1	0.0	0.0	33.6	2.4	0.2	2.8	1.1	0.3	7.1	0.0	0.1	0.2	0.0	0.0	2.6	13.7	0.0	0.2	5.0	0.1	0.2	0.0	7.4	0.0	0.0	0.1	9.1	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	2.1	2.8	2.8	2.6	2.8	2.8	2.9	2.4	2.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ART1	"ART2, ARTC1, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	57	"skeletal muscle: 47.4;tongue: 36.8"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	36.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3	ARTC3	ENSG00000156219	"ADP-ribosyltransferase 3 (inactive)"	Q13508	4	76011184-76112802	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 67.3;skeletal muscle: 220.2;testis: 96.4;tongue: 101.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 76.2;Spermatocytes: 262.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		48000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	1.0	0.4	3.4	1.1	4.2	0.0	0.9	6.9	9.4	2.2	4.0	3.7	0.3	0.3	0.5	4.7	0.9	0.2	67.3	4.7	4.6	0.2	0.2	0.4	0.3	3.3	3.3	0.4	7.9	0.1	2.5	0.1	2.8	2.0	2.2	0.2	3.1	1.3	220.2	0.9	2.3	0.4	3.5	2.7	1.9	96.4	2.7	0.6	0.3	101.6	0.1	0.7	1.7	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	14.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	6.9	9.4	4.7	4.6	3.3	3.3	2.8	3.5	2.7	9.9	0.4	0.0	0.0	0.7	0.1	0.5	0.5	1.1	0.0	0.5	0.2	0.3	76.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.3	2.1	0.4	0.8	0.0	0.0	37.9	0.0	0.1	2.6	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	13.5	1.8	0.2	1.8	0.0	0.0	0.3	0.0	5.0	7.3	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.3	0.0	21.7	2.7	262.8	24.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4
ART5	ARTC5	ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638512-3642316	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.4;testis: 29.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 18.3;Late spermatids: 18.5;Spermatocytes: 64.9"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 13.9"	"Not detected"	"Not detected"							"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.7	0.2	0.3	0.0	0.3	0.0	1.0	0.3	0.5	4.1	0.6	0.3	0.0	3.6	0.7	0.5	1.5	1.4	1.8	0.3	0.8	0.8	0.9	0.9	0.1	0.4	0.4	8.3	0.4	2.9	0.7	0.1	0.6	1.1	0.0	0.6	1.6	0.9	13.4	0.5	0.2	1.1	0.3	0.0	0.5	29.4	0.4	0.3	2.8	10.5	0.0	0.7	2.2	0.3	0.0	0.1	1.6	2.0	0.0	0.0	3.2	0.2	1.6	0.7	1.8	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.5	0.0	0.4	0.0	2.2	0.0	0.3	0.1	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	13.9	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.8	0.4	0.4	0.6	0.3	0.4	0.3	0.1	0.0	1.8	0.0	0.0	0.3	2.2	0.0	2.8	0.8	0.3	1.3	2.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.6	18.3	0.1	0.2	0.4	0.0	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.0	3.3	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.3	0.0	18.5	3.4	0.1	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.0	0.6	0.0	0.9	0.0	1.3	0.2	64.9	3.9	0.1	0.3	2.9	0.0	1.2	0.0	0.3
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.6	18.4	23.4	10.2	24.5	13.9	19.0	26.2	32.8	12.2	25.7	24.6	16.4	9.7	22.9	15.7	14.3	16.4	30.1	24.5	25.6	25.2	26.2	15.0	14.8	25.2	24.1	11.2	17.5	33.3	20.1	11.7	25.0	16.2	25.9	29.0	22.0	15.2	21.7	17.8	17.3	13.1	25.7	13.5	17.1	31.3	25.2	15.0	21.9	24.8	15.3	15.2	11.2	27.7	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	23.4	24.5	26.2	32.8	24.5	25.6	25.2	24.1	25.0	25.7	25.2	27.7	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ARVCF		ENSG00000099889	"ARVCF delta catenin family member"	O00192	22	19969896-20016823	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 22.9;Muller glia cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 20.1;REH: 10.5;SCLC-21H: 18.0;SH-SY5Y: 13.8;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.76e-6)"	3.8	3.1	6.4	0.7	5.4	3.2	4.4	18.4	6.2	4.3	1.2	5.9	1.0	4.8	3.2	1.3	3.5	1.3	6.4	5.6	7.1	6.2	6.8	4.5	0.5	7.0	5.2	3.5	5.1	1.7	9.4	1.0	5.7	5.7	0.3	1.4	7.0	1.7	7.4	4.7	2.8	0.7	4.9	10.8	4.8	4.9	8.3	0.2	15.6	1.2	0.1	2.8	2.8	5.1	4.1	0.4	5.5	7.1	0.1	0.0	5.6	1.0	0.4	0.3	0.6	1.1	0.9	1.7	4.5	0.5	0.5	3.8	0.9	1.8	0.0	0.5	6.8	0.5	0.5	4.4	1.6	0.6	1.3	0.1	0.7	0.3	0.2	0.3	4.5	1.3	20.1	0.6	0.1	3.8	0.3	2.6	5.6	1.3	2.3	10.5	0.3	0.5	0.9	0.9	18.0	13.8	1.1	1.7	2.7	0.9	1.5	0.5	1.7	0.1	15.6	0.7	0.3	2.2	0.7	0.5	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.4	18.4	6.2	5.6	7.1	7.0	5.2	5.7	4.9	8.3	5.1	2.3	3.2	2.6	24.2	0.7	2.0	3.0	4.4	0.6	9.7	6.6	7.9	6.0	5.7	3.2	1.8	22.9	5.6	2.3	1.8	0.0	8.9	2.7	2.4	0.9	3.0	9.0	4.0	4.7	5.5	2.2	2.4	1.5	4.5	0.0	4.7	2.5	4.1	1.4	5.0	6.2	7.0	10.2	1.0	1.2	1.7	4.1	0.8	3.6	5.6	0.0	21.7	7.2	8.0	1.8	10.7	0.6	3.4	0.9	4.7	0.8	5.6	4.9	8.6	0.0	7.7	6.2	2.3	8.4	0.4	1.8	4.4	0.6	1.6	2.1	1.5
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869470-102901899	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 302.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Basal squamous epithelial cells: 1.2;Proximal tubular cells: 1.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;REH: 54.6;SH-SY5Y: 27.8;T-47d: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	5.1	302.4	7.4	1.3	7.5	0.7	6.3	11.5	8.7	7.5	9.3	6.4	3.0	7.7	4.4	3.6	5.8	6.7	26.8	6.7	8.4	19.2	59.2	4.0	2.0	7.9	8.3	8.7	11.7	65.7	6.6	1.0	8.0	9.1	1.8	4.8	4.8	5.2	11.4	4.3	3.3	3.9	6.6	18.3	4.7	8.7	7.7	3.7	7.7	15.2	1.6	3.2	5.0	8.3	0.0	7.6	26.8	17.4	0.6	0.6	5.1	8.1	6.7	11.9	14.3	21.3	1.2	0.0	2.4	10.7	0.6	0.4	23.8	1.4	12.4	0.3	6.7	0.0	3.2	20.9	7.7	0.2	0.6	3.7	3.1	1.6	0.0	21.3	0.5	25.3	0.0	0.4	10.8	0.1	4.9	0.7	13.2	0.1	1.0	54.6	0.0	0.2	2.7	0.0	0.4	27.8	0.0	0.4	3.7	8.8	43.9	0.6	0.1	2.6	0.0	3.9	0.0	0.2	0.4	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.4	7.5	11.5	8.7	6.7	8.4	7.9	8.3	8.0	6.6	7.7	8.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 573.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 777.0;Hofbauer cells: 921.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 392.8;SK-MEL-30: 590.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	214.3	71.9	50.1	51.6	51.5	107.7	95.8	62.1	50.8	98.5	62.6	84.3	54.7	55.8	131.5	73.2	70.4	99.1	573.9	49.9	66.2	204.0	60.9	190.3	65.9	66.0	59.4	50.1	49.6	117.8	83.6	121.5	69.0	84.3	87.0	79.5	66.6	77.9	66.0	52.6	56.8	61.7	66.3	85.4	61.2	18.2	59.1	26.0	325.5	70.7	57.7	112.8	54.8	102.2	48.1	66.4	25.9	63.3	392.8	46.0	39.2	48.2	67.3	23.0	41.0	35.4	66.1	30.2	60.3	54.5	159.1	62.6	15.0	25.3	28.4	22.9	38.9	134.4	46.7	96.7	107.5	27.7	140.7	100.2	86.5	33.6	22.9	53.2	6.2	50.6	24.3	61.7	67.9	46.0	15.5	48.3	30.3	105.2	40.5	19.4	25.5	41.4	112.0	273.0	40.4	55.0	43.8	145.2	590.5	35.6	47.9	31.3	43.6	30.3	43.1	55.8	23.7	75.5	184.3	22.0	89.5	61.3	24.6	285.2	455.4	318.7	47.6	676.4	43.1	83.9	35.5	36.1	175.1	65.9	40.8	37.9	627.6	60.5	731.4	33.0	43.7	407.2	50.1	51.5	62.1	50.8	49.9	66.2	66.0	59.4	69.0	66.3	59.1	102.2	98.5	317.3	405.0	36.9	92.8	58.6	83.3	103.7	35.3	97.5	105.6	87.8	777.0	100.1	280.9	450.6	45.9	177.4	67.6	83.4	60.7	150.6	2.8	85.7	51.5	79.7	98.1	106.3	49.8	104.1	65.2	122.0	43.3	133.8	257.0	49.3	134.6	50.6	921.2	77.4	53.2	99.3	201.4	564.3	89.9	6.0	88.6	524.6	318.4	56.2	259.2	532.6	53.5	49.8	49.0	64.7	125.5	105.7	87.4	87.8	77.6	304.2	147.3	88.0	177.5	74.5	157.0	14.0	63.6	84.9	64.2	148.2	61.3	53.4	89.7	139.9
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50279720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 81.5"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 12.5;Muller glia cells: 9.0;Proximal enterocytes: 17.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebellum: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		2200000	"Cluster 32: T-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.4	0.8	0.0	0.2	1.1	0.0	0.5	8.1	0.4	0.7	0.1	0.8	81.5	0.8	0.5	0.7	0.8	0.3	0.8	0.1	0.4	0.5	2.9	0.6	0.3	3.2	2.9	0.8	1.4	0.6	0.6	0.6	2.2	0.4	0.4	7.3	0.6	0.2	0.8	0.7	64.6	1.2	1.5	0.2	5.0	0.8	0.6	0.5	0.7	0.4	0.1	0.5	0.4	0.6	1.2	0.9	1.0	1.4	1.8	0.7	1.3	1.2	0.9	2.5	2.2	0.7	3.0	0.0	1.4	1.9	2.0	1.1	1.4	0.4	3.0	1.6	2.5	0.9	2.2	1.9	1.1	0.3	0.1	0.2	1.7	4.3	4.8	0.3	0.5	0.0	1.7	0.8	1.7	1.1	1.0	0.0	3.2	0.0	2.7	0.0	4.2	1.1	1.3	0.2	1.8	4.8	1.7	1.2	2.1	2.4	1.0	0.7	1.4	1.2	2.8	3.2	4.0	1.2	0.1	0.0	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	8.1	0.4	0.1	0.4	3.2	2.9	2.2	1.5	0.6	0.6	0.1	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.0	2.8	0.4	0.3	3.8	0.0	0.9	0.0	2.1	0.4	1.4	0.5	0.0	0.9	4.8	0.1	0.2	0.5	0.0	3.2	1.1	1.6	0.3	0.6	0.0	0.2	0.0	0.2	0.4	2.1	0.2	1.7	1.5	1.8	0.0	0.0	0.0	12.5	1.2	0.0	0.0	0.0	0.0	9.0	1.0	0.0	0.2	1.6	0.1	1.5	0.0	0.3	17.1	1.0	0.7	2.1	6.6	0.6	0.9	1.9	0.9	0.0	0.1	0.3	0.5	0.2	1.2	0.2
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"intestine: 17.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 25.8"					"Low region specificity"	"Detected in many"			HPA061171	Supported		Approved	"Focal adhesion sites"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	1.5	3.7	1.9	1.9	1.8	1.3	2.8	2.0	2.3	2.1	1.7	2.8	17.2	1.6	3.4	2.6	2.6	2.4	5.2	1.9	2.5	4.4	6.4	2.0	1.7	2.4	2.2	3.0	3.5	4.6	3.3	1.0	2.1	3.6	3.2	7.0	2.6	2.4	3.7	1.8	11.1	2.6	1.6	0.9	3.9	3.0	2.6	1.6	3.7	4.0	1.7	1.8	1.7	2.7	2.5	3.7	3.9	6.3	1.4	3.1	3.0	12.9	7.1	7.5	6.1	8.3	7.4	0.1	4.5	3.4	2.4	2.4	4.3	5.4	6.1	4.6	5.4	1.6	10.5	6.4	5.1	2.2	2.3	3.9	5.6	7.1	10.4	2.3	1.7	0.0	8.0	3.0	5.9	6.0	3.7	0.2	5.0	7.6	25.8	0.1	8.9	3.1	4.2	9.7	7.2	14.7	4.1	5.0	4.3	4.0	8.5	1.4	8.0	3.0	14.0	6.3	16.2	3.9	0.5	0.0	15.5	0.0	5.7	0.3	0.0	0.0	1.1	0.0	3.2	0.4	1.9	1.3	0.0	0.7	2.6	2.5	0.2	0.3	0.0	1.8	2.4	0.8	1.9	1.8	2.0	2.3	1.9	2.5	2.4	2.2	2.1	1.6	2.6	2.7	0.6	3.2	1.1	1.0	1.1	1.7	1.0	1.5	3.4	7.0	2.9	1.7	5.1	5.7	2.1	5.5	8.4	1.7	0.6	1.4	5.9	4.4	0.2	1.6	1.4	1.3	6.7	0.8	6.4	4.8	1.5	2.0	3.6	1.0	0.0	2.3	1.8	7.3	0.3	0.0	6.4	4.2	2.0	0.0	0.0	1.0	1.8	0.1	1.8	2.8	0.2	4.1	2.1	7.1	0.5	4.4	2.5	1.2	2.2	1.3	3.5	6.0	2.0	4.6	0.0	1.0	2.4	4.3	3.0	3.4	0.4	0.5	2.2	2.3	3.9	1.0
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
ASAP2	"CENTB3, DDEF2, KIAA0400, PAP, SHAG1"	ENSG00000151693	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2"	O43150	2	9206765-9405683	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 46.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 141.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018615	Approved		Supported	Cytosol		NA	NA		260000	"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB018615: AB_2242947"	"unprognostic (1.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	12.4	3.3	3.9	5.6	11.8	0.7	6.8	11.0	9.1	11.4	4.7	17.7	13.8	12.8	10.0	8.8	10.7	10.1	9.6	6.3	7.0	23.7	3.8	10.0	2.8	8.1	6.1	7.7	7.8	9.9	9.5	10.4	8.9	5.2	16.1	8.8	5.6	9.2	2.5	13.1	13.6	13.9	0.8	1.5	24.3	46.8	3.2	2.7	19.1	6.4	3.1	8.5	7.8	7.0	34.8	19.9	35.8	21.2	26.0	35.9	5.9	34.4	27.7	24.9	24.9	13.9	51.0	0.1	29.8	39.2	54.7	32.8	19.9	60.6	30.6	25.1	8.1	8.0	15.4	24.1	63.1	0.0	2.4	13.6	24.5	30.1	96.8	74.5	51.9	6.4	3.7	3.6	97.8	21.1	10.2	2.0	16.9	49.5	23.2	19.5	53.7	6.5	48.7	26.7	15.6	59.6	28.7	18.9	30.7	18.7	13.1	5.5	81.8	41.6	1.9	32.5	31.7	0.0	0.2	0.1	30.4	0.2	54.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.9	11.8	11.0	9.1	6.3	7.0	8.1	6.1	8.9	0.8	3.2	7.0	41.0	19.2	8.3	141.0	1.4	37.2	22.8	16.6	14.8	28.2	8.4	7.7	1.6	4.3	12.9	35.0	0.0	1.6	0.3	60.7	50.9	15.4	67.0	14.9	20.8	36.1	9.1	0.0	76.2	14.0	0.3	26.0	52.5	26.8	1.3	9.7	51.8	4.4	12.8	6.7	46.5	40.8	20.3	4.4	12.9	50.7	2.8	10.6	33.8	39.4	7.9	20.4	0.0	48.2	55.0	62.1	45.4	3.8	0.2	33.8	21.6	31.1	12.9	5.3	26.3	24.9	35.3	39.8	8.9	5.5	32.1	0.4	1.2	1.6	21.4	53.3
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	24.1	39.1	11.5	3.2	11.6	0.1	21.9	12.5	12.4	32.6	10.0	18.4	1.6	18.6	4.2	32.3	24.3	5.1	30.1	10.5	11.2	21.4	19.8	15.9	1.6	14.5	12.7	58.3	22.2	11.7	18.6	8.0	13.2	31.0	5.2	3.0	38.0	8.0	42.9	52.9	11.0	5.9	12.7	5.0	25.4	18.2	13.4	1.0	29.0	11.7	4.2	21.3	33.4	12.1	1.8	1.8	17.6	11.6	31.8	29.9	21.6	3.2	3.8	4.9	6.3	1.3	0.1	9.2	3.7	6.3	2.9	8.4	12.2	2.9	2.8	0.4	1.6	0.5	4.8	11.8	17.1	0.0	0.9	38.4	4.4	7.9	7.1	14.6	3.9	1.3	6.4	0.0	3.1	3.9	1.3	0.1	3.0	5.0	4.2	4.9	1.9	0.0	3.4	3.7	0.6	6.0	14.1	3.5	3.5	8.7	13.2	0.1	1.4	2.1	5.2	5.9	0.2	3.9	4.2	1.1	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.5	11.6	12.5	12.4	10.5	11.2	14.5	12.7	13.2	12.7	13.4	12.1	4.5	9.6	6.7	35.9	0.3	2.0	1.5	2.0	2.8	1.1	6.3	3.7	15.5	0.0	4.1	3.7	0.0	2.1	0.0	6.7	3.9	5.8	5.1	2.4	7.3	6.6	1.2	0.0	7.6	6.1	43.3	12.2	10.2	4.4	1.3	28.3	3.9	4.0	1.8	0.0	4.9	8.5	2.0	0.0	1.3	8.1	12.5	0.4	0.0	7.5	0.1	8.3	0.0	18.1	4.2	2.5	2.1	13.5	0.2	2.4	0.8	5.4	4.3	0.6	0.0	2.0	3.4	8.2	11.8	3.7	4.3	1.4	0.2	15.9	5.2	2.1
ASB1	ASB-1	ENSG00000065802	"Ankyrin repeat and SOCS box containing 1"	Q9Y576	2	238426742-238452250	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003508	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA003508: AB_1845065"	"unprognostic (1.02e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	6.6	5.5	19.1	7.3	18.8	2.9	5.3	14.6	18.1	8.9	9.7	10.1	3.9	10.7	3.7	5.0	8.6	5.3	16.2	17.0	18.6	6.2	6.4	6.4	8.0	18.1	20.0	10.2	5.9	8.4	7.6	3.2	19.5	7.5	4.7	5.5	5.4	7.9	21.1	5.7	8.3	8.1	18.9	7.8	8.0	10.7	19.3	6.7	5.8	23.3	8.5	8.1	6.5	17.1	11.1	15.7	21.2	17.0	13.3	14.0	17.1	29.9	19.8	17.7	19.8	7.7	7.7	9.6	4.0	28.2	39.3	12.0	21.1	47.7	27.7	24.3	17.2	12.1	15.2	19.3	31.1	16.8	15.5	15.0	21.7	51.7	69.7	27.8	7.7	16.7	25.9	6.3	32.9	7.6	9.2	17.8	22.6	9.7	13.2	13.3	43.1	6.4	12.9	15.1	17.1	23.2	9.4	6.9	15.7	12.7	5.2	17.9	16.6	31.8	20.6	25.1	59.9	22.8	15.2	16.5	50.2	5.3	16.2	0.0	0.5	1.0	4.2	0.7	2.2	4.3	3.0	4.1	0.6	2.1	2.5	3.0	0.2	2.1	0.4	2.8	4.1	1.3	19.1	18.8	14.6	18.1	17.0	18.6	18.1	20.0	19.5	18.9	19.3	17.1	2.3	9.6	3.7	7.8	12.2	7.9	27.5	16.4	7.4	10.0	7.4	7.1	45.3	15.7	11.3	9.2	4.2	12.3	12.8	5.2	1.9	15.8	35.2	9.8	8.1	4.0	12.7	19.1	6.1	21.0	28.6	15.0	14.8	4.6	15.9	7.6	5.0	12.5	23.7	10.1	6.1	6.6	10.2	9.5	4.3	19.5	7.8	10.4	7.2	3.7	12.3	9.8	11.3	6.6	8.5	30.4	16.3	14.7	18.5	20.1	8.4	11.3	18.4	6.5	26.3	10.6	16.0	52.1	37.4	7.2	6.8	5.7	13.9	9.9	7.1	15.4
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 26.7;skeletal muscle: 77.9;tongue: 14.2"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079685	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA079685: "						"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	77.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224194-64230607	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"skeletal muscle: 90.5;tongue: 52.1"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 21.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;THP-1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049542	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.2	0.4	0.0	0.4	0.5	0.9	1.4	0.2	3.4	0.2	0.2	0.4	0.1	0.2	0.1	0.2	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.4	0.5	0.2	0.7	0.6	90.5	0.3	0.2	0.3	0.2	0.2	0.3	1.6	0.2	0.1	0.2	52.1	0.2	0.6	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.2	0.7	0.7	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	4.6	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	21.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.7;RPMI-8226: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	11.2	19.7	4.9	7.2	4.9	3.5	15.9	6.3	7.0	10.1	5.5	14.4	25.4	9.2	1.8	10.3	12.8	7.6	8.9	3.7	4.5	21.3	44.0	6.5	18.2	5.9	5.9	14.8	10.7	4.8	8.2	3.3	5.9	9.6	6.6	6.7	8.9	6.5	11.9	11.9	25.4	5.7	5.2	9.7	8.7	3.3	8.4	3.8	6.2	10.1	12.9	11.7	9.1	4.8	10.6	13.7	5.5	24.6	21.5	5.8	9.5	1.9	4.1	6.1	7.0	11.4	19.4	66.7	16.2	3.9	2.2	17.3	12.2	13.6	0.8	3.4	24.0	10.0	7.7	8.5	14.4	8.5	0.9	9.6	20.7	3.2	5.3	6.1	5.0	18.0	12.1	1.3	1.7	7.6	11.0	7.8	12.0	28.6	8.0	4.5	0.8	68.8	7.9	16.3	11.5	27.2	12.9	8.7	21.5	1.6	25.9	10.6	2.1	3.5	6.2	14.6	5.7	3.6	8.6	44.0	10.8	22.9	2.8	0.0	12.9	0.3	1.5	8.3	2.6	1.8	3.9	1.7	13.6	2.4	4.1	2.0	0.4	1.2	6.6	0.4	1.2	7.5	4.9	4.9	6.3	7.0	3.7	4.5	5.9	5.9	5.9	5.2	8.4	4.8	4.7	0.0	5.8	9.1	1.7	1.7	1.9	2.5	2.2	45.0	8.8	7.4	7.8	8.6	4.7	1.8	18.8	5.8	0.4	21.3	5.9	5.3	2.7	3.2	7.9	5.3	4.2	1.7	6.7	4.5	1.6	9.1	1.5	2.3	3.8	20.1	5.3	55.9	7.0	16.8	13.3	5.7	4.1	12.6	2.6	0.7	13.4	7.3	8.8	6.5	7.0	8.5	0.0	7.1	8.1	4.5	12.6	21.4	0.4	3.3	41.1	39.5	4.9	14.2	6.6	7.2	10.7	0.2	1.6	5.7	1.7	2.1	2.1	16.5	12.4	1.5
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179084	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 67.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.4;Horizontal cells: 1.7;Inhibitory neurons: 1.6;NK-cells: 2.1;Oligodendrocyte precursor cells: 1.5;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.8	1.0	0.8	2.3	0.9	2.2	0.6	9.8	1.2	1.1	0.0	1.5	2.1	1.9	0.0	1.0	1.4	1.1	4.6	0.5	0.3	1.1	0.6	1.1	3.3	1.5	1.8	1.7	3.6	1.6	1.9	0.6	1.6	1.6	0.0	2.3	2.0	0.2	67.7	3.2	2.1	0.6	0.1	3.1	2.0	1.0	1.1	0.0	1.2	13.1	0.0	1.2	0.8	1.6	2.1	3.9	4.6	4.2	0.0	0.0	3.7	4.2	0.0	0.0	0.0	3.0	2.3	3.2	2.5	0.0	1.0	4.9	0.0	0.0	0.0	5.0	6.8	2.0	8.0	3.4	0.0	2.1	6.2	0.0	0.0	0.0	0.0	1.2	0.0	4.7	3.7	7.6	0.0	3.5	2.6	4.0	1.3	0.7	4.5	8.0	4.4	4.8	0.0	3.1	4.6	2.6	2.0	0.6	0.7	1.3	6.0	2.0	2.1	5.7	5.1	3.5	2.7	11.8	6.2	2.9	1.3	3.0	3.8	2.3	1.3	5.8	1.7	1.2	2.0	2.5	1.8	1.6	0.7	1.9	2.3	1.5	4.1	2.6	1.1	1.6	1.9	1.6	0.8	0.9	9.8	1.2	0.5	0.3	1.5	1.8	1.6	0.1	1.1	1.6	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.4	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.7	0.0	0.1	1.7	1.6	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.7	2.1	1.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.6	0.2	0.3	0.4	0.3	0.0	0.0	0.2	0.3	0.1	0.1
ASB3	ASB-3	ENSG00000115239	"Ankyrin repeat and SOCS box containing 3"	Q9Y575	2	53532672-53860160	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003940	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA003940: AB_1845067"	"unprognostic (8.32e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.64e-4)"	"unprognostic (5.45e-5)"	"unprognostic (6.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.82e-1)"	"unprognostic (1.43e-5)"	"unprognostic (3.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.82e-1)"	8.4	11.5	28.1	8.3	29.9	15.0	10.3	32.0	32.8	10.4	14.3	7.6	6.7	11.4	14.0	8.4	9.5	7.8	9.6	29.1	23.8	9.0	10.8	10.0	11.0	18.9	25.9	12.2	7.4	10.3	14.5	11.5	18.4	13.0	8.0	23.4	8.8	10.2	7.2	9.6	8.6	8.2	17.5	12.7	7.1	11.5	24.7	17.2	11.6	7.7	12.2	7.9	9.8	27.9	15.4	12.5	26.8	10.6	17.6	14.7	23.0	16.3	11.5	12.2	15.2	10.8	10.9	14.5	26.1	11.6	22.6	9.4	19.6	12.1	18.0	29.0	17.6	16.0	16.2	21.2	13.7	20.7	12.2	12.3	8.0	11.4	22.4	21.1	15.1	18.9	17.6	17.9	18.1	9.9	23.4	27.3	20.7	14.3	10.8	21.5	20.2	11.9	13.9	12.8	19.1	15.0	18.8	17.4	15.3	23.2	6.8	11.4	13.9	19.0	11.3	15.1	18.8	26.4	13.3	8.1	16.3	15.5	16.3	16.6	6.9	12.9	9.0	6.6	12.7	12.2	10.4	10.2	7.5	10.4	11.1	11.1	5.0	11.2	7.5	6.2	11.6	6.8	28.1	29.9	32.0	32.8	29.1	23.8	18.9	25.9	18.4	17.5	24.7	27.9	5.9	25.6	23.2	16.3	14.4	0.0	6.3	0.0	12.5	16.1	5.1	6.1	0.0	5.7	14.9	1.8	4.2	11.6	6.4	1.5	0.0	4.8	5.0	6.6	7.2	6.0	1.2	9.0	3.6	2.7	10.0	9.1	7.1	3.1	16.4	5.5	4.6	4.4	4.6	3.3	3.1	3.6	0.0	5.7	0.0	2.5	9.6	5.9	0.0	3.7	4.0	10.1	9.2	26.7	3.5	4.4	1.5	9.8	18.9	3.2	3.3	3.9	12.4	10.3	6.6	6.5	5.7	16.8	14.5	8.9	0.0	7.7	11.3	6.5	3.0	3.4
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540233	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.1;skeletal muscle: 34.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Cardiomyocytes: 3.2;Early spermatids: 2.3;Late spermatids: 2.0;Respiratory ciliated cells: 2.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;Hep G2: 7.9;SCLC-21H: 4.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.5;hypothalamus: 31.7"	"Region enriched"	"Detected in single"	10	"midbrain: 4.3"	HPA055240	Uncertain					NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.1	47.1	1.8	0.2	2.3	0.6	0.4	2.3	2.1	0.1	1.5	0.1	0.3	0.1	0.2	0.3	0.3	0.2	1.9	1.8	2.4	0.2	1.5	0.6	0.3	2.5	3.8	0.2	0.7	0.0	8.4	2.1	2.6	0.2	0.1	1.3	0.6	0.2	34.2	0.3	0.4	0.1	1.8	0.3	0.6	0.3	2.2	0.2	0.3	10.5	0.1	0.0	0.0	2.8	0.2	4.9	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	4.7	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.3	2.3	2.1	1.8	2.4	2.5	3.8	2.6	1.8	2.2	2.8	0.1	0.0	0.5	7.2	0.0	0.1	0.1	0.5	0.0	0.0	0.4	0.1	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	2.0	0.6	0.0	0.0	1.0	0.0	0.0	1.0	1.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.7	0.1	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1
ASB6		ENSG00000148331	"Ankyrin repeat and SOCS box containing 6"	Q9NWX5	9	129634604-129642169	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004341	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA004341: AB_1845070"	"unprognostic (1.60e-2)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.00e-2)"	12.3	21.9	16.0	8.7	16.0	26.9	11.5	15.4	17.8	13.5	16.3	12.1	7.5	13.1	6.2	17.3	13.0	6.2	11.5	16.9	13.6	17.5	11.9	10.8	11.5	16.9	15.3	10.7	15.5	9.1	14.1	7.3	15.5	13.9	5.4	4.4	14.2	8.6	9.8	22.2	13.1	6.2	15.0	19.3	16.2	14.0	15.4	11.2	12.1	5.8	8.9	12.2	13.8	14.7	10.9	16.9	12.6	28.5	13.4	12.9	20.8	20.8	13.6	20.8	12.9	19.2	15.5	9.4	11.7	26.0	29.4	29.4	17.6	20.3	9.1	18.6	25.9	8.6	36.1	9.8	19.4	20.4	16.6	17.0	13.9	26.5	12.6	11.8	16.8	25.2	19.5	13.4	15.0	26.7	21.0	16.3	21.9	21.4	39.8	19.1	13.7	19.2	19.2	10.2	26.2	32.4	19.5	25.8	16.1	9.6	21.2	12.7	18.4	28.8	15.6	35.2	21.7	18.1	20.7	15.9	22.8	14.1	19.6	6.6	6.5	7.1	10.5	6.4	9.4	6.3	6.9	10.1	7.3	5.2	8.6	7.4	3.3	11.3	6.6	6.6	8.9	7.8	16.0	16.0	15.4	17.8	16.9	13.6	16.9	15.3	15.5	15.0	15.4	14.7	7.1	0.0	5.5	11.8	8.9	22.0	4.5	9.4	19.4	6.5	11.1	9.0	10.9	10.0	3.5	9.2	6.2	12.9	12.4	14.6	21.5	15.0	1.9	10.0	7.2	9.4	7.2	21.9	9.7	10.7	9.8	8.0	14.8	14.9	2.5	6.9	8.6	3.4	8.6	10.1	6.5	7.3	6.1	5.9	8.2	3.0	8.7	6.9	3.6	7.5	6.1	7.6	4.1	7.1	7.6	13.0	9.1	7.9	9.5	8.5	8.3	6.7	3.4	6.5	13.1	6.2	7.7	8.0	10.2	12.0	20.2	14.2	11.1	6.4	7.5	5.9
ASB7		ENSG00000183475	"Ankyrin repeat and SOCS box containing 7"	Q9H672	15	100602589-100651701	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003300	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA003300: AB_1845071"	"unprognostic (1.38e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	4.6	3.6	4.2	4.5	4.7	12.8	5.1	4.9	4.6	5.2	5.6	6.8	4.6	5.3	6.5	4.6	5.7	3.8	3.9	4.2	4.1	6.7	6.8	4.9	6.3	4.5	4.3	5.7	3.5	6.7	3.1	4.3	4.2	4.7	6.3	4.9	4.5	4.3	3.1	4.4	4.4	6.0	4.2	5.9	4.3	6.8	4.9	7.0	6.2	4.7	6.3	5.1	3.5	5.0	6.7	14.5	6.6	7.9	8.6	9.2	7.5	7.2	13.0	11.8	12.3	8.8	13.2	10.9	6.4	9.2	11.6	14.5	9.2	9.4	12.2	7.6	9.8	14.4	9.0	8.8	13.0	8.6	12.3	8.9	10.3	9.6	15.8	11.4	11.0	11.7	8.6	8.9	6.8	7.2	6.7	8.7	6.3	14.9	6.9	9.0	14.1	9.2	11.8	14.8	6.5	9.2	11.1	10.8	15.0	12.5	7.6	10.7	8.4	10.3	9.5	7.3	10.2	10.6	23.5	10.4	8.0	7.8	8.3	1.2	5.8	10.2	5.2	4.7	4.2	4.3	4.5	6.4	5.1	4.2	6.2	4.4	5.2	4.3	3.1	3.3	5.7	4.8	4.2	4.7	4.9	4.6	4.2	4.1	4.5	4.3	4.2	4.2	4.9	5.0	4.6	0.0	5.4	14.7	6.6	6.5	2.3	3.5	13.1	4.9	6.2	4.1	3.4	12.8	6.4	3.7	6.2	3.8	9.9	12.9	1.9	5.7	4.0	8.1	8.3	6.7	8.4	3.0	20.6	4.9	3.0	4.0	7.1	8.1	10.8	7.3	4.2	8.0	6.0	13.5	15.0	6.2	4.1	7.8	4.3	2.1	5.0	5.2	3.6	20.6	7.8	3.1	6.2	16.6	17.4	6.5	9.7	5.3	4.9	5.5	5.4	7.1	10.3	5.0	0.0	4.3	4.3	9.9	8.2	10.8	4.5	5.9	8.2	6.7	5.8	5.6
ASB8	"FLJ21255, MGC5540"	ENSG00000177981	"Ankyrin repeat and SOCS box containing 8"	Q9H765	12	48147789-48181213	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.9;tongue: 184.4"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003299	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA003299: AB_1845072"	"unprognostic (1.35e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.82e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.57e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.26e-2)"	19.7	22.6	21.1	20.1	22.9	61.6	21.2	35.1	28.2	15.8	18.3	22.0	21.6	19.2	21.5	22.7	18.6	15.9	45.4	22.6	22.5	27.8	28.2	17.4	23.1	21.4	20.2	22.1	21.8	33.4	16.7	15.5	23.1	20.7	26.6	73.1	21.2	21.8	291.9	21.4	20.5	24.4	20.9	22.7	21.4	17.2	20.9	29.4	18.7	184.4	26.8	17.8	13.2	24.7	19.3	16.1	17.6	26.9	26.9	23.9	12.7	33.1	23.1	23.1	20.6	24.4	23.4	31.5	26.6	30.4	12.7	16.5	28.3	19.8	26.2	37.3	24.9	38.9	22.1	12.8	20.4	36.5	33.9	23.4	18.8	29.5	17.1	39.6	23.3	35.5	29.5	38.6	20.9	18.2	33.8	25.8	6.6	24.1	28.4	21.7	27.1	32.6	18.3	19.6	27.6	17.6	18.9	24.5	21.2	16.3	45.7	24.8	17.9	19.4	14.0	19.9	15.0	33.1	41.4	27.1	24.6	81.6	11.0	91.7	23.2	117.0	30.8	26.3	28.5	28.6	32.8	31.4	22.8	20.9	32.9	34.3	53.5	36.7	35.8	24.4	33.7	23.1	21.1	22.9	35.1	28.2	22.6	22.5	21.4	20.2	23.1	20.9	20.9	24.7	26.7	22.4	22.6	11.8	26.9	7.0	9.1	15.4	17.6	63.4	18.5	22.4	68.4	27.1	16.1	16.5	62.6	23.2	35.3	29.5	41.1	22.6	24.0	10.4	17.0	23.1	18.6	40.8	19.2	21.8	12.8	22.5	20.9	12.4	20.3	25.5	23.2	31.7	24.6	40.4	21.0	24.3	12.2	24.8	11.8	75.3	24.2	22.9	21.4	7.5	33.5	55.8	46.4	15.6	19.1	19.1	24.3	27.8	25.4	10.8	31.2	42.0	16.0	120.0	52.6	37.4	24.0	35.9	21.1	22.9	11.1	17.1	29.3	37.0	22.1	9.2
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.8;liver: 17.4;lymphoid tissue: 11.7;pancreas: 9.5;testis: 25.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1;Proximal tubular cells: 38.1;Spermatogonia: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.8;EFO-21: 20.1;PC-3: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	2.3	0.8	0.7	0.4	0.6	2.4	1.5	0.9	1.0	2.3	0.6	1.7	1.6	1.3	0.8	1.5	2.2	1.9	2.5	0.6	0.5	16.8	17.4	3.5	0.9	1.0	0.6	0.6	9.5	0.6	0.5	3.1	0.8	1.0	2.3	0.1	3.8	0.8	0.5	1.8	1.0	2.3	0.6	11.7	4.0	25.8	0.7	4.1	2.2	1.4	1.2	1.4	0.8	0.7	1.5	25.8	0.2	2.4	0.0	1.1	0.7	0.6	2.7	2.9	1.1	5.8	0.1	0.3	20.1	0.9	14.1	7.5	0.0	1.2	1.9	5.4	0.6	6.2	12.6	12.5	0.0	0.0	0.0	6.6	0.2	0.2	0.1	0.3	9.4	1.9	0.1	5.9	1.7	1.8	5.4	0.1	12.2	3.6	53.5	0.1	11.1	5.8	8.0	4.2	2.6	2.6	0.7	1.4	9.0	1.3	0.1	0.7	8.1	0.1	1.8	1.3	3.9	0.4	5.1	0.2	0.8	0.0	14.2	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.1	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.7	0.6	0.9	1.0	0.6	0.5	1.0	0.6	0.8	0.6	0.7	0.7	10.7	0.0	0.0	0.0	1.1	1.9	1.1	0.7	2.2	0.0	0.8	0.9	0.5	12.8	1.0	0.0	0.0	0.1	0.1	0.9	41.1	1.1	2.4	1.2	0.3	11.1	10.7	7.2	0.1	2.0	0.1	1.2	2.6	0.3	1.3	3.4	20.0	12.6	4.7	0.0	0.3	0.3	2.0	4.6	4.4	8.0	1.8	3.3	16.0	1.0	0.3	0.0	0.0	0.0	0.1	0.9	0.5	0.7	0.0	0.6	0.0	38.1	4.8	0.0	0.0	0.0	0.6	1.6	126.5	2.4	3.1	0.1	0.3	5.7	1.6	0.6
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3, p50"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	19.0	24.9	18.3	13.9	23.5	7.3	16.4	22.4	24.5	16.1	18.8	14.4	9.0	17.1	16.4	14.3	15.3	13.7	24.8	17.2	20.7	15.2	21.6	13.5	18.5	23.4	20.6	17.9	22.7	14.2	11.9	13.0	23.6	11.9	9.9	15.7	12.8	14.5	29.7	17.1	14.6	12.4	21.7	17.1	14.4	18.4	20.4	22.3	13.4	17.3	16.8	15.7	13.6	30.4	29.3	40.3	25.8	58.1	34.0	37.9	21.1	18.0	33.5	26.5	30.7	31.4	105.3	37.0	35.6	26.3	17.9	38.4	21.1	30.6	26.5	27.2	20.1	24.1	29.1	36.4	32.7	25.2	24.1	33.3	68.9	26.7	45.0	38.1	36.4	40.4	34.8	51.8	35.0	25.7	34.2	36.1	15.7	18.8	8.8	20.1	21.1	27.4	49.8	21.0	27.1	16.9	26.1	65.7	49.4	23.9	21.7	18.5	32.0	15.2	27.1	11.6	19.4	28.4	40.4	45.5	24.6	55.9	10.8	20.4	19.0	35.0	16.5	20.3	17.0	31.4	19.4	17.7	21.0	32.5	27.2	25.8	12.5	26.6	15.4	28.9	29.2	19.0	18.3	23.5	22.4	24.5	17.2	20.7	23.4	20.6	23.6	21.7	20.4	30.4	16.7	9.6	5.8	25.5	20.5	6.2	14.0	22.8	9.6	12.9	9.0	6.3	23.6	10.0	13.4	12.9	14.6	17.7	18.6	4.7	23.5	20.4	27.5	12.1	13.8	13.9	3.6	11.1	33.1	20.0	19.5	16.5	6.6	12.1	12.7	12.6	10.4	22.0	18.2	25.2	42.9	5.2	16.2	24.1	8.7	14.2	20.5	12.7	19.6	27.2	21.4	19.9	16.5	35.7	52.8	14.7	8.4	20.7	14.5	8.0	9.5	11.4	9.8	14.3	13.1	10.8	15.9	27.8	28.2	10.9	7.0	15.2	17.9	18.9	6.5	9.2
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788609-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	26.6	31.3	11.4	22.7	12.7	53.7	24.9	12.6	13.7	23.7	16.7	24.5	23.7	21.0	16.1	42.0	19.9	17.1	22.8	11.6	11.9	19.8	35.8	22.1	24.5	13.5	12.9	19.9	23.5	21.8	26.7	21.8	13.2	27.1	24.6	8.4	29.8	18.0	43.5	30.1	23.1	19.2	12.9	29.4	37.0	24.5	12.5	29.6	28.3	32.3	34.0	26.8	27.5	13.3	46.9	26.8	28.4	38.7	41.6	36.7	40.7	47.6	36.3	48.4	48.1	31.5	24.7	46.5	33.4	46.2	30.7	55.5	36.8	54.0	40.5	59.8	64.3	39.9	33.0	38.0	52.1	72.3	115.6	39.6	48.2	55.0	50.0	28.4	42.9	30.7	41.8	43.7	44.3	57.8	44.5	37.9	20.7	65.6	36.0	53.0	34.9	48.6	29.6	76.1	43.8	38.5	44.3	48.2	35.4	28.8	34.3	37.4	42.8	67.1	11.3	41.2	47.9	51.9	42.8	54.4	39.2	39.9	49.5	44.7	29.8	53.6	32.1	49.2	28.4	18.8	23.6	26.9	37.7	15.0	24.1	24.6	9.2	33.7	43.9	21.7	30.3	20.0	11.4	12.7	12.6	13.7	11.6	11.9	13.5	12.9	13.2	12.9	12.5	13.3	27.7	19.2	14.7	18.6	35.8	30.0	25.2	38.1	13.1	9.4	23.3	12.3	19.1	31.5	33.3	40.5	4.2	46.3	40.5	38.8	11.7	25.4	110.2	14.0	28.1	20.7	15.5	116.0	13.5	24.9	63.3	22.9	69.8	20.0	34.9	24.3	22.9	25.7	30.6	5.0	13.8	23.2	44.7	29.2	37.3	155.2	31.1	29.1	28.4	11.2	27.9	12.2	56.7	15.6	16.3	27.7	34.0	24.8	32.4	16.2	46.8	18.2	24.4	13.6	19.7	19.6	19.7	48.4	22.5	35.0	39.2	44.3	34.9	27.8	23.9	34.2
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	6.0	6.6	4.1	10.0	5.3	11.2	9.2	6.6	4.2	10.2	7.7	9.3	8.2	7.9	8.5	8.4	5.8	7.5	6.5	3.9	5.2	5.0	12.5	7.1	10.1	4.7	4.3	5.9	6.4	10.7	6.2	12.9	5.1	9.2	11.3	5.7	6.3	8.1	6.0	7.2	8.5	8.5	4.7	8.3	8.6	8.6	4.6	12.7	7.2	5.4	11.0	14.8	7.4	6.0	16.8	21.1	30.1	18.6	32.9	41.7	48.0	71.5	45.5	24.1	27.6	43.3	13.0	52.1	14.4	48.3	19.0	37.6	26.2	63.5	38.7	35.2	23.2	38.7	36.0	27.8	30.1	41.0	28.5	38.1	31.7	35.4	44.2	22.6	45.1	20.5	47.1	23.0	67.3	16.5	21.1	12.7	15.9	31.8	16.4	24.7	23.3	18.7	23.7	46.6	20.2	15.3	30.1	26.7	12.5	53.3	14.7	23.2	64.2	26.9	20.6	23.3	30.4	9.9	11.3	46.4	19.4	30.6	29.0	6.2	2.7	1.8	4.3	4.3	5.2	4.2	3.8	4.0	2.9	5.7	4.3	4.2	0.2	4.4	3.8	6.4	3.1	1.4	4.1	5.3	6.6	4.2	3.9	5.2	4.7	4.3	5.1	4.7	4.6	6.0	32.7	32.1	24.9	58.1	45.4	25.5	41.3	33.3	19.4	27.0	24.1	24.0	32.0	20.0	37.7	3.7	22.9	24.4	49.0	17.3	11.7	23.1	11.3	30.1	77.3	25.2	13.8	20.8	166.0	25.1	66.3	32.2	46.9	35.0	22.1	29.9	10.4	30.3	17.7	28.6	166.2	22.8	22.4	17.2	12.5	3.7	23.0	27.5	5.4	103.0	26.2	14.6	29.9	150.8	132.3	28.6	14.4	17.3	66.4	66.9	17.5	10.6	32.0	31.1	6.6	39.6	30.0	50.2	30.3	38.2	27.4	38.0	43.7	42.6	23.5	65.4
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957674-102960513	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1"	"Group enriched"	"Detected in some"	5	"Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"SCLC-21H: 53.7;SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"							"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.0	1.1	18.7	0.0	18.3	0.0	0.0	18.9	23.0	0.5	13.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	18.2	16.8	0.0	11.1	0.5	0.5	20.1	18.1	0.4	0.2	0.0	30.1	0.0	18.5	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	1.2	0.1	18.7	5.5	0.1	0.0	0.0	0.0	0.3	19.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	29.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.3	18.9	23.0	18.2	16.8	20.1	18.1	18.5	19.9	18.7	19.4	0.1	0.0	0.0	17.0	0.3	0.0	0.3	0.0	0.0	4.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	36.4	0.0	1.7	0.0	0.0	0.2	4.6	0.1	0.0	0.0	0.0	1.8	0.1	5.0	4.1	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	0.0	42.7	0.3	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4
ASCL3	"bHLHa42, HASH3, Sgn1"	ENSG00000176009	"Achaete-scute family bHLH transcription factor 3"	Q9NQ33	11	8937579-8938211	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"salivary gland: 8.7"	"Cell type enriched"	"Detected in single"	923	"Ionocytes: 461.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027032	Uncertain					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA027032: AB_10602434"											"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"		"unprognostic (3.53e-1)"				0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	8.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	461.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASCL4	"bHLHa44, HASH4"	ENSG00000187855	"Achaete-scute family bHLH transcription factor 4"	Q6XD76	12	107774385-107776644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Langerhans cells: 3.1"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036116	Uncertain					NA	NA						"Cluster 41: Macrophages - Immune response"			"HPA036116: AB_10671833"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"			"unprognostic (1.86e-2)"	"unprognostic (8.88e-4)"		"unprognostic (2.09e-5)"	"unprognostic (1.40e-1)"		"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119512-14136613	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 32.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 60.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 60.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	0.9	1.4	0.2	5.6	0.3	11.7	1.3	0.3	0.2	2.2	0.1	7.4	5.3	1.0	0.1	10.3	0.7	0.7	0.7	0.1	0.2	1.0	1.3	2.1	12.5	0.3	0.2	0.7	0.7	0.3	0.7	3.6	0.3	0.8	7.7	0.0	1.9	0.3	0.5	3.2	6.0	2.0	0.2	6.7	3.2	32.0	0.3	23.2	0.6	0.4	14.7	1.8	3.2	0.3	64.6	25.3	37.7	28.9	3.8	3.6	16.2	33.1	28.3	63.8	79.5	26.5	31.6	59.1	30.0	17.5	26.5	38.0	41.8	24.1	49.7	54.0	26.9	55.5	48.7	18.6	0.2	39.0	35.1	0.7	1.7	35.8	12.4	7.2	25.1	44.1	50.2	83.8	31.8	75.7	80.8	34.3	17.3	69.1	56.7	77.0	56.0	51.6	20.1	28.3	46.0	16.5	39.8	29.2	17.4	10.3	22.1	41.5	10.6	36.0	21.6	91.0	56.6	43.2	46.5	80.3	28.0	71.9	36.1	0.7	6.2	1.5	1.7	8.0	0.9	1.1	1.5	2.0	1.2	0.9	0.9	1.7	60.1	1.7	8.5	0.5	5.1	3.2	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.3	0.2	0.3	0.3	1.0	0.0	0.6	0.3	5.6	2.5	2.4	4.5	1.2	0.1	4.8	8.5	1.2	1.5	1.1	0.0	0.0	36.1	3.8	11.7	0.0	1.0	36.4	2.1	1.3	2.1	1.2	43.6	0.5	1.2	35.4	4.1	23.4	2.3	4.5	9.2	0.4	0.3	21.5	0.0	0.4	9.9	8.2	5.6	5.6	29.1	0.0	5.0	1.8	1.0	2.1	0.3	4.1	0.0	0.5	1.1	2.2	0.7	20.1	1.0	2.4	0.3	0.2	0.9	0.0	1.1	3.3	73.2	87.8	8.3	1.1	10.4	5.3	3.0	20.9	2.4
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1092.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.6	1.5	7.7	3.7	7.8	2.5	1.8	17.0	10.9	1.6	7.0	1.2	2.2	1.3	0.6	1.7	1.8	2.9	1.1	7.9	7.6	1.4	1092.3	3.9	1.3	8.0	8.2	1.1	0.9	7.0	2.9	0.5	8.3	1.7	0.5	4.8	0.9	0.3	1.5	4.4	1.4	1.3	6.0	4.8	1.4	26.5	7.8	0.4	5.8	0.4	0.3	1.7	1.5	8.7	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	7.7	7.8	17.0	10.9	7.9	7.6	8.0	8.2	8.3	6.0	7.8	8.7	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.5	0.3	0.8	7.9	1.0	7.0	0.5	0.9	1.3	0.4	1.3	0.5	0.3	0.3	0.1	0.5	0.6	17.6	0.5	0.8	1.0	1.2	840.7	2.5	0.9	1.0	1.1	0.2	0.5	0.1	0.2	0.5	1.2	0.4	0.4	0.0	0.5	0.2	0.2	5.2	0.6	1.3	1.0	6.8	0.5	0.5	1.4	0.5	0.3	0.1	1.0	2.0	0.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	1.0	0.9	1.3	0.8	1.0	1.0	1.1	1.2	1.0	1.4	1.2	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.0;cervix: 3.4;endometrium 1: 3.4;retina: 4.6"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 1786.2;Inhibitory neurons: 666.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;RPTEC TERT1: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.0	0.6	13.0	0.0	11.4	0.0	0.1	4.4	10.3	3.4	0.0	0.1	0.4	3.4	0.0	0.0	0.6	0.0	0.0	12.4	6.0	1.1	0.0	0.0	0.0	6.2	6.0	0.0	0.0	0.0	0.5	0.0	3.3	0.1	0.1	4.6	0.0	0.5	0.0	0.1	0.3	1.4	5.8	0.0	0.0	0.3	6.2	0.0	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	11.4	4.4	10.3	12.4	6.0	6.2	6.0	3.3	5.8	6.2	8.2	0.0	0.0	0.0	17.0	0.0	0.3	0.0	0.0	0.0	25.7	0.0	0.0	1.3	0.0	0.0	9.2	2.1	0.0	0.0	0.1	0.0	0.1	16.3	0.1	0.8	0.1	6.0	0.0	1786.2	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	10.1	666.4	1.3	0.0	0.0	0.0	47.1	0.3	0.1	1.8	26.2	0.0	0.5	0.0	144.3	22.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3"	"Group enriched"	"Detected in many"	4	"glioma: 3.1;testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 16.7;U-266/84: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.8	2.1	8.2	0.3	9.0	0.6	2.7	11.7	10.9	13.3	6.7	7.9	1.1	7.7	1.5	1.9	7.2	0.7	10.9	7.9	8.8	4.8	4.0	3.2	0.8	9.3	7.9	6.4	2.1	0.5	18.1	0.6	10.3	5.3	0.6	8.7	1.6	0.4	6.0	2.9	4.1	0.8	7.0	2.8	3.8	19.9	8.6	0.6	4.1	0.9	0.7	3.1	4.3	11.5	1.5	4.0	1.7	2.7	3.7	0.0	7.4	0.4	0.2	0.3	0.5	0.8	1.9	0.9	0.4	0.2	1.8	2.4	1.0	0.0	0.7	8.9	4.5	1.7	3.4	0.0	0.0	0.1	3.9	0.9	0.7	0.2	0.0	2.9	0.1	1.1	4.2	6.8	0.5	6.3	0.3	0.4	1.8	0.1	3.3	3.1	1.7	0.5	0.3	1.4	2.3	8.2	0.6	0.5	4.3	4.9	1.8	0.4	0.1	1.4	2.1	4.3	1.1	16.7	10.2	0.1	2.3	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	9.0	11.7	10.9	7.9	8.8	9.3	7.9	10.3	7.0	8.6	11.5	0.4	0.0	0.5	2.9	0.5	0.6	0.0	0.2	0.0	9.7	0.6	0.6	2.1	0.0	0.2	0.0	12.5	0.2	0.3	0.6	0.0	0.2	15.6	0.9	1.1	0.3	0.0	0.0	3.4	0.4	0.2	0.3	0.5	0.8	8.9	14.8	0.0	0.9	0.6	6.7	4.2	0.1	0.0	0.6	0.9	61.0	1.5	0.4	0.0	0.0	0.6	1.6	0.0	1.5	5.1	0.4	0.0	1.9	0.1	0.3	0.2	0.2	0.6	4.9	0.0	0.7	0.4	10.3	5.6	0.0	0.9	0.7	0.3	0.2	0.2	0.2
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866277	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"intestine: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 14.8;heart muscle: 28.0;ovary: 41.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.4;dendritic cells: 44.1;Hofbauer cells: 15.1;Leydig cells: 12.5;Peritubular cells: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	356	"plasmacytoid DC: 134.8"	"Lineage enriched"	"Detected in single"	356	"dendritic cells: 134.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.2;HSkMC: 2.4;SK-MEL-30: 1.9;U-698: 1.9"	"Not detected"	"Not detected"							HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	1.4	0.6	0.2	0.0	0.5	0.3	2.4	0.1	0.4	4.2	0.0	0.5	0.0	2.0	14.8	0.1	4.0	0.1	28.0	0.1	0.1	0.9	1.3	0.3	0.4	0.2	0.1	41.7	0.1	0.0	0.6	0.2	0.6	1.5	0.0	0.3	0.7	0.2	0.9	5.7	0.8	0.0	0.0	0.3	0.3	1.5	0.2	0.2	0.3	1.2	0.5	0.5	1.1	0.3	0.0	1.1	0.4	0.4	0.2	0.7	0.1	0.1	0.0	0.0	0.0	3.2	0.0	1.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.7	0.3	0.5	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.1	0.0	0.7	0.6	0.9	0.0	0.3	0.2	1.7	0.0	0.1	0.6	0.3	0.3	1.4	0.0	0.1	0.2	0.2	0.0	0.2	1.9	0.5	0.3	0.2	0.3	0.5	0.5	0.0	0.3	0.4	0.4	1.9	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	134.8	0.0	0.6	0.2	0.5	0.1	0.4	0.1	0.1	0.2	0.1	0.6	0.0	0.2	0.3	0.4	0.0	0.6	1.3	0.8	2.5	0.0	0.0	0.0	0.0	0.3	0.5	27.4	0.0	0.0	0.0	0.0	0.2	44.1	0.0	1.9	0.0	1.1	0.3	9.2	1.2	0.0	0.0	2.1	0.0	0.2	5.6	0.0	0.4	0.0	0.2	2.5	5.8	15.1	0.0	1.8	0.0	0.0	0.8	7.0	1.7	12.5	2.1	1.8	1.0	0.3	0.0	0.0	2.5	2.5	0.1	0.0	10.5	0.0	0.1	0.0	8.3	0.0	0.0	6.6	0.1	0.6	1.7	1.9	0.2	3.1	0.8	0.6	1.0	0.0	0.1
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 396.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	21.7	16.1	5.9	16.7	6.0	23.9	22.0	6.6	8.5	18.2	8.7	53.8	60.7	17.0	6.7	28.7	18.1	27.7	16.9	5.9	8.0	61.2	396.4	27.4	10.3	7.4	7.1	19.7	37.1	15.1	19.8	9.1	9.8	19.5	35.7	2.4	18.3	9.8	8.7	15.1	45.6	10.1	6.2	30.5	43.9	4.5	7.6	5.3	24.9	6.9	8.8	19.3	19.8	6.7	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.9	6.0	6.6	8.5	5.9	8.0	7.4	7.1	9.8	6.2	7.6	6.7	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 92.5;monocytes: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 131.0"					"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	28.1	21.8	15.6	15.7	15.1	17.4	26.8	15.1	20.3	29.1	23.0	30.8	11.7	29.4	14.3	15.1	28.6	13.6	34.5	15.7	16.5	23.1	32.1	18.3	21.4	20.4	18.4	33.9	23.6	22.4	31.0	11.2	18.3	26.8	7.8	9.4	24.8	23.4	23.8	27.7	20.6	12.2	15.9	24.1	23.1	13.0	16.6	20.0	29.5	15.3	12.4	25.1	22.9	18.0	14.0	24.0	28.0	21.4	16.5	25.5	38.9	16.3	21.3	18.2	23.2	22.0	16.5	24.6	9.0	21.5	19.7	5.1	7.4	7.9	11.4	36.7	23.9	21.4	17.0	26.6	37.5	10.1	131.0	33.9	13.4	13.9	13.4	20.3	21.7	18.7	11.0	19.3	14.6	52.4	43.5	39.6	33.9	12.9	15.0	35.2	26.7	60.0	12.8	7.6	1.1	13.2	21.9	27.8	20.7	18.9	6.4	13.4	28.6	15.2	16.5	29.0	6.1	24.8	8.0	62.9	19.3	14.5	4.6	45.7	25.5	65.9	28.8	30.9	25.6	24.2	26.1	26.9	22.0	37.7	22.5	17.7	37.2	52.9	22.5	42.1	31.4	23.2	15.6	15.1	15.1	20.3	15.7	16.5	20.4	18.4	18.3	15.9	16.6	18.0	20.6	12.8	9.4	5.2	19.3	18.4	25.3	17.2	23.3	17.7	16.4	17.4	21.3	10.0	9.9	14.7	4.2	33.4	28.8	16.1	27.4	15.2	0.9	8.8	14.3	19.5	14.4	7.4	8.3	17.1	24.1	23.8	14.8	10.4	54.6	27.0	17.9	30.8	20.3	92.5	6.7	17.9	8.2	12.3	31.0	2.8	26.1	18.8	12.4	9.4	106.2	17.1	26.8	5.0	7.1	10.9	18.3	43.2	21.8	22.1	19.9	34.2	11.1	12.6	32.9	21.4	23.2	2.5	8.2	22.3	15.6	66.4	20.4	21.9	20.4	18.4
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 8.9;T-cells: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No		47000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	17.3	18.0	49.9	19.5	52.3	13.7	17.8	52.7	66.3	19.9	28.2	24.5	9.7	19.0	31.5	27.0	20.1	11.2	19.4	55.3	51.0	28.9	9.3	25.6	28.8	58.7	43.5	20.8	121.4	26.3	44.1	4.6	59.4	21.5	19.9	35.3	41.6	14.5	8.0	22.9	22.6	18.0	43.6	30.3	46.0	33.3	49.7	13.3	27.5	8.6	25.7	21.7	18.6	63.8	124.6	46.6	51.6	415.9	35.3	57.9	109.1	85.7	62.5	41.6	134.8	64.2	49.3	101.7	45.3	189.8	92.3	57.4	118.2	151.2	102.2	122.4	85.3	31.0	24.6	50.8	347.8	207.1	89.9	106.2	508.8	55.8	361.2	23.5	41.4	94.4	177.1	365.2	76.3	286.5	6.4	54.4	68.1	308.4	125.4	14.0	10.0	282.7	28.4	22.3	218.1	156.7	23.2	136.7	499.0	60.6	57.1	139.1	7.6	21.6	138.5	56.7	40.7	412.6	239.7	401.1	288.7	90.3	220.8	1.9	0.3	0.4	3.6	1.1	4.3	8.9	7.2	3.4	1.5	6.0	10.1	5.5	1.8	2.0	1.0	0.2	14.2	3.3	49.9	52.3	52.7	66.3	55.3	51.0	58.7	43.5	59.4	43.6	49.7	63.8	5.8	9.6	7.2	11.1	14.4	12.4	26.1	20.9	6.2	20.3	9.7	11.2	7.6	7.2	12.3	9.2	25.0	3.1	6.7	10.5	7.9	30.9	233.9	2.9	8.6	6.7	24.4	46.1	51.8	61.6	7.8	8.9	14.3	4.5	8.2	8.8	2.9	1.3	1.1	25.2	48.6	19.6	32.6	1.3	3.2	217.0	9.6	2.1	8.8	5.6	7.3	9.2	5.2	16.1	16.9	36.6	14.7	9.4	19.9	26.1	1.1	3.9	4.5	24.9	6.6	10.2	112.3	3.4	20.2	5.5	10.9	5.6	11.2	6.0	9.9	14.9
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	Q9NWL6	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	27.1	26.1	23.1	19.2	24.5	36.9	33.5	31.8	33.5	27.9	21.3	21.1	22.5	28.6	19.6	21.3	24.0	19.7	32.2	23.6	25.5	30.5	40.4	21.9	27.1	24.2	24.0	37.6	27.1	33.2	19.1	33.7	24.5	21.6	18.3	40.2	25.2	20.8	59.6	17.5	17.7	28.1	24.6	23.0	20.4	17.5	24.1	27.9	26.3	70.5	25.1	27.4	17.1	25.9	33.1	22.0	53.5	42.5	58.9	50.4	47.2	66.4	57.1	65.7	67.5	72.5	22.6	65.3	39.0	61.9	36.4	26.5	60.2	49.2	76.6	65.4	72.5	57.5	48.5	69.2	61.4	59.9	33.2	59.9	37.2	66.3	58.9	46.5	63.3	46.9	58.6	49.6	69.6	43.2	68.8	68.9	81.0	55.3	102.4	41.3	43.4	62.4	39.0	40.2	59.5	31.2	41.7	35.0	59.1	66.7	52.3	55.9	57.0	56.6	44.5	48.1	73.4	73.7	86.5	93.4	44.1	33.9	52.7	82.8	26.1	107.6	38.8	22.7	48.6	37.2	42.3	43.3	26.7	37.2	49.4	45.3	48.9	49.1	25.2	21.4	57.6	37.3	23.1	24.5	31.8	33.5	23.6	25.5	24.2	24.0	24.5	24.6	24.1	25.9	31.3	54.5	34.9	10.1	41.1	30.0	24.4	31.2	25.0	22.4	29.7	25.9	43.7	28.6	35.6	16.5	12.5	67.2	36.1	24.1	82.2	35.7	7.0	24.8	34.9	31.1	36.0	41.7	17.2	45.3	43.3	41.8	16.8	22.8	19.0	24.6	29.6	51.9	34.1	15.2	18.9	25.2	26.4	28.0	23.7	5.6	40.7	24.5	17.8	7.5	34.7	40.5	50.4	14.6	17.6	36.5	12.0	33.8	37.9	23.0	18.7	56.7	29.4	27.0	46.0	48.7	47.9	30.3	43.8	29.4	28.4	119.9	42.7	30.9	27.7	19.3
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;kidney: 39.0;liver: 132.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 135.8;Proximal tubular cells: 487.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		200000		"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	0.5	2.5	18.1	0.9	20.9	0.5	0.0	23.7	40.1	0.0	7.3	0.2	6.6	0.2	0.0	0.3	0.0	1.7	0.3	19.8	17.3	39.0	132.4	0.2	0.9	17.0	17.5	0.0	0.8	0.0	19.6	0.0	16.8	0.3	0.0	5.4	1.6	0.0	0.3	1.1	2.5	0.0	13.4	0.6	0.3	0.2	22.9	2.4	0.9	0.0	0.0	0.1	0.1	21.9	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.7	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	1.7	0.0	1.6	16.5	0.1	0.0	0.6	0.2	0.4	0.3	1.1	0.0	0.2	1.7	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	3.6	0.8	1.8	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	20.9	23.7	40.1	19.8	17.3	17.0	17.5	16.8	13.4	22.9	21.9	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.4	1.5	0.0	9.2	4.2	0.0	0.0	0.1	45.0	0.0	0.7	0.0	0.0	0.1	7.1	10.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	135.8	0.0	0.0	4.4	0.1	0.0	1.9	0.0	2.5	0.0	3.4	0.0	2.8	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.8	487.2	0.0	4.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085686-104115582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.4;liver: 151.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA069761	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 40: Granulosa cells - Unknown function"			"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	1.1	1.4	0.1	0.2	0.2	0.0	0.7	0.0	0.4	5.4	0.2	4.7	1.5	2.2	1.1	34.0	6.2	0.1	102.4	0.3	0.3	12.8	151.1	2.3	0.0	0.4	0.6	11.4	0.2	0.8	2.3	1.8	0.2	0.3	1.9	0.3	2.8	0.1	0.5	9.9	0.5	1.2	0.0	0.2	3.1	1.1	1.1	0.1	5.9	0.0	3.7	2.3	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.5	0.4	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.0	1.1	0.0	0.0	6.4	1.7	0.3	0.5	1.8	0.2	0.7	0.0	1.1	0.6	0.8	21.4	2.8	2.4	0.0	0.0	0.2	0.0	21.2	3.9	0.0	0.4	0.7	0.1	0.5	1.8	0.0	0.1	0.2	0.2	4.3	4.6	0.7	0.0	66.8	3.6	93.9	0.2	5.0	0.1	16.0	0.0	1.6	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.6	1.2	0.0	0.1	0.9	49.7	1.6	0.3	0.0	0.0	0.6	0.3	1.5	8.4	9.1	0.5	0.3	3.9	5.4	3.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASPHD1		ENSG00000174939	"Aspartate beta-hydroxylase domain containing 1"	Q5U4P2	16	29900375-29919864	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 138.6;choroid plexus: 79.3;pituitary gland: 36.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 27.1;Enteroendocrine cells: 29.4;Excitatory neurons: 25.1;Gastric mucus-secreting cells: 32.1;Inhibitory neurons: 22.6;Oligodendrocytes: 29.3;Pancreatic endocrine cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 61.7;Hep G2: 79.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045175	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045175: AB_10959899"	"unprognostic (1.58e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.34e-3)"	"unprognostic (6.96e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.37e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (5.55e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.03e-2)"	5.5	5.1	113.3	0.7	119.8	0.1	0.8	106.3	138.6	1.3	79.3	1.3	2.5	3.0	0.1	0.4	1.3	14.8	0.8	108.6	101.7	4.4	0.7	1.1	0.2	113.3	113.9	1.3	9.1	0.8	36.4	0.2	111.9	1.5	0.9	2.3	4.9	0.5	0.2	0.3	1.7	1.4	110.4	0.3	20.9	5.9	110.1	0.0	0.1	0.2	0.2	0.8	0.4	117.6	3.3	14.5	0.0	16.7	0.0	2.4	0.9	15.8	5.1	18.0	12.9	35.1	61.7	6.2	39.4	10.5	13.0	2.4	2.0	4.2	3.4	1.0	2.4	3.1	50.9	79.1	29.1	0.7	40.5	18.3	3.9	26.7	2.7	19.4	0.7	11.3	0.2	13.1	4.3	32.1	0.9	0.6	23.0	13.7	13.8	1.2	0.0	2.5	18.4	0.4	47.3	19.3	0.2	26.1	5.2	0.3	10.0	11.9	1.2	7.5	13.2	0.4	4.5	1.1	0.4	0.6	23.7	41.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.3	119.8	106.3	138.6	108.6	101.7	113.3	113.9	111.9	110.4	110.1	117.6	0.7	0.0	5.1	4.9	0.1	0.6	4.8	2.5	0.0	19.2	4.3	3.9	0.3	27.1	0.5	1.8	4.2	0.0	0.0	2.6	1.9	17.3	1.9	0.7	9.4	0.9	29.4	0.0	25.1	20.2	0.4	7.8	32.1	1.4	1.3	0.5	0.0	0.2	4.0	6.7	22.6	4.2	6.1	0.0	0.3	1.2	0.3	0.9	1.8	5.6	0.0	1.7	0.0	9.0	29.3	29.3	0.3	0.7	0.1	8.1	1.7	3.7	0.3	10.2	0.0	0.2	2.5	1.2	1.0	0.0	0.6	0.3	0.2	4.8	4.2	2.8
ASPHD2	FLJ39838	ENSG00000128203	"Aspartate beta-hydroxylase domain containing 2"	Q6ICH7	22	26429260-26445015	"Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;skin 1: 11.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.8;Early spermatids: 25.3;Late spermatids: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.4;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000820	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA000820: AB_1078231"	"unprognostic (1.12e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (6.55e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.11e-2)"	0.7	0.6	8.0	2.5	16.9	1.5	0.6	10.4	9.0	1.5	0.6	2.0	1.2	1.2	6.2	1.5	0.5	1.1	0.4	8.3	7.0	6.1	0.3	0.9	4.4	4.1	4.3	0.6	0.5	1.7	6.6	1.1	5.5	1.1	2.0	5.6	1.0	0.7	0.4	11.1	1.6	0.7	3.1	2.8	8.2	1.9	6.4	1.3	2.0	0.1	3.3	2.3	1.1	5.8	1.6	0.9	4.1	6.5	0.6	0.3	2.2	2.1	4.5	4.3	6.2	0.0	0.4	1.4	0.5	2.0	4.3	1.9	4.5	7.2	2.3	9.7	6.1	0.3	0.0	0.3	4.1	2.4	1.1	0.7	3.4	2.2	3.0	4.7	4.6	3.6	1.7	21.9	1.3	0.4	1.8	1.0	4.0	8.5	0.9	12.2	2.3	3.7	6.0	0.6	11.0	4.8	2.1	0.3	2.4	2.2	0.2	3.5	4.3	2.7	13.4	0.6	4.4	6.3	1.7	2.8	4.1	8.6	1.8	0.0	1.2	0.5	0.3	3.3	0.9	0.9	0.7	0.7	2.1	0.9	0.4	0.4	0.3	0.0	5.3	2.4	0.4	0.4	8.0	16.9	10.4	9.0	8.3	7.0	4.1	4.3	5.5	3.1	6.4	5.8	0.3	0.0	1.1	4.2	5.1	1.8	1.4	2.1	0.0	24.8	0.9	0.9	0.6	1.5	0.9	0.0	10.4	0.3	6.8	3.3	0.0	1.2	25.3	0.7	0.5	1.1	0.0	0.0	14.1	0.7	13.2	1.3	8.2	1.5	0.0	0.9	1.1	0.1	1.5	6.7	9.7	4.3	2.0	2.8	5.7	25.1	0.9	4.1	1.8	1.0	5.3	2.4	2.1	4.5	1.1	5.9	0.8	0.7	12.1	4.6	0.1	0.7	0.8	11.3	0.0	0.4	0.7	1.1	3.3	0.6	1.1	1.1	2.8	0.4	2.0	4.2
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 95.3;smooth muscle: 110.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.6	7.6	1.2	5.7	1.7	0.1	11.8	2.3	2.0	40.9	0.9	25.5	9.6	69.6	9.7	10.1	16.9	65.9	95.3	1.2	1.2	11.2	41.1	14.3	3.0	1.3	1.2	7.1	13.4	3.8	2.5	4.3	1.6	4.7	11.3	0.2	3.2	11.7	7.8	12.1	17.6	110.5	1.0	2.3	12.0	1.2	1.8	2.5	11.1	19.8	5.5	13.4	5.0	1.7	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.7	2.3	2.0	1.2	1.2	1.3	1.2	1.6	1.0	1.8	1.7	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Human disease related genes, Plasma proteins, Predicted membrane proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"skin 1: 424.0"	"Cell type enhanced"	"Detected in some"		"NK-cells: 3.1;Oligodendrocytes: 4.2;Spermatogonia: 3.3;Suprabasal keratinocytes: 10.7"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 8.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.9;REH: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced		Approved	Cytosol		NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	2.6	2.1	5.8	0.9	7.3	0.9	17.1	6.1	6.6	3.1	3.0	1.7	1.6	2.5	2.6	0.9	2.3	1.1	1.8	5.3	6.0	2.2	1.9	1.7	1.0	7.2	6.7	4.8	0.7	0.2	4.0	0.9	6.5	2.2	0.6	1.5	1.3	1.3	4.4	424.0	1.7	1.2	6.0	3.9	1.2	3.6	6.5	2.1	1.3	2.1	1.0	1.5	4.5	9.3	0.0	0.3	0.9	1.9	1.2	0.4	0.2	0.2	0.4	0.2	0.1	0.6	0.0	0.7	0.1	0.2	0.2	0.2	0.8	0.1	0.2	1.3	2.5	1.5	0.2	0.6	0.4	1.3	1.0	0.5	0.4	0.2	0.4	0.3	0.2	1.6	0.5	1.9	0.2	0.3	1.1	2.9	1.0	0.2	0.2	4.9	0.5	0.3	0.0	0.0	1.0	0.2	0.1	0.7	0.8	0.2	0.0	0.5	0.1	0.0	0.9	0.0	0.2	2.0	1.3	1.4	0.1	0.9	1.0	0.0	0.1	1.5	0.5	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.1	0.4	8.7	0.3	0.0	0.8	0.7	0.4	5.8	7.3	6.1	6.6	5.3	6.0	7.2	6.7	6.5	6.0	6.5	9.3	1.1	0.0	0.0	1.3	0.0	0.4	0.1	0.2	0.0	1.1	0.5	0.9	2.6	0.0	0.1	1.8	0.0	0.3	0.1	0.5	0.0	0.1	0.1	0.4	0.5	0.8	0.0	0.0	1.0	0.2	0.0	0.7	0.0	0.4	0.0	1.1	1.4	0.1	0.2	0.0	1.5	0.9	0.0	0.3	0.6	0.5	0.9	0.3	0.0	1.0	0.2	1.2	3.1	1.5	4.2	0.3	0.0	0.7	0.1	0.2	1.1	0.9	0.2	1.6	0.0	0.7	1.1	1.4	3.3	0.0	10.7	0.4	0.2	0.5	0.2	0.1
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1 tether for SLC2A4, UBX domain containing"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 298.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	16.5	20.4	16.6	8.4	17.0	15.0	16.9	16.5	20.4	16.2	17.7	16.0	13.6	15.6	7.9	16.8	14.0	7.7	26.1	16.2	15.5	27.3	57.9	17.3	12.2	20.1	16.6	13.4	22.8	14.8	30.6	12.9	18.3	21.6	4.6	5.7	18.3	6.7	44.3	20.5	18.1	5.2	14.7	20.7	22.7	30.0	17.2	8.3	25.9	5.8	6.4	16.0	14.2	21.5	19.3	33.3	13.0	17.9	7.5	9.3	55.4	17.7	12.6	19.3	19.5	20.3	21.3	19.2	18.1	12.4	16.3	9.8	12.0	13.1	6.2	12.9	41.0	21.4	28.7	298.1	25.5	19.1	29.9	10.9	13.9	9.5	6.6	10.0	19.5	16.0	22.0	25.0	11.6	65.0	16.9	41.8	15.5	32.8	23.5	19.2	18.7	39.4	18.0	17.0	32.4	34.8	14.6	42.2	35.2	12.3	27.2	41.4	16.6	35.7	24.5	26.4	22.8	20.2	12.5	21.6	19.2	19.3	21.3	24.0	11.7	8.6	6.6	8.0	3.7	9.0	10.0	8.8	14.7	9.0	7.7	5.8	2.7	8.0	10.4	9.3	5.3	5.6	16.6	17.0	16.5	20.4	16.2	15.5	20.1	16.6	18.3	14.7	17.2	21.5	13.9	9.6	44.7	19.9	24.1	13.4	23.7	24.4	23.3	23.3	19.6	15.6	13.6	27.1	19.8	14.7	41.7	73.7	25.8	29.3	39.2	24.2	49.1	16.2	14.9	16.1	25.0	17.9	12.4	26.2	222.6	17.5	46.9	20.1	21.5	31.0	12.8	56.1	44.7	50.5	12.1	31.5	20.3	26.7	18.6	96.0	11.8	21.7	19.6	1.9	23.8	57.8	19.6	10.6	14.1	17.6	25.8	17.7	27.3	24.9	42.5	58.3	18.5	39.4	13.1	14.7	37.4	41.7	51.0	20.3	14.3	59.4	18.4	23.6	33.3	23.1
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	3.4	3.2	2.9	4.9	3.3	6.7	5.5	6.1	4.8	6.0	3.4	5.4	5.8	3.8	5.9	3.7	4.5	3.9	2.9	3.2	2.5	3.7	6.1	4.1	7.0	2.5	2.8	5.7	3.3	5.0	3.3	3.9	3.0	3.8	5.8	4.7	3.1	4.2	2.3	4.1	7.1	3.4	2.9	4.4	4.7	6.1	3.3	7.2	7.0	2.8	6.8	3.9	2.9	4.6	9.7	7.1	4.5	4.7	7.7	8.4	1.9	5.4	4.6	6.4	7.0	11.4	4.2	10.8	8.2	5.5	5.5	10.5	9.1	4.4	9.6	5.8	5.3	6.4	3.6	5.4	7.9	9.9	3.6	5.3	6.1	5.2	4.9	5.7	5.4	8.7	5.9	5.3	6.7	6.6	9.0	5.2	4.1	11.6	6.8	9.4	6.4	9.4	5.2	5.9	7.7	7.2	10.5	2.4	7.6	4.3	6.3	6.9	3.8	7.2	4.8	12.1	4.3	6.6	6.5	14.0	5.6	8.5	3.6	51.2	13.0	28.4	20.4	15.3	21.3	15.5	22.0	17.7	14.5	16.5	28.3	21.2	9.4	29.4	20.9	10.7	28.2	11.8	2.9	3.3	6.1	4.8	3.2	2.5	2.5	2.8	3.0	2.9	3.3	4.6	6.5	12.8	5.8	7.5	14.6	3.2	3.7	4.8	2.2	9.2	5.1	7.4	1.8	4.3	6.3	3.7	14.6	6.0	17.5	11.1	5.9	4.9	42.1	4.5	5.8	6.9	6.7	6.1	8.3	6.0	4.8	5.1	8.6	4.6	8.8	7.0	10.0	5.6	4.8	3.3	6.3	7.0	4.1	5.7	2.0	12.6	7.2	7.2	1.8	5.6	3.9	5.8	18.6	7.5	10.5	3.6	7.8	4.9	8.7	2.9	15.6	3.5	2.1	13.9	0.0	3.6	6.1	4.4	4.9	3.6	1.4	4.0	15.7	6.1	7.1	2.8
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Predicted intracellular proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 4.1;brain: 4.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 1.0;Macrophages: 1.2;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"			"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.1	0.0	0.9	0.3	0.2	4.1	0.1	0.7	4.3	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.2	1.0	0.0	0.9	0.4	0.0	0.0	0.7	0.2	0.3	0.0	0.7	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.7	4.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116423112-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	3.3	9.8	26.1	2.7	26.3	3.6	4.3	39.0	36.0	5.3	9.0	5.2	3.4	3.2	3.9	2.2	8.0	2.5	22.5	27.0	25.8	5.5	4.1	2.2	2.4	29.3	36.2	2.8	6.7	3.1	11.6	1.8	28.7	25.2	3.2	13.4	5.8	11.3	7.3	2.4	4.1	2.8	21.4	2.4	5.6	17.6	35.0	6.0	1.8	5.6	1.8	3.2	3.5	39.2	3.7	12.0	4.3	7.1	7.6	7.0	15.4	5.7	2.3	2.5	2.8	8.1	4.4	8.8	6.1	3.8	9.3	1.3	11.5	0.6	3.1	4.8	2.9	3.1	5.8	17.0	3.0	1.8	6.2	9.5	1.1	7.8	0.7	5.4	1.8	10.5	3.9	5.9	7.9	3.8	4.1	1.4	13.2	10.6	6.4	4.9	27.5	2.5	8.0	12.3	6.3	37.9	6.8	2.0	4.8	14.5	15.5	1.3	3.5	5.9	9.1	5.6	4.9	9.0	5.0	8.3	10.5	2.0	25.8	2.5	0.4	0.5	2.8	0.3	3.6	1.5	3.1	2.4	0.2	1.6	3.0	2.5	1.9	5.9	0.6	0.9	8.8	1.0	26.1	26.3	39.0	36.0	27.0	25.8	29.3	36.2	28.7	21.4	35.0	39.2	0.6	6.4	8.9	354.6	1.1	1.3	3.2	0.4	1.2	4.9	4.2	4.8	22.7	2.8	5.0	1.8	10.4	0.4	1.0	0.4	3.9	0.8	122.5	4.7	5.5	1.3	12.6	0.4	370.0	1.1	0.4	4.9	4.1	0.7	6.3	37.0	0.7	2.9	3.2	10.1	1011.0	1.0	0.0	0.0	1.6	228.2	2.8	1.0	0.0	36.5	0.2	3.0	0.0	900.3	225.9	0.5	2.1	5.7	3.6	11.7	5.7	6.9	11.7	5.1	0.0	1.9	2.0	7.7	13.2	0.3	0.6	0.3	3.8	1.9	1.8	2.2
ASXL3	KIAA1713	ENSG00000141431	"ASXL transcriptional regulator 3"	Q9C0F0	18	33578219-33751195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 2.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 52.5;Excitatory neurons: 125.1;Inhibitory neurons: 101.1;Late spermatids: 31.6;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 62.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPMI-8226: 7.4;SCLC-21H: 2.8;SH-SY5Y: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039539, HPA040034"	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039539: , HPA040034: "	"unprognostic (2.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.47e-12)"	"unprognostic (4.69e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.67e-2)"	0.2	0.0	1.7	0.0	1.4	0.0	0.2	0.0	1.9	0.7	0.1	0.6	0.2	0.3	0.3	0.0	0.5	0.4	0.5	1.5	0.7	0.6	0.4	0.2	0.0	0.4	0.2	2.2	0.3	0.2	0.7	0.0	0.1	0.6	0.1	0.5	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.8	1.6	0.1	0.0	0.9	0.0	0.0	0.5	0.4	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	2.8	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	1.9	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.7	1.0	0.0	0.0	11.1	0.0	0.1	1.0	0.0	1.2	5.3	0.2	0.9	4.8	1.5	3.1	1.8	0.0	0.6	0.0	1.0	1.9	1.7	52.5	0.1	1.5	0.4	3.0	0.0	125.1	0.0	0.2	3.2	3.1	0.1	1.3	0.0	0.4	2.0	0.2	1.7	101.1	0.7	0.0	0.0	0.0	31.6	2.1	0.1	0.0	10.3	0.0	1.0	0.0	88.4	62.2	0.4	0.4	1.9	0.0	0.4	1.5	1.2	0.0	0.9	0.0	1.1	2.6	2.9	3.7	0.2	0.0	0.4	0.0	11.2	0.6	0.3
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 10.7"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 89.0;Spermatogonia: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.2	0.0	89.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ATAD1	"FLJ14600, Msp1"	ENSG00000138138	"ATPase family AAA domain containing 1"	Q8NBU5	10	87751512-87841361	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 987.5;Late spermatids: 1846.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	"Nucleoli rim,Mitochondria"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli rim"	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	15.7	17.4	9.9	9.0	10.3	4.9	16.3	11.3	12.6	16.0	10.7	18.2	10.9	16.8	13.7	16.2	13.8	10.5	36.1	10.4	11.5	16.7	18.0	14.5	11.8	10.7	11.5	15.9	12.7	28.5	13.4	15.2	11.1	18.7	14.5	28.0	14.9	16.1	37.2	15.1	12.5	13.6	10.0	10.0	13.6	26.4	11.0	13.8	17.4	31.8	12.1	15.5	16.0	10.2	18.8	18.2	20.8	18.2	27.4	29.5	14.4	19.7	33.4	19.6	20.6	14.6	53.8	17.6	15.4	17.3	9.8	31.3	18.9	14.4	21.2	18.6	26.4	15.3	24.0	18.8	30.5	41.7	8.0	23.0	45.4	20.7	42.1	37.2	12.7	14.1	15.9	20.7	22.7	11.2	23.1	22.9	16.4	13.9	10.0	15.8	13.2	19.2	28.9	13.4	14.2	31.5	20.3	12.3	32.0	21.0	29.1	18.0	19.3	16.2	13.9	11.2	24.5	25.4	39.4	22.5	20.8	23.7	11.5	8.4	2.8	4.9	6.3	4.9	10.3	7.2	7.3	8.3	5.4	5.7	9.1	8.6	1.7	8.6	6.9	4.6	7.6	5.7	9.9	10.3	11.3	12.6	10.4	11.5	10.7	11.5	11.1	10.0	11.0	10.2	31.0	54.5	28.0	46.4	41.4	26.8	42.9	46.2	44.3	50.4	29.8	20.8	81.3	27.1	44.9	22.0	35.5	37.7	35.2	33.8	23.5	37.0	987.5	22.3	38.3	21.7	22.8	24.6	69.0	28.0	33.2	35.6	32.6	28.7	29.2	23.1	20.0	28.9	27.3	70.7	73.1	22.9	50.8	18.0	20.1	1846.8	35.8	25.1	32.0	37.5	16.1	59.6	23.7	58.8	52.7	39.0	25.2	47.0	32.3	42.3	20.5	29.5	44.8	54.8	59.2	29.5	43.8	77.2	29.8	34.6	30.1	88.4	40.0	34.8	23.7	54.6
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 294.4"					"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	2.9	3.4	3.8	7.7	3.6	26.5	6.8	2.6	3.9	12.8	2.0	5.3	5.0	4.3	3.8	6.8	3.4	3.2	5.8	3.2	4.5	1.4	9.9	4.1	14.4	2.9	3.8	7.0	3.3	1.9	3.9	4.8	2.6	10.3	6.9	1.4	4.3	4.7	9.3	6.8	5.2	4.1	2.8	4.9	4.7	18.9	5.1	28.3	3.9	3.2	12.8	4.8	3.9	2.8	103.7	39.6	55.0	19.0	9.7	12.3	24.3	79.2	27.2	66.8	73.9	30.1	43.8	67.2	23.6	25.2	26.5	48.3	74.2	25.6	106.1	94.3	39.0	121.2	41.0	61.4	3.8	44.6	57.4	4.1	3.8	63.6	21.0	14.3	20.7	38.6	57.7	66.4	50.4	107.1	129.5	32.8	10.0	77.8	38.4	66.5	65.6	36.4	23.8	46.7	70.2	30.5	114.4	294.4	20.8	22.1	60.2	41.2	13.0	50.4	69.3	40.2	96.6	21.2	40.7	60.8	32.9	72.9	40.4	5.3	0.8	3.3	1.6	0.8	2.2	2.6	2.3	2.7	1.4	1.5	1.5	1.7	0.2	2.5	1.9	0.1	4.6	1.0	3.8	3.6	2.6	3.9	3.2	4.5	2.9	3.8	2.6	2.8	5.1	2.8	4.8	6.4	11.0	9.4	18.5	15.8	27.9	9.1	14.2	2.8	17.3	21.2	27.3	2.8	10.2	3.7	4.2	14.9	15.3	9.0	1.9	3.5	54.9	7.9	17.3	9.6	1.2	79.1	25.6	2.2	26.2	17.1	13.3	17.5	14.5	37.9	7.1	16.3	11.2	1.7	16.4	13.1	4.1	8.2	6.9	24.4	7.5	11.7	1.8	14.0	6.3	6.3	17.5	11.6	2.8	3.5	4.3	13.9	34.0	20.7	3.1	1.0	5.4	1.9	0.0	9.5	17.5	106.0	82.4	23.7	12.1	13.5	22.8	3.7	14.6	24.5
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family AAA domain containing 2B"	Q9ULI0	2	23748664-23927123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	4.8	3.1	4.9	5.9	6.1	9.8	4.5	8.1	5.5	5.9	11.0	4.2	5.1	4.9	2.6	6.0	4.6	3.5	3.7	4.0	6.1	3.7	4.1	4.8	7.3	6.5	5.7	5.8	4.3	3.3	4.1	4.0	5.7	4.3	4.3	9.4	4.8	2.3	4.4	8.3	5.2	2.8	4.8	5.1	3.9	4.3	5.9	10.3	5.2	2.8	6.5	4.0	6.6	7.7	4.1	3.4	11.0	5.0	3.1	3.4	8.5	2.7	2.2	3.5	2.4	5.5	2.0	13.4	2.4	2.5	1.6	5.3	8.6	3.0	2.9	8.8	4.1	11.3	4.5	6.6	3.4	10.2	8.1	2.7	5.2	2.1	3.4	2.9	4.8	7.4	12.2	5.8	2.7	7.0	9.5	11.9	6.5	6.8	1.9	10.8	11.8	3.1	3.8	9.1	5.1	8.4	7.4	9.0	4.2	6.0	4.4	10.0	4.6	3.5	4.0	3.0	3.2	6.0	2.9	10.0	1.9	11.5	3.3	15.8	7.9	5.1	3.9	4.7	4.4	8.5	3.6	3.5	7.6	6.4	5.2	4.2	12.0	6.0	6.2	11.0	3.4	1.8	4.9	6.1	8.1	5.5	4.0	6.1	6.5	5.7	5.7	4.8	5.9	7.7	18.4	3.2	16.0	93.0	26.1	10.7	7.7	6.4	13.1	27.6	9.5	7.1	11.3	10.0	12.2	9.2	47.9	8.4	33.8	15.2	0.0	7.7	60.2	10.1	20.1	14.6	15.6	11.1	60.3	12.2	7.4	14.7	19.9	17.0	13.3	21.2	11.7	10.7	8.2	10.1	95.5	11.0	10.2	14.4	17.6	36.1	12.5	23.8	3.6	85.3	30.9	13.0	22.6	143.7	125.3	8.9	18.6	10.9	14.0	10.8	17.2	2.4	8.5	45.4	6.6	19.1	13.5	23.5	16.8	20.0	17.5	10.9	22.6	13.1	11.3	16.5
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family AAA domain containing 3A"	Q9NVI7	1	1512162-1534685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.9	13.6	8.3	12.3	8.4	18.1	10.7	8.5	11.1	10.6	9.7	11.2	11.4	12.8	2.0	17.2	10.4	4.4	15.5	9.0	7.7	10.6	18.5	10.0	10.4	8.4	8.2	8.4	19.5	5.2	14.6	6.6	8.0	9.5	3.0	2.0	13.4	5.5	28.8	14.3	9.8	3.8	7.5	11.7	12.9	9.3	8.2	6.2	9.6	8.3	4.7	11.4	10.7	8.3	79.2	47.9	18.0	49.3	8.3	10.6	45.6	62.9	16.8	52.7	32.1	127.2	52.8	45.9	41.5	24.9	19.7	65.8	27.5	36.5	9.2	42.7	110.3	75.0	131.9	97.0	17.3	112.5	42.7	12.8	11.2	44.2	16.2	6.1	23.2	44.2	120.1	27.3	19.7	64.5	83.1	95.2	40.9	25.9	91.5	88.5	35.7	91.9	14.7	40.3	91.8	35.3	39.8	58.1	53.0	5.9	24.8	55.7	32.6	52.5	45.0	85.8	79.2	45.6	52.6	172.7	54.2	160.5	25.4	0.5	1.8	0.6	1.5	1.5	1.0	1.4	1.5	1.7	2.2	1.5	1.3	0.6	0.1	2.5	3.4	2.2	1.5	1.1	8.3	8.4	8.5	11.1	9.0	7.7	8.4	8.2	8.0	7.5	8.2	8.3	8.5	3.2	9.0	10.7	11.7	20.4	11.2	5.9	8.0	10.5	11.6	8.3	9.5	8.6	6.4	7.3	6.2	21.6	10.0	18.8	7.9	22.5	9.5	14.7	9.3	11.8	13.8	28.4	8.8	21.3	43.4	10.4	13.7	8.7	8.9	21.9	4.6	12.5	22.4	23.5	8.3	19.6	14.2	7.5	12.5	10.1	5.6	7.7	16.0	6.5	5.9	10.9	6.2	4.5	6.1	25.3	5.2	7.9	27.5	38.3	13.8	12.8	7.9	9.4	0.0	9.4	14.8	5.8	20.1	17.4	24.3	19.7	7.7	35.6	27.7	15.7
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family AAA domain containing 3B"	Q5T9A4	1	1471765-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	9.1	10.0	5.7	3.6	5.8	5.0	8.5	5.5	9.7	9.8	5.8	9.1	2.4	7.2	0.0	12.4	9.1	0.7	8.0	5.6	5.6	13.7	15.7	8.6	3.5	5.9	5.5	10.2	9.7	0.4	13.6	1.3	5.9	11.7	0.3	0.1	7.5	0.7	6.2	10.7	9.2	0.5	5.3	14.1	8.7	10.8	6.0	2.3	9.6	0.2	0.7	9.9	8.6	6.1	13.4	0.1	3.2	21.9	1.3	1.4	29.0	20.7	4.8	20.7	15.7	47.8	38.6	16.9	6.7	7.9	13.4	21.8	28.1	13.6	4.7	16.3	29.0	12.2	32.9	31.9	5.3	20.4	14.3	4.7	0.7	35.9	1.5	0.0	7.6	7.1	37.2	3.2	8.1	5.4	26.3	28.7	44.1	9.8	51.7	21.5	6.3	12.0	6.2	7.7	15.6	13.2	14.0	18.7	20.2	2.4	2.4	7.5	7.5	4.5	12.0	32.4	23.0	12.2	18.5	45.7	17.7	35.1	5.8	0.2	0.2	0.4	0.4	1.1	0.5	0.1	0.3	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	5.7	5.8	5.5	9.7	5.6	5.6	5.9	5.5	5.9	5.3	6.0	6.1	8.6	6.4	22.1	17.6	9.4	26.3	7.8	5.2	10.2	16.0	9.3	7.1	5.9	8.6	7.5	9.2	20.9	15.3	12.9	17.8	1.9	7.7	3.6	10.1	7.8	8.2	7.2	7.6	13.3	7.9	40.3	8.7	23.9	10.2	11.4	16.7	4.2	7.6	12.4	13.5	12.9	13.8	6.1	4.7	12.3	3.8	4.4	7.9	10.6	8.4	5.4	5.8	1.0	4.5	8.3	11.3	9.7	3.0	22.8	14.4	6.7	2.6	8.3	17.1	6.6	8.3	10.2	5.4	10.6	11.1	23.4	17.8	9.9	15.0	20.6	10.8
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
ATCAY	BNIP-H	ENSG00000167654	"ATCAY kinesin light chain interacting caytaxin"	Q86WG3	19	3879864-3928082	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 46.6;pituitary gland: 25.6;retina: 17.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 128.5;Excitatory neurons: 67.0;Horizontal cells: 47.1;Inhibitory neurons: 82.2;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in some"	8	"glioma: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 13.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017755	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA017755: AB_2669655"	"unprognostic (7.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.83e-4)"	"unprognostic (7.22e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.67e-1)"	0.1	6.9	32.1	0.6	34.6	0.3	0.0	0.5	46.6	0.9	0.0	1.1	0.5	0.1	0.1	0.2	0.0	0.2	0.1	29.8	36.1	0.1	0.0	0.1	0.2	17.8	13.8	0.1	0.3	0.0	25.6	0.1	16.7	1.8	0.3	17.6	0.1	3.2	1.2	0.3	0.6	0.2	3.3	0.1	0.4	0.2	17.3	0.0	0.1	0.0	0.0	0.1	0.6	24.6	0.5	0.1	2.7	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.6	0.5	0.2	0.0	1.5	0.4	0.2	0.0	0.0	0.2	0.2	0.8	1.1	0.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.5	0.1	0.2	0.2	0.4	7.3	0.1	0.1	0.2	0.4	0.2	0.1	0.2	13.2	9.3	0.2	0.2	0.1	1.2	0.2	0.2	0.5	0.3	0.6	0.4	0.7	0.3	0.3	0.2	0.3	1.3	0.2	0.6	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.1	0.1	32.1	34.6	0.5	46.6	29.8	36.1	17.8	13.8	16.7	3.3	17.3	24.6	0.2	0.0	3.4	3.3	0.6	0.6	0.8	0.0	0.0	128.5	0.2	0.1	1.9	2.8	0.0	0.0	22.9	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.9	0.7	0.0	0.0	67.0	0.0	0.2	1.1	0.0	0.8	7.0	0.1	0.7	0.1	0.1	47.1	82.2	0.2	0.0	0.6	2.6	0.0	0.0	0.5	3.6	5.6	0.1	5.4	2.1	94.0	3.9	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	18.7	0.0	1.9	0.7	0.7	1.7	0.0	0.4	0.0	0.6	0.0	0.1	0.4
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740424-121928492	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA		83000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	10.1	11.7	8.1	8.5	8.5	7.4	10.4	7.3	9.2	12.1	17.3	13.5	11.4	10.6	8.4	10.7	9.0	10.4	22.2	8.4	11.0	18.2	18.2	9.5	9.5	6.7	7.3	10.0	6.2	15.4	4.8	11.0	7.5	12.7	14.6	15.6	7.8	10.0	18.3	6.7	11.1	11.7	7.4	10.4	8.8	13.3	10.6	13.0	16.0	15.4	10.6	12.7	6.6	8.7	13.0	19.5	15.4	15.0	15.1	16.8	12.3	12.0	24.0	13.1	13.2	23.6	19.1	16.1	9.5	14.3	8.8	16.1	14.5	14.2	16.3	20.3	13.1	5.8	8.8	31.1	15.5	26.7	13.4	11.9	15.2	13.8	32.0	19.3	18.7	9.0	7.8	29.4	14.5	7.9	14.0	15.2	7.5	19.6	11.4	13.1	18.1	10.6	23.4	11.2	4.8	19.4	17.2	12.9	28.2	11.3	8.9	9.2	19.2	8.2	7.0	12.5	21.1	28.0	33.6	12.0	12.6	20.6	7.4	12.8	3.8	6.1	5.3	4.5	6.3	4.5	5.0	5.3	3.4	4.2	5.5	5.6	2.3	5.1	3.5	4.8	6.7	4.0	8.1	8.5	7.3	9.2	8.4	11.0	6.7	7.3	7.5	7.4	10.6	8.7	23.0	9.6	22.0	76.4	17.3	8.4	12.8	9.4	24.5	31.3	17.5	14.6	75.6	11.5	12.7	20.2	12.5	7.2	20.9	42.8	17.6	11.3	6.5	15.8	19.4	19.3	22.1	16.2	100.5	13.3	10.5	25.0	29.6	16.4	12.6	13.5	20.0	26.6	10.0	23.5	93.8	17.7	10.2	14.8	7.2	7.7	20.5	23.6	14.2	74.0	12.8	21.7	27.8	137.7	220.4	15.6	18.3	25.9	24.8	21.0	19.5	39.4	11.5	35.8	0.0	23.4	21.1	26.9	40.2	30.7	17.5	8.6	17.9	29.1	16.8	16.6
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821162	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	13.8	21.2	4.9	15.8	5.1	14.8	16.8	14.2	7.1	16.7	8.2	18.0	16.0	18.2	13.7	17.0	17.8	16.5	14.6	4.8	7.9	17.4	20.8	15.8	21.5	5.3	5.8	23.1	9.1	19.8	10.1	16.7	5.4	14.3	18.6	11.9	14.5	13.5	32.4	10.4	14.7	16.7	5.4	17.9	14.3	8.6	6.6	29.2	22.7	23.7	21.5	16.5	12.9	6.9	28.6	20.4	21.0	21.4	29.0	30.4	52.2	29.5	50.7	45.7	35.8	41.7	43.7	38.7	47.6	34.5	20.0	22.8	24.9	30.6	47.6	39.0	25.8	42.8	43.1	22.6	56.5	62.3	39.6	33.7	45.7	32.8	52.8	47.6	22.5	27.1	53.2	36.2	33.9	42.4	39.6	37.3	30.0	33.0	32.1	37.5	32.3	45.9	33.6	19.5	27.9	14.9	61.8	26.5	44.7	28.5	37.3	37.6	16.1	32.1	38.2	26.4	24.1	20.2	25.8	63.6	30.9	33.9	15.3	6.6	17.9	42.7	20.2	18.8	23.1	20.2	21.7	24.1	21.1	21.7	26.4	20.4	11.2	20.8	12.7	9.6	28.8	19.1	4.9	5.1	14.2	7.1	4.8	7.9	5.3	5.8	5.4	5.4	6.6	6.9	25.5	54.5	18.5	22.2	41.5	75.3	48.4	34.8	52.3	12.1	26.0	18.5	14.6	15.7	26.7	12.9	0.0	34.6	25.4	23.4	52.8	24.9	9.2	24.6	20.8	23.8	6.0	46.7	25.8	21.1	77.1	33.1	14.3	21.0	10.1	14.1	20.0	16.2	27.5	13.5	29.2	18.7	24.4	25.2	48.4	5.9	32.0	24.2	23.2	16.9	24.6	14.2	27.8	12.5	25.3	22.8	17.9	27.8	22.1	43.7	20.7	34.6	19.9	7.2	39.5	34.1	33.7	10.9	10.3	30.3	54.6	80.6	38.4	20.4	22.8	36.9
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	16.8	20.2	15.6	15.2	17.6	16.4	19.5	23.3	25.7	25.7	4.1	15.1	13.0	21.8	21.6	14.3	18.9	17.8	12.1	19.3	15.5	22.5	27.8	15.4	19.7	16.2	14.9	26.0	18.9	24.0	13.9	20.4	17.2	18.3	15.7	21.8	17.9	17.7	12.5	10.0	13.6	18.1	12.3	17.6	14.3	21.0	13.3	30.2	32.3	23.1	21.1	18.8	13.0	19.8	14.1	12.1	35.1	23.4	30.6	32.3	16.1	22.3	38.1	26.6	38.1	26.6	25.4	21.1	23.9	26.6	31.2	13.3	26.9	13.5	41.2	26.6	15.6	29.3	19.8	58.3	34.4	27.8	29.7	24.4	29.8	34.4	40.5	35.0	37.0	19.4	24.4	31.6	30.1	10.5	45.2	34.4	32.7	23.6	27.2	38.3	16.1	32.5	39.1	11.8	29.3	23.9	27.9	8.6	33.0	28.2	19.3	30.4	23.5	30.8	16.1	16.9	13.6	30.3	48.9	26.9	24.2	26.0	21.2	35.5	16.9	20.1	20.1	15.1	24.3	16.6	17.0	20.9	21.9	14.1	19.6	21.5	10.8	19.8	19.1	12.1	24.4	18.0	15.6	17.6	23.3	25.7	19.3	15.5	16.2	14.9	17.2	12.3	13.3	19.8	43.4	16.0	13.2	47.7	33.5	33.0	15.4	15.6	52.9	22.7	34.0	24.4	22.5	20.0	15.5	23.9	10.4	14.1	37.4	16.5	13.7	12.1	115.4	19.5	30.5	33.8	16.3	20.8	86.6	7.0	13.0	32.2	18.3	28.4	29.8	27.1	17.2	27.0	18.9	40.4	71.3	14.4	18.3	23.3	30.2	153.0	32.6	23.6	30.2	54.4	20.4	32.3	24.7	75.9	84.9	11.9	9.1	28.6	38.8	15.6	11.5	21.6	19.3	27.3	13.1	31.5	33.9	36.3	17.6	30.4	25.3	6.3	32.9	23.7	16.1	13.6
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.3"	HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	176.1	82.8	14.2	63.3	17.7	45.3	97.6	16.5	18.7	106.2	17.1	66.6	21.0	108.6	9.3	128.4	122.6	135.0	113.7	14.4	20.2	98.1	139.9	116.0	20.8	21.1	16.7	40.2	67.2	48.8	45.0	66.3	17.2	116.3	60.0	16.2	33.1	24.1	30.7	154.9	45.6	313.0	15.4	24.4	104.8	3.9	18.8	84.5	181.1	30.0	3.1	281.2	55.2	25.0	21.1	1.2	40.7	8.7	3.9	10.4	131.5	14.7	11.9	12.5	29.8	27.7	15.5	0.4	6.5	0.9	68.0	11.6	24.6	4.0	20.5	100.4	24.6	1.6	11.6	10.0	72.9	9.0	22.7	18.3	65.3	34.9	80.4	2.4	2.6	23.9	10.0	77.0	1.9	2.8	27.5	5.9	29.2	11.5	9.2	8.1	27.1	18.4	1.8	3.0	18.3	18.4	19.1	34.2	59.0	155.0	19.9	6.5	2.4	3.6	19.5	12.3	6.7	60.4	27.9	7.4	11.9	4.8	10.8	6.4	0.7	0.0	0.3	4.0	0.3	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	6.3	0.8	0.0	0.7	14.2	17.7	16.5	18.7	14.4	20.2	21.1	16.7	17.2	15.4	18.8	25.0	568.2	423.1	146.5	1.6	55.3	202.8	866.2	236.1	1462.0	4.4	753.9	510.9	689.3	92.9	136.0	55.2	0.0	178.9	100.3	611.7	1.9	186.2	3.7	1049.4	318.2	176.2	889.6	2.7	2.6	122.7	330.8	452.6	966.9	1429.3	78.6	5.6	30.7	25.8	103.7	1.7	2.4	758.4	114.0	29.8	282.8	2.8	17.4	351.8	174.3	3.7	32.3	39.9	0.0	1.5	10.8	185.7	484.8	1.2	161.0	457.5	421.3	3.3	133.2	5.3	98.6	279.4	573.7	2.2	3.1	474.6	202.7	420.6	97.1	5.8	349.6	263.6
ATF4	"CREB-2, TAXREB67, TXREB"	ENSG00000128272	"Activating transcription factor 4"	P18848	22	39519695-39522683	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011596	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"CAB011596: AB_725569"	"unprognostic (2.51e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (7.06e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.95e-1)"	582.7	408.4	322.1	204.1	337.9	888.2	488.9	349.4	416.4	362.4	319.2	853.9	215.2	389.2	232.2	391.5	381.8	245.6	389.9	316.2	328.3	393.7	492.9	438.0	223.9	353.2	336.7	346.1	629.0	202.6	304.7	247.8	346.6	454.8	218.4	497.5	472.4	278.6	789.2	370.6	362.7	347.4	336.5	351.1	574.5	154.1	339.1	243.7	317.8	420.8	280.6	572.8	363.9	366.3	398.5	230.6	412.3	532.3	450.0	437.1	670.3	470.5	726.2	366.8	462.1	508.5	300.0	760.2	100.7	358.0	300.6	305.1	676.3	551.9	463.7	475.2	461.0	518.9	259.5	516.8	962.7	992.0	479.4	733.3	1172.0	654.3	973.2	658.2	365.8	825.3	560.4	790.7	288.6	241.8	599.2	713.8	354.8	828.1	288.3	612.0	268.5	793.5	491.0	328.0	605.3	254.3	214.8	559.3	1405.8	374.4	342.4	1191.5	290.4	221.5	645.9	250.8	323.8	1004.7	1100.7	888.7	244.9	497.5	506.3	46.5	36.9	24.8	20.0	31.6	26.4	37.9	27.6	26.5	44.3	28.7	28.6	26.6	17.8	26.8	34.9	27.0	31.6	28.8	322.1	337.9	349.4	416.4	316.2	328.3	353.2	336.7	346.6	336.5	339.1	366.3	201.0	169.9	176.0	19.2	181.8	443.9	344.3	171.2	205.5	120.5	286.8	211.5	167.9	143.0	148.7	44.1	93.8	140.1	156.9	357.9	66.5	200.9	20.9	154.2	122.8	229.9	266.7	140.4	19.2	765.1	309.0	198.0	184.5	191.7	223.0	119.0	146.7	190.9	112.7	69.0	16.6	371.4	101.7	174.3	348.4	21.1	185.1	215.7	238.3	22.5	239.5	94.7	92.7	16.6	34.7	396.0	335.7	206.9	223.7	378.5	265.0	85.8	92.3	311.3	335.2	306.5	279.0	72.3	61.5	155.3	335.7	218.4	175.5	115.0	284.5	401.1
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2479.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1412.6"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	40.7	61.4	11.7	31.7	11.6	21.4	35.6	10.7	15.2	14.9	9.3	19.6	28.3	16.2	9.8	18.0	22.9	14.4	17.3	12.2	14.7	26.1	2479.9	17.0	23.3	14.5	17.0	14.1	29.1	10.0	14.7	12.3	15.7	23.2	10.3	12.5	21.1	10.3	30.6	17.7	23.2	10.2	13.6	27.3	24.5	44.3	12.4	13.1	118.7	9.5	20.0	24.4	14.3	15.3	68.5	47.3	17.8	12.0	18.3	15.5	17.8	48.6	40.8	49.4	30.2	35.7	36.5	60.7	24.3	28.6	34.0	24.2	22.7	20.0	23.5	313.2	22.6	41.7	14.8	27.4	12.5	162.7	113.6	108.3	31.5	36.5	8.5	12.2	21.4	132.6	38.1	523.4	24.7	64.3	23.5	35.9	8.8	18.6	62.6	194.2	19.1	24.9	56.6	90.9	28.2	20.1	113.2	47.8	34.9	6.6	39.2	452.4	36.6	95.5	61.3	11.3	49.8	13.8	715.6	316.2	75.1	63.6	36.4	0.4	24.0	1.0	1.4	22.4	2.0	1.6	1.4	1.7	14.3	0.8	1.2	1.8	3.6	3.2	6.0	38.5	1.9	4.7	11.7	11.6	10.7	15.2	12.2	14.7	14.5	17.0	15.7	13.6	12.4	15.3	16.3	12.8	11.9	2.6	41.7	22.6	12.3	11.1	39.9	3.8	31.9	29.3	7.4	38.6	9.4	16.5	6.2	33.9	23.5	22.0	13.7	13.1	260.8	36.5	17.4	21.1	21.5	64.2	1.2	29.8	19.4	27.3	34.1	35.3	6.3	27.1	40.0	1412.6	82.5	92.5	1.8	21.0	2.0	59.4	172.3	134.3	13.4	51.2	40.9	2.8	259.9	17.4	8.2	0.5	1.6	20.0	20.6	16.6	118.1	24.8	49.0	47.9	9.6	7.5	13.1	18.0	24.2	15.0	11.3	37.7	24.0	35.6	15.1	23.4	23.4	18.4
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766298-161977574	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved					NA	NA		46000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA005935: AB_2667472"	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	13.6	10.1	7.2	13.9	8.4	12.6	11.5	8.3	7.5	8.4	13.6	9.9	9.9	10.6	18.9	11.0	8.9	11.3	9.4	7.2	9.9	14.6	22.0	11.4	10.6	10.2	9.4	9.0	34.4	18.9	7.1	18.0	10.5	10.7	11.2	16.7	13.3	10.3	8.9	11.2	9.4	12.8	10.0	11.3	11.2	10.1	8.0	8.4	15.1	9.5	11.1	13.7	7.9	11.9	23.3	17.9	15.1	22.4	18.6	17.7	26.7	27.8	25.3	17.7	19.2	11.6	38.2	16.9	39.6	34.6	19.9	34.0	15.1	18.6	17.6	23.2	12.9	15.9	22.6	12.7	40.3	29.7	40.6	18.3	29.0	18.2	53.3	23.8	40.3	22.7	37.9	19.2	19.3	23.0	15.9	17.3	12.2	24.5	23.1	13.7	21.4	39.2	19.3	11.1	9.1	13.8	33.3	19.8	41.0	32.9	24.5	39.2	54.4	23.2	21.9	8.7	31.5	28.0	29.2	20.4	28.2	5.1	29.0	9.7	17.8	12.0	9.2	18.3	9.0	8.7	8.3	7.7	12.8	9.5	9.5	9.7	33.2	7.4	24.4	5.7	9.6	10.6	7.2	8.4	8.3	7.5	7.2	9.9	10.2	9.4	10.5	10.0	8.0	11.9	40.5	102.5	85.1	41.8	31.4	34.8	45.4	28.4	18.2	38.6	38.0	25.4	21.6	25.8	67.0	51.5	50.1	49.2	23.2	30.5	7.9	45.9	13.0	27.1	25.3	49.8	37.1	17.9	79.9	37.6	43.1	46.2	23.9	40.2	54.3	24.0	37.5	53.5	50.3	26.9	69.7	28.2	30.5	59.5	59.4	10.8	23.0	66.6	26.6	103.0	62.0	34.1	21.6	60.3	105.8	35.9	15.6	24.5	53.9	43.3	22.3	18.8	61.7	29.9	6.6	61.3	31.8	43.1	30.5	22.7	47.7	103.0	29.0	22.1	22.9	44.1
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		46000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	35.0	40.8	7.3	7.4	7.4	29.4	40.3	6.6	9.9	50.2	3.9	46.3	11.9	46.0	16.7	56.6	45.6	11.5	31.2	7.9	9.1	36.7	35.1	35.6	14.2	7.7	7.7	57.1	43.4	14.1	43.0	8.8	7.6	43.7	14.0	8.1	44.9	6.3	22.4	53.3	46.9	8.9	7.1	60.0	45.4	29.3	7.4	16.7	51.1	5.0	17.0	44.3	47.0	7.1	2.5	6.3	18.1	29.7	17.8	18.9	11.5	9.8	13.3	13.7	20.8	25.2	20.9	30.4	26.8	60.1	14.5	17.0	23.5	37.2	8.1	18.3	34.5	11.2	36.1	24.7	28.9	2.9	40.0	17.2	16.1	5.4	31.4	25.5	44.0	47.9	38.0	32.9	39.9	18.3	25.5	17.4	5.1	20.8	5.4	7.5	7.6	20.7	17.5	6.3	1.8	6.4	35.2	13.9	40.5	5.0	39.5	12.5	17.1	3.6	13.0	13.7	15.6	33.8	20.4	17.0	15.5	18.5	21.9	4.2	1.1	0.7	1.9	1.7	1.5	1.6	1.0	0.9	2.3	1.1	0.6	1.4	0.9	2.5	1.5	1.4	1.7	2.2	7.3	7.4	6.6	9.9	7.9	9.1	7.7	7.7	7.6	7.1	7.4	7.1	39.1	12.8	15.2	31.6	72.7	24.9	37.6	83.0	33.6	89.3	31.8	26.0	2.0	50.1	53.1	55.2	95.9	88.4	64.9	52.9	5.9	48.1	3.3	22.0	24.5	40.3	53.5	39.8	29.5	42.8	50.2	29.8	39.8	27.8	16.5	148.5	43.5	18.5	52.8	43.7	29.9	53.9	79.3	55.4	40.5	8.9	70.8	42.0	32.0	28.1	65.4	35.0	124.6	21.6	24.1	37.2	58.6	51.9	40.3	30.6	64.3	14.6	43.5	98.0	59.2	30.5	29.8	64.3	58.6	36.1	25.3	89.2	58.6	49.5	55.7	39.8
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	26.4	13.2	12.4	18.1	19.6	15.4	23.9	26.1	16.7	21.1	11.5	21.9	12.6	24.4	14.5	22.4	17.8	18.1	20.6	15.1	15.5	17.4	14.6	20.2	13.2	20.8	16.9	24.6	18.4	14.2	11.5	18.3	21.8	19.0	21.1	15.3	24.2	14.6	30.5	24.6	14.0	25.9	14.8	14.3	18.0	12.6	18.2	16.4	16.4	22.2	15.7	19.9	20.9	29.1	16.6	32.1	16.6	18.2	30.8	39.1	10.8	19.6	20.1	21.3	14.2	23.0	25.2	25.8	25.4	24.2	8.7	20.2	13.0	21.7	19.2	25.2	16.7	22.6	37.4	24.8	20.7	29.0	16.1	30.7	28.1	26.5	29.9	35.3	42.6	14.0	26.0	23.2	32.1	30.9	17.6	20.2	16.3	18.7	17.4	22.9	19.7	24.9	32.3	21.2	13.8	14.6	29.9	21.7	30.8	16.0	29.2	17.6	31.4	25.2	17.7	20.2	17.9	11.4	14.6	16.2	20.6	27.1	23.6	15.3	13.8	13.8	7.4	19.1	7.6	10.5	10.1	7.5	10.8	11.5	7.2	8.6	8.6	14.2	14.1	7.5	10.4	8.8	12.4	19.6	26.1	16.7	15.1	15.5	20.8	16.9	21.8	14.8	18.2	29.1	30.5	12.8	17.3	83.2	16.3	22.2	24.0	35.9	25.6	9.4	33.3	31.1	18.2	22.8	23.4	14.7	25.0	22.2	14.0	21.4	37.2	30.3	32.2	16.5	23.1	25.4	18.6	13.2	29.0	31.6	25.0	23.8	17.3	22.5	28.6	25.0	28.9	14.7	25.3	10.1	29.7	20.3	24.4	24.1	23.1	35.8	27.1	24.9	24.9	55.3	24.0	23.9	17.5	40.7	141.9	27.5	13.8	24.5	12.5	25.0	17.9	46.0	17.0	10.9	26.3	25.6	27.5	9.9	17.9	34.1	28.8	27.9	17.3	20.2	18.4	28.9
ATF7-NPFF		ENSG00000267281	"ATF7-NPFF readthrough"		12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.4"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	0.1	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.2	0.0	0.5	0.2	0.2	0.0	1.0	0.2	1.4	0.0	0.1	0.5	0.7	0.0	0.0	0.4	0.5	0.1	0.1	0.2	0.5	0.1	0.0	0.0	0.4	0.1	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.8	0.5	0.1	0.6	0.7	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.1	0.5	1.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	12.4	10.4	12.1	16.8	18.8	30.9	14.7	32.8	11.7	12.8	21.7	11.2	8.3	15.6	13.7	14.3	13.4	11.8	16.3	9.9	14.1	11.0	14.4	13.3	28.2	16.9	15.5	17.9	11.5	17.2	8.5	14.2	15.8	13.4	13.0	17.1	20.6	12.0	16.4	16.7	11.9	16.4	11.2	20.8	14.2	33.8	18.8	32.5	21.7	21.2	28.1	12.6	11.4	21.3	23.2	13.8	54.3	31.7	27.9	35.2	11.4	24.4	13.7	18.8	28.6	31.4	23.9	38.5	16.2	16.6	34.3	23.0	34.3	22.4	42.3	27.5	20.1	25.8	23.3	6.5	16.6	17.7	15.1	19.0	18.3	23.2	23.9	29.3	41.5	13.6	15.6	19.7	29.9	21.7	25.5	15.4	35.1	11.9	12.7	52.3	60.3	21.0	16.2	44.6	17.4	14.2	27.7	16.0	15.4	44.0	16.2	20.5	19.2	26.3	16.7	14.9	20.3	13.2	13.9	53.1	16.7	16.5	29.0	29.2	11.6	19.4	16.2	8.3	16.8	23.1	13.6	16.0	9.8	30.9	10.9	15.5	17.8	11.4	14.2	12.9	18.7	11.0	12.1	18.8	32.8	11.7	9.9	14.1	16.9	15.5	15.8	11.2	18.8	21.3	46.6	67.3	42.5	67.9	121.2	6.6	12.8	9.7	75.1	50.2	31.6	24.6	73.0	20.0	26.6	35.0	68.8	17.2	112.1	13.2	7.9	16.6	79.6	31.1	34.7	40.3	28.1	55.1	62.6	12.2	10.9	32.0	41.8	31.9	25.9	34.8	30.0	31.3	20.5	63.9	73.9	19.6	10.2	48.4	11.2	19.6	29.2	46.3	5.4	107.7	47.9	23.5	64.9	136.7	147.9	14.5	13.5	29.3	85.9	13.6	12.0	16.4	24.3	39.8	13.1	40.0	33.3	42.4	25.0	62.7	6.7	15.5	98.5	35.1	18.3	12.1
ATF7IP2	FLJ12668	ENSG00000166669	"Activating transcription factor 7 interacting protein 2"	Q5U623	16	10326434-10483638	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 19.2"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 145.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 14.2;THP-1: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.3;hippocampal formation: 2.3"	"HPA041156, HPA041228"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"			"HPA041156: AB_10795536, HPA041228: AB_10795586"	"prognostic favorable (4.98e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (8.57e-5)"	1.8	6.7	2.4	4.2	1.7	5.7	1.5	0.7	3.6	3.0	0.9	1.9	3.0	1.4	3.6	1.5	4.8	1.3	5.2	3.0	1.8	2.4	9.2	2.1	8.8	1.0	0.9	2.2	5.6	0.6	1.2	3.2	1.2	1.4	2.0	4.7	0.8	1.7	1.6	2.9	2.0	2.2	1.0	5.1	6.2	19.2	1.6	10.7	3.7	1.3	8.6	5.1	1.1	2.7	0.7	1.6	1.3	4.3	3.3	3.8	6.9	1.7	0.3	0.4	0.0	0.5	7.2	0.0	3.5	0.0	1.4	1.0	6.3	1.5	0.4	6.2	4.3	8.4	1.3	6.0	1.6	7.8	3.5	4.2	1.4	0.1	0.0	1.7	2.9	13.1	14.2	0.0	4.0	1.3	9.9	6.1	7.0	9.6	1.5	13.0	0.0	4.3	1.4	3.3	0.0	0.8	6.8	1.3	0.7	4.3	2.4	13.9	1.6	0.0	1.9	0.1	0.0	2.8	7.3	1.2	0.0	4.8	1.9	0.1	0.5	0.0	4.5	1.0	11.6	2.4	4.6	4.4	1.6	3.6	3.8	4.3	0.1	3.5	1.0	2.5	7.2	2.0	2.4	1.7	0.7	3.6	3.0	1.8	1.0	0.9	1.2	1.0	1.6	2.7	28.5	12.8	16.2	26.1	62.1	11.5	11.6	37.3	19.9	18.5	11.0	8.4	53.9	7.2	22.8	12.9	100.1	60.1	38.9	15.4	99.7	16.8	30.7	24.2	8.2	17.6	23.2	30.9	71.4	10.9	60.5	12.8	81.1	14.9	1.3	19.9	13.2	115.2	23.6	5.0	45.5	14.6	24.4	23.6	23.5	31.6	7.5	33.5	16.0	82.4	13.8	38.2	24.7	39.7	8.4	6.7	20.7	6.8	37.1	6.1	10.0	39.0	88.7	35.4	13.1	6.0	13.2	145.8	89.2	19.6	19.5	27.1	46.0	17.3	16.8	21.7
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972023-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	4.0	5.4	4.8	4.1	4.9	5.6	7.0	8.3	5.7	3.5	7.9	5.5	3.3	4.6	7.8	4.9	4.2	4.3	4.6	5.0	4.7	5.7	6.5	3.7	3.5	5.0	4.5	3.2	4.4	11.6	4.0	4.7	5.0	5.6	6.1	3.5	3.7	5.6	7.2	6.6	3.3	5.5	4.6	4.1	4.4	10.4	5.0	7.8	7.1	3.1	4.3	4.0	3.9	8.0	4.7	12.6	7.9	23.0	5.3	10.0	20.1	5.4	4.4	3.9	6.0	3.7	16.7	8.4	4.4	8.8	29.7	2.5	5.9	12.2	5.1	14.4	4.2	9.2	11.4	4.0	5.0	4.8	7.3	9.3	8.2	5.7	4.7	6.0	7.4	17.7	11.3	6.8	14.4	9.5	11.0	5.2	11.0	3.5	8.2	8.0	11.5	20.1	10.0	6.7	11.8	16.9	8.8	4.9	10.0	13.6	9.4	8.9	6.0	7.0	6.6	3.8	11.5	9.4	17.0	11.5	9.8	11.4	11.7	2.7	5.7	8.5	5.1	5.8	4.8	3.6	4.5	4.8	7.5	4.5	4.2	5.2	7.4	6.5	4.3	5.6	5.0	4.1	4.8	4.9	8.3	5.7	5.0	4.7	5.0	4.5	5.0	4.6	5.0	8.0	8.1	16.0	15.6	69.2	9.3	24.9	17.4	16.3	14.2	16.3	15.6	14.4	9.3	12.8	16.7	12.9	10.4	25.5	9.7	8.2	15.6	15.7	67.6	7.7	11.4	13.0	9.6	14.5	56.4	18.4	46.3	15.1	6.6	9.7	11.4	22.1	10.0	12.8	18.3	18.5	52.2	7.8	4.1	14.1	28.4	96.6	6.8	12.3	32.0	57.1	17.2	12.5	15.5	67.8	76.5	15.2	9.9	10.1	10.1	12.0	8.5	18.8	8.8	15.2	0.0	18.2	13.6	54.1	22.9	13.8	32.0	21.1	14.3	15.6	11.5	14.0
ATG101	"C12orf44, FLJ11773"	ENSG00000123395	"Autophagy related 101"	Q9BSB4	12	52069246-52077494	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 261.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 261.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039904	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA039904: AB_10673262"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (8.07e-7)"	"unprognostic (9.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.15e-1)"	32.7	30.1	24.3	21.4	26.5	23.9	26.3	26.0	29.8	22.6	25.7	27.4	19.6	24.4	34.6	32.1	24.4	27.6	29.7	27.0	25.7	38.1	38.0	31.1	24.2	24.4	24.3	24.1	33.9	27.9	29.0	20.2	24.5	30.4	17.5	8.5	37.7	19.2	39.5	44.1	24.2	21.5	24.5	30.5	39.7	36.4	26.0	27.6	27.0	24.6	21.8	34.4	25.2	27.1	63.0	173.0	35.8	49.0	52.3	40.3	52.7	75.6	76.0	69.8	54.7	202.3	71.2	46.7	67.8	91.3	61.3	51.0	44.6	69.4	47.2	53.2	46.8	46.0	135.0	126.1	135.2	39.6	60.0	39.0	77.8	93.8	66.3	53.6	54.7	39.3	44.0	81.8	50.9	237.9	52.0	88.4	69.7	46.6	74.4	36.5	29.8	64.9	49.9	97.4	34.7	46.7	51.6	74.9	103.3	27.3	81.1	47.1	62.0	61.3	55.2	58.1	60.0	51.8	70.8	47.5	63.2	45.7	95.6	8.9	38.2	46.4	28.4	38.0	30.8	40.6	27.9	32.7	49.7	46.3	27.3	30.6	7.1	25.9	47.7	261.9	36.4	38.2	24.3	26.5	26.0	29.8	27.0	25.7	24.4	24.3	24.5	24.5	26.0	27.1	36.0	19.2	22.4	3.9	48.3	0.0	104.6	0.0	56.9	14.8	78.7	54.7	3.1	38.6	9.9	29.5	12.5	52.1	80.9	43.5	70.5	60.8	19.6	52.6	25.2	34.4	30.5	12.8	3.9	65.4	55.7	40.4	38.7	57.8	45.1	26.6	45.3	46.7	45.1	5.0	3.0	54.4	0.0	28.6	0.0	33.1	27.1	40.6	0.0	3.7	57.1	23.0	22.6	2.5	4.4	63.1	49.4	36.5	49.8	108.9	56.5	61.0	9.5	21.3	26.3	65.0	43.9	77.0	75.1	48.1	0.0	65.8	36.2	45.7	41.3	133.5
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
ATG14	"ATG14L, KIAA0831"	ENSG00000126775	"Autophagy related 14"	Q6ZNE5	14	55366391-55411830	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037242	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"			"CAB037242: AB_1852353"	"unprognostic (8.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.49e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.30e-1)"	6.1	6.7	5.3	4.6	6.6	28.9	6.4	6.9	6.7	7.3	4.8	6.8	5.3	7.7	2.0	7.0	5.6	5.7	8.0	5.7	5.4	6.2	4.8	5.3	4.5	5.8	5.7	8.0	4.9	8.0	3.4	6.2	5.7	5.6	3.8	8.9	6.0	6.5	16.0	8.7	5.0	6.1	5.8	5.6	4.8	7.7	5.8	5.1	6.4	10.4	5.4	6.4	6.6	8.5	8.2	5.7	4.8	7.0	8.3	9.9	10.4	7.5	13.1	7.1	8.5	5.1	9.6	3.2	6.3	7.3	3.6	8.7	5.6	2.9	10.2	5.2	3.7	4.7	7.5	6.7	8.4	5.8	6.4	6.8	8.7	6.0	5.4	11.3	6.7	5.6	4.8	7.1	6.7	6.5	4.0	6.7	8.8	3.6	7.4	4.0	12.3	2.4	3.4	5.3	5.8	6.5	11.2	6.5	7.8	5.7	6.4	2.3	8.0	11.1	8.3	5.6	3.8	4.1	4.7	3.5	6.9	3.2	5.9	2.7	2.5	1.1	2.4	1.8	2.0	2.5	2.4	2.4	1.6	2.8	2.6	2.7	0.8	5.9	1.6	2.4	2.0	1.7	5.3	6.6	6.9	6.7	5.7	5.4	5.8	5.7	5.7	5.8	5.8	8.5	22.5	19.2	27.6	17.3	20.0	17.5	7.3	7.5	30.7	14.9	27.3	22.0	39.1	11.5	15.8	11.0	8.4	10.0	17.3	15.2	19.6	11.6	7.5	21.8	30.0	19.0	19.7	49.9	28.0	7.9	7.8	22.6	12.2	35.1	25.9	16.1	15.7	12.7	7.2	3.3	27.8	10.8	8.2	12.2	9.2	5.8	14.3	14.4	14.2	12.2	14.1	12.6	16.5	24.1	44.5	11.9	12.4	16.6	16.9	9.8	10.3	17.2	10.2	23.1	13.1	22.5	21.2	21.3	53.2	20.8	26.0	14.4	17.2	11.4	8.3	11.2
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.6	7.8	7.0	3.8	7.5	14.3	8.8	7.9	8.4	8.1	12.8	11.1	5.0	9.6	5.5	11.6	7.1	3.3	10.7	7.3	6.6	9.2	15.1	7.6	5.8	6.5	6.3	8.5	8.6	5.3	5.5	4.0	6.9	12.1	5.2	5.6	11.5	4.3	19.9	17.2	11.1	5.2	6.3	11.5	11.1	13.5	6.5	5.9	11.2	6.1	5.2	11.5	8.2	7.7	13.3	12.2	4.9	8.5	12.4	8.0	14.0	11.4	9.3	9.6	8.9	8.9	9.7	3.1	3.7	8.9	14.3	7.7	9.8	6.4	9.8	6.2	7.7	7.1	9.1	14.6	9.1	5.6	9.0	5.3	9.1	11.5	8.7	7.2	9.0	4.7	7.6	2.9	10.2	9.3	6.7	11.2	19.1	14.1	17.6	4.8	10.3	2.6	9.9	8.4	8.8	6.5	7.8	8.5	8.5	7.4	5.3	7.1	10.7	6.2	5.4	9.6	10.3	6.5	3.9	6.1	10.5	5.7	10.2	0.0	1.7	2.9	4.8	1.4	3.7	2.0	3.1	4.4	1.4	2.2	3.5	3.5	1.2	4.1	4.7	0.7	3.8	2.1	7.0	7.5	7.9	8.4	7.3	6.6	6.5	6.3	6.9	6.3	6.5	7.7	6.1	6.4	8.2	5.2	7.4	9.1	4.6	5.2	3.4	8.4	12.0	6.6	5.6	7.2	11.6	5.5	4.2	4.6	20.9	13.9	5.9	8.3	1.2	16.4	10.9	6.4	9.0	3.8	31.0	6.7	6.2	5.2	8.2	31.8	9.5	6.4	6.1	10.2	5.6	1.7	25.6	5.1	6.1	6.3	5.7	1.7	4.1	5.1	10.6	8.4	6.6	7.1	4.1	11.6	21.4	16.8	8.0	3.8	8.1	7.1	9.2	5.6	11.5	19.5	6.6	5.8	6.9	11.0	17.6	7.3	13.2	3.7	19.2	5.1	8.4	6.0
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814406-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 136.8;lymphoid tissue: 129.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 45.4;neutrophil: 59.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	20.2	18.1	18.1	33.0	19.2	136.8	14.9	20.2	24.1	21.6	16.2	20.4	10.8	14.6	7.5	26.1	22.1	18.9	20.8	18.0	16.0	20.1	18.5	41.2	34.3	18.9	17.7	23.4	15.1	6.3	13.7	10.2	18.0	14.4	17.0	2.9	13.6	8.2	7.7	72.9	34.0	15.0	15.3	129.0	17.7	6.5	21.1	9.7	15.9	7.4	25.2	18.9	22.2	20.9	2.7	2.5	7.5	5.9	8.7	7.2	4.6	6.1	5.9	2.9	4.4	3.1	6.4	18.3	4.0	7.7	5.3	5.2	0.9	20.1	5.0	14.2	3.0	14.5	14.4	5.1	6.4	18.8	58.2	6.9	2.7	6.6	8.0	32.2	9.0	32.7	1.9	24.1	3.4	9.1	22.5	32.0	1.1	12.0	2.9	10.6	5.5	8.6	9.7	9.2	5.5	4.4	2.6	13.2	5.8	5.9	6.6	25.5	12.6	7.9	2.9	14.4	5.0	11.0	2.9	8.1	3.5	16.4	4.5	5.9	16.3	45.4	2.7	9.3	2.7	2.6	3.9	5.4	10.9	4.6	2.2	2.6	59.6	5.2	11.8	1.7	4.0	4.0	18.1	19.2	20.2	24.1	18.0	16.0	18.9	17.7	18.0	15.3	21.1	20.9	19.5	6.4	14.4	11.4	37.6	16.7	5.1	6.1	10.2	3.6	8.7	9.0	5.0	4.3	6.2	5.5	2.1	9.6	29.0	13.0	0.0	5.0	0.8	8.9	12.0	12.7	13.1	9.9	14.0	1.0	3.7	7.1	17.9	7.9	22.9	10.6	18.9	3.8	16.2	5.0	11.1	9.1	8.2	48.5	18.1	2.1	10.2	45.7	3.6	23.4	39.2	4.4	30.9	18.1	9.7	2.7	59.1	7.9	17.3	2.5	8.3	2.5	8.1	3.5	0.0	8.8	11.4	4.9	13.4	15.7	17.3	12.3	21.3	7.2	14.0	6.0
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917211	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 16.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	16.4	20.1	11.4	6.5	10.9	60.2	16.9	8.6	40.1	19.9	11.4	18.9	7.5	18.2	1.8	15.7	19.2	4.2	18.4	11.5	9.8	22.0	59.2	24.2	6.1	13.9	12.3	24.9	22.7	4.9	21.6	4.9	12.7	21.6	2.6	1.9	15.2	5.7	26.7	34.9	21.4	3.3	9.0	25.7	23.2	15.3	11.4	5.4	19.3	4.4	3.3	17.7	15.6	10.4	13.2	12.6	4.4	12.0	5.7	4.0	12.3	7.1	10.3	9.4	6.8	11.0	9.9	9.3	14.7	6.0	12.0	10.8	4.5	8.3	2.5	9.1	15.7	8.7	19.1	10.0	8.4	6.5	18.2	10.9	7.1	11.8	6.3	5.4	7.9	9.5	16.1	7.3	4.1	21.3	7.8	21.9	5.1	3.5	14.3	8.6	7.1	13.5	5.0	10.9	16.5	6.7	10.6	14.6	13.3	3.3	14.3	8.1	10.1	9.0	8.6	18.3	5.3	14.7	5.5	6.5	13.0	5.2	5.6	3.0	2.0	2.2	2.5	2.1	2.1	0.8	1.7	2.2	1.4	0.9	1.3	2.4	16.9	1.8	1.7	2.4	0.9	1.2	11.4	10.9	8.6	40.1	11.5	9.8	13.9	12.3	12.7	9.0	11.4	10.4	9.8	9.6	16.2	20.2	17.0	28.9	8.7	35.7	16.5	16.6	15.8	10.3	8.1	7.2	17.6	9.2	33.3	12.7	40.1	38.8	1.9	10.2	2.5	12.4	9.2	10.2	35.9	16.2	7.6	10.3	5.3	12.6	16.8	24.4	9.5	15.4	7.9	23.2	10.9	13.5	8.4	17.6	24.4	20.1	19.9	3.6	12.8	24.2	30.2	5.6	11.9	12.3	19.6	6.6	7.1	14.9	21.7	10.1	27.3	12.2	26.8	6.6	13.3	26.0	13.1	11.6	10.6	9.0	6.2	16.3	38.4	66.9	40.2	27.2	19.0	15.9
ATG2B	"C14orf103, FLJ10242"	ENSG00000066739	"Autophagy related 2B"	Q96BY7	14	96279195-96363341	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 84.5;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001427, HPA019665"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"			"HPA001427: AB_1845551, HPA019665: AB_2274278"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.45e-2)"	"unprognostic (7.60e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.49e-2)"	6.4	6.2	5.8	3.9	6.8	6.7	6.5	8.6	7.9	7.2	5.8	6.3	4.4	7.4	5.5	5.2	6.9	4.2	4.9	6.2	5.4	5.6	9.8	6.0	4.7	8.1	5.4	7.2	12.1	8.2	6.8	4.0	8.2	5.9	4.3	12.1	5.4	4.0	8.6	11.4	7.3	5.0	5.0	6.4	6.4	8.6	5.9	6.9	7.3	7.2	4.9	5.7	6.3	9.0	3.8	4.8	5.8	4.5	9.9	9.1	4.6	5.5	7.8	5.9	6.7	2.6	2.6	8.5	5.1	9.1	3.9	5.1	8.0	5.4	9.5	7.9	4.0	3.7	5.2	2.3	6.5	6.9	3.9	7.6	5.4	8.0	6.3	6.3	7.6	6.3	4.3	7.5	4.8	6.2	6.2	5.9	2.8	4.5	4.8	5.6	13.0	5.7	6.7	4.6	5.6	6.4	8.4	3.4	4.0	5.9	5.3	3.9	10.2	3.3	1.5	8.1	3.5	7.4	6.5	7.7	6.7	4.7	3.2	0.1	0.2	0.4	0.3	0.1	0.5	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.4	0.5	0.2	0.3	0.5	0.1	5.8	6.8	8.6	7.9	6.2	5.4	8.1	5.4	8.2	5.0	5.9	9.0	15.8	12.8	12.3	47.3	11.0	13.8	3.7	4.4	21.6	24.8	12.2	7.7	14.2	12.8	6.3	9.2	27.1	5.8	12.3	9.5	3.9	5.8	41.0	20.8	16.9	12.9	8.3	21.8	84.5	6.1	3.2	14.0	10.7	26.9	7.0	10.9	14.6	27.2	4.2	32.0	66.3	13.3	2.0	12.6	10.7	48.9	12.8	8.9	1.8	36.5	6.4	7.9	6.2	105.6	84.2	5.3	10.7	10.5	27.2	9.0	12.5	8.9	7.0	19.4	6.6	13.8	12.6	17.7	14.9	19.6	28.1	15.7	13.0	8.7	9.4	3.7
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532510-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 657.9;Spermatocytes: 341.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	33.1	38.7	41.4	49.1	50.1	94.1	34.7	51.3	53.5	28.3	38.2	38.2	38.2	24.7	24.7	34.8	23.2	24.7	33.3	39.7	46.8	41.6	43.3	31.1	48.4	49.1	48.2	25.6	41.8	44.8	30.6	33.6	48.5	23.2	40.3	29.1	29.4	28.3	29.5	29.8	36.6	29.9	48.2	48.2	37.7	85.3	45.6	51.2	42.2	33.6	46.3	38.7	26.3	55.7	105.0	55.9	51.5	52.6	66.6	54.5	57.5	89.8	65.3	86.9	78.9	78.9	60.6	130.3	66.6	78.0	106.6	74.1	84.9	78.0	120.9	22.8	40.9	82.0	52.3	51.0	102.9	145.2	67.0	50.6	58.3	85.5	130.2	56.8	82.2	81.2	71.6	108.8	92.9	91.4	86.4	68.2	56.3	135.8	109.7	74.9	45.9	110.5	72.6	56.1	88.1	34.7	74.7	70.5	109.5	48.4	79.8	107.5	66.7	92.3	75.8	39.4	80.1	70.2	72.0	201.3	84.4	133.2	69.4	64.4	167.7	121.9	39.4	258.8	49.4	61.8	48.0	49.2	169.4	59.2	46.2	46.3	174.2	50.5	327.9	36.3	75.6	138.2	41.4	50.1	51.3	53.5	39.7	46.8	49.1	48.2	48.5	48.2	45.6	55.7	45.6	48.1	39.0	10.1	53.3	74.1	42.4	74.3	37.5	22.5	32.0	50.2	86.2	37.1	51.3	25.8	12.5	73.1	45.3	47.0	117.4	73.7	657.9	37.9	40.8	54.1	31.2	90.0	11.7	86.1	85.0	42.6	36.7	45.2	39.9	42.0	40.0	40.0	121.3	18.5	11.4	53.3	75.3	106.3	131.1	146.5	42.6	134.8	69.4	11.2	185.8	42.1	54.6	13.0	33.7	70.9	49.2	43.2	70.4	39.1	76.0	87.5	37.3	22.2	59.2	45.5	77.6	341.0	119.7	57.4	70.6	122.3	55.0	68.6	69.8	54.2
ATG4A	"APG4A, AUTL2"	ENSG00000101844	"Autophagy related 4A cysteine peptidase"	Q8WYN0	X	108091668-108154671	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036374, HPA064759"	Uncertain		Approved	"Actin filaments,Microtubules"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"	Microtubules	"Actin filaments"	"HPA036374: AB_10672354, HPA064759: AB_2685346"	"prognostic unfavorable (1.36e-5)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.20e-2)"	8.1	8.5	4.9	7.8	5.2	9.1	7.7	5.2	6.1	7.6	10.4	12.1	12.8	4.7	11.6	8.9	5.6	7.7	11.8	4.7	5.2	14.1	18.1	8.9	8.2	5.3	5.0	2.8	17.2	12.4	6.1	8.0	5.4	5.9	13.1	5.7	13.0	7.1	18.5	5.8	11.4	7.7	5.0	7.7	11.2	2.4	5.7	11.2	11.4	18.6	11.1	8.9	5.1	5.4	13.0	6.5	4.1	7.8	38.2	13.2	5.1	17.5	11.2	9.1	10.6	5.3	6.9	14.0	15.7	14.0	14.5	6.0	11.9	13.0	13.5	24.1	12.9	6.0	10.3	3.7	8.4	13.0	18.8	13.4	13.9	11.1	4.8	8.4	84.9	19.5	18.5	43.5	16.6	12.8	12.1	11.9	7.8	23.6	18.4	8.2	6.9	20.3	13.2	11.3	5.9	4.5	11.2	13.9	7.9	12.4	7.0	11.5	24.0	5.7	2.6	19.1	9.8	20.2	24.0	15.1	11.1	14.6	8.1	28.1	7.8	15.1	11.7	11.3	8.4	9.2	8.9	11.4	10.6	9.9	7.1	12.0	2.4	12.3	7.8	5.4	10.3	8.7	4.9	5.2	5.2	6.1	4.7	5.2	5.3	5.0	5.4	5.0	5.7	5.4	13.6	3.2	10.3	9.1	8.1	5.1	4.9	13.5	2.8	3.2	7.0	4.6	17.4	7.2	12.8	5.5	4.2	6.2	12.4	19.1	27.4	9.6	7.0	10.6	7.4	12.9	6.7	36.7	7.9	17.9	7.5	4.6	8.2	6.0	3.8	3.3	9.7	15.4	9.0	1.7	8.4	9.0	30.5	4.1	3.6	10.0	2.8	7.3	14.2	4.7	6.7	10.3	18.6	7.1	11.6	16.6	8.0	7.5	23.5	5.6	14.7	24.7	17.2	5.0	0.0	4.5	6.9	2.4	3.9	5.9	5.3	10.4	12.0	6.2	5.6	7.3
ATG4B	"APG4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	12.0	17.5	21.4	8.1	21.7	14.7	13.2	20.9	24.7	18.0	20.1	19.7	11.4	16.8	5.3	16.2	16.8	7.6	18.4	21.6	23.0	19.7	18.0	12.4	13.2	23.0	21.4	16.5	16.4	12.1	21.5	7.2	23.6	22.6	5.4	8.5	14.4	9.6	18.7	16.7	18.3	6.7	20.7	19.9	16.1	19.7	22.4	16.1	18.7	7.6	7.8	16.3	14.6	21.5	8.8	15.6	16.9	13.5	15.8	10.5	29.5	23.8	9.8	16.5	12.4	15.0	9.8	7.4	7.2	11.8	10.5	16.5	16.0	20.3	3.8	18.8	31.8	19.6	14.1	40.2	20.1	13.6	12.0	13.8	15.0	9.0	7.1	16.8	11.0	44.3	23.4	5.1	8.6	32.6	33.4	36.9	30.9	23.8	25.9	51.3	25.1	16.2	11.4	14.9	26.2	21.3	17.5	13.9	27.8	14.1	15.5	24.6	15.4	7.1	12.0	14.8	13.3	21.1	17.0	34.6	18.8	21.4	17.6	3.9	17.9	19.2	18.5	15.6	15.9	15.8	14.2	15.6	20.4	16.5	18.0	12.8	12.8	11.8	18.9	17.0	20.4	16.8	21.4	21.7	20.9	24.7	21.6	23.0	23.0	21.4	23.6	20.7	22.4	21.5	23.2	32.1	33.8	41.1	25.6	24.3	27.2	41.3	25.0	22.2	24.4	21.8	16.2	25.8	29.9	27.6	33.3	35.8	33.5	61.8	19.6	37.5	18.1	28.6	21.9	25.3	35.9	31.8	38.5	40.2	28.5	22.6	40.8	43.3	19.0	36.5	20.3	27.9	33.4	42.1	33.8	36.4	42.7	28.5	34.5	25.9	22.1	30.7	28.4	31.9	51.2	24.5	41.2	20.1	41.0	41.5	41.5	24.8	28.6	35.6	70.5	25.1	26.7	26.8	19.7	22.7	22.8	58.3	63.3	19.9	25.4	53.9	29.4	27.6	35.6	32.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784132-62865516	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 60.8"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	7.9	8.0	23.3	10.3	41.1	5.8	7.8	25.0	24.0	8.5	6.3	8.4	6.7	8.0	5.9	7.2	6.5	8.8	6.0	19.7	25.0	11.2	11.1	8.1	13.3	28.5	29.9	8.3	7.5	10.8	3.3	12.8	29.3	6.5	8.7	6.6	9.8	6.2	5.2	5.5	6.6	9.4	23.7	12.1	7.7	8.1	26.5	13.7	9.9	5.2	10.9	8.3	3.9	60.8	11.5	8.9	13.5	11.9	17.4	18.5	13.5	16.6	11.3	15.7	17.5	6.5	8.8	23.9	12.5	8.5	18.3	8.6	16.1	12.7	22.5	18.0	15.0	27.2	9.3	8.7	12.4	22.2	17.4	15.5	8.9	16.7	7.9	15.1	19.1	26.3	23.4	19.1	13.4	5.4	22.5	8.5	19.8	16.2	14.5	26.5	32.2	17.2	11.2	8.1	18.2	9.1	11.0	20.6	22.1	23.2	10.0	10.3	7.6	12.5	12.2	21.3	18.4	16.3	24.0	20.0	14.3	21.5	15.4	32.6	17.4	14.1	7.2	14.1	10.1	34.3	10.2	8.9	31.9	30.8	14.1	12.0	2.5	12.5	8.6	19.0	9.8	11.5	23.3	41.1	25.0	24.0	19.7	25.0	28.5	29.9	29.3	23.7	26.5	60.8	12.6	6.4	10.6	50.3	29.7	5.0	6.2	9.9	6.8	5.2	5.8	5.8	10.0	5.7	9.7	7.3	2.1	37.7	14.1	3.7	19.6	7.2	8.1	5.5	10.2	12.8	6.0	15.8	42.0	8.1	30.7	12.2	8.2	4.9	12.0	7.8	12.8	10.0	36.5	5.0	40.8	4.3	4.1	17.9	7.3	3.0	8.7	25.1	8.8	58.1	29.7	10.5	9.2	57.8	449.9	4.8	4.2	9.8	24.2	3.5	4.8	24.8	4.8	5.2	6.6	8.3	8.3	37.2	14.6	6.6	4.0	29.0	9.2	9.1	6.6	3.6
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 57.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	7.3	15.6	4.2	7.3	4.7	33.2	7.4	8.3	8.6	9.4	8.2	22.3	21.8	8.1	1.6	27.3	7.6	3.9	23.2	4.5	4.0	20.8	13.2	10.6	8.3	5.2	4.7	9.5	16.3	10.7	16.6	4.9	5.3	14.0	5.2	2.5	16.6	4.4	36.9	24.6	23.2	2.1	3.1	17.0	13.7	24.5	5.4	12.0	13.4	10.8	4.6	9.7	15.0	6.1	13.8	8.7	11.7	16.5	2.1	1.8	9.9	9.2	7.8	11.1	12.2	14.9	4.3	9.2	16.2	0.9	8.6	20.8	7.3	6.8	1.4	10.4	23.5	23.1	22.3	8.2	7.4	9.4	22.1	1.8	14.2	9.8	3.4	2.8	3.3	18.1	17.8	19.8	3.6	21.9	27.6	57.8	18.9	6.1	29.0	20.0	8.2	15.1	6.4	17.8	45.3	17.8	12.6	22.6	11.3	2.1	14.0	21.6	6.4	16.8	11.0	34.7	20.4	19.2	15.4	10.8	14.4	18.0	19.5	1.6	0.8	3.7	1.1	1.0	1.5	1.0	1.3	1.2	0.6	0.4	1.2	1.7	0.2	1.3	0.4	4.2	2.2	0.8	4.2	4.7	8.3	8.6	4.5	4.0	5.2	4.7	5.3	3.1	5.4	6.1	6.3	9.6	6.6	9.1	14.4	30.5	19.8	14.9	24.5	14.9	14.1	10.2	0.5	14.3	8.1	1.8	14.6	27.9	38.7	103.9	13.7	16.1	83.6	9.6	5.5	5.3	22.2	43.6	8.4	16.5	6.7	8.2	26.5	10.1	7.0	10.9	6.1	11.9	13.4	28.6	9.1	38.5	20.3	15.0	12.1	16.3	8.7	10.0	12.4	4.7	15.7	11.8	22.6	4.5	8.4	20.5	72.4	4.5	17.6	21.6	109.3	25.4	5.2	20.1	13.1	9.1	14.2	100.7	21.2	33.4	31.3	36.5	19.6	10.6	33.2	36.4
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	12.5	19.2	9.9	6.7	10.2	8.1	15.4	10.5	13.2	15.3	10.7	15.8	12.8	14.9	16.6	12.3	14.7	9.5	9.7	10.3	10.7	14.4	17.7	10.8	8.5	10.0	10.3	14.3	12.1	11.8	7.9	13.2	9.9	15.3	15.2	10.5	11.8	13.1	15.7	8.0	13.1	14.2	9.5	10.6	12.0	8.3	10.2	9.4	17.5	15.2	9.8	13.4	11.9	10.5	14.6	6.0	10.3	14.0	23.2	24.0	10.7	15.4	24.6	22.2	27.2	6.2	8.6	10.2	12.0	23.7	25.0	10.2	15.2	22.2	39.2	4.6	7.3	11.8	6.8	7.8	25.0	14.6	6.0	19.3	24.8	16.1	20.0	29.7	23.9	9.4	17.6	10.0	25.7	6.4	6.0	17.5	11.9	19.4	8.3	6.0	23.7	7.9	24.0	10.3	7.1	6.9	9.4	17.8	14.6	18.6	8.5	27.5	19.8	8.6	4.8	10.1	26.7	4.1	4.2	9.3	31.7	19.6	16.1	4.7	4.8	9.6	2.9	6.1	8.4	5.1	5.6	4.6	5.3	3.3	6.0	5.0	4.1	4.8	8.8	1.9	6.9	3.3	9.9	10.2	10.5	13.2	10.3	10.7	10.0	10.3	9.9	9.5	10.2	10.5	35.8	22.4	18.9	24.2	41.3	26.3	28.5	45.2	25.6	14.8	25.5	26.5	18.1	25.8	36.7	25.8	16.7	47.3	46.5	48.3	29.4	39.6	35.7	33.0	27.4	25.9	19.2	27.0	79.2	44.9	63.8	25.8	42.3	34.5	20.3	20.4	21.8	20.7	38.1	20.2	71.5	38.4	36.7	26.9	32.3	13.7	20.5	33.6	23.2	43.1	44.6	18.3	44.3	43.7	49.1	40.5	59.8	18.0	85.9	40.8	49.2	43.2	30.0	17.9	26.3	23.6	32.1	36.5	39.6	28.5	27.1	66.5	47.3	21.9	36.6	43.0
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.8;Late spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059551	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	25.6	23.6	27.2	17.3	29.0	44.7	19.2	27.8	36.6	19.5	10.0	25.6	31.4	24.1	14.2	31.4	18.8	21.8	42.1	30.0	24.3	20.0	25.9	23.7	19.4	29.0	26.7	20.4	28.1	31.2	17.6	30.7	26.2	21.6	21.8	24.6	23.9	22.8	116.8	32.1	29.7	28.1	24.3	21.7	22.8	62.2	27.6	15.7	18.4	62.7	21.2	22.7	22.7	28.6	29.4	35.7	26.9	64.0	50.3	55.1	35.9	52.1	56.1	67.3	60.2	52.9	38.8	7.7	43.7	79.8	54.7	58.0	43.2	56.9	49.6	22.6	70.7	55.7	90.1	63.9	54.9	14.1	40.6	56.7	91.4	68.7	63.0	60.9	68.2	18.6	75.6	27.0	46.2	38.3	12.2	33.4	19.5	28.5	26.9	16.9	36.7	30.2	40.0	38.6	42.6	25.7	52.0	46.7	46.5	52.0	17.3	39.3	52.5	67.0	32.3	28.7	47.1	15.5	14.7	11.2	55.7	33.9	37.2	6.5	12.4	6.3	7.2	18.0	7.2	5.6	5.6	9.1	8.5	3.6	5.4	6.1	11.2	9.7	22.6	4.1	7.1	11.6	27.2	29.0	27.8	36.6	30.0	24.3	29.0	26.7	26.2	24.3	27.6	28.6	0.3	0.0	4.5	12.7	8.2	7.8	7.6	10.6	8.6	18.9	0.3	0.3	33.2	17.2	7.1	0.0	14.6	26.8	4.1	44.0	0.0	0.2	83.8	0.6	1.5	10.0	13.8	34.7	15.2	0.5	24.4	9.1	11.7	0.8	10.2	0.3	16.8	37.1	11.5	21.9	14.1	17.6	6.1	13.3	7.0	105.9	14.0	4.8	10.6	5.6	7.0	20.5	9.2	9.5	12.5	0.3	27.6	8.6	6.7	13.4	39.3	0.3	4.7	15.7	13.1	7.1	5.5	54.9	13.8	14.2	11.1	34.8	7.5	0.8	18.5	10.5
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATL1	"AD-FSP, FSP1, SPG3, SPG3A"	ENSG00000198513	"Atlastin GTPase 1"	Q8WXF7	14	50532509-50634017	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 22.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027550	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027550: AB_10600983"	"unprognostic (2.06e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.23e-2)"	4.1	5.6	29.1	3.3	33.2	0.2	11.3	18.8	42.8	5.7	2.2	8.1	3.9	9.0	2.9	5.3	6.5	4.8	2.1	37.1	30.3	4.0	0.3	4.3	1.7	25.2	21.5	10.5	3.7	1.9	7.7	0.5	29.6	8.3	5.6	9.5	13.2	8.6	1.1	9.6	4.9	15.6	24.9	1.1	4.6	8.7	25.0	1.1	2.5	2.2	1.8	6.7	5.3	30.0	1.2	1.1	4.8	4.6	0.3	0.0	3.4	5.7	9.6	6.2	7.4	0.0	4.1	3.7	2.5	0.1	4.5	1.4	8.4	1.1	2.4	19.8	1.8	1.2	0.8	0.3	0.2	0.2	3.1	3.6	1.9	8.6	1.6	0.3	0.4	4.2	0.1	0.5	8.7	0.4	1.2	0.6	4.4	1.4	1.5	0.6	12.1	0.4	1.7	2.5	17.1	15.4	18.9	1.1	0.6	0.0	0.0	2.1	1.3	6.0	4.6	0.0	2.9	0.9	4.7	1.7	3.9	0.2	0.2	22.9	0.1	4.9	2.5	0.0	0.5	3.8	0.9	2.1	1.2	1.1	2.1	4.2	0.3	0.6	0.5	2.8	0.4	2.0	29.1	33.2	18.8	42.8	37.1	30.3	25.2	21.5	29.6	24.9	25.0	30.0	3.0	6.4	2.6	31.6	3.7	5.1	6.2	10.3	6.2	27.8	18.1	16.3	1.9	5.7	6.6	5.5	0.0	0.4	6.7	9.3	0.0	10.6	31.4	4.2	5.4	4.8	7.2	0.4	138.6	13.1	1.1	14.6	5.6	2.3	6.3	1.2	5.0	0.0	1.6	11.8	95.5	1.9	2.0	0.0	3.6	5.7	13.4	5.5	8.8	20.6	1.3	23.0	2.1	81.4	136.7	7.2	6.0	17.0	5.2	3.9	13.2	3.4	14.2	8.6	19.7	4.5	10.8	31.9	5.7	4.1	5.5	0.1	3.8	0.2	3.6	3.3
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38293954-38377285	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: AB_2732289"	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	19.1	32.4	15.0	16.9	20.4	32.5	41.6	26.6	18.0	29.1	16.8	52.5	33.7	33.4	19.5	41.9	29.5	18.5	16.7	17.1	14.2	28.1	40.2	22.9	19.2	13.5	13.6	37.0	15.7	15.8	13.5	16.8	12.0	31.4	26.7	25.4	51.8	31.2	53.7	50.0	31.4	36.0	11.2	20.3	31.7	17.9	16.3	27.9	54.9	46.2	35.1	27.4	33.2	14.7	84.3	36.0	51.0	37.2	44.8	27.9	61.1	31.5	25.0	33.9	38.7	40.8	65.2	61.6	33.7	20.2	47.4	94.8	64.7	32.2	56.4	74.5	44.7	38.9	26.6	58.7	24.5	47.1	35.8	20.3	68.6	32.7	45.2	21.7	34.6	23.5	60.3	37.5	28.7	31.1	56.0	46.1	64.1	89.5	22.4	46.9	50.4	45.4	25.9	43.6	26.1	44.2	32.0	40.3	38.2	39.0	22.1	28.7	21.9	34.8	52.4	33.2	57.8	48.8	48.3	79.0	23.4	47.9	42.7	1.3	2.7	10.6	2.3	2.1	3.8	2.8	2.7	2.7	3.4	4.3	4.1	3.3	3.3	2.5	3.8	2.0	3.6	2.4	15.0	20.4	26.6	18.0	17.1	14.2	13.5	13.6	12.0	11.2	16.3	14.7	18.5	12.8	32.4	62.7	18.7	36.8	32.5	25.9	14.8	20.6	40.8	33.8	7.6	11.5	44.8	7.3	14.6	15.7	14.9	12.0	7.9	11.7	22.1	12.3	17.4	17.0	6.6	22.9	66.3	5.0	14.7	16.5	11.7	17.8	4.5	14.3	14.3	34.4	10.8	21.9	55.5	11.7	77.3	8.5	16.1	19.5	14.3	12.9	12.4	59.0	8.2	8.6	7.2	46.3	20.4	5.7	8.7	16.6	13.1	23.9	17.8	12.6	23.5	21.1	32.9	16.9	19.4	16.7	21.3	46.4	46.9	14.6	13.6	9.0	12.7	31.3
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	125.2	148.3	71.7	33.7	60.1	6.9	120.6	94.2	120.0	143.8	14.5	155.4	36.3	146.4	25.5	71.9	148.9	43.2	94.2	66.8	75.7	95.5	42.7	109.0	20.4	81.3	70.6	234.6	79.6	56.7	188.9	43.8	60.0	117.6	21.1	58.8	89.8	59.5	81.9	79.2	82.0	49.4	41.2	74.2	100.4	33.3	71.5	16.3	189.0	34.4	14.0	122.2	108.8	67.4	56.4	72.1	75.9	154.7	69.6	61.7	126.3	65.5	55.4	65.1	45.8	73.6	65.6	15.2	20.4	80.8	54.1	36.8	46.2	63.8	33.3	178.0	46.3	70.6	71.7	35.6	108.3	14.6	103.8	101.8	46.1	82.4	63.6	112.5	64.4	22.4	61.1	29.9	58.2	81.2	31.9	13.5	156.0	26.2	30.1	65.9	40.6	11.2	48.3	78.3	23.4	75.3	66.5	77.2	47.1	73.6	29.5	40.3	85.2	76.7	97.9	61.1	102.2	22.7	8.1	10.7	60.1	18.7	82.3	0.5	0.1	0.7	0.6	0.0	0.5	0.7	0.2	0.3	0.1	0.5	0.3	0.4	0.0	0.1	0.0	0.5	0.3	0.2	71.7	60.1	94.2	120.0	66.8	75.7	81.3	70.6	60.0	41.2	71.5	67.4	66.3	16.0	17.2	76.4	9.1	30.2	13.5	22.9	30.1	26.6	51.5	57.4	16.4	24.3	20.4	29.5	18.8	27.4	11.4	37.4	15.6	20.5	2.3	39.9	61.2	40.7	21.7	4.8	23.8	30.3	15.3	30.9	34.7	51.7	10.1	37.1	39.7	8.0	11.9	25.2	29.7	23.0	8.2	10.9	21.0	3.5	63.6	13.7	21.4	23.4	4.8	17.3	3.1	17.6	18.2	29.9	25.3	52.6	9.5	17.4	24.2	12.1	15.4	23.9	19.7	29.4	39.5	9.7	7.7	22.1	24.9	37.1	10.9	26.2	20.4	17.9
ATOH7	"bHLHa13, Math5"	ENSG00000179774	"Atonal bHLH transcription factor 7"	Q8N100	10	68230595-68232113	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;liver: 3.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Excitatory neurons: 1.7;Hepatocytes: 1.1;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 7.5"	"Region enriched"	"Detected in some"	9	"cerebellum: 28.7"	"Low region specificity"	"Detected in some"			HPA027008	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027008: AB_10600783"	"unprognostic (7.17e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.20e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.28e-4)"	"unprognostic (4.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.06e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.18e-2)"	0.1	0.2	1.4	0.0	1.5	0.0	0.1	3.0	2.0	0.1	0.7	0.2	0.2	0.2	0.1	0.0	0.1	0.0	0.0	2.0	1.0	1.2	3.0	0.0	0.0	0.8	0.8	0.1	0.4	0.0	0.2	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	7.5	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	3.0	2.0	2.0	1.0	0.8	0.8	0.8	0.8	0.8	1.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	1.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.5	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677271-25865184	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 216.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 7.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041496, HPA042509"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	6.5	8.7	13.7	2.7	9.3	2.5	5.3	6.0	8.9	2.0	0.7	3.2	0.8	1.5	0.1	1.9	2.3	3.7	2.0	5.9	5.8	5.8	0.6	7.1	1.8	9.9	9.7	1.1	1.4	3.5	2.1	1.7	9.5	2.2	0.8	0.1	7.9	0.6	0.6	2.5	3.0	2.8	5.9	1.5	3.2	4.3	15.0	1.1	2.5	0.7	1.1	2.5	1.4	4.9	0.0	5.7	1.3	0.0	2.2	2.8	0.0	23.0	9.3	6.1	9.9	0.0	0.0	0.0	1.6	22.9	0.0	0.0	9.3	1.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	19.4	0.9	0.0	0.6	0.0	2.5	0.0	1.2	0.0	0.0	3.3	0.0	1.2	0.0	1.5	0.0	1.5	4.4	4.6	2.8	9.9	0.0	0.0	0.1	0.0	0.0	21.9	0.0	7.4	1.2	0.0	8.9	0.2	12.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.3	0.5	0.1	0.0	0.7	0.6	0.0	1.2	0.0	1.0	0.1	0.3	13.7	9.3	6.0	8.9	5.9	5.8	9.9	9.7	9.5	5.9	15.0	4.9	0.3	32.1	8.6	2.0	0.8	1.0	0.0	2.7	0.6	0.2	2.6	1.8	1.7	1.5	5.3	0.0	0.0	0.0	11.1	0.1	0.0	0.5	23.2	2.8	2.8	4.2	0.0	0.0	4.5	0.0	0.1	5.0	3.1	7.9	15.2	0.0	0.4	0.1	2.5	0.0	2.1	0.2	0.0	2.5	5.2	21.8	4.1	4.5	17.8	216.4	2.3	0.0	14.4	1.5	2.7	0.8	0.0	17.7	1.7	0.7	0.0	0.1	4.2	0.1	0.0	4.7	9.1	0.4	1.2	0.0	0.4	0.0	8.6	0.1	0.0	0.0
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;gallbladder: 16.6;intestine: 45.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 136.4;Oligodendrocyte precursor cells: 293.0;Oligodendrocytes: 419.4;Undifferentiated cells: 90.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034574	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.1	0.0	4.1	5.0	9.0	0.0	0.4	8.8	6.4	1.0	0.1	44.5	24.7	0.0	12.3	6.2	0.4	16.6	0.0	4.3	5.0	0.1	0.0	0.0	0.0	10.6	7.8	0.0	2.9	0.0	0.0	0.0	9.9	0.0	45.7	0.0	1.8	0.7	0.0	7.1	21.0	1.5	5.8	0.0	4.8	0.3	8.0	5.0	0.0	0.0	2.9	1.5	2.5	17.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	9.0	8.8	6.4	4.3	5.0	10.6	7.8	9.9	5.8	8.0	17.1	0.1	0.0	0.0	42.7	0.6	0.4	0.1	12.9	0.0	0.0	0.1	0.0	1.2	21.5	15.1	1.8	0.0	0.0	0.0	136.4	0.0	23.6	0.2	0.2	0.0	0.3	13.2	0.0	4.0	20.3	0.1	0.0	10.7	0.3	0.0	0.0	0.0	0.3	0.1	0.0	3.9	55.4	4.1	0.0	1.2	0.6	0.0	0.1	1.8	1.9	1.6	0.0	0.0	293.0	419.4	16.4	64.7	0.0	0.4	0.1	24.1	0.0	16.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.9	0.5	0.3	0.0	90.7	6.5
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793503-182921629	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	20.6	10.7	4.7	24.9	6.9	70.6	17.4	15.9	7.6	19.1	13.8	26.3	24.3	18.7	14.6	45.4	13.7	21.1	14.1	6.0	6.3	18.0	18.3	16.5	27.9	7.5	6.1	20.5	21.0	29.4	10.3	14.5	7.3	28.3	29.0	30.8	19.4	13.4	11.4	28.2	24.0	19.5	5.6	21.8	51.1	31.6	6.6	44.6	16.8	16.8	28.4	25.7	22.5	15.8	69.7	9.7	20.5	28.7	42.6	46.1	19.3	32.8	41.6	23.2	27.1	23.7	34.0	31.3	53.5	44.0	48.2	40.4	24.6	31.3	40.2	73.9	20.9	76.7	13.1	5.2	24.8	62.3	47.3	31.5	34.7	26.1	37.4	34.1	37.0	48.7	27.7	94.3	37.8	22.9	50.3	19.1	14.5	38.1	19.2	21.2	59.8	37.8	28.1	55.8	12.5	22.0	86.2	10.7	36.9	18.3	11.9	43.7	36.6	35.0	38.7	30.5	56.2	131.0	125.5	58.1	24.1	25.3	20.9	5.5	1.0	4.3	1.7	1.0	1.7	2.1	1.4	1.7	1.1	1.3	1.2	1.8	3.8	1.8	1.0	2.4	1.2	0.8	4.7	6.9	15.9	7.6	6.0	6.3	7.5	6.1	7.3	5.6	6.6	15.8	26.8	16.0	13.2	34.6	27.8	34.3	25.7	15.9	26.2	12.2	13.8	9.7	15.6	18.6	16.5	20.2	14.6	12.8	43.0	44.6	0.0	12.5	34.1	19.0	22.9	15.7	6.7	26.1	81.6	16.5	3.8	19.5	46.4	22.1	11.4	14.0	16.1	16.4	10.4	38.7	64.3	30.5	16.2	19.4	26.4	23.8	19.3	29.3	14.2	45.9	19.9	8.4	27.8	67.8	132.6	25.2	27.0	21.1	55.5	35.8	24.3	7.8	19.8	31.4	19.7	24.1	17.7	18.7	11.4	43.8	44.6	9.6	40.9	7.0	27.3	45.4
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	13.4	7.4	3.5	9.0	4.2	6.1	10.4	3.6	4.6	11.8	10.3	10.0	5.6	11.9	9.3	5.1	10.7	8.4	5.4	3.1	4.5	11.8	49.8	7.2	14.8	4.9	4.7	12.7	4.9	5.7	3.7	5.3	5.2	9.8	7.1	2.8	6.0	14.6	3.5	6.0	8.6	10.6	3.9	12.2	7.6	9.7	4.8	11.1	6.1	4.3	8.8	13.6	9.3	4.5	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.5	4.2	3.6	4.6	3.1	4.5	4.9	4.7	5.2	3.9	4.8	4.5	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP12A	"ATP1AL1, H-K-ATPase, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680408-24712472	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 75.6;Club cells: 49.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SuSa: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Actin filaments"	Cytosol	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.6	0.0	5.6	0.0	0.2	2.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	14.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.0	0.0	0.0	0.0	75.6	0.0	0.0	0.2	0.3	0.4	0.0	49.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	8.2	0.0	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.1	1.2	0.0	0.0	0.2	0.0	0.1	13.6	0.0	0.0	0.0	1.8	1.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	1.3
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	12.9	17.0	7.3	21.8	6.5	16.1	13.9	5.4	8.6	17.1	12.3	15.6	18.6	16.2	8.0	15.6	15.0	14.0	9.7	7.4	7.9	12.8	12.9	14.0	21.4	7.9	6.5	20.8	21.1	23.4	18.1	12.9	6.9	15.1	13.0	8.8	17.7	12.6	12.8	16.2	22.2	11.6	6.1	26.4	16.7	15.8	7.6	15.9	20.2	5.8	17.5	13.9	14.4	9.0	32.8	45.2	24.3	52.8	38.2	25.3	66.1	28.9	40.1	24.5	24.9	43.5	54.3	44.9	48.6	34.4	14.0	17.8	37.2	37.0	13.4	16.5	77.6	24.6	48.7	34.5	39.3	46.8	70.1	36.7	34.2	26.5	31.8	27.1	17.9	32.1	43.0	97.5	24.7	53.9	31.8	33.7	44.5	40.6	54.7	25.0	17.4	100.9	25.8	44.7	33.4	56.7	26.8	42.6	30.0	11.4	26.9	50.6	28.7	51.5	7.7	59.2	35.3	78.8	50.6	26.8	36.0	59.6	39.5	0.0	3.5	3.5	2.8	5.6	3.1	2.2	3.3	3.1	6.5	1.9	2.1	2.7	0.1	1.4	8.6	5.0	2.9	2.4	7.3	6.5	5.4	8.6	7.4	7.9	7.9	6.5	6.9	6.1	7.6	9.0	11.3	9.6	5.8	12.1	22.7	5.9	7.4	8.2	9.6	12.0	13.0	8.5	5.5	11.5	9.0	14.7	18.8	20.3	12.5	28.5	1.9	19.1	10.3	11.5	9.8	9.0	18.6	11.1	11.2	18.4	18.2	10.2	31.6	13.6	5.7	16.2	10.8	13.2	20.0	5.0	11.0	22.9	12.2	12.2	9.5	5.1	14.0	18.3	7.2	7.5	13.6	12.6	8.2	9.0	11.0	15.6	22.4	9.8	50.4	11.9	28.6	6.6	12.8	10.8	6.6	9.2	11.4	14.7	14.6	12.6	6.1	15.3	13.9	20.2	22.2	6.4
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase cation transporting 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	15.3	18.6	49.7	20.2	45.8	11.6	14.3	30.3	81.2	10.6	3.3	15.9	12.7	12.1	6.6	23.6	9.5	9.3	11.6	46.7	66.0	16.6	6.2	17.9	17.7	112.4	60.8	8.7	55.7	12.9	57.0	12.6	110.8	14.3	9.8	22.8	27.4	7.9	17.2	16.5	16.7	8.6	32.0	26.0	19.3	10.3	64.1	9.5	16.7	5.3	10.3	12.9	12.1	44.3	28.3	27.4	14.7	60.8	13.8	12.2	40.8	15.8	15.4	17.1	16.6	48.9	31.4	12.5	65.9	26.9	14.6	43.1	32.1	59.5	6.2	17.2	58.5	43.7	28.0	27.2	17.5	15.6	19.6	10.0	31.6	47.1	36.6	55.0	32.3	32.2	28.2	22.6	70.2	22.2	18.4	8.8	23.2	66.3	20.0	20.0	60.1	50.7	19.0	42.8	40.9	27.4	73.8	87.7	60.2	18.8	29.9	19.6	34.4	18.0	34.5	30.8	33.1	4.8	6.1	14.0	34.6	85.2	30.3	0.0	1.6	0.3	2.6	3.7	2.9	1.3	2.1	2.2	0.4	3.1	1.0	1.5	0.5	2.7	3.6	20.6	1.8	1.4	49.7	45.8	30.3	81.2	46.7	66.0	112.4	60.8	110.8	32.0	64.1	44.3	18.9	0.0	2.2	14.4	8.3	6.5	6.9	5.7	6.2	35.9	16.9	11.3	3.6	7.2	6.8	7.3	35.5	5.8	33.4	44.6	5.9	15.1	1.4	6.7	3.8	14.4	7.7	4.2	53.1	25.1	33.6	6.0	18.8	19.0	8.9	20.5	6.1	3.7	10.4	47.1	61.8	15.0	0.0	17.3	2.8	1.7	5.3	10.1	5.4	11.2	6.1	34.0	8.2	20.1	18.1	57.0	49.0	6.4	5.4	12.3	18.2	5.3	4.3	38.4	0.0	4.6	5.7	13.6	16.4	11.6	5.3	9.3	11.1	4.8	21.7	12.8
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	38.0	22.5	8.5	32.0	9.3	36.9	22.8	12.2	14.8	17.0	18.4	21.2	20.2	18.9	17.0	18.0	17.4	24.2	55.7	10.4	9.3	36.2	87.0	35.5	20.8	9.7	8.4	15.9	16.4	50.3	15.3	54.8	9.1	15.5	22.0	11.6	21.8	15.2	17.0	11.5	16.6	16.9	9.5	16.9	24.4	9.6	12.8	16.3	46.0	14.4	19.4	40.1	16.3	10.1	184.6	19.3	33.0	35.2	49.7	64.9	96.8	62.7	75.4	74.9	132.5	114.1	45.2	74.2	161.1	89.4	197.9	64.2	37.5	66.9	171.4	175.5	31.4	43.1	24.8	31.7	77.1	139.7	91.6	32.6	36.8	127.8	89.0	105.0	38.0	34.9	46.2	139.1	90.7	41.0	53.9	34.8	41.1	64.5	33.5	40.0	77.1	48.8	71.6	53.4	52.4	30.5	64.1	77.9	52.9	31.2	127.7	92.4	37.1	81.2	64.2	162.1	116.5	93.4	141.2	116.6	149.3	80.6	55.7	0.2	0.4	0.4	0.4	0.6	0.5	0.4	0.4	0.7	0.6	0.2	0.5	0.5	0.0	0.6	0.2	0.3	1.0	0.2	8.5	9.3	12.2	14.8	10.4	9.3	9.7	8.4	9.1	9.5	12.8	10.1	56.6	51.3	34.1	51.6	22.3	82.5	49.1	42.1	21.1	25.9	32.1	16.6	50.0	78.6	35.9	49.7	20.9	29.6	26.6	43.7	3.9	66.6	2.0	52.3	65.4	50.5	30.6	23.5	61.8	71.4	19.0	53.2	42.8	181.8	8.8	27.9	68.9	153.2	37.2	15.2	80.6	24.1	26.4	31.1	384.4	2.3	10.2	110.1	62.2	76.8	27.0	8.4	18.6	64.3	49.6	87.8	23.7	13.2	37.8	94.3	11.6	41.4	31.7	13.6	13.1	35.8	42.4	15.2	6.8	36.5	71.2	64.6	24.4	14.1	24.7	69.9
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274789-193378820	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031772, HPA031774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.0	0.1	2.3	0.0	1.9	0.2	17.3	1.5	2.7	0.0	38.5	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.2	3.1	1.8	0.2	0.0	0.5	0.1	1.6	2.3	0.2	0.1	0.2	0.3	0.0	1.5	0.0	0.0	0.8	11.7	0.0	1.3	3.9	0.0	0.0	0.8	0.0	1.6	0.4	2.4	0.0	1.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	2.3	1.9	1.5	2.7	3.1	1.8	1.6	2.3	1.5	0.8	2.4	1.8	0.1	0.0	0.5	37.9	0.0	0.0	0.0	0.3	0.0	0.0	5.8	5.8	0.7	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.9	0.0	0.0	0.0	26.2	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1482.3"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1879.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 2979.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		420000	"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	150.9	206.6	115.5	144.1	135.7	104.3	220.2	176.4	264.7	137.6	209.2	580.5	785.5	92.3	304.6	255.9	143.6	361.3	233.1	176.0	133.9	1127.5	132.5	255.7	89.7	140.8	103.5	137.7	661.3	1482.3	160.6	120.0	196.3	176.4	542.6	301.2	721.9	294.1	147.3	316.6	813.9	146.1	117.4	78.1	201.5	140.0	104.1	92.8	744.4	117.7	132.4	149.7	187.4	142.2	399.8	144.8	147.2	74.5	288.8	277.5	750.8	232.9	462.9	281.6	396.6	583.9	278.5	314.2	321.3	279.0	284.4	505.1	293.8	493.7	406.2	116.1	324.2	183.5	249.2	498.4	220.1	465.2	246.1	311.6	808.0	328.4	429.0	395.5	350.8	187.4	306.9	294.2	253.0	793.7	189.6	167.7	346.0	630.5	285.6	179.7	343.4	278.6	1023.2	405.1	143.8	126.7	363.0	679.6	2979.2	358.2	179.1	265.9	311.9	159.4	221.4	415.4	479.5	140.7	118.1	238.0	488.2	263.1	956.1	19.2	36.6	17.2	59.7	56.6	62.8	26.4	66.9	64.2	59.6	15.2	76.5	55.5	4.5	30.8	86.0	30.4	57.6	53.6	115.5	135.7	176.4	264.7	176.0	133.9	140.8	103.5	196.3	117.4	104.1	142.2	199.2	275.7	295.3	26.8	84.6	276.8	336.8	220.5	390.9	101.0	189.2	145.2	74.1	579.0	238.4	770.6	398.2	83.7	89.1	789.9	373.7	625.6	31.2	205.4	54.3	201.6	176.4	89.2	130.5	315.6	160.6	141.6	134.6	372.1	43.8	212.6	144.2	71.2	129.8	102.6	123.9	353.4	463.9	98.8	254.2	19.3	117.8	145.5	208.1	36.5	56.9	556.8	64.9	77.9	60.9	187.6	307.8	100.8	73.2	271.6	1879.9	308.2	171.6	147.7	32.9	109.8	147.4	20.2	35.8	320.7	268.9	67.6	133.3	58.3	498.6	280.6
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 645.2;heart muscle: 157.7;retina: 292.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 418.1;Cone photoreceptor cells: 171.0;Horizontal cells: 213.7;Inhibitory neurons: 119.1;Late spermatids: 115.6;Rod photoreceptor cells: 291.4"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.7;JURKAT: 36.3;Karpas-707: 35.9;REH: 37.1;SCLC-21H: 128.2;SH-SY5Y: 57.7"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA		220000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	0.2	18.0	115.4	1.4	126.3	0.6	0.1	76.0	645.2	0.0	0.0	3.6	0.9	0.0	0.0	0.3	0.0	0.2	157.7	165.8	275.3	0.1	0.1	0.2	0.9	390.1	61.8	0.1	0.8	1.2	15.4	0.0	320.4	0.2	0.8	292.4	0.8	0.0	0.2	0.3	1.5	0.8	26.3	0.5	1.3	31.5	174.9	2.1	0.2	1.8	0.6	0.1	0.7	200.7	0.0	2.1	0.7	23.1	0.0	0.1	0.1	0.3	0.0	1.6	1.6	0.8	4.3	57.7	2.6	0.4	5.6	0.5	16.2	0.2	0.6	10.7	3.1	5.0	0.2	0.4	0.0	0.0	18.2	0.0	0.2	0.0	0.3	0.3	0.0	36.3	0.0	35.9	0.4	0.8	10.4	0.1	3.0	8.4	14.3	37.1	18.5	1.8	0.0	0.6	128.2	57.7	0.3	4.2	0.1	0.0	3.4	2.6	0.0	3.0	3.2	0.0	1.1	3.7	2.6	12.7	5.5	20.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	115.4	126.3	76.0	645.2	165.8	275.3	390.1	61.8	320.4	26.3	174.9	200.7	0.2	0.0	4.4	9.1	1.1	0.3	0.4	0.0	0.6	418.1	0.3	0.3	19.3	0.0	0.0	0.0	171.0	0.0	3.2	0.8	0.0	0.0	43.7	0.1	0.1	1.4	0.0	0.0	59.1	0.0	0.1	1.0	1.1	0.1	1.3	0.1	0.0	0.0	0.2	213.7	119.1	0.4	0.0	0.0	0.4	115.6	1.8	0.7	0.0	8.4	0.4	40.0	6.2	14.6	11.4	0.0	0.0	0.4	1.0	0.2	0.0	0.1	0.0	291.4	0.0	0.7	0.4	21.2	2.8	0.2	0.3	0.3	3.6	0.4	0.5	0.4
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 1337.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		2100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	12.4	146.9	197.7	48.0	216.2	4.4	79.4	370.0	451.1	37.5	369.3	246.1	336.6	108.8	64.3	159.8	48.8	178.7	160.5	326.4	332.1	1337.8	180.1	92.6	8.5	558.7	264.3	58.1	178.5	732.7	79.8	44.1	540.2	48.6	201.1	99.3	314.1	72.6	342.9	67.0	284.4	96.6	248.8	52.6	402.1	46.3	375.1	19.2	330.2	337.8	84.0	101.2	52.1	382.2	89.7	215.8	73.3	56.3	15.9	3.3	23.8	45.3	33.1	41.7	43.3	276.8	183.5	0.1	158.3	35.1	50.8	102.4	38.1	83.2	45.1	1.1	16.6	5.7	152.6	138.9	26.6	4.0	7.5	9.1	21.1	31.8	42.5	79.7	40.5	6.6	1.3	1.4	52.6	38.0	7.9	16.0	28.1	919.7	47.4	1.3	89.3	15.6	513.0	118.6	54.3	382.5	263.1	271.3	12.5	85.4	55.7	9.8	92.0	35.2	90.4	60.9	159.3	4.8	6.8	2.0	42.0	13.9	47.9	13.2	1.0	0.2	2.7	3.2	1.5	1.5	3.3	1.3	9.3	0.2	1.0	1.1	0.3	6.2	1.1	0.4	10.1	1.4	197.7	216.2	370.0	451.1	326.4	332.1	558.7	264.3	540.2	248.8	375.1	382.2	14.4	240.4	251.5	79.0	18.4	52.5	156.5	490.4	153.1	86.9	274.2	166.5	147.3	664.8	425.7	1723.3	14.6	4.8	21.0	817.1	923.4	629.9	3.8	199.6	11.6	18.6	160.9	6.9	344.7	591.9	9.0	78.7	353.7	190.6	23.4	89.0	45.7	273.3	385.3	580.5	602.3	296.7	370.2	99.5	676.1	9.0	89.8	101.5	247.3	81.5	27.1	23.4	1.0	94.5	514.7	377.9	666.4	149.0	16.9	84.4	646.8	1070.2	332.5	64.9	6.6	93.6	32.5	10.6	66.9	142.8	31.7	9.9	48.2	111.8	436.0	322.8
ATP1B2	AMOG	ENSG00000129244	"ATPase Na+/K+ transporting subunit beta 2"	P14415	17	7646627-7657770	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"brain: 395.1;retina: 614.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 207.3;Bipolar cells: 330.2;Cone photoreceptor cells: 250.2;Muller glia cells: 303.2;Rod photoreceptor cells: 226.1"	"Cancer enriched"	"Detected in many"	17	"glioma: 200.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;HAP1: 2.9;K-562: 4.5;SuSa: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010698	Supported					NA	NA		160000		"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010698: AB_1845174"	"unprognostic (9.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.96e-3)"	"unprognostic (3.90e-3)"	"unprognostic (9.33e-2)"	"unprognostic (4.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.79e-2)"	6.1	10.1	212.3	0.9	251.6	11.4	5.0	268.1	288.8	13.3	25.8	9.1	1.2	8.8	17.4	2.2	12.3	3.6	8.6	196.9	250.0	10.1	2.7	4.2	1.7	353.9	395.1	29.5	2.5	4.5	45.3	4.5	282.6	6.6	2.7	614.8	1.9	7.5	4.3	2.3	3.5	5.5	256.3	5.0	3.8	5.5	364.8	0.8	4.6	5.3	1.1	4.6	7.7	174.7	0.0	0.0	9.6	0.4	0.3	0.2	0.1	0.1	0.0	0.3	0.2	0.4	0.0	0.3	0.2	0.1	0.2	0.3	2.9	0.2	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.9	0.5	0.0	0.3	0.0	0.1	0.0	0.2	4.5	0.5	0.0	0.2	0.2	0.3	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	1.8	0.0	0.1	0.0	5.7	0.1	0.2	0.0	0.1	0.7	0.0	0.2	0.4	0.1	0.0	0.9	0.2	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	212.3	251.6	268.1	288.8	196.9	250.0	353.9	395.1	282.6	256.3	364.8	174.7	8.5	0.0	0.0	207.3	1.8	1.9	0.4	0.0	1.8	330.2	2.3	6.2	3.7	2.8	0.0	0.0	250.2	0.0	1.1	6.7	0.0	0.2	0.2	0.8	8.3	7.7	0.0	49.2	2.9	0.0	0.1	5.9	7.7	0.6	0.0	1.0	11.4	0.2	0.3	18.5	38.8	2.4	2.0	0.8	0.9	2.3	18.6	1.6	0.0	7.5	0.2	303.2	0.0	45.8	1.6	0.0	0.0	46.3	0.8	0.5	0.5	0.2	0.0	226.1	26.3	2.4	50.0	1.2	6.1	1.6	1.1	0.3	1.6	0.5	2.6	0.2
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926549	"CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 982.6;Late spermatids: 930.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	229.4	349.6	62.2	81.0	62.8	63.0	87.0	78.5	78.8	98.4	100.5	146.7	112.7	75.7	37.6	182.3	96.2	55.4	102.8	63.6	74.7	128.4	24.5	191.0	41.3	71.1	66.6	180.0	36.7	20.3	168.7	96.7	76.5	102.0	168.0	43.6	85.8	46.2	26.7	259.3	125.0	71.4	68.7	65.7	66.3	75.8	70.6	51.4	75.8	16.0	57.1	101.0	161.2	62.2	280.8	170.1	155.5	145.6	411.7	118.0	354.7	322.2	287.6	224.2	252.1	253.7	136.5	223.3	278.2	243.5	328.4	595.8	157.0	152.2	253.4	120.4	190.0	195.7	161.4	156.8	161.7	164.9	149.1	126.5	355.1	179.1	169.7	162.4	245.7	156.3	135.9	193.7	233.8	114.6	165.6	275.0	213.6	384.5	76.1	225.0	116.4	227.1	191.1	186.7	127.6	86.0	413.2	188.5	455.9	270.7	145.6	197.2	170.7	196.4	76.3	298.8	189.8	138.0	197.6	367.5	259.5	176.5	165.2	69.7	104.1	35.4	70.4	174.3	51.7	39.7	56.3	74.8	103.3	30.4	32.6	59.6	6.7	32.0	260.4	64.8	68.4	103.7	62.2	62.8	78.5	78.8	63.6	74.7	71.1	66.6	76.5	68.7	70.6	62.2	114.7	57.7	41.9	38.2	143.4	492.8	428.3	535.9	326.7	35.9	53.0	46.4	19.7	17.2	177.6	220.7	25.0	281.3	464.5	982.6	41.1	73.9	465.9	86.0	72.2	199.2	56.1	147.1	107.5	60.6	226.8	164.1	24.5	127.2	130.7	94.3	100.6	9.0	305.9	25.2	91.2	65.2	164.8	148.0	678.3	930.5	84.8	455.3	222.3	37.5	364.8	46.3	75.2	46.3	54.7	70.6	321.1	68.4	153.1	396.5	413.3	41.5	33.3	28.4	124.9	99.5	265.2	69.0	200.2	178.4	414.4	391.4	216.1	122.2	134.9	370.2
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57906039-57959148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.0;Karpas-707: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	7.5	4.9	0.6	0.4	0.5	0.1	5.6	0.6	0.9	4.1	0.5	8.1	0.2	3.1	0.0	5.6	3.2	0.0	4.6	1.0	0.3	4.0	5.2	2.6	0.1	0.4	0.2	3.1	5.9	0.0	2.8	0.1	0.4	3.3	0.0	0.5	3.6	0.0	12.4	4.4	4.3	0.0	0.3	3.2	4.2	27.8	0.5	0.0	3.5	0.0	0.1	4.7	4.0	0.3	0.6	1.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.9	0.2	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.6	2.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.8	0.1	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.2	0.2	1.6	0.1	0.1	0.1	0.1	0.0	0.6	0.5	0.6	0.9	1.0	0.3	0.4	0.2	0.4	0.3	0.5	0.3	8.0	0.0	9.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.4	12.7	0.0	0.0	1.8	3.7	0.0	14.4	4.2	0.0	17.6	6.1	0.0	5.6	4.9	2.8	0.0	0.0	0.0	10.7	15.2	2.3	0.0	6.0	11.4	6.8	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	26.1	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	3.0	9.5	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904466	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	85	"skeletal muscle: 8241.7;tongue: 3199.6"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 65.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.0"	"Region enriched"	"Detected in some"	8	"thalamus: 13.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2"	"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		2800000	"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	1.5	1.1	0.7	1.6	0.8	1.9	1.8	0.9	2.6	1.0	0.1	1.4	1.6	1.5	0.4	27.7	1.4	0.5	1.2	0.6	0.8	1.3	3.1	1.2	2.9	1.1	0.7	1.6	1.0	0.5	3.2	0.7	1.5	9.5	0.4	7.9	67.2	3.5	8241.7	2.4	2.2	0.4	0.7	1.5	1.1	10.7	1.1	1.5	2.2	3199.6	0.4	1.2	1.2	1.4	7.7	8.0	14.4	8.7	0.7	2.3	13.3	3.5	2.0	0.6	0.6	4.5	6.7	11.9	4.1	0.6	4.8	7.9	3.6	0.2	1.0	5.9	30.0	4.2	19.0	14.4	0.3	1.8	3.8	5.9	1.6	0.9	0.7	7.3	0.4	21.8	8.2	9.8	0.4	15.2	17.3	9.5	14.4	2.8	11.2	26.4	10.2	9.1	0.1	0.9	9.2	7.3	5.0	6.8	5.2	5.2	5.1	4.2	3.1	4.5	9.4	8.5	4.5	14.2	9.5	12.0	8.7	23.4	4.4	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.0	1.6	0.0	1.0	0.5	0.2	0.7	0.8	0.9	2.6	0.6	0.8	1.1	0.7	1.5	0.7	1.1	1.4	0.3	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.6	2.1	0.5	0.5	0.5	0.0	0.2	0.0	14.6	0.4	0.0	0.6	0.0	0.1	1.3	0.4	0.4	0.3	0.0	0.0	2.3	0.2	0.2	0.5	1.5	0.7	0.0	0.7	0.0	0.6	0.1	0.0	2.3	0.3	0.0	0.6	0.0	3.9	0.3	0.3	0.0	1.0	0.0	0.3	0.0	0.5	2.3	0.2	1.2	0.0	0.1	0.2	0.7	0.1	0.4	4.7	0.0	65.2	0.6	5.7	3.4	0.3	0.1	0.7	0.4	0.7	0.6	0.1
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	60.4	49.6	26.2	57.8	34.6	46.0	34.1	36.0	28.0	43.4	23.2	64.2	47.5	46.6	39.0	181.2	67.0	60.5	1005.8	39.0	28.8	34.4	54.7	49.0	36.0	32.5	46.3	42.0	38.1	56.1	24.5	55.4	29.8	93.4	69.0	19.1	92.2	70.0	2856.8	46.5	56.4	74.4	29.8	30.5	47.2	74.1	57.6	36.2	73.3	2768.8	48.1	90.9	57.9	36.1	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	26.2	34.6	36.0	28.0	39.0	28.8	32.5	46.3	29.8	29.8	57.6	36.1	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.5;Distal enterocytes: 120.7;Enteroendocrine cells: 97.8;Gastric mucus-secreting cells: 153.4;Intestinal goblet cells: 128.4;Plasma cells: 96.0;Undifferentiated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 186.8;HMC-1: 266.1;JURKAT: 152.1;MOLT-4: 253.2;SK-BR-3: 195.2"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	6.8	13.7	6.8	62.2	8.7	98.3	7.7	20.0	6.1	6.0	15.3	55.0	30.7	9.1	1.6	9.7	6.1	13.7	8.0	3.0	4.5	11.4	4.6	22.4	101.5	2.3	12.8	3.1	64.0	2.1	2.5	2.8	3.9	20.3	33.0	0.2	185.3	19.6	3.3	28.2	75.3	6.3	2.0	98.2	92.8	2.1	11.6	97.5	11.7	3.3	58.7	17.0	7.2	2.3	0.3	7.6	0.3	6.8	0.0	0.0	0.3	0.4	0.9	0.2	0.6	2.5	1.7	186.8	11.0	0.6	0.1	0.8	3.1	0.0	0.0	23.5	2.1	98.0	6.0	0.1	1.7	108.0	266.1	0.2	0.0	0.7	0.0	0.1	0.3	152.1	20.1	117.1	0.1	116.8	253.2	115.5	1.2	53.1	1.6	27.5	0.2	43.3	0.0	3.3	11.5	3.4	1.5	195.2	0.2	1.1	12.2	26.3	0.5	0.0	2.1	0.4	0.1	43.4	14.2	66.0	2.5	75.6	0.1	16.0	1.4	33.7	10.8	0.9	8.3	9.8	6.7	10.3	1.6	11.4	4.8	6.0	13.1	3.8	0.5	15.8	6.4	6.7	6.8	8.7	20.0	6.1	3.0	4.5	2.3	12.8	3.9	2.0	11.6	2.3	7.1	0.0	1.9	0.7	82.5	0.9	0.4	0.7	1.2	0.0	4.7	1.7	3.8	2.8	2.7	23.9	0.0	0.2	59.2	120.7	0.0	1.3	0.1	0.3	0.4	7.8	97.8	22.5	0.5	12.1	0.3	1.9	153.4	0.3	33.0	0.2	8.9	1.0	2.8	0.0	0.6	128.4	36.7	3.1	2.5	0.2	0.0	17.8	12.4	5.6	5.0	0.2	28.8	0.0	0.3	25.2	50.3	0.7	96.0	4.2	14.0	0.4	2.7	0.2	0.0	1.0	3.4	0.0	1.5	0.4	0.3	0.0	38.4	0.4	65.6	4.6
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 106.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 781.6;Langerhans cells: 435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 314.6;LHCN-M2: 501.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	18.5	11.2	33.0	25.6	92.0	106.8	19.6	14.0	59.1	18.8	0.0	33.1	40.8	18.2	12.1	14.7	18.6	25.2	11.0	52.7	4.9	16.4	22.7	21.3	29.2	0.0	14.4	13.1	17.1	21.5	11.0	27.3	0.0	13.9	32.3	71.2	11.5	14.9	24.4	26.0	30.1	19.7	0.0	30.7	29.0	23.0	10.9	18.4	14.4	24.1	28.8	37.0	10.6	34.9	24.0	117.8	45.5	22.1	64.5	102.2	20.9	71.2	232.6	67.5	106.8	47.7	21.6	46.8	4.9	99.3	77.6	21.0	40.3	19.7	187.5	16.2	46.9	16.6	39.8	41.9	209.6	70.7	26.6	85.0	36.9	210.8	314.6	78.9	17.5	17.6	27.9	16.6	501.1	37.6	22.1	30.1	35.6	32.9	55.6	31.1	146.4	19.7	64.4	108.5	42.9	23.4	82.6	22.9	20.2	91.7	33.9	7.8	12.5	181.8	29.4	67.6	78.9	12.7	21.2	49.1	82.6	19.6	41.0	9.4	39.4	22.3	20.9	42.5	26.4	84.5	36.3	26.8	51.3	84.4	13.2	16.8	127.1	27.0	86.1	9.0	53.7	21.8	33.0	92.0	14.0	59.1	52.7	4.9	0.0	14.4	0.0	0.0	10.9	34.9	46.0	44.8	46.0	90.8	226.4	201.6	71.0	29.3	76.2	370.9	30.9	109.7	20.3	45.8	30.0	53.3	154.3	176.8	139.8	181.5	1.9	27.6	2.3	29.3	61.0	63.6	91.6	31.5	781.6	28.5	42.1	91.6	44.9	59.4	31.6	45.5	49.6	39.5	193.5	302.9	279.1	30.7	16.2	116.0	435.1	9.6	29.2	285.4	55.2	126.5	157.1	96.4	50.4	193.5	91.9	25.5	80.6	32.0	133.9	54.7	75.0	22.1	20.6	113.3	32.9	97.0	69.5	44.5	130.7	30.4	204.7	228.8	125.1	76.0	65.9	90.2
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 104.0;choroid plexus: 43.0;salivary gland: 33.2;skeletal muscle: 37.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 104.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	0.0	0.6	3.4	0.0	15.8	0.0	0.1	38.6	104.0	2.0	43.0	0.1	0.0	2.2	0.2	0.1	3.7	0.0	0.1	10.4	0.2	0.2	20.3	0.0	0.0	1.6	9.8	0.0	0.2	2.0	3.5	0.0	2.7	0.0	0.0	13.5	33.2	0.0	37.4	0.4	0.1	1.4	0.0	0.1	0.1	0.6	16.1	0.5	0.0	4.9	0.1	0.0	0.1	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	15.8	38.6	104.0	10.4	0.2	1.6	9.8	2.7	0.0	16.1	30.3	0.1	0.0	0.0	117.5	0.1	0.5	0.0	0.0	0.0	87.7	3.6	0.3	12.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.7	0.8	0.7	0.0	0.0	323.2	0.0	0.0	0.5	0.0	14.1	2.5	0.1	0.4	27.1	0.0	104.3	230.5	0.0	0.0	0.8	0.7	7.5	0.0	0.1	3.6	14.0	0.0	16.4	0.0	58.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.2	0.0	2.3	0.5	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 187.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.1;Endometrial ciliated cells: 6.5;Excitatory neurons: 23.7;Extravillous trophoblasts: 10.7;Inhibitory neurons: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.9;SH-SY5Y: 2.9;THP-1: 2.5;U-937: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported				NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 10: Non-specific - Unknown function"			"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.0	9.7	6.0	0.0	7.5	0.0	0.0	3.4	33.7	0.0	187.9	0.3	0.0	0.0	0.9	0.0	1.2	0.0	0.0	25.7	1.3	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.5	4.8	0.0	0.0	2.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.9	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.5	3.4	33.7	25.7	1.3	5.5	0.0	4.8	0.0	2.7	12.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	1.3	0.1	0.0	0.0	23.7	0.0	10.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	30.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.4	0.0	3.5	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.6	4.5	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626787-203744081	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 171.6;Oligodendrocyte precursor cells: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 200.0;BJ hTERT+: 276.4;fHDF/TERT166: 212.8;SuSa: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	58.9	25.0	39.7	25.6	36.3	16.0	16.6	0.0	33.5	47.5	0.3	58.2	12.5	104.5	20.1	32.5	48.4	25.2	59.5	40.2	13.3	9.9	9.3	35.1	12.8	8.0	8.0	40.6	9.9	11.8	3.8	40.6	11.2	33.0	30.2	42.5	7.1	69.7	14.4	54.8	14.4	175.3	0.2	12.2	15.4	27.4	44.7	21.7	15.1	27.7	19.4	37.2	15.3	2.6	45.7	7.8	15.6	15.1	120.4	175.1	84.5	200.0	276.4	32.1	27.4	3.8	22.8	9.8	28.8	212.8	43.5	43.5	22.6	27.7	34.3	126.5	8.0	28.7	37.4	2.5	43.1	42.0	51.3	130.5	26.9	102.9	16.2	81.6	63.5	57.1	12.9	20.3	25.1	2.5	44.3	14.5	9.7	8.7	24.2	22.3	11.6	16.7	11.3	4.0	4.6	6.7	68.3	10.5	30.2	222.1	9.3	21.4	54.9	80.5	11.4	136.6	48.3	13.4	20.9	5.4	80.7	31.0	24.5	3.2	2.0	0.0	8.7	1.3	6.4	0.9	5.4	7.2	2.2	0.3	1.3	3.4	4.0	3.8	2.2	3.7	5.7	2.7	39.7	36.3	0.0	33.5	40.2	13.3	8.0	8.0	11.2	0.2	44.7	2.6	171.6	89.8	68.2	127.6	9.9	97.1	18.9	43.1	41.5	4.8	11.2	9.4	76.5	7.2	35.0	18.4	2.1	27.9	56.2	2.2	0.0	35.3	5.8	78.0	92.4	67.6	23.9	35.9	55.9	14.9	18.9	56.0	13.7	89.7	10.1	30.6	58.9	18.2	38.5	117.8	9.8	2.4	14.2	14.7	38.8	4.8	43.8	20.4	26.6	37.5	18.1	136.1	66.9	199.0	40.4	31.4	11.1	38.0	27.6	48.2	7.2	3.3	39.7	7.8	19.7	50.7	81.2	21.7	2.8	54.7	150.9	26.0	59.7	8.0	3.3	62.0
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	32.2	32.7	34.0	25.3	36.6	38.6	32.9	31.8	42.8	33.4	76.9	36.5	23.9	30.9	28.0	23.6	37.2	27.2	31.9	40.7	38.6	44.7	28.5	51.4	21.9	37.0	38.9	28.8	22.6	78.0	22.7	32.7	40.3	85.8	35.9	59.4	29.2	25.2	28.1	31.9	26.9	31.0	33.6	19.5	31.5	25.2	48.8	36.2	35.0	21.1	26.2	31.6	18.1	48.6	133.1	51.1	49.9	48.5	136.7	110.0	53.9	141.2	186.8	69.4	87.0	83.5	106.3	47.6	95.6	134.4	96.4	153.6	95.1	77.9	100.8	104.4	34.2	127.2	51.5	39.0	87.2	51.2	148.4	86.8	76.6	73.2	82.2	126.3	74.6	59.3	37.3	84.1	86.7	59.0	50.6	40.9	57.0	71.7	54.8	36.3	49.9	75.6	127.5	87.7	76.7	45.9	121.4	37.8	72.8	70.8	55.7	41.7	102.6	73.3	40.8	95.5	65.8	54.6	71.1	69.9	75.8	38.0	62.6	30.6	8.9	15.9	7.4	7.6	7.0	5.6	7.3	6.6	9.5	3.6	4.9	4.9	4.3	11.5	9.6	8.2	9.3	6.5	34.0	36.6	31.8	42.8	40.7	38.6	37.0	38.9	40.3	33.6	48.8	48.6	30.2	38.5	53.0	162.6	17.4	39.4	34.5	34.8	26.7	25.9	34.4	22.4	30.2	35.8	41.1	46.0	20.9	16.3	15.5	39.0	5.9	35.3	17.5	26.9	34.1	27.8	35.6	23.3	172.5	38.0	27.6	25.9	33.1	55.8	28.5	28.2	26.7	27.4	27.7	82.4	136.5	32.4	36.7	26.2	34.8	18.9	16.1	39.5	21.4	128.4	20.5	26.4	19.6	148.3	154.3	51.1	27.5	14.7	18.5	69.0	16.3	19.8	52.7	33.4	6.6	27.7	25.9	16.2	14.1	24.7	52.8	17.6	19.5	17.3	31.2	36.9
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting subunit alpha"	P20648	19	35550031-35563658	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"stomach 1: 841.9"	"Group enriched"	"Detected in some"	6	"Gastric mucus-secreting cells: 66.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039154, HPA076684"	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	1.1	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	841.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.0	0.6	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting subunit beta"	P51164	13	113648804-113658198	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	305	"stomach 1: 1096.8"	"Cell type enriched"	"Detected in some"	76	"Gastric mucus-secreting cells: 145.8"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced		Uncertain	"Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.5	0.3	0.0	0.0	0.0	0.3	3.3	0.0	0.2	0.2	0.1	0.4	0.1	0.4	0.0	0.5	0.6	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1096.8	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.6	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1760.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		8800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	251.3	453.6	198.6	177.7	209.2	210.5	260.4	233.0	251.4	195.5	401.9	414.0	438.9	192.6	225.6	362.6	227.2	146.3	1498.3	207.7	246.0	730.4	441.6	175.1	223.7	234.6	237.8	211.1	299.9	868.5	277.4	201.7	226.0	211.4	419.8	465.4	307.4	265.9	1602.0	290.3	335.0	233.0	205.4	226.8	419.1	167.6	226.7	277.3	261.4	1760.3	337.6	244.9	224.7	209.6	355.2	353.0	459.6	434.3	546.0	601.8	508.6	399.5	562.4	601.0	522.8	532.7	271.9	833.2	238.9	487.4	322.3	641.7	801.1	614.1	556.4	373.0	450.3	551.7	413.3	667.2	357.1	1182.7	501.6	559.2	422.3	434.6	448.2	481.3	630.4	442.5	454.0	477.2	521.8	367.6	612.8	579.7	432.3	344.5	367.6	596.5	533.8	1131.4	816.2	849.7	465.7	434.7	293.3	361.5	506.9	428.6	466.3	679.3	370.4	328.7	282.7	174.9	354.9	542.5	501.5	533.0	328.1	698.0	358.7	119.1	573.9	162.7	353.6	511.8	455.9	492.3	422.7	388.4	959.5	392.9	503.3	421.7	55.9	414.5	485.1	468.3	527.4	1339.1	198.6	209.2	233.0	251.4	207.7	246.0	234.6	237.8	226.0	205.4	226.7	209.6	79.2	169.9	167.8	0.0	49.9	0.0	0.0	0.0	0.0	0.0	205.7	169.8	0.0	0.0	100.3	171.0	0.0	784.3	86.3	0.0	1173.9	358.3	0.0	125.3	163.3	73.0	0.0	0.0	0.0	269.7	463.0	97.8	0.0	119.3	89.6	198.7	0.0	0.0	409.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	179.9	0.0	0.0	0.0	0.0	199.1	0.0	0.0	24.0	0.0	0.0	939.6	95.5	0.0	0.0	0.0	87.1	0.0	0.0	0.0	0.0	578.2	54.6	319.2	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56645984	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2590.4;tongue: 3205.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		19000000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	432.7	555.5	217.6	300.5	231.4	465.8	301.5	281.6	303.8	241.8	443.3	741.6	689.5	235.4	223.4	527.6	277.9	225.7	2011.6	233.0	307.1	945.9	609.3	253.4	294.6	264.2	242.9	200.2	301.7	1311.6	252.6	301.4	280.4	280.9	767.6	484.2	407.7	356.4	2590.4	398.6	575.5	332.5	230.9	272.5	494.9	236.0	277.5	390.9	342.8	3205.3	458.3	404.1	311.2	244.7	693.6	834.9	632.3	1003.6	578.3	596.7	1159.8	683.2	645.6	1179.1	663.9	1375.7	755.6	1236.3	723.0	863.5	482.9	906.1	1378.1	851.5	1039.4	579.9	987.5	1333.1	726.4	872.5	716.6	1509.7	912.9	755.1	843.3	918.0	1171.2	870.2	985.8	901.7	1246.3	1363.1	992.2	671.5	1134.4	941.3	1085.9	905.6	1637.6	1079.3	711.0	1603.5	1315.6	1196.7	737.5	658.2	1042.3	1481.3	1214.0	663.4	1404.1	1151.8	657.6	454.8	507.9	671.9	751.0	659.5	865.7	1254.8	684.7	1007.8	718.4	403.5	549.4	281.8	293.5	643.6	326.3	303.2	275.4	313.6	713.4	248.4	221.0	266.8	137.1	296.9	750.6	360.9	372.9	1077.1	217.6	231.4	281.6	303.8	233.0	307.1	264.2	242.9	280.4	230.9	277.5	244.7	172.3	134.6	173.2	0.0	48.6	0.0	0.0	0.0	0.0	0.0	176.8	149.1	0.0	0.0	81.1	277.7	0.0	821.1	141.5	0.0	1238.5	517.7	0.0	194.1	169.2	115.7	0.0	0.0	0.0	367.9	592.7	115.0	0.0	163.3	145.1	267.6	0.0	0.0	608.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	281.2	0.0	0.0	0.0	0.0	333.3	0.0	0.0	26.8	0.0	0.0	951.7	102.7	0.0	0.0	0.0	151.1	0.0	0.0	0.0	0.0	1138.6	77.4	518.4	0.0	0.0
ATP5F1C	"ATP5C, ATP5C1, ATP5CL1"	ENSG00000165629	"ATP synthase F1 subunit gamma"	P36542	10	7788147-7807815	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 895.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060949	Approved					NA	NA		70000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA060949: AB_2684395"	"unprognostic (1.81e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.12e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.08e-2)"	123.7	265.0	82.8	103.2	82.4	149.0	164.8	111.3	111.0	122.5	102.6	240.9	254.7	100.9	150.1	145.9	114.7	112.6	710.9	81.5	94.3	399.9	368.6	93.5	133.0	85.4	83.2	86.8	182.2	411.4	76.7	147.5	86.4	117.5	274.7	161.6	168.3	136.2	537.8	110.7	205.7	146.1	88.8	96.4	174.3	71.1	89.1	192.5	161.7	895.1	175.3	163.8	91.0	90.9	301.2	266.8	255.2	219.3	212.5	276.7	241.2	211.1	176.1	365.7	351.6	511.4	293.8	323.8	163.3	248.0	95.3	337.9	318.3	342.8	325.5	222.3	381.6	351.7	169.3	479.8	172.2	193.6	249.6	222.9	234.1	224.7	134.5	315.7	426.7	321.8	283.4	230.1	352.6	419.0	451.9	217.7	173.3	623.4	201.8	301.9	179.1	460.6	637.5	301.0	141.3	168.2	186.0	417.5	417.1	287.3	437.9	315.9	202.7	151.7	205.3	349.2	229.8	159.2	194.7	265.5	224.7	286.2	127.3	373.0	273.8	241.9	158.5	363.1	185.3	199.2	180.7	174.5	370.4	158.6	146.4	159.6	88.5	226.9	428.2	237.8	261.4	349.3	82.8	82.4	111.3	111.0	81.5	94.3	85.4	83.2	86.4	88.8	89.1	90.9	196.2	118.6	95.4	0.0	30.4	0.0	0.0	0.0	0.0	0.0	156.2	239.3	0.0	0.0	60.7	215.2	0.0	517.1	85.3	0.0	890.2	453.9	0.0	160.9	125.4	76.7	0.0	0.0	0.0	381.8	428.5	89.5	0.0	170.4	97.1	163.2	0.0	0.0	423.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.6	0.0	0.0	140.6	0.0	0.0	0.0	0.0	304.4	0.0	0.0	12.0	0.0	0.0	938.6	64.8	0.0	0.0	0.0	102.0	0.0	0.0	0.0	0.0	371.9	49.1	413.9	0.0	0.0
ATP5F1D	ATP5D	ENSG00000099624	"ATP synthase F1 subunit delta"	P30049	19	1241746-1244825	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 806.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1702.2;Exocrine glandular cells: 566.6;Proximal tubular cells: 1831.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002865	Approved					NA	NA		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002865: AB_1078244"	"unprognostic (4.80e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.77e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	129.0	213.4	74.1	16.2	71.1	31.7	114.0	93.7	110.0	108.1	74.1	196.9	65.6	104.3	8.4	198.2	102.7	11.6	575.2	75.3	80.2	256.0	365.3	87.2	21.6	99.2	74.8	106.8	251.9	34.7	138.4	14.4	95.2	128.1	17.5	6.9	133.9	29.4	806.2	164.9	143.4	11.3	73.1	113.1	200.5	58.6	94.7	15.8	134.4	123.1	15.9	132.5	120.6	74.3	109.6	58.3	17.9	67.2	20.4	29.9	67.0	73.1	30.4	42.4	30.8	60.6	28.4	109.7	46.2	25.6	10.7	92.8	19.9	76.0	5.5	76.5	196.6	66.5	69.6	81.2	50.4	117.4	95.5	59.5	20.6	17.1	23.6	23.9	45.3	72.2	98.4	85.3	19.9	164.8	127.7	84.9	77.6	69.5	284.8	121.1	47.2	233.1	72.3	70.6	71.3	82.1	48.6	76.5	132.4	7.1	57.2	54.8	66.6	38.4	52.9	93.0	61.4	216.0	118.4	41.7	70.8	54.6	59.3	203.0	283.7	128.0	211.9	287.7	255.9	284.2	267.4	233.8	321.3	287.1	242.4	227.7	99.2	246.5	237.6	349.2	287.1	251.6	74.1	71.1	93.7	110.0	75.3	80.2	99.2	74.8	95.2	73.1	94.7	74.3	265.3	16.0	25.4	0.0	101.9	0.0	0.0	0.0	0.0	0.0	402.1	533.8	0.0	0.0	9.3	380.7	0.0	393.5	155.1	0.0	1702.2	351.2	0.0	145.6	261.2	80.3	0.0	0.0	0.0	566.6	471.3	109.6	0.0	256.9	5.1	263.9	0.0	0.0	416.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.7	0.0	0.0	133.4	0.0	0.0	0.0	0.0	437.8	0.0	0.0	40.7	0.0	0.0	1831.8	5.1	0.0	0.0	0.0	145.9	0.0	0.0	0.0	0.0	341.2	82.8	469.2	0.0	0.0
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1035.0;Endometrial ciliated cells: 1524.2;Exocrine glandular cells: 672.1;Granulosa cells: 1030.6;Proximal tubular cells: 1502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	96.9	215.1	98.4	50.6	98.6	144.3	108.8	95.6	140.0	123.3	95.2	234.8	163.1	113.0	44.5	184.5	139.4	28.0	585.8	100.0	106.5	384.9	342.6	116.0	64.5	99.6	96.8	134.9	163.4	90.1	246.5	37.6	97.8	156.0	59.4	71.0	145.3	37.1	456.7	165.0	199.6	28.5	93.7	153.7	215.7	355.5	99.6	60.0	169.2	179.8	47.9	116.6	134.0	104.1	271.9	136.4	79.3	75.1	58.0	62.7	94.1	118.6	57.9	98.6	96.2	132.0	192.5	189.1	173.8	72.1	37.6	161.5	91.2	118.0	77.6	143.9	306.0	162.9	612.7	180.8	62.9	125.5	158.1	73.5	190.2	88.2	70.4	96.2	95.7	222.0	292.9	167.9	71.2	178.0	187.6	230.4	262.7	100.9	167.8	177.3	87.5	270.2	196.9	175.5	158.9	114.2	146.5	150.8	160.4	76.5	224.4	136.6	100.6	31.9	88.0	126.5	142.1	432.0	282.8	268.6	151.1	338.8	38.1	133.3	116.6	126.1	144.2	111.1	145.8	195.2	154.3	155.5	142.8	154.0	144.1	139.3	102.7	142.9	102.7	213.5	226.9	214.1	98.4	98.6	95.6	140.0	100.0	106.5	99.6	96.8	97.8	93.7	99.6	104.1	207.3	205.1	284.9	0.0	61.7	0.0	0.0	0.0	0.0	0.0	251.1	314.3	0.0	0.0	150.4	546.2	0.0	453.8	165.4	0.0	1035.0	396.6	0.0	1524.2	210.6	84.0	0.0	0.0	0.0	672.1	226.0	114.6	0.0	453.2	172.8	1030.6	0.0	0.0	372.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.6	0.0	0.0	123.0	0.0	0.0	0.0	0.0	550.3	0.0	0.0	30.3	0.0	0.0	1502.7	621.6	0.0	0.0	0.0	90.6	0.0	0.0	0.0	0.0	251.7	92.0	281.6	0.0	0.0
ATP5MC2	ATP5G2	ENSG00000135390	"ATP synthase membrane subunit c locus 2"	Q06055	12	53632726-53677408	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1335.2;Breast myoepithelial cells: 1873.6;Distal tubular cells: 1762.9;Hofbauer cells: 1076.1;Proximal tubular cells: 2061.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051469	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA051469: AB_2681496"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (3.78e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.09e-2)"	250.6	297.8	487.0	240.0	510.5	445.5	485.5	498.2	574.6	338.4	492.0	444.0	383.6	279.1	463.7	340.5	533.7	296.1	759.6	475.9	499.0	437.4	469.4	243.6	406.4	509.5	488.1	487.2	499.1	503.0	18.9	265.3	507.8	322.2	551.7	275.9	483.0	284.9	1405.5	345.5	322.5	361.1	504.7	295.8	312.1	126.9	500.7	453.9	314.0	1447.2	540.2	365.6	15.2	519.7	325.4	684.8	701.3	640.3	478.0	1162.4	330.7	278.3	630.3	824.5	561.2	236.2	745.1	392.9	668.3	554.8	263.9	304.7	914.6	652.8	729.3	660.9	1096.7	1068.7	515.2	495.7	1034.1	819.7	508.5	1297.4	956.8	797.0	1315.9	1313.7	1078.7	468.0	776.8	1116.6	852.6	857.0	842.8	1996.5	603.6	681.5	756.7	838.3	665.2	981.9	1019.4	407.0	365.8	669.0	376.5	431.6	974.2	610.1	1403.7	1473.7	512.5	396.4	542.2	307.5	441.4	577.6	537.6	288.1	589.9	863.0	620.2	367.7	977.3	281.8	645.6	924.4	710.5	1119.6	826.1	693.6	1324.3	974.6	896.6	755.0	214.2	769.1	849.6	1023.6	955.8	1565.2	487.0	510.5	498.2	574.6	475.9	499.0	509.5	488.1	507.8	504.7	500.7	519.7	412.1	182.7	266.7	0.0	167.8	0.0	0.0	0.0	0.0	0.0	1335.2	1873.6	0.0	0.0	177.0	527.8	0.0	732.4	297.0	0.0	1762.9	470.7	0.0	529.1	446.9	190.2	0.0	0.0	0.0	676.5	777.5	222.2	0.0	454.1	224.5	715.4	0.0	0.0	1076.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.0	0.0	0.0	380.9	0.0	0.0	0.0	0.0	392.7	0.0	0.0	52.8	0.0	0.0	2061.3	215.7	0.0	0.0	0.0	248.9	0.0	0.0	0.0	0.0	507.7	182.6	802.8	0.0	0.0
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674330	"Metabolic proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2048.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	360.1	412.7	940.1	212.2	960.8	312.4	277.4	981.5	1172.2	263.3	926.5	555.7	460.3	237.4	242.7	511.9	218.8	94.5	1507.7	932.5	968.9	572.0	591.7	235.6	174.6	980.1	955.6	257.5	330.9	774.8	312.8	144.8	972.5	262.0	331.4	336.4	304.8	220.4	2048.3	297.8	436.7	172.8	952.6	281.3	414.9	130.6	960.4	315.7	270.1	1688.5	223.8	293.5	323.8	998.1	542.0	560.8	781.7	599.5	622.4	544.4	390.7	561.8	445.4	407.4	359.4	525.4	548.4	299.0	472.8	612.4	683.8	361.8	668.9	924.1	241.4	249.9	1082.7	854.6	1107.9	1435.2	659.0	1118.6	368.0	721.6	533.5	472.2	491.0	665.5	503.3	608.1	756.0	314.4	464.7	904.5	972.6	1337.3	861.9	1071.7	1438.9	584.4	555.0	620.7	863.9	1053.2	667.7	530.1	401.6	525.0	620.2	502.7	590.4	695.7	580.2	348.0	340.7	308.2	730.9	739.7	1273.2	947.0	528.0	712.7	391.3	1049.3	1044.5	1188.8	742.1	920.0	776.3	1470.4	909.2	839.0	1067.0	1131.6	837.1	811.9	962.2	943.5	822.7	1179.7	1086.3	1456.6	940.1	960.8	981.5	1172.2	932.5	968.9	980.1	955.6	972.5	952.6	960.4	998.1	311.8	153.8	199.7	0.0	88.6	0.0	0.0	0.0	0.0	0.0	461.7	421.8	0.0	0.0	121.9	886.5	0.0	404.9	188.8	0.0	1729.5	467.4	0.0	468.6	315.6	125.1	0.0	0.0	0.0	692.9	335.8	139.4	0.0	484.2	122.4	311.8	0.0	0.0	676.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.6	0.0	0.0	278.1	0.0	0.0	0.0	0.0	509.6	0.0	0.0	50.1	0.0	0.0	2485.3	183.6	0.0	0.0	0.0	156.7	0.0	0.0	0.0	0.0	274.9	97.8	146.6	0.0	0.0
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466186	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067267, HPA070412"	Approved		Supported	"Nuclear membrane,Mitochondria"		NA	NA		60000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear membrane"	"HPA067267: AB_2685815, HPA070412: AB_2686266"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	328.8	423.5	636.9	268.7	655.2	404.4	310.8	658.3	868.4	247.8	671.0	470.9	442.7	188.3	299.1	526.6	191.7	143.8	1184.8	658.1	663.7	559.3	561.2	241.8	293.1	657.5	648.0	179.1	271.6	509.6	332.1	235.7	647.0	315.5	367.9	320.7	317.8	205.9	1337.1	287.0	384.6	192.0	637.6	281.8	354.7	310.5	652.7	439.3	241.4	1439.0	301.2	303.1	303.5	641.3	1251.5	1130.6	905.3	1400.5	752.1	739.2	561.1	799.3	705.9	947.2	994.6	1226.2	1091.7	1161.7	822.7	548.5	1513.9	735.7	1064.0	981.3	1021.4	831.0	1333.6	800.1	1584.6	1555.4	530.7	1324.4	824.4	835.6	944.9	766.6	858.9	760.5	919.8	1009.4	1681.6	1213.0	1057.4	3128.1	1984.5	2396.1	1228.2	2594.9	1410.9	874.9	741.6	1985.9	1936.7	1376.1	845.3	925.9	1073.7	2519.4	773.1	1365.1	644.9	1687.5	703.0	706.0	1142.1	1197.3	1181.5	685.7	1795.6	2432.4	829.7	1325.8	1131.8	1020.3	904.1	1069.1	440.2	912.7	425.6	597.7	508.3	494.8	1122.9	512.2	445.1	468.3	428.0	555.2	731.2	890.5	754.9	1505.3	636.9	655.2	658.3	868.4	658.1	663.7	657.5	648.0	647.0	637.6	652.7	641.3	147.7	22.4	44.9	0.0	57.9	0.0	0.0	0.0	0.0	0.0	252.4	289.6	0.0	0.0	36.5	386.2	0.0	777.4	125.6	0.0	1430.2	460.9	0.0	302.6	225.3	82.0	0.0	0.0	0.0	578.8	636.3	110.5	0.0	278.3	64.3	188.1	0.0	0.0	787.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.2	0.0	0.0	339.1	0.0	0.0	0.0	0.0	589.5	0.0	0.0	18.6	0.0	0.0	1616.3	51.0	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	436.3	64.0	206.4	0.0	0.0
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	"ATP5MF-PTCD1 readthrough"		7	99419749-99466197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (1.15e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.84e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.50e-2)"	2.8	2.8	1.2	2.8	1.0	0.0	2.3	1.1	1.8	3.3	1.1	3.7	2.7	3.0	1.6	4.7	3.3	2.0	3.7	1.0	1.2	1.7	2.7	1.8	2.6	1.3	1.4	2.5	2.5	3.6	1.7	2.5	1.3	3.7	2.1	0.5	2.5	3.5	8.9	2.7	2.2	2.5	0.9	2.3	2.7	3.4	1.2	2.3	2.3	5.5	2.5	4.1	3.3	1.1	7.7	8.2	6.8	19.1	8.1	4.8	14.6	5.1	6.2	12.8	11.6	31.5	12.3	10.0	12.6	4.9	11.9	7.3	11.6	10.6	5.4	11.2	10.9	5.8	5.0	6.5	8.5	8.0	5.7	8.2	9.4	11.5	9.3	4.7	5.3	11.5	19.5	14.9	8.3	15.7	18.5	10.2	11.9	13.2	10.5	9.9	6.3	26.6	6.7	2.4	8.7	8.8	11.0	18.0	11.0	4.5	9.2	12.5	3.3	8.9	7.8	18.7	13.8	11.7	10.8	16.0	6.5	8.9	16.3	1.3	4.0	1.2	3.3	5.4	3.4	2.1	2.7	2.8	5.6	2.4	2.8	3.6	0.3	4.5	3.2	2.7	2.2	5.0	1.2	1.0	1.1	1.8	1.0	1.2	1.3	1.4	1.3	0.9	1.2	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401606-118431496	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria		NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	119.8	137.2	154.2	103.3	158.5	165.6	132.5	158.5	184.3	81.1	168.3	153.6	146.4	79.3	143.3	116.9	96.5	68.1	329.8	157.2	160.8	205.1	154.5	77.9	150.0	155.5	153.1	112.0	110.9	140.7	49.5	83.7	154.0	83.5	164.3	100.8	133.9	92.2	340.7	55.3	118.2	95.2	153.6	86.0	112.3	46.9	155.5	204.1	87.5	373.6	183.1	105.3	41.5	154.7	163.1	87.9	209.3	183.1	167.6	198.0	200.1	149.0	175.9	138.4	146.6	259.9	259.9	314.3	352.7	167.5	206.2	190.4	204.4	214.8	155.3	247.6	138.0	472.8	112.5	197.4	175.3	279.3	210.2	207.1	203.4	169.0	162.9	164.1	189.8	216.6	227.4	253.1	199.5	305.8	365.2	497.3	130.1	427.9	224.0	247.0	174.9	422.9	371.1	260.3	184.3	161.9	232.3	361.1	161.9	221.6	303.0	307.7	172.8	123.0	144.7	109.2	190.9	112.8	184.8	402.1	93.8	353.0	154.7	325.4	437.2	299.0	241.8	360.8	339.7	462.7	398.8	321.5	481.2	378.5	472.9	379.7	214.8	357.2	333.3	534.3	464.5	1112.1	154.2	158.5	158.5	184.3	157.2	160.8	155.5	153.1	154.0	153.6	155.5	154.7	324.3	362.2	364.1	0.0	211.2	0.0	0.0	0.0	0.0	0.0	893.9	1061.2	0.0	0.0	166.5	610.6	0.0	1407.2	378.3	0.0	2907.4	748.6	0.0	449.8	327.9	188.9	0.0	0.0	0.0	986.0	935.6	204.7	0.0	404.6	258.6	368.2	0.0	0.0	1367.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	427.7	0.0	0.0	678.1	0.0	0.0	0.0	0.0	922.2	0.0	0.0	94.9	0.0	0.0	2520.3	188.0	0.0	0.0	0.0	217.5	0.0	0.0	0.0	0.0	1001.4	224.2	370.0	0.0	0.0
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;brain: 2.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 11.6;Distal tubular cells: 5.9;Extravillous trophoblasts: 7.7;Hofbauer cells: 11.2;Syncytiotrophoblasts: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044629	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.1	0.0	0.7	0.0	0.5	1.4	0.0	2.7	1.1	0.0	0.8	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.6	1.0	0.1	0.0	0.1	0.3	1.3	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.3	0.0	0.1	0.9	0.1	0.0	0.3	0.1	0.2	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.9	0.1	0.2	0.2	0.1	0.3	0.7	0.5	2.7	1.1	0.6	1.0	1.3	0.6	0.7	0.3	1.3	1.6	1.1	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.8	0.0	11.6	0.7	0.0	5.9	0.6	0.0	0.8	0.8	0.9	0.0	0.0	0.0	1.1	7.7	1.0	0.0	1.3	2.5	1.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6	0.8	1.2	0.0	0.0
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoli fibrillar center"	"HPA058978: AB_2683867, HPA060520: AB_2684302"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	107.8	166.9	304.6	75.7	318.3	177.4	127.5	305.8	446.6	94.9	306.0	165.2	165.1	80.5	139.6	159.4	87.0	48.8	548.2	321.9	313.4	205.2	181.9	79.9	94.4	301.2	297.7	98.3	113.8	257.3	159.9	77.1	302.4	108.5	167.5	169.9	100.9	87.8	489.6	106.1	128.9	78.9	303.1	108.7	135.6	83.4	305.5	135.0	111.5	471.6	122.5	103.0	101.1	304.1	244.6	278.5	233.6	222.8	275.0	284.2	228.5	185.2	211.7	228.6	199.5	240.6	167.4	254.4	187.9	191.2	183.4	201.1	306.4	225.3	310.0	207.9	306.8	280.4	227.5	380.4	180.4	346.2	188.4	298.6	301.5	155.7	164.2	260.8	264.4	330.6	176.7	264.7	253.7	730.8	333.1	493.9	182.1	560.5	523.7	211.5	202.7	231.2	358.4	345.0	201.2	238.4	155.9	289.0	371.4	256.2	355.3	401.7	142.7	87.9	137.9	242.0	153.2	199.3	372.5	360.2	207.8	195.7	152.3	405.1	512.8	336.0	204.9	409.1	232.9	309.5	261.1	234.1	367.0	261.9	295.5	260.0	517.5	206.2	401.4	355.4	282.2	656.9	304.6	318.3	305.8	446.6	321.9	313.4	301.2	297.7	302.4	303.1	305.5	304.1	88.0	221.2	225.1	0.0	47.9	0.0	0.0	0.0	0.0	0.0	369.7	334.4	0.0	0.0	92.2	413.8	0.0	609.1	63.1	0.0	1602.3	504.6	0.0	341.3	245.9	104.1	0.0	0.0	0.0	572.6	671.4	113.8	0.0	297.7	93.4	207.9	0.0	0.0	920.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.3	0.0	0.0	335.5	0.0	0.0	0.0	0.0	570.5	0.0	0.0	0.0	0.0	0.0	1883.7	146.5	0.0	0.0	0.0	104.8	0.0	0.0	0.0	0.0	710.1	70.2	228.6	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.8;tongue: 131.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	19.3	15.7	10.3	11.5	12.5	15.3	18.8	14.5	27.4	17.4	3.9	51.6	28.8	16.6	16.0	26.8	23.9	16.3	109.0	12.1	10.2	40.3	40.2	13.7	24.0	13.4	12.0	19.2	18.5	33.8	7.1	21.6	14.9	22.3	33.6	28.5	29.8	18.7	135.8	15.7	19.0	17.9	9.6	15.2	22.6	15.5	12.8	15.7	31.1	131.0	22.4	21.9	7.4	14.1	55.6	17.6	44.1	36.9	35.6	34.2	34.1	57.0	68.9	67.3	54.7	31.8	29.1	84.9	52.3	45.5	14.3	56.1	69.4	79.5	65.1	61.9	33.2	76.1	21.3	21.5	26.0	98.3	70.8	30.3	40.9	69.3	66.9	17.7	60.0	11.9	78.7	33.6	46.3	35.4	153.3	30.0	34.9	19.2	90.5	41.2	143.6	34.0	54.7	26.0	37.2	13.4	49.4	72.7	55.6	12.6	54.8	46.0	50.6	32.0	49.1	59.4	61.2	41.8	44.5	172.1	70.8	77.6	60.8	3.5	15.4	7.1	14.8	10.0	12.2	12.9	15.1	13.3	16.1	15.2	16.9	10.4	4.8	9.8	9.0	9.2	15.1	44.2	10.3	12.5	14.5	27.4	12.1	10.2	13.4	12.0	14.9	9.6	12.8	14.1	73.2	67.3	83.8	0.0	31.5	0.0	0.0	0.0	0.0	0.0	112.9	155.3	0.0	0.0	57.6	125.0	0.0	346.5	56.4	0.0	461.8	237.3	0.0	132.5	111.0	58.8	0.0	0.0	0.0	196.7	405.2	57.0	0.0	125.4	89.6	82.1	0.0	0.0	373.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.0	98.8	0.0	0.0	0.0	0.0	162.6	0.0	0.0	9.8	0.0	0.0	434.6	74.3	0.0	0.0	0.0	58.0	0.0	0.0	0.0	0.0	347.7	41.8	208.0	0.0	0.0
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1142.6;Hofbauer cells: 465.0;Proximal tubular cells: 1059.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria		NA	NA		60000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	253.8	271.0	253.5	156.0	260.5	187.2	228.8	270.5	385.7	190.7	282.9	337.1	295.1	170.7	279.9	355.9	173.5	140.1	985.5	261.9	271.1	465.2	454.2	174.0	166.0	264.8	256.9	147.5	222.2	427.1	203.9	174.1	260.8	177.9	323.6	256.0	240.8	200.5	1102.8	264.7	257.4	211.3	260.2	155.0	307.4	93.8	262.3	175.2	263.7	1025.5	221.2	230.3	221.5	261.7	522.8	445.4	335.6	439.8	532.6	647.4	449.1	437.2	571.3	478.5	452.2	351.8	397.1	349.8	282.5	550.2	450.2	462.2	409.0	571.6	637.5	171.6	346.0	359.1	340.2	703.1	524.2	463.5	225.8	555.3	444.8	390.7	552.7	380.9	646.8	268.5	380.1	462.6	595.1	503.3	461.8	515.6	257.1	1185.3	626.9	322.3	970.4	652.3	1007.3	499.7	335.8	368.5	515.5	811.0	730.7	496.9	805.1	463.2	337.4	591.1	413.2	520.0	520.4	369.0	315.5	360.8	530.2	455.4	390.3	410.8	440.7	481.0	274.8	540.9	320.8	364.5	467.5	341.7	509.7	292.8	416.1	388.9	253.0	301.6	458.0	453.6	492.8	495.9	253.5	260.5	270.5	385.7	261.9	271.1	264.8	256.9	260.8	260.2	262.3	261.7	173.8	173.1	156.4	0.0	35.0	0.0	0.0	0.0	0.0	0.0	159.6	234.2	0.0	0.0	102.8	259.3	0.0	384.3	74.0	0.0	1142.6	313.6	0.0	188.2	153.6	70.4	0.0	0.0	0.0	379.5	328.4	82.7	0.0	207.6	88.3	84.6	0.0	0.0	465.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.1	0.0	0.0	208.8	0.0	0.0	0.0	0.0	284.3	0.0	0.0	13.8	0.0	0.0	1059.2	101.3	0.0	0.0	0.0	88.3	0.0	0.0	0.0	0.0	336.3	54.4	155.9	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1595.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031069	Supported		Supported	Mitochondria		NA	NA		820000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	274.6	276.3	291.2	136.4	295.4	175.1	205.5	302.5	424.4	156.3	316.1	333.5	276.4	128.8	368.1	258.1	129.9	129.7	1052.1	295.2	306.2	489.5	756.3	110.8	166.4	299.3	297.8	127.2	188.2	458.8	140.4	171.5	295.7	160.1	314.4	249.5	214.6	228.5	1161.7	113.6	250.6	189.8	298.7	111.2	226.9	131.5	299.4	217.5	166.0	1595.8	210.9	194.9	138.4	299.6	355.9	260.0	314.5	351.4	344.8	313.5	389.4	305.8	373.0	305.8	300.8	607.6	274.4	439.3	194.2	312.9	467.8	191.5	441.3	379.2	339.2	373.1	441.1	910.6	520.6	618.4	386.8	673.2	284.5	303.1	471.2	284.0	258.6	399.9	363.0	412.2	582.2	522.9	458.2	416.3	468.6	683.2	562.3	824.0	460.7	358.0	606.5	840.0	669.8	504.6	360.2	394.1	516.5	521.7	493.0	449.4	376.5	590.5	260.6	219.6	266.6	209.3	265.9	501.7	954.7	568.2	341.5	707.8	283.1	444.8	447.0	443.7	293.3	487.1	316.1	475.1	385.5	368.6	531.9	399.7	377.4	370.7	292.3	389.9	505.7	504.0	520.3	661.3	291.2	295.4	302.5	424.4	295.2	306.2	299.3	297.8	295.7	298.7	299.4	299.6	532.1	169.9	179.3	0.0	56.0	0.0	0.0	0.0	0.0	0.0	346.3	468.4	0.0	0.0	105.9	419.3	0.0	652.7	116.4	0.0	2375.2	447.0	0.0	299.2	257.6	150.6	0.0	0.0	0.0	472.5	522.8	135.6	0.0	308.5	109.7	341.2	0.0	0.0	522.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.2	0.0	0.0	226.4	0.0	0.0	0.0	0.0	427.1	0.0	0.0	21.4	0.0	0.0	1906.2	142.1	0.0	0.0	0.0	161.4	0.0	0.0	0.0	0.0	708.2	79.2	387.8	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915814	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1601.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 610.3;Distal tubular cells: 1794.2;Extravillous trophoblasts: 623.2;Hofbauer cells: 627.0;Proximal tubular cells: 1236.8;Syncytiotrophoblasts: 542.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		150000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	213.0	181.0	282.7	147.9	289.4	310.6	280.4	306.0	417.7	204.8	325.2	351.9	357.2	169.2	251.1	288.3	216.7	157.9	1114.5	291.2	317.4	458.0	401.8	148.9	243.3	298.2	290.8	273.1	196.7	432.9	108.0	192.2	296.5	158.0	391.9	219.4	236.3	202.0	1063.7	188.4	293.8	217.4	290.9	143.4	304.2	150.3	291.4	281.7	224.4	1601.7	292.9	242.3	161.6	292.4	398.4	187.3	491.1	486.6	340.0	435.1	554.6	218.5	394.4	371.4	361.9	553.5	372.7	531.5	187.2	345.1	355.2	217.5	549.0	764.7	440.6	400.0	544.0	790.3	260.4	513.5	389.7	603.7	260.9	445.8	467.9	358.4	581.9	407.0	522.8	421.2	656.3	665.9	488.5	402.5	461.6	593.0	561.3	992.2	540.1	471.6	490.1	1007.5	1032.8	337.0	404.4	232.1	380.2	559.7	525.7	425.6	562.9	660.5	291.0	236.8	280.6	423.0	252.6	429.1	524.2	559.7	438.2	1046.2	349.3	329.7	561.5	407.8	335.9	596.2	400.9	575.4	439.5	404.8	753.0	487.3	540.9	459.4	136.2	412.6	539.8	445.4	585.3	1077.9	282.7	289.4	306.0	417.7	291.2	317.4	298.2	290.8	296.5	290.9	291.4	292.4	195.8	243.6	191.1	0.0	82.1	0.0	0.0	0.0	0.0	0.0	282.6	476.1	0.0	0.0	121.3	222.5	0.0	610.3	81.3	0.0	1794.2	394.5	0.0	133.0	140.9	87.3	0.0	0.0	0.0	420.2	623.2	109.7	0.0	114.8	114.8	198.9	0.0	0.0	627.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.2	0.0	0.0	218.1	0.0	0.0	0.0	0.0	331.9	0.0	0.0	17.8	0.0	0.0	1236.8	102.0	0.0	0.0	0.0	119.0	0.0	0.0	0.0	0.0	542.1	67.4	208.9	0.0	0.0
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428633-154436516	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	56.3	93.5	108.3	43.1	109.2	59.1	56.7	99.6	118.0	59.6	123.6	61.5	48.4	54.2	145.1	85.2	60.0	46.0	92.7	116.2	115.4	104.3	51.4	96.8	46.9	114.0	96.8	63.3	86.6	176.0	110.4	77.9	121.6	85.1	57.0	74.0	87.4	54.8	53.8	83.6	57.4	49.0	104.6	94.7	70.4	47.5	104.2	40.9	81.9	54.4	42.5	63.7	60.9	121.6	110.1	101.6	88.2	146.2	145.7	77.4	162.2	78.5	116.6	122.5	176.1	93.4	135.1	64.7	337.8	177.1	216.5	112.3	133.8	71.9	76.6	58.6	135.1	37.5	113.7	100.0	170.6	60.9	260.2	98.1	126.7	112.4	68.2	139.5	177.0	47.8	45.6	176.4	84.7	158.1	43.6	96.8	32.1	171.0	100.8	66.6	59.1	170.7	139.9	87.3	84.6	89.7	72.6	289.7	159.3	87.3	123.1	157.8	135.5	87.4	79.0	151.1	135.6	256.3	311.8	77.0	104.4	132.8	90.2	246.6	295.1	363.9	147.3	313.8	148.6	91.7	118.4	127.8	376.7	113.6	107.1	117.8	326.9	140.3	255.6	215.9	155.2	216.9	108.3	109.2	99.6	118.0	116.2	115.4	114.0	96.8	121.6	104.6	104.2	121.6	39.4	38.5	57.5	17.0	32.3	30.2	42.7	122.4	25.6	105.8	58.5	42.2	37.7	54.3	102.1	97.5	47.9	145.1	40.1	84.3	19.6	65.4	3.1	52.5	33.7	50.1	89.0	35.8	17.0	52.5	104.5	48.8	36.7	57.4	77.3	51.8	54.3	46.6	246.3	129.5	24.2	59.0	160.7	143.6	88.2	5.5	41.3	130.3	72.9	15.0	79.9	68.4	27.8	22.1	26.4	42.4	67.5	42.5	61.7	34.1	63.7	49.1	112.5	69.2	65.7	35.7	45.5	64.4	10.7	31.6	32.8	196.5	36.3	74.1	54.6	47.2
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 765.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 702.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	81.2	71.5	85.6	60.6	86.5	124.4	95.1	76.4	116.9	106.1	72.4	82.9	32.1	86.6	91.3	70.1	75.6	79.7	55.1	90.8	90.2	165.6	96.8	87.3	67.4	80.4	79.8	68.9	53.3	765.1	30.7	106.9	83.4	86.6	89.0	99.3	39.4	97.9	18.4	71.9	47.8	124.7	84.6	69.0	49.1	40.4	87.6	72.0	177.1	40.1	72.5	97.7	41.4	98.7	83.9	117.5	78.7	106.7	472.6	312.4	47.9	182.4	274.1	127.0	152.9	68.0	142.6	48.4	88.1	257.0	141.3	86.6	114.0	136.0	168.2	92.7	97.7	57.5	100.2	66.5	172.0	104.6	111.6	259.6	175.2	154.2	121.4	200.3	168.1	46.1	63.8	130.7	201.7	109.8	45.5	93.7	73.4	140.8	112.7	43.8	132.6	161.6	182.8	96.8	55.2	51.9	185.8	111.7	118.4	284.2	147.8	97.1	172.5	175.0	91.3	207.7	62.8	38.0	70.7	46.2	139.1	93.0	138.5	269.0	511.1	404.8	156.1	364.9	164.3	106.7	157.3	161.9	341.3	110.3	174.8	159.3	255.9	141.2	378.6	124.2	167.2	692.9	85.6	86.5	76.4	116.9	90.8	90.2	80.4	79.8	83.4	84.6	87.6	98.7	102.3	57.7	65.6	36.2	65.4	97.3	135.4	254.3	46.1	155.8	74.1	61.2	30.4	94.4	175.4	138.0	54.2	173.4	109.6	70.3	62.6	146.6	3.6	97.2	115.5	94.7	57.1	62.3	44.8	59.1	106.3	156.5	34.7	124.5	87.5	63.7	96.0	64.0	702.2	188.4	56.3	54.6	349.9	279.5	263.3	9.5	117.4	222.0	149.4	28.1	185.4	193.0	72.1	40.2	40.6	64.0	58.9	151.2	74.8	97.9	61.0	106.4	127.4	93.3	105.2	116.7	138.7	106.7	43.1	60.0	99.9	174.4	100.3	188.2	63.6	121.1
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522582	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 130.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	17.7	28.2	30.6	18.0	35.2	21.5	16.3	16.8	42.7	13.4	0.0	22.1	34.6	20.9	19.6	17.4	17.1	22.7	18.9	43.6	44.1	37.4	21.0	24.1	13.1	25.6	26.2	20.0	17.4	86.0	39.0	21.2	34.6	17.4	20.5	130.7	13.5	18.6	59.3	28.1	24.3	21.5	12.1	21.8	16.3	18.7	30.9	15.2	30.3	25.3	14.9	11.9	12.8	27.2	18.4	37.0	22.1	40.1	36.5	31.7	12.9	12.7	23.3	26.4	34.2	23.9	39.9	3.4	22.6	26.2	36.2	38.7	34.5	21.5	30.4	28.3	36.2	29.2	27.3	19.0	22.7	12.8	50.9	23.5	30.3	42.4	18.0	32.6	18.9	13.2	108.0	111.3	39.7	15.8	5.1	11.3	14.3	23.9	0.4	0.2	23.0	51.2	30.2	14.4	60.9	32.0	19.7	17.7	37.1	28.8	43.0	19.0	11.4	22.3	0.9	33.0	15.3	45.0	66.1	6.8	29.7	0.2	26.5	21.6	14.5	11.2	1.0	4.4	1.6	4.7	0.7	0.2	12.2	7.3	1.2	0.9	18.7	0.1	3.3	6.2	3.7	6.6	30.6	35.2	16.8	42.7	43.6	44.1	25.6	26.2	34.6	12.1	30.9	27.2	20.0	19.2	48.0	47.0	23.0	19.8	56.7	15.7	32.5	164.8	15.7	16.5	21.1	28.6	18.3	14.7	294.0	34.3	16.7	46.2	11.7	16.3	4.0	32.8	27.4	22.2	84.9	45.8	125.0	18.5	15.7	31.0	23.4	74.0	24.1	74.5	16.4	37.8	53.8	95.9	112.3	27.3	12.2	37.8	29.2	3.9	17.4	42.8	40.9	38.4	17.7	59.3	3.1	61.3	80.5	24.2	37.6	23.7	13.8	32.7	56.9	32.5	11.4	403.4	6.6	39.4	32.3	38.8	18.2	21.7	20.2	99.9	6.9	35.0	24.5	14.9
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	6.6	4.4	5.6	7.0	6.2	10.4	5.7	7.4	6.5	4.7	6.9	5.5	8.7	6.0	3.9	4.3	4.8	3.8	4.7	6.0	6.0	3.8	4.2	6.3	8.3	6.6	5.8	4.1	5.7	3.7	4.9	3.7	6.5	4.7	5.8	6.7	7.6	4.0	6.5	9.4	7.0	5.1	5.6	6.6	8.8	4.9	6.2	7.5	4.8	3.5	8.2	5.3	4.5	7.9	4.8	10.3	12.0	17.8	9.2	7.0	6.7	6.2	6.2	5.4	5.8	6.9	2.7	18.0	4.2	7.6	5.5	9.0	16.1	6.2	4.5	11.4	10.2	27.9	9.2	5.4	10.2	16.8	51.0	6.7	4.4	5.9	7.4	9.0	5.0	15.0	14.5	3.4	8.1	8.4	15.4	24.8	11.5	6.6	6.5	15.7	9.9	6.4	8.3	10.4	7.2	13.6	9.3	6.9	9.4	6.6	5.9	14.4	8.3	8.0	3.1	10.8	9.1	10.8	12.8	14.9	9.4	12.1	6.5	6.3	0.7	13.7	1.7	0.9	1.0	0.9	1.7	1.5	0.8	3.7	1.6	1.8	2.0	1.7	1.5	2.8	1.0	0.8	5.6	6.2	7.4	6.5	6.0	6.0	6.6	5.8	6.5	5.6	6.2	7.9	13.0	6.4	11.0	3.9	20.4	10.1	10.8	4.6	11.4	20.5	7.9	5.3	8.8	12.8	8.3	9.2	12.5	5.2	27.9	17.9	0.0	8.1	10.2	11.0	11.9	10.6	13.2	50.3	21.2	10.9	5.7	11.3	18.3	12.3	75.3	8.7	18.2	11.4	8.4	11.8	19.3	9.8	2.0	9.4	17.2	4.5	8.7	11.3	1.8	7.5	13.2	9.0	25.7	10.6	17.1	9.2	9.0	9.4	19.7	15.7	11.1	4.0	13.5	28.8	6.6	12.4	10.9	23.6	12.6	9.6	14.2	6.8	21.8	5.7	11.4	11.4
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481181	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 380.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	51.3	112.9	103.1	66.9	107.1	82.3	50.3	84.1	118.4	65.2	82.4	89.8	69.0	69.2	56.6	88.6	57.8	55.9	71.5	119.9	145.1	86.2	73.0	78.7	66.9	112.6	107.4	35.1	59.2	116.3	107.7	55.8	136.0	60.5	72.7	41.4	62.8	55.0	127.6	85.9	79.9	79.6	82.6	96.1	69.4	69.5	99.4	64.7	75.1	84.7	64.0	66.8	62.2	98.5	78.9	111.6	67.3	87.5	167.2	91.2	64.3	92.7	149.1	187.0	224.3	116.5	82.6	33.0	74.2	134.7	125.3	91.9	99.0	117.7	108.8	40.3	90.5	60.5	58.4	97.6	159.4	60.5	243.3	139.8	115.1	187.4	44.5	68.2	117.9	38.0	69.7	41.9	151.9	193.7	45.7	134.9	65.2	70.6	77.9	80.2	78.5	92.1	113.3	129.3	130.4	60.4	244.0	65.8	103.1	52.3	104.8	91.1	114.4	93.4	38.6	113.9	49.8	69.5	106.8	94.9	130.1	63.8	56.3	312.7	732.5	542.4	130.1	511.7	89.9	189.4	96.3	120.3	469.2	174.5	73.1	91.3	936.5	155.5	485.5	168.4	128.0	742.7	103.1	107.1	84.1	118.4	119.9	145.1	112.6	107.4	136.0	82.6	99.4	98.5	46.0	16.0	47.2	11.1	80.1	73.8	61.5	138.2	45.5	73.3	65.7	50.5	38.8	54.3	78.0	68.0	73.0	112.1	74.7	258.8	181.9	127.7	109.6	93.3	46.4	42.6	121.9	68.8	22.7	111.0	73.1	61.5	68.3	74.5	50.1	44.2	42.5	50.2	380.4	82.4	25.7	160.2	154.6	149.4	186.7	50.1	58.7	183.1	124.5	7.5	260.9	70.6	77.2	13.6	23.1	102.0	179.5	53.0	57.0	38.8	203.1	173.6	92.7	52.9	118.3	26.6	53.2	125.7	64.0	55.0	87.5	283.6	54.7	91.3	101.6	63.2
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154225	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 60.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.3;SuSa: 5.8;U-87 MG: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	0.3	0.0	0.6	0.7	1.4	1.9	0.8	0.4	0.7	0.4	0.4	3.1	1.6	0.3	1.4	0.7	0.0	0.5	0.4	0.5	0.7	60.5	0.4	2.6	1.3	0.6	1.1	0.0	0.4	1.3	0.0	0.8	0.6	1.4	3.5	14.0	1.1	2.5	0.0	1.7	1.3	0.4	0.3	1.1	0.3	0.2	1.0	0.5	1.0	0.0	1.1	0.5	0.0	1.4	0.4	0.6	0.3	0.4	0.0	0.3	1.3	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.0	1.4	1.2	0.4	0.9	0.2	0.2	0.0	0.5	0.7	0.1	0.0	0.4	0.6	0.3	0.0	0.2	0.4	1.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	2.0	0.1	0.0	0.4	3.3	5.8	0.9	0.0	0.2	0.3	0.4	0.2	0.3	0.2	0.1	0.3	5.1	0.3	0.4	0.7	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.0	0.5	0.2	0.4	0.2	0.1	0.6	1.4	0.4	0.7	0.5	0.7	0.6	1.1	0.6	0.3	1.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.1	7.3	31.3	0.0	0.0	0.0	209.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	30.5	0.0	1.1	0.0	0.0	6.9	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.0	11.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197381-20226819	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 256.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1130.7"	"Group enriched"	"Detected in all"	10	"dendritic cells: 336.8;granulocytes: 1130.7;monocytes: 682.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 317.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		310000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	46.4	76.4	112.6	71.9	111.2	45.7	35.3	72.8	126.0	30.1	72.5	38.0	43.9	29.4	31.0	51.3	32.8	39.0	38.2	124.0	135.5	145.8	49.2	72.7	54.1	103.4	120.0	27.5	34.5	71.4	74.5	50.5	138.2	28.1	43.0	205.7	40.4	27.0	66.7	62.5	57.8	40.1	74.8	66.1	32.8	67.8	100.3	50.2	33.4	64.7	48.9	44.5	36.1	99.5	44.2	71.5	87.4	29.2	117.7	72.3	79.1	96.6	61.5	121.5	125.2	81.7	25.4	77.7	38.4	93.1	123.7	36.8	70.1	64.6	129.0	32.9	47.2	54.2	29.9	63.6	137.6	39.0	108.0	65.0	57.9	76.0	69.3	134.1	77.2	101.2	82.0	72.8	132.5	25.0	114.6	46.2	65.6	64.6	31.5	46.6	113.4	40.8	112.9	68.2	68.0	97.9	46.9	62.7	317.9	72.4	81.6	70.7	82.8	61.1	46.3	101.9	78.5	29.4	42.7	90.9	84.6	91.6	158.4	183.7	682.0	485.9	52.9	618.6	57.7	50.2	54.1	56.8	336.8	44.5	54.4	53.7	1130.7	50.8	576.1	82.7	73.0	622.6	112.6	111.2	72.8	126.0	124.0	135.5	103.4	120.0	138.2	74.8	100.3	99.5	16.6	25.6	20.7	20.5	28.1	58.0	28.4	52.1	33.0	106.1	18.5	15.6	17.6	25.8	28.8	29.5	102.2	109.2	38.9	23.3	80.3	43.2	40.8	20.2	13.6	24.1	74.4	35.8	64.3	38.5	56.4	38.8	25.0	35.9	22.2	22.3	25.7	34.7	178.5	190.1	68.0	21.4	36.7	185.2	178.7	24.4	19.6	167.6	104.9	30.0	169.1	51.5	20.6	27.6	29.0	45.2	19.7	28.2	20.7	17.4	75.0	256.7	18.0	137.8	13.1	29.3	34.2	121.6	55.3	43.3	71.6	124.6	27.1	23.1	24.7	20.1
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 162.7;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	23.8	32.2	31.6	23.8	36.8	9.7	21.6	18.7	38.2	17.8	20.7	15.4	16.1	19.0	14.2	15.6	16.8	19.8	30.1	39.4	28.9	51.7	27.5	18.6	26.2	25.4	24.5	17.7	18.8	39.0	22.2	30.2	31.5	18.3	18.8	36.7	15.3	16.1	17.2	11.9	17.8	20.6	20.2	19.9	17.4	20.9	25.5	21.9	37.8	24.3	24.5	25.2	14.0	26.3	68.4	38.6	20.2	15.6	54.6	39.3	27.7	49.0	49.7	60.6	68.9	30.4	76.7	41.2	58.2	40.8	97.5	29.6	42.4	41.0	87.8	30.3	26.4	39.2	28.0	35.8	59.5	20.8	52.5	28.8	55.4	77.4	36.2	35.6	43.9	28.7	54.6	37.3	71.4	32.1	46.2	16.7	19.1	67.9	37.6	24.6	36.0	36.4	70.3	48.8	28.5	22.6	26.9	26.9	102.0	40.5	58.9	27.8	44.4	33.2	36.1	74.3	35.0	45.1	17.7	42.1	60.2	47.2	33.2	16.8	30.5	38.1	15.1	44.9	17.2	18.7	12.7	15.1	29.0	18.7	14.4	16.0	50.2	18.7	42.7	15.8	23.1	21.1	31.6	36.8	18.7	38.2	39.4	28.9	25.4	24.5	31.5	20.2	25.5	26.3	31.3	32.1	26.4	38.2	22.9	34.9	33.1	31.2	21.1	32.3	21.9	20.6	43.3	15.7	26.5	31.3	16.7	35.4	15.5	14.7	64.6	36.9	162.7	18.3	19.5	25.5	15.6	33.6	64.9	31.5	35.6	28.4	12.2	16.4	24.1	14.0	17.5	19.0	101.8	37.0	56.6	12.4	46.8	47.6	99.6	166.9	24.2	62.8	19.6	36.5	34.3	34.5	14.4	39.2	44.7	30.4	18.2	18.4	25.1	34.7	19.2	139.1	41.2	25.3	19.7	20.7	45.5	11.1	23.4	19.5	32.8	74.8	18.5	17.4	13.5	27.4
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721100-10785110	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 80.3;salivary gland: 103.2;skin 1: 87.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.2;Distal tubular cells: 45.0;Enteroendocrine cells: 41.5;Glandular and luminal cells: 73.4;Ionocytes: 93.6;Syncytiotrophoblasts: 169.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 78.4;SK-BR-3: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	3.4	4.0	1.4	1.7	2.1	4.3	5.7	0.7	1.4	57.5	0.9	2.4	0.9	4.7	80.3	18.3	2.9	0.9	3.0	1.8	0.8	43.3	6.0	2.8	2.0	0.7	0.8	2.9	3.8	1.2	23.5	36.7	0.6	5.1	2.5	1.6	103.2	6.8	1.0	87.6	2.7	0.2	0.6	4.0	2.4	2.0	0.9	0.5	3.8	0.0	5.0	2.0	19.0	1.6	0.6	0.9	2.4	2.7	0.0	0.0	78.4	1.1	0.0	0.0	0.0	1.5	1.9	1.9	1.3	0.0	1.2	1.2	1.3	0.1	0.1	1.1	2.6	0.9	1.4	2.7	0.0	1.8	1.0	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.9	3.6	0.0	2.1	0.7	2.9	1.8	1.1	0.8	1.6	1.4	5.5	0.0	1.7	1.9	2.3	0.7	27.2	0.8	10.0	2.4	4.0	0.4	0.9	1.8	1.1	1.1	6.2	2.5	1.1	1.1	1.5	0.8	0.0	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.4	2.1	0.7	1.4	1.8	0.8	0.7	0.8	0.6	0.6	0.9	1.6	13.6	0.0	2.6	0.3	1.0	0.4	3.7	2.8	1.2	0.0	1.4	1.8	0.9	0.0	6.6	7.3	0.0	147.2	0.8	0.3	45.0	0.1	0.7	31.3	13.4	1.4	41.5	0.0	2.4	0.2	33.0	2.7	1.1	73.4	2.5	0.3	0.0	0.2	13.8	0.0	1.2	0.2	93.6	0.8	0.8	0.4	0.6	0.9	0.0	2.8	0.0	0.0	0.0	0.5	1.3	0.2	0.1	0.0	4.0	1.1	0.0	1.1	4.4	0.0	0.0	0.7	1.2	0.2	1.2	0.6	2.4	169.1	1.0	0.3	0.8	0.4
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 365.9;Proximal tubular cells: 365.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	43.4	116.2	98.0	32.2	103.2	28.8	43.8	91.8	119.7	40.3	101.8	52.9	40.4	34.3	72.5	96.7	48.1	38.7	136.6	107.2	103.5	129.8	51.7	37.5	33.3	96.1	98.4	26.1	36.2	88.8	65.8	43.4	106.7	55.7	57.5	78.0	45.1	49.8	78.5	40.4	41.7	46.4	95.1	24.3	43.8	42.5	99.7	52.4	89.5	108.5	46.3	54.5	54.1	99.6	242.5	64.7	96.2	62.4	80.2	82.8	73.5	199.1	109.4	145.8	109.1	76.2	85.2	24.8	73.9	155.1	105.3	89.2	72.6	117.9	195.7	82.5	50.8	23.4	74.5	51.0	144.0	24.9	64.8	65.1	77.7	105.4	73.1	131.4	97.6	58.6	50.2	55.3	206.6	78.5	66.5	46.2	60.7	104.6	83.3	48.8	84.2	32.8	171.2	104.3	120.2	49.8	122.9	65.4	145.6	96.2	98.3	53.4	123.8	162.4	121.6	77.6	120.1	55.8	46.1	33.4	150.2	44.1	96.1	106.7	77.5	92.8	48.5	78.8	40.8	39.9	53.2	52.7	83.4	42.0	41.6	41.7	94.0	48.9	83.5	73.9	78.8	65.0	98.0	103.2	91.8	119.7	107.2	103.5	96.1	98.4	106.7	95.1	99.7	99.6	31.3	54.5	63.0	13.4	27.6	96.2	66.6	112.3	26.2	60.0	44.8	41.8	160.8	55.8	85.0	82.8	54.2	92.3	51.4	91.6	365.9	125.9	190.3	120.8	44.1	40.7	54.4	78.1	22.7	48.9	85.5	51.5	42.3	71.8	41.2	39.8	27.5	45.8	132.0	87.5	21.0	49.4	175.0	44.6	61.0	97.9	32.9	62.2	80.0	6.5	58.5	89.4	47.4	9.5	22.1	121.5	78.7	50.8	21.3	65.9	80.9	365.5	184.1	94.2	13.1	44.5	64.1	100.1	61.5	78.4	138.4	205.9	40.8	71.6	40.6	113.8
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628749	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		34000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	119.5	165.0	209.8	68.3	220.9	90.4	109.5	214.3	287.3	101.7	200.4	128.9	56.6	112.2	135.8	117.2	96.0	84.7	224.9	231.8	226.9	230.5	85.6	110.3	88.6	220.3	202.3	81.9	59.5	239.9	117.1	113.8	230.8	95.0	99.7	128.4	83.7	126.4	232.8	120.3	83.1	121.0	215.9	99.0	101.8	67.3	218.1	108.2	100.8	178.6	109.5	114.5	97.6	245.6	121.8	108.6	96.4	94.3	314.4	169.6	106.0	159.3	212.0	198.7	228.0	137.3	97.5	76.1	132.8	215.0	251.8	187.9	152.8	140.2	174.9	145.9	173.3	137.1	97.5	182.7	459.9	159.8	226.5	212.9	267.7	192.4	138.7	220.9	170.2	95.0	174.8	150.3	341.9	127.4	136.5	114.5	71.0	269.6	152.6	80.3	140.7	45.7	331.6	189.0	70.3	122.7	146.0	101.0	358.9	187.0	98.6	180.4	146.3	137.5	72.6	174.0	119.2	145.7	275.5	96.3	221.2	76.7	189.3	178.1	106.3	184.7	64.0	100.9	63.0	78.7	64.7	61.5	83.6	59.8	60.8	63.7	137.6	76.0	120.5	81.2	97.7	112.8	209.8	220.9	214.3	287.3	231.8	226.9	220.3	202.3	230.8	215.9	218.1	245.6	66.5	76.9	83.4	13.4	47.1	41.9	77.6	121.8	19.9	54.6	33.9	34.8	126.8	74.4	83.9	138.0	27.1	235.1	63.8	105.2	461.8	143.8	7.6	74.3	56.9	69.3	41.9	49.4	24.9	119.7	143.9	60.8	40.8	79.2	90.5	41.6	72.5	46.8	186.8	53.8	24.4	54.0	116.0	75.1	52.1	17.9	94.1	91.9	80.0	15.0	144.1	94.1	85.5	13.0	31.9	154.7	104.7	97.8	38.3	60.1	65.4	411.3	78.8	50.4	59.2	39.0	74.5	71.7	74.7	34.3	51.6	479.1	54.6	57.6	40.1	93.1
ATP6V1E2	"ATP6E1, ATP6EL2, ATP6V1EL2, MGC9341, VMA4"	ENSG00000250565	"ATPase H+ transporting V1 subunit E2"	Q96A05	2	46490750-46542577	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 28.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 350.9;Late spermatids: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075092	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA075092: "	"unprognostic (1.62e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-2)"	1.8	2.3	4.1	1.4	4.2	0.9	2.1	3.6	4.4	1.5	3.1	1.7	0.4	1.5	6.4	1.2	1.4	0.7	1.6	3.8	3.7	2.1	1.9	1.2	1.7	4.0	3.8	1.7	2.8	1.7	2.8	1.1	4.0	2.9	0.7	2.4	2.4	1.6	3.4	2.9	1.4	0.8	4.0	2.0	1.6	28.4	3.8	1.2	1.4	1.4	1.6	1.8	1.6	4.0	8.6	5.5	1.8	4.2	1.7	3.1	0.9	2.9	1.1	1.3	0.6	1.7	1.4	5.1	5.2	2.8	4.2	2.0	4.2	2.1	2.8	7.8	3.3	1.2	1.0	1.2	1.9	2.2	2.4	2.6	19.2	1.8	4.0	1.5	1.3	5.4	3.6	8.8	0.9	5.6	1.5	6.6	3.5	4.4	4.6	3.7	4.4	6.4	2.6	1.9	4.8	10.3	1.9	2.0	4.3	3.0	1.3	1.0	1.3	1.4	5.1	2.5	2.1	4.3	3.7	5.3	2.0	6.6	2.3	0.0	0.8	0.2	0.8	0.4	1.1	0.8	1.5	1.6	0.7	1.0	1.1	1.6	0.5	0.3	0.5	1.7	1.0	0.5	4.1	4.2	3.6	4.4	3.8	3.7	4.0	3.8	4.0	4.0	3.8	4.0	4.7	3.2	0.5	5.5	12.9	5.7	11.3	1.7	8.6	11.8	14.8	18.5	6.7	5.7	2.4	3.7	12.5	2.9	4.0	2.5	9.8	3.3	350.9	3.8	7.8	3.1	3.5	2.5	7.2	3.3	2.2	9.8	5.1	3.9	0.0	5.0	5.0	2.7	2.2	18.5	6.8	2.1	0.0	7.7	5.1	196.3	9.9	5.9	5.4	1.0	7.0	16.5	6.2	4.5	7.4	3.3	0.1	6.8	7.0	5.5	0.3	7.1	3.9	25.8	6.6	6.8	7.4	7.7	10.4	5.0	8.1	0.8	7.8	2.7	3.1	3.8
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862856-128865847	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1054.6;Hofbauer cells: 1132.8;Proximal tubular cells: 1076.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	133.3	160.7	275.6	106.2	290.1	210.4	122.3	272.7	368.6	126.5	250.2	104.6	74.7	95.3	61.7	223.0	98.3	104.2	183.3	294.8	300.1	307.0	84.2	140.0	139.9	280.1	275.3	89.0	106.8	163.5	141.0	104.6	286.0	103.0	56.6	110.6	129.3	81.6	169.3	170.1	97.0	71.2	269.5	119.6	114.4	212.2	284.3	119.6	84.6	154.7	103.7	123.1	146.6	277.4	305.6	345.1	151.2	323.2	297.6	236.8	86.9	151.2	201.3	246.8	267.2	257.0	179.8	287.6	156.5	175.7	367.7	163.9	224.5	250.1	91.9	312.6	364.2	220.1	211.4	256.4	344.1	227.1	400.8	278.2	340.0	284.7	163.4	188.9	238.1	257.9	534.3	297.3	276.3	403.1	381.0	494.3	201.9	190.6	281.4	168.7	110.1	467.5	315.5	240.3	286.6	197.3	214.1	796.5	363.7	156.6	184.4	284.9	253.0	303.5	65.3	409.5	236.2	333.5	326.9	372.0	600.4	315.5	263.6	370.2	697.1	489.2	244.6	475.1	238.0	343.7	247.6	239.7	508.9	348.5	235.8	238.6	203.1	243.6	324.7	288.3	317.3	886.1	275.6	290.1	272.7	368.6	294.8	300.1	280.1	275.3	286.0	269.5	284.3	277.4	129.3	28.9	62.8	17.3	140.1	237.6	202.5	378.9	136.6	111.4	162.0	190.1	157.6	127.2	230.7	331.1	37.5	171.8	119.8	97.3	1054.6	241.0	574.0	128.6	96.3	163.1	113.2	63.1	27.0	222.2	289.0	155.1	78.5	131.0	275.1	114.0	124.6	112.0	1132.8	545.1	34.6	108.7	585.9	320.6	378.7	898.9	164.4	456.1	254.3	16.9	285.8	230.4	190.5	11.6	26.2	253.9	93.0	127.9	136.8	224.7	212.0	1076.3	200.2	96.4	85.5	69.7	168.9	399.6	102.0	328.4	326.6	401.4	136.3	184.5	98.9	362.7
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544444-31548427	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 97.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 83.7;Cone photoreceptor cells: 14.6;Enteroendocrine cells: 14.3;Horizontal cells: 30.3;Muller glia cells: 25.1;Rod photoreceptor cells: 14.1"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HSkMC: 3.2;Karpas-707: 6.7;RPMI-8226: 4.9;SCLC-21H: 9.5"									"CAB004616, HPA068667"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	1.0	2.3	53.0	0.7	61.0	0.1	0.9	77.1	97.0	1.7	21.3	4.6	0.3	1.6	0.2	0.7	1.6	1.0	2.8	60.0	52.0	2.7	0.8	1.3	0.5	51.3	43.7	3.0	0.8	0.0	9.2	0.0	51.1	2.0	0.3	13.7	0.8	0.0	1.8	0.7	2.8	0.4	43.3	2.8	1.7	1.9	52.4	0.0	3.0	0.0	0.5	1.1	2.1	75.1	0.0	0.5	2.6	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.8	0.0	0.0	0.5	3.2	0.5	0.7	0.1	1.4	0.0	0.9	0.7	6.7	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.2	0.0	4.9	0.0	0.0	9.5	2.3	0.0	0.2	0.0	0.0	0.8	1.4	0.8	0.5	0.1	0.0	0.0	0.3	0.4	0.3	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	53.0	61.0	77.1	97.0	60.0	52.0	51.3	43.7	51.1	43.3	52.4	75.1	0.9	0.0	0.5	0.0	1.2	0.4	0.3	0.4	0.0	83.7	0.7	0.8	2.3	0.0	0.1	1.8	14.6	0.2	0.1	0.3	9.8	0.3	0.0	0.1	2.6	1.2	14.3	0.4	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.2	0.0	0.2	0.6	30.3	0.0	0.5	2.0	0.0	1.1	0.2	0.9	0.4	1.8	0.0	0.1	25.1	1.0	0.0	0.0	0.1	0.0	2.2	0.5	0.1	0.7	7.8	0.0	14.1	0.0	1.7	3.2	0.1	2.0	0.4	0.1	0.1	1.5	0.4	0.1	0.1
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"kidney: 59.3"	"Cell type enriched"	"Detected in some"	48	"Distal tubular cells: 444.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028701	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.1	0.8	0.3	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	444.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715543-53843558	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		8300	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	24.1	44.6	42.5	15.9	46.7	25.6	26.0	27.5	58.8	23.9	30.2	31.6	12.9	25.4	32.9	34.1	22.6	20.7	31.2	57.4	38.0	60.5	19.1	24.2	21.4	30.5	30.2	24.1	17.4	47.7	42.4	23.9	32.7	30.2	20.4	37.4	28.7	27.4	37.8	35.2	19.1	24.1	29.4	20.3	31.8	18.5	31.0	26.6	52.4	27.3	22.0	28.5	26.4	37.9	42.8	35.6	29.8	31.8	50.9	32.9	23.4	40.5	44.5	54.8	56.7	33.5	54.1	27.2	38.7	40.9	69.7	67.8	52.6	58.9	56.1	39.9	35.8	28.8	34.3	40.9	69.1	19.6	31.8	46.5	82.3	37.2	66.4	52.5	37.8	28.9	39.4	14.0	81.6	36.0	30.6	32.5	27.4	37.0	17.4	28.2	10.6	18.6	88.4	67.4	23.5	34.9	28.7	54.6	79.5	34.4	64.0	16.3	43.2	24.4	19.7	54.6	25.5	25.9	30.4	32.3	57.8	27.4	27.5	25.7	14.8	36.2	13.2	16.6	14.9	13.6	14.3	15.4	20.2	12.0	14.4	16.0	14.5	22.6	23.4	15.9	20.7	11.8	42.5	46.7	27.5	58.8	57.4	38.0	30.5	30.2	32.7	29.4	31.0	37.9	18.2	38.5	27.4	84.2	39.0	29.6	40.1	55.5	42.1	72.8	27.8	21.0	28.9	38.6	50.3	58.8	112.6	76.0	35.9	39.0	105.7	49.1	8.3	94.1	27.7	25.4	35.3	27.0	154.7	31.1	43.6	23.6	26.0	145.7	15.8	22.0	28.9	21.9	64.7	62.2	105.8	17.4	75.3	43.0	103.6	8.5	43.2	52.9	30.2	42.2	35.1	48.4	37.0	58.3	57.7	44.1	30.1	48.2	20.9	32.5	31.4	64.9	39.6	76.4	19.7	16.8	24.6	28.5	52.9	37.6	31.4	100.0	38.1	36.4	21.8	41.4
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325525-154351304	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.8;Excitatory neurons: 28.5;Inhibitory neurons: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.9;fHDF/TERT166: 112.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046680, HPA061103"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046680: AB_2679749, HPA061103: "	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	17.2	9.5	8.2	22.7	7.8	5.4	14.0	18.8	11.0	28.7	20.7	17.8	12.5	39.2	17.7	11.0	30.8	18.2	15.2	10.8	9.2	6.3	3.4	18.0	25.4	8.9	8.1	35.3	5.9	10.5	19.3	15.3	9.6	18.9	9.1	2.1	7.2	21.2	3.5	8.5	17.6	39.7	5.6	19.5	14.5	16.3	8.8	18.4	15.0	7.4	19.6	19.7	17.9	7.7	2.1	15.6	20.0	20.5	120.9	80.4	0.3	41.8	77.4	26.1	30.5	0.3	0.6	1.9	21.4	112.4	17.7	9.2	23.0	5.5	19.3	46.6	16.8	19.7	20.4	18.9	37.2	0.1	14.8	53.4	1.3	40.6	38.7	35.6	40.0	25.1	37.6	47.8	22.7	21.8	36.2	2.5	43.7	0.4	17.4	39.9	12.7	71.5	5.3	0.4	17.4	22.7	11.3	2.8	30.3	28.3	14.9	15.3	34.7	40.2	19.2	51.4	13.5	58.0	75.7	11.1	14.1	2.2	24.7	2.8	0.0	1.7	1.1	0.0	0.7	0.3	1.7	1.9	0.0	0.2	1.4	1.2	0.0	0.5	0.0	0.3	3.7	0.5	8.2	7.8	18.8	11.0	10.8	9.2	8.9	8.1	9.6	5.6	8.8	7.7	6.4	3.2	4.5	26.8	7.7	2.5	1.4	0.9	0.0	4.5	1.9	2.3	6.2	0.0	1.9	0.0	2.1	0.1	16.0	0.1	0.0	1.6	0.6	6.5	20.5	9.0	0.0	0.4	28.5	0.2	0.5	12.8	0.5	2.4	7.6	10.8	13.6	0.8	0.4	8.4	31.7	0.2	0.0	1.0	4.2	1.4	11.5	1.3	7.2	4.7	0.9	3.4	7.2	4.0	4.2	0.9	0.0	14.7	13.9	5.6	0.0	0.2	4.4	0.5	0.0	9.5	11.2	2.6	4.3	0.6	1.6	0.3	17.2	6.7	0.1	0.8
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.1"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.3	2.5	2.4	78.1	0.7	3.5	6.5	1.5	3.0	1.1	0.7	6.4	4.2	0.5	3.1	2.2	0.4	4.5	2.9	1.2	1.6	1.1	1.0	2.5	2.6	0.4	0.5	0.2	0.3	3.5	2.8	0.6	1.7	0.1	0.5	0.8	0.1	0.3	1.3	3.1	3.1	2.6	0.6	0.4	2.4	0.5	0.1	0.1	1.0	1.4	0.4	4.9	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.3	2.4	3.5	6.5	4.5	2.9	2.5	2.6	2.8	3.1	2.4	4.9	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
ATP9A	"ATPIIA, KIAA0611"	ENSG00000054793	"ATPase phospholipid transporting 9A (putative)"	O75110	20	51596514-51768390	"Enzymes, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 112.2;Inhibitory neurons: 87.1;Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 74.0;SK-BR-3: 69.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020699, HPA035630"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB020699: , HPA035630: AB_10669526"	"unprognostic (5.19e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.67e-5)"	"unprognostic (5.82e-2)"	"unprognostic (5.81e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	30.6	11.5	55.9	5.8	63.2	2.7	14.1	26.0	63.7	8.5	0.0	18.5	13.6	12.4	18.5	12.9	24.8	12.0	11.6	67.1	52.2	9.2	7.5	9.7	3.7	41.8	50.0	18.8	15.1	29.5	16.2	4.9	46.8	20.5	16.4	20.5	25.7	15.5	16.3	6.8	17.8	12.7	33.2	2.9	20.4	18.8	53.4	7.4	28.1	17.6	3.1	11.9	9.8	48.7	25.8	21.7	17.2	38.8	49.0	36.8	0.4	9.1	17.1	5.8	1.7	50.4	51.9	0.0	74.0	37.2	29.1	20.1	22.9	12.9	5.7	20.2	7.1	0.0	23.2	19.8	6.7	0.0	0.1	12.1	25.6	1.3	3.5	13.3	31.4	4.7	0.1	0.2	6.6	35.9	2.0	0.2	3.1	25.4	27.0	4.1	0.0	0.1	11.6	35.7	32.7	23.2	36.3	69.9	13.2	6.0	13.5	0.6	20.7	48.1	12.7	19.1	3.9	0.0	0.3	0.8	12.7	0.1	4.4	4.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.7	55.9	63.2	26.0	63.7	67.1	52.2	41.8	50.0	46.8	33.2	53.4	48.7	4.8	16.0	13.6	43.4	0.5	2.9	14.6	13.8	4.0	35.9	16.0	11.3	12.7	31.5	19.1	18.4	4.2	0.4	2.5	64.3	1.9	21.4	0.8	20.4	4.7	9.8	55.2	0.8	112.2	17.2	0.5	9.9	26.5	28.8	1.3	14.3	11.0	12.8	5.4	43.7	87.1	34.9	18.3	2.2	2.1	3.4	13.4	12.1	3.6	40.3	0.2	5.0	2.1	60.8	90.3	24.6	28.8	23.3	2.1	33.7	36.3	1.4	34.9	7.4	6.6	10.1	8.0	1.2	8.2	9.9	4.1	0.3	2.3	0.7	24.8	27.3
ATP9B	ATPIIB	ENSG00000166377	"ATPase phospholipid transporting 9B (putative)"	O43861	18	79069285-79378287	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 128.2;Alveolar cells type 2: 156.2;Excitatory neurons: 126.0;Inhibitory neurons: 115.0;Oligodendrocyte precursor cells: 114.6;Oligodendrocytes: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029364	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA029364: AB_10602595"	"unprognostic (2.84e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.66e-4)"	"unprognostic (2.45e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-2)"	8.7	8.1	11.3	8.4	17.7	30.6	9.1	31.9	24.9	8.3	10.9	8.6	6.2	11.1	9.9	9.7	9.2	8.5	7.2	15.2	9.6	10.9	16.2	10.3	9.3	6.0	3.7	14.1	9.2	15.2	4.8	9.6	7.5	10.8	9.7	22.6	10.3	8.1	10.4	11.8	7.6	8.0	2.6	8.8	10.3	19.1	6.6	9.3	12.4	5.8	7.2	7.6	5.5	35.1	25.0	11.7	15.9	17.5	7.9	13.4	12.3	12.1	7.9	6.9	5.8	12.3	15.9	12.5	20.4	8.7	6.5	10.1	13.0	6.7	11.2	19.6	5.6	14.8	13.7	9.0	10.6	27.1	15.1	10.7	8.3	11.1	6.9	10.3	9.7	15.0	14.3	31.7	9.7	20.0	17.5	10.5	23.3	14.5	14.1	16.8	13.2	17.3	9.7	19.6	11.7	12.5	13.3	14.6	8.4	27.2	16.8	15.9	17.4	14.6	24.2	6.6	8.0	16.0	27.5	27.8	8.7	17.6	15.5	11.7	8.7	7.1	6.0	7.5	6.9	6.6	6.7	5.9	6.3	7.0	8.5	6.5	9.8	6.8	13.6	6.0	6.0	5.7	11.3	17.7	31.9	24.9	15.2	9.6	6.0	3.7	7.5	2.6	6.6	35.1	14.3	128.2	156.2	91.1	19.6	5.7	8.5	5.4	14.8	35.7	9.6	8.8	10.1	14.3	55.6	9.2	41.7	7.0	20.6	8.4	1.9	6.1	26.7	8.4	20.5	17.6	12.0	5.5	126.0	5.6	3.9	19.2	30.1	11.8	43.6	21.5	11.4	7.7	14.1	42.1	115.0	8.6	2.0	15.7	9.9	45.3	15.8	25.7	7.2	85.3	11.4	13.2	14.4	114.6	157.2	7.9	10.2	11.3	20.3	6.1	5.9	4.0	95.6	38.1	6.6	17.8	13.0	40.1	25.0	9.3	7.2	7.7	27.3	18.0	10.1	8.0
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 263.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 284.7;Distal tubular cells: 172.1;Early spermatids: 261.4;Late spermatids: 373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	66.0	89.9	87.5	23.3	94.4	27.4	30.2	97.1	115.2	30.0	102.8	44.9	35.3	22.5	29.4	30.1	27.3	25.8	221.0	82.9	107.7	97.1	95.3	21.9	27.9	85.8	85.6	28.8	41.2	121.5	43.8	32.3	85.3	32.2	48.1	63.9	48.4	29.0	221.0	20.1	35.2	32.3	80.7	21.6	42.1	41.5	90.6	37.8	37.1	263.4	28.5	26.4	20.2	82.2	57.8	46.1	61.1	54.8	65.1	52.3	51.0	42.2	52.6	62.0	49.7	37.2	24.5	34.1	55.2	53.6	54.9	43.6	97.3	54.7	83.1	75.0	76.7	60.2	54.5	65.0	52.4	60.2	3.4	51.4	64.3	66.5	57.7	49.2	39.3	62.8	28.2	65.4	48.0	52.3	89.3	33.3	96.3	49.8	68.8	38.1	16.5	74.3	71.4	45.2	71.8	53.8	71.4	74.9	114.6	70.0	69.3	83.8	34.4	21.1	52.1	43.1	58.5	80.6	78.9	23.2	34.7	23.0	40.6	0.0	1.6	4.1	2.1	2.8	2.7	1.8	2.2	2.5	1.6	1.2	3.1	1.4	1.3	5.6	1.2	1.2	4.5	1.2	87.5	94.4	97.1	115.2	82.9	107.7	85.8	85.6	85.3	80.7	90.6	82.2	12.6	3.2	18.6	31.0	22.3	9.4	21.2	9.7	27.3	34.0	27.8	19.4	284.7	31.5	13.1	31.3	27.1	64.0	14.5	26.7	172.1	22.1	261.4	15.6	15.4	13.2	19.2	31.3	37.1	20.1	30.0	28.5	29.0	15.9	15.9	40.6	10.4	39.8	39.2	47.1	48.5	38.1	16.2	21.6	12.9	373.7	19.0	16.1	24.9	15.9	14.6	39.2	15.5	28.1	33.7	11.3	18.0	26.7	36.3	15.2	30.2	119.1	10.2	29.2	26.3	25.1	28.9	45.2	40.4	34.3	13.5	46.9	19.2	55.1	42.2	21.9
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 104.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023329: AB_1845209, HPA059422: AB_2684011"	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	8.6	18.5	7.4	8.6	7.6	15.9	8.7	8.3	11.1	8.4	8.3	11.1	8.7	6.8	8.7	14.4	8.1	4.9	23.9	7.5	9.1	16.1	19.7	7.8	10.5	7.9	8.1	7.3	9.8	26.3	9.3	7.7	8.4	9.1	10.4	6.4	10.7	6.6	24.7	14.6	10.2	8.4	7.8	10.4	12.0	10.9	7.8	10.8	10.6	27.8	14.5	9.1	9.5	8.4	13.0	24.1	15.4	14.7	15.1	16.2	15.6	11.2	16.4	23.7	20.1	31.8	19.3	26.0	24.6	19.5	13.1	19.9	14.8	24.1	20.7	20.9	11.7	5.8	14.8	18.6	25.5	8.2	17.3	19.5	16.8	21.4	11.9	16.7	27.4	21.3	9.3	8.9	13.1	26.8	19.4	12.8	10.4	48.3	13.3	19.8	27.1	29.9	19.0	11.4	9.9	13.5	14.9	7.6	14.0	104.2	24.4	16.2	11.6	6.0	12.4	22.2	10.9	6.2	8.4	9.6	10.7	11.9	31.4	7.8	41.5	14.7	9.3	28.6	10.4	27.9	6.9	8.9	49.2	19.7	10.7	8.0	3.0	8.9	22.3	41.6	12.9	20.7	7.4	7.6	8.3	11.1	7.5	9.1	7.9	8.1	8.4	7.8	7.8	8.4	8.8	6.4	7.8	9.4	20.3	15.3	12.0	23.7	9.6	10.5	13.9	10.8	28.2	20.0	14.4	12.9	33.3	32.5	20.7	10.9	66.5	19.3	52.9	10.5	6.0	10.0	14.5	13.7	13.7	12.3	30.9	9.1	8.2	8.5	13.3	25.7	9.3	20.8	45.5	10.1	14.1	18.2	16.2	22.3	22.5	42.6	6.5	18.2	17.8	7.5	28.1	13.8	13.4	9.0	9.6	16.0	24.4	6.8	18.6	13.8	25.8	58.8	17.2	17.7	0.0	8.4	10.4	28.2	20.9	17.6	18.9	28.7	9.0	15.9	20.5	12.3
ATRAID	"APR3, C2orf28, HSPC013, p18"	ENSG00000138085	"All-trans retinoic acid induced differentiation factor"	Q6UW56	2	27212027-27217178	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051353	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051353: AB_2681451"	"unprognostic (4.58e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.92e-1)"	86.5	79.6	57.3	48.0	62.2	72.2	109.9	62.7	70.8	108.8	73.8	82.0	59.8	82.1	343.6	59.1	123.7	68.0	129.7	56.9	61.8	133.2	72.0	74.8	63.8	64.5	60.1	119.6	120.2	120.5	40.7	74.8	64.2	81.5	92.3	56.7	107.7	107.3	142.6	55.9	59.4	72.7	61.7	64.4	73.3	96.1	59.3	68.4	114.1	139.1	66.2	79.2	38.1	66.4	126.9	145.6	82.4	144.9	408.7	242.2	126.9	75.6	227.6	93.8	87.0	116.2	184.4	63.5	126.6	201.3	134.8	108.7	75.9	132.2	81.1	101.2	77.2	75.0	79.4	182.6	185.9	65.2	93.6	192.5	275.5	80.2	179.3	213.3	123.7	110.5	76.4	191.7	144.5	161.8	78.8	174.0	124.0	263.3	123.0	70.5	218.7	293.2	161.2	68.6	90.7	136.5	89.7	112.4	122.8	118.4	96.3	98.5	82.8	147.9	87.4	54.1	77.8	302.4	249.6	166.2	152.9	124.8	143.5	188.4	242.1	206.7	198.5	223.2	202.9	278.5	227.6	226.9	251.1	271.1	238.8	219.6	54.1	189.1	240.7	293.2	277.5	443.1	57.3	62.2	62.7	70.8	56.9	61.8	64.5	60.1	64.2	61.7	59.3	66.4	143.0	60.9	82.1	7.8	96.4	102.2	176.4	306.4	112.1	44.2	135.0	155.7	163.2	114.4	169.9	143.5	18.8	273.0	95.0	68.6	181.9	182.5	159.6	113.7	109.5	118.4	91.8	47.1	4.3	191.3	328.2	200.0	57.6	96.8	90.7	124.6	113.2	82.7	209.4	28.6	6.6	134.6	205.4	110.7	104.8	223.9	196.3	100.9	176.1	9.4	157.6	153.9	92.7	9.5	13.9	126.1	123.1	141.1	177.0	109.6	135.1	212.0	160.8	48.9	52.6	103.8	137.8	374.7	162.6	110.2	100.7	250.5	93.5	167.8	137.6	153.7
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.9"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033109: AB_634993, HPA047590: AB_2680094"	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	3.8	2.6	2.0	3.7	2.1	5.0	3.8	3.9	2.3	3.9	2.2	3.1	2.4	3.4	1.4	3.7	3.0	2.0	2.4	2.0	1.7	3.1	2.5	3.6	3.6	2.0	1.9	3.6	2.7	4.0	1.8	3.2	1.9	3.0	3.5	2.7	2.5	3.6	4.7	4.4	2.6	3.0	1.6	3.0	2.8	14.9	2.0	4.9	5.4	3.0	4.9	3.3	3.5	2.3	8.7	3.7	9.7	7.4	5.6	9.5	10.2	13.1	6.0	15.7	12.8	5.1	6.3	19.3	5.9	5.4	7.3	9.2	10.9	10.2	15.1	11.5	5.6	14.9	19.1	3.7	3.2	15.0	9.7	3.8	3.1	8.5	4.0	3.5	7.0	7.1	12.0	9.6	14.7	4.9	12.6	5.4	7.5	4.4	10.5	8.5	8.7	13.7	5.3	4.3	4.7	6.9	10.4	10.5	3.9	8.5	8.8	5.7	8.1	10.7	7.0	13.0	15.3	11.6	20.0	13.6	5.7	11.2	6.0	0.2	0.7	0.0	1.1	0.3	0.1	0.3	0.9	0.5	0.5	0.2	0.7	1.0	0.5	0.5	0.6	1.1	1.2	0.7	2.0	2.1	3.9	2.3	2.0	1.7	2.0	1.9	1.9	1.6	2.0	2.3	4.3	0.0	1.5	2.0	0.9	2.9	0.0	0.9	0.0	1.0	4.1	4.7	1.6	0.0	2.0	0.0	2.1	0.2	4.4	2.4	0.0	3.6	0.0	3.8	6.4	2.3	0.0	0.4	3.2	3.9	0.1	2.2	1.5	5.8	0.0	5.5	0.0	0.0	0.1	1.7	3.2	1.7	2.0	0.0	0.5	0.0	0.0	2.5	0.0	1.9	1.6	0.5	3.1	2.0	3.3	4.1	1.1	0.0	0.7	0.0	0.0	2.1	3.6	2.1	0.0	0.0	4.5	0.0	0.0	0.0	3.8	0.1	2.2	4.2	1.3	0.0
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471018-3651118	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		27000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.8	19.1	10.5	10.3	12.2	8.6	17.2	9.3	13.2	16.5	8.9	11.8	55.8	11.8	15.6	10.4	11.7	13.9	19.1	13.4	12.2	23.9	62.8	14.4	7.5	8.0	8.7	14.0	20.2	40.1	8.7	22.6	9.0	12.8	12.3	24.2	13.9	13.2	11.6	14.9	33.4	14.9	11.3	13.8	24.0	16.6	10.8	7.8	32.3	14.2	9.6	15.7	9.1	15.8	40.8	37.6	21.9	18.4	37.9	61.5	28.1	26.6	37.5	27.4	23.1	16.3	27.1	0.0	17.5	37.4	33.8	55.6	15.0	58.1	36.4	4.5	12.8	12.7	10.0	35.1	22.8	27.2	8.3	33.1	46.0	29.0	27.8	34.3	36.0	8.7	20.2	19.2	27.0	11.7	11.1	10.4	14.7	13.2	22.3	9.2	50.9	30.8	24.8	28.5	12.9	20.2	26.7	48.9	36.3	21.3	26.2	25.5	44.7	29.0	17.0	30.8	26.6	13.4	20.1	0.1	17.9	17.9	29.6	3.6	3.2	2.0	2.3	2.8	1.0	1.4	1.2	1.4	2.8	1.7	2.0	1.7	0.0	1.5	3.1	2.6	1.8	1.0	10.5	12.2	9.3	13.2	13.4	12.2	8.0	8.7	9.0	11.3	10.8	15.8	11.1	16.0	10.4	70.2	5.8	6.4	4.3	14.1	6.8	22.5	9.9	8.8	12.6	20.0	10.3	11.0	37.5	7.4	8.0	6.5	1.9	8.2	7.1	9.9	15.1	11.1	9.6	7.4	101.6	14.6	8.4	12.7	20.4	11.8	7.0	39.3	17.9	50.9	10.4	37.0	101.1	10.7	4.1	14.2	6.7	5.4	12.5	11.5	7.2	64.6	10.1	11.8	5.2	89.5	85.7	10.0	14.3	7.9	11.4	7.0	34.6	7.3	10.2	20.1	32.9	14.3	10.9	21.3	21.1	8.5	7.2	5.1	5.8	21.0	12.6	5.2
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX chromatin remodeler"	P46100	X	77504880-77786233	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	18.0	15.9	17.3	17.6	20.4	29.9	18.1	32.9	20.4	18.0	21.4	12.7	11.2	21.2	14.8	13.3	11.8	14.7	15.5	19.2	19.8	16.9	13.2	13.4	22.6	15.0	20.1	24.9	13.4	23.2	8.5	16.6	16.6	19.2	13.5	26.8	14.0	14.8	19.1	15.6	10.9	15.6	16.4	22.8	16.5	6.6	22.6	25.7	20.0	26.9	18.6	14.1	9.9	19.7	36.0	55.1	60.1	45.0	31.8	38.1	21.2	29.4	27.3	21.8	25.9	19.6	30.7	48.5	29.9	32.5	39.9	30.0	44.6	18.1	37.5	27.3	30.8	29.3	67.2	16.2	16.1	38.4	10.2	25.5	20.2	32.2	30.4	29.4	41.9	30.3	34.9	53.3	29.3	27.6	30.2	25.0	42.0	17.6	42.5	48.6	76.3	26.0	25.6	46.4	33.1	55.5	60.5	23.1	21.9	37.2	18.6	20.8	55.8	32.8	76.1	34.4	21.0	16.3	52.9	42.1	23.0	30.9	27.8	44.0	10.5	22.7	26.0	13.3	25.2	31.2	24.0	20.9	8.1	32.4	24.6	20.1	33.2	23.2	20.0	20.7	22.2	9.7	17.3	20.4	32.9	20.4	19.2	19.8	15.0	20.1	16.6	16.4	22.6	19.7	201.0	160.3	230.1	157.4	176.6	92.4	112.2	71.3	114.9	220.1	87.8	86.7	277.8	60.1	101.5	71.7	212.7	72.2	176.9	49.0	23.5	91.8	4.7	103.1	195.5	162.8	126.8	105.8	197.8	83.1	51.0	134.3	114.2	137.3	113.1	261.4	97.8	56.7	70.9	158.2	246.9	78.0	69.2	87.0	101.6	12.7	162.4	113.1	62.2	195.8	149.0	112.3	183.4	202.5	237.1	92.0	47.6	208.0	183.9	120.8	49.2	37.2	102.6	245.4	92.1	174.7	160.0	19.8	52.8	78.7	84.4	59.8	158.0	312.4	73.3	112.0
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		40000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA049531: AB_2680806"	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	40.9	59.5	42.2	34.7	46.1	41.9	41.7	35.3	56.8	50.6	26.9	43.7	23.8	50.0	39.0	46.4	56.1	39.6	74.5	50.2	49.6	53.5	64.8	38.2	48.3	37.6	40.1	57.7	57.4	64.9	56.1	48.8	42.1	46.5	36.3	55.1	41.6	40.9	70.6	34.9	27.8	50.2	42.5	34.2	34.4	57.3	46.5	65.9	63.0	59.3	51.6	51.1	45.8	44.5	163.4	84.9	156.2	95.0	70.5	107.6	85.4	181.0	194.3	128.1	139.4	42.9	106.4	169.3	73.2	184.5	66.4	94.4	114.3	121.3	137.7	32.8	119.4	78.9	141.7	79.8	101.9	213.1	56.4	109.0	82.9	66.5	103.1	153.1	96.3	76.2	58.7	89.8	197.2	69.6	116.7	95.6	104.2	90.8	64.0	166.2	60.7	135.9	162.6	152.3	86.9	136.6	113.5	67.2	129.2	119.8	101.4	111.9	87.6	127.5	47.7	46.0	61.4	87.8	57.3	136.8	79.5	88.5	138.5	80.5	99.9	91.8	69.0	121.7	92.3	72.1	68.0	84.3	163.9	72.6	74.4	71.9	4.7	86.2	138.5	58.1	70.8	120.2	42.2	46.1	35.3	56.8	50.2	49.6	37.6	40.1	42.1	42.5	46.5	44.5	38.1	35.3	33.3	127.3	50.6	50.5	124.2	156.0	68.9	66.3	45.4	50.0	94.2	65.8	76.7	58.8	20.9	101.9	32.3	17.1	68.4	91.1	69.2	53.7	53.7	44.4	60.3	63.1	148.6	69.5	106.3	70.7	34.1	49.8	39.9	93.5	36.4	54.9	72.2	70.7	157.9	35.4	79.3	49.0	36.5	40.6	57.5	48.3	24.9	103.0	67.9	79.3	27.8	186.5	168.1	51.6	24.0	75.6	53.3	115.2	18.6	66.9	67.6	53.6	46.0	45.1	54.6	133.8	108.3	65.1	41.5	52.3	47.8	102.2	44.5	102.0
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol		NA	NA		9600	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	19.6	23.5	20.5	11.2	21.9	8.0	17.5	22.8	30.3	21.6	20.8	22.8	11.2	21.7	13.9	14.2	20.4	12.0	22.2	20.5	29.9	17.5	20.1	19.7	9.5	25.2	26.0	25.9	13.8	18.6	21.9	16.3	24.5	19.4	11.6	15.7	14.5	15.6	25.8	15.6	14.9	18.3	18.6	14.1	16.3	23.2	22.7	12.8	17.1	20.8	8.9	19.6	18.3	25.8	31.0	38.0	30.3	38.2	35.9	29.0	29.4	35.8	25.9	28.8	23.4	25.2	25.7	25.8	14.2	47.7	23.8	25.5	45.0	18.2	36.0	23.3	33.9	38.2	22.8	42.4	49.7	27.1	21.4	32.4	20.1	38.0	42.6	48.0	27.8	20.2	46.8	13.1	37.2	24.7	23.2	24.2	30.1	19.4	24.6	21.8	18.6	19.2	30.1	34.5	28.7	25.2	38.5	49.3	24.7	29.1	30.9	16.5	34.9	36.9	21.6	30.4	20.6	23.4	30.0	22.5	19.0	20.9	23.5	4.5	3.6	5.8	3.9	3.4	5.2	5.1	4.9	5.3	5.0	2.7	4.1	3.6	3.5	5.6	6.4	2.7	2.2	2.8	20.5	21.9	22.8	30.3	20.5	29.9	25.2	26.0	24.5	18.6	22.7	25.8	43.0	80.1	72.6	175.3	26.7	35.3	34.3	18.4	35.9	101.0	33.6	26.3	36.6	30.0	36.6	36.8	135.5	32.5	28.9	25.6	3.9	26.0	11.1	87.2	72.2	43.9	41.4	34.9	146.7	25.3	25.4	40.0	23.9	50.3	23.5	67.2	63.5	38.1	24.5	65.6	171.8	26.7	24.4	35.9	35.9	11.9	65.6	30.6	32.0	106.8	35.1	32.6	48.4	128.7	209.6	32.6	16.0	47.4	24.2	43.0	22.7	16.9	56.0	90.4	32.9	41.5	46.6	78.0	70.7	25.7	35.2	46.9	27.4	68.7	31.5	42.2
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478"	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	67.8	78.2	80.2	51.6	86.2	82.9	65.3	89.9	116.8	83.3	72.7	75.6	43.8	71.3	20.9	81.9	77.8	29.2	68.8	82.2	82.2	85.7	96.1	85.9	62.7	83.2	80.4	81.3	96.8	33.7	116.4	39.0	83.4	80.6	27.0	56.5	70.1	27.9	63.8	76.9	86.3	33.4	75.5	117.0	82.6	178.9	83.5	52.5	83.0	23.7	46.9	75.5	77.7	86.0	77.8	97.6	99.0	112.1	59.9	61.5	116.1	76.3	73.7	82.1	91.3	124.1	90.1	178.6	95.4	54.4	128.6	110.2	93.9	76.9	90.5	140.9	83.3	119.5	124.3	127.4	107.5	135.9	161.2	78.8	90.1	116.4	166.1	72.4	73.2	174.4	158.9	219.9	68.4	109.9	166.1	228.0	100.6	46.9	67.2	216.4	68.5	125.6	48.9	79.6	102.8	81.9	44.6	83.5	95.8	62.3	91.3	141.0	88.2	101.2	83.6	65.8	106.2	311.9	238.1	159.4	76.3	128.1	119.6	0.4	2.1	1.4	1.6	1.9	1.6	4.3	1.9	2.0	1.6	2.9	1.8	2.3	2.4	1.9	1.6	5.6	1.7	1.1	80.2	86.2	89.9	116.8	82.2	82.2	83.2	80.4	83.4	75.5	83.5	86.0	30.2	28.9	33.3	26.1	48.2	36.6	25.1	20.2	66.0	31.6	29.8	26.3	2.1	21.5	19.8	20.2	45.9	23.0	39.1	19.8	1.9	17.8	71.7	37.7	34.9	27.8	24.6	23.1	37.3	20.2	21.9	20.8	31.6	53.1	25.9	23.4	27.1	14.7	24.8	26.9	37.5	23.4	14.2	29.3	33.3	25.7	21.5	36.5	8.8	24.4	26.4	10.0	33.0	18.6	31.5	32.2	19.4	19.9	65.1	33.0	19.7	4.8	18.8	48.9	13.1	28.9	22.1	83.9	28.3	46.3	31.1	34.3	48.4	24.5	23.4	27.4
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
ATXN3L	MJDL	ENSG00000123594	"Ataxin 3 like"	Q9H3M9	X	13318236-13320399	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 3.3"	"Group enriched"	"Detected in some"	86	"Early spermatids: 68.4;Late spermatids: 192.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA024123, HPA027539"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA024123: AB_1845133, HPA027539: AB_10602435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	192.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105604772-105876599	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 93.4;Excitatory neurons: 107.3;Inhibitory neurons: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	5.0	4.3	2.8	4.4	3.0	4.3	4.5	5.0	4.3	6.6	0.6	5.3	4.1	4.7	4.5	4.1	5.8	4.3	2.6	2.8	1.3	7.3	6.3	4.0	6.4	1.6	1.7	6.5	3.2	4.9	3.3	5.7	1.5	4.7	5.9	2.0	5.8	3.8	2.3	5.9	5.0	4.1	0.1	5.7	4.8	10.2	1.8	10.1	5.0	3.1	5.9	4.5	5.2	2.7	3.2	4.3	9.0	4.2	5.5	6.5	2.8	5.7	5.6	5.0	4.6	4.2	6.1	1.3	4.3	6.1	4.4	3.0	5.1	5.9	3.7	18.0	3.3	4.3	3.2	4.1	3.3	7.1	13.9	4.5	4.7	3.3	3.3	3.7	4.6	3.0	5.2	2.8	4.2	7.7	3.9	4.3	16.7	9.0	4.3	3.8	3.0	1.0	3.8	3.2	5.6	3.7	4.0	8.0	7.9	8.9	4.1	7.2	11.5	7.8	3.5	6.5	2.2	0.6	0.0	0.1	4.8	10.9	8.0	2.3	3.8	4.2	2.4	4.4	1.8	3.5	6.5	5.6	2.9	3.5	6.9	3.9	1.3	4.4	2.8	1.9	14.3	3.3	2.8	3.0	5.0	4.3	2.8	1.3	1.6	1.7	1.5	0.1	1.8	2.7	8.3	0.0	3.9	60.7	8.0	5.1	5.4	4.9	6.2	7.8	5.2	3.9	2.4	4.3	3.6	5.5	2.1	6.3	16.8	11.3	5.9	3.9	93.4	13.1	6.4	5.2	5.4	9.4	107.3	2.6	3.6	5.9	11.2	7.9	5.1	7.9	6.4	17.0	7.5	8.4	96.3	8.5	2.0	11.6	6.1	56.6	6.5	9.3	8.8	55.3	10.8	2.0	19.6	46.8	51.3	4.2	11.0	4.5	7.4	4.6	43.7	42.6	14.9	1.0	6.6	7.5	6.4	20.9	2.5	7.0	4.0	5.3	13.3	7.7	9.4	3.7
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	"Nucleoli rim,Vesicles,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: AB_2682647"	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	1.2	2.7	1.3	0.7	1.4	3.0	1.1	1.3	2.7	1.9	0.7	1.2	0.5	2.0	0.1	1.2	1.4	0.8	1.3	2.5	1.0	2.0	1.7	1.0	0.9	1.1	1.1	1.9	1.0	0.3	2.1	0.4	1.0	1.2	0.1	0.1	0.9	0.4	7.9	1.7	1.4	0.3	0.9	2.2	1.0	5.2	1.3	1.5	2.2	1.6	0.5	1.3	1.2	1.4	1.8	1.4	0.9	3.6	1.2	2.2	2.5	1.3	1.6	2.6	1.8	3.0	1.2	4.8	2.0	1.6	0.7	2.1	1.9	1.8	0.3	4.4	2.7	2.6	3.0	1.3	0.8	4.0	6.0	2.4	0.9	2.8	0.0	1.1	0.6	5.1	4.5	2.6	0.5	5.8	7.1	5.2	5.6	1.9	2.0	4.9	2.3	3.4	0.9	1.9	8.4	3.4	1.4	4.5	2.2	0.2	0.8	4.1	0.3	1.9	5.5	1.8	5.3	1.7	1.2	4.6	2.2	3.3	4.8	0.0	0.8	1.1	2.3	1.1	2.2	1.0	1.9	2.5	0.6	1.3	1.7	1.6	0.9	1.4	0.8	0.4	1.8	1.0	1.3	1.4	1.3	2.7	2.5	1.0	1.1	1.1	1.0	0.9	1.3	1.4	1.0	0.0	0.5	5.5	2.4	0.6	1.4	1.3	1.8	3.5	1.4	0.9	1.9	1.5	2.1	1.8	2.1	1.4	1.6	1.4	0.0	1.4	3.5	0.8	2.4	1.3	1.8	0.8	4.7	1.8	1.5	1.7	1.1	1.0	4.5	2.3	1.8	1.1	0.6	3.3	3.9	1.1	2.0	1.2	1.0	1.0	1.2	0.6	0.0	1.0	0.4	0.9	1.0	3.0	1.8	1.5	1.4	1.5	2.9	0.7	0.7	0.6	0.3	2.0	0.0	2.5	4.8	4.2	4.9	1.3	0.9	3.1	2.6	3.5	0.9	0.9
ATXN7L3	DKFZp761G2113	ENSG00000087152	"Ataxin 7 like 3"	Q14CW9	17	44191805-44200113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064316	Supported		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Plasma membrane"	"HPA064316: AB_2685243"	"unprognostic (2.37e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.86e-3)"	"unprognostic (6.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.40e-1)"	23.3	24.6	51.0	32.6	58.1	45.0	21.3	28.0	76.6	28.4	12.0	26.8	31.2	28.3	25.9	40.1	26.5	24.1	24.9	58.5	35.9	29.2	28.0	25.2	37.2	58.3	42.4	25.5	24.2	24.5	35.1	30.7	60.6	26.9	24.3	21.5	27.9	27.7	25.3	31.2	29.6	25.8	33.0	36.3	28.3	36.9	48.3	42.1	29.1	22.6	35.5	28.7	28.1	54.1	40.9	67.7	73.3	47.8	50.1	49.5	39.8	49.1	54.3	61.4	57.7	52.0	45.1	71.3	38.6	55.5	56.6	43.9	57.7	46.1	51.2	83.6	57.2	48.5	58.9	58.5	49.3	76.3	94.3	56.1	69.0	51.7	54.1	65.0	60.3	54.2	66.1	43.5	40.8	30.7	92.3	58.0	55.1	36.7	52.5	62.8	70.9	54.1	49.8	57.9	46.5	59.0	29.0	25.4	50.5	101.4	62.0	67.1	52.2	61.5	63.8	32.3	46.5	52.1	73.8	86.4	40.6	32.6	36.8	0.4	1.2	1.5	1.7	0.7	1.0	1.4	1.4	1.1	1.0	2.4	1.0	1.3	2.5	0.5	0.9	1.6	0.8	1.1	51.0	58.1	28.0	76.6	58.5	35.9	58.3	42.4	60.6	33.0	48.3	54.1	14.3	3.2	3.7	5.5	9.4	7.1	5.6	8.0	8.6	17.4	13.7	9.1	6.2	5.7	6.6	18.4	16.7	6.3	11.3	22.2	3.9	7.1	14.7	14.0	16.9	10.5	14.4	4.0	9.1	13.1	6.7	7.2	8.6	20.7	2.5	9.9	10.4	8.1	8.4	28.6	8.6	11.0	4.1	11.1	10.9	40.0	9.0	10.0	5.4	8.4	12.7	8.6	5.2	3.0	5.3	15.0	13.6	5.7	5.5	8.6	14.1	4.6	7.6	13.9	6.6	6.7	9.3	6.3	8.5	11.0	10.5	13.7	10.0	10.4	11.2	9.1
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361918	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 191.7;Inhibitory neurons: 137.0;Oligodendrocytes: 137.5;Proximal tubular cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	17.2	41.9	11.8	6.3	12.3	4.8	15.9	16.0	15.3	13.6	17.9	17.2	23.8	10.2	14.2	8.6	12.4	10.7	38.9	12.1	14.3	62.9	26.4	10.3	7.6	14.8	13.6	13.4	25.5	45.4	10.4	16.1	15.2	28.2	17.2	21.4	26.1	14.8	24.2	8.7	20.1	8.6	12.2	8.0	22.7	5.5	14.1	9.0	21.0	29.2	7.7	9.1	9.8	15.0	9.1	8.7	12.0	6.2	14.5	15.5	18.5	8.0	10.0	6.1	7.0	5.0	11.4	10.6	8.1	8.5	18.2	13.0	18.1	10.1	8.7	82.6	15.4	7.3	9.7	29.6	11.1	10.6	7.3	13.1	12.5	4.9	16.8	14.3	7.6	10.7	10.3	15.5	7.2	8.8	14.6	23.8	15.0	22.2	12.5	8.5	9.6	18.6	26.6	4.8	12.2	8.8	11.9	28.3	15.6	27.1	5.2	6.9	7.8	6.1	7.6	9.0	7.8	17.7	16.1	3.6	9.6	8.5	4.2	17.9	5.2	18.2	7.2	3.6	8.1	8.4	7.8	10.4	4.6	11.8	9.6	9.1	7.4	10.8	2.5	6.3	10.8	6.5	11.8	12.3	16.0	15.3	12.1	14.3	14.8	13.6	15.2	12.2	14.1	15.0	9.6	0.0	7.7	75.1	11.2	5.2	24.5	27.7	12.5	18.7	15.8	13.5	37.2	27.1	19.1	27.6	25.0	44.6	11.5	27.0	191.7	29.6	3.1	11.5	11.1	11.1	22.9	28.8	101.2	16.1	28.9	14.2	19.4	16.0	1.3	14.5	11.0	18.3	13.4	13.5	137.0	17.3	38.7	8.9	4.7	1.1	14.3	8.9	12.4	67.5	29.1	9.5	18.6	100.5	137.5	12.5	23.5	11.3	18.4	36.8	59.4	120.0	15.8	34.4	13.1	11.9	11.5	8.7	10.5	16.1	4.1	36.4	12.9	11.6	25.0	24.2
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.2;testis: 16.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.8;Late spermatids: 127.0;Spermatocytes: 54.9;Spermatogonia: 47.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028730	Uncertain		Supported	Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.2	0.9	0.5	0.9	0.4	6.2	0.4	0.8	0.9	0.3	0.0	0.7	0.9	0.3	0.5	1.4	0.2	0.2	0.6	0.6	0.0	0.4	0.5	0.3	1.2	0.3	0.0	0.2	0.2	0.0	0.4	1.8	0.4	0.3	0.9	0.9	0.3	0.1	0.7	0.5	0.8	0.3	0.0	0.7	0.5	16.0	0.1	1.3	0.2	0.0	1.7	0.3	0.5	0.6	19.8	5.6	8.8	11.3	0.4	0.6	8.5	11.1	5.1	22.0	17.9	4.7	15.0	19.0	8.3	4.0	7.7	15.7	23.9	10.8	17.6	11.0	17.7	42.0	8.8	7.3	0.2	20.7	18.3	0.5	5.3	13.5	9.2	1.7	5.0	14.7	25.7	9.5	6.2	10.5	15.2	17.3	15.2	13.1	6.6	12.4	16.3	12.1	6.9	6.4	12.3	5.9	15.4	17.5	12.4	9.7	6.3	10.8	2.1	6.5	9.7	13.5	10.0	3.6	7.6	14.2	4.5	34.3	10.6	1.5	0.7	0.5	0.1	1.0	0.1	0.2	0.2	0.2	0.6	0.3	0.2	0.3	0.5	0.3	0.6	0.4	0.8	0.3	0.5	0.4	0.8	0.9	0.6	0.0	0.3	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.0	1.6	0.3	0.4	0.1	1.4	0.6	0.0	0.3	0.6	1.4	0.0	0.2	0.0	2.1	8.9	0.3	0.2	0.0	0.4	52.8	0.3	0.4	0.5	0.0	13.0	3.8	0.5	11.1	0.7	0.0	0.3	0.0	1.4	0.0	0.0	2.1	0.0	1.7	0.5	0.0	0.3	1.2	127.0	2.1	0.7	0.0	0.0	1.1	0.2	0.0	1.5	0.8	0.6	0.0	0.7	1.1	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.5	54.9	47.4	1.7	0.4	7.4	0.5	0.4	1.0	0.2
AUP1		ENSG00000115307	"AUP1 lipid droplet regulating VLDL assembly factor"	Q9Y679	2	74526645-74529760	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007674	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA007674: AB_1078251"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (2.97e-9)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.96e-2)"	48.0	42.2	68.0	44.4	69.0	78.8	52.6	71.0	85.8	56.0	72.1	76.9	70.6	38.7	78.6	49.9	45.3	46.0	38.4	67.6	71.0	48.8	106.9	48.7	41.3	73.0	69.6	38.1	127.3	77.6	2.1	60.6	69.7	38.9	81.0	32.4	89.1	46.3	57.7	42.3	68.5	55.8	70.5	39.5	56.7	24.5	70.1	42.5	50.9	66.6	51.5	69.6	20.7	72.1	114.2	133.4	55.3	87.5	183.1	107.7	124.9	89.1	152.6	122.3	77.3	196.9	130.6	126.4	61.9	126.5	210.3	143.4	140.4	115.1	98.5	100.1	128.7	153.6	71.2	180.7	181.5	97.8	127.9	128.5	256.7	174.4	198.6	101.1	117.3	105.1	202.2	164.5	134.0	124.6	79.0	200.6	111.4	298.3	111.9	95.3	150.0	270.3	139.3	90.9	80.7	79.6	65.2	200.4	162.2	70.8	90.2	156.7	59.3	162.9	97.2	50.6	146.8	87.9	88.1	120.4	129.6	155.9	184.9	113.8	132.9	108.9	81.9	169.3	89.6	90.6	81.0	82.0	124.6	113.9	72.9	75.8	68.8	85.3	144.7	118.3	107.9	132.2	68.0	69.0	71.0	85.8	67.6	71.0	73.0	69.6	69.7	70.5	70.1	72.1	64.8	67.3	44.6	22.5	97.3	73.2	120.7	161.1	80.8	31.7	71.4	59.6	34.9	74.4	108.1	68.0	14.6	140.0	86.6	150.4	23.5	125.2	24.3	36.2	50.1	74.9	73.8	72.4	17.7	208.7	217.3	73.0	121.8	58.7	89.9	57.3	50.0	114.3	161.8	37.0	16.1	127.7	136.3	83.5	95.5	29.7	44.4	95.2	97.8	17.8	67.2	74.5	72.1	14.6	23.4	153.1	141.3	38.0	229.9	141.1	196.0	59.6	46.6	43.2	59.2	60.0	104.2	85.9	64.6	95.7	78.7	223.8	77.6	68.4	134.2	143.9
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1314.3;Late spermatids: 3668.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	98.0	129.1	116.2	43.4	117.6	51.5	90.0	125.2	142.4	64.9	130.2	110.5	71.7	70.0	23.5	118.0	64.1	26.1	260.8	113.4	116.3	151.8	215.8	67.2	41.4	125.6	116.8	58.2	120.1	73.4	92.3	35.8	116.1	85.9	27.5	23.6	88.2	38.7	281.3	91.0	85.6	22.4	116.9	85.8	121.4	300.6	128.4	37.9	83.1	171.3	27.2	87.2	72.9	118.4	197.8	116.9	62.9	113.6	54.6	68.2	115.7	116.8	76.8	180.7	127.6	206.3	177.5	103.2	169.3	79.6	90.7	142.4	86.5	154.6	51.9	124.7	245.8	83.6	156.1	194.0	106.7	109.0	109.0	90.4	68.6	127.1	51.3	52.8	99.2	96.3	167.2	138.5	106.6	150.3	134.7	386.9	119.1	123.2	329.1	154.8	77.5	222.7	145.9	51.6	200.7	150.6	83.7	288.4	295.1	38.1	125.0	250.7	75.5	111.3	144.4	134.1	175.7	179.1	177.0	223.4	155.3	159.2	77.1	279.1	231.8	266.6	171.6	200.3	162.7	190.6	178.4	181.7	207.4	202.7	166.6	161.1	291.7	142.4	177.7	294.0	230.1	225.6	116.2	117.6	125.2	142.4	113.4	116.3	125.6	116.8	116.1	116.9	128.4	118.4	118.9	48.1	73.5	18.9	137.4	162.3	166.4	271.4	87.0	109.8	228.1	240.2	231.3	180.1	149.6	165.5	64.6	384.1	134.7	642.0	677.0	310.2	1314.3	145.6	119.3	127.6	203.9	125.2	11.2	418.4	458.6	121.0	178.4	141.8	87.5	144.6	121.1	390.5	294.6	104.3	12.8	415.1	238.0	154.8	175.5	3668.5	136.1	149.7	217.1	5.6	208.1	299.8	166.9	13.0	17.9	425.2	484.3	118.5	240.5	272.5	607.4	780.2	142.2	124.5	157.8	104.4	152.4	572.4	149.2	190.4	197.6	438.1	116.3	181.0	414.3	270.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.2;Spermatocytes: 116.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	1.2	1.1	3.5	1.3	3.7	1.4	2.0	3.8	6.3	0.7	3.0	1.0	0.2	1.3	1.8	1.0	1.1	1.4	1.9	3.5	3.5	1.5	2.7	1.1	3.4	3.7	3.6	0.5	0.9	0.6	1.4	1.9	3.9	0.9	1.3	1.1	0.8	1.4	1.9	1.2	0.8	1.1	3.8	5.0	0.8	46.9	3.7	1.2	1.2	0.5	2.2	1.4	0.8	4.3	0.3	0.1	0.9	0.4	0.3	0.9	0.5	1.7	0.8	1.2	4.4	1.3	0.2	0.1	0.2	0.6	1.0	0.0	0.0	0.9	0.8	0.0	4.9	0.2	0.4	0.0	1.4	0.0	0.3	1.2	0.9	0.9	0.7	1.5	0.8	0.5	0.2	0.0	1.6	0.0	1.5	0.9	38.4	0.2	1.0	0.1	0.3	0.8	0.9	1.7	1.9	0.6	0.0	0.3	0.2	0.1	0.1	1.8	0.4	0.3	5.1	0.4	1.0	1.9	2.7	0.8	1.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.5	3.7	3.8	6.3	3.5	3.5	3.7	3.6	3.9	3.8	3.7	4.3	1.9	0.0	0.5	0.7	0.1	1.1	0.8	0.9	0.0	2.4	1.2	3.8	1.2	0.0	2.5	1.8	0.0	0.4	0.9	0.7	1.9	2.1	150.2	0.8	0.4	0.8	1.8	0.4	1.3	1.0	0.9	1.0	0.0	0.6	0.0	0.5	1.8	0.6	4.1	0.0	1.3	0.3	0.0	2.6	0.8	28.9	1.5	1.2	5.4	0.0	1.0	1.8	1.0	0.0	0.9	1.3	1.4	0.4	0.6	1.3	0.0	0.5	2.7	1.0	6.6	0.4	0.7	116.8	22.9	0.5	1.1	0.3	0.9	0.5	0.4	1.6
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33858782-34075155	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	13.7	11.4	8.5	7.2	8.6	4.4	10.8	8.9	10.1	11.4	10.5	15.2	7.4	12.5	5.2	12.3	11.3	6.4	28.5	8.2	9.2	5.5	16.9	7.2	4.8	9.2	9.0	10.5	20.8	3.0	5.8	12.4	9.4	9.4	9.4	2.5	7.9	9.1	31.1	11.2	7.5	12.5	8.8	6.5	12.3	10.7	9.0	6.9	5.6	13.6	7.9	16.2	10.8	9.1	16.4	26.3	26.0	8.6	21.4	24.1	14.7	41.1	36.2	31.9	19.9	7.2	11.3	15.2	24.8	34.8	24.2	10.4	12.2	26.9	25.7	14.6	7.7	26.1	15.9	20.5	31.5	26.6	18.2	19.8	50.9	18.4	45.8	38.6	35.2	7.6	26.6	21.1	45.6	17.3	10.5	46.1	11.9	22.2	8.5	15.7	14.6	32.2	26.4	21.0	13.4	16.8	22.6	11.6	11.4	10.7	12.6	29.4	24.5	27.7	9.5	12.0	34.6	21.2	17.7	31.1	13.3	31.0	15.2	0.0	0.2	0.0	0.5	0.6	0.6	0.4	0.5	0.2	0.2	0.1	0.2	0.3	0.0	0.5	0.2	2.3	0.9	0.1	8.5	8.6	8.9	10.1	8.2	9.2	9.2	9.0	9.4	8.8	9.0	9.1	9.0	3.2	5.3	16.6	5.6	5.7	8.7	1.8	3.4	5.6	7.5	9.0	32.7	2.8	0.8	0.0	6.2	11.0	10.5	7.4	0.0	2.9	13.8	4.4	14.3	10.2	4.8	9.5	21.8	8.6	44.0	8.5	5.6	5.6	0.0	14.7	8.6	19.1	7.4	8.4	24.1	7.7	0.0	4.1	4.4	6.5	7.5	5.0	3.6	22.5	3.5	10.9	7.2	26.7	86.6	7.0	5.2	10.5	15.6	21.5	9.4	4.6	1.5	5.3	6.6	4.9	9.7	6.2	7.4	12.9	9.7	9.4	6.5	23.1	6.0	14.7
AVIL	"ADVIL, DOC6, FLJ12386, p92"	ENSG00000135407	Advillin	O75366	12	57797376-57818704	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 28.3;Gastric mucus-secreting cells: 23.9"	"Cancer enriched"	"Detected in all"	5	"glioma: 9.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.6;RH-30: 8.5;U-266/84: 3.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA058864	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058864: AB_2683838"	"unprognostic (3.86e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.79e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-4)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.71e-4)"	1.3	3.5	2.0	1.5	3.6	0.7	1.3	7.6	2.5	1.3	2.6	2.8	3.0	1.0	3.2	0.6	1.3	1.9	1.5	2.2	1.7	1.6	1.7	1.5	0.7	2.2	1.8	1.6	3.8	0.3	1.8	1.4	2.0	1.5	1.6	4.9	1.7	1.2	9.3	5.6	3.4	1.2	1.0	1.3	1.1	0.8	2.3	1.0	2.9	1.5	0.8	1.2	1.0	1.4	0.3	0.4	2.9	2.0	0.7	1.3	0.2	0.2	0.1	0.0	0.2	0.0	1.0	4.6	0.4	0.4	0.0	1.6	0.1	0.0	0.3	0.0	1.4	0.5	1.3	0.9	0.3	1.9	0.0	0.9	0.7	0.1	0.4	0.1	0.4	0.4	0.3	1.9	0.0	0.4	0.0	2.0	0.2	0.0	1.0	0.1	8.5	0.3	0.2	0.9	0.6	0.0	0.4	0.3	1.0	0.6	0.6	0.0	0.2	1.2	0.1	0.9	0.0	0.9	3.5	0.5	0.5	0.3	0.3	0.2	0.8	1.4	0.6	0.4	0.7	0.6	1.1	0.5	0.3	1.1	1.0	0.8	5.0	0.4	0.5	0.8	0.3	0.0	2.0	3.6	7.6	2.5	2.2	1.7	2.2	1.8	2.0	1.0	2.3	1.4	5.3	3.2	7.7	15.0	3.4	2.9	3.7	3.6	4.0	28.3	8.8	7.4	1.2	5.7	4.6	3.7	18.8	1.3	1.3	11.9	0.0	4.7	6.0	6.1	5.4	5.0	7.7	2.7	13.4	6.0	1.0	5.4	23.9	11.1	1.3	2.0	12.8	2.8	2.2	8.4	8.5	3.4	10.2	3.3	3.1	2.8	4.1	2.6	3.6	5.6	3.4	11.3	5.2	5.5	7.0	4.5	3.7	0.7	1.3	4.9	2.9	1.1	3.2	21.6	6.6	8.8	4.1	1.4	2.7	2.5	4.1	2.9	2.7	5.8	4.1	2.7
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588726	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 93.9;Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	7.5	9.0	9.3	10.2	11.4	9.4	10.7	8.6	10.2	9.0	9.2	15.9	13.3	8.2	12.2	8.0	8.5	7.6	5.2	12.0	10.1	10.5	8.3	8.0	10.6	7.6	8.6	8.2	11.0	9.3	7.0	10.8	9.1	9.5	17.9	22.4	9.2	7.1	8.0	7.6	13.3	8.3	5.4	8.6	12.2	7.0	11.8	12.7	13.2	6.2	11.3	9.1	7.0	9.2	19.6	17.0	17.4	23.6	10.3	14.8	12.1	17.3	22.8	16.7	22.3	13.4	25.8	24.7	0.3	15.3	64.4	15.8	16.7	17.1	28.1	10.8	10.3	18.5	11.8	14.6	37.8	31.8	23.3	16.1	16.5	21.4	24.3	18.5	25.0	19.6	45.9	22.1	52.9	20.2	12.9	26.5	19.6	27.1	14.8	12.4	19.3	18.9	17.8	32.7	37.4	23.8	14.6	35.5	15.4	23.2	25.4	28.8	19.2	17.3	20.2	13.8	15.2	50.6	47.4	38.8	34.2	29.5	38.6	21.0	15.0	23.3	13.8	11.8	11.7	12.9	11.5	13.1	11.5	16.0	14.1	12.8	37.9	7.0	11.5	13.6	11.5	16.2	9.3	11.4	8.6	10.2	12.0	10.1	7.6	8.6	9.1	5.4	11.8	9.2	11.0	6.4	11.7	85.5	23.8	11.5	12.4	12.4	13.6	31.6	16.2	8.1	9.5	15.7	15.2	12.9	62.6	16.2	21.4	46.7	3.9	12.8	5.8	14.9	11.6	13.1	22.3	9.0	93.9	17.2	15.7	11.1	28.5	19.4	17.7	25.5	16.8	13.4	15.1	32.0	92.6	27.6	6.1	24.6	14.2	2.8	10.2	17.8	12.4	78.7	18.3	12.5	19.6	56.8	88.6	24.5	24.8	9.4	22.3	21.1	22.5	15.8	18.4	36.8	6.6	9.7	12.7	9.9	8.4	12.2	10.5	17.5	16.6	15.7	29.0	23.3
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1308	"brain: 7951.2"	"Group enriched"	"Detected in some"	6	"Late spermatids: 26.2;Proximal tubular cells: 46.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	131	"hypothalamus: 7951.2"	"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enriched"	"Detected in single"	13	"NB-4: 2.3"	"Region enriched"	"Detected in many"	10	"hypothalamus: 232.9"	"Group enriched"	"Detected in many"	337	"basal ganglia: 815.6;hypothalamus: 743.3"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	NA	NA	19300		"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB025318: , HPA071892: AB_2732190"										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.3	0.3	24.5	0.0	7.0	0.8	0.2	1.2	60.5	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.6	7951.2	1.5	0.3	0.1	0.0	0.2	0.7	0.1	0.1	0.0	6.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.0	1.0	0.0	0.0	1.4	10.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	24.5	7.0	1.2	60.5	1.6	7951.2	0.2	0.7	0.3	1.0	10.8	0.5	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	5.7	0.0	0.2	0.0	0.0	4.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.0	0.2	0.0	0.0	0.0	0.3	26.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	46.6	0.0	0.1	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687241	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 100.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	32.1	41.5	18.5	6.5	25.4	5.0	21.2	21.9	23.2	38.1	16.2	24.6	14.0	11.2	4.7	26.2	18.9	10.4	22.4	18.3	19.8	12.1	46.9	22.5	2.4	23.7	20.2	85.6	9.4	5.6	19.2	16.9	21.9	26.3	18.9	25.5	22.7	16.6	12.5	100.7	15.6	5.3	22.4	20.8	30.5	16.0	20.8	2.0	9.1	3.9	4.4	25.5	46.0	29.5	38.8	99.8	0.5	14.3	20.2	9.1	20.0	18.5	100.7	25.0	37.5	18.8	47.2	0.8	13.0	10.5	18.0	40.0	7.6	32.3	9.4	1.0	8.9	2.6	119.7	52.6	119.1	2.6	3.0	14.6	230.5	18.7	49.1	22.8	3.4	3.6	5.7	2.0	14.0	33.4	1.7	3.1	3.5	10.6	9.3	1.3	11.3	1.5	24.9	20.9	1.7	4.0	63.9	22.7	194.5	3.2	17.2	3.1	5.5	5.9	11.7	134.4	4.6	4.4	3.3	0.8	22.2	8.1	3.8	0.0	6.2	2.3	4.2	5.7	2.0	2.8	2.8	3.1	11.1	2.0	3.0	3.7	0.5	2.0	0.5	2.3	2.6	2.9	18.5	25.4	21.9	23.2	18.3	19.8	23.7	20.2	21.9	22.4	20.8	29.5	6.3	19.2	19.0	0.7	8.0	96.0	87.6	246.7	145.1	9.6	13.6	16.8	9.7	52.9	63.4	38.6	6.2	149.6	15.4	137.5	43.0	18.8	60.9	33.2	17.1	11.4	31.8	2.1	3.6	24.1	64.8	23.4	58.1	57.9	6.3	385.5	34.2	42.4	41.8	13.5	4.3	70.4	48.8	21.7	326.1	278.5	10.2	49.6	83.6	0.0	6.4	128.2	2.1	0.5	4.4	43.3	100.6	14.7	5.9	55.2	109.0	11.2	16.7	14.6	6.6	10.2	19.3	3.5	4.9	68.0	108.4	194.7	19.0	10.9	100.6	106.3
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206106936-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"pituitary gland: 6.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075404	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 44: Endometrium - Transcription"			"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	6.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240659	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skin 1: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA063412	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"					"HPA063412: AB_2685009"	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 11.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 8.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062748	Approved					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	8.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AXDND1	"C1orf125, FLJ32940"	ENSG00000162779	"Axonemal dynein light chain domain containing 1"	Q5T1B0	1	179365720-179554735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 15.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 226.5;Late spermatids: 247.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA071114	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA071114: AB_2686345"	"unprognostic (1.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.25e-1)"	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	15.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.3	0.2	0.2	0.1	0.0	0.5	8.8	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.8	0.0	0.8	0.0	2.1	0.1	0.1	16.3	0.0	0.2	226.5	3.1	0.3	0.2	0.0	0.0	3.1	0.2	0.3	0.1	31.6	0.3	0.0	0.2	0.0	0.0	0.1	0.0	3.2	1.5	0.0	0.0	0.0	247.2	1.5	0.5	0.0	1.0	0.0	0.6	0.0	2.0	2.5	0.6	3.8	1.9	0.1	0.1	2.0	0.1	3.2	0.7	0.0	0.0	0.2	50.2	4.3	0.0	0.0	0.1	0.2	0.6	6.1	0.2
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352723	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	11.9	9.3	10.5	9.2	10.8	23.0	11.5	14.8	12.5	12.9	9.1	17.1	12.3	13.2	3.1	16.3	11.8	6.2	11.6	10.0	9.2	11.6	11.2	13.7	10.5	10.2	10.2	13.8	13.0	7.2	12.6	5.8	9.8	12.9	6.9	2.6	11.5	6.0	21.1	20.1	15.0	5.4	9.2	15.0	12.9	11.8	10.1	12.5	11.9	7.0	6.6	14.5	13.1	11.9	18.1	25.6	13.4	23.7	9.8	9.0	28.0	11.9	10.8	16.1	13.8	37.9	20.4	27.7	18.0	12.3	19.4	25.4	21.1	18.5	7.2	27.5	34.6	18.0	21.9	27.6	16.6	20.9	19.3	9.0	31.7	16.6	20.3	14.1	10.7	19.8	45.6	14.8	7.4	48.1	22.7	14.5	30.6	21.6	15.4	42.4	12.2	38.8	12.2	10.5	30.4	18.6	22.6	24.9	38.3	10.0	16.5	26.1	12.4	15.9	17.0	18.5	17.5	17.3	18.1	34.2	7.5	13.7	15.9	1.2	0.9	5.0	8.3	0.8	7.6	1.5	2.4	5.8	0.7	1.2	2.4	3.4	2.7	3.5	0.6	1.2	2.6	2.3	10.5	10.8	14.8	12.5	10.0	9.2	10.2	10.2	9.8	9.2	10.1	11.9	7.9	3.2	8.6	4.9	5.7	18.4	7.6	8.5	5.7	4.3	11.2	9.5	4.9	5.7	7.2	3.7	0.0	3.5	30.1	27.4	0.0	7.2	1.4	10.2	7.0	6.3	10.8	8.6	18.5	6.9	27.5	6.7	15.3	14.4	10.8	10.5	5.7	5.1	7.5	5.0	12.7	15.1	6.1	6.2	9.0	2.1	5.3	6.7	10.6	1.0	5.7	4.5	28.8	8.5	8.9	11.0	12.2	4.9	7.0	13.4	11.1	2.4	7.7	5.7	13.1	8.7	7.6	5.5	8.8	7.2	15.2	3.7	12.4	5.0	15.7	10.5
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.7;Extravillous trophoblasts: 102.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	8.7	10.9	6.8	5.4	6.9	0.9	5.3	7.9	7.9	17.2	5.5	12.3	7.1	23.9	5.9	5.9	19.8	6.6	8.0	9.4	6.2	3.7	2.7	17.0	3.5	8.5	7.9	15.0	4.2	4.2	6.2	18.4	5.3	14.0	14.6	3.4	5.2	8.9	14.6	14.9	7.4	17.3	7.3	7.4	13.6	6.7	11.0	17.3	12.3	7.8	2.7	11.4	8.0	5.6	0.0	13.9	27.2	0.5	9.6	4.1	12.0	0.4	1.3	0.9	1.7	52.3	5.0	1.0	1.7	8.0	1.0	0.4	5.7	0.1	1.9	2.4	3.1	0.0	2.4	78.8	1.0	0.1	0.1	2.4	2.1	2.2	0.6	1.6	2.4	5.1	0.2	1.2	1.4	0.3	13.9	0.1	5.3	86.9	0.6	9.9	1.6	0.1	2.6	0.3	8.4	5.5	0.5	0.3	4.8	20.0	1.0	0.3	6.3	5.3	9.6	7.6	1.7	0.1	3.0	3.8	2.5	0.6	2.6	3.2	0.0	0.0	0.1	0.0	0.4	0.5	1.1	0.2	0.0	1.8	2.3	0.4	0.0	1.0	0.0	0.0	0.0	0.3	6.8	6.9	7.9	7.9	9.4	6.2	8.5	7.9	5.3	7.3	11.0	5.6	2.4	0.0	9.0	9.8	1.0	11.2	2.2	1.0	11.4	3.7	5.2	8.1	8.7	1.5	8.1	0.0	4.2	18.1	0.7	15.2	0.0	1.4	33.7	7.8	15.1	5.3	5.4	0.0	8.4	0.9	102.6	10.3	5.6	16.5	0.0	3.1	1.1	2.0	3.8	1.7	8.7	17.4	0.0	0.0	7.5	17.5	6.5	0.6	17.8	9.4	1.0	3.3	0.0	8.0	2.0	0.8	18.9	10.9	0.9	2.9	1.9	0.9	1.3	2.5	13.1	1.6	10.6	6.2	12.9	3.3	5.5	14.2	4.6	3.6	19.8	1.3
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.1;plasmacytoid DC: 25.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.7;NK-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 501.2;U-251 MG: 540.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	72000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	43.6	18.8	17.5	15.5	22.6	1.7	26.6	19.7	17.7	36.1	12.4	42.5	11.7	34.4	8.7	17.6	25.4	22.4	26.7	16.6	18.8	9.8	15.0	25.9	6.2	26.8	20.6	24.7	6.3	10.7	7.3	34.2	22.1	19.2	12.6	5.8	10.6	24.6	9.4	20.0	19.0	37.1	20.9	37.7	21.4	18.6	24.0	7.2	16.6	11.3	5.0	32.5	25.2	21.9	408.0	160.0	9.7	1.3	34.6	34.7	0.5	314.5	280.2	450.9	278.2	8.5	185.5	0.2	124.7	501.2	235.3	33.3	0.4	211.8	384.8	0.7	0.3	0.0	100.4	6.3	125.0	0.3	0.3	26.4	3.8	266.7	409.5	254.8	169.8	0.1	15.8	0.5	284.6	0.5	0.2	0.4	4.1	1.0	76.3	0.2	165.3	0.3	202.3	0.2	0.1	0.1	81.5	0.6	1.8	57.4	0.9	7.2	351.8	317.8	214.6	307.7	540.8	0.5	0.9	1.0	211.5	0.5	241.8	1.5	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.1	6.0	0.1	0.3	0.3	0.3	11.1	0.2	25.7	0.4	0.3	17.5	22.6	19.7	17.7	16.6	18.8	26.8	20.6	22.1	20.9	24.0	21.9	13.5	9.6	3.6	35.9	1.9	41.7	88.3	10.3	3.4	0.5	2.3	14.2	8.6	1.5	4.4	5.5	0.0	4.2	0.8	0.1	0.0	6.9	8.7	6.0	45.8	17.7	0.0	0.0	0.8	0.2	2.1	147.2	1.5	5.4	0.0	17.3	11.0	1.2	28.8	1.7	1.1	0.1	2.0	187.5	185.5	5.5	61.5	61.4	26.6	30.9	3.1	26.8	0.0	11.1	0.5	14.5	0.1	79.7	0.8	123.4	0.3	0.1	2.8	1.2	210.4	38.1	171.1	1.9	2.0	1.2	29.1	11.5	3.6	2.5	0.1	28.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
AZI2	"AZ2, FLJ21939, NAP1"	ENSG00000163512	"5-azacytidine induced 2"	Q9H6S1	3	28315003-28349050	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035258	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035258: AB_10602329"	"unprognostic (1.86e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.77e-4)"	27.1	11.6	17.1	9.1	17.4	20.8	12.7	17.5	19.8	12.5	18.4	10.4	12.0	12.0	10.7	9.7	10.6	13.1	14.7	16.2	19.0	14.9	11.3	12.5	9.9	17.1	17.2	13.1	11.2	12.8	13.9	12.3	17.6	12.4	9.8	13.6	17.8	10.5	14.1	9.8	11.3	11.8	16.3	10.0	10.9	16.5	18.8	14.0	14.0	12.0	8.6	11.7	8.6	17.8	20.5	20.6	27.4	16.4	43.0	69.0	40.3	25.5	52.6	44.3	52.7	18.3	20.2	12.6	15.5	36.0	29.7	8.4	21.2	42.4	35.9	34.2	23.7	23.8	20.6	25.4	64.4	24.6	14.5	69.9	57.1	35.7	61.9	28.9	24.6	26.6	36.0	22.9	41.1	19.4	31.3	19.4	19.1	13.5	30.0	14.6	29.5	13.0	19.3	11.5	14.6	35.8	22.3	25.6	52.3	24.7	17.7	25.6	17.0	29.4	24.2	24.9	31.3	26.5	27.6	18.3	31.1	51.4	27.2	74.7	37.8	26.3	13.3	31.2	16.1	6.3	12.6	15.5	16.7	8.4	12.0	11.0	10.4	11.0	28.1	13.5	18.9	19.1	17.1	17.4	17.5	19.8	16.2	19.0	17.1	17.2	17.6	16.3	18.8	17.8	31.6	64.1	49.5	21.9	17.0	24.9	34.4	53.6	34.7	29.3	33.0	28.6	23.1	24.3	46.9	23.9	37.5	32.4	34.9	33.1	45.0	26.4	26.9	49.0	46.8	28.1	26.9	31.8	28.2	28.2	57.0	55.6	16.8	30.2	19.6	27.5	32.9	38.3	33.7	15.2	43.6	29.0	38.7	63.0	11.0	28.1	46.9	57.6	8.8	16.9	61.8	30.5	22.6	32.6	32.6	30.5	28.8	41.0	32.8	28.8	34.8	50.0	57.9	30.9	46.0	44.4	34.6	68.0	61.3	32.0	34.7	62.7	28.7	32.0	24.5	28.3
AZIN1	"OAZI, OAZIN, ODC1L"	ENSG00000155096	"Antizyme inhibitor 1"	O14977	8	102826308-102893864	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 261.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027948	Approved		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA027948: AB_10602391"	"unprognostic (1.16e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.68e-1)"	61.7	48.1	45.7	48.1	50.3	141.1	57.8	44.8	51.2	55.3	43.5	49.1	66.6	44.4	30.3	52.7	64.0	43.6	51.5	51.9	50.5	39.4	78.0	40.1	58.1	48.1	48.2	38.7	136.6	38.3	31.6	82.8	48.1	52.5	53.6	57.8	47.7	49.5	41.9	32.7	80.8	44.5	53.8	35.9	52.2	35.7	46.7	58.6	67.5	30.9	60.6	62.3	27.3	60.0	320.4	81.7	129.0	92.6	122.7	83.3	77.6	145.4	168.5	103.5	106.8	87.1	217.5	148.0	111.0	121.9	64.3	119.5	113.8	114.5	165.8	244.7	57.4	147.4	30.1	72.3	156.0	81.0	120.7	58.9	136.1	72.5	182.4	92.2	72.8	86.0	112.6	124.0	165.2	92.6	201.8	59.3	144.9	239.3	123.0	87.3	136.5	84.2	108.2	146.7	208.2	327.3	49.1	100.0	144.3	209.9	131.7	84.7	85.9	83.2	83.9	135.7	118.6	122.3	104.2	207.4	98.3	120.1	117.0	73.3	57.7	68.0	31.2	64.1	36.7	43.7	40.8	29.9	55.9	27.5	33.1	32.1	68.5	40.1	64.5	44.3	50.0	65.7	45.7	50.3	44.8	51.2	51.9	50.5	48.1	48.2	48.1	53.8	46.7	60.0	56.3	60.9	27.7	30.0	59.6	93.8	121.1	52.8	93.4	31.5	64.0	39.8	46.3	28.6	52.8	42.3	37.5	148.7	54.0	48.4	52.8	39.6	62.6	95.1	37.9	34.9	84.9	62.7	35.9	50.5	55.0	55.5	59.1	85.4	68.5	31.9	33.5	65.0	54.7	23.5	31.9	77.3	63.1	72.8	127.2	107.9	49.7	86.0	64.0	23.4	53.0	50.4	32.0	30.2	23.7	66.6	44.0	32.4	97.6	106.7	114.6	52.6	167.6	42.3	19.7	36.0	57.1	34.5	30.7	90.8	82.3	261.9	71.6	26.2	66.0	117.0
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"bone marrow: 1578.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in some"	15	"THP-1: 659.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		320000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.8	0.2	0.4	0.0	0.4	1578.1	1.5	0.2	0.9	0.2	0.2	0.2	0.0	0.5	0.0	0.1	1.4	0.0	2.0	0.4	0.3	0.4	2.8	15.9	0.6	0.3	0.3	0.2	0.2	0.0	0.9	0.9	0.4	0.4	0.0	0.0	2.6	0.0	0.5	0.6	0.2	0.0	0.2	33.1	0.2	2.4	0.4	3.1	0.5	0.0	0.0	0.3	0.2	0.3	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.6	659.5	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.6	0.0	34.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.2	0.9	0.4	0.3	0.3	0.3	0.4	0.2	0.4	0.3	3.5	0.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.0	4.5	4.6	0.7	0.0	0.5	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	8.9	1.2	1.0	0.0	8.8	0.8	0.0	0.3	0.8	0.0	2.3	0.0	0.1	0.0	0.4	3.2	0.0	1.4	0.4	0.0	3.7	0.4	0.7	0.0	3.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.0	4.5	0.0	0.0	5.7	1.2	0.1	6.4	0.9	0.1	0.0	1.0	0.0	0.6	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235447190-235504452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007846, HPA050662"	Approved		Uncertain	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA007846: , HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	4.7	5.4	2.3	2.8	2.2	1.6	4.0	2.5	2.4	5.3	5.7	8.1	3.2	7.3	4.8	8.9	5.5	5.3	6.1	2.4	2.6	3.3	3.2	3.4	2.2	2.4	2.7	5.1	22.3	6.7	3.8	4.3	2.3	7.3	5.3	3.9	6.0	6.6	23.3	6.2	5.1	10.6	2.3	2.7	8.9	5.9	2.5	3.6	7.3	16.7	3.4	7.9	5.4	2.2	15.0	10.4	11.1	16.2	14.2	15.7	21.6	14.1	11.8	9.8	10.0	7.7	13.1	8.2	15.3	15.5	7.0	17.3	21.3	14.8	12.5	14.5	11.7	5.8	12.7	9.3	10.0	17.9	4.3	9.9	9.5	10.4	21.5	7.0	14.1	19.2	10.9	10.9	9.2	7.3	10.0	8.8	15.7	7.9	3.1	10.6	19.9	18.8	6.4	21.1	14.2	16.8	23.7	7.8	12.2	3.9	18.5	15.6	13.1	9.7	13.3	16.6	18.1	11.3	14.8	5.0	6.7	12.1	21.7	1.1	1.1	0.5	0.6	1.6	0.8	0.6	0.6	0.7	2.3	0.5	0.5	0.9	0.2	1.2	1.4	1.9	0.3	0.4	2.3	2.2	2.5	2.4	2.4	2.6	2.4	2.7	2.3	2.3	2.5	2.2	9.6	9.6	5.0	38.8	7.8	31.2	39.0	15.1	36.5	33.1	8.9	6.7	6.7	1.5	9.5	5.5	252.3	20.3	14.6	5.2	0.0	6.9	26.7	20.2	14.8	7.0	9.0	5.0	38.4	7.2	7.0	11.5	10.7	19.9	5.7	11.9	4.6	4.7	3.9	28.6	56.2	6.2	4.1	3.0	16.3	7.3	10.5	6.9	1.8	23.4	11.5	11.2	7.2	29.1	21.7	9.2	5.4	16.1	14.0	27.6	9.7	2.3	8.1	18.4	0.0	21.0	20.5	35.8	40.3	28.5	29.7	22.4	9.0	17.6	7.0	33.1
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277123-33284832	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.9"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.8;Spermatocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;MOLT-4: 1.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	9.3	8.8	0.4	0.0	0.8	0.0	8.0	1.8	1.2	8.5	0.5	11.7	0.0	8.1	0.0	19.5	6.5	0.0	8.5	0.2	0.4	7.0	1.5	7.6	0.0	1.5	0.9	3.5	3.4	0.0	5.6	0.0	1.2	9.0	0.0	0.0	12.4	0.0	2.5	15.2	10.8	0.0	0.8	12.8	9.5	27.9	0.8	0.0	7.3	0.0	0.0	9.7	11.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	4.6	2.4	1.8	1.8	1.8	3.1	2.5	8.8	1.8	2.4	2.8	5.0	5.7	4.7	4.5	2.0	0.4	0.8	1.8	1.2	0.2	0.4	1.5	0.9	1.2	0.8	0.8	1.3	12.6	12.8	4.8	1.3	12.0	3.2	6.3	18.9	4.0	14.5	7.6	4.2	3.8	15.7	18.9	14.7	4.2	18.4	20.2	38.2	5.9	17.7	36.8	12.1	3.1	11.1	12.6	5.2	1.0	18.4	12.9	8.2	13.3	11.0	10.2	5.0	15.0	0.4	20.3	11.8	1.4	15.8	16.2	22.3	8.6	71.8	7.8	15.2	8.8	4.7	27.2	9.8	54.6	1.5	2.1	20.0	32.6	6.0	6.2	9.1	35.5	6.1	26.0	15.0	6.6	3.3	5.9	81.2	2.7	13.2	4.8	32.0	14.2	5.1	11.2	17.0
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 23.5;RPTEC TERT1: 27.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.6"	"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.0	0.3	2.5	0.9	8.6	0.0	2.6	0.7	3.7	2.2	1.9	22.4	27.3	0.7	1.3	1.6	1.3	5.5	0.0	2.4	4.6	0.2	0.1	0.1	0.0	2.0	2.1	0.3	3.3	0.0	1.8	0.0	1.3	0.4	37.4	0.8	4.5	0.1	0.0	0.8	33.7	0.8	1.3	0.0	5.0	0.4	6.9	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.0	0.9	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.3	0.2	0.6	0.0	2.7	0.1	27.1	1.7	4.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.7	0.2	1.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	8.6	0.7	3.7	2.4	4.6	2.0	2.1	1.3	1.3	6.9	0.7	0.1	0.0	0.0	6.5	0.3	0.0	0.5	0.1	0.0	7.4	8.0	8.1	2.2	10.0	5.3	5.5	0.0	0.0	0.2	196.4	0.0	7.5	0.4	0.2	5.9	0.4	28.9	0.0	3.6	4.7	0.0	0.2	13.3	0.2	4.5	0.8	0.0	0.0	0.0	0.0	4.8	47.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.4	0.0	11.1	1.0	9.2	72.5	0.0	0.0	0.6	94.1	0.1	1.5	0.2	0.0	0.1	0.4	0.1	1.7	0.5	0.0	0.0	0.5	0.0	57.7	9.7
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134412242	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 195.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	0.2	4.2	146.6	0.4	135.6	1.0	3.9	114.3	195.2	0.4	32.5	0.9	0.5	1.4	0.2	0.2	0.4	0.3	0.3	191.8	85.5	1.8	5.8	0.6	2.1	133.6	145.2	0.2	0.4	0.0	4.5	0.1	118.9	2.8	0.1	23.8	1.2	0.4	0.1	0.5	0.6	0.1	115.0	1.4	34.9	0.9	133.6	0.4	6.2	0.2	0.4	0.7	0.3	176.0	0.0	0.0	23.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.9	1.2	1.6	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.1	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	22.1	1.1	0.0	0.4	0.0	1.7	0.0	0.1	3.1	8.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	146.6	135.6	114.3	195.2	191.8	85.5	133.6	145.2	118.9	115.0	133.6	176.0	0.1	0.0	0.0	27.4	0.1	0.0	0.0	0.0	0.0	37.0	1.2	0.8	1.1	2.8	0.0	0.0	4.2	0.0	14.4	0.1	0.0	0.0	1.8	0.1	0.1	0.4	1.8	0.4	37.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	4.7	0.1	23.5	30.4	0.0	0.0	0.3	0.0	3.9	0.0	0.2	0.0	3.7	0.0	116.2	15.5	33.2	77.8	0.0	0.0	0.4	7.5	0.9	0.0	1.9	0.0	8.6	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	3.8	0.0	0.0	0.3
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957060	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8;retina: 18.4"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 319.7"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.4	0.4	13.9	0.5	20.9	0.4	1.1	12.5	14.5	1.4	6.9	0.9	0.6	0.7	0.1	1.0	0.7	0.2	1.0	25.9	16.2	0.6	0.9	1.0	0.5	20.9	19.1	0.8	1.4	0.0	0.8	0.1	23.7	0.9	0.0	18.4	1.2	0.0	0.8	1.5	1.0	0.1	23.8	0.7	1.1	0.9	16.9	0.5	1.0	0.0	0.0	1.1	1.4	29.8	0.3	0.0	0.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.2	0.2	0.0	0.2	21.8	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.0	13.9	20.9	12.5	14.5	25.9	16.2	20.9	19.1	23.7	23.8	16.9	29.8	4.5	0.0	2.2	23.8	9.7	25.5	11.9	19.4	0.0	16.5	7.2	1.7	1.0	11.5	9.0	16.5	22.9	6.0	10.0	13.0	0.0	5.6	9.7	3.6	5.4	7.7	0.0	3.2	2.5	3.9	3.9	6.9	2.0	6.0	0.0	2.5	9.3	10.7	7.5	319.7	8.2	4.9	16.2	10.0	27.0	6.0	19.9	5.1	14.2	0.0	11.6	15.2	30.9	32.2	0.2	9.1	15.5	13.5	3.7	16.9	23.3	1.4	3.4	22.5	13.1	5.8	5.8	18.7	36.7	1.2	19.9	7.1	15.1	2.1	6.2	12.2
B3GAT3	GlcAT-I	ENSG00000149541	"Beta-1,3-glucuronyltransferase 3"	O94766	11	62615296-62622154	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051328	Approved				"Intracellular and membrane"	NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA051328: AB_2681444"	"unprognostic (1.55e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (4.94e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.58e-2)"	28.2	30.0	63.4	17.0	63.8	18.2	27.4	67.0	81.8	33.7	65.9	27.8	17.2	30.0	11.5	21.0	30.0	15.3	23.1	64.0	66.7	52.1	48.7	29.0	26.2	72.3	64.3	32.3	30.7	19.1	55.7	19.1	76.5	37.1	6.9	16.0	25.9	18.2	14.3	33.9	27.8	14.0	63.3	40.0	28.9	23.9	67.1	18.5	30.1	6.8	10.8	30.5	25.7	69.7	36.0	57.3	32.0	55.0	40.0	38.7	23.4	28.3	38.9	26.7	29.4	25.4	52.3	33.4	91.1	29.5	70.6	24.5	30.8	28.7	6.2	71.5	61.3	17.0	25.9	32.8	96.8	21.4	34.8	69.1	47.6	35.0	15.3	42.4	25.3	37.9	51.5	76.7	33.9	89.1	38.1	76.7	47.5	18.9	55.1	36.7	22.5	175.4	55.0	7.2	33.6	53.1	32.6	38.2	134.6	10.6	52.9	41.6	18.6	28.6	20.8	75.2	54.4	79.3	28.7	37.6	82.3	41.0	56.0	32.0	29.3	27.4	21.6	31.8	14.0	18.5	14.9	17.7	25.8	15.3	14.8	17.2	8.6	41.0	33.8	15.5	19.9	16.4	63.4	63.8	67.0	81.8	64.0	66.7	72.3	64.3	76.5	63.3	67.1	69.7	33.2	6.4	13.2	22.2	36.8	19.8	39.0	53.3	51.2	52.3	33.1	44.4	4.2	31.5	26.1	40.5	33.3	77.0	45.3	26.5	15.6	33.8	0.4	20.0	36.3	22.8	25.2	24.4	19.1	46.3	61.3	34.8	25.5	24.1	1.3	45.3	23.2	28.4	67.8	48.8	25.3	23.9	57.0	35.2	17.5	3.2	36.1	34.4	44.4	8.4	45.3	52.5	49.4	14.6	19.5	36.4	31.2	22.6	51.0	30.6	27.3	16.2	15.2	49.6	26.3	22.3	33.7	6.8	25.8	21.9	19.5	43.5	41.7	31.9	28.3	21.0
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813576	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;salivary gland: 31.4;stomach 1: 43.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 65.8;Cytotrophoblasts: 78.9;Distal enterocytes: 108.4;Paneth cells: 67.4;Proximal enterocytes: 50.5;Syncytiotrophoblasts: 68.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 44.2;BEWO: 40.9;CAPAN-2: 112.5;OE19: 102.1;RT4: 41.3;SK-BR-3: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA		74000	"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.3	0.1	0.3	5.7	0.1	0.2	3.4	0.7	0.4	4.4	0.3	44.0	32.6	0.4	0.0	21.7	1.0	23.8	0.0	0.3	0.3	3.8	2.4	0.5	0.5	0.3	0.2	0.1	3.9	0.5	0.0	12.6	0.3	2.2	40.5	0.0	31.4	3.2	0.0	2.7	29.5	1.7	0.0	0.1	43.2	0.1	0.1	0.2	0.3	0.0	4.7	18.5	8.1	0.5	44.2	12.5	0.0	0.2	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.7	112.5	0.0	28.9	0.0	0.1	4.2	0.0	12.9	0.0	0.0	0.2	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.2	0.1	0.4	102.1	19.2	0.2	0.0	1.2	23.9	41.3	0.0	0.1	0.0	38.4	0.0	0.0	1.7	0.2	0.1	0.3	3.3	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.3	0.3	0.2	0.3	0.0	0.1	0.5	0.1	0.0	2.3	0.0	0.2	0.1	3.6	5.1	0.0	0.0	7.1	6.2	0.4	65.8	17.1	16.5	0.0	78.9	0.5	108.4	1.9	17.9	0.0	3.8	0.8	2.3	16.3	0.0	0.1	28.4	7.5	0.7	19.9	7.7	5.7	0.0	0.7	0.2	6.0	0.0	0.2	40.7	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	33.2	67.4	0.0	0.0	7.8	50.5	3.5	7.7	0.0	0.0	0.0	0.9	0.2	0.3	0.2	0.0	68.3	0.2	0.5	28.4	39.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203681-122208952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.2	0.7	2.3	0.1	2.6	1.5	0.2	4.9	3.1	0.3	0.0	0.3	0.2	0.1	0.0	1.3	0.6	0.2	0.1	3.8	0.5	2.7	0.4	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.1	0.0	0.4	0.0	0.5	0.5	0.0	0.2	3.1	0.3	0.0	0.0	0.5	0.3	1.6	0.9	0.0	0.4	0.0	0.1	0.1	0.5	1.2	3.4	0.6	0.2	1.4	0.1	0.1	0.6	0.1	0.0	0.2	0.3	2.2	0.3	0.3	0.5	0.0	0.2	1.3	1.7	1.2	0.1	5.1	1.9	0.1	1.3	0.2	0.4	0.5	0.7	0.3	4.0	0.1	0.2	0.5	0.0	1.3	1.0	0.4	0.0	3.2	0.0	0.5	0.4	0.1	1.4	0.2	0.4	0.7	0.5	0.4	0.8	1.1	0.9	0.7	0.4	0.5	4.2	0.1	0.1	0.3	1.7	0.4	0.2	0.4	3.6	0.8	0.3	0.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.3	2.6	4.9	3.1	3.8	0.5	0.0	0.0	0.0	0.0	0.9	1.2	0.4	0.0	1.8	0.7	0.3	1.3	0.7	3.3	0.6	0.2	0.7	0.8	0.5	0.0	1.1	0.0	0.0	0.5	0.5	0.6	1.9	1.0	0.4	0.6	0.3	0.3	0.0	0.0	3.2	0.2	1.1	0.3	0.0	0.8	0.0	0.1	0.4	0.0	0.2	0.0	1.4	0.0	2.0	0.6	0.6	0.1	0.3	0.3	0.0	1.9	0.0	0.2	0.0	0.5	0.6	0.4	1.3	0.0	0.4	0.3	0.1	9.7	1.1	0.2	0.0	0.5	0.2	0.8	2.9	0.8	1.4	0.5	0.4	0.1	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253253-183298504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 14.7"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	11.9	2.4	3.3	13.7	3.5	76.5	5.5	2.3	3.2	6.0	0.9	22.6	38.2	5.1	9.1	37.5	9.6	21.3	3.5	3.7	4.0	3.8	3.3	15.0	1.1	5.6	3.8	4.6	7.5	3.5	5.7	13.9	4.6	7.9	19.6	1.2	10.1	3.3	7.4	10.3	42.0	6.7	4.3	1.6	11.3	7.3	3.5	7.6	5.2	4.5	5.3	24.2	13.8	5.5	46.2	4.4	23.8	14.7	19.5	57.0	21.5	0.7	1.1	4.6	3.8	9.0	23.6	0.0	2.7	0.1	82.4	20.6	24.7	70.3	3.9	0.1	15.3	2.4	1.9	0.0	24.8	23.4	10.9	27.0	83.5	3.7	62.1	6.2	43.4	0.1	26.6	0.1	38.1	0.0	0.1	7.6	10.1	26.9	38.5	7.3	12.0	0.1	14.4	12.7	1.0	22.6	12.7	0.1	5.3	10.6	0.0	28.0	64.6	1.1	9.0	1.4	11.0	0.0	0.0	0.0	8.8	54.1	23.8	0.0	1.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.2	0.3	3.3	3.5	2.3	3.2	3.7	4.0	5.6	3.8	4.6	4.3	3.5	5.5	151.2	6.4	17.5	2.3	1.2	65.1	70.2	35.8	101.3	10.0	18.4	10.4	2.2	21.5	40.5	5.5	22.9	31.0	1.9	150.4	1.9	18.0	13.4	58.0	13.1	26.3	38.2	6.3	1.8	11.8	10.7	9.2	70.3	55.3	14.0	2.4	2.2	0.6	29.6	3.3	1.5	88.2	34.6	15.6	123.2	26.5	1.5	76.8	12.4	80.6	9.4	3.1	0.0	4.5	0.8	35.7	126.4	0.4	1.4	43.1	74.9	4.8	118.5	13.1	0.0	23.6	5.4	7.9	0.8	169.9	84.8	157.9	4.3	0.2	36.2	144.4
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.8;salivary gland: 6.4;stomach 1: 24.9"	"Group enriched"	"Detected in some"	20	"Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.8	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	16.8	0.0	6.4	0.0	0.0	0.0	7.0	0.3	0.0	0.0	24.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.0	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	23.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	60.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.4	0.0	0.0	0.3	1.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.2
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395710-231401164	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		3600000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.1	12.9	5.9	2.8	5.1	14.2	3.8	4.0	5.8	2.5	4.6	56.2	25.2	1.9	6.8	2.9	4.6	14.0	4.7	5.6	6.5	2.2	1.2	15.3	1.6	6.0	7.0	16.7	25.4	14.3	8.8	5.4	5.3	3.2	71.2	2.1	7.5	4.4	0.4	5.0	28.4	2.3	4.3	5.1	35.6	1.3	7.3	2.4	8.4	0.3	1.5	3.7	0.6	5.4	0.7	2.8	0.3	0.6	0.1	0.2	1.0	0.2	1.1	0.1	0.1	1.4	19.5	2.2	5.8	0.3	0.2	5.1	0.2	0.0	0.1	0.3	0.5	15.6	0.5	0.9	0.1	0.1	0.8	0.1	1.4	0.2	0.3	1.1	0.2	0.4	0.5	0.4	0.1	0.9	0.2	0.7	6.3	7.7	3.3	0.3	0.1	0.4	0.6	1.7	0.5	0.8	0.3	1.7	0.7	6.9	0.6	14.0	0.2	0.4	0.4	0.2	0.2	2.3	0.9	0.7	0.3	0.2	23.7	0.7	0.1	0.7	2.9	0.5	0.5	9.9	0.1	0.4	6.5	7.0	0.1	0.7	0.2	32.1	0.6	3.1	0.2	1.0	5.9	5.1	4.0	5.8	5.6	6.5	6.0	7.0	5.3	4.3	7.3	5.4	0.9	41.7	30.2	0.3	8.7	2.3	1.7	8.7	0.0	0.4	5.2	2.5	1.1	95.8	29.7	1.8	2.1	0.6	61.7	272.8	0.0	16.1	0.4	13.3	2.2	4.7	103.0	0.4	0.5	84.3	64.9	2.3	51.5	18.5	9.5	17.3	3.3	0.2	11.2	0.0	0.4	145.2	18.3	10.1	38.6	1.2	1.5	9.7	3.6	0.0	2.9	0.5	10.3	55.3	0.2	69.8	126.4	8.2	5.5	11.6	93.2	0.4	82.2	1.8	0.0	0.5	2.3	0.9	1.4	0.0	2.7	2.1	10.0	0.4	354.6	16.2
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.5;vagina: 19.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.2;Distal enterocytes: 58.1;Ionocytes: 44.7;Paneth cells: 45.0;Proximal enterocytes: 68.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"basophil: 95.0;eosinophil: 117.5;neutrophil: 159.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 159.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.5;HUVEC TERT2: 3.5;K-562: 3.1;THP-1: 3.4;U-937: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		57000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	2.3	1.2	0.2	1.6	0.4	3.9	2.0	1.1	0.4	11.1	0.2	10.5	15.5	2.4	0.3	44.5	1.8	0.5	6.4	0.1	0.2	3.9	0.5	9.0	0.7	0.5	0.2	0.8	1.5	0.5	1.9	0.5	0.6	3.3	2.7	0.1	6.3	2.6	0.8	5.3	15.3	0.8	0.0	8.6	2.0	0.2	0.3	0.3	1.2	0.9	1.6	2.7	19.5	0.7	0.2	0.0	0.2	0.0	0.3	1.4	0.3	0.4	0.1	0.0	0.0	2.1	0.0	0.1	0.5	1.0	0.0	1.4	0.0	0.3	0.0	0.1	0.2	0.0	0.1	1.1	0.5	0.5	6.5	1.7	1.2	0.0	0.0	0.0	3.5	0.1	3.1	0.2	0.0	0.5	0.0	2.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.7	0.9	0.6	0.0	0.1	0.0	0.2	0.0	3.4	1.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	5.5	0.0	95.0	16.3	117.5	2.4	12.3	28.4	0.0	1.2	5.2	6.0	0.0	0.1	0.6	159.0	1.5	26.5	0.5	0.6	7.1	0.2	0.4	1.1	0.4	0.1	0.2	0.5	0.2	0.6	0.0	0.3	0.7	0.9	6.4	37.2	0.0	0.0	1.8	5.2	16.3	2.2	0.4	1.4	2.2	0.5	0.0	10.6	23.9	0.0	0.9	0.3	58.1	3.9	5.8	0.0	0.8	0.5	1.7	15.0	1.3	0.1	0.6	2.1	3.0	0.5	1.8	5.1	0.1	2.5	0.0	11.2	0.0	0.1	23.8	44.7	8.8	0.6	0.0	1.5	5.6	0.0	0.0	3.8	0.1	1.0	0.0	0.1	2.9	45.0	0.7	0.1	7.4	68.7	0.3	3.5	0.4	0.0	0.6	2.7	0.0	0.1	20.5	1.7	2.3	1.2	0.0	18.5	13.4
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148104-67150998	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	7.7	8.4	7.1	4.2	8.0	0.2	5.7	7.5	6.8	15.0	8.4	7.6	3.2	13.4	7.3	5.2	13.7	6.8	13.8	7.1	8.0	7.4	2.5	9.0	2.9	8.7	9.7	15.0	3.5	21.8	20.5	7.9	8.7	11.8	3.3	1.4	9.0	14.8	1.9	5.9	5.6	7.8	9.3	5.6	6.1	6.0	7.7	1.5	18.7	2.1	2.5	11.7	8.9	11.1	4.9	8.8	0.7	0.9	27.7	28.6	1.0	22.5	36.2	14.4	18.5	4.0	0.8	0.6	1.5	34.9	6.0	11.1	0.3	1.0	7.8	7.6	3.2	0.7	9.7	3.5	22.3	0.6	0.5	23.7	8.3	14.0	0.4	35.8	2.0	0.5	1.0	2.7	22.6	2.6	2.6	1.2	5.4	3.8	7.7	7.4	12.9	4.4	2.3	6.0	5.0	11.2	50.9	0.2	0.8	4.3	1.3	3.9	4.6	25.6	1.1	25.9	10.2	3.2	2.4	0.8	31.9	1.3	12.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	8.0	7.5	6.8	7.1	8.0	8.7	9.7	8.7	9.3	7.7	11.1	1.2	6.4	5.0	1.0	1.2	3.2	2.8	2.4	9.6	1.6	3.2	2.3	2.6	5.7	2.4	3.7	0.0	0.3	0.1	0.4	0.0	1.3	5.3	2.5	7.6	2.0	2.4	0.0	0.4	1.7	0.5	12.9	2.6	2.2	0.0	3.0	6.4	0.1	1.8	0.0	1.3	0.9	2.0	0.6	3.3	6.9	11.5	0.4	1.8	0.0	0.1	0.9	0.0	1.0	2.3	0.9	0.1	13.5	4.7	2.4	0.1	0.9	4.2	0.3	6.6	3.2	6.6	4.4	2.8	2.7	4.1	0.8	1.5	2.9	0.8	1.3
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 19.9;Respiratory ciliated cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.1;HL-60: 27.0;THP-1: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	2.9	2.8	1.8	2.9	2.1	7.8	2.4	1.4	2.3	3.5	3.9	2.0	1.7	3.7	1.2	2.4	3.7	1.3	3.0	1.9	1.4	1.9	2.4	3.0	2.3	1.3	1.5	3.9	2.3	0.8	2.6	1.4	1.6	2.6	0.9	0.5	2.1	1.5	3.8	2.3	2.1	1.8	1.3	4.2	2.0	3.0	2.1	2.3	2.4	1.4	1.1	3.1	2.5	1.6	11.9	7.8	0.2	3.7	2.1	6.6	4.7	4.2	3.7	4.8	3.7	4.7	25.1	5.8	8.1	5.2	11.7	2.2	1.9	0.0	4.1	8.9	5.1	12.2	12.6	16.0	7.5	27.0	0.5	2.4	2.1	2.9	4.8	2.4	5.9	8.9	5.4	5.5	3.9	2.7	7.6	10.3	1.8	8.1	5.6	9.8	0.9	0.4	2.7	2.5	2.4	0.9	3.6	2.7	3.7	3.4	0.0	25.5	9.7	9.2	6.2	1.4	7.6	1.1	2.9	4.4	10.3	3.6	1.3	3.0	6.0	1.0	2.8	5.9	4.4	3.0	4.4	3.3	10.4	5.5	3.9	4.7	19.0	3.2	3.2	4.1	13.5	4.0	1.8	2.1	1.4	2.3	1.9	1.4	1.3	1.5	1.6	1.3	2.1	1.6	2.6	3.2	4.5	4.6	2.9	1.0	2.0	4.4	3.4	3.5	3.0	3.0	2.8	1.5	6.4	5.5	4.2	5.7	3.6	1.3	1.9	1.9	15.3	6.8	4.2	2.3	1.2	7.6	11.3	1.0	3.1	4.0	3.1	1.9	7.0	7.6	1.4	2.0	7.7	3.3	9.2	1.5	6.1	7.3	2.8	19.9	3.1	8.9	1.8	6.5	5.5	1.3	8.2	5.0	4.7	2.1	2.7	4.9	5.2	2.8	0.2	2.4	20.7	3.5	0.0	2.5	2.3	0.9	5.0	5.6	1.7	1.9	6.8	4.8	3.5	2.1
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Distal enterocytes: 3.9;Glandular and luminal cells: 5.2;Intestinal goblet cells: 11.5;Ionocytes: 4.1;Proximal enterocytes: 14.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015721	Approved					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	1.2	1.3	1.4	7.8	1.0	4.7	0.7	6.6	2.1	0.2	2.3	33.5	2.1	1.1	0.6	0.7	0.4	2.2	1.0	1.7	0.8	9.1	0.9	1.4	2.2	0.7	0.4	1.0	1.7	0.1	0.0	0.7	0.5	0.7	14.2	7.5	2.0	0.3	0.8	2.8	8.4	2.7	0.0	2.2	5.9	1.5	1.1	0.2	5.9	0.1	0.8	0.6	0.0	1.5	0.9	1.7	1.7	3.0	0.1	0.0	0.9	1.3	1.0	0.0	0.1	4.0	1.4	2.1	2.1	0.0	0.6	0.9	0.7	0.1	0.2	1.8	1.8	2.2	5.1	2.1	0.0	1.1	3.5	0.2	1.4	0.3	0.2	0.7	0.0	1.6	1.3	3.3	0.0	1.1	1.4	1.5	2.1	0.3	0.8	2.5	0.7	0.6	5.4	1.4	1.4	1.5	0.6	0.7	0.6	1.7	1.8	1.4	0.6	2.2	1.3	1.3	0.7	2.6	0.9	2.3	0.7	1.4	0.9	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	1.0	6.6	2.1	1.7	0.8	0.7	0.4	0.5	0.0	1.1	1.5	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.3	0.5	0.0	0.9	5.5	0.0	0.0	0.0	3.9	1.9	0.6	0.7	0.6	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	4.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	14.8	0.1	0.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.1
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		3100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	29.0	19.0	61.4	13.0	55.0	6.6	24.6	48.0	70.1	28.4	44.0	43.7	12.5	31.0	9.6	32.4	20.0	14.9	40.8	58.4	51.6	24.6	38.8	19.6	5.9	53.6	53.6	19.6	51.5	14.2	24.7	10.1	53.0	31.2	10.2	8.9	27.3	23.8	61.0	32.8	15.2	26.3	52.6	12.0	22.4	22.6	55.2	3.1	14.3	33.2	6.8	37.0	26.8	52.6	61.6	38.4	45.3	76.0	51.3	54.5	37.8	54.2	55.9	54.8	50.9	30.4	51.4	38.4	31.6	112.3	52.5	39.9	36.8	72.8	14.0	39.6	80.2	23.2	37.8	66.9	43.2	20.6	0.8	47.0	79.1	39.3	71.4	55.3	65.5	15.9	51.7	25.3	46.7	45.3	15.3	18.6	65.6	35.7	56.7	44.3	48.2	62.7	33.9	29.3	72.7	58.5	31.1	89.4	38.5	16.9	38.6	17.5	39.3	90.8	102.4	63.8	78.5	7.6	17.8	15.9	40.4	16.9	64.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	61.4	55.0	48.0	70.1	58.4	51.6	53.6	53.6	53.0	52.6	55.2	52.6	9.7	0.0	8.8	7.5	2.2	7.8	10.3	10.8	1.8	13.3	15.0	18.9	14.0	7.2	7.4	14.7	4.2	2.0	1.2	10.2	1.9	13.3	16.4	6.2	16.2	10.4	16.3	1.3	8.0	20.6	8.0	15.2	13.7	8.7	0.0	23.8	6.1	18.7	2.3	18.5	5.6	22.6	2.0	1.0	3.3	6.7	16.4	1.5	3.6	1.0	1.6	15.0	0.0	5.0	9.8	27.3	6.1	12.4	5.0	25.9	6.4	8.8	4.4	12.2	6.6	9.8	14.3	6.2	15.6	7.6	12.6	0.5	1.7	21.1	15.3	16.1
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 114.8;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		130000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	28.4	21.9	20.0	16.0	20.5	19.0	21.6	17.9	21.1	21.8	18.6	19.4	17.2	14.7	18.3	25.1	19.0	14.4	24.9	20.5	22.0	27.7	22.5	25.1	23.4	18.4	19.3	29.0	34.0	21.9	32.5	21.7	19.1	21.8	17.5	8.0	32.3	12.3	24.6	24.6	18.6	10.6	18.2	31.2	27.6	19.4	22.9	16.9	21.9	16.3	20.7	23.7	21.4	19.3	35.2	22.3	32.8	43.6	47.5	24.7	52.5	19.2	34.7	39.6	36.3	44.8	68.4	32.2	54.2	22.1	37.8	34.3	34.9	21.7	22.8	34.1	42.5	18.6	14.2	35.8	34.1	37.0	48.6	33.7	31.1	36.5	39.6	47.0	45.2	41.3	60.3	69.3	32.2	35.4	24.1	34.4	40.9	70.3	48.0	28.5	18.2	79.4	33.5	20.9	46.6	54.7	19.7	50.4	41.7	44.2	50.7	64.8	18.9	19.5	35.4	22.4	57.7	246.6	146.5	43.0	28.5	31.2	32.0	10.7	14.9	12.6	27.0	17.2	24.3	26.2	25.9	26.0	18.0	21.2	25.0	23.2	9.7	25.9	23.3	37.4	43.1	21.0	20.0	20.5	17.9	21.1	20.5	22.0	18.4	19.3	19.1	18.2	22.9	19.3	18.1	19.2	20.0	1.6	34.7	38.5	36.6	26.2	19.9	17.3	32.8	19.9	10.2	15.7	17.7	25.8	2.1	44.8	30.3	15.3	5.9	28.7	10.1	8.2	7.8	24.4	28.8	34.5	6.2	22.9	91.7	24.7	15.3	10.9	9.5	21.0	27.8	13.2	29.7	26.9	7.1	20.7	26.4	16.6	17.9	5.7	9.6	16.2	23.2	4.7	10.2	9.4	47.4	5.0	4.5	31.4	20.0	7.2	114.8	46.1	19.0	20.9	12.4	8.6	26.3	11.1	24.7	14.9	46.9	21.7	41.9	114.2	29.5	11.8	22.7	51.4
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119240946	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 76.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.6;Urothelial cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	12.4	9.1	6.8	10.7	8.4	20.1	11.1	6.5	8.1	16.4	8.7	30.6	28.6	14.8	76.0	17.7	21.8	33.2	12.9	7.0	6.9	24.1	16.6	9.9	9.9	6.9	6.7	18.4	19.5	15.1	18.2	25.7	6.9	13.7	35.2	9.9	12.2	14.7	6.3	14.1	32.5	13.6	7.0	9.4	29.3	8.3	7.5	7.4	16.4	6.5	11.5	37.6	10.5	7.2	60.1	100.3	12.8	9.8	36.0	31.1	65.3	125.8	54.4	54.4	56.2	65.4	18.3	11.8	23.9	61.3	32.2	78.6	20.7	15.0	59.9	23.5	6.8	15.1	20.3	31.7	25.3	8.9	15.7	21.2	21.4	23.0	19.3	21.6	5.8	8.0	11.2	11.7	25.5	18.4	5.3	10.7	17.6	34.0	27.2	4.9	11.8	4.7	31.2	60.3	10.9	24.0	29.4	14.6	27.9	28.2	30.2	5.7	4.9	27.3	24.0	15.2	13.5	27.2	21.5	16.1	23.5	10.1	23.5	20.1	4.1	8.3	13.3	5.2	7.3	4.2	7.3	7.9	5.5	3.2	13.6	7.1	2.5	14.8	5.0	3.4	2.7	5.7	6.8	8.4	6.5	8.1	7.0	6.9	6.9	6.7	6.9	7.0	7.5	7.2	8.5	0.0	9.4	7.2	17.1	10.7	22.2	48.9	12.0	10.8	14.9	12.4	9.2	61.5	69.1	7.3	4.2	36.2	46.0	43.2	1.9	30.7	2.1	40.1	16.9	8.4	13.8	7.8	11.9	33.2	123.6	24.0	36.2	74.5	13.3	35.0	3.9	10.8	14.4	18.5	11.1	78.7	16.2	9.8	14.8	2.4	14.9	14.9	14.2	6.5	10.9	22.2	39.1	10.6	10.2	40.5	50.2	28.2	27.4	30.7	59.3	22.6	52.6	10.2	19.7	13.9	16.9	1.7	8.4	14.0	10.5	52.3	23.1	20.0	23.6	171.6
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.3"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 101.3;Cone photoreceptor cells: 39.6;Excitatory neurons: 71.5;Inhibitory neurons: 103.7;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 46.8;WM-115: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.8	12.1	2.0	2.7	3.1	4.5	1.3	8.4	10.2	1.1	1.6	3.4	7.2	1.9	2.0	4.5	2.3	6.6	3.6	5.2	4.8	3.2	2.6	1.1	1.4	1.2	2.7	3.8	1.9	7.4	1.8	2.6	2.1	5.1	3.3	25.3	4.5	3.8	3.5	2.1	9.2	1.7	0.9	1.6	3.0	5.2	5.0	6.3	2.0	6.4	1.1	2.4	0.6	0.4	6.0	13.1	23.7	13.4	0.4	0.5	8.7	1.9	0.0	0.4	0.2	25.2	5.0	9.4	10.9	2.3	28.4	2.4	12.7	10.7	1.5	37.1	11.2	12.4	1.3	0.6	2.6	22.6	2.0	2.4	2.3	3.6	7.5	12.0	13.3	21.9	1.8	0.0	0.1	3.6	25.4	1.7	10.2	7.1	7.2	46.8	4.2	0.0	2.9	12.3	12.6	19.7	8.7	1.5	15.7	19.1	1.7	6.8	13.4	26.5	5.5	0.0	14.9	8.9	0.5	19.4	10.8	20.2	126.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.0	0.1	2.0	3.1	8.4	10.2	5.2	4.8	1.2	2.7	2.1	0.9	5.0	0.4	3.2	0.0	0.5	12.7	0.0	5.5	0.9	1.5	12.0	101.3	2.0	1.8	7.6	0.0	1.2	1.8	39.6	0.6	5.9	2.6	3.9	1.3	6.1	1.2	6.2	3.6	3.0	4.6	71.5	1.1	0.2	3.0	2.6	1.3	0.0	4.5	4.2	2.1	0.7	13.5	103.7	2.1	0.0	0.6	1.2	3.5	1.2	1.5	0.0	9.4	0.3	4.6	6.2	81.4	5.3	2.3	3.1	2.6	1.1	2.3	5.4	1.2	0.6	5.6	0.0	1.2	1.6	1.0	9.7	3.7	1.7	0.3	1.4	1.4	3.8	0.7
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600132-177610330	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	19.0	43.7	21.1	15.3	20.1	24.8	17.0	20.6	25.5	18.4	21.8	15.1	16.9	20.1	12.5	16.6	16.0	12.5	23.4	20.1	21.8	20.2	30.5	13.4	20.1	24.8	25.1	19.8	37.6	24.3	31.5	14.1	24.8	22.5	11.9	5.9	24.2	18.8	20.2	13.6	14.7	11.8	18.5	21.3	21.8	23.9	22.1	10.6	18.5	10.1	11.8	17.9	13.9	18.7	20.2	34.5	14.2	35.6	28.0	20.7	63.7	30.1	31.9	26.9	30.7	32.6	30.8	25.2	54.7	30.9	47.3	22.9	9.8	64.9	11.7	85.4	25.8	13.3	27.5	23.4	40.0	13.8	22.4	31.8	22.7	29.0	23.5	24.7	30.3	16.9	11.8	23.7	27.4	46.0	11.9	17.1	13.9	17.7	50.0	24.1	10.3	27.8	20.6	29.6	12.5	14.4	15.0	29.8	27.6	11.3	19.4	16.3	23.5	34.0	19.5	22.6	30.6	29.5	14.9	18.4	28.8	33.0	31.8	16.8	16.7	9.7	14.0	19.7	12.6	14.4	12.8	12.2	19.3	18.4	11.4	11.3	1.3	11.1	19.4	15.2	9.2	10.9	21.1	20.1	20.6	25.5	20.1	21.8	24.8	25.1	24.8	18.5	22.1	18.7	16.3	3.2	5.6	5.2	24.5	6.6	15.4	27.8	15.9	12.1	16.5	19.3	6.9	12.8	15.8	16.5	4.2	43.8	16.4	13.8	7.9	34.1	13.9	12.5	17.8	15.6	14.5	8.2	4.3	38.9	132.4	21.2	8.2	13.5	10.2	30.0	10.8	15.9	31.7	11.8	6.0	22.2	8.2	17.8	8.9	9.8	14.0	18.8	21.4	3.7	25.6	13.7	13.4	3.0	3.4	34.0	12.4	18.4	52.8	30.7	17.4	19.6	9.3	16.1	0.0	13.9	16.4	14.3	11.3	13.9	8.8	43.9	12.8	33.4	23.3	16.3
B4GAT1	"B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT"	ENSG00000174684	"Beta-1,4-glucuronyltransferase 1"	O43505	11	66345374-66347629	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.3;Horizontal cells: 158.2;Muller glia cells: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015484	Uncertain				"Intracellular and membrane"	NA	NA		57000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA015484: AB_1845235"	"unprognostic (1.80e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.43e-3)"	"prognostic favorable (3.55e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.76e-3)"	16.6	41.4	120.6	6.1	124.9	1.3	16.0	71.0	125.2	23.1	68.7	30.1	16.2	28.5	15.2	8.3	23.4	9.9	44.6	115.3	220.2	25.3	18.8	17.3	6.7	85.9	97.3	34.3	25.5	22.6	62.3	22.5	101.0	17.3	7.7	46.0	15.8	22.4	27.7	12.1	14.6	14.0	91.9	10.2	25.8	8.2	150.4	6.5	21.0	19.2	4.3	20.2	16.3	83.9	10.8	26.7	29.7	36.5	32.6	29.3	39.4	18.4	42.5	28.1	22.9	20.1	14.9	8.9	76.1	16.9	24.1	16.8	32.0	20.6	13.5	17.6	58.2	1.3	20.4	77.6	19.3	7.0	2.7	28.6	15.6	17.5	7.4	92.8	33.5	14.8	8.6	13.7	13.6	18.1	16.7	19.1	20.2	10.6	28.0	24.0	23.2	15.9	29.6	2.7	17.8	33.7	15.8	10.4	74.8	18.4	42.6	6.8	19.7	21.8	15.9	28.0	9.6	26.1	19.2	5.3	36.8	5.8	26.0	0.0	1.2	0.0	7.1	0.4	9.9	5.7	7.8	7.6	3.0	3.2	9.0	8.3	0.4	4.6	0.3	7.4	5.7	4.4	120.6	124.9	71.0	125.2	115.3	220.2	85.9	97.3	101.0	91.9	150.4	83.9	13.5	22.4	10.8	25.8	2.9	0.0	1.6	0.0	14.2	72.3	6.2	12.7	45.9	25.8	1.8	20.2	58.4	57.8	8.6	8.0	5.9	7.4	0.5	3.9	9.7	17.1	4.9	0.8	22.1	6.0	22.6	23.4	6.6	2.6	1.3	22.5	30.4	24.4	12.7	158.2	35.0	8.0	0.0	2.4	0.0	2.4	32.6	2.6	0.0	10.3	1.3	70.1	2.1	22.6	14.2	4.3	4.9	40.6	6.1	2.0	13.3	17.5	2.9	47.4	26.3	21.2	11.8	1.4	2.8	5.8	0.0	18.1	2.6	28.0	7.2	0.3
B9D1	"B9, EPPB9, MKS9, MKSR-1"	ENSG00000108641	"B9 domain containing 1"	Q9UPM9	17	19334308-19378193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 226.2;Endometrial ciliated cells: 99.7;Late spermatids: 171.8;Respiratory ciliated cells: 159.5;Spermatocytes: 141.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022957	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA022957: AB_1848220"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.18e-3)"	7.7	20.9	20.1	3.9	22.0	5.7	12.2	16.5	23.0	14.3	38.1	10.2	6.0	15.4	54.8	9.3	62.7	11.1	13.5	20.7	19.4	26.0	10.4	9.5	3.8	18.9	20.8	15.7	22.1	34.2	60.9	5.1	15.6	11.3	7.5	21.8	11.4	18.1	5.9	7.1	5.3	11.8	17.0	7.4	10.4	65.3	21.0	3.7	39.4	5.4	4.5	8.1	7.9	17.9	66.7	61.2	14.9	20.9	18.8	29.2	18.6	10.9	55.8	35.4	37.5	14.1	17.6	18.0	13.9	21.3	20.6	27.3	11.2	31.6	22.1	6.2	41.0	1.1	30.8	43.8	30.6	4.3	2.9	23.4	24.4	22.2	42.0	50.3	33.2	21.5	10.5	2.0	33.2	57.6	2.1	5.3	10.7	32.0	21.3	11.6	1.6	29.9	74.9	4.5	43.6	10.8	22.8	5.7	15.5	42.7	47.1	7.2	6.4	9.4	23.2	10.4	11.7	11.6	2.3	5.5	23.0	2.4	15.7	0.0	0.6	0.0	0.7	1.8	0.9	2.2	0.5	0.6	0.2	0.4	0.6	0.4	0.0	0.8	1.6	0.3	0.2	1.0	20.1	22.0	16.5	23.0	20.7	19.4	18.9	20.8	15.6	17.0	21.0	17.9	1.5	16.0	11.9	13.4	8.1	3.8	10.7	23.0	13.1	5.8	10.5	13.6	10.9	8.6	19.9	38.6	12.5	4.4	0.7	2.6	64.6	19.8	226.2	99.7	8.1	4.9	20.4	9.0	14.5	14.6	4.8	14.6	12.2	5.9	0.0	9.5	3.3	4.6	5.4	5.0	10.6	12.8	14.2	1.0	1.7	171.8	13.1	2.3	16.0	1.9	1.3	14.0	1.0	10.1	8.2	9.6	2.9	9.8	27.2	11.1	1.3	82.6	159.5	16.6	6.6	7.3	30.8	141.5	26.8	14.2	2.0	2.6	2.1	25.2	7.3	7.0
B9D2	"MGC4093, MKS10, MKSR-2"	ENSG00000123810	"B9 domain containing 2"	Q9BPU9	19	41354417-41364165	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 64.8;Respiratory ciliated cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 127.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042229, HPA042618"	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA042229: AB_10959591, HPA042618: AB_10960695"	"unprognostic (9.25e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-3)"	4.2	8.5	3.9	4.0	4.2	8.8	4.4	3.7	5.6	5.5	8.1	6.6	3.2	6.5	1.9	4.3	10.5	2.7	4.1	4.3	5.4	9.0	5.0	5.5	3.9	4.0	4.6	3.4	4.5	2.2	5.8	2.1	4.1	5.4	1.8	1.2	4.3	3.6	3.0	3.6	5.1	2.4	4.3	7.8	5.5	8.4	5.5	4.7	5.9	1.5	2.2	5.1	3.8	3.8	6.7	22.0	5.8	5.2	2.1	3.4	1.4	4.2	5.0	7.1	4.4	5.9	5.8	1.7	15.6	5.1	3.0	2.0	3.9	5.8	1.7	6.8	5.9	5.6	7.4	5.1	4.2	7.0	12.6	3.9	4.0	6.3	1.6	4.9	8.0	6.1	4.1	5.9	3.4	5.8	6.5	9.0	2.8	3.1	6.6	5.4	1.3	6.0	6.0	4.3	4.9	4.1	7.3	3.1	3.7	1.1	3.9	12.9	11.9	8.1	3.6	4.3	8.4	2.6	2.4	3.9	8.6	7.4	5.4	47.2	32.3	25.6	10.7	19.8	14.0	15.8	19.7	14.7	22.6	10.3	20.5	14.0	127.5	21.0	16.3	26.1	24.8	18.3	3.9	4.2	3.7	5.6	4.3	5.4	4.0	4.6	4.1	4.3	5.5	3.8	4.0	0.0	9.4	2.0	12.0	4.1	9.8	17.3	5.7	1.6	5.9	3.7	2.0	20.0	17.1	20.2	8.4	8.3	8.0	20.1	37.2	17.4	24.2	64.8	5.6	9.9	15.5	4.8	1.1	16.8	14.9	6.1	8.2	7.6	12.6	4.3	10.0	4.6	13.1	0.0	1.1	13.3	18.3	12.9	4.3	36.7	2.8	8.0	3.6	0.0	8.7	5.4	6.2	0.0	0.6	12.1	37.4	6.4	5.5	7.8	9.9	32.6	76.9	6.1	6.6	9.1	6.8	18.4	12.0	3.9	3.3	6.8	10.3	9.2	10.2	12.6
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 721.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.5	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.4	0.1	0.5	0.4	0.3	721.0	0.4	0.0	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	1.0	0.5	0.4	0.4	0.3	0.5	0.1	0.3	0.8	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"adrenal gland: 380.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Distal tubular cells: 84.1;Ductal cells: 53.4;Proximal tubular cells: 84.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017926, HPA048867"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017926: AB_1845443, HPA048867: "	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	30.9	380.0	22.1	21.2	25.2	41.6	27.5	22.9	28.4	31.8	24.6	27.2	18.3	32.1	33.5	24.5	31.0	32.0	54.2	27.4	28.4	54.2	28.6	24.9	20.5	22.4	23.4	36.3	21.7	35.1	32.8	23.3	30.9	24.9	26.2	26.2	20.5	29.0	73.8	25.9	23.0	36.9	18.6	28.6	25.2	27.2	21.1	21.4	24.0	54.8	26.3	31.2	25.3	21.6	39.5	42.8	33.6	35.7	42.4	56.5	33.2	19.4	49.0	36.0	37.2	36.5	39.4	44.4	64.1	47.3	28.9	25.7	27.7	50.9	52.5	37.8	37.1	53.2	17.5	40.9	61.3	28.1	41.5	139.0	43.6	50.3	51.9	45.1	38.7	41.0	27.7	47.3	50.7	33.3	32.8	34.2	25.7	51.4	27.8	29.9	53.6	42.9	104.2	20.4	22.0	35.0	23.0	39.9	40.3	33.9	28.6	36.5	31.7	34.1	45.2	31.7	27.1	53.5	55.8	57.7	63.5	75.6	36.4	106.3	65.6	27.8	57.9	53.1	64.6	50.6	48.7	55.3	86.3	37.6	45.7	43.6	34.3	59.0	55.3	34.4	62.2	56.9	22.1	25.2	22.9	28.4	27.4	28.4	22.4	23.4	30.9	18.6	21.1	21.6	26.7	3.2	19.6	0.0	7.0	0.0	0.0	0.0	0.0	0.0	16.0	18.0	0.0	0.0	5.6	40.5	0.0	46.1	19.0	0.0	84.1	53.4	0.0	22.6	17.4	10.0	0.0	0.0	0.0	44.3	36.8	11.0	0.0	32.5	31.5	23.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	25.8	0.0	0.0	0.0	0.0	20.2	0.0	0.0	4.0	0.0	0.0	84.1	8.7	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	48.2	9.7	44.5	0.0	0.0
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-secretase 2"	Q9Y5Z0	21	41167801-41282530	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	10.0	1.6	2.1	4.3	3.1	0.6	7.7	4.4	2.6	6.1	9.4	7.3	3.5	8.7	1.9	9.4	6.3	8.3	6.2	2.0	4.1	9.8	1.7	4.3	3.1	6.7	3.8	2.7	13.1	2.3	1.5	2.9	5.1	8.3	4.5	0.3	26.8	2.6	2.2	5.0	4.5	4.7	5.5	4.7	22.9	1.0	4.1	1.1	4.6	2.2	3.6	6.7	5.6	8.7	27.4	2.1	12.6	0.0	2.5	2.1	0.1	6.3	0.0	3.9	3.8	0.0	9.6	0.1	12.2	7.1	7.2	8.1	0.0	13.6	1.4	0.0	12.6	6.2	3.3	0.0	1.0	0.0	14.4	5.5	2.8	0.5	2.7	20.9	12.1	6.4	0.0	0.1	6.0	6.1	3.4	0.0	8.5	73.8	12.1	1.0	0.0	9.8	11.5	2.5	0.4	0.1	0.5	53.3	52.6	1.0	12.0	0.1	15.8	7.3	5.3	6.5	10.9	0.1	0.1	0.0	17.8	0.0	46.2	2.9	0.0	5.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	3.1	4.4	2.6	2.0	4.1	6.7	3.8	5.1	5.5	4.1	8.7	55.0	12.8	15.9	11.8	28.6	18.5	91.6	25.6	42.7	0.8	40.3	33.8	9.7	123.0	72.5	20.2	2.1	127.6	0.5	40.5	93.9	146.3	24.3	65.4	19.8	90.2	18.5	22.1	11.7	105.2	64.2	34.0	186.6	115.8	90.7	6.7	35.3	1.0	28.0	0.0	7.5	86.2	44.7	17.0	8.2	16.0	14.3	3.6	179.7	20.6	2.9	3.1	0.0	9.5	46.0	86.6	23.9	18.8	3.2	290.4	7.3	1.4	76.5	0.8	0.0	15.9	23.6	0.6	1.4	43.5	11.8	514.7	6.2	8.7	56.6	134.2
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	60.8	85.1	94.0	13.2	91.1	23.3	58.8	89.0	133.1	64.9	86.6	81.7	26.5	64.8	12.7	72.9	58.8	15.5	118.0	93.1	87.8	87.6	96.1	58.7	14.7	93.4	92.7	55.2	53.7	35.6	55.3	21.7	89.4	79.7	15.1	17.2	57.7	27.6	50.7	70.6	44.7	14.0	89.9	45.0	87.1	55.1	98.9	17.2	75.8	15.1	12.4	65.9	57.7	92.7	95.0	85.1	25.2	38.3	30.0	36.4	36.9	38.2	45.9	60.0	47.5	54.8	53.1	19.5	67.7	37.4	46.9	49.9	16.8	62.7	11.9	77.6	58.7	24.9	81.4	26.1	45.9	20.7	45.0	35.3	53.7	45.8	28.3	45.9	37.5	44.1	10.1	42.9	26.6	94.7	49.8	49.7	9.8	27.7	109.6	46.7	13.8	57.9	36.8	44.3	51.2	67.1	39.2	46.8	49.9	9.6	70.5	32.0	30.3	72.8	48.1	112.8	43.8	79.6	64.0	21.3	59.2	15.6	40.6	88.0	69.7	102.3	52.9	56.7	54.7	58.6	55.4	51.9	50.5	57.5	39.8	40.9	92.4	59.5	55.3	94.0	71.8	51.4	94.0	91.1	89.0	133.1	93.1	87.8	93.4	92.7	89.4	89.9	98.9	92.7	56.3	32.1	45.1	7.8	32.9	103.1	54.1	170.2	51.2	67.7	76.7	74.8	51.6	70.1	66.4	53.3	18.8	162.5	32.4	214.4	137.0	101.2	43.5	71.5	64.8	56.8	104.1	69.2	10.4	109.9	197.8	75.3	53.0	45.4	24.1	58.2	62.4	51.0	73.8	47.1	7.5	141.8	89.5	24.1	72.6	93.3	74.3	32.9	110.3	2.8	52.4	95.9	36.0	4.0	8.9	120.7	210.0	85.4	33.2	62.1	138.1	152.8	83.2	52.0	59.2	36.2	72.6	69.5	25.0	57.7	119.1	255.0	36.0	57.8	117.1	63.4
BAG1		ENSG00000107262	"BAG cochaperone 1"	Q99933	9	33247820-33264720	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1043.2;Late spermatids: 2944.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 437.5;NB-4: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002486, HPA018121, HPA073236"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB002486: AB_563422, HPA018121: AB_1845255, HPA073236: "	"unprognostic (4.49e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-2)"	79.7	76.3	96.6	36.3	106.7	85.0	72.3	102.2	112.3	65.0	106.0	122.5	59.3	59.8	53.9	103.2	54.8	39.1	192.9	86.4	102.8	151.6	83.4	82.5	35.5	107.4	105.2	45.6	91.7	139.6	99.3	47.1	98.8	88.0	75.4	82.2	97.4	68.4	297.7	113.8	66.1	42.7	100.2	66.0	102.5	87.9	104.3	45.1	71.6	206.1	55.2	121.5	78.8	101.6	56.0	56.1	46.8	103.3	69.9	40.9	63.6	46.5	64.6	68.4	69.8	39.7	54.1	181.2	33.6	46.6	24.5	69.8	54.8	37.9	45.0	96.5	52.1	90.2	437.5	62.5	58.9	210.1	110.0	41.5	205.6	32.3	76.8	32.2	82.4	48.0	108.7	92.1	57.8	89.7	152.4	417.0	90.8	73.9	81.2	78.7	63.7	119.6	87.1	164.8	149.1	88.5	192.7	176.9	46.0	18.7	80.5	261.8	44.1	30.5	37.8	89.9	78.0	74.9	125.3	100.4	25.5	114.1	17.7	29.1	20.7	57.9	10.0	22.2	9.0	14.7	11.2	11.9	26.1	25.6	15.7	9.1	10.2	15.3	22.3	33.9	15.2	10.2	96.6	106.7	102.2	112.3	86.4	102.8	107.4	105.2	98.8	100.2	104.3	101.6	107.7	89.8	67.5	5.2	69.4	429.9	279.4	193.3	172.4	84.0	134.1	123.6	144.4	127.2	157.0	218.8	58.4	154.7	113.7	211.4	397.2	135.6	1043.2	109.3	72.2	86.6	198.1	259.1	5.9	189.0	59.9	79.4	104.5	193.3	41.9	36.7	66.8	72.8	104.9	38.7	7.1	287.8	170.9	86.4	162.7	2944.9	85.7	93.9	163.7	2.8	81.0	123.9	88.6	4.5	9.7	131.1	259.2	88.8	110.3	505.4	247.9	286.1	71.8	131.3	98.6	98.5	109.9	87.9	64.4	261.1	561.5	245.9	69.6	103.7	222.4	531.4
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BAG3		ENSG00000151929	"BAG cochaperone 3"	O95817	10	119651380-119677819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 349.1;skeletal muscle: 514.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Supported	Cytosol		NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	73.5	40.3	81.6	16.1	80.6	5.1	40.5	96.9	349.1	41.7	61.3	72.4	12.3	45.2	20.4	86.0	37.7	35.1	153.3	82.1	124.3	42.2	38.4	77.9	8.2	127.2	100.2	33.3	20.5	53.6	36.6	36.0	101.3	39.1	12.6	12.6	50.1	24.5	514.4	61.9	25.9	43.3	106.3	15.9	72.4	23.1	84.1	5.7	31.1	187.8	17.3	60.4	55.3	95.5	100.1	111.2	30.5	39.6	77.2	53.9	56.9	89.1	74.7	66.6	56.8	47.5	47.6	3.8	41.4	76.9	86.6	145.2	31.5	157.2	45.7	49.1	51.8	5.4	28.6	60.1	65.2	0.3	22.1	54.6	89.0	48.6	76.2	70.5	75.5	17.1	43.3	24.0	67.2	142.7	5.5	22.3	12.0	33.1	125.8	0.3	43.2	17.2	50.7	22.3	5.6	5.1	35.4	61.9	47.2	32.9	38.8	13.4	94.8	35.0	30.1	47.8	129.5	22.1	14.0	2.4	65.2	1.5	27.1	0.0	0.6	0.0	0.6	0.7	1.1	0.1	2.4	0.8	0.4	0.0	4.1	1.4	0.2	0.1	0.3	0.1	1.7	0.6	81.6	80.6	96.9	349.1	82.1	124.3	127.2	100.2	101.3	106.3	84.1	95.5	77.8	22.4	43.2	34.9	10.9	79.4	882.2	51.0	414.9	6.1	48.3	62.9	196.0	18.6	48.1	7.3	18.8	41.4	4.9	61.7	27.4	19.4	29.3	56.7	60.0	107.0	38.5	0.8	1.3	25.3	57.0	142.7	51.5	89.1	23.6	7.3	22.5	15.3	33.7	1.7	2.5	87.0	46.8	8.7	95.4	32.8	22.4	146.9	55.2	10.3	4.7	32.6	3.1	1.0	1.2	37.3	69.2	24.0	29.5	225.1	8.3	42.8	39.4	1.7	19.7	141.6	134.3	21.8	18.7	370.2	76.1	73.5	85.6	10.0	53.9	488.1
BAG4	SODD	ENSG00000156735	"BAG cochaperone 4"	O95429	8	38176533-38213301	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013716, HPA018951"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"CAB013716: , HPA018951: AB_1845260"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.50e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-2)"	10.3	5.7	10.8	5.9	12.5	28.6	7.8	10.8	17.8	7.3	3.3	5.5	5.8	6.7	6.8	6.7	5.2	5.5	4.9	13.6	9.0	9.6	16.8	5.7	7.3	9.0	7.5	11.0	5.2	8.0	4.6	11.4	9.0	7.5	5.8	9.6	6.7	7.8	14.4	7.3	5.6	6.0	4.8	6.5	5.5	4.3	10.0	7.5	6.8	6.8	7.6	6.3	5.6	9.8	16.3	18.4	14.9	22.7	27.8	18.5	13.8	16.5	20.3	17.6	19.4	19.0	9.5	19.5	18.1	14.2	11.9	16.4	25.0	14.4	24.2	9.0	14.0	32.8	10.6	27.3	14.0	15.3	13.4	15.5	16.1	18.4	17.7	12.1	10.1	14.0	34.8	11.5	14.7	9.7	27.3	18.0	32.5	12.7	8.2	18.9	17.7	8.9	16.1	17.8	11.4	15.6	13.7	8.9	13.5	13.4	10.7	9.0	14.4	16.3	16.9	27.6	11.1	10.4	16.5	22.9	9.7	17.4	17.2	17.1	13.9	15.1	8.2	11.6	9.7	7.5	7.2	7.9	12.5	7.4	9.3	8.6	8.7	5.6	21.3	6.5	8.4	9.4	10.8	12.5	10.8	17.8	13.6	9.0	9.0	7.5	9.0	4.8	10.0	9.8	10.6	12.8	12.4	15.3	14.7	43.1	13.2	12.7	38.1	18.9	13.1	10.8	11.1	12.8	12.1	20.2	27.1	23.5	10.8	10.4	17.6	11.0	4.0	13.5	14.6	10.9	5.4	19.4	30.6	11.6	19.0	16.2	13.7	16.0	7.6	11.4	12.8	25.5	24.5	13.5	27.5	8.9	6.1	26.7	30.8	4.4	15.2	19.4	37.4	13.1	23.9	10.4	9.2	7.5	20.8	9.1	8.3	13.2	20.6	19.2	15.3	21.1	10.9	11.8	6.6	16.1	12.7	13.3	11.5	24.0	33.8	12.2	14.8	15.7	12.0	18.7
BAG5		ENSG00000166170	"BAG cochaperone 5"	Q9UL15	14	103556545-103562657	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 127.7"	"Group enriched"	"Detected in all"	13	"Early spermatids: 1734.2;Late spermatids: 1796.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016429	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA016429: AB_1845261"	"unprognostic (3.02e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (1.58e-8)"	"unprognostic (2.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.53e-1)"	24.6	11.4	12.7	15.1	13.0	27.8	18.7	15.9	16.7	14.7	15.6	14.8	12.3	16.1	12.6	21.8	16.0	12.9	13.3	13.5	13.2	15.9	11.9	15.5	17.1	12.6	12.4	12.1	12.2	14.0	10.8	14.4	12.8	14.0	14.6	18.4	16.5	14.2	13.1	19.3	12.1	15.1	12.4	18.3	14.9	127.7	12.2	14.9	23.7	13.5	19.1	15.3	12.6	14.3	26.2	22.1	30.0	27.1	27.5	26.5	33.1	26.0	22.6	22.6	19.9	18.0	32.7	47.3	24.5	30.2	20.6	38.4	24.2	34.7	35.6	19.9	15.8	31.3	25.3	16.2	17.4	42.7	31.3	19.3	43.7	23.2	29.3	20.7	24.0	34.4	25.2	34.8	31.2	35.1	37.4	19.9	17.8	43.8	27.4	40.1	34.4	21.6	37.3	58.3	33.0	22.3	34.9	30.3	23.6	20.1	38.9	21.8	28.4	24.4	19.9	37.9	31.2	21.4	34.4	52.7	27.5	22.9	30.9	28.7	13.4	11.9	9.3	14.8	11.9	6.8	11.0	9.0	14.1	7.8	12.8	11.1	9.0	13.0	21.4	5.9	10.6	12.7	12.7	13.0	15.9	16.7	13.5	13.2	12.6	12.4	12.8	12.4	12.2	14.3	51.5	44.8	24.3	10.4	29.4	69.0	44.8	33.3	47.8	37.9	32.9	28.8	21.8	17.2	44.5	35.0	27.1	25.4	40.0	26.5	66.5	24.7	1734.2	78.6	43.7	41.2	31.7	29.5	18.9	19.1	17.7	31.7	26.0	89.5	32.3	19.3	52.5	25.6	22.1	75.7	14.7	25.0	32.6	29.2	26.4	1796.9	49.7	24.4	32.0	11.2	23.6	49.6	36.0	9.0	20.3	27.1	15.2	67.0	18.5	45.2	18.4	31.7	43.3	36.2	32.9	30.3	27.0	129.7	40.4	60.5	89.8	40.8	33.3	33.1	24.3	62.1
BAG6	"BAT3, D6S52E, G3, Scythe"	ENSG00000204463	"BAG cochaperone 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.8;Late spermatids: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	70.1	77.3	10.4	18.1	11.5	24.1	67.7	11.9	10.8	68.0	23.3	69.2	38.1	72.2	26.3	73.6	67.0	15.2	96.3	11.3	12.3	58.1	65.4	71.3	24.6	12.9	11.8	76.0	64.1	23.9	65.4	21.8	13.3	62.2	24.8	16.0	70.7	12.3	204.6	84.2	76.4	17.4	10.0	76.4	65.3	136.8	13.4	23.1	74.6	51.8	28.0	69.8	64.7	12.5	28.3	47.3	63.7	63.0	28.7	47.8	49.0	33.1	34.1	49.1	42.5	121.2	26.5	44.0	98.2	101.2	72.1	22.3	17.3	110.7	19.1	45.4	139.8	62.2	18.8	77.5	42.5	47.4	125.6	37.2	52.8	27.0	24.0	52.9	47.9	76.3	85.7	46.1	82.6	34.4	25.4	46.7	20.1	16.7	23.8	37.0	26.3	52.1	38.3	31.2	29.4	41.6	22.7	27.3	42.0	16.8	112.6	91.2	31.8	57.8	40.0	28.2	53.6	59.9	87.0	88.4	56.0	45.8	40.2	3.3	2.5	2.8	2.2	3.0	1.7	1.4	1.0	1.1	2.2	1.3	1.2	1.4	1.5	1.6	3.4	1.6	0.9	1.9	10.4	11.5	11.9	10.8	11.3	12.3	12.9	11.8	13.3	10.0	13.4	12.5	39.0	48.1	39.9	11.1	39.0	32.1	39.0	44.5	23.3	28.4	34.5	30.2	77.7	42.9	51.3	36.8	18.8	62.2	33.0	82.4	31.3	66.0	261.8	39.1	22.4	40.8	76.7	52.2	7.6	50.0	67.1	38.4	40.8	34.1	48.2	41.4	38.6	45.4	55.9	50.5	8.6	56.4	61.1	39.9	29.9	483.4	33.2	40.5	28.4	12.2	38.5	34.0	44.3	5.0	10.8	64.0	63.4	39.5	51.6	35.0	105.6	47.9	54.6	48.3	39.5	35.4	65.8	115.0	87.9	33.3	35.5	119.4	34.8	31.7	68.8	40.1
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"	Q9P281	17	81395457-81466332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.3;Cone photoreceptor cells: 22.9;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 25.5;MOLT-4: 31.7;NB-4: 108.4;REH: 33.0"	"Low region specificity"	"Detected in all"							"HPA023386, HPA076910"	Approved		Approved	Nucleoli		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoli		"HPA023386: AB_1859537, HPA076910: AB_2732325"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	5.4	4.0	1.8	5.2	4.9	5.0	7.9	6.4	5.8	0.0	4.9	3.3	6.6	1.0	2.9	6.7	3.1	4.0	3.2	2.6	5.6	3.2	4.4	0.7	4.3	3.6	7.7	5.2	2.1	5.2	0.9	3.3	5.6	0.9	2.1	3.7	1.9	3.8	3.8	4.3	1.5	1.1	3.7	5.7	4.0	6.0	4.0	8.3	0.9	0.4	5.9	4.0	7.6	4.1	6.9	4.9	16.3	1.7	2.6	2.3	3.0	2.6	1.6	0.9	1.3	1.8	0.1	4.3	3.4	2.3	4.1	2.4	1.9	0.3	0.0	7.5	5.6	1.8	2.1	1.5	25.5	5.2	4.4	0.7	1.4	1.4	2.5	1.8	6.2	4.0	0.0	0.7	2.4	31.7	108.4	0.3	2.5	4.6	33.0	3.4	0.0	2.0	0.3	22.5	3.5	3.8	0.0	13.3	0.5	0.8	20.3	2.2	8.8	1.2	4.8	1.5	0.0	0.0	0.0	0.0	11.6	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	5.2	7.9	6.4	3.2	2.6	4.3	3.6	3.3	1.1	6.0	7.6	6.7	6.4	13.1	11.4	0.0	0.0	1.5	0.0	3.4	47.3	4.8	4.3	10.0	8.6	3.7	3.7	22.9	0.1	4.4	2.4	1.9	3.3	0.7	1.4	2.0	6.7	8.4	1.7	15.5	4.0	0.2	7.5	4.1	1.7	0.0	7.3	6.1	3.7	0.6	33.7	18.9	4.7	0.0	2.8	0.0	0.4	7.5	2.8	0.0	2.8	2.5	8.6	0.0	12.5	15.1	2.0	1.7	5.7	0.0	1.8	4.6	1.2	2.2	17.8	0.0	7.6	9.8	1.8	10.0	3.1	0.0	0.0	0.2	4.9	5.4	0.9
BAIAP2	"BAP2, IRSp53, WAML"	ENSG00000175866	"BAR/IMD domain containing adaptor protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 19.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (7.58e-6)"	23.9	18.2	129.1	7.4	140.0	2.6	27.1	95.7	176.1	49.9	104.6	44.0	6.7	30.9	46.5	132.9	37.6	29.3	24.2	163.7	103.1	38.0	85.7	49.1	6.9	68.0	81.0	13.7	13.4	19.9	56.3	31.8	68.3	61.3	12.1	16.2	57.5	27.6	13.1	132.4	14.7	19.3	70.5	11.8	62.3	26.3	119.9	11.8	27.1	9.8	25.3	23.3	73.2	121.9	99.9	45.1	28.1	36.6	22.2	29.0	32.8	40.2	26.1	35.7	15.8	60.9	49.1	0.5	28.3	35.8	73.5	93.6	26.1	46.1	13.7	0.4	32.8	20.2	41.3	46.4	20.7	0.0	28.2	12.5	53.0	29.5	15.4	32.7	19.5	1.1	26.4	0.6	20.6	51.2	4.0	22.3	11.8	65.6	38.1	6.0	6.6	81.3	108.5	34.5	36.8	39.9	64.2	91.3	110.1	23.1	80.4	22.6	23.8	81.6	78.4	13.8	43.4	1.4	0.3	1.4	72.0	3.3	18.3	0.0	7.9	0.5	3.2	9.4	1.0	0.1	1.2	1.0	10.3	0.1	1.3	1.8	5.4	1.9	9.2	19.5	0.5	3.2	129.1	140.0	95.7	176.1	163.7	103.1	68.0	81.0	68.3	70.5	119.9	121.9	74.1	76.9	39.0	13.4	6.2	63.7	138.4	42.3	94.4	37.1	49.4	37.1	22.5	25.8	47.2	22.0	79.2	77.1	16.6	18.8	7.9	9.8	10.5	80.8	10.4	35.7	49.3	0.8	65.3	5.1	9.2	28.0	88.2	79.7	13.4	3.1	45.0	78.6	43.2	11.8	13.6	29.1	24.4	18.3	58.2	29.4	6.8	31.2	40.9	13.1	18.6	18.5	0.0	4.5	5.9	14.8	8.0	3.8	3.1	77.0	3.7	25.4	110.8	19.1	0.0	10.4	13.3	7.6	33.0	103.6	75.3	101.0	13.9	8.2	14.7	185.1
BAIAP2L1	IRTKS	ENSG00000006453	"BAR/IMD domain containing adaptor protein 2 like 1"	Q9UHR4	7	98291650-98401090	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 108.1;Prostatic glandular cells: 114.7;Urothelial cells: 147.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 72.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	5.8	20.7	1.5	6.2	1.5	0.4	7.8	1.3	1.7	10.1	3.1	23.0	28.6	2.8	1.4	29.2	11.6	15.5	5.2	1.4	2.1	13.9	33.4	14.0	1.4	1.7	1.7	1.3	31.2	13.1	13.0	10.2	1.8	26.2	21.4	0.6	23.6	2.6	2.8	19.9	25.4	2.6	1.5	1.9	58.8	9.8	1.8	2.1	14.9	1.6	4.6	16.8	17.1	1.8	43.2	33.6	0.9	0.7	0.0	1.5	55.0	10.9	7.1	5.6	4.1	47.0	62.9	1.8	15.9	4.1	47.4	37.3	15.6	46.1	5.0	0.2	20.3	0.0	14.3	27.0	6.7	0.0	14.7	1.5	61.0	3.2	44.4	12.3	0.2	0.1	26.4	0.1	4.8	36.1	0.1	0.1	26.3	61.8	18.5	0.1	0.5	7.0	35.2	37.2	23.5	4.6	25.3	72.2	12.8	35.3	20.2	1.0	1.4	8.3	39.6	1.6	5.1	0.9	13.1	21.8	0.9	5.4	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.5	1.3	1.7	1.4	2.1	1.7	1.7	1.8	1.5	1.8	1.8	16.9	12.8	22.9	23.5	0.8	16.7	64.8	31.5	14.2	0.6	17.4	7.6	2.3	30.0	36.3	22.0	4.2	11.8	5.5	100.3	9.8	60.8	33.1	25.2	3.0	11.2	32.2	2.7	23.1	77.6	78.4	2.2	108.1	33.4	0.0	4.5	0.7	16.6	2.4	1.7	26.1	53.6	18.3	0.3	1.7	52.5	0.9	1.0	8.8	37.5	2.6	1.2	0.0	26.7	31.4	102.6	84.7	0.7	0.6	114.7	35.3	2.4	58.6	0.8	0.0	1.9	6.7	50.0	56.3	22.4	19.5	12.2	1.9	0.2	44.7	147.8
BAIAP2L2	"FLJ22582, pinkbar"	ENSG00000128298	"BAR/IMD domain containing adaptor protein 2 like 2"	Q6UXY1	22	38084652-38111015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 98.6;kidney: 42.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 68.2;Intestinal goblet cells: 58.4;Oligodendrocytes: 31.0;Paneth cells: 32.6;Proximal enterocytes: 125.8;Undifferentiated cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 14.1;OE19: 44.2;RPTEC TERT1: 27.3;SK-MEL-30: 38.4;WM-115: 29.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in many"			HPA003043	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"HPA003043: AB_2227864"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.51e-2)"	2.5	1.1	3.1	2.8	3.0	0.1	1.8	2.6	6.1	3.7	2.8	41.0	98.6	2.1	0.4	9.7	1.9	14.9	0.8	3.1	2.6	42.5	3.7	0.9	0.3	2.8	2.8	1.5	2.7	0.1	3.5	0.2	2.9	2.5	12.7	0.4	1.9	0.3	1.2	2.4	81.6	0.8	2.6	1.4	8.5	5.9	2.7	0.6	3.1	0.1	0.4	1.2	3.4	3.7	0.2	12.3	0.0	0.0	0.3	1.9	1.5	3.0	0.0	0.0	0.2	9.6	0.8	0.2	4.6	2.7	0.0	1.6	0.0	0.4	0.0	0.3	0.4	0.9	0.0	14.1	0.6	0.0	0.8	0.3	0.7	7.0	0.5	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.6	0.3	1.1	44.2	0.0	0.4	0.0	0.8	27.3	0.1	0.2	0.2	0.0	5.3	38.4	0.1	0.3	0.2	0.1	0.1	0.4	0.0	0.0	0.9	0.1	0.2	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	2.6	6.1	3.1	2.6	2.8	2.8	2.9	2.6	2.7	3.7	0.2	0.0	0.0	7.8	0.5	0.8	0.2	1.0	1.2	2.8	0.3	0.3	1.1	17.2	0.2	0.0	2.1	0.3	0.2	68.2	1.9	0.6	0.7	2.2	3.8	0.3	27.6	0.0	17.2	0.0	1.2	0.8	21.9	12.8	0.0	0.5	0.4	0.9	0.5	6.7	13.1	58.4	0.0	0.3	0.2	0.5	1.2	0.2	5.4	5.6	0.1	0.2	1.0	7.5	31.0	5.4	32.6	1.2	0.3	0.2	125.8	19.1	0.1	1.4	0.0	0.2	1.3	1.3	4.4	1.4	1.1	0.4	0.5	0.3	41.4	0.5
BAIAP3	"BAP3, KIAA0734"	ENSG00000007516	"BAI1 associated protein 3"	O94812	16	1333638-1349441	"Predicted intracellular proteins"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 221.6;pituitary gland: 367.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.5;Endometrial ciliated cells: 23.5;Enteroendocrine cells: 50.3;Excitatory neurons: 19.2;Respiratory ciliated cells: 45.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.2;MCF7: 6.2;RT4: 5.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 123.4"	"Low region specificity"	"Detected in all"			"HPA015627, HPA015979"	Uncertain	Supported				NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA015627: AB_10603678, HPA015979: "	"unprognostic (1.37e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.52e-5)"	"unprognostic (5.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.43e-2)"	3.2	19.3	87.5	1.1	86.9	0.9	5.1	2.3	74.9	5.0	11.5	4.0	3.9	1.2	1.9	2.2	31.2	0.5	4.0	60.7	221.6	12.5	8.1	6.1	1.3	59.8	108.9	0.8	8.0	3.6	367.9	1.8	58.8	9.7	0.8	0.7	4.8	2.4	2.7	2.1	13.5	0.1	37.5	6.8	6.0	20.5	181.6	0.3	1.6	1.1	0.7	2.6	2.0	26.4	0.1	2.3	4.0	1.3	0.4	0.0	1.0	0.2	0.1	0.2	0.0	3.6	20.2	0.3	2.7	0.0	0.1	0.1	0.0	0.2	0.0	0.2	1.3	0.1	0.4	1.4	0.3	0.0	2.7	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.7	0.0	0.0	6.2	0.0	0.8	2.3	1.0	3.4	0.6	0.0	4.0	2.3	5.6	0.5	0.2	0.0	1.8	0.1	1.1	4.3	0.3	0.3	0.0	2.2	0.5	0.0	1.5	0.5	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.1	1.6	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	87.5	86.9	2.3	74.9	60.7	221.6	59.8	108.9	58.8	37.5	181.6	26.4	5.6	0.0	0.0	21.5	7.7	0.5	3.3	2.4	1.8	1.6	2.5	1.9	1.3	0.0	4.9	5.5	0.0	0.2	1.9	2.8	0.0	0.7	4.0	23.5	0.9	2.3	50.3	2.7	19.2	0.2	0.3	0.6	4.1	3.7	0.0	2.0	2.9	4.7	0.1	0.0	13.2	3.2	8.2	0.0	0.4	2.0	0.6	0.2	1.8	1.0	0.1	0.8	0.0	1.5	2.3	0.2	0.8	0.0	4.0	2.9	4.0	0.6	45.7	0.6	6.6	0.9	2.7	2.6	1.8	1.6	0.4	1.1	1.7	0.1	2.9	1.9
BAK1	"BAK, BCL2L7, CDN1"	ENSG00000030110	"BCL2 antagonist/killer 1"	Q16611	6	33572547-33580293	"Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.4;Proximal enterocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005029	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB005029: AB_562051"	"unprognostic (3.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.67e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (4.52e-4)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (6.07e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	9.4	29.6	10.4	20.7	10.6	27.7	7.5	10.5	13.0	10.4	12.2	32.4	47.0	10.1	9.1	34.0	7.9	10.6	23.2	10.3	9.8	23.9	11.5	13.7	22.0	11.8	10.9	7.2	12.8	13.5	12.0	11.1	11.2	11.2	24.9	3.7	11.9	9.1	18.8	18.7	37.1	13.5	11.0	30.5	21.9	7.8	11.7	19.2	7.7	18.1	23.4	21.8	12.0	10.4	37.6	20.4	21.3	32.2	14.3	14.0	27.1	19.1	15.3	53.7	41.8	42.2	28.7	32.5	32.6	28.1	24.8	38.3	41.0	77.7	23.6	37.7	43.6	20.6	18.8	34.4	36.6	44.5	32.3	23.0	60.7	45.1	52.6	15.7	29.4	28.7	18.9	28.6	20.1	55.0	38.8	29.7	23.7	26.4	50.0	37.0	20.5	59.9	45.6	30.6	26.3	19.6	24.4	77.3	37.1	26.6	25.4	74.5	28.2	28.3	30.0	18.5	24.9	75.4	100.4	27.5	9.6	52.6	31.7	63.5	45.2	85.1	34.7	64.8	39.5	25.3	32.1	34.7	42.8	18.4	17.6	23.2	30.6	22.4	57.3	15.0	56.1	53.2	10.4	10.6	10.5	13.0	10.3	9.8	11.8	10.9	11.2	11.0	11.7	10.4	8.6	3.2	3.4	3.9	24.6	27.1	11.6	15.5	14.2	6.6	10.7	8.3	6.4	11.5	8.0	3.7	8.4	16.3	22.1	75.4	13.7	20.5	4.7	7.2	8.9	10.1	22.1	6.1	4.5	18.7	41.8	7.5	17.9	10.0	11.4	11.1	10.0	6.3	30.2	5.0	3.6	32.5	14.2	21.9	30.2	1.7	7.8	16.9	21.4	2.8	25.8	4.7	12.3	1.0	2.7	27.7	47.9	11.7	54.5	10.4	79.6	9.6	5.6	6.9	13.1	5.6	11.8	0.3	1.0	19.1	21.6	9.9	24.6	25.2	40.6	20.1
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677510-28682932	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 81.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	4.4	44.1	13.8	2.3	16.3	6.0	23.7	18.4	17.6	5.7	20.7	3.8	1.6	17.9	2.9	2.1	6.3	5.4	43.5	13.6	15.9	19.9	23.9	12.0	2.0	19.9	16.9	81.6	6.9	8.2	8.5	39.3	21.1	7.4	4.7	13.4	6.4	16.7	1.8	5.4	2.1	12.2	16.6	18.0	3.8	8.7	14.8	0.4	1.2	1.9	1.4	30.0	5.4	22.7	1.0	41.0	4.2	2.2	4.8	0.1	24.5	9.7	3.5	15.4	10.0	166.7	17.3	0.5	5.7	7.4	8.8	12.2	10.2	1.6	7.2	10.1	21.0	39.5	6.2	63.7	5.9	2.4	51.5	3.7	2.3	10.4	1.6	96.7	2.4	2.1	22.1	18.7	3.1	70.1	0.2	3.3	71.6	34.5	9.9	0.3	7.8	3.6	12.9	40.4	6.8	5.2	13.2	78.5	199.0	357.8	23.2	3.0	0.3	10.4	7.3	17.0	4.7	0.5	15.0	0.0	1.0	8.9	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.3	18.4	17.6	13.6	15.9	19.9	16.9	21.1	16.6	14.8	22.7	6.6	9.6	5.9	15.0	5.7	4.0	7.6	0.6	13.1	14.3	174.7	163.2	34.9	58.6	3.5	11.0	4.2	12.0	9.3	33.8	1.9	20.8	0.1	14.3	15.3	7.3	26.8	0.0	0.5	0.2	22.2	46.1	58.6	21.1	1.3	334.8	14.6	16.0	6.7	6.7	0.2	3.8	0.0	1.6	4.2	1.2	3.4	5.4	16.0	15.9	0.7	50.2	0.0	46.3	21.2	12.1	34.6	2.2	4.3	10.8	1.1	16.1	1.4	5.9	0.0	4.2	42.7	1.9	15.5	13.5	1.3	8.5	7.8	6.2	3.8	14.1
BANF1	BAF	ENSG00000175334	"BAF nuclear assembly factor 1"	O75531	11	66002228-66004149	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	116.4	149.0	252.8	144.8	256.8	127.2	151.4	261.0	312.9	135.4	248.4	153.7	107.2	168.0	248.5	136.0	279.6	100.9	272.2	249.9	259.6	115.6	174.0	111.3	178.5	258.4	254.4	207.6	132.5	148.8	69.0	120.8	261.1	139.2	155.9	98.7	148.2	169.7	582.1	121.0	105.0	190.0	258.5	116.0	92.7	111.1	254.8	220.7	164.6	394.8	211.9	140.6	82.4	274.5	665.5	712.0	452.8	427.9	237.7	306.5	220.5	364.7	349.4	715.9	447.0	415.3	496.1	606.5	651.8	503.3	544.0	433.5	641.7	600.1	559.1	476.4	411.5	699.5	431.3	537.0	296.0	503.4	480.4	292.5	404.6	453.8	418.1	404.6	494.6	526.5	552.5	459.6	687.5	1196.3	607.7	1023.8	494.7	410.4	525.6	507.0	447.1	1297.4	647.9	361.7	362.9	458.0	399.1	636.4	469.4	352.9	698.8	378.6	350.4	535.8	574.2	601.8	515.8	313.6	680.4	771.1	442.7	420.2	485.5	112.7	231.7	82.2	165.2	239.1	159.1	243.7	139.0	160.5	252.9	234.6	166.0	174.4	28.7	219.7	266.2	238.2	125.5	324.0	252.8	256.8	261.0	312.9	249.9	259.6	258.4	254.4	261.1	258.5	254.8	274.5	135.8	54.5	41.9	11.4	112.7	126.8	154.6	301.2	142.9	52.8	164.8	230.0	32.1	102.9	153.6	196.8	25.0	296.5	101.4	70.7	326.8	196.8	17.1	164.8	147.2	126.5	142.8	144.5	12.3	177.3	346.6	126.6	86.6	116.2	140.2	199.7	79.9	130.8	324.5	50.5	13.4	171.4	223.8	80.6	169.8	41.9	142.0	124.7	186.7	8.4	155.9	123.8	186.4	9.0	22.2	170.3	107.1	123.8	110.8	126.8	77.4	251.5	187.7	57.8	72.3	123.9	145.5	250.2	325.1	227.0	118.1	174.7	104.9	172.6	196.2	148.9
BANF2	"BAF-L, BAF2, BAFL, C20orf179, dJ803K15.1"	ENSG00000125888	"BANF family member 2"	Q9H503	20	17693672-17735871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 110.2"	"Group enriched"	"Detected in some"	163	"Early spermatids: 899.1;Late spermatids: 2850.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042635	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA042635: AB_10795707"					"unprognostic (2.08e-1)"		"unprognostic (9.15e-2)"			"unprognostic (6.42e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.63e-2)"	"unprognostic (3.42e-1)"		"unprognostic (3.18e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.1	0.9	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	110.2	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	899.1	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2850.2	11.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	10.9	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA047164: AB_2679964"	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	8.8	9.3	8.1	9.5	8.8	12.1	7.8	16.0	9.5	10.2	11.3	8.8	5.1	9.6	3.3	7.5	9.6	4.9	8.0	9.1	8.9	9.0	13.9	7.4	9.6	10.6	9.0	12.3	8.7	6.2	9.9	7.7	9.8	8.1	3.6	6.4	7.9	5.1	10.2	8.0	8.7	4.3	7.3	12.1	7.5	11.0	10.3	10.4	8.0	5.1	6.4	9.3	8.3	12.1	12.5	19.7	9.6	14.4	8.4	10.1	32.2	14.8	7.4	14.3	9.7	21.6	17.0	16.8	19.6	3.5	13.0	14.2	14.4	6.7	5.2	13.1	15.5	10.5	12.9	18.0	7.1	11.2	8.3	3.0	10.7	8.8	6.3	12.9	8.9	10.9	17.9	9.3	8.8	14.5	15.5	14.6	16.5	9.7	23.6	16.4	11.1	12.4	8.5	5.9	14.2	11.7	18.8	11.0	13.8	14.1	13.5	14.3	11.0	15.4	10.7	9.1	14.8	7.6	13.9	25.7	9.2	17.2	15.1	22.9	19.9	40.7	22.2	18.2	18.7	25.1	23.5	19.9	24.7	21.5	24.9	22.3	64.5	24.5	22.5	29.7	23.0	19.5	8.1	8.8	16.0	9.5	9.1	8.9	10.6	9.0	9.8	7.3	10.3	12.1	12.0	9.6	8.3	15.0	28.6	14.9	11.8	7.4	6.2	14.2	14.1	13.2	5.8	10.0	5.1	16.5	4.2	19.4	42.2	9.2	3.9	12.5	5.8	10.7	9.7	13.6	12.1	4.4	32.7	8.0	27.3	16.3	4.1	13.4	8.2	17.9	5.3	10.3	12.4	26.9	28.3	8.9	2.0	11.1	48.3	8.2	10.8	22.6	19.6	20.6	16.0	11.6	22.6	23.1	28.6	11.0	8.6	10.9	21.2	16.2	10.0	7.8	6.3	17.2	13.1	10.8	22.7	33.7	22.7	6.2	21.3	56.6	19.1	10.2	8.9	17.2
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BARHL1		ENSG00000125492	"BarH like homeobox 1"	Q9BZE3	9	132582606-132590252	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	339	"brain: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons: 34.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	102	"SCLC-21H: 16.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.2;midbrain: 2.4;pons and medulla: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 5.8"	HPA004809	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"				"HPA004809: AB_1078266"					"unprognostic (2.29e-1)"					"unprognostic (6.42e-2)"	"unprognostic (8.07e-2)"			"unprognostic (9.31e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	30.7	7.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.1	0.5	0.0	2.0	30.7	7.0	34.6	0.2	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375848-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.0;salivary gland: 131.4;vagina: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 163.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.8;hippocampal formation: 1.7"	"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.3	0.0	0.1	1.3	0.3	0.0	14.9	1.1	0.3	24.2	5.5	7.0	17.9	0.1	0.2	158.0	16.7	4.7	0.2	0.3	0.4	5.4	0.0	0.3	0.7	3.0	1.6	0.0	10.3	0.3	1.7	3.6	3.2	4.8	4.9	0.2	131.4	0.6	2.2	34.8	13.0	0.2	1.8	0.0	6.4	2.4	0.4	0.4	0.3	39.3	8.8	0.4	72.2	2.9	23.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	0.0	1.0	20.9	0.0	5.1	0.0	163.7	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	3.9	0.0	6.2	0.0	0.0	0.0	20.6	0.9	0.0	0.0	39.8	0.0	0.3	0.2	0.0	0.0	19.4	0.1	0.4	3.8	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.3	0.3	0.4	3.0	1.6	3.2	1.8	0.4	2.9	0.2	0.0	1.1	0.3	0.5	43.1	128.5	8.7	3.4	0.6	50.4	16.9	0.5	4.3	8.0	0.0	0.0	13.4	0.8	29.4	7.9	23.7	7.2	11.3	0.6	1.2	1.8	0.0	1.8	0.7	5.8	2.7	6.6	4.6	0.0	0.0	0.0	0.2	1.9	0.0	0.3	13.4	0.0	0.3	2.2	1.6	0.0	0.7	10.6	0.0	0.1	0.7	0.0	0.0	0.3	6.2	29.8	0.4	0.9	25.6	34.0	3.4	11.8	0.3	0.0	0.6	1.7	0.1	5.3	136.4	82.5	4.2	1.7	0.0	19.4	84.8
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522455-75546993	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.7;lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 130.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6"	"Not detected"	"Not detected"							"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (8.30e-4)"	"prognostic favorable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (4.30e-4)"	5.5	1.3	1.0	20.5	1.8	21.7	7.8	1.0	1.4	2.2	1.1	3.0	2.6	1.3	1.1	2.9	1.9	5.8	2.4	1.0	1.2	1.4	2.9	8.0	30.6	1.5	1.4	0.5	0.9	8.0	0.5	4.1	1.7	5.5	1.4	0.0	6.5	1.8	0.4	2.9	9.7	2.3	1.2	26.9	7.8	0.6	2.2	7.2	1.9	1.0	20.4	18.2	2.9	1.5	4.7	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	368.9	0.0	7.5	0.0	1.6	11.5	10.0	36.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	2.0	10.3	0.0	134.7	4.7	30.8	0.2	54.9	0.0	1.1	0.0	6.3	0.0	83.3	0.1	0.0	0.0	64.8	2.7	0.0	6.1	18.7	0.0	0.0	0.0	4.4	0.3	32.8	36.9	0.3	0.0	101.6	0.1	3.6	25.5	8.2	55.0	13.7	43.4	21.3	59.7	74.2	25.2	17.5	23.1	50.4	14.4	21.3	13.2	2.9	130.3	27.8	1.0	1.8	1.0	1.4	1.0	1.2	1.5	1.4	1.7	1.2	2.2	1.5	2.9	9.6	29.3	0.0	17.1	5.4	50.8	5.7	0.6	0.0	105.4	73.9	0.3	1.5	13.5	3.7	0.0	0.4	36.9	0.0	0.0	0.8	0.5	0.9	0.6	5.0	0.0	7.2	0.2	2.5	0.4	4.4	10.2	1.9	243.7	0.0	2.5	0.7	61.3	0.0	0.1	0.0	34.6	15.4	10.7	0.6	0.0	21.7	5.4	1.0	16.7	0.0	103.0	0.0	0.1	11.0	0.1	0.0	29.9	22.1	0.0	0.2	12.8	0.0	0.0	1.0	2.0	0.0	0.1	0.4	3.4	1.1	116.5	0.2	0.5	74.3
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987945-64997018	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 21.2;Intestinal goblet cells: 8.5;Proximal enterocytes: 7.9;Undifferentiated cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.1;intermediate monocyte: 5.3;neutrophil: 7.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.3;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 13.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.0;GAMG: 19.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.2	4.4	2.7	8.7	2.8	0.5	1.4	2.4	2.9	1.7	2.8	8.6	9.3	1.2	0.7	1.0	2.6	3.9	3.0	2.5	2.6	5.7	4.7	7.0	3.2	4.1	2.7	3.1	9.2	0.9	2.3	2.8	4.0	2.8	6.2	0.5	13.4	4.4	4.9	0.4	6.5	2.7	4.0	13.5	4.5	0.7	3.0	1.6	2.0	2.7	1.2	4.6	1.0	2.6	1.5	1.0	0.2	0.0	0.1	0.8	0.0	0.5	6.5	13.1	20.0	1.9	5.8	0.1	2.7	1.0	19.5	0.1	0.0	1.7	0.9	0.2	0.4	1.8	0.0	5.3	4.8	0.0	1.1	0.4	0.4	1.7	2.2	0.5	3.2	0.1	4.3	0.1	0.3	0.4	0.0	0.1	0.5	0.0	0.6	0.0	1.3	0.6	1.6	0.1	0.1	0.0	0.8	0.3	6.9	0.1	0.5	1.0	2.4	0.7	0.7	1.1	0.0	0.1	0.2	0.4	1.1	0.5	0.6	0.0	2.1	1.0	0.0	5.3	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	7.3	0.1	2.8	0.0	0.0	0.8	2.7	2.8	2.4	2.9	2.5	2.6	4.1	2.7	4.0	4.0	3.0	2.6	3.7	3.2	2.0	1.0	1.3	0.0	0.5	1.8	0.0	0.2	1.2	0.5	0.6	4.3	2.6	1.8	0.0	0.0	0.0	21.2	1.9	4.8	0.8	0.4	1.2	2.7	2.4	0.0	0.2	6.6	0.3	1.8	2.6	0.1	0.0	0.1	5.0	0.9	4.7	0.0	0.1	8.5	0.0	3.5	0.3	2.4	0.0	1.0	0.0	1.0	1.0	0.9	0.0	1.0	0.1	4.9	7.6	0.7	0.0	0.2	7.9	4.1	3.5	0.2	0.0	1.7	1.7	0.1	0.6	0.0	0.0	0.0	0.1	1.1	8.4	2.4
BAX	BCL2L4	ENSG00000087088	"BCL2 associated X, apoptosis regulator"	Q07812	19	48954815-48961798	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004206, HPA027878"	Approved					NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB004206: AB_626729, HPA027878: AB_10601687"	"unprognostic (4.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.22e-2)"	30.2	30.4	24.4	59.2	26.8	65.7	27.2	25.5	29.3	27.6	23.9	78.1	68.2	29.9	23.2	35.8	33.2	37.6	22.6	24.5	25.5	31.0	33.4	46.0	59.5	27.1	25.4	19.6	32.7	26.1	15.9	43.3	27.0	25.7	58.8	7.2	26.5	27.0	18.1	29.8	64.6	36.3	26.1	60.0	43.8	12.4	26.3	83.2	23.4	11.8	44.7	46.7	26.1	27.1	177.4	286.0	170.1	150.4	165.4	161.7	280.2	117.8	233.4	151.7	210.6	76.4	168.6	214.6	53.9	181.2	141.3	93.8	78.0	229.0	125.7	166.6	181.0	91.9	56.6	288.0	265.7	96.3	280.9	222.3	161.7	126.1	75.5	183.3	354.6	83.4	91.4	86.0	264.8	123.1	157.6	150.3	132.8	171.3	82.5	109.2	113.1	82.4	161.0	168.4	97.4	114.7	99.2	69.8	57.4	240.6	56.2	171.2	210.2	194.0	212.1	120.1	165.1	97.9	136.6	145.0	118.1	129.2	275.1	5.2	12.1	13.4	6.5	18.4	4.6	7.3	3.7	7.1	12.2	5.9	2.4	6.0	13.1	12.2	20.9	12.5	7.5	8.4	24.4	26.8	25.5	29.3	24.5	25.5	27.1	25.4	27.0	26.1	26.3	27.1	83.2	3.2	4.8	8.1	164.6	54.8	63.8	160.8	101.3	19.3	64.1	67.4	8.4	78.6	98.7	60.7	10.4	126.0	130.2	152.9	74.3	122.7	1.1	43.4	65.7	83.7	114.0	79.3	7.9	96.2	157.9	57.0	114.2	46.0	43.9	151.7	59.3	28.1	263.6	30.3	8.3	102.7	209.5	121.8	143.0	4.0	48.1	148.3	83.6	3.7	295.3	43.9	140.1	7.5	13.8	139.4	177.0	38.4	96.2	126.6	229.8	227.4	66.4	15.9	46.0	35.8	259.4	20.3	38.1	92.0	56.4	101.9	149.4	175.5	149.7	86.7
BAZ1A	"ACF1, hACF1, WALp1, WCRF180"	ENSG00000198604	"Bromodomain adjacent to zinc finger domain 1A"	Q9NRL2	14	34752731-34875647	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 428.6;Early spermatids: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 29.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002730	Supported					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA002730: AB_1078269"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (2.44e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.37e-2)"	14.4	6.0	4.7	22.5	5.8	74.6	11.7	4.5	6.4	8.5	5.0	12.5	10.4	7.6	7.3	16.6	8.9	13.5	5.7	4.8	5.6	6.8	11.9	19.3	25.2	6.3	5.6	7.8	7.1	6.2	3.6	12.7	5.9	8.8	12.9	1.7	11.5	5.8	9.7	21.6	12.4	9.0	5.1	20.2	13.1	30.8	6.6	21.7	7.7	6.4	20.7	27.9	11.2	7.0	46.4	24.1	39.7	30.5	16.9	19.6	49.2	36.7	20.0	33.6	33.6	23.9	32.8	92.1	28.0	26.3	18.7	47.0	68.4	23.8	58.2	33.4	29.5	60.0	22.6	66.9	19.9	99.6	69.8	18.2	24.2	36.3	48.1	13.5	49.3	41.2	56.4	23.0	28.5	52.9	95.3	31.3	19.1	36.4	34.1	72.4	40.9	25.7	21.0	44.2	50.4	41.2	49.6	67.4	20.2	13.5	34.5	68.7	44.6	31.0	22.7	33.6	37.2	12.7	13.5	77.1	10.0	45.9	36.0	7.6	5.7	7.7	3.5	6.2	2.5	5.3	3.6	3.9	3.4	4.7	3.6	2.9	29.3	2.7	7.1	4.2	4.2	1.5	4.7	5.8	4.5	6.4	4.8	5.6	6.3	5.6	5.9	5.1	6.6	7.0	68.5	60.9	77.9	24.5	103.5	428.6	237.6	96.9	174.2	2.6	79.7	54.0	14.7	28.6	82.8	16.5	2.1	68.6	135.4	89.2	0.0	86.8	555.2	87.5	72.3	103.8	30.5	85.2	12.2	74.7	118.0	76.1	66.3	112.1	101.6	33.1	27.8	28.6	87.9	0.0	9.4	69.9	77.3	96.7	263.7	373.0	40.4	158.7	72.9	47.8	165.8	2.4	129.8	26.7	35.8	121.7	133.6	13.5	90.5	213.2	51.6	15.3	89.2	2.0	6.6	106.8	76.1	199.9	38.7	141.8	389.6	196.9	152.1	23.8	62.1	372.5
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616569	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Oligodendrocytes: 604.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 115.8;neutrophil: 213.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 213.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	20.6	23.8	23.0	18.1	43.7	36.7	22.1	57.4	26.8	23.8	3.6	18.2	17.1	33.6	19.7	22.1	24.4	26.1	18.4	21.8	41.4	17.3	16.8	24.7	14.7	45.3	29.1	42.4	19.3	24.6	17.5	20.5	47.7	18.4	16.4	52.0	23.4	19.8	18.4	17.5	18.5	23.5	26.0	20.9	17.0	26.4	43.7	21.5	25.4	22.3	13.6	20.9	14.7	75.3	7.4	14.7	48.4	29.4	14.2	22.8	8.4	15.3	18.7	8.2	9.6	22.1	19.9	12.4	25.8	15.0	8.4	16.6	19.4	20.7	13.0	4.5	11.1	24.7	26.9	3.1	9.3	16.3	17.0	18.0	22.2	20.6	22.2	30.4	42.5	8.3	25.7	2.3	13.1	9.1	5.6	10.5	16.1	1.5	12.4	13.1	15.7	8.8	16.4	26.2	32.1	27.9	30.3	3.7	18.5	25.0	5.8	46.7	42.6	14.9	30.1	6.5	10.3	9.0	1.0	14.0	14.1	17.5	10.0	115.8	27.4	36.4	10.1	12.0	8.3	6.5	6.1	10.5	17.7	9.6	4.1	6.6	213.2	19.7	11.3	24.5	7.1	6.0	23.0	43.7	57.4	26.8	21.8	41.4	45.3	29.1	47.7	26.0	43.7	75.3	105.3	99.3	148.0	477.3	34.3	32.6	70.1	35.8	66.0	91.8	56.4	38.9	60.8	61.5	71.5	68.0	310.6	18.5	40.1	45.4	9.8	55.5	158.0	69.8	63.9	82.5	99.9	42.1	180.4	38.9	7.2	54.9	59.7	118.9	73.9	71.9	71.0	29.4	25.5	94.2	177.3	52.1	36.7	58.0	37.1	35.4	59.4	76.6	14.2	289.5	81.4	87.3	41.2	300.6	604.3	54.3	55.5	35.0	42.2	50.0	51.7	12.4	73.3	332.3	13.1	74.9	54.1	98.2	20.7	49.6	37.5	26.7	38.9	83.2	48.6	91.6
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.4;Basal squamous epithelial cells: 111.5;Prostatic glandular cells: 132.9;Suprabasal keratinocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 4.5;neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 28.4;NB-4: 34.9"									"CAB007752, HPA070403"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (2.62e-5)"	3.1	4.4	3.1	2.1	2.8	4.8	4.0	4.3	4.7	3.2	1.8	6.4	2.4	3.4	0.6	1.9	3.6	2.0	3.9	3.3	2.4	5.1	5.6	7.7	2.7	2.8	3.7	3.2	7.7	2.0	2.1	1.9	2.9	4.1	1.8	0.2	7.5	1.2	10.4	8.2	5.0	0.7	2.3	6.1	5.0	2.6	2.8	4.0	3.1	1.1	0.8	4.9	3.4	2.5	3.8	8.3	9.0	1.9	2.1	4.1	22.1	5.9	7.9	1.4	3.5	2.5	6.3	14.7	2.5	1.5	2.5	1.2	1.3	5.3	0.2	9.3	15.9	4.2	2.8	16.4	28.4	0.7	13.4	9.8	8.4	3.0	2.8	3.7	10.3	4.4	10.9	9.0	1.0	8.6	1.6	34.9	5.6	6.5	1.1	4.1	1.3	17.7	0.4	1.3	1.5	13.5	2.7	5.6	18.7	7.1	1.9	11.7	6.9	1.7	11.1	0.2	1.9	14.4	3.4	9.5	2.6	2.2	6.2	4.5	0.4	0.2	0.4	0.5	0.4	0.1	0.1	0.3	0.2	0.0	0.5	0.3	3.4	0.6	0.4	0.1	0.3	0.2	3.1	2.8	4.3	4.7	3.3	2.4	2.8	3.7	2.9	2.3	2.8	2.5	16.2	9.6	7.4	1.6	21.7	117.4	78.8	40.3	111.5	6.5	46.4	29.1	5.6	10.0	21.8	7.3	0.0	4.7	28.3	51.9	0.0	52.4	14.6	65.2	14.0	15.8	21.4	16.8	3.2	39.8	5.5	12.1	23.4	66.2	12.7	8.4	3.9	3.5	7.1	0.0	3.9	40.6	30.5	10.3	31.9	3.3	6.2	17.1	64.0	2.8	15.7	3.7	32.0	1.0	0.5	55.2	49.3	4.1	19.3	132.9	16.2	4.1	22.9	4.4	6.6	12.4	34.9	0.5	1.7	59.4	143.3	20.5	28.5	10.2	27.4	66.2
BBIP1	"bA348N5.3, BBIP10, BBS18, NCRNA00081"	ENSG00000214413	"BBSome interacting protein 1"	A8MTZ0	10	110898730-110919201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055206	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055206: AB_2682737"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.85e-2)"	17.6	24.9	25.8	16.0	29.9	10.1	15.5	29.8	41.2	18.7	23.7	16.6	10.3	16.6	25.3	10.5	20.0	12.3	20.4	25.3	26.9	29.8	23.5	14.1	16.4	28.8	26.9	19.5	13.8	19.0	25.6	13.8	29.0	19.2	10.7	50.1	10.5	16.2	15.5	7.3	12.4	16.0	27.2	16.7	14.3	102.8	26.6	17.8	21.7	10.1	16.6	16.2	12.9	37.2	22.1	28.9	33.0	34.0	41.4	51.0	9.8	27.2	56.4	30.9	42.7	14.4	26.9	13.3	19.2	44.9	31.4	21.5	23.9	30.1	47.5	26.9	28.6	22.0	28.3	18.9	54.4	18.9	37.0	31.8	27.1	42.4	75.7	68.9	50.3	23.7	16.5	49.8	37.0	13.9	23.8	27.0	14.0	15.3	18.1	10.5	59.7	18.8	48.6	13.9	24.9	39.6	20.7	9.1	45.4	21.1	10.4	16.9	36.5	22.3	27.2	27.3	38.2	27.9	26.0	19.9	63.4	33.5	17.6	25.5	11.2	47.6	9.7	15.0	11.5	8.2	14.5	12.0	9.5	7.2	17.6	14.9	53.6	7.8	13.0	8.4	18.8	7.4	25.8	29.9	29.8	41.2	25.3	26.9	28.8	26.9	29.0	27.2	26.6	37.2	32.3	25.6	10.0	25.8	24.2	11.2	36.2	41.4	17.1	32.3	13.9	16.3	18.5	22.8	24.3	22.0	31.3	19.3	21.4	9.5	105.7	35.8	597.4	60.4	27.1	26.4	16.9	18.3	58.8	34.5	25.6	27.7	14.3	24.4	16.5	21.0	25.4	22.1	20.0	45.4	52.6	18.4	50.8	22.4	15.8	501.6	46.6	22.4	23.2	14.0	27.1	52.4	26.8	27.6	67.5	36.0	12.0	33.8	32.2	21.6	13.5	69.4	75.7	63.8	52.6	46.0	32.7	399.5	36.5	12.5	11.9	12.3	27.2	21.0	10.0	29.7
BBOF1	"C14orf45, CCDC176, FBB10"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019349-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	4.9	2.8	5.8	2.3	6.3	6.5	7.3	5.5	9.0	6.5	15.9	7.1	2.0	7.1	14.6	5.2	22.5	5.7	4.4	6.3	5.8	9.7	2.2	6.8	1.7	9.7	9.8	5.1	2.8	5.0	10.7	2.4	8.3	5.5	3.5	24.3	3.8	7.1	2.3	3.1	2.4	5.5	8.0	1.4	3.4	38.6	6.2	2.8	13.2	3.3	2.1	5.0	3.1	6.6	5.4	3.1	1.3	8.7	5.7	12.5	1.1	4.6	6.5	4.6	4.3	1.1	3.7	5.3	1.2	5.7	2.0	1.3	1.8	0.8	5.2	0.8	1.0	0.6	3.1	1.2	4.8	2.7	0.3	6.1	4.2	10.3	1.3	7.3	1.7	9.7	2.9	0.9	3.4	4.3	8.5	1.3	0.4	0.5	2.1	3.0	3.4	0.9	7.9	1.4	5.2	3.3	9.0	3.6	2.6	1.3	9.2	0.2	3.8	5.7	4.0	7.6	1.3	1.9	4.9	3.3	16.7	0.3	1.6	1.1	0.0	0.1	1.5	0.0	1.8	0.5	1.4	1.0	0.1	0.6	1.9	1.5	1.0	1.1	0.0	2.4	0.3	1.2	5.8	6.3	5.5	9.0	6.3	5.8	9.7	9.8	8.3	8.0	6.2	6.6	3.8	12.8	8.1	0.0	1.4	0.0	3.8	0.0	4.0	7.8	15.8	8.0	0.0	7.2	30.3	3.7	29.2	1.8	3.9	1.8	15.6	9.0	239.3	166.4	15.1	3.1	2.4	39.6	0.0	3.5	2.6	7.4	2.0	18.2	1.3	4.3	3.6	4.5	2.3	6.7	0.0	2.7	0.0	1.6	0.0	111.3	10.8	3.9	0.0	0.0	0.8	5.7	4.1	0.0	0.0	3.0	0.2	6.0	0.7	2.5	1.0	23.5	177.8	29.9	0.0	4.3	4.0	149.2	14.7	1.3	0.0	1.0	2.3	4.1	0.9	3.4
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 467.9;liver: 131.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	24.3	0.0	23.4	0.0	25.1	28.8	34.0	5.1	17.3	0.2	0.0	0.1	8.1	17.5	9.0	9.6	0.0	22.8	25.6	467.9	131.9	0.3	0.1	27.2	33.1	0.0	0.8	0.0	6.9	0.3	35.0	0.5	0.0	0.4	6.1	4.1	0.9	51.8	0.0	0.0	28.8	0.0	0.2	0.1	25.2	1.1	9.6	0.0	0.6	0.1	11.3	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	23.4	28.8	34.0	22.8	25.6	27.2	33.1	35.0	28.8	25.2	27.0	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
BBS1	FLJ23590	ENSG00000174483	"Bardet-Biedl syndrome 1"	Q8NFJ9	11	66510606-66533613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058283	Uncertain		Uncertain	Midbody		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Midbody		"HPA058283: AB_2683667"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.61e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.87e-4)"	10.5	15.2	11.5	4.9	13.0	2.9	11.9	10.8	17.8	18.9	13.9	18.0	6.5	20.7	17.7	9.0	28.0	12.6	10.1	11.6	12.7	24.2	7.0	10.4	5.1	10.2	13.5	27.5	13.5	38.0	17.9	8.2	10.1	15.8	7.3	21.4	16.8	22.0	8.1	9.6	9.4	14.1	10.5	6.0	13.8	10.5	13.3	8.0	27.1	8.2	5.0	15.4	10.9	10.7	5.7	6.0	13.7	5.4	24.9	17.2	6.3	4.8	9.6	6.3	6.0	9.5	10.1	0.8	10.0	11.5	5.6	10.6	10.1	10.6	6.8	5.2	5.8	2.5	8.9	5.3	11.7	4.7	1.8	17.7	9.7	9.7	7.1	17.8	8.9	8.5	5.5	4.3	7.8	5.1	3.7	4.1	10.4	18.0	10.5	9.2	9.0	7.4	19.3	6.4	14.0	9.3	8.1	8.7	18.6	6.6	18.7	2.5	8.7	5.0	5.7	6.0	1.6	3.1	1.5	1.4	16.3	1.3	5.4	0.0	1.5	0.2	1.8	1.6	2.6	2.2	2.5	2.0	1.2	1.1	1.7	2.2	0.9	3.1	3.0	0.5	0.8	1.9	11.5	13.0	10.8	17.8	11.6	12.7	10.2	13.5	10.1	10.5	13.3	10.7	0.5	0.0	2.2	19.9	2.5	0.5	1.3	1.6	0.6	3.9	0.9	1.0	0.5	1.5	1.1	0.0	8.4	1.6	0.5	0.6	0.0	0.8	4.1	2.3	1.8	1.3	1.2	3.0	28.5	0.4	0.6	3.1	7.1	0.9	0.0	2.9	0.7	0.3	0.6	0.0	28.4	0.7	2.0	0.9	0.7	2.6	0.9	0.5	0.0	14.0	0.8	1.7	1.0	13.6	9.0	0.4	0.5	1.5	2.5	0.8	0.4	1.7	9.2	10.8	0.0	1.5	1.6	4.9	2.6	2.2	1.0	1.0	1.4	2.0	0.9	0.9
BBS10	"C12orf58, FLJ23560"	ENSG00000179941	"Bardet-Biedl syndrome 10"	Q8TAM1	12	76344474-76348415	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058743	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058743: AB_2683806"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	11.6	12.0	7.3	6.0	7.9	0.9	11.8	8.8	10.8	7.6	6.5	4.2	3.9	8.2	9.8	6.6	7.6	5.5	10.3	7.0	7.1	9.8	9.1	6.0	9.0	7.7	7.2	12.6	4.4	7.6	4.3	7.6	8.3	8.2	3.9	11.4	9.8	7.9	5.5	7.3	4.4	6.1	8.4	9.2	5.1	6.2	7.0	8.9	9.3	7.8	7.7	5.4	4.8	10.3	10.9	6.9	14.2	7.4	19.9	21.0	6.0	11.9	8.6	10.0	7.5	5.7	5.1	5.2	11.9	6.4	8.8	11.6	9.7	10.2	14.0	9.0	10.3	7.1	7.7	8.1	25.2	7.6	5.4	13.8	14.5	13.3	16.1	26.8	14.0	15.0	8.9	4.0	19.4	6.9	7.7	8.2	8.8	5.3	9.6	7.9	17.6	8.4	9.9	5.6	8.7	16.4	15.5	3.0	11.1	13.6	16.2	8.1	10.9	12.3	7.2	12.5	7.8	8.4	11.3	4.6	8.9	6.1	9.4	2.6	2.1	5.0	0.5	4.0	1.2	1.6	1.0	0.8	2.5	1.2	2.2	1.4	1.8	0.7	7.2	1.6	0.9	1.2	7.3	7.9	8.8	10.8	7.0	7.1	7.7	7.2	8.3	8.4	7.0	10.3	4.0	3.2	3.6	5.9	3.7	4.0	3.7	3.5	5.2	4.4	3.4	3.2	8.8	1.5	5.1	3.7	0.0	3.7	3.8	0.4	3.9	3.1	0.1	2.8	7.3	4.0	3.0	4.0	5.4	2.5	1.0	6.2	2.0	1.8	0.0	4.1	4.6	8.7	3.0	1.7	5.2	1.6	2.0	7.3	2.1	0.6	8.7	3.4	0.0	6.5	2.4	8.7	1.0	4.5	9.9	3.2	1.7	11.3	0.3	2.2	1.5	8.4	6.7	4.3	6.6	6.5	3.9	8.7	6.5	4.9	4.1	0.8	2.1	2.1	1.6	1.7
BBS12	"C4orf24, FLJ35630, FLJ41559"	ENSG00000181004	"Bardet-Biedl syndrome 12"	Q6ZW61	4	122732702-122744942	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.0;Rod photoreceptor cells: 37.1;Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061856	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA061856: AB_2684626"	"unprognostic (9.59e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (5.69e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.89e-6)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	2.6	2.5	2.6	1.4	3.0	0.3	2.7	1.8	3.1	3.0	4.6	2.4	2.5	2.7	4.7	1.5	5.0	1.9	3.7	2.7	3.5	9.4	0.9	2.3	1.5	2.3	2.7	2.7	1.7	7.9	3.7	2.0	2.5	1.7	1.9	17.6	1.8	2.9	0.6	1.3	2.5	2.6	2.3	1.8	1.5	7.8	3.4	1.8	9.3	0.9	1.6	1.9	1.5	2.2	1.8	1.8	2.8	3.3	8.3	10.1	1.1	2.5	4.6	3.3	3.4	1.2	2.9	1.1	2.0	3.7	3.6	1.4	2.2	3.2	3.3	4.0	1.9	0.4	2.6	1.2	5.6	1.2	1.8	7.2	8.2	4.3	6.1	11.4	3.6	2.0	4.2	1.3	4.5	1.2	2.3	0.8	1.6	1.2	1.5	1.4	7.7	0.6	7.8	0.5	1.7	3.2	3.7	0.8	2.9	5.8	1.1	1.1	3.4	2.8	1.5	2.6	1.4	2.2	1.2	0.8	4.2	0.9	4.6	0.9	1.2	2.0	1.4	1.6	1.7	2.1	1.8	2.1	1.2	0.9	1.9	1.8	0.0	1.2	2.1	1.2	1.9	1.2	2.6	3.0	1.8	3.1	2.7	3.5	2.3	2.7	2.5	2.3	3.4	2.2	1.3	6.4	1.1	1.6	0.7	1.0	1.2	1.9	0.6	6.1	1.5	1.4	3.9	1.5	2.5	0.0	2.1	6.8	0.4	3.5	3.9	5.5	57.0	7.5	3.1	2.4	3.0	2.7	5.4	2.7	1.7	2.4	1.5	1.9	1.3	3.4	3.3	0.9	1.9	3.3	4.1	2.0	4.1	1.6	1.4	12.0	4.1	0.9	5.4	1.9	1.4	11.7	1.0	4.5	0.9	4.5	5.9	6.8	0.6	1.0	7.4	17.4	12.7	37.1	6.6	1.2	2.3	33.2	4.4	0.9	1.0	4.4	1.2	5.8	2.0	0.7
BBS2	BBS	ENSG00000125124	"Bardet-Biedl syndrome 2"	Q9BXC9	16	56466836-56520087	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 144.3;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041315	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA041315: AB_10960892"	"unprognostic (1.43e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.95e-2)"	20.3	78.3	90.1	9.3	102.5	6.0	29.5	93.2	117.7	31.1	80.7	23.6	13.5	25.9	47.1	23.2	32.7	21.6	32.8	87.5	89.4	41.7	13.2	20.2	18.4	94.4	90.4	40.7	15.7	53.7	38.1	16.1	96.2	26.9	16.9	86.5	20.0	27.0	41.5	36.4	17.7	24.0	89.4	21.0	17.2	28.6	91.5	18.3	28.1	50.8	16.2	21.1	29.7	107.9	22.3	19.7	29.6	29.9	47.1	56.9	17.4	10.7	40.9	23.1	29.8	11.0	18.0	22.1	17.6	24.3	19.0	25.3	11.7	36.4	36.0	4.9	26.3	10.4	19.4	28.1	30.7	12.1	11.4	35.4	26.7	18.3	16.8	49.0	50.0	16.7	4.7	2.7	28.9	15.2	16.8	14.1	7.9	14.9	32.7	12.9	8.3	25.7	36.2	18.1	20.7	15.5	51.9	20.2	27.8	23.7	17.2	14.3	43.3	18.3	11.6	8.3	5.7	10.4	8.7	17.1	31.6	10.5	13.7	9.9	9.6	24.5	15.6	13.6	15.8	11.4	18.7	20.6	11.8	12.4	24.4	23.2	2.7	7.4	22.4	3.4	16.4	14.0	90.1	102.5	93.2	117.7	87.5	89.4	94.4	90.4	96.2	89.4	91.5	107.9	11.5	0.0	24.3	144.3	9.6	11.2	15.6	19.1	23.9	21.5	10.7	11.3	24.4	5.7	18.7	11.0	25.0	14.3	6.6	8.7	7.9	7.1	21.1	22.4	10.7	12.3	6.7	4.6	41.0	5.8	7.3	18.6	7.7	16.9	10.1	27.0	12.1	6.9	11.2	20.2	39.6	10.3	24.4	11.3	6.3	19.7	18.0	8.9	10.6	26.2	9.0	26.6	7.2	71.4	97.8	6.0	10.4	20.7	4.1	4.7	11.5	20.0	56.1	34.6	19.7	16.7	12.0	18.4	20.7	13.1	14.1	7.5	10.5	59.2	11.1	10.0
BBS4		ENSG00000140463	"Bardet-Biedl syndrome 4"	Q96RK4	15	72686179-72738475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Rod photoreceptor cells: 89.9;Spermatocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 62.3"	"Low region specificity"	"Detected in all"							HPA039418	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039418: AB_10672962"	"unprognostic (3.47e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.76e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-1)"	9.5	14.8	11.0	6.8	11.2	7.7	10.9	10.1	13.1	13.3	18.1	12.0	5.1	12.5	15.4	5.8	17.5	9.3	11.1	10.9	11.9	15.6	12.7	10.4	8.0	10.9	12.4	14.0	11.1	17.4	20.7	7.9	12.6	20.7	7.6	45.4	7.9	9.4	18.7	9.2	7.9	9.3	10.9	7.6	11.0	20.4	11.5	11.5	16.1	10.2	7.0	11.1	9.1	11.0	6.1	15.7	34.0	14.4	16.5	19.7	9.0	11.9	24.4	11.3	14.8	8.1	20.2	9.6	24.7	10.2	8.6	9.4	9.1	9.9	10.3	10.0	11.0	11.4	13.3	9.2	13.5	10.2	8.6	18.8	13.2	16.3	12.8	17.1	8.9	18.3	25.4	8.2	18.1	10.7	9.6	9.6	48.8	12.3	6.8	6.4	17.1	12.3	19.2	15.2	16.4	19.2	20.8	15.0	31.2	13.1	20.4	11.3	12.5	13.2	10.0	62.3	6.7	17.1	17.8	21.0	14.9	15.3	18.1	5.5	1.9	3.3	5.1	2.9	4.9	4.8	4.3	5.5	1.6	6.0	4.3	5.9	1.6	11.0	2.5	3.1	5.7	2.8	11.0	11.2	10.1	13.1	10.9	11.9	10.9	12.4	12.6	10.9	11.5	11.0	6.0	19.2	19.2	35.3	8.3	3.1	6.0	9.4	10.8	39.0	8.4	10.5	19.8	4.3	18.2	12.9	120.9	10.0	10.6	3.5	5.9	14.4	19.9	28.8	11.1	8.1	4.2	5.2	18.6	11.3	5.8	12.4	7.7	8.4	13.9	8.7	7.1	7.4	7.8	21.9	22.8	8.0	6.1	5.8	2.4	12.2	15.8	5.9	5.4	19.7	4.4	39.4	9.2	31.7	30.7	8.9	4.9	20.3	9.0	8.0	5.1	9.4	48.8	89.9	0.0	11.0	11.5	79.0	63.6	4.6	2.8	5.3	9.3	24.3	5.1	2.8
BBS5	DKFZp762I194	ENSG00000163093	"Bardet-Biedl syndrome 5"	Q8N3I7	2	169479480-169506655	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 70.9;Early spermatids: 213.4;Endometrial ciliated cells: 49.1;Rod photoreceptor cells: 63.4;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 17.3"	"Low region specificity"	"Detected in all"							HPA046125	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA046125: AB_2679549"	"unprognostic (4.37e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.67e-1)"	4.2	5.5	5.9	2.8	6.2	1.4	3.5	4.9	6.0	4.4	9.5	4.4	2.6	4.3	3.8	2.6	7.8	3.1	5.2	6.7	6.3	4.2	2.1	2.9	2.1	6.3	7.1	4.8	3.2	7.2	7.9	2.2	6.2	4.2	1.3	11.3	2.7	4.2	7.1	3.9	2.0	2.9	5.9	2.5	3.3	8.6	6.1	1.5	6.1	3.2	1.0	4.4	2.9	5.3	1.0	2.8	3.2	5.2	8.0	6.4	3.2	7.2	2.3	8.4	3.6	2.0	2.0	0.1	3.3	3.5	5.6	3.1	2.4	1.2	3.2	4.9	0.9	1.8	1.2	4.0	8.0	3.9	4.3	7.1	7.3	5.9	1.5	3.9	2.9	5.0	6.7	0.0	2.5	4.0	6.5	4.0	2.7	0.7	3.6	0.0	0.7	0.0	4.6	3.0	3.0	5.4	4.9	3.7	17.3	1.1	3.7	4.3	2.9	11.8	5.6	9.5	6.6	4.5	6.8	0.1	7.0	2.5	7.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.2	4.9	6.0	6.7	6.3	6.3	7.1	6.2	5.9	6.1	5.3	3.7	0.0	5.1	18.9	0.7	1.3	1.2	1.2	2.8	17.1	3.4	4.2	5.1	1.5	3.5	11.0	70.9	0.8	0.3	0.3	0.0	2.1	213.4	49.1	10.7	2.5	2.4	0.4	38.0	1.5	0.5	4.9	0.5	5.8	0.0	3.2	1.1	0.7	1.4	10.1	34.1	1.7	4.1	4.5	0.4	38.4	5.0	2.0	7.2	14.0	0.1	12.2	0.0	17.6	19.0	1.1	0.5	6.0	1.7	0.7	0.4	2.1	15.1	63.4	0.0	5.5	4.2	62.3	7.8	0.9	1.7	0.3	1.1	7.8	1.0	0.4
BBS7	"BBS2L1, FLJ10715"	ENSG00000138686	"Bardet-Biedl syndrome 7"	Q8IWZ6	4	121824329-121870487	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 56.6"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 65.1;Inhibitory neurons: 58.6;Rod photoreceptor cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044592	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044592: AB_10795882"	"unprognostic (6.36e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.15e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.33e-1)"	6.9	6.4	7.3	5.3	7.7	2.1	6.1	9.8	12.4	7.9	2.6	6.3	5.0	10.5	4.9	6.2	7.9	5.9	4.7	7.7	6.4	6.7	2.4	5.3	5.0	8.9	7.8	12.4	3.7	9.1	9.1	4.7	8.7	6.8	6.3	56.6	4.8	6.6	3.8	6.8	5.3	10.3	5.1	4.6	4.8	9.1	8.4	6.4	5.5	5.5	4.8	5.8	6.9	8.9	13.7	6.6	14.9	10.9	18.8	27.2	5.4	18.3	14.6	15.5	14.2	5.2	7.4	15.0	5.1	21.7	11.6	7.1	15.5	14.8	17.6	14.4	12.1	8.9	10.0	6.2	16.7	12.7	8.0	14.0	10.6	17.7	13.3	20.2	16.8	10.0	6.0	14.8	22.1	4.3	21.3	6.1	7.9	8.3	8.2	9.7	19.3	4.6	15.7	4.8	16.4	7.0	17.5	7.7	14.0	19.7	6.5	4.7	16.9	11.6	12.5	16.2	11.8	13.9	10.3	13.1	13.4	10.0	11.6	0.6	1.0	1.7	1.9	1.1	1.5	0.9	1.5	1.8	1.2	0.9	1.2	1.6	0.2	2.0	1.2	1.2	1.6	1.0	7.3	7.7	9.8	12.4	7.7	6.4	8.9	7.8	8.7	5.1	8.4	8.9	15.7	6.4	8.4	12.7	6.9	8.7	10.8	13.7	5.7	16.6	6.0	9.3	8.4	4.3	13.0	11.0	47.9	8.5	6.6	6.4	13.7	14.6	22.2	14.4	19.9	11.2	6.1	9.5	65.1	9.8	21.5	14.4	6.1	10.6	15.2	9.2	8.6	5.0	11.4	16.8	58.6	8.2	16.2	6.3	6.1	12.9	13.1	7.7	8.8	16.9	6.3	12.6	5.2	30.7	26.4	15.6	5.1	11.3	5.6	9.3	6.0	15.1	16.5	68.9	19.7	12.2	15.2	39.6	22.4	10.9	8.5	5.7	10.7	11.4	8.4	8.6
BBS9	"B1, PTHB1"	ENSG00000122507	"Bardet-Biedl syndrome 9"	Q3SYG4	7	33109557-33877180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 125.7;Excitatory neurons: 162.6;Inhibitory neurons: 159.0;Microglial cells: 266.1;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021289	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021289: AB_1845286"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-1)"	"unprognostic (6.90e-3)"	6.9	8.0	9.1	2.5	10.7	1.9	6.7	8.8	8.6	10.8	13.7	6.3	0.7	5.8	4.2	4.7	6.9	3.8	6.4	7.9	8.5	6.8	4.3	5.8	3.4	9.9	9.8	9.5	3.9	10.4	13.2	4.5	10.0	6.9	3.0	21.9	6.3	5.7	3.5	5.5	4.1	4.4	9.5	4.8	4.4	9.9	10.6	5.5	11.4	3.6	3.0	6.2	8.5	10.6	3.1	3.2	6.0	6.4	12.1	11.0	2.7	3.7	11.7	3.4	10.1	2.7	5.2	4.7	4.4	8.5	9.6	3.9	3.1	7.0	8.3	2.3	4.8	0.9	5.6	3.2	5.3	1.4	2.1	10.1	3.8	6.6	2.6	10.5	8.8	9.9	2.8	5.5	7.3	2.9	3.0	2.5	3.3	4.6	4.4	3.6	2.0	2.7	4.4	1.4	2.7	5.2	7.6	3.3	6.6	8.8	8.0	0.8	4.0	3.3	4.9	6.9	2.3	6.8	10.3	6.6	8.7	2.3	5.4	4.9	2.9	4.5	4.9	4.6	5.5	4.4	4.5	5.3	2.4	4.4	4.3	5.4	1.1	7.4	2.3	0.9	5.6	2.9	9.1	10.7	8.8	8.6	7.9	8.5	9.9	9.8	10.0	9.5	10.6	10.6	7.3	3.2	3.7	125.7	6.9	3.7	6.7	3.1	7.4	6.8	3.6	3.4	14.2	2.8	5.0	5.5	29.2	3.6	4.3	1.8	3.9	3.7	28.6	17.6	7.2	7.4	3.6	3.8	162.6	1.5	4.6	7.3	5.1	3.6	0.0	5.9	5.3	2.5	3.7	5.0	159.0	2.7	8.2	2.5	2.9	6.6	4.1	3.4	1.8	266.1	2.2	7.8	4.1	238.8	366.6	1.5	0.5	5.7	8.1	1.6	1.8	3.8	15.6	51.2	0.0	6.0	5.5	25.6	14.7	6.0	3.3	2.5	7.1	4.6	2.3	4.3
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX high mobility group box domain containing"	Q8WY36	3	107522936-107811339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1071.7;Late spermatids: 571.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	13.9	25.0	19.3	12.8	39.0	18.5	14.5	23.7	22.2	17.2	18.7	11.5	9.5	19.0	38.6	12.9	16.8	16.7	16.5	17.0	29.4	19.5	10.2	13.3	13.9	31.0	26.3	27.0	12.3	46.4	10.2	24.2	32.8	22.7	9.3	20.0	13.4	31.6	6.7	8.1	9.1	16.5	25.6	18.9	12.1	58.1	28.5	16.4	26.2	16.2	13.7	14.6	8.7	59.9	40.0	39.7	31.1	47.0	26.5	35.1	25.5	38.6	36.5	33.2	35.4	4.4	31.4	20.2	46.5	23.4	37.5	26.9	34.4	44.2	45.7	29.0	16.3	31.9	30.0	9.4	31.1	43.3	18.2	31.6	31.3	32.5	62.4	44.5	26.2	23.8	14.9	29.6	27.7	13.5	25.2	4.6	15.5	0.4	30.2	35.8	30.1	22.9	20.8	32.2	22.5	22.0	69.0	6.3	31.5	30.7	25.4	8.6	38.3	38.7	30.7	15.3	26.8	12.9	10.3	25.0	36.9	21.4	23.2	76.0	19.9	50.4	47.0	20.8	54.4	75.9	42.2	48.3	28.3	75.0	52.5	43.3	32.0	58.0	42.7	36.2	30.8	27.7	19.3	39.0	23.7	22.2	17.0	29.4	31.0	26.3	32.8	25.6	28.5	59.9	76.9	64.1	84.1	106.7	123.0	85.1	145.6	103.3	80.8	92.8	72.7	79.4	112.7	85.8	72.5	95.6	64.6	208.2	87.7	18.1	49.0	92.9	1071.7	76.8	62.1	78.4	66.4	51.7	96.3	73.8	92.1	86.2	40.8	88.0	32.3	151.7	66.4	30.8	47.9	171.6	78.4	41.4	114.0	62.2	73.0	571.4	156.3	70.7	67.6	112.4	48.2	149.9	101.0	163.3	323.2	65.4	37.8	206.1	66.4	115.7	19.7	112.8	60.9	64.5	144.7	108.5	114.9	94.1	159.0	59.0	75.6	198.4	100.8	107.1	39.3	128.9
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		18000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	105.0	23.3	24.0	9.9	23.3	3.8	125.6	23.7	39.6	87.7	38.2	32.2	13.5	78.1	21.3	29.1	115.1	15.8	118.3	21.3	24.6	316.8	38.4	89.0	9.8	26.7	27.4	50.2	51.5	20.0	38.3	44.1	26.7	130.1	5.3	3.1	65.6	49.2	44.7	54.1	31.2	19.6	24.0	36.4	39.3	20.6	28.2	13.8	215.7	30.8	7.1	52.8	72.0	21.6	34.7	44.3	1.2	120.8	0.6	0.8	142.7	13.3	6.3	10.7	7.1	66.8	83.5	0.0	65.7	1.6	0.6	298.4	10.4	74.5	3.2	0.1	7.3	0.2	8.8	93.9	23.6	0.0	15.9	11.6	28.6	3.7	4.4	34.2	6.6	0.0	7.3	0.5	1.6	17.7	0.4	1.2	13.5	10.0	15.1	0.5	14.2	3.6	90.4	21.9	0.4	0.5	54.0	276.8	3.4	13.1	157.2	5.1	17.4	2.7	130.2	3.4	6.5	0.6	1.4	0.1	1.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	23.3	23.7	39.6	21.3	24.6	26.7	27.4	26.7	24.0	28.2	21.6	374.9	6.4	12.3	5.5	4.4	40.7	118.0	454.1	80.2	2.5	109.5	185.4	12.8	52.9	48.5	548.1	0.0	705.4	3.2	8.6	82.2	34.0	1.3	62.9	8.2	214.0	52.0	4.8	0.5	4.0	36.9	21.7	15.8	45.3	0.0	14.3	73.2	31.0	44.7	0.0	1.2	5.6	40.7	8.0	21.3	2.1	29.5	3.5	16.0	9.4	0.1	23.6	0.0	1.0	0.3	14.3	21.4	15.1	2.5	80.4	4.9	149.6	20.7	1.1	157.8	14.1	240.6	3.2	18.3	8.9	24.6	433.3	3.5	6.4	13.0	40.7
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 164.7"	"Group enriched"	"Detected in some"	8	"Astrocytes: 136.1;Horizontal cells: 109.4;Melanocytes: 186.7;Oligodendrocyte precursor cells: 288.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 348.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.7;K-562: 108.3;U-266/70: 63.3;U-266/84: 133.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	NA	NA		120000	"Cluster 34: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	0.2	8.4	155.0	0.6	119.5	0.0	0.2	108.3	164.7	2.7	38.3	2.2	7.0	5.9	15.4	0.6	4.0	3.4	0.5	133.1	104.8	0.2	0.1	0.4	0.3	107.5	100.0	0.2	0.1	1.7	2.8	0.7	103.4	0.2	0.0	4.1	1.6	1.8	0.6	15.6	7.8	2.0	94.3	0.5	2.2	1.2	113.7	0.1	0.2	0.0	0.0	0.9	0.9	116.3	44.2	28.4	0.2	8.1	0.0	0.0	11.9	0.4	0.0	0.0	0.0	1.1	21.0	0.1	45.8	0.0	1.0	30.9	0.3	0.0	0.0	76.7	2.9	8.0	20.9	25.6	0.0	3.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	3.8	108.3	21.0	0.0	12.6	0.1	0.1	2.2	22.2	4.2	0.1	46.7	0.1	0.0	5.4	0.2	0.8	0.1	0.0	43.8	2.2	0.2	2.8	8.8	0.1	24.7	8.7	11.8	63.3	133.2	0.2	8.5	20.4	3.4	7.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.0	119.5	108.3	164.7	133.1	104.8	107.5	100.0	103.4	94.3	113.7	116.3	0.2	0.0	0.0	136.1	0.0	6.9	0.0	0.0	0.0	6.0	0.2	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	2.9	0.1	1.8	0.7	1.8	0.0	16.8	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.5	109.4	20.2	0.1	0.0	0.0	1.9	6.9	0.3	0.1	186.7	9.4	0.0	2.1	1.0	288.0	3.5	0.8	0.1	0.0	0.0	0.3	0.1	0.4	0.0	3.2	0.0	0.2	1.7	5.4	6.5	0.0	1.7	0.0	0.2	0.0	0.0	0.0
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107580246-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Supported		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	47.1	25.7	19.4	22.5	23.7	16.7	28.0	18.1	27.0	48.6	12.8	32.6	16.1	42.6	18.6	34.4	21.7	23.0	61.0	24.4	17.9	20.1	33.3	26.0	16.7	17.5	17.6	21.4	18.9	34.5	12.2	26.7	18.0	31.9	31.2	9.6	18.4	25.0	38.7	22.1	18.8	38.2	19.5	18.1	22.4	70.1	19.2	12.8	85.5	31.5	15.7	30.9	32.5	21.1	71.7	22.8	26.4	13.8	65.2	81.6	22.6	80.6	68.2	32.9	39.7	23.2	72.1	13.4	54.5	58.1	75.1	35.8	13.7	38.6	52.5	50.1	17.3	27.1	35.6	26.2	63.3	33.6	41.2	48.9	31.8	46.7	38.0	95.4	116.9	25.3	58.3	33.4	75.4	67.2	23.2	34.3	15.4	29.7	30.0	18.6	34.1	34.6	60.6	49.1	10.2	37.7	68.2	54.9	58.2	39.3	25.6	37.5	113.9	102.5	52.1	94.6	104.7	31.7	67.9	27.5	66.5	30.5	77.2	47.5	10.5	25.5	9.5	13.6	9.3	12.8	7.5	9.5	10.0	8.5	4.3	8.5	3.9	9.9	21.7	10.1	13.6	8.1	19.4	23.7	18.1	27.0	24.4	17.9	17.5	17.6	18.0	19.5	19.2	21.1	169.8	67.3	57.2	35.6	33.9	38.5	80.7	99.0	25.0	35.2	40.4	34.2	117.8	27.1	77.7	23.9	10.4	30.2	31.4	38.1	15.6	46.4	227.1	54.6	93.3	99.0	22.3	73.2	81.1	73.6	50.8	72.9	32.6	102.0	58.3	14.8	73.2	40.7	52.6	8.4	71.3	35.8	69.2	36.6	35.6	95.8	61.2	49.6	37.4	44.0	41.6	28.3	22.6	50.8	49.7	71.2	32.5	89.1	17.7	110.4	15.6	19.5	55.9	26.7	78.9	62.9	91.3	202.2	35.0	46.5	38.8	70.7	33.5	32.0	45.4	83.5
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1 scaffold protein, Cas family member"	P56945	16	75228181-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	34.7	22.3	3.5	4.2	5.8	0.0	27.9	16.9	6.6	37.7	6.3	34.4	15.8	39.2	2.6	22.5	25.3	9.4	47.1	2.3	7.9	47.3	34.2	38.8	2.1	3.9	1.9	19.7	32.4	5.9	29.5	14.1	2.3	25.6	3.5	1.3	25.5	5.7	93.8	18.2	33.1	3.8	0.0	33.7	44.6	34.3	4.2	0.9	26.8	6.8	1.1	24.9	26.2	15.8	21.8	36.8	17.5	6.0	6.7	6.3	34.1	29.5	17.1	20.9	16.4	46.5	32.1	1.9	38.2	33.3	23.6	18.2	6.1	34.0	6.0	0.1	20.0	0.0	23.7	37.2	16.7	0.1	15.1	19.1	16.3	25.3	12.5	12.3	57.9	0.0	20.0	1.0	12.6	48.9	0.1	1.3	23.4	16.1	24.0	0.8	7.9	8.2	19.1	27.9	21.4	31.5	28.7	6.6	11.2	8.4	15.0	5.4	53.6	34.4	29.5	8.8	44.2	8.0	4.7	0.7	22.2	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	16.9	6.6	2.3	7.9	3.9	1.9	2.3	0.0	4.2	15.8	30.1	22.4	6.9	9.4	1.2	28.0	59.7	36.8	12.0	26.5	20.3	14.4	22.9	31.5	21.8	22.0	6.2	46.8	0.7	75.7	27.4	51.9	19.0	13.7	27.9	49.2	34.8	0.0	13.1	61.8	25.7	21.1	71.9	22.5	8.9	15.0	46.8	21.0	6.0	13.5	11.7	42.1	12.2	1.4	6.3	26.8	16.4	2.1	32.0	10.3	0.6	12.9	0.0	19.1	31.2	68.5	59.6	33.4	1.4	58.4	57.4	38.9	13.1	6.8	19.7	8.5	38.5	20.6	17.1	12.5	17.6	36.1	2.2	10.9	33.7	62.7
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3 adaptor protein, NSP family member"	O75815	1	93561741-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.5;Basal prostatic cells: 149.0;Extravillous trophoblasts: 75.0;Urothelial cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0;memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	31.0	10.6	17.7	6.6	20.9	1.0	18.5	19.3	15.3	10.0	21.1	15.3	13.4	5.7	3.6	8.1	9.5	7.5	13.1	14.8	18.7	15.9	11.9	14.2	13.8	21.1	20.6	11.4	4.2	4.0	4.6	17.0	18.9	8.9	16.6	1.5	21.9	9.5	24.4	15.6	12.9	8.0	19.0	4.8	16.2	6.3	21.7	4.3	10.4	21.1	13.0	13.6	9.8	17.8	56.0	23.4	43.5	3.4	18.4	14.4	37.1	56.9	98.3	45.9	28.1	4.0	40.9	9.0	18.9	88.1	59.4	34.0	1.3	73.5	39.7	4.0	1.3	0.0	16.2	10.3	33.1	0.4	0.2	17.3	79.5	47.5	159.7	44.1	51.1	1.1	1.6	0.3	125.7	8.6	1.0	0.2	13.6	24.5	79.7	3.7	62.7	1.3	120.4	70.1	1.5	3.6	27.4	29.1	36.1	16.8	32.9	2.2	60.8	67.3	17.5	29.2	76.0	4.5	2.1	1.2	10.1	0.2	25.2	2.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	17.7	20.9	19.3	15.3	14.8	18.7	21.1	20.6	18.9	19.0	21.7	17.8	26.9	3.2	7.2	72.5	10.2	9.8	149.0	11.3	2.8	0.9	7.9	13.5	7.1	11.5	11.7	14.7	0.0	27.5	2.5	30.8	27.4	11.3	11.3	13.3	2.6	17.9	14.9	0.4	5.2	6.3	75.0	6.3	15.8	16.6	3.8	33.7	5.7	10.3	11.9	21.9	11.2	20.7	8.2	5.3	12.7	12.8	10.2	8.3	19.6	64.6	9.4	4.0	0.0	3.0	2.1	28.0	22.0	1.2	8.9	36.3	25.8	23.7	18.1	0.4	72.3	23.8	19.9	4.2	3.7	4.8	10.2	18.9	3.7	8.3	10.3	106.1
BCAS1	"AIBC1, NABC1, PMES-2"	ENSG00000064787	"Brain enriched myelin associated protein 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 890.2;choroid plexus: 301.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.2	0.2	506.5	6.4	627.9	0.1	3.4	551.3	890.2	7.3	301.2	69.5	19.0	1.3	2.2	7.2	1.5	8.6	0.4	421.4	525.8	3.3	0.4	2.9	0.6	749.3	660.7	0.4	0.9	0.0	1.0	0.1	649.9	33.4	74.3	0.2	22.3	0.3	0.5	1.4	31.1	2.8	584.8	0.5	159.8	3.4	562.0	0.7	0.3	0.8	6.5	35.7	7.5	724.7	0.0	8.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	27.8	0.2	0.0	0.3	4.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	44.2	0.1	0.2	0.2	90.0	0.0	2.3	0.0	1.2	0.0	179.5	0.2	0.1	0.0	368.6	0.4	0.0	12.2	0.0	0.0	0.0	0.1	3.2	0.0	0.9	0.5	1.0	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.0	1.2	0.6	0.4	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.1	0.1	506.5	627.9	551.3	890.2	421.4	525.8	749.3	660.7	649.9	584.8	562.0	724.7	0.8	9.6	1.1	1.6	2.8	0.8	6.3	8.5	0.6	0.1	6.2	1.9	2.2	7.2	35.9	3.7	0.0	0.2	0.4	182.6	1.9	2.9	15.6	9.4	11.1	0.4	8.4	0.0	1.6	22.5	0.1	0.8	202.9	11.8	4.5	0.0	0.4	0.1	0.1	0.0	2.5	371.4	18.3	0.0	2.5	16.1	0.3	1.7	16.0	0.0	0.0	0.8	0.0	538.8	718.8	22.9	102.0	0.0	1.0	21.3	12.0	0.1	100.5	0.5	0.0	1.4	2.2	15.4	6.1	0.3	0.3	0.0	1.7	0.4	35.6	56.7
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2 pre-mRNA processing factor"	O75934	1	114567557-114581629	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 613.4"	"Low region specificity"	"Detected in all"							HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	31.9	40.6	32.8	28.0	35.4	76.2	38.2	36.7	45.3	27.1	34.6	31.6	25.5	35.1	49.7	34.1	24.9	31.8	39.3	35.7	38.8	44.6	51.3	26.9	38.5	34.9	37.6	32.5	28.8	41.3	33.1	27.8	37.8	35.6	32.1	40.4	29.6	27.2	56.4	29.8	26.1	27.8	34.7	26.1	28.7	31.8	34.6	32.2	42.4	25.9	36.2	41.5	23.4	37.7	100.0	35.6	70.8	69.9	37.8	43.8	108.8	71.3	57.0	95.6	97.4	50.8	40.6	88.8	93.9	46.9	64.3	47.8	85.5	72.7	133.3	76.7	75.7	45.0	67.2	74.6	68.8	117.8	48.1	39.2	79.4	97.5	121.3	44.2	63.7	95.0	89.6	64.5	80.5	613.4	103.1	87.5	125.6	60.8	80.8	73.9	127.6	62.2	68.1	85.9	93.5	62.2	90.3	70.3	114.3	59.6	62.3	91.0	52.8	58.2	74.7	116.9	138.2	68.5	76.9	143.4	113.4	94.7	223.9	54.4	36.8	65.3	56.0	45.2	78.9	63.3	71.6	70.6	39.7	58.0	73.8	71.9	34.7	75.0	51.0	51.2	77.6	72.8	32.8	35.4	36.7	45.3	35.7	38.8	34.9	37.6	37.8	34.7	34.6	37.7	51.6	28.9	45.4	11.1	110.1	77.9	114.2	155.9	91.0	62.6	36.7	49.1	76.0	27.1	85.4	49.7	37.5	76.6	99.0	26.4	95.9	66.6	30.3	79.0	51.5	46.9	50.0	30.5	16.4	66.8	89.8	60.0	25.0	139.1	99.1	46.0	28.2	31.3	66.9	38.7	15.1	43.1	103.7	34.9	93.3	17.7	39.7	80.8	67.6	12.2	50.6	98.3	55.6	15.1	18.1	51.2	37.9	43.6	176.7	49.8	29.4	103.9	55.6	67.1	39.5	55.5	71.4	80.8	40.6	95.7	63.4	101.2	117.4	64.2	36.0	114.2
BCAS3	FLJ20128	ENSG00000141376	"BCAS3 microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Astrocytes: 241.9;Excitatory neurons: 298.7;Inhibitory neurons: 299.2;Late spermatids: 282.3;Microglial cells: 244.5;Oligodendrocyte precursor cells: 285.0;Oligodendrocytes: 552.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 88.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	9.7	11.6	12.7	4.5	14.2	6.4	9.0	13.8	15.8	9.4	12.0	10.0	4.8	9.3	12.1	9.5	13.9	7.6	9.1	13.6	12.2	11.1	12.4	11.1	6.0	14.3	12.1	7.4	9.3	14.4	6.9	10.0	15.2	11.1	6.1	18.0	9.3	9.2	17.3	14.2	6.8	9.0	10.2	7.4	9.7	14.3	12.1	10.6	8.8	9.8	6.7	10.9	9.6	24.0	5.7	14.5	7.8	28.1	17.2	14.2	9.8	6.6	9.9	7.3	9.3	10.0	13.8	2.5	9.7	12.2	7.6	4.9	4.5	6.1	9.5	6.1	19.4	5.6	7.3	9.5	9.4	2.7	5.6	14.5	6.3	6.2	11.1	14.2	8.3	8.8	5.1	12.9	6.5	88.7	10.0	2.2	7.3	29.1	18.2	11.4	11.2	12.4	6.0	24.4	11.6	10.2	12.1	3.3	10.3	20.9	13.5	5.1	8.1	9.5	7.7	4.2	2.8	29.1	23.6	11.7	11.2	2.3	7.6	27.2	10.1	16.5	15.0	9.3	12.3	11.4	10.2	11.2	8.8	11.2	10.7	9.1	34.5	15.6	10.9	6.8	18.0	9.0	12.7	14.2	13.8	15.8	13.6	12.2	14.3	12.1	15.2	10.2	12.1	24.0	10.1	6.4	12.5	241.9	8.6	5.1	9.9	4.7	12.5	22.6	4.4	4.1	11.4	7.2	9.3	16.5	10.4	6.8	9.3	4.1	9.8	4.7	44.2	20.4	26.1	8.6	7.2	13.2	298.7	3.5	5.5	7.8	5.6	9.1	15.9	11.1	11.7	10.8	4.3	3.3	299.2	4.9	6.1	10.0	2.5	282.3	7.5	5.3	1.8	244.5	8.2	33.3	5.2	285.0	552.6	3.6	5.2	21.1	11.1	2.9	6.0	25.2	35.6	14.2	13.1	7.1	21.2	16.3	6.6	6.8	5.5	7.5	11.4	6.7	3.8	6.0
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 71.6;B-cells: 76.0;granulocytes: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 73.9;naive B-cell: 76.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 96.5;U-698: 88.7"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.6	1.2	7.6	7.7	8.2	2.2	3.0	4.8	14.9	5.0	7.2	3.7	1.0	4.1	4.1	2.7	2.8	2.0	1.8	15.4	6.0	5.8	0.8	2.1	21.3	4.8	5.6	2.0	2.0	4.8	4.0	2.2	5.3	6.0	0.7	2.3	2.8	4.0	1.0	1.2	7.6	1.8	3.3	9.4	3.5	3.6	6.4	11.7	4.3	0.8	23.1	5.3	2.8	6.8	12.3	21.8	1.7	9.3	3.3	8.7	3.7	15.8	14.2	11.1	7.8	10.4	7.3	96.5	5.8	6.7	22.3	18.2	10.8	22.9	6.3	6.2	9.4	0.4	8.3	8.7	4.7	0.1	0.5	2.8	13.0	8.5	4.2	13.7	0.6	7.5	0.3	0.6	4.0	42.9	3.7	0.3	7.6	1.8	17.6	30.5	2.9	0.9	5.1	11.0	9.5	9.9	24.5	23.2	0.5	8.1	45.9	1.1	0.5	11.8	17.3	12.1	3.9	1.4	7.4	88.7	4.9	0.7	1.1	2.2	0.3	0.2	15.3	0.2	8.7	73.9	9.4	19.0	0.2	76.1	32.2	25.4	1.4	20.0	0.2	18.8	8.9	13.3	7.6	8.2	4.8	14.9	15.4	6.0	4.8	5.6	5.3	3.3	6.4	6.8	1.2	22.4	71.6	6.5	76.0	2.0	27.5	28.9	2.2	6.2	12.6	8.3	17.7	4.3	35.3	9.2	2.1	29.1	16.1	0.3	41.1	11.8	4.0	6.0	6.4	23.7	33.6	5.2	11.5	3.1	4.8	26.6	3.1	7.7	113.5	9.4	2.2	0.4	3.2	8.4	14.3	3.7	44.7	1.3	2.8	1.1	1.5	6.2	5.4	0.0	1.9	10.6	21.6	8.5	0.8	8.9	0.1	3.0	6.1	15.0	0.7	5.2	40.0	6.6	6.6	4.9	35.7	3.2	11.0	1.2	2.4	10.9	35.7	1.5	1.1	25.5
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	4.1	7.1	5.7	2.4	2.1	11.1	10.6	3.6	0.0	3.0	0.8	8.6	1.0	2.0	7.2	4.4	1.8	3.0	19.6	1.2	1.3	9.6	6.4	19.4	19.8	7.2	58.2	0.4	6.6	15.2	22.7	0.9	2.6	14.5	1.7	0.8	0.7	0.6	3.6	5.7	6.4	2.0	1.8	7.1	14.0	5.2	1.2	2.0	5.3	4.1	1.3	7.9	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	4.1	5.7	11.1	10.6	3.0	19.6	19.4	19.8	22.7	6.4	14.0	7.9	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 254.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	27.2	85.4	27.5	11.4	27.8	6.1	25.2	34.6	34.5	29.7	72.3	38.8	14.8	27.0	5.3	33.7	30.2	10.7	63.4	29.0	26.5	40.5	22.1	30.4	14.0	28.2	29.7	53.3	76.7	20.1	30.7	12.4	27.8	38.4	17.4	5.6	29.1	17.0	58.7	28.0	23.7	13.5	26.1	19.7	66.4	20.2	30.8	12.0	28.9	29.4	16.5	56.6	29.0	29.2	62.9	73.3	19.3	40.6	78.1	26.3	34.2	27.3	13.8	32.7	31.7	74.5	37.4	73.3	30.2	24.3	10.1	28.8	29.8	47.4	16.5	46.0	76.0	27.0	32.7	5.0	75.3	36.9	24.2	38.5	29.8	24.2	35.0	31.8	45.5	55.3	34.9	43.8	12.2	74.8	50.4	38.9	16.9	98.5	35.7	75.2	33.1	80.8	30.8	254.3	102.6	29.4	41.0	66.7	20.7	13.3	42.3	17.9	25.9	31.5	30.3	37.6	34.3	40.8	58.4	35.8	17.2	56.7	21.0	0.0	14.4	3.0	14.3	16.1	20.1	23.5	17.5	18.8	25.6	20.3	15.7	14.1	0.6	14.8	6.2	28.9	24.9	12.3	27.5	27.8	34.6	34.5	29.0	26.5	28.2	29.7	27.8	26.1	30.8	29.2	13.1	28.9	44.8	59.7	14.1	6.0	28.3	32.3	14.2	10.4	23.5	17.9	25.5	31.5	20.6	12.9	20.9	67.6	11.0	28.8	72.4	38.6	8.0	16.2	22.4	13.5	19.9	6.3	11.2	21.3	25.2	15.3	32.6	23.8	23.5	18.3	12.8	11.2	26.2	1.7	10.6	30.4	38.7	7.9	10.5	10.2	17.4	7.5	24.9	8.4	21.6	7.3	7.2	9.0	11.2	15.8	17.7	30.1	15.1	16.1	13.9	39.4	13.2	13.4	19.7	9.9	17.3	8.0	19.5	32.6	7.1	45.8	9.5	21.9	33.9	47.7
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836043-49843106	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 22.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	2.0	2.9	5.4	2.8	5.5	1.1	4.0	6.0	6.8	2.9	5.3	2.3	2.4	2.5	3.7	2.7	3.9	2.4	2.6	5.4	5.2	3.3	3.7	2.1	4.8	5.5	5.2	3.8	3.5	4.3	2.2	2.3	5.5	3.8	2.8	2.6	4.2	2.7	22.1	3.8	2.8	2.6	5.3	3.2	3.1	2.5	5.3	4.2	3.9	3.0	4.2	2.4	1.9	6.4	2.8	4.0	3.8	5.8	8.0	4.7	3.8	3.9	5.1	4.1	4.2	2.1	7.0	2.5	4.2	1.8	3.0	3.4	3.9	2.3	2.2	8.7	5.1	3.3	3.1	1.3	6.3	4.0	3.3	2.5	9.2	2.9	4.1	5.1	1.9	5.3	6.4	6.7	2.6	7.2	4.5	6.4	3.8	6.3	7.1	4.7	3.6	5.0	4.0	2.6	5.2	7.2	4.6	7.4	5.7	3.0	8.9	4.4	2.1	3.2	2.4	5.0	2.1	6.3	5.7	4.8	3.5	2.9	2.2	4.0	3.0	1.6	4.5	4.0	6.0	6.7	5.7	4.4	3.2	5.7	6.4	5.9	2.4	4.4	4.2	1.7	5.3	3.0	5.4	5.5	6.0	6.8	5.4	5.2	5.5	5.2	5.5	5.3	5.3	6.4	4.0	32.1	25.0	2.9	9.4	2.2	7.3	7.6	5.2	6.8	7.4	6.7	2.4	5.7	10.2	1.8	0.0	12.6	4.8	3.6	13.7	10.1	1.7	5.9	6.0	4.6	1.8	9.5	3.3	9.8	7.4	6.8	5.1	5.0	10.8	4.6	3.9	7.7	5.8	5.0	5.2	5.6	6.1	4.1	1.2	0.9	8.4	4.3	0.0	2.8	3.1	7.2	13.4	4.0	11.0	6.4	4.8	6.4	4.9	5.7	6.9	8.7	14.2	6.2	0.0	4.7	4.5	11.8	8.7	5.1	3.1	7.7	9.1	6.8	5.1	2.8
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 525.1"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	30.4	11.6	9.3	2.7	7.4	0.0	4.7	7.5	12.0	22.0	5.0	36.1	4.7	41.0	24.3	25.8	36.2	6.0	9.7	7.9	7.3	4.9	525.1	10.9	0.2	7.9	9.4	3.7	2.3	0.1	1.8	0.0	7.8	12.5	16.1	8.8	1.9	32.3	2.7	8.7	10.6	29.7	7.4	5.9	3.5	1.3	12.2	2.9	1.3	5.1	0.1	11.3	5.1	9.4	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.4	7.5	12.0	7.9	7.3	7.9	9.4	7.8	7.4	12.2	9.4	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1 subunit alpha"	P12694	19	41397808-41425002	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA		7700	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	33.8	78.4	32.0	19.3	35.5	32.4	25.2	37.0	39.3	24.6	37.0	20.9	19.9	17.9	14.1	65.1	28.8	15.4	90.4	32.5	35.1	44.3	110.0	22.4	24.5	34.4	33.8	25.4	46.1	56.3	24.0	19.0	36.2	23.8	15.0	21.7	40.9	23.1	110.0	31.8	18.7	12.7	33.9	24.4	52.5	27.1	35.7	27.0	41.7	122.0	21.2	21.7	31.9	40.0	42.7	75.1	14.2	44.1	22.2	12.8	17.1	11.9	25.3	24.4	29.9	18.2	36.0	34.6	23.7	15.1	11.0	17.1	15.0	25.9	12.1	36.0	41.0	27.1	35.2	21.3	51.5	25.5	17.7	27.6	37.6	16.9	38.2	36.0	45.0	50.9	25.9	68.9	17.6	41.5	28.0	20.0	12.8	61.1	21.1	27.1	22.8	89.6	29.8	19.8	32.5	38.6	39.6	84.7	34.1	12.1	45.4	81.0	29.3	22.2	23.0	12.0	22.0	131.9	55.1	34.1	81.8	56.6	24.6	61.4	149.4	59.7	49.5	123.9	56.7	46.0	47.0	49.1	154.6	49.5	43.2	44.9	46.4	82.4	95.5	62.6	63.9	125.6	32.0	35.5	37.0	39.3	32.5	35.1	34.4	33.8	36.2	33.9	35.7	40.0	0.6	0.0	13.1	4.9	10.0	0.3	0.1	2.6	26.2	0.2	1.5	0.4	0.1	1.5	5.3	5.5	0.0	1.9	0.9	3.8	3.9	14.7	0.7	0.5	0.6	2.4	6.1	15.5	5.8	11.8	1.7	3.7	23.4	0.7	5.1	0.4	2.5	2.4	2.7	0.0	6.2	7.6	8.2	2.2	0.8	0.9	0.6	6.6	3.6	3.7	12.4	0.4	5.2	4.0	5.7	8.4	3.8	0.4	25.0	0.2	6.7	2.3	1.2	1.2	0.0	0.2	3.6	1.8	0.9	27.2	0.9	2.1	6.3	0.3	7.3	0.1
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCKDK		ENSG00000103507	"Branched chain keto acid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 95.9;granulocytes: 89.7;monocytes: 115.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	32.3	56.4	18.4	19.2	18.6	14.5	29.0	17.4	23.8	25.1	18.0	31.4	16.0	27.7	16.7	29.4	24.8	17.9	78.6	18.8	17.8	43.8	76.4	21.7	15.6	20.6	20.7	27.5	70.5	22.9	16.4	15.3	19.3	29.3	12.5	6.3	47.0	21.8	81.3	45.4	24.1	19.5	17.1	30.2	42.0	17.4	18.5	9.8	22.4	69.7	13.6	30.2	24.6	17.5	47.5	49.1	27.1	41.8	32.8	32.5	31.1	40.4	46.3	57.3	55.9	32.1	29.1	41.5	58.9	47.5	28.0	31.4	19.3	65.6	36.5	34.4	60.1	45.2	32.6	59.5	57.5	23.5	41.9	48.3	26.2	49.2	40.6	52.6	62.4	31.1	23.4	39.4	87.7	75.8	22.9	32.4	23.0	20.5	39.1	45.8	39.6	78.8	44.3	30.1	42.1	38.7	31.3	72.4	24.6	22.9	44.5	24.6	41.1	44.2	26.1	45.8	32.2	44.5	15.7	15.1	50.3	33.7	42.6	58.1	115.0	85.2	17.7	97.6	17.2	22.8	16.5	13.9	95.9	19.0	13.6	16.1	89.7	22.8	71.2	19.3	24.5	53.1	18.4	18.6	17.4	23.8	18.8	17.8	20.6	20.7	19.3	17.1	18.5	17.5	27.2	19.2	18.1	5.9	20.0	18.5	24.6	61.0	22.2	11.6	30.9	27.6	39.1	25.8	28.5	20.2	0.0	55.4	9.0	31.5	80.3	68.6	2.5	14.6	24.3	29.2	19.9	16.4	5.1	78.0	71.1	24.9	25.5	20.0	33.0	35.4	25.4	43.8	93.0	11.8	4.4	22.3	42.7	44.5	50.3	7.8	20.8	53.1	12.4	1.9	79.3	22.6	9.2	4.5	4.5	54.8	48.4	25.6	51.7	30.9	66.9	95.2	19.6	9.8	46.0	18.4	33.2	25.8	14.1	25.7	27.4	69.4	12.1	45.5	26.0	27.0
BCL10	"c-E10, CARMEN, CIPER, CLAP, mE10"	ENSG00000142867	"BCL10 immune signaling adaptor"	O95999	1	85265776-85276632	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 194.1;Paneth cells: 210.2;Urothelial cells: 297.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001944, HPA017925"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB001944: , HPA017925: AB_1845312"	"unprognostic (3.78e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (7.06e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.92e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-1)"	10.1	7.4	4.3	13.8	4.6	24.3	10.6	5.3	6.8	14.7	6.0	26.7	14.7	8.1	7.9	18.1	9.0	18.9	5.5	5.3	4.4	8.7	9.8	9.2	13.7	4.8	4.6	7.2	8.9	6.2	2.6	9.3	4.4	7.8	23.5	2.7	8.5	5.1	6.7	9.4	16.5	11.8	4.7	11.6	14.9	6.5	5.8	9.4	9.0	5.7	16.4	23.1	11.3	5.5	38.5	7.6	11.6	11.8	13.7	23.7	16.9	26.8	27.6	20.9	27.8	8.1	14.5	14.5	19.1	22.5	39.3	19.6	12.8	32.4	28.7	14.8	8.2	16.9	6.5	11.9	24.0	16.7	15.4	18.6	31.7	31.4	25.6	24.5	97.9	10.0	11.7	14.1	33.2	6.8	16.4	13.5	19.0	22.1	25.0	12.2	21.8	9.8	71.2	29.2	6.3	8.5	8.2	28.6	23.2	14.8	9.6	10.2	47.3	19.0	13.2	24.1	27.5	11.7	6.5	16.6	9.9	13.1	14.7	78.4	34.1	48.2	20.8	41.8	23.5	46.7	27.0	24.4	33.7	41.4	24.7	23.5	85.0	24.6	33.1	26.3	31.1	22.9	4.3	4.6	5.3	6.8	5.3	4.4	4.8	4.6	4.4	4.7	5.8	5.5	40.6	22.4	18.1	3.3	49.6	194.1	167.2	75.4	48.3	5.7	29.2	19.8	4.6	17.2	54.9	23.9	0.0	16.0	24.1	174.3	17.6	71.5	85.1	97.7	36.1	48.2	49.0	9.1	8.8	44.7	28.4	24.9	57.1	152.2	39.3	17.9	28.2	19.8	21.2	10.1	6.1	79.7	38.7	31.8	68.8	13.4	11.1	41.7	16.0	2.8	21.7	11.1	11.3	9.5	6.1	74.1	210.2	11.3	25.0	80.0	45.2	25.4	32.9	6.3	0.0	19.9	21.8	9.7	12.9	76.7	171.3	23.7	31.3	21.5	77.2	297.4
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"BAF chromatin remodeling complex subunit BCL11A"	Q9H165	2	60450520-60554467	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.8;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0"	"Group enriched"	"Detected in all"	15	"B-cells: 415.7;dendritic cells: 899.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7"	"CAB014891, HPA029003, HPA075941"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: AB_2672863, HPA075941: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	0.7	2.1	31.4	11.3	34.7	25.3	7.1	10.5	47.8	5.2	9.7	18.4	9.7	2.1	1.4	18.4	5.7	2.5	8.0	38.7	15.5	1.0	0.5	2.1	29.2	31.6	15.3	0.6	10.8	1.7	3.0	0.9	31.0	7.8	6.1	1.7	13.8	1.9	1.7	33.2	13.9	3.4	15.9	19.6	4.8	2.0	15.9	33.9	2.3	0.2	40.9	3.3	11.5	38.7	0.6	0.0	4.2	0.1	0.8	0.8	0.3	1.5	0.0	0.1	0.0	0.0	0.2	51.1	0.2	0.2	0.0	10.5	15.4	7.4	0.2	0.9	15.2	0.1	0.6	0.2	0.0	18.7	0.1	1.7	4.1	0.0	2.5	4.0	2.6	17.1	0.8	0.3	0.1	0.1	49.0	19.9	28.6	7.7	0.2	48.3	1.3	19.7	0.0	0.9	20.1	4.8	0.3	0.4	0.3	8.0	0.3	9.1	1.0	0.3	11.6	0.3	0.1	0.8	0.2	106.7	0.1	34.0	1.6	4.5	23.8	5.1	0.5	44.1	1.1	312.7	0.5	0.5	89.9	415.7	1.3	1.1	11.0	8.4	33.7	899.0	1.1	11.4	31.4	34.7	10.5	47.8	38.7	15.5	31.6	15.3	31.0	15.9	15.9	38.7	0.6	0.0	7.4	3.6	149.0	46.3	16.0	34.0	118.4	2.5	31.6	28.6	18.2	4.3	11.7	1.8	0.0	0.6	140.3	7.5	5.9	9.5	12.0	3.9	2.0	1.4	19.8	69.6	180.8	6.4	0.5	3.6	5.1	4.8	10.1	67.4	0.7	0.1	43.2	52.2	153.2	13.6	6.1	7.0	86.1	5.0	0.3	20.5	16.0	11.2	16.0	0.3	0.0	3.5	4.6	4.7	12.5	0.0	6.0	11.7	16.2	0.5	5.5	0.3	0.0	0.2	2.0	2.9	6.9	120.3	69.9	0.8	4.6	1.0	28.9	5.8
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 160.0;Pancreatic endocrine cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	80.3	46.9	46.3	26.1	53.7	99.0	71.0	46.7	54.5	46.5	88.2	42.4	49.4	39.2	11.9	77.8	42.7	51.7	77.9	42.2	48.2	95.7	85.2	95.1	25.8	49.5	49.4	23.1	54.7	30.4	49.8	42.0	51.1	52.0	26.2	41.0	70.6	25.2	55.4	65.7	48.9	25.0	41.3	53.4	66.6	46.2	54.4	111.5	51.4	38.8	28.9	42.8	54.7	59.7	327.0	188.4	30.7	32.4	167.8	123.1	101.0	73.8	113.2	69.6	66.4	429.2	150.9	48.2	176.7	108.4	140.7	105.8	42.9	216.7	46.2	55.1	8.6	231.3	34.4	231.6	123.0	19.6	137.7	90.7	77.4	89.4	194.0	102.4	106.0	81.6	150.0	34.5	238.7	94.3	73.9	20.6	45.4	150.8	153.2	43.5	92.9	164.3	249.3	83.4	85.4	38.4	89.3	92.6	42.4	57.2	180.5	26.3	154.1	90.0	109.1	36.8	139.4	22.7	150.7	37.9	143.5	99.5	59.5	28.6	11.0	25.6	39.9	11.7	30.9	4.8	17.1	26.8	10.4	6.0	7.7	18.6	12.5	19.8	13.4	7.0	21.8	28.2	46.3	53.7	46.7	54.5	42.2	48.2	49.5	49.4	51.1	41.3	54.4	59.7	41.6	16.0	9.2	22.5	10.1	18.4	70.2	40.8	26.7	21.9	25.5	15.4	9.7	91.5	36.3	38.6	45.9	27.1	13.7	41.7	86.1	92.2	10.2	71.4	14.6	35.8	24.7	160.0	21.8	65.9	11.3	15.5	37.2	58.2	12.7	10.6	36.4	40.8	38.2	28.6	19.5	26.0	69.2	22.1	13.3	4.6	19.0	27.6	17.8	49.6	76.9	24.1	54.6	13.6	55.6	187.7	22.4	42.9	38.0	102.9	54.6	76.5	76.4	33.7	46.0	14.9	42.7	31.0	15.1	13.6	9.8	18.9	24.9	13.6	19.6	143.0
BCL2L10	"BCL-B, Boo, Diva"	ENSG00000137875	"BCL2 like 10"	Q9HD36	15	52109263-52112775	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 9.6;skin 1: 6.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Proximal enterocytes: 11.4;Proximal tubular cells: 9.8;Squamous epithelial cells: 7.9;Suprabasal keratinocytes: 8.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"NB-4: 34.1"	"Not detected"	"Not detected"							HPA042222	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA042222: AB_10794271"	"unprognostic (5.33e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.18e-9)"	"unprognostic (9.59e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.20e-2)"	0.2	2.6	1.2	0.3	1.6	0.1	1.0	0.8	1.1	2.3	0.5	1.0	1.9	0.8	0.0	3.5	0.6	0.9	0.0	0.9	1.7	3.1	9.6	0.0	0.2	0.6	0.6	0.4	0.6	0.2	1.2	0.0	0.8	0.5	0.8	0.4	0.8	0.1	0.1	6.9	2.1	0.2	0.5	0.6	0.9	0.2	1.8	0.1	0.3	0.0	0.2	1.2	3.6	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	4.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	1.6	0.8	1.1	0.9	1.7	0.6	0.6	0.8	0.5	1.8	0.7	0.1	0.0	0.0	0.0	0.6	6.1	5.3	2.5	4.6	1.0	1.7	2.5	0.3	4.3	0.7	0.0	0.0	0.1	0.2	2.8	13.7	2.2	0.0	1.4	1.4	0.3	0.0	0.8	0.4	1.5	0.2	0.3	0.0	5.2	0.0	0.1	0.0	4.5	0.1	0.0	0.2	2.1	6.1	0.0	0.7	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.7	0.4	1.1	2.0	11.4	9.8	0.4	0.2	0.0	0.2	0.3	0.0	0.1	7.9	8.7	0.1	0.2	0.1	3.1	5.4
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168445	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.3;Plasma cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	8.1	7.4	4.2	16.4	5.0	38.8	12.5	3.7	3.7	7.2	4.6	11.0	7.2	6.5	4.9	9.8	7.0	8.8	5.7	3.0	3.9	10.7	14.3	8.5	24.2	4.3	4.0	10.3	10.3	18.8	9.4	6.0	4.5	7.8	11.9	12.1	10.1	7.1	12.3	5.8	11.7	4.8	3.9	16.3	7.0	8.1	4.4	18.9	16.6	7.3	23.0	8.9	8.2	6.7	8.0	2.4	10.8	10.4	9.1	4.7	29.1	1.2	2.3	3.3	3.3	6.6	24.9	32.0	6.5	1.2	18.9	9.5	10.0	3.9	2.0	24.9	18.2	39.7	8.1	10.5	3.9	14.6	8.8	4.8	10.5	3.7	3.8	7.0	4.6	14.2	20.8	46.6	0.7	5.2	15.3	14.7	13.2	6.3	7.5	19.5	10.3	40.7	4.5	13.0	9.3	24.0	11.0	14.5	8.3	7.1	5.0	31.2	1.9	1.7	11.4	3.7	4.3	91.2	19.5	45.3	2.7	10.1	1.5	5.2	3.7	1.8	1.7	2.6	1.8	3.3	2.3	1.9	1.9	1.9	1.5	1.5	5.2	1.7	5.7	0.4	5.9	1.5	4.2	5.0	3.7	3.7	3.0	3.9	4.3	4.0	4.5	3.9	4.4	6.7	33.9	3.2	9.9	2.9	61.3	17.5	18.2	7.0	34.7	7.4	19.5	29.2	19.3	12.8	10.3	9.2	10.4	4.6	43.9	37.6	13.7	9.7	118.3	36.6	10.8	18.0	21.5	26.5	2.2	6.5	7.8	11.6	8.6	54.7	11.4	5.9	14.6	11.3	10.9	0.0	4.8	15.2	12.2	26.8	52.6	39.2	5.9	34.8	23.2	6.5	41.0	12.1	5.2	3.0	5.3	8.8	16.4	3.8	137.9	15.9	16.6	6.4	15.2	21.1	0.0	11.8	11.9	7.3	17.7	66.1	10.9	5.7	41.0	2.5	12.3	16.0
BCL2L12		ENSG00000126453	"BCL2 like 12"	Q9HB09	19	49665142-49673916	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020856	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane"	"HPA020856: AB_1845320"	"unprognostic (2.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.87e-3)"	"unprognostic (6.12e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (8.75e-5)"	"unprognostic (8.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.56e-1)"	8.5	8.5	3.8	14.7	3.9	18.2	9.5	3.9	5.1	8.3	5.0	11.9	10.5	9.9	3.2	13.4	9.5	6.5	9.4	3.6	3.8	7.8	16.6	9.6	20.6	4.4	4.2	9.7	15.5	4.5	2.7	10.3	4.1	11.3	7.3	1.7	11.7	5.0	14.0	8.5	11.9	6.8	4.1	16.7	11.7	10.1	4.1	17.3	7.6	13.5	15.8	9.6	8.7	4.3	105.2	63.7	49.8	94.8	12.6	12.6	56.9	58.2	23.3	57.2	60.6	89.2	55.4	58.4	26.7	20.2	32.4	49.7	46.3	39.4	30.7	74.1	97.4	53.1	43.5	62.0	11.4	56.6	62.2	15.5	19.0	64.3	18.2	11.5	38.7	79.2	138.8	73.3	30.8	59.1	67.6	91.8	62.4	61.8	77.4	86.6	54.3	62.7	24.8	52.0	0.9	29.4	59.5	79.0	41.8	35.6	33.0	70.3	22.8	64.1	75.2	45.5	96.4	61.2	102.4	114.3	27.2	78.0	64.3	11.0	7.4	17.0	12.5	12.2	14.6	14.8	13.2	12.3	6.5	14.6	12.8	13.1	10.9	15.8	8.6	25.9	14.4	6.3	3.8	3.9	3.9	5.1	3.6	3.8	4.4	4.2	4.1	4.1	4.1	4.3	10.2	9.6	13.1	3.3	22.1	32.2	37.4	23.3	14.2	1.0	35.2	34.2	5.0	10.0	16.5	5.5	0.0	70.3	18.2	14.6	7.9	25.7	8.3	17.0	11.5	13.2	6.7	18.5	0.2	25.8	126.3	16.2	9.2	20.1	9.5	18.9	11.0	13.1	37.6	0.0	0.2	15.7	18.3	12.6	16.1	6.4	6.5	15.5	26.6	1.0	22.1	3.5	24.7	0.0	1.6	34.5	16.6	6.0	44.3	20.5	6.5	10.4	12.6	1.2	13.1	14.0	15.1	11.6	22.3	19.7	19.5	55.7	15.7	11.7	23.3	27.7
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA		100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	13.4	13.3	8.7	5.7	11.6	10.8	11.5	8.4	12.8	7.7	1.4	10.0	6.0	7.9	8.8	12.3	7.4	6.8	19.7	9.4	9.9	14.0	16.4	8.4	7.6	11.6	13.7	7.5	11.8	14.8	7.8	9.2	12.1	8.2	10.3	43.8	10.0	6.8	59.6	14.1	7.8	7.6	9.2	6.4	9.5	10.7	9.7	9.2	9.6	40.5	8.7	10.3	8.7	9.4	16.2	6.1	10.6	11.1	19.6	18.8	17.2	11.4	21.3	17.1	19.8	8.3	11.7	14.6	7.5	15.4	13.9	21.3	12.6	18.4	20.9	12.2	12.3	14.5	7.5	6.1	22.3	21.3	10.0	14.5	21.1	14.0	40.1	24.2	14.7	11.3	34.5	15.2	18.9	11.6	11.7	8.9	10.7	26.8	9.7	10.9	20.7	5.3	20.1	12.4	15.6	11.5	16.4	15.6	31.0	38.0	11.9	18.0	17.2	9.9	5.0	15.3	10.5	11.9	10.5	14.7	14.9	16.1	16.4	5.1	9.5	2.3	2.3	8.0	2.8	3.1	3.1	2.7	5.4	3.2	2.8	2.3	3.6	6.5	6.4	2.9	4.5	4.7	8.7	11.6	8.4	12.8	9.4	9.9	11.6	13.7	12.1	9.2	9.7	9.4	18.7	22.4	16.7	32.3	21.5	24.6	33.6	22.7	30.1	180.5	21.8	22.4	42.7	12.8	25.3	18.4	12.5	48.5	19.7	31.7	52.8	29.1	34.8	17.7	16.0	17.5	23.4	19.8	41.9	31.6	35.0	20.0	13.3	23.5	8.8	19.7	15.7	36.0	26.0	48.8	38.1	25.4	18.3	30.8	19.8	15.5	14.0	26.3	16.0	27.2	54.7	57.9	12.3	27.6	45.4	36.4	17.8	15.4	15.4	40.3	32.6	44.4	19.6	35.2	0.0	21.3	15.6	33.1	22.6	32.1	27.1	95.9	19.3	22.9	24.0	43.1
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.5;stomach 1: 9.4;testis: 31.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 385.6;Late spermatids: 863.1"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 5.2;pancreatic cancer: 1.8;stomach cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;NTERA-2: 1.6;OE19: 2.0;RT4: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040665, HPA059846"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA040665: AB_10964282, HPA059846: "	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.0	0.0	0.1	2.5	0.1	0.1	0.5	0.0	0.1	0.2	0.1	10.7	13.7	0.1	0.1	0.2	0.1	1.2	0.0	0.2	0.0	0.1	0.5	0.4	1.3	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.1	15.5	0.0	0.9	0.0	0.0	0.0	12.9	0.4	0.0	0.7	9.4	31.4	0.0	1.2	0.0	0.0	0.8	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.3	1.6	0.2	0.4	2.9	3.2	0.0	0.3	2.5	1.3	0.7	2.8	4.5	1.8	0.0	0.1	0.2	30.1	0.0	0.3	385.6	1.2	0.2	0.7	6.7	0.0	2.1	7.5	0.0	0.5	28.5	0.8	0.0	0.1	0.0	0.3	0.2	0.0	1.4	45.0	2.0	0.3	3.8	863.1	5.6	0.9	0.0	0.0	3.8	0.1	0.0	1.5	1.1	2.6	22.9	3.8	0.5	4.0	95.0	0.0	5.0	1.0	6.6	1.2	0.6	6.5	2.8	0.0	0.4	0.1	0.6	0.1	30.6	9.4
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113876816-113887581	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2;stomach 1: 18.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 67.6;Exocrine glandular cells: 115.9;Intestinal goblet cells: 39.3;Pancreatic endocrine cells: 74.9;Proximal enterocytes: 133.2;Undifferentiated cells: 54.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 16.9;EFO-21: 5.4;OE19: 15.2;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in some"	32	"cerebellum: 32.9"	"Low region specificity"	"Detected in all"			"HPA029732, HPA029733"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.2	0.1	1.2	3.1	1.4	13.2	0.5	2.7	1.9	3.9	0.4	32.5	43.2	1.0	5.2	2.2	0.6	8.3	0.2	1.4	1.4	0.7	0.2	0.5	0.2	1.2	1.7	0.1	9.6	0.1	0.1	0.1	1.1	0.3	26.9	1.3	0.3	0.2	0.3	0.2	41.8	0.8	0.8	0.5	18.4	0.8	1.1	1.2	0.1	0.0	0.2	0.5	0.6	1.3	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	2.2	0.3	0.1	0.0	15.2	0.0	0.1	0.3	0.6	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.3	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	1.4	2.7	1.9	1.4	1.4	1.2	1.7	1.1	0.8	1.1	1.3	0.6	0.0	1.3	2.0	0.9	0.4	5.0	3.4	2.2	1.6	0.3	0.3	0.4	4.3	12.2	23.9	6.2	0.1	1.0	67.6	0.0	4.1	1.4	4.3	0.5	1.2	2.4	0.0	2.3	115.9	0.0	1.2	29.6	5.5	0.0	0.4	0.0	0.3	0.8	1.7	1.8	39.3	6.1	0.6	5.0	0.2	0.0	1.6	0.0	0.0	2.5	0.3	0.0	0.5	1.6	74.9	23.3	0.0	1.0	2.7	133.2	0.4	6.3	2.6	0.0	6.6	2.2	0.6	0.6	2.0	1.1	0.1	1.8	0.4	54.9	14.9
BCL2L2	"BCL-W, KIAA0271, PPP1R51"	ENSG00000129473	"BCL2 like 2"	Q92843	14	23298790-23311751	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040539, HPA048740"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB040539: , HPA048740: "	"unprognostic (8.23e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.38e-2)"	48.5	36.6	102.4	26.0	95.3	13.9	35.6	83.7	112.4	30.2	61.8	86.9	28.5	43.0	30.5	46.8	35.4	24.7	37.3	89.8	88.8	35.0	20.9	34.6	13.9	94.8	94.0	31.8	53.3	52.9	38.1	23.8	91.7	47.4	31.8	51.9	52.2	45.5	24.2	46.5	34.3	41.5	101.0	20.5	54.2	25.1	108.3	10.7	38.5	19.9	16.4	55.6	34.9	92.4	24.1	23.0	25.6	19.0	43.4	39.2	19.3	43.9	28.5	21.8	24.9	16.3	42.6	16.8	14.2	26.6	27.4	43.9	15.9	28.1	29.4	8.9	12.7	18.4	44.4	30.3	26.6	20.7	30.0	30.3	54.0	17.6	27.1	30.6	18.6	2.9	17.3	18.0	27.8	17.8	1.6	14.5	8.0	33.4	41.3	12.8	28.1	8.2	19.7	45.5	31.7	18.0	20.8	31.3	31.2	15.6	20.6	15.5	37.1	35.1	24.8	27.6	23.1	22.0	12.7	2.2	21.6	16.0	43.5	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	102.4	95.3	83.7	112.4	89.8	88.8	94.8	94.0	91.7	101.0	108.3	92.4	9.2	9.6	13.1	0.0	2.6	8.7	9.5	12.7	5.7	20.0	11.0	8.0	28.9	4.3	13.6	5.5	25.0	5.3	3.5	16.8	13.7	8.0	20.1	11.1	10.4	10.8	18.6	2.1	0.0	18.3	4.0	10.4	9.7	12.1	5.7	12.0	11.4	7.2	5.5	20.2	0.0	16.8	6.1	8.4	4.0	6.1	11.1	5.5	7.2	0.0	7.5	7.4	2.1	0.0	0.0	25.5	11.0	21.4	4.5	17.2	16.3	9.2	12.2	12.7	6.6	12.6	15.5	0.5	0.9	10.8	11.1	5.6	1.5	8.9	10.5	17.6
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306833-23326175	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Excitatory neurons: 10.9;Inhibitory neurons: 14.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 13.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	8.2	4.1	8.8	4.2	10.8	10.7	9.6	7.2	20.6	10.9	1.3	17.2	10.4	8.3	2.0	11.6	10.8	10.9	7.2	9.8	8.3	3.5	4.2	7.3	4.3	8.7	9.3	4.6	12.4	8.0	7.1	10.9	9.0	12.1	6.3	5.6	24.9	22.1	4.8	11.0	8.8	7.7	10.1	6.0	10.3	12.5	11.7	1.2	8.7	0.9	4.1	13.4	7.5	15.8	11.4	18.0	15.2	31.3	15.3	29.3	14.0	13.4	27.3	39.8	44.2	10.1	38.0	3.5	4.0	21.2	22.5	24.2	16.9	21.4	17.9	8.5	21.6	4.7	11.2	26.0	14.5	10.0	29.7	37.4	29.7	17.6	6.1	27.3	14.7	0.2	8.2	8.2	19.3	18.1	0.4	7.5	17.3	10.3	18.2	7.9	4.0	5.9	10.3	10.1	16.0	10.0	9.8	22.6	15.2	10.8	8.7	8.2	15.4	18.7	8.4	17.1	12.8	4.9	6.6	1.1	25.2	10.5	19.4	0.8	2.5	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.8	1.0	0.1	0.0	0.5	1.6	1.4	0.4	0.0	0.6	8.8	10.8	7.2	20.6	9.8	8.3	8.7	9.3	9.0	10.1	11.7	15.8	0.0	3.2	3.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	10.9	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	16.6	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"BCL6 transcription repressor"	P41182	3	187721377-187745725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 485.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 269.1;non-classical monocyte: 76.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 269.1;monocytes: 76.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 166.4;HSkMC: 113.9;U-698: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	143.0	49.4	54.3	53.9	53.4	123.7	126.9	85.9	57.9	100.0	35.0	87.1	7.5	68.1	16.4	44.6	140.7	45.6	72.1	50.9	68.7	37.0	65.3	110.5	56.0	104.1	69.4	65.6	49.2	11.3	44.8	15.3	74.2	57.5	10.3	34.2	70.3	22.2	485.9	160.7	34.4	43.0	55.9	106.3	58.4	18.6	69.0	43.2	50.4	96.6	47.7	90.6	81.5	64.1	5.1	13.8	14.4	3.2	98.1	78.0	14.9	16.5	39.2	18.4	19.4	9.4	7.6	166.4	11.5	21.0	11.7	7.7	4.4	10.6	15.3	33.8	5.1	0.2	6.7	22.5	51.5	2.1	0.9	113.9	68.8	22.7	32.9	60.1	10.2	4.2	1.6	27.6	18.2	5.7	5.5	1.3	1.4	3.0	10.3	45.4	7.0	0.8	13.6	23.2	3.1	0.2	18.8	8.1	11.0	30.2	35.3	5.9	21.2	43.7	7.1	16.6	7.5	21.2	7.2	231.6	24.2	6.0	31.7	8.8	33.0	18.9	5.5	37.3	5.4	6.6	3.4	5.0	24.6	15.3	2.1	2.3	269.1	3.9	76.4	4.0	3.1	30.7	54.3	53.4	85.9	57.9	50.9	68.7	104.1	69.4	74.2	55.9	69.0	64.1	35.7	19.2	67.4	66.0	22.7	47.3	14.7	18.8	205.5	10.9	55.3	54.6	71.4	14.3	28.9	16.5	20.9	1.4	36.0	3.5	0.0	12.2	13.3	36.2	26.7	25.0	4.8	3.2	7.6	12.5	2.7	57.3	12.2	51.4	11.4	9.4	15.0	51.2	11.9	0.0	19.6	2.3	16.2	67.5	74.4	8.6	28.9	48.1	35.6	7.5	16.8	39.1	1.0	50.8	7.8	7.9	0.3	18.8	14.2	27.9	1.2	1.5	29.5	9.7	32.9	77.0	84.9	0.4	1.2	72.4	61.5	4.1	30.0	10.3	2.8	29.7
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BCL7A	BCL7	ENSG00000110987	"BAF chromatin remodeling complex subunit BCL7A"	Q4VC05	12	122019422-122062044	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.9;Horizontal cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.0;naive B-cell: 2.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	14	"B-cells: 2.1;dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 71.9;MOLT-4: 71.4;U-698: 95.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019762	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"HPA019762: AB_10962489"	"unprognostic (3.27e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (5.18e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.86e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.51e-2)"	3.1	2.8	9.2	5.2	10.8	9.8	5.7	8.9	11.2	5.1	0.0	4.0	2.5	4.5	6.7	2.8	8.4	2.4	7.6	9.6	3.2	9.1	4.9	3.9	16.2	3.5	4.7	3.7	9.1	9.1	5.2	1.9	3.3	5.1	2.9	4.1	7.0	5.9	11.5	8.2	3.0	3.3	2.9	5.8	3.8	2.2	4.5	24.7	9.0	8.9	15.4	4.8	4.8	9.1	6.0	6.2	29.9	17.9	2.2	1.1	6.0	3.2	3.1	5.3	4.9	3.2	2.4	71.9	9.2	2.7	2.7	8.8	22.7	16.4	5.3	0.0	25.0	3.5	0.4	5.5	6.5	13.8	8.1	4.7	21.3	3.9	26.7	8.1	7.7	42.3	18.3	0.0	4.3	10.7	71.4	1.3	10.7	9.7	11.0	33.2	8.5	1.2	13.4	14.3	26.5	28.9	3.4	0.8	13.1	7.7	17.4	13.6	6.9	0.7	5.1	10.0	6.1	9.4	5.4	95.8	2.1	9.3	6.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.3	2.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.1	9.2	10.8	8.9	11.2	9.6	3.2	3.5	4.7	3.3	2.9	4.5	9.1	4.6	22.4	9.2	8.5	51.6	35.9	77.9	26.5	22.8	41.8	32.7	33.5	28.6	42.9	19.0	38.6	18.8	1.5	38.1	5.9	58.7	33.5	6.9	39.3	10.9	5.6	21.5	18.7	15.9	10.9	0.9	11.9	7.1	26.8	10.8	16.6	5.3	18.6	4.2	107.7	19.9	8.6	16.2	2.2	14.3	18.7	14.0	9.8	12.4	1.9	6.2	5.5	1.0	13.6	16.2	10.0	6.9	7.9	6.8	29.9	1.6	31.3	20.7	14.0	6.6	34.7	16.6	0.7	7.7	5.3	30.1	0.5	3.2	42.9	11.7	32.3
BCL7B		ENSG00000106635	"BAF chromatin remodeling complex subunit BCL7B"	Q9BQE9	7	73536356-73557690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	35.6	23.8	34.9	18.7	35.0	90.0	18.5	28.1	43.5	16.3	28.3	32.6	21.8	15.5	17.4	27.5	16.6	22.5	49.5	36.5	34.1	21.9	25.1	27.4	24.4	30.6	31.2	9.0	25.6	30.3	20.9	21.7	29.7	17.8	16.4	17.7	16.0	23.5	66.0	11.1	23.6	29.8	28.3	23.0	20.6	20.5	33.4	22.4	22.1	55.8	19.4	33.4	11.4	34.3	67.8	46.9	26.7	47.8	21.5	34.0	27.1	56.1	58.9	58.0	52.9	52.0	73.8	56.7	14.0	58.7	84.7	30.4	19.4	45.7	42.7	73.9	27.5	31.5	28.7	28.0	61.3	54.3	85.3	22.8	45.0	59.5	58.7	23.9	38.4	31.7	50.6	65.0	41.6	79.5	93.0	71.2	46.5	43.0	67.7	49.2	28.6	67.6	46.5	51.8	59.7	57.9	49.6	85.0	62.3	11.3	53.0	73.3	39.6	69.8	44.7	47.9	84.1	37.0	35.9	105.2	68.7	82.8	89.0	13.7	13.3	19.7	11.4	15.8	13.8	11.7	13.1	15.3	13.5	17.6	13.7	11.1	6.5	21.2	20.3	15.9	11.4	8.3	34.9	35.0	28.1	43.5	36.5	34.1	30.6	31.2	29.7	28.3	33.4	34.3	50.4	32.1	20.7	6.8	59.8	64.6	81.9	18.7	39.3	27.5	37.4	32.1	29.5	24.3	17.5	16.5	6.2	72.5	55.9	63.3	54.8	46.7	8.0	35.4	16.8	37.3	34.6	17.9	10.3	45.8	43.6	30.4	21.9	31.6	32.4	21.5	34.2	18.1	51.0	42.1	8.8	40.6	32.6	37.5	46.4	6.7	25.7	48.3	32.0	6.5	41.1	32.4	62.8	6.0	10.0	67.9	58.3	30.5	35.7	61.6	50.4	47.0	15.7	21.8	46.0	52.4	46.7	64.1	71.6	28.7	57.7	101.8	58.3	27.3	37.6	74.1
BCL7C		ENSG00000099385	"BAF chromatin remodeling complex subunit BCL7C"	Q8WUZ0	16	30833626-30894302	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018676, HPA052654"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA018676: AB_1845322, HPA052654: AB_2681903"	"unprognostic (2.27e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.85e-1)"	30.2	18.5	41.9	22.2	43.8	40.7	28.8	42.9	52.2	35.4	38.3	32.2	22.3	27.2	14.9	25.8	28.1	21.4	32.6	39.1	42.9	39.4	19.0	20.8	27.6	46.2	44.2	40.5	23.2	20.6	21.3	18.0	45.8	27.3	15.6	7.9	33.2	35.0	34.8	32.1	25.0	23.2	42.4	23.6	23.9	24.5	43.7	19.5	24.6	25.5	21.3	30.2	27.2	42.8	84.3	51.4	46.4	132.7	34.5	52.3	32.4	54.8	51.9	65.1	47.2	47.2	54.4	1.8	79.9	69.1	35.7	44.7	22.9	58.0	26.0	53.0	101.2	18.5	37.8	77.0	49.1	34.3	42.5	60.1	58.5	43.3	22.4	27.6	65.9	37.1	46.2	27.5	54.1	120.3	35.9	103.4	26.8	48.7	84.5	74.0	48.7	66.8	38.2	30.1	30.8	52.5	56.2	51.8	42.5	22.7	83.8	53.8	35.4	85.8	81.0	52.0	53.3	28.2	25.9	37.2	57.2	61.1	61.3	8.1	4.6	8.0	7.7	3.1	8.8	9.0	6.7	9.5	4.3	5.8	5.4	6.5	2.9	2.9	3.4	5.7	7.3	2.4	41.9	43.8	42.9	52.2	39.1	42.9	46.2	44.2	45.8	42.4	43.7	42.8	76.4	12.8	11.4	21.9	31.5	39.6	80.5	21.9	37.5	11.4	67.7	100.5	17.2	47.1	14.0	71.7	6.2	54.3	66.8	45.5	217.2	36.2	21.5	37.2	49.4	52.8	37.3	33.4	7.6	35.5	58.5	67.7	23.9	42.5	2.5	55.9	51.4	26.5	57.1	13.5	20.8	42.8	16.2	38.6	49.1	26.9	55.9	39.5	55.2	16.9	65.6	49.1	64.9	22.1	21.4	48.1	25.2	51.6	17.2	51.4	42.0	78.0	8.8	13.8	19.7	47.3	88.9	5.7	3.5	53.3	42.6	25.0	56.4	49.4	64.3	77.1
BCL9		ENSG00000116128	"BCL9 transcription coactivator"	O00512	1	147541501-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	3.7	6.2	6.1	4.5	5.6	3.2	3.9	7.6	5.8	10.8	1.1	8.6	4.8	14.4	13.7	4.9	16.4	4.6	7.7	5.6	7.1	6.8	3.5	4.5	3.9	6.0	5.2	14.6	5.0	10.8	7.2	4.1	4.1	9.1	6.9	7.4	7.5	11.1	8.1	7.1	4.7	13.9	4.1	3.1	6.2	5.5	4.9	11.1	6.8	6.2	4.4	7.1	6.5	4.8	5.5	5.3	36.4	27.2	4.1	4.8	7.1	4.4	6.9	4.7	4.6	6.9	8.1	5.2	9.6	4.1	7.9	4.3	23.3	8.0	4.4	12.4	6.5	2.5	5.7	4.6	3.5	1.6	7.2	4.8	6.7	5.6	4.1	8.4	7.4	16.8	4.9	8.3	4.2	12.4	13.1	1.2	43.2	11.0	11.5	13.8	9.2	10.1	18.4	6.0	10.0	21.4	4.9	9.0	8.6	33.3	11.4	2.5	5.5	3.3	15.5	9.4	7.1	36.6	10.0	9.7	8.4	1.4	16.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.2	6.1	5.6	7.6	5.8	5.6	7.1	6.0	5.2	4.1	4.1	4.9	4.8	4.6	0.0	2.2	39.5	2.1	3.1	6.0	2.8	14.8	12.1	10.1	5.0	7.4	7.2	2.9	12.9	2.1	2.1	1.2	3.2	11.7	4.4	10.5	21.0	17.5	4.1	28.3	0.0	12.9	4.7	2.5	7.5	2.6	24.6	8.8	12.8	5.7	3.7	1.3	6.7	20.7	7.9	4.1	1.9	1.4	5.3	9.6	1.9	0.0	8.4	1.1	4.8	4.1	31.2	24.2	4.5	1.4	7.9	4.4	6.1	1.3	7.0	4.8	3.1	0.0	6.8	7.3	4.0	8.6	9.7	3.7	2.1	3.6	4.8	6.6	3.3
BCL9L	"B9L, Bcl9-2, DLNB11"	ENSG00000186174	"BCL9 like"	Q86UU0	11	118893875-118925608	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049370, HPA053421"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049370: AB_2680732, HPA053421: AB_2682145"	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.90e-3)"	24.3	24.8	5.7	24.1	4.6	20.5	21.1	17.7	6.7	28.5	4.7	23.8	17.4	32.3	4.7	26.4	29.6	18.1	20.9	4.9	1.2	12.1	10.8	24.4	19.5	3.3	3.7	29.4	21.3	8.5	7.8	24.4	1.3	18.1	5.4	2.9	25.9	16.6	29.0	30.8	19.8	17.7	1.1	19.6	18.5	6.4	5.3	13.7	16.8	12.3	12.8	24.6	24.8	1.8	40.5	71.6	10.2	18.5	32.2	30.8	64.3	54.6	41.4	16.9	9.9	77.0	78.2	11.0	70.8	57.4	68.7	76.0	5.0	99.9	4.4	13.4	2.6	10.9	41.2	26.8	36.1	3.7	10.0	39.2	60.8	20.3	40.5	32.5	15.1	6.4	14.3	12.4	11.9	67.2	8.2	3.1	12.1	24.1	40.8	17.2	4.3	7.4	17.5	27.6	5.5	8.1	76.7	114.2	10.3	18.0	90.3	4.5	51.1	53.7	40.7	16.4	46.9	2.6	0.1	3.3	29.0	12.5	31.3	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.2	5.7	4.6	17.7	6.7	4.9	1.2	3.3	3.7	1.3	1.1	5.3	1.8	16.3	16.0	11.5	9.1	18.3	38.7	9.3	18.5	13.1	20.0	23.8	16.5	2.4	15.7	14.1	7.3	4.2	12.7	42.2	10.9	0.0	14.0	0.1	36.6	31.5	12.3	5.4	1.3	3.9	15.1	8.4	14.1	13.3	61.9	2.5	12.2	11.4	9.7	4.4	13.5	4.8	5.4	4.1	6.1	11.6	0.5	14.6	8.0	7.2	12.2	16.5	5.5	32.0	5.0	1.1	29.3	7.4	14.3	14.8	23.5	10.8	3.3	14.0	3.1	26.3	12.4	26.4	0.6	1.4	34.7	45.3	35.4	33.0	8.6	6.8	11.1
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
BCLAF3	CXorf23	ENSG00000173681	"BCLAF1 and THRAP3 family member 3"	A2AJT9	X	19912860-19970298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 17.0;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027215	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA027215: AB_1847358"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.30e-2)"	"prognostic favorable (5.56e-4)"	4.6	3.0	3.5	3.8	4.0	3.6	5.2	10.2	3.8	4.7	2.0	5.2	3.4	5.5	8.3	3.5	4.0	4.2	3.4	4.0	3.1	4.3	2.7	4.5	4.3	3.4	3.4	5.0	3.4	5.7	3.4	3.3	3.6	5.0	5.9	6.4	3.4	5.1	4.5	6.0	4.4	4.0	2.6	4.1	3.9	2.6	5.0	5.3	4.7	5.2	4.2	4.2	4.1	5.0	4.8	3.8	5.1	8.7	4.5	6.3	2.8	4.4	3.7	2.8	3.9	3.4	5.0	4.9	2.6	5.2	4.9	3.5	4.6	3.3	5.3	3.2	3.7	3.1	4.3	3.4	6.3	4.4	5.3	5.7	5.0	3.1	4.2	6.5	3.2	3.9	2.3	11.5	3.2	3.6	3.1	2.9	4.5	4.5	4.8	1.3	5.1	6.7	7.3	4.7	3.1	4.8	5.6	4.6	4.5	9.5	5.5	3.9	6.0	4.7	2.3	11.4	3.3	3.6	3.0	4.0	4.0	2.4	4.1	1.8	0.3	0.6	0.4	0.4	0.5	0.4	0.3	0.4	0.2	0.8	0.3	0.4	1.5	0.4	0.4	0.7	0.2	0.1	3.5	4.0	10.2	3.8	4.0	3.1	3.4	3.4	3.6	2.6	5.0	5.0	10.8	16.0	17.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	8.1	0.0	0.0	7.4	9.2	0.0	4.5	8.9	0.0	1.9	6.1	0.0	8.2	9.4	3.4	0.0	0.0	0.0	3.6	3.5	5.0	0.0	10.9	6.3	12.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	6.1	0.0	0.0	3.6	0.0	0.0	6.2	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	4.5	3.9	7.4	0.0	0.0
BCO2	"B-DIOX-II, BCDO2, FLJ34464"	ENSG00000197580	"Beta-carotene oxygenase 2"	Q9BYV7	11	112175510-112224699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 47.2;liver: 52.3;retina: 55.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 410.8;Horizontal cells: 134.6;Rod photoreceptor cells: 254.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;HHSteC: 12.3;U-937: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061542	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA061542: "	"unprognostic (2.92e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	3.8	21.3	4.9	0.3	5.8	0.2	0.8	5.0	9.3	2.2	10.0	2.6	0.5	1.6	1.0	3.4	9.7	5.1	47.2	4.8	6.4	2.5	52.3	1.7	0.4	7.4	6.7	1.3	1.1	0.3	4.4	3.8	7.0	1.9	0.5	55.9	0.9	0.9	21.4	1.1	1.7	1.1	5.9	1.1	0.9	3.0	6.5	0.3	2.5	14.3	0.8	2.3	4.6	8.3	0.1	1.0	0.4	0.6	0.4	0.4	0.0	0.3	0.2	0.1	0.5	0.0	5.9	0.4	0.5	0.6	0.6	1.2	0.0	0.2	0.4	0.1	0.1	0.7	0.5	0.4	12.3	0.4	0.2	0.1	2.3	0.1	0.3	1.1	0.0	0.1	0.1	0.3	0.1	0.0	0.5	1.3	0.1	0.6	0.2	0.3	0.1	0.2	0.2	0.2	0.5	0.2	0.4	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.0	2.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	4.9	5.8	5.0	9.3	4.8	6.4	7.4	6.7	7.0	5.9	6.5	8.3	1.7	3.2	3.1	10.1	2.0	3.3	20.3	8.6	6.8	12.6	2.2	1.5	51.3	58.6	8.2	5.5	410.8	0.3	4.4	5.0	0.0	3.7	3.1	26.5	3.0	4.5	8.3	0.0	50.7	2.1	0.4	16.3	1.1	1.2	5.7	4.0	16.4	83.1	1.0	134.6	51.5	1.6	2.0	2.8	3.8	2.4	4.1	7.9	1.8	47.8	3.7	13.9	7.2	7.1	51.3	1.6	2.6	3.8	1.2	10.3	18.2	1.3	67.6	254.6	0.0	5.0	3.8	8.3	2.5	1.8	3.1	0.7	5.2	6.8	3.5	8.7
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058071	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.6;HAP1: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007"	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	3.5	3.1	2.4	2.6	2.5	5.6	2.1	4.5	2.6	3.5	0.4	2.9	2.6	4.5	2.2	2.6	4.3	2.0	2.8	2.4	2.7	2.6	2.0	2.9	1.7	2.9	2.1	5.5	4.5	5.8	2.6	11.3	1.9	3.2	2.0	2.0	3.3	3.7	3.3	2.9	2.8	4.3	1.4	2.8	2.2	6.5	2.1	2.3	4.5	3.3	1.7	2.6	2.6	1.9	3.4	8.0	18.7	29.6	10.6	8.0	5.3	4.5	5.2	5.7	6.5	9.6	2.2	1.5	9.9	8.8	5.5	2.0	44.2	1.8	5.2	3.4	6.7	16.2	3.9	3.1	5.2	3.8	4.8	4.9	3.6	11.0	0.6	8.3	6.8	5.2	7.7	16.4	3.6	1.9	6.0	11.3	5.2	2.6	5.9	12.6	7.5	2.2	3.0	0.4	3.2	10.9	2.3	0.7	3.0	9.4	6.7	5.9	5.9	4.5	6.0	5.7	4.5	5.1	10.1	2.5	2.9	7.8	2.2	0.0	0.3	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.2	2.4	2.5	4.5	2.6	2.4	2.7	2.9	2.1	1.9	1.4	2.1	1.9	5.4	0.0	2.8	6.8	2.9	11.9	2.8	2.2	10.8	1.7	12.5	7.5	7.1	4.3	1.9	7.3	0.0	14.1	6.1	3.7	0.0	3.0	0.5	3.7	7.0	7.9	12.0	2.5	4.6	1.1	4.8	6.9	2.6	4.7	7.0	4.3	4.6	2.8	3.2	8.4	4.4	2.4	2.0	2.2	5.9	1.2	4.7	2.7	7.2	5.6	3.0	2.3	4.1	4.5	8.5	2.6	1.9	3.8	3.2	3.8	4.2	2.3	2.9	1.3	6.6	8.0	6.1	3.4	6.9	9.2	11.5	93.4	4.9	0.9	3.6	2.8
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BCS1L	"BCS, BJS, h-BCS, Hs.6719"	ENSG00000074582	"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone"	Q9Y276	2	218658764-218663443	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037700, HPA037701"	Supported					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA037700: AB_10794619, HPA037701: AB_10805235"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.28e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.31e-4)"	19.9	29.3	24.0	11.5	24.8	12.4	21.3	25.0	25.9	24.9	23.9	22.6	15.9	21.6	14.3	28.2	20.3	10.9	40.8	24.3	25.0	30.5	39.9	16.3	15.5	25.2	25.4	25.2	41.2	17.8	17.4	11.8	26.1	27.2	16.5	13.5	20.8	17.4	32.0	24.2	20.9	16.8	24.5	24.2	25.8	10.1	24.8	9.8	22.1	22.5	14.4	25.5	23.5	26.1	17.1	34.3	19.3	26.8	42.8	28.6	28.9	28.4	15.7	44.9	32.9	92.1	28.0	25.2	40.4	29.1	30.3	46.2	63.0	73.1	25.4	37.2	67.9	40.4	45.5	76.0	49.4	35.6	24.4	36.6	55.0	61.1	79.5	18.4	46.0	35.3	58.3	35.6	41.1	57.7	26.6	48.2	23.7	39.9	43.5	38.3	23.8	40.0	37.6	31.1	41.1	17.9	20.1	48.2	36.9	30.4	25.4	34.9	26.7	33.3	27.7	22.3	39.5	28.1	23.2	43.2	21.1	54.2	32.6	20.1	12.2	10.5	10.3	7.7	11.7	13.5	8.1	9.7	24.6	12.8	9.9	11.9	1.4	7.7	1.1	13.7	13.4	10.2	24.0	24.8	25.0	25.9	24.3	25.0	25.2	25.4	26.1	24.5	24.8	26.1	16.0	9.6	7.5	6.5	6.4	10.6	15.2	29.9	8.6	13.3	13.0	16.0	32.7	20.0	18.3	5.5	6.2	31.4	5.4	9.2	21.5	18.1	1.3	9.2	15.4	13.7	6.1	7.8	3.8	10.1	18.0	13.8	11.2	10.8	11.4	14.6	10.4	11.8	17.4	6.7	3.9	11.0	20.3	5.0	9.0	2.2	9.0	6.6	14.2	2.8	9.2	12.1	11.3	8.0	6.9	11.4	12.7	15.4	9.8	11.6	13.1	22.2	10.7	15.9	6.6	14.7	19.4	5.5	11.6	16.6	9.9	14.5	6.4	18.8	17.0	12.9
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 324.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 44.2;U-937: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	9.6	6.8	14.4	4.1	17.9	7.3	9.7	18.4	19.8	6.8	30.8	45.1	17.4	6.3	3.9	48.0	9.7	3.8	52.4	16.5	14.3	19.2	324.0	5.2	3.9	14.3	13.8	8.2	7.0	15.5	12.6	0.3	14.4	16.2	19.8	9.3	25.3	4.1	21.5	30.4	28.1	2.2	12.9	7.9	16.6	4.5	16.3	6.1	17.7	22.8	7.1	9.9	14.7	14.2	23.7	2.9	1.2	11.3	1.9	0.1	0.0	2.8	2.2	11.4	6.3	20.5	7.5	0.2	33.0	0.7	0.9	10.3	10.0	5.4	4.2	0.3	0.0	12.0	8.3	7.0	8.3	27.0	12.3	3.4	6.0	4.4	9.4	1.2	2.8	13.7	0.0	8.4	0.2	40.9	20.5	18.8	8.2	44.2	4.2	19.6	4.1	31.5	12.3	9.9	20.1	8.8	8.2	1.1	4.5	0.5	26.3	22.7	0.3	0.7	3.9	0.1	21.6	10.4	20.5	0.3	0.7	75.8	1.5	2.9	1.3	0.6	4.6	0.2	6.4	5.1	5.1	4.2	3.5	4.6	7.6	4.7	0.0	4.5	0.2	3.8	3.7	3.4	14.4	17.9	18.4	19.8	16.5	14.3	14.3	13.8	14.4	12.9	16.3	14.2	0.4	3.2	9.4	27.7	7.0	9.3	8.5	10.0	16.5	21.3	20.3	14.7	36.7	17.2	13.8	12.9	20.9	2.0	7.1	68.9	52.8	6.6	9.5	34.1	3.6	2.2	27.2	6.7	60.5	5.6	5.1	2.8	17.3	16.5	1.3	6.6	5.0	112.3	8.9	18.5	58.0	43.2	10.2	5.4	8.5	13.9	5.6	3.5	16.0	8.4	1.0	17.5	11.3	27.2	12.5	3.0	36.4	4.1	5.4	6.5	62.8	30.2	48.0	33.6	0.0	2.4	3.7	16.8	4.9	36.3	10.9	1.9	8.5	10.0	68.7	13.1
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96256210-96268967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 23.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 40.8;Basal squamous epithelial cells: 41.5;Fibroblasts: 17.0;Squamous epithelial cells: 22.5;Suprabasal keratinocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.0;fHDF/TERT166: 18.8;HHSteC: 29.2;hTEC/SVTERT24-B: 29.2;U-2197: 27.9;U-87 MG: 90.1"	"Low region specificity"	"Detected in single"							HPA002935	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	10.7	0.2	0.4	5.2	0.7	0.0	1.2	1.3	0.9	6.9	0.3	4.2	1.8	0.9	0.6	13.4	5.1	14.1	1.6	0.5	0.3	8.3	0.2	1.3	0.1	0.5	0.4	0.4	6.5	0.0	0.2	0.7	0.5	1.5	2.7	0.2	1.9	0.2	0.1	3.3	3.6	6.0	0.3	0.1	4.5	2.3	0.4	0.1	1.1	0.5	0.4	23.4	7.4	0.6	0.5	1.4	0.0	1.2	2.9	9.9	0.1	2.3	32.0	3.1	0.5	0.0	0.6	0.0	0.1	18.8	1.4	2.4	0.0	0.4	5.0	0.3	0.1	0.0	2.7	0.0	29.2	0.0	0.1	1.0	2.4	29.2	0.6	0.2	0.0	0.0	0.0	0.1	4.2	0.4	0.0	0.0	0.0	1.7	0.2	0.0	7.2	0.2	0.2	0.1	0.7	0.0	8.2	2.4	0.0	0.3	0.0	0.0	0.0	9.5	0.6	27.9	1.8	4.6	9.3	0.0	90.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	1.3	0.9	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.6	1.4	0.0	0.5	0.0	0.0	40.8	2.9	9.0	41.5	1.7	0.0	0.3	0.8	0.0	3.2	0.0	0.0	0.3	0.0	5.5	7.9	2.3	1.1	0.9	3.7	5.0	0.0	0.0	0.4	1.2	1.4	17.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	6.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	4.9	0.4	0.0	1.6	2.3	0.1	3.3	0.1	0.0	1.6	2.5	0.9	1.3	22.5	17.2	1.5	0.2	0.0	0.4	2.8
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 41.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	14.0	1.4	0.8	5.5	1.0	0.0	5.8	3.8	1.1	15.6	0.9	12.4	7.9	6.7	2.4	17.2	7.2	20.8	1.2	0.9	0.8	13.4	0.7	2.5	0.3	4.9	1.3	1.0	9.4	0.9	0.8	1.3	5.0	4.8	12.2	0.0	3.5	6.2	0.9	5.4	9.7	10.2	1.0	0.1	4.9	0.2	1.5	0.9	3.6	1.8	1.7	41.1	15.4	1.2	1.7	6.1	0.1	11.0	16.2	49.2	0.0	5.5	94.5	3.2	3.7	0.3	10.4	0.0	0.2	8.7	3.7	14.8	0.0	2.4	2.8	1.2	0.1	0.0	1.1	0.0	7.8	0.0	0.0	15.1	7.5	9.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.1	20.4	0.0	0.0	2.2	0.0	3.2	0.0	3.4	1.1	1.8	15.6	0.1	2.1	1.0	0.0	0.0	0.3	0.3	3.3	0.1	0.2	0.0	0.0	39.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.0	3.8	1.1	0.9	0.8	4.9	1.3	5.0	1.0	1.5	1.2	8.2	3.2	3.1	0.0	0.0	9.2	0.7	5.3	6.8	0.0	0.2	0.5	0.6	10.0	11.6	9.2	0.0	1.2	0.0	19.3	7.9	11.5	0.0	7.5	16.1	18.2	7.1	0.0	1.8	3.8	3.6	25.8	1.1	4.6	0.0	0.0	3.3	0.2	0.2	0.0	0.4	7.2	8.2	0.0	15.2	0.0	0.9	0.4	5.4	0.0	0.0	0.0	0.0	1.0	1.9	6.9	6.2	1.2	0.0	1.0	10.6	0.2	12.5	0.0	0.0	4.5	1.2	0.0	0.0	15.3	5.8	4.0	0.3	0.1	0.9	2.9
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 38.5;Bipolar cells: 13.8;Cardiomyocytes: 9.1;Excitatory neurons: 22.3;Smooth muscle cells: 25.8;Theca cells: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 36.6;BJ hTERT+ SV40 Large T+: 28.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;HBF TERT88: 26.5;U-138 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	NA	Yes	16000000	24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.4	0.5	1.9	0.2	2.4	0.2	0.2	3.3	5.3	0.6	0.1	0.4	0.3	0.2	3.3	0.6	0.1	0.7	3.6	8.2	1.9	0.6	0.1	2.0	0.1	3.3	2.1	0.5	0.4	0.0	1.2	1.6	2.5	2.0	0.1	0.7	0.3	1.8	0.4	0.9	0.1	0.1	0.4	0.1	0.3	0.6	1.6	0.3	1.0	0.0	0.1	2.1	0.6	0.8	2.9	12.2	0.3	0.0	3.7	2.2	0.0	36.6	7.9	28.0	20.9	0.1	4.0	0.0	3.7	11.8	0.5	1.4	0.1	0.2	26.5	0.2	0.1	0.0	3.5	0.0	17.4	0.2	0.2	9.2	4.2	6.8	3.7	18.1	1.3	0.1	0.0	0.1	4.8	0.0	0.0	0.0	4.0	0.1	2.9	0.0	2.0	0.0	4.5	0.0	0.2	1.1	7.8	0.1	0.1	1.7	0.2	0.0	11.0	37.6	6.9	14.4	9.2	0.5	0.1	0.0	14.1	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.4	3.3	5.3	8.2	1.9	3.3	2.1	2.5	0.4	1.6	0.8	0.2	38.5	0.5	1.6	0.0	0.6	0.4	0.5	1.8	13.8	0.5	0.9	9.1	0.0	0.4	1.8	4.2	0.4	0.0	0.1	0.0	0.8	1.8	0.3	0.3	0.2	0.0	0.0	22.3	0.0	0.5	6.1	0.0	0.1	1.3	1.9	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.4	1.5	0.3	0.9	1.8	0.0	0.0	0.2	0.0	2.0	2.2	0.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	1.8	0.0	1.8	25.8	3.7	0.8	2.3	0.0	0.7	0.0	9.3	0.1	0.1
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427295-66493529	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.8;Early spermatids: 10.7;Excitatory neurons: 9.9;Extravillous trophoblasts: 10.9;Inhibitory neurons: 7.7;Late spermatids: 13.6;Oligodendrocyte precursor cells: 7.5;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.2;BEWO: 4.2;RPTEC TERT1: 9.1;U-87 MG: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Centrosome	"HPA053851: AB_2682280"	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	0.7	0.3	1.3	0.3	1.2	0.8	0.6	2.4	4.1	0.8	0.0	0.6	0.2	0.8	0.3	0.6	1.1	0.4	0.9	2.4	0.7	0.5	0.7	0.6	0.2	5.1	1.6	0.9	0.5	0.6	0.3	1.5	5.0	0.4	0.2	1.7	0.5	0.1	1.0	0.9	0.4	0.2	0.7	0.4	0.4	1.1	3.0	0.0	0.7	0.1	0.2	0.6	0.6	1.7	0.5	0.8	0.8	9.2	0.1	0.1	4.2	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.4	0.6	0.0	0.0	0.3	1.6	0.4	0.1	1.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.4	0.0	0.1	0.3	9.1	0.3	0.0	0.1	0.1	0.1	1.4	0.5	0.1	0.0	0.1	0.2	2.0	0.0	0.3	0.3	0.0	0.0	4.8	0.1	1.0	0.2	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.9	0.0	0.0	1.3	1.2	2.4	4.1	2.4	0.7	5.1	1.6	5.0	0.7	3.0	1.7	0.1	0.0	0.0	2.0	0.0	0.1	0.3	0.2	0.0	0.6	0.2	0.6	1.4	0.0	0.2	0.0	0.0	5.8	0.0	0.1	0.0	0.4	10.7	0.2	0.2	0.4	0.0	0.0	9.9	0.0	10.9	0.4	0.0	0.2	0.0	0.3	0.7	0.0	1.0	0.0	7.7	0.0	0.0	0.8	0.4	13.6	0.3	0.1	3.6	3.7	0.0	0.0	1.0	7.5	2.6	1.7	0.0	2.2	0.0	1.7	0.0	0.1	0.1	1.4	0.0	0.2	0.3	6.6	0.3	0.0	0.1	2.9	0.1	0.5	0.0	0.8
BECN1	"ATG6, VPS30"	ENSG00000126581	"Beclin 1"	Q14457	17	42810134-42833350	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Autophagy, Cell cycle, Cell division, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003949, CAB010143, HPA028949"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Nuclear bodies"	"CAB010143: AB_626746, HPA003949: , HPA028949: AB_2672839"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	45.3	41.4	26.9	41.8	27.7	50.7	43.9	27.4	37.8	35.7	30.9	70.3	56.6	31.5	47.7	49.5	36.1	34.4	58.9	28.5	29.1	47.9	43.7	39.6	47.9	27.4	27.9	26.7	39.5	41.7	20.5	26.2	27.8	42.3	64.8	26.5	36.0	41.3	95.8	36.4	50.1	44.4	28.4	39.8	53.0	24.2	28.3	41.4	36.7	77.6	56.2	49.2	29.7	28.5	47.4	79.0	27.9	48.7	95.7	56.8	54.9	95.1	104.2	69.5	73.8	61.4	61.9	68.9	69.3	118.9	70.0	52.7	48.9	85.3	123.4	105.0	59.4	58.0	74.9	105.5	71.4	111.0	114.3	76.8	99.1	69.4	66.0	61.8	90.2	75.4	50.5	67.1	86.4	40.1	66.1	61.1	29.0	88.5	40.6	56.3	100.6	69.3	74.1	88.6	33.5	34.9	52.0	43.5	100.7	61.4	72.0	92.9	121.6	82.8	38.8	57.0	99.7	103.8	84.8	57.4	84.3	54.0	106.7	154.1	133.2	122.1	103.1	152.1	105.1	112.6	114.4	111.6	120.2	123.7	96.4	100.2	191.0	107.8	144.2	75.7	180.1	171.8	26.9	27.7	27.4	37.8	28.5	29.1	27.4	27.9	27.8	28.4	28.3	28.5	43.7	38.5	46.1	11.8	38.7	29.7	26.7	40.1	39.3	12.3	38.3	22.7	6.0	30.0	39.1	12.9	10.4	23.5	37.8	59.5	58.7	46.2	18.2	35.0	28.3	33.9	28.3	36.2	12.1	69.6	32.3	23.1	42.3	31.5	43.1	20.5	31.4	46.2	38.8	21.9	11.7	60.2	30.5	65.4	36.8	11.9	21.5	43.1	42.7	3.7	67.2	26.9	50.4	5.5	9.8	53.6	45.4	26.7	51.2	37.8	49.1	40.3	51.7	13.4	26.3	25.6	36.0	31.6	14.9	44.9	37.6	38.0	39.8	33.8	51.1	46.7
BEND2	"CXorf20, MGC33653"	ENSG00000177324	"BEN domain containing 2"	Q8NDZ0	X	18162931-18220886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 18.6;Peritubular cells: 13.2;Spermatocytes: 84.5;Spermatogonia: 29.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.9"	"Not detected"	"Not detected"											"HPA009420, HPA013142"	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA009420: AB_2064489, HPA013142: AB_2668784"														"unprognostic (2.23e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.0	1.3	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	18.6	5.7	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.0	13.2	0.0	0.6	0.0	0.0	0.7	0.0	6.6	0.3	0.2	84.5	29.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115515	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Late spermatids: 6.9"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	0.8	0.7	1.0	0.9	0.8	0.9	0.7	2.1	0.9	0.7	0.4	1.5	1.2	0.8	1.0	0.9	0.9	0.6	1.0	0.7	0.7	1.2	0.7	0.9	0.8	0.7	0.7	0.7	1.5	0.6	0.8	0.5	0.7	1.0	1.5	0.8	1.5	0.4	1.2	0.6	1.1	0.7	0.8	0.6	2.0	1.8	1.0	1.0	0.8	0.6	0.8	0.7	0.5	0.9	2.9	4.0	11.3	6.4	1.3	0.9	9.3	1.1	1.4	1.4	1.6	4.7	2.1	8.6	2.8	3.0	2.6	2.8	12.2	6.3	2.3	3.4	6.1	2.2	3.1	5.2	1.0	6.1	2.9	2.4	2.6	2.2	3.1	1.0	1.9	4.0	6.7	3.4	1.9	5.8	5.3	4.7	15.9	7.4	2.5	7.3	3.2	5.7	2.4	8.6	11.3	5.5	3.6	6.0	2.2	5.7	3.6	4.9	2.2	4.1	3.7	1.8	5.5	2.3	3.4	8.7	1.3	4.7	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.1	0.9	0.7	0.7	0.7	0.7	0.7	0.8	1.0	0.9	1.3	3.2	2.7	1.3	0.7	2.9	1.1	0.8	1.8	1.0	1.3	0.8	3.0	4.3	1.8	0.0	6.2	1.1	0.8	0.6	0.0	1.0	5.8	1.3	1.8	1.2	1.2	0.8	1.2	1.8	1.2	1.2	2.6	1.5	0.0	1.9	0.0	0.5	0.6	0.0	2.1	2.4	0.0	1.0	1.2	6.9	0.9	1.0	0.0	1.0	0.1	0.5	0.0	3.0	1.6	1.4	0.8	0.0	1.6	1.6	0.5	0.9	1.1	1.5	0.0	2.1	2.5	0.7	2.5	1.8	3.0	0.8	1.1	0.5	3.3	0.9
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727519-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Proximal tubular cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 6.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.0"	"Cell line enhanced"	"Detected in some"		"AF22: 3.4;HDLM-2: 11.7;JURKAT: 4.5;MOLT-4: 4.8;REH: 6.5;SH-SY5Y: 2.9"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"	1.7	1.9	5.1	0.7	5.1	1.0	1.8	4.1	7.4	2.8	4.1	3.4	0.4	2.0	1.5	0.6	2.5	2.0	1.6	5.1	4.3	3.4	0.1	0.9	2.1	6.3	5.0	4.4	1.7	1.8	3.4	0.3	6.4	1.5	0.4	3.7	1.0	1.2	2.6	0.8	1.6	0.7	4.1	2.7	1.7	1.0	4.8	4.8	1.8	1.7	1.4	2.2	1.7	5.3	0.0	0.0	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	4.8	0.2	2.6	0.0	0.0	6.5	1.1	0.0	0.0	1.2	1.1	2.9	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	1.7	8.0	1.6	1.0	0.2	1.2	0.0	1.7	0.0	0.4	5.1	5.1	4.1	7.4	5.1	4.3	6.3	5.0	6.4	4.1	4.8	5.3	8.7	6.4	3.1	0.0	17.2	1.9	4.6	4.6	1.8	13.3	4.0	16.9	8.6	8.6	6.1	5.5	16.7	0.3	0.6	0.5	54.8	6.4	8.9	2.7	1.9	6.9	12.1	0.8	0.0	1.8	0.5	8.4	2.6	1.3	1.3	10.2	4.6	0.2	0.3	8.4	0.0	0.8	2.0	0.6	4.4	7.1	13.1	1.5	3.6	0.0	0.5	22.7	0.0	0.0	0.0	2.6	4.5	21.4	7.6	1.1	0.2	30.2	6.4	17.8	6.6	6.8	5.6	3.7	9.1	0.3	2.3	0.1	2.8	11.4	1.6	1.9
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955107-57027346	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.9;retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 8.8"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.8;fHDF/TERT166: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.2	2.1	12.1	1.5	14.2	0.7	0.6	30.5	30.9	4.0	2.9	1.4	0.5	2.8	0.7	1.2	1.0	3.8	2.4	12.6	16.0	0.6	0.2	0.6	0.9	19.5	16.0	2.0	0.4	0.7	1.7	2.0	20.4	2.4	1.5	11.8	0.5	2.4	3.9	1.0	0.7	3.6	12.1	0.8	0.8	1.0	15.7	1.1	0.8	0.6	0.8	2.8	1.7	21.7	5.4	2.2	1.3	0.6	17.6	28.8	4.9	16.1	15.6	7.1	8.2	0.2	2.4	0.1	5.2	28.7	9.9	0.7	1.8	0.8	8.7	2.4	1.0	3.6	7.5	0.4	4.7	10.3	0.2	12.7	4.5	9.8	4.3	11.9	4.7	13.3	4.6	9.2	14.3	5.5	6.2	2.5	4.4	0.3	1.3	0.1	0.2	2.6	2.6	5.4	6.1	6.2	10.8	1.3	1.4	6.1	0.3	5.9	6.1	21.5	0.7	14.5	3.6	12.6	15.2	4.3	12.6	6.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	8.8	0.0	0.1	12.1	14.2	30.5	30.9	12.6	16.0	19.5	16.0	20.4	12.1	15.7	21.7	0.4	0.0	0.0	16.6	0.3	0.9	0.2	0.2	0.0	82.6	0.2	1.1	3.6	0.0	0.7	0.0	4.2	0.5	10.8	0.0	0.0	0.2	0.6	0.5	11.9	0.2	0.0	0.0	87.3	0.4	1.6	5.6	0.0	0.5	0.0	13.5	1.1	0.0	0.1	42.1	118.6	0.0	0.0	0.0	4.0	0.8	1.8	1.1	3.6	13.1	0.3	4.9	0.0	49.8	22.9	0.6	0.0	3.0	0.0	0.4	0.0	1.0	0.0	4.8	0.0	8.7	2.7	0.7	5.8	0.2	1.0	0.0	0.1	4.4	0.0	0.1
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 167.3;Late spermatids: 268.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;hTERT-RPE1: 17.3"									HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	8.0	6.0	4.7	2.4	4.9	0.7	9.4	6.5	4.7	7.4	4.9	11.2	16.5	7.3	13.6	2.2	12.4	6.5	7.4	5.0	4.9	18.5	9.0	9.1	1.1	5.1	5.9	8.3	12.1	14.8	10.3	4.3	5.9	5.7	6.6	15.4	15.1	6.5	16.4	3.2	19.3	6.1	4.7	3.0	11.2	16.3	5.6	0.5	23.5	13.3	1.0	6.8	4.4	4.4	9.9	5.9	6.0	2.2	0.1	0.0	8.7	3.8	0.1	9.3	5.6	2.4	17.5	0.0	5.1	7.3	5.2	0.4	9.8	2.1	8.3	0.0	8.7	0.0	0.0	11.4	3.9	0.0	0.0	0.2	5.7	1.2	0.0	17.3	10.3	1.4	4.3	0.0	9.3	4.0	0.1	0.0	1.8	0.0	1.0	0.0	4.4	0.0	8.0	1.3	0.4	4.7	10.7	0.0	0.1	9.1	0.1	4.7	9.2	1.1	13.8	11.6	4.8	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.7	4.9	6.5	4.7	5.0	4.9	5.1	5.9	5.9	4.7	5.6	4.4	33.6	22.4	11.6	23.5	1.9	3.4	23.6	1.1	1.8	14.4	15.4	11.4	11.0	22.8	9.8	20.2	8.4	3.0	2.6	13.2	3.9	13.0	167.3	25.0	5.8	16.7	7.8	0.0	7.5	16.5	2.9	8.0	9.7	36.2	6.3	14.7	22.5	9.6	3.0	1.7	10.2	8.5	6.1	9.4	1.9	268.7	5.0	2.5	3.6	24.4	4.5	20.3	12.3	47.7	0.7	21.8	9.5	6.0	0.5	23.9	45.2	52.0	9.7	32.2	0.0	14.1	8.4	21.5	20.0	3.3	1.8	2.5	3.5	3.4	10.3	36.1
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61950063-61965515	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;brain: 41.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 272.8"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.6"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 71.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	9.1	3.7	16.3	8.3	30.5	26.3	5.3	24.9	23.2	5.3	10.2	3.8	1.7	4.1	10.0	2.8	5.9	5.1	5.7	16.5	20.2	3.7	2.6	10.3	2.3	27.9	27.3	4.6	2.5	0.3	3.4	2.4	26.7	4.0	1.0	6.7	2.2	2.0	1.6	2.7	3.9	1.8	19.2	11.0	3.3	5.4	28.6	0.4	2.7	1.4	0.4	5.3	4.7	41.7	0.8	0.8	0.4	0.7	17.7	3.8	1.4	1.0	1.8	0.4	1.3	0.5	0.5	0.1	1.7	1.1	2.0	1.1	0.0	0.0	0.3	0.3	0.2	0.0	6.7	0.9	4.9	0.2	0.5	5.6	1.6	1.9	4.1	1.8	0.0	0.8	0.8	7.6	1.9	0.6	0.1	0.6	0.0	0.8	2.1	0.0	0.1	0.3	0.0	2.0	1.0	0.9	1.6	0.1	71.6	0.8	0.7	2.3	0.2	0.9	0.5	0.7	0.3	10.3	0.8	0.7	4.8	0.6	1.2	2.6	3.9	3.9	0.2	4.6	0.2	0.7	0.2	0.1	2.6	0.2	0.1	0.1	37.6	0.1	5.1	0.4	0.3	1.9	16.3	30.5	24.9	23.2	16.5	20.2	27.9	27.3	26.7	19.2	28.6	41.7	2.7	25.6	59.3	9.1	11.4	36.3	6.3	54.8	18.8	2.0	22.0	7.4	3.3	14.3	57.2	1.8	0.0	14.5	5.6	22.5	0.0	3.8	8.3	5.3	9.0	16.4	10.3	29.0	0.3	3.3	23.4	32.4	9.2	9.0	76.4	1.9	21.0	13.8	37.1	0.0	0.7	10.7	22.4	75.4	272.8	2.9	15.2	49.0	55.2	1.0	14.1	6.0	3.1	17.1	43.0	3.1	21.0	6.8	5.9	11.8	28.0	5.6	37.7	9.6	6.6	16.1	20.8	3.2	4.1	6.2	32.7	20.4	24.5	0.9	11.9	13.2
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 45.3;skin 1: 17.3"	"Cell type enriched"	"Detected in some"	36	"Intestinal goblet cells: 136.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	HPA046229	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.2	0.6	0.7	0.7	2.3	0.5	2.8	0.8	0.2	0.5	45.3	0.1	0.5	0.7	0.2	0.3	0.6	0.4	0.7	0.5	0.2	0.3	0.4	0.5	0.9	0.8	0.5	0.2	0.3	0.0	0.4	0.8	0.3	14.0	1.5	0.9	0.3	0.3	17.3	15.5	0.7	0.2	0.5	0.3	0.4	1.1	0.2	0.6	0.1	4.9	0.2	1.4	1.5	0.3	0.2	0.7	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.8	1.3	1.1	0.3	0.0	0.2	0.7	0.0	0.2	0.2	1.3	0.6	0.9	1.2	0.3	0.1	0.4	1.9	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.5	0.2	1.1	0.3	0.6	1.0	0.1	0.7	0.1	0.4	0.2	0.3	0.3	0.7	0.7	0.5	0.0	0.1	0.8	0.6	0.1	1.0	0.3	0.3	0.6	0.7	0.3	0.5	0.3	0.5	1.0	0.7	0.5	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.1	0.0	0.7	0.5	0.4	0.4	0.4	0.1	0.6	0.1	0.2	0.6	0.7	2.8	0.8	0.7	0.5	0.9	0.8	0.8	0.2	1.1	1.5	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.1	3.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	136.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.8	0.1
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 69.1;tongue: 55.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 10.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 70.4;Skeletal myocytes: 28.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"REH: 36.1;RPMI-8226: 38.4;U-698: 63.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054582	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA054582: AB_2682530"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	0.0	0.6	3.9	0.1	3.7	2.8	0.6	15.4	5.8	0.1	0.7	0.2	0.2	0.1	0.6	1.9	0.1	0.2	0.4	4.2	1.4	0.4	0.3	0.1	0.2	5.2	3.8	0.2	1.1	0.1	1.1	0.3	5.3	1.9	0.2	2.6	3.1	0.1	69.1	0.9	0.1	0.0	2.7	0.1	0.1	3.1	3.2	1.4	0.1	55.8	0.2	0.0	0.0	7.8	0.2	0.5	1.3	0.1	0.0	0.0	0.3	0.3	0.3	0.7	0.8	0.3	0.4	2.4	0.6	0.0	2.0	0.2	0.0	0.1	0.8	0.5	0.1	1.0	0.8	0.3	0.0	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.4	0.1	0.5	0.0	1.5	0.2	0.0	0.1	1.4	0.7	0.5	36.1	1.1	38.4	1.8	0.1	0.7	0.0	0.2	0.2	0.0	2.3	0.3	0.0	0.2	0.3	0.9	0.2	1.3	0.2	0.4	63.7	2.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.9	3.7	15.4	5.8	4.2	1.4	5.2	3.8	5.3	2.7	3.2	7.8	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	10.3	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	17.9	0.0	0.2	1.8	0.0	0.0	7.6	0.0	70.4	0.1	0.8	0.0	0.0	0.0	0.6	0.0	7.0	0.0	0.3	0.0	28.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44788170	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 16.4;fallopian tube: 8.3;intestine: 27.4"	"Cell type enriched"	"Detected in some"	25	"Paneth cells: 1290.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-698: 1.8"					"Low region specificity"	"Detected in many"			HPA058564	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.2	1.9	1.2	0.7	1.1	0.7	0.5	2.2	1.3	1.6	16.4	27.4	9.1	0.7	3.0	0.2	8.3	0.2	0.3	0.8	1.7	0.5	0.6	1.9	0.6	1.9	3.3	0.5	0.3	0.3	2.7	0.2	1.5	0.4	16.0	1.1	0.3	0.5	0.4	2.2	8.1	0.5	1.3	0.5	0.4	0.7	1.6	0.5	0.6	0.1	0.4	0.3	0.2	1.0	0.0	0.2	0.3	0.4	0.1	0.1	1.1	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.2	0.0	0.8	2.5	0.1	0.0	0.3	0.2	0.3	0.1	0.2	0.6	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.8	0.3	0.1	0.1	0.1	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	1.8	0.4	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.8	0.6	0.7	0.0	0.5	0.2	0.5	0.1	0.3	0.0	0.3	0.6	0.1	1.2	1.1	2.2	1.3	0.8	1.7	1.9	3.3	1.5	1.3	1.6	1.0	0.2	0.0	0.0	0.0	0.8	0.3	0.8	3.4	0.0	0.8	0.4	1.0	0.5	0.0	4.2	5.5	0.0	0.3	0.4	31.2	1.9	0.7	0.0	26.7	0.5	0.2	2.4	0.0	1.9	0.8	0.2	0.6	0.5	1.2	0.0	0.3	0.4	0.0	0.3	0.0	4.3	3.2	0.0	0.0	0.9	0.2	0.9	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.6	1290.4	0.4	0.4	0.7	6.1	1.0	50.1	0.2	0.0	1.2	0.8	0.7	1.6	0.0	0.6	0.3	1.4	0.4	9.1	0.5
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	36.2	38.2	26.8	29.4	28.2	18.0	35.5	26.5	27.6	43.2	33.2	37.0	29.1	37.0	37.3	30.1	38.8	27.5	34.3	25.6	27.1	40.4	53.5	35.4	32.9	31.0	28.5	53.6	79.9	39.9	56.0	29.8	28.0	43.4	29.8	17.1	52.9	41.6	22.5	36.1	39.4	31.3	27.5	39.4	43.1	33.0	27.5	28.2	37.5	23.4	35.7	37.4	33.2	30.1	46.2	37.6	22.0	27.3	66.5	58.3	31.8	48.1	62.8	50.6	51.5	47.3	43.4	40.5	22.9	87.7	36.4	42.1	25.6	44.0	38.3	31.6	27.7	37.5	21.5	48.2	61.4	43.2	70.2	66.2	58.1	29.8	79.6	58.7	34.7	28.2	55.7	41.3	32.7	25.0	31.7	27.3	33.6	66.8	42.3	32.6	32.6	27.7	41.8	20.3	23.9	29.0	42.9	68.5	47.7	31.5	35.2	33.6	38.6	39.0	18.0	16.0	24.0	72.2	35.9	35.6	52.7	35.6	36.4	58.5	19.0	66.0	28.4	27.5	34.1	31.9	32.5	29.1	19.0	25.0	37.4	29.6	43.5	27.9	25.8	22.1	27.4	32.5	26.8	28.2	26.5	27.6	25.6	27.1	31.0	28.5	28.0	27.5	27.5	30.1	9.8	12.8	17.0	3.9	23.0	9.3	16.8	12.8	16.5	6.8	21.3	19.0	14.5	15.7	10.7	14.7	8.4	15.8	16.9	24.4	21.5	12.8	58.8	8.6	13.2	10.6	7.8	12.0	3.6	23.4	28.2	19.4	20.9	10.1	38.0	10.2	18.2	39.3	22.7	3.3	4.4	23.1	14.2	16.4	12.7	142.9	22.1	18.4	7.2	2.8	14.8	9.1	10.3	4.0	4.7	18.6	26.1	18.8	68.3	29.2	39.2	28.7	12.6	10.4	6.6	12.8	15.9	47.2	21.8	11.9	11.6	26.3	19.4	8.9	17.1	29.3
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064171	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 439.4;pituitary gland: 399.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.5	83.8	253.7	3.8	260.1	42.7	2.5	201.9	317.4	5.5	142.9	10.5	5.0	15.6	55.5	0.8	21.4	1.3	16.7	274.9	439.4	10.7	4.2	2.8	1.2	222.6	248.2	20.2	71.6	112.0	399.2	0.4	261.1	6.7	4.3	173.0	2.3	3.6	0.6	1.0	6.3	4.8	203.1	2.5	8.6	92.9	265.5	3.5	26.0	0.8	0.4	0.8	2.9	223.9	0.7	0.0	37.6	0.1	0.0	0.1	1.1	21.6	0.0	412.1	607.0	0.0	0.1	0.1	0.8	158.1	130.0	0.4	0.0	0.5	680.4	0.2	1.2	129.2	0.0	85.2	6.9	1562.2	2.6	9.2	0.0	89.3	0.1	1044.5	0.1	120.8	0.2	0.2	84.6	0.0	294.7	0.2	337.9	97.8	62.0	0.2	0.7	7.6	0.0	0.3	465.3	266.6	0.5	0.6	1.9	5.9	0.3	432.4	0.0	0.1	140.2	1.1	16.7	71.9	2.9	0.7	54.4	484.1	27.2	0.4	0.2	3.4	0.3	0.0	0.3	0.5	0.9	0.5	0.0	1.0	1.4	0.6	0.5	0.9	0.2	0.1	0.4	0.7	253.7	260.1	201.9	317.4	274.9	439.4	222.6	248.2	261.1	203.1	265.5	223.9	1.1	0.0	0.5	16.3	1.2	8.7	11.1	0.0	1.2	354.2	7.2	32.5	9.6	31.5	0.7	5.5	39.6	0.2	0.2	0.4	72.4	6.1	12.1	1.4	0.6	5.3	79.6	0.8	64.6	13.8	0.2	3.9	8.2	2.8	0.0	260.7	30.4	1.2	1.4	363.4	56.1	6.9	10.2	4.0	1.2	31.8	8.1	2.2	7.2	12.2	1.5	716.1	0.0	32.6	20.9	6.3	3.3	2.6	0.0	7.5	0.8	19.5	0.0	142.2	0.0	15.9	14.4	38.5	13.8	0.0	6.5	0.5	2.0	0.2	3.5	1.7
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311007	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 194.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 418.7;Muller glia cells: 285.9;Proximal tubular cells: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 52.7;NK-cells: 62.0;T-cells: 68.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.7;NTERA-2: 91.4;SCLC-21H: 135.2;SH-SY5Y: 61.4"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	5.8	73.6	133.5	6.8	134.9	13.7	19.4	119.0	167.3	16.4	98.2	10.2	3.4	27.6	123.8	9.9	15.5	7.6	29.5	134.4	153.2	58.7	2.5	12.7	14.2	120.7	125.6	62.8	35.5	123.1	194.6	8.0	123.7	24.2	6.0	83.5	26.7	21.0	9.1	17.1	14.0	8.7	117.7	18.5	16.7	43.1	138.6	21.0	103.3	11.5	16.9	8.7	10.7	132.2	0.0	2.8	11.3	0.1	0.2	0.0	45.5	0.3	6.1	7.7	11.3	8.4	3.8	0.0	31.6	0.0	55.4	2.0	0.1	9.4	6.6	0.1	25.4	1.4	1.4	0.4	46.0	0.1	25.4	2.8	94.7	3.7	29.1	17.8	0.5	33.6	17.4	0.7	1.0	4.2	20.1	0.2	91.4	0.0	8.4	0.1	0.0	0.2	3.8	3.7	135.2	61.4	5.9	1.4	22.2	10.7	11.2	0.1	0.0	0.1	9.0	0.3	2.1	30.8	21.6	0.1	15.3	0.0	1.3	13.4	0.4	1.1	21.8	0.4	31.0	52.7	43.8	25.7	1.6	42.3	68.6	50.0	1.4	62.0	0.1	10.0	33.7	18.4	133.5	134.9	119.0	167.3	134.4	153.2	120.7	125.6	123.7	117.7	138.6	132.2	3.7	16.0	68.5	15.0	41.6	31.6	95.6	17.4	100.7	184.7	65.8	145.5	27.0	60.1	43.4	114.0	43.8	72.2	20.9	5.0	418.7	47.5	17.9	11.6	3.3	13.7	100.5	9.4	56.7	42.7	19.9	13.1	23.0	17.0	12.7	87.6	3.6	0.9	7.0	121.1	53.0	29.6	16.2	0.3	5.3	69.4	15.8	4.6	26.6	7.5	2.5	285.9	27.8	35.2	25.8	19.8	8.4	22.2	16.5	64.5	3.7	201.3	9.0	120.5	6.6	32.0	11.4	16.8	5.8	25.7	26.7	63.8	30.2	22.3	22.3	51.1
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376395-103378164	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1607.8;Distal tubular cells: 1453.7;Granulosa cells: 700.3;Proximal tubular cells: 688.0;Syncytiotrophoblasts: 804.2;Theca cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 150.9;T-reg: 137.1"	"Lineage enriched"	"Detected in all"	5	"T-cells: 150.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavorable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	106.8	345.8	382.4	39.6	395.3	31.1	111.0	353.0	432.9	144.6	462.7	123.4	31.2	149.1	499.4	72.8	150.9	77.1	244.7	401.5	491.6	263.6	92.8	116.8	29.3	368.8	392.1	463.7	120.0	231.1	373.7	207.0	384.1	166.7	53.0	135.9	99.5	224.9	19.8	61.6	56.3	116.5	364.9	97.3	94.6	139.9	419.3	97.0	274.6	44.5	28.4	107.8	104.6	365.7	218.5	305.3	561.5	222.3	508.5	567.3	256.6	244.7	409.8	299.5	475.0	317.9	238.1	0.3	427.8	288.7	222.0	85.3	394.1	302.5	299.4	0.8	280.6	98.7	502.9	87.4	396.2	0.8	37.4	613.4	252.2	397.3	348.0	533.6	469.5	225.0	0.1	1.0	542.2	486.1	227.2	2.7	750.5	0.1	232.3	0.4	350.3	0.5	317.9	365.3	377.3	391.4	264.7	3.2	380.3	359.8	142.4	31.8	291.5	191.6	123.3	374.6	110.0	2.2	1.0	1.6	395.3	0.3	189.1	0.3	3.7	1.1	4.1	0.9	2.2	4.6	71.8	19.1	6.4	1.2	150.9	70.8	13.9	28.9	0.8	14.5	137.1	66.5	382.4	395.3	353.0	432.9	401.5	491.6	368.8	392.1	384.1	364.9	419.3	365.7	118.5	326.9	227.7	0.0	12.6	0.0	0.0	0.0	0.0	0.0	217.4	433.2	0.0	0.0	104.0	518.6	0.0	1607.8	4.7	0.0	1453.7	201.3	0.0	187.0	284.8	132.3	0.0	0.0	0.0	70.9	471.7	189.2	0.0	144.1	16.4	700.3	0.0	0.0	172.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	1.7	0.0	0.0	688.0	23.3	0.0	0.0	0.0	117.8	0.0	0.0	0.0	0.0	804.2	12.8	696.8	0.0	0.0
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215108-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 162.5;HMC-1: 188.1;K-562: 232.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	32.2	99.9	186.5	24.8	187.5	71.4	56.3	173.4	225.0	53.0	154.9	63.6	17.0	70.3	265.9	48.0	65.7	40.2	101.9	188.8	209.2	97.6	13.5	44.0	32.9	185.7	185.7	102.6	34.7	126.0	134.0	60.6	184.6	80.2	26.4	92.0	74.6	83.1	6.8	26.6	32.2	56.4	183.7	68.7	36.2	46.1	195.1	57.0	131.1	13.6	34.8	46.6	44.3	188.2	0.0	0.2	96.4	0.0	24.1	16.6	86.5	23.2	19.8	42.6	77.7	0.0	1.4	0.3	38.1	16.2	36.0	0.7	39.1	5.3	46.8	0.1	36.8	162.5	0.0	0.1	73.7	123.0	188.1	62.3	12.9	22.3	0.0	47.3	50.2	62.2	232.5	0.5	13.1	0.5	86.4	1.0	117.0	0.0	6.9	0.2	28.0	0.6	39.1	2.4	71.7	109.3	8.1	1.5	5.1	93.0	3.9	1.3	1.3	5.5	34.3	0.8	0.3	12.5	6.0	0.2	16.0	0.0	4.9	118.6	23.1	42.3	31.6	30.0	26.5	37.6	38.2	32.0	51.3	33.7	65.5	52.2	5.2	100.5	26.4	79.0	40.3	43.9	186.5	187.5	173.4	225.0	188.8	209.2	185.7	185.7	184.6	183.7	195.1	188.2	45.7	35.3	40.4	25.5	38.7	27.3	133.8	86.0	87.0	174.9	99.0	105.4	81.3	81.5	64.0	99.3	25.0	309.3	47.5	6.8	299.3	66.4	4.7	31.2	35.5	59.2	63.1	35.1	70.0	13.7	156.0	65.1	19.4	38.1	109.2	147.8	73.2	0.7	88.3	222.1	69.6	37.2	52.9	55.5	53.2	12.9	63.3	68.9	115.6	22.5	118.4	217.8	34.0	34.2	64.3	10.8	23.3	61.3	22.2	118.1	8.1	186.5	33.2	81.0	52.6	64.4	57.4	27.4	14.3	42.5	24.2	364.3	37.2	115.0	28.7	111.7
BEX5	NGFRAP1L1	ENSG00000184515	"Brain expressed X-linked 5"	Q5H9J7	X	102153708-102155977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 124.0;pituitary gland: 77.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 171.6;Distal tubular cells: 137.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 6.2;MAIT T-cell: 15.5;memory CD4 T-cell: 11.6;memory CD8 T-cell: 8.1;naive CD4 T-cell: 16.4;naive CD8 T-cell: 10.1;NK-cell: 10.1;T-reg: 11.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 10.1;T-cells: 16.4"	"Group enriched"	"Detected in some"	4	"HAP1: 16.4;Karpas-707: 61.9"					"Low region specificity"	"Detected in all"			HPA059058	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA059058: AB_2683894"	"unprognostic (1.88e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-2)"	3.2	15.6	73.5	3.7	73.2	2.1	7.7	56.0	124.0	4.3	45.0	5.1	4.0	6.3	33.3	1.9	5.0	13.0	5.6	73.4	116.1	20.4	3.5	13.6	4.9	73.0	72.1	13.7	26.3	33.7	77.5	0.0	79.7	6.6	6.1	30.8	7.6	3.7	0.5	3.4	3.3	3.4	59.5	4.4	8.2	13.1	84.0	1.1	25.8	0.5	7.8	2.1	3.4	75.2	0.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.3	1.4	16.4	0.3	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	2.4	0.4	0.1	6.0	2.5	61.9	0.3	7.1	0.4	0.1	7.3	0.0	2.6	0.0	0.0	0.2	5.8	0.0	8.9	0.9	0.1	0.1	0.0	1.2	1.6	0.0	6.0	0.4	4.2	0.5	0.0	7.1	4.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	6.2	0.0	15.5	2.1	11.6	8.1	0.1	0.9	16.4	10.1	0.0	10.1	0.0	0.8	11.9	2.9	73.5	73.2	56.0	124.0	73.4	116.1	73.0	72.1	79.7	59.5	84.0	75.2	9.0	3.2	5.6	4.2	12.2	14.9	24.2	0.1	10.2	53.2	25.9	32.1	19.4	171.6	7.4	38.6	0.0	0.0	13.4	2.1	137.0	16.5	1.3	6.7	0.7	16.3	35.9	1.7	18.1	22.8	0.1	5.8	2.6	8.4	22.8	25.1	26.7	18.2	0.3	57.2	14.0	31.9	0.0	0.8	6.2	7.0	2.5	1.3	30.2	6.5	6.0	55.5	7.2	6.6	3.5	8.5	2.5	0.4	24.5	16.4	0.5	23.2	6.8	25.4	0.0	8.8	2.3	2.1	1.2	4.3	11.2	0.0	13.4	21.5	6.2	11.0
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 5.7;NK-cells: 17.5;Spermatogonia: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;RPTEC TERT1: 19.5;SK-BR-3: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"amygdala: 2.5;cerebral cortex: 3.2;hippocampal formation: 3.6"	"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	1.1	1.3	2.0	0.5	2.2	0.4	1.1	1.6	2.1	1.3	2.0	1.3	0.3	1.8	1.4	1.1	1.3	1.3	0.7	2.2	2.1	3.7	0.3	1.7	0.3	1.7	1.8	1.5	1.9	1.0	0.9	1.9	1.8	1.2	0.5	0.4	1.5	1.1	0.3	1.0	0.7	1.1	1.5	0.4	0.9	3.8	2.1	0.2	2.5	0.4	0.3	1.3	0.9	2.4	0.8	8.1	2.6	0.3	0.7	2.6	0.4	2.0	9.5	1.3	1.2	3.7	7.0	0.0	1.6	1.2	5.1	1.2	2.8	1.6	1.0	1.8	2.1	0.6	1.2	1.1	1.5	0.5	0.9	3.1	4.9	0.7	2.3	10.8	5.7	0.5	0.3	0.4	4.2	1.6	0.0	1.2	6.1	5.2	2.2	0.0	1.8	0.4	19.5	1.5	2.7	0.3	2.4	10.6	4.3	1.2	5.2	1.8	6.5	0.3	0.6	0.7	2.0	0.0	0.1	0.0	1.4	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.2	2.0	2.2	1.6	2.1	2.2	2.1	1.7	1.8	1.8	1.5	2.1	2.4	3.8	3.2	1.7	0.7	0.0	0.9	0.5	0.7	0.0	0.2	1.9	1.5	1.2	1.5	0.4	0.0	0.0	1.2	2.6	0.1	1.9	0.8	1.3	1.1	0.4	3.1	0.0	0.8	2.1	0.9	1.7	1.2	1.5	0.6	0.0	0.2	3.9	0.2	0.5	0.0	1.2	0.2	0.0	0.0	0.8	5.7	1.8	0.2	1.8	2.8	0.0	1.0	17.5	0.5	1.1	0.8	0.0	0.0	0.4	0.4	0.0	0.3	1.8	0.1	0.0	0.5	1.0	1.1	11.9	1.1	0.9	0.4	1.0	0.4	0.3	0.5
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133400056-133475222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"T-reg: 13.4"	"Lineage enriched"	"Detected in single"	43	"T-cells: 13.4"	"Group enriched"	"Detected in some"	6	"Daudi: 2.4;U-698: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.1	5.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.6	0.0	1.0	0.1	0.1	0.0
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494980-153509546	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 795.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		3300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	165.8	213.0	54.1	93.1	57.6	0.3	118.0	51.2	91.5	371.0	69.5	69.3	22.0	234.4	83.7	45.8	143.7	326.1	795.8	56.1	48.7	396.5	347.9	477.3	42.4	50.6	50.8	94.9	67.9	26.6	144.1	199.1	53.2	184.2	24.8	1.1	107.7	135.5	32.4	118.9	48.8	213.2	45.5	352.1	51.6	69.9	64.6	15.9	250.0	46.7	35.9	126.8	180.0	65.4	0.0	0.0	29.7	0.1	31.5	70.5	1.1	312.6	400.8	56.7	18.6	39.5	0.0	0.0	56.9	568.9	2.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.6	3.9	27.0	0.0	0.2	283.9	2.2	235.2	10.7	29.0	561.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.5	0.3	0.2	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.1	11.8	1.3	0.0	120.0	249.5	2.3	1.0	1.5	0.9	0.1	0.0	0.1	0.3	114.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	57.6	51.2	91.5	56.1	48.7	50.6	50.8	53.2	45.5	64.6	65.4	30.5	3.2	5.6	5.9	0.6	104.1	1.3	7.3	5.7	0.2	1.2	5.6	16.1	4.3	2.5	9.2	0.0	15.5	0.7	0.0	1.9	2.7	1.8	1.4	28.3	45.2	0.0	5.3	0.1	0.2	50.0	180.0	7.7	1.1	3.8	8.4	223.5	1.6	4.4	3.3	0.1	0.0	0.0	4.0	43.6	13.5	147.9	3.0	35.6	25.3	2.0	0.1	0.0	20.6	0.0	1.2	0.0	782.7	0.0	3.0	0.0	0.8	1.6	0.2	1485.7	3.1	401.3	0.8	1.2	1.8	54.1	56.9	3.0	7.7	0.0	1.6
BHLHA15	"BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211439-98215457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 502.8;salivary gland: 145.9"	"Cell type enriched"	"Detected in single"	25	"Plasma cells: 12.6"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.8	3.6	0.6	0.3	1.5	0.1	2.0	1.9	0.1	4.0	4.0	0.1	0.8	0.9	0.1	0.7	0.2	1.3	0.9	0.6	5.2	0.9	3.8	0.6	0.5	0.4	502.8	0.1	1.5	0.1	0.6	8.5	1.5	0.0	145.9	3.9	0.2	0.6	3.4	0.0	1.0	5.0	31.3	0.2	1.5	0.7	1.9	0.0	4.7	2.5	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.1	0.8	0.9	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.6	6.7	5.9	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.2	0.0	0.0	53.5	0.0	0.9	0.0	0.0	0.8	6.2	0.8	0.4	0.0	72.0	0.3	0.0	4.3	1.2	0.0	11.2	0.0	0.0	0.7	0.1	0.0	0.0	0.7	0.1	0.1	67.6	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.6	0.1	2.0	1.3	0.9	0.6	0.5	0.6	1.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
BHLHE22	"Beta3, BHLHB5, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580365-64583627	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.2"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"THP-1: 78.4"	"Group enriched"	"Detected in all"	5	"amygdala: 30.7;cerebellum: 30.7;cerebral cortex: 22.7;hippocampal formation: 46.3;white matter: 13.1"					"HPA064128, HPA064872, HPA067500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	2.0	0.5	8.9	1.4	6.6	0.0	1.5	12.1	22.4	2.3	0.4	1.3	0.4	0.3	0.1	0.9	0.8	0.4	0.3	23.2	1.5	0.2	0.5	2.0	0.7	5.5	1.5	0.2	0.7	0.1	1.4	0.0	2.6	0.4	0.5	4.4	0.5	2.3	0.1	0.8	1.4	0.4	1.4	1.4	0.5	0.2	1.1	0.3	0.7	0.0	0.6	1.2	2.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.6	12.1	22.4	23.2	1.5	5.5	1.5	2.6	1.4	1.1	1.8	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	64.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.0	3.4	0.2	0.0	0.0	0.6	1.5	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.2	2.9	0.0	0.4	0.1	1.6	0.0	0.1	0.0	0.0	0.0
BHLHE23	"bA305P22.3, Beta4, BHLHB4"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 1.2"	"Cell type enriched"	"Detected in single"	32	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"MOLT-4: 13.9"	"Not detected"	"Not detected"							HPA030575	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.9	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHE40	"BHLHB2, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979437-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	154.1	99.0	38.5	52.9	38.4	188.2	200.0	36.1	48.7	141.6	41.4	67.9	30.8	67.6	34.6	353.2	61.5	100.4	153.4	38.1	32.8	151.4	187.9	112.1	52.4	52.0	47.5	76.0	79.8	67.5	92.6	72.2	39.3	98.1	47.4	118.3	117.3	32.5	251.7	207.2	42.6	65.2	40.5	26.9	43.5	14.1	49.6	40.6	82.7	46.8	50.7	172.1	272.3	37.0	40.4	53.4	0.1	14.7	30.8	23.8	78.6	7.5	19.7	7.7	30.2	3.4	39.7	0.2	19.6	14.2	118.9	31.5	6.6	108.0	13.2	488.2	4.7	9.8	39.6	11.9	29.7	25.5	192.8	55.1	63.3	88.9	25.4	53.4	30.0	1.7	53.9	228.4	20.3	28.4	3.9	10.8	2.9	45.6	87.1	0.7	17.6	23.0	74.4	7.9	0.8	1.7	132.6	34.2	40.0	45.9	78.6	38.8	39.7	30.4	29.3	28.9	50.0	175.9	82.8	1.6	218.0	19.8	15.3	101.4	9.7	54.5	24.7	4.9	24.9	7.7	13.1	16.6	15.2	4.5	2.9	10.1	14.3	54.9	0.5	19.9	0.9	11.9	38.5	38.4	36.1	48.7	38.1	32.8	52.0	47.5	39.3	40.5	49.6	37.0	172.5	67.3	191.3	32.3	24.9	165.4	112.8	330.5	373.3	15.4	136.6	74.7	65.0	40.0	297.7	46.0	0.0	32.0	159.8	52.9	11.7	75.2	0.3	210.2	69.6	161.6	10.7	2.5	36.6	72.5	89.3	102.6	68.3	386.7	439.2	0.5	75.0	56.5	38.3	10.1	4.5	32.6	136.3	52.1	354.0	1.7	7.2	117.9	108.5	27.2	42.9	95.1	44.3	11.1	3.3	138.8	37.9	3.8	38.0	61.1	8.8	23.1	102.1	11.5	6.6	55.3	94.4	0.2	0.4	517.2	262.0	158.4	97.8	0.3	24.4	129.4
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069767-79090069	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 333.1;liver: 429.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Hepatocytes: 201.2;Proximal tubular cells: 408.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.5;Hep G2: 78.2;hTEC/SVTERT24-B: 46.0;U-87 MG: 18.6"	"Not detected"	"Not detected"							HPA044573	Enhanced					NA	NA		1900000	"Cluster 17: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	31.3	16.6	5.6	3.0	6.0	0.3	15.5	4.5	5.0	8.5	14.2	15.7	1.7	12.1	37.6	7.6	7.6	7.4	13.6	4.9	7.3	333.1	429.9	3.1	1.3	5.2	7.0	7.8	1.8	0.5	12.3	0.4	6.2	12.0	2.4	1.3	2.1	14.4	10.2	2.4	6.1	13.0	4.7	0.6	9.1	3.8	6.9	0.9	18.8	4.8	1.0	18.1	3.8	4.7	0.0	0.2	0.1	0.1	8.5	6.0	2.8	7.8	17.5	4.0	7.7	0.0	0.1	0.1	0.1	9.7	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.4	78.2	6.6	0.4	0.1	7.3	0.0	46.0	0.0	7.9	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	2.2	0.1	0.5	0.0	0.1	0.5	0.1	0.2	0.0	0.3	0.1	0.3	0.1	0.1	0.1	0.3	18.6	0.4	0.1	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.3	0.0	0.1	0.0	0.0	5.6	6.0	4.5	5.0	4.9	7.3	5.2	7.0	6.2	4.7	6.9	4.7	1.4	6.4	0.5	6.2	1.2	0.8	0.4	0.1	0.0	1.5	0.2	0.1	4.4	1.5	0.0	46.0	2.1	0.2	0.0	0.0	95.9	0.1	0.5	0.4	11.7	2.9	1.2	2.7	4.1	0.0	0.4	17.3	0.0	0.4	0.0	4.5	2.5	201.2	0.3	0.0	0.6	0.1	0.0	4.4	1.2	1.3	27.4	2.5	0.0	11.2	0.3	4.2	0.0	2.0	0.6	0.0	0.0	37.2	0.1	0.4	0.0	408.6	0.1	1.2	6.6	6.2	3.1	0.4	0.5	0.1	1.0	0.3	2.2	30.0	0.0	1.0
BICD1		ENSG00000151746	"BICD cargo adaptor 1"	Q96G01	12	32106835-32383633	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 198.8;Excitatory neurons: 267.2;Inhibitory neurons: 331.5;Microglial cells: 96.5;Oligodendrocyte precursor cells: 167.4;Oligodendrocytes: 131.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041309	Approved		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA041309: AB_10804000"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-6)"	"unprognostic (5.93e-2)"	"unprognostic (4.57e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	5.8	3.8	7.8	6.0	6.2	3.2	4.5	29.8	10.3	13.7	0.0	4.0	2.1	9.8	4.9	2.0	9.8	4.7	5.3	6.7	7.0	6.0	1.2	6.0	6.8	4.4	6.0	20.6	1.8	6.1	6.9	8.7	7.3	5.2	2.8	7.9	2.7	2.6	3.8	2.3	3.8	5.4	2.6	8.0	2.8	3.1	6.0	7.4	6.2	3.4	5.3	4.6	4.1	8.5	14.5	9.9	7.1	4.3	6.9	9.3	8.1	16.4	6.7	16.5	11.6	12.8	9.6	21.0	13.3	14.5	18.8	6.7	36.2	13.8	25.7	14.9	10.6	28.3	9.9	6.2	7.7	22.8	16.8	5.5	6.8	19.4	15.9	25.4	16.8	22.8	13.0	41.7	6.5	5.8	22.3	8.7	73.7	6.2	11.0	16.7	23.9	15.7	21.7	8.3	31.7	17.4	12.5	0.9	12.8	48.7	8.3	5.0	16.6	25.1	24.0	18.6	23.7	13.7	20.9	44.3	16.8	10.0	27.3	0.0	0.5	0.0	1.5	0.2	2.3	2.4	1.4	0.9	0.8	2.0	1.8	1.5	0.1	1.9	0.0	1.9	2.4	0.8	7.8	6.2	29.8	10.3	6.7	7.0	4.4	6.0	7.3	2.6	6.0	8.5	15.1	16.0	1.1	198.8	22.0	0.4	8.2	13.6	6.8	30.5	5.4	6.3	8.3	1.5	9.1	9.2	37.5	0.4	10.7	0.7	1.9	9.1	0.6	11.7	26.2	17.0	6.6	9.2	267.2	4.7	0.5	12.6	1.1	34.2	0.0	35.1	13.2	0.5	6.5	23.5	331.5	1.2	16.2	1.3	4.2	1.2	4.1	5.1	8.8	96.5	4.2	39.2	4.1	167.4	131.7	8.3	0.5	4.5	34.5	7.0	0.6	2.7	2.6	19.3	0.0	18.1	12.3	6.9	9.2	3.9	2.4	0.3	10.7	28.1	2.6	3.7
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764833	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Squamous epithelial cells: 103.2;Suprabasal keratinocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	15.4	10.6	11.4	13.5	10.0	12.0	10.9	10.9	10.5	20.8	7.8	18.5	4.6	15.5	6.0	47.0	12.8	9.4	19.8	11.1	8.6	9.1	8.5	16.0	14.7	11.0	9.8	12.5	8.9	17.7	6.0	10.4	10.3	11.3	5.0	6.5	14.6	13.1	22.3	63.4	10.4	13.7	10.5	17.3	9.5	9.4	10.0	13.8	10.0	15.3	16.8	15.2	30.9	12.3	32.6	26.5	19.2	19.8	36.6	25.1	27.1	30.8	22.2	17.2	13.6	15.6	14.4	36.3	19.5	34.4	22.0	99.4	21.8	49.1	19.4	17.4	23.5	19.2	25.6	21.7	21.8	26.9	30.0	25.8	67.1	28.8	22.0	20.4	26.0	15.4	19.3	27.5	38.1	21.4	25.6	16.7	13.3	23.8	32.0	27.8	41.8	19.3	27.8	27.0	13.4	20.7	21.7	19.9	14.3	19.2	8.2	12.3	34.9	31.8	21.1	53.9	33.9	22.5	17.5	31.9	26.9	16.3	28.4	1.6	3.4	4.4	1.2	3.6	1.2	1.8	1.4	1.6	3.8	2.0	1.3	1.2	7.5	1.1	5.9	3.2	0.9	1.7	11.4	10.0	10.9	10.5	11.1	8.6	11.0	9.8	10.3	10.5	10.0	12.3	21.7	28.9	12.7	14.7	27.6	73.7	17.1	19.2	83.6	12.8	11.4	10.2	54.5	8.6	16.2	7.3	6.2	8.5	26.1	3.4	3.9	10.1	6.5	21.3	26.7	26.4	10.8	16.0	16.2	5.1	6.5	26.0	5.6	21.1	24.1	13.0	19.2	7.5	14.2	15.2	14.0	1.9	12.2	32.4	30.2	7.6	21.1	40.7	16.0	19.7	38.9	22.0	7.2	9.5	18.5	8.5	3.6	33.4	22.1	18.7	0.8	6.7	14.0	6.4	19.7	23.0	33.1	9.7	8.4	103.2	130.8	7.3	17.2	13.8	3.6	20.3
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 128.7;pituitary gland: 80.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 12.9;dendritic cells: 13.7;Distal tubular cells: 23.5;Plasma cells: 12.8;Proximal tubular cells: 27.3;T-cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 48.9;MCF7: 27.7;OE19: 25.2;SCLC-21H: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favorable (3.15e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (3.93e-5)"	"prognostic favorable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	24.8	2.7	7.6	10.8	8.8	3.0	2.9	5.4	13.3	7.4	0.2	3.2	4.0	0.7	37.5	35.8	4.2	4.1	2.9	7.6	10.9	128.7	5.6	6.0	23.8	5.6	3.4	1.1	7.7	2.5	80.2	1.1	5.6	4.9	3.1	67.6	8.3	1.0	0.4	64.2	7.3	0.6	2.6	7.1	20.9	40.8	6.9	18.2	24.4	0.0	15.5	3.1	21.5	6.6	3.5	10.6	0.6	0.0	0.9	0.0	12.6	0.0	0.0	0.0	0.0	9.5	5.9	16.8	4.4	0.0	9.1	7.9	1.3	1.6	0.0	1.2	1.7	0.1	4.7	18.3	0.0	2.1	17.1	0.0	48.9	0.0	0.6	0.0	0.0	14.1	0.5	2.1	0.0	27.7	12.3	0.2	21.1	25.2	5.0	1.3	0.9	4.5	6.2	8.4	30.8	2.2	3.6	9.7	2.6	5.1	22.4	8.3	0.0	0.1	2.9	0.0	0.2	4.2	17.1	6.5	0.6	2.4	1.7	0.3	0.0	0.0	1.2	0.0	0.4	0.1	1.2	1.0	0.0	0.1	0.9	0.7	0.0	0.0	0.3	0.0	0.2	0.2	7.6	8.8	5.4	13.3	7.6	10.9	5.6	3.4	5.6	2.6	6.9	6.6	0.6	0.0	1.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.8	2.2	0.0	0.0	1.3	12.9	0.0	1.0	13.7	0.0	23.5	1.1	0.0	3.1	1.0	0.1	0.0	0.0	0.0	3.5	0.6	2.7	0.0	7.7	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	12.8	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	17.6	0.7	0.0	0.0
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 104.8;pancreas: 127.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.2	1.9	0.2	0.0	8.6	0.4	0.4	20.7	0.1	25.1	10.4	0.7	2.6	104.8	6.0	3.4	0.0	0.2	0.1	5.8	0.9	5.9	0.0	0.6	0.3	0.1	127.2	4.1	1.5	0.3	0.8	16.8	6.4	0.0	44.4	3.2	0.6	43.8	13.5	0.2	0.2	0.2	21.5	0.1	0.3	0.2	6.1	0.0	3.1	11.4	44.3	0.2	9.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	2.6	14.4	0.0	0.0	0.0	0.0	22.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	6.4	0.0	0.1	0.0	0.2	0.0	10.8	0.2	0.1	0.0	11.0	0.0	0.3	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.8	0.2	0.3	0.2	0.3	12.8	18.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.2	22.1	0.0	0.0	12.4	16.5	0.0	4.5	1.3	0.0	3.9	34.3	0.0	28.9	2.8	0.5	0.0	0.0	0.0	49.8	6.1	0.6	0.0	28.3	2.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.6	0.3	0.0	0.0
BICRA	GLTSCR1	ENSG00000063169	"BRD4 interacting chromatin remodeling complex associated protein"	Q9NZM4	19	47608196-47703277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056211	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA056211: AB_2683068"	"unprognostic (2.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.58e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (9.72e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.34e-4)"	6.7	5.0	1.6	5.0	2.1	5.3	6.9	4.3	3.6	9.6	0.9	9.1	6.5	10.6	1.6	6.9	9.1	2.4	6.2	3.6	1.1	3.9	4.9	7.0	3.9	1.9	0.5	8.6	4.4	4.0	5.6	4.8	1.0	8.2	3.6	4.2	7.0	4.1	13.7	9.9	7.3	5.3	0.0	6.1	6.3	3.0	2.2	5.6	7.5	5.5	3.5	8.6	8.3	5.5	6.8	6.6	12.3	9.5	6.0	6.1	7.0	5.8	4.9	6.4	4.3	7.3	3.5	7.3	3.0	6.7	5.4	6.9	7.7	4.1	6.4	7.5	6.5	4.3	5.3	3.1	7.7	5.1	7.5	5.2	5.6	7.0	6.3	5.3	6.5	6.2	6.7	8.4	3.9	4.8	9.1	16.3	8.6	8.7	5.4	9.7	4.2	2.1	2.5	4.6	7.4	9.6	14.4	8.3	3.7	10.0	3.4	4.0	8.1	5.3	10.8	4.4	7.9	6.8	11.8	7.1	1.2	3.6	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.6	2.1	4.3	3.6	3.6	1.1	1.9	0.5	1.0	0.0	2.2	5.5	5.1	9.6	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.2	6.1	0.0	0.0	0.6	7.3	0.0	4.3	3.8	0.0	0.0	3.2	0.0	4.9	6.4	2.0	0.0	0.0	0.0	3.8	3.9	1.6	0.0	6.0	1.3	4.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	5.5	2.0	3.3	0.0	0.0
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
BID		ENSG00000015475	"BH3 interacting domain death agonist"	P55957	22	17734138-17774770	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 103.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 273.2;Langerhans cells: 658.8;monocytes: 491.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"dendritic cells: 345.8;granulocytes: 925.5;monocytes: 985.3"	"Cell line enhanced"	"Detected in all"		"MCF7: 241.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000722, CAB003771"	Enhanced		Supported	Cytosol		NA	NA		800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB003771: AB_365478, HPA000722: AB_1078283"	"unprognostic (1.59e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-13)"	"unprognostic (4.66e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.18e-2)"	13.6	6.9	19.4	30.5	20.9	103.5	10.7	19.2	22.4	6.0	12.8	14.7	15.1	5.7	7.2	7.5	6.2	14.7	17.4	20.0	19.5	10.0	28.2	12.0	35.6	19.9	19.8	5.7	9.5	3.5	6.4	7.9	20.8	8.1	11.0	36.9	8.1	4.1	23.3	7.6	17.5	6.8	20.1	30.0	12.2	3.6	22.0	26.4	5.8	7.8	16.7	34.4	7.5	20.2	117.5	90.6	14.4	43.7	15.2	27.7	20.4	59.1	45.4	44.8	38.4	55.4	67.2	22.8	41.5	25.7	52.3	97.8	14.5	14.7	24.7	37.0	73.4	101.3	39.7	81.3	19.1	110.4	107.0	26.7	31.4	49.8	11.3	35.6	46.8	64.8	84.0	27.2	23.0	241.6	161.0	148.2	47.2	130.2	62.8	76.6	37.3	32.8	12.0	141.2	91.3	65.9	12.5	38.2	37.1	6.2	80.3	132.9	80.4	26.0	36.0	43.9	46.7	39.8	57.2	75.7	74.6	113.0	33.8	156.9	417.0	691.4	82.1	748.3	81.7	53.0	75.8	92.5	345.8	33.0	61.2	72.2	925.5	124.1	985.3	245.8	108.0	428.1	19.4	20.9	19.2	22.4	20.0	19.5	19.9	19.8	20.8	20.1	22.0	20.2	49.0	16.0	14.5	16.0	34.5	71.9	53.1	273.2	21.1	3.0	30.0	30.5	17.5	17.2	142.6	9.2	2.1	9.3	70.3	25.1	7.9	67.9	0.6	10.5	14.5	47.4	34.1	23.3	17.6	51.4	5.6	24.9	13.7	11.4	25.3	34.3	23.2	44.0	134.1	0.0	15.6	38.7	63.1	69.1	658.8	1.6	5.3	164.2	58.7	13.1	491.3	3.0	65.9	4.5	2.1	78.5	85.1	4.1	45.2	186.4	16.5	28.6	59.7	1.7	0.0	12.0	24.3	1.3	11.9	13.2	64.5	5.1	38.3	13.6	49.8	213.0
BIK	NBK	ENSG00000100290	"BCL2 interacting killer"	Q13323	22	43110750-43129712	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 17.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 329.3;Club cells: 215.6;Ionocytes: 443.5;Paneth cells: 140.5;Respiratory ciliated cells: 204.1;Urothelial cells: 175.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 72.9;plasmacytoid DC: 58.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 89.9;CAPAN-2: 44.3;Daudi: 44.2;U-698: 172.1"	"Not detected"	"Not detected"							HPA051360	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051360: AB_2681453"	"unprognostic (1.18e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.86e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.45e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.04e-1)"	0.2	2.3	0.2	4.1	0.4	4.1	4.9	0.7	0.3	2.8	0.0	8.5	3.6	0.2	1.2	11.3	3.0	3.1	0.3	0.5	0.0	3.8	0.5	1.4	11.6	0.0	0.0	0.3	2.5	1.6	1.0	0.1	0.1	11.4	5.2	0.2	17.5	0.5	0.0	3.5	5.3	0.2	0.0	2.9	13.4	2.0	0.1	1.4	1.8	0.1	11.2	2.6	6.5	0.0	89.9	0.7	0.2	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	28.8	44.3	44.2	4.2	0.0	0.9	19.5	4.8	1.9	0.0	0.7	6.7	0.1	0.6	4.9	0.7	21.2	4.1	0.0	8.8	0.0	0.0	0.3	0.2	9.5	0.3	2.0	0.0	22.9	16.9	28.9	6.7	24.2	7.3	0.2	0.1	20.6	0.9	2.6	1.7	0.0	3.1	8.2	6.5	3.1	1.6	28.9	0.8	0.1	2.4	0.2	1.0	10.4	17.1	172.1	0.0	2.2	0.2	1.8	2.9	72.9	2.7	0.7	4.3	17.1	9.5	4.2	10.4	11.7	6.4	3.5	11.3	0.9	0.8	58.6	7.1	6.3	0.2	0.4	0.7	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	4.2	0.0	9.3	12.6	32.7	329.3	3.4	0.0	39.7	24.1	0.7	17.2	215.6	7.3	0.0	1.4	7.9	43.0	7.9	62.2	0.3	17.7	0.8	2.3	50.6	5.7	0.3	16.2	1.2	0.9	90.7	9.1	0.0	0.1	5.3	0.7	0.9	0.0	0.2	52.9	443.5	1.4	4.8	0.4	0.0	4.0	35.6	0.0	6.4	0.0	1.0	0.0	0.1	105.2	140.5	0.7	79.7	53.1	10.2	15.7	204.1	0.0	0.0	0.0	14.9	0.2	11.0	16.1	11.8	1.0	12.9	0.3	53.9	175.3
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107288	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 2105.3;tongue: 803.2"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8"	"Group enriched"	"Detected in all"	9	"B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		NA	NA		430000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	43.7	93.2	178.8	25.7	232.8	12.0	37.3	162.6	209.6	53.8	85.9	35.2	17.4	38.7	16.8	33.5	53.5	22.6	16.5	174.2	160.6	83.4	34.7	22.7	41.0	204.2	194.8	34.4	21.5	19.6	41.0	23.5	189.8	58.1	13.1	53.7	42.6	24.0	2105.3	14.8	31.5	19.6	155.4	54.7	45.0	10.4	199.2	18.4	28.5	803.2	27.5	89.0	36.6	310.5	52.0	27.9	32.8	39.3	95.9	76.5	11.4	15.3	33.1	35.8	23.4	107.6	31.3	0.0	46.0	28.9	20.8	6.8	14.6	25.0	9.5	5.9	4.1	15.1	46.9	7.1	86.2	0.2	2.8	70.2	6.1	77.3	14.0	46.4	49.1	5.1	3.2	1.6	44.8	1.1	4.9	43.3	24.8	114.2	31.4	11.8	36.3	4.8	126.7	0.1	22.4	61.9	55.5	21.2	17.7	34.7	1.3	9.7	59.3	40.9	39.9	52.8	52.1	1.3	1.4	0.3	60.3	2.6	19.2	1.2	3.1	0.6	186.6	2.0	163.9	165.9	192.1	187.4	15.1	181.2	177.1	171.1	6.0	178.9	3.2	21.5	249.8	133.5	178.8	232.8	162.6	209.6	174.2	160.6	204.2	194.8	189.8	155.4	199.2	310.5	15.6	9.6	10.0	10.7	80.1	18.6	10.0	3.3	1.2	144.1	10.7	9.1	5.6	44.3	5.5	14.7	125.1	1.8	98.3	18.6	37.2	15.2	16.1	11.7	46.2	21.9	46.0	11.6	36.9	29.4	4.2	68.7	29.0	19.0	2.5	28.7	15.0	18.3	164.9	30.3	47.2	28.0	10.2	27.0	62.3	55.8	78.6	50.1	23.2	58.1	10.4	25.3	176.1	11.6	186.4	16.7	18.1	30.5	14.6	26.2	14.3	255.7	1.4	133.4	13.1	75.7	28.8	2.6	10.9	1.6	8.9	2.9	98.2	40.0	50.1	9.8
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BIN3		ENSG00000147439	"Bridging integrator 3"	Q9NQY0	8	22620418-22669148	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Septation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023769	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA023769: AB_1845361"	"unprognostic (4.93e-3)"	"unprognostic (4.42e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	18.6	28.4	13.4	8.5	14.1	40.3	17.6	13.2	16.3	12.4	14.4	11.4	6.8	9.6	9.4	15.8	15.1	9.5	11.5	14.0	13.6	21.0	14.0	11.6	10.4	14.1	13.2	10.4	9.7	12.5	12.6	8.4	13.8	15.5	9.9	7.7	11.6	9.4	9.2	13.9	11.1	8.0	12.8	13.3	12.6	10.4	13.5	13.3	13.2	4.4	10.9	13.5	12.9	13.7	20.6	17.5	7.7	16.6	19.9	18.4	8.6	18.2	31.0	28.4	23.2	7.2	7.9	16.6	8.0	20.0	19.9	22.7	14.9	19.0	19.4	12.6	10.1	13.8	9.0	13.6	16.7	14.3	14.8	19.0	22.2	20.9	11.1	18.0	18.4	9.7	27.5	10.2	14.8	10.0	22.8	31.7	14.6	26.9	7.6	11.4	8.2	8.1	28.4	16.2	4.0	8.8	8.7	6.4	94.2	10.3	6.2	12.7	17.7	8.8	10.8	18.1	13.7	6.8	6.1	15.1	25.1	10.3	58.5	56.3	34.2	78.3	29.0	33.9	30.0	25.8	29.5	21.9	27.5	29.1	28.9	23.5	94.9	36.4	26.1	24.9	41.0	36.9	13.4	14.1	13.2	16.3	14.0	13.6	14.1	13.2	13.8	12.8	13.5	13.7	31.7	9.6	13.0	9.1	16.5	9.8	30.9	32.9	5.2	14.0	11.5	10.0	1.1	18.6	17.2	14.7	41.7	42.8	14.7	24.0	15.6	25.1	28.5	26.7	15.3	21.0	19.8	14.3	13.3	27.6	22.5	14.0	21.4	28.4	31.7	13.6	17.2	6.1	20.2	25.2	9.8	22.1	34.6	9.6	8.7	4.9	18.3	13.0	19.6	8.4	18.6	69.3	32.0	4.0	7.2	41.7	26.1	12.0	8.5	23.4	16.7	13.9	34.1	33.8	13.1	25.4	14.6	18.0	14.0	5.4	11.5	79.4	15.0	24.4	18.2	41.2
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.0;lymphoid tissue: 141.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 209.0;naive B-cell: 159.9"	"Group enriched"	"Detected in all"	13	"B-cells: 209.0;T-cells: 83.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8"	"Low region specificity"	"Detected in all"							HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	9.0	14.7	2.7	104.8	2.9	26.3	18.4	1.6	3.4	19.1	3.4	24.9	26.6	10.5	3.7	16.0	8.5	51.0	7.7	2.8	3.5	12.6	26.3	24.6	141.5	2.6	2.7	6.6	12.0	4.3	3.6	5.3	2.3	10.6	24.7	0.6	12.7	11.4	2.7	8.1	89.0	10.7	2.5	73.2	54.3	8.2	2.7	59.2	3.9	4.3	134.4	46.9	4.8	3.6	26.4	24.5	0.2	0.4	0.7	3.9	2.4	2.5	17.5	3.3	3.7	4.6	146.5	140.7	74.3	1.4	22.8	13.0	0.1	4.6	7.8	140.1	0.3	0.5	7.3	1.4	30.7	2.4	3.7	3.5	18.1	8.4	140.2	4.9	0.4	10.2	0.5	0.0	3.0	0.1	8.3	1.3	0.3	14.2	1.0	0.1	0.8	6.8	34.3	12.9	0.1	0.3	2.1	2.1	1.8	0.5	6.4	1.8	7.5	25.6	3.4	1.4	28.3	89.2	85.8	48.8	4.0	7.4	3.0	8.6	3.9	2.2	5.8	10.1	9.8	209.0	41.7	14.1	3.6	159.9	28.4	8.3	2.6	9.9	11.0	1.7	83.6	11.9	2.7	2.9	1.6	3.4	2.8	3.5	2.6	2.7	2.3	2.5	2.7	3.6	41.2	144.2	70.8	0.0	420.1	101.2	324.9	267.2	51.2	0.3	26.6	22.9	12.5	134.4	146.9	40.5	0.0	2.0	71.2	142.4	7.9	230.3	1.8	231.3	16.8	101.4	15.0	23.6	1.1	179.7	0.5	63.4	184.5	289.4	554.8	1.8	6.4	4.4	11.7	0.0	3.2	38.0	75.3	25.4	1400.9	2.1	5.0	170.0	192.1	2.8	1117.0	0.5	14.4	0.0	0.4	207.4	281.1	2.2	288.4	455.1	817.3	19.5	88.1	0.0	0.0	60.8	90.9	0.7	0.5	31.8	84.5	0.5	278.0	0.7	49.4	193.3
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799119-102841533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050126	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	7.4	7.1	8.2	3.6	8.6	3.6	8.8	10.9	10.6	8.6	7.6	7.1	6.3	9.2	11.5	5.5	7.7	6.9	19.4	8.3	7.8	16.3	18.8	6.7	4.5	7.5	7.9	9.2	10.4	9.1	8.9	7.7	7.7	7.8	8.2	9.0	6.1	7.6	17.8	7.2	6.3	8.9	6.8	7.4	8.6	2.3	8.5	10.4	8.0	18.9	4.3	7.4	6.5	9.1	16.8	4.6	19.9	18.7	24.2	37.4	4.1	19.3	23.9	14.5	16.5	6.1	7.7	0.1	8.2	22.1	10.3	11.5	17.9	16.3	17.5	17.1	16.3	14.7	14.2	8.8	19.5	16.8	22.2	28.2	18.8	7.9	20.5	25.4	20.2	22.7	14.4	0.0	25.7	3.7	19.3	16.1	4.3	24.1	12.9	0.0	9.0	6.4	50.0	7.2	23.8	21.1	8.5	9.2	12.3	7.2	13.3	22.7	12.9	13.0	4.3	9.4	11.8	12.5	5.6	0.1	21.2	0.0	25.9	5.5	0.4	1.1	2.2	0.2	5.2	0.5	1.4	2.9	1.6	0.5	0.7	1.4	0.3	7.6	0.0	0.4	1.0	1.0	8.2	8.6	10.9	10.6	8.3	7.8	7.5	7.9	7.7	6.8	8.5	9.1	9.3	9.6	12.8	2.9	2.6	3.7	3.8	7.0	11.4	19.0	7.7	6.1	30.7	21.5	11.2	18.4	14.6	7.1	3.8	5.6	29.4	6.5	0.5	5.1	11.8	11.0	21.8	9.2	13.9	5.5	7.8	11.8	6.1	4.9	6.3	15.2	17.2	34.0	7.0	23.5	16.8	15.3	6.1	5.0	3.4	0.4	13.7	3.3	3.6	4.7	2.4	8.1	5.2	9.0	6.3	4.1	9.3	11.3	4.5	4.9	9.7	30.8	8.9	12.4	19.7	10.4	9.8	2.0	12.6	11.4	4.8	2.5	8.1	10.3	15.2	3.4
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Club cells: 2.5;Excitatory neurons: 6.4;granulocytes: 2.5;Inhibitory neurons: 7.5;Oligodendrocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;HMC-1: 1.3;hTERT-RPE1: 1.3;RPTEC TERT1: 2.5;SK-MEL-30: 1.4"									"HPA045845, HPA050126, HPA050374"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106"													"unprognostic (6.01e-2)"					10.2	9.5	0.2	0.1	0.0	0.0	9.5	0.4	0.2	10.1	0.0	9.9	0.0	9.7	0.0	8.7	8.6	0.3	8.6	0.1	0.0	9.7	12.4	9.1	0.0	0.0	0.2	10.5	11.7	0.1	9.3	0.0	0.0	8.8	0.2	0.2	9.3	0.0	12.5	9.7	9.9	0.1	0.0	9.4	9.4	3.2	0.1	0.0	9.9	0.0	0.0	9.2	9.2	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	1.3	0.9	0.6	0.7	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.3	0.5	1.3	0.3	0.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.5	0.5	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.1	0.0	9.1	0.0	2.6	0.2	0.0	0.0	0.0	0.0	2.6	0.5	0.1	0.0	1.2	0.2	0.5	0.1	0.0	0.0	1.2	0.7	0.8	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.7	0.0	0.3	0.0	39.1	0.1	0.0	46.7	2.1	0.1	0.0	2.5	1.2	0.0	27.9	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96189171-96271587	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5"	"Group enriched"	"Detected in many"	101	"B-cells: 161.2;dendritic cells: 231.5"	"Group enriched"	"Detected in some"	6	"Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946"	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favorable (2.67e-6)"	2.2	3.2	3.8	27.5	3.4	10.1	6.3	2.4	4.1	7.1	13.9	16.9	38.9	2.4	30.1	39.9	6.1	10.8	1.0	3.5	5.1	28.5	39.2	6.6	57.6	4.7	4.0	1.5	12.1	17.4	1.8	6.4	5.0	7.3	18.2	1.4	10.9	13.2	0.5	8.0	34.0	3.0	3.8	54.0	29.2	1.3	4.9	10.6	11.6	1.1	70.5	9.9	15.8	5.2	0.3	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	68.7	0.4	0.0	0.3	0.6	0.1	0.8	0.1	5.5	0.2	0.3	0.3	0.1	0.0	0.1	1.4	0.1	8.7	0.0	0.0	0.1	0.0	0.8	0.3	6.4	0.0	0.7	0.4	0.2	0.2	0.2	0.0	168.4	0.3	94.4	0.9	13.0	0.3	0.3	0.2	15.1	0.1	0.2	23.7	1.1	0.2	0.2	0.8	0.1	0.2	5.4	0.4	251.4	0.1	0.5	0.1	0.3	1.6	0.2	0.3	1.3	0.1	161.2	0.3	0.2	20.6	140.5	0.1	0.1	1.1	1.9	0.1	231.5	0.6	8.1	3.8	3.4	2.4	4.1	3.5	5.1	4.7	4.0	5.0	3.8	4.9	5.2	0.4	6.4	7.7	0.7	94.2	1.1	21.0	13.1	21.1	0.0	4.1	3.4	1.2	30.0	7.3	40.5	0.0	23.0	64.0	9.2	27.4	14.6	3.1	14.4	1.9	0.3	4.9	5.3	1.0	13.8	17.5	0.7	35.7	22.9	1.3	0.0	2.9	27.8	22.8	0.0	1.3	19.4	30.5	9.0	13.8	1.1	0.3	18.2	1.8	157.4	4.8	0.0	0.0	2.5	0.9	4.4	22.4	0.0	80.4	5.1	64.6	2.3	3.4	0.0	6.6	0.3	0.7	1.6	0.1	34.7	1.4	41.5	3.6	0.5	22.5	23.8
BLOC1S1	"BLOS1, BORCS1, GCN5L1"	ENSG00000135441	"Biogenesis of lysosomal organelles complex 1 subunit 1"	P78537	12	55716037-55720087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 1180.5;Proximal tubular cells: 719.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021381	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA021381: AB_2228026"	"unprognostic (1.27e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.83e-2)"	125.6	168.5	248.4	81.5	256.8	223.7	112.5	261.4	294.0	94.0	248.6	184.6	145.3	118.9	151.1	177.1	133.4	77.0	169.7	249.4	260.6	196.1	219.3	113.0	107.5	259.1	254.9	93.6	110.1	175.6	109.6	71.6	258.7	113.1	167.5	81.7	107.3	77.1	309.8	114.8	155.4	99.7	258.9	174.9	164.8	55.0	250.9	146.8	118.8	201.1	111.7	125.2	106.2	271.6	134.9	258.3	133.7	113.3	170.6	217.1	75.7	93.7	154.4	112.9	111.8	148.5	267.3	148.6	166.5	194.6	95.2	91.7	70.8	132.4	110.9	142.5	160.5	84.6	220.5	224.9	163.6	104.5	177.7	139.8	137.3	108.2	83.1	145.8	152.4	172.0	77.5	221.0	183.3	294.0	164.3	123.8	84.6	219.1	134.2	110.9	129.9	163.3	182.9	164.2	85.1	141.6	85.1	86.0	150.5	93.2	177.5	169.2	114.2	87.2	142.7	96.5	74.0	99.4	126.2	134.6	158.8	97.2	121.8	612.0	471.8	746.5	238.6	543.1	162.2	345.1	224.4	239.8	486.6	326.5	160.9	201.1	631.4	221.7	586.1	409.0	318.2	637.9	248.4	256.8	261.4	294.0	249.4	260.6	259.1	254.9	258.7	258.9	250.9	271.6	155.2	16.0	20.7	0.0	110.4	83.1	120.0	143.2	61.5	51.6	123.8	158.5	37.6	160.2	92.0	160.0	25.0	98.1	159.5	439.5	369.8	207.3	53.7	123.9	60.6	92.1	99.5	191.3	0.0	320.7	182.3	105.1	103.0	88.6	20.2	77.9	122.4	378.7	430.7	30.3	0.0	266.8	179.0	403.1	213.2	213.9	134.2	238.6	176.1	0.0	347.9	192.0	230.7	0.0	0.0	291.0	409.3	98.9	66.9	122.6	1180.5	719.6	114.2	92.9	78.9	133.9	208.5	46.9	55.0	86.6	88.9	73.2	111.5	77.4	256.7	180.7
BLOC1S2	"BLOS2, BORCS2, FLJ30135, MGC10120"	ENSG00000196072	"Biogenesis of lysosomal organelles complex 1 subunit 2"	Q6QNY1	10	100273280-100286680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048088, HPA055010"	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA048088: AB_2680259, HPA055010: AB_2682670"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.53e-1)"	26.3	34.7	33.0	25.9	34.3	73.4	24.4	32.7	42.9	25.3	27.5	18.1	15.5	14.6	22.7	57.9	15.9	14.5	25.1	34.1	38.5	35.3	40.9	30.7	38.2	35.3	35.8	18.1	25.9	25.4	36.1	16.0	37.3	23.5	18.4	18.9	27.9	9.8	74.5	42.1	23.4	11.5	35.4	44.1	22.3	21.0	34.6	23.0	22.9	22.9	34.5	19.9	33.4	38.5	36.5	36.5	49.2	56.1	52.3	47.8	44.5	62.0	60.5	31.4	39.6	24.9	30.6	34.4	34.1	38.0	25.2	37.2	25.0	78.9	31.7	53.9	36.9	20.4	33.3	62.5	45.9	59.9	62.3	37.2	86.7	30.6	98.9	51.7	55.0	42.7	28.2	56.7	68.3	44.2	50.5	36.6	26.6	38.4	29.2	13.6	45.1	30.0	47.9	49.2	23.5	31.4	27.9	15.6	68.2	47.7	57.3	33.4	43.7	19.0	37.1	33.3	57.9	56.0	69.1	67.0	56.6	61.4	19.7	63.1	51.6	81.1	26.5	70.6	39.3	74.7	33.3	30.2	59.7	94.0	28.9	32.5	106.8	35.0	70.7	38.4	47.3	44.6	33.0	34.3	32.7	42.9	34.1	38.5	35.3	35.8	37.3	35.4	34.6	38.5	33.4	25.6	31.4	10.1	103.6	66.4	45.0	171.3	57.5	27.3	40.3	39.0	22.6	18.6	50.9	35.0	12.5	85.1	68.1	19.5	92.0	61.8	33.3	20.8	26.5	36.7	28.8	42.5	16.8	70.9	71.6	38.9	27.5	25.4	86.3	21.5	30.4	30.3	133.3	21.9	14.8	19.7	85.5	108.0	71.9	36.2	22.7	82.3	40.9	14.0	127.1	29.1	74.2	14.1	17.4	94.4	23.1	17.7	32.3	38.9	26.3	72.5	38.0	24.0	6.6	51.1	29.4	84.4	54.7	102.4	77.3	45.7	68.3	27.3	26.1	31.4
BLOC1S3	"BLOS3, HPS8"	ENSG00000189114	"Biogenesis of lysosomal organelles complex 1 subunit 3"	Q6QNY0	19	45178784-45216933	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050111, HPA070609"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA050111: AB_2681019, HPA070609: "	"unprognostic (1.17e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.94e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.89e-9)"	"unprognostic (1.92e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (6.86e-4)"	6.7	6.3	7.8	5.9	7.8	12.4	5.7	7.0	8.2	5.7	4.4	5.7	5.3	5.6	5.9	6.4	4.7	3.2	5.2	7.5	6.4	5.7	7.8	5.5	7.6	9.3	8.0	5.6	6.1	4.8	4.4	3.9	8.4	5.7	4.3	3.3	5.6	4.5	4.4	13.2	6.7	4.1	6.8	11.0	7.6	7.2	8.1	4.7	4.7	3.4	7.5	6.6	5.9	9.2	10.4	11.6	3.2	8.1	10.8	7.3	9.7	5.1	8.2	9.5	9.8	7.0	6.6	9.0	12.2	11.9	10.8	16.0	8.5	11.6	6.8	7.9	17.3	12.3	5.5	8.0	15.4	6.0	19.5	10.8	16.3	12.3	17.3	5.4	10.6	5.9	13.2	18.2	5.6	17.8	6.2	9.2	1.8	14.9	14.5	8.9	4.3	7.5	7.0	13.2	6.3	6.0	13.6	22.8	5.1	5.6	9.4	11.1	5.7	9.7	5.5	10.4	8.2	12.7	14.0	6.1	10.6	11.1	7.5	51.1	34.4	30.2	37.4	42.8	31.0	18.4	31.6	28.3	21.4	24.8	25.5	25.5	35.2	24.2	39.9	18.5	29.8	17.8	7.8	7.8	7.0	8.2	7.5	6.4	9.3	8.0	8.4	6.8	8.1	9.2	3.4	0.0	1.7	1.0	5.4	12.7	2.6	1.7	2.2	5.7	4.2	3.2	2.3	1.5	1.5	3.7	0.0	3.7	5.9	4.6	1.9	4.4	17.7	1.9	3.2	5.2	7.2	1.7	2.7	3.7	4.0	3.2	2.0	2.7	8.2	3.0	6.1	6.3	6.1	5.0	2.8	5.0	0.0	8.8	8.9	39.3	6.2	4.7	3.6	1.0	6.8	3.4	11.3	3.5	2.9	5.1	3.2	7.9	4.0	4.9	4.6	4.2	1.7	2.0	0.0	1.9	3.1	1.5	5.1	2.7	13.9	4.5	6.7	3.0	4.1	1.9
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716174-6717664	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	8.6	11.7	8.0	7.9	8.2	9.8	8.9	8.3	8.7	9.4	9.1	8.9	9.2	9.9	7.1	11.1	9.3	6.5	8.0	8.3	7.7	10.0	11.3	6.3	12.1	8.1	8.2	12.0	7.9	5.6	7.2	7.7	8.3	9.4	5.7	4.3	8.2	6.4	10.8	8.6	11.4	5.1	8.4	13.1	8.8	6.3	8.3	8.9	7.6	5.7	8.6	9.6	8.6	8.6	15.3	10.3	15.2	15.6	11.7	15.0	30.5	12.0	13.2	11.0	9.7	9.2	16.0	14.4	12.6	10.9	15.5	10.1	8.6	14.0	8.4	11.7	14.1	22.0	10.3	23.2	14.3	10.8	19.7	14.2	13.6	8.7	7.5	10.8	10.3	12.3	29.3	12.6	11.6	15.1	17.6	37.5	19.7	11.2	20.0	17.9	16.8	13.0	15.3	13.3	13.1	17.5	9.9	7.1	22.7	11.6	22.4	20.8	11.6	10.0	8.9	11.8	15.4	18.8	19.8	19.4	11.2	19.6	16.3	2.5	2.7	14.0	4.4	4.6	4.5	6.3	5.4	4.8	3.6	5.2	8.4	4.5	1.4	2.5	3.1	3.4	5.1	1.7	8.0	8.2	8.3	8.7	8.3	7.7	8.1	8.2	8.3	8.4	8.3	8.6	18.7	6.4	5.9	3.9	40.8	23.6	35.2	4.9	26.7	29.1	25.2	27.8	5.3	21.5	5.7	23.9	6.2	65.1	49.5	21.7	25.4	9.7	2.5	28.6	28.0	20.2	11.4	26.5	6.8	7.0	93.1	27.8	21.9	25.3	3.8	18.7	32.5	23.6	35.8	30.3	6.6	22.8	4.1	24.0	22.2	1.6	32.3	16.6	30.2	5.6	18.1	38.4	60.8	4.5	8.3	9.9	33.9	22.6	19.7	40.3	33.9	51.3	4.6	24.7	6.6	26.6	20.0	16.0	14.3	23.1	24.9	63.3	47.7	39.1	24.2	34.8
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064396	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	6.8	7.0	3.6	6.3	4.2	3.9	10.5	3.9	4.7	8.1	3.0	6.4	4.2	7.0	6.9	6.6	6.4	6.1	6.0	3.3	4.7	15.7	11.4	5.9	9.9	4.4	4.2	9.9	4.7	9.6	3.1	6.8	4.5	6.5	5.8	5.2	4.7	9.2	6.5	6.4	5.0	6.6	4.0	7.4	6.0	3.7	3.9	15.6	10.1	8.6	10.6	6.2	5.3	4.6	6.1	7.0	14.7	18.9	15.7	18.8	9.6	6.7	9.4	9.5	9.4	13.6	5.8	21.8	43.9	8.6	10.8	5.4	10.8	5.4	13.6	20.6	11.5	13.1	4.8	25.8	13.4	23.2	14.8	8.4	13.4	9.6	14.4	14.5	17.3	17.3	27.7	3.9	13.6	6.7	26.6	15.1	7.9	14.3	9.4	21.5	17.0	33.8	17.6	5.4	13.5	7.2	6.8	10.3	21.3	26.4	12.9	11.8	7.2	15.1	10.7	8.9	5.9	16.5	37.3	19.7	6.2	17.9	15.9	16.2	9.4	18.3	11.8	12.3	15.7	18.9	15.3	15.2	16.6	17.7	15.2	15.9	2.3	19.6	6.7	7.2	15.2	11.8	3.6	4.2	3.9	4.7	3.3	4.7	4.4	4.2	4.5	4.0	3.9	4.6	18.1	12.8	6.9	0.0	14.6	6.0	8.3	6.8	8.6	7.0	7.1	9.9	7.3	0.0	7.9	25.8	2.1	12.5	15.6	5.9	35.2	9.9	7.5	11.5	12.4	10.7	1.8	7.2	0.0	8.7	9.2	10.6	7.7	19.5	16.5	14.5	0.0	0.0	7.8	6.7	0.0	6.9	2.0	0.0	6.1	7.8	9.6	11.0	3.6	0.0	10.7	13.2	12.3	0.0	0.0	10.1	3.9	12.4	7.3	8.4	6.7	41.8	7.7	8.4	0.0	12.4	9.3	5.8	14.4	8.9	7.5	8.2	12.7	22.5	6.6	7.5
BLOC1S6	"HPS9, PA, PLDN"	ENSG00000104164	"Biogenesis of lysosomal organelles complex 1 subunit 6"	Q9UL45	15	45587214-45615945	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 230.8;Alveolar cells type 2: 292.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039928	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"			"HPA039928: AB_10673538"	"unprognostic (6.90e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.50e-2)"	30.0	31.2	15.3	31.1	17.1	58.2	25.5	15.6	19.1	25.8	13.9	21.2	20.2	30.7	18.4	21.0	18.1	26.5	25.1	17.0	22.7	24.2	26.8	20.4	41.9	14.8	18.6	37.8	20.4	16.8	19.0	26.3	17.7	36.4	21.5	24.6	20.7	20.4	23.6	18.2	21.3	24.3	13.8	27.9	20.1	17.0	19.2	25.2	44.4	23.2	35.4	28.5	15.6	16.8	31.5	15.9	38.9	46.2	70.1	57.0	22.2	59.0	58.4	28.5	30.4	37.6	15.9	78.1	36.2	47.5	42.6	27.6	41.7	43.2	36.6	52.8	22.0	79.8	34.9	26.2	44.1	82.2	112.9	44.6	36.7	30.7	55.9	43.8	42.4	54.7	62.4	78.7	50.7	11.8	40.0	38.6	22.5	31.4	22.4	55.8	60.3	43.9	36.6	47.9	29.3	49.4	32.7	21.2	33.9	36.8	33.8	83.2	49.0	68.6	35.6	68.6	55.7	81.2	134.8	102.4	69.5	57.1	62.5	19.3	12.5	10.5	7.5	12.6	10.5	12.9	7.3	7.7	16.8	12.8	9.0	10.2	6.0	7.0	11.1	8.1	6.7	8.9	15.3	17.1	15.6	19.1	17.0	22.7	14.8	18.6	17.7	13.8	19.2	16.8	42.0	230.8	292.6	13.7	59.6	34.5	38.7	21.5	39.3	59.8	33.5	30.4	38.4	21.5	126.0	18.4	37.5	26.0	58.9	15.9	37.2	29.9	37.2	36.2	81.8	54.8	62.1	57.4	31.8	33.0	25.6	75.9	22.4	58.7	197.7	38.0	35.0	36.6	37.6	50.5	27.3	30.4	12.2	67.9	123.0	28.4	28.0	97.6	26.6	17.8	80.4	54.0	40.2	22.6	31.0	40.1	25.9	37.2	67.7	71.8	21.2	60.4	141.5	46.7	19.7	52.1	39.2	51.8	37.8	36.9	32.8	22.0	56.1	34.5	24.7	34.4
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BMERB1	"C16orf45, FLJ32618"	ENSG00000166780	"BMERB domain containing 1"	Q96MC5	16	15434475-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 57.0"	"Cancer enhanced"	"Detected in all"		"glioma: 30.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	30.9	15.4	90.3	10.5	111.6	1.1	21.6	67.4	112.7	46.0	48.2	46.1	8.3	40.5	19.7	21.4	38.4	23.9	47.3	107.0	87.2	23.1	21.8	13.4	6.4	123.0	74.0	40.9	18.6	3.9	40.8	1.3	118.5	32.4	9.3	40.6	12.6	27.6	86.9	13.0	19.1	35.6	69.6	9.2	21.6	40.3	80.5	4.0	13.5	41.3	4.0	44.4	25.3	96.2	1.4	31.5	12.8	1.5	56.7	50.7	0.3	18.1	62.6	15.5	8.4	0.0	0.9	0.1	4.0	101.8	37.5	0.2	4.1	5.3	7.9	0.4	0.7	6.7	11.9	1.5	19.4	0.1	13.6	24.5	5.2	33.8	0.5	25.8	25.2	14.5	0.4	0.5	24.2	21.6	5.1	0.9	17.2	0.4	10.7	1.0	16.3	0.1	8.8	4.6	26.2	27.6	0.9	8.3	5.5	2.1	0.4	0.4	8.9	34.2	17.6	81.3	9.4	5.7	12.5	0.2	124.3	0.2	7.1	0.1	0.1	0.1	8.7	0.0	1.7	2.1	2.0	5.2	0.5	1.3	1.5	2.8	0.6	0.2	0.1	0.2	2.6	1.1	90.3	111.6	67.4	112.7	107.0	87.2	123.0	74.0	118.5	69.6	80.5	96.2	7.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
BMF	FLJ00065	ENSG00000104081	"Bcl2 modifying factor"	Q96LC9	15	40087890-40108892	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.0"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 14.9;Exocrine glandular cells: 15.1;Kupffer cells: 18.7;Langerhans cells: 12.8;monocytes: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 43.3;HMC-1: 44.2;hTERT-RPE1: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010120	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA010120: AB_1845385"	"unprognostic (2.94e-1)"	"unprognostic (4.92e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.83e-4)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (1.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.35e-2)"	3.7	2.9	1.9	12.6	1.8	33.0	5.7	2.2	3.0	9.6	3.9	10.1	21.2	15.8	7.2	2.9	11.9	12.2	5.3	1.2	3.5	10.7	3.4	12.8	13.7	4.3	3.0	14.1	7.7	6.0	2.7	6.4	4.1	6.0	8.4	3.0	10.4	4.7	5.1	5.3	23.6	10.1	3.4	18.9	10.1	2.1	5.0	76.0	17.1	5.3	23.5	7.5	3.8	6.4	1.0	1.4	22.9	5.1	0.6	0.9	15.5	0.1	3.6	0.4	1.1	23.6	1.7	6.8	7.3	1.0	7.0	4.9	5.7	0.1	0.1	16.0	4.7	3.5	43.3	5.5	2.1	0.6	44.2	11.3	1.3	0.4	0.4	57.0	6.0	5.0	1.9	2.9	2.0	1.3	2.3	17.6	6.2	11.8	0.8	4.3	5.2	20.4	1.0	5.4	12.1	9.8	4.4	11.6	10.6	24.3	6.9	13.8	4.6	0.8	3.1	0.7	0.3	28.1	28.4	4.3	1.6	3.3	2.7	0.0	2.6	2.4	0.1	2.9	0.2	2.9	0.2	0.8	1.6	0.9	0.4	0.0	3.2	0.0	4.0	2.0	0.7	0.7	1.9	1.8	2.2	3.0	1.2	3.5	4.3	3.0	4.1	3.4	5.0	6.4	2.3	3.2	2.2	0.3	7.3	1.1	0.9	1.0	1.2	0.2	2.1	1.3	1.6	4.3	5.0	0.0	0.0	1.4	0.7	7.9	0.0	14.9	1.3	5.9	1.2	3.8	1.2	3.2	0.1	15.1	1.3	2.3	1.5	8.5	0.0	0.8	1.4	1.0	8.4	0.0	0.8	1.1	6.1	18.7	12.8	0.5	1.8	8.8	0.0	3.7	14.2	0.3	0.0	0.5	0.5	10.9	1.2	0.7	7.0	1.7	9.6	2.4	1.0	0.8	0.0	1.3	1.3	0.4	1.4	0.9	0.6	1.8	3.5	0.2	1.2	1.0
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321099-22331484	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 165.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 508.3;U-937: 583.9"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	29.0	31.1	26.6	25.1	35.1	21.9	36.0	29.9	42.4	27.6	28.2	26.2	19.7	30.7	29.7	21.9	22.6	23.9	20.5	25.0	27.8	26.0	35.6	23.4	27.7	29.5	30.1	21.7	25.7	56.9	25.0	28.7	31.6	33.7	21.5	40.4	19.9	26.1	44.4	14.4	20.8	36.2	29.9	36.2	22.5	35.3	28.1	24.9	23.9	35.5	27.0	23.8	14.8	45.4	74.9	36.1	41.2	12.7	68.9	54.6	40.5	49.7	22.2	37.3	43.5	37.6	93.4	38.1	32.8	45.6	42.2	26.1	59.1	35.0	45.4	508.3	72.8	104.7	28.7	42.9	41.1	39.8	55.7	35.5	58.8	41.2	45.3	47.0	26.2	62.1	105.4	63.3	48.6	30.2	106.9	11.4	9.3	36.3	83.4	79.6	57.1	37.3	35.3	25.2	33.8	66.0	32.7	42.5	57.3	17.8	38.5	153.8	56.4	41.4	122.6	99.6	67.6	76.1	110.8	83.1	59.5	583.9	27.4	15.1	1.3	2.5	5.2	3.0	7.0	4.4	5.3	5.0	0.9	2.2	4.4	4.3	0.6	5.2	2.1	1.6	4.1	2.0	26.6	35.1	29.9	42.4	25.0	27.8	29.5	30.1	31.6	29.9	28.1	45.4	18.9	25.6	24.0	0.0	23.1	15.9	20.5	12.4	22.8	20.9	24.4	20.3	19.0	22.8	19.8	12.9	8.4	12.7	14.2	5.6	13.7	16.3	134.0	12.1	25.3	24.0	13.2	19.1	0.0	18.2	22.2	19.8	7.7	9.8	12.0	12.6	28.5	30.7	9.9	30.3	0.0	9.9	14.2	19.7	25.6	165.1	36.1	13.8	37.4	0.0	17.5	13.9	15.5	0.0	0.0	22.9	7.3	36.5	33.9	29.1	4.6	13.0	16.9	15.2	19.7	26.5	28.6	19.8	22.2	11.2	14.6	6.7	22.4	17.0	10.3	20.4
BMP1	"BMP-1, PCOLC"	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22165140-22212326	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 69.3;Endometrial stromal cells: 52.8;Smooth muscle cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	11.7	17.4	3.8	6.3	4.6	1.4	9.0	4.7	4.4	15.6	4.9	8.1	4.8	12.7	3.9	7.0	11.8	9.8	5.9	4.3	3.9	7.7	14.7	8.3	1.7	5.0	4.1	5.9	4.4	3.4	3.4	27.3	4.1	9.6	5.3	0.6	3.7	6.1	3.4	6.2	5.9	14.4	4.3	5.0	4.3	2.4	4.2	1.5	10.0	3.1	1.8	10.4	10.3	4.4	15.2	20.4	7.4	30.2	47.8	41.8	23.2	54.1	50.1	33.8	27.6	5.1	27.4	3.7	32.0	56.9	18.9	51.2	5.1	27.8	6.5	3.6	6.9	6.7	24.5	7.9	31.7	2.9	14.3	49.8	26.5	25.2	11.4	78.3	31.4	5.2	7.1	10.6	19.6	4.6	1.4	3.0	4.7	17.0	8.3	6.4	8.2	15.2	26.7	4.1	2.8	10.6	52.5	3.1	13.4	20.4	5.0	8.3	41.4	17.0	18.4	32.3	23.9	4.0	2.2	0.6	23.8	10.1	28.0	0.0	0.4	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	3.8	4.6	4.7	4.4	4.3	3.9	5.0	4.1	4.1	4.3	4.2	4.4	12.5	6.4	69.3	5.5	0.8	6.2	5.2	22.6	4.0	2.6	5.0	6.1	4.9	2.8	6.7	5.5	0.0	3.3	3.2	31.9	0.0	25.1	0.7	3.1	52.8	14.1	3.0	0.8	3.5	8.2	9.5	28.7	1.1	5.7	15.2	13.9	14.6	20.1	4.3	1.7	2.7	6.2	0.0	3.4	6.1	1.1	10.2	5.4	10.6	4.7	1.0	2.2	3.1	6.6	6.7	15.3	18.6	10.9	2.8	4.7	13.2	4.1	2.2	1.1	26.3	6.4	43.7	1.5	4.0	6.5	5.3	24.4	3.3	34.2	10.7	8.0
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916365	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	6.0	4.2	8.5	13.5	8.2	11.9	7.4	7.3	7.2	6.5	3.8	9.5	5.6	4.4	5.4	7.4	6.0	7.4	8.0	7.2	18.6	4.9	6.7	7.7	16.5	12.1	11.2	3.1	3.5	4.3	0.6	9.2	13.5	3.3	11.9	6.5	3.5	3.5	2.2	9.9	6.9	6.6	10.9	12.2	4.7	10.2	9.8	10.9	7.7	4.5	16.3	7.1	1.4	16.5	11.4	3.2	6.0	7.5	12.0	11.1	4.8	10.8	14.4	10.3	13.7	6.4	6.4	13.2	5.6	50.1	9.9	2.9	6.7	8.5	19.4	3.5	2.3	73.6	5.0	3.5	13.2	15.9	80.6	15.9	11.0	16.4	15.6	7.3	14.4	10.0	19.8	36.5	12.1	2.4	9.5	7.4	2.9	8.8	2.1	13.5	10.3	3.7	13.3	5.2	8.4	5.2	14.2	7.8	10.4	7.9	2.7	10.0	14.7	10.6	4.2	18.4	11.9	7.7	3.2	4.8	9.9	21.4	7.7	0.1	0.5	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.6	0.1	0.0	0.9	0.1	0.8	0.3	0.0	0.1	8.5	8.2	7.3	7.2	7.2	18.6	12.1	11.2	13.5	10.9	9.8	16.5	10.7	28.9	16.2	242.9	31.5	25.0	4.3	5.4	10.2	10.9	27.4	15.2	6.5	2.8	7.7	7.3	4.2	5.0	6.1	24.6	0.0	7.5	15.9	18.6	12.7	17.6	6.7	105.4	53.2	8.8	14.2	13.7	6.6	25.0	129.2	32.1	22.1	19.7	140.4	10.1	59.0	48.2	6.1	65.9	68.2	11.1	8.1	65.4	28.4	351.3	34.6	37.0	1.0	49.3	59.1	14.6	43.0	6.8	7.6	6.3	19.9	18.0	12.3	8.4	6.6	22.3	11.7	26.1	11.2	17.1	31.4	3.4	7.6	5.4	24.0	3.2
BMP4	BMP2B	ENSG00000125378	"Bone morphogenetic protein 4"	P12644	14	53949736-53958761	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 47.3;Fibroblasts: 65.2;Hepatic stellate cells: 52.8;Pancreatic endocrine cells: 40.1;Skeletal myocytes: 51.0;Syncytiotrophoblasts: 34.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 28.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"monocytes: 1.9;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 120.1;CAPAN-2: 298.6;Hep G2: 326.0;OE19: 219.1;SuSa: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006863, HPA066235"	Uncertain				"Secreted to blood"	NA	NA	162000000		"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB006863: , HPA066235: AB_2685641"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.45e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.24e-1)"	14.0	13.4	3.0	6.1	3.2	0.1	13.4	7.0	4.5	21.0	32.4	25.6	17.0	8.9	2.5	12.9	9.7	14.4	16.3	3.1	2.8	9.0	4.2	13.4	9.6	3.6	3.3	23.8	3.4	2.7	4.7	44.4	3.9	21.9	28.9	2.7	10.5	18.7	11.5	15.3	19.2	9.0	3.2	6.5	23.8	2.0	3.9	3.4	8.5	17.7	4.2	27.4	23.5	4.7	15.6	40.0	2.1	1.8	0.5	0.4	0.6	7.9	34.0	20.1	15.5	120.1	298.6	0.0	97.2	0.1	2.2	73.2	8.6	1.0	10.7	4.1	5.9	0.2	8.3	326.0	19.4	0.0	1.0	0.0	2.8	9.5	0.5	61.1	59.3	6.8	0.0	0.3	9.7	6.9	5.3	0.3	13.9	219.1	3.4	0.2	10.5	0.3	28.5	1.3	0.1	0.3	0.0	1.1	0.9	168.2	38.8	1.5	2.9	0.6	87.1	0.3	1.4	0.2	0.1	1.0	0.1	0.1	4.3	0.0	0.6	0.0	0.1	1.1	0.0	0.0	0.9	0.2	0.1	0.0	1.3	0.4	0.0	0.0	1.9	0.0	0.0	0.3	3.0	3.2	7.0	4.5	3.1	2.8	3.6	3.3	3.9	3.2	3.9	4.7	7.6	9.6	7.3	1.0	0.6	27.5	4.0	16.1	47.3	0.3	8.0	10.4	5.7	14.3	6.0	5.5	0.0	29.3	0.1	1.0	3.9	5.5	2.5	0.7	18.9	18.2	0.0	2.7	1.3	0.2	18.9	65.2	0.5	0.7	1.3	0.9	52.8	2.0	3.7	0.0	0.4	5.3	2.0	0.6	5.9	1.0	10.5	0.4	3.6	1.9	0.0	0.5	0.0	1.0	0.3	40.1	4.0	1.5	0.1	2.3	0.6	2.4	5.8	1.5	0.0	51.0	10.5	1.4	2.2	7.5	17.5	34.8	1.0	1.4	4.0	1.4
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	9.1	6.4	4.3	4.5	5.2	0.0	10.3	5.4	5.5	8.1	4.9	9.9	5.4	12.9	11.9	7.8	7.4	9.6	7.8	4.7	6.1	7.0	4.3	7.3	2.9	6.8	5.8	11.6	5.8	9.9	2.6	6.5	6.3	12.5	8.2	4.8	12.1	13.0	7.9	9.3	8.6	12.5	6.2	2.9	7.3	5.2	4.6	2.9	19.1	4.8	3.0	7.9	4.1	6.5	14.6	7.8	27.6	26.8	15.0	10.6	5.5	14.5	18.3	9.4	11.3	11.0	13.1	4.7	6.1	19.2	5.9	15.0	15.8	14.3	14.1	5.5	8.2	5.9	6.9	19.0	10.2	7.4	37.7	10.7	8.5	11.2	9.5	13.9	0.0	8.1	7.6	2.7	12.3	7.0	6.7	7.8	17.6	5.2	4.2	0.0	12.3	0.1	18.9	12.1	3.7	12.8	17.8	8.4	12.6	34.1	15.0	4.1	6.2	7.0	9.8	12.7	13.3	0.3	12.3	5.3	6.5	5.6	6.0	0.3	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	4.3	5.2	5.4	5.5	4.7	6.1	6.8	5.8	6.3	6.2	4.6	6.5	3.5	35.3	22.4	142.7	3.5	12.1	7.1	9.9	17.6	7.5	10.2	10.2	22.6	18.6	10.5	11.0	20.9	14.1	2.3	10.7	1.9	10.6	0.7	10.7	19.7	4.5	18.0	0.0	63.8	9.5	1.0	20.6	19.4	13.9	15.2	22.9	9.3	7.2	3.4	11.8	79.9	13.9	8.2	4.8	6.1	4.1	33.5	2.3	8.8	34.7	0.8	12.9	2.1	122.2	64.3	8.9	4.9	31.2	3.2	13.7	10.6	5.5	16.5	20.4	6.6	20.3	19.2	2.1	6.6	11.5	9.8	5.1	4.3	11.9	11.1	6.7
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376327-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.2;Inhibitory neurons: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.5	21.6	8.2	10.9	14.1	2.2	13.2	3.2	16.8	22.6	0.3	13.6	8.5	20.0	11.3	12.4	14.9	17.3	21.5	16.0	14.8	17.4	15.6	29.1	7.2	6.2	7.7	16.8	10.4	17.5	8.5	34.0	10.0	17.1	13.0	26.7	11.0	13.9	10.9	10.9	8.6	24.3	3.9	13.1	11.7	11.3	10.6	9.0	18.2	23.1	9.4	20.6	12.4	5.9	13.3	12.3	12.6	19.7	34.2	31.9	23.8	27.2	28.3	23.6	23.9	10.8	19.6	4.7	30.7	58.2	19.9	24.5	16.8	21.4	41.6	13.8	11.2	14.2	12.6	16.8	22.7	4.0	10.7	24.2	21.5	17.1	22.8	40.6	73.9	5.6	9.3	22.5	33.8	24.8	3.4	3.6	6.9	6.6	11.1	9.1	24.3	7.1	21.3	27.9	12.6	12.7	28.9	17.7	32.7	32.0	13.2	9.5	75.9	48.0	24.4	16.3	16.7	3.1	4.1	1.3	11.3	9.0	13.9	0.1	0.6	0.2	0.9	0.5	0.6	0.3	0.3	0.5	0.6	0.4	0.7	0.3	0.1	0.3	0.9	0.7	1.0	0.3	8.2	14.1	3.2	16.8	16.0	14.8	6.2	7.7	10.0	3.9	10.6	5.9	116.9	105.8	40.3	104.5	15.2	33.4	18.0	34.9	13.6	54.3	29.2	29.7	55.5	15.7	38.8	20.2	81.3	16.9	17.8	25.2	1.9	27.2	2.8	23.1	54.5	152.2	25.1	6.9	202.2	28.1	22.6	47.7	16.8	36.4	23.5	155.1	143.1	19.9	18.7	35.3	190.2	16.3	20.3	24.2	31.7	4.6	33.8	23.5	42.7	170.5	20.2	39.9	16.5	152.8	55.1	46.8	21.1	42.9	9.5	23.9	16.4	12.4	28.0	31.7	65.7	48.8	62.4	33.2	25.0	21.2	35.9	20.0	13.1	0.8	15.5	24.8
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BMT2	"C7orf60, DKFZp762M126, FLJ31818, SAMTOR"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939875	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Extravillous trophoblasts: 25.9;Hofbauer cells: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA044405: AB_10959783, HPA050733: AB_2681223"	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	3.9	4.0	7.2	4.8	7.4	4.9	5.8	8.9	10.7	5.9	5.7	4.9	2.6	7.3	4.2	7.3	4.4	5.0	12.7	7.3	8.4	5.4	2.3	4.3	5.8	5.3	6.6	5.8	3.1	4.8	2.9	5.1	5.6	5.6	4.3	9.3	5.0	6.4	3.2	3.8	3.3	7.2	6.1	6.0	3.1	8.0	8.7	8.2	5.2	4.2	5.7	6.3	4.3	5.8	5.9	4.9	12.3	11.1	16.3	18.6	3.7	6.1	27.5	10.8	15.6	3.0	4.6	2.0	7.7	11.2	11.9	2.8	6.6	9.1	17.6	6.2	6.7	10.3	3.1	3.7	7.3	4.0	9.6	14.2	7.1	8.5	7.4	13.5	8.8	3.7	3.3	3.8	13.2	4.5	9.5	11.5	2.7	4.2	5.1	4.7	16.1	6.2	8.3	7.8	4.9	12.5	11.5	4.7	6.8	11.8	2.3	3.6	6.2	13.8	3.3	8.9	4.8	4.9	4.9	3.7	14.9	5.9	8.2	6.7	3.8	6.5	3.2	3.9	3.9	2.5	3.1	3.7	3.9	2.4	4.2	3.7	8.7	3.7	4.4	2.3	5.2	1.6	7.2	7.4	8.9	10.7	7.3	8.4	5.3	6.6	5.6	6.1	8.7	5.8	6.8	6.4	5.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.9	7.6	0.0	0.0	1.8	12.9	0.0	6.9	4.8	0.0	0.0	3.4	0.0	4.6	8.5	2.6	0.0	0.0	0.0	2.5	25.9	2.7	0.0	5.4	0.0	8.9	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.6	0.0	0.0	6.6	3.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.2	2.6	5.8	0.0	0.0
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"epididymis: 102.6"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 28.2;Hepatic stellate cells: 93.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	77	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	119	"HUVEC TERT2: 353.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	7.7	0.3	0.3	1.7	0.5	7.1	4.9	0.3	0.6	1.7	1.1	3.8	4.4	2.3	102.6	2.3	2.6	2.6	8.8	0.3	0.3	0.6	0.7	3.0	1.5	0.3	0.4	0.9	0.9	0.3	0.2	4.7	0.3	0.9	2.4	0.0	1.1	0.9	1.3	1.6	4.8	2.6	0.3	2.2	1.4	0.2	0.4	0.7	2.0	2.2	0.4	2.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	353.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.4	14.1	0.0	1.1	1.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	28.2	4.2	3.2	1.3	0.2	0.0	1.1	4.6	0.2	0.0	0.1	93.9	0.7	0.1	0.0	1.2	0.1	2.0	0.0	1.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.8	0.0	0.0	0.3	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.4	0.4
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.9;ovary: 31.7;smooth muscle: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	5.6	1.0	1.4	3.7	2.5	0.7	3.3	2.3	4.4	12.1	8.2	10.1	1.3	26.9	2.1	4.6	18.4	7.2	2.9	2.6	2.7	6.4	0.3	3.1	0.8	4.7	6.0	31.7	0.5	2.9	1.7	3.4	3.9	3.7	3.0	0.8	1.3	4.8	3.5	3.4	3.3	31.7	3.5	0.7	3.0	6.9	4.7	2.5	2.1	1.9	1.1	6.3	5.8	4.9	0.3	1.7	1.2	0.1	17.5	21.1	2.7	11.4	19.5	7.8	6.4	0.1	0.0	0.0	3.7	7.8	5.8	0.1	5.1	0.0	7.9	0.2	2.0	0.1	5.3	0.0	13.4	0.1	0.5	31.9	0.0	16.6	0.1	13.7	18.0	0.0	0.0	40.4	11.1	0.0	0.0	2.8	6.6	0.1	10.2	0.0	12.5	28.0	6.0	0.3	0.2	1.0	0.1	0.1	18.6	8.3	0.1	0.0	17.7	18.6	13.5	15.1	20.9	0.2	0.0	0.1	7.6	2.5	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.5	1.4	2.5	2.3	4.4	2.6	2.7	4.7	6.0	3.9	3.5	4.7	4.9	5.5	0.0	2.2	46.7	0.0	10.1	0.6	0.0	33.6	8.2	0.2	0.4	4.8	0.0	0.6	0.0	0.0	3.2	10.7	0.1	0.0	1.0	7.2	2.2	9.1	10.5	0.0	0.0	1.6	0.4	1.2	38.6	3.1	2.0	22.2	25.1	10.4	0.3	7.3	0.0	1.9	1.1	6.1	1.6	2.3	4.5	90.1	4.2	10.6	230.5	0.1	2.6	30.9	1.0	1.6	0.1	0.0	67.7	3.9	0.7	5.7	35.5	0.7	0.3	6.6	31.5	5.1	0.9	13.5	5.7	5.5	1.2	3.1	36.5	1.8	0.1
BNIP1	"Nip1, SEC20"	ENSG00000113734	"BCL2 interacting protein 1"	Q12981	5	173144442-173164387	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008009, HPA008149"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA008009: AB_1078291, HPA008149: AB_2667993"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.07e-2)"	9.5	13.0	14.2	6.6	14.2	34.2	11.3	14.5	16.6	8.3	13.3	9.6	8.7	8.3	12.0	10.2	8.9	7.7	11.6	14.2	15.6	12.4	12.6	8.9	10.3	14.9	14.9	8.6	19.3	10.9	12.3	11.3	15.1	9.1	11.0	12.3	8.8	7.0	13.5	8.8	7.9	9.1	14.0	10.1	10.7	14.9	15.3	11.9	10.9	15.8	9.7	10.3	7.8	15.1	18.2	15.9	18.6	23.2	11.2	26.1	20.7	15.0	23.5	31.4	31.3	27.6	24.3	19.4	17.3	22.5	32.7	14.0	24.4	42.6	31.7	31.8	19.5	17.4	10.6	14.6	29.7	28.1	20.9	14.7	21.1	29.0	36.3	14.8	24.2	27.8	17.1	22.8	25.8	42.3	31.3	24.7	8.2	22.0	18.8	20.4	15.0	23.8	18.0	10.9	23.5	14.6	13.3	16.7	33.5	12.9	28.3	22.1	19.4	26.8	20.0	23.4	30.7	17.3	21.8	30.1	24.8	28.5	17.8	0.1	10.1	4.4	16.9	11.4	14.2	10.5	14.5	12.2	12.6	11.6	12.1	11.9	0.4	11.9	9.8	15.6	14.0	10.1	14.2	14.2	14.5	16.6	14.2	15.6	14.9	14.9	15.1	14.0	15.3	15.1	9.3	3.2	11.4	2.9	10.9	11.6	10.0	13.4	5.2	13.5	9.4	9.5	5.8	7.2	9.7	5.5	4.2	24.2	15.4	7.4	27.4	14.7	3.4	11.5	11.6	9.1	7.2	2.5	3.9	12.3	20.2	9.0	10.7	14.0	1.3	12.6	6.1	6.7	15.6	10.1	4.7	13.7	2.0	7.1	4.9	6.6	8.7	7.9	3.6	4.7	10.1	12.4	13.4	5.5	8.3	8.8	7.4	11.7	10.8	12.4	9.5	15.7	9.8	11.2	0.0	6.1	9.0	32.4	11.3	10.8	10.9	30.1	11.5	14.0	11.5	9.4
BNIP2	"BNIP-2, Nip2"	ENSG00000140299	"BCL2 interacting protein 2"	Q12982	15	59659146-59689534	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 131.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026843	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoli	"HPA026843: AB_1845403"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (6.70e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.68e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	49.6	22.4	14.2	41.0	15.8	131.6	30.7	14.7	13.5	28.7	10.6	20.8	16.4	36.9	19.2	30.5	20.5	27.8	47.7	11.9	16.8	19.3	46.5	41.4	48.6	17.2	15.9	31.2	13.9	17.5	10.3	42.7	17.2	26.6	23.2	27.3	20.5	29.4	32.6	20.9	20.3	41.4	16.7	46.5	18.0	22.8	16.2	43.4	18.9	48.8	48.1	41.2	21.2	18.1	39.4	35.9	45.9	37.8	70.8	57.9	40.2	60.3	85.0	54.3	61.9	29.0	18.2	67.9	39.5	87.9	74.4	72.7	48.9	70.1	73.4	49.3	31.1	83.0	52.6	30.8	77.6	107.3	91.7	68.6	71.9	49.4	85.0	51.2	91.1	78.9	48.3	70.8	88.5	22.6	50.5	44.6	41.2	7.7	25.8	55.3	57.5	87.7	56.9	87.3	36.9	50.2	39.5	52.7	104.4	66.4	43.7	112.9	72.2	58.3	71.0	38.0	60.2	52.6	112.7	90.0	46.5	98.1	60.5	50.6	46.6	72.2	29.6	46.9	35.1	31.9	31.1	31.8	43.1	28.9	31.8	32.1	81.5	34.8	40.1	34.5	36.3	43.8	14.2	15.8	14.7	13.5	11.9	16.8	17.2	15.9	17.2	16.7	16.2	18.1	116.7	73.7	44.0	20.2	87.9	86.7	98.8	56.0	70.6	32.5	35.3	29.6	81.9	28.6	43.0	14.7	47.9	64.0	82.6	31.3	37.2	31.5	9.0	41.8	44.5	105.6	15.5	57.7	15.4	26.8	76.8	68.0	46.9	65.8	96.4	31.0	87.8	49.6	91.7	50.5	17.5	24.3	32.6	115.6	106.7	6.1	43.5	125.6	51.6	25.3	120.8	55.3	64.9	20.6	28.2	36.9	22.1	57.2	63.1	75.1	20.0	16.6	45.4	50.2	78.9	56.2	68.1	28.8	32.2	64.4	92.5	193.9	73.5	42.3	19.4	136.8
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 361.5;skeletal muscle: 214.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 544.1;Hepatocytes: 437.4;Proximal tubular cells: 714.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 390.1;hTERT-RPE1: 286.7;U-87 MG: 347.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	49.2	35.0	52.3	8.1	54.9	5.9	35.7	63.6	63.0	30.1	38.1	25.9	7.7	17.4	23.8	30.0	20.5	16.8	92.8	71.2	55.8	63.9	126.4	25.9	10.0	61.5	67.9	82.2	361.5	20.3	36.7	30.0	67.4	40.6	4.8	81.4	46.9	12.8	214.4	36.3	14.9	12.1	55.5	13.7	27.9	15.7	65.8	10.0	23.2	91.4	7.9	28.2	39.4	62.3	390.1	30.7	21.6	60.9	56.7	59.5	110.9	92.7	85.3	68.3	193.2	6.4	8.4	0.7	146.5	53.6	79.5	23.3	46.2	131.4	254.7	20.7	34.9	13.8	19.2	90.1	75.4	17.9	10.6	41.4	32.7	66.6	66.8	286.7	48.1	23.6	36.0	1.4	112.9	31.0	9.2	99.3	18.5	2.7	91.1	21.8	11.0	33.3	75.1	6.4	28.5	66.3	18.9	38.7	54.3	91.1	23.7	24.7	55.4	96.0	32.3	36.4	74.4	63.5	58.1	54.0	347.4	0.9	16.8	4.2	6.3	9.8	16.6	4.2	17.7	11.4	23.4	17.7	5.6	11.6	39.1	26.3	1.5	4.3	6.2	4.3	25.4	16.5	52.3	54.9	63.6	63.0	71.2	55.8	61.5	67.9	67.4	55.5	65.8	62.3	49.3	48.1	56.5	34.3	22.5	29.8	98.3	101.0	34.7	98.2	75.8	63.1	159.2	137.2	43.6	84.6	39.6	173.8	24.7	2.6	301.3	185.1	110.3	84.7	64.4	53.6	81.0	21.5	39.6	87.9	544.1	64.6	27.5	98.1	0.0	107.4	61.4	437.4	79.1	333.1	30.0	10.3	59.0	28.4	20.4	112.1	70.2	28.2	33.8	7.5	28.1	169.2	27.8	16.1	22.8	133.8	9.5	103.4	37.5	140.5	63.5	714.8	72.7	64.6	39.5	53.1	60.0	35.3	100.2	6.5	13.1	247.4	38.4	47.3	5.3	48.9
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26383054-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	130.6	53.4	42.7	37.2	60.4	192.6	77.9	55.6	62.0	63.9	38.9	39.6	22.2	52.8	66.3	48.3	50.5	54.7	63.2	50.0	49.6	79.4	45.4	62.9	39.4	60.7	54.0	119.7	20.1	55.1	25.4	104.5	58.4	44.4	28.2	146.5	44.1	64.4	38.9	71.5	28.4	51.3	46.6	40.7	28.9	68.6	48.8	39.9	41.9	31.7	52.1	48.9	49.5	80.8	90.6	33.8	79.1	53.9	214.5	134.0	66.8	89.0	259.9	81.9	179.6	15.3	42.7	27.7	82.5	169.0	113.4	44.8	39.6	114.5	270.0	17.8	21.8	114.9	32.0	26.9	119.3	10.3	191.1	162.5	89.2	92.9	55.3	269.2	106.2	66.9	52.6	65.0	173.7	39.1	72.7	38.5	26.2	56.7	36.6	38.4	99.9	55.6	85.3	58.3	83.9	74.4	43.2	8.8	70.0	85.9	43.7	21.7	140.4	152.2	64.6	96.2	20.5	93.2	46.0	36.8	232.6	20.6	35.1	334.9	298.3	182.9	39.5	154.8	34.9	68.4	58.4	43.3	166.9	78.0	89.3	65.5	369.0	47.6	104.1	38.0	86.1	239.3	42.7	60.4	55.6	62.0	50.0	49.6	60.7	54.0	58.4	46.6	48.8	80.8	118.3	86.6	157.4	28.7	72.2	98.8	56.0	231.7	82.6	142.5	90.6	85.3	34.0	50.1	126.4	103.0	33.3	33.2	55.6	32.7	49.0	115.4	194.1	173.5	140.8	101.2	120.6	913.9	50.6	39.1	166.5	179.9	38.7	341.2	120.9	96.5	167.0	32.2	132.1	82.4	39.4	46.8	118.0	221.3	300.4	206.7	320.3	233.6	106.7	30.0	165.0	406.4	32.0	29.1	75.8	154.1	39.8	347.5	64.6	83.6	44.0	306.4	107.6	64.0	144.7	59.1	183.9	154.4	110.7	65.4	126.6	162.5	67.0	117.6	27.6	79.3
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"		Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	23.5	0.1	0.0	0.0	4.2	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
BOD1	FAM44B	ENSG00000145919	"Biorientation of chromosomes in cell division 1"	Q96IK1	5	173607145-173616659	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036293	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"HPA036293: AB_10673127"	"unprognostic (2.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.21e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	42.2	41.8	34.1	19.2	36.2	7.6	44.0	33.9	42.6	43.6	35.2	40.4	22.6	37.9	37.9	25.3	35.4	22.8	45.4	33.8	35.7	33.9	29.6	29.2	22.2	35.0	35.0	53.8	48.9	34.8	34.6	34.5	34.4	34.7	24.6	45.5	27.4	29.4	111.7	38.0	24.1	27.9	34.8	25.9	34.5	40.3	36.8	18.8	50.0	78.0	17.7	39.9	35.3	39.6	57.9	60.8	113.5	117.8	98.1	74.8	88.1	50.7	102.1	82.1	132.3	116.0	61.7	39.3	123.4	77.0	201.5	45.8	91.1	124.6	108.6	34.7	72.2	11.5	51.0	106.5	115.8	25.7	15.6	73.9	101.7	54.3	208.6	60.5	69.2	24.6	24.3	25.7	70.2	120.4	38.7	31.1	94.7	64.4	107.0	35.4	58.5	34.5	34.1	55.9	142.2	59.0	38.7	42.8	163.6	95.5	125.7	29.6	53.0	92.1	56.7	73.1	78.5	29.7	34.9	47.6	49.0	37.8	71.5	0.0	2.0	5.6	2.7	2.4	2.1	2.3	2.0	2.4	2.8	2.4	3.8	2.9	0.4	3.5	1.1	3.5	2.3	1.1	34.1	36.2	33.9	42.6	33.8	35.7	35.0	35.0	34.4	34.8	36.8	39.6	56.6	32.1	20.3	7.5	24.2	72.8	50.2	15.0	27.9	41.0	47.7	46.0	41.8	28.6	22.0	9.2	12.5	67.1	20.8	10.2	60.7	38.3	116.0	24.6	52.6	47.1	23.4	7.2	7.0	26.9	83.5	58.5	23.9	28.5	8.8	93.9	28.2	16.6	27.8	53.8	7.9	26.2	20.3	12.0	33.1	141.1	73.0	16.8	33.8	4.7	23.9	61.9	25.7	8.5	10.1	21.9	13.4	59.8	17.4	84.1	19.1	50.4	14.8	39.7	13.1	50.7	46.2	89.7	69.5	30.9	83.5	59.4	19.0	165.5	37.5	47.9
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627725	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	15.9	10.6	11.8	17.6	12.8	41.6	16.2	17.5	15.0	14.3	10.1	16.1	10.8	16.6	16.8	12.8	14.8	12.4	11.9	11.2	14.4	13.5	11.1	12.9	21.8	13.5	12.3	23.0	13.7	22.6	9.1	16.6	13.1	12.3	12.5	22.0	14.5	12.7	11.3	17.7	18.8	11.8	10.6	21.9	14.2	16.7	12.9	25.3	13.7	14.1	20.8	12.7	14.0	15.7	17.6	23.2	22.7	16.3	27.0	28.4	17.4	20.0	21.0	16.3	18.1	17.6	18.7	23.6	8.9	22.0	30.2	11.7	18.7	19.9	31.2	16.3	10.7	33.2	31.0	21.6	16.6	50.5	26.4	22.9	22.1	33.7	25.9	22.3	17.0	16.4	23.8	27.4	20.6	10.5	26.2	33.4	29.2	11.3	19.9	19.8	33.6	9.6	30.6	17.5	13.5	24.6	22.0	7.7	18.2	24.3	9.1	19.3	38.9	25.1	13.2	15.6	26.7	32.3	20.3	29.0	24.6	23.4	20.3	2.5	1.1	2.3	1.1	1.1	0.9	1.3	0.7	0.8	0.7	1.5	1.0	0.8	9.2	0.6	0.7	1.9	0.7	0.4	11.8	12.8	17.5	15.0	11.2	14.4	13.5	12.3	13.1	10.6	12.9	15.7	113.2	83.3	95.8	72.1	93.7	26.3	22.6	17.4	33.0	170.8	39.6	67.8	88.5	51.5	49.7	36.8	89.6	16.5	105.8	31.0	3.9	30.2	20.8	135.4	108.7	68.7	34.7	57.4	56.1	25.3	18.6	60.0	29.6	193.7	63.3	110.1	41.0	32.7	21.5	161.5	62.8	29.1	6.1	41.5	29.0	17.6	50.4	70.9	24.9	56.2	64.1	87.6	57.7	57.8	96.5	33.2	23.8	57.9	68.4	24.8	22.4	7.6	40.0	198.3	46.0	103.4	78.8	83.1	32.1	29.7	28.8	18.6	73.5	106.7	24.3	27.4
BOD1L2	"BOD1P, FAM44C, MGC33608"	ENSG00000228075	"Biorientation of chromosomes in cell division 1 like 2"	Q8IYS8	18	57147087-57150410	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	930	"testis: 276.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 1765.1;Late spermatids: 4911.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036293	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA036293: AB_10673127"					"unprognostic (2.35e-3)"					"unprognostic (3.72e-1)"					"unprognostic (2.47e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	276.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1765.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4911.3	45.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.0	585.3	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BOLA1	CGI-143	ENSG00000178096	"BolA family member 1"	Q9Y3E2	1	149887890-149900798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 49.3;MCF7: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007005	Approved				"Intracellular and membrane"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA007005: AB_1078294"	"unprognostic (5.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.84e-2)"	"unprognostic (8.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.41e-4)"	"unprognostic (3.14e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.93e-3)"	14.9	21.2	8.6	5.8	9.3	3.9	16.1	9.7	17.9	16.1	7.3	24.0	15.3	17.2	0.9	15.7	15.6	3.7	20.5	8.4	8.2	23.0	26.4	10.0	7.0	9.3	8.0	14.5	19.7	5.5	14.4	2.6	8.4	16.8	1.7	1.1	19.3	7.2	23.2	22.5	15.9	2.0	9.2	16.2	20.3	9.9	9.3	5.3	15.8	5.0	1.4	19.0	13.8	10.8	16.4	21.3	2.0	4.2	1.2	4.1	4.0	6.7	1.7	5.0	4.1	15.2	22.0	2.1	16.6	2.8	2.3	17.9	0.0	3.5	0.2	22.8	8.2	1.1	6.1	2.4	7.7	0.0	16.8	3.8	7.3	1.5	0.5	2.0	6.0	49.3	9.1	5.4	2.7	52.9	21.1	5.3	1.3	14.7	6.1	16.4	1.2	4.4	2.3	2.1	13.5	14.8	8.8	14.5	15.9	1.7	26.9	4.5	2.5	6.4	10.5	14.6	0.2	29.5	23.3	0.2	9.0	5.1	6.8	8.6	9.4	12.4	14.8	8.1	15.3	16.2	13.5	11.5	9.9	14.6	18.8	18.1	4.6	9.1	5.2	19.2	18.8	9.3	8.6	9.3	9.7	17.9	8.4	8.2	9.3	8.0	8.4	9.2	9.3	10.8	11.9	3.2	9.5	5.5	10.0	4.5	16.3	19.0	10.8	7.3	23.9	30.5	21.1	34.3	11.2	23.9	4.2	20.2	6.3	12.8	68.4	24.6	8.8	12.1	13.6	13.7	12.6	27.1	2.4	19.8	25.3	16.4	19.4	10.4	5.1	13.9	20.7	40.9	17.0	10.1	3.3	22.8	18.3	12.5	3.5	3.5	15.8	6.6	5.4	1.0	10.3	23.5	19.6	2.5	7.5	15.7	17.6	20.7	18.0	23.1	41.5	57.4	14.2	12.3	39.5	10.9	15.7	22.6	16.2	18.4	6.7	14.0	10.1	22.8	21.2	10.0
BOLA2	"BOLA2A, My016"	ENSG00000183336	"BolA family member 2"	Q9H3K6	16	29443056-29454964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Erythroid cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;HEK 293: 32.4;Hep G2: 22.1;MCF7: 33.7"									"HPA045380, HPA046696"	Supported		Uncertain	Nucleoplasm		NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA045380: AB_2679301, HPA046696: AB_2679757"																		6.6	8.0	0.3	0.8	0.4	2.6	5.8	0.3	0.7	4.6	0.3	9.2	2.4	3.9	0.0	10.2	3.9	0.5	7.0	0.3	0.3	8.6	7.6	6.7	2.0	0.4	0.3	2.2	5.3	0.3	7.9	0.4	0.3	5.1	0.1	0.0	6.6	0.2	6.4	6.6	9.0	0.1	0.3	12.2	8.0	13.2	0.3	0.2	4.9	0.0	0.3	6.6	6.1	0.4	7.0	24.7	0.7	1.3	0.5	0.8	9.2	1.9	0.8	2.3	2.5	12.5	3.2	4.4	9.2	0.2	2.6	4.5	0.4	1.6	0.1	10.2	32.4	8.2	9.4	22.1	1.2	2.8	5.9	0.4	0.7	2.8	0.1	0.2	1.9	11.2	2.6	1.2	0.4	33.7	3.4	6.7	2.9	0.2	18.6	8.0	2.9	8.6	0.5	5.5	3.7	3.3	2.2	4.3	2.0	0.0	1.9	1.3	3.3	5.8	1.6	4.1	3.4	8.4	8.7	7.6	4.2	6.4	3.5	6.0	7.1	7.2	5.0	9.8	6.1	15.3	6.2	6.7	4.4	12.4	5.3	5.3	1.6	4.6	8.2	10.6	8.3	8.8	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.4	0.0	2.7	0.3	0.7	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.3	1.0	0.7	0.0	0.4	0.5	0.4	0.6	0.2	0.0	2.7	0.9	0.8	0.2	0.4	0.0	0.8	1.3	0.4	0.0	0.4	0.2	0.0	1.0	0.3	0.0	0.6	0.0	0.6	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.3	0.4	0.8	0.1	0.7	0.0	0.0	0.5	0.4	0.2	0.4	0.5	0.3	0.3	0.8	0.1	0.3	0.3
BOLA2B		ENSG00000169627	"BolA family member 2B"	Q9H3K6	16	30192932-30194306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045380, HPA046696"	Supported		Uncertain	Nucleoplasm		NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA045380: AB_2679301, HPA046696: AB_2679757"	"unprognostic (2.49e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.02e-3)"	"unprognostic (9.80e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.29e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.91e-3)"	29.1	29.5	84.0	63.6	88.0	98.6	36.8	90.5	115.2	26.3	87.1	84.4	76.2	15.4	30.8	41.3	18.1	26.3	32.4	84.3	88.7	36.4	24.6	27.4	76.7	90.6	87.3	13.7	46.9	69.3	28.6	31.6	88.5	20.6	48.5	8.6	43.4	18.1	44.8	29.5	56.4	21.3	85.2	48.2	54.6	28.2	86.1	58.8	16.9	60.1	59.1	61.1	22.8	91.9	277.0	624.3	120.0	300.3	66.6	93.3	224.4	103.3	111.9	161.0	201.1	317.6	309.1	104.5	304.9	86.7	212.3	174.0	129.9	272.4	63.5	257.0	1029.1	229.0	322.0	937.7	158.6	190.2	270.7	79.6	186.6	307.1	168.3	43.6	204.0	365.9	161.2	359.9	139.3	875.3	292.5	379.3	362.2	275.3	651.2	382.2	143.2	699.6	219.4	272.7	305.0	310.0	59.5	558.5	143.8	42.3	227.1	174.4	112.0	173.6	144.4	259.4	276.8	458.9	353.3	302.1	253.4	303.2	277.1	130.8	178.0	156.5	193.4	226.7	196.8	313.6	191.2	204.6	156.7	245.1	144.6	185.2	31.8	160.2	213.7	254.6	254.0	195.8	84.0	88.0	90.5	115.2	84.3	88.7	90.6	87.3	88.5	85.2	86.1	91.9	4.4	16.0	19.2	0.0	11.7	6.2	3.2	7.5	6.2	0.9	18.3	16.0	107.5	22.8	24.6	23.9	2.1	7.5	11.3	35.7	46.9	14.4	27.8	8.3	4.4	12.6	28.9	5.2	0.0	24.5	5.7	14.1	11.2	8.3	30.3	2.4	16.4	27.1	11.3	1.7	0.0	22.8	8.2	22.0	8.0	31.6	2.5	12.0	7.2	0.0	12.3	7.3	14.4	0.0	0.0	29.6	25.2	1.5	11.0	3.9	51.4	32.7	24.7	2.3	6.6	2.4	11.0	5.7	8.0	5.6	11.2	3.8	14.5	2.7	23.7	4.1
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
BOLL	BOULE	ENSG00000152430	"Boule homolog, RNA binding protein"	Q8N9W6	2	197726879-197786762	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 48.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 178.2;Late spermatids: 129.3;Spermatocytes: 327.7;Spermatogonia: 63.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018678, HPA048813"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA018678: AB_1845411, HPA048813: AB_2680529"	"unprognostic (3.55e-2)"	"unprognostic (1.69e-1)"		"unprognostic (6.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.93e-2)"		"unprognostic (3.20e-1)"		"unprognostic (3.73e-1)"		"unprognostic (1.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.08e-1)"	"unprognostic (9.49e-2)"		"unprognostic (1.77e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	178.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	129.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	327.7	63.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"BORA aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 13.5;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	1.6	1.3	1.2	4.3	1.2	6.0	2.4	1.4	1.7	1.6	1.9	4.2	4.3	1.3	1.5	3.5	1.4	1.3	1.0	1.2	1.3	1.8	1.7	1.8	7.6	1.6	1.3	1.2	1.7	0.5	1.9	2.3	1.5	1.8	5.0	3.5	1.9	1.0	1.1	4.2	3.5	1.7	1.1	4.2	3.2	4.0	1.4	8.1	1.9	0.9	6.8	2.2	2.2	1.5	32.5	8.5	19.6	14.7	2.4	2.4	11.6	9.8	8.6	17.9	18.1	20.6	17.2	23.8	6.4	6.4	10.3	15.0	17.1	11.5	22.1	20.9	12.3	28.7	11.4	15.8	1.7	54.2	17.1	1.9	2.6	8.9	15.1	5.0	14.6	22.8	12.7	10.7	14.6	9.8	20.8	21.8	10.8	36.8	6.0	16.4	12.3	10.6	6.5	10.0	6.9	7.0	12.0	12.8	10.2	15.0	6.4	24.6	4.8	5.8	9.7	8.3	16.3	6.9	7.0	14.8	16.3	24.8	13.9	1.3	1.1	0.5	1.9	1.9	2.3	1.6	1.8	2.0	1.9	1.9	1.6	2.5	0.1	1.8	1.2	1.4	1.9	1.1	1.2	1.2	1.4	1.7	1.2	1.3	1.6	1.3	1.5	1.1	1.4	1.5	1.6	3.2	2.8	3.6	5.4	0.6	1.3	2.2	3.4	1.7	1.4	1.3	0.3	1.5	2.1	1.8	2.1	7.5	3.9	3.1	0.0	1.9	12.6	2.2	2.3	1.4	0.0	13.5	4.3	2.6	11.5	1.7	3.6	2.4	1.3	5.1	1.8	0.4	4.6	8.4	3.1	2.7	0.0	2.8	1.5	2.7	0.9	2.8	0.0	3.7	3.5	1.1	4.1	2.5	7.3	1.7	2.2	1.2	5.2	1.2	3.2	0.8	2.7	2.3	13.1	1.6	1.5	11.8	4.3	3.4	1.1	2.9	4.1	1.5	5.8	1.4
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357078-12471233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.6;T-cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039509, HPA043627"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"HPA039509: AB_2676550, HPA043627: AB_2678588"	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	6.3	8.1	5.1	2.5	7.1	6.2	6.1	5.2	6.4	6.6	2.3	5.8	1.7	5.8	5.8	8.0	5.7	2.4	7.1	4.1	5.8	5.9	8.5	6.5	2.9	5.6	5.4	4.9	7.2	3.8	7.1	2.7	6.2	5.9	2.2	2.8	5.4	1.9	8.4	8.7	4.7	3.0	4.7	6.2	5.9	9.1	5.4	3.1	4.6	3.3	3.9	5.6	6.8	8.2	3.9	4.1	2.9	3.0	6.4	8.7	3.3	3.4	3.9	4.1	5.1	10.0	3.9	4.9	2.0	5.5	2.9	2.7	5.0	4.9	4.4	14.0	4.5	2.7	3.9	5.7	6.1	2.9	3.8	4.9	3.5	5.6	6.5	6.5	4.9	6.1	3.8	6.6	5.4	8.4	4.2	3.0	9.0	4.1	2.6	3.4	4.1	5.3	5.1	2.6	3.6	4.1	3.3	3.0	7.5	9.6	2.3	3.1	4.1	2.7	6.1	3.5	3.1	3.4	3.2	11.1	5.8	4.4	4.6	2.8	6.1	9.5	10.1	10.3	11.9	7.7	11.5	11.2	7.3	5.9	7.6	7.7	6.7	12.4	6.7	5.1	14.2	7.0	5.1	7.1	5.2	6.4	4.1	5.8	5.6	5.4	6.2	4.7	5.4	8.2	11.1	9.6	2.3	0.0	37.9	0.0	11.9	0.0	10.8	16.9	10.5	8.4	0.0	10.0	2.5	7.3	12.5	9.2	42.6	2.2	9.8	9.5	5.6	8.8	9.0	6.7	4.9	5.9	0.0	12.4	11.7	8.3	19.9	8.9	2.5	7.4	6.1	5.1	14.5	13.5	0.0	3.8	0.0	11.0	0.0	3.9	5.3	26.3	0.0	0.0	19.0	12.5	14.4	0.0	0.0	9.5	3.5	7.2	33.0	9.1	10.3	14.1	2.9	16.6	26.3	8.3	8.1	23.4	8.6	14.6	0.0	14.5	39.5	7.5	4.6	8.3
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188345-8190180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		11000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA045415: AB_10964575, HPA060791: AB_2684367"	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	6.4	8.4	9.8	5.0	9.9	4.2	5.7	10.1	10.4	5.7	7.9	8.3	7.2	6.6	3.7	10.9	5.2	2.3	10.1	9.1	8.9	7.7	8.0	5.4	6.7	11.8	10.0	4.1	14.4	6.1	4.7	4.0	10.7	6.2	2.7	3.1	6.2	4.9	15.0	12.5	8.6	2.8	9.8	11.6	8.2	5.5	9.9	5.3	5.7	6.0	4.9	7.1	6.5	10.8	6.3	7.5	2.5	5.1	5.3	3.9	10.0	4.6	5.1	4.4	4.7	4.2	4.2	5.9	9.9	3.7	4.2	9.2	3.9	5.4	1.5	17.8	16.3	4.5	7.0	6.5	6.0	2.7	9.5	4.0	5.7	4.0	4.6	3.9	7.2	8.6	5.1	12.0	2.7	6.7	9.0	7.7	1.8	4.0	8.3	10.6	3.2	8.9	6.1	3.5	3.0	6.9	4.7	3.5	4.2	2.5	5.1	4.2	5.8	2.7	2.4	4.2	5.0	18.0	8.8	2.7	3.9	9.5	3.3	46.4	18.6	50.7	27.8	18.7	22.7	23.5	23.4	29.6	20.9	23.3	22.0	24.9	17.0	28.5	23.1	18.3	23.5	21.4	9.8	9.9	10.1	10.4	9.1	8.9	11.8	10.0	10.7	9.8	9.9	10.8	13.5	9.6	6.4	0.0	21.6	0.0	2.6	0.0	14.2	23.1	9.0	9.5	0.0	11.5	0.6	5.5	6.2	20.4	22.3	12.2	7.9	9.7	2.4	5.6	3.8	10.9	1.2	11.4	0.0	17.7	12.0	4.4	4.1	5.7	3.8	5.2	12.5	9.4	20.9	18.5	0.0	8.6	0.0	21.1	0.0	3.2	5.9	21.5	0.0	0.0	25.6	23.8	45.3	0.0	0.0	11.3	18.3	6.8	18.5	3.5	29.8	10.3	0.0	19.7	32.9	4.3	6.7	9.0	1.3	17.3	0.0	6.2	18.7	9.4	7.5	1.5
BORCS7	"C10orf32, FLJ40752"	ENSG00000166275	"BLOC-1 related complex subunit 7"	Q96B45	10	102854259-102864961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Proximal tubular cells: 208.5;Theca cells: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA037648	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"HPA037648: AB_10673634"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.46e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.08e-8)"	"unprognostic (9.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-3)"	25.4	58.5	20.5	12.8	20.9	23.4	29.8	20.3	25.1	21.3	22.3	19.7	23.2	21.8	23.7	13.4	29.7	22.4	22.3	21.5	23.1	39.8	67.0	23.8	15.1	21.2	21.7	21.8	17.5	53.3	23.7	21.7	21.3	27.2	15.2	20.2	16.9	17.4	28.6	13.9	19.5	16.7	22.5	24.4	20.9	20.2	22.7	14.6	55.3	25.9	12.3	17.4	16.0	23.0	14.9	19.8	23.4	20.7	25.6	35.1	19.5	21.6	44.1	16.3	15.5	13.3	16.6	9.4	11.1	34.6	17.1	12.2	7.9	11.1	12.0	12.1	16.7	21.7	12.5	27.7	29.5	39.4	35.9	44.1	29.8	11.0	17.4	34.0	28.9	13.2	13.0	9.7	26.4	10.9	11.0	16.2	7.9	20.3	18.4	19.8	31.4	13.8	13.6	16.1	6.6	25.5	8.0	14.2	34.7	10.4	27.0	22.2	21.6	13.7	14.6	14.1	15.3	24.9	40.8	11.1	29.0	22.7	5.0	31.3	30.1	22.9	17.3	35.0	19.4	26.5	17.9	18.0	22.1	23.2	19.8	18.4	9.6	27.7	32.9	47.1	19.7	15.1	20.5	20.9	20.3	25.1	21.5	23.1	21.2	21.7	21.3	22.5	22.7	23.0	85.2	54.5	79.6	0.0	49.1	0.0	61.0	0.0	45.5	50.9	94.5	62.9	0.0	48.6	32.2	42.3	39.6	89.6	57.4	18.0	201.5	35.3	21.1	61.1	38.8	67.3	34.0	18.3	0.0	33.3	39.2	60.4	39.8	31.9	34.1	44.2	68.2	74.9	51.7	63.9	0.0	33.4	0.0	49.8	0.0	22.8	42.3	54.1	0.0	0.0	52.1	109.8	53.5	0.0	0.0	28.5	48.5	62.1	28.6	53.8	70.1	208.5	43.7	50.6	39.5	53.3	44.0	80.1	52.4	44.7	0.0	121.5	39.8	209.5	41.0	54.5
BORCS8	MEF2BNB	ENSG00000254901	"BLOC-1 related complex subunit 8"	Q96FH0	19	19176903-19192591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045700	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA045700: AB_10968570"	"unprognostic (4.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.82e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.00e-2)"	12.7	12.4	27.2	11.9	27.1	15.9	8.4	27.1	34.7	6.1	25.3	9.7	11.0	6.5	6.4	11.7	10.8	7.6	17.4	27.2	29.7	13.4	10.7	10.5	12.5	28.0	27.7	5.3	11.0	15.9	20.3	7.6	28.8	10.0	8.7	5.5	9.9	7.9	14.3	8.7	8.1	8.8	25.4	10.1	9.8	8.6	27.2	12.2	12.5	18.0	8.7	10.8	6.3	28.4	21.9	15.4	13.5	14.4	17.8	8.7	22.5	22.4	16.3	25.9	25.7	17.9	26.1	12.9	36.6	22.1	19.1	12.9	12.9	28.5	9.9	12.6	18.9	11.1	23.0	18.0	14.8	17.4	17.8	13.6	15.0	23.2	9.2	11.0	29.7	19.0	26.1	21.1	28.5	38.6	25.7	14.5	9.8	23.3	18.7	10.3	9.9	18.7	27.3	17.1	26.2	14.5	22.4	17.0	15.9	10.0	20.8	17.3	17.0	14.1	14.9	32.5	34.3	15.7	15.3	15.3	16.8	14.0	27.8	45.3	32.4	57.2	14.5	44.9	12.5	27.0	15.4	14.6	22.2	19.6	12.9	13.2	79.9	14.9	45.9	30.1	19.7	20.0	27.2	27.1	27.1	34.7	27.2	29.7	28.0	27.7	28.8	25.4	27.2	28.4	16.6	12.8	21.6	0.0	13.6	0.0	15.4	0.0	5.2	17.0	19.6	18.5	0.0	25.8	7.4	14.7	10.4	31.8	22.5	11.6	43.0	38.0	5.0	25.4	12.1	12.3	10.9	10.8	0.0	32.7	34.9	11.1	13.3	15.7	10.1	11.6	12.1	16.6	41.0	18.5	0.0	9.3	0.0	23.4	0.0	5.2	7.8	24.0	0.0	0.0	37.1	13.2	15.5	0.0	0.0	42.4	9.5	6.8	15.3	14.7	25.6	40.8	13.1	18.3	0.0	11.6	15.0	33.8	23.9	7.4	0.0	39.5	14.0	18.6	9.5	17.2
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145569-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.0;U-266/70: 3.1"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.3	0.4	0.0	1.4	0.3	0.1	0.0	0.5	0.5	0.2	0.1	0.2	0.1	0.5	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.1	2.0	0.5	0.2	1.3	0.1	0.6	0.0	0.7	0.7	0.1	0.0	0.1	1.6	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.0	1.5	0.0	3.1	0.6	1.7	0.3	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.4	0.8	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.5	0.0	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.6	0.0
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646811-134679816	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.3"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 118.2;RT4: 186.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		81000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	11.4	12.6	16.3	9.1	17.1	87.3	12.4	17.9	20.5	12.5	15.8	12.9	8.4	9.6	18.5	26.9	8.5	12.9	13.5	16.5	19.0	35.1	13.1	14.0	11.1	17.9	17.8	7.1	8.4	35.3	18.1	47.0	18.2	13.5	10.0	19.9	17.8	17.9	37.8	10.7	8.0	12.1	19.6	12.5	11.9	14.7	17.7	16.3	11.9	27.0	26.2	39.0	17.2	18.5	14.0	16.3	21.7	29.6	24.3	14.4	21.9	41.3	49.9	15.7	23.2	6.5	18.5	17.1	12.0	23.2	30.9	11.2	23.3	22.7	27.6	118.2	19.9	9.8	15.4	7.8	16.7	18.8	12.4	14.2	20.0	29.7	16.0	24.0	58.0	20.8	28.8	20.9	37.8	6.6	30.7	26.0	22.7	27.7	15.3	23.2	15.5	12.4	36.1	186.8	18.7	31.1	19.3	23.1	21.7	23.1	15.1	11.8	44.7	25.1	6.0	33.7	33.9	33.9	41.2	21.5	43.3	17.7	43.7	61.1	16.4	48.9	23.3	22.2	16.7	19.3	15.0	20.7	17.5	18.9	20.7	21.1	30.2	18.5	23.0	11.4	21.1	23.6	16.3	17.1	17.9	20.5	16.5	19.0	17.9	17.8	18.2	19.6	17.7	18.5	17.6	9.6	25.5	6.5	15.7	39.0	18.5	60.6	10.8	19.2	15.9	18.7	25.0	18.6	52.3	27.6	2.1	44.5	43.0	5.0	129.1	45.9	3.4	10.0	7.0	18.8	13.1	456.6	8.0	18.2	32.7	17.0	4.1	8.5	24.7	6.6	10.0	4.7	15.1	20.2	9.3	4.6	36.7	11.7	10.5	7.2	10.2	11.8	23.2	5.6	15.7	25.6	47.4	7.5	11.6	49.0	4.6	12.0	14.2	26.0	5.5	68.8	50.5	13.5	6.6	12.0	22.1	33.9	21.8	13.5	13.2	368.9	25.0	7.8	4.8	19.2
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 110.4;liver: 84.8"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 99.7;Proximal tubular cells: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		14000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	24.1	15.3	9.4	3.9	9.8	3.5	11.2	9.5	14.5	9.3	11.8	10.6	33.8	7.0	28.8	13.2	11.1	8.9	11.6	10.1	10.8	110.4	84.8	5.2	4.4	9.8	10.2	6.5	11.5	10.8	12.7	5.0	10.7	6.8	9.4	4.2	11.3	4.7	15.5	11.2	32.8	5.8	8.6	3.9	10.0	5.0	9.8	4.8	5.5	12.5	5.9	9.0	9.1	10.8	12.0	13.8	26.8	30.6	22.5	16.2	10.2	7.1	8.7	8.6	11.4	12.4	15.3	18.6	19.7	9.2	21.4	22.1	11.7	8.0	7.6	24.8	10.5	2.7	5.4	21.8	7.9	6.3	1.8	16.9	14.1	6.3	6.0	17.7	15.5	18.8	7.2	3.0	19.9	18.2	14.8	8.3	22.5	21.1	21.9	16.1	17.7	27.9	19.7	30.3	31.7	23.3	13.2	9.0	58.4	39.4	25.6	2.2	7.7	12.5	3.4	13.1	4.9	8.6	27.8	20.4	3.5	4.0	18.4	13.6	9.8	0.0	8.2	12.9	10.9	17.5	9.7	8.4	15.3	12.8	9.1	12.7	0.6	14.6	7.8	8.4	5.4	7.5	9.4	9.8	9.5	14.5	10.1	10.8	9.8	10.2	10.7	8.6	9.8	10.8	15.9	6.4	9.3	11.1	8.2	8.9	8.6	26.0	10.8	11.1	15.1	19.0	4.8	31.5	19.3	16.5	20.9	28.6	5.6	13.6	70.5	28.1	0.5	13.6	14.0	9.1	16.1	6.9	9.3	13.5	32.2	12.2	11.2	8.2	2.5	31.8	6.1	70.9	23.7	16.8	12.8	14.9	38.7	2.2	8.3	1.6	14.9	8.0	32.0	10.3	13.9	12.2	7.2	9.0	4.7	19.6	14.8	13.9	4.5	8.4	99.7	336.3	38.2	6.9	6.6	19.0	12.5	6.8	20.6	13.9	9.2	14.0	7.6	32.9	19.0	8.1
BPI	BPIFD1	ENSG00000101425	"Bactericidal permeability increasing protein"	P17213	20	38304150-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"bone marrow: 1503.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 14.5;neutrophil: 7.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 7.1;monocytes: 14.5"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061284	Enhanced				"Secreted to blood"	NA	NA	7290000	78000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.5	0.2	0.1	0.1	0.2	1503.7	0.6	0.1	0.4	2.6	0.2	0.2	0.0	0.7	1.0	0.1	0.4	0.5	0.5	0.1	0.2	3.4	0.8	3.7	0.3	0.2	0.2	1.7	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	1.4	1.2	0.1	1.8	0.1	0.2	0.2	13.0	0.1	17.1	0.2	3.7	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.1	0.0	0.6	0.0	0.0	9.8	0.1	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.0	0.4	3.7	0.0	0.0	0.0	0.0	9.8	0.0	201.8	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	20.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	220.6	17.7	1.3	1.8	0.0	7.1	0.0	1.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	99.7	0.3	0.0	0.0	0.2	0.4	2.1	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 6.2;lung: 18.3;pituitary gland: 12.1"	"Cell type enriched"	"Detected in some"	6	"Club cells: 1205.8"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 2.0"	"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	NA	NA		1200000		"Cluster 19: Lung - Lung function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	129.5	0.0	0.0	0.0	0.0	0.0	0.0	1205.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	126.1	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.0	80.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1619	"salivary gland: 6860.0"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 649.0"	"Group enriched"	"Detected in some"	4	"lung cancer: 2.6;pancreatic cancer: 2.9;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.0;RT4: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6860.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.2	0.0	145.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	649.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	17.3	0.0	0.0	0.0	8.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5
BPIFA3	"bA49G10.4, C20orf71, SPLUNC3"	ENSG00000131059	"BPI fold containing family A member 3"	Q9BQP9	20	33217310-33227806	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	537	"testis: 53.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 3057.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062708	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA062708: AB_2684843"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	736.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3057.9	14.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	18.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309871	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 566.8;salivary gland: 271.3;stomach 1: 512.5"	"Cell type enriched"	"Detected in many"	5	"Club cells: 5748.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 4.8"	"Low region specificity"	"Detected in many"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		2700000		"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.0	0.1	566.8	0.0	0.5	25.6	0.0	0.0	47.1	0.1	3.4	0.0	0.4	0.0	0.0	0.1	112.5	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	1.2	0.0	0.0	271.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	512.5	3.5	0.0	0.2	0.0	0.0	1.2	8.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	3.8	0.0	0.4	0.0	0.1	0.0	2.2	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	22.7	0.0	0.0	1.3	1.4	614.0	0.0	0.0	2.0	1.3	0.4	2.8	5748.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	63.6	0.4	0.1	1.1	0.0	0.0	0.2	0.2	0.1	3.0	31.1	0.6	3.8	0.0	0.4	0.1	0.2	0.0	0.1	0.0	1021.3	0.0	1.9	82.9	0.3	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.0	2.0	0.0	0.0	1027.4	0.0	0.0	0.4	305.5	5.8	0.8	11.6	0.4	0.1	1.0	0.0	0.0	95.9
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007704-33023703	"Plasma proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"salivary gland: 2294.3"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 6.1;Breast myoepithelial cells: 9.1;Early spermatids: 4.8;Late spermatids: 9.3;Prostatic glandular cells: 7.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	582	"Hep G2: 232.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		36000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.4	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	99.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	1.8	0.0	0.0	2294.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	9.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Late spermatids: 1.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"HEL: 3.7;HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Secreted in other tissues"	NA	NA					"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB6	"BPIL3, LPLUNC6"	ENSG00000167104	"BPI fold containing family B member 6"	Q8NFQ5	20	33031648-33044047	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"salivary gland: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043057	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"					"HPA043057: AB_10796683"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 55.5;Proximal enterocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 183.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		420000	"Cluster 44: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	16.2	20.8	6.5	18.2	7.8	4.6	20.3	7.5	9.1	18.1	7.3	37.7	43.9	13.9	13.0	14.7	17.6	21.2	17.7	7.3	6.8	31.5	25.0	17.6	34.2	7.6	6.8	17.9	7.7	21.5	10.9	13.2	7.1	13.8	32.2	15.5	17.3	11.9	9.3	10.3	45.7	18.3	7.5	14.6	19.7	14.8	6.7	17.7	20.8	11.3	44.3	15.8	9.9	10.0	37.5	30.3	22.1	17.5	40.6	33.3	35.4	48.0	25.0	42.9	38.3	40.1	70.7	183.9	64.8	33.2	19.1	26.1	45.8	42.3	34.5	68.8	51.2	33.3	34.6	48.3	23.8	90.4	29.9	31.8	20.7	61.0	25.3	28.0	35.9	54.1	62.3	18.4	43.4	21.2	51.9	24.3	18.9	32.0	37.1	36.5	62.9	54.0	55.5	49.2	40.2	33.6	60.1	71.5	43.0	22.1	56.5	31.7	54.2	25.4	19.5	36.7	60.8	31.3	81.6	85.0	22.0	33.6	56.8	20.6	9.2	6.1	12.3	10.0	9.4	20.8	12.8	12.7	10.9	16.5	15.0	11.2	1.1	14.0	9.9	13.3	14.6	9.7	6.5	7.8	7.5	9.1	7.3	6.8	7.6	6.8	7.1	7.5	6.7	10.0	9.3	28.9	23.9	3.6	12.7	3.3	12.5	22.0	3.4	13.7	9.1	6.2	10.5	11.5	23.4	14.7	10.4	13.1	11.6	55.5	13.7	18.7	2.5	10.3	7.7	7.7	19.2	5.5	8.4	15.6	14.1	7.8	7.7	9.7	3.8	12.1	7.9	12.6	9.8	6.7	10.8	14.5	32.6	7.5	3.6	3.1	9.6	7.2	10.6	1.9	8.0	10.8	15.5	10.1	13.0	18.9	28.5	13.5	10.3	6.3	56.9	29.5	14.5	12.0	13.1	5.6	8.7	15.5	11.8	8.2	5.1	25.2	9.6	25.0	17.2	12.7
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825503-67984378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	25.5	23.7	24.1	25.4	29.5	32.0	25.5	88.1	26.3	30.3	10.9	27.9	15.7	27.9	28.7	26.6	29.6	19.1	20.7	21.0	38.2	27.9	20.7	22.6	43.7	26.4	21.9	38.1	22.9	27.4	34.6	22.2	24.3	25.2	22.2	44.0	25.2	16.7	25.9	37.5	28.5	19.6	17.6	31.4	23.6	32.1	22.6	52.9	27.4	22.3	39.2	24.4	27.7	34.3	42.2	52.8	76.3	38.7	41.6	39.0	42.2	32.0	29.4	37.1	31.8	49.6	29.0	167.7	22.4	35.4	28.5	32.2	74.4	34.5	60.0	24.2	72.5	64.9	50.4	68.8	19.8	97.3	49.9	28.6	37.3	36.9	27.6	34.0	70.2	52.9	75.1	46.1	32.3	64.0	99.1	47.3	58.9	37.9	47.8	70.3	91.0	33.6	32.5	50.6	56.5	65.6	42.8	117.4	46.4	91.4	49.1	53.7	49.6	56.2	43.7	20.7	39.7	39.3	42.0	97.9	26.9	45.1	22.0	20.3	4.2	8.5	7.2	2.4	5.7	6.2	5.9	5.7	3.0	11.8	6.1	6.3	9.2	10.7	5.7	10.9	4.5	1.6	24.1	29.5	88.1	26.3	21.0	38.2	26.4	21.9	24.3	17.6	22.6	34.3	118.7	115.4	148.2	192.3	130.9	75.2	55.3	37.8	87.0	216.8	76.2	78.5	136.0	61.5	92.0	58.8	143.9	39.4	170.3	64.1	7.9	63.8	26.6	147.7	174.5	108.1	126.1	114.6	124.4	63.1	30.8	94.8	88.2	165.9	121.4	124.9	71.0	46.4	42.2	198.5	136.4	68.9	48.8	56.3	54.4	25.7	108.7	84.7	64.0	109.6	88.0	129.3	146.2	231.8	262.7	65.4	64.5	111.3	129.2	62.1	37.7	17.4	80.8	202.6	65.7	167.3	92.3	144.9	101.3	82.6	75.6	38.7	128.8	126.6	85.8	60.7
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924929	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	8.8	5.8	6.3	5.6	7.7	15.9	8.8	12.5	8.7	8.2	5.4	8.6	4.7	8.3	8.3	7.5	8.0	5.8	7.6	8.3	6.7	7.6	6.6	9.9	6.9	4.0	3.6	9.8	8.3	11.5	9.0	7.2	4.6	8.2	5.4	17.0	7.2	5.9	8.6	10.4	6.9	6.0	3.1	6.7	7.8	13.7	5.2	8.7	10.2	8.4	6.4	9.9	8.5	6.7	6.3	5.2	7.7	9.4	9.1	11.8	12.3	6.8	7.5	5.4	7.6	5.7	6.7	10.8	5.0	7.3	8.4	3.4	6.8	5.5	10.0	9.8	5.4	7.1	5.1	5.2	7.6	11.7	6.8	7.9	6.1	6.0	12.0	8.2	6.6	7.7	11.3	19.1	9.8	3.3	15.6	12.0	6.9	6.2	3.1	10.1	6.5	8.9	5.3	11.9	8.9	7.3	7.9	4.9	7.3	7.5	4.5	7.8	9.7	5.9	4.3	12.9	5.5	21.6	12.9	16.7	9.7	11.3	6.6	1.9	1.0	4.1	1.5	0.9	1.0	1.3	1.5	1.2	0.8	1.1	2.6	1.3	2.0	3.5	1.3	1.0	1.5	0.6	6.3	7.7	12.5	8.7	8.3	6.7	4.0	3.6	4.6	3.1	5.2	6.7	43.4	22.4	45.7	151.1	58.4	21.5	24.6	6.0	23.3	29.7	31.2	21.2	19.8	10.0	18.7	25.8	35.5	15.7	73.5	8.8	7.9	14.3	68.6	50.6	37.4	23.4	19.2	14.9	252.3	9.8	12.9	22.0	21.9	69.2	24.7	45.5	9.3	9.6	9.4	25.2	242.4	9.8	8.2	13.6	37.1	36.5	16.4	30.1	16.0	126.5	14.6	11.3	15.5	206.1	202.6	15.4	8.1	10.1	48.7	23.8	8.0	13.4	20.0	33.0	6.6	24.1	24.7	43.8	26.0	14.5	24.0	75.5	41.4	30.9	8.7	33.4
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685956	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.6	8.8	7.8	7.9	9.2	33.6	9.2	9.8	9.8	8.0	7.3	9.6	9.2	8.8	6.9	9.5	8.5	7.5	9.7	8.1	8.8	8.5	10.0	8.0	10.5	8.8	9.2	9.8	8.2	10.5	6.2	10.6	8.8	8.3	9.2	9.1	8.4	8.3	19.8	12.8	8.8	9.4	8.5	9.0	7.7	67.2	8.4	12.8	9.9	14.0	10.8	9.2	8.1	10.6	14.6	21.1	16.9	19.5	17.7	14.8	28.2	20.0	16.7	22.8	17.5	28.6	10.0	28.0	11.7	19.1	12.9	17.6	23.8	16.4	24.2	18.0	15.4	34.8	12.9	19.4	22.2	30.7	22.5	16.9	22.8	19.7	31.8	19.6	20.0	19.0	36.7	8.9	19.0	18.6	25.7	29.6	22.8	15.4	22.1	23.6	18.4	25.1	15.0	30.3	20.9	15.5	23.5	19.8	19.5	19.3	21.7	19.3	18.8	14.6	13.5	13.3	14.4	22.6	30.9	30.4	13.8	16.8	16.3	22.7	16.8	32.3	17.5	17.5	17.3	16.1	18.5	17.9	15.1	16.5	17.1	17.6	32.7	23.1	14.6	10.9	24.7	16.1	7.8	9.2	9.8	9.8	8.1	8.8	8.8	9.2	8.8	8.5	8.4	10.6	11.6	22.4	11.2	14.7	14.9	11.2	8.9	9.7	12.0	8.9	8.8	7.5	12.7	17.2	10.8	11.0	29.2	13.7	13.7	15.4	5.9	13.5	319.6	11.9	11.6	11.4	9.6	22.9	24.7	7.7	14.9	12.3	15.3	12.4	8.2	13.3	10.4	9.1	10.9	3.3	23.3	12.9	14.2	9.8	11.5	380.1	13.4	11.7	3.6	10.3	19.7	8.6	17.5	13.0	23.3	14.5	12.7	13.5	15.0	13.4	13.5	14.6	13.8	11.8	6.6	11.6	15.1	147.8	38.6	15.4	12.6	22.4	13.5	10.2	11.0	14.5
BRAT1	"BAAT1, C7orf27, MGC22916"	ENSG00000106009	"BRCA1 associated ATM activator 1"	Q6PJG6	7	2537810-2555694	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029455, HPA076508"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029455: AB_10600761, HPA076508: AB_2686803"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (5.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.71e-2)"	17.4	31.0	10.7	6.8	10.9	7.9	17.8	10.4	14.3	22.5	9.6	16.2	8.8	19.4	2.2	15.1	19.2	3.7	14.5	10.4	11.2	15.2	20.7	12.2	7.2	13.5	11.4	21.6	20.2	5.2	19.8	4.5	10.1	24.5	1.3	0.9	17.4	6.6	14.8	21.6	16.6	2.5	10.6	21.1	19.6	31.5	11.2	5.0	18.7	3.7	2.1	17.6	18.8	10.5	35.1	31.1	7.5	27.2	6.8	6.3	24.5	11.7	6.5	10.1	8.5	22.5	21.5	26.3	18.1	7.8	19.4	35.1	8.8	13.7	1.6	10.4	44.4	12.2	23.5	14.3	8.7	16.5	18.2	10.6	9.5	10.2	3.0	5.8	11.4	20.2	39.1	9.6	7.1	50.0	11.8	77.9	35.3	8.8	47.0	28.6	21.9	25.5	6.5	11.3	19.5	30.2	17.1	29.8	12.9	3.5	26.5	33.4	11.8	13.8	43.3	28.5	23.2	20.7	17.3	19.0	15.2	32.8	33.2	5.1	30.8	17.5	21.9	28.2	19.3	18.6	19.8	22.6	32.4	15.2	16.3	17.9	25.4	15.9	27.1	22.7	18.4	22.8	10.7	10.9	10.4	14.3	10.4	11.2	13.5	11.4	10.1	10.6	11.2	10.5	10.1	12.8	6.4	19.9	11.1	7.8	17.5	22.6	16.5	12.8	11.3	8.9	6.8	15.7	14.8	9.2	12.5	21.1	15.0	14.8	15.6	10.6	20.8	7.1	12.3	13.0	11.4	10.3	14.2	13.8	12.9	12.8	26.0	7.5	14.0	34.9	15.4	15.3	34.2	3.3	16.2	14.8	8.2	13.1	6.7	9.4	22.7	13.3	7.2	12.2	17.6	14.4	9.2	13.6	11.3	12.0	12.1	22.2	14.4	9.1	15.0	16.6	8.1	11.9	6.6	9.4	10.7	28.8	39.5	8.0	6.8	14.6	11.9	31.7	17.9	7.6
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"	"Erythrocyte maturation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	11.4	7.3	3.1	8.1	3.0	15.0	10.8	12.0	5.0	12.5	3.6	14.7	11.7	15.8	2.8	12.8	13.7	7.7	7.5	3.4	3.2	5.4	6.9	10.0	9.4	3.2	2.8	16.0	13.2	8.5	11.2	8.3	2.9	8.7	5.8	6.1	12.1	8.0	16.7	23.2	12.0	6.7	1.5	12.0	11.5	30.7	3.2	14.0	10.2	8.9	7.6	11.8	12.3	4.5	12.7	12.7	22.8	12.8	9.2	8.2	19.3	13.7	9.3	14.2	11.1	19.3	8.3	13.3	7.9	11.4	5.2	17.9	14.7	9.8	6.1	13.4	26.6	13.2	20.3	11.8	17.8	30.5	18.2	12.2	15.1	8.3	10.5	10.3	10.4	15.9	15.3	14.3	7.3	20.8	23.0	15.9	15.7	9.4	10.1	33.6	19.9	13.9	5.5	18.2	14.6	25.8	17.6	22.7	18.4	10.5	10.6	24.9	12.9	13.1	14.1	9.9	12.7	16.8	4.3	18.9	9.3	10.7	11.8	0.3	0.6	0.7	0.5	0.2	1.0	0.4	0.8	1.0	0.4	0.7	0.8	1.0	0.6	0.8	2.9	0.9	0.3	0.5	3.1	3.0	12.0	5.0	3.4	3.2	3.2	2.8	2.9	1.5	3.2	4.5	25.9	22.4	27.6	16.3	13.8	15.8	5.7	7.1	8.6	26.6	14.0	14.7	8.4	5.7	12.7	3.7	29.2	6.7	76.8	13.3	0.0	6.7	7.5	32.4	37.1	13.9	16.2	8.2	25.3	9.3	6.6	17.2	14.8	47.7	10.1	28.3	14.3	12.3	6.7	33.7	22.2	13.9	4.1	13.3	14.0	6.7	11.8	15.4	12.4	16.9	11.2	13.8	7.2	19.1	21.9	9.5	8.7	13.9	43.1	9.1	10.6	3.2	11.3	36.1	0.0	25.4	20.1	42.6	19.7	10.7	18.5	10.1	40.6	26.4	11.3	9.0
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968594-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	64.2	61.8	0.8	22.1	2.1	66.5	62.4	4.7	3.8	67.7	0.2	62.1	19.8	71.3	1.8	67.9	66.6	17.4	51.7	3.0	2.8	68.3	61.9	65.3	22.1	1.5	2.4	81.7	80.4	26.3	71.4	19.4	2.1	60.8	11.6	10.1	66.1	18.2	71.4	69.5	60.8	11.7	1.4	71.2	66.0	82.9	2.3	26.9	77.0	10.4	21.2	61.6	65.0	4.0	45.7	19.5	41.6	41.8	31.8	28.5	38.3	44.6	44.4	48.5	35.8	22.7	22.5	37.3	44.6	37.2	32.4	28.1	39.3	33.2	27.7	49.5	147.7	41.2	18.3	14.6	23.5	60.6	39.2	29.2	28.7	38.2	44.9	27.6	21.3	35.2	44.4	76.0	21.7	12.1	77.0	8.5	24.0	28.9	20.4	76.2	18.7	53.8	13.8	26.6	85.6	28.9	54.5	63.7	52.7	27.8	37.4	39.0	27.5	58.6	32.0	21.5	50.0	61.1	69.5	77.9	23.1	19.7	47.8	9.6	7.6	11.6	14.5	8.8	13.0	9.2	9.4	9.9	10.6	8.7	6.6	10.4	9.7	10.3	9.5	8.5	13.3	11.7	0.8	2.1	4.7	3.8	3.0	2.8	1.5	2.4	2.1	1.4	2.3	4.0	325.8	76.9	121.5	38.2	327.1	212.1	232.7	70.0	478.1	78.6	295.5	383.9	171.7	94.4	80.1	60.7	104.3	91.7	395.7	210.7	21.5	69.2	302.4	201.9	149.3	191.2	259.1	97.6	16.1	91.4	145.0	224.2	249.8	256.6	115.2	103.1	113.2	85.3	79.9	55.5	19.9	247.5	77.3	92.6	209.2	177.9	86.9	194.5	124.5	26.2	94.7	62.8	107.1	15.1	22.1	81.2	137.3	77.1	313.0	211.5	133.7	39.5	84.4	65.1	39.5	240.0	251.3	88.4	137.9	365.0	226.9	205.1	356.7	71.2	179.5	248.4
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	10.6	10.3	14.2	7.3	14.7	8.2	10.2	13.0	13.6	12.9	6.4	16.1	7.9	14.6	9.4	8.6	12.5	6.9	9.5	11.6	14.6	7.8	11.0	9.2	7.5	13.9	12.6	11.6	10.7	10.1	9.2	9.0	11.7	11.8	5.6	10.6	9.6	11.6	19.3	12.6	9.6	9.0	10.4	12.4	9.9	13.0	13.5	13.4	11.8	11.5	5.8	11.8	10.3	15.9	8.5	25.3	31.4	24.6	17.1	13.8	28.7	8.4	9.5	9.2	9.3	21.2	13.7	3.2	8.7	7.7	10.4	28.7	29.4	11.7	7.2	20.1	16.5	18.2	29.1	24.1	15.3	24.1	15.7	14.8	14.1	10.6	12.0	14.9	15.2	30.0	16.7	9.3	9.5	28.4	44.9	32.2	42.0	21.9	19.2	32.8	45.3	16.1	13.1	8.9	45.8	42.3	37.7	14.1	10.1	18.7	20.3	39.6	19.5	22.3	12.3	14.6	7.6	5.0	5.6	3.0	11.2	16.4	15.1	6.6	12.9	15.8	11.4	10.1	9.6	6.9	9.1	10.2	12.9	6.7	8.6	9.1	15.0	16.3	8.6	17.1	4.6	9.4	14.2	14.7	13.0	13.6	11.6	14.6	13.9	12.6	11.7	10.4	13.5	15.9	27.6	32.1	21.9	13.1	18.3	32.4	21.2	19.8	42.1	60.9	32.8	24.3	24.3	28.6	25.7	23.9	37.5	26.0	31.8	22.6	19.6	42.7	49.2	22.9	37.9	32.1	54.0	70.1	13.4	24.4	20.5	32.4	21.9	25.3	15.9	53.2	35.7	34.0	18.7	57.2	16.8	26.6	14.2	27.9	22.8	20.7	57.2	33.6	23.2	10.3	33.6	45.6	30.9	12.5	19.3	27.7	21.4	67.4	9.1	51.0	19.2	15.7	20.1	58.0	59.2	55.8	40.0	20.7	53.1	31.9	35.7	32.7	26.4	178.7	30.8	22.3
BRD4	"CAP, HUNK1, HUNKI, MCAP"	ENSG00000141867	"Bromodomain containing 4"	O60885	19	15235519-15332545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015055, HPA061646, CAB068177, CAB068178"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575"	"unprognostic (2.83e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.53e-3)"	"unprognostic (3.03e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.98e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	24.4	24.4	16.1	23.3	16.1	24.3	23.8	8.5	34.0	26.9	3.2	26.1	14.1	25.9	8.3	27.7	23.5	12.9	30.6	14.5	17.3	24.4	32.7	27.7	20.8	11.5	12.8	30.2	26.8	13.4	20.9	29.4	9.2	24.8	8.5	12.1	22.9	13.6	62.7	33.7	25.5	13.2	2.8	28.7	22.4	24.7	10.3	16.9	24.1	19.1	15.8	25.2	26.7	15.2	46.7	49.1	31.0	58.6	26.4	20.1	32.5	32.5	29.3	28.3	29.6	47.1	71.4	58.5	48.4	36.5	27.6	47.1	30.8	32.4	24.0	51.3	21.4	58.0	41.1	43.7	42.2	53.2	59.7	29.4	34.6	35.2	68.7	18.1	26.1	41.5	91.7	62.7	18.3	55.5	53.6	41.6	58.5	23.4	54.2	63.8	32.5	37.5	22.3	48.8	35.3	31.1	44.7	34.5	40.5	24.4	33.7	38.3	45.0	72.5	32.6	63.3	53.0	43.9	39.0	25.7	39.7	47.0	58.5	3.4	2.2	2.2	2.1	2.8	1.6	3.6	1.8	1.8	1.4	4.3	1.8	1.7	6.5	3.1	2.8	2.6	1.5	1.6	16.1	16.1	8.5	34.0	14.5	17.3	11.5	12.8	9.2	2.8	10.3	15.2	85.9	64.1	52.7	26.8	97.9	117.6	118.4	33.9	80.8	67.0	71.8	54.7	79.5	58.6	33.9	25.8	83.4	219.8	91.6	93.9	25.4	53.6	130.3	83.1	102.6	84.7	113.9	117.0	46.3	67.1	72.4	75.9	56.1	128.2	36.7	95.2	64.6	84.9	60.5	79.1	44.2	71.5	16.2	83.4	101.0	249.3	77.3	87.7	44.4	48.7	72.8	37.0	63.8	28.6	39.3	65.3	62.6	79.7	77.4	137.3	50.7	35.2	30.2	84.2	72.3	103.1	92.0	52.6	48.8	84.7	143.2	254.3	77.4	65.9	71.8	147.0
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368988	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	32.6	34.1	50.8	33.6	55.8	65.9	36.0	53.4	69.4	36.0	49.2	42.8	31.1	36.8	47.0	49.3	34.3	26.7	36.4	49.5	55.3	40.3	30.6	35.3	46.6	55.4	53.4	33.3	47.8	56.0	30.8	43.1	54.8	32.7	38.5	49.6	35.0	33.1	54.4	43.4	35.1	34.5	52.4	37.4	39.5	57.0	53.3	57.2	40.1	44.3	50.0	35.5	35.6	57.6	78.4	67.8	116.4	69.7	48.2	47.7	76.6	62.8	61.7	96.9	43.8	114.3	77.5	116.1	64.2	56.0	60.4	70.7	107.6	63.3	111.1	53.2	89.1	79.0	54.2	159.2	56.7	110.0	83.5	34.9	93.2	49.9	85.5	58.8	65.6	113.0	115.8	36.2	59.9	51.0	125.2	147.0	91.5	82.0	63.5	151.8	109.2	84.8	85.6	54.5	90.0	73.1	76.3	73.2	53.6	99.0	43.9	98.5	66.8	61.3	74.4	51.0	62.0	17.0	7.1	196.9	48.1	78.5	62.2	6.2	5.1	7.6	6.4	4.4	4.9	6.1	6.4	6.0	4.1	6.2	7.1	8.7	2.9	9.8	4.1	8.5	6.9	3.0	50.8	55.8	53.4	69.4	49.5	55.3	55.4	53.4	54.8	52.4	53.3	57.6	73.7	38.5	64.4	16.0	54.6	50.7	41.1	16.9	20.5	89.0	63.4	63.8	35.7	52.9	29.6	49.7	66.7	70.6	124.6	51.1	107.6	22.3	47.4	75.1	62.9	42.0	36.0	76.4	14.6	23.0	49.5	41.3	40.2	89.1	15.2	84.3	38.6	45.8	29.9	90.9	15.8	46.6	20.3	40.3	24.5	22.5	32.6	45.9	26.6	17.8	38.4	81.2	82.4	30.2	32.7	23.9	36.4	28.2	74.2	62.2	32.0	72.3	36.7	120.6	52.6	78.4	46.5	203.6	157.2	44.8	63.2	72.4	55.7	59.3	46.1	66.6
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139770-138178953	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 120.8;Spermatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	21.8	21.5	23.4	15.4	24.2	22.4	25.1	27.4	28.5	30.1	21.5	30.5	15.5	28.4	41.3	23.5	26.6	16.4	19.5	22.0	23.4	25.0	25.4	19.5	20.6	21.5	21.1	32.7	30.6	26.2	46.6	24.9	22.2	27.3	24.8	38.7	25.1	23.9	27.8	23.6	23.3	25.1	20.8	27.6	24.9	83.1	22.7	38.0	34.3	25.1	22.1	24.3	24.8	29.6	28.7	36.8	63.1	101.8	45.0	42.0	57.0	43.4	47.9	61.6	64.4	55.4	62.6	28.6	42.2	40.3	62.9	32.9	67.4	41.5	65.9	50.3	50.1	38.5	93.6	38.0	25.0	23.6	39.2	31.4	27.2	48.7	44.1	49.3	39.7	52.2	35.2	35.8	41.3	31.8	48.4	37.6	28.6	32.9	18.8	46.4	52.2	35.1	41.4	41.3	55.7	27.9	51.9	22.4	40.1	85.0	38.5	43.2	25.0	30.2	34.7	21.2	38.1	31.5	37.9	39.1	23.1	34.7	28.5	16.2	10.8	14.1	14.6	8.0	15.8	10.7	12.7	13.2	12.0	11.0	15.9	16.0	20.2	23.8	8.8	8.4	13.0	9.8	23.4	24.2	27.4	28.5	22.0	23.4	21.5	21.1	22.2	20.8	22.7	29.6	21.0	25.6	38.3	28.1	17.8	6.9	10.6	16.4	31.9	33.7	19.8	20.3	44.8	14.3	27.0	27.6	37.5	27.7	19.0	17.0	19.6	19.5	120.8	30.1	51.1	24.3	31.2	26.5	26.2	12.4	13.2	32.5	20.9	29.7	24.0	43.2	13.6	17.2	11.9	30.3	23.7	23.3	14.2	14.8	9.8	43.9	31.4	14.3	24.9	12.2	31.3	27.1	19.6	27.6	30.8	16.0	16.8	24.0	21.8	18.1	15.4	22.4	29.0	34.9	26.3	23.2	31.7	226.9	65.0	23.2	7.0	25.3	19.1	41.9	18.6	10.1
BRD9	FLJ13441	ENSG00000028310	"Bromodomain containing 9"	Q9H8M2	5	850291-892801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021465, HPA023197"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021465: AB_1845441, HPA023197: AB_2671106"	"unprognostic (3.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.61e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (5.88e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.53e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.37e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.02e-2)"	7.7	7.4	14.3	9.1	14.2	8.1	8.5	13.0	15.0	6.9	12.6	7.3	6.8	8.6	7.3	6.6	7.4	5.9	10.5	13.2	12.7	5.8	5.5	7.8	10.0	15.0	14.1	8.8	8.7	9.0	4.5	6.9	13.5	6.6	7.0	3.6	8.8	8.2	16.9	6.8	7.6	7.9	13.5	8.0	7.9	7.5	15.1	13.2	8.0	9.9	8.5	8.6	6.0	14.7	14.4	14.2	27.5	28.6	11.7	23.7	32.5	28.2	19.4	29.7	23.5	26.6	19.5	17.9	46.0	30.4	33.3	14.1	20.4	27.7	27.5	110.2	17.0	22.2	37.0	17.9	23.7	34.0	20.3	17.7	9.9	20.8	19.0	22.1	29.6	34.2	29.5	12.8	25.4	22.9	40.0	32.1	18.5	15.0	22.4	26.9	16.4	16.5	17.2	21.5	16.8	29.7	56.3	19.1	13.4	14.9	17.1	43.1	28.7	24.2	18.8	12.4	29.3	23.3	10.0	32.5	22.7	35.5	32.3	7.0	3.3	3.7	3.0	1.5	4.0	4.9	4.2	4.5	3.0	6.0	3.8	3.2	2.0	4.2	2.9	3.1	5.2	1.4	14.3	14.2	13.0	15.0	13.2	12.7	15.0	14.1	13.5	13.5	15.1	14.7	36.8	19.2	14.4	13.1	32.1	25.4	18.2	12.5	39.3	70.2	23.5	21.7	25.2	25.8	13.8	23.9	45.9	17.1	39.5	33.9	23.5	23.4	93.5	46.7	80.7	25.0	16.3	21.0	9.3	20.0	30.3	24.0	42.8	52.7	19.0	40.9	27.8	22.2	21.0	101.0	8.2	33.9	4.1	25.4	14.9	56.8	22.7	25.3	14.2	6.5	31.3	29.1	42.2	9.0	11.8	31.1	27.4	19.5	44.8	20.6	21.3	18.7	7.7	87.8	26.3	28.5	25.0	49.2	68.2	32.0	20.3	19.7	47.8	27.1	27.6	16.5
BRDT	"BRD6, CT9"	ENSG00000137948	"Bromodomain testis associated"	Q58F21	1	91949343-92014426	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"testis: 131.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1313.5;Spermatocytes: 561.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	30	"BEWO: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB012237	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB012237: AB_304756"	"unprognostic (5.00e-2)"	"unprognostic (2.86e-1)"		"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"		"unprognostic (5.25e-2)"		"unprognostic (2.53e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.22e-13)"	"unprognostic (2.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.00e-3)"	0.0	0.0	0.3	0.5	0.5	2.7	0.3	0.8	0.7	0.1	0.5	0.1	0.4	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.2	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.1	131.4	0.6	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	21.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	0.3	0.2	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.3	0.1	0.2	0.1	0.2	0.3	0.5	0.8	0.7	0.5	0.3	0.5	0.1	0.4	0.1	0.6	0.9	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.6	0.0	0.0	0.0	0.0	38.0	1.7	0.0	0.0	0.0	1313.5	0.0	0.0	1.8	0.0	0.0	1.2	0.0	22.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	0.0	228.7	7.8	0.8	0.0	0.0	0.0	0.0	1.0	1.0	0.3	0.0	0.0	6.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	561.9	19.9	0.0	0.0	19.4	1.1	0.1	0.0	0.1
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1 RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	10.5	11.4	19.7	5.5	22.2	6.5	10.5	23.1	23.6	12.5	12.9	11.1	7.6	12.1	4.2	10.4	12.8	6.0	12.2	17.1	19.2	11.6	13.1	8.4	8.1	31.8	24.9	13.0	15.1	10.3	20.4	6.0	29.7	12.0	4.2	7.5	10.1	6.3	17.7	11.2	10.3	4.6	18.7	12.6	11.2	14.6	25.4	7.3	10.5	9.6	5.8	11.5	9.9	37.4	12.6	28.0	11.8	25.3	10.3	11.4	11.9	17.4	11.2	15.4	12.2	20.2	18.8	9.4	16.9	12.0	7.5	24.2	14.4	11.7	8.4	25.2	14.2	11.5	15.1	9.9	11.5	13.7	24.3	11.3	10.1	9.3	11.5	7.8	11.3	19.7	13.1	7.5	7.6	40.9	16.2	17.1	8.6	20.7	27.7	28.2	8.1	9.6	7.6	29.9	37.5	27.8	18.4	14.0	16.0	5.4	33.4	18.9	16.8	12.1	9.6	22.7	14.2	13.8	11.5	8.9	14.5	11.3	16.9	0.4	1.2	2.0	1.6	1.0	1.1	1.5	1.1	1.6	1.2	1.4	1.4	1.3	0.5	2.5	4.0	3.1	1.6	1.6	19.7	22.2	23.1	23.6	17.1	19.2	31.8	24.9	29.7	18.7	25.4	37.4	11.5	3.2	5.9	17.6	11.4	7.5	7.1	4.5	8.6	18.8	10.7	9.0	8.5	2.8	6.3	3.7	16.7	11.4	15.5	16.2	3.9	5.8	2.3	26.5	10.9	9.5	9.6	6.3	18.3	7.1	8.9	7.7	14.8	16.5	2.5	16.0	8.9	11.3	7.2	30.3	20.8	11.7	4.1	6.7	10.3	1.4	6.5	7.8	8.8	10.3	5.3	7.1	4.1	15.1	34.2	4.8	6.5	4.5	13.4	7.7	8.9	6.1	12.4	20.0	0.0	9.6	8.2	9.2	12.7	7.7	8.8	9.3	11.6	13.2	12.5	5.1
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2 RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849861	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.0	8.0	6.6	4.6	7.2	14.3	11.0	6.6	7.6	15.2	6.4	11.3	4.1	12.6	6.3	8.2	11.9	4.6	10.8	7.8	6.7	9.8	7.9	7.6	6.7	6.9	7.1	12.8	8.4	6.5	9.7	7.6	7.7	13.7	5.3	5.9	7.9	7.0	28.5	11.2	7.7	5.7	6.6	9.8	8.9	7.8	7.1	11.0	7.2	12.8	5.4	14.0	10.7	7.4	13.1	9.9	9.6	12.4	13.0	9.5	11.2	15.1	12.0	20.1	13.7	12.9	9.2	16.0	21.3	9.6	7.6	13.3	12.5	9.5	10.0	10.0	12.5	19.7	8.3	10.6	13.6	7.9	11.3	12.8	12.3	20.1	8.5	9.8	6.6	14.0	24.6	13.9	6.6	7.5	25.2	9.9	16.1	9.6	13.1	14.7	10.4	8.1	7.4	8.7	8.1	9.7	7.1	10.5	18.3	11.6	22.1	15.0	8.8	10.0	13.7	25.5	15.4	16.5	24.8	18.8	14.5	10.3	18.2	13.9	10.1	11.7	13.5	9.5	13.7	14.2	14.3	13.8	7.9	14.9	20.3	16.6	4.2	20.0	8.7	9.5	13.7	11.7	6.6	7.2	6.6	7.6	7.8	6.7	6.9	7.1	7.7	6.6	7.1	7.4	6.9	12.8	4.8	2.0	4.2	4.5	4.2	6.4	0.6	9.8	6.9	7.5	0.3	7.2	4.7	9.2	0.0	22.6	6.2	5.5	7.9	8.7	0.4	14.2	7.9	7.8	6.6	8.6	3.3	11.0	10.4	8.1	5.6	24.7	2.5	8.6	6.8	2.1	11.6	8.4	3.1	8.6	8.2	7.1	5.4	1.4	9.3	3.9	3.6	1.0	7.1	11.4	10.3	2.5	2.3	6.5	2.2	10.5	7.2	4.3	9.3	5.8	7.1	6.9	6.6	5.5	7.5	12.5	12.4	4.6	3.8	14.1	7.5	11.5	7.2	3.0
BRI3		ENSG00000164713	"Brain protein I3"	O95415	7	98252379-98310441	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042215	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA042215: AB_10794790"	"unprognostic (1.51e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.08e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (2.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.71e-1)"	132.7	159.3	42.2	37.0	45.0	94.8	102.2	42.8	46.2	88.3	50.0	94.0	67.6	80.1	31.7	63.6	72.1	45.3	150.6	36.4	42.0	122.6	179.4	167.3	32.9	46.4	44.2	73.9	127.4	24.1	98.5	69.1	44.3	84.6	35.8	10.8	93.5	26.4	237.0	82.1	81.2	33.6	41.6	122.4	133.1	53.2	56.6	14.1	78.8	65.1	18.3	99.3	69.4	46.0	130.5	20.6	36.6	47.3	231.8	104.0	86.6	105.1	122.4	86.6	114.5	17.1	60.0	13.6	220.3	191.8	275.6	45.5	46.9	66.7	59.9	46.5	53.4	8.7	15.0	29.9	228.2	10.0	43.3	85.7	95.3	74.2	135.2	119.8	107.6	15.9	26.6	84.2	164.4	9.1	32.1	32.9	44.1	87.8	55.3	30.8	20.2	43.7	83.2	9.3	30.6	62.3	27.7	114.4	279.2	63.2	12.2	64.0	108.4	175.1	103.4	228.1	82.6	91.5	128.3	35.9	199.5	44.4	91.8	2.5	15.0	24.2	0.9	25.3	1.3	0.9	0.9	1.0	7.0	1.1	1.5	1.3	42.8	0.2	24.0	10.3	3.0	3.1	42.2	45.0	42.8	46.2	36.4	42.0	46.4	44.2	44.3	41.6	56.6	46.0	354.9	83.3	120.3	18.3	52.8	146.3	278.2	24.1	47.3	90.6	191.1	277.6	121.9	204.5	37.4	134.3	33.3	122.9	118.4	193.5	569.4	62.1	680.8	176.9	149.2	223.9	78.5	49.0	13.8	119.5	431.4	161.6	122.3	192.0	22.8	140.8	238.1	258.0	695.0	129.5	17.8	161.9	26.4	482.9	329.4	132.1	100.3	503.0	167.2	20.6	167.5	291.4	28.8	15.1	26.6	82.4	234.2	121.5	37.4	416.5	261.5	670.8	35.8	84.2	111.7	166.2	145.6	61.6	58.5	59.0	171.5	169.4	48.7	131.3	154.6	473.3
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993645-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 20.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 174.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 114.9;U-698: 161.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.3	2.0	9.2	8.9	10.7	5.5	5.5	8.2	10.7	3.0	7.1	15.5	20.8	2.1	2.2	6.8	4.1	4.8	2.5	9.2	7.9	6.9	4.8	2.8	13.8	9.6	9.7	1.5	5.1	9.1	2.1	2.1	10.2	2.9	15.3	10.0	2.5	2.2	1.7	5.5	18.8	2.6	9.1	5.9	8.2	1.8	9.1	7.0	4.4	2.1	16.2	2.5	2.6	9.4	34.1	43.8	13.8	12.5	10.9	5.6	24.1	22.2	4.6	13.7	7.1	36.1	22.3	114.9	27.8	5.0	8.9	38.7	30.7	17.3	10.9	26.9	25.5	58.4	16.9	24.8	2.2	86.8	72.2	2.5	9.9	15.0	7.1	5.3	5.1	41.0	23.5	8.0	12.0	31.3	45.1	33.3	9.9	29.9	17.3	30.2	23.0	30.7	17.3	46.8	19.0	13.2	27.6	26.9	9.2	4.6	48.8	60.8	5.9	13.0	16.2	12.5	23.4	26.9	49.7	161.8	11.9	28.7	29.1	4.2	2.2	13.1	0.8	1.6	0.8	1.4	0.6	0.7	1.7	1.5	0.5	0.7	2.2	0.9	1.2	4.2	0.7	0.6	9.2	10.7	8.2	10.7	9.2	7.9	9.6	9.7	10.2	9.1	9.1	9.4	3.4	9.6	10.4	13.4	23.6	12.2	9.1	8.2	5.2	37.1	14.9	6.3	7.2	31.5	9.2	9.2	14.6	15.4	24.3	65.5	3.9	9.1	25.6	16.1	7.2	5.1	7.8	21.5	32.6	10.4	24.0	7.1	32.1	18.0	18.4	7.2	4.2	27.4	19.8	25.2	43.8	42.8	8.2	31.5	26.1	174.4	1.2	23.6	10.6	11.2	28.8	12.1	9.2	11.1	23.4	17.1	43.3	4.1	39.5	9.6	60.2	12.7	15.0	27.9	0.0	9.2	6.9	1.1	11.5	20.7	18.3	5.2	11.5	6.8	72.6	9.7
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369435	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.5"	"Group enriched"	"Detected in some"	8	"Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	0.1	3.8	28.8	0.0	23.3	0.0	2.4	20.5	43.5	0.5	0.0	0.2	0.2	0.7	4.9	0.6	0.0	1.4	1.8	35.7	17.8	1.7	0.6	1.9	0.0	9.6	20.6	0.1	0.0	0.0	1.6	0.0	16.8	1.5	0.1	5.3	0.7	5.2	0.3	0.1	0.6	0.1	16.0	0.3	0.2	0.5	27.7	0.8	0.3	0.1	0.0	0.3	0.2	18.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	17.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	7.4	3.2	0.0	0.0	0.0	6.0	0.6	0.0	0.0	1.1	1.8	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	23.3	20.5	43.5	35.7	17.8	9.6	20.6	16.8	16.0	27.7	18.8	0.1	0.0	0.0	178.9	0.0	0.0	0.5	0.5	0.0	8.7	8.1	4.2	0.9	0.0	0.1	0.0	25.0	0.1	0.0	0.3	0.0	0.0	2.1	0.5	15.9	0.5	2.4	0.0	285.7	0.0	0.0	0.4	0.0	0.4	0.0	0.2	2.9	0.0	0.3	1.7	163.4	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	8.4	0.0	1.6	0.0	204.6	4.9	0.1	0.0	0.4	0.0	0.4	0.0	23.9	0.0	2.6	0.0	0.0	0.4	1.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177170958-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.6;brain: 19.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 121.1;Excitatory neurons: 116.8;Inhibitory neurons: 148.3;Oligodendrocyte precursor cells: 96.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.7;PC-3: 1.3;REH: 2.1;SCLC-21H: 5.6;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.6	9.6	17.2	0.0	16.5	0.0	0.9	1.3	19.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	17.9	10.7	0.0	0.1	0.0	0.0	4.5	9.6	0.0	0.0	0.0	4.2	0.5	4.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	2.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	16.5	1.3	19.9	17.9	10.7	4.5	9.6	4.9	4.9	16.2	13.4	0.0	0.0	0.0	121.1	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.2	0.3	0.0	0.0	0.0	116.8	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.1	15.2	148.3	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	25.3	0.0	0.5	0.0	96.5	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0
BRINP3	"DBCCR1L, DBCCR1L1, FAM5C"	ENSG00000162670	"BMP/retinoic acid inducible neural specific 3"	Q76B58	1	190097658-190478404	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1;intestine: 17.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 266.7;Excitatory neurons: 333.7;Inhibitory neurons: 129.7;Oligodendrocyte precursor cells: 1079.2"	"Group enriched"	"Detected in some"	14	"breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054693	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054693: AB_2682575"	"unprognostic (3.18e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.40e-1)"			"unprognostic (1.72e-1)"			"unprognostic (8.25e-2)"	"unprognostic (3.65e-1)"		"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.58e-3)"	0.3	1.7	19.8	0.6	16.8	0.0	1.4	18.7	19.2	0.2	0.0	6.6	4.6	0.2	3.0	1.7	0.4	1.6	5.3	27.1	25.8	2.3	0.0	1.2	0.0	12.5	15.7	0.0	0.0	0.0	0.2	0.0	12.4	6.8	6.7	0.7	1.6	5.1	0.1	0.1	17.9	0.6	13.1	0.0	0.2	3.4	26.0	0.1	2.1	0.0	0.1	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	16.8	18.7	19.2	27.1	25.8	12.5	15.7	12.4	13.1	26.0	10.4	0.0	0.0	0.0	266.7	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.4	2.3	0.0	0.0	3.7	0.0	0.0	0.0	2.0	3.9	0.0	63.3	0.0	0.0	0.1	1.2	0.0	333.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	129.7	2.8	0.0	0.0	0.0	10.5	0.0	0.1	0.0	8.4	0.0	0.0	0.0	1079.2	4.3	0.0	10.8	0.0	0.0	1.0	8.1	0.3	0.0	0.1	0.0	0.0	5.8	2.0	0.7	0.1	0.0	0.0	0.0	0.0	5.2	0.1
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
BRME1	"C19orf57, MEIOK21, MGC11271"	ENSG00000132016	"Break repair meiotic recombinase recruitment factor 1"	Q0VDD7	19	13882348-13906452	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.2"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044012, HPA054615"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA044012: AB_10964782, HPA054615: AB_2682543"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.14e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.60e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.21e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-2)"	1.4	0.8	1.9	0.8	2.0	1.9	2.3	3.8	2.8	3.3	1.4	3.7	3.2	1.3	1.4	6.0	2.3	0.4	0.8	1.9	1.5	1.3	1.9	1.1	0.7	2.2	1.7	2.3	6.9	0.6	1.4	0.4	2.0	2.4	1.2	1.7	2.4	0.7	0.9	6.1	5.6	0.5	1.5	1.2	1.7	18.2	1.7	0.4	1.2	0.2	0.8	1.7	4.5	2.7	5.9	0.1	4.3	2.4	1.2	0.2	2.8	1.6	0.6	1.9	1.8	3.7	0.8	6.5	8.9	0.7	1.1	2.9	1.3	0.5	0.6	1.0	2.8	2.8	2.7	0.1	0.3	1.4	5.9	0.2	0.4	1.2	0.2	0.3	0.4	3.5	1.9	2.5	0.6	1.9	5.3	3.0	0.6	2.0	4.4	5.8	1.6	0.3	0.7	1.4	3.8	1.4	6.3	1.1	1.8	0.3	1.2	1.3	0.0	3.5	1.9	8.0	0.4	4.5	1.0	3.5	2.1	4.5	5.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.2	1.9	2.0	3.8	2.8	1.9	1.5	2.2	1.7	2.0	1.5	1.7	2.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0
BRMS1	DKFZP564A063	ENSG00000174744	"BRMS1 transcriptional repressor and anoikis regulator"	Q9HCU9	11	66337333-66345125	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010824, HPA019637"	Approved		Approved	Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"CAB010824: , HPA019637: AB_1845448"	"unprognostic (1.75e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.54e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-1)"	27.2	28.1	25.3	24.1	27.0	52.2	27.1	27.2	28.5	22.0	26.9	28.9	26.0	20.5	17.5	36.7	20.0	18.0	26.0	26.6	25.4	35.0	29.1	25.0	32.2	27.4	27.1	19.9	40.9	19.3	17.9	19.5	26.8	33.9	19.2	9.1	30.5	18.3	38.0	41.5	29.6	13.1	26.5	38.3	31.6	31.5	27.1	28.7	26.5	13.8	25.6	25.1	25.8	28.0	80.3	102.4	33.8	56.6	35.1	36.1	47.8	54.4	58.9	95.9	63.9	84.1	51.2	53.5	78.9	53.8	82.5	91.7	64.9	99.2	45.0	63.9	53.9	49.2	54.2	62.1	65.1	71.3	54.9	41.2	104.5	97.0	72.2	29.1	59.9	60.1	59.0	24.3	58.0	128.9	87.5	169.1	73.3	61.2	95.3	73.2	62.2	100.0	60.1	45.6	70.8	57.0	67.2	68.6	180.9	24.6	83.5	43.7	58.2	71.9	68.2	117.1	68.8	50.2	53.8	85.3	93.0	46.2	78.8	45.6	79.4	80.8	61.1	77.3	65.1	79.2	65.2	58.6	62.4	75.6	56.3	54.3	104.2	51.3	69.9	67.3	79.9	67.3	25.3	27.0	27.2	28.5	26.6	25.4	27.4	27.1	26.8	26.5	27.1	28.0	27.2	16.0	26.9	4.2	42.7	58.1	28.5	45.0	33.6	12.3	31.7	27.6	11.7	40.0	22.6	22.0	6.2	61.5	37.1	109.0	54.8	72.6	7.4	25.6	16.6	30.8	32.3	33.7	2.9	117.9	68.5	22.9	33.1	18.6	27.8	21.4	28.2	21.5	67.6	11.8	2.2	54.0	32.6	51.3	41.7	9.9	22.4	39.1	28.4	5.6	68.3	31.7	56.7	3.0	5.1	85.7	85.6	14.7	30.5	40.6	80.5	51.1	22.2	14.9	6.6	23.1	27.3	35.8	39.4	32.2	60.0	71.7	42.5	21.1	61.3	29.8
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"BRMS1 like transcriptional repressor"	Q5PSV4	14	35826338-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA046623: AB_2679724"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (6.87e-6)"	6.2	10.1	8.3	3.8	9.0	2.6	6.2	7.6	11.2	6.0	5.4	5.1	3.2	6.3	5.5	6.4	5.1	4.2	11.6	8.9	7.8	8.9	6.1	4.8	3.0	7.4	8.2	7.2	3.0	9.8	4.4	7.3	7.9	6.5	3.6	8.2	4.2	6.2	13.6	5.9	3.1	7.0	7.7	3.5	4.3	5.3	8.2	3.5	7.2	13.7	3.9	5.8	5.4	9.4	10.1	10.1	17.1	9.9	15.2	19.1	25.5	10.3	9.9	15.7	15.3	6.5	8.3	8.1	10.3	14.4	7.4	12.6	13.7	18.7	22.3	9.0	16.8	7.4	10.1	28.6	10.7	3.7	5.9	13.4	12.5	12.1	10.2	8.2	11.4	4.7	3.6	6.3	17.7	13.5	4.3	6.0	6.8	14.2	14.8	4.4	19.1	6.2	12.7	11.4	5.1	13.1	12.0	13.7	12.2	13.0	15.7	5.2	7.0	14.9	9.1	8.6	10.2	5.8	8.2	5.0	3.7	8.1	9.2	0.0	0.5	0.3	1.0	1.2	0.8	0.7	1.0	1.3	0.3	0.5	1.4	1.2	0.0	0.4	1.4	0.9	1.4	0.7	8.3	9.0	7.6	11.2	8.9	7.8	7.4	8.2	7.9	7.7	8.2	9.4	11.6	9.6	13.9	13.7	10.5	18.6	10.2	10.4	19.9	18.5	8.4	7.1	19.2	2.8	10.6	7.3	4.2	19.3	15.7	2.3	7.9	4.9	3.5	6.7	13.0	11.2	4.8	1.3	21.2	6.9	15.4	15.3	6.1	6.3	14.7	6.9	6.8	6.3	5.1	16.8	22.3	3.8	12.2	2.8	9.5	3.2	11.1	3.9	8.8	6.5	6.6	21.4	3.1	20.6	26.2	4.4	3.0	9.8	8.8	14.0	1.7	19.2	6.7	17.5	19.7	17.5	20.0	6.5	16.6	12.6	16.2	22.4	11.4	11.8	3.7	7.1
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		270000	"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	17.4	14.5	19.3	18.1	21.9	40.8	23.3	21.0	21.6	17.5	14.1	25.9	21.6	17.3	15.3	27.7	18.5	19.2	16.5	16.6	20.7	22.3	16.9	20.1	19.0	23.2	18.2	21.6	14.8	26.2	8.9	20.5	23.3	17.3	24.9	16.3	16.6	17.8	26.7	23.2	27.5	17.7	22.7	20.9	24.9	12.8	20.2	14.4	26.5	20.5	22.1	16.4	13.5	33.6	56.6	34.2	20.1	17.5	28.6	30.2	38.8	38.2	47.6	30.6	34.8	19.0	71.6	18.7	44.1	47.2	16.5	48.2	22.9	36.5	46.1	23.2	20.4	28.2	34.8	19.2	32.2	32.2	25.4	26.8	34.8	38.4	44.8	34.5	28.3	11.9	43.0	24.8	38.0	17.4	13.7	16.7	25.3	46.0	39.8	14.4	61.2	42.3	36.3	55.6	22.5	35.3	41.7	46.3	28.8	18.9	57.1	32.5	40.7	42.1	23.9	43.6	43.5	18.4	33.8	16.7	34.0	26.8	39.0	75.4	28.0	36.6	21.3	42.1	24.1	15.9	27.0	21.8	26.1	14.4	17.8	22.6	52.7	28.4	44.1	14.4	27.2	18.6	19.3	21.9	21.0	21.6	16.6	20.7	23.2	18.2	23.3	22.7	20.2	33.6	35.7	73.7	46.5	15.7	30.4	48.6	32.3	32.2	27.3	16.3	42.1	23.9	35.9	30.0	38.3	51.5	8.4	29.7	49.1	56.2	56.7	40.0	20.8	43.2	30.9	29.0	31.8	73.0	17.1	32.5	32.6	29.7	35.7	54.2	16.4	26.3	31.8	28.4	36.6	35.3	20.1	50.1	32.6	65.5	33.1	23.7	24.2	50.8	49.8	12.2	52.4	31.0	42.2	25.1	27.3	54.5	44.6	32.0	23.2	47.8	48.4	58.8	67.8	20.8	52.6	27.4	26.8	29.9	27.4	40.4	46.7	51.6	40.5	35.1	41.0	56.4
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	8.0	7.1	4.7	6.9	6.9	23.5	7.7	9.9	7.4	8.2	3.8	8.3	4.8	9.5	4.4	8.6	8.8	5.5	7.3	6.7	3.8	6.2	5.5	7.9	8.9	4.7	4.2	9.3	7.3	7.7	6.7	6.5	4.3	7.5	4.0	4.0	9.1	5.0	9.5	10.9	8.3	5.4	3.1	10.5	7.5	14.4	5.2	11.9	9.0	6.8	7.6	7.9	7.8	5.5	9.9	17.2	12.5	8.2	8.9	8.6	82.4	12.6	7.5	14.3	10.2	12.1	8.3	18.6	6.0	11.6	13.5	8.2	15.3	12.0	9.0	20.1	17.9	21.4	33.8	9.8	11.4	30.6	20.0	8.5	9.8	19.8	13.1	7.2	10.8	17.5	25.2	15.9	8.3	24.3	19.8	25.7	20.6	6.7	15.9	28.7	10.6	12.3	6.7	14.5	8.9	15.2	12.7	9.0	10.1	8.2	9.8	31.4	14.1	15.9	13.6	14.5	24.0	13.4	18.1	31.5	13.1	25.9	15.1	1.0	0.9	1.4	1.3	0.8	2.0	0.6	0.9	1.2	0.8	0.5	1.1	1.3	0.8	4.2	0.7	1.9	0.7	0.8	4.7	6.9	9.9	7.4	6.7	3.8	4.7	4.2	4.3	3.1	5.2	5.5	7.9	16.0	10.0	2.6	6.8	14.1	5.1	3.9	8.0	4.6	9.2	7.0	3.7	2.8	6.2	7.3	6.2	4.2	13.0	9.4	0.0	4.1	3.9	4.2	6.9	9.7	10.2	9.7	3.4	5.5	5.5	5.8	7.7	7.0	8.8	7.3	11.0	3.5	6.4	8.4	2.4	5.0	2.0	5.6	9.2	1.2	6.5	6.9	1.8	2.8	6.3	5.2	5.2	4.0	2.9	6.1	3.1	6.0	7.9	5.1	4.9	2.1	4.3	5.1	6.6	11.3	7.7	16.6	13.9	9.9	18.5	3.7	10.8	5.6	6.1	6.8
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80669503-80809877	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 69.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	3.2	2.2	1.5	4.0	2.2	5.1	3.1	6.0	1.8	3.0	1.2	3.0	3.6	3.0	2.5	4.4	3.2	2.4	1.9	1.6	2.4	2.2	3.1	3.4	4.3	1.6	2.3	4.5	3.1	2.0	3.1	3.6	1.7	2.3	3.2	5.8	3.3	1.9	1.4	6.1	4.1	1.9	1.6	3.9	3.1	3.9	2.4	5.2	3.5	1.7	3.9	2.8	3.5	2.0	4.4	4.6	7.1	4.6	2.8	3.4	5.0	2.5	2.1	3.1	4.2	2.2	5.9	4.7	5.7	2.3	3.8	7.7	10.7	4.2	4.2	4.0	4.5	9.6	7.8	3.3	2.1	5.5	6.2	2.3	2.9	3.5	4.9	4.6	4.8	4.1	7.1	11.5	3.7	0.8	3.3	5.6	10.6	4.8	1.9	2.8	12.2	2.9	3.8	3.7	1.6	4.0	6.1	3.3	2.7	12.9	1.5	5.5	4.4	3.7	4.5	3.4	2.7	5.1	5.7	5.4	3.0	11.0	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	1.5	2.2	6.0	1.8	1.6	2.4	1.6	2.3	1.7	1.6	2.4	2.0	16.1	12.8	13.4	48.3	14.5	17.5	8.0	8.6	13.6	27.7	9.7	6.2	8.2	15.7	15.4	5.5	16.7	5.7	13.1	13.8	0.0	6.5	2.8	11.5	15.6	13.3	7.2	12.0	47.0	6.0	7.7	10.5	21.9	16.6	11.4	22.4	8.2	5.6	5.5	62.2	54.2	10.8	2.0	13.2	17.7	3.7	9.9	19.7	1.8	45.9	17.5	8.1	6.2	69.4	53.5	8.8	22.4	10.1	13.5	13.0	17.1	4.0	12.7	20.8	6.6	14.3	11.9	6.7	9.6	16.8	20.9	7.7	15.1	12.7	12.1	19.2
BSCL2	"GNG3LG, seipin, SPG17"	ENSG00000168000	"BSCL2 lipid droplet biogenesis associated, seipin"	Q96G97	11	62690275-62709845	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid degradation, Lipid metabolism"		"Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 292.1;pituitary gland: 237.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042394	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA042394: AB_10794047"	"unprognostic (7.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.96e-1)"	24.9	88.1	126.6	7.4	133.2	12.0	26.2	75.0	155.6	38.2	85.4	24.3	10.8	28.4	156.7	24.1	63.7	21.5	18.7	134.9	292.1	50.8	39.3	26.7	15.3	138.1	139.0	32.7	79.4	61.7	237.0	10.0	203.4	35.4	13.3	52.6	66.1	30.3	30.9	25.1	17.2	13.7	83.1	16.2	37.1	190.3	169.3	14.4	37.9	15.5	8.9	17.5	26.1	89.9	18.0	61.7	49.6	83.8	130.8	41.5	7.2	7.2	34.4	13.6	14.5	9.6	26.3	11.9	16.5	25.2	11.8	62.1	5.2	21.8	7.0	30.7	5.0	10.9	33.4	7.8	27.7	9.7	13.5	27.8	16.6	26.9	10.9	19.7	10.8	33.0	7.8	242.1	19.8	44.0	11.4	21.8	132.4	13.9	13.0	21.3	4.2	176.1	65.0	2.4	181.2	29.4	28.2	13.9	25.3	5.7	41.3	15.3	6.5	16.5	3.7	24.5	4.2	32.2	72.5	16.6	82.4	3.2	14.5	26.6	59.2	34.6	24.7	46.2	27.4	27.5	25.5	26.1	42.4	29.7	25.7	27.0	14.2	41.0	40.3	54.3	33.1	43.3	126.6	133.2	75.0	155.6	134.9	292.1	138.1	139.0	203.4	83.1	169.3	89.9	0.8	16.0	5.6	0.0	7.1	1.7	1.0	1.4	35.9	2.5	3.6	2.2	0.2	1.5	1.6	3.7	0.0	2.4	0.9	1.7	3.9	2.0	25.5	4.8	1.5	2.9	0.0	8.8	0.0	1.1	1.9	9.2	20.4	1.5	2.5	0.7	1.4	2.1	1.9	3.3	0.0	1.6	6.1	2.5	3.1	53.1	2.5	6.2	12.4	0.0	0.7	0.8	1.0	0.0	0.0	0.5	1.6	3.0	86.3	0.9	2.5	6.0	23.9	1.2	6.6	1.2	4.1	32.6	18.1	24.7	4.0	1.5	6.5	0.7	1.2	0.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32364633-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 37.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	36.8	63.0	28.0	17.4	29.4	77.1	37.8	31.7	30.6	38.7	27.3	35.9	25.4	35.3	24.9	36.7	35.3	23.3	35.9	28.9	27.2	38.7	73.2	33.7	22.4	32.5	27.8	54.5	56.0	42.3	46.5	22.1	28.8	41.0	22.5	21.7	45.0	24.3	36.7	47.5	34.8	20.7	28.1	35.8	41.0	51.3	28.4	19.5	37.9	16.3	21.8	33.2	36.5	35.9	24.3	16.2	32.8	25.2	38.6	29.6	25.6	23.0	43.9	39.8	41.0	18.1	19.9	17.8	27.0	41.3	22.6	26.1	23.4	21.6	25.6	33.4	33.3	14.2	35.5	22.1	33.2	17.6	24.7	35.5	46.4	30.7	23.2	47.8	24.8	28.0	36.4	30.8	22.3	10.7	18.7	10.3	20.8	14.1	19.0	18.8	18.8	24.7	22.6	19.5	34.6	25.0	22.1	22.7	25.2	37.7	21.4	13.9	30.1	22.1	19.8	28.3	22.6	42.2	41.6	15.9	25.8	22.3	13.5	37.4	5.1	18.3	6.2	5.9	6.1	7.0	5.5	5.2	4.9	8.3	6.0	5.6	8.4	6.1	5.0	6.5	7.3	6.2	28.0	29.4	31.7	30.6	28.9	27.2	32.5	27.8	28.8	28.1	28.4	35.9	24.6	32.1	18.6	23.5	42.8	28.4	56.6	31.5	25.6	53.6	38.9	26.7	19.4	55.8	21.9	25.8	83.4	51.1	38.8	59.3	19.6	37.8	88.9	23.7	26.3	35.2	40.1	76.0	25.6	44.1	31.0	32.7	27.0	34.4	21.0	36.1	50.0	56.7	20.0	85.8	31.6	47.8	28.5	25.8	13.1	100.7	54.7	20.1	32.0	25.3	28.0	30.3	57.7	29.1	35.0	45.6	40.0	47.4	32.1	58.4	63.9	28.0	18.4	69.8	39.5	33.1	38.1	42.9	45.9	21.2	25.9	96.5	34.6	60.5	39.3	57.2
BSG	"CD147, EMMPRIN, EMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583494	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1535.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1408.0;Syncytiotrophoblasts: 1654.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	Vesicles		NA	NA		340000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (1.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.53e-3)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (1.95e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-1)"	378.6	518.8	652.6	154.5	615.4	431.3	313.8	575.6	847.5	320.6	975.8	543.5	231.3	413.3	259.5	245.1	323.1	176.2	1535.0	629.0	606.0	469.7	186.0	253.6	101.9	578.5	611.2	300.7	301.6	255.3	331.2	320.2	599.8	228.8	155.9	189.6	274.8	194.4	472.3	226.6	239.7	164.1	551.0	200.0	455.8	486.0	724.3	92.8	302.1	292.2	74.2	366.9	233.0	581.2	622.6	739.3	339.5	852.3	975.0	426.0	800.4	499.2	507.6	506.1	437.9	607.1	569.4	208.4	564.3	383.5	148.7	967.8	341.0	575.0	129.6	468.1	840.3	150.0	545.5	812.3	683.6	361.6	679.0	455.5	578.5	302.4	304.5	613.1	383.3	198.3	722.9	992.5	298.6	1015.8	261.6	706.6	901.9	353.7	408.3	522.8	301.2	745.2	655.9	412.1	561.0	539.1	984.4	408.1	769.7	257.9	432.3	1118.9	478.7	557.5	353.4	940.1	751.5	639.7	701.8	201.1	1066.9	510.2	712.8	189.0	324.7	348.9	226.4	245.9	200.5	115.0	150.7	218.4	209.6	93.2	114.0	144.7	474.8	173.5	284.2	235.2	192.0	434.0	652.6	615.4	575.6	847.5	629.0	606.0	578.5	611.2	599.8	551.0	724.3	581.2	313.5	22.4	31.5	75.1	101.5	208.6	176.8	668.0	91.0	157.7	202.8	187.6	80.6	128.7	253.4	286.9	204.3	1408.0	156.5	1140.1	146.8	580.9	261.6	156.6	296.6	246.7	255.1	1091.4	35.4	371.4	1095.5	279.8	192.1	190.1	116.2	181.1	132.1	96.9	416.7	139.7	31.4	337.2	510.6	137.8	179.6	600.2	300.4	139.8	506.9	122.7	264.5	495.5	221.4	20.6	30.7	458.0	929.1	336.7	192.4	172.8	450.7	306.7	178.8	269.2	203.8	74.3	235.6	347.9	604.4	127.7	156.7	1654.9	130.9	223.5	478.2	181.4
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554477-49671549	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 33.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 33.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	0.1	1.4	8.2	0.1	17.6	0.0	0.1	0.1	33.6	0.2	0.0	0.2	0.1	0.3	3.0	0.0	0.1	0.0	0.2	17.2	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.3	5.3	0.1	0.0	0.2	0.0	3.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	3.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	4.9	0.1	0.2	1.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.4	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.0	0.2	0.0	0.4	0.2	0.1	0.8	0.1	0.5	0.0	0.1	0.2	0.0	0.2	4.4	2.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	17.6	0.1	33.6	17.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	15.0	0.2	0.5	2.5	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.0	7.8	0.4	0.3	0.5	0.0	0.0	76.6	0.5	0.1	0.3	0.0	0.3	0.0	0.6	0.7	0.4	0.1	25.2	50.1	0.1	0.0	0.3	0.0	11.7	1.2	0.1	1.8	9.4	0.0	3.9	2.1	22.6	6.3	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	8.8	0.0	1.0	1.3	6.7	8.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory subunit beta"	Q8WZ55	1	54998933-55017172	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 9.4"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 25.4;Ionocytes: 87.5"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"RPMI-8226: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BSPH1	"BSP1, ELSPBP2"	ENSG00000188334	"Binder of sperm protein homolog 1"	Q075Z2	19	47968046-47992170	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"epididymis: 383.0"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048335	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA048335: AB_2732546"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	383.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 139.8;intestine: 48.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 257.7;neutrophil: 292.7"	"Group enriched"	"Detected in many"	95	"dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		190000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	21.2	2.7	1.9	13.7	2.1	139.8	9.4	2.1	4.7	11.0	1.6	8.3	48.6	6.3	2.9	4.6	7.9	18.2	19.1	2.1	2.0	17.0	8.5	12.7	7.1	1.9	1.4	9.3	3.1	1.7	1.3	13.7	2.2	3.7	9.7	1.0	3.9	4.6	2.7	5.0	29.3	9.7	0.8	18.6	3.2	2.7	3.0	3.9	4.9	6.8	3.5	16.8	7.4	3.3	0.6	10.5	1.2	1.0	28.8	7.0	1.6	21.0	2.1	20.4	22.2	0.3	12.1	0.8	1.9	12.2	0.6	0.3	3.3	0.5	17.2	0.8	0.7	5.6	0.8	0.6	6.7	7.2	15.1	5.7	1.5	12.9	1.0	0.9	3.0	5.0	0.7	0.5	12.5	0.3	2.3	4.3	2.7	0.9	2.2	0.8	1.8	0.5	0.5	0.6	1.4	4.3	0.4	0.7	14.2	1.2	0.5	76.0	40.4	0.6	1.0	7.9	1.1	0.6	0.2	0.7	2.7	52.5	44.8	41.8	257.7	20.8	1.1	97.4	1.7	2.2	0.9	0.8	78.9	0.9	1.1	0.7	292.7	0.4	73.9	26.6	1.0	109.8	1.9	2.1	2.1	4.7	2.1	2.0	1.9	1.4	2.2	0.8	3.0	3.3	5.4	3.2	3.7	1.3	0.3	4.6	0.8	0.1	1.8	0.6	1.2	2.0	1.5	2.8	1.0	1.8	0.0	16.0	5.5	3.7	1.9	4.4	4.4	8.0	9.9	3.8	1.2	2.5	0.7	2.5	24.0	22.5	0.0	16.2	15.9	20.6	6.4	2.1	40.8	0.0	0.7	8.1	0.0	26.3	11.5	1.2	3.1	33.3	14.2	3.7	80.1	0.6	3.1	0.5	3.6	1.1	11.9	2.2	0.4	0.6	79.0	9.6	3.0	0.2	6.6	3.9	15.5	2.5	1.4	1.7	3.0	7.1	1.8	1.4	23.2	3.3
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
BSX	BSX1	ENSG00000188909	"Brain specific homeobox"	Q3C1V8	11	122977570-122981834	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	48	"brain: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hypothalamus: 12.0;thalamus: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"hypothalamus: 4.5"	"Region enriched"	"Detected in single"	10	"hypothalamus: 3.4"	HPA015654	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA015654: AB_1845470"																		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.0	0.0	0.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 325.0;tongue: 230.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	36.8	26.7	39.8	24.9	41.0	36.3	28.8	40.4	48.1	24.8	26.2	33.4	32.5	24.2	25.7	30.4	31.5	28.7	107.2	41.3	43.8	37.8	34.3	23.9	36.7	40.7	41.4	23.6	17.2	46.4	22.1	24.1	38.5	30.1	35.5	28.4	21.0	24.0	325.0	16.5	29.9	26.5	44.4	25.9	23.9	58.4	46.8	35.5	37.1	230.8	34.2	36.2	18.2	46.0	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	39.8	41.0	40.4	48.1	41.3	43.8	40.7	41.4	38.5	44.4	46.8	46.0	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTBD10	"GMRP-1, GMRP1, MGC13007"	ENSG00000148925	"BTB domain containing 10"	Q9BSF8	11	13388008-13463297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 116.5;Spermatocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046777	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA046777: AB_2679801"	"unprognostic (2.38e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.27e-1)"	13.8	12.2	19.8	13.6	30.9	13.4	13.3	18.8	27.9	15.0	3.2	18.1	13.1	16.5	12.0	28.6	11.8	15.2	17.7	25.9	18.6	11.4	9.8	13.0	15.7	12.0	15.7	14.1	8.7	13.2	14.1	17.4	16.2	15.0	20.3	18.8	10.8	17.4	14.6	13.1	11.7	21.1	10.0	12.6	17.7	38.3	14.5	18.5	13.6	18.4	17.4	27.1	17.8	22.2	55.9	40.2	34.3	23.2	30.4	29.5	43.5	57.5	33.3	43.5	39.4	37.7	64.0	38.1	27.1	42.2	43.9	44.0	26.3	61.4	50.8	38.7	27.1	20.7	13.9	22.5	46.9	27.6	45.4	25.3	68.0	25.2	57.3	33.0	89.1	26.8	11.8	38.2	46.0	33.7	28.3	15.2	14.9	50.0	34.9	24.8	29.4	23.8	69.7	44.3	14.8	20.9	34.4	27.5	20.5	38.9	19.7	14.7	81.7	44.7	37.2	43.4	33.6	14.2	52.6	25.5	30.6	23.6	38.9	41.1	24.8	38.2	18.1	39.7	21.7	18.4	17.1	20.1	29.2	17.2	19.1	19.3	64.9	25.7	50.5	12.7	23.6	18.3	19.8	30.9	18.8	27.9	25.9	18.6	12.0	15.7	16.2	10.0	14.5	22.2	20.5	16.0	7.0	35.9	16.9	28.2	40.7	27.0	15.9	13.9	9.6	8.6	14.0	12.8	19.7	5.5	4.2	24.3	18.1	15.7	5.9	31.8	95.7	14.3	12.5	22.6	16.3	9.0	116.5	25.2	54.3	15.3	27.5	19.1	22.8	11.1	11.7	5.9	22.9	8.4	74.2	14.2	28.5	16.4	13.0	26.3	9.9	13.0	17.8	38.4	22.2	9.9	18.6	61.9	62.4	50.2	14.2	18.4	12.0	30.1	8.7	10.5	19.9	14.1	6.6	13.4	20.6	121.3	59.7	27.8	35.8	62.1	17.8	9.2	13.3	64.6
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271296-122338159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 8.3;testis: 7.8;urinary bladder: 20.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 123.2;Late spermatids: 69.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 33.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Cytosol	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.1	0.0	1.0	0.0	1.4	0.0	0.5	1.2	2.3	0.3	0.7	0.5	0.0	0.1	0.3	0.1	0.4	0.2	0.0	1.1	1.2	0.3	4.0	0.2	0.0	1.4	1.4	0.0	0.1	0.0	0.4	0.1	1.4	0.8	0.0	0.0	0.4	0.0	0.3	8.3	0.1	0.1	1.3	0.0	0.1	7.8	1.2	0.0	0.4	0.0	0.1	20.2	0.5	2.1	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.5	33.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	1.4	1.2	2.3	1.1	1.2	1.4	1.4	1.4	1.3	1.2	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	123.2	0.6	0.0	0.2	0.0	0.0	0.9	0.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.4	69.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.5	9.8	1.1	3.8	0.4	0.0	0.1	0.2	1.0	3.1	0.0	0.0	0.4	0.2	10.0	0.8	0.0	3.1	0.1	0.4	0.0	0.0	2.9
BTBD17	"BTBD17A, LGALS3BPL, TANGO10A"	ENSG00000204347	"BTB domain containing 17"	A6NE02	17	74356416-74361868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 7.1"	"Cell type enriched"	"Detected in some"	6	"Horizontal cells: 28.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"AF22: 2.9;NTERA-2: 3.8;SCLC-21H: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA025022	Approved				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA025022: AB_2067352"					"unprognostic (2.63e-1)"					"unprognostic (2.77e-1)"	"unprognostic (4.82e-5)"			"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-3)"		0.0	0.5	2.8	0.0	2.7	0.0	0.0	1.7	3.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.7	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.4	0.3	7.1	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	1.7	3.3	2.3	5.7	2.5	3.5	2.8	2.5	7.1	2.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	4.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BTBD18		ENSG00000233436	"BTB domain containing 18"	B2RXH4	11	57743514-57751781	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 3.1;testis: 2.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.7;Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 1.6;Spermatocytes: 5.5;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049325	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA049325: AB_2680713"	"unprognostic (6.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.17e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.88e-1)"	0.0	0.0	0.1	0.0	0.3	0.4	0.0	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.3	3.1	0.9	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.4	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	5.5	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.0"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.4;HUVEC TERT2: 5.1;TIME: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA042633: AB_2678091, HPA076404: AB_2686796"	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	2.7	4.3	0.4	1.1	0.4	0.9	1.4	0.5	1.0	3.8	9.0	1.1	0.4	5.4	0.7	0.7	4.0	1.2	2.0	0.5	1.2	1.5	0.8	2.3	0.4	3.2	2.1	4.2	0.6	1.5	5.3	0.8	2.0	1.3	0.4	0.0	0.8	1.2	0.4	0.6	1.1	1.6	1.4	0.9	1.0	0.7	1.7	0.1	3.2	0.4	0.3	1.1	2.1	1.5	0.1	0.9	0.8	0.8	1.7	2.0	0.6	1.7	1.0	0.7	1.6	0.0	0.7	0.0	0.7	2.9	0.4	0.2	0.0	0.8	0.3	0.8	0.1	1.6	0.3	0.9	1.8	0.0	1.2	3.0	0.1	2.9	0.5	5.4	5.1	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.9	1.0	0.0	0.0	11.9	3.0	2.3	1.4	1.3	0.4	0.1	0.0	1.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	1.0	0.5	1.2	3.2	2.1	2.0	1.4	1.7	1.5	5.8	3.2	4.2	0.0	1.4	2.0	1.9	0.8	3.4	0.1	4.2	1.8	1.3	1.5	2.9	1.8	0.0	0.4	1.2	2.6	0.0	0.9	0.6	3.8	6.8	5.2	0.0	0.4	0.6	0.6	0.4	6.2	2.0	7.3	2.5	1.1	6.1	3.3	2.9	0.0	0.3	1.7	0.0	5.9	6.2	0.1	3.1	8.1	3.6	1.9	0.5	1.1	0.0	0.5	0.1	1.0	1.4	1.2	2.3	1.1	2.6	3.3	1.5	0.1	0.0	9.3	4.5	1.0	0.2	2.1	2.3	1.2	2.7	4.1	1.0	1.4
BTBD3	"dJ742J24.1, KIAA0952"	ENSG00000132640	"BTB domain containing 3"	Q9Y2F9	20	11890723-11926609	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.9"	"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 223.0;Oligodendrocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 241.1;HeLa: 186.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041424, HPA042048"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA041424: AB_10794667, HPA042048: AB_10796469"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.51e-5)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.37e-2)"	11.2	22.1	20.6	7.1	34.2	12.2	12.7	66.2	80.9	16.9	12.3	21.4	10.7	18.7	7.9	9.9	15.4	13.4	13.9	79.6	30.9	11.6	7.7	12.2	4.1	30.5	24.7	11.5	13.7	11.2	8.9	42.0	23.1	15.1	17.5	42.5	13.9	10.6	15.9	20.7	10.9	16.5	24.2	7.8	27.3	14.7	23.7	10.8	11.5	13.2	3.1	18.4	10.1	64.7	7.0	19.5	52.1	241.1	10.6	11.3	14.0	21.9	14.0	24.3	15.5	11.2	10.7	2.0	18.1	31.7	9.6	18.1	27.2	15.4	39.1	0.1	24.1	7.1	186.9	23.9	11.1	11.6	4.2	20.2	18.8	21.8	17.5	13.4	13.8	12.0	12.7	18.8	24.3	5.1	14.0	10.7	25.0	29.0	5.5	18.4	10.4	7.0	22.2	34.0	22.7	40.0	60.8	24.6	53.3	27.9	14.4	11.5	10.7	13.2	33.6	12.4	24.6	6.9	9.9	0.3	8.6	3.2	87.6	0.0	1.2	0.1	0.0	1.7	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.0	0.3	0.7	3.5	1.0	0.0	0.6	20.6	34.2	66.2	80.9	79.6	30.9	30.5	24.7	23.1	24.2	23.7	64.7	17.4	16.0	8.4	24.5	2.8	16.6	10.8	8.0	18.8	15.3	15.2	11.9	16.5	10.0	8.3	5.5	79.2	23.3	1.0	41.0	3.9	9.8	8.3	51.3	223.0	25.0	20.9	4.6	46.9	8.3	4.0	15.6	28.5	55.8	2.5	9.4	33.5	8.5	8.5	65.6	38.0	9.4	10.2	4.8	13.4	13.6	16.4	6.5	14.2	39.4	3.2	17.7	1.0	61.9	254.9	9.7	25.9	8.6	2.7	13.2	11.4	6.6	24.1	56.9	6.6	19.9	18.6	10.0	16.1	11.7	17.2	21.8	1.8	42.0	13.3	11.3
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031355: AB_10611812"	"prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favorable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	69.4	26.3	52.1	20.4	52.6	28.2	56.6	48.3	60.3	32.6	48.1	43.8	28.8	31.4	28.1	50.9	30.8	20.5	52.1	54.2	51.7	34.5	44.2	34.7	22.0	49.7	51.0	36.7	13.2	12.6	39.9	15.6	49.9	43.6	23.1	14.6	42.8	23.5	169.4	48.5	39.5	18.8	48.4	31.4	46.9	79.3	52.1	18.4	30.4	144.6	19.0	38.9	37.7	51.3	50.8	39.8	21.4	56.8	66.8	46.2	0.1	45.6	41.1	69.2	46.9	31.3	45.2	15.9	27.4	67.0	14.5	66.2	41.3	43.9	34.0	41.2	33.5	11.7	58.6	0.0	45.6	35.8	21.7	48.3	59.6	31.9	25.7	26.9	55.9	52.2	0.0	0.3	37.3	71.8	37.8	14.5	9.1	47.6	67.6	40.3	0.1	14.9	26.5	55.0	34.8	14.8	42.9	34.3	35.0	14.7	69.9	45.3	37.9	55.5	1.5	82.1	57.8	10.2	14.7	7.8	57.2	16.4	44.1	0.5	0.6	2.9	2.3	1.0	2.2	1.3	2.4	2.3	0.7	0.7	1.8	1.2	0.3	0.4	0.8	1.5	5.3	0.6	52.1	52.6	48.3	60.3	54.2	51.7	49.7	51.0	49.9	48.4	52.1	51.3	31.5	25.6	24.3	3.9	5.4	11.7	25.7	6.5	6.2	23.1	24.0	23.4	22.0	14.3	15.3	11.0	6.2	2.8	25.3	31.0	21.5	5.7	15.0	25.6	19.5	17.8	20.4	5.2	12.4	0.0	3.8	17.3	10.2	34.9	24.7	22.2	17.9	15.4	7.8	20.2	12.5	31.2	10.2	9.8	10.0	35.2	9.3	10.3	12.4	8.4	3.6	19.1	5.2	5.0	3.7	1.0	11.6	7.5	7.6	16.3	20.5	11.6	15.5	18.8	13.1	15.7	13.0	7.8	8.3	9.6	12.6	2.2	16.4	15.2	21.9	19.5
BTBD7	"FLJ10648, FUP1"	ENSG00000011114	"BTB domain containing 7"	Q9P203	14	93237550-93333092	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049926, HPA053406"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"HPA049926: AB_2680956, HPA053406: AB_2682137"	"unprognostic (3.36e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.69e-6)"	"unprognostic (7.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.52e-2)"	3.9	2.7	1.2	2.2	2.1	5.6	3.4	3.6	1.8	3.4	0.0	3.3	1.8	3.5	1.5	4.5	3.4	2.0	3.1	1.2	2.7	3.9	2.9	3.8	1.2	3.0	3.1	3.5	3.4	4.0	1.9	2.6	2.6	2.9	2.3	2.5	3.6	1.7	4.7	4.1	3.3	2.1	1.7	2.3	3.0	8.0	3.6	1.2	3.5	1.6	1.4	3.5	3.9	4.1	6.6	4.0	5.2	1.8	2.9	2.5	9.0	6.0	3.8	5.0	3.0	4.5	4.9	4.3	4.9	6.5	3.6	6.1	4.6	10.4	7.7	5.1	3.5	2.9	2.5	3.3	1.7	7.6	3.6	3.6	2.0	5.1	7.3	3.8	7.5	1.7	3.1	3.5	5.2	7.2	2.0	2.9	3.2	3.3	11.2	5.9	7.6	0.9	6.1	15.5	6.7	6.2	7.9	3.0	2.1	5.6	5.3	5.4	8.9	4.2	4.3	3.0	5.3	2.5	3.5	3.9	2.1	2.1	3.0	0.8	0.1	1.3	0.3	0.2	0.1	0.6	0.2	0.3	0.1	0.4	0.1	0.2	0.5	0.1	0.3	0.4	0.4	0.0	1.2	2.1	3.6	1.8	1.2	2.7	3.0	3.1	2.6	1.7	3.6	4.1	53.6	51.3	27.7	76.4	29.0	32.4	29.0	18.1	26.7	27.9	31.9	23.9	20.9	30.0	19.6	55.2	37.5	24.2	31.6	34.5	13.7	32.3	47.9	58.2	55.7	48.5	28.8	23.4	80.2	24.6	22.5	35.6	29.0	75.5	24.7	33.3	51.4	18.6	17.8	26.9	81.6	26.2	14.2	27.7	39.5	45.7	23.6	36.1	10.6	99.3	39.5	23.9	26.8	89.0	175.7	45.2	22.0	39.5	36.0	45.8	22.1	39.3	22.9	30.4	13.1	58.3	56.4	23.7	36.6	32.9	36.9	30.6	28.2	33.1	27.7	64.5
BTBD8		ENSG00000189195	"BTB domain containing 8"	"Q5XKL5, Q9UPP5"	1	92080305-92184725	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 13.4;retina: 18.0;testis: 5.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.9;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 46.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	0.9	1.5	2.6	0.5	4.5	0.1	1.2	6.6	13.4	0.7	0.0	0.8	0.5	1.3	1.1	0.4	1.5	0.8	0.9	5.9	0.9	0.9	0.5	1.1	0.5	0.1	1.8	2.0	0.5	1.5	0.3	0.9	3.1	1.2	0.8	18.0	0.4	1.0	0.4	0.4	0.7	0.6	0.4	0.5	0.9	5.1	2.1	0.7	1.6	0.7	0.3	0.8	0.2	7.1	1.3	0.8	0.6	0.0	1.1	3.5	2.8	0.6	1.1	0.6	0.7	0.3	0.9	0.4	2.2	0.7	2.5	0.3	0.5	1.2	1.1	1.2	0.7	1.2	0.3	0.4	0.1	0.5	0.5	2.3	1.0	0.4	0.7	2.3	0.7	1.0	1.1	0.3	1.0	0.9	0.3	0.4	0.7	1.6	0.7	0.9	0.5	0.1	0.9	0.9	0.3	0.3	1.0	0.5	0.5	1.1	0.9	0.8	0.6	0.6	0.5	0.3	0.2	1.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.6	4.5	6.6	13.4	5.9	0.9	0.1	1.8	3.1	0.4	2.1	7.1	5.9	0.0	4.1	19.9	0.9	0.4	1.0	0.3	0.0	9.5	6.0	2.7	0.7	2.8	3.6	5.5	6.2	2.4	2.5	1.2	1.9	4.7	7.6	10.3	5.9	2.8	0.0	2.5	21.9	2.9	1.2	3.7	2.0	8.1	0.0	13.8	1.4	1.1	0.7	3.3	38.3	2.4	6.1	1.5	0.6	1.7	5.9	1.8	1.8	10.3	2.6	4.7	5.2	29.7	46.0	3.8	4.4	3.8	2.1	1.7	3.1	1.7	4.3	15.3	0.0	2.4	2.8	8.1	9.0	0.6	0.6	1.4	2.0	9.4	2.0	1.4
BTBD9	"dJ322I12.1, KIAA1880"	ENSG00000183826	"BTB domain containing 9"	Q96Q07	6	38168451-38640148	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Astrocytes: 191.3;Excitatory neurons: 390.4;Inhibitory neurons: 257.0;Microglial cells: 142.4;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041930	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA041930: AB_10795270"	"unprognostic (4.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (4.20e-13)"	"unprognostic (1.35e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.15e-2)"	4.2	4.7	13.1	4.3	13.2	8.3	3.8	1.8	22.6	3.8	10.1	5.1	5.2	5.2	4.4	5.6	8.7	5.8	8.3	18.8	4.2	6.2	3.2	9.2	4.7	3.0	7.8	8.1	3.5	13.7	4.3	4.3	4.1	5.2	5.6	7.1	4.5	4.1	7.8	5.2	7.2	5.0	0.7	4.8	4.7	8.1	7.5	3.7	6.7	6.7	4.4	4.7	3.5	10.7	5.4	4.7	6.8	8.5	4.6	6.7	5.4	5.3	7.4	5.4	6.3	6.2	3.1	3.1	3.7	8.2	7.3	3.5	3.2	6.7	5.9	7.4	7.0	6.9	5.1	2.5	4.0	6.5	13.4	5.2	6.0	7.4	7.9	4.9	9.3	4.8	3.2	5.2	5.6	3.4	4.6	2.7	2.0	4.9	3.6	3.0	4.7	6.1	5.1	12.3	10.2	5.8	4.5	5.7	5.2	4.6	5.8	5.3	7.0	5.6	3.7	6.6	5.5	3.3	2.5	3.7	4.9	4.4	6.6	12.3	1.8	3.2	2.4	2.6	3.3	2.6	2.4	2.2	1.7	3.7	3.0	2.7	4.5	3.3	4.0	2.6	4.1	1.9	13.1	13.2	1.8	22.6	18.8	4.2	3.0	7.8	4.1	0.7	7.5	10.7	3.9	3.2	17.9	191.3	14.2	4.6	2.2	2.9	4.6	11.5	3.6	2.9	11.8	8.6	6.7	9.2	8.4	2.7	7.3	15.5	5.9	4.6	17.5	12.8	5.3	4.1	4.9	1.3	390.4	5.8	1.5	4.6	10.2	8.1	0.0	5.5	7.5	3.0	2.6	5.0	257.0	3.9	6.1	3.5	3.0	24.6	3.1	5.6	1.8	142.4	1.5	5.9	2.1	193.5	218.3	5.5	5.0	3.4	10.4	2.1	13.1	6.8	8.7	5.6	0.0	5.4	6.1	3.1	2.9	4.4	5.8	4.7	11.1	3.7	6.0	3.2
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15722311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2800000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	25.3	16.7	10.7	8.0	12.7	13.1	16.4	20.2	12.6	13.7	11.0	15.9	46.1	13.2	62.4	9.9	18.3	19.9	10.2	11.5	10.3	37.6	95.9	15.9	9.6	12.0	10.0	25.3	44.1	27.7	5.9	17.0	12.6	19.5	17.0	35.2	16.0	21.1	7.8	9.5	30.7	14.1	10.3	11.3	24.4	18.2	9.9	10.6	26.8	11.4	10.4	14.3	7.5	19.1	9.2	22.0	7.8	7.3	51.7	15.3	39.6	15.4	18.4	16.2	28.3	10.1	21.5	4.1	16.3	31.6	7.1	9.7	5.3	16.7	18.7	7.6	11.7	12.9	28.8	24.8	12.7	8.8	14.7	18.3	16.9	42.9	5.1	39.7	30.5	5.9	8.7	32.3	44.7	11.1	4.5	8.2	8.5	16.9	13.0	5.9	18.4	27.9	16.5	17.7	5.3	11.8	17.9	5.2	24.4	15.1	19.9	11.3	24.3	20.5	13.6	19.1	10.1	8.9	11.4	4.1	21.4	7.7	14.4	74.1	20.7	44.9	22.9	19.6	21.0	14.7	23.3	19.2	21.4	13.1	19.7	15.4	19.8	15.0	15.8	24.9	28.8	16.5	10.7	12.7	20.2	12.6	11.5	10.3	12.0	10.0	12.6	10.3	9.9	19.1	14.9	6.4	11.0	11.8	11.7	5.9	12.4	25.0	6.2	13.5	9.1	7.9	6.0	45.8	16.7	18.4	18.8	25.3	19.7	9.9	5.9	21.1	31.0	9.5	6.0	9.1	7.2	4.0	6.6	28.5	22.4	14.5	9.7	5.7	5.1	8.9	20.3	63.3	14.9	5.0	12.2	8.5	16.2	8.2	5.9	17.9	32.3	9.2	10.6	5.6	8.7	19.2	6.2	27.2	23.9	12.0	17.9	18.0	16.6	6.3	52.1	32.0	19.8	54.1	13.1	8.5	8.6	45.3	7.5	7.7	5.5	23.1	13.6	17.4	8.9	9.5
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013007, HPA056420"	Approved		Supported	Cytosol		NA	Yes		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB013007: , HPA056420: AB_2683125"	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	633.3	440.1	241.0	373.7	251.2	861.1	763.0	250.7	307.9	658.2	234.9	593.6	460.9	547.0	422.0	735.8	584.3	376.6	477.8	230.9	261.7	469.8	522.5	416.4	644.4	256.5	247.8	1180.8	609.6	401.9	288.1	429.5	259.1	441.1	540.1	183.9	509.2	390.8	880.0	782.4	446.7	459.1	256.5	393.7	534.8	181.7	242.0	629.3	440.1	600.1	758.9	624.2	626.6	272.0	1148.3	747.2	798.7	1145.9	779.6	1301.4	1246.4	781.1	1084.9	1327.8	1267.4	972.1	1267.3	1719.2	1203.2	816.0	963.9	787.9	1176.6	2011.7	1517.2	716.2	1502.5	976.3	652.7	1280.2	1132.7	934.0	754.5	1139.7	1597.0	857.6	1572.3	1512.0	1227.4	975.3	924.1	1087.8	1134.7	1037.8	1410.0	1735.0	1017.4	423.0	742.0	1061.5	944.4	2147.0	1414.6	1126.0	930.6	1239.4	767.0	861.7	1650.4	744.4	1108.4	1884.6	894.7	569.6	780.5	690.2	2142.1	1020.7	1114.3	1607.2	757.0	1405.3	862.8	261.1	883.1	221.9	535.6	684.0	907.0	957.3	906.7	754.3	1140.2	788.4	986.3	892.7	116.0	878.6	556.1	637.6	1146.0	2128.9	241.0	251.2	250.7	307.9	230.9	261.7	256.5	247.8	259.1	256.5	242.0	272.0	753.2	246.8	324.7	17.0	889.7	1962.5	2039.6	2425.9	1664.7	138.9	1675.6	2355.4	357.8	566.2	908.0	323.7	43.8	1370.6	740.7	648.3	909.8	971.1	718.0	502.1	809.7	864.3	592.8	968.4	25.2	1219.7	2062.4	753.8	465.3	646.9	417.7	935.1	742.8	439.4	1066.3	85.8	29.3	1169.4	787.3	968.7	1357.2	464.2	1248.3	803.3	791.5	29.0	1487.9	376.5	726.1	20.6	49.6	1221.7	998.2	846.3	540.1	1626.5	1308.9	1229.5	432.9	137.6	644.2	1023.8	1051.0	333.7	238.2	1582.0	1953.2	1712.1	868.7	1029.7	1337.1	2269.9
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056199-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	44.6	51.9	28.4	30.3	29.3	61.0	43.6	28.8	36.1	31.4	28.3	25.1	14.5	36.4	30.7	36.0	36.5	23.9	40.1	28.8	33.0	35.0	40.9	26.3	36.6	31.0	31.2	52.9	38.3	42.1	31.0	37.4	31.6	29.2	23.6	31.4	29.9	24.5	70.1	35.9	18.6	34.8	30.3	28.1	27.6	34.0	31.8	49.2	43.1	59.0	40.8	42.3	29.9	39.7	99.8	23.7	113.5	59.6	60.4	76.4	117.3	96.1	96.3	108.0	115.2	43.8	50.8	92.3	93.9	68.3	127.1	56.6	111.1	75.0	137.0	64.4	77.7	105.8	41.0	65.5	163.8	118.2	70.0	79.2	101.0	100.2	140.1	89.1	86.9	75.1	81.5	57.0	98.0	42.1	82.6	69.9	202.7	76.7	51.2	53.6	132.1	109.8	105.3	78.6	89.1	100.6	112.5	102.8	141.7	124.8	92.8	124.8	64.0	60.5	65.4	78.4	114.8	98.9	176.3	89.4	52.2	90.0	77.9	70.3	74.2	70.9	29.7	78.9	40.2	49.9	42.8	31.0	72.9	49.7	49.1	38.2	31.6	49.7	70.9	34.3	62.6	64.3	28.4	29.3	28.8	36.1	28.8	33.0	31.0	31.2	31.6	30.3	31.8	39.7	60.4	35.3	22.3	17.0	76.0	107.7	91.7	153.6	65.4	43.6	81.2	75.6	44.7	52.9	82.2	69.9	33.3	111.1	45.9	18.7	168.3	106.0	115.3	82.9	83.6	55.1	52.2	114.9	30.8	80.1	137.6	77.2	44.4	73.3	22.8	128.2	56.0	81.0	129.3	38.7	32.9	33.8	120.1	127.8	92.9	25.4	72.4	87.4	78.2	27.2	86.5	62.0	49.4	29.7	39.5	72.7	26.3	55.7	58.7	135.9	23.4	162.9	75.7	33.2	59.2	73.7	106.3	97.1	31.1	108.5	160.3	145.8	56.0	114.9	34.8	106.7
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 965.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 161.8;HMC-1: 160.8;RT4: 131.3;U-266/70: 259.8;U-266/84: 141.2"	"Low region specificity"	"Detected in all"							HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	274.5	244.6	38.3	124.3	40.7	309.3	118.8	58.4	45.0	101.7	36.7	231.5	88.5	91.9	41.5	313.4	355.0	157.8	256.3	35.1	49.0	132.2	20.8	105.0	122.0	61.8	42.1	554.9	488.9	37.4	209.2	106.7	43.6	265.9	205.7	152.6	75.1	182.9	210.7	134.4	111.1	213.7	49.3	107.1	244.5	10.2	42.4	334.6	201.2	287.1	132.3	279.9	79.1	42.1	4.3	6.1	10.9	4.5	13.4	9.8	92.9	11.2	21.4	2.8	10.5	8.8	1.6	161.8	7.8	3.5	1.8	69.5	39.6	42.6	5.2	10.8	20.3	84.5	12.3	18.4	29.5	0.4	160.8	10.1	76.7	10.3	18.7	9.5	57.6	8.2	40.6	106.9	28.1	3.6	18.1	5.4	4.9	1.7	1.2	11.4	36.5	84.3	5.3	131.3	1.9	11.3	8.6	3.6	1.4	80.0	9.0	10.1	14.3	0.3	18.2	2.9	0.6	259.8	141.2	103.4	2.2	4.1	6.3	8.4	19.7	23.1	10.0	27.1	14.8	29.9	10.9	10.2	11.5	29.0	17.5	12.6	77.1	12.7	35.6	38.6	11.2	19.7	38.3	40.7	58.4	45.0	35.1	49.0	61.8	42.1	43.6	49.3	42.4	42.1	555.8	157.0	241.8	6.5	330.1	230.2	464.4	311.4	548.7	25.4	355.1	276.7	274.8	48.6	128.5	187.6	29.2	50.0	343.9	345.8	15.6	113.2	1.4	336.7	211.7	196.4	965.1	127.6	2.9	163.7	16.6	352.8	562.2	643.2	369.3	40.6	148.2	6.5	120.1	3.3	2.0	617.1	264.5	98.8	183.6	3.1	72.7	227.0	120.9	25.3	47.5	478.8	58.7	4.5	10.4	55.9	399.9	55.3	725.2	230.1	397.5	13.9	88.5	38.9	124.9	537.5	305.0	1.8	1.7	343.8	447.9	138.0	300.8	278.6	360.7	211.8
BTG3	"ANA, ANA/BTG3, APRO4, tob55"	ENSG00000154640	"BTG anti-proliferation factor 3"	Q14201	21	17593653-17612945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 526.3;Syncytiotrophoblasts: 1692.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 31.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018400	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA018400: AB_1845487"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.40e-1)"	30.8	27.9	13.1	14.0	14.6	55.9	24.2	13.3	16.1	32.0	14.0	28.8	16.5	48.2	110.3	25.4	51.5	22.8	28.8	14.4	16.2	23.5	12.9	44.7	13.9	14.8	13.4	28.4	21.0	35.3	43.7	61.1	15.0	25.2	26.9	5.1	27.2	20.5	4.9	42.5	16.4	28.4	14.7	15.1	21.2	47.5	15.5	27.4	27.2	5.3	16.4	39.3	37.7	17.8	70.5	14.4	84.9	6.8	28.4	50.9	62.6	96.0	109.8	83.5	84.9	33.0	29.3	31.5	44.7	34.8	108.7	17.1	42.5	63.3	91.9	99.6	60.6	23.5	30.9	31.5	59.4	26.6	44.3	44.4	88.2	70.8	67.7	47.7	42.0	30.7	22.9	113.6	78.3	0.0	51.2	4.0	44.4	9.7	4.2	16.6	110.5	23.1	55.2	31.3	43.2	34.9	71.9	36.6	86.7	96.0	1.2	28.6	27.7	84.0	89.1	65.6	96.9	74.1	64.6	29.5	84.4	0.2	102.2	1.0	2.3	4.0	8.1	1.7	9.4	7.4	13.6	13.0	1.9	6.3	6.6	9.1	0.2	6.2	1.9	8.8	31.7	5.5	13.1	14.6	13.3	16.1	14.4	16.2	14.8	13.4	15.0	14.7	15.5	17.8	65.2	205.1	156.5	0.7	44.7	360.1	526.3	309.9	178.7	1.1	64.8	55.0	9.3	34.3	195.5	58.8	0.0	436.5	61.6	25.3	39.2	56.9	8.6	197.0	97.1	51.0	108.3	99.1	2.2	39.3	88.6	132.5	17.9	147.3	65.4	13.5	32.2	5.5	55.6	23.5	3.1	47.9	69.2	16.5	140.4	24.8	70.2	54.5	85.4	16.9	33.5	19.5	12.3	20.1	14.6	52.9	22.7	46.6	75.1	463.0	2.6	2.1	104.3	1.0	92.1	95.5	99.1	300.0	267.2	92.7	294.4	1692.7	99.2	47.5	48.6	470.3
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.6;lymphoid tissue: 78.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 557.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 557.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	6.3	2.9	2.3	30.7	2.6	32.6	4.4	2.8	3.4	3.9	3.1	6.6	4.8	2.5	1.5	3.6	1.9	7.6	1.6	2.3	3.1	1.3	5.4	19.6	55.5	4.7	3.6	0.8	1.2	0.9	0.9	7.0	4.7	1.9	9.1	0.3	2.8	2.3	0.6	2.9	14.7	7.1	3.8	38.4	7.0	1.4	3.9	9.3	1.3	2.0	78.0	9.3	1.5	6.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	206.7	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.3	287.4	0.0	0.0	0.0	116.7	990.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	61.9	2.3	0.0	0.0	0.6	81.5	1.6	0.0	0.0	87.2	0.1	13.2	0.0	0.0	0.2	0.0	0.3	0.1	0.5	1.0	0.0	68.5	0.4	0.0	0.3	0.2	0.1	2.6	1.4	98.3	0.5	149.8	0.3	557.5	62.2	110.5	0.2	99.9	0.2	72.4	0.2	0.1	72.7	73.0	0.4	0.1	24.7	0.2	123.9	33.1	0.1	38.4	2.3	2.6	2.8	3.4	2.3	3.1	4.7	3.6	4.7	3.8	3.9	6.5	1.5	3.2	8.9	0.3	84.7	1.0	0.2	0.0	0.6	0.0	0.9	1.4	0.6	0.0	0.6	0.0	0.0	1.4	30.1	0.1	0.0	0.0	0.2	1.3	0.3	0.8	0.0	27.1	0.5	0.0	0.5	0.9	1.1	2.3	211.4	0.0	0.7	0.3	56.6	0.0	0.3	0.3	0.0	63.5	31.0	0.1	0.3	61.1	3.6	10.3	71.1	0.0	2.1	0.0	0.1	0.1	0.5	0.0	43.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.7	1.7	0.5	0.3	1.9	5.7	0.2	0.1	0.1
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463966-112499472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 28.6"	"Cell type enriched"	"Detected in some"	4	"B-cells: 66.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	4	"B-cells: 96.5;dendritic cells: 24.9"	"Cell line enhanced"	"Detected in single"		"U-698: 2.0"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.4	0.3	0.0	11.2	0.0	2.1	1.9	0.1	0.4	0.5	0.0	1.7	1.6	0.3	0.1	0.6	0.3	1.1	0.2	0.0	0.0	0.3	0.6	0.9	26.4	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.4	1.6	0.2	1.3	0.1	0.1	0.1	3.1	0.4	0.0	10.8	3.0	0.1	0.0	7.7	0.3	0.1	28.6	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.1	0.0	11.2	0.0	8.3	65.0	13.6	6.5	4.6	96.5	12.7	12.6	0.5	0.3	0.1	24.9	3.4	6.5	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	66.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.5	1.3	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.0	1.3	4.7	3.6	0.0	1.6	7.2	0.0	1.9	0.0	0.0	1.0	0.3	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.7	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.3	0.1	8.6	0.0	0.0	0.1
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"breast: 32.5"	"Cell type enriched"	"Detected in some"	43	"Breast glandular cells: 111.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011126, CAB037340"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 5: Breast - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	32.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	111.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019208	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (4.52e-5)"	16.1	17.3	10.8	11.4	10.7	16.8	13.3	19.9	13.1	15.5	11.4	17.7	9.8	16.7	8.3	8.9	16.1	10.2	16.0	11.1	15.2	13.6	9.1	18.4	13.9	12.1	13.2	15.2	8.9	4.8	11.9	19.0	13.7	13.3	11.0	4.5	9.5	14.4	11.7	8.2	15.0	16.9	12.0	25.7	12.2	11.7	13.5	10.6	10.5	10.1	11.4	17.3	13.3	12.2	16.4	14.5	28.9	18.3	12.7	10.2	1.4	36.1	30.1	42.3	38.7	13.5	11.0	13.3	47.3	24.5	54.9	7.0	22.1	8.9	40.2	18.4	21.6	7.9	15.3	16.0	19.9	11.8	21.2	13.9	8.2	47.1	15.2	25.1	15.3	25.4	13.5	20.6	35.7	6.7	19.9	18.2	9.7	4.8	11.9	17.0	27.3	13.6	16.5	7.3	28.9	16.4	11.2	14.8	26.4	17.8	4.3	9.9	21.3	32.1	16.6	28.1	40.8	16.1	40.4	11.1	12.8	22.0	52.1	43.6	9.0	30.2	11.1	5.2	9.8	8.6	9.3	12.4	8.4	6.2	8.6	11.0	51.7	9.9	8.8	8.9	16.0	7.2	10.8	10.7	19.9	13.1	11.1	15.2	12.1	13.2	13.7	12.0	13.5	12.2	21.2	16.0	14.7	7.5	20.0	8.0	8.0	8.5	9.1	8.0	11.8	10.9	17.6	7.2	11.7	9.2	6.2	6.1	35.4	16.0	3.9	10.9	3.2	18.1	17.7	22.1	9.0	4.6	8.9	12.8	11.2	14.7	18.8	20.8	24.6	13.3	21.8	6.2	11.6	3.3	10.2	14.8	12.2	17.9	16.7	6.2	12.8	18.4	10.6	10.3	21.9	6.0	25.7	10.6	7.8	16.4	10.2	12.8	18.9	13.1	11.4	4.7	26.9	2.3	39.5	12.4	24.4	8.7	12.9	7.3	8.1	11.8	25.0	14.9	12.9	17.9
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 30.3;Plasma cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 72.8;U-266/70: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051504	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.2	13.5	5.4	21.9	6.9	4.3	8.7	14.4	6.0	7.9	21.2	8.0	7.2	10.2	7.5	5.1	8.4	8.5	4.9	6.8	5.9	7.5	6.1	16.2	32.1	7.5	6.9	10.4	5.2	17.5	5.7	4.0	7.8	8.3	10.5	2.9	12.1	6.8	2.8	11.0	11.3	10.9	6.5	21.8	10.4	6.1	6.2	15.2	7.5	4.2	36.6	8.2	6.9	6.9	10.6	6.6	13.2	14.2	4.4	6.8	0.9	11.4	29.7	17.4	30.0	4.2	4.1	9.6	12.1	20.5	14.1	9.5	10.7	8.7	23.1	29.9	17.9	15.0	13.2	8.4	9.1	3.4	5.1	14.5	2.7	33.5	11.3	20.7	16.3	18.5	12.3	72.8	7.9	4.6	12.1	4.4	5.0	0.4	6.6	28.1	18.7	29.8	12.7	5.9	12.6	17.6	7.4	2.8	31.1	7.5	13.5	6.6	19.5	6.4	7.3	5.6	17.7	58.9	38.8	16.9	6.4	13.4	16.3	2.1	13.7	2.4	6.1	14.6	5.8	24.1	5.0	5.7	23.9	29.4	4.1	5.1	12.4	8.7	6.3	9.7	10.3	7.9	5.4	6.9	14.4	6.0	6.8	5.9	7.5	6.9	7.8	6.5	6.2	6.9	8.1	9.6	12.6	0.0	30.3	3.8	7.3	6.5	6.2	0.6	5.2	5.1	2.5	2.8	8.5	3.7	0.0	2.3	15.0	0.6	0.0	8.6	0.4	8.8	4.5	13.1	1.8	3.6	0.0	5.6	0.8	5.0	3.6	7.5	19.6	9.6	6.1	3.8	8.4	0.0	0.0	7.8	12.2	16.0	24.2	0.6	6.5	17.1	7.2	0.0	15.4	14.3	7.2	0.0	0.0	8.3	0.8	4.9	30.7	6.4	2.6	2.3	10.2	0.7	0.0	5.0	4.4	0.3	1.5	4.5	4.5	1.0	10.0	10.6	2.1	4.2
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"	19.2	20.7	10.2	44.8	11.1	29.6	20.1	9.8	10.5	21.2	10.3	24.8	28.5	28.0	16.0	11.9	22.5	30.5	12.1	9.1	12.1	12.8	18.9	41.4	63.4	16.4	10.9	35.1	13.1	13.1	13.7	19.2	12.5	16.5	28.8	3.6	23.9	13.5	12.8	24.9	35.1	21.3	12.2	84.0	31.3	5.0	11.4	33.1	11.5	14.5	52.6	20.0	17.4	12.0	7.4	6.2	9.3	9.5	25.9	27.5	1.2	6.2	24.1	13.5	39.4	0.3	16.7	19.7	20.4	11.2	20.9	5.1	3.0	9.7	8.2	19.5	6.4	10.4	8.5	4.7	11.8	9.5	9.3	15.0	5.6	11.8	5.4	20.4	19.3	31.0	2.5	25.3	5.5	0.6	17.6	6.6	1.0	3.3	2.1	24.2	4.0	45.2	8.3	9.4	4.9	9.8	3.4	7.1	13.5	1.4	6.5	4.0	4.8	10.3	2.6	3.1	5.9	41.8	45.9	7.3	15.6	21.4	8.4	53.8	11.1	28.8	44.7	11.7	40.4	18.8	27.8	42.3	9.1	10.5	24.1	32.0	23.9	40.5	12.9	4.3	36.0	28.0	10.2	11.1	9.8	10.5	9.1	12.1	16.4	10.9	12.5	12.2	11.4	12.0	24.8	16.0	6.5	0.0	27.1	4.2	3.9	3.5	2.2	4.3	8.6	8.1	4.2	11.5	8.5	5.5	0.0	5.5	59.1	8.2	0.0	7.4	0.1	5.5	10.4	18.0	4.8	13.3	0.0	3.2	4.3	9.9	9.2	10.3	25.9	14.0	11.7	3.9	7.2	0.0	0.0	17.3	2.0	19.2	6.1	0.8	3.7	15.4	1.8	0.0	13.7	1.9	73.2	0.0	0.0	2.2	6.3	2.6	47.6	5.4	15.9	1.3	6.7	0.4	0.0	6.7	5.5	0.0	0.1	3.6	3.3	1.5	50.1	8.4	7.4	5.0
BTN3A2	BTN3.2	ENSG00000186470	"Butyrophilin subfamily 3 member A2"	P78410	6	26365159-26378320	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.2;NK-cells: 239.9;T-cells: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 87.5"									CAB019392	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB019392: "	"unprognostic (3.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.89e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-3)"	19.4	27.3	8.6	41.9	8.5	9.5	18.4	7.6	8.7	18.1	7.9	29.0	29.3	21.7	21.0	13.5	22.0	25.0	13.8	7.3	9.3	15.8	23.6	41.0	45.5	13.1	8.9	29.6	10.4	10.4	12.7	18.4	9.9	14.9	31.7	2.4	19.4	14.9	8.4	21.7	32.9	20.8	10.5	88.3	32.6	7.1	8.7	38.3	14.4	10.7	44.6	22.9	17.0	10.9	10.6	4.8	6.4	6.7	37.4	42.9	2.2	10.2	48.2	18.8	52.6	2.7	34.4	30.6	35.5	16.2	27.5	9.2	9.4	18.6	17.1	18.5	13.2	33.1	19.1	20.1	20.7	18.9	26.5	27.0	7.5	17.9	8.5	43.9	36.0	54.0	8.5	41.1	13.1	1.4	16.2	30.4	0.4	8.6	3.6	24.3	11.5	87.5	17.1	6.5	4.2	12.8	8.2	7.5	25.7	1.9	7.5	14.0	22.4	17.7	4.0	7.6	11.3	86.1	79.7	17.7	32.2	33.2	17.5	67.7	26.7	57.6	128.3	35.9	96.1	64.5	81.3	113.8	19.2	53.4	81.8	100.1	40.0	98.8	47.5	13.5	111.2	71.3	8.6	8.5	7.6	8.7	7.3	9.3	13.1	8.9	9.9	10.5	8.7	10.9	62.5	32.1	22.2	2.3	61.3	10.3	12.2	8.6	13.1	0.7	16.0	9.9	7.5	17.2	7.4	12.9	0.0	14.3	117.2	21.8	1.9	25.6	0.2	23.6	21.3	46.0	10.1	25.2	1.0	13.7	17.3	20.2	15.8	14.7	47.4	23.4	40.0	9.8	17.8	0.0	2.5	37.9	10.2	54.0	10.0	1.9	11.1	37.1	3.6	20.6	52.7	7.0	239.9	7.1	1.7	10.6	16.9	10.5	76.6	13.2	50.5	3.8	11.8	1.4	13.1	15.7	10.2	1.5	0.2	8.3	13.4	3.3	108.0	51.0	25.5	16.8
BTN3A3	"BTF3, BTN3.3"	ENSG00000111801	"Butyrophilin subfamily 3 member A3"	O00478	6	26440472-26453415	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 26.9;NK-cells: 33.0;Plasma cells: 30.5;T-cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.8"									"HPA007904, HPA011871"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA007904: AB_1078307, HPA011871: AB_1845496"	"unprognostic (1.18e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.13e-3)"	"unprognostic (8.08e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.54e-3)"	14.9	19.6	7.4	20.0	7.0	5.5	12.0	6.5	7.9	16.6	8.0	15.0	17.5	16.7	18.7	8.3	20.3	20.3	9.0	7.2	9.0	8.9	20.6	33.7	29.2	10.0	7.2	19.5	4.8	5.0	12.2	10.2	7.6	9.4	14.6	1.8	12.3	11.2	5.8	11.6	16.7	17.1	9.0	47.2	16.3	3.3	7.5	21.5	9.2	14.4	22.8	16.7	9.5	8.2	4.1	1.8	1.8	1.6	33.2	62.8	0.5	5.4	29.7	12.0	43.8	0.0	12.3	25.0	24.5	9.0	11.1	2.9	2.6	9.7	5.8	21.4	4.2	11.5	11.8	1.3	24.2	6.4	2.1	33.4	3.8	10.5	3.9	19.3	24.1	9.4	0.5	3.7	6.7	0.0	16.7	5.3	0.1	0.0	2.9	16.7	3.3	24.9	9.4	3.3	2.2	3.9	3.3	3.1	6.2	0.4	0.8	3.5	15.0	5.8	1.3	6.5	3.8	4.1	1.0	2.5	15.4	12.0	6.2	49.0	15.7	13.4	54.7	23.2	43.7	19.3	37.6	55.5	12.4	14.0	36.3	49.0	11.6	45.9	24.6	6.4	46.2	33.3	7.4	7.0	6.5	7.9	7.2	9.0	10.0	7.2	7.6	9.0	7.5	8.2	20.3	9.6	7.7	0.3	15.9	1.8	1.9	2.8	8.0	0.2	3.6	2.8	4.9	0.0	5.2	0.0	0.0	2.5	26.9	6.4	1.9	5.3	4.6	4.2	9.4	22.1	1.2	9.9	1.4	2.3	1.6	11.1	7.1	4.3	3.8	8.7	15.7	4.0	4.3	0.0	2.1	8.9	0.0	20.8	4.0	18.0	4.1	12.4	3.6	2.8	12.6	2.3	33.0	1.5	0.4	2.4	3.9	2.2	30.5	2.0	12.8	1.1	3.3	0.0	6.6	4.9	4.0	0.4	0.3	3.1	2.0	0.5	27.1	12.3	6.2	1.9
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 119.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 79.6;Proximal enterocytes: 178.9"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 233.4"	"Lineage enriched"	"Detected in many"	221	"granulocytes: 233.4"	"Group enriched"	"Detected in some"	28	"CACO-2: 39.3;OE19: 56.2"									HPA039738	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.6	0.3	0.2	2.1	0.2	7.3	0.5	0.2	0.4	0.0	0.1	26.7	119.0	0.1	0.0	0.2	1.3	6.9	0.3	0.2	0.3	0.6	0.6	2.6	0.3	0.3	0.3	0.1	1.7	0.2	0.2	0.2	0.4	0.1	25.7	0.0	0.1	0.0	0.3	0.0	86.5	0.6	0.2	3.1	7.2	5.5	0.3	0.2	1.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	56.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	1.6	0.0	0.2	0.4	0.0	0.1	1.0	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.4	0.0	0.5	0.0	0.4	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	0.3	0.4	0.2	0.3	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	8.6	0.1	0.0	0.0	0.0	0.0	79.6	0.0	0.2	0.3	0.0	0.0	0.6	3.6	0.0	0.3	2.6	0.0	0.2	12.2	0.0	0.0	0.0	11.7	0.1	0.8	0.0	0.1	29.6	0.0	4.5	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.3	0.0	0.0	0.0	178.9	0.1	0.8	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	15.6	0.1
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	5.2	9.2	16.3	3.8	19.3	2.8	8.5	8.9	17.4	6.8	7.8	6.3	3.9	6.1	10.5	8.4	7.7	5.8	14.6	18.9	16.3	8.0	6.4	4.9	4.2	10.7	12.6	11.0	6.5	13.1	9.4	7.9	13.7	8.8	4.7	21.6	6.9	5.9	12.2	6.8	4.7	7.1	10.0	6.5	5.7	13.8	16.3	6.4	8.5	12.1	5.6	6.4	6.7	13.7	8.7	13.0	17.2	20.0	16.1	14.1	6.3	12.0	18.4	11.8	10.0	9.0	6.5	13.8	11.8	9.9	12.3	12.9	14.1	13.0	11.7	9.5	11.5	10.1	8.0	11.5	8.9	14.9	5.7	9.0	14.7	10.4	18.4	22.4	15.3	12.7	11.0	4.5	12.0	7.2	9.8	7.5	7.8	9.0	9.9	12.4	24.6	2.8	10.3	5.4	12.9	11.2	8.1	3.5	11.3	19.2	9.2	5.1	12.7	6.1	10.3	8.6	8.5	7.5	18.2	8.7	6.4	7.3	3.9	1.8	1.7	1.8	2.9	1.5	2.8	2.5	3.0	2.5	2.3	2.1	3.4	2.8	1.1	2.5	1.6	1.1	2.8	1.6	16.3	19.3	8.9	17.4	18.9	16.3	10.7	12.6	13.7	10.0	16.3	13.7	8.6	3.2	9.4	109.7	6.9	5.6	4.1	6.9	12.5	32.5	10.0	7.4	28.0	8.6	10.6	3.7	29.2	11.5	6.1	5.0	7.9	9.7	41.9	11.7	12.4	9.0	3.0	20.6	154.0	7.2	7.2	10.3	3.6	10.6	13.9	10.1	6.4	6.7	5.9	16.8	144.4	4.9	6.1	3.5	2.5	21.6	9.0	5.0	1.8	69.3	4.6	13.6	8.2	183.5	148.0	7.9	3.2	10.5	6.3	6.6	5.5	9.4	13.0	26.0	6.6	8.3	7.6	33.8	18.3	7.4	7.1	12.4	8.2	5.9	4.8	6.2
BUB3	BUB3L	ENSG00000154473	"BUB3 mitotic checkpoint protein"	O43684	10	123154402-123170467	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003601, CAB037075"	Supported		Supported	Nucleoplasm		NA	Yes		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB037075: AB_1078310, HPA003601: AB_1078309"	"unprognostic (7.82e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (9.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.93e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (4.45e-5)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (8.80e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.71e-2)"	36.6	49.8	27.3	63.3	34.5	102.9	41.1	35.0	35.0	36.0	30.7	49.0	42.2	35.7	35.2	56.6	37.6	35.8	28.0	31.9	36.4	32.6	34.9	33.5	99.9	34.1	50.6	42.9	30.1	32.6	36.0	38.2	39.6	30.6	49.1	25.5	39.5	28.8	36.9	44.1	47.7	36.4	35.7	52.9	38.4	58.5	33.0	100.6	37.4	33.5	87.2	49.5	40.4	48.6	309.8	302.5	190.4	211.5	105.4	100.3	166.2	316.2	329.5	340.3	268.8	266.3	203.2	275.9	116.3	145.2	163.6	195.9	285.1	343.0	349.9	228.8	294.2	173.0	355.1	291.8	110.1	338.1	206.8	86.5	132.9	307.9	382.4	182.1	232.7	228.9	216.1	266.7	308.4	264.1	281.8	206.9	117.6	159.0	293.0	378.6	96.2	175.7	156.3	333.1	141.4	143.1	179.2	116.6	151.9	77.5	135.0	173.4	188.5	262.4	163.9	167.6	473.8	143.0	220.6	433.9	143.0	333.2	113.2	200.3	113.2	165.7	246.0	122.2	224.1	216.7	223.0	251.0	119.1	209.7	237.9	249.3	56.1	241.6	112.3	127.6	366.9	294.0	27.3	34.5	35.0	35.0	31.9	36.4	34.1	50.6	39.6	35.7	33.0	48.6	55.8	25.6	36.5	15.3	99.7	130.5	65.5	154.6	73.4	30.8	53.4	48.8	39.2	44.3	66.9	38.6	10.4	108.1	119.0	37.1	70.5	68.8	160.8	26.1	41.4	62.1	40.7	93.6	14.4	58.9	136.5	62.6	34.7	28.1	50.7	56.3	45.0	43.0	80.7	10.1	12.9	57.3	118.0	58.1	68.6	159.3	45.1	53.1	96.0	16.9	140.4	55.7	97.9	21.6	35.9	64.1	40.2	46.3	107.1	64.7	44.5	78.4	51.2	25.1	105.2	42.2	70.6	199.8	145.4	86.3	133.3	65.0	150.3	84.1	67.8	62.9
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	10.8	7.5	7.4	12.2	8.9	12.7	13.5	10.5	9.3	11.8	8.5	11.9	11.0	15.4	10.5	11.4	13.7	8.1	8.0	7.3	8.8	9.1	9.7	12.2	16.4	8.6	8.1	16.0	11.3	10.5	8.0	11.0	8.8	10.2	13.4	10.6	10.1	10.6	12.3	11.2	12.8	12.8	7.7	12.7	11.3	21.6	8.5	25.5	12.0	14.0	18.8	11.0	11.2	10.4	22.4	12.0	33.3	20.1	10.4	12.5	16.6	21.6	23.9	24.3	23.5	28.6	33.0	47.1	26.8	17.9	25.4	30.7	27.2	16.8	26.6	27.8	11.1	55.1	8.8	21.8	12.7	46.9	31.6	11.3	19.2	20.6	20.8	15.6	24.0	46.1	36.0	22.8	20.2	17.7	57.5	41.0	20.0	31.6	19.0	42.9	28.6	36.3	17.0	25.5	19.7	26.2	25.3	18.3	10.0	21.0	25.1	30.6	13.7	27.7	17.5	14.3	29.0	9.3	12.4	39.1	9.0	42.6	25.3	15.8	7.6	20.2	10.0	7.8	10.8	10.4	8.6	7.9	8.2	7.4	9.5	8.1	9.1	7.5	8.7	7.2	8.1	5.7	7.4	8.9	10.5	9.3	7.3	8.8	8.6	8.1	8.8	7.7	8.5	10.4	11.7	9.6	5.6	6.2	14.3	7.6	10.8	7.1	11.4	6.8	6.6	6.0	4.9	2.8	6.5	9.2	12.5	9.2	9.5	11.7	7.9	8.5	13.5	10.4	8.7	8.5	9.6	17.7	7.2	8.1	10.5	7.8	7.1	9.3	11.4	9.6	7.1	8.0	8.2	3.3	6.8	6.9	2.0	12.0	6.7	5.3	9.0	7.8	7.2	3.7	9.4	7.3	26.8	9.0	11.2	6.4	8.5	10.9	16.6	6.4	15.4	5.8	10.9	7.3	6.6	8.5	7.7	51.2	21.8	11.0	4.8	9.9	13.1	7.9	11.3	7.0
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23 rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 712.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	39.8	49.2	34.5	40.0	36.7	58.7	43.4	36.4	39.8	36.3	41.0	48.6	47.0	38.6	72.3	41.7	58.9	34.5	87.9	36.1	39.0	53.3	47.2	38.5	52.6	37.0	36.1	37.8	70.8	49.2	45.1	30.7	36.3	37.8	47.7	20.3	55.9	42.2	128.0	43.8	40.3	41.4	36.4	42.1	44.9	130.0	36.6	44.7	56.5	78.4	51.7	51.9	32.8	38.5	142.1	151.8	53.6	429.2	72.0	64.2	91.1	95.1	83.3	118.5	96.1	211.4	182.6	163.6	48.9	99.5	204.0	97.0	124.8	91.0	108.4	116.6	147.1	72.0	174.8	86.7	91.2	200.3	98.8	57.3	102.2	103.2	93.9	59.7	77.4	130.3	285.4	288.9	103.7	219.6	128.0	277.8	130.2	317.8	172.2	110.5	106.8	712.0	132.5	100.2	163.4	124.4	126.3	329.2	146.5	53.0	207.9	159.0	85.2	101.8	130.3	130.0	208.3	99.5	192.6	275.5	232.3	155.6	218.0	54.8	64.9	60.6	112.0	74.2	124.9	175.3	127.1	122.5	122.9	153.5	132.8	121.5	11.9	125.4	68.0	190.9	150.6	132.6	34.5	36.7	36.4	39.8	36.1	39.0	37.0	36.1	36.3	36.4	36.6	38.5	67.0	44.8	64.5	0.0	26.5	0.0	0.0	0.0	0.0	0.0	75.4	85.7	0.0	0.0	42.7	46.0	0.0	75.7	64.1	0.0	97.8	119.9	0.0	133.6	51.2	28.6	0.0	0.0	0.0	140.8	82.7	24.5	0.0	79.6	46.7	49.2	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	21.2	0.0	0.0	0.0	0.0	126.0	0.0	0.0	16.5	0.0	0.0	103.5	78.7	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	106.7	28.1	73.0	0.0	0.0
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	48.2	47.1	51.3	32.6	51.0	91.7	45.9	54.5	59.7	37.8	52.3	46.4	32.0	38.1	35.4	49.6	39.9	32.2	39.6	51.9	51.8	65.5	42.9	43.4	45.5	51.4	51.3	39.0	33.9	41.1	54.0	33.9	51.6	42.3	25.7	14.8	37.9	30.8	31.6	40.8	35.2	29.2	51.5	40.9	44.0	68.4	55.0	41.1	41.2	25.1	35.8	40.3	40.7	53.2	111.2	123.9	67.5	153.9	67.3	75.0	67.0	103.7	96.7	113.4	124.1	148.5	104.5	83.7	122.7	98.3	123.8	65.5	76.0	92.9	93.8	102.3	106.9	61.1	83.1	98.2	139.4	106.0	78.2	73.8	112.1	104.1	195.1	66.4	89.8	87.6	151.7	182.3	106.2	283.9	143.3	281.2	152.2	114.6	156.8	73.2	69.5	145.7	100.7	85.6	120.3	145.8	101.8	114.9	216.8	43.8	72.2	129.0	74.8	108.1	138.5	216.8	163.6	115.0	207.2	220.9	94.9	153.6	199.4	390.7	206.8	516.9	175.8	232.0	164.7	226.1	165.5	171.2	175.9	223.9	140.0	145.7	451.2	203.7	252.6	171.2	215.7	360.5	51.3	51.0	54.5	59.7	51.9	51.8	51.4	51.3	51.6	51.5	55.0	53.2	103.2	83.3	81.2	3.6	88.1	192.7	142.3	192.7	103.6	32.8	94.8	134.1	12.8	68.6	110.5	92.0	10.4	169.9	118.5	157.7	238.7	169.9	173.1	137.3	91.7	98.1	146.8	85.2	5.7	187.1	163.0	97.9	65.2	111.9	91.2	79.6	86.0	84.3	151.5	16.8	5.6	187.2	111.9	89.2	125.1	121.3	82.0	90.8	136.9	5.6	148.5	103.5	116.4	5.0	6.8	248.1	153.8	74.1	68.4	153.9	155.4	242.3	171.2	40.1	59.2	77.4	144.3	298.2	135.7	99.1	183.8	182.4	112.0	86.9	132.3	174.8
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
BZW1	"BZAP45, KIAA0005"	ENSG00000082153	"Basic leucine zipper and W2 domains 1"	Q7L1Q6	2	200810594-200827338	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3845.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047288, HPA053272"	Uncertain		Approved	Vesicles		NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA047288: , HPA053272: "	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.08e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-3)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.49e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.97e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.24e-1)"	130.6	129.1	30.3	97.5	33.0	219.6	88.7	37.7	40.9	65.5	49.2	98.4	64.6	66.6	58.4	120.8	53.4	93.1	56.4	33.9	36.9	88.5	227.0	73.5	97.9	36.5	36.7	62.3	62.6	72.4	30.7	105.2	35.3	99.6	90.6	45.8	61.2	61.7	101.7	47.9	71.4	80.1	39.1	62.8	69.0	170.9	42.1	123.0	74.4	75.2	109.4	164.6	61.4	45.4	296.6	230.1	309.4	187.1	305.2	353.3	221.6	425.2	501.8	281.2	244.5	360.7	195.3	142.5	144.7	339.7	186.1	159.8	284.9	512.6	521.8	154.6	151.3	370.8	453.9	280.1	244.5	420.9	199.6	205.3	233.5	373.2	398.9	244.6	495.4	132.3	328.5	234.0	379.3	236.6	387.9	201.3	392.4	120.1	575.4	293.1	333.4	148.6	256.1	435.2	188.9	218.7	325.5	120.9	226.1	255.5	126.6	216.7	555.0	416.8	242.9	255.2	276.6	286.1	428.6	377.8	341.2	209.3	312.1	236.7	140.7	168.5	177.9	173.4	207.2	102.0	126.0	167.5	162.6	87.1	112.4	156.7	117.0	218.5	195.1	75.5	171.5	294.6	30.3	33.0	37.7	40.9	33.9	36.9	36.5	36.7	35.3	39.1	42.1	45.4	207.3	86.6	108.1	31.3	148.5	198.5	318.5	310.7	125.7	37.1	159.0	89.8	18.1	82.9	290.3	90.1	18.8	115.4	263.2	127.5	138.9	250.2	927.0	108.3	145.3	149.0	96.7	72.8	28.7	233.1	164.3	181.2	72.4	150.0	196.9	72.7	99.2	262.4	114.1	58.9	32.1	113.3	183.1	88.6	194.0	3845.6	102.2	169.1	124.5	15.0	308.1	119.6	170.0	24.6	36.6	464.4	106.5	95.9	132.7	242.3	68.2	163.3	121.7	33.4	98.6	159.4	179.8	175.2	169.2	133.2	196.1	195.2	200.3	103.3	106.1	370.9
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 265.5;skeletal muscle: 367.7;tongue: 258.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	26.1	18.1	8.5	26.8	10.1	45.7	49.7	6.9	14.3	19.1	9.7	51.2	28.9	18.4	9.9	42.6	20.2	17.2	265.5	10.2	6.3	37.8	18.4	20.0	30.0	5.2	6.3	16.0	30.0	6.7	10.4	80.4	6.5	19.3	56.8	88.0	23.8	34.3	367.7	55.5	30.0	39.0	5.6	16.5	50.2	11.6	6.9	33.0	36.5	258.9	38.4	59.5	26.2	8.8	91.7	81.3	138.2	201.7	67.5	118.3	125.7	126.0	156.3	117.6	124.9	201.8	129.7	208.0	143.7	96.9	87.6	181.6	164.8	141.5	152.0	27.8	99.8	129.6	84.4	117.0	70.5	180.3	79.1	90.6	74.6	104.0	187.7	92.4	171.6	149.7	251.9	43.5	96.9	105.0	90.0	210.4	143.9	259.5	174.1	111.0	91.2	216.6	113.4	152.6	179.9	106.8	50.8	419.9	67.7	156.7	187.8	149.5	97.6	93.1	119.1	141.5	136.3	89.5	92.8	288.1	45.5	220.6	340.3	2.6	46.0	5.0	27.3	55.2	44.6	44.6	39.8	36.9	98.8	42.9	56.8	47.1	2.1	56.8	41.6	38.5	31.8	44.0	8.5	10.1	6.9	14.3	10.2	6.3	5.2	6.3	6.5	5.6	6.9	8.8	32.8	22.4	60.5	3.9	30.0	57.6	69.9	60.5	82.6	55.9	52.3	57.0	278.2	17.2	53.9	47.8	64.6	214.3	26.8	42.4	58.7	47.5	9.8	31.9	43.2	42.9	30.5	63.5	48.6	65.6	875.6	43.5	110.1	40.6	21.0	33.3	8.9	13.7	65.0	6.7	32.0	49.5	61.1	33.4	46.0	6.4	12.2	30.7	24.9	12.2	47.5	19.7	19.6	19.1	17.9	47.0	42.9	9.8	31.9	52.0	19.2	20.8	32.6	106.4	6.6	30.2	54.2	11.3	4.1	99.6	51.6	762.9	29.3	52.6	90.6	79.0
C10orf53	Em:AC069546.1	ENSG00000178645	"Chromosome 10 open reading frame 53"	Q8N6V4	10	49679651-49710261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 39.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 499.3;Late spermatids: 1522.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037951	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA037951: AB_10671382"										"unprognostic (9.09e-2)"								0.0	0.0	0.4	0.0	0.3	0.3	0.0	1.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	39.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.3	1.8	0.8	0.2	0.4	0.7	0.6	0.4	0.1	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	499.3	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1522.4	4.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	98.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf62	bA548K23.1	ENSG00000203942	"Chromosome 10 open reading frame 62"	Q5T681	10	97589721-97590934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	155	"testis: 277.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 9848.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Vesicles"	"HPA072947: AB_2686562"		"unprognostic (3.66e-2)"		"unprognostic (3.97e-2)"	"unprognostic (2.81e-1)"		"unprognostic (5.36e-2)"		"unprognostic (3.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.63e-2)"		"unprognostic (2.53e-2)"	"unprognostic (2.04e-2)"				0.0	0.2	0.3	0.0	0.8	0.0	0.2	1.4	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.7	0.7	0.0	0.0	0.9	1.0	0.0	0.3	0.1	0.2	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	277.9	0.8	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.4	0.4	0.3	0.5	0.9	1.0	0.9	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1711.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9848.3	39.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	0.0	0.0	40.7	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23202696-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.1;fallopian tube: 4.8;testis: 12.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 38.5;Early spermatids: 40.2;Endometrial ciliated cells: 18.2;Late spermatids: 32.8;Proximal tubular cells: 17.9;Respiratory ciliated cells: 35.7;Spermatocytes: 70.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;SiHa: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038131	Approved		Approved	Vesicles,Microtubules,Mitochondria		NA	No			"Cluster 35: T-regs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Microtubules, Mitochondria"		"HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.0	0.2	1.5	0.2	1.4	0.3	0.1	0.9	1.6	0.1	5.1	0.1	0.5	0.2	1.4	0.1	4.8	0.2	0.7	1.7	1.3	3.5	0.4	2.9	0.3	2.0	2.2	0.5	0.2	0.4	1.2	0.1	1.5	0.0	0.0	0.9	0.1	0.1	0.5	1.3	0.3	0.0	1.3	0.2	0.1	12.4	1.9	0.0	0.6	0.1	0.1	0.0	0.0	2.0	0.7	0.1	0.9	0.1	0.0	0.2	0.3	0.1	0.0	0.9	0.8	0.2	1.3	0.1	0.1	0.8	0.1	3.0	0.1	0.3	0.8	0.3	0.2	0.3	0.7	0.2	0.5	0.1	0.2	0.2	1.0	0.3	0.4	0.1	0.0	0.1	0.3	0.5	0.0	0.3	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.7	0.2	0.5	0.2	3.9	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.8	0.2	0.1	0.5	0.1	0.0	1.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.2	1.2	0.0	1.5	1.4	0.9	1.6	1.7	1.3	2.0	2.2	1.5	1.3	1.9	2.0	0.0	38.5	2.4	0.3	0.0	2.8	0.1	1.9	0.0	0.4	0.0	0.0	1.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.9	0.2	40.2	18.2	0.2	0.1	0.0	0.0	4.7	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	32.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.2	0.0	0.7	0.0	0.0	0.0	17.9	35.7	1.6	6.6	0.0	0.1	70.1	5.2	0.0	1.3	0.0	0.3	0.5	0.1	0.0
C10orf88	"Em:AC073585.5, FLJ13490, PAAT"	ENSG00000119965	"Chromosome 10 open reading frame 88"	Q9H8K7	10	122930901-122954311	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 146.8;Late spermatids: 45.9;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039681, HPA040991"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA039681: AB_10796333, HPA040991: AB_10794432"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.59e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-2)"	2.9	4.4	4.2	4.4	4.2	1.5	4.0	4.3	6.4	3.6	3.7	3.1	3.5	3.9	4.3	3.1	2.9	2.9	3.3	4.3	4.7	3.4	3.3	2.9	5.8	4.4	4.4	4.6	2.3	4.2	2.1	4.4	4.5	3.6	3.6	6.6	2.7	2.9	4.3	3.5	3.3	3.2	4.1	3.9	3.0	10.7	4.5	5.1	4.2	4.2	4.8	3.8	1.5	4.6	6.1	6.3	7.9	7.7	5.9	8.4	6.0	9.8	11.9	10.4	12.2	5.1	5.8	6.0	4.1	7.6	9.2	6.6	8.5	4.9	15.3	10.3	7.0	6.6	5.7	5.9	8.8	7.0	10.0	6.6	9.6	9.9	13.5	14.1	10.9	7.9	6.3	6.8	17.7	3.5	7.8	7.8	4.7	5.2	5.4	7.6	9.2	1.8	6.1	3.8	4.4	9.0	5.1	4.9	11.2	8.8	4.1	4.8	8.2	7.6	4.6	7.4	12.2	6.9	6.7	7.8	8.1	9.6	6.3	1.4	1.7	3.3	2.7	0.8	3.2	3.0	3.6	3.6	2.4	3.1	3.5	3.4	0.2	3.9	1.0	2.1	5.3	2.7	4.2	4.2	4.3	6.4	4.3	4.7	4.4	4.4	4.5	4.1	4.5	4.6	4.7	3.2	4.8	9.4	5.8	6.0	2.3	6.9	6.8	9.8	3.4	3.0	4.6	5.7	6.8	0.0	6.2	5.6	7.2	2.8	11.7	5.3	146.8	4.0	7.0	4.6	4.8	6.9	10.9	3.0	5.3	6.0	3.6	6.0	2.5	4.9	2.2	2.4	4.9	6.7	11.9	3.2	6.1	3.3	2.0	45.9	4.1	4.1	3.6	6.5	3.1	6.1	5.2	13.0	16.7	4.5	1.3	5.7	2.4	2.2	2.5	5.5	5.6	9.2	6.6	5.0	5.7	52.2	14.8	5.3	4.1	3.6	5.9	3.2	3.2	1.7
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126798708	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 112.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 819.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	0.7	0.0	30.4	0.1	74.4	0.0	4.7	41.9	47.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	29.9	37.4	0.3	0.1	0.0	0.0	60.4	53.8	0.1	0.2	0.0	0.3	0.3	57.0	0.0	0.1	0.0	10.6	0.0	0.1	1.1	0.1	0.0	29.8	0.0	0.0	6.5	68.0	1.1	0.3	0.4	0.7	0.0	0.0	112.1	0.3	0.1	0.0	0.0	0.8	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.3	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.2	0.0	4.7	0.0	36.1	0.7	0.0	27.2	0.0	37.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	74.4	41.9	47.7	29.9	37.4	60.4	53.8	57.0	29.8	68.0	112.1	0.2	0.0	0.0	24.5	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	120.5	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	142.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	181.0	819.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	1.3	0.5	0.0	0.0	4.2	0.1	0.0	0.0	0.0
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173801-84185294	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 193.2;intestine: 274.9;vagina: 115.3"	"Group enriched"	"Detected in some"	11	"Distal enterocytes: 853.2;Intestinal goblet cells: 267.6;Paneth cells: 815.9;Proximal enterocytes: 364.8;Undifferentiated cells: 402.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 91.5;head and neck cancer: 102.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 52.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.4	0.0	0.0	16.8	0.0	0.0	0.5	0.0	0.0	46.7	0.0	268.5	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	274.9	0.1	21.7	2.6	0.0	38.5	21.5	13.1	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	17.4	33.5	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	853.2	0.0	0.0	0.4	3.3	0.8	0.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	267.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	815.9	0.0	0.0	1.0	364.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.0	2.3	0.0	1.4	0.0	402.8	46.4
C11orf1	FLJ23499	ENSG00000137720	"Chromosome 11 open reading frame 1"	Q9H5F2	11	111878935-111885975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 402.4;Late spermatids: 1147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038410, HPA057519"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038410: AB_10672591, HPA057519: AB_2683454"	"unprognostic (1.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.86e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.08e-1)"	21.5	37.0	25.9	10.4	29.0	18.1	49.2	26.4	36.1	20.5	24.6	26.3	20.4	17.2	64.2	24.0	28.6	19.6	33.0	26.1	27.5	70.3	54.9	16.3	15.1	26.1	26.7	28.0	48.0	39.9	28.4	9.4	26.5	27.4	26.4	22.3	33.0	26.8	16.2	34.8	21.4	14.9	25.7	11.6	30.6	61.2	27.1	20.3	41.1	21.1	17.8	22.7	18.4	27.0	25.1	31.9	40.3	44.6	45.6	34.3	42.0	13.5	34.2	10.9	13.8	54.5	45.6	91.9	63.5	23.2	31.4	28.9	16.5	50.2	17.0	40.6	23.4	30.9	6.9	42.0	28.6	45.7	20.9	63.8	76.9	39.0	74.4	48.4	13.5	96.2	45.3	66.8	36.9	25.0	62.2	70.8	46.3	86.8	48.0	31.5	42.0	127.6	69.4	46.0	36.3	34.1	8.7	31.5	31.3	38.4	63.1	31.8	11.7	40.2	28.8	17.6	19.1	38.8	61.2	136.7	20.3	53.1	24.9	6.5	7.4	9.0	13.0	14.6	24.9	26.0	22.0	17.0	11.1	17.7	34.5	26.5	1.7	16.7	10.1	32.8	17.6	10.2	25.9	29.0	26.4	36.1	26.1	27.5	26.1	26.7	26.5	25.7	27.1	27.0	14.3	25.6	19.8	3.6	22.6	23.7	67.5	60.6	71.2	8.6	56.5	79.6	57.6	28.6	43.4	35.0	6.2	28.9	17.3	15.1	201.5	21.8	402.4	30.5	17.3	15.3	26.4	26.3	3.5	27.2	22.5	16.5	22.4	22.6	29.2	23.3	11.0	43.4	23.0	15.2	4.7	39.8	28.5	7.9	11.4	1147.2	27.4	14.3	24.9	3.7	19.3	43.5	20.6	1.0	3.7	18.9	22.3	24.5	41.9	36.4	40.6	197.9	44.4	15.5	19.7	10.8	17.0	54.4	30.9	53.4	29.5	21.1	22.6	49.2	44.4	72.7
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.4	0.6	0.3	7.1	0.4	50.4	0.6	0.4	0.4	1.6	0.2	0.9	0.6	0.6	0.3	0.6	0.7	2.1	20.0	0.3	0.3	0.7	1.3	4.7	14.0	1.1	0.5	0.2	0.4	0.1	0.3	0.6	0.8	0.6	1.3	0.0	1.5	0.4	1.0	1.3	3.5	1.0	0.6	14.9	2.6	0.3	0.4	3.6	0.9	0.2	7.3	1.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	51.7	0.1	0.1	0.5	19.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	22.2	0.0	80.3	14.9	45.8	23.8	31.4	16.1	4.7	7.8	18.8	17.1	5.8	11.6	16.3	12.6	23.9	58.4	1.7	6.1	16.5	0.3	0.4	0.4	0.4	0.3	0.3	1.1	0.5	0.8	0.6	0.4	1.0	0.2	0.0	4.2	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.3	68.1	2.8	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	13.9	0.0	0.0	0.2	1.7	0.5	0.0	15.8	0.0	2.5	0.0	3.7	0.0	0.0	0.0	0.0	12.5	15.5	0.0	0.0	20.3	1.8	0.0	28.4	0.0	47.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.4	0.0	16.0	0.0	0.0	0.0
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261338-68272001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 107.7;Proximal enterocytes: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 222.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012411, HPA012748"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012411: , HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	25.0	17.6	8.9	20.7	12.2	4.7	21.0	12.1	12.7	23.3	8.2	29.2	53.8	39.2	7.3	15.5	22.2	17.6	31.5	9.7	10.5	17.0	87.4	24.1	15.5	14.4	11.6	19.3	27.3	7.3	14.5	16.1	12.5	22.9	17.4	3.0	34.0	17.6	13.7	15.4	59.4	32.6	11.0	20.8	23.6	14.6	12.8	6.4	17.0	15.2	16.7	22.3	19.4	15.2	44.8	45.5	26.4	51.6	62.1	62.5	29.7	105.4	67.5	51.8	53.1	96.2	26.9	20.1	31.7	131.3	47.2	49.4	39.1	47.4	33.2	22.1	23.1	21.4	44.8	65.3	50.1	18.3	68.7	52.1	34.6	78.8	32.0	31.0	21.2	10.6	37.9	32.2	44.6	55.7	4.5	26.4	44.2	72.1	53.8	8.2	44.8	104.1	23.9	21.1	17.3	31.8	33.3	27.1	222.8	21.8	25.6	15.3	23.3	80.8	50.2	103.3	47.3	39.4	41.4	18.8	65.1	14.1	79.9	16.7	12.1	12.6	14.0	19.0	9.4	26.7	7.9	8.9	19.5	35.7	7.3	7.7	1.8	9.9	14.1	26.7	8.4	12.6	8.9	12.2	12.1	12.7	9.7	10.5	14.4	11.6	12.5	11.0	12.8	15.2	6.8	9.6	3.6	3.3	25.5	14.0	12.2	11.7	9.6	4.8	8.2	8.9	10.4	11.5	6.9	9.2	2.1	11.9	12.4	36.2	1.9	21.9	3.5	5.3	17.8	6.6	4.8	9.1	4.1	31.5	30.7	21.1	18.3	6.8	45.0	5.0	9.3	107.7	15.8	0.0	4.2	50.0	6.1	12.9	23.5	7.1	14.0	12.3	28.4	5.6	14.9	6.8	18.6	6.6	8.5	26.9	16.6	16.1	67.0	13.0	162.5	10.6	9.4	2.9	13.1	11.2	20.2	20.7	27.1	9.6	11.2	10.5	6.5	9.6	15.5	10.6
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205557-6211135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 25.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 818.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nuclear membrane, Vesicles"	"HPA063404: AB_2685006"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.0	0.1	0.5	0.2	0.5	0.1	0.1	1.4	0.7	0.1	0.0	0.3	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.4	0.2	0.0	0.1	1.5	0.7	0.0	0.0	0.2	0.3	25.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.2	0.3	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.1	0.3	0.1	0.6	0.1	0.1	0.3	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.4	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.5	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	818.5	1.5	0.2	0.0	1.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.7;Hofbauer cells: 8.7;Kupffer cells: 5.9;Late spermatids: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.2;U-937: 8.9"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.6	3.3	1.7	0.7	4.4	0.8	0.9	0.6	2.1	1.0	0.8	0.7	1.4	0.5	0.6	2.9	1.0	2.0	4.5	1.4	1.6	2.0	0.5	2.6	0.8	1.9	1.9	0.9	2.6	3.8	2.3	2.1	1.6	1.1	0.9	0.2	1.6	2.8	0.1	6.6	0.9	0.5	1.1	1.5	1.8	1.1	2.3	2.4	1.8	0.2	0.9	1.2	1.3	2.2	2.4	4.5	0.0	0.0	0.3	0.4	1.6	0.8	4.7	1.7	4.2	6.3	5.8	0.0	3.2	0.5	4.2	2.3	2.4	11.2	0.8	0.0	1.1	0.3	2.7	0.0	0.2	0.0	0.0	0.3	1.5	1.3	0.9	3.8	1.0	3.5	0.0	0.2	2.0	1.2	2.6	2.4	1.8	1.0	3.9	1.1	4.6	0.5	3.9	1.1	0.0	0.2	1.8	5.0	0.3	1.2	0.8	4.4	0.5	0.0	6.2	0.0	0.8	0.1	0.0	0.0	0.8	8.9	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.7	4.4	0.6	2.1	1.4	1.6	1.9	1.9	1.6	1.1	2.3	2.2	0.1	0.0	0.5	0.0	0.0	2.8	1.3	0.9	5.7	0.0	0.3	0.4	1.7	0.0	0.2	0.0	0.0	2.0	0.0	0.1	1.9	1.0	2.0	0.3	0.1	0.2	0.0	0.0	0.3	0.8	2.1	0.3	0.0	0.5	1.3	0.3	0.4	0.0	8.7	0.0	0.2	0.1	0.0	5.9	0.8	8.2	0.0	2.2	0.0	2.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.5	1.7	3.0	0.9	1.2	0.2	0.1	0.2	1.1
C11orf49	"FLJ22210, MGC4707"	ENSG00000149179	"Chromosome 11 open reading frame 49"	Q9H6J7	11	46936689-47164385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 140.0;Excitatory neurons: 140.8;Inhibitory neurons: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040051, HPA040280"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040051: AB_10795412, HPA040280: AB_10795363"	"unprognostic (3.11e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.34e-3)"	8.1	13.4	52.4	6.2	51.6	3.3	10.0	45.9	54.7	15.6	46.1	14.3	11.2	16.8	14.1	9.7	32.5	9.6	12.3	52.4	53.3	15.7	3.9	12.1	6.3	47.0	53.9	14.9	12.7	22.6	30.3	6.8	49.2	12.4	11.4	21.8	11.0	13.2	7.3	31.6	11.9	12.8	46.2	7.0	15.4	20.2	53.7	13.7	16.1	6.4	7.2	11.9	11.4	45.5	10.9	30.6	37.9	27.9	17.8	25.7	9.5	11.7	26.9	24.6	29.9	6.9	17.0	9.1	12.3	24.4	29.7	14.8	18.8	28.7	20.9	18.1	27.2	12.2	36.6	12.6	30.5	14.6	16.2	17.5	19.1	11.2	16.4	47.0	27.6	22.1	10.3	11.7	18.2	22.8	23.0	16.2	14.3	26.5	16.4	8.2	9.5	10.1	43.3	11.7	25.5	36.5	13.4	14.9	14.7	19.7	25.0	8.5	6.5	13.8	11.0	22.0	17.7	10.4	9.2	7.5	33.7	3.0	17.5	12.7	10.2	9.0	19.2	13.7	23.0	24.1	18.1	22.7	24.6	17.6	19.1	20.3	0.3	25.2	10.3	21.8	19.0	18.3	52.4	51.6	45.9	54.7	52.4	53.3	47.0	53.9	49.2	46.2	53.7	45.5	6.6	9.6	26.7	140.0	9.9	13.0	16.4	30.6	12.0	22.9	12.0	13.0	9.4	12.8	24.0	23.9	18.8	19.4	5.6	18.3	46.9	30.2	53.2	42.8	20.4	10.2	19.2	8.0	140.8	20.4	13.4	18.0	25.5	14.1	16.4	23.3	8.6	2.4	9.9	37.0	112.7	12.8	22.4	3.3	7.0	35.8	12.8	6.2	12.4	41.2	10.9	45.0	7.2	93.0	71.9	16.2	21.2	20.3	5.8	8.1	22.1	33.4	66.7	53.1	6.6	12.2	13.5	63.3	7.6	10.5	18.0	10.0	10.8	32.6	13.7	12.1
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.8;Breast glandular cells: 3.3;Cholangiocytes: 2.8;Endometrial ciliated cells: 3.1;Gastric mucus-secreting cells: 4.1;Respiratory ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CAPAN-2: 23.5;Hep G2: 18.2;MCF7: 17.6;RPTEC TERT1: 27.1;SK-BR-3: 22.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	3.3	0.7	1.0	0.4	0.9	0.0	25.9	4.1	1.3	3.8	2.2	5.2	10.4	2.3	23.7	6.4	17.7	12.3	3.2	0.9	0.9	43.9	22.8	9.7	0.1	1.1	1.0	1.5	25.8	30.8	16.4	10.1	1.7	15.4	6.2	0.1	26.8	10.2	9.3	9.7	9.2	0.8	1.1	0.9	20.9	1.0	1.1	1.0	20.1	8.3	1.3	4.6	3.2	1.5	4.3	0.0	0.0	0.0	2.9	0.4	17.7	1.0	0.8	0.1	0.0	6.8	23.5	0.0	10.6	2.3	0.0	5.4	0.0	1.4	0.1	0.0	0.7	0.0	0.5	18.2	0.0	0.0	0.0	0.3	5.2	0.0	0.2	0.2	1.0	0.0	0.0	0.0	1.5	17.6	0.0	0.2	0.1	12.5	1.8	0.0	1.5	0.0	27.1	15.6	1.2	0.0	0.0	22.9	0.0	2.4	76.5	1.6	2.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	4.1	1.3	0.9	0.9	1.1	1.0	1.7	1.1	1.1	1.5	0.0	6.4	2.8	0.0	0.0	0.1	1.6	0.2	1.2	0.0	3.3	0.9	0.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	3.1	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.5	4.1	1.9	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.9	1.3	6.7	0.0	0.0	0.3	0.3	0.1	0.1	0.6	0.3	1.4	0.0	0.2	0.2	0.7
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245726-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 3.4;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"OE19: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	0.9	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	1.4	0.9	0.9	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.6	1.3	0.4	0.7	0.0	0.3	1.0	0.0	2.1	0.0	1.8	0.0	1.2	0.0	0.0	0.0	3.4	5.5	0.0	0.4	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	0.1	0.1	14.3	3.3	0.0	0.0	0.0	0.1	1.5	0.0	1.9	38.1	0.0	1.4	0.0	7.7	0.0	0.1	56.6	0.1	1.9	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	3.0	8.2	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.2	0.3	4.0	0.0	9.9	0.0	0.0	0.1	0.6	1.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	4.4
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 569.9;liver: 258.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 370.4;Proximal tubular cells: 1136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		1300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	20.1	24.6	10.2	19.1	16.4	7.4	31.4	15.2	14.8	20.7	18.0	40.8	53.0	21.7	19.6	17.6	32.3	47.2	21.5	9.5	14.8	569.9	258.8	30.3	21.5	18.3	12.9	30.1	51.6	20.9	16.7	25.3	16.5	39.6	43.8	20.7	28.9	25.0	41.8	21.2	51.5	20.8	13.0	17.3	37.9	19.8	12.9	28.1	35.9	54.7	23.4	17.0	12.9	25.2	9.4	13.5	30.9	18.3	23.5	26.8	36.1	13.8	23.6	13.8	19.0	5.6	52.9	39.4	85.5	25.6	14.4	22.2	37.5	10.0	19.4	39.9	11.4	21.7	34.9	26.5	27.7	20.7	11.0	24.7	17.0	24.7	16.6	34.8	21.6	26.2	29.6	26.6	12.8	8.0	33.0	23.7	10.5	64.9	22.1	31.4	40.8	62.2	74.6	19.6	15.2	20.2	23.0	28.2	27.7	22.7	65.9	13.4	13.5	13.0	10.0	22.5	6.6	12.0	38.2	37.8	9.8	29.2	23.3	75.0	30.0	74.0	21.7	21.5	22.3	27.1	22.1	24.7	23.0	23.0	27.0	23.7	100.9	24.8	19.0	31.9	31.5	18.8	10.2	16.4	15.2	14.8	9.5	14.8	18.3	12.9	16.5	13.0	12.9	25.2	25.1	64.1	54.7	28.1	27.4	5.5	10.6	18.4	21.1	18.0	21.6	14.6	34.7	190.1	33.5	47.8	16.7	51.4	21.6	53.6	178.1	17.4	14.4	34.2	20.5	18.3	22.2	23.1	23.7	13.9	14.8	23.9	32.6	43.6	15.2	40.2	29.6	370.4	17.5	15.2	27.8	37.1	28.5	29.2	7.2	6.4	25.7	22.2	8.8	15.9	18.2	17.0	10.3	25.6	37.8	13.1	38.4	23.0	25.7	29.0	75.0	1136.3	36.2	19.7	6.6	28.9	17.0	38.6	17.4	17.6	9.9	62.0	21.1	16.3	35.6	22.9
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16758340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	142.2	135.1	52.2	129.5	57.8	128.3	94.5	55.3	79.7	91.5	66.5	101.8	89.9	136.1	73.8	172.3	128.0	115.6	159.9	52.0	62.7	114.9	132.9	102.9	162.9	57.6	56.0	172.0	127.8	115.1	78.7	123.9	61.3	111.7	71.7	94.2	128.6	85.3	212.2	99.8	96.5	113.8	56.8	125.8	111.7	89.6	55.4	138.2	162.1	109.6	127.9	125.1	81.3	69.1	416.1	362.9	390.3	197.0	199.5	162.3	272.8	419.2	213.0	276.2	245.5	348.0	397.7	383.1	315.2	253.7	311.4	242.3	275.0	206.9	232.8	485.8	289.9	342.7	286.8	310.1	243.4	492.8	276.2	182.3	230.6	168.9	336.6	209.7	178.4	232.6	435.2	246.5	191.1	247.8	506.5	211.7	291.1	212.7	197.6	404.3	413.6	196.0	158.6	248.7	269.8	267.4	372.4	273.4	501.4	225.0	244.4	315.7	359.5	336.7	268.2	407.1	388.0	164.0	648.6	525.2	297.2	275.3	326.1	587.6	390.4	552.8	407.8	451.9	482.3	621.9	451.4	435.0	429.7	578.9	506.9	440.6	186.9	433.9	490.1	544.7	522.0	896.2	52.2	57.8	55.3	79.7	52.0	62.7	57.6	56.0	61.3	56.8	55.4	69.1	188.3	246.8	222.5	41.8	219.8	257.1	275.3	379.8	167.9	169.5	170.9	168.4	206.4	178.7	259.1	200.5	150.1	312.2	242.8	65.6	428.4	249.7	65.6	204.2	202.0	217.3	159.2	213.7	72.5	228.1	346.8	258.2	73.4	139.8	237.3	151.3	175.6	163.8	227.0	143.0	68.6	133.2	299.1	164.3	261.0	34.3	205.9	180.1	229.5	45.0	249.9	230.5	248.2	61.3	63.5	232.3	104.3	204.2	183.0	324.1	103.4	364.6	237.0	215.7	157.8	164.9	246.8	331.6	245.7	142.5	276.6	453.5	217.3	188.2	118.7	296.6
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916810-65919062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	36.0	29.3	68.1	14.9	70.3	10.1	33.5	74.7	82.3	50.4	59.4	50.1	17.2	56.1	39.0	29.7	40.5	20.7	50.7	71.0	65.1	31.2	28.0	31.9	24.8	69.0	67.0	43.4	27.2	25.6	24.0	23.4	67.6	42.6	15.7	12.5	30.9	31.7	81.1	32.8	31.0	27.0	66.3	41.6	32.8	53.9	67.9	29.1	32.6	51.4	21.3	45.9	39.5	71.4	76.4	33.6	20.4	22.2	70.0	67.3	17.6	59.7	90.2	74.3	45.2	12.6	83.9	15.6	40.6	89.5	118.6	24.0	15.9	36.6	39.8	24.2	16.1	18.5	23.4	33.2	55.7	14.9	23.7	62.9	53.8	53.9	58.9	76.6	56.1	26.1	25.1	37.7	136.2	34.5	19.7	35.9	20.5	16.5	165.8	28.8	23.1	44.4	39.6	14.5	13.9	21.6	23.1	30.1	59.8	21.0	39.0	14.0	61.4	118.0	57.9	162.1	30.9	25.3	11.9	13.1	69.8	11.1	94.1	6.8	2.5	3.7	5.3	3.9	3.8	3.0	3.4	4.4	2.0	5.3	5.2	5.2	9.1	3.8	2.1	2.7	4.2	2.2	68.1	70.3	74.7	82.3	71.0	65.1	69.0	67.0	67.6	66.3	67.9	71.4	17.8	16.0	5.1	6.5	7.3	15.3	32.9	4.2	6.8	11.4	14.7	22.5	16.6	14.3	2.3	16.5	10.4	16.4	14.5	10.8	7.9	14.5	7.9	8.1	17.8	13.8	4.8	2.1	7.9	11.7	16.5	18.5	7.1	11.8	3.8	12.9	18.2	10.5	14.2	16.8	7.5	13.1	4.1	13.9	7.5	24.5	21.5	8.7	10.6	7.5	14.1	26.7	22.6	4.5	8.6	19.3	3.4	35.3	3.6	23.2	11.8	5.4	1.9	9.9	19.7	13.5	16.4	15.0	17.1	6.2	12.8	21.9	8.3	23.3	9.2	31.3
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 66.0;Excitatory neurons: 101.2;Inhibitory neurons: 73.8;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038932, HPA038933"	Approved		Approved	Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA038932: AB_2676275, HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	4.0	10.8	5.9	5.9	6.5	5.5	11.1	14.3	8.3	8.8	1.9	9.4	9.0	4.1	14.0	23.8	5.5	2.9	5.9	5.8	5.7	24.6	3.1	6.0	6.8	1.8	2.5	4.0	5.9	10.1	12.2	3.3	3.2	13.8	9.3	12.2	14.4	7.0	1.2	41.0	14.2	4.4	0.6	9.9	5.6	23.8	5.6	13.0	4.2	1.4	15.0	5.0	13.4	3.9	16.1	8.7	17.1	11.7	0.9	5.3	3.2	6.8	7.9	7.8	9.8	28.7	19.5	26.4	3.8	5.8	5.2	28.8	7.8	9.8	7.7	6.9	4.5	4.7	12.0	7.3	2.1	3.2	4.7	1.4	35.0	6.1	11.0	11.9	25.2	9.6	7.7	10.0	4.7	17.9	10.8	9.7	26.9	46.4	11.6	6.5	8.1	20.4	33.6	5.8	12.8	12.6	11.2	30.0	24.2	15.1	21.3	2.0	11.7	5.5	9.9	6.0	9.9	7.2	16.2	19.1	6.2	5.5	6.9	2.2	0.8	3.0	1.8	0.4	3.6	10.7	3.3	2.6	0.5	7.4	3.5	3.0	1.6	1.5	0.9	9.1	4.1	0.7	5.9	6.5	14.3	8.3	5.8	5.7	1.8	2.5	3.2	0.6	5.6	3.9	2.8	19.2	3.6	9.8	17.0	11.6	3.2	11.9	4.6	3.6	9.4	7.6	0.5	4.3	8.0	35.0	18.8	1.7	6.0	10.7	9.8	17.0	66.0	5.0	2.1	3.0	13.8	5.7	101.2	11.7	2.3	2.5	5.6	4.4	4.5	3.2	2.2	2.7	3.3	0.0	73.8	12.4	14.2	1.0	5.2	125.5	2.5	1.3	3.6	14.0	4.3	2.0	8.2	9.5	8.5	14.6	12.1	0.4	43.6	2.8	46.2	4.1	4.8	8.7	6.6	2.3	3.0	22.0	22.9	20.4	20.0	1.5	5.9	0.8	10.3	3.2
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 68.0"	"Group enriched"	"Detected in some"	20	"Distal enterocytes: 212.2;Paneth cells: 132.8;Proximal enterocytes: 506.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;SiHa: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavorable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavorable (6.97e-5)"		"prognostic unfavorable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	15.4	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.4	68.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	64.2	0.7	0.1	0.0	2.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	132.8	0.0	0.0	0.0	506.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	8.4	0.2
C11orf87	"LOC399947, LOH11CR1A, NEURIM1"	ENSG00000185742	"Chromosome 11 open reading frame 87"	Q6NUJ2	11	109422190-109429167	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 15.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 52.4;Horizontal cells: 20.2;Inhibitory neurons: 33.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.9;fHDF/TERT166: 11.7;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA034656	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034656: AB_10600788"	"unprognostic (5.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.85e-1)"		"unprognostic (1.63e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.28e-5)"	"unprognostic (8.38e-2)"	"unprognostic (9.65e-2)"		"unprognostic (2.72e-6)"	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.0	15.3	0.9	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.1	0.1	2.9	1.4	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.2	0.0	15.3	6.5	0.1	0.0	1.1	0.0	1.5	9.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	52.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	4.5	5.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Late spermatids: 4.0;Sertoli cells: 6.6;Spermatocytes: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 16.2;hTERT-HME1: 10.0;HUVEC TERT2: 8.2;TIME: 12.6;U-2197: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA047064: AB_2679920, HPA050487: AB_2681142"	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	4.8	0.2	0.3	0.6	0.3	1.0	1.5	1.2	2.0	0.1	0.0	0.4	0.0	0.2	0.1	2.9	0.3	4.7	0.8	0.2	0.5	1.4	0.2	1.1	0.2	0.3	0.5	0.2	1.5	0.0	0.1	0.5	0.6	0.2	0.0	0.2	0.5	0.2	0.5	1.0	0.3	0.8	0.4	0.0	2.1	9.5	0.3	0.2	0.4	0.0	0.4	1.4	0.3	0.6	0.2	0.0	0.2	1.5	0.0	0.0	0.0	1.8	0.0	0.9	0.4	0.3	0.6	0.0	0.1	1.9	0.2	0.7	0.5	16.2	1.3	0.5	0.0	0.0	4.0	0.9	0.3	0.0	0.0	0.0	0.1	1.2	10.0	0.5	8.2	0.2	0.0	2.5	3.9	0.0	0.0	0.3	0.0	0.1	5.0	0.0	0.0	0.0	1.1	2.1	0.0	0.3	0.0	1.6	0.1	0.5	0.0	0.0	12.6	1.2	0.3	10.3	0.3	0.7	0.6	0.0	2.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.2	2.0	0.2	0.5	0.3	0.5	0.6	0.4	0.3	0.6	1.2	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	16.6	0.4	0.2	0.6	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.6	0.1	0.3	12.3	0.4	0.3	0.0	0.1	0.0	0.0	0.0	1.5
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf29	DKFZp434N2030	ENSG00000133641	"Chromosome 12 open reading frame 29"	Q8N999	12	88033846-88050160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039663	Uncertain		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA039663: AB_10795253"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.81e-2)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	4.7	9.8	7.5	4.5	8.1	8.7	11.0	7.0	10.0	6.5	4.9	4.8	4.8	6.6	12.8	16.1	4.5	5.2	5.8	8.1	7.8	8.4	12.6	5.1	6.8	7.5	7.8	7.5	5.9	7.2	3.1	5.3	7.6	8.2	5.1	5.4	8.3	6.1	4.3	15.5	3.9	5.6	7.8	5.3	5.2	5.6	7.1	6.2	9.9	8.7	8.7	7.4	6.0	8.8	13.1	8.1	7.9	9.2	16.7	21.5	5.8	17.1	14.6	14.4	12.9	7.8	5.0	24.0	2.3	8.8	8.1	11.3	15.5	11.8	24.8	10.4	15.9	20.5	6.5	6.9	20.1	26.9	9.4	14.7	17.8	13.5	16.8	16.8	11.2	9.2	20.3	4.8	22.7	4.6	18.0	13.6	12.0	11.0	15.7	10.4	13.5	19.9	16.3	10.4	19.0	17.0	9.8	22.8	12.5	6.5	14.6	19.2	9.0	12.9	4.3	13.3	13.4	10.7	16.0	14.5	10.0	19.1	11.4	4.5	0.8	0.6	2.7	0.8	4.9	2.0	3.9	3.3	1.0	1.7	4.6	3.9	0.0	3.4	0.9	1.4	2.1	1.8	7.5	8.1	7.0	10.0	8.1	7.8	7.5	7.8	7.6	7.8	7.1	8.8	20.4	9.6	13.6	7.8	17.7	51.5	29.2	29.1	21.6	14.4	19.0	17.8	16.1	20.0	29.6	5.5	6.2	15.3	16.1	5.1	37.2	21.5	34.2	14.2	16.8	17.7	7.8	44.6	22.8	24.2	17.1	26.4	8.2	19.1	10.8	6.7	9.7	16.4	9.6	10.1	20.0	8.9	18.3	6.6	11.7	22.8	32.0	6.6	26.6	4.7	5.3	16.2	11.3	5.0	12.9	22.3	5.0	30.9	13.5	39.7	4.2	33.3	19.7	17.8	6.6	24.9	25.2	50.4	31.7	29.5	71.5	9.3	21.3	8.6	13.0	31.2
C12orf4		ENSG00000047621	"Chromosome 12 open reading frame 4"	Q9NQ89	12	4487735-4538508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037871	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA037871: AB_10670531"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.96e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.92e-1)"	7.5	5.4	6.6	8.9	7.6	9.2	7.3	7.7	9.1	6.6	5.6	7.0	4.3	6.6	5.3	7.1	5.5	6.5	7.4	7.8	6.0	6.0	5.9	6.7	10.1	5.6	6.3	5.3	4.7	6.2	4.7	9.6	6.0	7.4	8.1	10.0	4.9	6.6	10.5	5.9	5.1	9.4	5.9	7.9	5.7	9.2	7.0	9.2	7.9	10.8	10.2	8.6	5.0	7.6	14.6	11.0	13.4	15.9	13.1	19.5	28.4	27.6	11.4	24.9	30.3	19.5	11.8	12.4	5.6	17.9	20.5	10.6	19.0	15.9	33.6	37.1	13.0	21.5	10.3	9.6	19.0	18.7	19.4	17.4	8.8	29.9	33.4	15.6	14.4	15.1	12.8	20.9	23.5	7.0	14.9	7.9	19.8	12.6	10.4	16.0	21.1	7.9	15.3	15.1	5.3	10.4	18.9	13.6	11.9	36.4	5.7	15.9	15.0	21.6	19.9	23.8	29.3	4.8	6.8	30.2	16.0	15.1	20.4	0.0	7.5	2.8	4.2	12.7	4.6	4.7	4.1	4.3	6.6	5.2	4.5	4.0	2.4	4.4	15.1	6.9	6.9	4.3	6.6	7.6	7.7	9.1	7.8	6.0	5.6	6.3	6.0	5.9	7.0	7.6	9.8	16.0	12.0	21.5	9.2	2.9	3.0	5.5	7.4	11.8	5.2	5.3	14.3	2.8	8.9	3.7	29.2	7.4	11.4	5.2	3.9	7.6	40.9	7.3	11.8	8.2	6.0	16.0	43.0	8.2	8.5	8.1	1.5	4.4	1.3	9.7	7.5	5.4	28.2	8.4	32.4	5.3	4.1	13.3	4.7	29.9	8.1	11.4	1.8	30.0	8.5	6.8	8.2	32.6	39.2	8.3	3.2	6.8	15.5	2.2	4.6	5.4	8.6	12.3	6.6	9.7	9.6	22.0	16.2	6.4	3.3	6.2	8.2	8.0	6.0	1.9
C12orf43	"Custos, FLJ12448"	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	9.8	8.1	11.7	6.9	11.9	7.4	9.3	8.8	13.6	7.8	7.2	11.2	5.0	9.5	4.4	7.2	9.0	5.1	7.4	12.3	9.5	8.2	10.5	6.7	8.7	10.9	9.6	11.2	7.5	9.0	7.4	7.2	10.8	7.7	5.3	6.0	8.7	6.2	7.2	6.7	6.7	8.4	8.6	7.8	8.2	6.1	9.4	7.2	6.4	5.9	7.4	9.6	7.0	10.4	14.2	31.4	16.2	12.8	14.0	11.0	17.8	17.2	17.5	28.3	17.9	22.8	13.0	26.2	17.2	16.8	15.0	15.7	19.2	26.3	16.8	31.6	21.4	21.1	12.4	17.1	16.7	28.1	16.2	12.9	13.6	26.0	16.4	17.9	16.4	27.0	25.5	6.7	15.1	23.3	30.9	22.0	28.8	11.1	23.2	27.4	19.0	19.8	17.5	20.8	22.0	14.0	23.0	9.9	18.6	13.4	27.0	13.1	15.9	15.6	18.7	12.8	18.4	12.3	19.1	20.5	20.5	16.5	23.6	5.7	15.6	9.0	23.8	21.3	21.8	23.8	23.5	23.2	16.1	19.0	27.5	23.6	2.2	18.4	18.5	13.3	23.8	20.6	11.7	11.9	8.8	13.6	12.3	9.5	10.9	9.6	10.8	8.6	9.4	10.4	16.1	25.6	18.1	3.3	17.3	8.8	16.4	12.2	6.8	19.6	12.4	12.4	7.0	11.5	9.6	18.4	20.9	24.3	13.9	8.6	23.5	16.5	5.9	9.8	17.1	16.0	2.4	10.7	6.8	18.5	22.3	16.3	8.2	10.1	14.5	22.3	12.5	11.7	16.7	16.8	6.4	9.5	10.2	10.4	7.3	13.8	13.7	13.2	14.2	3.7	21.7	18.8	24.7	4.0	4.8	15.6	12.3	12.8	11.3	13.8	5.3	16.7	16.3	15.7	19.7	19.6	16.9	16.3	16.4	12.7	7.7	13.7	17.6	16.0	10.9	14.0
C12orf45	MGC40397	ENSG00000151131	"Chromosome 12 open reading frame 45"	Q8N5I9	12	104986316-105074197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 462.1"	"Lineage enriched"	"Detected in all"	13	"dendritic cells: 462.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038722	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA038722: AB_10673118"	"unprognostic (1.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.58e-10)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.19e-2)"	11.9	8.5	11.8	10.5	12.0	12.2	10.5	15.8	21.0	12.0	6.9	9.7	10.1	8.3	5.9	10.3	7.4	4.3	9.5	10.8	9.1	9.0	14.6	7.2	11.1	7.0	6.7	8.9	24.7	2.4	7.8	4.4	8.4	9.7	7.5	4.5	14.7	4.2	7.5	10.5	7.8	6.4	4.4	11.4	15.1	6.4	10.9	9.2	11.0	2.1	11.0	9.5	10.3	13.3	23.3	32.4	15.3	39.2	12.7	13.0	70.9	20.6	5.2	12.2	6.8	32.8	11.4	44.2	20.1	9.3	30.5	15.2	12.9	31.1	13.5	12.6	22.9	29.5	14.9	45.4	18.4	44.4	22.1	19.1	12.9	18.5	19.7	20.4	20.0	36.4	24.7	11.1	12.0	38.5	29.2	75.3	29.9	34.6	46.2	39.0	18.6	99.9	16.9	29.9	19.5	14.2	20.0	41.9	32.7	27.8	34.8	17.8	9.9	30.2	20.1	26.3	31.6	23.2	28.5	47.5	14.1	30.7	29.2	8.3	34.0	0.6	13.6	30.7	17.1	34.6	18.1	17.3	106.0	25.4	18.6	17.9	3.3	27.8	17.2	462.1	32.9	21.0	11.8	12.0	15.8	21.0	10.8	9.1	7.0	6.7	8.4	4.4	10.9	13.3	15.7	6.4	33.4	1.3	30.4	39.0	44.2	52.8	23.3	11.5	23.4	31.8	37.9	20.0	39.9	33.1	25.0	34.7	66.9	15.8	27.4	27.2	20.8	33.8	25.0	18.0	12.5	12.4	3.8	55.3	63.7	23.0	15.8	40.7	20.3	17.5	11.0	48.2	37.7	3.3	4.2	20.5	30.5	24.2	69.6	10.6	15.2	37.8	39.2	1.0	42.0	18.9	9.2	2.5	4.0	39.0	14.5	10.1	65.8	39.2	12.8	43.7	25.9	11.9	0.0	22.3	24.9	15.9	31.3	19.2	32.7	22.0	23.4	18.1	28.4	39.3
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64390758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 6.6;testis: 7.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Late spermatids: 33.9;Oligodendrocytes: 13.5;Spermatocytes: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 5.2;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056986	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA056986: AB_2683300"	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.9	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	1.4	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	7.5	0.6	1.9	0.0	0.0	0.0	0.0	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.4	0.2	0.6	0.5	0.4	0.6	0.1	0.6	1.7	0.1	0.0	0.0	3.9	0.5	0.4	1.5	0.4	1.8	0.2	0.0	0.0	1.2	0.0	0.4	0.0	0.0	5.6	0.0	0.7	5.9	0.0	59.8	1.2	0.0	0.2	0.0	0.0	2.0	0.0	4.3	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	2.2	1.7	0.0	0.0	2.2	33.9	0.0	0.2	0.0	0.0	0.0	10.4	0.0	1.5	13.5	0.4	1.0	0.4	0.0	1.0	0.0	9.7	0.5	0.7	0.0	0.0	0.0	19.0	2.3	3.1	0.3	1.8	0.0	0.0	1.4	2.4
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	254.8	199.9	230.6	76.1	231.7	128.4	282.7	235.0	329.3	411.9	239.0	242.7	76.5	296.1	85.9	143.9	328.1	134.2	327.9	221.9	240.4	225.2	205.5	217.9	183.5	233.4	235.7	574.0	300.7	117.2	332.4	75.2	233.9	297.0	69.5	37.0	173.2	157.1	194.2	307.1	163.3	85.2	227.6	160.7	220.3	82.1	252.6	262.6	214.2	179.8	77.0	263.9	270.0	236.8	88.3	253.6	291.0	288.0	196.6	233.8	96.1	113.7	277.0	96.4	153.0	101.4	146.8	27.0	88.1	178.1	124.4	83.6	111.2	140.6	23.1	158.1	232.8	234.8	191.4	145.2	372.3	96.9	220.7	281.9	164.7	74.6	101.7	188.8	164.2	216.5	82.2	230.3	90.5	264.3	204.6	124.8	522.0	146.3	92.2	224.4	259.7	404.8	131.2	218.8	128.9	377.5	182.8	184.3	242.6	136.7	46.8	501.1	174.3	192.7	181.8	77.9	173.0	169.8	150.0	149.8	198.6	2.4	132.2	75.7	20.0	19.3	187.8	34.2	123.6	133.2	208.5	199.6	29.5	163.8	248.0	203.7	7.9	99.9	87.0	225.2	204.5	160.1	230.6	231.7	235.0	329.3	221.9	240.4	233.4	235.7	233.9	227.6	252.6	236.8	260.9	64.1	129.2	11.1	256.4	264.5	285.2	255.3	546.9	90.6	284.2	624.3	219.4	211.6	146.0	123.2	25.0	131.4	216.3	262.8	365.9	191.9	175.7	122.1	336.7	206.8	312.1	81.6	7.4	423.9	219.4	340.3	179.4	146.9	148.9	86.2	204.9	307.0	67.2	37.0	11.0	686.2	162.8	88.9	138.1	299.5	453.3	120.2	231.3	15.0	58.4	197.5	200.8	7.1	8.9	205.5	240.0	377.3	216.6	279.5	146.8	244.4	89.0	94.9	289.3	389.2	473.4	75.1	86.0	301.7	215.0	154.2	328.2	157.0	349.5	215.6
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123233385-123258079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.3	12.6	16.2	10.2	16.1	9.0	8.0	23.0	19.6	13.0	13.5	10.9	11.4	12.1	13.8	9.5	11.4	8.2	15.0	16.0	13.2	12.6	14.5	8.9	18.2	12.6	12.3	17.2	8.5	10.2	19.7	7.3	14.9	13.7	8.2	15.7	16.2	9.0	13.0	13.8	11.3	7.0	8.8	12.8	10.6	16.7	14.8	60.0	12.3	12.5	13.4	10.3	11.0	18.3	28.4	20.5	20.8	39.1	12.0	11.1	13.7	22.3	16.5	25.1	18.0	21.8	15.8	36.1	20.3	8.4	23.5	20.4	25.7	12.5	25.0	29.2	22.5	44.0	20.7	18.6	26.1	20.4	19.7	14.2	33.2	18.9	35.1	37.0	17.0	53.6	45.6	13.4	16.7	12.3	46.2	39.3	13.7	25.6	31.7	35.7	25.9	33.5	22.8	13.0	40.7	18.2	24.0	8.8	23.4	16.5	18.3	24.7	14.8	23.1	27.3	23.3	24.4	22.7	28.3	32.6	17.1	26.2	28.1	85.3	12.9	50.6	53.9	14.9	67.6	83.9	72.3	71.9	21.7	73.5	96.6	78.2	11.8	63.3	16.3	36.6	73.1	33.5	16.2	16.1	23.0	19.6	16.0	13.2	12.6	12.3	14.9	8.8	14.8	18.3	46.0	41.7	47.7	9.8	54.3	45.4	36.7	29.4	59.2	34.5	23.3	50.0	52.7	14.3	18.0	25.8	14.6	41.1	56.2	16.4	60.7	20.7	22.9	12.2	24.2	27.9	9.6	37.0	13.7	10.8	22.8	41.3	23.0	11.2	15.2	24.1	18.5	33.5	14.3	45.4	15.9	20.7	28.5	9.2	24.2	6.2	37.9	19.7	24.9	7.5	26.3	35.7	44.3	14.6	10.4	13.6	17.4	42.2	42.2	22.8	19.9	39.3	14.8	36.6	13.1	42.7	33.1	115.2	59.7	40.6	36.1	10.8	63.0	43.3	20.8	8.0
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Lysosomes	"Cytokinetic bridge"	"HPA046743: AB_2679782, HPA052855: AB_2681973"	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	2.9	4.2	3.6	3.4	5.3	1.7	5.4	4.0	4.8	2.8	1.9	2.8	3.1	2.6	4.8	4.2	3.9	2.5	2.3	3.5	4.3	5.5	8.6	2.8	4.9	4.0	4.4	3.9	5.2	5.7	2.6	2.1	4.5	2.3	3.1	1.6	2.9	2.3	4.4	5.6	2.5	2.3	3.7	5.0	3.0	3.4	4.3	3.3	5.6	3.2	4.8	2.6	3.0	6.8	5.5	8.7	1.6	4.7	4.3	7.2	4.5	3.0	3.7	4.4	2.7	2.7	4.3	17.4	4.1	2.4	7.1	6.3	6.9	5.3	4.7	13.3	4.6	6.3	2.1	2.5	5.6	6.9	3.6	5.6	9.0	5.7	10.3	5.0	3.2	12.0	8.8	11.3	4.4	10.6	7.9	6.0	7.7	6.5	6.8	4.0	4.9	13.4	6.6	6.4	3.8	3.8	4.9	6.7	4.8	4.2	10.8	4.4	2.5	4.4	2.9	4.4	2.9	14.9	13.2	9.7	6.6	5.9	5.0	0.5	2.6	0.2	3.3	2.6	5.7	8.5	6.4	5.0	4.3	7.2	8.7	8.4	0.2	4.0	1.8	3.1	10.8	4.2	3.6	5.3	4.0	4.8	3.5	4.3	4.0	4.4	4.5	3.7	4.3	6.8	3.4	3.2	2.7	5.5	9.3	2.4	8.8	3.4	7.4	2.1	5.9	4.1	2.7	7.2	5.5	9.2	2.1	6.3	4.0	1.9	9.8	4.1	9.2	3.3	4.0	3.9	4.2	3.4	7.1	5.2	3.9	3.5	7.1	3.6	1.3	3.6	1.8	10.8	4.9	0.0	5.5	2.7	4.1	6.3	2.6	7.3	4.7	4.3	1.8	1.0	2.1	2.5	1.0	3.5	17.4	2.6	2.6	1.9	2.8	4.7	2.1	12.9	2.4	1.6	0.0	7.4	2.8	4.4	8.8	6.9	4.3	1.8	5.8	4.3	3.7	4.3
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081057-27082578	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;testis: 3.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.4"	"Not detected"	"Not detected"							"HPA038359, HPA058728"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA038359: , HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.1	0.3	0.1	0.5	1.4	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.1	3.2	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.3	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C12orf73	"BRAWNIN, DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103940763-103965708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.0	11.4	15.6	7.7	15.4	4.4	7.9	17.1	16.1	8.5	13.3	7.2	7.0	8.2	10.3	6.4	7.3	4.6	12.3	15.5	16.7	10.3	8.3	5.8	9.2	14.7	15.0	10.1	7.7	10.0	10.8	6.1	15.2	8.7	7.6	13.2	7.2	7.3	42.5	8.3	6.8	6.5	14.4	6.9	8.9	10.9	15.3	8.3	12.9	27.6	8.9	7.3	6.9	17.3	11.8	21.2	31.8	19.4	8.9	11.6	20.7	12.6	7.4	13.4	10.8	23.2	9.9	13.7	15.9	7.5	11.7	18.3	19.1	15.6	10.1	19.7	38.4	20.9	32.9	29.1	13.1	30.8	18.2	10.3	17.6	6.9	11.9	32.5	12.5	39.5	27.0	9.2	12.5	13.2	34.5	46.1	15.6	11.0	35.9	19.7	11.9	13.7	17.8	16.6	51.8	18.5	13.0	21.9	29.7	14.1	36.4	16.7	6.5	16.4	9.3	12.4	12.8	24.5	40.6	28.8	22.4	17.4	14.5	10.1	5.6	10.6	11.7	5.0	11.4	14.6	10.6	11.1	8.6	11.3	15.7	14.8	1.7	14.5	4.5	13.3	17.0	4.2	15.6	15.4	17.1	16.1	15.5	16.7	14.7	15.0	15.2	14.4	15.3	17.3	6.8	6.4	6.8	7.5	7.8	6.0	9.4	16.3	18.8	16.3	9.0	11.0	16.5	7.2	10.0	9.2	0.0	11.6	8.6	7.1	27.4	20.3	87.1	8.7	10.3	8.3	11.4	18.5	5.0	12.1	11.7	7.9	15.3	9.1	9.5	13.8	8.9	15.5	17.5	8.4	6.0	13.2	20.3	7.9	5.1	36.6	8.7	8.7	1.8	2.8	12.4	17.1	22.6	7.5	9.0	19.9	5.6	8.6	13.7	13.7	16.0	25.9	10.9	15.2	6.6	5.6	11.7	31.1	25.6	16.0	5.3	8.9	8.8	6.4	12.3	8.6
C12orf75	"AGD3, OCC-1, OCC1"	ENSG00000235162	"Chromosome 12 open reading frame 75"	Q8TAD7	12	105235290-105396097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 841.2;Ductal cells: 626.3;Endometrial ciliated cells: 579.1;Extravillous trophoblasts: 1228.2;Proximal tubular cells: 762.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 661.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 661.2;T-cells: 169.9"	"Cell line enhanced"	"Detected in all"		"BJ: 877.8;BJ hTERT+: 517.0;fHDF/TERT166: 432.7;RPTEC TERT1: 425.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065311	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA065311: AB_2685463"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.00e-2)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.47e-3)"	12.2	7.3	4.3	8.9	4.7	11.3	11.6	9.4	7.2	31.3	2.1	24.9	9.2	18.5	6.1	8.7	20.9	38.2	2.5	4.1	8.8	58.5	2.0	7.5	14.7	5.3	5.5	6.6	33.8	20.1	3.5	9.3	4.9	41.2	22.0	2.8	4.2	109.3	32.0	9.5	8.8	6.7	6.5	6.3	49.9	26.6	8.8	10.8	2.9	11.8	19.1	5.0	27.0	5.4	43.6	66.6	16.5	14.9	61.2	117.3	30.3	877.8	517.0	194.2	109.4	133.2	3.6	12.2	348.9	432.7	31.7	70.4	36.6	50.3	212.9	241.1	65.0	38.8	17.7	26.5	7.7	29.8	37.7	49.6	12.0	66.4	73.8	113.0	26.1	69.9	1.9	58.8	192.4	14.4	115.3	262.5	39.6	15.8	153.3	21.6	44.3	11.2	425.3	4.3	73.5	18.4	36.9	7.7	16.2	45.2	22.6	7.1	44.2	201.7	77.2	77.0	118.1	34.9	57.6	58.8	44.5	9.7	55.3	39.0	0.7	1.2	165.5	0.5	80.4	19.7	69.2	169.9	23.3	16.2	19.8	102.4	3.5	69.4	1.6	661.2	144.1	88.3	4.3	4.7	9.4	7.2	4.1	8.8	5.3	5.5	4.9	6.5	8.8	5.4	12.8	3.2	2.8	1.6	61.2	100.2	65.9	21.9	38.7	4.5	32.2	26.9	1.1	271.7	20.9	187.6	4.2	35.3	519.5	469.8	841.2	626.3	152.3	579.1	32.6	14.8	333.2	15.8	2.7	222.3	1228.2	53.0	160.5	293.1	2.5	9.7	13.2	1.8	31.9	63.9	2.9	63.6	85.5	5.3	97.3	324.1	15.5	48.2	60.5	40.3	29.1	6.4	299.7	0.5	0.4	420.0	175.5	4.9	160.3	87.0	102.1	762.3	129.7	4.9	6.6	8.6	127.8	102.9	118.6	37.1	61.2	40.6	143.0	0.7	63.9	37.3
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"		12	110027028-110073634	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"brain: 77.2;choroid plexus: 44.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 60.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA039713	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 51: Myeloid cells - Hemostasis"	"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640"	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favorable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	4.0	5.0	58.2	5.4	61.5	2.4	7.4	67.2	76.0	6.8	44.0	6.2	3.5	5.6	9.9	3.9	10.3	3.7	4.0	59.5	61.6	8.4	10.1	8.0	8.5	64.9	63.6	8.4	6.4	3.9	10.2	8.0	67.3	6.7	4.7	16.6	5.0	5.1	6.7	4.6	5.7	3.4	60.0	9.2	4.6	8.3	61.3	7.1	9.6	4.1	6.1	5.5	5.4	77.2	3.8	7.5	10.7	8.8	5.2	12.2	10.9	3.4	3.0	7.3	5.0	4.8	4.3	8.1	4.6	1.8	5.0	8.8	4.2	5.4	5.0	9.8	9.9	8.5	7.2	13.3	7.2	13.6	16.2	13.7	14.9	4.7	11.3	19.7	10.7	13.4	13.0	3.0	5.4	4.1	4.3	25.2	9.4	5.1	6.1	10.5	7.0	12.5	11.2	4.1	26.4	12.5	5.3	2.8	11.1	13.3	8.4	6.2	6.2	3.5	4.9	3.4	1.5	8.4	12.8	4.4	8.2	6.3	3.5	60.0	10.2	11.0	6.4	7.8	9.2	18.6	12.7	7.1	10.9	11.6	17.4	10.2	5.8	18.8	5.2	9.7	12.8	12.0	58.2	61.5	67.2	76.0	59.5	61.6	64.9	63.6	67.3	60.0	61.3	77.2	22.5	32.1	17.0	13.4	15.2	7.9	16.2	18.7	13.6	26.4	24.9	39.8	7.1	18.6	10.5	16.5	2.1	30.2	13.3	6.4	35.2	11.6	31.0	42.3	18.7	18.3	6.1	14.5	32.0	15.1	10.5	17.7	6.6	17.4	5.1	22.8	21.8	22.4	26.4	32.0	28.5	10.7	16.2	24.2	13.1	13.5	26.1	35.9	19.6	15.0	25.3	39.4	24.7	53.3	174.6	11.8	7.5	33.8	10.2	11.7	13.3	38.6	33.9	20.9	6.6	16.4	16.5	25.2	11.3	9.0	8.5	12.0	21.8	15.4	9.5	9.8
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23095505-23100456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	41.5	49.2	26.7	34.3	28.6	15.5	46.9	30.3	32.0	41.1	34.7	42.8	33.6	40.1	42.3	45.6	33.2	27.5	36.6	26.8	29.7	49.4	37.2	38.1	34.2	30.3	29.6	33.6	31.6	35.3	38.4	33.7	30.6	30.6	51.3	25.5	36.2	38.5	32.9	30.9	41.2	48.8	29.7	47.1	41.0	25.2	31.5	40.4	33.9	31.1	50.8	47.5	33.9	32.2	53.9	52.5	77.4	47.2	166.8	144.3	62.1	88.5	129.9	114.1	134.6	41.9	81.3	40.9	44.8	144.2	138.0	89.9	74.6	117.4	157.6	65.2	36.5	61.6	41.4	180.8	130.7	93.2	91.9	177.0	104.1	96.3	70.5	104.0	126.6	72.7	41.9	44.4	127.2	77.8	44.3	72.1	48.7	124.5	79.2	38.6	57.5	47.0	130.8	85.9	37.1	33.8	73.7	68.6	81.0	85.5	46.4	53.2	103.0	54.0	47.0	81.6	40.6	41.5	52.6	50.5	49.4	58.3	49.2	317.0	160.8	302.7	122.6	106.0	140.9	143.9	138.9	137.3	150.7	121.0	144.0	142.6	94.5	131.0	74.4	102.2	188.7	203.2	26.7	28.6	30.3	32.0	26.8	29.7	30.3	29.6	30.6	29.7	31.5	32.2	50.9	48.1	47.7	4.2	41.9	26.5	89.0	144.5	23.9	28.6	41.9	50.5	23.7	34.3	75.9	31.3	8.4	89.0	53.5	44.1	129.1	95.9	22.6	39.0	45.2	56.2	28.3	65.4	3.8	84.3	105.5	42.9	30.5	33.2	54.4	39.6	46.4	29.6	107.8	20.2	4.4	57.4	81.4	38.9	32.1	15.1	64.0	53.1	48.0	5.6	93.2	36.1	58.7	2.0	11.5	97.0	42.4	48.5	31.4	59.8	61.5	100.3	48.3	21.5	32.9	18.6	47.1	52.7	25.6	33.5	34.0	143.1	46.5	81.3	51.7	83.2
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	16	"hypothalamus: 2.9;thalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.3	1.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.5	4.8	0.0	0.0	1.1	0.0	2.7	4.6	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.8	2.4	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.9	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985894-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	8.3	4.8	6.5	5.7	7.7	12.6	8.2	6.7	7.0	11.2	8.5	8.8	7.4	8.7	11.4	7.4	9.5	9.2	5.6	6.2	7.3	11.1	8.9	6.7	10.1	7.7	7.2	10.3	9.6	8.3	6.5	5.0	7.5	9.6	9.6	4.4	8.0	5.7	6.7	18.3	8.1	6.8	6.7	10.6	8.3	4.0	7.2	15.7	11.5	7.9	10.5	8.6	8.3	9.5	5.7	10.5	8.8	12.3	13.9	30.8	12.2	6.6	10.2	5.1	6.7	6.6	16.5	16.0	6.1	6.0	7.2	11.8	5.4	16.6	4.7	6.3	3.8	10.1	14.0	15.3	12.1	7.4	8.3	22.4	12.8	7.6	9.6	18.5	9.6	10.1	11.1	3.4	5.3	16.3	9.5	13.6	3.0	12.3	7.3	15.1	8.4	9.8	6.7	8.6	31.8	13.8	8.8	8.4	9.0	9.4	13.0	12.8	5.5	9.6	12.7	4.3	6.7	11.9	3.6	11.0	6.6	9.1	10.0	12.2	7.7	22.9	8.1	7.4	7.2	10.4	6.5	8.5	9.1	10.0	9.8	9.4	11.2	10.4	13.0	6.3	13.4	7.1	6.5	7.7	6.7	7.0	6.2	7.3	7.7	7.2	7.5	6.7	7.2	9.5	3.1	9.6	1.1	14.7	8.7	3.1	4.1	4.6	10.2	1.4	4.0	4.1	3.3	1.5	2.6	0.0	4.2	4.3	7.8	3.7	7.9	3.9	0.8	3.3	2.6	3.3	15.7	6.5	3.4	3.0	5.7	3.9	7.7	3.0	7.0	4.7	1.4	1.5	3.8	0.0	3.4	6.3	4.1	5.5	2.5	1.5	4.4	3.4	5.4	9.4	1.9	4.1	7.2	7.1	9.9	3.1	7.3	4.1	5.2	1.9	4.6	3.6	4.6	2.0	6.6	3.8	3.7	2.9	8.2	5.3	1.6	3.0	5.2	4.1	5.1	2.5
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.9;testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.9;Late spermatids: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA039961: AB_10673024, HPA041907: AB_2677736"	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.9	15.5	4.4	12.7	4.6	61.9	13.7	2.4	8.3	13.7	4.6	10.8	11.5	14.4	1.9	20.4	16.1	7.9	14.4	3.3	5.7	8.6	4.3	15.3	10.9	6.3	5.4	18.2	14.5	15.7	8.9	15.2	4.6	8.8	5.3	1.8	14.4	6.8	4.1	15.3	10.2	7.2	5.0	25.5	9.6	73.7	7.7	8.7	11.1	3.8	6.7	15.0	14.4	4.2	20.5	41.2	8.8	10.3	11.7	7.6	26.4	5.8	11.7	6.7	7.2	51.2	27.8	45.9	19.1	8.6	24.0	27.0	37.6	17.5	1.9	45.0	42.7	91.0	19.6	35.4	13.3	26.4	90.1	10.0	13.7	14.2	6.6	8.3	17.2	17.1	39.7	66.4	2.2	12.3	25.5	32.2	27.4	13.6	16.3	23.0	6.6	49.3	4.1	15.9	25.4	8.1	13.4	30.6	21.2	8.8	10.5	33.2	14.7	11.6	17.3	20.6	17.0	47.8	32.9	26.3	11.4	50.3	11.5	8.5	6.4	18.6	1.7	11.7	1.3	1.1	1.0	1.2	3.9	0.7	0.7	1.1	23.5	3.4	16.2	8.0	1.4	4.1	4.4	4.6	2.4	8.3	3.3	5.7	6.3	5.4	4.6	5.0	7.7	4.2	13.0	25.6	5.5	0.7	7.8	14.9	7.0	5.5	19.9	0.3	8.1	5.8	2.3	7.2	9.6	3.7	0.0	12.6	17.7	13.5	0.0	15.8	50.9	17.2	10.0	10.4	7.7	5.9	0.4	14.6	16.8	7.8	8.6	30.0	17.7	14.3	10.8	2.8	12.4	0.0	1.0	6.1	6.1	23.6	10.5	68.8	11.8	24.0	7.2	1.9	31.6	0.7	12.3	1.0	0.1	18.1	26.1	10.9	19.9	5.2	3.4	1.6	8.1	2.2	13.1	6.5	10.0	37.2	5.6	15.5	14.2	20.9	7.3	3.7	8.6	17.8
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041947, HPA042980"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA041947: , HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.4	13.5	8.3	10.1	8.1	13.9	13.2	12.4	10.8	11.0	6.1	12.4	13.7	9.2	19.8	12.1	9.0	6.5	8.1	8.1	6.7	19.1	13.0	8.2	13.5	8.1	6.3	10.5	12.4	9.7	9.3	7.6	7.6	9.4	8.2	10.2	12.4	5.8	12.4	14.7	12.9	6.1	4.2	11.9	11.2	13.9	7.0	10.7	10.3	6.7	11.2	10.1	10.7	15.3	16.8	19.7	12.8	17.4	15.9	14.4	11.6	10.1	16.0	9.7	10.9	13.7	26.6	16.6	13.4	7.6	23.8	29.5	28.5	20.2	10.9	32.1	19.0	15.7	26.4	15.9	15.3	26.6	15.6	12.1	28.8	16.1	18.1	12.8	16.8	43.6	22.1	26.6	9.3	15.7	22.6	14.3	21.4	23.8	12.5	30.5	17.3	22.7	16.7	23.5	29.7	18.2	26.0	20.4	40.8	16.2	23.3	15.4	10.4	20.0	29.1	15.5	17.7	25.4	42.0	31.8	26.0	26.4	22.4	58.0	20.9	31.2	28.1	22.0	31.4	46.7	29.7	29.5	21.2	38.8	34.7	29.9	20.6	42.2	21.4	29.6	41.1	20.5	8.3	8.1	12.4	10.8	8.1	6.7	8.1	6.3	7.6	4.2	7.0	15.3	27.3	28.9	32.5	16.6	41.1	12.0	27.8	45.2	51.2	28.9	33.6	41.0	11.6	38.6	46.2	25.8	12.5	46.6	22.3	42.3	93.9	47.3	36.7	30.0	21.1	27.2	28.8	32.4	11.6	56.1	30.0	29.9	32.1	19.0	27.8	33.7	26.0	37.7	30.0	30.3	14.3	26.4	34.6	28.4	12.0	30.8	33.2	28.0	26.6	8.4	42.7	32.1	63.8	11.6	19.9	62.7	29.6	36.1	41.2	26.7	77.6	127.3	51.2	30.1	19.7	28.6	25.9	107.3	66.8	46.5	15.3	35.6	39.3	39.9	29.9	26.3
C15orf48	"COXFA4L3, MIR147BHG, NMES1"	ENSG00000166920	"Chromosome 15 open reading frame 48"	Q9C002	15	45430579-45448761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 924.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2962.4;Exocrine glandular cells: 2020.8;Langerhans cells: 2043.7;Pancreatic endocrine cells: 3493.6;Paneth cells: 2254.4;Proximal enterocytes: 2942.0;Undifferentiated cells: 1875.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;intermediate monocyte: 1.6;myeloid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 70.9;CAPAN-2: 128.8;GAMG: 126.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012943	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA012943: AB_2668774"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.48e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-1)"	2.2	0.3	0.5	98.5	0.5	88.0	30.7	0.4	3.2	38.9	0.7	863.4	61.9	5.3	0.2	172.4	6.8	45.9	0.8	0.5	0.5	5.8	6.0	11.5	5.7	0.6	0.4	0.7	13.0	0.1	0.5	46.4	1.3	13.9	924.2	3.6	23.0	11.5	0.4	69.9	341.3	31.3	0.4	2.3	107.6	128.1	1.0	7.0	5.2	0.2	84.8	38.9	46.6	0.6	70.9	18.1	0.2	0.3	0.9	0.0	2.7	3.5	25.1	4.6	12.7	2.9	128.8	0.2	3.1	0.4	126.2	1.8	2.3	0.9	10.7	7.0	1.9	0.0	0.2	0.5	11.2	0.1	29.1	1.3	1.2	22.9	0.0	0.0	0.0	0.5	0.1	0.5	0.6	3.5	0.1	1.8	0.1	31.4	0.3	0.0	0.4	0.4	2.7	5.7	0.1	0.6	4.1	8.0	0.3	14.0	1.4	1.6	0.6	0.4	1.6	1.0	0.9	2.1	1.2	0.4	1.9	0.7	0.5	0.0	1.3	0.1	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.8	0.5	0.5	0.4	3.2	0.5	0.5	0.6	0.4	1.3	0.4	1.0	0.6	5.5	16.0	15.0	0.3	20.4	66.4	20.2	846.0	1.2	0.5	143.2	111.9	1.0	188.8	1117.6	5.5	0.0	286.2	7.4	2962.4	3.9	811.3	188.3	29.2	11.0	11.6	645.1	0.0	0.2	2020.8	450.3	16.4	250.2	67.7	33.0	0.2	1.4	3.7	398.4	114.4	0.1	1408.8	270.6	25.9	2043.7	235.4	7.2	388.4	58.7	0.0	489.4	0.7	1.0	0.5	0.4	3493.6	2254.4	7.5	4.1	200.5	2942.0	18.7	700.9	1.2	0.0	1.2	75.2	567.9	124.4	10.6	61.2	165.5	13.9	0.1	1875.4	633.4
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40769980-40772449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.0;skin 1: 17.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.6;Club cells: 5.0;Glandular and luminal cells: 6.3;Ionocytes: 6.1;Prostatic glandular cells: 5.5;Squamous epithelial cells: 4.7;Urothelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.7;SK-BR-3: 5.7"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in all"			HPA044636	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.8	1.3	0.7	1.5	1.0	1.7	2.3	4.4	1.5	3.5	0.0	2.0	1.9	1.7	0.1	26.0	2.1	1.3	1.4	0.7	0.2	2.0	4.0	1.8	2.1	0.7	0.5	2.5	2.0	0.1	2.1	0.4	0.8	2.4	0.1	2.4	8.3	0.1	2.0	17.1	2.6	0.0	0.1	2.3	1.9	0.6	0.8	0.7	2.0	0.1	5.0	1.8	6.9	1.2	0.5	0.4	1.6	2.0	0.6	0.1	0.4	0.7	0.1	0.0	0.2	1.9	2.2	1.0	1.8	0.0	1.3	4.1	0.7	0.0	0.0	1.5	1.6	1.0	4.4	0.6	0.0	0.9	1.2	0.2	0.8	0.0	0.1	1.8	0.6	0.7	0.9	1.2	0.0	0.5	1.3	1.6	0.7	2.8	0.8	1.4	0.3	0.5	17.7	1.5	3.6	0.8	0.6	5.7	0.2	0.6	2.0	1.3	0.8	2.0	0.9	1.8	0.6	1.4	1.0	0.9	0.6	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.4	1.5	0.7	0.2	0.7	0.5	0.8	0.1	0.8	1.2	0.2	0.0	0.0	0.3	0.3	0.0	3.6	2.1	0.6	0.3	1.7	0.6	0.7	0.0	5.0	0.0	0.0	0.1	0.2	0.1	0.0	0.5	0.0	1.6	0.9	0.3	0.0	0.0	0.1	0.2	0.0	0.2	0.0	6.3	0.0	0.1	0.0	0.8	0.2	3.3	0.1	0.1	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.1	0.0	0.0	5.5	0.3	0.3	1.3	0.5	0.0	0.0	0.3	0.0	0.0	4.7	1.0	0.0	0.2	0.0	0.3	11.6
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408495-55418798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;SK-MEL-30: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	1.3	2.1	2.8	0.5	3.0	0.6	3.2	2.6	3.4	4.3	5.3	4.0	1.8	1.9	6.0	0.8	7.9	3.1	5.6	2.8	3.1	7.2	1.3	2.3	1.1	3.6	3.5	1.2	8.5	4.6	8.9	0.5	3.4	3.3	3.6	7.5	9.0	2.7	6.9	1.4	1.6	2.1	3.1	1.2	6.3	9.0	3.0	1.5	4.0	2.8	1.1	1.6	1.1	2.9	0.9	1.3	2.7	1.7	4.0	5.8	0.4	1.5	2.2	1.2	2.5	0.0	1.5	1.2	4.0	5.1	3.2	1.2	0.0	2.5	0.4	2.5	1.8	1.2	9.3	0.4	7.6	2.8	1.5	1.9	13.2	3.8	1.0	6.9	2.4	0.0	2.3	4.0	5.8	2.1	0.1	7.6	0.7	4.8	3.0	0.5	0.0	10.5	7.0	0.0	7.7	4.3	1.9	3.2	13.0	1.1	6.4	2.7	1.8	2.1	0.9	2.0	0.7	1.8	4.8	1.0	5.9	6.7	1.1	4.7	0.4	1.7	0.2	0.7	0.0	0.9	0.0	0.3	0.3	0.8	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	2.8	3.0	2.6	3.4	2.8	3.1	3.6	3.5	3.4	3.1	3.0	2.9	3.3	3.2	1.1	4.6	3.3	1.3	3.7	13.1	2.2	1.7	8.6	10.8	7.8	5.7	8.0	5.5	0.0	1.1	0.5	6.7	17.6	8.8	168.5	79.4	4.1	3.9	3.6	0.4	4.0	11.0	1.5	3.6	5.1	7.2	4.5	1.9	4.6	1.7	2.9	3.3	2.7	18.8	14.2	1.9	1.9	17.0	4.4	1.0	3.6	1.0	0.8	5.1	0.0	1.0	0.9	6.6	16.8	5.7	2.6	4.8	1.9	22.5	47.5	8.2	6.6	3.2	3.4	23.9	3.6	0.8	1.7	0.0	1.0	4.2	4.8	2.1
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	0.5	0.5	1.9	0.4	1.9	0.6	0.8	1.6	2.8	0.7	4.0	0.3	0.2	0.7	1.2	0.3	2.7	0.4	0.3	2.2	2.1	1.0	1.0	0.4	0.1	2.0	2.2	0.4	0.7	0.5	1.8	0.7	2.1	0.9	0.2	1.3	0.4	0.4	0.7	0.1	0.2	0.4	1.9	0.2	0.3	5.9	2.1	0.2	2.8	0.3	0.2	0.6	0.4	2.4	1.2	0.2	0.4	0.2	2.0	0.4	1.1	0.2	1.5	0.8	0.5	0.2	1.7	0.3	0.7	0.3	1.0	0.4	0.4	0.8	1.5	0.3	0.3	0.3	0.9	1.1	1.2	0.4	0.9	0.8	0.6	2.0	1.2	0.9	0.7	0.6	0.8	0.6	0.6	0.9	0.1	2.4	0.5	0.4	0.2	0.9	0.1	0.2	1.4	0.7	0.6	0.5	1.7	0.5	0.3	0.7	0.5	0.6	0.6	0.4	0.2	0.3	0.3	0.6	1.0	0.7	0.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	1.6	2.8	2.2	2.1	2.0	2.2	2.1	1.9	2.1	2.4	1.0	0.0	2.3	11.4	0.5	1.9	8.9	6.4	2.2	2.3	5.7	3.2	2.3	4.3	4.6	0.0	4.2	8.2	0.3	0.6	5.9	1.2	94.7	17.3	2.0	1.7	1.2	0.4	12.1	0.4	15.8	2.1	0.5	1.7	0.0	0.3	1.1	3.3	3.3	0.0	9.0	1.7	8.2	0.6	1.0	112.4	8.1	1.5	5.4	1.0	0.3	5.6	1.0	7.1	16.3	0.5	0.6	7.5	0.5	7.5	0.1	3.9	31.8	8.1	0.0	3.1	2.0	32.7	6.8	0.8	2.7	6.3	0.7	0.8	0.8	5.0
C16orf54	FLJ35681	ENSG00000185905	"Chromosome 16 open reading frame 54"	Q6UWD8	16	29742463-29745990	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 41.4;lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 36.6;dendritic cells: 60.4;granulocytes: 33.6;monocytes: 22.0;NK-cells: 55.6;Plasma cells: 37.1;T-cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 18.6;HL-60: 18.9;HMC-1: 11.7;MOLT-4: 15.7;NB-4: 12.8;REH: 8.8;THP-1: 22.1;U-937: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060546	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA060546: AB_2684317"	"unprognostic (2.09e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.92e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-1)"	3.8	0.7	0.7	15.2	1.0	41.4	2.3	1.1	1.1	4.1	0.8	3.5	3.0	0.8	0.7	2.1	0.9	2.9	0.6	0.8	0.9	0.7	1.3	5.6	21.1	1.4	1.0	0.6	1.2	0.2	0.1	0.7	1.3	1.5	3.6	0.3	2.2	0.5	2.3	0.9	6.3	1.7	0.9	14.9	5.7	0.5	1.1	13.2	0.5	1.0	20.4	4.4	0.3	1.8	5.4	0.0	0.3	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.4	0.1	0.0	18.9	11.7	0.4	0.0	0.0	0.0	0.1	0.0	6.5	0.1	5.1	0.0	0.2	15.7	12.8	1.1	0.0	0.0	8.8	0.1	0.1	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.2	22.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.8	0.2	10.3	0.1	294.4	101.8	380.2	224.8	100.4	212.8	142.8	219.8	196.0	77.4	116.6	178.2	187.4	557.0	224.5	128.3	87.5	129.3	188.0	0.7	1.0	1.1	1.1	0.8	0.9	1.4	1.0	1.3	0.9	1.1	1.8	0.3	3.2	4.7	0.0	36.6	0.5	0.1	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.2	60.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	10.8	5.0	0.0	0.0	0.1	0.7	1.5	0.1	33.6	0.1	1.8	0.6	6.2	0.0	0.0	0.8	0.0	18.7	8.7	0.0	0.0	12.5	5.4	2.8	22.0	0.0	55.6	0.5	0.0	0.0	0.0	0.0	37.1	0.0	0.1	0.5	5.5	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.9	1.4	52.3	0.0	0.6	0.1
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109941-67148544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.9;Oligodendrocytes: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	11.3	10.0	15.6	7.6	16.6	18.1	11.1	15.5	17.4	13.2	10.8	10.2	7.3	11.2	8.9	17.8	10.6	7.5	10.3	18.5	13.6	14.0	57.3	9.8	9.2	15.7	16.1	11.1	8.3	16.1	10.9	11.8	17.0	14.4	10.1	8.1	12.0	8.5	29.7	30.4	10.0	10.8	16.2	14.7	8.6	13.8	15.6	9.2	9.0	15.3	11.7	10.5	14.6	21.4	13.7	19.3	19.0	19.9	23.6	13.9	44.5	15.4	16.6	30.7	33.3	22.1	11.7	13.9	13.3	18.2	16.9	18.0	23.7	14.9	39.7	7.1	19.7	10.6	12.2	47.4	14.5	10.9	58.0	14.1	20.6	30.2	13.9	16.6	17.3	17.5	17.5	5.8	19.4	13.6	21.2	16.6	21.5	18.4	29.4	29.5	32.2	21.9	13.4	8.2	24.5	13.2	46.2	10.7	12.0	18.7	22.0	9.0	13.4	21.5	18.4	15.5	13.5	8.8	17.3	41.3	19.4	10.9	17.5	3.2	17.4	6.1	4.4	12.2	5.9	6.9	6.6	8.1	14.6	4.5	6.8	6.3	6.2	5.9	13.6	4.8	7.2	8.9	15.6	16.6	15.5	17.4	18.5	13.6	15.7	16.1	17.0	16.2	15.6	21.4	5.1	6.4	5.9	11.1	6.6	9.1	2.5	5.1	19.4	7.4	8.7	6.7	1.3	1.5	3.2	0.0	0.0	8.8	5.0	4.9	5.9	4.4	1.6	12.9	8.5	6.2	7.2	11.1	20.4	2.9	9.5	5.1	8.6	30.6	9.5	8.7	5.0	47.9	18.6	10.1	18.5	8.4	4.1	13.5	7.8	1.6	4.7	13.2	10.6	17.8	13.3	2.7	3.1	11.1	41.6	4.8	8.6	6.4	7.5	4.6	5.4	10.3	11.0	5.9	13.1	5.3	6.4	24.7	24.8	20.5	12.1	7.0	6.7	8.2	5.7	1.3
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734344-4749396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 22.5;testis: 74.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 37.1;Late spermatids: 62.0;Respiratory ciliated cells: 22.6;Spermatocytes: 122.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.6;U-2197: 5.0"					"Low region specificity"	"Detected in all"			HPA049468	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.7	1.3	1.0	0.7	1.4	0.2	0.7	2.2	1.6	1.4	9.2	0.8	0.6	1.0	2.7	0.7	22.5	1.4	0.8	1.5	1.4	1.8	1.3	2.8	0.4	4.5	5.7	1.2	1.1	0.9	4.1	0.2	2.6	1.1	0.3	1.7	1.2	0.7	1.0	0.5	0.4	0.8	3.3	0.4	0.8	74.0	1.5	0.6	2.0	1.1	0.4	0.7	0.5	1.6	0.3	2.0	0.4	1.1	2.6	1.1	0.8	1.1	0.9	0.9	1.1	0.9	0.8	0.0	1.0	1.6	2.6	0.9	0.9	1.1	0.2	0.4	0.6	0.2	1.5	0.1	0.8	0.9	0.3	0.3	0.2	3.4	0.9	0.7	0.4	0.8	0.7	0.5	0.9	4.6	0.2	0.8	0.6	1.3	1.0	0.3	0.4	1.4	2.3	0.4	3.0	1.1	1.1	0.9	0.3	0.7	4.0	0.2	0.4	0.7	0.8	5.0	0.5	2.0	1.7	0.5	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.3	1.1	0.0	0.1	1.0	1.4	2.2	1.6	1.5	1.4	4.5	5.7	2.6	3.3	1.5	1.6	0.1	0.0	1.1	1.0	0.1	0.0	0.2	1.0	0.6	0.9	0.6	0.5	1.2	0.0	3.9	0.0	4.2	0.3	0.2	0.2	0.0	0.6	37.1	15.6	0.6	0.2	0.0	0.0	1.0	0.0	0.1	0.3	3.6	0.6	0.0	0.2	0.0	0.3	0.2	0.0	0.9	0.1	0.0	0.0	0.0	62.0	1.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.1	0.0	2.4	22.6	1.7	0.0	0.2	0.7	122.1	7.2	0.5	0.0	0.1	0.2	0.3	0.3	0.0
C16orf72	"FLJ41272, PRO0149"	ENSG00000182831	"Chromosome 16 open reading frame 72"	Q14CZ0	16	9091644-9121635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 643.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041568, HPA067492"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA041568: AB_10796677, HPA067492: AB_2685850"	"unprognostic (3.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.64e-3)"	"unprognostic (6.51e-2)"	20.0	17.4	15.7	18.2	17.8	106.1	17.2	14.9	20.3	15.9	14.0	14.9	14.8	15.2	17.3	19.6	12.8	19.0	15.8	18.8	16.7	18.6	26.8	17.5	20.1	14.1	15.8	14.2	18.6	22.3	9.8	17.1	14.9	15.9	15.0	20.8	14.2	14.7	32.4	17.0	13.6	16.8	13.8	20.9	15.8	17.3	16.8	19.4	18.8	27.8	22.0	17.8	15.2	16.8	17.3	18.9	29.6	27.1	34.4	26.7	15.5	33.2	27.6	18.8	19.3	15.9	22.0	30.8	18.6	38.6	14.8	19.8	27.5	29.4	39.2	20.3	15.4	20.7	27.2	33.6	44.4	26.3	23.2	40.7	45.3	31.5	44.7	30.1	33.1	31.7	31.6	45.7	33.6	24.9	23.5	23.3	36.1	17.7	16.5	39.6	36.1	33.1	24.6	31.3	19.1	21.4	39.9	27.8	35.1	27.4	32.1	26.6	38.3	36.6	24.0	47.6	21.7	51.7	48.0	42.5	32.6	23.2	30.3	5.5	2.8	3.2	3.7	3.1	4.2	2.5	3.1	2.6	2.2	3.0	3.5	3.2	10.9	2.3	3.4	2.8	2.7	1.7	15.7	17.8	14.9	20.3	18.8	16.7	14.1	15.8	14.9	13.8	16.8	16.8	65.3	48.1	37.2	17.6	47.5	76.9	45.4	13.0	78.6	43.6	81.6	53.8	39.3	35.8	19.1	22.0	87.6	29.6	76.0	45.8	19.6	28.1	210.0	75.7	75.1	52.5	48.2	21.7	27.6	29.4	35.7	42.9	35.2	115.7	18.3	51.9	38.6	59.5	32.5	43.7	28.2	35.1	8.2	83.8	65.6	643.5	24.5	83.5	32.0	28.1	49.0	41.8	33.0	24.6	33.3	38.9	37.7	27.1	59.2	52.0	44.5	36.8	15.9	51.2	32.9	78.0	56.3	41.5	22.3	84.5	64.4	57.1	58.8	35.3	34.9	70.1
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;Basal prostatic cells: 56.7;Bipolar cells: 55.8;Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 87.8;Syncytiotrophoblasts: 74.3;Urothelial cells: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 96.1;hTCEpi: 80.8;T-47d: 84.5"									HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Centrosome	"HPA049367: AB_2680730"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	3.6	0.7	8.4	4.3	8.5	8.9	6.5	6.8	12.0	9.5	7.8	3.1	1.4	1.5	2.0	9.4	1.5	2.2	2.2	12.2	7.4	2.5	1.1	2.2	8.4	7.5	7.4	0.8	1.8	7.5	1.3	6.7	7.0	9.2	1.1	27.7	4.2	7.3	0.5	9.0	5.6	0.9	6.7	16.0	2.9	2.1	7.6	1.4	5.0	0.3	6.4	17.2	14.5	7.4	35.3	11.5	0.4	4.7	5.1	5.6	14.1	4.2	5.6	13.1	3.7	8.9	32.1	0.3	47.2	3.3	5.5	49.4	2.0	96.1	7.4	0.0	7.6	0.0	5.3	0.9	13.9	1.0	0.0	12.2	80.8	12.6	54.7	9.8	43.4	5.8	0.0	0.2	0.4	29.6	0.0	54.0	2.9	37.7	32.6	1.4	0.0	2.8	0.1	39.5	10.7	2.8	17.5	8.9	9.1	3.6	84.5	14.9	44.8	8.4	22.0	3.8	12.7	11.7	9.3	40.0	0.0	12.6	1.7	0.1	16.8	21.8	1.3	6.3	4.4	46.7	8.8	7.0	18.3	49.4	14.5	9.3	6.6	7.8	2.0	0.3	18.0	10.8	8.4	8.5	6.8	12.0	12.2	7.4	7.5	7.4	7.0	6.7	7.6	7.4	10.1	3.2	1.1	6.5	47.4	9.3	56.7	23.8	8.0	55.8	19.0	20.3	1.8	1.5	9.8	1.8	58.4	45.8	3.4	0.1	3.9	3.0	1.7	4.4	4.6	7.2	0.0	0.8	0.4	1.1	19.7	5.7	1.5	4.1	0.0	0.5	2.5	0.0	5.0	15.2	0.4	0.0	8.2	1.2	2.9	0.4	3.4	2.5	19.6	1.0	5.2	18.8	4.1	1.5	0.8	3.2	0.0	3.4	44.2	36.5	0.0	2.4	3.9	87.8	0.0	0.3	2.5	0.9	8.4	8.5	7.0	74.3	3.7	1.5	0.2	55.7
C16orf86	FLJ41802	ENSG00000159761	"Chromosome 16 open reading frame 86"	Q6ZW13	16	67666814-67668757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 39.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 136.7;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.3;T-47d: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA073475	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA073475: AB_2686607"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.05e-1)"	3.5	2.7	2.3	0.9	2.3	0.6	3.4	2.0	2.8	3.0	2.1	4.1	0.3	3.5	0.3	1.4	3.5	2.2	3.2	1.9	2.5	4.3	2.2	2.0	1.5	2.6	2.4	2.1	2.4	2.6	2.4	1.1	2.4	2.4	0.5	0.7	1.7	1.5	4.6	1.7	1.8	0.5	2.2	2.4	1.9	39.8	2.3	1.9	2.6	2.7	0.5	3.3	2.1	2.7	0.1	0.3	0.6	0.2	0.9	0.8	0.6	0.8	1.8	0.4	0.6	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.9	3.3	0.0	0.5	0.1	0.6	0.7	1.2	0.1	2.0	0.9	0.0	0.1	0.4	0.3	0.3	0.0	1.3	0.0	1.5	1.8	0.1	0.4	0.2	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.6	0.6	0.7	0.1	0.1	1.1	2.3	3.0	0.7	0.7	1.2	1.9	1.8	1.0	3.8	3.6	0.5	1.1	0.8	0.8	0.7	7.4	1.2	1.8	2.3	2.3	2.0	2.8	1.9	2.5	2.6	2.4	2.4	2.2	2.3	2.7	6.2	0.0	3.7	5.5	5.8	1.5	2.4	2.6	3.4	7.5	3.6	4.1	1.9	4.3	2.7	5.5	6.2	1.5	5.2	0.3	7.9	3.3	136.7	1.3	3.5	4.8	3.0	0.8	1.1	0.7	0.4	5.6	0.0	0.9	11.4	2.6	5.7	3.1	6.2	5.0	1.9	0.8	2.0	6.0	4.7	25.7	5.6	5.9	3.6	4.7	5.4	13.5	5.2	2.0	2.3	0.9	0.2	7.5	4.5	0.7	0.2	17.8	1.7	8.4	0.0	5.4	4.0	100.9	3.0	1.1	1.6	0.8	2.5	9.2	0.3	0.9
C16orf87		ENSG00000155330	"Chromosome 16 open reading frame 87"	Q6PH81	16	46796603-46831180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 129.3;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041179	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041179: AB_10795002"	"unprognostic (2.44e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (7.95e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.84e-2)"	3.7	4.7	2.3	3.3	3.1	11.9	3.4	1.4	3.1	3.9	2.0	4.1	2.7	4.1	1.6	4.6	3.3	2.6	6.2	2.5	1.7	7.5	13.1	4.0	6.1	0.8	1.1	3.1	2.5	5.3	3.9	3.6	0.8	2.9	2.3	2.4	3.3	1.9	13.7	3.7	4.7	2.9	0.7	3.9	2.9	18.4	1.7	3.7	2.9	7.5	4.0	4.2	3.3	2.1	8.2	3.2	14.3	7.7	3.0	3.4	12.1	8.3	6.3	6.2	3.3	5.4	6.1	10.0	9.7	4.7	4.5	5.3	13.2	3.8	7.3	9.9	8.0	6.9	6.1	6.8	6.2	8.3	11.3	4.1	4.1	8.0	7.9	10.3	4.4	13.7	6.9	2.1	7.3	4.6	11.5	11.2	11.2	5.2	5.4	19.3	15.0	8.3	10.6	4.0	7.5	7.5	9.8	9.6	4.8	25.7	5.1	12.5	7.0	7.0	6.6	7.5	4.4	9.7	10.2	29.7	2.7	6.8	7.0	2.6	6.4	8.1	4.6	8.8	2.4	11.9	6.3	5.6	9.7	7.4	5.5	4.0	0.9	3.3	8.2	5.3	13.6	4.0	2.3	3.1	1.4	3.1	2.5	1.7	0.8	1.1	0.8	0.7	1.7	2.1	13.9	16.0	11.5	9.4	26.0	47.2	16.9	19.2	61.5	8.9	17.1	17.8	38.2	21.5	11.6	16.5	22.9	68.9	15.5	6.7	31.3	20.4	45.1	28.0	35.1	16.0	19.1	14.1	28.2	12.2	53.4	21.8	9.7	30.8	14.0	20.6	15.0	40.7	22.7	30.3	14.5	12.4	22.4	23.9	71.5	25.9	17.1	27.8	33.8	9.4	23.9	24.2	13.4	24.6	9.8	12.4	7.5	14.3	27.9	24.4	32.9	129.3	6.0	10.5	32.9	15.3	26.5	194.6	93.2	42.8	41.9	34.3	22.0	13.7	14.0	16.0
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 108.3;thyroid gland: 228.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1400000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	17.8	4.2	20.0	6.0	21.6	0.2	12.8	18.8	28.3	20.2	15.0	6.3	17.6	3.5	87.1	6.7	12.4	45.0	18.8	19.4	19.9	16.8	0.3	108.3	0.9	19.9	18.5	2.8	5.4	0.1	5.7	0.9	19.0	4.2	5.0	0.5	35.0	1.1	0.2	0.6	7.9	4.9	19.6	0.6	82.4	1.2	22.6	2.8	228.8	3.9	2.2	14.4	3.2	22.7	0.0	0.1	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	2.5	1.3	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.7	0.3	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.0	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	20.0	21.6	18.8	28.3	19.4	19.9	19.9	18.5	19.0	19.6	22.6	22.7	0.9	44.8	268.1	23.2	0.0	0.4	1.8	0.3	0.6	0.5	23.6	18.0	2.8	0.0	70.4	0.0	0.0	0.1	0.1	0.1	113.5	0.0	1.7	3.7	0.4	1.3	0.0	0.0	0.9	7.8	0.1	43.8	17.3	0.3	5.1	0.0	0.0	0.0	6.0	0.0	0.7	0.6	6.1	0.0	0.4	2.7	9.3	0.7	0.0	11.2	0.0	0.3	0.0	1.0	1.6	0.7	0.4	14.7	0.0	5.0	0.0	1.5	16.9	0.2	0.0	1.9	1.9	0.8	0.1	0.6	0.3	0.3	0.6	0.0	0.7	5.0
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 101.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 94.6;Late spermatids: 96.2;Spermatocytes: 127.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: AB_2685924"	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	2.5	3.8	2.2	1.2	2.2	3.3	2.2	2.5	3.3	1.1	1.7	1.6	1.4	1.2	0.4	1.5	1.2	0.9	2.6	2.2	2.2	2.7	6.9	1.3	1.3	2.1	2.3	1.5	3.2	1.3	2.2	0.4	2.4	1.2	0.8	0.6	1.5	0.6	4.3	1.2	1.5	0.4	2.2	1.6	2.2	101.4	2.5	1.7	1.2	3.1	0.8	1.4	1.2	2.0	3.4	9.2	3.2	3.9	3.7	2.1	5.4	3.1	1.3	3.0	2.3	4.4	5.4	8.3	8.6	0.6	3.3	2.7	3.0	2.1	1.4	4.2	5.4	7.9	3.5	6.5	3.2	0.9	1.5	3.7	0.7	3.5	1.1	1.5	2.9	6.1	7.2	4.2	3.6	8.7	3.0	7.4	3.0	2.1	5.5	6.7	1.4	4.8	1.9	1.4	4.0	3.3	7.6	0.4	2.5	1.1	4.5	4.2	3.3	5.5	2.3	3.3	3.0	12.5	10.9	16.2	7.4	8.0	3.8	0.0	2.5	0.6	2.6	2.7	1.8	1.7	2.1	2.3	2.4	1.4	1.7	2.9	0.4	0.7	3.4	3.3	2.9	1.8	2.2	2.2	2.5	3.3	2.2	2.2	2.1	2.3	2.4	2.2	2.5	2.0	1.9	0.0	1.5	1.0	1.9	1.7	0.5	0.6	6.2	2.5	2.0	2.9	2.4	1.5	0.3	0.0	2.1	2.6	0.4	6.0	1.9	2.8	94.6	0.5	0.4	1.3	0.0	6.9	1.5	3.4	3.4	1.3	4.1	0.4	0.0	0.7	2.2	5.9	2.9	1.7	1.5	3.4	0.0	1.6	1.8	96.2	3.4	0.9	0.0	1.9	2.7	3.7	2.1	1.0	1.8	4.0	2.4	5.3	6.4	0.6	6.4	3.4	1.0	2.2	26.3	0.4	1.8	127.9	8.0	3.0	0.6	1.1	1.1	0.6	5.3	0.4
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 16.6;pituitary gland: 27.0"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.0"	"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HMC-1: 3.2;hTCEpi: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.2	1.8	1.3	1.1	0.9	2.1	2.0	9.0	3.6	2.1	0.0	0.9	1.0	1.5	3.4	1.1	1.8	1.5	16.6	1.7	3.5	2.9	5.6	2.0	0.5	1.3	0.2	4.2	5.0	3.6	27.0	0.6	0.7	3.4	0.4	1.7	13.2	1.9	0.5	3.5	1.0	0.4	0.0	2.0	3.3	4.6	1.6	0.3	1.3	0.0	0.6	1.0	1.6	1.0	0.3	0.4	0.5	0.1	1.0	0.8	0.7	1.9	0.2	0.1	0.3	0.3	0.3	0.2	0.3	2.6	0.0	0.7	0.0	0.2	0.1	0.0	0.4	0.8	0.4	0.4	1.4	0.0	3.2	0.8	3.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.9	0.4	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	1.0	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.9	9.0	3.6	1.7	3.5	1.3	0.2	0.7	0.0	1.6	1.0	1.7	0.0	1.3	1.6	9.7	1.8	2.8	0.4	6.8	1.2	3.5	1.7	14.4	0.0	1.1	0.0	0.0	0.4	4.5	0.1	1.9	0.4	53.3	0.8	0.4	1.5	0.0	0.0	0.7	1.3	2.3	2.3	2.0	1.2	11.4	0.9	0.4	3.1	1.0	5.0	0.8	1.5	2.0	1.9	10.7	288.4	1.5	6.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	1.2	8.1	2.3	0.2	1.9	0.6	0.8	0.0	0.5	2.0	1.5	1.2	1.2	1.3	5.2	4.0	1.1	0.2	1.1
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 62.0;Smooth muscle cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	62.3	42.6	54.9	61.5	54.6	122.1	55.5	55.6	60.4	42.1	49.3	37.8	34.9	36.0	53.1	52.8	49.3	38.2	53.1	53.7	55.4	47.2	47.1	55.3	97.5	54.6	54.0	35.6	50.8	37.7	40.1	36.9	54.1	35.3	42.3	39.2	42.2	26.8	69.6	63.1	37.0	34.0	54.6	73.0	35.5	28.2	57.2	97.6	52.9	55.1	105.4	53.9	39.5	55.9	68.2	88.3	136.8	106.6	95.4	134.5	47.0	36.1	58.7	70.8	57.5	43.6	54.5	64.6	97.1	86.8	23.0	55.1	34.5	69.8	53.7	227.6	91.6	58.4	27.9	85.3	71.6	37.7	74.8	85.4	92.4	52.9	106.0	50.7	112.0	51.6	21.9	179.3	87.5	77.7	62.3	125.1	45.9	77.1	51.2	38.3	40.0	95.1	80.9	44.6	37.2	105.3	63.4	32.3	67.5	49.1	41.0	47.9	61.7	40.8	50.3	69.7	93.5	63.8	39.5	22.5	63.6	55.6	59.9	259.3	159.7	157.7	190.8	225.8	122.3	238.7	195.9	193.8	251.3	221.0	128.9	143.0	148.1	391.4	177.4	346.7	215.3	193.1	54.9	54.6	55.6	60.4	53.7	55.4	54.6	54.0	54.1	54.6	57.2	55.9	9.6	3.2	10.3	0.0	18.2	10.5	5.9	8.2	13.1	1.2	8.9	11.2	1.1	2.8	7.2	1.8	0.0	10.9	18.1	8.2	17.6	17.7	0.2	2.3	4.1	12.3	30.6	8.6	0.0	23.1	16.5	6.0	2.6	4.2	18.9	3.1	9.3	2.1	11.1	0.0	0.0	12.5	14.2	7.8	32.3	1.4	4.1	12.0	24.9	0.0	62.0	2.1	16.5	0.0	0.0	24.2	14.3	1.5	14.1	6.6	8.8	6.0	4.1	3.5	6.6	6.1	41.9	5.4	18.5	11.9	11.8	10.4	17.6	3.3	14.0	6.2
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991099-67996469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 35.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 55.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 37.3"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.9	5.4	5.2	2.8	5.5	3.9	16.9	5.4	10.0	26.8	4.8	8.4	4.0	15.1	6.9	5.1	7.8	4.7	5.9	5.7	5.3	6.1	9.4	3.4	3.2	5.4	5.3	4.8	4.8	3.2	2.0	35.6	5.1	5.8	7.3	8.9	4.3	3.6	3.5	3.5	4.6	10.9	5.5	2.3	6.8	3.0	5.2	2.1	6.8	7.3	7.1	8.8	7.6	5.5	9.8	9.5	9.3	11.6	6.6	16.6	7.3	4.0	11.4	6.9	11.2	5.6	12.4	13.0	8.9	3.3	12.1	4.9	21.3	8.6	16.6	23.5	21.5	8.4	3.2	17.8	10.4	7.2	14.9	9.2	10.2	6.7	15.4	7.7	32.7	11.2	18.2	19.6	6.7	13.1	1.3	9.5	10.7	23.6	10.0	3.1	10.2	17.4	8.7	6.5	6.9	12.5	6.0	55.5	20.8	11.4	15.8	8.2	6.1	5.8	5.9	4.2	8.5	38.9	30.9	11.6	14.8	12.6	10.5	8.6	2.8	5.0	2.2	2.9	0.7	3.0	0.8	1.7	3.9	0.5	0.3	0.8	1.1	2.7	5.0	0.1	0.4	1.8	5.2	5.5	5.4	10.0	5.7	5.3	5.4	5.3	5.1	5.5	5.2	5.5	21.6	0.0	1.7	6.2	3.5	4.8	5.5	5.6	7.4	8.9	31.0	21.8	4.7	12.8	6.1	11.0	10.4	28.6	4.1	10.5	23.5	10.1	0.9	21.0	40.5	16.3	3.6	8.4	5.0	9.3	21.7	51.6	19.9	19.4	12.7	3.8	14.3	18.5	16.9	5.0	4.6	15.0	10.2	9.7	21.5	2.8	3.7	7.3	8.8	2.8	18.4	31.9	12.3	3.0	4.6	10.7	10.0	5.3	7.0	11.6	10.9	19.7	16.5	15.6	6.6	36.2	14.1	7.3	6.0	20.7	8.4	15.3	4.1	8.3	10.1	7.6
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431426	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	173	"testis: 135.3"	"Group enriched"	"Detected in some"	25	"Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.5;granulocytes: 1.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.3	0.1	0.3	0.0	0.1	0.6	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.0	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	135.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	2.5	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.4	0.6	0.4	0.4	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1057.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	524.2	9.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	287.9	24.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.5;MOLT-4: 14.6;PC-3: 9.7"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 3.1"	"Region enhanced"	"Detected in many"		"spinal cord: 15.6"	HPA043479	Approved				"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	1.3	0.4	2.7	1.3	2.2	0.5	1.0	2.2	4.3	1.9	1.8	1.3	0.7	1.8	1.4	0.8	1.5	1.7	0.9	2.1	3.2	0.8	2.2	1.6	1.5	2.3	2.5	1.8	1.7	0.5	1.3	0.8	2.5	1.7	0.5	0.8	0.9	1.2	0.6	0.5	1.6	1.2	1.9	2.6	1.0	1.8	3.1	5.5	1.3	0.9	1.0	1.4	1.7	3.3	3.2	2.0	1.3	1.4	0.6	0.9	0.6	1.8	2.3	1.5	1.7	2.6	1.1	1.7	3.1	0.8	1.7	1.6	0.9	0.5	1.5	9.5	3.4	1.6	2.4	1.6	0.8	1.2	3.1	0.3	2.4	1.0	1.0	1.1	1.5	3.3	1.6	7.9	1.0	2.5	14.6	2.2	1.2	1.0	9.7	3.1	2.5	1.8	1.1	0.8	0.7	1.6	1.8	0.4	1.0	0.5	2.0	0.9	2.2	1.6	4.0	1.1	1.3	3.2	8.7	0.9	1.1	1.4	0.6	0.0	0.1	0.3	0.2	0.2	0.3	1.5	0.6	0.8	0.1	0.8	0.6	0.8	0.2	0.2	0.3	0.3	1.5	0.3	2.7	2.2	2.2	4.3	2.1	3.2	2.3	2.5	2.5	1.9	3.1	3.3	15.3	3.2	0.0	2.9	8.4	2.3	16.3	0.5	4.6	12.4	3.9	5.6	1.8	11.5	0.1	7.3	14.6	0.1	8.4	12.1	0.0	3.3	9.0	3.3	6.3	13.5	8.9	3.6	7.2	1.4	0.8	4.8	3.1	6.8	1.3	3.1	7.9	9.0	2.9	5.0	10.6	4.6	0.0	8.1	4.7	7.4	7.8	5.0	1.8	15.9	3.8	2.7	12.3	6.6	6.2	2.2	11.9	1.2	4.3	12.4	4.1	0.4	1.0	20.1	0.0	2.4	5.1	12.9	9.5	2.2	1.7	0.3	11.0	4.3	6.3	7.2
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	8.1	15.9	10.9	10.4	11.4	7.5	13.2	12.1	13.5	8.9	12.3	11.7	13.3	12.4	18.7	8.7	15.0	7.0	19.4	10.8	11.7	21.3	14.5	8.7	12.9	11.2	10.9	16.1	13.2	27.8	13.4	10.4	11.8	11.6	12.6	26.1	12.2	10.6	17.5	7.2	10.8	10.4	10.5	9.5	12.9	26.3	11.1	16.0	14.1	14.3	13.2	9.6	8.2	11.2	39.2	33.4	51.0	15.5	13.3	14.5	27.9	25.5	22.4	34.3	29.1	18.2	14.9	23.5	28.6	18.2	52.6	42.5	32.8	27.6	46.6	18.0	37.9	18.7	39.8	39.5	26.6	26.3	14.1	13.4	33.0	25.2	17.4	28.6	25.3	43.6	38.9	31.8	22.8	29.2	76.5	26.9	37.7	23.9	14.7	50.1	31.5	44.0	21.4	18.2	50.4	44.3	21.1	19.1	62.7	37.2	50.4	16.8	19.8	18.8	35.4	9.3	42.4	42.5	51.0	82.9	15.3	23.0	5.7	34.6	12.4	16.4	17.6	12.0	20.1	18.2	16.9	18.3	16.1	19.9	18.2	17.0	3.2	19.0	17.1	12.8	19.6	15.4	10.9	11.4	12.1	13.5	10.8	11.7	11.2	10.9	11.8	10.5	11.1	11.2	12.6	12.8	30.7	7.2	13.8	5.9	13.4	27.8	12.5	25.0	11.3	13.5	25.8	8.6	19.3	14.7	8.4	31.8	10.7	3.8	43.0	16.2	10.0	17.2	8.8	10.5	12.6	13.5	11.1	13.8	18.0	9.8	9.7	10.5	11.4	18.3	6.4	11.0	9.7	32.0	15.0	8.0	28.5	7.5	3.7	6.3	7.5	7.8	5.4	2.8	6.7	17.5	11.3	10.1	8.7	11.8	3.2	8.2	14.0	6.4	6.9	29.9	29.9	23.0	39.5	9.7	13.1	88.0	31.8	12.0	6.1	16.3	15.1	10.5	8.4	8.2
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.6	10.1	10.0	9.5	10.1	3.1	11.2	12.7	12.1	11.9	9.2	11.6	10.5	14.5	9.7	8.8	12.2	8.9	15.8	9.7	10.2	12.7	9.9	9.2	13.7	8.3	9.2	17.2	9.3	16.6	10.6	12.5	8.4	12.6	10.0	23.3	10.8	11.9	24.6	8.7	9.8	12.8	9.0	10.8	10.3	39.7	9.6	17.9	16.1	21.8	12.2	9.1	6.9	9.9	20.0	20.6	28.1	17.2	20.2	17.2	27.2	25.6	22.2	35.6	33.6	19.7	16.1	37.7	17.8	13.2	24.2	19.5	39.4	14.7	41.4	13.8	26.8	34.6	21.5	23.3	17.6	37.0	19.7	13.5	18.1	23.8	19.5	17.8	30.9	25.1	38.3	21.9	24.0	11.5	43.1	17.5	22.3	22.1	22.1	25.7	77.2	19.3	18.4	14.9	34.3	30.8	13.7	24.7	30.0	44.0	27.1	23.0	17.1	37.1	34.0	12.1	24.8	24.7	31.9	35.8	14.9	16.5	24.1	17.3	3.3	4.8	6.6	4.0	6.6	4.9	4.9	5.9	3.8	4.7	4.5	6.6	1.6	4.4	4.4	5.8	7.2	3.4	10.0	10.1	12.7	12.1	9.7	10.2	8.3	9.2	8.4	9.0	9.6	9.9	10.3	6.4	15.1	10.7	6.4	5.0	2.1	3.0	8.6	10.3	6.1	7.2	20.2	5.7	7.9	5.5	20.9	9.5	14.9	4.6	9.8	6.1	170.0	8.9	12.3	11.0	5.4	1.3	10.8	3.8	5.8	9.6	5.6	7.0	7.6	11.8	5.0	4.6	5.0	8.4	10.9	3.8	6.1	5.1	2.6	100.8	5.3	4.8	1.8	9.4	5.9	10.6	4.1	10.1	9.0	4.5	5.1	7.5	5.9	2.1	6.6	7.5	15.8	15.8	0.0	10.5	7.7	67.1	13.6	7.1	4.4	16.8	5.5	17.9	4.8	1.4
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410325-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 546.2;Late spermatids: 1313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.0;U-2197: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023583	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	5.2	1.2	1.0	1.6	0.7	2.8	0.6	2.4	4.1	2.9	4.0	0.8	3.9	1.8	3.2	8.9	1.8	3.8	1.2	1.0	8.5	2.7	2.8	1.2	1.6	2.6	3.8	2.9	1.9	7.0	0.3	1.3	3.1	1.1	2.7	3.1	2.4	4.7	3.7	2.5	0.6	1.4	1.5	3.0	58.8	1.1	1.9	6.9	0.7	0.6	2.7	2.5	1.2	2.1	3.0	1.4	1.7	0.7	0.6	0.7	1.5	1.0	1.1	0.7	0.0	3.1	0.5	1.1	3.4	0.9	7.0	3.8	0.8	1.1	0.3	0.4	1.5	2.6	0.2	2.5	0.3	0.6	0.7	1.9	2.6	0.3	1.6	1.2	3.4	0.2	0.0	0.7	1.8	5.2	2.7	2.1	6.2	0.9	0.5	0.3	1.9	4.8	1.7	0.4	1.6	1.9	2.6	0.4	2.3	1.6	2.3	1.1	1.4	0.7	9.1	0.6	0.2	0.2	0.0	1.7	0.7	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.6	2.4	1.2	1.0	1.6	2.6	1.3	1.4	1.1	1.2	1.4	3.2	5.9	2.6	0.8	3.3	3.5	6.5	0.0	4.3	7.7	6.0	6.1	7.2	9.5	20.2	20.9	1.6	0.9	18.4	62.6	13.3	546.2	87.1	6.3	3.3	16.1	5.7	3.3	3.5	0.3	3.5	4.6	8.4	2.5	8.6	2.5	5.3	1.9	1.7	3.1	8.5	14.2	0.0	1.5	1313.1	8.4	2.0	3.6	1.9	3.1	13.5	0.0	0.5	0.9	4.7	6.4	6.4	0.1	4.5	3.8	28.0	55.8	26.4	6.6	3.4	4.6	156.2	12.4	1.8	1.0	0.8	0.8	15.4	10.4	1.6
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835086-38841438	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 19.5"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 263.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"hTCEpi: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	263.7	0.2	0.1	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	29.4	1.2	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	3.3	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
C17orf99	"GLPG464, UNQ464"	ENSG00000187997	"Chromosome 17 open reading frame 99"	Q6UX52	17	78146353-78166177	"Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 9.0"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"HaCaT: 3.5;HMC-1: 7.1;K-562: 4.2"	"Not detected"	"Not detected"							HPA029655	Uncertain				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA029655: AB_10601691"	"unprognostic (3.55e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-4)"	"unprognostic (6.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	1.8	0.4	0.6	1.1	0.1	0.3	0.5	0.0	0.7	1.8	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	52.6	0.3	0.4	0.4	0.4	0.0	0.3	0.0	0.1	0.4	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.7	0.1	0.6	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.0	1.1	0.6	0.1	0.1	0.6	0.9	0.3	0.2	0.9	0.4	0.8
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972625-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	16.4	18.2	15.2	12.8	15.7	71.9	20.5	18.6	19.7	13.6	14.2	15.1	16.2	15.3	18.4	14.7	14.9	12.3	18.3	15.4	15.2	15.1	16.9	12.2	21.8	15.0	15.0	17.0	23.2	17.9	12.9	14.6	15.0	14.4	13.1	19.2	19.3	12.9	34.1	16.3	15.2	13.0	15.6	18.1	19.8	35.8	15.4	21.9	14.0	26.4	18.8	16.3	12.3	16.5	24.9	17.2	35.3	27.0	25.4	36.2	25.9	34.3	34.9	42.3	44.7	15.8	17.8	22.4	33.7	27.4	26.9	26.2	28.2	28.8	45.7	33.4	30.4	22.5	21.2	35.5	35.3	65.4	26.3	37.9	46.7	38.2	39.3	36.8	37.0	30.6	39.7	34.0	29.4	29.5	42.4	48.0	30.4	11.6	18.9	28.0	30.7	43.0	29.2	29.5	25.5	36.0	25.4	18.8	58.3	32.7	28.2	31.2	24.3	43.3	19.1	15.8	31.0	43.2	41.4	46.0	21.4	37.3	22.1	97.5	28.8	34.2	24.5	30.7	24.2	34.7	25.9	23.2	27.1	30.9	19.8	25.9	28.0	28.8	30.0	26.6	41.5	19.8	15.2	15.7	18.6	19.7	15.4	15.2	15.0	15.0	15.0	15.6	15.4	16.5	9.6	19.2	6.1	3.9	13.7	11.9	8.9	17.4	18.2	9.6	13.1	16.5	12.7	10.0	12.1	1.8	6.2	19.0	23.0	10.4	11.7	20.2	145.2	13.7	14.7	10.8	7.2	12.4	5.5	28.8	32.0	12.4	8.6	14.4	14.0	12.9	10.0	9.6	21.3	8.4	6.0	12.9	16.2	20.1	10.3	76.3	22.4	14.4	12.4	5.6	24.4	13.1	20.6	4.5	5.1	20.0	14.0	17.0	13.5	11.7	17.8	20.1	5.1	12.1	0.0	14.1	11.3	124.0	35.9	12.8	12.4	13.1	13.6	17.3	15.9	9.3
C18orf25	"Ark2N, ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	8.5	6.9	9.0	8.9	8.9	34.1	10.4	12.3	10.3	11.9	18.1	8.1	7.7	9.2	7.9	37.5	9.6	6.5	15.8	8.0	8.2	8.8	8.1	9.6	12.1	10.2	12.9	9.2	6.0	18.8	6.2	8.2	11.2	8.3	9.2	27.6	13.3	7.5	23.3	13.2	8.9	9.4	7.4	11.1	8.7	12.0	10.2	15.0	11.9	16.0	15.4	9.8	16.4	9.1	18.4	17.9	14.8	16.9	10.4	9.3	19.0	26.0	13.8	27.3	23.1	13.9	20.5	14.0	24.1	17.7	9.8	40.9	27.7	17.7	29.5	23.5	8.9	12.4	16.0	10.6	17.9	23.5	16.0	8.7	20.2	31.9	26.3	15.9	11.0	12.9	14.1	16.3	15.3	13.7	17.9	11.9	13.2	6.3	7.0	16.0	17.6	20.7	26.1	32.5	20.7	10.8	19.1	13.4	13.7	17.9	8.8	14.3	16.0	24.7	17.6	6.0	24.3	21.3	19.7	22.3	12.8	24.4	27.0	4.9	8.9	18.6	6.3	9.9	11.2	6.9	12.3	9.6	8.8	9.0	8.6	6.8	22.7	3.5	14.3	12.6	8.7	6.9	9.0	8.9	12.3	10.3	8.0	8.2	10.2	12.9	11.2	7.4	10.2	9.1	18.4	12.8	9.1	16.0	19.2	25.2	10.4	11.5	11.4	14.5	13.4	9.9	30.4	5.7	9.5	14.7	20.9	8.1	26.1	15.1	1.9	9.1	2.4	42.1	14.4	16.2	12.0	16.8	62.5	6.5	10.5	12.1	13.7	39.2	15.2	9.9	11.7	13.0	9.1	13.5	45.2	10.0	6.1	13.1	18.0	3.5	8.1	12.9	7.2	22.5	11.1	12.4	9.2	25.6	25.9	20.4	10.1	10.5	16.5	13.0	9.2	7.6	16.9	30.6	19.7	14.8	11.8	20.6	14.9	14.2	31.8	24.4	18.6	6.6	10.1	23.3
C18orf32	FLJ23458	ENSG00000177576	"Chromosome 18 open reading frame 32"	Q8TCD1	18	49477243-49487252	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 238.5;Late spermatids: 233.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040921	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Nucleoplasm	"HPA040921: AB_10795423"	"unprognostic (5.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.76e-2)"	"prognostic favorable (8.89e-9)"	"unprognostic (1.02e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.36e-2)"	41.5	66.7	10.8	5.6	13.8	6.8	39.8	15.3	20.0	34.9	8.3	46.0	6.1	35.6	5.6	32.3	34.5	6.6	59.3	11.3	13.5	79.6	86.8	46.5	7.9	14.8	13.0	38.8	47.0	18.5	67.9	6.9	14.0	39.4	10.2	24.6	43.7	8.4	37.9	27.8	39.9	7.3	13.4	39.2	58.1	40.9	13.1	8.5	43.9	7.2	10.4	38.8	32.6	18.7	4.3	3.2	14.4	13.3	12.3	8.8	8.6	5.5	7.6	6.0	6.8	0.5	3.7	4.9	8.6	7.9	9.0	11.1	5.1	10.6	12.6	11.3	4.1	4.2	2.3	5.4	11.2	5.1	11.2	9.9	21.0	5.0	6.1	16.0	12.2	10.1	4.1	11.4	9.9	1.9	4.6	2.5	4.7	4.9	5.9	4.0	3.6	3.8	7.1	5.0	10.7	12.3	5.1	3.4	4.4	19.8	3.1	2.3	13.1	9.6	5.0	1.7	6.9	13.4	24.1	9.1	5.2	5.9	7.1	27.4	8.4	25.8	8.4	8.8	8.7	8.9	6.9	7.7	6.6	7.4	6.6	8.4	41.4	6.2	11.3	9.5	8.2	10.3	10.8	13.8	15.3	20.0	11.3	13.5	14.8	13.0	14.0	13.4	13.1	18.7	20.2	44.8	29.2	0.0	50.8	5.5	4.6	21.2	39.3	35.0	26.2	15.0	5.5	31.5	22.4	23.9	43.8	22.9	33.8	92.9	39.2	87.5	238.5	38.1	21.0	17.5	95.5	20.2	0.0	82.7	17.7	28.7	63.2	30.3	45.6	5.3	23.6	40.4	22.1	18.5	0.0	57.3	32.6	38.0	12.0	233.1	17.1	48.1	23.2	0.0	73.9	41.4	34.0	0.0	0.0	92.3	77.5	10.1	83.0	5.6	92.7	57.2	42.4	36.3	19.7	10.3	22.7	12.7	13.9	58.4	7.7	38.7	43.4	4.5	40.8	5.2
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 118.9;tongue: 105.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	118.9	25.3	22.1	14.4	25.8	4.4	40.8	16.6	24.8	13.8	12.6	16.8	19.5	14.3	9.0	13.2	12.8	12.9	30.9	23.9	22.7	20.8	69.3	11.3	21.2	20.5	20.3	14.7	17.1	15.4	14.5	13.2	21.7	14.1	9.3	8.5	18.1	12.4	62.2	14.7	17.6	13.4	16.8	16.0	12.9	7.3	23.1	14.1	10.7	105.5	13.6	15.2	11.7	19.9	19.9	39.4	18.4	23.2	45.0	27.5	28.8	23.1	22.7	22.5	29.2	19.1	8.1	16.1	24.1	29.1	20.4	8.5	15.7	9.5	15.1	42.8	28.3	18.0	13.5	33.2	25.1	14.0	22.8	31.8	20.2	13.7	10.9	18.0	20.1	9.8	14.0	20.3	23.7	13.8	9.9	10.1	11.1	17.3	9.9	19.2	19.1	12.3	17.2	20.1	11.3	23.8	13.9	17.8	37.0	18.8	7.6	15.4	20.9	47.4	37.0	19.5	21.2	28.4	27.1	12.0	28.3	8.4	20.3	1.1	2.3	1.4	16.0	2.5	9.4	4.6	9.1	11.6	2.2	3.6	9.2	11.5	2.8	7.1	2.7	5.0	11.9	8.0	22.1	25.8	16.6	24.8	23.9	22.7	20.5	20.3	21.7	16.8	23.1	19.9	9.6	12.8	13.7	9.4	13.7	12.7	11.1	8.2	14.8	15.8	13.2	9.4	30.1	2.8	7.3	9.2	6.2	29.2	21.7	9.2	15.6	17.1	1.8	8.5	16.0	10.4	3.6	9.5	19.5	23.1	25.5	20.0	8.2	8.8	16.5	16.2	14.6	62.4	15.6	5.0	18.3	7.5	8.2	12.5	9.9	1.8	28.9	8.7	10.6	8.4	20.1	15.8	41.2	12.1	17.4	20.0	11.0	29.3	20.7	12.8	24.0	37.5	6.6	9.6	6.6	24.6	13.3	4.6	5.3	10.1	7.7	21.9	21.6	23.8	8.2	7.8
C19orf18	MGC41906	ENSG00000177025	"Chromosome 19 open reading frame 18"	Q8NEA5	19	57958437-57974534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.4"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 131.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEK 293: 3.0;RT4: 2.0;U-266/84: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014527, HPA079195"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus"		"HPA014527: AB_1845612, HPA079195: "	"unprognostic (5.38e-2)"	"unprognostic (6.36e-3)"	"unprognostic (3.70e-2)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.08e-5)"	"unprognostic (1.11e-2)"	"unprognostic (8.75e-5)"	"unprognostic (1.53e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-3)"	1.3	1.9	2.8	0.4	3.8	0.6	2.6	2.8	8.1	1.5	6.5	2.0	0.8	1.3	4.0	0.6	2.3	1.2	4.8	3.0	3.1	2.5	1.8	1.0	0.6	4.2	4.3	1.8	1.1	0.9	3.9	0.8	3.9	3.3	0.8	5.1	1.2	1.3	3.5	1.3	1.2	0.9	3.6	1.2	1.1	12.4	3.7	0.6	1.7	0.6	0.7	1.6	0.9	3.6	0.1	0.0	0.8	2.0	0.4	0.6	0.6	1.0	0.2	0.2	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.0	3.0	0.1	0.0	0.7	0.7	0.0	0.5	0.7	1.2	0.0	0.2	0.7	0.1	0.4	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.5	2.0	0.8	0.2	0.4	0.0	0.3	0.6	0.7	0.6	0.4	0.1	0.2	0.2	0.2	0.4	1.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	2.8	3.8	2.8	8.1	3.0	3.1	4.2	4.3	3.9	3.6	3.7	3.6	1.9	3.2	2.2	17.9	0.8	0.4	0.3	0.6	0.0	0.9	2.2	1.8	3.6	1.5	2.1	0.0	0.0	0.5	0.6	0.8	0.0	2.0	131.6	5.7	0.9	2.1	0.0	2.7	2.5	0.2	0.6	0.7	0.0	1.4	0.0	0.7	4.6	1.9	0.4	0.0	3.2	1.9	0.0	0.8	1.4	24.2	2.1	0.4	1.8	1.0	0.6	1.5	0.0	8.5	8.0	1.0	0.3	0.7	0.2	0.6	0.5	0.3	4.0	3.4	6.6	0.9	1.2	5.3	2.2	0.2	0.6	0.3	0.6	1.2	1.1	0.5
C19orf25	FLJ36666	ENSG00000119559	"Chromosome 19 open reading frame 25"	Q9UFG5	19	1461143-1479219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050270, HPA067491"	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050270: AB_2681069, HPA067491: AB_2685849"	"unprognostic (5.82e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.51e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-3)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.35e-2)"	"prognostic favorable (9.20e-8)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	14.4	23.5	33.3	8.8	33.2	7.8	15.9	31.1	43.8	17.7	29.3	18.0	15.6	15.8	5.3	20.4	15.7	8.1	21.2	31.6	30.0	31.0	29.5	14.8	15.0	35.3	33.1	15.9	19.9	15.6	27.1	8.6	32.0	22.1	5.2	6.9	17.6	8.1	16.2	17.3	17.7	6.1	32.7	23.4	17.8	22.0	34.0	9.7	23.8	7.4	7.0	17.5	15.6	36.7	25.0	19.2	11.6	18.3	11.0	10.0	23.4	24.4	16.8	25.5	23.5	27.4	12.1	14.2	18.7	13.0	12.1	30.1	17.9	15.0	6.0	44.7	27.1	17.3	12.2	32.3	23.6	27.5	33.5	9.2	33.2	10.7	17.2	18.3	13.2	29.3	46.1	32.7	16.6	13.9	25.6	21.8	36.2	15.2	29.5	41.4	16.0	36.5	17.8	16.7	19.8	26.5	18.0	23.0	28.5	6.0	33.4	31.8	16.3	19.8	22.4	40.6	23.4	46.3	26.7	24.2	20.4	27.4	35.1	50.1	32.1	59.1	41.3	33.0	33.5	36.6	37.9	35.7	23.4	45.6	38.2	30.9	52.0	30.5	27.7	47.6	52.6	38.6	33.3	33.2	31.1	43.8	31.6	30.0	35.3	33.1	32.0	32.7	34.0	36.7	24.2	16.0	8.7	10.4	44.3	19.2	30.5	27.3	18.8	62.7	28.9	29.7	10.3	21.5	19.9	51.5	64.6	41.5	45.2	68.1	49.0	40.1	6.2	14.7	21.0	23.0	50.6	17.2	14.5	46.1	33.3	21.7	31.1	19.3	11.4	30.4	29.3	18.2	35.9	97.6	11.5	33.7	34.6	27.9	24.9	7.3	26.4	26.4	24.9	8.4	56.7	49.2	82.4	14.1	20.6	52.6	52.0	21.8	26.7	33.5	83.2	35.5	15.3	87.8	46.0	20.0	24.1	33.8	33.0	14.8	19.7	52.9	47.3	36.1	38.2	33.6
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
C19orf44	FLJ21742	ENSG00000105072	"Chromosome 19 open reading frame 44"	Q9H6X5	19	16496394-16521352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 46.7;Late spermatids: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041683, HPA049414"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA041683: AB_10793929, HPA049414: AB_2680754"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.19e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.02e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-1)"	3.2	2.7	3.9	1.8	4.1	3.2	3.4	3.7	5.4	5.7	5.9	5.3	1.9	4.9	2.8	2.8	6.0	3.7	3.3	3.9	4.2	4.5	2.7	2.6	2.2	4.7	5.0	8.1	4.1	5.6	5.2	2.1	3.5	4.8	1.5	3.7	5.8	4.4	4.6	4.3	2.3	3.4	2.9	2.4	3.3	14.5	4.1	3.5	4.8	2.7	1.9	4.4	3.7	3.8	4.7	4.9	5.1	6.4	3.3	6.1	5.4	3.6	3.5	4.5	6.6	3.0	6.5	3.6	6.9	2.9	3.0	3.9	3.9	3.1	3.4	2.5	10.0	1.4	8.0	4.6	4.4	2.0	2.2	3.3	3.1	5.7	4.3	8.8	2.5	5.5	5.7	1.5	2.9	6.6	3.6	5.7	3.0	6.3	7.3	3.5	2.3	5.9	4.7	1.8	5.9	3.2	4.1	5.6	3.3	4.4	5.7	2.9	4.4	6.2	3.5	5.9	5.7	4.3	3.3	2.5	4.6	2.0	5.4	3.5	0.5	0.1	0.5	0.3	0.1	1.5	0.6	0.2	0.2	1.1	0.6	1.0	1.0	0.3	0.8	0.4	0.2	0.4	3.9	4.1	3.7	5.4	3.9	4.2	4.7	5.0	3.5	2.9	4.1	3.8	1.7	0.0	5.6	9.4	2.5	0.4	1.0	1.3	1.2	3.4	2.1	2.3	3.7	2.8	4.8	7.3	12.5	1.9	1.1	0.8	0.0	1.8	46.7	9.9	6.0	2.5	7.2	2.1	3.9	1.2	1.8	3.1	2.6	5.4	0.0	6.7	1.4	1.7	0.8	0.0	4.8	1.6	0.0	0.6	1.0	72.6	3.1	0.9	0.0	5.6	1.3	2.7	0.0	0.5	2.9	1.1	1.6	5.3	1.2	0.7	0.4	3.4	6.6	8.4	0.0	3.7	2.9	10.9	2.1	1.6	0.4	0.5	0.9	4.1	1.2	0.3
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 90.0;skeletal muscle: 259.4;tongue: 139.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.2;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	6.7	5.9	16.0	6.6	16.1	8.3	8.3	11.6	14.7	8.6	1.8	7.6	5.6	7.7	4.0	12.6	6.0	3.5	90.0	12.2	10.0	5.8	7.7	6.4	7.6	15.4	15.0	6.7	5.2	6.6	7.5	6.5	14.0	8.8	2.9	2.5	10.5	6.4	259.4	12.3	6.0	3.9	13.1	7.4	6.2	26.5	13.9	7.3	6.9	139.1	4.4	8.5	8.7	17.1	20.3	30.5	12.7	13.8	7.4	6.6	17.4	20.6	9.3	19.1	22.9	25.5	8.3	23.5	11.1	9.7	10.0	9.9	15.5	18.9	7.9	29.1	19.1	19.3	18.2	19.6	5.5	19.5	11.9	6.6	11.0	25.6	9.0	5.1	11.7	21.5	24.0	13.4	15.9	19.9	29.4	11.0	8.2	16.2	11.5	28.8	20.7	11.8	6.1	17.6	16.2	13.2	22.1	20.5	8.1	7.4	12.2	15.9	15.7	23.7	16.6	16.2	28.4	16.0	24.2	24.1	10.1	18.6	16.7	29.0	2.2	6.6	1.6	2.0	2.0	2.0	3.0	2.7	2.1	2.5	2.0	1.4	7.3	2.5	2.3	2.1	2.3	2.1	16.0	16.1	11.6	14.7	12.2	10.0	15.4	15.0	14.0	13.1	13.9	17.1	2.6	3.2	2.8	9.1	2.6	4.8	3.2	2.6	4.0	3.1	4.9	5.0	45.2	2.8	2.3	0.0	2.1	11.0	1.5	3.6	0.0	3.5	12.5	2.5	2.3	4.3	3.6	1.7	19.2	4.7	13.8	6.2	2.6	2.7	4.5	3.6	5.7	5.0	6.6	3.3	15.4	3.4	0.0	6.2	4.1	27.4	1.8	2.8	5.4	8.4	3.3	2.9	3.1	9.5	11.2	4.4	1.4	6.8	6.5	2.0	2.8	2.8	1.3	2.0	6.6	7.1	3.8	18.2	6.3	4.1	7.0	15.9	3.3	1.4	2.4	1.8
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774456-13778773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	95.6	117.7	154.3	52.1	157.8	80.4	88.9	161.0	209.6	97.0	148.4	94.3	45.4	91.6	85.6	92.3	87.6	49.8	155.6	154.4	163.8	124.4	111.0	80.1	76.9	159.4	159.9	111.7	95.5	92.8	111.6	40.2	157.8	98.8	41.6	35.7	76.9	52.8	167.6	95.2	72.4	63.0	157.5	82.1	91.2	51.6	158.0	101.5	90.4	107.2	70.8	88.6	82.6	157.3	176.4	249.9	123.0	98.9	169.6	191.1	80.1	167.0	145.5	201.0	200.7	235.8	83.5	95.4	198.2	202.4	146.6	90.1	111.6	250.1	102.7	113.5	362.3	90.1	254.6	260.5	174.9	140.7	109.4	237.8	174.7	188.1	105.9	129.0	171.0	136.6	140.9	154.2	157.9	406.2	193.6	145.9	152.6	133.8	441.8	105.7	94.9	160.5	177.1	221.3	108.6	132.4	115.1	130.8	172.5	89.2	120.0	139.0	118.4	221.9	89.2	239.4	227.5	172.3	240.3	144.4	132.3	157.6	121.8	264.1	220.1	275.7	211.0	238.2	240.4	333.2	270.7	248.4	202.2	321.1	318.1	289.7	107.1	184.7	214.3	289.4	337.9	496.3	154.3	157.8	161.0	209.6	154.4	163.8	159.4	159.9	157.8	157.5	158.0	157.3	167.0	115.4	97.8	13.7	205.2	291.1	260.1	349.2	147.4	50.5	258.7	352.9	263.3	213.1	207.8	268.5	22.9	218.6	176.5	230.1	628.0	242.5	176.8	229.3	189.8	194.4	227.3	174.0	10.5	335.2	406.3	184.4	109.6	233.0	128.7	132.4	179.9	367.5	368.2	35.3	10.2	254.3	236.0	247.1	287.1	621.4	218.7	187.5	231.3	5.6	338.9	220.3	260.6	6.6	18.8	269.6	272.8	182.4	164.1	360.5	353.9	820.0	189.3	65.9	92.1	138.5	206.0	102.6	137.0	187.7	348.5	213.0	216.0	169.8	257.5	345.2
C19orf54	FLJ41131	ENSG00000188493	"Chromosome 19 open reading frame 54"	Q5BKX5	19	40740856-40751553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059043, HPA059628"	Approved		Approved	"Intermediate filaments,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Intermediate filaments"	"Centriolar satellite"	"HPA059043: AB_2683886, HPA059628: AB_2684087"	"unprognostic (3.18e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.33e-2)"	5.8	10.1	6.2	6.9	7.7	6.0	5.8	7.3	6.6	4.7	6.8	8.1	10.5	5.1	6.4	6.0	4.9	6.2	7.2	6.1	6.0	9.1	15.3	8.8	5.5	8.4	7.3	3.8	8.6	5.7	4.6	4.8	7.7	6.2	7.1	5.3	5.6	4.5	15.3	5.9	10.7	4.0	6.8	9.8	7.5	8.4	7.1	5.5	7.8	10.3	6.0	6.3	5.0	8.7	7.6	16.6	13.9	12.4	7.4	10.0	10.2	5.4	7.0	9.5	8.9	11.3	11.3	16.5	13.6	6.4	4.7	12.0	23.0	9.2	7.8	11.5	20.7	10.3	24.4	14.3	22.5	7.1	8.8	15.2	4.8	9.3	19.9	11.7	5.7	22.1	13.3	22.8	6.7	9.0	10.0	8.2	10.5	17.4	6.0	18.9	14.2	14.3	9.6	14.5	11.3	7.0	19.5	8.1	8.4	15.3	8.4	9.6	4.8	11.7	11.7	6.1	3.7	25.6	18.9	13.0	11.3	15.4	8.3	0.4	4.5	1.3	1.3	3.8	0.5	1.2	1.1	0.7	5.7	0.9	1.1	1.0	1.0	0.8	5.1	3.5	1.9	1.9	6.2	7.7	7.3	6.6	6.1	6.0	8.4	7.3	7.7	6.8	7.1	8.7	2.9	3.2	8.9	6.2	2.9	1.7	3.7	3.3	5.2	1.6	4.2	3.0	8.0	2.8	1.2	5.5	2.1	7.9	2.5	5.5	3.9	3.4	6.7	3.3	3.7	3.5	1.2	4.6	0.4	2.5	6.6	2.3	7.7	3.1	0.0	4.1	1.8	6.4	8.4	0.0	0.7	5.0	4.1	10.7	1.6	2.9	2.5	7.2	0.0	1.0	8.2	2.2	1.0	1.5	3.4	2.0	4.8	1.2	5.4	2.4	12.3	6.7	2.9	3.8	0.0	1.9	2.3	17.8	12.0	4.4	1.7	5.6	2.8	6.1	5.5	2.8
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 53.7"	"Group enriched"	"Detected in some"	69	"Early spermatids: 566.4;Late spermatids: 357.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 92.7;SK-MEL-30: 48.2;WM-115: 170.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	2.6	4.5	3.7	8.1	3.5	10.5	2.2	15.0	5.6	3.4	0.0	2.7	8.5	4.9	0.8	3.5	4.5	3.8	2.5	4.4	5.6	6.3	3.5	4.4	9.5	4.6	3.1	4.7	7.6	0.7	7.5	3.2	3.8	4.1	0.6	3.3	12.3	2.3	2.5	13.0	7.3	0.9	1.4	9.8	6.0	53.7	4.6	1.9	11.0	0.5	1.2	2.6	2.5	10.9	15.9	12.8	4.1	5.5	0.1	0.1	8.3	9.8	0.0	0.0	0.0	8.1	4.7	2.8	7.2	0.1	20.8	13.8	0.1	0.7	0.0	16.0	7.5	2.1	92.7	2.4	0.0	2.1	9.7	0.1	0.2	0.3	0.1	4.5	0.1	7.3	11.1	13.9	0.0	11.1	3.5	5.2	3.5	0.5	3.9	5.3	6.1	14.9	0.0	6.2	9.7	8.9	17.0	8.5	48.2	1.9	9.6	5.2	13.2	7.6	9.9	23.2	9.3	11.0	3.1	4.1	22.7	9.4	170.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.5	15.0	5.6	4.4	5.6	4.6	3.1	3.8	1.4	4.6	10.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	566.4	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	357.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	2.7	1.6	0.0	0.0	0.1	0.1	0.2	0.0	0.1
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118402-49119143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	0.9	1.3	3.7	0.4	3.9	0.1	1.5	5.8	4.6	0.7	2.3	1.7	2.1	1.0	1.3	2.0	0.5	0.3	1.7	4.2	3.7	1.7	3.4	1.0	0.2	4.1	3.7	0.2	4.8	0.8	3.8	0.2	3.9	1.5	0.7	1.0	2.5	0.4	1.8	2.5	1.5	0.2	3.9	1.8	1.4	1.3	3.9	0.6	1.9	0.9	0.3	0.7	1.2	4.5	1.7	2.1	0.8	4.0	1.3	0.2	0.9	0.5	0.3	0.8	0.6	0.1	0.9	1.2	0.4	0.3	1.2	1.1	1.0	0.1	0.1	2.4	8.5	1.1	1.6	1.4	1.3	0.0	0.4	0.1	2.7	0.6	2.2	0.6	0.1	4.2	2.0	2.0	0.4	1.8	1.4	1.3	0.6	1.8	0.4	1.2	1.6	1.6	1.5	0.7	4.2	1.9	0.8	1.0	1.6	0.5	1.0	0.4	0.8	1.0	1.8	0.3	0.4	1.2	2.5	1.4	0.7	1.5	1.2	0.0	2.0	0.4	1.6	1.3	2.7	1.5	1.2	1.5	3.4	4.4	2.4	1.8	0.0	5.0	2.8	2.7	1.2	1.5	3.7	3.9	5.8	4.6	4.2	3.7	4.1	3.7	3.9	3.9	3.9	4.5	1.6	0.0	0.0	1.3	2.8	2.2	10.3	2.9	4.0	3.9	6.1	6.1	0.7	4.3	2.6	3.7	0.0	1.0	1.0	3.5	3.9	2.6	0.5	1.4	1.1	1.7	3.0	5.7	1.3	2.0	0.9	1.3	3.1	1.0	0.0	0.3	2.2	7.2	1.3	1.7	1.4	4.8	10.2	0.8	0.6	0.7	0.0	1.5	3.6	0.0	0.9	6.9	4.1	1.5	3.0	1.7	1.9	1.5	3.3	8.6	5.0	8.9	2.5	4.8	0.0	1.1	1.6	0.7	4.9	5.4	2.6	0.4	1.7	2.6	5.0	4.1
C19orf81		ENSG00000235034	"Chromosome 19 open reading frame 81"	C9J6K1	19	50649445-50659310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 2.4;testis: 6.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Early spermatids: 30.7;Muller glia cells: 65.4;Rod photoreceptor cells: 29.3;Spermatocytes: 17.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HMC-1: 1.5;JURKAT: 1.2;K-562: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060238	Enhanced		Approved	Vesicles,Aggresome		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Vesicles, Aggresome"		"HPA060238: AB_2684228"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.01e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.04e-2)"	0.0	0.0	0.6	0.0	0.5	0.1	0.0	2.4	1.3	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.3	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.5	4.3	0.4	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.0	0.8	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	2.4	1.3	0.8	0.6	0.7	0.4	0.8	0.2	0.4	0.8	0.2	0.0	0.0	0.3	0.5	2.2	1.7	0.0	12.0	14.9	4.0	4.3	1.3	1.5	0.0	20.2	8.4	0.1	3.0	0.1	13.7	7.9	30.7	2.3	1.4	1.5	0.0	0.8	1.5	1.3	0.3	0.9	0.0	5.4	0.0	1.4	1.8	0.0	0.9	11.8	2.1	0.0	0.0	0.3	0.8	6.4	0.6	0.9	5.4	1.0	2.6	65.4	0.0	1.5	3.5	4.4	0.0	0.7	0.1	6.0	0.0	0.2	0.0	29.3	0.0	1.1	1.8	17.1	5.0	0.9	4.3	0.0	0.8	2.7	0.0	0.4
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 22.1"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 31.9"	"Group enriched"	"Detected in some"	5	"ovarian cancer: 1.3;testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.4	0.2	0.4	0.6	0.0	0.4	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	22.1	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.4	0.7	0.4	0.4	0.4	0.5	0.5	0.3	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.3	0.3	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	21.7	25.3	11.6	17.0	11.8	48.1	21.4	11.9	19.0	19.9	12.8	19.1	16.6	20.0	17.0	19.3	18.3	14.7	22.2	12.0	12.8	31.5	33.4	19.0	21.4	11.3	11.8	19.3	15.8	24.0	15.3	17.5	11.6	19.5	14.7	16.6	18.7	15.5	46.9	17.5	18.5	13.7	12.0	21.7	21.4	14.8	12.0	17.5	19.6	31.9	16.5	17.4	28.2	13.9	36.6	20.3	22.0	21.0	22.2	27.0	29.6	48.7	28.1	29.3	22.4	40.8	45.0	45.2	27.2	28.9	28.1	18.0	24.7	20.4	43.1	43.0	36.6	43.5	17.6	46.3	22.3	68.1	54.4	25.0	32.4	22.1	20.9	36.3	22.0	41.4	44.8	41.1	26.6	22.2	51.3	69.6	25.4	29.8	24.4	29.6	28.3	39.9	28.2	29.2	20.5	25.4	15.1	30.0	51.6	26.7	22.2	41.2	30.9	27.9	34.5	34.0	38.9	38.0	40.8	58.6	38.9	41.3	34.2	45.3	17.6	43.7	19.0	23.3	22.5	24.2	22.0	16.6	20.6	21.3	23.4	24.3	34.9	30.3	25.2	19.2	25.3	15.2	11.6	11.8	11.9	19.0	12.0	12.8	11.3	11.8	11.6	12.0	12.0	13.9	65.2	76.9	47.9	13.1	70.7	85.0	83.2	132.8	33.6	34.3	52.9	58.4	36.5	64.3	86.3	64.4	22.9	98.9	76.2	48.1	234.8	83.4	52.4	53.7	47.2	42.9	51.6	121.2	17.7	59.4	82.7	60.2	44.9	46.6	44.3	32.8	43.5	81.7	87.5	35.3	15.9	42.6	109.9	61.9	46.1	21.7	55.6	66.9	56.9	8.4	80.1	57.4	88.6	14.1	21.9	65.6	63.3	59.0	58.5	78.1	57.0	251.4	95.4	36.8	98.6	54.2	65.3	164.5	100.3	44.5	86.2	107.8	62.9	52.2	32.8	109.0
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248616	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 204.3;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 288.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		43000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	12.9	7.2	12.8	14.2	17.7	37.7	16.6	16.1	15.5	18.5	25.0	15.2	29.4	5.6	6.4	21.6	16.2	16.6	12.6	11.3	13.7	30.8	22.0	15.0	19.1	17.7	15.6	4.6	6.1	45.8	8.6	27.0	17.7	5.1	18.0	23.6	23.3	6.8	7.5	8.8	19.3	7.3	17.9	15.5	22.4	7.3	14.2	14.3	12.5	11.3	14.0	13.0	7.3	24.6	63.5	25.9	9.6	16.0	28.1	57.0	28.0	71.5	60.7	32.4	51.1	20.0	63.9	33.4	17.0	31.7	93.5	18.3	14.0	27.5	58.3	15.1	8.1	31.1	15.9	62.3	28.1	34.3	13.2	44.0	20.0	75.7	70.0	47.4	30.3	29.9	61.0	19.9	288.7	10.5	8.8	22.8	51.7	47.8	20.3	29.6	53.1	19.3	46.6	32.4	9.9	27.2	46.9	57.0	52.8	57.5	15.6	19.6	30.4	55.2	76.7	74.7	31.3	34.4	28.7	32.9	36.9	42.9	55.8	56.0	12.9	38.4	17.7	20.2	19.7	20.4	16.6	20.6	15.1	16.6	17.7	19.4	29.1	22.7	34.0	16.4	16.2	14.1	12.8	17.7	16.1	15.5	11.3	13.7	17.7	15.6	17.7	17.9	14.2	24.6	23.2	41.7	54.2	32.3	57.1	26.3	17.0	48.4	29.0	28.1	24.5	10.8	24.0	25.8	40.6	18.4	33.3	91.9	44.8	29.9	5.9	29.1	17.2	28.4	8.7	12.7	15.6	49.7	44.3	25.3	81.1	26.0	41.3	31.7	12.0	36.2	13.9	23.5	38.2	47.1	42.5	18.8	30.5	21.1	20.5	19.9	6.5	33.0	23.2	65.6	21.9	22.9	49.4	52.3	204.3	46.2	22.6	6.4	43.2	14.5	27.7	40.0	29.7	34.8	6.6	17.2	15.3	16.6	35.6	46.4	19.5	204.8	39.6	8.9	26.7	25.7
C1GALT1C1	"C1GALT2, COSMC"	ENSG00000171155	"C1GALT1 specific chaperone 1"	Q96EU7	X	120625674-120630054	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010666, HPA015632"	Approved		Approved	Vesicles		NA	NA		21000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA010666: , HPA015632: AB_1845625"	"prognostic unfavorable (5.66e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.78e-2)"	15.3	27.8	4.2	8.7	4.6	2.8	14.5	4.9	5.6	15.7	6.4	15.7	10.1	12.2	16.8	14.8	13.7	8.3	17.7	4.2	5.9	13.8	21.0	12.0	8.8	4.9	5.2	9.7	15.8	16.3	33.9	9.2	4.9	10.5	14.5	6.3	20.0	11.1	7.8	5.8	13.2	9.5	4.8	13.0	13.5	6.1	4.5	7.4	13.2	7.0	9.6	11.5	12.8	5.2	15.9	15.1	8.2	14.2	126.7	24.0	13.0	28.4	39.9	14.7	27.7	9.9	49.8	10.3	13.9	57.6	28.4	21.9	16.2	13.9	23.4	17.6	19.6	6.6	13.1	14.7	19.7	11.7	10.1	21.0	12.1	18.3	6.1	36.9	47.0	5.1	4.2	11.8	17.5	21.6	3.9	11.0	9.3	53.3	15.1	1.8	6.4	28.5	29.9	10.6	9.0	8.6	27.0	18.4	14.6	15.0	15.9	11.2	43.4	6.7	8.3	27.2	26.9	5.1	7.9	8.2	24.6	22.7	15.0	12.1	12.3	20.4	12.0	16.4	13.3	12.3	15.4	13.0	14.6	7.6	15.6	12.5	22.7	12.3	13.6	16.7	15.8	12.2	4.2	4.6	4.9	5.6	4.2	5.9	4.9	5.2	4.9	4.8	4.5	5.2	27.1	6.4	10.4	6.5	16.3	6.8	22.7	107.9	15.4	8.3	17.6	10.0	17.6	14.3	75.9	38.6	2.1	56.9	16.3	18.7	15.6	40.3	2.7	30.5	20.2	27.6	13.8	5.9	4.7	44.3	51.7	34.7	10.7	25.3	2.5	14.5	21.4	22.3	24.1	20.2	6.5	20.8	77.3	16.2	11.4	6.4	22.7	19.6	30.2	3.7	20.7	17.5	15.5	5.5	10.1	30.0	20.8	19.2	50.1	10.7	16.9	20.3	71.0	10.5	6.6	18.1	24.4	6.5	8.4	14.1	7.2	20.0	15.2	25.8	21.5	20.5
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	8.8	10.7	7.7	7.3	6.8	8.0	9.7	7.1	7.5	8.9	5.9	7.2	8.2	10.2	10.0	10.1	9.8	6.9	8.3	7.0	7.5	9.2	7.8	5.5	11.9	7.0	8.1	13.4	14.6	15.0	6.1	10.4	7.6	10.6	5.6	5.3	12.3	10.1	9.7	10.5	5.7	8.2	7.9	7.7	6.9	8.3	10.3	9.1	11.4	10.0	9.7	8.1	7.9	8.2	17.7	20.1	16.9	27.8	14.5	10.4	38.5	20.9	14.7	30.7	22.6	30.8	20.8	25.0	24.4	9.2	14.2	25.3	31.5	21.2	31.3	40.3	35.1	28.3	20.7	19.5	27.9	31.6	18.0	14.2	25.7	30.4	39.8	13.4	15.7	21.6	57.2	29.5	17.7	12.1	30.9	13.9	52.9	18.1	38.0	30.2	35.4	69.0	16.4	14.9	50.8	24.4	18.4	27.9	43.1	16.9	15.7	13.9	10.6	30.7	19.3	25.0	40.8	24.0	29.0	52.0	15.4	30.4	33.0	3.5	9.7	6.9	18.9	7.9	29.9	21.2	22.8	18.3	11.6	18.7	28.8	25.0	1.9	24.8	8.8	54.1	12.5	15.0	7.7	6.8	7.1	7.5	7.0	7.5	7.0	8.1	7.6	7.9	10.3	8.2	10.9	6.4	7.9	4.2	12.9	50.2	24.1	5.9	22.8	10.1	15.6	15.1	5.5	5.7	10.8	3.7	10.4	14.9	12.2	6.7	13.7	10.5	1.5	5.8	12.8	11.5	4.2	45.3	9.5	7.3	14.0	14.4	6.1	6.2	11.4	9.6	6.4	6.6	5.4	16.8	7.2	5.1	8.2	4.4	9.0	1.0	9.9	4.8	12.4	4.7	7.3	10.4	17.5	5.0	5.0	10.2	8.1	13.9	10.9	21.3	5.5	8.9	5.6	14.6	0.0	17.5	8.5	25.7	25.5	15.5	62.1	7.9	12.0	11.9	8.3	13.2
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0;Spermatocytes: 37.1;Spermatogonia: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	1.8	1.2	0.6	3.3	0.9	9.0	2.9	1.7	0.8	2.3	0.5	2.6	1.2	2.9	1.0	2.0	1.5	1.4	1.0	0.5	0.4	1.1	2.6	1.7	6.3	1.0	0.6	2.2	1.5	13.5	1.0	3.4	0.8	1.8	4.1	5.4	1.5	2.0	0.9	2.4	1.8	2.7	0.7	2.8	1.9	10.3	0.9	11.6	1.7	1.5	7.9	3.1	1.7	1.5	32.7	17.5	21.9	11.3	3.5	4.8	32.2	21.1	10.7	30.0	30.6	19.1	27.7	29.0	9.3	7.0	10.7	26.0	27.6	14.7	34.3	16.9	16.5	27.1	23.0	14.1	1.2	35.8	11.3	1.5	1.9	22.5	5.3	3.5	12.8	16.8	44.9	48.0	24.8	7.9	31.5	10.3	28.8	22.9	12.1	23.3	24.7	19.5	4.0	16.1	16.2	16.9	13.4	22.1	6.9	20.6	21.0	18.3	9.5	24.1	19.1	17.8	28.9	12.9	20.9	30.6	9.0	26.4	24.1	2.2	0.8	1.0	0.6	1.9	0.4	1.4	0.6	0.6	1.2	1.4	0.3	0.5	0.1	2.1	2.3	0.4	0.7	0.6	0.6	0.9	1.7	0.8	0.5	0.4	1.0	0.6	0.8	0.7	0.9	1.5	1.2	0.0	3.3	4.2	4.0	1.8	2.7	2.6	1.2	4.1	1.7	1.8	0.5	0.0	1.5	0.0	6.2	9.1	1.6	1.9	0.0	2.7	8.7	0.9	2.1	2.2	0.0	3.4	9.9	3.4	9.1	2.5	2.6	1.2	4.5	9.8	2.9	3.8	6.2	1.7	9.6	1.2	6.1	3.5	2.1	4.1	2.1	3.0	3.6	30.0	1.3	2.4	0.0	13.0	13.2	3.0	0.3	3.8	5.5	1.0	0.8	0.7	2.0	6.6	6.6	1.4	2.6	37.1	20.3	2.8	1.0	3.8	3.3	2.2	2.6	2.4
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018522-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.3;lung: 72.9;stomach 1: 58.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 99.4;Club cells: 68.5;Urothelial cells: 128.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 65.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 57.7;CAPAN-2: 99.5;HaCaT: 123.1;HBEC3-KT: 118.6;hTCEpi: 61.4;RPTEC TERT1: 56.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		180000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.4	0.0	1.6	0.0	0.8	10.4	0.0	0.1	15.1	0.0	8.9	24.5	0.2	0.7	102.3	2.6	9.8	0.5	0.0	0.0	8.4	0.5	72.9	0.0	0.0	0.0	0.1	12.9	0.0	0.3	0.2	0.0	50.9	8.4	0.0	29.4	1.9	0.5	37.7	20.3	0.3	0.0	0.2	58.7	0.9	0.0	0.3	4.2	0.5	16.1	20.6	31.2	0.0	57.7	7.7	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.1	99.5	0.0	6.5	0.0	0.0	123.1	0.0	118.6	0.0	0.1	0.0	10.6	1.0	1.6	0.0	0.0	0.6	0.0	61.4	0.0	34.2	0.0	0.0	0.2	6.9	0.1	0.0	0.1	0.1	0.2	0.1	37.3	3.3	0.0	0.0	0.2	56.4	15.1	0.1	0.3	1.1	11.1	0.5	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	176.3	99.4	0.0	0.3	20.8	53.0	26.8	10.8	0.0	5.4	7.2	49.9	30.0	68.5	11.0	0.0	0.1	0.1	40.7	15.6	24.3	5.7	6.7	1.4	1.7	10.7	0.0	0.1	24.4	0.0	1.6	50.4	14.9	6.3	0.0	0.0	0.0	0.2	0.0	0.1	19.8	12.2	0.0	1.2	5.5	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	60.7	35.3	0.0	0.3	56.5	31.8	0.3	41.0	0.0	0.0	0.0	2.8	0.1	0.0	24.3	23.3	0.0	0.3	0.1	8.9	128.1
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	9	"Enteroendocrine cells: 20.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Cell line enriched"	"Detected in single"	4	"THP-1: 2.6"	"Not detected"	"Not detected"							HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.2	0.6	0.3	0.1	0.3	0.1	0.1	1.2	0.7	0.1	0.2	0.3	0.7	0.0	0.1	0.6	0.0	0.3	0.6	0.2	0.3	0.0	0.2	0.4	0.6	0.2	0.5	0.0	4.4	0.1	0.2	0.2	0.3	0.1	0.6	0.0	0.2	0.0	16.5	0.0	0.3	0.0	0.2	0.6	1.9	0.5	0.7	0.1	0.2	3.7	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.2	0.7	0.2	0.3	0.2	0.5	0.3	0.2	0.7	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.8	0.0	0.8	0.6	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf131	DKFZp547B1713	ENSG00000143633	"Chromosome 1 open reading frame 131"	Q8NDD1	1	231223763-231241187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028452, HPA029920"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028452: AB_10610979, HPA029920: AB_10600423"	"unprognostic (5.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (2.64e-9)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (9.84e-4)"	8.6	9.9	6.4	11.4	6.7	11.9	8.8	8.1	9.0	7.0	6.5	13.3	21.4	7.3	7.6	10.4	9.2	8.4	8.3	6.4	7.1	8.0	13.8	6.6	15.9	6.9	7.0	8.8	8.8	7.4	6.4	11.8	7.0	8.3	14.8	4.6	10.8	5.7	12.5	8.7	18.2	8.7	6.7	10.9	13.6	6.0	6.7	14.3	7.9	9.7	15.1	9.7	8.0	7.2	23.4	22.6	16.6	24.1	17.9	17.7	54.9	16.9	12.2	22.0	14.7	35.7	21.2	50.7	30.4	13.3	10.6	33.9	32.7	13.8	20.4	27.2	51.0	22.7	14.3	38.7	18.7	40.5	30.3	14.8	21.1	16.6	19.9	9.7	18.3	26.7	47.1	16.5	16.7	24.9	44.8	37.7	34.2	65.9	18.0	41.1	22.3	54.1	20.9	16.9	19.1	29.1	28.2	18.6	21.8	8.0	32.2	51.8	12.1	14.4	18.7	24.7	29.8	26.4	44.5	41.9	14.4	31.6	32.6	30.4	25.4	37.2	16.9	26.1	20.3	33.5	22.3	23.2	24.7	30.0	22.4	21.5	14.8	33.1	27.3	27.8	31.2	16.4	6.4	6.7	8.1	9.0	6.4	7.1	6.9	7.0	7.0	6.7	6.7	7.2	27.8	22.4	19.1	6.8	30.7	9.6	12.3	41.9	24.5	23.4	22.0	24.6	15.0	38.6	24.1	25.8	12.5	68.8	28.7	26.2	39.2	32.8	2.9	26.2	41.1	23.7	21.1	28.0	9.5	36.0	60.9	21.4	31.6	23.0	17.1	25.7	18.5	54.7	29.9	23.5	13.2	41.9	28.5	23.3	6.9	3.1	29.8	20.1	12.4	9.4	29.4	20.9	41.2	6.6	13.0	29.8	35.8	22.6	22.5	16.8	52.6	18.5	17.9	16.3	13.1	18.0	18.1	22.4	34.1	31.0	11.5	38.9	25.9	35.2	46.7	13.6
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9;Late spermatids: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Intermediate filaments"	"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	4.0	4.8	9.6	1.6	8.0	2.4	3.8	0.9	10.4	5.3	3.2	6.1	1.8	4.2	1.1	8.6	4.8	2.2	4.3	9.4	1.0	7.7	6.7	3.9	1.8	6.3	2.7	4.3	3.7	0.7	5.3	1.4	2.8	6.9	0.6	1.6	4.6	2.3	2.2	5.0	4.1	0.5	0.7	5.5	6.0	22.9	5.4	1.8	4.5	0.3	0.9	5.5	5.9	6.9	15.7	12.0	5.6	10.0	1.5	1.6	13.3	9.0	2.1	7.8	5.1	6.5	14.7	4.3	10.8	2.8	6.4	12.2	2.5	7.1	2.2	8.6	18.2	3.1	19.6	7.0	3.6	5.5	7.3	3.2	2.8	3.3	1.6	2.3	3.8	6.4	18.6	3.1	2.8	11.9	10.2	13.2	4.7	5.9	19.7	12.0	6.7	8.5	4.7	4.7	11.8	16.1	6.8	12.2	7.6	1.6	7.8	6.5	5.2	8.3	8.8	11.9	9.2	5.6	8.3	7.8	6.8	14.9	6.5	8.1	2.6	1.4	2.6	2.6	2.8	2.5	2.5	3.0	1.7	2.2	2.5	2.6	0.5	2.7	1.8	2.2	0.9	2.3	9.6	8.0	0.9	10.4	9.4	1.0	6.3	2.7	2.8	0.7	5.4	6.9	6.3	0.0	7.7	20.2	3.4	7.5	3.6	6.2	4.6	5.9	8.9	6.6	2.3	5.7	7.1	9.2	4.2	5.0	4.9	13.6	1.9	8.2	60.9	8.6	8.2	4.4	4.2	5.2	26.5	7.0	14.0	4.2	20.4	9.0	5.7	9.0	3.3	5.3	3.9	13.5	21.8	7.4	6.1	1.0	4.8	124.1	2.8	3.9	3.6	2.8	6.0	3.2	9.2	10.6	24.5	7.8	3.5	1.5	6.9	5.1	3.4	1.8	10.4	8.2	0.0	3.5	4.8	18.3	6.8	4.2	7.0	4.9	4.6	4.4	9.4	4.9
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.0;lymphoid tissue: 134.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	45.4	23.6	16.3	70.8	16.2	115.0	22.3	17.2	29.0	13.2	19.6	15.8	7.3	11.5	6.3	9.8	22.5	31.2	18.1	16.3	18.4	12.5	41.9	85.7	70.4	20.6	17.3	9.4	9.4	4.8	9.1	15.2	19.7	11.7	17.9	9.5	11.2	6.6	10.1	7.8	21.2	37.6	16.7	134.5	12.5	7.6	23.3	27.7	10.0	7.4	55.9	25.1	10.8	21.4	0.3	0.1	0.5	1.1	0.4	0.6	0.6	0.9	0.1	0.3	0.3	0.2	0.4	0.5	0.5	0.2	0.1	0.2	0.8	0.5	0.6	141.3	0.4	0.4	0.5	0.0	0.4	70.4	11.1	0.0	2.6	0.8	0.9	1.0	2.0	0.7	0.5	0.4	0.5	0.5	0.6	40.3	0.2	0.7	0.8	0.1	0.7	0.1	0.3	0.1	0.5	0.2	0.5	0.6	0.8	0.6	0.3	55.2	0.0	0.8	1.0	0.7	0.6	0.6	0.1	0.6	0.3	117.9	1.2	1114.1	1026.8	1294.8	166.6	1529.2	47.6	231.0	206.5	97.3	1021.6	296.4	318.0	193.6	143.3	536.7	1173.4	302.8	66.7	1189.5	16.3	16.2	17.2	29.0	16.3	18.4	20.6	17.3	19.7	16.7	23.3	21.4	4.4	22.4	43.9	8.1	84.1	7.9	0.7	0.4	0.6	4.0	2.2	5.2	3.8	10.0	4.5	7.3	2.1	1.0	103.4	0.6	0.0	0.2	36.7	0.8	0.9	8.1	1.8	23.5	9.2	0.2	2.0	3.2	0.5	1.0	182.3	0.9	15.7	8.9	195.3	0.0	13.0	0.0	0.0	797.4	226.7	90.7	2.8	413.5	12.4	12.2	278.6	0.2	355.3	6.0	7.7	0.2	0.0	0.7	4.2	0.8	0.9	1.0	0.9	4.2	32.9	2.4	2.9	2.4	2.0	0.2	6.5	1.6	59.8	0.3	0.7	0.3
C1orf167	"DKFZp434E1410, RP11-56N19.2"	ENSG00000215910	"Chromosome 1 open reading frame 167"	Q5SNV9	1	11761787-11789585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	47	"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Early spermatids: 18.0;Late spermatids: 18.7;Spermatocytes: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"U-698: 32.0"					"Not detected"	"Not detected"			HPA039114	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA039114: AB_10673606"	"unprognostic (2.93e-3)"	"unprognostic (1.34e-2)"		"unprognostic (7.48e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.55e-3)"	"unprognostic (3.92e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.46e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.3	0.1	28.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	4.5	22.4	2.6	0.0	0.8	1.1	1.4	0.3	0.0	0.5	2.8	1.1	0.6	0.0	0.9	3.7	0.0	0.7	0.3	1.3	1.9	1.2	18.0	1.1	1.9	2.5	0.0	0.0	0.4	8.2	0.3	4.8	4.6	2.4	0.0	0.2	5.0	0.0	0.5	5.0	0.4	0.4	0.0	0.3	1.2	18.7	6.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.8	2.3	3.8	0.6	1.4	1.2	4.2	0.2	0.3	0.0	4.2	3.6	20.0	4.0	0.5	1.7	0.3	0.4	1.8	0.5	3.6
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	11.6	12.1	8.7	10.2	9.0	13.4	11.2	9.0	10.1	10.7	9.9	13.4	6.8	11.8	9.4	13.8	10.8	8.5	10.9	9.3	9.0	13.4	18.5	10.3	11.4	9.0	8.8	11.0	14.4	6.9	7.5	10.3	9.4	10.3	6.5	4.3	11.1	6.9	15.5	9.9	12.2	7.8	9.4	15.4	12.2	13.2	8.8	13.9	11.5	14.0	11.9	12.2	11.0	9.4	27.6	15.5	23.2	22.0	20.3	12.1	15.6	23.6	13.7	21.8	22.1	24.4	43.4	21.5	28.8	18.7	31.1	27.7	27.6	17.5	23.5	39.3	25.4	56.6	14.2	33.8	11.8	39.9	29.1	13.1	9.9	24.2	15.3	17.3	18.6	27.3	45.9	22.2	14.8	21.8	44.4	30.2	28.6	36.2	32.4	32.7	42.2	20.6	15.1	16.4	23.6	19.1	22.2	30.5	35.7	23.4	14.3	24.8	20.4	29.9	23.9	52.4	25.1	7.2	7.8	39.7	15.5	42.4	10.9	61.5	26.5	50.8	43.7	50.7	38.5	25.2	29.7	34.0	31.8	23.8	27.4	35.4	22.6	29.6	33.5	17.4	32.9	23.9	8.7	9.0	9.0	10.1	9.3	9.0	9.0	8.8	9.4	9.4	8.8	9.4	20.7	9.6	7.7	4.6	21.1	21.9	13.1	17.6	19.9	11.9	15.6	12.8	3.9	22.8	15.6	5.5	8.4	59.8	46.2	11.6	27.4	22.4	114.8	14.7	16.0	16.8	11.4	28.2	5.1	19.6	61.9	16.1	14.8	13.3	36.8	21.6	13.9	15.7	31.5	11.8	7.2	15.6	16.2	17.3	14.5	20.5	17.1	20.7	14.2	4.7	20.4	13.3	50.4	6.6	13.2	17.7	15.2	19.2	17.4	18.9	15.1	20.9	11.7	12.6	13.1	16.5	17.4	32.3	32.6	21.8	17.6	26.7	24.7	21.7	19.8	12.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 106.5;testis: 147.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;SCLC-21H: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.0	0.1	1.7	0.0	1.9	0.0	0.2	2.1	2.8	2.1	14.0	0.4	0.3	1.1	1.2	0.1	106.5	0.0	0.1	2.3	1.8	0.2	0.0	4.4	0.0	3.3	3.3	0.1	0.9	0.2	2.4	0.0	2.8	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.1	0.0	0.3	147.9	2.2	0.3	0.3	0.0	0.0	0.3	0.0	2.3	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	1.9	2.1	2.8	2.3	1.8	3.3	3.3	2.8	2.1	2.2	2.3	0.0	0.0	4.1	0.7	0.2	0.0	0.2	53.9	0.0	0.6	0.8	0.9	3.5	0.0	61.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2151.8	931.5	6.1	1.8	0.0	0.0	1.1	0.2	0.0	0.7	0.0	11.2	3.8	0.0	0.0	0.0	0.1	0.0	1.0	0.4	57.0	0.0	0.3	3412.7	21.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	18.8	0.0	2.4	0.0	0.8	808.8	0.0	6.6	0.2	9.0	514.1	20.2	0.0	0.1	0.0	1.1	0.0	0.2	0.4
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 13.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 138.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		80000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	39.7	13.4	77.5	11.0	106.4	5.3	30.0	93.3	83.7	36.5	41.1	35.2	11.8	38.8	14.9	14.9	32.7	32.3	45.4	72.6	85.0	17.3	14.7	66.9	15.5	108.4	105.1	27.3	27.9	20.1	7.6	31.1	108.9	21.4	11.4	9.8	23.4	32.3	106.2	34.0	13.9	46.1	97.8	18.0	29.9	6.8	94.5	6.6	34.9	26.1	9.1	33.2	26.4	131.3	22.4	16.7	44.9	30.8	81.9	59.9	76.7	40.4	63.7	20.4	20.6	53.0	12.3	26.8	24.5	138.1	10.3	14.1	23.5	8.9	15.0	87.5	22.3	4.2	15.0	17.9	35.7	13.9	4.0	72.9	13.4	8.1	8.9	43.7	12.9	16.9	8.7	9.0	14.1	15.0	11.0	6.6	52.6	49.5	13.7	25.6	32.1	6.0	16.2	26.7	26.0	41.5	20.5	27.2	14.2	23.6	34.6	11.8	10.3	32.9	32.8	7.7	24.5	16.0	7.7	8.0	8.7	8.7	95.3	13.1	1.3	0.3	2.0	2.7	2.4	1.9	1.3	0.8	1.7	1.2	2.6	2.3	1.0	2.9	1.3	0.2	0.6	4.7	77.5	106.4	93.3	83.7	72.6	85.0	108.4	105.1	108.9	97.8	94.5	131.3	11.1	192.3	23.2	35.3	1.2	26.0	13.1	6.4	7.4	2.0	32.7	23.7	36.4	32.9	17.3	11.0	10.4	17.5	1.3	2.6	1.9	41.9	11.4	8.2	8.9	11.6	5.4	9.9	2.6	26.3	32.2	33.2	3.6	10.6	2.5	15.1	8.6	4.5	11.0	25.2	5.3	9.0	8.2	1.8	19.4	8.3	13.4	11.6	65.8	13.1	3.6	12.8	0.0	6.0	67.5	31.1	3.7	9.1	2.5	21.3	2.8	7.4	12.2	4.6	32.9	26.8	45.1	10.4	5.7	8.9	29.0	12.9	3.4	5.2	6.9	18.7
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387029-184629019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 52.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 305.1;Syncytiotrophoblasts: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 3.9;memory CD8 T-cell: 2.0;naive CD8 T-cell: 1.8;NK-cell: 2.6"	"Group enriched"	"Detected in many"	13	"NK-cells: 2.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.3;HSkMC: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	9.8	13.2	7.4	1.3	11.8	0.5	13.4	8.3	12.4	15.5	0.0	14.6	3.0	13.0	6.8	8.2	12.8	2.8	12.7	10.6	3.8	3.3	5.6	7.9	0.8	7.4	2.7	11.3	3.4	2.5	4.7	1.9	7.7	14.1	5.0	7.4	4.6	6.8	52.6	16.5	11.9	3.8	3.2	5.5	9.7	1.6	6.1	1.5	3.4	20.6	1.0	15.7	15.0	5.5	0.2	0.1	3.8	0.2	5.9	6.0	5.0	1.7	1.7	1.0	0.6	0.0	0.0	0.0	0.0	2.5	0.3	1.1	1.6	1.7	0.9	12.3	3.9	0.0	0.8	0.0	2.3	1.2	0.6	8.7	4.0	1.2	0.9	4.4	1.4	2.8	0.0	3.5	1.4	1.3	1.4	0.3	4.4	2.0	0.3	1.9	2.5	2.1	0.0	0.8	1.6	6.0	1.0	0.7	3.5	2.2	0.1	0.1	1.7	2.2	0.8	4.2	2.3	7.2	4.1	0.0	3.7	1.8	2.4	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.5	2.0	0.2	0.0	0.2	1.8	0.0	2.6	0.0	0.1	0.0	0.9	7.4	11.8	8.3	12.4	10.6	3.8	7.4	2.7	7.7	3.2	6.1	5.5	107.5	38.5	113.0	201.4	1.2	152.6	234.9	29.6	82.6	23.4	87.9	63.6	90.7	25.8	38.1	1.8	0.0	119.3	99.8	149.9	7.9	6.7	47.0	11.0	89.3	98.4	19.2	14.5	144.2	19.6	99.3	91.8	7.1	21.7	10.1	11.2	101.4	83.7	40.9	26.9	165.9	66.3	24.4	8.8	31.5	37.8	76.4	9.5	64.0	16.9	19.7	42.9	141.1	305.1	3.6	14.1	203.3	19.2	20.2	105.7	193.6	12.3	17.5	9.5	19.7	108.8	48.2	3.4	17.3	76.3	145.6	284.6	32.2	32.8	76.4	181.7
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281877-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.2	0.1	0.3	2.9	0.3	0.2	14.5	0.7	0.5	8.2	0.3	32.4	43.9	1.3	13.0	17.0	6.1	9.9	0.1	0.3	0.2	21.8	6.2	9.0	0.1	0.3	0.4	0.1	22.8	10.3	8.4	1.6	0.4	8.1	30.2	0.5	19.5	3.8	0.0	16.2	38.7	1.2	0.2	0.1	29.1	0.3	0.3	1.0	16.9	0.0	2.3	3.2	8.1	0.8	12.1	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	12.6	39.8	0.0	0.3	0.0	0.0	9.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.2	0.1	33.1	0.0	0.1	0.1	0.4	1.0	7.8	4.6	0.3	0.1	13.8	0.0	2.1	15.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.7	0.5	0.3	0.2	0.3	0.4	0.4	0.2	0.3	0.8	0.1	22.4	16.1	0.3	0.6	1.1	6.2	11.5	2.8	0.0	22.4	12.8	0.0	28.6	13.8	22.0	0.0	12.9	0.0	125.9	29.4	21.3	0.1	8.5	1.4	0.2	33.6	0.0	0.0	33.7	3.9	0.2	25.5	14.2	0.0	0.0	0.0	1.2	0.7	0.0	0.0	42.4	8.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.3	100.8	0.0	0.0	6.6	128.1	39.6	7.3	0.0	0.0	0.0	0.7	0.3	0.0	8.9	2.6	4.7	0.3	0.0	37.0	8.8
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713877-35718894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	10.5	10.6	35.8	6.1	39.1	4.5	7.6	25.1	47.8	10.7	15.8	17.3	3.5	13.2	11.3	5.6	9.1	7.6	11.7	42.6	37.0	4.7	5.3	9.9	7.3	31.6	27.5	8.2	4.4	7.0	9.3	4.7	33.3	8.7	5.3	28.8	5.2	9.9	15.6	7.7	7.9	16.0	27.3	8.8	7.1	9.8	33.4	4.8	6.0	14.7	7.0	10.7	7.9	37.9	7.7	17.6	8.6	12.5	43.5	31.7	6.3	21.1	25.9	31.9	30.3	10.7	16.3	8.3	15.2	32.5	26.0	7.1	24.1	14.6	27.5	31.4	10.3	57.8	27.6	2.9	16.5	28.1	36.6	32.9	18.2	22.8	7.4	23.6	21.2	6.3	23.4	25.6	34.9	12.9	10.5	24.8	13.6	8.4	14.9	7.0	11.5	8.2	11.0	9.0	12.7	12.4	20.3	4.1	44.1	5.3	8.2	12.6	24.8	25.6	19.5	19.0	22.2	7.6	20.3	6.0	25.6	27.6	40.9	0.0	2.7	0.1	4.3	2.8	1.3	2.0	3.3	5.3	2.5	1.5	0.8	3.1	0.0	0.6	2.1	0.5	1.2	2.9	35.8	39.1	25.1	47.8	42.6	37.0	31.6	27.5	33.3	27.3	33.4	37.9	4.9	0.0	2.2	5.9	2.3	6.0	3.5	2.9	0.6	19.6	3.6	2.5	7.1	0.0	1.5	1.8	14.6	2.5	7.1	0.1	0.0	6.0	14.8	1.0	3.7	6.1	1.8	7.8	17.6	2.7	1.5	7.3	1.1	1.6	4.5	5.2	6.4	2.3	7.9	23.5	15.0	0.3	2.0	4.8	6.1	8.5	8.4	5.0	16.0	9.4	6.9	21.0	10.3	7.1	8.7	2.0	0.1	20.7	2.7	1.7	0.1	0.8	0.3	31.8	0.0	6.8	7.8	11.2	5.2	0.2	4.5	1.1	6.2	4.7	0.7	1.5
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162378841-162386812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2;Early spermatids: 22.7;Hepatocytes: 30.0;Late spermatids: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 14.0;HEL: 18.4;OE19: 16.0"					"Low region specificity"	"Detected in all"			"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.9	9.6	3.5	1.1	3.6	2.0	8.1	4.6	3.1	3.8	5.1	9.3	5.6	2.4	2.4	4.1	3.2	3.4	3.4	3.7	5.1	11.3	21.9	2.5	0.4	7.2	4.0	1.2	3.7	4.0	9.9	2.4	5.3	4.8	9.7	7.0	8.5	7.7	0.6	5.2	7.9	2.4	5.8	0.6	8.7	4.0	3.5	0.4	0.8	0.6	1.5	2.5	2.2	7.3	14.0	0.9	13.1	8.9	0.4	0.0	0.2	0.9	1.4	0.8	0.5	2.0	7.2	0.0	9.5	0.3	4.7	10.3	3.7	0.9	0.7	0.1	4.4	18.4	0.8	10.2	0.3	0.0	0.0	1.4	1.1	0.0	0.5	3.9	3.2	2.3	1.7	0.1	0.2	5.6	0.5	0.0	6.3	16.0	7.5	0.3	2.2	0.0	12.1	7.0	5.9	3.7	4.6	1.6	3.1	5.3	5.7	0.9	3.1	0.1	1.4	0.1	4.0	6.3	0.0	0.0	2.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	4.6	3.1	3.7	5.1	7.2	4.0	5.3	5.8	3.5	7.3	2.5	3.2	2.6	0.3	0.1	0.8	1.7	1.1	0.6	0.8	10.3	14.9	3.4	4.3	2.4	14.7	29.2	0.1	0.1	11.6	0.0	0.9	22.7	2.6	1.1	2.2	2.4	0.0	2.8	2.3	0.1	0.7	0.0	4.2	0.0	3.4	4.2	30.0	0.1	6.7	1.8	11.6	4.1	1.0	0.7	38.4	2.1	0.1	0.0	3.7	0.0	5.0	0.0	6.6	3.7	1.7	3.6	1.9	0.0	2.6	7.7	0.2	2.7	0.4	0.0	0.2	0.6	1.1	0.9	0.6	1.4	0.1	0.3	0.5	7.1	2.5
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	11.3	12.5	20.6	6.3	20.4	14.3	11.7	19.5	24.4	15.5	18.2	13.4	7.9	13.4	5.5	18.8	13.0	4.0	9.4	20.5	20.3	11.2	11.6	8.6	9.0	20.8	19.7	16.1	12.9	7.4	9.9	7.1	20.6	14.2	3.9	2.7	12.5	8.5	9.6	19.6	10.5	5.0	19.2	10.8	12.3	7.5	20.3	9.2	12.1	3.5	7.3	14.4	14.7	21.0	22.2	24.3	17.0	10.9	8.2	8.3	40.0	16.8	7.4	14.6	10.9	24.1	22.2	22.7	35.6	6.6	10.3	25.4	16.0	16.6	5.3	24.6	76.7	13.9	20.1	23.1	13.3	32.0	16.7	7.6	19.5	14.3	13.1	9.2	16.1	26.1	35.2	13.3	10.7	27.8	42.0	44.4	34.4	28.5	55.6	32.1	24.2	36.4	13.6	18.2	28.1	27.2	16.0	29.4	23.3	4.5	31.0	29.2	15.1	11.8	18.1	32.7	37.2	23.9	12.7	21.6	14.2	18.3	19.2	14.9	29.0	43.3	28.2	35.9	35.2	37.2	31.1	30.7	37.6	29.9	36.1	30.2	4.7	35.9	34.9	49.3	34.7	17.5	20.6	20.4	19.5	24.4	20.5	20.3	20.8	19.7	20.6	19.2	20.3	21.0	37.7	22.4	22.4	10.4	29.8	66.8	35.5	58.5	47.3	51.4	41.1	50.9	18.1	28.6	31.0	38.6	18.8	76.2	49.8	61.6	45.0	38.0	4.4	28.2	31.7	33.9	26.3	57.4	12.9	39.5	59.3	34.3	25.0	43.7	24.7	36.9	32.2	24.4	40.4	47.1	10.1	58.8	54.9	24.2	72.7	5.5	51.3	29.8	32.0	2.8	32.4	42.5	30.9	9.5	14.3	37.5	43.5	46.6	28.1	37.4	47.8	38.3	25.1	54.5	65.7	31.6	44.7	44.0	50.0	54.1	80.6	28.3	47.2	28.0	56.6	25.8
C1orf43	"DKFZp586G1722, NICE-3"	ENSG00000143612	"Chromosome 1 open reading frame 43"	Q9BWL3	1	154206696-154220637	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010725	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA010725: AB_1078341"	"unprognostic (3.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.23e-1)"	126.7	131.9	148.0	72.6	160.4	77.3	119.7	158.9	168.6	90.5	145.1	109.3	118.4	80.7	115.3	107.7	100.5	86.7	179.7	141.7	158.3	187.7	222.0	106.3	82.0	153.0	152.6	77.1	149.7	149.6	85.7	67.6	151.6	94.9	121.2	135.7	99.1	90.2	477.6	105.8	106.1	90.6	152.4	81.6	117.2	62.0	154.2	92.0	108.7	368.2	99.0	113.9	85.7	169.3	183.5	188.4	156.5	185.1	231.1	230.7	96.2	180.2	309.4	205.0	188.4	127.7	249.8	237.9	268.1	162.9	177.5	182.4	218.5	163.3	147.2	191.1	232.1	184.9	182.6	168.1	357.9	235.4	209.6	187.1	376.6	219.8	449.7	278.6	239.9	262.6	199.1	220.1	268.4	287.5	177.4	212.1	302.3	414.8	282.3	159.8	145.8	435.9	256.0	180.6	254.8	333.5	161.1	420.8	624.9	180.8	416.6	513.5	164.4	157.9	133.6	193.3	229.7	403.5	424.1	227.6	263.4	234.4	430.9	189.9	204.8	134.3	85.9	185.4	102.4	100.3	98.7	93.3	211.5	90.0	102.8	86.8	114.9	83.3	174.6	156.2	154.3	242.7	148.0	160.4	158.9	168.6	141.7	158.3	153.0	152.6	151.6	152.4	154.2	169.3	107.2	115.4	100.8	27.1	92.1	94.2	128.4	155.3	81.4	112.6	132.9	114.4	135.8	128.7	115.4	71.7	29.2	87.2	86.8	106.1	252.4	171.5	247.1	69.6	62.1	105.4	122.0	110.0	27.3	202.0	125.1	80.2	77.5	58.1	62.1	79.5	100.6	146.9	178.9	58.9	30.8	133.9	116.0	162.5	116.1	171.8	65.0	131.5	124.5	16.9	155.4	107.0	64.9	26.2	50.5	162.8	131.6	74.9	104.1	186.1	218.3	262.1	85.7	89.5	72.3	75.8	86.6	70.7	59.2	113.9	100.6	126.1	76.7	117.4	133.6	167.5
C1orf50	MGC955	ENSG00000164008	"Chromosome 1 open reading frame 50"	Q9BV19	1	42767249-42779491	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Late spermatids: 201.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030236	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA030236: AB_10602110"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.72e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.53e-1)"	9.2	11.5	2.6	1.4	2.7	3.9	9.0	2.4	2.6	9.3	1.3	9.7	1.7	6.9	1.7	8.9	7.2	1.0	14.0	2.5	3.1	13.0	16.9	6.4	1.7	2.5	2.5	9.9	8.8	2.4	12.3	1.5	2.3	9.6	1.6	3.1	7.0	1.4	15.5	8.7	8.5	1.5	2.7	9.2	8.9	14.9	3.1	1.7	7.6	3.3	1.6	9.1	8.7	2.8	1.4	0.6	3.7	3.1	2.3	3.0	2.2	2.2	2.0	2.0	2.0	1.1	1.5	3.5	2.2	3.0	1.0	1.9	2.8	1.6	1.9	4.0	1.7	3.3	2.1	1.6	2.1	3.8	2.7	2.3	2.6	2.2	3.5	2.1	2.0	4.0	3.7	1.8	1.8	1.1	3.7	1.9	3.0	1.6	1.6	3.7	3.5	2.7	1.8	2.4	4.1	2.8	2.9	1.9	2.6	3.2	1.6	3.9	2.0	1.5	1.6	2.7	1.9	2.8	2.8	2.5	1.5	2.7	1.5	1.6	1.1	1.7	1.0	1.1	0.8	1.5	1.0	1.1	1.0	1.1	1.1	1.1	1.1	1.1	2.3	1.8	1.3	1.0	2.6	2.7	2.4	2.6	2.5	3.1	2.5	2.5	2.3	2.7	3.1	2.8	4.9	0.0	3.7	3.9	17.0	9.2	10.1	28.5	10.8	3.4	5.5	9.8	22.5	8.6	16.0	11.0	2.1	27.9	8.9	13.5	23.5	10.0	67.8	4.1	5.5	9.3	19.2	12.4	9.2	4.0	30.3	10.9	9.2	3.3	10.2	5.7	20.3	29.2	27.4	0.0	8.4	14.3	22.4	20.0	14.7	201.1	13.7	8.7	14.2	5.6	18.0	11.8	17.5	6.0	10.7	7.7	17.5	6.8	16.2	14.1	40.0	21.0	11.0	8.2	6.6	10.8	11.3	43.6	35.5	14.3	7.7	33.8	14.6	7.0	13.1	11.2
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	15.1	11.0	11.7	10.3	15.0	23.0	13.4	9.4	16.7	13.8	5.5	14.2	6.3	11.7	7.5	13.1	12.5	6.7	14.8	17.7	10.6	12.2	15.2	14.0	15.2	10.7	11.8	13.0	13.0	5.3	13.3	12.2	11.0	12.5	6.5	10.7	9.2	7.3	16.3	12.2	11.4	5.2	8.8	14.8	12.0	15.9	11.5	9.7	11.5	9.9	8.5	12.9	13.1	16.2	25.6	12.1	17.3	15.6	18.6	14.4	21.4	20.4	10.6	26.2	23.2	17.2	13.1	20.0	17.2	22.5	14.7	16.1	42.4	12.3	13.0	26.1	25.4	32.2	19.5	15.5	11.3	28.0	14.2	9.4	17.8	24.1	11.9	13.0	9.7	35.2	35.9	23.6	13.0	7.3	27.3	13.8	63.7	12.0	9.8	28.3	18.5	10.8	14.2	7.0	7.3	16.4	5.0	16.3	20.7	17.4	8.8	57.7	16.6	10.6	19.5	27.2	32.8	22.6	46.2	28.3	8.9	21.7	12.9	17.6	18.4	30.0	19.5	28.6	21.1	35.5	18.1	17.2	24.7	19.6	27.5	26.4	30.1	19.7	24.0	26.8	17.3	22.3	11.7	15.0	9.4	16.7	17.7	10.6	10.7	11.8	11.0	8.8	11.5	16.2	46.7	44.8	34.3	31.3	48.4	145.4	55.0	60.0	56.9	23.5	51.9	50.3	24.3	21.5	46.0	16.5	22.9	61.3	56.3	23.4	19.6	33.3	69.0	36.3	36.1	40.7	38.8	29.0	37.4	27.5	61.1	46.9	23.4	40.9	51.3	25.4	29.6	16.6	37.1	15.2	21.7	25.1	77.3	28.9	81.6	16.8	36.7	32.5	32.0	21.5	25.4	30.8	38.1	23.1	58.6	37.9	24.6	24.5	42.7	53.0	25.9	19.7	34.0	27.1	39.5	27.7	45.6	92.5	67.3	63.9	128.9	67.9	53.4	27.5	24.7	71.5
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Endothelial cells: 101.3;Kupffer cells: 145.7;Langerhans cells: 282.7;Leydig cells: 95.1;Peritubular cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"myeloid DC: 103.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 103.5"	"Cell line enhanced"	"Detected in many"		"AF22: 77.8;AN3-CA: 110.5;ASC diff: 86.1;ASC TERT1: 141.3;HSkMC: 102.1;HUVEC TERT2: 108.4;U-87 MG: 68.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	37.6	19.1	59.8	26.4	60.7	11.9	30.7	62.0	96.2	27.6	56.2	25.9	13.3	30.1	39.1	17.9	33.2	46.4	34.6	57.6	62.2	28.4	29.7	29.2	62.6	61.9	61.8	7.9	5.1	14.5	10.5	59.2	62.0	28.7	25.9	16.2	8.4	75.6	24.6	11.1	15.0	60.3	63.5	69.4	12.7	13.9	64.2	30.8	13.9	48.3	27.9	36.2	18.2	62.4	1.6	0.3	77.8	110.5	86.1	141.3	2.2	14.0	20.5	3.8	12.0	0.9	1.9	0.6	4.1	12.3	1.5	2.7	0.2	0.5	5.6	1.4	12.2	1.9	2.0	1.3	17.7	3.9	2.6	102.1	5.9	24.8	1.9	13.2	108.4	1.8	1.8	12.2	15.0	4.2	0.7	24.0	5.7	0.1	3.9	18.8	1.7	1.4	1.1	6.1	1.5	1.3	1.4	0.8	7.5	16.4	1.4	58.0	0.7	28.1	2.1	0.8	0.9	5.0	4.8	1.2	68.3	3.1	0.7	0.1	21.2	0.8	0.6	20.8	2.5	0.9	3.8	1.7	103.5	0.7	3.5	2.0	1.0	0.8	5.6	2.1	1.9	6.4	59.8	60.7	62.0	96.2	57.6	62.2	61.9	61.8	62.0	63.5	64.2	62.4	115.7	3.2	4.5	19.6	3.3	6.4	2.2	2.4	1.8	0.8	2.3	3.7	10.6	2.8	2.5	22.0	0.0	1.3	1.5	2.0	76.3	0.7	9.4	3.1	37.6	101.3	1.2	0.4	4.1	2.3	0.8	29.3	5.1	3.1	1.3	0.7	51.8	1.3	45.3	0.0	3.8	1.3	0.0	145.7	282.7	19.6	95.1	65.6	12.4	16.9	24.9	23.4	1.0	0.5	0.3	2.0	1.5	104.2	3.0	4.9	2.7	4.9	0.5	1.6	32.9	7.5	70.4	16.6	1.9	7.5	5.1	3.6	3.3	5.2	1.4	8.4
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047751-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 76.5"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 213.9;Early spermatids: 440.4;Langerhans cells: 245.2;Spermatocytes: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	NA	NA		87000000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	4.6	10.2	2.1	1.5	2.9	0.6	4.4	3.3	2.5	5.7	3.1	4.9	2.1	5.3	3.2	5.4	5.7	2.6	7.9	1.9	2.2	6.5	8.3	2.9	1.6	2.9	2.8	5.9	7.6	3.4	10.0	1.2	2.6	6.4	0.7	1.9	5.5	3.1	6.5	4.2	3.5	1.2	2.9	4.3	5.5	76.5	2.4	0.4	8.2	2.3	0.4	5.1	5.0	3.2	4.1	8.0	2.7	1.2	4.4	4.2	2.4	2.2	3.2	1.4	1.1	3.5	5.6	0.9	3.5	2.4	3.0	5.3	1.5	0.3	0.8	5.2	1.7	1.0	5.9	4.3	3.0	1.1	0.9	3.1	1.7	2.1	0.8	2.7	2.1	1.7	2.2	2.1	1.3	15.9	1.5	2.8	4.5	3.2	4.4	1.3	2.7	2.9	1.2	2.3	3.6	7.0	7.0	3.7	5.5	5.0	7.3	3.0	2.2	1.9	3.3	5.1	2.0	4.7	4.0	12.2	3.5	0.6	2.4	223.6	22.7	50.4	90.8	54.5	70.3	46.7	78.6	80.8	19.7	51.7	64.8	90.8	69.8	59.0	48.2	28.1	48.9	4.1	2.1	2.9	3.3	2.5	1.9	2.2	2.9	2.8	2.6	2.9	2.4	3.2	57.6	6.4	10.1	19.2	56.8	64.6	38.1	20.8	4.6	20.2	80.3	46.2	7.1	40.0	17.1	42.3	20.9	53.8	213.9	15.6	39.2	21.2	440.4	12.3	20.4	34.4	14.8	12.4	27.6	14.5	35.9	34.5	4.1	12.5	38.8	10.7	66.8	38.3	30.9	18.5	25.6	14.4	16.2	95.5	245.2	80.7	28.6	50.4	88.9	24.4	78.0	20.0	119.4	26.7	37.2	32.4	19.5	25.6	50.9	35.7	8.8	36.5	10.8	26.6	26.3	41.4	35.3	308.8	13.7	3.9	83.3	89.5	90.7	11.5	15.0	46.2
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 6.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 14.9;Glandular and luminal cells: 28.4;Squamous epithelial cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	0.6	0.9	0.7	2.4	0.7	1.1	2.2	1.8	0.7	0.9	0.2	1.6	1.3	0.8	2.0	4.0	1.1	0.9	1.5	0.7	0.9	1.9	1.7	0.9	4.3	0.8	0.8	0.9	0.8	1.2	0.8	1.1	0.8	1.6	2.0	0.9	1.9	0.9	1.0	6.7	2.8	0.6	0.7	4.2	1.7	1.3	1.1	2.1	1.2	0.9	2.4	1.9	1.7	0.8	4.7	2.4	1.5	0.8	2.0	2.3	3.5	2.6	3.4	3.1	3.2	4.9	3.5	4.9	1.5	1.7	1.9	9.3	0.9	7.6	3.6	4.9	3.1	3.2	1.7	0.4	2.8	4.6	1.4	1.4	6.6	3.9	6.3	2.6	1.8	6.6	6.5	3.5	2.7	2.4	3.9	4.7	6.4	3.2	4.1	4.0	7.2	6.9	2.7	4.0	6.0	6.5	3.5	2.7	4.0	3.4	4.2	2.4	1.7	2.6	3.1	2.7	4.2	3.2	3.4	5.4	2.3	3.7	3.8	4.7	0.8	0.7	1.3	0.9	0.9	1.8	0.6	1.0	1.6	3.7	1.1	1.2	0.5	1.5	0.5	2.7	0.6	0.9	0.7	0.7	1.8	0.7	0.7	0.9	0.8	0.8	0.8	0.7	1.1	0.8	0.6	3.2	2.2	0.0	1.1	2.2	6.1	4.6	6.8	1.6	3.7	2.8	2.0	0.0	1.8	0.0	0.0	3.9	1.5	3.5	7.9	1.9	0.1	14.9	1.8	0.8	3.6	2.1	0.5	2.0	5.0	0.9	2.6	28.4	1.3	2.2	1.4	2.3	2.8	1.7	0.6	5.9	0.0	1.3	0.3	0.6	2.5	1.6	0.0	1.0	1.3	2.2	0.0	0.0	0.3	4.1	3.5	0.0	0.6	5.1	2.4	7.4	1.8	1.3	0.0	0.4	1.0	3.6	4.7	25.0	4.8	4.0	1.1	2.8	3.4	12.1
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.1;fallopian tube: 29.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 113.0;Endometrial ciliated cells: 63.0;Late spermatids: 25.4;Respiratory ciliated cells: 101.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.0	0.0	2.2	0.0	2.6	0.0	0.0	0.6	0.9	1.0	3.2	0.0	0.0	0.5	0.0	0.0	29.9	0.0	0.0	1.5	2.3	0.1	0.0	3.2	0.0	8.4	9.1	0.0	0.0	0.6	0.3	0.0	5.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	2.6	0.6	0.9	1.5	2.3	8.4	9.1	5.9	6.2	2.4	2.7	0.0	0.0	1.5	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	113.0	63.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	25.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.7	0.0	0.0	0.0	0.7	11.4	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636628-22639678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1092.6"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 1663.2;Kupffer cells: 5007.4;Macrophages: 1874.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"intermediate monocyte: 226.1;non-classical monocyte: 181.7"	"Lineage enriched"	"Detected in many"	60	"monocytes: 226.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;NB-4: 1.4;RPMI-8226: 7.1;SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		2700000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	375.1	235.6	86.6	134.0	85.6	53.9	95.9	85.8	135.3	75.8	120.0	142.8	172.3	43.1	26.0	58.3	75.6	172.4	74.8	82.9	93.7	56.2	208.8	404.3	532.3	126.7	110.1	37.5	34.3	26.2	46.3	256.3	110.3	47.1	120.2	4.1	48.1	54.6	14.8	21.8	190.1	195.0	107.5	1092.6	90.8	38.2	109.4	100.3	36.5	49.3	68.0	257.5	30.4	131.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.5	0.2	7.1	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.4	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	5.2	0.1	0.1	226.1	0.0	0.0	0.1	0.1	3.7	0.0	0.0	0.0	0.5	0.3	181.7	0.0	0.0	9.7	86.6	85.6	85.8	135.3	82.9	93.7	126.7	110.1	110.3	107.5	109.4	131.6	17.4	35.3	55.8	0.0	19.0	18.4	2.3	0.0	2.2	0.4	5.1	24.6	8.9	37.1	18.0	0.0	0.0	8.7	2.7	0.5	0.0	0.0	4.5	0.2	0.5	46.0	1.8	41.0	0.0	0.2	11.3	9.6	0.0	0.2	21.5	0.2	76.1	26.2	1663.2	0.0	0.0	0.1	0.0	5007.4	291.4	9.9	13.1	1874.2	26.6	20.6	16.7	0.3	0.0	0.0	0.1	0.0	0.1	0.4	2.8	1.3	0.1	1.1	15.3	0.8	78.9	7.4	4.6	0.7	2.1	4.2	16.8	18.2	11.8	0.0	0.2	1.3
C1QB		ENSG00000173369	"Complement C1q B chain"		1	22652762-22661637	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lung: 546.4;lymphoid tissue: 990.2"	"Group enriched"	"Detected in many"	28	"Hofbauer cells: 1451.0;Kupffer cells: 4559.7;Macrophages: 1747.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	71	"intermediate monocyte: 140.6;non-classical monocyte: 101.2"	"Lineage enriched"	"Detected in many"	85	"monocytes: 140.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	439.2	229.0	95.8	149.4	94.2	53.5	87.1	97.2	148.7	65.4	132.6	162.0	186.0	27.7	26.4	63.0	50.5	194.9	62.6	89.8	107.7	18.3	243.4	546.4	514.6	161.0	143.3	39.6	40.0	28.5	1.8	249.2	138.4	28.0	146.0	7.8	44.9	51.2	5.3	6.1	186.1	261.4	138.2	990.2	88.0	39.9	142.2	72.0	23.6	38.6	58.4	255.8	1.1	185.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.4	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	1.7	0.0	0.0	140.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.8	101.2	0.0	0.0	5.3	95.8	94.2	97.2	148.7	89.8	107.7	161.0	143.3	138.4	138.2	142.2	185.8	13.8	12.8	22.1	0.0	17.1	6.2	2.1	0.0	1.8	1.2	4.9	23.1	5.5	24.3	10.5	3.7	0.0	6.6	2.7	0.6	0.0	0.0	3.3	0.1	0.2	65.9	0.0	32.8	0.1	0.0	9.6	5.9	0.0	0.1	11.4	0.1	52.1	26.0	1451.0	0.0	0.1	0.0	0.0	4559.7	92.1	7.8	8.4	1747.2	0.0	34.7	5.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	2.3	1.0	0.3	1.1	3.6	3.9	59.2	4.0	3.2	0.4	0.9	5.7	4.5	9.6	6.1	0.2	0.0	1.5
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643633-22648110	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 950.7"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 1356.5;Kupffer cells: 2134.6;Macrophages: 1040.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"intermediate monocyte: 57.2"	"Lineage enriched"	"Detected in single"	541	"monocytes: 57.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 2.6;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	2100000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	285.2	196.0	60.1	159.7	58.6	43.5	70.5	64.8	97.1	51.9	90.6	133.2	179.9	36.3	13.5	55.3	67.4	155.4	58.6	54.9	75.5	41.2	169.6	290.8	370.2	124.7	105.4	32.1	37.5	22.1	39.6	204.9	105.0	37.8	91.3	3.9	51.6	44.5	12.9	18.3	195.7	164.7	100.4	950.7	94.8	33.9	106.0	75.7	29.2	31.8	50.7	191.8	24.6	159.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.2	0.0	0.0	0.6	0.2	2.6	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	1.2	60.1	58.6	64.8	97.1	54.9	75.5	124.7	105.4	105.0	100.4	106.0	159.3	13.4	6.4	5.2	0.3	13.7	8.9	1.1	0.0	2.8	0.6	4.9	24.5	1.6	15.7	3.1	0.0	0.0	5.8	2.3	0.4	0.0	0.0	3.2	0.0	0.1	34.5	0.0	27.2	0.0	0.2	9.5	4.4	0.0	0.1	5.1	0.1	25.4	6.6	1356.5	0.0	0.1	0.1	0.0	2134.6	202.4	3.6	6.2	1040.7	7.2	29.0	23.6	0.4	0.0	0.0	0.0	0.0	1.1	1.2	0.9	0.4	0.0	0.4	0.7	0.6	46.0	2.5	1.8	0.4	0.8	3.3	6.5	9.9	3.5	0.0	0.0	0.7
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 26.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 28.3;Cone photoreceptor cells: 8.4;Oligodendrocyte precursor cells: 37.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.6"	"Region enhanced"	"Detected in many"		"hippocampal formation: 22.7"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA057934: AB_2683558"	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.0	0.0	17.6	0.0	9.4	0.0	0.2	3.9	17.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	16.3	0.0	0.0	0.0	0.1	7.3	7.0	0.1	0.0	0.0	0.5	0.0	6.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	4.5	0.0	0.0	0.2	20.3	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.4	3.9	17.0	26.5	16.3	7.3	7.0	6.1	4.5	20.3	8.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	28.3	1.3	0.8	0.5	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	37.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 214.2;heart muscle: 319.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 120.0;Sertoli cells: 105.2;Smooth muscle cells: 105.8;Syncytiotrophoblasts: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.5;BJ hTERT+: 72.9;HHSteC: 112.3;HSkMC: 61.3;U-87 MG: 66.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	40000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	214.2	75.3	9.5	14.8	15.2	0.5	156.0	16.1	13.3	50.2	45.3	38.3	4.6	45.1	6.5	18.9	63.5	24.3	319.1	9.1	18.2	25.3	45.7	44.4	14.0	18.3	25.4	70.5	14.9	13.5	17.5	42.2	18.0	57.1	6.3	0.9	34.9	44.0	27.0	38.6	29.3	13.3	14.1	35.7	25.0	5.4	21.9	5.1	115.0	21.3	6.6	34.7	42.3	13.2	0.1	32.3	0.3	0.1	313.5	27.1	0.2	13.6	72.9	7.0	11.9	2.7	14.0	0.1	1.5	5.1	18.1	0.7	1.0	0.5	5.0	0.1	3.5	0.2	11.7	1.5	112.3	0.1	0.2	61.3	0.2	14.5	0.8	9.3	8.8	1.6	0.1	0.3	1.6	0.1	0.3	0.2	3.0	3.7	27.9	0.1	22.3	0.4	0.0	0.4	1.3	5.3	9.2	1.8	32.7	1.2	0.0	0.0	1.4	32.6	0.8	4.0	4.8	0.3	0.1	0.1	66.2	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	15.2	16.1	13.3	9.1	18.2	18.3	25.4	18.0	14.1	21.9	13.2	36.1	0.0	0.6	4.9	0.4	6.5	0.7	12.3	0.6	0.1	9.2	1.8	10.8	5.7	0.5	1.8	0.0	21.5	0.4	3.2	0.0	19.5	0.1	0.6	17.9	38.3	4.8	2.7	0.2	5.9	1.5	23.6	2.6	0.6	0.0	25.3	120.0	1.9	2.6	0.0	0.9	6.3	2.0	7.5	11.3	0.7	10.5	1.1	3.6	5.6	10.9	0.5	0.0	0.5	0.3	3.7	3.1	3.4	0.1	1.8	0.9	0.2	0.3	0.5	105.2	12.7	105.8	0.0	0.7	0.4	4.5	47.3	0.8	18.1	5.2	0.6
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.5;Extravillous trophoblasts: 11.2;Proximal tubular cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.1;U-2 OS: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		"Cluster 40: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.3	0.1	0.4	0.2	0.4	0.0	0.7	0.3	0.5	0.5	0.0	3.4	6.8	0.3	0.0	1.3	0.5	0.1	0.8	0.4	0.7	3.4	0.5	0.4	0.0	0.8	0.4	0.2	0.2	0.0	0.3	0.2	0.5	0.3	0.7	0.0	0.3	0.0	0.4	6.6	6.7	0.0	0.4	0.2	0.4	2.4	0.9	0.0	0.4	0.0	0.1	0.3	0.6	0.5	0.1	0.0	0.0	0.3	0.2	0.0	0.8	0.6	0.0	0.0	0.0	0.3	0.2	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	4.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.7	0.8	0.4	0.5	0.4	0.9	0.5	19.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	3.9	0.5	0.0	0.6	1.2	0.7	0.0	0.0	0.0	0.8	11.2	0.5	0.0	0.7	2.5	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	45.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.0
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347754-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	2.8	0.6	0.9	0.7	0.9	0.1	1.9	1.2	1.3	4.7	0.1	2.5	1.2	3.3	1.1	1.4	2.3	1.8	3.9	0.9	0.8	0.6	0.4	2.4	0.3	0.3	1.3	1.3	0.3	0.2	0.5	0.8	0.2	1.9	1.1	0.2	1.3	1.0	1.9	1.4	2.3	1.8	0.2	0.6	2.0	1.8	2.5	0.1	2.1	2.1	0.3	2.1	2.6	0.8	0.3	0.0	0.5	0.1	0.0	0.0	0.0	3.9	5.3	0.9	3.3	0.1	0.9	0.0	0.1	1.4	0.6	0.2	0.1	0.4	0.2	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	34.4	0.0	0.0	0.2	0.0	0.8	1.0	0.1	0.2	0.1	0.4	0.1	0.2	15.1	8.3	1.5	4.4	0.1	0.0	0.0	0.5	0.0	6.8	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.9	0.9	1.2	1.3	0.9	0.8	0.3	1.3	0.2	0.2	2.5	0.8	2.0	0.0	0.0	0.0	0.0	6.5	0.2	0.2	0.6	0.8	0.3	0.4	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.1	0.0	0.1	1.0	4.2	0.0	0.0	0.6	0.2	0.3	23.7	0.5	0.2	0.0	0.2	1.1	0.0	1.1	0.0	6.2	0.1	0.0	0.0	6.2	0.4	23.3	0.5	5.4	1.0	0.6	0.1	0.0	1.0	0.3	0.1	0.1	29.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	16.9	22.8	0.1	0.5	0.6	3.8	0.8	0.3	2.1	0.1	0.3
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34017858-34043213	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.4;salivary gland: 52.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	211	"U-266/84: 810.2"									"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	44100000	24000000		"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	7.3	0.5	4.1	1.7	5.0	0.6	6.8	6.8	4.0	3.6	2.6	11.2	3.5	2.7	1.0	33.4	3.0	5.9	0.9	3.9	7.0	4.8	1.1	4.1	0.8	5.3	4.3	1.4	1.7	0.3	1.3	0.6	4.5	2.2	10.0	23.7	52.0	4.9	2.2	2.3	8.9	23.3	5.8	0.7	10.7	11.4	4.2	1.0	1.6	9.9	0.4	13.2	3.6	5.1	0.7	0.1	0.2	0.3	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.7	0.8	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.8	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.2	1.6	0.0	0.1	0.6	0.1	0.0	3.8	0.6	0.1	1.0	0.0	1.0	0.9	810.2	1.3	0.0	0.8	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	5.0	6.8	4.0	3.9	7.0	5.3	4.3	4.5	5.8	4.2	5.1	2.3	3.2	2.0	0.0	2.0	5.7	0.6	0.4	1.8	5.1	3.0	2.3	1.0	8.6	0.8	3.7	0.0	0.9	1.5	0.7	1.9	1.2	161.6	2.6	1.0	7.2	1.8	1.3	0.0	1.4	0.5	61.5	1.5	2.6	0.0	1.8	0.4	1.3	1.3	8.4	0.0	1.4	2.0	0.6	9.6	387.6	1.8	1.1	7.2	0.0	0.3	227.2	1.0	0.0	0.0	0.5	1.5	2.6	0.2	0.8	0.8	2.1	1.2	11.9	0.0	77.5	4.5	6.2	2.0	1.1	5.8	0.4	1.3	1.0	2.0	0.5
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.0;pituitary gland: 17.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0"	"Group enriched"	"Detected in some"	4	"glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"REH: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus, Vesicles"		"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	1.7	1.5	7.9	0.0	33.0	1.1	2.2	13.2	17.6	5.3	0.0	3.9	0.1	5.8	0.0	0.5	4.2	0.0	1.0	7.5	1.1	1.4	0.9	0.7	0.0	6.0	4.9	12.0	0.4	0.7	17.1	0.0	2.1	2.8	0.0	0.1	1.1	0.1	0.9	1.8	1.5	0.1	1.0	1.0	1.5	5.8	6.7	0.0	1.5	0.0	0.0	1.3	2.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	33.0	13.2	17.6	7.5	1.1	6.0	4.9	2.1	1.0	6.7	3.4	2.4	0.0	0.0	18.9	0.0	2.4	6.5	0.2	0.0	15.8	1.3	25.8	0.7	1.5	0.3	3.7	16.7	1.3	0.1	0.2	3.9	0.1	11.3	0.8	21.2	4.5	0.0	2.5	15.5	0.2	2.7	20.7	0.5	0.6	0.0	31.3	2.5	0.2	3.3	5.0	17.8	0.1	0.0	0.3	3.0	51.7	46.0	0.7	10.6	4.7	0.0	54.5	0.0	5.0	8.0	0.1	0.1	38.4	0.0	4.3	0.1	0.6	0.6	24.7	26.3	12.8	8.5	13.5	44.5	0.3	1.8	3.6	0.6	39.0	0.2	2.4
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338942-119340940	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 4.7;Endothelial cells: 1.5;Exocrine glandular cells: 1.1;Fibroblasts: 3.6;Gastric mucus-secreting cells: 1.5;Smooth muscle cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;fHDF/TERT166: 14.7;HHSteC: 35.8;hTERT-RPE1: 28.5;HUVEC TERT2: 54.7;TIME: 50.5"	"Low region specificity"	"Detected in all"							"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	NA	NA	219000000	1500000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"CAB025607: , HPA038604: AB_2676110"																		51.9	13.4	19.1	12.9	20.8	0.1	36.6	20.3	20.7	38.4	25.5	23.0	14.9	50.7	7.5	11.5	27.2	45.5	36.1	17.3	19.8	42.4	11.1	42.0	8.9	21.8	22.2	11.3	18.8	6.8	14.8	13.6	20.4	19.5	7.8	2.2	16.9	8.7	8.8	20.4	24.2	26.8	21.7	32.3	27.1	2.6	27.5	2.8	32.0	15.2	4.6	31.6	20.8	21.7	0.0	0.0	3.3	0.0	17.7	4.9	0.2	4.6	0.3	0.6	2.7	0.1	0.0	0.1	2.0	14.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	35.8	0.0	0.0	8.4	0.0	0.3	0.0	28.5	54.7	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.0	6.5	0.0	0.0	1.1	0.9	0.0	0.0	50.5	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	20.8	20.3	20.7	17.3	19.8	21.8	22.2	20.4	21.7	27.5	21.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	3.6	1.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.7;placenta: 29.6"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.9	6.7	4.4	6.6	4.5	1.6	4.0	4.3	5.3	11.1	4.3	5.5	1.6	31.7	1.4	2.7	7.0	8.8	3.7	4.5	4.3	7.4	13.0	5.2	5.1	5.1	4.5	5.5	3.5	2.2	2.5	29.6	4.8	6.8	3.6	0.5	3.2	2.9	1.5	5.0	5.4	8.2	4.4	6.5	3.5	6.2	4.8	2.4	3.8	0.7	2.3	5.6	4.3	6.3	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.4	4.5	4.3	5.3	4.5	4.3	5.1	4.5	4.8	4.4	4.8	6.3	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446167	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Fibroblasts: 32.3;Leydig cells: 22.7;Peritubular cells: 31.6;Skeletal myocytes: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 4.2;ASC TERT1: 2.8;HSkMC: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	7.8	1.4	1.2	1.6	1.2	0.0	4.7	1.2	2.6	23.1	0.0	8.6	1.2	16.5	10.2	6.0	6.3	14.0	7.0	0.8	1.8	5.5	1.2	10.8	1.2	1.1	1.8	20.9	0.8	0.1	1.1	7.2	0.9	9.5	4.2	0.1	2.5	3.2	0.6	3.2	3.8	12.0	0.6	9.7	9.0	1.7	1.8	0.4	3.8	6.6	0.5	10.3	10.3	1.3	0.0	0.0	0.0	0.0	4.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.6	0.8	1.8	1.1	1.8	0.9	0.6	1.8	1.3	1.2	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	15.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.1	0.2	6.5	0.5	0.0	0.0	1.0	0.0	0.3	32.3	0.0	0.6	0.0	2.0	0.0	0.0	0.1	1.7	4.4	0.0	0.0	0.0	3.2	0.5	22.7	0.3	5.4	6.5	0.0	0.3	0.0	2.5	0.7	0.0	0.0	31.6	0.2	0.1	0.0	2.8	0.0	1.2	6.6	15.2	9.9	0.0	0.1	0.6	3.0	0.0	0.7	5.7	0.0	0.1
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1088226-1096244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.8;fallopian tube: 1.8;pituitary gland: 2.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Endometrial ciliated cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA056438	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA056438: AB_2683134"			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.9	0.0	0.0	0.1	0.0	1.9	2.8	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.4	0.5	0.9	1.9	2.8	1.2	2.1	0.8	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 8.4"	"Group enriched"	"Detected in some"	10	"Adipocytes: 34.9;Endothelial cells: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000			"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	3.1	0.2	0.3	0.1	0.2	0.2	1.5	0.4	0.3	0.3	0.0	1.6	0.6	0.3	0.4	0.4	0.3	0.8	3.8	1.9	0.5	0.3	0.5	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	1.3	0.2	0.6	0.3	0.4	0.4	0.1	8.4	2.1	0.6	0.6	0.0	0.3	0.5	0.9	0.2	0.2	0.2	3.3	0.1	0.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.3	1.9	0.5	0.1	0.1	0.2	0.0	0.2	0.2	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.3	2.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.5	0.1	12.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.9	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.1
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23891099-23897502	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.8;skin 1: 17.9;testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.3;Early spermatids: 2.3;Endothelial cells: 1.4;Late spermatids: 2.1"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.8;OE19: 3.6"									HPA056632	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.2	0.7	1.0	0.6	0.9	0.2	0.4	0.3	1.2	0.3	0.4	0.4	0.5	0.7	0.0	1.6	0.3	0.8	3.5	7.8	1.9	0.2	0.1	0.4	0.2	0.3	0.6	0.4	0.6	0.1	1.1	0.6	0.3	4.2	0.1	0.7	1.6	0.2	4.0	17.9	0.2	0.7	0.3	1.3	0.8	8.8	0.7	0.0	0.5	2.0	0.0	0.6	0.1	0.4	0.7	1.7	0.6	0.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	1.3	1.7	0.0	0.0	0.0	1.0	1.4	0.3	0.9	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	4.8	0.4	0.9	0.0	1.1	0.2	0.0	1.1	3.6	1.6	0.6	0.8	1.3	0.0	0.0	2.0	0.0	1.0	0.0	1.7	0.4	0.5	0.2	0.1	1.6	0.4	0.0	1.0	1.4	0.2	0.7	1.9	0.6	0.3	0.0	0.2	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.4	0.4	0.7	0.0	0.1	1.0	0.9	0.3	1.2	7.8	1.9	0.3	0.6	0.3	0.3	0.7	0.4	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0
C1R		ENSG00000159403	"Complement C1r"		12	7080214-7092540	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"liver: 1425.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1"	"Low region specificity"	"Detected in many"							"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	540.6	203.6	15.8	122.4	15.9	1.1	400.6	15.9	23.3	470.5	21.7	277.3	38.3	353.8	80.8	119.0	526.3	279.1	458.7	15.4	19.6	148.9	1425.6	340.3	72.4	23.4	19.9	644.3	88.0	11.0	63.9	52.4	18.4	205.2	100.9	5.8	158.3	87.0	69.4	177.7	228.1	157.7	18.1	192.1	242.7	46.7	18.1	34.7	223.4	74.2	75.3	468.4	394.3	18.0	1.2	8.9	0.9	9.1	1089.8	546.0	0.4	108.9	461.9	143.0	303.4	1.4	2.4	0.5	4.5	108.8	11.8	2.3	11.8	5.5	18.3	18.3	1.1	0.5	4.1	3.6	226.5	0.8	2.3	672.1	3.2	74.7	4.7	121.0	2.9	0.5	0.3	20.5	21.2	0.1	8.0	0.8	3.1	0.1	0.9	8.6	3.8	0.8	0.9	5.5	0.4	2.3	95.1	3.7	2.8	1.3	0.2	0.2	0.4	38.3	6.3	152.1	0.8	1.1	3.0	0.2	53.1	1.0	5.4	0.0	0.0	0.6	0.3	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.6	0.6	0.5	0.8	0.0	0.0	0.3	0.1	15.8	15.9	15.9	23.3	15.4	19.6	23.4	19.9	18.4	18.1	18.1	18.0	45.4	22.4	90.5	3.6	7.1	54.7	58.8	76.6	33.6	0.3	5.9	30.9	20.8	183.0	22.9	18.4	2.1	4.1	1.8	0.7	3.9	280.8	4.6	13.3	442.3	45.4	0.0	40.6	0.9	44.5	3.7	684.4	16.3	11.6	10.1	24.9	114.9	1444.2	11.2	0.0	0.3	0.7	0.0	40.9	66.9	29.2	1142.6	7.0	53.4	13.1	1.6	16.0	0.0	2.5	0.1	51.1	1.3	388.1	6.2	17.7	0.3	6.1	5.3	1.4	170.9	87.5	140.4	6.8	6.7	5.6	40.1	5.2	11.5	15.2	0.7	11.2
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109238	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 54.2;Hepatocytes: 140.0;Leydig cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.2;HSkMC: 43.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	15000000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	38.3	72.5	3.4	12.2	3.3	8.2	36.5	2.6	3.1	38.6	7.1	28.8	7.6	30.2	6.3	17.5	40.8	11.7	18.4	2.7	4.0	20.1	141.9	33.1	9.5	7.4	5.0	49.4	36.7	8.0	17.5	5.1	4.4	29.3	8.7	1.5	33.7	6.9	11.0	18.1	26.3	13.7	3.7	32.3	27.5	6.1	3.9	6.9	21.7	6.0	7.7	38.1	27.5	3.3	3.0	7.7	0.7	7.9	22.4	38.2	5.4	4.9	22.7	5.0	14.8	4.9	13.4	1.3	4.1	4.1	5.0	6.4	2.1	8.1	1.9	12.0	0.4	4.8	8.5	11.4	18.7	1.0	21.9	43.1	15.7	3.0	9.3	23.3	5.3	2.8	3.6	3.1	3.1	0.1	0.7	0.9	1.4	0.6	0.2	2.7	0.0	1.0	13.1	13.2	0.6	1.7	16.7	2.0	2.8	1.3	1.9	4.1	5.0	4.3	7.7	4.9	0.9	2.3	1.0	0.2	8.1	3.4	2.0	3.8	0.7	4.0	0.6	1.1	0.3	1.2	0.6	0.5	0.8	0.5	0.4	0.4	5.4	0.3	1.3	0.4	0.4	0.4	3.4	3.3	2.6	3.1	2.7	4.0	7.4	5.0	4.4	3.7	3.9	3.3	11.0	16.0	38.6	7.5	8.4	3.8	15.4	16.4	25.6	0.5	15.6	14.5	2.6	30.0	24.6	5.5	2.1	0.2	7.3	8.3	1.9	36.3	0.1	7.9	22.6	14.6	4.2	7.8	10.2	54.2	0.4	29.0	27.5	10.4	3.8	13.8	25.0	140.0	3.6	0.0	1.3	7.7	10.2	10.0	4.9	3.0	55.6	10.2	3.6	14.0	13.3	4.0	21.6	2.0	0.4	25.8	9.7	20.3	8.0	10.2	9.3	8.2	15.9	1.1	0.0	11.8	10.1	0.6	0.9	8.5	3.1	0.1	9.7	13.6	9.5	8.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
C20orf144	"bclt, dJ63M2.6"	ENSG00000149609	"Chromosome 20 open reading frame 144"	Q9BQM9	20	33662327-33665619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1044	"testis: 177.6"	"Group enriched"	"Detected in some"	87	"Early spermatids: 2064.3;Late spermatids: 2549.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019029	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA019029: AB_2670016"	"unprognostic (2.16e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.72e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	2.3	0.0	0.5	2.9	0.7	0.1	0.0	0.9	0.3	0.3	0.3	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2064.3	0.1	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	1.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	2.0	2549.4	16.4	1.6	12.4	0.0	0.0	0.4	2.1	0.0	0.1	0.2	0.1	10.9	0.5	1.0	0.0	0.2	0.1	2.6	6.6	0.9	0.4	26.5	10.2	0.0	1.6	0.3	0.5	0.3	0.1	0.4
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249306-3407669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	11.8	9.5	19.7	5.2	22.4	3.6	8.7	18.5	20.1	10.1	6.8	14.4	4.1	10.4	5.4	8.4	9.8	8.3	15.3	19.5	21.4	11.2	2.6	10.0	4.5	21.5	22.9	12.3	6.3	4.2	8.8	9.1	21.1	8.6	4.3	16.4	5.8	11.6	32.3	5.6	6.6	12.9	19.6	7.3	9.7	10.4	21.8	3.8	9.6	11.6	2.9	12.6	8.9	26.0	4.0	3.6	9.7	4.7	19.7	21.6	1.1	9.2	10.3	6.0	7.5	0.0	4.3	0.0	2.5	12.3	7.7	4.7	3.7	9.1	8.2	0.9	1.8	1.1	1.4	10.0	9.2	1.2	0.5	17.7	6.9	7.9	6.8	8.6	12.2	3.5	2.0	0.0	8.9	1.8	2.5	6.5	2.9	2.2	2.3	2.9	8.8	0.1	7.8	8.1	1.9	5.7	4.1	7.2	12.0	8.3	6.8	11.3	13.7	7.5	3.2	4.7	4.5	0.1	0.0	0.0	2.4	1.2	5.8	0.4	0.8	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.9	0.4	0.1	0.3	0.0	0.0	0.4	1.0	0.4	0.2	19.7	22.4	18.5	20.1	19.5	21.4	21.5	22.9	21.1	19.6	21.8	26.0	23.6	28.9	9.2	226.9	3.7	6.9	6.7	10.8	8.6	35.1	10.1	10.8	28.5	15.7	10.3	12.9	202.3	1.8	8.9	0.1	1.9	9.1	31.8	10.6	15.9	20.1	0.0	4.0	205.6	4.7	5.4	13.4	19.4	12.1	14.0	53.3	25.7	2.3	19.6	30.3	163.1	0.5	4.1	34.0	25.5	8.9	19.9	22.4	8.8	89.9	14.1	10.0	3.1	135.7	191.2	9.4	14.8	13.5	1.5	5.4	7.4	8.4	21.8	13.9	13.1	18.4	22.2	28.5	25.0	7.2	5.7	1.8	7.8	16.4	1.4	5.2
C20orf202		ENSG00000215595	"Chromosome 20 open reading frame 202"	A1L168	20	1203454-1208279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Early spermatids: 3.6;Late spermatids: 2.1;Paneth cells: 1.3;Proximal enterocytes: 1.2;Sertoli cells: 6.6;Smooth muscle cells: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"	"Group enriched"	"Detected in some"	15	"cerebellum: 8.0;olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			HPA042786	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042786: AB_10795760"	"unprognostic (8.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.82e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.24e-3)"	0.6	0.1	0.5	0.1	0.5	0.0	0.3	1.0	0.9	0.2	0.3	0.3	0.3	0.1	0.0	0.3	0.4	0.7	0.6	0.4	0.5	0.4	0.1	1.3	0.2	0.5	0.5	0.1	0.3	0.4	0.2	3.3	0.6	0.1	0.3	0.4	0.4	0.6	0.5	0.5	1.1	0.2	0.5	0.2	0.3	0.6	0.7	0.1	0.2	0.3	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.5	1.0	0.9	0.4	0.5	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	1.2	0.1	0.0	0.0	6.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3767781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 178.7;Hofbauer cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 199.4;monocytes: 249.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	55.8	24.0	48.8	20.4	125.4	103.6	45.2	44.7	70.9	39.5	33.7	117.3	17.0	42.5	8.7	29.6	51.8	25.5	27.9	45.6	63.3	25.7	24.7	20.8	24.5	52.9	59.3	66.3	23.6	9.4	23.3	8.9	67.5	24.2	7.8	4.9	15.7	10.9	22.4	26.9	33.9	14.1	43.8	45.5	86.8	22.7	59.5	11.0	23.4	11.5	9.8	73.9	26.3	40.7	172.9	177.7	24.4	106.1	49.5	28.1	42.7	45.5	25.1	70.4	50.3	120.5	61.6	111.1	41.4	48.2	94.7	140.9	65.7	101.9	24.9	26.1	138.3	63.2	35.9	212.6	36.2	88.2	24.7	41.0	41.8	93.3	46.1	24.2	48.2	72.9	114.6	59.8	37.3	240.2	107.6	186.3	114.9	107.0	248.4	86.6	67.9	123.7	43.9	62.0	121.8	56.6	41.2	155.3	85.1	10.4	36.9	96.8	35.9	104.8	73.8	171.6	129.6	50.5	93.2	80.7	31.5	161.2	53.9	1.3	144.6	2.3	28.7	249.1	42.1	38.7	33.6	38.6	199.4	36.2	37.6	37.5	5.4	32.5	235.3	38.7	34.2	87.4	48.8	125.4	44.7	70.9	45.6	63.3	52.9	59.3	67.5	43.8	59.5	40.7	54.0	0.0	3.3	3.3	26.5	24.2	23.0	26.8	35.3	9.7	28.2	45.7	3.7	8.6	7.4	11.0	2.1	17.5	15.8	10.2	29.4	32.6	21.8	13.8	178.7	28.7	15.7	99.1	6.0	30.0	49.2	27.1	14.3	7.5	22.9	45.0	19.6	17.9	142.9	1.7	9.5	15.9	16.2	119.0	53.1	15.3	32.6	92.2	37.4	5.6	97.4	24.6	15.5	3.5	2.1	34.7	14.6	24.8	20.2	46.6	19.3	32.4	2.7	13.6	65.7	17.1	98.8	27.3	39.1	34.8	32.8	7.3	24.1	69.7	33.0	22.7
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150902-58161150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"fallopian tube: 455.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 412.1;Endometrial ciliated cells: 1096.5;Late spermatids: 413.4;Respiratory ciliated cells: 1504.4"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 57.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.6"	"Region enhanced"	"Detected in many"		"midbrain: 20.0"	"HPA058271, HPA065540"	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA058271: AB_2683661, HPA065540: AB_2685510"				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	12.9	1.3	0.0	0.0	5.1	0.2	0.0	455.2	0.0	0.0	0.1	1.0	0.1	0.0	25.5	0.0	2.2	3.1	0.3	0.0	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.2	0.1	0.1	77.9	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	1.0	2.2	3.1	1.0	2.2	0.9	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	98.3	0.0	0.0	0.0	0.0	0.0	0.0	122.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	412.1	1096.5	6.2	0.9	0.0	0.0	0.1	0.0	0.0	1.2	0.0	11.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	120.1	0.0	0.0	413.4	3.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.1	1504.4	0.0	0.0	0.0	34.5	95.9	3.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3
C20orf96	dJ1103G7.2	ENSG00000196476	"Chromosome 20 open reading frame 96"	Q9NUD7	20	270863-290778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.6;Endometrial ciliated cells: 89.2;Respiratory ciliated cells: 106.2;Spermatocytes: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048649, HPA056227"	Approved		Approved	"Centriolar satellite"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"		"HPA048649: AB_2680476, HPA056227: "	"unprognostic (1.59e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (4.62e-2)"	"unprognostic (5.12e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.05e-4)"	6.6	10.5	13.5	5.3	13.1	8.1	10.2	12.6	13.7	16.8	20.5	11.0	9.6	16.6	20.7	4.4	33.5	8.8	8.3	13.6	13.6	15.1	6.2	10.2	5.4	17.2	20.8	20.3	9.2	8.4	17.3	3.8	17.3	13.9	8.3	11.2	9.8	7.8	3.5	3.6	9.2	10.3	16.6	9.6	9.8	30.1	14.3	6.7	17.1	2.3	4.6	8.9	8.1	13.4	7.5	23.3	23.9	21.1	6.2	6.0	10.6	5.3	6.8	7.7	10.3	4.5	14.3	18.7	3.4	6.4	13.4	6.4	8.9	4.1	8.9	4.7	13.9	12.5	0.2	25.6	17.2	10.3	5.2	8.3	3.5	13.2	1.6	19.4	15.6	23.6	25.9	9.1	6.7	3.7	12.2	39.9	7.9	7.4	10.1	36.9	4.2	15.4	12.1	11.5	2.5	21.3	6.3	9.0	15.3	11.0	15.6	22.7	10.5	7.6	13.1	6.8	4.4	20.7	22.5	12.8	4.2	31.9	7.2	0.0	1.3	0.0	0.6	1.0	0.4	1.6	0.4	0.5	3.0	1.7	0.9	1.2	0.0	1.3	0.7	1.4	0.6	0.8	13.5	13.1	12.6	13.7	13.6	13.6	17.2	20.8	17.3	16.6	14.3	13.4	7.2	3.2	3.6	13.4	4.1	3.7	5.5	9.9	9.1	3.8	21.8	19.2	0.8	11.5	12.5	18.4	6.2	5.1	2.8	5.0	39.2	11.4	109.6	89.2	11.0	10.4	8.4	9.7	5.1	6.9	3.1	9.1	15.8	7.1	14.7	18.6	9.7	3.4	9.1	6.7	4.0	8.1	26.4	3.8	3.3	35.8	10.8	7.7	3.6	4.7	3.7	7.7	4.1	2.0	4.6	8.5	1.9	18.0	10.7	4.9	4.6	23.1	106.2	9.8	6.6	6.5	8.7	60.8	45.1	4.3	1.6	2.7	4.1	9.8	9.3	4.2
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32790673-32813743	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 19.7;ovary: 14.2"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 44.3;Distal tubular cells: 23.5;Skeletal myocytes: 26.2"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 3.8;RPTEC TERT1: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	1.6	0.3	1.7	0.4	2.2	0.5	0.1	1.8	2.0	0.0	19.7	0.1	0.1	0.0	8.4	0.2	0.7	0.4	0.2	2.4	4.1	6.9	0.2	0.1	0.2	3.2	7.2	14.2	4.1	0.0	3.4	0.0	2.8	3.6	0.0	1.0	0.1	0.2	0.1	0.2	0.4	0.2	2.0	0.2	0.3	0.3	4.6	0.0	0.1	0.1	1.1	0.0	0.1	5.8	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.2	0.0	0.1	0.3	0.0	1.7	2.2	1.8	2.0	2.4	4.1	3.2	7.2	2.8	2.0	4.6	5.8	0.0	0.0	0.0	2.9	0.5	0.9	0.8	0.4	0.0	5.9	0.0	0.0	0.2	44.3	0.3	5.5	6.2	1.2	1.3	0.1	23.5	0.2	1.5	0.0	0.0	0.8	3.0	0.0	0.8	0.0	0.4	3.6	0.0	0.0	0.0	0.2	2.5	0.2	0.3	0.0	1.4	0.0	0.0	1.3	1.9	0.3	4.1	0.4	3.6	0.0	1.0	5.8	4.1	4.0	4.7	0.0	0.0	1.9	0.0	0.5	0.1	2.6	0.2	7.1	0.0	26.2	1.7	1.0	1.0	0.0	1.0	0.3	1.1	0.2	0.2	0.4
C21orf91	"C21orf14, C21orf38, CSSG1, EURL, YG81"	ENSG00000154642	"Chromosome 21 open reading frame 91"	Q9NYK6	21	17788974-17819386	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 345.8;Late spermatids: 98.6;Oligodendrocytes: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 111.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018288, HPA049030"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules	"Cytokinetic bridge"	"HPA018288: AB_1845710, HPA049030: AB_2680605"	"unprognostic (3.28e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.51e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.90e-3)"	6.3	4.8	11.5	9.8	26.7	8.2	8.2	22.0	16.3	6.2	4.4	4.7	5.1	9.2	4.3	8.3	6.7	6.0	5.4	13.3	15.5	5.3	8.7	7.9	15.4	26.0	21.2	8.0	2.8	4.9	2.7	13.5	26.6	5.3	5.2	5.7	5.0	3.6	2.7	18.9	5.5	7.6	20.9	9.8	6.3	24.4	20.7	19.2	5.7	5.5	13.0	8.3	4.1	59.0	7.2	1.2	15.6	0.1	3.9	7.3	6.9	10.4	18.6	10.1	8.9	6.5	3.7	25.2	5.1	4.2	14.1	5.7	17.1	13.4	8.7	27.5	9.2	16.9	13.2	4.1	8.8	20.6	9.2	5.3	14.6	13.3	21.5	7.1	2.8	10.3	12.1	107.9	7.7	4.5	28.8	6.1	16.4	1.7	5.7	21.9	29.9	10.2	6.8	12.0	6.2	14.4	13.1	10.1	47.2	7.0	6.1	11.6	4.8	44.2	13.8	0.2	6.8	28.6	37.7	21.5	3.5	18.9	17.3	111.1	11.2	56.8	20.9	11.9	29.8	14.0	19.3	22.7	13.9	11.7	14.9	19.7	24.9	20.7	12.2	3.5	36.9	12.0	11.5	26.7	22.0	16.3	13.3	15.5	26.0	21.2	26.6	20.9	20.7	59.0	20.2	19.2	11.1	1.6	26.4	27.9	10.1	57.9	63.2	12.6	14.4	10.4	7.4	4.3	27.1	5.5	16.7	17.3	18.8	4.4	1.9	4.8	345.8	14.5	13.8	21.3	10.7	5.5	0.8	6.9	12.2	12.0	9.2	14.4	39.9	11.3	7.5	6.8	5.8	15.2	0.8	5.0	18.3	7.2	14.0	98.6	23.6	9.7	21.4	3.7	30.7	3.5	48.4	7.5	103.4	4.4	5.9	17.0	27.6	11.0	3.4	6.4	19.3	13.0	6.6	20.1	12.1	38.7	24.1	21.4	27.6	80.2	38.9	22.1	3.8	7.7
C22orf31	"bK747E2.1, HS747E2A"	ENSG00000100249	"Chromosome 22 open reading frame 31"	O95567	22	29058672-29061844	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 3.0;testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 70.0;Late spermatids: 43.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA000604, HPA068522"	Uncertain		Approved	"Nuclear membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA000604: AB_1079086, HPA068522: "																		0.1	0.3	1.7	0.0	2.3	0.0	0.3	2.3	2.7	0.3	1.3	0.3	0.2	0.3	0.9	0.3	0.3	0.0	0.1	1.9	1.5	0.4	0.0	0.2	0.0	1.5	1.6	0.6	0.0	3.0	0.4	0.0	1.5	0.2	0.2	0.3	0.4	0.1	0.2	0.4	0.3	0.1	1.2	0.1	0.4	8.7	1.7	1.0	0.2	0.2	0.1	0.3	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.3	2.3	2.7	1.9	1.5	1.5	1.6	1.5	1.2	1.7	1.6	0.0	0.0	0.0	8.5	0.0	0.1	0.2	0.2	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	70.0	0.3	1.6	0.1	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	43.3	0.9	0.0	1.8	1.0	0.0	3.3	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	3.7	0.2	1.0	0.5	0.2	0.9	0.0	0.1	1.0	0.1	0.1
C22orf42		ENSG00000205856	"Chromosome 22 open reading frame 42"	Q6IC83	22	32149006-32159322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	13	"brain: 12.5;testis: 10.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 95.7;Late spermatids: 31.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.8;prostate cancer: 1.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 8.9;midbrain: 4.5;pons: 4.5;thalamus: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019531	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA019531: AB_1853016"					"unprognostic (5.67e-2)"						"unprognostic (6.13e-3)"	"unprognostic (8.21e-3)"		"unprognostic (7.06e-2)"	"unprognostic (4.54e-2)"			0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.8	4.5	0.0	0.4	0.0	0.9	0.0	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	10.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.1	0.4	0.0	8.9	0.8	4.5	4.5	0.4	12.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.7	0.2	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C2CD2	"C21orf25, C21orf258, DKFZP586F0422, TMEM24L"	ENSG00000157617	"C2 calcium dependent domain containing 2"	Q9Y426	21	41885112-41954018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 51.6;Cone photoreceptor cells: 83.4;Granulosa cells: 100.0;Theca cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.1;SK-BR-3: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030922, HPA030924"	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030922: AB_2673660, HPA030924: AB_10669873"	"unprognostic (3.02e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.48e-1)"	39.9	126.3	18.6	8.3	18.0	1.3	23.3	18.4	19.8	12.0	16.9	12.9	4.9	8.3	8.4	10.7	9.4	8.3	7.5	16.4	18.6	10.1	8.6	7.9	9.7	21.8	20.9	18.9	11.3	29.2	7.2	5.2	20.2	17.3	5.8	24.6	10.8	11.5	2.8	15.6	9.0	7.8	20.5	41.4	11.7	3.3	23.4	6.7	8.5	4.1	7.9	12.8	11.4	26.1	13.4	5.5	3.9	8.9	79.1	21.7	15.1	9.3	14.4	5.7	5.2	8.7	15.0	0.2	5.0	18.0	14.0	1.5	13.9	9.7	7.2	0.9	6.2	2.3	7.1	7.1	10.6	1.0	0.0	14.0	8.9	30.3	11.7	12.5	27.1	0.7	8.4	0.1	15.3	1.2	1.9	2.7	21.4	5.7	18.7	1.4	5.7	8.0	8.5	27.8	6.3	2.8	10.1	44.6	8.1	7.6	11.7	5.9	9.3	13.5	1.9	4.5	7.6	5.0	7.9	1.1	39.2	7.7	2.8	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.1	0.5	0.3	0.1	0.3	0.1	0.0	0.3	0.1	18.6	18.0	18.4	19.8	16.4	18.6	21.8	20.9	20.2	20.5	23.4	26.1	24.8	3.2	15.5	20.5	4.4	4.1	9.1	7.6	15.9	51.6	8.2	7.0	3.1	8.6	8.3	3.7	83.4	12.8	4.4	3.4	0.0	5.6	0.3	6.0	6.7	19.3	4.9	5.9	20.3	8.5	4.8	11.9	17.9	8.3	0.0	100.0	46.1	5.2	3.6	1.7	14.4	6.9	6.1	7.0	10.5	0.2	3.7	5.6	1.8	24.4	2.5	3.6	3.1	11.6	18.8	8.1	5.0	2.2	8.1	15.9	3.0	2.5	7.7	36.9	13.1	7.4	17.9	0.1	3.0	14.3	2.6	9.3	2.8	82.4	6.9	16.6
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011044, HPA075369"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA011044: AB_2668414, HPA075369: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	6.6	8.2	26.9	6.5	27.6	13.6	5.8	15.5	28.9	6.4	15.3	11.1	16.1	6.2	4.8	10.8	8.8	5.3	10.2	26.8	19.6	11.6	13.1	10.3	8.1	18.0	18.4	6.0	11.0	5.7	23.9	3.9	18.4	7.1	7.3	14.1	9.6	5.3	15.3	15.3	17.1	5.1	15.2	14.9	8.1	4.3	21.4	8.5	6.7	7.3	5.7	7.0	6.6	23.7	6.1	4.5	6.0	12.5	7.7	3.2	3.9	9.0	7.8	8.7	7.2	7.3	6.3	9.1	23.1	6.3	9.1	13.4	7.6	3.9	3.4	14.3	6.2	35.7	5.9	5.3	10.2	10.5	50.5	3.7	7.9	16.4	6.1	9.8	5.4	13.5	15.1	16.1	8.3	16.2	11.9	24.9	2.2	15.0	11.8	7.4	5.3	10.5	8.7	3.8	18.7	10.5	3.8	20.1	5.9	2.3	35.3	13.9	6.7	8.1	2.8	9.9	16.1	6.8	4.5	3.5	4.9	17.6	9.1	0.5	1.3	2.7	0.2	1.4	0.4	0.1	0.6	0.6	0.5	0.0	0.6	0.3	0.4	0.8	2.0	0.3	0.6	0.5	26.9	27.6	15.5	28.9	26.8	19.6	18.0	18.4	18.4	15.2	21.4	23.7	5.1	6.4	4.2	9.4	3.7	10.7	1.6	2.3	10.2	15.6	6.8	5.0	2.4	2.8	4.3	1.8	37.5	0.9	7.4	40.6	3.9	3.4	5.4	12.1	2.6	5.7	1.2	7.0	15.1	2.8	1.7	2.5	3.6	4.6	2.5	2.2	11.4	5.4	9.4	21.9	15.0	8.0	0.0	13.9	16.1	1.3	2.1	11.4	7.2	5.6	15.3	5.9	7.2	4.5	8.4	5.1	10.4	1.5	7.2	3.2	33.0	4.0	21.9	29.9	6.6	2.1	3.6	3.7	2.0	10.3	10.9	1.1	8.6	3.6	5.5	1.9
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 domain containing 3 centriole elongation regulator"	Q4AC94	11	74012718-74171210	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 60.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centrosome"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	3.9	4.7	15.4	5.1	14.8	9.9	3.7	21.7	22.9	4.2	16.7	4.0	3.9	4.8	4.5	3.9	7.8	3.7	2.9	18.5	14.4	4.9	5.8	4.2	5.0	16.9	13.8	4.7	2.2	6.2	3.7	5.9	15.3	4.3	5.2	8.2	4.3	3.5	3.5	6.0	4.2	4.2	11.2	5.9	4.3	11.0	15.8	7.7	7.0	3.4	5.4	3.9	2.7	19.4	9.3	14.3	11.7	14.3	5.2	4.8	5.6	13.7	8.8	16.0	13.0	24.4	7.4	9.0	9.2	5.2	15.5	13.9	14.7	3.8	19.3	12.4	7.0	12.4	21.3	10.8	8.8	12.0	16.9	4.8	4.8	13.4	9.7	5.1	9.0	11.1	14.2	15.7	13.3	7.7	14.1	8.3	9.4	17.8	7.7	14.3	60.4	9.0	4.6	13.0	15.6	9.2	22.4	8.4	21.2	11.9	16.5	7.8	12.7	10.3	17.0	10.1	11.0	11.7	8.5	26.1	4.0	6.0	11.1	17.8	2.0	3.0	2.2	2.3	2.0	2.3	1.4	1.8	1.3	4.4	2.1	2.1	12.6	2.9	4.7	2.0	1.0	0.7	15.4	14.8	21.7	22.9	18.5	14.4	16.9	13.8	15.3	11.2	15.8	19.4	6.5	70.5	114.6	28.1	10.5	5.2	3.6	4.8	9.6	8.7	6.2	5.8	5.1	4.3	36.0	9.2	4.2	3.8	5.6	7.6	0.0	4.0	33.0	18.4	9.4	9.8	7.7	12.2	57.4	2.6	2.9	9.6	15.3	8.9	36.6	8.5	5.0	3.0	5.0	11.8	52.1	5.0	4.1	7.6	6.6	24.7	4.4	12.7	7.2	26.2	4.9	4.8	10.3	37.7	38.5	3.8	2.8	6.4	9.5	3.4	3.4	1.8	57.1	14.8	6.6	7.2	5.2	11.1	6.9	6.4	4.5	2.3	14.0	5.4	5.4	4.7
C2CD4B	"FAM148B, NLF2"	ENSG00000205502	"C2 calcium dependent domain containing 4B"	A6NLJ0	15	62163535-62165285	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 99.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 169.8;Endothelial cells: 116.2;Enteroendocrine cells: 214.4;Glandular and luminal cells: 128.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.9"									HPA046880	Uncertain					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA046880: AB_10959458"	"unprognostic (6.60e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (2.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.16e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.48e-1)"	23.1	1.2	1.5	0.6	1.0	3.0	19.6	0.8	1.2	7.2	0.5	2.5	2.2	4.1	0.0	1.6	2.8	1.6	6.3	0.9	0.9	5.5	1.9	13.0	0.4	1.5	1.3	1.0	99.3	0.3	6.5	0.4	1.5	2.3	0.4	0.0	1.6	0.2	2.8	4.7	2.4	0.7	1.7	0.5	24.4	1.0	2.1	2.7	2.7	1.3	0.0	5.0	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.8	1.2	0.9	0.9	1.5	1.3	1.5	1.7	2.1	0.9	169.8	3.2	5.5	0.0	0.1	6.8	3.0	0.1	0.6	0.8	14.5	4.3	1.3	5.7	0.9	1.8	0.0	0.0	0.9	6.1	0.0	2.1	0.0	40.4	15.2	116.2	214.4	0.0	0.0	24.0	0.0	3.2	17.9	128.9	2.5	0.0	11.4	0.4	0.4	0.0	0.1	22.5	6.1	1.0	12.1	0.0	0.0	1.3	3.6	1.9	1.6	0.1	0.0	0.0	0.0	9.8	1.3	0.0	0.1	2.4	1.3	0.0	0.1	0.6	0.0	6.8	4.1	0.1	0.4	0.8	7.0	0.0	1.7	0.5	4.3	3.5
C2CD4C	"FAM148C, KIAA1957, NLF3"	ENSG00000183186	"C2 calcium dependent domain containing 4C"	Q8TF44	19	405445-409147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.2;Excitatory neurons: 3.6;Granulosa cells: 3.7;Hepatic stellate cells: 3.6;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;MCF7: 4.4;NTERA-2: 6.2;SCLC-21H: 11.1;U-2 OS: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055915	Uncertain		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA055915: AB_2682968"	"unprognostic (1.29e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.39e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.74e-1)"	3.8	1.0	9.8	0.3	11.4	0.0	3.0	3.7	17.4	3.0	2.5	1.3	0.4	2.3	0.0	0.7	2.0	2.8	4.8	10.8	17.1	2.5	0.7	1.8	0.1	7.5	7.6	0.3	1.0	0.1	2.6	0.4	8.8	1.0	0.0	0.8	0.3	0.0	0.9	0.8	1.4	0.1	8.7	1.0	0.8	2.0	13.0	0.1	3.9	0.5	0.0	0.6	1.0	7.1	0.0	0.5	1.5	1.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	2.0	0.0	0.5	0.0	0.7	2.4	2.4	0.2	0.1	6.4	1.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	4.4	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.1	3.2	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	6.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.4	3.7	17.4	10.8	17.1	7.5	7.6	8.8	8.7	13.0	7.1	13.2	0.0	0.0	0.3	0.1	0.3	0.3	0.3	0.0	0.5	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	1.9	3.0	0.0	3.6	0.4	0.0	0.1	0.0	0.2	0.0	3.7	3.6	0.1	0.0	0.0	3.1	0.0	2.0	0.0	0.4	0.3	0.0	0.0	0.0	1.9	0.0	2.0	0.0	3.0	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.6	0.0	0.4	0.4	0.7	2.2	0.0	0.3	0.0	0.1	0.0	0.0	0.1
C2CD5	"CDP138, KIAA0528"	ENSG00000111731	"C2 calcium dependent domain containing 5"	Q86YS7	12	22448583-22544546	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 244.6;Inhibitory neurons: 253.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 103.0"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046194	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Centriolar satellite"	"HPA046194: AB_10965327"	"unprognostic (2.59e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-3)"	13.3	15.9	14.4	17.1	17.5	20.2	19.6	32.1	22.6	17.8	3.6	27.3	26.4	22.4	17.2	13.5	22.1	22.5	11.7	16.0	9.2	22.3	12.0	16.7	22.7	10.1	7.4	24.0	16.7	28.0	20.8	14.1	11.7	14.5	28.5	56.2	15.5	13.8	10.1	17.6	22.3	18.3	4.4	19.2	27.8	20.0	7.7	26.9	22.3	16.3	21.8	13.0	13.8	18.8	18.6	18.0	39.2	21.4	25.3	33.4	24.9	20.1	21.4	36.6	43.3	19.9	24.0	20.9	8.7	18.9	20.4	16.2	25.2	16.4	50.7	34.2	26.3	25.9	19.8	17.9	23.3	35.4	29.9	19.3	11.7	23.6	41.1	34.6	26.9	28.5	17.2	13.2	23.9	19.8	33.5	53.9	78.3	36.0	13.5	28.9	43.3	28.5	21.7	14.9	18.1	15.7	18.1	17.5	19.3	57.5	23.2	23.4	23.4	21.9	17.5	19.9	21.5	10.6	8.8	33.4	13.5	26.4	16.4	23.2	6.7	3.3	5.6	14.9	7.6	7.6	8.4	5.6	6.8	5.1	7.3	5.9	6.9	14.2	17.1	3.9	9.1	4.9	14.4	17.5	32.1	22.6	16.0	9.2	10.1	7.4	11.7	4.4	7.7	18.8	12.4	9.6	19.6	41.1	14.8	6.9	4.3	4.1	10.2	30.4	8.0	6.6	16.2	14.3	16.3	5.5	52.1	3.9	13.6	16.9	5.9	3.5	72.2	14.3	13.2	11.2	16.2	17.1	244.6	4.6	2.6	11.5	30.1	11.7	17.7	18.8	16.8	6.7	8.3	18.5	253.4	20.4	6.1	33.8	6.7	17.6	8.7	17.3	7.2	84.3	9.1	6.4	10.3	149.3	103.0	3.4	11.4	7.9	12.0	3.9	13.6	6.4	17.4	42.9	6.6	12.0	11.7	14.1	7.8	13.3	5.5	2.6	11.5	9.4	16.5	4.6
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.2	1.2	0.1	0.1	0.3	0.1	0.5	0.3	0.0	0.5	0.0	0.3	0.2	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.4	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149885-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 262.9;Late spermatids: 98.5;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068"	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favorable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.5	7.3	11.2	5.9	12.7	4.8	6.4	16.3	12.5	7.8	10.6	6.5	4.4	8.5	10.9	6.4	11.2	7.5	5.8	10.4	11.7	8.4	15.4	6.0	12.4	10.8	11.5	10.2	6.7	11.5	7.8	8.0	11.5	6.7	5.2	7.5	6.4	7.2	6.7	6.7	6.3	7.5	10.9	8.8	6.1	59.0	11.9	10.1	8.2	8.4	11.6	8.2	6.2	16.1	5.9	9.6	8.9	8.1	17.9	10.4	10.1	13.9	9.4	11.0	9.4	7.8	5.1	7.5	7.9	8.3	18.0	8.0	9.4	7.9	12.2	13.1	8.3	8.8	6.8	7.7	15.9	7.3	8.6	12.5	14.1	10.5	13.3	12.0	10.8	9.4	7.5	27.6	14.7	4.6	9.4	10.7	6.4	9.9	10.6	8.8	12.1	13.8	9.0	6.8	7.4	7.5	7.5	11.6	14.4	6.2	5.2	8.9	8.5	9.8	6.7	9.1	11.4	15.1	16.2	7.5	7.6	11.8	8.9	2.3	7.7	9.9	12.1	7.2	15.5	14.2	12.2	14.7	7.9	13.0	13.9	14.9	8.3	21.9	7.8	7.0	15.5	10.9	11.2	12.7	16.3	12.5	10.4	11.7	10.8	11.5	11.5	10.9	11.9	16.1	4.0	0.0	2.2	7.8	8.9	2.5	3.4	3.7	5.7	5.8	4.0	5.0	2.8	1.5	2.8	5.5	0.0	8.8	6.1	4.2	7.9	4.5	262.9	3.8	3.3	3.6	1.2	4.0	9.2	2.4	4.0	4.4	3.6	2.8	2.5	5.0	6.4	6.9	4.3	0.0	8.9	2.1	2.0	4.7	3.1	98.5	7.5	3.6	3.6	2.8	3.1	9.0	9.2	8.0	12.3	2.0	3.1	7.9	8.4	2.9	3.3	6.4	6.6	4.1	0.0	4.2	3.8	63.1	12.0	3.5	4.3	9.6	5.3	4.3	2.5	2.0
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337532-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	11.3	9.3	9.6	10.6	11.9	19.3	11.1	12.0	12.9	12.5	6.2	9.1	9.4	14.6	7.8	11.8	12.4	9.5	15.3	8.9	10.7	8.7	10.1	8.6	12.6	11.2	11.5	19.9	11.0	10.5	5.5	12.0	11.3	11.3	9.9	24.9	9.1	11.0	19.9	9.5	10.1	12.2	10.2	11.1	13.8	13.0	10.6	16.0	12.6	21.0	13.3	11.3	10.5	13.8	20.0	13.9	17.2	17.5	19.4	23.6	30.7	19.6	20.6	17.0	23.3	30.7	19.5	23.3	23.9	17.1	45.6	18.7	23.9	16.7	22.2	30.6	18.1	25.3	11.6	23.8	23.6	21.3	20.1	17.1	28.7	24.0	21.6	24.3	15.8	18.1	35.9	18.7	24.3	15.4	25.9	24.5	22.6	13.5	16.8	17.1	25.4	27.1	19.2	18.9	20.3	16.2	17.3	15.5	23.8	19.2	15.2	23.8	25.4	17.9	25.1	13.0	16.1	23.6	20.5	24.6	18.1	21.3	17.6	15.4	13.2	12.0	9.0	8.3	8.9	14.5	10.1	9.0	9.2	17.6	11.0	9.3	17.8	9.2	11.9	19.1	12.7	6.7	9.6	11.9	12.0	12.9	8.9	10.7	11.2	11.5	11.3	10.2	10.6	13.8	27.0	16.0	14.3	7.5	26.3	29.1	13.4	21.8	15.4	37.1	24.8	22.9	30.9	18.6	22.0	25.8	29.2	21.2	31.6	16.5	25.4	22.9	40.6	43.1	34.7	19.3	11.3	21.2	10.8	18.2	26.5	22.8	12.8	33.9	16.5	18.1	19.6	22.4	16.1	23.5	11.2	22.5	12.2	18.5	13.5	35.8	27.7	15.5	7.2	10.3	21.1	39.6	28.8	7.1	15.8	21.0	17.5	29.0	19.0	16.2	21.8	22.3	36.1	44.3	19.7	17.3	19.8	45.8	28.1	13.7	24.7	36.8	22.4	16.6	14.8	15.8
C2orf50	FLJ25143	ENSG00000150873	"Chromosome 2 open reading frame 50"	Q96LR7	2	11133128-11151317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.7;fallopian tube: 7.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"									"HPA062894, HPA067681"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	Cytosol	"HPA062894: AB_2684897, HPA067681: "	"unprognostic (6.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.92e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.97e-4)"	"unprognostic (7.03e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.25e-3)"	"unprognostic (7.36e-2)"	0.1	0.2	1.5	0.2	1.8	0.5	0.2	0.4	1.6	0.4	5.7	0.1	0.3	0.3	0.2	0.1	7.4	0.1	0.0	1.3	1.4	0.2	0.1	0.6	0.3	1.8	1.9	0.3	0.2	0.1	0.7	0.1	0.5	0.2	0.2	1.5	0.3	0.1	0.2	0.4	0.1	0.1	1.0	0.3	0.2	0.3	1.0	0.2	0.2	0.0	0.1	0.1	0.0	1.0	0.1	0.5	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.0	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.7	0.1	0.3	0.2	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.6	0.2	0.2	0.2	0.1	0.1	1.5	1.8	0.4	1.6	1.3	1.4	1.8	1.9	0.5	1.0	1.0	1.0	0.0	0.0	1.8	0.7	0.5	0.0	0.5	0.5	0.0	0.4	0.4	0.5	0.4	0.0	3.5	0.0	8.4	0.0	0.1	0.0	0.0	0.3	0.2	21.5	0.4	0.0	0.0	0.0	9.7	0.2	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	2.5	0.4	0.2	0.0	1.5	0.0	0.1	0.0	0.2	27.1	3.0	0.0	1.0	0.5	0.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"		2	196804417-196809355	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.9;brain: 5.1;pituitary gland: 3.7"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 36.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.0;RT4: 2.2;TIME: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	2.8	3.9	2.1	0.2	1.8	0.1	0.4	1.4	2.2	0.0	1.7	0.3	0.0	0.1	0.4	0.2	0.6	0.3	0.5	2.0	4.2	0.2	0.1	0.3	0.0	2.3	5.1	0.3	0.4	0.1	3.7	0.0	2.9	0.3	0.1	1.8	0.1	0.1	0.0	1.2	0.3	0.0	1.5	0.1	0.2	1.5	2.8	0.1	0.1	0.0	0.1	0.3	0.2	1.6	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.4	9.0	0.3	0.1	0.0	0.1	0.8	0.2	1.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.4	2.2	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.1	2.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	1.4	2.2	2.0	4.2	2.3	5.1	2.9	1.5	2.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85605254-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	11.0	9.4	8.8	10.0	11.6	10.5	12.6	15.4	9.9	18.7	10.7	13.6	11.0	15.7	12.2	12.1	15.2	6.6	12.3	8.6	9.4	12.8	11.7	14.0	14.2	11.7	10.8	20.4	17.2	8.5	14.0	12.5	11.0	16.4	10.9	20.0	16.4	10.7	21.8	16.3	16.6	9.9	9.8	16.9	14.3	9.5	10.2	13.7	16.3	9.8	13.9	13.6	15.4	15.2	8.8	7.9	15.7	11.5	14.2	7.6	10.2	4.3	5.6	6.7	8.7	7.1	10.6	12.4	6.0	7.3	6.0	10.4	7.9	7.5	7.2	6.8	19.1	21.1	13.8	8.5	11.2	12.3	11.4	11.3	9.7	4.4	12.7	10.6	10.1	14.7	10.7	12.4	6.3	9.3	13.3	13.4	6.9	10.2	7.3	14.8	27.8	11.5	8.5	10.1	19.8	14.2	6.5	8.5	9.0	8.7	9.1	6.5	7.0	4.8	12.8	5.9	4.2	17.9	11.8	10.8	7.2	12.9	6.0	32.7	30.5	59.0	22.4	21.8	21.3	14.6	21.1	21.0	22.4	20.7	30.5	28.2	49.2	31.2	27.0	15.2	17.7	16.7	8.8	11.6	15.4	9.9	8.6	9.4	11.7	10.8	11.0	9.8	10.2	15.2	8.2	64.1	63.1	15.0	18.6	5.9	18.2	10.0	9.6	17.4	16.0	12.3	10.7	37.1	24.3	35.0	35.5	47.2	24.4	24.6	17.6	17.9	4.8	9.4	8.7	13.9	19.2	19.5	2.7	19.8	17.7	12.9	17.9	9.6	34.7	15.6	17.9	25.3	23.3	25.2	6.8	16.9	12.2	34.9	14.3	12.8	24.2	26.0	14.2	15.0	31.4	12.3	38.1	10.1	16.9	19.4	14.0	13.5	13.6	14.4	32.7	26.6	21.0	27.0	19.7	13.7	8.5	37.2	20.1	27.4	9.8	24.9	18.1	10.0	15.8	19.2
C2orf69	FLJ38973	ENSG00000178074	"Chromosome 2 open reading frame 69"	Q8N8R5	2	199911293-199955935	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 132.1;Spermatocytes: 124.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045225	Approved				"Secreted to blood"	NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045225: AB_10960841"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-2)"	9.7	14.1	8.5	6.8	8.7	22.1	7.4	7.7	12.4	5.7	6.3	8.0	8.4	6.4	6.5	6.8	3.8	6.2	6.7	9.6	9.2	8.9	10.0	6.0	7.3	7.7	8.3	4.8	8.2	9.2	4.1	5.3	7.8	6.5	8.0	10.4	6.2	4.7	9.1	6.4	7.4	7.6	8.4	7.0	7.1	14.7	9.3	5.2	6.7	9.8	7.4	6.8	4.0	10.0	16.1	7.2	13.2	18.0	18.2	22.8	22.3	22.6	13.5	15.0	17.7	16.3	11.4	13.2	12.9	16.0	15.9	12.8	14.1	12.0	25.1	19.8	12.8	20.4	12.4	20.8	10.6	20.7	24.2	11.8	10.5	17.2	14.9	8.1	17.0	8.8	14.9	25.5	25.6	13.9	11.6	18.1	19.4	7.1	19.1	11.0	17.2	11.9	14.8	16.4	21.5	9.4	10.9	8.1	17.4	16.9	12.0	17.7	14.9	23.3	19.0	26.2	18.2	16.7	29.0	13.0	18.6	13.1	12.0	5.4	2.7	7.2	3.6	3.5	5.2	3.1	4.0	3.4	2.4	3.0	4.2	4.5	2.3	2.0	2.7	1.3	4.1	2.8	8.5	8.7	7.7	12.4	9.6	9.2	7.7	8.3	7.8	8.4	9.3	10.0	13.5	3.2	5.1	12.4	22.9	38.0	29.8	8.8	9.1	21.8	10.1	3.7	11.4	12.8	7.6	16.5	29.2	13.3	11.0	16.4	27.4	12.8	132.1	7.9	10.2	16.1	18.6	27.8	19.4	18.3	18.0	17.0	13.7	7.1	8.2	14.8	23.6	19.7	11.8	13.5	13.9	16.9	10.2	18.0	32.1	78.1	13.4	13.4	16.0	12.2	14.0	56.5	12.3	12.5	27.0	14.6	9.3	21.8	8.6	24.6	18.1	20.4	11.8	26.5	19.7	14.0	14.9	124.3	44.1	15.7	44.9	9.9	18.1	11.1	17.5	19.5
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037523-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;liver: 18.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	6.7	0.0	8.2	0.0	0.3	4.3	8.8	0.0	0.0	3.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	8.7	6.2	0.2	18.7	0.1	0.0	8.4	12.1	0.0	1.4	0.2	1.1	0.9	6.0	0.5	0.7	0.0	0.1	0.0	0.0	0.1	1.1	0.0	5.8	0.0	1.5	0.1	14.6	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.5	0.4	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	1.0	0.5	0.5	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.2	4.3	8.8	8.7	6.2	8.4	12.1	6.0	5.8	14.6	6.1	0.0	0.0	0.0	163.2	0.5	0.1	0.1	0.0	0.0	1.9	5.9	6.0	0.5	47.1	0.0	0.0	0.0	1.8	0.2	32.8	1.9	3.9	13.6	0.1	0.2	0.2	4.9	10.7	33.4	2.0	11.9	0.2	4.6	0.1	0.0	0.1	3.6	129.1	0.6	0.0	15.0	14.8	0.0	2.9	0.0	30.8	0.3	0.2	1.8	6.5	0.0	15.7	0.0	45.8	20.1	0.8	51.3	4.1	0.2	0.7	10.7	1.8	0.0	0.3	0.0	0.0	0.1	0.5	0.9	0.0	0.0	5.2	0.3	0.0	28.8	0.3
C2orf73	FLJ40298	ENSG00000177994	"Chromosome 2 open reading frame 73"	Q8N5S3	2	54330034-54383742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 50.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1101.7;Late spermatids: 600.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055221, HPA059596"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"			"HPA055221: AB_2682744, HPA059596: AB_2684077"	"unprognostic (1.56e-2)"	"unprognostic (7.00e-3)"		"unprognostic (1.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.46e-2)"		"unprognostic (2.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.80e-2)"	0.1	0.6	1.9	0.0	2.1	0.0	0.1	1.6	2.0	0.5	6.4	0.1	0.0	0.3	1.3	0.0	7.6	0.0	0.1	1.9	2.1	0.6	0.0	1.1	0.0	3.8	3.4	0.3	0.6	0.9	1.4	0.0	2.5	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	50.6	2.0	0.0	1.1	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	1.6	2.0	1.9	2.1	3.8	3.4	2.5	3.2	2.0	2.3	0.7	0.0	0.0	13.7	0.0	0.3	0.4	1.8	0.0	0.3	0.5	0.9	0.1	0.0	9.7	3.7	0.0	0.0	0.0	0.0	5.9	0.2	1101.7	36.0	0.6	0.8	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	2.1	0.0	2.0	0.0	0.4	600.3	7.8	0.3	0.0	1.0	0.0	2.4	0.0	1.5	2.1	0.0	0.0	4.1	0.0	0.2	0.0	3.7	56.4	1.7	0.0	0.2	0.8	97.8	7.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2
C2orf74	LOC339804	ENSG00000237651	"Chromosome 2 open reading frame 74"	A8MZ97	2	61145068-61164828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 191.7;Early spermatids: 573.5;Proximal tubular cells: 142.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026826	Approved		Approved	Centrosome		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome		"HPA026826: AB_10671091"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.54e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.22e-2)"	25.7	28.1	65.3	12.8	66.1	4.2	27.5	63.6	92.1	22.7	58.2	29.8	5.4	18.6	42.8	13.4	19.9	13.1	43.3	64.9	68.4	38.8	35.8	17.4	20.7	65.4	67.1	26.7	19.7	23.8	38.4	16.9	65.7	20.7	8.7	32.7	16.0	17.2	25.0	8.2	13.7	15.0	63.7	22.3	20.0	56.0	66.6	16.3	24.0	17.9	15.8	23.3	13.0	65.9	15.1	25.7	26.2	0.0	55.0	55.6	23.6	38.7	44.4	36.4	30.0	0.2	25.1	18.8	52.7	31.8	24.0	19.9	0.0	31.6	62.0	24.1	16.0	0.0	26.1	30.2	22.0	23.5	20.4	57.5	51.1	27.2	55.1	26.0	20.5	0.4	0.0	13.9	56.1	27.6	0.1	43.4	25.1	11.4	16.2	34.1	32.5	31.9	50.2	11.8	54.0	20.7	4.9	5.0	34.2	23.0	20.0	22.0	10.8	30.4	13.3	18.4	48.0	58.0	28.6	71.4	40.3	16.5	27.5	16.2	7.7	27.6	16.8	16.5	20.9	31.5	18.1	17.2	16.8	20.9	29.6	23.8	1.8	30.1	16.1	14.0	26.3	10.7	65.3	66.1	63.6	92.1	64.9	68.4	65.4	67.1	65.7	63.7	66.6	65.9	16.5	12.8	14.5	4.9	14.0	0.0	16.5	1.0	8.6	9.6	15.5	28.6	3.8	21.5	2.8	22.0	8.4	25.7	11.2	0.0	191.7	23.8	573.5	15.8	10.5	16.4	0.0	7.4	5.1	31.0	24.2	11.3	4.6	6.0	14.5	23.1	34.6	24.3	21.8	11.8	4.7	0.2	0.0	28.9	0.2	103.0	37.0	15.2	1.8	2.8	23.9	33.0	29.9	1.5	7.1	24.3	0.0	45.1	11.7	8.7	0.2	142.3	11.8	20.1	19.7	13.1	11.0	21.1	27.7	2.2	0.0	6.4	11.6	40.8	0.2	8.8
C2orf76	"AIM29, LOC130355, MGC104437"	ENSG00000186132	"Chromosome 2 open reading frame 76"	Q3KRA6	2	119302225-119366834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044977, HPA055362"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA044977: AB_10961918, HPA055362: AB_2682794"	"unprognostic (4.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (3.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.19e-2)"	20.2	19.7	23.2	10.2	23.3	10.0	22.4	23.8	29.5	13.0	21.3	12.3	6.9	17.1	43.4	16.2	20.5	12.6	16.1	22.2	23.5	19.9	14.1	9.9	15.2	24.3	23.2	17.8	15.7	20.6	10.7	11.3	24.4	16.0	11.7	9.4	16.0	15.4	10.3	20.6	7.6	16.7	24.2	10.9	11.3	19.3	23.0	13.5	20.5	14.5	14.0	13.9	10.9	26.6	17.0	15.7	22.4	14.3	31.7	38.3	12.8	23.4	16.7	15.0	16.3	10.1	11.3	20.7	40.6	24.7	17.4	7.8	10.1	14.9	15.0	17.7	33.5	39.1	11.7	13.5	21.8	15.0	24.6	20.4	25.3	21.3	13.8	19.3	21.7	15.7	12.6	19.6	22.5	25.7	15.7	28.5	12.4	13.3	12.4	9.6	4.7	29.1	33.9	18.0	14.8	16.7	17.0	24.1	33.7	21.0	13.2	52.5	20.3	17.4	13.5	14.6	12.7	12.8	22.5	22.1	17.5	11.1	20.0	29.1	20.9	21.9	19.9	20.2	18.0	20.0	15.2	18.3	21.3	14.7	13.8	19.3	37.2	32.5	12.7	20.1	16.8	11.9	23.2	23.3	23.8	29.5	22.2	23.5	24.3	23.2	24.4	24.2	23.0	26.6	30.3	6.4	11.4	22.5	11.1	25.0	17.2	47.7	17.1	3.3	18.5	19.7	18.5	12.8	24.4	14.7	0.0	26.4	15.2	7.1	78.2	14.7	11.7	27.6	15.4	20.4	10.9	16.4	12.4	17.8	32.4	20.7	9.7	19.7	22.2	8.4	15.0	11.6	26.7	1.7	8.6	11.2	22.4	15.0	23.4	7.7	19.3	13.8	44.4	12.2	20.6	19.8	26.8	14.6	25.2	14.0	9.2	17.0	8.9	11.8	12.2	47.0	42.8	4.6	6.6	13.8	18.8	38.8	22.4	18.8	35.7	20.7	15.3	11.4	10.0	13.0
C2orf81	"hCG40743, LOC388963"	ENSG00000284308	"Chromosome 2 open reading frame 81"	A6NN90	2	74414176-74421591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.6;Late spermatids: 31.4;Respiratory ciliated cells: 25.7;Spermatocytes: 20.1"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.1;RPMI-8226: 14.5;SCLC-21H: 17.8;SH-SY5Y: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049564, HPA054835"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA049564: , HPA054835: AB_2682620"																		2.1	1.5	3.4	1.7	3.9	0.5	2.6	3.7	4.7	5.7	10.0	3.1	1.1	4.9	0.8	1.1	17.7	2.4	2.0	4.4	4.2	5.1	0.7	3.8	2.6	6.1	6.3	4.0	2.2	5.5	17.6	0.6	3.7	5.0	0.4	3.0	2.1	2.5	0.7	1.6	2.5	0.9	4.6	3.7	2.1	27.3	3.6	2.2	3.7	0.5	0.8	3.1	2.5	3.5	4.4	8.0	2.4	8.6	2.6	2.2	0.8	0.6	2.6	0.7	0.8	0.2	4.9	10.5	1.8	1.3	2.1	1.6	0.2	2.1	0.8	5.9	0.4	1.1	0.5	0.0	1.3	2.1	2.1	1.3	5.2	1.0	1.0	3.0	0.1	5.6	0.2	1.6	1.3	15.1	2.7	5.5	4.6	2.4	1.7	1.4	0.8	14.5	3.2	1.9	17.8	19.3	2.4	3.9	1.3	0.3	3.7	1.9	0.0	0.9	3.8	2.7	2.2	3.7	7.4	3.4	5.2	2.0	1.8	0.1	1.9	0.0	0.6	2.0	0.3	6.6	0.7	0.8	6.3	5.8	3.3	1.6	0.1	3.0	1.5	13.3	0.7	1.3	3.4	3.9	3.7	4.7	4.4	4.2	6.1	6.3	3.7	4.6	3.6	3.5	1.7	0.0	2.4	0.0	0.8	0.6	1.0	2.9	1.8	0.9	1.9	4.7	1.4	4.3	3.6	3.7	0.0	0.0	2.9	0.7	5.9	3.2	45.6	11.7	1.9	2.1	7.2	0.0	1.1	2.2	0.0	4.1	0.5	3.1	0.0	1.1	4.2	0.0	0.0	3.3	0.9	1.7	4.1	1.9	3.4	31.4	3.4	1.1	3.6	1.0	6.1	6.1	1.0	1.0	0.2	2.6	0.3	7.5	0.2	0.7	0.4	5.9	25.7	3.9	6.6	2.4	3.9	20.1	1.5	0.1	0.9	0.0	0.6	1.2	1.2	0.3
C2orf88	"MGC13057, smAKAP"	ENSG00000187699	"Chromosome 2 open reading frame 88"	Q9BSF0	2	189879609-190203484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 496.6;Early spermatids: 1138.7;Late spermatids: 1344.3;Proximal enterocytes: 462.3"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 16.2;glioma: 4.8;ovarian cancer: 14.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.7;naive B-cell: 2.8;neutrophil: 7.1;plasmacytoid DC: 3.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.8;dendritic cells: 3.0;granulocytes: 7.1"	"Group enriched"	"Detected in many"	6	"HEL: 108.4;K-562: 92.2;RT4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049549	Approved					NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"			"HPA049549: AB_2680812"	"unprognostic (1.20e-4)"	"unprognostic (9.17e-2)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (6.09e-3)"	"unprognostic (4.55e-2)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (5.29e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-3)"	4.2	6.6	7.6	4.4	10.9	9.8	9.2	9.5	10.0	48.3	1.9	36.0	34.7	15.8	2.2	2.6	21.0	2.7	11.8	7.7	10.7	6.4	4.7	3.5	3.3	9.3	10.7	1.9	12.7	35.1	2.7	1.7	10.3	7.2	38.6	4.5	14.1	9.4	13.4	5.6	44.5	3.9	11.0	4.8	5.1	73.2	9.1	0.5	3.6	28.8	5.3	4.8	11.8	18.6	0.1	0.3	0.9	0.3	3.6	11.7	0.8	0.4	0.5	0.2	1.1	3.5	0.2	0.7	14.2	1.1	5.9	0.3	3.0	0.0	1.4	0.6	1.9	108.4	0.4	6.9	0.3	0.7	0.0	5.4	0.3	5.8	0.3	0.2	0.3	0.4	92.2	7.1	1.6	0.4	0.3	0.8	0.4	0.3	0.1	0.4	4.2	0.5	2.2	58.8	0.9	2.2	0.2	0.2	11.6	2.0	0.0	1.1	0.8	0.7	0.7	0.3	0.3	0.5	2.0	2.1	1.0	0.5	0.1	0.0	0.5	0.9	0.0	0.0	0.0	2.7	0.0	0.1	0.1	2.8	0.0	0.0	7.1	0.1	0.0	3.0	0.0	16.5	7.6	10.9	9.5	10.0	7.7	10.7	9.3	10.7	10.3	11.0	9.1	18.6	4.1	3.2	0.5	15.3	6.4	1.5	12.9	0.6	2.2	9.1	25.0	36.4	41.5	1.5	0.0	3.7	25.0	0.1	1.1	496.6	19.6	0.5	1138.7	164.4	23.8	21.0	4.2	51.8	28.1	15.3	0.5	7.8	2.6	228.4	0.0	21.7	83.9	3.8	0.2	8.4	26.9	67.9	0.0	5.9	1.8	1344.3	9.9	57.9	26.6	12.2	4.2	2.7	7.2	22.1	44.9	3.9	227.4	6.0	27.8	3.2	462.3	33.2	0.0	12.4	0.0	9.2	3.9	37.9	6.0	2.5	2.3	0.4	3.8	6.1	35.0	3.3
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 4761.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	585.2	286.5	46.0	194.3	53.7	1.5	213.9	47.8	46.0	237.5	31.5	128.9	22.9	82.9	41.1	76.4	350.3	354.9	221.6	36.5	81.8	51.4	4761.3	176.0	68.2	143.3	99.2	228.1	182.7	17.9	21.8	17.7	116.4	35.4	76.5	11.7	155.6	57.4	36.6	51.4	156.4	123.0	89.9	7.1	107.9	41.1	103.4	34.1	92.4	52.0	126.4	363.3	101.3	121.9	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	46.0	53.7	47.8	46.0	36.5	81.8	143.3	99.2	116.4	89.9	103.4	121.9	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3"	"Group enriched"	"Detected in many"	20	"granulocytes: 898.6;monocytes: 371.3"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 148.0"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	18.0	10.6	3.8	40.1	4.0	22.9	6.7	4.7	5.7	6.8	4.4	7.4	6.6	3.8	1.5	3.9	5.9	16.2	4.4	3.9	6.9	3.1	10.8	18.6	12.4	10.1	6.3	3.7	6.0	3.3	2.5	22.0	9.0	3.3	6.8	0.8	5.6	4.3	1.4	2.0	9.7	15.6	8.3	21.4	5.3	2.1	7.8	4.9	2.4	2.6	5.1	15.2	2.7	15.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.9	0.5	3.8	0.0	0.0	1.6	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	1.4	15.6	148.0	0.7	0.0	0.2	0.4	0.3	0.7	1.2	4.0	8.2	0.7	0.0	0.7	5.2	0.1	0.0	0.0	0.1	3.1	15.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.6	0.5	0.4	0.1	0.3	0.3	0.0	0.4	8.5	6.4	0.4	898.6	105.0	450.8	21.8	273.6	26.9	0.2	10.6	14.5	31.1	0.3	2.0	7.8	14.0	4.1	371.3	2.8	11.0	76.0	3.8	4.0	4.7	5.7	3.9	6.9	10.1	6.3	9.0	8.3	7.8	15.6	0.7	0.0	3.0	0.3	1.1	0.5	0.1	0.1	0.0	0.1	0.3	0.9	0.6	1.5	2.5	0.0	2.1	0.7	5.9	0.0	0.0	0.0	3.0	0.0	0.1	6.6	0.0	0.8	0.4	0.2	1.0	0.6	0.0	0.0	36.8	0.0	1.8	0.8	161.5	0.0	0.3	0.0	0.0	139.7	19.8	4.2	1.2	105.7	0.0	8.4	16.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.7	0.4	19.7	0.7	1.0	0.0	0.2	0.0	0.6	1.5	8.6	0.1	0.0	0.0
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62319015-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.7;Spermatocytes: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 28.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 408.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA048286: AB_2680340"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	7.6	15.9	35.4	5.9	37.3	1.3	35.6	32.3	44.5	6.7	23.0	8.3	3.5	7.8	8.1	18.8	4.2	6.5	10.2	37.6	36.7	15.0	3.4	6.9	5.8	32.2	31.4	9.1	12.6	3.8	31.0	5.0	33.0	17.9	4.3	27.2	12.4	5.5	1.3	17.3	4.8	7.1	33.5	4.3	6.2	32.8	33.8	3.7	9.1	1.3	9.2	12.7	9.3	33.0	0.1	22.1	27.2	0.0	18.9	24.8	19.3	33.6	21.2	41.7	41.0	0.3	36.8	0.0	0.1	20.4	84.6	6.7	0.0	21.4	32.1	0.0	14.5	20.5	0.0	0.0	12.0	0.3	45.2	11.3	28.9	47.8	39.6	0.9	21.0	0.0	2.4	0.3	43.0	408.7	0.0	0.0	33.4	31.9	41.9	0.1	0.0	11.8	37.0	64.3	45.9	40.8	21.3	90.0	38.7	20.5	34.0	25.1	0.5	22.2	0.2	105.1	34.8	24.1	0.0	0.0	22.1	0.0	78.4	9.2	4.7	0.7	0.2	17.9	0.0	4.1	3.9	3.3	5.4	1.4	1.1	0.8	0.5	0.9	28.1	7.6	7.9	2.4	35.4	37.3	32.3	44.5	37.6	36.7	32.2	31.4	33.0	33.5	33.8	33.0	8.7	22.4	11.8	11.8	3.3	36.8	23.6	41.5	31.3	34.7	90.2	77.0	7.7	11.5	38.1	22.0	4.2	21.4	8.0	2.6	60.7	35.7	159.7	11.3	14.8	12.1	87.4	2.1	34.8	55.1	19.6	20.9	4.1	12.6	1.3	7.9	5.7	3.1	32.0	37.0	33.4	3.8	44.7	10.0	27.2	62.9	14.0	13.4	46.2	3.7	56.6	35.4	0.0	13.0	15.8	35.8	0.8	10.5	0.5	21.8	2.7	41.5	12.3	28.0	0.0	15.8	21.6	173.2	53.5	30.8	28.7	9.9	5.0	20.6	3.9	23.3
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.3;Early spermatids: 54.2;Late spermatids: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;NK-cells: 2.0;T-cells: 6.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.8"	"Group enriched"	"Detected in all"	4	"cerebellum: 28.2;olfactory bulb: 27.5"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	6.1	8.7	23.0	2.9	23.6	0.9	5.6	30.0	24.0	10.8	25.8	11.9	1.8	10.6	4.4	3.5	9.3	3.6	33.3	22.2	25.6	9.4	4.9	3.7	3.8	23.6	24.9	12.6	6.6	27.3	12.5	2.1	23.2	9.2	2.6	28.4	7.1	9.8	36.2	3.1	5.3	9.5	22.8	5.2	10.1	19.7	25.1	3.1	9.0	26.8	3.6	9.5	6.4	22.1	1.8	2.7	3.1	0.6	10.1	9.0	1.0	11.1	17.2	9.9	7.2	0.2	2.8	2.3	2.6	15.2	9.3	0.2	0.0	4.3	5.2	48.8	0.3	5.0	6.9	0.8	5.0	0.0	6.0	8.9	0.6	9.6	0.5	7.9	1.9	7.2	1.1	2.2	5.9	0.4	0.4	1.5	3.8	1.9	12.3	1.0	0.3	2.7	0.6	0.4	3.4	16.1	2.9	0.6	0.3	3.5	3.4	1.3	0.6	9.9	7.7	18.1	1.4	2.8	2.5	0.3	14.0	5.1	0.2	0.0	0.4	0.7	5.1	0.1	6.3	2.2	4.3	4.8	0.4	1.4	5.0	6.1	0.0	2.0	0.1	0.8	2.2	2.5	23.0	23.6	30.0	24.0	22.2	25.6	23.6	24.9	23.2	22.8	25.1	22.1	1.8	0.0	1.1	8.1	2.2	1.1	1.1	0.9	1.2	10.2	1.8	2.0	29.3	0.0	1.4	1.8	8.4	0.4	1.3	0.3	3.9	2.1	54.2	1.1	2.3	2.6	1.8	0.0	5.6	1.8	0.8	4.9	1.5	0.5	0.0	3.1	2.5	2.2	1.6	1.7	8.3	0.7	0.0	1.3	0.3	62.6	4.7	1.1	0.0	3.7	8.9	12.4	3.1	3.0	3.3	0.7	0.1	4.1	1.6	0.5	0.1	3.5	1.2	17.3	13.1	5.6	5.3	2.7	2.5	0.1	0.4	0.1	3.0	2.7	0.3	0.2
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675141-14773036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 6.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.9;Early spermatids: 19.3;Excitatory neurons: 8.4;Inhibitory neurons: 6.9;Late spermatids: 34.6;Oligodendrocytes: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 4.0;HEL: 8.2;U-698: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.2	0.1	0.1	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	34.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.5	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C3orf22	MGC34728	ENSG00000180697	"Chromosome 3 open reading frame 22"	Q8N5N4	3	126526999-126558965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	485	"testis: 48.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1630.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059199	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA059199: AB_2683946"	"unprognostic (2.10e-1)"			"unprognostic (5.14e-5)"	"unprognostic (2.55e-1)"		"unprognostic (9.21e-2)"			"unprognostic (2.01e-1)"		"unprognostic (2.75e-1)"	"unprognostic (1.08e-3)"		"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	283.2	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1630.9	10.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806278	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA037663	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	2.7	10.7	5.2	1.3	5.6	2.0	4.2	5.3	7.8	4.0	6.2	3.1	2.6	3.7	5.8	1.7	3.9	2.3	6.1	5.5	5.5	6.2	3.1	3.3	1.6	5.4	5.5	4.5	6.7	7.5	4.9	1.3	5.4	4.4	2.3	2.7	3.2	3.9	4.9	1.3	2.2	3.3	5.4	2.3	3.1	4.1	5.8	1.5	8.7	4.4	1.0	2.7	2.5	5.4	5.5	7.5	3.6	4.9	0.3	4.4	1.5	2.4	3.5	2.2	5.2	2.6	6.9	0.9	5.3	2.3	3.3	0.8	3.7	0.0	3.9	2.7	5.4	3.3	1.0	7.0	6.0	4.8	1.1	3.4	4.0	2.4	4.6	2.8	3.8	5.5	5.4	2.4	3.8	4.1	4.9	4.0	4.6	5.2	1.8	4.8	1.8	5.2	12.2	2.7	2.6	3.6	5.3	6.7	4.6	1.8	9.8	5.7	2.3	2.5	1.8	5.5	5.9	4.1	4.3	0.0	1.8	4.4	2.6	2.1	1.2	0.2	4.0	1.1	5.1	1.8	3.1	3.6	2.1	1.4	3.9	4.1	0.1	4.0	0.8	1.7	2.2	2.1	5.2	5.6	5.3	7.8	5.5	5.5	5.4	5.5	5.4	5.4	5.8	5.4	1.6	3.2	6.7	13.7	1.5	1.3	5.2	4.7	5.2	8.5	3.1	2.7	11.9	5.7	6.7	0.0	6.2	4.2	0.9	1.8	5.9	3.7	6.6	1.5	2.7	2.3	3.6	3.8	14.9	3.3	3.1	4.8	1.1	1.4	7.0	2.8	2.5	3.3	2.4	6.7	14.9	3.8	4.1	0.3	2.0	5.4	6.2	1.4	1.8	3.7	0.6	15.6	6.2	11.6	10.7	1.4	2.5	7.9	2.2	5.1	1.0	7.0	3.5	7.6	0.0	8.4	4.1	14.5	14.8	2.7	1.4	3.7	2.8	3.8	3.7	2.5
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149959-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 341.2;Late spermatids: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	10.2	8.8	7.1	11.1	9.2	42.1	12.4	11.2	11.5	10.7	6.8	11.1	9.7	9.1	10.9	12.1	10.6	9.7	9.9	7.8	8.6	10.4	14.1	10.1	17.7	8.0	7.5	11.6	7.8	10.7	4.8	12.4	8.6	10.1	11.0	7.7	8.8	9.5	8.0	8.2	10.0	10.9	8.7	13.2	10.4	32.8	7.8	20.9	12.0	10.8	18.4	12.5	5.2	12.8	16.6	17.4	32.5	17.7	22.5	19.8	15.0	26.3	31.5	38.6	51.9	19.5	22.5	22.8	23.1	24.5	18.4	11.8	23.7	19.2	33.1	40.1	11.7	27.1	12.3	16.9	30.8	37.9	22.5	27.7	20.1	26.1	21.8	25.2	23.1	23.7	18.0	25.1	43.4	19.4	38.3	16.9	40.0	31.0	18.8	23.9	11.4	21.5	25.7	22.6	10.1	14.6	24.1	14.2	42.2	26.2	25.5	30.0	20.6	24.2	25.7	147.7	29.8	22.6	36.2	33.0	18.8	29.8	23.0	47.8	22.3	24.1	16.8	32.4	21.4	26.0	15.3	17.2	23.5	22.3	15.1	15.6	9.7	23.4	27.4	16.2	20.5	21.6	7.1	9.2	11.2	11.5	7.8	8.6	8.0	7.5	8.6	8.7	7.8	12.8	13.3	19.2	7.5	5.9	30.9	11.7	18.8	19.9	14.2	21.6	11.0	9.5	6.9	8.6	16.7	5.5	22.9	21.6	24.4	13.9	19.6	16.7	341.2	14.4	13.3	10.8	16.2	23.5	9.7	13.7	22.7	17.3	11.7	10.2	14.0	14.2	11.4	7.5	26.7	6.7	9.1	13.3	14.2	23.9	25.1	312.0	16.4	24.0	16.0	6.5	28.0	23.2	23.7	10.1	15.0	15.3	19.3	15.1	17.5	18.6	16.1	14.5	21.2	24.8	13.1	14.9	16.6	75.7	12.2	14.9	14.1	25.6	24.6	18.1	11.1	22.5
C3orf49		ENSG00000163632	"Chromosome 3 open reading frame 49"	Q96BT1	3	63819299-63848636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 19.5;Late spermatids: 34.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;MCF7: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053582	Uncertain		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Vesicles, Centrosome"	"HPA053582: AB_2682199"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.07e-1)"	0.0	0.2	0.1	0.2	0.4	0.6	0.0	1.2	1.7	0.1	0.0	0.1	0.6	0.3	0.0	0.7	0.1	0.2	0.3	0.2	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.3	0.0	1.1	0.9	0.3	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.2	0.7	0.4	0.4	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.7	0.3	1.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.6	0.8	2.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.4	0.0	1.8	0.4	0.4	0.5	0.4	0.1	0.6	0.4	0.9	0.0	0.4	0.4	0.3	0.1	0.9	0.1	0.1	0.2	0.3	0.5	0.3	0.4	0.6	0.7	0.2	0.9	0.1	0.9	1.4	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	1.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.2	0.1	0.5	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.5	0.2	0.2	0.1	0.0	0.0	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	34.4	0.3	0.0	0.0	1.0	0.1	0.2	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.3	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.3
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 17.4;skin 1: 26.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4;U-698: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.2	1.0	0.1	1.2	0.2	0.6	2.7	0.2	0.3	0.7	0.2	7.5	3.3	0.9	0.0	2.6	0.7	5.0	4.0	0.2	0.1	4.8	0.3	3.8	1.2	0.0	0.1	0.2	17.4	0.0	2.0	3.3	0.1	1.7	13.7	0.1	3.8	3.4	0.5	26.3	5.2	0.9	0.1	0.7	13.7	0.9	0.3	6.6	7.6	0.1	2.0	5.8	1.6	0.1	11.0	2.0	4.2	0.0	0.6	0.0	1.8	15.5	6.7	10.1	11.3	26.4	10.1	0.4	1.9	3.1	4.4	8.7	6.1	0.3	19.4	0.0	2.8	7.9	1.8	1.9	4.6	0.0	0.1	0.6	8.7	5.2	15.0	5.4	2.2	0.0	2.8	2.8	7.5	1.7	0.3	0.0	12.3	7.9	0.6	0.3	13.2	0.0	18.1	16.5	0.5	0.9	2.4	5.2	6.3	6.8	9.5	0.0	5.8	3.6	5.5	0.0	0.0	3.9	0.0	30.1	2.7	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.8	16.0	10.0	0.3	1.6	32.5	129.6	10.0	45.5	0.0	14.8	3.3	2.1	4.3	19.3	18.4	0.0	18.1	0.7	30.4	0.0	26.3	24.2	24.8	3.1	3.5	11.9	0.0	3.2	35.9	25.6	4.7	64.2	44.1	0.0	0.4	0.4	0.0	1.9	0.0	0.6	56.6	8.2	0.3	2.7	23.3	0.3	1.0	1.8	1.0	2.6	0.0	0.0	0.5	0.3	82.8	30.7	0.4	4.6	75.6	7.8	2.1	14.8	0.0	0.0	4.6	4.7	3.2	5.3	44.0	33.5	75.0	2.0	3.0	8.9	132.5
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185076838-185153060	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;smooth muscle: 14.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 76.8;Melanocytes: 39.2;Oligodendrocyte precursor cells: 143.2;Peritubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.9;SCLC-21H: 16.4;SK-BR-3: 7.2;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	2.2	0.8	10.8	2.4	8.5	0.1	1.3	7.2	8.8	3.1	0.0	11.1	2.6	9.8	2.6	5.1	5.2	2.2	2.0	9.9	9.1	0.5	0.3	0.9	0.4	15.9	11.5	2.3	0.2	2.1	0.8	1.3	10.1	5.1	4.1	3.9	3.0	8.4	0.5	1.5	3.6	14.8	13.6	2.1	2.8	4.0	12.0	0.3	1.1	0.6	0.6	4.9	2.0	14.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	2.6	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.6	2.2	0.1	0.5	0.0	0.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.8	2.0	0.1	0.0	3.9	0.0	0.0	0.4	16.4	0.1	0.8	7.2	0.4	0.0	0.4	1.8	0.6	0.0	1.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	10.8	8.5	7.2	8.8	9.9	9.1	15.9	11.5	10.1	13.6	12.0	14.0	5.1	0.0	0.0	45.7	1.0	4.1	0.3	0.0	0.6	76.8	1.0	0.5	1.6	0.0	0.0	0.0	0.0	10.8	0.0	9.1	0.0	0.1	1.2	0.1	2.3	4.4	1.2	0.0	13.8	0.2	0.6	3.8	0.0	0.1	0.0	3.9	6.8	0.0	4.0	3.3	19.4	8.8	0.0	0.6	0.7	1.5	3.4	0.3	39.2	6.5	0.6	2.5	0.0	143.2	10.1	0.5	2.2	49.7	0.1	0.3	4.6	0.1	0.0	7.3	6.6	1.3	15.4	6.8	12.5	0.2	1.8	0.8	0.2	1.8	6.3	0.3
C3orf80		ENSG00000180044	"Chromosome 3 open reading frame 80"	F5H4A9	3	160225422-160228213	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.5;esophagus: 4.6;intestine: 8.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.6;Excitatory neurons: 23.6;Hepatic stellate cells: 6.1;Horizontal cells: 6.7;Inhibitory neurons: 6.3;Oligodendrocytes: 5.9;Spermatocytes: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 140.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047439	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047439: AB_10965171"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.92e-3)"	"unprognostic (6.70e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.09e-10)"	"unprognostic (1.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.11e-3)"	"unprognostic (5.00e-2)"	0.9	0.1	2.8	0.6	4.2	0.6	0.4	1.2	5.5	0.4	0.0	8.0	0.7	0.4	0.1	4.6	0.2	0.5	0.4	4.9	0.0	0.3	0.6	0.8	0.0	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.6	1.3	0.1	0.4	0.2	0.0	0.1	0.5	0.7	0.0	1.2	1.1	0.9	0.0	0.0	0.2	0.1	0.1	1.0	1.4	2.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.8	0.1	0.1	0.3	0.0	0.2	2.9	1.7	12.2	3.3	0.1	0.0	2.4	140.5	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	2.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	1.3	0.0	0.0	0.1	0.4	29.8	0.0	0.1	0.5	0.0	3.7	0.3	0.0	0.0	1.0	21.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.2	1.2	5.5	4.9	0.0	0.0	0.1	0.0	0.0	0.0	2.6	1.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	1.3	4.2	3.0	23.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.3	0.1	6.7	6.3	0.0	0.0	0.0	0.4	1.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	2.3	7.1	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 115.8;liver: 336.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	27.9	115.8	0.2	10.6	1.6	0.4	15.7	0.3	2.2	12.6	0.2	31.3	7.5	16.9	11.8	2.6	29.9	2.3	21.8	0.5	1.2	43.1	336.8	14.9	4.5	5.8	1.9	57.5	23.0	0.6	20.6	0.5	2.3	11.1	3.7	5.5	14.2	0.0	1.7	1.7	17.0	0.0	0.5	15.3	11.7	4.1	1.7	4.2	44.5	0.0	2.9	23.1	4.1	1.4	0.0	0.3	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.7	0.2	0.1	0.1	0.4	0.0	58.5	0.5	0.0	0.3	1.0	0.0	0.0	0.0	72.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	17.1	33.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.3	2.2	0.5	1.2	5.8	1.9	2.3	0.5	1.7	1.4	0.0	9.6	46.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	8.3	2.8	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	4.4	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 221.5;liver: 385.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 103.9;Cardiomyocytes: 71.8;Club cells: 22.9;Fibroblasts: 53.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 129.8"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	29.7	221.5	4.0	0.4	2.5	0.6	15.9	2.5	2.3	10.3	2.4	27.3	2.0	16.6	0.0	2.2	24.0	5.9	22.7	3.2	13.3	39.8	385.2	13.6	2.7	7.1	12.4	56.5	25.1	1.1	20.1	1.6	7.7	10.2	6.0	2.5	21.0	1.2	1.3	1.1	16.6	9.7	9.9	16.3	10.3	3.1	11.8	7.5	49.1	0.2	4.3	18.5	3.7	11.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	21.0	7.8	0.5	0.0	26.2	0.1	0.0	0.0	2.6	0.0	0.0	0.0	129.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	2.5	2.3	3.2	13.3	7.1	12.4	7.7	9.9	11.8	11.6	0.0	3.2	103.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	71.8	1.5	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.2	0.0	53.9	0.0	0.0	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.5	8.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 1918.6"	"Group enriched"	"Detected in many"	14	"Alveolar cells type 1: 493.6;Alveolar cells type 2: 660.8;Hepatocytes: 1020.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.5"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 37.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	28000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	1.4	0.7	0.4	2.5	0.2	0.1	4.5	0.7	0.2	6.3	0.0	1.7	0.0	4.5	0.0	0.1	1.0	3.2	0.2	0.1	0.7	0.6	1918.6	173.3	0.3	0.4	0.2	1.5	9.6	0.2	0.1	0.7	0.5	0.1	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.1	0.1	1.2	0.4	0.3	0.3	0.0	0.1	0.0	1.1	0.1	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	37.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.7	0.2	0.1	0.7	0.4	0.2	0.5	0.1	0.3	0.4	0.0	493.6	660.8	0.0	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.4	0.2	41.5	22.5	0.0	0.0	0.0	0.0	3.2	0.0	11.2	0.3	18.0	7.6	1.9	0.0	21.5	0.7	18.7	0.0	1.1	0.0	48.8	3.8	0.0	22.1	1020.8	0.2	0.0	1.4	0.3	0.0	39.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.6	32.0	0.0	0.0	0.3	0.1	0.1	3.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	3.9	16.7	0.2	1.4
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 471.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 597.6"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	NA	NA	265000000000	1100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA000925: , HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	3.0	0.1	0.0	3.4	0.0	0.0	1.8	0.0	0.1	2.8	0.0	3.6	3.8	0.1	0.0	0.2	0.5	3.1	0.1	0.0	0.0	0.4	471.3	1.5	0.4	0.0	0.0	44.2	9.1	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.5	0.0	0.1	0.2	4.4	0.6	0.0	0.4	8.4	0.7	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	5.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	46.2	151.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	12.8	2.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	7.3	2.2	0.5	54.3	3.2	0.0	0.0	1.0	0.2	10.2	1.9	11.4	4.1	0.7	0.1	0.8	1.8	8.0	0.1	88.8	0.3	3.4	5.6	0.8	0.0	0.3	9.7	597.6	2.1	0.0	0.2	5.6	0.0	13.1	0.3	2.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	69.2	15.9	0.0	0.1	0.2	4.3	0.0	2.2	0.0	0.0	1.1	0.4	0.1	0.4	0.0	0.0	0.1	1.1	143.8	4.8	0.1
C4orf17	DKFZP434G072	ENSG00000138813	"Chromosome 4 open reading frame 17"	Q53FE4	4	99511012-99542303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 20.1"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 230.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060374, HPA060564"	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA060374: AB_2684268, HPA060564: AB_2684319"																"unprognostic (1.34e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453925-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.6"	"Group enriched"	"Detected in some"	5	"OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	3.4	0.3	2.7	3.0	2.9	3.8	3.8	5.3	4.3	10.2	5.9	25.5	17.7	6.7	0.2	2.1	2.8	9.2	0.4	3.5	4.2	12.4	36.0	3.7	0.5	4.9	4.9	0.2	24.9	16.0	1.2	7.6	4.2	1.7	23.7	4.6	28.2	6.8	0.2	1.6	19.6	4.0	4.5	0.3	20.7	1.4	4.9	0.2	1.5	0.4	4.3	8.8	2.9	4.1	0.1	0.2	3.2	0.3	0.0	0.0	4.2	0.7	0.0	0.0	0.0	12.6	5.2	0.1	3.0	0.0	0.1	0.4	0.2	0.8	0.1	0.0	0.4	0.0	8.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	14.3	0.2	0.2	0.5	64.6	1.7	0.1	7.8	0.2	12.7	81.0	0.9	0.3	0.5	32.6	1.0	4.0	113.1	0.7	0.6	0.4	4.5	0.2	1.6	0.2	0.1	0.5	0.0	6.9	5.6	0.9	1.4	2.1	0.6	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.5	0.8	8.6	0.8	0.1	1.6	0.7	0.3	2.7	2.9	5.3	4.3	3.5	4.2	4.9	4.9	4.2	4.5	4.9	4.1	0.3	0.0	12.6	45.4	0.7	0.3	7.8	4.9	0.0	0.6	7.1	3.9	0.2	27.1	10.1	11.0	0.0	6.7	0.2	61.3	11.7	25.2	1.2	9.5	0.4	0.9	9.6	0.0	2.3	51.8	4.7	0.3	33.6	5.5	0.0	0.0	0.0	13.1	0.7	0.0	2.4	28.0	4.1	0.0	0.3	2.4	0.0	0.2	3.6	22.5	0.6	5.3	0.0	46.8	1.8	53.6	67.2	0.0	0.0	7.8	52.3	9.2	12.3	1.0	0.0	0.2	0.9	0.3	0.2	0.5	0.0	47.5	0.4	0.1	31.8	19.1
C4orf3	"ALN, HCVFTP1"	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	80.0	67.8	96.4	54.1	107.1	34.1	69.4	103.1	148.1	123.2	83.3	80.2	60.5	79.7	77.9	268.2	68.9	65.1	107.8	90.1	99.6	97.9	110.8	70.3	61.3	107.9	104.9	85.5	51.5	55.5	56.6	60.3	106.4	71.8	43.6	74.7	89.6	69.8	79.6	89.3	67.3	70.6	109.6	63.1	49.6	39.8	109.2	64.8	71.4	59.7	56.8	75.9	150.2	112.8	116.8	13.7	58.4	49.8	107.1	97.0	34.1	59.3	31.6	35.3	62.6	15.6	44.5	95.9	36.6	87.3	31.0	24.8	29.6	54.1	61.8	57.1	21.3	40.9	33.5	67.9	35.9	64.7	42.8	96.4	64.5	30.0	14.4	120.6	52.8	29.1	33.8	50.4	137.6	41.8	50.9	64.0	24.2	60.7	20.9	32.9	62.6	27.3	53.5	32.2	38.4	54.8	46.4	58.5	43.2	56.9	32.6	37.5	55.7	80.3	34.6	52.5	21.4	51.3	59.8	37.2	156.7	36.7	40.9	257.8	110.0	145.4	85.1	132.6	92.9	126.7	109.6	101.5	95.1	104.8	120.4	114.4	239.4	109.6	128.0	131.6	112.9	157.1	96.4	107.1	103.1	148.1	90.1	99.6	107.9	104.9	106.4	109.6	109.2	112.8	213.2	157.0	150.5	11.4	211.3	315.5	292.0	809.1	132.1	79.1	198.4	191.9	544.4	158.7	456.3	222.5	25.0	321.5	228.9	117.0	383.5	288.5	38.1	272.5	148.7	245.6	68.4	78.6	22.2	179.1	403.9	215.0	46.4	134.3	186.1	108.0	234.9	446.4	317.4	153.1	21.6	170.2	408.9	303.5	298.4	31.0	167.4	244.9	199.3	16.9	423.9	233.4	253.3	6.6	16.3	207.6	196.8	215.5	239.0	392.5	500.1	1070.2	542.7	78.9	197.2	145.8	246.0	182.7	67.0	245.9	346.6	445.7	203.2	150.3	135.8	428.1
C4orf33	FLJ33703	ENSG00000151470	"Chromosome 4 open reading frame 33"	Q8N1A6	4	129093317-129116640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA061199	Uncertain		Approved	"Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nuclear bodies"	"HPA061199: AB_2684450"	"unprognostic (7.27e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.49e-5)"	7.8	10.3	4.6	6.4	5.2	16.1	9.5	11.6	5.6	5.5	3.9	20.5	17.0	4.8	9.4	9.1	8.4	9.2	5.8	4.7	5.4	14.2	9.9	8.4	6.5	6.3	6.5	11.1	9.4	6.0	12.2	9.4	7.0	4.6	16.7	13.4	6.7	4.1	2.6	6.8	15.1	5.7	6.2	7.9	16.2	5.6	5.5	8.9	12.0	2.7	5.8	9.9	5.8	7.0	7.7	4.3	9.7	9.8	7.8	7.5	15.7	7.2	10.0	8.4	10.8	2.2	36.1	6.4	17.8	10.4	13.0	4.8	11.2	11.5	6.8	38.3	8.6	15.7	11.4	3.0	9.5	7.8	16.0	7.6	10.2	10.0	4.0	15.5	6.9	22.9	20.5	26.9	8.6	3.1	12.7	6.2	0.5	16.2	5.4	5.3	10.3	8.3	23.7	8.7	12.4	2.8	5.5	13.1	8.7	2.2	12.2	5.9	5.0	7.4	2.7	5.5	5.8	14.4	6.8	11.3	15.4	20.4	6.4	18.7	11.7	30.3	3.3	11.6	2.5	5.6	2.6	4.0	11.8	2.7	2.7	4.3	5.7	9.3	12.3	6.4	4.8	4.9	4.6	5.2	11.6	5.6	4.7	5.4	6.3	6.5	7.0	6.2	5.5	7.0	10.7	6.4	14.1	11.8	9.2	10.5	7.4	22.9	10.8	15.1	13.4	8.3	4.2	18.6	16.3	12.9	8.4	21.5	19.8	24.7	50.9	10.4	6.9	34.8	7.4	7.9	4.9	8.2	12.8	9.3	18.9	8.3	18.8	17.5	14.5	5.9	8.6	5.2	14.2	1.7	11.2	14.7	22.4	18.1	16.7	3.0	2.1	18.6	12.4	10.3	13.3	11.8	7.2	12.1	21.5	8.1	17.9	2.2	9.6	2.7	25.6	30.9	36.9	11.5	0.0	5.0	12.9	4.6	5.4	13.5	9.2	18.9	12.2	15.5	16.4	8.9
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.7"	"Group enriched"	"Detected in many"	12	"Early spermatids: 129.5;Late spermatids: 349.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.8;CAPAN-2: 2.1;hTCEpi: 1.7;hTERT-HME1: 2.4"									HPA057434	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites"	Cytosol	"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.4	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.4	1.0	0.0	0.1	0.1	0.3	0.0	0.7	0.2	0.0	0.1	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.1	0.6	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.4	0.1	0.0	1.5	0.1	0.2	0.1	0.1	0.1	10.7	0.1	0.0	0.4	0.0	0.1	0.3	0.6	0.3	2.8	0.2	0.1	0.1	0.0	0.1	0.6	1.4	0.4	0.3	0.0	0.1	2.1	0.0	0.2	0.0	0.0	1.2	0.2	1.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.8	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.3	1.1	0.3	0.8	0.3	0.2	0.0	0.2	0.5	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	2.6	2.3	5.0	8.9	9.6	4.0	5.4	0.2	0.0	19.2	15.7	5.1	0.0	10.4	0.9	4.0	13.0	0.0	0.1	129.5	0.1	0.4	5.9	3.0	4.8	1.4	0.0	2.9	4.3	11.7	0.2	0.0	0.1	7.9	3.1	3.3	1.7	1.6	9.1	8.2	6.2	5.8	349.7	5.3	3.5	1.8	1.0	1.4	6.4	5.2	1.0	3.6	0.2	11.3	3.4	6.9	3.7	10.8	0.0	5.6	6.7	6.6	6.2	2.3	3.9	6.9	6.7	10.2	9.7	2.1	0.0	7.1	4.6
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666675-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	2.5	2.4	1.9	4.1	2.4	14.5	2.9	2.4	2.8	2.7	1.3	3.3	3.0	5.0	2.1	2.9	2.4	2.8	3.7	1.9	1.9	1.9	1.5	2.6	6.0	2.3	2.2	4.2	2.4	1.7	1.1	4.5	2.3	2.4	4.2	9.4	1.7	2.2	2.1	2.9	2.8	4.0	2.1	3.2	2.6	12.8	2.0	10.2	4.3	6.0	5.4	2.6	2.0	2.9	16.6	9.9	23.7	35.0	10.3	10.6	11.8	27.5	18.9	31.5	27.4	8.9	14.6	29.3	4.3	14.0	11.6	9.0	20.6	14.2	40.3	40.5	10.7	44.5	10.4	11.9	3.5	33.9	23.7	6.2	5.0	25.6	11.2	10.4	22.7	29.3	19.7	72.1	43.2	8.9	65.8	29.7	16.3	10.6	13.0	47.0	13.5	13.0	9.6	8.1	12.8	38.5	12.1	10.9	10.1	11.9	9.3	26.9	12.0	48.0	22.1	27.0	23.2	16.5	22.3	37.0	12.1	29.8	18.9	2.4	1.9	1.7	1.9	1.6	1.4	1.7	1.5	1.9	2.1	1.4	2.1	2.3	0.6	3.4	2.2	1.8	1.8	1.3	1.9	2.4	2.4	2.8	1.9	1.9	2.3	2.2	2.3	2.1	2.0	2.9	10.3	3.2	1.8	1.3	7.8	24.1	5.1	5.8	14.2	7.5	6.5	5.2	7.6	1.5	3.2	1.8	4.2	9.8	8.2	2.9	7.9	3.6	0.8	7.6	10.8	6.9	7.7	11.2	1.2	3.0	11.8	14.5	4.6	15.0	7.0	8.7	5.0	2.0	9.7	10.1	1.8	5.1	6.1	10.3	25.8	1.8	4.7	7.6	19.6	0.0	18.9	6.5	5.2	1.0	6.2	3.8	3.1	6.0	18.1	6.6	3.2	2.8	3.3	28.2	6.6	7.7	10.6	49.1	15.2	30.1	15.6	3.3	9.6	2.5	5.8	7.2
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.3;fallopian tube: 13.6;retina: 15.1;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.5	0.3	3.2	0.2	4.4	0.3	2.1	3.8	2.9	1.0	24.3	0.3	0.1	1.2	3.8	0.3	13.6	0.9	0.9	3.3	3.6	2.7	0.4	2.0	0.1	7.2	8.2	0.7	0.7	0.6	2.9	0.2	5.5	0.6	0.2	15.1	0.5	0.6	0.1	1.0	0.2	0.3	7.1	0.2	0.3	13.3	3.9	0.2	4.6	0.1	0.2	0.3	0.3	3.9	2.4	0.0	0.2	1.2	0.4	2.3	0.7	0.0	0.1	0.2	0.3	0.3	1.4	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0.5	0.5	0.4	0.0	0.1	0.3	0.5	0.0	0.1	0.5	0.5	0.5	0.2	4.9	0.0	0.5	0.3	0.1	1.8	0.3	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.7	0.0	1.3	0.6	0.4	0.0	1.5	0.5	0.1	0.4	0.7	0.4	0.1	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.0	3.2	4.4	3.8	2.9	3.3	3.6	7.2	8.2	5.5	7.1	3.9	3.9	0.6	3.2	1.5	21.5	2.0	0.6	0.9	8.7	4.6	0.9	2.2	3.9	0.6	1.5	13.2	3.7	10.4	0.1	0.4	0.4	1.9	2.8	191.3	50.0	1.5	1.3	0.0	0.0	36.6	0.6	1.5	2.4	6.6	3.4	0.0	0.3	1.1	0.1	0.2	1.7	26.3	0.0	2.0	0.6	0.4	20.9	0.6	0.7	1.8	4.7	0.1	3.6	0.0	18.6	13.4	1.0	0.0	0.7	9.6	0.6	0.0	3.7	106.6	14.8	0.0	3.0	3.1	12.6	5.0	2.6	0.6	0.3	1.5	0.5	0.0	0.3
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.9;choroid plexus: 62.6;pituitary gland: 74.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 412.4;Paneth cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 158.3;NB-4: 117.3;PC-3: 343.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	13.5	18.3	50.0	4.6	68.4	2.7	9.6	71.0	66.6	5.2	62.6	20.4	2.7	5.5	0.2	4.3	7.8	0.4	8.2	49.4	60.8	20.2	4.0	7.9	1.3	81.5	63.2	6.6	18.9	2.4	74.5	2.1	58.6	7.1	0.9	0.2	9.2	1.4	1.2	3.1	16.3	0.6	67.8	18.5	11.9	56.1	60.3	0.3	9.3	0.0	0.6	6.8	2.9	97.9	33.4	27.1	5.3	24.9	2.4	3.9	35.3	31.2	6.0	5.6	5.3	18.6	19.6	4.4	29.2	1.2	10.4	9.2	0.6	3.5	1.7	20.1	158.3	10.5	15.8	10.7	5.2	21.7	70.3	3.0	5.9	1.2	0.0	1.8	5.9	17.9	35.1	0.1	3.9	20.6	24.6	117.3	15.8	1.8	343.1	56.1	8.3	11.2	5.0	12.3	42.7	60.0	15.3	0.7	47.7	0.5	8.3	10.3	26.5	14.7	31.9	11.0	35.3	23.8	22.4	0.4	14.6	13.2	20.8	88.5	451.6	431.5	123.6	325.6	127.5	187.7	157.2	138.3	270.0	167.9	89.1	92.9	349.2	29.6	290.7	301.1	199.8	192.8	50.0	68.4	71.0	66.6	49.4	60.8	81.5	63.2	58.6	67.8	60.3	97.9	13.3	0.0	1.9	8.8	58.1	21.9	6.6	13.2	7.4	12.0	147.0	139.8	10.6	20.0	14.2	200.5	0.0	8.0	52.8	412.4	70.5	320.8	97.1	326.7	92.6	42.1	235.1	30.7	5.6	222.7	116.5	47.7	35.7	107.3	107.5	209.0	123.1	11.9	235.5	18.5	8.2	154.2	44.7	272.1	113.3	350.5	19.3	158.9	327.3	7.5	205.2	78.8	20.6	6.0	41.1	198.2	484.2	28.2	84.1	10.9	223.7	7.9	28.8	15.0	13.1	1.7	53.2	99.7	193.2	5.7	10.1	13.1	73.9	50.9	117.1	11.1
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 433.7"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	2.9	1.7	2.5	1.1	3.4	2.2	2.5	2.4	2.6	3.0	3.5	2.8	3.9	2.7	2.7	1.6	3.0	1.5	1.3	2.2	2.6	4.8	433.7	7.0	2.1	2.9	2.9	3.3	14.9	2.6	3.1	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	3.9	1.9	2.8	1.5	5.8	1.6	2.8	1.2	2.0	1.2	1.7	2.6	2.1	4.5	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.4	2.6	2.2	2.6	2.9	2.9	3.2	2.8	2.8	4.5	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332175-47347329	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 14.4;Hepatic stellate cells: 23.9;Kupffer cells: 48.6;Macrophages: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 17.8;eosinophil: 11.9;neutrophil: 33.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.0"	"Group enriched"	"Detected in some"	4	"MCF7: 20.7;T-47d: 24.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016629	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"			"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	4.2	1.2	1.1	4.1	0.8	5.8	2.2	1.2	2.9	1.2	1.8	1.3	0.4	0.7	0.4	0.6	2.3	0.7	2.1	2.4	0.5	1.2	1.9	6.5	0.9	1.3	0.7	0.6	0.8	0.1	0.9	2.2	0.7	0.4	0.4	0.4	1.2	0.3	0.3	1.4	1.5	1.0	0.5	14.1	1.1	3.1	0.8	0.3	0.9	0.4	3.2	1.2	1.3	1.3	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.4	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	5.2	0.1	0.0	0.8	1.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.4	0.0	20.7	0.1	2.4	0.2	0.0	0.1	0.3	0.1	2.7	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	24.8	0.3	0.2	0.8	0.2	0.5	0.1	0.3	0.3	0.9	0.8	1.4	0.1	17.8	2.7	11.9	0.3	2.3	0.4	0.3	0.2	0.2	0.6	0.4	0.2	0.2	33.0	0.3	4.4	0.3	0.6	0.7	1.1	0.8	1.2	2.9	2.4	0.5	1.3	0.7	0.7	0.5	0.8	1.3	0.6	3.2	1.9	0.3	1.1	0.4	2.8	0.1	0.0	1.3	4.7	2.8	1.6	2.8	2.6	1.8	2.1	0.1	1.7	0.0	0.0	0.0	14.4	0.5	0.5	1.7	0.0	3.2	0.6	0.0	0.2	2.1	0.0	1.1	1.3	6.1	23.9	1.2	8.3	0.0	0.1	0.0	0.0	48.6	4.6	3.0	0.0	34.5	0.0	1.0	8.3	0.3	1.0	0.0	0.1	0.0	0.0	0.4	1.3	2.0	0.0	0.3	0.8	4.2	0.0	4.0	1.0	0.2	0.4	0.1	0.9	0.1	1.3	4.1	0.0	1.9
C5orf15	"HTGN29, KCT2"	ENSG00000113583	"Chromosome 5 open reading frame 15"	Q8NC54	5	133955510-133968674	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011951, HPA039165"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA011951: AB_2668584, HPA039165: AB_10795580"	"unprognostic (2.25e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-2)"	35.4	49.5	15.5	35.6	16.2	18.6	44.7	16.6	22.9	38.5	24.8	32.4	48.7	35.4	34.4	24.0	48.0	41.3	40.7	15.5	17.1	73.6	80.3	39.9	47.5	16.7	16.6	36.6	26.3	44.7	19.9	58.9	17.2	39.6	33.1	24.5	30.9	25.1	22.3	30.7	48.6	30.5	17.4	37.3	48.8	26.6	15.9	33.9	53.1	22.6	37.0	46.4	19.0	21.3	70.4	51.5	70.5	81.3	101.9	115.9	85.9	71.3	95.4	107.2	178.7	49.9	204.1	49.5	127.4	87.3	108.4	51.1	57.7	104.0	125.6	56.3	87.7	18.7	34.2	63.9	96.1	30.8	79.8	102.2	62.7	84.7	44.7	152.5	45.9	31.3	39.7	57.4	86.7	44.7	35.9	57.9	39.0	34.1	30.8	34.0	72.3	73.8	175.0	53.9	62.8	47.0	71.9	24.2	117.1	126.0	74.9	91.7	42.4	95.6	88.4	39.2	71.8	42.9	44.1	30.3	113.3	72.9	143.6	19.5	31.6	16.8	14.6	34.6	13.7	22.8	16.6	16.0	37.0	24.3	21.1	17.1	16.3	22.0	34.2	26.7	17.3	29.4	15.5	16.2	16.6	22.9	15.5	17.1	16.7	16.6	17.2	17.4	15.9	21.3	18.6	25.6	33.2	12.7	32.3	30.7	39.8	85.7	33.6	22.0	41.3	22.1	17.9	51.5	54.1	49.7	10.4	83.6	19.6	27.1	17.6	73.7	45.6	68.4	34.2	21.2	37.2	17.1	17.1	46.8	71.9	61.1	25.0	32.2	15.2	31.5	23.9	48.5	55.7	5.0	15.6	30.4	81.4	32.8	57.7	7.0	51.3	34.0	64.0	21.5	97.1	27.6	19.6	37.2	35.3	47.9	24.1	39.1	28.8	33.5	51.5	71.8	125.5	26.9	26.3	30.6	36.3	46.8	29.1	23.3	32.5	58.0	21.5	80.6	21.2	22.8
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532287-31555053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 28.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	4.3	3.7	2.0	5.6	2.9	5.8	6.5	2.4	3.0	6.0	1.6	6.7	4.6	6.0	3.4	6.5	5.9	5.6	10.2	2.4	3.2	7.6	7.0	6.6	7.3	2.3	3.2	4.1	11.0	8.2	1.4	5.7	2.9	5.9	7.6	4.8	5.4	5.3	13.7	3.9	5.9	8.2	2.4	5.1	5.2	3.6	2.5	7.2	6.6	15.1	8.7	7.0	2.8	3.0	10.0	7.2	18.4	25.3	13.0	10.7	20.9	16.2	12.2	18.1	13.4	8.7	10.7	8.2	23.4	14.7	15.7	7.3	22.2	13.4	19.2	11.8	11.9	15.7	23.9	12.6	20.9	24.3	51.8	14.6	16.6	12.2	18.9	7.4	15.4	11.5	21.2	12.9	19.6	10.3	13.1	6.1	11.0	10.1	10.7	12.2	30.7	11.7	12.7	15.5	12.3	17.1	45.1	19.9	32.9	11.6	15.9	16.4	13.0	13.6	15.5	16.7	16.4	8.7	18.7	15.0	7.9	42.5	20.7	28.0	2.5	2.4	2.6	2.9	2.8	2.9	3.4	2.8	2.4	2.4	3.2	3.4	0.9	3.8	5.2	1.4	2.1	1.5	2.0	2.9	2.4	3.0	2.4	3.2	2.3	3.2	2.9	2.4	2.5	3.0	6.0	3.2	5.3	10.1	9.6	4.5	3.3	4.0	10.8	4.1	5.6	2.8	23.5	4.3	4.9	12.9	0.0	5.3	9.2	8.8	1.9	4.3	2.9	6.9	7.3	6.2	6.7	7.2	16.5	6.0	6.2	6.4	10.2	7.6	7.6	5.5	6.1	10.2	6.4	6.7	17.7	9.2	12.2	10.7	2.5	1.7	4.7	7.7	8.8	8.4	10.7	4.8	2.1	15.1	15.5	6.8	5.7	3.4	12.8	5.1	5.9	7.9	7.9	4.9	6.6	3.9	5.6	6.1	6.5	10.3	4.0	5.3	9.5	6.3	6.9	4.3
C5orf24	FLJ37562	ENSG00000181904	"Chromosome 5 open reading frame 24"	Q7Z6I8	5	134845680-134859735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057749, HPA062502"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA057749: AB_2683515, HPA062502: AB_2684785"	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.33e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.45e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (4.75e-2)"	24.1	25.9	17.3	17.8	20.7	24.9	20.2	26.3	31.2	20.2	16.2	21.2	22.1	28.9	15.8	21.0	17.5	21.3	19.5	18.4	18.3	41.0	43.2	22.9	16.3	19.5	18.7	20.0	13.2	26.8	15.4	28.6	18.9	21.5	18.4	19.3	18.3	18.3	21.5	19.1	17.1	26.7	19.8	16.7	16.1	12.4	18.7	15.0	29.8	26.6	14.6	22.1	16.8	23.4	26.0	21.5	43.8	63.7	53.0	62.3	15.7	54.7	38.5	29.6	35.3	28.7	29.0	24.0	46.4	39.1	37.6	17.3	25.0	37.9	51.3	18.0	35.3	27.1	50.4	33.9	40.1	11.8	30.8	51.6	45.0	42.9	48.9	59.5	55.2	39.5	19.0	29.1	64.7	14.8	26.0	20.4	9.8	16.1	21.8	29.4	41.6	27.4	75.4	23.9	27.0	51.5	56.7	15.0	82.2	19.4	30.8	38.1	61.4	59.4	25.7	43.8	39.5	30.3	23.2	30.3	43.6	33.2	44.9	4.5	9.0	9.6	5.5	6.9	4.4	6.7	3.7	4.5	7.8	6.4	6.9	4.3	1.7	5.5	5.7	10.5	4.9	4.2	17.3	20.7	26.3	31.2	18.4	18.3	19.5	18.7	18.9	19.8	18.7	23.4	71.8	86.6	34.1	21.2	44.1	43.1	34.7	50.0	56.9	47.2	64.3	56.8	33.2	64.3	34.8	106.7	37.5	33.4	45.9	26.4	58.7	52.0	18.6	33.0	85.6	83.6	53.9	45.0	31.1	43.7	35.4	60.1	27.0	48.2	21.5	48.0	78.1	94.4	32.2	69.0	33.9	32.4	28.5	33.6	47.9	10.8	70.5	33.3	64.0	22.5	40.3	28.2	68.0	22.6	44.3	83.9	34.7	71.5	32.3	44.7	42.4	132.8	29.1	45.9	72.3	61.3	88.0	66.9	44.6	67.8	49.3	22.2	37.6	34.6	35.0	25.0
C5orf34	FLJ32363	ENSG00000172244	"Chromosome 5 open reading frame 34"	Q96MH7	5	43486709-43515148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7;Spermatocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045386	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"HPA045386: AB_10965552"	"unprognostic (2.67e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.66e-4)"	"unprognostic (7.79e-3)"	"unprognostic (6.51e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-6)"	"unprognostic (9.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.99e-2)"	0.9	0.4	0.6	1.3	0.7	1.1	1.6	0.3	0.8	1.2	0.3	1.0	0.6	0.9	0.4	1.0	0.8	0.6	0.5	0.8	0.6	0.8	0.4	0.7	2.8	0.8	0.7	0.8	0.3	0.4	0.3	1.1	0.8	2.4	1.3	0.5	1.0	1.2	0.4	1.3	0.8	1.2	0.8	1.0	0.7	4.1	0.5	3.6	1.2	0.4	2.4	1.4	1.1	0.8	5.6	6.5	9.3	11.1	1.4	3.1	10.5	8.3	7.6	13.3	10.5	4.0	5.7	14.7	8.5	2.7	18.1	5.4	11.3	3.9	14.7	6.9	13.4	3.0	24.0	3.5	0.6	8.1	1.7	2.4	1.3	13.5	7.3	2.1	6.4	7.9	9.5	3.9	10.6	4.3	4.4	11.3	6.6	2.4	7.3	8.2	18.5	9.2	3.6	2.6	6.5	8.0	14.1	6.8	5.8	5.6	11.4	8.5	4.1	10.5	12.9	11.0	8.8	4.1	6.0	8.9	6.0	10.3	11.4	0.0	0.0	0.0	0.5	0.2	0.8	0.7	0.5	0.5	0.3	0.4	0.7	1.4	0.3	0.9	0.1	2.5	0.2	0.3	0.6	0.7	0.3	0.8	0.8	0.6	0.8	0.7	0.8	0.8	0.5	0.8	1.7	3.2	0.5	0.7	2.6	1.7	1.8	1.4	1.2	0.3	1.2	1.7	0.7	0.0	0.5	1.8	0.0	3.7	3.1	0.2	1.9	1.0	1.3	0.9	1.1	1.3	0.0	7.0	8.6	1.5	4.4	1.5	2.0	1.4	5.1	5.0	2.5	0.0	1.7	0.0	3.0	0.4	2.0	1.2	1.4	1.3	1.2	1.2	1.8	1.0	2.7	0.1	0.0	0.5	2.4	0.8	0.3	0.7	2.0	1.6	0.3	0.5	0.5	0.6	19.7	0.6	3.6	18.9	6.9	2.3	2.0	0.4	1.6	1.9	1.6	2.2
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"salivary gland: 181.8;skin 1: 113.1"	"Group enriched"	"Detected in some"	12	"Early spermatids: 320.9;Late spermatids: 189.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	10	"cerebellum: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 54.2;PC-3: 90.8;SiHa: 20.2;U-2 OS: 58.2;U-251 MG: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA		54000		"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	13.5	2.3	0.1	1.6	0.7	0.4	0.0	0.1	0.4	0.4	0.0	0.2	9.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.2	0.9	0.0	0.6	181.8	0.1	0.8	113.1	0.0	3.2	0.0	0.0	0.0	19.2	0.0	0.3	0.2	0.1	0.3	0.0	3.6	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	2.4	1.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.6	0.0	0.2	0.2	0.0	4.6	0.2	0.0	0.0	0.0	0.0	1.1	0.0	8.9	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	20.2	0.3	0.3	11.1	0.0	0.0	0.0	10.0	58.2	0.8	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	9.2	3.7	11.0	15.7	0.2	1.8	0.0	0.5	0.2	0.0	0.0	15.9	320.9	0.7	0.4	0.3	0.0	0.0	0.0	3.3	0.6	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	189.9	1.8	0.2	3.6	0.0	0.6	7.7	0.0	0.0	0.0	4.2	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	2.1	1.1	0.8	0.0	20.6	1.4	0.1	0.0	0.0	0.2
C5orf49	LOC134121	ENSG00000215217	"Chromosome 5 open reading frame 49"	A4QMS7	5	7830378-7851151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.1;choroid plexus: 27.4;fallopian tube: 75.7;testis: 37.1"	"Group enriched"	"Detected in many"	11	"Early spermatids: 821.2;Endometrial ciliated cells: 353.9;Late spermatids: 410.2;Respiratory ciliated cells: 502.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043759	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA043759: AB_2678655"	"unprognostic (1.55e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.93e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.20e-2)"	0.2	0.5	15.2	0.1	17.0	0.0	0.8	12.3	16.5	4.2	27.4	0.1	0.1	1.4	1.7	0.0	75.7	0.5	0.2	15.9	18.1	3.9	3.3	6.0	0.0	21.9	29.1	1.0	2.7	6.2	10.4	0.1	22.0	3.5	0.0	1.4	0.3	1.3	0.0	0.6	0.1	0.3	19.1	0.1	0.6	37.1	19.7	0.7	0.8	0.0	0.0	0.2	0.8	18.1	0.0	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	17.0	12.3	16.5	15.9	18.1	21.9	29.1	22.0	19.1	19.7	18.1	0.1	0.0	5.4	2.3	1.0	0.0	2.6	32.0	0.0	0.4	4.7	3.0	0.4	1.5	41.4	9.2	0.0	0.2	0.0	0.0	3.9	5.6	821.2	353.9	4.3	1.2	5.4	0.0	2.8	0.9	2.9	1.7	0.0	5.8	1.3	0.2	0.4	0.8	0.1	1.7	3.5	0.2	46.8	0.0	0.4	410.2	8.7	0.8	3.6	1.0	0.0	2.3	0.0	1.5	0.2	1.6	0.0	3.8	0.0	4.1	0.0	39.9	502.4	3.6	6.6	0.8	13.4	41.1	8.4	0.0	0.6	0.3	0.9	0.1	0.0	1.5
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	11.0	8.7	10.4	9.8	13.2	2.7	11.5	12.6	14.3	9.9	6.0	8.0	7.8	10.2	15.3	10.8	7.9	8.8	9.6	10.1	12.3	10.9	10.4	7.9	10.5	12.4	12.4	15.5	8.8	15.3	5.0	12.9	12.4	11.5	9.0	15.6	8.9	10.5	4.5	9.1	7.8	12.2	12.0	9.8	7.5	7.1	12.0	15.9	13.7	7.5	10.6	10.5	7.4	16.7	14.8	11.2	22.3	46.9	44.7	35.0	24.3	17.1	29.6	23.7	25.2	11.3	14.9	15.9	20.7	19.2	41.3	9.4	29.8	16.2	34.2	21.4	9.1	15.4	33.0	17.0	54.0	19.8	11.2	34.2	23.0	27.9	31.9	15.1	20.8	19.0	27.8	26.5	25.4	15.5	18.7	20.2	22.4	9.0	6.0	16.2	31.0	24.7	15.9	14.1	13.5	21.2	54.9	25.9	29.0	19.9	28.9	20.0	15.1	28.0	16.7	21.5	16.8	13.3	23.2	15.7	31.2	34.1	20.4	34.3	8.0	7.8	4.9	6.2	6.4	5.6	5.7	5.4	7.8	5.8	7.6	5.2	5.3	6.5	9.2	4.5	4.4	9.8	10.4	13.2	12.6	14.3	10.1	12.3	12.4	12.4	12.4	12.0	12.0	16.7	13.3	32.1	11.5	12.7	16.6	9.9	8.7	10.4	21.6	11.5	13.9	12.4	14.5	8.6	9.5	14.7	6.2	12.5	10.4	7.1	9.8	12.0	13.1	8.1	14.4	11.9	10.8	14.1	11.8	7.6	12.4	19.2	11.2	10.0	5.1	10.3	10.4	20.2	15.0	8.4	13.8	9.1	6.1	17.6	7.9	11.8	9.0	13.0	7.2	4.7	13.8	18.6	10.3	16.6	20.9	8.1	7.3	7.9	11.0	11.6	5.7	12.8	9.6	11.2	13.1	12.8	16.5	9.0	8.3	30.1	13.2	16.8	10.6	9.0	7.1	9.9
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 665.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	12.8	1.1	0.2	0.0	0.2	0.0	5.4	0.2	0.1	0.8	1.6	0.8	0.9	0.4	0.9	0.3	43.9	12.0	57.1	0.2	0.6	4.4	665.9	3.2	0.4	0.0	1.7	6.2	42.7	0.1	0.7	2.8	0.2	0.9	0.6	0.0	0.9	0.6	0.6	0.6	1.4	0.9	0.1	0.3	2.2	4.2	0.8	0.6	2.0	0.7	0.5	0.9	0.6	0.6	0.0	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.6	0.0	1.7	0.2	0.1	0.8	0.6	0.8	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.9	127.2	7.5	0.0	0.0	0.0	0.1	0.3	0.0	9.3	11.3	37.5	0.8	0.9	0.0	8.0	1.4	0.4	0.0	6.7	0.0	0.7	0.0	0.1	5.0	376.9	0.0	0.0	2.7	1.0	0.0	9.7	0.3	54.8	120.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.5	1.3	0.4	0.0	0.0	11.6	0.8	58.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.4	0.5	0.6	0.0
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;choroid plexus: 29.8;fallopian tube: 16.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 145.5;Endometrial ciliated cells: 140.4;Late spermatids: 57.6;Respiratory ciliated cells: 243.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.7;SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"							"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.0	0.0	2.7	0.0	2.3	0.0	0.0	0.9	1.1	0.6	29.8	0.0	0.0	0.4	0.0	0.0	16.4	0.0	0.0	4.0	2.6	0.0	0.0	2.1	0.0	8.4	10.6	0.0	0.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	7.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.9	1.1	4.0	2.6	8.4	10.6	5.3	6.4	2.8	3.7	0.0	0.0	1.5	0.3	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.1	0.4	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.5	140.4	1.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	10.2	0.0	0.0	57.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	243.9	0.0	0.0	0.0	1.8	16.8	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 116.9;Late spermatids: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"	NA	NA		620000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	21.6	16.6	10.2	14.5	10.7	7.7	15.2	10.8	11.5	13.1	9.8	15.5	16.3	11.2	9.3	13.4	10.3	13.1	9.6	10.6	10.6	19.3	28.0	10.6	16.4	8.8	10.8	15.6	14.2	12.0	6.1	20.0	9.5	12.0	14.4	26.3	13.7	12.0	13.8	9.0	15.9	13.4	10.7	13.7	14.8	8.7	11.2	12.4	10.4	13.2	15.5	15.2	6.7	12.2	13.9	10.9	26.2	40.1	71.4	59.3	29.6	28.5	40.9	23.3	27.2	14.9	12.7	11.8	22.4	35.0	38.7	20.8	17.2	26.1	38.9	20.0	41.6	16.8	10.5	31.4	50.6	28.2	25.7	73.2	21.0	27.8	32.0	40.8	28.6	26.7	45.0	32.8	40.6	25.1	15.3	19.3	22.4	24.3	12.7	11.1	14.4	32.0	28.9	15.3	10.6	24.0	23.7	14.9	19.6	29.7	24.9	36.7	31.8	9.8	19.2	52.3	19.6	42.2	69.3	16.7	32.5	25.7	26.3	6.2	7.9	7.1	3.2	7.6	4.3	3.2	4.7	5.6	6.3	4.9	6.2	5.2	4.2	3.1	6.0	2.1	3.4	3.9	10.2	10.7	10.8	11.5	10.6	10.6	8.8	10.8	9.5	10.7	11.2	12.2	11.3	16.0	5.3	7.2	14.1	9.8	12.6	9.9	12.0	15.3	12.5	9.4	8.8	5.7	10.3	14.7	25.0	27.5	13.2	20.2	9.8	10.6	116.9	9.7	18.5	9.7	14.3	18.3	9.5	15.8	31.6	19.5	16.3	10.8	9.5	11.3	8.9	18.9	16.6	8.4	12.9	12.7	14.2	16.9	6.5	272.5	17.7	13.6	19.6	1.9	15.2	28.6	10.3	11.1	10.3	10.9	10.3	11.7	18.8	13.1	22.4	12.7	12.4	24.6	0.0	10.3	10.8	15.4	12.3	12.6	10.2	29.0	10.9	9.2	12.9	14.7
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
C6orf136	Em:AB023049.8	ENSG00000204564	"Chromosome 6 open reading frame 136"	Q5SQH8	6	30647039-30653210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046804	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"			"HPA046804: AB_2679815"	"unprognostic (1.94e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.16e-8)"	"unprognostic (2.33e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (7.51e-4)"	10.9	19.2	8.0	1.3	8.2	1.8	11.3	9.6	12.0	11.7	8.8	39.5	6.5	10.3	3.9	22.3	11.6	0.7	56.3	7.8	8.5	40.1	28.8	11.7	1.9	8.8	8.6	9.3	20.2	6.4	26.2	1.4	8.6	15.2	5.4	3.5	18.5	2.7	49.2	17.2	37.1	1.5	7.6	18.1	22.3	18.1	8.5	0.6	23.3	5.5	1.0	14.6	14.2	8.7	2.7	4.4	2.3	2.0	3.4	4.2	4.1	1.0	1.2	2.6	3.6	2.8	1.9	2.4	1.6	0.8	2.2	3.5	0.4	0.1	2.8	2.0	3.3	1.3	3.4	1.7	0.9	3.8	3.8	1.9	4.0	1.9	2.4	2.5	1.0	3.7	3.1	1.6	0.6	4.4	1.7	4.4	2.5	4.2	2.4	3.3	2.1	4.8	5.9	3.9	5.5	1.1	1.4	4.5	3.4	0.9	2.2	0.8	0.5	0.8	3.8	1.6	3.4	4.5	5.6	1.6	1.4	3.4	1.8	0.0	0.3	0.0	0.5	0.3	0.7	1.2	0.7	0.4	0.3	0.7	1.1	0.7	0.6	0.3	0.3	0.7	0.5	0.4	8.0	8.2	9.6	12.0	7.8	8.5	8.8	8.6	8.6	7.6	8.5	8.7	8.9	0.0	4.4	15.0	14.8	9.3	11.1	29.7	16.5	16.8	10.7	8.9	26.7	17.2	18.2	36.8	4.2	17.3	11.3	67.1	58.7	18.5	14.3	7.4	3.4	10.1	22.9	9.9	17.2	17.5	11.1	8.0	23.9	6.5	12.7	4.6	8.9	12.2	15.7	11.8	19.5	45.0	30.5	4.7	7.6	17.4	7.8	7.1	10.6	8.4	10.0	13.9	11.3	6.0	9.8	17.1	54.2	6.4	18.8	13.4	108.7	27.7	11.1	20.0	6.6	5.3	17.5	51.5	49.5	24.1	10.7	16.8	13.5	6.7	47.2	16.2
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 41.3;Basal prostatic cells: 38.8;Distal enterocytes: 41.0;Ductal cells: 39.2;Enteroendocrine cells: 106.3;Gastric mucus-secreting cells: 50.4;Glandular and luminal cells: 61.7;Paneth cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.6;HaCaT: 8.7;HeLa: 8.4;PC-3: 11.7;T-47d: 7.3"	"Not detected"	"Not detected"							HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.0	0.1	0.0	0.5	5.4	0.0	4.2	1.1	1.8	3.0	0.0	1.8	6.4	1.8	0.5	2.8	2.2	6.0	0.3	0.4	0.1	0.2	1.1	0.5	0.3	2.4	0.4	0.5	3.1	0.0	1.6	0.1	2.4	0.4	0.7	0.0	4.2	0.3	0.7	2.8	1.0	0.4	0.0	0.0	5.5	1.8	1.2	0.0	1.3	0.4	0.4	0.9	3.5	0.0	4.8	3.1	0.0	0.0	0.0	0.0	1.6	0.9	0.9	0.0	0.0	0.2	3.2	0.0	0.5	1.5	7.6	8.7	0.9	2.3	0.0	0.0	5.5	0.0	8.4	0.0	0.2	0.0	0.0	0.3	6.6	0.0	4.7	2.6	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.2	1.2	11.7	0.0	0.0	0.0	1.5	5.3	0.3	0.0	2.1	0.0	0.0	0.4	7.3	0.0	2.7	0.4	0.0	0.0	5.8	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.1	1.8	0.4	0.1	2.4	0.4	2.4	0.0	1.2	0.0	19.9	0.0	3.1	0.0	0.0	41.3	38.8	2.9	13.1	0.0	8.1	3.7	2.1	8.6	7.6	0.0	0.0	3.9	0.4	41.0	0.0	39.2	0.3	36.9	3.8	11.9	106.3	0.0	1.9	9.0	18.5	2.3	50.4	61.7	0.0	0.8	0.4	0.3	0.9	0.0	0.4	3.1	4.1	0.0	2.1	0.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	39.6	0.4	0.1	8.2	0.7	0.1	3.9	0.0	0.0	0.4	0.9	0.5	1.1	25.7	35.9	2.1	0.4	0.1	7.6	19.3
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112575	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 5.5;lymphoid tissue: 3.5;skin 1: 6.7"	"Cell type enriched"	"Detected in some"	14	"Breast glandular cells: 73.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 13.4;U-2 OS: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.0	1.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344813-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 180.7;Late spermatids: 267.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.5"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.6	0.6	1.1	0.3	0.7	2.3	0.9	0.5	1.6	1.0	1.4	0.8	0.1	0.9	1.4	0.4	1.5	0.4	0.8	1.1	0.3	0.8	0.7	0.4	0.7	0.7	0.4	1.1	0.8	0.7	1.2	0.4	0.7	0.9	0.8	1.2	0.9	0.3	1.2	1.6	0.8	0.4	0.0	1.2	0.6	7.7	0.8	0.5	0.8	0.6	0.6	0.5	0.5	1.4	0.0	0.2	1.0	1.6	0.1	1.1	1.3	0.0	0.0	0.2	0.3	0.4	0.3	0.6	0.1	0.1	0.6	0.3	0.4	0.9	0.0	0.6	0.7	0.8	0.4	0.3	0.0	0.4	0.2	0.5	0.5	0.3	0.3	0.4	0.2	0.6	1.3	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.0	1.4	0.3	0.0	0.7	1.0	0.8	0.4	0.1	0.2	0.5	1.0	0.2	0.4	0.3	0.6	0.5	0.3	0.5	0.2	0.3	0.1	0.0	0.8	0.4	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.3	0.8	0.2	0.2	0.0	0.2	0.1	1.1	0.7	0.5	1.6	1.1	0.3	0.7	0.4	0.7	0.0	0.8	1.4	0.7	0.0	0.5	28.4	0.4	0.4	0.5	0.5	0.0	0.6	0.5	0.3	2.5	1.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.3	180.7	1.8	1.2	1.3	0.0	1.3	31.4	0.0	0.4	0.5	1.5	0.4	0.0	1.6	0.4	0.5	0.2	0.0	25.1	0.4	0.0	0.8	0.0	267.1	2.5	0.4	1.8	12.2	0.2	0.2	0.0	14.1	16.0	0.1	0.2	1.9	0.5	0.4	0.4	0.5	1.1	0.5	6.6	1.4	0.9	2.3	1.8	0.2	0.1	0.8	0.7	1.6	0.2	0.4
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	19.3	31.9	12.9	5.9	12.6	13.2	15.7	13.0	19.6	14.5	11.4	19.3	7.8	18.5	6.2	11.7	13.6	2.2	14.9	11.9	14.5	20.0	14.9	14.4	5.4	13.3	12.8	12.6	13.5	4.1	25.5	2.2	12.9	17.5	1.5	5.6	12.8	7.0	19.7	25.8	15.0	2.5	14.0	18.8	15.4	11.3	13.7	6.3	15.6	3.6	3.0	18.5	12.4	14.2	9.9	7.5	6.7	13.6	7.2	6.3	8.1	6.0	3.2	7.2	9.4	2.8	3.3	2.1	12.2	2.9	4.6	7.8	1.8	3.8	2.1	9.3	13.9	7.8	6.6	19.7	7.4	2.1	5.5	7.1	4.9	3.6	1.7	2.0	5.6	8.1	0.5	11.1	4.5	19.9	16.0	13.4	2.4	9.6	6.3	7.0	4.8	10.4	4.0	7.6	13.1	15.9	11.4	5.0	16.3	2.4	12.1	6.1	7.5	5.7	17.0	10.7	5.7	26.9	22.1	32.9	3.5	4.2	4.0	7.5	21.8	21.8	17.4	17.3	13.1	16.8	22.1	18.0	25.4	15.7	17.1	21.0	9.6	23.8	24.6	23.7	19.3	15.1	12.9	12.6	13.0	19.6	11.9	14.5	13.3	12.8	12.9	14.0	13.7	14.2	18.7	12.8	10.4	7.5	12.9	14.4	19.3	26.8	24.5	29.9	15.2	18.2	13.9	15.7	16.9	22.0	6.2	22.8	24.9	11.1	66.5	21.9	1.5	31.6	10.2	15.7	9.7	7.4	2.5	32.7	9.7	16.0	14.8	18.1	7.0	28.8	12.1	18.2	21.6	30.3	3.9	10.6	16.2	20.4	14.8	2.3	14.6	19.8	30.2	7.5	18.2	54.2	36.0	1.5	10.8	22.3	13.8	13.5	17.2	12.6	11.0	38.6	33.2	29.3	0.0	12.3	15.4	2.9	5.4	18.3	17.0	16.7	20.3	17.0	9.1	20.0
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660778	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;HBEC3-KT: 7.6;HDLM-2: 4.7;HEK 293: 6.1;U-2 OS: 5.5;U-266/84: 5.5"	"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	11.2	12.9	0.4	0.4	0.5	0.2	10.8	1.1	0.7	11.9	0.2	18.0	0.0	15.1	3.2	21.4	12.1	1.0	17.2	0.4	0.5	15.0	10.9	12.0	1.4	0.7	0.5	11.2	13.1	0.6	11.6	0.8	0.7	12.4	1.0	0.6	13.5	0.0	18.9	17.9	17.6	0.0	0.5	18.1	15.5	4.8	0.6	0.7	11.5	0.0	0.0	16.6	13.1	0.8	0.1	4.5	0.0	0.3	3.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.6	3.0	2.4	3.8	0.0	0.0	0.0	7.6	0.0	4.7	6.1	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.3	0.0	1.2	3.8	0.9	2.6	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.4	5.5	0.0	0.2	3.7	5.5	0.9	1.9	0.0	0.2	0.6	1.5	2.8	2.6	1.0	1.3	1.9	0.7	1.6	1.0	1.4	2.0	0.8	1.8	0.7	0.9	0.6	1.4	1.9	0.4	0.5	1.1	0.7	0.4	0.5	0.7	0.5	0.7	0.5	0.6	0.8	8.7	6.4	10.9	0.0	16.6	25.1	29.1	14.6	18.2	16.0	12.2	6.5	1.5	25.8	11.5	12.9	8.4	20.0	17.7	42.2	25.4	24.2	0.0	4.3	7.8	10.9	6.7	6.1	0.0	28.9	15.1	11.2	11.7	6.1	11.4	12.8	15.4	8.5	18.2	6.7	0.0	21.6	4.1	17.4	18.7	0.0	16.1	17.1	8.8	0.0	19.4	12.5	32.0	0.0	0.0	29.9	29.0	21.8	5.1	25.6	40.9	18.1	5.0	13.5	32.9	13.0	14.2	1.0	5.5	20.9	26.9	23.8	16.1	15.8	26.2	47.0
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 6.1;U-266/84: 6.4"					"Not detected"	"Not detected"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.0	1.8	2.2	0.5	2.2	0.3	1.1	2.3	4.0	0.7	3.1	0.8	3.3	0.5	3.5	0.6	3.3	0.2	0.6	2.2	2.5	4.4	0.7	1.0	0.4	2.6	2.7	1.1	2.2	0.3	2.0	0.2	2.6	2.0	0.3	0.8	0.8	0.5	0.5	1.3	0.7	0.3	2.4	0.7	1.6	13.7	2.3	0.5	0.8	0.2	0.6	0.6	0.5	2.8	1.0	2.0	1.8	1.7	0.6	0.0	3.3	0.3	0.0	0.2	0.4	2.7	1.6	0.2	2.9	0.0	2.8	0.2	1.8	0.0	0.6	1.2	4.5	0.8	0.5	0.5	0.0	1.2	0.5	0.3	2.6	0.7	1.0	0.4	0.0	1.9	3.6	0.3	0.7	6.1	1.5	6.1	1.9	1.4	2.3	1.3	0.4	0.9	0.8	0.5	3.8	2.1	0.8	0.5	3.9	2.3	0.2	1.0	0.7	1.4	0.5	1.0	1.4	2.6	6.4	1.4	2.3	0.9	1.6	0.0	0.2	2.4	0.6	0.5	0.2	0.2	0.7	0.6	0.5	0.3	0.3	0.3	0.3	0.7	0.3	0.4	3.1	0.3	2.2	2.2	2.3	4.0	2.2	2.5	2.6	2.7	2.6	2.4	2.3	2.8	0.7	0.0	2.7	3.3	1.2	1.5	2.0	4.2	0.0	1.6	3.2	3.7	1.3	1.5	2.6	3.7	2.1	2.9	0.2	1.6	5.9	4.1	46.4	44.9	0.9	1.9	3.0	0.0	0.9	6.1	2.3	1.1	2.0	2.5	0.0	0.6	1.4	1.9	1.2	1.7	1.0	1.2	0.0	0.3	1.0	27.3	2.1	0.6	3.6	0.0	1.6	3.3	1.0	0.0	3.5	2.8	2.7	0.0	2.5	2.0	1.3	9.6	37.7	0.9	0.0	1.1	2.1	36.1	20.4	0.6	1.4	1.4	0.4	0.4	1.7	1.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591820	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 612.7;salivary gland: 2257.3"	"Group enriched"	"Detected in some"	12	"Early spermatids: 14.3;Gastric mucus-secreting cells: 41.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;RPMI-8226: 2.8;WM-115: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	NA	NA		30000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.1	0.1	612.7	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	2257.3	0.0	0.2	0.0	0.2	0.1	0.0	0.3	268.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	2.8	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	14.3	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	41.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.8	0.7	0.0	0.1	0.3	0.0	0.2	0.0	0.3
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24719998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	110.0	82.6	105.0	115.1	108.3	118.0	87.3	101.8	112.5	60.7	92.1	76.5	90.3	70.6	100.7	56.6	76.6	62.7	59.7	94.2	103.9	92.9	107.5	96.5	144.3	121.4	120.6	93.8	121.8	71.2	45.4	87.4	106.2	84.2	76.8	151.0	94.0	75.4	84.1	93.5	93.1	69.2	107.8	156.2	110.3	125.0	126.8	133.1	85.5	58.3	143.0	73.7	36.9	109.6	154.6	73.9	108.2	169.8	106.6	142.2	118.5	178.0	172.6	204.4	211.2	91.8	116.7	177.9	258.3	172.0	230.8	114.5	103.7	137.1	221.0	301.2	61.9	194.0	104.8	112.7	191.0	235.0	201.4	106.0	267.6	138.6	182.8	152.2	162.0	97.8	160.6	121.6	199.3	96.3	160.4	325.9	118.0	79.9	86.0	127.8	126.0	164.7	131.2	165.5	170.9	99.5	219.8	239.4	349.4	105.4	197.1	174.2	192.7	214.7	108.8	83.7	239.4	289.6	494.0	213.6	75.9	294.8	209.8	214.5	246.5	271.9	211.0	253.7	227.1	204.4	215.0	229.7	192.9	170.8	216.6	241.0	177.8	223.4	277.4	198.1	226.3	522.4	105.0	108.3	101.8	112.5	94.2	103.9	121.4	120.6	106.2	107.8	126.8	109.6	136.4	83.3	76.7	67.3	91.1	57.5	53.0	56.7	58.6	56.6	107.7	86.7	36.6	94.4	56.3	93.8	50.1	50.8	147.9	105.8	37.2	63.4	147.2	83.1	92.0	85.9	95.9	128.6	50.9	74.0	62.2	78.0	86.6	112.8	55.2	122.8	86.7	132.8	90.1	42.1	39.4	89.3	48.8	354.8	105.3	53.9	54.0	138.8	49.8	94.6	120.8	43.6	96.8	35.2	53.1	83.2	84.9	47.4	54.3	98.3	90.2	71.5	80.5	63.3	52.6	120.5	64.9	98.9	101.6	103.2	56.0	75.2	95.7	61.6	98.8	63.3
C6orf89	"BRAP, FLJ25357"	ENSG00000198663	"Chromosome 6 open reading frame 89"	Q6UWU4	6	36871870-36928964	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 340.1;Late spermatids: 699.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 351.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012548	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA012548: AB_1845748"	"unprognostic (2.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (3.75e-3)"	"unprognostic (3.85e-1)"	"unprognostic (9.94e-3)"	"unprognostic (8.42e-3)"	37.4	37.5	24.6	27.3	28.8	37.6	32.0	26.1	24.6	45.8	22.7	33.8	28.1	36.8	50.0	35.4	38.5	33.1	49.7	26.7	31.2	32.9	34.1	32.8	24.7	29.0	29.4	44.9	46.2	54.3	28.2	33.3	29.1	37.0	37.1	13.4	42.3	47.6	36.6	24.2	27.5	45.0	29.9	24.9	33.4	47.5	30.2	30.2	58.2	44.3	31.4	31.7	26.5	35.3	37.9	22.9	31.1	44.8	111.0	76.2	18.3	73.1	91.6	50.5	55.2	23.7	39.2	33.6	55.5	150.6	54.1	40.3	38.3	46.0	72.9	60.4	33.2	48.8	23.3	26.8	55.5	39.6	48.3	66.0	56.2	62.0	58.9	60.4	44.5	60.1	93.8	90.1	79.0	37.7	43.5	15.0	11.6	43.1	25.7	21.1	30.9	61.1	33.7	33.2	54.9	39.5	48.8	23.5	50.8	25.8	56.0	53.3	52.7	72.3	41.2	57.6	57.4	48.4	63.8	351.0	32.6	55.8	77.3	28.1	16.7	20.9	18.1	16.4	17.9	9.8	14.8	16.8	14.7	9.1	10.2	11.2	27.2	11.2	22.5	9.2	16.4	14.4	24.6	28.8	26.1	24.6	26.7	31.2	29.0	29.4	29.1	29.9	30.2	35.3	31.2	38.5	56.8	22.9	24.6	6.8	23.9	28.8	19.4	15.5	24.6	19.0	67.1	41.5	31.6	38.6	10.4	34.0	26.6	39.2	19.6	41.2	340.1	24.9	36.1	36.1	17.4	56.0	38.4	58.1	41.6	37.7	27.5	33.7	30.4	52.6	25.0	45.5	40.0	23.5	35.3	27.9	32.6	29.8	12.5	699.2	45.1	27.2	10.6	29.0	24.9	53.9	28.8	31.7	54.5	56.3	27.9	50.8	44.1	26.6	30.5	20.1	28.3	12.8	19.7	35.8	36.9	33.7	38.5	23.5	8.9	46.0	28.5	50.8	25.9	26.1
C7		ENSG00000112936	"Complement C7"	P10643	5	40909497-40984643	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 735.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1"	"Cancer enriched"	"Detected in all"	4	"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 13.7"	HPA001465	Approved				"Secreted to blood"	NA	NA		48000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	470.9	607.7	2.6	21.7	3.5	0.2	46.4	2.6	9.6	118.5	13.6	165.3	19.3	124.6	163.6	52.9	377.3	211.7	558.7	2.8	2.5	298.1	110.6	206.7	99.2	4.4	2.7	735.4	149.8	15.0	23.1	359.2	3.0	101.6	32.5	1.5	18.0	105.7	4.3	12.6	139.8	256.3	4.3	138.2	120.2	28.0	3.0	32.2	105.1	1.6	22.5	122.1	118.3	3.0	0.0	0.0	0.0	0.0	116.5	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	155.1	0.0	0.0	212.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	146.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.5	2.6	9.6	2.8	2.5	4.4	2.7	3.0	4.3	3.0	3.0	7.9	6.4	4.1	0.0	1.4	0.6	0.5	0.0	1.8	2.1	1.2	0.3	56.7	7.2	2.5	0.0	0.0	0.2	0.1	0.4	0.0	0.2	4.7	0.5	7.9	127.6	54.8	26.7	0.1	1.3	0.1	578.4	0.0	0.2	1.3	2.7	662.5	8.3	0.5	43.7	0.3	1.3	0.0	14.5	4.2	29.8	1058.5	1.5	0.0	58.1	0.6	3.7	0.0	0.0	0.0	0.9	0.9	18.0	1.0	1.3	0.2	0.1	0.0	0.9	309.0	2.2	23.7	2.6	2.5	6.5	0.6	0.3	1.2	503.1	3.0	0.8
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 36.6"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	1.5	1.6	2.4	0.6	2.9	0.7	2.0	2.6	4.5	1.6	1.7	1.6	0.5	1.7	3.2	1.6	2.0	1.9	2.1	2.8	3.2	2.7	1.6	1.5	1.6	3.4	3.0	2.2	1.7	3.1	1.4	2.0	3.5	2.6	1.0	1.9	1.6	2.8	1.7	1.4	1.2	1.9	1.9	1.8	1.9	3.7	2.7	1.6	2.7	1.9	1.2	1.2	0.9	4.5	2.7	8.5	2.2	3.7	2.9	2.0	2.5	5.9	2.0	3.4	3.0	4.9	3.9	7.4	3.7	5.2	4.3	4.1	1.7	5.0	4.2	3.3	7.3	4.0	8.2	3.2	6.2	3.2	2.2	2.9	3.4	3.3	3.3	1.4	2.6	4.8	5.0	1.5	3.3	6.1	1.7	2.5	3.0	1.7	9.8	1.7	2.8	3.7	2.1	6.9	2.8	3.9	8.3	2.9	2.7	3.3	3.3	2.1	7.3	3.6	3.8	4.3	3.3	4.0	9.1	2.2	3.7	3.5	8.3	36.6	1.6	15.7	1.5	2.0	2.3	2.2	1.0	1.5	1.0	1.6	1.6	1.7	8.8	2.2	2.3	0.8	0.8	1.1	2.4	2.9	2.6	4.5	2.8	3.2	3.4	3.0	3.5	1.9	2.7	4.5	0.4	0.0	1.1	2.3	0.7	0.3	0.4	0.1	0.6	0.9	0.4	0.5	0.6	0.0	0.1	3.7	4.2	0.7	0.3	0.1	1.9	0.9	0.1	0.4	0.6	0.7	0.0	0.4	4.6	1.1	0.4	0.6	0.0	0.2	0.0	0.6	1.1	0.5	0.2	0.0	4.7	0.2	0.0	0.0	0.4	0.3	0.6	1.2	0.0	2.8	0.3	0.7	2.1	3.0	7.9	0.9	0.3	0.7	0.2	0.3	0.7	1.5	1.0	0.4	0.0	0.3	0.8	1.7	1.3	0.4	0.4	0.8	0.5	1.0	0.2	0.1
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590021-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	18.1	18.9	16.9	12.2	18.2	21.3	18.9	15.9	18.5	23.0	15.0	21.6	12.6	23.3	6.5	16.5	22.2	9.3	17.6	16.3	16.2	19.6	21.5	17.2	17.3	18.8	17.2	19.9	21.7	10.1	17.0	7.2	16.9	22.9	7.1	3.8	16.6	9.8	21.9	21.4	18.6	11.1	16.0	27.2	20.0	17.3	17.3	18.5	19.0	10.2	10.9	20.9	17.1	20.4	21.5	17.6	12.0	28.5	19.3	10.7	15.8	12.6	10.9	17.8	10.9	16.5	8.7	25.2	16.0	9.4	33.7	23.3	16.2	11.5	8.1	9.9	23.3	9.4	11.5	17.6	22.5	22.7	29.0	12.4	17.0	10.7	11.2	9.4	19.6	26.7	25.1	18.6	10.7	36.1	19.9	46.9	24.0	10.6	23.2	40.1	9.5	21.5	11.6	18.5	15.7	29.2	12.2	39.9	17.3	12.5	18.3	33.8	14.2	14.7	48.2	16.3	27.9	22.5	23.8	23.8	9.9	24.9	44.3	0.5	1.5	2.2	2.0	1.5	2.6	1.7	2.4	2.6	1.1	1.6	2.4	2.0	1.4	1.6	1.6	2.9	2.7	0.9	16.9	18.2	15.9	18.5	16.3	16.2	18.8	17.2	16.9	16.0	17.3	20.4	12.9	9.6	8.6	11.1	13.7	15.2	8.8	4.6	13.1	7.1	14.2	14.5	6.0	12.8	6.1	1.8	6.2	11.6	23.6	11.8	0.0	8.9	8.2	9.9	12.6	12.8	12.6	4.2	9.5	10.2	10.6	11.2	10.7	8.9	1.3	16.0	12.5	7.4	13.4	5.0	8.3	12.5	8.2	11.3	10.2	3.5	8.1	12.9	7.2	7.5	8.4	6.7	18.6	9.5	13.2	10.2	9.8	8.6	10.9	10.9	8.5	8.0	5.3	6.5	6.6	12.0	14.5	11.9	13.5	11.7	12.8	9.7	17.5	14.0	11.6	7.6
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 295.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	42.3	40.6	74.8	17.5	70.8	13.4	43.2	63.1	103.3	53.3	58.8	74.1	15.4	55.8	12.6	46.7	56.2	12.9	96.1	71.5	64.8	79.1	59.2	45.5	16.8	73.4	66.2	69.8	108.5	19.7	140.0	16.7	65.0	66.0	8.8	8.8	41.2	32.3	70.0	32.9	35.1	15.1	67.5	39.5	60.4	38.6	75.2	11.1	74.7	22.5	10.9	64.1	41.4	65.3	167.9	104.8	34.5	105.2	18.2	25.8	72.2	73.3	35.6	63.8	54.0	74.3	69.9	49.9	47.1	47.4	80.9	104.1	41.6	88.6	12.6	47.7	84.0	45.8	75.1	102.6	73.7	58.7	30.2	37.0	69.3	59.6	54.4	28.0	44.1	41.5	82.7	46.5	29.0	241.6	27.3	156.3	84.2	74.8	153.7	79.4	12.8	83.0	30.2	45.6	78.7	112.8	60.2	70.6	103.9	22.7	169.7	106.6	51.6	36.9	162.9	110.9	97.5	39.3	57.2	45.8	74.1	96.0	119.0	18.1	129.4	400.1	97.1	136.4	69.4	123.7	79.1	82.6	208.0	165.6	59.9	69.8	15.1	44.8	134.1	60.5	104.9	116.7	74.8	70.8	63.1	103.3	71.5	64.8	73.4	66.2	65.0	67.5	75.2	65.3	42.9	35.3	57.2	16.0	115.8	23.2	43.4	81.6	12.5	74.0	89.2	80.9	72.2	44.3	55.9	66.2	18.8	73.5	42.2	40.5	295.4	89.2	8.5	55.9	30.9	44.3	90.8	21.2	34.1	85.5	78.6	51.6	27.0	37.5	55.8	88.1	37.5	37.7	163.1	57.2	30.8	64.6	73.2	67.5	71.0	7.5	37.0	68.8	71.2	15.9	108.9	140.2	66.9	20.6	17.5	64.2	27.0	44.4	52.4	52.4	9.9	152.0	54.4	73.3	26.3	30.8	73.0	20.4	42.8	34.2	24.4	46.5	60.4	48.0	62.2	39.0
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0;choroid plexus: 6.4;fallopian tube: 13.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 52.7;Respiratory ciliated cells: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;hTERT-HME1: 5.5;U-266/70: 3.2;U-698: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.0	0.0	0.7	0.0	0.8	0.2	0.1	0.5	0.3	0.4	6.4	0.0	0.1	0.4	0.0	0.8	13.9	0.0	0.1	0.7	0.9	0.1	0.0	2.2	0.0	4.0	3.8	0.0	0.0	0.6	0.2	0.0	2.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	3.7	0.9	0.0	0.2	0.0	0.1	0.0	0.4	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.3	0.0	0.1	0.1	3.4	0.2	0.0	0.5	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.5	0.2	0.3	3.2	0.5	1.9	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	0.3	0.7	0.9	4.0	3.8	2.3	2.9	0.9	2.0	0.0	0.0	3.0	0.3	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.1	1.0	0.0	15.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.9	52.7	0.6	0.2	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	0.0	6.1	0.0	0.4	3.5	0.0	0.3	0.0	0.0	0.0	1.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	127.6	0.9	0.0	0.0	2.7	16.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1
C7orf61	IMAGE:4839025	ENSG00000185955	"Chromosome 7 open reading frame 61"	Q8IZ16	7	100456620-100464260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 68.4"	"Group enriched"	"Detected in many"	20	"Early spermatids: 588.7;Late spermatids: 349.4"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 25.2;NB-4: 9.6;TIME: 14.9"									HPA060395	Enhanced		Approved	Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA060395: AB_2684274"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.39e-13)"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.24e-2)"	1.3	0.6	11.5	0.5	14.7	1.4	0.9	12.5	13.4	2.0	7.4	1.6	0.0	0.9	0.3	0.9	1.4	0.5	1.2	11.0	12.4	1.0	0.8	1.6	0.8	13.7	13.3	3.0	0.3	0.2	2.9	0.6	13.1	1.5	0.1	1.9	0.5	0.6	0.5	0.8	0.9	0.2	11.1	2.6	0.7	68.4	12.7	0.8	1.1	0.6	0.3	1.1	1.3	16.3	1.0	0.2	0.8	0.9	0.9	2.2	0.3	0.4	1.5	0.2	0.8	1.1	0.5	0.7	1.7	0.9	1.4	0.7	0.3	0.0	0.6	1.0	1.7	1.4	2.2	0.0	1.2	0.5	0.4	0.3	0.4	0.9	1.4	2.4	25.2	2.4	0.7	1.3	1.5	2.4	0.5	9.6	0.6	0.3	1.1	2.5	0.0	0.5	0.4	0.4	0.0	0.0	0.6	0.8	1.5	0.5	0.4	2.6	14.9	1.3	2.2	2.8	0.4	0.3	0.2	1.0	0.3	2.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.6	0.0	11.5	14.7	12.5	13.4	11.0	12.4	13.7	13.3	13.1	11.1	12.7	16.3	1.7	0.0	0.0	16.0	1.0	8.3	0.5	0.7	4.6	1.7	2.9	5.5	1.4	1.5	0.4	0.0	0.0	0.2	1.7	0.4	0.0	0.5	588.7	0.8	1.2	2.2	0.0	0.0	1.2	0.0	0.4	2.0	0.0	1.1	0.0	1.5	0.7	0.0	0.9	3.3	1.5	0.4	0.0	0.3	16.8	349.4	7.8	1.4	5.4	0.0	0.7	7.4	0.0	4.5	14.1	0.2	0.1	3.8	0.0	0.7	0.5	0.1	0.4	0.1	6.6	1.7	1.8	22.9	2.6	1.6	6.1	0.1	2.2	0.4	0.4	0.4
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 840.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 295.1"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	840.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	1.0	0.0	0.1	0.0	5.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	7.1	295.1	0.1	0.0	0.1	0.0	0.0	7.6	0.0	11.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 564.4"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1134.7"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HMC-1: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.3	1.5	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.3	0.0	1.2	31.2	0.4	0.9	0.5	0.4	2.5	1.3	0.1	0.1	2.3	564.4	0.3	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.4	0.3	0.0	0.4	0.1	3.1	0.3	17.8	0.0	0.1	2.1	1.3	2.3	0.1	0.2	0.7	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	41.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.0	0.0	0.3	2.3	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.7	28.6	0.3	0.0	2.1	0.4	1.1	25.0	0.0	0.2	0.9	0.1	0.1	0.7	1.8	8.0	0.2	0.8	1.0	0.1	0.0	0.3	8.9	1.2	17.5	1134.7	0.3	0.0	0.2	5.0	0.0	25.3	0.2	1.5	0.0	0.2	0.0	0.0	0.0	1.1	4.1	0.5	0.1	0.5	4.7	0.7	0.0	0.4	122.3	6.7	0.1	0.5	0.0	0.3	0.3	0.7	0.6	0.5	0.4	3.4	1.8	0.2	2.0	0.2
C8orf33	FLJ20989	ENSG00000182307	"Chromosome 8 open reading frame 33"	Q9H7E9	8	145052465-145066685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024812, HPA026104"	Approved		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA024812: AB_10599490, HPA026104: AB_10600875"	"prognostic unfavorable (2.77e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (4.75e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	16.5	42.1	32.3	13.1	32.1	18.2	24.8	33.5	41.7	17.7	28.3	21.7	13.1	20.4	27.1	19.5	22.8	16.5	22.3	32.0	33.1	18.7	17.1	15.0	18.2	33.3	34.3	40.7	20.8	34.0	5.6	21.1	32.8	18.8	33.4	24.6	16.4	24.2	16.9	17.4	10.2	19.6	32.4	12.2	11.5	13.1	32.7	19.3	33.2	26.0	18.4	18.8	8.9	33.3	28.3	32.7	45.8	22.7	51.3	35.5	17.2	16.6	41.7	42.0	23.3	9.2	39.2	30.3	55.3	40.5	19.5	22.4	67.5	41.2	45.3	15.0	48.4	38.1	32.1	11.5	53.1	30.6	15.1	41.0	60.4	43.0	96.8	34.5	28.1	44.9	75.4	26.3	46.1	42.4	86.3	12.3	31.8	89.1	55.2	51.2	14.9	46.6	44.1	16.3	44.1	39.1	44.3	39.3	39.0	26.1	41.1	29.1	13.8	27.5	37.3	24.2	37.8	21.7	16.9	72.2	65.9	47.0	55.1	1.0	13.7	8.7	16.3	17.4	18.4	13.4	16.2	17.8	19.6	13.3	21.3	15.6	1.4	28.2	16.0	18.4	12.6	16.3	32.3	32.1	33.5	41.7	32.0	33.1	33.3	34.3	32.8	32.4	32.7	33.3	67.8	28.9	27.2	4.9	34.8	44.4	32.8	31.9	24.5	48.3	52.8	47.9	18.4	45.8	33.8	25.8	31.3	36.9	45.3	180.5	62.6	79.5	5.6	49.9	55.1	50.2	35.3	17.5	5.7	64.9	40.2	41.7	20.9	53.0	21.5	58.5	37.1	66.8	28.7	50.5	6.0	36.4	14.2	21.5	21.2	5.6	37.9	23.0	16.0	7.5	32.3	61.2	45.3	4.0	6.0	55.3	37.7	38.7	20.4	48.1	22.1	66.1	26.6	54.5	26.3	32.8	37.9	26.2	34.8	25.4	42.9	24.9	23.6	94.9	53.0	28.5
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330955-68819023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 396.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	2.7	0.3	4.0	0.2	5.4	0.5	0.7	3.6	3.9	2.1	2.0	0.2	0.2	0.6	0.6	1.0	9.1	0.6	0.7	6.2	3.8	0.4	0.2	2.5	0.2	6.4	10.2	0.4	1.1	7.4	1.7	0.3	4.6	2.1	0.3	1.0	0.6	1.0	0.3	0.9	0.2	0.1	4.0	0.2	0.8	0.7	6.7	0.8	0.4	0.9	0.2	0.4	0.2	6.1	0.1	0.0	0.3	0.1	0.6	1.0	0.1	0.9	2.3	0.3	0.3	0.1	0.2	0.1	0.3	0.5	0.1	0.1	0.1	0.3	0.1	0.0	2.3	0.3	0.5	0.2	0.1	0.0	0.2	0.1	0.3	0.4	0.8	0.1	0.0	0.3	0.1	0.4	2.7	0.3	0.0	0.2	1.0	0.0	0.0	0.1	2.7	0.0	0.2	0.2	0.5	0.0	0.1	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.2	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.1	0.4	0.1	0.1	4.0	5.4	3.6	3.9	6.2	3.8	6.4	10.2	4.6	4.0	6.7	6.1	0.2	16.0	18.7	9.4	0.0	1.7	0.8	0.2	0.0	1.5	0.2	0.0	1.2	0.0	3.9	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.5	26.4	0.7	0.5	0.0	0.0	79.2	0.0	0.3	1.9	0.0	4.3	1.3	0.1	0.0	0.0	0.3	0.0	396.6	0.1	0.0	0.0	1.2	1.3	0.3	0.4	1.8	3.7	0.1	0.0	0.0	9.5	10.1	0.5	0.0	0.4	0.0	0.8	0.0	0.0	20.8	0.7	0.0	0.6	1.7	0.6	0.4	0.1	0.9	0.4	0.4	0.2	0.0	0.4
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.7	1.8	1.7	1.2	1.9	0.9	2.3	2.3	2.2	2.3	3.2	1.0	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	1.8	2.4	1.8	1.5	2.2	2.3	2.9	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.0	1.5	1.7	1.1	1.5	1.0	2.3	2.7	1.7	1.1	1.7	1.8	2.4	2.4	1.8	1.9	1.2	1.4	2.9	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	1.7	1.9	2.3	2.2	1.7	1.8	2.3	2.9	2.2	2.7	1.8	2.9	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
C8orf44-SGK3		ENSG00000288602	"C8orf44-SGK3 readthrough"		8	66667596-66860472	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Astrocytes: 17.3;Excitatory neurons: 23.5;Inhibitory neurons: 17.5;Microglial cells: 11.2;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 18.0"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006699, HPA027146"	Approved		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"		"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"																		4.1	3.1	5.2	3.1	5.5	6.1	6.3	5.3	7.2	4.5	3.5	3.5	2.8	5.6	11.5	2.1	7.3	3.7	4.4	5.1	6.3	4.2	3.1	3.4	5.7	4.6	4.8	7.9	2.2	2.9		3.8	4.7	5.1	5.8	9.1	4.2	6.1	4.1	6.9	2.6	4.9	3.9	5.1	4.3	6.6	4.8	5.7	7.6	3.7	5.4	2.6		7.5	6.9	2.4	3.5	2.6	5.8	7.0	1.7	2.3	4.3	5.2	5.8	2.8	8.7	9.8	1.3	5.3	4.1	4.4	5.5	3.1	8.2	8.5	8.3	9.3	7.2	5.5	4.6	5.3	6.0	9.2	9.1	3.3	7.3	9.0	5.3	10.7	9.7	5.6	4.8	2.1	4.6	3.7	3.5	6.6	3.8	3.7	2.4	2.4	5.0	2.0	3.4	3.8	2.9	1.3	3.9	5.3	7.0	3.5	5.1	2.6	2.5	2.2	2.2	5.7	3.8	4.8	4.7	6.0	1.4	31.0	9.8	6.2	4.0	4.1	4.9	7.6	4.5	5.1	7.2	6.1	7.0	5.0	6.9	5.2	2.7	6.9	7.0	4.2	5.2	5.5	5.3	7.2	5.1	6.3	4.6	4.8	4.7	3.9	4.8	7.5	0.0	0.0	0.0	17.3	0.9	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	23.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.2	0.1	0.5	0.0	15.6	18.0	0.0	1.1	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	1.4	0.1	0.0	0.6	0.0	0.0	0.0
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566869-13568288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 33.3;Late spermatids: 51.9;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;U-87 MG: 11.5;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	1.1	0.2	1.1	0.6	2.2	0.0	1.8	1.3	1.6	1.3	0.2	0.5	0.4	1.1	2.9	0.6	1.8	1.2	1.3	1.2	1.2	1.2	0.8	1.2	0.4	2.2	1.5	0.6	0.4	0.3	0.5	0.6	2.6	0.2	0.4	4.8	0.4	0.4	0.1	1.3	0.4	0.9	1.2	0.2	0.9	7.0	1.7	0.2	4.4	0.4	0.2	0.8	0.3	2.9	0.0	0.1	1.8	0.0	6.0	6.0	0.0	5.5	6.1	2.9	4.9	0.0	0.0	0.0	0.0	2.9	13.5	0.6	0.2	1.1	5.7	0.0	0.6	0.6	0.0	0.0	2.1	0.0	0.9	1.9	3.6	3.9	1.0	0.7	3.8	0.0	0.1	0.0	7.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	3.2	0.0	0.2	6.3	2.0	0.0	0.0	1.7	5.1	4.9	6.0	5.0	0.0	0.0	0.0	11.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	1.3	1.6	1.2	1.2	2.2	1.5	2.6	1.2	1.7	2.9	1.0	0.0	0.0	2.0	0.0	1.0	0.0	1.0	0.0	0.2	0.9	0.8	0.3	0.0	0.9	0.0	2.1	0.0	0.0	0.1	0.0	2.7	33.3	1.8	3.0	0.7	0.0	0.0	0.6	1.1	0.0	2.7	0.0	0.2	0.0	0.3	1.1	0.5	0.1	0.0	0.3	0.0	2.0	0.0	0.0	51.9	5.0	0.2	5.4	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	3.0	0.0	0.0	0.0	3.6	1.9	4.3	6.6	1.2	4.5	18.2	2.3	0.8	0.4	0.0	0.1	3.4	0.0	0.1
C8orf58	FLJ34715	ENSG00000241852	"Chromosome 8 open reading frame 58"	Q8NAV2	8	22599599-22604150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.1;Extravillous trophoblasts: 30.4;Sertoli cells: 26.3;Syncytiotrophoblasts: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024667, HPA028286"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA024667: AB_1845783, HPA028286: AB_1845784"	"unprognostic (8.88e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	11.1	7.1	8.8	4.3	8.3	4.5	10.8	13.5	9.9	10.6	8.5	7.7	3.5	9.2	4.9	9.8	8.9	7.2	9.9	8.4	8.9	13.3	7.9	10.6	5.5	9.5	8.4	9.3	6.2	4.9	5.5	16.6	8.9	8.3	3.2	5.9	7.1	5.5	9.0	13.6	7.2	4.8	8.7	25.7	6.3	16.5	8.9	3.5	8.1	4.8	3.5	8.6	9.9	8.6	7.7	11.4	30.8	18.2	8.3	9.5	8.4	16.9	14.2	20.9	15.0	2.2	6.4	1.5	8.0	18.7	14.2	7.5	5.6	15.9	13.4	2.3	2.6	4.5	12.0	1.2	14.5	1.6	6.7	13.7	13.5	12.4	7.8	18.7	12.2	5.9	2.8	2.2	16.8	5.5	3.4	8.4	18.8	6.3	7.5	5.6	7.7	1.8	12.8	7.0	3.2	10.0	8.3	5.9	20.0	31.8	5.6	3.6	17.0	22.7	18.1	15.9	15.7	2.7	1.8	1.5	11.7	3.3	18.6	0.0	0.2	1.2	0.1	0.5	0.1	0.4	0.1	0.3	0.1	0.4	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.1	8.8	8.3	13.5	9.9	8.4	8.9	9.5	8.4	8.9	8.7	8.9	8.6	9.8	3.2	2.0	3.9	5.0	10.3	3.8	7.0	2.8	2.9	4.2	5.0	2.4	0.0	4.9	0.0	0.0	28.1	3.6	3.4	0.0	11.5	1.2	1.4	6.4	12.1	4.2	0.8	1.0	6.7	30.4	6.1	2.0	3.2	1.3	5.4	15.7	0.8	9.5	1.7	1.1	1.7	6.1	3.1	5.4	2.3	8.7	2.9	3.6	1.9	7.9	6.5	1.0	1.0	0.3	12.5	3.3	6.4	2.8	5.1	3.9	2.3	2.4	4.8	26.3	3.1	6.7	1.8	2.9	4.1	9.7	55.8	3.8	4.6	2.2	2.8
C8orf74		ENSG00000171060	"Chromosome 8 open reading frame 74"	Q6P047	8	10672628-10700590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"testis: 17.0"	"Group enriched"	"Detected in some"	90	"Early spermatids: 186.5;Late spermatids: 392.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027986	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027986: AB_10600762"		"unprognostic (4.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.68e-2)"		"unprognostic (5.54e-2)"		"unprognostic (2.37e-2)"			"unprognostic (1.56e-4)"			"unprognostic (6.82e-2)"			"unprognostic (2.20e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	186.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	392.8	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219967-123241377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 164.9"									HPA023708	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavorable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	10.5	14.1	12.0	9.5	12.8	12.6	10.8	13.3	15.0	9.3	13.3	10.8	9.4	7.7	11.4	15.4	8.9	8.7	13.0	12.0	12.6	9.2	18.4	9.4	14.1	12.3	12.5	8.3	10.8	7.7	17.3	12.2	12.4	10.5	11.8	11.0	12.5	8.1	15.2	8.4	11.1	7.8	12.7	14.3	10.0	7.3	12.6	13.9	9.8	7.9	13.9	10.5	10.3	13.4	24.7	22.4	20.3	14.3	19.5	17.8	13.9	22.7	22.0	26.0	26.1	20.5	17.5	16.8	24.4	21.9	19.4	18.4	22.9	12.4	29.3	27.0	31.9	19.7	10.1	28.0	35.0	10.5	15.6	13.1	23.3	23.3	19.4	15.2	23.4	25.9	28.6	12.8	21.9	72.3	30.7	23.1	16.6	59.4	37.6	16.1	10.4	19.3	22.4	20.1	26.7	24.8	22.7	164.9	25.0	20.6	20.2	24.7	12.9	14.8	28.3	16.1	19.0	16.8	19.8	18.2	15.9	23.7	16.3	19.9	18.3	28.3	13.6	21.4	14.4	11.7	14.8	17.6	19.2	14.8	14.0	14.1	10.9	15.0	18.1	16.8	21.3	13.2	12.0	12.8	13.3	15.0	12.0	12.6	12.3	12.5	12.4	12.7	12.6	13.4	12.4	12.8	2.0	7.2	17.7	13.5	17.8	29.0	17.1	8.2	13.8	13.8	5.9	7.2	25.4	1.8	10.4	27.4	23.4	21.3	5.9	16.4	5.1	10.7	15.4	11.7	24.7	8.6	6.8	11.8	31.5	15.1	8.2	11.5	22.2	10.8	8.9	11.1	22.6	136.3	8.2	12.5	32.6	14.5	17.7	4.0	12.8	16.3	14.2	3.7	21.7	12.9	20.6	3.5	8.8	14.8	13.8	7.5	19.1	21.6	19.4	11.2	48.3	7.7	19.7	11.5	28.7	14.4	17.1	12.6	11.5	40.2	18.1	8.8	15.7	39.9
C8orf82	MGC70857	ENSG00000213563	"Chromosome 8 open reading frame 82"	Q6P1X6	8	144525733-144529132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 138.9;Proximal tubular cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034331	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB034331: AB_1565393"	"unprognostic (3.56e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (1.70e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-3)"	10.6	14.6	9.0	4.5	8.6	2.8	11.4	11.1	10.5	14.7	4.2	14.1	11.1	11.8	2.6	16.7	11.9	3.8	17.0	8.2	7.5	16.2	35.6	8.6	3.8	9.4	8.1	15.1	13.2	6.6	12.2	3.3	8.6	26.3	3.8	4.6	11.6	5.5	12.0	9.1	11.7	2.8	7.2	9.9	12.3	7.4	8.4	4.5	12.6	3.5	2.4	15.0	11.8	11.5	6.8	16.8	9.8	7.9	4.0	3.4	8.2	7.2	3.9	3.9	3.9	8.3	11.2	11.9	11.4	4.5	3.3	8.1	2.2	2.5	1.4	9.0	25.7	23.0	10.4	15.6	4.2	3.5	10.8	5.1	5.5	2.5	2.5	6.4	2.7	6.6	19.1	5.9	2.9	35.7	8.9	14.2	5.3	10.1	46.6	9.9	3.3	5.8	6.1	10.1	33.3	27.3	11.0	7.8	7.1	3.3	14.3	7.1	14.6	7.5	28.7	8.4	5.3	4.2	2.8	9.8	9.9	4.3	7.3	0.1	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	9.0	8.6	11.1	10.5	8.2	7.5	9.4	8.1	8.6	7.2	8.4	11.5	12.2	3.2	6.9	0.3	12.9	15.9	49.6	1.9	23.3	30.4	39.6	38.6	17.9	18.6	1.9	16.5	14.6	33.4	13.0	46.3	138.9	5.8	16.8	10.3	22.1	12.3	34.2	14.9	0.1	7.7	35.1	18.5	19.4	26.0	5.7	16.3	9.7	69.8	18.6	28.6	0.1	31.9	2.0	16.1	16.1	21.4	24.2	15.2	33.8	0.0	7.5	28.0	13.4	0.0	0.1	6.7	22.1	20.3	16.3	55.6	35.4	99.1	0.4	35.8	32.9	21.1	23.0	24.4	18.8	36.9	20.9	25.2	13.1	34.5	34.6	43.3
C8orf88		ENSG00000253250	"Chromosome 8 open reading frame 88"	P0DMB2	8	90958471-90985238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 91.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 612.7;Late spermatids: 138.4;Spermatocytes: 329.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 63.4"					"Low region specificity"	"Detected in all"			HPA078486	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA078486: "	"unprognostic (2.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.95e-4)"	"unprognostic (4.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (6.23e-6)"	8.0	3.8	2.2	4.2	2.9	11.0	6.7	2.4	2.7	10.6	4.9	32.9	2.1	21.4	13.1	8.7	11.9	7.1	38.2	2.2	3.2	4.9	1.0	4.7	1.7	3.0	2.6	13.3	1.3	0.4	4.1	3.5	3.0	13.9	5.7	1.6	2.4	23.5	1.4	7.1	6.5	30.8	3.2	3.0	13.3	91.6	2.7	13.0	10.9	1.8	1.4	19.0	7.8	4.3	0.1	2.4	13.4	1.2	15.4	13.4	0.2	14.6	22.8	19.8	29.7	0.1	3.8	0.3	1.3	14.9	20.6	0.1	0.2	1.1	36.7	0.0	38.6	41.7	11.5	0.0	63.4	0.0	1.3	14.1	0.3	22.3	37.0	28.9	2.1	13.6	25.0	23.9	30.3	0.0	39.7	14.9	3.3	0.0	0.7	0.0	26.1	0.1	16.3	0.1	11.4	19.8	0.6	0.0	19.6	15.1	0.0	1.9	8.5	22.8	38.0	0.3	15.5	33.3	33.4	21.2	22.6	0.0	10.5	0.0	0.0	0.0	0.9	0.0	1.2	1.1	0.8	1.0	0.2	0.9	0.7	1.4	0.0	3.8	0.0	3.2	0.6	0.4	2.2	2.9	2.4	2.7	2.2	3.2	3.0	2.6	3.0	3.2	2.7	4.3	6.4	0.0	1.1	1.3	2.9	18.9	9.3	1.0	19.4	0.0	0.5	8.6	12.4	2.8	0.1	3.7	0.0	0.2	0.8	0.0	5.9	1.1	612.7	0.3	9.0	4.7	0.0	55.6	3.1	0.0	0.9	13.7	0.0	0.2	2.5	4.9	5.0	0.0	0.6	0.0	6.4	0.0	0.0	0.8	3.8	138.4	19.0	1.7	10.6	1.9	0.6	0.9	0.0	2.0	4.0	3.6	0.0	21.8	3.0	6.6	0.0	1.4	0.1	0.2	19.7	8.2	21.1	329.5	30.7	6.9	26.6	0.0	2.8	2.0	0.0	1.2
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39424868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	288	"liver: 1397.0"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 1962.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"JURKAT: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	64000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1397.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.8	2.0	0.0	18.7	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.5	1962.3	1.2	0.0	0.1	0.2	0.0	52.6	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.1	3.7	1.7	0.0	0.0	0.3	3.0	0.0	0.0	0.1
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 97.2;testis: 62.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.3;T-47d: 41.9;U-2197: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	2.6	16.3	11.9	0.8	12.8	0.9	3.1	10.7	13.0	5.5	24.5	2.1	1.0	4.2	25.7	1.9	97.2	2.8	2.0	14.0	13.6	9.5	3.5	9.2	0.7	15.8	19.7	2.8	6.5	6.8	16.9	1.5	15.9	4.2	1.2	10.1	3.4	6.3	1.5	1.8	1.4	1.2	15.4	1.9	3.1	62.5	14.5	0.6	8.1	0.9	1.2	2.7	1.5	13.0	11.0	18.7	8.1	12.7	3.5	7.4	1.6	7.3	5.1	8.7	5.9	7.1	10.9	1.9	9.5	4.9	4.7	7.4	9.1	4.1	7.4	0.5	8.0	0.0	21.0	22.1	9.7	1.5	5.0	5.2	3.2	4.4	1.4	7.1	4.2	8.6	10.3	1.4	4.2	41.3	5.7	1.9	17.1	17.2	21.5	8.7	3.9	6.9	21.0	7.7	7.9	8.3	10.3	4.4	1.2	3.7	41.9	1.8	2.1	5.0	6.5	42.9	2.9	4.7	12.6	1.8	14.7	0.7	1.5	0.0	0.8	0.0	0.5	0.5	1.2	0.2	0.4	0.4	0.3	0.4	0.7	0.5	0.0	0.6	0.1	0.1	0.5	0.3	11.9	12.8	10.7	13.0	14.0	13.6	15.8	19.7	15.9	15.4	14.5	13.0	1.2	9.6	7.8	2.3	1.9	0.9	1.8	39.7	2.2	5.0	11.7	9.8	1.7	15.7	46.3	14.7	14.6	11.5	0.7	0.5	11.7	26.0	520.9	442.5	6.6	2.1	1.2	1.3	2.1	7.8	3.4	5.2	4.6	23.9	1.3	12.0	0.7	1.6	3.6	3.3	2.2	1.0	38.7	1.2	1.4	579.4	8.1	1.3	0.0	0.0	2.0	13.2	0.0	1.0	0.2	6.9	1.7	7.5	3.6	2.4	1.3	58.8	610.3	19.9	0.0	1.4	15.0	133.8	20.0	1.3	0.3	4.5	1.6	41.4	1.7	3.1
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820817-69906227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 36.8;testis: 15.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 77.2;Early spermatids: 192.0;Endometrial ciliated cells: 198.0;Respiratory ciliated cells: 277.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.7;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	5	"HAP1: 11.7;NTERA-2: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.2	0.2	0.8	6.5	0.0	0.0	0.5	0.0	0.0	36.8	1.4	0.0	0.5	0.7	1.3	0.0	2.2	0.0	1.6	2.4	0.0	0.5	3.0	7.6	0.0	1.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	15.5	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.4	0.2	0.2	0.5	0.7	1.6	2.4	1.2	1.7	1.0	0.8	0.0	0.0	2.0	0.0	0.0	0.4	0.0	14.7	0.0	0.1	0.3	0.5	2.5	0.0	30.8	1.8	77.2	0.1	0.0	0.7	17.6	0.7	192.0	198.0	2.1	0.5	1.8	0.0	0.5	0.0	0.0	0.5	0.0	2.4	1.3	0.3	0.0	0.0	0.1	0.0	0.4	0.3	12.2	0.0	1.1	22.0	2.5	0.6	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.2	0.1	0.7	0.0	0.1	0.0	2.2	277.3	1.5	0.0	0.0	5.7	41.8	1.3	0.0	0.1	0.0	0.5	0.1	0.0	0.3
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.1	0.0	0.5	2.1	0.4	0.0	12.4	0.2	0.4	10.4	0.1	32.8	19.0	2.3	0.0	3.0	3.7	5.5	0.0	0.4	0.1	0.2	0.8	5.8	0.0	0.6	0.4	0.0	5.1	0.0	0.1	0.0	0.6	17.0	41.6	0.0	25.4	1.4	0.0	5.4	15.1	1.2	0.2	0.1	32.9	0.0	0.5	0.1	0.1	0.0	0.2	1.2	0.4	0.6	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	149.2	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.3	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.1	0.6	0.4	0.6	0.2	0.5	0.6	0.4	9.6	16.3	0.3	0.2	0.3	3.4	5.9	6.2	0.0	20.5	10.8	0.1	20.0	14.5	0.0	0.0	0.0	0.1	35.4	0.0	6.0	0.0	4.0	2.0	0.5	25.9	0.0	0.1	11.1	0.0	0.2	25.0	13.9	0.0	0.0	0.0	3.3	0.1	0.0	0.1	139.7	40.7	0.0	1.0	0.0	0.0	0.6	10.6	0.0	0.0	0.0	0.0	0.0	0.1	3.9	40.0	0.0	0.0	12.4	4.4	0.0	5.2	0.0	0.0	0.4	0.9	0.0	0.0	10.9	0.4	0.0	0.4	0.0	79.8	5.5
C9orf16	"EST00098, FLJ12823, MGC4639"	ENSG00000171159	"Chromosome 9 open reading frame 16"	Q9BUW7	9	128160265-128163924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 325.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 869.5;Urothelial cells: 938.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020725	Uncertain		Approved	Microtubules		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA020725: AB_1845816"	"unprognostic (8.85e-2)"	"prognostic favorable (7.60e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (6.42e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (8.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.09e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-3)"	"unprognostic (2.48e-2)"	81.3	325.2	174.9	22.8	145.7	66.8	75.7	96.3	295.9	75.5	121.4	62.8	24.4	67.0	9.3	89.0	53.3	27.8	78.3	314.3	114.6	85.4	63.0	59.0	41.2	123.0	114.2	42.4	93.6	18.5	81.6	12.8	136.5	93.4	8.9	5.9	100.1	32.7	41.8	160.6	52.8	13.1	107.4	88.8	64.0	51.7	148.2	41.6	53.5	11.7	22.2	108.2	100.1	154.2	36.4	48.0	26.9	150.2	18.0	39.7	63.1	34.2	27.9	27.7	21.9	23.9	95.4	41.0	67.6	14.9	6.7	103.5	7.5	27.3	1.5	77.0	60.7	29.2	57.3	48.7	31.5	32.6	72.0	30.0	39.8	14.5	7.2	21.9	39.5	111.9	78.5	79.4	15.1	210.4	109.0	139.0	60.4	74.2	89.1	102.0	17.9	170.7	35.7	31.9	67.1	98.9	60.8	54.1	74.0	6.5	60.8	30.1	48.2	28.9	69.4	37.3	30.0	76.5	61.5	63.8	80.1	45.9	29.4	221.4	119.4	205.0	155.7	105.1	169.6	168.8	178.4	153.3	135.4	178.0	139.9	144.2	138.0	165.9	92.5	144.4	254.8	142.0	174.9	145.7	96.3	295.9	314.3	114.6	123.0	114.2	136.5	107.4	148.2	154.2	146.3	6.4	4.8	11.8	149.7	197.2	356.6	519.8	124.1	77.1	265.6	298.3	33.9	108.7	199.9	355.0	14.6	97.1	209.8	291.7	309.1	223.8	162.2	100.5	88.4	151.9	407.8	139.5	26.4	354.5	88.3	103.8	77.5	120.2	162.0	112.7	133.2	106.4	247.4	18.5	19.2	254.0	193.3	247.3	251.6	869.5	76.7	203.1	224.1	9.4	236.7	91.4	311.0	8.0	11.6	223.6	233.9	83.1	129.0	281.5	131.2	224.9	93.7	46.1	72.3	58.1	197.3	30.7	82.9	142.3	233.4	60.3	215.2	155.3	205.9	938.8
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397810	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.2;choroid plexus: 105.6;fallopian tube: 108.7;testis: 90.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.2	0.6	20.6	0.3	26.6	0.0	0.7	19.5	29.8	7.8	105.6	3.2	1.9	0.7	0.0	0.4	108.7	0.3	17.5	20.8	22.8	3.4	0.3	18.4	0.2	35.9	39.2	0.4	0.9	0.1	10.6	0.2	29.8	1.6	0.7	1.2	1.9	0.4	1.4	0.6	5.4	0.5	33.0	0.2	1.4	90.6	22.3	0.3	0.6	1.7	0.3	0.9	0.4	25.5	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.3	0.0	0.4	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.6	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.4	0.1	20.6	26.6	19.5	29.8	20.8	22.8	35.9	39.2	29.8	33.0	22.3	25.5	0.4	6.4	15.1	11.4	0.3	2.2	3.3	67.3	2.2	1.4	1.6	1.8	37.0	1.5	116.4	7.3	0.0	0.6	0.1	11.3	72.4	1.1	744.6	841.0	6.1	2.1	12.1	0.0	11.3	1.5	0.3	3.5	0.5	9.8	8.8	0.2	1.4	4.1	0.4	0.0	12.6	13.4	81.4	1.0	1.0	3115.3	10.5	2.7	0.0	1.0	0.0	2.2	1.0	4.0	5.4	0.2	7.3	7.2	0.5	4.5	142.5	13.7	1312.6	0.9	32.9	0.5	25.5	21.0	6.9	0.4	1.0	0.5	1.6	0.0	20.5	2.4
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946583-74952912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Cardiomyocytes: 45.0;Erythroid cells: 39.2;Spermatocytes: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		230000	"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	4.9	2.1	6.9	4.3	6.8	6.2	4.4	6.8	9.6	4.2	4.5	5.8	8.4	3.7	1.5	3.9	3.1	1.6	2.9	7.1	7.2	2.6	3.1	2.1	4.7	7.4	6.9	2.6	2.3	2.9	3.1	3.7	7.2	2.7	5.1	7.9	2.2	2.4	3.1	2.2	11.3	2.7	7.3	3.9	2.6	11.8	6.8	4.3	2.1	2.5	4.7	4.2	4.2	8.4	29.6	6.3	16.3	6.6	6.5	8.2	30.2	23.0	7.1	15.7	16.8	1.8	9.0	26.5	6.7	5.8	26.2	8.6	12.9	1.3	24.9	36.0	19.9	14.1	11.2	11.3	5.2	17.2	21.5	4.1	8.5	8.7	6.2	6.3	4.9	19.1	20.3	17.5	20.7	8.3	30.3	19.9	19.2	15.4	19.2	28.0	12.8	6.5	6.7	7.1	17.7	7.8	10.1	8.5	7.3	14.3	10.3	13.1	6.4	14.1	15.9	19.5	20.4	33.2	26.7	17.0	10.7	19.0	15.5	0.6	0.1	2.1	0.3	0.1	0.1	0.8	0.3	0.3	0.1	0.5	0.7	0.4	0.1	0.0	0.2	0.3	0.4	0.1	6.9	6.8	6.8	9.6	7.1	7.2	7.4	6.9	7.2	7.3	6.8	8.4	29.9	3.2	0.5	2.3	5.8	2.4	4.4	1.1	3.4	9.7	6.0	6.2	45.0	0.0	0.6	3.7	8.4	20.9	3.2	13.4	1.9	3.3	12.0	2.9	6.2	12.1	1.2	39.2	5.8	3.1	24.9	5.9	2.6	6.4	0.0	3.1	8.2	3.8	11.3	1.7	4.6	7.9	0.0	4.2	3.7	2.9	4.4	3.5	1.8	6.5	2.6	4.8	2.1	1.5	4.0	2.5	7.3	5.3	4.2	5.4	20.3	2.2	1.0	16.4	0.0	3.8	5.8	42.2	10.6	7.1	5.3	12.3	4.8	9.2	17.0	3.9
C9orf50	FLJ35803	ENSG00000179058	"Chromosome 9 open reading frame 50"	Q5SZB4	9	129612225-129620776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"testis: 8.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 60.9;Late spermatids: 233.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA026743	Enhanced					NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA026743: AB_1845829"	"unprognostic (2.23e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.28e-2)"	0.1	0.1	1.4	0.0	1.2	0.0	0.1	1.4	2.0	0.4	1.0	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.1	1.2	1.4	0.9	0.0	0.1	0.0	1.7	1.5	0.1	0.0	0.0	0.6	0.0	1.3	0.3	0.0	0.1	0.3	0.3	0.0	0.1	0.1	0.0	1.4	0.1	0.1	8.5	1.4	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	1.4	2.0	1.2	1.4	1.7	1.5	1.3	1.4	1.4	1.4	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.2	0.2	0.4	0.3	1.5	0.2	3.7	0.0	0.0	0.0	0.0	5.9	0.2	60.9	5.3	0.5	0.3	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	233.9	0.9	0.1	0.0	0.0	0.0	12.5	0.0	2.5	0.2	0.2	0.0	1.9	0.0	0.2	0.0	1.6	0.4	0.4	0.0	0.1	0.5	1.4	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2
C9orf64	MGC10999	ENSG00000165118	"Chromosome 9 open reading frame 64"	Q5T6V5	9	83938311-83956986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054903, HPA066190"	Uncertain		Approved	"Golgi apparatus"		NA	NA		9400	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA054903: AB_2682636, HPA066190: AB_2685633"	"unprognostic (2.07e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.48e-3)"	8.1	9.2	4.7	8.4	5.6	2.3	7.9	5.1	5.6	8.9	11.0	7.9	23.6	10.2	11.3	5.9	11.4	6.3	8.4	4.8	5.8	13.5	24.5	8.8	8.4	5.7	6.0	10.9	6.1	14.0	4.6	8.0	5.7	8.8	8.2	5.5	6.6	8.7	7.7	4.3	22.1	10.4	5.3	6.6	9.7	8.2	5.5	10.0	16.1	7.1	8.1	7.7	4.9	6.7	23.4	19.7	0.3	0.1	9.9	13.4	23.7	15.0	4.3	14.2	15.8	17.9	20.5	0.1	12.5	16.9	5.7	14.2	0.0	0.5	18.4	25.2	13.1	10.4	25.6	34.9	22.8	0.0	30.1	15.4	19.8	13.6	0.0	3.2	9.3	0.1	25.3	0.3	17.4	23.0	4.9	0.8	18.7	14.8	9.6	0.1	29.9	1.1	11.4	3.7	19.2	18.9	27.0	6.4	21.1	0.3	8.4	20.1	2.9	1.7	20.0	31.7	4.4	6.3	0.3	0.9	13.1	0.8	10.2	7.0	10.4	9.8	6.5	11.8	6.2	2.4	4.9	6.6	11.9	3.3	5.3	6.3	4.2	12.6	12.9	8.3	5.8	4.6	4.7	5.6	5.1	5.6	4.8	5.8	5.7	6.0	5.7	5.3	5.5	6.7	6.5	12.8	10.8	2.0	3.6	2.2	4.5	5.2	4.0	4.3	5.5	4.2	5.4	4.3	3.3	3.7	4.2	12.7	4.1	6.2	11.7	11.6	6.7	11.1	9.0	5.4	4.2	3.4	2.6	8.7	19.4	8.5	8.6	8.4	9.5	6.0	4.6	24.7	12.3	3.3	2.9	7.2	14.2	12.8	4.6	2.9	8.1	8.7	1.8	1.9	13.2	11.9	7.2	3.0	3.8	10.6	10.4	10.9	3.6	3.7	22.1	17.3	6.5	7.3	0.0	11.3	6.7	9.6	5.5	3.7	1.4	4.4	4.2	10.7	10.5	3.0
C9orf72	"DENND9, DENNL72, MGC23980"	ENSG00000147894	"C9orf72-SMCR8 complex subunit"	Q96LT7	9	27535640-27573866	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Intracellular and membrane"	Yes	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	11.7	12.1	9.5	16.6	9.5	25.3	9.4	21.0	12.5	9.8	12.4	8.8	6.8	12.0	11.3	7.6	16.0	10.2	9.3	9.7	13.5	7.0	16.0	17.7	9.2	14.6	11.9	24.2	9.6	6.9	16.2	12.1	12.5	14.2	7.8	31.3	6.7	5.8	14.9	8.8	8.3	8.6	12.4	16.8	7.8	17.6	11.3	11.1	13.1	9.9	8.8	9.2	8.5	14.5	4.4	3.7	28.7	4.4	5.7	7.0	4.4	5.9	4.9	3.5	1.8	0.4	1.4	10.2	3.7	5.3	7.5	3.1	9.4	7.2	2.5	19.8	3.6	4.9	11.0	3.0	8.9	3.4	5.2	7.3	8.6	0.8	16.1	3.5	7.6	11.1	9.8	18.6	4.3	0.8	6.6	5.0	14.2	6.8	16.0	2.4	9.5	5.1	2.8	3.3	9.9	24.4	4.0	4.4	3.7	10.9	3.7	2.9	6.6	0.0	14.5	8.6	4.0	4.8	15.8	6.8	11.4	11.0	3.8	24.3	32.0	2.4	1.9	44.7	3.3	3.4	2.7	2.5	25.2	2.5	4.6	2.9	34.3	4.3	36.9	3.9	4.0	10.0	9.5	9.5	21.0	12.5	9.7	13.5	14.6	11.9	12.5	12.4	11.3	14.5	15.4	16.0	14.7	19.2	43.2	35.9	50.7	15.0	26.2	22.1	7.2	6.6	15.6	4.3	15.2	7.3	20.9	21.2	11.7	5.0	1.9	8.4	2.6	94.4	11.8	15.0	11.4	3.0	53.0	9.3	7.3	18.7	16.8	57.6	16.5	18.4	8.2	9.3	25.8	11.8	58.9	12.5	10.2	71.9	127.8	4.2	6.2	94.8	19.6	42.2	58.2	45.2	3.1	30.2	60.9	8.6	11.1	3.8	10.7	30.0	4.1	5.4	80.7	27.5	0.0	17.5	20.6	29.2	20.9	15.2	29.1	34.6	18.2	7.9	5.1	37.6
C9orf78	"CSU2, HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 414.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	38.4	36.9	53.7	33.4	55.5	113.6	35.7	53.8	62.3	35.3	49.7	41.7	27.2	36.1	35.4	36.9	32.4	31.3	37.5	54.0	55.4	47.8	61.0	29.7	49.6	55.5	55.3	36.3	38.2	29.2	29.4	27.9	54.8	35.5	33.5	20.7	35.5	30.8	67.6	40.9	37.1	29.1	54.4	37.3	36.5	33.2	56.5	60.5	37.9	36.5	44.4	40.9	34.3	56.3	36.0	36.3	36.9	59.8	66.4	44.4	44.4	51.7	41.0	44.7	32.5	37.0	38.3	57.9	41.6	60.5	72.6	71.8	52.8	41.9	36.9	57.2	37.8	92.1	63.6	40.8	42.7	131.5	91.1	39.2	78.2	56.5	47.9	44.2	42.9	242.6	235.4	68.3	57.3	87.4	175.0	160.3	53.2	143.9	81.4	47.8	57.1	117.8	46.3	24.9	31.6	60.0	76.2	73.0	63.3	35.8	63.9	88.6	47.2	68.5	50.1	68.2	63.6	30.2	94.6	89.9	57.1	105.1	57.3	164.4	82.1	219.5	150.2	131.0	150.4	105.3	156.0	164.3	69.7	106.5	174.8	159.8	63.8	147.9	172.7	82.7	184.6	138.6	53.7	55.5	53.8	62.3	54.0	55.4	55.5	55.3	54.8	54.4	56.5	56.3	55.7	89.8	84.6	7.8	93.9	78.1	64.8	60.2	55.2	39.8	57.3	58.5	55.5	57.2	81.6	57.0	37.5	71.9	160.1	60.7	125.2	65.1	58.8	46.7	57.7	58.4	84.4	414.9	12.5	89.6	78.3	55.4	39.3	41.1	134.1	34.8	45.7	83.3	66.3	32.0	12.8	64.5	109.9	66.6	78.2	17.7	59.0	75.0	72.9	8.4	102.6	62.3	178.2	5.0	9.9	65.7	44.0	60.9	73.9	68.4	102.8	183.4	72.8	35.1	78.9	59.9	68.0	119.8	117.7	63.2	85.0	67.6	172.4	45.3	58.0	55.9
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	7.5	6.6	7.5	6.4	9.0	6.0	8.9	8.2	7.8	9.2	5.0	7.8	11.9	7.3	5.7	9.9	6.5	6.8	6.2	7.0	7.2	7.1	7.9	5.0	8.7	8.5	7.6	9.5	7.8	4.9	5.9	8.4	8.2	7.2	7.5	6.3	8.9	5.0	8.7	11.2	8.2	6.3	6.5	6.7	6.8	5.4	8.2	8.5	8.5	8.4	8.0	9.8	8.4	12.9	11.6	7.5	12.6	10.4	12.7	23.4	12.8	13.8	22.0	11.1	11.0	1.5	6.4	18.5	6.9	12.1	11.7	20.1	13.4	13.6	15.4	12.9	6.5	11.3	10.3	9.5	13.9	16.7	8.5	19.2	18.2	11.4	25.2	17.5	13.8	17.1	13.8	11.8	14.5	5.7	20.4	11.8	11.6	17.8	17.6	11.6	22.4	0.5	16.3	16.7	10.1	13.9	7.0	17.8	25.0	13.8	6.0	9.6	12.1	10.2	13.3	23.7	10.6	12.0	21.7	8.5	14.0	12.6	6.5	15.1	6.6	10.6	9.9	7.5	10.5	8.7	8.4	8.5	7.3	8.6	10.2	10.8	7.6	13.0	6.8	10.5	8.4	7.4	7.5	9.0	8.2	7.8	7.0	7.2	8.5	7.6	8.2	6.5	8.2	12.9	19.2	6.4	17.0	35.6	15.7	7.6	13.6	12.8	25.6	10.9	13.9	22.9	14.0	8.6	12.6	5.5	8.4	20.3	18.4	25.2	21.5	14.2	10.8	9.4	19.7	15.0	6.6	8.2	27.4	19.9	19.0	14.1	19.9	10.8	18.4	13.7	18.5	9.7	14.8	5.0	19.2	23.4	10.2	16.1	8.9	7.5	20.8	15.2	3.6	24.4	17.7	12.5	33.0	44.2	112.1	17.8	30.6	13.2	9.5	12.7	29.3	22.8	8.4	13.0	13.1	19.3	17.3	20.6	14.6	23.2	9.8	10.8	16.2	21.9	16.8	27.0
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1798.9;intestine: 2109.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	2.0	0.4	0.4	0.5	0.3	1798.9	2.1	1.0	1.5	0.3	0.0	1023.3	0.2	1.6	0.1	0.7	2.2	0.3	1.6	0.2	0.2	2.0	6.7	5.9	0.2	0.3	0.3	0.4	0.3	0.1	1.9	20.7	0.3	0.4	2109.9	0.4	1.1	1.8	1.0	1.4	1.8	30.7	0.1	35.4	2.3	0.2	0.5	0.5	0.9	3.4	0.1	0.4	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.4	0.3	1.0	1.5	0.2	0.2	0.3	0.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.9;cervix: 21.8;retina: 44.5"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 1607.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.2;RT4: 2.1;SCLC-21H: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.0	3.2	22.9	0.0	21.0	0.0	0.0	54.9	27.2	21.8	7.9	0.4	0.3	0.2	0.0	0.0	0.4	0.1	0.0	23.0	20.6	7.2	0.0	0.0	0.0	33.4	19.3	1.9	0.2	0.0	3.9	1.0	33.4	0.0	0.1	44.5	1.2	0.0	0.0	0.0	0.5	0.1	19.5	0.0	0.1	10.2	30.6	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	2.1	6.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	21.0	54.9	27.2	23.0	20.6	33.4	19.3	33.4	19.5	30.6	17.6	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.4	0.0	0.0	3.7	4.2	0.0	0.1	0.0	15.6	0.0	134.5	0.0	0.0	0.3	0.0	0.0	343.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	17.0	0.0	0.0	0.0	0.2	84.4	1.2	0.1	0.0	14.0	0.0	5.1	0.0	1607.5	4.2	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	11.9	0.0	0.1	0.0	1.5	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63381846	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 290.2;skin 1: 142.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 174.6;Distal enterocytes: 422.6;Paneth cells: 160.8;Squamous epithelial cells: 185.3;Suprabasal keratinocytes: 252.2;Undifferentiated cells: 138.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 213.0;ASC TERT1: 213.0;RT4: 226.2;SK-BR-3: 177.9;T-47d: 286.8;U-138 MG: 300.5;U-87 MG: 361.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008773, CAB025181, CAB062549, CAB068179, HPA073203"	Enhanced					NA	NA		52000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: AB_2686580"	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	8.3	0.2	6.1	18.7	42.9	0.1	42.8	5.2	7.2	50.7	129.0	104.1	0.4	28.4	4.1	75.4	25.0	7.7	3.2	6.8	6.6	290.2	0.7	3.0	0.3	0.9	9.6	0.6	70.2	0.3	10.7	2.3	3.2	5.5	94.2	1.9	26.3	8.7	0.6	142.1	8.2	56.2	0.9	0.8	7.9	0.6	16.1	0.1	4.6	0.1	8.7	27.4	49.0	1.5	0.0	213.0	3.5	0.5	27.3	213.0	11.2	15.7	13.7	2.5	4.1	1.6	0.5	0.0	51.4	12.6	81.7	1.1	0.0	10.4	6.2	0.3	7.7	0.0	13.9	0.4	0.6	0.0	0.3	81.3	11.4	63.6	20.4	0.1	2.7	0.1	0.0	0.3	2.8	125.2	0.3	0.2	3.4	0.0	33.4	0.1	0.0	0.1	0.2	226.2	1.8	0.2	0.9	177.9	0.0	2.1	286.8	0.1	0.4	300.5	16.0	10.1	0.2	0.0	0.0	0.1	361.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	42.9	5.2	7.2	6.8	6.6	0.9	9.6	3.2	0.9	16.1	1.5	0.7	0.0	6.9	11.4	1.1	174.6	20.0	87.7	93.4	0.1	93.5	50.4	1.3	1.5	30.3	40.5	0.0	0.4	1.6	422.6	54.8	17.2	12.1	28.4	6.2	2.1	8.4	0.0	1.3	58.4	2.0	14.6	8.2	75.0	1.3	0.3	0.0	0.2	0.6	0.0	0.8	111.4	20.3	0.3	11.9	3.9	0.0	4.0	23.2	0.0	0.0	2.7	0.0	1.0	0.1	10.2	160.8	0.0	0.0	19.8	15.6	73.9	6.9	0.2	0.0	0.2	4.1	0.0	0.0	185.3	252.2	1.8	2.8	0.1	138.8	17.4
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257251-150265078	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 33.3;retina: 39.4;skeletal muscle: 33.7;tongue: 47.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 69.5;Melanocytes: 53.4;Muller glia cells: 164.5;Oligodendrocytes: 25.7"	"Cancer enriched"	"Detected in many"	5	"melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 102.2;AN3-CA: 65.9;NTERA-2: 83.9;SK-MEL-30: 217.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.0	0.2	8.6	0.2	14.4	1.2	0.3	15.9	27.6	0.1	33.3	3.8	0.4	0.1	0.4	1.9	1.7	0.6	7.6	8.7	11.3	0.3	8.7	0.2	0.1	14.3	14.0	1.4	0.2	3.4	0.5	0.3	14.6	4.0	0.7	39.4	0.4	20.3	33.7	5.4	1.3	0.5	12.5	0.2	1.2	0.5	13.3	0.0	1.0	47.4	0.0	0.6	0.1	20.6	0.9	0.2	102.2	65.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.1	0.0	0.2	1.1	0.3	0.3	6.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.6	0.0	0.9	0.3	0.3	83.9	0.4	1.1	0.1	0.3	0.3	0.0	0.2	3.2	1.8	0.0	0.3	217.9	14.6	0.8	0.4	0.1	0.1	0.2	0.2	0.4	0.9	4.9	0.4	0.7	0.5	0.2	0.0	0.2	0.4	0.4	0.5	0.1	0.5	0.2	0.3	0.0	0.6	0.3	0.3	0.5	0.0	0.1	0.6	0.0	0.0	8.6	14.4	15.9	27.6	8.7	11.3	14.3	14.0	14.6	12.5	13.3	20.6	0.1	3.2	0.5	0.3	0.2	2.2	0.3	0.3	0.0	1.3	0.1	0.0	69.5	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.7	0.1	3.4	0.0	0.2	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.3	0.0	0.3	0.9	0.2	0.9	0.1	53.4	0.0	0.0	164.5	0.0	0.0	25.7	1.9	0.3	3.4	0.0	0.3	0.0	0.1	0.1	4.9	0.0	0.6	0.5	0.0	0.2	0.0	0.4	0.3	0.1	0.0	0.2	0.5
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463968-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 687.4;stomach 1: 1108.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1773.2;Erythroid cells: 2448.1;Gastric mucus-secreting cells: 1380.7;Muller glia cells: 1536.4;Paneth cells: 781.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 263.8;HEK 293: 1097.8;THP-1: 461.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001550, CAB010102"	Enhanced					NA	Yes		570000000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	7.4	10.1	95.9	36.8	127.5	246.8	37.9	122.1	143.8	5.0	444.0	687.4	285.2	2.9	10.6	19.8	2.7	112.7	15.9	105.2	107.8	331.2	273.5	43.1	6.6	115.5	112.0	0.4	55.1	10.1	6.1	19.6	114.2	1.9	643.6	390.4	74.7	68.4	42.7	81.0	31.3	32.3	98.2	8.4	1108.7	21.2	115.6	5.1	15.9	62.8	4.3	2.9	5.2	145.5	3.7	2.8	12.2	0.0	0.1	0.0	31.2	0.0	0.0	0.0	0.0	15.1	0.9	0.0	9.5	0.0	0.1	263.8	37.4	13.2	0.0	0.0	1097.8	35.8	17.0	0.5	0.0	23.7	5.1	0.0	63.9	0.0	3.7	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.4	41.4	3.7	86.5	0.0	21.2	1.3	0.5	3.7	8.8	0.2	0.3	5.0	0.0	0.1	9.6	0.0	461.5	0.0	0.0	6.6	0.0	0.4	0.4	1.0	0.1	1.8	0.1	0.0	51.2	5.3	8.6	0.2	15.0	7.4	1.3	0.1	0.8	15.4	3.0	0.0	0.0	12.6	0.1	13.4	1.4	0.0	33.3	95.9	127.5	122.1	143.8	105.2	107.8	115.5	112.0	114.2	98.2	115.6	145.5	19.4	16.0	79.9	34.0	19.6	90.6	1.3	152.5	17.6	23.1	56.9	18.4	19.8	430.4	22.4	161.8	64.6	15.2	2.4	1773.2	348.3	60.1	65.9	3.3	1.3	26.7	30.5	2448.1	1.4	11.3	403.1	6.4	1380.7	8.3	15.9	0.4	4.2	135.6	35.4	13.5	22.3	116.0	10.2	11.0	216.5	232.1	3.4	51.8	74.7	6.5	6.6	1536.4	1.0	3.0	226.4	16.1	781.9	2.2	10.3	3.5	0.3	468.2	3.9	66.1	0.0	12.1	8.2	3.1	2.8	31.2	111.7	17.1	11.7	0.7	390.8	0.5
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 5273.7"	"Group enriched"	"Detected in many"	8	"Erythroid cells: 221.3;Skeletal myocytes: 304.0"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 47.3;RH-30: 78.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced					NA	NA		53000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favorable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	43.4	3.8	2.4	0.3	2.3	9.9	6.4	2.7	3.7	5.1	1.4	1.7	1.8	8.3	2.1	64.8	9.8	2.2	19.5	2.3	2.8	3.7	2.4	24.6	0.4	2.9	2.3	1.4	1.3	1.0	3.8	0.3	2.0	89.5	1.1	5.5	15.4	2.7	5273.7	5.2	4.4	19.1	2.5	0.8	4.1	2.9	2.5	1.4	3.0	1018.8	0.6	1.5	5.5	2.8	2.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.5	0.2	47.3	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	78.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.4	2.3	2.7	3.7	2.3	2.8	2.9	2.3	2.0	2.5	2.5	2.8	0.3	3.2	4.2	2.3	0.1	0.5	1.7	0.6	1.2	0.0	14.5	0.6	1.0	5.7	0.6	0.0	6.2	1.1	0.4	0.4	0.0	0.6	24.1	0.4	0.2	2.2	0.0	221.3	2.2	0.2	0.2	9.1	0.0	0.7	0.0	0.2	2.5	0.3	0.4	0.0	2.5	0.4	0.0	0.3	0.4	7.0	0.3	2.5	0.0	0.0	0.0	29.6	0.0	1.5	0.7	0.2	1.7	0.0	0.0	0.5	8.5	0.6	1.0	1.6	0.0	304.0	5.1	0.6	1.3	0.2	1.0	1.6	1.4	0.3	0.9	0.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149942-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.6"	"Group enriched"	"Detected in many"	16	"Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 99.5"	"Lineage enriched"	"Detected in single"	995	"granulocytes: 99.5"	"Cell line enhanced"	"Detected in single"		"OE19: 1.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 300.3"	"Low region specificity"	"Detected in all"			"HPA011089, HPA017258"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA		190000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	83.0	2.3	17.8	3.1	18.8	19.5	80.9	86.8	34.2	12.7	13.9	263.6	3.8	6.0	51.9	1.0	5.0	38.3	55.2	22.8	13.9	47.6	0.7	87.2	0.6	13.4	17.8	6.2	31.8	16.9	15.7	8.6	22.8	8.2	172.6	0.1	10.4	36.9	30.5	3.8	11.2	2.7	12.7	16.0	10.0	1.3	15.1	1.6	74.6	42.3	0.1	6.2	5.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.5	0.0	0.0	0.0	0.0	0.1	17.8	18.8	86.8	34.2	22.8	13.9	13.4	17.8	22.8	12.7	15.1	14.9	704.2	0.0	2.4	1.3	1.5	1.5	0.3	0.0	2.2	0.0	2.3	2.5	9.1	0.0	0.6	14.7	0.0	0.0	1.2	1289.3	33.2	11.7	0.5	0.6	13.0	88.3	19.3	0.0	3.8	0.2	0.0	4.4	0.0	0.2	11.4	23.2	1.4	0.0	0.6	0.0	1.4	24.6	0.0	0.0	1.2	0.1	0.6	1.1	0.0	23.4	0.0	0.1	0.0	1.0	0.4	0.1	2368.3	0.0	1.2	0.1	14.9	72.4	0.7	0.0	6.6	5.0	23.4	0.1	0.0	0.1	1.1	0.0	2.4	0.4	41.7	0.3
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788411	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 37.9;Muller glia cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.3;fHDF/TERT166: 27.0;hTERT-HME1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	5.9	3.1	5.3	4.2	5.8	3.5	8.3	3.9	5.4	21.5	5.8	2.8	1.6	7.3	2.6	6.5	7.5	7.3	4.0	3.9	7.3	4.8	2.1	6.0	5.6	8.4	6.5	11.9	3.4	9.1	2.4	3.1	6.9	4.8	3.6	10.5	4.5	4.6	1.6	5.7	2.6	7.6	6.3	4.3	4.4	10.3	6.1	4.3	7.2	5.4	6.8	5.2	5.5	4.6	4.3	2.6	2.9	4.8	8.5	22.3	1.7	4.4	5.6	3.2	4.6	1.3	2.8	1.2	4.5	27.0	6.1	4.6	10.3	5.0	5.7	1.2	4.8	2.3	3.3	1.1	8.3	3.0	5.0	5.3	5.3	4.3	34.2	5.7	4.8	3.5	1.2	3.0	15.4	2.3	2.5	2.3	1.2	0.8	18.6	1.4	2.1	2.2	4.9	3.1	2.6	5.3	6.1	2.2	3.8	3.4	3.1	3.0	6.5	3.8	2.5	20.4	2.5	2.2	2.4	1.4	4.2	6.0	7.2	4.4	3.9	0.4	16.7	4.8	14.5	4.6	16.6	15.5	4.7	5.0	12.1	10.4	2.2	11.0	3.1	0.7	14.3	10.0	5.3	5.8	3.9	5.4	3.9	7.3	8.4	6.5	6.9	6.3	6.1	4.6	9.6	0.0	7.9	14.0	19.1	4.2	6.3	3.4	6.2	9.5	7.3	5.2	2.4	0.0	7.1	1.8	16.7	1.8	37.9	1.6	1.9	4.4	1.1	9.6	7.1	13.9	3.0	11.2	11.5	4.0	1.8	10.5	11.7	6.2	2.5	6.7	6.1	2.7	1.9	1.7	11.8	2.2	8.2	9.3	11.1	1.8	7.8	10.8	3.6	19.7	9.1	35.9	32.0	8.5	10.6	4.1	1.6	5.3	18.7	11.5	1.2	2.9	12.2	7.8	6.6	8.1	8.3	4.2	5.6	5.5	4.5	1.9	30.0	12.1	1.5	7.9
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	295	"salivary gland: 9393.1"	"Group enriched"	"Detected in some"	44	"Breast glandular cells: 77.9;Ionocytes: 99.7;Melanocytes: 179.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.6;naive CD8 T-cell: 16.4"	"Lineage enriched"	"Detected in many"	11	"T-cells: 16.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;U-2197: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	NA	NA		24000000	"Cluster 32: T-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.4	0.4	0.3	0.7	0.6	2.0	20.8	0.9	0.7	0.0	0.5	0.1	0.3	0.2	2.3	0.2	0.1	0.2	1.5	0.4	0.3	0.1	0.1	0.3	1.3	0.9	0.4	1.9	6.3	0.0	0.1	0.9	0.7	0.2	0.2	0.7	9393.1	0.0	0.4	31.8	0.5	0.0	0.1	1.2	0.4	0.3	0.7	1.2	0.3	0.0	1.0	0.1	0.0	1.8	0.2	0.0	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.3	0.4	1.7	0.1	0.1	0.4	0.3	0.1	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.0	0.5	0.5	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.4	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.6	0.3	1.3	0.2	0.4	0.1	0.4	0.1	0.4	0.4	1.4	0.3	0.2	0.3	0.2	0.3	0.3	0.7	2.7	0.0	0.5	5.6	16.4	1.3	0.4	0.2	0.3	0.3	1.6	0.3	0.6	0.9	0.7	0.4	0.3	0.9	0.4	0.7	0.1	0.7	1.8	0.2	0.0	0.0	0.0	0.1	0.1	0.1	1.4	0.0	0.0	77.9	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	99.7	0.0	1.3	0.2	0.0	0.2	179.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.5	0.0	0.0
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844414-66854153	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 57.0"	"Cell type enriched"	"Detected in some"	40	"Paneth cells: 3026.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 1.1;THP-1: 1.9"	"Region enhanced"	"Detected in all"		"cerebellum: 67.2"	"Low region specificity"	"Detected in many"			HPA047237	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.0	0.0	5.1	0.2	6.7	0.0	0.1	4.8	10.7	0.0	2.1	57.0	6.9	0.1	0.9	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	0.0	0.0	3.8	3.5	0.0	0.0	0.0	0.1	0.0	3.5	0.0	48.6	0.0	0.0	0.2	0.0	0.0	10.0	1.1	2.6	0.0	0.0	0.5	4.7	0.1	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.7	4.8	10.7	8.0	3.1	3.8	3.5	3.5	2.6	4.7	5.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3026.3	0.0	0.0	0.5	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	39.9	0.1
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60185412-60281400	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3;parathyroid gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Enteroendocrine cells: 35.2;Gastric mucus-secreting cells: 40.2;Oligodendrocyte precursor cells: 129.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	24	"basophil: 76.2"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 76.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;JURKAT: 11.0;K-562: 20.3;NB-4: 12.3;OE19: 17.4"	"Region enriched"	"Detected in all"	38	"cerebellum: 1260.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 86.3"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	1.6	0.9	5.2	0.3	5.8	0.5	4.6	18.3	5.6	4.3	2.0	1.3	1.0	1.9	10.2	0.2	1.5	0.3	4.3	4.4	5.3	5.3	0.0	0.9	0.4	4.7	4.9	0.2	1.9	40.1	8.5	6.2	5.0	1.5	2.0	2.3	3.7	0.2	1.2	0.3	1.0	0.5	3.1	0.8	4.4	4.1	5.1	1.3	0.3	2.3	0.3	0.6	0.3	4.0	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	10.1	4.5	0.0	0.0	3.6	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	20.3	0.2	0.0	0.0	3.3	12.3	0.2	17.4	0.0	0.0	0.0	0.2	0.4	0.8	5.1	0.0	0.0	1.1	0.0	2.0	4.5	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	76.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	5.2	5.8	18.3	5.6	4.4	5.3	4.7	4.9	5.0	3.1	5.1	4.0	22.0	0.0	4.8	92.7	1.6	1.0	0.4	4.1	0.0	8.2	15.6	10.3	4.7	0.0	5.7	3.7	0.0	8.3	10.9	2.0	3.9	8.1	9.9	9.8	2.4	16.7	35.2	13.5	4.7	6.0	0.3	4.0	40.2	26.2	0.0	1.1	0.0	0.0	9.9	0.0	25.6	25.0	6.1	1.9	1.1	4.9	1.5	1.1	7.2	18.7	0.0	2.6	1.0	129.7	0.4	1.6	3.5	1.5	14.0	2.1	0.3	0.0	1.2	1.0	0.0	0.8	2.3	3.8	5.5	0.2	0.4	1.4	0.7	3.1	3.3	1.5
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673918-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 289.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 85.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	3.8	0.4	0.0	0.2	0.0	0.0	0.1	5.6	0.6	0.5	0.0	0.6	14.5	0.2	0.1	0.8	0.4	24.4	2.0	0.2	0.1	0.2	1.3	0.2	0.0	0.0	0.1	0.7	6.6	0.0	0.5	0.0	0.2	0.5	0.0	1.0	0.1	0.1	0.1	8.2	13.6	0.1	0.0	0.0	289.3	5.5	0.5	0.0	0.0	0.0	0.0	0.7	0.7	0.0	189.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.3	2.5	0.0	0.1	0.0	0.1	0.0	0.5	5.7	0.0	0.9	1.5	98.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	113.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.5	0.0	0.0	10.6	0.0	0.6	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	18.9	0.4	0.0	4.7	0.0	0.4	0.1	374.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	4.5	0.7	275.3	0.0	0.4	0.1	0.0	0.4	62.9	28.1	0.0	0.0	0.0	0.0	0.1	0.0	49.1	205.8	0.0	0.1	0.2	0.0	0.0	0.1	50.9	0.6	1.2	259.5	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.6	4.0	18.3	0.0	0.0	19.6	1.5	0.1	0.0	0.0	0.6	1.3	0.0	0.0	0.0	26.6	0.0	0.7	0.3	0.8	0.7	0.1	5.5	0.0	0.0	0.0	1.5	0.9	4.0	0.0	3.1	0.3	0.1	0.7	5.3	0.4
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892803	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	7.0	20.4	4.3	10.5	4.5	7.7	10.8	4.8	6.2	9.1	11.0	18.6	17.4	8.2	16.9	11.3	9.2	9.8	5.7	4.4	5.1	16.3	23.8	7.8	14.7	4.4	4.3	6.6	10.8	18.9	7.4	9.7	4.3	10.6	19.5	8.6	11.2	9.5	7.1	10.2	12.7	10.0	4.0	8.5	11.2	12.6	4.6	14.2	27.4	7.5	15.1	10.6	6.8	4.7	24.2	14.9	24.3	23.9	15.9	13.4	18.5	17.4	17.1	16.4	20.1	4.4	14.9	28.6	17.5	14.9	9.4	12.8	25.3	17.0	22.4	39.0	15.4	49.6	22.6	28.2	26.4	21.7	23.9	13.7	21.4	12.7	29.7	18.5	27.8	18.4	14.1	21.0	19.1	13.9	33.8	9.0	32.2	23.8	12.3	23.1	10.9	19.0	42.6	17.7	19.4	38.5	15.9	17.5	16.3	21.5	14.9	25.6	16.7	0.0	24.5	10.1	16.4	9.6	19.2	33.0	8.0	22.3	10.3	14.9	11.3	8.2	16.2	17.6	20.9	18.8	17.7	18.9	18.4	18.7	14.7	15.3	1.4	20.1	15.7	17.2	18.8	16.0	4.3	4.5	4.8	6.2	4.4	5.1	4.4	4.3	4.3	4.0	4.6	4.7	13.9	22.4	21.6	42.1	20.3	9.9	11.3	18.4	15.9	10.8	18.2	14.6	9.7	14.3	27.6	31.3	8.4	18.3	16.4	28.1	58.7	20.6	18.8	25.6	15.3	14.9	15.5	21.7	34.0	19.8	14.7	13.4	18.8	25.5	18.3	15.8	10.4	34.3	12.1	8.4	42.5	26.0	26.4	11.1	10.3	5.4	8.4	17.7	8.8	26.2	15.6	22.1	12.3	41.2	33.8	22.6	23.1	6.4	26.0	17.5	13.4	29.5	23.7	12.7	13.1	16.9	14.8	41.9	18.4	31.6	14.6	10.8	20.1	28.0	32.1	12.6
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712842-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 188.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	Nucleoli,Cytosol		NA	NA		100000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	43.7	31.0	30.1	55.2	32.9	50.9	29.6	31.5	40.6	26.5	29.3	53.7	48.0	30.7	35.0	55.8	30.0	41.3	55.6	34.3	33.9	54.1	38.6	40.0	58.0	36.5	34.5	29.2	33.1	42.5	17.1	35.5	36.4	39.9	56.0	45.6	34.4	31.2	188.5	34.3	51.2	40.4	34.0	38.0	46.2	41.3	33.6	45.1	37.3	127.8	59.1	49.4	30.5	39.5	131.6	30.0	39.8	34.0	48.2	59.8	45.3	73.7	91.8	45.4	47.2	36.6	140.0	33.8	56.5	64.5	76.5	59.1	44.8	138.5	91.9	142.1	35.1	90.5	36.9	39.5	40.9	126.6	100.8	42.5	79.1	58.5	128.4	51.8	57.1	46.1	153.9	30.3	43.8	45.6	59.1	77.9	39.8	53.4	52.0	67.8	59.3	33.5	84.6	104.9	43.2	26.4	55.2	68.2	59.9	44.7	16.9	72.4	73.1	63.9	24.3	68.2	61.0	39.0	31.8	53.8	45.4	72.4	53.4	4.0	3.6	6.0	4.7	4.4	4.8	3.0	5.8	6.1	3.0	2.4	4.7	6.5	10.3	9.3	4.3	2.2	6.2	2.4	30.1	32.9	31.5	40.6	34.3	33.9	36.5	34.5	36.4	34.0	33.6	39.5	41.6	64.1	37.5	42.1	29.6	97.8	44.2	23.0	23.3	14.4	28.3	18.9	69.1	17.2	30.5	51.5	33.3	20.8	32.3	162.5	29.4	26.0	12.0	41.4	25.2	29.6	20.4	32.0	85.1	32.7	18.7	24.1	28.5	39.5	20.3	16.6	28.2	29.3	56.8	28.6	69.3	48.5	24.4	81.2	72.4	13.5	17.4	66.2	30.2	93.7	49.6	39.6	29.9	58.8	64.3	72.3	62.4	32.0	37.0	84.4	54.6	39.8	55.6	40.5	13.1	27.5	27.3	30.8	29.5	31.2	85.1	23.1	52.0	18.9	34.8	88.6
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444064	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 200.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 41.8;RT4: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954, HPA076632"	Approved		Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.91e-4)"	"prognostic favorable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	23.7	37.4	25.0	4.4	26.4	2.2	37.3	21.0	20.7	14.5	68.2	57.7	6.0	15.3	16.3	31.2	18.3	16.5	22.0	24.6	38.7	14.0	5.3	19.5	4.2	24.6	35.0	21.5	12.0	29.2	8.4	12.4	25.1	41.4	11.6	14.8	16.9	22.5	7.5	16.1	12.5	11.5	27.4	4.0	27.1	33.4	31.4	9.4	9.7	13.0	5.2	26.5	17.3	28.4	1.6	1.7	9.8	2.8	9.3	8.7	14.8	9.3	17.9	5.9	4.1	41.8	6.0	14.2	1.2	6.5	6.5	3.4	5.4	6.2	10.2	4.7	4.5	3.7	2.0	2.6	5.2	3.3	1.6	6.4	4.8	4.4	6.8	7.3	8.0	2.2	0.7	3.2	8.1	2.8	3.2	2.4	7.6	5.4	2.7	2.8	1.3	2.3	8.3	43.4	1.2	3.7	5.1	11.8	12.1	11.8	18.4	4.9	7.6	2.5	2.7	5.3	7.6	2.5	2.3	16.3	2.8	2.5	5.7	6.7	2.6	5.4	2.6	2.4	2.0	2.7	3.2	3.4	2.6	1.6	2.3	2.3	5.6	1.9	2.1	0.4	3.6	2.3	25.0	26.4	21.0	20.7	24.6	38.7	24.6	35.0	25.1	27.4	31.4	28.4	6.9	16.0	11.9	52.2	2.4	3.1	12.6	6.6	7.4	6.4	27.1	14.4	14.5	4.3	13.4	11.0	6.2	26.4	3.1	3.9	11.7	10.1	200.0	8.3	9.2	5.4	2.4	1.7	45.0	10.6	14.0	42.5	5.6	3.7	4.5	4.2	3.9	1.9	6.4	1.7	32.4	2.4	16.2	3.5	4.7	32.1	15.5	5.0	12.4	24.4	5.6	14.9	7.2	50.3	43.3	10.3	2.0	11.7	4.6	16.7	0.8	5.0	17.7	5.2	6.6	9.4	16.8	46.0	5.0	16.0	4.4	29.0	3.6	3.9	2.3	21.7
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662929-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6;testis: 15.5"	"Group enriched"	"Detected in some"	10	"Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.79e-4)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.0	0.5	4.2	0.2	4.2	0.0	1.2	3.5	3.9	4.2	5.9	1.2	0.3	3.5	0.5	0.3	26.6	0.8	0.2	4.4	4.6	1.8	0.3	4.1	0.0	6.8	8.9	0.2	0.5	2.9	4.2	0.8	7.2	4.1	0.6	0.9	1.0	2.5	0.1	0.3	0.5	0.7	8.3	1.0	0.5	15.5	4.0	0.1	0.7	0.0	0.1	0.4	0.6	7.8	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.4	1.7	0.3	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.9	0.5	0.1	0.0	0.1	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	3.5	3.9	4.4	4.6	6.8	8.9	7.2	8.3	4.0	7.8	1.9	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.0	0.8	0.0	60.4	4.1	0.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	88.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.0
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	27.2	28.7	28.9	15.5	29.1	30.9	24.3	33.3	40.9	33.3	32.6	37.0	13.6	32.4	8.7	23.4	35.9	10.1	30.9	28.8	25.6	36.0	28.2	28.5	19.6	28.0	27.5	27.3	28.1	15.6	46.2	8.2	28.1	34.0	8.4	13.3	22.1	14.1	17.4	24.7	33.1	11.0	23.1	37.2	31.9	34.4	29.2	19.5	50.3	7.0	10.0	29.7	27.1	28.9	24.7	17.7	23.6	20.8	20.9	24.1	33.3	20.4	17.5	16.0	18.1	22.0	11.9	28.6	11.0	20.5	20.8	23.1	28.4	18.5	14.2	48.3	27.8	24.6	21.1	46.8	9.9	57.1	25.6	20.5	11.6	19.6	14.7	19.2	27.1	25.1	52.1	15.2	9.2	32.0	27.1	62.1	14.7	34.5	12.6	26.3	17.3	36.0	14.6	24.8	30.2	25.9	25.2	17.4	26.1	21.3	15.6	25.6	22.3	37.0	28.6	14.3	14.9	26.5	17.1	16.9	17.3	27.3	15.8	7.2	3.9	15.5	5.7	2.7	6.3	2.5	4.3	7.5	2.6	4.1	5.2	4.8	17.4	5.4	1.9	3.0	3.7	2.5	28.9	29.1	33.3	40.9	28.8	25.6	28.0	27.5	28.1	23.1	29.2	28.9	14.5	22.4	37.5	37.5	22.7	8.3	8.9	11.0	13.1	33.3	14.2	10.8	18.5	4.3	9.1	9.2	89.6	17.4	24.6	19.9	7.9	11.6	16.6	43.6	19.6	15.1	14.8	18.3	54.2	9.7	6.9	16.4	29.6	26.8	17.7	21.1	13.2	9.4	21.7	33.7	39.4	13.0	20.3	12.6	16.2	16.0	21.5	16.1	10.6	20.6	19.2	14.5	44.3	21.1	35.9	10.8	6.6	19.9	24.4	7.1	8.8	7.9	24.4	50.1	19.7	14.6	32.6	60.7	41.6	13.6	9.5	22.4	36.5	18.4	13.8	7.3
CABP1		ENSG00000157782	"Calcium binding protein 1"	Q9NZU7	12	120640552-120667324	"Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 312.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 126.7;Excitatory neurons: 296.9;Horizontal cells: 323.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;NTERA-2: 6.8;RT4: 3.9;SCLC-21H: 3.2;U-87 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051438	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051438: AB_2681486"	"unprognostic (2.57e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.13e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.12e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.85e-1)"	11.6	1.7	138.0	0.6	169.4	0.0	5.1	99.4	312.4	3.0	74.7	2.9	0.8	2.8	3.2	1.4	3.1	1.0	12.7	151.5	86.8	24.3	0.2	0.6	0.3	96.4	88.5	1.2	1.5	7.4	5.5	1.2	97.3	3.6	1.5	25.7	0.4	3.7	2.8	0.9	2.3	2.3	87.0	1.2	2.9	1.4	84.9	0.2	1.3	5.5	0.2	6.1	2.9	207.3	0.1	0.5	2.8	0.9	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.2	0.0	0.0	0.5	0.0	1.2	0.2	2.5	0.0	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.3	0.3	0.0	6.8	2.2	0.4	1.7	0.0	0.0	2.7	3.9	3.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	138.0	169.4	99.4	312.4	151.5	86.8	96.4	88.5	97.3	87.0	84.9	207.3	43.4	0.0	0.0	9.1	0.0	0.1	0.2	0.1	0.0	126.7	0.4	0.3	2.6	0.0	0.0	1.8	0.0	0.1	0.0	0.5	31.3	0.1	2.1	0.0	0.1	8.9	0.0	0.0	296.9	0.0	0.4	2.8	3.1	0.1	0.0	0.0	0.0	0.0	0.3	323.0	44.2	0.5	0.0	0.0	2.0	3.6	0.3	0.3	0.0	9.4	0.0	9.9	0.0	22.6	8.5	0.0	0.0	2.2	0.0	0.3	0.0	3.7	0.0	10.9	19.7	0.5	12.6	0.4	1.8	0.0	0.3	0.3	0.2	0.1	0.0	0.2
CABP5	CABP3	ENSG00000105507	"Calcium binding protein 5"	Q9NP86	19	48029383-48044079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	509	"retina: 388.6"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 153.8;Rod photoreceptor cells: 284.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	10	"U-2197: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043698	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA043698: AB_10797147"																		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.6	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.8	0.0	0.0	0.3	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	21.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	284.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	3.1	0.0	3.0	0.2	0.1	19.8	35.0	0.1	0.6	0.8	0.4	0.1	0.0	0.1	0.1	0.0	0.2	38.2	4.2	0.2	0.3	0.1	0.1	27.7	14.8	0.1	3.1	0.0	0.4	0.0	30.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	22.2	0.4	0.3	0.6	3.9	0.0	0.3	0.0	0.0	0.1	0.1	16.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	3.1	3.0	19.8	35.0	38.2	4.2	27.7	14.8	30.0	22.2	3.9	16.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CABS1	"C4orf35, CLPH, FLJ32897, NYD-SP26"	ENSG00000145309	"Calcium binding protein, spermatid associated 1"	Q96KC9	4	70334981-70337116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 106.3"	"Group enriched"	"Detected in some"	144	"Early spermatids: 1299.5;Late spermatids: 4446.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044016, HPA055352"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA044016: AB_10964494, HPA055352: AB_2682790"															"unprognostic (1.36e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1299.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4446.4	19.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138987-24161600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"testis: 303.5"	"Group enriched"	"Detected in many"	18	"Early spermatids: 2505.6;Late spermatids: 3543.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.8;memory B-cell: 4.7;naive B-cell: 5.0;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 5.0;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040703: AB_2677087, HPA047801: AB_2680159"	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	1.5	3.3	5.4	1.2	6.6	1.1	5.2	3.7	9.4	6.8	10.9	1.2	1.0	2.9	2.0	1.7	3.6	1.8	0.9	7.5	8.0	0.8	1.1	1.0	1.2	6.5	4.2	1.7	0.7	0.4	8.3	0.9	7.0	2.3	1.1	5.7	2.1	1.5	1.0	2.1	1.1	3.6	3.7	1.2	1.5	303.5	5.2	1.5	1.0	0.1	1.0	2.4	1.4	10.5	4.9	11.9	3.4	1.7	3.4	9.1	14.7	8.2	5.4	10.2	10.6	2.5	9.2	0.2	6.8	12.6	0.5	4.5	3.4	6.9	10.7	0.6	5.6	0.3	6.9	2.3	4.8	0.4	0.5	11.2	11.1	12.7	3.3	4.8	2.9	0.6	0.0	0.3	2.6	1.4	0.1	0.4	11.3	0.5	7.4	0.7	0.4	0.2	4.2	5.5	7.2	8.3	26.8	5.2	0.5	2.0	11.3	1.2	1.7	0.8	2.3	3.4	0.2	0.3	0.3	0.1	4.7	0.9	0.5	4.8	0.3	0.6	0.2	0.2	0.1	4.7	0.3	0.3	0.1	5.0	0.3	0.6	1.9	0.8	0.4	0.4	0.2	0.4	5.4	6.6	3.7	9.4	7.5	8.0	6.5	4.2	7.0	3.7	5.2	10.5	1.1	0.0	0.0	1.6	1.0	0.3	0.9	7.2	1.2	2.0	3.1	7.1	0.8	0.0	1.9	0.0	2.1	0.2	0.3	2.2	0.0	0.8	2505.6	76.2	3.3	2.0	0.0	0.4	10.7	0.2	0.5	0.9	0.0	5.1	0.0	0.9	0.4	0.0	0.6	0.0	9.9	1.9	6.1	0.0	0.7	3543.7	23.3	2.4	1.8	2.8	0.0	0.0	1.0	7.5	12.6	0.4	1.3	21.8	0.0	0.1	0.2	0.1	2.8	2.1	19.7	0.7	2.0	166.3	19.1	0.5	0.0	0.0	0.5	0.9	0.4	0.3
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 99.3"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 101.4;Enteroendocrine cells: 214.1;Excitatory neurons: 318.3;Horizontal cells: 249.0;Inhibitory neurons: 372.1;Oligodendrocyte precursor cells: 271.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	4	"cerebellum: 99.3;cerebral cortex: 30.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 45.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in all"							"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	1.0	2.3	15.4	0.3	15.8	0.1	0.9	99.3	30.4	0.6	0.0	0.7	1.2	0.8	1.1	0.2	3.2	0.1	0.6	15.1	6.8	0.5	0.2	0.2	0.4	7.2	11.2	0.9	2.6	0.1	4.2	0.0	10.6	0.4	0.4	7.1	0.2	0.1	0.5	0.3	1.7	0.2	9.4	0.6	2.7	2.3	11.3	0.1	0.7	0.1	0.2	0.3	0.7	15.2	0.0	0.1	0.1	6.0	0.2	0.2	0.0	2.2	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.2	5.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	2.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.1	0.2	1.4	0.1	0.3	0.6	0.0	0.1	0.0	0.1	45.1	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.1	0.9	0.2	0.1	0.0	0.0	0.0	23.9	0.1	0.6	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	15.4	15.8	99.3	30.4	15.1	6.8	7.2	11.2	10.6	9.4	11.3	15.2	7.7	6.4	3.2	31.3	9.6	0.6	3.4	0.0	0.0	101.4	3.1	7.4	2.8	0.0	1.3	1.8	16.7	0.0	2.9	0.6	0.0	0.5	27.1	1.2	6.3	6.5	214.1	0.4	318.3	0.4	0.2	4.7	10.7	2.6	1.3	5.2	1.8	1.2	0.5	249.0	372.1	5.0	4.1	1.9	1.4	28.0	1.2	2.1	0.0	28.1	1.2	3.0	4.1	271.9	11.5	1.5	0.1	0.4	0.5	0.8	0.2	2.0	3.7	7.0	0.0	5.1	17.6	4.3	7.1	0.4	0.1	0.3	2.0	2.5	1.0	0.9
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;pituitary gland: 6.8;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 388.8;Inhibitory neurons: 330.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 5.9;basal ganglia: 7.8;cerebral cortex: 10.2;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.0	2.8	5.9	0.1	7.8	0.0	0.0	0.8	10.2	0.3	0.0	0.4	0.0	0.0	0.6	0.0	3.1	0.4	0.3	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.8	0.0	0.0	0.5	0.1	3.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.3	5.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	3.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.8	0.8	10.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	43.4	0.0	0.0	0.1	0.0	0.0	11.7	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.2	0.1	0.0	0.0	388.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.7	330.9	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	17.8	0.6	1.7	0.0	16.1	10.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	8.2	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 20.7;heart muscle: 27.1;intestine: 29.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 606.7;Horizontal cells: 301.2;Inhibitory neurons: 476.2;Oligodendrocyte precursor cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HDLM-2: 87.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.0	0.9	4.5	1.4	0.9	0.0	1.9	0.0	3.0	5.6	0.0	29.9	0.7	20.7	0.5	2.1	4.2	2.3	27.1	2.0	0.5	2.5	0.4	4.6	0.3	0.0	0.5	1.9	0.9	0.1	5.2	2.1	0.0	6.5	1.3	1.7	1.0	3.3	0.9	1.3	5.0	10.2	0.0	3.0	5.4	2.5	1.8	0.2	1.3	0.8	0.3	12.3	3.4	0.1	0.0	0.0	0.1	0.0	3.3	2.0	0.2	3.4	4.1	2.2	1.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	87.0	0.8	0.1	0.0	0.0	2.1	0.0	0.1	5.1	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.4	0.6	5.2	0.0	0.1	0.2	0.0	4.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.5	0.9	0.0	3.0	2.0	0.5	0.0	0.5	0.0	0.0	1.8	0.1	2.2	0.0	0.0	96.6	0.2	0.6	1.0	0.0	0.0	20.7	0.8	8.3	48.8	0.0	0.0	0.0	2.1	0.2	1.3	0.6	0.0	0.1	35.6	5.1	14.6	5.2	36.6	0.8	606.7	0.0	0.4	4.2	2.0	0.9	0.0	2.7	2.2	0.1	0.3	301.2	476.2	0.6	0.0	0.0	1.1	90.3	0.9	0.2	0.0	72.1	0.0	6.0	1.0	194.5	21.7	0.4	1.2	4.1	0.2	1.2	0.0	0.1	0.0	1.3	13.1	1.6	26.7	3.4	5.8	0.1	0.1	0.1	1.1	0.2	0.5	3.1
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.1	6.6	7.0	0.2	4.3	0.7	1.8	2.3	10.4	6.0	0.0	1.5	1.7	3.7	7.3	0.5	7.7	2.0	0.6	3.6	0.8	2.2	1.0	3.7	0.1	0.0	1.2	0.5	2.8	1.2	3.5	0.6	0.4	3.0	1.5	4.3	0.5	1.8	0.2	0.7	2.4	0.7	3.5	1.8	0.8	1.6	6.1	0.2	2.9	0.2	0.1	0.6	0.1	6.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.1	0.1	0.0	0.4	0.9	0.0	0.0	0.2	55.5	0.5	3.6	4.7	2.1	0.3	10.1	1.1	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	4.3	2.3	10.4	3.6	0.8	0.0	1.2	0.4	3.5	6.1	6.0	0.6	3.2	36.2	7.8	0.6	0.9	0.8	4.6	2.2	33.3	7.2	1.8	2.3	10.0	9.1	1.8	35.5	0.9	0.5	3.0	0.0	7.2	4.9	4.3	40.1	2.4	59.4	2.7	251.2	2.3	0.2	3.4	5.1	3.3	12.6	1.7	0.0	3.4	0.2	8.4	354.1	3.8	2.0	0.8	4.0	8.3	4.4	2.1	5.4	126.5	0.5	4.0	0.0	197.5	29.9	3.8	5.6	27.1	0.1	1.7	9.5	2.7	9.5	12.9	0.0	0.2	8.6	1.0	3.7	0.5	1.0	0.3	1.7	9.6	7.6	0.9
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"retina: 125.3"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 66.5;Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 97.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA068379	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.2	0.4	0.7	0.4	0.7	1.9	0.7	2.3	1.4	0.2	0.8	0.6	0.8	0.2	1.0	0.2	0.5	0.2	0.2	0.8	0.4	0.3	0.0	0.6	1.3	0.4	0.1	0.3	0.6	0.0	0.1	0.0	0.5	0.1	0.7	125.3	0.6	0.4	0.0	1.0	1.6	0.2	0.0	0.8	0.6	0.2	0.4	0.8	0.4	0.0	0.5	0.2	0.1	0.8	0.1	0.7	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.8	0.4	0.5	0.4	0.5	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.1	0.3	1.3	0.1	0.0	0.7	0.7	2.3	1.4	0.8	0.4	0.4	0.1	0.5	0.0	0.4	0.8	0.2	0.0	0.5	0.0	1.1	0.0	0.1	0.1	0.0	66.5	1.1	0.9	1.9	0.0	0.0	1.8	133.5	0.1	2.8	0.2	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.4	0.9	0.2	0.2	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.2	6.7	0.4	2.3	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	7.4	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.4	0.1	0.1	97.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.3	0.1
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.5;cervix: 9.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 176.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6;testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.2;GAMG: 3.2;HeLa: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"			"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	1.6	0.2	7.1	0.2	5.3	0.3	1.0	19.3	9.9	9.9	0.0	0.4	0.2	2.8	0.1	0.4	3.4	0.2	3.6	2.6	10.3	0.0	0.0	0.3	0.3	4.1	19.4	5.4	0.1	0.0	0.2	0.4	1.4	1.1	0.1	8.8	0.3	0.4	0.1	1.4	0.1	0.6	12.8	0.1	0.2	0.6	37.5	0.1	0.3	0.1	0.2	0.1	3.7	6.2	0.0	9.2	2.1	2.4	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.8	0.2	0.0	0.6	0.1	3.2	0.3	1.1	0.0	0.2	1.1	0.4	0.6	3.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.7	0.5	0.4	1.0	0.8	0.0	0.0	0.1	2.7	1.1	1.8	0.1	0.0	1.5	0.0	0.1	0.2	0.8	2.5	0.3	0.1	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	5.3	19.3	9.9	2.6	10.3	4.1	19.4	1.4	12.8	37.5	6.2	0.2	0.0	0.0	0.3	0.0	1.9	0.2	0.0	0.6	176.7	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.6	11.2	0.6	0.0	0.0	16.0	0.0	0.6	4.5	0.0	0.6	0.0	0.1	0.0	0.0	0.4	5.0	21.5	0.0	0.0	0.0	5.7	0.2	0.0	0.9	3.6	1.0	0.0	2.3	0.0	22.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.0	0.3	3.7	0.7	0.9	0.8	2.8	0.1	0.3	0.0	0.1	0.1
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 107.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	13.6	28.0	13.6	5.2	24.5	0.1	7.6	2.1	12.1	26.3	0.0	107.7	6.4	57.3	2.6	7.1	37.8	10.3	9.3	11.0	8.1	14.1	13.4	11.8	0.7	3.0	3.8	80.1	4.6	3.6	45.9	2.1	2.9	28.0	2.4	1.8	1.9	27.5	6.2	19.4	22.3	15.6	3.7	0.7	27.5	19.4	13.5	0.5	11.0	3.0	0.2	57.0	17.1	0.2	0.0	17.9	3.0	25.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	10.4	0.1	0.0	11.0	3.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	3.0	4.9	0.0	0.0	48.3	0.0	0.0	9.4	16.0	3.6	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.9	1.0	13.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	24.5	2.1	12.1	11.0	8.1	3.0	3.8	2.9	3.7	13.5	0.2	1.3	0.0	0.0	1.0	0.0	1.5	0.1	0.0	0.0	22.8	0.3	0.1	2.7	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	7.2	0.2	5.3	2.2	10.8	0.0	2.6	0.0	0.1	1.3	0.5	0.2	4.5	0.0	0.4	7.8	0.1	0.0	0.7	1.0	2.0	0.0	0.3	15.5	8.4	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.4	0.4	25.9	0.0	7.2	0.0	0.7	0.0	1.5	26.3	0.4	22.4	3.4	5.1	0.0	3.4	0.0	0.2	0.3	0.1	1.3
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	86	"skeletal muscle: 254.9;tongue: 193.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Cone photoreceptor cells: 6.2;Late spermatids: 5.9;Skeletal myocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"BEWO: 1.1;HSkMC: 1.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 2.6"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.9	1.5	0.0	254.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	193.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.8	0.2	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443777	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.7;tongue: 98.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		390000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	11.6	14.5	9.8	4.3	11.9	0.0	4.1	1.2	15.4	5.3	0.0	13.0	5.1	7.4	2.4	5.3	3.9	6.4	31.3	18.8	13.3	8.4	1.3	3.4	1.9	4.6	26.0	7.9	1.5	1.2	6.3	4.2	9.5	13.7	5.1	8.3	2.6	6.4	78.7	4.7	3.4	12.2	8.1	4.4	5.6	3.7	34.2	3.9	18.9	98.5	3.1	7.1	3.4	12.8	0.0	12.7	10.6	0.0	18.2	22.9	0.0	23.4	15.0	11.4	11.1	0.0	3.5	0.0	0.0	20.4	14.1	0.0	11.2	0.0	14.8	0.0	15.0	0.7	14.4	0.0	11.9	5.3	0.0	13.6	0.1	39.6	0.1	127.4	54.9	0.0	0.0	0.2	25.7	0.1	0.0	0.0	12.6	0.0	5.0	2.3	2.1	0.0	0.9	0.9	21.1	62.3	4.6	0.1	0.0	11.1	0.1	0.0	39.6	20.1	15.0	20.1	0.0	0.1	0.0	0.0	16.9	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.9	1.2	15.4	18.8	13.3	4.6	26.0	9.5	8.1	34.2	12.8	6.3	0.0	1.7	137.1	0.0	5.7	4.5	0.1	8.0	47.7	6.6	3.9	88.0	0.0	1.3	7.3	18.8	0.1	0.1	0.0	0.0	0.0	64.2	0.5	20.7	6.8	38.8	0.0	543.1	0.0	0.0	20.6	14.3	0.4	25.3	29.9	1.4	0.4	0.2	25.2	383.3	2.6	16.2	0.0	2.9	42.4	10.2	0.4	1.8	87.1	0.6	5.6	0.0	357.9	662.8	0.8	0.0	6.0	0.2	11.2	0.0	9.5	0.7	6.1	6.6	17.6	21.5	1.5	1.9	1.9	6.5	0.1	0.4	32.7	0.2	1.4
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"retina: 20.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	20.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.7	0.2	2.8	14.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	4.4	0.0	2.1	1.7	4.2	0.0	1.0	1.5	2.9	0.0	0.5	0.3	0.1	0.4	0.5	0.1	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	1.9	0.7	2.4	0.9	0.4	0.1	1.2	56.3	0.7	1.0	0.9	2.8	0.8	0.0	156.4	0.1	5.5	2.4	0.0	0.8	56.3	0.2	1.2	1.5	1.2	0.4	0.8	0.4	0.2	1.8	1.1	0.2	15.2	0.8	1.4	1.2	23.7	0.0	0.4	2.1	0.0	29.2	5.7	117.6	0.9	23.2	3.6	0.0	17.3	6.9	18.6	0.0	1.8	0.3	3.4	0.4	0.8	0.2	12.2	1.3	1.1	98.5	0.0	0.3	2.3	9.0	4.9	0.4	0.6	0.1	8.6	0.6	3.4	0.3
CACNB1	CACNLB1	ENSG00000067191	"Calcium voltage-gated channel auxiliary subunit beta 1"	Q02641	17	39173453-39197703	"FDA approved drug targets, Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 328.8;tongue: 216.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Excitatory neurons: 14.3;Skeletal myocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023343	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA023343: AB_1845866"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.99e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-11)"	"unprognostic (7.62e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.44e-3)"	5.7	3.6	17.8	2.6	23.7	1.4	5.6	0.0	31.7	12.2	0.0	7.6	1.5	6.3	5.4	6.8	6.9	2.1	7.5	23.4	10.9	3.2	0.9	9.3	2.5	4.4	5.9	6.7	2.6	1.6	7.7	1.7	13.0	8.1	2.5	5.5	13.5	5.4	328.8	12.1	4.1	2.9	1.0	4.7	3.7	7.6	5.0	4.4	6.8	216.0	1.8	6.5	6.5	20.4	6.1	2.7	3.3	7.6	3.6	4.4	0.1	3.6	4.4	3.3	4.1	2.0	6.0	10.4	3.6	5.4	4.7	5.6	3.2	5.9	2.4	5.0	3.7	1.5	7.4	0.8	7.4	0.2	0.9	4.9	1.9	6.9	7.8	4.3	2.4	6.4	0.9	8.9	3.5	1.7	7.6	2.8	2.4	0.9	1.9	5.1	10.9	4.6	1.3	1.9	8.3	5.0	2.1	11.2	3.5	1.2	7.9	4.1	3.4	5.9	6.8	4.4	3.7	4.1	1.5	1.7	4.8	0.0	2.4	0.0	0.4	0.0	0.6	0.1	0.9	0.0	0.6	0.8	0.1	0.0	0.2	0.3	0.0	0.6	0.1	1.0	0.1	0.2	17.8	23.7	0.0	31.7	23.4	10.9	4.4	5.9	13.0	1.0	5.0	20.4	1.4	3.2	3.2	20.9	0.8	2.9	0.7	2.3	2.8	3.1	1.5	1.1	1.7	0.0	2.2	0.0	0.0	0.1	4.0	7.1	0.0	0.6	4.2	1.1	3.3	1.5	0.0	0.4	14.3	0.9	0.1	4.9	2.6	1.7	0.0	2.1	0.4	0.1	1.0	0.0	8.3	1.4	4.1	0.8	5.1	2.4	1.8	1.6	5.4	1.0	0.6	7.2	1.0	2.5	2.1	1.5	1.0	1.2	2.3	2.4	0.0	0.0	0.8	1.4	0.0	13.4	7.0	2.9	0.8	1.1	3.0	0.1	4.6	1.6	1.0	1.1
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140424-18543557	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035326: AB_10669903"	"unprognostic (3.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.67e-4)"	"unprognostic (8.03e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.16e-2)"	2.8	9.4	1.3	2.1	3.9	1.3	3.8	5.4	12.9	7.4	0.1	17.6	1.1	12.8	2.7	5.0	10.1	2.2	17.8	5.4	7.4	3.2	10.7	3.9	0.9	0.0	0.1	13.6	7.5	0.6	19.3	0.5	0.0	8.5	3.2	35.1	3.9	8.8	1.1	4.2	11.4	5.3	0.0	1.5	7.7	2.1	2.2	0.7	2.5	0.7	0.2	16.8	4.6	1.5	0.2	1.0	0.7	0.5	0.3	0.3	0.5	0.3	0.0	0.0	0.3	0.4	0.5	0.9	0.2	0.2	0.3	0.7	6.4	0.0	0.0	0.3	2.4	0.8	1.7	1.5	1.6	0.5	1.5	8.1	0.0	0.0	0.0	0.3	0.0	1.4	0.9	1.6	0.0	0.7	0.8	1.0	2.4	0.0	0.0	0.7	0.7	0.8	0.0	0.8	2.9	0.8	0.1	0.0	0.4	0.8	0.1	0.9	0.0	0.6	1.5	0.3	0.6	1.6	1.8	1.7	0.2	1.2	0.3	1.4	0.1	0.2	0.2	0.2	0.4	0.4	0.3	0.1	0.0	0.5	0.5	0.8	0.1	0.3	0.2	0.2	1.1	0.0	1.3	3.9	5.4	12.9	5.4	7.4	0.0	0.1	0.0	0.0	2.2	1.5	2.1	0.0	0.6	863.5	0.1	3.3	1.3	0.0	1.8	31.9	1.1	1.3	22.4	0.0	0.0	0.0	108.4	0.4	0.7	2.8	1.9	0.4	0.9	1.1	13.9	1.5	37.1	0.8	545.7	0.2	0.0	3.0	0.0	2.6	0.0	3.8	0.0	0.9	0.1	8.4	357.8	9.4	0.0	0.0	1.1	0.8	0.9	0.5	1.8	96.5	0.0	15.9	0.0	95.5	13.7	0.2	2.4	4.5	0.3	2.1	5.9	0.8	0.0	75.7	6.6	2.6	14.2	0.1	0.1	0.0	4.1	0.3	1.0	5.3	5.7	1.3
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24256335-24362412	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 53.4;retina: 17.7"	"Group enriched"	"Detected in some"	24	"Excitatory neurons: 157.1;Horizontal cells: 176.7;Inhibitory neurons: 107.6"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.0	1.8	22.1	0.0	32.0	0.0	0.0	2.9	53.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	7.1	0.0	0.0	0.0	0.0	6.1	15.5	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	7.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	32.0	2.9	53.4	36.2	7.1	6.1	15.5	11.9	5.8	7.3	26.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	176.7	107.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.6	0.0	0.4	0.0	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.1;prostate: 11.7"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.5	0.8	26.5	0.1	35.1	0.0	5.3	6.9	26.8	0.4	4.2	0.8	0.2	0.5	0.1	0.2	4.2	0.4	0.2	14.5	17.9	0.2	0.0	5.7	0.0	11.7	16.7	0.1	0.4	1.2	0.3	0.7	15.0	11.7	0.1	0.7	1.7	1.3	0.1	0.5	0.1	1.1	14.3	0.0	1.5	0.2	29.6	0.0	0.1	0.0	0.0	0.4	0.7	9.5	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	35.1	6.9	26.8	14.5	17.9	11.7	16.7	15.0	14.3	29.6	9.5	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66894751	"FDA approved drug targets, Predicted membrane proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 11.2;retina: 15.8"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocyte precursor cells: 74.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"olfactory bulb: 124.3"	"Low region specificity"	"Detected in many"			HPA050115	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA050115: AB_2681022"					"unprognostic (1.85e-3)"					"unprognostic (3.84e-2)"	"unprognostic (1.44e-1)"		"unprognostic (2.46e-6)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	4.8	0.0	3.3	0.1	0.0	1.3	5.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.5	0.1	0.0	0.0	0.4	3.6	6.4	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	15.8	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.2	0.0	0.1	11.2	0.1	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.3	1.3	5.9	2.1	3.5	3.6	6.4	2.3	6.2	11.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53962937-53990215	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"brain: 33.9"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.0	0.0	9.6	0.1	9.3	0.2	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	32.6	3.7	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.4	0.2	0.1	0.1	1.8	0.1	0.2	0.6	6.4	0.0	0.1	0.2	0.0	0.0	0.0	9.4	0.0	2.4	7.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.5	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	2.7	0.7	0.1	1.1	0.0	23.7	0.3	0.0	0.1	0.3	8.4	2.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.5	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.1	0.1	0.0	0.2	0.2	0.0	14.9	0.1	1.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.1	5.5	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	9.6	9.3	0.0	33.9	32.6	3.7	0.7	1.2	0.4	1.8	6.4	9.4	3.6	0.0	0.0	5.9	0.4	1.7	1.5	0.0	0.0	6.9	0.1	1.5	3.3	0.0	0.7	1.8	0.0	0.0	0.0	0.4	0.0	1.9	2.3	0.7	1.0	6.4	0.0	2.7	61.9	0.0	0.0	0.6	0.0	1.0	0.0	0.0	5.7	0.0	0.1	50.5	66.0	0.3	0.0	0.8	2.1	1.7	0.0	0.5	0.0	0.0	0.3	1.1	1.0	29.7	4.3	0.2	0.1	0.4	0.0	1.5	0.1	0.2	2.6	1.7	0.0	3.8	1.0	6.2	7.1	0.0	1.1	0.1	0.6	0.5	0.9	1.3
CACTIN	"C19orf29, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610645-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	14.6	14.2	20.6	7.8	19.6	10.0	14.8	19.4	24.0	15.7	16.6	15.4	6.2	16.7	2.6	15.4	16.8	3.0	16.3	20.3	18.8	17.0	19.9	12.3	7.6	21.1	19.6	24.7	17.3	4.2	13.3	4.6	19.1	17.2	3.2	4.6	13.2	4.2	19.4	17.8	15.2	2.9	18.5	18.4	15.8	18.2	19.8	8.7	15.3	6.1	4.4	16.5	14.6	20.1	22.2	12.5	10.3	17.9	7.4	7.2	15.6	15.4	6.3	9.1	10.2	12.5	9.7	18.4	12.9	9.7	10.6	20.4	10.8	12.9	5.5	18.7	14.8	11.4	19.2	15.1	10.3	15.7	15.9	7.1	12.2	8.4	5.8	5.4	13.2	15.6	25.9	19.8	4.9	13.3	28.0	13.5	22.0	13.4	14.8	29.4	13.5	17.5	8.5	11.0	14.2	19.9	17.4	12.1	13.3	5.5	9.8	17.7	17.2	12.3	15.5	27.0	27.4	30.3	21.6	20.7	15.2	24.8	16.8	0.0	0.4	0.0	1.2	1.0	0.4	0.6	0.5	0.5	0.3	0.6	0.6	0.8	0.2	0.3	0.1	1.4	0.5	0.4	20.6	19.6	19.4	24.0	20.3	18.8	21.1	19.6	19.1	18.5	19.8	20.1	7.4	0.0	2.7	5.9	6.3	6.0	4.1	2.8	5.7	5.1	6.9	7.1	3.1	5.7	2.2	1.8	2.1	3.6	7.2	6.9	0.0	5.1	3.3	6.7	5.8	5.3	1.2	7.4	3.9	4.9	5.2	5.1	9.2	7.4	4.5	8.5	3.3	4.8	5.1	0.0	4.1	5.8	2.0	3.9	6.5	4.5	5.9	5.3	1.8	3.7	6.1	6.0	8.2	2.5	5.8	5.2	4.4	5.7	6.0	6.0	3.6	3.1	2.4	6.2	0.0	7.2	6.4	10.8	8.8	7.9	8.0	3.3	5.6	7.6	6.1	3.6
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175012027	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 191.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	26.5	22.6	60.7	25.5	63.4	33.8	20.6	66.8	191.9	21.8	48.5	25.6	15.9	19.1	24.4	23.8	17.4	14.7	26.8	66.3	65.6	27.2	25.7	23.7	32.7	60.8	61.8	34.8	15.9	20.5	26.9	22.8	66.8	15.3	20.7	52.5	17.5	18.5	37.7	17.4	19.1	16.4	57.8	24.1	20.3	30.5	58.7	27.9	14.9	27.4	28.9	28.0	20.4	71.9	127.7	85.6	124.0	53.1	40.2	44.8	79.5	94.7	55.6	119.8	86.8	88.9	76.9	132.8	96.0	67.5	85.8	67.3	155.0	69.4	122.7	70.6	92.4	99.6	80.8	96.3	30.1	135.4	59.9	30.3	42.2	98.7	58.8	62.0	85.5	117.0	203.7	72.2	87.0	47.4	208.2	121.5	118.0	189.1	39.4	93.6	87.9	152.5	85.4	99.8	84.9	81.4	64.7	111.0	106.3	165.7	86.8	116.6	44.9	67.9	73.3	96.0	153.8	68.6	211.5	301.8	57.1	117.1	80.6	34.0	25.5	27.9	29.4	41.7	35.4	43.0	42.0	36.2	32.3	33.7	44.6	39.9	14.6	43.7	54.9	28.3	48.7	46.1	60.7	63.4	66.8	191.9	66.3	65.6	60.8	61.8	66.8	57.8	58.7	71.9	70.6	86.6	41.9	13.1	82.1	117.0	183.6	102.2	63.7	57.7	61.8	79.0	108.1	40.0	62.7	35.0	62.6	238.8	68.7	66.2	152.6	96.8	102.2	124.5	67.6	80.0	119.6	113.0	22.4	95.0	304.1	92.8	36.7	167.3	92.0	52.8	44.3	39.4	196.3	30.3	24.1	101.6	67.1	56.0	188.2	30.6	86.0	110.9	108.5	13.1	231.0	77.8	60.8	8.5	28.0	106.9	58.4	73.7	90.7	115.4	80.7	171.4	78.0	84.0	32.9	57.6	108.4	186.7	139.9	88.7	85.7	143.5	188.0	76.5	139.1	106.9
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 287.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.0;myeloid DC: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.1;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 294.7;WM-115: 187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		220000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	7.1	29.9	46.9	6.1	59.2	0.4	17.0	78.7	53.0	21.3	6.1	11.7	7.8	17.4	103.7	12.6	22.6	12.1	25.7	47.6	57.4	29.1	65.3	72.0	14.1	41.1	40.1	12.3	16.0	56.6	26.0	37.9	44.6	15.2	8.1	287.7	38.0	28.0	7.2	10.9	8.8	8.6	30.3	8.0	12.5	50.5	55.8	8.6	69.7	8.1	14.6	13.1	4.8	38.0	0.4	23.3	25.6	0.1	0.0	0.0	0.1	24.1	41.1	3.1	0.3	294.7	26.1	0.0	75.9	36.5	25.2	4.8	4.8	27.4	2.0	1.0	38.3	0.0	7.8	114.5	0.3	0.1	56.5	0.0	38.6	0.0	63.8	16.5	1.1	17.3	0.0	2.7	4.3	19.3	20.0	0.6	24.0	0.3	0.0	0.1	0.4	61.6	44.8	0.9	50.2	107.1	0.0	25.4	21.7	102.4	92.4	1.3	0.0	2.3	44.9	23.3	13.0	64.9	98.9	18.7	36.3	0.2	187.5	0.2	0.0	0.0	8.0	0.0	3.4	1.5	2.9	2.1	8.1	0.3	0.1	1.8	0.0	0.5	0.1	0.0	4.7	1.9	46.9	59.2	78.7	53.0	47.6	57.4	41.1	40.1	44.6	30.3	55.8	38.0	14.0	464.8	195.3	980.7	6.5	20.6	26.7	2.8	19.4	566.6	22.1	22.5	61.7	34.3	27.5	36.8	350.3	71.6	6.8	1.5	11.7	39.2	189.1	88.5	6.0	10.6	7.8	5.3	301.7	2.0	5.0	13.2	3.6	126.9	24.1	36.8	2.9	45.9	36.8	30.3	310.9	2.1	4.1	8.5	20.9	224.0	5.9	14.2	44.4	60.0	13.3	489.9	2.1	676.5	622.8	9.3	0.5	4.1	88.9	38.5	0.3	8.2	8.7	759.5	0.0	13.3	11.7	55.2	23.0	9.2	23.4	32.2	8.1	5.2	4.3	13.5
CADM2	"IGSF4D, Necl-3, NECL3, SynCAM2"	ENSG00000175161	"Cell adhesion molecule 2"	Q8N3J6	3	84958989-86074429	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"brain: 42.1;retina: 94.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 1985.3;Excitatory neurons: 4097.4;Inhibitory neurons: 3632.5;Oligodendrocyte precursor cells: 3613.6;Oligodendrocytes: 5060.4"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;AN3-CA: 31.4;U-266/70: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010024	Enhanced					NA	NA		250000	"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA010024: AB_2068039"	"unprognostic (2.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-4)"	"unprognostic (8.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.07e-5)"	"unprognostic (9.82e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.16e-2)"	4.7	4.6	10.8	0.4	20.7	0.0	1.7	12.8	42.1	0.6	0.0	3.5	0.3	0.2	0.5	1.0	3.0	0.9	2.7	20.7	13.0	0.1	0.8	0.5	0.1	15.2	17.4	0.6	0.7	0.4	2.9	0.2	16.3	1.7	1.0	94.9	0.6	4.4	3.9	0.3	0.9	0.4	7.0	0.2	1.8	0.5	21.1	0.2	0.4	4.1	0.1	0.9	0.9	14.6	0.0	0.1	10.9	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.5	0.0	0.0	0.0	0.0	3.6	2.3	0.9	0.0	0.0	0.0	0.0	0.0	1.1	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	20.7	12.8	42.1	20.7	13.0	15.2	17.4	16.3	7.0	21.1	14.6	57.3	0.0	1.1	1985.3	0.0	1.0	0.7	0.1	5.7	230.3	2.2	3.4	13.2	0.0	0.8	0.0	519.1	0.3	0.2	0.7	0.0	0.2	3.0	0.1	0.5	3.5	1.8	0.0	4097.4	0.2	0.2	3.6	0.0	0.1	0.0	0.3	2.9	0.0	0.4	94.2	3632.5	0.5	0.0	0.0	0.8	2.1	1.8	1.4	3.6	145.2	0.0	60.8	0.0	3613.6	5060.4	0.2	0.0	0.4	0.0	0.7	0.1	0.1	0.0	576.3	0.0	265.0	0.9	0.4	6.4	1.6	1.0	0.0	0.3	0.5	0.1	0.3
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 151.6;placenta: 80.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 146.4;Excitatory neurons: 35.5;Fibroblasts: 39.5;Horizontal cells: 35.3;Inhibitory neurons: 40.5;Muller glia cells: 39.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 65.0;HSkMC: 218.8;hTERT-HME1: 118.5;WM-115: 60.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported			"Intracellular and membrane"	NA	NA		800000		"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	17.3	7.9	102.0	15.1	139.6	0.1	9.2	151.6	145.4	27.6	1.2	28.2	4.4	3.9	1.3	11.5	9.2	6.2	18.1	143.1	96.2	2.2	0.6	5.0	14.3	87.4	84.1	1.5	2.2	0.2	31.0	80.6	120.7	5.1	14.4	66.8	5.9	4.7	2.3	13.0	15.8	6.1	66.3	13.3	11.1	3.0	99.4	1.2	7.3	6.5	9.8	16.2	31.0	60.8	0.0	0.0	0.6	0.0	4.2	1.2	0.0	0.0	0.0	9.4	1.8	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	3.7	0.0	0.0	65.0	0.0	0.2	218.8	0.0	0.1	118.5	0.0	5.3	0.0	0.0	0.2	2.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	4.1	0.0	0.0	5.0	0.0	0.1	9.1	0.0	32.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.0	139.6	151.6	145.4	143.1	96.2	87.4	84.1	120.7	66.3	99.4	60.8	4.2	0.0	0.5	11.4	0.0	6.6	0.1	0.0	0.6	146.4	0.1	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.0	0.0	0.2	8.0	0.0	0.0	35.5	0.0	0.8	39.5	0.5	0.0	0.0	0.0	3.6	0.0	1.2	35.3	40.5	0.0	0.0	0.0	10.7	8.3	0.6	0.3	24.9	1.9	0.0	39.4	0.0	18.6	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	16.3	3.6	3.1	2.6	0.3	4.3	0.7	0.6	0.0	0.0	0.1
CADM4	"IGSF4C, Necl-4, SynCAM4, TSLL2"	ENSG00000105767	"Cell adhesion molecule 4"	Q8NFZ8	19	43622368-43639850	"Predicted membrane proteins"	"Cell adhesion"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 186.0;choroid plexus: 108.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 42.3;Oligodendrocytes: 50.8;Proximal tubular cells: 31.2"	"Cancer enhanced"	"Detected in all"		"glioma: 108.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in many"	5	"WM-115: 557.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012612	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear membrane"	Nucleoplasm	"HPA012612: AB_1851530"	"unprognostic (8.80e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.81e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.39e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.93e-2)"	3.6	23.3	142.5	4.6	165.9	0.6	8.8	166.7	144.2	14.3	108.6	26.5	3.6	14.3	8.7	20.8	5.9	4.8	12.1	133.9	154.4	18.9	6.0	3.8	2.0	158.6	165.0	13.1	15.7	38.1	31.6	0.8	152.7	19.8	3.2	14.5	19.8	14.2	7.6	20.1	7.6	9.1	147.7	2.1	15.1	4.7	163.9	2.9	4.7	2.4	4.5	8.7	14.7	186.0	45.2	12.9	67.3	88.8	0.3	1.4	3.8	2.1	3.6	6.2	9.1	19.4	7.7	0.3	16.2	0.7	3.8	10.5	15.1	9.1	7.5	0.4	11.9	0.4	3.1	28.7	7.9	0.1	6.9	2.7	19.5	32.3	1.2	31.5	4.2	3.9	4.7	0.7	0.7	6.7	6.7	0.9	7.4	9.4	4.4	36.3	0.9	4.3	9.0	9.3	7.8	43.2	4.7	13.7	17.9	10.0	10.1	2.1	1.9	0.9	101.8	0.8	4.4	6.4	4.4	0.3	4.8	0.9	557.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	142.5	165.9	166.7	144.2	133.9	154.4	158.6	165.0	152.7	147.7	163.9	186.0	0.8	0.0	1.7	23.5	1.0	5.0	19.1	7.6	9.1	17.5	8.5	11.8	3.5	4.3	5.4	7.3	2.1	0.2	5.7	0.4	5.9	10.6	21.3	2.5	3.8	2.9	0.0	0.0	11.4	3.2	0.1	1.7	4.1	5.3	0.0	15.5	4.6	3.2	0.4	20.2	22.0	0.4	12.2	0.0	8.2	21.8	0.3	1.1	14.2	3.7	0.1	21.4	0.0	42.3	50.8	3.5	0.0	1.5	2.3	26.3	0.0	31.2	3.3	4.0	0.0	1.9	8.7	0.7	0.7	6.7	8.5	0.0	1.0	1.5	1.2	13.4
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875416	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.6;retina: 184.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 772.6;Cone photoreceptor cells: 627.6;Excitatory neurons: 830.8;Inhibitory neurons: 1152.7;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 11.5;SCLC-21H: 19.7;SK-MEL-30: 9.0;U-698: 13.2;U-87 MG: 20.5"									HPA059328	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059328: AB_2683982"	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	0.4	16.4	32.2	2.0	47.7	0.1	0.7	18.7	84.6	2.8	0.0	2.8	3.2	0.6	2.5	0.2	0.4	2.4	16.7	32.1	26.0	0.2	0.2	0.8	0.5	83.2	39.7	1.9	13.5	0.2	39.6	0.2	84.5	3.6	2.4	184.3	1.4	2.8	0.1	1.4	3.3	0.8	4.1	0.6	3.0	3.2	33.0	0.6	0.2	0.0	0.7	0.4	1.4	61.7	0.0	0.0	0.8	0.0	4.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	11.5	0.0	0.1	0.0	0.0	0.0	0.0	19.7	1.5	0.0	0.0	9.0	0.4	0.0	0.0	0.1	1.6	0.1	3.3	0.9	0.0	1.7	13.2	20.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	47.7	18.7	84.6	32.1	26.0	83.2	39.7	84.5	4.1	33.0	61.7	0.0	0.0	1.9	93.0	0.1	1.3	0.2	0.0	0.0	772.6	0.5	2.8	25.6	7.2	0.0	0.0	627.6	0.1	0.0	0.4	0.0	4.1	1.1	0.2	1.1	0.9	95.9	0.0	830.8	0.4	0.0	3.2	0.0	0.1	42.5	0.2	0.0	0.0	0.0	47.1	1152.7	5.0	0.0	0.0	1.6	2.1	15.2	0.0	8.8	30.0	0.0	21.3	0.0	266.9	27.0	0.9	1.3	2.6	0.0	0.3	0.7	0.1	0.0	64.7	0.0	3.2	1.2	0.2	0.7	0.0	0.1	0.0	0.4	36.9	1.8	0.2
CAGE1	"bA69L16.7, CT95, CTAG3"	ENSG00000164304	"Cancer antigen 1"	Q8TC20	6	7326656-7389742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 5.0"	"Group enriched"	"Detected in some"	9	"Early spermatids: 151.3;Late spermatids: 59.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029832	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029832: AB_10602412"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.25e-4)"	"unprognostic (4.80e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-6)"	"unprognostic (4.71e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.3	0.3	0.7	0.8	0.0	0.4	0.6	0.6	0.3	0.0	0.3	0.0	0.0	0.1	1.6	0.6	0.0	0.1	151.3	0.5	0.5	0.4	0.0	0.0	1.4	0.0	0.2	0.3	1.5	0.8	0.0	0.1	0.0	0.0	0.2	0.0	1.6	1.0	0.0	0.3	0.9	59.2	0.3	1.2	0.0	1.0	0.1	0.1	1.0	0.0	2.5	0.1	0.0	0.4	0.6	0.6	0.3	0.1	0.1	0.6	0.0	1.0	0.5	11.2	2.0	0.0	0.3	0.1	1.5	0.4	0.4	0.6
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 320.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 26.1;Collecting duct cells: 27.6;Cone photoreceptor cells: 91.8;Distal tubular cells: 31.3;Horizontal cells: 99.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 134.9;EFO-21: 189.8;HeLa: 65.9"	"Region enhanced"	"Detected in all"		"cerebellum: 430.7"	"Group enriched"	"Detected in all"	4	"basal ganglia: 49.7;cerebellum: 119.6"	"CAB002138, HPA023099, HPA056734"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	2.4	1.6	7.4	2.0	31.3	1.3	1.7	63.0	21.1	5.5	0.0	1.7	3.2	1.2	3.4	8.5	1.9	1.4	0.9	9.2	14.0	320.6	2.6	3.6	0.9	16.8	10.4	1.2	2.5	2.2	8.4	3.9	6.3	0.8	2.5	54.1	1.7	0.5	1.9	3.5	2.7	1.3	15.9	1.3	2.3	3.6	32.1	2.7	2.5	0.3	1.2	0.5	0.1	7.8	134.9	6.1	30.2	1.2	1.1	4.9	4.0	2.0	5.8	0.7	1.1	2.9	15.1	0.5	189.8	0.1	0.8	47.8	46.0	54.6	9.1	0.3	2.5	3.2	65.9	0.7	5.3	0.8	4.4	1.5	17.3	2.5	25.4	7.0	36.1	2.6	9.9	3.4	35.9	0.6	1.9	0.1	45.3	2.9	17.9	1.3	1.2	3.9	12.9	0.7	5.0	2.9	38.2	2.3	0.6	45.8	1.7	1.1	0.1	3.9	28.1	6.6	11.9	3.1	3.9	1.0	0.5	0.9	0.2	1.5	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.3	0.0	0.4	7.4	31.3	63.0	21.1	9.2	14.0	16.8	10.4	6.3	15.9	32.1	7.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	1.5	0.0	0.0	27.6	91.8	0.0	0.0	0.0	31.3	0.0	14.9	0.0	0.1	0.3	3.5	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	99.3	14.7	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	15.8	0.0	1.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.0	0.3	0.4	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 109.6;hTERT-RPE1: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	125.7	71.3	81.0	25.0	92.7	35.0	115.3	93.5	100.3	102.4	95.0	163.1	31.0	105.3	69.1	71.2	101.7	55.6	142.9	82.0	81.9	73.8	57.0	98.3	33.8	85.2	81.4	110.9	108.3	65.6	80.2	50.3	87.1	90.6	35.4	47.6	119.8	55.5	264.2	180.8	88.3	53.2	78.1	91.0	126.5	49.5	82.7	36.3	89.2	120.6	37.5	125.0	96.4	88.7	12.1	13.8	20.4	26.8	109.6	71.5	13.1	26.4	56.2	19.4	26.6	6.7	52.7	4.9	23.7	61.3	10.0	15.8	8.2	22.3	20.7	20.1	17.1	9.9	31.5	5.4	53.3	4.2	22.0	99.8	58.2	20.3	19.8	146.7	35.2	22.0	8.1	46.7	34.2	5.2	13.5	15.9	4.2	10.9	15.1	13.6	11.3	17.2	31.9	8.4	11.7	21.0	15.1	8.3	26.7	42.5	24.6	13.0	41.2	10.0	13.0	9.5	3.8	42.5	12.8	1.8	46.1	4.9	12.8	85.2	19.6	76.7	26.1	22.4	18.7	14.5	17.8	20.8	11.6	17.1	15.7	17.6	72.0	20.2	23.7	8.8	33.4	23.8	81.0	92.7	93.5	100.3	82.0	81.9	85.2	81.4	87.1	78.1	82.7	88.7	33.0	35.3	14.4	18.9	19.8	32.4	19.0	16.7	30.1	34.3	32.8	27.6	11.7	25.8	16.8	22.0	35.5	23.8	26.0	13.6	5.9	16.7	40.7	27.1	19.4	23.4	28.6	32.0	31.1	11.7	8.8	29.2	16.8	17.5	7.6	29.1	31.8	17.9	15.9	26.9	33.3	18.7	24.4	26.0	15.3	54.0	47.5	28.6	19.6	11.2	21.9	25.3	64.9	20.6	22.6	22.0	17.5	41.3	53.5	20.1	25.9	14.0	26.5	44.6	19.7	28.6	29.5	24.2	9.3	16.7	50.7	45.6	27.3	27.5	13.0	26.4
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48831018-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 1127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	117.9	59.2	36.5	55.3	43.8	62.9	95.3	41.6	50.8	81.0	72.3	101.0	68.1	69.2	61.0	88.6	82.2	66.2	139.1	35.3	45.3	75.7	120.3	91.4	53.2	48.7	42.0	86.6	56.6	76.8	46.6	63.3	49.2	55.6	101.5	76.4	52.5	72.5	158.4	68.2	75.4	87.8	39.0	68.8	71.6	136.3	41.0	74.4	75.3	170.3	67.1	80.9	76.9	52.0	126.0	79.4	33.1	64.0	241.2	173.7	95.0	120.2	160.0	135.9	151.3	150.8	80.6	42.5	117.0	146.5	115.9	68.2	81.4	101.7	162.6	193.3	66.9	40.7	48.0	59.1	276.8	137.4	196.8	258.1	148.1	144.3	103.9	129.0	101.3	130.7	74.9	124.3	119.2	36.8	119.5	73.6	10.3	278.9	97.7	77.8	161.7	81.0	52.2	39.2	13.1	27.9	37.6	24.3	106.0	66.6	154.2	76.5	97.7	147.1	44.9	91.0	85.8	110.4	165.1	30.0	89.2	69.0	61.4	108.9	115.1	115.5	56.6	121.5	54.2	54.1	49.9	58.9	67.1	46.7	50.5	55.8	132.8	105.0	132.3	33.6	107.2	89.7	36.5	43.8	41.6	50.8	35.3	45.3	48.7	42.0	49.2	39.0	41.0	52.0	166.2	115.4	98.1	20.5	42.1	36.6	73.3	40.9	40.9	16.8	34.7	32.4	169.1	37.1	48.4	33.1	50.1	50.2	48.6	124.5	37.2	47.2	1127.4	37.4	89.7	104.6	50.4	40.8	31.0	42.2	45.3	79.1	31.6	44.0	100.0	29.8	110.3	58.9	27.6	8.4	21.2	44.7	24.4	119.2	54.3	233.3	70.2	70.7	26.6	28.1	57.4	45.9	64.9	26.7	27.3	37.7	54.6	74.1	56.2	57.6	81.5	48.9	28.4	72.7	72.3	69.6	76.2	152.5	32.7	55.6	46.9	81.3	54.6	96.3	66.1	66.1
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424486-93574730	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 5.8;kidney: 1.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Late spermatids: 7.7;Microglial cells: 15.9;Skeletal myocytes: 46.0"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.6;SuSa: 2.9;T-47d: 2.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.3;hypothalamus: 24.6"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported	Approved	"Vesicles,Cell Junctions,Centriolar satellite"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"	"Vesicles, Centriolar satellite"	"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.1	0.2	1.6	0.0	0.5	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	5.8	1.5	0.0	0.2	0.0	1.8	1.6	0.2	0.0	0.0	0.1	0.6	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	2.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.2	0.0	5.8	1.8	1.6	3.4	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.8	0.6	7.7	0.6	0.6	0.0	15.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	3.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 70.7;lung: 76.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 173.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	70.7	6.3	3.4	12.3	4.0	0.4	15.8	6.1	4.4	27.8	3.4	6.9	6.0	21.5	4.6	8.6	11.4	24.4	20.4	3.9	3.8	14.0	12.6	76.8	7.9	11.1	6.2	15.7	4.3	13.0	3.6	11.7	10.8	7.3	9.5	0.9	7.1	7.7	6.2	3.9	6.3	27.1	15.5	8.6	7.1	2.7	3.9	4.6	28.3	20.2	9.1	14.1	4.7	15.2	0.2	0.0	8.8	0.0	6.2	1.6	0.0	0.8	1.3	0.1	1.0	0.0	1.0	0.0	2.3	0.7	0.2	0.0	0.0	0.6	0.2	1.5	0.5	1.5	0.0	0.2	4.9	0.2	0.0	4.6	0.2	0.3	2.1	0.5	173.6	0.1	0.0	2.5	1.2	0.0	0.8	0.1	0.5	0.0	0.0	0.0	3.1	0.5	40.5	0.0	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.2	25.3	0.7	0.1	0.1	0.4	6.2	0.1	0.7	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	9.2	0.0	0.8	0.1	0.1	1.0	1.0	2.6	0.0	0.9	3.4	4.0	6.1	4.4	3.9	3.8	11.1	6.2	10.8	15.5	3.9	15.2	138.3	0.0	11.9	19.6	1.2	9.3	2.3	1.7	21.6	0.2	0.8	1.8	12.3	2.8	3.6	0.0	0.0	0.4	2.4	0.0	3.9	0.3	0.8	3.1	92.7	248.7	0.0	4.8	15.4	0.4	0.2	56.5	1.1	1.7	5.1	12.3	259.2	1.8	0.9	0.0	2.1	0.0	2.0	10.3	29.7	1.0	7.8	15.4	10.6	47.8	16.1	0.0	1.0	293.0	1.0	0.1	0.0	2.6	4.9	1.9	0.0	13.2	2.8	0.1	6.6	4.1	21.5	1.3	0.7	18.2	6.8	0.3	3.0	6.0	0.0	1.8
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALHM1	FAM26C	ENSG00000185933	"Calcium homeostasis modulator 1"	Q8IU99	10	103453240-103458900	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sensory transduction, Taste, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1.6;NK-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061816	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA061816: "	"unprognostic (2.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.65e-3)"	"unprognostic (3.44e-2)"		"unprognostic (2.86e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-2)"	0.0	0.0	0.8	0.1	0.6	0.1	0.0	1.1	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.2	0.8	0.0	0.0	0.0	1.9	0.9	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	1.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.6	1.1	1.1	0.7	1.2	1.9	0.9	2.1	0.1	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	49.7	18.5	7.2	12.5	6.5	2.1	38.9	6.3	9.0	54.4	7.0	18.4	6.5	58.1	5.5	12.2	43.3	21.6	34.2	7.0	7.3	10.7	4.5	23.2	13.7	8.0	6.4	48.1	7.1	3.1	7.3	10.0	7.8	21.1	4.3	0.4	14.9	10.6	9.7	17.9	19.6	15.9	7.7	35.3	13.8	11.5	8.0	5.6	21.6	11.1	6.1	33.9	39.3	7.9	11.0	7.5	1.8	2.4	27.3	45.1	9.1	37.7	37.5	11.2	15.7	3.3	5.3	3.3	4.2	43.2	0.7	5.0	3.8	0.0	2.1	0.4	21.5	7.8	2.5	0.6	12.4	1.3	0.7	15.6	0.0	3.3	0.1	20.8	13.5	8.3	1.8	19.8	7.5	25.0	3.0	3.7	4.8	2.3	6.7	9.2	3.0	7.5	1.0	0.9	5.3	2.3	1.5	6.2	2.1	0.8	1.2	2.5	24.5	3.6	4.4	12.6	2.7	3.0	7.6	3.8	31.0	24.0	0.8	70.0	91.9	1.8	83.7	178.4	69.6	27.7	56.5	69.7	152.1	7.3	10.8	42.3	3.6	62.9	214.6	17.8	82.7	85.6	7.2	6.5	6.3	9.0	7.0	7.3	8.0	6.4	7.8	7.7	8.0	7.9	18.2	3.2	0.6	1.0	4.9	5.4	2.9	0.6	4.0	0.1	3.4	4.4	3.3	1.5	0.0	3.7	0.0	3.1	11.3	0.1	0.0	4.2	1.0	1.4	19.8	25.5	1.2	5.7	2.3	0.2	75.1	38.2	1.5	2.1	8.8	11.4	48.2	0.6	53.7	0.0	0.5	0.1	2.0	28.8	18.8	2.5	45.7	21.5	8.8	2.8	17.3	0.2	33.0	1.0	0.2	0.1	0.1	16.1	3.1	0.8	0.0	0.3	0.0	0.1	19.7	16.8	27.9	0.8	0.9	0.8	3.8	19.2	19.4	6.0	0.0	1.0
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Taste, Transport"	"Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Early spermatids: 2.2;Extravillous trophoblasts: 6.7;Late spermatids: 2.0;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-266/84: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 16: U-266 - Nucleosome"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.3	2.6	0.3	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	14.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511639-116524788	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: AB_2674390"	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	3.3	0.5	0.6	1.1	0.7	0.0	1.6	0.5	0.6	1.3	0.7	1.5	0.6	1.3	0.6	1.2	0.9	1.5	2.3	0.6	0.5	1.9	0.5	1.7	0.9	0.6	0.5	0.5	0.1	0.5	0.3	4.4	0.6	0.9	1.0	0.0	0.6	0.7	1.6	1.0	0.9	2.1	0.5	1.7	0.6	0.7	0.8	0.1	0.8	2.5	0.5	1.4	1.2	0.6	0.0	0.0	4.5	0.0	2.7	4.3	0.0	3.6	5.3	1.4	3.8	0.2	0.0	0.0	0.3	5.6	3.8	0.0	0.0	0.0	1.5	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.0	2.6	0.0	3.4	0.0	1.0	5.6	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.9	2.5	0.8	0.3	0.2	0.0	0.0	0.0	2.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.6	0.6	0.5	0.6	0.5	0.6	0.5	0.8	0.6	10.6	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408268	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018558, HPA044999"	Supported		Supported	Cytosol		NA	NA		75000000	"Cluster 44: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	264.2	143.5	429.9	152.3	537.5	349.1	123.1	442.8	839.7	134.2	259.8	332.9	289.6	105.1	209.7	304.6	251.4	153.8	287.0	635.9	371.6	326.3	210.9	209.1	165.7	466.2	374.6	104.4	121.7	225.5	143.9	207.4	447.5	169.5	312.2	241.6	188.0	215.3	588.9	104.0	279.2	227.2	328.7	166.6	202.2	123.6	443.5	146.5	118.0	185.6	210.5	191.6	125.2	527.2	189.3	256.3	308.0	115.7	332.2	286.5	256.9	347.4	295.3	260.0	283.2	278.1	320.9	200.8	171.1	413.0	123.4	309.4	194.6	490.1	431.0	398.3	119.7	212.4	211.0	264.1	185.9	327.6	167.2	188.0	232.7	261.6	93.1	173.6	592.9	140.3	101.3	270.0	353.9	653.7	112.4	316.2	178.4	521.1	351.6	216.9	264.9	134.4	215.3	574.5	621.2	259.1	292.3	507.7	195.5	254.0	335.6	112.0	363.1	212.9	137.7	224.8	289.0	149.5	371.0	222.2	335.9	267.6	301.5	1289.6	356.8	826.7	1005.3	420.4	1230.3	496.8	1039.1	1079.6	483.1	400.2	745.7	882.7	513.3	1036.9	647.3	453.3	1168.3	1477.9	429.9	537.5	442.8	839.7	635.9	371.6	466.2	374.6	447.5	328.7	443.5	527.2	1812.3	387.8	374.4	119.8	573.2	567.1	572.2	604.2	543.5	1729.1	343.7	514.8	867.5	346.0	523.1	399.1	123.0	427.7	1471.8	828.8	459.7	550.8	154.9	1026.1	249.0	996.0	599.8	143.5	367.6	444.7	984.2	521.4	317.0	377.6	490.3	148.5	652.5	333.7	795.1	604.0	258.9	513.9	730.4	286.5	837.4	101.5	210.6	639.9	627.9	131.2	856.3	1061.8	1100.9	108.0	188.9	534.2	615.8	500.2	591.8	287.7	1637.2	1430.5	1618.4	321.1	315.5	387.5	901.6	128.8	199.8	553.8	580.4	1147.6	1139.3	247.8	666.6	458.5
CALM2	"CAMII, PHKD"	ENSG00000143933	"Calmodulin 2"	P0DP24	2	47160083-47176921	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007790, HPA044999"	Approved					NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB007790: AB_562257, HPA044999: AB_2679177"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (1.24e-1)"	509.3	652.1	1177.9	334.4	1219.1	240.3	686.1	1229.7	1745.6	420.1	988.8	683.9	549.8	507.6	551.1	366.8	526.5	390.8	443.0	1229.0	1219.0	445.7	493.1	505.6	427.9	1209.1	1192.8	416.1	213.3	332.3	441.3	468.9	1227.6	449.1	706.0	574.8	490.8	561.5	262.9	304.2	621.2	634.7	1209.4	643.0	390.4	508.8	1257.9	571.0	443.3	258.1	467.2	459.0	340.2	1411.8	2459.6	905.8	1062.2	459.7	579.4	679.5	655.8	2177.2	1504.3	1437.1	1240.1	958.1	923.2	956.1	979.5	1753.2	1030.4	624.7	878.3	855.6	1907.0	729.3	438.6	821.6	526.6	1409.6	779.5	996.3	686.2	381.2	825.0	1265.3	1347.0	1230.4	977.3	312.8	812.1	854.7	3485.7	635.9	1270.2	984.3	801.3	2961.6	488.6	314.3	1142.9	1021.9	1631.0	441.0	756.8	2016.6	726.5	756.0	1120.1	1144.3	573.7	556.7	1084.8	1060.8	1135.8	627.0	1703.6	648.8	529.1	1038.2	718.8	711.3	1357.7	944.7	447.6	776.8	139.7	844.1	177.2	285.6	203.4	213.2	354.0	182.1	173.7	201.6	417.9	277.1	761.4	445.6	227.4	496.5	1177.9	1219.1	1229.7	1745.6	1229.0	1219.0	1209.1	1192.8	1227.6	1209.4	1257.9	1411.8	597.4	1387.8	613.5	195.2	570.7	1780.5	1101.0	2616.3	524.8	654.3	844.4	572.9	639.6	581.9	1751.8	759.6	98.0	931.4	649.8	906.5	2304.8	1977.0	312.7	889.1	363.8	652.0	597.1	697.1	317.5	683.4	627.9	943.6	354.8	452.5	665.4	484.5	280.6	536.6	1267.1	341.6	179.0	1020.1	3352.8	867.1	1858.2	287.0	1055.3	911.0	1771.6	143.4	1167.2	2063.1	350.1	129.7	339.8	2584.9	1114.4	863.6	309.7	1016.8	1231.6	1020.2	3245.3	334.2	907.2	671.6	1882.0	2193.5	714.3	503.0	1663.1	255.3	669.1	615.4	771.1	1062.2
CALM3	PHKD	ENSG00000160014	"Calmodulin 3"	P0DP25	19	46601074-46610782	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 868.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1863.5;Late spermatids: 2674.8;Spermatocytes: 875.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044999	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA044999: AB_2679177"	"unprognostic (3.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.01e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.10e-4)"	"unprognostic (2.72e-1)"	136.3	186.9	309.9	153.9	428.0	194.4	113.2	19.8	868.1	187.9	0.0	178.8	203.6	175.4	97.6	118.4	148.8	135.9	272.4	498.5	183.4	177.3	137.2	125.7	179.4	240.2	77.0	189.0	116.3	110.3	138.6	133.3	199.8	143.6	158.2	152.0	73.1	157.7	340.0	85.6	228.9	166.8	25.8	122.2	143.4	469.0	184.3	270.8	118.1	253.0	172.2	173.2	150.8	505.1	392.6	437.1	493.9	174.6	256.1	338.9	119.5	405.8	333.6	358.0	473.1	374.8	342.5	322.3	185.2	599.0	249.7	297.6	496.9	322.0	453.5	498.0	387.6	433.7	201.8	404.5	139.0	324.5	596.5	334.6	106.9	281.1	218.3	274.2	450.6	353.4	335.7	447.0	345.3	250.1	354.3	818.1	251.6	575.7	192.3	644.7	254.5	121.9	341.4	463.3	253.6	279.7	304.6	194.1	123.7	484.3	227.9	364.7	329.2	197.6	366.2	150.5	298.5	370.2	280.6	262.1	197.9	279.5	255.7	190.6	158.2	262.4	67.2	193.9	61.0	74.7	95.5	90.0	93.5	68.6	112.0	71.6	433.7	103.6	194.3	55.1	195.6	150.7	309.9	428.0	19.8	868.1	498.5	183.4	240.2	77.0	199.8	25.8	184.3	505.1	77.6	41.7	56.8	23.8	101.8	57.2	82.8	82.0	32.5	136.2	82.4	86.1	177.5	87.2	59.9	69.9	12.5	202.9	120.0	301.1	260.3	265.0	1863.5	101.6	76.4	88.7	122.4	318.4	114.1	221.5	545.1	112.3	89.2	82.4	106.0	130.6	125.7	106.4	760.3	89.2	89.4	178.2	59.0	307.8	112.7	2674.8	106.9	349.8	92.5	32.8	525.0	184.2	225.6	23.1	30.2	205.1	273.5	122.6	143.3	67.6	457.2	365.6	85.4	88.2	92.1	47.8	130.9	875.3	157.4	64.6	65.9	184.8	161.1	192.7	208.8	111.9
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524961-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 507.1;skin 1: 179.0;vagina: 200.8"	"Cell type enriched"	"Detected in some"	8	"Squamous epithelial cells: 1257.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 150.9;head and neck cancer: 196.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0"	"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					NA	NA		1200000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.5	0.1	0.2	0.0	0.2	0.0	5.4	1.5	0.1	107.9	0.0	0.1	0.0	0.1	0.1	507.1	1.2	0.0	0.1	0.0	0.3	17.3	1.6	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.3	0.0	0.2	2.9	0.0	0.0	121.0	0.1	1.0	179.0	0.2	0.0	0.0	0.1	0.3	1.7	0.7	79.5	0.1	0.0	39.8	0.2	200.8	0.0	21.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.3	0.5	0.3	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	28.4	29.8	6.3	157.1	2.2	13.3	22.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	4.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	28.5	0.0	1.4	8.3	0.3	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	59.6	0.7	0.3	0.0	0.0	0.9	6.7	0.1	1257.1	55.0	0.0	0.7	0.0	0.2	30.6
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 3060.6"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	3.9	0.5	0.0	0.0	0.0	0.1	41.2	0.0	0.0	94.0	0.0	0.8	0.0	0.3	0.7	67.5	0.1	0.0	1.3	0.0	0.0	0.3	1.7	0.8	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	554.0	0.0	11.7	3060.6	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.2	0.6	0.0	13.4	0.1	306.6	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 11.3;brain: 44.3;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 88.8;Excitatory neurons: 130.6;Inhibitory neurons: 212.7;Oligodendrocyte precursor cells: 44.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Karpas-707: 44.5"	"Low region specificity"	"Detected in all"							"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Plasma membrane"	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.1	11.3	12.2	0.0	18.5	0.6	0.2	44.3	15.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	25.4	40.6	0.0	0.2	0.0	0.0	27.9	17.0	0.1	1.0	0.0	0.5	0.0	30.2	0.2	0.1	1.9	0.0	1.1	0.0	3.5	0.0	0.0	15.2	0.0	0.0	3.2	8.3	24.7	0.1	0.0	0.0	0.0	3.2	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	44.5	0.0	0.0	0.1	0.0	6.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	7.2	0.1	0.0	7.0	7.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	18.5	44.3	15.0	25.4	40.6	27.9	17.0	30.2	15.2	8.3	26.5	0.0	0.0	0.0	88.8	0.0	2.3	0.4	0.0	0.0	3.8	0.0	0.6	5.6	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.1	0.1	0.3	0.0	2.1	130.6	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.4	0.4	0.1	0.0	212.7	1.5	0.0	0.3	0.7	7.0	0.0	0.1	0.0	14.0	0.0	0.2	1.0	44.7	15.7	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.0	0.8	0.0	6.1	0.2	8.8	12.8	0.0	9.8	0.1	0.2	0.2	0.1	0.1
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		210000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	295.5	257.6	201.7	352.9	213.4	554.9	218.9	238.0	213.5	256.3	324.0	304.6	287.3	275.8	647.7	338.2	266.7	164.1	303.2	203.5	239.7	296.9	782.3	308.9	230.0	260.4	230.1	272.2	319.7	292.2	284.5	403.3	254.5	277.9	336.7	96.2	299.3	247.2	119.8	189.3	277.2	349.7	237.7	277.3	300.6	165.2	267.3	245.3	702.9	104.7	319.4	252.2	236.6	274.2	1681.4	673.6	832.5	1984.9	1110.8	861.5	724.6	2075.3	1160.8	839.6	1280.4	1044.2	1353.5	1087.2	1960.0	2528.4	1064.5	672.1	906.1	1476.5	800.7	730.0	588.1	894.3	689.0	1619.6	2667.5	3638.5	1171.8	946.8	638.7	1222.3	957.7	1472.5	1507.8	743.1	814.5	536.3	911.7	1222.3	1040.0	2511.9	808.7	952.0	970.1	777.0	770.8	1329.9	1138.3	846.9	312.4	668.4	1438.7	769.8	472.6	789.9	1014.4	1558.9	1460.6	1113.2	666.2	1533.6	938.3	644.3	569.7	985.8	1567.6	1616.3	1258.1	67.5	72.8	39.7	172.8	147.8	119.3	90.0	99.7	130.0	76.3	77.5	73.0	134.4	23.8	103.1	122.7	215.6	83.4	75.8	201.7	213.4	238.0	213.5	203.5	239.7	260.4	230.1	254.5	237.7	267.3	274.2	385.2	147.4	160.7	34.6	385.7	261.7	336.3	217.3	221.4	76.8	214.9	140.8	43.7	163.0	175.4	222.5	127.2	652.9	515.5	524.4	64.6	582.7	27.8	206.3	364.2	305.6	353.6	266.1	14.2	285.5	1717.5	422.5	289.5	348.2	207.4	341.6	312.7	612.4	789.3	35.3	23.8	595.1	93.6	208.8	433.2	30.6	318.7	378.4	213.5	31.9	229.9	316.5	360.5	28.6	31.1	410.2	462.8	311.1	1059.6	426.1	377.8	182.8	147.5	167.7	203.8	224.2	328.9	276.1	306.6	245.5	213.5	964.4	345.8	399.4	471.4	329.6
CALR3	"CRT2, CT93, FLJ25355, MGC26577"	ENSG00000269058	"Calreticulin 3"	Q96L12	19	16479061-16496167	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Chaperone	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"testis: 64.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 51.0;Late spermatids: 13.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025749, HPA043355, HPA048460"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403"	"unprognostic (1.19e-1)"	"unprognostic (3.84e-1)"		"unprognostic (7.17e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.18e-2)"	"unprognostic (6.69e-7)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	13.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128773400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 504.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 2467.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	115.8	56.6	20.6	137.9	22.7	22.8	66.2	22.8	28.5	133.5	54.7	97.5	37.6	113.6	61.1	60.4	57.1	92.7	236.9	24.5	23.5	45.1	74.2	68.5	38.8	24.1	22.2	54.8	52.6	85.0	28.8	211.8	24.2	113.0	81.3	19.6	67.7	150.1	82.1	29.9	40.0	328.4	22.3	47.5	62.5	39.8	33.2	31.0	77.1	117.1	45.2	160.1	48.2	26.6	257.8	207.4	486.6	152.7	1348.5	1229.5	270.9	1821.7	1378.1	577.5	770.7	238.6	388.3	100.0	351.5	2467.8	850.4	144.9	258.2	318.2	826.5	80.6	138.2	136.6	283.7	295.0	657.1	187.2	254.3	930.5	223.6	868.3	370.6	904.4	537.3	116.4	237.9	172.8	1131.8	141.0	130.2	95.5	305.2	247.0	197.3	122.9	333.3	164.5	243.5	132.7	44.3	238.2	595.4	481.5	753.1	932.2	106.2	145.6	799.8	1706.6	234.2	1350.8	754.6	306.8	385.7	224.8	1478.6	223.6	1857.2	21.7	38.8	23.5	28.3	41.4	27.9	23.7	19.5	22.0	33.4	16.6	17.1	20.0	4.5	26.2	35.7	32.9	23.4	31.2	20.6	22.7	22.8	28.5	24.5	23.5	24.1	22.2	24.2	22.3	33.2	26.6	67.3	22.4	38.5	25.5	29.9	81.3	68.1	82.0	31.3	28.2	51.7	42.7	247.0	25.8	62.7	25.8	18.8	116.8	25.0	14.4	17.6	69.5	11.4	37.5	186.3	104.0	19.7	42.3	37.7	60.5	504.7	198.8	37.2	72.8	59.6	62.6	113.2	54.2	136.9	28.6	47.0	55.9	22.4	58.9	70.7	9.3	100.3	44.6	120.9	27.2	26.3	32.4	21.6	31.2	32.2	71.5	11.4	118.8	140.9	110.6	12.6	17.7	57.2	12.8	59.2	64.9	162.8	27.1	41.9	30.9	76.9	243.0	30.9	69.7	26.1	90.5
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 236.9;pituitary gland: 167.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 155.7;Excitatory neurons: 72.6;Horizontal cells: 72.3;Inhibitory neurons: 128.5"	"Cancer enriched"	"Detected in some"	4	"pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"	0.2	17.9	55.4	0.8	42.4	0.1	0.1	2.5	75.0	0.2	0.0	4.7	2.4	0.0	0.1	0.1	0.2	0.0	0.2	38.1	236.9	0.2	0.3	0.4	0.2	47.6	74.8	0.2	3.4	0.6	167.6	0.0	71.8	0.5	0.5	11.1	0.2	0.1	0.1	0.3	2.3	0.3	30.1	0.6	2.4	4.3	88.5	0.0	0.4	0.0	0.1	0.2	0.9	35.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	42.4	2.5	75.0	38.1	236.9	47.6	74.8	71.8	30.1	88.5	35.0	0.2	0.0	0.0	26.1	0.1	0.3	0.0	0.0	0.0	155.7	0.8	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	2.2	0.0	0.5	0.6	19.5	0.0	72.6	0.0	0.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.1	72.3	128.5	1.5	0.0	0.0	0.4	2.0	0.0	0.2	0.0	18.7	0.0	11.5	0.0	10.6	20.1	0.6	0.0	0.4	0.1	0.6	0.0	0.4	0.0	31.7	0.0	0.2	0.5	16.3	7.9	0.0	0.0	0.3	2.8	0.2	0.1	0.0
CAMK1	"CaMKI, CaMKI-alpha"	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757347-9769992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 280.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 280.5"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 403.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	52.4	99.7	50.1	17.2	48.9	5.1	37.2	39.9	61.0	27.0	31.8	33.6	9.2	31.8	13.7	8.0	37.0	11.1	20.5	61.2	46.3	24.9	36.4	23.9	11.1	37.8	41.7	41.2	8.4	14.4	21.6	6.7	38.8	31.1	10.6	5.9	9.8	19.7	7.1	7.9	16.5	26.0	36.8	16.7	21.7	29.8	46.9	4.3	19.5	7.8	15.0	28.4	18.3	46.1	0.5	16.4	12.6	0.0	64.7	24.3	32.6	38.4	21.1	43.1	40.4	24.1	3.0	1.1	9.0	26.0	6.2	2.7	0.0	5.0	27.0	0.4	95.4	53.5	32.1	34.1	35.9	4.5	403.3	25.3	4.1	60.6	6.7	35.4	36.8	0.9	7.2	1.2	16.3	10.3	0.3	38.8	9.0	0.4	25.7	0.3	0.4	1.1	25.9	2.8	4.2	16.7	6.6	0.7	4.0	5.3	4.1	67.2	19.6	19.8	24.4	28.0	48.7	0.4	0.3	1.0	41.5	14.7	3.0	17.8	21.3	280.5	0.3	42.2	0.1	0.1	0.4	0.2	14.1	0.2	0.3	0.1	1.0	3.6	43.0	0.4	2.0	4.7	50.1	48.9	39.9	61.0	61.2	46.3	37.8	41.7	38.8	36.8	46.9	46.1	58.3	0.0	3.1	17.9	2.8	5.0	19.2	3.4	5.7	9.9	5.2	4.6	0.1	12.8	2.1	11.0	2.1	0.4	3.0	2.6	9.8	14.4	1.8	1.8	14.9	22.8	6.0	4.8	25.6	4.0	1.2	23.3	5.6	3.1	30.5	16.7	30.4	23.5	76.2	0.0	14.5	2.3	0.0	46.4	40.2	7.2	36.1	71.2	5.4	8.4	36.7	39.4	3.1	6.6	2.7	5.5	2.9	45.1	0.2	17.5	3.6	47.4	1.3	7.7	59.2	12.2	42.7	1.5	3.7	1.5	3.8	0.8	7.1	6.6	7.6	11.0
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349547-12835545	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 57.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5"	"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 113.8;U-266/70: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	6.6	4.8	14.9	8.4	16.7	6.8	4.3	4.5	35.6	7.4	1.1	11.4	3.5	3.2	2.8	8.6	3.8	5.9	14.6	29.6	0.6	2.6	8.2	7.5	9.6	3.7	0.1	2.7	16.9	0.9	2.8	2.9	0.0	4.7	12.4	57.9	4.3	7.0	1.5	18.5	6.3	5.2	0.7	10.9	3.1	6.1	1.3	23.5	13.0	2.3	12.6	7.1	9.2	14.5	0.3	6.1	6.8	0.3	4.0	1.4	0.4	0.9	2.2	1.4	2.0	8.6	4.8	3.4	0.7	0.6	3.4	3.2	8.4	1.2	1.1	113.8	4.1	13.6	19.4	0.4	1.1	0.3	11.8	0.2	5.2	2.7	0.2	14.6	0.8	7.2	0.4	0.4	1.7	7.2	26.9	5.6	4.6	0.0	2.7	20.2	3.7	6.4	0.2	6.5	10.4	4.8	13.2	4.9	0.0	0.9	3.4	3.3	0.3	5.6	8.1	18.1	4.0	50.3	16.8	11.3	8.2	8.8	0.1	19.5	4.9	75.1	3.8	7.1	3.9	12.1	3.3	4.8	9.3	14.7	3.8	2.6	29.8	3.1	8.7	2.8	1.1	3.4	14.9	16.7	4.5	35.6	29.6	0.6	3.7	0.1	0.0	0.7	1.3	14.5	12.5	3.2	25.2	130.6	68.0	22.9	8.6	26.3	13.1	167.4	3.4	1.7	17.1	12.8	36.6	1.8	392.0	0.2	22.1	36.7	0.0	9.0	20.4	3.6	4.0	13.7	16.1	7.6	416.9	22.0	0.9	30.4	2.0	2.0	23.4	2.0	15.0	13.7	16.0	45.4	233.6	27.4	10.2	50.1	61.2	9.2	23.6	36.2	3.6	168.6	34.8	24.2	30.9	111.6	7.2	10.5	42.8	60.9	23.9	4.9	2.0	1.2	27.5	214.2	26.3	7.2	10.2	4.8	11.0	24.6	41.2	0.3	21.6	8.7	33.2	20.9
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486210	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 461.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;MAIT T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	20.1	61.6	340.5	9.3	322.3	0.5	19.8	172.0	461.3	32.5	115.4	85.0	80.4	27.8	38.1	27.8	22.3	27.4	22.3	354.6	206.5	86.2	53.8	67.9	1.9	224.8	222.4	30.2	8.8	42.4	37.7	11.6	215.9	35.8	77.0	32.6	30.4	40.8	7.1	12.0	86.9	22.7	226.7	12.2	19.5	4.7	265.4	2.0	10.8	9.9	7.0	27.3	24.3	348.6	63.1	17.5	15.0	212.1	28.4	52.6	2.2	52.6	119.0	9.5	4.8	20.1	199.1	6.3	14.7	21.7	7.7	103.2	4.6	90.0	5.9	11.7	3.8	1.3	0.9	165.6	31.4	0.1	6.2	8.4	41.2	5.6	21.2	19.6	16.4	4.3	6.3	0.5	105.8	17.4	0.2	0.5	2.8	109.7	3.9	5.6	9.4	0.4	59.3	93.5	57.6	16.2	28.5	159.6	16.3	10.2	30.6	0.6	5.0	34.9	46.1	48.5	21.1	0.1	0.1	2.5	119.5	13.5	22.0	0.0	0.0	0.0	1.6	0.0	1.1	0.5	0.5	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	340.5	322.3	172.0	461.3	354.6	206.5	224.8	222.4	215.9	226.7	265.4	348.6	28.3	3.2	1.1	35.6	7.6	9.3	11.7	2.3	0.6	248.6	96.5	104.5	20.8	178.7	2.5	248.3	6.2	0.5	10.1	640.5	229.0	20.1	0.8	6.2	45.6	20.0	299.2	8.0	132.5	40.8	2.9	65.1	9.2	12.0	1.3	4.6	9.3	201.6	0.3	85.8	108.7	431.4	14.2	1.9	12.1	3.9	62.7	5.6	39.2	26.2	0.6	81.1	0.0	27.6	249.1	141.5	367.7	94.0	3.5	37.7	183.2	519.2	1.2	35.6	131.5	86.2	96.4	0.8	2.8	1.0	7.5	2.1	14.7	0.8	223.5	50.3
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261553	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 104.3;pancreas: 33.6;pituitary gland: 39.6"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 62.2;Inhibitory neurons: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1"	"Low region specificity"	"Detected in all"							"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	0.1	14.6	60.0	0.2	29.5	0.0	0.1	45.8	49.8	0.1	0.0	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	36.0	69.1	0.2	0.7	0.1	0.0	95.7	70.7	0.1	33.6	0.8	39.6	0.1	79.5	0.3	0.0	5.5	0.2	0.1	0.0	0.2	0.2	0.1	50.7	0.1	0.5	0.2	104.3	0.0	0.1	0.0	0.0	0.1	0.1	29.7	21.2	0.5	3.2	1.7	0.5	0.5	2.2	0.5	6.2	4.0	4.1	1.2	1.1	2.0	5.4	0.3	13.0	2.8	1.1	0.7	2.2	16.1	1.4	0.7	0.5	0.9	0.1	1.4	3.0	0.5	1.0	0.6	2.8	1.4	0.0	0.9	0.3	7.5	0.6	14.5	0.4	1.1	13.3	1.5	8.4	33.4	9.4	3.2	0.9	5.0	33.2	7.3	3.9	1.7	0.3	0.3	13.3	0.2	0.2	32.1	15.0	4.3	6.7	4.1	8.1	6.8	8.1	3.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	29.5	45.8	49.8	36.0	69.1	95.7	70.7	79.5	50.7	104.3	29.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.2	0.3	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.4	0.2	3.6	0.0	7.8	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.8	0.0	62.2	45.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	2.8	0.0	2.0	0.0	7.5	2.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	0.4	3.8	5.0	4.4	30.6	3.1	0.4	70.4	8.2	0.9	0.0	1.3	1.4	0.6	0.3	0.7	0.3	1.5	0.1	7.6	0.0	0.7	1.4	1.1	8.1	0.0	0.4	0.6	0.4	0.0	0.6	0.2	1.4	3.4	1.4	4.7	0.4	1.4	0.1	0.1	2.3	0.8	0.0	2.6	1.5	9.4	0.8	55.4	0.2	0.0	5.2	1.7	0.4	0.0	0.0	0.0	3.1	2.1	0.6	2.3	0.0	0.8	6.8	8.0	7.8	0.0	0.1	0.0	4.0	0.4	5.4	0.3	6.8	0.8	5.8	88.9	5.2	1.3	2.8	0.0	0.2	0.6	0.3	0.3	0.0	16.8	1.7	4.9	1.4	61.3	0.0	3.3	0.4	0.0	27.9	0.0	4.1	0.0	0.2	4.0	5.0	0.2	2.9	0.1	18.8	33.5	1.2	0.0	5.6	0.2	0.1	0.5	0.1	16.3	9.5	0.1	14.7	2.6	0.3	0.0	8.0	0.0	6.3	0.1	0.0	0.0	4.8	0.0	24.3	1.3	17.3	13.5	0.0	0.3	33.1	18.5	0.9	1.4	0.0	0.1	21.3	5.5	5.0	30.6	70.4	8.2	7.6	0.0	0.0	0.4	1.4	0.0	0.8	0.0	1.8	0.0	1.1	57.8	9.4	1.1	0.3	1.3	8.6	70.9	0.6	0.6	5.3	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.1	306.2	0.2	1.6	1.1	0.0	0.0	212.2	0.0	0.2	4.6	3.6	0.4	4.5	0.3	0.7	0.3	0.2	0.0	131.8	0.8	0.0	1.3	2.1	108.4	4.1	2.0	0.0	12.2	2.7	2.8	1.0	133.2	5.4	1.2	0.0	1.5	11.5	0.5	0.0	0.1	0.1	4.3	0.0	0.6	3.8	30.3	6.2	2.4	1.0	0.0	83.3	0.1	0.0	0.3
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.9;Excitatory neurons: 52.7;Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 21.5;basal ganglia: 24.2;cerebral cortex: 54.4;hippocampal formation: 24.8;white matter: 31.9"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3;U-87 MG: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	6.0	10.7	21.5	5.2	24.2	4.1	5.4	5.6	54.4	12.7	0.0	10.2	2.9	13.1	4.8	6.8	7.0	3.6	5.7	24.8	0.8	3.6	1.0	5.0	2.6	6.0	1.9	8.1	12.7	4.1	24.4	2.0	6.6	8.2	2.7	12.0	29.9	10.4	3.4	15.9	6.9	5.8	0.6	9.6	4.2	10.1	5.0	5.1	7.6	1.6	2.3	16.1	13.8	31.9	7.0	11.8	1.2	5.9	4.1	7.2	0.4	4.7	5.1	4.4	2.0	4.3	2.1	4.2	5.0	9.1	4.6	20.3	3.2	5.8	2.7	0.1	10.7	4.8	28.3	1.6	4.2	0.7	3.6	5.5	4.9	8.4	2.8	3.8	2.0	6.0	3.8	0.2	2.2	1.9	6.0	2.7	1.3	10.1	11.0	3.0	5.1	4.8	4.8	4.4	6.7	3.8	1.8	13.9	3.1	0.7	5.3	1.6	2.8	7.6	10.2	9.9	4.0	0.5	0.3	0.1	27.9	4.0	1.0	0.0	0.9	1.9	0.2	2.0	0.5	0.0	0.3	0.2	0.8	0.0	0.3	0.1	2.7	0.0	2.1	0.4	0.0	0.7	21.5	24.2	5.6	54.4	24.8	0.8	6.0	1.9	6.6	0.6	5.0	31.9	5.5	6.4	12.5	8.1	7.0	3.7	2.1	1.5	1.8	41.9	2.5	1.3	6.3	0.0	3.3	1.8	16.7	0.3	3.4	1.7	0.0	0.4	0.1	1.7	7.8	5.6	4.2	0.4	52.7	1.6	0.1	5.5	0.5	1.6	17.1	0.9	2.9	0.6	4.3	8.4	13.9	1.3	2.0	3.2	3.3	1.3	1.2	6.9	8.8	9.4	0.8	4.7	2.1	4.0	3.5	0.6	0.6	1.2	2.2	2.2	0.2	0.3	1.5	25.1	0.0	2.0	1.7	0.1	1.1	4.1	5.4	0.3	2.9	1.2	2.1	1.1
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237675-121298308	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.8;Horizontal cells: 62.2;Late spermatids: 89.6"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 32.7;eosinophil: 62.1;intermediate monocyte: 42.3;myeloid DC: 15.9;neutrophil: 39.2;non-classical monocyte: 39.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.9;granulocytes: 62.1;monocytes: 42.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	26.0	16.7	39.6	17.0	56.2	30.8	22.7	135.4	65.5	22.3	14.3	22.8	25.7	22.9	10.8	17.5	27.5	12.9	17.8	44.8	24.8	16.7	30.9	23.6	15.3	20.8	20.1	27.4	16.8	12.4	11.8	15.3	24.9	29.5	19.4	7.1	18.6	23.8	11.5	18.3	26.6	20.7	18.3	39.6	24.0	7.0	23.6	13.4	17.1	11.2	15.6	25.9	21.1	42.7	27.9	20.5	16.3	30.9	46.7	43.0	22.8	22.0	23.8	19.0	17.3	21.4	12.1	43.0	18.1	48.1	14.1	22.7	20.0	25.8	15.1	29.3	35.9	22.0	14.4	21.3	31.1	50.0	20.0	28.2	37.2	18.0	41.4	26.0	45.0	33.5	25.2	23.6	18.4	27.2	55.8	40.6	11.7	24.9	22.7	35.3	18.4	37.7	18.8	32.1	60.2	22.4	31.5	16.5	19.1	12.9	39.7	62.0	32.2	14.8	11.8	13.1	13.0	84.8	55.6	32.7	27.7	34.4	16.0	2.0	32.7	62.1	4.7	42.3	4.6	4.8	3.5	4.2	15.9	2.8	3.2	3.8	39.2	8.6	39.5	3.6	3.3	15.8	39.6	56.2	135.4	65.5	44.8	24.8	20.8	20.1	24.9	18.3	23.6	42.7	25.4	9.6	5.6	9.8	5.7	7.9	6.0	8.1	8.0	22.2	11.6	10.5	8.2	12.8	8.3	9.2	2.1	9.2	10.6	18.2	3.9	9.6	16.0	6.5	19.6	21.9	34.3	12.0	64.8	10.4	8.2	18.0	13.3	10.9	6.3	23.3	15.0	19.7	7.9	62.2	21.4	16.2	8.2	14.8	15.6	89.6	20.5	16.6	8.8	12.2	36.3	5.4	12.3	10.1	19.3	8.5	10.9	31.6	11.9	16.5	26.6	9.6	7.2	7.0	19.7	7.7	20.6	0.8	2.9	13.3	6.0	3.4	7.6	32.7	17.6	6.3
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49869935	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 91.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	0.0	0.8	66.5	0.0	91.8	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	19.0	0.1	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.1	0.0	12.9	0.0	0.1	2.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.2	7.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.1	0.9	0.2	34.1	0.0	0.2	1.3	0.0	6.9	0.0	0.0	17.7	8.3	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.5	91.8	0.0	84.9	73.3	19.0	0.2	8.7	0.0	12.9	37.2	39.2	0.0	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	12.2	0.1	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.2	0.0	32.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	27.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	4.7	0.0	0.2	0.0	2.5	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.0
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738495-134752157	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 845.6;Late spermatids: 1655.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	52.3	37.2	50.6	17.5	52.1	31.7	42.1	50.7	69.4	57.0	48.2	54.8	34.4	45.8	48.2	29.5	45.3	27.4	26.9	52.3	55.9	29.7	29.3	28.6	26.2	51.9	53.8	68.6	30.7	27.0	43.1	17.9	54.3	34.9	15.9	29.1	29.0	31.8	60.4	36.7	30.4	28.5	52.8	26.1	36.5	51.3	52.1	25.8	27.0	35.6	25.3	44.2	41.1	53.3	27.5	22.2	33.0	64.1	76.3	118.3	14.4	39.0	55.8	26.8	52.8	38.9	40.1	113.9	56.2	27.5	42.7	34.2	29.2	46.9	35.0	54.3	54.5	29.9	33.2	32.8	56.3	13.7	89.2	96.9	49.5	35.1	57.9	92.3	54.8	49.0	18.6	47.1	39.9	31.2	43.1	58.2	17.1	34.7	21.5	46.2	40.7	44.3	46.0	26.4	52.2	36.9	27.1	15.3	97.1	40.8	48.4	33.9	53.2	24.5	16.4	40.2	35.2	45.8	55.1	42.5	46.2	48.5	14.8	62.0	26.4	60.7	30.5	31.8	41.1	43.5	43.5	38.4	29.1	39.5	45.0	44.2	47.9	31.4	44.6	26.1	52.6	31.6	50.6	52.1	50.7	69.4	52.3	55.9	51.9	53.8	54.3	52.8	52.1	53.3	86.8	38.5	36.4	13.7	92.9	167.1	107.0	113.6	157.1	80.5	121.9	124.7	45.1	100.1	68.9	42.3	25.0	50.3	93.3	42.8	92.0	63.9	845.6	57.6	116.4	99.5	62.4	76.6	29.4	90.9	62.5	107.4	32.6	61.7	123.4	66.6	102.4	69.1	69.9	55.5	32.0	69.4	107.8	111.5	130.8	1655.8	168.0	76.6	96.0	10.3	126.9	127.7	90.6	15.1	18.6	67.5	58.0	132.4	55.2	148.6	158.2	199.1	51.3	71.4	98.6	119.5	109.7	241.5	68.6	119.3	201.6	73.2	101.6	67.9	90.9	107.9
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"	P49913	3	48223347-48225491	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 2914.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 84.4;neutrophil: 335.4"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 335.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5"	"Not detected"	"Not detected"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000	28000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"			"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.8	0.1	0.1	1.6	0.1	2914.5	0.5	0.1	0.5	0.6	0.1	0.3	0.0	0.6	339.9	0.4	0.1	0.3	1.4	0.1	0.1	0.4	3.9	7.4	6.8	0.2	0.1	0.2	0.1	0.1	0.5	2.4	0.2	0.5	0.1	0.0	15.2	0.6	0.2	3.7	1.7	0.1	0.1	23.2	0.4	1.9	0.1	10.7	5.7	0.2	2.9	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	19.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	1.0	1.4	0.1	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.5	0.0	3.4	0.1	37.9	5.5	84.4	0.0	9.8	0.0	2.3	0.0	0.0	7.7	2.4	0.0	0.0	335.4	2.6	28.1	4.7	0.0	86.9	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.9	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.3	0.9	0.3	0.2	0.0	2.1	0.0	0.2	0.0	6.9	0.5	1.4	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	1.3	1.1	17.4	0.9	3.6	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	9.4	0.0	0.1	0.7	0.0	0.0	0.0	0.1	5.0	7.2	0.0	0.0	0.0	1.0	0.0	0.4	0.6
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 105.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	6.7	7.4	12.5	5.5	12.7	10.3	5.4	12.7	12.6	9.2	2.5	7.4	3.2	7.5	5.2	20.0	7.7	5.2	7.8	14.1	9.8	5.1	4.3	6.8	5.8	8.3	9.3	10.7	7.9	6.1	8.7	5.2	8.8	6.2	3.5	105.5	7.5	6.5	32.8	10.4	4.4	6.9	5.6	5.3	5.0	18.1	11.5	11.1	4.4	17.5	6.9	7.4	11.7	11.6	15.4	22.3	36.0	25.5	8.2	7.1	17.6	12.2	10.2	13.0	9.8	19.7	13.2	7.1	17.0	15.4	16.7	30.8	19.0	13.2	9.7	24.0	10.5	10.3	24.9	9.9	12.4	18.0	14.8	9.5	16.3	16.6	22.6	12.3	14.8	15.5	21.4	15.0	17.1	27.5	16.8	11.0	20.4	18.2	15.8	32.5	29.7	17.4	12.8	18.7	39.1	38.2	15.6	11.2	17.0	11.7	15.9	14.6	18.3	24.6	19.0	18.3	20.9	7.3	14.7	19.2	16.0	12.0	14.5	1.5	0.3	0.0	0.2	0.4	0.4	0.6	0.4	0.3	0.2	0.1	0.3	0.4	0.1	0.2	0.3	0.2	0.3	0.3	12.5	12.7	12.7	12.6	14.1	9.8	8.3	9.3	8.8	5.6	11.5	11.6	6.3	6.4	3.9	31.6	5.5	22.7	17.4	10.8	9.6	34.4	11.8	9.8	14.0	4.3	15.7	3.7	339.9	12.6	5.8	4.5	0.0	11.8	13.1	41.5	13.2	8.8	12.6	6.6	37.7	8.9	3.5	6.6	8.2	32.4	6.3	20.4	7.5	8.2	10.3	16.8	34.1	4.4	10.2	8.1	13.5	15.8	5.9	11.7	12.4	25.3	12.2	19.2	4.1	27.2	35.9	15.7	3.0	6.0	11.9	14.2	2.7	4.3	37.1	236.1	13.1	16.8	11.7	24.4	34.4	35.2	31.7	5.6	6.5	15.6	4.5	24.8
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 194.4;Inhibitory neurons: 189.1;Oligodendrocyte precursor cells: 275.5;Oligodendrocytes: 155.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 161.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	15.2	16.0	16.4	6.6	20.0	0.3	11.9	22.3	27.9	13.6	0.0	10.6	3.9	16.2	10.2	11.0	10.7	12.1	11.1	20.6	14.6	11.8	7.1	12.5	3.7	14.2	12.7	19.1	5.0	21.9	9.7	18.4	14.4	10.9	6.3	26.0	7.8	13.0	8.2	13.9	5.1	15.7	11.1	8.3	7.3	15.0	15.5	5.3	18.8	13.4	5.5	14.3	12.2	19.3	33.4	22.1	29.9	27.1	23.6	30.9	34.3	32.9	28.4	26.0	21.5	16.1	19.7	0.0	18.3	36.7	23.8	29.4	31.1	48.5	31.1	19.8	15.8	1.7	32.9	7.4	26.3	2.1	8.2	22.6	72.9	41.7	161.7	28.0	40.1	2.8	4.3	10.2	42.6	17.5	0.4	0.7	27.9	10.2	30.8	13.4	32.8	15.1	22.2	24.3	15.6	27.7	48.5	29.6	27.6	36.1	28.4	1.8	48.3	42.3	25.1	26.6	41.2	20.4	36.0	17.2	30.7	5.2	32.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.4	20.0	22.3	27.9	20.6	14.6	14.2	12.7	14.4	11.1	15.5	19.3	64.0	60.9	39.1	114.9	1.2	79.8	26.8	22.4	51.8	50.9	14.4	15.6	93.5	10.0	34.5	14.7	14.6	17.3	0.6	4.3	1.9	15.2	30.3	14.3	44.7	50.1	11.9	0.0	194.4	8.2	16.4	36.4	14.3	29.9	5.1	22.3	29.6	6.4	10.1	50.5	189.1	2.6	10.2	11.3	32.7	35.7	28.6	12.5	19.6	78.7	4.3	53.5	2.1	275.5	155.5	18.7	2.0	45.5	1.1	24.8	1.5	6.3	9.3	17.0	26.3	39.6	41.4	27.4	20.0	25.8	49.2	40.0	2.6	37.8	4.3	30.0
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595863-7618304	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.4	3.3	3.2	0.8	4.4	0.0	5.3	2.5	9.0	7.7	0.1	10.3	14.9	0.5	2.3	24.8	3.1	1.6	0.4	4.2	0.7	12.0	24.3	4.6	0.2	2.5	0.0	0.5	20.6	2.7	8.2	0.4	0.4	10.2	2.4	3.2	18.1	4.5	0.2	62.7	11.5	0.1	0.0	0.6	15.5	13.0	0.2	0.5	11.1	0.0	1.1	3.6	13.4	2.4	11.2	1.8	0.3	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	26.7	5.8	3.1	4.5	0.0	1.2	9.7	4.3	2.8	0.0	2.0	10.1	0.0	0.5	15.6	0.0	0.0	4.4	0.0	5.5	0.0	0.4	0.4	0.0	4.5	0.9	0.0	0.0	13.0	0.2	0.2	6.6	8.4	4.7	0.7	0.0	3.7	1.9	6.0	8.2	8.7	1.3	12.5	0.0	1.6	10.4	1.7	0.0	0.0	2.0	0.0	0.4	5.0	1.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	2.5	9.0	4.2	0.7	2.5	0.0	0.4	0.0	0.2	2.4	0.2	9.6	19.2	3.3	1.1	9.8	2.7	2.4	3.4	22.7	19.3	12.1	1.5	20.0	5.3	9.2	0.0	0.5	0.2	40.0	3.9	5.7	4.4	9.6	1.4	1.5	13.1	0.0	9.1	11.8	0.7	0.2	38.7	13.5	5.7	8.6	0.4	24.8	0.2	10.1	10.1	22.4	0.0	1.9	1.2	2.9	1.5	1.0	0.0	1.9	0.0	1.5	0.0	4.5	0.6	13.1	28.4	0.0	0.6	6.2	29.2	15.6	2.9	13.4	0.0	0.0	1.1	0.4	2.8	9.8	18.9	0.5	0.9	1.5	18.4	8.0
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785454-7769706	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA036342: AB_2675072, HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	37.1	43.7	56.2	23.6	55.3	26.5	38.7	63.4	75.8	33.0	29.4	71.8	52.8	40.1	81.7	37.5	36.0	30.4	114.0	55.0	68.6	68.4	70.5	36.7	27.3	69.4	66.0	35.4	26.4	43.3	35.5	26.4	68.7	47.0	48.5	68.2	50.5	50.5	101.6	26.0	41.1	42.4	61.5	30.7	45.2	44.5	66.4	31.9	52.0	104.7	33.5	56.5	35.2	60.8	67.6	37.2	101.2	51.7	51.2	77.6	28.4	71.0	54.7	75.3	63.1	45.1	83.2	55.5	54.6	75.2	50.3	40.8	53.6	73.7	106.5	41.8	57.8	62.7	85.1	89.6	83.0	48.2	43.6	52.5	50.2	54.5	83.0	64.6	85.1	77.7	44.8	73.2	87.9	65.0	64.6	130.9	70.2	85.2	43.2	42.5	90.2	123.7	103.4	38.7	104.2	83.7	50.4	74.1	113.9	72.3	40.2	59.4	50.1	53.1	44.9	55.3	45.2	55.2	74.3	153.2	79.6	107.4	30.7	80.1	74.7	70.5	25.8	48.5	28.3	48.1	39.8	32.0	73.4	41.8	32.2	28.1	15.4	26.7	37.9	77.5	45.6	46.3	56.2	55.3	63.4	75.8	55.0	68.6	69.4	66.0	68.7	61.5	66.4	60.8	142.1	54.5	48.8	314.7	74.3	309.7	340.6	306.6	169.0	106.7	231.7	283.2	565.2	101.5	135.3	191.3	252.3	69.8	44.3	198.3	418.7	180.1	166.1	84.1	80.3	155.8	130.8	81.8	346.1	206.3	144.9	134.4	63.2	99.8	55.2	205.4	106.1	239.0	106.3	158.2	479.3	185.8	223.8	95.5	254.0	137.9	76.4	122.0	238.3	117.1	172.9	112.3	38.1	330.3	227.5	184.2	234.5	128.6	87.9	486.4	251.7	750.7	117.1	156.2	138.1	91.1	233.2	151.0	211.0	158.9	282.7	88.1	68.2	137.8	186.5	413.7
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269358-67319953	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		5900000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	18.4	23.1	19.6	19.9	21.4	22.6	25.9	25.3	21.8	21.4	15.9	19.8	19.5	21.2	27.8	22.5	19.2	18.3	12.6	20.9	21.7	24.3	27.4	16.8	27.5	18.8	19.0	25.0	18.7	28.3	19.3	23.2	21.2	22.4	20.6	37.5	16.5	20.0	9.9	29.3	18.5	21.6	19.5	19.1	18.2	27.8	19.5	38.8	26.0	11.4	30.8	23.3	19.3	19.5	62.1	62.6	93.1	66.6	69.7	54.3	62.4	60.2	51.6	62.0	54.2	58.4	34.5	132.9	51.0	60.6	38.9	57.8	101.1	68.3	70.6	50.8	60.5	75.1	46.5	55.7	45.7	89.5	40.9	51.5	51.0	56.8	51.9	75.8	58.7	63.9	60.4	72.3	67.7	61.0	81.6	60.3	98.8	47.4	43.1	78.4	79.8	56.3	57.3	103.9	95.2	47.3	74.9	68.0	49.9	77.8	73.2	40.7	50.3	49.0	31.5	34.1	46.1	23.5	31.1	111.5	58.3	52.2	51.4	9.3	6.4	7.4	14.0	7.4	17.0	10.9	16.8	15.3	10.0	14.7	17.7	14.9	2.7	19.0	14.0	8.6	19.3	5.7	19.6	21.4	25.3	21.8	20.9	21.7	18.8	19.0	21.2	19.5	19.5	19.5	37.6	60.9	36.3	38.5	61.2	58.1	50.2	51.6	57.5	92.4	51.4	40.6	17.0	42.9	42.0	44.1	116.7	37.4	61.5	47.3	13.7	30.7	3.9	45.2	53.9	44.6	45.4	34.9	48.8	28.6	42.7	47.7	41.3	51.1	7.6	71.0	40.4	49.8	31.3	87.5	61.7	50.4	34.6	42.4	52.4	11.0	69.0	35.9	33.8	32.8	54.6	53.8	48.4	49.8	63.5	35.2	28.6	60.9	55.1	56.6	59.8	32.3	55.3	115.3	26.3	52.1	50.7	82.5	47.7	47.1	63.9	44.6	59.3	66.4	46.5	64.2
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 135.0"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.4;REH: 12.4;U-266/84: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	3.0	3.2	7.9	0.5	7.9	1.0	1.9	6.4	8.7	4.8	7.6	6.5	0.9	6.4	2.2	2.4	6.2	1.7	25.3	8.0	9.6	2.4	1.6	2.4	0.8	8.0	7.4	5.0	2.4	5.4	8.3	0.8	8.3	3.6	0.7	2.2	3.3	3.0	135.0	1.4	2.3	3.4	6.6	2.2	3.3	15.7	8.8	0.8	3.1	36.2	0.6	4.4	2.7	8.6	0.8	1.6	5.6	0.2	0.2	0.1	0.3	1.4	0.6	3.4	4.1	0.9	0.3	1.0	1.9	0.9	0.9	0.2	6.4	0.1	2.6	1.8	19.4	1.5	2.9	1.4	5.2	0.2	0.1	1.2	0.3	3.1	0.1	3.3	0.7	7.2	5.3	1.0	1.0	3.3	2.6	0.8	3.8	0.4	2.0	12.4	1.2	1.0	0.2	1.5	3.9	4.6	0.1	0.9	1.2	1.1	1.6	6.3	0.4	1.0	0.9	1.0	1.4	1.3	9.9	8.4	0.6	1.2	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	7.9	7.9	6.4	8.7	8.0	9.6	8.0	7.4	8.3	6.6	8.8	8.6	0.9	3.2	1.1	5.9	0.2	0.4	0.8	0.6	1.8	16.0	0.4	0.5	4.8	1.5	0.7	1.8	10.4	0.2	0.2	0.1	0.0	0.9	120.6	0.4	1.4	1.8	0.0	0.4	19.3	0.0	0.2	2.6	0.5	0.3	0.0	5.6	3.3	2.0	4.2	13.5	25.3	0.0	0.0	0.0	0.8	23.2	4.7	0.4	0.0	4.7	0.0	2.9	1.0	12.1	7.2	0.0	0.0	10.1	0.2	0.5	0.0	0.7	0.3	3.1	0.0	4.1	4.0	1.4	5.3	0.4	0.1	0.1	1.0	9.2	0.0	0.4
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991716-79009867	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 445.4;T-47d: 282.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	Yes		3300000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	15.8	23.9	10.4	24.7	12.4	19.1	25.4	13.6	11.3	32.3	13.8	89.2	51.9	17.4	8.7	44.8	18.2	25.2	17.0	11.1	12.6	16.1	17.3	16.4	15.2	14.6	14.5	14.6	19.6	24.5	17.5	25.9	13.9	71.8	82.8	7.4	62.7	32.4	14.9	14.9	55.5	15.5	13.8	26.5	51.1	20.7	14.5	14.7	13.9	12.4	15.1	16.7	21.7	17.8	106.5	112.1	31.9	46.3	29.7	35.2	38.9	66.0	51.3	66.7	55.9	53.8	99.6	25.3	36.1	46.1	83.0	53.7	27.1	49.8	68.4	43.0	46.4	33.7	34.1	45.9	25.0	33.0	51.6	33.7	32.4	62.7	34.2	40.9	116.1	42.5	42.3	43.2	46.4	58.4	50.2	19.8	22.1	445.4	103.1	27.6	51.8	29.8	29.8	53.5	45.6	45.4	33.9	227.2	50.2	50.3	282.6	38.6	56.6	101.9	90.5	46.4	83.1	48.9	43.8	24.3	64.4	24.9	65.3	6.3	4.0	8.7	5.5	4.4	5.7	3.9	4.3	4.8	3.8	2.5	4.1	4.1	17.4	3.1	3.0	2.7	3.6	4.6	10.4	12.4	13.6	11.3	11.1	12.6	14.6	14.5	13.9	13.8	14.5	17.8	12.6	28.9	20.6	5.9	11.8	16.6	15.3	16.8	6.8	6.4	49.9	16.3	13.3	14.3	15.1	12.9	14.6	36.6	8.9	139.5	3.9	34.7	14.0	10.7	13.1	16.3	51.0	15.2	4.1	28.8	39.4	13.5	38.2	19.0	5.7	20.0	41.7	14.4	24.9	5.0	5.2	155.6	16.2	12.4	9.5	15.7	11.8	14.2	14.2	3.7	18.1	8.1	11.3	5.0	10.2	37.7	55.8	7.5	16.6	33.4	39.4	6.7	9.7	8.7	6.6	9.5	13.3	23.9	5.8	12.0	13.1	101.5	11.1	11.3	100.2	19.4
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179731641	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 817.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 528.3;SK-MEL-30: 790.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	128.3	112.8	15.0	36.3	17.6	76.0	110.6	18.8	31.1	121.4	25.1	108.7	45.0	137.7	171.7	106.7	109.8	6.2	137.5	13.8	24.1	121.4	193.2	112.7	18.4	24.7	24.1	129.6	209.7	9.6	96.5	75.0	20.2	96.0	62.6	68.0	123.3	17.8	111.6	83.5	97.4	85.0	19.2	73.2	115.2	75.0	17.9	9.0	159.2	53.6	16.6	112.0	95.6	22.6	13.0	91.5	89.5	53.0	295.4	229.3	37.9	261.4	342.8	341.2	298.2	148.2	49.6	309.3	351.0	127.8	121.4	18.7	120.2	121.1	405.9	64.6	6.3	63.0	247.8	22.9	399.9	82.9	50.0	39.1	313.5	118.6	528.3	56.1	93.9	23.9	43.2	99.9	39.9	51.2	40.9	15.1	9.4	11.7	6.4	43.2	71.3	24.9	252.1	82.8	24.4	8.0	62.7	16.7	790.3	182.7	267.3	16.3	234.7	49.9	56.5	36.1	200.2	19.7	87.2	46.1	53.3	50.4	46.5	51.8	61.8	17.4	29.9	38.9	34.4	14.4	21.2	25.0	47.6	10.0	15.3	15.6	9.6	32.1	30.1	38.7	16.4	74.1	15.0	17.6	18.8	31.1	13.8	24.1	24.7	24.1	20.2	19.2	17.9	22.6	187.0	198.7	296.6	53.5	109.4	148.5	115.4	181.3	152.0	117.4	245.8	153.5	537.0	185.8	247.0	182.1	158.4	162.5	148.6	174.3	49.0	173.6	225.5	160.9	253.9	204.0	178.0	133.3	45.5	153.5	245.8	202.8	156.5	255.5	197.9	137.7	157.5	438.7	227.7	159.9	77.0	250.0	134.3	206.4	215.6	817.5	159.1	218.3	176.1	44.0	181.1	213.8	84.5	63.3	79.4	153.1	125.1	191.1	327.3	249.5	188.2	196.4	294.3	160.9	92.1	114.6	211.2	158.4	72.7	182.3	161.8	244.8	105.8	183.1	251.0	157.8
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 832.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 1954.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		73000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	175.2	96.8	78.6	275.0	92.3	314.9	137.5	87.6	95.3	131.2	77.8	223.7	143.7	207.2	100.4	196.2	134.2	135.3	82.3	82.6	85.3	130.7	124.4	181.7	266.8	98.0	87.6	87.7	67.8	115.1	62.8	184.2	94.4	105.0	210.4	63.4	117.4	140.1	48.1	120.2	165.0	236.6	89.7	206.1	147.8	75.0	91.5	186.8	106.8	56.0	326.4	231.2	130.4	107.9	435.9	185.1	216.4	134.8	310.6	290.5	338.9	749.8	437.7	398.9	399.9	272.5	440.1	339.5	295.7	598.7	275.7	267.1	265.8	535.7	548.1	461.6	164.9	520.2	188.7	216.8	286.4	326.9	1417.9	297.5	280.6	612.5	345.4	456.5	346.4	185.7	201.6	215.0	621.7	129.2	265.4	194.9	367.7	312.1	207.9	197.0	297.6	198.6	451.3	452.0	107.5	222.9	308.7	366.4	523.8	443.1	170.0	1954.7	628.9	347.3	317.9	188.0	641.4	178.9	381.8	301.0	451.5	353.8	466.9	1371.5	776.8	2592.7	665.8	1097.6	526.2	328.0	473.4	643.9	868.3	325.6	397.1	537.9	1560.4	479.8	1402.6	333.8	701.5	1838.4	78.6	92.3	87.6	95.3	82.6	85.3	98.0	87.6	94.4	89.7	91.5	107.9	132.5	121.8	90.9	17.6	179.0	112.3	149.0	236.2	48.9	40.8	81.8	89.9	15.7	80.1	161.8	114.0	27.1	212.9	206.9	372.1	111.6	364.1	411.3	94.5	109.8	163.2	76.1	73.4	22.3	272.3	439.6	107.9	74.5	182.9	229.1	70.9	167.0	77.0	426.0	42.1	16.7	180.2	142.4	411.6	333.3	480.3	88.0	390.8	99.6	25.3	606.5	160.9	315.1	13.0	30.4	832.7	202.0	176.8	117.1	130.7	159.7	142.1	105.6	49.5	164.3	68.9	207.1	118.0	67.9	97.2	132.8	237.8	238.0	74.8	151.5	221.4
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586734-240617705	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	10.0	18.6	16.8	6.8	16.2	7.9	9.6	21.0	25.0	11.8	16.5	12.7	13.1	10.7	3.7	14.5	13.7	6.1	24.6	17.9	14.0	23.8	14.7	12.2	10.6	15.6	15.8	13.3	12.6	5.3	18.1	4.5	15.4	14.9	7.1	10.6	10.2	5.3	5.8	12.1	14.0	2.8	12.6	29.8	15.8	17.0	16.7	6.4	13.2	2.8	5.4	11.1	10.0	16.8	8.0	11.2	11.2	9.5	4.5	3.6	19.7	9.9	4.1	6.5	5.9	8.7	18.7	5.9	3.5	3.6	8.9	12.7	3.0	6.6	3.3	23.0	19.8	10.9	20.4	16.0	7.1	7.1	15.3	2.6	4.8	6.7	2.7	6.7	5.2	16.8	12.5	7.3	2.8	7.1	16.2	27.5	17.4	9.5	8.1	15.5	8.1	13.1	9.9	9.8	28.1	22.0	6.3	9.3	13.8	3.5	4.8	9.3	8.6	11.0	9.7	9.5	11.8	16.3	4.2	10.7	10.4	12.8	11.0	1.5	0.9	1.8	1.0	0.6	0.3	1.0	0.6	1.1	0.4	1.1	0.7	0.9	4.1	3.0	0.6	1.2	1.3	0.4	16.8	16.2	21.0	25.0	17.9	14.0	15.6	15.8	15.4	12.6	16.7	16.8	8.9	3.2	6.0	19.6	7.5	4.6	7.2	3.8	6.2	14.9	6.2	5.3	9.5	12.8	4.8	9.2	14.6	5.4	14.2	7.2	7.9	13.0	1.9	14.7	5.7	7.0	11.3	1.7	9.5	9.1	5.2	5.3	4.6	13.8	22.9	11.3	7.5	3.0	6.7	48.8	9.0	6.3	8.2	5.3	1.7	2.6	9.0	7.8	1.8	7.5	7.7	13.4	8.2	7.5	7.2	13.8	4.6	9.4	7.4	10.1	9.9	6.2	9.4	18.6	0.0	5.6	7.6	12.6	7.7	3.7	5.3	5.5	11.3	9.0	6.4	6.9
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184401	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 30.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.0;Breast myoepithelial cells: 11.8;Early spermatids: 24.7;Late spermatids: 9.8;Spermatocytes: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.2;TIME: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018070, HPA030955"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB018070: AB_2069481, HPA030955: AB_2673672"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.6	0.4	0.2	0.3	0.2	0.5	2.3	0.4	0.5	0.8	0.1	0.2	0.0	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.8	0.4	0.3	0.1	0.1	0.2	30.3	0.3	2.2	0.3	0.2	0.3	0.4	0.5	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.4	0.5	0.3	0.3	0.2	0.1	0.2	0.1	0.3	0.5	14.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	24.7	0.0	0.0	3.9	0.0	2.7	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.1	1.1	0.0	1.3	0.0	0.3	0.1	0.0	0.3	0.3	9.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	50.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.1
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.2;stomach 1: 28.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.3;SK-BR-3: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.8	0.0	1.4	0.0	7.2	0.9	1.3	9.7	1.0	11.4	20.8	0.2	0.3	0.9	1.1	2.8	0.0	0.7	0.8	2.5	0.2	7.2	0.0	1.1	1.3	0.0	3.6	0.4	0.2	0.0	1.0	3.8	24.6	0.0	1.2	0.1	0.0	0.2	29.2	0.2	1.0	0.1	28.5	0.1	1.1	0.0	0.0	0.0	0.6	4.1	0.5	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.3	0.1	0.4	0.0	21.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.9	1.3	0.7	0.8	1.1	1.3	1.0	1.0	1.1	2.3	0.0	6.4	3.1	0.3	0.0	0.0	10.2	3.5	4.0	0.0	4.2	1.8	1.3	0.0	76.6	1.8	0.0	0.0	0.0	16.9	0.0	1.3	0.8	2.0	0.0	0.1	15.0	0.0	0.3	5.3	0.0	0.6	50.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	1.5	12.0	6.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.4	1.9	6.2	0.0	0.0	2.7	35.2	0.2	12.4	0.0	0.0	0.0	6.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	18.1	19.4
CAPN15	SOLH	ENSG00000103326	"Calpain 15"	O75808	16	527712-554636	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 4.7;neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011960	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011960: AB_10610556"	"unprognostic (4.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.54e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.23e-3)"	13.0	12.0	3.6	7.2	2.5	8.1	10.8	11.6	6.2	12.2	0.2	20.2	16.3	13.4	0.4	18.5	13.2	1.6	11.2	3.2	0.2	18.4	17.2	15.3	5.1	4.1	1.0	13.2	24.8	2.2	15.2	2.6	1.4	12.3	2.3	1.1	12.6	2.8	14.9	22.3	22.7	1.2	0.2	21.2	16.5	18.7	2.1	2.8	11.7	0.9	2.5	12.5	12.8	0.8	16.8	21.5	3.0	9.3	1.7	3.4	46.2	17.5	4.6	4.9	3.3	28.2	12.1	24.0	16.3	3.2	5.0	21.9	2.0	6.9	1.8	25.2	37.1	20.2	25.7	17.6	7.3	23.8	27.3	3.9	4.0	4.9	2.2	2.9	5.3	14.7	37.6	7.1	1.6	25.9	27.1	26.0	26.7	8.6	20.2	46.5	8.7	24.2	3.3	11.0	19.6	17.8	11.7	16.2	10.2	1.8	13.3	24.7	26.2	15.3	21.4	15.7	22.0	18.2	11.0	21.3	6.7	13.8	9.7	4.7	1.3	0.8	0.3	0.8	0.1	0.4	0.1	0.4	0.3	2.3	0.1	0.2	16.2	1.1	1.3	0.5	0.2	0.3	3.6	2.5	11.6	6.2	3.2	0.2	4.1	1.0	1.4	0.2	2.1	0.8	7.6	3.2	8.4	10.1	5.9	8.9	5.7	6.2	3.4	12.1	7.6	6.6	3.1	8.6	5.6	7.3	16.7	3.7	22.3	54.3	1.9	6.2	16.5	6.1	8.9	8.7	4.2	1.7	10.6	15.7	4.4	6.9	20.4	13.3	7.0	10.8	8.9	16.5	6.8	20.2	11.3	26.9	8.2	12.0	6.8	6.2	7.5	8.2	1.8	7.5	6.5	9.1	23.7	10.6	7.8	14.3	37.1	4.5	5.8	13.4	33.1	5.7	4.6	11.2	0.0	10.2	5.2	5.3	7.4	5.8	8.0	2.5	9.2	9.6	25.9	11.6
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 858.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		2800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	118.8	93.9	40.2	64.9	50.0	40.9	92.4	45.3	39.6	110.4	29.4	140.1	46.2	67.7	58.0	134.3	120.5	119.7	71.8	36.9	42.7	115.2	31.2	182.5	35.5	51.9	46.1	83.2	55.1	136.3	28.0	68.3	46.6	47.5	131.4	19.2	151.2	91.2	82.2	41.6	58.5	87.3	43.4	42.5	130.4	26.3	49.1	27.0	80.9	81.6	54.3	85.6	89.3	49.3	419.9	263.7	79.2	54.9	257.6	356.6	79.4	383.9	541.3	267.2	151.1	209.2	323.6	0.4	125.0	417.1	209.1	255.1	86.3	593.1	243.4	109.8	95.2	7.8	124.9	25.6	232.3	21.5	13.9	193.3	187.3	416.6	217.8	472.3	537.1	0.1	123.2	106.8	789.3	8.6	1.0	19.4	45.5	49.7	346.3	35.4	262.4	7.3	454.9	24.3	17.7	94.7	198.1	524.2	122.8	189.7	80.9	98.7	858.1	252.7	212.0	220.6	498.4	32.5	66.8	1.4	625.3	46.2	284.7	7.9	118.6	7.2	106.8	77.9	89.8	34.4	72.6	103.2	163.9	16.6	22.9	62.2	6.1	24.5	73.7	7.4	81.7	136.6	40.2	50.0	45.3	39.6	36.9	42.7	51.9	46.1	46.6	43.4	49.1	49.3	240.0	394.2	134.9	82.9	42.3	47.3	136.6	197.5	38.7	12.0	35.7	32.8	38.4	115.8	264.4	53.3	33.3	24.4	72.4	356.0	181.9	271.4	94.5	70.0	52.7	125.3	24.6	6.9	13.3	195.9	92.0	105.0	103.5	93.3	27.8	47.8	35.7	9.7	38.9	13.5	23.1	104.4	242.1	50.0	239.3	232.8	77.3	86.4	112.1	22.5	66.0	22.6	78.2	48.7	21.6	373.0	191.5	68.8	83.3	237.7	104.1	23.6	288.8	18.0	39.5	85.0	107.9	3.4	3.3	67.5	27.6	8.2	83.5	63.5	98.2	268.2
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359498-42412949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 279.2;skeletal muscle: 905.9;tongue: 377.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	27	"SK-MEL-30: 238.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	13.5	8.8	136.1	4.0	206.6	47.6	14.1	194.2	243.3	18.8	113.0	13.3	3.1	11.2	163.7	14.5	13.7	4.5	16.1	142.9	159.9	93.6	36.9	21.5	7.0	212.0	194.9	15.7	8.7	2.4	11.3	3.0	212.1	16.0	5.3	7.5	18.6	5.2	905.9	54.9	14.0	4.7	155.2	19.1	8.9	30.8	187.8	3.4	10.7	377.4	5.1	11.7	15.5	279.2	0.5	0.3	0.6	1.1	8.8	6.1	0.6	2.6	1.9	0.5	0.8	1.2	0.5	0.2	0.9	1.6	0.4	3.7	0.4	3.5	0.3	0.9	0.8	0.8	0.8	4.1	0.6	1.0	1.5	4.7	3.7	0.8	0.7	1.5	0.1	0.7	0.2	1.8	0.7	0.1	0.2	1.2	0.4	0.2	0.9	1.1	0.4	1.9	1.9	1.3	0.4	0.1	0.2	0.5	238.0	1.0	0.0	5.4	0.9	0.3	0.4	2.6	0.7	1.5	2.1	0.2	0.4	2.4	1.8	0.5	1.0	0.1	0.7	0.2	0.8	0.3	0.1	0.3	0.5	0.5	0.1	0.9	0.9	0.6	0.1	0.5	0.4	0.6	136.1	206.6	194.2	243.3	142.9	159.9	212.0	194.9	212.1	155.2	187.8	279.2	0.5	12.8	34.5	16.0	2.9	20.1	0.8	2.2	3.4	2.2	0.4	0.3	0.4	1.5	4.4	1.8	2.1	0.7	1.4	2.0	1.9	0.1	512.5	0.5	0.6	2.2	0.0	0.0	4.0	0.0	0.6	1.6	3.6	0.7	1.3	0.4	2.2	8.7	32.7	0.0	5.2	1.8	2.0	4.4	11.6	183.6	5.3	2.9	482.0	13.1	2.5	3.7	2.1	4.5	220.2	0.0	5.4	3.4	0.6	0.9	2.4	59.5	2.6	3.9	0.0	13.8	1.6	15.9	4.7	1.6	8.5	3.3	1.8	1.2	2.3	0.8
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252916	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	13.9	11.9	4.6	11.6	5.9	13.2	16.6	12.5	5.4	16.9	9.3	12.1	12.9	16.1	14.9	11.4	14.4	11.1	11.6	4.1	8.1	15.2	19.1	12.1	14.3	5.9	5.7	19.8	15.3	20.1	9.2	12.9	5.5	14.1	12.2	28.5	13.9	12.7	25.3	11.6	13.6	13.8	6.0	11.4	14.0	12.1	6.8	16.9	23.5	16.5	15.7	10.2	9.8	9.7	14.3	18.5	15.1	9.5	26.0	20.1	51.4	18.1	20.8	22.1	16.7	13.3	10.0	24.6	12.3	20.7	13.6	9.7	22.5	23.3	19.0	23.7	17.5	30.8	24.8	17.7	19.3	25.1	15.0	13.9	33.2	28.7	14.1	20.9	15.9	23.3	30.3	25.1	21.6	20.8	17.9	10.5	14.5	20.7	17.7	10.2	25.1	17.1	16.4	25.8	12.2	15.8	29.5	15.7	20.8	19.2	27.9	25.8	14.4	19.8	14.9	25.9	21.4	17.2	37.1	12.4	18.1	18.0	17.5	4.6	3.0	5.1	3.3	2.5	5.3	3.5	3.6	2.8	2.9	3.1	4.9	4.6	1.8	3.6	4.4	2.4	3.0	3.0	4.6	5.9	12.5	5.4	4.1	8.1	5.9	5.7	5.5	6.0	6.8	9.7	15.8	12.8	23.6	44.1	35.0	21.4	13.5	10.6	47.3	42.7	20.3	16.0	33.2	8.6	20.6	1.8	56.3	21.2	21.7	11.2	9.8	12.6	15.5	32.2	31.5	19.0	20.9	14.9	60.2	16.9	12.6	27.6	30.1	29.9	15.8	28.9	14.6	20.8	12.2	55.5	65.8	11.3	4.1	11.9	23.0	14.8	24.8	20.9	21.4	49.6	18.4	31.2	10.3	73.9	86.0	13.0	6.9	26.4	52.8	20.0	16.7	15.2	34.9	98.1	39.5	31.5	24.8	26.8	17.8	29.7	23.2	26.1	34.2	21.1	11.8	14.3
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.2;stomach 1: 60.3"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 10.7;SCLC-21H: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.0	0.6	1.4	0.9	2.2	0.0	0.4	1.3	1.2	0.4	0.0	13.7	6.6	0.2	0.5	0.2	2.5	0.6	0.4	1.1	1.4	0.0	0.0	7.5	0.0	2.1	1.7	0.6	0.2	1.0	0.0	0.0	1.8	0.6	22.2	5.0	11.3	0.1	0.2	0.1	11.7	0.5	1.9	0.0	60.3	0.2	1.7	0.1	0.1	0.1	0.0	2.0	0.1	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.5	10.7	0.0	0.4	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.3	1.2	1.1	1.4	2.1	1.7	1.8	1.9	1.7	3.4	0.0	25.6	3.0	0.3	0.1	0.0	0.6	0.7	0.0	0.0	0.6	0.3	6.0	0.0	3.2	0.0	0.0	0.1	0.0	4.1	0.0	0.2	5.2	1.5	0.1	0.1	3.0	0.0	0.4	0.2	0.0	0.4	93.8	0.5	2.5	0.1	0.0	0.0	0.1	0.0	0.4	71.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.6	1.7	5.0	0.0	0.2	0.5	3.3	0.1	8.2	1.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.1	1.5
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139953-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		9000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	425.4	357.9	363.0	171.4	374.4	235.7	371.7	359.4	507.1	368.1	353.9	371.4	263.2	303.5	193.8	761.7	306.6	197.8	692.5	379.8	411.1	488.5	273.5	396.7	167.4	401.0	392.3	267.6	250.9	330.9	317.9	147.3	401.0	357.0	287.6	136.2	374.9	281.4	491.3	211.9	341.4	290.0	356.5	363.6	311.1	273.6	400.3	200.8	329.9	373.4	275.1	354.8	402.5	384.1	395.2	977.6	240.0	342.7	566.3	683.0	48.2	315.8	673.4	631.3	488.1	223.3	572.2	141.9	463.7	1067.5	225.6	207.0	291.3	780.8	514.7	592.4	142.9	166.0	259.7	373.0	655.0	166.7	393.9	740.8	477.9	411.1	577.5	767.3	699.8	173.5	204.4	554.4	978.6	522.7	295.4	301.4	137.9	754.6	490.6	156.5	194.7	262.3	1208.8	368.7	159.1	199.4	385.1	532.0	155.5	279.4	308.6	261.4	460.6	555.5	424.3	188.1	318.7	198.4	277.6	126.8	630.4	225.9	480.8	24.8	50.1	22.6	44.4	75.6	28.5	29.4	30.9	36.4	46.1	32.3	18.7	25.2	25.2	24.6	83.4	58.7	34.7	21.1	363.0	374.4	359.4	507.1	379.8	411.1	401.0	392.3	401.0	356.5	400.3	384.1	172.7	125.0	98.6	10.4	49.3	30.7	76.2	69.1	29.6	21.1	91.7	75.1	149.5	130.1	85.9	163.7	0.0	74.9	107.1	250.1	62.6	226.3	102.9	168.5	118.3	136.6	107.8	47.3	13.4	251.3	87.8	83.3	66.8	234.4	63.4	84.7	157.1	78.4	155.1	16.8	11.9	220.3	52.9	244.6	86.9	230.2	93.2	130.5	39.2	15.9	208.4	78.2	109.2	6.6	21.9	254.2	187.5	76.0	50.2	98.0	243.5	135.3	74.6	33.1	46.0	64.3	92.9	120.1	6.5	109.1	28.8	70.1	62.8	132.2	165.6	112.4
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566684-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.7;skin 1: 102.4"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 87.8;Basal squamous epithelial cells: 117.3;Squamous epithelial cells: 108.6;Suprabasal keratinocytes: 149.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.8;intermediate monocyte: 1.0"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 1.0"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 223.0"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.4	0.0	0.4	0.1	0.7	0.6	6.6	0.9	0.5	14.3	0.4	0.0	0.0	0.1	0.2	85.7	0.8	0.0	0.1	0.5	0.6	0.0	0.1	0.2	0.0	1.5	0.9	0.1	0.1	0.0	0.1	0.3	1.6	4.2	0.0	0.1	16.8	0.1	0.7	102.4	0.1	0.0	1.1	0.1	0.1	0.0	1.1	0.2	0.3	0.0	18.6	18.1	33.5	1.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	23.0	0.0	1.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.7	0.8	0.0	223.0	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	1.1	0.1	7.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	1.2	0.0	0.1	3.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.7	0.9	0.5	0.5	0.6	1.5	0.9	1.6	1.1	1.1	1.5	0.6	0.0	0.5	0.0	0.0	87.8	10.0	13.7	117.3	0.0	0.2	0.3	0.0	0.0	11.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.8	7.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.5	0.7	0.0	0.0	108.6	149.3	2.3	0.2	0.1	0.0	15.4
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051731-34102610	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.0;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA		43000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	45.2	30.6	26.1	42.2	28.6	70.3	56.8	25.0	30.9	56.8	21.8	48.8	46.0	52.7	30.5	47.1	61.8	41.7	44.9	28.7	28.3	49.9	39.9	43.3	42.9	26.1	26.7	60.5	47.5	59.9	21.6	53.8	27.3	45.7	60.5	58.7	38.6	53.5	45.3	30.3	41.1	66.2	32.3	40.1	42.1	123.0	26.9	77.6	53.3	54.0	62.6	58.9	31.8	36.7	134.7	168.8	245.6	137.2	180.9	182.5	117.5	168.0	175.8	202.4	188.2	154.9	80.8	211.1	104.9	213.9	169.4	173.1	311.9	204.3	244.9	134.7	155.5	174.1	153.3	131.9	109.4	282.0	122.8	164.0	109.2	129.1	236.3	174.7	204.2	153.7	228.1	103.6	211.3	114.5	243.7	55.8	114.8	155.3	150.6	191.8	339.2	93.7	120.4	263.1	155.5	147.7	202.6	101.1	88.8	150.5	183.5	104.4	205.3	172.7	116.4	167.9	190.8	110.9	175.5	238.7	117.2	116.3	191.7	25.0	33.3	13.9	18.8	39.7	27.3	19.4	20.9	23.2	39.0	17.8	21.6	21.1	13.5	30.7	43.4	18.2	28.1	31.0	26.1	28.6	25.0	30.9	28.7	28.3	26.1	26.7	27.3	32.3	26.9	36.7	42.1	35.3	43.5	37.9	46.0	77.8	45.5	51.5	68.9	38.1	63.7	43.9	55.4	24.3	37.2	64.4	18.8	46.7	47.2	46.0	31.3	56.6	483.0	90.0	116.5	52.1	71.8	79.0	37.4	60.1	60.2	54.6	65.7	132.2	17.1	63.1	39.7	46.1	57.2	25.2	38.8	51.1	54.9	75.8	72.3	289.3	47.8	57.9	39.2	37.5	57.0	36.7	35.0	44.2	53.1	71.3	40.4	72.6	83.0	72.7	42.9	47.4	49.5	32.3	39.5	40.4	64.3	201.7	74.8	93.2	72.9	45.8	46.5	53.9	65.5	77.7
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (8.36e-4)"	4.2	6.1	11.7	4.0	12.1	8.5	3.7	11.3	20.3	5.7	3.2	6.3	2.8	6.3	7.4	2.9	5.1	4.4	13.5	10.7	37.4	5.7	5.6	4.7	4.3	20.5	8.8	7.3	5.8	9.4	10.0	3.0	16.3	5.6	4.0	18.0	3.2	6.9	6.0	8.0	4.9	6.1	3.8	6.1	5.5	17.4	12.7	3.6	5.0	5.0	3.6	6.0	4.3	12.1	7.4	5.1	9.4	7.9	9.1	9.5	5.7	13.4	11.2	5.7	7.7	2.8	4.6	4.3	11.5	14.1	11.3	5.8	5.0	22.0	10.3	6.5	5.6	18.0	9.5	10.4	5.1	2.9	1.8	11.1	8.4	18.2	14.6	23.6	13.0	7.7	1.1	4.3	13.6	1.4	3.7	4.6	11.0	3.9	15.2	1.6	14.1	2.1	2.5	26.1	11.7	7.1	5.0	3.6	5.6	22.3	3.2	0.9	17.8	11.0	6.0	33.5	24.9	8.1	6.1	4.1	13.2	0.9	7.3	6.2	0.8	0.7	2.4	0.3	2.9	2.6	1.5	2.6	0.4	2.1	1.7	1.6	0.1	1.7	0.4	2.4	1.1	0.6	11.7	12.1	11.3	20.3	10.7	37.4	20.5	8.8	16.3	3.8	12.7	12.1	9.8	22.4	27.7	45.1	9.0	7.1	4.9	3.8	7.4	28.9	6.4	9.1	28.7	0.0	6.3	3.7	22.9	8.6	14.7	5.3	9.8	5.6	17.2	21.8	12.2	11.6	16.7	23.5	73.8	11.2	1.7	12.2	11.2	10.0	22.1	19.6	7.9	8.0	9.6	11.8	68.5	5.0	0.0	7.8	4.4	13.7	6.8	6.7	3.6	12.2	4.5	10.5	11.3	49.3	19.4	33.9	2.2	8.6	8.8	2.5	4.5	11.9	13.0	34.2	6.6	13.2	11.3	8.2	33.5	9.2	4.5	12.3	11.8	9.8	3.9	3.3
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.5;Excitatory neurons: 133.8;Inhibitory neurons: 95.8;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 102.6;Respiratory ciliated cells: 77.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	1.0	1.5	1.2	0.3	1.2	0.5	1.4	1.7	4.0	1.2	8.8	1.0	0.6	2.0	3.7	1.3	10.0	1.3	2.3	1.1	3.1	2.7	1.8	2.4	0.3	5.5	4.3	1.6	0.9	3.9	2.5	0.1	2.5	2.0	0.6	11.8	2.4	1.3	1.7	0.9	0.6	0.6	2.7	1.0	1.3	3.8	2.3	0.6	4.0	3.2	0.3	0.7	0.7	2.6	0.7	2.1	0.6	0.1	1.0	0.7	0.0	0.4	0.1	1.1	1.2	0.0	1.0	0.2	1.8	0.3	0.4	0.5	0.0	1.0	0.8	0.7	0.3	0.9	0.4	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	6.8	0.1	0.7	0.2	0.3	1.5	0.0	1.0	0.8	0.3	0.0	0.3	0.0	0.0	0.1	1.5	0.0	1.2	0.6	0.1	0.0	0.6	0.1	0.7	0.3	0.5	1.0	0.5	0.2	0.1	0.1	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	1.2	1.2	1.7	4.0	1.1	3.1	5.5	4.3	2.5	2.7	2.3	2.6	3.3	9.6	2.8	85.5	1.7	1.8	2.6	2.9	7.4	1.5	3.1	3.0	8.2	1.5	11.5	5.5	4.2	1.2	0.9	0.4	5.9	1.1	35.8	24.3	2.1	2.3	0.0	4.6	133.8	1.7	0.6	4.8	4.6	0.9	0.0	6.0	3.3	2.4	0.5	1.7	95.8	1.3	2.0	1.6	1.7	14.9	6.2	1.3	0.0	46.9	0.1	6.7	2.1	117.1	102.6	0.6	0.3	7.2	2.5	1.0	0.5	3.5	77.2	22.4	0.0	3.8	3.8	8.5	1.6	4.1	0.6	0.3	1.6	3.3	0.8	0.6
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904288-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 110.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.0	0.0	3.3	0.0	2.8	0.2	0.1	1.9	2.1	2.5	25.4	0.0	0.0	2.0	8.4	0.0	110.9	0.0	0.0	2.1	3.6	0.8	0.0	7.7	0.0	9.9	10.2	0.1	0.5	1.2	13.6	0.0	7.5	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	8.0	0.0	0.1	9.9	4.0	6.6	5.4	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.2	0.0	1.0	0.1	0.0	0.1	0.0	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	1.2	2.1	0.0	0.5	0.0	0.0	19.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.8	1.9	2.1	2.1	3.6	9.9	10.2	7.5	8.0	4.0	7.6	0.0	3.2	7.3	0.3	0.0	0.0	0.1	58.0	0.0	0.0	0.2	0.0	0.0	0.0	66.2	1.8	0.0	0.0	0.0	0.0	1.9	0.1	167.1	400.1	2.4	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	4.7	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	65.1	0.0	0.0	148.9	0.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.0	1.6	709.5	0.0	0.0	0.0	19.2	21.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1
CAPZA1		ENSG00000116489	"Capping actin protein of muscle Z-line subunit alpha 1"	P52907	1	112619805-112671616	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB045963	Approved					NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB045963: AB_11126023"	"unprognostic (7.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (1.17e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.59e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-1)"	73.7	49.1	42.5	115.3	43.6	156.4	55.7	46.4	51.7	48.3	45.7	86.1	67.9	43.1	61.5	96.3	42.9	59.1	27.9	40.5	49.7	41.1	73.1	65.4	154.0	51.6	49.3	30.6	35.5	39.6	21.4	85.4	51.2	42.4	95.0	37.2	38.5	37.4	25.4	92.4	70.8	63.9	49.1	105.2	70.9	71.1	50.6	118.2	48.1	22.1	187.7	97.3	52.8	57.5	308.0	88.9	148.4	120.7	180.6	207.9	186.5	237.7	245.3	236.7	210.9	120.7	126.9	319.6	174.8	277.6	108.0	142.6	199.9	251.3	293.4	245.5	100.2	279.0	141.8	148.7	212.8	507.3	376.5	224.6	186.5	230.7	219.2	140.5	268.1	143.2	287.3	191.6	335.6	177.2	262.8	222.6	146.3	179.7	180.3	192.5	292.0	158.8	207.9	221.3	102.2	109.6	274.3	246.9	192.6	118.2	127.8	441.6	305.8	192.8	191.6	317.7	292.2	135.0	134.2	359.8	331.4	381.5	450.4	396.9	254.5	319.7	172.1	385.9	194.5	198.3	188.8	209.1	207.9	145.0	105.4	171.0	524.7	145.9	434.0	164.6	252.5	369.9	42.5	43.6	46.4	51.7	40.5	49.7	51.6	49.3	51.2	49.1	50.6	57.5	59.5	28.9	49.0	59.4	186.0	180.9	73.7	87.4	63.2	31.2	73.3	35.3	22.0	54.3	69.0	101.2	25.0	138.8	194.9	152.4	92.0	94.9	380.4	62.1	95.4	78.0	61.1	104.5	48.3	111.9	206.8	72.1	59.1	86.0	92.0	48.8	83.2	74.5	233.1	43.7	47.8	101.5	52.9	320.0	361.0	210.2	57.2	211.9	122.7	54.4	236.5	33.5	125.7	55.8	73.7	168.9	135.7	55.3	137.2	105.7	89.0	88.8	71.4	31.2	65.7	42.8	79.6	166.3	67.7	110.2	237.8	184.0	196.7	73.9	110.3	147.0
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line subunit alpha 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007470, HPA007643"	Uncertain		Approved	Cytosol		No	No		4500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	26.3	20.1	17.0	20.0	17.3	43.3	21.8	22.5	25.8	18.0	16.9	24.4	20.4	19.7	19.0	20.8	14.2	20.7	45.7	21.3	17.5	37.3	33.9	23.8	20.1	17.0	17.1	12.6	13.4	19.4	7.5	24.9	20.5	20.3	23.9	13.4	14.6	20.5	64.3	12.3	23.4	28.1	14.5	22.3	20.0	8.7	19.6	16.4	22.8	53.1	17.3	28.1	11.3	18.3	30.0	19.5	19.8	25.2	35.9	37.8	9.8	28.7	41.3	28.8	32.7	14.5	38.1	20.8	46.5	41.3	36.1	18.2	20.4	24.1	45.4	22.7	14.9	31.3	18.0	24.6	22.2	21.2	40.9	30.2	26.9	22.9	21.9	34.8	63.2	12.9	20.8	35.2	57.9	13.0	28.3	35.6	29.5	31.3	16.8	19.7	26.2	42.1	69.3	24.6	20.6	23.5	27.7	104.1	29.7	25.0	14.5	25.0	23.0	47.0	14.6	37.5	28.5	27.7	21.0	39.6	28.0	29.6	34.0	57.3	34.8	45.6	11.1	45.6	13.2	14.4	13.5	11.9	33.2	12.6	12.9	13.1	69.4	15.9	54.9	18.1	18.1	45.3	17.0	17.3	22.5	25.8	21.3	17.5	17.0	17.1	20.5	14.5	19.6	18.3	177.9	73.7	67.4	44.4	109.4	243.1	219.8	224.3	94.4	106.6	85.1	67.3	219.4	71.4	146.5	171.0	27.1	151.7	96.2	147.4	516.5	193.1	9.6	139.4	113.7	189.5	121.2	263.9	59.2	160.3	204.0	124.8	103.5	340.1	126.2	48.8	262.3	110.6	314.1	107.7	48.0	102.6	286.8	238.5	274.9	16.2	74.6	262.9	181.5	64.6	222.4	164.5	72.1	49.8	47.1	193.1	147.5	110.9	83.0	140.9	182.6	519.7	99.7	95.9	92.1	122.8	188.9	43.1	47.0	94.1	218.8	144.1	108.6	78.7	109.9	207.0
CAPZA3	"CAPPA3, Gsg3"	ENSG00000177938	"Capping actin protein of muscle Z-line subunit alpha 3"	Q96KX2	12	18738119-18739188	"Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"testis: 182.5"	"Group enriched"	"Detected in some"	186	"Early spermatids: 2526.3;Late spermatids: 7326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA038688	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA038688: AB_2676151"	"unprognostic (5.56e-2)"						"unprognostic (1.43e-1)"				"unprognostic (4.45e-3)"			"unprognostic (5.67e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	2.1	0.0	0.0	0.0	0.0	1.3	182.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2526.3	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7326.9	26.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	25.3	14.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.5;U-2197: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	10.0	8.4	3.7	5.0	3.3	0.1	10.5	2.9	4.0	6.5	2.8	13.3	34.1	6.0	1.3	8.4	7.5	7.8	10.7	3.1	3.0	14.9	12.4	6.1	2.1	4.7	3.3	3.1	9.2	2.7	2.1	4.7	5.0	5.4	8.8	0.3	19.0	4.2	8.0	9.7	35.9	4.2	3.3	4.1	9.9	15.0	4.2	0.8	6.8	8.2	1.0	6.1	5.8	2.9	31.3	23.1	4.1	3.0	0.1	8.7	19.6	2.8	6.5	12.8	10.0	14.2	21.8	0.0	10.8	5.4	12.4	43.0	4.9	56.5	3.9	0.1	11.8	0.7	15.6	22.1	5.4	0.5	1.9	2.9	11.5	24.5	31.2	10.2	26.1	0.0	3.3	0.0	9.9	11.0	0.1	2.0	7.2	17.0	13.2	0.0	38.9	3.0	19.1	5.4	1.5	2.4	21.0	9.5	2.1	5.0	10.1	1.7	35.0	9.5	26.9	82.8	16.4	0.1	0.0	0.0	30.2	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.3	2.9	4.0	3.1	3.0	4.7	3.3	5.0	3.3	4.2	2.9	22.6	0.0	2.0	0.0	0.2	8.5	6.8	3.4	2.2	1.2	3.9	4.3	3.7	10.0	1.6	3.7	0.0	0.4	0.2	35.5	1.9	25.4	7.8	3.3	0.4	24.8	7.7	0.0	0.1	19.6	1.6	1.9	15.8	6.2	0.0	0.4	17.9	4.8	0.1	0.0	0.6	19.8	4.1	0.0	1.2	8.6	0.0	0.4	5.4	3.7	0.0	0.0	0.0	0.0	0.1	39.4	27.6	0.7	0.2	8.6	35.5	12.4	1.2	0.2	0.0	6.2	1.1	0.4	3.4	2.5	3.8	0.0	0.6	1.0	11.3	9.7
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.9;dendritic cells: 47.2;Microglial cells: 49.6;NK-cells: 28.8;Pancreatic endocrine cells: 24.9;Plasma cells: 26.7;T-cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 122.7;K-562: 50.1;RT4: 91.4;U-698: 108.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"	1.3	3.1	6.9	21.8	1.5	18.5	1.2	1.8	1.5	2.3	1.0	2.4	3.7	1.3	0.2	1.3	2.2	8.8	1.0	1.3	4.9	1.6	1.6	4.7	47.3	4.2	8.4	1.3	1.4	0.7	0.9	0.5	3.7	1.4	2.3	0.2	3.3	1.6	0.6	0.7	18.3	0.6	3.0	31.5	7.5	1.7	14.0	20.9	1.5	0.2	29.5	17.1	1.3	4.6	16.7	2.6	0.1	0.1	0.0	0.0	12.2	0.1	0.0	0.5	0.0	32.4	35.5	122.7	29.2	0.0	0.0	27.2	0.0	0.4	0.3	42.1	1.1	0.1	3.1	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.8	23.1	13.3	50.1	0.0	0.0	0.3	4.7	0.0	44.9	20.6	0.1	5.9	0.1	30.7	11.4	91.4	0.3	1.5	0.1	0.2	0.1	17.7	0.2	2.5	15.4	0.2	11.8	0.1	0.1	12.3	0.1	108.0	0.0	0.0	0.2	0.5	0.0	0.0	7.7	0.0	7.2	5.4	4.4	5.2	0.9	6.2	2.9	5.3	0.2	5.5	0.0	31.4	3.5	2.9	6.9	1.5	1.8	1.5	1.3	4.9	4.2	8.4	3.7	3.0	14.0	4.6	0.5	0.0	0.0	0.7	34.9	0.0	0.3	0.3	0.6	0.6	0.3	0.4	2.0	0.0	0.3	1.8	0.0	0.0	47.2	0.7	0.0	4.6	0.2	0.4	0.3	0.6	0.0	0.8	2.1	5.3	0.0	1.6	14.3	0.7	5.7	8.6	0.4	0.2	1.5	0.0	1.6	0.3	0.0	2.4	1.8	0.4	0.3	5.4	3.6	49.6	1.0	0.1	28.8	1.0	0.6	24.9	0.0	0.0	26.7	0.3	0.0	0.1	1.0	0.2	0.0	0.3	0.9	1.5	0.2	0.0	0.3	0.0	28.6	4.5	0.4	8.1
CARD18	"ICEBERG, pseudo-ICE, UNQ5804"	ENSG00000255501	"Caspase recruitment domain family member 18"	P57730	11	105137714-105531697	"Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 41.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 3.2;Basal respiratory cells: 1.9;Early spermatids: 8.7;Late spermatids: 8.2;Suprabasal keratinocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;hTCEpi: 2.5;K-562: 2.9;OE19: 2.3;U-2 OS: 4.8"									HPA038582	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 61: Skin - Cornification"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"			"HPA038582: AB_10960549"		"unprognostic (3.90e-1)"				"unprognostic (2.95e-1)"			"unprognostic (1.77e-1)"					"unprognostic (2.88e-1)"	"unprognostic (3.42e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	7.4	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.7	0.4	0.0	0.1	41.8	0.1	0.0	0.0	0.0	0.0	0.9	0.1	1.1	0.0	0.0	0.0	0.0	2.8	0.1	0.1	0.0	0.1	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.0	1.9	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.2	2.3	1.1	0.0	0.0	0.0	0.0
CARD19	"bA370F5.1, BinCARD, C9orf89, MGC11115"	ENSG00000165233	"Caspase recruitment domain family member 19"	Q96LW7	9	93096217-93113283	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 142.0;Pancreatic endocrine cells: 121.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010921, HPA010990, HPA038297"	Approved		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938"	"unprognostic (7.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	12.2	13.7	2.5	3.7	2.1	3.2	11.3	4.8	4.5	11.5	3.1	14.4	6.1	12.0	2.6	11.0	10.8	5.8	10.3	1.8	3.4	16.2	10.8	10.9	4.0	4.0	2.9	7.9	5.5	6.1	6.6	3.3	4.9	8.7	3.2	0.1	9.4	4.2	14.2	10.8	9.5	4.2	3.6	10.5	12.9	19.1	3.5	3.1	8.7	5.5	2.6	11.5	11.5	5.9	33.0	31.3	4.1	9.2	5.3	10.1	12.9	26.7	13.0	18.2	8.2	7.8	10.6	7.0	18.3	9.5	15.4	56.0	3.3	21.9	1.5	134.9	12.3	12.4	6.5	18.4	21.1	11.2	11.4	23.5	8.1	13.2	5.2	20.0	21.4	6.1	5.7	13.8	12.4	64.7	12.1	30.0	3.6	21.1	70.8	8.2	20.7	29.4	22.9	12.1	9.8	17.3	14.4	6.9	30.6	0.8	15.6	11.6	21.6	9.3	18.6	17.9	8.4	10.4	10.1	1.5	39.0	11.3	32.4	27.8	37.4	23.6	10.2	30.0	10.5	12.6	10.0	10.9	30.6	7.5	9.0	8.9	40.3	18.4	17.3	11.1	21.7	22.4	2.5	2.1	4.8	4.5	1.8	3.4	4.0	2.9	4.9	3.6	3.5	5.9	29.3	22.4	20.9	0.0	14.4	0.0	52.8	0.0	25.6	12.0	81.2	75.6	0.0	27.1	5.6	16.5	16.7	22.9	25.7	27.7	62.6	76.6	49.5	19.4	26.8	34.1	15.8	7.8	0.0	58.1	34.6	26.2	36.2	20.3	30.3	8.2	41.7	13.9	79.0	5.0	0.0	19.8	0.0	41.3	0.0	15.3	45.7	142.0	0.0	0.0	68.3	21.9	17.5	0.0	0.0	121.6	10.3	43.6	15.0	58.7	38.9	61.7	2.2	29.8	59.2	30.4	31.1	98.7	26.4	27.9	0.0	21.6	34.0	8.5	18.6	71.0
CARD6	CINCIN1	ENSG00000132357	"Caspase recruitment domain family member 6"	Q9BX69	5	40841308-40860175	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.8;Gastric mucus-secreting cells: 26.5;Pancreatic endocrine cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 27.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.7;granulocytes: 27.4;monocytes: 13.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.5;HUVEC TERT2: 34.0;TIME: 36.9"	"Low region specificity"	"Detected in many"							HPA036438	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036438: AB_10670105"	"unprognostic (8.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.88e-3)"	9.0	12.0	1.7	5.5	1.9	3.1	5.8	1.9	1.9	4.8	3.3	2.6	7.8	3.5	1.5	10.6	4.5	11.4	4.4	1.8	2.2	4.8	4.0	9.7	4.8	2.8	2.1	1.8	3.1	2.2	1.7	6.9	2.5	1.9	2.8	0.7	7.5	2.8	2.1	2.4	5.3	4.9	2.5	12.9	12.1	1.3	2.8	2.4	5.3	5.4	4.5	8.4	4.1	2.4	3.4	5.8	0.8	0.1	13.0	20.5	0.1	1.7	3.1	0.2	0.7	0.6	1.2	6.4	10.8	4.0	6.9	2.1	0.3	8.4	0.7	0.6	1.4	7.7	10.8	0.6	4.1	6.3	14.4	13.2	6.7	7.6	1.7	9.5	34.0	0.1	7.9	1.1	3.0	0.1	0.0	6.1	0.1	3.3	1.7	0.1	0.2	6.6	12.6	7.2	0.0	0.0	9.6	2.8	1.5	0.1	0.3	11.5	36.9	1.6	1.4	0.4	2.4	0.3	0.1	0.8	3.0	13.3	5.9	27.4	11.2	4.1	1.2	11.3	1.0	1.0	1.7	1.1	7.7	2.0	1.6	1.2	10.7	1.8	13.9	3.0	3.6	4.5	1.7	1.9	1.9	1.9	1.8	2.2	2.8	2.1	2.5	2.5	2.8	2.4	23.8	0.0	17.5	0.0	3.1	1.7	1.5	6.6	5.2	0.0	2.9	2.0	1.4	11.5	6.4	1.8	0.0	0.7	1.8	0.2	0.0	15.9	0.6	5.7	9.6	20.1	0.0	4.8	0.1	14.0	0.8	10.2	26.5	10.3	13.3	0.4	15.4	3.1	9.2	0.0	0.1	0.4	4.1	16.6	1.8	1.0	3.1	14.1	0.0	4.7	11.2	0.7	2.1	0.5	0.1	21.7	1.2	1.2	0.9	0.4	3.2	0.9	4.4	0.0	0.0	1.1	2.7	0.6	0.2	11.3	2.3	0.5	3.0	8.5	1.2	9.1
CARD8	"CARDINAL, Dakar, KIAA0955, NDPP, TUCAN"	ENSG00000105483	"Caspase recruitment domain family member 8"	Q9Y2G2	19	48180770-48255946	"Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 114.4;HUVEC TERT2: 154.6;NB-4: 131.8;TIME: 148.6"									"HPA042071, HPA043513"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042071: AB_2677831, HPA043513: AB_2678522"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (1.72e-5)"	27.7	8.7	7.8	29.1	9.6	23.7	17.1	9.0	8.7	13.1	11.0	11.2	12.7	10.9	7.8	8.2	8.9	14.4	12.9	7.5	9.3	8.9	12.4	19.1	38.2	10.8	9.6	8.5	11.5	9.7	5.8	23.6	10.6	7.1	11.9	5.4	8.0	7.8	16.3	7.7	14.7	15.9	9.8	38.8	13.8	10.6	11.5	31.3	13.0	20.1	36.9	15.4	7.7	11.1	13.4	31.1	28.1	9.1	10.0	15.3	10.9	12.4	15.6	19.0	29.1	10.8	20.1	28.7	15.8	11.9	12.8	8.2	16.9	9.2	17.1	43.8	14.9	114.4	17.0	21.6	11.8	59.2	87.3	11.2	7.0	10.8	11.7	16.5	154.6	28.6	16.8	32.5	15.6	9.5	24.4	131.8	7.1	27.9	7.8	40.9	13.4	7.1	11.2	17.1	9.7	14.6	20.4	14.2	18.5	13.6	8.9	52.2	148.6	11.3	14.3	5.0	21.2	28.9	78.3	18.0	5.2	42.1	21.2	104.9	45.8	76.8	29.2	63.5	33.8	30.7	29.4	34.4	39.9	31.2	27.4	29.5	167.3	28.1	68.2	27.9	45.0	32.2	7.8	9.6	9.0	8.7	7.5	9.3	10.8	9.6	10.6	9.8	11.5	11.1	115.7	3.2	29.2	11.4	38.9	9.3	4.9	6.5	2.2	8.9	11.4	8.3	9.9	12.8	8.6	12.9	12.5	26.9	50.9	5.1	5.9	7.9	25.3	5.8	10.3	68.6	5.4	36.2	2.0	10.8	11.2	12.1	7.1	6.7	34.1	25.6	73.5	25.9	41.9	6.7	2.7	7.4	6.1	79.5	30.9	59.3	7.8	61.6	21.4	55.3	47.6	4.2	79.3	13.6	17.3	11.2	6.7	7.9	40.1	3.5	9.7	11.7	9.3	3.4	6.6	11.2	11.3	19.6	14.2	6.5	7.1	15.5	55.6	8.6	7.0	3.4
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 14.1;Hofbauer cells: 21.2;Horizontal cells: 15.2;Kupffer cells: 18.8;Langerhans cells: 12.9;Macrophages: 22.3;monocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 57.6;non-classical monocyte: 50.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HMC-1: 69.7;NB-4: 50.0;THP-1: 63.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.2	1.3	0.5	4.7	0.5	13.0	1.2	2.5	1.0	2.0	0.3	1.0	1.3	0.8	0.4	1.0	1.8	1.0	0.5	0.5	0.7	1.0	0.9	3.4	1.2	1.9	0.9	0.3	0.5	0.1	0.8	0.9	1.3	1.8	0.4	0.2	1.1	1.0	0.2	2.7	1.8	1.1	1.4	9.9	0.6	0.4	1.1	0.4	0.4	0.0	1.5	1.2	1.1	1.7	0.1	0.0	0.3	0.0	0.0	0.0	4.6	9.5	0.3	0.2	0.0	0.7	0.0	0.0	0.1	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.5	0.1	6.8	4.9	12.2	69.7	0.0	0.1	0.2	0.2	0.0	0.1	0.0	5.3	0.0	0.0	0.2	0.0	50.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	12.3	0.0	16.0	0.1	0.0	4.1	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	16.0	0.0	6.9	34.5	11.5	0.0	57.6	0.9	0.0	0.0	0.0	26.0	0.0	0.0	0.0	2.3	0.7	50.5	0.1	0.5	14.1	0.5	0.5	2.5	1.0	0.5	0.7	1.9	0.9	1.3	1.4	1.1	1.7	0.8	0.0	4.6	4.6	1.1	1.8	0.6	0.3	3.4	0.2	4.2	4.3	2.6	0.0	4.9	3.7	0.0	0.4	2.2	0.4	1.9	0.1	1.0	1.2	14.1	1.1	0.0	2.5	2.1	0.0	0.4	2.1	1.5	1.4	10.8	0.4	0.7	0.1	21.2	15.2	1.1	0.0	0.0	18.8	12.9	6.9	0.3	22.3	1.8	6.5	16.3	4.6	3.1	0.0	0.2	0.0	0.1	0.0	1.4	0.1	0.0	0.3	0.6	0.9	0.0	0.3	1.5	1.0	1.5	0.9	1.7	0.4	1.4	0.2	0.2	0.6
CARF	"ALS2CR8, FLJ21579, NYD-SP24"	ENSG00000138380	"Calcium responsive transcription factor"	Q8N187	2	202912214-202988263	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034557, HPA043191"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA034557: AB_10601663, HPA043191: AB_2732503"	"unprognostic (4.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.58e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	4.5	5.3	4.2	5.7	8.6	5.4	7.7	6.4	5.1	5.9	2.5	5.2	4.5	9.4	9.9	5.5	6.8	6.0	4.9	4.4	5.0	6.8	4.5	5.1	8.8	5.9	6.0	7.9	3.9	7.8	5.1	4.7	6.5	6.7	6.0	16.1	4.6	6.4	4.5	7.4	4.9	6.6	4.6	7.5	6.0	21.5	5.5	9.4	10.6	5.4	7.8	5.7	5.0	12.3	2.5	2.4	6.1	5.4	4.5	9.5	4.7	3.7	4.7	3.8	3.4	2.8	6.2	3.8	1.6	4.3	4.6	4.5	3.2	2.7	4.3	3.0	1.7	5.9	3.0	1.7	3.8	3.5	2.9	7.8	5.2	3.3	8.6	9.6	2.3	13.9	2.5	15.5	5.9	4.9	7.2	5.6	2.6	1.6	3.5	5.1	4.2	3.1	6.9	2.6	4.3	4.6	4.0	2.2	1.7	7.7	3.6	6.5	2.7	7.1	1.8	4.6	2.4	13.7	8.4	4.2	6.1	4.1	4.4	1.4	1.0	0.8	2.2	1.9	2.4	2.0	2.2	2.1	1.2	2.4	3.1	2.2	0.4	8.8	1.1	1.9	4.7	0.6	4.2	8.6	6.4	5.1	4.4	5.0	5.9	6.0	6.5	4.6	5.5	12.3	5.6	9.6	15.7	28.7	14.6	3.2	3.9	5.5	5.2	33.5	6.7	5.5	6.6	7.2	14.1	14.7	18.8	4.2	9.2	2.7	11.7	4.4	19.0	7.1	5.0	5.6	1.8	7.6	21.5	2.4	9.3	7.4	5.6	2.9	20.3	19.6	8.2	3.2	3.9	26.9	25.0	4.7	6.1	8.2	3.7	16.7	10.8	4.9	1.8	16.9	5.9	9.6	18.6	39.2	66.1	2.9	3.2	9.4	4.0	2.0	9.5	5.8	17.7	31.1	6.6	7.1	5.6	37.2	8.6	4.4	2.7	1.8	10.2	10.5	6.2	2.7
CARHSP1	"CRHSP-24, CSDC1"	ENSG00000153048	"Calcium regulated heat stable protein 1"	Q9Y2V2	16	8852942-8869012	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 422.7"	"Group enriched"	"Detected in all"	7	"Early spermatids: 2062.2;Late spermatids: 6999.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051911	Enhanced					NA	Yes		280000	"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA051911: AB_2681660"	"unprognostic (4.08e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.76e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"prognostic favorable (7.24e-4)"	101.4	132.5	49.4	33.7	75.0	70.0	67.7	46.8	58.4	101.7	46.5	46.4	31.3	38.2	13.5	193.7	51.0	33.8	48.2	50.1	50.8	109.6	188.2	116.7	46.9	56.1	49.7	68.5	54.8	9.8	33.2	59.2	51.2	35.3	25.6	3.0	110.7	13.9	17.4	34.5	47.1	24.2	47.6	56.7	52.5	422.7	51.0	59.6	35.9	21.3	59.4	45.8	101.7	60.4	84.2	134.8	200.2	40.3	52.1	83.0	98.9	110.7	93.5	92.9	117.8	95.4	224.6	109.1	70.2	83.5	70.9	82.0	79.3	87.9	65.4	87.9	102.1	34.5	108.1	369.8	177.5	59.2	84.6	181.7	40.0	91.8	60.7	87.8	92.6	241.5	94.5	136.1	120.5	152.0	313.5	147.6	124.6	89.0	82.2	367.0	245.9	179.3	75.5	56.0	119.0	153.2	104.9	106.1	104.0	112.4	134.9	60.3	99.9	77.8	144.9	94.6	57.4	67.6	77.4	135.0	173.9	71.9	134.9	81.6	29.6	35.8	25.8	14.3	16.1	17.5	25.0	25.3	25.8	28.6	17.0	23.7	89.2	41.6	19.0	47.4	62.8	20.8	49.4	75.0	46.8	58.4	50.1	50.8	56.1	49.7	51.2	47.6	51.0	60.4	166.3	25.6	9.1	19.6	48.9	42.7	67.2	158.4	22.8	8.0	71.4	38.0	6.0	221.6	86.4	82.8	6.2	141.5	65.1	152.6	54.8	619.1	2062.2	101.9	82.0	145.3	144.9	147.5	4.4	241.8	312.6	86.4	42.8	114.4	39.3	118.0	128.8	323.5	70.5	11.8	5.9	107.7	91.6	62.4	55.3	6999.5	96.3	36.1	58.7	9.4	66.5	7.7	121.5	8.0	25.6	340.0	179.5	73.0	63.9	139.3	174.2	479.0	70.9	11.2	111.7	31.2	95.5	72.7	52.7	84.2	42.1	153.5	65.1	17.0	108.4	169.8
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871553-10923075	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	20.3	17.1	24.7	19.6	26.6	22.7	17.6	18.9	34.1	30.6	17.2	28.4	17.3	31.7	7.8	36.7	23.4	14.7	25.4	27.6	23.7	18.8	20.1	16.4	19.8	22.8	21.8	21.9	22.3	11.5	14.8	20.4	22.6	20.2	14.3	6.4	20.2	17.5	110.5	22.6	20.9	21.3	19.9	18.6	20.3	45.4	22.6	10.9	13.4	72.4	15.4	26.3	28.0	26.0	62.5	46.8	64.9	88.3	52.5	71.1	63.2	42.8	75.6	63.9	61.0	73.4	21.8	85.2	52.4	77.4	32.1	58.0	65.4	66.2	40.1	98.4	52.7	26.5	29.1	89.9	44.8	39.3	33.9	49.0	42.4	43.8	52.4	35.9	82.1	67.9	65.8	79.2	38.2	116.7	70.0	34.3	81.4	40.7	74.8	97.5	32.8	100.7	38.9	29.7	47.0	45.1	30.7	36.2	43.6	31.7	38.4	35.3	48.7	75.4	43.2	72.3	54.0	75.0	64.1	77.2	51.1	63.8	35.3	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	24.7	26.6	18.9	34.1	27.6	23.7	22.8	21.8	22.6	19.9	22.6	26.0	12.9	9.6	12.2	7.2	11.6	7.8	5.9	4.1	12.0	36.4	14.0	13.7	1.1	14.3	6.5	9.2	52.1	18.5	6.4	42.3	7.9	13.4	32.7	20.1	30.8	12.7	27.6	30.7	12.9	19.7	33.1	13.8	13.7	25.4	1.3	17.8	12.8	27.8	26.7	45.4	10.6	24.9	4.1	20.0	10.9	23.5	28.3	14.8	5.4	5.6	23.9	8.7	4.1	10.6	5.8	24.8	27.2	19.2	11.7	14.1	22.6	9.2	7.4	21.1	6.6	19.6	13.0	23.8	17.5	25.7	7.0	12.0	6.5	6.6	25.7	11.8
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.9;Collecting duct cells: 35.0;Distal tubular cells: 46.9;Endometrial ciliated cells: 37.3;Glandular and luminal cells: 39.3;Granulosa cells: 31.8;Proximal tubular cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 36.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	4.4	3.9	2.7	2.8	4.1	0.7	6.5	6.4	5.9	5.2	0.0	10.7	15.3	2.5	7.1	4.3	5.5	5.8	3.7	2.2	2.5	8.5	2.1	8.0	3.6	1.0	3.5	4.3	4.5	5.1	1.2	4.6	0.8	3.3	10.0	1.0	5.3	2.7	0.4	5.9	15.8	2.7	1.3	2.8	7.4	11.4	3.2	7.6	5.2	2.0	3.7	5.2	3.7	1.2	12.9	12.7	3.5	4.5	3.2	1.6	12.1	4.3	9.7	4.5	7.9	13.7	9.4	4.4	13.8	6.9	13.2	13.7	13.6	12.2	3.3	11.1	7.2	10.7	14.0	1.7	8.9	0.5	1.6	1.7	8.2	8.7	13.3	5.6	0.2	1.6	0.3	3.5	2.9	10.0	0.7	0.0	4.8	22.7	5.2	1.5	2.1	36.0	34.7	11.5	9.0	1.9	19.1	32.4	12.4	10.1	7.8	0.3	0.2	3.3	5.8	15.8	4.4	0.5	0.2	7.0	5.2	3.9	12.6	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.4	1.3	1.0	0.1	0.0	0.6	1.3	0.9	0.0	0.1	2.7	4.1	6.4	5.9	2.2	2.5	1.0	3.5	0.8	1.3	3.2	1.2	3.2	19.2	27.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	17.5	11.6	0.0	0.0	4.3	35.0	0.0	20.8	0.4	0.0	46.9	16.7	0.0	37.3	7.0	4.0	0.0	0.0	0.0	15.6	7.9	12.8	0.0	39.3	8.8	31.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	17.6	0.0	0.0	7.6	0.0	0.0	58.8	3.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	10.9	1.6	14.9	0.0	0.0
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644988-67657569	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;intestine: 13.4;lymphoid tissue: 21.6"	"Group enriched"	"Detected in some"	4	"B-cells: 3.6;dendritic cells: 3.7;T-cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;JURKAT: 47.3;MOLT-4: 64.6;REH: 105.6;RPMI-8226: 58.4;U-698: 107.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041402	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"	0.9	0.5	5.9	12.5	6.3	5.9	0.5	4.5	11.4	0.4	2.4	2.0	1.8	0.3	0.1	0.9	0.5	1.2	0.3	9.8	5.1	0.9	0.8	1.7	21.6	5.6	4.0	0.2	0.4	0.1	4.5	0.2	5.4	0.8	0.7	0.3	1.4	0.1	0.0	0.4	13.4	0.2	3.4	19.9	1.9	0.9	4.9	20.9	1.2	0.0	10.9	1.5	0.7	6.8	0.2	0.1	0.1	0.3	0.0	0.1	18.1	0.6	0.0	0.5	0.0	9.6	0.6	64.2	1.1	0.0	0.1	0.1	6.0	0.0	0.0	14.3	7.5	3.8	0.3	1.2	0.5	7.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	47.3	0.9	1.0	0.0	1.1	64.6	32.2	10.7	0.3	0.3	105.6	0.1	58.4	0.0	0.0	15.9	1.7	0.1	0.2	0.5	1.5	0.4	1.9	0.2	0.9	2.0	0.1	0.4	17.6	33.4	107.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.7	0.1	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.3	0.7	0.1	5.9	6.3	4.5	11.4	9.8	5.1	5.6	4.0	5.4	3.4	4.9	6.8	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0
CARMIL3	"BC008134, C14orf121, crml-1, LRRC16B"	ENSG00000186648	"Capping protein regulator and myosin 1 linker 3"	Q8ND23	14	24052009-24069729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.6;pituitary gland: 8.1;skin 1: 3.9;testis: 2.2"	"Cell type enhanced"	"Detected in single"		"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.5;HMC-1: 3.7;Karpas-707: 3.3;SCLC-21H: 5.4;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030596	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA030596: AB_10603012"	"unprognostic (2.67e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (6.13e-2)"	"unprognostic (8.92e-4)"	"unprognostic (4.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.16e-1)"	0.1	0.3	2.0	0.3	1.5	0.2	0.3	3.6	2.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	0.1	0.3	0.1	1.9	1.3	0.7	0.2	0.3	0.3	2.0	1.4	0.1	0.7	0.0	8.1	0.0	2.0	0.3	0.1	1.0	0.6	0.0	0.0	3.9	0.7	0.0	0.5	0.5	0.3	2.2	1.9	0.1	0.5	0.0	0.4	0.1	0.5	1.8	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.2	0.8	0.0	0.3	0.1	0.1	0.4	0.0	0.0	0.0	0.0	5.4	2.6	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	3.6	2.1	1.9	1.3	2.0	1.4	2.0	0.5	1.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
CARNMT1	"C9orf41, FLJ25795"	ENSG00000156017	"Carnosine N-methyltransferase 1"	Q8N4J0	9	74980790-75028423	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 256.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 24.6"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026756	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026756: AB_1845824"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	5.1	6.1	1.8	7.0	13.8	8.3	7.0	24.6	6.0	5.8	0.1	9.2	12.7	6.1	8.3	10.0	6.2	6.8	5.4	3.7	0.4	12.2	17.1	5.4	9.7	0.1	2.5	6.1	9.0	11.3	3.9	5.3	1.8	6.4	8.5	7.8	9.1	5.3	8.7	8.4	12.4	6.1	0.2	6.7	7.8	16.4	1.0	8.4	13.6	8.5	8.5	9.1	5.1	3.5	27.6	16.1	6.6	17.0	10.3	22.4	24.6	24.4	10.0	9.0	8.2	4.1	17.9	43.7	12.9	17.4	19.2	26.7	20.0	25.3	25.5	40.0	17.4	22.3	15.5	18.4	12.6	40.7	21.2	15.0	12.4	17.0	17.3	13.3	18.6	15.6	19.1	36.9	17.4	7.3	29.8	10.8	31.4	33.0	14.7	14.4	20.2	25.4	23.5	19.0	6.5	3.6	18.7	46.2	9.2	11.8	23.5	11.7	14.8	14.8	19.9	18.2	21.3	28.2	38.3	13.1	22.9	27.6	9.8	0.0	0.4	1.0	1.3	0.8	1.9	1.7	1.3	2.0	0.6	0.9	1.6	1.5	0.1	1.5	0.4	0.6	2.0	0.7	1.8	13.8	24.6	6.0	3.7	0.4	0.1	2.5	1.8	0.2	1.0	3.5	8.5	6.4	11.7	0.0	10.2	0.0	11.6	0.0	21.6	14.5	16.6	8.0	0.0	11.5	6.8	27.6	10.4	7.0	18.6	4.5	25.4	7.5	256.8	11.2	19.6	9.4	7.3	6.3	0.0	11.9	13.0	6.6	13.7	14.8	2.5	8.7	8.9	29.8	8.1	20.2	0.0	12.8	0.0	9.1	0.0	44.3	7.5	8.5	0.0	0.0	8.9	5.6	17.5	0.0	0.0	9.3	8.8	10.9	17.4	17.7	22.6	37.3	4.4	10.4	0.0	9.3	5.6	17.7	10.3	33.5	0.0	5.1	17.1	16.2	13.2	15.0
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 278.3;skeletal muscle: 75.5"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 447.9"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"RPMI-8226: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA038569	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	11.7	0.3	62.1	0.4	149.5	0.5	0.7	127.6	119.0	0.7	20.4	0.7	0.4	0.5	1.4	0.9	1.3	0.5	8.8	64.6	89.6	0.8	0.4	0.9	1.2	168.6	137.6	0.9	1.2	0.9	0.6	0.0	145.9	0.7	0.2	0.0	1.3	0.2	75.5	0.6	0.9	0.2	101.8	2.1	7.5	0.2	122.2	0.4	5.6	30.1	0.5	0.5	0.6	278.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.3	1.0	0.0	0.6	0.4	1.0	0.0	0.5	0.0	0.0	0.2	0.3	62.1	149.5	127.6	119.0	64.6	89.6	168.6	137.6	145.9	101.8	122.2	278.3	0.6	3.2	0.5	1.0	3.5	0.3	0.2	0.2	0.0	0.0	0.3	0.4	13.5	7.2	0.7	0.0	0.0	0.1	6.1	0.6	0.0	0.5	0.0	0.3	0.2	1.0	3.0	0.0	1.2	0.0	0.1	1.5	23.0	0.5	0.0	0.1	0.4	0.4	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	4.1	2.5	447.9	0.1	0.1	0.4	4.0	0.2	0.2	0.3	0.9	0.5	0.0	3.5	3.0	0.0	0.3	0.1	0.9	0.0	2.3	0.3	0.2	0.1
CARS1	CARS	ENSG00000110619	"Cysteinyl-tRNA synthetase 1"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		200000	"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	22.1	17.4	8.1	12.0	8.5	7.3	19.9	8.7	21.6	13.6	8.4	21.8	12.0	15.9	7.5	19.2	12.8	10.3	13.3	8.2	9.8	13.7	21.1	17.5	12.7	9.6	9.9	8.9	32.8	9.6	18.6	10.3	10.6	12.7	12.8	5.3	20.6	6.8	31.7	23.8	17.4	16.0	9.7	17.2	23.5	16.8	9.9	14.6	17.3	14.7	17.8	18.1	14.9	11.5	29.2	14.0	17.8	55.6	67.3	61.4	16.2	70.0	78.6	46.7	84.1	34.2	64.7	43.1	20.1	88.2	0.0	68.7	58.3	78.6	64.0	123.7	13.5	24.4	23.7	25.8	161.1	50.9	50.2	102.2	64.1	40.1	46.8	0.0	62.3	103.6	42.2	147.0	47.1	41.9	35.7	0.0	65.2	97.9	25.0	17.2	29.7	54.9	0.0	46.1	39.0	49.7	17.1	48.1	80.1	13.3	0.0	0.1	21.8	19.5	18.2	48.2	0.2	107.8	106.8	27.2	0.1	26.6	40.3	16.3	18.6	13.5	20.9	15.4	17.4	10.9	18.3	18.6	19.4	8.5	9.9	16.0	25.4	23.7	37.9	7.5	27.0	19.2	8.1	8.5	8.7	21.6	8.2	9.8	9.6	9.9	10.6	9.7	9.9	11.5	10.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	22.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	40.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	32.3	1.4	0.0	0.0	0.0
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 204.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	18.3	24.4	8.8	18.9	9.3	28.4	15.0	16.3	13.3	20.3	15.8	20.8	17.5	16.0	13.7	18.6	16.4	11.1	25.9	9.7	9.3	15.4	19.9	16.7	19.3	9.0	9.3	15.3	15.8	15.0	17.6	12.1	9.7	15.2	13.8	9.2	18.9	12.3	45.8	17.6	18.5	12.6	9.2	17.8	17.2	11.2	9.7	12.9	14.3	26.7	14.1	17.7	15.9	10.5	116.0	37.7	21.2	52.6	55.7	51.7	28.7	49.9	45.7	49.6	60.6	53.5	50.7	53.5	68.4	55.4	75.6	61.0	36.6	63.8	40.2	49.2	58.5	33.5	79.6	63.8	58.5	83.0	39.3	66.7	50.7	43.3	51.8	35.5	36.0	40.9	23.2	16.6	71.2	27.2	37.5	27.6	18.4	88.9	36.8	54.2	15.6	22.3	54.2	33.4	37.7	28.9	40.7	62.0	61.1	22.7	29.8	94.0	32.5	41.8	15.6	53.2	51.6	29.0	35.8	32.4	204.5	50.1	41.9	0.0	2.9	0.4	1.1	3.3	1.2	1.8	0.3	0.4	2.4	0.8	1.1	0.5	1.7	0.4	4.6	2.0	0.4	1.1	8.8	9.3	16.3	13.3	9.7	9.3	9.0	9.3	9.7	9.2	9.7	10.5	18.2	9.6	15.9	24.5	24.4	12.9	24.2	10.3	8.6	21.4	21.8	23.4	39.3	18.6	9.5	27.6	25.0	26.7	28.2	17.6	50.9	17.7	66.5	24.1	21.7	13.6	18.7	10.7	29.2	4.7	29.1	21.6	18.8	27.3	16.5	45.3	9.3	26.6	26.9	23.5	25.1	17.7	12.2	31.2	9.0	221.4	20.5	32.8	12.4	24.4	51.4	24.3	14.4	14.1	26.6	12.1	10.8	18.0	18.6	18.2	23.0	38.1	10.6	25.9	6.6	29.2	24.7	8.6	7.5	22.3	13.5	16.8	19.8	44.2	28.5	17.6
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719275-71721048	"FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 118.6;brain: 183.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 47.4;Early spermatids: 25.4;Prostatic glandular cells: 39.5;Spermatocytes: 55.7"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 117.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 209.0"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB025515: , CAB079776: , HPA046278: AB_10961570"			"unprognostic (1.37e-1)"		"unprognostic (1.43e-1)"					"unprognostic (2.27e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (4.36e-4)"		"unprognostic (1.14e-1)"		2.4	118.6	85.6	4.4	10.1	0.0	9.3	2.6	48.9	0.0	3.9	16.8	5.5	2.8	0.7	0.3	0.4	0.2	0.1	28.0	134.0	0.3	0.0	0.1	0.0	69.8	111.9	0.1	0.5	0.0	5.2	0.0	183.6	8.6	4.5	21.4	0.1	0.0	0.0	0.1	3.4	15.1	24.5	0.0	14.6	7.1	102.4	0.2	5.4	0.0	0.0	0.0	0.3	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.6	10.1	2.6	48.9	28.0	134.0	69.8	111.9	183.6	24.5	102.4	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	47.4	0.2	0.3	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	25.4	1.6	0.1	1.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	39.5	0.0	0.0	0.0	8.1	0.0	0.0	0.1	55.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2
CASC3	"BTZ, MLN51"	ENSG00000108349	"CASC3 exon junction complex subunit"	O15234	17	40140318-40172171	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 239.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024592, HPA050262"	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane"		"HPA024592: AB_1846034, HPA050262: AB_2681067"	"unprognostic (3.76e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-2)"	45.5	27.9	88.0	29.9	96.9	37.2	38.5	79.3	95.1	41.0	62.2	48.2	22.9	49.5	38.2	30.3	46.9	25.0	24.8	77.0	90.4	29.0	20.8	35.4	34.1	94.3	88.4	55.6	33.3	35.0	26.0	30.3	89.3	36.1	31.9	39.0	31.8	47.9	55.4	38.1	32.2	47.7	84.9	34.1	35.3	54.1	94.0	40.1	40.4	43.5	37.6	47.7	33.3	96.6	44.6	44.9	58.5	64.9	46.1	48.2	34.3	45.5	40.6	61.3	52.5	48.3	38.3	81.7	67.2	57.7	50.4	77.8	71.8	48.0	83.5	54.8	58.1	58.6	55.4	50.6	42.0	74.7	39.6	50.2	43.9	59.9	93.6	46.8	77.4	45.8	64.0	61.5	50.8	25.6	110.9	44.3	44.5	39.8	26.0	67.3	74.5	85.9	32.1	39.5	85.4	49.8	63.8	239.4	59.4	91.1	78.2	58.9	50.0	51.7	53.3	48.7	71.0	56.5	56.3	81.1	50.4	40.2	57.1	7.8	9.4	13.1	12.5	11.5	11.1	8.6	9.3	11.5	10.0	8.6	10.5	10.4	35.9	10.2	18.2	5.8	9.1	8.6	88.0	96.9	79.3	95.1	77.0	90.4	94.3	88.4	89.3	84.9	94.0	96.6	32.8	19.2	36.8	31.0	29.5	19.8	22.9	11.3	31.3	40.8	38.5	32.5	26.7	14.3	31.8	23.9	22.9	19.9	38.0	21.4	21.5	17.8	14.8	30.2	38.8	34.0	31.2	23.5	29.0	24.3	21.3	26.9	26.0	31.4	16.4	32.5	23.9	21.9	17.0	30.3	32.8	20.8	18.3	26.4	29.2	24.5	36.1	25.8	35.6	22.5	23.9	23.5	26.8	15.1	34.5	21.0	17.6	29.7	26.5	27.2	17.3	18.1	27.2	38.5	13.1	42.0	40.2	59.4	67.7	28.1	19.9	27.1	30.1	22.7	20.6	24.7
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	11.1	25.3	11.4	9.6	14.0	6.0	15.7	11.1	12.9	11.3	4.8	16.5	6.5	14.1	14.6	6.3	11.0	10.0	17.1	14.9	17.4	12.4	9.0	11.3	12.5	8.8	10.7	16.4	9.8	13.8	8.7	12.3	12.9	13.9	19.3	22.1	20.3	9.4	14.1	3.8	6.1	11.0	11.3	10.6	7.3	13.1	14.6	11.2	16.0	19.6	10.8	9.1	4.3	14.0	5.5	10.4	34.7	12.9	10.4	12.3	5.9	7.2	12.8	7.9	10.2	6.5	13.2	13.9	18.5	9.8	14.1	3.0	8.8	2.5	15.4	22.2	7.1	12.3	8.5	11.9	8.8	20.5	0.0	11.4	9.2	7.2	10.3	15.4	12.6	16.0	6.7	29.3	19.6	8.0	28.5	11.6	17.7	7.7	8.2	19.3	28.0	10.8	15.9	14.9	13.1	44.5	11.4	20.7	7.4	24.9	5.4	12.8	6.7	19.6	15.5	16.2	10.6	28.0	28.1	28.5	10.7	4.7	12.9	0.0	0.2	0.0	0.6	0.2	1.6	0.6	0.9	0.8	0.4	0.5	0.9	0.7	0.0	0.6	0.2	0.3	0.6	0.2	11.4	14.0	11.1	12.9	14.9	17.4	8.8	10.7	12.9	11.3	14.6	14.0	26.2	28.9	26.3	76.0	15.4	4.6	5.8	5.8	4.0	56.4	14.4	12.8	21.1	17.2	12.8	20.2	18.8	14.2	14.6	29.7	3.9	5.1	3.4	18.0	13.1	16.4	7.2	4.6	93.7	5.6	5.7	14.6	5.1	9.9	10.2	23.7	16.1	13.3	8.8	67.3	108.5	30.2	2.0	9.8	5.5	7.0	11.5	10.8	24.9	61.8	7.1	23.3	10.3	122.6	170.3	6.8	11.8	9.8	9.2	10.0	0.6	10.8	18.1	31.4	19.7	41.2	12.2	9.6	12.8	4.7	4.5	16.8	12.2	25.8	19.5	4.5
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 47.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	10.2	11.1	13.6	11.9	12.9	7.3	15.7	12.3	11.1	11.6	12.4	25.3	32.1	11.1	9.4	13.7	10.5	18.5	6.8	14.2	17.1	16.4	13.4	12.2	12.5	13.2	19.4	13.5	12.8	11.8	6.3	16.3	15.7	10.6	27.3	19.8	13.2	8.3	5.0	9.3	31.9	12.0	15.4	12.4	19.8	3.6	25.2	15.4	10.6	6.1	10.4	15.3	8.8	18.0	27.4	32.5	31.4	19.1	21.6	18.6	10.9	23.2	18.7	13.2	12.3	72.3	42.6	0.4	12.0	29.3	23.8	52.3	35.2	23.2	22.8	25.4	20.9	0.6	27.7	26.2	22.1	4.4	3.6	19.8	63.2	25.1	30.1	27.5	11.6	15.3	2.2	21.3	30.2	30.9	8.4	2.2	29.7	37.6	22.6	12.7	79.8	13.2	31.2	54.8	29.7	15.6	43.7	17.7	13.9	52.7	19.0	0.8	14.2	24.4	25.8	22.1	13.3	7.6	5.2	9.5	24.4	3.1	16.9	47.1	1.5	8.7	0.8	1.1	0.8	0.7	0.9	1.3	0.4	0.9	1.2	1.1	1.7	4.3	0.7	0.5	4.5	0.6	13.6	12.9	12.3	11.1	14.2	17.1	13.2	19.4	15.7	15.4	25.2	18.0	13.0	12.8	20.4	101.9	8.8	32.6	42.7	11.1	8.0	42.2	23.7	16.5	7.8	8.6	14.6	7.3	22.9	2.0	12.1	25.8	50.9	13.7	0.9	9.6	24.1	16.0	13.8	0.8	96.6	14.5	0.7	18.8	18.8	11.9	0.0	17.4	8.9	15.0	21.3	50.5	135.8	28.7	14.2	2.8	21.5	1.0	9.9	10.7	10.6	60.0	2.5	9.3	0.0	447.8	59.7	22.1	24.1	9.4	7.0	16.4	35.2	20.9	15.7	25.7	19.7	38.2	20.6	2.9	2.1	13.9	32.5	1.6	26.5	47.7	41.8	33.2
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196605	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 45.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Bipolar cells: 22.9;Excitatory neurons: 20.8;Horizontal cells: 42.1;Inhibitory neurons: 26.4;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 28.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.8;HDLM-2: 14.7;HEK 293: 3.2;SCLC-21H: 6.4;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	0.1	0.2	15.1	0.0	16.6	0.0	0.4	0.4	45.8	0.6	0.0	0.4	0.0	0.4	0.0	0.1	0.3	0.0	3.0	22.5	6.4	0.2	0.0	0.0	0.0	23.9	8.0	0.5	0.5	0.9	3.9	0.0	14.9	0.5	0.0	2.1	0.6	0.1	0.1	1.0	0.1	0.0	0.2	0.0	0.1	1.2	19.3	0.0	0.7	0.0	0.0	0.0	0.3	11.0	0.0	0.4	1.6	3.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.3	0.0	14.7	3.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.9	0.1	0.0	1.1	0.0	0.8	0.6	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.4	3.1	0.1	0.2	0.2	0.1	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	16.6	0.4	45.8	22.5	6.4	23.9	8.0	14.9	0.2	19.3	11.0	0.0	0.0	0.0	39.5	0.1	0.4	0.2	0.6	1.2	22.9	1.2	1.3	3.5	0.0	0.1	0.0	8.4	0.0	0.2	0.4	0.0	0.1	0.0	0.6	1.1	0.3	0.0	0.0	20.8	0.2	0.2	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.1	42.1	26.4	0.1	0.0	0.0	0.3	0.1	0.3	0.1	0.0	4.7	0.0	20.2	0.0	28.6	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	6.4	0.0	0.1	0.1	0.4	1.6	0.4	0.4	0.1	0.1	0.1	0.0	0.1
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.5;Endothelial cells: 42.2;Hepatic stellate cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA071906: AB_2732191, HPA075184: AB_2732281"	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favorable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	33.8	22.7	19.4	4.9	22.6	0.4	30.0	19.7	18.6	15.1	4.6	16.5	9.0	21.0	2.7	10.8	21.7	11.2	28.2	16.7	17.2	26.9	11.3	42.3	2.9	22.6	21.7	12.0	10.8	9.4	13.6	11.8	18.7	14.9	2.9	4.8	11.5	8.7	15.3	12.7	11.4	10.4	18.1	30.8	15.0	5.6	20.0	2.9	22.6	9.9	1.5	16.0	14.3	23.1	13.3	17.2	10.2	14.4	6.6	4.1	11.2	6.6	8.7	15.8	10.2	19.0	5.6	0.5	7.4	7.7	10.5	12.0	8.2	7.7	3.9	4.7	10.8	9.4	17.2	7.5	7.7	0.5	12.6	3.5	10.4	8.2	5.9	5.3	16.2	13.3	6.9	1.6	5.0	31.1	24.3	0.7	7.5	10.3	17.5	12.8	21.8	2.1	10.2	13.4	10.4	10.2	13.9	18.7	11.0	8.7	13.7	4.0	13.9	16.1	14.6	7.9	8.7	1.2	5.9	1.5	5.6	0.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	22.6	19.7	18.6	16.7	17.2	22.6	21.7	18.7	18.1	20.0	23.1	75.5	3.2	2.2	11.1	1.3	8.0	2.5	3.5	6.8	6.5	5.8	5.0	11.4	2.8	1.8	9.2	10.4	2.2	0.6	11.7	3.9	5.1	0.5	2.8	4.4	42.2	7.7	8.0	1.3	5.3	1.9	6.0	8.2	5.7	0.0	14.9	56.7	6.8	2.7	3.3	1.7	4.3	8.2	4.1	3.1	2.3	8.1	1.2	1.8	7.5	2.0	28.2	0.0	15.1	8.3	6.0	6.0	11.3	1.6	2.5	8.4	3.1	1.4	6.8	0.0	5.5	6.4	2.7	4.4	4.5	7.0	2.2	0.5	5.7	4.6	2.2
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CASP10	"FLICE-2, MCH4"	ENSG00000003400	"Caspase 10"	Q92851	2	201182898-201229406	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.3"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	8.8	2.4	5.7	9.2	5.5	19.5	6.5	4.5	5.8	4.0	4.4	13.2	21.8	3.3	6.2	8.8	5.4	7.4	6.7	4.7	5.1	8.1	6.2	11.5	8.9	6.0	5.0	1.6	4.8	2.3	1.3	9.6	5.8	3.9	13.4	1.3	5.4	3.1	4.9	5.7	18.4	5.1	5.6	22.6	10.2	1.2	7.3	8.7	5.3	2.8	10.4	9.0	5.1	5.4	4.4	3.5	0.3	0.4	0.1	0.3	7.5	0.7	4.6	0.4	1.8	4.6	9.8	0.5	7.0	2.5	1.7	2.9	0.2	2.3	1.3	2.1	4.8	12.2	4.0	15.1	1.6	8.3	12.7	0.5	2.0	5.3	0.4	0.3	25.3	5.1	14.9	17.4	0.4	0.3	15.9	7.8	0.6	6.0	2.4	8.8	0.5	18.4	8.7	6.2	0.2	0.1	4.1	0.2	1.9	3.0	0.2	7.8	10.0	0.4	0.8	3.4	0.2	18.7	12.1	0.5	4.5	6.3	0.2	5.9	11.7	0.7	6.4	16.5	5.6	8.2	5.2	3.6	6.5	7.7	7.2	6.4	2.1	8.5	19.3	6.6	1.2	7.2	5.7	5.5	4.5	5.8	4.7	5.1	6.0	5.0	5.8	5.6	7.3	5.4	20.7	19.2	10.0	0.3	15.8	6.0	2.7	10.6	5.2	0.0	1.3	0.9	1.8	8.6	9.4	9.2	0.0	1.1	20.5	71.3	1.9	16.2	1.2	7.7	7.4	29.7	2.4	14.9	0.3	10.4	0.7	4.2	26.5	12.0	7.6	0.8	26.4	7.1	9.4	0.0	0.5	21.6	4.1	26.6	17.5	0.0	0.6	16.2	7.2	33.7	22.0	0.5	44.3	0.0	0.9	8.6	44.5	0.0	49.7	2.5	26.1	8.7	24.4	0.4	0.0	2.9	2.2	0.1	0.1	6.6	4.5	0.4	12.9	4.1	16.4	10.3
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.3	6.6	6.0	13.9	6.7	40.2	10.5	7.8	6.7	11.8	6.7	11.1	10.7	10.2	9.6	15.3	10.3	7.0	8.4	5.9	6.2	9.1	6.4	10.4	22.0	7.2	6.4	9.3	8.4	11.1	5.3	12.4	7.7	7.6	12.7	7.7	11.9	6.3	3.9	17.4	15.4	9.4	5.9	19.0	9.6	9.1	6.9	27.5	8.8	5.0	27.1	7.5	11.2	10.0	27.5	25.4	28.8	51.0	15.1	17.5	15.4	27.7	13.0	25.4	27.8	26.0	31.3	52.0	25.9	18.4	19.4	27.3	29.4	22.6	34.0	45.8	22.5	31.2	40.4	18.3	8.4	60.7	37.4	13.0	18.1	31.0	11.0	11.3	22.0	41.3	26.3	32.6	27.5	27.5	109.1	64.4	36.5	27.4	26.3	79.1	14.6	32.6	15.1	23.3	31.5	34.2	54.8	24.3	17.3	19.6	26.3	23.4	24.1	22.5	15.5	40.7	28.1	27.0	28.5	59.4	24.9	72.6	41.1	69.2	17.9	17.2	24.5	21.7	24.2	25.7	33.3	25.3	17.3	28.8	24.3	28.3	21.7	24.2	34.1	21.1	38.9	15.3	6.0	6.7	7.8	6.7	5.9	6.2	7.2	6.4	7.7	5.9	6.9	10.0	14.1	9.6	8.3	4.2	17.4	15.2	7.0	9.4	6.2	4.8	19.0	13.5	6.2	17.2	7.0	7.3	8.4	20.0	19.3	8.7	3.9	8.1	36.6	10.8	17.9	16.4	10.7	9.7	11.2	7.7	14.6	9.3	8.2	20.1	10.1	22.7	18.2	7.2	10.1	6.7	8.8	11.5	0.0	16.9	23.3	51.0	11.8	12.2	21.4	4.7	20.8	4.4	13.4	4.5	22.4	9.4	5.9	8.2	13.0	5.8	9.1	4.2	4.9	15.4	0.0	8.3	10.9	13.7	25.9	16.1	13.8	5.7	16.7	9.3	15.5	7.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 571.0;eosinophil: 408.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 571.0"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		94000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	16.3	12.1	11.3	26.6	10.9	32.8	16.3	18.6	11.4	12.7	10.0	34.2	54.1	12.7	12.9	27.7	9.2	19.9	14.7	10.8	12.2	8.5	22.0	12.8	43.4	10.8	11.5	8.9	13.4	9.0	8.8	26.1	11.4	11.3	33.9	12.7	13.2	10.6	13.9	16.1	41.8	15.3	11.6	23.0	31.2	9.3	11.3	39.0	10.6	14.1	41.9	24.4	12.0	13.0	31.0	16.7	65.3	31.6	39.4	52.2	37.6	90.2	67.7	61.9	35.4	30.7	25.2	42.4	13.9	44.1	29.2	25.5	52.1	32.1	69.7	109.9	28.7	68.2	12.9	71.4	47.3	55.9	62.3	71.7	38.3	39.3	31.4	44.4	77.6	43.1	57.2	259.8	64.5	13.2	89.1	51.8	65.1	33.7	20.9	63.6	30.8	41.2	52.9	49.3	37.1	40.5	39.1	35.1	52.1	64.3	19.2	35.9	54.1	28.2	25.9	21.1	42.4	118.9	121.6	29.2	34.2	38.5	40.9	571.0	26.1	408.6	32.1	43.3	34.4	26.0	29.5	46.3	33.3	18.6	22.2	32.8	35.6	62.0	71.0	26.5	64.1	47.5	11.3	10.9	18.6	11.4	10.8	12.2	10.8	11.5	11.4	11.6	11.3	13.0	28.6	19.2	15.8	26.4	32.3	48.7	22.2	34.1	35.9	18.6	21.7	17.0	17.5	5.7	36.3	12.9	0.0	46.9	54.8	37.4	13.7	18.4	9.6	24.9	17.1	26.6	18.0	62.3	9.6	23.7	33.6	19.5	24.5	24.9	17.7	24.8	21.0	15.3	23.9	13.5	12.6	37.6	44.7	27.0	17.4	4.0	7.5	33.3	30.2	13.1	41.5	15.4	37.0	11.1	18.4	25.0	18.8	7.5	118.6	20.1	26.6	8.4	30.4	11.3	13.1	19.0	20.8	7.9	16.4	34.6	28.6	51.4	43.8	23.1	24.4	36.7
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969366	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	45.7	21.7	7.0	69.4	7.2	48.5	44.4	7.4	12.4	26.4	8.6	27.6	62.4	18.4	33.1	47.7	34.9	50.1	17.8	7.5	8.0	33.3	54.1	61.3	80.2	9.7	8.1	43.2	52.5	4.7	11.0	70.2	8.7	21.7	30.7	2.0	55.2	15.5	7.5	46.7	58.8	32.2	8.3	71.1	42.4	4.9	9.0	57.2	15.6	18.1	82.1	76.5	30.5	8.7	33.8	9.5	0.0	12.9	58.2	140.4	27.8	68.0	103.2	80.5	117.0	22.4	128.5	22.3	123.1	71.5	110.4	52.7	0.0	94.3	78.8	22.4	0.4	53.1	7.4	55.8	158.2	48.5	19.2	122.6	127.0	97.9	144.4	104.7	143.8	0.5	1.3	0.0	64.4	2.8	26.1	46.7	0.0	71.6	28.2	21.4	21.5	14.2	64.9	46.2	0.6	0.4	60.8	31.6	49.3	0.7	11.9	62.5	93.2	84.4	30.4	80.8	40.5	0.0	0.0	0.3	42.2	105.5	63.4	136.4	292.0	50.6	208.9	312.9	224.8	141.9	155.6	193.9	205.5	144.4	93.4	138.5	667.2	226.2	255.4	35.4	257.9	410.9	7.0	7.2	7.4	12.4	7.5	8.0	9.7	8.1	8.7	8.3	9.0	8.7	78.1	60.9	60.8	0.3	87.4	55.8	63.3	130.1	21.1	0.0	40.8	48.4	5.6	47.1	107.0	22.0	0.0	129.1	80.4	12.4	15.6	157.5	0.6	35.9	27.7	73.0	20.9	12.4	0.0	189.9	103.0	53.6	33.1	45.7	34.8	32.6	82.1	34.7	116.7	0.0	0.2	37.8	73.2	168.0	81.2	2.1	29.2	105.2	30.2	23.4	141.5	1.9	177.1	1.5	0.2	148.5	8.6	20.7	50.5	31.1	85.4	41.1	86.1	0.4	6.6	38.1	34.2	0.2	0.5	25.8	45.9	115.9	102.1	36.8	32.9	80.0
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	6.5	6.7	3.9	8.4	4.0	10.8	10.5	4.3	5.4	7.6	4.0	35.3	40.8	7.7	5.1	7.4	7.6	9.3	5.6	3.8	4.0	11.5	18.1	7.8	9.6	3.7	3.7	8.3	13.3	4.8	4.2	4.8	3.8	9.1	31.5	3.0	8.6	6.5	3.3	10.7	36.8	7.4	3.8	8.0	15.8	1.8	3.7	11.5	8.5	2.4	7.7	8.1	7.0	4.3	26.6	8.4	16.5	14.8	11.0	11.2	24.3	15.3	9.2	12.4	13.4	13.8	50.3	2.7	16.4	14.7	17.3	12.1	19.7	21.8	8.4	43.5	13.0	22.8	7.1	12.9	9.4	23.5	15.7	12.6	15.1	12.4	2.8	17.1	22.9	30.1	29.9	76.1	19.2	13.7	62.0	14.4	12.7	17.1	16.1	20.5	10.8	13.3	39.6	24.8	17.2	13.2	15.0	25.7	8.8	19.6	11.0	8.0	20.3	12.8	14.6	6.6	16.7	11.4	23.0	2.8	17.1	26.9	7.1	16.3	6.9	8.9	6.3	6.9	7.0	6.1	23.8	12.3	8.8	8.6	28.0	16.1	1.4	7.5	11.2	11.6	24.8	9.4	3.9	4.0	4.3	5.4	3.8	4.0	3.7	3.7	3.8	3.8	3.7	4.3	10.5	16.0	14.6	5.2	7.7	10.8	10.2	26.7	12.0	6.9	23.6	16.0	4.1	28.6	23.2	20.2	6.2	20.9	7.6	54.0	9.8	40.8	2.6	19.8	9.5	12.2	59.2	19.7	6.4	46.4	41.1	13.4	18.3	23.3	10.1	112.3	9.7	20.4	19.8	0.0	7.3	53.9	32.6	8.7	9.3	1.7	12.8	14.5	1.8	2.8	17.9	16.0	6.2	5.5	5.8	45.9	52.5	9.8	8.8	7.4	71.7	35.7	18.6	1.3	6.6	7.6	12.3	1.9	8.6	10.8	11.6	5.7	17.5	12.4	74.2	8.0
CASP7	"CMH-1, ICE-LAP3, MCH3"	ENSG00000165806	"Caspase 7"	P55210	10	113679162-113730907	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 229.1;Paneth cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB025563	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025563: "	"prognostic favorable (2.11e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (5.45e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.33e-3)"	21.0	10.3	11.8	26.2	12.2	8.4	18.6	11.5	20.4	18.4	12.8	75.1	65.3	16.3	10.5	15.4	17.9	16.8	11.3	11.8	12.0	19.6	23.6	24.9	16.9	12.3	12.5	16.2	22.4	10.4	7.0	20.9	11.9	21.3	58.2	6.8	34.1	12.3	13.8	17.4	68.1	18.5	11.4	17.5	45.5	6.8	12.8	19.8	10.2	14.5	18.4	31.6	16.1	12.8	28.9	29.4	24.1	13.0	43.4	37.5	16.7	32.9	49.9	56.1	69.7	22.4	51.0	30.1	19.0	29.8	21.1	24.8	30.4	24.2	39.5	46.9	41.0	19.6	22.0	38.0	28.9	20.9	24.7	24.5	15.9	32.0	13.3	25.0	75.4	28.2	5.3	39.8	21.1	38.2	51.1	16.0	4.4	31.7	17.3	51.7	98.0	18.1	44.8	21.4	1.9	14.4	24.9	35.5	17.6	23.1	43.1	18.4	37.8	12.8	24.1	13.5	27.7	30.7	20.1	0.8	13.1	38.7	14.3	22.9	14.7	11.7	11.1	21.3	9.5	11.5	9.2	14.1	10.4	9.2	7.1	9.7	2.6	7.4	18.5	1.4	14.0	9.8	11.8	12.2	11.5	20.4	11.8	12.0	12.3	12.5	11.9	11.4	12.8	12.8	36.3	9.6	12.3	27.4	13.8	19.8	21.2	26.0	13.1	0.6	15.8	9.9	2.5	11.5	26.2	22.0	0.0	12.4	10.3	229.1	11.7	46.1	0.3	21.0	22.9	23.8	9.6	4.0	1.6	39.0	25.5	16.2	30.1	13.5	12.7	10.9	17.2	15.6	17.0	0.0	1.1	81.1	28.5	12.8	6.9	0.6	9.6	18.4	7.2	10.3	68.9	7.9	13.4	1.0	0.8	37.2	113.4	4.1	21.5	42.6	88.0	25.9	42.8	1.7	19.7	12.3	16.3	2.9	28.2	13.3	14.8	10.9	15.7	5.2	50.7	39.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	12.0	50.8	14.1	7.0	14.5	11.5	8.9	16.1	18.8	19.3	13.3	11.8	6.4	14.4	12.5	14.1	22.5	9.4	16.4	14.2	13.0	20.7	14.8	10.8	6.9	14.8	14.2	57.6	37.8	12.0	32.4	7.1	14.1	19.2	5.3	12.3	8.9	9.8	12.7	5.5	11.0	6.6	13.6	10.6	12.4	25.9	14.6	8.7	25.9	9.4	7.9	12.9	12.8	17.1	10.4	17.8	4.6	8.9	11.0	5.4	5.3	7.5	9.9	11.1	12.7	12.5	10.1	13.4	16.2	7.5	13.1	4.2	10.5	8.2	11.7	5.9	11.6	9.8	32.8	10.8	10.8	10.6	11.5	9.7	11.5	15.3	3.8	8.3	8.7	13.3	20.4	13.4	5.8	5.2	3.3	8.6	5.9	11.3	8.2	7.4	13.4	16.4	12.3	6.7	4.4	9.0	9.6	1.8	15.6	12.1	5.7	7.9	4.8	13.8	5.8	15.6	5.1	13.3	21.5	16.3	8.9	9.9	5.0	54.2	24.7	54.8	11.0	17.4	8.2	21.3	6.6	7.6	25.1	30.0	3.1	4.8	36.3	29.3	18.9	11.4	6.9	15.0	14.1	14.5	16.1	18.8	14.2	13.0	14.8	14.2	14.1	13.6	14.6	17.1	2.8	3.2	3.7	18.3	17.1	2.9	8.2	5.0	4.6	3.2	7.0	4.7	9.3	11.5	7.3	18.4	6.2	17.0	8.0	7.0	1.9	7.5	12.6	10.9	5.2	3.3	3.0	5.7	7.9	9.1	10.8	5.6	12.8	7.6	1.3	5.7	4.2	4.7	9.5	5.0	9.9	6.3	6.1	4.8	12.9	5.5	2.1	12.9	0.0	6.5	4.8	7.5	10.3	9.5	8.8	8.4	7.3	3.8	9.9	4.0	9.8	7.2	8.9	6.3	0.0	5.3	9.7	16.4	7.1	6.0	2.4	35.7	6.4	7.9	5.6	7.4
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700021-115768714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1056.7"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 777.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HSkMC: 13.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 43.1"	"Low region specificity"	"Detected in all"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	31.9	3.0	3.5	6.4	2.3	0.0	8.9	2.8	4.0	8.0	2.0	59.8	3.3	17.2	6.5	38.5	14.7	6.6	1056.7	1.8	3.6	3.5	0.6	5.3	0.8	1.9	4.8	5.3	1.2	1.6	0.9	1.6	2.1	13.8	17.0	0.3	7.6	20.2	182.1	4.9	9.1	39.1	1.9	0.8	14.2	1.5	6.4	1.6	4.1	165.0	1.3	43.9	6.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.8	4.0	1.8	3.6	1.9	4.8	2.1	1.9	6.4	1.9	2.7	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.6	0.2	0.1	0.4	777.8	0.0	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	15.5	0.3	0.0	4.8	0.0	0.0	0.7	0.0	0.3	17.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	20.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	1.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	92.1	11.0	73.4	0.1	0.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffold protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.2;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 14.0;Kupffer cells: 8.2;Langerhans cells: 7.1;Macrophages: 12.1;Microglial cells: 29.0;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 23.1;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.5;HEL: 13.7;HMC-1: 38.9;K-562: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB034217	Approved					NA	NA		680000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	1.7	0.9	1.9	9.6	1.9	2.8	0.9	1.6	1.9	1.0	1.7	1.0	1.4	0.5	0.2	0.9	0.6	2.3	0.6	1.6	2.0	0.7	1.7	12.2	3.9	2.6	1.9	1.4	0.4	0.4	0.3	4.5	2.0	0.5	1.0	0.4	0.6	0.4	0.3	0.7	2.1	1.3	1.7	5.6	1.0	0.3	2.0	1.9	0.3	0.5	2.4	2.0	0.4	1.8	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.7	0.2	0.1	0.3	0.2	2.5	0.2	0.1	7.5	0.2	0.2	0.1	0.0	0.5	0.2	0.2	13.7	0.1	0.9	0.2	0.5	38.9	0.8	0.3	0.2	0.0	0.4	0.0	0.2	16.1	0.2	0.5	0.2	0.3	5.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	1.7	0.3	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.1	1.5	0.2	0.7	4.0	23.1	1.3	0.9	2.0	0.1	2.2	2.4	6.9	0.1	4.2	3.8	68.9	2.8	0.1	2.4	1.4	2.6	1.9	1.9	1.6	1.9	1.6	2.0	2.6	1.9	2.0	1.7	2.0	1.8	0.4	0.0	1.1	1.6	0.9	0.1	0.0	0.0	0.6	0.0	0.3	0.3	0.5	0.0	1.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	1.8	1.5	0.0	14.0	0.0	0.4	1.1	2.2	0.0	1.4	0.0	0.0	8.2	7.1	0.1	0.0	12.1	0.0	29.0	6.5	0.0	5.2	1.5	1.0	0.0	0.0	0.0	4.3	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.3	13.1	0.1	0.0	0.0
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 858.4;Early spermatids: 979.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	144.4	68.4	32.3	86.1	36.3	119.1	104.1	35.0	40.8	147.2	55.5	160.1	120.5	83.8	49.0	342.8	79.7	78.7	303.7	30.7	42.2	82.0	116.8	112.1	52.9	46.7	43.2	83.1	56.1	111.7	51.2	116.1	44.4	100.2	148.2	17.1	130.0	78.7	317.3	157.4	137.2	92.2	38.3	64.1	100.5	98.8	39.1	43.1	97.9	166.4	104.3	129.4	216.4	41.7	300.3	239.7	42.6	112.1	240.1	390.1	145.4	220.9	288.8	169.1	215.8	60.4	189.6	44.1	189.8	286.1	263.1	465.6	81.3	283.5	202.8	292.4	78.5	65.9	251.0	71.1	172.9	38.9	100.1	201.8	254.8	239.6	375.0	222.9	194.8	33.5	51.7	144.5	196.4	98.0	17.9	2.0	35.4	85.0	89.9	18.2	141.9	78.3	327.1	114.1	179.6	45.0	222.6	118.2	142.5	94.0	77.4	39.5	263.9	239.0	94.6	154.9	211.4	51.2	140.4	22.1	264.7	21.8	67.5	10.5	156.6	24.1	75.6	85.3	74.1	79.4	68.2	76.9	107.5	79.1	34.8	45.7	38.2	61.6	109.8	28.8	79.2	108.1	32.3	36.3	35.0	40.8	30.7	42.2	46.7	43.2	44.4	38.3	39.1	41.7	251.6	403.8	221.4	58.1	153.8	239.6	439.8	223.6	169.0	39.4	133.6	84.5	858.4	163.0	277.0	108.5	18.8	181.2	227.1	484.0	133.1	263.6	979.7	348.0	213.4	188.5	142.1	229.3	60.2	249.7	96.2	259.0	153.4	327.8	177.1	71.8	138.8	169.3	113.7	13.5	53.0	253.9	103.7	209.4	259.1	414.4	172.1	243.8	131.6	63.7	354.4	36.9	293.6	33.2	70.2	325.1	346.8	146.3	126.3	314.7	302.9	152.3	379.0	19.5	92.1	267.8	175.0	23.6	17.9	348.9	251.7	140.8	207.7	69.8	221.2	548.5
CASTOR1	GATSL3	ENSG00000239282	"Cytosolic arginine sensor for mTORC1 subunit 1"	Q8WTX7	22	30285117-30289622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 48.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.8;Extravillous trophoblasts: 55.4;monocytes: 45.5;Syncytiotrophoblasts: 36.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073183	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA073183: "	"unprognostic (1.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.37e-5)"	"unprognostic (9.28e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.26e-2)"	12.7	6.4	11.5	3.3	11.3	1.5	13.3	9.9	15.8	24.7	10.1	7.3	0.6	9.1	2.5	48.0	11.1	4.3	9.3	10.6	11.0	12.3	7.5	10.9	7.2	11.0	11.8	13.8	5.5	14.5	8.6	11.0	10.4	13.5	0.6	1.2	12.0	11.9	2.7	12.3	5.9	3.3	9.9	9.3	7.8	17.2	11.5	4.8	13.1	3.1	3.4	10.3	35.2	9.9	1.5	5.9	1.8	6.2	6.6	7.3	12.6	0.5	1.5	0.9	1.0	2.1	1.4	0.5	1.9	3.5	9.4	2.9	1.8	2.4	0.1	0.9	1.4	0.4	1.1	1.7	13.5	0.5	4.5	12.9	5.4	3.0	0.5	9.4	6.1	10.8	1.3	5.2	3.5	7.6	3.4	4.0	1.0	6.2	2.8	5.0	3.2	5.0	3.5	2.0	0.4	4.2	1.8	3.8	1.4	5.5	5.8	0.7	4.8	3.6	3.8	2.3	0.4	0.4	0.4	0.3	1.7	2.2	1.3	12.2	7.6	19.5	9.8	5.1	5.9	15.6	12.9	10.4	7.6	16.3	21.4	16.0	3.0	29.2	2.6	8.2	14.8	7.5	11.5	11.3	9.9	15.8	10.6	11.0	11.0	11.8	10.4	9.9	11.5	9.9	13.6	0.0	2.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.0	5.7	0.0	0.0	1.8	7.3	0.0	71.8	2.6	0.0	9.8	6.0	0.0	1.5	1.3	2.4	0.0	0.0	0.0	2.4	55.4	3.1	0.0	4.0	2.5	2.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	45.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	11.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	36.4	1.5	2.6	0.0	0.0
CASTOR2	"GATSL1, GATSL2"	ENSG00000274070	"Cytosolic arginine sensor for mTORC1 subunit 2"	A6NHX0	7	74964705-75031528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.3;skeletal muscle: 48.5;tongue: 26.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 2.1;Glandular and luminal cells: 5.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057229	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"			"HPA057229: AB_2683374"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-5)"	"unprognostic (1.28e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-3)"	1.5	1.9	19.9	0.7	16.8	4.7	1.2	11.3	21.4	1.3	0.0	1.4	1.7	2.1	1.6	1.4	1.8	1.6	3.1	21.9	12.8	1.2	0.7	1.2	0.6	24.4	18.2	3.9	3.2	1.7	1.8	2.0	28.3	1.9	0.6	5.3	2.0	2.4	48.5	2.7	1.4	1.8	11.6	0.8	1.0	2.1	18.6	2.1	0.7	26.2	1.1	0.9	1.4	13.0	2.6	18.9	3.5	12.1	6.7	2.1	7.3	2.4	1.5	0.9	1.2	8.8	1.0	0.7	2.0	4.9	2.4	1.2	4.7	1.7	1.2	2.0	3.1	1.5	8.0	15.5	2.6	0.7	2.5	5.8	0.9	2.8	0.3	1.2	3.1	5.8	2.8	1.0	1.1	8.5	3.6	4.1	6.3	7.1	1.7	7.5	3.0	2.5	8.5	4.2	8.8	5.9	3.2	5.4	0.8	4.9	3.9	0.8	3.9	2.0	4.1	5.5	0.9	1.7	3.7	3.3	1.7	2.8	1.1	1.7	0.2	0.8	0.4	0.2	0.3	0.1	0.2	0.3	0.0	0.2	0.2	0.3	1.8	0.3	0.2	0.2	0.7	0.2	19.9	16.8	11.3	21.4	21.9	12.8	24.4	18.2	28.3	11.6	18.6	13.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	7.4	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9"					"Low region specificity"	"Detected in some"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	2.1	2.0	0.6	2.2	0.8	4.6	7.0	0.1	1.1	5.9	2.4	20.6	12.0	7.8	0.8	15.3	5.6	2.7	20.1	0.2	1.2	7.4	2.7	11.3	1.3	1.0	0.7	0.9	6.0	0.2	2.1	1.7	0.8	18.2	3.3	35.1	19.9	5.8	34.4	49.0	11.6	3.3	2.3	2.2	17.3	1.7	0.9	1.3	3.4	5.8	1.9	10.7	11.6	0.1	12.4	1.0	2.2	2.2	0.0	0.0	0.5	0.4	0.1	0.4	0.4	2.6	2.8	0.5	2.5	0.5	1.0	10.5	2.3	2.4	0.2	13.4	4.1	0.8	2.0	2.8	0.3	1.4	3.8	0.1	8.7	0.1	0.8	0.0	0.4	1.9	0.0	0.0	0.1	6.6	0.7	8.9	0.2	6.4	0.6	1.0	1.5	0.1	2.0	5.0	19.8	1.8	3.2	18.9	0.3	0.8	10.1	1.3	0.1	0.0	1.6	1.0	0.2	0.0	0.0	1.3	0.1	3.8	0.2	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.6	0.8	0.0	0.1	0.6	0.8	0.1	1.1	0.2	1.2	1.0	0.7	0.8	2.3	0.9	0.1	12.9	28.9	21.7	1.6	6.1	33.0	20.1	21.2	30.7	12.7	57.9	30.4	25.2	17.2	17.8	14.7	608.8	0.7	15.3	60.4	3.9	14.1	0.6	41.8	5.6	14.4	41.3	1.3	1.6	8.9	1.2	2.3	57.6	66.7	4.5	4.5	5.0	5.1	1.1	138.0	0.9	39.1	16.2	0.3	5.1	1.6	0.0	1.8	1.8	1.9	6.7	28.4	9.2	0.5	0.3	18.1	40.8	6.8	6.1	33.4	46.3	1.1	41.2	477.7	0.0	6.8	5.1	2.5	3.5	31.0	61.2	0.7	7.6	1.5	27.1	27.6
CAT		ENSG00000121691	Catalase	P04040	11	34438934-34472060	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1217.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	13	"eosinophil: 4736.8"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 4736.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 391.4;THP-1: 321.2;U-937: 265.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		760000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	281.3	115.1	27.1	52.1	29.6	407.7	123.6	27.9	35.5	82.0	39.4	82.6	145.1	53.1	34.8	40.1	86.8	59.8	58.1	26.6	29.4	296.6	1217.3	163.2	58.4	35.2	29.4	46.7	86.3	43.2	13.6	78.0	34.3	66.8	71.3	9.8	83.7	64.0	103.8	70.6	136.3	59.4	29.6	78.6	74.1	11.4	29.5	74.9	122.6	136.6	56.7	105.8	39.9	40.8	31.7	34.3	24.5	38.9	233.2	100.6	52.3	39.3	49.8	43.3	47.1	19.7	30.9	78.3	37.5	79.2	63.9	73.9	42.3	42.9	47.3	68.8	38.8	65.6	34.0	113.7	27.6	391.4	31.1	54.5	29.3	13.2	5.1	59.9	53.2	46.2	139.3	31.3	55.1	30.2	81.1	77.4	0.1	148.7	82.6	56.5	117.9	64.9	120.2	117.2	13.1	19.8	44.5	70.6	60.0	0.0	101.4	321.2	38.3	25.9	24.9	65.4	23.8	25.0	15.2	16.8	51.3	265.6	19.3	256.5	324.7	4736.8	54.4	265.1	64.6	133.9	63.7	61.0	353.5	124.1	61.7	66.7	290.2	105.7	298.5	235.8	92.7	397.9	27.1	29.6	27.9	35.5	26.6	29.4	35.2	29.4	34.3	29.6	29.5	40.8	196.9	227.6	275.9	41.1	53.8	28.9	93.7	44.9	27.9	13.5	42.6	36.1	44.9	82.9	66.9	73.5	27.1	96.8	92.0	59.4	225.0	36.0	2.7	72.2	41.4	43.8	48.0	722.4	12.6	26.2	30.0	53.1	54.6	29.3	24.0	38.7	57.1	443.4	138.5	0.0	1.2	56.9	91.6	125.5	95.8	6.2	78.3	93.9	26.6	16.9	253.4	19.5	28.8	22.6	45.6	15.3	44.8	77.5	25.4	37.0	151.6	333.2	96.9	19.4	78.9	46.6	68.0	6.3	11.3	24.4	27.1	40.5	37.7	57.7	95.6	97.5
CATIP	"C2orf62, MGC50811"	ENSG00000158428	"Ciliogenesis associated TTC17 interacting protein"	Q7Z7H3	2	218356857-218368099	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 20.0;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 11.7;Early spermatids: 13.6;Endometrial ciliated cells: 36.1;Late spermatids: 18.6;Proximal tubular cells: 11.3;Spermatocytes: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"BEWO: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044818	Supported					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA044818: AB_10959301"	"unprognostic (7.11e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.19e-1)"	0.1	0.1	0.9	0.0	0.9	0.1	0.0	0.7	0.5	1.3	6.0	0.0	0.0	0.4	4.9	0.0	20.0	0.3	0.0	0.9	1.4	3.4	0.0	2.2	0.0	2.5	3.4	0.1	1.1	1.8	1.3	0.8	2.0	1.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.2	0.1	7.3	1.2	0.0	3.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.9	0.7	0.5	0.9	1.4	2.5	3.4	2.0	2.5	1.2	1.5	0.1	0.0	0.5	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.7	2.8	0.0	5.5	0.0	2.2	0.0	0.0	11.7	1.4	13.6	36.1	0.4	0.2	0.0	0.0	0.9	0.2	1.3	0.1	1.1	0.8	0.0	0.1	0.7	0.1	1.3	0.0	0.6	0.0	0.0	2.7	0.0	18.6	0.6	1.8	0.0	1.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	11.3	0.7	0.1	0.0	0.2	0.2	10.2	0.1	0.0	0.0	4.7	0.1	0.3	0.0	0.1
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	53	"testis: 11.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 65.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CATSPERD	"MGC39581, TMEM146"	ENSG00000174898	"Cation channel sperm associated auxiliary subunit delta"	Q86XM0	19	5720637-5778734	"Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"HEL: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024056	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA024056: AB_1858093"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"		"unprognostic (3.77e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.74e-2)"		"unprognostic (6.85e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.95e-8)"	"unprognostic (2.54e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.74e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.0	0.1	0.0	2.2	0.7	0.0	0.4	0.2	4.7	0.0	0.0	0.3	0.6	0.5	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	120.2	67.5	0.7	0.5	0.0	0.0	1.3	0.2	0.1	0.4	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	8.2	0.3	0.0	165.8	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	149.9	0.0	0.0	0.5	2.0	18.7	1.2	0.0	1.4	0.3	0.1	0.0	0.0	0.1
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAV2	CAV	ENSG00000105971	"Caveolin 2"	P51636	7	116287380-116508541	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 227.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 887.8;Basal keratinocytes: 484.0;Pancreatic endocrine cells: 447.4;Prostatic glandular cells: 428.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	114	"basophil: 97.0"	"Lineage enriched"	"Detected in single"	399	"granulocytes: 97.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 274.1;HBEC3-KT: 329.8;LHCN-M2: 341.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013488, HPA044810"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB013488: AB_2533493, HPA044810: AB_2679098"	"unprognostic (4.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.09e-3)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.81e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.84e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.34e-3)"	227.4	9.9	8.8	18.7	10.0	0.9	75.6	9.1	13.0	64.2	6.5	41.4	11.3	35.8	23.1	43.6	30.3	72.2	153.0	9.1	8.6	17.1	41.4	161.3	8.8	10.4	9.1	36.2	28.2	5.9	5.9	93.2	10.2	32.0	16.5	16.9	24.5	32.4	23.4	47.6	17.5	42.8	10.1	52.3	19.8	15.6	10.9	9.4	108.4	37.8	7.3	45.0	36.8	10.9	230.3	61.7	2.9	0.6	103.9	111.5	4.9	157.7	184.4	51.9	45.9	11.8	274.1	0.2	181.9	165.7	160.9	217.4	2.9	329.8	72.9	0.6	16.9	2.1	45.6	0.1	64.4	0.4	1.1	66.7	185.1	70.4	143.5	84.1	173.5	0.1	11.8	8.9	341.1	13.1	0.1	0.3	3.0	7.6	41.7	2.6	76.0	3.1	190.1	7.0	0.3	0.2	120.5	4.3	30.1	32.4	0.4	1.6	240.9	0.5	31.6	101.3	52.6	9.7	0.6	0.8	20.8	0.2	111.4	97.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.5	8.8	10.0	9.1	13.0	9.1	8.6	10.4	9.1	10.2	10.1	10.9	10.9	313.9	887.8	89.0	0.3	2.0	484.0	306.6	341.8	121.8	4.8	27.1	65.7	223.9	164.5	207.3	40.5	4.2	15.3	2.1	1.9	35.2	279.1	25.7	5.1	27.6	235.5	1.8	4.0	1.9	100.1	128.2	66.2	2.0	9.8	2.5	9.8	144.2	42.4	4.9	0.0	1.1	12.9	107.8	6.1	48.6	18.2	94.4	5.4	145.9	12.2	2.1	223.3	0.0	5.5	1.0	447.4	1.4	194.1	3.5	428.5	7.9	4.3	48.8	8.0	190.7	44.4	198.9	4.8	1.5	45.4	282.0	12.4	5.9	199.6	4.8	202.5
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402449-42423256	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		440000	"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	397.8	65.3	42.6	69.1	47.2	3.7	295.3	55.8	40.9	239.9	50.6	314.0	30.8	344.3	56.8	101.0	207.5	78.1	220.9	35.4	49.7	66.4	21.0	202.8	30.0	68.8	55.0	162.5	28.4	26.5	34.8	151.3	60.1	181.5	50.7	3.6	84.2	215.4	144.8	161.9	104.1	242.3	53.5	109.0	132.8	22.6	47.2	16.6	112.4	92.7	24.0	255.4	192.3	58.0	315.9	264.8	5.5	69.8	342.3	409.6	6.9	1105.9	477.8	432.2	340.5	134.6	20.1	0.5	216.3	796.6	177.4	509.7	46.8	331.6	351.0	1.1	9.5	137.5	154.8	66.1	215.8	0.3	1.2	283.0	120.5	340.8	115.8	230.2	592.3	0.4	95.5	1.3	187.9	5.0	7.4	1.6	25.8	48.1	1.8	0.6	173.3	0.6	186.1	1.6	0.4	2.0	371.9	6.4	91.7	145.2	29.8	2.0	920.9	912.0	429.5	330.9	407.9	0.8	0.9	1.6	270.7	0.5	104.8	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	42.6	47.2	55.8	40.9	35.4	49.7	68.8	55.0	60.1	53.5	47.2	58.0	575.1	429.5	117.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	55.4	154.9	0.0	0.0	50.8	23.9	0.0	159.8	3.4	0.0	3.9	45.6	0.0	11.7	130.4	217.4	0.0	0.0	0.0	4.4	11.3	114.2	0.0	16.9	63.1	116.3	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.5	0.0	0.0	1.1	3.6	0.0	0.0	0.0	211.7	0.0	0.0	0.0	0.0	77.2	4.5	6.6	0.0	0.0
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CAVIN3	"cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC"	ENSG00000170955	"Caveolae associated protein 3"	Q969G5	11	6318946-6320532	"Predicted intracellular proteins"	"Biological rhythms"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 140.5;Exocrine glandular cells: 252.2;Extravillous trophoblasts: 88.9;Fibroblasts: 88.7;Pancreatic endocrine cells: 219.0;Smooth muscle cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 16.2;myeloid DC: 42.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.8;monocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 120.7;BJ: 111.6;HaCaT: 91.7;TIME: 133.6;U-87 MG: 125.9;WM-115: 137.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055136, HPA073327"	Supported		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA055136: AB_2682711, HPA073327: AB_2686595"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (3.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-2)"	69.3	20.3	5.0	16.4	5.3	0.5	51.7	4.9	7.3	73.5	10.3	69.8	5.8	106.5	1.3	19.2	48.8	1.3	57.9	4.3	4.3	24.9	8.3	37.8	2.5	5.1	4.3	37.0	21.4	1.3	8.1	11.7	5.4	43.6	4.0	0.0	20.3	13.1	17.1	28.3	29.6	22.9	4.9	25.0	37.3	12.1	5.7	1.1	22.6	5.6	1.4	79.3	58.2	4.1	120.7	12.1	0.1	0.4	5.4	24.7	0.0	111.6	45.1	18.5	20.5	0.0	0.1	0.0	36.6	26.1	1.9	91.7	0.0	9.0	3.4	30.1	0.0	0.0	14.0	0.0	14.6	0.0	0.5	16.6	12.4	6.9	9.0	0.0	35.7	0.0	0.0	0.7	19.8	0.0	0.0	0.1	74.6	0.9	2.0	0.0	0.0	0.2	25.6	0.0	0.0	0.1	40.9	0.2	27.0	0.7	0.2	0.5	133.6	0.0	0.4	46.0	0.4	0.2	1.0	0.2	125.9	0.0	137.7	0.0	16.2	0.0	0.0	1.1	0.0	0.0	0.8	0.0	42.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	6.1	5.9	5.0	5.3	4.9	7.3	4.3	4.3	5.1	4.3	5.4	4.9	5.7	4.1	140.5	12.8	6.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.7	36.2	0.0	0.0	8.1	16.5	0.0	3.6	1.0	0.0	39.2	6.0	0.0	6.9	59.7	70.3	0.0	0.0	0.0	252.2	88.9	88.7	0.0	8.0	0.0	2.6	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	30.5	0.0	0.0	0.0	0.0	219.0	0.0	0.0	0.5	0.0	0.0	47.6	10.2	0.0	0.0	0.0	146.0	0.0	0.0	0.0	0.0	8.5	1.6	45.7	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100588389	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 276.1;tongue: 92.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.9;SCLC-21H: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	0.2	0.1	1.6	0.2	2.9	0.1	0.1	2.0	5.6	0.4	0.4	0.4	0.0	0.5	0.1	4.3	0.1	0.3	45.9	1.7	2.5	0.2	0.2	0.4	0.1	2.7	2.7	0.2	0.1	0.0	0.2	0.3	2.7	4.5	0.1	0.3	2.4	0.1	276.1	0.2	0.1	0.3	1.8	0.1	0.3	3.7	2.7	0.4	0.5	92.4	0.1	0.3	0.2	3.5	0.5	0.3	6.1	2.2	1.4	2.0	4.3	1.1	0.9	0.8	1.0	0.0	0.4	0.2	0.3	0.6	2.1	0.3	3.1	0.1	1.7	1.4	2.0	0.1	1.0	0.0	0.4	0.2	0.4	5.0	0.3	0.8	0.5	1.5	1.1	1.5	0.2	0.2	3.9	0.1	1.8	0.3	8.9	1.0	0.7	2.6	5.8	0.0	0.8	0.3	13.2	3.4	0.2	0.2	1.1	4.1	0.1	0.2	1.1	1.5	1.2	1.0	1.0	0.3	1.1	0.6	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	2.0	5.6	1.7	2.5	2.7	2.7	2.7	1.8	2.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.7	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.9	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0
CBFA2T2	"MTGR1, ZMYND3"	ENSG00000078699	"CBFA2/RUNX1 partner transcriptional co-repressor 2"	O43439	20	33490075-33650036	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 128.3;Excitatory neurons: 114.7;Inhibitory neurons: 116.6;Oligodendrocytes: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 45.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060523, HPA072433"	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles"		"HPA060523: AB_2684305, HPA072433: AB_2686520"	"unprognostic (6.51e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.85e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-3)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.12e-2)"	6.4	4.8	11.3	5.8	11.6	5.5	6.6	9.0	13.8	11.8	4.9	11.9	7.5	7.5	5.0	9.2	8.4	4.1	7.6	13.1	11.7	7.5	7.5	8.5	6.6	10.5	9.7	11.6	7.0	9.1	9.7	4.5	11.5	16.8	9.1	15.4	8.2	5.8	9.6	12.1	10.6	5.9	7.5	8.9	8.8	11.1	11.8	8.9	10.7	5.7	6.3	9.5	10.6	17.7	6.8	6.5	9.3	6.8	9.2	7.0	9.5	4.1	4.9	5.5	4.6	13.8	6.3	7.9	8.4	5.7	12.3	9.0	5.4	6.8	4.8	3.3	4.1	10.9	6.5	8.3	5.8	4.5	9.0	5.9	8.9	5.7	7.9	6.8	4.9	8.1	6.2	5.1	4.8	6.1	9.6	7.6	3.2	8.3	7.1	7.5	10.3	8.3	6.3	9.7	30.1	45.1	20.7	8.0	6.7	9.4	7.5	6.9	5.3	13.1	5.9	8.9	5.0	9.3	11.0	4.5	6.7	4.1	4.2	4.2	1.1	1.2	2.1	1.0	1.9	2.7	2.2	2.7	0.5	2.7	1.3	1.8	2.2	1.2	0.7	1.5	1.9	0.7	11.3	11.6	9.0	13.8	13.1	11.7	10.5	9.7	11.5	7.5	11.8	17.7	9.9	12.8	21.7	128.3	17.8	19.1	12.9	9.3	26.2	29.9	15.9	11.3	11.4	7.2	11.1	12.9	45.9	12.8	12.7	17.1	1.9	8.5	12.0	14.4	11.6	11.8	90.4	11.6	114.7	6.4	11.4	14.1	19.4	17.1	1.3	16.3	11.4	8.1	9.4	13.5	116.6	50.1	14.2	11.0	13.7	14.9	14.0	8.4	17.8	59.0	12.1	10.9	17.5	74.4	166.9	9.4	15.6	12.8	19.1	21.8	14.4	5.4	11.4	38.5	13.1	12.5	11.9	24.1	18.1	20.4	15.3	8.9	19.5	7.5	18.9	15.2
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 partner transcriptional co-repressor 3"	O75081	16	88874858-88977207	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;lymphoid tissue: 29.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.8;B-cells: 26.2;dendritic cells: 25.7;Erythroid cells: 21.0;Intestinal goblet cells: 19.2;Langerhans cells: 23.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 35.8"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 64.2;K-562: 114.9;MCF7: 52.3;MOLT-4: 58.0;NB-4: 70.1;REH: 113.6;T-47d: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	9.2	2.3	3.6	6.8	4.7	7.7	7.7	35.8	8.4	3.9	0.0	4.9	3.2	5.0	0.7	2.4	3.7	1.7	17.0	5.7	0.0	1.2	4.3	11.3	8.8	0.6	0.9	1.0	27.3	0.7	4.2	3.1	1.7	6.4	1.0	0.8	4.8	0.8	14.0	3.5	10.8	1.1	0.0	18.5	3.7	4.6	0.0	29.5	3.9	3.2	5.1	3.5	3.8	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	3.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.1	64.2	0.0	0.0	0.1	17.2	30.6	0.0	0.0	0.0	0.0	0.1	0.0	30.2	114.9	0.5	0.0	52.3	58.0	70.1	1.2	0.0	0.0	113.6	0.8	11.4	0.0	0.0	21.3	4.8	2.5	0.5	0.4	0.3	50.1	17.9	0.4	0.0	0.4	0.3	0.0	0.4	0.5	37.9	0.0	19.8	0.0	1.0	2.5	2.7	0.0	2.8	0.0	3.1	0.0	0.0	6.6	1.7	0.0	0.0	3.4	0.0	4.8	10.6	0.0	1.8	3.6	4.7	35.8	8.4	5.7	0.0	0.6	0.9	1.7	0.0	0.0	0.8	24.8	0.0	1.1	0.3	26.2	2.5	6.2	1.9	0.6	10.8	1.1	0.9	3.3	1.5	2.4	0.0	0.0	0.1	25.7	0.8	0.0	0.3	0.0	0.6	0.6	9.1	3.6	21.0	5.9	2.9	0.2	2.7	2.0	0.5	6.3	0.1	2.2	10.8	3.0	0.0	2.1	19.2	0.0	5.0	23.3	0.3	2.1	9.8	0.0	9.4	14.8	0.2	0.0	2.0	0.6	0.9	0.5	0.7	14.4	2.9	1.7	0.6	0.5	1.4	19.7	10.8	15.6	0.2	4.8	1.7	2.3	0.3	1.3	3.3	1.0	3.8
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor subunit beta"	Q13951	16	67028984-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 243.7;U-698: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	18.2	11.7	5.7	17.3	12.0	11.8	16.5	9.3	7.3	19.2	6.0	11.4	5.5	15.4	2.7	23.3	16.6	5.2	18.0	7.1	8.1	16.4	14.2	18.1	16.3	13.9	9.3	17.3	14.7	9.8	15.0	7.3	11.5	14.5	3.5	3.8	21.3	4.8	38.6	17.4	14.5	4.9	8.6	18.0	15.1	6.9	9.5	13.4	15.9	10.5	12.1	15.2	20.3	17.2	54.8	43.7	14.8	40.6	8.7	12.2	54.0	76.1	23.6	43.6	30.0	79.1	51.0	106.3	81.2	39.7	16.3	53.7	30.7	22.6	29.2	63.3	48.3	67.2	27.3	38.0	17.8	77.7	171.3	18.2	11.1	51.3	30.4	10.2	25.4	42.2	104.9	28.9	20.8	44.5	115.8	28.9	25.5	16.4	74.1	243.7	92.7	73.4	15.5	43.2	37.9	31.5	166.2	11.0	37.6	10.4	15.4	28.6	87.1	70.8	70.2	34.6	79.6	76.8	147.8	336.8	50.2	50.7	65.0	29.2	7.6	6.3	6.0	9.5	6.5	6.2	5.5	6.4	10.2	7.2	5.0	3.9	4.1	18.2	5.6	2.3	6.0	5.6	5.7	12.0	9.3	7.3	7.1	8.1	13.9	9.3	11.5	8.6	9.5	17.2	20.1	9.6	20.2	37.2	38.2	56.2	42.2	18.0	27.9	5.8	27.8	14.7	19.8	21.5	18.8	40.5	12.5	15.8	30.0	11.9	27.4	17.6	6.1	23.8	16.0	26.1	19.0	18.5	11.5	28.0	32.1	28.7	16.8	29.8	27.8	34.2	28.5	15.8	37.9	10.1	16.5	12.8	22.4	41.9	66.8	7.6	23.9	39.1	51.6	53.4	25.0	13.2	44.3	97.5	99.8	74.1	6.8	21.1	38.3	50.5	6.9	11.6	20.8	15.3	13.1	21.6	21.0	17.4	19.1	32.2	63.1	17.0	48.6	11.2	11.8	62.0
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206298-119313926	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Approved	Cytosol		NA	NA		67000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	6.8	4.0	5.6	9.5	5.7	8.5	5.6	5.3	6.5	5.0	0.2	6.2	3.9	6.5	3.4	5.6	5.6	3.9	4.1	5.3	8.1	4.4	2.7	7.9	10.7	5.8	6.3	3.7	3.8	6.1	2.9	6.4	6.5	4.0	5.0	8.3	3.6	4.6	2.5	5.2	6.6	7.4	5.2	9.9	5.2	18.2	7.9	22.5	4.1	3.2	11.2	5.8	4.9	6.0	10.7	7.6	26.6	16.7	7.8	9.2	16.0	11.2	11.4	10.8	10.2	16.7	12.6	25.1	10.0	14.0	21.7	15.2	18.4	9.4	22.7	14.8	4.7	26.4	6.2	5.1	9.5	30.3	27.9	8.1	10.1	26.7	28.4	11.1	26.3	23.7	21.7	9.9	19.1	11.3	16.2	17.0	14.0	9.2	8.8	17.5	13.5	4.6	9.3	8.2	3.7	11.3	20.9	8.8	7.3	18.1	9.4	24.8	22.8	16.0	11.5	11.6	14.7	3.3	5.3	19.9	6.7	25.4	11.9	0.8	2.4	2.0	0.9	2.8	0.8	1.5	1.1	0.9	2.6	1.2	1.2	1.3	8.6	0.4	2.5	1.4	1.0	0.9	5.6	5.7	5.3	6.5	5.3	8.1	5.8	6.3	6.5	5.2	7.9	6.0	23.2	9.6	8.3	23.5	23.2	18.0	5.9	7.5	19.4	14.0	13.6	11.7	8.8	5.7	6.0	11.0	45.9	6.3	24.0	7.6	1.9	6.1	28.2	9.9	19.6	23.2	8.4	5.7	38.5	6.7	10.5	9.4	9.2	16.8	3.8	20.8	20.0	3.1	16.0	13.5	39.1	4.9	2.0	59.1	43.2	42.0	7.8	41.2	16.0	45.0	46.8	13.2	22.6	26.2	19.6	10.6	11.6	12.8	19.7	8.0	5.1	5.4	4.8	33.3	26.3	11.6	22.7	38.0	36.2	18.5	21.9	7.0	24.9	10.6	5.1	10.9
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800652	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.3;intestine: 50.9;skin 1: 42.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 108.6;Pancreatic endocrine cells: 95.0;Paneth cells: 108.1;Proximal enterocytes: 154.6;Undifferentiated cells: 67.1;Urothelial cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.6;BEWO: 28.9;CACO-2: 28.3;CAPAN-2: 56.9;HaCaT: 41.0;HBEC3-KT: 34.8;hTCEpi: 26.0;OE19: 37.3;RT4: 34.7;SK-BR-3: 31.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.1	0.0	3.1	0.0	0.0	5.1	0.0	0.1	8.0	0.0	25.0	50.9	0.9	0.1	39.3	2.5	4.4	0.0	0.0	0.0	7.4	21.1	1.3	0.0	0.0	0.0	0.1	20.6	1.6	0.5	0.4	0.0	11.8	11.7	0.1	13.3	2.4	0.1	42.4	38.6	0.6	0.0	0.0	17.7	0.7	0.0	0.3	1.7	0.0	4.0	8.3	18.4	0.0	43.6	0.0	0.0	0.1	0.0	0.0	28.9	0.0	0.0	0.0	0.0	28.3	56.9	0.0	0.0	0.0	0.0	41.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.3	0.0	0.0	0.0	0.0	0.0	34.7	0.4	0.1	0.0	31.1	0.0	0.2	22.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	15.0	44.0	30.8	16.5	0.0	9.3	7.4	0.2	4.3	27.7	7.3	0.0	5.8	0.2	108.6	1.9	53.8	0.1	7.0	1.3	0.9	17.4	0.0	0.4	48.9	2.3	0.5	59.7	15.5	0.0	0.0	0.0	11.1	0.3	0.0	0.9	40.0	18.3	0.0	1.4	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.0	0.3	95.0	108.1	0.0	0.1	34.4	154.6	17.2	9.8	0.0	0.0	0.0	1.3	0.0	2.6	29.9	25.7	2.5	0.7	0.0	67.1	76.9
CBLIF	"GIF, IF, IFMH, INF, TCN3"	ENSG00000134812	"Cobalamin binding intrinsic factor"	P27352	11	59829273-59845499	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1859	"stomach 1: 1575.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"stomach cancer: 10.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039908, HPA040774"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 4: Stomach - Digestion"					"HPA039908: AB_10796335, HPA040774: AB_10795626"			"unprognostic (2.78e-4)"								"unprognostic (1.04e-1)"		"unprognostic (2.45e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.66e-1)"			0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1575.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743949-107761667	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	11.2	8.1	3.1	12.5	5.3	40.0	15.1	7.8	9.5	12.0	3.0	11.3	9.5	13.5	8.4	11.3	11.2	8.7	10.4	4.2	5.8	10.0	11.2	10.3	16.1	4.1	3.7	14.3	11.7	14.1	5.1	12.0	4.1	16.5	11.1	14.4	8.9	12.7	29.0	10.7	10.3	13.4	3.0	14.2	9.2	19.7	3.7	20.2	13.8	21.0	17.8	11.9	7.2	6.6	27.8	31.1	23.7	30.7	21.7	18.6	16.2	20.5	21.6	22.8	22.5	21.4	27.9	40.6	28.5	23.5	37.6	19.3	33.4	25.0	31.0	28.4	21.1	32.5	23.0	18.2	24.9	49.1	30.9	19.6	22.7	30.7	33.0	17.6	23.8	27.8	53.0	33.3	22.4	48.0	66.5	34.4	34.4	23.3	21.3	30.6	25.4	42.0	17.4	25.5	25.4	39.6	30.7	44.9	23.4	27.7	15.1	24.7	23.4	35.0	25.0	33.4	32.0	53.0	62.3	64.1	21.3	29.8	30.3	88.8	31.1	53.3	39.5	32.0	58.2	39.0	61.9	45.8	36.9	39.8	41.8	40.0	48.9	55.1	38.0	20.1	92.6	48.4	3.1	5.3	7.8	9.5	4.2	5.8	4.1	3.7	4.1	3.0	3.7	6.6	18.2	19.2	11.0	6.5	29.6	23.6	16.7	10.5	27.3	12.2	15.9	13.7	16.4	17.2	10.7	3.7	4.2	10.3	27.6	9.9	7.9	9.7	12.4	15.6	19.8	13.5	16.8	39.1	13.9	10.8	9.5	12.6	10.7	13.7	13.3	16.6	12.5	11.0	10.7	10.1	13.1	8.0	8.2	23.3	12.4	5.4	9.3	15.1	19.6	15.9	15.0	7.6	25.7	10.1	20.5	10.1	15.0	11.7	17.3	16.2	8.5	11.2	8.9	14.4	19.7	13.2	14.5	27.2	14.3	19.5	19.9	10.3	27.3	9.5	10.0	18.4
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426545-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.0;Theca cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	11	"cerebellum: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8"	"Region enriched"	"Detected in many"	25	"cerebellum: 429.5"	"Region enriched"	"Detected in many"	42	"cerebellum: 446.5"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	7.3	17.1	2.7	8.3	3.0	0.6	4.7	93.9	7.0	4.6	2.1	4.2	2.1	2.7	7.4	2.9	4.0	5.6	3.7	2.4	3.3	4.4	6.0	4.8	13.7	3.9	5.8	10.1	2.0	2.9	4.2	3.7	8.4	4.5	2.1	0.5	4.3	3.1	1.8	3.5	5.4	2.2	3.2	13.7	3.3	5.1	3.4	3.9	4.5	0.6	9.1	4.9	4.6	4.8	1.5	1.3	0.7	2.5	6.2	13.4	0.4	5.5	11.1	2.1	2.7	0.7	2.6	2.4	1.2	3.4	2.4	0.3	0.8	2.9	1.4	17.2	0.6	0.0	5.2	1.1	3.3	0.4	0.9	23.3	1.3	2.7	2.1	8.8	1.9	1.0	0.7	18.3	2.8	0.8	0.0	0.7	0.1	1.5	1.5	0.0	0.0	1.8	1.2	0.5	0.9	0.5	0.5	0.1	0.8	0.3	0.8	0.6	8.7	7.7	1.5	3.2	0.3	12.8	3.2	2.7	0.4	1.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	93.9	7.0	2.4	3.3	3.9	5.8	8.4	3.2	3.4	4.8	1.4	0.0	0.0	0.0	2.6	0.4	0.6	1.5	0.0	0.0	0.8	1.0	0.5	0.0	0.4	0.0	0.0	0.9	3.0	0.8	0.0	1.1	0.0	0.3	2.0	0.8	0.0	0.4	0.3	1.1	0.6	2.6	0.0	0.5	0.0	0.9	0.0	0.2	0.9	0.0	0.1	0.5	0.0	0.3	0.4	0.3	2.5	0.7	0.0	1.0	2.6	1.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	0.5	0.9	0.8	1.4	0.2	0.0	0.7	1.4	0.0	0.2	0.2	0.6	0.8	0.2	5.7	0.6	0.6
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 583.9"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 524.2;Distal tubular cells: 757.2;Proximal enterocytes: 1270.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 45: Intestine - Brush border"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	32.4	95.3	150.0	25.6	200.0	10.1	29.5	186.1	174.1	52.7	207.0	68.6	583.9	41.3	50.5	189.5	34.6	47.1	29.5	154.6	166.7	125.6	252.8	41.1	28.3	173.1	175.1	28.8	36.1	38.6	35.3	27.6	175.6	48.7	50.9	10.2	101.8	42.2	33.6	111.8	345.9	34.4	166.2	39.9	133.5	18.1	180.3	22.7	46.4	23.3	36.7	51.0	85.3	266.6	114.4	180.4	22.6	55.9	115.0	115.3	1.2	123.6	97.0	72.4	86.4	68.9	67.8	28.2	78.7	128.1	137.3	84.6	46.3	132.3	55.7	133.8	95.3	82.5	105.1	48.1	65.7	49.1	77.5	56.1	165.6	70.7	30.8	83.0	78.4	0.0	0.0	21.3	67.6	121.2	24.7	50.7	0.4	0.0	123.3	0.4	0.4	80.5	195.7	60.9	60.5	52.1	121.3	186.3	157.3	17.6	86.1	69.4	71.1	78.8	30.8	202.9	96.1	131.8	268.9	0.7	144.0	48.6	115.6	7.1	134.0	68.6	64.4	198.5	54.6	67.2	79.7	60.8	109.6	61.2	102.6	75.4	9.2	77.3	156.9	39.6	89.0	162.1	150.0	200.0	186.1	174.1	154.6	166.7	173.1	175.1	175.6	166.2	180.3	266.6	26.4	121.8	69.3	17.9	22.5	128.2	63.1	295.2	524.2	11.6	27.7	98.8	20.9	77.2	117.1	95.6	2.1	116.6	15.7	91.2	757.2	93.7	8.9	31.7	45.5	23.1	38.6	32.0	6.5	70.0	80.4	65.7	127.4	45.1	34.9	30.8	41.7	277.2	85.1	3.3	6.8	94.4	396.7	66.6	27.5	4.3	122.7	49.5	90.7	4.7	79.2	69.8	23.7	16.6	128.2	91.8	146.6	132.4	41.3	66.4	1270.3	326.0	121.2	8.3	26.3	51.3	90.7	5.8	17.4	403.5	123.6	89.2	30.7	55.6	145.8	55.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36135079-36146562	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.3;salivary gland: 41.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 64.9"	"Region enhanced"	"Detected in all"		"basal ganglia: 48.6"	"Low region specificity"	"Detected in many"			HPA018434	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	17.3	2.3	12.8	4.0	14.7	1.4	15.3	13.9	19.8	12.4	11.2	7.8	3.0	7.5	11.0	56.3	8.8	6.5	6.1	13.2	12.4	2.7	0.8	4.6	2.9	12.8	12.1	11.2	1.6	0.6	2.4	2.9	12.3	9.9	3.6	0.6	41.4	5.1	3.1	21.6	5.4	6.1	12.0	3.1	5.2	3.1	12.2	2.0	4.6	7.8	7.6	11.6	16.8	12.4	33.5	9.5	4.0	8.2	31.0	47.8	5.9	35.4	42.4	40.6	32.1	0.4	6.9	0.0	10.2	37.2	13.7	15.0	5.5	7.2	16.2	45.3	17.2	1.4	10.0	0.3	2.6	0.1	0.1	6.8	0.8	28.1	3.6	19.1	24.9	3.7	0.0	0.3	12.1	25.4	3.1	14.7	3.2	10.3	41.5	6.7	7.6	64.9	13.7	14.2	2.1	2.9	27.3	32.6	53.3	2.2	9.8	3.9	17.1	25.7	2.2	28.8	35.0	1.5	0.6	0.0	26.9	0.9	47.3	0.0	0.6	0.1	2.2	0.5	3.0	23.6	25.1	7.7	2.4	23.9	33.7	23.5	0.9	11.5	1.0	0.7	10.9	11.5	12.8	14.7	13.9	19.8	13.2	12.4	12.8	12.1	12.3	12.0	12.2	12.4	41.7	0.0	3.2	6.8	5.2	71.0	22.1	102.5	107.0	0.8	23.1	38.6	0.2	2.8	23.0	0.0	0.0	1.2	2.9	1.9	9.8	4.7	0.7	13.1	7.5	26.5	0.0	1.7	3.9	0.7	0.3	53.4	7.7	14.7	5.7	1.1	14.3	0.3	8.4	0.0	5.5	12.6	69.2	3.8	41.3	4.0	67.7	5.8	65.8	2.8	20.9	1.9	0.0	1.5	0.5	2.6	1.7	75.6	1.4	43.4	1.3	0.2	13.1	0.6	0.0	21.4	19.7	0.4	0.2	230.4	46.7	0.3	7.0	1.0	8.1	21.1
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		51000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.1	14.1	11.2	7.9	13.1	6.7	14.1	13.1	14.4	9.4	12.4	12.1	12.8	9.9	20.1	8.3	9.3	8.1	17.8	11.1	12.4	27.3	49.6	7.3	11.0	12.8	12.3	11.0	10.0	11.7	9.9	8.1	13.4	11.7	13.9	17.5	13.2	11.2	17.3	15.7	11.8	8.8	11.7	9.4	10.8	7.5	12.7	9.7	15.6	15.9	11.5	8.4	8.4	15.9	9.0	6.6	20.2	12.8	17.2	20.3	4.1	6.3	8.6	7.5	6.9	7.9	9.3	18.3	3.4	4.9	7.0	9.4	18.8	20.1	8.2	7.0	9.3	32.3	16.9	10.7	10.3	12.9	10.9	13.4	17.1	5.4	9.1	17.8	22.4	15.3	17.8	14.4	12.0	4.6	13.5	21.0	7.3	6.2	10.0	11.6	7.1	8.0	26.5	9.4	17.9	13.4	7.7	10.9	16.7	16.7	11.7	8.2	13.4	7.8	4.2	8.8	6.4	14.2	10.2	8.8	13.6	15.6	4.9	7.9	4.0	6.4	6.6	3.6	3.9	5.7	4.5	6.4	3.5	7.5	4.9	6.4	3.0	5.8	5.3	4.8	4.0	2.1	11.2	13.1	13.1	14.4	11.1	12.4	12.8	12.3	13.4	11.7	12.7	15.9	16.1	0.0	9.4	86.2	24.2	23.1	32.2	27.7	10.8	37.3	20.7	12.1	30.0	28.6	19.9	49.7	39.6	40.6	19.8	24.2	50.9	66.5	16.1	22.5	17.5	20.5	29.3	34.9	68.0	42.9	27.5	17.8	16.8	15.8	2.5	36.0	24.7	81.6	24.9	62.2	82.3	26.5	34.6	26.6	8.9	34.6	44.4	16.8	35.6	61.8	26.1	28.3	46.4	150.3	135.8	37.6	39.8	31.2	8.7	24.6	31.7	93.4	19.8	51.3	59.2	18.5	16.3	56.6	41.6	15.3	20.2	20.2	15.9	38.3	27.4	29.6
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4"	"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	6.6	2.8	42.5	1.0	39.5	0.2	3.4	58.5	55.3	12.3	29.3	4.8	3.0	4.5	0.0	2.0	5.8	1.2	7.7	41.4	40.3	3.8	174.9	10.2	2.7	42.5	44.6	30.3	99.0	2.5	8.8	1.2	42.7	12.7	0.9	2.5	19.9	1.1	1.1	2.3	7.0	2.3	38.4	1.7	16.5	2.0	48.1	0.7	17.4	1.2	1.4	11.6	6.2	45.4	30.0	17.0	31.3	113.4	48.9	31.5	177.5	39.5	10.0	15.6	15.4	53.7	1.5	0.1	19.2	67.2	0.3	1.5	172.8	13.2	3.1	0.0	20.5	12.3	73.1	63.8	224.1	7.9	19.1	21.7	1.4	16.0	16.4	13.2	38.6	85.6	138.7	118.1	11.1	197.7	16.1	0.1	20.3	65.7	29.4	0.0	0.2	197.4	0.5	15.5	57.8	85.1	78.5	5.4	44.4	18.4	27.0	91.2	5.4	0.8	42.5	0.3	4.8	34.8	30.2	41.2	19.0	11.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	42.5	39.5	58.5	55.3	41.4	40.3	42.5	44.6	42.7	38.4	48.1	45.4	0.2	0.0	0.5	0.7	0.0	0.4	0.0	2.3	0.0	0.2	0.5	0.1	4.9	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.8	1.2	0.0	0.1	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.9	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.6	0.0	1.0	0.1	0.1	0.0	0.2	0.1
CBSL		ENSG00000274276	"Cystathionine beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 88.1;pancreas: 48.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	14	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 105.1;NTERA-2: 246.2;U-266/70: 75.7"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA		510000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	3.8	1.2	0.9	0.8	0.8	0.1	1.7	1.6	1.3	7.5	0.3	2.3	2.0	1.8	1.4	1.0	5.6	1.0	4.4	0.6	0.9	1.6	88.1	4.8	0.1	1.3	1.6	14.7	48.5	2.2	4.4	0.8	1.1	6.1	0.0	1.1	4.6	8.9	0.6	1.2	3.7	0.0	0.6	1.2	8.2	1.0	1.6	0.2	12.3	0.0	0.4	5.0	3.1	1.3	0.1	0.0	36.3	105.1	0.0	0.0	1.4	23.3	15.2	8.9	29.3	0.2	18.2	0.0	0.1	0.0	17.1	12.1	0.2	13.5	5.6	0.0	35.4	0.0	0.0	0.0	1.0	0.0	16.1	12.8	51.5	0.1	23.1	0.0	0.2	0.8	0.7	41.5	0.3	0.0	18.9	2.6	246.2	0.5	0.0	0.3	0.0	0.3	40.5	0.0	38.7	58.5	0.0	3.4	44.9	0.0	0.1	0.1	0.0	2.7	0.0	17.3	4.4	75.7	29.6	0.3	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.6	1.3	0.6	0.9	1.3	1.6	1.1	0.6	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 185.1"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	18.6	34.4	8.7	15.3	9.2	13.0	19.9	10.6	11.1	14.3	13.0	16.9	13.3	13.7	20.8	26.8	14.6	10.6	20.7	9.0	10.2	40.1	26.8	16.1	13.4	9.0	9.0	15.4	30.0	38.3	19.4	22.2	9.2	19.9	15.2	27.5	23.7	12.2	21.8	22.3	14.1	12.2	9.0	16.9	19.1	16.4	9.1	13.2	25.4	17.6	20.1	23.4	17.1	9.9	43.3	16.1	22.7	12.2	29.1	26.2	50.3	22.2	14.6	30.4	23.0	23.4	16.1	39.4	28.3	8.2	18.4	7.3	11.3	21.1	32.4	67.8	38.9	0.4	39.1	72.6	31.5	115.1	17.2	23.5	9.9	7.3	59.0	19.5	32.9	19.7	13.6	84.3	25.2	52.1	25.1	185.1	22.9	37.6	34.6	47.7	34.6	75.8	39.4	120.7	40.8	24.8	45.8	16.8	17.8	55.5	35.6	109.2	34.4	16.0	22.9	20.8	19.7	10.1	14.6	44.6	39.6	60.6	19.2	3.6	65.7	19.3	10.3	75.6	16.9	21.1	18.6	16.8	74.1	15.7	16.2	17.7	10.2	12.8	60.8	19.6	18.1	48.3	8.7	9.2	10.6	11.1	9.0	10.2	9.0	9.0	9.2	9.0	9.1	9.9	19.5	54.5	50.1	8.1	41.2	47.7	29.9	47.6	97.9	50.8	49.4	37.6	51.8	30.0	49.8	35.0	108.4	96.3	17.7	20.4	35.2	79.9	51.7	14.9	10.1	23.0	31.2	44.6	17.0	118.5	41.2	23.0	34.7	11.9	32.8	26.7	20.7	19.0	32.0	38.7	17.1	39.0	50.8	25.1	38.0	16.4	18.0	37.9	32.0	18.7	81.5	32.2	18.6	5.5	16.7	66.9	38.2	13.2	90.0	32.0	49.5	73.6	31.0	63.5	32.9	20.2	27.8	48.6	28.1	83.8	50.6	124.8	23.5	24.1	62.3	24.9
CBWD2		ENSG00000136682	"COBW domain containing 2"	Q8IUF1	2	113437691-113496204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 110.3;Suprabasal keratinocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (7.69e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (7.57e-3)"	4.7	8.3	5.8	5.3	6.3	1.5	7.0	7.0	7.2	8.2	7.1	8.4	2.2	7.0	7.1	9.4	4.5	4.5	15.9	6.3	6.7	13.8	10.5	4.0	3.2	6.0	6.2	5.4	5.6	16.2	8.8	5.9	6.1	6.4	5.9	6.3	8.1	7.4	26.0	4.3	4.6	8.1	5.5	4.9	6.5	2.0	6.0	6.8	9.6	23.9	4.6	8.7	5.4	6.4	16.1	9.7	9.8	11.2	25.7	11.8	19.2	11.9	7.4	9.1	12.0	16.0	9.6	20.7	36.2	12.8	42.1	13.2	10.8	13.2	12.0	7.5	28.9	17.4	16.8	29.8	8.6	8.1	7.8	11.1	8.1	13.4	8.1	17.7	17.1	11.1	10.1	22.2	13.4	17.1	23.3	24.2	11.9	30.2	20.7	10.9	26.6	54.6	24.6	25.1	28.0	8.0	31.4	4.6	5.1	33.7	14.5	21.6	20.8	7.7	10.7	4.8	11.9	8.5	38.2	10.5	12.8	44.5	19.3	15.6	67.7	35.6	12.1	68.4	13.2	17.9	18.2	14.3	65.3	22.7	15.3	14.1	18.5	20.2	56.2	16.2	27.0	52.9	5.8	6.3	7.0	7.2	6.3	6.7	6.0	6.2	6.1	5.5	6.0	6.4	5.6	9.6	20.5	11.8	32.5	110.3	12.8	24.5	62.6	10.5	15.9	14.9	49.6	18.6	20.0	14.7	16.7	17.6	7.1	7.2	39.2	29.6	18.6	10.3	7.1	11.9	2.4	23.7	27.3	14.3	13.2	16.4	23.0	11.1	15.8	9.5	6.1	11.4	9.0	13.5	25.8	11.4	16.2	9.4	62.5	18.4	10.8	20.0	26.6	21.5	53.8	10.9	2.1	15.6	24.9	12.7	14.1	17.3	78.7	14.9	13.7	33.9	26.4	14.0	0.0	9.6	17.1	21.7	13.6	61.0	120.0	25.9	18.4	11.6	17.3	12.2
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300035	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	12.2	19.4	7.5	18.8	7.5	13.5	17.3	9.8	9.5	9.8	5.3	14.0	13.0	9.9	7.3	17.2	9.7	6.6	13.0	8.1	8.9	21.2	28.4	10.2	16.9	8.4	7.7	12.0	27.2	8.6	18.4	15.6	8.8	10.5	9.8	18.0	13.5	10.2	17.5	13.1	20.6	8.9	4.4	12.7	17.5	12.3	6.9	12.7	14.3	13.3	13.0	18.8	12.2	10.6	73.0	52.6	25.1	41.2	18.9	6.7	34.3	35.6	14.1	15.2	17.4	15.0	69.4	84.1	33.9	26.1	67.5	86.7	48.0	70.5	39.8	128.2	31.0	31.9	137.8	73.6	24.8	60.9	38.3	15.6	21.3	27.0	35.3	30.5	35.6	93.1	60.4	66.1	22.3	47.4	71.8	81.9	38.5	86.4	88.7	32.6	78.7	94.0	17.3	32.8	40.3	25.7	58.0	36.2	46.3	46.6	26.7	71.5	16.6	22.6	58.1	38.4	70.1	38.3	165.4	102.3	68.8	92.3	41.6	29.8	86.1	66.2	27.8	71.5	24.0	52.5	25.2	28.7	62.0	52.3	27.6	25.5	86.5	16.1	52.0	46.5	37.9	59.8	7.5	7.5	9.8	9.5	8.1	8.9	8.4	7.7	8.8	4.4	6.9	10.6	4.3	25.6	30.0	2.0	15.9	14.5	16.2	6.0	12.0	25.2	14.5	9.7	28.7	7.2	21.0	11.0	29.2	13.2	5.6	9.7	1.9	7.1	4.7	4.0	2.4	9.0	4.2	5.2	10.8	11.6	7.9	8.9	8.6	3.8	12.6	12.4	6.1	8.2	5.0	11.8	8.9	9.1	2.0	11.0	10.1	2.4	5.0	6.8	5.4	6.5	19.7	5.9	8.2	10.1	5.6	8.8	17.4	3.0	20.3	12.6	28.9	7.1	24.1	36.2	6.6	5.3	6.3	16.7	7.8	7.3	21.5	15.5	10.6	7.6	10.7	12.9
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 178.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	9.8	15.2	20.7	8.4	21.1	7.0	17.0	21.7	25.8	11.2	20.6	11.4	11.0	6.5	9.0	15.5	10.9	5.2	12.5	21.1	22.3	26.0	41.9	9.6	6.6	21.1	21.3	10.6	19.4	7.8	16.8	6.7	21.5	17.4	10.5	8.7	9.6	7.7	8.4	11.0	13.9	5.9	20.7	21.2	11.4	11.4	21.0	4.6	15.6	4.2	9.7	12.7	9.8	21.8	37.7	40.1	14.0	17.3	20.8	9.5	16.4	26.0	17.6	20.2	20.6	5.2	33.6	51.2	16.2	15.3	29.1	27.2	64.1	21.3	38.2	8.4	15.4	14.4	69.3	91.0	16.2	32.8	8.9	16.9	23.9	18.7	14.8	25.0	37.3	19.4	20.5	36.9	21.1	45.8	16.4	34.2	16.3	64.4	42.4	28.1	19.2	49.9	32.4	23.9	18.1	18.3	21.2	16.1	8.0	24.5	76.4	21.3	10.6	9.1	33.6	27.7	30.2	12.0	34.8	11.8	37.4	35.9	35.3	1.7	11.8	8.8	3.2	15.0	3.7	5.3	5.3	4.6	12.4	3.0	4.8	4.0	7.8	2.8	9.8	5.2	4.4	10.6	20.7	21.1	21.7	25.8	21.1	22.3	21.1	21.3	21.5	20.7	21.0	21.8	17.8	41.7	51.8	13.4	58.4	65.1	31.8	24.6	178.7	37.7	59.4	36.7	33.6	25.8	38.5	20.2	68.8	44.0	10.6	33.2	21.5	33.1	10.5	17.4	8.4	22.8	16.8	25.9	60.6	39.0	23.0	20.1	49.5	15.4	10.1	16.3	16.4	48.0	15.9	35.3	60.8	32.6	12.2	25.1	36.6	4.6	21.1	27.5	30.2	20.6	45.2	13.5	7.2	37.2	32.2	33.7	51.1	17.3	143.5	32.3	76.9	42.7	27.8	62.4	6.6	10.4	18.8	35.2	25.5	119.4	85.5	50.5	29.6	12.3	34.2	30.5
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.4;Excitatory neurons: 24.9;Inhibitory neurons: 20.2;Langerhans cells: 30.0;Oligodendrocyte precursor cells: 18.6;Suprabasal keratinocytes: 42.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.3;PC-3: 26.8;TIME: 16.6"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	2.0	5.3	1.8	0.7	1.8	2.2	2.1	1.8	3.4	1.0	2.5	1.9	1.1	1.2	0.2	2.9	0.9	1.5	3.4	1.8	2.1	3.4	7.2	2.0	0.3	1.9	1.9	1.6	3.4	0.1	2.7	0.2	2.2	1.7	0.1	0.9	2.5	1.9	3.6	1.5	1.9	0.3	1.9	2.1	2.2	1.9	2.0	0.1	2.2	0.0	0.5	1.1	1.9	1.8	2.0	0.5	0.9	0.2	0.9	2.4	1.6	11.0	12.4	12.6	0.0	4.3	1.2	2.7	0.5	9.0	0.5	1.8	15.9	0.3	0.4	2.8	10.6	0.7	6.4	2.9	0.1	3.4	1.0	0.2	1.5	8.4	10.1	0.9	9.7	0.8	1.4	1.5	17.3	1.8	5.1	0.7	2.3	4.5	26.8	1.2	10.8	3.6	11.5	0.5	0.7	1.2	2.7	0.8	1.1	2.2	0.9	1.5	16.6	0.2	1.0	0.3	1.2	4.9	0.8	13.5	1.5	1.0	1.2	1.6	4.1	1.7	0.6	5.0	0.9	3.5	2.9	2.3	2.3	1.2	1.8	2.2	0.6	0.4	7.0	2.7	1.3	2.4	1.8	1.8	1.8	3.4	1.8	2.1	1.9	1.9	2.2	1.9	2.0	1.8	2.0	3.2	8.9	5.2	1.3	39.4	0.0	11.0	0.0	0.0	5.1	2.7	0.0	0.0	7.5	5.5	0.0	5.2	1.4	0.0	3.9	4.3	0.0	1.5	0.9	1.4	0.0	0.0	24.9	4.9	5.2	1.4	0.0	1.4	8.8	2.2	0.0	0.0	3.0	0.0	20.2	0.0	8.2	0.0	30.0	0.0	0.0	1.4	14.2	5.6	1.6	0.0	0.0	18.6	8.1	4.4	0.0	0.0	1.4	0.0	0.0	8.8	7.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	42.9	6.3	2.8	1.4	0.0	0.0
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101478	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8;Spermatogonia: 304.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		120000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	30.9	31.4	60.3	35.5	59.9	16.5	37.2	61.6	73.2	53.6	54.5	40.7	19.0	66.5	47.9	36.8	40.2	27.9	32.1	59.8	63.9	37.9	21.6	26.9	35.0	63.2	59.7	77.5	22.3	43.8	34.8	34.7	64.0	38.0	33.1	59.5	29.7	47.1	68.4	28.8	24.0	55.6	64.9	33.7	26.6	69.1	60.3	73.6	39.5	46.0	46.9	36.4	37.9	67.3	217.3	121.1	392.4	185.6	78.0	69.3	217.7	197.0	95.1	188.0	200.6	319.2	84.5	148.4	204.5	155.6	144.8	85.3	146.3	124.6	329.2	273.8	118.1	119.8	121.1	119.3	47.5	115.5	71.9	49.8	68.4	140.3	178.3	144.7	157.1	176.6	152.0	67.2	153.8	135.7	325.9	79.8	150.6	118.8	156.9	241.8	322.7	95.8	110.3	121.7	138.5	345.6	135.0	44.6	75.5	281.8	211.0	82.5	110.7	260.2	238.9	112.0	201.1	94.0	227.9	140.4	71.4	50.4	119.0	5.1	12.2	16.0	12.4	12.7	10.0	16.1	11.2	10.4	9.9	15.7	11.5	9.7	33.6	9.5	9.3	10.6	12.4	5.9	60.3	59.9	61.6	73.2	59.8	63.9	63.2	59.7	64.0	64.9	60.3	67.3	32.9	67.3	27.6	7.8	31.4	43.6	30.5	46.1	36.5	46.9	48.0	54.7	70.9	18.6	33.6	42.3	20.9	66.4	27.5	19.2	35.2	68.7	26.8	40.8	78.9	40.2	40.3	34.3	13.0	29.7	86.6	61.5	10.2	39.6	39.9	65.3	30.0	15.6	69.6	50.5	15.5	27.3	42.7	33.5	24.5	59.5	80.2	26.7	40.9	7.5	47.7	106.6	42.2	12.5	13.7	34.7	12.9	91.7	20.0	51.1	9.6	30.9	32.2	36.3	39.5	33.3	71.8	350.8	304.0	26.7	36.2	27.8	25.6	35.8	28.6	20.1
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.4	0.3	1.1	0.7	0.9	2.2	1.2	0.8	0.9	1.3	0.5	0.5	0.4	1.2	1.8	4.2	1.0	0.6	2.3	0.8	0.7	1.6	0.4	1.2	1.3	1.0	0.9	2.1	1.3	0.5	0.2	2.2	1.1	0.6	0.2	0.5	0.9	0.5	0.7	2.1	0.6	0.7	0.8	1.6	0.5	12.8	1.0	7.3	0.5	1.1	1.3	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	0.9	0.8	0.7	1.0	0.9	1.1	0.8	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213607	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		180000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	76.2	93.0	55.5	99.2	57.8	168.8	98.5	58.8	74.1	65.0	56.6	75.3	105.8	76.7	79.7	63.9	62.9	58.5	64.2	54.2	63.2	87.6	84.9	62.1	145.7	60.2	61.0	79.5	56.3	51.5	40.5	88.8	60.7	56.6	87.2	122.7	61.3	59.8	87.2	54.7	99.0	65.9	60.2	82.0	61.7	99.6	58.2	190.4	55.3	68.6	140.4	84.1	55.7	63.6	365.4	156.3	330.0	332.2	115.0	205.8	257.8	275.9	209.1	205.2	207.2	185.8	296.8	544.1	218.7	183.9	440.6	283.0	275.7	231.2	332.1	151.8	209.1	312.8	201.0	208.5	126.1	508.3	294.7	153.9	197.5	163.2	231.2	253.9	281.7	343.2	506.1	263.9	351.7	207.5	489.4	625.9	424.4	311.3	225.1	313.6	303.9	452.3	303.8	201.4	401.1	448.2	230.5	482.6	274.9	345.3	412.4	455.1	212.0	186.0	340.5	222.1	376.8	394.6	596.5	929.3	163.2	422.3	864.3	135.7	85.9	137.7	77.3	116.3	96.9	86.8	114.4	96.1	89.1	77.7	118.4	119.6	92.6	99.2	123.2	72.4	148.3	87.2	55.5	57.8	58.8	74.1	54.2	63.2	60.2	61.0	60.7	60.2	58.2	63.6	139.1	109.0	98.4	16.3	158.5	143.6	93.3	128.0	105.3	101.8	223.8	181.0	124.1	133.0	119.7	64.4	77.2	176.3	138.7	111.2	140.8	167.6	162.2	132.4	215.4	142.6	110.2	306.6	27.4	141.4	362.1	123.6	81.1	129.0	222.0	166.2	145.3	289.2	143.1	50.5	26.8	156.6	107.8	254.9	200.0	41.9	136.4	157.6	104.9	15.0	183.3	155.9	166.9	23.1	35.8	166.3	103.8	98.2	129.1	135.1	112.6	187.4	107.3	132.1	78.9	60.0	110.1	274.5	388.6	112.5	107.8	270.8	155.2	133.1	205.9	110.9
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839440	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 130.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.8;SK-MEL-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	9.3	14.2	9.6	11.1	10.8	130.3	9.0	8.8	12.5	9.1	0.0	7.9	7.1	6.3	4.6	20.7	8.1	6.3	16.0	12.4	9.7	10.6	21.6	12.3	14.6	11.5	9.5	9.6	19.0	17.0	19.1	15.2	10.7	9.3	3.2	12.3	13.2	4.6	3.4	31.6	11.9	3.8	8.2	20.9	12.9	6.9	12.2	23.1	8.6	1.4	7.2	6.7	10.3	16.6	32.1	28.3	8.4	36.3	5.2	4.7	23.5	14.3	8.5	5.1	5.4	20.5	17.5	12.3	19.7	5.6	11.4	16.3	9.3	9.5	3.8	13.3	17.7	7.0	28.0	38.4	25.4	37.0	52.5	6.5	54.4	4.7	8.4	8.5	4.3	35.5	21.7	67.5	5.5	23.0	50.9	37.7	4.6	33.2	28.2	51.9	8.6	56.3	7.2	15.3	8.7	16.6	21.4	110.8	130.9	3.5	26.3	58.3	11.2	29.8	26.3	18.4	18.6	58.0	32.4	35.0	18.7	31.6	40.4	1.6	0.5	1.8	0.9	0.6	0.6	1.5	1.2	1.3	0.3	1.5	1.4	1.3	2.1	0.4	0.7	1.7	0.2	0.6	9.6	10.8	8.8	12.5	12.4	9.7	11.5	9.5	10.7	8.2	12.2	16.6	40.4	3.2	15.7	4.6	31.8	23.3	5.4	13.4	36.5	31.7	65.2	79.8	51.6	30.0	12.1	1.8	22.9	34.2	77.6	26.6	0.0	7.5	0.2	63.9	19.3	21.6	52.7	7.8	5.5	7.3	5.0	15.8	20.9	62.8	7.0	22.3	15.7	16.3	13.8	20.2	5.5	49.5	2.0	19.8	17.0	1.0	4.4	35.4	17.8	12.2	15.4	39.2	15.5	6.0	11.6	10.0	18.4	5.7	26.1	6.3	9.6	2.8	14.6	44.3	6.6	15.3	24.4	0.5	2.4	65.7	30.7	8.6	42.5	13.7	29.7	5.2
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230942-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 102.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm		NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	8.1	14.0	20.9	12.6	22.4	17.2	13.8	14.1	19.8	10.9	102.6	10.5	7.5	9.7	15.0	9.4	16.0	8.9	20.8	19.3	37.3	17.2	8.0	9.5	18.8	18.7	25.7	18.3	9.9	25.6	19.8	12.3	22.3	11.5	10.9	22.9	8.6	11.8	13.8	17.3	8.7	10.8	24.4	10.7	10.3	25.4	39.1	31.0	23.9	7.7	21.5	7.1	8.4	28.8	33.1	96.3	147.9	68.5	19.3	41.4	34.2	50.1	35.8	41.5	42.8	37.8	102.8	91.0	65.3	49.7	49.4	27.1	106.1	31.2	70.2	144.7	23.1	80.1	108.4	13.5	15.0	42.8	32.8	20.6	20.6	71.0	62.1	46.8	46.4	82.6	92.8	87.4	69.2	57.4	137.2	44.8	118.6	13.9	11.5	133.9	82.7	50.6	43.1	30.0	73.9	113.5	93.6	21.0	10.7	58.0	80.6	71.5	61.4	69.3	59.5	26.6	59.8	22.0	25.9	169.4	44.3	43.0	74.3	1.0	5.4	4.7	6.8	6.0	5.5	11.7	7.3	6.5	9.3	14.3	7.2	6.7	0.8	7.7	8.1	21.8	10.0	4.3	20.9	22.4	14.1	19.8	19.3	37.3	18.7	25.7	22.3	24.4	39.1	28.8	39.4	38.5	50.5	33.3	46.5	46.3	42.6	46.5	40.9	120.5	59.6	55.4	138.2	55.8	47.0	82.8	45.9	58.2	32.1	25.9	105.7	61.7	117.4	53.9	58.9	49.1	27.0	102.2	28.4	59.7	56.5	69.0	22.4	37.0	30.9	81.3	38.6	37.5	38.7	183.4	38.9	37.6	48.8	22.9	35.8	58.3	64.7	25.9	35.6	23.4	44.5	68.6	36.0	46.3	40.0	45.4	14.1	80.5	49.2	41.4	11.6	63.2	79.3	64.1	32.9	70.2	67.9	221.4	80.1	40.8	32.7	26.1	40.5	83.5	44.1	29.8
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861422-38872249	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	16.3	22.4	67.1	16.5	53.6	28.3	12.3	9.9	83.6	21.0	0.0	39.3	6.5	34.0	14.5	13.3	27.0	11.3	17.7	88.2	10.1	18.7	6.3	17.2	14.2	16.6	14.0	24.4	17.1	49.5	27.5	4.3	10.0	22.0	7.2	8.5	13.7	25.9	8.9	8.2	17.1	26.1	5.5	15.9	20.5	4.3	21.8	12.5	19.0	6.7	15.3	31.0	11.9	30.8	40.3	41.7	9.1	31.3	68.5	38.2	2.8	42.8	24.5	21.8	20.3	21.1	36.5	65.3	31.2	29.5	15.3	46.8	17.0	18.3	11.9	63.1	53.0	6.7	18.5	7.4	37.2	32.6	31.1	57.0	9.1	49.7	23.5	30.1	24.9	18.4	14.9	32.2	15.1	45.5	20.2	9.5	8.1	23.1	31.9	29.9	30.5	25.9	31.3	37.4	44.3	9.8	27.5	36.4	23.7	3.2	25.0	19.3	32.7	18.9	57.9	33.2	29.6	32.9	34.1	23.5	37.0	33.6	40.1	2.2	9.1	4.7	18.6	12.4	15.3	6.7	12.6	13.1	9.1	7.7	10.3	12.6	4.0	9.1	12.5	46.1	8.0	20.0	67.1	53.6	9.9	83.6	88.2	10.1	16.6	14.0	10.0	5.5	21.8	30.8	30.5	16.0	14.7	9.8	25.1	33.9	47.4	18.4	16.5	100.4	42.6	31.6	27.5	52.9	22.1	73.5	39.6	12.4	83.0	9.6	35.2	102.6	1.1	6.9	46.0	36.4	122.7	17.7	28.9	50.1	2.0	48.5	3.1	17.5	6.3	18.7	46.8	32.4	19.8	124.5	27.3	3.2	30.5	40.8	121.1	2.9	74.3	33.2	81.8	14.0	91.1	91.2	57.7	15.1	23.3	46.9	9.1	80.9	24.5	58.9	0.1	51.7	18.0	59.4	72.3	54.4	85.1	4.2	6.8	10.4	34.0	4.7	35.8	40.9	0.9	82.6
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152680	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 37.2;U-266/70: 30.7"	"Low region specificity"	"Detected in all"							"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146"	"prognostic favorable (6.18e-4)"	"prognostic favorable (3.63e-4)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favorable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	36.6	31.2	53.6	15.9	52.9	6.0	32.3	53.8	72.1	54.6	38.1	85.2	17.2	61.2	29.1	24.5	62.7	17.7	57.4	53.7	44.5	32.5	17.7	30.4	27.4	49.2	47.8	58.5	28.8	41.5	42.7	8.3	48.9	50.9	14.2	34.0	35.3	57.7	68.0	28.1	42.9	27.4	38.6	42.5	48.0	10.8	46.0	14.2	33.3	51.3	21.6	66.3	39.1	53.2	6.9	2.9	1.4	11.0	13.1	5.0	3.6	6.5	8.0	3.5	4.2	1.4	4.7	1.2	7.5	4.9	6.3	2.5	0.9	3.0	2.6	37.2	3.6	0.2	5.5	0.7	4.5	1.7	14.0	2.5	4.4	1.7	0.7	4.5	1.0	5.5	1.7	18.1	2.7	6.7	2.5	0.8	0.8	8.8	4.9	2.8	2.3	10.1	1.8	2.8	3.6	0.9	3.3	4.8	7.6	2.3	5.8	2.7	2.6	5.8	10.9	5.9	2.9	30.7	18.4	4.2	11.8	2.7	2.5	0.4	0.3	2.9	1.9	0.0	2.0	1.5	2.1	2.1	0.0	2.0	2.6	2.5	3.1	1.0	0.5	0.4	2.2	1.0	53.6	52.9	53.8	72.1	53.7	44.5	49.2	47.8	48.9	38.6	46.0	53.2	17.5	6.4	8.7	16.3	27.9	4.6	11.7	3.7	7.4	57.0	9.6	11.6	74.6	24.3	9.5	14.7	35.5	4.3	10.5	10.5	9.8	4.3	8.2	5.1	4.8	14.4	4.2	20.0	17.0	3.8	1.5	16.2	6.6	3.3	10.8	9.6	28.5	11.8	4.4	60.6	18.8	7.6	8.2	11.7	6.4	18.6	35.1	6.2	19.6	14.0	11.6	16.4	42.2	13.0	28.8	3.4	5.1	27.8	12.0	10.5	18.2	13.6	6.4	62.7	46.0	28.3	24.9	7.0	5.3	3.1	4.8	3.6	22.8	4.1	5.4	7.5
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	4.3	3.3	1.9	2.5	1.8	2.1	3.3	1.9	1.8	3.3	1.9	2.5	2.9	2.4	10.9	2.9	8.5	1.9	3.8	1.6	1.9	7.3	5.6	3.2	3.1	2.0	1.9	2.1	3.6	6.6	7.6	2.5	2.1	2.2	0.7	4.5	2.5	2.0	2.4	2.9	2.7	1.1	1.4	3.0	2.8	10.9	2.3	3.8	3.0	0.8	2.0	2.0	1.8	2.9	12.4	24.9	6.5	23.7	3.5	2.2	8.0	6.2	4.4	5.2	3.6	13.6	6.2	9.1	17.1	3.5	4.6	11.6	8.5	1.9	2.3	7.0	11.9	3.3	13.9	14.8	4.1	13.8	27.4	1.9	3.8	3.3	0.9	5.2	1.1	10.7	8.2	4.0	1.6	15.2	15.7	20.3	2.7	9.0	13.4	14.5	5.8	16.9	4.1	8.5	9.5	19.3	8.9	28.2	14.8	2.3	14.8	17.7	2.8	10.9	15.0	4.4	9.9	11.3	4.8	6.0	6.8	13.5	6.2	0.9	5.0	15.0	3.2	6.8	1.1	4.5	1.8	1.9	5.7	1.8	1.7	1.7	6.3	3.3	7.3	4.6	1.9	2.0	1.9	1.8	1.9	1.8	1.6	1.9	2.0	1.9	2.1	1.4	2.3	2.9	2.3	0.0	0.5	0.7	2.8	1.8	1.2	4.4	4.0	5.3	2.7	2.2	4.1	8.6	2.3	3.7	8.4	7.1	4.1	3.9	0.0	4.6	2.8	15.6	4.9	2.1	9.1	0.0	0.2	5.4	2.8	2.4	5.6	5.2	5.7	2.3	0.7	2.5	5.0	8.4	0.3	7.1	2.0	2.2	1.0	0.4	0.9	2.3	1.8	0.0	1.9	7.2	2.1	0.0	1.0	4.4	5.1	2.2	2.7	0.9	4.3	2.3	5.4	11.0	0.0	0.6	3.9	6.2	11.5	3.8	1.1	2.5	3.4	4.0	4.7	0.4
CBY2	"NURIT, SPERT"	ENSG00000174015	"Chibby family member 2"	Q8NA61	13	45702320-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	441	"testis: 99.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 36: Testis - Spermatogenesis"		"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	99.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBY3		ENSG00000204659	"Chibby family member 3"	A6NI87	5	179678560-179681034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 15.4"	"Group enriched"	"Detected in some"	117	"Early spermatids: 211.1;Late spermatids: 351.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.3;HeLa: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069037	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA069037: AB_2686069"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.68e-3)"	"unprognostic (7.69e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.10e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.76e-3)"	"unprognostic (7.85e-2)"	"unprognostic (5.04e-3)"	"unprognostic (4.98e-2)"	0.2	0.4	0.4	0.0	0.3	0.0	0.3	0.5	0.4	0.6	0.0	0.6	0.1	0.5	0.0	0.2	0.7	0.0	0.4	0.2	0.1	0.4	0.2	0.2	0.2	0.6	0.2	0.8	0.9	0.0	0.9	0.0	0.4	0.5	0.0	0.4	0.5	0.0	0.4	0.3	0.5	0.0	0.1	0.4	0.4	15.4	0.4	0.0	0.6	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.3	0.2	0.5	0.1	0.2	0.9	0.5	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.4	0.3	0.5	0.4	0.2	0.1	0.6	0.2	0.4	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.1	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	351.4	1.5	0.2	0.0	1.9	0.0	0.0	0.0	1.0	2.4	0.0	0.0	1.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CC2D1A	"FLJ20241, Freud-1, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	16.8	16.4	11.6	3.8	11.3	3.7	21.3	10.1	18.1	19.4	10.3	37.4	16.2	16.2	2.1	33.3	19.8	2.9	20.5	11.8	11.9	22.9	26.9	16.0	3.2	11.3	11.4	18.7	34.3	7.9	31.8	3.1	11.8	25.8	4.7	4.1	27.4	5.2	28.3	35.5	33.1	3.4	9.8	17.7	24.7	15.9	13.2	2.6	20.6	3.9	3.1	21.2	24.8	10.8	22.0	8.5	2.3	9.9	5.1	3.1	9.3	6.9	8.1	10.2	10.4	14.5	6.8	11.2	11.4	6.1	6.4	15.2	5.3	10.1	3.3	17.0	30.9	5.2	11.0	6.9	9.0	4.1	15.2	4.7	12.5	7.2	4.3	6.5	7.2	11.5	6.4	8.5	3.4	22.4	11.6	12.1	7.1	18.5	16.7	11.2	6.3	8.9	6.5	16.3	10.2	7.1	9.8	13.3	12.2	1.6	10.4	9.8	6.3	8.3	4.4	20.9	8.9	15.2	7.3	6.6	10.8	14.3	7.8	0.5	0.3	0.8	0.4	0.7	0.1	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	11.6	11.3	10.1	18.1	11.8	11.9	11.3	11.4	11.8	9.8	13.2	10.8	20.6	9.6	8.3	23.8	12.6	9.1	14.2	15.6	19.4	66.6	19.2	64.6	8.4	21.5	16.5	11.0	93.8	22.3	11.7	103.4	9.8	22.0	2.2	10.1	6.7	13.2	33.5	18.7	38.4	27.7	10.7	10.5	63.7	11.3	17.7	29.3	12.8	12.4	14.5	30.3	43.3	46.6	24.4	12.2	13.0	6.5	64.3	11.3	7.2	10.3	16.3	15.6	23.7	31.2	24.1	26.0	77.6	87.3	12.3	13.0	97.9	6.8	16.7	93.2	13.1	8.0	9.3	10.2	12.4	24.8	13.8	21.3	14.8	16.1	64.3	18.8
CC2D1B	"Freud-2, KIAA1836"	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366205	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	13.4	15.0	14.5	8.7	18.0	5.0	12.6	17.3	15.9	10.4	13.5	13.0	8.0	11.0	9.2	16.7	10.0	7.0	13.3	13.1	16.0	18.9	17.2	17.8	12.1	19.1	17.7	13.3	15.6	10.2	19.5	7.5	18.6	13.7	6.5	4.0	12.7	7.1	29.1	12.0	15.0	5.5	17.4	17.9	12.8	16.7	17.1	11.0	17.7	11.7	9.7	12.2	12.0	19.5	12.4	17.2	7.8	12.2	28.1	10.7	18.3	15.6	27.3	19.9	15.0	11.5	10.1	7.7	12.9	18.2	43.6	8.3	10.1	21.6	9.0	14.2	11.1	8.5	13.6	9.7	22.6	11.8	19.8	15.9	19.3	22.2	16.9	19.3	12.4	12.2	14.7	8.2	22.2	8.5	12.4	9.7	15.2	12.5	19.2	7.9	14.7	11.3	21.0	17.2	8.5	8.0	15.2	22.7	22.7	20.0	8.0	17.4	14.9	22.9	12.6	12.6	17.9	11.7	11.5	9.9	30.3	12.7	28.8	10.4	1.1	2.8	2.3	0.6	1.9	1.7	1.8	1.8	1.1	1.2	1.4	2.0	1.6	1.9	0.5	1.1	1.6	1.3	14.5	18.0	17.3	15.9	13.1	16.0	19.1	17.7	18.6	17.4	17.1	19.5	6.7	9.6	13.4	4.6	7.5	3.2	3.3	3.4	5.2	5.6	3.9	2.7	5.6	4.3	7.6	11.0	0.0	9.0	9.0	10.2	3.9	10.0	3.7	6.7	4.1	5.8	6.0	2.5	4.6	12.7	10.3	3.9	14.8	9.6	15.8	6.7	9.7	8.2	11.6	1.7	4.6	5.7	2.0	6.9	1.5	2.4	3.4	8.0	1.8	2.8	5.9	6.5	8.2	2.0	5.9	12.2	9.1	6.4	6.7	3.8	8.6	5.3	5.4	4.9	0.0	5.1	4.1	16.6	8.8	4.9	3.1	15.7	8.9	5.8	4.9	3.5
CC2D2A	"JBTS9, KIAA1345, MKS6"	ENSG00000048342	"Coiled-coil and C2 domain containing 2A"	Q9P2K1	4	15469865-15601552	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 84.7"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044124	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA044124: AB_10969197"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.01e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.42e-9)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.18e-2)"	8.3	9.3	13.5	2.7	13.0	2.7	8.8	14.2	16.5	14.2	22.1	17.3	4.9	12.8	11.1	8.3	34.2	12.4	7.4	13.2	13.5	23.6	2.9	10.7	2.0	13.7	14.6	11.7	5.1	10.0	12.7	8.5	12.6	10.0	5.9	84.7	3.3	12.5	2.5	2.3	5.0	15.4	12.0	3.3	8.2	4.9	14.7	1.2	8.2	11.1	1.4	9.3	6.4	12.7	5.4	11.3	15.6	7.0	18.4	34.4	3.8	6.8	11.5	12.7	15.5	5.1	13.2	0.5	7.3	13.1	27.7	3.4	13.1	8.7	15.9	0.0	7.3	5.5	10.1	7.1	13.5	0.5	0.1	25.0	22.8	20.7	15.5	23.3	5.9	0.2	14.7	0.4	24.4	3.9	0.2	0.9	25.9	0.2	23.3	3.5	4.9	1.1	32.1	2.6	9.7	11.1	4.3	3.1	32.2	14.6	4.9	1.3	2.2	20.2	12.0	8.6	14.4	0.4	0.5	0.3	24.3	0.3	13.1	1.9	2.4	0.2	0.4	1.6	0.6	0.3	0.3	0.1	3.8	0.3	0.2	0.4	4.8	0.9	0.8	0.2	0.9	0.6	13.5	13.0	14.2	16.5	13.2	13.5	13.7	14.6	12.6	12.0	14.7	12.7	8.4	12.8	14.6	39.8	0.7	2.2	5.6	5.7	14.2	15.1	6.5	9.0	22.9	10.0	23.5	25.8	569.2	10.2	0.3	0.8	33.2	6.6	12.0	96.8	14.0	7.0	6.0	2.7	20.9	0.9	3.1	18.7	4.1	9.0	0.0	15.2	8.9	1.6	5.0	8.4	43.4	0.9	8.2	5.7	4.6	6.7	9.3	4.4	12.4	16.9	1.2	18.4	0.0	62.8	19.5	1.0	0.5	16.6	1.3	4.4	2.1	57.1	128.4	136.4	6.6	14.7	17.7	2.6	0.7	6.4	1.3	1.5	1.9	12.9	2.9	4.0
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96033745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044091, HPA072122"	Enhanced		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"		"HPA044091: AB_2732514, HPA072122: AB_2686489"	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.7	1.9	0.9	1.9	2.7	2.5	0.5	1.2	1.6	0.8	3.4	0.9	1.0	1.5	0.4	0.8	0.9	1.5	1.1	0.5	3.5	0.9	0.6	0.8	1.3	2.1	0.9	1.1	0.4	0.7	0.3	1.1	2.6	0.6	0.3	2.8	1.0	0.4	2.2	2.4	0.6	1.2	1.0	1.2	1.0	8.7	2.2	0.2	3.0	0.2	0.2	0.8	0.8	5.4	1.1	4.4	3.7	7.4	0.2	0.4	4.1	3.8	0.4	0.7	0.1	3.3	0.8	4.4	3.0	0.0	3.8	3.0	0.3	0.3	0.0	4.9	8.5	9.7	3.5	2.8	0.0	9.8	0.7	0.7	0.0	0.4	0.1	1.3	0.3	1.4	7.8	2.9	0.9	2.6	4.6	3.1	7.9	3.3	6.8	12.1	3.4	3.8	0.7	0.8	6.5	3.2	3.9	1.0	2.5	4.4	6.8	4.9	3.7	4.3	4.5	3.0	5.7	2.6	11.7	0.2	3.3	8.4	2.8	0.0	0.3	0.0	0.5	0.1	0.9	1.2	0.4	0.3	0.3	1.2	0.4	0.1	0.3	0.2	0.2	0.3	0.2	0.1	0.9	2.7	1.2	1.6	0.5	3.5	2.1	0.9	2.6	1.0	2.2	5.4	1.1	0.0	0.0	25.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.8	0.2	0.4	1.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	15.0	0.2	0.0	0.0	13.6	7.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	17.4	21.4	14.4	20.2	16.0	23.4	17.2	21.1	25.4	15.9	15.2	17.9	16.8	16.7	16.1	20.1	14.5	16.5	15.6	13.6	17.0	18.4	19.1	15.9	30.3	16.9	14.9	19.9	20.4	15.9	14.5	21.7	16.4	17.3	22.2	20.9	18.5	13.5	20.6	23.9	19.4	16.0	13.2	21.5	17.8	14.3	16.8	29.8	18.2	17.9	28.7	21.7	17.0	19.2	64.0	64.8	73.9	49.7	31.4	30.3	57.7	56.0	47.4	59.3	40.0	87.2	50.8	74.7	29.9	39.1	29.8	49.3	78.4	44.3	64.8	51.5	48.2	60.1	46.1	54.5	35.7	96.2	67.5	30.5	54.2	50.1	61.7	36.7	48.5	37.5	83.5	46.8	58.8	46.5	64.2	60.7	74.1	49.7	58.4	74.2	44.1	44.7	52.5	48.6	42.7	36.9	55.1	89.1	57.1	57.6	60.6	58.9	48.1	36.8	46.3	40.1	61.4	32.2	45.5	78.5	30.8	63.8	35.6	6.1	14.6	14.3	16.3	13.0	14.6	14.2	11.3	15.8	21.0	17.3	13.5	14.3	3.3	10.6	15.5	13.1	18.4	11.3	14.4	16.0	21.1	25.4	13.6	17.0	16.9	14.9	16.4	13.2	16.8	19.2	50.5	35.3	85.5	61.4	69.2	37.0	49.6	54.7	66.0	51.0	36.1	40.0	65.5	41.5	49.0	46.0	58.4	73.1	62.9	44.1	23.5	68.0	28.8	55.2	68.5	54.0	46.1	61.2	49.7	78.1	83.8	49.2	45.3	62.2	67.2	76.8	39.3	40.4	49.2	55.5	51.2	55.1	30.5	47.4	36.3	14.5	53.7	49.8	21.4	41.2	65.4	36.5	66.9	47.7	66.1	77.7	34.2	50.4	61.0	45.3	36.0	18.3	49.1	68.7	65.7	53.2	62.3	128.7	77.2	50.4	37.4	109.5	61.3	83.2	67.2	49.4
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		19000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	64.1	68.3	39.2	75.4	44.2	145.5	64.4	40.2	52.4	65.6	45.6	68.5	52.1	75.0	33.0	63.4	67.9	59.7	52.0	47.0	33.8	54.8	41.1	61.4	86.7	36.9	42.3	74.6	56.4	59.8	65.1	54.0	38.6	61.1	45.6	59.8	61.5	46.9	101.4	89.0	69.3	44.9	34.7	85.6	60.0	89.4	39.6	96.0	60.6	43.5	74.3	65.4	57.6	47.9	133.7	242.8	230.8	120.8	89.5	74.7	154.0	127.7	124.9	184.3	163.9	219.5	107.4	218.6	156.4	140.5	169.6	163.2	214.5	151.9	132.9	89.2	128.2	259.1	189.5	172.8	82.9	143.6	212.0	77.8	133.1	147.0	90.0	106.4	134.4	194.4	276.2	134.8	138.0	157.5	435.0	150.5	337.6	143.2	88.1	286.7	190.7	116.8	95.2	311.7	115.1	267.6	143.7	163.0	112.6	110.7	148.8	133.2	219.3	135.8	178.4	165.3	171.1	98.5	134.0	261.4	152.7	123.4	215.7	25.9	16.2	23.5	34.8	26.6	29.4	18.7	26.5	26.6	16.6	17.5	25.7	28.4	5.7	19.9	35.6	15.5	32.6	25.8	39.2	44.2	40.2	52.4	47.0	33.8	36.9	42.3	38.6	34.7	39.6	47.9	14.4	16.0	4.2	11.1	14.1	13.9	9.5	12.2	17.6	12.9	13.5	13.1	7.5	15.7	9.4	16.5	16.7	27.3	19.4	24.1	9.8	18.1	4.7	14.1	12.3	13.1	22.2	16.4	12.5	18.0	22.2	12.8	18.8	14.3	8.8	20.2	11.7	12.0	15.7	10.1	11.9	19.6	14.2	11.9	8.5	7.3	14.9	11.0	12.4	10.3	11.2	15.9	20.6	11.1	10.3	23.6	10.4	12.0	14.8	11.7	14.4	9.4	19.5	12.9	19.7	12.4	12.2	30.0	24.1	16.9	15.3	23.7	19.3	23.5	21.7	10.5
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430939-59697662	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 33.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.1;Rod photoreceptor cells: 38.2;Theca cells: 78.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"BJ: 101.2;BJ hTERT+: 103.2;BJ hTERT+ SV40 Large T+ RasG12V: 96.4;HBF TERT88: 113.3;hTERT-HME1: 153.2;LHCN-M2: 176.9;TIME: 93.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 2.7;hippocampal formation: 8.7"	"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	4.1	10.2	2.7	1.2	3.4	0.5	1.8	2.2	3.0	10.5	0.7	16.7	1.1	6.9	0.5	2.8	8.3	1.3	2.1	6.5	1.1	3.3	5.7	9.9	1.3	0.2	1.9	33.5	1.1	2.9	0.4	0.5	0.3	2.4	2.8	1.1	0.6	4.0	15.3	3.0	2.5	3.2	0.2	0.5	1.6	0.6	3.7	1.2	0.9	0.9	0.7	0.8	1.3	1.5	20.6	1.9	0.0	0.2	15.1	47.2	30.7	101.2	103.2	73.5	96.4	0.3	0.3	0.4	0.2	40.6	16.7	2.3	0.2	65.5	113.3	0.4	0.3	0.2	0.4	0.3	35.1	0.3	0.2	32.0	2.9	57.0	153.2	31.2	3.6	0.3	0.2	0.5	176.9	0.6	0.1	0.2	0.3	0.0	0.6	0.1	0.2	0.2	3.9	2.0	0.4	0.7	0.3	0.2	0.9	7.2	0.3	0.5	93.3	0.2	10.0	15.3	0.3	0.3	0.3	0.2	5.0	0.3	2.4	9.2	0.2	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.5	0.4	0.1	0.2	0.1	0.1	2.7	3.4	2.2	3.0	6.5	1.1	0.2	1.9	0.3	0.2	3.7	1.5	1.5	3.2	1.3	3.9	0.2	4.6	2.0	1.0	2.2	6.4	0.8	0.4	1.6	2.8	1.9	0.0	8.4	1.0	0.2	0.2	0.0	0.2	0.8	8.8	5.1	2.2	0.0	0.0	56.1	0.2	1.3	14.5	0.0	0.6	1.3	6.8	9.7	0.2	0.4	15.2	15.1	0.0	0.0	1.0	8.9	1.1	9.6	0.5	7.2	1.0	0.2	2.4	0.0	0.5	0.7	0.3	0.0	0.4	0.1	1.5	0.1	0.1	0.9	38.2	0.0	1.6	5.9	0.4	0.9	0.2	4.3	0.8	1.2	78.0	0.1	0.9
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512181-57536571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.8	2.7	1.6	0.5	4.8	1.7	2.4	10.9	4.1	11.1	2.3	11.0	1.1	3.5	8.8	1.5	6.8	1.6	1.7	5.2	1.5	4.5	3.0	2.5	2.4	8.0	3.3	1.5	2.3	2.5	2.0	8.4	0.5	0.1	4.0	3.8	1.6	4.9	4.7	2.4	2.1	5.1	4.8	3.0	2.4	1.6	5.8	0.5	1.7	11.9	8.2	1.5	6.6	7.9	3.0	4.3	1.0	1.4	6.2	4.2	2.3	2.4	1.2	3.2	7.5	6.0	16.4	1.3	3.2	4.8	1.5	2.2	0.9	4.9	6.8	0.8	3.8	1.3	3.7	0.4	7.7	3.5	1.4	2.0	0.5	5.2	1.9	2.1	4.6	0.0	0.8	2.7	5.4	5.3	7.1	0.7	14.6	4.8	3.4	2.4	3.0	1.0	0.5	7.8	6.6	2.1	3.2	1.1	4.5	2.9	5.2	4.4	14.5	0.4	3.8	6.9	2.7	2.2	2.5	2.1	7.4	0.0	0.0	0.0	1.1	0.0	0.9	0.9	0.2	1.2	0.0	0.5	0.5	0.8	0.1	0.6	0.0	0.3	0.0	0.2	1.8	1.6	1.7	2.4	1.6	1.7	2.5	2.4	2.0	2.1	2.4	1.5	8.8	0.0	3.0	0.7	8.2	12.9	8.0	2.4	14.8	0.0	4.9	10.3	3.1	5.7	2.2	7.3	0.0	1.6	16.3	0.5	9.8	1.9	0.6	6.0	8.5	10.6	0.0	3.4	0.0	0.9	1.1	13.2	2.0	1.8	0.0	14.6	7.1	0.9	0.3	0.0	0.1	1.0	0.0	0.6	2.8	1.3	19.6	1.5	1.8	1.0	0.5	3.5	18.6	0.0	0.0	0.9	0.1	34.6	18.8	10.6	1.1	10.5	3.1	0.2	19.7	10.8	11.8	2.8	8.9	2.3	5.7	0.3	10.5	3.3	1.0	3.2
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Early spermatids: 138.2;Excitatory neurons: 80.8;Late spermatids: 83.3;Oligodendrocytes: 90.1;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.2;BJ hTERT+: 29.0;fHDF/TERT166: 26.2;HSkMC: 15.4;Karpas-707: 10.2"									"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	7.1	2.9	1.5	3.7	1.8	0.7	2.7	0.6	3.5	2.8	0.0	3.8	1.5	1.7	1.1	3.4	1.8	13.6	3.2	1.3	2.0	4.3	1.7	14.3	8.6	2.6	1.6	0.9	1.5	2.6	0.9	28.4	3.1	1.2	4.5	2.2	1.3	1.3	0.6	1.0	2.6	3.7	2.0	2.2	3.6	2.0	2.3	1.5	5.2	1.1	2.0	10.6	1.5	3.6	0.0	0.0	4.0	0.3	3.6	14.2	0.2	0.8	29.0	0.3	0.5	0.1	0.4	0.1	0.6	26.2	0.5	0.4	0.1	0.2	0.4	1.2	0.4	0.8	0.0	1.3	7.0	0.1	0.4	15.4	0.6	0.4	3.5	0.6	0.2	2.0	0.0	10.2	2.4	0.0	0.6	0.3	0.8	0.2	0.5	1.3	0.2	0.5	0.1	0.0	1.7	1.5	0.1	0.0	0.1	1.6	0.3	1.3	4.0	0.6	0.2	0.2	0.3	4.4	0.3	0.8	2.1	1.7	2.5	0.0	0.1	0.3	1.0	0.2	0.9	0.5	0.6	0.8	0.2	0.6	1.8	1.1	0.0	1.0	0.2	9.1	0.3	0.3	1.5	1.8	0.6	3.5	1.3	2.0	2.6	1.6	3.1	2.0	2.3	3.6	11.5	0.0	2.2	72.8	4.4	0.6	0.8	0.8	0.6	6.4	2.7	2.9	10.0	0.0	2.1	3.7	6.2	0.8	12.4	0.4	5.9	0.7	138.2	2.9	6.7	6.8	0.0	3.0	80.8	1.8	0.6	15.3	0.0	1.1	2.5	5.7	8.6	0.8	3.2	6.7	33.6	0.2	0.0	1.9	1.8	83.3	32.3	3.3	0.0	44.0	2.1	11.9	7.2	36.2	90.1	0.2	2.6	9.1	2.2	0.4	0.3	5.3	1.5	13.4	78.9	3.8	37.3	1.9	5.7	0.7	0.6	0.3	3.8	3.7	0.4	0.6
CCDC105	FLJ40365	ENSG00000160994	"Coiled-coil domain containing 105"	Q8IYK2	19	15010726-15023276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 15.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 201.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058585	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA058585: AB_2683763"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 9.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	12.0	21.7	27.8	5.1	32.7	2.6	11.9	20.4	37.6	11.4	17.7	18.7	4.1	13.4	6.4	8.0	13.3	6.5	21.9	33.0	22.4	29.1	24.3	9.4	10.3	21.8	23.1	12.7	9.8	13.6	27.3	5.1	21.1	15.2	2.7	6.5	11.1	11.2	24.5	9.3	13.7	7.1	18.4	18.2	13.7	20.8	23.5	4.7	16.7	20.2	9.0	12.8	8.3	24.7	8.7	33.6	14.4	25.3	10.1	9.6	2.0	7.4	12.9	25.0	21.0	7.3	13.2	25.6	5.6	13.8	0.7	7.3	24.6	16.0	7.1	1.3	82.2	26.7	23.4	13.3	30.1	1.8	14.3	15.6	1.9	5.9	1.4	17.4	8.0	16.0	20.1	15.7	12.5	2.3	16.3	10.8	6.9	0.8	18.3	25.5	7.3	17.7	25.9	0.8	15.8	29.4	5.9	41.3	14.7	8.5	17.9	17.3	9.0	7.7	7.9	0.7	5.5	9.3	3.5	33.0	20.7	8.4	0.6	0.0	2.3	0.0	0.4	1.5	1.4	7.2	0.4	0.6	2.9	9.6	3.1	1.9	0.0	0.8	0.1	8.9	0.3	1.7	27.8	32.7	20.4	37.6	33.0	22.4	21.8	23.1	21.1	18.4	23.5	24.7	12.0	0.0	1.3	8.8	18.1	2.5	6.0	14.0	12.0	22.3	16.0	17.1	23.8	11.5	6.5	20.2	4.2	13.5	6.8	4.6	41.1	19.6	4.0	3.9	7.2	10.8	4.9	4.2	6.4	7.2	15.0	9.7	11.7	3.3	8.9	10.5	10.0	17.5	17.5	37.0	6.4	8.7	8.2	9.4	6.4	2.7	14.0	7.9	3.6	3.7	11.7	34.1	3.1	4.5	3.6	8.7	8.0	18.8	7.0	6.0	10.6	69.4	3.2	9.7	13.1	9.3	9.0	4.7	30.2	10.3	3.7	8.8	3.9	18.9	6.0	5.7
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267190-115296693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045120, HPA050621"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	4.3	3.6	5.7	5.3	6.3	7.3	6.0	7.4	7.3	4.5	2.6	9.1	7.2	5.6	6.2	4.5	4.1	3.1	6.0	5.8	6.6	2.8	1.2	5.5	4.6	6.4	5.5	2.1	10.2	4.5	4.6	2.4	6.3	6.7	9.3	7.9	6.5	5.0	4.3	4.9	6.3	5.4	5.7	4.6	6.4	40.7	5.9	3.7	4.0	2.5	4.2	3.8	3.6	7.8	12.0	5.9	11.5	18.5	7.1	14.0	2.9	10.5	5.3	7.7	8.7	2.6	6.7	14.8	8.9	7.2	11.4	7.5	12.1	6.0	16.0	12.0	10.1	9.8	8.8	3.8	9.7	12.9	4.8	6.4	7.2	9.8	13.0	8.8	12.1	13.1	4.1	11.6	10.8	9.3	19.2	11.4	13.1	11.0	11.0	20.6	14.5	113.7	7.7	4.2	17.9	23.5	11.5	7.2	32.8	7.8	12.2	18.9	12.6	10.1	6.9	19.7	14.8	13.2	13.2	3.0	6.7	9.9	6.0	0.3	5.0	11.0	2.9	4.0	3.3	2.8	2.2	2.5	5.4	4.0	2.8	1.9	3.2	3.0	4.9	10.2	0.1	2.1	5.7	6.3	7.4	7.3	5.8	6.6	6.4	5.5	6.3	5.7	5.9	7.8	15.7	16.0	14.0	16.0	19.2	14.1	5.0	6.0	8.0	29.2	19.4	18.4	17.6	8.6	8.4	5.5	10.4	0.7	19.5	23.6	5.9	28.2	8.5	23.0	21.4	12.4	40.6	20.8	26.4	25.9	2.0	11.5	14.3	12.3	9.5	15.0	7.9	3.1	32.7	10.1	15.2	33.4	6.1	28.6	31.5	18.5	4.1	31.5	14.2	15.0	36.6	11.0	11.3	21.1	54.7	27.1	18.7	4.1	27.3	8.0	11.8	4.4	11.7	24.9	13.1	18.5	18.2	201.8	73.3	13.8	22.6	0.5	9.2	5.5	32.8	3.4
CCDC113	"DKFZp434N1418, HSPC065"	ENSG00000103021	"Coiled-coil domain containing 113"	Q9H0I3	16	58231157-58283836	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 31.4;testis: 18.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 182.3;Endometrial ciliated cells: 140.3;Late spermatids: 171.8;Respiratory ciliated cells: 194.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.5"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040759, HPA040869"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA040759: AB_2677121, HPA040869: AB_2677180"	"unprognostic (8.50e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (8.65e-4)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.87e-4)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.61e-2)"	2.2	2.8	5.5	1.1	5.2	0.3	2.5	2.8	5.2	2.5	10.8	1.4	0.5	2.0	1.8	1.8	31.4	1.7	3.6	5.4	4.5	1.8	1.1	3.8	0.7	7.3	9.6	1.7	1.4	6.8	3.3	0.7	6.0	2.3	1.6	9.5	1.2	1.9	3.1	2.5	0.6	1.6	7.4	0.4	1.7	18.1	4.8	0.4	2.7	2.4	0.6	1.5	0.9	5.6	5.7	4.7	2.1	8.6	4.6	4.9	6.8	3.3	2.1	2.7	0.6	0.6	7.2	0.1	4.3	1.0	2.9	0.8	0.7	3.1	2.6	0.6	1.6	0.1	3.4	0.6	4.6	2.9	0.6	2.6	5.4	0.7	7.4	1.7	0.5	2.7	5.1	0.0	0.6	4.2	0.2	0.8	3.2	0.4	7.0	1.7	0.0	1.1	4.8	1.6	2.2	3.5	28.3	2.3	1.2	0.9	8.0	2.9	0.2	2.8	2.8	1.8	1.0	2.2	1.5	1.5	6.6	1.8	2.0	6.5	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.2	2.8	5.2	5.4	4.5	7.3	9.6	6.0	7.4	4.8	5.6	1.4	0.0	2.8	6.2	0.3	0.5	1.4	5.4	3.4	5.7	3.8	4.1	11.2	2.8	19.9	1.8	12.5	0.0	0.1	1.2	3.9	5.5	182.3	140.3	6.7	1.8	1.2	0.0	9.6	3.8	1.9	3.4	0.5	4.5	0.0	2.9	0.4	2.1	0.1	3.3	8.6	1.2	4.1	0.0	0.7	171.8	4.7	0.6	1.8	1.0	0.0	7.7	0.0	4.0	5.8	2.7	0.3	4.1	0.5	1.3	0.1	1.3	194.6	12.1	0.0	3.3	3.4	32.1	8.7	1.0	1.6	1.1	0.6	10.4	1.1	0.8
CCDC114	"CILD20, FLJ32926"	ENSG00000105479	"Coiled-coil domain containing 114"	Q96M63	19	48296457-48321971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 12.1;choroid plexus: 28.8;fallopian tube: 25.5;testis: 13.3"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 106.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;U-266/70: 1.7"									HPA042524	Approved					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA042524: AB_10795706"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.70e-5)"	"unprognostic (1.54e-2)"	"unprognostic (5.09e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.50e-3)"	"unprognostic (4.35e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.15e-2)"	0.0	0.1	1.6	0.0	1.1	0.5	0.1	0.7	0.6	0.7	28.8	0.0	0.0	0.7	0.1	0.0	25.5	0.0	0.1	2.1	1.6	0.2	0.0	3.0	0.1	7.7	12.1	0.8	0.1	0.7	0.4	0.0	4.9	0.1	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.0	4.4	0.1	0.2	13.3	1.7	0.2	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.1	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.4	0.0	0.6	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.5	0.0	0.6	0.0	0.1	0.0	0.2	1.7	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.7	0.6	2.1	1.6	7.7	12.1	4.9	4.4	1.7	2.0	0.1	0.0	3.4	0.7	0.1	0.1	0.2	4.7	0.0	0.7	0.6	0.4	0.5	0.0	9.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.9	60.4	0.6	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.0	1.5	3.8	0.2	0.0	0.2	0.0	1.7	0.4	0.3	6.1	0.0	0.3	6.5	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	106.5	0.6	0.0	0.2	1.4	20.8	2.2	0.1	0.1	0.0	1.0	0.5	0.2	0.1
CCDC115	"ccp1, FLJ30131, MGC12981"	ENSG00000136710	"Coiled-coil domain containing 115"	Q96NT0	2	130337933-130342699	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034598	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Vesicles	"HPA034598: AB_10601697"	"prognostic favorable (7.59e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.16e-2)"	27.8	25.1	25.3	18.0	25.8	24.8	25.4	26.4	28.0	33.7	21.7	25.3	21.2	29.5	32.3	31.1	29.9	19.9	18.4	25.2	26.6	29.8	17.8	26.6	29.8	26.8	25.3	41.6	20.2	40.2	22.9	13.8	26.3	24.0	19.3	15.8	29.1	27.7	12.9	39.3	24.2	17.7	26.1	26.1	24.1	10.4	25.4	23.3	30.3	12.3	26.0	26.8	28.1	27.5	22.5	10.5	13.3	8.1	27.2	30.7	16.3	10.5	28.2	22.4	26.1	24.4	48.5	25.7	36.6	18.3	11.4	20.7	10.8	19.2	16.1	33.4	20.2	20.2	5.4	27.3	22.7	20.8	40.2	26.2	44.2	14.6	8.1	21.8	23.7	24.3	19.8	22.6	27.7	20.7	38.5	37.5	17.2	11.2	26.4	29.4	14.2	24.1	18.8	18.6	12.4	22.8	12.3	22.4	24.2	8.7	24.5	25.3	18.6	10.1	10.4	18.5	8.3	12.4	13.0	19.7	22.9	22.1	13.5	129.9	94.6	154.8	80.8	136.0	71.8	96.3	85.1	85.8	95.2	98.9	81.1	74.8	33.3	80.6	174.9	73.8	103.6	132.8	25.3	25.8	26.4	28.0	25.2	26.6	26.8	25.3	26.3	26.1	25.4	27.5	37.5	19.2	28.3	3.6	43.6	51.9	42.3	104.2	40.5	25.9	43.3	41.9	13.9	35.8	50.8	77.3	10.4	76.7	35.1	29.9	105.7	47.4	1.4	14.5	16.9	30.8	27.6	13.5	8.7	42.7	36.6	30.6	21.4	20.3	53.3	22.7	33.2	21.4	63.5	23.5	12.3	35.6	99.7	45.5	60.7	4.5	42.6	49.4	53.4	5.6	97.3	48.4	49.4	10.1	12.2	27.5	49.1	52.3	16.9	14.9	51.9	65.9	24.3	27.6	46.0	29.2	31.7	9.0	24.0	42.4	70.0	26.4	51.3	39.1	41.6	30.0
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	9.5	10.2	11.8	12.7	12.7	21.8	11.9	15.7	22.8	14.2	13.4	11.2	11.8	11.5	8.0	8.2	9.1	9.5	7.9	11.6	12.5	9.8	24.2	9.4	18.2	11.6	11.8	12.5	9.4	12.6	6.7	19.1	11.5	9.8	11.2	10.6	18.3	9.3	16.9	8.2	9.4	9.7	11.8	12.6	10.0	36.6	13.1	17.9	10.9	20.7	20.3	10.6	7.5	17.6	19.9	16.0	32.2	31.7	20.6	18.0	25.5	19.7	23.9	33.4	29.2	24.6	9.4	61.7	8.6	18.0	14.2	20.2	47.8	7.8	31.6	33.6	31.4	25.2	17.3	36.6	14.1	40.6	30.9	12.2	16.8	19.3	11.9	14.9	23.5	20.0	36.0	26.6	15.2	25.6	24.1	32.8	26.4	35.3	7.7	48.1	50.8	27.0	14.9	7.6	12.3	16.4	30.4	28.0	12.7	38.0	34.9	17.4	13.7	41.7	28.3	13.3	15.3	61.7	68.9	51.2	14.6	21.9	18.1	13.5	14.6	15.3	10.0	13.2	10.2	10.0	8.3	9.8	14.6	12.4	14.5	11.8	6.7	25.3	12.9	12.7	11.6	14.9	11.8	12.7	15.7	22.8	11.6	12.5	11.6	11.8	11.5	11.8	13.1	17.6	11.1	22.4	14.3	4.2	18.3	10.6	14.4	4.3	6.2	7.7	21.9	14.2	10.4	15.7	8.5	14.7	14.6	16.5	20.4	13.2	7.9	9.9	104.0	20.7	32.5	15.5	20.4	17.4	6.6	10.0	17.8	14.3	6.6	31.0	17.2	11.9	10.8	42.3	9.3	3.3	7.1	12.3	4.1	18.9	19.0	38.2	12.8	15.4	17.8	7.5	14.7	6.2	21.6	4.5	12.8	9.7	8.9	7.9	26.4	22.6	9.0	12.5	13.8	15.2	0.0	9.6	16.1	49.5	48.5	9.5	10.9	24.6	14.7	9.0	12.4	22.3
CCDC12	MGC23918	ENSG00000160799	"Coiled-coil domain containing 12"	Q8WUD4	3	46921726-46982010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056814, HPA060530"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056814: AB_2683241, HPA060530: AB_2684309"	"unprognostic (1.47e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.15e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.65e-2)"	39.1	55.5	40.1	38.3	40.7	57.9	40.2	41.8	45.3	48.4	39.2	44.4	39.7	45.2	22.1	75.2	33.4	22.1	53.5	39.8	40.4	53.3	46.1	39.4	51.0	40.9	40.0	40.4	40.9	33.7	35.2	26.7	40.7	38.4	21.3	19.1	42.3	22.9	80.6	72.5	42.8	21.1	40.7	48.9	46.9	30.1	40.9	41.4	43.2	30.1	33.4	39.2	55.6	41.4	63.7	52.5	60.4	31.7	33.4	27.1	46.5	63.1	32.1	46.6	34.0	68.5	53.5	123.9	56.1	38.2	66.3	35.1	51.6	58.6	19.6	122.3	39.3	136.0	77.8	104.6	45.5	147.1	93.1	37.2	54.6	59.2	52.2	36.9	45.7	78.0	148.3	59.6	23.1	77.0	114.6	139.0	78.7	62.5	42.9	48.0	46.9	79.6	49.2	65.5	32.0	62.1	77.0	62.8	62.7	26.7	47.8	143.9	94.6	31.1	61.4	63.5	101.4	77.5	185.8	155.1	43.5	102.2	45.6	50.0	132.0	122.0	139.3	142.8	109.8	209.7	106.6	122.8	126.9	222.4	90.8	107.3	40.4	123.7	155.8	202.1	148.8	118.9	40.1	40.7	41.8	45.3	39.8	40.4	40.9	40.0	40.7	40.7	40.9	41.4	58.0	80.1	54.7	15.0	119.1	79.2	146.0	146.6	73.4	53.4	55.9	47.1	53.3	82.9	97.4	80.9	54.2	137.0	132.2	137.2	111.6	103.7	4.3	64.4	54.8	66.1	79.1	38.7	15.9	124.8	112.5	53.5	85.6	89.4	82.4	52.4	55.6	54.1	100.0	58.9	14.6	104.4	87.5	70.8	75.6	9.8	58.4	58.6	46.2	16.9	112.7	68.8	213.1	15.1	21.0	103.5	132.4	48.2	73.9	124.1	147.7	90.5	71.1	90.7	39.5	82.8	55.6	21.7	57.5	97.1	108.8	166.9	98.6	82.0	112.6	209.0
CCDC121	"FLJ13646, FLJ43364"	ENSG00000176714	"Coiled-coil domain containing 121"	Q6ZUS5	2	27625638-27629012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051791	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Actin filaments, Cytosol"		"HPA051791: AB_2681611"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-3)"	"prognostic favorable (4.12e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.65e-4)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.87e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.86e-2)"	"unprognostic (5.42e-2)"	4.0	3.1	5.1	1.8	5.7	1.3	5.2	6.1	6.3	3.9	5.0	3.0	2.4	4.8	4.4	2.8	7.1	2.6	6.0	4.8	5.6	5.3	2.9	4.0	2.3	8.6	7.2	9.9	2.4	7.7	2.5	3.4	6.0	4.3	3.0	7.2	5.3	5.7	3.6	3.0	2.2	3.4	5.4	4.1	3.4	25.3	8.6	2.4	7.1	5.6	2.2	2.3	1.8	7.8	3.3	3.8	5.1	5.7	9.1	4.0	6.4	1.7	0.8	1.7	0.8	2.9	3.0	1.7	2.6	1.1	4.9	3.1	3.8	1.4	1.8	2.4	4.1	1.0	2.1	3.8	1.7	1.5	2.9	1.3	4.5	0.9	2.4	2.8	3.4	0.8	4.6	2.3	2.4	2.8	1.2	1.6	5.3	4.2	1.9	5.7	12.4	3.0	3.5	2.6	6.6	7.6	1.4	6.3	2.2	4.1	5.2	3.6	1.8	1.5	5.5	1.3	4.7	1.4	1.5	2.5	3.6	2.1	1.8	1.8	1.9	10.8	0.4	2.9	1.3	2.3	1.4	0.5	1.4	1.9	2.3	1.6	4.2	2.3	3.4	0.4	0.3	1.0	5.1	5.7	6.1	6.3	4.8	5.6	8.6	7.2	6.0	5.4	8.6	7.8	7.3	6.4	2.6	1.6	2.9	0.6	1.7	0.8	0.6	5.1	2.4	3.2	3.2	4.3	1.9	0.0	20.9	3.1	1.3	1.9	7.9	3.6	186.5	17.1	5.2	5.8	1.2	1.7	0.7	1.1	2.0	4.2	2.6	7.6	0.0	2.8	5.3	2.0	1.9	3.3	1.1	1.3	2.0	1.6	2.1	44.7	8.7	2.2	1.8	0.0	0.8	12.7	0.0	1.5	2.9	2.0	0.8	6.8	0.3	1.2	1.4	3.9	21.2	12.4	13.1	5.6	3.2	31.0	10.0	1.4	1.1	1.8	1.7	4.9	2.1	0.8
CCDC122	FLJ31846	ENSG00000151773	"Coiled-coil domain containing 122"	Q5T0U0	13	43823909-43879740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 148.5;Spermatocytes: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034233, HPA054995, HPA061456"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.75e-2)"	2.3	2.9	1.7	1.9	2.9	0.9	3.8	1.4	2.0	2.7	0.7	2.9	1.7	4.1	5.3	2.1	4.4	3.1	4.6	1.5	1.9	3.0	2.4	2.0	2.7	2.5	2.2	6.1	3.6	4.0	3.2	3.1	2.5	4.9	3.5	0.6	3.2	2.4	1.1	4.0	2.5	3.3	1.7	2.9	3.1	4.1	2.2	2.1	4.9	0.3	2.7	2.9	2.0	4.9	2.2	1.8	0.8	0.0	0.6	4.0	2.3	5.7	6.4	3.0	3.3	3.0	7.6	3.8	3.2	3.4	4.9	3.4	0.7	0.8	3.9	5.7	2.8	1.6	1.0	1.6	8.1	0.9	0.4	10.4	6.7	4.2	10.9	2.5	1.4	1.4	0.0	1.1	4.0	2.6	0.6	0.6	0.9	0.5	2.1	0.9	0.0	2.1	4.5	1.2	2.0	3.1	4.0	0.1	3.4	4.3	0.6	0.6	7.1	0.2	0.8	4.9	0.0	0.0	0.0	1.8	2.7	0.1	2.9	3.5	0.6	1.1	0.5	0.6	0.6	1.0	0.7	0.5	0.5	1.3	0.5	0.5	1.4	1.4	1.1	1.2	0.7	0.4	1.7	2.9	1.4	2.0	1.5	1.9	2.5	2.2	2.5	1.7	2.2	4.9	5.6	9.6	11.7	8.5	5.2	3.1	8.9	6.1	9.6	1.9	10.5	12.1	11.1	10.0	8.5	7.3	0.0	17.5	1.7	4.5	19.6	13.1	2.8	14.3	11.3	6.7	18.0	6.1	15.8	10.1	11.6	9.2	4.6	8.3	1.3	13.8	5.7	4.9	2.0	10.1	24.7	9.4	0.0	2.2	2.7	2.3	17.7	3.9	1.8	21.5	0.8	12.7	0.0	28.6	148.5	7.6	2.9	7.9	1.3	8.3	6.4	12.0	19.1	0.6	0.0	7.4	6.7	43.2	26.3	5.5	3.8	7.9	2.9	14.0	7.1	6.4
CCDC124		ENSG00000007080	"Coiled-coil domain containing 124"	Q96CT7	19	17933015-17943991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041708, HPA046765"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA041708: AB_2677628, HPA046765: AB_2679793"	"unprognostic (9.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.22e-1)"	82.9	67.6	62.4	32.0	62.9	42.7	78.0	64.1	104.5	77.3	54.0	115.7	25.6	78.6	7.1	100.3	67.8	11.2	131.9	61.9	60.7	88.5	88.0	70.8	22.7	63.2	62.1	64.9	72.2	22.1	55.7	20.3	64.8	77.9	8.4	9.0	69.3	22.2	210.2	92.8	58.5	14.2	57.3	67.5	81.2	48.5	66.0	17.7	65.6	38.3	12.2	84.5	80.9	68.2	242.7	165.3	54.2	111.3	35.4	26.9	178.8	118.9	36.7	59.0	49.8	125.0	97.1	182.8	166.7	47.5	38.8	90.1	60.0	108.3	17.2	194.7	341.8	152.7	140.5	147.0	68.4	174.4	100.6	43.2	70.7	59.7	56.9	33.9	62.7	115.0	196.3	74.4	30.8	232.8	166.1	212.3	126.3	79.2	282.2	163.2	103.6	195.1	48.9	85.7	108.6	155.8	83.4	92.4	121.3	22.0	86.2	62.6	142.0	102.3	128.1	198.0	185.6	102.8	121.7	178.5	128.6	203.1	133.0	81.1	82.2	73.5	85.9	95.1	69.2	61.0	66.8	80.8	85.5	66.4	51.8	63.5	20.5	76.3	71.3	75.4	84.1	66.2	62.4	62.9	64.1	104.5	61.9	60.7	63.2	62.1	64.8	57.3	66.0	68.2	58.8	19.2	4.8	8.1	41.1	90.5	60.0	115.9	44.9	22.9	49.3	57.3	15.6	35.8	58.7	73.5	2.1	93.8	44.1	108.9	137.0	146.2	33.4	46.7	50.9	57.3	61.0	79.8	7.4	199.0	140.2	58.1	79.0	56.5	27.3	73.9	50.7	57.1	110.3	10.1	6.4	89.0	101.7	60.0	73.2	106.1	32.6	50.3	96.0	4.7	86.4	50.9	50.4	4.5	7.1	227.9	70.0	41.3	68.7	108.7	78.5	142.3	44.8	23.1	19.7	43.4	76.0	30.9	39.9	79.6	109.8	82.8	42.8	184.7	88.6	73.5
CCDC125	KENAE	ENSG00000183323	"Coiled-coil domain containing 125"	Q86Z20	5	69280175-69332809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.0;neutrophil: 11.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041878	Approved		Uncertain	"Nucleoplasm,Nuclear membrane,Intermediate filaments"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane, Intermediate filaments"	Nucleoplasm	"HPA041878: AB_10796787"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (4.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (2.51e-4)"	3.3	3.9	2.3	2.9	2.4	10.9	7.0	2.6	2.8	2.8	2.7	4.8	4.9	2.7	2.6	4.5	3.6	3.3	2.1	2.1	2.5	3.8	12.9	3.3	2.9	2.7	2.7	3.0	5.1	3.2	4.3	3.9	3.2	6.9	5.6	3.2	6.6	1.9	2.0	3.8	5.4	1.3	2.0	3.5	5.9	1.4	2.5	2.4	2.9	1.1	2.4	3.2	2.9	3.5	3.1	5.0	0.9	14.0	1.6	0.9	17.9	1.8	2.6	1.2	0.7	4.4	15.3	5.5	10.4	2.1	1.1	3.9	10.3	5.3	1.1	19.4	8.1	3.5	7.5	8.6	4.2	3.9	1.9	5.5	2.6	5.7	1.7	2.8	2.0	6.6	10.6	2.3	1.1	12.5	4.9	6.1	0.2	3.9	3.2	7.2	0.0	7.4	6.7	3.5	5.8	3.6	3.7	8.2	2.8	0.2	27.0	3.9	2.3	1.1	2.0	3.4	2.9	10.8	17.8	2.0	3.5	20.5	0.5	6.9	1.0	15.0	1.1	1.0	0.9	1.1	0.9	0.8	1.7	0.8	0.8	0.5	11.4	1.1	2.8	1.3	0.7	0.9	2.3	2.4	2.6	2.8	2.1	2.5	2.7	2.7	3.2	2.0	2.5	3.5	4.7	25.6	20.4	21.9	5.7	1.0	4.0	8.5	7.4	4.7	13.4	10.3	5.9	7.2	16.8	1.8	2.1	34.2	4.4	11.0	5.9	13.7	0.9	31.6	5.6	3.4	1.2	9.2	17.2	12.2	8.5	5.5	28.5	15.1	15.8	9.9	1.8	17.9	6.1	3.3	16.7	14.1	10.2	4.1	2.7	1.9	2.1	8.7	1.8	17.8	7.8	4.5	5.2	16.1	13.4	8.6	17.1	2.2	6.9	5.5	9.6	8.9	60.7	7.4	0.0	5.3	4.7	1.8	3.1	8.5	1.0	12.4	5.2	14.1	7.9	4.8
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597382-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.6"	"Group enriched"	"Detected in all"	18	"Early spermatids: 642.3;Late spermatids: 490.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 479.0"	"Lineage enriched"	"Detected in all"	23	"granulocytes: 479.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		39000000	"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.5	7.5	3.7	4.5	4.1	7.6	8.4	6.5	4.9	6.6	2.5	5.2	8.6	7.2	4.8	5.9	6.4	5.9	5.0	3.6	4.6	7.2	11.6	6.1	8.9	5.0	5.2	6.8	8.4	11.7	4.3	4.5	4.5	5.5	6.1	8.4	5.4	5.5	7.1	4.8	7.0	6.2	4.6	6.3	6.5	34.6	4.7	5.4	9.4	10.0	8.8	6.3	4.4	4.1	6.0	4.1	8.9	11.3	14.6	8.1	20.4	7.4	7.3	6.2	9.0	4.3	1.9	12.8	11.3	6.2	11.8	3.4	3.9	3.5	8.1	2.7	5.1	2.2	1.6	5.6	5.8	5.9	10.9	8.7	10.0	2.0	1.9	5.2	8.4	5.3	5.2	3.5	7.6	2.8	4.1	7.1	4.2	7.9	5.1	2.7	14.0	3.9	6.5	2.7	5.4	10.2	7.6	7.2	5.6	13.8	6.1	5.4	10.2	3.7	6.5	8.4	5.9	9.9	10.5	9.2	4.1	8.5	20.2	479.0	18.0	86.7	14.7	17.0	17.6	20.7	15.8	17.0	15.6	19.3	19.2	15.0	35.2	16.8	17.1	3.2	19.3	15.6	3.7	4.1	6.5	4.9	3.6	4.6	5.0	5.2	4.5	4.6	4.7	4.1	17.3	6.4	8.1	12.7	12.8	19.1	7.9	8.0	13.6	14.1	15.4	10.7	9.0	12.8	8.2	12.9	8.4	10.2	9.3	7.3	7.9	10.1	642.3	11.1	9.0	10.8	15.0	4.8	14.0	9.1	6.8	11.5	13.3	9.5	7.0	3.7	10.8	15.2	6.9	8.4	17.4	8.7	16.2	7.9	9.6	490.0	11.5	9.5	14.2	12.2	11.4	7.7	14.4	18.6	20.1	10.4	7.3	14.3	12.8	8.3	8.4	8.9	14.6	14.1	13.1	12.0	12.9	31.1	26.3	12.1	23.7	20.2	11.3	29.2	5.9	6.9
CCDC127	FLJ25701	ENSG00000164366	"Coiled-coil domain containing 127"	Q96BQ5	5	196868-218153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045052	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045052: AB_10960630"	"prognostic unfavorable (7.01e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (2.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (2.42e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-1)"	4.6	7.8	4.2	4.2	4.6	2.1	4.1	5.3	5.7	5.1	5.8	6.0	4.8	6.2	3.9	7.4	5.5	7.0	9.8	4.2	5.3	4.3	3.8	3.6	7.6	5.9	5.3	8.1	4.7	2.7	4.4	4.0	5.7	5.7	1.9	20.3	4.4	3.0	12.1	6.9	5.8	3.2	2.9	4.1	5.2	6.3	5.1	3.0	13.2	5.1	2.3	4.6	3.9	5.2	5.6	7.3	8.0	14.5	9.6	7.3	7.8	10.6	5.5	4.7	4.6	7.6	11.5	11.6	15.0	4.9	6.1	7.2	4.9	4.1	4.5	29.8	8.8	4.1	35.8	6.8	5.6	3.1	7.3	6.0	6.5	4.4	3.1	11.1	3.9	6.3	7.0	4.0	5.0	4.5	6.0	6.7	6.8	3.4	8.8	7.0	5.9	9.6	8.8	5.7	8.7	13.8	14.7	10.0	9.7	6.3	13.1	6.2	8.3	11.8	6.9	4.8	4.4	6.7	6.0	8.0	7.7	5.6	7.5	3.5	3.1	5.1	5.2	3.6	5.7	6.6	5.4	6.4	3.1	6.0	6.3	7.1	1.8	6.3	3.3	5.6	4.4	3.9	4.2	4.6	5.3	5.7	4.2	5.3	5.9	5.3	5.7	2.9	5.1	5.2	13.8	16.0	10.4	3.9	7.8	14.1	13.6	29.2	10.2	17.4	11.4	15.0	28.0	5.7	16.8	5.5	18.8	33.1	13.9	9.8	3.9	30.7	7.8	16.6	17.9	14.8	8.4	6.5	3.8	15.1	28.8	19.9	4.6	15.5	9.5	17.2	14.6	12.5	19.9	38.7	4.6	9.6	16.2	6.5	10.7	7.3	20.8	10.6	8.8	1.9	20.3	34.8	11.3	7.5	5.8	15.8	3.7	19.9	8.7	14.9	20.0	8.6	19.3	31.4	13.1	11.6	13.4	40.1	30.8	6.9	8.0	30.1	11.1	21.1	7.6	12.9
CCDC130	MGC10471	ENSG00000104957	"Coiled-coil domain containing 130"	P13994	19	13731760-13763296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056977	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA056977: AB_2683297"	"unprognostic (6.54e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.83e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.69e-2)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.82e-4)"	24.4	20.9	17.3	20.5	21.1	23.1	26.2	18.3	24.8	30.4	21.2	24.8	17.1	27.3	3.6	22.5	28.9	11.7	26.8	17.3	20.7	26.9	24.7	27.2	23.4	22.9	20.1	37.5	25.8	13.1	28.9	15.0	22.1	27.2	7.5	13.4	24.3	10.6	28.2	26.4	29.6	10.9	17.9	31.3	25.0	20.4	21.2	16.5	32.6	11.6	12.2	25.5	27.1	28.7	14.9	10.1	19.3	19.7	12.5	9.7	11.9	15.6	13.2	14.3	13.5	9.5	10.2	12.6	11.3	12.5	11.4	14.4	8.9	8.0	4.6	21.6	26.2	9.7	34.3	14.5	24.4	9.5	24.9	13.8	17.3	17.6	12.0	15.2	16.6	23.2	9.9	22.9	9.0	11.1	25.8	21.1	13.2	7.7	20.1	22.1	9.4	17.1	11.4	16.8	11.8	15.5	10.0	10.4	25.0	9.7	8.3	22.5	13.7	23.2	9.6	27.9	20.4	36.5	14.8	10.3	20.2	22.6	16.2	18.3	12.9	20.3	13.2	11.3	16.4	15.2	14.2	14.1	13.1	18.0	13.0	14.8	13.5	14.4	15.2	10.8	12.8	11.3	17.3	21.1	18.3	24.8	17.3	20.7	22.9	20.1	22.1	17.9	21.2	28.7	25.5	9.6	17.9	21.5	29.0	13.4	15.4	20.2	15.4	30.3	18.6	18.4	14.5	8.6	18.6	29.5	27.1	17.3	31.4	25.6	7.9	17.6	40.2	22.7	24.8	22.4	18.7	16.0	19.8	15.7	19.1	19.5	53.0	26.9	24.6	34.9	17.5	10.8	18.0	26.9	24.9	18.1	24.4	18.6	33.8	24.4	19.0	21.9	24.9	15.0	24.9	26.0	17.5	14.1	30.3	18.1	25.5	17.0	27.3	12.8	32.1	18.9	23.0	41.7	26.3	16.6	23.6	35.5	20.3	19.2	15.6	35.0	31.0	31.8	17.5	11.0
CCDC134	FLJ22349	ENSG00000100147	"Coiled-coil domain containing 134"	Q9H6E4	22	41800679-41832164	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003936	Approved				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA003936: AB_1078419"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (4.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.24e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.47e-1)"	"unprognostic (6.63e-2)"	1.4	10.2	2.2	3.7	2.5	12.6	2.7	9.0	2.4	2.0	2.3	2.6	3.3	1.8	10.5	2.7	3.6	1.3	2.1	2.0	1.9	2.8	2.7	2.4	4.0	3.3	2.7	2.1	3.7	5.0	1.6	2.7	2.8	2.5	2.8	5.8	4.3	2.6	2.8	4.6	3.6	1.8	1.8	2.9	4.2	6.1	3.8	3.7	2.5	2.3	4.6	1.6	1.4	3.5	8.6	6.4	7.3	11.0	4.4	1.3	5.9	7.1	3.8	9.4	11.2	9.7	5.4	8.6	12.1	5.0	7.2	9.5	7.7	5.6	7.0	7.5	11.2	7.5	19.4	7.1	2.3	10.8	8.7	2.2	2.5	11.6	2.5	4.3	4.4	7.5	4.5	16.1	6.1	5.8	7.0	7.3	4.9	11.5	5.4	12.6	11.6	11.0	7.7	7.1	3.6	3.2	13.8	10.3	5.3	4.1	12.6	5.5	3.6	7.5	11.6	4.5	12.0	18.3	11.9	6.8	7.2	6.6	12.2	1.1	3.3	6.9	4.1	5.1	2.9	3.8	2.6	3.5	1.5	2.5	4.7	3.3	1.9	3.6	5.2	1.6	5.2	2.2	2.2	2.5	9.0	2.4	2.0	1.9	3.3	2.7	2.8	1.8	3.8	3.5	1.0	3.2	2.0	6.8	2.5	0.3	1.5	2.4	0.6	1.1	2.1	1.5	0.8	2.8	1.5	3.7	2.1	4.0	3.0	3.3	0.0	5.0	0.8	3.5	1.3	1.7	0.0	2.5	6.0	1.9	18.2	1.7	3.6	2.5	0.0	2.1	0.4	1.6	4.3	0.0	6.4	2.0	0.0	1.0	0.7	0.9	0.6	1.7	1.8	10.3	4.1	0.7	2.1	9.0	5.8	2.6	1.9	0.4	7.9	1.8	3.5	1.4	2.6	2.3	0.0	1.7	2.1	3.7	1.3	1.8	0.0	2.9	2.1	3.3	3.1	1.6
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;retina: 52.5;testis: 185.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 780.2;Late spermatids: 2032.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.5;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010646, HPA071015"	Enhanced	Approved	Approved	"Nuclear membrane,Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nuclear membrane, Plasma membrane"	"HPA010646: , HPA071015: AB_2686334"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	1.8	3.7	37.2	1.9	24.4	0.8	1.7	42.7	39.9	5.2	6.2	20.1	1.6	9.3	2.2	1.7	3.3	2.2	5.7	24.2	34.7	0.7	0.3	1.1	2.7	30.5	54.2	2.8	0.8	1.6	6.4	1.4	26.3	12.1	3.1	52.5	1.6	13.6	4.4	0.9	4.8	11.6	34.9	1.5	4.6	185.7	87.6	5.2	1.3	4.0	1.7	13.1	3.9	30.6	1.1	1.5	11.7	7.9	6.3	5.4	2.0	4.7	6.0	4.6	4.3	1.8	1.0	6.5	0.5	6.2	18.4	2.5	7.8	0.9	4.3	17.2	7.7	10.7	3.1	0.0	2.2	1.5	22.2	6.0	0.8	5.0	0.4	4.1	2.7	10.0	4.0	6.0	1.9	2.3	8.0	3.4	16.3	0.1	5.1	19.5	2.3	2.9	0.3	2.4	7.4	20.4	2.9	3.3	5.1	4.1	0.3	3.1	2.4	7.4	4.2	3.7	3.5	3.4	1.6	6.1	30.5	46.2	1.9	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	37.2	24.4	42.7	39.9	24.2	34.7	30.5	54.2	26.3	34.9	87.6	30.6	1.6	0.0	0.5	11.4	1.1	0.5	0.9	0.1	1.8	306.0	0.6	3.8	7.5	1.5	0.7	0.0	98.0	0.1	2.2	0.0	0.0	0.7	780.2	0.3	2.2	2.0	0.0	0.4	23.3	1.5	0.3	2.6	1.5	0.1	0.0	1.9	1.1	0.0	6.8	40.4	48.0	0.1	0.0	0.6	1.6	2032.0	18.0	2.3	0.0	10.3	0.7	22.5	2.1	28.6	13.3	0.6	0.1	7.5	1.1	0.9	0.0	0.2	2.0	20.7	6.6	1.6	6.1	321.9	17.2	0.1	0.4	0.4	3.4	0.3	0.0	0.3
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666737-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	8.2	9.5	13.8	12.3	13.7	17.7	7.6	13.5	17.5	10.7	14.2	9.3	11.4	7.5	5.5	23.1	7.8	6.1	6.5	13.7	13.8	10.2	10.8	7.7	16.3	14.4	14.3	6.7	8.2	7.0	6.2	7.7	14.7	11.7	5.8	2.8	9.9	6.4	7.7	22.8	10.7	6.0	13.4	15.6	8.8	10.4	14.5	11.8	7.8	4.5	11.5	9.8	13.8	14.3	38.0	62.8	21.5	35.3	13.9	13.1	35.2	41.6	19.7	53.0	30.6	55.1	22.8	33.8	22.4	21.2	36.6	47.9	34.5	43.8	30.6	19.4	51.7	51.6	30.1	48.0	20.7	46.6	37.5	19.8	26.3	47.6	26.3	14.6	37.4	41.1	53.3	19.1	28.3	34.5	45.7	56.6	46.9	32.9	59.8	55.4	34.6	24.1	19.8	29.6	45.1	57.7	41.1	87.8	37.1	28.9	58.8	48.3	27.8	82.0	53.5	34.9	65.9	53.1	28.7	36.8	30.8	42.9	48.8	2.2	7.7	11.7	11.5	9.6	6.3	10.4	8.7	8.8	7.5	13.2	9.2	8.8	3.3	13.1	11.9	12.9	9.8	5.9	13.8	13.7	13.5	17.5	13.7	13.8	14.4	14.3	14.7	13.4	14.5	14.3	17.9	22.4	17.0	5.9	29.8	31.7	22.8	19.7	74.6	6.8	17.4	13.7	6.7	15.7	20.9	12.9	2.1	25.7	31.5	19.7	19.6	25.2	1.7	26.5	32.9	20.3	7.2	37.5	4.5	21.4	41.0	16.5	29.0	29.4	19.6	28.1	15.4	11.8	24.3	18.5	4.6	17.0	14.2	12.9	11.5	1.7	13.7	16.8	16.0	4.7	24.2	13.8	37.0	4.0	5.0	35.2	16.0	13.5	25.7	40.0	12.4	15.9	21.6	9.1	6.6	13.7	22.3	30.8	44.9	57.0	34.4	20.8	29.7	22.8	22.4	24.2
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	1.0	0.9	2.0	2.0	1.8	3.5	2.4	4.8	3.1	1.3	2.1	1.9	1.0	2.1	1.3	2.1	4.3	1.8	0.7	2.4	2.3	1.7	2.8	1.3	4.5	2.6	2.4	1.6	1.7	0.7	0.8	1.3	2.4	1.4	2.3	2.3	1.3	0.7	1.0	2.4	1.7	1.5	2.0	1.2	1.8	10.9	2.0	6.4	0.8	0.7	3.8	1.6	1.3	3.0	14.7	6.7	22.4	11.6	1.8	2.0	14.2	6.3	2.0	14.6	10.6	21.8	8.4	35.2	9.2	2.0	7.3	12.2	16.3	8.5	13.0	8.2	21.0	16.3	11.6	18.2	2.2	22.4	2.3	1.4	2.5	17.2	5.1	2.2	7.7	15.0	31.4	15.8	7.5	8.2	32.2	15.3	33.3	8.0	6.9	21.1	21.2	21.3	8.1	11.5	15.7	15.3	13.6	7.3	11.1	13.6	7.8	10.7	4.9	9.2	16.2	6.0	13.5	4.9	12.2	36.4	3.8	17.2	9.3	2.6	0.5	0.8	1.1	1.2	2.2	3.0	1.5	2.3	0.5	3.2	2.2	2.6	0.3	2.0	0.4	4.8	2.4	1.2	2.0	1.8	4.8	3.1	2.4	2.3	2.6	2.4	2.4	2.0	2.0	3.0	2.4	0.0	3.3	14.7	7.9	2.4	3.5	4.5	6.8	7.3	3.6	3.9	1.4	2.8	9.6	1.8	8.4	5.2	13.6	0.9	1.9	3.7	154.1	38.9	7.0	2.7	5.4	5.9	56.5	1.4	5.5	6.3	8.6	7.3	4.5	6.7	1.1	2.4	2.2	6.7	58.9	2.5	2.0	1.6	1.5	34.0	3.7	3.9	1.8	10.3	1.3	1.8	6.2	19.1	48.7	3.3	0.5	1.9	14.4	1.1	0.7	1.7	43.8	7.0	0.0	5.0	3.5	29.5	20.1	7.0	2.8	1.4	5.9	5.5	2.9	2.3
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	"Centriolar satellite"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite"		"HPA035278: AB_2674548, HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (4.76e-4)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.72e-5)"	11.8	9.6	5.3	12.8	8.5	36.6	21.4	6.4	7.5	17.1	4.6	22.5	12.8	22.1	35.5	10.0	14.5	13.6	8.6	5.1	8.7	14.4	15.3	13.7	16.6	8.8	7.5	17.4	16.8	5.6	13.7	10.6	9.0	16.3	34.8	43.2	14.9	7.9	6.2	23.8	15.4	14.2	7.7	12.4	13.9	23.7	10.1	20.5	13.2	2.9	15.0	12.0	12.4	10.0	42.6	22.5	72.1	28.0	10.6	16.1	34.0	79.9	26.2	41.6	45.2	17.5	28.5	12.4	19.9	19.1	30.1	44.5	27.1	14.8	55.9	10.5	20.0	49.9	50.7	17.7	9.0	31.2	29.9	15.1	9.7	20.7	21.9	49.0	19.7	48.9	25.8	21.0	28.1	18.3	26.4	17.3	22.2	19.0	28.0	47.2	29.0	15.2	23.3	34.1	25.4	28.3	45.2	13.0	33.4	46.5	27.5	31.2	22.9	91.1	45.8	28.5	26.5	20.0	15.8	32.8	32.2	25.6	31.5	1.1	0.6	1.3	1.4	0.9	1.0	0.8	1.2	1.2	0.3	0.7	1.3	1.1	0.1	2.5	0.2	1.8	2.6	0.7	5.3	8.5	6.4	7.5	5.1	8.7	8.8	7.5	9.0	7.7	10.1	10.0	22.1	22.4	71.5	72.8	21.3	21.9	36.4	31.2	25.6	35.9	48.9	37.7	14.6	38.6	29.4	36.8	60.5	27.5	27.6	67.9	0.0	26.1	38.6	33.7	44.0	23.8	89.7	72.1	83.8	13.8	22.9	32.3	26.0	29.9	25.9	67.9	28.5	22.3	20.9	28.6	67.7	85.6	67.1	19.7	29.9	17.3	32.6	21.0	24.9	41.2	20.1	18.6	49.4	91.0	77.1	22.8	63.7	31.2	25.3	20.4	41.6	12.6	18.9	75.5	19.7	39.2	29.4	144.0	49.6	18.2	16.1	11.6	30.3	33.5	77.7	22.9
CCDC142	FLJ14397	ENSG00000135637	"Coiled-coil domain containing 142"	Q17RM4	2	74471986-74483408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 28.3;Respiratory ciliated cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056946	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA056946: AB_2683282"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.05e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.31e-3)"	1.9	2.6	3.0	2.4	2.9	1.5	1.9	5.6	3.5	2.7	3.6	2.8	4.4	2.6	1.3	2.4	2.4	1.2	1.8	2.8	2.6	2.2	4.6	1.8	2.6	3.5	2.7	2.6	2.2	2.7	2.9	1.2	3.1	2.8	1.9	1.3	2.4	2.0	1.5	2.6	3.3	1.5	2.3	3.3	2.4	3.2	3.1	2.5	2.4	1.2	2.2	2.3	2.0	4.1	2.7	2.1	4.3	3.4	2.8	2.7	7.5	4.0	2.4	3.2	2.4	6.3	3.8	3.2	2.6	2.5	3.9	4.8	2.8	3.1	2.1	4.5	8.9	5.6	7.7	4.6	1.2	3.6	4.2	1.9	2.1	5.0	2.1	4.1	2.5	3.8	2.6	2.2	3.0	2.3	4.8	3.6	4.1	4.7	5.3	5.7	7.8	2.9	1.9	3.9	5.5	3.4	3.1	6.4	3.5	3.1	4.3	2.5	2.1	6.3	4.0	4.4	4.9	6.6	3.1	3.2	2.9	1.9	3.7	6.3	3.0	5.9	5.1	1.8	4.1	3.3	2.9	3.6	1.6	5.3	4.6	3.8	2.4	4.7	3.8	2.9	1.4	1.1	3.0	2.9	5.6	3.5	2.8	2.6	3.5	2.7	3.1	2.3	3.1	4.1	2.5	9.6	28.3	3.3	6.1	3.2	2.4	1.4	1.8	16.4	2.8	2.0	4.1	2.8	16.2	0.0	18.8	3.1	6.1	6.2	1.9	2.7	1.1	1.3	4.2	5.6	6.0	4.8	3.3	2.0	2.2	6.7	4.1	1.8	18.3	8.6	6.8	2.1	2.0	5.0	3.6	5.3	0.0	3.3	3.0	0.4	7.5	5.8	0.0	5.6	4.2	11.5	16.5	2.5	2.4	1.5	5.7	6.0	4.6	1.7	14.0	1.3	31.2	22.9	0.0	6.1	4.0	8.1	5.0	1.2	3.0	1.9	7.7	5.9	6.3	2.0
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 2.4;cerebellum: 7.6;cerebral cortex: 6.9;hippocampal formation: 4.9;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.5;TIME: 8.5"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	1.3	1.3	0.6	2.1	2.4	4.2	1.5	7.6	6.9	1.1	0.0	1.7	0.7	3.5	2.5	0.8	1.6	1.2	1.2	4.9	0.0	0.5	1.1	1.3	1.7	0.8	0.0	4.5	2.7	0.4	1.6	2.7	0.8	1.5	0.9	7.4	1.2	1.0	1.0	2.5	1.0	1.6	0.0	1.8	1.5	9.1	0.0	3.3	0.8	2.3	1.2	1.6	0.9	3.9	0.5	3.4	0.8	2.1	3.0	9.5	0.4	0.2	0.0	0.2	0.2	4.4	0.1	0.5	2.8	6.2	0.2	5.3	4.4	0.3	0.2	3.2	0.2	0.4	0.5	0.3	0.2	0.7	2.7	1.7	0.1	2.1	0.2	0.9	0.1	0.1	0.4	0.3	2.0	0.1	0.0	1.1	0.6	0.9	0.4	1.4	0.2	0.1	0.1	4.1	1.1	1.2	0.6	0.2	1.2	1.5	3.4	0.1	8.5	0.7	0.4	4.6	1.4	5.7	6.3	0.2	0.3	6.2	1.6	0.2	0.1	0.0	0.5	0.1	0.3	0.2	0.5	0.3	0.1	0.1	0.9	0.5	0.2	0.2	0.4	0.2	0.5	0.0	0.6	2.4	7.6	6.9	4.9	0.0	0.8	0.0	0.8	0.0	0.0	3.9	5.9	0.0	14.9	15.7	3.1	4.0	6.4	1.9	0.0	40.8	4.5	2.5	2.8	2.8	2.9	0.0	54.2	4.9	6.4	1.7	0.0	1.8	59.1	8.0	25.8	9.1	1.2	1.7	21.2	0.0	7.1	9.7	2.0	10.4	26.0	6.2	3.6	2.0	4.2	33.7	19.8	2.4	2.0	6.8	7.7	6.5	7.2	6.3	5.4	1.0	3.6	7.1	6.2	17.1	4.0	1.7	3.8	9.1	1.7	8.6	1.2	1.1	3.9	49.4	6.6	11.7	10.2	165.9	36.1	0.2	3.7	1.9	6.9	22.2	2.1	4.6
CCDC146	"KIAA1505, MBO2"	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 34.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020082, HPA020105"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	2.2	1.1	4.0	2.5	3.7	1.7	2.4	2.0	2.5	4.5	18.3	3.8	2.4	4.6	2.5	3.6	34.0	3.1	1.8	2.7	4.4	4.2	1.8	5.2	3.0	11.5	11.4	3.3	2.5	3.9	3.8	1.9	7.4	3.7	2.7	14.5	4.1	2.3	1.1	9.4	2.8	3.0	7.8	3.7	3.3	21.5	3.9	3.1	7.7	1.6	2.7	3.1	3.9	6.3	0.6	0.9	2.7	1.4	1.7	1.7	0.3	0.7	0.6	0.7	1.1	0.0	4.6	1.4	0.1	0.2	2.6	0.9	0.4	0.8	1.1	1.9	0.3	1.8	1.5	0.8	0.5	1.8	1.3	0.8	1.3	1.2	0.2	2.2	0.6	1.4	0.0	1.4	0.1	0.2	1.5	2.9	0.3	0.6	0.6	4.0	0.4	0.2	2.8	0.5	2.0	1.3	1.0	0.9	0.6	0.8	0.8	0.6	0.9	1.0	0.4	1.4	0.4	2.7	4.5	1.2	2.3	2.7	2.3	0.9	0.6	14.3	4.4	0.9	3.0	1.2	1.9	3.1	0.8	0.2	1.2	2.0	15.4	5.3	0.4	2.0	1.6	0.8	4.0	3.7	2.0	2.5	2.7	4.4	11.5	11.4	7.4	7.8	3.9	6.3	6.9	3.2	9.7	34.0	3.6	7.1	2.6	16.9	6.2	8.6	2.7	4.6	32.0	2.8	56.9	5.5	62.6	1.2	9.3	2.8	21.5	3.2	308.3	460.8	11.1	4.8	1.8	0.4	49.0	1.6	0.7	15.4	6.1	106.0	6.3	6.1	23.6	0.8	1.6	5.0	48.8	1.4	24.4	3.5	7.1	52.4	12.2	4.5	5.4	50.6	2.0	12.1	20.6	151.3	62.8	1.7	5.2	6.4	3.7	5.8	2.9	30.1	417.9	55.1	6.6	15.6	11.6	149.4	10.8	5.5	3.4	2.5	8.6	7.2	4.0	5.4
CCDC148	MGC125588	ENSG00000153237	"Coiled-coil domain containing 148"	Q8NFR7	2	158171073-158456753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.0;testis: 3.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Early spermatids: 39.4;Excitatory neurons: 33.6;Inhibitory neurons: 53.0;Oligodendrocytes: 38.6;Respiratory ciliated cells: 34.1;Rod photoreceptor cells: 30.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;HBF TERT88: 1.8;RPTEC TERT1: 1.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042626	Uncertain		Uncertain	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA042626: AB_10806244"	"unprognostic (1.88e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.94e-4)"	"unprognostic (3.29e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (6.57e-3)"	0.2	0.3	0.5	0.0	0.6	0.0	1.0	0.9	0.4	0.7	3.0	0.0	0.0	0.4	1.2	0.1	1.8	0.3	0.1	0.5	0.4	2.4	0.1	0.4	0.0	0.9	0.7	0.7	0.2	2.5	1.0	0.0	0.6	0.3	0.0	2.0	0.6	0.4	0.0	0.2	0.0	0.1	0.5	0.0	0.1	3.4	0.5	0.0	1.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.4	0.7	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.5	2.7	0.0	0.1	0.4	0.2	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	0.2	2.0	0.1	0.3	0.2	0.2	0.6	1.2	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.6	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.9	0.4	0.5	0.4	0.9	0.7	0.6	0.5	0.5	0.3	1.1	0.0	1.5	13.4	0.2	0.0	2.6	4.2	1.2	10.9	3.8	4.6	3.0	0.0	3.0	7.3	56.3	0.0	0.0	0.0	13.7	5.5	39.4	15.2	0.6	1.5	0.0	0.0	33.6	2.0	0.0	0.6	0.0	2.8	0.0	1.3	1.1	1.3	0.1	5.0	53.0	0.0	10.2	0.3	0.0	7.7	0.9	1.0	0.0	5.6	0.8	6.0	0.0	19.6	38.6	2.6	0.0	1.9	0.0	1.2	0.0	6.4	34.1	30.8	6.6	1.6	0.7	22.6	4.0	0.6	0.4	0.0	0.2	1.3	0.1	1.7
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	9.7	5.3	11.0	6.2	12.1	2.0	11.9	7.8	13.1	10.4	7.5	11.1	3.7	10.4	6.3	4.6	10.1	6.8	8.4	12.1	10.7	8.4	8.7	8.9	2.2	9.1	9.2	10.6	19.1	8.1	7.2	8.4	9.2	11.4	5.9	8.5	18.8	6.7	7.0	6.6	5.9	10.2	7.9	4.9	13.1	3.7	12.3	2.5	8.8	7.6	2.2	9.0	7.0	11.5	6.0	2.3	4.8	0.8	7.5	13.4	1.3	8.4	13.4	6.9	7.9	0.1	6.9	0.0	3.9	17.0	7.8	1.1	1.4	1.0	4.5	0.0	0.0	0.0	0.4	0.5	6.2	0.0	0.0	9.3	6.5	4.1	0.0	18.8	5.6	0.0	0.0	1.2	4.2	6.3	0.0	0.1	5.3	0.6	5.3	0.0	0.0	0.4	12.5	4.2	5.3	0.1	3.2	5.5	17.8	5.1	9.3	13.8	12.0	10.0	0.9	7.5	7.3	0.1	0.0	0.0	30.6	1.4	6.8	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.5	11.0	12.1	7.8	13.1	12.1	10.7	9.1	9.2	9.2	7.9	12.3	11.5	14.3	0.0	9.5	23.5	0.4	6.2	7.2	2.7	6.8	11.9	11.7	6.9	5.7	5.7	3.7	7.3	10.4	7.1	0.1	2.3	0.0	6.6	1.1	7.4	6.6	13.6	1.8	2.7	30.2	10.4	1.5	8.1	6.6	7.8	0.0	8.3	10.4	6.4	12.2	5.0	39.8	11.9	0.0	9.7	2.1	1.7	10.8	8.1	8.8	16.9	6.7	9.1	0.0	27.6	20.9	8.7	5.6	11.7	1.1	11.0	0.7	2.3	3.1	11.6	6.6	12.5	9.7	1.6	2.8	1.7	3.1	10.7	0.7	2.0	5.2	6.7
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	0.7	0.3	0.5	0.9	0.8	2.1	2.8	0.5	0.6	0.6	0.3	0.8	0.7	0.6	1.5	0.8	1.1	0.5	0.2	0.6	0.5	0.6	1.3	0.7	1.2	0.9	0.6	0.8	0.8	0.6	0.5	0.7	0.6	1.6	0.8	1.7	3.9	0.5	0.1	2.1	0.7	0.6	0.7	0.8	0.6	10.5	0.7	2.8	0.7	0.2	1.4	0.5	0.6	1.2	5.4	1.0	6.9	0.0	0.5	1.9	0.0	5.7	6.9	5.3	6.5	0.1	4.4	6.3	4.9	2.0	10.5	4.2	2.9	3.8	9.4	5.3	1.1	7.7	0.8	1.6	0.2	2.3	4.3	0.5	2.7	11.0	5.5	1.0	4.0	7.8	5.2	6.3	11.2	1.2	4.9	2.6	1.6	4.6	6.3	5.9	12.6	2.0	0.8	2.1	3.9	3.4	3.3	0.4	1.5	3.3	7.9	2.0	2.9	10.8	2.4	4.8	7.2	1.5	1.8	5.3	1.5	12.6	7.3	4.0	0.5	0.8	1.0	0.7	1.1	0.3	0.9	1.7	0.1	0.7	1.2	1.4	0.4	1.1	0.8	0.5	1.7	0.5	0.5	0.8	0.5	0.6	0.6	0.5	0.9	0.6	0.6	0.7	0.7	1.2	2.4	3.2	1.1	5.2	2.3	5.0	2.1	2.2	2.2	6.4	4.2	2.8	0.6	0.0	2.9	0.0	0.0	0.9	2.9	1.1	0.0	2.3	42.8	2.6	2.0	3.4	1.2	26.3	1.2	3.5	0.4	2.5	3.6	1.4	8.9	4.4	1.4	1.4	3.2	3.3	2.0	2.1	0.0	2.6	3.3	25.8	4.4	2.6	3.6	1.0	0.7	3.6	8.2	5.0	6.1	1.8	0.5	2.2	1.2	1.1	0.2	1.0	5.3	2.8	6.6	2.2	2.3	99.7	34.5	3.2	3.8	0.1	3.4	0.9	1.7	1.2
CCDC150	FLJ39660	ENSG00000144395	"Coiled-coil domain containing 150"	Q8NCX0	2	196639554-196763490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.6;testis: 4.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.5;Granulosa cells: 16.5;Late spermatids: 20.9;Oligodendrocytes: 16.4;Spermatocytes: 32.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048104	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA048104: AB_2680264"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.58e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.91e-4)"	"unprognostic (2.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.17e-3)"	"unprognostic (5.66e-4)"	"unprognostic (7.29e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.69e-5)"	0.1	0.0	0.2	0.2	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.6	1.2	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.9	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.3	4.4	2.8	0.1	0.3	1.9	1.0	0.5	0.7	1.9	1.5	0.9	0.6	0.5	0.7	0.6	1.3	1.7	0.8	1.9	4.2	2.4	1.4	2.4	2.5	0.0	0.9	0.6	0.0	0.1	1.0	0.5	0.2	0.5	1.5	2.0	1.8	0.5	0.5	0.8	1.3	2.6	0.3	1.0	1.8	0.6	0.6	0.3	0.4	4.6	0.9	0.7	0.4	0.2	2.2	0.7	0.5	0.9	1.5	1.4	1.4	0.9	0.8	0.8	1.4	0.5	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	1.5	3.2	1.7	2.3	1.0	1.5	2.2	0.2	0.0	3.6	0.6	1.3	1.5	1.5	0.1	0.0	2.1	2.2	0.7	1.4	1.9	0.3	54.5	2.1	1.7	2.6	0.0	2.1	1.1	0.4	2.0	2.3	1.5	3.8	3.8	16.5	1.4	3.8	1.3	1.7	3.0	1.4	0.0	1.3	2.5	20.9	1.5	1.3	7.2	0.0	0.5	1.1	2.1	2.0	16.4	0.4	1.2	1.9	2.4	1.3	0.7	12.5	2.5	1.3	0.0	4.0	2.3	32.2	14.8	2.0	1.0	0.7	1.2	2.8	1.7	1.3
CCDC151	"MGC20983, ODA10"	ENSG00000198003	"Coiled-coil domain containing 151"	A5D8V7	19	11420604-11435782	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.0;parathyroid gland: 9.8;testis: 10.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Kupffer cells: 51.6;Muller glia cells: 58.9;Respiratory ciliated cells: 29.6;Spermatocytes: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.0;T-47d: 4.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054626	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 5: Muller glia cells - Visual perception"			"HPA054626: AB_2682547"	"unprognostic (1.50e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.76e-4)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.05e-1)"	0.4	2.8	4.6	0.0	4.6	0.0	0.4	4.7	6.5	1.6	15.0	0.3	0.0	0.6	0.3	0.2	8.5	0.0	1.9	5.0	4.7	3.5	0.7	2.3	0.0	6.4	6.8	0.6	0.4	9.8	7.0	0.4	5.7	0.8	0.0	0.9	1.7	0.5	0.1	0.5	0.2	0.0	5.2	2.6	0.4	10.4	4.6	0.0	2.9	0.0	0.0	0.3	0.8	4.9	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.2	0.1	0.3	0.4	0.0	0.0	0.1	0.2	0.1	1.2	0.1	0.5	0.2	0.0	0.5	0.5	0.2	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.5	0.1	0.4	0.0	0.1	0.2	0.1	1.0	0.2	0.0	0.7	0.3	0.0	2.0	1.3	0.6	0.1	0.1	0.1	4.8	0.2	0.0	0.8	0.1	1.7	0.0	1.7	1.4	0.1	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	4.6	4.7	6.5	5.0	4.7	6.4	6.8	5.7	5.2	4.6	4.9	1.1	0.0	0.0	6.5	5.7	0.9	0.7	1.0	0.6	1.1	0.8	1.3	2.2	1.5	2.6	12.9	0.0	0.5	0.0	0.0	29.4	0.2	12.4	20.3	4.2	2.9	0.0	0.0	2.3	0.2	0.5	3.8	0.5	1.1	4.5	1.6	14.3	1.2	4.7	1.7	1.7	0.5	2.0	51.6	1.7	14.5	2.8	7.8	7.2	1.0	2.6	58.9	0.0	1.0	0.8	0.1	0.0	0.7	0.8	0.1	0.1	1.1	29.6	3.2	6.6	15.2	6.8	22.7	6.6	0.1	0.4	1.2	1.5	1.0	0.0	0.5
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756818-42802439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 178.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 43.4;Spermatocytes: 103.0;Spermatogonia: 37.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 13.6;JURKAT: 13.3;U-2 OS: 23.5;U-266/84: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	7.5	5.7	2.3	2.2	5.4	1.5	6.5	4.6	2.9	6.0	2.9	5.2	3.9	3.0	0.6	2.2	4.1	4.9	7.8	2.1	4.7	8.6	178.0	6.1	7.4	5.8	5.1	8.3	4.0	0.0	7.8	2.3	6.6	4.6	0.3	2.2	2.7	0.3	1.8	3.3	13.3	0.4	4.0	14.9	4.5	5.0	4.6	4.0	3.3	0.6	2.6	2.6	4.9	7.1	0.4	0.1	1.0	0.1	3.2	4.1	0.0	5.7	0.1	0.0	0.4	0.0	0.3	0.0	0.3	2.6	4.3	4.6	0.0	0.0	0.5	0.1	0.4	0.2	13.6	5.5	3.2	0.1	0.0	5.3	0.0	2.3	0.0	8.5	1.8	13.3	0.6	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.4	6.5	0.0	0.1	0.0	4.7	0.4	0.1	0.1	0.2	23.5	5.2	0.2	0.1	16.8	0.2	6.9	0.2	0.1	0.0	0.1	0.1	3.1	0.6	3.7	2.0	2.3	3.9	0.6	2.7	3.0	4.7	0.2	5.1	0.3	8.3	1.6	1.0	2.3	5.4	4.6	2.9	2.1	4.7	5.8	5.1	6.6	4.0	4.6	7.1	4.9	60.9	43.4	3.9	10.2	3.7	0.3	0.7	2.2	15.8	1.9	1.5	11.7	2.8	7.6	1.8	0.0	1.6	6.0	2.4	0.0	0.8	14.9	2.3	11.1	4.3	1.2	10.3	2.6	1.1	1.0	17.7	0.0	3.1	9.5	5.3	7.1	5.1	2.6	33.7	9.3	2.9	2.0	14.4	5.6	7.4	6.5	8.0	3.6	1.0	0.9	34.2	21.6	7.5	13.0	1.9	3.0	7.5	3.4	0.3	6.4	0.7	3.9	2.7	0.0	13.0	5.0	103.0	37.8	3.5	4.0	1.8	9.1	10.5	1.3	0.3
CCDC153	LOC283152	ENSG00000248712	"Coiled-coil domain containing 153"	Q494R4	11	119189638-119196769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.1"	"Group enriched"	"Detected in many"	7	"Endometrial ciliated cells: 92.3;Respiratory ciliated cells: 186.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 4.0;neutrophil: 15.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;EFO-21: 4.2;HEL: 5.0;T-47d: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041497	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA041497: AB_10794378"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.98e-3)"	1.1	0.7	1.5	0.5	1.2	2.5	0.7	2.7	1.6	0.9	2.7	0.7	0.3	0.8	0.2	1.0	11.1	1.1	0.3	1.3	1.6	1.3	0.4	1.5	0.3	2.0	1.9	0.2	0.3	2.8	3.3	0.9	1.4	0.4	0.5	1.5	0.5	1.1	0.4	0.7	0.6	0.5	1.7	0.5	1.1	1.8	2.0	0.3	0.8	0.0	0.2	0.4	0.5	1.8	0.6	0.9	0.9	1.0	0.2	0.1	2.8	0.6	1.1	0.4	0.5	1.9	4.8	0.2	4.2	0.2	1.3	0.5	0.3	1.1	0.1	1.1	0.6	5.0	0.4	0.3	0.7	0.6	0.3	0.5	0.7	1.2	0.3	1.4	1.2	0.6	0.7	0.9	0.1	3.4	0.3	0.7	0.3	1.2	1.0	0.7	0.1	0.3	0.4	0.8	1.0	0.2	1.3	0.8	0.7	0.3	8.8	1.4	1.2	0.7	0.5	0.3	0.4	0.4	0.5	0.2	0.3	0.2	0.3	0.5	2.3	4.0	0.3	1.6	0.1	0.3	0.2	0.4	1.7	0.3	0.5	0.4	15.8	0.2	1.6	1.7	0.4	0.8	1.5	1.2	2.7	1.6	1.3	1.6	2.0	1.9	1.4	1.7	2.0	1.8	4.4	0.0	6.1	0.0	0.6	2.8	1.7	14.9	1.8	0.4	2.3	2.2	0.4	1.5	19.8	7.3	0.0	4.3	0.7	5.3	0.0	1.1	3.5	92.3	1.9	3.3	1.8	0.0	0.5	2.0	3.5	2.1	4.6	2.3	0.0	1.5	3.3	1.8	3.6	0.0	0.4	4.2	12.2	4.6	5.5	7.0	0.3	2.7	3.6	1.0	4.5	0.8	1.0	0.0	0.6	1.1	11.3	2.6	3.0	1.0	3.3	4.8	186.9	2.0	6.6	0.7	9.9	5.9	4.0	1.6	2.3	3.3	0.6	0.5	2.9	2.7
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"		16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 51.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323"	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	0.8	1.5	0.9	1.7	1.0	0.8	1.7	2.2	1.9	0.5	1.2	1.4	1.0	0.3	0.4	1.9	0.5	0.7	1.4	1.3	2.3	0.7	0.8	1.4	1.8	1.4	1.5	1.2	0.1	3.8	0.4	1.6	1.5	0.1	0.8	0.7	0.4	0.8	1.5	1.2	0.2	0.9	2.2	2.0	11.6	1.5	0.4	2.8	0.1	0.4	0.8	0.9	2.4	9.5	0.4	0.3	0.6	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.4	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.7	0.0	4.7	0.2	0.0	0.1	2.8	0.1	0.2	0.0	0.2	33.2	0.5	0.1	0.2	1.4	0.1	1.0	2.4	0.0	0.4	0.1	0.4	0.0	5.8	1.6	0.1	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.7	2.2	1.4	1.3	1.8	1.4	1.6	0.9	1.5	2.4	0.2	0.0	0.0	9.8	1.4	0.0	0.5	0.2	0.0	3.2	0.5	0.6	0.6	1.5	0.1	3.7	8.4	0.0	0.4	0.1	0.0	0.1	51.6	0.3	0.3	0.1	0.0	0.0	3.9	0.4	0.0	0.3	1.1	0.3	1.3	1.5	0.4	0.2	0.8	6.7	4.8	0.5	0.0	0.3	0.8	11.1	1.5	0.6	1.8	7.5	0.8	2.4	0.0	2.0	3.8	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.8	4.2	0.0	0.3	0.6	10.1	1.2	0.0	0.4	0.0	0.7	0.4	0.0	0.2
CCDC157		ENSG00000187860	"Coiled-coil domain containing 157"	Q569K6	22	30356635-30378658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.0;Late spermatids: 142.4;Respiratory ciliated cells: 44.9;Spermatocytes: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA042943	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA042943: AB_10794767"	"unprognostic (3.69e-3)"	"unprognostic (1.72e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.74e-3)"	"unprognostic (8.72e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.89e-4)"	"unprognostic (2.33e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-2)"	0.7	1.4	3.9	0.9	3.5	1.8	1.2	2.9	3.8	1.5	7.3	0.9	0.9	1.0	1.8	1.1	7.4	1.2	0.7	3.8	4.1	3.0	0.9	2.2	1.1	4.3	5.9	1.2	1.9	2.2	5.0	0.5	3.3	1.7	0.4	1.9	1.5	0.9	0.6	1.0	1.2	0.4	3.6	1.6	1.1	27.6	5.0	0.8	3.6	0.5	0.7	0.9	1.0	2.7	1.8	2.0	1.8	3.4	1.0	0.6	2.2	0.9	1.1	1.7	1.7	2.6	1.3	1.6	1.1	0.9	2.6	1.9	1.0	1.2	0.9	1.1	4.3	0.9	2.0	1.4	1.1	1.7	1.4	0.6	0.8	3.1	0.5	1.1	1.0	2.3	1.5	1.4	1.4	1.6	2.2	1.8	2.4	1.2	1.0	1.9	1.0	1.4	4.2	1.8	6.1	4.0	2.8	1.1	1.2	1.3	3.3	0.8	1.8	1.8	2.2	1.1	0.8	1.2	0.7	1.2	2.7	1.0	1.4	0.8	0.6	0.8	0.7	0.4	0.8	0.4	0.7	0.8	0.3	0.5	0.4	0.6	2.5	0.7	0.6	0.9	0.7	0.5	3.9	3.5	2.9	3.8	3.8	4.1	4.3	5.9	3.3	3.6	5.0	2.7	2.6	3.2	3.3	2.0	2.6	1.3	2.4	4.2	0.6	6.2	6.6	5.2	0.9	4.3	7.3	9.2	12.5	2.5	7.0	3.0	0.0	5.5	118.0	31.3	3.3	2.8	1.2	0.4	4.2	2.3	2.3	2.6	2.0	5.0	2.5	3.8	5.7	0.9	2.0	6.7	3.1	1.5	8.2	3.8	3.9	142.4	3.7	3.4	0.0	1.0	2.2	4.4	4.1	1.0	0.6	3.0	3.2	2.6	6.6	1.4	1.7	6.9	44.9	28.3	0.0	6.7	3.8	59.3	16.5	1.5	1.7	3.4	4.8	4.5	1.8	1.9
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 275.7;Late spermatids: 277.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	15.7	43.4	29.3	17.3	33.8	32.6	18.2	28.9	41.0	30.0	29.2	25.8	22.9	22.5	24.9	18.2	24.0	20.6	21.8	32.3	31.3	25.9	36.0	22.8	20.9	34.4	31.3	31.3	23.3	39.5	33.5	9.3	33.4	45.1	11.8	12.4	21.6	18.5	6.1	19.0	24.0	13.8	27.4	41.8	26.2	43.2	34.2	12.4	30.4	6.7	14.5	24.2	21.7	38.1	3.7	3.2	2.6	8.0	10.3	14.8	2.7	5.8	6.0	6.7	8.9	1.0	3.8	3.0	14.7	11.0	2.0	3.0	1.5	9.2	4.1	15.0	2.2	7.2	2.5	3.9	17.9	2.8	10.4	17.8	24.0	4.9	6.5	7.1	19.2	5.3	6.5	33.6	3.4	4.5	4.5	6.0	1.4	5.0	11.5	4.8	0.0	19.6	6.1	5.3	1.1	4.3	5.9	6.6	11.0	4.6	9.8	11.9	12.8	5.3	1.6	9.3	5.5	30.8	8.0	6.2	7.2	14.7	7.9	51.5	52.8	38.5	21.5	46.3	21.1	16.0	14.6	20.2	31.6	20.4	13.2	10.4	25.3	30.2	33.8	8.4	31.5	23.5	29.3	33.8	28.9	41.0	32.3	31.3	34.4	31.3	33.4	27.4	34.2	38.1	10.7	16.0	13.6	7.5	14.5	7.5	15.4	14.9	10.8	11.3	12.5	8.9	9.8	12.8	16.7	18.4	41.7	5.1	12.4	13.0	25.4	8.2	275.7	9.0	8.8	10.3	10.8	4.6	4.5	9.5	5.5	8.1	30.5	10.0	34.2	11.5	12.8	10.9	23.3	6.7	3.0	12.5	10.2	26.7	14.8	277.4	11.5	20.3	12.4	2.8	28.9	16.6	39.1	2.0	10.2	8.7	24.0	13.5	15.0	16.6	29.2	38.6	16.9	27.9	0.0	5.2	8.4	4.7	3.9	11.0	8.1	6.0	17.9	20.1	9.5	19.7
CCDC166		ENSG00000255181	"Coiled-coil domain containing 166"	P0CW27	8	143706694-143708109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"testis: 4.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA025058	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA025058: AB_2671717"	"unprognostic (2.65e-1)"	"unprognostic (3.64e-1)"								"unprognostic (6.18e-2)"				"unprognostic (4.97e-1)"	"unprognostic (1.67e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482938-37499893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 281.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 145.2;granulocytes: 140.2;T-cells: 423.5"	"Cell line enriched"	"Detected in all"	9	"U-698: 1553.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	13.2	19.2	49.8	22.8	52.1	28.3	18.5	52.7	54.2	22.1	49.0	19.9	11.6	15.8	45.1	26.6	21.3	11.9	34.9	49.0	51.0	22.0	56.4	13.3	49.5	53.4	51.1	8.5	19.1	27.2	15.0	15.4	52.9	22.8	23.5	14.4	22.6	13.5	21.4	13.4	14.4	31.6	53.0	28.3	15.0	37.7	51.9	90.7	15.1	26.2	70.3	16.8	17.1	57.7	27.2	61.9	137.1	95.4	37.4	65.5	50.4	31.6	25.8	48.8	54.5	66.1	39.5	146.9	69.4	54.8	92.1	20.7	90.4	74.1	49.7	122.9	166.9	69.7	25.3	168.7	39.1	68.4	26.4	30.7	153.4	52.1	47.4	34.2	154.0	150.2	44.1	123.1	85.1	90.2	129.1	56.6	8.0	76.7	39.3	79.0	48.4	108.9	66.3	53.6	93.3	109.6	47.1	46.0	74.3	119.3	50.1	70.3	38.5	31.8	61.6	17.8	32.5	89.3	97.1	1553.2	30.8	147.9	90.8	34.9	32.6	140.2	140.0	35.6	169.2	145.2	230.0	177.9	56.3	122.6	105.5	99.7	10.0	55.8	29.5	35.8	423.5	165.8	49.8	52.1	52.7	54.2	49.0	51.0	53.4	51.1	52.9	53.0	51.9	57.7	18.6	6.4	10.3	5.2	50.6	14.1	26.5	62.1	10.8	9.4	22.4	30.4	50.0	24.3	36.0	14.7	8.4	67.1	33.4	31.8	31.3	69.3	108.2	19.1	31.8	23.4	25.2	86.7	2.2	50.4	108.7	26.4	16.3	31.7	15.2	61.9	25.0	141.9	89.8	15.2	3.2	56.2	48.8	18.8	31.4	281.6	13.1	23.8	55.2	1.9	25.2	56.5	29.9	2.0	7.3	57.9	13.6	18.8	100.2	35.9	10.8	89.0	30.3	11.8	6.6	14.0	28.7	96.8	118.9	26.2	15.2	29.7	59.7	38.1	36.6	31.9
CCDC168	"C13orf40, FLJ40176"	ENSG00000175820	"Coiled-coil domain containing 168"	Q8NDH2	13	102729367-102759072	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 8.8"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 1011.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048184, HPA058793, HPA078547"	Uncertain		Approved	Nucleoli,Centrosome,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Centrosome"	Cytosol	"HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: "	"unprognostic (2.06e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	0.0	0.3	0.3	0.0	0.7	0.0	0.0	0.0	0.7	1.8	4.5	0.0	1.8	0.0	0.0	0.3	2.3	0.1	0.0	0.3	1011.0	0.2	1.2	0.6	0.0	0.0	1.1	0.4	0.5	0.4	0.0	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.9	0.0	0.0	0.6	0.0	91.3	2.1	0.6	0.0	1.0	1.6	0.0	0.0	0.5	0.6	0.4	0.0	0.7	1.4	0.5	0.0	0.2	0.0	0.0	0.0	2.9	0.7	3.1	1.5	0.0	0.0	0.4	0.9	0.2	0.2	0.2
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"fallopian tube: 36.0"	"Cell type enriched"	"Detected in many"	5	"Respiratory ciliated cells: 374.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028338	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.1	0.1	0.2	0.1	0.3	0.4	0.0	0.2	0.8	2.1	0.2	0.1	0.2	0.1	0.0	0.0	36.0	0.0	0.2	0.2	0.2	0.1	0.1	3.3	0.1	0.7	1.1	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.8	0.2	0.2	0.7	1.1	0.7	0.2	0.2	0.2	3.1	3.2	4.1	1.0	0.4	1.1	0.3	14.2	0.6	0.1	2.4	1.7	1.6	0.0	23.4	0.0	0.0	0.6	2.0	4.6	5.9	0.5	0.0	74.5	1.1	2.1	1.2	0.4	0.1	0.9	0.2	1.9	1.1	3.2	1.3	0.3	1.1	0.9	0.6	0.0	0.1	2.3	10.2	0.6	1.4	0.4	1.2	1.8	0.0	1.0	1.0	0.4	0.0	0.0	1.7	1.3	3.2	2.2	0.3	0.6	4.2	1.1	374.1	0.5	0.0	0.9	5.2	0.8	0.7	0.9	0.6	0.5	0.8	0.7	2.6	0.4
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494017-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 33.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 10.4;T-47d: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	4.2	1.5	1.3	1.4	0.1	3.7	0.9	0.7	3.0	8.0	0.7	2.5	3.6	0.4	0.4	33.4	1.3	0.8	1.3	1.8	0.8	1.3	4.1	1.4	3.6	4.9	5.6	0.1	0.1	0.2	1.4	3.1	0.4	0.6	0.2	0.2	0.4	0.3	0.2	1.1	0.9	3.2	2.2	1.7	2.7	1.7	0.3	5.6	0.1	0.6	1.1	0.5	2.8	0.0	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	5.9	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	6.2	0.0	2.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.1	2.8	0.1	0.0	0.6	1.5	1.4	0.9	0.7	1.3	1.8	3.6	4.9	3.1	3.2	1.7	2.8	1.2	3.2	1.5	7.5	0.4	0.6	0.3	6.5	1.2	0.3	27.3	8.9	0.7	0.0	39.5	0.0	22.9	0.1	0.4	1.1	0.0	0.3	53.0	236.6	23.6	1.2	0.0	0.0	5.5	1.1	0.4	5.2	3.1	14.1	3.8	3.5	1.1	1.5	11.9	0.0	5.9	0.0	12.2	17.5	11.3	82.6	7.2	16.8	0.0	0.0	11.0	2.5	0.0	3.0	0.8	2.7	5.8	0.0	0.1	0.9	0.5	5.8	379.4	1.0	0.0	0.4	6.5	19.1	1.1	0.2	1.0	0.0	1.2	14.0	0.3	0.5
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.3	0.7	2.8	2.1	1.6	3.7	3.2	1.4	0.0	0.9	0.8	5.8	1.1	1.0	2.0	1.5	1.0	2.5	0.3	1.2	0.4	1.1	1.1	1.5	0.3	2.9	1.3	1.4	1.1	0.9	2.0	1.1	1.1	5.5	0.8	1.2	0.8	2.4	1.0	3.3	0.2	0.6	1.4	11.3	0.5	4.8	2.0	1.1	1.0	0.8	0.9	3.3	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.3	2.8	3.7	3.2	2.5	0.3	1.5	0.3	2.0	0.2	0.5	3.3	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCDC173	"C2orf77, LOC129881"	ENSG00000154479	"Coiled-coil domain containing 173"	Q0VFZ6	2	169645425-169694405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.2;testis: 80.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 939.2;Endometrial ciliated cells: 118.1;Late spermatids: 133.4;Respiratory ciliated cells: 232.6;Spermatocytes: 460.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042995, HPA048454"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA042995: AB_2678260, HPA048454: AB_2680400"	"unprognostic (1.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.26e-6)"	"unprognostic (8.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.41e-1)"	0.3	0.3	7.4	0.7	7.8	3.6	1.3	4.4	11.6	1.0	22.2	0.2	0.6	1.2	1.1	0.2	14.9	0.5	0.1	8.7	7.1	0.9	0.4	2.5	0.2	13.7	16.6	0.8	1.4	1.6	2.6	0.1	9.6	0.4	0.4	6.7	0.2	0.8	0.1	0.2	0.4	0.6	11.3	0.1	0.4	80.2	8.1	0.2	3.4	0.0	0.0	0.2	0.2	9.6	0.5	0.8	0.8	0.2	0.0	0.1	0.9	0.4	0.0	0.4	0.1	0.3	0.1	0.1	0.1	0.0	0.7	0.6	0.7	1.0	0.7	0.1	0.5	11.1	0.7	0.3	0.0	1.1	2.5	0.0	0.1	1.4	0.0	0.6	0.0	0.6	2.5	0.1	0.0	1.2	0.2	0.3	0.2	0.3	0.6	0.0	0.0	0.0	0.3	0.5	2.7	0.7	0.1	0.0	0.0	0.3	0.6	0.1	0.0	0.2	0.1	0.7	0.4	0.4	0.3	0.3	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	7.8	4.4	11.6	8.7	7.1	13.7	16.6	9.6	11.3	8.1	9.6	1.5	9.6	8.3	12.7	1.6	0.1	2.5	3.8	1.2	13.3	2.2	3.9	0.6	0.0	31.7	1.8	8.4	0.2	4.1	0.1	5.9	0.4	939.2	118.1	3.3	1.2	0.0	0.0	5.8	0.4	2.6	3.5	1.5	2.3	2.5	0.5	1.4	0.8	0.0	0.0	2.3	0.7	8.2	0.3	0.2	133.4	7.5	1.0	1.8	2.8	0.0	7.3	0.0	1.5	0.5	0.1	0.0	6.8	1.9	0.5	0.0	3.2	232.6	13.7	13.1	21.2	1.8	460.3	13.7	0.0	0.0	0.1	3.3	0.1	0.1	0.9
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	9.5	7.0	7.7	7.0	8.5	17.2	9.2	8.8	8.5	10.9	6.8	9.8	9.4	10.4	7.5	8.9	9.4	6.8	8.2	7.7	8.0	8.9	8.7	7.1	9.6	8.1	8.4	14.7	10.1	11.9	8.6	8.6	8.1	9.7	7.3	6.7	8.6	8.0	11.1	9.7	9.5	7.9	7.5	10.6	10.3	9.1	8.2	11.6	9.0	10.7	10.2	9.6	9.5	9.6	6.2	6.7	10.0	10.7	13.6	11.1	25.3	8.1	11.6	10.0	7.8	7.5	7.0	12.8	5.8	7.2	6.8	5.3	7.3	6.8	7.8	9.7	8.9	13.0	8.1	8.1	19.7	12.9	14.5	12.9	17.0	13.5	16.5	14.0	8.6	13.4	13.2	11.4	7.6	10.9	13.6	11.3	13.5	10.1	10.9	10.1	9.3	10.6	10.4	10.8	4.8	13.1	9.5	7.4	13.4	11.6	11.2	18.1	8.0	8.0	7.8	7.4	9.5	15.0	14.3	14.7	8.0	9.8	11.1	25.4	10.7	22.2	12.9	11.3	15.2	17.4	16.1	15.1	9.7	16.4	17.4	13.8	20.5	18.8	12.2	10.9	12.5	10.0	7.7	8.5	8.8	8.5	7.7	8.0	8.1	8.4	8.1	7.5	8.2	9.6	29.5	9.6	34.5	11.4	48.0	16.2	31.3	38.0	26.7	32.8	25.0	28.4	37.0	32.9	35.7	12.9	20.9	32.1	42.3	27.3	56.7	34.7	152.5	27.3	35.4	31.0	18.5	43.4	12.8	34.9	25.2	33.7	20.4	34.7	52.0	22.0	38.6	29.3	26.5	15.2	16.6	34.1	32.6	27.2	16.5	59.1	33.5	30.5	14.2	5.6	45.2	22.2	34.0	11.1	15.8	38.2	34.9	40.3	34.9	28.8	36.8	46.4	31.1	24.9	32.9	28.4	37.2	78.7	33.5	19.9	13.5	65.7	41.6	23.5	23.1	31.8
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 18.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 18.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.0	0.0	0.1	0.0	0.2	0.1	0.0	18.4	0.5	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	18.4	0.5	0.0	0.2	0.7	0.8	0.8	0.4	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	8.4	0.0	0.0	1.1	0.0	0.0	11.9	5.0	0.1	0.0	0.0	1.7	15.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	1.5	4.8	0.0	0.3	0.0	0.0	0.1	1.5	0.0	5.0	3.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.4	11.4	0.0	0.4	0.3	17.7	4.4	0.0	0.0	0.0	0.0	0.1	2.4	0.1
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.6;lymphoid tissue: 8.9;testis: 9.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	1.9	1.0	1.3	4.3	1.4	10.6	1.1	1.6	1.1	1.0	1.0	1.9	1.7	1.2	0.8	1.6	0.7	1.1	1.0	1.1	1.3	0.6	2.0	1.7	8.9	1.4	1.3	1.3	0.4	0.3	0.8	1.3	1.4	0.6	2.7	0.6	0.7	0.3	2.0	2.1	1.6	1.2	1.1	3.5	1.5	9.5	1.3	6.5	0.7	0.9	5.9	1.6	0.9	1.4	24.8	8.1	18.7	5.9	4.5	4.7	9.7	15.1	7.9	15.1	15.3	4.3	8.3	31.9	8.2	8.1	14.7	11.5	8.2	11.8	21.9	15.9	10.7	21.9	18.5	7.6	1.6	23.1	9.8	3.1	1.0	11.5	11.1	4.2	10.0	14.0	23.8	23.9	20.4	3.5	11.1	9.3	17.1	6.7	10.0	14.0	22.3	9.4	7.4	10.9	8.2	5.2	21.4	10.8	6.1	8.3	5.1	13.3	7.7	17.7	12.4	11.5	17.5	10.2	14.5	18.8	3.7	20.1	4.8	5.1	3.6	5.8	2.3	4.1	2.7	10.2	2.1	2.2	1.7	11.6	1.7	1.9	6.0	1.2	3.8	12.5	2.5	0.5	1.3	1.4	1.6	1.1	1.1	1.3	1.4	1.3	1.4	1.1	1.3	1.4	5.0	19.2	9.6	16.6	17.6	4.1	7.9	4.5	8.0	2.4	3.8	4.2	9.5	0.0	3.6	3.7	4.2	5.7	18.4	3.6	0.0	2.3	50.5	6.6	7.6	4.6	0.0	40.2	13.2	2.9	6.7	8.8	8.2	6.1	19.0	13.5	5.0	4.5	8.2	1.7	12.6	3.2	6.1	14.2	10.4	16.3	6.2	17.5	3.6	15.0	12.9	0.7	7.2	7.5	15.7	2.0	4.4	6.4	22.7	4.6	2.1	1.5	5.6	0.7	6.6	9.8	8.1	137.2	47.7	8.2	7.2	2.9	15.7	5.1	6.9	8.9
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 41.5;testis: 27.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 66.1;Cone photoreceptor cells: 66.7;Early spermatids: 289.9;Late spermatids: 69.3;Respiratory ciliated cells: 109.6;Rod photoreceptor cells: 89.4;Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 7.1;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.4;SH-SY5Y: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.4	2.5	7.4	0.5	7.9	0.5	0.4	8.4	11.9	3.1	14.2	0.7	0.2	3.6	1.9	0.4	12.3	3.6	1.9	7.7	10.3	6.2	0.1	1.8	0.2	8.0	9.0	6.3	3.8	12.1	18.2	0.1	7.6	2.0	0.2	41.5	0.4	2.0	0.2	0.6	0.4	2.0	7.5	0.1	1.6	27.6	8.9	0.4	0.5	0.3	0.1	1.2	1.0	7.1	0.2	0.3	7.1	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.7	0.1	0.2	0.1	0.1	0.0	7.4	0.1	0.3	0.0	0.3	0.2	1.6	1.8	0.2	0.0	0.0	2.0	0.1	0.7	0.0	0.4	0.0	0.1	0.1	5.7	0.1	0.1	1.3	0.1	4.5	0.0	13.8	0.1	0.0	0.0	5.9	0.1	1.1	0.0	8.4	9.9	0.0	0.3	0.5	3.7	0.0	0.0	0.5	1.4	4.4	0.2	6.4	2.1	2.0	0.0	2.8	0.1	5.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	7.9	8.4	11.9	7.7	10.3	8.0	9.0	7.6	7.5	8.9	7.1	0.2	3.2	4.7	6.8	0.0	0.0	0.2	2.7	0.6	66.1	0.8	0.4	6.3	0.0	22.5	9.2	66.7	0.0	0.2	0.1	15.6	1.2	289.9	47.0	1.9	1.5	19.2	2.1	16.2	1.6	0.0	3.1	0.0	1.7	1.3	4.5	0.7	0.0	0.1	25.2	13.1	0.0	6.1	0.0	0.0	69.3	3.1	0.5	0.0	5.6	0.0	23.5	0.0	8.5	3.9	0.7	0.0	10.5	0.0	0.1	0.0	16.2	109.6	89.4	6.6	13.1	3.4	201.8	41.1	0.4	0.0	0.1	0.4	4.0	0.0	0.5
CCDC182		ENSG00000166329	"Coiled-coil domain containing 182"	A6NF36	17	57744495-57745299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 28.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 250.6;Late spermatids: 180.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA023446	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA023446: AB_1859510"					"unprognostic (1.22e-1)"										"unprognostic (3.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	180.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC183	"bA216L13.7, KIAA1984, MGC15438"	ENSG00000213213	"Coiled-coil domain containing 183"	Q5T5S1	9	136796338-136807741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 22.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 251.7;Late spermatids: 146.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in some"		"OE19: 2.8"									HPA043812	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA043812: AB_10961860"	"unprognostic (2.91e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.89e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.16e-3)"	"unprognostic (4.32e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.20e-2)"	"unprognostic (5.15e-2)"	0.2	0.5	2.2	0.2	2.2	0.3	0.7	3.2	2.5	0.4	1.3	1.0	0.3	0.4	0.7	0.1	0.7	0.5	0.7	2.0	2.5	0.3	0.2	0.4	0.4	2.5	2.9	0.7	1.0	1.2	0.7	0.8	2.5	1.9	1.1	1.6	0.5	0.5	0.4	0.3	0.3	0.4	2.0	0.4	0.7	22.0	2.3	1.4	0.6	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.6	0.3	0.5	0.3	0.4	0.6	0.2	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.0	0.5	0.2	0.0	0.0	0.5	0.4	0.0	0.8	0.8	1.0	0.2	0.5	1.1	0.5	0.0	0.3	1.2	0.0	0.6	0.2	0.2	0.0	0.3	0.2	0.0	0.0	2.8	0.0	0.1	0.4	0.9	0.7	0.0	0.6	0.4	0.2	0.2	0.1	1.1	0.7	0.2	0.3	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	2.2	2.2	3.2	2.5	2.0	2.5	2.5	2.9	2.5	2.0	2.3	2.5	2.0	0.0	3.1	2.3	0.7	0.3	0.8	0.8	0.6	4.3	2.4	2.8	0.5	2.8	1.7	1.8	0.0	2.3	16.4	5.0	1.9	1.8	251.7	1.6	0.9	0.9	7.8	0.0	3.0	0.7	1.1	1.3	1.1	1.9	0.0	2.3	0.7	0.6	0.5	5.0	3.0	7.2	4.1	0.8	1.0	146.6	2.8	0.7	3.6	1.9	0.8	3.1	0.0	3.0	3.2	0.8	21.9	3.8	2.0	2.6	3.8	0.6	2.7	4.4	6.6	1.1	1.3	3.7	0.8	0.7	0.1	7.0	1.3	1.3	5.0	0.8
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183644-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.5;Late spermatids: 15.1;Sertoli cells: 46.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;AF22: 6.3;hTERT-RPE1: 2.4;SH-SY5Y: 4.3;U-2 OS: 2.5;U-87 MG: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	1.1	5.3	12.3	0.9	12.0	0.1	1.0	11.2	21.4	3.5	1.1	1.8	0.2	5.4	0.3	0.9	1.0	1.3	2.3	10.8	25.7	0.7	0.3	0.8	0.2	18.3	12.5	7.5	0.6	5.8	11.6	2.3	24.5	1.4	0.4	5.0	0.4	0.8	0.9	0.4	0.9	1.4	7.5	0.9	1.0	6.2	11.9	0.0	0.9	0.4	0.0	2.0	1.5	10.8	0.0	2.7	6.3	0.2	0.5	0.5	0.0	0.2	1.2	0.3	0.5	0.3	0.1	0.0	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.3	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.7	2.5	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	12.0	11.2	21.4	10.8	25.7	18.3	12.5	24.5	7.5	11.9	10.8	1.2	0.0	0.0	2.6	1.1	0.0	0.1	0.0	6.2	2.3	0.3	1.9	0.6	0.0	0.6	0.0	0.0	0.7	2.0	0.1	0.0	0.3	62.5	0.4	9.4	3.1	5.3	0.0	5.6	0.0	0.6	11.2	1.1	0.2	0.0	4.2	6.8	0.0	0.9	5.0	12.7	0.0	0.0	0.3	0.0	15.1	0.3	0.5	0.0	1.0	0.0	3.0	0.0	1.5	1.1	0.1	0.0	2.2	0.2	0.1	0.0	0.0	5.1	7.0	46.0	8.6	7.6	12.7	1.8	2.2	0.0	1.5	3.2	1.8	0.0	0.0
CCDC186	"C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104"	ENSG00000165813	"Coiled-coil domain containing 186"	Q7Z3E2	10	114120862-114174232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 49.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 49.3;granulocytes: 26.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014569, HPA018019"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA014569: AB_2066352, HPA018019: AB_1845513"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (7.65e-8)"	"unprognostic (8.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	7.4	7.3	2.8	9.0	3.3	32.8	12.5	8.6	5.4	8.5	9.2	12.4	15.4	7.5	9.6	12.5	8.2	6.8	9.4	2.8	5.9	14.9	7.2	10.8	9.1	3.4	2.9	8.0	21.1	13.1	7.1	9.4	3.7	15.1	11.9	14.1	15.6	9.2	7.1	12.6	16.1	6.2	2.5	11.0	16.7	16.6	4.8	12.0	14.7	9.2	10.2	7.7	6.8	4.3	17.9	6.1	6.0	6.9	6.8	7.9	7.8	11.0	13.2	5.1	8.1	11.2	18.3	4.2	7.0	9.1	6.3	14.1	7.1	9.8	9.8	21.9	7.3	3.3	7.0	6.6	6.3	9.6	14.6	5.9	11.1	6.0	16.9	12.6	7.7	11.1	6.1	13.5	6.0	6.5	8.8	5.3	3.5	10.6	3.9	8.4	20.7	6.6	9.0	10.9	4.2	4.4	9.7	13.4	6.6	9.7	8.6	4.1	11.2	3.9	7.8	3.9	9.3	7.6	13.3	8.4	4.1	0.1	3.0	26.5	3.3	11.7	8.6	3.8	8.5	7.9	6.6	7.8	4.0	8.6	6.4	6.4	19.9	5.8	3.7	49.3	8.7	2.6	2.8	3.3	8.6	5.4	2.8	5.9	3.4	2.9	3.7	2.5	4.8	4.3	63.2	141.1	85.7	23.8	46.7	0.0	79.5	0.0	63.2	63.8	73.5	49.0	57.4	38.6	57.6	77.3	62.6	94.9	174.6	107.1	66.5	78.2	221.9	98.4	40.6	41.3	64.6	33.1	53.0	70.7	40.7	43.7	48.9	108.9	24.7	28.1	21.0	20.9	21.4	107.7	49.9	78.9	0.0	25.0	0.0	143.6	50.1	37.1	0.0	33.7	40.0	31.7	70.0	25.6	27.7	74.9	89.9	44.4	77.8	94.8	91.4	84.0	64.1	74.0	26.3	61.7	28.3	83.7	69.2	56.1	0.0	113.6	62.1	32.5	53.7	120.3
CCDC189	"C16orf93, MGC104706"	ENSG00000196118	"Coiled-coil domain containing 189"	A1A4V9	16	30757423-30762221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 208.2;Late spermatids: 318.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041806, HPA046289, HPA075094"	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: "	"unprognostic (5.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.45e-4)"	"unprognostic (3.60e-2)"	"unprognostic (5.41e-3)"	"unprognostic (7.76e-5)"	"unprognostic (1.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.06e-7)"	"unprognostic (1.75e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.41e-2)"	1.1	5.2	6.7	1.6	6.8	7.9	2.7	5.8	8.7	3.0	12.2	1.9	1.1	1.8	4.3	1.7	10.4	1.6	0.7	7.4	6.7	6.5	1.3	3.9	1.1	6.9	8.1	2.1	3.7	2.3	12.6	0.6	8.9	4.1	1.7	3.5	3.3	1.9	0.3	1.2	1.8	0.7	6.8	2.1	2.0	18.4	6.7	1.7	6.5	0.1	2.1	1.4	1.2	5.9	7.1	5.2	1.1	5.3	1.5	1.7	0.3	2.6	1.2	2.8	2.1	0.3	5.0	0.2	4.3	2.1	1.4	8.2	0.8	4.3	1.2	0.7	9.8	1.9	10.1	2.5	0.3	2.4	1.8	0.4	0.4	5.1	4.4	4.0	2.2	1.8	2.6	1.2	2.2	4.3	2.9	4.6	1.9	2.2	2.5	2.8	1.6	5.2	6.2	0.0	4.2	1.5	3.0	7.7	1.6	1.3	7.5	3.6	1.8	1.3	1.0	2.2	2.6	3.6	2.2	2.1	8.3	7.3	0.4	1.9	1.1	6.0	0.1	1.3	0.9	1.0	0.0	0.2	1.8	0.1	0.0	0.2	0.4	1.9	3.3	12.2	0.1	0.8	6.7	6.8	5.8	8.7	7.4	6.7	6.9	8.1	8.9	6.8	6.7	5.9	0.6	0.0	3.1	0.0	4.3	0.0	4.0	0.0	4.6	1.0	6.8	4.2	0.0	0.0	3.7	7.3	4.2	2.9	16.1	1.6	5.9	3.9	208.2	42.9	2.3	1.4	2.4	14.3	0.0	3.0	1.1	3.5	12.8	4.0	1.3	2.3	0.7	1.1	4.5	0.0	0.0	2.0	0.0	2.2	0.0	318.0	7.5	5.4	0.0	0.0	4.8	3.7	1.0	0.0	0.0	1.9	1.6	4.9	11.9	3.6	1.0	8.6	49.6	15.0	0.0	1.0	1.5	52.7	15.7	2.0	0.0	2.5	2.1	7.0	1.8	3.7
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"brain: 2.3;choroid plexus: 1.0;esophagus: 3.3;lung: 1.8"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;hTERT-RPE1: 4.8;HUVEC TERT2: 4.8;LHCN-M2: 7.3;TIME: 16.7;U-2197: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.1	0.1	0.9	0.0	1.0	0.0	0.0	0.3	1.0	0.1	1.0	0.0	0.0	0.1	0.3	3.3	0.5	0.4	0.5	1.4	2.1	0.0	0.0	1.8	0.0	1.6	2.1	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.3	2.3	0.0	0.1	0.1	0.4	0.1	0.0	2.3	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.9	2.4	4.8	4.8	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.4	0.0	8.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.0	1.4	2.1	1.6	2.1	1.0	0.5	2.3	2.3	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	26.2	0.0	0.0	0.4	0.5	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.5
CCDC191	KIAA1407	ENSG00000163617	"Coiled-coil domain containing 191"	Q8NCU4	3	113964137-114056594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Endometrial ciliated cells: 68.0;Respiratory ciliated cells: 104.2;Rod photoreceptor cells: 40.4;Spermatocytes: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047833	Approved		Approved	Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA047833: AB_10961639"	"unprognostic (2.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.45e-4)"	2.9	3.3	4.2	3.1	3.9	2.9	4.7	3.1	4.4	4.6	11.7	3.4	1.8	5.3	7.9	2.5	12.1	3.5	1.8	3.8	4.0	7.7	1.9	4.7	4.4	5.7	5.7	4.8	5.1	7.9	10.9	2.1	4.2	5.0	3.2	14.0	3.6	4.8	0.9	7.6	4.0	2.7	4.7	5.6	3.1	9.7	4.0	2.8	8.3	0.8	4.1	3.5	3.3	4.0	3.7	1.9	3.0	2.5	0.8	4.3	0.9	0.8	1.5	1.1	1.8	0.4	4.1	1.0	1.4	1.5	1.0	4.6	0.9	1.6	2.6	0.7	0.7	0.8	0.7	0.3	1.2	1.1	0.5	1.8	4.2	1.5	2.2	2.0	2.2	2.8	0.3	2.1	0.7	1.6	2.3	0.4	0.5	2.4	1.4	1.4	0.6	2.0	4.2	1.8	1.8	2.9	1.5	0.3	1.5	1.5	7.2	0.4	2.4	2.1	0.5	0.9	0.5	3.0	2.6	3.5	2.7	0.6	1.0	0.1	0.8	1.6	0.9	0.8	1.0	8.9	1.8	1.5	0.9	8.3	0.9	1.5	4.4	0.8	0.5	3.7	1.4	0.9	4.2	3.9	3.1	4.4	3.8	4.0	5.7	5.7	4.2	4.7	4.0	4.0	5.2	12.8	14.4	0.0	20.0	0.0	4.0	0.0	4.6	8.9	5.7	7.0	0.0	0.0	16.1	12.9	37.5	1.8	7.9	1.5	13.7	5.4	27.1	68.0	9.5	3.7	4.9	2.1	0.0	3.6	0.5	4.0	9.7	10.6	1.3	9.1	4.6	1.3	3.0	20.2	0.0	2.3	0.0	3.2	0.0	13.1	4.1	3.0	0.0	0.0	2.0	21.6	4.1	0.0	0.0	2.6	1.0	5.3	3.0	1.7	2.4	5.0	104.2	40.4	0.0	6.3	3.5	68.3	13.3	4.3	0.0	0.3	4.5	8.1	2.7	2.8
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235470-49250520	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888, HPA075980"	Uncertain	Approved	Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Vesicles"		"HPA000229: , HPA000888: AB_1078420, HPA075980: "	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	10.3	12.3	9.4	10.1	10.0	18.6	10.3	9.9	10.8	11.7	8.8	12.1	10.4	12.2	5.3	14.2	11.3	6.4	12.8	9.4	9.2	12.3	12.9	10.7	15.0	10.8	9.4	11.2	14.2	8.7	11.2	6.9	10.1	13.5	5.2	4.7	12.3	8.7	17.2	13.8	13.4	6.0	9.6	20.5	12.9	3.8	10.0	13.6	11.0	7.7	8.5	11.9	11.1	10.8	18.8	16.0	9.6	33.5	8.8	8.9	20.4	10.9	7.9	12.0	13.6	16.3	16.0	6.9	15.9	9.7	14.3	15.0	10.6	18.0	4.9	18.1	23.6	7.3	15.6	15.5	14.7	20.8	12.4	8.2	15.2	15.9	8.6	6.1	11.9	13.7	14.7	11.8	8.6	58.3	15.3	24.4	11.2	9.5	23.2	22.0	15.6	30.1	9.4	9.4	11.4	8.8	16.7	19.4	15.0	9.8	30.2	20.2	13.3	15.4	16.5	19.2	11.6	21.2	12.6	12.5	16.8	38.5	12.3	8.6	37.0	23.8	18.3	30.9	20.1	18.9	18.8	21.3	38.2	16.8	16.7	19.6	2.8	10.8	27.1	15.1	21.8	28.0	9.4	10.0	9.9	10.8	9.4	9.2	10.8	9.4	10.1	9.6	10.0	10.8	8.6	0.0	4.4	3.3	15.0	5.6	9.6	13.0	6.2	11.6	7.4	6.1	2.4	15.7	12.0	11.0	6.2	15.2	11.2	12.5	15.6	13.9	0.3	5.8	4.6	7.8	6.7	8.6	3.7	7.3	14.8	7.6	7.1	6.9	11.4	8.6	11.0	7.2	32.0	1.7	2.9	18.2	8.2	14.4	11.9	0.4	8.1	13.8	7.2	1.9	18.0	9.9	9.2	1.0	4.2	8.6	7.6	7.5	10.2	6.2	15.6	12.1	5.6	8.0	6.6	9.1	9.5	0.1	0.9	8.0	6.7	20.2	13.3	11.0	15.7	8.3
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.6	4.8	11.8	1.3	11.9	0.4	3.3	11.3	15.9	5.9	12.3	3.8	1.9	3.2	1.9	2.1	11.2	3.1	1.3	11.8	12.0	11.8	3.6	2.9	1.4	11.6	11.8	2.4	5.6	6.2	12.9	1.0	11.7	7.2	2.1	6.6	4.4	5.0	0.8	1.1	2.4	1.3	11.8	2.4	3.8	19.1	12.3	0.9	9.1	0.2	1.0	4.1	2.4	11.5	4.7	2.8	1.2	1.4	1.2	0.8	2.7	0.2	1.9	1.4	2.4	1.8	13.4	3.8	5.0	0.5	4.0	4.7	0.7	6.5	1.3	3.9	1.6	1.9	1.7	0.5	1.3	0.6	3.2	0.3	0.6	4.5	0.4	4.3	1.1	1.4	0.8	1.4	2.0	4.0	0.2	1.4	2.7	4.2	2.2	1.3	0.0	0.7	5.5	1.8	2.9	2.6	4.0	2.3	2.6	2.5	6.7	0.1	0.3	2.1	5.9	1.5	0.7	0.5	1.8	0.8	5.3	0.5	1.7	0.0	0.4	1.0	0.3	2.2	0.2	3.5	0.1	0.1	0.4	2.2	0.0	0.0	0.4	0.3	1.8	0.3	0.0	0.2	11.8	11.9	11.3	15.9	11.8	12.0	11.6	11.8	11.7	11.8	12.3	11.5	1.7	3.2	7.2	17.0	2.3	1.1	7.9	26.5	9.1	8.9	13.3	12.1	1.0	12.8	22.0	9.2	6.2	5.6	0.9	11.3	21.5	9.4	20.7	30.9	2.4	2.1	36.4	1.3	17.7	7.2	2.2	2.5	21.9	6.9	2.5	1.6	2.5	2.6	3.3	3.3	10.0	13.6	14.2	2.0	2.2	11.7	2.1	3.6	3.6	1.9	2.7	10.2	0.0	5.0	2.4	6.5	8.3	3.0	1.8	5.7	6.3	11.5	57.6	15.4	0.0	2.9	3.8	50.6	19.9	3.9	0.9	2.5	1.3	3.9	10.2	11.4
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733316-27772653	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	14.0	20.9	10.1	11.8	11.4	4.9	17.4	10.5	17.1	10.1	7.3	14.3	35.5	10.4	14.3	14.2	12.9	11.9	12.2	9.9	11.3	22.5	32.3	8.8	14.0	11.1	10.5	10.8	16.3	18.3	7.5	10.6	11.5	11.6	15.7	11.1	13.5	12.0	28.4	10.3	30.8	10.3	11.3	10.5	20.0	10.9	11.9	11.4	18.8	15.2	14.2	11.7	9.4	13.0	50.1	27.9	25.8	24.7	22.8	33.0	17.2	41.0	39.5	24.7	24.0	11.2	17.9	53.6	27.7	20.9	21.2	23.1	23.6	40.0	35.5	20.3	16.4	66.9	23.1	19.3	36.9	23.8	20.8	37.1	25.9	27.1	37.6	28.7	54.0	33.7	32.2	24.6	27.8	19.2	55.3	19.9	37.9	49.4	14.8	18.7	44.4	28.8	32.3	26.7	15.1	41.7	27.5	21.0	42.8	19.0	24.0	13.1	44.6	22.5	33.4	38.9	21.7	24.5	33.8	19.5	35.0	30.8	23.8	20.3	8.9	6.6	15.2	12.6	17.8	19.8	19.6	16.1	11.6	15.5	18.3	19.3	3.2	14.3	13.4	18.1	23.2	10.4	10.1	11.4	10.5	17.1	9.9	11.3	11.1	10.5	11.5	11.3	11.9	13.0	47.5	25.6	38.9	12.4	34.8	21.4	39.6	46.5	55.2	42.6	57.3	61.6	62.5	60.1	44.5	53.3	12.5	77.6	31.2	61.6	109.5	76.9	183.1	46.8	51.0	54.2	26.5	46.7	30.5	134.6	56.0	49.3	63.2	33.3	63.9	39.3	55.0	144.5	44.7	55.5	21.9	58.6	46.8	33.5	27.2	162.9	47.2	27.4	37.4	12.2	44.4	60.2	35.0	12.1	17.7	83.7	51.1	47.4	40.7	55.2	182.1	128.6	53.7	38.9	46.0	44.4	49.1	91.1	59.6	56.7	22.3	42.4	38.7	88.1	71.2	36.0
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200595-32205453	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 225.3;tongue: 75.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 90.1;monocytes: 65.5;NK-cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 124.9"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA028589: AB_10602175"	"prognostic favorable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	3.8	13.9	14.3	7.1	12.9	6.8	3.3	14.5	18.7	6.6	12.1	7.6	1.7	5.3	1.7	5.5	5.6	4.9	20.8	13.2	13.3	6.5	2.4	3.9	14.1	12.8	13.3	6.0	5.6	19.2	21.1	5.0	12.2	5.3	2.5	5.1	3.6	4.1	225.3	2.7	4.3	6.2	12.6	5.4	3.9	20.8	15.8	12.4	6.3	75.0	9.5	5.0	4.3	13.1	10.6	4.5	20.8	22.7	6.8	8.5	1.2	8.2	11.9	13.2	9.3	9.0	13.2	23.3	14.2	9.3	1.7	0.5	18.7	9.2	2.6	27.0	25.5	29.9	20.7	4.1	10.1	0.2	13.7	10.5	3.5	15.5	0.2	9.2	19.3	40.5	20.5	0.5	9.6	1.3	43.2	8.7	29.4	2.8	5.8	46.5	10.4	19.2	12.2	0.0	45.6	22.9	11.9	3.2	16.3	12.0	12.0	11.5	11.4	7.1	9.5	8.7	7.6	2.1	1.6	0.9	11.7	43.9	10.3	9.7	13.7	3.0	36.3	6.9	17.6	22.0	19.4	34.3	30.6	31.5	28.4	29.3	1.9	46.7	2.1	37.1	26.9	21.8	14.3	12.9	14.5	18.7	13.2	13.3	12.8	13.3	12.2	12.6	15.8	13.1	10.5	0.0	6.1	3.9	11.1	9.1	4.4	17.9	5.7	33.3	9.6	12.7	16.1	11.5	5.3	12.9	22.9	1.9	25.8	1.6	35.2	17.5	13.8	8.1	18.1	15.2	90.1	30.7	3.1	7.6	4.0	19.0	5.6	5.1	3.8	8.0	12.1	0.6	11.7	23.5	3.9	5.7	54.9	4.2	39.2	32.8	20.2	5.7	17.8	0.0	65.5	23.9	106.1	5.5	1.7	7.8	1.7	17.0	1.8	3.4	0.3	4.9	4.2	45.9	0.0	12.5	18.0	3.9	13.3	3.5	7.7	2.2	15.3	48.1	3.4	2.6
CCDC30	"FLJ20972, LOC728621, PFD6L"	ENSG00000186409	"Coiled-coil domain containing 30"	Q5VVM6	1	42463221-42657190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.9;Endometrial ciliated cells: 62.9;Excitatory neurons: 109.2;Inhibitory neurons: 70.3;Respiratory ciliated cells: 109.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036344, HPA036345"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036344: AB_10795572, HPA036345: AB_10796213"	"unprognostic (3.21e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.70e-3)"	"unprognostic (6.95e-3)"	0.8	1.5	3.9	0.7	3.5	1.6	2.3	4.5	4.0	2.4	13.0	0.7	0.6	1.8	5.1	0.7	6.1	1.3	0.7	3.6	5.3	4.7	0.7	1.8	1.0	6.2	5.4	2.2	1.5	3.3	1.6	0.9	2.6	1.5	1.0	3.1	1.4	1.9	1.6	1.7	1.1	1.1	2.6	1.2	0.8	3.9	5.4	1.0	4.9	0.5	0.8	0.8	0.2	3.6	1.4	0.9	2.1	2.2	1.0	1.2	0.7	0.7	0.3	1.1	1.0	0.8	2.5	1.6	1.0	0.2	1.2	0.9	1.0	1.2	1.5	1.3	1.4	1.0	2.0	0.7	1.0	1.3	8.8	0.6	2.3	1.9	0.8	2.0	0.8	1.0	0.9	0.9	0.5	0.8	0.8	1.6	1.3	0.7	0.6	0.7	0.8	0.9	2.7	0.7	2.6	2.1	0.8	1.7	1.5	1.9	1.2	3.2	0.3	1.0	1.0	1.3	1.1	1.1	1.0	0.7	1.9	2.4	1.0	5.8	1.0	2.4	1.0	0.6	1.1	1.0	0.6	0.9	0.7	1.4	1.0	0.8	4.6	1.3	1.7	1.8	1.0	0.4	3.9	3.5	4.5	4.0	3.6	5.3	6.2	5.4	2.6	2.6	5.4	3.6	2.8	6.4	12.9	43.1	2.0	1.3	2.8	2.5	2.2	5.8	5.5	4.2	2.7	5.7	21.1	7.3	8.4	1.6	6.3	3.1	1.9	5.9	81.9	62.9	5.5	3.8	3.0	4.0	109.2	2.4	1.0	5.2	2.0	4.2	8.9	11.8	2.5	0.9	1.2	6.7	70.3	2.0	2.0	2.5	1.7	37.7	5.9	3.0	1.8	33.7	4.5	5.3	5.2	40.2	41.6	1.3	2.9	7.2	1.3	2.3	3.0	9.1	109.1	9.3	6.6	9.0	5.3	42.4	6.6	1.0	1.0	1.8	3.9	7.1	1.3	1.9
CCDC32	"C15orf57, MGC20481"	ENSG00000128891	"Coiled-coil domain containing 32"	Q9BV29	15	40528683-40565057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041688	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Vesicles	"HPA041688: AB_10796779"	"unprognostic (7.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.25e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.47e-2)"	16.0	20.5	16.2	17.0	14.8	20.2	15.5	13.9	18.1	16.0	16.9	17.3	17.0	14.6	17.3	9.3	18.2	17.8	18.1	18.3	17.1	22.8	13.0	14.2	28.7	16.1	17.6	25.0	17.9	20.0	13.6	21.3	18.6	13.9	19.8	15.1	13.0	14.9	15.5	10.3	14.9	15.4	15.6	21.5	18.0	8.3	18.2	19.4	20.9	11.1	25.8	19.2	12.1	16.2	15.4	10.8	14.1	22.8	28.8	29.9	8.4	12.0	17.8	20.9	21.8	16.4	20.9	5.6	32.9	18.0	30.2	28.3	13.8	13.8	14.8	35.0	16.2	62.6	18.1	20.6	19.6	24.0	31.5	25.4	14.1	16.3	11.0	19.8	26.7	22.0	35.0	36.9	16.1	13.3	11.2	20.4	5.6	35.3	13.6	19.1	18.5	19.1	39.6	36.3	15.8	15.5	17.9	18.5	9.3	16.6	19.6	43.4	29.8	19.5	17.0	34.1	17.5	21.1	21.1	18.4	20.7	37.2	27.8	58.2	32.4	33.9	32.6	34.2	25.9	147.1	35.6	35.3	43.0	167.2	35.8	30.7	34.0	29.1	35.7	57.6	50.6	42.1	16.2	14.8	13.9	18.1	18.3	17.1	16.1	17.6	18.6	15.6	18.2	16.2	32.1	12.8	13.4	0.0	24.6	0.0	0.0	0.0	0.0	0.0	18.6	20.8	0.0	0.0	9.9	20.2	0.0	80.5	19.6	0.0	29.4	27.0	0.0	22.7	13.7	10.2	0.0	0.0	0.0	29.2	32.5	11.3	0.0	14.4	6.3	15.5	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	10.3	0.0	0.0	0.0	0.0	38.3	0.0	0.0	7.8	0.0	0.0	30.0	12.4	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	81.4	10.1	35.0	0.0	0.0
CCDC34	"L15, NY-REN-41, RAMA3"	ENSG00000109881	"Coiled-coil domain containing 34"	Q96HJ3	11	27330827-27363234	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 159.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037574	Uncertain		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane, Nucleoli fibrillar center"		"HPA037574: AB_10795136"	"unprognostic (8.23e-3)"	"unprognostic (1.09e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.32e-7)"	"unprognostic (9.09e-2)"	"unprognostic (1.34e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.11e-2)"	3.8	5.3	16.1	5.6	15.9	13.7	11.2	13.8	32.8	4.4	16.7	8.8	10.7	4.9	11.3	5.5	12.5	3.4	3.4	15.9	15.4	5.0	4.6	2.3	6.5	15.2	14.9	9.7	4.3	8.1	5.5	5.1	15.4	5.4	10.1	6.2	4.1	4.3	3.1	6.5	8.9	3.5	14.3	4.4	9.3	48.8	15.9	15.8	5.6	3.4	8.8	3.3	3.5	14.8	46.1	50.4	41.6	44.7	7.5	17.6	30.8	29.5	11.1	29.8	28.8	28.2	8.3	49.4	20.2	15.8	42.7	40.2	41.9	18.2	54.3	19.5	58.2	39.4	62.6	74.1	3.8	40.6	15.4	5.7	13.4	26.0	12.5	13.2	23.3	70.1	39.0	15.9	32.1	32.6	79.3	63.1	42.9	31.4	44.1	74.8	152.8	7.4	12.8	15.2	32.2	42.2	44.0	19.5	20.8	23.4	52.8	21.4	11.1	47.8	45.2	91.3	69.4	153.2	159.4	34.8	44.5	2.0	42.7	0.0	0.2	0.4	3.1	1.0	3.7	3.4	3.9	4.2	1.0	4.0	4.5	2.8	0.0	3.7	3.8	2.3	6.7	1.1	16.1	15.9	13.8	32.8	15.9	15.4	15.2	14.9	15.4	14.3	15.9	14.8	5.1	0.0	1.7	4.9	10.1	22.8	22.9	33.2	13.1	10.3	71.4	73.3	9.2	27.1	20.6	23.9	12.5	45.5	3.4	41.0	19.6	14.1	383.4	156.1	12.5	11.1	21.6	91.3	11.5	12.3	25.1	17.2	31.1	15.3	7.0	30.9	10.0	16.0	22.0	3.3	7.5	40.5	18.3	8.9	8.4	82.4	21.5	5.7	14.2	0.0	4.7	26.6	7.2	1.0	1.2	5.5	12.1	20.7	13.9	10.3	6.2	17.6	101.5	20.6	6.6	11.6	18.3	336.8	218.8	33.2	20.6	16.1	9.1	10.3	71.2	15.5
CCDC39	"CFAP59, CILD14, DKFZp434A128, FAP59"	ENSG00000284862	"Coiled-coil domain containing 39"	Q9UFE4	3	180602858-180684942	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.7;retina: 21.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Early spermatids: 106.9;Endometrial ciliated cells: 38.7;Late spermatids: 58.3;Respiratory ciliated cells: 159.7;Rod photoreceptor cells: 40.3;Spermatocytes: 56.0"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035363, HPA035364"	Enhanced					NA	NA					"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035363: AB_2674588, HPA035364: AB_10601095"																		2.3	4.2	0.4	9.3	0.7	5.6	0.2	1.0	2.6	0.5	4.9	1.8	6.9	5.1	0.4	3.5	11.3	7.9	3.6	0.6	0.9	1.4	0.5	4.4	21.7	2.8	2.2	7.6	2.7	0.0		1.5	1.6	2.8	0.0	21.9	4.4	0.0	2.9	20.3	7.0	0.1	1.7	10.8	4.2	9.3	0.3	0.0	8.0	0.0	0.0	2.5		2.1	5.1	2.9	11.5	2.6	0.0	0.0	3.5	2.9	0.0	0.0	0.0	3.7	4.3	13.9	4.3	0.0	2.6	4.6	0.1	0.0	0.0	7.6	6.4	6.7	10.7	7.9	0.0	10.4	6.0	0.0	0.0	0.0	0.0	11.9	0.0	13.7	4.5	1.0	0.4	1.3	5.8	0.2	6.6	2.3	6.4	7.4	3.7	16.5	0.0	6.9	5.3	5.8	3.0	2.6	2.2	5.5	7.4	6.9	8.1	8.5	3.6	3.7	9.0	8.5	6.9	13.5	5.6	9.4	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	1.0	2.6	0.6	0.9	2.8	2.2	1.6	1.7	0.3	2.1	0.1	0.0	0.0	1.3	0.2	0.5	0.0	3.3	0.0	7.0	0.0	0.0	0.0	0.0	9.6	0.0	64.6	0.0	0.1	0.0	0.0	0.0	106.9	38.7	0.3	0.4	0.0	0.0	21.8	0.2	0.0	4.0	0.0	0.5	0.0	0.1	12.8	0.1	0.0	1.7	6.8	0.0	0.0	0.9	0.7	58.3	13.4	0.3	1.8	0.0	0.0	2.8	0.0	4.0	1.3	0.0	0.0	9.8	2.4	0.2	0.0	0.0	159.7	40.3	6.6	4.1	1.3	56.0	6.9	0.2	0.6	0.0	0.2	0.2	0.0	0.1
CCDC40	"CFAP172, CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640"	ENSG00000141519	"Coiled-coil domain containing 40"	Q4G0X9	17	80036632-80100613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.5;Respiratory ciliated cells: 92.9;Rod photoreceptor cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022974	Enhanced		Approved	Microtubules		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules		"HPA022974: AB_1848791"	"unprognostic (5.89e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-5)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.26e-2)"	2.0	2.3	2.3	0.9	2.2	0.3	2.2	1.8	2.3	2.6	31.4	2.3	0.5	3.2	2.5	0.7	14.8	2.1	3.1	2.2	4.1	7.5	1.7	3.2	0.7	7.4	10.8	1.7	2.6	1.8	6.9	0.6	3.7	3.2	0.5	5.7	2.3	1.6	0.8	1.1	1.6	1.0	4.6	1.2	1.8	8.4	4.8	0.3	4.9	0.5	0.5	1.7	1.2	2.2	2.2	7.0	6.2	6.9	0.8	0.9	1.6	2.0	1.4	1.7	1.8	0.7	3.0	0.3	0.9	1.4	2.9	0.6	1.6	1.5	0.4	0.1	1.3	0.1	3.9	3.5	1.4	0.1	2.2	1.6	2.1	2.1	0.2	3.0	0.9	1.3	0.8	0.0	1.4	2.5	0.1	0.4	2.8	3.0	2.3	1.8	3.3	0.0	3.5	1.4	12.1	8.7	3.1	1.5	1.4	3.3	2.8	0.2	1.1	3.8	2.3	2.5	0.4	2.0	0.7	0.3	0.8	0.2	1.9	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.3	2.2	1.8	2.3	2.2	4.1	7.4	10.8	3.7	4.6	4.8	2.2	0.8	12.8	5.2	16.6	0.6	0.6	2.4	2.5	0.6	4.2	2.9	3.0	3.6	0.0	10.0	7.3	14.6	0.4	0.1	0.3	1.9	2.9	13.6	58.5	4.0	1.4	3.0	0.0	10.7	1.5	1.0	2.3	1.5	4.7	0.0	1.8	1.8	1.2	1.4	11.8	11.7	1.7	8.2	4.3	1.4	7.9	1.2	1.5	0.0	10.3	0.3	4.7	0.0	8.0	1.9	0.9	1.1	3.4	0.1	1.5	0.3	2.1	92.9	28.6	0.0	3.3	3.2	16.0	5.3	0.5	0.3	0.3	0.5	2.4	0.7	1.1
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	9.6	10.2	9.5	11.4	10.3	20.8	12.5	11.5	14.3	9.3	8.1	12.1	11.7	10.0	10.9	12.0	9.3	7.5	20.4	10.6	10.3	14.2	9.5	9.7	13.5	9.5	9.0	8.1	9.6	15.4	4.8	14.0	10.2	12.0	14.9	18.5	8.9	8.9	73.5	11.3	9.7	10.8	9.8	9.8	11.2	9.5	10.4	13.8	13.5	42.7	14.6	11.8	8.1	11.5	24.9	29.3	27.2	24.1	18.2	26.7	49.8	37.1	21.8	35.7	34.9	39.7	26.0	43.1	28.0	30.4	25.5	19.2	45.3	42.9	51.5	53.1	52.5	38.8	48.8	59.0	32.5	54.8	28.0	24.1	42.7	37.2	50.2	24.4	35.1	34.8	41.6	29.3	36.6	31.0	53.7	38.8	28.2	23.5	37.1	34.5	68.2	37.6	36.7	16.0	27.3	26.9	27.2	21.6	39.5	40.7	55.2	36.6	30.6	43.9	32.5	26.6	50.0	29.5	40.1	49.4	32.1	31.4	32.2	11.6	15.7	11.0	11.9	18.4	11.0	9.1	11.3	13.7	17.5	11.3	11.0	12.0	3.2	16.4	12.5	12.4	15.1	10.2	9.5	10.3	11.5	14.3	10.6	10.3	9.5	9.0	10.2	9.8	10.4	11.5	24.4	12.8	21.0	6.8	19.1	13.3	10.8	20.0	13.1	24.4	15.2	15.7	41.1	17.2	21.5	9.2	10.4	41.1	13.4	10.7	39.2	21.6	0.9	23.4	27.1	23.9	18.0	15.4	10.5	24.5	46.7	17.1	13.7	24.0	32.4	19.9	20.0	15.5	30.6	21.9	8.2	17.1	8.2	18.8	16.0	3.5	14.0	19.2	21.4	1.0	24.6	19.6	9.2	6.6	6.5	21.0	12.4	12.8	26.9	12.9	15.0	36.8	19.8	25.4	6.6	23.4	17.5	3.6	12.4	24.8	11.2	25.3	16.7	22.6	22.6	8.7
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329085-191398659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 630.7"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 630.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	63.2	28.3	19.6	34.3	20.7	10.3	30.6	21.5	19.1	24.1	18.8	26.9	24.2	33.0	24.8	27.9	24.3	34.8	39.7	17.6	23.3	32.4	56.5	31.6	42.2	24.1	22.0	46.2	35.1	27.6	13.5	34.9	24.1	26.2	25.4	11.8	23.7	33.3	19.0	18.4	25.8	48.1	23.2	45.0	24.3	29.6	21.3	17.7	27.4	26.1	41.0	36.7	18.6	24.7	74.9	24.5	93.6	24.7	82.3	72.1	32.3	135.4	135.2	95.4	95.0	52.6	28.9	14.6	163.0	76.8	70.6	83.6	75.6	60.5	141.9	109.0	37.8	10.0	31.7	60.3	120.8	36.8	37.8	58.2	79.3	75.6	169.7	82.2	148.7	0.0	33.9	77.3	85.4	26.0	0.2	23.1	33.2	7.6	103.0	56.3	51.9	73.1	104.3	31.9	21.8	33.2	48.2	51.6	95.8	67.3	35.6	32.9	153.3	93.4	78.4	68.4	176.3	118.6	54.9	0.9	50.5	0.1	76.9	0.1	22.1	2.1	5.9	20.8	2.4	128.5	6.1	3.9	44.3	76.5	1.3	1.5	2.2	24.0	12.1	630.7	22.1	18.0	19.6	20.7	21.5	19.1	17.6	23.3	24.1	22.0	24.1	23.2	21.3	24.7	143.5	25.6	54.5	40.5	134.5	46.9	52.5	30.7	30.7	27.2	32.5	37.5	48.4	58.6	34.7	51.5	27.1	28.1	363.7	44.1	31.3	120.4	183.0	97.3	58.1	134.0	22.8	11.2	15.8	78.5	36.3	66.6	41.8	79.0	2.5	58.5	175.6	79.5	84.4	25.2	41.3	33.8	38.7	59.4	78.3	92.1	69.3	61.4	53.4	98.4	101.4	32.1	5.2	365.4	28.9	174.7	33.9	75.6	102.7	69.8	37.6	71.8	26.3	14.4	59.2	74.1	65.7	73.2	26.6	24.0	32.5	33.5	22.4	49.5	33.7	62.4
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	10.1	13.7	10.7	7.3	10.9	5.0	8.7	10.8	11.6	8.3	22.2	12.2	11.0	8.0	10.1	13.8	8.8	5.4	11.9	11.1	10.6	13.9	13.0	6.7	9.6	11.3	10.8	7.7	5.4	9.4	6.1	8.2	11.3	6.7	13.6	7.7	7.0	9.0	15.5	10.1	8.6	9.0	10.7	12.6	7.6	7.8	11.7	9.9	10.3	11.7	11.8	9.0	9.5	10.7	22.7	26.7	15.7	18.7	23.1	24.2	43.6	14.6	13.4	28.6	23.2	42.9	36.9	48.6	20.5	11.7	21.6	32.2	39.5	47.8	17.4	22.9	25.6	41.4	44.1	32.7	35.3	20.4	18.2	18.4	106.8	35.6	38.8	15.7	16.7	28.0	23.4	13.7	27.7	21.4	24.1	26.5	34.8	48.2	42.8	16.5	18.6	37.7	39.3	27.8	13.1	27.2	24.2	26.2	39.9	14.7	28.2	31.3	12.6	16.5	22.3	41.6	28.5	22.0	34.8	25.5	22.0	43.8	16.0	3.0	14.1	7.0	15.5	14.9	15.8	28.1	14.5	19.7	25.5	23.0	14.8	17.4	6.0	16.5	9.1	21.1	19.8	14.6	10.7	10.9	10.8	11.6	11.1	10.6	11.3	10.8	11.3	10.7	11.7	10.7	7.1	12.8	2.6	2.6	5.9	4.7	3.7	28.8	17.6	7.3	6.6	8.1	8.2	15.7	12.8	9.2	0.0	40.1	5.0	12.6	23.5	15.1	3.3	19.4	7.3	5.9	5.4	5.9	2.4	12.4	22.0	10.0	6.6	16.5	3.8	10.1	4.6	13.1	15.9	8.4	2.4	7.6	14.2	3.8	3.3	2.7	12.2	4.4	14.2	1.9	9.1	11.0	11.3	3.5	3.2	15.2	8.0	13.2	5.1	5.4	21.6	43.4	9.3	10.7	6.6	4.0	6.2	7.2	16.3	13.0	4.7	6.7	4.8	20.0	13.4	3.4
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Late spermatids: 729.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 3.7;naive CD8 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	6	"T-cells: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.3	8.4	3.3	5.8	5.1	8.3	8.3	6.1	8.2	13.0	6.4	8.7	7.2	9.4	6.4	3.5	11.0	6.6	4.3	3.7	1.5	12.4	7.4	8.1	5.3	2.1	1.4	12.3	10.5	7.9	16.9	3.4	1.3	14.4	3.0	9.0	9.1	5.8	4.0	5.6	6.6	3.6	0.1	6.2	7.7	12.2	1.8	8.1	17.7	1.1	2.8	6.9	6.5	3.1	5.2	10.4	5.4	6.9	3.1	5.8	6.0	3.9	3.9	2.8	2.5	3.0	7.9	2.7	3.7	3.2	2.9	12.0	1.6	7.2	1.6	2.8	10.6	4.5	20.3	6.7	4.0	4.5	5.6	5.9	5.5	5.3	6.9	6.5	3.4	3.9	5.8	1.5	2.0	7.5	8.8	8.5	1.7	3.0	4.1	4.7	2.4	3.8	5.5	6.2	18.5	11.3	3.4	17.3	6.7	3.4	9.9	5.3	3.7	11.0	10.0	4.8	8.2	11.0	1.2	0.9	8.5	5.1	4.5	0.5	0.4	0.5	0.6	0.1	0.2	0.4	0.5	0.8	0.4	0.3	3.7	7.6	1.3	0.3	0.1	1.2	0.2	1.0	3.3	5.1	6.1	8.2	3.7	1.5	2.1	1.4	1.3	0.1	1.8	3.1	5.9	25.6	62.7	19.6	35.8	11.7	22.7	23.7	19.4	22.5	82.3	66.2	5.3	17.2	41.9	29.5	41.7	36.2	45.4	27.6	9.8	15.8	116.1	44.9	15.9	6.9	42.7	14.1	72.8	17.1	34.2	9.8	36.2	19.2	34.9	33.2	7.1	101.0	29.9	25.2	54.4	46.9	30.5	42.1	35.8	729.3	8.1	28.7	33.8	13.1	39.6	10.0	48.4	16.1	10.6	18.1	26.9	10.1	36.5	20.4	31.6	13.2	52.3	66.3	6.6	14.3	9.9	13.6	6.9	21.2	18.3	12.4	40.2	10.5	37.2	23.1
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051965	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoli	"HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	14.7	21.0	16.9	15.7	17.8	18.0	19.0	18.2	28.2	10.7	18.4	28.5	22.5	11.7	24.6	23.2	10.6	13.4	27.3	17.1	17.6	46.8	49.8	9.0	23.3	17.8	18.1	13.1	13.8	14.9	7.8	14.4	18.2	11.1	29.1	17.1	11.3	10.6	78.8	15.0	18.6	11.4	17.4	12.1	16.4	9.4	18.1	16.2	18.3	47.2	21.5	22.6	12.5	18.3	135.1	41.9	78.2	50.2	28.5	39.8	100.6	50.5	54.3	119.4	116.4	118.4	66.4	98.0	84.6	38.6	92.7	91.9	127.9	86.3	142.5	34.1	45.3	115.9	28.5	145.6	47.5	174.5	39.5	33.0	43.9	73.5	79.8	50.7	55.9	85.8	133.6	41.6	63.7	67.2	111.7	123.6	150.0	147.2	78.1	72.8	92.9	120.1	83.7	70.3	78.8	38.4	58.5	61.5	150.5	65.3	61.2	112.8	32.6	66.4	86.1	28.6	102.3	32.9	47.5	217.4	75.7	83.3	60.0	0.9	7.7	2.7	15.2	16.7	18.0	20.9	19.9	20.1	16.5	19.2	23.0	22.2	1.4	19.2	14.2	29.2	17.2	6.7	16.9	17.8	18.2	28.2	17.1	17.6	17.8	18.1	18.2	17.4	18.1	18.3	5.7	3.2	17.0	8.1	18.1	15.3	19.1	21.4	21.1	10.5	14.1	10.4	32.0	20.0	22.2	12.9	10.4	21.8	8.4	19.6	54.8	31.4	0.5	24.7	20.5	13.7	5.4	14.1	11.3	30.0	44.7	12.8	16.8	26.2	21.5	14.4	10.8	50.5	17.8	0.0	13.2	27.7	16.2	8.7	7.6	1.5	12.8	8.9	8.8	2.8	19.8	9.7	16.5	11.6	11.8	31.9	14.7	8.2	12.5	30.7	23.9	114.0	22.5	9.6	13.1	15.1	41.8	23.1	31.0	30.8	18.5	15.2	10.9	11.8	35.1	23.0
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	12.9	6.3	7.1	5.2	7.4	40.3	10.9	7.8	10.3	9.2	3.7	10.0	4.2	9.2	10.9	10.6	10.0	7.0	9.0	7.1	6.5	6.5	9.7	8.0	8.8	7.4	6.1	11.3	7.8	9.6	6.7	9.6	7.0	7.0	7.5	4.7	6.7	6.7	16.0	8.5	6.0	8.0	6.1	6.3	7.4	12.3	6.9	12.5	8.6	19.3	11.1	11.1	8.7	10.2	27.2	22.9	18.9	16.0	22.5	20.1	33.1	24.0	28.5	43.4	35.3	52.9	16.0	31.0	12.0	26.0	29.9	18.3	95.3	46.7	36.4	35.7	51.3	34.3	15.1	34.6	66.7	40.3	15.7	36.1	39.0	43.5	55.9	34.6	35.9	55.8	62.8	17.1	26.9	50.6	39.6	57.1	30.4	25.6	54.4	28.4	31.9	27.6	23.4	28.4	33.8	16.4	27.4	15.6	34.6	23.1	32.3	55.0	17.6	18.0	16.3	15.1	45.7	22.7	30.2	66.2	15.7	32.8	29.0	25.9	9.2	18.3	10.7	12.6	22.0	16.4	19.0	20.9	9.9	24.1	22.2	18.7	22.3	14.9	19.0	21.4	29.5	5.9	7.1	7.4	7.8	10.3	7.1	6.5	7.4	6.1	7.0	6.1	6.9	10.2	76.6	67.3	56.3	10.1	81.7	85.8	129.9	84.9	65.4	33.7	57.3	80.1	44.3	40.0	66.5	44.1	22.9	80.0	88.2	33.1	129.1	48.7	125.8	63.1	71.5	62.0	35.8	41.2	9.4	57.5	88.3	61.5	29.6	85.0	78.6	45.8	64.2	53.9	56.8	43.7	9.9	62.5	50.8	70.9	53.8	28.4	53.4	62.0	48.0	5.6	66.9	47.2	64.9	12.1	17.2	54.8	44.0	53.8	54.7	88.1	56.1	93.0	51.5	40.6	19.7	118.1	57.8	204.9	135.2	57.6	89.9	146.8	95.6	43.5	56.7	100.6
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788747-59906556	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No		12000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	11.9	12.2	21.1	13.9	23.4	16.8	22.4	10.2	20.0	23.4	8.5	23.5	22.8	24.9	16.7	34.1	25.3	16.7	10.0	24.9	21.4	21.2	12.1	17.3	21.4	12.4	15.8	15.7	25.2	17.9	11.5	13.2	17.4	19.4	19.8	18.3	29.0	14.3	17.3	28.6	16.2	30.8	11.9	14.7	18.6	11.4	20.8	12.1	18.3	12.2	21.6	17.3	23.1	12.6	42.9	38.0	18.7	41.9	27.8	41.6	37.9	20.6	27.2	20.2	23.7	74.4	81.8	36.5	30.2	34.6	11.7	61.7	37.7	37.5	30.0	55.1	18.7	29.8	29.1	45.5	33.5	34.5	26.9	30.3	48.7	33.7	81.8	28.3	30.2	20.4	22.6	22.7	26.6	57.6	14.5	19.8	29.9	40.1	25.6	19.2	30.5	23.0	33.9	36.2	19.0	16.6	26.1	107.8	23.1	24.1	68.7	18.4	31.1	18.8	33.9	29.3	34.9	12.0	14.9	16.3	29.6	64.6	11.9	0.0	2.0	0.0	1.0	2.3	1.1	4.3	1.5	1.3	5.0	4.9	1.3	1.0	0.1	0.8	1.3	1.3	1.4	1.0	21.1	23.4	10.2	20.0	24.9	21.4	12.4	15.8	17.4	11.9	20.8	12.6	24.0	99.3	25.9	45.1	41.6	95.0	51.7	25.3	70.0	15.1	51.2	38.7	16.5	28.6	46.3	25.8	41.7	37.8	31.4	42.6	29.4	50.2	27.6	105.2	54.6	22.4	27.0	25.7	83.2	65.3	18.8	27.8	39.8	134.5	29.1	45.2	17.2	20.1	23.1	16.8	58.4	38.9	30.5	40.7	35.3	80.6	24.5	36.4	16.0	32.8	23.0	11.5	13.4	55.3	34.2	50.2	25.0	19.5	26.4	52.2	47.1	48.4	28.1	49.8	19.7	31.4	27.0	2.3	22.4	92.3	80.1	27.0	24.3	32.5	46.3	46.1
CCDC61		ENSG00000104983	"Coiled-coil domain containing 61"	Q9Y6R9	19	45995461-46021318	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in all"		"NB-4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040325, HPA061548"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040325: AB_10672970, HPA061548: AB_2684559"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.23e-3)"	"unprognostic (7.27e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.09e-1)"	9.3	11.2	6.9	8.0	8.1	5.9	9.3	13.7	11.2	11.6	4.8	11.1	7.9	10.0	7.2	10.4	16.2	5.0	8.4	7.8	5.4	12.2	12.5	8.6	11.0	6.6	5.1	12.5	10.3	9.9	13.3	5.9	5.4	11.2	4.9	1.6	9.0	8.0	5.6	12.7	10.3	5.1	4.0	13.9	11.0	24.9	5.3	9.7	12.4	4.1	6.9	11.2	10.0	7.8	13.9	10.0	5.2	9.0	9.6	7.0	7.9	9.8	5.0	5.8	9.7	6.1	12.0	8.7	4.7	6.9	8.0	11.6	5.7	13.1	4.3	16.6	5.4	9.3	8.6	10.1	10.6	8.9	12.2	7.6	17.9	5.0	10.4	9.9	11.7	16.3	10.5	17.5	7.5	4.4	20.4	57.2	1.9	14.9	4.3	13.7	1.7	14.1	9.5	11.4	5.6	5.1	9.7	12.5	7.6	5.1	5.3	12.7	10.0	4.2	1.7	2.0	11.2	10.6	5.5	8.9	9.4	9.8	7.1	6.5	0.4	0.4	0.9	0.4	0.5	0.8	0.5	0.5	0.2	1.2	0.6	0.5	1.3	0.3	0.5	0.3	0.5	0.2	6.9	8.1	13.7	11.2	7.8	5.4	6.6	5.1	5.4	4.0	5.3	7.8	8.8	0.0	4.4	4.6	7.0	6.2	7.1	1.1	4.6	4.3	4.3	5.3	6.0	4.3	3.0	11.0	0.0	11.2	5.1	11.9	9.8	1.6	3.4	9.0	5.7	5.3	3.6	2.1	4.0	2.0	8.5	6.4	12.8	5.6	0.0	11.8	4.2	4.4	8.0	3.3	4.1	8.6	0.0	5.3	2.7	1.6	5.3	5.5	3.6	1.9	2.3	3.3	2.1	1.5	2.6	1.8	5.8	5.7	6.1	4.3	6.6	8.4	3.5	1.9	6.6	4.6	6.0	13.9	6.2	6.4	5.3	7.8	7.3	9.8	10.9	4.3
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774526-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 70.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.3	1.2	0.2	1.3	0.2	0.1	0.7	1.8	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	1.3	0.5	0.1	0.1	0.1	0.3	0.6	0.4	0.1	0.1	0.3	0.7	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.7	0.4	0.2	0.1	0.2	0.5	0.1	70.0	0.5	0.2	0.1	0.3	0.3	0.1	0.1	2.0	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.9	0.1	0.0	0.0	0.6	0.8	0.1	0.3	0.4	0.1	0.1	0.0	0.7	0.3	0.2	0.4	0.1	0.0	1.2	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.1	0.2	2.9	0.1	0.1	0.3	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.0	1.2	1.3	0.7	1.8	1.3	0.5	0.6	0.4	0.7	0.2	0.5	2.0	0.5	0.0	0.0	9.1	2.1	0.5	0.2	0.1	0.6	1.4	0.4	0.5	1.0	0.0	0.0	0.0	4.2	0.1	0.6	0.1	0.0	0.3	259.2	0.5	0.4	0.4	0.0	0.0	11.7	0.2	0.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	1.7	8.1	0.2	0.0	0.3	1.7	75.0	3.1	1.3	1.8	3.7	0.2	0.5	1.0	5.0	8.0	0.1	0.0	2.6	0.3	0.5	0.1	0.0	0.0	1.3	13.1	0.5	0.2	188.2	2.9	0.4	0.9	0.0	0.3	0.2	0.3	0.2
CCDC65	"CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28"	ENSG00000139537	"Coiled-coil domain containing 65"	Q8IXS2	12	48904110-48931840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 26.6;testis: 37.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 151.1;Endometrial ciliated cells: 92.7;Respiratory ciliated cells: 155.7;Spermatocytes: 85.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 8.7;MAIT T-cell: 9.1;memory CD4 T-cell: 7.5;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.6;naive CD8 T-cell: 6.2;T-reg: 4.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 9.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038520, HPA057573"	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Centriolar satellite"	"HPA038520: AB_10672714, HPA057573: AB_2683473"	"unprognostic (3.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.23e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.03e-4)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.16e-2)"	0.4	0.4	1.5	0.7	2.3	1.4	0.4	0.0	2.8	1.4	3.4	0.4	0.3	1.1	2.8	0.3	26.6	1.2	0.3	3.2	0.3	1.8	0.3	2.9	1.0	1.4	2.3	0.8	0.8	1.4	2.1	0.1	1.3	0.4	0.0	7.1	0.3	0.4	0.4	1.5	0.5	0.1	0.5	1.1	0.4	37.3	1.5	0.2	2.5	0.0	0.3	0.2	0.3	0.3	0.6	2.5	1.1	2.2	0.0	0.0	1.1	0.6	0.0	0.3	1.0	3.1	1.4	0.9	0.8	0.0	0.3	0.7	0.0	0.0	0.4	1.4	1.1	1.4	4.4	1.1	0.1	1.1	1.2	0.0	0.0	0.6	0.0	1.7	0.0	0.7	0.6	0.3	0.0	1.5	0.3	1.5	2.5	0.9	0.6	0.8	0.5	1.0	2.0	1.6	0.6	1.0	0.7	0.9	0.8	1.7	2.3	1.0	1.0	0.8	0.8	0.9	0.5	1.1	1.2	0.8	0.9	0.9	0.2	0.0	0.0	0.0	8.7	0.0	9.1	0.2	7.5	7.3	0.0	0.5	4.6	6.2	0.1	0.8	0.0	0.0	4.8	2.9	1.5	2.3	0.0	2.8	3.2	0.3	1.4	2.3	1.3	0.5	1.5	0.3	0.9	0.0	1.1	2.0	0.6	0.9	0.2	6.2	0.0	1.2	0.4	0.5	0.5	0.0	13.8	0.0	12.5	0.1	6.5	0.0	7.9	1.0	151.1	92.7	3.0	0.6	0.0	2.7	7.2	0.6	0.1	0.8	0.5	4.2	0.0	0.5	0.0	0.5	0.0	0.0	4.0	0.0	12.2	0.0	0.8	22.7	1.5	0.3	1.8	1.0	0.2	2.2	33.0	2.0	0.8	0.3	0.0	2.2	1.0	0.2	0.0	3.4	155.7	11.5	0.0	0.5	3.6	85.9	4.8	0.0	0.1	0.1	7.3	0.5	0.0	0.1
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.8;placenta: 32.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.5	3.8	1.6	4.1	1.5	0.4	3.4	1.4	2.7	4.2	2.3	18.9	20.2	3.3	0.8	1.8	2.4	5.1	5.7	1.5	3.6	2.8	9.5	13.0	0.8	2.0	2.3	15.7	2.8	0.8	3.6	32.4	2.0	4.2	18.2	0.6	1.8	1.3	1.5	0.9	24.8	2.7	1.2	7.2	14.3	8.8	3.3	0.6	2.6	4.4	1.3	2.3	1.8	1.3	10.8	3.3	0.0	0.0	3.0	8.3	0.0	0.3	4.2	0.6	0.7	5.9	6.2	0.0	7.6	0.0	0.1	0.1	0.7	6.8	0.5	0.0	1.6	0.8	3.6	1.2	13.6	0.0	0.0	14.9	0.0	3.2	0.1	0.0	4.9	0.0	0.0	0.1	0.4	0.8	0.0	0.2	0.0	7.6	3.6	0.3	0.0	0.3	1.2	10.5	0.1	2.5	3.3	1.0	0.1	1.2	0.0	0.0	28.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.6	1.5	1.4	2.7	1.5	3.6	2.0	2.3	2.0	1.2	3.3	1.3	38.5	19.2	10.3	0.3	1.0	0.3	7.4	4.8	1.2	0.1	2.0	1.9	5.5	10.0	13.3	1.8	0.0	2.3	0.3	95.2	1.9	7.2	95.4	15.0	2.5	40.8	6.0	3.6	5.7	35.6	2.7	9.6	38.2	27.1	8.8	2.6	37.5	7.0	0.4	0.0	0.5	21.8	8.2	3.2	1.3	36.7	3.4	0.6	0.0	12.2	1.0	3.3	1.0	0.0	0.1	87.9	68.7	0.7	0.0	32.4	61.1	5.3	4.2	0.2	6.6	0.9	3.0	1.2	2.2	1.1	0.0	6.0	0.4	3.8	20.2	6.4
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 351.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1"	"Region enhanced"	"Detected in some"		"cerebellum: 4.8"	"Low region specificity"	"Detected in all"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments"	"HPA043648: AB_10795877, HPA052896: AB_2681983"	"prognostic favorable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	108.9	89.6	6.7	45.8	8.4	46.3	60.5	12.2	7.9	15.2	13.4	138.5	19.6	32.9	13.3	54.1	37.1	19.3	96.9	5.9	8.9	10.7	24.0	39.0	70.4	13.3	13.8	27.1	47.5	32.1	8.5	14.8	13.6	23.0	20.5	1.8	14.4	29.4	351.9	13.3	44.7	45.6	11.3	55.4	37.0	13.2	9.2	37.8	11.6	163.8	66.8	87.7	21.9	7.2	8.0	1.6	0.4	6.4	129.2	13.1	4.2	1.5	13.1	2.6	2.4	2.1	1.1	199.9	6.3	0.5	3.3	1.0	3.0	2.8	0.9	0.1	2.7	27.0	0.0	17.5	21.1	9.9	34.4	33.0	0.2	1.0	0.0	2.5	13.1	0.0	23.7	44.0	0.1	0.6	43.8	23.3	7.5	0.1	15.2	36.0	1.0	12.1	0.5	5.9	0.2	0.8	2.4	3.2	1.7	3.2	2.0	24.0	32.0	1.0	6.1	0.6	1.5	120.5	60.1	119.1	1.4	22.2	0.0	30.9	12.4	13.5	11.3	10.9	10.3	5.4	8.8	10.8	10.0	10.4	6.1	6.6	9.6	14.3	10.3	19.3	8.5	11.5	6.7	8.4	12.2	7.9	5.9	8.9	13.3	13.8	13.6	11.3	9.2	7.2	51.0	12.8	78.4	0.7	68.8	2.5	3.0	3.5	1.2	0.4	4.8	2.4	124.5	1.5	13.5	1.8	0.0	7.3	106.9	0.2	0.0	2.9	0.5	26.8	2.7	58.9	1.8	32.2	1.8	20.0	9.6	18.4	7.1	1.3	34.8	138.2	28.2	39.7	7.3	6.7	2.7	0.0	4.1	64.0	12.2	2.4	5.6	46.5	10.6	11.2	73.5	4.9	197.8	1.0	0.6	8.8	0.1	7.9	133.6	3.6	4.5	3.2	51.3	1.4	13.1	4.7	14.8	1.2	1.0	0.7	1.3	35.4	65.7	132.1	0.9	23.5
CCDC70	"DKFZP434K1172, FLJ25853"	ENSG00000123171	"Coiled-coil domain containing 70"	Q6NSX1	13	51861969-51866232	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	233	"testis: 135.2"	"Group enriched"	"Detected in some"	122	"Early spermatids: 982.5;Late spermatids: 3017.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA079644	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA079644: "					"unprognostic (5.73e-3)"									"unprognostic (1.88e-1)"				0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	982.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3017.7	13.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC71	FLJ12800	ENSG00000177352	"Coiled-coil domain containing 71"	Q8IV32	3	49162535-49166331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047547	Uncertain		Approved	"Nuclear membrane"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"		"HPA047547: AB_2680083"	"unprognostic (1.06e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.71e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (9.65e-9)"	"unprognostic (3.53e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.14e-2)"	13.0	15.4	5.0	9.6	5.4	7.3	14.5	5.4	6.2	13.6	4.9	9.9	8.3	14.9	9.6	13.8	16.4	9.1	12.2	5.0	5.9	10.6	12.6	11.1	13.5	5.3	5.4	18.2	9.5	13.6	9.6	10.1	5.4	12.0	7.6	3.4	12.5	10.5	14.8	13.0	10.7	10.0	5.3	13.3	10.5	12.2	5.4	13.0	16.1	9.5	9.5	12.9	11.9	5.3	12.6	16.9	19.4	18.8	21.8	15.8	18.6	15.2	21.8	26.1	22.9	17.6	19.8	11.2	13.0	26.2	20.9	13.0	19.3	40.7	9.3	24.9	14.0	22.7	22.0	17.9	25.7	18.3	16.5	26.9	31.4	31.0	23.7	19.4	25.8	26.7	23.1	4.6	21.1	26.9	31.8	11.2	30.2	18.8	18.1	11.5	10.8	10.5	24.8	24.0	9.8	21.3	15.5	16.3	18.5	15.6	21.7	30.2	17.1	18.3	19.4	18.3	20.0	17.5	8.2	15.6	13.3	17.2	20.7	0.0	1.0	0.4	0.9	1.7	1.4	0.5	0.8	1.2	0.9	1.3	1.2	0.8	0.9	4.8	1.3	0.3	1.0	0.6	5.0	5.4	5.4	6.2	5.0	5.9	5.3	5.4	5.4	5.3	5.4	5.3	5.1	6.4	1.5	1.6	7.9	2.7	12.5	23.8	6.8	1.5	7.5	8.5	1.4	5.7	11.2	7.3	0.0	23.3	4.1	8.3	25.4	21.3	9.3	2.4	3.5	8.0	8.4	11.8	2.1	11.8	16.5	7.7	7.1	1.8	2.5	6.5	16.1	9.3	20.1	0.0	2.0	8.4	24.4	5.6	2.1	10.2	11.8	5.3	5.4	6.5	8.8	3.6	12.3	1.0	1.0	15.2	9.3	13.5	9.3	10.8	10.4	14.1	7.1	1.2	13.1	4.1	7.0	10.6	18.4	9.2	2.7	22.4	5.8	6.6	8.2	11.5
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106654360-106661158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	51.5	9.8	2.7	19.6	2.7	15.8	18.7	2.0	2.9	13.1	3.3	14.6	6.5	16.9	2.8	6.8	36.2	10.8	8.2	2.9	3.2	18.1	46.7	22.1	9.6	8.2	2.8	10.1	9.3	5.2	6.4	3.7	3.7	11.2	5.4	1.0	12.6	6.6	5.3	6.2	15.8	7.2	3.3	18.7	16.3	6.9	4.6	14.5	10.2	2.5	8.0	40.0	9.3	3.6	24.8	5.1	7.4	8.9	16.3	15.4	0.0	37.0	47.5	14.2	15.4	0.7	15.3	16.5	12.6	63.3	27.1	2.8	3.6	10.7	11.7	38.7	8.5	2.1	0.9	0.0	25.5	8.4	19.4	13.2	6.4	6.5	3.7	24.1	50.0	9.2	56.0	39.9	17.1	7.1	11.5	13.3	16.0	2.0	17.0	15.4	2.1	3.3	7.3	1.4	3.2	22.1	23.9	8.6	55.9	15.4	3.9	10.1	22.0	31.4	2.9	3.7	14.6	38.4	3.8	13.5	24.3	10.8	35.3	4.9	0.6	1.8	1.1	0.4	0.8	1.3	0.8	0.8	0.4	0.9	0.4	0.6	4.1	0.6	0.7	1.4	1.7	0.5	2.7	2.7	2.0	2.9	2.9	3.2	8.2	2.8	3.7	3.3	4.6	3.6	44.0	3.2	11.6	1.0	9.4	8.2	50.5	2.1	6.8	4.3	39.9	33.0	6.2	18.6	1.6	5.5	2.1	3.0	26.2	12.9	11.7	7.4	1.2	18.7	78.7	21.4	6.6	11.6	1.8	10.7	7.4	47.8	3.6	20.2	12.0	3.3	45.7	34.4	8.1	6.7	2.8	7.3	4.1	10.0	13.9	2.1	21.8	22.5	12.4	1.9	6.5	5.0	10.3	2.5	1.8	13.9	10.1	17.7	4.3	11.0	10.1	4.7	6.8	4.8	0.0	24.5	30.1	7.1	4.9	4.0	5.1	3.3	13.7	3.4	9.5	18.3
CCDC73	NY-SAR-79	ENSG00000186714	"Coiled-coil domain containing 73"	Q6ZRK6	11	32602246-32794658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.7"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 160.3;Spermatogonia: 84.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038668, HPA038669"	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA038668: AB_10673292, HPA038669: AB_2676142"	"unprognostic (9.41e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.62e-5)"	"unprognostic (3.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-3)"	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.8	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.6	2.3	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.9	0.0	4.8	1.8	0.5	0.6	0.0	0.0	4.5	0.2	0.1	0.2	0.0	0.6	0.0	0.2	0.0	1.1	0.2	0.0	3.9	0.1	0.0	0.0	0.0	4.3	0.6	0.1	0.0	7.5	0.1	0.0	0.0	3.5	1.7	0.3	1.2	0.7	0.3	0.3	0.0	0.9	1.0	0.6	6.6	0.0	0.2	160.3	84.2	0.0	0.0	0.1	0.2	4.3	0.0	0.5
CCDC77	MGC13183	ENSG00000120647	"Coiled-coil domain containing 77"	Q9BR77	12	389273-442642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038854	Approved		Approved	"Nuclear membrane"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"HPA038854: AB_10673121"	"unprognostic (3.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.26e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.11e-7)"	"unprognostic (2.54e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.41e-3)"	3.4	5.0	3.1	6.2	4.9	4.6	4.5	3.1	4.9	3.6	1.8	4.1	4.6	5.0	2.2	4.1	3.8	3.2	3.1	3.9	4.6	3.8	3.4	3.9	6.8	4.5	4.1	5.2	2.5	2.3	2.4	3.6	4.3	3.5	4.7	3.4	3.0	2.6	4.7	5.2	3.6	3.4	2.8	4.8	3.3	12.5	3.9	9.7	4.0	3.2	6.2	3.1	3.6	7.7	10.0	13.2	28.7	18.9	9.5	8.1	29.4	24.7	11.6	23.3	37.4	13.4	17.1	23.8	5.9	9.8	13.6	13.6	20.5	7.2	25.0	52.0	20.1	26.9	26.5	17.8	5.5	22.2	12.9	6.5	4.3	21.9	13.5	14.0	15.6	22.7	22.4	24.2	23.9	6.0	21.6	15.7	57.0	13.8	9.9	24.4	51.8	14.7	8.7	7.3	8.2	21.1	24.5	9.4	12.9	42.4	7.4	16.7	14.8	11.6	22.5	20.6	29.0	6.8	13.9	29.8	15.7	22.0	20.3	2.5	4.5	3.9	4.7	6.4	4.9	5.9	4.3	5.2	4.8	8.1	3.0	4.5	3.4	6.2	8.1	5.2	3.3	3.1	3.1	4.9	3.1	4.9	3.9	4.6	4.5	4.1	4.3	2.8	3.9	7.7	4.6	0.0	6.2	2.6	9.4	4.1	3.6	3.5	3.4	3.1	4.1	4.4	3.7	2.8	4.4	3.7	6.2	6.8	8.6	2.9	7.9	3.2	24.2	5.6	5.5	4.4	2.4	5.0	8.1	2.0	8.0	4.7	6.6	4.5	7.0	8.1	3.6	2.3	5.5	1.7	7.9	4.5	8.2	6.6	2.9	15.3	4.1	5.5	1.8	3.7	6.0	6.5	8.2	8.0	13.7	2.0	5.9	4.5	7.0	2.6	2.0	3.4	5.4	5.5	6.6	7.4	4.3	22.3	18.0	6.7	3.8	5.6	6.6	4.4	4.1	2.2
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410329-46413564	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 36.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	4.1	16.3	4.1	2.7	3.8	0.7	8.8	3.9	2.6	13.9	7.5	3.3	0.9	13.9	10.5	1.3	22.9	4.2	24.7	3.6	3.9	11.2	0.7	4.4	0.9	5.2	7.4	36.8	13.6	9.1	12.9	6.7	5.3	6.4	1.2	1.3	10.8	7.5	2.1	3.1	2.2	6.5	4.8	2.3	2.2	5.9	4.2	5.6	9.0	2.4	0.8	7.5	7.3	4.4	1.9	0.1	18.5	22.2	4.8	6.0	8.9	9.6	0.0	2.1	0.9	0.1	0.1	0.2	12.5	7.6	0.4	0.2	0.1	15.0	1.0	0.0	9.4	0.0	0.2	1.0	16.0	0.1	0.1	19.6	0.0	5.2	15.2	0.3	0.1	0.1	20.3	0.0	6.8	0.0	0.0	1.3	13.3	0.0	0.0	0.7	24.8	0.0	16.1	0.1	2.9	0.1	0.1	0.1	0.1	14.2	0.1	4.7	1.7	1.2	4.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	3.8	3.9	2.6	3.6	3.9	5.2	7.4	5.3	4.8	4.2	4.4	0.7	0.0	1.1	1.3	0.0	0.9	6.5	1.5	0.0	0.4	1.8	19.3	27.0	7.2	4.0	11.0	0.0	7.5	0.1	0.0	39.2	14.8	0.4	15.0	13.9	1.2	0.0	0.0	0.0	1.1	10.0	17.3	0.0	3.9	1.3	25.7	1.1	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.9	2.9	70.8	0.6	1.8	1.0	0.0	14.6	0.0	1.5	0.1	3.6	0.0	57.9	0.0	3.7	0.0	1.2	2.4	0.5	13.1	12.3	8.3	0.4	5.5	0.0	0.1	2.1	0.2	32.7	0.0	0.8
CCDC80	"CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596797-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	244.9	15.0	6.4	83.5	6.9	1.1	218.3	9.6	8.6	305.3	24.4	74.5	8.7	276.5	76.8	92.4	82.2	234.0	218.8	6.8	10.2	17.7	6.6	74.0	18.5	12.2	11.4	62.2	28.7	12.4	10.8	26.0	9.3	67.8	73.4	9.4	34.7	78.7	13.4	79.1	25.1	360.3	11.1	34.8	47.5	42.7	9.2	17.1	87.5	34.9	30.8	194.4	131.8	13.5	26.1	11.0	127.6	5.8	521.4	411.2	6.9	359.0	108.5	118.6	171.8	2.9	2.1	1.2	13.5	1281.3	11.4	33.5	5.3	4.8	123.7	24.3	1.2	0.7	27.7	0.7	109.5	1.0	0.5	409.7	14.4	174.9	11.0	2404.9	27.8	0.6	0.4	1.0	352.7	0.5	0.3	0.7	31.6	0.7	4.2	0.3	14.0	0.6	3.3	0.5	0.4	2.5	53.5	2.3	1.8	23.0	2.1	1.0	141.7	345.6	56.6	66.6	160.1	1.6	0.8	1.2	102.4	0.7	56.8	0.9	0.3	0.2	0.3	0.1	0.3	0.4	0.3	0.3	0.1	0.6	0.4	0.4	0.3	0.3	0.2	0.7	0.2	0.0	6.4	6.9	9.6	8.6	6.8	10.2	12.2	11.4	9.3	11.1	9.2	13.5	104.5	6.4	15.9	13.1	1.5	60.9	4.2	44.7	26.7	1.1	5.9	59.7	22.5	10.0	62.7	5.5	0.0	57.9	1.0	0.3	1.9	23.7	450.8	95.4	93.2	43.9	0.0	0.0	1.0	1.2	101.5	921.6	16.8	18.4	1.3	44.3	53.6	0.9	9.4	0.0	0.3	0.8	30.5	2.2	121.5	353.6	77.0	9.7	144.1	3.7	2.0	101.4	0.0	0.0	0.0	13.5	0.0	34.6	5.8	3.6	0.0	0.1	112.4	2.5	19.7	177.7	198.4	6.9	4.9	11.9	51.7	27.9	9.0	23.0	0.1	1.9
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCDC85A	KIAA1912	ENSG00000055813	"Coiled-coil domain containing 85A"	Q96PX6	2	56183990-56386172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.7;Excitatory neurons: 228.7;Inhibitory neurons: 160.5;Microglial cells: 60.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.9;fHDF/TERT166: 74.5;U-266/70: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043106, HPA057020"	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043106: AB_10794770, HPA057020: AB_2683311"	"unprognostic (2.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.55e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.83e-2)"	12.5	0.6	5.4	0.6	7.4	0.0	3.5	1.2	8.0	2.5	0.0	0.7	0.3	6.3	0.8	0.7	2.1	1.2	4.5	6.9	7.2	1.0	0.1	5.5	0.5	17.3	6.5	0.5	0.7	1.3	0.2	10.0	7.0	2.0	0.7	4.0	1.2	2.7	5.4	1.7	0.4	4.7	11.8	0.7	0.5	0.4	5.1	0.6	9.1	7.5	0.6	0.7	0.7	15.2	0.0	0.8	0.1	0.0	13.9	0.8	0.0	11.6	1.1	9.8	0.9	0.0	0.1	45.9	1.7	74.5	0.0	2.0	0.0	0.0	5.6	0.0	0.3	0.0	0.6	0.0	0.7	0.0	0.1	3.3	0.3	0.0	1.2	5.5	9.7	0.0	0.0	6.1	1.3	0.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	1.7	1.3	0.0	0.3	0.1	0.0	2.1	5.3	0.0	15.3	7.9	2.3	0.1	0.9	32.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	7.4	1.2	8.0	6.9	7.2	17.3	6.5	7.0	11.8	5.1	15.2	57.7	25.6	0.6	15.3	0.8	3.3	0.5	0.0	0.0	7.8	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.3	3.6	0.2	1.9	14.8	1.2	0.0	228.7	0.4	0.1	3.7	0.0	0.5	0.0	0.2	8.6	0.0	2.3	0.0	160.5	0.2	0.0	0.3	2.0	11.9	0.3	0.3	5.4	60.0	0.0	0.7	0.0	33.7	7.2	0.7	0.1	0.0	0.1	0.3	0.0	0.3	0.0	1.5	0.0	10.0	2.7	0.2	0.8	0.1	1.3	0.1	0.1	3.6	0.9	0.3
CCDC85B	DIPA	ENSG00000175602	"Coiled-coil domain containing 85B"	Q15834	11	65890673-65891635	"Predicted intracellular proteins"	"Differentiation, Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 437.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 251.3;WM-115: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054415	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA054415: AB_2682481"	"unprognostic (4.58e-2)"	"unprognostic (1.64e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (4.44e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.87e-2)"	60.3	48.5	66.9	8.7	47.4	12.2	42.4	26.1	119.8	37.5	0.6	45.3	7.5	45.6	1.2	30.7	44.6	2.0	83.8	85.2	21.2	33.7	23.0	53.3	5.1	51.3	32.2	43.0	25.7	1.8	27.0	5.8	38.8	37.9	0.8	1.4	16.8	5.0	49.7	43.5	26.0	2.2	30.5	57.6	32.1	22.9	62.8	1.4	31.7	1.9	1.9	50.0	35.4	45.9	136.2	19.9	4.6	19.6	6.7	12.4	17.4	123.9	16.9	5.9	7.1	5.8	45.9	87.0	118.0	9.0	34.0	61.7	2.4	9.4	0.6	94.2	43.6	63.8	12.7	20.3	10.1	56.2	30.3	11.0	3.5	5.2	8.3	15.1	20.3	12.2	50.0	29.2	4.3	50.9	37.2	180.7	59.1	3.2	251.3	98.5	37.5	79.2	3.4	4.1	42.2	46.1	34.7	21.1	128.4	0.8	16.0	17.8	134.6	50.4	77.7	131.0	86.4	32.3	38.8	22.1	90.8	47.3	244.8	1.8	9.0	20.7	15.9	6.5	21.6	23.3	18.7	22.0	8.3	19.5	24.8	19.9	1.6	16.0	10.8	16.3	16.1	5.1	66.9	47.4	26.1	119.8	85.2	21.2	51.3	32.2	38.8	30.5	62.8	45.9	382.8	0.0	4.2	13.7	126.0	275.6	173.8	59.7	171.4	181.4	103.4	171.8	27.5	35.8	17.5	36.8	150.1	18.4	177.2	47.8	33.2	41.6	6.5	30.5	159.9	362.1	57.6	64.1	33.7	70.6	53.1	112.9	38.2	36.1	85.2	90.6	437.6	38.5	99.5	101.0	30.2	46.7	28.5	152.9	188.6	17.8	84.5	150.3	156.5	22.5	168.9	121.9	346.1	19.1	16.3	49.8	12.6	100.8	91.7	177.0	24.3	32.9	17.8	102.3	164.3	71.4	143.0	3.9	20.5	111.8	212.1	19.0	167.0	121.0	54.9	95.4
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500190-99604207	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	5.2	22.0	26.4	4.3	32.9	9.7	7.1	72.9	27.1	5.8	20.6	31.3	18.7	15.4	14.3	28.3	11.3	5.4	19.6	24.8	20.9	14.4	18.2	8.1	2.5	30.8	24.1	5.1	18.5	16.4	17.0	8.6	27.0	15.0	11.1	34.7	26.4	16.2	20.7	19.4	17.7	13.1	24.5	3.6	19.2	8.5	28.6	5.0	9.3	5.6	7.5	16.1	8.9	21.0	48.4	43.4	52.7	31.7	0.7	0.2	48.9	16.0	16.2	31.4	18.1	52.9	49.8	0.3	61.7	18.2	8.6	63.3	39.2	38.4	19.5	79.2	23.3	2.5	43.6	36.1	4.2	0.5	4.9	0.1	19.9	9.0	25.9	18.6	9.9	27.9	11.8	7.2	3.9	80.3	21.8	6.6	19.3	55.4	44.7	32.1	22.1	10.8	22.3	18.8	26.0	32.6	40.7	21.5	9.5	19.9	46.9	9.8	22.6	6.2	51.5	22.4	16.2	11.2	15.8	0.4	1.0	4.3	4.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	26.4	32.9	72.9	27.1	24.8	20.9	30.8	24.1	27.0	24.5	28.6	21.0	8.5	22.4	5.6	15.7	6.7	8.8	8.7	4.0	13.6	35.2	12.1	9.3	3.0	5.7	7.3	1.8	62.6	6.3	3.9	21.2	0.0	7.6	3.1	18.8	8.1	9.2	9.6	3.4	2.8	9.4	4.5	6.2	17.3	35.6	6.3	14.1	5.3	16.7	1.8	1.7	5.4	9.6	6.1	1.6	1.2	2.1	0.6	5.0	8.8	4.7	0.4	30.6	1.0	1.5	11.7	17.4	13.2	0.7	10.4	11.0	23.3	6.5	3.0	51.7	0.0	5.7	4.1	1.4	3.5	20.4	14.1	4.9	8.3	2.3	13.0	12.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCDC88A	"APE, FLJ10392, GIV, GRDN, HkRP1, KIAA1212"	ENSG00000115355	"Coiled-coil domain containing 88A"	Q3V6T2	2	55287842-55419895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA replication, Neurogenesis"	"Guanine-nucleotide releasing factor"	"Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 634.4;Late spermatids: 699.8;Oligodendrocytes: 754.9;Spermatocytes: 429.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 7.4;classical monocyte: 7.2;intermediate monocyte: 7.0;myeloid DC: 11.3;non-classical monocyte: 6.8;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in all"	7	"dendritic cells: 23.9;granulocytes: 7.4;monocytes: 7.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038101, HPA038102"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA038101: AB_10670654, HPA038102: AB_2675833"	"unprognostic (1.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (1.42e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.74e-3)"	"unprognostic (8.96e-3)"	11.4	9.7	48.4	14.0	65.3	15.6	8.4	53.2	77.6	8.7	29.6	9.6	3.8	9.8	3.3	5.4	7.5	7.7	9.2	48.8	54.4	4.7	8.4	14.5	17.2	54.8	60.8	9.3	10.7	3.4	13.2	8.3	57.7	5.9	5.2	26.3	6.7	5.4	7.3	4.2	7.1	9.3	48.8	13.3	6.5	47.3	62.6	18.8	5.8	9.6	15.1	9.6	6.2	80.9	22.8	19.7	45.2	18.3	29.4	24.3	4.0	32.3	30.1	18.9	20.6	2.1	12.0	60.2	19.5	32.6	28.9	0.4	28.9	19.3	46.8	69.8	16.8	41.4	21.7	28.6	12.6	70.7	26.8	15.8	3.8	44.6	28.6	27.1	50.3	48.1	44.9	95.9	51.9	0.2	33.5	41.1	37.4	0.3	24.8	39.7	71.1	0.3	22.9	12.1	23.5	34.8	57.4	0.1	28.9	26.2	1.1	20.2	34.9	54.4	36.5	36.6	39.6	28.8	24.0	25.8	38.0	56.2	23.7	7.4	7.2	2.1	1.4	7.0	0.8	1.8	0.6	1.1	11.3	0.6	0.7	0.6	0.6	1.2	6.8	23.9	0.3	2.1	48.4	65.3	53.2	77.6	48.8	54.4	54.8	60.8	57.7	48.8	62.6	80.9	35.6	12.8	27.9	197.9	25.5	8.4	7.4	11.2	9.1	225.1	7.2	11.9	52.8	4.3	12.8	5.5	37.5	6.5	90.5	0.2	1.9	4.2	634.4	8.0	58.8	41.0	10.8	51.3	317.1	16.8	18.4	38.1	9.2	3.1	152.8	64.4	22.1	18.5	110.8	79.1	318.9	0.0	4.1	142.0	126.7	699.8	29.8	184.2	16.0	129.3	236.1	109.8	11.3	296.6	754.9	31.1	0.2	28.6	114.7	2.9	0.0	8.1	10.1	61.9	32.9	45.1	55.4	429.0	95.5	5.9	6.5	2.3	22.4	82.3	0.1	2.8
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CCDC89	FLJ38159	ENSG00000179071	"Coiled-coil domain containing 89"	Q8N998	11	85683848-85686195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 43.6"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 434.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.1;SCLC-21H: 3.9;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040628	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA040628: AB_2677053"	"unprognostic (5.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-3)"	"unprognostic (7.75e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.52e-1)"	0.7	0.9	0.6	0.3	0.7	0.0	1.3	1.4	0.6	1.2	0.9	0.7	0.3	2.6	1.0	0.3	7.8	1.0	0.9	0.5	0.9	1.1	0.2	1.1	0.3	1.5	1.5	4.8	0.1	1.3	1.2	0.7	1.6	1.3	0.7	1.6	0.3	1.5	0.3	0.4	0.5	1.5	1.3	0.4	1.1	43.6	0.7	0.4	0.2	0.4	0.1	0.7	0.6	1.1	0.0	0.0	0.0	0.0	2.3	2.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.1	2.5	2.1	2.5	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.1	0.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.1	1.3	3.9	0.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.1	0.0	4.8	1.7	0.0	2.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.4	0.6	0.5	0.9	1.5	1.5	1.6	1.3	0.7	1.1	0.1	0.0	0.6	1.0	0.0	0.3	0.1	1.0	0.0	0.3	0.4	0.4	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.1	434.9	7.3	2.0	0.4	0.0	0.0	0.5	0.0	0.1	1.7	0.0	0.2	0.0	0.4	0.4	0.0	1.7	6.7	0.6	0.1	2.0	0.8	0.0	43.1	3.1	0.2	0.0	1.9	0.0	1.0	0.0	0.5	0.5	0.0	0.0	4.5	0.4	0.0	0.0	1.5	30.2	0.8	0.0	1.7	1.4	45.9	1.4	0.0	0.3	0.0	0.2	0.8	0.0	0.1
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.6;Late spermatids: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA045624: AB_10961402, HPA072007: AB_2686482"	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	22.7	21.1	11.7	16.1	12.2	40.7	22.2	10.5	16.1	27.8	17.3	24.8	13.7	24.7	8.8	18.1	24.8	10.3	21.8	12.7	10.0	25.9	22.7	26.6	10.6	15.9	12.0	30.7	49.0	14.0	16.6	13.6	11.3	25.8	8.5	12.6	20.0	12.3	26.2	34.9	18.9	9.8	9.5	23.1	24.8	35.8	12.6	9.3	23.0	11.7	7.7	23.8	23.9	12.3	27.5	27.7	21.2	23.7	6.6	17.9	24.1	37.2	16.4	22.4	24.5	29.5	21.1	12.5	10.0	24.8	18.6	25.5	19.7	16.0	12.1	33.3	12.3	32.3	27.3	22.7	21.1	13.2	31.9	19.2	23.0	21.4	20.0	19.0	15.1	15.6	45.0	61.8	15.0	32.8	15.4	116.9	23.7	45.3	10.8	26.9	20.2	14.4	10.2	19.7	8.3	21.1	50.5	36.4	20.3	17.3	30.2	26.7	20.9	25.8	23.0	15.6	32.2	20.5	38.5	19.0	24.2	17.8	20.3	0.4	1.1	2.0	1.3	1.4	0.7	0.6	1.0	1.0	0.9	0.9	1.0	0.7	3.6	1.1	0.8	1.4	1.9	0.4	11.7	12.2	10.5	16.1	12.7	10.0	15.9	12.0	11.3	9.5	12.6	12.3	13.6	6.4	1.7	1.3	16.4	14.0	15.7	1.8	12.0	3.1	8.9	5.2	3.0	2.8	1.9	1.8	4.2	5.4	9.3	13.1	5.9	7.5	50.6	13.0	10.3	9.7	3.6	8.2	1.4	11.2	9.1	7.6	14.3	16.8	8.2	4.3	3.3	3.6	5.8	0.0	1.0	12.0	2.0	7.8	14.4	79.3	4.4	9.8	7.2	1.9	10.4	1.8	7.2	0.5	0.9	11.1	11.5	3.8	15.2	8.9	7.8	6.7	2.1	7.6	6.6	8.7	10.5	2.8	7.5	12.7	17.8	15.3	12.2	5.3	8.4	13.5
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	16.4	37.3	23.2	13.0	24.5	16.1	21.3	24.2	29.8	17.1	23.3	18.1	14.7	14.7	33.8	16.2	15.6	18.2	22.1	22.9	25.4	18.4	38.9	13.5	20.5	25.3	25.0	22.3	18.3	14.9	19.4	22.2	25.0	16.0	17.3	12.6	17.1	16.3	16.2	14.1	16.6	16.7	25.2	15.5	16.9	54.5	24.4	17.2	25.6	17.7	17.0	15.3	14.2	27.1	19.1	27.3	46.1	15.2	59.6	44.7	27.7	37.4	31.6	22.7	24.3	32.2	63.0	46.7	47.7	55.0	47.5	23.5	20.1	47.3	30.3	31.9	16.0	28.2	17.7	27.3	50.1	29.2	23.5	50.2	62.3	29.5	83.8	45.3	52.3	49.6	41.9	37.9	83.7	33.5	29.4	36.7	37.9	80.2	33.4	33.1	40.9	39.3	47.3	27.5	22.2	50.9	26.4	21.0	26.1	60.8	53.9	26.4	51.6	44.8	28.8	85.9	26.0	36.3	51.2	46.8	18.1	23.2	45.5	77.7	18.7	71.6	24.2	41.3	31.2	39.8	34.7	34.2	27.0	37.9	30.2	30.2	9.8	50.7	43.8	20.4	46.0	27.4	23.2	24.5	24.2	29.8	22.9	25.4	25.3	25.0	25.0	25.2	24.4	27.1	50.8	12.8	13.1	14.0	40.5	23.6	49.6	102.8	26.7	36.3	33.5	49.7	58.0	28.6	48.3	36.8	14.6	74.0	41.4	21.0	68.4	59.4	447.3	39.5	38.0	45.8	33.6	36.2	16.0	48.5	55.4	44.5	26.5	31.4	49.4	83.0	35.7	43.3	63.7	42.1	23.3	35.2	52.9	34.6	32.4	233.9	42.6	38.6	21.4	10.3	52.8	35.3	53.5	31.2	48.2	67.6	32.9	25.6	44.6	38.9	44.1	78.0	32.6	50.0	26.3	40.3	43.5	333.0	107.8	32.5	29.0	51.7	37.1	86.8	31.2	49.9
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	18	"Early spermatids: 2093.1;Late spermatids: 7910.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	17.5	18.3	15.0	13.0	15.8	12.3	16.1	23.2	29.3	11.5	3.5	14.4	12.1	17.8	17.3	14.3	12.3	14.6	30.9	16.6	12.3	20.2	14.3	12.0	16.4	20.7	13.8	17.7	27.1	30.8	12.1	8.5	20.7	15.1	12.6	27.1	13.6	14.0	41.6	10.2	13.1	13.0	11.1	13.6	17.1	34.5	14.6	21.7	24.6	21.7	13.7	16.6	10.5	20.7	21.2	14.8	13.4	0.4	13.6	12.6	25.1	17.5	18.5	15.1	19.3	8.4	27.6	11.0	14.7	20.9	9.0	23.7	12.3	28.2	22.6	29.7	10.2	36.2	29.4	7.7	21.3	35.0	17.1	12.5	27.6	15.0	43.7	28.5	12.3	19.2	33.4	36.0	14.6	7.6	34.8	29.7	27.5	16.2	13.5	21.1	38.7	18.3	24.6	14.3	11.3	20.4	32.7	10.9	55.4	36.4	21.3	27.3	9.3	31.8	22.1	31.5	10.3	44.4	52.5	30.1	27.6	28.0	18.4	21.8	2.3	3.6	5.1	4.5	6.7	6.7	6.5	7.4	3.4	5.2	7.6	7.0	0.7	7.1	5.9	4.1	8.4	3.4	15.0	15.8	23.2	29.3	16.6	12.3	20.7	13.8	20.7	11.1	14.6	20.7	23.4	38.5	41.0	129.3	47.2	34.9	37.4	49.5	34.7	61.5	42.1	36.8	80.8	20.0	40.8	22.0	45.9	14.0	48.4	26.0	43.0	46.2	2093.1	36.9	19.0	19.7	38.4	19.1	199.3	47.3	16.3	24.8	21.4	26.2	40.4	21.9	11.7	26.7	30.6	45.4	266.0	23.9	28.5	35.0	39.3	7910.6	57.8	39.0	37.4	135.9	35.7	52.0	53.5	152.8	221.0	33.8	25.0	51.9	34.2	33.6	25.5	35.0	54.5	74.9	39.5	28.6	31.7	72.0	39.0	19.9	40.5	16.0	50.6	28.5	18.3	33.6
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 89.2;Excitatory neurons: 123.0;Inhibitory neurons: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	56.3	26.7	18.5	3.7	17.4	1.2	47.5	2.9	44.2	39.8	0.0	53.6	5.8	40.4	7.1	20.1	37.7	4.0	77.4	24.3	4.8	39.7	38.4	37.7	3.4	17.6	6.3	35.5	21.1	5.5	58.5	7.0	18.6	36.3	2.7	7.2	24.8	4.7	77.8	17.4	34.3	5.5	4.6	27.0	32.9	74.0	14.3	3.2	40.9	7.6	2.4	37.5	28.7	20.0	4.9	5.5	2.7	4.9	17.5	9.6	4.9	8.1	15.3	4.5	4.8	2.9	1.4	2.4	2.7	10.2	2.5	3.4	3.0	2.1	3.0	15.0	7.0	3.1	2.2	1.8	9.2	0.5	11.3	5.5	9.2	5.7	3.5	13.7	12.6	5.3	3.2	1.1	4.0	3.3	3.0	5.4	1.2	2.4	11.6	3.7	1.5	0.7	6.1	5.1	5.1	7.3	4.0	1.9	5.7	6.3	5.7	2.7	12.6	8.9	1.9	5.8	2.8	3.7	2.1	0.7	7.1	4.2	3.9	1.6	0.4	0.7	0.7	0.2	1.2	0.5	0.9	1.1	0.3	0.5	0.6	0.9	0.4	0.5	0.0	0.4	0.1	0.6	18.5	17.4	2.9	44.2	24.3	4.8	17.6	6.3	18.6	4.6	14.3	20.0	17.6	19.2	28.5	52.5	8.3	3.8	7.5	8.1	4.0	33.6	14.2	11.7	40.8	18.6	8.6	18.4	14.6	4.4	16.4	7.2	7.9	14.7	89.2	15.1	13.0	17.7	4.8	4.4	123.0	10.9	2.7	19.2	10.2	14.5	20.3	31.2	18.9	14.5	18.9	21.9	106.1	6.2	8.2	12.0	6.3	63.9	13.7	14.2	8.8	30.9	9.9	15.0	22.6	50.8	70.0	15.5	2.7	17.3	3.2	9.5	10.0	37.0	9.0	13.6	72.3	15.3	24.6	40.9	10.1	6.3	3.0	5.6	13.7	26.3	7.6	7.5
CCDC93	FLJ10996	ENSG00000125633	"Coiled-coil domain containing 93"	Q567U6	2	117915478-118014133	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054183	Approved		Enhanced	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA054183: AB_2682408"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (2.51e-1)"	"unprognostic (8.12e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.40e-2)"	10.2	14.5	9.3	10.4	8.5	21.7	9.6	9.6	12.7	9.1	15.0	11.3	11.9	8.2	9.8	7.4	9.3	7.1	21.3	8.4	9.4	9.8	7.8	11.8	10.3	9.7	9.0	13.3	13.0	15.9	16.1	8.1	10.3	7.6	10.6	26.0	9.1	8.4	12.9	11.0	12.8	8.1	8.4	12.1	9.1	12.1	11.5	10.1	11.9	10.3	10.1	8.6	8.1	8.5	18.7	8.1	22.0	19.4	31.2	21.3	18.5	21.8	14.2	14.0	14.3	17.7	11.7	15.9	14.5	17.1	24.9	15.8	12.8	11.2	18.1	20.8	13.0	20.1	15.5	23.9	13.7	22.1	22.0	14.6	11.5	21.9	25.9	19.4	15.0	18.9	11.1	11.0	15.8	8.1	14.0	23.8	9.9	13.4	13.0	17.6	17.2	10.7	11.5	19.6	17.4	10.3	14.2	10.6	15.1	19.6	8.9	13.5	21.2	23.9	20.0	20.4	15.3	14.3	16.0	24.7	13.8	16.1	14.2	2.9	1.6	1.8	2.1	2.1	2.0	1.6	1.5	1.8	1.2	1.4	2.0	1.7	1.7	1.7	1.3	0.5	0.7	1.0	9.3	8.5	9.6	12.7	8.4	9.4	9.7	9.0	10.3	8.4	11.5	8.5	17.4	19.2	28.2	61.0	28.6	17.6	14.6	11.2	9.6	32.0	12.4	10.0	43.0	7.2	17.5	1.8	47.9	12.6	31.9	21.5	9.8	24.0	4.5	14.9	15.2	16.5	16.7	9.9	57.1	16.7	8.5	14.7	11.7	17.0	15.2	25.1	12.8	6.0	15.2	20.2	60.6	11.4	10.2	16.3	15.9	10.6	13.7	19.9	3.6	32.8	19.9	13.8	20.6	53.3	37.9	32.0	11.9	14.3	19.4	13.9	17.1	9.4	16.3	36.0	6.6	21.4	15.0	46.0	31.1	10.1	16.1	12.9	24.3	12.8	14.0	15.0
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7043001	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 65.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 5.3"									HPA047546	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	2.0	2.0	0.5	2.4	1.3	1.2	2.4	2.1	1.1	6.0	0.8	0.9	0.8	0.7	1.3	10.7	0.8	0.6	2.5	2.1	1.4	0.5	1.7	0.8	3.4	3.7	0.7	1.3	1.0	3.3	0.5	3.0	1.0	0.6	1.8	1.0	1.1	1.1	1.7	0.8	0.6	2.7	0.8	1.1	65.4	2.6	0.7	1.5	0.7	0.6	0.7	0.9	1.9	1.0	2.7	1.4	1.1	1.8	1.2	0.3	2.7	1.6	3.0	1.8	0.9	2.4	0.6	0.7	1.5	3.9	1.2	0.5	1.2	0.9	0.1	0.4	0.6	1.1	0.7	0.9	0.8	1.5	1.1	1.3	1.8	0.2	0.3	1.2	1.9	0.4	0.2	1.9	2.4	1.6	1.0	0.5	0.9	1.6	0.6	0.9	0.1	5.3	1.0	3.8	0.8	2.2	1.0	0.5	1.3	1.0	1.5	1.3	2.5	0.7	1.5	2.1	0.0	0.1	0.5	1.9	0.0	0.8	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.1	2.0	2.4	2.4	2.1	2.5	2.1	3.4	3.7	3.0	2.7	2.6	1.9	3.1	0.0	4.8	0.0	1.0	0.6	0.8	2.8	0.6	4.0	3.7	3.2	0.9	0.0	6.9	3.7	12.5	0.6	0.7	2.5	1.9	2.2	76.7	59.7	4.0	2.3	5.4	0.0	0.0	1.1	0.6	1.5	0.5	2.4	0.0	0.6	2.9	0.9	1.2	0.0	0.0	1.9	4.1	2.2	0.9	93.4	3.1	1.7	1.8	0.0	1.1	6.9	0.0	0.0	0.0	1.7	2.7	4.1	0.1	1.2	0.2	4.5	53.4	19.6	0.0	4.6	2.3	30.6	3.6	1.2	1.0	0.5	0.8	2.7	0.8	0.9
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310172-41324873	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	14.6	12.9	19.0	17.8	21.3	23.0	14.3	17.7	17.7	20.3	14.4	14.0	14.2	17.3	23.4	20.2	21.9	12.3	15.6	16.5	18.2	12.0	11.8	14.3	23.8	23.5	20.2	24.0	17.7	15.8	13.7	10.5	19.9	16.2	11.2	10.7	18.0	14.6	30.6	20.2	16.6	14.2	18.1	20.0	15.7	32.1	20.4	21.9	16.3	20.5	22.2	14.8	17.2	20.5	25.2	54.1	28.2	32.9	36.2	28.7	20.3	16.6	13.4	25.7	21.9	32.4	23.6	23.9	17.4	13.9	17.3	16.7	38.8	33.1	19.5	44.1	37.6	21.9	25.5	21.5	27.5	36.6	45.3	28.1	41.7	30.0	25.0	21.1	18.0	25.8	28.5	44.4	24.9	18.3	33.6	8.9	13.2	30.5	19.3	37.5	22.4	17.5	23.7	47.3	25.1	22.2	37.0	40.3	16.5	18.6	27.5	27.6	21.6	22.1	22.0	11.5	27.8	45.3	42.2	22.7	21.0	26.7	30.0	9.4	7.2	8.5	12.0	7.6	13.4	9.1	8.1	8.7	5.8	10.0	8.7	7.8	11.9	10.4	12.6	6.3	7.2	8.1	19.0	21.3	17.7	17.7	16.5	18.2	23.5	20.2	19.9	18.1	20.4	20.5	7.3	12.8	6.7	5.2	22.3	4.6	11.4	11.3	6.2	11.8	11.2	8.8	6.7	7.2	8.9	9.2	12.5	11.1	23.9	13.5	7.9	13.1	3.7	9.3	8.6	8.4	11.5	7.8	4.1	26.1	4.5	10.0	15.3	9.8	16.5	11.2	9.7	6.5	15.3	10.1	4.7	12.1	18.3	10.0	7.9	8.4	12.8	12.3	1.8	3.7	16.1	7.1	25.7	1.0	6.6	20.5	5.9	11.3	18.6	10.0	16.7	9.3	12.2	8.5	0.0	13.1	8.5	22.5	12.9	10.8	5.8	18.3	20.1	7.2	10.7	13.3
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	4.9	10.3	9.5	7.7	13.1	2.8	8.1	10.9	10.7	12.0	15.0	73.4	9.9	23.9	7.3	33.2	10.8	12.0	53.0	9.0	12.7	10.2	5.0	12.3	3.3	13.1	12.6	4.0	25.3	11.3	10.2	3.9	12.7	16.2	12.5	4.3	28.3	22.7	67.4	15.4	18.1	24.2	11.6	5.6	22.3	8.3	12.7	1.3	45.2	65.1	5.9	25.9	16.7	12.6	50.0	6.8	0.0	0.4	1.1	4.6	2.5	14.8	14.6	16.1	15.6	0.5	44.7	0.3	20.1	47.8	58.6	122.5	0.2	40.4	15.1	0.0	0.3	14.9	64.4	4.7	8.5	0.2	2.8	5.7	9.0	6.9	20.3	110.8	11.6	0.8	0.1	0.7	27.9	0.0	0.5	0.0	0.2	23.1	12.7	0.0	4.2	0.2	48.0	2.8	0.1	3.6	8.8	19.1	8.4	0.2	1.9	2.3	62.1	29.7	47.2	7.9	39.8	0.0	0.1	0.6	36.2	2.8	138.3	4.3	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	0.4	0.1	0.2	0.0	0.2	9.5	13.1	10.9	10.7	9.0	12.7	13.1	12.6	12.7	11.6	12.7	12.6	2.7	12.8	10.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.5	3.0	0.0	0.0	1.3	20.2	0.0	0.0	0.2	0.0	1.9	30.0	0.0	1.8	0.4	0.6	0.0	0.0	0.0	3.7	0.1	0.6	0.0	2.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Melanocytes: 617.2"	"Group enriched"	"Detected in many"	5	"glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.4;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069716	Uncertain				"Secreted - unknown location"	NA	NA		8800		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.5	0.6	2.2	0.2	2.4	0.7	0.8	2.3	3.4	1.2	1.8	0.9	0.3	0.7	0.3	1.2	1.1	0.1	0.9	2.3	2.2	1.8	2.9	0.5	0.3	2.9	2.2	0.7	0.5	0.2	2.5	0.1	2.4	1.4	0.1	1.0	0.9	0.2	2.3	4.2	0.9	0.1	2.1	1.1	0.6	4.9	2.2	0.4	1.2	0.0	0.1	0.9	0.8	2.4	0.1	1.4	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.9	0.0	0.9	0.2	0.4	0.3	0.0	0.2	0.7	0.1	0.2	0.1	0.6	0.4	0.2	0.1	0.1	0.0	0.1	1.0	1.4	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	2.3	3.4	2.3	2.2	2.9	2.2	2.4	2.1	2.2	2.4	0.1	3.2	0.0	3.9	0.1	76.9	0.1	0.1	0.0	2.5	0.4	0.5	0.4	1.5	0.1	1.8	4.2	0.4	0.4	0.3	0.0	0.0	1.4	0.3	0.2	0.6	1.2	0.4	2.3	0.0	0.1	0.8	0.0	0.5	0.0	0.3	0.0	0.6	0.2	0.0	3.3	0.2	0.0	0.3	7.2	4.9	0.3	0.2	617.2	0.0	0.0	1.3	0.0	3.5	2.2	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.4	3.8	0.0	0.4	0.7	1.1	2.1	0.0	3.0	0.3	0.4	0.2	0.6	0.1
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266185	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 317.9;choroid plexus: 89.5;intestine: 115.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 236.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 74.4"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA	43700000			"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.2	0.9	134.4	0.5	202.6	0.0	0.2	85.8	317.9	0.0	89.5	4.4	115.7	0.0	0.0	0.3	0.5	0.0	0.1	160.1	96.9	1.2	0.4	3.4	0.0	99.9	103.4	0.1	0.4	0.0	18.4	1.1	94.5	19.5	0.1	4.4	0.2	0.2	0.2	0.4	17.0	0.2	93.9	0.0	2.1	2.3	123.9	0.2	0.1	0.0	0.0	0.1	0.1	143.7	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	236.5	0.1	0.0	0.0	1.1	25.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.4	202.6	85.8	317.9	160.1	96.9	99.9	103.4	94.5	93.9	123.9	143.7	0.4	0.0	0.0	40.1	0.2	5.7	1.3	0.3	0.6	6.8	1.3	1.9	0.3	0.0	0.2	5.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	2.5	0.0	0.0	154.8	0.4	0.1	42.5	5.1	0.4	0.0	0.0	1.4	0.0	0.1	0.0	157.7	11.4	2.0	0.3	3.0	0.3	0.0	0.6	40.9	34.7	0.0	36.7	0.0	34.7	40.9	0.7	0.0	0.0	0.0	63.8	0.6	0.1	0.0	3.5	0.0	0.8	6.4	0.1	1.7	0.0	1.3	10.5	0.0	0.0	0.5	8.7
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363233	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 2.2;lymphoid tissue: 1.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;granulocytes: 8.9;Late spermatids: 1.6;T-cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"HMC-1: 702.6"									HPA049861	Uncertain				"Secreted to blood"	NA	NA	84400		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	702.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.8	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983288-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 632.7"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 1156.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"HUVEC TERT2: 92.1"					"Low region specificity"	"Detected in all"			"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	NA	NA	5200000	37000000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	411.9	102.7	0.4	6.4	0.3	3.3	400.7	0.2	1.7	192.0	2.8	66.6	2.9	198.0	59.3	62.0	233.5	69.3	98.6	0.3	0.3	69.2	82.6	66.4	49.0	0.5	0.3	44.1	22.6	12.4	39.5	0.9	0.7	97.4	9.8	0.0	61.9	49.5	55.9	93.3	50.5	94.3	0.4	632.7	67.5	16.0	0.4	34.4	123.9	24.5	28.2	116.8	177.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.7	0.3	0.3	0.5	0.3	0.7	0.4	0.4	0.3	136.5	0.0	8.2	0.0	2.2	1.9	0.1	0.0	3.4	0.0	0.6	1.1	0.2	18.6	0.6	0.0	0.0	0.0	0.1	2.0	0.0	0.0	24.2	0.4	0.3	203.8	0.0	26.7	0.0	0.0	0.0	9.4	0.0	0.2	1.3	0.0	1156.5	11.0	0.3	0.0	0.0	1.0	0.0	58.8	3.1	63.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	2.3	1.1	2.6	0.0	0.0	0.3	2.3	0.0	0.0	2.0	1.4	0.0	1.8	0.1	0.6	0.2
CCL17	"ABCD-2, SCYA17, TARC"	ENSG00000102970	"C-C motif chemokine ligand 17"	Q92583	16	57404767-57416063	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 21.1"	"Cell type enriched"	"Detected in some"	55	"monocytes: 12161.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	640	"HDLM-2: 2395.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.3"	CAB002583	Uncertain				"Secreted to blood"	NA	NA	248000		"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002583: AB_564022"	"unprognostic (4.62e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (5.83e-2)"	"unprognostic (3.52e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.14e-3)"	"prognostic favorable (5.80e-4)"	1.2	0.1	0.1	8.3	0.1	0.0	1.9	0.1	0.4	1.4	0.0	1.5	0.1	0.0	0.0	3.1	0.6	2.9	1.3	0.2	0.0	0.6	0.3	4.5	8.4	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.3	2.7	0.0	2.5	0.2	0.1	2.4	3.7	2.6	0.0	0.8	0.7	0.5	0.1	21.1	0.8	0.2	5.7	3.4	0.9	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.3	0.0	0.0	0.0	2395.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	2.9	1.5	0.1	0.1	2.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.3	0.0	5.1	0.0	0.4	10.8	0.1	3.4	0.0	0.0	1.1	1.5	0.0	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.3	0.1	0.0	0.6	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	1.0	217.9	0.3	0.0	48.7	0.0	0.0	12161.5	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	12.0	0.0	0.5	0.0	2.7	0.0	0.4	0.0	0.0	0.7
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689570-34691276	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 632.5"	"Group enriched"	"Detected in some"	12	"Basal keratinocytes: 74.7;Basal respiratory cells: 56.9;Fibroblasts: 59.6;Langerhans cells: 111.9;Melanocytes: 92.5;monocytes: 107.1;Smooth muscle cells: 150.9;Suprabasal keratinocytes: 54.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HDLM-2: 3.2;TIME: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"	NA	NA	195000	63000	"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA067758: AB_2685897"	"prognostic favorable (2.88e-5)"	"prognostic favorable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	133.1	3.4	3.0	609.4	3.6	0.0	43.6	2.6	8.2	27.7	5.5	34.3	7.9	5.4	3.8	55.6	14.1	69.3	40.8	2.5	2.8	47.7	49.1	48.7	632.5	4.5	3.8	2.4	4.8	0.3	7.9	0.0	4.2	34.3	70.2	0.1	49.5	2.0	0.4	42.8	146.4	32.5	2.9	59.6	68.8	4.0	3.4	526.3	51.6	2.2	603.0	108.4	9.1	2.9	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.6	2.6	8.2	2.5	2.8	4.5	3.8	4.2	2.9	3.4	2.9	3.3	0.0	0.0	0.0	0.8	74.7	0.0	56.9	0.0	0.0	0.4	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	59.6	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	1.3	111.9	0.2	0.0	3.7	92.5	1.0	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	150.9	0.7	0.6	0.9	54.0	0.0	6.6	0.0	0.0	0.5
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 756.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 7.5;eosinophil: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.0;monocytes: 7.5"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 1902.2;HMC-1: 2427.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 9.9;spinal cord: 39.4"	"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	390.9	129.8	15.6	167.2	15.1	96.5	76.8	14.7	26.8	20.4	24.4	169.5	41.2	30.2	15.0	47.1	85.6	256.5	305.8	16.0	21.1	229.5	161.1	405.1	78.4	32.7	16.5	19.3	141.6	34.6	70.5	39.1	21.9	153.1	103.5	11.5	47.0	45.4	19.6	40.3	80.3	150.7	21.4	73.2	121.2	12.1	43.3	142.7	84.4	47.0	16.6	756.1	36.3	25.3	0.1	15.3	40.4	0.0	110.7	94.5	0.3	116.6	1902.2	243.3	516.8	7.1	0.2	0.3	90.4	27.6	3.8	64.0	4.3	0.1	122.9	0.6	0.9	0.2	13.5	0.0	3.5	0.4	2427.9	105.9	0.0	50.6	2.9	162.6	112.4	0.0	6.5	20.2	0.0	0.0	0.7	19.6	5.8	0.0	0.4	0.6	3.3	20.9	354.7	0.0	0.1	8.1	0.3	6.0	3.3	108.4	4.6	2.5	6.4	129.0	5.7	3.6	0.7	1.2	0.5	0.1	75.7	37.6	84.3	0.0	7.5	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	15.6	15.1	14.7	26.8	16.0	21.1	32.7	16.5	21.9	21.4	43.3	25.3	218.3	182.7	126.5	2.0	3.6	568.6	866.2	595.3	1152.5	0.1	23.5	50.9	29.5	92.9	120.7	138.0	0.0	2.7	2.2	0.0	0.0	3382.2	0.0	8.4	37.8	577.2	0.0	0.0	0.7	919.2	3.6	840.5	5.6	11.4	353.0	0.1	50.3	0.4	439.1	0.0	0.1	0.0	6.1	8.9	408.5	0.4	12.2	593.1	213.5	8.4	37.8	13.8	0.0	0.0	0.1	781.2	0.0	1.5	2.9	889.0	0.0	67.7	27.7	0.7	131.5	994.7	1507.0	0.4	0.3	13.0	222.8	4.5	44.3	1.7	0.1	40.6
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710136	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 2726.3"	"Cell type enriched"	"Detected in many"	8	"Endothelial cells: 1213.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;K-562: 1.2"					"Low region specificity"	"Detected in some"			HPA051210	Enhanced				"Secreted to blood"	NA	NA	198000	920000		"Cluster 16: Immune cells - Immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	173.7	46.9	0.0	269.5	0.1	0.0	180.7	0.1	0.3	154.7	0.6	111.7	46.3	75.6	34.1	128.2	253.3	80.8	41.7	0.1	0.1	75.1	66.0	196.4	2726.3	0.4	0.0	33.9	15.3	0.8	2.5	1.7	0.2	38.2	135.7	0.0	21.5	19.0	6.8	46.4	498.8	69.0	0.0	336.8	60.9	10.3	0.1	28.8	519.4	30.6	998.8	74.1	50.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.7	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.2	58.4	22.4	53.3	0.0	1.9	145.3	2.4	3.8	1.8	0.0	13.5	4.3	10.1	0.0	13.0	1.8	0.0	0.2	1.4	0.2	0.0	10.0	5.7	0.1	0.3	1213.6	0.0	2.7	0.0	3.6	0.2	22.9	0.0	0.2	11.4	0.0	107.1	0.5	0.6	0.0	0.0	2.1	0.0	1.8	148.8	11.0	0.6	6.5	144.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	29.6	1.5	0.0	0.0	10.2	0.0	0.0	3.4	120.0	0.2	0.3	11.5	137.7	0.3	9.2	0.0	0.0	0.4
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017972	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Hepatic stellate cells: 243.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	163	"eosinophil: 183.7"	"Lineage enriched"	"Detected in many"	163	"granulocytes: 183.7"	"Group enriched"	"Detected in some"	4	"HEL: 17.6;THP-1: 37.4"									HPA042015	Uncertain				"Secreted to blood"	NA	NA	937000	130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	7.9	6.7	0.0	7.0	0.0	3.7	7.3	0.0	0.2	18.5	0.1	4.3	0.2	14.8	1.6	4.7	11.9	3.3	0.7	0.0	0.0	12.0	7.5	21.4	1.6	0.0	0.0	2.9	1.0	0.0	0.3	0.3	0.0	8.6	8.7	0.0	3.5	0.3	0.5	3.6	9.3	10.8	0.0	14.1	3.3	0.6	0.1	0.8	3.1	0.1	1.3	5.5	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	1.0	0.7	183.7	0.1	0.7	0.0	1.0	0.0	0.4	0.7	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.5	3.2	2.3	0.0	0.9	1.7	0.4	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.6	0.0	0.0	0.0	0.7	1.6	0.0	0.0	1.6	0.0	0.2	44.6	0.0	5.7	0.0	0.0	0.0	0.7	0.0	0.0	10.1	0.0	243.8	2.6	7.0	0.0	0.0	0.5	0.0	14.7	2.7	0.1	0.0	3.7	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21.4	0.0	0.1	0.1	0.5	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.1	2.7	0.3	0.6	0.0	4.2	0.2
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052318-8062660	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1030	"intestine: 581.5;lymphoid tissue: 771.3"	"Cell type enhanced"	"Detected in some"		"Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.4;stomach cancer: 33.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9"									HPA055883	Approved				"Secreted to blood"	NA	NA	183000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.5	0.0	0.1	1.3	512.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	581.5	0.0	0.1	0.5	0.5	0.6	0.3	771.3	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.1	0.0	0.3	6.1	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	149.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.6	0.0	1.5	0.0	774.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	399.3	0.0
CCL27	"ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine"	ENSG00000213927	"C-C motif chemokine ligand 27"	Q9Y4X3	9	34661880-34664048	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"skin 1: 485.0"	"Group enriched"	"Detected in some"	26	"Basal keratinocytes: 704.5;Suprabasal keratinocytes: 1004.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.9"					"Not detected"	"Not detected"			HPA073848	Enhanced				"Secreted to blood"	NA	NA	436000	1800000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 61: Skin - Cornification"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA073848: AB_2732243"																		0.3	0.0	1.8	0.1	1.8	1.6	27.6	3.5	4.8	0.6	1.5	0.1	0.3	0.7	3.1	0.7	0.2	0.7	0.6	1.8	1.8	0.0	0.3	0.1	0.3	2.0	1.8	0.9	0.1	0.1	0.1	0.3	1.9	0.2	0.2	0.9	0.3	0.1	1.4	485.0	0.1	0.2	1.9	0.1	0.1	1.3	1.8	4.6	1.2	0.3	0.2	0.1	0.6	2.2	0.0	0.0	0.3	1.9	0.8	0.3	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	1.1	0.7	0.0	0.0	1.1	0.4	0.3	0.0	0.0	1.4	0.8	0.2	0.0	0.3	0.0	0.5	0.2	1.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	1.3	0.7	0.0	0.0	0.9	0.8	0.7	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	1.8	3.5	4.8	1.8	1.8	2.0	1.8	1.9	1.9	1.8	2.2	0.1	0.0	0.0	0.3	0.0	704.5	0.3	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	7.8	0.0	0.3	1.7	0.0	0.0	0.2	0.2	0.8	2.3	0.0	0.1	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.2	0.0	0.0	28.4	9.6	0.3	0.0	32.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.2	0.0	0.2	1.6	4.5	1.5	0.0	1004.0	1.9	0.8	0.0	0.2	0.1
CCL28	"CCK1, MEC, SCYA28"	ENSG00000151882	"C-C motif chemokine ligand 28"	Q9NRJ3	5	43376645-43412391	"Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"salivary gland: 302.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 192.4;Breast myoepithelial cells: 147.4;Distal enterocytes: 172.9;Ductal cells: 110.1;Paneth cells: 117.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.7;EFO-21: 12.8;SiHa: 29.9;SK-MEL-30: 16.7;T-47d: 40.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077434	Supported				"Secreted to blood"	NA	NA	700000000		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA077434: AB_2732346"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.85e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.20e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.53e-2)"	1.7	1.2	0.7	4.6	0.9	3.3	60.9	0.8	0.9	14.3	0.9	30.7	24.1	2.3	1.4	4.0	4.3	19.7	1.0	0.7	0.5	2.8	1.8	2.9	4.6	0.8	1.5	1.5	7.9	2.2	1.1	3.1	0.9	3.1	28.3	2.1	302.4	2.3	0.3	5.4	12.6	1.9	0.4	4.3	15.0	1.6	0.5	2.4	22.6	0.5	3.9	1.4	2.1	1.5	0.8	0.0	0.1	0.2	0.9	0.1	4.7	0.7	0.4	0.0	0.0	2.1	10.7	0.1	12.8	0.3	0.0	1.6	0.0	0.2	0.0	0.1	0.2	0.8	1.2	0.0	0.7	0.1	0.2	1.0	2.7	0.2	0.5	0.4	0.1	0.1	0.1	0.1	1.2	0.2	1.9	0.1	0.1	0.0	1.6	0.1	0.0	0.5	0.1	1.3	0.2	0.1	29.9	1.1	16.7	0.3	40.1	8.0	0.2	0.1	1.2	0.2	0.1	0.7	0.1	0.1	0.0	0.1	8.9	4.0	0.2	0.3	3.2	0.2	2.5	4.0	3.7	2.7	0.6	4.3	4.3	3.1	0.7	3.5	0.1	0.9	6.0	1.4	0.7	0.9	0.8	0.9	0.7	0.5	0.8	1.5	0.9	0.4	0.5	1.5	4.0	0.0	7.7	1.6	10.9	2.7	4.9	15.6	5.7	0.1	192.4	147.4	0.4	62.9	17.9	5.5	0.0	6.2	10.1	172.9	5.9	110.1	3.7	12.9	1.9	6.4	3.6	2.5	1.7	66.4	3.2	2.9	36.2	13.0	11.4	0.0	7.5	1.9	2.6	0.0	0.7	48.5	20.3	1.2	1.2	1.2	12.5	1.5	17.8	2.8	1.3	9.6	17.5	0.5	0.9	21.7	117.0	4.9	1.2	13.7	38.7	0.2	46.2	0.9	0.0	0.4	2.6	5.3	3.1	6.1	1.3	2.7	9.5	0.5	58.5	24.4
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Group enriched"	"Detected in some"	6	"U-266/70: 51.6;U-266/84: 13.3"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	38.9	28.0	2.0	32.0	2.0	192.9	10.5	3.4	5.5	16.0	4.1	9.9	7.6	10.3	6.4	15.0	8.2	45.1	4.4	2.0	1.9	6.8	84.2	33.9	34.3	3.2	2.9	5.0	15.6	12.0	2.5	17.8	2.8	7.6	11.1	0.1	5.1	3.4	1.0	0.9	11.4	18.0	2.5	65.3	10.3	2.7	2.1	24.1	5.9	4.5	15.4	56.4	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	51.6	13.3	0.2	0.2	0.1	0.0	14.4	3.4	135.0	414.7	4.8	101.6	8.4	46.0	240.6	2.3	17.7	13.8	181.7	55.8	42.8	11.1	2.6	0.5	138.9	2.0	2.0	3.4	5.5	2.0	1.9	3.2	2.9	2.8	2.5	2.1	3.3	52.3	0.0	54.5	0.0	135.9	15.6	1.9	0.3	24.5	1.5	26.3	49.3	11.2	14.3	7.2	0.0	0.0	9.7	3753.7	1.2	0.0	0.4	20.8	3.7	4.7	77.6	1.2	60.9	0.0	0.4	11.3	18.9	118.3	5.5	60.8	0.2	21.4	10.5	849.7	1.7	0.0	1.5	0.0	429.4	428.0	32.6	0.9	1168.2	51.6	3.7	10.5	1.1	1232.8	0.0	0.0	0.2	0.1	0.4	974.5	0.8	0.4	2.8	5.8	5.2	0.0	3.9	20.9	0.4	0.4	11.0	14.5	25.9	1948.3	0.0	0.9	1.6
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 122.1;lymphoid tissue: 135.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 6788.6;memory CD8 T-cell: 7164.3"	"Group enriched"	"Detected in all"	7	"NK-cells: 2041.1;T-cells: 7164.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1"									CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	2900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	17.2	17.1	3.9	36.3	4.0	122.1	19.5	3.8	6.5	15.5	5.4	27.7	48.7	15.7	14.4	15.8	14.0	42.9	8.9	3.9	3.7	7.5	28.4	57.4	135.2	7.3	4.3	16.9	7.0	3.0	3.8	6.3	6.4	10.4	25.6	0.3	33.5	7.9	4.8	4.0	84.5	10.5	5.8	123.9	47.9	4.6	4.7	29.5	11.5	2.7	33.4	31.4	9.5	6.1	0.7	0.5	0.2	0.0	0.5	0.4	0.8	0.3	4.0	17.8	20.8	0.4	1.7	0.3	1.6	0.9	1.3	0.9	0.0	0.0	2.3	6.5	0.3	0.0	1.5	0.6	0.5	94.1	0.8	0.1	0.2	5.5	0.3	0.0	0.2	0.1	0.1	12.5	0.2	0.6	0.1	539.9	0.5	0.0	0.0	0.6	0.2	14.0	0.2	0.5	0.1	0.5	0.2	1.2	13.4	0.5	0.2	139.9	0.3	0.6	0.3	0.6	0.4	14.2	6.6	0.8	0.4	120.1	1.3	657.8	30.0	35.8	6788.6	21.3	4221.0	61.3	1394.5	7164.3	49.8	41.6	332.4	4032.4	189.9	2041.1	26.1	46.5	25.9	6664.4	3.9	4.0	3.8	6.5	3.9	3.7	7.3	4.3	6.4	5.8	4.7	6.1	22.4	99.3	244.4	0.3	55.2	7.4	1.3	6.0	4.6	1.3	19.9	18.2	5.4	21.5	41.7	1.8	0.0	1.8	2049.9	3.1	1.9	6.3	1.2	5.5	5.4	24.2	1.8	106.3	0.5	0.2	7.1	26.0	46.9	6.7	80.8	0.2	45.0	7.0	33.8	0.0	0.3	3.5	0.0	48.0	25.0	0.1	0.3	256.3	12.4	2.8	38.5	0.4	2344.0	0.0	0.4	1.6	6.9	0.4	179.5	1.7	2.4	6.7	29.2	1.1	0.0	6.5	28.2	1.1	1.2	5.5	6.3	16.0	1947.0	0.1	3.5	1.9
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffold protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 140.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	32.7	40.7	62.5	25.1	74.5	15.5	26.6	58.7	89.1	19.1	48.4	30.2	13.2	20.3	6.4	22.4	18.9	11.5	37.1	63.0	62.4	24.2	86.0	29.2	43.6	67.6	62.8	16.1	26.6	21.4	30.4	14.5	69.2	23.8	10.8	9.4	18.8	14.5	48.2	21.1	27.6	16.9	60.0	54.6	24.0	30.3	71.5	45.4	18.7	36.9	29.6	27.2	20.0	68.6	38.7	41.8	24.4	49.2	45.5	39.8	17.7	45.9	37.3	32.0	43.3	30.6	39.3	53.7	34.5	58.5	101.8	49.5	15.3	58.9	21.4	61.0	29.7	23.3	34.0	22.1	39.9	9.9	61.5	44.7	38.0	56.3	24.0	30.0	59.2	76.8	27.5	42.1	64.7	58.2	47.9	131.6	28.4	32.3	46.1	25.7	14.2	43.9	33.1	36.8	46.9	36.8	37.5	29.2	20.9	31.7	33.3	45.7	45.1	43.4	36.4	44.2	44.8	75.9	64.0	109.2	42.3	35.7	53.4	108.1	33.5	105.8	52.2	40.2	35.2	42.0	62.3	57.4	23.6	43.6	58.9	44.1	103.9	60.9	47.7	23.8	167.1	40.2	62.5	74.5	58.7	89.1	63.0	62.4	67.6	62.8	69.2	60.0	71.5	68.6	28.7	19.2	19.4	26.1	57.5	46.8	22.6	27.6	54.7	19.0	13.5	24.6	13.0	20.0	18.8	14.7	4.2	28.3	53.7	30.5	25.4	30.2	6.9	6.0	14.3	26.7	15.6	13.7	33.3	38.5	35.8	25.0	11.2	7.4	36.1	23.8	30.4	56.5	49.3	82.4	24.9	15.2	12.2	47.9	51.1	12.8	21.1	47.7	33.8	56.2	140.0	34.1	122.6	20.1	51.7	45.3	11.4	20.3	69.1	40.4	13.6	22.9	8.0	14.4	19.7	16.2	29.6	15.3	37.8	16.8	23.0	10.4	55.7	36.9	15.2	19.7
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 141.6"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.9	5.4	7.2	1.6	7.3	0.0	15.0	9.5	6.8	8.7	4.2	4.6	1.3	8.9	0.6	3.7	7.7	2.5	23.2	6.1	5.8	13.3	2.2	11.8	1.5	6.8	6.4	3.6	2.6	1.4	4.1	7.8	7.0	5.8	1.1	0.4	3.4	1.8	4.8	3.9	5.4	3.3	6.1	141.6	4.2	1.6	7.3	0.8	10.2	4.8	0.9	6.4	6.3	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	7.3	9.5	6.8	6.1	5.8	6.8	6.4	7.0	6.1	7.3	5.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CCN1	"CYR61, GIG1, IGFBP10"	ENSG00000142871	"Cellular communication network factor 1"	O00622	1	85580761-85584589	"Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 256.5;Cardiomyocytes: 107.6;Cytotrophoblasts: 258.1;Extravillous trophoblasts: 529.9;Fibroblasts: 296.2;Syncytiotrophoblasts: 131.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 25.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 431.8;BJ hTERT+ SV40 Large T+: 422.0;EFO-21: 410.9;SiHa: 551.2;TIME: 541.3;U-251 MG: 642.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029853	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA029853: AB_10611822"	"unprognostic (6.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-3)"	571.1	99.7	1.0	28.2	3.9	0.2	313.4	1.0	25.0	255.7	9.6	197.1	5.1	273.6	0.1	48.7	472.4	64.8	400.6	3.7	0.0	212.8	200.5	407.8	3.8	4.9	3.8	123.1	70.7	14.8	56.0	29.8	3.1	157.3	1.7	1.1	94.2	2.9	97.8	197.1	102.0	141.7	0.0	131.2	201.7	20.1	5.1	11.1	268.1	17.3	0.0	264.4	150.8	3.6	159.3	5.2	0.7	1.0	47.4	90.6	77.4	431.8	216.6	422.0	264.6	24.1	4.3	0.0	410.9	185.5	82.8	36.3	15.9	33.4	164.4	0.7	6.9	0.3	6.8	0.7	245.2	3.7	0.2	39.9	6.9	121.2	50.1	13.4	366.0	0.1	1.6	0.0	150.3	0.8	0.3	0.7	24.9	1.8	42.2	0.4	94.9	0.7	166.0	2.5	0.4	4.0	551.2	17.7	62.1	4.9	16.5	0.8	541.3	272.3	213.3	82.2	642.6	0.3	0.7	1.8	1.9	0.2	73.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	1.0	25.0	3.7	0.0	4.9	3.8	3.1	0.0	5.1	3.6	256.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.6	0.0	0.0	0.0	0.0	258.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	529.9	296.2	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.1	0.0	0.0	0.0	0.0	131.3	0.0	0.0	0.0	0.0
CCN2	"CTGF, IGFBP8"	ENSG00000118523	"Cellular communication network factor 2"	P29279	6	131948176-131951372	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	81	"B-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	265.9	107.5	18.9	168.0	18.8	2.0	206.4	16.3	34.0	531.0	31.5	148.8	43.7	418.5	34.4	271.9	243.8	441.4	371.8	25.8	14.2	235.7	82.9	226.3	73.6	18.8	32.1	77.0	194.0	43.0	44.8	198.2	20.2	364.6	136.1	2.4	138.2	154.3	51.8	155.1	151.2	576.3	14.2	569.1	182.6	24.7	20.8	49.5	464.7	61.9	14.9	324.0	102.5	18.2	4.6	7.5	126.8	3.7	279.9	158.5	1.8	373.1	178.2	226.8	119.4	0.2	12.2	0.6	1605.0	482.7	185.0	6.2	4.2	26.4	211.3	2.5	3.5	0.2	55.7	137.3	109.6	0.3	0.5	232.2	5.9	163.9	40.2	340.7	1377.0	0.0	0.4	0.3	650.8	2.5	0.5	1.2	61.8	41.3	21.7	32.6	6.0	0.7	81.9	0.4	0.5	0.8	38.3	62.2	18.3	308.5	6.1	3.1	2874.4	311.6	242.4	397.8	694.0	11.5	1.7	4.1	42.5	0.7	399.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.9	18.8	16.3	34.0	25.8	14.2	18.8	32.1	20.2	14.2	20.8	18.2	101.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	47.1	261.8	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCN4	"WISP-1, WISP1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"Cellular communication network factor 4"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HSkMC: 110.5;hTEC/SVTERT24-B: 64.5;U-2197: 61.9"	"Region enriched"	"Detected in some"	6	"olfactory bulb: 9.8"	"Low region specificity"	"Detected in many"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.4	10.3	1.3	7.6	2.6	0.0	0.9	0.5	1.4	10.9	0.9	3.9	1.2	14.0	0.9	0.9	5.9	7.8	3.7	1.3	0.4	15.8	2.0	8.3	3.0	0.7	0.6	6.0	0.8	9.2	2.3	2.8	0.7	3.3	0.8	0.0	1.1	1.4	0.4	1.4	2.3	13.6	0.6	2.2	2.8	1.2	0.9	0.2	1.1	0.2	3.9	6.0	3.6	0.8	0.0	0.5	0.0	0.0	7.6	4.2	0.1	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	110.5	0.0	64.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.0	0.0	0.0	14.8	0.8	61.9	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.6	0.5	1.4	1.3	0.4	0.7	0.6	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCN5	"CT58, CTGF-L, WISP-2, WISP2"	ENSG00000064205	"Cellular communication network factor 5"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 394.6;cervix: 355.7"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 165.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 42.6;ASC TERT1: 113.8;HeLa: 62.7;HSkMC: 46.5;U-2197: 375.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB019273	Approved				"Secreted to extracellular matrix"	NA	NA		1200000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	394.6	41.5	1.8	0.7	2.0	0.2	116.5	0.9	2.9	355.7	0.7	23.6	0.7	35.3	0.7	25.4	39.0	7.7	161.1	1.6	1.3	0.7	5.6	136.4	1.9	1.4	1.4	147.1	4.4	0.6	0.8	1.4	1.4	37.0	1.6	0.1	30.7	25.5	39.2	197.1	11.5	6.5	1.0	4.0	11.4	33.1	1.4	1.3	14.2	5.1	0.4	36.7	111.6	1.5	0.0	3.7	0.1	0.0	42.6	113.8	0.0	0.2	1.2	0.1	0.2	0.0	0.0	0.1	0.5	0.7	3.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	62.7	0.0	0.1	0.1	0.1	46.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	1.1	0.3	0.0	1.9	0.2	0.0	0.1	0.2	375.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.9	2.9	1.6	1.3	1.4	1.4	1.4	1.0	1.4	1.5	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.2;testis: 81.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	5.9	0.4	5.9	2.1	0.7	2.3	7.8	5.8	4.1	0.6	0.4	3.7	7.0	0.4	18.0	0.7	0.3	5.5	7.3	0.5	0.1	1.4	0.3	5.3	5.4	0.5	0.1	22.2	8.2	0.0	10.7	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.9	0.6	0.4	81.3	6.1	0.4	0.6	0.4	0.6	0.6	1.1	4.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.9	5.9	2.3	7.8	5.5	7.3	5.3	5.4	10.7	4.9	6.1	4.0	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641156-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 874.2;WM-115: 1239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB000024: AB_563678, HPA027802: AB_2672390"	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	55.6	29.2	12.1	10.0	14.6	1.5	40.2	15.0	11.9	17.0	33.4	19.8	22.7	14.8	27.6	72.9	30.8	19.5	64.9	10.8	14.6	32.2	107.3	61.1	10.5	17.5	15.5	4.6	86.3	82.7	25.7	63.7	18.3	53.3	17.2	3.2	30.4	50.4	3.6	120.3	16.0	23.3	15.9	37.2	52.7	3.2	21.7	9.9	45.5	5.2	19.0	29.5	43.9	24.0	467.3	183.0	59.5	1.8	178.3	186.7	127.4	717.5	264.9	82.1	47.6	206.9	349.9	0.1	317.6	375.5	137.2	332.1	6.5	195.2	146.0	1.2	36.5	0.3	46.7	211.7	43.3	3.3	6.7	106.5	37.9	116.0	44.0	192.5	142.1	0.2	0.6	1.3	654.2	197.1	0.4	26.6	109.0	190.7	198.3	1.2	187.9	11.3	379.4	282.8	10.0	231.4	9.2	167.7	458.4	143.5	102.6	9.5	600.4	399.5	111.0	176.1	496.2	874.2	559.4	1.5	341.6	5.9	1239.0	0.2	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	1.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.1	14.6	15.0	11.9	10.8	14.6	17.5	15.5	18.3	15.9	21.7	24.0	84.6	182.7	115.6	0.3	8.3	202.5	234.7	499.7	133.1	2.3	163.4	140.0	80.0	92.9	271.6	125.0	2.1	10.9	2.4	44.8	31.3	504.0	0.4	104.2	23.5	141.0	56.5	2.5	0.5	142.6	1.2	67.6	127.4	199.5	29.1	0.0	98.2	165.2	75.0	0.0	2.2	42.6	75.3	18.8	61.9	2.0	4.1	23.6	51.6	17.8	2.4	79.1	0.0	49.8	0.3	622.1	118.0	57.6	0.5	262.0	19.4	57.1	85.9	3.1	131.5	13.0	184.8	0.5	23.4	292.3	351.1	2.5	8.8	3.4	82.2	412.6
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4269771-4305353	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2"									"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	20.0	52.6	5.4	8.7	12.9	20.3	13.0	0.0	13.5	26.9	0.0	40.8	17.4	26.1	7.5	12.2	22.1	2.7	51.9	14.4	1.1	9.7	1.9	17.2	5.3	9.6	0.2	14.2	24.5	9.9	23.5	12.9	2.7	20.7	10.4	0.7	10.8	9.1	1.8	12.6	25.9	9.8	7.8	19.7	12.7	4.0	0.0	3.2	20.3	0.0	5.1	26.5	19.9	4.5	0.0	0.0	152.4	0.0	10.1	0.4	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	0.4	0.0	0.0	16.2	0.1	136.6	0.0	238.8	2.5	0.7	0.0	0.0	0.0	57.0	12.6	23.8	2.4	0.0	97.0	0.0	0.0	0.8	17.0	287.9	6.8	0.0	0.0	52.8	50.8	0.0	0.0	0.0	202.7	114.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	89.6	0.0	0.0	4.2	0.0	39.3	0.0	0.0	1.4	60.7	0.0	0.0	32.3	0.0	6.6	0.4	4.7	11.1	0.0	17.1	3.1	16.3	13.8	0.4	1.7	10.4	12.1	1.1	9.4	0.0	1.1	13.6	6.8	5.4	12.9	0.0	13.5	14.4	1.1	9.6	0.2	2.7	7.8	0.0	4.5	23.9	60.9	46.6	10.1	82.9	106.8	23.9	73.4	174.2	7.6	3.4	41.8	354.3	2.8	37.4	12.9	0.0	4.0	128.7	37.5	0.0	3.1	0.8	3.3	110.8	35.7	64.8	37.2	54.1	68.3	2.7	123.6	4.6	3.6	55.8	438.5	19.6	2.2	13.0	3.3	55.2	147.7	12.2	11.9	255.3	3.3	52.5	39.3	39.2	19.7	9.8	170.0	89.6	55.3	4.0	20.7	49.4	124.1	371.2	35.8	34.4	1.4	10.3	6.5	26.3	21.4	112.6	0.8	5.1	50.9	39.6	6.3	122.6	41.5	159.7	8.4
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934934-42050357	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 256.6"	"Cell type enhanced"	"Detected in all"		"NK-cells: 555.1;Syncytiotrophoblasts: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 696.3;REH: 651.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	74.3	137.6	84.8	63.1	84.6	220.2	64.8	80.0	94.5	36.9	78.4	45.6	40.6	35.4	15.3	39.6	43.2	34.4	68.1	86.2	88.6	42.4	22.1	102.5	143.3	87.4	82.5	36.0	31.6	23.7	33.3	55.4	84.0	50.4	27.0	10.3	50.4	25.6	18.2	52.3	78.5	28.6	79.7	170.4	66.1	11.1	86.4	256.6	58.7	32.5	83.6	45.4	44.3	80.8	67.7	242.2	24.6	54.8	43.7	88.6	286.1	77.1	43.7	77.7	57.1	45.9	29.7	288.9	127.8	51.9	68.9	40.5	65.8	93.4	39.2	49.2	43.4	458.8	106.6	37.3	94.9	75.9	385.2	84.7	59.8	76.0	27.9	23.5	96.6	188.3	236.7	27.2	111.6	92.0	696.3	354.6	10.9	202.8	51.5	651.8	96.3	32.2	179.1	44.9	83.8	21.8	65.8	83.3	38.6	30.6	51.5	288.4	162.9	86.2	47.9	74.7	88.1	17.9	15.2	458.5	50.4	157.6	53.3	1281.3	246.3	725.1	390.4	294.4	276.5	127.1	266.4	318.1	343.3	180.8	306.4	328.3	339.3	333.2	405.6	221.4	193.0	635.4	84.8	84.6	80.0	94.5	86.2	88.6	87.4	82.5	84.0	79.7	86.4	80.8	102.2	60.9	67.9	31.0	102.9	27.0	95.8	52.3	48.9	19.6	49.9	45.1	26.2	64.3	27.8	20.2	6.2	201.0	227.3	66.4	29.4	20.3	12.8	12.1	10.8	68.3	9.6	133.6	37.1	24.3	82.4	32.3	19.9	11.2	26.6	7.7	70.6	7.2	45.3	11.8	23.7	19.5	50.8	115.7	51.7	9.4	41.3	152.2	37.4	47.8	79.0	40.8	555.1	18.1	9.3	29.9	30.5	51.9	48.7	40.3	18.6	19.8	22.5	16.2	46.0	19.2	31.9	4.3	6.3	21.7	22.6	236.6	195.0	141.6	32.7	52.8
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197177	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 20.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEL: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	3.2	1.4	2.3	1.3	2.1	20.0	2.1	3.8	2.6	1.4	1.9	1.7	1.5	1.4	2.1	1.2	2.0	1.0	1.3	2.0	2.4	1.5	1.7	2.7	2.2	2.4	2.3	0.7	1.3	1.1	1.2	1.4	2.5	1.3	1.9	1.8	1.5	1.1	1.7	2.8	2.6	1.2	1.8	2.6	2.1	0.9	2.6	1.5	1.7	1.2	1.9	1.7	1.1	2.4	0.2	0.2	0.4	0.2	1.3	0.8	0.4	0.3	1.6	0.3	0.3	0.4	0.3	0.5	0.4	1.1	0.1	0.5	1.1	0.5	0.2	0.7	1.1	13.5	0.6	0.5	0.9	0.7	0.7	1.5	1.2	0.1	0.2	1.3	1.0	0.2	0.8	0.4	0.4	0.0	0.4	1.4	0.9	0.5	0.3	0.4	0.5	1.2	1.7	0.6	0.6	0.9	0.5	0.4	0.3	0.5	0.0	1.1	1.2	0.2	0.1	1.0	0.2	1.4	0.6	0.1	1.3	1.4	0.4	21.8	1.9	5.6	5.1	3.7	5.4	4.7	5.5	5.2	1.8	5.3	5.6	5.9	6.2	4.8	9.5	3.0	8.4	1.8	2.3	2.1	3.8	2.6	2.0	2.4	2.4	2.3	2.5	1.8	2.6	2.4	59.8	48.1	54.9	11.1	81.8	34.7	55.7	83.3	25.0	28.9	38.0	40.9	52.6	40.0	78.6	29.5	20.9	362.7	92.0	63.6	90.1	64.0	24.2	61.6	33.8	45.2	46.2	361.2	20.7	59.3	82.1	55.9	45.3	37.0	57.0	40.2	53.6	31.0	85.4	45.4	17.8	47.7	154.6	83.5	36.2	12.6	47.2	57.1	64.0	11.2	137.8	55.9	74.2	9.5	23.4	68.6	55.8	29.3	54.2	42.1	85.8	47.5	128.0	66.0	46.0	35.2	49.4	124.3	61.6	27.8	40.3	1055.9	85.9	37.8	42.2	88.5
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.3	2.1	35.8	0.8	2.8	2.7	1.0	0.9	3.9	3.0	1.4	0.6	4.4	0.9	1.0	2.3	2.0	2.5	1.0	0.7	1.1	6.1	2.0	2.1	0.8	1.8	2.8	0.9	30.8	2.0	1.0	4.7	2.0	1.5	1.4	2.1	4.1	2.5	2.2	1.7	4.2	2.1	12.1	2.5	4.5	1.6	1.8	7.8	3.0	1.8	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	2.1	2.8	2.7	2.0	2.5	2.0	2.1	2.0	1.7	2.5	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCNE2	CYCE2	ENSG00000175305	"Cyclin E2"	O96020	8	94879770-94896678	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.6;Oligodendrocytes: 34.5;Spermatocytes: 77.7;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 101.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007825, CAB019374"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB007825: AB_598148, CAB019374: "	"unprognostic (1.80e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (8.37e-4)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.01e-12)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.03e-1)"	2.0	0.6	3.7	6.9	8.3	37.0	2.2	9.0	7.7	1.7	0.3	5.4	3.6	1.8	0.1	4.7	0.6	2.4	1.4	3.2	5.4	0.5	2.3	1.8	10.9	9.9	8.1	1.5	1.8	0.5	0.6	4.3	8.8	1.2	5.7	5.2	1.8	0.2	0.7	5.9	4.3	2.2	7.4	2.3	4.0	14.5	8.0	15.1	1.7	0.7	9.6	2.1	1.5	13.4	47.2	6.2	24.0	15.0	2.9	5.4	16.5	47.3	16.6	29.4	28.9	11.3	20.6	24.5	31.4	20.3	9.1	24.4	19.4	17.5	39.5	17.4	17.5	49.5	26.6	4.2	0.2	20.2	29.0	1.4	1.1	21.4	2.1	6.4	15.5	30.1	21.7	101.5	42.5	14.2	77.8	9.7	8.1	37.4	14.1	54.1	41.7	11.7	8.1	26.4	34.8	14.5	31.8	8.4	5.9	3.0	42.0	21.2	13.0	30.7	20.2	22.9	42.8	19.1	21.1	59.3	24.8	36.1	23.1	0.0	0.2	0.1	0.8	0.2	0.3	0.3	1.1	1.3	0.7	1.0	0.3	0.6	0.6	1.5	0.1	0.0	5.2	0.6	3.7	8.3	9.0	7.7	3.2	5.4	9.9	8.1	8.8	7.4	8.0	13.4	7.5	6.4	1.7	0.7	3.0	4.2	1.6	2.3	6.8	2.9	5.9	8.9	2.5	0.0	1.9	1.8	6.2	7.2	7.2	12.3	0.0	0.2	6.9	1.3	2.7	3.5	0.0	33.6	2.3	0.2	7.8	2.6	4.1	2.9	0.0	2.1	2.5	1.3	4.4	8.4	2.6	4.0	0.0	2.5	1.9	9.0	1.2	4.8	0.0	0.0	0.0	1.0	1.0	1.5	34.5	0.2	2.4	0.4	14.6	1.1	6.3	0.1	1.1	4.7	6.6	2.6	4.3	77.7	26.2	9.5	3.8	1.9	7.5	1.2	3.3	0.8
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	1.4	1.0	2.5	3.8	2.1	7.3	1.9	2.9	2.7	1.3	0.0	2.0	2.8	0.8	2.0	4.0	0.8	0.8	0.6	2.4	2.0	0.6	0.7	1.0	7.4	1.5	2.0	1.0	0.8	0.5	0.8	2.5	1.3	1.6	2.0	0.8	2.1	1.1	1.3	4.8	2.1	1.1	0.8	2.2	1.6	2.7	2.6	15.1	0.7	1.3	9.6	1.7	1.5	1.7	21.0	32.4	31.3	28.9	2.2	2.9	23.8	24.1	12.2	34.2	26.1	64.6	25.6	42.3	8.0	14.1	10.2	33.1	52.2	19.6	16.4	30.9	23.4	46.1	35.3	20.4	2.3	30.4	30.7	2.0	2.5	24.1	11.7	4.4	25.5	36.5	52.0	28.5	17.6	45.6	46.1	25.0	31.2	22.6	13.2	76.2	35.1	39.5	9.5	9.3	29.8	17.0	36.0	32.8	6.4	15.6	34.3	16.6	18.1	19.1	46.7	13.5	27.1	16.4	20.9	74.5	5.6	31.8	26.9	0.0	0.3	0.0	0.7	0.1	0.4	0.6	0.4	0.9	0.1	0.4	0.3	0.4	0.0	1.3	0.3	0.5	0.5	0.6	2.5	2.1	2.9	2.7	2.4	2.0	1.5	2.0	1.3	0.8	2.6	1.7	0.9	0.0	3.9	3.3	2.7	2.8	2.7	1.4	6.2	5.3	2.4	2.0	1.9	0.0	1.6	1.8	12.5	7.0	3.7	2.4	0.0	1.2	0.9	1.0	2.7	2.2	1.2	37.5	5.7	0.6	12.2	2.2	5.6	1.0	1.3	8.9	2.5	0.9	6.1	8.4	5.6	2.6	4.1	2.4	1.6	0.0	1.8	1.5	5.4	0.0	0.8	0.9	2.1	1.0	1.0	1.1	0.3	2.6	7.2	1.9	0.9	0.2	0.3	1.6	0.0	0.8	2.7	3.9	5.7	3.5	1.1	1.9	3.4	1.7	4.7	1.6
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	51.2	48.8	21.0	30.4	23.0	38.3	67.2	22.9	25.8	63.4	27.8	68.0	137.2	50.5	73.4	47.8	61.8	56.7	50.4	19.1	23.4	123.5	129.6	33.4	49.0	24.7	21.6	112.0	74.4	39.7	14.6	54.0	25.0	71.4	87.0	21.3	56.3	55.7	163.6	23.5	109.1	52.3	23.5	35.5	57.3	20.7	21.7	50.3	62.4	120.6	47.0	59.7	33.8	28.6	54.9	59.8	246.6	138.8	207.9	397.3	258.2	74.1	181.2	73.8	165.2	130.4	109.4	134.1	73.7	100.1	121.7	22.2	137.2	185.0	107.9	63.7	171.9	106.6	71.7	230.0	226.4	49.9	68.9	433.8	105.6	73.3	75.1	221.5	241.1	88.3	92.3	92.8	253.4	33.8	89.6	66.5	113.3	40.1	52.7	74.6	120.7	75.2	179.5	209.4	57.6	65.6	0.4	30.5	154.0	155.2	115.5	155.8	140.5	47.6	101.0	40.8	66.2	81.5	34.2	87.7	84.3	81.4	80.6	44.5	25.6	31.0	35.8	36.1	53.9	55.4	63.2	49.3	59.6	33.9	84.5	72.0	10.9	40.7	36.7	22.6	80.9	63.9	21.0	23.0	22.9	25.8	19.1	23.4	24.7	21.6	25.0	23.5	21.7	28.6	20.8	25.6	20.0	7.5	67.3	57.2	94.7	64.7	103.0	12.4	64.4	33.0	52.9	77.2	39.7	36.8	0.0	138.7	49.8	48.2	162.4	73.0	8.1	30.6	27.5	43.5	71.0	96.3	8.4	119.0	107.7	57.1	110.6	46.1	43.7	108.8	61.1	51.7	60.0	15.2	8.8	113.2	44.7	74.8	70.5	6.1	75.8	60.8	37.4	15.0	52.0	29.9	54.6	4.5	12.7	91.1	80.2	72.2	63.5	107.2	223.4	265.9	11.2	10.8	39.5	42.4	73.4	8.8	12.1	61.5	44.2	97.3	76.4	81.5	182.7	104.3
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157207-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	46.4	23.6	15.5	35.6	18.2	88.0	81.5	64.3	20.8	39.6	8.3	33.5	28.0	39.2	26.7	136.0	18.8	32.8	14.9	17.5	11.4	71.0	11.0	26.3	73.5	13.5	14.7	37.4	14.7	46.3	8.8	64.6	13.5	78.1	34.4	81.2	34.3	31.4	12.3	29.2	25.1	33.8	13.1	48.1	25.4	11.2	15.2	67.3	53.2	34.4	73.5	53.5	37.1	19.2	30.9	3.9	66.5	35.5	43.1	54.9	45.0	25.4	72.6	19.4	36.0	4.6	43.8	61.7	40.0	23.7	18.4	21.7	17.6	83.8	37.2	43.2	11.8	5.2	18.1	9.1	22.4	9.3	62.1	46.9	40.8	9.1	19.9	64.6	29.4	35.9	3.0	36.7	36.0	12.0	42.9	19.7	6.8	15.0	4.1	24.3	64.8	4.1	121.9	84.1	17.7	56.1	30.0	46.7	18.0	39.4	34.9	13.8	27.6	26.3	26.0	19.1	4.2	26.9	21.9	43.8	18.4	14.4	13.4	14.8	1.7	21.0	0.9	2.7	2.1	3.2	1.3	1.0	1.9	6.3	1.0	0.6	8.0	2.1	3.1	2.8	6.1	0.8	15.5	18.2	64.3	20.8	17.5	11.4	13.5	14.7	13.5	13.1	15.2	19.2	25.0	12.8	12.3	14.7	55.8	37.1	29.0	27.8	113.8	112.4	101.1	53.6	4.7	8.6	25.4	55.2	22.9	29.7	35.5	57.6	86.1	33.7	0.8	50.4	44.6	35.7	16.7	1.7	13.8	19.6	98.7	61.5	18.3	107.7	39.3	20.3	35.3	3.9	32.3	25.2	26.7	38.0	50.8	45.3	56.7	2.3	27.7	35.8	56.9	10.3	61.8	28.4	17.5	17.1	13.9	49.2	24.6	27.4	20.5	74.3	29.6	70.9	15.3	46.8	65.7	61.3	41.5	9.2	10.1	40.8	26.7	15.7	31.1	17.1	16.1	57.8
CCNH	"CycH, p34, p37"	ENSG00000134480	"Cyclin H"	P51946	5	87318416-87412930	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.5;Plasma cells: 219.9;Spermatocytes: 202.6;T-cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019416, HPA044138"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB019416: AB_2259936, HPA044138: AB_2678828"	"unprognostic (5.65e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.93e-2)"	"unprognostic (6.43e-2)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.62e-2)"	36.6	26.6	6.9	18.8	7.6	38.3	29.0	15.6	10.9	19.4	6.9	16.0	17.6	14.9	24.2	17.7	17.6	24.6	22.0	8.7	9.0	24.5	37.5	25.8	24.1	7.7	6.3	26.9	23.0	29.9	27.1	15.6	6.9	26.5	19.9	11.4	20.4	18.4	29.1	15.4	16.6	15.6	7.1	18.4	17.6	54.1	6.7	36.8	26.9	22.6	25.9	27.3	18.3	10.3	62.6	26.6	27.1	18.1	39.3	27.5	28.1	44.4	54.8	73.8	101.2	46.7	35.0	40.5	15.8	66.4	77.7	31.1	32.5	67.5	68.4	42.9	39.9	73.1	44.8	46.4	69.3	61.9	57.6	37.0	25.4	38.6	93.8	37.8	65.6	38.7	50.0	70.7	61.7	35.1	42.4	49.5	11.6	15.7	99.4	34.5	63.3	60.9	62.5	32.8	27.8	18.1	23.3	21.7	53.8	16.3	51.7	46.8	45.6	70.9	29.3	41.9	39.4	25.1	23.9	63.4	45.6	55.7	33.6	49.3	37.7	58.8	26.4	47.2	37.4	36.7	35.4	34.8	44.5	32.0	34.4	36.2	28.0	35.4	50.2	26.1	44.8	36.9	6.9	7.6	15.6	10.9	8.7	9.0	7.7	6.3	6.9	7.1	6.7	10.3	67.5	35.3	33.7	15.0	111.2	37.3	64.3	55.1	40.5	29.0	30.1	24.3	13.2	20.0	37.7	18.4	16.7	21.0	154.2	14.7	41.1	40.1	281.5	28.0	25.2	37.6	24.0	33.7	28.3	34.5	25.6	52.5	41.3	24.2	57.1	19.9	30.0	19.9	45.3	18.5	43.7	15.2	36.7	67.9	73.4	41.4	29.5	125.2	48.0	20.6	25.5	44.9	41.2	20.1	23.5	31.1	15.8	25.2	219.9	31.7	27.0	53.8	34.4	32.9	52.6	43.3	120.0	202.6	48.3	22.3	34.5	30.1	207.8	35.7	19.4	41.0
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747426-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.6"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 25.7"					"Low region specificity"	"Detected in all"			HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.2	0.3	1.2	0.9	1.9	0.1	0.2	1.3	1.5	0.5	0.0	2.6	3.6	0.1	0.3	0.1	0.3	0.4	0.3	0.9	0.8	3.1	0.0	0.5	0.8	2.2	1.3	0.2	1.2	0.0	0.6	0.1	1.6	0.9	2.7	1.1	2.6	1.3	0.3	0.3	2.1	0.1	0.9	0.4	2.4	0.7	1.5	1.5	0.4	0.0	0.9	0.9	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.4	0.0	0.6	25.7	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.9	1.3	1.5	0.9	0.8	2.2	1.3	1.6	0.9	1.5	4.3	0.2	0.0	0.5	0.0	0.9	0.1	0.4	0.8	0.0	0.1	0.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	0.1	3.4	3.9	0.4	2.2	0.4	0.0	0.1	1.2	0.0	0.6	1.5	0.2	0.3	7.1	0.5	1.3	0.0	0.0	0.0	0.1	1.7	0.5	3.5	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.0	4.9	0.0	1.0	2.4	1.5	2.3	0.0	4.8	0.6	1.8	0.3	1.0	0.2	0.0	0.1	0.2	0.2	0.7	0.0	0.1	0.0	1.9	0.1	4.2	0.6
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 42.1;AN3-CA: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: AB_2683623"	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	3.6	4.5	1.9	4.2	2.4	11.5	3.9	2.9	2.1	3.3	1.7	3.3	4.4	4.3	3.1	2.7	2.8	3.8	2.2	1.7	2.5	2.6	2.5	3.1	4.9	2.5	2.2	2.8	4.3	5.0	2.1	3.5	2.4	3.3	3.6	4.0	2.7	3.1	3.8	2.9	3.6	3.4	2.1	5.0	2.8	4.2	2.4	4.0	3.2	4.0	3.9	4.4	1.8	2.6	9.0	6.6	42.1	42.2	4.2	3.1	6.1	5.6	5.9	7.7	6.9	17.2	3.7	12.3	6.4	5.4	6.5	5.2	27.4	5.9	10.0	6.1	11.8	12.0	5.2	26.0	9.7	12.0	5.4	5.7	8.2	7.5	17.3	7.6	18.8	11.0	17.6	0.2	4.9	8.6	20.9	14.8	23.6	0.8	6.0	24.3	2.0	0.9	9.4	8.1	6.4	22.2	6.2	1.8	12.6	14.1	10.1	13.7	9.1	4.8	11.1	5.6	13.1	2.5	1.0	11.5	5.8	20.5	3.3	0.1	1.7	0.5	0.9	1.4	1.2	0.7	0.8	0.4	2.9	0.7	1.1	1.1	0.1	0.4	1.3	0.6	0.7	0.9	1.9	2.4	2.9	2.1	1.7	2.5	2.5	2.2	2.4	2.1	2.4	2.6	2.6	6.4	3.1	2.3	3.3	1.9	3.1	1.3	2.8	5.1	3.1	2.0	4.0	1.5	2.4	5.5	14.6	1.5	2.1	3.4	3.9	2.9	3.7	2.6	4.8	4.8	4.2	4.2	4.2	2.7	3.0	3.2	2.0	2.5	0.0	4.6	10.4	1.4	3.6	1.7	5.8	3.5	2.0	6.5	4.6	7.6	1.8	5.0	1.8	1.9	2.8	3.1	1.0	5.5	3.7	4.0	1.5	1.9	1.9	4.0	1.4	2.1	4.3	3.2	0.0	4.1	4.0	10.1	6.9	2.3	1.4	1.1	2.2	3.1	3.2	2.9
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249083-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 23.4;Intestinal goblet cells: 28.5;Paneth cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 18.6"	"Group enriched"	"Detected in some"	17	"neutrophil: 12.7;NK-cell: 4.2"	"Group enriched"	"Detected in many"	85	"granulocytes: 12.7;NK-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.8;RT4: 28.0;WM-115: 38.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear speckles"		"HPA049970: AB_2680974"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.10e-4)"	"prognostic favorable (8.02e-4)"	0.9	3.8	1.2	1.6	1.2	1.4	1.3	18.6	3.1	2.6	1.3	7.8	1.3	0.7	0.6	1.0	1.3	0.7	5.7	4.7	1.2	4.0	0.7	7.8	0.4	1.8	2.0	5.4	0.2	0.1	3.8	0.9	2.1	1.4	5.8	1.5	4.8	1.3	0.2	0.5	3.3	0.8	1.4	7.5	7.2	12.2	2.2	2.6	4.2	2.6	1.1	3.4	1.5	1.3	3.9	20.8	16.4	0.2	0.0	0.0	0.0	0.0	0.3	1.9	0.8	7.9	16.8	0.0	13.2	0.2	13.9	5.9	2.3	49.8	1.3	0.0	0.3	6.0	7.3	6.8	0.2	0.0	0.2	0.0	4.2	2.7	11.9	9.9	12.7	5.8	0.1	0.0	5.3	2.7	0.0	12.1	11.5	0.0	7.8	3.4	4.6	1.7	12.6	28.0	4.7	10.5	2.9	3.7	17.1	6.2	9.9	1.1	14.9	2.6	13.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	4.2	0.0	0.0	0.0	0.2	1.2	1.2	18.6	3.1	4.7	1.2	1.8	2.0	2.1	1.4	2.2	1.3	0.6	22.4	23.4	9.4	0.0	0.3	1.8	3.8	0.0	0.7	1.0	2.3	4.8	0.0	6.8	3.7	0.0	0.0	4.5	4.4	5.9	2.7	1.0	0.5	1.4	2.6	2.4	0.0	0.7	0.2	0.0	1.2	1.1	1.4	1.3	11.5	2.2	0.2	0.1	0.0	9.3	28.5	8.2	0.3	0.3	3.6	2.1	2.1	5.4	2.8	0.6	8.3	14.4	1.5	0.7	1.7	26.8	2.6	0.5	1.3	4.3	0.2	1.5	0.1	0.0	0.7	1.9	0.5	10.0	0.4	0.4	0.0	2.2	11.2	4.6	2.4
CCNK	CPR4	ENSG00000090061	"Cyclin K"	O75909	14	99481169-99535044	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Cyclin	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000645, HPA077073"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA000645: AB_1078606, HPA077073: AB_2732331"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"unprognostic (9.22e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.78e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.21e-2)"	20.7	18.0	8.8	26.6	10.2	102.1	16.9	11.5	12.8	17.9	10.5	26.3	25.5	18.9	18.8	25.5	22.1	18.5	19.3	9.8	11.8	16.6	17.9	21.7	28.4	11.9	10.8	25.8	16.7	13.5	19.7	19.8	10.9	17.0	28.0	16.3	20.7	16.2	39.2	22.1	27.7	19.8	9.1	24.9	25.0	45.4	10.6	33.3	20.0	22.4	34.1	21.5	19.1	12.9	53.9	59.3	59.7	50.2	47.5	49.4	109.3	69.9	62.2	71.4	82.3	86.3	69.7	84.3	47.7	75.9	53.1	59.9	64.3	89.9	99.5	83.0	33.7	78.1	38.6	75.2	62.4	111.1	85.6	53.7	68.2	71.1	81.4	33.8	54.4	82.9	72.1	72.8	62.7	115.1	85.9	44.6	59.0	66.2	52.1	76.5	80.2	44.7	39.8	101.1	49.1	36.5	62.7	31.9	28.6	57.7	87.4	49.6	66.5	25.6	40.7	226.1	63.3	61.7	86.6	101.5	65.5	50.9	53.4	5.3	5.3	12.6	7.2	5.7	6.3	5.4	5.6	6.4	4.7	4.9	6.5	6.0	12.8	5.1	6.2	5.0	6.3	3.4	8.8	10.2	11.5	12.8	9.8	11.8	11.9	10.8	10.9	9.1	10.6	12.9	29.6	12.8	37.9	13.7	41.8	36.8	48.6	31.3	33.6	16.9	29.5	23.6	11.5	14.3	37.7	22.0	20.9	23.5	52.7	36.0	13.7	20.1	51.5	39.2	39.6	24.1	19.7	39.2	13.7	24.7	29.3	27.6	49.5	56.7	20.3	29.3	25.7	18.7	24.2	18.5	14.0	34.2	30.5	32.7	32.1	22.0	22.4	41.1	17.8	16.9	38.0	13.4	47.4	14.1	18.5	31.8	26.4	18.0	44.9	42.1	26.2	17.2	43.4	28.8	0.0	40.1	23.0	78.9	64.3	35.7	45.3	27.2	46.5	24.9	32.4	70.2
CCNL2	"ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138"	ENSG00000221978	"Cyclin L2"	Q96S94	1	1385711-1399335	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053137	Supported		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053137: AB_2682053"	"unprognostic (3.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.61e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.46e-7)"	65.1	79.9	16.3	29.6	17.5	33.3	74.0	24.1	21.5	101.8	27.8	76.9	36.0	88.7	30.9	67.2	86.6	26.4	57.9	16.9	14.2	65.6	100.5	62.1	32.2	16.9	15.7	104.3	90.2	31.7	73.4	34.4	18.4	76.0	22.8	22.9	78.1	31.9	49.7	73.7	75.8	26.6	15.7	62.1	71.3	31.1	17.0	31.6	91.4	18.4	28.1	77.0	82.5	26.6	30.1	24.5	72.5	29.7	39.2	63.9	37.1	63.8	33.8	32.1	31.6	27.5	57.9	30.6	35.3	42.8	27.7	68.4	26.8	40.9	24.6	14.7	68.9	38.4	142.0	43.8	47.8	19.9	42.8	81.1	29.0	31.4	48.5	94.6	34.9	41.0	37.3	32.4	37.6	32.1	25.1	78.7	23.7	21.2	48.5	48.8	17.6	39.1	56.5	37.1	45.4	63.0	40.7	60.6	37.5	42.8	48.8	30.3	60.1	70.8	32.5	29.4	25.2	64.9	12.1	53.7	35.0	50.7	18.5	5.4	6.1	8.5	7.4	4.6	5.0	7.2	7.2	7.9	7.1	9.0	8.3	7.4	5.8	6.6	7.3	6.7	4.3	2.9	16.3	17.5	24.1	21.5	16.9	14.2	16.9	15.7	18.4	15.7	17.0	26.6	66.4	35.3	107.5	76.7	46.6	45.5	36.6	48.3	50.7	31.7	50.8	56.4	37.2	40.0	58.1	29.5	47.9	43.2	48.7	43.1	21.5	30.6	22.4	49.0	82.1	56.0	50.6	26.5	44.7	26.7	33.8	49.9	78.5	55.2	43.1	81.4	37.5	45.6	24.7	60.6	41.2	41.5	52.9	22.9	34.0	14.6	51.3	31.0	32.0	48.7	27.2	35.5	47.4	31.2	52.5	40.2	40.7	32.7	46.7	31.1	33.9	18.4	58.6	39.4	59.2	56.8	59.9	45.1	30.6	40.3	44.0	63.8	46.4	73.6	34.6	39.0
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233608	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation"	Cyclin	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.3;pancreas: 10.1;testis: 13.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 39.3;Club cells: 51.4;Collecting duct cells: 33.1;Endometrial ciliated cells: 38.1;Ionocytes: 61.1;Respiratory ciliated cells: 97.2;Spermatocytes: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.2;T-47d: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA050090	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA050090: AB_2681011"	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favorable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.1	0.4	1.3	0.0	2.8	0.0	0.5	1.1	2.3	1.0	12.3	0.3	0.3	0.2	0.3	1.0	2.1	0.1	0.1	2.2	1.8	1.9	0.2	1.3	0.0	1.7	1.9	0.8	10.1	1.1	5.3	0.1	1.1	2.0	0.0	0.1	1.8	1.2	0.0	1.8	0.5	0.0	1.2	0.0	5.6	13.2	2.0	0.0	5.5	0.0	0.0	1.8	0.4	1.3	2.8	3.2	0.0	1.6	0.2	0.0	5.2	0.0	0.0	0.4	0.5	0.0	3.1	0.0	2.0	0.0	1.0	2.6	0.1	0.0	0.0	0.0	4.1	0.1	3.5	0.3	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	2.7	0.0	0.1	0.2	0.4	4.4	1.5	0.3	0.0	1.2	1.0	1.9	0.0	3.5	0.8	1.1	0.0	7.5	0.5	0.2	0.0	2.2	2.8	1.2	2.6	1.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	1.1	2.3	2.2	1.8	1.7	1.9	1.1	1.2	2.0	1.3	0.2	0.0	1.5	0.7	0.0	1.0	3.7	39.3	5.7	11.9	9.2	5.0	0.5	2.8	51.4	33.1	6.2	0.7	0.3	2.7	0.0	4.2	12.5	38.1	0.5	0.3	0.0	0.0	2.8	28.5	1.9	0.6	13.3	5.4	0.0	0.1	0.0	0.0	0.1	1.7	0.3	3.4	61.1	0.0	0.7	4.4	1.2	0.2	1.8	0.0	0.0	0.1	0.0	0.5	0.1	11.1	2.7	0.4	0.0	7.9	5.7	1.0	97.2	0.5	0.0	0.3	5.1	53.9	21.5	3.3	2.4	0.3	0.2	0.0	4.2	5.9
CCNP	"CNTD2, FLJ13265"	ENSG00000105219	"Cyclin P"	Q9H8S5	19	40222208-40226697	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.1;kidney: 4.9;liver: 3.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Syncytiotrophoblasts: 3.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.1"	"Immune cell enriched"	"Detected in single"	45	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"					"Not detected"	"Not detected"			HPA045615	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA045615: AB_2679390"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.79e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	0.7	0.5	0.4	0.0	0.3	0.0	0.5	3.1	0.7	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.4	0.2	4.9	3.7	0.2	0.0	0.2	0.1	0.4	0.1	0.0	1.8	0.0	0.4	0.5	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.1	0.7	0.4	0.2	0.2	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0
CCNQ	"CycM, FAM58A"	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587925-153600045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	11.8	12.8	19.9	8.2	21.3	7.3	11.7	19.6	24.9	11.9	15.6	16.2	8.9	12.9	12.7	13.1	11.1	4.0	33.9	20.8	20.5	13.5	13.2	10.6	12.5	23.2	21.6	10.5	15.0	10.3	23.6	9.2	23.4	13.6	8.0	6.4	12.9	8.8	34.3	12.1	13.6	6.1	20.0	17.2	13.3	6.2	21.2	9.0	11.1	13.6	12.2	14.0	11.7	24.9	43.7	31.2	12.1	43.5	20.9	11.2	18.7	25.0	21.8	23.5	23.6	33.3	14.3	34.9	44.6	25.1	35.3	26.7	38.4	22.6	22.2	20.3	39.2	7.8	19.4	23.5	19.0	28.2	18.9	14.1	20.1	15.7	16.1	10.0	19.0	16.1	10.6	15.6	19.1	50.5	19.7	38.0	15.1	44.4	52.4	22.6	20.0	17.8	17.0	17.6	16.0	21.1	12.0	19.3	34.4	11.9	7.3	25.0	14.6	20.5	29.3	46.7	38.5	21.8	23.1	43.4	18.5	45.4	15.7	0.0	1.6	4.9	2.7	1.4	1.0	6.1	2.3	1.9	1.3	4.1	2.5	1.7	0.9	0.7	0.8	1.2	3.4	1.1	19.9	21.3	19.6	24.9	20.8	20.5	23.2	21.6	23.4	20.0	21.2	24.9	21.0	3.2	13.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	24.1	31.0	0.0	0.0	3.1	7.3	0.0	40.7	20.4	0.0	72.4	23.3	0.0	11.9	17.3	7.8	0.0	0.0	0.0	37.1	98.6	8.4	0.0	8.7	2.5	16.3	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	34.0	0.0	0.0	5.9	0.0	0.0	41.6	2.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	120.9	10.0	18.4	0.0	0.0
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	9.4	9.6	5.3	9.6	5.5	29.4	9.9	7.3	6.4	7.1	7.8	7.7	6.7	9.2	8.2	7.8	8.2	7.1	6.8	4.7	8.6	8.9	8.4	8.3	11.7	5.7	5.8	10.8	8.8	11.5	6.7	7.9	5.7	7.6	8.3	12.2	6.3	7.0	10.2	9.6	7.8	7.9	6.1	10.5	7.3	11.5	6.3	13.0	11.7	9.9	11.3	7.5	6.9	7.5	15.1	21.8	20.6	19.8	14.9	18.2	23.8	20.0	16.6	15.3	11.8	26.0	17.3	40.4	25.6	13.4	10.4	19.3	35.6	13.7	22.6	24.0	20.5	43.9	34.2	11.2	18.4	45.1	20.0	14.1	19.6	21.4	25.3	21.0	11.9	23.5	44.7	18.1	18.9	9.9	24.6	20.9	20.7	8.7	16.1	21.8	33.4	17.0	14.0	26.2	23.0	24.0	32.0	15.5	23.5	14.9	21.3	25.8	12.5	16.1	17.0	11.7	17.1	25.8	37.0	35.3	19.1	64.9	9.4	9.0	2.6	7.7	3.3	1.7	4.5	4.3	2.7	3.2	1.6	5.3	3.9	3.6	13.6	3.5	2.0	4.4	1.8	0.9	5.3	5.5	7.3	6.4	4.7	8.6	5.7	5.8	5.7	6.1	6.3	7.5	41.4	16.0	18.9	16.0	38.0	38.5	19.4	11.8	48.9	23.5	21.9	19.0	14.4	12.8	16.1	12.9	22.9	13.8	58.7	13.1	3.9	8.2	131.4	18.9	23.7	26.4	12.0	24.0	18.9	6.9	16.7	23.9	29.0	26.1	29.8	27.3	27.8	15.2	10.2	38.7	18.5	15.8	14.2	17.5	33.0	27.9	16.8	29.9	21.4	19.7	12.1	16.2	18.6	18.6	22.6	8.1	9.2	14.7	37.8	26.2	13.3	9.8	25.1	16.3	6.6	23.3	28.5	18.3	14.4	32.1	44.9	17.4	45.0	27.3	13.7	33.3
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	13.4	12.1	10.1	12.2	10.2	29.0	15.6	13.7	12.4	16.4	10.6	13.0	13.4	13.5	14.8	12.8	14.0	9.4	11.7	9.9	10.8	10.9	18.3	14.9	15.5	10.4	10.0	17.4	19.8	15.0	15.1	12.0	10.8	13.5	12.1	19.0	13.0	10.7	10.3	15.4	14.4	8.5	11.1	15.6	14.8	12.3	10.5	14.4	14.5	9.7	14.1	15.0	16.3	14.4	9.0	4.4	28.0	10.5	13.6	13.7	21.3	12.2	9.9	11.2	13.9	11.9	10.1	14.6	8.9	10.0	5.4	11.4	17.0	9.1	16.3	7.9	11.5	15.8	11.9	16.9	13.3	14.3	13.4	12.6	17.6	11.1	13.5	14.4	16.8	10.8	13.4	14.6	13.2	6.1	16.0	21.2	22.8	7.4	9.0	15.2	10.0	11.7	17.4	24.4	19.1	15.8	8.9	10.3	14.2	20.3	10.8	17.3	15.3	14.4	15.9	6.2	9.0	10.2	6.7	15.1	9.0	11.2	12.5	3.8	1.6	2.0	1.7	2.0	2.1	1.6	1.9	2.1	2.1	1.2	3.3	2.6	2.1	2.8	1.0	1.9	2.6	1.3	10.1	10.2	13.7	12.4	9.9	10.8	10.4	10.0	10.8	11.1	10.5	14.4	27.1	25.6	26.0	49.6	38.0	15.0	28.8	17.9	26.7	34.7	21.6	15.4	23.5	14.3	21.8	14.7	33.3	11.9	35.3	22.4	7.9	16.2	5.5	20.2	30.2	21.5	18.5	20.0	73.6	14.9	9.6	23.7	46.9	33.1	11.4	31.1	18.9	20.9	10.1	42.1	70.1	16.4	6.1	15.7	22.1	14.6	14.0	25.2	8.8	52.5	23.6	12.9	19.6	76.9	81.8	14.2	19.0	22.2	26.5	35.4	19.1	7.0	12.4	34.5	19.7	17.7	24.2	17.7	23.6	25.3	18.2	13.7	29.0	25.2	17.1	50.5
CCNY	"C10orf9, CBCP1, CFP1"	ENSG00000108100	"Cyclin Y"	Q8ND76	10	35247025-35572669	"Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Late spermatids: 3651.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.8;granulocytes: 26.4;monocytes: 23.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036290	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036290: AB_10600860"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (3.37e-2)"	"unprognostic (6.15e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	28.6	21.9	35.1	21.2	37.1	35.9	23.7	31.6	35.1	21.8	24.8	28.4	21.5	28.4	26.9	20.5	22.2	22.7	33.1	37.0	32.4	24.8	31.0	25.9	23.4	32.0	33.6	25.2	20.6	17.9	15.5	38.7	31.9	18.3	20.0	19.3	17.0	20.1	25.5	19.3	22.2	25.7	32.3	24.4	26.3	81.2	35.5	22.5	29.6	22.9	21.0	25.4	17.3	33.4	52.3	22.2	29.3	28.2	41.6	56.5	38.2	27.4	27.7	26.0	24.9	32.4	51.7	33.2	38.1	44.1	22.7	27.1	26.3	34.6	27.7	105.0	17.3	62.0	16.0	42.4	45.8	22.7	28.3	40.3	48.1	39.9	27.1	57.6	63.3	38.3	49.1	27.3	51.6	33.2	39.9	19.6	11.2	29.6	46.2	33.0	54.4	20.7	33.2	24.6	25.8	39.3	21.5	42.7	38.6	25.4	36.9	41.8	75.5	32.1	38.6	49.4	23.9	18.3	16.6	24.4	56.0	46.6	15.1	1.7	23.4	5.2	3.3	6.5	3.6	3.1	3.2	3.5	7.8	2.4	3.2	3.6	26.4	2.9	3.4	4.0	2.3	7.6	35.1	37.1	31.6	35.1	37.0	32.4	32.0	33.6	31.9	32.3	35.5	33.4	102.2	32.1	25.9	91.1	23.4	26.9	14.1	29.0	13.6	43.5	30.2	28.7	33.1	41.5	32.1	38.6	20.9	12.0	35.2	25.8	5.9	16.5	709.0	29.5	37.2	59.8	52.8	12.4	205.5	27.8	18.1	34.4	20.4	33.4	16.5	35.3	32.5	85.3	28.9	48.8	130.0	29.0	26.4	80.4	46.9	3651.5	41.3	56.6	16.0	192.0	89.3	62.4	24.7	167.9	445.2	27.9	19.2	38.7	11.7	27.7	31.5	23.1	28.5	39.6	6.6	56.0	26.5	33.8	40.2	17.1	29.5	9.4	26.2	43.2	28.6	20.9
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 62.7;Paneth cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046825	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	12.8	4.7	3.8	10.6	4.9	9.9	7.1	2.8	5.3	8.2	3.7	15.3	11.7	5.0	5.2	17.8	4.2	7.9	6.1	5.2	5.1	10.9	12.4	11.8	8.6	4.8	4.2	3.4	13.7	4.2	4.5	13.6	5.1	4.8	13.3	9.0	6.9	4.8	7.8	3.9	11.3	8.7	4.2	8.1	11.0	16.2	4.5	6.1	11.4	4.4	9.3	10.4	9.5	6.8	25.7	11.0	14.5	20.4	18.6	21.2	83.3	15.6	25.8	15.7	17.7	51.1	23.7	9.9	14.2	28.6	38.5	17.4	17.7	29.4	15.2	3.7	13.5	13.3	12.8	41.6	18.7	11.9	15.2	10.7	12.0	20.0	20.9	13.8	52.5	11.5	6.8	9.4	21.9	13.6	10.5	11.2	28.1	10.3	12.2	9.4	12.4	8.0	16.2	19.5	3.5	10.8	18.5	8.0	23.5	33.6	7.2	31.5	27.3	17.7	16.6	23.2	10.5	5.6	8.4	13.4	18.5	13.5	15.4	0.7	1.1	0.5	0.3	0.6	0.4	0.3	0.5	0.5	0.5	1.1	0.4	0.8	1.3	0.6	0.5	0.5	0.4	0.3	3.8	4.9	2.8	5.3	5.2	5.1	4.8	4.2	5.1	4.2	4.5	6.8	31.8	3.2	19.1	10.1	14.1	12.2	13.8	7.6	5.7	6.2	10.0	10.0	9.0	2.8	8.5	23.9	10.4	12.6	13.2	62.7	1.9	5.8	13.7	13.6	7.7	17.0	9.6	6.5	34.1	14.7	42.9	11.4	25.0	20.4	5.7	5.8	23.9	12.5	16.2	5.0	11.6	13.1	8.2	17.5	29.9	10.9	2.8	18.7	8.8	7.5	20.8	10.2	7.2	14.6	28.7	13.9	121.3	3.8	7.7	16.1	10.1	12.6	6.3	12.3	0.0	16.0	10.4	23.9	9.5	7.6	10.5	7.7	10.9	4.3	17.0	18.0
CCP110	"CP110, KIAA0419"	ENSG00000103540	"Centriolar coiled-coil protein 110"	O43303	16	19523811-19553408	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 210.2;Respiratory ciliated cells: 118.8;Spermatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039402	Approved		Approved	"Centriolar satellite"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"		"HPA039402: AB_10671041"	"unprognostic (2.83e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.37e-1)"	5.6	5.9	23.6	6.6	41.3	15.7	9.2	22.7	34.5	7.3	11.4	5.5	3.9	9.2	7.3	6.6	13.3	5.9	4.7	22.6	25.1	4.5	3.6	8.6	8.2	27.4	30.2	10.5	4.0	11.5	11.8	4.9	25.2	7.3	5.6	13.8	5.2	6.9	5.0	5.9	4.9	7.9	18.6	6.4	6.4	35.8	30.7	16.5	7.1	5.8	7.7	6.2	5.2	48.1	22.4	10.2	24.7	24.1	12.1	10.7	12.7	23.4	13.5	20.4	22.9	8.3	11.7	32.8	14.5	11.6	15.5	15.4	25.6	7.4	34.2	15.1	11.6	16.4	14.5	14.3	6.0	42.6	20.2	5.3	10.0	23.0	14.0	12.6	15.9	33.1	17.5	16.0	24.1	17.3	43.8	16.5	19.0	10.7	7.6	55.1	46.1	11.5	9.3	9.3	48.5	24.5	25.4	11.9	7.6	16.4	21.9	25.6	9.5	23.7	15.6	16.0	19.5	17.6	17.7	23.5	15.2	18.0	14.1	14.5	2.8	5.2	3.8	2.7	2.4	2.5	3.4	3.7	3.0	3.2	3.8	2.2	5.5	1.7	4.3	2.0	2.9	2.0	23.6	41.3	22.7	34.5	22.6	25.1	27.4	30.2	25.2	18.6	30.7	48.1	9.3	32.1	34.6	19.9	12.7	13.5	9.2	10.8	14.8	18.1	16.4	11.2	14.7	8.6	27.6	23.9	33.3	11.4	19.4	6.9	5.9	9.2	5.1	75.1	19.5	10.7	1.2	46.3	30.6	4.7	7.0	15.7	10.2	13.5	30.3	12.5	12.1	7.5	7.0	30.3	30.9	9.9	6.1	18.2	12.8	9.0	21.1	10.7	10.6	13.1	11.6	14.5	12.3	21.1	210.2	9.0	6.0	16.6	12.7	9.2	8.0	5.3	118.8	66.0	19.7	22.5	12.5	169.2	38.6	13.3	14.6	24.5	14.4	9.5	6.1	6.9
CCPG1	"CPR8, KIAA1254"	ENSG00000260916	"Cell cycle progression 1"	Q9ULG6	15	55340032-55408510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 279.2;neutrophil: 296.6"	"Group enriched"	"Detected in all"	7	"granulocytes: 296.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009432, HPA026861"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA009432: AB_2668242, HPA026861: AB_1846192"	"unprognostic (3.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (5.07e-4)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (1.15e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.72e-2)"	38.9	37.8	24.0	23.7	27.7	63.8	34.1	23.1	28.4	61.1	36.8	33.3	24.3	26.7	36.1	20.1	22.0	53.8	56.2	24.7	26.9	51.5	66.9	39.3	22.2	18.4	17.3	22.9	84.8	73.3	32.3	27.4	17.7	41.0	33.2	48.2	77.1	42.3	53.0	13.5	25.6	33.5	17.2	28.7	47.5	29.6	27.3	12.2	84.4	35.3	24.2	29.9	9.7	22.9	13.9	47.7	10.9	24.4	173.6	59.3	15.5	30.0	56.4	17.2	26.1	14.4	23.5	20.8	99.5	97.5	33.6	18.7	9.5	25.1	14.4	55.5	14.2	28.1	58.4	12.8	223.9	39.6	84.2	49.5	59.8	35.6	34.4	143.3	65.2	0.8	47.7	337.4	55.1	17.9	0.2	19.3	6.5	54.4	11.8	6.2	17.4	84.8	36.1	10.1	14.0	21.5	35.3	19.5	151.4	35.0	31.0	85.1	65.7	50.8	11.1	38.9	20.4	65.2	259.6	13.0	95.6	77.2	41.0	220.8	59.4	279.2	26.8	50.7	22.5	18.1	16.6	20.7	27.6	13.4	13.9	20.0	296.6	25.7	84.2	4.7	23.0	32.9	24.0	27.7	23.1	28.4	24.7	26.9	18.4	17.3	17.7	17.2	27.3	22.9	92.3	115.4	118.1	0.0	44.6	15.4	30.3	99.2	13.6	68.7	40.2	40.1	14.4	50.1	136.5	88.3	93.8	29.3	42.9	43.7	5.9	60.9	136.2	49.6	41.0	60.1	16.7	25.2	0.0	145.3	23.2	78.6	33.1	62.3	39.1	30.0	76.1	96.1	51.0	85.8	0.0	28.8	114.0	55.9	25.2	216.1	56.5	71.7	48.0	0.0	89.8	72.6	38.1	0.0	0.0	67.6	45.1	116.6	180.8	42.6	29.5	36.7	123.8	128.0	52.6	80.2	48.1	43.3	41.1	11.8	16.6	24.6	41.8	70.0	16.2	21.8
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"plasmacytoid DC: 24.7;T-reg: 72.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.7;T-cells: 72.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	4.5	2.1	1.1	0.7	1.1	0.2	5.2	3.1	2.7	6.6	0.0	4.8	1.8	8.5	0.3	0.8	8.5	0.2	4.4	0.7	6.5	2.8	0.8	4.1	0.3	3.9	4.6	6.2	2.3	0.0	20.2	0.7	6.6	3.8	0.2	0.7	2.2	0.6	4.7	1.5	3.1	0.5	1.0	3.2	2.6	4.0	4.0	0.2	2.8	0.4	0.0	2.4	3.2	1.2	0.5	0.8	0.8	4.7	0.3	0.7	1.1	1.7	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	1.6	0.8	0.0	0.1	0.1	2.0	1.2	0.0	3.2	0.4	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.5	0.1	0.3	2.6	8.4	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.1	6.5	1.1	0.0	0.7	1.0	0.4	0.0	0.2	0.3	0.8	0.9	1.9	2.1	0.5	0.7	0.2	17.1	8.4	2.5	1.3	0.6	0.9	0.0	0.6	0.2	0.4	0.1	0.3	5.3	10.9	5.4	0.4	5.9	1.3	1.8	0.2	0.2	0.4	24.7	72.4	1.5	1.1	1.1	3.1	2.7	0.7	6.5	3.9	4.6	6.6	1.0	4.0	1.2	7.3	0.0	0.0	0.7	14.1	0.8	0.3	0.4	0.6	12.8	1.0	1.3	2.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	3.9	0.3	0.5	1.6	2.9	2.9	1.8	0.0	5.1	0.5	0.3	5.4	1.5	0.9	0.0	0.6	2.2	0.2	1.9	1.7	4.6	0.6	2.0	2.5	3.7	2.5	5.6	1.2	5.4	0.0	3.8	2.5	2.1	1.0	1.3	0.3	0.1	2.6	62.7	0.3	0.2	0.7	1.0	3.2	19.7	2.3	16.7	1.6	2.1	0.3	0.3	0.0	2.9	1.9	0.7	0.1
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353744-46360940	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 560.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.4"	"CAB003793, HPA063255"	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoli fibrillar center"	"CAB003793: AB_344889, HPA063255: "	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.6	1.9	0.1	25.9	0.1	1.9	3.1	0.1	0.2	1.6	0.3	4.6	7.5	1.2	0.9	1.2	1.2	3.4	1.1	0.1	0.1	1.2	2.1	5.8	11.6	0.4	0.2	1.1	0.8	0.3	0.2	0.8	0.2	1.2	5.1	0.0	3.1	1.7	0.5	1.9	5.7	7.1	0.3	20.4	5.2	1.0	0.2	4.3	1.1	0.5	7.2	5.5	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.7	0.0	185.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.3	416.5	177.7	0.0	0.1	3.3	0.1	560.9	146.2	2.6	11.9	12.8	89.2	7.9	24.3	20.2	145.2	1.8	0.6	0.7	3.8	14.0	0.4	113.6	11.4	81.6	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.2	0.3	0.2	0.3	0.1	0.0	1.3	0.0	5.8	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	1.5	0.0	0.0	0.0	0.1	40.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.0	1.8	0.9	0.8	0.0	0.0	0.0	0.0	43.1	10.5	0.7	0.0	25.2	0.0	0.0	34.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	8.2	0.1	0.1	0.0
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;granulocytes: 1.3;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"basophil: 3389.4;eosinophil: 2509.9"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 3389.4"	"Cell line enriched"	"Detected in some"	10	"RPMI-8226: 29.6"	"Not detected"	"Not detected"							"CAB003795, HPA069514"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.1	0.0	0.2	1.6	0.3	0.4	0.0	0.1	0.5	0.1	1.7	0.8	1.3	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.1	0.1	0.6	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.4	0.0	0.7	0.0	0.0	0.1	1.7	0.8	2.6	0.9	0.0	1.5	1.2	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	2.6	0.1	0.8	0.0	0.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.3	0.0	29.6	0.0	2.4	0.1	0.0	0.1	0.8	0.0	0.8	0.0	0.7	0.0	0.1	0.2	0.0	0.1	3.0	2.6	0.0	0.0	0.5	0.0	3389.4	1.0	2509.9	0.5	1.5	0.8	1.2	2.6	1.4	1.1	0.7	0.3	0.9	115.8	0.5	1.4	3.5	31.1	7.6	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.0;urinary bladder: 5.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 2.5;Horizontal cells: 5.0;Plasma cells: 2.1;Spermatogonia: 1.8;T-cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.9"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.9"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 206.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	0.5	0.2	0.3	8.6	0.3	1.7	0.6	0.8	0.7	0.6	0.2	0.9	0.6	0.4	0.3	1.2	0.2	3.3	0.2	0.4	0.4	0.3	0.6	1.7	7.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.4	0.8	1.2	0.1	0.5	0.1	2.0	2.1	1.5	0.6	0.0	3.2	1.4	0.8	0.2	13.0	0.3	0.1	8.0	5.4	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	206.5	0.0	12.2	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.0	5.8	3.2	0.8	0.0	0.0	1.8	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.5	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.2	0.1	0.2	0.2	0.2	0.0	1.4	0.3	0.3	0.4	0.3	0.4	0.3	11.5	3.4	0.1	0.4	0.3	0.3	1.1	0.3	0.3	0.4	60.9	1.7	0.3	0.3	0.8	0.7	0.4	0.4	0.2	0.1	0.4	0.0	0.2	0.7	0.1	0.0	0.6	0.0	0.4	0.4	0.7	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.5	0.0	0.4	0.1	0.1	5.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.8	0.0	0.5	0.2	0.0	1.8	0.0	0.1	0.0	7.8	0.0	0.0	0.6
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 35.8"	"Group enriched"	"Detected in many"	4	"B-cells: 44.0;Late spermatids: 26.4;T-cells: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 77.4;T-cells: 74.5"	"Group enriched"	"Detected in some"	6	"Hep G2: 9.4;OE19: 3.2"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"			"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.2	0.5	11.4	0.5	2.5	2.2	0.2	0.7	0.9	0.1	1.9	2.8	0.4	0.6	1.4	0.6	2.1	0.1	0.6	0.3	0.5	0.6	1.2	18.1	0.3	0.3	0.2	0.1	0.1	0.0	0.1	0.3	1.0	2.2	1.4	0.6	0.3	0.1	2.4	6.6	0.4	0.2	12.5	3.6	2.7	0.5	3.6	0.6	0.1	35.8	4.4	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.3	0.0	0.2	9.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.4	0.3	0.2	0.4	4.5	0.0	74.5	69.0	30.7	11.6	17.5	77.4	0.3	0.2	0.7	1.5	0.1	2.1	58.7	6.9	0.5	0.5	0.2	0.7	0.6	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.7	0.0	4.2	1.0	44.0	1.0	0.3	0.0	0.0	0.8	2.1	1.1	0.0	0.0	1.9	0.0	2.1	0.1	3.0	0.0	1.9	0.2	8.6	0.8	0.3	1.0	0.0	0.4	1.8	0.2	0.0	0.9	4.1	0.3	2.5	0.2	1.1	0.8	0.1	0.0	1.1	2.0	0.0	0.0	7.3	26.4	0.0	5.5	1.8	0.0	3.7	0.5	0.0	1.0	0.3	0.1	0.1	0.4	5.5	0.2	4.6	0.4	0.9	3.8	0.0	0.7	0.5	2.2	0.4	0.1	0.4	0.1	40.1	0.1	0.8	0.1
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;lymphoid tissue: 84.0"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 415.0;monocytes: 1586.1;Syncytiotrophoblasts: 517.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 4597.2"	"Lineage enriched"	"Detected in all"	4	"T-cells: 4597.2"	"Cell line enriched"	"Detected in some"	82	"HDLM-2: 1386.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"prognostic favorable (3.84e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	4.6	0.6	0.0	67.2	0.3	15.2	2.3	0.0	0.2	2.7	0.6	3.6	1.2	1.6	0.0	2.0	3.9	5.1	2.5	0.1	0.0	2.1	2.3	2.7	84.0	0.2	0.1	1.8	0.6	0.1	1.4	1.1	0.2	1.9	5.1	0.5	1.8	0.3	0.5	2.2	21.3	0.9	0.0	28.6	5.3	1.9	0.2	58.8	2.8	0.4	83.3	8.8	2.0	0.8	0.4	1.5	0.0	0.0	0.0	0.3	16.8	0.4	0.1	0.0	0.0	0.2	0.0	0.6	0.9	0.0	0.1	0.2	0.0	0.0	0.0	1386.6	0.1	0.0	0.2	0.5	0.0	3.9	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.3	0.8	0.2	0.0	0.4	1.2	3.0	0.1	0.0	0.0	4.5	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.2	1.0	0.6	1.6	0.0	0.4	0.1	1.6	0.7	7.5	0.9	9.0	1.9	0.1	0.0	25.6	6.5	4.2	61.1	3.5	69.2	794.6	996.2	285.4	4.2	1122.5	4597.2	2462.0	45.3	970.9	6.4	58.5	637.3	2489.9	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.8	1.2	0.0	3.7	0.0	201.4	5.0	1.5	0.0	0.0	0.0	0.7	0.4	0.3	0.0	1.3	1.8	0.0	143.8	9.5	0.0	0.0	0.6	0.3	0.5	0.3	1.0	0.0	0.4	0.0	8.3	24.2	1.6	1.1	0.4	2.5	0.0	0.4	0.0	12.8	0.0	0.0	0.0	0.0	0.0	415.0	0.2	0.0	75.7	16.0	0.0	1586.1	0.4	3.1	0.0	0.1	0.5	0.0	0.0	3.6	0.2	0.0	0.3	0.0	0.0	0.0	0.2	2.4	0.6	0.8	0.0	4.4	517.6	75.2	0.1	0.0	4.6
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329709-39333680	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 7.7"	"Cell type enhanced"	"Detected in single"		"T-cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 25.7"	"Lineage enriched"	"Detected in single"	32	"T-cells: 25.7"	"Cell line enriched"	"Detected in some"	22	"HDLM-2: 99.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042383	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042383: AB_2732497"	"unprognostic (2.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.63e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.37e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.65e-8)"	"unprognostic (7.96e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.14e-1)"	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.3	0.0	0.0	7.7	0.1	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	25.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45886504-45903175	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 124.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 24.0;naive B-cell: 15.6;T-reg: 8.1"	"Group enriched"	"Detected in many"	42	"B-cells: 24.0;T-cells: 8.1"	"Cell line enriched"	"Detected in some"	54	"MOLT-4: 112.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB006839	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB006839: "	"unprognostic (3.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.88e-3)"	"unprognostic (4.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-3)"	0.0	0.0	0.0	1.1	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.2	3.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	5.4	0.0	0.2	1.0	0.2	0.0	0.1	124.3	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	24.0	2.8	2.4	0.3	15.6	0.4	0.1	0.0	0.0	0.0	0.3	8.1	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407166-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043238	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	11.7	1.6	2.1	11.4	2.1	9.0	8.4	2.2	3.7	2.3	2.2	11.5	11.7	1.2	0.6	0.9	1.1	5.5	2.7	2.1	2.2	2.2	4.4	12.4	4.9	2.8	2.3	0.5	1.5	0.8	0.8	5.1	3.1	0.8	10.4	0.2	0.9	0.8	1.1	0.7	12.1	2.5	2.6	8.5	5.5	0.3	2.9	7.7	1.3	1.1	3.8	6.0	1.1	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.7	4.6	0.0	21.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	5.0	0.2	0.0	7.2	4.2	2.8	0.1	5.0	0.0	1.6	2.6	0.0	8.4	15.3	0.4	0.3	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	15.4	0.6	0.3	0.7	0.3	0.0	8.6	0.2	7.5	6.5	0.0	8.7	15.4	4.3	2.8	22.1	3.4	1.7	1.6	4.7	9.9	3.9	1.0	2.5	2.6	6.7	10.1	3.0	4.7	5.0	2.1	2.1	2.2	3.7	2.1	2.2	2.8	2.3	3.1	2.6	2.9	3.3	35.0	0.0	4.7	0.0	4.4	2.0	0.2	0.2	0.0	0.0	0.4	0.4	1.1	1.5	1.2	0.0	0.0	0.3	4.5	19.5	0.0	0.6	0.1	0.1	0.2	12.1	0.0	26.5	0.0	8.8	1.2	1.4	4.6	0.1	9.5	0.1	6.4	0.4	42.7	0.0	0.0	16.6	0.0	22.1	36.5	0.0	0.0	56.2	1.8	1.9	6.7	0.0	0.0	0.0	0.0	9.8	12.4	0.0	4.2	0.2	17.2	0.2	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	1.1	2.5	6.4	0.4	9.2	1.1
CCS		ENSG00000173992	"Copper chaperone for superoxide dismutase"	O14618	11	66593153-66606019	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008672, HPA040026, HPA044090"	Approved					NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-3)"	21.1	26.6	29.6	18.5	30.5	34.4	14.1	33.4	40.5	18.5	30.7	21.9	27.9	19.8	18.3	16.5	17.7	21.1	21.4	30.7	31.1	21.3	56.2	15.6	23.8	32.4	30.9	23.6	31.1	22.6	17.3	17.9	30.4	22.6	14.7	24.9	36.8	20.0	19.1	21.9	30.1	17.2	30.3	21.8	23.3	16.9	31.3	15.9	17.3	14.2	17.3	17.7	14.7	35.0	24.6	34.1	24.4	26.9	22.0	21.4	29.9	22.4	18.7	15.9	10.7	38.8	26.5	14.4	31.3	19.9	23.8	24.6	7.2	25.8	5.3	26.8	10.9	23.3	30.5	51.1	42.3	6.0	18.3	35.8	18.9	16.9	11.1	33.6	26.0	16.5	12.3	19.2	16.5	55.0	9.5	30.1	22.7	40.2	23.9	17.4	23.3	29.8	25.0	25.6	19.9	12.9	37.2	25.4	49.7	14.4	38.9	17.4	23.6	10.8	17.7	24.4	10.8	32.1	19.2	7.6	29.7	9.2	26.5	23.6	26.4	60.0	19.7	21.0	17.0	32.5	16.9	16.0	31.1	25.3	17.7	17.9	17.8	19.1	13.0	83.7	18.4	17.3	29.6	30.5	33.4	40.5	30.7	31.1	32.4	30.9	30.4	30.3	31.3	35.0	37.8	19.2	33.7	58.8	56.1	24.2	52.9	44.7	31.3	42.4	33.6	37.5	29.9	45.8	30.4	36.8	25.0	55.2	59.3	49.7	82.2	34.1	25.4	16.5	38.0	28.7	73.0	204.4	20.2	59.8	43.8	60.4	44.4	27.2	21.5	63.9	39.3	163.5	64.9	11.8	19.1	41.1	26.4	35.8	32.3	12.6	71.4	43.8	44.4	23.4	38.5	65.4	44.3	15.1	20.6	40.5	44.9	57.2	50.6	31.2	90.4	132.9	19.7	104.2	19.7	31.8	67.1	46.7	31.4	30.1	20.3	51.6	41.0	191.3	46.7	37.2
CCSAP	"C1orf96, CSAP, FLJ41471"	ENSG00000154429	"Centriole, cilia and spindle associated protein"	Q6IQ19	1	229321011-229343294	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.3;retina: 25.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 105.0;Oligodendrocytes: 52.7;Syncytiotrophoblasts: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028402, HPA043443"	Enhanced	Supported				NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA028402: AB_10603681, HPA043443: AB_2678485"	"unprognostic (4.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.50e-13)"	"unprognostic (9.67e-2)"	"unprognostic (4.93e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.03e-1)"	2.6	2.7	16.4	3.9	18.4	13.0	5.3	22.2	24.3	3.1	6.2	2.3	2.7	2.7	2.0	2.9	1.9	2.7	2.5	19.7	8.2	1.7	2.8	3.8	3.9	7.2	12.3	5.2	2.2	3.2	6.2	13.1	8.4	3.4	2.6	25.8	4.3	2.6	2.2	11.1	3.0	2.1	9.3	4.4	2.4	1.9	14.6	14.0	1.9	2.3	3.2	2.6	2.9	18.4	12.4	6.6	8.7	16.0	5.7	5.3	70.5	8.9	4.5	9.9	9.4	8.2	7.6	7.8	6.4	7.9	8.1	9.5	18.6	6.6	10.0	14.6	18.1	8.2	6.4	5.9	3.5	13.6	15.6	2.0	5.2	7.7	9.7	7.8	7.1	17.9	11.3	11.6	8.0	4.2	38.7	14.3	8.1	9.3	9.8	11.3	22.2	5.1	4.6	7.6	17.5	23.7	16.7	9.9	8.4	7.1	7.8	18.8	4.6	8.5	13.1	11.7	14.0	10.6	17.5	5.7	10.2	13.3	10.3	3.7	0.5	1.3	0.3	1.2	0.7	0.2	0.4	0.5	0.5	0.3	0.4	0.3	0.9	0.2	1.4	0.7	0.6	0.1	16.4	18.4	22.2	24.3	19.7	8.2	7.2	12.3	8.4	9.3	14.6	18.4	2.2	9.6	1.1	7.8	8.4	8.2	5.0	1.7	9.6	105.0	8.3	10.8	4.4	1.5	1.8	1.8	41.7	15.2	15.1	2.0	5.9	1.3	33.7	3.8	3.1	2.4	2.4	7.4	48.3	0.4	39.1	5.7	3.6	5.5	0.0	4.3	1.8	2.7	11.1	18.5	36.7	4.6	4.1	14.7	23.1	27.9	0.0	22.0	5.4	7.5	9.2	11.7	7.2	12.5	52.7	0.5	0.3	2.6	14.5	7.6	0.5	0.1	1.8	43.8	0.0	6.4	4.7	1.4	1.4	12.2	16.3	101.8	10.1	0.8	2.9	4.7
CCSER1	"FAM190A, KIAA1680"	ENSG00000184305	"Coiled-coil serine rich protein 1"	Q9C0I3	4	90127535-91601913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 3.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1954.8;Inhibitory neurons: 1639.5;Oligodendrocyte precursor cells: 577.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;OE19: 2.4;RT4: 1.2;SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041880, HPA054709"	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041880: AB_10796461, HPA054709: AB_2682581"	"unprognostic (4.03e-4)"	"unprognostic (4.21e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.64e-4)"	"unprognostic (6.94e-2)"	0.2	1.3	1.5	0.2	1.5	0.7	0.9	2.1	2.6	0.1	0.1	0.3	0.3	0.3	0.3	0.2	0.8	0.3	1.0	2.1	0.7	1.1	0.1	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.4	0.1	0.5	0.5	0.2	3.6	1.1	0.3	0.0	0.5	0.4	0.2	0.1	0.4	0.4	2.6	0.9	0.3	0.9	0.1	0.2	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.1	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.4	0.2	0.0	0.0	0.1	0.1	1.2	1.3	0.4	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	2.1	2.6	2.1	0.7	0.4	0.2	0.5	0.1	0.9	1.9	12.4	6.4	3.2	72.5	21.4	4.5	11.9	0.1	15.9	23.7	5.5	4.4	11.1	1.5	2.2	3.7	177.2	3.6	0.2	9.0	9.8	1.2	261.8	2.4	0.4	3.1	3.5	2.5	1954.8	3.5	5.6	0.9	23.4	4.8	5.1	0.8	3.3	0.2	1.0	5.0	1639.5	10.9	2.0	0.6	8.6	339.4	3.1	5.7	1.8	89.0	2.4	2.6	0.0	577.5	33.7	4.9	7.7	1.2	5.7	8.8	13.0	2.6	0.2	78.8	6.6	0.4	0.5	5.6	4.7	1.6	2.3	1.8	0.5	0.3	5.1	14.9
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328586-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 1945.3;Late spermatids: 5466.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	20.1	10.0	22.4	9.4	22.1	9.6	13.7	28.6	23.1	18.4	15.8	20.7	11.5	18.9	15.3	27.8	10.2	12.2	55.7	22.4	28.3	11.6	12.7	16.5	12.1	31.0	25.1	13.6	11.8	11.4	6.6	10.7	32.2	14.6	12.2	18.5	9.5	15.5	66.2	13.3	11.3	24.7	25.4	10.3	10.8	63.1	31.0	16.3	24.5	62.9	11.3	16.5	11.0	26.8	17.1	13.0	15.2	33.7	21.4	35.1	10.7	20.2	33.1	12.3	23.8	7.4	17.7	11.4	12.9	37.1	19.7	14.2	11.5	12.8	18.4	37.5	7.2	4.1	5.8	9.3	20.1	6.1	8.3	17.4	18.1	19.8	62.2	31.5	33.7	21.0	5.4	33.6	22.2	10.6	10.6	4.3	6.6	5.9	10.3	10.6	7.8	4.2	11.0	17.8	4.6	8.4	11.1	7.3	34.7	20.9	13.4	3.0	30.5	36.7	16.6	18.2	21.5	33.5	12.2	9.0	23.7	7.7	16.2	4.9	4.3	7.7	19.4	3.9	19.8	7.5	14.3	18.2	4.1	6.9	12.8	13.8	5.9	20.3	3.2	6.2	9.6	8.5	22.4	22.1	28.6	23.1	22.4	28.3	31.0	25.1	32.2	25.4	31.0	26.8	50.9	41.7	40.8	120.2	28.8	35.3	57.8	28.1	22.8	87.0	43.7	43.1	218.6	12.8	32.6	16.5	31.3	24.9	101.2	16.1	37.2	31.3	1945.3	21.2	33.9	54.1	16.3	3.0	146.7	45.8	19.3	52.2	21.4	28.8	14.5	28.5	37.1	24.0	20.9	62.2	142.5	28.9	22.4	21.4	66.2	5466.2	51.6	29.2	26.6	124.6	39.5	58.5	81.4	209.6	222.3	34.1	13.8	59.8	42.1	55.4	49.6	26.1	22.0	55.9	13.1	61.8	65.3	103.6	84.0	36.4	47.0	68.4	90.4	30.0	21.4	67.2
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585426-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1471.3;Spermatocytes: 625.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (8.38e-4)"	"prognostic unfavorable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	64.0	69.9	56.8	77.7	61.3	140.5	85.5	62.4	70.6	51.9	68.4	70.6	53.2	66.9	43.7	69.4	69.5	54.7	68.6	60.6	64.4	92.9	72.2	46.6	94.9	62.4	59.5	65.2	53.3	71.6	37.8	70.2	62.5	57.9	85.9	57.5	45.4	52.5	103.9	55.9	51.5	83.3	62.2	51.5	52.0	216.0	59.8	100.7	56.1	73.2	108.8	106.6	49.6	63.8	266.1	388.1	343.8	330.7	154.2	174.5	392.3	280.4	203.8	448.0	276.1	529.7	121.7	572.6	266.2	222.9	281.8	250.2	538.2	313.0	536.6	319.1	398.6	418.7	313.5	331.8	171.8	520.1	255.5	152.7	195.3	425.9	248.1	308.7	296.4	311.4	519.2	165.0	410.2	378.9	496.0	446.7	482.4	273.2	403.7	389.3	375.9	373.1	369.4	476.9	334.1	281.3	291.0	314.2	289.2	284.3	411.4	371.6	196.0	231.4	292.2	275.0	427.3	203.5	409.6	614.6	201.9	354.8	290.8	36.6	41.0	12.5	47.3	66.0	72.7	74.2	54.0	61.5	72.9	60.7	62.2	68.5	3.7	65.3	62.1	66.9	63.7	70.0	56.8	61.3	62.4	70.6	60.6	64.4	62.4	59.5	62.5	62.2	59.8	63.8	80.4	35.3	47.4	17.3	97.2	136.6	233.9	173.8	126.3	51.1	70.1	89.7	81.5	57.2	110.8	80.9	79.2	189.1	93.3	48.1	92.0	198.8	1471.3	150.9	126.5	95.3	106.2	226.4	21.5	128.4	209.1	102.1	60.6	107.1	105.4	112.3	52.5	46.2	127.1	42.1	31.3	94.4	109.9	44.3	74.9	430.3	76.7	70.5	46.2	11.2	87.7	67.9	57.7	21.6	20.6	150.7	50.8	66.5	100.7	165.8	34.4	127.4	127.5	56.6	85.5	128.4	178.3	625.4	391.5	112.1	117.3	153.4	93.9	154.1	154.8	161.9
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	85.3	122.3	121.4	103.0	125.8	79.5	119.4	132.2	176.7	77.1	139.0	95.3	87.2	93.6	77.1	106.9	119.9	67.4	100.8	125.3	135.5	114.5	108.3	60.1	123.9	129.4	126.1	113.5	82.3	120.4	65.3	93.3	129.5	86.6	112.9	135.7	74.9	89.8	134.8	93.8	83.3	137.3	132.4	67.1	80.7	120.3	130.2	129.1	87.6	120.8	148.5	136.7	70.6	143.8	432.3	562.3	324.3	311.9	352.5	261.2	419.7	388.8	315.9	617.9	378.0	611.1	396.3	689.5	442.3	337.9	392.5	395.5	1045.2	519.9	519.1	384.3	660.6	437.6	438.6	579.2	261.9	547.7	357.2	333.7	312.4	556.6	514.7	303.3	531.6	425.3	795.2	250.1	375.5	603.5	688.2	372.1	656.4	859.5	702.1	587.3	314.5	771.1	496.9	349.9	434.9	448.1	347.0	635.0	388.7	531.0	560.2	707.3	366.1	249.0	373.0	263.3	717.1	457.5	808.2	975.7	288.1	349.1	408.1	75.1	107.1	49.0	129.0	137.0	171.2	142.1	144.3	138.8	171.7	156.8	177.0	156.7	14.9	145.8	146.8	120.8	164.3	222.3	121.4	125.8	132.2	176.7	125.3	135.5	129.4	126.1	129.5	132.4	130.2	143.8	82.8	54.5	62.5	18.3	104.8	144.9	241.1	247.4	119.5	124.5	133.2	118.5	121.1	98.7	132.3	90.1	106.3	226.7	100.5	71.7	113.5	208.6	111.9	118.4	137.4	122.4	125.3	134.0	29.7	183.2	217.8	113.9	70.8	86.6	73.0	180.1	74.6	88.4	162.6	74.0	34.6	93.8	193.3	83.0	96.5	226.7	83.6	78.1	112.1	22.5	153.6	158.1	105.0	37.2	41.9	199.1	78.8	88.0	95.8	169.0	115.9	212.3	137.6	244.3	118.3	110.3	145.4	410.0	232.4	123.1	159.8	184.6	112.1	347.9	149.8	157.9
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT5	KIAA0098	ENSG00000150753	"Chaperonin containing TCP1 subunit 5"	P48643	5	10249929-10266389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002238, HPA005958, CAB006271"	Enhanced					NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"CAB006271: AB_425898, HPA002238: AB_1078427, HPA005958: AB_1846209"	"unprognostic (7.02e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (6.57e-11)"	"unprognostic (6.40e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-2)"	85.3	79.5	68.6	95.3	70.4	82.0	74.7	73.2	112.4	58.2	79.2	85.7	67.5	66.8	53.3	100.8	77.4	48.1	74.8	72.7	82.4	76.0	74.1	58.7	96.3	71.5	74.7	50.8	58.4	175.6	46.1	85.8	78.7	52.3	97.2	48.9	60.3	52.9	128.2	60.5	62.2	89.5	74.5	62.3	62.6	104.3	76.0	106.6	63.2	90.8	118.4	105.8	63.7	83.8	350.5	489.8	405.1	463.7	250.9	188.5	568.4	454.1	288.6	704.0	492.6	657.8	372.2	537.6	490.4	326.4	615.9	332.8	770.4	492.7	774.2	504.5	527.9	440.2	1063.7	510.7	293.8	667.6	303.7	221.3	300.3	556.8	368.9	191.4	422.7	343.6	597.5	188.2	453.3	494.0	481.4	659.7	432.6	348.3	579.4	437.9	304.4	275.8	447.3	359.1	304.8	335.3	953.5	424.6	335.6	316.9	327.2	490.9	285.2	576.4	517.7	214.1	687.9	192.2	322.7	570.1	323.7	955.4	470.8	125.6	181.5	139.3	117.5	248.8	155.7	151.6	131.3	130.7	188.9	125.6	121.8	123.7	101.4	147.3	286.1	69.5	150.3	255.3	68.6	70.4	73.2	112.4	72.7	82.4	71.5	74.7	78.7	74.5	76.0	83.8	81.7	67.3	41.3	12.1	71.5	88.2	172.1	206.6	60.3	46.7	50.7	54.6	23.6	51.5	116.7	49.7	18.8	214.2	60.7	81.4	49.0	217.4	235.1	127.0	107.5	92.8	70.9	98.2	16.8	162.8	271.8	81.8	62.7	101.1	48.8	100.7	40.0	52.5	175.7	35.3	19.3	89.9	116.0	69.2	64.7	93.1	83.0	84.0	40.9	13.1	92.1	56.6	72.1	19.1	22.9	199.0	81.8	75.6	59.6	128.5	61.0	99.2	131.7	60.8	72.3	81.0	272.5	282.3	184.4	93.1	74.6	155.4	66.5	170.2	126.9	126.1
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051685-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 1612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	58.5	58.8	48.3	66.6	50.5	67.0	59.7	52.6	71.1	43.5	55.9	52.6	53.2	52.0	38.2	68.1	50.9	39.8	56.7	50.2	56.4	72.5	53.3	41.1	69.6	52.5	52.9	42.1	60.8	69.4	39.1	56.4	53.9	44.9	60.1	46.5	45.5	49.4	124.3	58.0	51.8	61.4	53.2	46.1	52.2	49.5	53.5	61.3	49.7	85.5	81.1	72.1	47.6	55.3	1612.6	357.8	211.6	322.5	145.7	181.6	243.2	293.0	165.4	284.4	227.7	407.0	196.7	487.8	222.9	192.1	511.6	333.2	438.2	339.2	390.0	276.8	328.1	306.1	337.0	363.8	157.3	444.1	240.5	157.1	191.1	287.8	284.4	224.8	283.7	221.2	682.0	121.2	325.5	199.2	346.4	392.7	449.3	356.6	466.8	315.1	213.9	284.8	321.6	302.3	280.3	282.0	259.2	440.7	272.6	321.8	324.6	341.6	238.6	194.1	372.4	651.4	617.1	146.7	321.5	596.7	194.4	389.0	658.4	21.0	69.9	34.0	57.8	87.7	77.3	65.9	59.7	63.3	96.5	50.4	59.8	64.8	8.4	77.7	103.0	54.0	68.3	81.2	48.3	50.5	52.6	71.1	50.2	56.4	52.5	52.9	53.9	53.2	53.5	55.3	94.6	89.8	106.4	13.1	83.3	108.8	201.4	175.3	91.6	60.2	77.4	83.2	114.0	65.8	187.7	47.8	27.1	199.6	93.4	56.6	88.0	263.1	22.5	209.6	121.0	129.4	102.1	163.4	19.3	274.2	264.8	97.0	88.2	133.8	131.7	123.4	71.0	66.7	148.2	38.7	23.7	94.2	124.1	83.5	79.2	19.5	70.5	104.0	58.7	19.7	206.9	80.7	80.3	18.1	22.7	245.6	66.7	90.7	106.4	184.8	65.2	146.4	190.3	60.8	59.2	99.1	136.3	115.0	219.8	160.9	109.7	199.9	91.8	189.7	138.6	145.9
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"testis: 126.1"	"Group enriched"	"Detected in many"	27	"Early spermatids: 448.5;Late spermatids: 185.2;Spermatocytes: 490.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	2.9	3.3	1.9	0.8	2.3	3.8	5.5	2.0	2.7	2.2	1.6	1.7	1.4	1.9	5.5	1.8	2.7	0.9	1.7	1.7	2.0	4.0	5.0	1.2	1.4	2.2	2.1	2.4	2.6	2.5	2.7	0.6	2.3	2.7	1.1	2.3	3.3	2.6	5.1	2.7	1.4	1.6	2.3	1.6	2.0	126.1	2.0	1.6	2.9	3.8	1.7	1.9	1.5	2.7	0.7	1.0	2.6	1.1	3.3	2.0	0.9	1.3	5.3	2.2	3.1	0.7	2.1	5.0	0.5	2.4	1.6	1.0	0.1	0.7	0.7	0.5	1.9	0.7	0.3	0.6	4.5	2.4	0.7	2.7	1.3	0.2	2.6	0.4	0.6	0.8	0.5	5.0	2.4	1.9	0.5	5.2	1.4	0.4	0.6	2.4	1.2	12.2	1.4	0.8	3.0	1.5	2.4	0.9	4.1	0.6	1.9	2.4	0.5	1.0	0.1	1.2	0.6	4.4	1.0	4.7	1.1	1.5	1.3	0.0	1.1	0.9	0.6	1.1	0.6	0.9	0.7	0.4	2.6	0.8	1.0	1.0	0.0	1.6	1.1	0.6	0.3	0.6	1.9	2.3	2.0	2.7	1.7	2.0	2.2	2.1	2.3	2.3	2.0	2.7	2.4	0.0	3.1	4.6	2.6	2.4	2.8	3.2	6.2	1.5	8.7	7.0	4.2	4.3	3.9	1.8	0.0	1.8	4.0	0.9	3.9	3.4	448.5	8.8	3.7	2.1	0.0	0.8	3.9	8.0	0.5	3.5	1.5	3.6	2.5	4.6	0.7	3.1	1.5	0.0	3.7	2.3	6.1	2.2	4.0	185.2	10.8	2.9	5.4	4.7	1.6	8.7	4.1	7.1	10.7	2.7	1.6	4.1	3.9	2.1	0.7	6.9	8.8	2.5	0.0	3.7	3.0	490.2	13.5	3.1	2.6	0.8	2.7	6.9	1.8	3.6
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol		NA	NA		1900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	113.3	150.8	104.5	108.6	109.7	93.4	111.4	114.6	110.9	109.6	118.1	113.6	84.8	123.0	117.1	119.7	133.3	69.0	162.9	109.1	114.5	111.9	114.0	83.4	126.5	109.7	109.4	140.4	114.2	134.7	97.0	101.4	114.0	115.2	123.2	83.7	92.1	110.7	252.4	103.9	88.3	147.5	112.7	98.7	106.8	162.9	110.7	153.0	87.4	241.2	158.5	120.0	101.1	120.7	396.3	641.9	361.8	393.0	259.1	211.7	460.7	348.6	311.8	573.6	359.0	1054.5	272.1	760.3	219.0	365.9	529.3	328.2	816.6	533.8	635.9	420.7	722.9	516.2	403.2	755.3	287.5	614.9	367.5	328.9	297.7	565.9	683.3	301.4	521.0	444.7	650.2	265.8	488.7	613.6	686.5	776.1	519.1	540.6	455.8	614.8	927.2	535.0	411.6	374.7	512.4	315.9	302.6	411.0	406.7	333.6	235.2	331.4	339.7	390.9	464.3	245.7	679.7	298.1	341.1	709.2	319.4	686.1	435.6	157.7	131.4	78.1	190.8	178.8	211.3	216.6	193.5	191.4	202.0	208.8	208.9	195.3	39.5	192.1	209.8	203.7	186.0	299.3	104.5	109.7	114.6	110.9	109.1	114.5	109.7	109.4	114.0	112.7	110.7	120.7	77.7	57.7	45.6	12.4	87.5	69.1	149.7	161.5	55.8	81.1	63.8	77.1	99.2	68.6	96.7	58.8	18.8	190.2	74.3	54.8	109.5	148.2	393.0	99.8	96.4	91.6	75.3	77.8	10.8	139.0	213.2	94.8	57.1	58.1	73.6	108.2	61.8	69.3	133.6	82.4	13.3	102.2	118.0	58.8	58.1	246.3	104.7	57.3	74.7	10.3	98.9	125.5	74.2	12.1	15.0	134.1	60.3	107.2	112.3	156.0	67.3	133.2	108.2	88.6	72.3	91.8	126.7	288.9	127.8	71.1	73.6	166.5	77.2	190.6	127.6	112.5
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	32.5	55.8	10.7	12.8	10.9	26.9	30.2	12.2	13.7	28.7	12.9	31.1	13.0	29.7	9.4	40.8	25.2	10.3	31.3	11.4	10.5	27.3	27.3	26.0	15.4	10.7	10.4	23.0	27.3	29.9	24.9	12.2	10.6	24.6	16.0	12.6	32.1	11.9	43.2	30.3	26.9	13.9	10.5	31.5	29.0	22.1	11.0	20.5	25.5	13.0	16.2	31.7	28.9	11.6	52.2	29.8	30.3	27.1	41.8	35.4	15.3	15.6	30.1	23.1	25.0	9.1	27.2	42.8	4.8	40.8	61.9	27.8	16.6	26.7	26.5	16.2	37.3	18.1	30.2	16.8	38.0	13.1	7.1	40.5	42.4	15.6	19.5	42.5	57.2	25.4	52.4	29.7	38.8	26.9	16.8	56.9	39.5	26.4	28.3	36.0	13.8	28.9	21.1	38.3	23.9	31.9	15.3	36.6	13.6	57.9	26.1	21.0	27.7	28.8	57.4	18.7	25.7	13.6	24.6	58.0	9.6	30.8	41.6	3.1	1.9	2.7	1.8	2.3	1.4	1.3	2.2	2.2	1.8	1.3	1.5	1.6	3.4	3.0	2.4	1.8	4.6	0.7	10.7	10.9	12.2	13.7	11.4	10.5	10.7	10.4	10.6	10.5	11.0	11.6	30.7	3.2	23.5	15.7	26.3	45.2	30.6	21.2	9.6	59.2	29.5	20.2	11.0	24.3	24.0	31.3	62.6	45.0	47.2	38.0	31.3	61.0	6.5	18.7	18.1	35.0	29.9	26.7	20.2	71.4	35.9	26.7	11.2	21.3	15.8	21.1	76.4	17.6	35.7	23.5	20.5	30.8	50.8	39.0	61.6	4.9	37.9	27.5	46.2	8.4	80.8	41.5	72.1	15.6	28.7	74.0	30.1	36.1	14.3	26.2	40.2	21.9	32.9	69.2	78.9	19.4	32.0	40.6	34.5	11.0	54.1	34.9	32.8	38.2	34.4	33.7
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.6;intestine: 6.1;lung: 6.5"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.7;Macrophages: 9.0;monocytes: 6.0;Oligodendrocyte precursor cells: 4.5;Sertoli cells: 6.6;Skeletal myocytes: 4.8;T-cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 92.7"	"Group enriched"	"Detected in many"	18	"dendritic cells: 32.6;granulocytes: 92.7;monocytes: 51.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		NA	NA		630000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria		"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.4	0.7	0.2	3.2	0.2	4.6	0.6	0.0	0.3	0.4	0.1	1.8	3.4	0.6	0.4	0.9	0.5	1.1	0.4	0.2	0.0	0.2	0.6	6.5	1.9	0.2	0.1	0.3	0.9	0.0	0.1	0.2	0.1	0.6	2.3	0.1	1.4	0.4	0.1	0.9	6.1	1.3	0.2	3.0	1.4	0.4	0.1	1.2	0.3	0.0	1.4	1.2	0.6	0.2	0.5	0.0	0.9	3.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	1.4	2.1	0.1	0.0	0.0	1.2	0.1	1.0	0.0	0.0	0.2	27.3	0.3	1.4	0.0	0.1	0.2	0.2	0.5	0.1	0.7	0.1	1.8	0.0	3.3	0.9	0.0	0.0	0.0	0.5	0.0	0.7	0.7	0.4	0.7	0.5	0.6	0.3	0.6	1.0	0.7	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.8	2.1	1.7	0.1	20.3	92.7	0.3	26.3	1.8	0.3	0.6	3.2	32.6	0.0	0.9	3.0	0.8	0.0	51.5	0.1	3.0	7.4	0.2	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.0	1.1	2.0	0.6	1.3	0.2	0.1	0.6	0.0	1.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.3	2.1	0.1	0.3	0.1	1.8	0.0	1.8	0.6	0.0	0.7	1.1	0.9	1.3	0.8	0.0	0.5	0.6	0.0	1.1	0.0	2.0	6.7	3.9	2.4	0.3	9.0	0.0	1.0	6.0	0.0	0.0	4.5	0.3	0.2	0.1	1.2	0.5	0.3	0.1	0.0	0.8	0.0	6.6	4.8	0.5	0.0	0.1	0.4	1.6	0.0	5.1	1.1	0.2	0.1
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832887-839831	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	332.4	159.5	54.0	79.7	53.5	25.0	277.8	52.5	67.6	181.6	66.1	219.7	140.6	264.6	103.0	97.5	184.3	132.4	345.8	54.2	65.3	194.3	145.3	240.1	35.4	64.5	57.4	116.2	278.3	85.9	81.1	110.1	60.5	182.9	99.8	9.6	243.5	194.2	113.1	107.0	149.4	255.2	58.3	94.8	187.3	44.8	58.6	15.0	133.5	77.0	30.6	203.1	151.3	58.0	380.0	475.3	71.8	256.3	1088.7	422.8	110.4	587.1	400.4	285.0	241.2	252.6	677.2	0.2	224.0	943.5	388.4	358.4	71.1	498.4	96.1	135.0	236.6	112.8	139.1	193.4	366.7	90.2	157.4	388.6	328.2	164.5	367.8	1089.2	348.8	16.4	135.1	56.3	485.9	196.1	1.9	99.5	48.0	232.9	569.4	20.0	173.7	106.4	642.8	102.1	99.5	111.8	578.9	371.5	121.5	81.6	145.8	102.4	600.0	462.6	209.3	147.5	352.9	62.0	66.5	4.5	437.5	89.7	265.8	24.6	19.1	15.2	5.7	19.3	6.8	3.0	4.7	5.0	11.9	2.0	1.9	3.0	7.3	8.2	24.1	1.8	2.9	10.8	54.0	53.5	52.5	67.6	54.2	65.3	64.5	57.4	60.5	58.3	58.6	58.0	294.4	208.3	79.1	13.1	12.8	70.6	143.2	328.2	60.9	16.6	180.9	203.7	180.0	133.0	159.8	248.3	4.2	222.6	15.6	542.3	19.6	716.2	2.6	60.8	114.6	214.8	127.6	28.6	10.0	636.7	423.8	173.8	236.5	143.7	81.3	103.7	265.2	54.0	130.0	37.0	5.5	388.5	138.4	59.3	70.4	11.3	123.6	81.8	128.1	15.9	75.6	94.8	23.7	3.5	0.7	736.6	477.9	283.2	26.6	307.1	440.6	124.6	52.2	17.0	210.4	96.6	310.3	5.6	13.6	73.4	54.4	185.7	29.7	61.1	289.8	199.6
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 240.5"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	171.8	85.6	6.1	152.5	7.0	17.6	50.8	5.2	18.4	25.6	21.5	48.7	12.4	27.3	3.6	16.4	68.1	43.5	52.7	4.9	7.9	27.3	89.7	131.7	54.4	15.8	10.9	23.1	21.4	8.8	11.4	109.4	18.0	15.5	21.6	4.3	25.9	7.2	11.4	15.3	52.9	130.4	7.2	240.5	35.6	9.7	55.9	18.7	17.2	17.6	7.2	68.5	16.3	10.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	6.1	7.0	5.2	18.4	4.9	7.9	15.8	10.9	18.0	7.2	55.9	10.3	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.9;lymphoid tissue: 31.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 27.5;Breast myoepithelial cells: 20.3;Excitatory neurons: 18.9;Inhibitory neurons: 16.6;Melanocytes: 14.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.8;HDLM-2: 10.1;HUVEC TERT2: 10.6;TIME: 10.1;U-87 MG: 22.7"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		660000		"Cluster 14: B-cells - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	7.5	2.0	0.6	6.4	0.7	0.1	3.7	0.4	1.4	2.0	1.3	14.6	8.6	0.9	0.6	3.0	0.7	4.2	1.3	0.6	0.5	0.7	2.6	2.7	8.0	1.7	1.3	0.3	0.4	0.3	0.5	10.6	1.8	0.5	21.9	1.8	0.8	1.2	0.4	0.6	18.5	3.2	1.2	31.8	4.5	4.1	3.6	4.6	0.7	0.9	6.3	6.1	0.3	1.0	0.2	0.5	0.3	0.0	1.1	0.4	0.0	1.0	2.1	0.2	0.9	0.0	1.7	0.0	0.4	1.0	10.8	0.0	0.0	1.4	1.6	10.1	0.0	0.0	0.6	1.6	0.0	0.7	0.1	0.3	0.0	0.3	3.9	0.7	10.6	0.0	0.2	5.6	6.3	0.0	0.0	8.1	0.2	0.0	0.0	1.9	1.8	2.2	0.0	0.0	1.4	6.5	5.1	8.0	0.0	0.4	0.0	6.6	10.1	3.5	3.2	0.3	0.0	0.1	0.1	0.0	22.7	0.5	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	1.4	0.6	0.5	1.7	1.3	1.8	1.2	3.6	1.0	4.1	0.0	0.0	2.6	0.3	1.3	0.0	1.1	0.0	2.5	27.5	20.3	0.7	0.0	2.1	0.0	4.2	0.1	0.5	0.4	0.0	0.0	3.1	0.0	0.1	2.5	0.0	0.0	18.9	1.4	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.4	9.1	0.0	16.6	0.1	4.1	4.1	5.2	1.5	0.0	6.4	14.2	7.5	0.2	1.1	0.0	4.5	2.4	3.3	2.6	0.0	1.2	0.0	0.0	0.1	1.2	2.1	19.7	2.1	10.5	3.4	0.8	0.1	1.3	0.3	0.3	0.0	0.1	0.1
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	260.9	123.6	43.6	119.1	53.6	213.9	211.2	57.4	69.5	151.0	68.9	264.8	252.0	117.0	161.9	95.0	124.8	159.3	91.8	40.6	57.7	298.1	256.8	121.9	137.8	65.3	56.1	126.4	124.1	219.2	89.5	190.1	64.1	146.1	270.5	36.4	303.8	112.7	96.0	89.2	277.6	116.1	52.3	121.0	272.8	113.6	50.7	132.0	360.4	91.7	122.9	154.2	76.0	70.7	130.0	73.0	34.6	242.9	503.0	496.6	235.7	230.8	304.0	213.7	308.0	148.1	194.9	105.7	218.0	261.5	198.0	125.4	136.9	152.7	315.4	220.1	144.5	177.8	72.0	173.9	294.9	209.5	399.0	384.6	279.7	211.3	186.5	270.3	196.9	86.9	178.9	279.9	287.8	141.1	191.5	251.2	52.9	273.1	119.6	126.3	109.0	135.1	292.2	180.5	40.2	80.9	144.6	184.0	348.6	168.0	167.7	265.0	205.6	138.8	99.1	199.5	188.6	96.3	147.4	121.2	244.0	242.8	147.2	349.0	192.3	167.0	166.8	198.6	175.0	126.2	135.2	155.1	189.7	111.0	138.0	150.1	128.5	255.2	197.5	214.1	192.9	413.8	43.6	53.6	57.4	69.5	40.6	57.7	65.3	56.1	64.1	52.3	50.7	70.7	76.5	163.5	78.9	22.5	168.1	200.1	180.2	149.6	128.7	33.8	251.1	123.3	70.9	174.5	153.5	281.4	25.0	244.9	372.7	600.0	93.9	178.8	103.8	111.9	109.2	89.2	166.5	92.8	22.1	136.8	407.2	176.3	175.8	151.2	128.6	76.7	98.2	177.4	311.9	33.7	16.4	427.3	215.7	360.4	223.9	97.3	158.8	237.3	247.3	38.4	147.1	113.3	266.8	15.6	83.1	177.6	430.0	182.1	173.6	230.3	425.5	348.0	351.2	44.4	124.9	110.0	138.1	160.5	184.4	143.0	231.0	674.5	165.9	87.7	285.0	334.7
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383333	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.9;fallopian tube: 30.0;salivary gland: 13.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.3	0.0	0.3	0.0	2.5	0.2	0.4	4.9	1.0	0.2	0.0	0.3	0.5	19.9	30.0	0.1	0.0	0.4	0.3	0.9	0.2	5.1	0.0	2.0	1.5	0.0	0.8	0.8	3.4	0.0	0.6	4.1	0.2	0.0	13.5	0.3	0.0	11.1	0.1	0.0	0.8	0.0	0.7	0.5	0.2	0.9	0.4	0.0	1.8	0.0	9.3	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.4	0.3	2.0	1.5	0.6	0.8	0.2	0.4	0.2	0.0	3.7	0.0	0.2	2.9	9.6	12.9	28.5	0.0	5.7	14.4	0.9	0.0	10.1	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.2	53.6	0.5	1.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.5	12.2	0.0	0.4	1.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.2	3.4	0.0	0.1	146.1	0.0	0.0	0.1	2.8	0.1	1.0	9.3	2.8	0.0	0.4	0.0	0.5	4.4
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353686-43363172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 285.9;intestine: 164.6"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 632.4;Paneth cells: 314.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 3.6;cerebral cortex: 7.7;pons: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 8.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.7"	"Cell line enriched"	"Detected in some"	26	"RPMI-8226: 98.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041820, HPA046601, HPA077640"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: "	"unprognostic (4.32e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	4.8	0.4	0.1	7.2	0.3	285.9	1.3	3.6	7.7	6.0	3.7	155.2	0.3	0.4	0.2	2.2	2.3	0.2	2.2	0.3	0.1	1.9	2.6	20.6	0.2	0.3	1.0	0.3	1.1	0.0	2.9	1.6	2.3	64.8	164.6	0.1	1.8	0.2	0.7	0.4	0.7	3.0	0.3	64.4	1.4	0.2	0.4	1.4	0.7	0.8	10.4	2.1	5.4	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.3	0.6	0.6	0.0	0.0	0.1	2.4	0.6	1.7	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.2	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.4	1.2	0.0	0.2	0.0	0.0	98.0	1.4	0.3	0.7	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.3	2.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	1.2	0.0	0.7	0.0	0.1	0.3	3.6	7.7	0.3	0.1	0.3	1.0	2.3	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.1	0.0	0.0	0.0	0.0	632.4	0.0	0.5	0.4	0.2	0.1	0.0	8.4	3.6	0.0	0.2	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	87.2	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	314.8	0.0	0.1	29.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	28.0	0.2
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 33.0;lymphoid tissue: 75.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 135.3;Early spermatids: 38.2;Plasma cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	80	"memory B-cell: 138.2;naive B-cell: 172.1"	"Lineage enriched"	"Detected in many"	89	"B-cells: 172.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 143.3;REH: 77.1;U-698: 33.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"	0.6	0.1	0.0	28.5	0.1	6.2	0.1	0.9	0.4	0.1	0.0	2.0	0.9	0.2	0.1	0.9	0.2	0.9	0.1	0.0	0.0	0.7	0.3	0.5	72.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	1.6	0.1	1.2	0.1	0.0	0.0	33.0	0.2	0.0	72.7	3.9	3.8	0.2	5.7	1.2	0.0	75.3	2.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	77.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	33.0	0.0	0.1	0.0	1.9	0.2	0.2	0.0	0.3	0.0	138.2	0.1	0.0	0.3	172.1	0.4	0.1	1.3	0.3	0.4	0.2	0.0	7.2	0.0	0.1	0.9	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.6	0.0	135.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.0	0.0	38.2	1.5	0.0	1.0	0.0	0.8	0.0	0.0	0.8	0.8	0.5	0.1	0.0	0.4	1.4	0.3	1.7	0.0	0.0	0.1	0.0	0.8	0.6	7.9	0.3	1.1	3.6	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.7	30.5	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	7.4	4.2	0.0	0.0	0.7	2.4	0.6	0.5	0.1
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254424-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 318.0"	"Cell type enriched"	"Detected in some"	20	"Langerhans cells: 151.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"classical monocyte: 6.4;intermediate monocyte: 4.2;memory B-cell: 10.1;myeloid DC: 11.4;naive B-cell: 5.3"	"Group enriched"	"Detected in many"	37	"B-cells: 10.1;dendritic cells: 11.4;monocytes: 6.4"	"Group enriched"	"Detected in some"	81	"JURKAT: 41.4;MOLT-4: 66.4"					"Not detected"	"Not detected"			"CAB000009, HPA010734"	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.3	0.2	0.0	0.0	10.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.1	27.1	0.2	0.0	0.0	1.3	0.8	0.1	0.0	318.0	0.2	0.0	3.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	66.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.2	0.2	10.1	0.0	0.0	11.4	5.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	151.7	0.0	0.0	4.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.0	0.0	0.2	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	157	"lymphoid tissue: 528.9"	"Cell type enriched"	"Detected in some"	21	"Langerhans cells: 153.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"myeloid DC: 19.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 19.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 587.9"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.1	0.2	1.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	3.3	0.2	0.1	0.0	1.0	0.7	0.0	0.0	528.9	0.3	0.1	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	587.9	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.9	153.1	0.2	0.0	7.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158178030-158186427	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 18.2;liver: 15.3;lymphoid tissue: 23.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 22.2;Kupffer cells: 54.6;Macrophages: 40.8;monocytes: 45.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 139.0;intermediate monocyte: 63.8;myeloid DC: 139.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 139.3;monocytes: 139.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 10.2;JURKAT: 49.4;MOLT-4: 13.6;THP-1: 8.8"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		880000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	2.7	2.0	0.1	7.5	0.2	3.1	2.0	0.1	0.4	1.5	0.7	4.4	7.4	2.2	0.5	0.8	2.1	1.8	3.3	0.1	0.2	2.2	15.3	3.4	4.7	0.3	0.2	0.6	1.9	0.3	1.0	0.4	0.3	2.2	2.9	0.3	1.1	0.7	1.1	0.3	18.2	2.3	0.1	23.9	2.3	2.5	0.2	9.4	2.7	0.6	3.0	1.8	1.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	3.5	0.0	6.0	0.0	0.0	0.1	0.2	0.0	0.0	10.2	0.1	0.0	3.9	0.6	0.0	0.7	0.0	0.0	49.4	0.0	0.0	0.0	0.0	13.6	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	8.8	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.3	0.0	3.7	0.4	0.2	139.0	0.4	0.2	63.8	0.5	17.6	0.1	0.1	139.3	13.4	0.1	0.0	7.2	0.3	11.0	1.4	0.2	80.7	0.1	0.2	0.1	0.4	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.4	9.4	0.0	3.6	0.0	22.2	0.3	0.5	0.8	0.6	0.7	0.1	0.9	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	5.6	0.4	2.0	2.4	2.4	1.7	0.0	0.0	0.2	0.5	0.0	0.3	1.3	0.1	3.3	6.3	11.3	1.7	0.2	2.0	0.0	54.6	0.8	2.1	0.0	40.8	0.0	0.0	45.4	0.6	1.0	0.0	0.0	0.0	6.4	0.0	3.7	0.1	7.3	0.1	0.0	0.3	0.0	1.2	0.4	1.0	2.1	0.0	0.1	0.1	0.6	0.1	4.5	0.1
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 962.6"	"Cell type enriched"	"Detected in some"	13	"Langerhans cells: 549.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.5"	"Cell line enriched"	"Detected in some"	43	"MOLT-4: 1276.2"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	0.7	0.5	0.0	4.4	0.0	0.0	1.8	0.0	0.0	2.1	0.0	2.1	2.2	1.1	0.4	7.9	0.9	4.8	1.0	0.0	0.0	0.8	1.5	3.1	6.4	0.0	0.0	0.6	0.3	0.5	0.1	0.0	0.0	1.1	5.6	0.0	1.5	0.6	0.4	13.9	2.8	0.9	0.0	5.1	4.7	0.5	0.0	962.6	0.8	0.2	9.9	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.0	0.5	1276.2	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	0.8	8.4	0.0	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	549.5	0.0	0.0	41.7	8.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	7.1	0.1	0.7	0.0	0.0	0.0
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD200	"MOX1, MOX2, MRC, OX-2"	ENSG00000091972	"CD200 molecule"	P41217	3	112332347-112362812	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 97.4;Excitatory neurons: 54.5;Inhibitory neurons: 55.7;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 30.7;naive B-cell: 83.6"	"Lineage enriched"	"Detected in many"	23	"B-cells: 83.6"	"Cell line enhanced"	"Detected in some"		"AF22: 75.9;HHSteC: 27.2;NTERA-2: 47.7;REH: 42.4;SK-MEL-30: 29.8;WM-115: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031149	Approved					NA	NA		26000	"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA031149: AB_10600694"	"unprognostic (1.84e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-3)"	"unprognostic (4.97e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.22e-2)"	25.3	12.1	27.7	15.6	27.3	2.4	11.6	13.2	34.0	20.1	2.9	6.7	3.3	28.4	7.1	8.9	26.7	13.1	9.3	27.9	41.3	8.5	1.0	9.6	26.1	11.9	16.3	11.6	4.9	10.5	26.8	28.2	18.8	12.1	8.2	15.1	9.0	16.5	1.8	4.4	6.9	18.3	15.1	6.2	5.2	2.9	30.4	23.6	18.9	3.6	24.9	27.5	5.9	18.3	0.0	0.0	75.9	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.1	0.0	0.9	0.1	8.2	0.4	0.2	0.2	0.5	0.0	0.3	0.4	27.2	0.0	0.1	0.5	0.2	1.6	0.2	0.2	10.8	0.0	0.1	0.7	0.2	0.0	1.2	0.0	47.7	0.0	0.0	42.4	0.1	0.5	0.6	0.1	19.9	23.0	0.0	0.4	29.8	14.0	0.0	0.3	0.1	0.3	2.6	0.0	0.2	0.1	0.1	0.0	0.6	0.2	83.7	3.6	0.4	0.3	0.3	0.1	3.5	30.7	2.0	0.6	1.3	83.6	2.1	1.3	1.7	1.6	0.3	2.8	1.0	3.4	27.7	27.3	13.2	34.0	27.9	41.3	11.9	16.3	18.8	15.1	30.4	18.3	15.2	3.2	9.1	10.7	27.8	4.2	12.6	0.3	0.0	26.8	0.7	13.0	0.8	1.5	1.3	1.8	0.0	3.0	1.6	0.8	0.0	0.3	25.1	20.6	4.2	97.4	38.4	0.8	54.5	0.0	12.1	13.0	3.1	41.0	2.5	0.7	1.4	0.0	1.0	3.3	55.7	8.1	0.0	0.3	6.1	30.3	0.3	1.1	8.8	6.5	14.0	7.1	0.0	29.7	38.5	0.2	10.7	0.0	1.9	15.4	0.9	0.3	2.7	2.5	0.0	13.1	2.6	0.6	0.4	0.7	3.3	75.9	2.9	9.3	7.1	21.6
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830211-70835816	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 87.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Langerhans cells: 9.7;Macrophages: 7.6;Melanocytes: 5.4;Suprabasal keratinocytes: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002222, HPA011216"	Enhanced		Uncertain	Cytosol		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.4	0.1	0.0	0.3	0.0	0.0	3.2	0.0	0.0	1.6	0.1	1.2	3.7	0.8	0.4	17.8	0.9	2.0	0.2	0.0	0.0	0.1	0.7	1.6	0.9	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	2.4	2.7	5.5	1.1	0.8	0.8	87.7	4.9	0.7	0.0	3.7	1.4	0.5	0.0	3.4	0.1	0.3	4.8	1.4	1.7	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	4.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.2	0.0	7.6	5.4	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.2;placenta: 22.8"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;monocytes: 1.4"	"Cell line enriched"	"Detected in single"	14	"THP-1: 3.3"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	34.2	3.9	0.3	8.6	0.6	0.4	4.4	1.3	3.0	4.0	5.7	10.5	14.3	1.4	1.0	4.8	2.5	8.6	4.5	0.3	0.7	2.1	3.3	4.9	18.1	1.0	0.6	1.0	1.0	0.8	0.7	22.8	0.8	0.8	13.9	0.1	2.1	1.9	0.9	1.4	19.3	10.6	0.9	2.4	4.1	2.1	0.6	5.4	1.4	1.5	2.3	20.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.3	0.6	1.3	3.0	0.3	0.7	1.0	0.6	0.8	0.9	0.6	0.8	0.3	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	15.6	14.7	0.3	0.0	12.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.1
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 141.3;lymphoid tissue: 230.2;ovary: 132.8"	"Group enriched"	"Detected in many"	7	"B-cells: 143.6;granulocytes: 95.8;Granulosa cells: 51.3;Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.6;naive B-cell: 120.3"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 280.6;REH: 83.8;U-698: 219.9;WM-115: 50.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002418, HPA024353, HPA066523"	Enhanced					NA	NA		13000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.7	5.5	39.2	75.3	66.8	13.6	1.7	42.8	58.4	2.7	17.8	4.9	2.3	3.7	2.5	2.2	30.9	4.1	1.3	42.7	53.2	2.1	1.5	7.4	219.2	63.3	53.8	132.8	0.6	0.7	2.1	1.8	60.3	2.9	6.4	0.0	3.5	1.1	0.2	0.3	53.4	2.1	37.8	161.6	7.0	3.8	55.8	11.4	6.3	0.4	230.2	5.7	1.6	141.3	0.9	1.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.4	0.0	5.1	280.6	5.6	0.3	15.0	0.5	0.0	0.0	0.1	1.5	0.0	0.0	0.2	2.2	0.1	0.3	12.4	0.0	0.0	0.2	4.1	0.1	0.0	0.0	1.5	0.1	2.6	0.5	0.1	0.0	0.1	0.4	0.4	83.8	0.3	0.2	0.0	0.0	0.0	0.0	0.3	1.4	6.6	0.2	0.5	0.1	0.3	2.6	1.5	0.0	0.0	0.0	0.1	219.9	2.2	0.9	50.1	0.1	0.1	0.1	0.0	1.1	0.0	97.6	0.0	0.0	4.6	120.3	0.0	0.0	1.0	0.2	0.7	3.8	0.0	4.9	39.2	66.8	42.8	58.4	42.7	53.2	63.3	53.8	60.3	37.8	55.8	141.3	1.7	3.2	3.0	0.0	143.6	0.3	0.4	0.0	0.0	0.0	1.0	3.3	0.7	0.0	0.6	0.0	0.0	0.2	4.1	0.1	0.0	0.0	0.6	0.2	0.4	2.1	0.0	2.7	0.3	0.2	1.3	2.8	0.5	0.5	95.8	51.3	3.3	0.2	6.8	0.0	0.3	0.0	0.0	5.6	2.0	0.2	3.7	6.9	1.8	0.0	0.9	0.0	1.0	0.0	91.5	0.2	0.1	0.7	2.3	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.4	1.1	0.0	0.4	0.1	4.1	12.2	0.0	0.1
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	3.2	1.7	2.3	25.3	2.3	49.0	1.9	2.2	2.5	1.9	1.9	4.3	7.1	2.3	3.1	2.1	1.8	5.5	1.3	2.3	2.3	2.0	5.4	10.9	57.7	2.3	2.2	0.8	0.8	0.5	0.8	1.4	2.2	1.8	4.6	0.2	2.4	1.6	1.4	1.1	14.3	1.5	2.1	40.2	7.0	0.4	2.9	179.4	2.5	0.9	36.4	7.3	1.9	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	155.9	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.1	0.0	0.0	167.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	8.3	1.0	0.4	376.4	1.4	208.9	9.3	190.0	219.7	1.5	4.9	237.8	195.1	8.7	225.3	1.2	2.8	254.5	231.2	2.3	2.3	2.2	2.5	2.3	2.3	2.3	2.2	2.2	2.1	2.9	2.5	3.4	3.2	16.0	3.3	8.2	1.5	0.1	0.0	0.6	0.4	3.5	3.2	0.6	1.5	1.3	0.0	0.0	0.1	492.1	0.4	0.0	0.5	0.2	0.7	0.8	1.8	0.0	14.7	8.8	0.0	0.1	2.2	6.1	1.1	6.3	0.4	7.1	1.4	0.3	3.3	9.4	0.5	0.0	7.8	1.4	0.2	0.0	5.9	3.6	14.0	7.6	0.1	727.1	0.5	3.7	0.0	1.2	0.0	51.9	0.1	0.2	1.3	2.2	0.2	0.0	0.9	1.2	0.1	2.5	1.4	0.6	0.1	247.2	0.0	0.1	0.1
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444955-6451718	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 147.8"	"Group enriched"	"Detected in many"	11	"B-cells: 119.4;Melanocytes: 97.8;Plasma cells: 352.1;T-cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in all"		"T-reg: 640.4"	"Group enriched"	"Detected in all"	7	"B-cells: 293.4;T-cells: 640.4"	"Group enriched"	"Detected in some"	107	"Daudi: 238.2;U-698: 141.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002420, HPA038936"	Enhanced					NA	NA		100000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB002420: AB_563539, HPA038936: AB_2676278"	"unprognostic (2.75e-3)"	"prognostic favorable (3.77e-5)"	"unprognostic (8.87e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.65e-7)"	"unprognostic (3.56e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.31e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.35e-2)"	2.1	2.6	0.3	59.0	0.5	10.6	4.3	0.0	0.5	2.4	0.1	18.0	22.5	1.7	1.0	10.2	1.9	11.0	3.9	0.1	0.1	1.3	2.0	8.2	147.8	0.5	0.2	3.0	1.4	0.0	0.3	0.4	0.8	2.5	11.6	0.4	12.3	1.4	0.6	1.9	34.5	1.6	0.2	73.8	16.6	0.9	0.4	44.7	6.5	0.7	106.3	19.0	1.4	1.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	238.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.8	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.5	0.1	0.0	0.0	0.0	141.7	0.3	0.1	0.0	6.2	1.6	1.4	117.2	1.3	201.2	293.4	283.5	262.6	1.0	114.8	382.8	281.1	6.2	65.0	1.6	2.4	640.4	182.4	0.3	0.5	0.0	0.5	0.1	0.1	0.5	0.2	0.8	0.2	0.4	1.0	1.1	0.0	4.9	0.3	119.4	2.3	0.1	0.0	0.6	1.1	1.1	1.3	0.1	0.0	0.6	0.0	0.0	0.1	7.0	0.3	0.0	0.2	0.0	0.2	0.3	0.9	1.2	8.4	0.2	0.0	0.0	1.5	3.1	0.3	1.3	0.0	2.5	1.5	0.3	0.0	0.3	0.1	0.0	3.2	4.4	0.3	0.3	3.0	97.8	0.0	5.7	0.4	14.4	1.0	1.0	0.0	0.1	0.4	352.1	0.2	0.0	0.9	0.8	1.4	0.0	0.7	1.3	0.1	0.1	0.6	3.1	0.3	109.5	0.0	2.4	0.0
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.7;granulocytes: 28.4;Langerhans cells: 50.9;monocytes: 42.4;Syncytiotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 89.6;HHSteC: 55.5;U-251 MG: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	2.6	2.0	1.0	10.3	0.9	1.9	1.5	0.9	1.2	1.8	0.6	1.4	2.7	1.5	1.8	2.5	1.8	4.0	8.9	0.8	1.9	2.6	3.4	16.8	6.6	1.8	1.6	1.5	1.9	5.0	2.6	6.8	2.0	2.0	2.1	1.2	1.5	1.5	4.5	0.7	1.9	2.2	1.7	10.2	1.9	0.9	1.6	13.0	3.5	4.3	5.3	7.2	1.3	1.1	15.6	0.2	0.0	0.5	0.1	0.1	0.0	30.5	25.7	7.7	10.4	0.0	5.0	0.2	0.6	0.8	3.8	0.6	0.0	13.2	24.6	89.6	0.0	9.0	0.3	0.0	55.5	0.0	0.0	0.5	0.1	15.7	22.9	7.7	15.0	0.9	0.0	2.9	23.4	0.0	0.4	0.1	0.0	0.0	0.3	0.1	4.2	0.8	1.6	0.3	0.0	0.3	0.4	2.4	1.9	2.2	0.1	0.3	28.1	16.1	5.1	0.5	98.1	0.5	0.2	0.3	5.4	0.3	0.2	6.6	0.0	0.2	0.7	0.1	1.2	0.5	1.4	1.1	0.0	0.1	0.7	0.4	3.6	0.3	0.0	0.0	0.7	0.4	1.0	0.9	0.9	1.2	0.8	1.9	1.8	1.6	2.0	1.7	1.6	1.1	3.0	12.8	11.4	0.7	1.9	4.6	1.5	4.4	1.8	1.4	1.4	1.3	7.8	0.0	2.9	0.0	0.0	6.1	2.4	2.6	0.0	5.9	1.0	1.4	0.3	5.5	0.0	3.2	1.9	4.4	27.7	1.9	0.5	0.9	28.4	0.2	7.1	0.8	5.7	0.0	3.3	0.5	4.1	2.9	50.9	0.2	0.3	4.2	3.6	8.4	42.4	0.5	1.0	1.0	0.9	19.0	0.1	0.4	2.2	2.1	1.9	0.4	4.0	0.2	0.0	2.3	0.9	1.0	0.8	1.2	2.6	44.5	3.1	0.1	0.4	2.0
CD276	"B7-H3, B7H3, B7RP-2"	ENSG00000103855	"CD276 molecule"	Q5ZPR3	15	73683966-73714514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 215.6;Hofbauer cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 175.0;U-2197: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009285, HPA017139, CAB017826"	Enhanced		Approved	Vesicles		NA	NA		16000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246"	"unprognostic (1.05e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.57e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (9.81e-4)"	"unprognostic (2.57e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (1.17e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-3)"	24.1	19.1	6.6	12.9	4.3	0.7	15.3	0.4	6.5	22.2	15.6	11.4	11.0	20.2	4.3	5.8	10.0	18.2	14.8	4.2	5.7	5.4	11.8	11.6	3.6	5.9	6.7	13.4	15.3	4.3	6.1	26.2	4.1	16.7	4.2	4.6	15.0	9.6	5.0	16.2	8.4	10.8	2.4	9.0	10.9	6.0	7.5	1.6	8.5	2.2	1.6	14.6	13.0	6.7	43.7	44.6	32.5	82.8	57.7	35.0	102.8	47.5	42.0	33.4	30.4	85.3	90.1	0.6	77.7	39.5	64.1	175.0	31.7	39.9	4.4	30.6	76.3	2.8	47.6	47.1	20.9	0.7	51.8	32.7	17.9	28.3	15.4	19.7	38.7	0.0	15.0	0.8	6.2	66.0	0.3	2.3	84.9	8.6	35.9	0.5	47.9	7.0	27.9	53.8	24.9	59.5	40.1	21.2	88.0	23.0	38.1	26.4	49.8	68.6	60.0	231.6	52.5	0.9	0.8	0.8	114.8	3.4	49.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	6.6	4.3	0.4	6.5	4.2	5.7	5.9	6.7	4.1	2.4	7.5	6.7	4.4	19.2	8.1	6.5	1.2	15.0	11.5	12.5	8.0	20.2	14.1	11.8	9.1	2.8	17.0	11.0	31.3	11.6	0.2	6.7	1.9	48.6	0.9	14.4	26.7	22.0	9.0	0.0	18.4	19.0	215.6	43.7	14.3	31.6	14.7	41.4	4.6	14.6	82.5	10.1	12.9	13.1	4.1	8.8	30.8	2.2	9.9	14.7	24.9	7.5	4.2	8.4	0.0	5.5	1.7	24.7	15.1	17.3	1.7	12.1	3.1	2.7	5.8	27.5	13.1	7.0	32.1	1.8	4.9	3.4	10.2	12.3	1.4	8.4	10.6	8.4
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 34.1;T-cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	4.0	0.3	0.0	14.9	0.1	3.3	0.8	0.1	0.1	1.1	0.9	1.7	1.1	0.7	0.3	0.9	0.5	4.1	0.6	0.1	0.1	0.5	1.3	1.9	28.0	0.1	0.0	0.3	0.5	0.2	0.1	14.8	0.1	1.0	1.9	0.1	0.6	0.8	0.3	0.3	3.0	1.4	0.1	7.2	2.5	0.7	0.2	30.8	0.5	0.1	18.6	4.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.7	2.0	0.0	360.6	0.2	0.0	19.9	0.0	0.1	0.0	0.0	0.1	0.3	173.2	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	294.1	283.7	2.9	0.3	0.1	0.0	1.7	0.6	1.0	8.3	0.5	50.6	0.3	54.5	26.1	0.1	0.3	48.1	18.6	13.8	0.2	0.5	0.2	101.9	14.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.5	0.0	1.3	0.0	2.4	2.9	0.1	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	1.0	2.0	0.1	1.3	0.0	0.0	0.1	34.1	0.0	0.0	0.0	0.0	0.8	5.3	0.2	0.0	4.4	0.0	1.0	1.5	0.0	2.1	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.2	1.6	0.1	52.6	0.0	0.0	0.0
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350773-30355308	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	31.1	49.3	38.9	34.0	39.7	23.9	32.9	38.0	41.5	39.6	34.0	39.3	29.9	45.0	24.9	35.3	41.0	22.0	35.2	39.9	41.2	42.8	27.3	32.8	38.8	41.4	39.8	36.9	40.7	42.5	42.7	24.4	39.1	38.3	23.7	16.2	30.0	35.5	46.9	33.6	35.2	31.6	39.0	46.4	36.9	24.0	41.6	35.7	42.5	26.6	43.7	37.0	30.1	42.0	55.4	65.7	54.4	49.4	44.3	41.9	46.0	60.0	71.5	66.8	71.3	50.6	64.9	84.6	72.3	65.5	61.4	59.4	57.0	70.3	53.6	50.6	66.6	35.9	67.7	60.3	63.6	51.3	63.4	45.2	58.7	74.2	47.3	45.6	70.3	62.1	41.4	63.2	67.7	132.1	71.6	43.6	73.8	42.9	38.5	104.2	45.3	64.3	54.2	54.7	44.7	85.1	40.2	69.9	42.0	44.7	66.4	41.1	50.6	76.3	53.3	38.9	53.1	105.0	82.3	78.5	52.5	47.2	64.0	107.4	61.7	116.6	71.3	76.3	56.8	87.5	57.3	66.7	55.8	97.3	47.6	58.9	121.9	74.5	102.7	67.1	94.4	79.6	38.9	39.7	38.0	41.5	39.9	41.2	41.4	39.8	39.1	39.0	41.6	42.0	38.1	32.1	29.0	7.2	39.5	28.8	49.6	58.4	31.9	29.8	33.2	29.6	26.5	45.8	41.2	36.8	20.9	61.0	57.0	50.5	60.7	83.6	19.9	41.7	30.7	42.8	33.0	22.3	6.7	97.5	58.1	36.4	28.1	45.2	47.6	33.4	28.2	13.9	69.7	11.8	7.1	32.7	36.7	38.3	23.6	14.2	35.4	34.0	39.2	8.4	84.1	47.6	97.9	3.5	10.7	87.8	64.9	35.7	52.7	40.7	60.3	81.5	46.3	29.0	39.5	30.5	44.6	38.5	40.1	27.4	30.4	88.7	41.9	38.9	31.6	50.7
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609885-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.1;lymphoid tissue: 37.5"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 71.8;Macrophages: 112.4;monocytes: 100.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"thalamus: 3.7"	"Group enriched"	"Detected in some"	6	"classical monocyte: 88.0;intermediate monocyte: 135.1;non-classical monocyte: 148.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 148.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA015570	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	14.1	0.8	0.5	37.5	0.2	48.1	0.8	1.3	1.7	0.5	2.5	1.2	0.5	0.6	0.1	0.5	3.2	3.7	1.9	0.3	0.4	1.7	2.5	16.8	1.1	0.4	0.6	0.4	0.9	0.2	0.3	3.1	0.7	0.6	0.9	0.5	0.6	0.2	1.3	0.7	0.6	10.2	0.1	11.0	1.0	0.5	3.7	0.7	0.5	0.3	0.7	18.1	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	88.0	0.6	0.2	135.1	0.1	0.1	0.1	0.1	21.8	0.1	0.1	0.0	1.9	0.1	148.5	0.6	0.1	53.9	0.5	0.2	1.3	1.7	0.3	0.4	0.4	0.6	0.7	0.1	3.7	0.4	0.3	6.4	15.9	0.0	2.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.6	1.8	0.0	0.1	2.9	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	4.0	0.5	0.0	3.8	0.0	0.4	0.4	4.1	0.0	0.2	0.0	0.0	71.8	13.0	0.1	0.0	112.4	1.8	0.0	100.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.5	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.4	2.3	0.0	0.0	0.0
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.0"									HPA027756	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 3: HMC-1 - Innate immune response"				"HPA027756: AB_10601097"			"unprognostic (8.03e-2)"											"unprognostic (3.30e-1)"				0.0	0.1	0.0	0.6	0.2	0.9	0.0	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.4	0.3	0.1	0.0	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.2	4.9	0.4	0.2	0.3	0.8	0.1	0.0	0.2	0.5	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.0;lung: 17.7;lymphoid tissue: 28.9"	"Group enriched"	"Detected in some"	5	"granulocytes: 22.8;Hofbauer cells: 20.6;Kupffer cells: 33.2;Macrophages: 47.0;monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 234.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 63.8;granulocytes: 234.2;monocytes: 193.0"	"Group enriched"	"Detected in some"	6	"THP-1: 25.6;U-937: 48.6"					"Low region specificity"	"Detected in some"			HPA013712	Supported					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	1.9	0.6	0.9	13.5	1.1	27.0	0.8	6.2	4.2	1.3	0.7	3.4	3.8	0.6	0.2	0.5	0.7	2.7	0.5	1.0	1.3	0.6	2.2	17.7	8.8	2.6	1.8	0.2	0.5	0.4	0.4	1.7	2.4	0.7	3.5	0.2	0.8	0.5	0.3	0.1	3.6	3.3	1.7	28.9	1.6	0.4	2.8	2.0	0.4	0.8	5.4	3.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	2.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	48.6	0.0	48.4	96.3	234.2	0.3	165.3	0.5	0.2	0.1	0.2	63.8	0.2	0.2	0.1	74.7	3.7	193.0	6.7	0.4	44.8	0.9	1.1	6.2	4.2	1.0	1.3	2.6	1.8	2.4	1.7	2.8	3.2	0.1	0.0	6.4	0.0	1.3	0.1	0.0	0.1	0.0	0.4	0.1	0.4	0.2	1.5	3.3	0.0	2.1	0.1	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.0	1.7	2.7	0.0	0.2	0.3	0.0	0.0	22.8	0.0	1.1	0.3	20.6	0.0	2.1	0.1	0.0	33.2	0.7	0.2	0.0	47.0	0.0	3.7	39.9	0.0	1.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CD320	"8D6, 8D6A"	ENSG00000167775	"CD320 molecule"	Q9NPF0	19	8302127-8308358	"CD markers, Disease related genes, Predicted membrane proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 418.4;RPMI-8226: 381.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014500, HPA073489"	Approved		Approved	Cytosol		NA	NA		61000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA014500: AB_1846295, HPA073489: AB_2686609"	"unprognostic (9.97e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (4.19e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.90e-2)"	61.8	44.7	39.3	15.8	36.7	8.1	57.5	41.1	42.8	26.2	46.7	52.9	18.8	34.2	63.4	15.7	28.4	16.5	48.4	34.1	40.0	31.2	24.1	25.9	15.3	42.8	40.9	27.7	45.3	15.5	25.7	11.4	46.7	35.2	15.5	4.7	21.3	12.8	34.2	15.8	43.8	13.0	40.9	57.1	45.5	38.3	44.1	10.5	44.4	16.7	7.1	32.5	21.3	36.0	71.7	71.5	15.5	201.1	49.2	25.6	36.6	36.6	48.5	71.2	54.3	77.0	41.7	63.7	111.4	26.8	53.3	44.7	0.1	57.7	13.8	90.0	216.7	30.8	58.4	111.5	33.1	58.8	74.6	24.4	13.6	41.7	34.4	31.7	70.3	42.3	95.4	214.4	28.4	67.6	63.1	418.4	109.3	62.1	293.6	76.6	21.5	381.7	53.9	1.7	143.4	62.3	75.5	32.1	94.5	11.5	2.6	26.2	40.5	82.0	60.6	122.9	117.0	200.5	136.3	71.0	58.4	214.3	90.2	0.5	2.7	0.1	219.9	3.0	125.9	48.4	140.0	117.7	5.1	49.4	94.1	107.1	3.3	91.0	2.2	113.8	102.4	69.4	39.3	36.7	41.1	42.8	34.1	40.0	42.8	40.9	46.7	40.9	44.1	36.0	419.5	12.8	18.8	6.2	34.4	18.5	29.8	39.3	25.6	53.7	42.6	47.6	34.6	14.3	13.0	18.4	33.3	42.7	53.4	126.2	13.7	46.5	25.2	14.6	28.2	146.8	50.9	22.5	6.1	18.5	54.0	53.3	23.0	22.5	11.4	65.6	143.5	20.0	29.5	21.9	10.2	69.6	26.4	7.5	20.2	57.9	21.8	6.4	39.2	34.7	6.2	21.6	33.0	9.0	5.5	18.6	54.7	17.0	121.2	60.8	3.3	48.0	8.8	46.2	13.1	32.0	26.3	122.1	30.2	10.4	14.1	35.4	43.3	119.3	128.6	21.1
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Adipocytes: 298.7;Endothelial cells: 292.4;Fibroblasts: 121.9;Hepatic stellate cells: 136.0;Leydig cells: 146.3;Peritubular cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 64.3;MOLT-4: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		93000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	202.7	28.5	29.2	13.9	28.8	5.7	122.3	27.3	34.2	95.4	21.0	54.2	13.5	71.6	42.3	28.9	82.8	54.3	153.2	25.1	27.5	49.4	5.6	69.1	18.1	29.8	29.5	35.4	18.9	21.8	10.1	219.5	30.8	36.2	19.3	2.3	37.4	33.2	58.5	67.5	39.3	75.5	24.8	21.7	34.4	20.2	32.9	19.0	79.5	68.2	17.1	74.0	61.6	28.0	0.0	0.0	0.2	0.0	3.2	0.3	0.2	0.4	2.4	0.7	1.7	0.0	0.0	0.0	6.2	0.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.7	64.3	1.1	0.0	0.0	1.7	0.0	66.5	0.3	0.5	0.0	0.0	0.1	3.7	0.0	0.3	0.0	0.1	0.2	0.0	0.6	0.1	0.4	2.3	0.0	9.9	0.2	2.8	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	29.2	28.8	27.3	34.2	25.1	27.5	29.8	29.5	30.8	24.8	32.9	28.0	298.7	3.2	7.8	1.6	1.0	16.7	0.2	0.3	4.6	0.6	2.1	3.0	21.9	2.8	0.1	3.7	2.1	0.2	1.5	0.0	0.0	0.5	11.6	1.0	5.2	292.4	0.0	22.3	0.2	0.2	0.3	121.9	0.5	1.0	1.3	0.1	136.0	0.6	0.4	0.0	0.1	0.0	0.0	1.2	21.8	5.0	146.3	2.4	17.8	33.7	0.3	0.2	0.0	0.5	0.3	0.2	0.0	123.0	1.6	0.3	0.0	0.1	0.0	0.2	6.6	7.7	15.2	1.0	2.0	1.5	12.9	0.1	2.2	4.0	0.0	0.3
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"lymphoid tissue: 906.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 231.0;T-cells: 665.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	52	"gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4"	"Lineage enriched"	"Detected in all"	66	"T-cells: 1660.4"	"Group enriched"	"Detected in some"	4	"JURKAT: 621.5;MOLT-4: 1299.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	4.1	3.8	0.3	77.5	0.4	28.6	9.9	0.4	1.4	5.2	0.7	18.8	21.7	3.6	5.7	7.6	4.5	15.7	3.7	0.3	0.6	2.3	7.9	20.6	222.7	1.1	0.4	3.2	1.3	0.9	0.8	1.2	0.6	5.9	22.4	0.3	8.3	3.1	2.5	4.0	30.1	3.9	0.7	60.9	23.8	2.4	0.5	906.7	3.8	1.4	166.9	26.7	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	621.5	49.8	0.0	0.0	0.0	1299.8	237.2	1.2	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.2	0.8	0.0	0.5	0.0	1.5	1.1	0.0	0.9	1.1	0.4	0.0	0.1	0.0	10.1	5.3	4.6	1462.4	3.3	990.0	9.6	1206.1	1368.7	5.0	3.7	1091.4	1338.9	25.1	4.2	5.3	6.0	1660.4	1138.7	0.3	0.4	0.4	1.4	0.3	0.6	1.1	0.4	0.6	0.7	0.5	0.8	5.9	6.4	29.6	0.0	18.6	15.3	0.3	0.0	1.8	0.0	5.4	6.7	2.8	7.2	2.6	3.7	0.0	0.4	231.0	0.9	0.0	1.3	0.4	0.8	0.8	5.0	1.2	16.8	0.0	0.0	0.0	8.3	21.4	0.9	12.6	0.0	7.9	3.1	0.6	0.0	0.0	0.2	0.0	14.9	28.4	0.7	0.0	14.2	12.4	1.0	25.0	0.0	32.0	0.0	0.0	0.1	0.2	0.0	21.0	0.3	0.0	3.4	1.5	0.0	0.0	2.5	5.8	0.1	1.2	1.4	11.8	0.3	665.7	0.0	1.1	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD40	"Bp50, p50, TNFRSF5"	ENSG00000101017	"CD40 molecule"	P25942	20	46118278-46129863	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 127.5;Basal respiratory cells: 126.0;Langerhans cells: 191.4;monocytes: 242.0;Prostatic glandular cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 139.4;naive B-cell: 157.9"	"Group enriched"	"Detected in all"	6	"B-cells: 157.9;monocytes: 43.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 76.0;Daudi: 42.1;EFO-21: 131.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002495, HPA031567, HPA031568, CAB072868"	Enhanced				"Secreted to blood"	NA	NA	705000		"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937"	"unprognostic (6.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.28e-2)"	25.9	8.4	6.7	34.9	7.0	2.7	20.5	7.6	7.7	19.4	9.4	11.8	12.6	14.4	7.6	12.4	19.7	14.3	16.3	6.6	7.2	26.1	18.3	34.4	57.8	8.0	7.1	24.5	21.9	46.5	9.9	12.4	7.6	23.6	9.6	1.1	24.5	15.4	8.6	17.0	21.8	14.0	7.8	35.1	15.6	3.8	7.3	17.3	20.4	7.1	57.7	32.9	21.0	8.0	26.6	4.1	0.0	12.8	4.7	2.7	5.0	4.9	1.4	3.8	3.6	0.0	76.0	42.1	131.8	0.8	18.7	3.1	2.3	16.2	3.9	29.0	0.0	10.0	0.0	7.5	36.6	0.0	13.0	16.2	6.2	15.3	0.0	0.0	28.3	0.0	3.5	0.0	0.8	0.0	0.0	0.2	1.8	9.3	0.1	1.1	1.0	4.5	32.7	0.3	0.0	0.0	23.1	12.6	0.0	0.0	2.7	14.5	0.0	0.0	41.2	0.0	0.1	0.1	0.1	29.2	9.6	5.0	0.1	4.0	28.0	0.4	4.8	43.3	3.5	139.4	2.6	2.0	16.1	157.9	5.0	3.7	2.8	2.9	32.1	8.3	4.1	20.0	6.7	7.0	7.6	7.7	6.6	7.2	8.0	7.1	7.6	7.8	7.3	8.0	68.8	12.8	15.0	6.5	127.5	43.6	63.3	126.0	30.1	1.2	3.8	10.0	3.9	30.0	32.9	14.7	0.0	0.4	7.3	1.5	0.0	68.4	9.0	1.3	2.4	61.5	1.2	5.2	0.9	29.7	3.2	37.9	11.7	3.3	3.8	0.6	55.3	17.0	40.5	0.0	0.9	6.2	14.2	13.0	191.4	14.6	25.7	48.1	28.4	12.2	242.0	9.0	6.2	0.5	0.2	37.9	8.8	22.6	25.1	130.2	6.1	4.3	12.2	0.4	32.9	28.0	31.6	1.9	5.7	13.2	34.1	0.4	4.8	2.3	6.8	64.4
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.8	0.3	0.1	7.9	0.0	1.9	1.1	0.2	0.2	0.9	0.2	1.9	1.8	0.3	0.2	1.0	0.4	2.0	0.2	0.1	0.2	0.4	1.0	2.4	15.5	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.8	3.1	0.0	0.6	0.3	0.1	0.6	3.8	0.6	0.0	4.9	2.0	0.3	0.1	15.5	0.5	0.2	14.8	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752054-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 296.7;eosinophil: 382.4;neutrophil: 401.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 401.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	98.6	237.4	30.0	64.0	35.0	80.5	128.4	33.5	39.5	74.0	61.4	103.1	124.6	62.1	77.1	102.2	110.0	73.8	64.9	30.2	34.4	173.2	133.9	129.1	58.2	37.4	33.6	61.2	112.5	310.6	41.8	221.5	38.1	167.4	103.2	72.6	166.9	107.4	47.4	47.7	98.6	67.1	34.8	79.6	117.4	40.5	36.3	44.4	86.8	58.1	66.6	97.2	68.2	41.5	130.0	71.7	66.1	30.8	202.9	199.2	99.9	95.0	137.3	61.3	82.5	71.3	335.4	19.8	94.3	95.3	84.5	170.7	50.0	130.5	93.0	99.9	70.9	42.9	73.8	128.6	128.8	94.8	142.8	172.9	189.6	92.9	72.5	144.4	174.2	76.8	91.8	83.4	95.7	61.3	45.4	82.8	75.6	76.9	70.9	30.2	104.7	123.0	251.4	252.6	66.5	45.4	120.5	266.8	160.1	130.8	210.2	79.8	150.9	65.6	57.7	139.2	109.9	111.2	144.3	60.1	95.8	61.2	63.0	296.7	79.8	382.4	50.1	82.4	68.9	43.5	63.3	55.8	47.3	34.1	71.1	60.5	401.8	46.9	87.5	24.9	60.5	102.4	30.0	35.0	33.5	39.5	30.2	34.4	37.4	33.6	38.1	34.8	36.3	41.5	186.0	201.9	241.1	59.7	60.3	52.9	89.3	87.2	108.1	63.0	144.3	85.7	61.4	75.8	177.8	145.3	66.7	247.3	94.0	105.2	15.6	77.4	227.7	206.1	67.0	106.7	72.8	46.9	61.0	79.9	76.2	70.5	97.9	231.3	114.5	78.1	77.8	120.9	59.9	40.4	73.6	91.1	87.5	78.9	63.1	36.9	47.2	91.6	62.2	82.4	88.7	25.3	39.1	112.1	153.9	72.8	117.7	44.0	76.0	144.5	92.6	54.4	208.8	87.3	52.6	69.7	89.3	17.1	20.2	104.5	45.9	343.7	89.9	99.4	115.9	165.7
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043091-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 589.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	51.8	64.9	39.2	116.4	47.9	232.2	89.3	64.4	63.5	57.4	30.4	89.0	74.6	53.0	92.4	93.9	100.5	86.7	59.5	47.2	41.9	44.4	71.4	154.6	137.9	53.1	40.5	46.1	41.5	27.2	34.6	80.1	48.5	122.2	99.3	285.7	105.3	55.7	57.9	59.8	79.3	55.4	50.9	100.1	104.2	59.0	49.2	79.1	91.2	22.8	161.7	110.1	52.4	76.4	303.3	49.9	108.0	62.1	130.3	122.6	147.9	106.0	139.4	70.8	126.0	2.1	159.1	129.6	180.0	90.7	216.5	201.0	52.2	98.7	91.7	81.5	35.8	311.6	45.9	3.9	73.8	227.4	467.6	85.7	58.1	71.6	53.6	118.5	73.4	132.6	85.1	323.6	108.5	148.1	268.5	77.0	46.7	298.4	133.6	154.2	69.3	187.8	185.3	115.8	69.7	37.9	63.6	111.7	124.4	56.5	227.4	85.8	76.5	210.9	40.9	120.7	79.4	124.2	100.8	208.0	131.5	119.8	65.6	185.2	119.2	232.8	178.1	244.2	155.6	191.6	209.7	192.0	181.6	188.7	149.2	169.0	145.4	232.6	339.2	133.3	334.5	296.9	39.2	47.9	64.4	63.5	47.2	41.9	53.1	40.5	48.5	50.9	49.2	76.4	72.3	368.6	157.4	98.6	192.9	165.3	311.7	504.4	101.3	102.9	119.0	93.1	51.9	110.1	205.7	93.8	95.9	169.9	218.6	36.5	15.6	589.6	81.5	157.2	17.0	76.5	63.8	112.6	219.2	412.5	85.5	119.1	36.2	120.4	57.7	250.0	83.6	34.2	186.4	122.8	129.3	70.8	148.5	79.6	200.7	52.2	34.2	121.5	117.4	39.4	100.5	51.7	219.4	107.1	150.4	344.7	92.6	48.5	143.8	439.0	53.7	16.3	162.2	229.7	65.7	47.1	85.4	111.5	19.6	97.1	140.1	121.2	160.8	80.6	94.3	321.3
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	11.8	5.9	1.4	115.3	1.5	148.4	18.8	1.5	4.7	10.2	2.3	24.9	20.5	6.7	5.0	8.4	5.7	26.6	4.3	1.3	1.7	4.4	19.9	31.0	283.9	2.6	1.8	3.1	2.0	1.6	1.6	5.8	2.7	8.1	32.5	0.1	14.0	4.4	2.9	3.5	48.3	12.5	2.1	160.0	32.5	2.9	3.2	138.9	5.2	3.4	256.8	41.8	4.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	220.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	6.0	0.0	2.1	0.0	0.0	0.0	27.1	236.9	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.4	78.6	0.0	0.0	78.9	38.4	0.1	0.0	0.0	4.7	0.1	34.3	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.3	0.2	0.4	501.4	360.3	89.9	0.2	66.7	0.1	218.1	327.1	230.8	242.8	470.2	335.8	206.2	275.2	283.4	329.7	161.2	277.9	301.6	82.1	160.7	487.4	57.0	229.9	603.5	1.4	1.5	1.5	4.7	1.3	1.7	2.6	1.8	2.7	2.1	3.2	4.1	3.7	0.0	9.6	0.7	336.1	5.5	0.8	0.0	1.8	0.0	2.0	1.7	1.1	2.8	1.3	3.7	0.0	0.6	251.2	0.1	1.9	0.2	0.1	0.7	0.5	2.8	1.2	21.5	0.1	0.2	0.8	2.4	6.6	0.6	90.7	0.1	7.1	2.0	86.4	0.0	0.1	0.1	0.0	245.8	106.5	0.5	1.8	218.3	39.2	1.0	366.6	0.0	454.2	0.5	0.0	0.1	0.0	0.4	127.4	0.4	0.0	4.9	2.2	0.0	0.0	1.7	2.1	0.5	0.3	0.7	3.0	0.4	376.2	0.0	1.2	0.5
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102489-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Langerhans cells: 9.3;Muller glia cells: 16.0;T-cells: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 138.2"	"Lineage enriched"	"Detected in many"	33	"T-cells: 138.2"	"Group enriched"	"Detected in some"	66	"JURKAT: 21.0;MOLT-4: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"prognostic favorable (4.05e-4)"	"prognostic favorable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favorable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favorable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"	1.4	0.9	0.4	22.6	0.4	12.2	1.0	0.1	0.5	0.9	0.0	2.8	3.1	0.7	0.4	2.3	0.8	4.9	0.9	0.6	0.4	0.8	1.5	5.7	38.0	0.2	0.0	0.8	0.4	0.2	0.4	0.3	0.5	1.0	2.7	1.8	6.4	0.3	0.6	1.4	7.1	1.2	0.0	14.1	7.9	0.8	0.3	46.5	1.0	0.3	22.2	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.1	70.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.6	45.9	0.4	32.8	1.5	108.7	72.5	3.7	3.4	88.4	69.8	1.8	0.4	3.4	4.1	138.2	61.5	0.4	0.4	0.1	0.5	0.6	0.4	0.2	0.0	0.5	0.0	0.3	0.0	0.4	0.0	1.7	0.0	4.1	0.9	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	2.7	0.0	0.1	0.2	0.0	1.3	0.3	0.0	0.0	0.9	2.6	0.1	1.3	0.0	1.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	9.3	0.9	0.0	1.8	3.6	0.0	2.1	16.0	1.0	0.0	0.1	0.1	0.3	0.0	6.3	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.6	0.4	0.7	0.2	0.3	0.0	57.0	0.0	0.2	0.2
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110871188-110899922	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 448.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 310.0;dendritic cells: 375.0;Hofbauer cells: 365.7;Kupffer cells: 324.3;Macrophages: 294.8;NK-cells: 383.1;T-cells: 297.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 473.5;HDLM-2: 214.8;HMC-1: 298.4;Karpas-707: 188.1;U-266/70: 251.2;U-698: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	63.4	30.8	10.1	284.4	11.1	126.6	27.0	12.6	16.3	20.8	12.3	41.5	37.9	17.3	10.5	20.0	22.8	58.5	12.2	9.7	13.4	15.1	46.8	114.9	397.9	18.9	16.0	9.2	11.9	6.6	6.2	58.5	18.9	12.8	54.8	2.0	19.3	12.8	4.5	6.7	103.4	55.8	18.3	269.4	44.3	5.7	17.5	144.9	11.3	10.6	448.3	85.1	9.0	31.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	473.5	0.2	0.0	0.2	0.5	0.0	0.0	0.0	214.8	0.0	26.4	0.1	0.0	0.0	60.4	298.4	0.0	0.0	0.0	0.0	0.0	0.0	139.2	11.2	188.1	0.0	0.0	103.1	71.1	0.4	0.0	0.0	98.0	0.7	104.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	88.4	17.2	0.2	0.4	0.1	0.5	251.2	123.2	149.2	1.5	68.7	3.4	1483.0	779.5	479.0	732.4	808.6	658.1	794.0	527.8	649.2	631.9	745.1	377.9	552.5	1144.2	526.6	882.9	517.5	740.3	1621.0	10.1	11.1	12.6	16.3	9.7	13.4	18.9	16.0	18.9	18.3	17.5	31.9	4.2	16.0	24.4	0.7	310.0	7.0	0.6	0.0	0.6	0.0	2.3	5.1	1.0	5.7	8.6	1.8	0.0	2.1	375.0	0.2	0.0	0.5	0.4	0.4	0.5	13.0	0.0	42.9	5.8	0.2	5.4	6.7	7.1	0.6	162.2	0.0	16.4	6.7	365.7	0.0	1.4	0.3	0.0	324.3	161.5	1.9	2.1	294.8	39.2	69.3	156.3	0.1	383.1	1.0	0.6	0.3	0.1	0.4	134.0	0.3	0.0	1.6	4.4	0.6	6.6	1.9	1.8	0.1	0.6	1.1	5.5	4.1	297.0	0.0	0.2	0.3
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321532-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 2227.6;Syncytiotrophoblasts: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 662.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 472.3;HMC-1: 665.7;PC-3: 395.0;U-2197: 405.3"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	360000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	64.9	161.5	13.8	99.6	23.3	134.0	59.0	15.8	28.3	103.3	19.0	47.7	47.7	58.3	17.3	58.3	28.0	49.4	48.4	15.7	29.4	20.5	28.0	224.1	26.7	21.1	20.0	67.7	24.5	28.9	26.3	92.5	26.2	16.1	42.9	9.2	126.1	18.1	108.9	85.9	50.7	46.6	15.2	43.1	44.0	36.0	20.8	15.8	47.6	59.5	41.3	183.2	41.8	34.4	33.2	43.6	0.1	14.6	54.2	55.1	220.7	62.5	100.1	31.3	33.1	139.5	44.3	60.8	50.3	35.8	123.3	17.4	65.2	12.9	29.1	29.0	26.4	79.9	472.3	23.3	162.3	50.5	665.7	25.9	150.5	40.8	171.8	133.8	169.7	9.6	89.6	29.3	19.4	35.6	5.3	37.8	43.2	78.9	395.0	7.4	42.3	50.7	54.3	30.7	17.7	0.4	321.2	64.3	53.9	95.1	54.4	41.5	80.4	17.6	33.2	405.3	23.8	24.7	31.4	42.7	44.8	19.6	78.9	317.7	181.2	247.6	35.0	174.4	51.8	108.2	46.0	36.4	121.7	115.2	102.6	101.9	662.2	134.5	223.7	64.8	34.6	159.3	13.8	23.3	15.8	28.3	15.7	29.4	21.1	20.0	26.2	15.2	20.8	34.4	95.9	2227.6	405.3	2.3	529.8	705.1	214.1	143.6	59.2	3.1	69.9	53.8	72.7	7.2	542.6	23.9	0.0	217.5	201.7	196.1	3.9	98.6	324.6	345.6	101.9	143.4	17.3	79.8	7.6	180.2	411.7	244.7	387.9	709.3	146.9	88.9	46.8	9.1	70.0	1.7	10.7	155.7	77.3	177.5	449.2	66.3	32.6	377.3	160.1	7.5	122.6	4.8	69.0	6.0	54.3	388.9	241.2	9.1	305.4	334.9	138.4	3.2	259.5	3.3	6.6	56.1	98.0	8.9	13.7	273.4	765.9	847.7	215.4	281.5	145.1	578.6
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 3747.5;U-2197: 3049.9"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		58000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	517.4	248.3	284.5	209.6	310.8	198.8	555.9	329.0	365.1	305.5	542.2	255.1	120.7	290.7	971.7	478.9	368.1	475.3	608.3	288.2	359.7	577.4	339.8	553.5	148.8	327.9	340.2	228.5	353.6	706.1	250.3	485.6	340.9	256.8	271.4	130.7	693.6	443.2	529.3	282.8	167.9	380.0	330.5	131.8	422.7	127.7	337.0	167.7	308.1	915.0	288.6	550.5	325.5	315.6	297.2	278.4	77.6	212.0	1697.1	1314.9	46.8	1765.7	1778.5	408.9	451.9	129.7	822.1	23.9	291.5	1802.5	475.5	314.0	141.0	1589.9	561.1	475.5	218.2	31.3	846.7	193.1	483.2	183.4	94.8	631.8	387.2	343.3	1550.6	1104.9	2475.5	109.3	207.9	585.9	2575.4	282.7	79.9	70.3	43.5	541.8	1421.8	30.1	232.1	227.8	1304.4	510.0	54.3	79.5	576.2	243.7	298.2	218.0	187.5	18.1	3747.5	838.6	235.5	3049.9	595.9	273.8	558.8	30.4	734.2	1.3	1556.9	164.9	22.3	209.6	50.9	7.9	64.8	63.9	104.9	56.6	95.4	59.6	68.2	41.4	134.3	92.5	4.8	49.9	298.2	53.5	284.5	310.8	329.0	365.1	288.2	359.7	327.9	340.2	340.9	330.5	337.0	315.6	728.0	272.4	247.2	32.3	39.1	286.0	1103.2	951.4	82.0	51.3	434.9	270.0	315.5	444.7	569.7	242.8	33.3	553.5	29.2	344.6	164.4	1445.2	129.4	94.3	91.6	792.6	166.6	206.0	25.1	618.3	407.2	303.5	109.6	115.6	139.4	88.2	585.0	185.7	486.7	47.1	29.9	112.8	722.2	139.4	374.2	61.6	237.3	88.2	1270.0	54.4	161.7	198.3	26.8	32.6	22.2	1195.7	392.2	204.7	149.7	1678.0	41.7	208.2	1042.5	56.2	276.1	159.1	410.7	130.6	31.2	83.7	284.4	836.6	52.4	139.5	104.9	1531.0
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830911-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 572.9"	"Group enriched"	"Detected in some"	36	"Hofbauer cells: 279.0;Kupffer cells: 567.0"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	NA	NA	4030000000	4300000000		"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		1.4	0.0	0.0	1.5	0.0	17.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	104.7	1.6	9.2	0.2	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	572.9	0.5	0.1	0.1	6.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	6.1	6.1	279.0	0.0	0.0	0.0	0.0	567.0	0.0	1.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.3	0.0	0.0	0.0
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.6;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5"	"Lineage enriched"	"Detected in many"	51	"T-cells: 51.4"	"Group enriched"	"Detected in some"	12	"JURKAT: 10.2;MOLT-4: 39.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	NA	NA	5270000	160000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.4	0.9	1.5	21.9	0.9	11.3	1.2	0.5	1.1	1.3	0.7	3.2	4.0	0.9	0.7	1.8	1.4	3.9	0.5	0.6	1.7	1.0	1.4	6.6	43.1	1.5	2.0	0.9	0.6	0.2	0.4	0.3	1.7	1.1	3.1	0.2	3.2	0.4	0.8	1.3	13.6	0.7	0.9	18.0	6.6	0.7	2.5	39.6	1.4	0.3	29.0	4.8	1.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.2	0.0	0.0	0.0	39.2	0.1	0.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.7	0.0	24.7	1.0	51.4	48.4	0.3	0.9	34.4	25.2	0.7	0.2	0.0	0.0	25.5	13.8	1.5	0.9	0.5	1.1	0.6	1.7	1.5	2.0	1.7	0.9	2.5	0.9	3.2	0.0	2.5	0.3	10.8	2.0	0.2	0.1	0.0	1.4	0.9	0.8	2.6	1.5	0.1	0.0	0.0	0.2	25.7	0.2	0.0	0.2	0.9	0.4	0.3	1.2	0.0	0.0	0.8	0.6	0.2	1.5	8.2	0.3	0.0	0.1	2.5	0.8	2.0	1.7	0.9	0.0	0.0	1.9	4.4	0.4	0.3	3.4	3.6	1.0	2.4	0.0	49.4	0.0	0.2	0.7	0.2	0.0	18.5	0.0	0.1	0.2	0.1	0.2	0.0	1.0	0.9	0.4	0.9	1.0	1.4	0.3	107.3	0.7	0.5	0.4
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1857.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 4897.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	954.0	882.1	509.4	457.9	526.5	747.2	769.6	532.6	717.1	715.6	611.8	809.3	394.5	854.6	1492.1	396.1	647.3	607.0	1152.2	508.5	565.7	625.3	565.1	882.2	325.0	564.7	539.9	645.9	830.1	524.7	486.6	588.0	544.3	520.0	736.0	269.1	871.6	547.4	919.3	410.0	559.3	744.5	534.9	597.7	790.8	224.3	583.6	193.3	657.7	587.4	284.9	835.3	539.7	561.7	481.0	669.0	432.6	430.8	4897.7	2932.4	577.5	1914.8	3104.6	979.2	1048.9	750.3	939.2	120.5	581.2	2608.7	787.7	436.3	301.7	732.6	1197.9	372.5	248.7	760.9	542.8	443.3	2006.7	338.5	1699.0	2315.1	639.7	1164.8	979.2	2305.1	1052.2	64.6	386.8	936.3	3062.5	626.3	64.1	439.5	395.7	1062.7	880.7	146.0	949.3	345.7	1699.3	1433.6	170.1	425.8	528.3	392.5	3348.6	630.4	546.4	1089.6	948.0	710.1	514.8	984.9	649.8	377.3	239.3	92.5	2023.9	208.1	1326.3	1279.9	610.3	1857.5	323.2	458.8	235.2	111.0	126.9	260.0	473.0	73.9	55.9	186.0	656.0	733.0	320.4	309.8	121.6	850.4	509.4	526.5	532.6	717.1	508.5	565.7	564.7	539.9	544.3	534.9	583.6	561.7	798.7	512.8	689.0	28.1	147.6	567.2	1382.5	3135.4	155.4	190.3	606.5	601.1	820.9	836.4	1789.7	875.4	152.2	608.3	322.0	1083.4	232.8	2621.2	16.7	446.7	766.7	916.3	581.1	97.0	8.8	3429.0	2756.5	1538.0	371.1	727.3	1030.0	531.6	739.6	423.9	3372.5	33.7	9.3	1251.6	1715.1	854.6	1698.3	65.5	1727.3	1146.7	1993.9	11.2	575.7	893.8	487.1	21.1	26.5	3437.4	1394.0	1157.0	326.9	2039.2	878.1	794.2	1012.6	258.8	1255.6	1845.2	1278.7	43.8	68.9	137.1	400.5	2708.1	310.4	645.8	761.6	1868.9
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 358.0;lymphoid tissue: 370.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1378.6;monocytes: 3740.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 472.0;U-87 MG: 751.0"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	139.6	78.3	10.4	236.1	9.8	266.2	72.6	11.2	33.4	77.8	14.6	88.8	279.5	26.7	9.0	126.4	43.1	161.1	38.9	8.2	26.7	50.6	156.7	358.0	217.3	45.5	31.2	19.4	22.1	14.2	8.9	173.1	36.0	13.1	91.9	4.8	52.6	19.8	23.0	24.8	240.2	79.0	16.1	370.7	87.5	15.2	58.5	44.2	22.7	21.3	84.2	149.3	50.6	31.6	243.4	48.6	3.2	3.5	472.0	177.6	2.1	75.6	203.9	97.8	113.4	10.1	71.3	2.9	84.2	220.8	174.6	10.6	1.2	47.6	65.9	2.2	9.0	38.8	13.2	59.0	42.0	19.2	207.8	57.1	9.8	205.4	150.4	162.6	26.3	4.3	15.7	24.2	95.5	2.2	1.7	17.2	2.8	63.1	36.0	3.3	4.5	144.4	20.9	10.9	1.6	3.0	63.2	31.3	72.1	2.2	1.6	146.1	82.4	123.7	8.0	125.7	100.1	1.4	2.1	1.9	751.0	46.4	64.0	243.5	3255.5	21.4	9.1	3655.9	11.1	80.2	4.1	6.2	817.3	59.0	5.8	5.1	219.4	18.7	3740.6	1378.6	6.5	3324.3	10.4	9.8	11.2	33.4	8.2	26.7	45.5	31.2	36.0	16.1	58.5	31.6	10.4	0.0	19.7	1.3	20.5	15.7	39.0	58.8	3.4	0.2	7.2	9.8	0.0	12.8	53.2	5.5	0.0	8.9	110.3	22.5	5.9	82.1	0.8	8.3	11.3	15.9	4.9	6.6	0.3	156.8	58.1	45.6	29.6	18.7	43.6	0.9	16.4	23.9	1820.4	0.0	0.4	15.8	16.2	701.2	341.5	2.1	6.5	791.2	39.2	5.6	179.2	0.3	7.2	0.0	0.1	121.0	86.1	1.9	8.5	33.3	335.3	50.2	20.6	1.0	26.3	8.7	11.7	0.5	1.2	12.4	14.3	33.4	10.8	0.5	28.9	99.9
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	14.0	6.2	0.9	48.1	0.7	169.1	18.9	1.2	1.0	9.3	2.2	8.9	8.2	6.0	2.9	11.9	7.7	27.3	3.5	0.7	1.7	4.9	12.9	22.6	94.4	1.7	1.1	2.6	1.7	2.0	4.0	2.6	1.6	10.4	21.3	0.2	5.1	2.9	0.7	4.3	19.5	14.3	2.2	43.6	11.8	1.3	1.0	57.0	6.9	4.6	60.1	18.0	7.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	12.1	0.0	0.0	1.5	30.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	19.5	58.4	0.0	0.0	0.0	20.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.9	8.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.5	2.7	25.6	0.0	97.8	0.0	1.3	0.1	5.9	22.9	0.1	30.8	6.0	14.5	16.9	0.1	6.2	20.6	15.6	0.3	26.7	0.0	0.0	7.9	7.3	0.9	0.7	1.2	1.0	0.7	1.7	1.7	1.1	1.6	2.2	1.0	2.4	13.5	41.7	116.7	0.0	1017.1	18.5	3.8	0.0	10.8	0.1	11.8	14.7	2.0	7.2	5.0	1.8	0.0	0.9	694.0	1.1	0.0	1.1	0.4	5.7	3.6	14.3	0.0	33.7	0.0	0.0	0.3	15.4	63.7	16.7	1455.3	0.0	14.6	2.4	16.6	0.0	0.0	0.2	0.0	15.4	77.1	0.3	0.0	80.1	33.8	10.3	3.2	0.1	57.7	0.0	0.1	0.0	0.1	0.0	308.8	2.2	0.4	2.1	1.5	0.6	0.0	4.3	9.2	0.1	0.3	4.2	18.2	1.9	1185.9	0.0	0.9	3.3
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.6;lymphoid tissue: 53.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 625.0;NK-cells: 1299.7;T-cells: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 231.5"	"Group enriched"	"Detected in many"	22	"NK-cells: 231.5;T-cells: 71.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 52.0;JURKAT: 26.7;MOLT-4: 119.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"	8.2	1.3	0.7	32.9	0.8	28.6	2.6	0.8	1.3	2.5	0.9	7.3	12.4	3.0	0.4	3.9	3.9	3.2	1.8	0.6	1.1	7.1	7.7	17.1	36.8	1.4	0.8	0.8	1.2	0.1	1.4	3.3	1.0	4.4	1.9	0.0	3.1	1.0	0.8	1.7	21.1	1.1	1.2	53.7	8.1	0.6	1.1	48.8	3.5	0.1	14.8	3.9	3.9	1.2	0.0	0.0	0.0	0.0	0.1	0.4	12.9	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.7	52.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.1	0.0	119.2	0.0	0.0	0.0	0.2	0.1	0.1	2.3	0.2	0.0	0.4	0.3	1.8	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.3	1.0	0.0	1.2	0.2	0.0	0.2	0.0	0.0	0.5	0.4	0.5	66.6	0.2	57.6	0.4	29.8	49.0	0.3	0.2	69.4	71.5	2.3	231.5	0.6	6.9	28.7	30.9	0.7	0.8	0.8	1.3	0.6	1.1	1.4	0.8	1.0	1.2	1.1	1.2	5.3	0.0	0.0	0.0	12.1	7.5	0.6	0.1	1.8	0.0	4.2	3.7	0.5	4.3	0.3	0.0	0.0	0.7	625.0	9.4	0.0	1.3	0.1	2.8	2.0	4.5	0.0	47.7	0.0	0.5	10.3	12.4	43.8	5.3	8.2	0.0	16.8	3.3	3.6	1.7	0.0	1.5	0.0	18.5	8.8	0.0	0.0	19.2	12.4	0.0	11.6	0.0	1299.7	0.0	0.0	0.1	5.8	0.0	82.7	3.8	8.1	1.4	0.5	0.0	0.0	0.5	3.9	0.0	1.3	1.0	4.4	1.9	527.4	0.0	2.1	3.8
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609979-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 65.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 95.6;dendritic cells: 18.3;Hofbauer cells: 18.7;Kupffer cells: 25.6;Macrophages: 21.1;NK-cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 232.9;naive B-cell: 413.5"	"Lineage enriched"	"Detected in all"	20	"B-cells: 413.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.4;Karpas-707: 14.5;REH: 7.8;U-698: 44.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.1"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	4.5	2.3	1.9	20.6	2.0	6.7	1.7	2.0	3.3	1.4	4.2	1.9	1.3	1.0	4.8	0.6	1.2	4.1	0.7	1.8	1.8	2.2	6.0	2.8	65.0	2.8	1.8	0.8	2.2	1.1	2.5	3.3	2.4	1.5	1.3	0.4	1.6	0.7	0.6	2.0	8.4	1.6	1.9	53.6	2.6	0.8	3.3	6.9	2.4	0.0	50.2	4.2	0.9	2.3	0.1	0.0	0.6	0.5	0.9	5.2	0.1	0.3	0.1	0.4	0.7	0.0	0.2	21.4	0.1	0.3	0.1	0.0	0.0	0.1	0.5	1.8	0.4	0.6	0.2	0.0	0.5	0.3	4.1	1.5	0.0	0.2	0.4	0.9	0.0	4.9	0.0	14.5	1.1	0.0	0.3	2.7	0.2	0.0	0.1	7.8	0.0	5.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.7	0.2	0.2	0.0	0.3	0.3	44.4	0.8	0.5	0.0	0.6	2.0	0.3	3.1	3.5	4.3	232.9	1.5	2.2	20.2	413.5	0.7	2.4	1.4	10.6	0.5	11.0	1.7	14.8	1.9	2.0	2.0	3.3	1.8	1.8	2.8	1.8	2.4	1.9	3.3	2.3	0.7	0.0	0.6	5.9	95.6	1.0	0.5	0.9	0.6	0.0	1.3	1.3	1.1	1.5	0.4	3.7	0.0	0.2	18.3	0.7	0.0	0.8	0.2	0.4	0.6	0.9	1.8	2.7	1.0	0.7	0.3	0.9	1.1	0.4	0.0	0.8	0.7	0.2	18.7	0.0	1.2	0.2	0.0	25.6	14.6	0.3	0.9	21.1	0.0	0.0	3.0	0.6	19.6	2.0	4.4	1.1	0.0	0.4	2.7	0.5	0.6	0.7	1.3	0.7	0.0	0.5	0.9	1.1	1.7	0.2	1.1	0.3	5.9	0.5	0.4	0.4
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877279-41881372	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 152.3;lymphoid tissue: 545.2"	"Group enriched"	"Detected in some"	5	"B-cells: 1186.4;Plasma cells: 956.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"memory B-cell: 1273.8;naive B-cell: 1457.5"	"Lineage enriched"	"Detected in all"	40	"B-cells: 1457.5"	"Group enriched"	"Detected in some"	22	"Daudi: 1598.7;REH: 491.0;U-698: 1366.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000019, HPA056444"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB000019: AB_2244527, HPA056444: "	"prognostic favorable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	4.8	4.9	0.2	213.4	0.2	47.2	9.5	0.2	0.4	3.6	0.1	47.3	37.9	2.4	1.4	9.9	1.8	13.0	2.9	0.1	0.1	3.4	2.6	8.9	482.4	0.3	0.2	3.7	0.6	0.1	0.3	1.2	0.2	4.3	28.9	0.0	28.5	2.2	0.7	0.4	152.3	2.2	0.6	286.5	76.9	2.4	0.2	93.7	8.1	0.4	545.2	32.3	1.9	0.3	1.1	0.8	0.3	0.1	0.2	0.7	0.2	0.2	0.0	0.3	0.0	0.0	0.1	1598.7	1.2	0.0	0.1	0.0	0.2	0.2	0.0	0.5	0.7	2.7	0.0	1.7	0.2	2.6	1.8	0.5	0.6	0.2	0.0	0.0	0.0	8.0	3.1	0.4	0.1	1.1	1.6	9.9	0.1	0.1	0.4	491.0	0.8	2.5	0.1	0.0	0.5	0.5	0.8	0.5	1.3	0.0	0.0	4.8	1.6	0.1	4.3	0.3	0.8	7.8	1.4	1366.7	0.0	52.1	0.1	12.4	1.5	6.9	1.7	1.8	0.7	1273.8	4.1	2.1	2.5	1457.5	4.9	26.3	4.6	2.6	4.3	36.3	10.4	62.7	0.2	0.2	0.2	0.4	0.1	0.1	0.3	0.2	0.2	0.6	0.2	0.3	0.2	0.0	2.4	0.0	1186.4	1.8	0.5	0.5	0.6	0.0	0.7	0.9	0.2	1.5	0.2	0.0	0.0	0.2	18.2	0.7	0.0	1.8	0.2	0.1	0.3	0.5	0.0	10.5	0.0	25.6	0.4	2.2	6.6	0.2	0.0	0.4	2.2	1.0	0.8	0.0	0.0	0.4	0.0	4.1	1.4	0.0	0.3	5.3	138.7	0.0	6.3	0.0	15.5	0.0	0.0	181.7	0.4	0.4	956.7	0.3	0.2	0.9	0.0	0.0	0.0	0.2	0.7	0.3	0.6	0.9	1.4	0.1	23.5	0.2	5.3	0.2
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 266.7"	"Cell type enriched"	"Detected in many"	4	"B-cells: 491.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1132.1;naive B-cell: 1505.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1505.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1060.0;REH: 350.2;U-698: 1475.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	5.0	1.7	0.9	70.5	0.9	54.6	3.4	0.9	1.4	1.9	1.7	7.7	4.7	1.4	1.6	2.6	1.5	6.8	12.3	0.9	0.9	4.7	3.4	4.9	266.7	1.0	0.9	0.6	0.7	0.7	25.3	3.8	0.9	2.5	7.2	0.0	7.8	0.8	3.4	2.4	66.2	2.6	0.9	147.7	10.7	1.0	1.0	27.1	4.1	5.8	208.4	13.4	2.2	1.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	1060.0	7.8	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.4	0.6	0.6	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.4	1.2	56.9	0.0	0.0	0.6	23.0	0.3	0.0	0.0	350.2	0.9	4.4	0.0	0.0	0.5	0.0	1.7	0.0	0.7	5.8	0.0	16.2	1.7	0.1	3.7	0.3	0.6	51.3	54.4	1475.5	0.0	2.2	0.0	6.2	13.0	1.1	44.9	192.2	51.3	1132.1	57.1	30.1	47.0	1505.8	38.4	23.2	5.8	42.4	304.3	6.7	107.9	112.1	0.9	0.9	0.9	1.4	0.9	0.9	1.0	0.9	0.9	0.9	1.0	1.0	24.9	0.0	1.3	0.0	491.9	4.5	0.4	0.0	1.8	0.0	1.1	4.4	1.4	1.5	0.0	0.0	0.0	0.2	24.2	0.3	0.0	0.1	0.6	0.3	1.0	25.2	1.2	8.6	0.0	0.0	0.4	3.3	0.5	0.3	15.2	0.0	51.4	1.3	5.8	0.0	0.0	0.4	0.0	14.8	5.1	1.4	1.2	13.4	21.4	0.0	14.3	0.0	36.0	0.0	0.0	0.0	0.1	1.9	99.6	0.4	0.0	1.0	0.0	0.0	0.0	4.4	5.4	1.2	0.3	0.7	3.1	0.4	27.0	0.5	0.8	0.2
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559614	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 3.0;lymphoid tissue: 6.8"	"Group enriched"	"Detected in some"	4	"Langerhans cells: 17.4;monocytes: 65.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;T-reg: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.9;HDLM-2: 42.3;Karpas-707: 17.0;U-266/70: 7.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB025368: , HPA050092: AB_2681012"	"unprognostic (2.36e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.03e-8)"	"unprognostic (3.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.94e-2)"	0.4	0.1	0.1	5.3	0.1	1.4	0.2	0.2	0.3	0.2	0.7	0.7	1.0	0.2	0.0	0.1	0.1	0.6	0.1	0.2	0.1	0.1	1.5	3.0	5.6	0.4	0.1	0.0	0.2	1.7	0.1	0.4	0.3	0.1	1.3	0.0	0.2	0.2	0.1	0.0	0.8	0.3	0.4	3.4	0.6	0.2	0.5	2.5	0.6	0.0	6.8	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	17.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.3	0.4	0.5	0.4	0.2	0.0	1.5	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	1.3	0.0	0.4	0.0	0.0	4.5	17.4	0.5	0.0	8.5	0.0	1.0	65.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620358	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 280.3;Proximal enterocytes: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 536.4"	"Group enriched"	"Detected in all"	6	"B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 463.8;U-87 MG: 323.3"	"Region enhanced"	"Detected in all"		"white matter: 210.9"	"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	39.2	9.1	47.7	57.3	80.5	140.9	36.6	45.2	48.8	38.8	48.5	24.7	74.1	9.1	31.9	130.9	54.0	39.6	25.6	41.9	51.7	26.1	36.9	87.3	68.5	58.5	74.3	14.9	31.3	7.8	7.5	41.0	49.8	27.5	17.2	4.2	81.1	72.1	23.1	84.2	81.6	16.6	39.6	47.3	62.8	4.5	79.0	45.0	22.4	20.0	82.6	47.6	66.1	67.2	30.0	5.2	35.1	7.2	24.0	98.4	1.2	16.9	132.9	29.4	78.5	2.0	19.6	30.9	20.8	8.1	61.1	118.8	4.6	88.4	59.6	145.4	2.7	220.9	9.3	0.6	21.3	58.8	463.8	142.1	99.2	128.3	62.1	68.4	49.7	26.9	1.6	9.4	247.3	25.0	46.7	97.7	1.1	103.2	2.4	1.5	190.0	43.9	16.8	36.1	1.2	2.0	13.0	162.6	23.0	4.2	161.2	51.3	33.9	94.4	12.5	1.8	179.0	3.6	0.4	0.9	323.3	32.5	56.0	369.9	59.3	110.7	29.9	33.0	51.4	310.1	150.7	70.3	14.9	211.9	51.1	23.1	536.4	50.1	25.0	44.5	173.1	65.9	47.7	80.5	45.2	48.8	41.9	51.7	58.5	74.3	49.8	39.6	79.0	67.2	43.6	48.1	38.8	9.4	112.8	55.1	108.1	149.0	107.6	2.4	68.1	54.7	7.7	58.6	143.8	158.2	2.1	1.3	14.9	17.4	11.7	79.7	2.0	23.1	5.0	41.0	13.2	92.9	0.3	66.7	1.1	29.1	58.6	25.2	280.3	0.7	59.6	32.5	64.3	1.7	0.6	36.8	63.1	26.6	18.2	2.0	40.4	52.3	64.0	3.7	11.0	35.7	0.0	54.3	22.4	86.7	50.3	8.2	16.0	59.1	220.6	2.5	73.0	2.7	13.1	109.0	46.0	2.1	5.9	161.3	67.2	1.4	46.3	0.6	43.1	142.8
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454, HPA073595"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Golgi apparatus"	"CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: "	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	10.2	19.9	14.7	34.9	13.9	209.6	7.0	16.1	17.9	26.2	23.0	5.2	4.6	7.3	4.0	4.5	5.1	17.0	4.8	15.6	19.2	18.7	14.9	39.9	51.3	20.2	16.6	16.5	4.2	6.6	7.2	9.2	21.0	8.3	9.2	5.0	19.5	13.8	1.3	5.0	11.5	6.9	16.7	20.1	5.7	5.2	21.0	38.0	5.3	2.9	70.2	15.5	15.4	21.6	18.1	0.8	12.7	17.7	18.2	4.2	0.4	5.1	17.6	8.3	14.4	1.3	11.6	79.1	14.6	1.3	16.8	2.0	4.8	5.5	27.0	71.9	7.6	10.6	21.4	2.1	0.6	15.8	16.5	4.8	2.3	8.0	2.6	2.5	0.2	26.4	2.4	0.0	0.8	6.5	12.6	29.7	5.3	3.2	3.7	12.1	28.1	10.9	6.0	17.2	2.8	5.2	1.0	0.6	13.5	7.3	3.0	12.3	0.4	12.8	8.1	1.9	12.0	0.7	0.2	121.5	2.8	21.6	19.7	0.0	3.1	2.0	4.4	19.0	4.8	19.7	4.0	3.7	9.0	31.0	2.8	3.3	2.2	5.0	29.3	3.2	6.2	4.4	14.7	13.9	16.1	17.9	15.6	19.2	20.2	16.6	21.0	16.7	21.0	21.6	41.3	19.2	77.9	5.2	668.5	49.5	16.0	10.0	41.5	4.2	26.5	46.4	30.9	2.8	8.2	11.0	6.2	1.5	100.4	5.4	3.9	0.9	0.9	29.0	24.1	39.1	24.0	3.0	5.6	1.6	2.4	31.1	11.2	74.8	238.8	8.1	2.9	1.1	145.6	1.7	6.1	7.3	4.1	83.0	1390.2	1.9	0.3	539.4	44.4	13.1	513.6	3.5	1.0	2.5	1.3	2.1	0.4	0.0	20.4	26.2	1.7	17.7	4.9	2.7	0.0	17.2	17.0	2.1	10.2	17.2	38.5	2.7	69.2	21.0	11.6	3.5
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		35000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	3.3	2.4	1.9	19.4	2.1	7.9	2.7	2.3	2.4	2.8	1.9	3.2	2.4	1.4	0.9	2.2	1.1	6.2	1.4	1.7	1.9	0.8	5.2	7.8	24.2	5.2	3.1	1.5	2.0	0.9	0.4	7.1	4.5	1.1	4.5	0.2	1.4	3.4	0.4	1.3	4.6	4.0	3.8	15.2	3.6	1.9	5.2	9.9	1.1	0.7	13.2	4.7	0.8	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	45.3	0.1	0.0	0.0	13.1	49.7	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.1	0.0	0.0	12.9	9.7	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.0	2.9	0.0	32.7	9.6	15.0	8.2	8.0	6.5	6.3	7.0	10.1	7.1	6.0	4.0	7.4	1.2	1.4	3.2	4.1	10.5	8.8	1.9	2.1	2.3	2.4	1.7	1.9	5.2	3.1	4.5	3.8	5.2	7.2	1.3	0.0	6.4	0.0	27.4	2.4	0.7	0.0	0.6	0.2	0.6	1.5	1.2	2.8	1.3	0.0	0.0	0.5	20.5	0.2	0.0	0.1	0.9	0.5	0.2	4.2	0.0	21.5	0.1	0.2	0.5	1.2	2.6	0.2	187.1	0.1	3.3	1.1	91.1	0.0	0.2	0.1	0.0	177.0	42.2	1.5	0.6	90.6	5.4	34.7	76.4	0.0	4.1	0.0	0.1	0.0	0.0	0.0	10.8	0.9	0.3	0.3	0.7	0.2	0.0	1.6	1.5	0.1	0.4	0.5	2.4	1.0	46.8	2.9	0.2	0.6
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2"	"Group enriched"	"Detected in many"	18	"B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 296.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	7.8	5.3	3.5	34.5	3.4	10.3	4.4	4.0	3.6	3.5	4.8	6.3	3.7	2.4	1.0	4.0	2.1	14.3	2.7	3.2	6.1	1.9	11.2	18.6	28.8	7.2	5.5	2.1	2.6	2.9	1.1	15.0	7.0	2.4	7.7	0.9	2.3	2.5	0.8	2.0	6.8	7.4	5.3	23.4	5.2	3.1	5.0	10.6	1.3	0.8	22.0	14.9	1.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	296.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.2	0.0	32.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.0	0.1	0.0	0.1	15.1	0.6	35.1	0.0	0.9	0.0	0.1	79.9	0.8	0.0	79.0	0.0	41.0	0.2	0.3	78.8	28.5	0.2	0.1	0.9	3.7	85.2	8.3	1.6	33.4	3.5	3.4	4.0	3.6	3.2	6.1	7.2	5.5	7.0	5.3	5.0	10.2	0.9	0.0	7.7	0.3	36.5	3.6	0.1	1.3	0.0	0.0	0.4	1.3	0.3	1.5	3.2	1.8	0.0	1.8	3.3	0.0	0.0	0.2	3.7	0.1	0.0	2.6	0.0	1.3	0.2	3.5	0.8	0.8	0.5	0.0	2.5	0.1	1.8	0.8	121.3	0.0	0.3	0.0	0.0	107.8	148.3	2.7	0.0	151.8	7.2	78.7	489.4	0.0	0.0	0.5	0.1	0.3	0.0	0.0	20.6	0.3	0.0	0.1	0.1	0.4	0.0	0.3	0.7	0.2	0.3	0.2	4.0	1.9	2.1	0.1	0.0	0.3
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 111.7;T-cells: 242.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 4.0;MOLT-4: 15.2;RPMI-8226: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	5.3	4.6	2.1	21.2	2.8	22.5	4.7	1.9	3.0	3.8	1.4	4.9	11.8	3.0	3.6	4.4	4.0	9.8	2.3	2.1	2.1	1.8	7.4	10.5	45.0	2.8	2.1	2.5	2.6	1.1	1.5	0.6	2.5	3.4	5.9	0.2	8.3	1.9	0.8	1.3	20.7	2.4	2.2	117.1	16.4	1.0	2.3	369.0	4.4	0.4	21.4	9.1	4.0	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.6	15.2	0.9	0.5	0.1	0.2	0.1	0.7	3.3	0.0	0.3	0.7	1.9	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	30.0	0.3	234.4	0.6	2.3	523.0	0.4	0.6	2.2	476.8	4.3	27.9	0.9	1.2	0.8	152.4	2.1	2.8	1.9	3.0	2.1	2.1	2.8	2.1	2.5	2.2	2.3	2.1	2.2	0.0	4.6	0.0	5.7	2.0	0.2	0.0	0.0	0.3	1.5	1.5	3.4	1.5	0.6	0.0	0.0	0.0	111.7	0.2	0.0	0.2	0.3	0.5	0.3	1.3	0.0	7.8	4.2	0.0	0.0	2.6	8.2	0.4	2.5	0.0	6.4	2.3	0.1	0.0	3.1	0.3	0.0	1.9	11.5	0.2	0.0	6.6	0.0	1.0	5.9	0.1	38.1	0.0	0.2	0.0	0.0	0.0	30.8	0.2	0.0	0.4	1.5	0.4	0.0	1.1	1.4	0.4	0.4	1.1	1.8	0.1	242.4	0.0	0.6	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 53.2;T-cells: 162.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Cell line enriched"	"Detected in some"	60	"RPMI-8226: 1113.4"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.9	1.9	0.4	10.6	0.3	8.3	2.9	1.1	0.6	33.4	0.1	2.1	5.0	1.2	1.1	1.6	1.5	4.3	1.0	0.1	1.2	1.0	1.6	4.2	25.9	5.0	2.1	0.9	0.9	4.6	8.8	0.3	4.8	1.7	3.0	0.0	2.4	1.0	0.6	1.4	15.1	1.1	0.7	15.6	5.1	0.4	2.4	459.6	2.0	0.4	15.1	3.4	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	1113.4	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	42.0	1.0	0.8	15.7	1.1	79.3	0.7	1.9	601.8	0.6	1.2	4.6	1053.9	6.1	1.1	1.7	1.0	2.2	427.6	0.4	0.3	1.1	0.6	0.1	1.2	5.0	2.1	4.8	0.7	2.4	0.5	1.3	6.4	5.5	0.0	4.4	4.0	2.2	0.0	0.6	0.0	2.2	2.8	1.0	1.5	0.0	0.0	0.0	0.1	53.2	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.0	1.7	0.4	0.0	0.0	2.0	7.1	0.2	0.0	0.0	0.7	0.5	0.1	0.0	0.5	4.6	0.0	4.0	4.3	0.5	0.0	4.1	5.4	5.6	7.5	0.0	10.3	0.0	0.1	0.0	0.1	0.0	10.8	0.7	12.4	0.2	0.0	0.0	0.0	2.0	1.2	0.2	0.1	0.5	2.8	0.0	162.9	0.0	7.5	0.3
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.5;T-cells: 117.2"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066754	Enhanced					NA	NA		85000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"	5.2	1.7	0.7	12.2	0.8	16.0	2.8	1.2	1.0	3.1	1.8	5.0	6.0	2.6	0.9	1.8	1.9	5.8	0.8	0.8	0.8	1.6	3.7	8.3	26.9	1.8	0.7	0.9	0.4	0.2	0.7	1.0	1.2	2.1	5.9	0.1	2.7	1.1	0.4	1.0	10.1	1.4	0.7	12.8	6.8	0.8	1.2	61.8	3.9	0.1	20.2	11.8	2.6	2.2	0.1	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.3	1.6	0.3	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.0	15.9	0.2	0.2	0.0	0.8	1.3	0.0	0.0	0.1	0.1	1.2	0.0	18.2	0.3	2.0	0.0	0.0	68.7	0.2	0.6	0.0	0.0	0.1	1.9	0.5	0.6	58.2	0.1	0.0	0.2	0.9	0.1	0.3	0.3	0.2	0.0	0.3	1.1	0.3	0.1	5.6	1.9	0.0	0.3	59.0	12.2	2.3	0.5	15.6	74.0	0.3	117.2	10.8	67.0	85.3	0.3	18.8	68.7	81.8	2.7	79.5	0.7	0.5	47.4	46.4	0.7	0.8	1.2	1.0	0.8	0.8	1.8	0.7	1.2	0.7	1.2	2.2	1.5	19.2	19.0	0.0	12.5	3.2	0.8	0.1	1.2	1.6	1.6	1.4	1.0	0.0	9.3	1.8	0.0	0.6	96.8	0.8	0.0	0.1	0.8	2.1	0.8	3.0	0.0	9.3	0.7	0.0	0.2	4.3	8.6	1.6	16.4	0.4	2.2	0.9	0.2	0.0	0.4	0.7	0.0	5.0	6.7	1.1	0.3	6.7	3.6	6.5	2.9	0.5	58.7	0.0	0.1	0.0	1.3	0.0	29.6	0.3	0.0	0.4	1.7	2.1	0.0	0.8	1.0	0.4	0.7	0.6	3.1	1.9	199.9	0.2	0.5	0.6
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691187-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 1614.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"		NA	NA		62000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	476.3	143.3	132.0	119.2	142.1	105.4	327.7	148.8	135.4	367.4	126.5	353.2	148.5	305.5	132.4	208.8	249.4	264.5	343.7	128.8	247.5	112.7	227.7	256.5	146.6	210.9	178.1	303.0	234.6	46.8	132.9	194.8	216.8	270.3	152.9	15.1	184.2	258.4	163.7	284.7	210.0	226.1	224.4	186.0	209.1	199.6	139.4	562.1	152.6	168.3	129.2	296.3	314.6	227.6	259.4	276.5	308.5	424.8	1217.7	939.2	195.0	681.6	1050.1	419.2	604.8	412.3	179.1	18.3	130.0	929.4	217.5	99.4	124.1	168.4	337.5	350.8	321.2	53.1	179.5	353.4	390.1	81.7	375.0	580.1	204.9	223.7	155.6	271.8	766.4	256.3	66.4	0.9	391.9	191.2	672.3	266.8	107.5	28.6	310.0	118.7	273.2	513.5	240.7	165.4	1.0	141.2	168.7	138.2	432.6	744.9	129.6	229.4	750.2	509.7	86.1	487.1	230.2	1.0	0.8	116.1	338.1	203.1	323.8	23.6	526.0	18.3	1089.2	131.2	620.5	340.1	730.3	961.1	496.5	231.8	267.4	549.7	45.1	377.3	32.3	682.1	833.7	1421.2	132.0	142.1	148.8	135.4	128.8	247.5	210.9	178.1	216.8	224.4	139.4	227.6	297.7	64.1	68.3	20.5	172.0	250.6	207.4	274.4	138.9	5.1	66.9	48.3	86.6	112.9	88.4	71.7	0.0	223.6	507.7	68.4	13.7	145.3	8.8	180.2	279.7	387.7	80.8	136.5	0.9	138.4	189.7	604.7	116.7	188.8	230.4	1614.3	512.9	123.0	799.8	0.0	1.1	150.8	54.9	187.4	579.9	26.4	645.2	342.4	691.9	37.5	175.9	52.0	632.4	1.0	0.9	139.9	158.2	511.2	300.2	385.8	230.9	63.3	117.5	3.2	341.8	231.1	351.9	16.4	56.9	147.9	222.9	123.0	468.9	403.2	262.3	307.0
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766336-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 179.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.1;Horizontal cells: 52.2;Inhibitory neurons: 57.2;Oligodendrocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (8.74e-4)"	46.1	28.1	68.5	14.8	69.5	7.3	29.7	71.0	99.6	33.4	26.8	40.1	10.0	39.9	24.5	14.5	30.5	19.2	61.6	69.9	80.4	24.9	47.3	25.2	13.2	104.7	77.9	38.9	18.7	14.6	23.8	21.5	107.2	25.8	10.6	43.4	14.8	32.6	179.1	13.4	19.2	32.4	71.5	26.9	21.8	11.2	91.6	14.5	16.8	99.2	10.7	29.4	21.0	80.2	8.1	79.8	29.5	36.9	153.3	95.2	8.7	65.2	76.1	32.3	46.3	5.5	10.2	29.3	154.0	114.6	24.2	13.0	40.4	44.4	26.6	68.5	31.9	12.7	17.8	8.2	41.2	21.4	23.3	90.3	14.5	24.0	45.4	50.3	38.6	22.4	8.9	74.9	41.1	17.3	18.9	31.1	12.4	6.9	42.7	18.8	24.2	40.5	31.7	5.4	38.9	19.9	25.8	21.9	29.6	21.6	6.2	36.6	45.8	47.5	14.4	62.2	48.0	62.6	112.3	28.3	59.6	42.3	36.4	7.3	8.6	5.9	6.2	7.6	5.4	4.5	5.8	6.3	8.1	4.8	5.5	6.0	2.1	7.2	12.5	5.8	4.4	7.0	68.5	69.5	71.0	99.6	69.9	80.4	104.7	77.9	107.2	71.5	91.6	80.2	14.1	16.0	7.8	21.5	8.2	3.1	2.3	3.6	4.6	26.8	3.7	3.2	42.8	11.5	6.4	12.9	18.8	10.1	7.4	2.0	5.9	4.4	0.3	5.6	10.1	13.8	8.4	6.5	49.1	5.3	3.9	15.9	7.1	3.6	7.6	12.6	17.2	26.6	10.2	52.2	57.2	2.9	8.2	16.4	6.8	2.8	20.8	8.6	10.6	23.4	8.1	18.2	2.1	21.6	60.7	3.6	3.1	30.1	12.5	3.4	5.3	11.3	5.0	18.7	0.0	15.9	12.0	2.8	4.9	3.3	1.3	13.5	6.4	11.8	3.3	1.3
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20589086-20618903	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 193.5;esophagus: 87.1;liver: 86.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1234.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1234.7"	"Cell line enhanced"	"Detected in many"		"A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	7.1	3.0	8.0	9.6	8.1	193.5	3.7	8.3	10.6	19.7	7.4	23.7	6.4	5.3	5.5	87.1	6.4	4.3	6.7	7.9	8.3	14.0	86.7	7.1	1.5	9.0	8.2	1.5	0.8	3.2	1.2	10.8	9.5	4.3	27.8	0.5	15.0	3.1	1.7	17.1	16.3	11.3	8.3	23.4	2.1	1.0	8.9	2.0	4.5	6.4	4.4	5.5	38.5	8.7	200.3	21.4	0.0	0.0	0.2	5.5	0.0	16.7	4.3	4.1	16.2	1.0	141.9	0.0	8.1	30.8	8.7	63.9	4.5	46.8	10.7	0.1	3.9	0.0	207.1	34.4	1.4	0.0	0.0	8.8	8.9	31.4	0.0	0.5	2.7	0.0	0.0	0.0	1.6	0.2	0.0	1.0	0.1	24.7	107.0	0.0	0.1	3.4	1.5	0.0	0.1	0.0	249.9	0.0	0.3	2.2	0.0	4.3	3.4	0.2	8.3	18.5	1.2	0.0	0.1	0.0	2.4	96.9	0.0	216.2	207.2	471.1	0.5	124.7	0.8	0.1	0.4	0.9	12.7	0.2	0.3	0.4	1234.7	0.4	110.8	3.1	0.7	86.8	8.0	8.1	8.3	10.6	7.9	8.3	9.0	8.2	9.5	8.3	8.9	8.7	9.9	3.2	1.1	0.3	1.2	1.5	0.1	2.4	0.0	0.2	0.2	0.3	2.6	1.5	2.7	5.5	0.0	1.1	0.0	364.9	43.0	7.5	0.8	2.1	2.6	42.7	0.0	6.1	0.2	1.5	6.4	9.1	0.0	20.3	0.0	0.0	47.2	107.8	5.9	0.0	0.3	23.1	85.5	60.7	0.9	1.0	0.3	36.6	0.0	5.6	61.5	0.1	0.0	0.5	0.0	120.2	400.5	0.0	3.0	2.1	137.6	0.6	0.4	0.1	0.0	1.3	1.3	0.0	1.2	6.3	1.1	2.5	1.7	0.0	19.8	0.8
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.6;Late spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	5.0	6.8	4.9	2.3	4.5	6.3	4.2	5.8	6.5	4.0	5.8	4.7	3.1	3.8	5.1	3.2	4.2	2.7	4.3	4.5	5.5	9.5	8.1	3.5	3.1	4.9	5.4	4.5	2.7	5.5	3.2	2.0	5.1	3.9	3.2	5.2	3.4	4.4	4.4	2.2	3.0	3.7	4.7	4.1	3.9	7.9	5.6	4.3	9.4	5.2	2.6	3.5	3.6	5.4	2.1	2.6	2.2	2.7	10.8	5.9	1.1	5.0	3.1	2.5	2.6	2.6	1.7	2.9	1.0	2.2	2.4	3.6	4.6	2.2	3.2	6.3	3.7	3.3	2.5	2.7	4.7	6.3	1.7	4.1	5.5	2.3	3.0	4.4	3.7	5.6	2.1	2.1	3.2	0.7	6.0	5.1	0.8	3.6	2.2	4.0	2.4	2.9	3.6	0.7	1.3	1.1	3.4	2.1	2.9	1.4	1.5	5.4	2.8	1.3	2.4	3.5	2.4	0.6	2.4	1.8	1.1	7.2	3.7	9.9	1.1	0.9	1.4	0.9	1.5	0.4	1.0	1.9	0.8	0.6	0.9	1.3	1.2	1.2	1.8	0.8	1.6	0.9	4.9	4.5	5.8	6.5	4.5	5.5	4.9	5.4	5.1	4.7	5.6	5.4	12.4	6.4	12.4	9.4	6.6	8.0	7.3	10.7	11.4	12.7	8.5	9.7	15.0	5.7	8.6	18.4	12.5	4.6	19.1	4.7	9.8	5.3	174.6	12.6	14.6	8.7	6.7	10.3	16.0	10.7	10.9	17.1	6.6	6.0	24.7	10.0	11.7	11.5	6.2	3.3	21.4	6.9	4.1	9.1	8.3	77.7	15.8	9.9	7.2	3.7	5.4	25.9	9.2	14.1	12.4	6.7	5.7	14.3	10.6	7.3	7.9	25.4	18.9	12.2	0.0	15.3	17.8	39.3	15.5	7.7	5.4	2.5	14.1	17.2	6.0	5.7
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	4.0	5.0	2.1	3.6	2.2	8.1	4.3	4.3	3.1	7.7	3.2	4.5	2.8	5.9	4.4	4.1	6.1	2.5	2.9	2.1	0.9	3.2	4.0	3.5	4.2	3.0	1.5	11.3	4.8	3.5	5.1	3.2	2.7	6.9	2.5	2.6	5.4	3.5	4.2	4.9	4.2	2.8	0.7	4.6	4.5	6.3	1.4	5.2	5.1	2.8	3.4	5.8	5.6	2.6	8.1	5.4	7.2	10.4	6.3	5.4	8.6	10.4	4.3	9.9	7.2	13.6	4.2	3.9	11.2	5.8	9.7	15.5	7.7	4.7	2.9	9.9	7.2	14.5	10.3	5.3	4.7	10.8	13.2	7.4	5.2	6.3	4.5	6.1	7.6	13.0	18.9	5.7	8.2	4.5	8.4	14.2	3.6	7.7	8.5	11.9	9.0	3.4	3.1	7.9	5.9	6.8	8.2	11.3	1.7	4.6	8.6	15.9	5.6	10.4	9.2	8.6	12.1	11.2	12.7	8.7	5.4	15.8	8.6	1.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2.1	2.2	4.3	3.1	2.1	0.9	3.0	1.5	2.7	0.7	1.4	2.6	2.0	0.0	3.7	4.6	2.4	1.9	2.0	1.5	1.8	3.3	3.2	1.8	2.2	2.8	1.5	7.3	4.2	3.0	2.6	1.9	0.0	1.5	0.4	2.0	2.8	2.3	4.8	1.7	7.6	1.8	1.6	2.9	3.6	2.0	1.3	9.0	3.9	3.6	2.1	1.7	6.3	1.6	4.1	2.5	0.9	1.2	4.4	1.6	0.0	4.7	1.5	4.5	2.1	5.5	3.8	1.6	0.5	4.9	2.5	2.3	2.2	1.3	1.9	4.7	19.7	3.4	2.4	5.4	2.1	2.8	1.3	2.2	2.5	4.6	2.6	1.7
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	44.9	40.0	38.1	53.8	44.3	73.5	45.9	40.6	46.1	43.5	39.1	54.1	37.1	39.0	46.9	50.1	42.3	34.0	61.0	41.7	41.5	42.6	55.6	35.8	69.1	40.3	38.4	31.4	29.4	42.3	33.0	50.8	40.5	35.4	58.3	29.7	31.5	39.3	49.7	44.3	39.1	53.4	41.3	45.3	35.4	35.7	40.1	65.2	41.5	52.5	81.1	63.6	34.7	43.7	155.4	187.4	148.3	157.1	125.4	136.3	117.7	137.0	94.2	194.8	205.5	274.0	186.5	259.7	123.5	153.6	116.1	157.7	237.0	223.3	172.0	176.8	206.6	199.3	142.8	266.6	162.1	151.6	159.0	131.3	118.9	214.0	126.5	98.0	206.3	320.6	224.2	114.5	178.6	135.0	208.3	133.8	221.4	223.1	76.3	195.7	111.9	234.0	173.2	86.3	72.3	140.8	139.6	165.4	152.6	120.4	180.7	179.2	200.9	107.7	127.6	167.9	166.6	112.5	233.5	320.7	135.4	155.3	69.7	133.8	99.2	242.2	103.6	117.0	108.1	158.6	114.8	115.0	139.0	170.5	93.5	99.9	233.4	121.1	129.4	116.0	143.5	167.3	38.1	44.3	40.6	46.1	41.7	41.5	40.3	38.4	40.5	41.3	40.1	43.7	48.6	32.1	35.9	18.3	51.5	54.2	49.2	162.1	39.9	28.5	28.0	32.3	56.4	24.3	75.8	35.0	6.2	120.8	55.3	25.1	86.1	91.1	7.9	26.8	39.5	49.7	20.9	36.8	33.2	82.6	138.2	46.3	26.5	26.1	49.4	36.6	34.2	37.6	101.3	26.9	27.9	31.9	105.8	25.9	34.0	10.1	41.7	37.2	46.2	21.5	79.3	43.3	45.3	19.6	23.5	84.3	34.3	45.9	44.2	46.5	30.7	73.0	62.5	29.9	39.5	32.3	59.8	50.2	41.5	46.5	74.0	77.6	51.3	72.4	47.0	50.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC16	"ANAPC6, APC6, CUT9"	ENSG00000130177	"Cell division cycle 16"	Q13042	13	114234887-114272723	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042826	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA042826: AB_10793987"	"unprognostic (7.32e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.51e-2)"	37.6	36.6	51.2	24.7	52.2	25.7	38.9	51.9	69.2	44.3	56.7	37.0	26.7	37.4	50.3	33.1	45.4	23.9	34.2	51.6	52.9	37.8	49.8	31.7	35.5	52.9	53.5	41.5	48.0	33.4	39.4	34.8	53.7	38.9	37.6	42.8	31.6	31.9	41.7	41.9	35.2	39.2	52.2	44.3	38.1	42.0	51.8	42.8	35.3	37.5	39.5	37.4	35.9	55.6	75.4	42.1	63.1	65.8	78.5	98.7	36.0	76.3	63.0	78.7	75.6	38.9	60.7	68.0	28.7	104.8	75.4	41.6	56.6	72.5	104.2	42.7	65.9	56.8	53.7	39.8	83.8	104.6	76.4	72.2	78.5	53.7	69.0	77.8	76.8	35.7	48.7	26.1	109.7	34.6	45.7	49.2	71.1	129.0	38.8	22.2	32.6	41.3	94.0	50.9	61.2	58.8	42.3	68.8	130.0	106.8	53.3	126.0	61.7	34.8	61.4	27.8	46.6	38.2	32.3	72.2	83.3	63.0	47.5	2.3	2.9	3.3	3.3	3.2	3.1	8.4	2.3	4.3	4.4	6.8	2.5	2.7	0.7	11.2	2.6	6.1	4.7	2.2	51.2	52.2	51.9	69.2	51.6	52.9	52.9	53.5	53.7	52.2	51.8	55.6	27.2	38.5	30.3	69.2	24.7	17.8	21.7	23.0	17.1	17.1	20.4	20.7	37.4	24.3	39.7	35.0	25.0	38.1	24.0	13.6	23.5	34.4	34.6	63.3	25.9	27.1	19.7	45.0	41.6	37.2	33.8	33.5	30.1	31.3	26.6	30.4	28.2	32.6	34.7	13.5	39.3	31.0	16.2	22.0	12.9	29.1	26.4	24.9	23.2	23.4	27.3	23.0	19.6	45.8	65.3	33.0	12.9	29.0	24.9	26.2	19.2	28.7	71.0	23.3	26.3	31.6	23.5	53.9	49.5	21.4	19.0	24.9	21.8	31.3	23.8	18.0
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112971-55173177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 2.1;kidney: 1.1;testis: 2.6"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 18.8;Ionocytes: 12.2;Respiratory ciliated cells: 24.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053900	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.3	2.4	1.2	0.0	0.9	2.3	0.5	0.0	2.1	0.0	0.0	0.1	0.2	1.6	0.0	0.1	0.3	18.8	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.5	12.2	0.6	4.1	0.0	0.0	0.7	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.7	0.9	2.7	0.8	24.5	0.0	0.0	0.5	0.5	1.3	0.8	0.7	0.1	0.1	0.3	0.1	0.7	0.1
CDC23	"ANAPC8, APC8, CUT23"	ENSG00000094880	"Cell division cycle 23"	Q9UJX2	5	138187650-138213343	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039593	Approved				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA039593: AB_10795146"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.46e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.68e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.46e-1)"	12.4	11.8	12.3	13.6	12.7	14.1	17.4	14.5	15.7	12.7	10.0	14.0	11.4	15.1	17.2	14.5	12.4	10.6	15.3	12.5	11.7	19.8	18.3	13.3	17.9	11.6	11.6	14.8	9.5	18.4	10.0	26.2	11.8	15.5	15.6	14.0	11.8	13.6	10.1	16.5	10.9	16.9	12.0	14.4	12.8	15.1	11.8	20.3	16.1	12.2	19.4	14.6	11.7	13.1	42.7	35.8	51.2	62.7	22.2	24.8	59.8	34.8	26.8	70.0	72.3	83.9	46.7	52.0	52.3	32.6	71.9	41.6	67.5	54.0	64.4	40.3	61.9	41.5	30.6	37.7	30.8	33.1	39.4	26.0	36.4	43.9	37.0	29.1	47.3	55.1	43.7	39.1	34.9	28.6	65.6	40.3	32.6	52.6	28.6	58.3	60.8	36.0	38.8	26.9	40.7	36.8	51.8	33.1	61.1	97.3	49.3	41.2	32.6	42.0	27.6	37.1	56.7	43.6	46.7	67.7	28.9	57.2	37.2	41.4	15.1	21.6	18.3	16.5	22.2	16.8	17.9	19.3	14.4	16.2	23.4	20.7	2.9	27.0	12.3	10.4	18.1	16.0	12.3	12.7	14.5	15.7	12.5	11.7	11.6	11.6	11.8	12.0	11.8	13.1	11.7	19.2	9.5	9.8	9.7	8.0	13.9	18.8	11.4	10.5	11.8	10.5	19.0	5.7	23.3	9.2	25.0	31.9	10.3	8.2	39.2	12.5	0.8	9.1	15.1	13.2	6.1	19.8	14.0	7.2	20.4	11.9	8.6	12.3	9.5	13.5	11.0	20.0	15.7	16.8	12.8	9.0	26.4	13.0	4.7	1.1	8.7	8.8	12.4	5.6	12.6	16.4	9.2	10.6	13.5	9.7	4.6	6.4	11.4	11.3	5.6	26.4	10.4	13.1	6.6	9.7	13.2	14.5	25.3	15.9	10.1	40.8	11.2	13.1	9.8	13.8
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDC26	"ANAPC12, APC12, C9orf17"	ENSG00000176386	"Cell division cycle 26"	Q8NHZ8	9	113255835-113275572	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044130	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044130: AB_10963690"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.79e-2)"	42.9	33.1	27.1	34.1	27.4	28.9	39.0	27.3	39.5	34.0	33.8	37.7	30.9	28.2	41.7	34.2	31.0	25.3	52.9	26.3	29.3	49.2	53.1	34.2	42.5	28.1	27.2	33.8	29.9	58.8	29.6	27.7	29.5	36.9	34.2	41.7	32.5	31.8	47.5	36.2	37.2	26.5	29.1	42.0	34.3	22.4	27.7	46.0	35.2	52.4	46.9	40.3	32.7	29.2	47.0	73.3	62.5	32.2	104.4	89.3	29.0	67.1	100.7	67.6	66.3	78.0	53.9	84.1	56.6	58.3	77.2	88.8	53.2	99.1	66.8	80.3	38.9	55.7	71.4	73.1	50.8	99.6	55.0	62.2	68.9	62.5	92.2	70.3	91.7	67.2	85.3	63.7	51.8	94.7	86.2	62.9	102.7	213.1	65.1	73.1	134.3	42.9	71.1	78.2	48.1	45.7	88.4	63.7	51.4	68.2	57.9	43.4	62.1	40.5	37.9	61.4	87.5	43.5	79.5	67.4	57.1	58.3	41.0	239.6	116.9	274.2	177.6	127.3	220.0	233.4	222.3	195.9	122.2	201.0	253.5	195.2	182.8	192.8	122.9	103.8	241.6	171.5	27.1	27.4	27.3	39.5	26.3	29.3	28.1	27.2	29.5	29.1	27.7	29.2	91.9	35.3	40.9	3.3	58.5	77.9	79.3	111.8	68.3	20.3	58.2	79.8	5.3	45.8	61.2	22.0	22.9	45.7	59.6	51.1	113.5	64.4	22.2	53.4	67.4	65.7	31.8	55.2	5.0	59.5	68.6	54.3	21.4	43.3	27.3	48.6	63.1	83.3	58.4	15.2	5.5	50.7	73.2	51.6	92.0	13.9	80.2	49.6	51.6	2.8	67.9	76.7	72.1	5.0	6.7	58.0	62.7	43.6	51.7	91.4	88.9	169.2	68.1	36.4	26.3	54.2	43.7	35.3	16.8	55.0	90.8	47.9	75.4	50.0	47.2	97.7
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 149.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	23.0	15.2	9.3	20.1	12.0	27.6	18.1	18.3	15.2	18.0	5.6	15.2	14.6	20.7	13.1	16.6	15.1	18.4	23.3	11.6	12.0	15.2	22.4	18.1	23.4	10.6	10.8	17.0	14.5	24.4	10.6	25.5	11.5	15.1	17.7	13.7	12.2	15.4	22.4	12.1	13.8	24.5	10.5	19.1	15.9	25.0	11.3	25.0	42.4	28.8	24.0	19.8	11.2	11.3	80.7	84.1	69.1	56.1	45.5	72.0	41.0	110.9	99.0	103.3	105.1	54.2	41.4	107.4	72.7	93.5	66.0	37.5	75.2	62.6	141.2	155.5	77.2	125.0	92.9	48.6	49.2	74.4	54.6	52.4	30.2	93.5	73.1	49.7	108.6	61.6	101.6	58.0	85.2	68.3	91.8	33.5	32.8	45.2	67.8	48.9	177.3	47.8	62.0	50.0	45.8	55.9	55.4	19.4	61.2	58.6	58.6	51.7	116.9	107.1	91.9	68.6	82.9	58.8	110.2	95.8	59.4	43.6	76.0	9.3	3.2	4.9	5.3	7.1	5.2	4.0	4.2	5.5	4.2	6.3	4.2	5.0	4.0	8.7	5.3	5.2	8.3	3.5	9.3	12.0	18.3	15.2	11.6	12.0	10.6	10.8	11.5	10.5	11.3	11.3	63.7	9.6	26.3	61.0	28.7	26.0	17.8	25.9	38.1	22.1	21.3	17.5	39.8	21.5	27.1	20.2	16.7	31.4	22.5	11.5	15.6	28.1	28.9	20.8	33.9	50.7	13.8	149.8	124.5	26.5	35.6	41.4	21.4	22.1	26.6	24.8	38.9	27.1	27.2	35.3	104.4	12.8	8.2	28.5	22.1	33.6	28.3	30.6	7.2	83.4	31.5	19.4	35.0	89.0	96.1	30.1	9.5	29.7	39.0	18.7	13.5	23.6	16.2	14.9	19.7	41.6	40.8	97.3	38.6	32.6	26.9	11.5	27.8	34.2	16.2	17.1
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34, ubiqiutin conjugating enzyme"	P49427	19	531760-542092	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	35.1	36.7	52.0	13.3	51.2	34.5	34.2	51.5	63.0	36.9	47.5	62.5	17.8	33.5	14.1	40.5	33.6	10.1	80.0	52.7	48.7	32.1	88.0	32.1	12.5	51.0	50.7	35.6	58.5	18.7	43.4	29.2	50.8	36.9	11.5	28.2	34.2	19.3	105.0	51.8	27.6	18.5	48.2	31.0	38.6	100.2	52.7	16.4	26.7	63.2	9.7	43.7	34.2	52.7	54.8	54.6	66.4	54.7	29.2	28.4	68.5	47.8	36.1	50.2	51.9	86.1	32.8	29.5	49.3	34.1	30.1	36.9	52.1	40.2	25.0	49.2	146.0	27.8	35.5	94.5	73.6	39.0	32.4	36.4	58.9	42.2	43.6	38.8	60.6	41.2	120.3	57.5	33.8	80.7	53.3	53.6	85.3	39.4	51.7	49.1	35.1	51.2	38.0	32.4	87.2	65.9	41.5	42.1	85.2	53.2	34.0	57.4	50.5	36.5	43.7	86.2	65.2	57.7	47.3	40.1	50.0	55.6	38.8	3.2	2.5	4.7	1.6	2.7	1.1	2.3	2.1	2.9	2.0	1.0	1.6	1.6	8.2	1.2	3.5	1.6	2.5	1.0	52.0	51.2	51.5	63.0	52.7	48.7	51.0	50.7	50.8	48.2	52.7	52.7	39.4	0.0	5.4	21.9	11.4	46.8	17.5	5.4	16.5	35.5	43.4	47.1	27.7	27.1	3.5	14.7	25.0	44.3	30.9	47.4	13.7	24.9	63.9	29.6	28.3	27.7	13.2	77.7	8.3	20.5	55.4	21.4	16.8	42.3	0.0	28.1	15.7	41.1	27.9	16.8	6.3	34.0	14.2	14.5	38.6	249.4	18.0	20.6	19.6	2.8	15.1	68.9	20.6	6.6	12.9	45.0	27.0	15.1	25.0	34.8	25.9	18.9	5.5	44.3	13.1	22.6	34.9	22.4	54.6	15.2	54.7	63.1	22.0	27.1	23.7	27.9
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37, HSP90 cochaperone"	Q16543	19	10391133-10420121	"Cancer-related genes, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol		NA	NA		610000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	149.9	93.6	82.2	81.3	84.6	89.5	130.6	75.0	104.2	111.4	72.1	109.9	58.1	110.0	34.2	125.7	98.5	39.8	186.0	86.3	85.8	123.2	102.2	129.9	66.5	85.9	85.8	105.9	100.3	59.3	74.6	62.7	88.1	105.0	48.2	34.6	96.6	52.2	313.2	100.9	96.3	50.2	75.7	137.5	102.8	77.5	82.5	69.3	100.8	222.6	52.4	110.3	103.0	87.8	279.2	181.2	95.5	137.5	128.8	111.8	122.9	322.8	144.6	198.3	168.8	209.1	106.7	165.3	254.7	198.3	117.2	169.9	130.6	208.7	136.4	133.6	387.2	313.9	147.2	300.9	202.5	183.9	137.9	136.9	112.5	231.8	104.0	113.5	258.1	142.2	248.2	193.8	156.1	265.3	184.3	450.2	234.6	175.5	317.8	181.0	128.3	190.3	185.1	178.2	111.5	161.9	151.5	158.1	143.1	72.7	108.4	195.7	290.0	230.8	133.9	319.9	262.2	261.3	276.5	204.4	181.4	294.1	191.2	77.2	110.8	97.1	114.4	107.9	103.1	73.2	91.8	103.5	105.2	62.9	70.0	81.8	60.2	101.1	112.6	89.4	106.8	145.6	82.2	84.6	75.0	104.2	86.3	85.8	85.9	85.8	88.1	75.7	82.5	87.8	420.1	54.5	95.5	51.6	163.7	148.6	119.3	149.0	127.5	78.0	85.0	75.8	71.3	75.8	114.8	64.4	39.6	188.9	166.1	192.3	101.8	199.8	119.0	88.2	120.5	267.5	81.3	89.8	35.0	199.0	430.2	108.3	226.8	126.4	134.3	90.8	172.1	45.3	210.2	89.2	24.6	181.3	105.8	83.9	313.8	253.8	106.2	165.6	138.7	29.0	165.1	75.8	135.9	21.1	32.5	297.6	183.5	103.4	170.5	120.1	117.9	89.7	78.2	84.4	78.9	94.4	138.6	72.4	73.5	138.1	133.7	242.4	164.2	123.0	186.1	156.1
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708399	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 126.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favorable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	20.4	15.6	10.6	9.5	10.9	8.0	13.8	12.2	13.1	14.2	11.6	13.8	10.1	12.9	13.8	19.9	13.2	14.6	31.2	14.0	12.8	16.6	55.0	10.5	13.1	11.1	12.0	15.0	19.6	11.6	10.1	9.6	12.4	15.9	7.9	12.9	12.5	12.0	86.5	10.2	10.4	12.3	11.2	8.4	11.8	14.2	11.9	9.8	14.7	52.5	9.4	17.6	11.1	12.0	17.1	15.2	7.8	12.7	27.9	20.4	12.1	19.6	13.4	11.7	13.3	4.9	10.4	10.8	5.4	14.3	7.8	7.4	8.8	11.9	11.3	126.8	7.6	28.7	15.8	13.3	16.7	11.6	11.3	13.3	15.3	8.7	13.7	12.9	8.5	9.7	3.4	16.2	13.1	8.2	9.2	24.0	20.0	11.2	5.3	7.3	9.6	6.2	16.6	6.9	22.5	11.2	14.6	11.7	9.8	10.0	9.6	10.9	9.1	17.5	8.2	9.9	13.1	12.5	21.2	7.8	15.6	8.2	5.7	26.5	7.7	15.7	17.0	7.5	16.7	14.1	17.0	18.1	7.5	15.0	25.8	23.5	9.0	12.3	10.0	8.6	17.4	10.6	10.6	10.9	12.2	13.1	14.0	12.8	11.1	12.0	12.4	11.2	11.9	12.0	17.7	28.9	18.3	23.2	19.6	65.9	48.0	31.9	31.9	28.3	24.7	19.0	80.4	25.8	26.3	16.5	33.3	19.7	27.9	15.1	49.0	33.5	9.8	25.9	23.3	20.7	17.9	5.7	24.2	41.2	17.0	35.1	19.9	16.1	23.5	12.9	17.5	103.9	11.3	20.2	29.4	20.0	40.7	13.6	25.1	5.1	36.1	14.8	40.9	9.4	14.9	36.7	18.6	21.1	23.0	27.3	17.3	36.5	20.9	76.5	15.7	66.0	25.3	22.6	32.9	27.8	43.0	77.3	58.1	25.0	57.4	33.8	31.9	15.5	12.0	44.0
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 320.3;Excitatory neurons: 447.6;Inhibitory neurons: 479.0;Oligodendrocyte precursor cells: 444.3;Oligodendrocytes: 671.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	15.6	12.5	26.3	5.5	32.4	3.5	12.2	33.5	30.0	15.8	12.2	21.2	14.7	15.0	7.7	10.1	12.6	13.7	16.4	24.9	25.2	17.3	14.7	12.3	2.0	25.7	26.8	14.0	13.1	19.7	14.6	12.7	27.0	15.8	10.3	23.7	7.6	14.9	11.4	6.3	12.9	14.5	19.8	6.6	22.4	24.4	29.7	2.2	8.1	13.6	1.8	23.0	11.3	37.0	22.6	21.1	21.9	10.4	21.5	26.4	7.7	25.4	35.7	17.2	17.9	17.1	50.1	0.1	26.6	42.4	13.0	10.3	16.3	14.2	20.9	0.1	13.2	17.4	25.5	6.7	24.3	14.1	7.5	18.6	17.9	27.8	27.8	21.3	58.0	13.6	45.1	0.1	28.2	6.2	0.4	2.5	18.0	29.3	20.0	0.0	37.0	0.1	27.7	43.1	15.7	22.9	43.0	17.8	24.8	13.4	23.1	0.8	59.0	31.3	16.2	36.1	33.9	0.1	0.1	0.1	41.4	0.0	42.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	32.4	33.5	30.0	24.9	25.2	25.7	26.8	27.0	19.8	29.7	37.0	82.6	41.7	35.7	320.3	0.8	11.7	26.0	15.9	12.0	97.7	14.0	12.8	59.9	30.0	38.9	44.1	118.9	5.9	1.8	49.3	13.7	26.0	128.0	18.7	45.1	68.4	26.4	45.6	447.6	41.1	7.3	44.4	92.8	25.7	7.0	21.5	47.8	28.9	3.7	223.8	479.0	30.5	22.4	4.4	9.9	132.3	44.1	6.4	16.0	180.8	5.9	33.4	0.0	444.3	671.8	65.1	74.0	85.4	1.8	30.1	50.7	41.3	24.8	66.9	78.9	64.0	68.4	45.6	57.7	8.0	8.0	1.4	1.3	23.4	34.4	43.1
CDC42BPB	"KIAA1124, MRCKB"	ENSG00000198752	"CDC42 binding protein kinase beta"	Q9Y5S2	14	102932380-103057549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022821	Approved					NA	NA		12000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA022821: AB_1846376"	"unprognostic (6.73e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.67e-10)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (7.56e-2)"	38.7	31.3	42.7	17.8	42.5	3.6	31.2	31.2	40.2	33.5	21.0	35.8	30.2	38.0	17.9	37.8	31.3	29.5	36.3	44.3	36.4	32.3	28.9	32.9	9.8	38.6	40.2	33.4	33.1	34.2	32.5	29.5	35.7	28.7	20.2	24.1	27.9	30.4	27.2	33.0	34.9	32.3	38.5	22.2	32.0	25.2	40.8	8.6	29.6	24.2	12.6	35.0	33.2	46.1	42.8	83.8	52.7	38.7	57.3	65.1	53.0	47.9	50.3	49.7	45.4	28.8	49.0	0.0	51.1	93.7	37.7	53.0	54.9	57.2	52.3	52.2	24.8	23.4	68.0	29.0	62.2	0.2	24.1	56.7	57.6	51.0	48.5	52.2	97.7	9.8	19.3	11.7	48.3	89.2	0.4	5.4	25.3	66.5	68.4	0.2	44.3	1.2	63.1	82.6	38.2	41.6	85.1	31.6	35.8	55.7	48.7	14.9	125.3	47.3	31.6	105.8	45.3	15.1	17.4	12.4	53.2	5.2	46.9	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	42.5	31.2	40.2	44.3	36.4	38.6	40.2	35.7	38.5	40.8	46.1	57.1	57.7	35.8	37.5	7.8	14.5	16.5	14.5	17.6	45.8	19.1	15.4	28.8	28.6	27.4	55.2	33.3	12.6	0.5	35.4	3.9	29.8	14.2	35.8	55.0	46.3	25.2	11.0	40.3	21.8	11.1	25.7	32.1	59.4	13.3	37.8	36.0	20.5	12.8	57.2	33.1	16.1	30.5	13.5	14.7	7.9	32.3	21.7	12.4	31.9	11.1	29.3	0.0	31.7	74.6	44.2	15.4	55.3	3.5	26.1	28.2	15.4	28.1	42.3	6.6	38.6	29.3	15.5	17.0	27.2	18.3	16.8	3.2	37.3	27.5	32.4
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823052-64844653	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 14.8;Gastric mucus-secreting cells: 23.0;Paneth cells: 18.3;Squamous epithelial cells: 19.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.3;HaCaT: 22.5;MCF7: 30.7;RT4: 18.4;SK-BR-3: 18.4;T-47d: 18.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 10.5"	"Low region specificity"	"Detected in some"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	4.9	0.2	1.4	0.3	2.1	4.8	9.7	1.2	5.4	5.5	8.8	10.6	0.4	2.0	26.5	3.8	2.8	0.4	0.4	0.3	7.7	0.9	7.8	1.3	0.4	0.7	2.2	14.1	6.4	11.0	4.2	1.0	8.5	4.5	0.3	17.7	3.7	0.2	33.7	9.3	0.2	0.3	1.8	12.2	3.3	0.3	2.4	6.0	0.0	2.0	5.8	13.0	0.3	8.9	1.2	0.8	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	11.7	7.5	0.1	4.3	0.0	0.4	22.5	1.3	8.8	0.0	0.4	3.6	0.7	5.3	3.8	0.0	0.3	2.2	0.0	10.9	0.1	0.1	0.1	0.1	3.5	6.1	0.1	0.0	30.7	0.2	1.7	2.7	8.3	1.3	1.3	0.5	4.3	5.5	18.4	15.6	0.7	2.8	18.4	0.5	4.3	18.1	0.4	0.1	0.0	3.1	0.1	0.1	2.1	2.2	2.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	9.7	1.2	0.4	0.3	0.4	0.7	1.0	0.3	0.3	0.3	1.0	9.6	7.9	0.0	1.2	6.5	2.3	3.6	9.6	0.0	5.1	5.8	1.8	2.8	9.6	1.8	0.0	6.4	1.7	14.8	0.0	2.4	0.6	13.2	0.7	0.4	3.6	0.8	0.1	6.2	4.9	0.7	23.0	7.9	1.3	0.4	0.0	0.0	1.0	0.0	0.1	4.8	2.0	0.0	0.4	0.8	0.0	1.3	0.0	0.0	1.2	0.8	1.0	0.0	0.1	2.9	18.3	0.0	0.1	1.6	12.4	0.5	9.5	0.0	0.0	2.2	0.8	1.7	1.3	19.3	8.1	6.7	1.4	0.6	5.7	3.4
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314866-65322417	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 171.5;monocytes: 118.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavorable (2.89e-5)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	42.1	5.7	15.4	7.7	25.1	0.4	23.1	20.7	20.0	13.9	5.8	15.4	9.1	16.6	1.7	7.7	15.3	15.2	22.4	15.7	17.0	15.3	4.1	19.1	1.8	24.9	23.6	10.8	5.8	0.6	5.0	11.6	22.3	10.2	1.6	1.9	4.9	4.5	6.6	5.6	13.0	6.8	17.5	18.4	14.5	2.1	21.4	0.4	16.8	5.6	1.2	18.6	9.4	44.3	7.1	6.6	0.9	4.3	14.6	26.4	1.3	7.4	28.8	5.5	6.2	19.8	16.7	0.5	20.9	19.9	2.0	8.9	2.5	26.0	1.2	1.0	3.8	1.3	12.8	14.8	51.5	0.4	0.5	11.5	2.7	20.3	28.8	4.5	22.4	1.0	2.6	4.3	7.1	10.7	0.8	1.6	3.7	18.5	61.0	0.8	0.7	0.5	19.5	4.9	0.5	1.7	18.0	14.7	1.1	0.7	2.5	0.4	30.6	6.7	5.6	55.9	3.1	0.1	1.7	0.6	11.2	0.3	2.7	0.0	50.4	2.1	0.1	118.8	0.1	1.2	0.0	0.1	9.9	0.0	0.1	0.0	171.5	0.0	88.5	0.4	0.0	17.8	15.4	25.1	20.7	20.0	15.7	17.0	24.9	23.6	22.3	17.5	21.4	44.3	25.8	0.0	0.0	0.0	1.5	12.7	11.0	25.8	6.8	15.3	12.1	6.3	6.3	2.8	17.0	12.9	0.0	0.5	1.6	10.0	3.9	50.5	0.5	6.0	11.6	36.4	1.8	2.7	0.6	40.3	3.5	32.3	9.7	11.1	5.7	1.5	26.7	0.9	1.3	3.3	0.4	8.0	8.2	18.7	77.7	1.9	18.6	33.3	12.4	1.0	18.3	1.0	0.0	0.0	10.6	65.1	15.6	13.5	1.8	7.4	21.2	3.7	6.3	5.3	39.5	16.6	16.2	1.7	3.4	4.8	10.1	1.6	1.4	1.8	8.4	36.4
CDC42EP3	"BORG2, CEP3, UB1"	ENSG00000163171	"CDC42 effector protein 3"	Q9UKI2	2	37641882-37738468	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 233.5;Langerhans cells: 259.6;Melanocytes: 200.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 607.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034986, HPA061792"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"HPA034986: AB_10602207, HPA061792: AB_2732670"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.53e-2)"	55.2	10.3	4.4	21.9	5.4	86.5	38.8	0.4	24.8	50.5	22.2	42.4	6.1	92.7	10.7	21.1	24.3	21.2	59.6	7.2	6.9	24.4	9.0	29.3	25.5	2.8	3.9	23.8	27.2	8.3	6.8	26.3	5.9	93.4	20.6	15.4	14.6	107.0	57.7	15.1	17.3	96.4	2.2	26.8	14.4	41.9	5.5	36.2	15.9	22.0	23.4	45.4	20.3	3.3	100.2	38.0	21.6	1.2	80.6	42.2	33.8	84.2	221.1	127.5	92.2	69.8	39.3	17.6	66.5	198.9	39.2	47.1	27.1	99.6	129.4	68.2	9.5	31.6	37.5	0.0	156.1	7.1	1.8	129.6	91.7	110.1	243.2	206.6	75.6	7.0	5.0	13.8	607.0	0.8	3.4	59.3	44.1	1.2	23.5	2.8	163.8	9.3	93.1	47.4	23.7	69.9	41.6	29.7	50.2	37.7	9.9	58.8	57.5	152.3	40.0	40.2	86.9	27.0	37.9	5.9	63.1	48.4	215.4	54.6	88.2	6.9	69.4	56.7	74.6	24.9	44.5	60.2	30.9	11.0	14.3	37.3	189.4	38.3	119.5	0.9	35.8	61.5	4.4	5.4	0.4	24.8	7.2	6.9	2.8	3.9	5.9	2.2	5.5	3.3	233.5	6.4	50.4	1.6	50.3	37.1	137.3	81.4	5.7	12.3	31.9	40.1	97.5	12.8	28.9	31.3	35.5	30.8	63.8	7.8	9.8	20.8	51.7	49.6	24.4	113.9	41.2	14.5	15.6	15.9	68.2	29.7	14.3	33.6	129.6	9.2	83.2	1.5	12.2	101.0	34.9	59.6	32.6	44.1	259.6	158.0	15.2	86.0	200.9	9.4	78.6	27.5	106.1	4.0	0.5	24.9	3.0	126.7	43.4	32.7	1.1	5.0	73.3	13.2	0.0	29.2	29.4	67.2	13.6	3.1	13.5	12.0	97.7	1.4	6.0	38.5
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312005	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Horizontal cells: 753.7;Muller glia cells: 570.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	94.5	54.9	84.9	15.3	84.7	14.9	74.5	90.6	76.3	47.4	75.0	55.6	35.7	52.7	60.1	33.3	69.4	19.1	50.5	82.2	103.1	28.6	32.2	38.6	16.1	141.9	104.5	70.7	77.5	20.5	45.0	22.9	83.7	38.7	17.4	98.1	41.5	43.1	28.8	40.6	36.0	25.5	103.5	24.1	42.4	20.5	105.9	20.2	45.4	18.8	27.6	33.8	39.5	109.5	30.1	70.1	24.7	20.9	48.8	40.5	65.0	26.2	32.6	24.3	17.9	14.8	42.1	0.1	22.9	31.6	27.6	20.6	17.2	18.0	14.6	1.4	17.0	6.7	35.2	34.7	24.3	1.1	7.3	51.4	14.9	21.2	10.5	19.2	27.9	0.6	18.9	1.4	14.9	23.2	1.2	8.6	13.5	87.8	48.4	0.8	11.0	3.1	28.8	34.3	16.4	24.8	19.7	53.1	18.4	19.0	64.3	9.8	28.7	22.7	47.6	18.1	18.9	1.4	1.2	0.2	37.3	4.7	60.7	3.3	3.2	5.9	0.1	8.5	0.2	0.1	0.0	0.0	4.3	0.0	0.2	0.0	5.4	0.3	20.1	0.1	0.0	2.1	84.9	84.7	90.6	76.3	82.2	103.1	141.9	104.5	83.7	103.5	105.9	109.5	117.1	12.8	15.6	54.9	2.8	48.7	58.5	54.9	97.9	11.5	45.8	37.1	10.8	31.5	29.1	12.9	6.2	32.1	2.5	47.3	11.7	29.4	0.6	29.7	47.6	43.8	31.2	9.1	1.0	43.6	35.0	46.1	31.1	41.2	13.3	19.6	42.8	27.7	6.1	753.7	1.3	41.3	14.2	5.5	30.1	2.7	18.3	9.1	30.2	6.5	11.1	570.4	0.0	2.5	2.5	30.4	33.5	15.4	2.5	42.6	53.1	8.0	18.0	26.2	131.5	98.0	69.9	1.1	2.0	83.2	44.9	84.3	6.0	13.6	30.2	124.1
CDC42EP5	"Borg3, CEP5"	ENSG00000167617	"CDC42 effector protein 5"	Q6NZY7	19	54465026-54473296	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;prostate: 60.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 435.6;Intestinal goblet cells: 547.3;Paneth cells: 288.4;Prostatic glandular cells: 193.3;Undifferentiated cells: 257.0;Urothelial cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.4;BJ hTERT+: 5.9;CAPAN-2: 6.5;EFO-21: 9.6;HHSteC: 6.6;TIME: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043449	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043449: AB_10961041"	"unprognostic (7.67e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.73e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (1.36e-4)"	24.3	8.1	0.7	0.2	0.6	0.0	23.4	0.5	1.1	26.2	0.6	83.8	18.4	13.6	0.0	16.7	16.9	0.8	19.0	0.5	0.4	13.5	3.4	24.1	0.4	1.8	0.4	12.7	14.5	0.1	5.5	1.4	1.1	60.4	4.4	0.1	40.1	2.1	3.8	11.4	52.4	0.4	0.3	9.2	19.6	6.0	0.6	0.2	11.0	0.5	0.3	42.5	22.9	0.9	0.0	0.0	0.7	0.4	0.7	4.8	3.3	8.4	5.9	0.4	0.1	1.4	6.5	0.0	9.6	2.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.9	0.1	0.0	0.4	1.5	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.7	0.1	2.2	0.1	3.8	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	8.9	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.5	1.1	0.5	0.4	1.8	0.4	1.1	0.3	0.6	0.9	123.5	0.0	0.0	0.3	1.3	10.3	75.4	2.3	13.1	0.9	107.8	114.7	1.3	0.0	2.4	18.4	0.0	0.4	2.3	435.6	0.0	3.1	6.4	4.3	37.0	50.7	39.0	0.0	0.5	11.4	12.6	33.8	50.0	5.0	8.9	0.8	61.1	0.3	0.8	0.0	0.2	547.3	0.0	1.9	5.9	12.0	10.2	1.5	17.8	7.5	0.6	26.7	0.0	0.0	0.5	11.2	288.4	9.1	0.0	193.3	117.0	0.3	0.4	2.5	6.6	3.8	17.6	0.5	1.2	18.3	7.5	0.7	2.4	17.3	257.0	385.7
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 320.7;NK-cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 453.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	54.4	48.0	39.2	63.8	40.7	81.6	41.9	41.0	48.7	46.0	38.1	40.2	20.0	35.0	26.8	97.4	44.0	37.2	44.8	38.8	40.5	59.2	30.0	73.2	84.3	43.1	42.2	44.0	36.5	71.5	37.2	48.6	43.7	56.1	33.7	20.6	54.1	33.2	21.9	61.6	58.7	37.3	42.9	122.3	44.6	11.1	43.2	56.4	46.0	19.2	84.5	65.7	64.1	44.1	61.5	28.5	48.4	30.5	37.0	35.5	73.9	45.6	47.1	51.1	43.5	27.6	64.3	44.2	36.2	51.3	27.4	74.9	51.6	79.8	44.6	69.9	27.7	71.6	30.2	13.6	49.1	64.1	110.0	39.8	125.7	64.3	49.6	71.8	64.6	43.9	114.1	100.8	58.2	91.3	46.8	46.1	54.5	56.2	30.5	41.1	40.8	49.6	64.5	97.2	20.7	49.3	39.4	83.6	82.8	75.9	93.1	113.1	61.7	49.5	36.6	38.5	84.2	65.6	56.1	453.9	35.8	47.8	111.8	124.6	43.9	228.5	88.5	80.7	70.0	44.0	75.5	81.0	58.3	44.9	62.9	78.4	369.7	91.1	82.7	21.9	123.2	38.1	39.2	40.7	41.0	48.7	38.8	40.5	43.1	42.2	43.7	42.9	43.2	44.1	76.4	38.5	56.2	22.2	110.5	66.2	54.4	41.0	42.1	28.3	94.1	64.1	8.1	27.1	44.8	55.2	25.0	57.9	320.7	36.1	21.5	41.3	85.0	23.4	38.0	50.5	35.3	24.4	30.5	37.0	72.1	40.0	33.1	35.1	71.7	19.0	65.0	33.9	73.2	26.9	29.1	29.9	50.8	138.8	204.1	16.6	11.5	115.0	55.2	32.8	159.8	23.0	233.8	36.7	44.9	66.7	39.3	24.0	93.8	41.9	19.4	27.5	21.8	24.2	32.9	47.9	46.5	35.0	18.7	59.6	93.6	114.8	142.7	22.2	21.4	73.4
CDC42SE2	"FLJ21967, SPEC2"	ENSG00000158985	"CDC42 small effector 2"	Q9NRR3	5	131245493-131398447	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-cells: 242.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038624	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA038624: AB_10670783"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (4.50e-5)"	"unprognostic (2.37e-3)"	"unprognostic (7.38e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.65e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (7.50e-4)"	16.5	10.6	30.7	53.6	32.5	78.7	22.8	26.8	42.3	22.1	20.2	46.6	39.2	18.7	21.0	13.2	16.6	27.4	11.2	35.5	27.8	31.3	21.7	24.7	81.2	28.5	29.6	18.9	27.3	23.9	12.3	15.2	27.7	20.4	48.4	7.1	16.5	16.0	12.9	16.8	45.5	17.2	30.0	57.8	32.0	30.9	28.2	48.6	36.7	11.0	66.4	29.3	9.8	37.0	31.6	33.8	22.4	33.4	22.4	11.5	42.2	23.0	14.8	15.4	15.9	37.4	86.7	49.5	50.5	16.4	25.9	22.1	17.6	43.4	22.4	88.2	11.1	39.9	13.9	24.0	27.9	48.2	51.5	15.2	81.2	21.0	46.7	15.9	23.3	56.5	27.2	67.1	26.5	20.4	84.1	51.8	18.2	21.6	10.1	43.5	38.1	63.2	67.6	51.3	23.8	18.1	32.1	20.4	29.6	31.9	24.4	55.9	29.3	21.3	18.4	12.8	28.9	42.1	66.4	62.4	19.1	54.0	18.9	233.4	42.8	134.4	111.5	44.7	131.1	74.9	131.4	137.7	64.1	51.5	131.6	148.6	114.7	113.4	44.6	54.6	117.9	181.4	30.7	32.5	26.8	42.3	35.5	27.8	28.5	29.6	27.7	30.0	28.2	37.0	38.0	32.1	20.6	44.1	166.8	54.2	38.5	45.6	21.6	9.2	30.6	22.4	14.4	52.9	30.0	104.8	8.4	35.4	211.5	148.6	99.7	50.9	29.2	73.7	27.2	33.7	85.6	37.5	84.3	51.0	106.0	18.3	33.6	104.1	54.5	30.6	35.0	35.5	37.9	6.7	78.8	65.7	40.7	111.9	192.3	21.9	14.0	77.6	46.2	72.1	119.9	21.7	134.9	51.8	149.2	66.3	60.6	17.3	113.1	54.4	79.3	148.0	27.3	7.5	0.0	17.7	22.1	58.7	57.7	11.8	45.5	24.8	242.7	15.7	67.2	60.8
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121983-193254815	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	11.3	9.5	5.8	7.3	6.9	8.9	10.7	6.1	7.3	11.1	4.5	10.2	5.6	10.3	8.5	8.4	7.2	5.9	9.6	4.6	8.1	10.4	9.2	7.9	7.5	6.9	7.2	11.5	6.4	12.9	5.6	9.4	7.9	15.1	9.0	10.1	7.7	9.7	12.2	7.0	7.7	10.3	7.9	8.6	7.0	5.9	6.5	10.6	13.1	5.6	7.9	9.7	8.5	8.3	9.3	2.4	16.6	11.5	18.3	18.9	4.9	6.7	16.1	19.5	16.4	6.5	12.3	10.5	5.2	20.4	8.8	10.7	16.8	14.9	24.7	6.1	4.1	7.3	8.1	7.2	16.1	16.0	11.6	13.7	16.0	14.9	17.7	20.6	17.8	11.1	8.1	14.2	28.8	3.5	13.9	9.2	11.9	21.9	2.5	10.6	7.0	15.0	26.6	8.2	3.9	12.3	8.6	26.8	22.3	21.0	18.3	14.0	9.2	19.3	2.2	16.4	12.6	12.2	7.2	7.6	11.9	10.2	30.1	2.2	0.5	0.7	0.8	1.0	1.2	0.9	1.1	0.6	0.6	0.5	1.4	1.2	0.3	1.3	0.8	1.0	0.9	0.4	5.8	6.9	6.1	7.3	4.6	8.1	6.9	7.2	7.9	7.9	6.5	8.3	44.5	35.3	25.4	54.5	44.9	37.2	35.6	38.4	36.5	30.4	24.4	21.8	44.5	25.8	27.2	33.1	35.5	25.0	48.0	18.2	33.2	37.5	19.7	24.6	39.6	38.0	11.4	40.8	71.9	32.2	42.0	39.1	28.1	30.8	41.1	17.6	25.4	17.2	31.6	21.9	76.4	15.8	34.6	27.4	49.1	8.5	33.5	38.3	28.4	54.4	46.0	35.2	41.2	78.4	112.3	35.5	16.9	36.1	50.3	34.9	19.2	36.3	20.6	36.7	26.3	49.0	48.3	55.6	33.0	36.8	34.9	38.0	44.4	30.3	18.6	27.9
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082277-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.2;Basal respiratory cells: 92.6;Pancreatic endocrine cells: 137.1;Urothelial cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.3;NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 94.9;HBEC3-KT: 109.0;hTEC/SVTERT24-B: 265.2;hTERT-HME1: 177.9;PC-3: 89.7;RPTEC TERT1: 81.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.5	0.4	4.4	0.7	0.9	5.6	0.4	1.2	8.5	12.8	17.4	17.7	3.2	9.2	37.2	4.0	6.2	0.5	0.7	0.7	4.8	0.8	8.2	0.8	1.4	0.8	0.3	7.9	1.4	1.2	2.2	1.3	5.1	17.0	0.2	12.6	5.6	0.3	23.3	15.1	3.1	1.1	0.7	16.5	0.6	3.6	0.6	7.7	0.0	5.8	9.7	16.4	2.6	52.2	15.1	0.0	0.2	0.1	2.4	12.1	9.7	1.6	4.4	4.1	21.3	94.9	0.0	11.8	2.9	2.5	40.5	0.3	109.0	8.9	0.0	0.1	0.1	16.4	0.1	8.1	0.1	3.6	3.7	56.1	265.2	177.9	16.0	1.0	0.1	31.1	0.2	13.8	0.1	0.1	0.9	7.4	24.7	89.7	0.0	0.0	8.6	81.1	40.7	3.4	0.1	20.1	5.0	0.1	4.8	22.9	0.4	4.6	0.2	0.2	3.3	0.2	0.1	0.1	0.1	1.5	1.1	1.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.9	4.2	0.0	0.0	0.0	0.2	0.4	0.7	0.4	1.2	0.7	0.7	1.4	0.8	1.3	1.1	3.6	2.6	0.1	3.2	13.1	0.3	0.3	121.2	83.3	92.6	50.7	0.0	12.9	6.6	0.5	14.3	57.7	9.2	0.0	5.8	0.3	76.6	0.0	78.6	0.1	36.5	6.3	1.9	37.6	0.4	2.0	71.6	7.5	4.6	37.8	59.3	8.8	0.1	0.0	0.0	10.8	0.0	0.4	37.9	18.3	7.9	37.6	0.5	3.1	13.4	3.6	0.0	10.7	0.0	0.0	1.0	0.3	137.1	34.9	0.0	2.5	75.8	30.8	0.0	56.6	0.0	0.0	0.4	3.6	0.0	0.4	59.8	75.0	3.3	1.8	13.5	28.9	117.4
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA031143	Uncertain				"Secreted - unknown location"	NA	NA									"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDH10		ENSG00000040731	"Cadherin 10"	Q9Y6N8	5	24487100-24644978	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 13.0;prostate: 4.4"	"Group enriched"	"Detected in some"	20	"Astrocytes: 169.4;Excitatory neurons: 423.4;Inhibitory neurons: 216.9;Oligodendrocyte precursor cells: 488.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.1;HAP1: 4.6;hTERT-RPE1: 4.2;SuSa: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010651, HPA012085"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		270000		"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA010651: AB_1078370, HPA012085: "	"unprognostic (4.31e-3)"			"unprognostic (2.77e-1)"	"unprognostic (1.88e-1)"			"unprognostic (3.66e-2)"		"unprognostic (4.48e-1)"	"unprognostic (6.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.59e-7)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-1)"		"unprognostic (8.74e-3)"	0.0	0.7	5.6	0.0	8.4	0.0	0.1	13.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.9	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.1	0.0	0.4	0.0	2.2	4.4	0.2	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.1	4.6	0.0	0.0	7.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	11.7	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.4	13.0	8.7	9.0	0.9	0.3	1.7	2.2	1.2	1.1	4.6	0.0	0.0	0.0	169.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.1	0.0	0.0	423.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	216.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.9	0.0	0.6	0.0	488.6	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0
CDH11	"CAD11, OB"	ENSG00000140937	"Cadherin 11"	P55287	16	64943753-65126112	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 178.2;placenta: 122.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Endometrial stromal cells: 125.0;Excitatory neurons: 122.2;Fibroblasts: 102.2;Microglial cells: 145.2;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 106.3;Theca cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 246.5;BJ hTERT+: 139.3;fHDF/TERT166: 332.3;HSkMC: 217.4;PC-3: 291.2;U-2197: 194.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013072	Enhanced					NA	Yes		4800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013072: AB_2533068"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.93e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.75e-2)"	"prognostic unfavorable (2.48e-9)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-3)"	15.1	8.6	12.4	25.7	27.9	0.3	10.7	10.8	15.8	57.7	13.8	11.4	7.0	52.8	9.5	7.4	12.5	58.6	10.2	19.2	21.4	10.2	1.8	45.6	17.5	17.1	24.1	178.2	3.4	2.6	10.4	122.2	17.3	20.0	12.2	14.0	12.7	24.3	2.6	10.9	8.9	54.3	21.1	89.3	11.8	8.0	19.3	3.7	8.1	3.1	13.0	47.6	13.6	21.4	0.2	0.0	51.4	0.1	35.7	77.5	0.3	246.5	139.3	61.0	34.5	4.6	0.2	0.0	0.0	332.3	0.0	0.1	0.1	1.7	43.4	0.0	2.1	0.0	1.4	0.0	29.7	0.0	14.4	217.4	0.1	74.7	14.9	0.0	17.4	0.0	0.0	0.0	33.1	0.3	0.1	0.3	19.2	37.4	291.2	0.8	38.0	0.0	0.0	0.0	0.8	36.0	0.1	0.3	0.2	64.5	0.3	0.1	0.0	124.4	17.2	194.0	70.1	0.0	0.0	0.1	21.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	27.9	10.8	15.8	19.2	21.4	17.1	24.1	17.3	21.1	19.3	21.4	11.4	3.2	0.0	93.0	0.1	3.8	1.0	7.9	0.0	19.9	1.0	7.4	3.1	1.5	3.3	0.0	0.0	2.6	0.2	0.1	0.0	0.1	2.7	3.9	125.0	17.8	0.0	2.7	122.2	0.0	2.3	102.2	0.5	2.7	0.0	60.0	68.9	0.0	4.7	0.0	67.6	0.6	0.0	0.6	6.9	4.2	52.5	0.9	5.4	145.2	0.0	41.9	0.0	158.3	106.3	0.8	0.0	77.5	0.0	1.6	0.0	1.4	0.4	2.1	26.3	12.8	38.0	1.7	1.1	0.5	3.1	5.6	1.1	160.2	0.3	0.5
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853344	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;retina: 11.6"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 859.5;Inhibitory neurons: 887.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 6.6;cerebral cortex: 3.8;hippocampal formation: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 2.2;SCLC-21H: 3.1;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA029325: AB_2672998"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.0	2.0	0.8	0.0	6.6	0.0	0.5	0.2	3.8	3.0	2.1	0.0	0.0	0.3	0.2	0.0	2.2	0.0	0.0	2.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.1	0.8	0.0	0.1	11.6	1.4	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.2	3.8	2.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.4	0.0	0.0	41.4	0.0	0.1	0.0	0.0	0.0	25.1	0.4	0.6	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	2.1	0.0	0.0	859.5	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	20.2	887.7	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	15.9	0.0	2.2	0.0	31.2	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.2	0.0	2.6	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626965-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.1;skeletal muscle: 68.6;tongue: 57.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 328.8;Inhibitory neurons: 867.0;Oligodendrocyte precursor cells: 335.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 222.2;U-138 MG: 279.2;U-87 MG: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		240000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	20.3	2.8	18.7	3.8	21.5	0.6	10.0	0.0	14.3	42.5	0.0	5.0	1.5	47.2	3.3	9.5	7.6	5.0	57.1	10.5	3.3	5.0	1.8	16.1	1.4	1.5	6.5	3.1	0.6	2.4	0.5	6.0	0.6	3.5	6.2	1.5	4.9	7.2	68.6	21.1	2.3	29.9	6.3	2.1	1.7	1.8	22.9	1.8	5.8	57.7	1.9	7.1	19.4	3.2	10.2	0.0	3.6	0.5	63.2	60.6	0.1	47.1	51.9	53.6	23.1	0.1	0.4	0.1	8.5	138.5	26.0	89.1	1.0	70.7	79.8	0.0	0.2	0.1	31.4	0.1	36.4	0.0	0.4	7.9	59.9	107.8	130.4	83.9	26.7	0.0	0.2	0.5	222.2	0.5	0.1	0.2	10.6	0.0	19.4	0.0	57.7	0.0	46.2	0.4	0.1	0.1	84.4	0.3	0.1	103.5	0.8	0.1	43.1	279.2	22.7	1.6	43.0	0.2	0.1	0.2	244.0	0.2	70.1	2.2	0.5	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.5	0.5	0.0	0.0	1.1	0.0	4.3	0.3	0.0	0.2	18.7	21.5	0.0	14.3	10.5	3.3	1.5	6.5	0.6	6.3	22.9	3.2	125.4	0.0	0.5	11.1	0.3	70.7	28.7	32.3	25.0	3.0	1.0	5.8	86.9	0.0	2.6	3.7	0.0	0.1	0.9	2.1	7.9	0.4	44.5	1.0	27.1	49.2	1.8	0.0	328.8	0.0	0.2	9.7	0.0	0.7	0.0	0.0	29.6	0.3	0.6	5.0	867.0	1.6	0.0	1.9	13.3	43.3	0.3	1.4	8.8	17.8	0.0	0.4	0.0	335.8	65.0	0.1	1.4	0.0	0.0	36.7	0.0	1.3	0.8	0.4	0.0	51.0	22.7	2.9	0.6	3.3	18.8	0.1	1.2	0.7	0.1	6.4
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 24.4;skeletal muscle: 57.0"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	15	"cerebellum: 24.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.1	0.0	0.2	0.0	0.0	24.4	0.8	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	1.3	0.4	0.0	0.1	0.8	0.2	1.4	0.0	0.1	0.7	1.6	0.4	0.0	0.0	0.9	0.0	57.0	0.1	0.0	0.0	0.3	1.2	0.2	0.6	0.1	0.0	0.0	5.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	24.4	0.8	0.0	0.1	0.1	0.8	1.6	0.3	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918917	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 250.0"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 617.9"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	99	"RPTEC TERT1: 225.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB013526, HPA036260"	Enhanced					NA	NA		130000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB013526: , HPA036260: AB_2675027"		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favorable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.3	0.3	4.7	0.3	11.0	0.3	0.1	0.0	0.0	250.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.4	6.7	0.0	0.0	617.9	0.0	0.1	0.0	0.4	74.3	0.1	2.9	18.0	2.1	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	1.9	124.4	0.0	0.0	0.0	0.6	0.9	0.0	0.2	1.9	0.0	1.0	0.8	0.0	0.7	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19471296-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 35.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 923.8;Inhibitory neurons: 694.3;Oligodendrocyte precursor cells: 248.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 35.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.4;GAMG: 7.6;hTERT-RPE1: 4.2;U-2 OS: 6.8;U-2197: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"	NA	Yes				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014416: AB_2668996"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.0	4.6	2.7	0.0	6.8	0.0	0.0	35.9	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	8.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	4.0	0.0	5.7	0.0	0.0	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.3	0.0	0.6	2.9	2.5	0.1	1.6	0.1	0.5	0.0	0.0	0.0	4.4	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	1.7	4.2	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	6.8	6.2	0.0	1.7	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	35.9	12.3	6.1	8.4	0.0	0.4	5.7	0.0	1.9	1.9	0.0	0.0	0.0	22.9	0.0	0.0	1.3	0.0	0.0	6.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.0	0.0	0.0	923.8	0.0	5.3	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	694.3	0.0	0.0	0.0	0.0	19.2	0.3	0.1	0.0	17.8	0.0	0.2	0.0	248.3	15.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.1	0.1	6.4	3.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0
CDH19	CDH7	ENSG00000071991	"Cadherin 19"	Q9H159	18	66501083-66604138	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;heart muscle: 37.1;intestine: 19.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 60.1;Melanocytes: 44.4;Oligodendrocyte precursor cells: 57.8;Oligodendrocytes: 192.6"	"Cancer enriched"	"Detected in some"	21	"melanoma: 16.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SK-MEL-30: 35.9;WM-115: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056332	Uncertain					NA	NA		320000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056332: AB_2683102"	"unprognostic (1.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"		"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.58e-3)"	"unprognostic (8.16e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-5)"	2.3	4.2	3.3	3.1	11.4	0.1	1.3	4.4	7.2	6.7	0.0	19.4	2.2	0.9	1.6	3.0	1.9	2.6	37.1	4.7	5.3	0.4	4.1	1.2	0.1	8.8	7.4	1.1	1.2	0.1	0.4	2.9	7.5	4.2	2.8	0.1	3.4	4.1	4.2	1.9	5.4	1.7	2.7	2.2	4.9	0.7	7.7	0.1	1.0	1.2	0.0	5.2	5.9	18.4	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	35.9	0.1	1.5	0.0	0.0	0.1	0.3	0.2	0.1	4.0	0.2	0.0	0.1	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	11.4	4.4	7.2	4.7	5.3	8.8	7.4	7.5	2.7	7.7	18.4	0.0	0.0	0.0	1.0	0.0	1.1	0.3	0.2	2.8	0.0	1.1	0.3	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	2.8	0.0	0.0	60.1	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0	0.5	0.0	2.0	0.6	1.0	0.2	5.3	0.1	44.4	0.0	0.0	0.0	0.0	57.8	192.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	3.6	2.7	0.9	0.3	0.3	0.0	0.1	0.0	0.0	0.4
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27932879-28177946	"CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 196.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9"	"Cancer enhanced"	"Detected in all"		"glioma: 39.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.7;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Cluster 10: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	66.5	27.4	2.6	29.0	0.2	0.3	20.6	31.6	6.6	7.9	4.8	0.8	6.2	1.1	0.4	10.5	3.1	196.0	30.0	31.6	18.1	57.2	1.0	1.9	21.7	26.3	6.7	0.9	29.8	8.1	0.4	20.1	2.4	1.1	60.3	0.4	10.8	0.4	0.3	1.4	6.8	24.1	13.5	5.9	44.4	33.3	3.8	6.2	2.2	1.6	1.1	2.7	22.7	0.3	25.8	278.2	0.3	48.1	7.8	0.2	230.7	72.0	94.9	80.8	0.1	0.4	0.0	128.3	459.1	46.0	36.7	50.0	0.2	130.4	0.4	35.8	0.0	66.8	86.7	48.0	0.0	0.1	4.6	0.4	198.6	37.4	212.9	84.0	15.4	0.0	0.1	77.8	0.0	59.4	0.1	43.8	0.1	30.5	0.2	37.1	45.6	0.1	9.9	83.4	144.4	0.1	0.2	26.8	116.8	0.3	0.5	11.6	206.6	63.6	2.9	181.6	0.2	0.3	0.3	40.6	0.2	163.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	27.4	29.0	20.6	31.6	30.0	31.6	21.7	26.3	20.1	24.1	33.3	22.7	0.8	0.0	0.6	217.7	1.2	0.3	0.0	3.4	0.0	38.7	1.6	0.4	368.8	67.2	1.2	11.0	150.1	0.1	0.0	0.0	0.0	12.9	53.2	1.4	15.2	9.8	0.0	6.1	311.2	0.4	0.0	16.7	0.0	2.6	0.0	312.5	12.5	125.3	0.3	3.3	198.2	0.0	2.0	2.2	0.4	17.7	2.1	1.2	3.6	106.8	0.1	157.9	0.0	267.9	138.6	19.2	0.0	12.8	0.0	0.1	0.0	47.5	1.7	99.9	6.6	0.4	45.8	4.8	24.1	0.0	0.0	0.3	0.6	1.6	0.0	0.1
CDH20	"Cdh7, CDH7L3"	ENSG00000101542	"Cadherin 20"	Q9HBT6	18	61333430-61555779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 33.7;retina: 11.0;tongue: 24.1"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1264.4;Oligodendrocyte precursor cells: 742.4;Oligodendrocytes: 1030.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;ASC diff: 5.7;HHSteC: 2.6;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015490	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015490: AB_1845900"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.93e-1)"	4.7	0.1	22.1	0.0	29.9	0.0	0.9	24.8	19.9	0.2	2.3	0.0	0.0	0.1	0.6	0.8	0.2	0.0	0.1	20.0	19.8	0.1	0.0	0.0	0.0	27.5	28.7	0.0	0.1	0.0	1.6	0.0	29.1	0.2	0.0	11.0	0.4	0.0	4.7	0.5	0.2	0.0	21.5	0.1	0.1	0.4	23.1	0.0	0.3	24.1	0.0	0.3	0.0	33.7	0.0	0.0	1.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	22.1	29.9	24.8	19.9	20.0	19.8	27.5	28.7	29.1	21.5	23.1	33.7	0.2	0.0	0.0	1264.4	0.1	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.6	0.1	0.2	0.2	0.0	0.0	146.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	98.7	0.1	0.0	0.3	0.0	2.7	0.0	0.1	0.0	41.2	0.0	11.1	0.0	742.4	1030.7	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.1	0.0	1.0	0.2	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CDH22	"C20orf25, dJ998H6.1"	ENSG00000149654	"Cadherin 22"	Q9UJ99	20	46173739-46308498	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 19.5"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 48.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"amygdala: 10.7;basal ganglia: 5.0;cerebellum: 19.5;cerebral cortex: 15.2;hippocampal formation: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012164, HPA012715"	Uncertain	Supported				NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA012164: AB_1845902, HPA012715: "	"unprognostic (2.41e-4)"	"unprognostic (1.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.39e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.50e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.09e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.83e-2)"	0.1	1.4	10.7	0.0	5.0	0.0	0.1	19.5	15.2	0.5	0.0	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.9	7.5	1.2	0.2	0.0	0.0	0.0	1.1	1.3	0.3	1.7	0.0	1.4	0.0	2.3	1.1	0.0	1.2	0.2	0.5	0.5	4.0	0.1	0.0	0.8	0.0	0.2	1.1	2.6	0.0	0.1	0.0	0.0	0.0	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	5.0	19.5	15.2	7.5	1.2	1.1	1.3	2.3	0.8	2.6	2.8	0.0	0.0	0.0	1.3	0.0	0.8	1.3	0.0	1.8	9.3	0.0	0.0	3.5	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.3	7.1	0.0	48.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.4	7.2	0.3	0.0	0.0	4.7	0.0	0.8	0.0	12.1	1.7	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.3	0.6	0.3	0.0	0.1	0.0	0.1	0.0	0.0
CDH23	"CDHR23, DFNB12, USH1D"	ENSG00000107736	"Cadherin related 23"	Q9H251	10	71396920-71815947	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6;ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4;Late spermatids: 67.7;Microglial cells: 33.7;Muller glia cells: 90.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 26.8;non-classical monocyte: 38.1;plasmacytoid DC: 9.5"	"Lineage enhanced"	"Detected in many"		"monocytes: 38.1"	"Group enriched"	"Detected in some"	4	"RT4: 13.4;SCLC-21H: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017232	Approved					NA	NA		950000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017232: AB_1845903"	"unprognostic (6.76e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.40e-4)"	11.3	3.3	9.6	2.1	11.6	2.2	6.2	10.6	7.9	3.3	10.2	1.7	1.1	4.9	1.6	1.8	8.9	2.2	5.4	6.3	16.2	0.9	14.4	7.8	1.7	35.6	18.5	35.3	8.4	9.9	1.2	0.5	34.7	3.7	1.2	14.4	1.2	0.7	2.7	1.6	2.3	2.1	8.6	7.0	1.7	11.0	23.6	5.3	1.8	2.5	1.4	4.2	2.6	8.8	0.0	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.9	0.4	1.3	0.0	0.0	0.1	1.2	1.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.1	1.5	0.4	0.0	1.1	0.0	0.1	0.0	13.4	5.3	1.1	0.8	0.2	0.1	1.1	0.1	2.2	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.2	1.5	1.0	0.0	0.0	6.0	5.1	0.1	26.8	0.4	0.0	0.2	0.1	4.9	0.0	0.2	0.6	6.1	0.0	38.1	9.5	0.0	2.9	9.6	11.6	10.6	7.9	6.3	16.2	35.6	18.5	34.7	8.6	23.6	8.8	8.2	0.0	0.6	9.4	1.1	0.8	4.1	0.3	0.6	1.9	0.2	1.1	4.7	0.0	1.0	1.8	0.0	1.5	11.5	0.9	0.0	0.4	78.4	1.9	0.7	10.0	7.2	0.0	1.1	0.4	4.4	3.4	1.1	0.3	0.0	0.4	7.9	20.4	2.2	0.0	2.7	1.1	0.0	12.2	11.6	67.7	2.5	15.0	7.2	33.7	10.6	90.7	3.1	1.5	8.5	0.2	7.5	0.7	0.4	2.6	1.6	0.8	0.7	4.2	6.6	5.1	1.7	3.4	1.0	0.0	1.1	0.3	1.0	0.2	0.7	3.6
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958423-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 36.4"	"Low region specificity"	"Detected in some"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.9	0.4	1.0	0.3	1.5	1.0	0.8	1.2	2.0	2.0	0.3	0.7	0.4	0.6	0.4	3.4	2.0	0.4	0.7	0.9	1.8	0.5	0.3	2.1	0.4	1.6	1.7	0.3	0.5	0.3	1.7	0.4	1.5	8.0	0.3	0.4	2.0	0.5	1.0	0.6	0.8	0.4	0.6	0.8	1.2	0.7	1.9	0.9	0.6	0.3	3.0	2.7	1.3	2.6	0.0	0.7	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.1	0.0	0.8	0.8	0.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.1	7.9	0.1	0.1	0.0	0.3	0.3	0.1	1.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.7	0.1	36.4	0.8	0.1	0.4	0.2	0.1	0.4	0.2	0.4	0.2	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	1.2	2.0	0.9	1.8	1.6	1.7	1.5	0.6	1.9	2.6	4.3	6.4	6.1	17.9	0.1	0.1	1.2	6.6	0.0	0.5	1.6	0.5	0.7	0.0	18.7	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.2	2.1	0.4	2.1	0.0	2.5	9.3	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.7	0.1	0.6	0.0	8.4	0.0	6.1	1.3	0.4	1.7	0.0	1.4	0.0	7.5	0.6	0.2	1.0	7.1	14.9	0.0	0.0	0.0	0.4	10.9	0.2	0.1	39.6	0.0	0.0	0.5	2.4	0.9	0.2	0.2	0.0	14.9	0.2	0.1	0.2	7.4
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68727468	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;ovary: 32.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.8;Basal prostatic cells: 67.2;Basal respiratory cells: 161.4;Basal squamous epithelial cells: 71.7;Granulosa cells: 77.6;Melanocytes: 60.5;Pancreatic endocrine cells: 85.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 100.6;HaCaT: 263.9;HBEC3-KT: 126.9;hTCEpi: 94.3;hTERT-HME1: 72.7;RPTEC TERT1: 116.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.7"	"Low region specificity"	"Detected in all"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		510000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	3.6	0.2	1.3	3.4	1.5	0.1	8.2	1.9	1.6	9.7	47.1	0.4	0.5	10.0	8.8	26.8	12.0	1.5	0.3	3.5	0.8	6.0	0.0	2.0	2.5	1.2	1.0	32.7	0.6	1.5	4.4	4.5	0.6	13.6	0.7	0.8	12.4	4.6	0.2	25.8	0.7	4.0	1.9	10.9	1.0	1.6	1.1	18.8	1.2	0.0	11.7	3.9	11.2	1.1	100.6	0.2	0.9	0.1	0.1	0.0	8.6	0.0	0.0	0.3	0.1	61.4	36.6	0.0	0.4	0.0	0.2	263.9	2.6	126.9	0.4	0.0	1.2	0.0	0.2	0.0	0.2	0.2	0.5	0.0	94.3	0.1	72.7	0.3	0.0	0.0	0.0	0.2	0.0	48.8	0.1	0.1	5.3	0.9	8.8	0.0	0.0	0.0	116.8	44.5	0.5	0.2	0.8	0.0	50.0	45.6	29.2	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	1.6	3.5	0.8	1.2	1.0	0.6	1.9	1.1	1.1	0.2	16.0	4.6	0.7	0.0	60.8	67.2	161.4	71.7	1.2	6.8	39.2	1.4	0.0	35.9	14.7	2.1	23.4	0.5	0.5	0.0	35.7	0.5	0.9	8.2	1.3	1.2	0.0	6.0	32.1	2.1	3.7	0.0	0.9	1.3	77.6	0.0	0.0	2.8	0.0	9.1	1.5	20.3	0.0	1.9	0.2	0.6	0.7	60.5	0.0	1.0	0.4	1.0	3.0	2.2	85.7	0.1	9.4	1.2	44.5	0.0	0.1	12.6	0.5	0.0	0.6	5.9	0.4	1.0	26.5	30.7	6.3	1.2	0.1	1.5	43.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000		"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.2	1.4	9.3	0.2	2.6	2.2	3.7	4.3	0.5	1.3	1.3	2.3	1.8	2.4	6.8	9.2	2.0	2.2	7.4	14.8	0.7	4.5	0.6	4.9	9.5	0.7	0.7	1.1	1.0	3.6	6.0	1.1	0.9	1.5	0.7	1.8	1.2	1.0	1.2	2.6	3.2	0.8	1.0	0.3	9.8	0.4	2.3	1.6	0.7	2.3	1.9	3.9	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	9.3	2.2	3.7	2.2	7.4	4.9	9.5	6.0	3.2	9.8	3.9	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
CDH7		ENSG00000081138	"Cadherin 7"	Q9ULB5	18	65750252-65890337	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 45.7;Inhibitory neurons: 111.4;Muller glia cells: 39.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;HEK 293: 2.9;Karpas-707: 5.6;RH-30: 7.3;U-87 MG: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061419	Supported					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA061419: AB_2684511"	"unprognostic (2.81e-3)"		"unprognostic (6.95e-2)"		"unprognostic (2.26e-1)"			"unprognostic (2.24e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.28e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.49e-1)"		"unprognostic (1.72e-1)"	0.0	0.1	0.6	0.0	4.1	0.0	0.0	11.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	15.9	3.2	0.3	0.0	0.0	0.4	0.0	16.4	0.7	0.0	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.4	7.3	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.1	7.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.7	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	4.1	11.6	3.5	0.4	3.0	15.9	3.2	16.4	0.6	7.3	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	14.9	0.1	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.6	3.5	0.0	45.7	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	111.4	0.0	0.0	0.0	0.0	3.2	0.6	0.1	0.0	1.0	0.0	39.3	0.0	11.1	1.4	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	4.1	6.6	0.1	0.2	1.4	4.4	0.0	0.0	0.0	0.1	1.1	0.0	0.2
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.4"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA		870000		"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.1	0.1	7.2	0.0	9.9	0.0	0.3	0.0	22.4	0.4	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.2	16.3	5.7	0.0	0.0	0.1	0.0	6.4	9.8	1.7	0.0	0.1	0.7	0.3	18.4	0.4	0.1	2.2	0.4	5.0	0.4	0.1	0.2	0.4	7.6	0.0	0.1	0.3	9.1	0.5	0.1	0.9	0.0	0.4	0.1	2.5	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.3	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	17.3	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.1	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.9	0.0	22.4	16.3	5.7	6.4	9.8	18.4	7.6	9.1	2.5	0.4	0.0	0.5	3.9	0.0	0.1	0.8	1.3	1.2	15.1	0.1	0.9	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.5	0.0	0.0	220.8	0.0	0.2	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	236.4	0.0	2.0	0.0	0.0	1.3	0.0	0.1	0.0	8.4	0.0	0.7	0.0	7.5	145.7	0.0	0.0	0.4	0.0	0.3	0.0	0.2	2.7	0.7	0.0	0.7	4.7	1.3	2.5	0.5	0.1	0.3	0.1	0.1	0.0	0.8
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880597-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;kidney: 5.7"	"Group enriched"	"Detected in some"	33	"Excitatory neurons: 307.2;Inhibitory neurons: 459.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 6.8;basal ganglia: 4.3;cerebral cortex: 6.4;hippocampal formation: 5.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"K-562: 7.3;NTERA-2: 10.1;U-698: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.3	0.2	6.8	0.6	4.3	1.9	0.3	0.0	6.4	0.0	0.0	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.1	5.8	0.0	5.7	0.1	0.3	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.5	0.6	1.3	0.2	0.1	0.1	1.0	0.8	0.4	0.0	0.4	0.5	2.2	0.0	0.2	1.0	0.1	1.0	0.3	0.0	0.9	1.9	0.7	0.4	0.6	0.2	0.0	1.2	0.0	0.3	0.1	0.2	0.0	0.7	1.0	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.4	0.6	2.2	0.0	0.0	1.2	0.2	0.3	0.0	0.0	0.0	0.1	0.6	7.3	1.8	0.0	1.3	0.6	0.4	10.1	0.2	0.4	0.2	0.2	0.3	0.3	0.4	2.2	0.2	0.0	0.3	0.3	1.8	0.3	0.7	1.3	0.1	0.7	0.6	0.2	2.0	0.8	4.6	0.6	0.8	0.6	1.2	0.1	0.2	0.1	0.4	0.3	2.3	0.1	0.1	0.1	1.6	0.1	0.3	4.9	0.0	0.7	0.5	0.5	0.6	6.8	4.3	0.0	6.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	10.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	11.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194537-84219621	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 313.8;skin 1: 214.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 7.5"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3"	"Region enriched"	"Detected in many"	21	"olfactory bulb: 333.0"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA		55000	"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.2	1.9	7.4	1.0	18.3	0.4	4.5	2.3	8.7	5.3	46.2	29.2	0.1	0.6	4.4	10.7	0.5	0.4	1.2	6.6	7.5	0.4	0.5	0.2	0.9	13.4	2.3	1.1	0.1	0.0	3.0	0.2	13.9	1.4	53.2	313.8	1.5	4.2	1.0	214.0	12.2	1.2	0.1	7.0	0.2	0.3	3.2	3.3	0.2	0.0	1.1	0.1	3.5	3.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	10.2	2.0	0.0	0.0	5.2	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	4.4	0.0	0.0	0.0	0.0	1.4	16.3	0.0	3.4	0.8	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	7.4	18.3	2.3	8.7	6.6	7.5	13.4	2.3	13.9	0.1	3.2	3.5	0.0	0.0	0.5	1.3	0.1	51.2	0.3	1.4	3.4	24.1	0.0	0.1	1.8	0.0	0.7	0.0	379.5	0.0	2.1	47.9	0.0	0.1	0.0	2.7	0.7	1.8	12.7	0.0	4.9	0.0	0.0	0.6	0.0	3.1	0.0	3.7	0.4	0.4	0.0	5.0	7.7	46.9	0.0	0.3	5.2	0.2	0.0	0.1	3.6	1.0	0.0	26.3	1.0	7.5	4.4	0.0	31.2	0.0	0.7	0.3	23.0	0.2	0.1	240.4	0.0	0.2	0.3	0.6	0.3	3.0	67.5	0.0	3.0	0.3	52.9	0.2
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 275.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	0.8	4.5	0.4	0.2	0.0	0.1	0.7	0.0	0.0	23.2	275.8	0.1	0.0	0.1	0.6	5.0	0.0	1.2	0.4	10.1	30.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.1	238.3	1.1	0.0	0.1	12.4	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	0.7	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106036432	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 46.4;fallopian tube: 108.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.7;Endometrial ciliated cells: 136.4;Excitatory neurons: 70.2;Inhibitory neurons: 63.8;Respiratory ciliated cells: 358.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;Daudi: 6.5;WM-115: 4.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 11.8"	HPA011218	Supported					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	1.2	0.9	4.6	0.9	3.9	0.9	4.1	4.2	5.0	4.6	46.4	7.5	1.9	1.7	3.2	0.5	108.8	0.2	1.7	5.7	2.3	2.0	2.1	14.2	0.7	9.8	20.4	2.4	1.0	0.0	1.6	0.1	7.8	0.9	1.6	6.7	0.4	0.6	0.8	0.7	4.7	3.2	7.0	0.2	9.3	0.5	5.6	0.1	2.6	0.4	0.9	0.7	0.8	5.6	0.1	0.3	5.7	0.7	1.5	2.1	0.1	0.3	0.3	0.3	0.1	0.0	0.1	6.5	0.0	0.3	0.6	0.0	1.4	0.0	0.2	0.4	0.8	0.0	0.2	0.7	0.0	0.1	0.2	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	1.1	2.2	0.4	0.0	0.0	0.2	0.1	0.1	0.4	2.1	0.0	0.4	0.3	0.8	0.0	0.0	0.2	1.0	0.2	1.3	0.0	0.0	0.0	2.1	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.9	0.1	0.0	0.9	0.3	0.1	0.1	0.3	0.1	4.6	3.9	4.2	5.0	5.7	2.3	9.8	20.4	7.8	7.0	5.6	5.6	2.5	3.2	10.4	170.7	1.7	2.7	1.6	9.5	2.8	6.4	1.8	3.4	1.4	5.7	37.6	0.0	0.0	0.6	2.8	2.0	5.9	0.7	8.5	136.4	1.4	1.8	29.9	0.0	70.2	0.6	0.3	2.8	15.3	2.9	3.8	3.8	0.0	2.9	0.1	0.0	63.8	4.9	8.2	0.0	2.7	3.8	2.8	0.7	8.8	16.9	0.0	10.2	6.2	4.0	4.3	0.2	3.3	1.5	1.4	0.7	5.0	6.2	358.4	1.3	6.6	2.2	8.8	1.2	3.2	0.6	2.0	0.3	2.4	1.4	3.0	0.7
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 59.4"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	HPA076277	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.5	0.1	0.6	0.1	0.6	0.2	0.2	0.4	0.3	5.5	1.0	0.5	0.1	1.7	0.4	0.1	59.4	0.1	0.2	0.6	0.7	0.2	0.1	7.4	0.0	2.7	6.1	0.2	0.0	0.0	0.1	0.1	3.4	0.3	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.2	1.2	0.0	0.1	7.5	0.8	0.0	0.2	0.0	0.0	0.2	0.3	1.0	0.1	0.5	0.1	0.0	0.1	1.3	0.1	0.1	0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.7	0.0	0.6	0.4	0.0	1.9	2.0	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.7	0.4	0.1	0.1	1.0	0.5	0.1	0.2	0.1	3.9	0.6	0.6	0.4	0.3	0.6	0.7	2.7	6.1	3.4	1.2	0.8	1.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.1	0.1	0.4	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	74.2	0.9	0.5	0.0	0.0	0.1	0.2	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	20.3	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	160.4	0.0	0.0	0.2	1.7	4.8	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 296.8;liver: 129.8"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.6	0.1	0.4	0.5	0.4	0.1	2.2	102.2	241.2	0.2	0.0	0.3	0.3	3.9	0.0	0.2	0.0	44.9	129.8	0.2	0.2	0.2	0.1	0.2	1.8	0.0	0.6	0.0	0.3	0.1	51.9	0.1	0.0	0.1	0.1	0.1	296.8	2.7	0.0	0.1	4.3	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CDIN1	"C15orf41, FLJ22851, HH114, MGC11326"	ENSG00000186073	"CDAN1 interacting nuclease 1"	Q9Y2V0	15	36579626-36810248	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 78.6;tongue: 34.5"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.8	5.1	2.9	2.4	7.9	0.7	2.9	4.3	4.1	5.9	1.6	5.6	6.7	6.8	1.8	9.4	4.1	4.0	78.6	2.5	3.5	2.8	3.7	2.5	2.4	3.9	3.4	4.3	2.2	2.4	2.3	2.1	4.3	6.0	3.2	9.6	5.0	6.6	12.0	5.6	3.3	9.5	2.9	2.2	3.3	7.1	3.4	4.2	2.5	34.5	3.6	9.5	8.3	4.9	19.0	10.0	12.4	4.7	13.5	15.6	5.1	8.9	4.5	11.1	9.1	13.9	7.4	3.0	8.8	22.1	8.1	33.8	13.0	7.7	12.7	1.5	9.1	9.9	9.0	10.3	11.8	8.4	7.1	12.0	8.3	9.5	5.2	8.5	10.7	9.6	12.9	3.1	15.4	8.6	2.6	4.9	6.8	8.6	5.1	7.9	3.5	2.0	7.4	25.8	7.1	4.4	5.7	5.5	4.8	9.0	5.5	13.1	7.6	10.8	5.9	7.3	2.5	7.2	11.2	13.7	13.7	15.0	10.2	0.0	0.5	0.3	2.5	1.3	2.2	2.1	1.9	2.4	1.4	2.2	2.3	1.9	0.0	3.3	0.4	1.1	5.1	1.1	2.9	7.9	4.3	4.1	2.5	3.5	3.9	3.4	4.3	2.9	3.4	4.9	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.6	0.0	0.0	0.0	0.0	8.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	10.8	0.2	0.0	0.0	0.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510669-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4;RPMI-8226: 68.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	19.6	43.2	27.2	5.0	30.0	2.1	18.4	21.2	65.1	26.8	0.0	24.6	14.5	30.0	1.0	22.3	24.6	7.9	57.3	26.6	21.3	49.7	44.1	14.5	5.4	22.3	21.3	34.0	37.9	7.1	65.2	5.3	25.4	25.3	2.5	6.9	14.0	10.9	41.1	17.9	26.0	7.0	15.0	20.1	21.5	28.7	29.3	11.5	24.2	8.4	4.0	20.3	20.1	36.2	10.6	3.6	14.0	3.0	1.7	0.0	0.4	14.9	2.3	11.5	10.6	22.6	2.2	0.7	12.2	10.8	4.6	0.8	12.8	41.9	3.0	27.6	25.8	40.7	12.9	59.4	10.5	20.5	21.0	10.5	44.7	10.2	3.4	3.4	9.6	13.1	1.2	9.1	14.5	1.3	15.0	19.2	19.9	10.6	10.1	50.1	12.8	68.3	3.0	0.5	27.9	13.6	24.2	1.4	16.6	7.2	4.4	13.4	0.8	5.5	16.3	7.7	0.7	27.5	29.1	37.9	0.5	16.7	4.7	4.5	5.8	14.4	11.7	9.0	6.9	6.4	4.1	7.3	5.7	5.7	9.0	6.8	5.0	12.0	17.7	6.6	7.0	5.9	27.2	30.0	21.2	65.1	26.6	21.3	22.3	21.3	25.4	15.0	29.3	36.2	27.1	16.0	7.0	28.7	19.4	29.6	21.5	25.4	38.1	63.5	7.7	14.4	26.5	7.2	9.0	16.5	12.5	1.8	16.3	12.1	52.8	13.0	90.9	1.5	18.7	20.3	9.6	7.2	23.5	9.2	1.6	15.4	7.7	2.9	22.9	11.3	25.7	18.5	19.6	70.7	26.4	6.1	14.2	12.2	11.7	25.4	18.0	17.5	14.2	8.4	7.1	41.4	45.3	9.5	14.7	8.2	13.2	16.6	24.1	13.3	39.6	65.0	0.9	16.1	6.6	8.4	11.3	21.1	27.7	15.2	14.9	6.7	22.9	13.7	6.7	11.5
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863414	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	93.8	101.7	75.1	32.1	73.8	26.8	81.0	79.0	86.2	84.5	64.2	104.7	39.0	91.1	31.1	61.1	76.2	51.7	105.4	73.6	76.2	80.6	114.5	65.1	36.1	78.4	74.6	109.6	86.8	87.9	68.7	42.3	78.9	78.1	24.4	34.0	67.2	55.5	49.7	82.8	69.6	38.9	69.1	66.3	89.1	43.9	73.6	40.6	69.1	43.9	24.8	89.7	73.6	70.1	40.0	85.6	23.7	47.3	125.8	86.3	70.5	71.0	76.6	47.9	47.4	50.5	75.1	26.9	125.2	80.3	42.2	62.0	38.7	44.5	21.3	67.5	85.3	19.5	61.4	74.1	87.7	28.5	47.2	148.0	77.2	64.3	29.7	75.8	60.9	49.9	29.5	67.1	44.0	127.7	40.3	56.2	55.5	42.2	65.7	74.8	29.5	78.7	63.7	38.1	96.4	53.8	36.9	76.1	55.7	41.2	57.5	74.8	52.8	70.3	22.1	58.0	35.8	51.4	62.1	19.3	77.2	46.0	43.4	11.7	8.2	28.9	8.5	6.2	5.7	6.5	7.9	9.1	3.8	6.4	7.7	7.2	20.6	11.4	7.9	8.1	12.0	3.8	75.1	73.8	79.0	86.2	73.6	76.2	78.4	74.6	78.9	69.1	73.6	70.1	54.7	25.6	28.3	10.4	25.1	41.3	41.4	22.9	30.1	53.4	42.1	49.7	57.9	41.5	15.4	46.0	45.9	120.6	31.9	57.5	41.1	72.0	54.0	18.1	30.4	48.0	37.3	22.7	16.4	71.8	127.3	59.3	19.4	29.6	13.4	30.7	46.1	41.7	65.0	58.9	19.3	30.6	10.2	41.8	21.3	12.8	76.7	33.3	23.2	11.2	45.2	57.7	36.0	9.0	11.5	44.9	37.9	61.7	31.7	38.9	87.9	34.5	15.1	56.3	46.0	24.4	44.6	10.2	14.7	32.3	50.7	73.2	30.5	34.1	34.8	39.3
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702379-1724357	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 85.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	17.7	17.0	14.9	24.8	15.3	41.7	17.7	18.7	16.2	22.2	14.9	25.0	29.3	19.4	8.8	15.7	20.6	9.4	13.5	14.3	15.8	15.5	18.6	27.4	23.3	15.9	14.6	20.3	17.2	9.3	18.5	12.5	15.4	20.3	14.7	13.1	16.8	7.8	26.0	19.8	36.7	8.8	12.9	36.7	20.3	21.6	15.1	17.0	20.0	7.6	13.8	17.8	19.1	16.4	26.6	16.3	18.7	16.9	20.5	14.5	13.4	25.4	14.3	18.7	20.1	21.9	30.1	31.8	15.2	10.0	19.8	27.1	14.3	15.0	14.3	25.4	19.4	28.8	42.6	20.4	13.3	29.6	45.9	17.1	10.7	13.5	12.2	20.3	22.2	21.4	35.7	27.4	11.1	15.5	19.0	33.4	18.1	18.4	16.0	27.7	19.0	18.9	12.3	13.0	17.7	22.6	25.0	36.3	37.9	7.6	20.4	19.4	22.7	24.3	18.5	10.9	17.2	38.0	31.1	35.3	9.8	33.1	7.2	64.1	16.7	22.0	14.5	9.0	12.1	19.3	12.4	10.7	5.6	19.5	12.0	9.9	85.3	12.0	11.6	33.3	10.9	3.5	14.9	15.3	18.7	16.2	14.3	15.8	15.9	14.6	15.4	12.9	15.1	16.4	27.7	51.3	59.0	5.9	33.9	14.0	16.0	12.5	22.2	33.0	11.3	10.4	1.0	14.3	38.3	14.7	27.1	16.2	54.1	28.8	9.8	19.7	37.6	18.0	24.2	26.4	9.1	29.0	5.3	15.3	22.6	16.6	52.5	21.8	84.6	18.9	18.5	15.6	12.2	40.4	5.0	29.1	12.2	12.2	26.9	16.3	35.4	28.5	10.6	2.8	25.6	16.1	44.3	4.5	8.7	25.9	51.0	21.4	42.7	16.3	62.0	11.7	34.5	42.4	13.1	21.3	19.1	124.0	93.7	15.3	14.6	30.5	48.1	16.5	23.0	14.3
CDK11B	"CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58"	ENSG00000248333	"Cyclin dependent kinase 11B"	P21127	1	1635225-1659012	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 174.6;Spermatogonia: 176.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025061, HPA073626"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (7.52e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.75e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (6.52e-3)"	31.8	29.0	20.6	17.6	20.8	43.0	30.0	18.1	20.9	32.4	16.6	46.1	25.6	35.9	5.8	30.3	31.6	9.9	39.6	18.3	20.2	28.2	32.1	41.0	19.5	21.2	19.8	33.4	35.0	8.9	30.5	10.6	20.7	31.7	9.4	9.0	28.4	12.7	85.9	39.3	44.6	10.4	20.4	47.7	34.5	49.8	20.8	13.2	30.8	17.8	10.6	37.9	30.8	21.6	47.2	36.4	21.9	17.4	17.8	12.0	30.6	43.7	18.8	24.0	20.8	41.3	43.7	40.8	43.9	18.7	16.9	35.4	18.6	22.0	18.4	36.3	40.4	43.9	68.9	36.1	24.1	50.4	44.3	16.1	15.8	26.2	19.9	14.1	24.5	42.3	51.9	26.9	14.4	31.0	47.9	42.5	38.9	13.8	43.7	46.9	43.4	33.5	12.7	16.6	28.3	36.4	40.3	36.7	42.3	15.0	25.2	33.4	37.4	29.8	33.0	22.7	43.0	60.5	58.7	85.6	37.4	55.9	23.2	7.2	3.3	5.3	6.1	2.8	2.7	3.3	3.8	3.6	2.8	3.7	4.1	3.1	13.8	4.4	3.2	5.1	3.2	1.6	20.6	20.8	18.1	20.9	18.3	20.2	21.2	19.8	20.7	20.4	20.8	21.6	35.2	19.2	43.1	13.7	42.9	14.4	19.5	10.2	25.6	32.0	22.2	18.3	42.9	30.0	31.7	27.6	20.9	27.7	44.7	86.6	9.8	33.3	39.7	28.1	34.2	32.3	28.8	25.0	14.1	35.2	31.5	25.1	48.9	36.3	55.6	24.1	25.7	38.6	20.5	15.2	12.3	73.8	10.2	30.1	14.5	25.6	28.9	33.9	5.4	15.0	36.3	20.5	76.2	10.1	18.2	37.4	93.3	26.7	54.7	19.6	95.4	19.2	29.4	42.4	52.6	25.9	31.0	174.6	176.5	27.5	17.3	44.6	48.9	16.5	56.9	15.9
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461486-39564907	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 307.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	9.5	7.6	2.5	14.0	1.9	34.3	9.5	8.0	4.0	11.0	4.1	9.8	9.9	10.8	6.0	10.4	9.2	9.2	6.8	1.6	2.9	8.0	12.3	9.2	15.1	3.0	1.7	11.9	8.7	13.0	6.2	11.5	1.6	9.8	10.4	11.7	9.2	9.3	6.7	10.6	10.4	10.0	0.3	12.9	10.3	17.7	3.4	17.9	12.2	7.8	15.3	13.1	9.1	3.3	31.9	40.0	24.9	22.2	17.2	19.0	21.1	28.9	24.7	39.9	29.0	48.1	19.8	45.4	24.6	31.1	38.7	51.8	49.2	36.6	38.4	29.6	38.7	49.7	26.9	36.3	16.4	66.9	33.4	20.4	25.0	48.2	37.6	16.0	24.4	27.7	85.2	30.7	22.9	14.3	57.9	17.7	23.8	16.0	16.9	36.8	50.3	25.7	14.8	38.8	24.6	15.7	37.0	307.8	25.1	34.8	38.5	29.3	26.4	34.5	27.6	24.5	37.9	23.6	18.4	63.5	24.2	28.2	23.0	11.2	2.0	3.2	2.6	1.5	1.8	1.8	1.5	1.7	1.2	3.1	1.7	1.6	7.0	4.5	1.3	2.7	1.2	0.7	2.5	1.9	8.0	4.0	1.6	2.9	3.0	1.7	1.6	0.3	3.4	3.3	41.4	25.6	29.1	50.9	59.0	64.6	58.5	31.2	50.1	46.6	38.1	26.9	14.5	32.9	40.3	38.6	64.6	33.2	59.0	44.6	13.7	30.2	25.1	49.8	63.4	40.6	31.1	39.3	53.9	27.5	29.9	39.2	45.3	63.1	29.1	43.8	32.2	46.3	27.4	35.3	52.9	39.6	42.7	45.9	49.1	17.3	37.3	41.3	26.6	32.8	41.4	27.8	48.4	47.3	53.1	47.9	33.9	33.8	53.5	81.5	33.3	16.7	38.1	65.4	32.9	48.0	48.5	140.2	104.8	53.0	69.0	58.3	59.0	46.0	39.9	84.8
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39950121-40099580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	11.4	10.2	8.8	14.6	10.8	28.1	11.1	19.3	9.9	12.8	6.7	11.9	10.5	13.6	14.2	14.7	15.0	12.7	10.4	8.1	10.7	12.7	15.9	12.1	21.7	10.5	8.5	20.1	12.8	17.2	8.0	13.6	8.6	11.2	13.6	19.7	12.9	11.8	11.2	12.0	12.0	12.0	7.2	16.6	12.3	19.0	10.1	19.6	20.6	14.0	20.2	13.4	10.0	14.9	28.4	16.6	28.2	27.0	24.9	24.1	19.3	22.1	23.8	19.8	24.6	17.8	19.1	51.0	12.6	23.4	34.8	33.6	23.4	19.4	29.0	25.3	17.3	22.8	20.0	16.0	23.7	34.8	23.5	14.3	25.5	22.6	30.0	22.6	23.6	23.1	39.0	34.3	20.7	14.7	28.0	24.9	40.8	20.0	19.1	30.5	18.5	20.5	18.5	28.1	20.0	28.8	27.6	59.8	19.9	36.7	24.6	43.0	28.3	27.0	26.0	17.6	30.5	28.3	26.0	41.2	19.8	30.9	35.4	7.8	2.2	4.0	4.1	1.9	2.8	6.4	3.8	3.0	1.3	10.5	3.8	3.9	5.9	4.3	3.1	3.3	3.9	1.3	8.8	10.8	19.3	9.9	8.1	10.7	10.5	8.5	8.6	7.2	10.1	14.9	47.6	44.8	72.0	131.6	49.7	21.4	18.5	15.9	29.0	47.8	36.7	27.7	30.9	25.8	37.1	31.3	70.9	13.7	91.0	23.1	7.9	20.4	13.9	54.3	51.4	30.9	18.7	5.9	179.0	15.4	9.1	31.7	30.1	72.6	17.1	95.5	19.2	23.7	13.2	37.0	166.2	17.6	14.2	23.8	17.4	9.2	26.1	31.6	14.2	145.2	27.9	22.4	53.5	171.9	199.6	28.6	12.9	17.7	50.1	21.8	15.2	12.7	32.8	69.4	6.6	38.5	32.0	36.1	33.4	34.7	26.1	12.2	49.7	56.8	20.1	25.0
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 545.4;Horizontal cells: 173.3;Inhibitory neurons: 426.8;Oligodendrocyte precursor cells: 320.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 9.0;memory B-cell: 8.5;naive B-cell: 4.8;neutrophil: 4.8"	"Group enriched"	"Detected in many"	10	"B-cells: 8.5;granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	10.1	4.4	9.7	7.8	12.8	7.1	8.6	11.6	31.2	10.1	0.0	5.9	2.7	8.5	3.1	3.1	12.2	12.2	11.9	18.5	7.9	20.7	13.4	9.6	12.4	7.8	17.9	14.5	15.1	3.0	9.2	6.1	7.8	11.2	3.3	17.4	8.3	6.7	4.6	2.5	3.8	7.6	6.4	8.2	8.0	7.9	19.2	5.5	13.3	7.2	12.9	5.7	5.2	20.5	18.0	0.2	35.0	4.5	31.9	32.0	8.0	14.7	14.0	8.8	9.5	0.4	8.6	58.9	1.8	14.6	13.1	5.2	1.8	20.7	16.9	0.1	8.3	0.0	11.2	0.4	14.7	18.3	0.3	22.7	5.3	26.5	9.4	14.7	11.6	0.4	0.3	78.4	18.4	0.1	0.1	7.3	21.8	0.1	9.6	49.3	47.4	50.2	4.6	4.9	7.7	21.9	37.3	0.2	0.7	15.4	4.7	9.2	28.4	37.8	48.5	32.1	23.0	43.1	36.3	41.9	14.6	23.8	37.9	9.0	0.3	0.5	0.0	0.6	0.0	8.5	0.0	0.0	0.8	4.8	0.0	0.0	4.8	0.1	0.5	0.1	0.2	0.5	9.7	12.8	11.6	31.2	18.5	7.9	7.8	17.9	7.8	6.4	19.2	20.5	11.0	19.2	5.1	118.2	37.4	0.8	7.7	6.0	2.2	6.9	7.0	8.9	18.3	12.8	9.1	11.0	0.0	0.2	0.2	0.4	7.9	9.8	53.9	1.7	13.4	2.8	1.8	4.0	545.4	6.7	0.1	16.1	4.1	1.5	0.0	11.2	1.4	11.3	3.7	173.3	426.8	0.3	4.1	3.4	4.9	46.4	15.5	7.0	5.4	66.5	1.7	9.4	0.0	320.7	32.9	13.4	1.3	15.8	78.1	12.8	0.1	22.7	3.9	9.7	0.0	6.3	15.9	5.4	6.6	1.2	1.3	0.0	1.9	6.5	0.3	4.2
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 217.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	48.2	61.3	59.0	30.4	63.6	65.7	38.6	63.8	75.0	37.9	35.7	41.4	34.2	37.5	19.7	60.7	37.6	23.8	113.3	64.3	46.5	62.7	35.0	41.6	24.3	57.2	52.4	45.3	43.1	50.6	41.7	37.9	54.9	37.2	29.6	33.6	43.9	30.4	217.6	41.9	36.3	37.7	39.6	34.0	39.1	55.2	74.3	29.9	50.3	180.4	26.5	34.2	36.8	60.6	177.6	132.5	124.8	185.0	89.5	76.2	124.2	82.4	100.7	122.3	90.5	150.2	83.3	42.1	51.2	148.1	225.7	97.7	134.3	174.7	81.8	50.9	212.6	46.0	193.8	118.8	115.7	48.7	103.0	95.5	109.6	173.8	207.4	101.7	111.0	43.7	69.6	69.7	108.4	153.1	42.7	111.1	97.9	66.3	141.8	44.9	98.8	74.4	91.7	137.7	105.0	79.4	223.2	169.9	86.5	144.4	152.0	59.3	112.9	81.1	131.4	125.4	99.8	54.6	58.2	41.8	71.4	223.0	93.1	2.6	7.8	7.5	3.7	9.3	4.9	3.4	5.0	6.0	9.7	9.8	4.3	4.6	3.2	5.5	8.4	11.3	5.5	6.1	59.0	63.6	63.8	75.0	64.3	46.5	57.2	52.4	54.9	39.6	74.3	60.6	18.8	0.0	6.1	7.2	20.2	32.5	33.0	30.6	33.6	23.5	38.2	26.8	43.3	21.5	22.1	31.3	4.2	25.7	20.1	67.2	54.8	33.7	26.5	41.2	24.5	21.8	28.1	20.6	12.5	37.0	45.2	24.0	46.4	57.7	5.7	27.8	19.2	16.7	25.3	30.3	15.8	34.3	32.6	19.5	30.8	94.8	17.1	23.5	33.8	2.8	12.6	17.1	9.2	3.5	7.8	48.4	46.1	13.2	31.9	48.3	45.1	34.7	17.9	14.6	0.0	19.1	22.6	27.6	17.5	64.2	34.7	26.0	21.5	30.0	48.6	63.3
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504596-205532793	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.6;heart muscle: 116.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 462.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 32.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.5;HeLa: 35.3;hTERT-RPE1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	6.1	9.0	68.6	4.1	131.1	1.1	5.1	141.2	82.6	10.9	40.0	13.1	28.8	8.6	3.4	5.7	8.6	10.4	116.3	57.8	90.8	26.5	10.6	11.0	2.8	179.2	148.1	12.6	16.9	7.8	11.5	16.1	147.7	9.2	9.2	13.3	29.2	23.6	6.1	3.3	24.9	7.0	115.2	9.5	35.8	1.6	122.1	3.6	9.5	5.3	3.7	5.7	7.5	179.6	22.2	1.4	0.2	1.3	0.0	0.0	22.6	0.4	4.1	1.0	5.5	9.4	17.8	12.4	3.2	0.2	1.9	21.2	4.9	38.5	0.9	3.4	3.8	3.0	35.3	10.5	4.0	0.1	0.2	2.5	1.9	0.1	0.8	32.2	0.0	18.4	0.1	15.2	0.3	17.7	1.2	0.6	18.4	6.1	0.9	1.6	0.1	16.6	3.6	13.5	7.9	2.8	6.4	3.2	14.2	24.5	15.3	6.2	0.0	0.0	8.1	0.1	0.1	4.1	2.1	2.5	0.2	9.4	3.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	68.6	131.1	141.2	82.6	57.8	90.8	179.2	148.1	147.7	115.2	122.1	179.6	4.6	0.0	0.5	12.4	1.0	3.4	6.9	17.4	11.4	7.0	4.6	5.6	29.6	5.7	6.8	73.5	0.0	5.7	0.2	12.1	7.9	18.5	2.4	2.1	0.7	2.9	6.0	1.3	12.0	6.7	2.3	3.8	15.8	4.6	0.0	13.3	2.5	3.7	5.3	0.0	4.5	12.9	2.0	3.8	4.5	4.0	0.9	3.8	3.6	12.2	4.4	28.2	1.0	4.5	462.9	6.5	111.2	1.5	0.9	10.8	35.6	18.7	3.3	1.2	6.6	5.8	12.8	6.6	17.0	5.3	1.3	1.9	1.4	22.7	13.7	9.2
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.1;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 476.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007053, HPA007062"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA007053: AB_1233803, HPA007062: "	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	6.2	3.4	22.7	7.2	32.1	11.7	6.4	17.9	29.0	6.6	7.5	6.9	5.3	10.2	3.8	8.2	5.4	8.3	4.4	20.8	19.3	6.4	5.0	6.7	9.4	28.8	24.7	9.8	3.9	6.5	2.3	11.5	22.7	26.7	6.4	8.8	4.4	5.9	3.3	8.5	6.7	7.3	19.4	8.0	7.1	18.5	26.9	13.6	6.1	5.4	9.2	5.3	6.6	40.8	5.7	6.1	21.8	26.4	11.1	15.6	10.8	18.8	19.4	6.7	8.8	7.6	6.4	14.7	6.5	13.2	13.9	3.2	8.0	3.9	15.4	18.2	4.5	26.0	8.8	8.9	6.8	10.5	18.2	10.7	8.6	9.7	14.1	17.0	6.8	12.3	7.6	20.2	14.5	9.7	14.3	15.0	2.0	8.1	4.1	14.8	11.3	5.8	7.8	11.0	10.6	19.8	14.4	11.3	17.0	7.2	3.9	37.1	7.7	14.2	7.6	29.6	11.4	2.1	3.2	12.8	15.6	13.7	14.9	2.1	1.2	0.9	0.4	0.7	0.4	0.6	0.3	0.3	1.0	0.6	0.2	0.3	4.6	0.7	0.4	0.5	0.4	0.3	22.7	32.1	17.9	29.0	20.8	19.3	28.8	24.7	22.7	19.4	26.9	40.8	15.9	3.2	17.8	50.6	19.2	9.8	14.4	6.7	12.0	19.2	14.6	9.4	8.2	18.6	8.7	16.5	16.7	7.0	17.8	27.0	1.9	10.5	102.3	13.7	16.5	13.6	12.6	21.6	85.3	4.7	18.4	12.0	13.7	25.6	7.0	23.0	20.0	12.2	16.4	23.5	51.5	13.5	8.2	33.9	19.9	137.1	10.8	22.1	26.6	62.8	19.6	33.9	22.6	154.8	476.3	7.0	20.0	16.1	5.9	30.0	16.1	7.7	6.9	13.9	6.6	11.2	12.3	56.6	15.8	20.3	16.2	7.9	13.3	10.1	13.8	11.1
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 21.9;Spermatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	7	"NK-cells: 3.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 18.2;THP-1: 29.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.9	14.8	8.8	1.5	9.8	1.0	3.1	5.5	9.5	7.2	11.1	6.4	3.5	5.7	3.8	2.3	13.3	3.5	3.4	10.0	10.6	8.3	3.3	3.0	1.2	6.4	6.8	7.8	6.1	8.4	12.7	1.8	6.9	5.2	2.2	8.4	3.3	5.5	1.0	3.3	4.8	3.6	6.1	1.4	4.4	15.9	10.9	1.3	5.3	1.3	0.5	7.6	3.7	7.1	3.1	3.6	3.2	9.5	2.6	3.5	1.2	2.7	5.4	7.7	6.9	1.1	4.6	0.0	3.7	4.6	13.0	3.7	0.0	2.8	3.2	7.3	3.2	0.0	1.9	0.0	9.2	3.7	4.4	2.6	5.5	12.0	5.1	5.9	0.0	6.7	0.4	0.0	2.2	9.1	2.2	1.2	2.4	7.2	1.1	0.0	0.0	0.1	9.6	2.8	18.2	5.2	2.9	3.9	4.9	1.1	3.9	29.8	0.0	3.4	1.3	0.6	3.0	4.2	4.6	0.0	11.7	2.4	3.5	0.0	0.3	0.2	0.6	0.4	0.3	0.0	1.4	1.0	0.3	0.0	2.3	1.6	0.0	3.6	0.3	0.3	1.5	0.6	8.8	9.8	5.5	9.5	10.0	10.6	6.4	6.8	6.9	6.1	10.9	7.1	0.3	3.2	4.4	5.2	0.2	2.2	2.3	2.2	5.7	6.1	3.0	3.2	2.0	2.8	4.0	1.8	2.1	4.6	0.8	5.8	1.9	5.2	6.3	15.8	6.7	0.8	0.0	0.8	8.3	1.5	2.3	3.4	4.1	5.8	1.3	4.0	0.7	0.8	0.9	8.4	6.7	2.8	4.1	0.0	0.2	4.3	4.4	1.1	0.0	1.0	0.3	5.0	2.1	3.0	2.9	1.4	1.6	6.8	0.3	3.0	7.3	6.3	21.9	15.0	6.6	1.1	3.2	30.2	3.4	0.8	2.3	4.0	1.1	11.6	3.4	1.2
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123250112-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 44.3;intermediate monocyte: 152.6;myeloid DC: 52.5;non-classical monocyte: 175.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.5;monocytes: 175.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046"	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	96.1	82.8	239.4	62.7	255.4	70.6	105.0	270.5	285.1	114.8	199.5	111.8	40.1	111.9	127.7	115.1	81.5	87.7	95.1	238.3	272.2	82.2	56.7	78.3	51.0	296.1	256.0	56.0	53.2	72.3	88.8	64.4	288.2	103.5	63.1	43.4	158.8	97.7	91.5	68.1	53.9	120.3	292.7	48.6	84.9	69.1	260.8	86.0	61.4	109.9	56.5	124.9	105.3	288.3	125.7	172.4	451.1	481.5	352.6	443.9	81.8	399.1	369.6	311.1	234.7	131.0	117.5	0.1	174.9	611.4	115.9	111.3	484.0	261.3	256.1	77.6	120.7	66.4	98.0	208.4	192.0	104.9	68.7	282.8	267.0	180.2	116.9	283.4	449.4	151.0	90.6	0.5	594.9	244.3	140.3	170.2	296.1	154.9	129.2	528.7	193.0	54.0	259.7	295.2	416.7	496.5	290.9	141.5	412.0	119.4	272.5	104.3	273.2	286.5	149.1	172.9	267.6	21.0	41.6	116.1	156.6	48.9	640.9	15.9	44.3	21.3	0.5	152.6	1.9	0.9	0.5	0.9	52.5	0.1	0.3	0.5	1.5	1.3	175.4	4.2	0.4	29.7	239.4	255.4	270.5	285.1	238.3	272.2	296.1	256.0	288.2	292.7	260.8	288.3	10.4	28.9	39.7	32.0	3.0	1.3	1.5	8.7	18.2	0.3	6.9	8.8	1.8	8.6	21.7	12.9	0.0	1.6	1.4	12.3	1.9	24.0	30.7	8.0	31.6	14.0	7.7	13.7	12.2	16.7	3.3	13.8	19.9	7.6	19.0	3.2	16.4	6.9	6.0	3.3	5.0	16.7	4.1	26.0	4.9	131.8	13.4	18.8	3.6	14.0	11.4	19.4	1.0	17.1	25.0	24.3	12.5	14.3	2.8	0.4	5.4	3.4	12.5	0.3	0.0	3.2	10.3	1.4	8.1	46.9	2.8	1.4	1.9	1.0	16.2	0.9
CDK2AP2	"DOC-1R, p14"	ENSG00000167797	"Cyclin dependent kinase 2 associated protein 2"	O75956	11	67506497-67508649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038872, HPA047599"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA038872: , HPA047599: AB_10963069"	"unprognostic (2.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.73e-3)"	45.6	69.3	83.5	46.1	87.6	32.1	34.2	90.5	107.0	40.7	76.3	46.6	42.9	41.2	85.8	45.2	37.5	27.2	98.5	82.8	87.3	103.0	109.7	46.1	64.8	99.2	89.3	27.9	67.9	25.1	43.7	29.8	95.5	41.9	28.1	25.7	47.2	45.7	23.3	19.7	40.5	30.3	91.5	47.1	47.8	12.6	87.1	55.7	78.0	22.6	48.2	42.8	27.2	93.1	92.9	77.6	33.3	72.4	55.0	19.8	46.9	30.0	25.7	54.8	43.6	104.2	121.6	58.1	111.0	32.6	64.4	67.7	59.5	77.4	16.7	156.0	29.7	36.2	60.8	81.8	113.2	32.7	48.8	17.5	84.8	47.3	93.5	44.2	64.3	86.9	32.5	204.4	23.7	183.5	196.6	111.3	35.2	221.7	83.4	83.6	18.4	245.3	129.1	30.4	23.2	50.9	44.2	130.5	150.8	30.3	73.0	70.0	35.6	26.5	46.4	61.7	27.7	55.0	39.8	65.7	73.2	49.3	34.6	284.3	119.2	266.2	297.9	222.7	261.5	229.6	221.4	267.7	174.8	222.3	117.4	176.3	97.5	292.7	266.1	793.7	291.1	215.2	83.5	87.6	90.5	107.0	82.8	87.3	99.2	89.3	95.5	91.5	87.1	93.1	54.6	64.1	86.2	4.2	112.0	67.0	47.0	118.3	186.1	27.8	88.8	75.3	76.6	88.6	80.3	117.7	31.3	94.9	206.5	187.0	215.2	85.1	1.7	98.2	50.4	56.8	102.8	42.5	3.5	53.2	192.7	49.0	78.5	104.1	74.8	49.5	45.7	131.3	84.6	33.7	3.6	151.1	81.4	46.8	94.9	2.6	24.5	71.5	113.8	11.2	109.8	61.1	171.0	6.0	14.0	99.1	158.5	30.5	240.8	71.1	139.6	329.7	64.6	29.4	26.3	22.0	76.2	10.2	31.1	170.3	51.0	194.4	131.4	30.1	123.2	76.4
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	12.7	11.0	11.4	7.7	11.8	10.6	12.2	11.5	13.8	15.7	12.0	14.9	10.4	11.5	10.7	11.1	13.7	10.3	8.4	11.3	12.2	18.4	34.8	14.2	10.5	12.0	11.7	15.9	15.1	4.8	19.7	8.9	12.2	25.7	10.1	6.9	13.6	8.4	3.6	24.7	14.7	7.6	11.5	21.9	12.2	15.6	11.8	5.8	19.5	3.3	10.5	10.8	13.3	13.6	5.5	7.5	13.5	6.5	7.3	9.0	26.1	4.6	4.6	8.0	7.4	7.0	11.0	6.5	4.5	5.7	4.6	11.6	10.2	4.1	5.6	3.3	14.1	12.7	17.8	7.3	6.7	5.9	14.9	8.7	10.8	7.3	5.1	13.0	6.9	4.1	5.6	4.5	4.3	12.1	6.3	21.8	6.3	3.8	8.4	10.4	5.2	7.2	6.9	15.8	8.4	22.0	3.8	12.0	3.2	14.2	17.4	10.9	5.5	16.4	9.6	5.4	6.7	9.9	7.2	6.2	5.4	5.5	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	11.4	11.8	11.5	13.8	11.3	12.2	12.0	11.7	12.2	11.5	11.8	13.6	4.3	0.0	0.0	0.0	0.5	2.7	0.0	4.0	0.0	0.0	5.3	5.0	0.3	0.0	2.2	0.0	0.0	0.0	3.1	0.0	1.9	2.0	0.0	2.9	3.9	1.4	0.0	0.0	0.0	2.3	0.0	1.3	0.0	5.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	4.4	0.0	0.0	1.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	1.2	2.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.7	0.0	1.0	2.8	0.0	0.0
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981781	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	45.8	48.2	83.8	42.0	85.7	52.3	48.7	83.7	111.3	58.1	100.4	53.0	54.5	42.4	91.9	52.8	54.2	46.1	39.2	85.5	85.5	60.2	80.6	44.6	51.7	86.4	84.7	69.5	133.6	53.6	93.0	34.3	85.7	62.6	53.8	34.1	77.0	48.5	29.6	43.5	68.5	33.8	83.1	81.4	81.8	83.5	86.6	44.2	73.2	28.1	54.8	48.1	48.3	86.7	72.7	116.5	60.8	114.6	52.6	53.3	112.7	51.4	63.9	52.3	51.0	92.5	72.3	88.7	107.8	55.5	35.2	72.8	41.6	61.4	59.3	127.0	58.1	43.4	157.9	123.8	58.7	50.0	47.5	60.7	51.5	45.9	91.8	64.2	52.8	169.1	49.6	80.8	52.9	140.3	128.3	79.2	38.5	87.4	55.0	74.6	101.4	101.7	52.8	91.3	43.0	104.1	38.3	37.1	51.7	65.3	84.5	65.4	38.9	43.6	38.2	53.1	66.8	106.8	102.9	54.2	54.3	69.1	53.5	20.8	62.6	54.8	33.8	63.8	36.8	40.9	31.4	30.6	50.1	44.7	28.0	31.4	30.5	45.3	67.4	46.0	32.9	41.3	83.8	85.7	83.7	111.3	85.5	85.5	86.4	84.7	85.7	83.1	86.6	86.7	31.3	25.6	62.6	60.7	61.8	33.6	63.3	89.3	50.7	52.0	52.8	40.4	28.4	44.3	84.1	40.5	31.3	68.8	44.9	56.5	50.9	56.8	53.0	35.7	32.9	32.1	61.6	22.9	31.1	67.7	57.4	44.7	147.8	42.5	69.6	68.3	27.5	55.6	61.7	57.2	27.9	70.8	71.2	33.6	40.7	36.3	40.7	44.1	46.2	25.3	47.6	45.1	33.0	25.6	50.6	37.1	60.9	29.7	87.2	49.0	77.2	45.1	85.2	52.6	32.9	34.3	33.2	132.8	45.7	31.0	25.9	61.6	53.0	38.6	56.8	56.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 169.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453, CAB079975"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	13.4	19.8	9.4	9.5	10.2	29.1	14.8	10.9	12.9	17.5	11.5	13.7	13.3	12.1	12.9	37.3	12.5	6.4	12.4	9.5	10.5	18.4	13.6	12.7	4.8	9.7	9.7	11.7	14.1	3.2	18.2	16.2	9.8	13.7	7.4	12.8	18.9	4.8	26.8	25.3	12.2	7.7	9.8	12.6	13.5	30.6	10.0	9.3	13.2	15.0	13.3	16.1	19.9	9.4	42.8	5.9	19.4	30.6	6.4	24.4	169.5	30.9	37.5	46.2	42.9	62.2	64.5	3.7	36.4	36.8	34.2	65.3	10.8	31.3	40.6	9.0	3.1	8.6	21.4	25.9	32.8	17.9	33.8	7.1	61.3	1.8	46.0	24.5	32.5	22.3	16.3	16.1	13.3	33.3	9.4	51.7	20.7	2.8	25.4	12.3	0.7	27.1	42.6	25.4	8.6	17.5	11.6	50.4	42.4	28.1	44.9	39.3	7.4	17.1	27.4	33.1	18.2	14.4	30.4	16.5	31.4	10.2	15.5	27.9	7.9	16.2	5.3	8.9	7.9	10.6	7.8	10.6	7.3	14.5	5.9	6.4	8.2	8.6	4.7	8.9	10.5	6.1	9.4	10.2	10.9	12.9	9.5	10.5	9.7	9.7	9.8	9.8	10.0	9.4	12.2	16.0	13.2	10.7	7.8	57.7	21.4	32.9	15.4	6.4	12.3	14.7	11.3	10.0	20.2	5.5	12.5	121.0	11.7	10.2	15.6	27.8	26.8	33.1	10.7	11.6	3.0	9.9	17.6	21.6	343.6	13.0	9.7	27.2	15.8	7.4	7.1	6.7	24.0	1.7	13.7	12.3	20.3	8.5	6.0	7.9	7.5	8.5	7.2	11.2	11.6	10.4	15.5	8.0	11.9	29.3	16.2	7.2	5.8	28.2	12.3	29.3	42.4	8.7	26.3	10.0	12.5	70.1	18.6	15.9	41.9	64.6	11.4	6.8	13.2	29.8
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50326265-50416461	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	13.5	3.6	3.4	4.9	4.4	3.6	3.5	1.4	9.0	13.9	3.7	8.8	13.2	13.9	3.2	5.2	15.4	5.2	2.3	5.5	2.3	19.4	1.6	6.5	6.5	2.0	2.1	13.8	1.3	1.2	0.6	6.5	2.9	5.9	6.6	20.2	2.8	9.0	7.1	13.5	6.9	8.5	2.9	7.0	4.9	2.0	1.8	1.9	7.9	1.0	2.6	6.9	6.6	8.1	7.7	4.9	3.5	4.3	5.3	6.1	2.3	2.2	3.2	1.9	2.0	4.0	5.9	6.1	2.8	3.2	3.2	5.9	0.8	0.3	1.9	8.9	3.1	12.2	4.6	3.9	6.2	9.7	5.3	1.5	3.0	3.2	8.0	2.4	6.7	10.3	3.3	4.8	1.1	2.5	2.8	4.7	1.9	2.6	3.9	3.3	3.8	3.1	5.3	6.6	4.6	3.4	4.2	18.3	2.1	1.3	2.4	6.2	4.0	6.7	4.1	7.1	5.0	2.4	1.8	2.9	1.7	8.7	7.6	3.2	1.4	2.6	3.5	1.4	3.1	2.6	2.3	3.2	0.8	3.0	1.9	1.9	0.7	2.3	0.2	0.8	2.4	1.3	3.4	4.4	1.4	9.0	5.5	2.3	2.0	2.1	2.9	2.9	1.8	8.1	3.2	19.2	9.9	6.5	3.0	3.1	4.1	0.2	3.4	0.7	0.4	0.5	0.5	0.0	2.6	11.0	0.0	0.1	2.3	7.2	5.9	1.4	0.4	23.4	9.6	3.3	1.8	6.1	46.2	1.8	0.1	7.6	1.1	4.9	1.3	3.2	6.4	0.3	0.4	0.0	20.6	2.1	2.0	0.9	1.5	1.5	9.0	1.5	0.0	7.5	0.8	0.9	2.1	46.8	25.4	1.9	4.8	3.4	0.2	3.1	4.9	8.0	20.4	0.7	0.0	4.0	4.6	0.0	0.3	4.7	2.7	0.3	4.2	3.6	5.2	2.2
CDKL4		ENSG00000205111	"Cyclin dependent kinase like 4"	Q5MAI5	2	39175646-39229588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.0;testis: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.8;Excitatory neurons: 5.4;Late spermatids: 6.8;Respiratory ciliated cells: 5.9;Spermatocytes: 8.7;Spermatogonia: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.1;RT4: 1.3;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"							HPA067895	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA067895: AB_2685920"	"unprognostic (3.57e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.46e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.77e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.45e-4)"	"unprognostic (8.59e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.26e-2)"	0.1	0.4	0.6	0.0	0.6	0.0	0.1	0.7	0.7	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.7	1.1	0.1	0.0	0.2	0.1	0.5	0.6	0.1	0.1	0.2	0.5	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	2.9	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	2.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	1.3	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.6	0.7	0.7	0.7	1.1	0.5	0.6	0.5	0.2	1.0	0.4	0.5	3.2	0.0	0.7	0.0	0.1	0.2	0.3	0.0	0.1	0.6	0.5	0.2	0.0	2.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	11.8	1.2	0.3	0.3	0.0	0.0	5.4	0.2	0.4	0.2	1.1	1.8	0.0	0.2	0.0	0.1	0.2	0.0	3.4	0.0	2.0	0.0	0.0	6.8	0.3	0.2	0.0	1.9	0.0	0.2	0.0	1.5	0.4	0.4	0.1	0.4	0.1	0.4	0.0	0.3	5.9	0.8	0.0	0.5	0.1	8.7	4.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	53.4	44.7	53.6	40.1	70.6	68.1	50.2	73.4	81.3	55.3	43.1	43.9	44.5	41.0	24.5	29.1	47.3	24.6	32.9	47.9	58.9	30.2	35.2	38.9	55.3	58.6	58.3	66.1	23.9	34.4	24.4	41.0	61.2	35.9	32.5	55.3	36.3	33.4	81.4	45.4	40.7	24.8	55.1	55.1	30.0	25.8	58.3	71.8	33.7	63.4	39.9	32.0	44.5	91.2	37.1	16.6	94.5	16.6	32.0	18.0	46.1	31.5	53.8	46.0	56.4	47.7	40.4	0.3	12.5	19.6	16.6	34.2	44.9	16.7	41.1	62.4	31.5	28.8	46.5	53.2	42.5	24.5	18.6	19.8	35.3	15.2	44.0	107.8	27.8	54.5	31.5	101.6	16.6	45.9	32.7	35.3	38.0	32.1	16.8	25.2	30.9	63.1	22.5	38.6	35.6	58.4	48.9	34.8	65.8	33.7	18.6	54.6	19.1	22.6	34.9	20.7	33.3	86.1	59.4	33.2	28.2	36.6	22.5	6.2	3.8	8.6	5.9	3.5	6.1	6.8	7.7	7.2	3.6	5.0	8.0	6.1	20.9	7.3	5.5	3.9	12.3	4.0	53.6	70.6	73.4	81.3	47.9	58.9	58.6	58.3	61.2	55.1	58.3	91.2	64.2	44.8	29.3	6.2	126.2	52.6	20.7	21.0	115.5	45.6	39.5	30.1	39.1	21.5	27.1	9.2	27.1	42.9	92.5	32.3	15.6	10.8	70.0	31.2	35.8	51.1	45.7	70.5	8.1	9.3	47.6	39.3	25.5	34.3	31.0	21.3	47.2	30.7	26.8	10.1	13.4	41.4	24.4	55.3	66.0	67.7	55.9	65.1	74.7	23.4	31.6	182.9	60.8	6.0	29.5	10.1	21.3	26.7	121.2	30.3	33.4	16.9	36.4	29.4	92.1	20.2	53.5	7.7	10.8	102.3	52.6	39.0	166.1	20.9	41.9	22.7
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444635-183449064	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 161.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	11.7	11.7	10.1	11.9	10.7	38.0	15.5	13.4	13.4	12.8	9.9	14.3	19.0	15.7	12.3	22.2	11.8	12.9	10.3	9.8	10.4	18.3	17.5	11.2	19.8	10.2	10.2	22.6	18.5	15.4	11.4	13.9	10.1	12.8	13.6	13.1	12.8	13.0	9.0	12.0	17.3	9.7	10.9	14.3	17.8	20.1	10.8	24.0	13.5	14.2	18.8	11.8	12.3	12.3	14.4	8.1	23.2	16.8	19.0	14.0	17.7	23.9	19.9	23.9	16.0	11.9	13.5	47.1	4.9	16.1	10.0	11.3	21.0	17.3	25.1	19.4	12.6	49.7	39.4	15.9	14.8	37.3	19.5	16.3	15.6	14.3	18.7	12.6	19.1	18.0	25.1	50.4	16.5	7.8	41.6	30.5	17.0	5.5	16.2	36.1	11.2	19.5	161.1	13.5	23.9	20.7	17.2	72.0	29.9	14.9	10.5	32.0	11.0	8.5	12.3	7.9	19.6	24.4	10.9	25.0	13.3	31.4	13.9	61.0	8.0	18.6	14.4	9.7	14.9	12.2	17.4	15.4	7.7	14.1	22.6	20.8	9.7	15.0	10.3	5.2	19.2	14.6	10.1	10.7	13.4	13.4	9.8	10.4	10.2	10.2	10.1	10.9	10.8	12.3	49.6	16.0	33.1	3.6	58.9	35.9	38.5	9.1	130.3	21.2	35.5	40.1	18.9	17.2	24.2	16.5	10.4	21.8	51.8	36.4	17.6	12.5	150.8	207.0	48.9	33.5	30.4	32.0	5.8	15.5	14.7	38.8	62.2	333.9	62.1	29.7	16.4	13.5	15.7	21.9	5.8	25.5	20.3	12.6	24.2	70.5	21.1	25.7	21.4	7.5	13.2	24.3	22.6	7.5	9.9	17.6	21.1	17.3	47.2	31.5	37.8	13.1	28.8	21.2	13.1	60.8	37.5	36.6	40.3	124.7	39.8	18.7	55.3	22.4	33.3	60.9
CDKN2AIPNL	"C2AIL, MGC13017"	ENSG00000237190	"CDKN2A interacting protein N-terminal like"	Q96HQ2	5	134402065-134411881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043966	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043966: AB_2678750"	"unprognostic (7.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.79e-2)"	15.5	23.7	25.8	11.0	27.2	17.0	14.2	25.8	30.6	11.4	20.0	16.8	19.2	12.3	15.6	12.8	11.7	9.4	35.5	27.8	28.2	20.9	17.3	10.8	16.6	29.4	25.2	12.7	33.0	19.7	19.3	11.4	29.3	13.9	13.9	24.3	18.3	10.4	81.7	14.9	17.4	10.0	25.2	14.5	19.2	19.7	27.8	19.0	21.0	42.9	15.8	15.7	11.8	25.7	71.2	42.1	44.1	95.4	22.5	30.5	46.1	37.8	21.5	47.2	52.1	73.1	41.8	47.1	50.3	25.5	68.0	23.0	59.2	93.0	50.8	67.4	89.5	44.1	45.0	43.8	37.8	30.8	25.8	24.5	44.6	59.4	46.3	37.9	49.7	75.3	42.4	54.3	35.4	41.2	50.6	58.2	77.6	37.3	53.1	43.0	46.5	58.3	44.2	23.9	58.7	64.5	50.8	14.1	69.1	49.3	63.1	55.2	33.4	55.8	37.0	44.7	53.7	38.8	69.2	50.2	65.2	53.7	58.7	10.5	16.7	12.4	17.8	18.2	22.7	30.1	22.9	17.7	20.2	28.1	21.7	21.6	4.6	17.8	20.9	24.2	25.3	15.2	25.8	27.2	25.8	30.6	27.8	28.2	29.4	25.2	29.3	25.2	27.8	25.7	21.3	3.2	15.6	3.3	23.7	13.5	16.6	33.6	13.6	21.9	23.9	20.2	50.7	18.6	14.1	9.2	14.6	37.8	17.4	15.3	58.7	28.6	22.0	17.3	16.4	22.7	31.0	34.5	8.8	36.3	40.4	17.2	8.6	12.3	15.2	34.7	22.1	12.6	24.6	15.2	9.1	21.2	36.7	19.4	15.4	46.1	22.1	14.2	23.2	3.7	31.3	30.1	15.5	3.5	7.0	26.0	17.4	19.9	22.6	11.9	30.0	45.4	10.7	26.8	19.7	15.6	22.4	35.1	32.3	18.6	15.3	20.2	17.6	23.5	22.9	14.4
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009305	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 240.7;Pancreatic endocrine cells: 164.5;Proximal enterocytes: 139.0;Squamous epithelial cells: 142.0;Urothelial cells: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 3.3;intermediate monocyte: 3.3;non-classical monocyte: 9.0"	"Lineage enriched"	"Detected in single"	17	"monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.1;HaCaT: 35.0;HeLa: 33.9;hTERT-RPE1: 60.1;SiHa: 48.0;SK-MEL-30: 35.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	18.7	1.9	2.0	2.9	1.8	0.4	8.6	1.1	1.9	9.6	9.1	22.4	21.7	3.8	0.6	36.2	1.7	2.4	1.0	1.6	2.2	1.2	1.2	12.6	1.1	2.7	1.5	0.9	1.2	3.3	3.5	2.3	2.3	3.6	19.7	2.8	6.7	4.7	7.2	12.9	30.9	2.1	1.7	4.6	6.0	5.3	2.4	0.8	1.1	1.1	8.1	7.9	20.2	2.4	0.0	0.0	0.3	2.1	28.2	38.1	0.7	1.8	0.0	4.6	12.6	3.6	10.3	0.0	3.4	2.3	0.0	35.0	0.8	6.9	5.5	2.6	9.7	0.0	33.9	1.5	14.4	1.1	6.1	8.1	0.0	6.5	25.8	60.1	4.4	0.0	0.0	17.1	7.3	2.8	0.0	0.1	1.7	1.7	19.5	0.0	2.4	0.7	10.0	0.0	5.4	0.1	48.0	11.5	35.7	25.8	3.0	0.0	14.8	0.0	0.7	0.1	0.0	13.5	8.4	0.1	0.0	1.0	0.0	0.0	3.3	0.0	0.1	3.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.0	9.0	0.0	0.0	1.0	2.0	1.8	1.1	1.9	1.6	2.2	2.7	1.5	2.3	1.7	2.4	2.4	3.5	67.3	6.7	0.3	2.9	5.4	27.0	40.5	5.7	3.2	6.4	9.8	3.1	1.5	37.5	5.5	0.0	1.2	3.2	240.7	0.0	57.7	11.3	31.8	7.5	4.1	7.7	0.0	0.1	38.2	0.8	11.5	30.5	37.2	0.0	0.4	1.8	0.1	1.2	0.0	0.5	31.6	14.2	17.6	3.8	2.7	0.6	5.6	3.6	2.8	3.2	4.8	0.0	1.0	0.5	164.5	75.6	1.2	2.1	65.3	139.0	0.1	17.9	7.2	0.0	2.7	8.9	13.8	3.5	142.0	24.2	3.1	2.9	1.2	23.3	241.6
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974634	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 98.4;lymphoid tissue: 96.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 73.5;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 273.1;U-937: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	98.4	23.2	21.6	9.1	23.6	36.0	30.6	22.6	31.4	17.5	20.3	19.3	13.4	20.4	11.8	11.1	15.2	15.5	24.2	21.6	23.0	10.4	7.2	9.9	22.5	23.0	22.4	47.6	17.4	19.9	7.8	7.3	24.0	9.9	12.6	7.8	8.8	24.9	20.5	18.9	14.2	22.2	21.2	11.1	7.4	5.2	22.2	96.2	9.7	8.6	23.4	13.1	16.3	30.3	67.6	32.9	5.9	99.6	108.0	16.4	1.5	61.8	76.2	121.8	107.8	1.8	25.7	140.3	58.5	63.5	41.6	8.2	71.4	9.8	63.4	78.4	90.7	102.5	254.6	21.5	5.5	74.0	42.8	5.6	1.9	32.8	14.6	45.6	32.7	115.0	45.0	0.0	76.2	22.0	91.1	40.4	0.1	31.6	71.3	108.6	86.8	0.4	42.9	34.1	49.6	114.3	88.1	67.5	23.6	0.6	31.3	273.1	21.6	130.8	44.1	76.3	0.9	128.1	131.9	113.2	0.0	284.5	118.3	22.4	3.7	17.9	7.3	2.2	8.4	4.9	10.8	9.7	9.3	4.3	6.0	5.8	0.4	10.5	0.9	11.5	22.0	5.6	21.6	23.6	22.6	31.4	21.6	23.0	23.0	22.4	24.0	21.2	22.2	30.3	9.5	0.0	3.9	2.0	5.6	10.1	2.6	8.1	23.9	8.2	3.8	29.5	14.3	5.7	6.1	3.7	16.7	4.9	11.3	2.8	17.6	6.3	4.9	1.1	18.2	8.1	8.4	73.5	0.6	3.4	12.1	31.0	3.1	1.2	16.5	12.6	20.3	8.8	28.3	5.0	0.6	10.2	14.2	20.5	16.0	7.1	39.4	11.0	7.2	1.9	17.1	26.9	17.5	2.0	3.3	3.1	10.2	47.8	14.0	1.8	24.6	40.8	3.2	9.9	85.5	38.9	26.7	32.0	15.0	22.0	11.2	1.9	18.2	28.6	9.1	1.2
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566460-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 283.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 146.8;Erythroid cells: 116.6;Macrophages: 105.4;NK-cells: 155.5;Spermatocytes: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 90.6;MOLT-4: 113.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	13.7	9.8	61.0	13.3	64.9	283.7	9.5	43.9	86.9	9.4	37.3	14.2	6.3	7.0	3.1	14.3	11.0	6.4	18.8	64.8	59.7	11.3	7.1	30.8	23.9	53.8	51.5	7.1	5.8	3.3	15.7	8.2	59.9	8.0	5.6	16.3	7.3	4.1	19.7	18.1	14.5	7.8	46.1	42.4	9.4	38.6	57.6	78.0	6.2	15.9	16.1	11.2	12.9	57.4	30.8	4.8	15.1	10.0	8.0	12.2	3.8	19.8	23.2	21.4	18.8	6.1	7.3	8.5	6.4	21.1	21.6	6.4	5.2	5.1	7.7	34.3	12.6	90.6	5.8	10.2	9.2	9.2	70.2	5.1	16.2	11.0	8.2	17.7	6.1	52.6	3.8	72.3	21.5	4.3	113.9	48.3	3.0	23.4	22.7	18.4	14.7	5.1	9.7	2.6	21.3	11.2	14.0	10.4	15.2	2.8	9.4	24.0	4.7	25.2	12.9	42.1	30.1	44.9	16.5	15.8	26.7	15.5	18.4	143.5	17.7	79.7	30.2	23.2	24.2	56.7	24.9	34.1	17.4	50.0	23.3	27.4	139.9	41.1	35.6	51.0	22.5	31.8	61.0	64.9	43.9	86.9	64.8	59.7	53.8	51.5	59.9	46.1	57.6	57.4	35.2	6.4	7.0	4.6	65.2	23.2	13.7	17.1	38.7	32.4	11.1	15.2	9.2	5.7	8.2	5.5	12.5	4.8	146.8	11.8	9.8	7.7	21.2	26.9	10.2	29.3	7.2	116.6	18.5	4.9	8.4	11.0	3.6	16.7	21.0	4.8	26.7	3.8	10.4	47.1	14.8	6.4	36.7	42.2	47.7	13.7	7.2	105.4	30.2	1.9	46.4	22.2	155.5	1.0	8.2	14.2	9.4	6.0	9.2	11.4	5.0	5.1	10.9	37.1	19.7	8.3	25.8	126.0	83.7	38.6	33.1	4.9	63.4	4.5	6.9	23.8
CDNF	ARMETL1	ENSG00000185267	"Cerebral dopamine neurotrophic factor"	Q49AH0	10	14819245-14838575	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.9;tongue: 20.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 99.9;Late spermatids: 274.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 8.4;U-266/70: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044587	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044587: AB_10795881"	"unprognostic (2.80e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.62e-1)"	2.5	2.4	0.8	0.5	1.1	0.4	3.6	1.2	1.2	1.7	1.3	1.2	1.8	2.0	3.8	1.5	3.9	1.5	2.2	0.9	1.3	3.4	8.6	1.1	1.5	1.2	1.3	2.8	5.4	2.9	2.0	0.5	1.4	2.9	1.1	1.7	3.8	1.8	25.9	5.0	1.1	0.7	1.3	1.0	2.5	10.1	1.0	1.2	4.1	20.3	1.5	1.2	1.3	1.7	0.4	0.4	1.0	0.4	2.2	1.9	0.1	0.8	1.7	0.7	0.5	0.6	0.9	3.3	0.7	0.5	0.0	0.3	0.1	0.0	0.7	0.3	1.0	0.5	0.5	0.2	1.4	0.2	0.0	1.7	1.2	0.3	1.3	1.1	0.7	1.5	1.0	2.1	1.0	0.9	0.4	0.3	0.6	0.6	0.2	0.6	0.4	8.4	0.4	0.1	0.8	1.3	0.2	0.5	1.4	0.5	1.2	0.3	0.5	0.1	0.3	1.4	0.1	4.5	1.2	0.5	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.3	0.5	0.3	0.3	1.2	0.8	0.0	0.9	0.1	0.4	1.6	0.2	0.8	1.1	1.2	1.2	0.9	1.3	1.2	1.3	1.4	1.3	1.0	1.7	0.5	0.0	2.2	2.0	2.3	2.0	1.4	0.7	4.0	1.0	2.3	2.2	2.0	2.8	2.3	0.0	2.1	0.9	0.6	0.1	3.9	1.0	99.9	4.2	0.8	0.9	0.0	0.4	1.0	3.6	1.6	2.1	5.1	0.6	0.0	0.7	0.4	5.8	0.4	0.0	1.4	0.5	2.0	1.2	0.6	274.2	1.2	0.4	0.0	1.0	0.2	3.1	3.1	1.5	3.3	0.6	0.5	1.2	4.8	0.9	1.4	5.2	5.8	1.0	0.0	3.2	1.8	18.9	7.5	1.6	0.1	1.4	1.2	0.5	0.7	1.2
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 506.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	119.3	18.1	26.1	3.3	28.2	0.2	35.9	24.6	31.2	9.5	109.8	4.8	0.7	8.3	140.3	3.5	13.7	10.5	26.1	28.3	30.7	3.1	506.7	11.7	6.6	23.6	26.2	25.8	14.2	0.7	20.7	35.2	25.6	9.1	1.8	15.9	7.2	72.8	8.5	3.0	4.0	6.2	25.6	3.7	4.1	15.6	26.7	1.3	9.6	19.9	3.1	8.1	5.7	25.6	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.1	28.2	24.6	31.2	28.3	30.7	23.6	26.2	25.6	25.6	26.7	25.6	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CDON	"CDO, CDON1, ORCAM"	ENSG00000064309	"Cell adhesion associated, oncogene regulated"	Q4KMG0	11	125955796-126063335	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 58.3;Fibroblasts: 23.5;Inhibitory neurons: 49.5;Muller glia cells: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 23.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;ASC diff: 32.7;RH-30: 48.9;SuSa: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB012422, HPA017377"	Uncertain					NA	NA		15000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB012422: AB_2260246, HPA017377: AB_1846453"	"prognostic favorable (1.35e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.25e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"	"unprognostic (5.77e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (5.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.86e-4)"	12.6	0.7	1.9	1.6	2.0	0.0	5.1	23.0	4.0	7.9	1.2	12.4	1.0	14.0	2.1	1.7	14.2	4.8	4.0	1.6	1.8	0.8	1.2	2.7	1.1	2.2	1.9	20.6	1.2	2.5	3.0	2.7	2.7	1.3	1.6	10.1	1.7	2.8	1.2	9.9	2.9	17.0	0.5	0.7	4.6	3.6	2.3	2.8	18.5	1.6	1.5	2.5	3.0	2.1	1.6	3.2	28.4	2.8	32.7	14.5	0.4	0.5	2.9	0.9	0.3	1.1	9.4	1.4	6.8	0.6	3.3	0.4	7.1	1.0	0.8	5.5	6.3	0.5	6.5	2.9	6.4	0.4	1.8	4.5	1.2	0.6	0.0	12.2	0.3	4.8	0.1	1.9	2.7	0.4	3.6	1.0	2.6	0.8	3.7	1.1	48.9	0.9	1.7	0.5	2.4	9.6	3.7	0.3	4.7	23.8	2.4	1.0	0.5	3.2	2.2	6.3	3.3	2.5	5.5	0.2	2.0	1.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	23.0	4.0	1.6	1.8	2.2	1.9	2.7	0.5	2.3	2.1	3.0	6.4	9.9	11.1	0.1	15.2	1.4	0.8	2.2	5.1	5.4	1.9	5.2	2.8	5.6	0.0	16.7	0.6	0.1	0.2	0.0	1.3	3.1	1.7	0.5	3.0	7.7	0.4	58.3	0.6	0.4	23.5	1.5	1.1	0.0	1.8	1.1	2.1	0.3	0.0	49.5	0.3	0.0	0.0	7.6	2.7	14.9	0.2	3.6	2.8	0.1	39.3	0.0	14.1	5.8	2.4	0.4	11.3	0.8	1.1	0.6	0.5	4.2	4.6	0.0	2.9	2.7	1.8	3.8	0.5	10.7	0.7	0.6	13.2	0.4	1.6
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	6.2	9.5	7.1	4.1	7.3	2.6	6.1	6.9	8.6	8.1	6.7	10.3	4.2	7.8	2.9	4.9	7.2	4.0	8.6	6.9	6.8	7.9	7.5	4.6	6.3	7.6	7.1	7.7	6.7	6.2	6.4	3.8	7.0	8.9	2.8	2.6	6.7	5.1	7.9	5.0	6.3	4.8	6.7	9.1	6.7	3.2	7.1	7.4	8.0	5.8	4.0	7.7	5.7	7.4	5.5	7.2	6.5	9.8	4.7	6.9	6.7	3.3	4.5	6.6	6.3	1.8	7.0	5.1	4.0	2.7	5.3	7.7	3.8	2.8	3.9	7.3	10.3	3.1	5.2	6.3	7.0	9.3	4.3	7.4	7.8	5.8	7.4	7.5	5.8	13.0	5.2	6.9	6.2	3.8	12.1	5.8	5.2	8.0	6.7	8.9	4.3	11.7	5.8	2.1	3.1	7.8	4.2	7.8	9.4	3.8	8.9	5.1	3.7	10.7	7.4	5.9	4.7	7.9	4.0	5.9	5.8	6.3	11.1	1.4	6.4	10.5	10.4	9.1	9.9	6.9	10.0	9.0	6.3	8.3	11.3	8.5	1.6	10.0	9.9	10.9	8.7	8.0	7.1	7.3	6.9	8.6	6.9	6.8	7.6	7.1	7.0	6.7	7.1	7.4	6.9	6.4	3.9	1.0	7.1	1.8	2.9	8.1	1.2	4.5	4.7	6.7	6.1	5.7	4.0	7.3	0.0	12.8	4.5	1.3	7.9	10.7	1.0	2.5	3.3	8.9	4.2	3.4	1.1	11.2	10.0	5.8	3.1	1.9	14.5	6.9	6.8	4.8	9.3	0.0	1.8	3.7	6.1	5.0	2.0	1.2	5.0	4.2	5.4	0.0	8.1	5.7	19.6	1.5	2.5	8.3	1.4	7.9	3.8	5.1	3.4	8.1	6.9	5.4	13.1	4.5	6.5	4.3	8.1	3.1	2.0	4.5	6.1	9.1	5.3	2.1
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 70.2;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	19.1	12.0	9.5	19.0	17.7	23.9	14.6	13.6	10.9	18.8	32.0	22.5	28.6	17.8	10.3	12.1	15.9	22.2	14.3	9.8	9.5	25.0	22.9	21.6	25.4	8.6	7.6	14.9	13.9	13.2	21.8	15.0	8.5	20.7	19.3	74.0	15.7	23.1	5.9	10.6	22.1	27.2	5.0	18.7	17.5	62.0	10.5	28.2	49.0	5.6	19.3	29.2	14.0	8.3	38.9	26.8	22.8	24.2	55.2	47.4	23.9	36.4	57.0	36.7	48.4	35.3	25.9	33.3	19.3	62.4	22.2	36.5	49.2	20.8	43.0	26.2	25.1	25.3	29.4	111.0	63.4	27.6	49.6	35.6	18.8	36.2	40.3	46.3	46.2	42.6	25.1	53.3	35.4	28.0	27.8	20.0	32.4	32.3	22.0	40.1	29.4	49.5	45.7	24.8	17.5	12.5	24.8	51.9	36.4	25.7	15.4	13.7	31.9	36.2	22.9	34.5	32.9	27.6	49.7	46.9	23.8	27.1	31.7	8.4	0.8	1.2	1.6	0.7	3.6	0.9	5.3	3.4	0.9	0.6	4.1	3.5	0.7	2.5	0.9	1.1	6.5	1.7	9.5	17.7	13.6	10.9	9.8	9.5	8.6	7.6	8.5	5.0	10.5	8.3	18.2	3.2	5.1	3.6	8.7	34.0	17.3	4.3	15.4	8.9	27.4	9.1	3.5	10.0	7.0	9.2	14.6	1.7	12.7	22.0	1.9	8.7	36.7	6.9	10.0	13.9	6.6	17.2	8.0	7.1	10.8	19.6	19.4	12.0	0.0	9.6	10.0	9.5	9.4	8.4	10.5	16.1	6.1	5.0	11.5	8.8	6.8	7.4	10.6	2.8	4.0	10.1	4.1	3.5	2.2	13.8	12.2	10.9	24.9	19.4	22.4	12.4	4.9	70.2	6.6	9.7	15.8	50.9	16.1	8.7	24.3	1.4	25.8	2.7	7.8	14.8
CDR2L	HUMPPA	ENSG00000109089	"Cerebellar degeneration related protein 2 like"	Q86X02	17	74987632-75005800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.2;Glandular and luminal cells: 28.9;Late spermatids: 30.9;Pancreatic endocrine cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 61.8;U-138 MG: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022015	Enhanced		Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA022015: AB_1846462"	"unprognostic (4.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.36e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	9.0	5.9	17.7	2.7	34.2	0.1	8.0	40.8	21.7	10.3	19.4	10.5	22.4	12.7	0.9	6.7	6.8	8.8	19.6	14.9	25.2	16.5	1.5	12.9	0.9	42.2	33.9	3.2	4.3	2.6	6.0	7.0	38.6	7.4	1.4	1.7	8.3	5.1	2.1	4.6	11.5	5.4	28.4	1.8	15.1	7.8	35.5	0.5	4.7	3.2	0.7	9.5	6.9	45.1	15.0	42.1	9.2	19.3	15.8	13.8	4.2	21.3	9.4	12.2	15.5	25.1	13.5	0.0	21.9	37.3	11.0	39.2	11.0	5.2	8.0	0.3	18.6	0.1	26.2	16.3	9.1	1.7	0.7	8.1	8.1	29.0	3.0	8.7	26.5	3.2	6.5	2.1	13.0	13.5	2.0	1.6	12.0	35.3	20.6	6.9	14.0	6.5	32.5	9.3	15.8	53.4	26.8	61.8	2.0	5.5	17.1	2.8	19.0	62.4	13.1	39.7	13.6	2.0	1.3	0.0	17.3	5.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.7	34.2	40.8	21.7	14.9	25.2	42.2	33.9	38.6	28.4	35.5	45.1	9.4	16.0	0.0	0.7	0.0	6.0	2.1	2.3	4.6	3.9	7.3	5.8	4.1	11.5	3.4	5.5	0.0	2.9	0.8	0.3	15.6	12.9	7.5	23.2	12.8	12.5	4.9	0.0	2.6	6.9	0.5	6.8	14.8	28.9	0.0	0.7	7.9	0.4	1.6	0.0	5.3	4.2	2.0	0.6	4.6	30.9	2.8	1.6	1.8	5.6	0.6	0.9	0.0	2.5	16.8	26.0	0.0	2.6	0.4	8.1	19.5	2.7	4.0	2.5	0.0	4.2	6.8	3.1	1.7	2.6	2.4	2.3	0.5	1.6	2.3	14.1
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 20.9"	"Group enriched"	"Detected in some"	24	"Early spermatids: 117.5;Late spermatids: 88.5;Spermatocytes: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 3.8"									HPA055952	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"		"HPA055952: AB_2682983"	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.4	0.1	1.2	0.2	0.6	0.1	1.4	0.5	0.2	0.4	0.2	0.7	0.2	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.1	0.4	0.3	2.7	0.6	0.1	0.4	0.2	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.7	0.0	0.1	3.3	0.8	0.0	0.1	0.9	0.4	20.9	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.7	1.3	0.9	2.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	2.5	0.3	2.1	0.4	0.0	0.3	0.9	0.0	0.0	0.0	2.1	3.8	1.2	2.6	1.8	0.0	1.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	1.0	1.0	0.4	0.0	0.5	1.0	1.6	0.8	1.5	1.2	0.8	0.3	0.8	0.0	1.0	1.0	1.8	0.2	0.5	0.3	2.7	0.4	0.5	1.1	3.2	0.4	0.8	0.9	0.7	0.8	0.9	0.5	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.4	0.5	0.3	0.0	0.6	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDRT4	FLJ36674	ENSG00000239704	"CMT1A duplicated region transcript 4"	Q8N9R6	17	15436015-15503608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"Early spermatids: 65.8;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.1;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021590	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA021590: AB_1848906"	"unprognostic (5.46e-6)"	"unprognostic (9.47e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.74e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-5)"	"unprognostic (2.00e-3)"	"unprognostic (1.74e-6)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (9.27e-2)"	5.8	18.7	14.1	1.7	12.9	6.1	9.3	14.3	12.0	19.3	13.2	10.6	0.9	8.8	23.7	10.8	20.7	3.2	5.7	12.2	13.9	16.5	10.0	8.8	5.0	11.7	13.5	20.4	19.8	1.5	48.0	2.5	11.6	20.1	4.6	11.8	15.9	3.8	1.8	21.8	11.9	2.3	8.4	15.9	11.4	15.3	14.7	3.2	23.5	0.8	2.9	9.0	12.8	12.0	2.5	2.2	2.8	1.0	2.4	1.7	2.9	0.9	2.5	1.1	1.0	1.4	0.7	0.0	1.2	1.4	0.2	0.8	3.0	2.4	1.7	0.5	0.4	0.4	2.0	10.1	0.7	0.9	3.9	1.9	3.6	1.6	4.0	4.3	2.6	1.0	0.5	1.6	2.1	0.4	1.0	8.0	0.9	0.4	0.8	0.4	0.0	0.0	2.9	2.0	0.4	1.3	0.8	0.4	0.8	6.2	1.1	2.0	2.4	0.3	1.1	1.0	1.0	2.2	0.9	0.1	0.0	0.0	0.3	0.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	14.1	12.9	14.3	12.0	12.2	13.9	11.7	13.5	11.6	8.4	14.7	12.0	0.4	0.0	1.1	0.0	0.3	0.1	0.2	0.2	0.0	1.4	0.6	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.0	0.8	65.8	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	2.5	1.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	202.7	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.4	0.4	0.0	3.7	1.5	0.0	0.3	0.2	1.0	0.7	0.0	0.0	0.1	0.2	0.5	1.0	0.3
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84583127-84651334	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 129.8;Respiratory ciliated cells: 210.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.1;hTCEpi: 56.9;OE19: 45.5;SK-BR-3: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	1.0	6.1	8.8	1.5	9.5	0.6	10.2	11.1	17.8	6.3	19.0	20.0	40.2	3.0	29.0	20.1	32.2	8.0	0.5	8.9	11.6	14.9	0.5	10.7	0.6	15.9	11.2	5.2	4.7	28.3	4.8	7.2	16.6	9.4	21.3	22.4	12.5	4.7	0.1	15.4	34.4	1.2	9.9	1.6	18.4	7.4	14.7	3.5	30.4	0.1	5.1	6.7	9.2	8.2	26.5	0.6	1.5	0.3	0.1	0.0	26.5	0.0	0.4	0.6	0.5	11.2	46.1	0.0	2.0	0.0	5.4	27.2	8.5	23.2	0.3	1.8	12.6	0.0	3.8	2.7	0.0	0.8	1.8	0.2	56.9	0.0	8.2	1.0	0.0	1.5	0.1	0.0	0.1	18.8	0.2	0.1	3.8	45.5	1.8	0.1	0.0	5.7	12.7	20.0	10.6	0.2	2.9	62.1	0.1	4.9	19.0	0.5	0.0	0.0	1.4	2.8	3.5	0.0	0.0	0.0	2.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	9.5	11.1	17.8	8.9	11.6	15.9	11.2	16.6	9.9	14.7	8.2	0.8	16.0	42.3	33.3	0.4	29.1	27.7	26.4	26.7	16.7	26.6	13.6	1.4	24.3	39.5	40.5	10.4	60.0	0.4	63.0	3.9	26.4	12.1	129.8	3.8	3.3	22.3	0.0	43.1	22.8	12.1	3.5	41.3	45.2	0.0	15.4	1.4	0.7	12.7	21.9	64.6	53.9	48.8	3.5	13.9	4.5	0.6	3.5	0.0	9.4	1.2	29.0	0.0	3.5	2.4	40.8	30.4	0.4	0.1	30.8	80.0	15.9	210.7	32.0	0.0	1.2	4.3	13.1	6.6	41.1	54.1	57.3	1.6	4.8	51.6	38.3
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126879-5197887	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.3	13.8	30.0	9.1	32.4	13.0	10.6	22.9	28.6	10.5	2.1	13.0	5.2	11.5	8.2	9.2	10.7	8.9	24.8	30.3	34.6	14.6	12.8	13.4	8.8	27.2	36.1	9.3	6.5	17.3	14.4	9.9	37.4	13.4	10.7	31.5	7.6	16.7	9.7	5.9	10.1	18.0	18.8	9.4	10.6	11.7	42.5	13.3	12.5	12.7	12.6	10.8	7.7	21.7	25.4	27.4	28.1	13.7	16.4	14.9	11.7	13.9	28.5	22.7	32.2	17.8	23.8	19.8	6.8	26.4	41.1	36.5	23.1	29.5	23.9	18.4	6.8	23.5	7.9	27.0	15.3	13.9	8.1	12.8	16.1	29.8	11.5	20.3	30.7	26.5	11.6	23.9	21.4	4.6	30.1	5.7	12.1	12.4	7.6	25.0	22.5	9.4	14.5	25.0	11.4	15.5	15.3	26.2	34.6	33.8	16.4	6.7	25.4	15.6	11.6	14.1	14.0	20.8	160.2	15.9	7.4	11.7	8.1	55.3	17.3	21.2	15.2	14.7	16.6	12.1	15.6	17.3	13.8	11.4	12.0	11.8	49.7	12.0	13.4	10.9	19.5	23.7	30.0	32.4	22.9	28.6	30.3	34.6	27.2	36.1	37.4	18.8	42.5	21.7	43.3	19.2	15.7	36.9	36.2	17.6	30.3	33.0	14.2	60.1	17.7	14.4	55.2	18.6	19.6	33.1	95.9	22.2	29.6	15.3	5.9	33.1	71.6	20.1	14.0	42.3	10.7	14.9	39.3	22.7	40.0	17.9	15.3	21.5	21.0	20.5	27.8	21.7	60.8	43.7	52.0	12.4	12.2	36.6	26.1	33.3	16.1	31.5	32.0	21.5	38.7	21.9	28.8	28.6	56.1	31.7	20.3	24.8	48.9	23.1	15.7	13.2	23.5	65.5	19.7	19.7	52.1	26.8	34.7	14.8	15.3	16.3	36.7	13.0	13.1	29.1
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115087-31120446	"Human disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	104	"skin 1: 696.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 2.6;Gastric mucus-secreting cells: 2.0;Glandular and luminal cells: 7.1;granulocytes: 4.5;Suprabasal keratinocytes: 5.3"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"A-431: 1.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.5"	"Not detected"	"Not detected"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.0	0.1	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	696.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	6.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	0.4	2.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	7.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	1.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.2
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803789-88809258	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 38.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 149.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.7	0.8	0.8	3.8	1.2	38.5	0.7	2.5	1.3	1.7	0.0	3.3	4.1	0.5	0.2	6.7	0.5	0.2	0.5	0.8	2.3	0.7	1.0	1.3	4.8	2.2	1.1	0.4	0.6	1.3	2.1	2.8	1.9	0.7	1.6	0.4	1.1	0.2	0.1	3.6	3.9	0.6	0.7	3.1	2.4	3.5	1.1	8.7	0.6	0.0	3.3	0.5	2.3	1.0	33.6	34.5	16.5	25.3	0.7	3.4	64.2	24.1	6.6	19.4	12.0	79.3	33.8	51.4	24.2	5.5	12.7	46.0	21.6	17.7	6.2	18.2	92.1	51.8	28.8	59.9	0.3	28.8	21.5	1.8	1.4	19.8	4.4	1.6	5.9	60.9	80.8	18.4	7.6	90.6	109.3	149.4	41.8	12.2	31.6	120.3	22.9	42.4	4.3	23.8	36.6	26.2	44.4	13.1	16.9	7.4	39.0	55.9	5.9	24.6	42.6	37.2	35.4	61.4	55.7	73.6	19.3	71.9	31.6	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.7	0.4	0.1	0.1	0.7	0.2	0.8	1.2	2.5	1.3	0.8	2.3	2.2	1.1	1.9	0.7	1.1	1.0	0.4	0.0	1.1	0.7	4.9	11.2	4.3	1.4	7.4	0.7	5.4	7.5	2.2	1.5	1.7	1.8	0.0	51.4	2.2	12.7	1.9	1.1	0.4	1.4	1.4	2.2	2.4	71.3	0.2	0.0	92.0	5.2	9.2	2.2	0.0	29.0	0.4	1.0	19.5	0.0	0.8	16.1	4.1	5.6	5.5	1.2	0.3	2.8	1.8	0.0	1.9	1.5	4.1	0.0	0.6	0.6	2.3	0.4	23.1	2.2	2.0	1.6	2.1	1.9	0.0	2.1	3.4	6.6	37.1	10.8	7.1	24.8	5.4	5.7	30.1	4.4
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573686-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 559.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	117.0	68.6	39.1	113.7	42.0	161.3	73.0	40.6	42.9	59.3	48.3	80.0	57.5	60.6	54.9	78.7	51.6	76.4	74.5	37.0	47.1	64.4	112.9	83.6	159.3	46.0	41.8	57.9	84.3	85.8	43.0	108.5	46.0	43.2	70.8	49.2	52.7	47.7	250.9	55.0	65.5	75.7	44.6	121.6	89.0	95.9	45.8	194.5	97.4	155.9	165.6	104.3	49.3	47.8	376.2	85.5	147.6	98.0	166.7	203.6	174.5	201.6	261.1	197.6	194.7	213.4	147.0	473.9	298.0	227.4	229.2	158.2	213.5	202.0	366.4	306.1	80.1	282.3	93.2	130.9	258.2	318.7	173.4	194.7	206.7	178.2	473.4	139.6	254.5	137.9	205.7	309.9	289.5	107.1	260.9	180.9	148.9	161.6	108.2	156.8	197.6	382.2	206.9	150.7	116.5	87.8	192.0	140.4	246.0	210.0	456.3	190.8	316.4	209.4	198.5	168.5	202.7	446.9	363.2	1103.9	117.0	187.8	124.7	14.3	10.5	17.6	13.0	12.3	13.5	11.1	12.2	13.2	9.7	7.0	9.7	15.2	9.7	6.4	13.7	15.9	24.0	5.7	39.1	42.0	40.6	42.9	37.0	47.1	46.0	41.8	46.0	44.6	45.8	47.8	116.3	57.7	69.8	7.2	114.9	145.9	217.3	19.5	63.7	22.6	97.6	77.2	86.2	74.4	34.4	84.6	10.4	51.6	169.7	158.0	37.2	42.1	324.7	174.0	160.5	99.5	47.2	59.5	13.2	87.6	82.0	93.7	88.7	314.4	45.0	63.0	91.1	97.2	118.5	23.5	12.3	102.4	10.2	146.8	117.7	559.5	34.2	145.0	55.2	17.8	100.4	109.5	90.6	8.0	14.5	88.1	101.2	35.7	239.4	320.2	26.9	74.4	27.4	29.9	26.3	120.9	92.5	21.2	30.9	94.0	128.3	35.2	126.5	124.4	90.1	219.5
CDX1		ENSG00000113722	"Caudal type homeobox 1"	P47902	5	150166778-150184558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 131.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 349.6;Intestinal goblet cells: 193.4;Paneth cells: 295.0;Proximal enterocytes: 196.8;Undifferentiated cells: 312.5"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 125.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 6.7;SuSa: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055196	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055196: AB_2682734"	"unprognostic (2.50e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-7)"	"unprognostic (2.10e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.16e-3)"	0.3	0.0	0.1	9.6	0.1	0.0	0.7	0.1	0.4	0.7	0.1	131.3	63.9	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.2	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	124.4	0.0	0.1	0.5	0.0	0.3	94.5	5.2	0.1	0.1	0.5	2.4	0.2	0.1	0.1	0.0	1.7	0.2	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	349.6	0.0	0.0	0.1	0.0	0.5	0.1	59.5	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.4	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	295.0	1.5	0.0	0.0	196.8	0.2	0.0	0.0	0.0	0.0	1.6	2.8	15.3	0.0	0.3	0.1	0.8	0.1	312.5	0.0
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27960918-27969315	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	31.3	0.0	0.0	0.1	0.0	0.0	35.9	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	287.5	0.0	28.9	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	214.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.9	181.7	0.0	0.0	0.2	226.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.4	0.0	194.4	0.3
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"skin 1: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 1.2;Suprabasal keratinocytes: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CDY1	CDY1A	ENSG00000172288	"Chromodomain Y-linked 1"	Q9Y6F8	Y	25622162-25624902	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA									"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY1B		ENSG00000172352	"Chromodomain Y-linked 1B"	Q9Y6F8	Y	24045229-24048019	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 2.2"	"Cell type enhanced"	"Detected in single"		"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2A	CDY2	ENSG00000182415	"Chromodomain Y-linked 2A"	Q9Y6F7	Y	18025787-18027746	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"epididymis: 1.1;testis: 2.0"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2B	CDY	ENSG00000129873	"Chromodomain Y-linked 2B"	Q9Y6F7	Y	17878260-17880220	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA									"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	14.0	6.0	6.9	10.2	6.8	20.0	11.5	5.0	6.7	15.0	4.9	13.0	7.0	15.2	10.5	16.8	10.6	8.4	10.4	6.0	6.4	7.2	5.6	8.9	12.1	6.6	6.2	9.9	7.5	12.4	5.1	18.2	6.0	7.6	13.2	6.7	9.0	11.9	19.5	17.8	9.0	14.5	5.6	9.6	9.2	9.0	6.7	9.3	9.7	12.7	12.9	15.6	13.0	6.9	23.7	22.1	30.1	25.5	23.3	15.9	34.4	23.1	17.9	21.3	22.9	18.0	17.2	5.3	22.1	17.6	33.3	19.8	24.2	28.2	24.9	16.4	20.2	20.9	21.0	16.4	28.5	27.9	21.7	12.5	49.8	25.0	37.5	12.9	20.6	19.2	37.9	16.2	10.8	22.9	14.8	25.9	32.6	17.9	21.3	19.0	26.2	43.7	14.7	20.5	25.5	15.4	28.5	24.9	36.9	86.5	15.0	26.3	28.1	25.2	21.6	18.5	26.8	33.7	57.8	18.4	8.3	17.7	28.1	5.3	1.3	0.6	1.5	0.6	1.1	1.0	1.1	1.2	1.6	1.1	0.7	1.1	0.4	1.6	0.8	6.8	0.1	1.3	6.9	6.8	5.0	6.7	6.0	6.4	6.6	6.2	6.0	5.6	6.7	6.9	32.7	19.2	9.4	28.7	18.4	37.3	23.9	11.9	10.8	16.7	31.2	35.8	18.8	14.3	12.0	14.7	22.9	12.9	64.5	44.7	15.6	10.8	62.8	26.9	43.2	22.9	32.3	41.5	52.3	10.4	22.0	18.7	6.1	60.3	5.7	24.3	18.9	11.7	10.5	45.4	41.5	26.6	6.1	17.3	57.9	74.9	5.9	28.1	8.8	101.2	22.7	25.4	19.6	54.3	64.1	16.8	41.8	8.2	22.3	30.1	4.6	10.7	12.1	25.7	6.6	29.7	20.9	10.4	25.3	9.8	41.9	63.8	17.5	10.9	22.6	56.9
CDYL2	FLJ38866	ENSG00000166446	"Chromodomain Y like 2"	Q8N8U2	16	80597907-80804598	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 69.6;Glandular and luminal cells: 34.3;Late spermatids: 26.4;Microglial cells: 30.9;Oligodendrocyte precursor cells: 27.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 9.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.0;non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.9;HUVEC TERT2: 22.7;MCF7: 20.2;TIME: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041016	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041016: AB_10794183"	"unprognostic (8.63e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.69e-3)"	2.9	1.3	4.1	3.4	6.1	5.6	3.1	12.5	9.5	4.2	0.0	1.2	3.2	2.3	1.9	1.9	0.8	1.6	1.0	5.9	5.8	3.6	1.8	2.1	3.7	2.2	23.6	0.3	1.2	2.6	0.8	11.0	7.5	9.8	1.4	1.1	2.5	6.1	0.4	0.8	2.9	2.9	1.0	2.2	1.8	11.1	7.4	1.7	1.3	0.7	3.4	3.4	1.2	4.9	0.0	0.0	0.3	0.0	5.3	5.3	4.6	5.6	3.7	1.5	0.4	0.2	2.8	0.5	1.8	3.4	0.0	0.1	0.2	5.6	0.8	15.9	3.1	2.0	8.3	0.2	0.2	0.2	0.2	1.7	2.1	2.9	2.6	8.1	22.7	1.8	0.0	0.2	0.8	20.2	0.0	0.1	1.7	0.2	6.1	0.0	0.0	0.0	8.8	7.1	1.4	0.0	0.7	4.6	0.0	1.3	4.5	3.3	33.9	0.1	9.9	0.0	1.4	0.0	0.0	0.0	3.4	4.3	0.1	0.3	0.1	0.5	0.1	1.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	4.0	0.0	0.2	0.1	4.1	6.1	12.5	9.5	5.9	5.8	2.2	23.6	7.5	1.0	7.4	4.9	5.2	3.2	1.7	15.0	1.7	2.8	2.7	0.3	0.6	0.6	7.7	2.7	1.6	2.8	1.0	3.7	0.0	11.8	2.7	0.7	3.9	2.4	13.1	7.4	7.2	7.0	1.2	4.4	69.6	4.2	5.9	3.1	0.5	34.3	0.0	3.1	6.1	4.5	2.3	0.0	21.8	2.6	0.0	9.1	1.7	26.4	2.8	4.3	0.0	30.9	16.2	0.7	0.0	27.6	2.0	2.1	0.5	4.5	1.1	8.3	4.8	5.9	0.2	0.4	0.0	0.1	3.8	4.7	10.2	0.7	1.1	16.3	4.9	4.3	2.0	2.9
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 246.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"eosinophil: 43.6;neutrophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 43.6"	"Group enriched"	"Detected in many"	5	"CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	11.9	10.6	1.3	31.1	0.8	74.5	13.3	3.2	1.8	16.4	0.0	246.3	53.3	11.1	3.9	64.9	6.0	7.4	4.0	1.9	0.0	31.9	60.5	6.8	4.3	0.4	0.1	1.1	2.4	1.7	3.8	33.1	0.5	20.2	141.2	0.6	58.9	10.3	2.7	3.3	51.0	13.1	0.0	7.9	19.9	3.7	0.2	2.3	3.1	3.1	21.5	37.0	29.2	0.0	0.6	5.6	0.3	0.3	0.0	0.0	14.4	0.0	0.2	1.0	0.5	2.3	30.6	1.7	12.2	0.0	3.2	0.8	0.0	7.9	0.4	0.1	0.5	0.3	0.2	101.0	1.7	0.2	13.3	0.0	0.1	0.1	0.1	0.0	0.7	1.4	0.0	5.0	0.0	3.2	0.3	0.2	0.9	80.9	1.7	2.6	0.0	1.3	0.6	59.2	0.5	0.2	0.0	0.2	67.4	7.3	0.3	0.0	2.1	0.3	1.2	1.4	0.5	1.8	0.0	3.7	0.2	0.4	1.0	0.8	0.0	43.6	0.1	1.7	0.3	3.3	0.9	0.4	0.2	0.8	0.6	0.2	26.3	0.1	3.3	0.1	2.7	0.6	1.3	0.8	3.2	1.8	1.9	0.0	0.4	0.1	0.5	0.0	0.2	0.0	16.7	6.4	8.2	1.0	6.0	1.3	335.2	10.4	2.8	6.0	16.3	12.7	1.8	7.2	14.7	0.0	4.2	2.0	0.7	731.7	0.0	21.3	3.5	5.0	5.2	22.3	17.3	0.4	1.7	16.1	9.4	2.9	12.8	28.7	8.9	4.6	41.4	37.7	1.4	5.0	1.4	46.1	4.1	5.9	3.1	0.2	0.0	2.6	7.2	0.0	0.9	1.3	2.1	0.5	0.6	58.7	585.4	0.7	0.2	244.9	97.5	11.1	3.9	6.4	0.0	2.7	3.1	4.3	3.9	9.2	1.0	0.7	5.5	2.2	33.2	618.9
CEACAM16	DFNA4B	ENSG00000213892	"CEA cell adhesion molecule 16, tectorial membrane component"	Q2WEN9	19	44699151-44710718	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"pancreas: 2.0"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 7.7;Skeletal myocytes: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	20.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0
CEACAM18		ENSG00000213822	"CEA cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"intestine: 10.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CACO-2: 4.3;OE19: 3.5;RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059487	Uncertain		Approved	Midbody		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEACAM19	CEAL1	ENSG00000186567	"CEA cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.9;Skeletal myocytes: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;RPTEC TERT1: 15.8;TIME: 20.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	3.9	5.6	3.7	1.3	3.7	1.5	3.8	4.9	5.1	7.0	3.5	4.7	3.0	5.2	1.7	5.1	6.8	2.4	11.7	4.0	3.8	9.4	8.2	8.2	1.1	2.8	3.0	6.6	8.9	1.5	7.0	2.2	2.7	7.8	3.4	2.4	5.7	3.1	13.8	12.4	3.8	3.1	1.9	3.5	4.6	5.7	3.7	0.9	6.5	3.4	2.2	4.2	8.7	4.7	5.1	10.3	1.5	1.0	3.5	4.0	3.8	2.8	4.2	0.9	1.8	0.4	1.1	0.1	1.0	3.8	1.0	6.2	2.6	1.1	0.8	1.5	5.8	0.1	6.7	1.7	3.6	0.2	1.0	1.3	10.0	2.6	6.1	12.2	2.4	0.7	0.3	0.3	1.4	1.2	0.0	0.6	0.9	1.4	1.1	0.0	1.8	0.2	15.8	1.2	1.9	0.5	1.1	1.1	0.9	1.4	1.4	0.3	20.9	0.4	6.8	1.5	0.9	0.1	0.3	0.0	0.5	2.0	1.7	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.7	3.7	4.9	5.1	4.0	3.8	2.8	3.0	2.7	1.9	3.7	4.7	3.6	3.2	2.2	2.0	0.0	2.0	0.9	2.1	1.2	2.9	1.9	1.5	4.5	1.5	2.4	0.0	0.0	0.2	0.1	2.1	0.0	1.6	3.8	0.9	0.9	4.1	1.8	0.0	7.9	3.3	0.2	1.0	3.6	2.4	0.0	0.8	4.6	2.6	0.3	0.0	6.1	2.3	4.1	0.6	0.8	1.9	3.1	0.5	0.0	1.9	0.4	0.3	1.0	2.0	2.4	4.5	2.6	2.6	0.0	1.8	1.2	0.4	1.8	0.6	0.0	8.8	1.7	3.1	0.9	1.2	6.0	0.0	0.2	1.6	2.5	0.9
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.5;lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.3	0.7	1.4	2.2	0.8	17.5	0.8	0.8	1.3	2.2	0.6	0.8	0.6	2.6	0.3	0.4	0.7	0.5	0.5	0.8	2.8	0.7	1.2	3.8	5.3	1.9	2.7	0.4	0.2	0.1	0.4	1.5	2.2	0.6	0.6	0.0	0.5	3.6	0.1	0.2	2.6	0.5	1.8	10.2	0.9	1.1	3.9	2.2	0.6	0.1	3.5	0.8	0.3	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.8	0.8	1.3	0.8	2.8	1.9	2.7	2.2	1.8	3.9	1.2	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"CEA cell adhesion molecule 3"	P40198	19	41796587-41811554	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 44.3"	"Cell type enriched"	"Detected in some"	13	"Paneth cells: 56.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 289.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 289.3"	"Not detected"	"Not detected"											HPA011041	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.1	0.0	5.1	0.0	44.3	0.1	0.0	0.9	0.3	0.3	0.3	0.0	0.2	0.0	0.4	0.3	0.3	0.3	0.0	0.0	0.1	0.6	1.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	5.1	0.1	0.0	0.0	0.6	0.1	1.2	0.4	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	0.0	0.0	19.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	289.3	0.0	45.8	0.0	0.0	3.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	3.3	0.0	1.4	0.0	4.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	56.4	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.4
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 181.5;esophagus: 195.2;intestine: 220.3;lung: 286.7;salivary gland: 177.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"OE19: 1799.0"									"CAB008370, HPA011041"	Enhanced					NA	NA		86000000	"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	2.0	0.4	0.3	29.7	1.2	181.5	2.7	0.6	0.6	39.2	0.0	195.0	33.0	0.6	1.8	195.2	8.2	130.1	0.2	0.2	0.0	0.3	0.7	286.7	0.3	0.3	0.1	0.4	5.2	0.1	0.3	0.5	0.2	2.4	220.3	0.0	177.6	1.4	0.1	6.8	24.4	6.6	0.0	2.4	15.5	0.4	0.3	2.1	0.3	0.0	32.5	9.6	79.1	0.4	0.1	162.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.5	4.6	0.0	0.2	0.0	0.5	19.4	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.1	11.2	0.1	0.2	0.2	1799.0	4.5	0.1	0.0	0.1	1.0	0.7	1.8	0.1	0.0	4.2	0.0	0.2	0.6	1.9	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.1	0.0	3.1	0.3	1.2	0.6	0.6	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.0	942.3	84.5	0.0	2.3	0.0	4.9	17.9	0.0	0.0	3.5	2.0	0.2	75.8	322.1	0.0	0.0	0.0	0.0	640.1	0.0	77.0	0.2	0.4	0.1	1.3	5.4	0.0	0.1	16.3	0.0	1.3	1.5	0.8	7.0	0.0	0.4	0.3	0.0	0.0	0.1	102.3	14.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.7	391.1	0.0	0.0	24.2	5.7	0.0	71.8	0.0	0.0	0.0	9.9	0.0	0.1	15.6	0.0	0.0	1.2	0.0	31.7	182.3
CEACAM7	"CEA, CGM2"	ENSG00000007306	"CEA cell adhesion molecule 7"	Q14002	19	41673303-41706976	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 651.8"	"Group enriched"	"Detected in some"	9	"Distal enterocytes: 1454.0;Paneth cells: 731.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA069621, HPA073910"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"HPA069621: AB_2686162, HPA073910: "	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.6	0.0	0.0	71.4	0.0	0.1	2.9	0.0	0.0	13.3	0.0	595.8	0.5	0.3	0.0	52.6	0.6	39.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	651.8	0.0	4.0	0.8	0.1	1.4	0.7	5.7	0.0	0.2	2.0	0.1	0.0	0.0	0.0	0.0	12.0	23.4	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	1454.0	0.0	116.6	0.1	0.0	0.0	0.5	8.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	1.0	731.2	0.0	0.0	1.4	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	38.4	30.3
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"CEA cell adhesion molecule 8"	P31997	19	42580243-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 217.6"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 1.6;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.6;monocytes: 1.2"	"Not detected"	"Not detected"											CAB033676	Approved				"Intracellular and membrane"	NA	NA		9200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB033676: AB_1125678"		"unprognostic (2.01e-1)"	"unprognostic (4.52e-2)"		"unprognostic (3.31e-1)"			"unprognostic (6.30e-2)"		"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"		"unprognostic (1.71e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.62e-2)"		0.2	0.0	0.3	0.2	0.2	217.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.4	0.0	0.1	0.5	0.1	0.0	0.0	6.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	1.6	0.2	1.2	0.0	0.0	2.7	0.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT enhancer binding protein alpha"	P49715	19	33299934-33302534	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.7;liver: 194.7;skin 1: 118.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	98.7	2.9	16.2	5.7	17.9	22.6	67.7	18.3	26.9	8.7	10.4	21.0	21.2	2.9	0.8	20.9	4.3	3.0	2.8	15.7	18.8	3.6	194.7	25.5	9.1	27.4	22.4	1.3	9.7	26.8	2.6	16.0	21.3	8.8	11.5	0.6	9.8	3.4	19.1	118.7	20.8	2.5	25.7	7.7	12.5	1.0	24.5	4.1	6.5	4.5	6.3	8.7	14.8	34.8	2.5	5.1	0.1	7.1	55.8	0.0	196.9	0.1	1.5	0.1	0.0	24.8	0.1	0.0	3.0	0.0	1.1	9.4	5.8	0.6	0.0	35.8	7.2	0.1	0.1	110.9	0.9	36.6	42.1	2.2	25.4	0.0	0.2	0.0	0.0	2.8	2.4	0.0	0.0	12.7	0.2	114.1	5.0	61.8	2.7	0.0	0.4	1.1	0.2	17.7	0.4	1.7	0.7	0.5	0.8	6.2	13.7	407.7	0.1	0.1	0.8	0.1	0.9	0.4	0.0	0.2	0.0	130.9	0.0	16.0	7.1	0.0	0.8	12.3	0.7	0.0	0.1	0.5	5.1	0.1	0.2	0.4	2.5	0.0	15.7	0.2	0.0	2.1	16.2	17.9	18.3	26.9	15.7	18.8	27.4	22.4	21.3	25.7	24.5	34.8	5.4	16.0	37.8	0.0	2.8	37.3	20.8	3.3	22.2	0.7	6.2	12.2	0.4	57.2	5.1	0.0	0.0	40.3	14.4	91.6	3.9	0.5	0.0	0.8	0.8	4.9	4.2	5.7	1.9	5.8	44.3	9.5	12.8	1.3	1.3	0.0	2.2	106.5	87.0	0.0	0.3	24.8	4.1	35.0	27.4	0.2	3.1	42.9	5.4	17.8	28.2	8.4	6.2	1.0	0.4	1.9	30.6	1.5	2.0	15.1	42.5	4.9	5.1	0.5	0.0	4.1	3.1	0.2	0.7	29.7	171.8	212.3	5.0	0.3	51.5	12.2
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CEBPE	CRP1	ENSG00000092067	"CCAAT enhancer binding protein epsilon"	Q15744	14	23117306-23119255	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 51.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	218	"eosinophil: 750.4"	"Lineage enriched"	"Detected in many"	250	"granulocytes: 750.4"	"Group enriched"	"Detected in some"	4	"HL-60: 233.8;NB-4: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.1	0.0	0.1	1.6	0.1	51.8	0.0	0.0	0.2	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	3.2	0.3	0.1	3.4	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	233.8	39.6	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.9	122.5	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	26.3	0.0	0.5	3.0	750.4	0.0	0.6	0.1	0.5	1.0	0.4	1.5	0.5	1.8	1.5	3.4	0.0	0.3	1.5	0.0	1.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	1.4	0.6	0.1	0.0	2.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.0	0.0
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT enhancer binding protein gamma"	P53567	19	33373685-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	19.1	8.8	16.0	14.2	16.9	15.4	15.1	17.6	23.8	11.0	12.4	30.2	34.1	12.0	9.1	20.1	11.9	11.4	14.8	15.6	19.3	12.9	34.6	16.0	12.4	17.0	17.6	5.3	28.3	15.1	11.0	16.8	17.6	12.0	28.8	17.3	13.5	9.4	47.4	27.7	35.3	14.6	18.7	9.7	18.8	12.5	19.0	14.1	25.7	44.2	13.8	16.3	14.2	18.4	33.4	29.7	30.9	31.0	14.8	21.6	41.8	24.8	22.1	21.9	26.4	35.3	14.4	54.0	19.1	11.8	26.2	16.6	54.8	25.0	37.5	91.7	23.3	29.1	15.6	34.5	49.3	49.1	31.0	28.6	121.0	27.7	86.7	11.1	27.7	45.1	39.3	49.7	17.9	20.4	33.0	25.7	17.5	94.2	18.2	35.1	21.0	22.5	12.4	19.9	61.1	37.2	25.8	26.7	61.3	22.6	22.7	96.8	26.7	22.2	26.3	23.8	39.6	28.4	27.0	32.4	23.4	53.2	31.4	7.5	9.7	4.4	3.6	11.8	4.3	4.6	4.9	5.6	10.3	3.7	5.2	5.0	0.8	3.0	19.1	3.2	6.0	5.6	16.0	16.9	17.6	23.8	15.6	19.3	17.0	17.6	17.6	18.7	19.0	18.4	61.3	19.2	13.2	2.6	30.5	124.3	95.8	51.5	67.7	11.3	32.8	31.9	15.1	48.6	29.6	14.7	8.4	42.6	27.6	160.5	19.6	37.0	90.3	43.2	14.9	50.4	35.3	22.3	11.7	54.1	71.5	26.1	34.1	26.6	26.0	9.5	31.4	66.2	45.6	3.3	8.3	81.8	34.6	35.4	65.1	74.5	6.8	34.4	28.4	10.3	63.9	27.7	28.8	6.0	3.9	75.8	107.7	9.1	30.5	70.2	115.7	30.4	49.4	12.9	6.6	24.7	31.5	76.4	45.2	57.8	155.7	74.8	29.4	5.1	67.8	120.4
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT enhancer binding protein zeta"	Q03701	2	37201612-37231596	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.1	27.8	10.3	18.9	11.5	31.3	26.2	15.8	12.8	17.9	11.9	19.5	17.4	20.1	19.9	20.5	17.2	16.7	15.3	9.8	11.8	25.3	27.1	19.3	24.6	10.9	11.0	23.9	20.6	22.3	10.2	23.0	11.4	19.7	20.0	24.4	16.3	15.6	36.3	17.9	18.1	16.9	10.8	19.9	17.4	38.4	11.1	24.0	22.4	24.4	24.4	26.6	12.6	14.2	61.2	46.6	46.9	26.1	45.2	48.6	39.9	57.0	39.2	47.2	50.5	74.5	45.1	111.5	49.4	33.8	64.4	51.0	122.8	58.5	60.2	71.8	53.9	104.0	47.5	60.9	35.8	105.7	44.9	37.3	56.4	62.8	63.4	31.1	43.3	27.8	114.8	49.8	48.6	31.8	61.5	82.4	153.3	81.0	43.2	48.6	76.3	84.3	45.3	56.9	49.9	80.7	47.5	57.6	65.5	67.6	41.8	45.9	35.5	45.8	52.3	41.3	79.1	55.5	62.0	88.1	40.8	95.6	51.2	34.8	16.8	16.3	23.8	21.7	30.0	29.6	24.7	23.4	17.6	30.0	31.1	26.1	6.1	26.1	22.3	25.6	21.4	14.6	10.3	11.5	15.8	12.8	9.8	11.8	10.9	11.0	11.4	10.8	11.1	14.2	73.4	86.6	82.9	15.0	91.6	107.1	109.2	64.4	83.1	45.5	50.4	54.1	34.4	47.1	81.9	49.7	43.8	54.7	93.4	36.7	107.6	56.1	282.1	56.0	87.2	60.5	44.2	66.7	15.6	62.5	37.4	67.4	52.5	67.5	73.4	44.7	43.9	76.4	35.1	43.7	19.3	56.6	44.7	37.0	36.1	43.3	60.9	44.6	21.4	15.0	54.1	57.1	63.8	18.6	21.4	54.9	30.2	50.8	67.7	79.0	30.2	89.1	54.2	95.5	52.6	94.3	68.3	186.7	99.3	56.8	101.2	45.0	87.7	62.1	64.2	80.9
CEBPZOS	CEBPZ-AS1	ENSG00000218739	"CEBPZ opposite strand"	A8MTT3	2	37196488-37216193	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053866	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA053866: AB_2682283"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (3.46e-7)"	"unprognostic (3.69e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	22.3	46.5	23.6	15.0	24.7	25.4	22.4	26.4	32.7	23.9	25.6	28.8	23.8	23.4	38.5	24.3	23.9	17.7	42.5	26.4	24.9	35.9	27.9	17.8	22.7	24.7	24.0	28.3	22.9	24.9	31.1	22.0	24.8	29.9	22.6	28.1	26.1	18.2	53.4	23.9	22.5	20.2	23.1	20.6	24.5	22.7	24.5	18.3	26.0	37.3	19.6	24.0	22.0	27.9	59.9	19.4	41.1	32.9	42.5	47.0	39.4	43.2	39.3	27.2	19.8	18.5	26.4	20.7	22.9	42.8	36.2	33.7	22.4	32.9	33.4	55.3	47.1	56.2	21.6	29.0	38.2	70.5	29.4	49.6	44.0	37.1	42.1	36.7	44.3	21.4	42.6	28.9	45.3	11.9	17.2	67.6	60.2	47.6	29.5	51.4	55.8	47.2	48.6	15.9	43.4	42.6	33.4	54.0	43.5	22.1	23.9	41.2	39.0	29.1	35.9	43.2	38.1	53.0	0.5	44.1	54.0	41.2	42.5	32.4	23.0	21.2	27.3	26.4	32.2	34.1	31.1	29.2	22.8	26.9	38.5	34.9	8.8	23.2	20.6	49.2	23.5	22.3	23.6	24.7	26.4	32.7	26.4	24.9	24.7	24.0	24.8	23.1	24.5	27.9	46.6	54.5	40.9	13.7	37.7	0.0	51.6	0.0	51.2	46.5	37.6	38.9	43.0	27.1	21.1	38.6	18.8	83.0	43.6	25.7	92.0	46.8	76.0	59.1	35.7	27.9	17.5	30.1	14.7	33.7	50.7	35.6	41.3	41.4	17.1	30.3	27.5	27.4	44.5	32.0	19.5	32.6	0.0	27.7	0.0	18.2	47.2	34.7	0.0	18.7	39.9	59.8	46.4	13.6	27.1	41.8	31.0	44.4	30.4	38.9	54.2	92.1	27.0	56.2	46.0	31.0	33.0	115.8	58.8	48.5	0.0	69.1	37.8	33.4	33.1	41.6
CECR2	KIAA1740	ENSG00000099954	"CECR2 histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;retina: 15.6;skeletal muscle: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	0.7	0.4	5.2	0.2	12.8	0.5	1.0	22.5	8.3	1.4	1.2	1.2	0.2	2.3	0.6	0.4	1.7	0.2	3.4	5.3	8.0	1.3	7.6	2.6	0.1	9.8	9.0	2.9	2.6	0.0	6.4	1.0	8.7	1.0	0.3	15.6	0.9	0.2	21.8	0.9	0.5	0.9	5.4	0.4	0.5	3.5	9.8	0.2	2.2	10.6	0.2	1.3	1.0	12.7	0.2	0.1	15.5	5.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.7	0.1	14.4	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	8.3	0.0	0.0	0.1	0.0	0.5	22.8	0.0	0.0	1.8	1.0	0.1	0.0	5.1	10.1	0.0	0.0	0.2	0.9	9.0	1.6	2.5	0.1	0.1	3.4	0.0	0.0	5.8	1.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	12.8	22.5	8.3	5.3	8.0	9.8	9.0	8.7	5.4	9.8	12.7	1.9	6.4	10.6	109.4	0.3	0.0	1.1	0.2	0.0	22.1	0.7	0.6	11.8	0.0	0.8	1.8	168.9	10.1	0.0	0.0	0.0	0.1	6.3	6.3	6.2	2.0	0.0	0.0	2.3	0.2	2.5	3.1	0.0	17.2	0.0	3.5	4.2	10.7	0.7	5.0	4.3	0.0	0.0	0.3	0.3	4.0	1.2	1.4	0.0	34.7	0.2	18.3	0.0	120.1	137.7	0.1	0.0	1.2	0.8	1.8	0.0	1.4	0.9	94.1	6.6	33.9	3.2	1.9	15.9	0.1	0.1	33.0	0.2	0.4	0.0	3.6
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase 3A"	P09093	1	22001657-22012542	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2216	"pancreas: 262614.2"	"Cell type enriched"	"Detected in some"	56	"Exocrine glandular cells: 34710.4"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"MOLT-4: 24.9"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			20.0	4.5	0.0	3.0	0.0	2.8	11.6	0.0	0.0	12.9	0.0	4.5	21.3	4.1	0.0	7.4	3.0	0.1	44.6	0.0	0.0	4.1	13.5	3.0	6.0	0.0	0.0	118.5	262614.2	0.0	6.9	14.9	0.0	8.8	0.0	0.0	44.0	0.0	3.9	5.2	12.2	0.0	0.0	6.3	47.7	3.2	0.0	0.3	3.1	0.0	0.0	2.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	25.5	40.7	0.1	0.0	0.6	0.0	0.0	0.1	34710.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	197.1	0.3	2.4	0.0	0.0	94.0	0.0	0.0	0.0	0.0	619.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase 3B"	P08861	1	21977022-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2088	"pancreas: 49621.1"	"Cell type enriched"	"Detected in some"	45	"Exocrine glandular cells: 14881.1"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				9.0	1.8	0.0	0.6	0.0	0.8	4.5	0.0	0.0	4.4	0.0	1.8	6.2	1.6	0.1	2.6	1.2	0.0	8.4	0.0	0.0	1.6	5.0	1.2	1.1	0.0	0.0	23.7	49621.1	0.0	2.2	3.4	0.0	3.1	0.1	0.0	9.5	0.0	1.6	1.9	2.6	0.0	0.0	2.3	17.2	2.4	0.0	0.0	1.2	0.0	0.0	1.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	10.4	78.6	0.3	0.0	0.6	0.0	0.0	0.2	14881.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	309.9	0.9	0.9	0.0	0.0	60.4	0.0	0.0	0.0	0.2	325.6	16.0	0.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	27.3	32.2	36.5	31.9	44.8	46.0	25.8	59.0	37.3	29.7	35.4	34.5	22.4	31.7	23.9	32.0	28.4	24.4	30.1	34.7	31.5	26.9	56.1	32.1	39.4	24.1	26.0	26.0	28.0	48.0	23.4	27.6	20.7	23.6	25.8	29.2	26.1	22.6	74.3	30.7	30.6	29.0	20.2	34.6	26.6	29.8	30.3	28.9	28.8	58.0	38.5	29.4	29.4	24.9	48.6	84.4	68.8	71.0	52.9	55.8	58.5	51.0	52.5	62.9	65.4	72.3	56.0	127.6	34.6	55.2	75.6	70.6	107.5	72.3	104.9	53.5	46.9	39.2	117.3	52.2	51.3	62.2	41.4	43.0	43.7	68.5	82.5	44.4	58.0	54.2	75.0	50.5	40.6	64.8	64.5	49.3	96.5	60.0	49.3	65.5	54.8	49.9	54.3	85.4	64.3	54.3	67.9	62.0	41.1	70.0	87.8	40.5	67.0	71.3	69.7	69.1	70.0	42.9	42.2	99.7	57.6	29.2	59.3	13.9	11.6	22.8	12.5	10.2	15.8	14.4	13.3	14.6	13.1	15.0	14.0	11.9	14.9	7.9	17.7	8.0	10.1	9.5	36.5	44.8	59.0	37.3	34.7	31.5	24.1	26.0	20.7	20.2	30.3	24.9	56.2	54.5	41.9	90.8	74.6	107.7	78.0	82.1	79.6	82.4	78.8	59.3	51.1	72.9	56.2	79.1	95.9	52.6	84.1	51.6	21.5	57.3	16.3	76.5	68.4	73.2	85.6	81.0	134.4	56.1	48.8	48.8	57.1	94.4	21.5	92.6	92.4	233.5	72.4	127.9	108.5	62.3	52.9	123.2	98.2	12.4	52.8	81.3	42.7	91.8	106.2	52.2	98.9	76.4	65.8	86.5	53.7	55.3	55.3	103.5	46.2	43.5	106.1	42.9	52.6	52.3	72.0	50.1	69.7	70.2	109.1	36.0	68.8	50.2	70.0	101.1
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243040-37565827	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 122.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SCLC-21H: 46.7;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	0.6	11.5	102.9	1.1	104.8	0.3	0.4	59.5	122.2	0.3	11.1	1.9	0.8	0.4	0.6	0.5	0.4	1.2	1.0	96.4	81.2	1.5	0.3	0.6	0.8	58.3	69.7	1.3	3.9	0.3	28.4	0.8	71.4	0.8	0.4	21.4	1.7	0.2	11.0	1.3	1.2	0.5	34.6	1.1	1.7	3.6	57.4	0.0	1.5	0.2	0.1	0.2	0.5	94.4	0.1	0.1	0.7	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	1.0	0.0	0.2	0.6	0.1	0.0	0.0	0.8	0.4	0.0	1.8	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.8	0.0	0.3	0.1	0.5	1.7	0.0	0.3	0.1	0.0	2.1	0.0	0.1	46.7	11.7	1.1	0.3	0.1	0.3	0.2	0.1	0.0	1.4	0.7	0.3	0.2	2.9	0.5	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.9	104.8	59.5	122.2	96.4	81.2	58.3	69.7	71.4	34.6	57.4	94.4	0.2	0.0	0.0	22.5	0.8	0.4	1.4	0.9	0.0	126.4	0.4	0.5	1.9	0.0	0.3	0.0	41.7	0.3	0.1	0.2	0.0	0.4	46.9	0.7	0.9	4.1	12.7	0.0	197.7	1.1	0.3	1.2	2.0	1.2	0.0	1.8	0.7	0.0	8.6	294.4	197.5	2.5	6.1	0.0	0.0	22.6	0.6	0.3	0.0	14.0	0.0	7.3	0.0	19.1	12.3	2.6	0.2	5.3	0.0	2.7	4.4	6.7	0.3	22.0	0.0	4.3	8.2	12.6	7.6	0.0	0.6	0.3	0.3	1.5	3.5	1.2
CELF5	BRUNOL5	ENSG00000161082	"CUGBP Elav-like family member 5"	Q8N6W0	19	3224661-3297076	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 93.1;Excitatory neurons: 88.7;Inhibitory neurons: 72.8;Oligodendrocyte precursor cells: 22.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;REH: 4.3;SCLC-21H: 4.3;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042012, HPA060336"	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA042012: AB_10796896, HPA060336: AB_2684256"	"unprognostic (1.09e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.07e-2)"	0.0	0.2	13.5	0.0	15.1	0.0	0.5	0.0	21.9	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.5	0.0	0.0	15.7	14.4	0.1	0.2	0.0	0.0	0.0	0.0	4.1	0.5	1.3	0.9	0.0	0.0	0.2	0.1	4.4	0.8	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.3	2.1	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.6	0.0	0.0	3.4	1.4	0.0	4.3	0.0	0.0	0.0	0.0	4.3	2.6	0.2	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	15.1	0.0	21.9	15.7	14.4	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	3.3	0.2	0.4	2.1	0.0	0.0	93.1	3.9	6.6	2.2	2.8	0.0	0.0	0.0	0.4	0.2	1.6	0.0	0.6	19.3	0.2	0.2	0.4	1.2	0.0	88.7	0.2	0.1	0.4	0.0	0.6	0.0	12.1	0.0	0.8	0.1	8.4	72.8	1.4	0.0	0.3	0.3	15.5	0.3	0.3	0.0	8.4	0.0	3.4	0.0	22.1	3.2	0.4	0.1	2.2	0.0	2.3	0.1	0.4	0.0	3.7	0.0	1.1	0.8	2.5	7.7	0.0	0.3	0.0	0.3	1.4	1.6	0.9
CELF6	BRUNOL6	ENSG00000140488	"CUGBP Elav-like family member 6"	Q96J87	15	72284727-72320157	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Astrocytes: 17.3;Excitatory neurons: 18.9;Inhibitory neurons: 21.9;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 3.6;U-937: 1.9"									"HPA046985, HPA053526"	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA046985: AB_2679891, HPA053526: AB_2682178"	"unprognostic (6.83e-3)"				"unprognostic (7.06e-3)"		"unprognostic (9.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.16e-1)"		5.2	5.7	17.9	1.0	16.8	2.7	4.8	7.5	17.3	9.6	3.6	8.5	1.1	6.5	7.4	1.6	10.8	1.9	4.0	12.9	28.5	19.6	3.8	5.3	1.8	13.0	23.7	14.3	3.7	0.7	23.8	1.7	23.1	7.2	1.6	22.1	2.8	4.1	1.5	2.4	5.4	2.0	8.2	6.1	3.4	12.3	21.8	1.9	14.6	0.4	1.3	5.4	4.8	10.3	0.0	0.0	0.1	0.0	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.6	0.4	0.1	1.1	0.5	1.4	0.0	0.0	0.3	0.0	0.5	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.7	0.6	1.0	0.0	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	3.6	1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	16.8	7.5	17.3	12.9	28.5	13.0	23.7	23.1	8.2	21.8	10.3	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	5.5	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109249539-109275751	"G-protein coupled receptors, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 97.6;Oligodendrocytes: 48.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 13.3;basal ganglia: 21.6;cerebral cortex: 44.6;hippocampal formation: 50.8;white matter: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.9;HaCaT: 48.4;MCF7: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol		NA	NA		1300000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	0.9	1.4	13.3	0.5	21.6	0.3	4.1	0.1	44.6	5.6	0.0	2.9	0.8	2.2	3.1	13.9	16.1	1.1	5.2	50.8	0.0	4.7	0.6	1.1	0.7	4.1	0.6	0.6	3.8	6.0	2.9	0.9	1.0	3.0	0.7	5.7	5.6	7.9	8.9	24.7	1.1	1.6	0.6	0.4	2.0	9.4	1.5	1.2	9.1	4.0	2.4	1.9	9.4	26.6	14.0	12.8	47.9	8.9	0.1	0.0	13.0	1.6	1.1	2.9	0.8	2.0	0.4	2.5	10.9	1.0	2.2	48.4	12.5	7.8	1.5	0.3	5.3	1.1	11.8	2.8	1.0	0.8	6.2	0.2	18.5	1.2	0.8	10.8	0.5	7.7	8.5	0.6	0.0	56.6	1.4	0.7	15.7	1.6	2.5	12.8	4.4	0.7	10.3	4.7	19.5	9.2	7.6	16.2	10.1	11.3	15.3	3.1	0.0	0.0	8.5	0.8	12.4	3.2	1.0	0.7	2.6	1.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	21.6	0.1	44.6	50.8	0.0	4.1	0.6	1.0	0.6	1.5	26.6	0.9	9.6	5.0	15.0	0.2	15.7	5.1	19.7	9.6	13.2	16.4	16.3	13.5	2.8	11.3	18.4	4.2	2.2	1.9	1.3	1.9	2.6	5.1	12.8	1.4	1.5	1.8	0.0	34.0	0.4	1.3	1.2	2.6	17.7	1.3	5.5	0.4	7.1	1.1	97.6	27.7	0.9	2.0	0.8	3.4	9.3	3.4	0.9	10.6	5.6	1.0	29.9	3.1	24.6	48.1	1.5	0.5	19.2	0.4	4.3	0.2	3.1	8.4	5.2	6.6	5.0	4.9	1.6	6.8	31.0	22.9	0.5	1.5	0.0	2.0	6.9
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636463-48662886	"G-protein coupled receptors, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.3;pituitary gland: 7.3;retina: 3.8;testis: 2.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Cone photoreceptor cells: 16.7;Enteroendocrine cells: 9.0;Excitatory neurons: 10.1;Horizontal cells: 30.3;Inhibitory neurons: 10.8;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.9;HeLa: 16.2;SH-SY5Y: 18.4;SiHa: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.2	1.2	2.4	0.3	2.9	0.6	0.2	7.3	5.6	0.2	0.0	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.4	0.0	0.0	0.2	0.8	0.2	7.3	0.2	0.0	0.2	0.3	3.8	0.1	0.2	0.1	0.4	0.4	0.2	0.0	0.3	0.6	2.2	0.0	0.1	0.2	0.0	0.2	0.1	0.2	1.1	5.0	3.7	6.0	3.6	0.7	1.1	1.6	0.3	0.7	0.8	1.1	7.0	3.7	1.1	0.9	0.2	3.1	0.6	1.9	0.3	0.4	16.9	1.0	1.7	16.2	2.5	1.1	1.6	2.6	0.5	4.7	0.4	8.5	0.2	0.1	3.5	0.6	5.0	1.2	5.4	0.1	0.1	3.4	1.8	1.6	0.4	0.8	5.2	0.0	3.4	13.5	18.4	16.6	0.3	0.6	0.8	8.1	3.2	0.1	5.9	5.6	7.8	2.9	0.4	9.5	4.4	4.2	1.2	9.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	2.9	7.3	5.6	2.8	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.5	0.7	0.7	0.4	0.1	0.3	1.2	16.9	1.8	2.0	2.7	0.0	0.1	0.0	16.7	0.2	0.8	1.0	0.0	0.2	3.5	0.7	0.9	0.8	9.0	2.1	10.1	0.0	0.3	0.3	0.5	2.5	1.3	0.5	0.4	0.6	0.2	30.3	10.8	1.9	0.0	0.0	0.3	2.3	0.3	0.3	0.0	0.0	0.1	1.0	0.0	1.5	3.6	0.2	0.1	0.0	0.9	0.2	0.2	0.1	0.2	10.9	0.0	0.3	0.7	5.7	3.9	0.6	0.4	0.1	0.6	0.5	0.5	0.1
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CEMP1	CP-23	ENSG00000205923	"Cementum protein 1"	Q6PRD7	16	2530035-2531417	"Metabolic proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.9;granulocytes: 1.3;Late spermatids: 8.3;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	7	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;HEK 293: 6.6;REH: 4.2;T-47d: 3.5;U-937: 3.6"									"HPA057658, HPA075926"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA057658: AB_2683492, HPA075926: "																		7.4	14.4	0.7	0.9	1.0	0.2	6.7	0.1	1.0	7.7	0.6	8.0	0.2	5.8	0.0	7.1	4.2	1.5	6.0	0.7	0.4	19.4	11.2	6.2	3.5	0.9	0.5	5.8	5.4	0.3	7.0	0.1	0.6	8.2	0.0	0.6	7.3	0.4	3.4	7.2	10.9	0.0	0.6	16.5	6.4	4.1	0.5	0.1	8.0	0.0	0.0	7.0	6.1	0.5	0.0	0.0	0.7	4.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.2	6.6	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.6	1.0	0.0	0.0	0.9	0.0	1.5	0.5	1.2	4.2	0.2	0.0	0.0	1.5	2.2	1.2	0.6	3.1	1.0	0.2	3.5	0.6	0.2	1.1	0.5	1.2	0.9	0.0	1.4	1.5	0.8	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.0	0.1	1.0	0.7	0.4	0.9	0.5	0.6	0.6	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
CENATAC	"CCDC84, DLNB14"	ENSG00000186166	"Centrosomal AT-AC splicing factor"	Q86UT8	11	118998138-119015793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039906, HPA071715"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA039906: AB_2676740, HPA071715: AB_2686436"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (8.14e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	11.1	14.0	6.8	2.0	6.9	3.5	11.1	7.3	11.5	14.2	8.6	13.6	1.9	9.5	3.0	11.2	11.7	1.3	12.7	6.8	7.0	15.4	19.0	15.4	2.9	6.8	6.9	11.0	11.2	2.2	15.1	1.7	6.9	16.2	1.7	3.6	10.4	2.7	10.9	13.0	13.9	1.8	6.7	21.7	10.7	7.0	7.0	2.8	15.3	2.1	2.8	13.1	11.8	7.2	3.8	3.2	2.7	3.7	2.7	0.9	3.0	3.4	3.5	2.9	1.8	19.1	2.4	1.4	10.7	3.8	4.5	9.8	1.3	1.8	2.9	5.3	2.2	6.4	6.2	5.5	2.6	2.7	3.5	1.1	1.9	2.9	3.3	3.0	1.7	4.3	1.4	4.8	2.9	6.1	7.0	5.1	3.7	5.6	8.6	9.5	5.5	6.4	4.4	5.6	3.8	2.6	8.6	2.4	0.8	4.3	7.7	2.7	1.9	2.8	13.7	4.0	2.3	3.9	4.0	5.8	2.3	5.3	5.3	0.4	1.3	2.6	2.7	0.9	3.4	4.1	3.6	3.0	2.2	4.2	3.4	2.6	2.1	3.7	0.9	2.6	5.8	1.9	6.8	6.9	7.3	11.5	6.8	7.0	6.8	6.9	6.9	6.7	7.0	7.2	9.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	15.3	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787115-790113	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 234.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	0.1	5.5	55.0	1.0	78.8	0.0	0.1	56.9	234.7	0.2	20.0	4.0	0.6	0.9	0.2	0.4	0.1	0.0	1.1	67.4	79.3	1.2	0.3	0.2	0.3	103.8	57.9	0.2	0.2	0.3	26.0	0.0	93.4	3.2	0.1	7.6	0.2	1.5	0.2	0.2	1.4	0.5	21.6	0.3	0.9	0.3	106.3	0.0	0.2	0.0	0.1	0.8	1.1	116.6	0.0	0.7	0.7	1.4	0.2	0.3	0.2	1.3	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.5	13.6	0.5	0.0	0.0	0.0	8.5	0.3	0.0	0.1	0.0	0.1	0.0	5.3	0.6	0.0	0.8	0.0	0.0	0.2	0.0	0.0	31.0	0.5	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	54.1	20.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	1.2	0.9	21.1	6.2	1.3	28.6	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	55.0	78.8	56.9	234.7	67.4	79.3	103.8	57.9	93.4	21.6	106.3	116.6	0.1	0.0	0.0	17.6	0.5	0.1	0.1	0.0	0.0	94.2	0.0	0.0	0.5	0.0	0.0	0.0	10.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	42.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	75.7	45.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.5	0.0	6.7	0.0	15.1	10.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	25.5	0.0	0.1	1.7	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.2	0.3	0.0	4.0	0.0	3.7	0.4	0.1	0.1	0.5	0.0	2.9	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.4	7.3	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.1	2.6	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.0	1.6	2.2	0.1	13.3	0.1	0.0	8.4	0.7	1.1	0.0	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477"	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	45.2	39.8	115.4	20.4	120.8	14.9	40.3	97.8	109.8	41.1	68.0	56.9	21.4	45.5	11.0	42.2	36.2	15.3	54.8	89.6	91.8	40.4	42.3	36.0	17.5	121.9	113.7	36.6	40.7	26.1	29.6	15.3	108.2	40.0	12.6	3.9	35.0	24.1	95.0	53.7	34.9	19.4	119.6	35.9	44.3	10.8	111.8	17.7	35.0	43.2	13.7	48.2	33.9	133.5	111.9	140.4	27.1	58.1	56.2	44.4	17.4	78.2	56.4	49.1	39.5	57.5	78.1	38.7	24.0	72.9	77.0	88.3	21.7	88.9	24.6	55.5	37.1	82.3	51.5	51.4	65.2	27.0	26.7	50.5	46.9	70.5	45.0	38.5	42.5	49.2	53.9	23.8	42.4	183.2	81.1	61.8	34.0	62.7	165.4	66.8	3.6	28.3	52.2	67.6	66.2	49.4	64.7	89.7	62.4	12.2	56.7	59.1	73.2	84.9	45.8	74.1	121.3	28.5	44.1	22.5	29.8	95.2	56.9	0.0	1.7	0.6	1.9	1.7	1.3	1.0	1.3	1.2	1.3	1.4	1.1	1.4	0.2	1.7	1.1	1.7	0.4	1.1	115.4	120.8	97.8	109.8	89.6	91.8	121.9	113.7	108.2	119.6	111.8	133.5	30.2	6.4	19.5	2.3	6.8	13.9	5.7	11.2	15.9	18.3	23.8	23.1	16.5	30.0	11.6	14.7	10.4	6.2	17.2	48.0	3.9	18.9	1.2	12.7	21.5	24.7	20.4	12.0	2.6	29.8	7.9	14.6	15.8	18.1	7.6	24.0	17.9	25.6	22.7	21.9	4.5	27.1	6.1	25.7	12.3	7.5	21.8	15.3	17.8	3.7	17.3	31.1	12.3	1.5	3.8	31.0	25.4	25.9	5.7	12.5	28.4	8.7	10.8	13.0	13.1	22.4	21.9	1.1	1.5	17.4	14.1	4.5	11.8	46.5	26.9	7.4
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPL	"C1orf155, dJ383J4.3, FLJ31044"	ENSG00000120334	"Centromere protein L"	Q8N0S6	1	173799550-173824720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.6;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044520	Uncertain					NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA044520: AB_10794500"	"unprognostic (8.72e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.88e-3)"	"unprognostic (6.43e-6)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.60e-4)"	"unprognostic (1.78e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.46e-10)"	"unprognostic (2.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.09e-1)"	2.1	1.2	1.4	3.1	1.5	9.6	2.4	1.4	1.8	1.9	1.0	2.4	2.3	1.8	1.0	2.3	1.2	1.7	1.7	1.2	1.3	1.4	1.0	1.3	6.6	1.7	1.3	1.6	0.7	1.1	0.6	3.0	1.6	1.3	3.0	1.5	1.4	1.2	1.4	2.2	1.8	2.4	1.6	2.1	2.1	9.8	1.3	9.1	1.7	2.7	5.7	1.9	1.4	1.8	27.5	7.3	13.5	18.2	3.9	6.7	9.9	23.6	14.4	24.9	17.3	9.5	14.3	19.8	11.0	12.9	9.4	17.6	14.6	11.6	27.4	18.0	7.2	14.6	7.6	5.5	1.9	22.4	14.7	3.4	3.9	17.6	14.0	4.7	14.8	15.2	25.8	28.6	23.0	6.4	18.5	10.3	14.1	19.3	40.4	18.9	16.7	16.7	8.9	7.5	13.6	11.3	18.7	22.5	15.7	10.9	15.8	18.5	8.6	28.6	19.6	14.8	27.6	15.9	29.2	31.5	9.4	16.4	26.6	3.9	1.0	2.4	4.7	1.1	5.3	3.3	4.3	5.5	0.9	5.0	5.5	6.0	0.6	8.6	0.7	4.3	7.1	2.6	1.4	1.5	1.4	1.8	1.2	1.3	1.7	1.3	1.6	1.6	1.3	1.8	16.0	9.6	3.7	1.6	8.5	4.7	6.9	2.8	1.2	4.9	7.3	24.5	5.0	2.8	2.1	1.8	14.6	9.2	13.1	4.8	0.0	2.2	2.2	4.6	12.8	6.3	1.8	22.7	2.2	3.8	15.9	7.7	3.1	7.9	4.5	13.1	3.3	0.8	6.7	1.7	2.0	4.8	2.0	4.4	7.1	3.3	4.7	4.5	5.4	2.8	3.6	2.4	7.2	1.5	2.5	3.6	4.5	1.9	7.4	6.3	4.0	1.3	1.7	4.7	0.0	14.5	10.7	38.8	20.2	8.8	6.0	5.9	9.2	11.2	5.3	4.5
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938737-41947152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.0;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 116.7;Erythroid cells: 60.0;Plasma cells: 70.8;Respiratory ciliated cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.8"	"Group enriched"	"Detected in many"	6	"B-cells: 38.6;T-cells: 50.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042404	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA042404: AB_2677981"	"unprognostic (3.78e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.3	1.5	0.6	9.9	0.6	29.0	1.9	1.8	1.1	2.3	0.3	9.9	8.4	1.7	0.1	9.9	10.8	2.0	0.7	0.5	0.7	2.3	1.6	3.8	25.1	0.8	0.8	0.7	0.7	0.3	0.5	3.2	0.8	1.4	5.3	0.1	3.6	0.3	0.9	8.0	8.3	1.8	0.5	10.6	6.1	12.8	1.0	22.6	0.8	0.4	16.3	2.0	4.0	0.5	79.1	79.0	43.5	28.8	3.3	3.3	18.4	37.8	19.4	65.2	66.2	92.3	41.0	101.5	27.8	20.2	42.2	29.5	32.9	38.8	16.2	29.4	137.4	47.8	82.3	64.9	3.2	91.4	51.9	2.7	2.9	42.1	19.3	6.9	24.8	91.5	36.7	95.0	38.8	121.9	91.9	94.8	23.6	47.5	58.1	86.8	43.4	105.6	26.9	46.5	49.3	9.4	58.5	34.5	20.6	7.2	32.8	58.4	12.5	62.8	93.4	42.0	64.1	50.5	38.0	95.2	21.9	75.9	70.0	1.8	0.3	0.0	6.2	0.2	8.8	27.9	18.6	8.4	0.7	38.6	3.5	4.6	1.1	7.4	0.2	0.4	50.8	7.9	0.6	0.6	1.8	1.1	0.5	0.7	0.8	0.8	0.8	0.5	1.0	0.5	0.4	0.0	3.4	0.3	50.7	2.0	4.8	17.8	1.8	1.9	10.9	10.3	0.6	0.0	7.9	0.0	0.0	39.7	5.4	25.3	17.6	2.1	4.5	116.7	4.2	2.6	7.7	60.0	0.5	0.7	38.9	6.4	10.7	18.0	2.5	15.8	3.6	1.3	43.4	3.3	0.8	34.5	28.5	2.9	3.5	6.7	1.2	5.4	7.2	1.0	1.8	0.1	2.1	1.0	0.2	1.5	8.4	0.4	70.8	2.8	4.0	0.3	102.6	0.6	0.0	0.2	7.0	36.4	29.8	13.3	1.0	8.8	18.5	2.9	36.6	9.0
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325953-92620529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	3.4	3.0	1.7	3.5	2.1	12.3	3.0	5.6	2.1	3.8	0.8	2.4	2.8	2.9	0.7	4.4	2.0	2.8	2.8	2.0	1.5	2.0	1.8	1.9	5.6	1.7	1.4	2.2	2.1	2.4	1.8	3.1	2.0	2.3	2.7	2.4	2.2	1.5	9.0	21.4	1.9	3.0	1.0	2.7	1.8	4.5	1.8	7.1	1.4	4.5	6.4	2.3	4.0	1.8	14.2	8.7	12.0	8.8	4.9	5.3	11.7	14.6	8.2	17.9	14.3	4.0	7.9	18.5	6.7	4.7	16.5	16.8	11.6	8.0	16.6	26.3	15.1	18.6	7.2	5.7	2.6	38.2	17.0	5.8	4.5	17.3	11.1	2.5	9.2	17.5	20.8	25.2	13.8	9.0	53.4	11.6	10.1	26.6	17.9	17.9	20.3	20.0	2.7	14.1	27.8	9.6	16.8	10.5	5.4	8.7	5.6	11.4	4.4	17.4	8.7	26.6	21.2	16.7	21.6	23.9	19.5	18.9	16.1	1.8	1.8	2.6	2.6	6.4	4.7	4.6	3.0	2.3	2.3	3.6	2.7	2.7	0.5	3.5	3.3	3.0	3.5	2.0	1.7	2.1	5.6	2.1	2.0	1.5	1.7	1.4	2.0	1.0	1.8	1.8	3.7	0.0	0.5	17.3	4.5	63.3	4.0	4.5	5.2	6.2	4.0	2.7	2.1	2.8	1.3	0.0	8.4	6.2	3.3	1.6	1.9	1.7	17.5	2.4	4.2	4.4	1.2	11.2	73.4	2.3	9.2	5.8	5.6	2.3	0.0	6.4	2.5	0.9	17.1	1.7	70.5	1.5	0.0	2.1	11.7	4.7	4.4	4.0	14.2	94.6	0.5	2.8	1.0	38.2	74.5	1.1	0.4	4.9	11.9	2.8	0.4	1.8	0.3	7.8	6.6	20.8	9.2	30.2	16.2	9.8	100.9	3.8	3.6	4.4	2.6	2.7
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463370-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	4.8	4.7	4.7	5.4	5.8	4.9	5.4	5.8	6.9	3.1	3.8	3.9	2.8	4.7	3.0	4.3	4.0	3.5	6.4	4.2	5.1	3.8	4.4	3.8	7.0	5.8	5.2	6.2	2.5	3.6	2.3	5.9	6.0	4.5	4.7	4.2	2.8	3.3	5.0	4.0	3.3	4.4	5.3	4.7	3.8	6.0	4.8	9.4	3.7	8.4	8.4	3.7	3.3	7.6	35.3	9.7	30.1	18.9	8.0	12.4	26.4	44.6	25.5	41.9	58.4	11.9	13.8	23.7	21.7	12.7	32.8	12.5	15.8	16.2	61.6	25.9	22.0	17.5	14.6	19.2	3.4	37.4	21.2	5.7	8.7	51.5	17.9	10.7	15.5	20.4	27.3	22.9	31.4	10.2	26.4	17.6	18.8	30.6	8.7	18.8	35.6	25.8	12.3	14.3	16.2	16.0	21.0	12.4	23.9	29.6	15.9	33.8	9.2	32.3	25.2	25.7	40.4	10.4	28.9	21.4	21.9	27.8	32.0	2.2	1.2	4.1	2.0	1.4	2.0	4.4	2.1	2.3	1.3	4.5	2.3	2.3	0.9	2.4	1.8	2.7	3.2	1.2	4.7	5.8	5.8	6.9	4.2	5.1	5.8	5.2	6.0	5.3	4.8	7.6	8.6	0.0	2.7	7.2	9.5	8.7	9.9	10.4	8.6	6.3	4.1	4.7	6.2	4.3	5.2	7.3	2.1	17.3	8.7	4.2	7.9	7.8	1.3	8.8	5.6	8.0	2.4	5.9	3.0	7.9	30.8	9.3	6.6	5.4	4.5	6.3	14.3	3.4	10.1	6.7	3.1	3.7	2.0	11.4	6.0	2.3	8.7	5.9	3.6	11.2	7.6	14.5	13.4	6.6	13.5	7.8	8.0	10.9	7.5	5.4	1.7	4.4	9.4	5.1	6.6	15.2	6.5	17.7	34.6	6.5	7.0	12.4	5.9	4.2	5.9	6.2
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041220: AB_2677367, HPA058036: AB_2683585"	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	7.0	5.6	7.2	3.1	7.1	5.3	6.4	7.4	10.0	7.9	5.7	8.1	2.4	7.0	1.4	6.6	7.3	1.8	8.0	7.4	7.8	6.3	5.3	6.3	3.6	7.5	7.3	7.7	9.6	4.9	4.3	4.2	7.6	6.5	2.0	0.8	5.8	4.3	8.2	24.8	6.3	4.7	6.8	5.5	7.4	19.6	7.3	4.4	5.1	5.6	2.3	7.3	6.9	7.2	7.6	7.4	10.0	10.2	8.1	7.8	14.7	29.5	13.6	30.2	24.1	7.9	5.6	3.3	7.1	19.8	5.3	12.4	7.5	13.2	10.3	5.3	9.5	1.2	3.2	11.3	5.1	0.6	6.9	8.5	7.7	20.7	4.4	4.4	12.3	8.1	19.3	3.6	14.5	11.9	9.8	10.7	13.5	5.9	7.1	13.4	4.5	17.6	11.2	3.1	3.9	6.8	22.2	4.6	5.8	6.3	6.1	10.0	9.7	4.3	7.4	6.6	7.0	7.0	5.8	19.4	3.3	6.1	7.4	1.4	7.2	6.3	6.5	6.6	7.0	4.9	6.0	8.2	6.0	6.1	5.3	7.0	3.4	5.4	4.3	6.0	8.5	5.1	7.2	7.1	7.4	10.0	7.4	7.8	7.5	7.3	7.6	6.8	7.3	7.2	21.0	16.0	11.3	10.4	17.4	21.0	20.2	24.4	12.5	24.9	20.3	19.3	8.2	14.3	17.2	20.2	8.4	31.5	25.4	27.5	5.9	19.0	52.2	8.8	17.8	19.7	13.1	30.3	16.9	14.2	25.0	23.0	34.1	11.2	8.2	20.9	17.5	9.4	15.2	25.2	12.3	11.3	24.4	8.5	17.8	47.9	24.2	17.9	17.8	7.5	9.8	13.7	21.6	12.1	8.4	19.7	17.8	22.2	26.9	11.1	16.3	10.3	12.2	10.5	26.3	19.9	25.1	89.8	33.5	12.8	19.5	30.1	22.6	24.3	13.7	13.6
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812086-3857396	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Cone photoreceptor cells: 458.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	9.0	9.1	7.0	6.6	11.6	3.1	6.4	9.3	7.7	6.9	12.0	8.1	5.2	7.1	4.3	7.6	7.9	6.2	7.6	5.4	7.9	11.3	8.7	7.5	7.1	10.1	11.4	7.5	8.8	14.0	8.1	6.6	10.2	7.7	6.6	9.0	7.8	8.6	9.5	7.1	7.1	9.3	7.7	6.6	7.6	9.6	10.1	8.4	9.9	6.9	8.7	8.1	6.7	9.1	13.4	10.8	8.8	11.8	20.9	15.9	6.8	14.0	11.2	19.5	12.8	8.0	11.4	15.7	17.6	14.8	14.0	12.8	20.3	13.1	23.1	22.1	15.5	15.8	12.7	10.2	13.5	15.5	13.3	8.0	13.0	17.9	28.0	13.6	16.6	17.3	19.6	15.7	18.3	6.2	22.8	6.3	6.3	18.9	20.2	14.1	12.3	17.1	12.7	7.8	22.1	8.8	21.7	23.8	15.0	10.8	10.2	8.0	19.1	14.0	6.5	23.6	11.4	13.0	20.6	22.5	7.9	17.4	5.6	0.3	0.1	1.5	0.6	0.2	0.5	0.2	0.4	0.6	0.3	0.7	0.7	0.1	0.2	0.7	0.4	0.9	0.2	0.1	7.0	11.6	9.3	7.7	5.4	7.9	10.1	11.4	10.2	7.7	10.1	9.1	13.7	25.6	25.9	15.7	14.7	15.9	14.2	9.2	12.0	24.8	12.8	9.1	14.1	12.8	13.9	25.8	458.7	16.3	18.6	16.2	7.9	26.0	74.9	34.3	14.4	15.4	11.3	10.7	23.7	19.6	24.4	12.9	12.2	18.9	10.8	12.6	8.9	18.4	13.2	58.9	24.6	13.5	4.1	14.6	7.8	91.7	12.5	14.3	19.6	12.2	21.0	13.8	22.6	12.1	34.1	24.3	11.7	20.7	23.2	19.2	16.6	18.5	28.7	55.2	19.7	19.8	16.1	63.7	23.5	15.0	20.0	11.4	17.2	18.2	12.7	13.7
CEP120	"CCDC100, FLJ36090"	ENSG00000168944	"Centrosomal protein 120"	Q8N960	5	123344890-123423592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028823, HPA051556"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA028823: AB_10601355, HPA051556: AB_2681533"	"unprognostic (3.65e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.58e-1)"	8.3	7.1	1.6	7.1	1.9	3.0	7.2	2.0	2.6	8.8	2.1	7.2	4.9	9.3	3.6	4.5	9.4	7.2	6.2	2.1	2.1	7.0	7.9	7.3	9.6	2.0	2.1	15.5	6.3	7.6	6.5	6.0	1.9	6.9	5.1	11.6	5.2	7.7	4.4	4.1	7.3	8.0	1.7	9.1	5.1	13.8	1.9	14.1	8.2	6.2	10.9	6.7	6.1	2.3	8.5	7.7	10.6	12.7	11.9	13.7	9.1	11.4	14.1	10.8	19.3	5.7	7.2	11.9	9.7	6.7	17.6	5.3	9.2	10.0	18.5	27.1	4.1	6.2	2.7	6.9	12.8	7.0	11.1	11.5	12.3	14.8	19.3	9.2	9.7	9.8	6.0	20.5	12.6	3.0	13.3	2.8	5.8	3.8	7.1	7.2	15.5	8.9	5.8	2.9	11.3	8.1	9.1	4.0	13.8	12.4	5.8	16.3	8.3	11.7	9.5	5.8	13.7	12.4	11.5	8.3	10.8	14.2	12.3	0.8	0.2	0.6	0.4	0.4	0.5	0.7	1.0	0.7	0.3	0.3	0.6	1.0	0.1	0.3	0.1	0.0	1.7	0.4	1.6	1.9	2.0	2.6	2.1	2.1	2.0	2.1	1.9	1.7	1.9	2.3	15.1	12.8	10.3	8.8	24.5	5.9	4.1	5.0	15.4	10.2	6.3	4.8	10.0	1.5	10.3	7.3	29.2	4.3	12.4	4.2	1.9	2.8	9.4	12.4	7.8	10.8	2.4	7.2	22.8	4.7	4.3	10.8	9.7	5.7	2.5	20.9	4.6	7.2	5.6	8.4	28.2	3.9	4.1	12.0	4.3	6.4	11.8	9.9	8.8	29.0	9.4	7.6	7.2	19.1	24.2	4.2	3.1	13.9	19.1	3.1	7.1	3.3	26.2	17.4	6.6	10.3	8.9	17.4	9.9	6.3	1.8	2.3	23.0	8.2	3.9	3.2
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 24.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Microglial cells: 46.9;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 71.0;Plasma cells: 81.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.8;T-cells: 7.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 59.9;MOLT-4: 55.7;U-266/70: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001116, HPA018498, HPA077688"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Centrosome		"HPA001116: AB_1078323, HPA018498: AB_1845560, HPA077688: "	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	2.0	0.8	1.4	2.5	2.5	6.2	3.8	4.1	1.5	1.2	1.1	2.0	1.4	2.0	0.6	1.7	2.5	1.0	1.2	1.1	1.3	0.9	0.9	1.4	4.7	2.1	1.4	1.5	0.6	1.7	0.9	1.0	1.7	1.2	1.7	1.6	1.7	1.0	1.8	2.4	1.0	1.9	1.4	2.4	1.7	5.2	1.1	24.9	1.7	0.9	5.2	2.2	1.3	3.0	14.8	7.9	6.8	5.6	1.6	2.6	3.6	15.5	4.8	9.5	9.3	5.3	8.4	34.5	2.8	4.8	6.2	7.8	7.4	4.9	18.0	19.5	4.7	6.7	9.8	2.7	0.8	6.6	8.6	0.6	1.2	13.6	7.3	1.8	7.3	17.0	8.5	59.9	9.1	9.4	55.7	3.7	5.3	4.0	9.4	9.8	16.8	26.7	2.0	7.7	8.6	4.1	13.1	5.4	2.8	6.5	6.0	5.1	6.7	20.5	11.2	5.7	16.4	110.1	4.8	15.2	5.8	9.1	7.3	0.0	0.6	1.3	2.2	0.2	1.7	1.6	2.3	1.6	2.0	0.6	2.0	0.9	0.1	0.9	0.4	6.8	7.8	0.7	1.4	2.5	4.1	1.5	1.1	1.3	2.1	1.4	1.7	1.4	1.1	3.0	2.3	3.2	2.8	40.1	7.5	4.0	2.6	1.1	1.2	6.6	3.2	3.0	3.8	2.8	5.7	3.7	2.1	2.4	12.7	0.6	0.0	1.6	8.5	14.8	3.2	2.7	1.2	7.4	27.3	1.2	9.0	3.5	3.1	2.8	2.5	7.8	3.3	0.3	2.5	6.7	25.5	1.0	2.0	0.0	4.6	5.1	1.5	4.8	3.6	46.9	10.3	4.8	1.0	37.7	71.0	1.2	0.3	1.5	81.1	0.9	0.1	0.5	17.2	13.8	6.6	6.6	2.5	16.7	3.8	4.1	1.7	2.3	8.8	2.3	1.5	1.6
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Microtubules	"Cytokinetic bridge, Centriolar satellite"	"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	9.1	8.6	6.7	5.2	6.4	10.2	10.3	7.8	10.0	14.7	7.5	9.8	4.6	11.4	0.9	9.1	11.5	2.0	16.8	6.5	5.8	11.7	6.8	10.7	7.9	6.8	6.2	12.8	10.1	2.2	15.4	4.1	6.2	12.0	0.8	1.8	9.3	2.1	11.1	10.5	10.3	1.6	5.7	19.0	9.9	28.2	6.7	3.5	10.3	2.0	2.2	10.4	10.7	6.8	21.1	20.0	10.6	19.4	1.7	2.7	33.6	14.4	2.5	10.3	7.9	23.8	10.5	14.8	8.0	3.5	6.3	14.9	3.1	7.0	2.5	6.2	26.8	14.3	32.7	41.3	2.9	12.5	30.6	2.3	4.6	7.5	2.1	3.3	7.3	15.6	10.6	8.5	2.7	23.5	29.0	24.3	9.5	6.1	17.7	29.0	12.1	6.1	3.9	18.4	24.2	27.2	18.5	11.4	18.0	3.9	17.2	12.3	10.0	18.6	32.1	16.7	19.2	22.0	4.0	11.3	9.6	10.7	13.5	2.1	0.8	0.5	1.2	2.3	0.3	2.9	0.7	1.1	1.8	1.7	1.1	0.8	1.3	1.0	4.6	2.0	0.1	0.8	6.7	6.4	7.8	10.0	6.5	5.8	6.8	6.2	6.2	5.7	6.7	6.8	6.5	0.0	4.4	5.5	6.6	0.0	3.4	0.0	3.4	5.8	3.3	4.4	13.4	2.8	1.3	3.7	6.2	8.7	4.8	5.6	0.0	4.5	14.0	8.4	3.5	6.0	6.7	5.7	2.1	3.7	7.2	6.9	6.6	2.8	15.9	9.3	2.5	1.7	5.2	5.0	2.9	5.1	0.0	1.9	0.0	17.9	9.6	3.6	0.0	1.0	1.3	6.0	7.2	2.5	2.8	5.2	0.8	3.0	4.4	1.2	1.8	1.4	3.6	6.9	0.0	4.3	5.7	14.7	20.5	3.7	0.0	6.0	3.5	8.4	7.9	2.7
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039408	Approved		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	2.2	1.3	1.2	3.5	1.4	16.3	1.9	2.0	1.9	1.9	2.6	2.3	2.9	1.4	0.9	2.6	1.9	1.8	2.1	1.0	0.9	2.2	1.0	2.2	4.3	1.2	1.2	2.5	2.9	1.3	0.9	4.7	1.4	1.7	3.1	1.9	2.4	0.9	1.0	3.0	2.9	1.9	0.7	2.4	2.3	9.8	1.8	5.6	2.9	0.6	3.7	1.4	2.3	1.8	8.0	6.1	12.2	15.0	2.1	3.9	7.9	13.9	5.6	10.0	12.3	13.2	6.8	18.6	5.9	4.0	14.1	18.6	13.6	5.0	14.5	16.5	8.3	30.1	34.6	7.2	1.4	25.6	13.4	1.4	3.9	11.1	6.6	3.9	7.5	19.2	18.4	21.6	8.6	4.5	18.6	23.8	7.7	9.5	6.1	22.7	16.4	22.9	3.6	7.5	14.6	9.8	10.7	8.9	4.2	13.3	6.7	12.3	6.2	24.4	12.9	18.9	15.6	9.2	10.8	21.4	7.8	36.2	17.6	2.1	1.0	1.9	0.8	1.4	0.7	0.9	0.9	0.9	0.8	1.7	1.0	1.0	1.8	1.2	1.5	1.5	1.0	0.5	1.2	1.4	2.0	1.9	1.0	0.9	1.2	1.2	1.4	0.7	1.8	1.8	3.9	6.4	2.8	22.2	9.3	3.8	4.1	2.8	4.0	1.5	2.9	3.6	3.9	4.3	1.8	3.7	2.1	31.5	6.8	7.8	0.0	4.7	192.5	6.4	5.3	6.7	3.6	29.9	14.7	6.7	8.5	9.0	7.1	5.0	8.2	20.9	6.1	3.3	7.6	0.0	8.4	8.2	4.1	7.2	6.4	49.5	23.9	8.6	1.8	16.9	6.9	2.9	10.3	6.0	7.0	7.9	3.5	27.1	15.9	3.2	9.1	1.7	8.4	3.6	6.6	6.5	5.4	24.4	10.3	7.0	3.4	46.9	9.9	3.4	10.1	4.1
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413266	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 454.5;Early spermatids: 241.0;Late spermatids: 291.7;Rod photoreceptor cells: 268.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.0	5.8	6.7	9.7	8.2	7.3	6.8	10.8	8.0	10.5	11.5	7.3	4.2	10.8	8.1	8.6	11.4	8.4	4.3	5.5	7.9	5.1	7.3	6.7	7.6	8.2	7.5	11.9	26.3	5.6	11.1	4.6	8.1	6.9	5.1	26.0	5.7	5.8	3.1	8.0	6.2	10.3	4.9	8.5	5.8	23.9	9.2	7.7	8.4	1.3	8.5	7.1	7.5	14.0	13.2	18.0	13.0	25.9	12.8	21.7	4.2	25.6	14.3	18.0	17.5	22.4	20.8	25.9	18.1	15.9	17.7	17.1	14.6	15.0	15.3	25.8	12.0	7.8	18.9	7.1	18.9	11.3	16.8	15.2	12.6	27.3	26.5	16.1	23.6	12.6	21.7	16.4	14.4	11.2	10.6	10.2	9.2	8.5	19.4	14.0	15.5	10.1	7.9	11.3	15.1	21.8	20.3	12.2	14.4	14.4	16.9	13.2	25.7	21.3	13.2	20.7	23.8	5.8	7.7	15.2	10.3	12.6	14.5	96.2	34.3	23.4	35.4	30.9	22.9	38.8	44.3	40.4	13.9	41.0	41.4	32.6	82.5	29.6	42.0	49.4	52.6	10.8	6.7	8.2	10.8	8.0	5.5	7.9	8.2	7.5	8.1	4.9	9.2	14.0	21.0	6.4	13.1	28.1	15.4	7.6	10.3	13.2	10.8	97.7	14.5	23.6	5.8	15.7	10.3	11.0	454.5	4.5	14.3	9.0	1.9	11.1	241.0	26.5	30.3	18.3	15.5	8.0	19.0	14.7	6.8	17.2	17.9	14.7	19.6	17.6	13.2	9.0	12.9	74.0	26.3	10.2	10.2	11.7	11.4	291.7	23.9	14.5	5.4	8.4	21.2	23.4	15.5	21.6	28.7	11.7	5.8	17.0	11.0	9.8	5.4	6.2	31.6	268.7	0.0	30.3	21.4	37.6	17.2	11.4	8.1	2.2	16.4	45.0	11.9	5.6
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 52.6;brain: 66.3;testis: 89.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1490.6;Late spermatids: 4804.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Supported	Centrosome,Cytosol		NA	No		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453"	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	8.0	5.0	9.5	8.5	24.1	52.6	5.9	27.7	15.5	6.2	0.0	5.5	3.1	7.2	3.6	4.8	5.2	8.1	7.5	9.7	17.8	2.7	6.3	8.6	6.5	32.3	19.9	8.9	2.1	2.1	4.3	8.2	29.1	4.0	3.0	10.9	3.7	4.1	10.2	3.7	4.4	6.2	27.3	6.7	3.4	89.8	24.6	10.8	12.4	5.8	6.3	6.5	4.4	66.3	17.9	21.7	28.6	23.2	17.8	30.3	9.4	58.3	19.3	23.3	18.6	13.6	14.4	17.0	33.8	33.8	8.5	8.2	23.1	17.6	23.7	36.8	24.9	18.5	21.5	5.8	12.1	28.7	26.4	25.8	4.8	81.3	36.0	51.2	54.3	8.4	43.3	12.4	21.6	4.0	14.8	13.1	47.2	2.7	53.6	31.7	33.6	5.3	5.2	3.1	47.7	79.1	28.0	1.5	19.4	19.0	6.1	26.8	109.7	50.7	21.8	33.9	51.4	16.9	22.4	29.9	31.3	22.3	120.1	4.3	8.7	8.1	1.8	10.6	2.8	3.4	3.7	1.6	9.2	9.4	4.6	2.7	12.8	3.3	11.9	5.9	3.1	2.5	9.5	24.1	27.7	15.5	9.7	17.8	32.3	19.9	29.1	27.3	24.6	66.3	33.4	19.2	19.8	90.4	46.4	15.2	4.8	11.2	26.2	40.2	8.7	12.1	22.2	8.6	9.6	12.9	6.2	3.8	10.9	0.7	0.0	19.5	1490.6	25.3	40.1	43.4	10.8	16.4	115.9	6.9	7.5	37.3	5.6	12.8	23.4	31.3	22.5	7.3	35.9	45.4	124.6	2.4	4.1	38.9	85.0	4804.7	44.1	70.9	23.2	141.5	36.9	11.9	4.1	147.2	299.7	27.4	1.2	35.3	22.3	2.5	1.0	2.8	24.0	19.3	26.3	41.2	34.4	73.5	29.4	16.9	11.5	1.9	13.6	29.1	1.6	3.1
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865268-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 229.4;Distal enterocytes: 81.2;Rod photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Microtubules,Centrosome,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Microtubules, Centrosome"	"HPA000871: AB_2666124, HPA059017: AB_2683883"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.41e-4)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	13.0	12.8	13.0	4.9	14.1	0.2	13.2	0.0	27.6	11.9	0.0	27.8	17.9	14.8	2.6	31.3	14.7	6.0	9.9	16.6	1.7	29.2	20.2	14.9	0.8	12.3	4.4	6.3	27.7	6.1	21.1	2.7	10.6	19.5	5.7	10.2	18.5	7.7	6.5	36.2	21.1	4.1	0.0	4.5	24.3	15.4	5.1	1.0	20.7	1.4	1.9	16.1	16.4	10.3	23.4	19.1	1.4	17.8	7.4	5.3	41.3	18.0	7.0	8.9	5.9	20.3	14.0	0.0	21.5	13.8	6.1	50.7	4.2	21.1	2.3	8.6	8.8	0.0	22.9	13.4	14.9	0.1	18.2	5.2	26.2	9.3	13.5	7.0	9.0	0.1	6.0	0.2	7.7	49.4	0.1	0.3	5.9	33.2	16.3	7.7	0.1	5.6	8.9	39.1	4.8	5.0	26.7	15.5	24.2	3.0	27.1	3.4	20.0	14.0	15.3	39.0	12.3	0.8	0.1	0.1	11.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	14.1	0.0	27.6	16.6	1.7	12.3	4.4	10.6	0.0	5.1	10.3	1.7	9.6	15.3	5.2	0.8	23.8	12.6	12.8	10.2	18.0	15.2	11.4	3.7	22.8	10.0	18.4	229.4	3.6	0.2	81.2	1.9	12.2	0.8	16.2	6.3	4.4	22.1	0.0	17.7	24.0	7.6	5.4	48.4	18.2	5.7	5.7	8.6	12.8	1.4	40.4	14.9	41.0	8.2	0.8	5.2	1.7	3.7	1.3	8.8	2.8	1.0	11.1	0.0	5.5	5.9	31.8	42.9	8.6	0.7	30.3	27.5	5.0	20.1	112.6	6.6	6.8	7.8	1.7	5.2	13.9	24.6	6.7	1.9	0.0	35.6	24.5
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 144.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA047614: AB_2680103, HPA071138: AB_2686348"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	1.6	2.6	5.1	3.1	5.3	1.2	1.1	4.7	6.3	1.7	5.7	1.4	0.9	1.6	3.0	1.5	4.1	1.9	1.4	5.4	5.9	2.6	1.1	1.6	2.9	5.2	5.3	1.8	0.7	3.4	3.8	2.0	5.1	1.6	1.0	6.6	1.2	2.1	0.6	1.6	1.2	1.4	5.0	3.4	0.9	9.9	5.8	7.6	2.2	1.8	3.5	1.8	1.5	5.5	6.0	4.1	5.6	3.5	12.6	9.6	1.6	4.8	9.0	5.1	6.6	2.1	3.9	4.4	13.3	2.4	11.1	2.6	3.8	1.1	5.9	6.2	3.8	6.8	2.0	0.6	5.0	3.1	8.3	4.4	5.5	6.6	1.8	9.3	2.0	5.4	3.8	5.4	5.2	3.1	7.8	5.6	2.9	2.6	6.9	9.0	3.4	2.9	5.4	0.5	5.6	4.0	6.4	0.8	7.6	4.7	5.0	5.9	1.7	5.8	1.3	9.1	3.2	16.2	16.6	9.1	8.4	7.9	5.8	51.5	4.0	59.0	5.4	3.2	6.0	3.8	8.0	7.3	2.6	4.4	10.3	6.6	144.2	7.3	3.7	11.0	4.8	3.9	5.1	5.3	4.7	6.3	5.4	5.9	5.2	5.3	5.1	5.0	5.8	5.5	2.6	0.0	2.0	3.6	4.5	2.0	1.3	2.2	5.2	5.8	2.7	3.0	2.0	2.8	2.1	1.8	0.0	1.8	5.1	0.6	5.9	2.0	54.8	14.8	5.2	3.7	0.0	1.3	8.4	0.8	1.5	3.4	0.0	1.3	1.3	5.0	5.0	0.3	3.1	5.0	6.6	0.4	4.1	2.2	4.7	6.3	6.5	2.4	0.0	1.0	15.3	9.5	14.4	1.5	1.4	0.8	0.0	5.3	7.1	0.8	0.1	4.9	21.4	8.3	0.0	2.9	2.2	66.3	39.6	2.1	0.9	0.4	3.9	8.8	0.4	0.5
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CEP20	"C16orf63, DKFZp686N1651, FLJ31153, FOPNL, FOR20, PHSECRG2"	ENSG00000133393	"Centrosomal protein 20"	Q96NB1	16	15865719-15888625	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;Cardiomyocytes: 28.2;Cytotrophoblasts: 40.4;Extravillous trophoblasts: 27.1;Hofbauer cells: 21.1;Syncytiotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040599	Supported		Supported	Centrosome		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA040599: AB_10794036"	"unprognostic (1.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.78e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.45e-3)"	16.5	19.1	7.7	12.7	7.7	14.1	19.1	8.0	16.5	17.2	8.9	14.9	13.0	13.8	1.3	27.6	15.0	13.9	16.9	7.6	9.5	17.4	19.0	13.6	24.2	8.0	8.0	18.7	18.2	8.5	14.3	9.8	8.3	15.5	13.8	10.5	14.2	11.1	45.7	17.4	12.4	8.0	8.1	13.4	15.3	31.5	8.4	15.8	32.5	5.8	15.8	17.5	17.3	8.3	43.1	45.6	16.0	3.6	35.4	43.2	2.5	23.7	26.7	23.6	27.6	24.4	6.1	31.1	30.2	6.9	43.9	33.5	39.8	3.7	49.4	33.2	29.5	4.5	10.2	12.0	29.7	9.3	34.3	4.0	53.4	5.8	36.8	7.4	39.9	70.8	85.0	5.6	7.1	33.2	28.0	34.7	38.8	29.8	3.8	6.9	37.3	4.1	3.6	13.1	14.4	1.4	2.1	30.6	51.1	33.0	4.5	5.5	14.0	4.9	3.7	47.4	83.5	11.3	38.2	53.1	42.6	72.0	36.4	38.1	14.4	7.3	12.6	15.0	16.8	15.9	15.4	15.4	16.1	15.9	16.1	14.7	4.2	19.2	13.3	18.3	16.7	14.7	7.7	7.7	8.0	16.5	7.6	9.5	8.0	8.0	8.3	8.1	8.4	8.3	11.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	40.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	27.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	29.0	1.3	0.0	0.0	0.0
CEP290	"3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6"	ENSG00000198707	"Centrosomal protein 290"	O15078	12	88049016-88142099	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	Activator	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 150.5;Spermatocytes: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB029995, HPA043918, HPA064397"	Approved		Supported	Centrosome		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Centrosome		"CAB029995: , HPA043918: AB_2678730, HPA064397: AB_2685255"	"unprognostic (7.42e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.84e-3)"	5.2	5.1	2.7	4.0	3.4	2.8	5.0	3.1	3.8	7.9	1.9	6.3	1.5	6.4	2.7	2.4	8.0	2.6	4.5	2.8	2.9	7.1	3.6	5.0	3.6	2.8	3.0	12.3	4.6	9.0	8.4	3.3	3.0	6.8	2.6	7.2	3.5	2.1	2.9	3.7	4.6	2.9	2.7	4.5	4.8	8.6	2.9	4.3	7.3	1.2	2.6	6.0	4.9	4.3	8.3	4.9	9.8	2.0	4.2	16.1	3.8	8.2	6.6	5.8	5.0	7.3	3.3	7.6	3.6	6.1	9.1	6.4	2.7	5.2	9.1	4.2	4.7	7.5	4.5	4.7	7.6	10.0	3.4	8.3	3.3	12.5	10.4	11.3	11.3	6.5	15.4	1.4	11.0	3.8	5.7	6.2	2.5	1.3	8.5	4.5	11.6	5.1	4.9	6.1	4.7	8.3	5.0	2.5	6.4	7.6	11.3	3.3	10.0	9.5	5.5	8.1	10.7	6.0	10.4	8.2	3.5	3.7	3.9	0.0	0.0	0.1	0.6	0.1	0.8	0.2	0.7	0.5	0.0	0.3	0.7	0.5	0.0	0.5	0.2	0.6	0.5	0.0	2.7	3.4	3.1	3.8	2.8	2.9	2.8	3.0	3.0	2.7	2.9	4.3	29.0	86.6	32.1	56.2	22.5	6.4	16.9	17.5	17.1	65.9	15.1	16.5	50.0	25.8	35.2	29.5	102.2	13.0	28.6	8.4	7.9	26.0	70.6	89.0	57.0	24.6	4.9	12.4	91.8	13.1	8.8	26.1	14.3	32.1	19.0	56.2	13.9	5.7	13.9	65.6	93.7	17.4	34.6	6.3	7.4	29.4	28.6	13.5	14.2	30.9	11.4	35.0	33.0	67.3	100.4	19.0	6.5	37.6	22.5	9.2	6.9	11.0	81.8	150.5	32.9	42.5	32.2	143.9	53.5	6.4	5.5	5.6	23.7	46.1	15.8	9.4
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661682-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	6.6	5.8	7.5	6.3	8.1	16.0	8.3	14.4	10.5	7.6	5.0	8.7	6.2	7.0	7.4	5.8	6.8	5.2	5.3	7.3	6.9	6.2	5.0	6.0	11.1	6.3	5.9	8.3	6.6	4.7	8.4	6.3	6.6	8.3	6.8	14.7	5.5	5.2	5.3	8.9	7.5	5.5	4.9	9.4	6.2	12.0	7.6	10.3	8.7	5.8	7.4	7.7	6.6	10.2	10.5	9.4	23.9	20.4	10.8	10.4	11.6	13.2	9.7	12.2	14.2	17.3	19.2	3.1	19.1	8.3	16.9	18.7	11.8	9.5	12.4	15.0	9.4	19.0	28.2	8.6	6.5	17.1	17.4	7.7	5.6	11.6	10.0	11.5	10.4	16.9	21.6	19.4	15.8	8.8	8.9	28.1	7.5	19.6	9.7	17.7	22.6	12.6	10.1	17.9	13.9	12.9	20.9	13.8	3.7	14.8	22.8	9.4	9.6	11.3	14.8	20.9	10.1	6.9	16.7	20.2	6.7	19.7	15.9	3.3	1.7	3.6	1.5	0.9	1.2	3.2	1.3	1.0	0.8	3.5	1.6	1.4	5.2	1.6	1.3	1.7	1.1	0.4	7.5	8.1	14.4	10.5	7.3	6.9	6.3	5.9	6.6	4.9	7.6	10.2	10.9	9.6	14.3	24.2	14.0	0.0	3.3	0.0	5.2	30.5	7.0	8.9	9.4	5.7	5.6	5.5	27.1	12.8	8.6	2.5	3.9	7.8	78.7	12.4	15.0	9.6	3.6	25.7	41.2	7.8	10.3	8.8	11.2	10.2	16.4	48.8	6.8	4.2	8.0	18.5	40.8	5.5	0.0	7.9	0.0	21.4	12.8	7.7	0.0	15.0	10.3	10.3	10.3	23.6	33.5	5.3	4.1	14.3	12.2	5.6	5.8	4.0	5.1	38.1	6.6	9.4	8.7	48.8	18.6	7.5	0.0	6.6	9.8	15.8	5.8	2.8
CEP295NL	"DDC8, KIAA1731NL"	ENSG00000178404	"CEP295 N-terminal like"	Q96MC4	17	78870910-78903217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 9.2;testis: 33.6"	"Group enriched"	"Detected in some"	133	"Early spermatids: 298.6;Late spermatids: 504.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;Karpas-707: 1.1;TIME: 1.2;U-2 OS: 1.9"	"Not detected"	"Not detected"							"HPA023609, HPA024619, HPA025717"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900"	"unprognostic (1.68e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.03e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.75e-3)"	0.1	0.1	1.9	0.0	2.2	1.3	0.1	0.5	2.8	0.4	1.6	0.1	0.0	0.2	0.0	0.5	0.2	0.0	0.1	0.9	1.8	0.0	0.0	0.1	0.0	2.8	1.9	0.3	0.1	0.0	0.1	0.1	3.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.3	0.1	33.6	3.3	0.0	0.0	0.0	0.0	0.1	0.3	9.2	0.3	0.0	0.0	0.3	0.1	0.2	1.4	0.6	0.0	0.2	0.3	0.1	0.2	0.0	0.4	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.3	0.0	0.4	1.2	0.5	1.9	0.6	0.2	0.4	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	1.9	2.2	0.5	2.8	0.9	1.8	2.8	1.9	3.4	1.0	3.3	9.2	0.7	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.6	0.3	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.5	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	504.5	2.8	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	3.0	1.4	0.1	0.0	0.0	0.1	0.7	0.0	0.1
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954773-180114875	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 835.2;Late spermatids: 824.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633"	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	10.9	7.0	10.7	11.5	22.1	24.6	11.4	20.8	13.4	9.1	6.0	11.2	9.3	8.6	7.5	9.3	8.3	8.7	7.8	7.7	14.0	8.9	10.4	7.9	15.5	16.7	16.7	14.0	10.6	16.9	7.5	10.0	17.0	7.7	11.1	20.9	7.5	9.2	31.4	11.8	11.6	8.4	11.4	11.7	11.0	24.9	15.6	24.0	11.3	36.9	14.0	10.5	8.6	25.5	23.8	16.4	21.2	7.5	17.6	16.2	20.0	15.8	21.0	13.2	14.5	18.7	13.8	26.0	16.8	14.2	11.4	28.8	16.1	9.0	17.2	25.9	11.4	18.6	20.6	11.9	19.2	37.1	16.7	16.3	13.7	17.3	22.5	9.7	16.4	24.4	36.9	19.5	14.3	17.2	21.9	10.4	19.8	23.0	4.3	18.9	23.4	20.3	9.3	48.2	14.8	15.9	26.2	17.3	29.7	14.9	19.0	32.8	16.8	18.7	13.0	16.7	16.9	33.5	46.2	49.9	8.7	15.9	28.6	1.4	2.1	5.0	2.9	1.9	3.3	2.3	2.1	1.8	1.7	3.7	2.2	1.9	3.8	1.9	1.7	3.4	3.4	0.8	10.7	22.1	20.8	13.4	7.7	14.0	16.7	16.7	17.0	11.4	15.6	25.5	63.6	118.6	67.4	138.4	75.9	38.0	28.4	23.9	45.5	56.8	34.3	27.4	84.3	37.1	42.2	12.9	85.5	19.7	76.4	35.3	5.9	23.3	835.2	61.0	59.5	49.4	46.2	81.4	108.3	38.9	23.9	47.5	47.9	53.6	29.7	42.9	74.6	28.4	29.4	62.2	121.3	29.3	22.4	72.3	60.9	824.3	53.7	79.0	19.6	89.0	101.0	36.2	70.0	121.2	172.9	37.2	22.4	42.2	100.1	37.5	52.0	11.8	57.3	56.4	26.3	74.0	51.3	233.9	45.0	48.5	46.7	26.3	75.2	40.7	29.5	40.0
CEP41	"DKFZp762H1311, FLJ22445, JBTS15, TSGA14"	ENSG00000106477	"Centrosomal protein 41"	Q9BYV8	7	130393771-130442433	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Autism, Autism spectrum disorder, Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 526.8;Late spermatids: 160.6;Spermatocytes: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024090	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA024090: AB_10966276"	"unprognostic (3.87e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.17e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-7)"	"unprognostic (1.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.45e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.57e-1)"	3.8	5.2	4.9	3.5	5.0	4.2	3.6	3.6	5.6	3.5	8.8	3.0	3.2	4.3	3.7	2.6	9.4	4.6	2.0	5.3	5.2	3.3	2.7	3.2	4.7	4.8	8.1	3.5	2.2	5.1	4.7	4.5	5.2	3.2	3.6	7.7	17.8	3.6	1.6	2.4	2.2	5.3	4.7	4.2	2.8	47.0	5.3	8.6	4.1	2.3	4.9	3.2	1.4	6.4	15.9	16.5	17.6	11.4	5.1	8.9	3.6	21.0	10.4	12.4	13.9	9.8	19.3	23.1	11.3	12.3	34.4	15.2	17.6	11.3	17.2	8.0	5.0	8.4	7.2	5.2	8.5	16.7	8.0	9.7	8.6	16.2	7.2	12.0	21.9	16.7	4.8	5.3	21.5	10.7	43.2	14.7	15.7	17.4	12.6	30.3	25.7	0.7	9.1	10.3	25.4	21.0	14.0	19.9	16.3	9.9	6.1	12.8	11.0	18.4	7.2	17.6	27.3	12.2	39.9	28.8	20.7	16.4	27.8	7.9	4.6	5.9	7.5	6.9	4.9	3.6	5.4	5.7	8.3	4.5	8.4	13.9	0.8	11.2	3.3	4.0	6.3	7.4	4.9	5.0	3.6	5.6	5.3	5.2	4.8	8.1	5.2	4.7	5.3	6.4	8.7	9.6	4.1	7.2	5.0	1.8	6.4	13.5	4.6	18.1	11.6	9.0	4.4	4.3	10.1	9.2	37.5	16.2	3.8	3.1	11.7	12.9	526.8	35.9	8.9	9.6	14.4	12.4	14.5	9.2	10.9	7.8	4.6	5.3	11.4	13.3	12.8	3.4	18.7	15.2	12.5	4.7	10.2	8.9	2.2	160.6	10.5	8.0	5.4	5.6	4.0	10.2	9.2	17.1	14.2	7.0	3.7	8.2	1.9	4.0	2.0	5.2	55.5	22.0	6.6	6.3	7.4	96.0	35.0	4.1	1.6	19.2	5.8	8.7	6.3	6.5
CEP43	"FGFR1OP, FOP"	ENSG00000213066	"Centrosomal protein 43"	O95684	6	166999317-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876	Approved		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA071876: AB_2686467"	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.9	14.8	8.8	12.6	8.3	16.7	14.3	8.3	10.0	13.5	9.2	12.4	15.9	14.9	16.9	9.0	27.0	11.2	8.9	8.1	8.3	17.4	36.3	7.3	14.8	8.7	11.4	13.0	11.3	10.5	14.1	8.4	9.4	9.4	16.9	25.4	8.8	9.1	8.5	11.6	15.8	10.4	7.7	11.1	11.3	58.4	8.4	15.7	15.5	10.4	17.7	9.2	9.3	9.4	26.1	14.3	35.3	24.2	20.3	15.1	42.7	33.0	21.9	26.4	25.3	53.1	21.6	31.0	18.3	20.2	70.3	24.0	31.4	23.3	49.3	19.5	27.0	21.4	26.7	58.2	10.8	38.4	21.6	8.4	16.8	54.2	25.2	16.4	18.5	34.5	70.9	25.8	34.2	24.0	31.1	55.8	30.2	50.0	10.9	35.3	23.9	25.7	27.8	13.8	26.2	26.2	26.9	28.6	11.7	24.6	23.5	46.7	12.2	26.1	43.7	31.6	42.1	21.8	32.3	31.4	29.4	35.4	32.7	0.4	6.5	23.5	5.1	6.1	7.6	12.1	5.8	4.8	10.7	8.4	3.4	5.5	38.8	6.3	6.7	16.4	11.7	4.9	8.8	8.3	8.3	10.0	8.1	8.3	8.7	11.4	9.4	7.7	8.4	9.4	3.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	14.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.0	0.0
CEP44	KIAA1712	ENSG00000164118	"Centrosomal protein 44"	Q9C0F1	4	174283730-174333380	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 73.9;SH-SY5Y: 142.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041515, HPA041835"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA041515: AB_10795638, HPA041835: AB_10794637"	"unprognostic (2.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (8.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.72e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	6.1	8.7	5.7	7.8	8.2	11.1	9.7	11.5	7.6	7.9	7.4	9.2	7.6	10.5	9.2	8.7	7.6	8.1	8.7	7.8	6.0	5.9	7.8	7.1	10.2	7.5	6.5	10.8	6.3	9.2	8.1	11.5	8.5	8.4	8.6	12.6	7.6	6.1	5.8	13.0	8.6	7.6	6.6	8.8	8.7	13.4	6.6	11.0	9.0	6.2	8.5	7.3	7.3	13.2	12.5	11.4	19.2	9.6	12.1	17.3	10.7	18.7	7.1	12.1	12.5	6.9	27.1	19.0	18.1	4.8	11.5	10.1	20.4	9.3	15.5	30.9	32.2	23.2	33.1	8.0	8.3	17.7	16.6	9.2	14.4	9.9	10.6	12.0	10.6	14.7	30.9	73.9	14.6	4.9	20.7	13.7	10.0	9.4	9.8	15.4	18.2	15.6	10.8	5.0	34.5	142.6	16.1	12.8	14.2	17.6	13.8	12.7	11.5	9.6	10.5	23.1	11.8	18.7	14.0	24.0	18.6	15.7	19.6	5.9	3.1	2.3	3.9	3.7	3.9	5.6	4.1	3.4	3.2	5.6	5.2	4.5	2.3	2.8	4.6	3.0	8.7	2.7	5.7	8.2	11.5	7.6	7.8	6.0	7.5	6.5	8.5	6.6	6.6	13.2	12.6	9.6	16.4	24.5	14.4	9.9	9.0	10.1	14.8	22.8	10.7	8.0	17.1	8.6	11.9	1.8	33.3	6.6	14.2	8.0	5.9	7.8	6.6	25.4	15.8	9.1	7.7	27.4	24.0	8.0	10.3	14.2	10.2	20.0	12.0	19.4	6.1	7.8	6.6	15.2	25.5	7.8	8.2	9.5	6.0	7.9	16.4	12.3	8.8	10.3	7.9	11.1	8.2	39.2	58.4	9.5	4.9	10.1	13.7	7.2	9.2	4.9	31.5	30.3	13.1	21.1	14.6	44.8	15.0	8.8	11.1	6.7	13.0	9.3	8.1	10.1
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 462.9;Late spermatids: 372.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA018315	Approved		Approved	Microtubules,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.6	14.0	10.6	19.2	11.4	29.0	21.6	15.0	13.3	19.0	12.6	17.7	32.4	21.8	19.8	15.0	17.7	27.3	15.6	10.4	11.2	15.7	44.6	16.9	30.1	12.2	11.2	31.2	22.8	12.2	14.9	16.1	10.8	16.2	18.6	25.9	14.1	17.3	12.8	17.8	21.9	15.5	10.9	20.5	17.8	27.9	11.7	34.2	22.7	14.3	30.6	14.0	15.1	12.4	26.7	13.1	42.0	32.7	19.4	38.6	34.4	29.8	48.6	41.4	46.1	47.5	55.1	47.1	39.6	22.4	24.2	43.8	34.7	29.5	43.8	38.1	21.8	66.4	36.9	38.4	33.9	67.0	37.2	25.9	42.5	43.2	80.4	39.3	33.4	49.6	43.8	25.3	33.8	13.1	74.7	89.1	23.3	30.2	29.2	43.8	53.2	40.7	34.8	27.8	21.5	28.9	36.1	34.4	38.3	29.7	35.1	44.0	17.2	35.2	28.3	52.0	28.2	16.9	38.1	51.7	14.6	74.4	31.0	19.0	11.8	24.3	19.5	14.4	25.9	23.6	25.7	22.7	15.6	21.7	24.8	23.5	11.6	26.0	13.2	21.1	33.7	17.5	10.6	11.4	15.0	13.3	10.4	11.2	12.2	11.2	10.8	10.9	11.7	12.4	43.7	54.5	51.1	35.9	58.5	36.3	30.6	35.7	51.2	72.3	30.6	42.7	41.3	85.8	41.7	29.5	35.5	44.1	42.8	16.2	54.8	34.2	462.9	52.2	33.0	38.2	28.8	88.1	68.0	25.7	50.8	41.1	18.3	33.0	27.3	58.4	30.7	71.5	33.1	57.2	78.3	34.0	16.2	35.0	37.3	372.7	33.8	33.2	17.8	27.2	37.6	29.6	44.3	57.8	60.9	26.2	23.9	35.7	57.8	28.8	45.2	40.2	52.6	59.0	65.7	34.4	37.8	75.8	46.1	42.0	32.0	38.4	59.1	53.0	47.2	27.6
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485721-134575017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 179.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 179.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	23.9	15.2	7.4	14.0	9.8	30.2	16.1	10.0	13.7	13.1	6.8	16.4	10.0	12.9	16.9	12.4	12.2	11.3	25.1	7.5	10.9	16.4	21.9	11.8	18.5	9.4	9.1	16.2	17.0	18.8	12.7	14.4	9.7	14.5	14.3	22.0	16.0	15.9	41.5	14.8	11.2	16.4	7.7	16.2	14.7	45.2	9.3	27.5	18.9	29.0	17.4	15.7	12.5	11.7	32.9	12.6	26.2	17.5	36.9	30.7	24.6	35.1	29.1	26.7	21.9	11.8	13.7	36.5	21.0	24.4	26.0	18.6	14.5	18.0	32.3	41.7	7.4	47.9	15.0	16.1	25.3	30.5	22.0	26.4	23.3	14.8	47.1	28.8	27.9	48.2	14.7	31.3	32.4	20.1	37.7	34.5	18.4	20.1	16.9	23.5	38.7	52.8	23.7	20.3	14.8	14.6	31.2	12.1	47.3	30.2	24.7	38.1	30.1	30.1	18.4	30.3	26.9	27.1	21.9	46.7	33.4	30.8	39.2	72.7	20.1	34.3	12.7	20.6	16.9	15.9	12.2	16.5	24.6	22.2	17.2	13.1	179.4	20.3	29.5	16.3	16.8	12.7	7.4	9.8	10.0	13.7	7.5	10.9	9.4	9.1	9.7	7.7	9.3	11.7	19.9	19.2	27.6	39.2	25.5	10.7	14.6	22.6	13.6	31.6	16.8	22.5	84.7	22.8	23.1	7.3	20.9	25.3	16.5	11.8	31.3	25.8	93.2	21.8	23.6	21.0	13.1	26.5	63.5	20.0	26.0	25.8	14.8	17.9	52.6	25.2	14.6	17.3	29.4	32.0	58.3	16.0	16.2	27.7	12.8	54.9	23.9	25.1	17.8	28.1	30.2	26.3	19.6	71.4	67.8	21.0	16.2	25.9	27.3	19.2	12.5	29.6	31.1	43.8	19.7	31.7	25.1	139.1	51.7	17.3	9.8	17.4	20.6	18.8	16.2	16.2
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	15.9	5.8	11.2	6.9	11.3	4.6	14.1	13.8	11.6	15.3	8.5	12.1	5.5	16.9	6.1	9.8	13.7	10.1	13.9	12.3	9.5	7.1	2.6	7.8	10.0	10.5	9.2	21.6	9.1	9.9	5.9	10.2	10.9	11.0	7.0	7.4	10.7	12.3	26.7	11.8	7.5	14.3	8.1	9.2	8.1	6.0	10.1	10.6	9.6	27.7	8.5	10.3	10.5	11.0	3.9	6.9	13.2	9.7	11.6	13.0	24.2	3.7	6.5	5.6	4.9	5.4	3.4	6.6	4.5	6.7	5.7	5.3	8.7	5.6	5.8	8.0	7.5	9.0	2.5	6.5	3.2	5.1	6.1	12.3	7.8	5.1	7.1	9.8	16.1	13.5	8.4	20.7	7.1	4.5	8.6	9.4	13.3	7.1	5.5	8.9	15.9	7.8	5.0	5.1	23.1	15.7	7.3	5.3	7.9	8.0	3.1	3.3	6.4	5.2	7.1	8.2	3.7	22.4	6.5	15.3	2.8	3.9	6.4	0.9	1.3	0.3	2.3	2.5	2.6	2.6	5.4	4.3	3.5	3.6	8.3	5.2	1.1	4.4	5.0	7.2	4.4	2.5	11.2	11.3	13.8	11.6	12.3	9.5	10.5	9.2	10.9	8.1	10.1	11.0	72.0	28.9	10.9	17.9	13.2	7.1	14.2	15.5	22.2	26.7	11.8	13.6	16.7	8.6	15.5	9.2	25.0	15.4	15.4	3.6	9.8	10.3	3.7	11.2	22.2	47.1	13.1	7.2	28.8	21.4	7.5	17.8	9.2	19.8	6.3	24.9	28.5	6.9	9.4	23.5	31.6	5.8	8.2	7.2	14.4	6.2	37.9	18.9	7.2	22.5	18.4	15.5	8.2	22.6	21.2	8.9	4.3	27.1	6.9	8.9	2.8	9.0	15.0	21.3	32.9	30.5	18.5	11.6	23.9	10.1	5.8	34.1	16.1	9.9	11.2	7.3
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3"	"Group enriched"	"Detected in many"	10	"B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	7.5	12.0	20.1	6.3	20.9	5.9	13.3	24.1	22.3	30.6	16.2	17.6	56.2	20.9	21.6	12.0	30.6	13.1	15.8	18.1	25.4	21.4	29.4	14.7	5.5	22.1	21.8	18.5	24.1	21.8	15.6	3.9	21.8	21.0	18.1	35.8	8.7	21.7	18.0	6.8	19.0	11.7	20.5	6.1	13.1	69.0	23.9	42.4	39.2	20.8	6.9	12.1	11.7	22.7	53.7	11.1	25.3	30.8	15.2	16.9	23.5	10.4	19.4	14.0	20.5	15.5	27.9	12.5	24.0	19.2	53.1	23.0	23.2	20.6	31.1	22.2	15.3	35.7	26.0	20.1	24.2	1.6	12.5	92.3	11.7	10.6	26.2	37.0	20.5	40.1	26.6	40.5	23.1	20.1	38.4	2.1	15.0	13.9	24.6	41.7	32.9	32.3	26.9	23.8	30.7	19.8	54.5	12.7	60.8	28.4	64.3	17.7	12.1	10.3	19.0	21.3	12.9	37.2	22.1	42.6	22.9	3.3	35.7	0.2	0.0	0.1	2.8	0.1	3.3	1.7	2.1	2.3	0.0	1.4	4.1	4.0	0.2	2.3	0.0	0.1	1.3	1.2	20.1	20.9	24.1	22.3	18.1	25.4	22.1	21.8	21.8	20.5	23.9	22.7	7.0	32.1	69.3	44.1	4.8	9.7	46.3	14.0	22.2	15.8	11.8	9.8	34.3	22.8	27.4	20.2	35.5	8.1	4.6	10.5	72.4	24.9	222.5	114.0	14.9	7.7	15.6	13.7	51.8	17.6	4.4	11.8	16.3	52.6	20.8	21.9	6.1	14.7	2.4	21.9	48.5	11.1	8.2	0.3	3.0	299.3	9.9	2.3	10.6	19.7	0.6	26.4	2.1	60.8	30.5	12.7	8.1	12.8	9.2	29.5	3.3	21.1	34.5	31.1	6.6	17.5	12.4	163.6	9.5	18.6	8.1	9.6	8.9	9.5	23.9	28.6
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612340-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.3"	"Cell type enriched"	"Detected in many"	4	"Melanocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;NK-cells: 4.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;HeLa: 40.0"	"Region enriched"	"Detected in many"	8	"cerebellum: 14.1"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Centrosome	"Nucleoplasm, Mitochondria"	"HPA058235: AB_2683649, HPA074879: AB_2686720"	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	1.1	0.9	1.3	1.9	1.2	3.1	1.4	1.5	1.3	1.6	0.8	1.2	1.4	1.3	1.0	2.2	1.6	1.5	0.9	1.4	0.6	1.4	2.1	1.4	2.7	0.7	0.8	2.8	1.9	1.2	1.5	0.7	0.8	1.3	0.8	1.1	1.7	0.8	0.7	2.4	1.6	0.9	0.6	1.8	1.8	7.3	0.9	3.0	1.8	0.6	1.4	1.2	1.7	1.8	7.5	11.9	10.6	15.0	0.9	1.0	19.1	3.2	1.4	7.1	6.2	10.8	11.2	8.8	8.2	1.4	13.2	7.1	7.5	5.4	2.8	46.0	11.8	9.7	40.0	4.3	1.3	11.3	6.3	1.1	2.3	6.1	4.1	1.4	2.8	17.0	10.1	10.1	3.5	5.7	17.1	9.8	7.0	6.4	11.1	12.8	6.1	12.2	2.3	5.8	8.1	6.2	23.3	7.6	2.0	3.3	7.6	8.7	0.9	6.8	9.9	6.5	4.6	6.3	6.4	8.8	4.2	15.7	7.3	0.0	0.3	0.3	1.3	0.1	1.7	1.4	1.1	1.2	0.1	1.6	1.6	1.6	0.0	4.5	0.6	0.4	1.5	0.8	1.3	1.2	1.5	1.3	1.4	0.6	0.7	0.8	0.8	0.6	0.9	1.8	0.7	3.2	1.5	1.3	2.9	5.7	0.9	2.4	0.6	2.5	1.1	1.8	2.2	2.8	1.0	0.0	0.0	1.2	1.1	1.1	0.0	2.5	4.0	2.4	1.5	1.1	0.0	4.2	2.5	0.9	5.1	1.0	3.6	1.9	0.0	3.8	0.4	1.7	1.4	3.3	1.3	0.7	4.1	0.8	2.9	2.2	1.2	0.7	135.2	1.0	1.4	0.9	2.1	2.0	3.9	2.3	0.5	2.6	4.7	1.1	0.1	0.5	3.4	2.0	0.0	1.3	1.1	30.7	10.1	2.8	3.7	1.6	1.9	0.9	1.3	2.5
CEP76	"C18orf9, FLJ12542, HsT1705"	ENSG00000101624	"Centrosomal protein 76"	Q8TAP6	18	12661833-12702777	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 209.7;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 60.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 55.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.3"	HPA039395	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039395: AB_10673357"	"unprognostic (3.39e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.00e-4)"	"unprognostic (7.88e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.21e-2)"	3.0	3.4	2.5	2.6	2.5	6.2	3.8	7.7	3.3	3.4	2.6	2.9	2.7	3.3	5.1	5.3	2.7	2.6	2.7	2.3	2.5	3.1	4.8	2.7	3.8	2.3	2.4	3.2	2.3	2.5	2.2	3.4	2.5	2.8	3.9	4.5	2.9	2.8	3.2	4.0	3.1	3.3	2.3	2.5	2.8	8.2	2.6	7.9	3.7	3.5	4.7	3.2	2.8	2.6	7.3	7.2	12.1	5.9	7.1	3.8	11.7	8.4	9.4	16.1	12.5	16.6	8.5	9.7	7.3	5.5	9.4	5.6	12.1	5.3	13.7	6.1	9.8	8.5	8.0	14.1	5.3	20.0	9.5	3.0	5.3	9.5	6.2	4.5	8.5	13.5	14.5	14.3	10.4	5.5	17.5	13.9	8.7	60.5	4.7	12.2	10.5	10.4	8.4	7.1	9.2	8.0	10.5	6.7	6.9	7.9	4.8	11.0	8.0	10.8	21.9	10.6	10.0	8.0	14.8	11.5	5.4	9.7	7.2	0.4	2.3	2.1	2.6	4.4	3.5	1.8	2.9	3.2	2.1	2.3	2.9	3.4	0.7	3.7	1.7	1.2	3.5	2.2	2.5	2.5	7.7	3.3	2.3	2.5	2.3	2.4	2.5	2.3	2.6	2.6	4.3	6.4	5.9	7.5	7.2	9.7	3.9	3.0	5.2	6.3	4.1	4.6	1.8	1.5	5.4	0.0	12.5	5.9	6.7	3.7	1.9	3.0	209.7	5.5	5.8	5.2	6.0	13.9	16.9	2.5	7.5	4.0	2.0	4.6	5.7	14.0	4.2	4.8	4.1	3.3	16.7	5.5	4.1	3.5	4.1	57.8	3.7	3.4	7.2	3.7	2.5	2.9	6.2	7.5	7.9	3.8	0.6	4.5	10.3	5.1	7.8	2.5	3.5	8.0	6.6	7.1	3.7	27.7	22.1	12.4	8.2	6.2	6.4	11.5	4.8	5.7
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 39.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 39.1;T-cells: 18.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"	2.2	2.9	4.3	4.6	5.0	12.3	4.3	5.9	4.4	4.1	3.8	3.5	2.8	5.6	3.2	3.5	3.4	2.4	1.6	4.2	4.7	3.6	3.5	3.4	6.2	4.6	4.5	4.3	2.5	4.3	2.7	3.9	4.6	3.1	3.9	9.2	3.3	3.4	1.6	3.5	2.9	4.7	5.1	5.0	3.0	15.1	4.3	11.5	3.7	1.7	7.7	3.2	3.0	6.2	31.7	14.5	33.3	20.5	5.4	9.4	22.3	25.6	10.1	15.1	19.1	2.7	8.4	28.9	12.7	9.2	21.4	36.9	49.6	13.7	22.5	24.3	16.6	15.4	17.1	11.4	4.9	26.0	14.6	5.2	2.9	17.1	11.1	7.5	23.4	29.4	12.2	22.4	19.8	20.3	32.6	12.8	35.2	32.7	14.0	32.2	38.4	8.4	9.0	14.0	30.4	21.1	33.7	10.6	8.4	22.7	12.6	6.9	12.5	13.3	22.6	27.5	24.7	13.1	17.8	18.4	11.8	17.6	23.0	0.7	0.8	0.7	18.3	3.4	8.9	5.0	7.9	16.0	2.3	3.4	3.9	12.8	0.5	39.1	5.5	4.2	13.1	8.3	4.3	5.0	5.9	4.4	4.2	4.7	4.6	4.5	4.6	5.1	4.3	6.2	10.3	25.6	9.2	26.1	13.7	5.1	8.1	6.9	8.0	27.1	7.6	10.5	8.9	4.3	7.2	1.8	110.5	14.0	106.8	3.9	5.9	8.4	14.1	18.7	16.9	9.0	7.7	25.7	28.6	6.7	19.5	10.3	10.2	10.4	5.1	20.6	7.1	9.0	9.6	3.3	20.5	8.0	4.1	6.1	6.1	9.9	14.9	10.0	1.8	9.4	9.7	14.7	249.3	27.2	24.6	4.7	4.1	15.1	43.7	3.7	1.0	5.1	22.1	49.4	0.0	14.8	11.3	82.1	34.2	10.0	4.8	4.0	34.0	12.3	13.2	4.0
CEP83	"CCDC41, NPHP18, NY-REN-58"	ENSG00000173588	"Centrosomal protein 83"	Q9Y592	12	94306449-94459988	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.1;Oligodendrocyte precursor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038161	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA038161: AB_10674547"	"unprognostic (4.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.59e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (5.00e-10)"	"unprognostic (1.29e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-2)"	5.5	7.9	4.7	5.3	4.7	6.9	6.8	5.3	5.3	6.0	7.3	5.4	3.9	6.2	6.0	5.1	11.5	3.9	15.2	5.1	4.4	6.1	5.1	5.4	6.0	5.5	6.5	7.8	9.7	5.5	5.1	4.5	5.5	5.2	7.1	5.3	4.1	2.8	5.1	4.9	4.3	4.5	5.6	5.3	5.1	18.6	4.7	5.3	7.1	3.3	5.9	4.6	5.4	6.1	8.2	9.1	15.1	14.2	6.5	8.7	12.9	14.2	4.5	10.1	10.3	11.3	6.7	21.3	3.0	4.3	6.4	11.4	18.3	10.9	15.5	12.5	13.3	12.7	9.2	11.5	6.5	20.9	8.3	5.7	8.9	8.4	25.6	5.9	9.6	17.1	16.6	8.5	10.6	8.3	14.3	34.5	17.2	14.0	16.6	19.4	14.2	21.6	9.1	10.2	15.6	6.5	11.9	13.9	9.9	13.3	9.5	13.0	5.7	11.8	7.3	5.9	11.3	11.1	13.3	19.3	4.9	21.8	11.4	0.6	2.5	1.5	3.8	2.5	3.6	4.7	3.9	3.1	5.7	4.8	4.0	3.6	1.0	4.6	1.2	6.1	5.2	1.5	4.7	4.7	5.3	5.3	5.1	4.4	5.5	6.5	5.5	5.6	4.7	6.1	10.3	16.0	10.7	37.5	17.9	0.0	15.3	0.0	23.9	12.9	12.7	11.7	39.0	1.5	11.8	3.7	14.6	6.8	9.4	8.9	1.9	4.7	55.4	109.1	26.3	8.0	14.9	14.9	51.7	3.5	9.6	13.3	17.3	17.0	26.6	17.8	2.9	5.2	5.7	5.0	45.6	11.9	0.0	4.6	0.0	16.6	10.8	11.6	0.0	46.9	15.1	4.9	11.3	74.4	55.0	3.5	5.2	6.4	17.4	15.0	1.9	5.5	48.1	12.0	0.0	24.9	7.8	45.4	24.0	18.4	0.0	3.3	10.5	15.2	12.5	13.2
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234200-26278808	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.9;tongue: 65.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 19.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.8	3.5	3.9	5.3	8.3	20.8	3.8	5.6	6.7	4.1	3.7	5.4	3.4	3.2	3.2	8.6	2.7	2.7	25.5	4.3	5.9	6.0	5.8	4.7	6.9	7.1	6.8	3.3	5.0	8.8	6.1	3.2	8.9	2.9	6.0	14.1	5.3	2.4	132.9	9.8	5.2	3.7	3.7	6.3	4.7	31.1	7.1	13.6	7.8	65.9	7.8	3.2	6.2	14.3	29.6	12.5	30.2	22.6	7.3	8.9	52.5	18.8	11.5	31.9	28.5	17.4	28.2	34.3	20.1	9.2	14.6	25.5	41.0	14.4	29.9	23.5	20.9	49.7	31.9	19.4	6.6	46.2	43.8	3.8	13.7	24.9	16.4	12.8	14.5	47.7	57.4	39.9	19.2	9.8	38.7	35.2	23.0	17.4	20.8	39.8	31.3	29.7	10.4	5.5	41.4	16.7	24.5	19.8	15.7	21.5	14.5	26.4	14.3	17.1	26.7	19.3	24.7	30.0	48.4	38.9	9.8	65.2	27.5	5.0	6.4	19.2	3.5	6.1	2.8	2.6	2.6	2.7	4.9	1.8	2.2	3.5	0.6	2.3	7.4	2.1	3.6	3.6	3.9	8.3	5.6	6.7	4.3	5.9	7.1	6.8	8.9	3.7	7.1	14.3	1.0	0.0	2.2	3.6	2.7	6.9	4.0	2.5	6.2	11.2	3.7	2.9	29.0	1.5	3.7	5.5	12.5	3.4	5.1	6.9	7.9	1.7	1.0	3.4	2.3	2.0	1.8	16.8	12.8	1.3	3.9	2.3	3.6	4.9	2.5	9.1	1.4	3.1	4.8	0.0	9.9	3.7	2.0	5.0	3.7	2.9	1.5	4.3	1.8	4.7	4.0	1.8	2.1	3.0	28.8	2.7	3.4	0.4	4.4	2.5	2.3	1.1	2.0	11.1	0.0	2.4	2.3	40.9	34.2	8.6	6.1	41.7	3.4	2.3	4.5	4.5
CEP85L	"bA57K17.2, C6orf204, NY-BR-15"	ENSG00000111860	"Centrosomal protein 85 like"	Q5SZL2	6	118460772-118710075	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 266.1;Early spermatids: 445.2;Late spermatids: 742.5;Oligodendrocyte precursor cells: 251.9;Oligodendrocytes: 189.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029137, HPA029138, HPA029139"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220"	"unprognostic (3.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.87e-5)"	"unprognostic (2.72e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-2)"	3.3	5.2	4.0	7.1	5.5	11.5	2.5	11.7	5.2	3.9	0.0	2.6	1.8	4.1	2.1	3.0	3.8	3.2	4.6	3.8	5.2	1.4	2.2	3.3	13.5	5.1	7.4	7.5	2.6	3.5	5.1	4.2	5.5	2.2	2.4	3.3	4.5	2.0	8.5	1.3	4.1	3.1	4.0	7.7	8.0	29.9	6.8	19.1	2.2	11.8	9.7	5.2	2.6	5.4	1.3	1.1	6.5	3.7	3.5	6.5	25.7	3.4	5.1	3.0	3.4	0.2	0.3	6.6	1.0	5.0	2.5	1.7	2.9	4.9	5.5	3.6	3.4	8.8	2.0	0.8	2.8	0.6	2.5	3.8	2.6	3.7	4.0	6.0	4.4	9.5	8.7	6.1	5.0	1.0	16.0	4.0	2.0	0.2	1.8	3.8	5.1	1.5	3.6	2.9	4.0	2.3	2.6	0.1	5.0	5.2	0.8	3.3	3.6	4.8	2.7	4.2	5.6	7.8	6.1	6.0	4.0	2.9	5.0	1.5	10.7	9.0	6.6	11.6	6.7	3.4	5.4	5.4	5.5	4.6	7.1	5.9	15.7	6.9	11.2	2.6	4.7	4.0	4.0	5.5	11.7	5.2	3.8	5.2	5.1	7.4	5.5	4.0	6.8	5.4	24.1	6.4	4.6	266.1	26.3	6.9	10.7	10.6	9.6	31.6	4.5	7.1	33.9	0.0	3.5	3.7	10.4	26.7	35.5	0.2	1.9	3.7	445.2	7.5	43.2	25.8	3.0	2.5	156.1	4.3	5.9	23.4	33.1	16.6	8.8	12.5	14.6	6.5	8.4	33.7	147.1	0.6	2.0	25.7	16.7	742.5	32.0	24.0	23.2	80.6	22.9	4.7	19.6	251.9	189.4	9.4	1.2	29.0	28.7	7.1	0.0	2.1	5.2	9.8	19.7	53.4	32.2	38.2	49.7	3.5	4.8	22.2	48.3	48.3	0.6	8.1
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506865-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052426, HPA052428, HPA061371"	Approved		Uncertain	"Centriolar satellite,Cytosol"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495"	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (5.78e-4)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	8.4	6.4	8.1	11.7	10.2	42.5	17.5	20.5	10.8	12.8	15.4	11.7	13.5	23.4	15.9	9.4	16.6	13.0	8.5	8.5	8.6	10.4	11.3	11.3	20.1	10.4	10.7	25.6	14.4	10.4	6.3	9.5	10.7	14.6	14.6	40.4	9.6	11.7	9.5	23.1	11.8	12.5	8.9	14.0	13.9	19.0	8.3	18.9	21.3	6.9	16.4	9.7	7.9	16.2	18.5	10.7	26.3	22.8	8.6	15.4	23.7	9.6	10.9	12.8	16.9	14.4	11.3	28.7	6.1	13.3	13.2	25.3	21.2	15.9	24.9	7.3	15.6	27.2	28.2	30.8	21.1	28.9	15.3	18.9	19.8	14.2	30.7	18.5	10.9	29.1	31.5	21.5	12.5	21.4	40.3	23.4	14.8	20.9	14.2	31.6	46.1	21.0	16.5	28.4	14.9	28.0	11.8	22.0	30.2	39.1	20.2	25.0	12.7	27.6	23.9	11.5	13.1	23.6	18.5	31.4	11.6	21.5	19.0	0.6	2.7	2.1	2.9	2.9	7.1	3.5	3.6	4.3	3.0	3.7	5.9	4.0	0.9	2.0	2.8	2.9	3.2	1.8	8.1	10.2	20.5	10.8	8.5	8.6	10.4	10.7	10.7	8.9	8.3	16.2	14.9	41.7	26.3	44.7	29.4	16.2	25.6	14.3	40.5	29.9	17.9	20.2	17.6	14.3	29.4	3.7	45.9	9.4	25.1	18.1	7.9	18.6	58.0	45.9	28.9	13.8	7.7	26.5	47.5	11.8	10.8	23.5	18.8	44.8	29.7	31.9	13.2	8.9	8.5	18.5	56.2	13.8	8.2	10.3	12.8	18.5	20.8	16.6	12.4	23.4	15.2	21.3	15.5	42.7	46.7	14.1	10.4	21.4	21.1	15.4	20.2	6.8	53.1	84.8	13.1	41.3	21.6	38.8	27.5	28.4	20.3	6.6	23.7	23.8	19.7	21.9
CEP97	"FLJ23047, LRRIQ2"	ENSG00000182504	"Centrosomal protein 97"	Q8IW35	3	101724593-101770562	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002980	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA002980: AB_1848820"	"unprognostic (7.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.05e-1)"	2.1	2.7	4.6	3.6	7.7	4.9	2.6	6.0	6.4	2.3	3.1	2.1	1.7	3.5	2.5	2.0	5.3	2.2	2.0	4.5	5.8	2.2	1.3	2.3	4.6	6.1	6.4	3.2	1.1	6.1	2.7	2.7	5.9	2.4	2.3	5.5	2.0	2.2	2.6	2.7	1.8	4.2	5.7	3.0	2.3	7.3	5.6	5.9	3.3	3.5	4.5	2.4	2.0	12.7	12.0	7.0	11.7	8.7	6.5	5.2	3.6	12.6	8.8	9.6	11.8	3.0	5.5	10.6	5.6	7.1	7.7	7.9	8.8	6.9	16.1	11.5	4.3	6.0	7.6	2.2	3.2	7.6	8.9	3.0	5.6	8.2	6.9	5.1	5.4	10.4	4.9	17.9	11.8	3.6	12.4	4.0	4.2	4.3	9.1	9.0	16.1	7.2	3.3	4.5	22.4	9.2	6.8	4.5	6.1	6.1	7.4	6.8	5.4	12.9	9.5	3.8	9.4	11.3	11.0	18.3	5.3	6.8	13.0	2.1	0.1	0.6	0.7	0.0	0.5	1.0	0.6	0.4	0.1	0.5	0.4	0.3	0.9	0.3	0.4	0.4	0.8	0.2	4.6	7.7	6.0	6.4	4.5	5.8	6.1	6.4	5.9	5.7	5.6	12.7	8.7	3.2	6.2	24.5	9.1	4.7	2.4	4.7	9.1	13.6	5.2	4.3	7.0	4.3	9.6	1.8	12.5	3.7	14.6	1.6	3.9	4.4	20.7	32.7	14.3	6.4	4.2	9.1	28.6	2.1	2.9	8.8	5.1	10.4	9.5	14.5	3.9	4.1	2.8	18.5	36.0	3.7	10.2	3.1	2.7	9.1	7.8	3.0	8.8	8.4	3.4	19.6	4.1	50.8	96.5	4.0	1.0	7.5	24.0	1.8	0.9	3.1	42.5	14.6	13.1	13.1	8.6	30.4	11.9	8.0	3.7	1.9	9.2	11.0	3.3	1.5
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722733	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"epididymis: 1.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 4.0;NTERA-2: 7.0;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"			"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536672-181680665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.1;retina: 16.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 43.5;Proximal tubular cells: 13.4;Respiratory ciliated cells: 38.7;Rod photoreceptor cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 58.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.5	0.3	0.2	0.6	0.0	1.0	9.7	0.4	3.1	6.0	2.3	0.2	0.8	0.3	0.5	7.8	0.7	0.5	0.8	0.6	8.0	1.3	5.1	0.9	1.8	2.0	0.3	0.7	0.6	0.7	0.1	1.8	1.0	0.3	16.6	1.0	0.2	0.4	0.4	6.8	0.2	1.8	17.1	1.2	0.5	0.4	0.4	0.9	0.3	1.9	1.3	1.2	1.8	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.4	0.0	0.3	0.2	0.0	0.3	2.0	0.0	0.4	0.3	0.4	0.0	0.0	0.6	0.5	0.1	0.3	0.6	0.0	0.5	0.9	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.8	0.4	0.0	0.4	1.2	0.0	0.0	0.9	0.0	58.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.8	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	9.7	0.4	0.8	0.6	1.8	2.0	1.8	1.8	0.4	1.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	1.0	0.0	0.5	0.0	0.0	0.7	1.5	4.9	0.0	18.8	0.0	1.5	0.0	9.8	0.0	4.6	43.5	0.7	0.3	1.8	0.0	6.8	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	2.7	13.4	38.7	22.8	0.0	0.2	0.5	0.4	0.9	0.0	0.0	0.0	0.6	0.0	1.2	0.0
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 298.6;choroid plexus: 92.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 126.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.5;melanoma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	0.9	3.1	206.4	0.8	244.8	0.2	0.6	256.1	216.6	2.1	92.2	3.5	0.1	0.7	0.5	1.0	0.7	2.5	4.3	218.8	200.4	0.8	0.2	0.5	0.0	298.6	233.8	2.8	0.9	2.9	12.8	0.3	240.9	1.4	0.2	4.8	0.9	0.5	21.3	0.6	1.0	1.5	247.7	0.2	1.2	29.3	251.3	0.3	1.0	12.3	0.1	1.7	1.7	248.3	0.2	3.3	19.1	32.1	1.1	0.4	0.8	2.2	0.1	5.4	3.9	15.7	1.2	0.1	22.0	1.4	4.4	0.3	13.8	0.6	2.1	0.0	34.7	0.2	0.7	11.7	2.4	3.4	0.5	1.2	0.2	1.7	0.6	6.0	1.3	0.2	2.2	0.2	3.7	8.4	0.3	39.3	25.2	0.1	0.7	0.2	0.6	0.7	4.1	0.0	17.8	15.8	0.8	0.1	14.1	6.0	5.5	20.5	0.5	0.1	4.3	3.4	4.8	0.7	0.5	0.1	0.2	1.2	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	206.4	244.8	256.1	216.6	218.8	200.4	298.6	233.8	240.9	247.7	251.3	248.3	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.6	0.6	1.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	21.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.0	1.0	0.0	1.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	126.6	1.2	0.2	1.8	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	1.6	0.0	1.0	0.4	1.4	2.9	0.0	0.4	0.3	0.1	0.4	0.0	0.0
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129289-50167533	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006780, HPA026589"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA006780: , HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	26.2	22.3	27.6	4.8	28.5	5.1	26.6	29.7	48.1	37.2	27.4	24.1	3.0	30.5	12.0	24.0	28.2	6.9	16.2	27.7	29.6	44.1	14.2	22.9	6.1	28.3	28.6	35.1	22.9	9.1	42.3	5.5	28.9	31.2	2.9	5.5	21.5	3.5	5.5	34.1	20.6	4.6	27.5	29.2	21.6	13.8	29.5	7.6	24.8	2.3	3.7	29.5	29.2	29.0	12.1	13.2	17.1	3.5	6.5	3.9	10.6	23.3	6.6	8.0	7.4	36.2	13.9	10.6	20.2	24.4	7.7	7.9	6.1	4.4	6.7	23.4	12.7	6.1	11.2	23.2	16.5	8.0	12.4	19.4	13.9	11.6	6.3	18.7	11.9	10.0	6.1	10.8	8.6	18.7	15.4	45.6	8.2	4.1	7.0	10.7	4.3	12.7	28.7	17.7	5.2	6.9	10.3	9.4	33.6	10.7	13.0	9.9	10.6	17.6	10.2	11.6	8.0	8.1	14.3	11.6	12.8	5.9	8.4	36.3	23.0	42.4	37.0	37.4	28.7	22.0	28.6	28.6	26.8	30.6	20.1	28.9	41.2	39.6	55.1	36.0	37.1	37.1	27.6	28.5	29.7	48.1	27.7	29.6	28.3	28.6	28.9	27.5	29.5	29.0	14.9	19.2	18.4	22.5	17.7	17.3	20.9	29.1	12.0	41.0	11.5	9.8	6.8	14.3	16.5	14.7	20.9	32.9	23.1	8.1	7.9	21.2	0.9	7.7	16.7	17.2	15.6	9.1	47.7	14.0	65.2	21.9	10.7	11.8	15.2	15.0	18.2	4.6	19.0	32.0	56.1	7.9	28.5	17.9	18.3	2.2	16.8	14.3	12.4	20.6	26.6	21.3	24.7	40.2	34.8	19.0	6.8	17.3	12.7	15.5	14.2	7.7	8.6	44.3	32.9	18.2	20.8	7.6	8.1	9.3	14.3	33.7	22.1	15.7	6.7	14.7
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168456249-168775134	"Metabolic proteins, Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 271.7;Inhibitory neurons: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044683	Approved					NA	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044683: AB_10965059"	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	13.4	14.3	10.1	10.1	11.6	12.5	13.5	11.8	17.4	12.7	2.4	28.2	25.8	11.6	18.1	13.7	6.7	8.5	27.6	12.9	14.4	13.2	13.3	7.6	8.6	4.1	7.4	15.3	7.6	12.3	4.7	9.4	7.9	12.9	30.2	9.2	3.6	13.3	6.0	19.1	32.2	11.0	9.0	6.9	24.1	12.0	8.8	24.9	27.2	10.7	8.3	12.6	6.9	8.1	15.8	14.2	24.2	27.8	58.8	43.2	0.1	15.5	16.1	16.7	22.2	22.2	33.8	0.0	21.7	14.1	23.3	28.9	32.2	36.6	27.6	0.0	21.4	29.1	13.8	15.9	51.5	61.1	13.4	48.7	102.1	34.7	27.3	16.0	8.5	42.2	15.8	0.1	34.6	17.2	54.0	16.9	22.4	33.6	20.0	41.3	45.5	27.3	15.5	46.9	32.6	39.4	15.0	38.2	8.2	19.9	34.0	34.4	4.7	41.3	17.3	11.3	27.1	0.3	0.0	0.1	26.8	31.8	28.2	0.6	1.0	0.0	0.1	0.7	0.3	0.1	0.3	0.1	0.8	0.4	0.9	0.7	0.1	0.7	0.6	5.4	0.0	0.3	10.1	11.6	11.8	17.4	12.9	14.4	4.1	7.4	7.9	9.0	8.8	8.1	7.0	6.4	10.3	114.3	10.2	108.8	55.2	37.4	38.1	24.1	42.4	30.6	45.1	21.5	33.6	11.0	0.0	0.7	45.2	79.1	0.0	14.0	6.8	7.9	20.3	13.4	103.8	15.3	271.7	22.5	3.4	11.3	57.6	18.9	10.2	15.2	12.8	43.8	24.3	37.0	293.2	92.2	20.3	49.4	54.1	3.6	19.9	40.8	10.6	37.5	77.8	28.1	6.2	124.7	10.3	17.9	48.3	39.9	9.8	40.3	63.7	9.3	49.2	3.0	65.7	13.4	28.8	3.0	9.4	34.9	92.8	0.5	10.1	15.7	115.8	46.3
CERT1	"CERT, COL4A3BP, GPBP, STARD11"	ENSG00000113163	"Ceramide transporter 1"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 132.3;WM-115: 118.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	38.1	26.1	12.4	16.5	16.1	27.2	17.6	18.0	15.4	33.9	14.0	20.8	18.7	20.6	15.1	24.9	22.4	23.3	20.8	14.0	15.1	27.9	31.2	24.3	20.3	14.7	17.5	23.1	16.4	26.1	8.0	22.9	16.7	24.3	19.6	18.2	14.0	19.9	28.9	18.7	21.1	18.3	14.7	25.3	23.5	28.8	15.5	21.2	49.9	28.3	22.7	23.7	16.0	17.6	44.9	22.7	21.6	19.0	132.3	36.6	29.0	24.8	30.8	18.8	24.8	34.4	25.3	21.5	52.3	26.9	25.8	26.7	33.4	34.4	28.6	27.1	15.2	18.2	24.4	18.4	33.6	18.2	20.1	27.9	23.8	22.3	24.9	30.5	22.1	28.3	33.0	32.0	25.0	23.0	21.6	13.2	27.9	10.2	16.8	18.0	28.5	20.2	30.5	54.0	16.4	16.5	31.6	21.6	31.8	45.4	21.3	30.5	30.1	12.6	15.1	22.8	20.3	29.1	41.6	24.8	21.4	30.7	118.2	9.6	19.8	16.0	8.2	22.4	7.8	9.1	8.3	7.7	14.5	9.1	7.7	7.8	29.6	7.8	25.4	8.3	13.0	9.0	12.4	16.1	18.0	15.4	14.0	15.1	14.7	17.5	16.7	14.7	15.5	17.6	23.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	17.7	20.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	16.8	10.5	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	27.8	3.8	0.0	0.0	0.0
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 703.3;liver: 345.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.8	38.1	21.2	18.1	20.6	6.3	13.5	24.1	23.0	22.0	25.6	191.2	703.3	14.6	14.4	132.7	17.9	19.5	51.4	22.1	20.6	96.5	345.7	15.6	11.9	20.8	20.8	17.0	14.4	38.0	15.7	10.1	20.6	16.7	178.8	16.2	32.9	15.0	33.8	32.7	576.5	19.7	20.0	12.4	41.6	9.3	20.9	13.1	27.9	14.3	20.8	13.7	33.5	20.5	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.6	24.1	23.0	22.1	20.6	20.8	20.8	20.6	20.0	20.9	20.5	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961245-66975149	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.2;liver: 52.5;skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.8	0.5	3.1	3.2	2.7	0.9	2.3	2.5	2.9	1.3	1.3	38.2	30.0	0.7	0.2	4.2	2.9	0.9	0.7	3.8	2.0	12.2	52.5	0.7	0.3	3.3	2.7	0.6	4.1	1.0	1.9	0.6	3.5	0.5	31.3	0.6	12.0	0.3	24.7	1.2	23.7	1.2	1.4	0.4	7.7	1.1	2.2	0.2	0.4	1.5	0.2	0.1	0.8	2.2	0.4	3.1	0.3	7.4	0.2	0.2	1.2	0.2	0.2	0.3	0.5	0.5	3.8	8.5	2.4	0.0	0.2	0.6	1.1	0.5	0.1	1.5	5.5	4.3	1.3	2.6	0.0	0.9	0.7	0.3	0.9	0.8	0.1	0.2	0.0	13.5	2.8	1.7	0.3	1.1	1.4	1.4	1.5	2.6	0.4	1.3	0.7	1.3	0.1	0.4	0.4	0.8	0.2	5.8	0.2	0.6	5.0	6.5	0.3	0.4	2.4	0.7	0.2	0.9	3.6	1.3	0.3	7.2	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	3.1	2.7	2.5	2.9	3.8	2.0	3.3	2.7	3.5	1.4	2.2	2.2	0.1	3.2	6.7	0.7	0.4	0.5	0.0	1.3	1.2	0.2	9.1	5.7	1.4	2.8	0.9	0.0	0.0	0.0	0.0	120.1	0.0	0.2	0.5	3.2	0.3	0.2	19.7	0.0	1.8	0.9	0.0	0.2	11.7	4.4	1.3	58.5	0.4	53.4	0.3	0.0	2.9	32.0	0.0	3.2	0.9	5.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	1.5	0.1	1.0	67.0	1.2	0.1	0.1	66.0	9.9	4.8	0.2	0.0	0.6	0.2	2.3	2.9	1.1	0.3	0.0	0.4	0.1	44.3	0.2
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 16.9;skin 1: 13.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 44.4;Excitatory neurons: 53.6;Oligodendrocytes: 37.6;Respiratory ciliated cells: 47.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.3"	"Region enhanced"	"Detected in many"		"white matter: 10.2"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.1;HMC-1: 5.2;PC-3: 4.5;SiHa: 7.8;SK-BR-3: 5.7;U-266/70: 5.9"	"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.6	1.5	1.2	0.8	2.6	1.2	2.5	0.1	2.5	1.0	0.0	0.6	0.8	0.5	3.9	1.0	16.9	0.8	2.4	2.3	1.0	2.6	8.4	1.5	0.7	1.7	0.2	1.0	1.1	3.1	3.6	1.0	1.2	0.9	0.7	0.8	4.3	2.1	4.9	13.6	0.8	0.3	0.0	0.5	1.4	0.8	0.8	0.7	2.7	0.2	0.9	1.2	0.7	10.2	0.2	1.5	0.1	0.0	0.9	0.8	0.0	0.4	0.7	0.1	0.0	0.0	2.3	0.0	0.0	1.5	0.0	0.7	0.0	0.2	0.0	19.1	0.0	0.0	1.2	0.0	0.1	0.0	5.2	1.8	3.5	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	4.5	0.2	0.0	1.1	0.0	0.3	1.4	0.9	7.8	5.7	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	5.9	2.2	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.5	2.5	0.5	0.6	1.0	0.5	0.8	0.0	0.9	0.2	0.0	0.0	3.5	1.2	0.3	0.7	1.2	2.6	0.1	2.5	2.3	1.0	1.7	0.2	1.2	0.0	0.8	10.2	0.4	0.0	11.4	2.0	3.5	5.4	5.7	5.0	3.4	23.1	44.4	7.7	2.8	4.3	7.3	5.5	14.6	4.7	3.9	4.1	1.9	0.9	1.7	9.9	1.4	1.0	9.0	0.0	53.6	1.6	0.9	3.9	3.1	11.1	9.5	4.9	1.1	22.1	5.6	0.0	29.7	1.8	4.1	4.1	2.1	1.2	13.7	3.2	0.0	4.7	5.7	8.3	4.1	6.6	37.6	0.9	9.7	12.8	1.3	3.5	5.8	1.5	47.1	15.3	0.0	1.5	1.8	32.1	11.8	4.1	5.3	4.5	3.3	13.5	3.5	7.5
CETN1	"CEN1, CETN"	ENSG00000177143	"Centrin 1"	Q12798	18	580380-582114	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1084	"testis: 134.3"	"Group enriched"	"Detected in some"	34	"Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001470, HPA028956, CAB037244, HPA069157"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: "															"unprognostic (1.51e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	930.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.6	12.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	675.9	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826994-152830757	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 243.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001470, HPA028956"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA001470: , HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favorable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	30.2	41.0	61.8	19.8	62.3	26.2	40.3	58.3	80.4	64.6	90.5	54.6	15.2	57.6	116.2	37.2	243.6	31.7	34.6	60.6	65.8	74.7	31.5	39.8	16.0	68.0	75.8	57.2	24.0	55.7	73.9	21.4	70.4	50.3	25.8	40.1	24.4	77.7	19.6	23.8	21.6	54.8	67.4	16.8	29.3	23.3	64.8	21.0	67.2	20.2	21.9	37.3	36.1	67.1	145.2	65.0	78.8	59.6	102.5	110.5	31.4	61.6	73.8	79.9	60.9	29.5	75.8	51.6	157.8	83.1	128.8	55.3	55.3	76.7	94.1	23.2	40.0	11.5	32.1	86.6	38.5	48.7	12.5	67.0	99.2	74.1	39.1	95.4	64.0	40.3	31.0	20.9	78.3	67.9	36.4	53.0	27.5	119.9	82.6	31.9	57.2	53.2	146.9	35.4	38.5	50.0	41.2	42.2	38.2	70.8	45.4	37.2	59.8	56.0	44.9	111.9	69.9	20.9	29.7	81.0	118.3	28.9	28.0	19.9	11.4	35.9	11.7	13.6	14.2	11.9	11.5	13.1	13.5	9.7	12.2	12.5	10.9	12.3	13.7	20.0	10.5	11.8	61.8	62.3	58.3	80.4	60.6	65.8	68.0	75.8	70.4	67.4	64.8	67.1	21.6	51.3	35.7	3.9	19.2	22.6	52.4	201.6	21.6	13.6	46.1	47.6	37.1	64.3	155.8	169.2	6.2	66.6	16.2	13.8	238.7	100.3	60.1	639.9	65.4	29.6	37.1	33.2	4.2	41.1	69.8	42.9	12.2	68.7	24.6	41.0	44.3	96.5	50.0	13.5	3.5	31.7	150.5	23.7	21.3	72.5	67.7	27.3	37.4	1.9	27.8	104.4	20.6	0.5	2.5	39.6	16.0	111.7	16.6	29.3	15.4	345.8	1116.5	29.4	19.7	22.7	64.2	76.5	70.4	33.7	30.5	41.5	19.7	51.8	29.2	42.4
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 130.4"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.4	21.6	18.5	14.7	20.6	7.6	24.0	19.3	26.3	20.6	19.0	16.9	9.7	20.0	21.8	13.5	22.7	10.3	22.1	18.3	20.0	19.8	13.5	13.4	19.1	21.2	19.6	31.0	9.3	24.4	16.8	19.3	21.2	19.0	19.6	35.3	15.1	14.7	14.4	15.4	10.6	13.9	19.3	15.1	12.9	130.4	19.8	20.6	15.2	14.1	21.0	11.3	11.7	27.1	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	18.5	20.6	19.3	26.3	18.3	20.0	21.2	19.6	21.2	19.3	19.8	27.1	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394909-126436556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 23.3;choroid plexus: 30.6;fallopian tube: 27.1;testis: 32.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 316.1;Late spermatids: 703.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046354	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA046354: AB_2679634"	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.0	0.0	5.2	0.0	4.9	0.0	0.0	2.1	2.0	3.1	30.6	0.0	0.0	1.0	0.0	0.0	27.1	0.0	0.0	5.2	4.5	0.1	0.0	6.2	0.1	16.6	23.3	0.1	0.0	0.0	0.3	0.0	9.8	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	32.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.9	2.1	2.0	5.2	4.5	16.6	23.3	9.8	11.8	5.3	6.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	316.1	60.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	703.3	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.8	48.1	0.0	6.6	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFAP126	"C1orf192, Flattop, Fltp"	ENSG00000188931	"Cilia and flagella associated protein 126"	Q5VTH2	1	161364733-161367876	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 151.6;skeletal muscle: 84.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 120.4;Endometrial ciliated cells: 242.9;Respiratory ciliated cells: 201.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045904	Enhanced					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA045904: AB_10960411"																		11.6	13.4	8.5	5.2	11.4	2.9	0.7	12.0	7.9	4.4	30.8	4.9	10.4	10.4	0.7	18.4	151.6	11.7	39.5	3.7	10.5	16.7	9.9	14.0	7.7	9.7	14.0	12.2	9.7	0.1	3.6	3.6	14.4	6.8	0.0	32.8	12.7	0.9	84.2	18.8	11.1	0.1	11.4	6.3	7.6	24.2	14.3	0.8	26.3	0.1	0.2	5.3	0.0	17.4	9.2	16.2	18.4	16.8	0.4	0.2	12.5	14.9	0.0	0.0	0.0	37.0	13.6	2.2	34.8	0.0	2.8	20.2	0.1	0.0	0.0	19.8	16.9	7.9	16.4	12.8	0.1	10.4	6.0	0.4	0.0	0.0	0.0	30.1	0.0	12.4	26.1	1.3	0.0	12.5	7.8	4.4	12.9	32.0	7.4	4.0	12.9	12.0	0.9	17.0	17.7	19.3	28.8	24.2	17.5	45.6	34.3	15.9	26.1	9.5	4.9	31.6	9.1	16.8	40.1	19.6	19.7	13.5	10.2	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.3	0.3	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.1	8.5	11.4	12.0	7.9	3.7	10.5	9.7	14.0	14.4	11.4	14.3	17.4	0.0	6.4	4.1	0.7	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.4	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	120.4	242.9	1.4	0.8	0.0	0.0	0.2	0.0	0.1	0.7	0.0	2.5	2.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.6	0.3	0.5	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.0	1.0	0.0	2.5	201.9	0.3	0.0	0.6	0.1	27.3	0.7	0.0	0.0	0.0	0.4	0.2	0.0	0.4
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706988-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;choroid plexus: 35.9;fallopian tube: 59.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 56.8;Endometrial ciliated cells: 153.5;Late spermatids: 85.0;Respiratory ciliated cells: 189.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 7.3;HeLa: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.2	0.3	2.4	0.1	1.4	0.1	0.2	0.8	0.4	9.1	35.9	0.1	0.0	1.1	1.8	0.8	59.5	0.6	0.3	3.2	3.3	0.5	0.1	11.2	0.4	12.6	18.6	0.4	1.1	0.2	4.7	0.2	7.2	0.3	0.0	0.1	0.5	0.2	0.3	0.6	0.1	0.1	7.5	0.3	0.2	10.1	2.6	0.1	0.4	0.0	0.0	0.4	0.1	1.9	1.4	7.3	0.9	1.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.8	0.8	1.4	1.0	0.0	1.6	3.6	0.0	0.0	0.0	2.8	1.2	0.8	6.2	1.7	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.5	0.0	2.1	2.9	0.4	0.0	5.0	1.1	0.4	0.7	1.5	3.6	2.0	1.1	1.2	0.0	0.3	5.1	1.0	1.7	2.9	0.4	0.1	2.4	0.4	1.5	1.6	1.4	4.1	0.8	0.7	2.3	0.9	0.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.8	0.4	3.2	3.3	12.6	18.6	7.2	7.5	2.6	1.9	0.2	9.6	10.5	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.3	0.6	0.0	0.0	27.9	0.0	0.0	0.1	0.1	0.2	1.9	0.3	56.8	153.5	1.9	0.8	0.0	0.0	0.0	0.0	0.1	1.0	0.0	4.8	2.5	0.1	0.4	0.2	0.2	0.0	0.0	0.6	0.0	0.6	0.0	85.0	0.3	0.5	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.1	0.7	0.1	0.4	0.5	0.4	189.5	0.4	0.0	0.4	0.3	14.3	0.9	0.0	0.0	0.0	0.3	1.4	0.3	0.2
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 34.8;fallopian tube: 15.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HEL: 84.4;K-562: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076975	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.4	0.1	0.8	0.1	1.2	0.6	0.2	4.3	1.1	0.6	34.8	0.1	0.0	0.6	0.6	0.1	15.8	0.2	0.6	1.2	0.6	0.3	0.2	2.7	0.1	2.5	3.5	0.1	0.2	0.3	1.7	1.3	2.0	0.1	0.0	1.3	0.2	0.2	0.2	0.5	0.1	0.2	3.0	0.5	0.2	6.4	1.2	0.0	0.6	0.8	0.2	0.2	0.1	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	84.4	0.2	0.2	0.0	0.0	11.0	0.0	0.0	0.3	1.0	0.0	1.7	0.0	29.2	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	1.2	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	3.4	0.8	1.2	4.3	1.1	1.2	0.6	2.5	3.5	2.0	3.0	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	26.5	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	23.3	0.6	0.0	0.0	0.0	15.6	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP20	"C16orf80, fSAP23, GTL3"	ENSG00000070761	"Cilia and flagella associated protein 20"	Q9Y6A4	16	58113592-58129381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018195	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA018195: AB_1850408"	"unprognostic (9.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.47e-1)"	20.3	23.8	34.9	15.6	36.9	26.0	20.9	35.2	37.9	20.7	33.8	16.8	17.3	20.1	23.1	18.9	36.2	18.0	43.1	35.5	38.2	20.6	33.8	20.5	25.5	33.3	35.0	31.3	14.6	34.7	30.9	30.2	35.1	18.6	16.1	28.5	17.5	17.8	12.1	20.8	16.6	17.5	37.8	18.1	16.4	30.8	35.8	39.3	26.5	20.0	21.9	18.1	17.8	38.1	58.1	45.6	75.5	40.9	27.6	22.0	59.2	53.7	37.4	83.3	53.7	73.3	61.4	60.1	75.5	36.4	37.8	58.0	70.7	53.3	82.2	34.5	75.0	34.1	25.3	97.7	32.1	51.7	64.9	24.9	36.3	53.1	47.9	31.8	51.6	92.5	57.2	28.0	66.3	43.7	147.4	104.2	69.5	39.7	91.6	141.5	94.3	56.7	46.8	35.6	68.7	61.2	95.7	36.9	54.0	51.8	32.0	63.3	36.1	51.0	67.0	56.3	62.1	33.7	33.5	115.1	33.3	53.5	70.0	88.6	29.6	52.9	46.4	30.2	45.5	55.0	48.1	49.6	33.9	49.7	64.0	54.3	24.8	66.6	31.1	56.8	94.9	52.5	34.9	36.9	35.2	37.9	35.5	38.2	33.3	35.0	35.1	37.8	35.8	38.1	70.9	12.8	20.3	10.4	21.8	0.0	38.5	0.0	60.3	28.7	28.7	50.9	51.7	30.0	16.1	20.2	33.3	101.9	29.3	7.4	56.7	36.7	336.7	60.1	29.2	58.7	24.3	19.1	7.3	16.5	75.3	40.8	18.8	22.0	12.6	22.5	30.4	35.7	35.1	18.5	7.7	19.6	0.0	11.4	0.0	137.7	33.8	17.4	0.0	3.7	17.4	32.3	23.7	16.6	21.0	22.6	17.2	31.2	19.1	30.8	23.5	34.7	33.5	38.8	19.7	60.9	30.3	109.7	30.3	35.6	0.0	65.9	31.6	38.5	17.2	19.5
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407972-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 22.3;testis: 59.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 300.7;Spermatocytes: 128.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RPTEC TERT1: 2.6;T-47d: 4.5"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.1	0.4	1.0	0.0	0.9	0.0	0.3	0.5	0.9	0.7	4.3	0.0	0.0	0.5	0.6	0.0	22.3	0.1	0.2	0.8	1.4	0.9	0.1	1.5	0.0	2.3	2.6	0.1	0.1	0.7	1.2	0.1	1.6	0.5	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	59.1	1.7	0.0	1.4	0.1	0.0	0.2	0.0	0.9	0.0	0.5	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.6	0.5	0.3	0.2	0.2	0.1	0.0	4.5	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.5	0.9	0.8	1.4	2.3	2.6	1.6	1.5	1.7	0.9	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.9	0.3	300.7	15.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.5	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	1.4	43.7	0.4	0.0	0.0	0.1	128.8	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CFAP251	"CaM-IP4, MGC33630, WDR66"	ENSG00000158023	"Cilia and flagella associated protein 251"	Q8TBY9	12	121918592-122003927	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.8	1.6	0.3	2.4	0.1	1.3	1.3	1.7	3.5	13.2	0.2	0.1	1.9	4.7	0.3	22.3	1.2	1.3	2.4	3.9	2.7	1.4	3.0	0.6	5.5	6.6	2.2	1.7	2.9	6.5	0.9	3.6	0.7	0.1	4.6	1.1	1.6	0.3	1.5	0.2	0.6	2.7	1.7	0.4	19.9	4.1	0.5	4.7	0.4	0.9	0.3	1.3	1.6	4.7	0.4	0.4	0.2	0.5	0.5	0.5	0.3	2.5	1.2	3.0	0.3	1.4	0.2	3.7	0.2	0.7	0.9	0.3	31.8	4.4	0.2	0.5	0.2	0.6	0.3	3.7	0.1	8.6	1.8	30.8	2.4	19.9	0.7	1.3	0.5	7.5	0.1	1.9	0.9	0.3	0.6	0.4	0.4	0.2	0.4	0.8	0.0	5.4	0.5	2.5	0.1	0.2	0.1	0.2	0.8	0.9	0.1	1.0	2.5	3.9	0.5	0.5	0.5	0.2	3.8	2.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	1.6	2.4	1.3	1.7	2.4	3.9	5.5	6.6	3.6	2.7	4.1	1.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CFAP298	"C21orf48, C21orf59, CILD26, FBB18, FLJ20467, Kur"	ENSG00000159079	"Cilia and flagella associated protein 298"	P57076	21	32592079-32612603	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.0;Distal tubular cells: 78.2;Ductal cells: 78.5;Endometrial ciliated cells: 272.0;Extravillous trophoblasts: 70.2;Proximal tubular cells: 95.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA018453, HPA019055, HPA028849, CAB034170"	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB034170: AB_1564311, HPA018453: AB_1845700, HPA019055: AB_1845701, HPA028849: AB_10602111"	"unprognostic (9.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.39e-1)"	"prognostic favorable (8.90e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.37e-2)"	23.3	29.1	30.3	12.2	30.2	14.0	25.0	35.3	37.0	28.6	38.5	26.5	14.1	27.0	21.2	30.7	35.5	12.0	26.7	30.5	32.0	37.8	29.0	25.1	16.5	29.7	31.2	27.0	36.3	21.3	48.8	12.3	29.6	30.7	13.8	27.6	28.7	10.5	35.2	27.7	22.9	11.4	28.5	23.7	29.3	62.1	32.1	16.0	33.5	11.7	16.5	24.7	26.2	29.5	47.5	26.1	21.4	37.3	11.9	9.2	43.6	23.9	16.1	22.8	15.0	41.9	33.2	36.3	26.4	18.3	24.6	21.9	30.9	29.5	19.5	25.8	53.6	44.5	37.1	57.6	17.2	50.8	31.8	7.8	28.5	37.6	22.8	22.4	16.1	40.6	96.8	18.9	16.4	56.9	49.7	86.8	99.2	63.1	31.6	37.2	24.0	76.5	50.9	26.3	113.8	49.4	35.1	46.5	65.2	21.9	48.6	54.3	24.6	19.6	24.0	32.6	30.4	43.7	66.9	66.0	38.5	68.4	25.3	12.8	13.9	16.2	13.4	15.3	11.1	20.8	17.9	19.0	17.1	24.6	19.9	18.2	1.3	19.9	19.6	23.8	21.4	18.8	30.3	30.2	35.3	37.0	30.5	32.0	29.7	31.2	29.6	28.5	32.1	29.5	38.3	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	35.8	40.4	0.0	0.0	0.0	46.0	0.0	74.0	28.0	0.0	78.2	78.5	0.0	272.0	34.3	13.2	0.0	0.0	0.0	53.2	70.2	11.1	0.0	45.8	0.0	22.5	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	19.7	0.0	0.0	0.0	0.0	50.9	0.0	0.0	4.3	0.0	0.0	95.1	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	38.0	12.3	28.3	0.0	0.0
CFAP298-TCP10L	"C21orf77, FLJ10932, LINC00846"	ENSG00000265590	"CFAP298-TCP10L readthrough"		21	32402511-32612865	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019055, HPA028849"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"				"HPA019055: AB_1845701, HPA028849: AB_10602111"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.11e-1)"	6.1	6.9	2.1	6.6	2.1	5.0	9.6	2.2	3.5	10.0	3.0	8.9	6.0	9.7	19.5	10.4	28.4	8.5	11.0	2.0	2.2	14.2	11.6	7.4	9.6	2.0	2.0	8.1	7.7	13.9	1.1	7.6	2.0	10.4	11.9	10.6	9.4	9.1	9.4	7.4	5.6	10.9	2.0	4.3	5.8	26.3	2.0	5.6	16.1	5.0	12.6	9.8	0.8	2.1	22.9	14.3	17.6	23.2	15.8	14.4	22.8	13.9	18.9	24.0	18.1	21.9	18.0	20.9	11.9	18.9	16.7	8.5	29.0	27.3	28.6	9.8	10.6	30.5	14.7	35.4	20.3	41.6	20.3	7.7	33.0	38.5	28.4	21.1	26.7	24.4	45.2	12.8	21.2	36.7	29.3	17.8	24.0	41.3	10.6	19.0	21.6	31.3	43.5	14.6	28.7	19.7	19.2	23.8	33.1	21.0	24.6	20.3	9.8	7.2	8.0	16.4	20.2	4.5	36.9	40.1	15.0	50.9	15.6	3.1	2.2	2.4	7.6	1.8	11.3	3.3	5.2	5.5	4.5	2.1	3.3	5.0	0.4	6.1	3.6	3.8	3.6	1.4	2.1	2.1	2.2	3.5	2.0	2.2	2.0	2.0	2.0	2.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFAP299	C4orf22	ENSG00000197826	"Cilia and flagella associated protein 299"	Q6V702	4	80335730-80963750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 19.8;testis: 27.4"	"Cell type enriched"	"Detected in some"	54	"Endometrial ciliated cells: 54.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.0	0.9	0.0	1.0	0.0	0.1	1.4	0.5	0.7	2.6	0.1	0.1	0.2	0.0	0.0	19.8	0.1	0.0	1.0	1.0	0.3	0.0	1.4	0.1	5.3	3.7	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	27.4	1.2	0.1	0.6	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.7	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	1.4	0.5	1.0	1.0	5.3	3.7	2.3	3.5	1.2	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	54.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CFAP300	"C11orf70, FBB5, MGC13040"	ENSG00000137691	"Cilia and flagella associated protein 300"	Q9BRQ4	11	102047437-102084554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.2;testis: 30.2"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 142.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038585	Enhanced		Approved	Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.7	3.4	2.3	0.4	2.6	0.0	2.6	2.2	2.1	5.4	10.9	1.3	0.8	4.3	10.7	1.8	29.2	3.3	1.3	2.5	3.3	1.7	0.1	3.0	0.9	5.8	6.7	4.1	0.8	2.7	4.0	3.3	5.5	4.0	0.8	1.4	0.8	6.6	0.2	1.3	0.8	2.9	4.7	0.1	1.8	30.2	3.3	0.6	3.6	0.0	0.5	3.0	1.9	4.0	0.1	8.5	8.5	0.0	7.5	17.9	0.2	3.4	8.6	4.6	6.5	0.6	11.1	0.0	2.0	6.7	2.3	2.1	2.1	1.0	3.3	0.0	1.3	0.0	1.3	0.0	5.3	0.0	0.0	7.8	10.5	11.9	8.0	8.9	0.1	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	12.6	2.4	9.4	0.0	11.0	0.1	0.0	0.0	9.6	0.0	1.3	1.1	3.5	11.2	2.8	0.1	0.0	0.0	3.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	2.6	2.2	2.1	2.5	3.3	5.8	6.7	5.5	4.7	3.3	4.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	29.5	0.0	7.1	0.1	0.0	1.9	4.0	0.0	142.5	9.8	0.2	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.2	6.0	0.0	0.0
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies"	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	39.1	42.7	72.7	20.2	74.8	16.5	48.9	61.8	98.8	49.8	82.8	52.3	15.1	47.1	77.0	21.9	62.3	40.9	35.7	75.0	78.5	63.2	17.7	33.9	21.7	71.8	70.4	58.9	33.6	78.0	106.7	20.6	72.1	41.6	23.2	124.3	28.7	45.0	19.2	18.8	25.2	37.4	65.9	18.2	42.1	145.2	73.6	22.8	78.0	27.1	19.7	40.7	33.6	70.1	59.5	47.3	50.2	66.3	64.4	119.4	30.4	36.6	73.4	54.9	46.6	34.6	21.2	21.3	82.3	48.9	81.9	38.4	39.3	51.4	67.7	51.9	76.2	31.0	43.9	38.1	70.0	59.4	38.4	58.1	82.7	74.0	92.1	146.8	58.9	42.5	40.1	18.2	66.1	44.4	35.7	67.5	25.2	38.7	44.8	27.2	59.7	21.7	112.1	33.7	74.1	36.6	49.4	25.6	68.5	26.2	42.1	19.7	32.5	57.6	33.7	58.5	50.8	29.9	14.2	7.3	94.0	26.7	26.8	15.5	4.3	13.6	18.3	5.0	35.4	16.9	50.6	29.6	5.8	11.7	41.1	26.0	5.2	12.3	6.4	13.5	30.5	15.9	72.7	74.8	61.8	98.8	75.0	78.5	71.8	70.4	72.1	65.9	73.6	70.1	51.3	48.1	30.6	15.7	14.5	0.0	52.6	0.0	22.2	39.6	48.7	77.2	37.9	38.6	27.2	35.0	8.4	14.3	14.8	6.4	92.0	61.9	1342.4	184.4	51.8	42.9	17.0	21.0	51.6	60.7	27.0	44.7	21.9	36.3	39.1	27.1	42.1	10.7	23.6	23.5	41.1	12.2	0.0	8.7	0.0	262.5	75.2	12.8	0.0	14.0	16.9	145.0	16.5	21.6	13.3	37.0	11.5	67.7	11.4	41.3	7.6	146.9	99.1	92.4	59.2	43.0	43.4	346.0	29.8	16.1	0.0	7.8	24.7	36.0	9.9	35.6
CFAP410	"A2, C21orf2, LRRC76, YF5"	ENSG00000160226	"Cilia and flagella associated protein 410"	O43822	21	44328944-44339402	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 30.8;Extravillous trophoblasts: 15.7;Hofbauer cells: 35.5;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	19.8	22.2	14.5	5.1	14.6	11.4	19.5	13.8	18.6	22.9	12.7	21.1	6.5	23.4	2.3	12.5	26.3	3.8	19.9	14.9	14.5	26.0	26.8	18.5	6.6	16.5	16.8	22.3	24.0	7.5	34.4	3.3	14.5	26.3	1.4	10.0	18.6	5.0	16.1	17.9	19.2	2.4	13.9	20.9	20.7	30.9	18.5	4.2	32.8	4.9	2.3	19.2	14.8	16.2	12.9	5.2	4.9	6.3	3.2	2.0	19.3	6.4	3.7	2.5	1.3	9.4	3.7	9.1	12.5	2.2	5.1	6.0	0.9	1.2	0.6	14.2	12.9	9.5	4.3	11.2	4.1	10.2	9.8	2.9	2.2	1.0	2.2	4.4	1.6	6.7	11.6	15.1	1.6	15.5	11.2	25.0	12.2	6.4	7.8	28.6	6.3	20.3	2.9	18.0	12.9	12.2	8.9	2.1	11.0	2.9	9.3	22.0	7.5	5.4	6.9	5.8	4.9	25.1	14.2	6.4	13.2	20.4	9.9	1.7	10.2	1.6	9.4	12.6	11.3	16.6	10.0	13.2	10.5	11.6	11.3	11.1	1.3	17.3	9.5	31.3	6.1	7.6	14.5	14.6	13.8	18.6	14.9	14.5	16.5	16.8	14.5	13.9	18.5	16.2	5.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	30.8	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	15.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	32.7	1.1	0.0	0.0	0.0
CFAP44	"FLJ11142, WDR52"	ENSG00000206530	"Cilia and flagella associated protein 44"	Q96MT7	3	113286930-113441610	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.4;Endometrial ciliated cells: 40.0;Late spermatids: 61.2;Respiratory ciliated cells: 104.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.7"	HPA067258	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA067258: AB_2685814"	"unprognostic (2.83e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-6)"	"unprognostic (8.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-2)"	"prognostic favorable (7.09e-6)"	1.6	1.2	1.1	0.9	1.2	0.8	2.5	1.2	1.0	3.7	11.9	2.7	0.7	2.7	2.6	1.6	6.8	1.0	1.7	1.3	1.4	1.9	2.1	2.5	1.3	5.5	4.8	3.3	3.7	1.9	6.3	0.7	2.6	4.2	2.3	8.7	4.9	1.1	1.3	2.3	2.9	0.7	4.4	2.0	3.0	6.1	1.4	1.4	3.2	0.4	1.0	2.4	2.6	2.0	1.1	0.7	1.6	1.4	0.9	1.5	1.5	0.5	0.3	0.3	0.7	0.1	0.6	1.4	0.1	0.2	0.3	1.5	0.9	0.5	0.6	0.3	1.0	0.8	3.4	0.3	0.0	1.5	0.9	0.4	1.4	0.3	0.3	2.0	0.2	1.3	0.2	0.7	0.3	0.7	0.8	1.3	0.5	1.9	1.8	0.8	0.2	0.0	0.8	1.8	1.5	1.4	0.7	0.1	0.8	0.8	1.0	1.1	1.1	0.5	0.8	0.4	0.5	0.9	0.6	0.1	0.7	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.2	1.0	1.3	1.4	5.5	4.8	2.6	4.4	1.4	2.0	3.8	9.6	13.7	27.4	2.9	0.0	2.1	0.0	5.7	7.5	6.7	5.2	5.1	2.8	18.6	3.7	20.9	0.9	1.1	3.2	0.0	2.6	57.4	40.0	6.3	4.2	0.0	1.3	34.8	3.0	1.0	5.2	12.2	9.5	11.4	4.3	1.8	3.7	0.5	8.4	14.0	4.7	0.0	0.6	0.0	61.2	6.2	1.8	0.0	20.6	0.9	4.0	3.1	21.1	21.9	2.1	1.9	6.8	2.5	2.2	2.2	1.1	104.9	19.0	0.0	9.7	2.5	23.6	4.9	1.8	0.0	0.8	2.9	6.2	2.7	2.2
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.6	0.1	1.8	0.4	1.3	0.8	0.6	1.0	0.9	2.7	13.5	0.3	0.2	1.4	0.0	0.4	44.8	0.2	0.8	1.7	1.8	0.7	0.1	5.0	0.2	7.9	7.0	0.3	0.2	0.1	0.4	0.4	4.7	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	5.9	0.7	0.6	28.4	2.3	0.3	0.7	0.1	0.2	0.5	0.3	4.1	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	1.8	1.3	1.0	0.9	1.7	1.8	7.9	7.0	4.7	5.9	2.3	4.1	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CFAP46	"bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40"	ENSG00000171811	"Cilia and flagella associated protein 46"	Q8IYW2	10	132808392-132942823	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.5;skeletal muscle: 33.4;testis: 41.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Endometrial ciliated cells: 70.8;Excitatory neurons: 42.8;Respiratory ciliated cells: 59.0;Rod photoreceptor cells: 74.4;Spermatocytes: 53.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037786, HPA038034, HPA038867, HPA038868"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247"	"unprognostic (2.83e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.11e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-4)"	"unprognostic (1.21e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.08e-2)"	0.0	0.2	5.9	0.0	7.0	0.0	0.1	4.2	10.0	1.5	22.5	0.0	0.1	0.1	1.3	0.2	16.1	0.1	0.7	6.5	6.1	1.0	0.2	3.4	0.0	13.5	17.3	0.2	0.4	1.1	2.2	0.0	8.5	0.2	0.0	3.9	0.4	0.4	33.4	0.1	0.1	0.0	9.4	0.1	2.4	41.8	6.6	0.0	4.2	10.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	5.9	7.0	4.2	10.0	6.5	6.1	13.5	17.3	8.5	9.4	6.6	4.6	0.2	0.0	4.8	9.8	0.3	0.0	0.5	0.0	0.6	6.3	1.3	1.1	3.7	0.0	9.3	7.3	95.9	0.0	0.0	0.0	5.9	4.8	18.0	70.8	0.9	0.9	0.0	0.0	42.8	0.2	0.0	1.5	5.1	1.5	3.8	4.3	5.0	0.2	0.6	1.7	22.0	0.0	0.0	0.6	0.0	11.3	1.2	0.3	0.0	1.0	0.0	4.7	0.0	2.0	0.9	1.6	0.0	2.2	0.2	0.7	0.0	5.6	59.0	74.4	0.0	0.4	0.4	53.7	7.2	0.7	0.0	0.0	0.3	7.3	0.0	0.6
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385317	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;choroid plexus: 7.1;fallopian tube: 4.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 45.4;Endometrial ciliated cells: 66.2;Respiratory ciliated cells: 20.4;Rod photoreceptor cells: 14.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 1.6;U-266/70: 3.0"									"HPA044633, HPA054859"	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA044633: AB_10960684, HPA054859: AB_2682627"	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.9	0.7	0.2	7.1	0.0	0.0	0.1	0.4	0.0	4.7	0.0	0.0	1.6	2.8	0.0	0.1	0.5	0.0	8.1	6.3	0.0	0.0	0.4	1.8	0.0	4.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.7	2.5	0.0	0.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.9	0.7	1.6	2.8	8.1	6.3	4.4	4.4	2.5	5.3	0.1	0.0	0.0	45.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	2.5	1.8	8.4	0.2	0.0	0.0	0.0	0.0	6.0	66.2	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	2.1	0.3	0.1	0.0	1.9	0.0	0.6	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	14.7	0.0	0.0	0.1	2.2	4.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.7;choroid plexus: 18.2;fallopian tube: 57.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	3.8	0.0	4.3	0.0	0.1	2.3	2.9	2.3	18.2	0.1	0.7	1.1	0.1	0.2	57.8	0.2	0.0	4.0	4.1	0.3	0.2	4.4	0.0	10.7	13.7	0.2	0.2	0.3	3.2	0.2	8.4	0.3	0.0	2.4	1.2	0.2	0.0	0.2	0.7	0.0	9.9	0.0	0.1	12.2	3.9	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.3	2.3	2.9	4.0	4.1	10.7	13.7	8.4	9.9	3.9	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266495	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 28.5;testis: 79.6"	"Group enriched"	"Detected in many"	14	"Early spermatids: 809.6;Endometrial ciliated cells: 331.5;Late spermatids: 528.4;Respiratory ciliated cells: 216.5;Spermatocytes: 481.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.7"									"HPA041069, HPA066142"	Enhanced		Approved	Midbody		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Midbody		"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.3	1.2	3.0	0.4	3.4	0.7	1.1	5.0	3.2	2.0	8.5	0.5	0.2	1.1	5.7	0.4	28.5	0.7	0.5	3.1	3.7	2.7	0.4	3.3	0.3	6.8	7.8	1.0	1.1	2.5	3.3	0.3	6.0	0.9	0.2	3.5	0.6	1.2	2.3	1.0	0.4	0.3	5.3	0.4	0.5	79.6	3.4	0.5	3.9	0.4	0.2	0.6	0.6	5.0	1.2	0.8	0.5	1.0	0.7	1.3	0.9	0.2	0.1	0.1	0.2	0.1	1.0	0.7	0.7	0.3	0.3	0.5	0.3	0.5	0.2	0.5	0.7	0.3	0.3	0.1	0.3	0.5	0.4	0.4	2.0	0.5	4.7	1.1	0.3	1.9	1.4	0.4	0.3	1.2	1.2	0.2	0.2	0.2	0.5	0.1	0.2	1.0	1.4	0.0	0.8	0.6	0.1	0.0	0.4	1.3	0.6	0.1	0.0	0.7	0.5	0.4	0.4	2.1	0.8	0.1	0.7	0.5	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.2	0.2	0.0	3.0	3.4	5.0	3.2	3.1	3.7	6.8	7.8	6.0	5.3	3.4	5.0	0.6	6.4	4.2	2.6	0.6	0.0	2.0	0.0	1.8	4.3	4.7	3.8	0.4	0.0	21.1	9.2	8.4	1.7	0.2	0.3	9.8	3.4	809.6	331.5	3.8	1.4	0.0	0.4	3.8	0.6	0.5	2.2	2.6	7.9	1.3	1.4	1.8	1.0	0.4	1.7	4.4	0.2	0.0	0.0	0.0	528.4	8.4	1.3	0.0	2.8	1.0	2.7	1.0	3.0	6.5	0.8	0.1	5.7	0.9	1.3	0.8	20.5	216.5	10.5	6.6	2.1	0.7	481.5	32.5	1.3	0.0	0.7	1.0	1.7	0.4	1.1
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;choroid plexus: 30.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 80.1;Club cells: 42.7;Endometrial ciliated cells: 65.8;granulocytes: 37.8;Oligodendrocytes: 47.7;Respiratory ciliated cells: 106.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in many"							HPA039897	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	0.8	0.7	5.6	1.3	8.1	2.7	0.9	9.2	10.3	0.6	30.7	0.7	1.8	1.6	1.6	0.7	5.0	0.8	0.5	7.0	4.6	0.9	0.9	1.4	1.2	14.6	14.7	1.0	0.2	0.6	1.0	0.7	7.3	0.9	1.1	6.2	0.8	0.6	1.3	1.6	1.2	0.6	8.5	1.5	1.0	5.4	7.0	0.5	1.3	0.2	1.1	0.4	0.1	12.4	1.4	0.6	0.8	1.1	0.4	0.6	0.9	0.7	0.2	0.2	0.4	0.6	1.9	1.0	1.6	0.4	0.9	1.0	0.3	0.3	0.3	2.0	0.6	0.9	2.3	0.7	0.1	1.5	1.5	0.2	0.3	1.1	0.5	1.8	7.7	0.9	0.6	3.5	0.8	0.7	1.2	1.5	1.7	0.6	1.0	1.2	1.1	1.3	2.2	1.3	1.6	1.2	0.8	0.7	1.0	0.9	2.1	0.7	9.4	1.7	2.2	1.8	1.5	4.2	2.1	0.6	1.3	0.9	1.3	2.4	0.7	0.6	0.7	0.6	0.5	0.7	0.5	0.6	0.3	1.1	0.6	0.6	1.3	0.7	0.7	0.6	0.4	0.1	5.6	8.1	9.2	10.3	7.0	4.6	14.6	14.7	7.3	8.5	7.0	12.4	2.1	70.5	80.1	27.1	2.6	0.0	0.3	0.0	0.0	3.9	0.3	0.6	1.0	1.5	42.7	0.0	22.9	0.3	2.2	0.0	0.0	0.2	33.2	65.8	2.9	6.8	1.2	1.3	21.9	0.0	0.3	6.4	0.5	1.9	37.8	0.6	0.4	0.0	0.2	0.0	3.9	0.0	0.0	0.8	0.0	15.4	0.3	3.2	0.0	1.9	0.1	8.1	0.0	4.0	47.7	0.3	0.1	0.0	5.0	0.5	0.0	0.3	106.4	7.8	0.0	1.7	0.5	16.8	7.0	0.0	0.0	0.0	4.2	1.9	0.1	0.3
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172330-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.7;fallopian tube: 23.4;testis: 15.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 38.6;Endometrial ciliated cells: 62.4;Late spermatids: 26.7;Respiratory ciliated cells: 85.2;Spermatocytes: 25.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;HDLM-2: 1.8;TIME: 1.5"	"Low region specificity"	"Detected in many"							"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.1	0.8	0.0	1.2	0.0	0.3	0.3	0.5	1.0	10.7	0.0	0.0	0.6	2.8	0.1	23.4	0.2	0.2	1.2	1.6	1.0	2.7	2.5	0.0	3.6	4.9	0.2	0.6	0.1	2.0	0.2	2.5	0.4	0.1	1.5	0.1	0.2	0.0	0.6	0.0	0.1	2.7	0.0	0.1	15.8	1.7	0.2	1.0	0.0	0.1	0.2	0.1	1.2	0.9	0.3	0.2	0.1	0.0	0.0	0.2	0.3	0.7	0.5	0.5	0.3	0.3	0.0	0.3	1.0	0.3	2.8	0.2	0.3	1.1	1.8	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.1	0.7	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.3	0.1	0.3	0.0	0.3	0.3	0.6	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.8	1.2	0.3	0.5	1.2	1.6	3.6	4.9	2.5	2.7	1.7	1.2	0.2	6.4	0.5	1.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.5	0.0	5.6	0.0	6.2	0.9	0.0	0.2	0.0	0.2	38.6	62.4	0.6	0.3	0.0	0.0	3.5	0.2	0.1	0.6	0.0	1.2	0.0	0.1	1.1	0.5	0.1	1.7	1.2	0.0	0.0	0.0	0.0	26.7	0.9	0.2	0.0	0.0	2.1	0.6	0.0	0.0	1.1	0.3	0.0	0.7	0.0	0.1	0.7	1.9	85.2	1.2	0.0	0.0	0.1	25.4	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353833-104455102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;U-2 OS: 6.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.4	0.6	1.0	0.5	1.3	0.4	0.4	0.4	0.7	2.2	2.4	0.5	0.1	1.8	0.2	0.2	8.4	0.2	2.5	0.8	1.2	0.7	0.1	1.3	0.3	2.9	3.7	0.5	0.3	0.7	1.5	0.4	2.2	0.5	0.0	0.6	0.2	0.4	1.3	0.3	0.2	0.6	2.0	0.3	0.3	13.4	1.0	0.1	0.8	0.8	0.4	0.3	0.6	1.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	1.0	3.1	0.6	1.6	0.0	0.0	2.4	0.2	0.4	1.7	0.2	0.0	0.2	1.8	0.3	0.1	0.5	0.9	0.0	0.3	0.3	0.4	0.3	1.3	0.5	1.6	1.3	1.0	0.1	0.7	0.7	0.8	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.4	0.2	0.0	0.1	0.5	0.7	0.1	0.4	2.0	0.6	6.5	0.3	1.8	0.2	0.0	0.1	0.7	0.8	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.7	0.8	1.2	2.9	3.7	2.2	2.0	1.0	1.1	0.4	0.0	0.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	10.0	0.0	9.3	0.0	0.0	0.1	0.1	0.0	0.0	0.6	73.3	25.1	0.3	0.4	0.0	0.0	4.0	0.2	0.4	0.7	0.0	0.4	0.0	0.3	1.8	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	58.9	0.6	0.2	0.0	1.9	0.1	0.7	1.0	1.0	0.0	0.3	0.0	1.2	0.0	0.2	0.0	0.0	56.9	0.3	0.0	0.8	1.0	34.4	4.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360703	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 16.1;skeletal muscle: 28.6;testis: 15.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 88.7;Excitatory neurons: 20.6;Late spermatids: 73.2;Spermatocytes: 17.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.7;HMC-1: 2.6;SCLC-21H: 5.1;SK-MEL-30: 2.2;U-87 MG: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009079	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.1	0.7	1.4	0.0	2.2	0.0	0.2	0.9	1.2	0.6	16.1	0.1	0.0	0.7	0.9	0.1	12.2	0.1	12.4	2.2	3.2	0.7	0.0	1.3	0.1	5.3	7.3	0.3	0.3	0.5	3.6	0.0	3.9	0.3	0.0	1.8	0.2	0.2	28.6	0.5	0.0	0.1	4.3	0.0	0.1	15.5	3.7	0.1	0.7	10.2	0.1	0.0	0.1	2.6	0.2	0.5	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.4	4.7	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.4	0.0	5.1	0.0	0.1	0.3	2.2	0.0	0.4	0.0	0.4	0.0	0.2	0.3	0.2	0.7	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.4	2.2	0.9	1.2	2.2	3.2	5.3	7.3	3.9	4.3	3.7	2.6	0.0	0.0	0.5	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	12.7	0.0	2.5	1.8	4.2	0.0	1.4	0.0	0.0	0.0	88.7	12.1	0.3	0.1	0.0	0.0	20.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	73.2	0.6	0.2	0.0	1.0	0.0	0.0	0.0	3.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	8.7	0.5	0.0	0.6	0.1	17.3	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.1;choroid plexus: 13.5;fallopian tube: 25.7;testis: 9.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 204.5;Late spermatids: 164.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 10.8"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.0	0.1	2.3	0.0	2.1	0.0	0.1	1.0	1.0	1.3	13.5	0.1	0.0	0.5	1.8	0.0	25.7	0.4	0.0	2.6	2.8	0.4	0.0	2.7	0.0	8.4	12.1	0.0	0.3	0.1	3.5	0.0	6.2	0.1	0.2	9.2	0.1	0.1	0.0	0.0	0.4	0.0	6.1	0.0	0.3	9.4	2.4	0.0	0.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.0	1.0	2.6	2.8	8.4	12.1	6.2	6.1	2.4	3.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.8	7.7	8.8	0.0	4.3	6.8	0.0	12.5	0.0	0.1	1.1	0.0	0.6	204.5	45.1	0.5	0.2	29.1	0.0	0.0	1.5	0.0	0.2	2.0	1.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	25.2	0.0	0.0	0.0	164.3	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.8	0.7	0.0	1.1	1.9	1.1	29.2	19.5	0.0	0.1	0.0	14.4	5.7	0.0	0.0	0.0	0.2	0.1	5.1	0.1
CFAP69	"C7orf63, FAP69, FLJ21062"	ENSG00000105792	"Cilia and flagella associated protein 69"	A5D8W1	7	90245174-90311063	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Olfaction, Sensory transduction, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.4;Endometrial ciliated cells: 55.3;Excitatory neurons: 57.6;Inhibitory neurons: 46.4;Respiratory ciliated cells: 51.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062883	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA062883: AB_2684893"	"unprognostic (7.69e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.44e-3)"	8.0	3.0	3.5	1.7	3.9	0.0	8.0	3.0	5.1	6.9	20.4	6.0	1.9	4.6	12.5	3.0	14.3	3.1	5.0	3.6	3.8	8.1	6.6	7.4	0.4	7.0	6.7	6.9	4.8	5.1	11.8	0.7	4.8	24.8	2.1	11.9	5.8	3.0	1.9	4.4	3.4	3.4	5.4	3.6	4.5	7.7	4.4	0.1	10.2	0.6	0.7	4.6	3.8	4.5	2.8	1.7	0.2	3.2	3.5	3.6	0.6	0.1	2.5	1.0	1.5	6.0	2.4	0.3	0.1	2.9	3.9	1.0	1.1	1.4	1.7	0.0	1.1	0.0	0.8	1.7	2.0	0.3	0.0	4.1	1.6	4.2	1.5	5.6	1.1	0.3	1.4	0.0	1.8	1.6	0.0	2.6	1.6	0.1	0.8	0.0	0.4	0.0	5.6	0.7	0.6	1.4	2.6	0.3	0.7	0.6	1.0	0.1	0.2	3.2	0.7	3.2	1.1	0.6	0.2	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.9	3.0	5.1	3.6	3.8	7.0	6.7	4.8	5.4	4.4	4.5	1.5	3.2	6.3	28.4	0.2	0.0	1.5	0.0	3.4	4.8	5.5	4.3	3.0	8.6	6.8	5.5	18.8	0.2	0.0	0.9	1.9	1.9	24.1	55.3	5.6	1.0	0.0	0.8	57.6	1.6	0.1	9.1	2.6	3.4	0.0	4.2	1.1	1.6	0.1	8.4	46.4	0.8	0.0	0.3	0.0	6.2	1.2	0.4	0.0	12.2	0.0	4.2	0.0	13.0	8.2	0.6	1.0	2.2	0.0	7.0	1.9	3.7	51.7	18.2	0.0	9.5	3.8	22.7	1.8	1.5	0.0	0.1	0.1	4.9	1.1	1.4
CFAP70	"FLJ25765, TTC18"	ENSG00000156042	"Cilia and flagella associated protein 70"	Q5T0N1	10	73253759-73358859	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.4;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Early spermatids: 61.9;Endometrial ciliated cells: 153.6;Respiratory ciliated cells: 179.3;Spermatocytes: 60.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037582, HPA070304"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037582: AB_2675560, HPA070304: AB_2732153"	"unprognostic (2.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	1.3	4.5	4.3	0.5	4.4	0.3	3.1	3.9	4.9	2.8	24.4	0.7	1.2	1.6	11.3	0.6	14.7	1.4	1.3	4.9	5.5	7.8	2.3	3.1	0.7	10.0	12.5	3.2	2.9	4.7	13.5	0.5	8.4	4.3	0.6	10.5	2.3	1.9	0.9	2.9	0.7	0.5	8.4	1.4	1.3	20.9	5.0	0.6	6.3	0.6	0.8	0.9	1.1	6.2	1.1	1.3	1.4	1.2	2.4	2.1	0.4	0.5	0.1	0.3	0.4	1.0	4.6	0.5	0.7	0.2	0.9	0.7	0.8	1.0	0.5	1.0	2.3	1.0	1.0	1.1	0.2	0.5	0.6	1.3	2.3	0.7	0.6	1.7	0.0	3.1	0.4	2.9	0.4	1.8	1.3	1.0	0.5	1.1	5.4	0.8	1.2	2.4	2.3	0.3	1.9	0.2	0.4	0.9	0.9	0.8	1.8	0.8	0.8	0.3	1.2	0.5	1.3	3.0	1.8	1.5	1.7	1.0	0.4	0.0	0.0	0.4	0.3	0.1	0.7	0.5	0.6	0.5	0.2	0.8	1.3	1.1	0.1	0.5	0.1	0.4	0.6	0.2	4.3	4.4	3.9	4.9	4.9	5.5	10.0	12.5	8.4	8.4	5.0	6.2	2.0	9.6	8.4	68.6	2.2	0.0	3.6	0.0	2.8	15.3	6.7	3.9	2.1	1.5	36.5	5.5	29.2	1.4	0.3	0.3	3.9	1.9	61.9	153.6	3.3	1.8	4.9	0.4	29.5	0.6	0.2	3.2	3.1	7.4	2.5	3.2	4.6	2.6	0.5	6.7	37.6	0.5	0.0	0.3	0.0	39.0	4.7	1.1	0.0	5.6	0.1	16.0	0.0	12.1	22.4	0.2	0.1	3.0	1.3	5.5	0.5	2.8	179.3	28.0	6.6	5.3	1.1	60.4	14.8	2.0	0.0	0.3	1.3	8.1	0.8	2.5
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.6;choroid plexus: 28.1;fallopian tube: 42.2"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 110.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.4	3.2	0.4	2.8	2.1	0.3	1.1	1.0	3.8	28.1	0.3	0.3	0.5	0.3	0.5	42.2	0.2	0.2	5.5	5.8	1.7	0.5	7.1	0.7	17.9	21.6	0.4	0.4	0.1	1.2	0.0	11.3	0.6	0.0	0.2	2.3	0.7	0.3	4.7	0.5	0.0	15.0	0.6	4.0	0.5	4.6	0.0	0.8	0.0	1.2	0.2	0.2	3.4	0.2	0.0	0.2	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	2.0	4.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.2	1.7	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.7	0.2	0.7	0.3	0.8	0.1	2.2	0.0	0.3	0.5	0.5	0.4	0.1	0.0	0.6	0.0	0.2	2.5	0.0	0.1	0.1	0.7	0.2	0.1	0.4	0.1	9.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.8	1.1	1.0	5.5	5.8	17.9	21.6	11.3	15.0	4.6	3.4	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	6.2	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	110.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	23.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2
CFAP74	"C1orf222, FLJ45476, KIAA1751"	ENSG00000142609	"Cilia and flagella associated protein 74"	Q9C0B2	1	1921951-2003837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.1;testis: 5.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 11.5;Endometrial ciliated cells: 36.0;Excitatory neurons: 11.6;Late spermatids: 20.3;Respiratory ciliated cells: 18.2;Spermatocytes: 16.4;Spermatogonia: 10.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028521, HPA029274, HPA030240"	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455"	"unprognostic (5.41e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	0.2	1.3	0.1	0.4	0.3	0.9	0.2	2.8	1.3	0.4	2.9	0.2	0.3	0.5	0.2	0.9	7.1	0.7	0.2	0.9	0.3	0.1	0.6	1.4	0.7	1.4	2.5	0.2	0.0	0.1	0.5	0.3	1.1	0.2	0.2	0.8	0.4	0.4	0.8	3.2	0.1	0.1	0.2	0.3	0.2	5.2	0.8	0.1	1.1	0.0	0.1	0.3	0.0	2.1	0.7	0.0	0.9	0.7	0.0	0.9	1.0	0.1	0.0	0.0	0.4	1.7	0.1	1.0	1.4	0.3	0.7	0.2	0.0	0.3	0.2	0.9	1.4	2.1	2.6	1.1	0.3	1.6	0.6	0.7	1.0	0.0	0.0	0.4	0.0	0.7	3.0	0.5	0.5	0.3	0.8	0.3	0.9	0.1	1.2	0.8	0.3	0.5	0.0	1.4	1.5	0.5	0.3	0.1	0.0	0.3	0.3	0.4	1.7	0.9	0.9	0.4	1.1	1.0	0.4	1.1	0.1	1.6	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	2.8	1.3	0.9	0.3	1.4	2.5	1.1	0.2	0.8	2.1	0.2	0.0	1.8	0.7	0.1	0.0	1.0	0.0	0.0	1.5	0.2	0.4	1.9	0.0	4.3	0.0	8.4	1.1	0.2	0.0	0.0	0.0	11.5	36.0	0.4	0.6	0.0	0.0	11.6	0.0	3.3	0.9	0.0	0.7	0.0	0.3	3.6	1.0	0.1	0.0	5.9	0.0	0.0	1.0	0.0	20.3	1.2	0.6	0.0	9.4	0.0	0.3	1.0	1.0	1.0	0.0	0.0	0.0	0.0	1.1	1.6	0.2	18.2	2.4	0.0	1.5	1.1	16.4	10.1	0.0	0.0	0.8	0.7	0.8	0.1	0.5
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.5;fallopian tube: 29.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	1.2	0.0	1.0	0.0	0.0	2.0	0.1	1.2	11.5	0.0	0.0	0.5	0.2	0.0	29.7	0.0	2.4	1.0	1.5	0.1	0.0	2.1	0.0	4.1	6.0	0.0	0.1	0.0	0.6	0.0	3.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	19.3	1.4	0.2	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	2.0	0.1	1.0	1.5	4.1	6.0	3.1	3.3	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	58.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	36.5	3.8	0.0	0.0	0.0	25.5	3.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1
CFAP91	"AAT-1, AAT1, AAT1alpha, C3orf15, CaM-IP2, MAATS1, SPATA26"	ENSG00000183833	"Cilia and flagella associated protein 91"	Q7Z4T9	3	119703022-119767102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.1"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;hTERT-RPE1: 1.4;RPTEC TERT1: 2.4;SCLC-21H: 3.5;SH-SY5Y: 2.5;T-47d: 1.8;U-87 MG: 1.9"									HPA074084	Supported					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA074084: "	"unprognostic (6.70e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.46e-2)"	0.6	2.1	0.8	0.0	1.0	0.0	1.8	0.5	1.0	3.4	5.7	1.4	0.0	4.0	5.0	0.3	14.1	1.2	0.4	1.0	1.7	2.5	0.4	2.1	0.1	2.4	2.1	3.4	4.9	4.0	7.2	0.2	1.8	2.3	0.5	4.1	1.5	4.5	0.1	0.3	0.6	0.8	1.6	2.4	1.7	8.7	1.4	0.4	4.6	0.0	0.3	1.1	1.1	1.0	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.2	1.2	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	2.4	0.0	3.5	2.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.5	1.0	1.0	1.7	2.4	2.1	1.8	1.6	1.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CFAP92	"FAP92, FLJ43738, KIAA1257"	ENSG00000114656	"Cilia and flagella associated protein 92 (putative)"	Q9ULG3	3	128909866-129002690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 22.1"	"Group enriched"	"Detected in some"	4	"Adipocytes: 1.3;Cardiomyocytes: 1.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"neutrophil: 34.0"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 7.6;HL-60: 13.5;THP-1: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042811, HPA048445"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042811: AB_2678180, HPA048445: AB_2680397"	"unprognostic (4.17e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.50e-2)"	0.4	0.6	3.1	1.0	2.1	2.1	0.8	3.9	2.2	0.4	4.4	0.7	0.8	0.7	0.5	1.1	3.3	1.4	0.6	3.7	2.5	0.5	0.2	1.1	1.0	3.1	4.7	1.2	0.9	1.7	1.8	1.1	3.2	1.0	0.8	2.7	0.7	0.3	0.7	4.3	0.9	0.2	1.4	1.0	1.1	22.1	3.3	4.2	0.8	0.5	0.3	0.4	0.1	1.3	1.0	1.4	7.6	1.6	0.1	0.2	2.4	0.3	0.3	0.1	0.0	1.2	1.0	1.5	0.3	0.0	0.7	1.1	2.3	0.1	0.0	0.6	1.1	3.3	1.9	1.0	0.0	13.5	0.7	0.0	1.4	0.0	0.1	0.5	0.1	2.9	0.9	1.7	0.2	1.5	1.3	2.5	1.4	2.6	1.4	1.1	0.8	0.9	0.0	1.5	1.5	0.7	0.4	0.5	0.6	1.0	2.6	9.2	0.4	0.8	1.2	0.8	0.5	2.2	2.0	2.5	0.6	5.0	0.6	0.8	0.7	2.9	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.5	34.0	0.3	0.3	0.3	0.2	0.2	3.1	2.1	3.9	2.2	3.7	2.5	3.1	4.7	3.2	1.4	3.3	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFAP94	"CASC1, FLJ10921, LAS1, PPP1R54"	ENSG00000118307	"Cilia and flagella associated protein 94"	Q6TDU7	12	25108289-25195162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.4;fallopian tube: 14.0;testis: 22.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.9;Fibroblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039662, HPA040141"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Vesicles	"HPA039662: AB_10795468, HPA040141: "	"unprognostic (6.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.62e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.21e-4)"	"unprognostic (2.54e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (2.01e-1)"	"unprognostic (8.74e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.19e-1)"	0.2	0.7	1.6	0.2	2.3	0.6	1.5	0.9	2.0	2.0	12.4	0.3	0.0	1.6	6.0	0.5	14.0	0.7	0.4	2.1	2.3	2.7	0.0	1.9	0.4	5.7	6.0	1.2	0.7	3.3	4.0	0.1	4.2	1.0	0.0	5.1	0.7	1.1	0.1	1.0	0.1	0.3	4.0	0.2	0.6	22.9	3.0	0.4	4.1	0.0	0.1	0.2	0.2	2.5	0.1	0.3	0.4	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.0	1.0	1.1	0.3	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	1.1	0.6	0.4	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.4	0.1	0.0	1.0	0.1	0.6	0.2	0.1	0.0	0.1	0.5	1.3	0.0	0.0	0.1	0.8	0.5	0.1	0.4	0.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.6	0.0	0.2	0.0	0.9	0.1	0.2	1.3	0.3	0.2	0.3	0.0	0.1	1.6	2.3	0.9	2.0	2.1	2.3	5.7	6.0	4.2	4.0	3.0	2.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 276.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA049446: AB_2680770, HPA053335: AB_2682117"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	17.0	11.8	6.6	14.6	7.7	5.2	20.8	9.4	10.0	17.6	10.4	11.2	7.5	18.8	9.4	19.1	15.8	15.1	9.0	6.5	7.6	16.2	18.8	13.6	17.5	7.5	7.1	22.1	10.2	20.3	6.4	13.9	8.6	17.6	11.3	18.0	12.2	17.5	6.7	11.4	9.7	17.3	7.1	18.6	11.2	37.4	6.8	11.8	27.3	7.0	16.2	14.6	9.7	11.1	29.5	17.9	23.6	40.8	27.1	47.8	14.2	38.3	34.7	28.1	22.2	11.2	36.2	73.1	12.6	44.2	21.0	15.8	26.9	33.3	37.2	65.3	17.7	29.5	10.5	26.1	33.5	40.5	22.4	31.0	45.9	30.6	66.6	34.9	24.6	33.7	53.1	66.8	39.9	14.0	21.5	20.0	13.6	9.1	14.2	31.9	11.7	45.8	34.4	15.6	15.8	42.3	28.3	27.2	53.9	13.6	18.2	24.4	35.8	26.4	16.4	10.4	30.4	26.4	12.5	22.4	33.0	34.5	53.8	9.5	6.4	2.9	27.8	11.5	32.8	30.7	27.0	27.4	8.5	29.7	27.0	18.9	1.3	19.9	18.9	29.3	21.0	10.0	6.6	7.7	9.4	10.0	6.5	7.6	7.5	7.1	8.6	7.1	6.8	11.1	84.0	64.1	41.3	17.0	50.5	0.0	64.7	0.0	58.6	61.5	68.5	75.4	29.6	52.9	22.9	46.0	52.1	29.5	54.4	2.8	70.5	57.2	276.4	66.9	81.7	49.9	12.2	30.1	10.8	51.5	33.8	53.0	34.7	39.3	27.8	39.7	41.4	65.1	20.7	69.0	19.3	11.6	0.0	26.3	0.0	156.3	81.7	25.7	0.0	15.0	41.0	61.9	63.8	26.2	20.3	49.1	6.6	87.6	41.9	73.0	15.0	109.2	36.5	69.6	72.3	75.5	51.4	171.7	109.3	48.3	0.0	15.7	47.7	122.0	14.8	37.8
CFAP97D1	C17orf105	ENSG00000231256	"CFAP97 domain containing 1"	B2RV13	17	43780435-43787620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053028	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 7: Non-specific - Mitochondria"			"HPA053028: AB_2682020"	"unprognostic (7.80e-2)"	"unprognostic (5.46e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.41e-1)"	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.1	13.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	1.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592165-130599575	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.0;pancreas: 30.7;pituitary gland: 59.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.9;Enteroendocrine cells: 20.5"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 24.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RPMI-8226: 12.1;SCLC-21H: 6.7;SuSa: 4.0"									HPA041773	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			1.7	0.6	4.6	0.0	2.3	0.0	0.0	2.9	3.5	0.1	0.0	0.2	0.0	0.2	0.1	0.0	1.5	0.0	1.9	1.3	24.0	0.0	0.0	0.1	0.0	3.9	8.1	0.0	30.7	0.0	59.3	0.0	5.6	7.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	10.7	0.6	8.6	5.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.3	2.9	3.5	1.3	24.0	3.9	8.1	5.6	3.9	8.6	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	20.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	Gastrulation	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"pituitary gland: 2.4"	"Cell type enriched"	"Detected in single"	9	"Bipolar cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Approved				"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"			"HPA041773: AB_2677664"																		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	2.4	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433503	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	45.0	51.0	57.4	24.0	58.0	35.0	45.2	60.8	75.3	69.1	57.9	47.5	30.4	58.6	62.3	41.2	55.6	29.7	36.8	57.1	61.7	64.5	43.1	37.3	27.1	58.8	59.3	83.1	41.2	30.8	57.1	63.1	58.8	39.9	40.2	49.6	39.4	38.1	35.7	42.4	36.4	51.0	56.7	30.2	34.7	59.5	59.6	57.0	45.0	34.9	35.8	44.8	50.7	60.8	65.0	47.6	158.9	59.2	141.2	156.3	47.2	63.2	74.1	83.0	119.1	82.5	86.6	61.3	91.1	79.3	92.7	71.5	123.3	101.9	164.9	26.4	58.6	63.0	46.6	177.2	97.3	69.2	51.6	98.4	85.5	100.2	121.4	144.6	91.5	114.0	91.3	28.3	93.9	149.0	102.2	152.6	77.1	110.0	24.8	182.7	64.3	108.5	93.1	35.5	94.5	79.4	105.7	22.3	92.5	136.4	91.8	121.6	53.8	59.2	63.1	63.2	40.8	54.4	89.2	228.6	59.3	89.9	53.3	61.3	45.5	60.8	31.2	47.8	44.5	33.6	42.7	34.7	48.8	35.4	38.7	36.5	38.1	28.5	46.2	48.7	68.5	25.8	57.4	58.0	60.8	75.3	57.1	61.7	58.8	59.3	58.8	56.7	59.6	60.8	87.4	38.5	57.5	37.5	45.5	57.9	116.3	135.9	47.3	87.2	89.5	103.4	34.7	91.5	111.2	115.8	116.7	119.0	50.5	493.3	197.6	79.1	133.7	197.7	118.5	97.6	82.2	78.9	49.5	94.9	114.0	82.9	61.2	121.3	28.5	194.5	62.8	153.9	77.1	62.2	50.5	219.2	59.0	53.1	44.5	69.7	125.2	51.1	33.8	45.9	64.8	60.8	84.5	49.8	75.6	92.4	745.2	112.5	42.3	116.9	612.2	637.6	205.3	112.5	98.6	55.3	88.2	311.2	178.0	49.5	65.6	154.9	51.6	103.5	120.0	130.4
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196652043-196747504	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 1676.3"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 448.0;Hepatocytes: 1114.8;Leydig cells: 283.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 18.7"	"Lineage enriched"	"Detected in single"	26	"T-cells: 18.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 123.1;HSkMC: 119.5;hTERT-RPE1: 374.9;RT4: 227.0"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	100000000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	125.3	42.1	18.1	32.7	21.5	1.3	66.9	20.0	29.6	76.8	43.0	51.0	30.5	12.8	15.9	63.8	24.2	133.6	301.5	18.1	18.6	25.5	1676.3	70.8	27.4	19.3	19.0	165.1	14.0	6.4	16.0	26.1	19.9	23.0	80.2	4.3	126.7	24.0	21.1	74.5	52.1	32.5	19.5	13.9	46.9	14.3	21.6	12.1	102.5	84.0	25.9	149.9	27.0	21.1	0.0	64.9	0.0	0.0	96.5	54.7	0.1	25.8	63.1	3.5	13.5	0.1	11.9	0.3	9.6	0.1	0.2	2.2	0.0	23.6	2.6	1.3	0.0	20.0	74.7	0.0	123.1	0.9	0.3	119.5	0.3	18.4	7.9	374.9	79.2	0.0	74.4	2.7	89.4	0.1	0.5	0.1	0.4	0.0	0.1	0.2	89.8	21.0	0.0	227.0	0.0	0.1	0.4	0.0	0.1	0.6	0.1	0.0	5.6	73.6	0.9	0.8	0.8	0.8	0.0	0.3	13.1	0.2	5.8	0.0	0.1	0.0	2.0	0.0	18.7	0.0	6.6	4.0	0.2	0.0	0.4	1.5	0.7	0.0	0.0	0.0	0.0	1.1	18.1	21.5	20.0	29.6	18.1	18.6	19.3	19.0	19.9	19.5	21.6	21.1	73.9	9.6	17.6	0.7	4.2	44.2	63.6	140.6	14.2	2.4	1.3	3.4	10.9	35.8	141.1	5.5	0.0	0.0	3.1	0.1	0.0	6.2	2.6	2.3	3.8	49.8	0.0	52.6	0.6	0.8	0.0	448.0	8.6	1.9	3.8	6.9	47.8	1114.8	1.1	0.0	1.0	0.0	14.2	43.8	62.1	7.4	283.9	5.7	44.4	38.4	0.3	0.3	0.0	0.0	0.2	5.3	0.0	138.8	2.6	13.0	0.0	0.5	115.6	1.4	6.6	94.2	59.6	1.4	1.0	10.9	38.2	0.1	13.2	26.3	0.0	61.5
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196832189	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	272	"liver: 2081.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 320.0"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	1.5	0.6	0.1	1.8	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	7.6	2081.3	0.1	6.7	0.1	0.8	0.3	0.3	0.0	0.1	0.1	0.4	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.7	0.2	0.1	6.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.3	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.0	2.4	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.8	0.4	0.1	0.2	0.1	0.5	3.2	0.0	0.0	2.2	0.4	0.1	0.0	0.0	1.2	0.0	0.1	1.8	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.7	0.0	0.0	0.0	9.9	0.0	0.0	0.0	6.0	15.0	320.0	5.6	0.0	0.4	0.0	0.0	16.9	0.4	0.2	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	41.0	2.1	0.3	1.5	0.0	0.0	0.3	1.4	5.6	0.1	0.1
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943738-196959622	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2752	"liver: 1311.8"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 38.5"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		4800000000	"Cluster 6: Non-specific - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1311.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	38.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1675	"liver: 167.5"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 102.7"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1900000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	102.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CFL1	CFL	ENSG00000172757	"Cofilin 1"	P23528	11	65823022-65862026	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013086, CAB033687, CAB037077, HPA053761"	Approved		Supported	Cytosol		NA	NA		290000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251"	"unprognostic (1.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	609.5	435.4	578.8	932.7	598.8	1322.1	514.5	590.1	661.2	451.5	475.3	1145.1	1169.2	713.1	343.2	706.0	481.5	413.6	501.9	637.3	599.8	612.5	471.0	683.4	987.6	626.4	571.5	344.7	264.6	301.8	340.6	479.2	622.1	440.6	990.3	208.9	453.1	457.6	261.9	503.1	1120.7	847.3	608.3	775.2	633.8	267.4	632.2	939.6	370.9	230.6	1100.5	682.9	471.2	695.4	2284.3	1783.6	1908.5	1529.8	1142.6	1157.0	1031.6	2309.7	1942.4	2457.5	1460.7	1012.4	1815.2	1700.8	1755.3	2925.7	1780.5	1623.2	1389.2	2103.8	1824.9	1869.0	718.2	2185.8	1271.2	1162.1	1222.6	1890.2	2854.6	1339.3	1412.4	2166.7	1108.0	1494.0	2663.1	1099.4	1037.6	1648.5	2635.7	2133.0	2739.4	2965.4	2095.8	1985.4	1432.7	2050.3	941.1	2181.9	1847.8	1468.6	952.7	2106.6	1250.6	1733.6	1682.2	1053.4	2104.1	1427.8	2330.5	2087.3	1603.5	2672.6	2194.0	1193.1	2065.2	2251.0	2146.2	1161.7	2004.4	1690.2	2720.0	2973.1	2534.0	2955.4	1964.6	1561.4	1992.5	2296.2	3343.8	1527.0	1459.3	1905.2	2946.2	1961.1	3255.3	2558.6	2696.1	6842.2	578.8	598.8	590.1	661.2	637.3	599.8	626.4	571.5	622.1	608.3	632.2	695.4	805.5	246.8	223.0	24.5	890.8	1349.3	1253.3	1197.1	598.8	198.5	655.2	646.0	74.8	459.0	595.7	520.5	58.4	1239.8	1439.8	2052.9	892.1	2114.0	459.4	376.6	648.1	918.4	779.0	557.7	38.8	1965.0	2470.6	579.0	642.8	603.3	598.2	527.4	698.2	436.3	2911.0	203.6	30.3	1448.8	891.1	1185.5	1706.6	373.2	352.2	1474.2	985.4	38.4	2903.8	478.3	2075.2	22.6	62.0	3082.4	1894.7	502.9	639.1	991.2	2279.4	1246.5	295.5	118.0	420.7	448.2	1184.3	177.4	412.8	703.8	1267.4	1732.4	1276.2	621.7	1315.3	1383.3
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116154-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 609.9;Urothelial cells: 521.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 392.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 392.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 214.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	122.4	50.6	38.8	103.9	40.9	247.6	83.1	54.1	47.4	57.0	75.6	86.0	59.2	57.9	60.6	68.0	66.6	71.6	184.8	39.4	32.7	57.5	59.2	174.6	91.1	46.5	40.5	38.3	40.7	31.8	29.4	94.0	42.1	65.6	56.4	12.4	58.0	63.2	222.8	51.0	64.8	58.8	36.6	98.1	56.5	25.3	51.9	54.1	78.8	89.2	107.3	78.7	61.7	46.1	21.5	42.9	30.0	17.9	92.3	71.0	37.5	53.6	92.1	34.3	41.6	50.4	78.4	5.8	49.6	62.5	41.6	15.5	9.8	40.3	53.9	160.7	29.9	32.3	38.4	82.2	63.6	24.2	102.2	76.8	39.6	58.2	50.3	41.7	176.7	7.3	110.8	131.2	63.1	17.9	11.3	96.3	10.2	17.2	32.7	11.7	7.2	46.5	42.5	44.0	6.6	11.8	35.7	31.2	43.2	19.6	22.1	44.8	193.6	71.0	29.5	26.7	26.1	214.6	76.2	35.9	50.6	19.5	36.3	91.8	60.3	70.3	54.4	61.8	48.4	25.6	46.5	52.1	33.4	20.9	29.5	38.3	392.6	45.2	68.5	23.0	60.7	42.0	38.8	40.9	54.1	47.4	39.4	32.7	46.5	40.5	42.1	36.6	51.9	46.1	191.3	451.9	234.9	30.3	126.4	54.8	229.6	164.9	29.0	10.9	38.9	30.0	205.8	102.9	206.7	69.9	31.3	77.2	166.2	132.5	74.3	148.8	83.3	202.8	75.0	261.0	95.1	59.1	6.9	72.5	34.8	89.5	73.4	219.2	81.6	93.4	201.0	97.5	68.6	13.5	16.8	76.8	40.7	123.2	609.9	44.8	51.9	278.0	97.8	146.1	247.0	23.4	276.0	29.7	56.8	166.4	155.6	49.7	317.8	386.0	116.7	101.5	276.1	30.7	39.5	113.2	77.9	14.4	12.2	33.2	86.1	70.1	168.3	56.1	50.9	521.3
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"CF transmembrane conductance regulator"	P13569	7	117287120-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.6;intestine: 42.7;pancreas: 210.7"	"Group enriched"	"Detected in many"	4	"Ductal cells: 485.4;Ionocytes: 252.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.0	0.5	4.7	2.0	0.0	0.4	0.7	1.3	8.5	0.0	42.7	36.2	1.1	1.1	0.8	2.2	54.6	0.1	0.3	0.7	2.1	1.6	8.2	0.0	1.1	0.7	0.0	210.7	0.2	0.1	0.6	0.7	2.2	40.7	0.0	21.5	0.5	0.0	1.9	19.9	2.0	1.7	0.0	3.1	1.7	1.0	0.1	0.1	0.0	0.3	0.7	0.0	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	98.9	0.1	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.7	1.3	0.3	0.7	1.1	0.7	0.7	1.7	1.0	2.9	0.0	6.4	65.6	0.0	0.5	0.0	2.0	2.6	0.0	0.5	0.5	0.0	2.4	55.8	17.8	0.0	0.0	0.0	0.0	45.8	0.0	485.4	3.2	9.6	1.2	0.4	7.2	0.0	2.2	4.5	0.0	0.3	4.1	19.8	1.3	0.1	0.0	0.4	0.0	0.0	1.1	13.9	252.3	0.0	0.0	2.6	0.3	0.1	0.0	1.0	6.7	0.5	0.0	0.5	23.8	14.8	86.4	0.0	0.0	4.0	8.6	0.0	5.6	0.0	0.0	0.0	1.6	2.2	0.5	0.0	0.0	0.0	0.3	0.1	87.3	5.8
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4389.4"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.8	4.1	0.2	0.1	0.4	1.9	0.1	0.7	0.7	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.5	0.3	0.3	2.7	2.0	0.7	0.3	2.1	1.6	0.5	1.3	18.9	4389.4	725.8	0.9	2.7	0.3	0.3	0.5	1.1	3.3	2.1	0.3	3.4	0.1	1.1	38.1	0.5	1.0	0.8	0.5	0.0	0.3	0.4	0.2	1.5	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.4	0.7	0.7	0.3	0.3	2.1	1.6	0.9	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CGAS	"C6orf150, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452297	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	2.9	1.1	1.7	6.4	2.1	14.0	1.7	2.2	3.0	2.4	1.7	1.9	2.7	1.9	0.6	2.3	1.8	2.6	1.5	1.9	2.0	1.1	0.8	3.5	7.4	2.6	2.2	1.2	1.2	0.6	0.6	3.1	2.6	1.9	1.8	0.2	1.8	1.8	0.5	1.1	2.5	2.0	2.4	5.2	2.3	1.0	3.0	2.3	1.6	0.9	4.7	4.3	2.1	3.4	19.9	5.8	0.1	0.2	1.2	2.7	0.1	10.1	3.7	11.3	12.6	20.7	14.2	0.2	20.9	4.3	6.3	10.1	9.8	0.2	12.0	31.9	0.0	16.9	8.2	0.1	4.0	12.3	11.5	1.6	3.2	11.8	0.1	0.0	3.5	0.1	0.0	37.1	8.7	8.0	0.0	27.1	6.2	2.4	11.2	23.4	43.8	45.2	0.0	7.3	0.3	0.1	17.3	0.4	10.2	0.2	0.0	33.9	5.0	0.0	9.1	8.5	0.2	8.1	19.8	0.2	0.1	17.5	11.4	26.3	12.7	19.0	6.0	17.5	4.7	8.4	7.9	5.9	7.5	6.7	1.8	3.4	8.5	4.2	11.6	17.6	8.0	6.0	1.7	2.1	2.2	3.0	1.9	2.0	2.6	2.2	2.6	2.4	3.0	3.4	10.2	3.2	4.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.6	0.0	0.0	0.2	12.0	0.0	0.0	2.0	0.0	8.4	8.5	6.0	0.0	0.0	0.0	3.9	0.7	2.3	0.0	12.5	5.1	1.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.3	8.0	0.7	0.0	0.0
CGB1		ENSG00000267631	"Chorionic gonadotropin subunit beta 1"	A6NKQ9	19	49035569-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"pancreas: 2.7;pituitary gland: 4.3"	"Cell type enriched"	"Detected in single"	77	"Syncytiotrophoblasts: 69.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 17.7"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	69.9	0.0	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin subunit beta 2"	Q6NT52	19	49031890-49033238	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 40.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.7	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	4.1	0.0	0.5	0.0	0.1	0.3	0.0	29.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.8	0.0	3.9	12.1	15.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.5	1.8	0.0	0.0	40.0	0.0	0.0	0.0	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin subunit beta 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 9.8"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 865.9"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 2.9;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"BEWO: 65.8"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	2.1	9.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.3	0.2	0.1	0.4	0.0	0.0	2.1	0.7	0.0	0.0	0.1	0.4	0.0	3.3	1.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	118.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	865.9	0.0	0.0	0.0	0.0
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin subunit beta 5"	P0DN86	19	49043848-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pituitary gland: 8.7;placenta: 25.6"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 19.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0;testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 120.1;U-251 MG: 53.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	8.7	25.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.4	0.0	0.0	0.0	0.0	120.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.2	0.0	53.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin subunit beta 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 3.2;skin 1: 3.9"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 16.5;Syncytiotrophoblasts: 58.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HaCaT: 3.1;hTCEpi: 3.2;U-251 MG: 7.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	1.1	0.2	0.0	0.1	0.1	0.1	2.4	0.6	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.0	0.1	0.3	0.1	0.7	0.0	1.5	0.4	0.1	3.2	0.0	0.0	1.1	0.4	2.2	3.9	0.0	0.0	0.1	0.1	0.0	1.1	0.1	0.2	0.2	0.1	0.0	1.1	1.8	0.1	2.2	0.3	0.1	1.0	0.0	0.0	2.7	0.3	0.0	0.6	0.8	0.5	1.8	0.0	0.1	0.5	1.2	3.1	0.0	2.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.2	0.2	0.4	1.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	1.0	0.0	0.0	1.1	0.6	0.1	0.0	1.5	1.5	0.0	7.5	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.6	0.1	0.6	1.8	0.0	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.0	58.7	0.0	0.0	0.0	0.1
CGB8		ENSG00000213030	"Chorionic gonadotropin subunit beta 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 18.8"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 44.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 157.9;U-251 MG: 57.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	157.9	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.1	1.0	4.0	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.1	0.2	0.6	0.0	2.8	7.1	0.7	57.2	0.1	0.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 528.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	40.2	31.0	22.2	45.8	25.5	75.7	36.9	26.5	29.8	39.9	27.1	32.8	35.6	45.3	32.7	35.6	33.5	37.3	35.9	23.5	27.3	40.2	41.3	39.5	65.2	23.0	22.9	56.2	37.9	44.4	23.2	42.0	23.3	35.5	39.6	48.8	35.2	35.3	37.6	28.1	37.6	44.3	24.4	52.7	33.7	32.5	23.6	85.3	47.0	47.4	61.9	35.7	27.7	34.9	37.4	64.1	109.3	77.4	92.8	78.1	34.5	81.9	71.4	82.0	97.9	46.7	56.4	81.9	52.7	74.7	63.0	30.2	91.4	63.2	103.2	126.0	46.5	132.3	66.0	47.4	79.7	86.3	93.8	74.4	53.8	95.0	118.7	99.2	85.1	99.0	58.2	87.5	89.5	62.9	136.5	59.5	58.1	62.5	59.0	83.6	106.9	58.0	56.0	66.3	22.0	66.6	66.9	35.6	179.1	79.6	57.5	95.6	81.5	98.8	72.5	528.4	81.8	64.0	83.2	90.5	73.1	81.5	84.9	107.9	42.7	81.2	44.2	45.7	43.8	45.0	39.6	46.4	40.6	47.6	46.6	39.6	77.0	47.4	51.6	34.0	48.9	44.7	22.2	25.5	26.5	29.8	23.5	27.3	23.0	22.9	23.3	24.4	23.6	34.9	65.1	51.3	48.0	32.3	75.1	53.2	65.7	45.6	60.9	35.8	59.8	45.3	45.9	42.9	47.8	40.5	16.7	55.0	66.0	49.0	66.5	39.0	21.0	37.8	64.5	63.0	41.9	107.5	40.6	42.0	63.6	57.5	50.4	46.8	46.9	61.1	74.6	55.1	41.2	67.3	35.6	38.3	38.7	56.2	72.8	36.3	69.6	58.7	40.9	42.2	52.4	70.6	53.5	62.8	91.1	52.8	43.9	50.0	63.7	63.0	41.1	65.1	25.3	32.9	65.7	63.3	79.0	94.1	47.9	52.5	50.0	83.9	80.5	31.8	36.0	72.7
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0"	"Low region specificity"	"Detected in many"							"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	5.8	1.1	1.9	6.0	3.3	0.4	9.0	8.5	3.3	4.9	6.5	37.2	52.7	1.4	1.5	8.6	13.2	13.6	0.6	2.0	3.7	12.2	32.1	27.3	0.4	5.5	3.0	2.0	24.2	32.1	3.7	1.6	5.6	10.1	25.1	3.7	21.1	7.0	0.2	17.9	56.4	1.5	1.7	0.4	30.4	6.6	3.4	0.7	4.9	0.1	2.3	8.3	6.2	6.7	28.9	3.2	2.7	4.6	0.0	0.0	35.4	0.1	0.1	0.8	0.9	91.4	59.1	1.3	9.4	0.0	4.9	27.0	8.6	5.0	0.6	17.3	6.0	2.4	1.3	1.8	0.0	0.4	3.6	0.0	1.0	1.3	0.7	0.0	0.3	7.8	1.2	8.1	0.0	26.8	5.0	0.6	22.9	58.6	2.5	5.4	2.8	4.3	17.9	44.0	8.9	4.4	1.8	27.1	1.0	10.3	33.5	0.3	0.5	0.3	8.3	0.5	1.2	7.7	8.4	5.2	0.3	3.3	2.4	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	1.9	3.3	8.5	3.3	2.0	3.7	5.5	3.0	5.6	1.7	3.4	6.7	0.1	118.6	33.3	2.3	0.2	0.3	3.3	5.9	0.6	4.3	14.9	9.1	0.7	24.3	22.4	3.7	0.0	3.5	0.5	173.2	0.0	21.5	0.3	13.8	2.1	0.6	10.3	2.7	0.8	25.4	0.3	2.3	54.6	27.3	0.0	0.5	0.0	29.6	0.3	0.0	10.4	32.7	8.2	0.0	0.4	1.2	0.6	0.5	3.6	0.0	2.1	13.5	0.0	3.5	11.7	49.5	108.7	0.7	0.5	11.9	88.7	3.0	46.8	1.5	0.0	0.1	1.0	1.5	6.9	4.2	1.8	0.4	0.6	1.8	27.2	18.3
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550717	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"		No	No				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102"	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	5.0	11.5	23.6	1.5	23.0	0.0	19.8	19.8	18.5	32.0	47.2	3.2	1.2	17.8	4.4	11.0	8.9	2.8	20.1	18.6	24.2	68.3	36.0	21.0	1.1	28.9	28.2	5.8	18.6	9.6	4.1	28.8	27.7	28.7	2.3	12.3	32.3	16.2	0.7	11.5	2.5	10.8	20.0	0.4	15.5	6.6	29.9	4.6	19.8	1.9	3.2	8.9	20.2	15.7	0.0	1.3	13.1	0.0	0.0	0.0	0.2	0.2	2.9	1.1	2.4	8.4	0.1	0.0	11.4	1.7	1.9	0.0	6.2	0.1	1.8	0.1	1.0	0.1	0.1	5.7	0.2	0.1	0.0	0.4	0.4	1.3	0.0	4.4	52.7	0.5	0.0	0.0	2.1	2.4	0.0	0.2	6.5	3.7	0.6	0.1	6.6	0.3	4.4	0.0	0.3	0.7	0.0	5.1	0.0	37.6	0.5	0.6	32.5	0.0	3.3	0.1	1.9	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	23.0	19.8	18.5	18.6	24.2	28.9	28.2	27.7	20.0	29.9	15.7	3.9	51.3	87.2	79.7	0.2	4.6	13.4	5.1	4.6	0.4	27.4	27.1	21.0	10.0	11.7	22.0	0.0	1.0	1.6	0.9	41.1	9.9	3.0	11.0	9.4	21.8	13.1	2.7	0.7	13.2	1.0	17.1	11.2	11.8	1.3	3.5	58.5	65.5	0.3	0.0	1.9	3.7	18.3	1.6	4.9	18.1	19.9	0.9	7.2	156.4	0.6	43.7	0.0	11.1	1.5	4.3	1.2	27.8	0.0	18.6	0.2	39.4	2.2	1.4	0.0	6.6	2.3	0.6	0.6	0.8	2.4	1.4	1.2	0.6	2.2	7.0
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119128	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;salivary gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 40.1;SK-BR-3: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA		700000		"Cluster 65: Brain - Ion transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	4.2	2.3	20.4	1.0	21.7	1.9	6.3	17.1	28.3	3.5	2.1	2.6	3.9	11.6	1.4	3.5	12.4	3.9	4.9	27.0	18.1	3.8	14.9	1.1	0.5	12.8	12.1	13.9	2.1	0.2	3.3	0.3	12.8	4.2	3.8	3.7	25.3	0.9	6.5	2.3	5.6	5.4	10.2	0.6	11.4	3.8	17.2	0.2	1.8	6.9	0.4	3.7	1.5	16.4	7.6	6.3	0.3	8.1	18.3	6.8	0.7	9.1	0.0	0.8	0.4	1.7	6.2	0.1	2.4	18.2	2.2	0.4	1.4	2.1	0.5	0.7	3.7	0.1	10.4	16.4	16.9	5.3	0.6	4.7	18.1	2.6	2.1	11.6	0.7	1.3	0.2	0.4	1.2	24.0	4.0	6.8	2.1	40.1	16.8	0.3	0.0	0.6	0.1	0.3	17.8	26.6	17.7	78.7	9.4	0.2	25.3	13.3	0.0	0.0	6.9	0.0	0.7	2.3	0.8	0.7	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.7	17.1	28.3	27.0	18.1	12.8	12.1	12.8	10.2	17.2	16.4	0.1	0.0	0.0	2.6	0.4	0.6	0.2	0.0	1.8	9.2	9.2	12.6	1.4	0.0	0.0	0.0	4.2	0.0	0.1	0.2	0.0	0.1	1.1	0.3	3.0	0.4	0.0	5.5	16.6	1.5	0.2	3.8	4.6	0.1	0.0	0.4	3.6	5.0	0.4	0.0	15.9	6.8	0.0	0.6	0.7	3.1	4.4	0.2	0.0	1.9	0.0	0.5	0.0	12.5	0.8	2.1	0.0	8.6	1.1	1.8	3.4	4.4	0.0	2.2	0.0	1.7	0.7	3.2	16.2	2.2	0.4	0.1	0.1	3.2	0.9	0.1
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.9	9.2	20.5	3.9	21.1	7.9	11.9	22.2	25.8	9.6	21.2	11.7	5.3	11.0	13.8	5.9	11.2	5.9	12.3	20.2	21.2	14.5	7.8	7.5	6.0	21.2	21.4	10.0	13.1	12.8	12.7	7.0	21.2	11.3	6.9	13.6	8.5	10.9	19.3	4.2	8.5	8.6	22.1	8.5	9.7	22.3	20.9	5.6	12.7	12.5	5.3	10.1	7.5	22.3	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.5	21.1	22.2	25.8	20.2	21.2	21.2	21.4	21.2	22.1	20.9	22.3	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956512	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 68.6;skeletal muscle: 68.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2;Exocrine glandular cells: 27.8;Gastric mucus-secreting cells: 33.6;Pancreatic endocrine cells: 19.3;Plasma cells: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 109.5;HHSteC: 80.7;hTCEpi: 130.8;SK-MEL-30: 95.0;U-266/70: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Mitochondria		"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	9.1	0.6	12.3	1.4	12.0	1.8	0.9	11.1	30.7	2.1	7.1	1.9	2.0	0.7	1.5	23.3	1.7	1.8	2.4	11.4	16.6	4.0	11.5	2.0	0.9	13.0	14.5	0.7	68.6	1.4	1.9	0.8	16.9	1.3	0.8	1.1	5.1	1.0	68.4	1.6	1.4	0.8	12.6	0.9	14.8	0.7	17.6	0.5	1.5	11.7	3.0	4.3	3.7	16.6	9.1	6.0	1.5	27.2	4.3	3.2	11.1	53.5	109.5	5.8	15.5	15.1	2.2	2.8	4.1	4.8	17.2	6.0	12.0	4.4	4.1	10.4	2.5	2.5	1.6	0.0	80.7	7.3	0.1	36.1	130.8	17.1	23.2	1.8	5.4	62.3	7.7	12.5	4.8	5.5	5.3	0.1	4.9	31.0	21.3	4.8	0.1	12.8	3.0	3.5	5.3	7.9	1.6	9.5	95.0	3.3	3.6	51.1	1.8	1.3	16.1	1.5	9.4	81.1	19.0	11.0	4.8	10.3	12.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	12.3	12.0	11.1	30.7	11.4	16.6	13.0	14.5	16.9	12.6	17.6	16.6	6.2	0.0	2.0	0.3	3.1	2.8	3.8	11.5	3.4	2.6	2.2	2.4	4.6	4.3	6.5	0.0	2.1	0.3	2.6	8.0	35.2	6.4	0.1	1.8	0.4	2.7	3.5	3.2	1.3	27.8	0.3	0.6	33.6	2.1	0.0	0.4	1.8	0.7	0.4	0.0	1.5	8.0	6.1	0.3	1.5	0.0	0.3	0.8	5.4	0.0	1.0	0.5	0.0	0.5	0.2	19.3	2.3	0.0	21.4	6.5	0.8	0.3	3.3	0.4	0.0	0.3	3.2	1.1	1.1	1.5	4.3	3.4	1.6	0.5	4.8	14.6
CHAC2	GCG1	ENSG00000143942	"ChaC glutathione specific gamma-glutamylcyclotransferase 2"	Q8WUX2	2	53767804-53775196	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 44.0;Plasma cells: 27.0;Spermatocytes: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049235	Approved		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA049235: AB_2680686"	"unprognostic (2.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (3.80e-7)"	"unprognostic (5.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-6)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	5.0	4.4	1.6	4.8	1.7	6.9	2.1	2.4	2.4	1.2	0.9	4.4	7.3	1.1	2.6	4.5	0.7	1.3	2.5	1.6	2.0	2.9	4.4	1.4	6.6	1.6	1.6	0.6	1.9	1.3	1.6	1.1	1.5	1.7	3.7	3.7	1.7	1.5	4.9	1.2	4.5	2.2	1.3	4.2	4.5	5.4	1.8	4.9	1.0	4.7	6.5	3.2	2.2	1.4	39.9	13.0	13.5	12.1	6.7	3.3	2.9	17.9	3.6	12.5	14.8	9.1	10.0	33.5	25.3	7.8	18.8	14.0	31.1	21.3	21.7	71.3	27.1	26.6	16.3	15.0	10.2	31.8	11.6	4.2	6.2	23.2	17.5	3.3	24.8	23.0	27.8	19.2	16.6	13.0	38.0	26.5	17.5	17.1	23.1	28.6	28.9	34.2	17.3	10.6	16.8	4.7	20.7	15.3	8.7	8.1	9.3	12.5	11.0	7.3	26.1	28.2	29.3	18.9	26.1	28.8	9.9	39.5	10.2	1.3	0.3	0.8	3.5	0.7	3.7	4.3	3.8	3.9	0.8	4.4	4.3	4.1	1.0	1.1	0.5	1.8	3.9	1.9	1.6	1.7	2.4	2.4	1.6	2.0	1.6	1.6	1.5	1.3	1.8	1.4	2.3	0.0	1.1	2.0	11.7	3.4	3.7	7.4	0.6	1.6	2.2	2.0	3.0	7.2	4.1	1.8	0.0	1.9	5.1	3.4	11.7	5.4	13.1	2.2	1.0	3.0	0.0	44.0	4.8	8.0	0.9	1.6	10.2	2.2	1.3	1.5	3.3	7.6	7.8	1.7	4.3	4.6	2.0	1.9	3.0	3.5	2.8	1.7	3.6	1.0	5.8	5.7	8.2	5.0	2.1	7.9	1.4	4.1	27.0	4.1	3.7	9.8	1.9	6.8	0.0	2.4	3.1	47.0	6.6	5.5	3.4	0.4	5.3	5.1	10.6	4.0
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468906	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2;pancreas: 32.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 23.7;liver cancer: 10.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"memory B-cell: 21.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in single"	76	"B-cells: 21.5"	"Cell line enhanced"	"Detected in some"		"RT4: 4.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		22000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	2.1	14.1	6.2	0.7	7.9	0.3	9.6	17.4	7.3	21.8	3.9	6.7	7.6	0.5	0.1	1.8	0.8	1.5	1.7	5.5	6.3	2.4	36.2	1.6	0.6	5.6	4.9	3.1	32.6	0.0	1.3	0.5	5.7	1.9	4.0	0.5	21.3	0.2	14.5	8.5	10.3	0.1	5.1	1.1	10.8	1.2	5.8	0.2	4.2	0.9	0.2	1.2	1.6	5.4	1.0	0.8	0.7	0.6	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.6	0.7	1.2	0.7	1.5	0.0	0.4	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.1	0.7	0.9	0.1	1.5	0.0	4.0	8.5	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.9	2.1	0.4	0.1	0.0	1.4	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	6.2	7.9	17.4	7.3	5.5	6.3	5.6	4.9	5.7	5.1	5.8	5.4	0.0	0.0	0.0	1.3	1.0	0.3	0.2	0.3	0.0	0.0	4.6	2.4	0.2	1.5	0.2	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.2	4.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.5	0.1	0.0	2.5	0.0	1.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.4
CHADL	SLRR4B	ENSG00000100399	"Chondroadherin like"	Q6NUI6	22	41229510-41240931	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 109.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 40.3;Oligodendrocytes: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;Hep G2: 3.4;hTCEpi: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005696, HPA024654"	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA005696: AB_1079724, HPA024654: AB_1846615"	"unprognostic (6.14e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-8)"	"unprognostic (8.36e-3)"	"unprognostic (4.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.09e-2)"	2.6	4.7	25.4	0.5	62.4	1.0	2.6	57.5	43.9	3.5	5.2	12.4	1.5	1.3	1.5	4.2	2.2	2.7	16.5	25.1	32.4	2.1	3.1	2.1	0.8	69.6	51.8	2.6	3.5	0.5	4.3	0.6	61.3	6.5	0.3	1.0	11.3	3.8	2.2	6.1	3.4	0.8	43.4	0.7	5.0	3.5	56.3	1.7	4.4	1.6	0.4	2.9	3.6	109.6	0.6	0.2	0.2	0.3	0.1	0.1	11.8	0.4	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.5	0.0	0.6	0.0	0.1	0.2	0.0	0.3	3.4	0.4	0.1	0.1	1.0	3.4	0.3	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.3	0.2	0.6	0.3	0.3	0.4	0.1	0.5	0.2	0.2	0.3	0.7	0.1	1.3	0.2	0.1	0.0	0.0	1.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	1.6	0.0	0.1	0.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.0	1.2	0.0	0.3	25.4	62.4	57.5	43.9	25.1	32.4	69.6	51.8	61.3	43.4	56.3	109.6	2.7	6.4	2.2	8.1	0.2	4.0	10.2	1.8	17.6	1.4	7.3	6.5	3.5	2.8	1.7	3.7	0.0	3.0	0.4	0.8	7.9	2.0	18.6	2.5	0.6	1.3	3.0	0.0	2.8	1.2	6.4	5.5	2.6	1.6	0.0	3.2	2.5	2.5	5.1	0.0	2.5	0.8	2.0	0.8	2.1	12.0	3.7	3.4	17.8	1.9	0.4	40.3	0.0	12.5	83.1	0.8	1.0	3.0	0.3	3.7	1.3	5.9	4.1	1.6	0.0	2.5	1.2	0.3	0.8	6.5	3.7	1.5	0.5	0.7	1.4	6.5
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402640-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.7;granulocytes: 4.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	4.9	4.4	3.5	9.7	3.0	31.4	4.8	5.6	6.6	4.7	1.3	6.9	6.5	3.9	2.0	10.2	4.0	2.7	3.9	3.7	3.0	2.4	4.1	4.0	13.4	3.4	3.1	3.7	3.9	3.3	3.7	6.2	3.0	5.8	6.6	3.4	5.5	3.0	12.2	10.8	6.7	4.1	2.4	6.9	5.1	14.5	3.1	16.3	2.9	4.1	10.5	4.7	5.6	4.1	65.8	44.0	71.8	45.3	7.0	8.5	36.7	61.2	24.8	50.5	56.7	53.5	22.8	100.4	24.7	19.6	28.6	50.3	61.6	41.5	59.8	58.1	67.2	62.9	69.4	42.7	3.5	73.7	48.8	4.8	8.6	41.5	17.7	9.4	24.0	54.9	76.8	88.0	31.3	37.8	119.2	40.7	80.1	33.5	35.6	87.2	56.8	57.2	13.1	76.7	50.6	39.2	41.6	29.1	24.5	45.2	25.7	53.9	17.5	41.3	35.9	71.1	74.9	43.7	71.0	96.3	34.7	92.8	49.9	3.8	2.3	4.7	0.5	2.3	0.4	1.6	0.6	0.1	2.1	1.0	0.5	0.4	1.2	1.2	0.4	15.7	0.9	0.9	3.5	3.0	5.6	6.6	3.7	3.0	3.4	3.1	3.0	2.4	3.1	4.1	2.3	0.0	3.9	2.0	12.5	9.7	4.6	3.5	6.2	12.1	5.1	3.6	5.7	1.5	2.6	5.5	2.1	25.3	17.3	13.9	1.9	8.5	6.7	5.3	4.2	4.6	1.8	50.3	4.1	6.7	37.9	6.1	10.7	6.5	2.5	19.3	3.3	4.8	12.1	1.7	3.6	10.7	0.0	4.8	21.4	6.7	3.1	11.8	1.8	1.9	11.5	5.2	5.2	2.5	2.9	6.8	1.7	3.8	32.5	4.1	4.6	1.8	5.0	8.4	32.9	5.7	5.5	94.3	103.8	18.7	14.9	14.6	7.7	9.4	14.6	5.9
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385392-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favorable (5.44e-5)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	1.3	0.6	1.5	2.4	1.2	6.9	2.6	2.2	1.5	1.3	0.3	1.9	1.6	1.7	1.5	2.5	1.3	0.9	0.6	1.6	0.7	1.3	0.7	1.0	3.0	0.6	0.4	1.4	3.3	1.6	1.0	1.1	0.7	1.6	2.1	1.7	3.0	0.9	15.6	2.7	1.9	1.5	0.1	1.3	1.2	4.2	0.8	4.1	0.9	1.8	3.5	1.0	1.5	1.0	25.5	15.0	25.3	14.4	1.9	5.0	13.8	17.6	10.1	21.4	22.2	17.1	13.3	19.9	7.6	9.2	21.7	8.2	26.3	11.7	17.2	20.2	20.5	30.9	15.5	12.2	1.3	19.8	14.4	3.1	2.8	20.0	8.6	4.1	10.2	24.1	27.3	18.0	11.0	17.7	31.0	11.5	17.6	23.0	10.8	45.0	13.6	11.4	7.5	12.4	15.2	12.6	27.0	20.3	9.8	10.1	15.9	13.4	6.3	17.2	8.5	15.4	20.8	13.1	26.0	23.1	11.0	21.5	22.3	1.5	0.2	0.3	1.4	0.1	1.2	1.0	1.0	1.0	0.3	1.1	0.6	1.0	1.2	1.7	0.2	0.4	2.2	0.7	1.5	1.2	2.2	1.5	1.6	0.7	0.6	0.4	0.7	0.1	0.8	1.0	1.3	0.0	2.7	2.0	1.8	2.8	6.2	3.7	5.2	1.6	2.8	3.4	1.3	2.8	3.4	3.7	0.0	7.6	2.5	1.7	0.0	7.3	9.1	2.5	1.2	2.5	0.0	10.7	4.4	2.2	9.7	2.6	4.1	2.4	2.5	9.4	1.4	0.5	4.5	1.7	3.1	2.3	10.2	0.9	1.6	6.7	0.6	1.2	5.4	1.9	1.5	1.5	5.2	1.0	2.5	2.2	0.2	0.0	4.4	4.6	0.4	0.3	3.1	2.6	6.6	3.4	2.5	14.4	11.8	7.4	2.4	2.5	2.4	0.5	4.7	3.4
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49667942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 13.0;placenta: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"NB-4: 20.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 20.6"	"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.0	0.0	0.6	0.2	2.8	0.0	0.0	0.3	13.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	7.9	5.1	0.0	0.3	0.0	0.0	5.5	9.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.8	20.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.8	0.3	13.0	0.1	3.1	7.9	5.1	9.4	1.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHCHD1	"C10orf34, FLJ25854"	ENSG00000172586	"Coiled-coil-helix-coiled-coil-helix domain containing 1"	Q96BP2	10	73782047-73783652	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 561.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039046	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	"Nucleoli fibrillar center"	"HPA039046: AB_10673234"	"unprognostic (4.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.42e-4)"	30.1	53.2	38.7	29.3	39.1	26.7	34.4	40.0	45.1	25.4	41.9	38.1	40.0	25.9	52.0	49.8	25.6	18.5	52.9	38.9	39.6	55.9	54.7	25.6	36.4	38.8	38.5	24.1	31.3	42.8	31.0	29.2	39.2	36.7	29.0	21.9	45.6	21.9	64.2	29.9	35.1	19.1	39.3	40.3	37.6	24.8	39.4	34.6	31.9	50.6	30.8	27.7	30.1	40.1	115.8	87.6	70.8	98.3	57.0	56.6	71.1	58.3	70.7	59.8	80.0	78.6	99.3	56.9	63.3	52.9	60.1	77.9	69.8	79.8	46.9	87.6	132.4	42.7	73.2	119.6	68.6	65.8	65.7	52.3	96.3	51.5	33.0	87.4	83.9	78.8	67.0	61.7	78.3	117.3	82.1	146.5	66.3	109.6	561.7	77.3	53.9	72.6	97.5	63.0	34.2	67.4	36.0	246.2	127.3	56.8	138.0	92.5	47.2	35.7	79.7	60.2	102.4	61.5	70.7	91.2	83.4	133.7	28.5	44.2	51.3	32.5	36.1	54.9	43.9	62.6	43.7	43.5	52.5	50.8	36.1	36.9	21.2	36.6	45.6	75.1	65.2	35.8	38.7	39.1	40.0	45.1	38.9	39.6	38.8	38.5	39.2	39.3	39.4	40.1	45.0	41.7	48.4	5.2	50.7	35.1	34.4	117.2	29.0	27.0	68.7	74.4	77.3	47.1	84.4	60.7	22.9	151.6	49.3	112.1	199.6	80.8	73.3	99.0	64.1	44.5	61.8	61.2	8.6	88.3	166.3	38.2	41.8	75.8	29.8	63.9	51.4	132.5	139.7	20.2	8.0	106.2	122.1	61.2	35.6	16.3	56.5	52.7	40.9	5.6	82.5	76.8	51.5	5.5	9.6	96.4	96.4	55.3	53.3	55.3	101.0	243.3	99.0	35.3	52.6	36.1	52.4	70.1	48.7	71.2	43.5	128.1	41.6	83.9	98.4	54.9
CHCHD10	"C22orf16, MIX17A, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23767972	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1622.6;skeletal muscle: 1220.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1264.7;Distal tubular cells: 2498.5;Hepatocytes: 1879.9;Proximal enterocytes: 1501.3;Proximal tubular cells: 1437.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	216.5	136.5	181.6	30.3	188.3	12.5	144.5	183.0	248.9	77.3	262.6	261.2	92.6	35.5	32.4	147.3	43.1	10.9	1622.6	176.6	190.5	409.5	789.7	56.9	28.6	182.2	182.2	29.0	118.0	220.0	112.3	11.9	187.6	106.4	76.2	63.1	148.3	50.5	1220.9	71.8	159.0	17.9	169.5	100.3	160.2	27.8	204.8	14.0	224.7	660.7	34.5	110.2	89.1	179.3	33.1	66.4	19.7	85.9	42.1	27.7	41.9	11.9	22.8	23.5	28.4	124.1	35.1	113.5	30.7	41.2	12.9	99.8	109.2	34.1	20.5	35.9	140.6	22.5	48.8	117.1	73.8	63.6	108.2	53.3	91.9	35.6	9.3	4.9	29.0	17.2	47.7	48.0	20.6	121.8	21.8	48.2	16.9	194.9	183.5	90.0	4.0	209.0	112.7	55.3	41.3	23.8	13.9	145.7	149.7	36.6	54.9	47.0	15.3	1.0	1.1	18.3	0.2	28.8	11.1	62.5	20.5	54.9	11.2	0.2	4.1	11.2	3.0	9.1	1.9	11.7	3.2	4.0	1.8	10.6	4.9	3.5	0.0	0.8	8.2	7.3	4.3	1.2	181.6	188.3	183.0	248.9	176.6	190.5	182.2	182.2	187.6	169.5	204.8	179.3	88.7	12.8	10.5	36.2	294.8	48.2	415.4	28.2	144.5	136.2	156.9	238.2	503.8	268.8	20.5	419.3	114.7	42.5	104.7	1264.7	2498.5	88.1	27.0	76.6	229.8	47.4	310.5	74.3	38.5	54.5	255.7	67.8	300.7	94.3	84.0	171.9	78.1	1879.9	647.5	99.3	37.6	860.9	26.4	262.1	127.5	18.0	48.7	243.1	373.5	15.9	107.8	188.5	25.7	17.1	17.4	45.9	890.1	29.3	297.3	192.4	1501.3	1437.4	10.0	287.8	124.9	254.0	200.4	32.3	43.4	459.3	43.9	105.2	123.0	216.0	952.4	470.1
CHCHD2	"C7orf17, MIX17B, MNRR1"	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101573-56106476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 3195.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027407, HPA052510"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	250.6	665.5	321.4	167.4	331.8	426.3	253.9	361.8	358.5	220.7	351.0	257.6	252.0	219.0	252.4	269.6	210.6	132.1	412.4	325.3	352.7	349.4	316.7	213.8	205.0	340.1	341.5	246.3	315.9	322.9	272.3	151.8	343.2	237.2	191.7	226.2	281.2	196.7	791.4	233.3	243.9	150.5	354.6	223.3	287.6	120.7	352.2	267.7	208.2	591.3	200.2	217.8	214.2	367.9	3195.8	553.5	351.8	732.5	275.9	379.3	261.7	456.7	436.2	584.6	561.3	513.0	517.4	932.1	589.1	285.1	741.3	527.6	456.5	507.4	469.6	609.1	831.5	549.2	422.0	738.9	510.5	745.9	844.8	339.1	571.9	438.0	532.4	312.3	444.1	800.3	1182.9	546.7	486.4	449.9	1007.2	2306.5	760.6	867.3	872.6	668.3	343.3	1539.3	532.5	417.0	671.5	834.3	360.6	874.7	597.1	239.4	1002.5	1046.8	354.2	354.2	823.5	1473.9	683.6	497.1	785.4	1698.9	555.3	802.0	448.0	354.1	509.1	400.6	362.1	458.7	377.4	461.2	387.4	387.2	575.8	435.0	344.9	354.9	268.0	400.9	467.1	785.2	550.9	1066.7	321.4	331.8	361.8	358.5	325.3	352.7	340.1	341.5	343.2	354.6	352.2	367.9	465.1	256.4	284.0	44.4	521.9	717.5	956.6	1072.0	387.0	348.7	758.3	929.8	160.8	513.3	612.1	413.8	62.6	955.1	577.6	807.9	1860.7	1034.0	167.2	593.3	396.0	446.5	541.2	666.1	26.7	1325.1	1259.9	514.7	393.0	622.8	394.3	458.8	377.0	727.2	969.6	492.9	35.6	973.0	752.7	483.5	701.2	213.4	614.2	496.2	763.1	28.1	806.5	769.6	593.2	19.6	43.2	1190.3	974.5	505.9	803.3	1321.7	1138.5	1558.4	559.1	353.7	427.3	620.2	583.8	520.4	574.2	680.8	719.3	1228.8	492.5	633.1	929.0	1464.2
CHCHD3	"FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784870-133082090	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 125.6;skeletal muscle: 351.7;tongue: 243.0"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042935	Enhanced		Supported	Mitochondria		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	40.4	33.3	18.0	29.0	19.4	51.5	32.8	21.7	25.4	25.5	22.2	45.5	56.7	28.0	19.2	28.3	25.5	22.5	125.6	20.1	19.3	54.8	32.1	26.4	30.3	19.6	19.0	27.2	26.6	59.7	17.2	30.2	19.2	25.4	49.7	40.3	24.3	28.6	351.7	20.8	42.2	37.1	17.7	21.9	31.6	16.8	18.2	42.5	35.6	243.0	29.8	31.8	23.0	21.5	102.0	103.8	99.7	138.9	70.6	64.9	60.2	97.0	90.3	106.7	117.4	121.0	108.9	83.1	37.6	61.1	237.1	69.1	117.0	82.7	148.7	113.4	111.8	85.9	101.9	70.7	139.3	194.7	62.1	59.0	55.8	146.9	151.7	53.2	75.9	107.6	186.1	74.2	100.1	134.3	284.0	169.9	165.1	160.3	117.2	140.6	146.2	119.8	103.9	83.1	127.4	158.8	80.5	62.4	186.7	67.6	52.5	116.2	63.5	101.8	44.3	162.0	176.7	71.3	100.4	206.6	161.1	163.9	146.6	42.3	43.7	33.2	30.5	62.8	28.9	38.5	27.6	29.6	57.9	23.2	23.9	26.9	6.4	45.2	52.1	49.5	41.9	34.0	18.0	19.4	21.7	25.4	20.1	19.3	19.6	19.0	19.2	17.7	18.2	21.5	32.0	25.6	26.2	103.8	36.5	34.9	28.7	56.9	31.9	26.5	29.0	25.7	138.8	38.6	36.2	14.7	22.9	69.7	29.0	40.4	125.2	61.5	99.6	27.8	33.6	34.3	35.9	64.3	201.3	60.7	79.5	38.9	32.6	22.4	34.2	34.6	17.2	20.7	78.4	15.2	210.5	48.9	30.5	27.3	44.4	103.4	31.4	38.3	37.4	100.2	49.7	34.2	37.0	161.4	143.5	50.1	31.0	35.3	46.5	44.4	50.7	88.8	29.6	27.0	32.9	43.4	53.5	20.9	29.2	37.0	40.3	68.4	34.0	55.8	73.1	42.6
CHCHD4	"FLJ31709, MIA40, TIMM40"	ENSG00000163528	"Coiled-coil-helix-coiled-coil-helix domain containing 4"	Q8N4Q1	3	14112077-14124870	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Proximal tubular cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034688, HPA063727"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034688: AB_10696361, HPA063727: AB_2685103"	"unprognostic (3.89e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.63e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.65e-2)"	"unprognostic (7.85e-3)"	12.2	14.0	12.3	8.6	12.9	3.3	11.5	12.8	16.4	9.8	13.3	19.5	14.6	8.9	10.1	12.4	9.6	5.8	25.8	12.4	14.4	20.9	18.8	7.6	8.9	13.0	13.8	10.4	11.1	22.9	9.6	8.5	13.0	10.8	15.5	11.4	10.1	11.8	34.1	10.3	11.5	8.8	12.5	10.3	13.6	8.7	12.7	9.4	9.6	29.0	12.7	15.1	9.9	13.3	19.1	39.2	19.8	19.8	16.9	18.9	57.5	20.3	18.7	24.4	21.4	23.3	15.3	40.9	19.4	15.5	24.7	15.3	41.5	41.8	29.8	25.7	41.6	47.9	28.5	31.3	28.2	32.5	19.9	16.6	43.5	40.0	63.5	17.3	27.7	32.4	50.6	35.6	26.3	40.7	41.0	19.6	30.6	59.5	52.1	29.3	19.9	87.5	27.8	20.7	16.3	20.1	22.6	72.2	30.1	17.0	34.6	32.8	10.0	22.3	16.2	27.8	37.4	19.8	56.1	40.6	21.9	49.5	16.6	12.0	15.6	10.7	7.8	24.0	14.0	15.0	13.2	12.1	25.7	22.0	16.8	11.5	6.9	21.8	24.8	10.5	16.3	11.6	12.3	12.9	12.8	16.4	12.4	14.4	13.0	13.8	13.0	12.5	12.7	13.3	6.7	16.0	8.6	2.9	10.6	9.4	14.5	17.9	13.1	7.9	13.3	11.4	24.5	11.5	8.8	9.2	0.0	21.6	3.5	12.2	84.1	18.8	2.6	6.7	8.3	9.0	4.9	20.8	3.2	13.4	22.3	8.9	5.6	5.4	10.8	7.6	3.9	20.4	21.0	5.0	3.8	13.3	16.2	10.0	6.6	5.3	11.5	9.7	8.8	1.9	11.4	9.9	15.5	2.5	3.5	13.1	10.0	10.1	13.2	25.3	22.4	62.2	5.9	7.2	6.6	9.9	11.8	24.7	40.4	20.8	11.8	13.0	7.3	12.0	17.9	11.6
CHCHD5	"C2orf9, MGC11104, MIC14, MIX14"	ENSG00000125611	"Coiled-coil-helix-coiled-coil-helix domain containing 5"	Q9BSY4	2	112584240-112589275	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038263	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA038263: AB_10671525"	"unprognostic (3.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.18e-3)"	"unprognostic (8.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	19.1	28.9	20.6	12.4	22.0	18.3	22.4	22.6	28.7	18.5	19.8	19.2	18.0	17.8	6.4	28.2	19.6	14.4	24.5	20.0	21.7	35.8	40.2	17.8	14.6	21.4	21.6	15.8	46.1	28.1	31.7	9.8	21.3	22.2	6.3	5.7	16.5	12.6	38.9	23.3	17.2	6.5	21.5	18.5	25.4	22.9	22.6	16.7	27.1	18.7	7.9	19.6	18.8	21.9	32.5	53.1	23.3	0.1	9.3	19.7	22.0	14.0	18.2	28.3	20.0	58.1	39.0	24.7	54.4	19.4	23.9	23.4	8.9	31.2	3.8	26.8	43.2	33.4	15.6	46.4	40.8	28.5	22.5	26.5	26.3	37.4	22.8	13.2	15.8	0.1	35.1	36.5	18.1	80.3	25.8	45.1	26.0	24.1	25.9	0.9	19.3	48.7	37.8	29.1	29.7	33.4	17.7	26.3	31.6	6.2	33.9	24.9	22.0	28.2	39.7	17.2	20.4	65.0	66.3	29.1	39.1	7.7	33.9	22.1	69.0	68.6	49.9	66.6	42.1	49.3	46.8	47.5	64.1	63.2	48.1	49.9	38.3	62.3	62.6	81.3	78.6	61.9	20.6	22.0	22.6	28.7	20.0	21.7	21.4	21.6	21.3	21.5	22.6	21.9	39.3	9.6	13.9	2.0	41.1	43.1	65.1	153.3	51.8	19.2	100.0	109.6	40.4	90.1	73.8	82.8	10.4	131.9	41.2	138.5	219.2	109.7	188.8	138.1	63.5	44.3	91.7	44.6	2.2	176.7	109.5	43.8	67.8	79.6	24.7	50.8	51.4	211.4	123.9	6.7	2.8	107.3	97.6	122.0	63.5	290.9	30.7	63.7	53.4	1.0	101.0	61.5	87.6	1.5	4.4	123.2	140.1	28.2	41.0	76.8	184.7	286.7	99.3	28.3	13.1	33.9	47.8	141.8	39.4	112.2	58.1	92.8	44.6	89.2	97.7	85.7
CHCHD6	"CHCM1, MGC13016, Mic25, MICOS25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704240-126960420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Late spermatids: 106.6;Melanocytes: 172.5;Spermatocytes: 119.7"	"Cancer enriched"	"Detected in all"	4	"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047673, HPA051975"	Approved		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA047673: AB_10961761, HPA051975: AB_2681679"	"unprognostic (3.94e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	9.4	12.8	22.2	3.8	24.7	4.2	10.8	17.7	34.3	13.1	16.4	11.6	3.9	11.5	5.0	10.9	13.7	5.0	11.9	35.0	22.7	14.4	7.4	10.7	3.9	19.0	21.6	17.7	14.8	15.6	16.5	4.1	21.0	10.5	3.0	8.3	14.1	7.8	4.7	16.3	6.2	5.4	18.4	6.9	11.7	53.0	21.4	4.9	13.0	3.2	2.9	11.1	11.5	22.1	37.1	21.1	18.4	44.7	6.4	9.8	10.5	14.1	9.5	16.0	15.5	29.3	15.8	16.3	31.8	8.5	17.5	21.3	13.9	38.3	7.9	4.5	37.7	13.5	15.8	29.0	19.0	29.2	8.5	9.9	22.9	7.8	16.3	13.1	10.6	28.4	12.2	9.4	14.2	27.7	43.2	29.1	22.3	20.9	23.7	22.8	28.0	38.9	14.3	15.8	33.6	21.0	14.5	24.3	45.4	9.0	14.2	10.8	9.7	17.9	22.2	24.5	14.6	12.0	5.9	20.4	20.1	9.6	17.0	0.0	2.4	2.1	6.8	4.1	8.8	8.4	9.9	8.4	6.8	11.6	9.4	11.2	0.0	7.7	3.7	4.8	10.0	4.6	22.2	24.7	17.7	34.3	35.0	22.7	19.0	21.6	21.0	18.4	21.4	22.1	8.9	19.2	12.5	20.5	7.1	29.6	21.7	35.5	9.6	15.4	20.0	31.5	18.5	8.6	24.0	14.7	18.8	40.8	3.4	6.4	58.7	22.7	99.0	18.6	8.8	7.3	7.7	8.2	48.1	24.2	12.1	14.8	9.7	5.8	14.0	45.6	6.8	7.2	178.2	20.2	45.1	10.8	28.5	10.1	15.6	106.6	15.8	33.0	172.5	12.2	2.7	20.2	2.1	22.6	22.0	18.9	9.0	22.2	7.1	29.6	2.6	27.9	56.1	16.1	0.0	10.9	17.9	119.7	51.4	16.0	30.1	15.5	8.2	14.1	13.3	21.1
CHCHD7	"COX23, MGC2217"	ENSG00000170791	"Coiled-coil-helix-coiled-coil-helix domain containing 7"	Q9BUK0	8	56211686-56218809	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050783	Approved		Approved	"Cell Junctions,Aggresome"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Cell Junctions"	Aggresome	"HPA050783: AB_2681236"	"unprognostic (1.64e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.46e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.04e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.47e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.50e-1)"	24.9	20.2	25.8	30.0	27.1	29.2	25.8	30.8	32.5	22.9	25.2	30.7	33.2	18.6	46.0	22.8	24.5	17.1	41.6	26.6	26.6	42.2	26.2	28.0	39.4	27.0	26.3	49.1	26.9	36.0	38.1	19.3	27.3	26.4	30.2	32.6	35.3	21.0	37.5	21.3	36.0	18.5	28.6	46.3	27.7	11.7	26.7	36.5	28.0	39.7	38.1	28.1	24.2	28.7	59.3	18.9	39.4	13.1	100.9	71.3	42.4	41.0	37.0	30.7	23.0	46.2	68.9	54.7	34.8	23.6	43.6	32.3	40.7	61.3	38.6	24.5	77.4	83.6	45.5	66.2	51.8	72.1	52.0	86.2	54.2	22.2	98.0	43.8	32.8	100.0	41.8	34.9	74.1	29.0	72.2	106.5	35.1	93.5	25.6	82.0	12.0	46.3	57.3	63.3	10.2	7.0	21.8	32.2	31.2	47.8	34.1	40.5	49.0	16.5	35.4	53.7	39.5	37.1	40.3	93.5	46.0	105.3	28.9	55.2	37.8	53.3	42.4	38.2	40.2	60.4	46.9	43.5	44.1	52.5	55.0	49.6	15.2	49.7	35.0	62.6	60.1	33.9	25.8	27.1	30.8	32.5	26.6	26.6	27.0	26.3	27.3	28.6	26.7	28.7	31.7	19.2	77.9	2.6	72.5	20.8	44.1	49.0	16.5	31.4	37.1	27.1	93.7	35.8	48.0	49.7	14.6	44.0	66.0	75.4	125.2	41.4	27.5	25.2	15.9	29.8	39.6	32.6	9.1	75.4	80.8	26.3	92.8	32.2	53.8	13.8	42.8	78.4	162.3	13.5	8.0	66.3	34.6	67.8	45.3	13.4	37.0	58.0	53.4	14.0	68.5	50.8	60.8	1.5	6.5	65.4	63.9	30.9	59.3	45.3	115.0	82.3	41.5	37.9	13.1	23.9	39.0	51.4	39.4	34.7	23.9	42.1	61.7	21.7	73.5	48.8
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98929007	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	14.7	10.3	6.9	17.8	7.3	69.6	9.2	17.9	14.1	8.0	8.8	10.5	9.8	12.7	7.0	7.9	8.1	15.0	5.4	6.1	8.3	8.3	13.2	9.4	13.7	9.7	7.7	14.1	10.0	9.4	4.8	14.2	8.8	8.2	10.3	14.9	5.4	7.1	9.7	6.2	9.5	9.0	7.4	15.7	8.2	18.1	7.3	49.6	8.8	9.0	13.8	12.4	5.9	9.3	23.0	20.7	47.5	32.3	15.7	16.1	41.3	23.2	15.1	18.4	23.8	25.9	17.3	19.3	22.0	13.5	29.8	18.6	37.6	25.6	38.2	30.5	28.2	34.2	25.8	19.8	17.3	33.3	25.5	14.0	10.2	32.0	32.2	12.5	22.6	62.0	42.0	28.9	18.7	18.5	66.4	14.4	32.0	7.2	24.8	55.7	33.2	29.2	16.0	21.6	22.1	18.9	29.8	15.4	37.9	24.6	15.0	22.6	25.7	39.3	21.2	24.9	41.6	20.0	22.6	40.0	21.5	32.6	24.2	13.1	7.1	10.1	5.4	6.6	6.9	9.4	5.1	5.3	6.5	8.3	7.0	5.6	14.4	7.4	6.8	4.7	5.9	2.0	6.9	7.3	17.9	14.1	6.1	8.3	9.7	7.7	8.8	7.4	7.3	9.3	87.2	48.1	72.2	35.3	145.3	155.5	99.0	26.6	115.5	39.3	85.9	56.1	29.9	22.8	57.4	36.8	43.8	53.9	203.6	64.0	7.9	36.5	101.0	84.3	114.3	79.5	31.8	40.8	50.9	32.0	38.4	104.6	50.0	107.3	89.2	45.2	40.0	30.6	35.6	33.7	59.8	31.2	16.2	65.8	145.9	19.8	32.3	169.7	67.6	90.9	89.1	20.5	59.8	66.4	72.1	35.3	51.4	19.2	121.0	82.6	28.1	15.5	45.3	49.5	46.0	173.8	113.5	67.1	54.6	74.1	188.5	90.3	148.2	49.9	39.4	75.4
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242654-147295765	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	14.4	14.9	19.2	11.9	20.4	17.1	14.6	20.0	28.0	14.6	17.8	16.4	14.4	19.1	9.4	12.7	17.3	6.7	10.8	18.6	18.9	16.5	33.7	17.5	13.1	19.7	19.6	10.9	13.1	19.8	20.1	9.4	19.3	16.4	15.1	4.9	11.6	8.9	12.8	14.4	19.3	16.1	20.3	27.1	15.8	19.5	20.0	14.9	10.6	11.2	11.1	13.1	11.7	20.9	40.0	34.0	28.0	21.2	25.1	21.4	29.6	38.7	31.4	30.4	29.1	30.6	29.2	49.9	15.4	33.9	21.9	37.7	31.2	35.3	30.6	53.6	40.6	43.8	27.5	87.0	31.5	58.9	24.0	25.6	15.1	30.2	31.1	27.9	34.1	51.5	56.0	19.8	44.3	42.2	39.8	43.1	46.9	80.0	47.4	48.8	35.1	41.1	32.2	30.7	16.6	36.4	32.4	39.2	30.8	46.3	21.7	99.3	34.5	19.2	33.2	18.2	49.0	14.9	22.4	37.9	46.7	19.6	33.3	11.3	8.7	3.2	8.7	7.9	8.1	11.7	7.4	6.6	20.3	14.2	6.9	7.9	0.4	10.0	9.2	17.5	5.4	8.2	19.2	20.4	20.0	28.0	18.6	18.9	19.7	19.6	19.3	20.3	20.0	20.9	7.7	12.8	15.6	45.7	27.1	11.5	10.0	8.8	15.9	7.2	12.5	8.5	6.5	11.5	16.4	5.5	6.2	21.7	17.1	15.4	21.5	10.0	21.2	6.4	12.5	11.1	9.0	43.7	48.3	8.2	19.1	12.6	21.4	9.8	21.5	25.1	5.3	33.7	21.8	1.7	40.8	16.7	16.2	16.1	20.7	25.6	7.2	25.5	16.0	36.5	15.9	14.5	12.3	60.8	80.7	10.3	14.4	11.3	14.4	10.8	13.0	12.9	16.1	9.3	6.6	11.9	12.5	38.3	27.4	20.9	10.4	11.8	13.4	18.8	19.7	9.1
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 37.6;liver: 35.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 3.1;T-reg: 1.3"	"Group enriched"	"Detected in many"	17	"granulocytes: 3.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036633, HPA058130"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.6	2.8	13.6	1.8	14.3	0.6	7.3	12.5	11.4	3.7	16.5	8.9	8.4	2.7	1.4	0.9	2.6	2.7	2.4	11.3	10.9	37.6	35.8	2.4	1.0	14.5	13.9	1.3	16.4	8.3	7.8	0.4	10.1	5.8	9.2	1.5	15.0	1.0	3.9	2.4	14.7	0.9	10.3	0.5	8.0	6.9	15.9	0.2	2.6	1.2	1.2	0.4	0.9	12.0	0.4	4.6	1.2	0.1	0.0	0.0	5.2	0.3	0.5	0.0	0.0	11.4	0.8	0.4	0.8	0.8	0.1	0.0	7.4	0.0	0.0	0.0	4.0	0.0	1.7	35.8	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	5.7	0.7	0.0	6.9	0.0	0.1	7.2	25.3	0.8	0.0	1.8	8.2	5.1	4.0	3.0	4.0	1.8	0.1	0.0	0.9	11.2	0.1	0.0	0.0	0.8	0.2	1.0	1.0	1.6	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	13.6	14.3	12.5	11.4	11.3	10.9	14.5	13.9	10.1	10.3	15.9	12.0	0.6	3.2	6.8	19.6	1.3	6.6	5.6	1.1	1.2	23.8	23.5	19.8	11.3	52.9	5.9	11.0	14.6	3.7	0.4	16.6	7.9	19.4	28.9	3.2	11.0	1.4	47.9	0.0	2.4	13.8	2.3	2.3	21.4	9.4	7.0	2.2	1.4	51.8	0.3	1.7	3.5	38.9	0.0	1.9	2.5	46.2	5.9	2.6	3.6	1.0	0.1	18.8	0.0	27.2	5.2	8.0	15.1	15.4	5.3	19.8	70.1	87.8	3.8	13.4	0.0	1.0	3.4	15.1	2.3	0.7	5.3	0.8	2.4	2.0	45.4	2.2
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: AB_2732242"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	9.8	8.1	7.8	15.6	7.9	22.0	9.1	7.1	9.1	9.8	6.0	12.4	15.9	10.7	3.3	15.6	8.7	9.9	10.7	6.9	7.0	8.6	9.0	12.2	20.9	7.9	7.3	6.2	11.9	7.6	9.4	17.7	7.9	9.9	8.5	6.3	9.4	9.6	8.0	12.3	15.0	12.6	6.0	17.5	12.9	15.4	8.6	25.2	9.1	9.2	13.8	14.4	10.8	9.1	11.0	24.1	19.3	1.6	16.8	21.3	41.0	23.4	17.9	23.7	22.7	20.6	8.7	0.2	21.6	25.3	16.7	18.6	2.1	21.5	12.2	1.3	21.0	36.5	16.7	24.4	42.0	1.2	67.5	32.4	20.0	19.6	13.5	15.5	30.1	2.8	15.9	0.0	16.7	40.4	24.5	25.3	27.4	20.9	19.8	2.9	2.5	11.4	15.3	49.4	20.8	28.2	18.2	20.0	17.8	22.5	34.4	36.2	33.3	1.2	4.7	11.8	7.7	37.0	0.1	4.2	0.0	6.8	21.7	38.3	25.5	35.5	16.7	29.6	15.8	10.5	13.2	17.8	20.7	6.4	12.0	13.3	34.8	23.2	31.5	10.6	21.5	19.3	7.8	7.9	7.1	9.1	6.9	7.0	7.9	7.3	7.9	6.0	8.6	9.1	11.2	12.8	19.5	20.5	17.2	6.1	7.9	6.0	4.6	22.1	8.2	5.7	9.9	4.3	15.3	7.3	93.8	12.3	29.4	17.9	9.8	10.2	53.0	11.1	14.3	13.1	21.1	13.0	33.4	13.8	15.7	10.8	28.1	12.2	66.4	14.4	11.4	7.7	19.4	21.9	32.0	10.2	14.2	21.7	9.3	89.1	7.5	22.0	10.6	24.4	29.4	8.8	40.2	18.1	31.3	16.9	11.4	8.6	24.2	11.2	11.7	4.4	10.8	117.9	19.7	9.2	10.7	19.0	24.6	11.1	9.7	23.7	24.2	16.1	8.6	13.8
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6568.4"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	16	"cerebral cortex: 326.0;white matter: 124.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.5	1248.5	8.6	9.4	11.4	0.2	0.3	0.0	326.0	8.3	0.0	92.0	242.7	0.4	0.3	1.0	1.1	0.2	0.2	4.4	1.7	1.0	0.4	1.6	0.1	14.4	0.0	0.2	102.5	6568.4	446.2	0.0	4.1	12.2	105.2	11.0	0.2	0.3	0.1	0.6	179.9	0.9	0.0	0.1	364.5	77.7	4.3	0.6	24.6	0.0	0.0	1.3	1.2	124.4	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	11.4	0.0	326.0	4.4	1.7	14.4	0.0	4.1	0.0	4.3	124.4	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 200.6;salivary gland: 142.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 118.1;B-cells: 76.4;Breast glandular cells: 32.2;Breast myoepithelial cells: 30.4;Leydig cells: 74.9"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 91.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"JURKAT: 634.6;MOLT-4: 346.8"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	NA	NA		420000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (9.10e-5)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	22.1	3.0	12.4	112.7	12.0	2.4	44.6	9.2	41.6	1.0	10.9	3.2	1.2	1.7	0.2	5.1	2.2	11.8	23.0	12.3	13.6	3.1	0.9	66.1	59.8	63.7	34.7	2.1	0.8	36.6	4.5	13.7	27.1	7.4	2.6	1.7	142.1	0.7	2.0	11.3	10.0	3.7	18.6	21.5	5.9	11.7	34.5	200.6	11.8	7.5	119.0	53.5	4.5	26.4	0.3	0.0	0.4	0.5	100.3	19.1	0.2	0.1	1.3	0.2	0.2	0.0	0.3	0.8	0.2	0.1	8.8	0.6	3.5	0.2	0.1	29.0	0.1	0.2	0.5	1.6	1.5	0.2	1.7	27.9	0.3	0.4	0.5	5.5	0.0	634.6	0.2	1.2	0.3	0.2	346.8	0.5	0.0	0.1	0.1	1.8	0.9	0.6	0.0	0.7	0.1	0.3	0.4	0.9	0.3	2.1	0.3	0.3	0.5	7.5	1.4	0.2	0.7	5.2	0.6	76.8	23.4	0.5	2.3	1.0	3.6	0.2	22.4	0.8	5.5	45.0	16.0	37.5	0.8	43.2	91.6	34.4	2.2	17.2	0.3	1.4	10.8	27.3	12.4	12.0	9.2	41.6	12.3	13.6	63.7	34.7	27.1	18.6	34.5	26.4	0.5	9.6	118.1	1.0	76.4	2.3	1.6	8.3	0.0	0.1	32.2	30.4	0.5	0.0	3.1	0.0	0.0	0.2	7.8	0.1	0.0	20.1	3.8	0.3	7.0	0.9	1.2	0.0	0.2	0.4	0.9	10.8	0.0	0.7	2.5	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	2.2	0.7	12.0	74.9	2.2	16.0	0.0	0.8	0.0	23.7	0.0	0.3	0.9	0.0	1.5	2.6	3.5	0.0	0.5	0.2	0.0	0.0	1.8	0.7	0.5	0.6	0.3	1.3	3.1	12.8	1.5	0.0	1.3
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase acidic"	Q9BZP6	1	111290851-111320566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"stomach 1: 327.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 34.6"	"Group enriched"	"Detected in some"	4	"lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059193	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.5	1.6	0.3	0.0	0.1	0.1	0.1	0.1	0.2	10.6	0.3	0.2	0.1	0.1	0.2	2.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	327.5	0.5	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 47.0;Excitatory neurons: 62.7;Inhibitory neurons: 59.6;Microglial cells: 29.0;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: AB_2681714"	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	2.9	7.0	4.4	3.0	4.8	0.6	3.7	4.6	8.5	7.1	2.4	5.2	2.3	5.6	3.8	2.4	4.2	4.6	5.4	5.7	6.1	6.3	1.5	2.7	3.9	5.9	4.6	5.7	2.2	5.9	5.6	2.1	6.0	4.8	4.2	5.4	2.8	5.1	2.6	3.0	3.4	5.4	4.9	4.1	2.5	1.5	5.8	2.8	6.5	5.2	3.5	4.2	3.4	5.1	4.6	4.7	2.3	3.0	6.5	8.7	0.0	5.1	6.8	4.1	4.9	3.1	5.8	2.1	6.9	4.6	8.1	1.4	3.3	2.5	9.0	5.3	4.1	3.2	4.0	0.0	4.2	0.0	6.0	6.1	2.9	7.7	4.1	5.2	5.9	2.1	0.8	20.3	8.1	0.7	1.9	0.0	7.3	0.0	4.6	1.8	5.9	1.3	5.1	2.3	1.3	1.9	5.8	2.7	6.3	3.9	2.3	1.3	6.9	4.7	4.6	9.4	3.1	5.7	15.3	0.0	6.9	3.4	3.7	0.2	0.0	0.0	0.4	0.0	0.7	0.2	0.3	0.4	0.0	0.2	0.3	0.4	0.0	0.3	0.0	0.0	0.3	0.1	4.4	4.8	4.6	8.5	5.7	6.1	5.9	4.6	6.0	4.9	5.8	5.1	8.3	3.2	9.1	47.0	9.4	2.7	4.6	2.7	4.6	10.0	4.2	3.6	12.7	5.7	4.1	3.7	6.2	0.2	7.5	2.1	0.0	3.5	4.1	10.9	5.6	9.4	0.0	4.4	62.7	3.5	0.0	8.2	1.5	7.3	5.1	5.3	5.3	1.6	1.6	13.5	59.6	7.5	2.0	2.2	1.8	1.8	3.1	2.3	5.4	29.0	1.6	5.7	8.2	66.9	76.1	2.4	6.1	9.1	6.7	5.4	1.4	11.4	3.9	7.5	0.0	8.3	5.0	2.0	2.4	2.4	4.5	0.0	8.8	5.9	3.4	4.6
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064605	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 348.7;Suprabasal keratinocytes: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 365.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317"	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	20.8	15.9	9.1	12.9	8.5	27.1	18.1	12.6	9.6	16.0	12.1	12.4	12.3	12.3	10.3	27.4	12.1	20.5	15.1	8.6	9.2	14.2	20.3	19.7	14.7	8.6	8.5	13.0	9.9	6.5	9.3	13.5	9.0	12.9	8.9	5.9	15.2	5.7	9.8	27.5	13.2	10.5	7.8	17.3	12.9	39.6	9.2	21.9	11.9	6.6	13.3	15.1	18.1	9.7	25.4	4.6	12.8	11.9	21.5	16.8	13.1	34.6	36.1	20.1	20.3	18.1	22.0	21.4	29.5	22.0	17.2	7.7	17.9	25.1	22.0	11.9	9.5	11.7	4.2	13.6	65.1	19.2	23.4	22.6	19.8	30.3	45.3	38.3	30.0	22.2	13.0	15.4	40.6	7.1	22.3	30.7	8.7	11.2	16.9	14.3	7.3	8.4	23.3	8.1	19.7	18.3	8.3	12.2	26.6	18.3	6.1	26.8	51.3	25.2	19.9	36.6	21.4	18.4	9.5	17.2	18.7	18.7	18.7	365.5	79.3	171.5	60.1	64.7	57.7	41.3	60.0	68.6	55.9	40.1	54.6	59.6	325.0	74.2	68.3	47.0	81.5	77.9	9.1	8.5	12.6	9.6	8.6	9.2	8.6	8.5	9.0	7.8	9.2	9.7	58.1	6.4	7.3	35.6	42.5	348.7	95.5	61.0	68.3	8.1	61.6	33.5	4.1	15.7	25.9	7.3	8.4	27.8	57.8	27.2	17.6	42.8	55.4	64.1	58.0	64.3	25.8	72.6	39.7	28.0	38.7	80.8	32.6	34.2	36.3	36.8	38.6	23.9	24.7	13.5	40.2	21.9	40.7	36.4	144.2	13.4	17.1	50.3	67.6	49.6	32.6	9.0	28.8	74.4	23.2	61.8	42.1	24.5	40.2	85.1	41.9	29.2	56.0	7.2	19.7	53.9	45.1	163.5	89.9	97.4	373.8	47.7	65.8	39.8	21.0	135.9
CHID1	"FLJ42707, MGC3234, SI-CLP"	ENSG00000177830	"Chitinase domain containing 1"	Q9BWS9	11	867859-915058	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 404.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039374	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"	"Intracellular and membrane"	No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Intermediate filaments"		"HPA039374: AB_10673609"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.96e-2)"	"prognostic favorable (6.76e-4)"	"unprognostic (4.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	43.9	63.3	43.1	22.7	44.1	46.2	40.2	41.0	51.7	44.5	60.0	34.2	30.9	38.0	89.5	34.8	63.5	41.3	54.4	44.1	47.2	52.5	85.8	30.9	27.2	42.9	42.9	58.0	149.9	46.1	62.8	42.7	42.5	42.3	29.7	25.2	82.2	41.3	37.0	34.9	27.7	35.7	42.6	71.6	47.1	74.1	45.7	20.1	47.3	31.1	20.2	34.3	35.3	47.0	75.6	71.7	53.2	131.6	203.3	107.5	90.1	83.2	97.0	78.8	76.7	78.7	214.6	61.1	75.1	121.7	78.4	145.2	53.1	95.9	57.3	53.7	131.9	44.1	25.9	75.1	92.6	102.9	37.4	104.1	59.2	53.9	77.2	130.3	67.2	76.6	81.2	152.6	55.8	52.9	58.4	134.0	47.2	141.6	107.3	49.0	50.9	111.8	57.5	21.5	101.8	84.5	90.3	124.0	78.4	53.0	50.4	156.8	66.6	89.6	38.9	25.3	68.3	88.9	81.4	36.0	100.2	88.6	71.7	21.1	50.4	19.2	34.7	45.0	37.1	45.7	33.2	36.8	74.0	32.1	34.9	35.3	6.2	43.4	45.6	69.6	32.4	46.0	43.1	44.1	41.0	51.7	44.1	47.2	42.9	42.9	42.5	42.6	45.7	47.0	33.0	41.7	36.7	4.2	28.6	22.8	62.2	78.9	22.2	38.5	69.9	75.7	25.6	51.5	49.0	53.3	18.8	121.3	34.4	25.2	72.4	62.3	120.9	44.0	44.4	31.5	53.3	56.4	7.8	58.3	79.7	69.6	20.9	36.8	29.2	107.6	50.0	91.2	81.1	30.3	7.8	42.8	57.0	66.6	24.7	404.8	62.7	34.0	55.2	1.9	35.2	60.6	20.6	6.0	6.8	38.0	43.2	58.3	123.7	86.5	71.5	85.1	45.7	53.2	52.6	45.9	41.7	208.3	139.9	37.2	23.3	91.5	19.2	85.4	59.9	62.6
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.8;lung: 36.4;lymphoid tissue: 21.7"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	6	"cerebral cortex: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 4: Macrophages - Innate immune response"			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	13.6	0.3	0.2	0.4	0.2	49.8	8.3	0.0	12.4	8.1	0.0	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.7	36.4	21.7	0.4	0.2	0.5	2.1	0.0	0.0	0.7	1.3	1.0	1.0	0.0	0.4	0.0	0.2	0.4	0.8	0.0	0.4	5.7	0.5	0.0	0.3	3.4	1.3	0.0	1.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	12.4	0.2	0.0	0.4	0.2	1.3	0.4	0.3	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CHKA	"CHK, CKI"	ENSG00000110721	"Choline kinase alpha"	P35790	11	68052859-68121444	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 179.6;Early spermatids: 357.3;Late spermatids: 267.3;Oligodendrocytes: 203.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024153, CAB072803"	Approved		Approved	"Endoplasmic reticulum"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"CAB072803: , HPA024153: AB_1846664"	"unprognostic (5.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (2.36e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (5.00e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.73e-2)"	17.0	35.8	49.4	7.1	54.2	33.8	20.9	51.8	57.8	18.3	53.5	25.8	21.6	12.2	20.5	6.2	13.2	10.3	14.5	49.5	50.7	23.9	43.3	17.8	9.0	56.6	53.6	20.1	38.0	8.0	21.6	5.2	61.5	31.0	12.8	21.1	44.9	16.4	8.3	8.7	23.1	5.4	51.0	30.0	40.0	75.5	54.0	5.7	43.6	4.5	5.5	19.4	9.3	71.7	25.6	21.3	24.2	24.1	8.0	6.1	24.5	7.7	13.6	22.5	14.4	92.2	70.5	18.9	27.4	12.4	23.2	16.2	34.4	5.6	18.5	8.7	12.1	23.8	29.6	106.9	22.9	25.6	12.5	11.0	9.4	10.0	4.8	12.3	12.7	11.9	23.1	34.7	12.0	19.4	14.6	68.4	40.1	83.2	14.2	21.3	26.1	54.6	18.1	27.3	17.9	19.6	14.9	74.6	183.8	19.9	31.6	34.4	7.3	14.2	16.3	32.4	10.4	37.0	42.5	34.4	14.6	32.8	13.0	0.0	0.8	6.1	0.1	1.5	0.0	0.7	0.1	0.2	0.9	0.3	0.4	0.2	0.4	1.1	0.9	0.7	0.2	0.2	49.4	54.2	51.8	57.8	49.5	50.7	56.6	53.6	61.5	51.0	54.0	71.7	27.2	44.8	36.6	179.6	10.1	15.8	16.6	6.5	18.2	10.6	49.4	35.7	3.6	35.8	20.2	3.7	33.3	8.2	14.2	48.1	13.7	9.6	357.3	42.7	16.2	13.6	28.1	6.7	89.0	19.3	3.4	9.2	37.2	59.0	19.0	23.4	11.7	19.8	17.6	57.2	63.2	16.3	0.0	28.5	19.4	267.3	6.2	31.0	23.2	59.0	8.5	21.4	2.1	100.0	203.5	18.4	18.0	2.6	10.1	17.3	21.6	4.6	23.1	28.4	0.0	9.6	9.8	121.9	20.7	9.2	10.4	13.0	8.2	16.9	31.7	39.2
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578959-50601455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.1;RPMI-8226: 19.8"									HPA018797	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.0	10.3	0.7	10.3	12.1	13.4	10.5	16.8	10.6	12.2	10.5	3.3	9.5	12.0	11.1	12.0	1.5	11.5	10.1	10.8	13.2	9.4	13.3	4.3	10.5	11.0	8.6	7.7	17.7	14.3	7.2	10.6	12.0	4.8	1.6	11.9	7.2	8.3	11.6	10.7	5.3	10.7	18.1	11.6	14.5	11.0	9.2	12.6	11.7	9.8	11.7	11.1	10.8	4.2	1.3	0.5	1.6	6.7	5.9	10.8	7.3	16.7	4.7	3.1	1.4	2.1	2.1	4.2	3.8	2.4	0.0	1.5	2.0	1.0	0.3	5.4	3.1	2.2	2.3	19.1	2.5	4.8	2.0	6.5	0.6	8.1	4.5	17.1	5.5	1.8	0.3	12.4	5.3	2.0	8.6	0.7	7.0	1.9	3.5	1.8	19.8	11.5	2.0	2.0	3.2	3.0	7.3	5.9	0.2	1.1	2.8	6.9	0.0	1.7	0.0	2.2	7.4	0.0	3.0	2.3	0.4	3.4	12.0	39.5	27.0	26.4	38.4	25.7	24.0	24.2	27.6	35.7	23.6	22.6	20.8	9.6	37.0	26.1	34.1	33.4	32.6	10.3	10.3	10.5	16.8	10.1	10.8	10.5	11.0	10.6	10.7	11.0	10.8	16.7	6.4	28.2	0.0	13.6	4.8	2.3	6.9	8.6	4.8	10.0	7.4	7.7	20.0	12.7	7.3	4.2	8.8	14.0	18.4	3.9	30.6	11.6	3.9	3.4	8.0	15.7	9.0	0.0	23.8	14.1	8.6	19.9	3.3	19.0	2.5	10.4	5.4	14.6	8.4	0.0	19.3	12.2	16.6	9.2	30.5	2.5	10.0	3.6	0.0	48.4	3.3	14.4	0.0	0.0	23.5	24.2	3.0	14.6	2.1	29.3	5.5	11.2	6.0	6.6	2.4	6.8	12.6	10.0	14.5	6.3	8.5	11.2	2.8	17.3	2.2
CHL1	"CALL, FLJ44930, L1CAM2, MGC132578"	ENSG00000134121	"Cell adhesion molecule L1 like"	O00533	3	196763-409417	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.6;Excitatory neurons: 423.8;Inhibitory neurons: 320.7;Oligodendrocyte precursor cells: 918.4"	"Cancer enhanced"	"Detected in many"		"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.7;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 91.8;WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003345, CAB026120"	Enhanced				"Secreted in brain"	NA	NA		5800000000	"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB026120: , HPA003345: AB_1078516"	"unprognostic (5.54e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	13.6	4.1	18.6	8.6	33.9	0.3	8.5	2.3	35.5	3.3	0.0	14.7	4.4	3.4	1.6	8.9	2.6	4.8	11.5	35.8	26.7	17.8	0.8	5.1	6.2	12.5	5.3	16.3	1.7	0.5	2.6	0.0	5.7	3.7	7.9	15.9	6.9	6.3	0.3	12.9	6.2	5.4	10.0	3.0	4.0	1.5	10.6	0.7	0.9	1.4	2.9	3.1	5.3	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	33.9	2.3	35.5	35.8	26.7	12.5	5.3	5.7	10.0	10.6	5.0	4.1	0.0	0.0	223.6	8.8	22.9	0.6	2.8	56.9	1.2	0.6	13.6	18.0	1.5	15.8	11.0	0.0	0.0	0.1	0.0	11.7	0.0	2.0	2.9	0.1	2.3	0.0	0.0	423.8	0.0	0.0	33.5	0.0	1.9	1.3	106.2	1.4	1.3	0.0	1.7	320.7	0.0	0.0	0.3	4.4	1.4	2.8	0.6	3.6	22.5	0.0	58.7	0.0	918.4	11.6	0.2	0.0	0.0	1.4	6.2	0.0	19.7	17.8	2.7	0.0	2.7	11.2	3.0	1.3	15.6	12.1	0.0	1.1	12.4	0.0	0.8
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM Rab escort protein"	P24386	X	85861180-86047561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	9.3	11.1	2.7	7.3	3.4	2.4	7.7	2.7	4.4	9.3	3.6	6.1	4.6	8.8	4.6	6.7	11.0	7.2	7.2	3.9	2.5	12.1	7.7	7.0	7.1	2.9	2.2	7.8	5.9	14.2	3.8	9.5	3.0	7.6	6.4	9.3	5.6	7.1	6.4	4.2	4.7	8.7	1.3	8.1	7.3	4.6	2.9	8.5	10.9	10.5	6.3	7.6	3.5	3.2	16.8	10.9	10.9	7.2	17.4	18.4	6.9	19.3	16.2	13.2	14.4	8.8	15.0	5.7	24.3	14.0	46.1	9.4	23.9	10.9	22.5	10.9	11.4	3.4	14.6	8.4	13.8	14.3	23.8	14.1	10.1	21.4	26.9	14.6	22.9	9.4	11.9	19.0	20.7	4.8	8.8	5.2	16.2	11.6	17.5	9.0	19.5	8.8	12.2	9.5	9.6	14.8	23.3	7.1	18.3	14.9	6.0	6.7	16.4	16.7	11.0	59.0	9.7	7.2	27.7	7.9	18.0	11.9	14.9	2.2	1.9	0.9	1.6	2.3	1.5	1.8	1.3	1.7	1.5	2.1	1.7	1.8	1.0	1.6	1.9	1.4	1.7	1.2	2.7	3.4	2.7	4.4	3.9	2.5	2.9	2.2	3.0	1.3	2.9	3.2	34.5	3.2	11.0	33.6	22.3	6.9	17.6	18.9	15.9	35.2	14.2	10.3	11.9	15.7	15.9	16.5	8.4	9.6	26.5	10.2	19.6	16.3	0.7	13.8	29.5	22.2	18.7	12.6	82.5	12.4	9.6	21.6	15.3	18.4	16.5	18.2	14.6	12.5	15.5	23.5	94.7	11.8	10.2	23.0	9.1	2.1	15.5	21.4	5.4	52.5	19.6	27.5	18.6	78.4	76.5	15.7	11.4	12.4	17.3	18.9	7.5	35.2	17.7	20.9	46.0	28.0	27.8	3.7	12.2	12.8	7.4	18.3	22.1	28.7	9.4	15.6
CHML	REP-2	ENSG00000203668	"CHM like Rab escort protein"	P26374	1	241628851-241640369	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	2.7	1.8	0.7	3.5	1.5	7.5	3.6	0.0	3.6	3.1	0.0	3.0	2.2	4.2	2.7	3.3	2.8	3.2	3.0	1.5	0.2	2.9	2.4	3.8	3.7	0.1	1.0	7.4	2.0	4.1	1.5	11.4	0.0	1.9	3.4	3.3	2.3	1.5	2.6	3.2	2.8	3.2	0.0	3.9	3.1	6.1	1.7	6.4	4.4	3.4	3.0	2.1	2.3	1.5	31.3	9.5	14.6	11.7	4.3	12.8	28.4	12.1	6.0	10.3	7.0	17.5	5.6	8.6	18.1	8.1	8.4	6.3	20.6	13.1	19.0	16.5	19.2	11.3	39.4	12.3	8.7	27.2	14.0	10.7	5.8	13.6	14.0	7.2	8.2	22.7	31.0	10.2	12.3	12.2	18.1	18.1	19.4	11.8	30.6	27.3	18.0	28.8	10.4	19.2	18.6	30.6	15.2	11.5	13.3	14.2	13.5	17.4	16.7	20.9	40.8	10.6	23.3	11.9	31.2	9.0	20.3	16.0	33.0	1.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.1	0.2	0.7	0.0	0.0	0.7	1.5	0.0	3.6	1.5	0.2	0.1	1.0	0.0	0.0	1.7	1.5	14.0	48.1	7.0	0.0	17.2	8.5	6.1	3.8	3.4	3.6	9.9	11.7	19.6	4.3	7.9	0.0	0.0	23.5	26.4	6.2	5.9	14.8	12.3	14.4	15.1	8.1	6.7	10.3	0.0	21.3	26.7	6.5	6.6	34.8	3.8	21.3	4.2	2.1	7.1	5.0	0.0	4.2	6.1	17.6	31.0	30.9	10.5	34.7	17.8	0.0	18.6	3.1	4.1	0.0	0.0	22.5	4.3	18.0	5.8	3.9	4.3	2.2	2.0	4.7	13.1	11.4	20.7	9.0	12.6	7.6	7.2	20.1	5.8	9.9	5.0	4.3
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555105	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		230000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	131.8	185.9	144.9	86.8	149.6	162.3	125.1	153.7	171.9	108.9	143.5	141.3	113.4	111.7	150.1	154.9	104.6	83.1	182.6	144.4	147.8	163.3	161.3	116.9	81.9	151.1	147.0	101.9	125.0	147.8	118.7	95.8	151.3	112.5	124.1	75.2	137.2	97.1	222.9	158.4	121.9	83.6	149.0	121.2	143.8	73.9	146.8	82.6	123.2	151.7	95.1	114.3	113.7	157.4	110.4	290.9	91.4	85.0	138.9	172.9	112.9	100.0	204.3	52.0	56.0	86.3	160.1	29.3	143.2	168.1	149.2	87.7	76.1	190.4	43.7	98.8	628.2	71.8	214.0	134.7	266.6	121.1	108.0	201.5	266.0	81.5	257.8	175.3	153.1	135.5	86.8	135.6	159.5	187.1	153.7	111.3	38.3	304.2	220.3	65.2	78.6	222.0	230.1	246.8	107.3	181.2	162.0	213.7	123.4	57.3	164.3	121.5	174.4	262.0	37.7	77.2	117.3	339.0	404.9	95.2	185.0	141.0	176.6	278.9	247.4	351.1	134.9	232.7	114.5	127.0	148.0	153.1	216.2	123.0	102.0	116.3	820.6	131.6	243.9	197.1	215.5	208.4	144.9	149.6	153.7	171.9	144.4	147.8	151.1	147.0	151.3	149.0	146.8	157.4	166.1	99.3	119.8	9.4	72.9	165.6	261.4	287.7	69.4	73.9	124.7	120.6	118.7	154.4	207.2	165.5	16.7	288.8	76.5	555.2	442.2	332.6	121.9	194.0	109.2	143.6	155.4	142.5	5.3	522.5	296.8	113.5	115.7	198.8	121.5	102.1	142.5	214.0	269.1	52.2	5.6	296.6	217.7	142.0	145.8	90.9	145.1	134.5	215.3	6.5	203.6	217.6	147.2	3.0	13.4	479.8	615.3	133.2	77.3	258.5	607.0	599.8	242.1	94.3	85.5	103.9	169.7	116.8	89.7	109.5	198.5	460.0	89.2	149.3	226.3	372.7
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255556	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035069: AB_10602798, HPA052754: AB_2681936"	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	26.0	24.2	15.7	22.8	20.2	42.7	26.3	22.3	22.2	28.9	16.2	41.6	38.5	29.5	22.5	35.2	22.6	28.8	27.0	15.1	18.2	29.6	34.5	22.9	21.9	25.1	21.0	24.9	29.2	24.3	30.4	25.0	24.1	34.9	37.5	15.3	24.9	27.7	35.3	26.4	40.8	29.6	23.7	22.1	31.1	16.1	20.3	17.2	43.1	28.0	21.6	42.3	29.7	31.2	68.4	71.6	25.4	17.4	45.0	38.4	29.7	52.8	71.2	45.1	57.1	57.0	115.0	25.3	36.7	60.1	38.6	35.0	31.6	37.6	56.0	41.7	34.7	29.5	24.6	25.4	39.2	44.9	42.5	29.3	63.2	42.9	58.3	42.6	35.8	29.6	17.3	36.7	50.2	53.2	41.1	18.3	32.4	91.1	65.5	21.4	31.0	26.1	36.0	71.3	9.7	10.8	54.2	45.6	91.4	28.8	40.6	13.7	30.6	42.9	36.5	445.0	37.7	37.7	56.3	41.6	47.6	24.8	30.9	124.7	50.7	136.7	27.3	65.2	37.3	49.6	34.6	34.8	55.1	53.4	32.0	32.4	96.8	31.4	67.8	31.3	52.4	37.8	15.7	20.2	22.3	22.2	15.1	18.2	25.1	21.0	24.1	23.7	20.3	31.2	56.2	83.3	68.7	11.4	58.7	132.0	254.5	90.0	53.5	19.9	59.8	52.1	68.8	62.9	85.0	49.7	4.2	75.4	45.7	268.7	138.9	170.6	6.8	86.7	45.2	54.4	46.7	36.2	14.1	261.2	187.0	68.9	48.4	86.9	74.1	27.1	48.5	60.8	86.9	37.0	15.1	80.3	73.2	61.9	87.6	7.5	66.2	72.6	40.9	9.4	62.0	213.9	42.2	10.6	36.0	237.4	241.3	96.3	30.0	226.0	101.7	145.8	90.5	16.3	72.3	58.5	57.5	78.7	76.7	62.8	145.6	180.9	52.9	38.1	81.3	330.3
CHMP3	"CGI-149, NEDF, VPS24"	ENSG00000115561	"Charged multivesicular body protein 3"	Q9Y3E7	2	86503430-86563479	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015673, HPA073383"	Supported					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA015673: AB_1858761, HPA073383: AB_2732224"	"unprognostic (2.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.64e-1)"	70.0	56.1	39.5	41.0	54.3	30.9	64.2	49.3	45.6	57.9	26.1	72.3	63.1	68.8	56.9	93.0	51.8	54.8	100.2	46.3	39.9	59.9	23.3	64.0	34.0	35.9	36.5	49.0	66.7	70.3	33.1	31.8	37.1	64.3	75.9	30.8	52.9	61.9	97.1	58.6	64.5	73.4	38.7	40.3	60.5	34.2	42.5	31.7	68.0	80.9	39.9	70.2	50.6	38.1	105.3	96.1	54.4	39.6	71.2	136.7	52.5	76.7	103.2	64.4	55.6	86.2	90.2	34.3	71.7	97.7	71.8	82.8	33.3	67.0	70.3	21.0	42.5	45.5	45.5	98.8	62.5	36.4	47.7	82.4	147.7	40.8	64.9	70.4	73.1	34.1	49.1	25.3	104.7	90.7	24.4	32.4	18.8	138.9	73.8	15.3	125.2	27.2	85.7	117.3	65.7	71.4	73.3	68.0	66.1	25.8	58.3	55.7	88.7	114.2	46.8	112.2	86.7	21.0	33.1	22.9	81.5	58.0	61.3	158.5	61.5	171.5	28.0	73.8	33.6	49.5	41.8	33.8	49.9	49.3	48.7	37.9	228.7	35.5	66.5	42.1	46.1	54.4	39.5	54.3	49.3	45.6	46.3	39.9	35.9	36.5	37.1	38.7	42.5	38.1	102.5	147.4	93.5	0.0	49.6	95.3	83.3	94.4	83.6	55.7	115.2	72.6	125.2	147.3	111.4	40.5	41.7	51.1	42.7	222.1	148.7	180.7	206.6	46.7	84.9	96.2	133.5	73.0	0.0	174.8	59.2	67.4	58.6	70.4	147.6	30.0	144.5	59.1	89.5	69.0	0.0	159.2	65.1	126.2	48.4	108.5	71.7	77.2	71.2	0.0	93.6	60.5	78.2	0.0	0.0	186.7	219.4	91.0	25.0	95.9	201.1	173.3	76.1	42.4	65.7	73.6	78.5	100.7	57.3	101.9	94.1	85.0	47.5	57.3	165.4	103.4
CHMP4A	"C14orf123, HSPC134, VPS32A"	ENSG00000254505	"Charged multivesicular body protein 4A"	Q9BY43	14	24209615-24213830	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068473	Approved					NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA068473: AB_2685994"	"unprognostic (4.33e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.74e-4)"	"unprognostic (2.02e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.90e-2)"	58.8	39.5	73.9	49.3	77.3	38.5	51.4	74.2	109.3	39.1	68.5	59.2	39.4	33.6	79.0	50.5	45.2	35.8	46.9	71.2	73.4	52.4	53.5	36.1	72.6	76.6	75.6	30.8	42.5	72.9	23.0	33.9	76.5	51.0	64.5	15.5	31.5	60.6	20.1	51.6	43.6	51.6	76.8	51.5	45.8	16.5	78.1	70.4	43.4	27.4	84.9	47.7	32.0	77.7	48.7	100.5	43.8	49.1	75.4	67.9	59.7	52.9	62.6	53.0	60.7	46.6	114.9	79.0	48.5	80.6	49.8	56.4	47.5	84.7	58.8	142.6	25.6	64.7	91.6	207.4	131.8	101.1	69.9	69.1	121.6	43.9	168.4	60.8	72.3	84.6	68.2	119.7	107.1	136.1	98.0	93.5	29.0	123.3	83.0	71.9	37.5	86.7	99.3	128.4	28.4	34.3	112.7	101.8	73.8	49.8	65.7	90.2	49.4	33.0	40.0	42.7	47.2	117.1	133.2	86.4	31.2	71.7	71.3	144.3	152.2	103.4	123.4	195.6	132.9	182.8	131.8	138.5	179.9	169.3	101.6	109.9	42.6	138.4	193.6	190.0	185.2	171.6	73.9	77.3	74.2	109.3	71.2	73.4	76.6	75.6	76.5	76.8	78.1	77.7	74.2	16.0	33.3	13.4	78.6	52.6	76.0	154.8	18.8	31.8	66.7	65.7	2.1	92.9	86.3	62.5	64.6	93.4	111.4	50.0	97.8	116.0	11.0	49.1	52.5	58.8	39.2	53.7	14.3	82.3	84.0	39.3	25.5	53.2	76.5	41.1	67.5	73.1	162.5	25.2	12.6	69.9	99.7	94.8	90.3	19.1	66.8	80.1	69.4	11.2	202.6	64.7	178.2	12.1	15.5	76.0	66.7	48.5	44.8	76.1	144.9	159.3	72.2	24.2	98.6	40.6	58.1	20.4	18.3	32.3	78.8	120.7	102.8	43.8	79.7	70.4
CHMP4B	"C20orf178, dJ553F4.4, Shax1, SNF7-2, VPS32B"	ENSG00000101421	"Charged multivesicular body protein 4B"	Q9H444	20	33811348-33854366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041401, HPA051751"	Enhanced					NA	NA		53000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041401: AB_10965028, HPA051751: AB_2681591"	"unprognostic (2.56e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.85e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.33e-2)"	105.8	112.3	93.3	75.8	95.3	213.7	102.2	93.9	112.3	112.9	82.5	155.1	103.0	107.8	58.6	159.0	84.4	80.6	147.1	98.4	98.9	122.9	67.7	101.5	70.7	97.7	94.5	94.9	82.1	74.8	74.6	74.7	95.6	90.4	98.7	53.3	118.1	82.4	231.3	120.9	119.9	76.3	93.7	83.0	117.3	60.2	97.5	82.8	88.4	132.6	71.2	132.0	106.9	99.4	206.4	131.3	72.3	69.3	118.8	95.2	114.5	120.4	159.1	126.1	117.5	279.1	171.2	98.1	183.3	122.3	192.0	160.8	83.2	182.3	99.2	51.0	89.3	174.1	90.4	189.3	137.5	86.1	88.1	137.2	99.4	116.3	106.6	125.2	141.9	113.1	84.2	139.0	97.8	130.2	189.8	246.5	63.4	226.3	179.8	97.7	147.2	120.7	142.7	234.0	56.4	68.6	225.0	192.2	165.8	85.1	149.0	123.9	129.9	216.8	85.0	108.7	117.9	132.4	101.3	117.0	176.5	91.6	65.8	0.0	1.8	0.8	0.7	1.7	0.9	1.6	1.1	0.8	1.0	1.1	0.8	0.7	2.3	0.5	1.4	4.0	1.4	0.5	93.3	95.3	93.9	112.3	98.4	98.9	97.7	94.5	95.6	93.7	97.5	99.4	66.0	60.9	54.6	17.9	71.5	298.0	224.4	133.8	113.3	22.5	149.1	64.3	95.9	112.9	148.1	110.3	18.8	197.7	77.9	565.8	144.8	360.9	17.8	81.8	76.1	126.0	127.4	81.6	18.7	497.0	151.2	130.1	112.7	130.6	28.5	22.3	71.7	69.8	215.3	18.5	13.8	212.7	154.6	119.3	383.6	18.8	93.8	140.2	220.5	15.0	289.8	73.6	46.4	10.6	17.4	540.2	536.6	120.7	139.0	426.2	482.1	180.0	101.6	20.9	92.1	79.7	120.5	24.5	29.2	291.0	341.3	440.3	62.9	35.7	227.4	413.2
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CHMP6	"FLJ11749, VPS20"	ENSG00000176108	"Charged multivesicular body protein 6"	Q96FZ7	17	80991598-81009517	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023001, HPA024460"	Approved					NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023001: AB_1848689, HPA024460: AB_1848691"	"unprognostic (6.05e-3)"	"unprognostic (2.25e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.40e-3)"	18.9	18.1	13.4	13.5	13.0	8.9	19.2	12.9	13.8	21.3	10.8	21.4	13.2	19.9	9.5	24.7	16.2	8.8	24.4	12.9	10.9	21.4	35.4	17.8	14.1	14.5	12.6	15.6	19.2	19.1	16.2	13.6	13.2	19.9	15.6	18.5	17.2	12.6	45.1	22.0	18.9	17.2	12.4	25.6	17.6	10.5	12.3	17.1	18.2	29.2	14.7	18.7	18.0	15.6	27.6	43.5	32.1	19.5	16.8	17.2	22.2	26.6	29.8	44.2	32.3	10.9	14.8	28.0	20.7	42.2	27.4	18.5	7.0	30.5	31.3	13.5	23.8	23.1	9.0	38.0	25.0	28.1	28.0	18.4	20.7	27.5	29.7	27.5	62.4	28.1	24.4	22.9	23.0	25.8	34.9	28.8	10.4	7.4	26.9	27.3	28.5	19.0	25.2	37.1	10.5	31.9	19.9	30.8	29.9	25.6	27.5	21.4	35.7	61.1	34.5	18.1	36.3	13.8	3.6	14.4	26.1	17.0	29.0	66.9	40.6	84.1	37.2	42.7	23.9	26.2	22.4	30.5	32.5	19.8	24.6	22.0	25.9	43.7	52.6	30.9	19.0	39.2	13.4	13.0	12.9	13.8	12.9	10.9	14.5	12.6	13.2	12.4	12.3	15.6	19.1	6.4	9.3	5.9	12.8	6.1	8.9	16.3	8.0	20.2	14.7	16.6	1.0	17.2	14.5	14.7	4.2	39.9	20.1	36.8	13.7	37.4	1.5	8.2	11.2	17.4	21.1	8.8	1.7	43.9	31.6	16.6	20.4	9.9	21.0	23.8	18.2	17.3	41.6	10.1	1.9	19.7	18.3	24.2	6.5	2.5	10.2	20.1	16.0	1.0	37.1	26.7	35.0	3.0	4.4	33.9	35.5	12.8	11.5	9.5	36.7	23.2	8.6	44.3	13.1	15.8	14.1	9.0	12.2	14.0	5.8	50.3	16.7	18.9	22.2	8.8
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"B-cells: 35.7;T-cells: 76.3"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.7;U-698: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	4.6	5.9	2.3	19.5	2.4	9.8	4.5	3.6	3.2	5.1	1.4	6.0	4.0	6.2	1.4	4.8	4.9	3.4	3.9	2.3	2.9	3.4	3.5	4.7	32.8	3.4	2.0	4.4	2.7	2.7	3.6	2.1	3.5	4.1	3.4	2.2	5.2	3.6	7.0	4.6	14.7	2.6	1.9	16.9	5.8	4.8	2.9	31.0	4.4	3.9	27.7	5.6	4.7	4.8	6.2	8.6	4.6	7.8	4.2	4.0	5.2	5.0	3.6	7.2	6.1	9.6	4.8	39.7	6.0	3.7	6.9	5.9	4.3	6.3	2.9	10.6	7.4	8.4	11.5	4.9	3.6	2.4	11.4	3.4	4.2	7.0	1.9	4.1	6.0	16.7	9.3	5.6	4.2	6.0	7.3	9.3	7.1	5.9	6.5	2.8	3.7	5.5	3.7	8.0	5.6	5.5	3.9	5.9	2.3	2.5	6.2	4.5	6.7	8.9	5.7	6.7	4.0	15.1	8.5	47.2	6.6	6.6	6.6	1.2	4.8	5.0	6.3	4.8	12.7	35.7	41.3	19.0	3.7	35.6	76.3	45.2	4.3	5.4	3.5	3.0	46.8	32.7	2.3	2.4	3.6	3.2	2.3	2.9	3.4	2.0	3.5	1.9	2.9	4.8	8.6	6.4	7.9	7.2	48.6	13.6	15.8	12.1	12.5	11.9	11.3	10.9	13.2	11.5	11.8	14.7	4.2	15.8	12.7	16.9	19.6	19.7	43.5	5.5	11.3	12.1	13.8	8.6	9.3	15.8	18.8	11.1	11.7	10.2	12.0	13.1	6.4	7.0	15.9	13.5	11.4	13.1	14.2	7.5	7.7	13.7	9.9	13.1	16.0	1.9	17.3	20.6	21.6	3.5	9.5	20.5	12.4	10.5	24.0	15.9	16.0	18.8	7.1	10.6	6.6	10.1	13.1	15.7	16.8	9.2	10.7	20.7	25.7	10.1	10.8	19.6
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.0;intestine: 70.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 68.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	4.6	6.3	19.0	5.3	33.0	2.2	3.4	101.0	37.5	10.2	12.4	8.5	70.1	4.1	2.3	2.6	8.0	7.0	11.7	22.2	27.1	13.1	37.9	5.6	3.1	30.4	26.5	20.2	25.1	0.5	3.4	10.8	33.2	8.0	9.8	51.5	2.7	4.1	4.7	1.9	57.9	4.3	24.2	8.2	6.6	2.5	25.4	3.8	7.8	1.4	2.5	6.3	3.2	59.6	0.3	0.8	3.0	0.0	0.0	0.0	19.0	0.0	0.0	0.7	0.0	10.4	2.9	0.9	6.0	0.2	1.2	5.2	10.1	0.1	0.0	18.1	3.8	37.4	1.7	18.4	0.2	0.0	68.3	0.0	6.4	0.0	0.7	0.0	3.5	5.9	1.5	0.5	0.0	0.4	11.2	0.4	1.2	6.8	3.4	0.8	0.0	2.0	18.2	12.0	18.3	1.4	3.9	5.8	10.2	10.7	0.7	2.0	0.4	1.0	0.3	0.1	0.4	3.6	15.2	0.0	0.3	2.2	1.2	4.4	11.6	0.1	2.8	12.7	1.9	0.3	0.4	2.1	10.1	0.1	0.4	1.1	0.5	9.6	7.3	1.1	0.0	3.6	19.0	33.0	101.0	37.5	22.2	27.1	30.4	26.5	33.2	24.2	25.4	59.6	3.3	6.4	3.6	5.5	2.0	2.7	0.8	0.2	0.6	307.9	0.3	0.3	14.1	5.7	2.0	3.7	43.8	24.6	6.1	15.3	0.0	0.5	130.6	8.8	0.3	8.5	39.4	9.5	139.5	2.1	33.5	3.8	12.2	2.7	23.5	2.2	3.9	84.4	18.5	6.7	28.8	24.0	2.0	29.0	33.1	118.1	5.0	20.5	17.8	145.2	29.3	11.7	22.6	10.1	496.8	0.2	14.3	4.9	1.3	1.0	107.8	2.3	7.6	15.9	0.0	5.4	1.1	2.6	6.2	0.2	0.6	16.4	14.4	0.7	23.6	1.1
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;lymphoid tissue: 14.1;testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9"	"Group enriched"	"Detected in all"	4	"olfactory bulb: 66.4;spinal cord: 38.6"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	3.3	2.0	1.6	1.1	1.4	0.0	1.1	0.7	1.6	0.2	0.8	2.8	1.6	0.6	1.1	0.9	0.5	0.8	3.7	1.7	5.4	3.6	0.0	0.3	0.4	11.5	2.6	0.6	0.1	0.3	2.5	1.9	10.8	5.6	3.5	0.6	0.5	1.8	0.6	2.3	1.0	0.3	1.6	14.1	0.7	31.0	10.2	0.3	1.1	1.7	1.2	0.7	1.1	3.8	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.8	7.2	0.2	7.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	1.6	1.4	0.7	1.6	1.7	5.4	11.5	2.6	10.8	1.6	10.2	3.8	1.7	0.0	0.0	5.2	1.0	4.0	0.8	0.8	3.4	1.1	1.0	1.3	0.5	0.0	0.9	0.0	0.0	0.2	0.9	0.0	1.9	0.4	5.0	1.4	38.6	1.5	0.0	0.0	5.5	0.0	0.2	4.6	0.0	0.8	0.0	12.3	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.8	4.0	3.1	0.1	1.8	4.7	0.0	0.4	0.0	12.5	50.1	0.0	0.0	1.9	3.1	0.2	0.0	0.3	0.3	0.1	0.0	28.3	10.5	1.3	1.7	0.5	2.3	0.5	1.3	26.7	0.1	0.3
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90200429-90223077	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 94.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Approved	Cytosol		NA	NA		160000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	20.2	19.8	17.4	10.5	18.4	10.7	12.0	18.2	94.5	16.2	18.6	14.0	5.4	15.3	8.4	17.5	14.5	7.1	21.7	19.6	20.7	15.9	21.7	18.1	13.4	18.8	18.4	25.4	12.9	5.0	22.3	12.2	18.7	15.4	6.9	7.7	12.3	7.2	18.0	10.3	12.4	6.9	18.4	16.5	14.2	13.7	18.9	10.6	16.9	13.1	13.7	17.0	17.2	26.4	28.1	74.8	26.0	17.0	24.7	14.9	39.6	34.1	11.6	34.9	29.3	113.9	21.9	49.3	54.0	15.1	60.8	35.0	76.7	17.3	38.7	42.4	37.3	46.6	45.1	55.7	19.0	35.0	29.6	5.5	22.9	29.4	33.8	18.7	26.9	28.5	71.8	19.9	41.5	13.9	32.2	45.9	29.9	96.0	63.3	49.2	15.5	29.3	28.5	12.7	24.8	10.2	37.3	28.8	13.8	29.7	49.0	16.6	24.0	25.4	51.1	35.5	40.6	9.4	80.0	38.9	7.3	49.9	22.1	8.6	8.0	8.9	12.0	13.6	13.1	13.1	13.0	12.7	12.7	11.5	13.6	13.2	2.4	16.5	9.2	9.8	17.9	11.2	17.4	18.4	18.2	94.5	19.6	20.7	18.8	18.4	18.7	18.4	18.9	26.4	49.4	19.2	27.4	18.6	55.5	70.7	164.8	20.1	32.5	45.1	33.2	31.8	30.7	12.8	29.3	11.0	135.5	41.3	62.1	30.1	11.7	23.8	93.9	112.7	75.0	48.2	68.8	25.7	65.7	16.1	76.5	50.2	20.4	93.9	87.0	34.0	15.7	14.8	39.2	65.6	60.0	32.7	22.4	19.2	109.2	57.1	32.6	61.7	28.4	30.0	30.5	22.9	39.1	46.8	81.5	20.9	28.5	31.2	42.9	97.5	10.7	25.3	48.0	53.7	13.1	32.6	71.0	98.1	47.0	26.5	81.8	50.9	104.9	51.6	37.0	89.6
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281887	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	66.9	55.3	22.1	28.0	24.4	58.4	32.8	26.0	26.5	34.0	24.7	113.8	85.4	21.8	34.1	74.5	20.8	48.1	53.2	30.3	32.9	76.1	185.1	52.7	18.6	32.9	31.0	19.1	42.2	54.1	21.6	26.3	35.8	34.3	81.9	20.5	49.9	27.5	81.0	45.5	70.0	27.6	26.9	20.2	112.7	10.7	33.3	20.1	49.8	86.5	41.1	44.8	41.3	28.4	72.4	72.7	28.3	109.0	120.4	113.8	41.0	56.2	69.1	44.8	48.0	66.6	140.4	12.6	59.8	77.7	47.7	89.0	56.0	83.9	51.5	44.8	20.0	50.8	58.1	103.6	93.5	66.5	73.7	116.7	98.8	51.9	53.3	68.0	82.1	37.9	81.2	79.5	52.5	43.5	27.7	72.5	29.0	118.4	35.9	35.9	46.2	34.0	92.5	144.1	17.4	44.3	96.4	178.2	48.7	49.9	101.0	66.3	108.3	47.5	50.3	76.9	36.7	45.0	131.6	59.4	84.9	42.2	44.1	255.5	227.6	274.8	49.5	204.4	51.5	40.2	46.2	50.0	152.1	33.0	29.1	41.4	173.3	56.5	207.4	95.1	60.7	116.5	22.1	24.4	26.0	26.5	30.3	32.9	32.9	31.0	35.8	26.9	33.3	28.4	28.3	44.8	117.3	20.9	26.8	72.3	62.4	48.1	20.5	11.0	101.6	39.2	80.5	243.1	50.7	103.0	10.4	33.3	38.3	434.4	389.4	96.7	52.5	68.0	48.8	39.5	55.6	58.5	24.8	150.6	62.4	38.2	112.7	114.4	37.4	18.9	78.1	353.6	68.5	11.8	21.0	136.2	34.6	170.1	134.8	122.6	29.5	77.1	129.9	19.7	113.4	32.7	36.0	9.5	23.6	173.9	206.4	29.3	24.0	80.1	425.0	231.1	33.7	10.3	26.3	46.6	41.4	13.7	19.3	50.6	108.5	66.9	32.9	65.7	161.4	130.8
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538948-219543809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		570000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	29.9	45.7	26.9	12.5	24.9	1.7	22.3	25.8	34.2	59.1	36.7	21.9	26.7	55.9	13.7	27.3	30.2	24.2	134.8	38.4	31.2	41.1	97.8	42.8	6.5	34.0	30.4	127.4	138.9	24.6	128.3	40.6	32.1	58.6	4.7	8.5	56.1	25.6	16.3	26.2	23.2	12.6	27.4	16.6	40.9	97.5	33.2	3.6	52.8	3.9	4.5	34.3	30.0	34.0	67.5	13.0	9.6	81.0	36.0	55.8	109.7	66.4	55.4	18.5	16.8	36.8	57.5	20.7	139.0	64.6	63.3	84.1	6.3	40.3	2.9	32.3	22.5	7.4	18.0	161.9	49.8	6.6	42.1	75.0	69.2	18.8	17.9	66.7	0.1	7.1	47.2	49.6	17.7	105.5	1.0	17.6	39.8	22.8	50.6	0.1	30.4	41.6	22.4	29.7	23.4	36.0	32.1	30.7	94.3	17.9	10.5	22.6	1.6	67.9	37.1	81.9	35.2	58.9	19.9	9.7	62.1	6.7	70.4	1.7	0.0	6.5	1.9	0.1	2.4	1.0	1.5	1.3	0.0	0.1	1.7	0.6	0.0	1.9	0.0	9.5	1.2	0.7	26.9	24.9	25.8	34.2	38.4	31.2	34.0	30.4	32.1	27.4	33.2	34.0	2.1	0.0	15.2	16.0	16.5	14.5	23.2	52.8	17.1	14.6	40.0	29.6	30.5	22.8	31.2	75.4	10.4	163.7	21.7	15.9	9.8	58.1	4.1	14.0	22.2	2.9	43.0	3.2	4.3	80.4	182.7	56.0	25.5	42.4	10.2	27.4	4.2	64.0	18.5	43.7	9.2	57.8	36.7	2.4	9.1	7.1	24.8	2.3	67.6	5.6	1.8	56.8	9.2	5.5	3.7	65.6	32.7	63.2	123.6	42.3	60.7	20.6	14.6	11.5	26.3	19.3	27.1	11.9	6.3	14.2	11.1	310.3	9.7	46.3	14.3	33.0
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.7	31.7	9.5	17.4	9.3	23.1	13.6	3.8	12.9	14.6	13.5	17.4	13.0	19.5	10.3	14.0	14.6	15.1	19.8	9.6	11.6	14.9	20.4	17.6	16.6	11.1	8.7	14.0	26.2	13.2	43.7	16.1	10.0	19.1	9.0	2.9	22.2	12.9	8.1	14.7	18.9	14.9	5.4	28.9	20.1	9.6	10.5	10.9	17.6	5.0	10.7	16.7	13.6	6.7	27.9	22.3	14.7	43.1	50.0	49.2	22.2	57.3	88.4	30.5	37.1	14.9	46.1	8.4	98.7	91.6	41.5	34.3	6.5	40.8	13.1	32.1	20.3	8.9	25.4	21.0	46.7	18.2	70.9	75.8	22.7	28.9	10.3	63.1	48.6	13.8	8.6	23.7	49.2	45.7	17.0	70.6	19.7	11.6	25.6	15.8	8.7	28.1	29.6	21.7	15.9	28.1	30.7	29.8	15.2	11.0	11.6	29.4	66.9	33.6	5.6	45.2	49.3	43.3	6.8	12.3	122.3	23.9	46.6	0.9	4.4	6.2	4.0	3.6	3.7	1.9	2.1	3.6	4.7	2.0	1.4	1.6	7.2	2.0	3.9	6.9	2.4	3.3	9.5	9.3	3.8	12.9	9.6	11.6	11.1	8.7	10.0	5.4	10.5	6.7	8.3	9.6	11.8	2.3	11.2	4.6	6.6	15.1	6.2	8.8	10.5	5.6	1.9	10.0	11.7	11.0	4.2	11.5	23.4	21.3	1.9	12.4	0.6	6.5	11.0	8.9	8.4	8.6	6.1	16.8	16.3	13.3	18.8	9.0	6.3	14.6	12.5	9.6	12.6	25.2	5.0	12.0	14.2	10.9	6.8	1.0	17.1	11.1	7.2	3.7	11.0	5.3	11.3	5.5	1.8	17.7	17.4	15.1	26.5	11.5	8.5	3.5	8.8	7.4	19.7	7.8	14.6	5.0	3.1	6.6	4.4	10.3	13.0	15.8	9.8	10.5
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 344.4;Late spermatids: 650.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 36.9;eosinophil: 14.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.79e-1)"	39.8	47.7	48.6	17.7	49.1	62.0	102.9	43.8	65.6	50.5	41.9	49.4	88.1	19.2	56.1	24.9	33.4	40.2	91.3	46.1	47.3	73.5	157.4	38.4	20.0	50.0	51.2	18.7	25.0	92.4	12.4	22.8	44.9	35.0	48.9	4.8	130.0	50.0	27.8	28.0	75.7	18.8	50.0	23.5	56.0	28.1	54.4	9.0	38.0	28.3	21.2	32.4	26.2	48.9	11.3	51.2	13.7	29.3	106.6	35.7	38.9	40.2	46.2	39.7	25.5	19.3	7.7	17.3	22.1	55.1	54.3	16.9	83.8	14.2	37.3	26.2	70.1	69.7	25.7	112.6	59.4	34.8	13.5	33.6	4.1	18.0	32.7	59.0	20.0	36.4	102.8	43.1	39.4	27.6	20.8	118.5	36.2	53.8	67.4	15.9	26.8	12.4	17.9	43.4	13.8	10.4	37.2	52.3	103.2	21.4	53.8	23.6	14.7	36.1	18.7	28.5	39.9	24.3	7.9	21.2	28.4	39.7	53.4	36.9	2.2	14.6	0.6	1.7	0.6	4.4	1.2	0.9	2.9	2.6	0.4	0.6	3.1	4.6	2.2	3.7	0.6	0.5	48.6	49.1	43.8	65.6	46.1	47.3	50.0	51.2	44.9	50.0	54.4	48.9	27.1	48.1	27.6	159.6	135.1	37.5	313.3	4.2	21.6	19.3	243.8	76.7	45.3	102.9	13.1	64.4	29.2	123.9	32.6	61.7	70.5	8.1	344.4	17.1	50.2	22.5	21.1	168.6	95.8	13.8	56.1	75.4	69.8	21.0	10.8	15.3	31.1	189.7	56.4	35.3	95.6	53.4	2.0	102.9	55.7	650.9	85.4	81.2	145.9	36.5	27.0	68.1	5.2	65.9	10.2	9.6	113.3	89.1	55.4	172.1	174.1	183.7	4.3	16.0	19.7	88.2	37.8	193.8	43.2	43.1	43.2	60.3	41.3	3.4	90.7	291.6
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 130.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		350000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	11.1	12.2	13.9	2.1	13.9	0.0	9.9	19.0	21.2	40.0	9.1	7.6	1.6	32.9	3.2	3.3	15.0	2.5	11.2	15.1	9.4	18.8	130.0	7.2	1.5	10.1	9.9	16.3	17.1	1.1	6.0	2.4	10.2	9.7	0.8	0.0	3.8	5.2	4.4	5.4	6.0	4.6	10.3	9.7	7.8	1.1	9.7	0.2	7.7	2.7	0.3	7.2	15.4	13.6	0.0	0.0	0.3	1.1	0.1	0.1	1.4	0.3	0.0	0.2	0.1	2.8	0.0	0.0	1.1	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	11.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	4.0	1.4	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	13.9	19.0	21.2	15.1	9.4	10.1	9.9	10.2	10.3	9.7	13.6	2.6	0.0	0.0	11.8	0.4	2.7	0.0	0.0	0.6	2.9	2.1	1.8	3.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	31.2	2.6	0.0	0.0	28.2	3.1	0.0	16.4	1.1	4.5	0.0	0.9	3.3	36.4	0.7	0.0	37.5	0.2	0.0	3.2	3.1	0.0	3.7	0.4	1.8	4.7	0.0	0.0	0.0	7.1	2.5	1.1	0.0	2.2	0.0	0.1	0.0	4.0	0.0	0.5	6.6	19.1	16.4	0.3	0.3	0.3	1.1	0.1	0.7	0.1	0.0	0.3
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 224.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 50.3;Fibroblasts: 83.8;Leydig cells: 41.0;Muller glia cells: 81.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"ASC diff: 537.8;ASC TERT1: 724.7;hTERT-RPE1: 341.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"	NA	NA		610000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (2.23e-4)"	188.3	7.3	7.1	26.2	14.5	0.9	69.8	8.3	14.1	38.8	6.5	74.8	10.8	148.2	20.2	58.0	53.5	47.9	22.0	9.4	6.2	15.1	1.8	76.3	24.4	4.4	4.5	7.1	12.5	84.9	6.4	21.9	4.0	141.6	35.5	55.6	23.3	224.4	6.1	17.5	22.1	101.3	4.3	16.0	17.9	6.5	5.8	10.9	37.8	34.9	11.7	28.3	20.0	6.3	0.0	0.1	3.3	0.0	537.8	724.7	0.3	7.6	3.3	18.8	16.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.0	0.0	17.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	58.7	0.1	1.6	0.0	341.2	0.0	2.0	0.0	0.0	0.1	0.0	1.0	0.3	21.3	0.0	0.0	0.0	0.0	0.1	3.0	0.0	1.7	5.2	0.0	0.0	0.4	1.4	0.0	0.0	0.0	5.8	4.2	60.4	7.8	0.1	0.1	0.0	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.1	14.5	8.3	14.1	9.4	6.2	4.4	4.5	4.0	4.3	5.8	6.3	8.4	0.0	2.7	50.3	0.1	4.8	0.0	0.0	0.6	1.5	0.3	0.4	2.3	0.0	1.8	1.8	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	1.0	13.8	0.0	0.0	4.2	0.0	0.1	83.8	2.0	0.2	1.3	0.3	2.2	0.1	0.2	0.0	9.3	0.0	0.0	0.0	8.1	1.4	41.0	1.1	8.8	1.0	0.0	81.6	0.0	13.6	0.2	0.0	0.0	9.1	1.4	0.3	0.0	4.1	1.5	2.9	0.0	2.7	11.2	0.2	8.2	0.3	4.4	0.1	1.0	0.0	0.0	0.1
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731426	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 145.1;gallbladder: 106.0;lymphoid tissue: 115.8;smooth muscle: 122.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 194.1;Hepatocytes: 112.2;Skeletal myocytes: 533.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;PC-3: 1.3;SiHa: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA021771, HPA076522"	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9700000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"HPA021771: AB_1846689, HPA076522: "	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (6.08e-4)"	2.7	0.2	0.6	115.8	0.4	0.0	5.1	0.4	0.7	64.7	0.1	88.7	4.1	145.1	0.8	4.1	9.4	106.0	24.4	0.4	0.6	5.2	46.3	2.9	0.4	1.0	0.6	2.5	3.1	0.4	0.4	4.5	0.7	22.6	2.6	0.5	0.5	8.9	6.6	1.2	10.8	122.1	2.3	1.3	57.7	3.4	0.7	0.0	0.9	4.8	2.8	46.3	21.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.4	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.7	0.4	0.6	1.0	0.6	0.7	2.3	0.7	0.2	1.2	0.0	2.6	0.7	0.3	0.3	0.5	0.2	0.0	0.0	194.1	3.8	2.2	15.7	0.1	9.2	0.0	0.0	0.8	0.0	0.0	13.8	31.4	0.6	0.2	2.1	0.0	0.0	0.1	10.3	0.1	5.3	0.0	0.5	0.0	0.2	2.9	112.2	0.1	0.0	0.2	0.0	0.0	2.4	0.0	2.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	4.1	0.0	0.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	533.4	1.2	0.6	4.3	0.0	0.0	0.1	0.5	0.4	0.0	0.5
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 27.0;prostate: 29.6;salivary gland: 28.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Breast myoepithelial cells: 3.6;Excitatory neurons: 8.7;Inhibitory neurons: 7.8;Intestinal goblet cells: 3.2;Melanocytes: 3.6;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 4.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	178	"amygdala: 12.4;basal ganglia: 18.7;cerebral cortex: 27.0;hippocampal formation: 22.6;white matter: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 3.7;OE19: 12.3"	"Low region specificity"	"Detected in many"							HPA014101	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.0	3.3	12.4	0.3	18.7	0.0	2.7	0.0	27.0	0.0	0.0	0.8	0.4	0.1	0.0	0.3	0.2	0.1	0.1	22.6	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.0	29.6	0.7	0.1	28.8	0.0	0.0	2.8	0.7	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	12.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.4	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	18.7	0.0	27.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	1.8	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	3.2	0.0	0.0	0.3	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	3.0	1.0	0.0	0.1	0.0	0.0	4.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868652-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 36.1;intestine: 21.2"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 59.9;Excitatory neurons: 49.4;Inhibitory neurons: 119.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 86.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022338, HPA029795"	Approved					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.1	0.2	2.8	1.3	2.0	0.1	0.0	0.1	2.3	0.3	0.0	21.2	0.7	0.4	0.0	0.3	0.3	10.7	36.1	0.1	2.5	0.0	1.1	0.8	0.0	9.3	5.4	0.2	0.1	0.0	0.0	1.4	9.1	0.2	3.5	0.8	0.0	0.0	0.0	0.1	4.4	9.7	1.8	0.0	5.9	0.6	6.8	0.1	0.0	0.0	0.0	8.9	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	17.6	0.2	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.0	0.1	2.3	0.1	2.5	9.3	5.4	9.1	1.8	6.8	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	59.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.2	0.0	0.0	49.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	119.2	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;salivary gland: 17.5"	"Group enriched"	"Detected in many"	28	"Excitatory neurons: 802.9;Inhibitory neurons: 624.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.3	0.4	4.6	0.8	7.3	0.2	0.8	0.0	11.8	0.4	0.0	7.0	1.4	1.9	0.4	7.5	0.8	0.7	0.4	7.5	0.0	1.1	0.4	1.1	0.1	0.0	0.0	4.8	10.6	0.5	0.5	0.8	0.0	1.1	2.8	1.7	17.5	3.0	0.0	1.3	1.5	4.1	0.0	0.7	5.0	2.5	4.1	0.1	2.0	0.1	0.1	7.0	0.4	2.9	0.0	0.1	0.4	0.4	0.0	0.0	0.9	0.6	0.1	0.3	0.1	0.0	0.0	0.0	2.1	0.0	0.0	5.8	0.6	3.8	2.7	0.0	3.7	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.1	9.1	0.9	1.4	0.0	0.0	4.6	4.6	9.1	0.0	1.1	17.2	0.7	0.8	0.1	53.5	0.0	0.1	0.1	4.0	1.8	0.0	0.3	2.3	0.8	0.1	0.5	21.7	16.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	7.3	0.0	11.8	7.5	0.0	0.0	0.0	0.0	0.0	4.1	2.9	6.1	0.0	3.7	6.2	0.0	0.0	2.1	0.0	0.6	19.0	4.6	3.2	1.2	0.0	0.8	0.0	0.0	3.2	0.3	11.0	1.9	0.4	19.6	0.1	0.1	3.0	3.5	4.6	802.9	17.3	0.7	3.9	11.7	0.2	1.3	7.5	4.2	0.3	0.5	0.0	624.0	6.0	0.0	0.0	0.0	3.9	0.0	0.2	7.2	22.5	0.0	0.3	0.0	8.5	11.2	2.6	25.3	0.4	0.2	2.5	2.2	1.4	1.6	0.6	0.0	0.2	1.1	12.9	3.0	0.2	0.0	0.5	0.1	0.8	15.5	0.2
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 18.5;cerebral cortex: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.8"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.1	0.5	1.6	0.2	18.5	1.7	0.1	0.0	4.6	0.1	0.0	1.5	3.2	0.1	0.0	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.2	1.2	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.0	2.0	6.8	0.1	0.0	15.9	0.6	5.0	1.7	2.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	2.1	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	0.0	1.8	0.1	1.3	0.1	0.0	1.6	0.2	0.4	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.1	0.4	0.1	0.1	0.0	3.4	0.0	0.0	0.1	10.0	0.2	0.2	0.0	0.1	0.2	0.1	1.7	0.0	0.3	2.8	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	18.5	0.0	4.6	1.8	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968497-34067458	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 18.8"	"Cell type enriched"	"Detected in some"	9	"Oligodendrocytes: 178.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 13.2"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013172: AB_1854212"	"unprognostic (8.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.61e-4)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	0.1	0.1	2.4	0.3	5.8	0.4	0.3	4.2	4.8	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.0	1.8	8.4	0.2	0.6	0.1	0.3	9.5	8.3	0.1	0.3	0.0	0.2	1.5	9.0	0.1	0.0	1.3	0.1	0.0	0.2	0.4	0.5	0.0	3.1	0.2	0.1	1.5	18.8	0.0	0.6	0.0	0.0	0.0	0.1	13.8	0.1	0.1	0.5	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.6	0.2	0.2	0.0	0.4	10.4	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.5	1.0	0.0	0.1	0.2	1.9	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.2	0.1	0.7	0.2	0.3	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	2.4	5.8	4.2	4.8	1.8	8.4	9.5	8.3	9.0	3.1	18.8	13.8	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	0.0	5.9	0.2	0.1	0.0	0.0	0.0	8.7	0.0	18.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	12.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.8	0.1	0.2	1.0	2.5	178.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.8	0.0	0.2	0.0	0.0
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 170.1"	"Cell type enriched"	"Detected in some"	48	"Skeletal myocytes: 193.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Group enriched"	"Detected in some"	13	"cerebral cortex: 12.8;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"LHCN-M2: 445.4;RH-30: 360.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.1	12.8	0.6	0.2	1.5	0.2	0.0	0.2	0.6	0.0	0.0	0.3	5.5	0.2	0.0	0.2	0.6	0.8	0.5	0.2	0.0	0.0	0.0	3.3	0.2	0.5	2.0	0.9	0.0	3.2	0.0	170.1	0.5	0.0	0.0	0.3	0.0	0.0	0.4	0.3	1.1	0.0	20.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	21.5	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.2	445.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	360.2	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	12.8	5.5	0.2	0.5	0.2	0.5	0.3	0.3	0.7	0.1	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.6	0.4	1.7	0.3	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	193.5	0.3	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.2	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.3	39.3	4.4	5.1	2.0	0.0	0.1	6.3	1.0	1.0	0.3	8.1	1.5	0.5	0.0	0.1	0.0	0.3	0.4	0.7	2.3	0.0	0.0	0.2	0.3	3.1	6.4	0.1	0.2	0.0	1.1	0.1	10.0	0.2	4.0	53.5	0.1	0.0	0.1	0.7	3.0	3.7	0.3	0.1	2.8	1.0	9.2	65.8	0.2	0.0	0.8	0.2	0.7	1.0	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.0	6.3	1.0	0.7	2.3	3.1	6.4	10.0	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.8;liver: 58.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 42.0;Horizontal cells: 139.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"midbrain: 21.8;pons: 20.5;thalamus: 33.5"	CAB034064	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"			"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.0	0.2	6.7	0.0	6.5	0.0	0.0	0.6	6.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.7	8.7	3.4	58.0	0.0	0.0	5.7	15.7	0.1	0.0	12.7	0.8	0.0	6.2	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	1.6	28.8	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.5	0.6	6.2	6.7	8.7	5.7	15.7	6.2	0.5	28.8	4.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.0	0.0	139.7	8.8	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.9	0.0	7.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.7	0.0	1.7	0.1	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 13.0;Extravillous trophoblasts: 11.5;Intestinal goblet cells: 9.8;Spermatocytes: 12.4;Spermatogonia: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	0.8	2.0	1.9	1.9	1.8	0.5	1.5	2.7	3.0	1.0	2.0	4.0	4.8	1.3	1.1	1.6	0.5	4.4	1.3	1.7	1.8	0.3	0.3	0.5	0.7	1.7	2.2	0.7	1.9	0.3	0.2	1.1	2.4	1.9	4.2	2.5	0.7	0.4	3.9	0.6	2.4	2.1	1.6	0.3	2.8	3.1	2.4	0.7	0.3	0.5	1.1	1.8	1.1	2.7	16.5	41.8	22.4	12.5	2.7	1.9	9.1	12.0	5.8	13.0	23.4	16.1	76.7	9.8	28.6	2.6	34.7	14.3	43.5	17.6	13.2	20.1	51.9	18.3	29.5	16.2	1.4	12.4	24.7	0.7	3.1	3.5	4.7	4.8	24.5	13.6	18.2	12.5	8.3	36.1	15.9	4.3	18.2	32.4	11.5	20.1	25.8	9.9	15.7	39.2	37.7	55.0	28.6	27.5	14.1	12.7	61.2	3.2	5.3	17.6	21.0	13.0	38.0	14.3	63.4	11.3	10.6	19.8	16.5	1.0	0.4	0.7	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.3	0.7	0.3	0.4	0.2	0.0	0.1	1.9	1.8	2.7	3.0	1.7	1.8	1.7	2.2	2.4	1.6	2.4	2.7	0.9	0.0	0.0	0.3	1.4	3.2	13.0	0.5	8.6	7.6	1.2	2.9	1.2	2.8	0.2	0.0	0.0	2.6	0.4	1.2	0.0	0.3	1.2	0.5	0.6	2.0	3.5	0.8	1.0	2.0	11.5	1.0	0.5	0.6	0.0	1.5	0.0	0.3	1.0	5.0	1.1	9.8	0.0	0.0	2.3	2.6	0.3	0.8	1.8	0.0	0.2	0.4	1.0	0.5	0.9	0.7	0.1	0.4	0.9	6.7	0.1	0.4	0.1	0.7	0.0	1.3	1.6	12.4	28.8	2.9	1.6	1.0	2.0	0.2	2.1	3.2
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.8;intestine: 9.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8"									"HPA029422, CAB033624"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.3	7.8	1.2	0.4	1.1	0.9	1.0	1.8	1.8	0.4	2.1	1.5	4.4	0.5	0.3	0.3	0.4	0.9	0.5	1.0	4.5	0.4	0.1	0.5	0.7	4.5	3.9	1.6	2.4	6.4	1.0	0.0	7.0	1.2	2.3	2.5	0.5	0.7	0.5	0.3	9.7	0.4	1.5	1.2	6.6	2.5	3.3	0.4	2.2	0.8	0.7	1.5	0.7	1.1	0.0	1.3	2.7	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	1.7	0.6	0.0	2.2	0.0	0.4	1.0	0.0	0.0	0.2	0.0	0.1	0.4	2.5	0.0	0.2	0.3	0.2	0.0	0.2	1.5	3.7	0.0	0.0	4.2	0.3	0.5	12.9	0.5	8.3	0.2	13.3	0.0	0.7	0.0	0.5	1.2	0.0	10.8	0.3	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.2	1.1	1.8	1.8	1.0	4.5	4.5	3.9	7.0	1.5	3.3	1.1	0.5	0.0	0.0	1.0	0.0	0.3	3.0	0.0	7.4	1.8	1.1	1.3	1.1	2.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.1	0.2	0.3	1.5	3.0	0.0	9.0	2.5	0.0	0.4	26.0	0.6	1.3	4.6	0.7	0.0	0.1	16.8	30.7	8.9	0.0	0.0	0.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.5	1.1	1.6	2.9	0.0	0.2	0.7	14.4	0.2	0.0	0.0	0.0	0.4	0.3	0.2	5.9	3.2	0.0	0.0	0.1	0.2	2.0	1.2
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457710	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 34.6;RH-30: 71.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	7.0	30.6	6.9	2.4	7.8	9.1	6.7	7.3	7.5	7.5	8.8	6.3	2.9	6.6	5.1	7.0	5.4	1.9	11.5	6.9	6.9	10.7	16.5	5.1	3.6	7.5	7.0	5.4	16.5	9.1	6.7	6.7	7.3	5.1	2.5	3.2	10.7	3.0	158.4	8.1	5.5	3.2	7.3	7.9	5.2	3.2	7.1	6.5	13.0	57.7	3.9	5.5	7.2	8.1	1.6	2.2	3.8	4.5	6.0	4.0	8.6	1.1	3.8	5.6	4.6	1.3	2.0	6.2	4.0	2.5	2.0	13.6	1.4	25.1	2.0	7.6	4.8	3.5	2.3	8.1	2.6	2.2	8.6	8.8	6.8	3.4	11.0	9.3	3.8	12.0	4.6	3.4	34.6	1.0	6.7	4.1	2.7	1.5	1.1	4.4	71.0	15.8	15.3	1.2	0.6	11.1	2.4	4.0	4.7	5.9	3.9	3.0	3.6	2.3	6.4	1.7	5.0	8.1	9.6	1.7	2.1	4.9	2.1	9.9	5.4	13.6	7.9	6.3	6.1	6.7	8.7	8.0	7.0	7.0	7.0	9.2	1.7	11.0	10.4	5.2	7.9	6.1	6.9	7.8	7.3	7.5	6.9	6.9	7.5	7.0	7.3	7.3	7.1	8.1	8.8	0.0	4.8	4.6	8.9	6.4	3.8	12.6	6.2	3.9	9.3	11.2	9.8	4.3	7.2	9.2	2.1	39.0	17.7	5.2	23.5	16.1	2.2	5.1	7.1	10.1	2.4	3.4	1.4	13.4	9.4	8.1	3.6	7.1	13.3	5.8	10.4	10.8	12.6	15.2	1.5	4.8	14.2	7.2	8.7	2.1	21.8	7.9	12.4	1.0	17.0	14.0	29.9	1.0	5.6	17.3	4.9	17.0	5.8	4.1	10.2	15.5	9.5	7.1	0.0	47.3	8.1	2.8	2.8	6.1	6.5	30.4	11.2	12.1	5.9	3.8
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697366-42737407	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"brain: 12.1;retina: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Bipolar cells: 1.5;Excitatory neurons: 2.2;Inhibitory neurons: 2.9;Microglial cells: 1.0;Rod photoreceptor cells: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 12.1;midbrain: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 1.1;U-266/84: 2.7"	"Region enhanced"	"Detected in many"		"midbrain: 6.9"	"Low region specificity"	"Detected in all"			HPA045555	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA045555: AB_10960891"					"unprognostic (8.63e-2)"						"unprognostic (4.12e-1)"			"unprognostic (7.29e-2)"	"unprognostic (1.62e-1)"			0.0	0.0	0.2	0.0	1.7	0.0	0.0	12.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.1	0.0	10.2	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.7	12.1	0.3	0.5	2.2	0.0	10.2	0.2	0.0	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		680000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.3	6.7	26.5	4.2	28.2	3.2	5.1	24.3	33.6	7.1	18.8	6.3	2.3	11.5	13.3	4.2	9.7	5.5	11.0	27.2	23.2	4.3	1.2	8.1	4.4	24.6	26.4	12.7	5.6	9.6	11.5	8.2	23.2	8.0	2.4	9.4	6.1	5.2	6.0	2.2	3.6	12.0	24.8	5.0	4.4	6.1	28.6	5.7	10.0	8.3	5.4	5.5	3.7	25.1	0.2	14.6	28.4	14.6	8.5	11.9	14.2	16.7	11.8	22.4	14.3	0.3	8.5	20.4	14.1	10.1	39.6	0.0	20.2	2.2	14.3	29.1	21.2	10.5	8.3	23.1	10.1	21.5	26.5	8.8	2.7	10.6	2.0	10.7	17.8	19.5	31.0	0.1	9.7	4.8	19.1	16.8	42.0	0.2	17.7	13.6	17.6	0.2	6.2	6.4	30.5	24.9	1.2	0.1	23.3	20.0	7.8	29.0	16.4	15.5	24.5	11.7	15.7	0.0	0.1	21.2	19.0	18.7	18.6	0.0	0.0	0.0	1.3	0.0	0.4	0.8	0.2	1.0	0.2	0.6	0.3	0.7	0.0	0.0	0.0	1.1	0.0	0.5	26.5	28.2	24.3	33.6	27.2	23.2	24.6	26.4	23.2	24.8	28.6	25.1	2.8	16.0	3.1	21.5	4.4	0.9	1.1	0.3	0.6	9.7	2.4	2.0	6.3	1.5	4.4	1.8	0.0	5.4	2.3	0.0	3.9	3.5	1.5	2.7	6.7	4.9	1.8	3.0	10.7	2.9	10.5	5.0	0.0	6.2	0.0	6.5	0.4	0.0	6.2	6.7	7.5	0.0	0.0	0.8	1.1	0.4	2.1	1.3	0.0	6.5	3.2	16.7	1.0	12.5	5.9	2.2	0.0	5.3	2.3	1.5	0.0	1.1	0.7	4.8	0.0	3.7	3.5	1.5	5.1	0.3	0.6	1.4	3.4	8.5	0.1	0.2
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0;choroid plexus: 59.1"	"Group enriched"	"Detected in many"	4	"Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		55000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	5.0	10.2	14.5	20.1	13.9	39.0	3.5	11.1	14.1	5.6	59.1	4.2	3.0	11.9	13.3	3.4	3.7	9.4	4.5	15.0	16.0	3.6	3.0	12.2	15.2	17.9	16.4	6.2	4.6	1.3	4.5	15.5	17.1	3.9	4.0	2.2	2.2	8.0	1.1	1.7	6.2	10.9	13.1	12.8	6.3	2.3	17.3	19.5	3.3	1.0	11.7	8.3	3.8	17.5	38.8	18.2	8.2	5.3	20.5	10.0	27.8	3.1	1.2	1.8	1.5	0.0	51.2	0.2	5.6	5.4	42.3	9.9	4.9	20.8	2.2	0.4	7.1	53.2	4.8	0.2	3.1	62.4	60.6	3.7	2.9	32.9	5.4	30.7	13.2	74.4	82.8	13.2	3.5	9.7	47.8	73.1	6.6	0.4	7.0	54.0	27.3	12.9	17.0	0.4	13.6	21.9	2.1	26.3	48.3	7.2	7.7	62.7	29.2	5.7	6.2	29.4	32.3	67.2	75.9	10.6	26.3	43.5	57.7	12.7	1.4	11.2	3.0	1.4	1.7	1.0	1.5	2.2	0.8	2.8	0.7	1.9	15.6	1.6	1.3	2.9	3.2	0.8	14.5	13.9	11.1	14.1	15.0	16.0	17.9	16.4	17.1	13.1	17.3	17.5	8.4	16.0	13.1	142.4	33.8	2.8	18.2	2.6	4.0	3.1	0.5	1.1	5.7	1.5	6.4	5.5	0.0	41.6	45.6	0.1	0.0	4.9	0.9	1.3	24.7	12.9	0.0	36.2	43.8	61.4	12.0	9.5	2.6	0.9	41.3	1.4	18.2	0.5	42.6	10.1	114.4	0.0	0.0	26.8	42.9	2.0	7.5	56.5	3.6	281.1	65.6	2.3	30.9	1012.8	3.5	28.6	0.0	17.0	64.0	3.9	0.0	6.0	8.1	0.6	6.6	1.8	12.8	0.6	2.5	0.9	2.8	26.5	49.0	15.5	0.3	3.7
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403588-2448484	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		960000	"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	16.1	13.3	4.5	5.1	3.5	6.1	15.0	7.3	5.0	15.4	0.2	13.7	5.4	17.8	0.6	7.9	15.8	1.2	15.5	9.0	2.6	11.3	7.1	14.5	2.9	9.4	4.7	11.6	11.7	1.4	17.6	2.8	4.6	13.6	0.6	1.2	10.3	2.8	8.3	15.6	10.6	1.4	3.8	24.5	11.1	9.1	5.9	1.4	14.1	0.9	1.0	13.1	13.1	4.3	9.5	9.1	2.7	10.0	3.8	2.3	29.5	17.2	4.2	4.2	5.7	9.0	3.2	8.5	31.6	2.7	10.3	7.1	1.6	2.2	0.8	11.2	17.7	5.9	7.0	9.9	2.6	19.4	60.1	4.8	0.9	3.8	0.5	3.3	4.2	11.5	15.1	25.0	1.2	6.8	19.8	57.4	19.1	1.3	14.4	7.1	7.6	42.1	1.2	3.8	6.8	28.7	8.4	4.5	4.0	2.0	6.6	22.3	13.0	9.6	26.5	20.0	15.2	88.9	37.1	3.9	7.8	8.8	17.9	59.1	10.4	53.2	87.6	9.1	54.4	14.7	30.0	71.4	20.4	18.3	12.6	37.8	3.1	121.6	3.9	64.9	33.0	22.9	4.5	3.5	7.3	5.0	9.0	2.6	9.4	4.7	4.6	3.8	5.9	4.3	36.8	16.0	50.5	9.1	32.8	18.1	35.5	24.3	18.8	45.6	18.0	13.0	8.3	15.7	30.5	18.4	66.7	104.5	158.7	6.2	1.9	22.4	6.7	4.7	21.1	59.4	12.7	37.0	11.0	15.3	15.0	37.0	6.1	6.4	38.0	13.4	152.8	7.2	24.8	47.1	12.3	9.1	24.4	26.4	22.9	5.8	95.7	21.2	21.4	10.3	21.3	15.1	368.7	14.1	9.5	13.3	6.7	67.7	107.8	18.4	16.2	9.5	15.2	50.5	19.7	25.6	17.9	37.8	30.6	9.2	15.3	133.5	93.2	18.4	12.2	13.1
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470984-40473158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA		20000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	14.2	9.6	6.8	7.7	7.5	3.4	13.7	7.0	6.5	22.0	7.3	11.8	4.5	21.6	8.0	8.7	16.5	11.3	13.8	6.2	7.0	10.1	8.8	13.0	8.5	8.0	7.1	21.1	8.1	11.3	14.4	27.0	7.2	14.6	4.6	1.6	11.0	15.4	5.0	9.1	9.9	12.6	7.5	13.6	9.4	7.9	7.0	8.6	15.8	7.4	7.5	16.1	16.1	7.3	26.2	17.1	26.4	71.6	40.4	31.0	43.0	25.2	47.3	43.5	40.9	21.2	12.8	4.3	37.6	42.7	76.7	43.7	23.7	14.2	20.3	31.5	15.0	13.4	16.9	19.8	22.5	5.7	33.4	38.3	11.6	15.4	11.6	47.8	39.2	15.1	13.6	15.0	32.6	20.1	9.6	29.8	17.0	7.9	20.1	26.2	33.4	7.6	29.5	13.3	19.7	30.2	22.2	24.4	8.4	31.9	35.7	23.9	31.9	73.0	27.1	23.3	25.5	30.3	22.6	12.2	32.8	19.6	53.7	7.6	1.1	2.2	2.2	1.1	0.6	0.3	1.1	1.9	2.0	1.1	0.9	0.8	0.1	3.3	0.6	0.7	0.8	0.7	6.8	7.5	7.0	6.5	6.2	7.0	8.0	7.1	7.2	7.5	7.0	7.3	10.6	12.8	1.1	2.0	5.8	3.4	5.4	4.1	9.1	0.6	5.8	9.7	3.2	7.2	4.6	3.7	0.0	46.5	3.5	0.5	0.0	7.7	1.8	3.2	14.5	10.2	2.4	10.7	0.1	4.9	32.4	19.3	0.0	5.6	4.5	14.9	15.4	3.7	9.3	1.7	0.1	1.4	2.0	5.6	3.3	1.3	17.7	5.6	5.4	2.8	3.4	9.8	6.2	2.0	0.5	5.2	0.3	11.7	1.9	3.6	0.2	1.1	3.0	0.8	6.6	11.8	9.2	7.5	1.3	5.6	2.6	13.5	4.9	3.9	1.9	1.3
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007668-124093598	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 69.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 69.0;monocytes: 38.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 66.0;REH: 90.4;U-266/70: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	17.0	10.4	9.3	19.8	25.4	7.0	11.4	5.3	14.6	10.6	23.8	19.8	9.8	7.9	8.3	9.4	15.0	12.8	5.5	17.2	6.0	9.6	13.6	17.2	17.8	8.3	8.2	37.0	14.1	2.8	8.4	6.6	6.7	9.7	8.8	2.8	9.4	13.8	13.7	9.2	15.4	10.6	10.2	36.7	11.5	4.3	9.5	9.3	19.8	5.8	14.2	12.4	9.2	11.6	32.3	21.2	7.8	1.7	7.5	4.0	0.1	6.4	8.6	3.4	4.9	0.6	17.1	0.0	20.1	26.4	2.3	35.9	1.5	20.8	2.9	0.2	5.9	0.1	9.3	16.0	2.4	0.0	39.2	2.5	23.5	9.5	8.0	8.3	6.9	0.1	0.0	66.0	17.0	18.0	0.1	0.1	6.8	4.9	0.1	90.4	10.6	21.6	17.1	3.1	0.8	1.7	17.1	9.6	0.0	19.3	7.0	0.1	8.3	0.9	0.3	24.3	1.0	59.5	15.7	16.9	0.2	0.0	0.1	0.0	21.8	15.3	0.0	33.3	0.0	4.5	0.0	0.0	4.2	4.4	0.3	0.0	69.0	0.0	38.7	4.9	0.3	9.1	9.3	25.4	5.3	14.6	17.2	6.0	8.3	8.2	6.7	10.2	9.5	11.6	14.3	22.4	9.6	4.2	13.5	16.8	16.1	15.3	2.2	5.6	10.5	5.2	2.2	12.8	12.1	20.2	0.0	1.8	7.2	0.1	0.0	9.7	29.5	7.4	5.9	18.2	1.8	0.0	43.8	0.7	2.3	8.4	0.5	14.0	5.7	0.4	42.1	9.0	10.5	0.0	33.2	0.0	16.2	50.2	3.6	34.8	10.2	34.0	1.8	43.1	30.3	0.1	2.1	35.2	1.0	9.8	0.0	1.9	34.3	14.7	0.0	0.7	11.9	0.5	19.7	13.4	11.5	10.4	10.0	2.4	11.6	1.0	1.4	0.8	0.1	15.8
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964395-72013558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		690000		"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	18.4	13.4	10.7	5.5	17.9	0.0	11.4	16.8	11.5	10.7	6.2	11.9	0.9	16.0	3.7	6.4	12.9	4.7	14.3	9.9	12.9	7.9	1.2	7.9	1.6	27.9	18.2	20.6	4.6	1.2	4.6	8.0	19.8	11.1	2.1	2.1	6.4	14.8	17.7	8.7	5.4	17.1	14.0	2.5	14.7	18.1	17.3	4.2	5.5	9.0	1.4	9.4	8.4	25.3	15.4	16.4	8.2	20.3	36.6	14.4	0.3	32.0	30.4	19.3	12.8	14.4	30.1	0.0	21.4	37.9	15.5	19.7	7.4	21.9	15.3	0.4	5.5	0.1	27.8	13.8	18.7	0.0	0.1	19.8	24.9	19.0	25.9	37.3	5.7	0.7	4.7	0.0	20.6	0.4	0.0	0.1	3.5	0.5	5.3	0.2	9.9	0.0	26.9	15.7	0.5	8.1	24.2	0.6	24.1	9.9	1.8	3.1	11.9	23.6	27.1	39.6	65.1	0.0	0.1	0.1	17.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.9	16.8	11.5	9.9	12.9	27.9	18.2	19.8	14.0	17.3	25.3	23.9	0.0	1.9	14.0	0.1	2.8	4.9	6.1	13.6	0.1	4.3	8.0	10.4	5.7	2.5	7.3	0.0	4.6	0.0	0.1	3.9	9.7	0.8	20.1	24.7	5.6	0.0	0.0	0.2	2.7	2.2	9.3	2.6	17.9	1.3	26.9	13.6	0.3	0.8	0.0	0.3	0.0	2.0	0.6	1.9	3.2	20.5	0.7	8.8	4.7	0.7	6.6	0.0	26.7	27.1	12.7	0.0	21.8	0.0	4.2	0.0	3.6	2.0	0.2	6.6	26.8	13.9	1.0	2.1	7.5	2.4	1.1	0.4	5.5	0.1	1.3
CHST4	"HEC-GLCNAC-6-ST, LSST"	ENSG00000140835	"Carbohydrate sulfotransferase 4"	Q8NCG5	16	71525233-71538748	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"gallbladder: 69.4"	"Cell type enriched"	"Detected in some"	24	"Cholangiocytes: 165.8"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 10.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;HL-60: 2.7;NB-4: 5.0;NTERA-2: 7.5;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021955	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA021955: AB_1846723"	"unprognostic (2.22e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.76e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (1.26e-1)"		"unprognostic (1.70e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	0.4	1.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.5	1.7	0.0	0.0	0.1	0.0	0.2	5.4	69.4	0.0	0.2	0.1	0.0	4.4	0.2	1.3	0.4	0.6	0.0	12.4	0.0	0.5	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.9	0.0	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.1	0.1	1.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.1	165.8	6.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 85.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.5"									"HPA043804, HPA068029"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA043804: AB_10960563, HPA068029: "	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.1	0.2	2.2	1.3	2.0	0.6	0.4	1.9	2.2	0.4	2.2	46.1	85.0	0.4	0.3	0.2	1.1	0.2	0.3	2.2	1.0	0.4	0.1	0.3	0.3	1.9	1.5	0.5	0.1	0.4	0.7	0.2	0.7	0.3	55.3	1.5	0.1	0.3	7.7	0.2	75.6	1.0	1.2	0.4	4.7	0.7	1.8	0.3	0.3	0.8	0.1	0.2	0.1	1.6	0.1	0.3	0.4	0.5	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.6	0.4	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.9	0.2	1.3	0.3	0.0	1.5	0.2	0.1	0.9	0.5	0.1	0.7	1.2	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.5	0.3	0.9	0.1	0.2	0.7	0.0	0.3	0.1	0.3	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.2	0.1	0.0	2.2	2.0	1.9	2.2	2.2	1.0	1.9	1.5	0.7	1.2	1.8	1.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	2.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.6	0.0	8.1	0.0	0.0	0.0	11.6	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0
CHST6	MCDC1	ENSG00000183196	"Carbohydrate sulfotransferase 6"	Q9GZX3	16	75472052-75495445	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.5;cervix: 9.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 60.0;Oligodendrocytes: 17.0;Respiratory ciliated cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.3;CAPAN-2: 9.9;NTERA-2: 4.8;SK-MEL-30: 4.1;U-2 OS: 5.0;WM-115: 5.4"									HPA068029	Approved				"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA068029: "	"unprognostic (2.28e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.80e-4)"	0.1	5.4	8.6	0.2	11.8	0.1	0.0	8.5	7.9	9.4	3.4	0.8	4.5	0.4	0.2	1.3	1.2	0.1	1.9	7.2	10.7	0.3	0.0	0.9	0.1	12.5	13.2	0.0	0.0	0.2	1.2	0.1	11.5	0.4	1.5	0.3	2.7	0.1	0.1	0.1	3.9	0.3	10.9	0.1	0.1	0.8	13.5	0.1	0.1	0.1	0.0	0.2	0.1	11.7	0.1	0.5	0.6	9.3	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.2	9.9	0.1	1.1	0.0	0.1	0.1	0.9	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	4.1	1.4	0.0	0.3	0.1	0.0	5.0	0.0	0.0	0.1	0.1	2.1	0.2	0.0	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	8.6	11.8	8.5	7.9	7.2	10.7	12.5	13.2	11.5	10.9	13.5	11.7	0.2	0.0	2.4	7.5	0.2	0.0	1.7	0.7	0.0	0.7	0.2	0.1	1.0	0.0	4.8	3.7	0.0	2.1	0.1	3.8	0.0	0.1	1.3	60.0	0.8	0.4	0.0	0.0	0.4	0.0	0.2	1.6	0.0	7.5	1.3	0.2	0.0	0.0	0.2	0.0	1.3	4.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	1.9	0.0	0.6	0.0	6.0	17.0	0.2	8.9	0.0	0.0	1.5	8.9	0.0	16.4	0.4	0.0	1.0	0.7	0.3	0.6	0.0	0.0	0.7	0.4	0.1	2.2	3.9
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573765-46598496	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		9800	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.2	3.4	5.4	1.7	7.3	2.5	7.5	6.4	7.0	11.2	3.7	3.7	0.8	5.8	0.4	2.5	4.9	1.9	17.4	5.4	7.1	4.0	7.5	3.6	1.8	6.1	7.3	35.3	2.0	1.2	4.2	2.0	6.0	4.1	0.8	0.9	3.5	1.4	4.4	7.3	4.0	1.4	4.7	10.2	3.4	2.1	8.0	1.4	5.8	3.9	0.7	4.5	7.7	4.0	5.5	4.7	3.9	3.5	10.8	7.5	0.2	7.6	5.4	2.0	2.6	1.2	2.1	0.0	22.8	3.1	1.3	4.1	3.8	1.3	1.7	3.2	8.1	1.1	0.3	4.1	16.6	1.9	0.1	2.5	1.1	3.8	3.1	3.4	6.2	2.5	0.0	4.7	1.5	2.6	0.7	2.4	20.5	0.4	17.0	3.6	3.2	10.3	5.5	0.2	8.8	3.4	1.1	0.2	0.9	9.6	1.3	0.4	1.4	6.1	0.6	3.3	3.5	11.0	2.4	1.7	6.8	0.1	0.4	2.4	2.2	0.7	1.5	7.1	1.4	1.2	5.8	2.8	1.2	0.6	1.2	1.1	10.9	0.6	10.2	0.8	18.5	1.9	5.4	7.3	6.4	7.0	5.4	7.1	6.1	7.3	6.0	4.7	8.0	4.0	33.8	0.0	3.1	22.9	2.5	12.4	2.0	4.8	1.2	0.8	2.2	3.7	7.4	10.0	2.6	1.8	0.0	5.3	11.5	1.7	1.9	2.8	0.0	3.6	20.8	16.3	0.0	0.0	0.9	2.5	4.3	23.6	0.0	1.6	0.0	19.7	15.7	4.5	11.5	3.3	4.1	2.9	0.0	14.2	45.4	0.3	19.0	14.1	14.2	4.7	55.5	5.2	4.1	13.0	1.0	1.8	1.5	60.2	4.7	6.7	0.7	2.1	1.9	0.8	52.6	43.1	11.2	0.5	1.3	1.3	13.2	1.4	9.9	11.4	0.9	3.3
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621953-33773509	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"brain: 30.3;pituitary gland: 63.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	0.7	0.7	7.8	0.3	6.7	0.0	1.8	11.5	10.4	0.9	0.1	0.4	0.0	0.6	0.0	0.3	1.2	0.9	0.4	11.0	11.4	0.1	0.1	0.2	0.4	29.8	7.2	1.0	0.7	0.0	63.9	0.0	30.3	0.7	0.0	0.7	0.2	0.0	0.1	0.3	0.3	0.1	5.4	1.3	0.3	1.4	11.5	0.0	0.6	0.0	0.2	0.3	0.5	8.2	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	4.7	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.1	24.7	0.0	0.4	13.5	23.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	6.7	11.5	10.4	11.0	11.4	29.8	7.2	30.3	5.4	11.5	8.2	0.2	0.0	0.0	0.7	0.0	0.8	0.4	0.0	0.0	3.1	3.8	0.6	5.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.3	0.2	0.4	0.0	0.0	11.8	0.0	1.3	0.2	0.0	0.1	0.0	7.9	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	12.1	3.6	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.3	3.2	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	1.1
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185308	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 13.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.0	0.2	0.8	0.1	0.9	0.0	2.9	0.7	2.4	2.8	0.0	1.6	0.2	0.1	0.4	1.6	10.3	3.1	2.6	2.7	1.2	1.6	8.2	4.3	0.0	3.5	2.3	0.0	9.3	0.0	1.9	0.0	1.2	3.5	0.2	7.3	13.8	1.8	0.2	0.1	0.3	0.1	2.0	5.7	0.7	6.9	1.2	1.0	0.0	0.9	0.6	1.5	0.7	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	41.8	0.0	9.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	2.4	2.7	1.2	3.5	2.3	1.2	2.0	1.2	1.9	0.1	0.0	2.7	24.8	0.0	0.6	32.6	56.6	4.6	1.3	8.2	8.0	9.2	35.8	115.2	5.5	0.0	0.4	0.1	0.0	11.7	13.0	7.1	49.9	0.7	0.3	3.5	0.0	10.1	0.6	0.1	4.2	0.0	1.8	5.1	0.1	0.0	10.7	0.3	0.0	29.3	0.1	22.4	0.0	0.0	4.4	0.6	0.5	7.2	1.0	0.0	69.2	0.0	167.4	1.0	1.3	0.0	0.4	0.0	8.9	0.0	0.3	311.6	3.2	0.0	3.2	3.7	0.9	1.3	4.7	0.0	0.3	0.4	0.0	0.0	40.3
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904465-130186634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 509.1;Inhibitory neurons: 349.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 2.0;basal ganglia: 2.6;cerebral cortex: 2.9;hippocampal formation: 2.5;white matter: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.1;ASC TERT1: 11.5;HSkMC: 7.6;TIME: 7.4;U-138 MG: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	6.0	0.5	2.0	1.0	2.6	0.0	2.8	0.0	2.9	4.5	0.0	0.7	0.5	1.5	0.1	0.6	1.1	2.8	1.3	2.5	0.2	0.2	1.7	1.8	0.5	0.0	0.4	0.3	0.3	0.4	0.3	2.2	0.0	0.5	0.5	1.0	0.5	0.6	1.0	1.3	0.5	2.0	0.2	0.7	0.5	0.7	0.4	0.2	1.2	0.5	0.4	1.7	1.9	1.1	0.0	0.1	1.2	0.0	13.1	11.5	1.0	3.0	0.1	0.4	0.4	0.0	0.1	0.0	0.3	4.6	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.9	5.6	0.5	1.2	0.0	0.0	7.6	0.0	0.1	1.2	0.6	3.2	0.0	0.0	1.9	5.2	0.0	0.0	0.0	0.7	0.0	1.2	0.4	5.7	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.3	1.1	0.2	0.5	7.4	14.2	3.0	0.2	2.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.6	0.0	2.9	2.5	0.2	0.0	0.4	0.0	0.2	0.4	1.1	2.0	9.6	1.1	20.2	0.0	0.5	0.0	0.0	1.2	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.5	14.8	2.4	0.0	0.0	509.1	0.0	0.1	2.9	0.0	0.3	0.0	4.1	3.6	1.8	1.9	0.0	349.5	0.0	0.0	1.3	0.7	0.1	1.2	0.1	3.6	87.1	0.0	1.3	0.0	76.9	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	6.6	0.9	6.3	1.6	0.7	0.3	0.3	0.4	0.2	0.6	0.0	0.1
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	42.4	44.8	48.1	36.5	54.1	62.5	44.2	54.7	56.0	52.5	48.3	44.2	30.3	45.2	36.2	50.3	47.5	21.9	63.3	47.8	51.1	66.5	54.8	39.3	46.6	51.9	50.7	55.2	63.4	35.9	48.7	33.4	52.2	48.4	32.7	59.9	44.4	29.6	124.4	52.6	46.8	30.5	50.0	65.4	47.9	37.6	49.6	65.7	55.8	68.4	44.4	45.1	47.9	63.5	74.3	63.9	106.2	65.0	45.2	33.1	84.3	51.2	47.0	71.3	61.2	71.6	72.9	83.5	75.6	48.0	46.6	66.8	103.4	74.7	46.9	97.8	95.7	65.5	102.2	60.0	56.1	101.8	78.8	38.5	84.8	69.0	97.5	59.2	57.7	89.4	82.1	62.2	54.1	94.3	109.8	102.6	123.6	106.9	79.1	67.5	65.0	92.5	69.8	100.5	64.3	74.5	54.6	77.8	91.6	69.9	83.7	138.6	50.0	47.7	70.4	60.7	83.8	86.2	77.8	95.5	50.1	81.9	56.8	84.9	42.9	40.9	46.0	44.8	46.2	46.2	45.3	45.3	54.4	43.3	45.2	41.0	30.8	35.1	43.0	41.7	51.9	46.4	48.1	54.1	54.7	56.0	47.8	51.1	51.9	50.7	52.2	50.0	49.6	63.5	46.4	32.1	37.3	32.3	50.1	63.0	103.6	59.7	37.5	40.8	45.6	33.5	74.1	57.2	43.5	53.3	33.3	91.7	47.7	49.2	50.9	69.5	34.9	50.6	42.6	54.2	60.3	81.9	16.1	64.8	121.9	47.1	42.3	63.4	46.3	59.7	43.9	41.2	69.7	43.7	17.6	56.4	42.7	48.9	38.2	18.0	44.7	40.9	35.6	14.0	69.3	44.0	52.5	16.6	40.1	61.3	58.1	42.2	48.2	101.8	48.4	49.0	33.2	57.5	19.7	34.9	59.7	125.2	115.2	46.5	61.7	128.6	45.7	57.9	52.3	110.2
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CHURC1	"C14orf52, FLJ33064, My015"	ENSG00000258289	"Churchill domain containing 1"	Q8WUH1	14	64914361-64944591	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040072	Approved		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA040072: AB_10963788"	"unprognostic (2.94e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.78e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	47.8	42.0	29.9	39.1	34.8	43.8	37.4	34.5	41.2	41.2	27.2	43.8	30.9	40.0	32.6	34.3	34.2	32.5	58.8	29.8	33.7	34.7	52.4	29.3	43.8	38.8	33.3	43.9	30.2	46.1	25.2	34.5	38.6	32.4	36.4	35.7	26.5	37.7	82.9	30.1	33.9	45.8	34.7	42.2	33.7	25.4	34.3	61.2	32.9	53.0	43.3	38.3	30.5	40.3	119.6	61.8	58.8	43.7	70.1	75.6	68.9	85.3	74.3	47.4	53.9	34.1	75.1	69.9	57.7	73.7	75.2	84.9	51.7	69.2	51.8	79.7	25.3	67.9	47.7	79.3	66.1	37.7	64.9	89.9	50.5	43.0	81.4	79.7	51.6	107.2	30.6	60.5	58.1	97.6	72.7	61.6	31.4	140.9	101.1	63.4	63.2	42.6	64.5	83.8	30.0	36.7	57.6	59.8	81.0	53.7	101.8	78.4	64.8	41.3	87.8	45.0	56.0	49.5	46.8	162.0	43.0	44.6	51.8	201.6	131.9	145.4	111.5	137.6	128.2	161.8	167.5	134.1	107.4	135.9	166.3	139.8	292.8	122.4	138.3	154.7	238.5	143.5	29.9	34.8	34.5	41.2	29.8	33.7	38.8	33.3	38.6	34.7	34.3	40.3	154.6	102.5	89.0	0.0	128.2	58.5	73.8	176.8	130.3	73.8	85.0	98.7	53.4	94.4	98.2	99.3	43.8	90.4	97.9	89.3	131.0	160.7	82.0	130.8	87.3	109.9	89.8	91.5	0.0	222.7	89.7	100.9	75.4	80.8	95.6	69.6	127.5	190.4	89.3	53.8	0.0	100.3	107.8	172.6	69.6	27.1	104.1	130.5	83.6	0.0	214.3	155.2	132.8	0.0	0.0	216.8	118.9	121.5	79.7	70.5	124.6	211.0	145.1	87.2	131.5	100.6	135.7	131.1	81.1	158.3	65.9	89.8	137.0	205.8	121.1	72.2
CHURC1-FNTB		ENSG00000125954	"CHURC1-FNTB readthrough"		14	64914485-65061803	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Astrocytes: 11.1;Excitatory neurons: 10.4;Inhibitory neurons: 8.1;Microglial cells: 10.3;Oligodendrocyte precursor cells: 18.6;Oligodendrocytes: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 3.2"									CAB009260	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB009260: AB_2294228"	"unprognostic (9.48e-2)"	"unprognostic (8.51e-2)"			"unprognostic (4.96e-2)"	"unprognostic (8.55e-3)"		"unprognostic (1.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.27e-3)"	"unprognostic (9.98e-2)"	"unprognostic (7.68e-5)"	"unprognostic (2.90e-1)"		"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	0.5	0.6	0.2	0.0	0.5	0.7	0.4	0.8	0.8	0.3	0.5	0.4	0.0	0.6	0.0	0.3	0.8	0.2	0.6	0.2	0.5	0.2	0.3	0.3	0.2	1.0	0.4	0.4	0.5	0.0	0.3	0.3	0.9	0.3	0.0	0.1	0.2	0.1	1.3	0.4	0.2	0.2	0.7	0.1	0.7	1.7	0.5	0.4	0.2	0.0	0.1	0.3	0.3	1.4	0.6	2.1	1.0	1.0	1.5	0.9	0.9	2.1	0.4	0.8	0.1	0.0	1.8	0.1	1.2	0.2	0.9	2.5	0.3	0.0	0.5	1.6	0.0	0.0	0.4	0.0	1.2	0.0	0.7	0.6	0.3	0.0	0.4	1.7	0.1	0.3	0.5	0.5	0.4	0.0	0.6	0.3	0.8	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	1.1	1.4	2.0	0.4	0.2	0.7	1.3	0.0	0.0	3.2	0.6	1.0	1.4	0.9	0.6	1.5	0.9	0.4	3.0	1.4	1.5	0.8	1.4	1.5	0.6	1.1	1.0	1.1	0.6	1.2	0.9	2.6	1.1	0.8	1.2	2.5	1.8	0.2	0.5	0.8	0.8	0.2	0.5	1.0	0.4	0.9	0.7	0.5	1.4	0.0	0.0	2.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	18.6	15.4	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266159-96274173	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	18.4	32.4	26.8	17.0	28.3	12.1	19.4	30.2	29.7	18.9	26.3	16.8	20.1	14.8	18.0	20.1	19.7	15.1	30.4	27.8	27.8	31.0	32.8	17.6	22.3	27.7	27.6	18.6	17.9	36.2	13.4	18.7	28.3	16.9	17.6	17.4	23.6	19.5	27.8	19.3	17.6	16.5	28.9	21.3	16.7	17.1	28.6	22.2	20.5	28.0	21.3	18.6	13.9	30.2	31.8	27.2	28.8	32.3	49.8	40.9	32.0	27.1	31.9	37.5	39.8	44.1	23.0	44.6	46.6	29.8	42.0	28.0	40.8	29.7	33.4	25.0	58.0	28.9	19.4	47.4	28.8	37.8	32.2	35.1	34.5	28.5	43.2	35.9	39.9	33.8	36.9	29.8	35.9	38.1	42.2	40.8	51.3	44.5	58.0	38.3	33.2	47.3	42.6	31.6	36.0	42.2	19.9	48.0	53.1	40.1	24.8	41.4	30.4	26.2	35.4	36.7	29.3	43.5	49.6	30.1	38.4	37.9	31.4	30.9	27.7	34.2	27.8	23.8	31.9	20.9	25.8	29.8	29.1	24.9	24.3	28.5	23.6	30.0	33.8	18.8	23.5	33.0	26.8	28.3	30.2	29.7	27.8	27.8	27.7	27.6	28.3	28.9	28.6	30.2	33.3	28.9	31.4	26.8	32.4	29.1	28.7	39.0	35.9	24.3	23.2	28.4	27.0	15.7	31.6	14.7	14.6	59.3	42.5	21.8	39.2	40.0	25.0	21.2	30.7	30.1	15.7	32.4	44.5	33.6	60.1	32.6	28.1	21.2	37.2	33.3	19.2	27.4	45.2	26.9	36.6	21.1	44.7	23.4	29.6	25.8	20.2	30.6	19.6	20.6	40.6	19.0	42.2	25.1	25.2	35.5	13.0	16.6	44.8	51.7	43.6	72.7	36.2	24.0	32.9	27.3	34.4	42.5	42.3	43.5	34.5	49.8	38.6	54.5	23.6	43.0
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIAO2B	"CGI-128, CIA2B, FAM96B, MIP18"	ENSG00000166595	"Cytosolic iron-sulfur assembly component 2B"	Q9Y3D0	16	66932065-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 143.6;Cytotrophoblasts: 204.8;Extravillous trophoblasts: 190.4;Hofbauer cells: 201.5;Syncytiotrophoblasts: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	92.2	131.3	151.9	59.2	162.7	49.1	78.5	168.2	176.4	89.4	148.5	94.0	63.3	76.8	62.5	156.3	84.2	57.8	215.0	152.9	158.5	158.4	152.9	92.4	83.6	159.3	156.5	90.1	69.9	115.1	112.3	66.0	159.1	80.5	59.8	32.7	69.5	48.8	347.5	60.8	80.3	52.8	160.6	81.8	82.9	76.9	156.7	69.9	87.0	119.6	63.3	86.5	82.6	169.1	131.6	291.8	96.8	122.1	119.9	112.7	118.2	117.3	130.7	175.7	219.5	309.5	147.8	118.4	148.6	139.4	151.1	169.7	140.0	141.7	125.1	148.9	198.1	72.3	83.6	368.3	227.1	107.8	275.1	112.2	135.5	208.4	180.8	133.2	120.8	206.9	124.1	76.7	144.9	252.6	184.6	258.8	129.7	112.5	351.2	155.5	103.3	228.6	264.9	117.0	170.0	190.0	251.4	67.2	186.4	74.4	74.5	176.7	103.6	130.9	156.2	74.5	165.9	167.0	146.7	311.7	231.9	111.3	174.4	209.5	190.1	202.2	169.9	222.3	167.9	226.6	180.2	186.1	216.7	189.7	142.8	159.1	94.9	185.8	241.3	389.8	270.1	207.5	151.9	162.7	168.2	176.4	152.9	158.5	159.3	156.5	159.1	160.6	156.7	169.1	56.8	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	204.8	53.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	190.4	38.9	0.0	0.0	0.0	0.0	0.0	0.0	201.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	248.6	10.9	0.0	0.0	0.0
CIAO3	"FLJ21988, HPRN, IOP1, NAR1, NARFL, PRN"	ENSG00000103245	"Cytosolic iron-sulfur assembly component 3"	Q9H6Q4	16	729760-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 11.6;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 10.9;Hofbauer cells: 16.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 142.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.4	13.8	16.8	7.5	18.0	10.7	12.3	17.2	27.2	11.6	14.1	16.1	13.3	12.1	11.5	18.5	12.2	6.7	23.1	17.6	16.0	19.5	22.4	9.4	11.7	17.6	17.1	10.1	15.7	12.1	14.9	5.8	17.8	18.9	4.9	4.5	16.8	9.2	20.5	18.1	16.5	4.8	16.3	17.3	16.1	11.3	16.6	12.0	13.0	13.2	7.9	13.1	13.7	17.5	9.1	26.1	10.1	14.9	10.3	7.3	24.6	12.7	9.4	17.2	15.0	18.8	22.0	12.9	19.2	8.0	12.7	20.3	10.0	15.4	6.1	24.1	22.8	10.9	14.7	15.5	13.2	19.3	15.0	9.2	19.1	10.2	8.5	11.4	12.9	50.7	20.3	12.0	8.5	33.9	17.5	9.0	8.6	18.4	16.5	142.5	15.3	23.7	10.6	9.0	11.8	16.1	15.3	36.0	13.4	6.0	33.0	19.7	14.0	14.5	13.6	16.1	11.5	15.8	12.1	35.7	9.9	11.0	19.0	2.7	11.1	8.9	10.9	9.9	8.3	14.8	11.0	8.9	11.9	9.2	8.6	12.4	2.3	15.5	11.6	9.4	11.7	9.9	16.8	18.0	17.2	27.2	17.6	16.0	17.6	17.1	17.8	16.3	16.6	17.5	3.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	20.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	10.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	14.2	0.5	0.0	0.0	0.0
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.1	32.8	22.1	19.7	22.3	20.6	18.9	23.2	26.8	16.3	26.3	29.4	21.3	16.3	15.5	30.2	16.1	16.6	38.7	22.5	23.8	30.8	27.3	19.9	24.2	24.3	23.2	12.9	19.6	37.4	17.7	31.6	23.8	18.0	25.9	20.9	19.7	16.3	41.3	28.3	20.9	22.0	20.7	21.6	22.3	68.0	25.1	31.0	18.4	38.4	34.3	24.3	20.2	21.8	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	22.1	22.3	23.2	26.8	22.5	23.8	24.3	23.2	23.8	20.7	25.1	21.8	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CIART	"BC017397, C1orf51, CHRONO"	ENSG00000159208	"Circadian associated repressor of transcription"	Q8N365	1	150282543-150287093	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.7;Bipolar cells: 43.1;Cone photoreceptor cells: 102.2;Muller glia cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.2;memory CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.4;Karpas-707: 36.8;U-266/84: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027515, HPA054349"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA027515: AB_10600757, HPA054349: AB_2682457"	"unprognostic (1.77e-1)"	"unprognostic (5.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.34e-2)"	6.9	13.5	15.1	3.1	22.2	0.4	7.5	20.1	19.9	6.7	17.8	22.8	3.3	9.6	9.3	8.2	10.2	4.5	29.4	15.4	15.8	10.1	13.7	5.8	2.6	13.3	14.8	10.1	5.0	32.0	17.7	2.7	13.7	9.4	2.8	22.2	17.8	23.9	54.2	40.5	6.4	9.0	13.2	2.8	13.8	9.8	16.7	2.0	19.0	46.4	3.5	11.8	8.3	14.1	0.2	1.0	6.7	3.4	3.0	1.3	6.6	4.8	11.8	6.2	8.2	1.8	26.4	0.1	8.3	10.4	14.1	4.5	0.2	4.8	9.3	0.1	0.6	0.2	0.4	0.1	10.5	1.6	3.7	4.0	7.1	15.8	3.2	14.4	1.2	0.1	0.2	36.8	3.6	21.8	0.0	0.8	8.9	4.9	19.9	1.1	0.0	0.3	6.2	1.0	4.1	1.5	7.9	0.7	14.6	1.7	6.7	0.6	2.1	17.3	0.2	0.7	10.5	8.2	29.6	0.2	16.0	0.1	10.5	0.0	0.0	0.0	0.1	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.1	15.1	22.2	20.1	19.9	15.4	15.8	13.3	14.8	13.7	13.2	16.7	14.1	2.8	0.0	1.5	5.5	0.6	0.0	5.5	0.0	30.7	43.1	5.5	7.7	7.3	4.3	1.3	0.0	102.2	0.2	0.6	0.4	9.8	3.2	0.6	2.9	2.5	3.0	2.4	0.0	3.1	1.5	0.1	4.8	3.6	2.1	0.0	3.5	0.7	4.2	1.3	6.7	3.9	0.9	0.0	0.3	0.0	1.4	5.3	1.9	0.0	0.0	1.0	28.2	0.0	1.5	1.1	4.1	1.2	9.4	0.2	4.4	7.7	3.9	0.7	18.1	0.0	4.6	4.5	7.2	10.9	11.2	0.0	0.0	0.9	4.1	0.7	2.7
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CIB2	"DFNB48, KIP2, USH1J"	ENSG00000136425	"Calcium and integrin binding family member 2"	O75838	15	78104606-78131535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 47.7;lymphoid tissue: 47.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 73.1;Late spermatids: 269.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in single"	48	"dendritic cells: 18.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.0;GAMG: 39.0;HAP1: 38.6;SCLC-21H: 38.8;SH-SY5Y: 40.1;SuSa: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036697	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036697: AB_10672475"	"unprognostic (5.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.73e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.18e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.64e-3)"	7.0	12.1	16.7	3.1	16.9	1.6	4.8	15.9	22.9	13.1	13.8	9.6	18.7	9.1	3.1	4.0	5.7	2.8	47.7	18.1	17.4	9.1	1.2	3.0	3.5	20.1	18.3	7.3	5.9	13.4	10.4	3.7	20.1	10.4	7.1	5.0	8.1	8.7	11.4	6.8	24.6	6.6	17.5	3.0	3.9	23.3	16.9	47.8	4.0	1.9	6.5	8.6	7.8	16.2	3.5	8.6	24.2	44.0	1.1	1.4	18.1	2.4	0.9	2.0	4.2	0.0	9.6	0.4	4.8	11.3	39.0	1.9	38.6	7.7	0.6	21.7	26.8	2.6	1.6	1.4	4.3	0.0	3.4	2.1	3.2	3.5	2.0	5.0	4.2	13.0	9.1	0.2	3.7	0.7	1.1	0.4	31.1	1.2	0.3	16.9	0.1	1.0	2.8	0.7	38.8	40.1	5.9	3.1	3.5	49.2	0.6	2.6	0.3	0.1	20.3	2.2	0.3	0.4	0.4	6.7	1.0	0.1	5.4	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	18.7	0.0	0.2	16.7	16.9	15.9	22.9	18.1	17.4	20.1	18.3	20.1	17.5	16.9	16.2	11.0	0.0	0.0	1.6	3.6	5.5	26.6	2.3	1.8	2.9	3.4	12.6	11.4	1.5	0.5	1.8	6.2	19.4	17.3	14.9	9.8	3.0	73.1	1.6	8.1	3.0	3.0	3.0	1.6	1.1	15.5	9.5	2.0	1.5	0.0	10.7	2.5	0.4	2.8	5.0	3.9	25.1	2.0	0.6	1.4	269.9	3.4	2.3	7.2	1.0	0.1	18.1	1.0	2.5	0.4	1.5	16.2	2.6	1.7	12.3	35.9	10.6	0.2	2.2	6.6	11.5	4.9	10.0	17.5	0.4	3.1	9.3	2.5	18.0	11.1	11.5
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 30.2;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	1.4	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	30.2	0.0	0.1	0.0	0.0	0.2	0.1	1.8	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIB4		ENSG00000157884	"Calcium and integrin binding family member 4"	A0PJX0	2	26581205-26641366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.3"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 181.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.7;thyroid cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036130, HPA036131"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA036130: AB_10670709, HPA036131: AB_2674959"	"unprognostic (3.63e-3)"		"unprognostic (1.78e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.63e-1)"			"unprognostic (1.66e-1)"		"unprognostic (1.27e-1)"	"unprognostic (4.29e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.20e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.50e-1)"	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.1	0.2	0.0	0.8	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.6	0.3	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	14.6	0.0	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	181.0	0.0	0.3	0.3	1.8	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	24.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	11.9	0.7	0.0	0.0	0.8	0.0	0.5	0.0	0.0
CIBAR1	"FAM92A, FAM92A1, FLJ38979"	ENSG00000188343	"CBY1 interacting BAR domain containing 1"	A1XBS5	8	93698561-93731527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 110.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 13.3;Extravillous trophoblasts: 14.1;Fibroblasts: 8.4;Hofbauer cells: 6.4;Syncytiotrophoblasts: 3.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034760, HPA058942"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"HPA034760: AB_10599947, HPA058942: AB_2732628"	"unprognostic (2.65e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.07e-2)"	14.3	23.9	17.5	5.6	18.8	3.5	10.9	18.6	25.0	16.5	22.9	14.2	3.2	16.0	26.2	5.0	13.1	14.1	25.3	17.8	16.2	20.2	18.5	9.9	5.7	13.4	14.5	18.0	21.1	21.5	20.8	10.1	13.3	12.1	5.9	14.1	5.7	11.6	10.3	6.6	7.7	15.0	12.9	5.7	9.8	110.2	17.1	5.0	14.5	11.1	3.1	14.6	9.3	17.4	37.8	20.0	52.9	54.6	55.8	78.9	14.0	34.2	49.8	45.2	43.5	3.5	8.6	3.2	42.7	50.7	52.0	26.6	54.0	32.5	41.0	1.2	29.5	21.5	20.8	18.7	64.1	1.0	5.5	50.4	14.3	44.3	36.0	64.9	49.0	18.1	13.4	1.7	35.8	14.2	23.8	4.1	22.2	0.8	1.1	2.3	39.7	0.8	35.3	8.7	15.3	18.7	24.4	0.5	41.6	23.7	8.2	11.8	27.2	44.2	17.4	46.3	28.0	2.6	2.7	1.2	38.8	3.0	15.8	0.1	1.7	0.0	0.1	1.2	0.2	0.4	0.4	0.1	2.9	0.0	0.1	0.3	0.0	1.3	0.1	0.3	0.8	0.5	17.5	18.8	18.6	25.0	17.8	16.2	13.4	14.5	13.3	12.9	17.1	17.4	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	14.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0
CIBAR2	"FAM92B, FLJ44299"	ENSG00000153789	"CBY1 interacting BAR domain containing 2"	Q6ZTR7	16	85098358-85112472	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 85.5"	"Cell type enriched"	"Detected in single"	8	"Plasma cells: 2.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041022	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	1.3	2.0	1.3	1.8	0.4	0.3	1.0	0.8	3.5	11.2	0.7	1.3	1.3	0.2	0.1	85.5	0.1	0.0	1.9	4.9	0.2	0.0	10.2	0.6	8.2	11.2	0.1	0.1	0.0	16.2	0.0	5.5	0.1	0.4	0.3	0.5	0.1	0.0	0.4	0.7	0.0	5.3	2.6	0.4	0.4	4.7	0.2	0.0	0.0	1.9	1.1	0.0	2.5	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	1.8	1.0	0.8	1.9	4.9	8.2	11.2	5.5	5.3	4.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Vesicles	"CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	41.9	41.5	43.3	23.4	36.1	31.8	42.7	40.7	47.4	53.8	2.3	45.6	15.6	62.3	8.7	34.3	49.1	16.1	35.4	36.3	27.7	41.7	44.6	40.8	24.2	39.5	27.8	70.1	39.4	12.2	58.7	12.6	35.7	40.5	5.8	13.5	35.4	18.7	45.2	47.2	36.9	16.0	17.4	46.9	38.6	74.6	29.4	21.0	44.3	15.3	13.5	39.6	37.5	32.5	31.8	56.7	26.4	34.4	16.6	30.7	10.7	22.8	22.5	22.9	20.9	18.5	21.4	26.7	20.8	21.8	19.6	16.6	14.6	38.9	7.6	61.9	19.6	22.2	44.7	23.0	20.1	11.8	50.9	36.7	25.5	24.4	15.5	24.8	19.2	15.9	21.8	52.5	13.3	31.9	25.1	25.6	16.2	12.6	5.8	21.5	21.2	14.3	20.5	25.3	33.6	27.1	23.7	15.7	21.6	8.3	18.3	25.8	27.5	52.0	43.7	15.9	33.2	41.0	29.8	18.1	37.9	19.4	32.6	0.0	0.5	0.1	0.7	0.8	0.5	0.5	0.3	0.5	0.5	0.6	0.2	0.4	1.1	0.2	0.6	0.6	0.1	0.6	43.3	36.1	40.7	47.4	36.3	27.7	39.5	27.8	35.7	17.4	29.4	32.5	27.8	0.0	3.0	15.7	13.7	25.9	12.8	16.2	27.9	38.3	20.7	16.9	7.8	21.5	7.1	9.2	20.9	6.9	9.1	14.2	3.9	13.4	5.1	14.6	14.9	20.3	14.8	8.4	8.0	15.3	5.1	11.2	17.9	22.3	12.0	11.1	13.9	19.2	11.9	42.1	9.0	10.1	10.2	18.0	23.6	3.3	21.8	15.3	24.9	7.5	13.0	18.4	8.2	4.0	10.3	16.9	11.2	18.0	10.4	11.3	10.6	6.2	8.0	18.8	26.3	19.9	17.6	19.4	20.2	16.5	19.5	13.0	13.2	14.2	10.6	11.9
CIDEB		ENSG00000136305	"Cell death inducing DFFA like effector b"	Q9UHD4	14	24305096-24311430	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 310.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 258.9;Proximal enterocytes: 301.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HEL: 11.0;Hep G2: 24.0;HL-60: 15.5;Karpas-707: 10.6;U-266/84: 14.8;U-937: 17.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA001272	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001272: AB_2666255"	"unprognostic (2.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.35e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.64e-1)"	13.2	37.2	1.6	5.6	1.6	12.3	11.6	2.3	2.2	17.3	2.2	10.7	70.6	8.6	4.4	35.5	12.9	3.8	7.5	1.5	2.2	31.1	310.8	10.5	4.8	2.0	2.0	25.3	19.3	1.9	12.2	2.0	1.9	11.2	3.5	0.2	14.2	4.8	2.5	22.6	58.1	4.0	1.9	88.9	8.0	2.2	2.6	3.6	7.6	1.3	7.2	8.6	20.1	1.9	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.4	0.1	0.2	0.1	1.4	0.5	0.0	0.0	0.6	0.0	2.0	0.0	0.2	0.0	21.5	0.0	11.0	0.0	24.0	0.1	15.5	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.0	0.0	10.6	0.0	0.0	0.1	7.3	0.0	5.6	0.0	1.8	0.1	5.5	0.0	0.7	4.5	0.0	5.9	0.1	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	8.4	14.8	0.1	0.0	17.9	0.0	0.9	5.2	6.9	3.4	1.8	3.2	0.5	2.2	2.1	5.2	0.4	1.4	1.7	2.9	5.2	0.9	1.3	1.3	2.0	1.6	1.6	2.3	2.2	1.5	2.2	2.0	2.0	1.9	1.9	2.6	1.9	8.8	0.0	1.7	0.0	6.9	7.0	6.4	5.6	29.6	0.4	4.6	5.6	0.0	11.5	3.3	1.8	2.1	0.1	15.0	14.4	9.8	1.5	0.1	4.3	2.0	7.0	1.8	13.0	0.0	9.6	0.2	4.0	5.1	1.2	8.8	0.3	12.5	258.9	7.9	0.0	0.1	11.7	8.2	30.5	2.6	0.5	6.2	13.2	5.4	1.0	8.8	0.6	21.6	0.0	0.1	15.4	24.4	3.0	7.2	0.7	301.5	51.6	10.5	0.6	0.0	0.9	2.8	0.2	2.3	33.4	6.1	0.3	11.1	3.6	8.6	1.8
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 740.3;breast: 492.9"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 219.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 1683.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018837, HPA020553"	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	740.3	5.6	0.1	1.1	0.2	0.0	492.9	0.0	0.4	1.2	0.0	15.9	68.9	4.6	0.3	0.7	2.2	5.0	9.5	0.1	0.1	2.1	10.0	0.2	1.2	0.1	0.2	0.4	7.4	0.1	0.2	0.0	0.2	2.3	3.9	0.0	16.2	3.7	6.1	18.1	89.8	1.6	0.1	0.2	7.4	0.9	0.2	1.5	3.9	11.6	0.0	13.3	4.8	0.2	0.0	0.2	0.0	0.0	1683.2	376.0	1.2	0.1	0.0	0.0	0.0	7.5	9.1	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	19.1	2.8	0.0	0.0	228.9	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.3	0.0	0.6	1.6	0.0	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	30.0	1.9	0.0	0.5	0.2	0.1	0.1	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	8.4	0.0	0.0	0.4	1.0	2.5	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	14.5	0.4	0.0	0.4	219.4	1.1	0.0	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.0	0.0	0.2	0.1	3.8	0.3
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194760-65211473	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		13000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	49.8	0.8	0.2	9.5	0.2	0.1	21.9	0.3	0.3	44.9	0.1	20.3	2.3	13.8	3.6	11.0	15.8	36.8	27.4	0.2	0.2	1.0	1.6	2.9	1.6	0.2	0.2	7.5	3.0	0.3	0.7	2.5	0.2	3.1	6.9	0.5	9.4	4.8	15.5	14.0	22.6	51.0	0.2	0.6	8.3	12.1	0.2	1.8	2.4	32.9	0.8	26.9	28.1	0.2	0.0	0.0	0.0	0.0	4.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	8.1	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	0.9	0.4	0.5	2.1	0.0	0.4	1.8	0.0	0.0	0.2	0.1	0.0	0.1	1.7	1.2	42.9	1.5	0.0	0.0	0.3	0.0	0.0	138.1	4.1	1.7	0.0	0.1	2.2	0.1	0.1	0.0	0.6	0.1	2.0	0.0	11.9	7.1	231.5	1.7	1.8	1.9	0.0	0.2	0.0	1.0	0.3	0.0	0.0	57.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	14.7	6.6	0.6	0.3	0.1	6.1	0.0	1.6	83.5	0.2	0.0
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 26.2;Late spermatids: 21.8;Sertoli cells: 6.6;Spermatocytes: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HEK 293: 2.8;NB-4: 2.2;THP-1: 2.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"medulla oblongata: 2.7;spinal cord: 7.3"	HPA041847	Uncertain				"Secreted to extracellular matrix"	NA	NA		22000000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	0.8	0.0	0.4	0.2	0.7	1.0	0.3	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.4	1.5	0.4	0.4	1.2	0.3	0.2	0.4	0.3	0.2	0.2	1.6	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.1	0.0	0.2	0.0	5.5	0.9	0.0	1.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	4.6	0.1	0.6	0.6	0.0	0.3	0.0	1.3	0.5	0.0	1.2	0.2	0.0	0.5	0.1	0.0	0.0	0.3	2.8	0.0	0.1	0.1	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	1.7	1.5	0.9	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.3	1.5	0.1	0.2	0.3	2.8	0.0	0.0	0.5	0.2	0.1	0.4	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.4	0.4	1.2	0.2	0.2	0.2	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	26.2	0.3	0.3	0.1	0.0	0.0	0.2	0.0	0.2	1.5	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.3	21.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.4	0.0	0.1	0.0	0.0	6.6	0.4	0.3	27.8	4.0	0.7	0.6	0.0	0.2	0.1	0.0	0.5
CIP2A	KIAA1524	ENSG00000163507	"Cellular inhibitor of PP2A"	Q8TCG1	3	108549864-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.5;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	1.1	1.1	0.3	3.4	0.6	7.5	1.4	0.9	0.8	0.9	0.1	1.9	1.2	1.8	0.6	1.7	0.9	1.2	0.7	0.6	0.5	1.0	0.7	1.4	6.7	0.2	0.9	1.9	0.4	0.6	0.7	2.1	0.2	1.8	2.7	2.6	0.6	0.8	0.6	1.2	1.7	1.5	0.0	2.3	1.2	5.7	0.1	6.9	1.2	0.7	5.2	2.0	0.9	0.4	42.2	12.2	33.9	21.8	1.4	3.2	13.8	31.1	14.7	36.2	41.9	15.0	18.5	27.6	10.4	11.4	27.7	20.9	11.7	11.0	65.8	8.8	11.3	33.9	17.4	11.3	0.5	21.8	23.2	1.4	2.3	28.4	11.5	5.9	16.3	12.7	21.1	44.5	36.1	8.7	26.7	19.2	35.0	15.8	20.8	30.1	31.2	15.3	11.0	11.5	16.4	21.6	22.9	9.0	12.7	19.7	15.3	15.6	12.2	37.0	41.7	11.3	38.3	10.2	12.1	46.1	16.4	23.2	38.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.6	0.9	0.8	0.6	0.5	0.2	0.9	0.2	0.0	0.1	0.4	1.2	9.6	1.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	2.5	3.7	0.0	8.0	1.8	0.0	1.9	2.8	0.0	2.5	2.8	2.6	0.0	0.0	0.0	7.3	12.9	3.0	0.0	2.7	3.8	25.3	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	2.4	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.4	1.7	5.4	0.0	0.0
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, CIR1"	Q86X95	2	174348022-174395712	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 187.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 187.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favorable (2.04e-5)"	26.7	23.8	36.3	23.4	38.1	67.3	35.9	38.5	61.1	26.6	39.5	27.7	25.8	27.4	43.5	20.3	28.3	23.4	28.7	36.0	37.3	25.9	27.5	26.7	31.1	36.8	37.0	33.7	24.9	27.4	25.1	29.8	36.6	26.2	26.3	23.6	24.9	26.0	30.7	30.5	26.7	20.7	35.9	35.0	25.5	31.4	36.3	32.3	29.0	25.2	29.5	24.0	24.2	40.1	20.4	11.4	26.5	21.2	36.3	50.4	39.2	32.9	46.5	32.3	39.5	21.5	30.7	14.1	30.3	32.4	28.3	24.0	22.1	23.4	38.6	26.1	29.1	29.4	17.8	34.9	35.1	35.2	26.0	41.7	41.9	35.5	26.5	55.6	32.4	24.9	30.7	30.8	31.0	19.5	44.1	55.6	24.5	33.2	31.6	24.7	38.1	42.2	38.4	32.1	30.7	36.1	22.7	28.7	52.9	45.7	21.6	51.6	33.6	26.1	19.0	24.9	17.3	34.6	31.4	5.2	37.4	18.2	23.3	71.0	33.8	55.9	28.4	31.7	28.4	41.2	32.2	30.5	21.4	40.5	33.4	30.9	187.8	45.3	33.9	39.5	37.2	28.3	36.3	38.1	38.5	61.1	36.0	37.3	36.8	37.0	36.6	35.9	36.3	40.1	82.0	118.6	79.8	30.0	80.8	28.6	52.2	118.6	39.3	51.7	40.6	66.8	61.4	61.5	101.2	42.3	31.3	72.7	116.5	69.1	119.3	67.3	201.5	192.2	79.7	58.7	51.4	102.5	30.4	78.7	58.1	69.9	30.1	79.6	81.6	59.1	75.7	58.6	63.8	45.4	33.7	81.9	85.5	93.0	30.3	43.4	107.2	75.3	33.8	22.5	108.2	85.7	111.2	30.2	37.3	57.7	79.8	82.4	49.1	37.5	91.6	114.0	202.3	56.2	72.3	71.4	72.1	219.5	54.7	25.4	32.0	116.0	80.5	62.6	53.5	45.7
CISD1	"C10orf70, MDS029, mitoNEET, ZCD1"	ENSG00000122873	"CDGSH iron sulfur domain 1"	Q9NZ45	10	58269162-58289586	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 82.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 716.1;Proximal enterocytes: 539.1;Proximal tubular cells: 726.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074383	Supported		Supported	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA074383: AB_2686684"	"prognostic unfavorable (1.11e-4)"	"unprognostic (8.60e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (6.69e-4)"	5.2	10.1	10.0	6.3	9.8	0.9	5.9	10.4	13.6	6.6	11.8	9.7	22.7	5.6	3.4	11.2	6.1	7.2	43.0	10.1	12.7	26.4	16.6	4.3	6.1	10.1	9.9	6.8	5.3	82.3	5.8	5.5	11.2	7.6	8.8	8.2	9.9	7.1	46.4	8.4	21.8	8.0	9.5	4.6	7.2	2.8	9.6	6.5	10.1	49.9	5.9	7.8	3.0	8.9	20.5	10.2	8.0	14.6	10.5	11.6	4.7	16.9	19.2	16.4	22.5	24.1	18.8	36.1	13.9	17.5	9.6	12.9	21.7	15.1	14.7	16.2	29.4	9.5	16.4	19.6	11.9	17.0	7.1	14.6	12.1	15.7	23.9	13.9	19.5	17.9	21.2	16.5	11.6	6.8	14.6	18.2	8.5	15.5	31.4	11.0	29.3	19.0	22.1	7.1	25.0	9.0	12.9	34.1	12.4	7.0	22.7	9.0	19.3	7.1	12.8	20.5	20.4	16.6	29.0	27.2	18.9	16.6	7.0	0.0	4.5	0.2	4.3	3.4	5.3	6.3	4.9	5.0	7.6	5.4	5.7	5.7	2.3	5.4	2.3	5.0	6.8	4.2	10.0	9.8	10.4	13.6	10.1	12.7	10.1	9.9	11.2	9.5	9.6	8.9	31.4	60.9	45.7	27.4	33.0	128.7	87.3	309.4	78.0	84.6	46.4	61.1	321.6	97.2	180.2	134.3	43.8	174.8	22.7	71.1	716.1	98.0	240.9	42.8	30.4	61.6	225.4	24.8	47.2	82.1	78.5	52.7	38.2	43.8	34.3	23.0	63.9	249.6	68.6	42.1	53.1	141.9	272.6	37.0	37.9	366.1	42.3	31.0	183.2	21.5	34.0	47.2	44.3	36.7	30.9	83.2	121.9	40.3	31.7	109.1	539.1	726.8	138.6	56.3	32.9	50.1	55.6	159.4	65.6	94.9	114.2	72.7	26.2	65.0	147.3	69.4
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	11.2	19.1	2.4	5.5	2.7	6.0	9.0	3.9	3.2	9.5	4.1	11.5	1.7	9.5	5.3	12.5	8.8	4.3	10.5	2.6	3.2	17.9	46.0	10.7	5.5	2.9	2.9	8.9	20.0	5.4	12.8	3.1	3.0	9.5	3.8	6.1	12.0	1.9	7.4	9.7	10.9	3.0	2.7	14.7	11.4	6.5	3.0	4.0	13.6	1.7	3.5	9.8	10.1	4.0	16.8	5.5	5.8	7.2	14.2	15.2	3.7	12.6	4.6	5.4	8.2	6.5	27.7	12.1	10.9	12.2	12.9	8.1	28.2	10.1	24.8	10.7	4.2	10.5	3.6	6.7	10.1	18.7	16.1	5.9	15.1	23.0	17.8	5.2	9.8	6.7	22.7	21.3	14.7	4.6	16.5	5.4	11.2	5.7	4.0	6.7	5.9	22.2	13.6	5.3	13.4	7.8	7.5	12.8	12.8	6.6	8.5	4.0	4.4	15.8	17.8	21.3	7.8	16.3	23.5	24.2	11.2	5.7	12.6	4.6	2.8	5.8	2.6	2.7	2.7	2.5	2.6	2.7	2.7	2.1	1.7	2.2	2.0	4.4	3.1	3.5	3.5	2.3	2.4	2.7	3.9	3.2	2.6	3.2	2.9	2.9	3.0	2.7	3.0	4.0	24.2	25.6	26.1	10.1	65.3	85.7	45.3	131.0	60.3	33.5	61.2	51.3	27.8	58.6	70.4	77.3	20.9	74.2	52.7	52.9	72.4	101.8	12.2	39.9	41.8	35.8	43.0	256.8	17.5	77.2	131.0	39.6	39.8	48.3	57.8	24.2	26.0	159.9	110.9	30.3	22.1	94.2	146.5	93.5	128.9	6.9	23.9	66.4	69.4	12.2	78.4	36.9	45.3	17.6	25.9	74.3	88.5	33.8	194.3	63.7	82.7	203.9	63.1	33.1	32.9	22.1	41.6	41.7	36.7	56.4	90.1	56.8	54.0	33.4	68.6	53.9
CISD3	"Miner2, MiNT"	ENSG00000277972	"CDGSH iron sulfur domain 3"	P0C7P0	17	38730341-38735605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 454.6;Hepatocytes: 673.4;Paneth cells: 406.2;Proximal enterocytes: 715.7;Proximal tubular cells: 500.6;Undifferentiated cells: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.3;U-138 MG: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053436, HPA054400"	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"			"HPA053436: AB_2682149, HPA054400: AB_2682475"	"unprognostic (9.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.42e-1)"	13.1	18.0	0.4	0.1	0.0	0.0	13.5	0.9	0.7	9.7	0.2	14.7	1.4	11.1	0.4	8.2	11.0	1.4	23.8	0.1	0.2	17.8	24.8	8.6	0.3	0.4	1.2	8.0	19.4	0.1	7.8	1.3	0.6	11.1	0.1	0.6	8.4	0.2	13.3	9.0	12.9	0.1	0.1	7.9	14.8	4.7	0.3	0.0	11.9	0.0	0.0	12.1	8.8	0.0	0.8	1.5	1.6	5.3	0.0	0.1	1.0	0.7	0.0	0.2	0.0	0.4	4.3	0.0	0.1	0.0	3.5	3.7	0.1	0.1	0.4	0.2	0.0	0.6	0.5	1.2	0.2	0.0	2.3	0.1	0.0	0.1	0.0	1.6	0.1	4.8	0.4	1.4	0.2	0.0	0.9	0.0	5.1	0.0	1.2	1.6	0.0	0.3	0.1	0.8	0.8	2.7	1.0	0.7	3.8	0.0	4.3	0.9	0.0	6.5	4.0	4.1	2.8	0.6	0.1	0.5	2.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.7	0.1	0.2	0.4	1.2	0.6	0.1	0.3	0.0	58.6	19.2	23.6	6.2	21.4	26.5	41.4	27.3	22.8	20.0	92.6	86.5	261.4	175.8	29.6	62.5	14.6	26.1	44.7	454.6	205.4	102.1	2.2	34.8	35.8	41.9	129.0	45.5	5.3	241.4	52.3	41.8	111.1	29.1	31.8	34.6	43.9	673.4	136.7	6.7	3.9	262.5	16.2	87.4	47.9	7.0	45.7	58.3	55.2	1.9	73.3	36.7	165.8	2.0	4.9	152.6	406.2	47.8	24.0	95.0	715.7	500.6	21.5	15.2	59.2	31.8	72.2	8.8	31.4	70.9	35.9	13.1	47.2	53.1	398.5	51.5
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606489-50611774	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 316.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	19.0	4.8	1.0	8.7	1.0	7.6	24.5	1.1	1.3	10.0	1.9	9.9	10.2	9.4	3.1	9.6	9.8	4.5	26.5	0.9	1.4	47.6	60.7	28.0	8.5	2.8	1.9	14.5	20.2	22.1	14.3	23.2	2.2	7.5	8.9	0.3	13.1	8.9	40.0	13.3	8.8	4.9	1.7	9.9	10.4	2.3	1.6	9.7	36.4	5.2	6.7	5.9	10.0	1.5	2.4	0.8	2.8	5.9	0.7	3.4	2.5	0.6	0.6	0.3	0.4	2.3	0.6	0.0	2.0	0.9	1.3	2.8	4.7	3.8	0.3	316.3	0.8	18.7	1.8	2.5	2.1	2.5	22.0	14.2	1.6	0.7	1.3	0.2	0.6	2.0	75.6	0.6	0.6	14.8	4.1	17.4	2.7	8.7	2.9	1.8	1.2	19.4	6.3	2.7	1.4	4.7	1.0	37.7	0.7	0.8	20.9	15.4	0.5	0.8	2.2	2.8	1.4	0.3	0.4	0.0	0.5	22.7	0.4	21.3	10.2	13.7	33.8	6.2	51.1	0.9	54.0	41.6	7.0	0.4	40.5	40.6	8.6	2.0	3.9	4.6	35.3	19.6	1.0	1.0	1.1	1.3	0.9	1.4	2.8	1.9	2.2	1.7	1.6	1.5	7.1	3.2	38.5	0.0	1.8	8.0	7.4	1.9	10.2	0.7	18.3	12.1	14.3	0.0	6.7	18.4	0.0	9.1	14.1	8.9	58.7	11.7	2.6	6.6	4.3	3.5	2.4	11.6	0.1	16.4	4.0	11.6	3.6	8.5	1.3	16.9	2.2	7.0	12.7	0.0	0.0	9.6	2.0	8.4	10.0	0.6	8.4	12.8	1.8	1.0	17.3	0.1	14.4	0.0	0.0	7.2	6.7	3.8	4.0	3.0	6.5	58.2	0.8	0.2	13.1	7.6	8.8	1.0	1.3	7.3	8.9	15.9	31.0	3.4	12.1	3.6
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"epididymis: 1473.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 244.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Supported		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	2.3	5.1	13.0	0.3	6.9	0.2	23.1	5.1	12.2	5.9	3.4	1.0	0.7	3.6	1473.6	0.3	1.5	0.0	0.7	6.7	56.2	5.1	0.4	0.6	0.3	8.5	8.8	1.5	1.5	0.0	209.9	0.0	24.5	11.2	0.2	4.5	0.8	3.0	0.4	0.6	1.0	8.1	4.3	0.4	1.0	199.9	30.6	0.2	8.0	0.4	0.1	0.5	1.0	6.2	0.4	0.3	2.2	57.1	2.5	0.0	2.1	0.0	0.5	0.4	0.3	0.1	0.6	0.0	0.2	0.0	0.6	0.0	20.5	1.4	0.1	6.1	8.0	0.9	0.4	0.0	0.0	0.2	10.4	1.1	0.8	0.5	1.0	0.2	0.2	0.2	2.5	0.0	0.4	0.8	0.2	4.4	3.3	0.0	3.6	0.1	3.6	3.2	0.1	0.4	25.8	12.5	0.4	5.1	244.4	0.2	1.4	1.0	0.0	0.2	1.9	0.4	0.8	0.2	0.5	0.2	0.5	0.4	5.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	6.9	5.1	12.2	6.7	56.2	8.5	8.8	24.5	4.3	30.6	6.2	2.2	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	5.6	87.4	47.6	0.4	1.5	0.1	3.7	6.2	0.1	0.3	0.3	0.0	0.1	20.4	0.5	0.8	1.0	1.2	0.0	0.7	0.8	0.1	0.7	0.0	0.3	0.0	31.0	0.4	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.7	58.4	7.5	0.8	3.6	1.9	0.1	1.7	0.0	0.0	0.1	0.4	33.8	3.0	0.0	19.3	0.7	0.3	0.0	3.8	13.1	1.2	3.2	12.6	6.8	0.0	0.0	0.0	0.1	0.5	0.5	1.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CITED4		ENSG00000179862	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4"	Q96RK1	1	40861054-40862363	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 172.1;Breast glandular cells: 183.7;Breast myoepithelial cells: 225.0;Cholangiocytes: 258.7;Endometrial ciliated cells: 350.4;Glandular and luminal cells: 202.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 91.3;THP-1: 264.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056434	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA056434: AB_2683132"	"unprognostic (5.39e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.38e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.13e-2)"	13.7	15.1	9.3	1.1	10.6	19.1	30.3	9.4	9.5	18.0	4.3	28.9	1.6	17.1	2.4	29.0	14.4	1.9	26.6	6.6	14.5	20.4	38.8	11.4	1.7	14.6	15.4	10.3	49.1	4.4	4.9	1.7	10.6	16.4	0.4	0.8	34.2	8.5	33.0	51.5	7.7	2.3	12.0	29.9	13.4	25.4	13.1	1.2	7.3	9.2	1.3	8.9	23.7	10.5	29.5	5.7	1.6	34.6	0.7	1.3	34.4	1.9	2.1	0.7	0.8	3.0	38.5	0.1	4.6	0.5	1.0	44.6	2.4	24.0	0.6	0.1	0.4	0.2	3.3	4.9	5.9	1.0	0.4	4.2	10.1	2.3	7.6	2.8	1.8	0.4	0.1	0.1	1.3	0.9	0.5	19.6	11.1	0.9	3.9	0.3	0.0	0.1	91.3	16.9	6.7	1.9	1.4	35.8	2.0	3.7	17.4	264.9	2.3	0.0	0.0	0.4	1.1	0.0	0.8	0.0	0.0	13.8	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	9.3	10.6	9.4	9.5	6.6	14.5	14.6	15.4	10.6	12.0	13.1	10.5	17.4	9.6	1.1	1.3	4.0	19.1	172.1	2.1	37.0	4.0	183.7	225.0	10.4	258.7	3.5	22.0	0.0	1.0	11.9	3.7	43.0	14.2	47.9	350.4	24.4	48.9	7.7	9.7	2.0	43.6	0.9	14.0	17.9	202.6	0.0	30.5	11.4	43.1	1.3	1.7	1.7	4.8	2.0	10.4	3.2	64.8	5.0	13.7	19.6	1.0	4.6	46.1	2.1	2.0	3.8	33.0	3.4	5.7	2.4	65.6	0.2	88.0	6.5	3.0	19.7	72.2	19.7	0.9	1.5	49.9	24.3	0.1	14.6	37.3	3.6	122.3
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	57.7	38.9	36.1	28.5	37.1	55.3	48.3	36.5	46.4	60.1	19.7	68.4	34.5	53.5	24.4	46.3	47.6	33.9	46.0	36.4	33.8	31.8	21.4	38.0	35.1	35.9	31.4	69.9	70.7	35.0	33.8	28.0	34.2	40.8	26.7	26.9	44.6	33.6	90.4	65.8	41.9	36.9	26.8	35.5	51.3	56.4	36.4	35.3	37.0	42.5	29.5	57.8	50.0	40.9	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.1	37.1	36.5	46.4	36.4	33.8	35.9	31.4	34.2	26.8	36.4	40.9	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237881-106304279	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 106.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 106.8"	"Cell line enhanced"	"Detected in many"		"BJ: 549.7;BJ hTERT+: 687.6;fHDF/TERT166: 834.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792"	Enhanced					NA	NA		560000	"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA000278: AB_1078527, HPA000792: AB_1078526"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (6.61e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	26.6	40.0	14.7	34.7	16.1	100.5	21.8	14.2	15.4	49.5	27.9	42.9	19.3	40.6	59.2	71.3	31.2	26.3	40.0	14.2	17.4	21.3	30.4	33.5	10.5	18.1	16.1	30.6	41.1	26.1	20.2	51.8	17.2	37.6	45.8	18.8	57.5	36.9	14.5	39.4	19.0	46.7	15.6	25.1	52.3	9.9	19.6	7.8	19.8	13.5	22.8	51.4	40.5	18.4	86.8	106.7	126.5	138.3	240.6	212.5	73.2	549.7	687.6	262.7	300.1	45.6	19.4	5.6	98.0	834.0	89.3	153.1	93.5	83.5	187.5	3.0	54.1	0.1	56.5	89.9	179.2	0.4	1.7	205.5	111.9	223.5	159.9	331.9	311.7	6.5	0.6	11.0	253.0	29.1	4.4	3.1	73.8	45.6	127.9	40.1	91.0	7.5	80.5	76.9	41.5	46.0	98.0	65.9	54.4	112.9	73.9	39.3	268.9	205.8	112.2	86.3	157.9	29.0	0.3	60.2	148.5	10.9	184.5	106.8	18.8	22.5	1.1	6.8	1.6	9.5	1.7	1.0	5.8	4.1	2.2	2.0	30.1	0.2	11.3	0.2	0.5	7.1	14.7	16.1	14.2	15.4	14.2	17.4	18.1	16.1	17.2	15.6	19.6	18.4	17.7	22.4	26.5	9.1	26.3	54.8	37.9	63.2	56.3	11.8	37.6	34.4	43.2	35.8	33.4	23.9	10.4	26.9	2.8	43.0	5.9	37.8	1.1	38.6	103.1	33.8	41.4	1.3	5.8	87.7	107.0	92.9	51.5	139.9	19.1	62.8	43.2	52.3	20.1	47.1	11.2	198.7	16.2	31.8	16.8	2.7	68.3	33.1	33.8	8.4	59.9	23.4	2.1	7.5	1.6	52.4	22.9	61.3	144.5	92.0	3.9	9.2	13.3	23.3	13.1	45.1	52.3	4.9	12.6	122.3	71.9	26.4	6.7	73.3	69.0	46.7
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519667-103522833	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 694.7;intestine: 653.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"non-classical monocyte: 290.8"	"Lineage enriched"	"Detected in many"	18	"monocytes: 290.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol		No	No		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	90.7	60.0	471.6	25.8	627.0	3.2	47.2	641.1	694.7	105.2	192.7	653.4	36.0	222.6	16.0	54.5	197.9	17.9	269.8	428.7	482.3	161.0	9.0	60.3	4.0	427.5	440.4	58.8	27.7	108.2	74.0	4.7	345.1	301.8	151.9	471.3	37.9	208.3	80.0	76.5	120.8	113.8	434.5	6.8	479.9	97.6	596.2	2.8	87.9	47.1	5.1	298.4	101.6	383.6	2.4	54.5	321.1	14.7	4.4	2.3	6.3	37.5	0.3	2.4	1.4	455.8	7.3	0.4	36.9	29.1	9.9	70.2	109.9	1.5	0.2	9.6	1399.8	111.0	242.1	165.4	16.6	0.7	87.9	14.7	0.6	3.9	0.8	3.3	0.0	5.1	198.7	3.7	4.8	20.0	2.3	3.9	109.1	48.3	213.6	13.9	6.8	275.9	65.9	2.5	792.2	352.2	65.3	10.6	25.2	21.6	21.1	40.9	2.2	1.5	56.3	4.7	147.3	21.1	2.7	7.2	6.4	2.1	14.1	2.4	0.5	14.6	0.3	28.5	0.4	0.0	0.2	0.1	16.4	0.2	0.1	0.5	1.0	0.2	290.8	0.0	0.7	6.0	471.6	627.0	641.1	694.7	428.7	482.3	427.5	440.4	345.1	434.5	596.2	383.6	14.8	195.5	103.5	515.8	13.5	153.7	296.2	257.6	56.3	2767.4	41.5	48.9	553.5	145.8	117.9	114.0	1909.9	4.4	3.4	4691.8	2281.3	127.6	445.8	773.2	205.7	60.8	467.1	9.9	178.0	42.5	11.7	96.6	359.4	408.5	28.6	476.1	74.6	9.2	8.2	5042.4	147.0	726.0	187.2	2.8	44.9	147.4	304.1	39.8	181.5	88.1	74.2	3639.8	0.0	93.5	161.2	131.4	1996.9	1089.3	6.6	279.8	9.5	118.0	456.1	3789.9	59.2	15.4	222.6	127.3	97.4	22.1	175.2	41.6	19.1	12.2	755.6	220.1
CKLF-CMTM1		ENSG00000254788	"CKLF-CMTM1 readthrough"		16	66552587-66579135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Early spermatids: 3.9;granulocytes: 20.2;Late spermatids: 8.9;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 17.4"									HPA017136	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA017136: AB_1846992"	"unprognostic (9.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.65e-2)"	"unprognostic (5.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-1)"	0.8	0.8	1.5	2.9	1.6	0.8	0.7	1.8	1.8	1.1	0.7	1.1	0.8	1.8	1.1	0.9	1.4	1.5	1.0	1.7	2.3	1.1	0.5	1.4	1.6	1.8	1.4	1.9	1.4	1.0	1.0	1.3	1.9	0.8	0.6	0.9	0.7	0.8	0.2	0.7	1.7	1.0	1.1	2.0	1.1	5.7	1.8	3.3	1.1	0.3	1.0	0.8	0.9	1.7	4.7	5.9	2.3	5.6	2.6	5.1	0.8	5.4	2.9	4.6	7.0	2.1	4.9	1.8	2.9	0.6	1.4	3.5	2.8	0.3	3.0	5.3	1.5	0.4	1.9	0.2	1.9	4.0	3.0	0.2	0.3	2.7	0.6	8.3	2.7	6.3	2.1	5.0	3.6	1.4	9.1	5.0	1.4	0.6	2.4	17.4	8.2	5.9	4.1	1.3	3.5	4.9	9.4	0.6	1.7	0.2	2.2	2.1	1.9	6.3	11.3	4.5	2.0	3.0	6.6	7.1	4.1	4.0	10.5	9.8	4.1	11.8	2.8	1.7	3.0	0.4	1.1	1.8	3.6	0.7	0.5	1.4	12.9	2.0	2.1	1.4	4.0	3.0	1.5	1.6	1.8	1.8	1.7	2.3	1.8	1.4	1.9	1.1	1.8	1.7	0.0	3.2	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.2	3.9	0.0	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.0	20.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	8.9	0.3	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306413-45322875	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 73556.4;tongue: 26058.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 5353.0"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 64.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 68.8"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 1.5"	"Low region specificity"	"Detected in many"			HPA047859	Enhanced					NA	NA		170000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	8.5	2.7	0.1	0.0	0.3	0.7	12.4	0.2	0.3	0.9	0.0	6.6	0.1	1.8	0.0	512.5	0.4	0.2	4618.8	0.0	0.0	2.1	5.2	8.7	0.4	0.1	0.0	2.8	5.3	0.0	2.1	0.3	0.2	134.8	0.1	0.2	340.9	2.1	73556.4	23.4	4.3	2.4	0.0	2.5	23.5	9.9	0.0	2.5	8.5	26058.9	0.4	1.5	3.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	5.8	0.0	0.3	16.3	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.0	6.3	0.2	0.2	0.0	0.0	68.8	0.0	0.0	0.1	0.1	0.0	0.1	16.3	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5353.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.7	0.1	15.3	0.8	0.9	51.2	0.0	0.0	0.4	0.0	0.7	141.8	0.0	0.1	1.3	0.4	0.4	0.0	6.6	0.0	0.5	0.0	0.0	0.9	0.3	53.2	1.5	3.2	0.0	0.0	0.9	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.0	639.9	47.3	16.5	1.6	0.0	0.1	0.3	2.6	3.6	0.0	0.1
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;intestine: 75.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.0;Distal enterocytes: 110.5;Intestinal goblet cells: 53.4;Paneth cells: 57.4;Proximal enterocytes: 94.5;Syncytiotrophoblasts: 94.0;Undifferentiated cells: 92.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 127.5;hTCEpi: 56.8;OE19: 144.3;SK-BR-3: 107.8;T-47d: 100.3"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	1.8	3.8	20.8	7.1	22.1	0.0	7.7	29.3	46.4	10.1	12.6	75.0	70.6	0.5	0.4	83.9	2.1	9.4	0.8	21.9	27.3	6.0	0.2	0.9	0.1	24.9	15.8	0.1	3.5	12.3	8.5	9.5	26.9	4.4	69.4	31.8	31.4	1.1	0.1	38.0	63.1	3.4	10.7	0.1	23.3	0.3	23.0	0.2	2.8	0.0	14.7	8.3	26.1	25.7	0.3	2.9	0.7	0.1	1.3	0.0	31.9	0.0	0.0	0.0	0.0	6.8	22.1	0.1	1.4	0.0	2.4	127.5	22.4	39.0	0.0	0.0	17.1	0.0	2.1	0.7	0.0	0.0	6.1	0.2	56.8	0.0	10.3	0.0	0.0	5.0	5.7	0.1	0.0	34.8	0.0	0.2	10.1	144.3	8.2	0.1	0.0	6.7	6.7	4.7	47.1	20.0	0.0	107.8	8.6	2.9	100.3	0.8	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	22.1	29.3	46.4	21.9	27.3	24.9	15.8	26.9	10.7	23.0	25.7	0.1	0.0	0.0	2.3	0.3	17.7	10.5	30.3	1.8	6.7	4.2	5.2	0.5	10.0	14.9	1.8	20.9	73.0	0.1	110.5	27.4	4.2	0.0	0.7	0.0	0.3	18.0	0.0	10.6	20.2	23.5	0.4	26.0	0.8	8.9	1.5	0.0	0.0	4.5	6.7	9.0	53.4	12.2	0.0	0.7	0.2	0.0	0.0	5.4	1.0	0.0	4.8	0.0	1.5	1.6	12.9	57.4	0.0	0.0	2.7	94.5	1.0	4.1	11.6	0.0	0.0	0.9	0.0	0.1	16.1	18.5	94.0	0.4	0.0	92.7	20.1
CKMT1B	"CKMT, CKMT1, UMTCK"	ENSG00000237289	"Creatine kinase, mitochondrial 1B"	P12532	15	43593054-43604901	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;esophagus: 74.3;intestine: 80.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.4;Distal enterocytes: 146.4;Intestinal goblet cells: 78.3;Paneth cells: 69.9;Proximal enterocytes: 124.6;Syncytiotrophoblasts: 137.9;Undifferentiated cells: 123.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 139.8;hTCEpi: 69.2;OE19: 156.0;SK-BR-3: 183.1;T-47d: 100.7"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2000000		"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043491: AB_2678510"	"unprognostic (3.47e-2)"	"unprognostic (9.73e-3)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.36e-2)"	1.9	1.9	24.6	6.3	25.1	0.0	6.0	38.0	58.5	8.0	14.3	80.7	63.4	0.3	0.4	74.3	1.9	8.9	0.7	26.5	31.5	5.3	0.1	0.7	0.1	32.4	25.2	0.1	3.1	11.9	9.5	12.8	34.6	3.1	66.0	23.4	28.5	0.8	0.1	26.7	49.4	4.0	13.8	0.0	29.6	0.2	28.6	0.1	6.2	0.0	13.3	8.4	22.0	22.2	0.3	0.9	0.8	0.0	0.2	0.0	35.3	0.0	0.0	0.1	0.1	7.8	23.8	0.0	1.0	0.0	7.2	139.8	28.4	55.8	0.1	0.8	16.0	0.0	3.0	3.8	0.0	0.1	8.6	0.0	69.2	0.0	6.9	0.0	0.0	5.9	9.1	0.0	0.0	38.2	0.1	0.2	12.0	156.0	14.9	0.0	0.0	0.8	3.0	3.7	55.4	19.5	0.9	183.1	10.9	2.3	100.7	0.0	0.0	0.1	1.8	0.2	2.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	25.1	38.0	58.5	26.5	31.5	32.4	25.2	34.6	13.8	28.6	22.2	0.1	0.0	0.5	2.6	0.1	25.1	10.4	40.5	3.4	7.5	3.8	4.1	0.4	5.7	12.7	5.5	18.8	122.4	0.4	146.4	21.5	4.0	0.0	0.9	0.0	0.5	21.0	0.0	37.6	28.0	26.1	0.5	33.1	0.5	0.0	1.1	0.0	0.0	9.4	6.7	36.5	78.3	10.2	0.0	0.7	0.0	0.0	0.1	3.6	2.8	0.0	2.2	0.0	5.0	2.4	18.6	69.9	0.0	0.1	2.0	124.6	0.9	6.0	12.2	0.0	0.0	0.7	0.0	0.0	17.5	24.7	137.9	0.6	0.0	123.7	19.9
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	49	"heart muscle: 1240.1;skeletal muscle: 1430.8;tongue: 2324.4"	"Cell type enriched"	"Detected in many"	20	"Cardiomyocytes: 814.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 3.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	18.2	33.6	12.3	0.8	15.0	0.1	4.6	17.3	12.3	8.1	24.4	3.2	1.1	6.4	11.4	20.2	6.9	8.1	1240.1	11.2	15.0	14.7	1.0	2.5	1.3	16.3	16.8	10.2	7.7	15.7	4.5	0.7	14.9	13.1	0.7	1.6	26.3	13.1	1430.8	4.7	2.8	8.8	12.0	1.8	17.9	3.6	16.1	0.8	4.9	2324.4	0.4	4.1	4.1	17.7	0.3	0.7	0.8	1.3	1.9	0.4	3.5	0.1	0.0	0.0	0.0	2.4	0.2	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	1.5	2.4	0.1	1.0	3.2	2.6	0.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	2.1	0.3	0.5	0.0	2.2	1.2	0.2	1.0	0.0	0.7	0.6	1.0	0.1	0.0	0.0	1.4	1.0	1.2	0.3	1.4	1.5	6.3	0.3	0.7	0.4	1.2	0.7	0.2	0.2	0.1	1.3	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	12.3	15.0	17.3	12.3	11.2	15.0	16.3	16.8	14.9	12.0	16.1	17.7	1.8	0.0	0.5	40.1	0.0	0.1	0.4	0.0	1.2	0.9	0.9	0.8	814.1	7.2	0.6	12.9	0.0	0.1	0.0	0.1	37.2	1.7	25.1	13.6	3.5	9.8	0.0	0.0	11.4	0.6	0.4	16.2	6.6	27.8	0.0	0.8	0.0	0.0	0.1	0.0	18.1	0.3	0.0	0.0	0.0	2.2	7.2	0.3	3.6	23.4	0.0	1.4	0.0	4.5	9.1	0.4	0.0	15.1	0.0	0.3	0.3	0.6	0.7	1.0	0.0	11.6	15.0	1.0	0.4	0.1	0.1	0.3	0.8	23.7	2.5	0.2
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	59.0	31.9	15.0	33.6	15.8	117.7	67.8	16.4	19.8	44.3	15.0	49.4	40.8	35.0	36.8	61.6	40.9	22.2	35.5	15.4	16.2	37.9	73.3	29.0	71.3	17.5	15.8	31.7	22.4	35.5	18.4	50.6	17.7	26.1	50.5	6.0	28.4	32.9	14.5	51.2	44.3	34.8	17.4	37.0	35.5	48.6	15.7	88.7	30.1	23.5	74.1	30.1	42.6	18.8	459.2	616.5	455.9	245.3	66.9	68.1	361.4	209.1	166.8	463.4	367.8	599.9	653.4	433.8	345.9	143.2	251.2	410.6	468.0	305.2	428.7	392.9	293.9	294.6	249.9	426.5	19.4	359.7	257.9	39.8	132.2	391.4	532.8	91.5	232.5	298.2	486.6	566.8	353.9	452.8	337.3	273.9	575.3	442.1	547.6	334.8	373.6	554.3	165.6	164.2	184.3	463.9	313.6	292.0	347.3	530.2	391.6	492.9	126.0	282.5	292.4	237.0	505.3	348.9	734.7	617.0	179.6	300.1	399.8	2.2	13.0	6.9	19.8	82.0	24.4	74.2	28.0	27.1	22.1	70.4	34.0	32.8	1.7	28.7	105.4	92.6	33.3	28.1	15.0	15.8	16.4	19.8	15.4	16.2	17.5	15.8	17.7	17.4	15.7	18.8	31.7	12.8	33.3	1.3	46.5	217.6	101.3	170.6	74.0	3.4	90.6	140.5	9.2	87.2	63.1	29.5	0.0	224.0	40.7	48.3	80.3	93.0	15.8	43.1	24.6	51.9	20.4	140.1	0.8	112.1	651.8	84.6	20.9	28.3	21.0	66.7	29.6	89.8	132.1	1.7	0.8	57.4	120.1	46.0	121.0	21.7	76.1	37.4	113.8	0.0	41.3	20.7	20.6	0.5	3.5	119.0	41.7	45.9	38.4	130.2	63.1	87.5	52.1	3.0	19.7	50.6	53.0	124.7	151.0	74.9	203.6	131.9	40.7	27.2	80.0	99.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLASP1	"KIAA0622, MAST1"	ENSG00000074054	"Cytoplasmic linker associated protein 1"	Q7Z460	2	121337776-121649476	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 197.9;Excitatory neurons: 248.4;Inhibitory neurons: 212.5;Oligodendrocyte precursor cells: 233.2;Oligodendrocytes: 283.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065219	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA065219: AB_2685436"	"unprognostic (6.21e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.94e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.14e-1)"	13.2	12.6	17.7	8.2	18.7	17.2	11.9	27.9	21.6	11.9	13.9	13.4	6.3	11.9	11.7	11.2	11.3	8.9	20.4	19.7	22.3	10.7	11.6	9.8	10.3	17.1	14.9	15.9	10.1	11.2	11.5	9.0	17.0	11.1	6.9	43.8	9.2	11.4	42.6	15.4	9.7	10.7	11.0	11.4	9.5	18.8	19.1	13.2	13.3	27.5	9.6	11.7	11.9	18.0	15.6	14.1	36.2	21.4	26.0	25.6	11.0	16.9	20.6	16.7	19.4	22.0	10.1	24.3	13.1	18.1	17.1	13.1	26.1	32.2	20.4	30.4	9.6	45.1	18.3	24.9	21.0	20.9	21.7	23.7	24.5	22.7	54.1	18.3	18.9	14.4	29.2	26.9	24.6	13.9	23.8	20.4	21.7	5.8	14.1	30.7	18.3	17.6	19.2	21.9	21.0	26.9	19.6	10.1	17.5	22.3	6.4	14.9	21.3	21.7	21.5	12.6	12.1	15.7	16.5	24.1	17.2	18.9	33.8	1.7	0.8	0.9	1.9	0.8	1.5	0.8	1.0	1.1	0.8	0.8	1.1	1.1	0.9	5.7	1.1	1.0	0.9	0.9	17.7	18.7	27.9	21.6	19.7	22.3	17.1	14.9	17.0	11.0	19.1	18.0	21.8	22.4	12.8	197.9	12.1	10.7	10.0	14.0	22.2	35.0	12.7	10.4	43.6	11.5	13.1	12.9	45.9	6.6	27.1	7.3	5.9	11.8	31.4	19.6	14.7	17.5	9.0	20.6	248.4	6.0	4.4	13.8	9.7	22.6	14.5	22.1	42.1	21.9	7.7	62.2	212.5	6.2	14.2	14.1	6.9	47.6	28.6	12.0	8.8	131.2	12.9	29.4	46.4	233.2	283.4	11.9	7.4	56.8	21.9	8.1	5.6	7.9	17.6	57.0	6.6	20.6	15.2	14.3	23.4	16.3	11.8	3.7	17.6	10.3	6.6	9.6
CLASRP	"CLASP, SFRS16, SWAP2"	ENSG00000104859	"CLK4 associating serine/arginine rich protein"	Q8N2M8	19	45039045-45070956	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060469, HPA062455"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA060469: AB_2684289, HPA062455: AB_2684770"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.69e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.02e-5)"	12.0	8.7	6.3	6.4	7.5	19.5	12.3	6.3	11.2	12.7	3.9	12.7	6.9	12.5	2.6	14.0	13.8	2.8	9.0	6.4	7.0	9.8	11.1	12.0	7.5	9.1	8.6	15.6	15.6	4.6	13.4	4.1	9.2	13.2	3.2	2.6	11.1	4.3	12.3	15.2	13.3	4.0	7.7	14.1	13.4	14.6	8.5	6.2	13.1	3.1	5.4	11.3	12.5	11.7	18.5	25.8	10.4	7.7	3.3	5.1	23.0	15.7	5.8	11.6	11.7	12.2	17.1	28.7	11.7	6.1	4.6	19.9	15.7	11.7	5.1	14.5	23.8	17.0	15.0	15.3	7.6	11.4	22.4	6.5	6.4	7.9	13.9	5.6	8.0	19.0	27.6	15.9	4.1	18.6	30.9	38.2	14.4	11.9	14.8	24.4	11.6	22.0	7.9	18.2	12.0	18.6	12.6	11.9	12.3	5.6	15.2	24.9	12.3	11.5	14.4	9.7	24.0	23.1	20.0	25.3	8.0	18.4	9.6	0.4	2.2	3.7	2.3	1.7	2.0	4.0	1.4	2.4	2.0	3.4	1.9	1.7	5.5	1.8	2.0	3.2	1.1	1.4	6.3	7.5	6.3	11.2	6.4	7.0	9.1	8.6	9.2	7.7	8.5	11.7	16.1	3.2	3.2	28.1	39.0	23.3	25.5	19.5	46.1	25.3	22.7	16.9	4.7	18.6	10.9	16.5	16.7	24.3	24.7	31.7	5.9	12.2	19.2	12.2	16.0	14.6	9.6	17.5	25.2	15.1	32.9	16.9	67.2	18.7	12.7	22.9	15.4	15.0	17.4	20.2	21.5	27.1	14.2	18.5	21.7	10.2	21.8	21.2	3.6	18.7	19.6	19.7	15.5	13.0	65.1	15.0	40.0	17.7	35.0	25.2	30.6	7.0	8.5	29.6	32.9	21.1	18.5	76.7	33.9	29.8	21.6	36.3	20.9	17.6	25.6	21.6
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: AB_2677822, HPA061117: AB_2684434"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	3.6	7.8	5.7	1.3	6.0	1.6	5.8	3.7	6.4	8.0	11.1	5.6	1.7	7.6	11.5	7.8	14.9	3.4	3.0	6.2	7.5	15.9	6.9	5.8	1.5	5.5	6.5	7.1	14.4	9.3	21.7	1.8	4.4	9.6	2.6	3.1	8.1	6.1	1.8	7.6	3.1	3.3	5.0	3.2	5.9	23.9	7.0	1.3	18.2	1.2	1.2	6.0	5.4	4.2	5.1	8.9	2.7	8.3	2.6	3.8	4.1	4.0	3.7	4.7	2.1	0.8	8.7	0.5	8.3	4.0	2.5	10.9	1.0	6.0	3.0	4.2	3.2	0.3	8.9	0.4	9.2	2.3	2.2	2.3	13.6	5.1	10.1	8.0	2.7	4.2	3.1	1.4	2.8	17.5	0.9	6.6	3.4	5.0	8.5	3.2	1.5	2.9	10.4	2.9	17.1	8.9	5.7	2.5	5.0	1.7	18.0	3.1	3.0	5.9	2.7	12.0	3.1	1.6	1.1	0.5	7.6	0.7	4.2	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.1	5.7	6.0	3.7	6.4	6.2	7.5	5.5	6.5	4.4	5.0	7.0	4.2	1.0	16.0	3.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.4	7.4	0.0	0.0	2.5	16.5	0.0	1.8	0.4	0.0	3.9	7.9	0.0	29.9	8.1	0.9	0.0	0.0	0.0	1.3	0.8	1.3	0.0	8.8	2.5	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	6.5	19.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.4	6.5	0.0	0.0
CLC	"Gal-10, LGALS10, MGC149659"	ENSG00000105205	"Charcot-Leyden crystal galectin"	Q05315	19	39731255-39738029	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"bone marrow: 451.9"	"Cell type enriched"	"Detected in some"	15	"Erythroid cells: 127.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	312	"basophil: 28756.2;eosinophil: 21481.0"	"Lineage enriched"	"Detected in all"	2254	"granulocytes: 28756.2"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 7553.4"					"Not detected"	"Not detected"			HPA041751	Enhanced					NA	NA		400000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA041751: AB_10793973"		"unprognostic (4.53e-2)"	"unprognostic (3.04e-2)"		"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.34e-2)"	"unprognostic (6.60e-2)"		"unprognostic (2.21e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.24e-1)"	2.0	0.1	0.0	30.0	0.0	451.9	0.3	0.2	0.4	0.3	0.0	10.2	25.4	0.3	0.1	0.9	1.7	16.6	0.5	0.0	0.5	0.3	4.8	6.2	1.8	0.1	0.1	0.0	0.4	0.2	0.4	1.4	0.1	0.1	8.1	0.0	0.9	0.2	0.1	1.5	41.6	24.5	0.1	11.3	15.6	0.6	0.8	7.3	0.3	0.2	0.2	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	619.0	7553.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	3.5	0.7	0.9	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.3	0.0	0.0	3.8	0.0	2.4	28756.2	5.0	21481.0	2.5	11.1	6.0	4.8	6.9	1.7	5.3	6.2	3.1	9.2	80.3	2.5	12.7	7.8	4.0	100.3	0.0	0.0	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	127.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500259	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 1399.9"	"Cell type enriched"	"Detected in some"	16	"Intestinal goblet cells: 3524.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		77000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			1.1	0.0	0.0	109.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	739.9	909.7	1.2	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1061.8	0.0	0.0	0.5	0.0	0.0	1399.9	15.4	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	3524.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	54.8	0.0	0.0	0.0	213.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	68.3	0.1
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108927361-108963504	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	14.6	16.5	10.1	11.4	14.3	6.1	16.3	10.6	11.7	17.0	7.8	15.4	13.2	17.0	24.3	9.9	15.1	14.0	18.3	10.7	11.5	11.0	22.2	13.0	10.5	12.8	10.9	18.6	24.8	21.3	18.3	17.7	12.1	20.2	13.2	11.8	22.3	20.0	27.2	10.3	12.7	14.9	11.0	11.5	16.1	7.6	11.8	5.2	21.9	24.8	10.8	15.2	13.4	16.0	44.2	22.3	25.1	45.8	36.7	33.9	35.6	43.8	34.2	30.1	34.2	22.6	21.0	10.8	43.7	33.3	18.5	17.1	23.9	16.1	39.4	38.0	23.2	30.4	24.7	23.5	28.9	28.7	28.2	25.2	21.9	33.2	25.7	28.3	27.1	12.1	38.6	47.7	22.1	18.9	2.3	10.1	21.5	16.6	19.8	24.5	13.1	31.2	24.3	30.5	15.9	22.7	46.9	49.6	38.9	18.9	15.9	19.7	26.7	38.3	27.7	35.1	38.4	32.1	33.3	17.1	44.7	21.8	82.5	4.1	5.6	6.1	5.6	8.4	6.1	6.1	4.5	4.4	5.6	3.2	4.9	4.5	1.4	4.7	12.4	6.4	6.8	4.4	10.1	14.3	10.6	11.7	10.7	11.5	12.8	10.9	12.1	11.0	11.8	16.0	13.3	25.6	20.9	26.8	11.8	3.7	14.0	11.7	1.8	12.3	11.8	9.1	5.9	20.0	18.0	11.0	29.2	28.7	9.0	7.1	0.0	18.6	6.7	8.1	21.3	10.9	3.6	5.9	25.0	21.1	12.8	19.5	10.7	13.5	12.0	16.3	9.7	22.3	13.1	21.9	30.3	9.0	16.2	6.7	5.1	2.8	19.9	9.3	8.8	14.0	12.0	11.4	3.1	35.7	39.3	17.7	3.8	18.8	17.7	17.7	7.2	5.0	14.9	18.9	19.7	18.6	10.7	5.5	5.4	6.4	6.3	18.5	8.4	12.5	9.8	9.9
CLCF1	"BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6"	ENSG00000175505	"Cardiotrophin like cytokine factor 1"	Q9UBD9	11	67364168-67374177	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA042444	Uncertain		Approved	"Nuclear bodies,Vesicles"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies, Vesicles"		"HPA042444: AB_10794527"	"unprognostic (2.68e-1)"	"unprognostic (7.87e-3)"	"unprognostic (6.21e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.47e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.37e-1)"	16.2	6.0	1.3	8.0	0.5	13.7	5.3	0.0	1.5	13.9	0.9	13.4	1.4	16.6	1.0	4.4	17.1	17.7	8.8	1.0	0.6	19.0	4.2	9.3	5.3	1.4	0.5	6.7	6.5	0.2	6.5	4.2	0.4	7.2	1.7	1.4	9.1	1.8	1.5	2.6	9.4	8.3	0.0	8.1	11.2	1.9	2.1	0.7	9.7	1.9	4.4	18.1	7.6	0.2	15.1	31.4	2.2	9.7	4.2	5.8	0.0	20.9	11.6	14.4	7.0	5.1	40.3	9.1	17.1	26.8	17.5	10.3	0.4	10.7	6.3	0.5	0.3	0.1	23.9	4.0	13.6	1.9	2.4	7.6	2.6	15.0	6.5	27.4	3.1	0.0	3.5	0.4	15.0	12.0	0.1	6.8	8.1	18.9	28.8	0.9	4.8	0.5	22.7	0.8	0.1	1.6	57.8	2.2	1.3	4.4	1.3	2.5	12.5	27.6	11.6	35.4	31.5	2.0	0.1	1.0	35.4	1.8	11.1	0.0	0.9	15.2	10.5	3.4	6.2	10.8	4.8	8.3	1.3	13.8	0.1	3.5	0.3	0.2	10.5	0.0	1.1	3.2	1.3	0.5	0.0	1.5	1.0	0.6	1.4	0.5	0.4	0.0	2.1	0.2	4.2	16.0	4.8	1.3	10.6	3.7	25.9	6.5	1.8	0.0	14.5	2.4	0.8	25.8	9.6	7.3	0.0	0.4	10.0	3.8	1.9	24.0	1.8	41.8	19.4	6.2	1.2	0.0	0.7	11.8	0.6	14.0	5.1	104.9	3.8	2.1	2.9	1.0	1.2	0.0	0.5	2.3	6.1	0.3	10.7	4.7	3.4	6.7	8.8	1.0	6.5	1.7	3.1	0.5	0.1	56.2	14.3	0.0	9.5	56.4	0.2	5.2	1.7	0.3	0.0	32.6	10.4	0.3	0.9	1.6	4.4	0.1	9.7	0.1	1.5	65.2
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361650	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.4	5.1	2.2	1.8	3.1	1.0	1.6	3.1	3.0	3.0	1.6	16.2	9.2	3.6	3.8	1.7	2.4	7.5	1.2	2.0	2.4	3.0	1.7	1.2	0.7	3.4	3.0	4.0	4.5	3.4	2.8	1.0	2.7	2.3	10.8	0.6	2.8	2.9	0.9	1.6	8.4	1.6	2.9	1.5	2.2	10.6	3.3	1.3	2.7	0.5	0.9	2.1	2.0	4.3	8.9	3.2	2.5	6.9	2.2	1.8	5.8	2.9	1.7	3.1	2.0	16.8	3.0	3.0	8.2	1.6	8.0	15.1	3.6	3.5	0.9	2.8	4.2	2.7	7.0	7.7	1.3	1.2	2.6	3.6	2.7	2.6	3.0	1.5	2.9	3.3	1.0	1.6	1.1	5.9	0.8	1.6	3.7	7.6	4.4	5.4	2.3	10.7	3.8	6.9	4.0	2.4	3.3	11.4	5.2	1.6	9.4	1.2	1.4	1.5	4.5	7.7	7.7	3.6	5.5	2.1	2.7	5.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	3.1	3.0	2.0	2.4	3.4	3.0	2.7	2.9	3.3	4.3	2.2	3.2	4.1	16.6	0.4	1.0	0.9	0.8	1.2	2.1	2.5	2.8	1.2	14.3	1.1	0.0	0.0	1.0	1.9	81.7	0.0	3.7	2.3	2.5	4.5	1.9	3.0	0.8	4.1	2.0	0.6	2.6	2.6	4.4	1.3	11.3	2.5	0.6	0.7	1.7	8.1	3.7	0.0	1.0	0.3	2.7	5.3	1.1	0.0	1.9	0.6	1.7	0.0	6.0	15.1	2.2	16.0	4.9	0.8	0.6	27.4	2.3	2.6	2.5	0.0	0.9	2.1	3.3	1.7	1.1	0.4	1.5	1.2	62.5	9.0	0.5
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	21.1	34.5	20.1	20.6	28.7	12.3	31.9	29.1	30.2	23.9	20.5	47.5	30.1	18.7	29.4	40.7	26.4	38.0	35.3	22.8	30.5	36.4	25.7	21.2	17.3	32.3	41.0	23.1	41.0	37.2	18.2	24.1	32.1	32.7	52.6	78.3	78.0	21.8	24.7	29.1	29.8	17.8	32.3	16.7	41.2	33.3	26.5	21.0	37.0	22.1	24.5	37.4	17.1	42.0	32.6	33.2	48.7	62.1	96.1	80.8	24.0	42.9	53.5	28.3	34.3	23.7	72.2	40.0	26.1	35.9	32.7	27.2	61.2	26.6	46.9	35.9	24.4	33.8	50.6	27.3	65.8	41.0	54.2	56.6	59.7	50.5	49.5	117.4	51.7	55.2	85.1	88.0	49.7	11.8	56.2	9.4	20.0	56.2	22.4	25.0	21.5	31.6	58.1	66.6	51.9	51.5	38.4	40.9	66.9	39.3	27.9	19.2	43.5	22.5	25.3	36.5	33.7	39.3	64.3	35.5	67.6	15.4	60.8	3.8	4.1	2.9	5.0	4.8	6.5	5.0	3.7	4.7	5.7	3.8	5.7	5.2	2.9	4.5	4.0	7.1	4.7	4.7	20.1	28.7	29.1	30.2	22.8	30.5	32.3	41.0	32.1	32.3	26.5	42.0	35.5	32.1	26.2	58.8	30.7	11.3	25.7	21.5	20.5	90.3	54.6	27.9	66.5	42.9	25.3	62.5	131.3	23.8	23.1	118.3	7.9	37.2	88.1	46.9	35.9	35.2	66.9	83.1	102.4	44.3	18.7	29.5	51.5	51.8	113.0	32.3	38.6	39.3	18.6	60.6	126.1	64.2	20.3	32.9	9.8	67.4	24.5	47.8	32.0	44.0	17.1	136.7	28.8	139.7	141.5	31.9	55.3	21.1	21.4	45.3	37.1	17.9	67.8	115.1	6.6	34.6	21.5	17.2	15.5	42.8	26.1	71.1	21.0	67.0	65.4	34.0
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156975-10237660	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;retina: 37.9;skeletal muscle: 45.0;tongue: 34.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.0;Cone photoreceptor cells: 102.2;Excitatory neurons: 45.7;Horizontal cells: 52.2;Inhibitory neurons: 54.0;Oligodendrocytes: 76.5;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.3;HEL: 24.3;SCLC-21H: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	2.6	2.7	16.2	1.5	27.4	1.8	1.1	28.8	23.1	1.3	5.2	0.9	0.8	0.6	22.6	1.7	2.9	2.1	12.3	19.6	19.7	2.8	3.2	3.0	2.8	27.1	24.1	1.6	2.2	10.8	5.3	1.1	24.5	1.5	0.7	37.9	2.2	1.0	45.0	1.0	0.7	0.7	18.5	2.6	1.5	1.8	26.8	2.6	6.5	34.2	1.8	1.2	0.7	33.3	5.9	4.6	2.7	0.0	1.5	2.5	0.1	0.2	0.0	0.0	0.0	9.1	4.6	5.0	13.0	1.5	25.3	1.4	1.4	2.9	0.2	0.1	5.7	24.3	2.2	3.5	7.3	0.0	0.1	12.9	3.4	7.0	1.5	4.7	9.4	0.0	1.5	0.1	3.3	1.1	0.0	0.2	4.0	7.1	15.3	0.0	4.5	0.0	2.1	0.8	24.1	8.7	8.6	1.1	0.0	2.7	1.7	2.7	7.4	3.1	5.8	15.3	0.6	0.5	12.1	1.8	10.5	0.0	4.5	1.6	0.3	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.4	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	16.2	27.4	28.8	23.1	19.6	19.7	27.1	24.1	24.5	18.5	26.8	33.3	1.0	9.6	3.1	11.8	4.9	0.5	0.6	2.0	0.0	85.0	1.1	0.4	31.1	8.6	2.2	7.3	102.2	0.2	0.0	0.1	0.0	2.5	0.1	2.6	1.3	3.0	15.0	9.4	45.7	3.6	0.1	4.0	1.1	3.1	1.3	0.7	13.6	5.1	3.1	52.2	54.0	0.6	4.1	4.8	2.3	0.0	0.9	3.4	0.0	15.9	1.0	15.4	0.0	24.6	76.5	4.1	0.1	3.8	0.4	0.8	0.0	2.9	5.3	42.6	0.0	8.7	6.0	0.0	0.5	0.2	0.1	0.3	0.1	2.6	0.3	1.3
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.7;kidney: 46.2;liver: 16.9"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.1	2.5	1.7	1.7	1.9	1.5	1.6	3.8	1.6	1.8	2.5	2.4	4.9	4.0	23.7	2.4	3.0	3.9	1.3	1.5	2.9	46.2	16.9	2.8	1.3	3.2	3.2	7.0	2.1	1.4	2.3	5.8	3.7	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.8	2.9	2.5	1.8	2.9	2.1	2.7	1.1	2.2	2.8	1.2	1.4	2.0	2.3	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	1.7	1.9	3.8	1.6	1.5	2.9	3.2	3.2	3.7	2.5	2.7	2.3	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11848079	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	13.6	14.8	19.1	7.5	19.1	7.7	11.9	17.3	21.3	14.8	8.2	13.7	6.3	12.6	8.7	7.4	12.6	4.9	13.2	18.0	23.5	11.8	13.7	13.8	7.4	29.6	29.5	18.6	9.2	6.0	20.2	6.4	32.1	12.5	4.8	15.2	7.8	5.5	11.6	9.8	13.0	7.3	15.4	12.0	10.5	17.1	22.5	5.3	14.4	8.1	6.1	11.5	11.1	19.4	5.1	6.4	13.9	11.1	15.2	15.4	3.8	4.1	11.1	7.1	11.7	8.6	15.9	7.9	4.4	5.5	19.3	8.8	9.0	8.8	6.7	3.6	4.5	9.4	13.8	12.1	20.1	3.9	7.6	10.1	6.2	12.7	7.7	9.4	6.9	9.6	10.6	11.7	7.8	3.1	5.7	13.4	5.7	3.3	4.5	7.0	7.4	8.6	9.7	4.4	5.7	9.6	3.9	5.1	13.0	9.5	5.0	10.6	7.4	6.5	7.0	10.1	3.3	7.2	4.0	17.6	8.5	10.2	5.3	0.0	0.8	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.6	0.9	0.2	0.3	0.0	0.1	1.6	0.6	0.0	0.4	19.1	19.1	17.3	21.3	18.0	23.5	29.6	29.5	32.1	15.4	22.5	19.4	6.4	19.2	23.6	6.8	12.5	3.4	3.7	5.1	6.2	21.7	5.6	4.7	23.5	8.6	7.0	3.7	14.6	3.7	2.5	5.8	0.0	4.5	15.0	7.7	6.6	6.5	6.6	8.2	9.0	4.6	2.9	8.5	12.2	9.8	2.5	12.6	7.1	7.9	7.5	26.9	9.4	2.9	4.1	10.8	7.8	9.0	7.5	10.2	1.8	9.4	7.4	7.7	3.1	9.0	8.8	5.6	4.4	7.2	3.9	4.7	6.3	3.9	8.9	17.0	0.0	8.9	6.4	9.3	9.8	4.8	3.1	4.1	3.8	8.0	3.2	4.5
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475084	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	18.1	37.3	14.4	16.9	14.2	34.3	17.3	12.8	18.0	18.7	18.0	20.0	16.6	20.3	6.3	12.4	17.0	12.3	16.6	14.2	14.1	21.1	22.0	19.1	18.3	17.9	19.2	15.1	21.8	20.8	21.7	12.4	20.7	16.5	7.1	9.2	16.8	12.0	28.0	23.1	22.7	13.2	11.9	27.3	22.3	19.2	18.0	15.6	23.1	8.3	12.1	16.0	11.9	15.8	14.2	36.9	21.0	33.7	41.3	21.5	34.3	18.9	36.4	35.2	41.5	30.8	51.2	16.3	38.6	23.7	73.8	29.4	18.4	21.0	11.4	26.1	31.5	11.6	37.9	30.0	72.4	29.4	45.1	42.9	28.4	32.1	28.5	23.9	23.0	36.3	48.0	29.2	18.5	28.4	21.3	50.6	21.7	9.0	21.8	96.7	13.3	45.2	16.4	18.2	22.5	24.9	30.8	37.5	120.2	11.8	33.6	78.0	26.3	34.9	16.2	39.1	18.4	47.3	32.1	16.5	28.2	54.3	22.6	0.0	1.6	1.2	0.8	2.7	0.3	1.0	0.4	0.4	1.2	1.0	0.2	0.3	0.3	0.3	3.4	1.1	0.1	1.0	14.4	14.2	12.8	18.0	14.2	14.1	17.9	19.2	20.7	11.9	18.0	15.8	12.6	0.0	7.5	25.1	16.5	7.4	5.5	6.3	9.1	45.0	14.5	12.7	4.4	4.3	8.2	20.2	35.5	10.2	12.3	20.4	1.9	16.2	10.2	14.0	14.9	11.1	12.0	8.0	22.3	17.8	8.9	11.0	18.8	17.9	6.3	24.0	16.8	15.6	36.3	74.0	20.6	14.5	4.1	28.3	11.5	8.6	11.5	29.6	39.2	24.4	22.4	27.3	13.4	8.5	17.9	17.9	7.3	8.2	9.3	9.0	14.5	14.7	7.8	28.1	0.0	9.9	11.9	13.5	10.7	5.6	6.8	15.5	9.4	19.4	15.1	5.2
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 344.0"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 271.5"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 7.4"									HPA057717	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.7	2.9	0.4	0.0	0.4	0.0	0.9	2.2	0.4	0.6	4.9	0.4	0.0	0.6	0.5	0.0	0.5	0.1	0.6	0.7	0.4	344.0	0.2	0.3	0.0	0.4	0.5	0.9	3.5	48.9	18.2	0.0	0.7	0.8	0.0	2.3	6.9	0.2	0.5	0.7	0.1	0.2	0.3	0.1	3.9	4.5	0.4	0.0	21.6	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.2	0.4	0.7	0.4	0.4	0.5	0.7	0.3	0.4	0.4	0.0	3.2	0.5	0.3	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.1	3.8	0.0	0.7	25.8	0.0	0.4	0.0	0.1	25.4	0.3	40.2	0.1	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	13.5	0.2	0.1	67.1	0.0	0.0	271.5	0.3	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	1.9	1.2	0.0	0.0	0.7	0.1	0.0	0.3	0.2
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 209.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Distal tubular cells: 58.7;Early spermatids: 24.6;Ionocytes: 116.0;Late spermatids: 104.2"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in some"	6	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HeLa: 1.1"									HPA057717	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.6	1.7	0.1	0.0	0.3	0.0	0.3	7.0	0.3	0.7	0.6	0.4	0.0	0.9	0.7	0.2	0.4	0.2	4.0	0.1	0.3	209.7	0.0	0.4	0.0	0.4	0.5	1.3	1.1	4.9	2.5	0.3	1.2	0.7	0.3	1.2	48.1	1.5	0.1	0.1	0.1	0.3	0.3	0.1	0.7	2.8	0.5	0.1	16.1	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.7	0.0	1.6	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.3	0.1	0.3	0.4	0.5	1.2	0.3	0.5	0.6	0.0	3.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.3	4.2	0.0	1.4	23.9	0.0	0.3	0.0	0.6	58.7	1.0	24.6	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.3	116.0	0.0	0.0	104.2	0.9	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.6	0.9	0.0	0.0	0.5	0.1	0.0	0.9	0.1
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 309.8;skin 1: 288.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 25.4"	"CAB002602, HPA048319"	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	40.8	47.9	1.5	1.2	1.1	0.2	22.7	0.8	1.3	17.7	20.7	1.7	1.1	64.2	31.9	40.9	56.6	15.5	2.5	1.5	1.2	10.5	309.8	9.1	0.5	1.2	2.8	6.3	34.3	0.4	2.4	5.3	1.7	13.6	1.6	0.9	34.0	46.0	1.1	288.2	0.7	126.6	0.7	1.5	1.0	4.3	1.1	9.4	36.2	4.9	44.2	40.4	35.9	1.0	34.0	29.7	0.2	0.1	0.0	0.1	0.0	2.5	52.7	1.1	2.1	17.7	69.1	0.0	658.6	0.3	58.5	236.5	1.5	77.7	6.2	0.9	1.4	0.1	9.3	41.5	49.6	0.4	0.2	0.5	288.6	6.0	87.0	2.4	0.6	0.0	0.1	0.1	0.1	6.5	0.1	0.1	1.5	2.3	5.5	0.0	0.6	0.2	414.9	267.0	0.2	0.0	31.0	5.7	18.4	3.5	53.5	0.5	12.9	0.6	9.9	0.2	1.4	0.7	0.6	1.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.8	1.3	1.5	1.2	1.2	2.8	1.7	0.7	1.1	1.0	0.4	12.8	34.7	0.0	0.5	440.1	291.1	217.3	84.2	0.0	35.6	2.0	1.0	170.1	143.2	31.3	0.0	2.4	0.6	0.6	0.0	203.3	0.1	44.4	10.0	7.0	1.8	0.0	0.7	56.3	0.3	29.2	2.0	100.0	1.3	0.4	1.4	188.2	1.0	0.0	1.6	0.3	54.9	3.8	66.5	1.7	15.5	8.5	32.0	0.0	5.7	0.0	0.0	24.6	0.0	139.9	0.0	35.3	0.0	501.6	0.1	4.1	144.6	0.0	0.0	0.3	11.2	0.3	0.8	298.2	836.1	33.8	2.6	5.0	1.0	562.9
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 135.2;pancreas: 216.5;salivary gland: 91.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 182.4;Cholangiocytes: 328.8;Club cells: 251.6;Ductal cells: 394.1;Glandular and luminal cells: 220.2;Proximal tubular cells: 285.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.3;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 14.9;NTERA-2: 12.7;RPTEC TERT1: 29.0;SuSa: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012969, HPA042348"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (4.75e-3)"	1.0	0.1	33.0	0.0	31.3	3.2	3.1	28.6	45.8	30.4	24.1	0.3	1.1	9.3	20.8	7.9	19.2	25.5	0.5	32.6	30.5	135.2	3.7	2.1	0.0	27.9	30.2	0.9	216.5	0.4	3.1	0.8	27.2	1.3	0.4	2.7	91.5	0.4	0.1	16.8	0.2	0.4	27.4	0.7	0.9	1.5	30.1	0.5	0.2	0.7	27.4	0.5	0.4	29.8	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	1.9	0.0	0.0	2.9	0.0	0.1	0.0	0.5	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.7	0.2	0.0	0.0	0.1	0.0	29.0	0.0	0.2	0.1	0.0	0.0	0.0	73.3	0.7	1.8	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	33.0	31.3	28.6	45.8	32.6	30.5	27.9	30.2	27.2	27.4	30.1	29.8	0.6	0.0	0.0	93.4	1.0	0.3	5.5	182.4	0.0	0.3	22.6	5.0	0.8	328.8	251.6	99.3	0.0	15.0	0.4	0.0	135.0	394.1	3.4	83.2	28.5	4.2	0.0	0.0	0.6	82.5	7.9	1.4	0.0	220.2	0.0	0.1	1.1	0.4	1.9	0.0	1.6	0.0	77.3	0.3	0.3	2.5	0.0	2.8	69.4	4.7	1.6	78.7	0.0	33.7	0.4	103.1	0.0	0.4	0.1	22.1	0.0	285.9	43.3	3.8	6.6	0.2	16.8	12.2	19.9	1.5	0.6	23.1	2.2	0.5	0.0	5.0
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418868-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 130.1;ovary: 95.4;testis: 116.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 56.4;Leydig cells: 105.3;Oligodendrocytes: 394.5;Peritubular cells: 67.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 141.3;ASC TERT1: 174.2;EFO-21: 91.8;HUVEC TERT2: 162.2;TIME: 252.1"	"Region enriched"	"Detected in all"	5	"white matter: 2084.8"					"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favorable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	29.9	5.4	18.8	0.0	51.7	0.0	15.3	48.7	36.5	6.7	4.4	7.6	0.1	8.1	1.5	5.1	18.0	8.7	7.8	22.7	34.6	6.4	2.2	4.8	0.2	130.1	44.2	95.4	0.8	0.0	20.9	1.2	88.6	11.2	0.3	0.2	5.2	1.0	1.5	6.5	6.6	0.4	52.5	1.2	3.1	116.9	47.4	0.0	1.8	0.7	0.1	13.2	13.2	94.6	0.0	0.0	0.1	0.0	141.3	174.2	0.0	1.2	8.5	11.0	19.6	0.0	19.2	0.0	91.8	14.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	10.6	42.8	0.0	0.0	61.0	0.0	60.9	0.0	0.4	162.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	4.6	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	51.7	48.7	36.5	22.7	34.6	130.1	44.2	88.6	52.5	47.4	94.6	16.4	0.0	0.6	2.3	0.4	14.4	15.6	1.0	0.0	0.5	5.7	27.7	1.4	1.5	0.1	1.8	0.0	0.9	0.8	0.3	0.0	0.1	8.3	0.5	0.2	37.3	0.0	2.7	1.5	0.0	1.6	56.4	0.0	0.6	0.0	27.2	49.2	1.1	0.9	0.0	2.8	0.0	0.0	1.2	23.8	24.3	105.3	1.1	14.2	24.4	0.0	0.4	0.0	3.5	394.5	0.7	0.0	67.7	0.0	15.4	0.2	0.2	0.2	0.1	0.0	2.9	6.6	11.6	4.1	1.0	10.2	0.8	0.6	1.6	0.1	2.0
CLDN12		ENSG00000157224	"Claudin 12"	P56749	7	90383721-90513402	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 354.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026945	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026945: AB_10603786"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (3.84e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.30e-1)"	8.3	21.9	16.1	7.0	18.1	3.2	21.1	19.0	22.0	13.7	17.2	22.2	18.7	14.0	19.8	11.9	15.4	19.0	18.6	15.8	20.7	24.1	52.0	12.1	2.0	16.0	16.9	20.5	14.6	21.6	22.5	10.2	16.4	24.1	23.9	31.4	19.7	12.4	17.3	8.3	21.3	13.2	15.4	4.6	21.6	12.8	18.4	5.7	17.1	23.0	5.1	15.8	10.4	15.7	25.5	22.6	26.3	17.8	27.1	22.2	14.3	30.3	33.6	19.9	33.2	21.7	65.0	4.1	24.1	18.2	43.9	21.2	23.4	27.9	39.8	6.0	22.1	2.5	19.9	23.8	26.8	5.1	2.8	27.8	29.7	33.3	52.3	35.9	10.5	5.0	14.8	14.3	30.0	12.1	6.8	12.0	44.7	32.6	14.4	3.4	37.9	6.2	31.0	17.0	21.4	39.1	16.8	15.6	51.7	42.1	18.2	16.4	25.8	46.6	29.2	36.6	33.5	7.8	8.1	0.6	33.1	3.6	24.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.6	0.1	1.0	0.1	0.2	0.3	0.0	0.0	0.0	0.3	0.5	0.2	16.1	18.1	19.0	22.0	15.8	20.7	16.0	16.9	16.4	15.4	18.4	15.7	3.6	32.1	10.3	21.2	0.9	9.8	14.8	23.5	8.6	34.5	21.8	10.9	15.7	20.0	23.4	18.4	20.9	8.7	0.7	19.1	7.9	18.9	354.5	13.4	9.5	4.8	16.7	1.3	35.9	41.0	10.0	13.8	10.7	18.1	0.0	5.7	8.6	51.2	7.2	20.2	33.4	18.8	18.3	0.8	5.7	31.2	10.5	2.8	19.6	9.4	2.7	49.6	1.0	28.1	3.9	32.3	13.0	10.5	3.3	48.7	13.4	26.4	36.3	20.9	13.1	8.4	10.1	22.3	6.7	11.9	10.9	5.1	1.6	5.0	18.7	51.8
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 63.6"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.1	1.5	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.2	63.6	2.2	0.4	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.1	0.1	0.1	0.1	0.3	0.3	9.7	0.0	1.0	0.3	0.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165565-30166805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 2.3;esophagus: 6.1;salivary gland: 6.4;vagina: 7.2"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"lung: 252.2;stomach 1: 724.9"	"Group enriched"	"Detected in some"	53	"Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.6;stomach cancer: 186.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"OE19: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.3	0.3	0.3	0.4	0.4	0.1	0.2	1.0	0.5	0.4	2.2	0.7	1.5	0.2	0.5	0.6	0.5	3.3	9.7	0.3	0.2	0.2	0.1	252.2	0.0	0.9	0.9	0.5	0.8	0.0	0.5	0.3	0.5	0.2	0.2	0.7	0.3	0.4	0.1	1.1	0.8	0.1	0.7	0.5	724.9	1.3	0.5	0.1	0.1	0.0	0.7	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.5	15.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.5	0.3	0.2	0.9	0.9	0.5	0.7	0.5	0.2	0.0	1602.5	431.2	1.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	17.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.3	0.2	0.6	0.0	0.0	0.5	11.4	0.0	1.4	1153.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	442.5	0.0	0.0	1.3	0.0	0.0	0.1	0.7	1.3	0.0	0.9	0.1	15.3	11.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLDN25		ENSG00000228607	"Claudin 25"	C9JDP6	11	113779747-113780500	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA053555	Uncertain					NA	NA									"HPA053555: AB_2682186"	"unprognostic (1.02e-2)"											"unprognostic (3.22e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 439.7;breast: 420.9;lung: 398.7"	"Group enriched"	"Detected in many"	10	"Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4"	"Cancer enriched"	"Detected in all"	4	"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 18.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.8"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 85.4;SCLC-21H: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	439.7	16.2	124.1	6.1	101.0	0.3	420.9	111.7	127.4	70.2	205.2	75.9	9.2	86.1	3.0	54.4	83.1	6.5	138.3	93.8	103.3	45.5	16.9	398.7	9.6	124.5	114.0	36.4	20.7	1.5	16.9	12.5	127.8	50.2	3.6	2.0	36.0	3.5	101.6	95.9	71.0	6.4	109.2	44.8	41.4	10.5	160.7	1.8	122.5	14.9	2.2	103.7	75.9	107.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.1	0.1	0.2	1.1	0.0	0.0	0.0	0.0	85.4	0.1	0.7	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.9	0.7	0.1	0.0	0.0	53.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	7.1	0.1	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	18.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	4.6	0.2	5.8	0.0	0.1	0.1	0.0	26.9	124.1	101.0	111.7	127.4	93.8	103.3	124.5	114.0	127.8	109.2	160.7	107.4	2644.3	3.2	7.7	0.7	2.4	32.4	1.1	0.1	3.4	1.8	5.9	7.6	14.8	2.8	0.6	7.3	0.0	0.3	4.2	0.0	0.0	0.7	5.0	8.1	0.7	775.2	2.4	8.0	0.0	0.8	0.1	12.5	0.0	1.0	1.3	0.3	701.4	2.7	0.8	0.0	0.1	0.2	4.1	17.0	33.3	5.5	5.3	46.2	14.2	129.3	0.7	2.4	1.0	0.5	0.3	0.0	0.0	0.7	2.8	4.0	0.0	0.0	0.3	7.3	0.0	61.7	12.1	1.1	1.9	1.2	30.5	0.0	4.6	25.0	0.0	6.7
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 341.3;intestine: 341.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	6.7	8.0	0.4	17.6	0.4	0.2	31.2	0.5	0.6	47.3	0.4	341.0	146.7	4.8	43.9	341.3	41.3	27.4	2.7	0.4	0.4	123.8	40.2	61.8	0.8	0.6	0.5	1.5	108.5	49.0	31.1	14.2	0.6	44.5	128.6	1.1	169.2	30.0	1.5	13.1	248.9	6.2	0.5	5.7	5.2	1.9	0.6	2.4	76.7	0.0	21.2	40.5	96.3	0.9	10.8	1.1	0.2	0.3	0.0	0.6	84.1	0.3	0.3	0.0	0.0	90.2	173.2	0.1	3.2	0.4	0.4	364.9	0.1	11.2	0.0	0.1	1.9	0.1	2.4	0.0	6.5	0.1	0.8	1.5	17.3	0.0	0.6	0.0	8.1	0.1	1.0	0.3	0.1	129.8	0.1	1.2	0.6	139.6	3.4	0.2	0.0	2.5	0.1	0.0	20.4	0.4	1.1	150.2	0.0	6.6	55.0	1.3	16.8	0.2	0.6	0.7	0.2	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	0.0	0.5	0.8	1.3	0.1	0.3	0.8	0.4	0.9	0.9	1.7	0.0	0.7	0.0	0.0	0.3	0.5	0.4	0.4	0.5	0.6	0.4	0.4	0.6	0.5	0.6	0.5	0.6	0.9	4.4	112.2	55.6	0.0	7.4	2.0	295.4	316.3	66.6	0.7	200.4	102.4	0.6	240.2	550.3	321.8	8.4	281.3	3.1	1391.1	39.2	787.5	0.1	210.1	26.6	9.0	326.8	4.0	0.0	790.0	342.7	5.2	15.3	225.5	5.7	0.1	3.6	41.2	33.7	0.0	0.0	741.7	362.2	4.1	6.4	0.2	1.2	11.0	24.9	1.9	11.0	1.6	0.0	0.0	0.0	822.1	1276.4	0.0	0.5	406.5	1390.9	78.6	498.5	6.7	0.0	0.2	38.6	0.4	3.5	366.1	2.6	588.9	10.2	1.0	691.9	975.8
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216097	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 224.3;Distal enterocytes: 110.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.7	0.0	27.2	0.0	0.1	9.3	3.9	1.1	0.0	0.0	0.0	0.0	69.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.5	0.0	7.5	50.8	0.0	40.1	13.9	0.0	8.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	0.3	0.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	10.8	2.7	0.0	0.0	29.9	11.6	0.0	0.0	10.5	224.3	0.0	0.0	0.1	110.2	11.7	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.4	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	15.9	0.6	0.4	20.3	0.0	0.0	0.0	0.3	0.0	0.0	4.6	8.4	0.0	0.4	0.0	18.0	23.1
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CLDND2	MGC33839	ENSG00000160318	"Claudin domain containing 2"	Q8NHS1	19	51367098-51369003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.9"	"Cell type enriched"	"Detected in many"	9	"Early spermatids: 344.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056971	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA056971: AB_2683294"	"unprognostic (2.86e-1)"	"unprognostic (4.29e-5)"	"unprognostic (2.29e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-9)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.70e-2)"	4.9	4.6	9.4	1.9	8.8	9.7	4.1	9.8	12.2	3.9	7.6	4.6	4.5	2.7	0.1	2.6	3.7	1.6	3.3	9.7	9.9	4.3	4.7	3.2	2.0	9.6	9.2	4.4	5.3	1.0	3.4	0.9	9.7	4.3	1.2	1.8	4.3	1.4	2.4	2.0	4.3	0.6	8.4	6.6	2.9	44.9	9.4	1.0	3.5	2.6	0.5	4.8	3.3	9.5	2.0	5.5	2.0	2.7	2.8	2.5	1.1	0.9	0.4	0.9	1.2	0.6	6.4	5.1	1.1	0.5	0.6	2.5	0.6	0.3	0.2	3.6	8.6	4.5	9.1	11.0	1.1	1.3	1.3	1.9	0.9	0.2	0.5	1.3	0.6	2.5	3.0	3.7	0.8	1.2	1.1	7.5	0.8	5.6	6.9	1.0	4.5	2.1	1.5	1.4	1.1	1.3	2.3	0.5	1.8	1.0	1.4	0.3	1.2	1.9	3.9	2.0	0.8	3.4	3.9	2.0	4.7	5.1	1.2	3.0	0.4	2.1	1.7	1.0	0.9	0.8	0.4	2.2	0.7	0.4	0.3	0.7	0.2	2.9	0.4	1.5	0.6	0.3	9.4	8.8	9.8	12.2	9.7	9.9	9.6	9.2	9.7	8.4	9.4	9.5	4.3	0.0	3.7	8.5	3.1	1.7	5.6	1.3	5.7	5.4	7.8	8.3	6.9	12.8	1.2	16.5	0.0	1.8	8.1	4.9	3.9	1.0	344.4	0.9	3.0	2.4	10.3	8.2	2.1	0.7	1.7	3.4	6.6	1.5	15.8	1.8	5.3	17.4	2.6	3.3	4.3	16.8	4.1	4.1	4.0	36.1	6.2	3.7	1.8	4.7	2.4	2.5	9.2	0.5	3.2	0.7	5.8	6.4	3.7	3.4	13.3	5.5	6.0	2.3	0.0	5.4	5.4	23.5	1.3	7.5	2.7	0.8	4.4	1.4	12.3	5.5
CLEC10A	"CD301, CLECSF13, CLECSF14, HML, HML2"	ENSG00000132514	"C-type lectin domain containing 10A"	Q8IUN9	17	7074537-7080307	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	6	"Langerhans cells: 805.4;Macrophages: 213.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	12	"myeloid DC: 465.9"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 465.9"	"Not detected"	"Not detected"											HPA021937	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA021937: AB_1846905"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.65e-1)"	20.9	3.3	0.3	29.4	0.4	2.5	8.5	0.3	0.6	4.1	1.6	13.6	15.8	3.8	1.2	10.4	4.5	18.8	6.4	0.3	0.4	2.7	6.9	12.3	19.8	0.4	0.5	2.1	2.8	1.3	1.3	0.7	1.2	3.0	18.2	0.0	4.3	4.7	3.0	10.0	25.5	18.9	0.3	18.5	7.7	2.5	0.6	7.8	2.6	3.1	13.6	19.9	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.1	0.0	39.0	0.2	0.0	0.2	0.1	465.9	0.3	0.1	0.0	2.1	2.2	0.3	9.2	0.3	20.5	0.3	0.4	0.3	0.6	0.3	0.4	0.4	0.5	1.2	0.3	0.6	0.5	1.1	3.2	3.9	0.0	3.6	13.3	0.0	0.0	1.2	0.0	0.2	0.5	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.1	1.5	0.0	3.0	0.2	0.0	0.2	2.0	0.0	0.1	1.3	0.0	0.4	1.1	18.4	0.0	0.0	0.1	0.0	77.9	805.4	1.2	0.3	213.9	21.4	0.0	26.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.0	0.0	6.6	0.5	1.7	0.0	2.3	0.4	11.8	0.1	1.6	0.0	0.0	0.0
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 79.9;lymphoid tissue: 22.1"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 121.9;Macrophages: 141.6;monocytes: 154.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	37	"dendritic cells: 72.6;granulocytes: 202.6;monocytes: 136.6"	"Group enriched"	"Detected in some"	6	"HL-60: 21.8;U-937: 66.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 6.2"	"Not detected"	"Not detected"			HPA048515	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favorable (9.33e-4)"	6.4	2.6	0.3	13.9	0.2	79.9	1.1	0.3	1.0	2.0	1.3	2.8	1.0	1.0	1.2	1.2	1.0	5.1	1.9	0.2	0.2	0.7	6.4	16.6	6.6	0.6	0.2	0.4	0.7	0.6	0.4	2.4	0.3	0.9	3.0	0.3	1.3	0.4	1.3	1.4	4.5	7.7	0.2	22.1	1.8	0.6	0.3	2.5	1.1	0.7	2.1	4.9	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	21.8	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	66.5	0.0	23.9	136.6	202.6	0.2	114.6	0.5	0.2	0.1	0.1	72.6	0.1	0.4	0.5	47.2	3.7	130.2	6.4	0.2	61.6	0.3	0.2	0.3	1.0	0.2	0.2	0.6	0.2	0.3	0.2	0.3	0.3	0.7	3.2	5.0	0.0	2.8	0.4	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	3.1	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	7.2	0.3	0.0	1.0	1.5	0.5	0.1	30.3	0.0	0.7	0.8	19.2	0.0	0.3	0.0	0.0	121.9	16.9	0.0	0.0	141.6	0.0	0.0	154.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.9	0.9	0.2	0.6	1.4	4.2	0.0	0.0	0.0
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944564-11182186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	10.2	12.8	12.1	7.2	13.4	13.2	9.4	16.7	17.3	11.2	23.6	9.5	8.2	9.0	6.9	13.9	9.4	4.8	14.6	11.3	11.1	16.6	16.2	12.8	9.3	13.8	14.5	8.2	8.9	11.7	17.3	7.0	13.8	11.3	5.9	11.5	9.1	5.7	17.5	14.2	10.8	6.2	9.7	12.4	10.4	46.8	21.0	10.9	13.3	8.3	8.8	9.1	10.4	11.7	11.6	12.1	9.0	11.9	14.8	10.3	8.0	11.7	11.4	9.6	12.5	13.5	21.1	22.8	26.6	14.3	10.6	10.1	11.6	21.7	12.3	110.3	12.5	10.4	16.4	14.4	10.4	11.5	21.5	12.3	10.4	15.9	13.4	8.8	13.3	12.4	17.6	13.8	11.5	19.0	18.2	9.1	7.2	10.0	9.5	24.6	7.6	13.5	20.1	8.4	11.5	15.3	16.8	17.1	9.1	10.4	12.1	17.7	14.2	12.4	16.1	18.3	10.4	9.7	9.2	18.7	15.5	16.4	13.1	2.7	1.9	1.4	2.2	1.5	1.3	1.7	1.8	1.5	1.5	2.8	2.1	1.8	2.6	1.8	3.0	2.0	1.4	1.1	12.1	13.4	16.7	17.3	11.3	11.1	13.8	14.5	13.8	9.7	21.0	11.7	7.1	16.0	10.0	130.9	12.8	7.1	3.7	5.9	11.4	11.7	5.2	5.1	5.9	8.6	8.8	3.7	37.5	3.4	5.5	12.1	0.0	6.0	118.7	7.5	6.0	6.1	7.7	8.6	93.3	6.4	2.6	6.2	9.2	8.0	8.2	5.7	9.7	12.6	4.8	11.8	135.1	7.9	6.1	5.4	6.2	84.8	5.6	6.8	3.6	40.3	8.6	3.9	4.1	69.4	72.9	6.5	4.0	8.6	8.8	3.5	10.3	3.5	8.9	18.3	0.0	7.4	4.5	27.1	8.4	13.4	8.2	3.8	8.6	3.3	6.7	4.9
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 23.9"	"Cell type enriched"	"Detected in some"	23	"Proximal tubular cells: 78.0"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.2	0.9	0.1	0.0	0.2	0.3	0.3	0.6	0.5	0.3	2.8	0.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.2	23.9	0.2	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.4	0.0	0.4	0.3	0.1	0.1	0.6	0.0	0.2	0.3	0.7	0.0	0.2	1.2	0.5	3.2	0.2	0.3	0.4	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.5	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.0	1.1	0.0	0.9	0.1	0.0	0.2	0.0	1.6	0.3	0.4	0.5	2.8	0.4	0.0	2.1	0.1	0.3	3.3	1.9	0.3	0.4	0.4	0.1	0.4	0.0	0.0	0.3	0.2	0.1	0.3	2.0	0.5	0.0	0.6	2.5	0.4	0.4	3.3	0.4	1.0	0.0	0.6	0.3	0.8	0.3	1.1	0.0	0.0	0.9	0.9	1.0	0.0	0.0	0.5	0.4	0.0	0.2	0.2	1.5	78.0	0.7	1.3	0.0	0.7	1.3	0.5	0.2	0.0	0.0	0.3	0.6	0.6	1.3	0.2
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 33.4;testis: 11.8"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 26.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;renal cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;JURKAT: 1.6;K-562: 3.1;U-266/70: 1.1"									HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.9	3.4	0.4	3.7	0.1	0.2	4.5	4.9	0.5	2.6	0.2	0.4	0.1	0.6	2.7	0.3	0.3	0.2	3.8	3.8	33.4	0.6	0.2	0.1	3.7	3.6	0.2	0.6	0.0	0.8	0.1	4.0	0.5	0.1	2.3	0.6	0.0	0.2	0.2	0.3	0.1	3.6	0.6	0.3	11.8	3.3	0.2	0.6	0.0	0.0	0.1	1.7	4.4	0.0	0.6	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	1.1	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	4.5	4.9	3.8	3.8	3.7	3.6	4.0	3.6	3.3	4.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.9	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.4	26.8	0.0	1.4	0.0	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 17.8"	"Cell type enriched"	"Detected in single"	46	"Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CLEC1B	CLEC2	ENSG00000165682	"C-type lectin domain family 1 member B"	Q9P126	12	9985642-10013424	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 65.3"	"Cell type enriched"	"Detected in some"	8	"Hepatic stellate cells: 535.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.8;monocytes: 5.0"	"Group enriched"	"Detected in some"	6	"Karpas-707: 11.3;U-266/84: 28.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051108	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA051108: "	"unprognostic (2.03e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"		"unprognostic (4.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-2)"	0.1	0.4	0.1	0.9	0.2	9.2	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.1	65.3	2.2	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	2.9	0.2	2.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	3.3	0.0	13.8	5.0	7.5	0.0	4.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	3.3	0.1	4.1	1.2	0.0	13.8	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.4	0.0	0.6	0.4	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	7.4	0.0	53.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	535.8	5.0	0.1	0.0	0.0	0.0	0.0	49.9	0.0	0.3	0.0	64.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.6	0.0	0.0	0.0	1.1	0.6	0.0	0.0
CLEC2A	"INPE5792, KACL, PILAR, UNQ5792"	ENSG00000188393	"C-type lectin domain family 2 member A"	Q6UVW9	12	9898673-9932370	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 57.6"	"Group enriched"	"Detected in some"	11	"Basal keratinocytes: 18.7;Suprabasal keratinocytes: 37.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 22.0;U-937: 54.6"									"HPA048530, HPA072407"	Approved		Uncertain	"Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA048530: AB_2680429, HPA072407: AB_2686518"		"unprognostic (3.10e-1)"							"unprognostic (5.29e-2)"						"unprognostic (2.23e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	3.5	2.1	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	57.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.3	0.2	0.3	0.5	0.3	0.5	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	37.1	0.0	0.1	0.0	0.0	0.1
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852369-9869386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 113.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;dendritic cells: 255.7;NK-cells: 265.7;Suprabasal keratinocytes: 240.8;T-cells: 276.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 221.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.7;ASC TERT1: 87.7;fHDF/TERT166: 49.5;HSkMC: 50.3;U-937: 229.5"					"Low region specificity"	"Detected in all"			HPA008194	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	32.4	7.4	10.7	21.9	10.8	113.0	23.5	13.1	20.0	23.1	12.5	9.4	7.2	19.9	6.5	17.4	15.5	20.5	14.6	10.7	10.4	8.2	16.3	39.3	32.2	12.2	11.2	33.1	2.5	2.9	4.2	17.6	12.3	9.8	13.5	2.4	12.7	6.0	17.2	80.0	14.0	14.5	11.2	44.7	9.1	3.0	12.8	16.3	10.4	20.6	16.0	19.8	23.9	11.8	0.3	2.6	0.0	0.2	56.7	87.7	0.4	1.6	11.0	0.8	2.9	0.1	1.8	1.2	0.9	49.5	32.8	17.4	8.0	0.1	0.2	1.8	0.1	2.3	0.1	0.1	19.9	2.0	0.4	50.3	18.1	2.2	0.4	2.9	29.1	9.0	0.1	7.4	13.0	0.1	15.2	4.1	0.3	0.0	2.0	20.9	0.4	0.1	0.1	18.3	0.1	0.0	0.8	0.2	13.9	0.2	3.6	0.6	41.8	0.4	9.2	1.6	5.3	13.2	1.2	1.7	13.5	229.5	16.8	54.8	37.8	14.6	68.2	58.1	55.4	12.6	42.3	69.7	34.5	20.0	40.2	62.2	221.4	67.2	75.6	12.6	36.0	84.4	10.7	10.8	13.1	20.0	10.7	10.4	12.2	11.2	12.3	11.2	12.8	11.8	216.3	3.2	23.1	0.0	102.0	201.6	76.4	393.1	106.4	0.1	4.4	7.7	3.6	7.2	122.3	0.0	0.0	0.9	255.7	0.5	0.0	5.1	0.3	5.8	84.2	179.5	1.8	32.8	0.0	0.8	2.0	97.1	3.6	5.5	54.4	1.3	142.8	3.6	74.4	0.0	0.0	1.0	61.1	141.5	208.2	2.4	49.7	183.2	80.0	15.0	59.2	1.1	265.7	0.0	0.2	1.9	0.0	17.7	102.8	23.9	0.3	1.1	17.4	0.7	6.6	45.8	26.4	0.3	0.5	99.9	240.8	1.9	276.6	16.7	1.1	140.9
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699553	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2"	"Group enriched"	"Detected in all"	11	"B-cells: 127.5;T-cells: 223.0"	"Group enriched"	"Detected in many"	4	"Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.68e-7)"	6.1	1.8	3.6	16.7	3.5	16.0	5.6	3.3	4.9	6.4	3.1	4.8	3.3	4.5	11.8	3.2	5.3	5.5	5.3	3.2	3.7	3.9	2.9	8.6	53.5	4.0	3.4	6.0	2.4	0.8	2.3	2.6	3.9	7.3	3.9	2.2	6.5	4.5	2.9	3.7	20.3	2.0	3.5	26.6	5.5	9.5	4.1	31.6	4.5	1.3	41.7	5.7	4.6	4.2	1.2	2.5	3.5	0.3	0.5	1.4	4.0	1.7	2.5	0.6	2.1	1.9	2.1	67.9	0.3	1.8	1.0	0.7	1.2	0.2	1.1	53.3	0.9	2.1	1.6	2.9	5.7	1.7	1.7	2.3	1.7	0.5	2.1	8.0	0.1	1.2	0.5	31.0	1.5	4.5	0.7	5.9	3.2	0.2	0.4	14.9	1.6	2.2	3.4	3.6	0.6	1.3	0.9	2.8	3.0	6.6	0.6	1.8	0.6	1.3	1.8	1.0	1.2	4.4	1.1	105.8	2.8	3.1	2.1	6.8	2.1	1.5	188.1	1.4	114.5	95.0	183.3	208.7	2.3	127.5	192.3	223.0	6.0	16.5	1.3	1.6	175.2	109.8	3.6	3.5	3.3	4.9	3.2	3.7	4.0	3.4	3.9	3.5	4.1	4.2	8.9	6.4	20.7	11.8	128.6	4.1	39.7	2.1	1.8	1.3	6.5	6.1	9.6	4.3	7.1	1.8	4.2	10.4	112.0	0.8	7.9	3.0	95.5	3.6	6.9	13.0	0.0	21.5	6.3	1.9	6.0	12.2	4.6	6.2	20.2	18.1	12.5	2.3	9.2	5.0	6.8	2.5	0.0	20.9	17.8	28.3	8.4	19.4	1.8	56.2	81.6	3.2	131.8	27.6	4.4	2.8	2.0	9.8	71.5	17.2	0.5	2.1	7.4	2.3	19.7	26.2	8.7	5.7	6.3	1.9	4.8	4.8	215.1	7.4	3.5	24.3
CLEC2L	FLJ32986	ENSG00000236279	"C-type lectin domain family 2 member L"	P0C7M8	7	139523685-139544985	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 36.6;parathyroid gland: 14.2;retina: 10.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 51.7;Inhibitory neurons: 49.5;Theca cells: 72.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 12.0;U-266/84: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045050	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045050: AB_10965839"	"unprognostic (1.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.20e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.29e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.31e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.57e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.02e-2)"	0.4	0.1	13.4	0.2	13.2	0.4	0.1	28.8	33.7	0.8	3.0	0.4	0.1	1.5	0.0	0.6	0.1	0.8	0.3	15.4	17.5	0.1	0.0	0.1	0.1	35.2	14.9	0.2	0.1	14.2	0.5	0.0	36.6	0.0	0.1	10.3	0.1	0.0	3.1	0.2	0.3	0.8	11.6	0.2	0.1	0.6	31.8	8.0	0.2	6.5	0.1	0.1	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.5	0.0	1.2	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.4	13.2	28.8	33.7	15.4	17.5	35.2	14.9	36.6	11.6	31.8	18.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	51.7	0.0	2.8	1.7	0.0	0.1	0.0	2.7	0.0	0.0	0.2	5.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.8	1.9	0.0	0.0	0.4	0.0	72.8	0.0	0.1
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"	O75596	16	78022515-78066761	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;breast: 9.3;urinary bladder: 5.8"	"Cell type enriched"	"Detected in single"	7	"Prostatic glandular cells: 4.7"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Region enriched"	"Detected in single"	6	"midbrain: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.4;T-47d: 21.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051511	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA051511: AB_2681514"	"prognostic unfavorable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 420.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 76.3;Endothelial cells: 27.9;Fibroblasts: 126.4;Hepatic stellate cells: 57.5;Leydig cells: 30.1;Microglial cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 297.9;ASC TERT1: 591.9;U-2197: 120.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	NA	NA	6540000000	25000000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.53e-4)"	"prognostic favorable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	420.3	51.0	44.4	9.3	46.4	1.7	214.8	45.5	66.6	89.4	50.9	83.9	31.6	60.4	17.1	49.9	41.1	35.6	259.9	43.0	42.9	131.4	29.0	201.2	33.1	51.3	56.1	26.0	14.6	14.3	27.7	142.8	48.0	33.5	37.4	0.7	49.8	19.1	74.8	149.7	78.2	25.5	44.8	264.5	43.5	113.2	50.7	10.1	88.4	68.0	8.2	100.9	74.9	43.0	0.0	0.0	0.1	0.2	297.9	591.9	0.0	40.1	62.9	1.2	6.2	0.0	0.0	0.1	0.1	3.1	0.0	0.1	0.0	0.1	0.1	0.3	0.9	0.6	0.1	0.1	0.5	0.1	0.7	47.5	0.1	0.3	0.1	0.4	0.5	0.3	0.0	1.7	0.5	0.2	0.0	2.2	0.0	0.0	0.6	0.0	0.1	2.2	0.0	0.0	0.3	1.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	4.5	0.2	120.6	0.1	1.0	1.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	46.4	45.5	66.6	43.0	42.9	51.3	56.1	48.0	44.8	50.7	43.0	76.3	0.0	0.0	1.6	0.3	3.4	0.0	0.0	1.8	0.0	0.7	0.3	0.8	1.5	0.0	0.0	0.0	0.0	0.5	0.0	3.9	0.0	4.0	0.3	16.9	27.9	0.0	2.7	0.8	0.2	0.0	126.4	3.1	0.3	0.0	0.0	57.5	0.3	0.9	0.0	0.6	0.0	0.0	1.2	9.5	19.5	30.1	2.2	3.6	69.3	0.7	0.4	0.0	1.5	0.7	0.1	0.0	6.4	0.5	0.0	0.0	0.0	0.0	0.3	0.0	1.0	12.3	0.0	0.0	0.7	3.8	0.1	0.7	0.4	0.0	0.0
CLEC4A	"CD367, CLECSF6, DCIR, DDB27"	ENSG00000111729	"C-type lectin domain family 4 member A"	Q9UMR7	12	8123617-8138607	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 21.6;lymphoid tissue: 26.9"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 79.9;Langerhans cells: 119.3;Macrophages: 88.5;monocytes: 98.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 226.8;classical monocyte: 331.7;intermediate monocyte: 198.1;myeloid DC: 327.4;neutrophil: 298.3;non-classical monocyte: 130.0"	"Group enriched"	"Detected in all"	13	"dendritic cells: 327.4;granulocytes: 298.3;monocytes: 331.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007842	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA007842: AB_1078534"	"unprognostic (9.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.34e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.79e-2)"	4.1	2.4	3.0	26.9	3.0	21.6	4.6	3.1	5.9	3.2	2.9	4.6	5.1	3.9	4.3	2.6	2.6	7.4	1.9	3.0	3.0	1.7	4.2	11.1	9.4	4.0	3.1	4.3	1.8	1.0	2.0	4.9	3.1	2.3	6.0	3.5	2.8	3.0	1.6	5.4	4.7	4.6	3.1	15.4	2.4	2.4	2.6	6.2	1.7	2.6	8.9	7.7	1.8	3.3	0.2	0.0	0.3	0.9	1.7	4.2	0.5	1.2	0.5	0.9	1.3	1.6	0.7	0.7	0.1	0.6	0.3	0.2	0.9	0.2	0.6	1.2	1.2	0.7	0.7	0.4	2.1	2.3	2.9	2.1	0.9	0.4	1.2	2.7	0.2	1.6	0.4	0.6	1.2	0.6	0.6	1.7	0.6	0.6	0.4	0.4	0.7	1.1	0.6	1.1	0.2	0.4	0.2	0.8	0.0	1.4	0.1	0.1	0.2	1.6	1.0	0.6	0.8	0.7	0.1	0.9	0.2	0.8	0.0	226.8	331.7	1.1	0.5	198.1	0.6	14.1	0.9	1.3	327.4	25.0	0.6	0.6	298.3	3.3	130.0	44.4	0.6	168.9	3.0	3.0	3.1	5.9	3.0	3.0	4.0	3.1	3.1	3.1	2.6	3.3	1.1	0.0	4.6	3.9	8.6	4.2	0.8	0.6	0.0	0.6	0.7	2.0	0.8	0.0	2.0	0.0	4.2	0.3	8.9	0.4	1.9	0.1	5.5	0.2	0.6	1.5	1.8	2.7	2.2	0.5	0.2	1.4	0.5	0.3	2.5	1.5	0.7	1.3	23.8	0.0	2.4	0.3	0.0	79.9	119.3	1.5	2.5	88.5	7.2	3.7	98.8	1.0	6.2	4.5	2.9	0.6	1.2	1.5	0.7	0.8	0.0	0.3	2.3	1.1	0.0	1.1	1.1	0.6	0.4	0.3	3.3	0.3	2.1	0.7	0.2	0.9
CLEC4C	"BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL"	ENSG00000198178	"C-type lectin domain family 4 member C"	Q8WTT0	12	7729383-7751605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.5"	"Cell type enriched"	"Detected in some"	21	"dendritic cells: 107.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	16	"plasmacytoid DC: 468.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 468.0"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 2.1"									HPA029432	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA029432: AB_10601259"	"unprognostic (3.55e-3)"	"unprognostic (3.01e-2)"		"unprognostic (1.03e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.37e-5)"		"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	0.3	0.1	0.0	1.4	0.1	1.6	1.4	0.4	0.2	0.1	0.7	0.1	0.0	0.1	0.0	0.2	0.1	1.2	0.0	0.1	0.0	0.1	0.2	0.6	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	3.8	0.2	0.9	0.0	2.1	0.1	0.0	5.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	5.3	0.7	30.0	0.1	0.1	0.1	0.6	0.1	0.1	4.1	2.6	0.1	0.0	14.7	2.9	0.0	468.0	0.2	3.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	107.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.0	0.1	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	4.9	0.0	0.3	0.0	0.8	0.0	0.0	0.0
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 64.7"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1"	"Cancer enriched"	"Detected in single"	50	"testis cancer: 11.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 57.1;neutrophil: 98.7"	"Group enriched"	"Detected in many"	32	"granulocytes: 98.7;monocytes: 57.1"	"Group enriched"	"Detected in some"	5	"NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004906	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA004906: AB_1078535"	"unprognostic (1.10e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.81e-1)"	"unprognostic (7.91e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-1)"	2.3	0.2	0.0	7.3	0.1	64.7	0.2	0.0	0.2	3.1	0.3	0.1	0.1	0.1	0.5	0.4	0.7	0.4	0.3	0.0	0.0	0.2	0.5	3.1	0.6	0.1	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.2	0.8	0.0	7.0	0.2	0.2	0.4	0.3	0.1	0.7	0.3	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	9.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.9	57.1	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.4	0.0	0.0	0.1	98.7	0.0	1.2	0.7	0.0	12.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.6	0.8	0.0	0.0	11.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540905	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.7;lymphoid tissue: 52.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 128.8;neutrophil: 448.8"	"Group enriched"	"Detected in many"	17	"granulocytes: 448.8;monocytes: 128.8"	"Group enriched"	"Detected in some"	4	"NB-4: 4.3;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	13.3	5.4	2.3	37.5	2.1	75.7	4.5	1.8	4.4	5.8	2.2	2.2	0.4	2.3	0.4	3.2	5.5	11.8	2.5	2.3	2.9	3.6	6.6	22.4	7.6	1.3	1.3	1.7	6.2	1.7	1.9	2.1	1.2	2.3	1.0	1.3	1.4	1.2	0.7	0.9	3.1	5.7	0.7	52.3	2.5	1.1	2.0	2.2	10.5	5.0	2.3	9.6	1.7	2.9	0.1	0.4	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.1	0.1	2.0	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	1.5	0.0	0.5	0.2	0.2	0.2	0.2	0.0	0.1	0.0	4.3	0.3	0.0	0.0	0.0	0.2	0.1	12.4	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.4	1.0	0.5	0.1	1.0	0.1	0.2	0.1	0.1	1.3	0.4	0.1	0.2	128.8	0.5	0.1	18.1	0.3	0.1	0.1	0.1	16.9	0.1	0.0	0.1	448.8	0.0	0.7	0.7	0.0	30.3	2.3	2.1	1.8	4.4	2.3	2.9	1.3	1.3	1.2	0.7	2.0	2.9	6.2	0.0	4.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	5.7	1.8	1.8	0.0	0.0	0.3	0.0	0.0	9.0	0.3	2.1	4.4	3.5	0.0	0.0	0.0	0.0	0.1	1.4	0.0	31.9	0.0	0.0	7.1	2.1	5.6	0.0	0.0	0.0	0.0	158.0	9.0	2.9	0.9	115.2	0.0	0.0	109.5	0.0	4.1	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.2	0.7	0.0	13.1	0.2	0.4	0.2	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.1
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728958-7733906	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.9;liver: 53.3;lymphoid tissue: 15.1"	"Cell type enriched"	"Detected in some"	15	"Hepatic stellate cells: 730.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 18.8;myeloid DC: 15.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.1;monocytes: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003789, HPA014044"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	14.9	0.5	1.9	2.4	1.9	1.2	2.6	4.0	2.9	0.1	2.0	1.4	0.4	0.1	0.3	0.4	4.8	1.6	1.2	2.5	1.9	0.5	53.3	1.0	15.1	2.3	2.1	0.5	0.3	0.0	0.1	1.0	2.1	0.3	0.9	0.0	1.1	0.3	0.4	1.1	2.0	1.0	2.1	3.4	0.9	0.4	4.3	0.2	0.5	0.0	0.3	7.7	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.8	0.0	0.0	4.2	0.0	0.3	0.0	0.0	15.1	4.2	0.1	0.0	0.4	0.5	0.5	0.7	0.0	4.5	1.9	1.9	4.0	2.9	2.5	1.9	2.3	2.1	2.1	2.1	4.3	2.1	0.1	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	18.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	730.3	7.1	0.8	0.0	1.1	0.0	0.0	46.7	2.9	0.0	0.3	2.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.0	0.3	0.3	1.1	0.8	0.0	0.1
CLEC4M	"CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN"	ENSG00000104938	"C-type lectin domain family 4 member M"	Q9H2X3	19	7763210-7769605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 62.6;lymphoid tissue: 16.4"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 270.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033689, CAB033691, HPA042661"	Supported				"Intracellular and membrane"	NA	NA		3400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101"	"unprognostic (1.56e-1)"				"unprognostic (3.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"		"unprognostic (1.27e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.15e-2)"		"unprognostic (1.43e-1)"	1.4	1.1	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	62.6	3.2	16.4	0.8	0.6	3.0	0.1	0.0	0.1	7.3	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.4	0.0	2.2	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.8	0.6	0.5	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	3.5	0.0	18.7	0.1	0.0	0.0	1.3	0.0	0.0	0.0	15.7	270.2	2.8	0.7	0.0	0.2	0.0	0.0	14.8	2.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.4	0.1	0.0	0.0	0.3	0.3	23.4	0.0	0.2
CLGN		ENSG00000153132	Calmegin	O14967	4	140388453-140427661	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 59.5;testis: 113.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	6.6	0.9	1.0	0.7	2.4	2.7	3.8	1.6	0.9	2.0	2.6	0.5	1.6	0.6	1.2	13.7	0.4	59.5	0.9	2.6	0.4	3.2	0.5	0.7	2.7	1.9	0.3	2.2	0.6	11.2	0.2	2.6	22.5	1.3	17.2	1.0	0.7	0.4	0.2	1.3	1.5	1.2	0.2	2.0	113.6	2.3	2.4	2.7	1.6	1.2	0.6	0.1	0.9	0.2	10.2	10.3	6.9	4.0	21.1	2.4	0.1	9.4	10.0	18.6	0.3	0.9	0.0	27.8	0.9	8.4	0.2	7.5	0.1	16.2	0.4	9.0	3.0	9.8	7.4	41.4	38.9	0.6	2.2	39.2	1.0	0.9	53.0	0.2	9.6	2.0	0.0	0.0	0.5	47.8	0.5	12.0	0.2	28.1	31.5	0.0	0.4	0.0	0.3	16.8	29.8	6.5	4.1	1.8	3.8	1.9	5.6	0.0	27.4	4.7	9.7	73.6	14.4	31.7	19.9	43.4	1.6	2.9	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	3.8	1.6	0.9	2.6	2.7	1.9	2.6	1.2	2.3	0.9	0.8	0.0	2.2	0.3	0.1	0.0	0.9	8.5	1.2	9.2	3.3	1.8	313.3	0.0	6.4	0.0	4.2	0.5	0.0	0.5	0.0	1.2	162.4	93.4	1.3	11.9	5.3	8.6	7.2	4.2	0.1	10.2	0.0	11.3	0.0	10.1	0.7	3.7	0.1	25.2	6.7	0.4	30.5	0.0	0.0	60.2	5.0	0.7	1.8	0.0	0.1	176.4	0.0	6.6	0.6	0.9	3.9	4.5	0.1	33.8	0.2	0.1	24.6	16.3	0.0	0.6	2.0	465.5	23.9	2.8	0.1	0.3	0.7	0.2	0.8	1.3
CLHC1	"C2orf63, FLJ31438"	ENSG00000162994	"Clathrin heavy chain linker domain containing 1"	Q8NHS4	2	55172547-55232563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Early spermatids: 52.6;Late spermatids: 40.1;Oligodendrocyte precursor cells: 48.2;Oligodendrocytes: 40.2;Respiratory ciliated cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045418, HPA053557"	Uncertain		Approved	"Nucleoli fibrillar center,Centrosome"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center, Centrosome"		"HPA045418: AB_10962144, HPA053557: AB_2682188"	"unprognostic (1.60e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-4)"	"unprognostic (6.36e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.15e-4)"	2.3	2.8	2.7	1.8	3.2	2.1	3.3	6.7	3.8	3.2	11.4	2.8	2.1	4.2	5.0	2.6	4.4	3.1	2.4	3.2	2.7	3.6	1.6	2.5	2.8	4.9	5.5	3.2	2.6	5.4	5.9	3.6	3.1	4.5	3.1	7.7	2.7	3.5	1.7	4.9	2.7	3.5	3.4	3.4	2.4	15.1	3.0	4.1	3.9	1.0	2.1	2.9	2.9	4.5	3.4	2.2	6.6	3.4	2.4	3.3	5.1	4.2	3.9	2.1	1.9	4.5	2.8	4.7	2.6	1.9	2.7	5.3	2.8	3.7	4.3	4.3	3.6	7.1	7.9	4.5	2.8	4.4	3.5	4.3	3.0	2.8	6.0	6.6	2.2	4.3	3.8	2.9	2.4	2.5	3.9	4.6	2.3	1.2	1.0	3.8	3.3	3.0	3.5	4.2	6.4	4.4	2.8	4.0	4.7	4.7	2.8	2.4	5.8	5.2	3.4	2.7	3.5	5.4	1.5	2.6	4.3	4.4	1.4	0.5	0.2	1.3	0.3	0.6	0.0	0.4	0.5	0.3	0.4	0.4	0.6	0.3	0.1	0.9	0.5	0.9	0.4	0.3	2.7	3.2	6.7	3.8	3.2	2.7	4.9	5.5	3.1	3.4	3.0	4.5	3.0	0.0	4.1	35.6	2.7	1.9	5.2	7.0	4.0	12.3	3.9	3.8	4.7	1.5	9.8	3.7	16.7	3.4	1.0	2.1	5.9	3.8	52.6	19.3	7.1	3.0	7.3	2.1	18.8	1.4	1.7	5.1	3.6	4.3	0.0	13.5	5.0	0.3	2.3	10.1	27.0	1.7	4.1	4.6	0.7	40.1	4.1	3.1	1.8	15.0	2.0	9.6	2.1	48.2	40.2	1.0	1.2	5.7	1.6	3.9	1.8	3.0	44.9	19.7	0.0	3.8	3.7	29.9	2.3	3.5	2.3	3.4	2.2	7.6	2.9	4.1
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	8.6	0.6	0.9	1.3	1.0	4.0	2.6	1.3	1.6	75.0	1.4	1.3	0.3	1.8	4.6	317.0	1.7	0.8	8.6	0.7	1.0	1.0	1.0	38.6	4.1	1.3	0.9	0.6	0.6	0.2	2.4	41.6	1.0	3.0	0.2	0.0	37.7	1.1	1.0	122.0	1.7	0.3	0.8	6.9	7.5	0.7	1.0	7.6	109.6	1.2	20.5	2.1	132.2	1.2	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	1.0	1.3	1.6	0.7	1.0	1.3	0.9	1.0	0.8	1.0	1.2	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34668994-34718227	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 235.9;stomach 1: 138.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Club cells: 41.6;Gastric mucus-secreting cells: 26.5;Respiratory ciliated cells: 81.1;Skeletal myocytes: 24.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.6;NTERA-2: 3.6;T-47d: 7.3;THP-1: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065285	Enhanced					NA	NA		180000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA065285: AB_2685454"	"prognostic favorable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	11.4	0.1	1.2	4.3	0.7	0.1	11.9	2.4	1.0	15.8	235.9	4.0	2.0	2.1	2.7	2.6	11.4	8.8	11.1	11.3	0.7	2.6	0.9	9.8	1.2	3.0	4.5	4.9	3.2	28.3	3.3	0.1	2.6	9.8	2.9	0.2	25.4	7.0	1.6	6.0	3.1	0.7	1.3	1.0	138.5	0.3	4.4	8.4	13.2	4.3	3.8	12.9	5.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.9	7.3	3.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	2.4	1.0	11.3	0.7	3.0	4.5	2.6	1.3	4.4	0.7	0.3	6.4	20.7	1.3	0.0	0.6	5.1	7.3	4.0	0.0	15.6	11.0	11.4	30.0	41.6	9.2	0.0	0.0	0.2	2.2	1.9	8.0	0.1	15.1	0.3	0.4	4.9	0.0	0.3	0.9	0.0	3.7	26.5	2.2	1.3	11.8	0.0	0.0	0.1	0.0	0.6	1.4	16.2	0.0	0.4	0.3	0.3	0.4	7.2	0.0	0.6	0.0	0.0	0.0	0.1	17.2	0.6	3.0	0.4	10.2	0.1	0.2	81.1	0.0	0.0	24.0	2.4	0.2	0.2	0.6	0.4	0.0	0.4	0.0	2.8	20.4
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422669	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 169.1"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 479.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"		NA	NA		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	29.6	36.7	22.5	27.8	23.5	18.0	23.2	63.0	24.4	22.8	18.3	34.1	16.9	26.2	18.0	70.8	17.0	22.3	43.1	24.4	24.0	29.7	46.2	28.1	18.4	19.0	22.5	13.1	26.8	90.1	16.4	38.9	17.7	32.5	20.6	26.9	25.2	44.4	165.4	41.3	19.7	42.4	15.7	17.3	19.6	24.8	23.3	13.9	69.5	169.1	25.2	48.3	29.8	24.3	54.2	63.5	46.0	39.1	34.8	51.7	79.4	76.3	69.2	49.2	30.0	31.7	24.4	24.2	49.8	95.7	66.9	65.6	29.7	31.2	57.9	95.0	17.0	7.7	40.2	36.3	68.6	27.8	41.5	32.1	103.3	57.0	87.6	70.3	49.2	20.2	29.4	15.0	47.7	34.6	17.4	8.7	16.7	25.7	53.2	14.7	31.5	11.6	45.5	61.9	16.1	10.7	162.9	39.5	64.0	44.9	31.4	15.9	98.2	36.8	40.1	84.3	49.3	17.0	14.4	14.1	63.0	14.0	25.6	3.3	6.5	4.0	6.6	10.6	5.1	4.9	6.1	5.9	5.6	3.0	4.5	3.2	17.1	4.7	9.4	3.2	6.3	4.1	22.5	23.5	63.0	24.4	24.4	24.0	19.0	22.5	17.7	15.7	23.3	24.3	50.2	134.6	129.9	116.2	32.4	67.2	162.6	42.4	23.9	69.6	50.0	30.1	142.2	50.1	106.5	44.1	43.8	129.7	34.5	38.0	7.9	69.0	156.9	101.2	53.1	57.3	13.9	11.3	115.3	65.5	32.9	69.1	26.0	115.0	72.7	41.3	46.4	48.3	38.3	132.9	107.7	22.3	42.7	41.8	48.5	82.9	35.8	57.0	55.2	45.0	54.2	34.8	46.4	45.2	40.7	95.6	28.5	62.1	33.0	134.4	26.4	13.2	146.5	41.8	72.3	114.6	68.4	22.0	27.4	40.3	143.3	479.4	48.5	39.6	23.0	223.9
CLIP2	"CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4"	ENSG00000106665	"CAP-Gly domain containing linker protein 2"	Q9UDT6	7	74289407-74405935	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9;Excitatory neurons: 63.9;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 111.2"	"Cancer enhanced"	"Detected in all"		"glioma: 43.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 70.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020430, CAB020767"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB020767: , HPA020430: AB_1846958"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.96e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.38e-1)"	7.8	9.4	66.9	10.6	80.7	4.1	5.9	71.3	65.7	13.5	24.8	18.5	11.3	11.3	2.1	6.7	7.7	10.9	7.0	65.0	68.1	15.5	3.0	10.9	5.5	87.2	79.8	16.9	17.7	5.0	11.7	8.8	80.8	9.7	10.0	4.7	4.1	9.2	2.4	10.2	13.6	8.1	71.2	6.6	15.0	3.2	69.4	5.0	3.6	3.1	7.3	11.7	11.0	88.8	7.0	24.1	19.5	21.2	22.5	25.1	0.2	17.2	36.5	10.5	11.5	5.6	33.0	1.3	3.4	33.2	70.3	26.8	3.6	20.3	4.6	46.1	1.8	5.6	3.3	14.4	21.9	1.1	6.8	28.3	9.1	31.9	26.4	27.5	15.5	0.7	1.5	0.4	20.4	2.4	0.8	38.8	8.9	33.5	24.5	37.8	7.2	1.7	13.5	24.1	3.9	21.7	9.8	3.0	35.9	14.8	2.2	4.5	18.3	27.6	16.4	37.1	10.9	1.0	0.4	0.1	32.7	10.4	24.4	0.8	0.3	0.0	0.0	0.6	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	66.9	80.7	71.3	65.7	65.0	68.1	87.2	79.8	80.8	71.2	69.4	88.8	5.8	0.0	0.0	19.9	3.5	30.2	6.2	3.3	31.3	10.2	1.9	3.0	2.3	5.7	1.3	3.7	0.0	0.3	3.3	48.9	0.0	10.3	0.2	5.7	8.1	6.6	10.3	3.0	63.9	6.2	0.4	8.2	42.3	13.3	1.3	3.4	3.9	1.4	6.0	18.5	45.2	16.9	0.0	4.6	33.0	0.6	2.8	8.3	12.4	32.8	7.5	4.2	2.1	84.4	111.2	8.2	17.8	7.9	0.9	4.2	16.3	0.3	1.4	4.3	13.1	5.6	11.2	0.1	3.4	4.4	6.8	1.0	4.1	3.6	12.1	1.6
CLIP3	"CLIPR-59, RSNL1"	ENSG00000105270	"CAP-Gly domain containing linker protein 3"	Q96DZ5	19	36014660-36033343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 158.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.9;Excitatory neurons: 24.8;Granulosa cells: 25.7;Horizontal cells: 42.1;Inhibitory neurons: 30.7;Muller glia cells: 26.9;Peritubular cells: 24.5"	"Cancer enhanced"	"Detected in all"		"glioma: 65.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 83.3;fHDF/TERT166: 61.5;HSkMC: 93.1;hTERT-RPE1: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079430	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA079430: "	"unprognostic (1.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.56e-10)"	"unprognostic (6.31e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.09e-2)"	16.4	13.5	109.8	9.7	117.0	0.5	14.0	92.0	142.5	50.9	0.3	75.3	6.5	66.2	12.7	16.3	35.7	23.5	12.7	122.5	121.5	11.5	2.9	10.0	7.0	105.2	158.4	48.6	3.6	2.6	46.9	9.3	140.0	29.2	8.6	54.9	6.3	33.4	3.4	7.8	21.4	37.9	60.3	9.9	25.7	12.0	92.6	9.4	5.5	3.5	6.2	68.2	32.4	106.2	1.3	3.8	33.0	1.4	53.8	83.3	1.1	19.1	45.9	15.6	23.4	4.0	1.3	1.8	7.6	61.5	1.3	1.6	0.6	0.2	11.1	2.4	1.3	1.0	4.1	0.8	54.1	1.0	1.0	93.1	0.9	13.4	0.3	80.8	17.7	13.0	1.9	3.5	35.2	2.9	18.6	1.3	4.0	1.3	0.9	2.4	0.6	1.1	0.5	1.2	32.2	37.6	2.2	0.8	1.0	13.5	1.2	0.4	4.9	26.8	21.9	1.3	1.2	2.8	2.5	1.4	41.1	1.8	10.2	0.0	0.1	0.3	0.2	0.2	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.2	0.1	0.4	0.0	0.1	0.2	0.1	109.8	117.0	92.0	142.5	122.5	121.5	105.2	158.4	140.0	60.3	92.6	106.2	1.1	0.0	0.0	11.4	0.1	0.6	0.6	0.5	0.6	30.9	0.4	4.3	4.3	0.0	0.1	1.8	2.1	0.6	0.0	0.3	0.0	0.1	11.3	0.7	15.3	3.6	2.4	0.0	24.8	0.2	0.5	16.1	1.1	0.7	0.0	25.7	5.0	0.2	0.8	42.1	30.7	0.9	0.0	0.3	2.3	19.2	22.1	0.5	3.6	10.3	0.0	26.9	0.0	14.6	15.3	0.3	0.0	24.5	0.2	0.4	0.3	0.3	0.7	13.7	6.6	8.7	12.8	2.3	3.5	0.5	1.3	1.2	0.6	2.9	0.2	0.1
CLIP4	"FLJ21069, RSNL2"	ENSG00000115295	"CAP-Gly domain containing linker protein family member 4"	Q8N3C7	2	29097705-29189643	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 169.2;Inhibitory neurons: 142.8;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 25.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043366, HPA056246"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA043366: AB_10963051, HPA056246: AB_2683078"	"unprognostic (1.97e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.62e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-2)"	19.3	9.8	15.1	9.5	24.7	1.9	14.2	20.6	19.7	14.3	18.3	20.8	4.8	13.7	8.7	23.4	15.5	13.4	30.0	15.2	18.9	9.0	4.5	18.7	10.2	20.6	21.8	22.7	6.3	14.3	20.0	16.4	20.9	16.6	7.0	17.9	13.9	15.2	71.9	30.9	10.7	18.6	18.6	10.0	10.2	17.5	18.1	13.5	33.5	43.8	10.7	20.8	19.9	31.4	82.3	22.6	3.4	12.1	31.4	47.0	0.1	31.8	54.4	17.5	19.9	0.7	52.7	10.2	15.9	55.1	69.9	33.0	3.6	24.7	24.8	18.9	5.4	0.0	29.1	1.2	79.7	0.0	16.2	33.3	61.3	23.2	83.8	62.8	12.4	7.4	0.5	31.5	26.7	0.6	7.9	3.6	0.9	4.8	5.0	0.1	20.1	1.6	32.0	14.4	5.3	13.7	27.6	11.2	29.0	3.3	0.0	4.9	39.4	4.1	31.6	13.7	13.8	16.2	0.1	0.1	19.0	0.0	12.7	2.5	6.1	0.2	7.9	14.8	12.4	1.4	6.1	8.4	2.4	0.5	6.9	6.8	1.2	5.6	25.9	0.0	2.3	5.6	15.1	24.7	20.6	19.7	15.2	18.9	20.6	21.8	20.9	18.6	18.1	31.4	0.9	64.1	15.0	78.7	7.2	17.1	27.6	26.8	30.1	31.0	11.4	8.9	76.2	0.0	18.5	12.9	29.2	6.7	18.6	0.1	3.9	10.7	169.2	16.1	8.4	2.5	0.0	2.5	75.1	9.1	1.7	26.5	4.1	12.9	5.1	13.1	1.4	1.8	9.9	20.2	142.8	0.0	8.2	36.1	6.0	91.1	27.4	25.9	8.8	15.9	17.5	18.7	19.6	130.2	247.2	22.1	0.0	24.0	30.9	25.8	0.0	5.9	32.1	17.9	13.1	24.2	9.2	9.4	1.6	29.7	27.3	21.5	21.9	16.4	0.2	24.2
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	89.6	82.7	132.9	25.4	137.1	178.0	72.2	140.9	201.6	118.5	136.2	78.3	20.8	65.8	51.1	58.5	85.5	56.5	83.9	133.9	137.7	83.3	84.4	90.3	55.9	138.1	133.4	140.3	63.6	29.0	82.3	64.8	138.6	109.7	24.2	133.8	68.9	49.6	80.4	62.5	51.6	30.9	135.2	113.0	53.2	28.1	134.1	76.0	92.5	71.4	42.0	77.8	112.8	176.0	17.9	13.5	22.6	6.5	24.4	26.1	17.1	19.2	26.8	19.3	25.5	24.6	11.8	5.5	13.1	11.4	11.1	19.7	27.9	8.8	38.2	27.3	24.0	18.1	35.9	30.7	14.7	19.5	31.1	12.3	39.9	23.4	41.8	20.6	11.4	9.5	23.3	77.1	27.0	12.3	23.0	58.4	13.9	11.4	29.8	24.8	25.7	31.8	13.0	11.2	22.0	17.8	16.4	6.1	32.7	12.9	5.3	13.2	19.5	21.4	14.8	21.5	22.0	46.8	20.9	13.7	14.2	15.4	14.9	40.0	7.2	18.6	14.5	5.0	17.3	17.4	15.7	15.8	4.8	11.7	15.6	12.9	16.9	9.5	6.0	11.1	17.2	10.4	132.9	137.1	140.9	201.6	133.9	137.7	138.1	133.4	138.6	135.2	134.1	176.0	122.1	44.8	85.4	112.0	164.2	168.8	263.0	73.6	114.4	59.0	112.9	97.0	96.6	41.5	87.1	27.6	100.1	46.7	213.5	110.9	19.6	31.4	2.3	111.2	108.8	113.6	134.3	87.5	51.7	26.9	56.6	142.5	81.1	173.6	136.9	77.9	82.1	43.3	58.5	52.2	53.6	124.2	50.8	100.5	285.8	9.4	92.9	192.3	154.7	62.8	56.2	54.6	76.2	58.3	169.0	32.0	117.7	75.6	169.0	133.3	88.2	14.9	70.1	99.6	111.7	97.8	128.4	33.1	27.7	117.0	151.7	90.3	261.2	43.0	88.6	184.2
CLK2		ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	23.7	25.6	11.6	10.7	11.9	11.4	24.4	14.2	14.4	39.2	14.1	24.1	11.7	29.8	12.7	22.6	28.7	9.6	18.5	11.7	12.7	26.8	29.0	22.0	19.6	12.3	11.7	33.9	23.9	14.0	31.4	13.8	12.4	33.1	8.7	9.4	23.3	11.2	16.2	27.5	24.0	10.9	11.7	40.1	20.8	16.2	12.4	18.6	33.2	8.5	15.9	28.1	29.9	13.2	10.8	10.5	29.8	11.4	17.3	9.1	22.5	8.1	12.3	8.2	7.8	13.1	8.7	23.3	9.7	6.6	4.0	17.0	16.8	13.5	6.3	11.4	17.7	20.4	12.9	15.4	14.6	26.8	20.5	7.6	10.7	11.3	20.3	19.0	13.6	16.9	29.6	15.4	10.5	22.2	12.1	11.3	21.2	27.2	17.6	17.7	21.6	28.0	17.9	25.8	11.8	25.1	4.5	10.9	9.9	21.4	15.9	24.9	9.3	4.3	12.1	9.1	9.1	31.6	28.6	22.9	9.9	19.1	5.9	0.5	0.8	1.9	0.8	0.4	1.6	1.2	1.5	0.8	0.9	0.9	1.6	1.6	0.8	0.5	0.4	0.8	0.9	0.6	11.6	11.9	14.2	14.4	11.7	12.7	12.3	11.7	12.4	11.7	12.4	13.2	9.2	16.0	24.3	9.8	13.7	4.6	5.7	4.2	17.6	5.7	7.8	7.5	14.9	12.8	12.6	7.3	4.2	8.0	7.1	5.4	0.0	6.5	6.5	6.9	15.2	11.1	6.7	8.4	8.3	4.4	8.0	11.3	25.0	9.5	10.1	12.1	7.5	8.4	6.9	5.0	6.8	9.1	2.0	11.4	4.5	6.6	7.8	10.4	3.6	9.4	9.5	5.4	8.2	9.5	8.0	4.9	4.8	3.0	17.1	5.7	5.1	3.2	5.1	7.2	6.6	6.4	12.6	8.6	4.3	14.3	4.5	12.4	11.0	7.4	7.2	5.1
CLK3		ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	35.9	28.7	30.3	26.5	31.8	112.4	34.6	36.4	35.9	36.7	32.8	36.6	28.9	32.3	25.9	38.6	31.3	32.7	28.3	30.2	31.2	30.0	29.4	34.0	37.7	32.8	31.6	38.4	33.9	35.3	32.3	31.6	32.5	31.9	21.8	33.1	36.1	29.7	50.7	41.7	33.7	26.2	29.5	41.7	35.1	44.4	32.2	55.8	32.3	52.1	30.3	37.8	33.8	35.4	56.7	35.1	45.5	25.6	57.2	43.4	35.8	37.7	59.2	52.7	64.3	47.9	36.4	51.2	27.2	33.9	73.5	39.0	85.4	36.3	34.3	73.2	46.9	63.0	52.0	33.6	90.7	17.2	46.6	54.8	71.0	69.4	57.4	64.0	58.6	51.0	31.3	36.2	31.1	39.9	50.9	57.3	29.1	55.7	24.6	40.7	21.8	33.7	41.1	40.3	25.5	29.9	30.2	33.0	34.3	34.7	31.4	33.8	27.3	31.0	23.7	19.7	50.2	59.0	51.8	42.2	27.2	82.4	40.1	74.2	65.5	90.0	68.9	74.1	68.2	71.0	73.6	71.9	61.3	78.8	74.4	70.9	115.9	90.7	97.7	69.5	87.7	85.9	30.3	31.8	36.4	35.9	30.2	31.2	32.8	31.6	32.5	29.5	32.2	35.4	29.8	6.4	38.4	14.0	34.1	44.9	44.9	41.6	26.2	35.5	22.8	15.9	18.6	28.6	35.1	12.9	56.3	27.7	41.8	46.7	31.3	34.2	83.6	25.8	19.9	28.6	29.3	31.5	6.6	24.2	46.2	24.5	37.8	41.5	21.5	27.4	21.4	13.4	27.5	28.6	7.9	34.7	42.7	23.3	34.4	19.8	27.7	28.4	28.4	6.5	29.5	18.0	29.9	7.1	9.6	30.8	52.0	20.3	26.6	38.9	35.5	18.6	23.4	42.6	13.1	20.4	35.8	45.4	21.4	21.0	41.9	58.6	40.1	20.4	28.1	63.5
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 297.5;Late spermatids: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	13.8	11.9	14.0	7.8	14.9	10.4	13.6	22.9	20.1	20.1	14.0	14.4	9.4	12.8	11.9	10.1	13.7	9.8	13.0	14.1	14.5	13.4	13.7	10.8	17.6	15.0	14.0	18.3	17.6	7.9	10.3	10.8	15.2	16.7	6.6	34.4	13.0	8.3	17.8	15.1	12.6	5.5	14.0	18.6	12.5	15.2	14.2	16.6	16.6	21.1	10.0	12.5	21.0	19.3	8.1	7.2	6.8	10.0	19.9	15.9	11.2	7.6	8.8	4.5	8.4	7.7	6.6	4.6	6.0	3.2	5.2	10.4	8.9	6.0	7.5	16.8	6.8	1.8	15.2	8.8	7.4	3.8	5.7	7.2	8.8	7.6	9.6	15.1	3.2	3.1	4.1	13.4	5.5	3.3	5.2	13.8	3.4	5.4	4.5	4.8	6.0	6.7	4.2	2.3	7.4	5.0	8.4	4.7	8.4	3.8	5.1	8.0	6.9	9.5	3.4	4.9	8.4	8.4	3.5	3.5	6.8	9.0	5.0	7.7	5.9	12.7	8.9	4.1	12.6	12.8	9.5	8.4	5.9	10.2	12.2	9.5	16.1	8.4	4.3	7.4	9.6	4.9	14.0	14.9	22.9	20.1	14.1	14.5	15.0	14.0	15.2	14.0	14.2	19.3	31.9	16.0	27.8	45.7	57.8	31.9	44.5	18.4	40.9	70.8	23.5	21.6	22.9	11.5	23.7	14.7	39.6	20.1	52.1	12.2	5.9	9.4	297.5	22.8	30.1	25.4	6.0	38.7	79.6	4.7	18.4	29.2	20.4	19.8	27.9	36.1	18.9	13.0	10.1	28.6	40.5	10.7	14.2	13.9	24.7	518.3	30.7	21.4	16.0	43.1	18.3	29.6	27.8	61.9	60.6	7.2	16.5	29.3	36.5	23.9	25.0	10.1	26.8	81.3	19.7	17.1	30.9	30.3	18.4	19.7	24.6	15.9	42.0	24.1	10.2	26.9
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319908	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	11.1	1.1	16.6	4.2	38.9	1.1	10.9	11.4	28.1	7.5	6.9	11.5	3.0	4.9	7.4	2.9	9.2	5.8	5.3	15.5	12.2	13.3	14.1	4.9	1.3	21.5	25.7	2.9	17.3	1.7	2.9	2.3	23.3	6.9	12.8	9.8	9.2	5.0	3.8	3.2	6.7	2.8	7.3	3.0	7.2	32.8	42.9	1.0	5.9	5.5	1.6	4.7	6.9	67.0	6.3	8.4	1.3	0.2	4.9	2.2	0.5	0.1	0.0	0.4	0.3	0.7	10.5	0.0	0.9	0.0	13.8	5.5	0.6	3.7	0.0	4.3	1.5	0.2	0.3	5.0	0.5	0.0	0.1	2.4	3.6	1.6	5.8	1.9	4.2	2.3	0.0	1.2	3.0	5.6	0.3	0.5	0.5	7.7	2.0	4.8	4.4	2.8	3.9	10.3	1.7	1.6	2.1	16.0	8.2	1.2	13.5	0.4	1.2	0.1	3.6	0.0	0.3	1.6	0.1	5.8	2.9	2.5	15.5	7.3	6.9	0.6	0.0	2.4	0.0	3.0	0.0	0.0	1.4	1.5	0.0	0.1	5.7	0.0	1.5	2.4	0.0	2.1	16.6	38.9	11.4	28.1	15.5	12.2	21.5	25.7	23.3	7.3	42.9	67.0	12.9	16.0	3.4	21.9	18.0	6.2	39.2	11.7	37.0	61.8	39.0	22.2	58.6	42.9	17.3	58.8	14.6	2.5	3.5	93.1	27.4	53.1	161.8	76.7	16.9	11.4	23.4	0.4	9.3	47.5	1.8	12.2	33.6	37.3	4.5	0.4	2.2	81.9	7.3	38.7	11.5	72.5	8.2	11.9	7.2	313.5	22.4	15.6	3.6	1.0	17.1	3.5	0.0	5.0	418.6	40.1	44.1	10.9	21.9	62.3	15.9	21.0	115.6	28.2	105.2	4.8	100.6	4.2	15.3	7.1	2.6	2.9	2.8	0.2	50.2	51.5
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3 lysosomal/endosomal transmembrane protein, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 178.0;SK-BR-3: 186.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063280	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	18.1	30.5	13.1	19.6	14.2	13.4	21.4	14.2	16.0	16.9	16.5	38.3	21.9	15.9	9.9	22.2	16.0	15.2	11.7	13.2	13.6	21.2	31.9	23.6	13.8	14.6	13.6	16.8	27.7	30.0	8.2	36.9	15.1	17.3	29.2	3.1	34.5	21.0	14.5	24.1	25.7	13.3	13.5	20.4	26.1	7.9	15.6	14.0	24.7	13.8	12.1	19.3	15.6	17.1	23.1	39.2	15.4	38.4	41.1	19.9	178.0	14.8	40.7	28.3	34.9	19.7	52.9	16.0	45.8	24.8	52.0	23.5	25.8	24.7	12.9	38.0	38.5	15.6	24.1	60.6	60.5	23.3	64.7	28.0	66.8	21.9	14.7	26.3	32.9	24.9	30.9	55.0	28.8	61.9	20.7	45.1	21.8	35.3	26.0	37.2	13.4	54.5	30.2	53.0	20.8	19.6	5.7	186.5	18.3	14.0	62.2	32.4	20.2	19.2	10.1	24.9	22.5	58.3	64.2	15.9	28.4	47.3	11.9	63.4	59.8	98.4	57.6	47.6	42.7	24.3	43.6	53.6	63.8	29.3	38.3	40.6	23.8	41.2	38.7	68.1	53.5	46.6	13.1	14.2	14.2	16.0	13.2	13.6	14.6	13.6	15.1	13.5	15.6	17.1	1.2	22.4	15.9	11.1	10.8	0.1	17.2	0.0	23.9	10.9	1.7	0.6	0.0	38.6	6.2	1.8	12.5	315.9	25.8	46.4	0.0	2.2	1.1	1.8	1.3	11.2	17.0	17.5	7.5	0.5	106.9	9.3	20.9	2.6	2.5	7.6	21.0	39.0	70.1	13.5	8.1	39.3	0.0	36.7	0.4	2.5	19.0	17.7	0.0	2.8	17.5	25.0	40.2	7.1	11.4	1.5	43.7	12.4	13.1	10.6	53.1	0.8	1.5	12.1	13.1	9.9	3.5	3.2	8.4	17.1	0.1	451.4	15.9	3.6	50.2	13.3
CLN5		ENSG00000102805	"CLN5 intracellular trafficking protein"	O75503	13	76990660-77019143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041788	Approved				"Intracellular and membrane"	NA	NA		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA041788: AB_10962726"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.52e-9)"	"unprognostic (2.35e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.15e-2)"	20.9	19.8	13.9	14.4	12.8	13.3	21.8	27.0	18.9	25.1	17.0	16.1	11.3	19.1	41.9	10.9	24.5	25.2	14.2	13.5	10.5	50.5	35.5	20.5	19.8	12.5	11.6	26.6	16.8	45.6	14.4	23.3	12.2	22.3	16.5	24.1	21.4	22.7	8.4	14.6	13.6	15.9	7.0	16.7	18.8	16.1	13.0	18.3	72.9	10.7	18.5	18.8	12.0	19.0	25.0	11.7	16.4	13.7	74.4	48.5	21.1	23.7	43.3	18.4	31.9	12.3	23.2	9.7	17.3	33.5	21.0	25.0	11.5	25.5	20.0	18.4	21.5	13.9	13.1	12.2	33.8	19.5	20.4	43.6	28.4	8.9	18.7	37.1	33.0	13.5	9.4	17.2	43.2	7.7	11.6	12.5	10.7	48.6	10.4	9.5	14.4	9.0	42.6	13.8	7.3	11.3	14.1	17.4	26.3	21.3	19.0	26.0	31.2	13.2	10.4	15.4	14.2	21.7	30.0	12.2	35.4	13.5	29.2	58.4	15.6	39.4	3.5	22.4	3.1	13.2	17.0	6.0	10.8	14.5	21.5	13.3	11.4	1.0	27.7	11.0	25.6	14.1	13.9	12.8	27.0	18.9	13.5	10.5	12.5	11.6	12.2	7.0	13.0	19.0	30.5	16.0	32.4	16.6	29.2	11.5	32.5	75.1	17.1	19.8	22.3	20.2	8.7	25.8	59.2	68.0	10.4	53.2	15.2	24.0	9.8	39.3	1.6	26.6	25.0	24.1	13.8	7.8	9.7	38.4	128.5	36.9	13.3	24.8	22.2	23.5	25.7	33.0	48.1	6.7	12.6	13.6	97.6	22.4	16.7	4.5	49.7	22.7	24.9	11.2	31.5	50.4	5.2	15.6	21.5	25.0	14.4	47.4	18.8	23.1	23.9	44.1	48.2	25.4	19.7	24.4	27.2	25.8	34.7	14.6	11.5	46.4	15.2	34.0	11.4	21.8
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6 transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.8;Hofbauer cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	11.6	17.6	12.7	14.8	13.0	29.9	11.5	13.3	14.9	11.0	13.2	17.5	14.6	9.8	6.8	16.9	9.8	9.6	9.3	12.1	12.6	20.0	22.7	13.2	16.2	13.3	13.1	6.8	19.1	10.4	10.1	11.6	13.8	12.4	14.9	11.8	14.8	9.2	17.0	14.7	14.6	10.4	12.8	20.7	13.3	10.9	13.0	11.6	12.9	7.3	16.7	10.7	9.6	14.5	38.2	93.1	23.9	33.9	14.5	11.8	57.1	35.3	17.0	42.8	34.9	72.1	60.5	57.6	17.2	21.4	31.7	69.5	69.8	34.5	17.0	38.5	82.3	84.3	66.1	54.3	29.7	95.6	58.1	20.8	11.4	34.7	23.7	9.0	29.1	33.1	56.9	116.0	33.6	103.8	44.0	69.4	57.1	67.3	38.3	42.1	71.8	80.6	36.2	97.0	48.2	20.0	39.5	61.7	34.3	18.0	33.1	95.5	19.3	48.1	55.7	35.8	127.2	81.3	97.3	47.4	30.0	115.4	47.6	0.0	8.8	0.6	3.0	13.0	4.0	2.9	2.2	4.3	5.2	2.3	2.8	1.3	10.5	2.0	16.1	4.4	2.3	3.5	12.7	13.0	13.3	14.9	12.1	12.6	13.3	13.1	13.8	12.8	13.0	14.5	1.4	9.6	6.9	7.2	13.4	20.1	22.0	13.9	14.8	181.8	2.0	1.9	27.4	10.0	9.6	5.5	16.7	42.8	7.1	22.7	0.0	3.3	0.4	1.0	4.8	9.7	15.1	32.8	8.9	1.8	58.4	9.1	8.2	1.4	8.9	5.6	11.0	21.9	88.4	21.9	8.1	20.5	16.2	24.2	14.0	1.4	9.0	11.3	19.6	8.4	12.9	16.9	11.3	5.0	10.2	3.6	26.0	8.2	33.4	23.7	15.6	2.1	3.3	32.7	6.6	7.5	5.6	1.0	19.5	21.1	14.1	21.8	9.5	5.3	35.6	16.3
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637794	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	53.1	88.7	86.1	63.1	91.8	72.3	79.9	89.3	92.7	62.2	82.0	72.7	49.7	63.5	99.6	85.3	74.8	53.2	76.4	79.9	94.1	59.6	105.6	45.7	99.5	88.0	86.6	103.3	90.0	60.2	54.0	65.6	89.8	61.2	77.5	97.0	58.2	57.5	98.4	54.0	53.6	56.8	90.5	61.9	65.7	45.7	87.9	102.8	79.0	100.7	105.4	74.6	61.0	94.8	138.4	134.7	216.6	160.7	157.1	224.8	86.8	119.1	181.3	189.0	168.9	326.5	190.0	308.6	194.5	144.6	148.1	162.8	263.0	245.6	227.2	178.6	160.1	301.9	161.7	188.8	132.5	451.8	134.1	182.9	278.9	165.9	311.7	185.5	217.4	187.1	404.8	91.9	186.6	205.0	299.2	364.5	205.7	458.8	243.9	161.5	419.8	332.7	136.7	191.9	219.0	250.1	158.2	177.7	112.1	155.2	241.8	195.8	144.4	138.7	171.2	274.4	116.8	184.3	276.6	330.1	55.0	166.9	114.4	48.1	100.6	39.1	61.1	107.1	68.9	96.5	76.1	66.3	138.7	99.5	91.1	77.8	7.1	101.2	93.6	85.3	72.8	105.7	86.1	91.8	89.3	92.7	79.9	94.1	88.0	86.6	89.8	90.5	87.9	94.8	47.9	16.0	20.3	14.7	91.6	82.7	107.0	248.2	116.7	67.2	75.4	78.6	71.6	71.4	102.6	58.8	50.1	132.9	70.0	27.4	84.1	76.4	17.0	45.1	57.4	53.1	31.8	123.6	21.7	87.5	145.9	72.5	43.8	34.5	78.0	117.0	57.5	62.2	91.1	58.9	24.3	65.3	87.5	108.7	99.3	13.6	87.7	74.9	76.5	10.3	153.8	221.9	57.7	17.6	24.9	65.4	54.3	68.4	64.8	108.2	79.3	97.6	71.6	60.3	52.6	61.8	54.5	116.0	109.4	128.0	86.1	80.6	69.2	126.7	112.5	103.9
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55546909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	5.5	6.1	3.7	4.2	4.2	1.3	5.9	8.9	5.4	8.0	5.5	5.1	4.9	6.9	5.7	9.2	5.3	4.3	7.5	4.7	5.3	6.5	5.5	4.6	2.9	2.8	3.7	6.2	5.1	10.3	5.5	5.5	3.3	6.2	5.7	11.6	4.6	6.1	9.8	6.8	5.6	7.1	3.8	4.5	6.9	14.1	3.8	3.0	10.1	9.2	3.7	5.6	6.8	5.0	20.0	9.1	7.5	11.6	11.8	11.5	3.6	18.7	16.4	12.9	12.7	5.1	14.8	5.1	9.9	22.8	10.3	15.9	9.5	15.4	23.2	6.9	3.1	4.4	9.4	6.7	10.3	7.0	4.7	6.7	15.8	18.8	18.7	10.4	13.1	4.6	10.1	10.1	21.3	10.6	4.0	4.1	5.0	16.3	9.4	2.5	8.7	3.3	11.0	10.9	7.6	6.2	13.5	16.7	8.9	6.2	5.7	4.2	17.1	18.4	19.5	6.0	26.6	9.1	7.5	3.1	15.6	5.8	14.6	0.0	0.7	0.2	0.7	0.7	1.3	0.4	0.9	0.8	1.1	0.7	0.4	0.6	0.2	0.9	0.7	0.5	0.9	0.4	3.7	4.2	8.9	5.4	4.7	5.3	2.8	3.7	3.3	3.8	3.8	5.0	32.2	41.7	27.7	49.3	15.2	31.1	21.8	28.5	27.9	63.4	21.5	14.9	55.2	14.3	27.4	14.7	43.8	11.3	11.9	21.5	1.9	13.6	34.5	34.2	39.9	32.1	39.7	3.8	95.9	16.5	6.8	28.0	25.0	32.0	3.8	16.6	28.9	27.7	11.6	33.7	114.6	18.5	18.3	17.0	26.1	16.9	23.9	16.9	10.6	70.3	14.0	26.7	19.6	82.0	93.1	28.3	13.2	36.1	18.5	34.0	29.6	19.7	25.2	41.4	13.1	36.5	28.2	64.9	72.5	55.1	37.5	5.2	14.0	21.7	15.6	51.6
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"Caseinolytic mitochondrial matrix peptidase chaperone subunit B"	Q9H078	11	72285495-72434680	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 144.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 5136.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 25.5;granulocytes: 7.7;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	6.0	7.2	3.2	6.6	4.2	11.7	3.5	6.3	7.7	2.9	0.4	3.7	3.9	3.4	2.0	4.0	3.2	3.0	6.2	3.9	6.2	9.0	11.2	3.5	3.7	7.6	5.0	2.9	5.9	9.3	2.2	6.1	8.6	2.3	3.4	6.7	5.9	3.8	8.8	2.4	2.6	6.4	5.0	3.9	3.8	144.6	6.6	4.0	5.7	7.2	3.3	3.8	2.6	5.2	12.7	39.4	9.5	20.5	12.2	9.8	28.8	12.9	8.9	21.8	15.5	55.5	19.1	28.6	30.5	13.0	35.0	26.5	30.6	31.0	23.0	26.3	24.0	23.5	38.3	28.4	10.1	28.0	45.3	14.6	7.7	37.7	33.2	6.4	23.3	26.9	39.7	20.3	12.7	33.0	26.7	23.3	10.5	40.4	35.4	22.2	16.6	14.3	9.9	22.6	27.7	16.9	16.8	39.9	30.8	11.5	22.4	22.0	16.9	29.0	18.0	27.4	25.9	9.9	16.6	18.4	14.6	22.2	19.5	7.7	15.7	0.8	3.0	13.5	3.1	1.9	1.6	2.8	25.5	1.8	2.1	1.8	1.1	2.6	7.8	4.3	1.1	7.8	3.2	4.2	6.3	7.7	3.9	6.2	7.6	5.0	8.6	5.0	6.6	5.2	9.0	16.0	9.7	4.6	6.1	0.4	5.3	5.9	2.2	4.1	7.7	5.0	3.7	2.8	8.6	9.2	4.2	13.0	3.2	3.9	5.9	13.7	1135.5	7.2	13.4	8.0	0.0	11.4	9.8	16.3	17.1	5.5	7.1	9.7	3.8	9.2	1.4	10.7	21.6	3.3	9.8	1.8	10.2	5.9	4.2	5136.8	25.1	13.2	1.8	14.0	8.8	1.9	2.1	11.1	10.4	10.4	1.4	18.4	14.2	6.3	4.3	24.3	5.3	5.5	13.1	3.5	8.1	40.9	22.9	6.0	1.1	33.1	3.6	16.7	2.6	6.6
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361531-6370242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA		8500	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	48.6	65.8	52.0	41.5	51.5	42.9	45.1	52.2	63.8	39.1	58.0	46.6	47.4	41.1	17.8	56.1	40.1	20.8	78.0	50.9	52.7	60.5	90.7	39.7	47.7	52.8	52.4	38.5	53.6	36.6	44.5	25.4	49.5	41.0	22.9	15.6	48.3	31.2	146.8	47.5	43.6	25.1	51.8	45.6	55.6	45.2	54.5	45.2	36.1	59.3	35.6	44.6	37.9	53.9	146.7	98.2	61.2	113.9	38.7	54.8	62.4	76.9	59.5	112.2	102.5	87.2	48.9	124.1	122.8	61.3	61.1	83.1	63.5	109.1	38.5	133.8	189.3	95.8	82.2	122.9	106.6	90.7	129.8	73.4	74.4	78.9	82.9	69.7	113.9	188.5	97.5	174.5	72.3	192.8	153.1	104.5	93.2	100.6	207.8	108.6	73.2	206.2	81.2	79.4	99.3	95.9	48.9	123.8	133.0	36.7	67.3	130.6	76.9	70.5	69.7	180.7	156.0	235.4	225.3	137.2	103.5	132.9	117.3	29.4	82.6	47.8	112.0	79.6	133.5	119.5	159.4	139.6	102.4	131.5	138.4	137.4	62.1	126.5	55.5	155.5	207.2	162.6	52.0	51.5	52.2	63.8	50.9	52.7	52.8	52.4	49.5	51.8	54.5	53.9	39.6	22.4	35.2	8.1	45.9	44.9	59.5	90.8	38.1	31.0	47.6	57.9	45.8	55.8	46.2	44.1	12.5	72.2	43.7	56.0	144.8	88.8	105.5	27.6	43.1	51.6	35.3	54.9	5.4	96.6	113.6	42.4	36.2	35.0	26.0	63.1	61.8	89.6	81.3	21.9	7.5	50.9	54.9	38.9	35.0	229.8	42.6	38.7	55.2	4.7	70.6	46.6	46.4	4.5	9.5	101.9	67.7	43.2	82.4	89.5	110.9	189.0	44.5	24.6	13.1	30.0	79.9	67.7	48.1	56.5	37.1	57.7	65.3	95.1	65.4	65.4
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1696	"pancreas: 262086.0"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 23175.0"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1600000	"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			30.4	6.1	0.9	5.8	1.8	9.0	17.8	0.1	0.7	13.4	0.2	6.8	40.2	6.0	5.6	9.9	3.8	0.0	46.3	1.2	0.1	5.5	17.7	4.1	10.5	0.2	0.2	154.4	262086.0	0.0	6.3	11.9	0.3	7.9	0.0	0.0	41.7	0.0	5.8	8.1	24.0	0.0	0.1	7.9	27.7	4.0	0.6	0.0	3.8	0.0	0.0	3.3	5.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.9	1.8	0.1	0.7	1.2	0.1	0.2	0.2	0.3	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.0	0.0	1.1	11.9	0.0	0.0	23175.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	130.8	0.0	0.0	0.0	0.0	1331.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 607.6;pancreas: 178.4"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Group enriched"	"Detected in many"	4	"amygdala: 1.1;basal ganglia: 2.5;cerebral cortex: 2.3;hippocampal formation: 2.9;white matter: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	1.1	0.0	2.5	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	607.6	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.1	178.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.5	0.3	2.3	2.9	0.3	0.3	0.4	0.3	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"epididymis: 532.1"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 3.4;Breast myoepithelial cells: 2.2;Enteroendocrine cells: 1.8;Exocrine glandular cells: 4.0;Pancreatic endocrine cells: 2.1;Spermatogonia: 2.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"T-47d: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051655	Approved				"Secreted in male reproductive system"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	532.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.7	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.1	6.3	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.4	0.2	0.8	0.6	0.4	0.2	0.4	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.2	4.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
CLPTM1		ENSG00000104853	"CLPTM1 regulator of GABA type A receptor forward trafficking"	O96005	19	44954585-44993341	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068767	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA068767: "	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.59e-1)"	69.1	152.8	54.7	34.3	56.9	27.3	62.7	40.1	103.3	56.7	36.4	63.6	50.6	58.5	36.0	70.2	51.6	27.4	106.5	54.4	50.1	92.9	130.7	54.6	33.4	56.3	58.4	63.5	86.6	78.0	60.2	38.8	50.9	63.4	32.9	35.1	66.6	43.1	109.0	87.4	66.0	37.0	34.8	64.8	81.0	76.2	60.0	25.4	63.2	51.3	43.4	55.0	57.6	55.5	88.5	213.8	48.6	96.9	158.3	63.4	52.5	90.8	102.0	107.5	114.9	93.3	95.0	96.1	93.1	124.2	79.0	112.0	87.2	84.4	72.3	72.4	126.8	74.5	74.7	79.3	111.6	59.9	83.2	99.8	87.8	102.9	66.1	76.3	75.9	54.7	78.7	129.3	96.2	86.9	58.1	35.0	43.9	139.3	73.6	60.4	52.8	93.1	100.1	132.7	57.4	59.5	115.6	169.1	51.4	43.0	92.7	47.1	72.4	119.9	73.7	60.4	116.0	82.4	180.2	65.5	98.9	58.3	112.7	17.7	28.4	43.5	25.8	38.4	21.4	27.1	27.9	37.3	24.9	27.4	21.7	18.7	24.6	21.4	49.5	38.8	26.3	22.9	54.7	56.9	40.1	103.3	54.4	50.1	56.3	58.4	50.9	34.8	60.0	55.5	33.9	6.4	7.8	25.5	31.9	36.7	36.1	68.4	25.0	40.3	36.6	26.8	12.3	41.5	42.1	36.8	39.6	94.0	27.7	82.7	13.7	77.3	53.0	23.5	27.5	32.7	40.7	21.5	20.7	74.1	83.7	35.7	30.1	36.0	10.8	31.7	31.4	46.6	75.2	43.7	22.9	47.1	65.1	29.3	29.9	51.1	30.1	31.2	33.8	9.4	87.8	57.2	23.7	24.6	19.1	68.4	64.7	30.1	58.3	40.3	106.0	62.7	17.7	36.3	26.3	30.3	32.5	33.5	29.6	31.5	44.0	120.0	26.0	67.3	49.4	35.6
CLPTM1L	"CRR9, FLJ14400"	ENSG00000049656	"CLPTM1 like"	Q96KA5	5	1317752-1345099	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 474.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014791	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA014791: AB_1847250"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.47e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.17e-2)"	37.7	37.2	23.1	28.9	23.5	28.9	35.6	23.1	26.6	28.5	34.0	41.5	45.4	32.1	15.2	36.0	29.2	18.0	33.4	24.3	24.9	58.4	133.9	49.7	37.4	24.8	31.5	24.8	74.1	22.3	36.2	20.1	23.7	33.4	20.1	5.3	65.0	21.5	23.8	36.6	43.4	17.2	24.8	59.3	67.7	43.1	26.4	41.4	48.7	10.0	29.6	35.7	27.9	24.5	71.1	117.6	39.5	106.8	63.0	26.9	103.9	71.0	46.9	62.9	61.8	129.3	109.8	67.2	212.7	67.2	138.3	60.8	53.7	59.4	28.6	275.4	147.8	35.7	261.5	86.2	70.5	93.6	87.0	43.4	66.6	57.6	53.9	46.1	51.6	149.7	81.7	222.9	48.0	116.5	104.2	121.7	72.9	77.2	126.2	86.6	64.1	207.5	49.0	66.8	41.4	82.0	123.5	106.0	56.6	32.8	177.7	138.7	38.5	74.2	211.0	51.9	103.4	399.4	474.2	109.0	55.4	139.9	86.7	5.1	4.9	10.1	5.6	4.8	6.6	7.6	5.9	5.6	4.6	10.3	5.6	6.6	3.9	10.1	8.1	9.3	7.7	4.0	23.1	23.5	23.1	26.6	24.3	24.9	24.8	31.5	23.7	24.8	26.4	24.5	33.4	57.7	64.7	7.2	50.2	22.3	23.3	24.3	8.0	10.1	40.4	36.4	12.7	51.5	30.4	29.5	14.6	11.2	35.1	49.0	5.9	17.9	2.8	32.1	27.5	25.4	44.5	17.0	13.7	32.3	26.6	23.2	27.5	35.0	24.7	40.4	26.0	113.8	23.7	21.9	10.7	52.2	14.2	39.5	16.0	6.2	17.4	27.9	16.0	7.5	22.4	28.7	27.8	12.1	12.7	45.6	29.0	19.2	95.6	48.3	46.1	66.2	31.0	11.5	13.1	19.4	21.3	28.9	40.3	14.4	23.4	10.9	24.4	60.3	39.8	33.3
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit X"	O76031	15	65148219-65185342	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	7.9	10.8	9.2	6.1	9.7	8.0	9.3	9.5	11.0	7.6	7.4	9.2	8.8	7.8	8.6	13.3	7.9	6.3	14.1	7.8	8.3	12.2	32.9	6.5	9.1	9.8	8.9	9.4	9.4	11.9	4.6	9.8	8.5	8.0	8.0	10.1	7.6	6.0	26.8	14.7	7.4	7.1	8.8	8.4	9.2	9.1	9.4	10.6	9.8	24.0	9.9	7.9	8.9	10.1	8.1	13.7	11.7	14.8	12.2	15.5	12.5	9.2	10.2	9.8	10.3	13.7	11.1	25.0	7.5	12.3	7.3	16.9	43.2	12.1	10.5	9.9	7.9	18.9	12.8	17.4	17.3	24.4	10.5	18.6	16.2	9.0	17.1	11.3	12.6	13.3	17.6	8.6	11.7	10.3	11.6	21.4	13.1	16.0	6.1	22.4	13.9	26.1	18.6	18.5	10.1	8.1	12.4	19.3	13.8	15.3	8.9	20.3	11.2	9.8	8.7	8.0	8.7	9.2	15.0	13.0	9.6	30.4	7.8	2.2	4.1	6.5	4.3	3.5	3.9	4.4	3.7	3.2	3.9	3.9	5.0	4.0	6.4	4.7	3.3	5.9	3.5	2.7	9.2	9.7	9.5	11.0	7.8	8.3	9.8	8.9	8.5	8.8	9.4	10.1	16.4	35.3	35.5	15.3	23.6	19.2	18.8	20.9	18.8	32.3	17.0	15.6	69.9	27.1	29.5	33.1	14.6	41.0	28.5	16.7	21.5	36.8	104.5	24.4	28.7	21.0	10.3	56.8	15.6	31.6	29.2	25.5	33.6	27.5	16.4	37.8	21.0	90.1	22.6	32.0	15.2	20.3	28.5	28.3	16.6	242.3	28.9	20.3	17.8	16.9	34.1	25.9	20.6	12.5	23.9	29.0	18.2	29.7	30.8	24.9	23.1	33.8	27.7	27.2	26.3	23.1	30.1	45.0	30.6	29.1	30.1	89.2	24.4	59.0	24.3	25.5
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042407	Uncertain					NA	NA									"HPA042407: AB_10806237"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892941	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 89.0;kidney: 43.9;liver: 79.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.3;renal cancer: 30.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"OE19: 96.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA014482	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.6	0.1	0.4	5.6	0.4	0.0	0.3	0.3	0.5	0.0	0.3	71.1	73.4	0.1	0.0	0.0	0.0	15.2	0.0	0.4	0.3	43.9	79.9	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.2	0.0	0.4	0.0	70.3	0.0	0.0	0.2	0.0	0.0	89.0	1.7	0.3	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	96.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	102.0	15.6	0.4	0.0	0.2	0.0	0.1	41.5	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	43.0	0.0	0.0	0.1	75.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	95.9	0.0	0.0	0.0	155.4	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.6	0.0
CLSTN1	"CDHR12, CSTN1, KIAA0911"	ENSG00000171603	"Calsyntenin 1"	O94985	1	9728926-9823984	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 437.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012412, HPA077705"	Enhanced					NA	NA		86000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA012412: AB_1846981, HPA077705: "	"unprognostic (4.63e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.10e-7)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.72e-2)"	28.1	27.4	49.7	23.1	65.8	10.8	31.7	29.5	137.5	61.2	80.6	59.5	29.2	85.4	21.4	51.4	69.8	48.1	35.9	79.6	15.5	41.3	6.1	29.6	33.5	24.7	18.4	60.2	65.7	36.2	48.4	35.7	32.8	61.8	38.2	110.8	79.0	45.7	23.1	83.5	41.1	49.4	7.0	28.3	31.0	15.0	23.5	35.0	40.0	28.9	27.1	38.0	59.9	45.9	120.9	55.4	52.5	64.8	71.1	50.1	35.0	80.5	71.4	82.0	70.2	32.1	235.0	90.5	203.1	95.2	52.6	157.7	41.2	245.6	32.1	114.2	74.6	27.3	53.0	39.6	116.1	46.3	41.4	58.0	156.5	105.9	50.0	78.6	113.9	52.7	13.1	52.6	35.8	47.2	53.2	26.6	37.9	53.1	59.7	80.6	21.4	42.9	73.1	20.9	91.4	53.7	94.8	160.1	79.1	22.1	34.7	73.9	155.0	89.3	80.5	56.6	109.9	75.6	75.4	124.3	72.2	79.6	95.7	6.2	0.6	2.3	3.0	0.8	1.5	0.8	1.9	2.3	1.4	1.0	1.3	1.2	0.2	0.4	0.9	0.8	1.6	1.5	49.7	65.8	29.5	137.5	79.6	15.5	24.7	18.4	32.8	7.0	23.5	45.9	40.2	28.9	15.7	63.6	23.7	43.8	61.0	73.7	84.2	205.1	53.3	47.0	14.7	55.8	44.6	51.5	437.9	34.1	35.0	221.1	1.9	29.2	4.5	44.6	47.0	36.0	30.7	17.9	150.9	38.8	14.3	40.6	29.6	52.2	11.4	54.0	35.3	2.2	28.8	180.0	138.1	96.5	14.2	24.2	13.3	5.6	46.3	21.3	32.0	46.9	21.0	160.9	28.8	90.0	56.0	59.7	66.9	50.4	31.2	42.4	54.9	27.9	68.3	165.6	85.5	39.5	31.4	24.6	37.5	44.5	26.1	19.2	33.8	47.2	59.6	42.7
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.2;brain: 26.7;ovary: 64.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000		"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.2	4.8	17.3	0.3	15.3	0.0	8.8	0.0	26.7	4.2	0.0	1.4	0.5	5.1	0.7	1.0	4.7	2.1	6.1	23.4	0.0	4.3	0.8	1.1	2.7	13.3	3.1	64.7	1.6	0.8	0.9	0.9	9.1	5.3	0.8	2.7	1.3	1.1	1.6	2.0	1.3	6.8	0.0	0.1	1.0	0.6	0.0	0.7	2.8	2.2	0.2	1.6	3.2	15.6	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	15.3	0.0	26.7	23.4	0.0	13.3	3.1	9.1	0.0	0.0	15.6	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	172.8	174.2	131.6	80.8	139.1	67.2	165.6	144.7	165.1	170.9	137.5	163.3	107.9	165.6	100.7	207.1	158.9	64.4	98.1	133.3	143.8	236.0	146.8	146.2	84.1	145.1	138.5	205.6	164.3	104.3	139.3	124.4	151.4	145.0	108.6	84.8	162.8	71.2	87.7	163.2	136.0	84.9	141.6	153.0	161.4	108.5	141.7	85.2	160.1	51.5	93.4	150.9	158.4	151.5	326.3	257.2	188.4	146.3	270.0	269.8	302.6	328.5	248.2	258.1	301.5	194.2	143.9	243.8	177.0	220.9	460.7	136.2	238.8	228.2	238.4	166.0	193.1	187.5	255.0	199.8	359.4	201.0	166.5	297.3	250.5	297.4	234.3	241.0	329.6	129.3	166.0	126.4	399.0	113.3	182.2	254.8	301.8	218.8	360.3	173.3	124.8	142.1	353.7	229.1	146.1	245.3	137.3	160.0	289.4	220.2	146.9	244.2	418.4	209.4	234.0	240.3	347.9	83.0	208.9	259.5	256.9	278.0	188.9	142.2	221.7	115.4	97.1	239.6	101.9	121.0	104.9	100.2	222.6	119.6	92.9	82.0	86.7	96.2	191.8	192.2	162.9	209.4	131.6	139.1	144.7	165.1	133.3	143.8	145.1	138.5	151.4	141.6	141.7	151.5	291.5	128.2	143.9	14.4	105.9	197.3	274.3	374.3	169.0	139.4	274.0	315.0	51.5	217.3	247.4	180.3	60.5	958.0	140.1	349.3	463.7	480.5	51.9	241.5	174.3	244.0	183.8	154.8	28.5	335.6	469.1	187.5	142.2	182.7	73.5	198.4	312.7	170.6	903.7	92.5	30.4	350.5	248.2	391.7	172.0	97.6	262.9	249.3	195.7	20.6	343.5	282.8	117.4	16.1	49.0	465.2	426.4	215.5	97.7	320.5	411.5	651.7	304.7	127.3	177.5	170.0	310.4	288.0	216.8	210.9	193.2	1299.5	103.7	281.6	380.0	360.4
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291719	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 187.4;testis: 47.2;tongue: 61.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;neutrophil: 5.2"	"Group enriched"	"Detected in many"	20	"granulocytes: 5.2;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.8;K-562: 31.8"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA		2300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	6.8	16.0	5.4	0.8	6.1	15.6	4.8	6.2	6.5	5.0	5.0	2.4	0.5	3.1	1.6	3.6	3.8	1.2	14.8	5.2	7.8	3.2	6.5	3.0	0.7	7.4	8.6	3.6	2.5	2.1	13.4	1.5	8.5	5.2	1.0	2.0	3.9	0.8	187.4	4.1	1.8	1.7	5.7	3.5	2.8	47.2	9.1	3.9	8.0	61.3	0.5	2.8	3.7	6.9	4.5	4.6	3.0	4.9	10.8	5.9	1.4	3.1	3.3	4.2	6.3	1.7	1.4	1.9	0.4	7.0	3.3	1.5	4.7	8.5	3.5	0.3	4.6	0.2	4.4	5.3	5.5	6.5	64.8	25.0	7.0	7.8	10.9	12.5	2.7	2.4	31.8	1.7	10.0	3.6	0.6	22.4	3.8	18.1	2.8	2.4	24.2	0.1	3.4	1.8	6.9	1.2	6.6	4.1	0.4	3.6	8.9	27.1	0.8	7.6	15.5	4.2	5.2	3.1	8.4	0.8	4.5	17.4	1.6	0.0	2.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.4	5.4	6.1	6.2	6.5	5.2	7.8	7.4	8.6	8.5	5.7	9.1	6.9	1.4	3.2	0.5	9.4	0.1	0.6	0.5	1.0	1.2	2.4	0.7	0.3	11.3	1.5	1.8	0.0	14.6	0.4	0.2	1.2	0.0	0.8	19.3	1.2	1.9	0.9	0.0	0.8	4.5	0.0	0.2	1.4	1.5	1.4	0.0	3.5	1.1	2.4	0.3	0.0	8.9	1.3	6.1	1.0	0.7	17.0	2.5	0.5	0.0	4.7	1.3	1.5	0.0	12.5	12.5	1.2	0.8	4.1	0.1	1.3	0.2	1.3	1.0	2.0	0.0	2.6	4.5	14.5	4.7	1.0	0.9	1.1	0.1	6.2	0.9	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27614700	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 10230.8;liver: 9779.1"	"Group enriched"	"Detected in all"	4	"Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 767.1"	"Lineage enriched"	"Detected in all"	33	"granulocytes: 767.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253, HPA075983"	Enhanced		Supported	Cytosol	"Secreted to blood"	NA	NA	169000000000	29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: "	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.66e-5)"	"unprognostic (5.29e-2)"	1438.7	3809.7	6730.2	897.0	6536.5	53.2	1423.8	6992.3	8050.5	1389.4	6057.7	1407.9	323.9	1152.5	9148.8	768.6	3543.7	2863.5	617.7	6660.5	8149.9	1170.5	9779.1	827.8	2309.4	10230.8	8450.9	756.7	2246.3	1689.2	827.2	131.2	8001.8	986.4	276.1	3274.6	1453.0	5466.4	114.1	281.9	662.7	1439.9	8813.6	295.4	1081.6	2709.4	7385.0	388.1	2406.8	267.7	2343.1	1777.4	741.0	9752.3	13.0	1673.1	73.2	86.4	401.4	546.1	230.7	297.8	584.8	77.3	40.1	323.4	265.5	6.6	1159.9	267.1	926.6	561.2	318.4	48.1	50.3	1268.7	306.4	741.8	3644.3	403.7	348.8	19.2	1891.2	923.4	189.1	334.0	95.5	719.5	1028.1	10.6	10.1	842.2	27.5	288.4	5.7	56.5	603.3	505.3	197.6	6.5	276.1	236.3	763.0	1220.2	66.7	41.7	412.3	3500.4	18.1	349.1	2562.4	10.3	153.2	24.0	2225.3	131.8	101.9	108.1	419.0	16.1	1808.8	122.4	10.3	767.1	18.4	8.9	19.8	6.2	7.4	0.7	23.1	21.3	6.2	1.6	2.8	7.0	79.8	9.3	1.1	11.8	6.5	1073.6	6730.2	6536.5	6992.3	8050.5	6660.5	8149.9	10230.8	8450.9	8001.8	8813.6	7385.0	9752.3	255.3	32.1	91.8	720.5	16.1	81.3	944.6	134.1	118.9	74.3	475.3	480.4	86.1	2586.5	514.0	3525.7	77.2	116.3	15.2	23.6	41.1	488.3	311.3	196.9	31.1	442.0	9.5	92.4	73.4	620.7	22.7	614.8	226.8	185.6	803.0	31.4	1037.7	4230.2	12.6	30.3	81.0	30.9	28.5	180.5	88.9	789.3	114.3	244.6	206.3	69.3	25.1	8522.6	11.3	61.3	54.3	174.8	15.0	57.2	11.6	200.5	9.9	459.2	709.1	221.4	13.1	334.4	157.7	189.8	20.3	58.8	55.3	85.6	58.7	288.9	49.3	353.7
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500976-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Vesicles	"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	9.7	10.7	11.1	5.9	12.6	3.9	14.7	14.2	14.5	21.1	17.8	11.0	4.2	24.2	16.0	11.1	31.8	10.6	11.4	11.2	11.6	18.6	7.7	12.1	7.4	10.4	12.7	24.6	12.2	31.4	11.7	10.6	9.1	17.0	9.8	28.9	9.1	19.9	9.9	5.6	5.4	20.2	9.8	6.6	9.0	40.0	12.0	12.4	22.0	11.6	6.0	10.8	7.8	10.4	15.7	18.3	20.8	28.9	31.4	32.0	11.0	19.9	26.7	31.4	23.7	5.1	31.3	8.2	16.5	33.7	18.8	16.8	14.7	23.6	26.2	6.6	13.1	6.9	10.3	10.5	36.7	12.5	7.2	21.1	25.4	29.1	29.4	33.1	17.2	16.4	21.7	1.0	23.6	19.3	12.0	14.0	21.5	6.6	11.1	25.9	14.3	15.7	45.7	4.9	23.2	19.8	11.6	8.8	14.3	16.0	18.7	28.8	11.5	20.8	13.8	17.1	15.0	12.8	10.9	2.2	8.0	7.3	15.3	6.2	3.6	1.2	6.2	4.2	12.1	7.3	17.8	10.8	6.8	6.1	26.9	18.4	1.3	9.0	2.4	6.6	10.3	5.8	11.1	12.6	14.2	14.5	11.2	11.6	10.4	12.7	9.1	9.8	12.0	10.4	14.5	22.4	20.5	17.0	3.5	5.6	12.3	29.1	14.8	41.0	13.4	13.8	11.7	11.5	30.6	14.7	108.4	20.7	7.5	3.3	43.0	24.3	215.5	119.2	49.7	12.4	17.5	4.6	23.6	8.0	7.7	21.9	6.6	26.4	5.1	28.1	13.6	9.2	10.4	38.7	26.3	7.9	18.3	4.9	5.7	63.4	31.4	5.0	3.6	5.6	18.1	40.7	12.3	11.1	10.3	8.6	5.3	33.1	3.5	9.4	5.3	34.6	181.3	116.8	6.6	24.7	22.7	150.0	58.4	6.4	4.1	9.3	12.1	36.7	9.0	6.5
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 266.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"		NA	NA		5500	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Nuclear bodies"	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	30.8	56.7	13.8	18.1	12.7	14.3	28.5	16.3	18.3	19.8	19.7	45.9	46.6	21.3	1.9	67.7	19.2	15.4	80.8	14.5	11.2	50.6	135.0	19.6	14.6	14.6	13.2	17.0	50.4	15.6	20.3	9.0	15.3	24.7	13.2	7.2	32.1	11.8	127.8	47.5	34.2	8.5	9.3	25.2	35.1	25.2	17.3	6.4	25.2	52.9	11.1	29.6	29.2	11.2	69.5	131.9	8.9	33.3	20.2	14.1	99.9	34.9	13.0	41.9	31.0	266.2	30.0	122.6	41.5	19.4	26.9	127.6	45.3	52.9	14.7	43.6	86.4	68.0	112.2	93.9	17.1	53.7	44.1	22.6	29.7	48.9	24.7	9.4	20.5	43.3	81.8	42.2	11.7	79.8	69.6	58.0	28.2	35.8	67.8	104.7	37.0	70.8	26.0	117.3	43.9	32.6	40.0	129.4	44.4	6.6	72.7	31.3	33.7	33.7	44.9	92.2	80.5	18.2	22.9	49.7	35.4	73.2	41.6	0.0	2.2	0.0	1.7	3.1	1.3	2.2	1.0	0.9	2.4	2.2	2.3	2.1	0.2	0.6	2.0	2.7	1.5	0.9	13.8	12.7	16.3	18.3	14.5	11.2	14.6	13.2	15.3	9.3	17.3	11.2	5.8	6.4	20.9	20.9	6.5	30.5	12.0	11.7	16.5	18.5	23.5	22.7	42.1	41.5	16.7	18.4	22.9	9.7	7.6	47.8	11.7	18.4	1.8	12.7	10.8	8.5	25.8	22.1	9.9	18.3	8.2	6.8	22.4	24.6	1.3	18.1	6.8	122.1	13.1	8.4	11.4	38.8	14.2	10.3	6.3	4.0	5.0	7.9	21.4	4.7	7.4	6.5	2.1	7.5	6.2	19.6	21.2	6.0	11.7	22.9	39.2	35.1	14.1	17.1	6.6	12.3	11.3	8.6	17.5	42.4	35.5	8.2	7.2	43.3	68.3	22.5
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"retina: 297.9"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 407.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.3"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA		11000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.4	1.0	2.7	0.5	6.1	3.9	2.3	2.0	4.0	1.5	7.2	0.9	0.5	1.4	0.5	1.2	1.8	2.0	0.3	3.1	4.2	5.3	0.5	1.4	0.7	3.0	3.4	4.9	1.3	3.6	3.9	0.6	3.1	8.5	0.1	297.9	2.3	1.1	0.2	0.7	1.4	0.1	3.1	0.1	3.1	2.6	4.3	1.7	6.8	0.0	0.0	0.8	0.1	9.5	3.6	5.4	10.1	6.8	0.0	0.0	6.1	3.9	0.3	0.0	0.0	4.2	2.1	4.3	1.0	0.0	3.6	1.5	0.0	0.6	0.0	3.6	9.3	7.3	2.9	34.3	0.0	2.5	1.3	0.3	0.0	0.0	0.0	1.7	0.4	10.5	10.5	12.3	0.0	1.2	4.4	7.8	0.7	4.4	2.4	8.8	4.8	15.5	1.1	1.1	8.8	6.2	4.0	2.5	3.4	8.0	3.3	1.0	0.8	4.0	5.7	2.8	2.0	6.9	13.3	9.7	3.2	4.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	2.7	6.1	2.0	4.0	3.1	4.2	3.0	3.4	3.1	3.1	4.3	9.5	0.1	0.0	2.6	0.3	0.1	0.0	3.8	1.5	2.8	29.6	2.8	5.0	0.2	0.0	1.7	0.0	20.9	0.8	0.0	0.1	1.9	0.4	0.7	2.5	0.3	2.0	0.0	0.0	5.2	0.2	0.1	0.4	0.0	3.2	0.0	3.5	0.0	0.0	0.2	16.8	3.8	0.0	0.0	0.0	0.3	0.8	0.9	0.2	0.0	1.0	0.0	58.1	0.0	0.0	4.9	0.0	0.0	1.2	0.0	5.5	0.0	0.5	2.4	407.5	6.6	0.0	0.3	10.6	8.6	0.2	0.1	0.4	0.1	17.3	0.1	1.6
CLVS1	"C6orf212L, CRALBPL, MGC34646, RLBP1L1"	ENSG00000177182	"Clavesin 1"	Q8IUQ0	8	61057158-61501645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 5.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 113.1;Inhibitory neurons: 158.1;Oligodendrocyte precursor cells: 90.0;Oligodendrocytes: 37.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;SCLC-21H: 3.7;SH-SY5Y: 1.6;U-266/70: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076650	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076650: "	"unprognostic (1.86e-2)"	"unprognostic (3.09e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.96e-7)"	"unprognostic (1.11e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.02e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.25e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.79e-8)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-2)"	1.5	0.4	5.1	0.3	5.6	0.2	0.5	9.9	8.0	0.2	0.0	0.2	0.1	0.0	0.1	1.5	0.5	0.3	0.3	4.9	6.5	0.2	0.6	0.1	0.5	3.8	2.1	0.1	0.1	0.0	2.4	0.1	4.0	0.2	0.1	5.2	1.2	0.0	0.5	1.5	0.2	0.0	2.0	0.4	0.2	2.0	3.8	0.7	1.2	0.0	0.9	0.1	0.3	4.3	0.2	0.4	0.1	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.4	0.8	0.2	0.2	1.2	1.0	0.1	0.4	0.0	3.7	1.6	0.1	0.2	0.0	0.2	0.2	0.5	0.3	0.1	0.2	0.1	0.1	1.6	0.8	0.2	0.9	0.0	0.0	1.1	0.3	0.2	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.5	0.2	0.3	0.8	0.5	0.1	0.3	0.0	0.3	5.1	5.6	9.9	8.0	4.9	6.5	3.8	2.1	4.0	2.0	3.8	4.3	6.1	6.4	0.5	9.8	0.3	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.4	0.0	0.0	113.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	158.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	19.7	0.0	11.2	0.0	90.0	37.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.0	1.8	0.0	1.0	0.2	0.4	0.6	0.3	0.1	0.8	0.0	0.0	0.0	0.2
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122996235-123072925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 137.8;Inhibitory neurons: 171.5;Muller glia cells: 60.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 12.2;SCLC-21H: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.0	0.9	5.8	0.0	5.7	0.0	0.0	41.1	9.2	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.8	8.5	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.9	0.0	5.2	3.0	0.1	8.2	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	41.1	9.2	5.8	8.5	5.3	0.3	5.2	0.0	0.2	1.9	0.4	0.0	0.0	22.2	0.0	0.0	17.9	0.0	0.0	5.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.3	0.0	0.0	137.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	2.8	0.0	60.8	0.0	27.2	4.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	0.0	4.8	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6
CLYBL	CLB	ENSG00000125246	"Citramalyl-CoA lyase"	Q8N0X4	13	99606669-99897134	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.9;Distal tubular cells: 138.9;Hepatocytes: 84.1;Proximal tubular cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 56.1;SCLC-21H: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced					NA	NA		7300	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	7.1	16.2	11.4	5.5	11.8	5.1	10.5	24.4	12.7	7.7	35.3	20.6	25.0	6.5	13.0	11.3	7.9	6.9	22.6	12.6	8.6	66.0	109.7	5.6	10.4	9.1	9.0	5.7	9.8	14.4	6.7	3.7	7.3	6.9	21.9	7.3	12.3	8.9	43.3	9.3	23.5	6.4	5.6	8.6	8.7	9.3	10.7	5.8	12.3	69.5	10.8	7.4	6.9	8.8	0.4	2.3	16.6	7.5	7.6	7.0	3.6	0.8	1.6	1.4	2.6	0.3	12.4	3.0	4.8	1.0	3.2	3.9	1.5	2.8	1.8	15.3	2.4	19.2	4.9	11.8	5.2	10.4	1.3	3.8	8.3	0.2	6.4	1.6	2.2	15.7	2.7	9.8	1.6	4.3	4.7	14.3	10.8	56.1	3.4	6.0	0.7	7.1	16.6	1.1	53.1	8.1	3.4	3.8	3.6	5.9	8.0	13.2	0.3	0.7	1.9	1.4	2.7	22.3	4.7	0.6	11.3	14.9	2.3	1.7	4.5	0.5	9.9	10.0	12.0	14.5	17.4	13.9	9.4	15.7	13.3	15.8	0.6	14.2	4.8	10.3	24.2	7.7	11.4	11.8	24.4	12.7	12.6	8.6	9.1	9.0	7.3	5.6	10.7	8.8	7.4	6.4	5.0	84.9	8.6	5.5	9.1	18.4	8.6	2.3	8.9	11.3	36.1	21.5	10.9	14.7	2.1	14.3	9.2	17.9	138.9	11.6	1.6	6.1	4.1	6.2	1.2	2.5	30.6	8.1	3.2	5.9	5.6	4.4	6.3	7.1	4.6	84.1	7.6	0.0	25.6	11.5	10.2	6.7	4.5	4.8	2.1	5.4	16.0	48.7	4.4	6.5	7.2	21.6	9.5	4.0	13.8	4.1	3.8	4.3	23.1	144.7	4.1	5.0	0.0	7.6	18.1	3.0	10.5	6.9	6.3	7.4	8.3	13.6	19.1	6.7
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046218-22065674	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 532.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	19.7	57.0	46.6	23.2	51.1	47.9	32.9	40.3	57.8	29.2	35.8	77.8	66.2	23.5	69.0	71.6	21.8	24.4	42.6	51.2	57.3	28.9	72.2	18.1	24.2	43.8	57.1	25.3	42.5	79.4	30.0	34.0	57.1	36.7	71.9	24.8	32.6	26.7	44.0	29.3	63.6	27.7	41.8	20.1	29.7	69.9	49.0	19.8	23.8	41.1	26.1	24.2	40.3	44.0	63.4	50.2	59.5	29.3	47.0	57.5	88.8	43.2	46.2	45.0	47.2	114.1	72.0	56.5	41.3	37.3	83.9	50.9	35.8	60.1	60.7	75.0	45.4	169.1	38.8	57.2	43.2	45.4	85.5	38.5	56.4	58.1	86.3	61.5	61.3	58.7	108.8	28.1	80.9	83.8	52.0	105.3	147.5	69.4	69.5	36.2	63.6	53.7	56.0	67.8	23.8	42.0	34.2	59.6	51.9	120.2	82.3	62.0	45.5	51.2	42.4	46.2	81.1	19.4	26.0	74.9	83.6	34.6	54.3	22.7	27.3	32.1	20.4	29.7	26.1	19.0	26.9	27.0	31.5	18.2	24.2	24.6	2.8	36.9	27.4	20.2	33.8	25.5	46.6	51.1	40.3	57.8	51.2	57.3	43.8	57.1	57.1	41.8	49.0	44.0	21.5	12.8	17.5	12.4	19.2	29.2	76.8	117.2	14.8	38.3	31.9	21.2	72.7	41.5	102.3	23.9	4.2	175.2	17.8	158.1	76.3	56.6	12.4	17.2	19.6	36.8	41.6	153.9	38.7	83.6	141.3	41.7	21.9	20.0	22.8	28.2	34.2	63.6	66.2	35.3	29.2	118.2	93.6	29.8	22.0	19.0	25.4	32.5	44.4	8.4	45.3	33.4	26.8	16.6	25.5	79.7	156.2	27.8	16.7	112.3	133.6	87.0	82.5	20.4	19.7	30.4	42.3	112.2	97.1	52.3	44.5	532.6	24.6	63.0	90.8	190.6
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10307902	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 172.4;skeletal muscle: 164.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 185.2;Distal tubular cells: 215.2;Proximal enterocytes: 716.0;Proximal tubular cells: 465.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 48.5;K-562: 51.4;PC-3: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					NA	NA		580000		"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	11.3	31.5	8.9	3.8	8.7	4.0	10.6	7.2	10.2	7.2	8.1	53.6	95.8	8.5	9.9	3.8	13.5	14.2	22.9	8.5	8.5	168.5	172.4	6.8	1.2	8.5	8.9	23.3	16.6	26.6	10.6	2.1	9.0	14.3	34.7	1.3	9.6	7.4	164.4	2.8	85.0	6.4	8.0	2.7	28.5	3.2	10.0	2.9	9.8	42.4	0.5	9.7	6.4	7.7	5.9	7.2	8.2	20.3	32.0	35.7	41.2	9.7	11.1	3.0	4.5	3.0	30.9	0.1	15.4	7.8	14.5	0.1	19.7	12.8	4.1	0.3	13.4	27.4	28.6	24.3	9.8	0.2	0.2	48.5	8.5	6.7	6.1	11.7	9.4	0.0	51.4	0.4	11.6	1.3	0.1	1.1	12.1	0.0	46.0	5.9	0.0	0.6	32.2	3.8	6.3	9.7	23.1	2.2	0.7	9.7	16.7	1.0	2.7	4.6	6.0	7.6	0.1	0.2	0.1	0.1	8.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	8.9	8.7	7.2	10.2	8.5	8.5	8.5	8.9	9.0	8.0	10.0	7.7	4.0	25.6	17.2	2.9	2.2	3.7	17.8	6.3	14.8	2.0	40.1	16.8	86.0	55.8	14.8	23.9	4.2	15.3	0.9	185.2	215.2	10.7	3.2	26.5	25.8	7.1	19.2	56.1	5.0	15.6	10.6	37.1	133.0	19.2	13.3	47.4	14.3	161.2	12.1	0.0	6.9	100.5	2.0	4.1	3.8	3.5	47.8	5.5	1.8	1.9	0.4	17.5	1.0	4.0	0.4	16.1	118.6	41.3	0.5	17.5	716.0	465.4	13.0	3.1	0.0	31.0	12.7	1.0	5.9	5.2	3.8	4.9	4.4	145.0	162.7	15.6
CMC1	"C3orf68, MGC61571"	ENSG00000187118	"C-X9-C motif containing 1"	Q7Z7K0	3	28241584-28325142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 418.8;NK-cells: 694.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 162.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043333	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043333: AB_10797139"	"unprognostic (1.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.90e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.30e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (3.54e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.55e-1)"	"prognostic favorable (5.52e-4)"	15.9	18.7	9.4	4.8	9.4	4.9	11.8	9.6	14.3	10.6	9.7	14.7	7.6	10.1	5.3	11.9	11.4	4.0	34.6	9.1	9.8	24.2	24.8	11.5	4.3	9.4	9.4	10.5	11.8	5.0	16.9	6.5	9.6	11.4	4.0	3.2	9.3	4.5	24.8	9.1	9.9	3.4	9.3	12.3	14.7	4.2	9.6	4.1	9.6	13.7	2.9	12.2	11.4	9.5	15.2	24.7	6.8	7.1	18.5	18.5	17.4	20.0	6.1	8.5	8.5	7.3	21.0	13.5	24.8	3.3	14.2	7.1	8.7	18.7	5.1	30.4	21.9	14.5	22.1	16.2	19.1	9.3	10.9	9.9	13.8	8.6	10.8	19.2	10.7	34.0	14.2	19.3	6.9	13.7	13.6	25.1	7.9	15.2	27.0	12.7	7.9	11.0	10.9	6.7	6.7	12.5	14.7	9.1	44.9	9.4	18.8	27.4	12.9	9.1	11.2	13.8	13.1	8.9	22.0	19.7	24.1	20.5	19.2	24.2	21.9	17.1	40.2	28.9	57.7	18.4	25.4	69.6	29.9	17.1	18.8	41.9	6.7	162.2	32.9	30.4	27.2	29.4	9.4	9.4	9.6	14.3	9.1	9.8	9.4	9.4	9.6	9.3	9.6	9.5	51.5	38.5	33.0	26.4	28.3	21.2	38.0	68.6	23.9	16.2	40.0	53.5	202.8	30.0	42.3	31.3	10.4	68.4	418.8	68.2	221.1	61.3	226.4	67.2	38.5	42.1	28.2	128.6	51.5	58.6	42.4	39.4	24.5	42.5	36.7	25.9	50.3	88.7	64.5	3.3	61.2	71.7	67.1	61.7	26.2	31.1	49.4	36.4	30.2	41.2	53.8	37.4	694.1	53.8	63.3	66.1	71.3	39.1	32.7	42.9	56.2	134.4	56.0	25.4	39.5	31.2	71.6	26.3	49.3	28.6	32.8	31.5	222.5	58.2	67.9	42.2
CMC2	"C16orf61, DC13, MGC45036"	ENSG00000103121	"C-X9-C motif containing 2"	Q9NRP2	16	80966448-81020270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006871, CAB026396"	Approved		Supported	Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB026396: , HPA006871: AB_1845581"	"unprognostic (2.43e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.57e-3)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-1)"	22.1	24.6	47.6	14.0	50.0	45.2	17.0	49.0	60.2	17.2	41.2	22.7	19.1	12.4	16.6	20.4	11.6	17.0	68.4	48.4	50.7	43.5	44.0	24.3	22.4	47.6	47.6	13.7	27.3	30.4	26.1	16.3	47.5	34.9	16.9	16.1	14.8	12.4	54.0	15.3	20.3	15.0	48.3	21.7	27.2	47.0	51.2	30.1	16.2	33.9	17.1	20.7	17.0	54.2	74.8	103.1	76.1	43.7	25.1	25.0	44.9	73.4	33.1	64.0	32.9	71.7	49.9	33.5	53.3	35.8	62.9	52.6	52.5	42.8	84.9	50.9	63.3	51.9	68.4	78.6	40.6	43.5	85.4	21.8	23.8	77.7	43.5	29.2	57.1	83.1	124.2	43.5	63.3	140.1	68.1	138.4	45.2	59.7	62.0	84.2	41.2	43.8	50.4	35.9	64.1	37.1	110.6	39.8	87.3	39.4	78.7	39.2	32.8	57.9	82.0	56.6	75.3	45.4	107.6	193.8	44.6	55.3	69.1	33.2	28.0	37.3	28.8	29.6	27.5	39.1	36.5	30.1	31.6	34.9	25.3	29.2	12.0	44.6	34.2	45.3	64.4	18.0	47.6	50.0	49.0	60.2	48.4	50.7	47.6	47.6	47.5	48.3	51.2	54.2	41.2	35.3	38.8	48.0	54.9	97.6	75.5	53.9	48.9	31.9	48.0	50.7	204.7	42.9	36.5	47.8	54.2	44.8	78.9	29.5	158.5	34.4	95.4	44.2	33.7	36.0	38.3	55.5	88.6	38.0	62.8	45.0	42.8	45.2	95.5	37.3	25.4	86.0	51.4	30.3	62.2	42.9	59.0	70.5	84.1	168.3	24.5	59.7	65.8	14.0	33.8	29.3	51.5	48.7	74.0	39.0	31.9	29.3	83.5	69.1	48.5	166.1	31.4	16.7	59.2	33.3	47.0	263.5	121.5	65.0	102.1	38.0	84.7	55.3	44.8	74.4
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071136	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.5"	"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				14.5	11.5	15.1	9.3	17.0	8.2	12.2	17.5	17.7	13.3	14.8	17.0	12.5	12.4	16.7	11.2	11.8	10.6	52.6	14.3	16.6	15.1	23.3	8.4	15.0	18.0	16.5	15.2	32.7	12.7	11.8	8.2	17.0	12.8	7.0	7.3	18.9	12.6	31.8	10.8	10.1	7.9	16.6	9.7	11.8	8.0	16.0	6.8	14.1	24.5	8.4	12.4	11.6	17.9	63.7	16.6	9.5	19.8	24.5	23.6	14.2	12.0	17.5	16.7	28.3	10.2	11.1	40.7	30.8	13.9	48.0	20.5	11.8	16.2	10.8	45.5	30.7	6.2	10.2	13.5	25.2	12.8	9.3	22.8	24.9	16.7	20.2	15.9	13.3	25.3	6.2	15.2	17.1	23.5	17.2	23.8	5.6	25.3	42.5	14.6	20.9	28.5	18.3	4.2	19.0	14.4	16.0	17.9	20.3	10.9	13.3	8.1	17.3	26.1	16.9	16.4	16.8	62.9	67.3	113.5	23.7	29.5	16.9	2.0	12.9	22.2	14.8	7.5	15.3	19.1	11.9	14.3	19.6	18.6	3.5	9.5	1.2	23.1	3.0	3.8	15.1	8.3	15.1	17.0	17.5	17.7	14.3	16.6	18.0	16.5	17.0	16.6	16.0	17.9	3.9	0.0	4.1	3.3	1.9	0.8	1.1	2.6	2.8	1.0	3.4	5.0	0.0	1.5	6.0	0.0	0.0	1.0	3.9	0.9	3.9	1.5	0.1	2.4	2.7	1.8	1.8	7.8	1.6	0.5	1.0	2.8	2.0	1.4	5.1	2.5	2.2	4.7	1.0	0.0	2.3	0.8	0.0	1.3	2.6	1.4	3.7	1.9	1.8	1.9	1.0	1.4	2.1	2.5	4.6	0.7	1.2	1.9	4.0	0.5	2.0	4.1	4.8	0.3	0.0	1.2	2.0	1.4	0.8	4.2	2.4	1.2	2.9	1.2	1.6	0.7
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81444808-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 180.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	27.9	22.1	45.2	32.1	46.2	26.1	23.2	12.6	50.1	30.7	0.0	26.5	40.4	18.8	6.1	35.8	23.0	25.6	13.0	48.8	51.1	20.7	13.5	26.3	22.2	29.9	34.8	22.8	19.3	7.8	55.6	28.4	46.1	17.7	23.1	10.8	20.1	15.0	4.7	34.3	49.9	22.5	19.9	22.5	33.3	17.2	52.7	20.1	15.6	5.3	18.2	31.2	32.8	34.4	40.9	133.5	25.9	13.3	13.4	10.7	52.7	28.9	19.5	17.9	7.9	45.5	81.5	18.2	24.2	24.1	23.9	40.6	16.9	96.2	17.0	11.6	12.3	87.4	24.4	80.0	13.3	27.2	180.8	10.5	39.9	33.1	42.5	27.1	50.0	31.7	77.6	15.3	11.1	40.9	47.7	33.8	20.6	39.5	28.1	84.9	8.5	17.8	22.6	39.7	135.0	27.1	67.4	24.7	8.6	25.9	19.1	35.7	34.6	28.5	30.6	27.7	26.8	19.2	15.9	78.0	33.6	31.5	11.7	3.0	0.7	1.0	0.4	0.5	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.2	2.4	0.2	0.1	0.2	0.1	0.4	45.2	46.2	12.6	50.1	48.8	51.1	29.9	34.8	46.1	19.9	52.7	34.4	81.5	12.8	16.6	59.4	31.7	107.3	66.6	43.8	48.9	15.6	21.5	21.1	7.8	47.1	27.7	14.7	0.0	46.5	71.2	58.0	7.9	22.3	70.0	51.1	9.2	77.3	72.1	17.9	119.1	23.8	106.6	25.7	35.7	45.4	45.1	29.8	70.6	31.6	32.0	25.2	95.2	128.0	40.7	69.4	115.9	100.8	47.5	95.5	12.4	100.2	68.2	8.0	37.0	69.9	52.9	65.5	30.9	143.3	35.2	69.6	47.3	49.6	57.6	3.4	13.1	8.0	24.1	5.0	15.4	51.8	143.5	88.7	42.8	6.4	39.1	111.7
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339317	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 17.3;Hofbauer cells: 32.4;Kupffer cells: 69.6;Macrophages: 27.1;Microglial cells: 39.4;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 14.5;plasmacytoid DC: 18.1"	"Group enriched"	"Detected in many"	22	"dendritic cells: 18.1;monocytes: 14.5;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 11.9;ASC TERT1: 45.3;BJ hTERT+: 34.9;hTERT-RPE1: 13.6;LHCN-M2: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	10.4	5.9	3.3	11.7	3.0	0.9	4.9	2.5	3.2	4.7	4.2	7.5	4.5	8.3	1.6	3.1	4.4	5.5	6.4	2.6	4.9	3.3	6.9	12.8	17.6	5.9	4.7	1.9	3.2	1.7	3.4	22.2	5.3	3.8	8.9	0.3	4.7	4.5	2.4	4.2	5.1	14.7	4.0	34.3	2.8	2.6	5.9	4.2	8.7	5.1	8.1	8.1	2.5	7.5	0.0	0.0	0.1	0.0	11.9	45.3	0.2	0.0	34.9	0.1	0.0	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	13.6	0.7	0.0	0.0	0.0	10.6	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	4.1	0.0	7.0	14.5	0.0	0.0	1.1	5.1	1.1	0.0	0.4	3.5	0.3	0.6	2.8	18.1	0.3	5.1	3.3	3.0	2.5	3.2	2.6	4.9	5.9	4.7	5.3	4.0	5.9	7.5	1.9	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.1	0.3	2.2	1.5	0.6	0.0	0.0	0.4	17.3	0.0	0.0	0.0	0.1	0.0	0.7	5.8	0.0	2.7	0.5	0.0	0.5	7.8	0.0	0.0	0.0	0.0	11.4	0.6	32.4	0.0	0.4	0.0	0.0	69.6	2.5	0.3	0.3	27.1	3.6	39.4	7.6	0.0	30.9	1.0	0.0	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.7	0.1	6.6	4.1	5.1	0.0	0.0	0.1	0.6	0.5	2.2	0.5	0.0	0.0
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		1400000	"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	88.2	45.2	47.0	64.2	50.6	53.1	102.2	51.9	73.1	74.8	49.8	134.1	163.9	44.2	42.2	108.2	35.2	88.5	63.3	44.5	56.9	78.7	217.2	63.8	71.8	52.6	52.4	38.1	90.9	57.7	32.9	48.8	54.2	95.0	141.0	29.2	157.4	50.7	71.1	65.1	152.5	56.0	52.6	58.0	109.0	17.5	52.3	61.7	92.0	73.9	87.9	80.6	63.8	55.3	124.9	68.4	86.6	77.9	154.6	179.3	122.5	216.4	129.8	128.6	129.9	61.3	84.1	183.4	108.6	147.9	120.5	82.7	64.8	112.1	174.9	279.5	52.7	142.9	91.0	106.7	100.8	206.2	100.2	101.2	132.7	107.5	119.7	121.1	135.2	67.4	137.3	143.5	169.8	45.9	168.2	96.8	55.1	162.9	93.6	103.4	149.8	138.5	126.5	134.9	78.3	41.3	155.0	177.7	128.9	113.7	44.2	121.0	127.7	159.6	92.7	154.5	180.8	103.8	154.3	124.4	126.3	125.3	111.7	43.3	12.8	24.2	16.1	14.0	20.7	13.6	18.0	20.0	13.5	14.3	16.9	16.4	5.3	19.4	17.0	11.4	20.9	15.6	47.0	50.6	51.9	73.1	44.5	56.9	52.6	52.4	54.2	52.6	52.3	55.3	101.7	70.5	54.4	14.4	148.1	175.5	125.3	88.9	102.4	34.2	167.8	67.7	48.9	147.3	87.0	75.4	16.7	82.3	117.9	280.0	174.1	186.8	1.6	56.2	63.3	83.8	117.5	126.0	28.5	181.6	133.0	91.2	125.4	98.2	94.0	39.7	88.5	235.9	75.9	43.7	30.2	326.6	91.6	122.0	265.0	5.0	59.4	107.1	254.3	31.9	100.5	66.9	124.6	20.6	25.0	146.8	168.6	70.0	119.8	203.5	234.6	254.5	112.3	31.1	85.5	75.9	95.8	14.0	29.8	167.0	195.1	118.3	160.5	49.0	240.2	250.8
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6;salivary gland: 8.5"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	2.1	1.4	1.7	1.4	2.8	6.4	1.8	0.7	1.8	1.4	1.7	1.3	1.6	0.9	0.3	0.7	0.7	0.8	2.1	1.2	1.9	1.1	0.9	2.8	1.3	6.0	3.0	0.4	1.3	0.9	1.1	1.6	3.2	0.7	0.6	0.1	8.5	0.7	1.1	0.4	2.2	0.9	10.6	3.5	2.9	2.0	2.0	1.9	1.2	1.6	0.7	0.9	0.6	1.5	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.2	12.8	11.9	0.0	1.4	3.1	0.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.2	20.3	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	0.0	0.0	2.0	5.8	0.1	0.0	0.1	11.8	3.6	0.3	0.0	1.0	3.6	0.0	0.0	0.0	0.4	0.4	0.5	0.2	0.0	1.9	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.6	0.8	3.1	1.6	4.9	0.3	3.9	0.2	1.1	0.2	0.2	1.1	0.1	0.2	0.3	1.1	0.5	2.0	0.1	0.4	0.7	1.7	2.8	0.7	1.8	1.2	1.9	6.0	3.0	3.2	10.6	2.0	1.5	20.8	3.2	7.5	0.0	1.9	0.4	0.9	0.5	0.0	1.5	1.7	1.3	1.6	0.0	0.5	1.8	0.0	3.0	3.4	10.0	1.9	2.6	4.0	5.4	0.8	11.7	7.2	86.3	1.9	6.6	2.9	2.7	11.2	1.0	2.5	1.7	7.1	1.4	19.5	0.0	2.5	2.5	0.0	12.3	2.8	1.6	1.5	11.3	0.0	9.4	11.9	5.3	3.1	1.5	0.2	6.2	8.4	5.7	2.1	1.0	8.4	0.7	4.1	0.2	0.0	2.2	2.0	2.7	4.4	0.7	0.4	0.8	4.5	1.6	1.6	2.0
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog"	Q9BQ75	3	99817837-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	24.5	33.1	23.0	15.8	21.7	20.8	23.4	26.7	30.1	22.4	17.8	21.0	8.6	21.8	9.7	15.8	20.9	10.5	28.2	21.8	20.9	20.7	15.0	15.8	17.1	22.8	20.1	23.6	26.7	21.8	24.5	11.6	19.6	16.0	11.6	24.6	14.0	13.3	69.4	17.4	12.6	13.2	17.9	13.8	16.4	30.3	21.3	16.7	14.8	29.9	15.0	24.5	18.1	21.7	116.2	51.0	50.0	72.6	34.7	40.1	51.0	53.5	28.8	93.3	77.0	64.1	37.5	126.3	90.6	28.2	82.4	68.4	70.3	60.2	120.3	66.8	66.5	99.9	32.9	53.2	62.6	137.0	51.3	28.2	56.7	71.4	116.6	30.3	65.2	100.9	63.5	78.1	67.0	78.8	110.3	126.4	73.0	109.4	126.1	49.1	81.3	134.1	57.2	27.5	139.9	58.9	52.8	42.5	125.0	47.8	51.4	84.0	18.5	73.6	207.4	43.3	109.8	56.3	121.1	244.9	49.1	149.4	124.8	1.0	11.0	2.3	22.2	27.3	32.0	57.3	32.8	30.3	23.8	55.7	41.3	42.0	4.1	28.6	25.1	62.1	33.9	18.2	23.0	21.7	26.7	30.1	21.8	20.9	22.8	20.1	19.6	17.9	21.3	21.7	26.7	6.4	19.4	48.6	41.3	62.2	37.4	45.5	26.2	32.8	43.8	40.4	41.7	42.9	23.2	62.5	18.8	41.7	25.1	8.5	97.8	42.1	165.0	21.7	56.8	38.7	15.0	30.9	154.3	47.7	56.6	44.3	9.7	19.8	62.1	47.7	24.7	61.4	27.2	127.9	132.8	14.4	16.2	7.9	45.5	215.8	50.7	18.7	37.4	58.1	12.8	28.0	19.6	114.1	116.2	35.8	4.6	58.6	36.2	82.8	1.1	87.9	22.4	27.0	26.3	67.3	50.1	163.4	146.1	21.3	66.1	21.9	30.1	54.1	22.6	27.0
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 31.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 75.5;Late spermatids: 144.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 8.7;eosinophil: 6.2;neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 19.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	1.0	1.1	1.0	2.5	1.0	0.3	0.5	1.5	1.8	1.1	0.0	1.3	2.0	1.5	0.4	0.7	1.1	1.7	0.6	0.9	2.7	0.9	0.5	1.2	1.6	2.1	0.9	1.8	0.6	1.1	0.8	1.2	1.8	0.7	0.5	0.9	1.0	0.5	0.4	0.9	1.5	0.6	0.2	3.2	1.2	31.3	1.5	2.6	0.9	0.5	1.0	0.9	0.8	1.7	5.1	7.8	1.4	6.4	2.7	2.5	1.4	6.5	3.0	5.1	5.2	1.6	3.3	2.3	3.3	1.9	1.6	3.9	2.2	0.4	2.7	8.8	1.5	0.9	3.7	1.7	1.2	4.7	5.6	2.2	0.6	4.6	0.5	7.7	2.7	4.6	4.2	3.1	2.2	1.9	8.9	4.5	1.1	0.7	2.8	19.8	16.3	5.5	4.5	2.3	3.6	4.8	9.0	0.7	2.2	0.2	2.3	3.3	6.6	8.9	14.1	5.5	2.8	3.1	8.3	8.7	4.3	6.3	10.7	8.7	1.7	6.2	1.4	0.5	1.2	0.1	0.4	0.7	1.6	0.2	0.4	0.4	7.0	1.2	1.1	0.5	0.5	1.0	1.0	1.0	1.5	1.8	0.9	2.7	2.1	0.9	1.8	0.2	1.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	75.5	0.0	0.1	0.2	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	144.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.1	26.5	0.4	0.0	0.3	0.1	0.4	0.1	0.0	0.1
CMTM3	"BNAS2, CKLFSF3, FLJ31762"	ENSG00000140931	"CKLF like MARVEL transmembrane domain containing 3"	Q96MX0	16	66603874-66613892	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013870, HPA072695"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA013870: AB_1847003, HPA072695: AB_2732210"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.65e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (4.42e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	49.3	16.6	15.5	25.0	14.3	20.0	32.8	15.6	28.1	40.2	9.5	16.8	7.1	30.4	16.6	10.4	25.5	32.7	26.2	15.6	18.0	19.7	10.7	35.4	32.3	24.9	15.8	38.9	7.9	29.4	10.1	44.4	19.3	23.4	12.1	3.0	17.4	16.7	6.4	22.2	18.8	27.7	17.0	36.1	11.9	59.7	19.1	35.5	16.1	13.0	20.9	34.3	26.7	20.4	6.7	33.8	93.4	66.2	68.4	42.6	59.2	17.5	78.6	34.4	34.0	18.6	21.0	0.2	47.7	49.0	59.7	7.8	63.7	57.4	27.3	34.6	23.2	21.5	4.4	53.5	92.2	65.8	77.4	85.5	4.5	36.6	7.7	141.3	78.9	59.5	34.6	0.7	42.8	7.8	53.1	108.9	45.0	0.5	31.8	164.7	65.6	3.3	16.4	0.8	9.9	33.9	8.5	0.3	58.5	59.9	0.7	59.3	54.0	48.7	58.8	12.0	21.1	4.4	0.7	21.8	30.5	50.0	53.7	7.9	14.2	9.9	9.2	13.9	12.9	2.6	10.3	10.5	12.3	0.9	8.0	9.8	8.0	8.6	8.9	24.9	15.7	5.8	15.5	14.3	15.6	28.1	15.6	18.0	24.9	15.8	19.3	17.0	19.1	20.4	38.0	0.0	7.1	0.3	12.9	14.7	33.5	10.0	6.8	0.5	12.3	25.7	2.0	4.3	6.4	5.5	0.0	10.7	101.2	0.4	0.0	28.1	2.8	4.9	56.0	50.4	12.5	12.8	0.6	6.4	222.1	62.6	2.6	6.2	91.3	140.8	44.3	1.3	119.8	0.0	0.3	0.7	8.2	74.7	77.9	9.4	39.4	78.0	28.4	10.3	61.5	10.0	82.4	8.0	0.2	41.0	0.1	24.5	5.7	40.8	0.1	4.4	3.1	0.8	6.6	26.3	36.1	4.9	8.1	1.1	8.7	9.4	68.9	10.5	0.2	21.6
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696743	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Granulosa cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	4.5	5.0	36.4	2.7	34.1	2.5	5.7	32.8	34.5	3.9	28.3	16.1	11.9	4.4	20.1	6.0	10.6	2.9	4.1	43.1	37.1	26.3	4.1	8.4	0.6	42.1	41.7	3.4	19.2	32.7	14.4	2.1	35.4	7.7	12.6	7.8	11.1	3.8	3.3	7.7	12.9	3.4	41.8	2.0	31.4	6.9	45.5	0.5	38.6	2.1	1.1	3.2	4.1	41.6	16.0	12.9	7.8	19.1	2.6	4.2	31.7	6.6	5.9	3.5	5.6	24.2	17.7	0.7	10.8	3.9	4.8	20.0	19.7	7.8	5.2	1.3	17.2	1.7	5.3	15.2	5.6	1.4	3.0	6.7	13.4	4.2	8.1	11.9	2.0	2.3	8.0	4.1	5.1	18.5	0.1	3.2	8.7	28.6	8.6	3.5	10.6	4.9	15.2	14.2	17.9	7.1	27.4	14.6	9.3	5.6	15.3	3.4	4.3	6.5	7.0	1.8	6.6	1.4	3.3	0.7	8.1	3.2	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.4	34.1	32.8	34.5	43.1	37.1	42.1	41.7	35.4	41.8	45.5	41.6	2.6	22.4	11.1	32.7	0.8	5.2	8.8	21.9	4.6	9.5	23.5	10.8	7.1	15.7	19.3	23.9	8.4	5.0	1.6	51.7	13.7	15.9	1.9	20.7	2.7	4.3	39.0	0.8	68.0	24.0	29.6	3.5	27.5	12.3	4.5	67.6	1.8	6.1	2.4	30.3	37.7	24.1	20.3	2.8	0.9	3.0	2.5	1.9	3.6	7.5	4.4	24.2	0.0	37.7	51.3	30.8	19.5	3.0	0.6	29.0	30.7	19.9	40.0	11.1	6.6	3.1	8.8	6.4	7.7	7.5	5.5	2.9	0.9	2.5	43.4	19.4
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CMTM6	"CKLFSF6, FLJ20396"	ENSG00000091317	"CKLF like MARVEL transmembrane domain containing 6"	Q9NX76	3	32481312-32502852	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 815.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026980, HPA063491"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA026980: AB_10602801, HPA063491: "	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.55e-3)"	40.3	26.2	11.6	69.0	11.4	97.3	54.4	11.7	13.5	50.4	24.8	47.7	26.7	46.3	41.0	40.3	176.6	50.3	18.5	10.8	13.4	40.0	132.4	54.3	53.9	14.5	12.5	18.6	23.5	41.6	9.2	70.1	14.3	48.6	58.4	13.0	33.2	39.9	5.0	49.4	29.5	41.6	14.5	55.4	46.9	40.4	13.5	47.8	61.7	13.6	78.3	79.0	18.9	14.7	107.4	34.2	66.5	50.1	112.1	111.0	292.4	77.5	110.4	79.7	91.5	36.6	174.4	63.5	86.1	104.6	53.8	67.6	47.0	128.9	108.2	285.4	57.3	80.4	22.8	54.5	79.6	135.3	153.0	110.5	81.3	92.0	68.6	128.2	130.3	60.9	39.8	116.0	103.0	33.4	81.9	70.0	59.3	88.6	50.0	68.6	51.7	49.9	111.1	147.9	15.3	44.3	70.5	39.5	76.1	66.9	58.3	133.5	117.8	88.0	57.9	86.7	94.1	59.6	63.9	58.6	61.4	116.8	112.1	176.8	84.4	208.0	29.1	133.4	32.8	54.4	38.1	28.3	72.7	42.2	22.0	24.7	313.4	65.1	210.2	38.6	46.3	108.6	11.6	11.4	11.7	13.5	10.8	13.4	14.5	12.5	14.3	14.5	13.5	14.7	57.0	35.3	49.9	12.4	243.7	96.0	82.4	159.3	55.2	13.9	233.0	57.5	5.8	60.1	112.0	95.6	12.5	253.6	122.5	88.0	33.2	113.8	12.3	129.1	68.3	70.7	132.1	41.2	14.2	83.0	101.7	74.9	63.2	180.9	126.8	186.5	124.9	305.2	156.5	50.5	19.2	117.6	118.0	310.1	815.8	8.4	39.4	326.0	81.8	30.0	425.8	130.1	71.1	18.1	9.4	136.7	46.1	42.9	104.7	147.1	23.8	63.4	183.0	17.3	39.5	32.9	74.3	36.1	20.2	89.7	126.6	261.7	120.9	50.3	64.6	110.3
CMTM8	CKLFSF8	ENSG00000170293	"CKLF like MARVEL transmembrane domain containing 8"	Q8IZV2	3	32238679-32370321	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BEWO: 208.4;SK-BR-3: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055077, HPA073258"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA055077: AB_2682691, HPA073258: AB_2686591"	"unprognostic (9.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	14.8	12.9	6.0	3.3	5.8	1.2	15.5	4.9	6.7	5.9	5.9	7.0	7.3	4.4	17.4	3.5	8.4	3.4	13.6	5.5	5.0	10.2	41.2	17.9	3.9	6.2	5.4	1.4	47.7	12.0	3.6	17.4	6.3	11.7	7.4	1.1	19.7	6.0	4.7	9.2	6.2	2.5	5.5	1.3	14.9	1.0	7.0	9.5	13.6	5.1	4.1	4.8	3.7	4.9	10.6	10.8	2.1	13.5	9.5	14.7	208.4	0.1	0.3	1.1	1.2	15.0	14.9	0.0	21.8	0.0	0.0	5.8	17.2	3.5	0.9	0.0	31.5	6.8	2.1	25.2	0.6	2.8	5.3	28.8	10.8	1.5	10.4	5.2	8.4	11.2	0.1	0.0	10.7	7.8	8.9	1.0	4.4	16.4	9.9	12.4	2.5	2.1	13.1	12.1	3.7	3.0	1.7	59.3	5.8	2.5	17.0	1.4	7.6	0.0	15.5	0.0	3.2	0.5	0.4	0.1	0.0	4.8	3.7	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	6.0	5.8	4.9	6.7	5.5	5.0	6.2	5.4	6.3	5.5	7.0	4.9	94.7	38.5	36.3	1.0	2.8	11.6	35.2	4.6	18.8	0.1	75.4	45.6	2.2	17.2	16.1	0.0	0.0	107.6	2.3	13.7	11.7	18.1	13.0	22.1	5.6	51.9	22.2	5.7	2.2	37.0	67.5	17.7	32.1	29.2	0.0	129.9	54.7	79.5	9.8	0.0	41.6	40.7	16.2	5.3	15.0	2.4	2.5	3.6	5.4	36.5	1.2	35.6	0.0	17.6	1.0	25.8	17.7	1.2	1.4	64.9	21.3	24.3	9.9	2.7	0.0	2.2	12.3	3.5	3.7	12.1	6.5	116.2	18.6	10.9	21.0	49.7
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	20.1	22.1	21.0	19.2	21.2	30.9	19.5	20.3	22.9	23.6	18.6	26.8	18.1	23.1	17.4	16.9	22.4	15.1	25.1	20.7	22.0	19.4	21.8	20.4	25.3	21.5	21.0	28.0	22.1	27.5	26.0	24.9	20.3	21.9	15.2	28.5	21.7	18.4	30.1	23.2	23.2	20.4	20.2	28.8	21.9	62.9	23.5	30.9	20.3	23.4	25.6	21.6	20.0	20.2	23.5	21.9	31.0	50.7	34.2	31.1	37.4	27.5	37.7	68.1	75.9	33.3	15.3	48.6	30.5	40.7	63.8	25.7	39.7	28.4	51.7	33.8	35.2	26.8	26.8	37.2	26.3	38.9	17.6	27.1	20.9	37.6	26.7	35.7	32.2	44.3	60.6	34.5	36.3	38.5	49.8	34.6	15.6	15.7	20.7	39.0	36.7	28.1	22.0	28.2	34.2	25.6	30.8	23.4	40.2	22.1	39.8	29.7	30.0	40.7	30.3	16.3	31.1	39.3	21.8	253.0	16.0	40.1	45.6	4.2	5.4	3.5	4.9	7.1	4.1	5.5	4.3	5.2	5.1	3.8	4.7	3.9	3.3	5.6	5.5	4.2	6.1	4.6	21.0	21.2	20.3	22.9	20.7	22.0	21.5	21.0	20.3	20.2	23.5	20.2	11.3	9.6	9.2	5.9	12.0	3.6	3.9	4.0	8.6	14.2	6.3	5.5	10.4	8.6	11.5	7.3	33.3	18.0	15.4	5.3	0.0	4.5	20.2	7.7	15.4	9.6	8.4	6.5	15.1	8.5	8.0	8.8	11.7	8.9	3.8	24.9	7.9	10.1	7.5	11.8	13.9	8.4	4.1	7.5	2.3	11.3	7.8	9.5	3.6	14.0	11.5	8.8	7.2	10.6	14.2	8.5	3.3	6.8	12.4	4.3	4.7	4.0	11.2	11.9	6.6	8.5	13.5	16.8	10.6	5.8	4.7	20.8	11.5	22.0	6.9	3.6
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	"Nuclear speckles"	"HPA041700: AB_2677623, HPA048265: AB_2680334"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	6.7	8.8	4.0	10.3	4.6	7.2	15.9	4.6	4.2	7.6	8.0	10.1	14.9	8.5	12.2	14.3	9.0	9.4	7.0	3.2	4.7	12.5	14.3	11.4	14.4	5.1	4.4	11.2	8.1	10.7	7.8	10.6	4.8	10.8	10.4	7.3	13.3	8.0	5.7	10.3	14.2	9.0	5.2	13.6	10.0	13.8	4.9	10.7	14.1	5.7	17.9	9.7	7.6	6.6	17.8	11.6	23.2	19.5	18.9	15.3	10.6	14.9	18.2	17.4	18.4	10.6	26.5	10.0	18.4	13.7	18.9	19.4	11.1	14.2	24.9	10.5	7.9	22.3	13.1	8.3	20.3	16.8	37.7	12.7	24.7	15.4	17.9	12.8	18.5	22.2	11.6	6.6	31.1	15.9	18.8	23.1	11.0	14.2	6.7	28.5	10.2	24.5	16.3	19.5	12.0	12.8	15.1	12.2	15.4	10.3	18.0	10.4	18.7	21.1	15.1	15.5	11.4	13.3	17.6	21.3	14.7	14.6	16.8	22.6	9.6	9.2	10.8	10.3	13.2	13.1	10.6	11.7	13.7	12.0	11.4	11.1	0.7	16.6	6.9	3.9	9.8	11.4	4.0	4.6	4.6	4.2	3.2	4.7	5.1	4.4	4.8	5.2	4.9	6.6	11.4	3.2	11.8	13.7	28.1	14.1	14.5	10.7	15.9	20.3	23.9	13.7	8.6	20.0	9.4	16.5	31.3	24.2	30.2	25.8	7.9	12.2	95.6	12.6	15.1	14.6	18.6	17.0	9.9	9.7	12.7	11.5	15.8	11.5	8.2	26.1	18.9	32.7	16.1	15.2	10.3	20.5	18.3	18.0	11.4	30.9	16.8	13.6	1.8	21.5	17.8	12.1	51.5	17.6	21.5	12.9	15.2	12.4	17.9	13.5	46.3	17.7	6.5	25.5	6.6	11.1	10.1	26.1	13.8	22.0	24.3	26.4	20.0	21.8	17.9	18.2
CMYA5	"C5orf10, DKFZp451G223, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689836-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 623.5;tongue: 799.5"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3425.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;RT4: 1.5;THP-1: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	0.9	0.1	1.4	0.2	1.4	0.0	3.9	1.2	2.1	1.7	3.1	1.3	0.1	5.9	4.6	6.6	2.1	0.9	155.8	0.6	0.6	2.5	1.2	0.5	0.0	1.6	2.0	14.6	0.3	3.6	2.0	1.1	1.1	6.1	0.2	1.7	6.1	2.1	623.5	2.2	0.4	4.6	1.1	0.0	0.6	0.5	1.7	0.9	2.3	799.5	0.1	2.1	1.2	0.8	0.0	0.0	0.0	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.2	2.1	0.6	0.6	1.6	2.0	1.1	1.1	1.7	0.8	2.7	9.6	2.8	69.5	0.4	1.3	17.9	2.9	4.6	2.0	24.4	46.6	3425.2	5.7	12.2	25.8	0.0	21.4	1.3	0.4	17.6	0.7	0.3	29.3	7.2	19.7	1.8	0.0	32.9	0.4	2.9	113.7	3.6	55.2	1.3	2.5	0.4	2.3	2.1	217.0	10.7	0.2	8.2	0.6	1.6	2.3	14.9	1.4	0.0	6.5	0.1	8.8	2.1	156.3	2.9	0.6	0.2	13.5	0.6	4.8	0.0	15.4	6.2	3.0	0.0	165.6	23.1	2.5	2.0	2.2	5.4	32.8	1.2	1.7	0.2	18.1
CNBD1	FLJ35802	ENSG00000176571	"Cyclic nucleotide binding domain containing 1"	Q8NA66	8	86866415-87615219	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 6.6"	"Group enriched"	"Detected in some"	33	"Early spermatids: 155.4;Late spermatids: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Karpas-707: 4.4;U-266/70: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025037, HPA027469, HPA027786"	Uncertain				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	155.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	92.3	1.2	0.0	0.0	1.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNBD2	"C20orf152, CNMPD1, dJ954P9.1"	ENSG00000149646	"Cyclic nucleotide binding domain containing 2"	Q96M20	20	35954564-36030700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 173.9;Late spermatids: 99.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA043182	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA043182: AB_10794389"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.59e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.82e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	2.5	4.4	6.3	1.8	6.6	8.8	3.9	6.9	7.7	2.8	6.9	4.2	3.8	3.1	12.5	3.1	2.8	1.6	4.0	6.2	6.6	7.7	5.5	2.4	4.1	6.7	6.6	2.7	7.0	5.7	5.0	1.7	6.5	3.7	2.8	15.8	4.2	2.5	23.7	5.8	4.6	1.9	6.6	5.7	3.8	25.9	6.6	4.3	4.6	16.8	3.3	2.8	2.5	6.9	2.2	3.3	4.4	4.4	3.7	1.8	2.9	0.5	1.9	3.5	3.2	8.2	4.7	3.9	1.5	2.7	2.6	3.5	3.4	5.9	3.5	1.5	5.4	5.8	10.7	17.1	3.0	3.2	1.4	3.5	5.4	2.7	2.9	1.7	5.4	6.2	1.7	19.0	2.2	5.7	3.4	8.7	1.1	3.1	4.9	3.2	3.2	13.8	4.8	1.9	9.6	4.1	2.0	5.6	4.4	1.2	2.6	5.3	2.3	2.4	4.1	1.6	0.4	15.9	10.0	9.9	2.4	5.5	0.7	2.1	0.4	0.1	1.5	2.0	0.3	1.0	0.6	0.7	0.2	2.1	0.7	0.4	0.6	3.7	0.8	0.4	3.4	0.5	6.3	6.6	6.9	7.7	6.2	6.6	6.7	6.6	6.5	6.6	6.6	6.9	8.3	0.0	6.5	7.8	11.7	0.3	9.3	0.1	8.6	10.8	18.3	23.5	0.6	14.3	3.1	11.0	22.9	7.0	32.1	13.6	29.4	4.4	173.9	7.8	6.5	5.5	12.7	8.6	4.1	5.5	7.1	4.5	11.2	6.1	1.3	4.7	8.2	9.7	8.0	23.5	6.7	16.2	0.0	13.8	0.4	99.0	6.5	7.9	0.0	3.7	4.6	21.1	9.2	7.5	5.9	3.3	13.9	3.0	20.8	6.9	19.1	19.5	2.2	39.7	19.7	7.1	5.9	20.2	16.4	18.4	0.1	4.9	20.5	5.8	10.3	7.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534500-74587212	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 85.6"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 361.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	38	"U-266/84: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008933, HPA073283"	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	0.0	0.0	27.4	0.0	74.2	0.1	0.0	80.4	39.0	0.0	6.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	30.5	51.3	0.5	12.9	0.0	0.0	85.6	76.9	0.0	0.0	0.0	0.2	0.0	74.3	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.2	0.0	39.7	0.0	0.0	0.3	74.9	0.0	0.2	0.0	0.0	0.0	0.0	80.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	27.4	74.2	80.4	39.0	30.5	51.3	85.6	76.9	74.3	39.7	74.9	80.7	0.2	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.6	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	8.6	0.5	0.2	0.2	0.0	2.7	1.2	0.2	0.0	0.3	0.0	1.5	0.0	0.2	0.7	35.1	0.1	0.0	1.5	0.7	0.0	1.2	1.1	3.1	0.0	0.2	0.0	1.0	0.0	0.5	0.0	3.0	361.7	0.2	0.1	0.0	0.0	0.4	0.4	24.5	0.0	1.0	0.0	0.6	0.2	1.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNEP1R1	"C16orf69, FLJ38101, NEP1-R1, TMEM188"	ENSG00000205423	"CTD nuclear envelope phosphatase 1 regulatory subunit 1"	Q8N9A8	16	50024410-50037088	"Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042815, HPA077906"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA042815: AB_10794765, HPA077906: AB_2686868"	"unprognostic (4.11e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.37e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	9.6	8.4	6.4	14.4	7.3	23.8	7.9	8.0	7.1	8.4	5.9	9.4	8.9	9.2	12.9	12.0	7.6	10.7	9.0	6.7	6.6	7.1	10.6	9.5	14.3	6.6	5.9	9.8	7.1	8.6	8.4	15.6	6.6	8.3	13.4	9.6	8.3	8.2	10.1	11.6	9.2	11.0	6.7	13.4	9.8	18.0	6.7	9.5	5.4	7.3	15.3	10.0	9.0	7.9	11.2	10.2	12.4	13.9	23.5	23.1	17.4	22.5	17.1	21.4	12.5	11.0	15.3	12.4	16.3	18.7	14.6	17.0	10.0	10.9	27.1	9.1	11.7	6.1	6.7	17.8	16.7	8.1	18.1	17.0	18.2	13.9	10.8	16.6	14.8	15.5	7.6	6.9	27.4	3.4	16.0	21.0	9.0	4.9	13.8	19.3	16.4	12.8	15.9	7.4	9.3	11.1	21.3	8.5	9.0	10.7	7.4	10.0	19.3	20.7	15.9	19.7	8.0	11.4	11.3	14.5	12.0	8.1	17.4	16.6	21.0	16.3	16.0	29.2	15.1	9.4	12.4	11.9	17.5	8.7	12.4	14.5	51.0	12.7	36.4	6.9	13.4	14.5	6.4	7.3	8.0	7.1	6.7	6.6	6.6	5.9	6.6	6.7	6.7	7.9	8.2	3.2	7.8	8.8	10.1	10.6	3.4	6.5	5.7	5.8	5.9	3.9	11.4	8.6	6.9	7.3	4.2	17.7	10.6	7.7	3.9	5.2	4.6	5.9	8.6	8.6	4.8	7.8	13.7	5.4	25.1	9.7	8.6	6.8	12.7	5.6	10.0	6.9	14.8	6.7	13.2	3.7	2.0	20.0	20.8	3.9	5.9	18.2	16.0	6.5	15.4	12.2	12.3	8.5	12.5	5.8	6.4	7.9	7.7	4.2	5.0	5.5	4.5	10.0	6.6	9.4	8.4	26.4	18.8	5.5	9.8	14.4	13.3	5.7	5.6	3.8
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390297	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 952.0;esophagus: 3093.3;vagina: 1442.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"memory B-cell: 61.2;naive B-cell: 70.2"	"Lineage enriched"	"Detected in many"	12	"B-cells: 70.2"	"Cell line enhanced"	"Detected in many"		"A549: 18.1;HEK 293: 25.7;MCF7: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	4.3	5.3	1.8	0.4	4.2	0.6	12.9	1.9	2.2	952.0	1.3	3.2	0.4	1.5	7.3	3093.3	1.6	0.1	1.9	1.9	2.8	2.3	1.4	0.9	0.7	2.1	1.9	1.0	3.3	1.6	2.2	0.1	1.7	8.6	1.3	0.1	661.6	1.1	1.7	555.6	3.5	0.5	1.7	3.3	3.3	2.4	2.9	2.8	1.8	0.0	276.8	2.4	1442.7	1.6	6.0	18.1	0.4	1.6	0.8	0.9	0.2	1.0	0.3	0.4	0.4	1.0	1.6	5.1	8.0	0.2	1.2	2.4	1.5	2.3	0.1	0.0	25.7	0.4	6.9	1.9	0.0	0.0	0.1	1.8	4.0	1.0	0.0	0.1	0.0	4.7	1.1	0.2	0.0	12.6	0.1	0.1	6.6	8.1	5.4	2.2	0.3	2.9	1.6	2.3	2.7	7.7	3.4	5.1	2.5	2.7	6.2	2.6	0.0	0.0	5.3	0.2	0.1	5.8	7.6	3.6	0.1	2.2	0.3	0.1	4.6	0.1	1.7	3.9	0.4	61.2	1.3	1.2	5.9	70.2	0.6	0.9	1.3	0.0	0.9	1.3	0.1	2.2	1.8	4.2	1.9	2.2	1.9	2.8	2.1	1.9	1.7	1.7	2.9	1.6	32.7	3.2	2.2	0.0	24.6	4.6	16.8	28.5	14.8	0.1	57.9	51.6	0.8	2.8	20.2	33.1	0.0	0.2	2.1	24.5	7.9	13.1	1.5	20.6	3.9	9.3	32.5	3.6	0.1	2.5	0.3	2.3	4.6	23.9	4.5	7.2	3.9	0.7	5.7	0.0	0.2	33.4	14.2	3.8	7.7	3.9	5.3	6.3	3.6	0.0	6.4	0.3	7.2	0.0	0.1	2.4	39.4	4.5	0.5	11.5	43.8	12.3	10.5	0.1	0.0	0.9	8.0	0.4	17.4	71.8	12.9	0.3	1.3	1.1	41.8	27.0
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel subunit alpha 2"	Q16280	X	151738451-151745304	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015065	Uncertain					NA	NA									"HPA015065: AB_1847034"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel subunit alpha 3"	Q16281	2	98346188-98398601	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7;intestine: 4.2;pituitary gland: 10.1;retina: 5.9"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 43.8"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 6.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;hypothalamus: 1.9"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.6	0.5	0.5	0.0	0.2	0.2	0.8	0.0	2.9	4.2	1.0	0.0	0.0	1.5	0.4	0.0	0.0	0.7	5.6	0.1	0.0	0.1	0.0	3.4	1.5	0.0	0.3	0.0	10.1	0.0	3.6	0.0	1.1	5.9	0.2	0.2	0.0	0.0	1.3	0.8	5.7	0.0	0.9	0.5	1.3	0.0	0.0	0.0	0.0	0.6	0.1	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.8	0.7	5.6	3.4	1.5	3.6	5.7	1.3	4.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel subunit beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.1;retina: 13.1"	"Cell type enriched"	"Detected in some"	13	"Cone photoreceptor cells: 158.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SCLC-21H: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA057244: AB_2683380"	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.0	0.0	0.2	0.3	0.3	4.1	0.0	1.2	0.5	0.2	1.7	0.1	0.5	0.2	0.1	0.0	0.9	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.4	0.4	0.6	0.0	0.0	0.1	0.2	0.1	0.0	13.1	0.3	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.3	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.3	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	1.0	18.9	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.5	0.3	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	158.4	0.1	1.3	0.0	0.0	0.0	5.6	0.1	0.6	0.2	0.0	0.0	2.4	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	1.0	0.2	1.5	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.1	1.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
CNIH1	"CNIH, CNIL, TGAM77"	ENSG00000100528	"Cornichon family AMPA receptor auxiliary protein 1"	O95406	14	54423561-54441391	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002544	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA002544: AB_2081856"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.09e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (8.95e-4)"	73.2	61.7	40.2	50.9	42.1	37.2	73.6	45.2	49.5	59.8	58.5	86.9	99.4	49.6	50.8	72.5	67.0	74.4	84.6	42.8	47.2	79.9	232.9	46.7	61.2	44.3	43.4	44.0	41.8	59.8	41.2	58.4	44.8	57.2	95.1	60.3	49.7	57.1	58.9	36.0	85.4	68.2	49.1	33.8	45.4	37.1	41.3	56.2	65.0	95.5	79.0	95.1	39.4	50.7	233.4	141.3	113.8	129.2	301.0	380.9	107.8	276.8	348.6	232.0	264.4	86.5	316.4	289.7	180.2	209.2	141.6	226.5	208.3	200.3	287.5	111.9	124.5	112.1	80.9	152.8	303.6	136.5	90.2	314.4	244.3	217.1	304.0	236.8	221.3	117.7	111.5	95.5	262.4	138.4	151.5	102.9	84.2	266.3	281.3	114.8	191.8	97.3	264.2	171.4	95.5	106.3	163.4	127.8	316.7	104.8	197.5	144.9	143.7	194.7	192.9	165.4	167.8	59.7	138.8	141.2	235.9	115.3	176.5	5.3	84.6	10.7	32.5	66.8	54.8	64.3	57.3	47.0	86.0	55.2	75.1	52.1	20.9	44.0	53.7	48.4	65.1	96.6	40.2	42.1	45.2	49.5	42.8	47.2	44.3	43.4	44.8	49.1	41.3	50.7	41.1	35.3	60.6	14.7	64.9	105.7	86.2	186.1	141.7	41.9	69.2	64.0	85.6	50.1	79.8	46.0	20.9	95.7	48.1	98.8	90.1	89.3	44.4	54.8	57.9	72.3	104.4	65.0	26.9	62.3	123.4	90.3	52.5	32.8	197.3	32.4	70.3	140.0	115.5	67.3	34.8	91.5	99.7	102.8	80.0	17.0	60.0	73.5	83.6	9.4	110.3	59.9	35.0	17.6	22.5	65.6	96.6	65.8	84.0	92.0	149.9	164.7	79.9	45.1	46.0	60.5	68.1	68.7	64.1	144.9	110.0	70.9	69.3	68.4	123.0	91.4
CNIH4	HSPC163	ENSG00000143771	"Cornichon family AMPA receptor auxiliary protein 4"	Q9P003	1	224356858-224379459	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 320.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044268	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"			"HPA044268: AB_10965330"	"unprognostic (2.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (4.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.96e-3)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.27e-6)"	"unprognostic (3.15e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.63e-2)"	21.9	19.4	14.6	12.1	15.3	26.9	19.7	15.1	17.4	15.5	17.8	19.9	16.6	18.4	12.1	23.5	16.0	12.1	18.3	14.7	16.0	19.4	18.3	21.4	9.3	15.5	15.1	15.6	11.8	18.9	10.5	18.5	15.9	13.2	15.5	14.8	14.4	15.6	25.1	19.5	17.8	19.2	14.9	15.1	16.5	10.0	14.8	9.7	12.3	19.1	11.3	20.8	18.3	15.2	81.1	110.4	51.6	46.3	91.6	59.5	42.5	54.4	50.7	55.8	51.1	110.7	93.7	24.0	86.5	54.9	60.5	94.6	95.4	59.9	58.6	29.8	101.1	20.6	70.7	59.0	79.6	40.9	38.9	61.7	80.8	69.7	91.0	55.9	74.8	42.3	49.3	31.1	66.8	62.8	17.6	37.0	68.2	106.3	63.0	19.1	94.8	26.4	92.4	89.9	13.1	43.9	82.4	90.1	69.3	64.6	69.4	96.2	71.9	51.5	44.6	64.2	112.6	13.4	18.7	23.9	63.5	55.3	56.1	54.5	60.0	72.7	36.7	106.6	35.4	25.8	47.8	42.2	52.3	23.9	38.1	41.8	48.4	31.6	153.7	17.5	36.0	58.1	14.6	15.3	15.1	17.4	14.7	16.0	15.5	15.1	15.9	14.9	14.8	15.2	68.4	125.0	84.9	9.8	27.3	66.5	137.0	320.0	42.7	20.4	49.5	74.0	117.8	61.5	160.2	53.3	29.2	145.9	29.7	138.7	29.4	140.3	16.2	61.3	62.6	76.2	15.6	56.2	15.4	125.2	180.6	90.9	27.5	60.8	32.3	54.0	58.5	70.1	107.6	20.2	14.2	38.5	120.1	124.4	60.0	10.9	65.9	86.5	58.7	12.2	72.9	52.9	45.3	13.6	16.9	132.9	116.7	65.1	28.1	148.7	136.2	101.5	127.7	34.3	85.5	45.5	196.5	145.6	63.4	73.0	86.9	161.2	50.4	45.7	72.7	149.0
CNKSR1	"CNK, CNK1, KSR"	ENSG00000142675	"Connector enhancer of kinase suppressor of Ras 1"	Q969H4	1	26177484-26189884	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 18.6;BEWO: 16.0;CAPAN-2: 29.1;HaCaT: 20.3;hTCEpi: 17.2;OE19: 15.9;SK-BR-3: 20.8;T-47d: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030847	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA030847: AB_10601100"	"unprognostic (2.73e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.91e-4)"	0.7	0.1	3.6	2.6	4.1	0.3	6.0	5.3	4.7	6.6	2.2	9.4	11.9	2.5	8.2	18.7	8.2	3.6	1.4	3.6	3.7	9.5	1.6	7.3	1.4	4.0	3.6	3.2	13.4	11.7	9.6	4.7	3.8	10.3	7.4	0.9	15.6	6.6	57.2	16.6	11.4	0.7	3.2	2.4	10.5	2.4	3.8	1.1	16.7	14.3	2.9	5.5	9.0	4.9	18.6	0.0	0.3	0.2	0.3	0.0	16.0	0.3	0.0	0.2	0.0	2.9	29.1	2.0	9.1	0.0	0.2	20.3	0.5	13.0	0.4	0.0	0.9	0.4	7.4	9.2	0.1	0.2	0.3	0.0	17.2	0.0	5.0	0.0	0.0	0.6	2.2	0.1	0.0	8.4	0.2	1.5	7.7	15.9	1.7	0.2	0.2	0.0	1.9	10.7	3.5	0.9	0.1	20.8	0.3	6.9	16.7	0.0	0.0	0.0	2.4	1.0	0.2	5.8	1.1	0.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	3.6	4.1	5.3	4.7	3.6	3.7	4.0	3.6	3.8	3.2	3.8	4.9	1.6	16.0	7.2	3.6	3.1	14.7	16.9	36.6	17.6	2.8	22.9	20.2	1.1	17.2	21.2	35.0	2.1	34.2	0.5	26.7	1.9	12.3	1.1	15.9	2.8	1.9	18.6	0.0	3.3	12.4	13.7	1.3	34.7	25.9	0.0	1.8	0.7	0.2	2.8	0.0	3.7	20.0	28.5	0.0	1.2	0.8	1.2	0.8	1.8	0.0	1.4	0.7	0.0	0.5	5.1	25.0	29.9	0.7	14.3	15.7	28.4	0.5	33.1	2.9	0.0	3.6	3.3	2.4	4.2	20.2	11.4	32.4	1.1	0.1	20.0	26.6
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387515-154510685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.6;Glandular and luminal cells: 155.4;Oligodendrocytes: 142.3;Skeletal myocytes: 211.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.1"									"CAB037133, HPA049651"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Mitochondria	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	3.7	1.1	6.4	1.9	7.6	0.9	3.2	4.8	5.5	4.0	15.0	6.5	5.8	7.6	1.9	13.3	4.1	4.9	6.4	3.6	4.2	7.7	9.7	3.7	1.4	7.8	8.3	6.1	18.9	0.7	2.3	5.6	7.2	3.3	3.4	2.6	5.7	4.8	1.1	3.9	6.4	6.6	5.3	4.5	4.0	4.4	12.7	2.1	2.1	1.4	2.5	4.3	5.3	13.3	0.4	4.9	3.3	6.8	5.8	4.1	0.4	6.0	3.5	10.2	8.3	21.1	0.5	0.1	6.4	6.6	3.4	2.1	9.5	0.7	5.3	0.0	6.3	15.4	1.0	12.1	2.5	0.0	2.7	6.1	3.2	3.9	4.1	1.6	3.2	1.3	2.2	0.1	2.8	1.2	0.1	0.2	2.3	4.1	6.2	4.6	5.9	8.0	11.7	3.1	2.0	12.6	2.8	1.5	1.3	1.4	0.0	1.3	3.7	0.9	3.0	7.7	4.0	0.1	0.0	0.2	0.2	0.3	4.4	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	6.4	7.6	4.8	5.5	3.6	4.2	7.8	8.3	7.2	5.3	12.7	13.3	24.7	12.8	38.4	9.4	0.9	26.5	15.4	7.8	12.5	2.0	11.0	8.3	33.8	30.0	20.2	25.8	0.0	9.2	0.4	31.0	9.8	20.3	42.5	109.6	14.7	66.8	43.2	15.6	23.8	12.3	1.1	12.9	9.2	155.4	5.7	10.8	61.8	65.9	1.7	0.0	1.5	18.4	10.2	7.1	22.5	23.6	5.9	3.5	32.0	24.4	0.8	22.8	0.0	54.8	142.3	7.3	18.5	10.5	0.5	18.7	43.6	31.8	11.7	2.5	0.0	211.8	8.0	1.2	6.3	29.4	23.9	21.5	2.6	14.8	14.1	10.0
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739820	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;retina: 8.4;salivary gland: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	35	"NTERA-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010510	Uncertain				"Secreted to extracellular matrix"	NA	NA		9500		"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"			"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.0	0.0	1.8	0.0	4.9	0.0	0.0	2.3	2.6	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	2.0	0.0	0.0	1.6	0.0	2.4	2.3	0.0	0.3	0.0	1.0	0.1	2.2	0.5	0.0	8.4	6.7	0.0	0.1	0.0	0.1	0.0	2.7	0.3	0.0	1.8	2.4	0.1	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	4.9	2.3	2.6	1.8	2.0	2.4	2.3	2.2	2.7	2.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538767-11550323	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 1872.4;intestine: 2657.3;smooth muscle: 2207.8"	"Group enriched"	"Detected in many"	5	"Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1;stomach cancer: 103.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	115.6	58.4	6.4	160.6	8.3	0.0	89.7	5.7	14.2	366.9	7.5	2657.3	136.3	1872.4	177.0	677.5	655.6	234.3	274.1	6.8	8.5	42.9	10.6	98.7	7.3	6.1	6.8	114.1	24.2	3.0	9.0	28.4	6.3	676.0	326.4	0.7	61.6	1585.7	21.8	57.8	431.3	2207.8	6.1	22.1	673.7	91.4	7.5	2.6	38.5	11.7	0.9	1386.6	305.7	6.3	0.1	1.3	5.9	1.0	0.6	0.2	3.2	91.5	34.9	48.0	64.6	27.9	0.0	0.4	2.7	26.1	4.4	0.3	0.0	0.0	71.2	0.0	0.2	0.1	0.1	2.3	2.5	0.0	0.4	3.0	0.1	28.7	0.1	1.6	0.0	0.0	35.8	0.0	0.0	0.0	0.3	3.8	2.9	0.0	0.7	0.2	0.6	3.8	0.0	0.0	0.1	1.3	0.1	0.2	0.2	72.5	0.1	0.1	0.4	0.4	34.6	1.2	1.2	0.1	0.4	0.1	3.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.4	8.3	5.7	14.2	6.8	8.5	6.1	6.8	6.3	6.1	7.5	6.3	2.4	0.0	0.0	0.0	0.2	4.8	4.1	1.6	0.6	0.0	4.2	191.0	51.4	0.0	0.3	1.8	0.0	0.8	0.7	0.0	0.0	14.5	335.0	3.1	20.7	2.4	0.0	0.0	0.5	0.4	1.0	21.5	0.5	0.7	0.0	0.5	6.8	0.0	2.3	0.0	0.3	0.0	0.0	0.0	9.4	554.6	8.4	0.9	3.6	2.8	0.6	0.5	0.0	0.0	0.1	0.9	0.0	221.2	0.0	4.0	0.0	0.4	0.4	0.0	39.5	1.1	180.9	8.3	19.5	0.4	7.1	0.7	1.1	0.7	0.0	1.1
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927223	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 315.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 10.5;naive CD4 T-cell: 11.6"	"Group enriched"	"Detected in many"	12	"B-cells: 10.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		660000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	163.9	255.6	152.7	78.9	153.7	2.1	160.0	148.6	186.3	164.8	147.7	142.4	135.9	214.0	71.0	149.7	147.1	152.3	127.6	151.7	189.9	245.1	143.7	209.0	51.4	197.4	170.9	153.1	83.3	53.1	101.7	256.0	173.1	126.2	82.8	125.0	125.5	133.7	26.3	62.5	100.0	196.0	180.8	94.1	111.8	50.2	164.5	55.1	125.0	52.6	44.3	156.5	166.2	174.0	416.6	77.9	429.0	380.1	286.0	264.2	191.7	197.2	381.3	319.4	511.2	348.7	35.6	0.1	436.6	243.4	315.7	116.2	307.2	169.9	428.1	1.6	113.0	18.8	47.5	256.2	545.0	0.2	0.8	246.2	25.5	394.1	89.4	539.6	282.8	26.7	4.1	35.3	798.9	0.2	19.8	0.9	333.6	0.3	43.3	0.6	524.2	1.8	392.9	156.6	26.3	264.2	163.0	65.0	272.8	301.7	124.8	38.5	182.4	212.2	364.9	80.2	647.0	43.9	27.2	1.5	46.0	0.6	327.1	0.2	0.0	0.0	2.2	0.1	3.4	4.6	2.1	1.2	0.1	10.5	11.6	8.3	0.4	0.9	0.1	0.0	0.0	2.6	152.7	153.7	148.6	186.3	151.7	189.9	197.4	170.9	173.1	180.8	164.5	174.0	183.5	150.6	80.7	82.9	18.1	78.3	435.7	232.3	48.9	11.9	122.2	64.1	42.2	88.6	156.2	126.9	20.9	236.1	3.2	36.0	436.3	275.1	156.1	77.4	151.1	278.3	72.4	20.0	12.9	240.7	40.9	287.8	33.1	104.9	14.0	164.4	373.0	152.1	22.6	1.7	16.9	58.7	429.3	20.1	56.3	150.7	274.6	9.3	197.5	29.0	4.7	394.6	0.0	62.4	22.7	130.8	53.2	382.1	2.6	319.1	117.9	518.5	95.1	14.4	263.0	399.8	374.9	10.8	34.7	91.4	77.7	205.8	14.9	214.5	131.0	327.4
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329356-99394330	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.2	1.1	9.9	0.2	9.9	0.0	0.5	5.4	16.7	1.8	0.0	0.7	0.4	0.9	1.7	0.8	1.0	0.3	0.1	7.3	7.3	1.7	0.2	0.1	0.0	3.6	2.9	2.6	1.1	0.6	3.6	0.0	3.5	1.7	0.4	5.2	0.8	0.8	0.0	1.2	0.6	0.4	2.0	0.1	0.6	9.8	4.7	0.1	0.1	0.1	0.1	1.7	1.4	10.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	2.8	7.4	6.7	11.3	0.0	4.4	0.0	0.0	1.4	0.1	1.7	8.7	0.0	4.8	0.0	0.9	1.9	2.8	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.4	2.7	0.3	0.0	0.9	7.7	0.8	0.0	0.0	0.0	0.9	0.0	2.2	6.1	2.0	0.4	1.0	0.5	0.0	0.0	0.0	0.6	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.9	5.4	16.7	7.3	7.3	3.6	2.9	3.5	2.0	4.7	10.1	0.6	0.0	0.0	4.6	0.0	2.3	3.3	0.1	5.2	25.3	0.7	2.8	1.4	0.0	0.2	1.8	14.6	0.0	0.0	0.0	0.0	0.6	103.1	0.5	1.0	0.4	0.0	0.8	69.9	1.5	0.0	1.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	50.5	89.5	0.1	0.0	0.0	0.8	88.0	2.1	0.3	1.8	4.7	0.1	1.3	0.0	10.6	2.2	2.0	0.3	2.6	0.0	5.9	0.1	0.7	0.6	3.4	0.0	2.0	0.5	1.9	1.6	1.5	1.0	0.0	0.2	1.2	0.1	2.4
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96835382	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	7.8	8.9	8.0	6.7	10.1	7.0	7.9	15.0	9.5	8.4	8.0	10.5	17.3	8.5	5.2	5.6	10.9	9.4	5.7	7.5	7.1	7.5	20.0	9.1	9.1	9.2	9.0	10.3	26.6	21.4	8.0	10.2	8.5	8.9	8.8	13.1	12.4	9.0	45.1	8.5	14.2	5.8	6.9	9.5	12.4	11.3	8.6	11.4	8.4	6.1	7.2	8.3	7.6	12.5	10.4	9.2	8.7	13.4	10.2	5.4	24.3	6.8	5.5	6.4	6.3	25.3	16.4	11.7	23.3	5.2	7.4	11.8	12.6	8.8	4.8	11.3	29.4	15.3	12.9	28.1	8.9	14.0	11.2	4.5	11.8	8.1	7.3	8.7	7.9	9.6	14.1	19.8	2.7	13.0	12.8	17.4	11.6	15.6	11.5	15.6	11.6	14.4	11.3	12.7	26.5	17.0	8.7	14.2	8.2	13.3	13.5	10.2	3.7	5.6	16.1	9.2	9.8	17.8	18.1	8.6	3.5	13.2	6.0	1.6	0.8	3.5	2.6	0.6	1.6	1.8	1.6	2.1	0.3	2.1	1.5	1.5	3.3	1.5	1.4	1.8	2.2	0.8	8.0	10.1	15.0	9.5	7.5	7.1	9.2	9.0	8.5	6.9	8.6	12.5	4.1	9.6	4.8	9.1	5.4	1.3	2.7	1.1	0.6	17.5	4.9	5.0	15.6	8.6	3.0	0.0	8.4	5.0	8.9	4.7	0.0	5.0	7.3	5.3	4.4	3.7	4.2	5.7	5.7	4.3	2.6	4.3	5.6	12.6	0.0	11.7	6.4	17.4	2.6	33.7	9.5	7.6	4.1	3.4	0.6	1.3	2.5	1.9	3.6	4.7	2.3	6.4	6.2	18.1	19.6	2.7	1.9	4.1	6.4	7.1	8.4	1.9	2.8	13.5	13.1	5.7	4.5	5.9	6.3	2.8	1.6	1.6	6.9	11.5	8.2	3.4
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811874	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 38.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	2.8	3.6	5.0	6.1	6.8	4.9	7.0	11.2	5.4	5.8	2.8	32.4	6.2	4.0	4.7	7.1	10.4	4.4	12.5	4.9	4.4	6.8	4.4	8.0	4.6	4.1	4.5	5.1	7.4	6.3	9.1	5.8	4.2	5.7	34.3	38.8	6.8	5.1	24.8	7.2	11.3	4.7	3.5	5.3	12.8	7.9	4.5	3.5	9.5	13.1	4.9	5.5	6.4	5.7	11.1	7.2	5.7	10.5	5.8	3.9	15.6	4.8	6.8	6.9	9.3	13.2	11.8	8.1	13.5	5.0	9.5	14.1	14.9	8.1	6.3	16.3	11.7	6.4	4.8	7.2	8.1	3.1	6.2	3.8	10.0	11.0	6.6	4.6	3.8	8.0	3.3	22.3	3.6	15.7	6.6	4.5	7.5	20.5	9.8	9.7	2.6	9.3	6.9	8.6	26.7	8.0	9.1	45.7	6.8	15.9	22.3	5.3	3.4	4.0	8.9	8.8	5.4	7.7	6.6	4.0	5.9	6.1	7.2	1.2	0.4	0.1	0.8	0.4	0.2	0.9	0.4	0.4	0.6	0.5	0.2	0.5	0.2	0.2	0.7	0.4	0.2	0.3	5.0	6.8	11.2	5.4	4.9	4.4	4.1	4.5	4.2	3.5	4.5	5.7	4.5	38.5	7.7	12.4	6.4	5.7	4.9	4.0	4.6	43.1	14.7	11.2	14.1	4.3	11.6	7.3	112.6	5.4	6.1	103.4	0.0	3.2	4.9	14.3	4.4	4.0	10.1	0.8	9.8	4.2	1.7	3.2	12.2	16.1	1.3	5.9	2.2	3.3	3.3	33.7	8.3	26.4	6.1	5.4	4.8	1.6	0.9	5.9	0.0	8.4	2.3	8.3	2.1	11.1	14.6	5.2	21.3	1.2	4.5	4.1	22.3	1.2	10.6	51.5	0.0	4.6	4.3	4.6	2.5	7.3	4.1	6.7	5.4	6.7	26.5	6.1
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629885	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Autism spectrum disorder, Disease variant, Holoprosencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046577: AB_2679706, HPA049664: AB_2680844"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	29.8	35.2	8.4	46.9	10.7	45.6	36.3	17.4	11.5	34.7	33.5	60.1	55.0	31.8	27.6	73.1	38.9	28.3	26.3	8.6	9.4	39.8	36.0	33.3	58.1	11.5	10.5	39.2	41.1	59.7	21.2	35.1	11.3	31.2	57.3	32.4	38.8	30.6	52.4	43.1	52.3	33.7	8.9	42.9	42.1	108.2	10.6	76.4	42.4	44.1	69.5	49.1	38.6	15.2	128.8	148.2	110.0	88.1	52.1	66.2	127.6	99.6	85.8	111.4	82.0	167.6	75.3	194.0	47.4	75.8	65.5	122.3	177.9	101.0	149.2	72.5	98.8	150.4	121.8	193.7	70.8	235.8	162.4	64.0	67.5	129.7	151.5	66.9	87.7	107.2	181.0	55.3	76.4	52.0	182.6	61.2	114.4	84.9	127.2	229.0	189.5	122.7	62.4	180.0	90.9	58.6	336.0	113.5	56.0	100.5	67.9	121.3	100.9	81.3	80.0	62.2	88.7	124.7	138.2	390.3	85.5	99.4	76.9	18.3	12.1	13.4	13.8	15.6	18.2	14.7	12.9	14.0	14.6	13.8	12.1	12.6	18.6	15.4	22.5	7.3	15.4	11.5	8.4	10.7	17.4	11.5	8.6	9.4	11.5	10.5	11.3	8.9	10.6	15.2	44.4	16.0	42.9	33.0	57.8	47.4	32.6	42.9	25.6	28.2	33.9	27.9	23.8	37.1	45.2	23.9	29.2	33.7	86.3	64.5	9.8	29.8	107.7	57.6	48.0	31.3	36.1	45.0	31.7	47.0	29.9	30.7	35.2	78.2	32.2	45.9	23.9	42.3	35.7	40.4	35.6	54.2	24.4	51.5	39.5	38.6	24.8	46.4	19.6	42.2	50.0	20.0	34.0	42.3	54.9	42.5	34.9	32.4	59.8	43.6	60.1	22.9	51.6	24.3	32.9	38.7	30.4	136.6	64.3	56.0	47.0	37.9	52.1	27.9	64.5	61.2
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	8.4	7.8	5.9	11.4	6.5	17.4	12.6	7.8	7.1	10.9	7.2	11.6	9.8	10.7	11.5	9.8	14.1	8.7	7.7	5.7	6.7	10.6	12.5	9.8	14.6	6.1	5.8	12.2	9.4	13.0	10.3	8.5	6.2	9.1	13.8	6.5	8.5	7.5	9.5	13.2	10.6	10.1	6.1	14.5	9.1	39.8	6.3	19.7	12.3	5.8	16.5	9.8	8.7	7.5	24.4	26.7	27.2	25.9	12.9	14.8	181.2	20.1	20.0	28.0	31.3	20.5	20.5	39.6	13.0	14.4	18.1	20.9	32.5	26.5	27.8	34.5	33.3	51.0	23.2	20.0	37.6	42.3	18.9	10.9	23.3	30.9	40.4	18.7	23.2	36.4	54.1	30.1	16.6	20.1	38.0	20.4	41.2	28.0	25.3	37.9	18.5	39.8	18.0	28.1	15.5	29.9	29.5	41.1	24.4	19.3	40.0	47.4	14.3	17.3	24.6	23.0	33.7	30.8	67.8	39.6	17.7	31.7	21.4	18.5	12.0	17.7	11.4	17.1	12.4	15.3	18.6	13.7	15.1	17.4	18.1	16.0	9.6	10.2	25.2	8.4	16.0	12.3	5.9	6.5	7.8	7.1	5.7	6.7	6.1	5.8	6.2	6.1	6.3	7.5	11.6	16.0	22.8	28.4	19.6	10.5	7.2	13.0	9.1	16.8	9.4	9.0	13.2	14.3	15.3	14.7	33.3	14.8	21.0	15.3	5.9	12.9	60.3	23.4	12.9	14.1	15.6	21.2	37.7	13.5	17.1	12.0	15.3	14.1	10.8	17.2	12.8	9.8	11.9	15.2	36.5	10.6	10.2	18.8	14.3	34.3	9.6	14.5	12.4	20.6	37.2	7.4	10.3	29.1	35.3	11.7	16.4	10.5	17.5	6.6	15.2	7.0	29.9	20.9	6.6	14.9	12.5	63.0	33.1	10.2	14.5	8.2	20.1	17.8	14.4	7.3
CNOT11	"C2orf29, C40"	ENSG00000158435	"CCR4-NOT transcription complex subunit 11"	Q9UKZ1	2	101252886-101270316	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069823, HPA074943"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA069823: AB_2686209, HPA074943: "	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (4.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.72e-3)"	15.7	20.3	16.7	26.3	17.5	34.7	19.1	18.4	21.1	22.6	20.6	31.4	33.1	19.8	24.8	36.4	20.9	25.0	37.7	17.3	17.8	27.9	30.8	19.7	37.7	17.6	17.2	14.1	30.9	21.9	14.5	34.1	17.8	20.0	36.1	16.1	24.8	19.1	33.0	25.3	31.5	20.8	17.6	29.8	30.3	29.5	17.8	31.8	17.3	26.4	40.9	24.3	20.2	18.7	42.6	29.1	46.2	64.1	38.2	46.0	137.4	43.1	54.6	52.5	55.4	64.2	47.8	75.0	49.7	39.1	66.1	50.6	56.0	51.7	63.4	51.4	47.6	62.6	32.1	96.6	42.5	76.2	59.5	36.5	46.3	37.7	40.0	43.1	59.7	41.8	71.1	44.4	48.0	44.5	74.8	82.0	58.0	67.5	40.6	47.5	50.3	58.1	72.3	79.4	69.1	44.1	26.1	76.6	72.4	52.6	48.5	69.2	40.3	40.7	47.2	35.4	36.4	63.2	63.5	58.8	45.0	84.4	48.6	9.6	2.0	3.9	3.1	2.9	2.1	2.0	3.2	3.8	1.7	3.1	3.0	4.1	7.9	1.2	2.8	2.6	4.5	1.3	16.7	17.5	18.4	21.1	17.3	17.8	17.6	17.2	17.8	17.6	17.8	18.7	13.4	6.4	13.4	11.1	17.3	11.7	24.7	13.8	14.2	10.7	18.1	10.7	27.8	28.6	14.6	40.5	14.6	65.8	21.1	32.1	31.3	52.1	8.7	53.3	14.0	19.1	10.8	9.4	12.5	41.3	52.6	12.9	25.0	41.8	6.3	13.8	16.8	32.1	23.0	6.7	12.5	26.2	12.2	17.9	8.9	9.3	9.6	16.8	5.4	14.0	29.3	19.9	21.6	9.5	18.2	43.6	18.6	12.0	25.6	32.7	24.6	34.8	24.1	11.3	39.5	10.6	22.4	34.1	15.7	26.9	12.8	57.6	22.1	30.0	25.7	39.3
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70243002-70354993	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA067711: AB_2685893"	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	29.8	25.6	24.2	31.2	33.3	78.5	35.0	65.9	28.1	29.2	24.9	31.6	30.2	34.3	34.5	24.4	29.0	27.3	24.0	25.2	28.8	28.7	34.9	29.5	40.4	33.7	32.1	35.1	24.1	32.5	23.4	32.1	30.0	27.8	34.5	46.2	26.0	27.0	33.4	50.3	30.9	30.5	28.6	35.8	25.7	26.2	32.3	50.1	30.7	33.8	42.7	32.8	27.9	43.5	46.2	44.5	70.7	45.3	38.5	42.8	60.1	49.2	59.5	53.8	46.1	55.8	42.1	100.2	45.1	57.4	33.8	43.9	50.2	49.1	59.7	47.1	50.2	66.4	38.8	55.7	40.7	84.3	54.6	50.1	52.4	50.5	59.1	78.7	59.0	61.5	61.9	55.4	47.2	52.4	95.7	61.0	61.0	46.1	46.4	75.1	59.9	61.1	50.7	93.2	50.6	55.7	59.1	46.4	45.6	60.5	59.1	68.4	44.7	50.2	33.6	45.8	40.7	50.3	59.5	77.3	52.5	42.3	41.9	92.8	49.2	57.6	50.1	69.4	56.6	54.0	54.7	58.9	60.3	51.5	62.6	67.6	30.3	62.6	58.5	44.4	55.8	56.3	24.2	33.3	65.9	28.1	25.2	28.8	33.7	32.1	30.0	28.6	32.3	43.5	71.1	41.7	43.2	76.7	79.8	51.1	37.7	45.4	47.3	64.4	40.9	38.0	30.1	58.6	45.6	36.8	56.3	45.3	144.3	50.2	33.2	49.5	44.5	47.8	55.8	55.4	58.0	49.2	110.9	44.7	47.4	57.4	41.3	62.2	76.5	60.1	46.4	34.6	40.3	52.2	115.8	39.0	44.7	55.1	46.7	12.6	45.7	62.7	32.0	86.2	46.3	54.3	56.7	123.6	204.0	45.8	44.4	46.6	77.9	45.4	45.2	30.3	44.7	54.8	39.5	72.3	64.5	53.8	44.7	46.7	64.1	35.4	94.2	50.4	39.2	48.9
CNOT3	"KIAA0691, LENG2, NOT3, NOT3H"	ENSG00000088038	"CCR4-NOT transcription complex subunit 3"	O75175	19	54137749-54155681	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 213.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006408	Approved		Approved	Cytosol		NA	NA		39000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA006408: AB_1078543"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.08e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	21.3	29.0	11.3	17.5	11.6	19.6	22.9	13.7	14.1	27.0	7.6	27.1	16.8	27.3	19.6	26.8	27.5	12.5	19.4	10.9	14.2	24.8	25.3	21.2	20.4	12.0	9.5	30.5	28.3	17.5	34.0	19.2	10.4	27.6	13.2	18.0	26.1	18.7	24.1	30.3	25.1	16.8	7.1	29.9	26.6	35.2	10.8	23.6	30.0	11.0	18.1	25.6	25.5	12.0	45.5	69.1	69.7	40.8	25.4	25.2	48.0	39.2	68.4	52.2	45.9	44.2	36.2	53.1	24.8	46.1	41.8	44.1	77.3	39.2	53.1	55.5	213.4	81.7	44.5	39.1	43.3	47.7	54.9	32.1	35.8	46.7	77.3	37.1	41.5	39.0	61.8	47.9	38.3	53.3	63.8	27.9	43.1	87.7	52.4	57.8	52.4	35.7	33.7	85.4	44.9	37.2	75.1	54.6	25.8	50.6	31.3	50.2	37.8	47.3	50.3	23.4	54.4	46.3	54.1	71.2	38.7	37.1	48.0	0.9	1.6	3.1	1.6	1.0	1.2	1.3	1.1	1.5	1.4	1.4	1.2	1.3	4.2	0.8	1.4	3.4	1.2	2.0	11.3	11.6	13.7	14.1	10.9	14.2	12.0	9.5	10.4	7.1	10.8	12.0	14.2	12.8	7.4	10.7	17.4	9.9	17.2	15.7	18.8	17.5	14.0	13.8	2.0	12.8	14.4	7.3	16.7	28.8	20.5	17.8	9.8	14.8	19.9	20.9	19.6	13.2	14.4	13.3	6.1	14.5	28.5	13.6	20.9	21.4	3.8	22.7	12.5	8.5	16.2	16.8	7.0	17.1	18.3	9.7	6.9	6.6	17.1	13.1	5.4	4.7	15.6	12.0	16.5	5.0	8.0	15.1	23.9	9.4	20.8	21.4	14.9	9.0	14.3	18.5	6.6	17.3	17.9	49.2	47.9	16.6	9.9	50.1	15.4	21.6	13.2	17.3
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	9.2	8.9	10.3	8.2	11.0	7.9	8.3	16.2	14.0	11.3	5.9	8.7	7.4	11.1	9.1	10.1	10.4	8.9	12.5	10.7	13.7	10.0	10.4	8.7	10.1	9.4	10.6	15.4	9.2	13.4	6.5	10.7	9.4	9.5	8.4	15.4	11.4	9.4	21.7	10.2	7.7	11.0	7.7	9.5	8.1	17.6	10.2	11.9	13.6	22.2	11.5	9.0	8.7	11.2	15.4	14.3	14.3	19.3	23.3	18.4	10.3	16.9	18.3	14.1	17.4	12.4	15.4	15.2	14.3	15.6	20.0	14.2	18.3	12.8	20.0	17.3	14.1	12.6	11.9	11.0	12.9	14.4	14.5	14.2	16.0	18.1	11.1	16.2	14.7	10.7	22.4	11.8	21.0	19.2	19.8	21.2	18.9	14.1	11.9	12.7	14.1	16.6	16.6	14.0	15.1	17.7	19.7	21.7	11.6	13.2	13.5	15.8	20.0	17.0	10.0	15.9	18.5	18.1	18.2	21.5	17.2	16.4	23.2	23.7	10.5	14.6	12.4	10.8	13.6	9.8	10.4	10.4	9.4	10.7	11.1	10.5	9.4	15.8	13.1	7.5	9.7	9.2	10.3	11.0	16.2	14.0	10.7	13.7	9.4	10.6	9.4	7.7	10.2	11.2	53.9	22.4	43.0	83.9	63.0	67.7	76.3	54.0	45.5	50.6	49.7	58.2	42.7	31.5	44.3	36.8	106.3	31.5	60.9	30.0	70.5	32.9	30.7	31.3	56.7	48.3	40.7	50.9	103.7	20.7	22.5	58.4	35.2	45.1	62.6	46.1	40.0	25.0	25.5	55.5	94.0	30.2	30.5	28.1	61.0	20.7	65.3	33.4	42.7	88.1	61.0	69.1	68.0	119.6	102.8	32.4	31.2	69.2	58.9	73.0	32.0	56.2	35.4	72.4	19.7	83.8	75.3	113.4	75.7	42.1	75.7	44.6	61.6	45.9	29.3	89.4
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494379-180578358	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	6.6	6.5	8.7	12.0	9.1	11.9	9.5	16.1	8.8	8.0	10.1	10.0	12.1	9.2	8.6	11.5	9.4	7.3	6.2	7.9	9.3	10.0	5.1	9.7	11.4	8.9	8.7	9.4	6.6	8.7	5.6	11.8	7.9	9.4	11.5	17.5	7.1	7.4	5.2	9.3	11.9	8.1	8.4	10.0	10.1	13.5	9.2	19.7	9.0	7.4	14.0	11.4	8.0	9.4	24.9	29.6	59.2	47.5	9.6	10.9	61.0	17.9	12.0	23.2	27.5	36.1	35.7	26.2	26.5	11.8	32.2	25.5	50.0	59.4	27.1	77.5	25.2	28.6	38.4	23.4	14.3	33.6	20.1	9.3	28.1	17.1	36.1	21.6	28.6	30.2	30.9	24.5	21.8	51.1	43.0	20.2	17.5	25.0	13.9	39.1	29.6	18.6	25.6	48.5	43.0	36.4	30.1	39.7	26.2	28.7	49.9	33.5	31.4	24.5	28.1	18.0	32.0	16.0	30.9	27.4	23.4	45.3	20.6	0.7	0.8	1.2	1.2	1.4	1.3	0.6	1.0	0.7	0.8	0.7	1.4	1.4	0.8	0.7	2.3	0.8	0.8	0.6	8.7	9.1	16.1	8.8	7.9	9.3	8.9	8.7	7.9	8.4	9.2	9.4	12.4	28.9	13.4	16.3	11.9	21.7	6.4	12.9	15.9	18.0	19.5	11.7	11.4	14.3	12.4	11.0	22.9	9.4	21.9	17.1	1.9	11.0	6.4	32.3	22.3	13.2	14.5	27.8	27.2	9.3	12.8	11.8	11.2	21.1	2.5	29.7	13.6	5.7	12.5	18.5	24.9	13.8	6.1	16.2	15.4	9.3	13.1	14.4	10.6	18.7	20.1	13.5	26.8	30.2	33.4	17.6	8.4	18.8	15.5	17.3	12.1	13.1	20.2	17.5	26.3	11.7	13.1	38.6	48.7	23.2	22.3	11.5	16.2	12.8	16.5	19.9
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 366.6;T-cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	11.8	9.5	6.9	22.4	7.7	29.5	13.4	14.4	8.1	12.4	6.1	12.9	13.1	11.1	9.8	16.6	11.6	14.0	6.1	6.4	10.1	13.2	19.6	11.6	36.1	7.5	7.7	13.6	19.9	17.8	6.0	22.5	7.1	11.7	15.5	12.9	12.6	12.2	7.2	13.7	13.6	14.5	8.2	23.6	14.7	11.2	11.5	49.5	14.4	8.6	38.5	15.7	8.4	9.0	17.0	9.6	12.5	9.1	14.7	13.6	13.1	13.1	17.8	11.9	15.9	3.5	18.3	26.5	15.4	18.9	8.6	10.9	17.5	18.7	14.9	28.4	10.0	25.4	9.8	10.3	9.1	24.0	22.9	8.1	22.7	12.1	24.3	10.9	38.2	21.2	22.7	38.0	13.9	9.0	52.3	14.0	6.2	13.4	3.2	12.4	38.4	21.5	12.5	13.5	16.0	7.2	23.3	20.1	7.9	15.4	6.8	13.7	35.6	10.9	11.5	19.9	7.3	48.1	21.0	35.1	12.3	11.9	8.6	21.4	4.4	10.6	9.4	7.0	9.9	5.5	7.2	7.7	4.4	7.2	6.7	8.2	6.9	8.2	10.3	6.4	6.4	4.1	6.9	7.7	14.4	8.1	6.4	10.1	7.5	7.7	7.1	8.2	11.5	9.0	93.0	22.4	21.0	34.3	101.1	57.9	13.3	15.9	59.2	39.5	30.5	20.8	16.7	31.5	24.0	36.8	39.6	31.1	366.6	16.9	60.7	8.2	4.7	30.1	24.6	54.0	26.3	31.5	74.8	12.4	8.6	25.1	26.5	46.2	38.0	22.1	45.3	32.6	17.1	32.0	70.7	29.8	14.2	41.0	50.1	3.7	18.6	50.0	24.9	105.9	39.2	19.3	128.8	68.9	60.7	11.0	16.1	12.8	178.5	33.9	28.4	26.3	17.0	43.5	32.9	26.6	29.2	49.4	39.9	44.7	66.1	24.4	240.0	37.9	24.1	26.7
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876792	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA051398: AB_2681468"	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.41e-4)"	62.3	39.9	35.5	38.4	36.5	118.3	46.5	37.0	43.3	42.0	47.4	41.2	33.5	33.8	36.9	26.6	29.5	29.9	26.1	34.5	35.1	28.9	29.2	49.3	58.7	37.7	36.5	30.2	22.8	40.0	18.3	42.2	38.4	28.8	46.6	25.0	35.1	28.1	21.7	41.7	37.0	32.0	38.8	49.8	30.8	39.0	39.4	69.7	35.6	26.0	53.1	35.9	29.8	40.6	33.4	36.6	64.3	71.2	60.6	55.1	49.1	51.4	55.9	54.8	83.9	47.7	73.5	58.9	61.8	43.6	43.2	36.2	45.2	62.3	61.8	29.3	47.4	49.8	55.7	42.9	38.5	114.3	86.5	37.5	54.5	49.0	42.2	57.0	68.5	81.5	44.6	43.1	58.4	39.4	100.3	118.5	35.6	39.4	21.4	85.7	55.2	61.6	43.7	44.5	50.9	74.4	68.0	54.2	64.9	35.7	50.4	92.7	52.9	57.1	35.3	32.2	34.0	41.4	56.8	91.0	40.1	89.5	36.1	277.6	127.3	269.5	72.3	91.6	79.8	79.9	87.4	86.9	133.2	81.5	115.5	84.6	126.2	91.7	74.6	70.5	107.8	169.6	35.5	36.5	37.0	43.3	34.5	35.1	37.7	36.5	38.4	38.8	39.4	40.6	29.1	19.2	39.7	14.7	39.8	31.9	16.5	37.4	23.9	12.1	23.4	17.5	12.8	12.8	31.5	16.5	0.0	32.5	37.5	17.8	17.6	25.1	124.5	21.5	36.7	35.1	27.6	37.0	15.2	20.2	44.6	28.8	18.8	23.0	17.7	33.2	28.2	13.8	27.1	18.5	11.4	32.1	26.4	49.1	47.1	54.6	45.4	32.5	28.4	26.2	51.2	12.1	23.7	15.1	23.3	31.5	18.7	38.0	21.3	24.2	22.6	13.0	19.9	8.0	6.6	19.6	25.7	29.6	23.1	21.1	41.8	22.8	38.1	29.8	27.7	27.2
CNOT9	"CAF40, CT129, RCD1, RCD1+, RQCD1"	ENSG00000144580	"CCR4-NOT transcription complex subunit 9"	Q92600	2	218568580-218597080	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046622	Approved		Approved	"Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"		"HPA046622: AB_10962694"	"unprognostic (7.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.41e-9)"	"unprognostic (8.08e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (4.69e-9)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	17.2	21.9	18.3	26.0	19.7	40.2	16.6	20.8	19.4	17.8	18.9	17.7	18.1	17.6	19.4	21.4	18.8	16.1	20.1	18.7	19.4	16.3	21.0	18.2	31.3	18.6	19.2	18.7	15.8	21.0	25.2	18.0	18.6	18.4	22.6	26.1	15.1	15.0	22.4	20.5	17.3	20.2	19.4	22.6	17.1	27.0	18.9	33.6	15.4	17.1	36.2	21.8	17.6	22.1	49.9	38.2	62.2	82.2	35.2	33.8	79.8	55.5	57.4	69.6	67.4	68.2	40.4	55.4	33.7	64.3	60.9	57.2	88.1	61.6	81.4	79.8	55.6	110.6	72.1	81.1	48.9	120.2	61.7	31.0	48.5	73.1	74.2	32.7	53.1	74.0	67.1	121.1	56.3	40.0	117.2	72.8	94.5	38.4	60.4	97.8	88.7	57.1	37.1	71.5	79.2	64.8	54.5	47.5	52.2	59.1	38.1	66.5	43.2	75.5	55.8	55.3	69.0	57.6	62.6	128.3	53.7	73.1	55.0	36.9	25.6	29.1	41.5	31.7	36.4	29.9	34.0	35.4	30.4	26.6	31.8	35.0	10.5	35.5	34.0	35.1	30.8	37.9	18.3	19.7	20.8	19.4	18.7	19.4	18.6	19.2	18.6	19.4	18.9	22.1	22.1	22.4	20.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	20.4	15.1	0.0	0.0	9.9	12.9	0.0	28.4	27.1	0.0	27.4	21.2	0.0	32.2	21.2	10.3	0.0	0.0	0.0	20.7	40.7	10.9	0.0	22.4	16.4	18.9	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	25.6	0.0	0.0	7.0	0.0	0.0	16.1	10.2	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	28.3	11.0	16.9	0.0	0.0
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966763-41977740	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1395.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 555.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 149.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"white matter: 1789.4"	"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		46000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	34.4	33.5	493.1	31.2	889.6	23.4	29.6	715.5	681.5	41.7	193.5	56.9	21.4	33.5	36.7	63.4	28.9	32.6	25.3	505.1	577.0	58.1	44.8	21.7	35.7	839.4	761.8	32.2	27.8	23.7	28.1	23.5	793.8	41.5	18.4	20.5	47.2	37.2	26.3	34.3	31.4	30.3	644.6	25.8	29.8	16.7	791.1	31.2	24.7	22.2	35.1	37.3	40.5	1395.7	56.9	92.4	85.8	106.6	71.7	67.2	38.5	70.1	102.5	171.1	191.5	73.0	49.6	59.0	54.3	88.5	88.1	95.0	58.3	44.6	59.0	59.7	76.8	56.7	59.3	127.7	76.9	56.7	49.6	111.0	31.5	94.1	22.8	61.9	79.4	58.0	42.4	46.4	60.6	35.1	148.5	50.9	20.7	29.8	66.5	91.4	126.7	58.7	45.7	55.7	50.9	69.5	85.7	127.0	155.5	41.6	57.2	82.3	80.2	66.6	73.7	92.3	81.9	53.4	66.6	47.5	66.1	42.9	266.4	18.7	38.2	23.4	21.5	40.7	17.2	28.0	18.8	17.4	33.8	19.2	16.6	19.6	7.7	23.5	34.0	149.4	22.4	33.0	493.1	889.6	715.5	681.5	505.1	577.0	839.4	761.8	793.8	644.6	791.1	1395.7	26.6	16.0	12.7	14.4	19.0	16.7	17.5	10.4	16.5	22.0	29.5	24.0	13.0	20.0	19.5	35.0	6.2	30.6	53.2	39.9	125.2	46.3	1.3	19.1	27.1	24.8	19.7	25.2	6.8	41.7	50.2	27.7	17.9	21.3	9.5	20.2	20.3	32.3	39.8	50.5	9.5	16.2	18.3	17.0	14.5	4.0	38.8	20.3	55.2	14.0	25.0	84.7	23.7	45.2	555.6	35.5	19.0	36.1	27.8	21.7	19.0	80.5	12.8	25.4	32.9	36.6	29.4	5.1	16.0	30.9	18.9	13.0	16.9	33.3	20.6	17.4
CNPPD1	"C2orf24, CGI-57"	ENSG00000115649	"Cyclin Pas1/PHO80 domain containing 1"	Q9BV87	2	219171897-219178106	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049303	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA049303: AB_2680703"	"unprognostic (9.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.74e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.54e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.62e-10)"	"unprognostic (1.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.54e-2)"	62.0	90.8	43.0	41.4	50.4	78.6	51.6	51.5	46.9	45.7	36.8	70.3	58.9	46.2	37.2	81.2	39.2	27.9	67.2	41.9	47.0	91.0	49.3	41.3	54.3	52.4	49.3	48.2	53.3	89.3	24.7	30.1	51.4	46.8	43.9	16.5	52.2	41.4	97.2	70.8	69.9	34.4	49.4	71.7	54.0	42.1	47.0	43.6	60.2	57.1	51.7	55.3	47.5	56.7	43.3	32.0	31.5	58.3	63.5	31.7	44.8	54.7	32.0	44.5	35.4	69.3	52.3	24.5	31.5	53.6	35.5	59.1	42.0	44.2	25.9	63.3	24.6	100.1	34.2	69.5	77.7	59.4	66.5	33.8	55.8	44.0	39.2	39.9	37.7	65.4	81.3	89.5	26.1	78.7	65.3	45.2	20.2	49.9	40.4	96.0	23.3	83.6	69.3	59.7	40.8	48.8	31.4	77.8	59.2	34.1	62.3	67.2	35.9	36.2	33.8	71.6	52.7	70.4	29.9	52.8	48.9	70.2	23.7	82.6	63.4	65.5	53.2	95.2	46.3	79.4	51.6	54.2	97.6	87.7	35.5	39.9	76.4	56.9	122.3	53.4	73.2	79.4	43.0	50.4	51.5	46.9	41.9	47.0	52.4	49.3	51.4	49.4	47.0	56.7	23.4	19.2	17.7	6.2	61.4	13.5	14.0	32.9	19.4	11.8	24.0	23.4	24.8	34.3	23.7	42.3	4.2	31.9	46.3	90.8	56.7	36.7	1.9	12.4	16.4	22.1	28.9	46.3	4.2	33.3	21.3	22.8	26.0	27.4	13.3	12.7	26.4	23.7	37.7	11.8	5.6	48.9	38.7	45.2	29.0	4.7	22.4	36.1	21.4	10.3	85.8	28.0	55.6	5.5	13.4	39.9	45.6	21.1	34.3	23.1	73.9	64.2	11.5	12.1	19.7	11.5	21.8	26.5	33.5	28.5	15.9	55.0	38.6	19.1	42.9	16.0
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.4"	"Group enriched"	"Detected in some"	6	"Astrocytes: 2.6;Oligodendrocytes: 2.0;Spermatocytes: 2.3;Spermatogonia: 6.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Group enriched"	"Detected in many"	6	"cerebellum: 23.4;midbrain: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AF22: 30.7"	"Region enriched"	"Detected in some"	29	"cerebellum: 192.3"	"Region enriched"	"Detected in some"	10	"cerebellum: 58.6"	HPA047400	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.1	0.4	0.1	0.7	0.4	0.0	23.4	1.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.1	0.2	0.7	6.6	0.1	3.6	0.0	0.1	0.0	2.5	0.0	0.1	1.1	0.2	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.1	0.9	0.6	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.0	30.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	2.7	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.2	0.1	0.0	0.1	0.8	0.2	0.1	0.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	23.4	1.1	0.5	0.3	0.7	6.6	2.5	0.4	0.6	1.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNPY2	"HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316119	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	36.7	52.5	28.4	25.8	30.3	24.7	41.8	30.0	30.7	43.3	38.1	36.6	30.9	35.6	74.4	34.1	38.1	25.4	28.4	27.7	31.8	37.8	75.7	30.5	22.0	31.1	29.0	42.7	58.9	47.3	66.8	40.8	28.9	35.3	38.5	18.8	53.1	36.4	21.2	23.5	34.6	24.9	30.5	35.1	42.1	20.0	29.8	27.0	44.7	18.6	26.6	32.9	31.1	32.2	50.6	75.5	76.0	62.8	186.0	64.0	120.7	51.0	117.4	108.7	76.5	116.0	87.9	51.2	95.0	132.4	53.2	72.4	92.3	62.8	68.7	51.3	57.5	49.9	106.1	121.8	83.6	94.9	60.4	76.5	80.5	89.9	106.6	165.5	91.1	59.0	73.8	113.5	81.3	76.2	58.2	105.3	72.6	107.5	109.5	65.1	58.3	84.9	90.1	47.6	67.9	41.7	85.1	86.8	93.6	92.7	78.0	176.8	41.2	42.7	33.6	52.2	74.7	58.4	88.2	41.5	90.2	88.2	70.9	56.8	66.5	36.8	65.8	56.9	77.8	73.2	70.7	71.7	69.5	66.2	70.4	67.0	9.8	70.9	34.6	71.3	68.4	76.4	28.4	30.3	30.0	30.7	27.7	31.8	31.1	29.0	28.9	30.5	29.8	32.2	76.2	48.1	93.7	17.3	79.2	54.8	75.2	129.9	17.1	80.5	178.6	191.6	9.8	140.2	95.2	101.2	64.6	248.3	74.0	80.2	52.8	191.8	40.2	54.7	59.9	72.6	141.9	34.3	31.8	168.7	475.0	77.5	31.1	53.1	91.3	60.7	98.9	185.8	147.4	58.9	32.4	187.2	103.7	59.2	55.8	17.7	103.8	47.8	122.7	13.1	99.7	88.6	125.7	40.2	45.6	162.4	114.1	100.1	68.2	107.4	176.6	145.5	74.1	92.2	26.3	59.1	82.8	72.4	44.0	20.0	53.8	236.4	60.5	78.2	177.8	71.0
CNPY3	"CAG4A, TNRC5"	ENSG00000137161	"Canopy FGF signaling regulator 3"	Q9BT09	6	42929192-42939294	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Chaperone	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 248.5;Kupffer cells: 233.3;monocytes: 207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016560	Uncertain				"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 57: B-cells - Immune response"			"HPA016560: AB_1858173"	"unprognostic (5.26e-3)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (8.15e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.70e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (9.85e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.98e-3)"	35.3	31.4	58.2	64.3	59.1	144.6	32.7	59.0	72.8	40.0	70.0	30.9	30.9	37.5	32.3	23.4	49.8	37.8	28.8	59.7	64.2	31.8	64.7	45.4	78.6	70.0	63.1	48.5	90.0	29.0	41.7	47.6	67.0	45.1	29.7	23.9	32.5	33.8	10.9	22.2	50.1	42.0	62.8	105.2	36.7	46.7	65.8	115.8	34.1	16.7	69.2	43.3	30.0	75.8	78.2	75.6	72.8	157.0	118.4	44.8	73.5	60.3	78.9	79.1	91.0	85.2	57.0	82.1	91.0	102.9	170.8	63.7	54.7	68.7	48.2	82.7	61.6	88.6	65.2	134.0	70.0	155.7	173.3	54.3	41.7	61.2	67.4	113.9	72.4	77.6	73.3	157.3	51.9	147.9	141.4	188.8	59.1	367.3	42.1	97.2	50.6	123.2	79.6	58.6	78.5	68.9	37.7	38.6	134.4	93.4	49.8	334.6	54.6	82.7	82.9	30.9	66.0	107.0	78.9	115.0	34.2	178.6	70.9	212.7	483.3	249.0	115.2	336.3	110.9	267.3	101.1	126.1	407.0	258.7	112.6	115.1	852.8	132.3	327.2	696.4	102.2	404.5	58.2	59.1	59.0	72.8	59.7	64.2	70.0	63.1	67.0	62.8	65.8	75.8	32.3	12.8	11.1	4.2	132.1	22.8	32.1	41.1	31.9	41.6	25.6	29.7	16.9	22.8	26.2	23.9	14.6	51.1	176.5	16.7	7.9	47.4	61.0	25.9	24.2	36.7	55.3	47.9	5.1	34.1	180.8	33.9	20.9	31.8	46.3	81.5	42.1	58.9	248.5	1.7	6.7	31.1	34.6	233.3	61.7	81.7	33.5	184.3	30.2	18.7	207.0	20.8	62.8	4.5	6.6	27.9	34.9	30.1	70.7	50.8	38.4	18.1	32.8	11.1	19.7	12.6	28.0	72.3	39.9	23.9	17.0	36.1	64.1	39.8	36.5	37.9
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119634-100125508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Leydig cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	13.7	16.8	13.3	9.6	13.9	6.1	11.0	14.3	14.9	24.6	14.7	14.1	6.4	21.2	14.8	5.7	15.4	16.7	13.1	13.1	13.7	10.4	6.6	9.2	10.8	14.2	13.8	24.5	4.5	12.8	16.6	21.3	14.1	10.8	9.9	17.2	5.7	15.9	5.1	8.3	9.7	21.4	13.8	13.6	7.8	6.8	13.6	14.3	10.4	7.1	9.8	12.4	14.8	14.3	7.9	13.5	33.2	59.6	76.0	36.5	16.6	29.0	31.2	14.9	27.8	7.5	7.0	17.2	32.9	52.5	10.9	7.9	13.0	14.2	15.6	16.2	13.4	7.1	23.3	10.4	21.5	12.1	12.8	33.4	3.8	13.7	6.2	32.7	52.4	8.2	6.0	11.1	21.5	22.9	25.8	15.9	17.1	5.0	19.2	7.5	24.9	9.2	15.4	2.0	8.3	16.9	27.8	22.4	15.4	21.4	11.3	6.7	42.9	47.5	28.5	20.2	13.3	9.4	16.3	15.3	27.8	18.4	19.7	11.8	5.1	8.6	15.1	11.2	19.8	3.9	15.6	19.0	7.2	2.9	12.7	19.0	2.3	12.3	13.9	4.6	13.8	6.7	13.3	13.9	14.3	14.9	13.1	13.7	14.2	13.8	14.1	13.8	13.6	14.3	15.2	6.4	2.6	4.2	3.4	3.6	2.3	7.9	2.8	6.9	3.4	6.2	3.4	5.7	4.0	12.9	2.1	35.3	5.2	3.7	1.9	6.4	0.5	5.1	20.2	15.0	2.4	11.8	3.4	2.5	10.3	28.4	1.1	4.2	9.5	16.1	18.2	1.3	14.0	8.4	4.0	1.9	4.1	2.5	2.4	2.2	35.1	4.7	16.0	2.8	5.1	26.6	8.2	2.0	2.8	2.4	2.8	31.6	1.9	0.5	2.8	3.3	4.4	15.8	13.1	12.7	15.5	1.1	4.5	2.1	3.8	18.3	8.6	30.5	2.3	1.0
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.0;brain: 25.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 44.6;Inhibitory neurons: 200.3;Sertoli cells: 98.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 81.4;HSkMC: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	23.0	5.4	10.4	3.5	25.1	0.7	16.9	7.5	22.8	5.7	0.0	12.3	1.1	6.9	2.6	2.4	11.2	2.0	1.0	19.5	11.8	0.9	0.1	4.0	4.4	9.9	1.1	3.8	1.5	0.5	20.7	3.1	0.5	2.9	2.9	1.5	2.6	2.1	2.4	3.8	10.5	3.6	0.0	1.7	4.3	1.2	18.0	1.3	5.1	1.2	6.6	4.1	5.1	3.0	0.0	0.1	3.8	0.0	81.4	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	1.9	2.9	0.0	5.3	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.5	0.0	6.8	0.0	1.7	0.1	0.0	0.0	0.0	0.3	0.0	1.4	4.9	0.0	0.0	0.1	0.0	0.0	1.6	7.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	25.1	7.5	22.8	19.5	11.8	9.9	1.1	0.5	0.0	18.0	3.0	3.4	0.0	10.4	3.6	7.1	0.6	0.5	0.0	0.0	1.7	0.1	0.4	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.4	3.8	0.0	0.0	44.6	0.0	0.0	0.9	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	200.3	0.0	0.0	0.3	0.8	0.0	1.5	0.2	0.0	5.6	0.0	0.0	0.0	9.0	3.2	0.0	0.1	0.4	4.2	0.0	0.0	0.0	0.0	0.2	98.6	6.4	12.4	0.0	0.5	0.2	0.1	0.1	0.5	0.0	0.0	0.8
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	5	"B-cells: 27.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.1	0.0	0.2	2.4	0.1	1.5	0.0	0.5	0.2	0.0	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	1.6	0.2	3.4	0.1	0.0	8.8	0.4	0.1	0.2	1.0	0.2	0.0	7.5	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.4	0.0	0.1	0.0	49.3	0.1	35.1	3.2	0.1	3.8	29.6	0.1	3.0	0.4	27.9	0.2	1.8	1.2	19.4	0.2	1.7	0.2	2.0	0.2	0.1	0.5	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.1	3.2	3.9	0.3	27.8	0.6	0.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	1.8	0.0	0.0	0.1	2.1	0.5	0.0	0.0	0.2	0.1	0.3	0.3	0.0	3.2	0.4	0.0	0.0	0.9	0.0	0.2	3.8	0.1	0.4	0.3	0.2	0.0	0.4	0.0	0.0	0.6	0.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	5.2	0.0	0.5	0.1	2.0	0.0	0.5	0.5	0.0	0.1	0.7	0.7	0.0	0.9	0.4	0.3	0.2	0.0	0.3	0.3	2.4	0.2	0.0	0.8
CNST	"C1orf71, FLJ32001, PPP1R64"	ENSG00000162852	"Consortin, connexin sorting protein"	Q6PJW8	1	246566444-246668595	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007225, HPA007226"	Approved		Supported	Vesicles		NA	NA		480000	"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA007225: AB_1848869, HPA007226: AB_2667782"	"unprognostic (1.55e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.26e-1)"	13.1	19.2	8.8	10.5	9.7	23.5	10.9	14.4	16.1	9.0	17.1	13.7	10.2	9.0	8.1	16.7	8.8	8.7	8.9	10.3	11.1	8.6	23.5	9.9	16.7	6.9	7.8	10.5	10.2	11.3	7.5	9.3	8.4	8.1	12.0	16.8	7.2	7.3	31.8	10.1	13.2	10.1	5.6	10.4	8.4	12.9	7.6	14.3	13.9	39.0	13.4	11.3	8.8	9.5	8.4	11.0	7.9	7.0	12.8	14.7	16.0	26.9	26.5	26.7	20.2	10.5	10.9	24.6	11.7	26.9	7.9	8.6	12.3	9.2	36.2	13.8	4.2	28.9	10.4	8.0	18.4	14.5	53.5	14.0	8.7	25.9	27.4	13.2	8.4	13.0	37.3	10.5	15.3	6.1	15.9	6.7	25.9	11.7	9.5	15.5	14.2	20.1	10.1	24.4	18.0	21.6	11.5	6.7	34.0	9.2	12.3	12.6	12.0	33.0	7.9	13.8	18.5	31.8	43.8	25.0	8.1	21.2	32.5	47.1	8.1	23.9	14.4	8.8	16.1	35.6	24.8	13.6	8.1	35.7	31.1	16.9	10.7	15.1	22.2	11.7	33.2	15.9	8.8	9.7	14.4	16.1	10.3	11.1	6.9	7.8	8.4	5.6	7.6	9.5	41.3	12.8	17.2	21.2	46.0	24.9	21.5	6.7	27.3	31.5	10.2	7.5	14.3	12.8	17.7	3.7	14.6	4.0	18.2	46.9	7.9	6.9	44.7	43.7	17.2	29.0	15.0	25.2	58.5	6.0	6.2	22.5	16.3	68.3	40.4	8.1	30.0	22.1	10.0	16.8	54.1	19.3	10.2	12.5	12.2	41.6	9.6	32.9	14.2	22.5	10.1	14.9	18.6	43.2	35.7	8.8	31.4	7.9	26.4	16.4	42.7	5.9	23.4	24.4	13.1	20.6	29.2	16.7	13.1	20.6	26.9	9.3	31.7	8.3	14.3	23.3
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622665-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.9;brain: 7.7"	"Cell type enhanced"	"Detected in single"		"Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 7.9"	"Low region specificity"	"Detected in all"							HPA019654	Approved		Approved	Vesicles		NA	NA	69200			"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	0.9	0.5	1.2	0.6	3.0	6.9	0.7	2.9	2.4	0.2	1.2	0.6	0.9	0.2	0.9	0.6	4.7	0.5	1.6	1.1	2.0	0.6	0.8	0.6	0.5	5.8	3.6	0.2	0.5	0.4	0.4	0.4	3.9	0.3	0.8	0.8	1.1	0.3	3.2	0.9	0.7	0.4	3.4	0.4	0.4	0.6	2.2	0.7	0.6	1.8	0.4	0.4	0.3	7.7	1.3	0.5	2.1	2.2	0.6	0.2	1.1	0.9	1.4	1.0	0.7	1.9	1.8	2.8	0.7	1.4	1.1	2.4	2.3	2.5	2.0	1.9	1.3	1.4	3.1	1.0	0.3	2.2	2.5	0.6	0.8	3.2	1.0	0.4	1.0	1.9	2.2	0.6	1.3	0.5	2.1	2.1	1.3	1.0	1.0	1.3	1.4	2.0	1.2	1.6	0.9	2.6	1.4	1.5	3.7	1.5	1.8	1.6	0.7	1.5	1.1	7.9	2.6	1.4	3.3	2.3	4.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	2.9	2.4	1.1	2.0	5.8	3.6	3.9	3.4	2.2	7.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 94.1;skeletal muscle: 129.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Fibroblasts: 22.4;Muller glia cells: 83.6;Paneth cells: 30.6"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 109.3;SH-SY5Y: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					NA	NA		55000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	60.0	10.3	67.2	1.3	91.9	0.0	49.7	81.5	69.0	29.7	16.3	7.6	3.3	2.8	2.6	3.9	13.0	6.3	39.0	54.3	58.5	2.9	12.4	3.8	1.0	57.0	82.8	5.2	2.2	0.2	9.7	5.2	62.2	11.0	2.2	13.9	11.3	7.7	129.7	11.5	8.7	0.7	49.8	30.6	7.0	7.2	94.1	5.1	13.7	35.1	0.4	5.6	17.1	47.4	0.0	0.0	109.3	0.0	13.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	52.1	0.1	0.1	0.0	1.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	91.9	81.5	69.0	54.3	58.5	57.0	82.8	62.2	49.8	94.1	47.4	0.9	0.0	0.0	57.1	0.0	3.6	1.1	0.0	1.2	19.3	11.9	1.5	1.3	8.6	0.0	0.0	6.2	0.9	0.1	6.5	1.9	0.1	4.3	0.1	2.4	0.3	0.0	0.0	4.1	0.0	0.6	22.4	0.0	0.1	0.0	0.0	2.5	1.4	1.4	3.3	9.3	0.5	0.0	0.0	2.7	1.9	9.9	0.1	3.6	2.8	0.0	83.6	0.0	15.1	0.5	0.0	30.6	2.2	0.3	0.2	14.1	0.1	0.0	3.2	0.0	1.2	1.9	5.5	19.8	0.3	2.4	2.3	0.2	0.0	0.5	0.3
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEL: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	4.4	2.4	2.3	2.1	2.4	7.3	3.5	7.7	2.2	5.0	3.3	4.5	1.2	7.1	2.4	2.7	4.3	4.2	2.3	1.7	2.6	2.4	10.5	2.8	2.7	2.7	3.1	8.8	1.7	4.4	2.2	3.6	3.0	2.7	2.2	2.1	1.6	3.2	1.6	1.9	2.2	4.5	2.6	3.9	1.9	5.2	2.5	2.8	3.1	2.5	1.6	3.5	3.5	2.8	8.3	5.6	12.1	6.8	5.8	13.6	0.4	9.5	6.3	7.0	9.5	0.4	2.7	6.0	1.5	6.6	7.5	0.3	14.1	3.9	10.9	0.3	4.9	35.5	11.7	2.0	6.4	4.9	7.4	8.6	2.0	5.8	5.7	6.5	10.0	2.2	1.3	1.1	11.3	0.6	4.0	7.8	9.4	1.4	10.3	5.8	11.2	3.0	4.1	2.0	7.6	7.9	11.6	0.2	3.0	4.8	2.3	12.3	7.5	9.5	3.7	10.4	8.3	4.7	6.1	0.1	4.4	6.1	4.4	0.2	1.3	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.1	0.5	3.9	0.7	0.1	0.2	2.3	2.4	7.7	2.2	1.7	2.6	2.7	3.1	3.0	2.6	2.5	2.8	32.0	6.4	17.6	59.7	1.6	8.8	13.7	6.1	13.1	12.3	3.6	5.8	13.4	7.2	3.4	9.2	0.0	2.5	1.1	2.4	5.9	10.1	16.3	23.4	30.7	24.9	2.4	17.1	20.3	12.0	5.2	29.2	4.1	17.0	7.6	42.4	20.0	38.8	18.4	20.2	37.2	5.9	4.1	40.3	11.6	8.8	45.7	24.0	8.8	91.8	31.0	21.4	1.0	70.4	29.6	4.0	0.8	30.9	1.8	3.8	5.3	8.5	6.7	8.1	13.1	34.2	21.3	84.3	48.9	5.3	5.5	1.0	1.7	31.6	5.5	6.3
CNTN1	"F3, GP135"	ENSG00000018236	"Contactin 1"	Q12860	12	40692439-41072415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 158.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025200, HPA070467"	Enhanced	Approved			"Intracellular and membrane"	NA	NA		450000000	"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025200: , HPA070467: AB_2732156"	"unprognostic (3.18e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-4)"	"unprognostic (6.98e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (3.75e-4)"	3.9	33.2	64.0	2.5	75.3	0.2	8.8	119.4	84.2	14.1	0.0	3.1	1.7	11.5	2.6	9.1	2.2	11.7	0.8	93.6	59.8	12.4	1.2	4.4	4.5	72.6	94.7	49.2	6.0	1.4	10.4	0.3	70.0	27.8	3.8	26.8	5.4	27.7	0.8	12.8	3.0	10.6	129.0	8.2	5.0	9.4	79.2	1.0	1.2	1.6	3.9	21.5	6.6	158.2	0.1	224.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.1	0.1	0.0	0.0	40.3	6.0	11.2	0.0	0.2	2.4	0.0	0.7	0.0	0.0	0.0	0.7	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	1.5	0.2	0.1	0.0	1.0	0.3	0.0	0.0	68.5	40.3	0.1	2.5	2.7	1.0	0.1	0.6	0.0	0.1	4.3	0.1	10.0	2.8	0.1	0.0	0.3	0.0	0.9	2.6	0.5	0.7	0.3	0.2	0.3	0.4	0.2	0.2	0.1	0.4	0.4	0.2	1.2	0.7	0.4	0.9	0.2	0.0	64.0	75.3	119.4	84.2	93.6	59.8	72.6	94.7	70.0	129.0	79.2	158.2	0.3	0.0	5.9	763.9	0.1	5.2	1.1	1.6	4.0	32.1	0.4	1.8	0.7	0.0	4.5	5.5	29.2	0.0	0.0	0.0	1.9	0.0	34.9	4.3	7.1	0.7	0.0	0.0	844.8	0.0	0.0	13.3	0.0	0.3	0.0	5.0	0.0	0.0	0.1	11.8	699.0	0.0	2.0	0.0	4.0	149.5	62.7	0.1	10.6	54.4	0.0	34.6	0.0	1021.4	23.9	0.7	0.0	60.2	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.5	3.6	0.6	0.8	2.1	13.5	0.0	0.5	0.3	0.0	0.2
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 248.9"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000		"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	82.6	0.4	145.4	0.0	0.1	125.7	112.4	0.6	32.4	2.1	0.1	0.0	0.0	0.2	0.1	0.1	0.7	85.2	96.6	0.1	0.0	0.0	0.0	161.6	128.1	0.0	0.1	0.0	8.0	0.0	139.8	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	110.1	0.1	0.5	6.1	125.7	0.1	0.1	0.0	0.3	0.2	0.7	248.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.6	145.4	125.7	112.4	85.2	96.6	161.6	128.1	139.8	110.1	125.7	248.9	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
CNTN3	"BIG-1, PANG"	ENSG00000113805	"Contactin 3"	Q9P232	3	74262568-74521140	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 274.0;Inhibitory neurons: 195.1;Oligodendrocyte precursor cells: 228.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BJ: 7.1;fHDF/TERT166: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003341	Approved				"Intracellular and membrane"	NA	NA		130000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003341: AB_1078556"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.94e-5)"	"unprognostic (4.25e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.30e-7)"	"unprognostic (4.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	2.7	3.0	5.0	0.4	6.4	0.0	1.4	0.0	10.1	2.4	0.7	3.2	0.4	0.9	1.7	0.4	7.6	2.0	2.1	6.2	0.7	3.7	3.1	0.8	0.1	1.3	3.0	1.3	2.0	0.2	4.0	0.1	1.9	5.8	2.8	1.3	0.8	4.2	0.2	0.8	0.5	0.4	0.0	1.8	1.4	0.7	1.3	0.9	1.6	0.2	0.5	4.3	0.5	1.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	7.1	0.0	1.1	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.4	0.0	1.4	0.0	0.1	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	6.4	0.0	10.1	6.2	0.7	1.3	3.0	1.9	0.0	1.3	1.0	0.2	3.2	1.7	21.9	0.0	0.6	0.8	0.3	0.0	6.2	2.2	1.3	3.5	10.0	4.2	9.2	0.0	0.0	0.0	3.3	1.9	1.9	2.9	32.7	1.8	0.7	1.2	0.0	274.0	0.5	0.0	4.5	0.0	10.8	0.0	0.4	5.7	6.6	0.1	21.9	195.1	6.4	0.0	0.0	2.1	1.8	0.0	0.1	0.0	3.7	0.0	0.2	0.0	228.7	9.8	0.9	3.9	0.0	0.0	4.0	0.6	7.4	4.8	0.9	0.0	2.3	0.9	0.1	1.1	0.0	0.3	0.0	0.5	0.1	7.1	1.9
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020949-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 968.9;Inhibitory neurons: 2295.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	NA	NA		480000		"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	4.7	1.1	0.3	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.2	0.5	2.6	0.5	0.0	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	4.1	4.7	1.1	0.0	1.3	0.5	0.0	2.9	0.1	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	3.5	0.1	0.0	0.0	0.0	968.9	0.0	0.2	1.1	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	2295.2	0.0	2.0	0.0	0.0	0.4	0.9	0.0	0.0	42.2	0.0	0.1	0.0	112.1	23.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	12.5	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092658-1404217	"Predicted membrane proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.0;thyroid gland: 9.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016645	Uncertain					NA	NA		4700000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.0	3.2	1.3	0.0	2.4	0.0	0.1	11.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	1.4	0.1	0.0	3.2	0.0	2.2	2.2	0.0	0.0	0.0	0.3	2.0	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	3.7	0.0	9.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	11.0	2.3	1.1	1.4	2.2	2.2	2.7	1.9	3.7	1.3	0.0	35.3	3.6	15.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.5	0.0	3.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	127.6	0.0	0.2	3.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	75.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	52.8	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.0	0.0
CNTNAP1	"Caspr, CNTNAP, NRXN4, p190"	ENSG00000108797	"Contactin associated protein 1"	P78357	17	42682531-42699993	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 11.4;Bipolar cells: 15.6;Endometrial stromal cells: 15.5;Excitatory neurons: 45.6;Inhibitory neurons: 37.7"	"Cancer enhanced"	"Detected in all"		"glioma: 10.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;TIME: 68.5;U-138 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011772	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA011772: AB_1079541"	"unprognostic (4.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.16e-14)"	"unprognostic (9.52e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.37e-3)"	7.1	3.6	27.5	5.6	30.8	0.6	5.0	13.5	46.7	12.0	0.0	23.8	1.8	21.8	6.1	2.2	14.0	6.3	8.2	29.5	15.7	6.4	1.5	6.9	2.4	21.6	15.4	15.7	11.5	0.6	19.3	4.5	19.1	7.2	3.9	11.3	2.9	6.5	3.7	2.2	6.0	25.9	8.1	4.9	9.8	3.3	18.8	1.2	4.9	2.5	2.4	8.0	8.5	29.4	4.1	5.4	13.2	4.2	20.0	40.4	0.8	25.6	43.5	18.2	16.5	0.5	1.0	0.1	1.3	27.7	18.6	4.8	6.4	2.0	14.2	9.0	2.1	0.0	24.0	6.4	9.8	0.2	0.4	39.7	0.1	17.5	3.5	29.1	23.3	0.2	1.2	7.6	7.1	0.7	0.1	3.8	4.7	0.3	5.5	0.7	1.4	2.0	4.8	0.0	2.4	7.7	7.6	0.1	4.7	12.0	4.1	2.3	68.5	76.2	12.5	18.0	7.0	8.5	5.7	0.2	21.4	1.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	27.5	30.8	13.5	46.7	29.5	15.7	21.6	15.4	19.1	8.1	18.8	29.4	1.0	0.0	4.1	11.4	0.5	0.5	0.2	0.4	1.2	15.6	0.2	0.1	1.3	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.0	0.0	0.9	3.2	15.5	1.2	0.0	0.0	45.6	0.0	0.0	4.2	0.5	1.0	0.0	0.1	1.8	0.0	0.1	1.7	37.7	0.1	0.0	0.0	0.8	0.3	1.5	0.2	0.0	6.5	0.8	0.9	0.0	7.5	5.2	0.1	0.1	0.7	0.4	0.3	0.0	0.1	1.6	3.0	6.6	1.1	6.3	1.4	1.1	0.3	0.3	0.3	0.6	0.2	0.1	0.2
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;retina: 14.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3383.0;Inhibitory neurons: 6845.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;CACO-2: 6.7;NTERA-2: 12.0;SCLC-21H: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.2	0.8	10.0	0.2	13.8	0.0	0.6	1.4	20.7	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.6	0.0	0.2	5.6	5.7	0.1	1.9	0.0	0.4	5.7	0.5	1.1	0.2	0.3	3.8	0.5	3.8	4.1	0.4	14.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.2	0.5	1.8	3.7	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.2	0.0	2.0	1.7	0.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.0	1.4	0.0	0.0	0.0	2.2	0.0	0.0	21.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	13.8	1.4	20.7	5.6	5.7	5.7	0.5	3.8	0.0	1.8	0.0	0.1	0.0	0.0	65.6	9.3	0.1	0.3	15.5	1.8	33.9	0.3	0.0	1.2	7.2	4.1	0.0	2.1	40.8	0.0	1.8	0.0	1.4	7.2	0.6	0.0	0.6	2.4	0.0	3383.0	0.7	6.8	1.1	0.5	0.7	0.0	0.2	0.0	8.9	3.3	1031.4	6845.7	3.9	0.0	0.6	2.0	2.7	1.2	0.4	0.0	180.8	0.2	8.2	1.0	429.3	914.7	4.1	2.1	0.0	0.3	7.4	4.7	0.5	0.9	16.7	0.0	0.0	0.9	2.4	12.0	9.1	0.0	6.3	0.0	1.2	6.8	0.2
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein family member 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Excitatory neurons: 18.6;Hepatic stellate cells: 30.0;Inhibitory neurons: 103.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"A549: 18.9;AF22: 22.5;TIME: 14.5;WM-115: 37.9"									HPA047731	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.7	0.4	4.8	0.5	7.6	1.2	3.2	0.4	2.7	1.3	2.7	4.0	0.8	0.6	0.5	7.2	2.2	1.2	4.0	5.0	3.3	1.8	0.8	1.1	0.3	0.9	5.4	0.3	0.4	0.1	1.1	1.6	0.9	1.5	1.3	2.7	3.4	1.4	0.4	7.2	1.8	2.3	0.1	2.6	0.6	1.8	1.7	2.5	1.2	0.7	0.6	1.0	2.5	2.8	1.1	18.9	22.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	1.4	4.7	1.9	4.4	0.0	0.0	1.6	0.0	5.2	0.5	0.2	0.3	0.0	0.5	4.1	0.0	1.7	9.4	8.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.9	0.2	5.7	0.0	0.6	5.4	0.4	0.8	2.1	0.7	6.7	0.0	3.7	2.4	0.0	3.2	14.5	0.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	4.8	7.6	0.4	2.7	5.0	3.3	0.9	5.4	0.9	0.1	1.7	2.8	8.0	3.2	1.7	26.1	0.0	6.2	4.0	1.8	18.2	1.3	0.9	3.0	3.5	4.3	1.5	1.8	2.1	0.8	0.0	0.1	0.0	0.4	1.9	1.4	0.7	7.5	3.5	0.0	18.6	0.2	2.5	1.2	0.0	0.2	0.0	0.1	30.0	1.3	0.1	0.0	103.1	0.3	0.0	1.6	0.8	0.9	0.3	0.2	0.0	13.1	0.0	10.5	0.0	3.0	13.3	0.7	0.0	0.0	1.2	1.4	0.0	1.9	4.1	0.7	0.0	0.5	0.9	1.7	8.8	10.4	7.7	0.7	0.4	0.0	0.1	2.7
CNTNAP3B		ENSG00000154529	"Contactin associated protein family member 3B"	Q96NU0	9	41890314-42129510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 69.6;Hepatic stellate cells: 91.8;Inhibitory neurons: 161.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	38	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"A549: 29.9;AF22: 41.8;WM-115: 28.5"									HPA047731	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA047731: AB_2680137"	"unprognostic (2.68e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.78e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-4)"	8.9	1.6	6.1	1.4	10.0	0.3	10.1	2.9	6.3	3.7	6.4	8.6	1.4	2.5	0.7	9.3	5.0	2.5	5.7	7.1	7.4	7.0	2.6	3.4	1.0	4.7	9.0	1.1	1.5	0.4	2.9	3.8	4.4	2.8	2.8	6.3	6.6	2.1	1.6	8.8	3.7	3.2	2.5	3.8	2.1	1.9	5.1	2.4	2.1	1.6	1.1	3.2	4.2	3.4	0.2	29.9	41.8	0.0	1.3	0.5	0.1	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.1	0.6	3.7	2.4	2.3	0.0	0.1	1.3	0.0	5.4	2.6	0.9	1.4	0.0	3.3	3.4	0.4	0.5	10.4	7.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	4.1	1.0	9.0	0.0	0.7	11.9	1.4	0.8	3.0	0.3	1.1	0.0	5.8	1.3	0.0	4.2	7.4	0.2	2.8	0.1	0.8	0.0	0.0	0.0	0.0	1.3	28.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	6.1	10.0	2.9	6.3	7.1	7.4	4.7	9.0	4.4	2.5	5.1	3.4	69.6	0.0	6.3	34.6	0.6	4.2	7.8	2.4	15.4	2.6	3.9	11.8	7.1	4.3	1.2	3.7	0.0	3.1	0.3	0.3	0.0	2.1	2.0	2.8	0.3	35.0	1.8	2.7	34.6	3.3	2.1	6.2	0.0	1.3	1.3	0.4	91.8	7.5	0.1	0.0	161.6	1.6	6.1	3.8	0.8	1.4	0.9	0.5	5.4	33.7	0.0	27.9	0.0	8.0	1.3	2.0	0.0	0.7	0.0	3.2	0.0	9.7	11.1	1.0	0.0	0.7	3.6	0.8	7.0	8.4	5.3	0.7	0.7	0.2	0.1	6.0
CNTNAP4	"CASPR4, KIAA1763"	ENSG00000152910	"Contactin associated protein family member 4"	Q9C0A0	16	76277278-76560757	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 121.6"	"Group enriched"	"Detected in some"	8	"Inhibitory neurons: 326.7;Oligodendrocytes: 1150.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Daudi: 11.0;HSkMC: 4.3;Karpas-707: 3.3;RPMI-8226: 7.1"									HPA031859	Enhanced					NA	NA		2800000		"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031859: AB_10601360"	"unprognostic (7.88e-2)"	"unprognostic (7.19e-2)"			"unprognostic (6.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.26e-4)"	"unprognostic (1.83e-2)"		"unprognostic (2.00e-2)"	"unprognostic (4.56e-1)"		"unprognostic (1.09e-1)"	0.3	0.9	24.5	0.0	58.6	0.0	0.1	47.7	41.2	0.2	5.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	24.0	40.6	0.0	0.0	0.0	0.0	76.3	47.7	0.0	0.0	0.0	0.5	0.0	74.9	0.2	0.0	7.4	0.0	0.3	0.0	0.0	0.1	0.0	48.2	0.0	0.0	0.7	53.5	0.0	0.0	0.1	0.0	0.0	0.2	121.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.5	58.6	47.7	41.2	24.0	40.6	76.3	47.7	74.9	48.2	53.5	121.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.1	0.1	0.0	0.0	87.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.7	0.0	0.0	0.0	0.2	9.0	0.0	0.0	0.0	7.5	0.0	4.6	0.0	15.6	1150.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.0;testis: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	2.5	13.8	3.6	28.0	5.0	4.0	3.2	4.4	6.9	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	2.1	3.3	2.8	4.1	6.7	23.3	5.4	5.5	7.5	3.9	2.8	3.1	6.3	4.1	4.5	5.6	7.5	3.6	3.8	1.1	4.9	5.2	4.9	3.7	12.6	7.8	35.3	3.4	23.9	4.8	1.8	21.7	6.5	2.8	5.3	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	2.5	3.6	4.0	3.2	2.1	3.3	5.4	5.5	4.1	3.7	3.4	5.3	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949920	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	18.2	14.6	17.1	13.5	17.7	32.2	17.3	17.9	20.7	26.6	16.2	24.0	10.7	38.0	18.1	20.0	20.1	12.8	15.1	17.8	19.0	18.6	18.1	28.7	15.2	17.8	18.0	20.8	16.8	19.8	18.0	12.0	17.7	19.5	18.9	17.9	16.4	12.5	12.6	26.2	17.2	25.5	16.3	19.0	16.7	65.5	18.7	29.2	19.6	9.8	17.7	18.7	19.5	19.0	51.1	31.0	48.7	25.5	19.1	26.7	15.0	43.9	40.5	59.8	44.0	26.5	18.0	50.2	22.4	38.5	26.9	41.2	36.8	29.9	64.9	50.6	27.4	33.6	58.6	21.5	28.6	31.9	52.8	24.2	21.1	42.0	41.7	28.5	36.6	53.0	24.6	25.9	40.8	15.9	49.5	29.6	10.4	18.5	25.6	51.9	32.6	20.2	26.5	16.1	16.2	29.4	34.3	17.8	14.8	25.2	24.6	20.0	33.2	32.8	27.6	45.2	61.0	38.7	27.1	35.1	28.4	39.6	47.2	6.4	1.8	0.7	1.8	2.5	1.7	1.4	1.4	2.4	1.3	0.9	0.9	1.6	0.2	2.5	1.1	5.3	2.0	2.1	17.1	17.7	17.9	20.7	17.8	19.0	17.8	18.0	17.7	16.3	18.7	19.0	4.2	6.4	19.6	6.5	4.2	7.9	7.5	5.2	4.6	6.6	6.7	6.5	3.4	7.2	6.9	12.9	8.4	4.4	7.4	5.9	1.9	5.8	3.1	5.8	18.0	5.4	3.0	14.1	3.8	6.9	4.7	6.4	6.6	5.4	18.4	10.9	5.7	3.5	6.5	3.3	5.5	7.0	2.0	6.7	9.1	4.8	5.3	9.2	3.6	5.6	1.9	6.4	6.2	4.5	4.3	6.6	3.1	7.9	7.5	5.5	4.4	3.5	5.7	6.2	0.0	5.8	5.4	44.4	8.1	9.0	8.7	2.5	5.7	5.5	8.4	4.5
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011944	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	17.1	17.1	20.8	17.2	21.2	23.8	16.0	22.0	25.9	7.7	22.3	12.7	12.9	9.4	14.3	17.0	10.5	12.3	59.2	20.6	21.9	28.3	16.6	13.6	31.5	20.8	20.9	6.9	28.4	25.7	6.4	12.9	21.4	8.5	16.3	23.5	16.4	8.4	74.5	5.6	11.8	10.4	21.0	15.5	17.2	10.9	21.1	27.2	16.5	78.2	35.2	16.3	8.2	21.5	35.4	93.4	75.6	75.2	21.8	24.4	50.7	47.5	82.7	64.5	66.7	71.9	78.8	67.0	79.7	29.9	135.8	50.4	88.9	74.7	81.1	60.4	81.3	83.5	48.8	67.3	35.9	65.7	35.6	20.2	47.1	47.0	69.1	69.0	59.8	79.3	144.1	56.4	52.7	48.6	97.2	164.2	47.9	73.4	66.8	58.2	69.5	125.0	80.3	39.2	46.5	83.0	48.6	89.1	32.5	108.7	66.9	43.6	44.9	31.7	69.2	31.5	69.7	133.7	117.8	122.9	90.4	82.4	86.4	2.0	23.6	21.3	18.7	27.7	13.4	31.8	17.1	18.9	27.6	33.0	23.4	30.2	32.8	30.3	24.1	24.4	18.7	23.3	20.8	21.2	22.0	25.9	20.6	21.9	20.8	20.9	21.4	21.0	21.1	21.5	30.0	28.9	38.8	52.9	52.1	13.0	65.3	41.2	38.1	46.1	39.9	43.6	59.0	30.0	34.4	35.0	45.9	33.7	42.9	14.0	117.4	55.3	7.3	39.0	27.8	33.8	27.6	84.4	76.1	42.9	47.9	27.6	29.0	28.6	26.0	40.9	20.7	26.7	58.6	33.7	88.1	22.3	54.9	38.0	19.6	9.6	29.5	32.0	37.4	70.3	45.5	37.3	57.7	100.5	71.7	41.0	15.9	19.5	51.3	59.4	39.8	124.7	30.9	56.3	13.1	35.0	27.4	97.4	85.7	48.9	16.8	17.9	47.1	40.4	26.9	55.2
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 710.2;Proximal tubular cells: 729.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	64.8	73.0	122.8	30.8	122.9	15.3	63.7	128.2	160.5	71.5	125.8	110.8	106.0	55.6	172.3	128.4	73.7	42.9	102.4	125.6	124.5	223.4	158.9	45.7	41.0	124.6	125.4	55.8	172.6	106.8	59.7	38.9	127.2	84.9	89.7	34.9	66.1	66.7	119.6	58.0	81.1	41.5	125.8	50.5	128.5	25.2	125.5	42.7	57.9	94.3	49.8	60.5	78.6	125.3	66.8	219.9	99.4	54.7	89.5	75.8	61.0	51.1	77.2	119.2	107.3	87.5	81.8	3.9	141.0	62.5	112.4	63.5	77.3	124.8	111.9	65.1	202.8	44.7	96.3	280.8	63.4	61.0	52.0	77.4	92.0	112.7	64.2	61.0	96.1	31.6	72.9	55.5	106.9	108.9	20.2	132.9	45.7	135.9	78.5	79.4	145.1	113.6	122.6	90.2	73.8	61.9	52.2	54.9	91.5	85.3	170.3	78.5	59.3	129.6	67.5	55.4	69.0	65.1	76.3	36.2	97.3	60.1	89.8	206.7	209.6	141.5	136.2	208.1	143.5	218.9	140.0	138.3	178.8	187.5	128.4	126.2	22.7	187.5	177.7	120.3	191.1	245.9	122.8	122.9	128.2	160.5	125.6	124.5	124.6	125.4	127.2	125.8	125.5	125.3	55.4	28.9	68.7	7.5	44.5	36.8	52.2	192.7	50.7	36.5	99.9	110.9	263.9	173.0	113.8	266.7	20.9	153.9	30.3	233.8	710.2	136.5	13.2	203.0	70.0	65.4	79.9	54.3	8.1	239.8	177.5	72.5	103.5	154.6	35.5	77.5	69.3	390.1	121.6	45.4	9.2	205.9	195.3	75.3	33.4	18.8	55.9	54.8	88.9	6.5	86.0	94.7	63.8	6.6	11.8	134.7	201.6	45.1	73.2	79.0	221.7	729.1	145.2	37.0	39.5	46.2	88.0	48.4	52.1	242.0	55.5	102.2	43.4	97.6	258.9	67.7
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	45.1	96.2	46.9	36.8	52.5	25.4	39.0	51.6	52.0	37.1	46.2	44.5	49.0	35.8	32.5	48.0	40.2	40.3	63.1	46.0	49.4	70.4	99.7	31.3	47.3	51.0	50.4	37.8	46.5	49.6	34.2	37.6	51.0	45.1	42.2	15.7	42.7	36.2	72.2	33.1	49.6	32.4	50.6	37.1	41.6	31.6	50.3	32.3	55.7	55.9	36.0	54.6	37.4	56.9	106.4	201.9	80.2	119.0	70.6	86.6	79.3	107.4	75.5	126.0	107.2	147.4	132.5	91.3	214.7	90.2	99.9	105.7	124.2	146.1	98.3	120.6	115.1	156.3	118.1	141.8	130.5	107.2	115.0	109.4	136.1	207.0	136.6	70.9	120.0	87.0	135.3	87.5	118.3	210.8	83.7	168.1	104.3	422.7	205.9	96.2	174.3	244.0	137.5	101.3	72.5	121.3	99.0	110.7	295.3	78.8	162.3	108.0	83.8	102.8	91.7	212.9	142.8	103.3	125.1	313.1	57.0	132.0	121.4	18.5	49.6	12.7	35.9	52.2	47.0	58.1	42.0	37.8	61.1	48.5	44.6	48.2	3.4	43.1	51.4	80.2	47.7	38.6	46.9	52.5	51.6	52.0	46.0	49.4	51.0	50.4	51.0	50.6	50.3	56.9	48.9	35.3	36.0	6.8	48.6	53.5	75.7	89.7	47.8	19.5	64.3	86.1	66.7	85.8	55.5	55.2	22.9	168.8	36.7	97.8	129.1	89.2	37.3	77.2	90.9	49.7	72.6	68.3	3.6	94.9	111.3	54.2	69.3	72.0	62.1	83.9	33.2	184.1	97.5	18.5	5.8	98.6	28.5	44.8	34.2	13.3	55.0	44.7	28.4	2.8	55.2	67.5	49.4	8.5	18.8	98.2	85.1	38.4	47.3	139.5	174.2	266.2	47.1	18.5	6.6	81.6	51.0	78.7	34.2	86.3	51.3	122.3	39.9	150.7	121.2	98.7
COA5	"C2orf64, FLJ27524, MGC52110, Pet191"	ENSG00000183513	"Cytochrome c oxidase assembly factor 5"	Q86WW8	2	98599314-98608515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0;Proximal tubular cells: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057768	Uncertain		Supported	Mitochondria		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA057768: AB_2683521"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.32e-3)"	"unprognostic (3.71e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.00e-5)"	14.9	20.9	39.7	10.4	40.9	9.7	18.5	46.0	46.0	19.0	35.6	21.4	14.7	18.5	29.8	11.7	19.2	11.0	21.2	40.1	40.4	26.6	22.8	12.9	16.3	40.7	40.8	21.2	15.6	22.0	23.5	13.4	40.6	19.8	14.4	38.4	15.1	17.6	28.5	16.8	17.7	12.4	40.3	19.4	17.8	12.9	42.6	17.3	22.5	22.0	15.5	18.1	14.1	44.1	18.5	7.9	24.4	17.5	28.1	22.6	20.4	10.6	8.5	11.4	11.8	16.3	15.1	9.6	18.4	8.7	21.7	13.1	21.2	11.5	13.8	24.5	18.5	13.3	15.2	26.0	20.4	13.1	11.6	22.7	23.6	8.1	10.5	19.7	12.0	26.6	18.6	10.8	12.4	14.6	17.2	22.9	16.9	19.8	16.7	10.4	17.2	21.1	24.8	9.9	18.4	23.1	9.1	11.3	27.6	27.4	13.9	26.4	11.1	17.2	15.3	10.4	9.0	17.6	25.0	12.0	21.0	28.0	14.5	20.2	24.9	29.4	23.9	23.5	20.3	23.6	21.0	22.5	24.0	25.3	25.5	25.5	28.0	20.1	25.8	31.2	31.1	22.9	39.7	40.9	46.0	46.0	40.1	40.4	40.7	40.8	40.6	40.3	42.6	44.1	39.5	16.0	28.7	10.4	27.3	10.5	26.3	46.5	28.5	25.5	45.5	62.6	66.6	37.1	32.6	47.8	6.2	36.9	34.8	26.3	180.0	43.4	28.0	52.8	30.4	30.6	27.0	29.4	12.0	24.5	38.8	29.8	21.9	35.6	26.6	33.3	31.8	63.6	52.8	21.9	12.4	37.2	59.0	38.1	12.5	14.9	32.6	30.5	28.4	4.7	41.3	51.4	54.6	8.5	19.1	30.8	29.6	35.0	24.0	34.4	46.1	175.0	49.2	32.0	13.1	23.5	29.7	118.4	33.8	32.5	11.6	32.7	23.5	46.1	33.2	33.6
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234385080	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	23.5	34.2	38.2	21.6	44.0	17.1	21.1	35.7	45.1	15.2	37.0	30.4	44.8	15.1	32.2	31.9	15.3	16.2	41.0	39.7	36.4	44.8	36.7	15.3	30.9	35.5	35.9	15.9	25.8	26.4	16.4	14.2	37.6	22.6	25.6	16.3	24.3	13.2	101.4	16.1	31.2	14.0	36.2	21.2	27.7	9.0	36.2	25.8	17.2	60.9	21.2	21.8	19.4	39.1	69.6	87.2	31.0	35.2	31.7	62.3	98.2	49.9	29.7	51.0	47.8	67.6	90.2	68.4	90.0	28.6	95.7	86.6	48.6	61.4	40.5	86.0	207.1	30.9	92.8	181.4	121.9	77.0	57.6	41.4	80.8	67.2	51.6	44.5	63.9	75.0	153.4	60.2	56.2	37.1	73.7	148.0	76.2	155.5	41.0	43.0	37.1	135.6	65.0	64.6	55.0	39.9	48.5	84.7	162.1	19.7	75.2	130.0	48.9	60.2	50.2	81.7	151.7	71.2	149.8	86.0	46.2	120.3	110.3	59.4	70.3	23.2	40.0	68.2	39.0	65.4	63.3	49.7	76.3	43.4	65.0	49.2	18.8	44.9	59.0	52.2	85.9	48.6	38.2	44.0	35.7	45.1	39.7	36.4	35.5	35.9	37.6	36.2	36.2	39.1	31.2	9.6	24.0	5.9	29.6	57.2	50.2	80.7	34.1	13.6	35.6	57.0	88.1	30.0	51.1	47.8	4.2	50.8	21.1	61.4	103.7	55.2	4.2	63.3	32.9	27.8	22.2	33.7	19.0	69.4	79.2	31.0	31.1	40.9	22.2	35.4	26.7	52.4	84.3	11.8	13.6	64.2	52.9	37.7	32.3	4.9	26.1	39.6	30.2	5.6	45.5	28.1	28.8	9.0	5.9	62.7	42.0	28.2	24.3	77.0	83.4	131.3	64.0	17.8	19.7	22.8	31.9	23.7	26.9	57.9	58.7	43.6	30.6	63.5	72.4	81.8
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684449-52698347	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	6.8	4.8	5.7	5.4	5.5	3.9	7.3	5.2	6.5	4.6	2.5	7.9	7.7	5.5	4.2	6.3	4.6	3.5	5.5	5.3	5.0	9.6	12.1	3.9	4.0	4.7	4.5	3.7	10.7	5.2	2.5	5.2	4.8	3.6	7.5	4.3	3.3	3.6	16.0	6.5	5.6	5.9	3.9	3.9	5.1	3.2	5.1	2.7	7.1	20.4	4.5	5.5	3.5	5.7	26.0	14.5	13.0	21.1	20.7	17.9	28.6	19.1	15.9	23.4	19.5	18.2	9.0	59.4	12.7	11.4	29.6	19.5	31.9	27.1	30.4	18.4	31.9	49.9	22.5	20.9	25.5	49.7	16.4	19.8	23.5	26.6	33.0	10.3	16.3	16.6	46.5	10.0	17.9	17.3	17.0	25.3	57.7	27.7	40.8	32.9	44.6	43.2	20.7	25.9	29.2	15.4	27.9	35.0	36.3	18.3	20.5	33.4	18.2	18.3	24.0	25.5	26.7	21.2	57.0	27.2	8.5	35.4	15.2	1.6	2.9	0.4	1.1	4.3	1.5	1.8	1.2	1.1	3.0	0.7	1.0	1.1	0.6	1.1	2.2	1.1	0.7	1.6	5.7	5.5	5.2	6.5	5.3	5.0	4.7	4.5	4.8	3.9	5.1	5.7	6.0	6.4	12.4	0.7	4.5	11.5	31.2	7.1	9.6	8.8	6.1	5.2	13.2	10.0	7.1	3.7	4.2	17.1	1.7	11.4	27.4	11.9	0.5	3.2	12.3	8.8	2.4	5.5	1.6	13.3	17.0	7.8	5.1	3.4	0.0	8.0	3.6	13.7	13.7	16.8	2.1	7.0	6.1	4.7	3.5	0.8	7.5	7.0	1.8	1.9	8.7	6.8	4.1	3.5	1.5	11.0	7.0	7.5	9.9	19.3	5.0	20.1	2.6	10.2	6.6	11.4	14.0	4.6	13.0	9.7	12.9	16.6	4.2	10.5	10.5	17.8
COASY	"DPCK, NBP, PPAT"	ENSG00000068120	"Coenzyme A synthase"	Q13057	17	42561467-42566277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022875, HPA022912, HPA023273"	Approved				"Intracellular and membrane"	NA	NA		20000	"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068"	"unprognostic (2.83e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.54e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.55e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	27.4	60.0	24.0	23.1	24.0	29.5	32.8	24.7	28.1	27.6	26.7	35.6	43.3	25.2	17.2	54.4	29.8	16.9	29.4	25.4	23.9	45.6	70.9	30.3	25.0	27.8	24.7	26.0	59.0	39.0	30.3	25.5	28.1	32.4	24.3	13.3	58.5	28.7	38.6	46.6	36.9	17.2	23.8	35.9	47.2	32.4	25.7	27.6	39.0	25.3	25.2	26.8	31.1	24.6	94.2	149.1	27.2	55.2	55.5	34.8	89.2	38.3	52.9	65.8	46.5	85.7	89.2	52.7	65.6	50.4	69.5	146.9	66.1	81.4	43.7	47.6	122.2	52.5	91.2	140.9	70.2	56.4	73.1	51.5	97.8	62.4	66.6	52.4	63.2	70.5	98.7	70.8	46.6	59.2	71.5	87.2	36.7	125.8	75.1	39.1	93.5	88.1	89.9	66.7	63.3	50.1	34.9	37.3	75.4	52.2	158.0	70.4	41.6	68.3	62.3	52.4	40.1	84.6	127.4	31.0	80.9	55.3	47.5	23.3	29.8	26.8	19.7	31.8	20.5	15.8	15.8	19.1	33.6	15.7	15.7	16.3	19.5	21.0	22.5	23.6	18.1	24.0	24.0	24.0	24.7	28.1	25.4	23.9	27.8	24.7	28.1	23.8	25.7	24.6	15.4	6.4	23.8	9.8	24.1	15.0	21.7	49.5	25.6	17.8	38.2	22.9	22.9	40.0	33.3	71.7	0.0	89.4	21.2	53.7	33.2	44.8	4.4	31.5	20.6	20.6	17.4	30.3	5.6	52.5	51.6	18.7	40.2	28.0	10.2	101.2	23.9	94.2	40.3	33.7	5.7	36.7	42.7	23.6	16.1	7.7	14.9	19.9	14.2	4.7	36.2	29.4	20.6	3.5	5.9	38.9	32.4	16.6	25.3	31.2	66.3	94.8	36.5	18.0	26.3	15.2	18.6	46.7	31.1	33.4	17.8	77.2	16.9	36.6	45.1	30.7
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 218.8;Cone photoreceptor cells: 250.2;Microglial cells: 351.3;Syncytiotrophoblasts: 331.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 15.0;naive B-cell: 9.4;plasmacytoid DC: 8.1"	"Group enriched"	"Detected in many"	13	"B-cells: 15.0;dendritic cells: 8.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 62.6;RPTEC TERT1: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	35.1	51.4	9.5	7.4	8.5	4.1	13.8	6.4	9.2	10.1	28.7	8.0	10.7	4.6	15.6	32.6	4.8	12.3	7.2	6.6	7.1	68.8	107.6	18.2	12.8	8.9	7.9	12.5	43.7	10.9	5.0	50.9	9.4	27.4	7.8	56.8	17.9	28.0	3.3	16.9	7.8	7.4	6.8	9.9	30.0	2.0	12.8	4.8	18.4	7.2	16.2	22.6	16.4	6.3	10.7	2.2	5.9	0.0	7.1	1.3	11.9	34.0	13.3	4.7	5.6	8.9	4.3	1.0	6.9	3.2	5.0	38.4	26.2	21.3	5.6	2.9	10.7	10.5	9.5	36.3	10.2	0.0	0.0	1.8	19.8	1.0	27.6	5.8	21.1	1.3	0.0	62.6	7.5	12.5	0.3	0.1	2.9	25.9	12.8	1.3	22.4	10.4	63.1	36.0	14.4	5.8	16.1	14.7	4.6	11.4	10.7	0.0	9.5	11.3	9.7	3.8	8.3	24.3	10.0	3.6	4.7	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.8	0.0	8.1	0.0	0.4	9.5	8.5	6.4	9.2	6.6	7.1	8.9	7.9	9.4	6.8	12.8	6.3	56.4	70.5	66.5	7.5	102.5	97.3	54.3	14.5	30.7	21.6	22.4	22.4	9.3	30.0	26.0	218.8	250.2	52.1	40.8	11.3	62.6	25.5	0.1	24.6	12.2	47.1	22.2	22.5	23.7	33.8	71.3	35.0	53.5	19.5	34.1	9.0	6.1	127.9	8.7	3.3	30.9	11.0	24.4	3.9	9.0	1.3	14.6	3.7	19.6	351.3	0.7	144.5	0.0	5.0	1.6	29.8	4.9	7.9	154.8	46.0	12.6	28.6	12.4	190.2	46.0	8.6	71.2	0.6	2.7	69.0	70.3	331.4	8.3	8.0	10.0	75.6
COG1	"KIAA1381, LDLB"	ENSG00000166685	"Component of oligomeric golgi complex 1"	Q8WTW3	17	73192632-73208507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029224	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"HPA029224: AB_10600698"	"unprognostic (8.93e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (2.91e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-3)"	"unprognostic (5.31e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.21e-1)"	23.9	23.4	37.1	11.1	39.6	15.8	21.0	29.0	41.1	23.0	26.4	24.6	16.2	21.7	17.6	13.2	20.4	12.1	43.5	42.0	31.9	17.4	15.4	15.3	12.1	26.0	28.0	23.7	27.5	17.6	33.0	13.5	29.2	19.3	19.6	25.3	18.9	17.4	52.5	20.7	19.9	18.8	25.5	17.4	20.9	15.9	31.4	13.6	17.7	31.8	12.7	21.1	17.4	32.2	25.3	19.1	16.1	17.3	25.9	24.5	19.8	34.8	29.5	32.0	29.9	16.6	16.1	14.0	19.2	33.0	29.5	15.6	16.4	24.2	46.9	6.1	18.3	12.5	19.5	30.1	27.4	15.4	14.2	20.9	18.4	25.7	24.7	21.5	30.3	18.7	14.1	20.5	32.7	24.6	21.3	12.2	4.9	24.5	34.2	14.9	27.3	17.2	19.7	16.1	17.5	23.8	16.6	22.9	18.0	30.4	33.4	11.2	17.5	36.7	28.1	24.9	28.0	26.9	13.0	15.3	15.8	10.1	14.6	8.6	9.6	18.1	15.7	12.3	17.2	12.5	17.7	16.8	11.8	7.3	16.0	17.9	7.5	17.3	9.5	6.4	14.0	11.8	37.1	39.6	29.0	41.1	42.0	31.9	26.0	28.0	29.2	25.5	31.4	32.2	17.8	6.4	9.6	9.8	12.0	4.0	6.8	7.8	8.6	21.9	7.8	6.5	5.1	14.3	18.0	9.2	33.3	19.8	9.4	12.5	1.9	11.4	17.2	17.1	9.0	11.2	17.4	9.9	28.3	11.8	10.8	10.9	19.4	13.9	18.3	16.4	8.6	9.5	8.5	28.6	17.2	18.7	18.3	3.2	4.3	16.3	12.2	5.7	5.4	10.3	11.0	16.6	21.6	13.0	9.9	11.0	12.5	15.8	17.2	7.0	13.2	11.2	22.7	28.6	13.1	15.9	11.7	19.5	13.0	6.2	3.4	16.3	15.0	15.4	10.5	6.4
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523560	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	17.8	22.0	25.3	12.8	27.2	14.2	15.7	27.8	27.0	20.2	29.0	20.3	10.5	17.4	11.1	30.1	19.7	12.8	25.7	25.3	26.5	16.9	16.9	18.3	15.4	26.9	26.3	18.8	10.6	27.9	19.0	19.8	26.6	14.4	16.6	14.5	17.1	16.5	67.7	23.8	16.3	19.2	25.9	17.9	17.4	19.2	27.7	22.3	15.9	49.4	17.7	18.5	20.7	28.3	37.3	59.9	47.1	31.3	62.6	43.7	53.0	41.0	53.7	51.0	43.9	48.3	66.7	25.0	57.7	64.9	35.5	53.4	60.8	65.3	70.9	21.5	36.7	23.1	59.8	47.5	36.7	15.3	15.0	51.9	41.9	66.1	40.6	59.7	51.7	31.6	55.9	18.1	57.6	75.9	25.1	23.4	45.2	50.4	30.9	46.8	31.2	57.4	42.3	31.0	43.9	45.5	80.7	30.5	24.3	48.0	77.9	26.4	49.7	46.3	29.1	35.3	29.8	19.1	26.2	78.0	50.7	15.8	46.1	20.6	26.4	23.8	19.7	28.8	14.4	11.8	19.3	17.9	32.8	14.6	16.9	15.7	13.8	14.4	34.4	15.2	24.4	25.1	25.3	27.2	27.8	27.0	25.3	26.5	26.9	26.3	26.6	25.9	27.7	28.3	13.6	16.0	16.0	21.9	11.0	9.1	12.1	22.6	11.4	24.5	9.2	8.0	23.3	2.8	21.1	3.7	14.6	47.7	13.1	20.8	9.8	23.4	3.1	11.9	13.0	16.8	12.6	12.6	10.9	16.0	26.8	16.5	18.8	13.4	8.8	28.7	16.8	17.8	24.7	8.4	13.0	18.0	24.4	14.1	8.9	6.7	14.6	11.1	8.8	7.5	14.7	29.3	12.3	19.6	19.1	17.6	21.0	19.2	12.3	6.3	21.7	13.8	18.5	29.9	32.9	14.0	18.6	37.5	25.7	13.1	10.7	39.0	12.9	37.3	19.4	8.9
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COG6	"COD2, KIAA1134"	ENSG00000133103	"Component of oligomeric golgi complex 6"	Q9Y2V7	13	39655627-39791665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040410, HPA040441"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Golgi apparatus"		"HPA040410: AB_10793964, HPA040441: AB_10794030"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	8.7	10.5	2.1	7.9	3.8	2.1	9.7	5.3	5.8	12.0	5.0	9.3	10.5	9.2	4.4	10.6	9.9	10.5	15.8	5.5	2.6	9.8	8.9	6.8	8.3	2.1	2.3	14.2	19.0	18.3	13.3	13.7	3.2	13.0	8.4	7.2	13.0	8.8	6.4	10.1	9.7	7.7	1.7	8.0	12.5	16.4	2.1	8.8	14.0	8.5	7.7	10.2	6.4	6.1	10.8	7.0	10.8	7.7	21.0	26.5	20.6	17.0	24.1	14.2	17.4	8.6	16.8	18.2	9.6	24.7	16.7	13.5	11.5	12.9	15.1	21.5	16.1	17.7	7.0	12.5	12.0	17.9	18.1	11.2	15.9	8.9	10.0	17.8	13.9	16.5	7.5	6.8	23.1	11.0	13.4	16.5	10.6	30.2	8.9	12.8	29.3	8.8	10.0	13.6	6.3	8.2	15.4	12.8	13.0	14.8	14.9	11.2	20.7	7.9	9.3	17.6	8.5	5.3	5.5	13.6	23.4	9.5	23.6	3.0	3.2	4.0	3.8	5.0	6.6	4.7	4.9	5.3	4.5	4.4	4.1	5.4	0.7	7.1	3.1	2.5	6.4	4.2	2.1	3.8	5.3	5.8	5.5	2.6	2.1	2.3	3.2	1.7	2.1	6.1	8.7	19.2	7.8	46.0	12.6	9.7	5.9	9.5	8.0	15.2	11.0	8.4	22.0	2.8	10.2	12.9	10.4	15.6	9.5	9.9	5.9	7.7	23.4	13.9	14.8	8.5	9.1	9.5	123.1	10.0	29.6	12.3	10.7	13.0	10.1	9.7	12.1	9.6	8.6	5.0	99.9	19.8	8.2	6.7	3.9	12.6	13.4	7.6	1.8	37.5	5.9	15.5	7.2	82.9	89.4	8.7	10.8	12.8	17.7	5.0	10.2	12.4	13.2	12.5	6.6	12.2	9.7	39.0	27.4	11.9	13.4	16.0	10.3	12.6	10.3	5.7
COG7		ENSG00000168434	"Component of oligomeric golgi complex 7"	P83436	16	23388493-23453189	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040758, HPA041824, HPA064645"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	8.7	13.1	9.2	7.2	8.7	9.8	10.3	7.5	10.0	14.9	16.7	13.2	8.3	10.9	11.2	12.1	15.0	8.4	10.0	8.6	8.6	12.7	9.5	10.0	6.8	8.8	9.4	13.4	10.2	16.3	23.8	7.5	9.1	16.2	11.8	13.8	13.4	10.4	9.8	12.2	10.5	8.6	7.4	9.8	12.7	10.0	8.8	8.1	14.6	6.4	7.2	11.4	12.2	10.7	10.2	19.5	11.9	13.5	10.4	16.9	10.8	11.2	14.1	12.9	12.9	8.3	17.6	4.8	11.6	17.8	8.2	15.2	10.8	13.8	9.8	15.7	16.3	5.0	15.3	22.2	11.0	13.9	14.2	11.0	11.0	9.9	10.4	16.0	15.2	15.7	12.2	13.6	10.5	29.9	9.3	10.2	10.7	15.7	9.3	18.7	10.3	17.3	14.0	10.0	7.2	9.2	12.6	14.2	9.7	8.9	21.0	17.8	10.7	14.3	7.5	13.4	8.2	12.4	14.1	6.5	19.1	8.1	14.0	8.4	6.7	7.3	6.0	7.7	7.6	3.9	5.5	5.7	8.0	4.6	5.6	8.5	1.6	5.6	10.0	5.7	7.0	4.9	9.2	8.7	7.5	10.0	8.6	8.6	8.8	9.4	9.1	7.4	8.8	10.7	8.0	25.6	16.9	30.3	6.2	6.6	10.1	13.7	10.2	10.1	12.0	12.2	7.2	8.6	19.9	12.9	31.3	12.5	5.5	19.4	1.9	12.0	5.0	24.4	10.8	7.7	19.2	10.8	39.7	13.8	7.6	9.8	27.5	14.2	8.2	13.1	6.1	6.0	6.4	11.8	39.8	19.3	8.2	4.0	2.3	3.6	9.9	7.7	8.8	19.7	4.4	9.2	5.2	45.8	40.6	12.9	11.3	12.4	7.2	9.3	11.6	8.7	39.1	22.4	13.1	10.1	8.6	16.5	13.3	9.1	5.4	11.8	8.9	7.2	15.9	10.7
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"	Q96MW5	16	69320140-69339583	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA041406: AB_2677459, HPA049429: AB_2680763"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	9.9	14.5	19.7	8.5	23.2	6.5	11.1	23.2	24.4	9.8	24.0	10.5	10.5	10.8	14.1	9.9	13.9	7.7	11.2	19.4	19.7	13.4	15.0	10.2	11.3	21.1	20.6	13.7	14.2	19.9	12.0	7.9	21.2	10.3	9.9	7.7	13.8	10.6	18.1	16.3	10.0	10.5	20.3	10.9	11.2	20.3	20.9	12.2	13.0	15.8	11.3	9.4	7.7	28.1	13.2	28.5	18.2	26.7	30.1	21.0	19.4	16.9	18.6	23.0	18.7	26.2	19.8	23.7	18.1	23.0	12.4	24.9	29.5	24.3	19.8	11.9	26.4	17.0	19.9	35.0	21.3	21.1	14.8	25.2	23.5	25.2	14.7	22.2	22.6	20.4	35.4	5.7	16.7	38.3	19.4	31.3	32.2	17.8	20.5	35.6	12.6	33.3	23.6	11.1	26.0	31.1	37.5	15.0	17.5	18.4	35.4	17.8	20.5	16.8	14.4	15.8	14.1	31.3	27.1	36.8	17.3	18.8	19.2	41.4	19.6	20.6	17.8	19.0	19.6	13.3	19.2	18.2	18.6	19.0	17.4	16.7	15.6	22.2	17.6	10.7	19.6	16.8	19.7	23.2	23.2	24.4	19.4	19.7	21.1	20.6	21.2	20.3	20.9	28.1	3.2	9.6	9.7	1.3	9.4	4.2	10.4	5.8	5.2	18.9	7.3	6.7	0.0	24.3	10.6	11.0	18.8	15.0	5.0	12.6	1.9	7.6	17.4	6.1	6.4	7.2	12.7	5.5	1.9	8.0	9.1	7.4	7.1	4.6	7.0	9.0	15.7	28.5	9.5	11.8	2.0	11.7	20.3	7.9	3.3	4.8	12.8	3.1	5.4	1.0	8.4	12.1	10.3	2.0	2.6	5.4	9.5	15.8	9.0	9.6	19.3	15.3	10.2	19.9	13.1	15.5	6.2	9.9	13.6	7.2	4.1	9.2	8.3	5.4	16.7	7.2
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206267	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"fHDF/TERT166: 1432.1;SiHa: 846.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 29.1"	"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		9100000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	105.1	15.7	2.2	16.0	1.9	0.0	65.4	0.8	2.7	112.8	0.4	74.9	8.7	124.5	5.5	36.2	42.2	20.9	25.5	1.0	1.2	25.9	3.5	24.6	7.2	1.8	4.8	123.2	5.9	5.0	4.8	1.8	0.6	20.8	17.2	0.4	16.1	42.4	14.4	48.9	40.6	72.1	0.6	11.4	18.1	4.6	2.0	5.5	19.3	12.5	4.2	26.3	45.8	0.8	0.2	2.2	11.5	0.2	270.2	162.0	28.3	275.4	229.3	186.2	257.3	27.5	0.7	0.0	27.7	1432.1	3.9	59.2	0.5	28.7	174.6	0.2	1.4	0.2	101.1	0.1	97.9	0.3	0.2	234.9	5.0	42.2	50.6	173.6	32.0	0.1	0.0	0.0	29.4	0.2	0.1	0.2	6.4	0.0	15.3	0.1	23.1	0.2	8.9	14.4	0.0	0.0	846.1	21.2	0.3	15.5	131.8	0.5	0.2	78.5	97.0	41.5	91.4	0.1	0.1	0.4	26.4	0.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.8	2.7	1.0	1.2	1.8	4.8	0.6	0.6	2.0	0.8	14.2	76.9	5.1	2.3	0.0	20.6	0.6	12.7	5.2	0.4	4.7	7.1	4.1	0.0	4.7	3.7	0.0	0.6	0.0	0.0	0.0	1.4	24.1	6.3	44.3	11.0	0.0	0.0	52.9	4.6	1.3	99.7	2.6	14.1	1.3	0.1	3.3	0.0	0.8	0.0	32.4	0.0	0.0	0.3	18.4	14.7	60.3	1.8	21.4	38.4	0.0	0.0	0.0	19.6	1.2	6.7	0.0	13.2	0.1	1.7	0.0	0.9	1.7	0.0	46.0	20.0	48.6	0.3	0.6	0.6	13.1	0.7	2.5	1.4	0.1	0.3
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801880-69964275	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Osteogenesis"	"Developmental protein, Heparin-binding"	"Congenital myasthenic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 30.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 10.1;granulocytes: 20.3;Melanocytes: 5.4;Microglial cells: 6.5;NK-cells: 9.2;Smooth muscle cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 63.6;BJ hTERT+: 61.6;hTERT-RPE1: 83.7;HUVEC TERT2: 102.2;PC-3: 93.1;TIME: 137.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050392	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	1.2	1.9	1.5	2.6	1.7	0.3	2.0	9.5	3.3	5.7	1.9	4.6	2.9	1.8	30.4	1.9	2.8	2.4	3.4	1.4	1.5	2.0	0.8	10.9	0.9	1.6	1.6	0.9	2.1	0.8	3.7	1.7	1.8	13.6	3.4	0.0	0.7	8.0	0.9	5.2	3.8	2.9	1.6	8.0	6.2	0.7	1.7	0.3	1.5	1.4	0.8	3.8	1.8	1.5	1.5	0.6	22.1	0.0	0.1	4.3	0.1	63.6	61.6	10.9	5.5	0.0	1.4	0.2	10.5	30.1	1.0	2.3	0.0	0.2	18.9	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.1	9.8	0.1	27.5	9.0	83.7	102.2	0.0	0.0	0.1	10.4	0.4	0.0	0.2	5.3	0.0	93.1	0.1	0.0	10.3	0.4	0.0	2.4	0.0	0.0	0.2	3.4	0.9	0.0	0.2	137.4	0.3	17.1	5.7	45.7	13.4	0.0	0.1	37.2	0.1	51.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.5	1.7	9.5	3.3	1.4	1.5	1.6	1.6	1.8	1.6	1.7	1.5	0.9	0.0	0.6	0.3	0.0	3.4	0.3	0.3	0.6	0.2	0.1	2.0	2.1	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.2	3.4	0.0	0.0	1.4	0.0	0.0	10.1	0.0	0.1	20.3	1.8	1.1	0.0	0.1	0.0	0.3	0.0	0.0	0.3	2.3	0.0	0.0	0.3	5.4	6.5	0.0	0.1	9.2	0.0	0.3	0.1	0.0	0.4	0.3	0.5	0.9	0.0	0.1	0.0	0.0	1.1	5.6	0.5	0.5	0.2	3.0	0.1	0.6	0.5	0.1	0.1
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405165-45513720	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0"	"Region enriched"	"Detected in all"	6	"cerebellum: 22.1"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		290000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	136.4	87.6	14.5	33.9	22.3	15.9	97.1	26.4	21.8	229.4	34.4	91.2	30.4	135.6	35.4	50.1	118.3	28.9	122.2	15.7	18.1	218.2	561.9	83.2	19.8	43.7	28.6	257.3	102.3	7.9	106.5	40.7	39.1	91.0	5.5	5.4	35.8	46.8	26.5	77.8	65.7	28.5	26.6	86.8	44.5	30.0	27.0	9.0	101.1	7.4	7.2	109.8	112.2	45.4	10.5	84.0	20.6	18.0	38.6	31.9	3.3	82.0	139.0	39.1	10.5	48.8	28.9	1.5	309.4	82.8	21.6	37.9	4.6	5.0	7.4	0.7	20.0	47.9	1.4	69.6	37.3	0.7	4.4	37.6	3.3	3.8	4.5	8.5	121.3	0.5	49.6	0.3	14.4	16.7	0.8	3.2	170.6	3.2	30.7	0.7	12.6	4.0	131.6	1.3	22.8	16.3	7.6	7.8	26.6	73.0	7.5	9.9	186.0	0.5	11.4	0.4	17.7	0.4	0.8	1.5	0.1	1.7	32.7	0.8	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.0	0.1	0.0	0.1	14.5	22.3	26.4	21.8	15.7	18.1	43.7	28.6	39.1	26.6	27.0	45.4	156.9	0.0	4.1	6.5	3.9	67.7	15.5	19.0	67.7	13.5	9.3	32.1	15.7	61.5	5.0	112.2	4.2	1.9	3.4	0.1	9.8	117.5	1.5	58.3	99.5	91.2	0.0	33.0	4.9	5.8	1.1	101.1	3.6	144.2	57.8	6.6	75.0	479.6	2.4	0.0	15.8	0.1	4.1	12.1	32.5	6.7	79.9	6.5	49.8	82.4	3.2	141.9	7.2	4.0	28.0	9.9	0.0	126.0	4.6	14.0	0.0	72.9	0.7	6.3	223.5	138.2	268.6	4.1	6.0	7.9	28.6	2.5	15.3	47.5	0.4	2.6
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866556-70212468	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;Excitatory neurons: 66.6;Inhibitory neurons: 164.2;Oligodendrocyte precursor cells: 39.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 9.1"	"Group enriched"	"Detected in some"	218	"memory B-cell: 14.6;naive B-cell: 31.9"	"Lineage enriched"	"Detected in single"	299	"B-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;RH-30: 11.4;SCLC-21H: 3.7;SH-SY5Y: 2.9;SK-MEL-30: 9.6;WM-115: 9.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	0.0	0.1	1.2	1.5	1.6	0.3	0.0	9.1	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.7	2.3	0.1	1.4	0.1	0.0	2.6	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.3	0.7	0.7	0.6	0.1	0.0	0.7	0.0	0.7	0.0	0.0	1.6	1.1	0.4	0.0	1.1	0.0	0.2	3.2	2.2	0.2	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.7	2.9	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	31.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	1.6	9.1	1.9	2.3	0.1	0.2	0.2	0.3	0.0	0.0	2.1	0.0	0.0	0.0	11.1	33.5	0.1	0.2	0.0	0.0	4.4	0.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	66.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.7	0.1	0.0	0.0	164.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	8.4	0.3	0.1	1.0	39.7	10.6	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.7	0.1	0.0	11.2	0.4	1.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8"					"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	7.6	0.6	0.6	1.0	0.0	0.0	2.9	0.5	0.8	0.4	1.0	0.3	1.9	0.2	0.1	0.4	0.3	0.2	0.3	1.4	1.9	0.0	0.0	0.5	2.9	1.2	0.2	0.1	1.4	44.0	0.0	0.6	3.0	0.1	5.2	0.9	2.4	0.7	0.0	0.4	1.6	4.3	0.2	2.2	1.1	2.0	2.1	0.2	1.1	1.2	0.9	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	2.9	0.5	0.3	1.4	2.9	1.2	0.6	4.3	2.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	3.7	2.5	0.0	0.3	0.2	0.3	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	39.6	0.1	0.2	0.8	0.0	0.0	13.0	0.2	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.0	5.9	0.0	0.8	0.0	8.2	0.0	0.0	33.7	0.3	0.3	0.0	1.0	0.6	25.5	0.0	0.5	0.3	3.0	0.0	0.0	0.0	4.8	0.0	0.1	0.2	1.6	0.0	0.1	0.3	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.1	1.9
COL23A1	DKFZp434K0621	ENSG00000050767	"Collagen type XXIII alpha 1 chain"	Q86Y22	5	178237476-178590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 22.1;thyroid gland: 78.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.2;Cardiomyocytes: 11.3;Excitatory neurons: 21.8;Muller glia cells: 62.6"	"Group enriched"	"Detected in many"	4	"renal cancer: 41.3;testis cancer: 16.0;thyroid cancer: 14.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 8.4;NB-4: 9.6;THP-1: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067824	Uncertain					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 5: Muller glia cells - Visual perception"			"HPA067824: AB_2685907"	"unprognostic (5.24e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (3.04e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.37e-1)"	1.3	1.2	0.3	0.0	0.6	1.8	2.4	1.2	0.8	3.5	0.0	2.4	1.0	1.5	0.0	1.3	1.9	0.1	22.1	0.1	0.1	4.6	1.6	2.5	0.1	1.1	0.3	0.3	0.4	0.8	1.6	0.0	0.5	8.8	0.1	2.1	2.0	1.4	2.1	8.5	5.5	0.0	0.1	2.0	2.8	5.2	0.5	0.0	78.5	0.0	0.1	0.7	3.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	1.2	0.8	0.1	0.1	1.1	0.3	0.5	0.1	0.5	0.0	1.8	0.0	0.0	20.2	0.0	2.2	4.2	0.4	1.2	1.0	0.2	3.2	11.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	6.3	2.2	0.0	0.0	21.8	0.0	0.4	3.7	0.0	0.7	0.0	0.6	2.2	0.1	0.5	0.0	9.1	0.0	0.0	2.1	5.0	0.4	0.3	1.8	0.0	4.7	0.1	62.6	0.0	1.0	2.2	0.1	0.0	2.6	0.0	1.9	0.0	0.6	0.0	3.4	6.6	0.1	4.8	1.4	2.5	0.1	4.7	0.1	0.5	0.1	0.0	0.2
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362875-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;liver: 5.5"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 68.4;Inhibitory neurons: 18.5"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	45	"plasmacytoid DC: 9.2"	"Lineage enriched"	"Detected in single"	45	"dendritic cells: 9.2"	"Cell line enhanced"	"Detected in some"		"AF22: 30.0;BEWO: 23.9;HAP1: 10.7;NTERA-2: 25.4;SuSa: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.1	4.4	5.2	0.1	7.4	0.2	0.1	0.2	12.8	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	9.8	1.2	4.9	5.5	0.4	0.5	1.1	0.9	0.4	2.2	3.9	0.9	0.3	0.9	2.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.4	0.2	0.3	1.0	2.0	1.2	0.1	0.0	0.1	0.2	0.1	4.2	0.0	0.8	30.0	1.9	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.3	0.0	0.1	4.7	0.0	0.1	0.0	10.7	0.0	0.0	1.0	1.3	0.0	0.0	7.9	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	25.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.2	19.2	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	5.2	7.4	0.2	12.8	9.8	1.2	1.1	0.9	0.9	0.4	2.0	4.2	0.0	0.0	0.0	3.3	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.2	1.5	0.1	1.7	0.1	0.0	0.0	68.4	0.6	0.4	0.5	0.0	0.2	0.0	1.0	0.0	3.6	0.1	0.0	18.5	0.0	0.0	0.0	0.0	3.5	0.0	0.5	0.0	5.6	0.0	0.0	0.0	3.5	2.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.4	0.0	0.9	0.0	0.4
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155537-114312511	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 93.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 60.1;Extravillous trophoblasts: 75.5;Gastric mucus-secreting cells: 43.8;Hepatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;Hep G2: 48.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in all"	19	"cerebellum: 71.0"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	9.2	8.7	4.0	3.5	3.4	0.3	9.1	29.6	4.8	93.7	3.0	11.2	3.9	39.7	16.1	8.1	16.7	7.9	10.9	3.6	4.7	33.1	42.7	7.0	3.1	7.0	7.9	27.6	21.2	1.0	4.1	11.7	6.5	22.5	1.4	1.5	5.4	13.7	5.8	15.7	6.9	10.5	4.9	4.7	11.9	6.4	6.4	9.2	13.5	2.8	2.2	8.1	37.7	4.3	3.8	7.8	17.9	6.6	1.3	1.9	54.8	8.7	5.9	6.3	5.2	8.1	0.2	0.0	2.1	4.3	4.7	9.2	6.2	8.1	3.4	0.0	0.7	0.0	7.5	48.7	1.9	0.0	19.8	4.9	2.3	7.6	3.4	3.6	9.4	7.4	0.0	1.9	3.6	1.8	0.1	3.5	6.5	15.1	2.1	25.9	18.1	3.7	14.6	4.2	0.3	0.2	0.4	0.2	1.1	6.8	1.6	5.8	8.9	5.5	11.1	0.7	13.9	1.0	0.0	0.0	4.5	0.1	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	3.4	29.6	4.8	3.6	4.7	7.0	7.9	6.5	4.9	6.4	4.3	2.9	3.2	23.0	15.0	0.8	27.1	4.9	14.2	18.2	1.2	24.3	22.1	34.4	60.1	6.1	9.2	6.2	1.0	2.0	0.5	3.9	12.8	3.7	3.3	25.3	7.1	4.8	0.0	11.0	5.1	75.5	15.0	43.8	11.5	0.0	6.9	3.6	43.6	6.5	1.7	4.6	1.8	0.0	1.0	4.1	1.6	19.3	0.8	23.2	8.4	0.1	5.6	0.0	25.6	0.8	4.7	2.5	4.5	0.4	10.6	0.3	9.8	0.6	1.4	26.3	4.9	40.1	0.5	2.0	5.8	22.4	2.3	1.4	23.8	2.4	3.2
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972967-48004554	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 19.1;pituitary gland: 9.2;retina: 5.6;stomach 1: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 43.9;Late spermatids: 9.7;Muller glia cells: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 156.3;HAP1: 98.9;HEK 293: 36.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	No	NA		1400000		"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	1.3	0.0	0.0	9.2	0.3	0.3	1.0	0.3	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.5	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.7	0.0	0.0	0.0	98.9	0.0	0.0	0.0	36.3	0.2	0.0	5.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	11.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.0	0.6	5.7	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	15.4	0.3	0.1	0.2	43.9	0.0	0.2	0.0	0.3	0.5	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	1.7	0.0	0.9	0.3	0.6	1.1	0.0	0.0	0.8	0.1	0.1	1.7	0.1
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974373-189012746	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 2369.0;gallbladder: 2092.8;placenta: 1981.7;smooth muscle: 2140.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2812.0;Fibroblasts: 1764.2;Smooth muscle cells: 643.0;Theca cells: 466.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 15.0;thalamus: 10.9;white matter: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 1362.4;ASC diff: 2465.0;ASC TERT1: 4252.6;fHDF/TERT166: 1815.7;HHSteC: 1690.0;HSkMC: 3189.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 61.1"	"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		32000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	763.6	48.9	1.1	575.5	2.3	1.1	340.0	1.4	15.0	2369.0	11.5	275.9	84.5	768.9	60.9	298.5	177.6	2092.8	234.6	1.3	1.4	42.9	97.4	187.0	119.0	1.8	2.0	146.9	45.2	37.0	13.6	1981.7	2.2	147.5	334.7	0.0	65.6	276.9	67.1	329.8	152.5	2140.7	1.9	134.7	156.9	63.5	10.9	40.9	71.8	71.8	73.1	1097.6	273.8	4.6	0.0	0.2	1362.4	53.0	2465.0	4252.6	0.9	558.6	495.3	239.4	212.8	8.1	0.0	0.6	0.3	1815.7	0.1	0.8	1.1	1.0	26.4	0.0	0.9	0.7	228.9	0.2	1690.0	2.0	0.6	3189.5	0.0	291.5	46.9	1.0	12.5	0.0	0.4	0.0	146.4	0.0	0.2	1.4	2.6	0.1	1.7	0.3	38.5	0.5	0.0	7.2	1.3	21.1	14.5	0.4	0.0	954.8	0.1	0.0	0.7	2.3	28.0	117.3	0.5	2.8	1.3	0.4	0.5	1.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	1.4	15.0	1.3	1.4	1.8	2.0	2.2	1.9	10.9	4.6	111.8	3.2	13.7	0.0	0.6	171.6	0.4	1.9	3.4	0.0	7.7	9.9	11.1	0.0	1.3	0.0	0.0	57.9	1.6	0.0	0.0	2.4	29.0	75.4	2812.0	68.4	6.0	0.0	0.0	0.0	58.1	1764.2	4.1	60.7	6.3	9.7	235.2	0.9	91.1	0.0	0.2	0.0	0.0	0.6	275.3	20.8	323.1	17.5	172.5	20.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	235.9	1.5	0.6	0.0	0.2	1.6	0.0	453.6	224.3	643.0	0.9	1.5	2.2	155.7	126.3	29.1	466.8	0.0	0.4
COL4A1		ENSG00000187498	"Collagen type IV alpha 1 chain"	P02462	13	110148963-110307157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 900.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 401.4;Endometrial stromal cells: 312.2;Endothelial cells: 385.9;Extravillous trophoblasts: 672.4;Sertoli cells: 506.2;Smooth muscle cells: 415.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 501.6;EFO-21: 915.3;TIME: 331.3"	"Low region specificity"	"Detected in all"							CAB001695	Approved				"Secreted to extracellular matrix"	NA	NA		75000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001695: "	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.47e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-2)"	348.4	33.6	10.8	135.9	5.2	0.4	130.4	3.7	9.0	65.7	8.9	108.5	24.8	105.3	14.8	40.8	64.1	116.8	81.9	12.6	5.2	53.4	22.1	137.0	27.7	9.1	7.0	27.0	36.0	36.3	12.8	900.3	7.5	53.6	30.4	1.8	19.0	85.6	40.1	25.2	43.4	312.7	6.8	76.3	50.1	10.7	13.7	10.7	54.7	47.0	11.1	120.8	38.2	6.9	40.0	15.2	195.9	0.3	501.6	148.9	274.9	246.2	59.5	134.0	65.3	4.2	0.8	0.1	915.3	46.2	59.7	26.8	0.0	55.8	30.3	1.3	29.5	0.2	28.2	0.0	142.8	0.0	0.4	49.7	8.9	132.8	59.4	212.8	207.7	0.1	0.3	0.2	31.1	0.1	0.1	0.8	28.1	0.2	3.6	0.4	58.6	0.1	278.8	0.0	1.4	29.8	0.1	0.4	61.0	192.4	0.1	13.9	331.3	39.9	121.4	1.0	97.4	0.3	1.8	3.9	0.4	0.7	297.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	10.8	5.2	3.7	9.0	12.6	5.2	9.1	7.0	7.5	6.8	13.7	6.9	401.4	41.7	8.9	5.2	1.9	14.0	9.7	8.5	2.8	1.0	3.5	16.5	41.1	10.0	0.9	23.9	0.0	49.7	0.5	0.1	1.9	22.6	0.7	19.8	312.2	385.9	0.0	0.0	10.5	0.2	672.4	211.8	1.5	48.7	1.3	215.8	134.6	1.3	27.7	0.0	18.9	0.5	0.0	4.4	19.2	2.8	38.5	4.2	30.2	36.5	0.6	2.5	0.0	1.0	0.9	0.6	0.1	109.4	0.5	6.2	0.5	26.7	2.8	0.4	506.2	142.8	415.1	1.2	5.0	0.8	15.2	45.0	4.2	45.9	0.6	2.2
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513209	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 474.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1041.3;WM-115: 428.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		2700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	240.5	51.2	15.1	103.5	2.3	0.6	153.5	1.7	5.9	111.6	3.4	282.0	29.5	219.4	10.4	51.8	122.9	84.2	113.0	19.3	1.8	71.7	19.1	181.7	22.8	4.3	7.8	51.9	32.6	25.6	17.5	474.0	6.0	121.3	18.9	2.8	35.0	95.8	44.7	45.2	84.1	226.8	2.6	121.5	96.4	15.7	11.5	7.9	74.9	21.5	7.1	186.2	74.4	2.9	88.9	45.7	218.7	0.6	213.7	99.0	312.8	307.9	97.4	167.3	76.1	2.5	0.7	0.6	1041.3	60.0	75.0	85.4	0.1	82.4	27.3	28.1	46.3	0.2	76.6	0.7	150.5	0.5	1.0	42.8	4.5	114.8	71.2	193.5	158.5	0.0	1.3	0.9	25.4	0.3	0.3	12.1	34.2	0.8	11.7	0.6	87.8	0.4	125.6	0.0	6.4	35.4	0.3	0.9	81.2	84.7	0.6	6.7	327.7	94.9	237.9	2.3	161.9	0.6	3.0	7.4	5.8	0.4	428.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	2.3	1.7	5.9	19.3	1.8	4.3	7.8	6.0	2.6	11.5	2.9	313.6	83.3	5.8	17.9	2.9	9.6	8.0	16.3	1.8	2.4	7.0	56.8	31.8	20.0	1.8	53.3	0.0	77.4	0.1	10.0	1.9	39.0	1.7	19.4	308.3	278.2	0.0	8.0	17.7	4.4	512.9	159.1	5.6	50.1	1.3	223.8	102.1	1.8	30.9	0.0	44.0	7.0	2.0	3.3	13.3	3.4	60.6	3.8	39.2	46.9	2.0	7.3	0.0	5.5	1.1	2.8	1.4	176.0	1.5	12.3	23.9	32.7	2.1	0.3	374.7	64.7	338.9	0.9	8.5	0.7	7.0	67.2	3.6	49.4	5.4	2.4
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164624-227314792	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Bipolar cells: 62.1;Cone photoreceptor cells: 398.2;Muller glia cells: 143.1;Oligodendrocyte precursor cells: 84.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 18.8;hTERT-RPE1: 14.5;Karpas-707: 9.9;RPTEC TERT1: 11.0;U-266/70: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.6	11.5	1.9	2.1	1.8	0.3	1.0	1.5	1.7	0.4	21.5	0.8	0.7	1.2	16.3	1.0	2.1	3.2	8.9	1.4	2.0	30.5	0.6	15.0	2.9	3.3	3.1	3.9	5.0	0.2	16.2	0.2	2.7	6.0	1.0	52.9	1.2	9.9	22.2	0.5	6.7	0.8	1.6	7.2	1.8	1.7	6.3	0.4	20.5	15.2	5.6	1.4	1.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.3	1.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	1.2	0.0	9.9	0.0	0.4	0.0	0.1	1.4	0.0	0.0	0.1	0.0	3.2	11.0	2.3	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	9.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	1.5	1.7	1.4	2.0	3.3	3.1	2.7	1.6	6.3	2.2	0.5	169.9	31.7	3.9	14.0	0.1	0.1	0.1	0.6	62.1	0.1	0.9	2.6	1.5	9.3	42.3	398.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	2.4	0.0	0.0	5.5	1.0	0.0	4.6	0.5	0.3	1.3	22.8	0.4	0.2	0.0	1.7	14.1	0.0	0.0	0.0	0.3	0.3	8.4	0.3	1.8	13.1	0.0	143.1	0.0	84.9	3.6	1.0	0.0	12.0	8.0	0.1	0.0	1.9	0.1	11.9	13.1	11.7	3.6	0.4	0.0	0.3	0.3	0.0	1.2	0.1	0.0	0.0
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010504	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Astrocytes: 510.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041695, HPA048256"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		330000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA041695: , HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	47.4	5.0	33.2	9.9	33.2	0.1	32.3	30.6	45.9	44.9	43.6	19.3	3.7	27.3	1.9	9.0	22.8	4.1	33.5	33.3	26.4	7.9	13.4	14.2	3.2	35.2	30.2	6.3	5.2	3.0	3.5	32.8	32.3	16.6	2.0	21.1	7.3	8.9	15.3	21.7	11.7	10.3	31.0	1.7	9.9	4.7	30.2	4.5	12.7	6.0	3.9	12.6	26.4	28.4	0.0	0.0	0.5	0.0	12.4	38.9	0.0	23.6	26.2	14.4	5.7	0.0	0.0	0.0	0.2	4.4	0.3	2.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	28.2	0.6	5.2	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.1	0.0	0.0	0.0	11.6	5.5	0.5	0.0	0.0	0.0	0.0	1.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	33.2	30.6	45.9	33.3	26.4	35.2	30.2	32.3	31.0	30.2	28.4	13.7	0.0	0.0	510.3	0.0	4.2	0.1	0.2	2.2	65.1	0.3	0.9	6.4	0.0	0.1	0.0	6.2	0.1	0.3	1.3	0.0	0.2	6.9	0.4	12.0	8.1	0.0	0.0	15.6	0.0	0.2	17.5	0.5	0.4	0.0	0.0	3.9	22.9	0.6	3.3	3.4	0.0	0.0	0.0	3.2	2.1	17.4	0.4	14.2	36.5	0.1	2.6	0.0	73.9	2.5	0.3	0.1	8.2	0.0	0.3	0.2	0.1	0.9	28.3	92.1	8.5	58.0	0.3	0.3	3.2	7.1	0.1	1.9	0.9	0.0	0.3
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414207	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 391.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Region enriched"	"Detected in many"	4	"spinal cord: 12.0"	"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	150.8	8.3	0.1	126.5	1.0	0.4	74.5	0.2	3.0	212.6	5.2	94.8	22.9	156.3	10.2	44.1	91.8	236.4	61.2	2.4	0.1	5.7	10.3	65.8	30.7	0.6	0.1	123.8	21.1	17.3	2.8	132.9	0.7	47.7	51.7	0.0	45.2	55.4	32.5	35.7	46.6	391.3	0.8	19.0	41.5	15.6	1.8	24.8	38.1	62.3	16.1	188.4	62.7	0.9	0.2	0.5	0.6	0.0	3311.7	4227.5	60.9	815.6	1279.6	167.0	188.2	0.0	0.1	4.5	0.1	818.7	67.4	0.6	0.7	0.9	98.8	2.0	0.1	0.0	0.0	0.0	669.9	0.0	0.4	2705.3	0.0	596.3	1.8	7.8	0.2	0.0	0.1	0.6	6.2	0.0	0.1	0.2	0.5	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	17.3	0.0	0.4	2.9	19.0	45.1	27.6	142.4	1.0	0.0	0.1	859.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	3.0	2.4	0.1	0.6	0.1	0.7	0.8	1.8	0.9	48.2	0.0	10.5	0.3	0.6	61.1	0.5	0.5	1.8	1.0	2.5	2.9	10.6	1.5	3.8	0.0	0.0	4.5	1.2	0.0	0.0	0.9	5.4	11.0	355.2	17.6	0.0	0.0	0.8	0.0	6.2	567.9	6.6	8.7	1.3	1.8	25.4	1.8	8.1	0.0	0.4	0.0	0.0	1.3	85.4	9.6	315.1	5.5	72.9	29.0	2.2	1.1	1.0	0.0	0.3	2.4	0.0	103.4	2.0	0.9	0.0	0.2	1.0	2.3	32.9	19.2	197.7	1.5	1.3	3.3	61.5	5.7	9.3	48.7	0.0	1.0
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"lung: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 3.4;Early spermatids: 5.6;Erythroid cells: 3.8;Fibroblasts: 5.5;Langerhans cells: 5.2;Late spermatids: 3.0;Suprabasal keratinocytes: 3.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	64	"HDLM-2: 15.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.0	0.0	0.0	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.7	0.0	0.0	0.0	1.0	0.8	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.3	0.0	3.8	0.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	3.4	0.0	0.2	0.0	0.0	0.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"parathyroid gland: 97.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SuSa: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"spinal cord: 10.0"	HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		700000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	1.8	0.0	0.0	0.0	0.2	0.2	2.5	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.9	0.3	0.1	3.3	0.0	0.0	0.0	0.8	7.3	0.0	0.0	0.0	0.2	0.0	97.8	3.6	0.7	0.0	0.0	0.0	0.3	1.5	0.0	0.1	0.4	0.0	0.5	0.0	1.2	0.1	0.4	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	1.1	1.3	0.0	0.9	0.0	0.0	0.0	1.1	0.2	0.4	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.9	0.1	0.0	0.0	4.6	0.0	0.0	20.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	3.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.3	0.8	0.0	0.4	0.0	0.9	0.1	0.2	0.0	0.0	0.0
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 98.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 41.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8"									"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		6000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	0.8	1.1	1.4	3.8	1.0	0.1	4.9	2.8	2.1	24.3	0.4	2.9	1.7	12.1	6.7	21.8	6.4	4.0	3.2	0.3	6.5	7.4	1.3	1.7	1.2	7.0	3.2	3.4	0.4	0.0	2.5	1.6	3.0	34.2	0.9	1.4	11.5	12.2	3.5	98.2	4.1	2.5	2.6	6.5	2.1	3.6	6.5	1.2	0.5	0.6	1.3	6.6	29.2	0.6	0.2	25.4	1.2	0.5	9.2	12.3	31.0	65.7	40.8	16.9	10.0	0.4	0.5	0.1	2.0	15.0	15.4	63.5	0.0	100.6	3.1	97.8	0.5	0.2	146.2	4.3	25.6	0.0	0.4	19.9	58.8	34.4	26.8	23.1	0.0	0.7	0.5	0.7	2.0	0.3	0.0	0.9	3.1	1.3	1.3	0.5	2.2	0.2	9.2	0.2	0.2	0.2	82.8	0.1	0.8	3.7	1.3	0.3	0.0	5.6	3.2	3.2	50.1	1.8	1.8	0.1	49.0	0.4	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	2.8	2.1	0.3	6.5	7.0	3.2	3.0	2.6	6.5	0.6	0.4	0.0	0.0	10.7	0.2	72.5	24.1	59.3	67.2	17.7	1.0	10.2	6.6	0.0	10.6	11.0	10.4	1.4	0.1	0.6	0.0	0.9	11.8	3.1	45.3	1.4	1.8	0.0	6.8	0.7	1.0	8.3	1.1	4.0	0.0	0.8	0.4	0.7	1.6	8.4	11.6	0.7	0.0	0.3	4.2	6.3	5.0	0.8	8.8	8.4	0.1	2.6	0.0	4.0	4.4	15.6	0.1	5.7	0.0	5.7	0.2	0.3	2.5	12.9	0.0	2.0	13.4	2.6	1.5	11.3	24.2	1.2	0.8	5.0	0.2	5.8
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 34.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	33.0	7.0	1.7	5.8	2.9	0.0	5.7	1.8	2.6	3.8	4.4	12.4	1.0	5.2	2.7	11.1	9.1	10.8	39.1	1.3	3.0	5.9	0.9	32.8	0.9	3.1	3.9	9.2	1.2	17.9	11.3	4.2	3.4	12.7	6.9	0.5	7.0	12.0	2.3	3.2	3.7	31.5	2.7	1.0	5.3	0.5	2.6	0.4	27.5	7.8	0.5	25.0	5.4	2.5	0.1	0.4	3.0	0.3	142.2	236.4	0.2	68.5	45.7	69.6	138.6	0.0	0.3	0.1	5.9	1098.3	1.9	0.1	0.4	88.2	157.8	0.1	0.2	0.1	7.9	0.0	26.8	0.0	0.1	142.8	3.2	52.6	82.9	431.9	129.4	0.0	0.1	0.2	313.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	144.3	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.1	0.2	471.5	31.0	24.1	1.6	34.2	0.1	0.0	0.1	58.4	0.0	241.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	1.8	2.6	1.3	3.0	3.1	3.9	3.4	2.7	2.6	2.5	4.4	246.8	22.1	0.0	0.4	0.8	0.5	2.8	14.8	0.4	1.8	5.2	4.9	4.3	3.9	9.2	0.0	0.1	0.9	0.0	0.0	0.1	1.3	0.2	2.6	14.1	0.0	0.0	1.9	0.0	0.3	53.3	2.0	0.3	5.1	0.2	102.8	0.8	0.1	0.0	0.7	0.0	0.0	1.9	2.3	1.0	2.1	0.8	1.8	4.7	0.2	0.7	2.1	9.0	0.6	0.1	0.0	9.4	0.5	0.2	0.0	1.6	1.0	0.6	0.0	1.9	51.6	0.3	0.3	1.0	0.6	0.4	0.9	0.1	0.0	0.5
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095239-36125222	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 10.2;Cardiomyocytes: 13.5;Fibroblasts: 13.4;Macrophages: 6.8;Melanocytes: 7.2;Microglial cells: 8.4;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.8;fHDF/TERT166: 4.3;HHSteC: 14.1;hTERT-RPE1: 18.2;THP-1: 4.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"spinal cord: 3.6"	HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	5.2	1.2	2.5	4.4	2.2	0.5	5.6	6.1	2.4	9.0	18.3	5.9	1.4	5.7	1.6	5.8	4.2	4.8	5.4	2.3	2.9	1.1	0.6	4.6	3.1	9.0	4.2	3.3	0.8	0.7	4.0	12.8	7.1	6.1	2.0	0.4	7.4	11.4	0.6	5.5	2.4	3.7	6.1	8.5	9.1	0.9	4.2	4.9	7.5	2.1	3.5	13.3	5.9	5.7	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.8	1.7	1.6	0.9	0.2	0.1	0.0	0.8	4.3	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.1	0.0	0.0	1.7	0.1	0.7	0.0	18.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.1	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.7	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.5	2.2	6.1	2.4	2.3	2.9	9.0	4.2	7.1	6.1	4.2	5.7	0.6	0.0	1.8	0.3	0.0	2.2	2.2	1.8	0.0	0.1	1.3	10.2	13.5	0.0	0.7	0.0	0.0	0.4	1.4	0.0	0.0	0.4	0.1	0.2	0.2	0.7	0.0	0.0	0.2	0.2	0.3	13.4	0.5	0.3	2.5	0.5	1.1	0.0	6.2	0.0	0.4	0.0	0.0	2.0	2.7	0.2	3.1	6.8	7.2	8.4	1.2	0.3	0.0	0.5	0.1	0.6	0.0	6.0	0.1	5.3	0.0	0.0	0.2	0.2	6.6	0.7	1.4	0.0	0.3	0.1	1.3	0.8	1.2	0.3	0.0	0.4
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70216040-70303084	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 68.8"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 310.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 25.7;NTERA-2: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.2	0.0	5.1	0.1	5.3	0.0	0.1	4.5	5.6	0.8	68.8	1.3	0.8	0.3	0.1	0.1	0.2	0.3	9.1	5.6	5.7	1.2	0.0	0.0	0.0	7.1	5.8	0.0	0.3	0.1	5.1	0.0	6.0	15.2	0.5	9.5	1.5	0.3	0.0	0.1	0.9	0.2	5.1	0.0	1.5	4.1	5.3	0.1	0.4	0.3	0.0	1.3	2.9	6.3	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	4.5	5.6	5.6	5.7	7.1	5.8	6.0	5.1	5.3	6.3	0.6	0.0	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	0.0	4.2	0.0	0.0	1.0	1.9	0.0	21.4	1.2	0.1	0.8	1.2	0.0	1.4	0.2	0.0	0.5	0.0	1.7	0.0	1.0	0.0	0.0	0.1	35.3	6.7	0.5	0.0	0.0	0.0	11.6	0.0	0.1	0.0	2.8	0.1	68.5	0.0	310.1	0.6	0.0	0.8	0.4	0.0	2.3	0.0	0.1	0.0	3.2	0.0	0.3	4.2	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.8	0.1
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300489-40317813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.2;pituitary gland: 108.1"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 3.2"	"Group enriched"	"Detected in many"	4	"HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	2.2	3.4	42.6	3.7	71.5	10.9	5.9	58.9	51.1	12.1	21.6	6.5	5.8	5.0	1.7	1.6	11.4	8.5	2.2	38.2	49.7	24.6	0.9	4.3	5.9	65.9	74.1	1.3	2.3	21.0	108.1	1.1	66.2	13.7	3.1	23.1	16.3	24.2	0.2	4.6	10.4	1.4	52.0	9.8	16.5	2.6	58.6	1.8	12.2	0.3	3.1	12.1	2.0	86.2	12.0	0.3	1.8	0.8	2.6	1.3	7.8	0.0	0.0	0.6	1.3	0.4	6.8	3.4	10.0	0.3	0.0	2.0	0.1	0.0	0.3	98.6	1.4	2.0	0.8	27.6	1.5	0.9	90.3	4.8	0.0	0.1	0.0	0.7	0.0	1.5	0.1	19.8	0.0	2.7	1.2	2.1	2.2	0.0	1.2	2.3	0.0	6.9	0.0	14.3	1.4	2.3	0.1	11.8	1.3	6.6	15.0	105.0	0.1	0.0	11.6	0.2	0.4	1.4	0.2	3.4	1.0	12.3	0.6	0.0	0.1	3.2	0.0	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.0	0.0	0.5	0.2	0.3	0.1	0.1	0.0	42.6	71.5	58.9	51.1	38.2	49.7	65.9	74.1	66.2	52.0	58.6	86.2	0.5	0.0	3.3	26.1	10.8	1.0	3.0	8.5	0.0	2.0	7.1	9.7	1.0	7.2	10.0	25.8	0.0	3.2	2.5	7.2	0.0	11.7	0.2	13.6	0.9	0.6	12.7	0.4	0.3	0.8	0.6	2.1	26.0	20.0	26.1	1.6	1.1	0.0	3.4	0.0	0.3	6.6	2.0	0.3	22.4	0.9	2.1	6.4	1.8	3.7	22.1	295.4	1.0	62.4	128.1	4.9	9.6	0.0	4.0	6.1	5.0	0.3	12.9	10.9	0.0	1.3	1.8	3.4	6.2	0.2	0.6	1.4	2.7	1.8	13.4	13.4
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7;choroid plexus: 34.4;thyroid gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8"					"Low region specificity"	"Detected in all"			"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	1.6	1.5	17.5	0.7	35.7	0.0	2.8	22.4	21.6	3.3	34.4	12.1	0.7	1.2	0.2	1.3	1.7	0.1	6.3	13.0	16.5	2.9	0.6	0.4	0.2	37.4	31.0	1.7	7.6	0.1	14.0	0.5	24.2	3.2	0.1	1.6	23.6	1.2	0.5	1.9	3.1	0.1	20.5	0.3	2.7	20.7	31.6	0.1	25.4	0.0	0.0	2.8	3.8	39.7	0.2	0.3	0.3	0.2	0.0	0.8	143.4	0.1	0.0	0.1	0.0	1.6	0.2	0.0	13.1	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.9	0.0	8.2	59.6	0.3	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.0	0.0	1.0	0.7	6.4	8.2	0.0	2.5	0.0	1.8	0.0	0.1	0.0	1.5	0.2	0.1	51.1	4.6	0.2	5.4	0.0	0.0	0.7	0.1	1.0	0.2	0.1	0.0	0.2	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	35.7	22.4	21.6	13.0	16.5	37.4	31.0	24.2	20.5	31.6	39.7	1.6	3.2	0.0	1.0	26.1	3.2	2.2	1.2	1.8	0.9	2.1	2.5	1.6	0.0	0.2	5.5	10.4	5.1	0.4	0.7	1.9	3.6	116.6	2.7	0.4	3.7	4.2	1.3	2.5	0.0	46.4	15.3	6.1	0.7	0.0	0.6	2.5	6.8	2.2	0.0	2.0	3.3	0.0	2.2	0.9	401.9	4.1	1.7	3.6	0.0	0.5	95.8	0.0	84.9	68.9	0.1	7.3	1.5	44.0	1.2	2.3	23.7	2.5	3.7	0.0	0.8	1.0	2.9	7.8	0.9	7.0	4.0	1.4	3.7	2.0	1.0
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.2;liver: 143.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 37.4;Hepatic stellate cells: 89.3;Peritubular cells: 52.3;Proximal tubular cells: 127.1;Sertoli cells: 72.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 135.7;SH-SY5Y: 111.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA035241	Uncertain				"Secreted to blood"	NA	NA		130000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	13.8	40.6	1.0	0.9	1.0	1.9	3.3	4.8	1.9	1.8	6.9	2.8	3.5	1.2	0.4	1.6	4.4	54.2	46.6	1.4	0.9	24.8	143.1	2.4	1.9	1.3	0.5	46.4	13.8	1.2	5.8	2.4	1.3	3.3	0.6	0.5	0.6	1.1	0.6	1.4	3.8	1.1	0.4	3.8	3.1	7.4	1.1	4.0	17.0	0.8	0.2	7.1	1.0	1.3	0.2	1.4	0.7	2.5	0.0	0.0	11.7	0.7	0.0	0.3	0.2	0.7	0.2	0.3	4.0	0.1	0.4	0.4	0.1	0.4	0.3	0.2	0.8	0.6	1.4	5.0	135.7	0.2	1.0	1.6	0.1	0.2	0.0	0.4	0.1	0.8	11.1	0.8	0.0	0.1	0.0	0.8	0.6	0.2	0.9	0.0	0.0	0.5	0.0	0.3	2.1	111.7	1.6	1.1	0.8	0.3	0.5	1.0	0.0	0.0	0.7	0.6	0.5	3.2	26.2	1.5	0.3	1.3	0.6	0.7	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.9	0.3	0.1	0.2	0.1	0.0	1.0	1.0	4.8	1.9	1.4	0.9	1.3	0.5	1.3	0.4	1.1	1.3	7.3	0.0	0.0	0.7	0.6	1.0	0.0	0.0	2.8	0.5	0.1	0.3	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	17.6	0.0	0.3	1.1	22.0	4.2	0.0	0.0	2.2	0.0	1.4	37.4	0.0	0.6	0.0	1.3	89.3	7.9	2.5	0.0	0.9	0.1	0.0	1.9	0.3	0.5	7.5	0.8	3.6	1.0	0.0	1.4	0.0	0.5	0.2	0.1	0.0	52.3	0.0	0.2	0.0	127.1	0.0	0.1	72.3	0.3	18.0	1.3	11.6	0.6	0.9	1.2	0.7	27.0	0.0	0.1
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316737-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 31.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		580000	"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	12.4	1.7	5.1	2.4	4.8	0.2	5.5	4.7	5.7	31.6	9.7	5.5	1.5	9.0	1.0	2.0	6.5	4.4	6.6	4.6	7.2	2.4	0.3	11.4	2.0	7.7	6.5	2.0	1.1	0.9	0.9	20.0	5.2	4.0	2.4	5.3	4.1	1.4	3.1	3.6	3.5	5.1	4.3	0.3	3.4	1.4	6.5	1.3	5.2	2.0	2.5	8.1	4.0	5.5	0.0	0.0	2.1	0.0	2.3	24.3	0.8	12.1	4.2	1.7	3.1	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.0	0.0	20.0	0.0	1.0	0.0	0.7	4.7	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.0	6.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	1.9	0.1	0.0	0.0	2.8	0.4	31.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	5.1	4.8	4.7	5.7	4.6	7.2	7.7	6.5	5.2	4.3	6.5	5.5	6.8	3.2	104.4	34.3	2.1	4.1	3.2	0.0	1.2	6.4	2.6	1.7	4.0	2.8	10.7	3.7	10.4	149.0	1.4	0.3	0.0	0.2	11.1	0.5	3.9	15.8	15.7	2.7	0.5	0.0	5.3	79.6	0.0	0.8	13.9	1.2	5.7	0.4	155.9	6.7	1.4	1.0	0.0	4.9	8.9	31.4	61.5	32.1	1.8	245.4	16.2	74.5	3.1	2.0	10.4	0.3	0.6	7.2	1.2	6.5	1.4	0.2	1.7	12.4	0.0	13.2	21.6	1.3	2.5	1.8	3.8	111.2	4.8	11.6	0.8	1.3
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555649-17583162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No		9700	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	38.6	14.3	5.9	38.1	6.9	32.9	27.5	7.9	8.4	31.1	10.6	27.7	16.2	28.4	4.4	17.9	26.5	19.0	22.4	7.1	9.1	12.7	16.3	34.9	29.7	12.1	9.3	23.5	15.8	9.0	10.1	40.9	12.3	15.5	15.2	3.2	15.9	16.3	15.1	23.9	24.7	35.4	7.6	39.5	18.2	11.9	18.9	9.9	14.7	7.5	15.8	28.1	22.8	12.6	103.1	118.0	56.7	79.8	222.3	136.3	90.9	95.9	55.1	121.8	125.9	90.4	159.6	53.0	164.7	166.9	104.2	91.5	58.4	110.6	73.4	29.5	94.9	51.2	147.4	87.9	121.6	123.0	147.8	115.2	97.6	136.7	56.7	49.7	138.8	33.3	105.5	25.8	45.1	45.6	61.9	81.1	43.0	75.8	115.3	65.2	73.8	80.9	26.4	67.2	41.2	29.9	102.8	80.6	97.0	36.7	41.9	177.7	98.7	240.8	67.7	215.3	156.2	45.4	125.1	58.3	142.7	232.4	113.0	1.7	25.7	12.5	5.2	28.1	2.8	3.5	4.8	4.9	18.1	3.3	3.4	5.3	3.6	2.1	20.8	7.0	3.1	14.5	5.9	6.9	7.9	8.4	7.1	9.1	12.1	9.3	12.3	7.6	18.9	12.6	35.0	19.2	23.5	11.1	10.3	19.5	7.0	10.4	10.8	3.7	8.8	9.5	11.2	10.0	15.5	11.0	6.2	7.9	28.6	14.7	0.0	13.1	3.6	8.5	28.5	29.3	5.4	10.3	10.9	8.2	76.2	30.9	20.9	13.6	8.8	20.3	7.9	14.2	91.0	13.5	9.9	15.1	4.1	70.7	24.1	3.1	19.0	59.6	17.8	19.7	26.6	2.3	10.3	6.6	12.8	10.4	7.6	21.8	6.0	9.5	9.5	4.4	8.7	3.6	13.1	9.5	24.3	2.5	13.1	13.8	20.9	8.3	12.0	24.9	18.2	8.4
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 50.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.5;Excitatory neurons: 79.9;Inhibitory neurons: 71.5;Late spermatids: 76.2;Oligodendrocyte precursor cells: 115.1;Oligodendrocytes: 359.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"basophil: 11.1"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.1;OE19: 13.8;SK-MEL-30: 18.6;U-251 MG: 18.0;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	1.7	6.4	15.7	0.8	29.3	1.1	1.5	22.7	18.6	1.0	0.0	4.3	0.5	1.8	3.1	0.7	2.8	2.3	11.4	16.5	17.3	0.8	0.2	3.7	0.3	26.8	24.0	1.3	2.3	0.5	2.2	0.1	28.7	5.3	0.9	3.5	2.9	2.2	8.8	0.3	1.0	1.7	20.2	0.5	1.9	3.5	25.8	0.3	3.3	6.3	0.5	1.8	1.5	50.6	0.1	0.0	5.7	0.4	3.0	4.4	0.1	1.8	0.7	0.8	1.0	2.8	0.2	0.0	0.5	4.4	1.1	0.0	5.6	0.0	1.4	6.6	3.3	0.4	0.0	17.1	0.1	6.0	0.1	2.6	0.0	0.8	0.1	8.4	0.0	0.2	5.7	7.2	6.1	0.2	0.3	0.3	3.9	13.8	0.0	0.5	0.0	0.0	0.0	1.2	2.2	3.5	0.3	0.0	18.6	3.7	0.0	0.3	0.1	0.7	0.7	0.1	18.0	10.8	0.1	0.1	0.5	2.8	22.5	11.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	15.7	29.3	22.7	18.6	16.5	17.3	26.8	24.0	28.7	20.2	25.8	50.6	0.1	0.0	0.0	53.5	0.0	0.4	0.5	0.0	0.0	4.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.6	40.3	0.2	0.5	0.9	0.0	1.3	79.9	0.0	0.0	9.9	1.5	0.5	0.0	0.2	0.0	0.1	0.3	0.0	71.5	0.1	0.0	0.3	9.5	76.2	2.1	0.9	1.8	4.7	0.0	5.7	8.2	115.1	359.3	1.2	0.0	4.1	1.9	0.2	0.0	0.3	0.0	0.4	13.1	2.3	3.1	0.3	1.3	0.0	0.4	0.0	4.5	0.4	0.0	0.4
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: AB_2680680"	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	20.8	26.4	22.2	21.9	23.4	20.4	27.0	25.2	33.0	23.0	22.9	18.6	22.6	20.0	30.1	24.8	20.9	20.2	54.7	23.5	22.9	31.2	35.9	18.7	23.5	22.1	22.1	21.3	24.1	24.4	14.8	26.5	22.6	22.2	22.6	20.1	33.5	20.2	35.2	22.2	14.9	29.9	22.4	20.6	19.2	24.4	22.2	20.7	28.1	38.1	25.5	23.9	19.8	24.1	23.2	29.1	32.0	25.4	41.2	41.2	27.4	27.2	45.6	53.7	37.9	50.1	20.4	40.4	22.3	50.8	45.8	17.6	18.0	33.1	55.8	43.9	21.1	31.5	16.3	56.0	35.1	49.6	23.8	34.6	37.7	26.1	30.8	39.2	54.6	23.2	19.6	64.3	56.7	43.6	38.6	87.4	27.9	19.0	39.0	27.1	42.4	46.7	49.3	25.0	19.5	21.7	30.7	50.9	28.6	31.8	32.4	21.4	25.9	48.1	41.5	30.2	42.4	26.6	22.9	48.6	26.5	42.8	42.8	62.4	96.2	48.4	63.0	86.5	63.4	91.8	71.5	72.0	117.3	84.7	68.1	73.8	8.1	91.1	78.4	109.5	88.8	110.8	22.2	23.4	25.2	33.0	23.5	22.9	22.1	22.1	22.6	22.4	22.2	24.1	53.0	35.3	33.8	56.8	38.2	54.4	73.8	98.7	47.8	35.4	47.0	72.4	176.7	41.5	57.3	35.0	10.4	127.3	37.3	27.4	129.1	71.5	195.6	50.6	52.1	53.2	21.6	43.1	91.9	65.1	75.5	67.6	32.1	47.2	57.7	60.4	52.5	72.4	101.7	28.6	78.4	29.8	63.1	36.0	81.3	163.5	41.3	46.3	83.6	71.2	118.6	45.3	30.9	89.5	109.7	57.1	37.1	49.7	71.5	48.9	49.0	192.3	49.1	33.2	32.9	57.6	97.2	124.5	58.7	49.6	61.7	147.2	38.6	81.6	30.1	64.0
COMMD10	PTD002	ENSG00000145781	"COMM domain containing 10"	Q9Y6G5	5	116085016-116412762	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045441, HPA054156"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045441: AB_10961905, HPA054156: "	"unprognostic (1.14e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.59e-1)"	19.4	24.1	12.5	14.2	12.4	14.9	23.1	12.8	15.9	19.2	14.4	17.0	13.0	16.7	32.2	15.6	12.9	17.3	31.3	11.7	13.3	35.4	24.6	13.9	22.1	12.8	13.2	13.9	24.1	25.4	14.3	19.6	13.4	20.7	20.1	17.1	30.7	17.0	14.3	9.6	13.8	19.6	13.5	18.6	16.3	8.1	13.2	16.3	27.4	17.5	20.3	18.0	13.6	14.7	34.7	36.7	37.5	20.0	27.3	37.1	40.2	26.5	30.0	37.5	31.0	29.2	43.7	17.9	29.0	37.9	75.0	18.6	20.8	42.6	56.9	49.3	14.6	22.1	10.7	22.9	30.8	17.5	37.1	23.7	28.7	22.4	29.2	31.1	37.9	25.2	13.6	12.1	50.2	24.2	32.9	41.9	32.7	26.8	16.9	30.9	40.1	51.2	54.7	21.8	20.2	26.0	31.3	30.5	39.7	28.1	34.6	64.1	20.9	31.5	38.5	15.3	46.0	11.9	16.3	45.8	32.1	63.2	36.5	13.6	24.6	18.3	9.9	29.7	13.7	16.2	12.9	12.8	32.7	11.3	12.5	13.0	4.7	22.7	31.0	24.9	15.3	18.9	12.5	12.4	12.8	15.9	11.7	13.3	12.8	13.2	13.4	13.5	13.2	14.7	25.7	9.6	20.0	97.3	36.7	22.2	30.4	54.0	17.6	15.7	28.1	18.3	48.9	11.5	29.5	23.9	6.2	44.9	16.9	11.5	92.0	26.2	1.9	15.8	22.2	24.0	10.7	18.5	84.8	15.1	53.4	25.0	27.0	22.8	46.3	22.5	26.4	15.1	48.7	16.8	90.5	25.1	46.8	28.7	38.4	3.7	21.1	33.1	32.0	184.6	27.1	30.2	15.5	142.7	236.7	17.1	17.2	20.3	30.6	33.1	17.3	101.3	10.4	20.9	0.0	13.4	22.4	8.7	15.6	20.5	25.1	49.5	28.4	36.3	25.5	32.0
COMMD2	HSPC042	ENSG00000114744	"COMM domain containing 2"	Q86X83	3	149738472-149752495	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044190	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 5: Breast - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA044190: AB_10966289"	"unprognostic (2.17e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.86e-2)"	8.6	7.4	8.5	7.5	9.4	8.9	15.2	9.3	10.6	11.6	8.3	7.3	7.9	13.4	7.3	8.9	8.2	7.7	8.5	8.4	8.5	10.5	9.1	12.6	10.8	9.0	9.0	12.4	6.4	10.3	4.3	13.8	9.0	9.3	8.4	10.6	8.4	8.4	6.4	9.6	6.7	12.3	9.0	10.1	7.2	5.2	8.9	12.3	14.0	8.0	10.4	7.5	7.4	10.2	27.4	7.8	25.2	14.7	21.6	24.7	16.6	16.8	17.6	25.6	25.6	13.9	16.6	22.0	18.6	16.5	16.0	17.1	24.4	20.6	29.7	16.2	22.9	19.8	9.8	9.4	22.9	28.6	8.6	18.8	22.3	12.7	22.5	17.3	18.3	13.6	9.8	12.0	18.5	8.6	20.0	14.0	27.9	16.6	10.4	18.2	25.6	29.6	24.5	7.2	11.5	17.6	19.7	15.6	37.0	20.0	28.9	18.7	16.0	14.9	5.9	15.1	20.2	21.5	9.0	35.8	14.6	25.5	6.3	16.9	6.3	11.2	5.8	9.6	8.5	6.6	7.1	7.1	8.0	6.1	7.4	7.9	4.7	9.7	12.5	4.9	6.3	7.3	8.5	9.4	9.3	10.6	8.4	8.5	9.0	9.0	9.0	9.0	8.9	10.2	48.5	64.1	25.7	11.8	41.8	20.9	37.0	60.9	26.7	55.5	39.1	47.9	16.5	31.5	58.7	22.0	187.7	55.2	41.9	18.6	43.0	55.4	3.2	26.1	37.7	42.7	24.6	26.9	21.6	39.7	60.8	36.8	25.5	23.9	46.3	35.3	40.7	16.9	45.5	28.6	16.2	17.5	52.9	29.2	52.8	4.8	36.4	30.1	33.8	16.9	91.0	33.0	36.0	21.1	25.4	55.0	22.2	36.1	32.0	28.7	26.5	31.7	33.0	116.8	52.6	29.3	35.3	65.2	47.9	35.9	21.6	31.9	37.2	45.7	20.8	23.9
COMMD3	"BUP, C10orf8"	ENSG00000148444	"COMM domain containing 3"	Q9UBI1	10	22316386-22320306	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 432.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 307.8;U-937: 403.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036584	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036584: AB_10670803"	"unprognostic (3.11e-2)"	"unprognostic (5.97e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (5.46e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.88e-3)"	30.9	35.3	33.3	38.3	35.7	38.1	52.6	36.8	45.0	29.1	33.9	38.2	37.5	31.0	47.8	38.1	34.6	32.9	79.8	34.7	35.8	38.7	62.8	28.2	45.4	36.3	34.2	23.4	51.7	53.5	24.9	22.8	35.6	36.7	36.8	29.5	51.8	30.7	75.4	36.6	36.8	38.9	37.0	32.5	33.0	32.1	33.7	61.2	33.1	76.2	43.4	39.6	21.0	41.0	53.8	65.0	23.5	14.4	91.0	97.0	22.7	48.1	48.3	45.8	60.4	16.9	77.8	61.6	47.7	58.8	41.8	33.4	37.8	68.5	34.8	307.8	44.1	80.2	23.1	62.7	87.8	29.0	66.5	86.3	74.6	35.7	35.2	67.8	92.5	93.7	55.0	70.6	103.5	47.8	126.2	29.6	5.7	69.0	101.5	54.9	57.5	89.0	64.8	30.2	14.4	54.3	38.1	71.8	85.8	20.2	48.8	199.1	82.4	30.3	77.3	73.0	42.1	94.4	93.0	63.9	67.5	403.0	28.7	154.6	98.0	73.1	48.5	97.8	56.8	93.2	63.3	52.0	117.8	85.2	39.9	48.8	15.2	83.2	87.6	140.3	83.2	118.3	33.3	35.7	36.8	45.0	34.7	35.8	36.3	34.2	35.6	37.0	33.7	41.0	37.6	41.7	31.7	0.0	59.0	38.2	48.4	148.4	18.2	42.0	52.7	82.5	98.8	30.0	73.0	33.1	14.6	61.0	55.2	20.9	117.4	83.0	432.9	42.2	35.7	37.9	41.3	69.2	0.0	82.9	53.4	42.6	19.4	27.4	54.5	43.7	30.7	61.5	99.0	45.4	0.0	43.4	118.0	51.8	48.3	97.0	58.7	47.6	53.4	0.0	103.6	71.4	52.5	0.0	0.0	67.0	36.7	56.8	63.2	29.1	67.1	102.2	72.1	65.2	46.0	45.7	66.6	35.6	42.9	20.5	51.1	26.1	34.7	51.4	40.7	44.7
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 10.1;testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8"									"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"		"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				0.9	2.2	0.4	1.0	1.4	0.3	0.8	1.0	1.9	1.5	0.8	0.8	0.6	0.4	0.0	1.8	1.3	0.2	3.0	0.3	1.6	0.4	0.5	0.9	1.0	1.3	0.7	0.6	0.8	0.4	0.1	0.7	0.9	0.5	0.2	10.1	1.8	2.7	6.4	0.7	0.8	0.3	0.4	0.9	1.1	6.7	1.3	2.0	0.4	2.3	1.5	1.0	0.8	2.0	2.1	6.4	3.9	0.2	2.5	2.3	0.4	0.9	1.3	1.4	5.8	7.8	1.2	1.9	0.8	3.0	5.1	1.1	2.8	2.2	1.3	23.3	2.4	5.4	1.5	0.0	1.7	0.6	3.0	2.9	3.2	3.3	0.1	4.3	1.6	8.3	1.4	2.8	0.8	0.0	12.7	0.9	0.4	3.9	2.1	1.7	3.1	1.7	0.5	1.9	0.4	2.7	5.5	1.1	0.2	1.4	0.0	4.7	6.8	2.3	3.9	1.3	0.7	4.9	0.9	3.5	1.2	23.8	0.0	7.4	2.1	3.0	3.4	2.4	3.7	7.5	3.2	4.1	2.2	7.3	2.4	1.8	0.7	4.9	1.3	0.3	6.5	4.9	0.4	1.4	1.0	1.9	0.3	1.6	1.3	0.7	0.9	0.4	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75336020-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039935, HPA066957"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Vesicles, Plasma membrane"	"HPA039935: , HPA066957: AB_2685754"	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	36.2	72.3	38.8	33.5	39.4	52.9	36.8	40.5	50.4	31.1	43.7	41.6	48.3	30.3	30.2	39.9	34.6	37.3	38.9	36.9	39.7	54.6	51.0	34.6	44.7	39.5	38.1	24.4	33.8	48.9	33.9	31.2	38.6	34.2	33.8	13.4	43.4	34.0	30.3	35.0	42.2	24.7	40.8	41.3	42.5	81.2	42.4	53.3	38.8	15.3	36.7	33.6	31.8	42.0	138.2	222.5	97.5	124.8	42.3	64.9	98.5	98.8	106.2	191.2	196.6	133.8	184.0	88.8	100.2	79.5	168.8	144.8	175.2	116.5	82.7	70.1	242.4	104.8	169.8	151.0	76.4	79.4	111.0	74.3	63.6	116.2	21.9	48.4	96.5	103.6	108.2	128.1	147.1	179.7	71.0	117.4	140.9	75.2	127.9	127.5	137.4	127.8	98.6	127.8	79.2	114.8	131.2	105.1	169.8	63.8	164.7	160.9	78.6	135.3	119.2	125.8	184.8	93.4	218.7	101.4	138.9	181.9	125.4	27.0	44.1	40.7	84.7	61.8	52.8	47.5	51.7	63.2	50.0	46.4	31.9	47.4	9.5	76.8	55.6	70.6	87.6	39.4	38.8	39.4	40.5	50.4	36.9	39.7	39.5	38.1	38.6	40.8	42.4	42.0	43.7	28.9	52.4	15.0	26.2	27.0	44.8	58.5	28.5	40.7	44.3	50.3	18.7	38.6	46.2	35.0	31.3	80.9	34.8	59.6	58.7	72.6	12.2	37.1	44.9	42.7	30.5	60.8	9.0	78.7	107.0	43.4	33.1	45.7	41.8	91.1	37.5	41.9	127.5	16.8	8.8	72.8	44.7	35.8	27.0	17.6	49.0	41.3	37.4	11.2	28.5	78.1	53.5	7.1	17.6	72.4	61.7	34.3	43.0	26.6	71.2	98.1	39.8	49.4	46.0	36.1	59.3	152.9	63.5	34.3	30.7	50.8	32.2	53.4	58.7	48.7
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.8	32.1	33.8	21.8	34.1	50.8	24.3	35.1	36.7	17.2	29.6	19.6	21.1	14.1	25.1	24.9	20.3	20.5	31.1	33.8	33.8	38.7	36.6	26.8	26.0	34.2	34.4	19.4	26.4	27.4	23.2	24.8	33.9	14.0	24.2	20.3	21.9	13.3	64.2	27.1	20.2	21.9	36.9	26.8	19.7	14.9	36.0	30.6	25.1	61.7	32.0	20.6	16.6	39.1	28.8	33.4	36.1	38.2	54.5	37.8	20.0	33.6	42.6	74.7	69.8	27.3	23.9	33.0	32.5	67.1	57.5	41.4	64.0	45.2	69.6	39.9	75.2	18.2	57.6	48.0	51.0	71.6	52.3	48.0	49.5	40.9	25.0	38.5	62.2	43.3	45.7	34.7	59.4	36.9	47.9	49.6	38.5	55.6	70.3	52.1	81.7	38.9	78.6	26.6	44.1	49.2	47.9	47.1	43.6	29.2	102.7	27.0	41.9	45.0	34.4	107.9	49.8	24.3	53.2	37.2	51.8	66.4	44.0	85.6	376.6	173.7	91.4	359.0	86.8	130.7	87.5	88.4	383.6	138.3	99.8	83.4	42.7	94.8	300.9	145.8	114.5	315.2	33.8	34.1	35.1	36.7	33.8	33.8	34.2	34.4	33.9	36.9	36.0	39.1	26.9	22.4	29.4	2.6	27.0	15.3	12.7	37.4	13.1	16.6	25.6	38.7	29.9	12.8	20.2	18.4	10.4	43.2	28.3	16.9	78.2	70.1	9.5	13.2	20.3	22.8	25.7	23.1	9.4	46.4	52.9	21.2	11.7	17.0	19.0	25.6	15.4	17.1	105.1	5.0	8.7	20.4	34.6	59.5	35.6	28.9	17.7	57.5	24.9	1.9	61.3	36.3	33.0	4.5	8.8	46.5	17.7	11.7	10.4	4.9	30.3	62.5	8.5	22.9	13.1	12.3	22.8	32.8	33.3	19.6	21.6	24.9	19.2	28.4	24.6	12.0
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233641-75236030	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	11.0	17.9	1.1	1.0	1.5	1.5	9.8	1.2	1.8	18.3	5.8	23.3	7.4	7.5	0.4	70.6	7.2	0.4	33.5	1.3	1.7	29.1	37.5	11.7	0.6	1.7	2.0	8.0	128.6	3.4	17.1	0.9	1.7	11.8	1.0	1.1	23.9	1.0	28.2	25.3	25.2	0.5	1.1	12.4	27.8	3.4	1.6	0.5	18.5	0.7	0.7	8.3	29.0	0.9	6.9	2.2	0.5	1.3	0.1	0.7	19.0	2.1	1.0	0.3	0.6	1.6	6.0	20.0	3.5	0.4	1.1	9.0	0.9	1.9	0.1	3.2	30.2	0.8	4.8	3.3	1.1	3.5	3.3	0.6	3.2	0.1	2.9	1.3	0.3	3.6	7.8	4.7	0.1	6.2	5.3	11.0	1.2	5.1	38.3	10.6	1.3	24.5	1.8	0.6	8.4	2.3	2.4	16.0	4.8	0.5	8.9	0.5	1.4	0.6	5.9	1.2	2.1	21.5	4.5	9.8	0.7	3.4	0.6	0.0	7.1	3.9	10.6	10.0	11.6	7.1	10.6	11.0	8.5	5.6	3.5	6.1	1.4	7.3	9.4	15.3	8.9	6.8	1.1	1.5	1.2	1.8	1.3	1.7	1.7	2.0	1.7	1.1	1.6	0.9	23.6	19.2	11.5	1.6	18.2	29.4	40.5	54.1	133.1	6.0	29.3	37.1	31.1	57.2	33.8	53.3	10.4	33.4	30.8	334.8	144.8	162.8	1.6	10.5	7.7	13.5	40.2	16.0	3.4	249.5	79.1	13.4	148.8	33.4	12.7	10.3	25.4	84.0	35.1	1.7	3.9	206.0	42.7	24.2	21.3	3.5	9.6	21.8	37.4	6.5	31.8	10.7	24.7	1.5	0.5	109.2	272.5	7.2	50.8	38.7	435.9	140.3	11.3	34.5	32.9	6.2	25.6	2.6	3.4	285.3	38.2	30.4	29.2	10.7	143.8	56.7
COPA	HEP-COP	ENSG00000122218	"COPI coat complex subunit alpha"	P53621	1	160288594-160343273	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	47.7	43.1	46.6	38.5	48.9	30.0	42.0	57.2	57.1	52.9	67.4	42.3	53.7	46.7	55.1	38.3	41.2	38.6	55.1	48.6	53.7	48.6	55.0	47.0	36.1	57.9	51.0	46.9	49.9	51.8	59.8	48.3	60.0	43.5	47.9	26.2	57.6	39.4	59.1	40.0	49.0	50.0	53.9	42.7	43.5	24.4	51.1	37.6	60.1	38.2	38.9	41.3	37.9	66.4	91.0	68.5	70.1	66.9	164.9	154.7	78.6	116.5	144.3	103.1	138.7	72.0	60.5	64.4	73.3	194.0	57.7	86.0	92.0	81.3	126.5	68.6	64.3	76.8	95.2	79.0	115.1	94.1	74.5	134.8	49.1	140.0	128.9	126.3	126.4	64.4	71.9	69.7	124.4	43.6	49.3	53.3	80.1	97.3	79.0	49.2	89.2	118.9	94.3	94.7	62.1	84.3	157.3	109.2	148.0	115.0	140.4	133.9	162.8	84.3	54.1	108.2	80.2	106.8	76.3	106.6	104.2	51.3	122.8	48.1	39.0	25.4	18.6	36.7	25.5	17.8	16.7	21.3	40.4	14.2	14.3	17.9	10.9	26.7	36.2	17.8	22.9	35.5	46.6	48.9	57.2	57.1	48.6	53.7	57.9	51.0	60.0	53.9	51.1	66.4	53.6	76.9	54.7	44.7	66.4	28.2	35.5	41.6	29.6	52.4	53.0	41.3	51.8	42.9	49.7	40.5	81.3	41.0	83.2	66.8	13.7	49.9	14.7	50.7	68.1	50.4	55.3	37.0	77.6	49.6	63.3	66.2	65.2	64.3	45.6	63.0	52.8	71.1	51.2	45.4	73.8	83.8	30.5	93.7	58.0	6.4	71.1	84.3	26.6	67.5	75.0	41.0	38.1	65.9	178.9	55.5	48.1	56.8	115.9	52.9	98.9	41.4	66.2	53.7	39.5	57.6	52.4	37.6	25.7	35.8	31.8	69.2	58.3	58.1	66.6	61.2
COPB1	COPB	ENSG00000129083	"COPI coat complex subunit beta 1"	P53618	11	14443440-14500027	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	48.1	47.1	19.9	55.0	21.8	79.8	62.6	26.2	25.3	64.9	44.7	59.8	57.7	52.6	69.3	46.7	49.2	54.9	43.7	20.1	23.6	65.3	73.6	49.9	59.1	24.2	21.8	49.1	59.2	67.6	48.4	69.2	23.7	66.9	67.1	39.3	67.5	53.8	33.1	36.6	58.8	61.1	23.5	46.3	59.7	46.8	23.0	68.1	81.0	38.1	64.5	60.4	40.0	27.6	134.9	113.6	118.6	89.4	193.1	221.3	95.9	199.2	206.5	173.1	202.0	89.1	203.5	130.1	87.1	252.9	164.6	144.7	134.6	133.3	212.1	122.7	114.0	138.3	74.3	135.8	171.3	128.9	134.4	156.3	172.4	116.0	217.8	158.9	183.7	71.6	104.5	103.8	221.1	101.6	117.2	78.7	61.7	163.3	123.1	94.9	163.1	89.0	156.1	123.3	75.6	81.2	154.2	123.2	104.8	135.5	112.3	110.1	189.5	166.2	85.4	181.3	110.1	55.2	100.5	143.8	125.1	79.2	158.6	52.8	38.7	43.5	45.7	47.8	55.7	38.4	38.1	47.6	52.3	32.0	37.8	39.8	31.2	44.6	49.8	31.1	44.8	43.2	19.9	21.8	26.2	25.3	20.1	23.6	24.2	21.8	23.7	23.5	23.0	27.6	55.6	109.0	63.2	29.0	64.3	38.9	59.7	82.6	52.3	28.4	43.0	27.9	31.3	35.8	107.8	44.1	27.1	65.4	71.2	55.9	41.1	77.1	17.2	72.6	81.4	55.5	43.8	50.9	36.9	81.7	69.6	70.5	63.2	72.5	65.2	50.7	51.4	58.1	60.9	18.5	39.1	87.5	61.1	50.7	43.5	10.7	51.0	61.5	21.4	35.6	70.1	34.0	44.3	32.6	49.6	93.6	37.5	55.3	107.4	54.3	60.6	57.3	131.9	29.5	52.6	60.8	78.7	87.5	64.3	48.7	35.8	117.0	77.0	49.3	51.5	60.7
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"COPI coat complex subunit beta 2"	P35606	3	139353946-139389736	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		63000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	46.7	58.2	17.9	50.5	19.7	22.3	60.4	20.4	21.0	76.5	35.9	62.5	57.4	48.5	62.5	55.0	47.5	48.4	47.9	17.4	21.8	52.9	71.1	44.3	44.8	20.5	18.9	38.9	89.7	68.2	60.0	68.9	20.4	72.2	71.7	37.0	71.1	57.0	33.5	37.4	53.4	63.5	20.8	42.8	60.7	35.0	20.2	54.4	64.3	31.2	61.5	56.2	42.2	25.0	192.1	84.0	111.2	99.0	247.2	214.9	96.8	223.9	235.9	158.2	204.7	143.4	83.5	90.2	203.0	287.1	145.1	110.9	136.2	141.0	210.6	139.0	85.2	138.2	114.9	152.3	152.7	121.9	139.7	160.1	114.7	132.2	138.5	178.6	161.6	76.5	86.7	105.7	199.4	138.6	59.4	59.7	102.2	215.0	99.5	75.8	93.6	149.5	141.2	133.4	85.2	61.7	254.6	212.0	147.2	168.6	193.2	123.2	185.1	90.3	66.4	122.8	83.7	148.0	80.8	129.7	115.2	61.0	138.0	74.4	49.8	52.0	36.0	56.3	35.8	35.3	31.0	37.6	57.7	23.8	24.2	31.1	45.0	44.1	57.2	30.2	38.1	44.2	17.9	19.7	20.4	21.0	17.4	21.8	20.5	18.9	20.4	20.8	20.2	25.0	36.6	57.7	46.6	18.3	45.8	19.6	39.5	61.2	29.6	38.0	41.3	29.3	58.5	32.9	74.5	20.2	31.3	83.3	34.9	52.4	41.1	83.4	40.8	64.9	62.9	45.2	63.9	51.1	25.1	82.1	76.1	66.6	75.4	54.8	45.0	50.4	36.4	48.5	52.7	42.1	25.5	86.7	46.8	34.6	21.3	8.6	54.7	42.8	21.4	13.1	60.1	62.0	29.9	20.1	30.8	79.7	34.8	50.0	118.6	46.6	46.9	42.4	108.6	51.1	19.7	47.3	69.6	83.1	45.6	36.5	14.9	133.1	37.5	74.4	44.7	52.9
COPE	epsilon-COP	ENSG00000105669	"COPI coat complex subunit epsilon"	O14579	19	18899514-18919387	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"		NA	NA		66000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563"	"unprognostic (1.48e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	102.3	163.7	127.2	85.5	133.4	159.6	100.3	139.4	176.0	101.3	131.3	113.8	90.5	104.1	45.0	160.3	89.8	44.1	135.2	122.4	131.0	141.9	194.3	108.3	91.7	140.6	132.0	80.8	152.0	80.8	160.1	59.3	130.0	127.4	37.7	23.5	144.2	65.4	128.0	120.9	107.8	42.9	137.1	150.0	126.8	171.9	135.9	82.4	123.7	50.0	56.9	99.2	107.1	151.2	186.7	177.4	99.3	177.3	89.0	104.7	287.2	159.2	150.8	174.8	198.7	215.1	148.2	150.8	210.5	134.9	112.9	123.2	82.5	161.0	33.9	94.2	369.9	89.6	150.9	331.1	236.1	180.0	221.1	128.3	149.2	106.2	115.6	92.5	138.9	170.5	140.2	373.6	90.0	443.0	196.9	341.0	188.4	243.0	420.2	222.4	89.6	448.2	115.8	185.4	138.8	222.4	100.0	159.1	181.1	44.9	134.8	291.3	140.9	110.5	81.5	283.3	170.9	357.7	337.5	187.7	189.1	309.9	187.3	656.0	598.5	639.1	337.1	533.1	298.1	391.2	321.9	298.6	528.4	381.9	236.4	270.9	594.9	344.4	468.5	659.3	449.3	930.0	127.2	133.4	139.4	176.0	122.4	131.0	140.6	132.0	130.0	137.1	135.9	151.2	110.5	3.2	16.2	22.2	204.7	159.8	197.9	390.9	54.1	53.2	140.5	111.6	10.4	111.5	205.8	115.8	29.2	386.5	242.8	408.9	463.7	323.7	179.7	134.4	131.8	127.1	168.5	130.5	8.6	368.7	439.1	140.7	166.2	187.8	102.9	176.7	113.6	153.4	447.2	57.2	11.3	445.5	303.2	189.4	286.8	381.0	144.8	217.8	245.5	4.7	373.5	251.9	187.4	8.5	20.8	336.7	421.4	133.2	417.5	255.7	425.6	493.1	152.6	72.1	124.9	92.8	200.5	178.4	202.1	108.6	196.6	542.2	174.9	235.3	297.4	267.2
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPG2	2-COP	ENSG00000158623	"COPI coat complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 50.6;Oligodendrocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045712: AB_2679428"	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.1	21.3	17.0	9.3	16.2	12.4	20.3	3.2	14.1	13.2	2.6	12.2	9.3	16.5	17.0	14.6	19.1	12.7	15.8	15.5	30.9	12.3	9.1	9.8	9.3	9.7	16.2	39.3	9.6	25.8	13.9	15.8	11.5	11.9	13.8	28.1	9.5	14.3	17.3	20.8	8.7	13.9	6.3	9.8	9.7	24.5	33.5	15.6	18.3	14.4	15.2	12.7	12.1	8.8	44.2	24.8	44.7	22.5	19.3	34.2	11.6	20.2	30.5	33.2	32.2	15.4	23.8	30.4	16.6	26.3	36.7	21.9	15.0	38.0	43.3	33.2	31.1	31.0	12.1	22.2	30.6	40.9	27.6	27.5	18.9	27.0	41.1	32.2	31.7	30.5	50.3	8.8	42.6	44.2	39.6	31.9	56.4	29.2	19.9	37.9	58.6	18.2	40.2	57.9	34.3	49.4	42.1	38.9	32.7	37.3	25.3	13.2	28.1	29.8	15.4	25.0	30.2	19.4	25.4	35.2	33.2	33.3	26.3	1.2	1.5	2.6	0.7	1.4	0.6	1.6	0.7	0.5	1.8	0.8	0.7	0.6	0.4	0.8	2.0	0.7	0.7	0.7	17.0	16.2	3.2	14.1	15.5	30.9	9.7	16.2	11.5	6.3	33.5	8.8	4.9	0.0	2.0	23.2	6.5	9.1	7.7	9.4	7.4	13.8	8.8	6.3	5.1	5.7	8.3	14.7	14.6	18.5	4.5	4.1	11.7	9.5	3.5	7.6	6.4	5.5	2.4	5.0	42.9	24.1	13.4	6.5	7.1	4.8	1.3	11.6	11.7	5.0	9.0	5.0	50.6	7.0	6.1	10.7	7.5	2.3	5.9	7.8	8.8	22.5	9.9	9.3	2.1	39.7	52.0	9.2	2.2	6.8	6.8	3.5	2.8	8.1	9.2	13.1	13.1	9.9	7.5	18.6	26.5	11.0	10.1	22.4	6.0	9.6	7.1	6.8
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	51.1	46.5	127.4	20.1	130.0	14.2	49.8	124.6	172.8	42.8	129.5	99.0	16.0	43.4	117.6	26.4	51.7	32.0	66.1	128.7	136.2	55.8	68.1	33.9	21.0	123.6	126.7	51.7	41.9	49.0	67.4	19.7	128.8	60.2	27.4	56.0	35.4	46.3	53.5	30.3	31.1	44.4	123.3	25.1	51.6	241.4	131.2	13.2	63.2	53.3	27.8	57.1	33.3	124.1	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	127.4	130.0	124.6	172.8	128.7	136.2	123.6	126.7	128.8	123.3	131.2	124.1	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"		Yes	No		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424"	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	61.7	43.4	24.8	34.4	28.5	124.5	67.0	35.0	36.8	61.9	25.3	43.2	43.3	58.4	44.0	63.2	43.2	53.7	61.5	26.1	30.4	60.8	57.6	35.0	45.5	30.9	27.7	76.7	54.0	65.7	26.4	45.0	32.8	45.2	41.6	32.2	40.0	47.0	92.6	35.5	37.2	56.5	35.2	32.0	36.4	51.0	27.5	49.6	61.8	112.1	48.8	59.0	35.3	41.7	92.0	53.1	111.6	94.4	134.2	189.9	76.7	157.3	149.8	135.4	123.5	113.0	49.1	151.1	105.2	152.2	108.7	131.9	160.3	130.9	148.0	103.3	64.5	141.0	105.4	91.7	102.6	134.7	70.7	161.2	104.3	110.4	193.3	149.3	144.0	82.5	184.4	78.8	149.3	49.5	72.3	67.3	72.6	128.4	68.9	78.2	105.2	227.7	143.5	136.5	108.4	78.6	90.7	96.4	127.8	129.4	95.6	133.3	93.4	132.1	71.0	249.6	167.9	71.0	196.3	191.0	123.4	215.1	109.4	11.7	17.9	12.2	13.1	23.5	24.4	14.6	19.7	19.2	21.0	13.9	24.8	16.2	7.4	16.6	22.9	13.3	28.4	16.0	24.8	28.5	35.0	36.8	26.1	30.4	30.9	27.7	32.8	35.2	27.5	41.7	72.8	76.9	56.1	14.4	50.0	87.1	57.1	90.8	80.8	23.2	47.6	59.3	104.3	27.1	69.8	23.9	10.4	56.1	48.2	18.5	54.8	40.3	28.2	56.7	91.6	53.6	20.8	50.1	35.2	29.9	71.0	79.6	36.2	94.0	52.6	39.3	46.1	32.5	43.9	33.7	36.1	25.1	32.6	47.5	44.9	21.6	55.3	46.1	35.6	19.7	49.3	24.8	27.8	21.6	48.7	35.9	21.6	53.4	63.5	53.0	41.0	84.8	47.4	19.7	19.7	74.6	109.0	93.1	43.3	63.2	98.9	131.9	54.0	58.6	34.6	64.4
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246616-17281273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: AB_2681176"	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (1.56e-4)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	30.8	29.1	27.6	29.5	29.0	110.1	28.3	29.9	39.9	27.2	24.7	34.5	24.7	26.3	23.8	41.6	24.0	17.2	59.0	29.8	31.8	23.5	29.1	23.0	37.3	30.8	29.7	23.5	44.3	36.4	39.9	29.0	30.7	25.0	29.8	25.4	30.1	25.8	156.7	33.9	24.9	29.1	29.3	26.7	32.5	76.3	28.4	51.2	24.0	100.7	40.9	29.7	29.0	31.1	141.8	128.8	96.0	86.3	46.2	63.8	58.2	102.6	62.6	150.6	119.3	209.7	50.9	196.9	82.5	83.4	67.5	100.8	138.9	104.2	175.3	76.0	182.1	137.6	90.8	87.0	76.4	120.3	146.1	58.0	77.1	104.3	102.1	43.1	90.0	108.2	114.3	70.4	97.0	137.8	217.4	142.9	90.9	156.3	80.4	163.9	178.9	102.5	61.0	55.2	79.7	63.9	94.0	44.9	83.8	286.9	64.6	76.1	63.2	89.7	101.0	164.7	184.5	54.9	74.5	106.0	81.8	113.2	93.4	37.4	43.0	44.0	35.4	51.3	40.7	35.4	40.0	41.3	60.8	39.1	40.4	37.9	55.6	46.0	52.4	30.8	47.7	56.9	27.6	29.0	29.9	39.9	29.8	31.8	30.8	29.7	30.7	29.3	28.4	31.1	32.0	32.1	19.1	11.1	52.7	54.2	43.3	69.0	33.0	23.2	31.1	27.8	50.5	34.3	38.6	14.7	14.6	95.1	52.2	17.1	33.2	52.8	136.1	27.4	30.1	33.3	37.6	117.0	13.6	51.2	84.5	37.5	21.4	33.5	40.0	26.7	22.9	23.1	67.0	25.2	16.3	37.3	44.7	36.4	52.3	79.2	39.7	43.6	35.6	11.2	60.0	41.3	53.5	13.6	16.0	33.4	18.6	38.0	65.6	43.0	27.4	36.6	25.5	38.0	19.7	52.5	49.9	262.3	109.8	50.1	47.6	104.4	51.3	43.9	43.3	36.5
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 347.5;Late spermatids: 427.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		37000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	43.5	43.8	52.1	33.3	54.2	39.4	45.2	58.3	62.6	34.2	52.0	45.5	45.6	34.0	43.6	42.2	35.6	31.6	100.0	53.2	57.1	56.3	71.0	33.1	40.9	55.1	53.3	33.4	43.0	58.5	31.1	50.9	56.8	36.4	51.6	39.7	42.3	36.6	125.2	36.0	47.8	47.6	57.4	33.4	37.6	58.7	56.2	52.6	37.8	134.9	48.7	42.2	30.0	59.7	104.0	97.8	79.6	74.4	83.1	88.3	63.3	89.0	74.0	121.2	108.9	62.6	125.4	96.5	39.9	93.6	86.8	84.1	109.2	98.9	134.0	92.4	92.1	135.9	95.2	87.3	82.2	86.3	79.1	81.0	126.2	99.1	132.6	95.2	121.2	100.3	163.0	64.6	111.8	96.5	154.3	157.6	107.1	217.2	108.6	97.2	56.7	76.4	131.3	91.6	48.6	66.7	51.0	98.4	91.6	71.2	160.9	90.8	89.9	60.1	74.9	74.7	70.3	81.4	108.5	127.7	89.1	97.6	84.1	65.8	52.0	64.5	35.8	55.7	37.2	36.8	34.6	39.9	63.9	33.7	36.1	32.4	38.3	51.9	56.6	34.0	53.2	43.8	52.1	54.2	58.3	62.6	53.2	57.1	55.1	53.3	56.8	57.4	56.2	59.7	55.0	22.4	26.0	19.2	40.6	49.3	45.1	102.6	28.5	36.4	43.7	51.8	119.9	58.6	61.2	31.3	33.3	143.8	58.0	38.1	88.0	73.4	347.5	44.6	38.2	46.4	34.2	69.2	21.5	60.0	101.4	45.2	25.5	37.1	36.1	50.9	34.2	35.5	79.3	25.2	21.5	41.5	59.0	31.7	28.5	427.2	43.2	40.2	28.4	10.3	59.9	62.0	56.7	18.6	32.4	50.1	48.6	51.1	46.6	54.0	87.8	81.9	46.1	53.0	32.9	49.1	87.8	123.4	49.6	42.9	47.5	127.8	42.3	72.5	55.4	50.6
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088969-100092187	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	71.3	85.5	98.5	48.7	103.0	51.8	68.6	102.5	102.0	87.1	99.5	101.3	44.1	86.5	84.0	90.6	78.1	52.9	112.9	101.9	100.7	70.8	71.6	56.5	50.3	99.3	98.4	74.8	60.2	100.8	79.2	64.0	100.4	68.8	57.8	61.4	65.0	74.2	147.3	61.8	58.4	78.5	101.7	63.1	78.4	57.4	98.7	63.1	61.5	152.8	60.6	90.5	74.7	105.0	167.6	233.4	136.2	163.5	116.1	138.4	86.6	147.7	223.5	239.7	174.9	191.9	153.8	114.4	186.1	242.2	267.3	124.1	155.1	247.9	240.4	114.9	242.6	98.2	215.9	149.3	243.3	112.1	97.6	137.5	161.4	259.2	273.9	159.5	333.0	172.7	142.7	160.5	286.4	413.7	251.6	164.8	124.0	241.3	273.2	117.6	226.6	275.4	193.6	153.8	213.4	158.6	152.7	298.5	114.1	176.4	123.7	109.2	177.9	231.3	211.1	280.5	264.8	118.1	140.2	235.3	175.5	150.0	350.6	231.8	187.8	168.2	178.8	206.6	180.7	168.0	176.8	170.9	211.3	170.3	137.4	153.6	73.5	163.5	194.6	157.8	225.8	146.6	98.5	103.0	102.5	102.0	101.9	100.7	99.3	98.4	100.4	101.7	98.7	105.0	87.8	51.3	44.2	24.8	73.4	110.6	118.1	208.1	70.0	108.3	62.8	76.3	166.3	88.6	117.2	86.5	52.1	197.3	84.2	55.1	211.3	138.3	76.5	61.6	103.4	94.9	75.3	69.0	20.9	113.5	133.7	116.0	52.5	48.3	90.7	100.5	90.3	63.2	128.8	95.9	21.0	67.4	158.7	69.6	82.5	197.1	127.7	55.1	156.5	13.1	101.4	147.0	115.4	17.6	24.0	115.1	64.7	125.3	84.3	95.0	84.2	214.2	117.9	127.1	98.6	76.3	261.5	80.5	100.2	81.2	100.3	137.9	82.7	137.9	87.1	96.1
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6724014-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		54000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	45.0	52.8	69.2	32.9	69.1	19.7	36.1	69.7	71.7	34.1	66.0	44.5	29.9	39.2	46.7	55.2	44.7	32.7	79.1	71.9	70.9	48.3	53.3	34.7	29.9	72.0	72.0	34.8	40.3	71.9	51.1	42.7	71.4	42.8	30.1	46.8	44.5	40.2	103.6	39.2	29.0	43.1	67.3	33.3	41.2	24.0	77.1	22.8	45.8	98.1	30.4	45.8	38.5	67.4	73.3	78.8	34.0	33.3	96.3	114.0	84.9	93.2	107.8	87.6	86.7	54.3	95.0	47.1	37.1	111.2	49.9	55.9	45.7	86.6	75.5	70.3	57.8	47.0	50.1	63.9	84.6	47.1	28.3	106.7	80.6	97.5	183.4	100.1	61.8	29.2	33.3	18.1	116.0	58.7	29.5	30.3	92.9	91.4	64.1	18.8	71.9	47.2	69.0	69.0	19.4	47.2	58.4	67.5	97.2	79.5	29.9	68.0	70.1	90.8	48.4	82.3	85.6	21.0	24.7	38.4	150.6	60.0	104.7	85.9	56.4	86.1	36.3	73.2	35.8	26.2	30.7	32.2	65.3	36.0	30.2	29.8	43.7	31.0	58.9	41.3	30.9	49.9	69.2	69.1	69.7	71.7	71.9	70.9	72.0	72.0	71.4	67.3	77.1	67.4	23.7	16.0	17.5	17.0	14.7	13.9	31.4	39.8	25.0	37.0	29.1	27.6	36.7	22.8	28.0	23.9	6.2	72.6	11.7	15.7	66.5	47.8	4.3	21.4	28.0	23.4	12.6	17.0	13.0	49.7	58.2	34.8	13.7	22.9	16.5	13.0	22.9	26.3	63.2	30.3	15.3	18.6	69.2	24.2	14.4	6.5	23.0	26.1	12.4	5.6	50.0	51.4	13.4	11.1	11.9	49.8	18.6	25.6	16.2	34.3	22.3	47.3	23.8	23.8	39.5	21.7	33.2	16.9	40.6	39.2	13.9	59.1	12.6	40.6	17.1	30.7
COPS7B	CSN7B	ENSG00000144524	"COP9 signalosome subunit 7B"	Q9H9Q2	2	231781671-231809254	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034675, HPA034676"	Uncertain		Supported	Nucleoplasm		NA	NA		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034675: AB_10696360, HPA034676: AB_2674274"	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (2.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.55e-3)"	10.8	15.6	16.5	11.3	17.6	11.7	11.3	16.3	26.3	16.7	14.3	15.1	6.9	14.2	10.6	12.7	15.1	8.1	10.8	17.0	16.4	11.9	14.6	11.6	17.8	16.0	17.4	13.8	11.5	19.8	15.5	15.0	17.3	14.9	15.1	9.4	14.1	14.9	13.6	17.0	13.3	16.7	16.2	17.5	15.9	20.5	16.8	22.9	13.9	12.8	22.3	13.9	13.8	18.4	24.8	20.9	31.7	33.5	22.1	27.8	33.9	19.8	18.6	31.5	37.3	35.9	26.6	23.4	21.2	24.3	38.1	19.5	45.6	36.1	46.8	40.3	42.3	46.2	17.9	51.4	23.8	49.1	25.0	19.4	36.2	35.2	25.8	28.6	36.4	58.2	51.7	18.6	30.2	31.8	49.7	40.0	48.5	24.8	22.0	54.6	38.8	25.6	24.2	21.1	34.2	28.5	18.6	15.8	35.4	44.9	20.1	39.6	23.6	22.9	22.1	26.8	27.7	29.9	26.9	65.0	22.0	34.2	23.4	12.6	8.4	4.6	12.3	9.9	12.1	13.3	9.6	11.4	12.5	13.3	13.1	9.4	1.8	15.8	13.7	9.8	10.5	11.5	16.5	17.6	16.3	26.3	17.0	16.4	16.0	17.4	17.3	16.2	16.8	18.4	10.6	16.0	11.3	28.1	17.1	12.4	12.2	24.0	18.2	13.8	16.7	16.5	6.7	10.0	15.2	16.5	10.4	24.2	19.7	8.6	13.7	14.1	54.6	10.7	10.1	11.1	23.3	7.6	14.8	9.3	20.5	12.3	9.7	9.0	5.7	18.1	14.6	7.9	15.1	13.5	14.3	15.7	18.3	12.7	9.7	14.9	18.0	10.1	12.4	14.0	18.6	9.5	35.0	18.1	17.8	13.7	9.5	20.3	13.5	12.5	10.4	9.9	11.4	18.3	13.1	8.3	13.5	43.3	61.4	16.5	8.1	17.8	16.5	21.1	14.3	12.1
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085882-237100474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 451.5;U-138 MG: 536.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	51.2	47.8	58.1	36.0	62.8	41.2	42.0	61.2	67.3	42.8	54.9	36.3	17.0	44.1	38.1	26.8	37.4	42.4	83.7	64.5	76.1	51.9	34.4	29.4	32.5	59.4	59.4	48.2	22.6	64.1	37.5	43.7	62.4	34.1	24.7	91.8	27.7	35.9	172.9	30.4	23.8	54.1	62.2	24.1	30.3	47.2	64.0	48.7	37.2	118.1	32.9	52.0	32.5	63.2	58.9	48.6	103.5	51.8	289.5	226.1	69.2	100.7	99.0	100.3	110.7	31.9	57.9	39.9	37.6	110.0	159.5	43.3	102.4	136.1	138.8	94.9	66.2	58.0	57.5	113.8	199.4	76.3	33.3	376.9	153.0	101.2	451.5	124.6	119.4	84.7	81.9	37.4	320.9	55.7	94.7	77.7	91.7	63.0	70.2	71.7	123.3	79.9	124.7	46.4	50.8	87.3	60.3	51.2	155.4	82.4	59.5	61.4	127.4	536.9	91.1	106.1	110.7	71.1	64.0	127.9	167.4	46.0	138.7	59.1	45.2	56.1	57.1	53.3	70.9	68.3	60.4	65.8	55.7	56.9	58.3	60.7	14.1	72.2	58.0	40.2	70.7	70.5	58.1	62.8	61.2	67.3	64.5	76.1	59.4	59.4	62.4	62.2	64.0	63.2	46.8	32.1	24.4	13.1	38.5	75.5	50.0	97.1	39.9	55.2	32.3	26.8	114.2	31.5	44.4	33.1	27.1	61.6	32.5	12.5	142.8	65.1	34.7	45.0	41.2	52.2	21.0	39.6	20.6	40.8	79.3	85.7	23.0	28.7	42.6	38.9	38.9	23.5	61.0	35.3	20.1	16.5	95.6	29.6	59.3	21.1	72.7	24.2	126.3	11.2	44.6	98.2	39.1	15.1	20.6	52.6	16.7	75.6	44.4	44.9	22.6	96.9	55.3	63.0	59.2	44.7	69.8	98.1	116.1	33.6	64.5	44.5	44.5	50.0	21.0	41.8
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 340.8;Breast myoepithelial cells: 395.6;Distal tubular cells: 498.9;Exocrine glandular cells: 383.2;Pancreatic endocrine cells: 347.0;Proximal tubular cells: 720.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	141.9	129.3	373.7	62.2	373.1	80.5	139.6	386.7	485.1	118.8	367.8	164.4	73.5	97.0	142.5	167.4	93.3	59.3	245.9	386.8	372.6	176.8	93.3	92.1	88.4	373.9	376.2	105.7	183.9	72.3	168.3	50.2	375.8	129.9	52.1	50.3	124.6	69.2	282.2	142.7	99.4	59.3	376.9	113.7	149.6	105.2	384.0	74.9	119.2	131.2	58.0	115.3	125.4	396.2	151.7	200.3	154.5	162.4	209.0	169.6	142.0	213.7	147.0	136.5	173.9	146.2	131.7	41.4	62.5	196.0	218.1	118.9	138.4	197.5	94.0	177.6	510.6	125.0	182.8	458.8	166.1	126.7	112.4	201.1	159.9	102.0	126.3	126.1	203.2	207.8	147.3	87.0	201.8	324.3	204.2	391.0	235.5	188.5	433.3	158.3	207.2	129.3	172.4	256.1	178.7	178.8	112.1	150.7	243.1	118.5	139.0	242.2	165.7	179.5	203.1	231.3	206.9	177.4	166.2	220.1	223.8	148.6	180.9	514.1	298.1	415.1	292.3	315.9	293.1	322.9	298.6	301.0	287.2	237.6	260.5	294.1	106.3	259.4	330.2	364.2	386.0	415.1	373.7	373.1	386.7	485.1	386.8	372.6	373.9	376.2	375.8	376.9	384.0	396.2	187.9	128.2	121.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	340.8	395.6	0.0	0.0	55.7	275.8	0.0	175.1	117.0	0.0	498.9	220.7	0.0	182.6	190.7	75.6	0.0	0.0	0.0	383.2	193.7	82.8	0.0	193.1	61.8	174.9	0.0	0.0	322.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.4	0.0	0.0	145.3	0.0	0.0	0.0	0.0	347.0	0.0	0.0	18.6	0.0	0.0	720.0	67.1	0.0	0.0	0.0	93.1	0.0	0.0	0.0	0.0	132.4	69.8	129.2	0.0	0.0
COPZ2	MGC23008	ENSG00000005243	"COPI coat complex subunit zeta 2"	Q9P299	17	48026167-48038030	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 49.8;Endometrial stromal cells: 63.8;Fibroblasts: 77.7;Leydig cells: 50.4;Smooth muscle cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.4;ASC TERT1: 185.6;BJ: 127.1;BJ hTERT+: 133.1;fHDF/TERT166: 271.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055999	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055999: AB_2683003"	"unprognostic (2.66e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.45e-9)"	"unprognostic (7.42e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (2.89e-6)"	"prognostic unfavorable (4.66e-4)"	71.7	28.6	11.8	11.7	12.6	1.0	46.4	13.0	19.1	41.8	22.8	57.0	6.2	38.3	21.4	15.9	32.6	22.9	57.1	12.4	16.4	19.2	33.2	22.1	5.8	15.3	12.5	13.6	19.7	24.3	14.8	22.5	15.1	34.2	14.7	5.1	23.4	36.8	90.8	35.3	18.2	45.6	14.0	11.7	27.1	11.6	13.1	4.9	32.1	48.6	6.9	37.3	33.1	15.7	38.7	7.5	4.1	0.0	167.4	185.6	0.0	127.1	133.1	35.0	38.6	0.0	4.4	0.0	28.3	271.6	0.0	39.5	0.0	0.5	34.9	1.7	0.1	13.6	21.3	0.1	68.4	0.0	0.8	111.7	16.0	26.2	3.5	41.1	5.3	0.3	0.1	0.8	86.9	18.1	0.4	0.0	0.2	2.6	2.5	0.0	0.0	6.1	2.4	0.0	0.2	5.7	24.6	0.0	28.3	1.0	6.0	4.2	34.4	91.5	14.5	72.9	0.5	91.6	11.1	1.3	99.3	0.0	13.1	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.1	11.8	12.6	13.0	19.1	12.4	16.4	15.3	12.5	15.1	14.0	13.1	15.7	31.6	9.6	2.2	8.1	2.6	49.8	16.7	9.4	9.1	1.2	7.3	30.1	37.1	0.0	1.4	7.3	0.0	1.0	7.5	0.4	11.7	1.0	7.0	2.1	63.8	15.6	0.0	0.0	1.4	5.1	1.2	77.7	0.0	1.5	1.3	2.7	16.4	39.0	6.9	0.0	1.7	2.3	2.0	4.4	28.4	21.1	50.4	3.4	28.4	7.5	0.8	34.8	4.1	2.5	7.6	2.5	0.0	41.8	3.5	6.0	0.1	19.1	0.6	1.3	6.6	21.6	49.2	14.1	3.7	3.1	26.0	2.3	3.7	8.5	0.4	11.7
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA046057: AB_2679518"	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	25.0	37.7	15.2	17.4	15.4	46.8	19.1	16.2	19.0	15.7	18.6	19.7	16.2	16.5	15.9	18.8	13.0	26.1	34.3	16.2	17.1	28.6	35.1	17.6	19.8	16.3	16.5	10.5	15.9	29.6	14.3	21.6	16.8	17.5	20.3	18.3	12.7	17.6	12.8	12.7	15.4	24.9	16.7	18.8	18.3	10.7	17.3	17.3	21.1	19.1	19.4	31.0	12.2	17.9	15.7	14.7	10.5	18.8	49.6	35.3	24.6	40.2	57.5	42.3	46.8	30.0	18.5	14.7	33.4	32.5	52.5	14.1	15.3	21.3	47.8	29.0	13.2	21.0	19.1	35.4	41.5	17.0	46.6	39.5	32.8	40.3	28.5	22.9	23.3	20.9	17.9	38.1	40.9	20.4	18.6	26.4	16.2	18.4	30.0	13.9	15.7	19.4	45.7	42.0	6.8	13.1	18.4	23.9	52.0	37.2	17.1	23.9	24.6	41.4	14.4	46.8	29.3	36.0	55.0	16.5	51.7	16.3	32.7	70.8	30.0	57.5	43.7	35.5	49.2	32.8	41.4	43.6	26.4	25.2	43.0	44.4	90.7	34.1	42.8	16.7	56.5	38.0	15.2	15.4	16.2	19.0	16.2	17.1	16.3	16.5	16.8	16.7	17.3	17.9	73.2	19.2	19.9	7.2	54.4	105.5	106.5	55.7	44.9	30.2	42.3	24.3	29.0	24.3	42.3	40.5	41.7	32.7	62.5	43.7	129.1	44.9	38.7	35.8	34.5	48.9	26.9	38.3	12.4	46.1	43.7	67.6	33.1	43.5	60.3	12.2	22.9	36.7	32.0	63.9	11.8	44.3	57.0	23.8	74.6	20.7	20.5	44.3	71.2	7.5	29.2	56.7	49.4	7.1	16.0	54.2	36.3	30.5	45.1	65.6	30.0	73.7	41.7	36.6	46.0	60.8	71.0	20.9	39.4	29.0	106.6	173.9	70.9	33.7	19.1	100.0
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369401-99394195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.8;Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	6.4	10.1	13.4	5.2	14.3	4.6	8.6	14.7	18.0	5.6	13.7	10.7	8.2	5.2	7.6	9.3	5.1	3.5	30.9	13.8	13.9	12.7	15.1	3.5	5.6	13.8	14.0	6.8	6.6	14.2	8.5	3.0	13.9	7.7	12.5	11.9	9.6	8.4	37.3	6.9	6.6	6.3	13.7	6.4	7.4	3.0	13.8	7.9	5.2	51.1	7.1	6.8	6.5	13.7	20.2	11.4	13.5	19.2	8.6	9.6	18.4	17.0	10.5	25.2	29.0	15.9	8.5	19.6	11.1	12.8	16.3	18.3	22.7	26.6	30.6	21.0	29.1	24.1	15.5	17.1	11.3	35.0	9.0	6.1	16.0	14.9	14.9	5.5	15.6	23.8	37.2	14.5	13.6	19.8	15.5	29.0	16.4	19.7	21.7	7.5	13.8	26.1	19.9	17.3	21.0	11.2	11.8	18.0	22.9	9.0	22.1	22.8	5.6	10.9	16.0	17.0	26.4	5.1	10.0	30.9	14.0	33.6	16.4	14.1	2.9	2.4	5.0	6.9	5.8	5.6	6.4	8.1	7.3	2.5	10.5	7.8	0.4	10.1	6.1	4.9	5.2	4.7	13.4	14.3	14.7	18.0	13.8	13.9	13.8	14.0	13.9	13.7	13.8	13.7	4.7	3.2	3.7	6.5	3.9	4.5	6.8	26.1	7.4	8.1	5.0	6.3	42.8	5.7	11.2	3.7	0.0	14.0	2.2	3.7	33.2	11.5	0.5	3.5	4.9	5.5	0.0	8.2	10.6	10.5	13.3	5.9	3.6	2.6	1.3	6.6	3.3	8.6	6.8	6.7	13.2	7.3	24.4	1.3	3.5	0.3	8.1	2.4	5.4	1.0	2.0	13.2	4.1	4.5	7.6	9.2	5.8	6.0	4.7	2.4	5.2	12.0	4.9	8.7	6.6	6.5	10.6	3.6	10.9	8.0	4.3	6.3	3.7	11.1	9.8	4.7
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322544-128334072	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA021406: AB_2670691, HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favorable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favorable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	23.9	52.9	33.9	21.7	35.3	19.7	28.2	32.9	43.6	31.8	43.1	35.9	76.7	24.9	19.4	62.1	51.8	21.5	39.6	34.8	37.8	62.9	63.8	25.0	24.4	33.4	33.9	30.5	64.1	45.5	53.4	17.6	33.2	41.2	23.7	22.3	47.1	28.3	31.8	56.4	54.1	15.4	32.3	27.5	39.5	22.6	34.3	20.3	51.2	22.6	22.9	31.1	34.1	36.0	36.6	54.4	31.5	36.6	22.4	31.2	58.2	31.7	20.6	40.1	28.0	48.4	46.5	48.6	28.1	24.2	31.6	99.9	27.0	38.0	14.6	25.1	50.5	18.1	112.9	52.9	38.9	51.5	27.0	37.4	45.2	33.6	36.6	21.9	32.4	40.8	121.1	31.5	26.0	106.2	60.5	38.0	37.0	75.1	60.7	60.7	45.2	91.0	49.0	36.9	58.8	40.1	64.7	71.5	41.4	13.8	92.2	18.0	43.3	38.0	35.1	56.9	43.9	53.4	50.4	38.5	47.4	25.0	28.1	22.6	31.1	19.0	44.1	36.4	39.8	39.9	39.4	44.1	39.6	34.4	31.1	38.2	3.8	35.5	37.2	63.7	34.5	29.9	33.9	35.3	32.9	43.6	34.8	37.8	33.4	33.9	33.2	32.3	34.3	36.0	21.3	22.4	29.0	25.8	31.9	28.8	47.1	75.1	47.3	29.9	60.2	65.9	43.0	42.9	48.9	57.0	27.1	90.3	36.5	70.3	142.8	56.4	15.3	139.7	39.8	25.4	31.8	36.0	23.9	63.4	47.5	32.1	35.7	42.2	36.8	37.1	30.0	77.4	49.8	30.3	26.3	65.6	57.0	26.7	23.9	27.4	30.1	24.0	40.9	8.4	27.2	37.4	27.8	17.1	28.8	46.1	66.2	30.9	60.8	32.8	185.3	202.4	161.9	53.3	26.3	27.9	33.4	47.2	31.6	79.4	50.0	47.2	32.3	69.3	85.5	58.0
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503279-120534434	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Mitochondria	"HPA049487: AB_2680789"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	22.7	29.9	22.3	15.9	25.3	11.3	24.1	24.5	29.0	19.7	26.7	24.7	23.4	17.9	23.0	20.4	22.2	14.4	40.7	22.1	23.4	38.9	60.7	15.4	23.3	24.9	24.2	20.5	20.6	21.6	18.1	23.3	24.8	18.9	24.7	26.3	22.4	15.8	98.5	17.6	20.0	18.2	22.8	21.1	19.3	24.7	24.3	22.3	25.7	69.2	23.4	17.2	17.6	29.5	35.7	56.1	49.2	14.2	63.5	48.5	33.7	42.3	27.6	42.5	26.9	22.5	29.2	35.6	48.8	44.7	29.9	37.7	44.2	47.2	43.3	45.4	26.3	47.4	35.0	37.8	51.8	52.2	28.7	46.8	50.2	40.0	46.1	66.0	38.0	67.5	47.4	25.3	49.7	46.9	30.3	60.0	43.2	25.4	43.2	55.9	49.8	52.0	55.2	26.7	37.0	29.8	30.7	15.5	58.3	51.2	77.8	42.6	37.9	29.1	33.4	21.8	28.5	53.9	48.5	40.5	33.3	48.9	35.8	28.6	44.3	32.3	39.7	44.9	39.0	45.6	42.4	43.2	61.0	52.7	56.8	45.5	9.3	60.6	43.5	40.3	57.2	54.4	22.3	25.3	24.5	29.0	22.1	23.4	24.9	24.2	24.8	22.8	24.3	29.5	14.4	12.8	12.8	7.2	15.5	7.8	11.5	33.5	10.8	12.6	17.5	15.2	30.5	18.6	18.1	14.7	14.6	73.0	12.9	16.1	46.9	32.3	59.8	17.8	12.1	15.4	15.0	17.5	5.7	20.0	45.6	16.5	11.7	11.3	17.2	24.0	15.4	42.4	46.3	5.0	7.8	17.0	22.4	12.8	10.1	23.1	16.4	13.6	23.2	3.7	29.0	18.0	23.7	6.6	17.5	11.0	23.9	18.8	11.0	11.2	35.8	66.7	22.4	15.6	6.6	16.3	14.4	34.7	14.8	14.3	8.9	58.3	15.0	32.8	28.1	10.9
COQ6	CGI-10	ENSG00000119723	"Coenzyme Q6, monooxygenase"	Q9Y2Z9	14	73949926-73963670	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051371	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051371: AB_2681459"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.33e-3)"	"unprognostic (9.45e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.89e-1)"	11.2	38.4	10.5	5.6	11.0	5.5	12.0	10.9	13.1	12.1	15.5	13.0	10.2	10.0	11.3	10.1	10.5	6.7	32.0	10.8	11.1	23.0	25.7	7.4	6.3	10.6	10.6	11.5	7.0	25.1	15.9	8.0	10.6	12.6	9.5	5.8	11.1	9.9	38.6	9.3	10.8	9.8	10.7	11.3	13.4	22.0	11.0	7.3	12.3	42.6	7.0	13.6	10.5	11.1	12.2	21.7	11.1	25.7	13.2	10.7	15.4	14.8	13.6	21.8	18.4	16.4	21.0	10.7	13.7	15.3	15.0	19.1	16.6	14.8	20.6	16.3	13.3	7.2	12.8	14.3	18.0	7.2	24.9	18.1	19.2	19.9	19.5	14.1	13.9	21.5	6.4	9.6	19.2	33.3	12.4	11.7	4.0	24.8	26.0	11.7	14.1	7.6	22.9	15.2	16.6	8.8	25.2	21.5	14.6	7.2	36.4	13.3	9.4	24.8	22.9	19.0	10.8	8.9	9.0	9.0	13.7	10.6	17.1	5.4	11.3	9.2	11.3	14.2	11.3	10.3	11.2	11.3	12.1	5.3	15.6	9.4	2.3	14.5	13.1	8.9	7.6	8.5	10.5	11.0	10.9	13.1	10.8	11.1	10.6	10.6	10.6	10.7	11.0	11.1	11.9	25.6	25.5	6.2	11.4	4.7	8.1	26.9	6.8	18.9	12.3	12.4	10.3	11.5	23.1	12.9	12.5	26.3	4.1	8.3	19.6	10.8	167.0	14.1	11.0	9.1	4.8	7.4	10.0	10.9	12.6	11.9	12.2	9.9	25.3	13.9	11.4	14.7	16.2	20.2	10.0	9.7	20.3	5.4	4.2	49.5	10.8	7.5	10.6	3.7	9.6	12.0	15.5	5.0	8.4	8.6	8.4	12.4	10.6	6.0	23.3	41.3	15.8	28.1	19.7	10.5	20.5	24.7	21.0	11.5	6.0	23.8	11.9	39.9	9.4	7.1
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067614-19080095	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 40.4;neutrophil: 126.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 126.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	10.2	13.6	10.7	7.0	11.2	4.8	13.4	10.9	11.6	10.8	12.5	14.1	12.4	15.6	12.3	12.4	15.5	10.7	23.4	11.0	10.8	14.1	12.3	10.0	8.3	10.6	11.3	20.0	10.3	24.4	9.7	10.0	11.1	17.7	13.2	14.0	10.4	14.7	45.8	7.9	11.8	11.6	10.4	10.0	12.8	20.9	11.3	10.3	16.2	44.9	8.4	10.3	8.8	13.1	23.5	24.8	21.1	12.4	11.6	12.2	17.7	13.5	11.0	18.0	18.5	15.9	19.1	17.8	63.9	10.4	19.4	24.5	29.6	16.9	13.0	15.2	29.9	9.5	22.8	49.3	14.4	22.9	20.1	10.3	14.6	16.8	12.2	14.8	14.8	20.9	26.4	16.2	12.9	42.4	24.0	18.4	16.1	9.1	13.1	29.0	23.3	22.8	15.7	15.5	30.4	17.4	12.6	27.4	16.2	10.2	25.2	30.7	16.3	19.0	10.9	14.1	19.7	15.0	26.2	19.7	20.4	13.1	12.5	40.4	11.4	17.8	9.9	10.6	9.4	16.3	8.9	8.7	12.6	15.3	12.2	10.8	126.5	12.9	12.3	15.6	6.2	5.6	10.7	11.2	10.9	11.6	11.0	10.8	10.6	11.3	11.1	10.4	11.3	13.1	13.3	16.0	12.6	6.2	35.5	11.0	26.3	20.9	13.6	31.2	18.3	21.1	21.8	31.5	14.9	16.5	39.6	21.2	28.7	38.1	45.0	25.2	14.8	23.7	16.2	16.1	24.0	4.8	6.0	18.0	17.9	14.9	32.1	23.2	25.4	31.1	20.7	11.1	23.3	20.2	8.8	39.0	30.5	29.4	12.9	8.5	18.6	18.8	10.6	4.7	11.6	39.5	8.2	5.0	9.4	13.2	30.4	13.9	11.6	17.8	71.5	23.7	24.4	53.9	19.7	20.0	20.2	81.3	53.1	12.8	12.4	32.2	23.9	38.2	39.8	24.0
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691514-40725784	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	15.1	25.2	10.1	5.7	10.7	5.9	15.3	10.4	12.8	23.4	10.9	19.4	9.7	22.0	2.3	16.0	29.8	7.6	21.9	9.8	10.6	21.0	25.7	16.4	6.0	10.6	10.8	22.5	20.7	8.4	49.3	3.5	10.3	23.2	2.3	1.3	16.9	7.3	14.4	20.2	17.8	3.8	11.2	18.3	23.9	17.3	10.6	8.8	23.3	8.6	3.3	20.3	18.4	10.5	9.9	39.5	7.9	18.5	7.8	6.1	8.5	6.6	7.8	5.6	5.1	15.4	14.3	13.8	20.0	4.3	7.8	9.8	7.0	10.5	2.0	20.0	10.4	11.6	12.7	6.4	12.1	4.1	19.2	8.4	10.6	5.4	5.4	5.2	7.4	13.7	7.7	8.1	6.0	6.4	4.9	5.7	6.4	11.5	3.6	11.5	13.1	12.4	15.7	17.6	15.1	11.0	12.5	20.4	21.0	4.4	22.8	17.1	9.4	5.1	20.6	3.9	5.5	9.4	9.0	7.3	27.8	5.2	9.1	10.2	9.4	8.7	6.7	9.3	8.3	7.1	5.5	7.8	9.9	5.9	4.6	5.1	9.0	6.9	9.2	4.6	4.9	7.3	10.1	10.7	10.4	12.8	9.8	10.6	10.6	10.8	10.3	11.2	10.6	10.5	8.5	12.8	3.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	11.6	8.0	0.0	0.0	2.5	12.9	0.0	11.1	6.8	0.0	11.7	16.5	0.0	16.4	7.8	1.7	0.0	0.0	0.0	10.9	9.8	5.0	0.0	10.3	1.3	11.7	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.5	0.0	0.0	1.2	0.0	0.0	13.0	8.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.4	3.2	19.8	0.0	0.0
COQ9	"C16orf49, DKFZP434K046"	ENSG00000088682	"Coenzyme Q9"	O75208	16	57447425-57461270	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 255.4;tongue: 241.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040918	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"		"HPA040918: AB_10794154"	"unprognostic (9.18e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.03e-11)"	"unprognostic (7.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-2)"	24.3	44.7	21.7	15.1	22.7	10.6	18.0	23.4	26.1	19.6	38.4	48.6	47.3	16.8	16.6	40.0	24.0	19.4	139.7	21.2	22.1	61.3	53.2	14.4	15.6	21.5	21.8	16.6	27.9	79.7	14.9	16.7	20.7	26.2	38.2	11.8	44.1	28.8	255.4	25.2	41.8	28.3	21.3	12.2	35.3	23.8	24.3	18.7	29.2	241.0	17.3	38.2	21.6	21.7	33.6	67.2	18.3	45.8	36.0	27.3	21.3	31.9	25.3	44.8	24.9	41.2	43.0	40.3	59.0	28.8	34.3	70.5	52.8	56.6	28.3	21.4	49.3	27.7	44.2	66.1	39.8	36.1	44.4	45.6	73.7	35.9	68.1	29.8	51.1	35.6	54.7	18.1	27.4	48.6	30.5	26.8	29.6	74.4	90.6	60.8	58.7	104.8	71.3	37.4	56.3	56.7	108.4	103.8	54.9	16.1	59.4	39.5	34.4	32.4	38.9	34.8	40.4	42.9	29.5	48.0	44.4	51.2	37.3	21.0	28.2	23.0	19.5	36.6	20.1	18.8	16.6	17.1	34.4	19.1	17.7	26.0	8.9	24.0	38.2	21.5	25.5	21.9	21.7	22.7	23.4	26.1	21.2	22.1	21.5	21.8	20.7	21.3	24.3	21.7	17.1	12.8	18.9	37.9	15.7	8.4	17.1	55.3	19.9	16.2	21.7	23.1	79.5	45.8	28.7	25.8	16.7	74.7	14.2	68.8	217.2	53.9	37.9	20.4	17.3	17.3	27.6	21.2	21.2	29.3	25.6	20.7	35.7	18.0	7.0	40.7	18.5	53.6	38.8	20.2	24.0	46.6	83.4	16.3	5.4	28.4	21.1	14.1	28.4	7.5	22.7	29.1	14.4	20.6	14.5	27.2	37.0	20.3	15.9	21.5	90.7	114.1	30.0	24.0	13.1	22.6	19.8	66.0	38.8	37.3	11.2	78.7	12.8	91.2	70.2	18.4
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 301.4;Paneth cells: 324.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 221.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		960000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	54.4	56.4	20.2	29.7	23.8	20.3	53.4	23.4	27.0	55.7	21.1	70.2	62.9	72.8	14.6	80.2	54.2	44.1	26.1	19.4	22.7	48.2	47.2	53.7	41.9	28.0	23.6	42.7	52.5	24.6	35.1	31.2	25.1	71.0	34.5	6.6	73.2	39.6	13.0	42.4	62.3	36.7	24.2	66.0	77.1	13.9	25.1	21.1	55.8	9.9	18.4	58.3	53.5	26.3	80.9	81.4	37.5	76.0	94.1	81.3	56.6	58.5	118.0	94.2	70.8	134.1	116.0	6.4	111.3	80.8	95.8	67.9	41.9	74.9	16.8	19.4	40.7	54.9	47.3	57.9	148.1	2.3	120.8	110.6	66.3	80.1	37.2	59.7	120.7	49.4	42.7	9.2	54.2	238.4	14.4	11.2	47.7	198.2	73.4	11.2	41.0	14.9	62.6	104.3	40.7	50.8	52.4	139.6	181.6	26.0	178.5	63.0	92.2	63.4	47.4	87.4	35.2	1.6	3.3	14.6	103.4	8.2	66.4	57.3	102.8	8.0	10.9	212.9	8.3	20.0	37.6	14.6	79.0	11.0	21.2	11.4	47.8	11.9	221.8	60.8	55.2	57.8	20.2	23.8	23.4	27.0	19.4	22.7	28.0	23.6	25.1	24.2	25.1	26.3	58.7	3.2	2.2	4.6	53.4	27.9	60.1	90.8	40.9	13.0	53.8	39.0	1.6	50.1	66.4	47.8	8.4	87.8	39.2	301.4	60.7	111.4	8.9	43.6	32.9	52.0	99.0	19.8	1.8	105.0	229.8	35.8	111.1	64.8	28.0	46.7	47.8	22.4	251.8	15.2	2.4	188.6	81.4	138.6	66.4	5.0	39.4	96.3	71.2	10.3	195.3	30.0	41.2	4.5	6.8	136.9	324.9	34.6	64.3	55.6	263.5	84.0	41.2	14.6	52.6	22.1	55.1	8.1	6.6	47.6	31.0	150.5	100.3	54.8	128.0	74.5
CORO1C	"coronin-3, HCRNN4"	ENSG00000110880	"Coronin 1C"	Q9ULV4	12	108645109-108731526	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041737	Approved					NA	NA		13000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA041737: AB_10804115"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.90e-3)"	68.5	30.6	36.1	49.7	36.1	52.5	36.6	28.1	36.8	49.9	22.1	116.6	28.9	96.1	24.1	67.7	55.9	54.4	33.7	41.3	39.1	25.8	49.1	76.4	31.6	43.9	37.1	30.4	13.0	36.4	22.0	48.2	39.0	35.8	53.3	10.5	24.6	67.3	30.0	52.1	42.9	142.9	38.3	26.1	45.0	22.5	40.8	47.4	14.2	23.6	33.6	71.5	44.7	53.4	188.2	207.2	274.3	140.8	137.3	186.5	117.3	347.8	372.0	443.2	353.6	245.8	81.5	10.6	88.8	547.9	173.2	85.4	153.3	255.1	558.1	82.8	71.4	313.8	95.3	192.7	123.8	76.6	154.1	173.7	120.3	501.0	376.9	262.3	234.1	51.8	157.0	101.0	473.6	68.4	34.7	90.5	70.5	68.7	197.9	53.3	158.6	121.9	176.0	122.5	75.0	66.3	115.6	16.0	156.6	173.0	83.0	58.0	263.7	316.1	165.1	297.7	296.8	99.4	245.7	232.8	246.3	64.0	215.5	42.3	70.7	32.0	7.4	78.1	3.5	24.6	2.9	4.5	75.7	19.1	1.0	3.3	81.9	12.6	75.2	75.9	7.5	44.7	36.1	36.1	28.1	36.8	41.3	39.1	43.9	37.1	39.0	38.3	40.8	53.4	24.5	54.5	20.7	18.3	27.8	138.0	168.2	47.7	66.0	7.1	18.2	14.1	19.0	18.6	34.6	12.9	2.1	28.4	39.1	41.3	3.9	59.7	58.9	33.6	47.2	51.9	30.9	25.5	32.8	22.7	125.3	38.4	20.4	39.1	41.8	43.3	17.2	49.8	122.2	15.2	39.7	23.4	16.2	71.0	181.4	56.4	22.4	108.8	90.7	37.5	81.7	6.7	8.2	46.3	42.6	76.9	29.8	58.6	31.6	92.8	19.0	30.1	10.5	5.3	13.1	42.8	53.2	26.8	22.9	60.6	167.8	46.8	12.0	9.9	30.7	93.2
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192637	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.2;Proximal enterocytes: 93.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.9	1.7	1.9	4.9	1.5	14.8	4.7	4.9	3.2	6.1	0.0	17.5	34.3	1.6	0.7	15.2	4.7	18.2	0.3	1.2	2.9	1.1	3.3	7.4	2.9	3.7	3.4	0.3	0.4	2.5	4.0	2.1	4.9	14.3	12.9	1.2	6.1	1.4	0.3	9.3	35.1	2.2	0.8	3.0	11.1	9.2	4.5	5.7	1.2	0.3	5.9	12.8	7.7	1.8	8.4	2.9	0.6	2.0	1.2	1.3	66.6	0.6	0.7	2.1	3.2	19.1	1.4	0.1	9.4	1.2	3.2	23.1	7.7	12.7	1.3	6.9	1.8	0.2	11.6	17.1	2.7	7.9	0.7	0.4	15.4	1.0	18.6	0.7	0.7	10.0	6.8	3.8	0.3	6.3	1.5	7.8	8.6	56.4	2.2	6.1	0.1	0.2	1.3	23.5	1.7	2.4	4.4	45.3	1.6	15.0	5.3	12.8	0.6	0.2	9.7	0.2	2.4	0.7	4.0	0.7	0.5	2.5	2.8	11.2	1.4	11.4	2.4	2.9	5.2	0.6	3.9	3.7	0.5	0.5	2.5	3.3	1.0	1.7	7.8	0.7	11.9	1.5	1.9	1.5	4.9	3.2	1.2	2.9	3.7	3.4	4.9	0.8	4.5	1.8	2.8	12.8	27.8	0.7	3.1	6.6	18.9	47.2	14.8	2.1	8.5	4.3	1.9	28.6	46.4	0.0	4.2	10.5	2.1	76.2	0.0	4.5	2.6	15.6	11.6	6.0	7.2	0.8	11.6	5.1	42.2	2.2	36.2	19.9	0.0	38.1	0.7	3.8	6.0	1.7	10.5	15.7	20.3	12.0	2.6	3.9	0.0	10.6	0.0	1.0	1.8	0.7	2.1	0.5	0.8	22.6	19.7	0.4	1.4	15.7	93.0	1.7	35.8	1.7	0.0	1.5	3.7	0.5	3.3	29.4	9.9	15.9	10.7	0.2	36.3	30.4
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
CORO7	FLJ22021	ENSG00000262246	"Coronin 7"	P57737	16	4354542-4425705	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 75.3;RPMI-8226: 142.8"									"HPA041657, HPA053586"	Uncertain					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA041657: AB_10796351, HPA053586: AB_2682201"	"unprognostic (4.75e-3)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.25e-4)"	"unprognostic (3.80e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.06e-3)"	15.5	15.8	10.8	16.8	16.4	69.5	13.4	12.1	15.5	12.7	5.0	20.4	15.3	13.8	1.8	10.9	16.7	9.0	11.6	12.6	10.9	15.5	8.8	27.5	24.2	16.5	13.5	8.1	10.8	4.5	13.5	9.7	15.5	17.0	4.7	1.4	13.4	5.6	6.5	11.6	31.0	5.5	10.3	56.5	15.3	27.4	15.2	10.9	14.4	1.6	7.9	14.6	11.6	24.1	8.8	12.0	8.0	8.7	1.6	1.1	13.3	5.0	4.4	7.5	6.8	6.8	20.3	18.0	5.0	5.2	5.9	12.2	6.1	9.1	2.5	6.1	29.9	6.1	15.0	6.2	7.0	20.6	48.3	6.3	2.3	4.5	1.9	2.3	13.6	15.0	18.7	75.3	3.8	30.8	15.2	58.1	10.0	6.5	3.1	47.2	24.9	142.8	4.7	13.3	14.9	5.5	6.4	5.7	14.6	3.3	4.8	32.9	16.9	6.5	10.3	16.7	6.7	35.9	20.3	48.7	4.9	29.2	6.6	17.1	16.8	30.8	14.5	23.5	16.4	8.6	13.1	16.8	14.0	3.6	6.5	9.7	17.3	9.1	20.3	7.3	15.5	15.9	10.8	16.4	12.1	15.5	12.6	10.9	16.5	13.5	15.5	10.3	15.2	24.1	10.3	3.2	10.8	0.0	21.2	9.4	6.4	4.8	2.2	13.6	6.4	3.8	2.7	7.2	6.2	5.5	43.8	11.3	41.2	16.6	3.9	12.1	6.6	9.5	4.0	11.9	7.8	2.1	0.0	16.3	12.3	6.3	8.6	8.0	12.0	3.8	21.0	2.4	37.9	28.6	0.0	9.5	28.5	42.8	19.3	5.8	5.0	31.4	17.8	0.0	26.6	7.4	33.0	0.0	0.0	17.3	16.4	3.4	32.1	7.3	16.0	3.0	14.6	19.1	6.6	11.6	5.9	11.5	7.9	4.4	11.9	9.2	34.4	6.0	13.9	8.2
CORO7-PAM16		ENSG00000103426	"CORO7-PAM16 readthrough"		16	4340251-4420494	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Club cells: 2.5;Oligodendrocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041657, HPA053586, HPA062721"	Uncertain		Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA						"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849"	"unprognostic (2.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.11e-4)"	"unprognostic (4.39e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.85e-1)"	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565596-84618078	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.2;lymphoid tissue: 374.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 1271.3"	"Low region specificity"	"Detected in all"							"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	87.8	36.8	65.8	296.0	82.1	273.2	54.2	80.6	67.4	31.7	57.7	68.7	90.4	46.7	12.1	32.4	49.5	75.2	25.1	68.8	82.8	140.5	44.6	110.6	374.3	87.5	80.5	24.1	30.3	32.4	47.4	78.0	86.6	44.5	66.0	44.4	24.9	28.5	10.9	20.4	104.8	66.6	78.0	330.5	126.5	20.5	101.5	88.6	38.0	12.2	263.5	118.4	28.3	86.4	546.3	445.0	994.2	1058.1	111.5	305.0	299.5	462.0	295.8	355.8	136.6	609.1	818.7	149.6	137.6	349.7	211.7	266.8	61.3	364.1	355.1	1.1	77.9	281.9	87.7	162.7	314.0	320.1	1069.3	245.6	57.6	344.2	305.0	222.2	172.2	326.4	26.5	60.5	215.3	88.3	99.1	191.7	123.1	178.5	448.8	10.4	33.7	9.3	529.2	227.5	156.7	7.9	430.7	101.9	238.8	116.9	77.1	256.7	445.9	509.0	290.2	165.8	341.4	11.5	58.1	123.7	397.7	154.1	1271.3	740.1	2441.1	3418.8	69.9	4072.1	92.5	546.6	441.0	417.2	2395.7	279.2	192.6	229.6	1758.0	667.2	4579.3	123.7	685.2	2954.6	65.8	82.1	80.6	67.4	68.8	82.8	87.5	80.5	86.6	78.0	101.5	86.4	44.0	3.2	12.2	20.5	331.8	63.5	116.5	7.5	27.3	10.4	22.2	32.9	5.1	17.2	6.2	77.3	244.0	136.4	104.5	47.0	39.2	73.0	6.8	17.6	74.5	94.4	145.6	78.4	6.8	34.5	1402.6	59.9	181.0	29.8	141.8	126.0	189.2	6.6	595.3	25.2	14.1	77.8	2.0	1015.5	1146.3	10.8	8.1	1046.2	96.0	39.4	949.1	31.5	74.2	27.6	2.1	108.2	19.8	16.1	130.1	165.3	52.8	305.3	4.5	43.2	6.6	15.4	75.7	5.1	39.5	9.2	38.2	172.8	354.9	11.9	140.2	179.6
COX10		ENSG00000006695	"Cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10"	Q12887	17	14069490-14231736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.5;tongue: 44.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 88.2;Late spermatids: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	7.1	7.5	3.1	5.4	2.9	10.4	6.0	4.1	4.4	5.8	4.3	12.5	12.5	5.2	4.4	10.9	5.6	4.2	27.9	3.3	3.9	11.6	10.6	4.4	5.8	3.8	3.5	4.5	9.9	9.6	3.3	7.0	3.5	5.6	12.3	5.6	7.2	5.5	44.5	7.4	10.1	7.2	3.0	4.8	9.3	21.1	4.0	5.4	6.2	44.3	7.5	8.5	6.6	3.6	10.1	19.7	7.7	11.9	7.7	5.6	19.5	12.3	8.4	21.9	14.6	16.3	6.6	23.5	9.8	13.0	6.8	20.2	16.6	16.3	17.3	13.1	15.7	14.5	12.4	20.0	14.2	15.5	12.3	9.8	19.5	14.0	17.6	7.9	11.4	15.8	20.4	8.2	9.5	13.1	13.5	10.5	12.8	37.6	9.5	10.3	28.8	18.5	15.2	20.1	5.2	9.8	12.0	18.5	16.5	36.1	9.6	9.2	9.9	8.9	8.0	9.9	15.8	10.1	15.6	11.2	14.9	15.7	11.9	3.8	11.3	4.4	9.8	16.1	10.6	13.2	11.3	10.5	14.9	9.2	11.9	11.5	1.2	10.0	13.9	4.6	20.1	11.0	3.1	2.9	4.1	4.4	3.3	3.9	3.8	3.5	3.5	3.0	4.0	3.6	5.9	0.0	14.7	25.8	9.6	9.7	9.5	9.8	14.2	7.5	8.7	7.4	88.2	5.7	7.3	11.0	10.4	19.7	5.7	13.8	41.1	9.1	41.1	9.6	9.6	7.8	12.6	13.3	33.5	8.7	17.5	8.8	16.3	9.4	5.1	7.5	3.9	9.6	10.8	0.0	43.0	16.4	8.2	4.4	4.7	81.0	2.1	6.7	5.4	22.5	6.3	4.6	8.2	34.7	26.9	8.8	11.4	6.8	12.5	8.7	26.6	17.8	5.8	12.2	0.0	5.2	12.5	22.8	19.2	19.4	10.4	16.1	8.6	6.6	18.9	13.7
COX11	COX11P	ENSG00000166260	"Cytochrome c oxidase copper chaperone COX11"	Q9Y6N1	17	54951902-54968703	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044020	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044020: AB_2678777"	"unprognostic (1.42e-1)"	"unprognostic (6.59e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.13e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.11e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.85e-2)"	14.3	15.8	6.8	7.3	8.0	1.3	14.6	9.1	9.5	15.7	8.8	18.7	31.3	16.9	8.1	12.1	16.4	5.4	17.0	6.6	6.8	26.2	28.3	14.7	7.5	6.1	7.1	16.4	7.4	7.1	13.5	4.7	6.8	17.0	7.2	20.4	13.6	7.0	33.4	13.4	18.5	5.2	6.8	7.8	12.4	10.1	7.7	4.6	16.5	7.6	5.7	17.3	13.4	8.5	14.6	52.7	12.5	15.8	7.4	9.0	13.1	15.1	2.9	6.8	6.5	34.8	6.7	22.1	27.3	5.9	9.7	12.1	8.4	5.0	8.2	37.8	31.9	21.8	35.9	44.0	2.8	14.6	5.0	7.8	3.2	7.2	3.5	7.3	4.0	15.1	13.2	7.7	10.5	26.9	21.9	7.7	7.6	9.7	30.1	15.8	22.3	13.4	10.6	19.9	16.2	22.0	14.0	9.4	9.7	8.1	20.0	5.0	13.2	18.2	9.6	16.5	24.0	15.1	21.4	16.5	14.9	8.4	10.1	3.7	3.3	4.6	4.3	5.0	5.7	5.6	6.6	5.0	6.6	7.9	5.6	6.9	0.2	3.4	2.4	2.6	7.9	3.7	6.8	8.0	9.1	9.5	6.6	6.8	6.1	7.1	6.8	6.8	7.7	8.5	29.2	25.6	23.4	24.5	29.5	31.5	44.9	47.1	32.5	53.1	17.5	17.8	35.0	32.9	22.2	20.2	70.9	38.5	22.9	25.0	162.4	42.6	63.8	27.9	26.7	28.1	43.3	24.6	33.8	44.2	31.2	31.5	19.4	16.6	20.3	22.8	36.4	33.2	26.7	35.3	30.1	27.6	28.5	23.3	33.7	18.4	54.3	16.7	35.6	11.2	25.4	45.7	35.0	26.7	28.3	29.5	32.1	59.0	26.1	15.6	50.4	118.7	24.4	73.0	72.3	34.0	42.7	81.6	50.5	20.3	27.1	17.5	35.3	35.0	62.8	23.9
COX14	"C12orf62, MGC14288"	ENSG00000178449	"Cytochrome c oxidase assembly factor COX14"	Q96I36	12	50112082-50120457	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 835.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044618, HPA062014"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044618: AB_10960419, HPA062014: AB_2684657"	"unprognostic (5.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-3)"	124.0	106.4	96.3	47.1	101.4	66.2	105.6	110.3	129.7	63.6	120.1	92.4	83.4	46.2	130.5	68.5	54.9	62.9	238.6	94.5	105.5	143.8	145.4	62.3	74.5	102.6	99.8	52.8	62.0	127.8	88.0	54.7	102.9	67.0	77.5	60.6	84.9	80.7	247.6	49.8	84.0	58.7	102.9	66.9	76.5	32.6	104.0	54.9	87.3	276.7	62.0	74.2	47.3	110.2	78.4	168.3	32.8	79.4	169.4	105.7	60.5	61.1	92.7	98.8	89.5	156.7	109.1	69.9	171.9	78.3	82.6	79.0	57.2	87.5	91.7	78.7	236.6	154.3	140.4	139.2	65.1	112.1	133.7	123.8	129.9	67.1	76.7	100.5	96.2	83.1	70.2	153.4	109.1	193.3	93.7	170.3	51.5	116.4	211.3	77.6	52.4	176.8	155.0	149.1	91.0	51.4	92.4	177.5	195.6	72.6	115.1	103.6	75.2	55.0	58.1	92.3	50.1	106.3	199.0	93.5	77.9	105.0	30.9	258.8	197.8	172.7	146.1	194.5	155.6	213.7	186.9	167.0	190.0	188.0	176.7	173.7	67.0	153.1	178.2	247.2	224.8	214.8	96.3	101.4	110.3	129.7	94.5	105.5	102.6	99.8	102.9	102.9	104.0	110.2	91.5	60.9	120.6	11.1	108.8	124.9	91.2	212.9	87.0	68.2	169.2	192.5	524.4	161.5	138.7	222.5	22.9	191.9	111.1	320.9	565.4	131.4	7.1	117.5	58.7	99.2	156.0	69.2	13.1	170.1	122.6	90.3	81.6	88.1	65.4	64.0	88.9	397.9	219.6	47.1	16.3	214.7	187.2	152.3	110.4	22.9	129.2	117.7	149.4	6.5	181.2	111.0	111.2	7.1	22.3	116.8	262.4	109.4	93.0	129.5	492.6	835.5	157.5	67.4	105.2	51.5	130.8	51.1	56.0	121.6	159.3	127.5	112.2	115.4	227.4	118.6
COX15	CEMCOX2	ENSG00000014919	"Cytochrome c oxidase assembly homolog COX15"	Q7KZN9	10	99710868-99732127	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616"	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	15.0	31.2	12.9	9.7	13.3	6.6	13.8	12.9	16.4	16.7	14.3	17.1	12.6	15.6	14.2	18.8	15.2	10.4	21.3	12.7	12.7	21.1	23.4	11.4	13.7	12.4	12.9	19.0	16.2	14.6	16.2	10.8	13.0	14.5	16.0	15.3	14.2	11.0	34.5	14.7	15.6	10.9	12.7	17.8	16.2	12.0	13.6	13.4	13.6	27.2	16.1	19.6	15.0	14.1	22.7	50.3	19.6	42.9	28.4	22.4	15.9	16.9	22.1	25.0	23.9	37.6	30.2	42.8	26.6	15.4	15.6	32.1	44.2	25.7	26.5	19.2	21.0	25.1	23.5	39.6	30.0	33.5	22.3	23.3	23.9	27.7	40.9	36.6	26.3	36.1	27.3	29.6	24.2	24.8	24.7	27.6	21.0	22.1	22.0	30.2	29.5	27.9	24.8	16.6	16.7	26.4	29.9	16.6	29.5	15.7	61.2	13.2	22.1	12.4	17.1	18.7	25.6	25.2	36.2	28.5	22.7	53.2	10.7	19.6	12.8	12.4	7.4	15.2	8.8	12.7	8.6	8.4	13.9	11.3	8.6	8.9	7.9	8.7	18.5	5.7	9.9	9.7	12.9	13.3	12.9	16.4	12.7	12.7	12.4	12.9	13.0	12.7	13.6	14.1	11.4	22.4	8.4	32.0	14.1	6.1	10.3	13.2	12.0	14.7	14.2	11.2	25.2	14.3	15.9	14.7	10.4	23.7	9.0	16.5	29.4	17.6	1.9	14.0	15.4	10.8	17.5	9.4	18.7	15.8	20.7	9.6	11.7	14.6	2.5	21.5	7.9	27.2	17.4	13.5	23.7	13.4	6.1	27.4	8.6	1.9	10.5	14.7	12.4	12.2	18.5	13.4	13.4	16.6	26.1	13.2	11.9	10.1	9.0	7.5	16.5	24.5	27.7	15.5	0.0	11.0	9.4	10.1	9.5	12.2	9.2	22.7	10.3	35.8	16.6	9.3
COX16	"C14orf112, HSPC203"	ENSG00000133983	"Cytochrome c oxidase assembly factor COX16"	Q9P0S2	14	70325081-70416984	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 302.9;Ionocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062659	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA062659: AB_2684823"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.03e-12)"	"unprognostic (4.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.72e-1)"	19.4	27.1	20.2	18.2	19.9	22.8	27.8	20.4	29.2	16.5	22.9	26.6	30.2	12.8	27.1	17.1	17.3	19.4	24.4	20.1	20.7	29.3	40.5	16.7	21.7	21.0	20.1	17.2	43.5	26.9	12.7	14.3	20.5	20.7	22.1	24.3	21.9	13.7	84.0	17.5	26.7	10.5	20.2	18.9	33.4	17.7	20.2	20.8	23.3	44.5	19.0	19.3	12.6	22.5	100.2	31.2	65.9	56.0	26.7	36.0	48.3	55.0	37.1	38.9	34.7	19.2	93.5	26.2	36.6	33.8	33.5	41.8	27.6	35.5	48.9	18.9	27.5	36.9	31.3	22.1	16.1	35.9	48.7	36.1	25.1	24.0	23.0	41.5	34.2	69.2	20.8	54.6	39.0	49.6	85.4	43.8	68.3	83.3	44.5	57.6	53.2	37.0	46.2	49.0	57.8	46.0	46.2	102.4	53.9	42.2	87.4	69.1	42.5	50.2	111.6	55.4	40.6	57.6	38.9	48.2	75.4	19.1	61.1	48.6	33.8	8.0	24.2	38.0	29.2	45.7	34.5	29.1	36.3	39.8	32.3	34.8	2.5	45.6	38.3	55.7	43.6	44.0	20.2	19.9	20.4	29.2	20.1	20.7	21.0	20.1	20.5	20.2	20.2	22.5	22.0	51.3	53.9	0.0	45.0	84.4	9.4	302.9	70.6	8.2	29.7	18.8	7.1	32.9	162.2	23.9	2.1	14.8	22.9	23.8	52.8	47.1	2.7	43.6	21.3	28.5	31.2	46.0	0.0	64.8	20.2	36.0	99.4	62.1	33.5	7.4	31.8	57.7	18.2	1.7	0.0	35.8	187.2	34.6	89.3	4.6	18.3	40.0	96.0	0.0	26.3	25.2	25.7	0.0	0.0	59.1	27.0	15.8	99.3	11.2	42.5	48.6	137.1	10.0	6.6	13.6	27.5	15.4	21.0	125.7	100.7	10.9	39.8	7.3	39.4	14.4
COX17		ENSG00000138495	"Cytochrome c oxidase copper chaperone COX17"	Q14061	3	119654513-119677454	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042226, HPA048158"	Supported		Supported	Mitochondria		NA	NA		220000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA042226: AB_2677911, HPA048158: AB_2680292"	"unprognostic (1.98e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.64e-2)"	81.6	178.5	106.5	77.1	111.2	113.3	68.8	117.5	122.4	50.3	149.2	90.2	90.2	41.2	114.1	55.9	47.3	59.4	279.9	105.5	123.6	94.7	172.7	62.3	110.4	115.8	115.3	31.5	102.0	412.1	119.2	63.9	115.7	78.6	78.7	120.6	80.8	90.7	401.4	43.3	88.5	62.9	112.5	64.9	107.5	44.4	113.0	106.6	94.4	363.9	89.8	75.9	35.7	118.6	219.6	257.0	122.7	33.3	53.4	53.1	45.7	130.5	84.2	127.3	133.4	226.4	157.7	164.6	158.0	72.1	174.8	84.0	138.5	154.9	74.9	205.5	155.9	145.0	195.3	180.1	63.1	205.0	246.7	56.6	142.7	77.9	106.0	82.2	87.9	200.8	122.4	370.7	155.4	410.2	212.8	283.5	133.8	212.2	413.3	88.3	82.3	273.7	203.2	141.0	210.5	86.4	153.1	137.1	189.7	76.9	180.5	313.0	66.6	91.3	144.9	59.8	168.4	257.5	348.9	361.1	129.0	157.8	164.2	591.4	241.1	630.6	218.1	357.5	208.1	378.3	241.7	230.3	252.8	320.4	189.1	187.0	174.4	213.6	487.3	538.7	352.6	260.1	106.5	111.2	117.5	122.4	105.5	123.6	115.8	115.3	115.7	112.5	113.0	118.6	194.5	157.0	167.1	5.2	161.5	94.1	132.8	267.9	46.7	108.9	153.8	147.2	622.8	238.8	202.4	498.4	43.8	137.4	116.7	385.3	716.1	264.0	115.0	282.4	64.3	164.7	214.2	162.9	3.8	413.7	193.9	99.3	150.3	178.8	309.3	70.2	116.0	779.8	216.1	75.7	5.6	327.8	427.2	181.8	281.2	39.9	91.0	190.8	277.5	11.2	345.7	178.8	137.0	8.5	8.8	459.7	512.8	136.9	176.5	198.2	434.6	786.2	280.2	174.4	184.1	112.9	171.6	286.0	159.2	85.4	125.4	211.0	129.0	49.6	151.1	199.0
COX18	FLJ38991	ENSG00000163626	"Cytochrome c oxidase assembly factor COX18"	Q8N8Q8	4	73052362-73069755	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046772, HPA049489"	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA046772: AB_2679799, HPA049489: AB_2680791"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (9.01e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.22e-7)"	"unprognostic (1.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.22e-3)"	1.5	3.9	0.7	0.4	0.8	0.5	1.4	1.3	1.0	1.3	1.1	1.6	0.6	1.5	0.9	1.4	1.2	0.4	2.7	0.8	0.9	1.7	2.4	1.2	0.7	0.4	0.6	1.5	2.0	0.7	1.3	0.6	0.5	0.9	0.6	1.3	1.9	0.6	2.7	1.3	1.4	0.4	0.3	1.3	1.7	1.3	1.0	0.4	1.1	1.2	0.5	1.2	1.2	0.7	0.6	1.0	1.0	1.0	0.9	0.9	0.8	1.0	0.9	0.4	0.5	0.8	1.1	1.8	0.7	0.6	0.7	0.6	1.0	0.7	0.4	1.4	0.7	0.9	1.3	1.3	0.7	1.5	1.2	1.1	0.7	0.4	0.8	1.1	0.8	1.6	1.4	1.7	0.8	0.5	1.8	1.0	1.5	1.1	1.1	1.0	1.6	2.6	0.8	0.6	1.5	1.0	1.1	0.9	0.4	0.8	0.8	0.8	1.1	1.0	0.8	1.3	0.5	1.7	0.8	1.1	1.2	1.1	0.8	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.1	0.1	0.7	0.8	1.3	1.0	0.8	0.9	0.4	0.6	0.5	0.3	1.0	0.7	5.6	3.2	6.3	7.2	10.1	2.5	3.7	4.5	1.2	11.7	7.1	4.2	13.9	5.7	7.3	9.2	22.9	8.0	9.0	5.5	13.7	6.5	4.0	6.7	8.4	6.7	5.4	7.8	10.5	8.0	8.3	7.0	5.6	7.1	0.0	17.4	11.4	16.7	8.8	20.2	10.6	7.7	4.1	13.9	3.0	2.0	9.0	8.4	5.4	6.5	12.5	6.6	11.3	10.1	13.4	9.3	5.2	9.4	18.1	6.6	6.6	13.0	8.1	14.3	13.1	7.5	6.0	10.2	7.3	5.5	1.4	3.0	8.6	12.7	9.6	3.4
COX19	MGC104475	ENSG00000240230	"Cytochrome c oxidase assembly factor COX19"	Q49B96	7	898778-975549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	4.5	12.3	4.0	3.2	4.7	6.7	4.4	6.3	4.8	5.4	2.2	6.8	5.3	4.8	2.2	5.8	6.8	2.0	5.2	4.0	4.3	6.2	5.9	4.9	4.4	4.8	4.2	5.5	7.5	6.4	5.9	2.7	5.0	6.2	3.5	2.9	6.0	2.8	7.5	8.0	7.4	2.4	3.6	7.6	5.9	4.0	4.4	3.7	5.6	4.9	3.5	5.0	4.8	6.9	13.9	3.7	4.1	5.2	3.1	4.4	7.8	6.1	4.4	5.2	4.3	9.6	7.6	6.8	2.0	3.7	8.2	9.1	4.3	4.2	4.1	2.1	7.2	3.0	4.5	7.1	9.8	7.3	6.8	5.1	9.7	4.0	9.2	5.8	3.3	6.9	9.0	5.7	3.4	9.0	3.1	8.6	10.6	16.3	8.6	7.4	0.9	3.3	4.6	6.0	5.4	5.4	3.5	14.4	12.0	6.7	7.2	17.1	4.2	5.2	7.6	6.0	9.5	7.1	5.2	6.6	4.6	10.4	8.7	9.4	5.2	8.3	5.8	5.1	5.9	6.6	6.1	5.2	4.5	6.1	7.5	7.2	5.0	5.4	5.5	7.9	5.9	4.4	4.0	4.7	6.3	4.8	4.0	4.3	4.8	4.2	5.0	3.6	4.4	6.9	25.4	12.8	21.4	6.2	35.4	24.6	35.9	37.7	19.4	19.3	21.7	19.2	14.2	31.5	24.1	31.3	12.5	27.8	49.7	29.9	15.6	34.9	7.4	58.4	23.8	23.5	44.9	17.2	13.1	34.0	41.8	19.0	17.3	49.3	34.9	28.1	25.0	31.0	26.1	15.2	13.3	32.6	36.7	24.9	28.5	2.7	19.6	29.4	21.4	13.1	46.6	33.3	64.9	6.6	22.7	49.6	31.7	14.3	20.8	36.8	37.7	25.8	36.2	27.0	6.6	18.7	23.2	19.2	32.7	21.4	25.7	41.9	39.5	30.9	32.2	45.3
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"Cytochrome c oxidase assembly factor COX20"	Q5RI15	1	244835616-244845057	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 414.8;Proximal tubular cells: 464.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	17.5	44.2	28.1	23.3	30.9	20.1	22.1	37.4	49.2	13.9	23.6	23.9	24.3	24.8	29.9	21.5	17.2	15.3	42.9	27.9	30.1	50.2	29.6	15.8	21.4	30.3	30.3	35.4	23.2	22.8	11.1	17.7	28.8	28.7	18.7	58.3	17.1	18.6	43.3	15.2	25.0	20.5	29.2	15.0	23.1	25.0	29.3	16.3	37.0	37.4	16.5	20.4	9.6	30.1	132.6	34.1	33.5	100.4	22.5	17.3	75.2	54.0	35.7	31.0	27.2	93.9	88.9	21.3	65.7	36.6	58.3	36.1	17.8	43.0	40.8	56.0	15.6	38.6	47.6	85.7	28.7	95.7	57.5	16.0	20.2	44.5	30.8	44.9	35.2	22.7	81.2	80.2	63.0	33.0	53.5	43.5	84.2	94.9	68.6	38.5	42.0	121.5	59.5	33.1	19.6	54.2	68.1	36.1	79.6	32.1	67.0	28.7	69.3	67.3	88.7	59.9	120.1	128.0	188.7	43.7	90.9	108.2	65.3	14.5	15.3	21.4	27.1	36.4	26.3	34.2	31.3	30.2	26.5	32.6	21.2	28.7	3.9	24.2	34.5	26.1	43.4	20.4	28.1	30.9	37.4	49.2	27.9	30.1	30.3	30.3	28.8	29.2	29.3	30.1	66.7	19.2	52.1	44.1	77.7	85.1	115.1	144.3	38.1	111.5	104.4	110.1	68.6	183.0	90.5	191.3	45.9	231.5	74.4	97.7	414.8	154.1	38.6	78.4	74.1	61.4	61.8	82.0	16.6	188.9	164.6	56.1	57.6	119.5	73.4	53.1	42.5	294.8	122.1	89.2	24.4	91.7	77.3	64.8	79.6	75.9	69.6	73.4	72.9	9.4	97.6	195.2	110.2	27.6	34.1	178.6	87.0	80.1	51.9	75.9	134.8	464.0	67.7	133.4	65.7	83.2	85.0	67.1	122.4	61.6	75.6	264.5	81.4	63.6	115.3	87.8
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938083	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		530000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	175.6	176.7	187.1	105.1	189.5	148.5	150.8	231.1	258.1	109.8	201.3	454.2	326.9	98.2	110.7	293.0	89.3	67.8	1749.5	193.1	229.3	373.5	349.6	133.0	125.6	216.1	207.5	71.1	259.3	385.3	141.1	88.0	208.8	118.4	398.2	194.1	211.2	99.2	1609.7	169.0	269.6	95.0	194.8	150.8	306.8	217.8	220.4	150.7	141.5	1735.8	197.9	141.2	146.3	193.8	300.4	309.1	376.8	331.1	227.2	260.2	443.1	262.7	222.3	317.7	294.8	346.0	352.1	700.0	322.0	219.5	387.8	567.7	898.3	368.4	263.7	401.0	906.2	566.6	299.7	436.0	283.9	642.7	335.0	266.6	389.9	198.3	445.1	217.4	377.7	450.0	522.2	429.9	321.2	222.4	558.8	494.6	408.7	575.8	540.1	499.0	369.7	778.4	469.8	472.4	570.5	250.1	396.6	569.2	871.3	407.6	286.3	507.6	274.3	241.4	238.7	303.9	421.1	508.4	1000.3	759.0	258.2	836.1	224.5	332.4	361.5	210.2	198.1	465.6	238.6	296.4	242.4	235.7	452.9	227.3	171.6	198.0	87.4	354.9	432.7	365.2	372.6	426.4	187.1	189.5	231.1	258.1	193.1	229.3	216.1	207.5	208.8	194.8	220.4	193.8	120.7	99.3	119.6	20.5	166.6	158.2	235.3	623.6	151.4	113.4	202.6	313.4	1645.3	221.6	324.0	171.0	39.6	502.8	162.7	987.6	1475.2	407.5	1046.3	199.4	124.3	163.8	461.4	227.3	18.9	436.7	528.2	156.3	247.2	192.8	104.0	143.3	117.8	471.8	571.5	92.5	25.1	890.5	496.4	286.0	209.1	819.6	100.3	238.6	250.8	17.8	413.7	159.9	162.7	15.6	20.2	412.1	817.3	85.7	350.7	319.3	1276.3	921.7	242.7	176.8	92.1	139.6	590.9	523.0	253.6	371.3	159.0	511.0	144.2	216.5	1045.6	393.3
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646062-97648383	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1151.3;skeletal muscle: 1332.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3614.3;Distal tubular cells: 3621.5;Proximal enterocytes: 2795.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	209.1	252.9	323.0	42.8	339.7	113.3	178.7	373.1	436.0	138.1	349.2	322.6	164.2	124.6	72.3	284.6	136.9	32.6	1151.3	319.2	357.2	478.6	372.8	120.4	40.3	341.7	339.9	138.4	165.6	234.0	169.0	47.1	339.9	158.2	113.4	74.5	196.7	90.1	1332.7	213.2	211.9	51.1	332.9	153.2	290.6	101.2	353.1	64.4	185.0	705.9	54.3	179.8	179.1	355.3	144.9	165.5	106.8	169.7	115.9	105.8	428.3	180.0	100.8	118.3	130.5	459.9	148.7	240.8	377.3	116.5	188.4	217.9	117.5	181.8	56.4	188.7	493.2	324.2	166.6	559.8	220.3	310.6	231.2	193.8	161.6	113.4	91.2	125.4	104.4	187.8	243.6	115.5	94.0	360.0	203.5	450.0	196.6	257.2	854.3	194.9	170.6	368.8	167.5	227.9	202.2	210.3	175.0	225.0	374.8	146.0	115.7	345.5	186.9	107.5	181.4	174.4	118.7	265.8	274.7	183.1	194.9	264.5	113.5	1086.6	1062.7	933.1	458.0	1057.0	445.1	801.5	547.4	481.8	990.1	666.0	528.0	468.8	1016.6	469.6	926.3	677.6	783.4	1543.0	323.0	339.7	373.1	436.0	319.2	357.2	341.7	339.9	339.9	332.9	353.1	355.3	461.0	221.2	256.0	33.3	292.7	386.6	629.5	1166.0	377.9	239.1	433.2	536.2	3614.3	567.6	618.5	800.0	227.2	736.0	257.4	1960.0	3621.5	599.5	207.5	399.4	300.8	380.0	740.3	308.8	27.3	604.1	897.1	391.6	616.7	439.7	330.6	392.2	361.3	1234.9	875.0	141.3	33.7	1430.5	1043.6	485.2	651.9	360.8	351.6	456.6	912.4	30.0	711.7	461.5	314.1	15.6	39.4	505.4	1836.0	304.6	353.3	468.2	2795.9	2663.5	485.4	386.3	447.0	340.2	569.9	265.2	310.7	944.2	479.9	613.2	291.9	455.7	1576.9	915.9
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440737	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria		NA	NA		85000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA062394: AB_2684749"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	353.0	396.5	1004.7	203.3	1040.0	368.0	321.3	1052.0	1305.8	265.4	959.8	597.1	611.5	248.1	273.9	582.2	248.6	231.3	263.9	1030.7	1086.0	664.3	707.1	269.0	273.3	1062.6	1045.6	207.4	373.0	986.0	344.2	193.5	1075.6	282.7	443.1	392.4	373.3	244.3	59.7	372.2	481.2	230.4	995.3	262.3	493.9	224.4	1086.7	327.9	316.1	88.5	255.3	319.6	348.8	1046.6	532.7	1142.5	627.4	653.5	475.4	403.9	755.8	327.1	447.7	585.1	497.2	1388.3	528.9	1115.9	955.5	477.1	442.6	865.0	624.6	737.3	382.3	663.5	1314.3	596.5	594.9	1036.8	434.6	661.9	405.9	487.3	895.5	531.3	632.3	477.0	505.0	801.0	602.9	337.1	494.2	1528.7	965.1	1667.1	566.1	1034.6	1627.5	644.7	414.7	1044.5	945.3	1302.6	822.4	708.6	595.6	589.9	803.5	347.1	1051.4	742.9	373.0	355.0	431.9	370.9	466.8	513.0	791.3	897.5	558.7	643.2	484.9	225.6	347.3	316.4	258.9	353.6	278.9	377.1	305.3	287.3	486.9	296.9	279.3	287.3	297.9	253.7	374.0	516.7	460.6	534.3	1004.7	1040.0	1052.0	1305.8	1030.7	1086.0	1062.6	1045.6	1075.6	995.3	1086.7	1046.6	346.4	397.4	312.4	41.1	355.0	383.3	526.3	1145.7	508.2	238.3	411.3	426.7	124.4	543.3	683.0	774.3	577.6	774.8	289.0	1306.7	1481.1	659.4	207.3	487.3	239.6	311.2	515.7	348.0	26.3	661.9	701.5	304.0	437.3	425.9	272.2	263.9	266.0	971.0	779.3	146.4	38.1	861.7	980.6	376.6	426.0	136.4	302.0	377.7	524.7	19.7	583.9	440.8	332.7	23.6	56.9	726.1	1417.1	265.5	565.2	506.1	1857.6	1701.6	718.9	414.2	341.8	259.0	508.6	455.8	373.7	1155.8	388.0	927.2	341.0	399.5	1049.7	778.9
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648323-35658782	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 2453.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004192	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	322.3	211.6	733.9	206.6	741.0	465.2	371.1	780.8	935.9	291.0	758.1	598.9	427.0	197.2	633.9	410.0	329.7	245.8	1284.7	749.3	761.3	519.5	582.3	201.7	316.0	768.3	740.1	241.1	292.4	850.2	169.9	222.3	757.0	249.2	690.0	276.5	356.6	328.6	1467.0	264.7	351.3	342.8	735.4	193.3	336.8	107.0	759.7	426.3	270.5	2453.4	510.5	402.2	205.1	747.2	480.3	1219.5	479.2	649.4	665.5	701.3	455.3	383.4	641.0	684.8	686.4	1018.3	478.0	555.8	663.1	656.6	413.4	341.7	836.5	700.6	683.5	632.0	570.1	929.4	626.6	1014.1	521.1	835.0	454.9	800.2	906.5	619.5	361.1	606.3	690.4	577.8	616.9	783.0	714.9	1019.4	589.2	626.8	357.0	2445.6	811.5	502.1	525.9	930.4	1567.1	1035.9	434.4	484.5	615.9	1049.3	393.4	568.5	419.6	892.9	365.9	363.8	398.0	382.3	605.6	450.5	683.3	776.7	470.9	695.0	472.7	1138.1	1099.7	998.5	628.9	1228.5	607.0	1150.2	854.9	732.8	1140.2	956.3	839.9	744.3	1115.9	672.8	1178.4	1176.1	1138.3	2058.8	733.9	741.0	780.8	935.9	749.3	761.3	768.3	740.1	757.0	735.4	759.7	747.2	324.6	243.6	227.3	27.4	409.4	427.1	436.6	1071.1	373.3	143.5	498.4	615.2	2710.8	664.8	529.6	698.9	64.6	623.0	361.5	1496.0	2985.6	711.7	328.0	427.4	293.2	312.6	625.7	436.5	21.2	808.9	735.5	360.9	484.2	397.2	280.8	277.9	338.8	1270.7	1041.1	89.2	27.9	1277.1	736.5	800.2	705.9	942.4	327.7	582.7	748.8	18.7	807.7	351.1	435.6	16.1	31.6	863.0	1445.3	273.1	523.2	548.7	2291.0	2228.5	445.5	193.3	263.0	293.8	454.2	175.7	186.6	784.8	565.6	670.7	373.1	229.1	1277.5	717.0
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99893707	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014295, CAB016244"	Enhanced		Supported	Mitochondria		NA	NA		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	134.0	147.5	180.8	52.9	183.9	152.6	125.7	186.1	291.0	166.4	190.2	268.1	334.8	194.0	175.6	197.3	189.5	20.4	781.6	191.8	195.6	254.9	328.5	108.4	71.1	186.0	188.4	161.9	107.3	101.7	159.5	89.9	189.2	162.6	110.4	147.0	108.1	58.1	666.1	121.4	172.3	42.7	182.4	122.9	180.0	170.8	192.7	44.8	129.1	554.1	51.5	188.7	148.6	188.9	137.6	57.8	63.8	251.3	140.0	100.5	103.1	44.5	42.7	30.1	34.3	54.7	284.5	326.8	320.1	70.1	47.7	176.4	36.4	363.3	51.0	60.5	89.1	684.6	66.9	160.4	88.9	319.3	201.9	95.1	475.3	26.0	56.4	129.2	45.1	103.8	49.8	571.1	51.6	134.2	337.9	289.6	117.9	205.5	127.7	381.0	21.2	320.6	453.4	713.3	191.8	115.2	30.9	654.2	351.5	65.0	461.7	201.1	40.1	220.4	286.0	235.8	63.8	140.7	126.3	209.6	310.2	128.2	200.8	345.8	134.7	114.1	177.8	210.5	189.0	209.7	270.6	193.5	212.9	189.8	319.7	294.9	16.6	187.7	266.5	301.9	272.7	252.9	180.8	183.9	186.1	291.0	191.8	195.6	186.0	188.4	189.2	182.4	192.7	188.9	527.8	403.8	485.1	29.7	382.1	490.8	493.5	1431.9	279.4	217.6	561.3	642.7	2146.4	491.8	731.2	605.1	102.2	978.9	416.1	1263.2	2226.5	673.6	834.3	579.3	778.7	436.9	807.5	400.2	27.6	849.4	853.9	502.0	440.4	551.9	362.5	219.3	384.1	1855.5	1066.5	156.5	33.5	1221.3	1027.4	451.1	539.5	266.5	664.8	440.8	732.8	23.4	778.0	545.0	449.0	22.6	32.1	808.6	1338.7	587.5	412.2	448.4	2173.5	1791.0	702.9	282.0	493.0	367.1	555.9	1180.5	505.2	666.4	640.6	1784.9	452.1	428.0	1246.7	715.5
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899440-77907376	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1122.9;tongue: 756.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2237.0;Distal tubular cells: 2283.3;Proximal tubular cells: 1865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058041	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favorable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (2.43e-4)"	99.1	94.8	198.6	74.5	200.9	205.6	81.5	218.2	376.7	46.2	228.4	176.5	182.4	50.2	94.4	72.1	55.3	42.0	326.8	202.2	214.7	222.6	181.5	45.7	64.3	203.2	202.9	38.7	49.1	301.3	21.3	53.6	205.4	61.6	158.5	184.1	93.5	65.9	1122.9	42.8	156.7	74.8	205.0	51.3	125.1	19.1	208.4	96.6	54.3	756.7	76.3	87.8	19.6	207.3	242.8	239.4	257.8	214.6	111.8	90.1	179.5	159.7	78.8	101.8	113.1	259.6	213.0	158.6	271.8	96.1	333.1	302.5	298.7	183.6	112.7	138.9	372.7	218.5	441.3	343.5	104.2	441.1	185.5	133.0	137.0	154.2	129.9	173.0	113.0	186.1	186.3	409.8	118.6	282.6	350.6	445.5	253.4	972.4	614.5	250.5	297.0	594.4	344.6	420.8	177.3	158.1	305.8	396.8	334.2	209.0	148.7	295.0	149.7	91.1	222.0	232.6	167.7	157.9	407.0	364.8	212.2	504.2	130.5	212.5	226.7	168.6	152.7	326.5	165.2	213.6	166.5	174.8	303.7	146.3	155.7	185.6	142.8	205.9	316.1	213.2	238.6	261.1	198.6	200.9	218.2	376.7	202.2	214.7	203.2	202.9	205.4	205.0	208.4	207.3	238.9	134.6	178.0	28.1	247.7	297.5	297.2	1151.7	225.9	111.4	204.5	244.9	2237.0	487.6	463.6	369.6	35.5	412.9	272.2	1219.8	2283.3	504.6	20.8	424.0	243.9	210.0	516.0	428.5	11.2	395.7	424.2	227.2	382.8	356.4	226.3	134.7	194.5	1179.5	718.3	47.1	14.8	922.1	734.5	438.9	432.1	43.1	199.4	368.3	538.9	10.3	488.1	214.0	258.5	12.5	19.5	425.5	1090.3	176.4	297.3	307.7	1516.9	1865.2	314.0	174.3	210.4	274.2	315.4	81.4	108.8	583.4	345.5	591.7	258.4	166.9	978.4	472.5
COX7C		ENSG00000127184	"Cytochrome c oxidase subunit 7C"	P15954	5	86617928-86620962	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2380.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4586.0;Distal tubular cells: 4724.9;Proximal tubular cells: 5650.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046647	Approved					NA	NA		39000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046647: AB_2679736"	"unprognostic (1.45e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.46e-2)"	338.6	433.9	600.9	274.3	610.7	314.7	324.9	620.1	771.4	329.2	657.2	563.0	545.8	271.8	402.9	420.1	288.0	194.7	1546.9	609.6	648.8	715.2	621.3	243.3	314.5	619.9	616.5	392.7	382.2	781.1	402.4	196.2	613.5	305.4	398.2	236.6	459.7	253.1	2380.2	274.3	537.4	207.5	614.4	270.0	429.7	174.6	624.6	370.8	328.0	1599.4	319.8	344.4	315.0	614.7	576.6	687.2	595.1	1043.0	551.4	550.5	653.4	432.8	364.4	298.2	416.7	806.4	989.9	794.6	459.2	342.3	799.3	594.8	539.3	876.2	487.2	585.2	829.5	623.6	1006.0	844.4	458.9	732.2	692.1	648.0	745.3	377.5	518.0	841.6	486.3	687.0	392.7	860.9	443.7	1209.9	766.2	954.2	594.7	593.0	1958.6	728.4	654.3	1426.2	909.4	1129.8	700.4	518.2	406.7	946.9	973.0	646.9	963.0	1008.6	449.2	254.2	470.5	448.4	846.6	832.8	1056.8	903.4	652.5	860.4	491.6	344.5	526.0	414.6	399.1	558.3	500.0	682.6	620.5	497.6	668.6	567.2	648.4	579.2	52.3	404.7	538.3	619.0	606.5	996.5	600.9	610.7	620.1	771.4	609.6	648.8	619.9	616.5	613.5	614.4	624.6	614.7	408.8	512.8	732.9	33.0	879.5	723.5	946.8	1663.7	715.4	276.2	1141.9	1079.4	4586.0	1574.2	959.9	1213.8	156.4	1271.2	657.5	1604.6	4724.9	1314.8	1011.8	856.3	538.7	570.2	916.6	651.1	24.6	1506.3	878.3	605.7	677.3	706.8	618.0	814.7	809.2	2748.0	1388.3	230.5	30.2	1829.4	933.8	1457.0	904.7	488.5	985.7	785.3	1115.3	18.7	1443.9	714.6	782.7	15.1	25.9	1114.6	1964.4	720.7	617.5	975.5	3353.2	5650.8	734.8	313.3	598.2	662.7	740.8	927.7	381.9	1319.3	935.4	1320.8	826.7	634.8	2108.4	1356.3
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974620-63976543	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055942	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	322.0	443.8	421.6	134.1	435.5	292.0	286.8	470.0	544.7	259.3	524.0	516.1	337.8	236.1	121.2	612.5	246.8	78.4	1287.8	415.9	469.2	771.1	449.9	265.4	119.9	421.5	420.4	248.0	275.7	366.3	373.9	105.7	414.7	316.0	250.2	149.5	362.1	223.8	1523.9	362.0	381.5	132.3	427.7	277.0	467.3	96.7	480.4	206.6	342.9	1005.3	175.8	307.1	331.2	427.9	613.9	803.9	505.6	505.2	213.8	260.8	365.3	317.0	355.2	621.2	480.1	543.1	489.1	290.1	680.8	447.1	581.6	597.7	395.7	550.9	212.5	427.6	687.8	423.2	621.8	650.3	341.4	431.0	527.7	336.7	412.4	497.3	398.6	274.1	391.9	676.2	503.9	613.3	397.7	1600.5	613.8	1461.1	460.7	726.4	1401.4	473.9	406.3	1234.3	512.9	512.7	457.8	645.0	377.1	541.2	816.1	215.0	796.1	459.8	240.7	356.1	481.0	769.2	374.2	760.8	662.4	461.7	462.0	420.9	436.9	764.9	743.9	692.9	407.0	848.8	301.5	398.5	441.6	403.5	867.0	347.3	337.1	369.6	530.6	418.3	794.1	851.2	589.5	723.9	421.6	435.5	470.0	544.7	415.9	469.2	421.5	420.4	414.7	427.7	480.4	427.9	236.7	224.4	259.8	13.7	255.3	294.6	392.2	640.4	385.3	196.8	394.3	458.2	1263.1	424.7	396.1	437.7	73.0	451.2	305.9	1382.7	2341.9	453.1	9.6	271.6	217.2	215.7	721.6	272.9	12.5	483.1	559.6	246.1	395.0	305.1	224.5	209.3	227.4	811.5	927.5	107.7	16.8	1011.7	592.0	535.2	427.0	25.6	239.6	455.4	627.9	11.2	508.9	429.3	416.1	7.5	15.2	562.9	1103.8	221.2	393.2	419.8	1417.0	1658.2	345.2	187.5	157.8	256.0	339.9	74.0	55.5	844.0	370.9	366.9	290.4	203.7	1088.7	593.4
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347182-93348356	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"testis: 76.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"U-937: 27.4"	"Low region specificity"	"Detected in many"							HPA003127	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	76.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.5	0.2	0.3	0.5	0.4	0.5	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.6	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	865.6	1.2	0.0	0.8	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1864.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.3	1.2	0.0	19.7	0.0	0.1	424.3	124.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	13.0	2.3	17.9	2.2	18.1	0.9	20.8	18.7	29.8	70.2	129.2	13.0	9.8	14.8	0.0	5.6	8.3	1.1	39.2	17.5	33.0	9.5	1871.4	13.4	18.9	28.1	20.3	0.8	6.5	3.9	28.6	3.4	24.9	7.9	16.4	246.5	39.9	0.9	2.6	13.0	20.8	2.4	19.2	23.1	3.0	1.5	20.1	0.5	16.1	8.3	20.0	23.9	2.3	29.0	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.1	18.7	29.8	17.5	33.0	28.1	20.3	24.9	19.2	20.1	29.0	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2326	"pancreas: 237498.3"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 10133.0"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 11.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		110000000		"Cluster 25: Pancreas - Digestion"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	27.9	4.8	0.2	5.6	0.2	4.7	13.6	0.1	0.2	11.9	1.2	4.5	33.6	5.0	0.1	6.9	3.7	0.2	43.5	0.2	0.3	4.6	12.9	3.3	8.7	0.1	0.1	102.1	237498.3	0.0	5.0	18.4	0.1	6.9	0.0	0.2	39.5	0.1	4.7	6.6	20.8	0.4	0.2	7.7	21.3	5.4	0.2	0.1	3.0	0.4	0.0	2.8	4.0	0.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	3.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	12.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	10133.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.9	1.2	0.0	1.0	44.5	2.1	0.0	0.0	0.0	527.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	16.2	2.7	0.9	5.5	0.0	0.0	1.6	0.0	2.5	0.0	0.1
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266863-130289798	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	416	"pancreas: 45360.2"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 4973.8"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000		"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	5.5	1.0	0.3	0.7	0.8	0.4	2.6	1.0	0.9	1.9	0.2	1.3	17.4	0.8	0.1	1.5	0.7	0.0	8.4	0.3	0.6	0.9	2.6	0.7	1.4	2.8	1.3	19.7	45360.2	0.0	1.4	3.2	2.5	1.5	0.4	0.8	7.8	0.0	0.8	1.1	30.6	0.0	1.2	1.2	108.9	2.2	1.1	0.1	0.6	0.0	0.0	0.5	0.8	3.1	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	3.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.6	0.4	0.3	0.0	0.4	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.0	0.9	0.3	0.6	2.8	1.3	2.5	1.2	1.1	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	1.9	8.1	4.3	0.0	0.0	0.9	0.0	0.0	0.1	4973.8	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	10.5	0.3	0.5	0.0	0.0	13.9	4.6	0.0	0.5	1.0	471.3	52.9	0.0	0.0	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.3	0.4	2.0	0.0	0.1	0.3	0.0	0.2	1.5	0.2
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892951-17026815	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.7;prostate: 34.1;seminal vesicle: 36.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.5;Alveolar cells type 1: 22.4;Alveolar cells type 2: 29.8;Collecting duct cells: 27.6;Leydig cells: 31.4;Prostatic glandular cells: 19.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 19.5;EFO-21: 12.6;T-47d: 34.4"					"Region enriched"	"Detected in single"	8	"spinal cord: 5.6"	"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	NA	NA		2700000		"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Focal adhesion sites"		"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	6.8	2.5	7.9	0.5	15.6	0.5	6.2	35.7	3.7	7.7	4.3	1.0	0.3	2.2	10.5	0.5	1.8	0.3	23.8	2.4	7.2	19.0	0.8	15.0	0.2	23.5	26.2	1.6	0.4	3.2	4.1	4.2	21.3	34.1	0.1	0.5	2.8	36.1	2.8	1.6	1.2	0.4	25.5	1.7	0.8	2.3	17.8	1.2	21.0	2.9	0.3	1.6	3.1	32.0	0.0	0.0	0.8	0.0	0.0	0.0	19.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	12.6	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	1.1	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.2	0.7	0.0	0.0	1.9	0.0	0.1	0.5	2.8	0.1	0.0	0.0	0.6	0.0	0.1	34.4	0.2	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	15.6	35.7	3.7	2.4	7.2	23.5	26.2	21.3	25.5	17.8	32.0	19.5	22.4	29.8	3.6	0.5	0.9	10.1	5.8	1.2	2.3	7.5	9.0	6.1	1.5	10.7	27.6	0.0	9.1	0.4	1.0	0.0	0.9	1.8	3.1	3.2	15.1	0.0	0.0	0.8	0.0	6.1	2.8	2.0	6.1	2.5	1.8	11.7	0.3	3.1	0.0	0.8	0.7	0.0	6.3	1.4	4.3	31.4	5.8	0.0	1.9	3.3	0.1	2.1	1.5	1.0	1.2	1.4	6.4	3.4	19.3	0.0	0.1	4.7	0.1	0.0	1.6	2.1	6.2	1.2	0.4	0.6	6.0	0.4	1.7	0.2	6.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1970	"pancreas: 226925.8"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 7306.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		88000000	"Cluster 17: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	15.7	83.0	0.4	5.1	1.7	2.5	78.3	0.6	1.4	6.0	0.1	2.6	31.2	4.7	0.3	3.5	1.8	0.1	40.8	0.6	0.8	2.0	7.1	1.7	8.1	1.0	1.2	115.1	226925.8	0.0	2.1	13.7	1.1	4.7	4.5	0.0	36.3	0.0	2.2	2.8	17.2	0.0	0.4	19.2	28.3	2.9	1.2	0.1	1.6	0.0	0.0	1.4	2.0	3.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	4.0	0.3	0.5	1.3	0.4	0.9	0.4	0.5	1.1	0.1	0.7	0.3	1.4	1.9	1.4	0.5	0.5	0.3	0.4	0.4	1.7	0.6	1.4	0.6	0.8	1.0	1.2	1.1	0.4	1.2	3.3	2.2	0.0	0.0	1.0	0.0	0.6	0.5	0.0	0.0	0.0	8.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.6	11.2	0.0	0.1	1.1	164.9	1.3	0.3	7306.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	1.0	2.5	0.6	1.5	0.0	0.0	18.1	0.0	0.0	0.0	29.8	590.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	4.2	2.5	0.0	1.1	0.1	0.3	0.3	0.3	1.1	0.2	0.2
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1484.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.5	0.1	3.1	0.7	0.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	4.8	0.0	0.5	1.4	0.4	1484.1	17.6	0.1	1.7	2.0	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.6	1.8	0.5	1.4	1.7	2.0	2.5	0.3	2.2	5.1	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378927-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	25.9	7.4	10.8	19.7	13.1	32.2	20.5	15.4	25.6	40.9	9.4	18.0	20.3	15.8	13.2	12.1	23.0	31.8	9.1	11.8	13.0	19.7	25.4	18.2	7.9	19.5	13.3	7.8	15.7	28.5	6.1	30.3	17.8	16.8	20.1	14.9	44.8	11.2	8.1	8.2	19.8	23.3	18.3	9.3	37.3	41.3	13.5	8.3	57.6	14.0	9.9	18.3	7.1	28.0	39.4	58.9	50.0	51.6	51.0	95.9	18.0	53.1	77.2	36.0	43.9	69.6	24.9	5.1	65.8	61.3	45.6	27.6	32.7	67.1	60.3	18.7	46.7	11.2	32.5	43.2	61.8	73.8	28.3	172.3	29.4	46.2	44.3	59.7	74.3	16.5	22.1	56.1	29.2	7.7	23.9	20.3	14.1	89.8	13.4	22.6	57.8	15.3	67.3	44.2	12.5	31.5	63.4	54.0	27.6	58.0	51.2	50.4	89.2	35.7	23.3	56.2	51.3	22.5	50.0	16.1	45.6	47.2	30.9	4.5	7.7	8.4	4.1	3.6	4.5	0.2	2.1	3.5	4.4	0.4	1.6	2.0	25.0	2.7	3.2	0.5	1.5	3.6	10.8	13.1	15.4	25.6	11.8	13.0	19.5	13.3	17.8	18.3	13.5	28.0	124.4	32.1	23.9	28.4	7.5	22.0	34.2	99.2	21.6	30.8	34.9	18.8	13.7	155.8	129.5	29.5	45.9	24.8	35.9	37.8	1.9	32.4	96.1	21.9	24.9	51.9	32.3	15.6	62.9	24.8	11.1	25.6	72.4	35.2	24.1	21.6	56.0	93.9	15.9	47.1	57.1	69.0	85.5	31.2	20.4	56.0	16.8	33.7	30.2	90.9	32.9	13.4	29.9	45.8	164.5	32.8	26.4	16.1	38.1	58.5	50.1	18.5	84.2	33.8	0.0	21.3	23.4	31.0	21.0	21.1	18.6	24.1	35.6	14.2	34.4	50.7
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988697-121297442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 78.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 48.4;Microglial cells: 229.5;Peritubular cells: 81.6;Theca cells: 94.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.8;intermediate monocyte: 11.3;myeloid DC: 25.2;non-classical monocyte: 7.6;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 25.2;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.6;Hep G2: 51.6;K-562: 182.3;LHCN-M2: 60.0;U-138 MG: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012058	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	55.0	18.5	2.1	6.5	2.6	0.9	10.0	2.4	2.6	25.2	5.5	16.1	9.1	32.9	13.3	16.5	15.8	26.7	21.5	1.8	2.6	7.1	44.3	16.7	1.8	4.5	3.1	78.5	3.4	1.4	3.3	24.9	4.5	28.1	15.0	1.1	4.1	36.7	17.4	2.0	11.5	38.6	4.1	17.8	10.3	5.5	4.5	1.9	3.7	38.7	1.8	20.7	6.1	5.4	6.3	0.0	0.3	0.1	14.0	40.7	0.3	25.5	87.6	8.6	23.5	0.8	0.3	0.9	0.3	14.0	9.7	0.3	0.4	0.0	22.4	0.3	0.9	7.1	0.3	51.6	24.3	0.2	0.2	16.7	0.0	20.0	0.4	6.9	4.4	0.1	182.3	12.8	60.0	0.0	0.1	0.2	0.1	0.0	1.1	0.1	34.6	17.3	0.0	0.6	0.0	2.2	0.0	0.1	0.6	0.4	0.1	0.6	2.6	50.2	1.3	42.5	24.3	5.6	0.1	0.6	5.8	0.2	2.5	2.0	10.8	0.0	0.0	11.3	0.1	1.4	0.0	0.0	25.2	0.5	0.0	0.0	0.4	0.0	7.6	15.0	0.0	2.9	2.1	2.6	2.4	2.6	1.8	2.6	4.5	3.1	4.5	4.1	4.5	5.4	19.1	19.2	0.5	12.4	2.5	3.1	0.6	0.0	1.2	0.1	0.6	1.7	20.3	1.5	0.0	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.2	0.8	23.2	6.9	0.0	2.1	0.9	0.0	2.9	48.4	0.5	0.5	0.0	11.9	28.2	21.9	4.3	3.3	14.7	0.0	0.0	14.5	28.5	1.9	21.1	23.1	3.6	229.5	5.3	14.0	1.0	1.5	0.7	0.0	0.0	81.6	3.0	1.5	0.0	0.2	0.0	0.4	0.0	9.1	32.1	0.6	0.7	1.0	2.0	0.4	0.8	94.5	0.0	2.6
CPLANE1	"C5orf42, FLJ13231, Hug, JBTS17"	ENSG00000197603	"Ciliogenesis and planar polarity effector 1"	Q9H799	5	37106228-37249376	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.4;Collecting duct cells: 22.0;Endometrial ciliated cells: 50.3;Endometrial stromal cells: 42.9;Glandular and luminal cells: 20.6;Granulosa cells: 40.8;Theca cells: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 21.9;SiHa: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036775, HPA036776"	Approved		Approved	Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA036775: AB_10669914, HPA036776: AB_2675308"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-1)"	2.4	3.1	1.4	1.4	1.9	1.0	3.8	2.6	2.7	3.4	2.5	1.9	1.0	4.2	3.7	2.3	4.2	3.2	1.8	1.4	1.8	3.6	1.5	3.3	1.7	1.3	1.3	5.3	2.4	5.4	2.2	3.3	0.6	4.3	2.0	5.7	2.9	3.6	1.4	2.3	1.1	3.2	0.3	2.3	2.2	4.8	2.5	6.3	6.9	3.3	1.7	2.7	1.4	2.8	5.7	3.5	8.4	6.4	11.4	10.3	3.7	5.8	4.2	6.6	5.2	4.0	7.6	1.4	3.7	5.2	10.4	2.7	2.4	3.5	6.5	3.8	2.6	3.3	21.9	2.4	5.8	0.0	1.8	7.8	4.7	6.7	3.5	7.8	6.5	3.6	0.0	1.2	11.8	0.0	4.2	4.8	2.2	0.0	2.7	4.0	14.9	0.0	6.0	1.7	4.7	3.3	48.7	0.3	3.1	6.8	2.6	3.5	8.0	10.0	6.2	2.7	4.5	1.7	0.0	1.6	2.4	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.4	1.9	2.6	2.7	1.4	1.8	1.3	1.3	0.6	0.3	2.5	2.8	19.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	11.3	8.9	0.0	0.0	0.0	22.0	0.0	7.4	8.8	0.0	0.0	8.8	0.0	50.3	42.9	4.8	0.0	0.0	0.0	5.3	5.8	7.6	0.0	20.6	0.0	40.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	2.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	3.6	3.2	18.9	0.0	0.0
CPLANE2	"C1orf89, MGC10731, RSG1"	ENSG00000132881	"Ciliogenesis and planar polarity effector 2"	Q9BU20	1	16231692-16237183	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Distal tubular cells: 3.9;Ductal cells: 2.4;Endometrial ciliated cells: 4.1;Extravillous trophoblasts: 2.3;Hofbauer cells: 2.4;Proximal tubular cells: 3.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028453	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028453: AB_10601692"	"unprognostic (7.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.45e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	2.0	5.9	9.7	2.3	9.2	3.8	2.1	4.7	8.8	3.2	3.3	3.2	2.5	4.5	1.4	5.2	6.7	2.3	4.8	9.1	12.7	4.2	3.2	2.3	2.9	9.2	10.9	5.6	4.9	6.2	6.5	1.8	10.2	3.0	1.9	2.3	4.9	4.0	1.9	4.4	2.4	1.7	5.9	3.7	3.9	6.3	12.8	2.9	6.1	1.7	2.4	4.0	2.4	3.5	4.5	12.1	3.6	12.0	2.4	4.3	3.3	5.0	3.2	4.0	1.7	4.4	6.7	9.7	9.7	2.8	7.8	3.6	6.6	6.4	0.4	14.7	5.6	4.8	11.1	0.9	5.9	3.2	8.4	2.3	5.4	4.6	4.1	4.0	3.8	7.3	17.8	3.7	3.3	5.5	3.5	2.4	0.9	4.8	4.7	8.8	0.4	7.8	3.4	2.8	8.7	5.8	1.9	3.0	4.7	2.7	9.0	3.0	3.8	1.1	1.9	2.3	1.6	10.1	4.1	5.7	3.1	7.0	6.7	0.0	0.5	1.9	2.2	1.6	2.8	1.2	1.3	0.6	1.0	1.3	1.3	0.9	0.4	1.4	1.1	0.3	1.5	0.6	9.7	9.2	4.7	8.8	9.1	12.7	9.2	10.9	10.2	5.9	12.8	3.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	7.3	0.0	2.0	0.7	0.0	3.9	2.4	0.0	4.1	0.9	0.3	0.0	0.0	0.0	0.9	2.3	0.4	0.0	1.5	0.0	1.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.4	1.4	0.0	0.0
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826129	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 273.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 84.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	17.2	13.4	26.1	1.2	43.0	0.1	18.2	59.7	273.5	16.9	0.0	5.0	1.0	10.8	0.1	5.7	16.4	0.4	11.5	18.5	72.8	10.9	8.3	9.4	0.8	135.5	25.1	9.4	3.2	1.4	12.8	0.3	128.2	13.8	0.2	5.7	9.6	0.7	4.1	3.4	5.1	0.4	13.9	27.2	4.9	8.6	124.2	3.6	7.5	0.2	0.2	8.3	12.9	89.9	5.7	0.5	0.1	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	16.3	1.7	4.2	1.9	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.3	0.0	2.5	2.3	0.0	2.6	4.4	2.6	0.1	0.0	1.6	0.0	0.4	84.3	11.8	0.4	5.5	0.0	0.2	8.5	0.3	0.1	0.0	0.5	0.1	0.1	0.2	4.7	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	26.1	43.0	59.7	273.5	18.5	72.8	135.5	25.1	128.2	13.9	124.2	89.9	45.5	0.0	0.0	5.9	0.4	1.0	3.2	0.4	1.8	33.4	7.8	8.1	3.6	0.0	1.9	0.0	4.2	0.1	2.8	2.5	1.9	1.2	1.4	1.1	5.4	29.6	21.5	0.0	44.2	0.8	3.2	1.8	2.6	1.4	0.0	0.3	14.3	4.8	0.2	18.5	90.7	2.1	0.0	0.3	1.9	2.3	1.8	0.5	1.8	8.4	0.0	16.8	0.0	8.0	4.7	0.8	5.2	0.0	0.6	2.6	0.3	1.2	0.0	21.7	0.0	0.4	2.3	4.3	9.8	0.2	1.1	1.0	1.6	0.8	2.7	1.3
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 308.9;epididymis: 128.6;pituitary gland: 65.6"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.3	239.7	1.0	136.0	0.0	0.1	78.2	291.5	0.0	0.0	3.5	2.1	0.0	128.6	0.1	0.0	0.0	0.2	308.9	62.3	0.1	0.2	1.3	0.0	62.2	98.8	0.2	9.0	0.1	65.6	0.0	50.2	0.2	1.4	19.4	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	19.6	0.1	0.2	0.0	0.0	0.1	0.5	157.7	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.7	136.0	78.2	291.5	308.9	62.3	62.2	98.8	50.2	0.0	19.6	157.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPLX4	CPX-IV	ENSG00000166569	"Complexin 4"	Q7Z7G2	18	59275156-59318649	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	287	"retina: 314.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 74.1;Cone photoreceptor cells: 112.6;Muller glia cells: 31.8;Rod photoreceptor cells: 173.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047627	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA047627: "					"unprognostic (1.85e-1)"		"unprognostic (4.46e-1)"			"unprognostic (4.20e-2)"		"unprognostic (4.05e-2)"		"unprognostic (9.90e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	314.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.3	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 156.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 16.6;monocytes: 21.0"	"Group enriched"	"Detected in many"	4	"ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		7100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	156.1	11.5	6.4	14.4	13.3	3.5	40.2	10.1	10.5	14.4	3.8	33.5	4.4	23.9	0.9	10.1	16.2	16.1	4.6	7.6	10.2	41.3	26.5	59.3	16.1	19.3	11.5	18.0	13.0	12.0	1.0	70.1	11.9	14.7	26.6	6.7	4.1	2.8	5.8	21.7	5.9	6.4	7.5	19.4	15.3	5.4	28.0	4.3	7.5	9.7	10.5	9.3	5.7	23.5	0.1	4.0	0.1	0.0	71.1	50.0	0.7	9.8	1.1	1.7	2.3	3.2	4.1	0.5	9.6	1.4	4.1	0.0	1.4	2.7	4.1	0.1	2.7	0.0	15.1	0.3	0.4	1.2	1.9	91.2	0.6	1.0	2.0	8.6	0.0	0.3	0.0	0.1	7.3	1.7	0.0	0.7	1.7	0.0	5.2	3.1	0.6	0.0	7.2	5.9	0.4	0.2	68.9	10.7	7.9	5.5	1.2	26.5	0.2	1.2	7.5	0.5	0.2	0.4	0.5	13.1	4.3	13.1	5.9	0.6	21.0	0.1	0.2	14.5	0.0	1.8	1.5	0.1	16.6	3.5	0.9	0.2	1.6	0.5	7.4	1.1	1.9	7.3	6.4	13.3	10.1	10.5	7.6	10.2	19.3	11.5	11.9	7.5	28.0	23.5	83.3	359.0	362.2	34.6	4.9	12.4	3.5	6.1	0.6	3.3	7.8	8.9	2.6	135.8	70.1	51.5	0.0	32.3	1.1	97.5	29.4	57.9	16.6	100.9	8.3	29.0	10.8	3.6	1.2	212.5	59.9	14.1	4.6	237.1	112.5	6.7	73.9	36.6	134.6	0.0	1.3	28.7	0.0	368.5	36.3	17.5	105.0	202.2	10.6	19.7	23.3	68.9	1.0	23.1	161.8	68.0	65.9	79.0	2.4	38.7	1.9	63.7	16.4	5.7	762.6	7.2	126.9	0.6	3.9	2.4	9.9	172.4	14.5	46.3	32.7	2.8
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 218.6"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.0	0.7	0.4	0.6	1.5	0.2	0.6	1.1	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.7	0.8	14.7	218.6	0.2	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.4	0.2	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.7	0.8	0.2	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092583-57148369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.3;Hepatic stellate cells: 82.8;Oligodendrocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: AB_2677316"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	35.1	7.3	34.5	12.8	50.2	60.6	24.9	41.1	45.3	36.5	36.9	29.2	6.0	20.7	6.6	15.9	28.0	14.3	15.5	36.7	46.6	14.1	9.4	37.2	11.0	52.9	48.1	10.7	7.3	10.9	7.5	27.9	48.6	14.0	28.3	1.7	10.9	17.1	11.7	11.7	21.2	25.1	39.3	18.2	9.2	16.4	61.0	6.3	15.9	13.5	9.2	16.7	18.5	87.4	23.9	45.1	68.0	38.1	12.0	11.6	11.3	25.4	39.8	56.8	39.5	12.7	27.0	14.2	22.7	38.6	31.4	36.7	27.1	15.1	30.6	17.7	15.9	5.9	17.5	10.7	21.6	4.8	0.6	11.1	16.8	22.3	10.8	42.4	84.5	7.6	16.0	0.5	14.5	11.1	7.2	69.9	15.5	11.6	9.5	88.8	21.3	11.9	37.7	9.0	1.4	27.6	32.3	6.9	19.4	30.5	7.5	94.4	60.3	51.6	27.7	13.1	33.5	3.4	3.0	31.8	33.4	20.6	37.0	0.0	1.5	0.8	0.2	0.4	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	1.5	0.1	0.1	0.0	0.2	0.4	34.5	50.2	41.1	45.3	36.7	46.6	52.9	48.1	48.6	39.3	61.0	87.4	84.3	19.2	7.4	8.1	1.5	2.3	17.1	6.0	7.4	0.4	8.2	6.9	2.3	4.3	5.1	5.5	0.0	0.6	1.4	43.4	5.9	4.7	19.9	33.4	13.8	41.0	3.6	0.8	1.0	4.2	2.9	12.3	1.5	39.3	0.0	26.7	82.8	2.0	23.6	0.0	7.4	13.7	4.1	25.3	7.4	5.9	6.8	12.0	7.2	8.4	10.7	3.6	0.0	17.1	86.3	6.2	25.1	7.5	0.8	14.2	35.4	2.6	9.2	0.0	32.9	9.3	21.7	0.6	2.6	6.2	4.3	0.8	8.4	2.1	18.2	16.3
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514435-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		71000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	35.4	29.3	14.6	22.4	17.4	76.6	42.3	23.0	15.0	40.7	24.3	35.0	32.1	33.2	21.4	73.6	32.0	30.1	52.4	15.5	19.2	51.5	46.2	33.8	39.5	15.3	17.6	39.2	29.7	52.1	11.8	25.5	17.3	41.2	34.2	18.2	37.1	29.9	17.5	36.3	30.8	31.7	16.4	28.4	30.1	8.3	16.2	38.5	60.9	26.4	46.5	34.9	25.5	21.8	135.1	46.8	30.9	40.9	116.9	92.1	24.6	63.3	93.3	51.9	58.2	30.4	44.5	36.7	40.6	77.6	31.6	101.2	68.7	67.5	92.5	39.5	52.1	6.0	27.2	34.7	41.0	2.3	1.5	63.0	71.2	57.6	76.0	83.1	64.6	17.6	33.2	68.4	65.0	51.6	65.9	1.8	10.5	110.6	64.4	30.7	28.9	174.4	67.4	92.2	66.2	51.5	55.4	249.3	39.6	35.7	95.0	10.3	69.3	44.5	44.1	61.3	49.4	47.0	63.3	9.9	66.0	12.6	42.9	28.6	32.6	54.3	33.2	38.1	26.2	26.4	27.5	23.8	63.1	26.9	23.8	26.1	46.5	27.6	52.5	62.2	20.9	32.0	14.6	17.4	23.0	15.0	15.5	19.2	15.3	17.6	17.3	16.4	16.2	21.8	84.1	137.8	103.9	23.2	52.0	81.8	110.6	111.8	96.2	16.2	80.2	73.9	120.2	75.8	89.3	69.9	14.6	73.0	85.4	49.4	99.7	77.9	1.6	66.9	73.5	66.3	50.2	28.4	37.0	83.7	55.1	92.6	48.9	83.5	8.2	44.7	66.4	103.9	50.4	45.4	39.9	55.3	81.4	71.0	93.8	4.5	85.7	64.0	53.4	13.1	75.0	75.6	36.0	58.3	24.5	59.3	51.7	87.6	49.4	112.5	53.3	126.1	78.8	17.4	59.2	102.1	77.4	3.2	8.8	183.2	91.1	78.0	55.2	71.4	75.1	91.8
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.3;prostate: 25.3"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 351.2"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	0.6	0.5	4.8	0.1	34.3	0.0	0.2	0.0	15.2	0.2	0.0	0.3	0.7	0.2	0.6	0.3	0.4	0.0	0.9	16.8	3.7	1.0	0.1	0.4	0.0	0.0	4.2	0.0	0.2	1.9	3.0	0.0	0.1	25.3	0.2	2.0	0.4	3.7	0.0	0.2	0.5	0.3	0.5	0.8	0.5	1.4	12.1	0.0	0.3	0.1	0.0	0.1	0.4	1.2	0.0	6.2	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.8	0.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.8	34.3	0.0	15.2	16.8	3.7	0.0	4.2	0.1	0.5	12.1	1.2	0.9	0.0	0.0	8.8	0.0	0.3	0.4	0.1	0.0	0.8	0.0	0.0	17.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.6	0.1	0.6	4.9	0.0	351.2	0.0	0.0	0.6	3.6	0.6	0.0	0.2	0.0	0.0	0.1	1.7	33.0	0.1	0.0	0.0	0.3	5.6	0.3	1.1	0.0	8.4	0.6	0.3	0.0	8.5	7.1	0.1	0.0	0.0	0.0	17.0	0.0	2.6	0.3	0.6	0.0	0.0	0.4	1.4	1.1	0.3	0.1	0.0	0.0	0.1	0.0	0.9
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36839444	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4;heart muscle: 92.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6"	"Cancer enhanced"	"Detected in all"		"glioma: 11.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 62.4"	"Group enriched"	"Detected in some"	80	"memory B-cell: 51.6;naive B-cell: 26.8"	"Lineage enriched"	"Detected in single"	105	"B-cells: 51.6"	"Group enriched"	"Detected in some"	5	"Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 135.5"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	6.4	0.9	16.6	10.7	62.4	1.4	2.3	0.0	29.5	3.9	0.0	6.2	5.6	5.8	1.0	2.4	19.9	2.0	92.7	23.0	2.7	4.5	0.8	2.6	23.6	0.0	4.6	6.6	1.0	0.4	11.0	1.4	0.0	5.8	5.0	2.8	3.5	2.5	0.5	1.8	8.6	4.7	1.1	20.0	5.1	25.3	0.8	2.3	3.3	0.2	28.1	4.9	5.7	13.3	0.9	0.0	0.5	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.5	0.0	0.2	59.4	0.5	0.8	2.7	0.4	0.1	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.7	0.0	4.1	25.7	0.2	0.2	1.7	0.5	0.0	0.0	0.4	0.1	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.5	0.1	0.0	0.0	5.3	0.3	0.0	0.8	5.9	0.4	0.7	0.0	2.1	19.7	17.1	28.1	0.3	6.5	0.1	0.0	0.1	0.0	0.0	0.2	0.2	51.6	0.2	0.0	0.1	26.8	0.0	0.0	0.4	0.0	0.2	0.3	0.0	4.5	16.6	62.4	0.0	29.5	23.0	2.7	0.0	4.6	0.0	1.1	0.8	13.3	2.8	0.0	3.6	1.3	50.6	0.6	0.2	0.2	0.0	13.4	0.3	0.5	30.0	0.0	0.0	0.0	0.0	0.0	1.5	15.1	1.9	0.0	3.3	0.4	0.8	7.4	4.2	0.0	35.1	0.2	0.0	2.8	1.5	1.4	12.6	0.3	5.0	1.0	0.4	0.0	8.6	1.8	0.0	1.9	0.6	4.8	0.0	6.2	3.6	2.8	0.2	1.3	2.1	36.7	0.8	0.5	12.5	0.4	89.6	0.2	2.3	0.1	0.0	1.6	0.0	2.3	1.0	0.8	1.5	1.1	0.1	0.0	2.0	0.2	1.7	0.4
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.3;retina: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031636, HPA076665"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"			"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	0.2	0.2	42.1	0.2	37.7	0.2	0.0	20.0	41.1	0.2	12.2	1.5	2.5	0.2	0.3	1.7	0.3	0.0	0.2	54.3	24.9	7.0	2.1	0.1	0.0	31.4	23.2	0.1	0.0	0.0	8.0	0.0	32.7	2.8	0.5	16.4	0.0	12.3	0.1	0.4	3.4	0.3	20.8	0.0	0.4	0.5	31.3	0.1	0.2	0.1	0.0	0.7	0.4	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	37.7	20.0	41.1	54.3	24.9	31.4	23.2	32.7	20.8	31.3	26.0	0.0	0.0	0.0	15.3	0.0	0.1	0.0	0.0	0.0	26.3	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	6.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.4	0.2	0.0	0.0	0.0	18.1	0.6	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.3	6.5	2.4	0.0	3.8	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPNE7		ENSG00000178773	"Copine 7"	Q9UBL6	16	89575758-89597246	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;epididymis: 19.3;pituitary gland: 14.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.2;Collecting duct cells: 20.2;Excitatory neurons: 9.3;Inhibitory neurons: 9.1;Spermatogonia: 10.2;T-cells: 9.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 103.2;TIME: 58.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043359	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA043359: AB_10794884"	"unprognostic (6.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (7.22e-4)"	0.5	0.4	13.5	0.9	13.2	0.9	1.5	0.0	17.6	1.4	0.0	0.7	3.6	0.6	19.3	2.1	2.1	3.3	0.4	15.1	11.4	4.3	1.2	1.7	0.5	2.6	16.2	0.5	0.9	2.4	14.1	0.3	7.4	1.8	0.1	1.6	1.4	6.1	0.0	1.6	3.4	0.2	1.0	0.8	3.2	4.1	28.0	1.6	0.8	0.1	0.4	1.6	1.3	6.0	0.1	24.7	0.2	0.4	40.8	41.8	0.3	10.7	4.5	14.6	11.2	24.8	20.7	0.0	9.5	4.2	0.5	16.8	15.4	0.7	5.0	6.0	12.2	0.2	21.5	0.5	103.2	0.1	4.1	16.3	1.1	7.7	29.0	49.3	0.2	17.4	27.3	0.3	35.1	3.8	8.0	4.8	16.1	15.6	19.1	0.4	0.0	17.6	2.2	0.1	13.7	0.2	3.6	5.2	1.1	0.3	4.6	3.2	58.8	28.4	0.0	17.7	0.0	0.1	0.0	5.0	27.8	17.3	12.0	0.0	0.0	0.1	0.7	0.0	4.9	0.0	1.1	1.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.2	0.2	13.5	13.2	0.0	17.6	15.1	11.4	2.6	16.2	7.4	1.0	28.0	6.0	0.5	0.0	0.6	1.3	0.1	2.3	1.1	0.1	0.6	11.2	3.9	5.2	0.8	1.5	0.8	20.2	0.0	0.0	1.4	0.1	0.0	0.9	0.0	1.0	0.5	0.7	0.0	0.4	9.3	0.2	0.2	0.3	3.1	2.2	0.0	0.1	0.4	0.0	0.1	0.0	9.1	0.3	0.0	0.0	0.4	0.6	0.3	0.9	1.8	0.0	0.0	0.3	0.0	3.5	0.6	0.6	0.0	0.7	0.1	1.2	0.7	1.7	0.2	0.9	0.0	0.3	0.5	0.3	10.2	1.2	1.1	0.0	9.5	0.0	1.9	2.1
CPNE8		ENSG00000139117	"Copine 8"	Q86YQ8	12	38646822-38907430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 115.5;Microglial cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 66.8;THP-1: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038600	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038600: AB_10674690"	"unprognostic (1.57e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.93e-3)"	"unprognostic (6.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.40e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.73e-3)"	12.0	8.3	7.0	5.4	7.6	4.6	9.6	3.1	11.5	7.8	9.2	8.1	3.3	5.1	3.5	5.4	5.0	9.0	12.2	10.1	8.9	11.2	15.5	10.1	5.4	5.0	6.5	5.7	3.2	2.5	3.3	12.0	4.6	3.7	10.2	6.0	3.2	8.9	2.9	6.1	4.6	9.1	8.8	10.6	3.7	5.8	8.0	3.1	7.8	5.3	3.2	10.1	5.3	5.5	3.1	18.7	1.3	18.5	17.0	14.3	8.6	1.6	0.1	0.0	0.0	9.4	18.2	0.0	26.3	12.7	6.8	1.0	10.8	5.6	0.0	0.0	11.3	9.9	26.3	2.2	11.3	0.0	7.8	6.7	14.2	4.2	14.9	12.9	14.3	0.0	6.0	0.0	0.0	0.0	0.0	0.1	13.8	11.5	19.0	0.0	0.0	4.3	66.8	0.5	0.0	0.5	26.0	4.7	14.1	18.8	2.3	38.8	13.6	0.0	12.7	21.6	0.1	6.5	19.3	0.2	17.2	17.8	11.0	2.7	12.0	0.0	1.6	9.4	0.3	0.2	2.1	1.8	7.7	0.6	0.9	1.5	0.7	4.5	6.3	2.5	2.1	2.5	7.0	7.6	3.1	11.5	10.1	8.9	5.0	6.5	4.6	8.8	8.0	5.5	68.8	12.8	8.2	66.3	1.6	31.1	5.9	40.8	19.9	2.1	0.6	6.5	20.3	15.7	23.3	12.9	0.0	29.2	6.9	35.8	15.6	7.6	68.9	2.7	9.4	55.9	11.5	7.4	115.5	4.9	27.2	27.1	0.0	3.0	3.8	18.5	36.0	16.5	25.7	0.0	36.3	9.1	6.1	34.1	42.4	14.5	9.6	19.4	46.2	77.8	19.8	36.4	2.1	25.6	2.9	3.6	51.3	8.2	3.3	7.4	0.0	20.9	17.0	2.7	0.0	24.5	16.9	2.7	2.1	6.1	11.2	7.8	4.3	8.6	8.9	3.5
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12803887	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 674.2"	"Group enriched"	"Detected in all"	28	"dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 144.2;HMC-1: 129.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	12.5	9.4	9.1	19.3	14.1	14.0	8.2	13.0	11.4	11.0	7.3	13.3	21.3	7.9	5.1	25.2	7.1	11.2	10.1	8.3	13.3	33.7	34.4	13.7	11.7	14.0	13.1	7.6	4.8	3.9	4.1	18.5	14.4	11.1	14.8	3.7	13.1	8.6	8.2	6.5	21.4	12.9	11.3	29.8	8.7	15.5	12.2	9.2	13.2	9.6	16.6	11.5	8.8	17.3	5.0	29.7	3.3	7.7	12.0	25.3	0.5	54.1	14.5	28.4	23.1	14.5	15.2	7.3	54.6	39.6	12.5	0.4	0.0	13.5	29.3	17.0	8.2	62.5	4.2	144.2	7.4	0.1	129.9	25.4	3.0	2.5	20.2	0.1	43.1	9.9	22.1	4.3	70.4	6.3	5.6	29.1	8.7	2.4	4.2	11.9	18.8	15.6	43.0	9.4	15.3	10.0	0.2	48.5	20.0	15.3	10.5	13.7	65.0	40.6	8.5	0.2	0.1	0.1	1.0	11.6	9.1	31.7	8.8	57.1	224.0	146.1	9.1	320.0	7.8	10.8	7.6	10.0	168.5	8.4	2.4	5.7	674.2	13.5	320.8	41.1	13.8	129.7	9.1	14.1	13.0	11.4	8.3	13.3	14.0	13.1	14.4	11.3	12.2	17.3	12.3	9.6	16.7	8.1	8.7	4.6	3.4	4.9	4.6	3.3	4.7	4.7	10.7	10.0	11.4	14.7	8.4	105.2	18.5	9.2	60.7	43.1	3.6	5.3	13.5	16.7	6.0	31.7	13.1	12.8	15.6	12.6	4.1	9.4	54.4	8.1	7.5	45.8	47.1	10.1	10.2	9.3	6.1	80.3	30.7	4.1	15.5	59.0	7.2	30.0	127.4	13.5	8.2	21.1	70.9	31.9	18.3	24.0	4.4	3.2	40.6	66.0	13.4	6.1	26.3	17.6	11.9	2.5	9.9	14.8	4.5	131.9	8.3	13.6	15.4	1.7
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645242-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 225.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 150.2;Oligodendrocytes: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 250.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	46.2	35.9	22.6	25.4	33.9	31.8	34.7	28.0	26.7	75.1	20.6	39.6	29.3	46.0	36.2	25.9	39.8	57.8	51.8	21.6	27.0	80.5	70.0	32.3	22.8	32.6	27.5	87.4	46.7	60.7	25.6	39.2	33.2	40.2	33.1	16.8	32.8	54.2	13.3	20.6	35.0	64.7	25.9	31.3	32.1	13.9	30.3	8.2	225.9	33.2	17.0	46.3	38.6	38.6	0.6	2.1	2.1	0.1	116.1	131.4	0.5	35.3	55.6	12.8	26.5	2.0	0.9	0.4	27.2	59.0	15.7	1.0	2.4	2.8	12.0	31.4	4.4	28.4	1.5	17.7	25.6	4.9	37.0	69.6	6.5	15.0	3.7	108.2	6.0	0.1	27.1	97.0	29.4	1.2	0.5	14.1	2.5	0.2	5.2	4.3	0.0	0.6	26.7	13.2	2.4	0.3	10.2	0.4	28.2	25.8	12.3	28.6	21.3	51.9	4.9	0.8	11.5	7.9	0.9	0.3	32.2	21.6	33.5	32.0	71.3	45.1	27.3	49.6	27.6	5.4	20.3	24.0	51.8	7.4	17.6	24.6	250.5	25.9	47.5	14.8	22.2	40.6	22.6	33.9	28.0	26.7	21.6	27.0	32.6	27.5	33.2	25.9	30.3	38.6	46.6	12.8	12.5	150.2	11.7	19.4	25.7	21.3	9.6	12.7	12.1	27.9	27.2	42.9	13.9	47.8	29.2	12.1	40.8	9.3	17.6	22.7	5.0	6.6	43.3	27.1	13.8	7.2	24.0	10.7	1.8	123.8	10.7	8.6	38.0	43.1	51.0	48.3	54.0	10.1	31.3	7.9	24.4	56.0	44.9	9.0	72.4	39.4	78.2	131.2	33.7	43.4	39.1	44.7	299.6	11.7	9.5	73.0	11.9	12.4	42.4	56.0	9.7	16.3	52.6	71.1	67.8	5.6	3.4	2.8	13.1	6.0	23.8	38.6	12.2	13.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1063.2"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000		"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.5	0.4	1.0	0.4	10.0	0.1	1.5	4.9	1.7	0.9	0.1	0.8	211.8	1.6	2.8	1.5	0.9	1.6	1.2	0.7	2.3	1.9	1063.2	1.0	0.3	6.9	8.7	2.9	0.8	0.1	0.9	2.5	6.0	0.8	0.4	0.3	0.5	0.8	0.6	1.4	123.4	2.1	3.4	1.2	0.6	6.0	5.8	0.3	1.7	0.5	0.2	0.6	0.7	6.3	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.0	4.9	1.7	0.7	2.3	6.9	8.7	6.0	3.4	5.8	6.3	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121969-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	14.8	14.5	7.3	24.9	9.7	11.5	11.8	9.3	10.1	13.7	13.0	16.1	14.7	15.0	15.0	18.3	11.7	15.0	13.1	6.8	8.9	13.6	19.7	14.7	21.0	9.5	9.2	12.6	14.9	18.2	10.7	16.7	10.6	15.6	16.8	13.9	13.6	14.1	27.1	11.1	14.4	17.8	8.5	18.6	17.4	26.0	8.5	27.3	18.3	25.6	24.8	16.6	12.3	12.2	48.1	46.9	47.0	48.6	23.9	21.1	69.5	60.7	59.0	55.1	54.3	41.4	64.9	51.3	38.9	65.1	37.2	69.2	65.2	55.2	79.2	83.3	22.4	75.4	46.1	39.5	70.5	76.3	60.6	34.7	46.2	52.5	93.8	36.5	52.2	54.5	68.8	62.9	62.1	69.6	88.3	26.8	53.3	76.8	42.3	86.0	72.7	45.9	37.5	67.1	51.7	34.7	71.7	39.9	51.1	41.9	82.9	47.4	56.3	43.9	27.7	33.4	52.4	37.6	66.2	103.0	53.0	58.9	69.7	16.6	12.9	9.3	7.8	11.7	10.4	7.6	6.9	8.4	11.3	4.0	6.1	8.6	4.4	11.1	9.8	7.3	12.1	9.5	7.3	9.7	9.3	10.1	6.8	8.9	9.5	9.2	10.6	8.5	8.5	12.2	14.2	28.9	31.8	23.2	22.9	10.3	15.2	15.1	15.9	12.7	13.4	9.5	27.1	10.0	25.5	7.3	29.2	24.0	19.8	14.6	13.7	18.0	28.2	24.3	30.0	22.9	13.8	33.0	13.6	24.0	22.7	20.0	17.3	16.8	30.4	26.2	20.7	27.2	24.8	11.8	17.5	17.3	12.2	32.9	8.8	11.2	19.0	31.1	3.6	19.7	41.2	16.9	27.8	18.6	27.9	23.8	14.0	23.0	35.4	29.9	12.5	16.3	34.1	22.7	32.9	19.6	23.2	61.7	41.3	27.2	12.8	25.3	22.8	26.6	18.2	20.2
CPSF3	"CPSF-73, CPSF73, YSH1"	ENSG00000119203	"Cleavage and polyadenylation specific factor 3"	Q9UKF6	2	9423651-9473101	"Predicted intracellular proteins"	"mRNA processing"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 187.6;Spermatocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034657	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA034657: AB_10669728"	"unprognostic (9.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.45e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-2)"	14.2	15.0	10.5	18.4	11.9	23.4	16.9	11.7	13.5	14.5	12.2	17.1	13.9	13.2	23.4	16.2	14.4	11.3	11.1	10.2	11.3	15.6	19.9	12.9	26.3	11.6	10.8	10.4	12.7	14.3	10.6	16.2	12.1	12.7	19.4	11.6	11.5	13.3	15.0	19.2	13.2	16.8	11.4	15.4	13.8	50.9	12.1	32.2	16.4	12.4	30.5	16.4	11.5	13.5	35.7	79.2	85.1	74.4	46.6	54.6	89.2	56.2	60.3	67.2	63.7	100.6	64.5	112.2	51.8	49.3	61.0	61.6	96.0	66.6	81.5	73.9	70.5	95.6	37.7	94.5	40.1	92.8	61.0	49.0	44.6	84.6	61.3	38.2	55.9	71.9	117.0	46.9	64.1	78.7	96.2	121.0	125.9	89.2	54.9	92.6	107.2	94.2	59.9	52.4	46.4	110.7	55.0	41.5	63.5	71.5	40.7	63.1	42.5	53.3	46.1	54.3	70.8	56.1	80.5	118.9	62.3	95.0	57.9	32.9	34.4	23.1	22.2	39.9	23.3	25.3	20.3	23.3	50.1	23.6	20.9	22.6	5.8	38.0	38.4	33.2	36.7	30.5	10.5	11.9	11.7	13.5	10.2	11.3	11.6	10.8	12.1	11.4	12.1	13.5	7.1	6.4	12.7	3.9	15.7	10.5	10.5	26.4	8.6	12.2	7.2	6.5	11.1	8.6	19.5	5.5	8.4	39.5	19.7	9.0	19.6	22.5	187.6	14.6	15.7	11.8	12.6	36.2	9.8	22.5	43.4	13.1	8.6	14.0	8.2	19.9	6.8	14.2	26.1	21.9	9.6	11.9	26.4	20.1	9.5	33.9	11.1	20.6	19.6	10.3	36.3	18.2	16.5	8.5	13.7	16.4	7.4	12.4	15.7	6.5	9.7	18.7	18.0	20.1	6.6	12.3	38.0	151.4	43.2	16.1	8.8	27.2	13.1	26.1	15.1	8.7
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CPSF4L		ENSG00000187959	"Cleavage and polyadenylation specific factor 4 like"	A6NMK7	17	73248449-73262352	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Skeletal myocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 3.0"	"Region enriched"	"Detected in single"	36	"cerebellum: 10.2"	"Low region specificity"	"Detected in many"			HPA044047	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044047: AB_10961638"	"unprognostic (7.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.57e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.03e-8)"	"unprognostic (6.71e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.4	0.9	0.5	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.5	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	43.2	44.1	39.1	36.0	40.7	55.0	44.2	40.0	48.4	55.2	39.8	48.9	32.0	54.8	44.1	46.6	55.1	27.3	39.5	37.9	41.3	44.2	62.8	38.0	43.3	38.1	41.0	55.6	49.2	35.0	79.1	37.8	39.1	47.3	34.3	40.7	41.4	34.7	68.0	52.3	49.0	43.7	33.9	57.4	47.3	42.0	39.3	57.8	58.9	48.1	43.7	47.4	45.7	44.3	72.5	71.0	98.0	78.2	52.0	45.8	68.7	58.9	56.2	76.7	58.4	83.7	60.6	107.7	61.4	63.6	65.0	87.4	94.7	67.4	93.1	71.8	48.4	90.9	95.8	68.0	52.5	111.4	77.9	48.7	54.3	81.3	118.4	46.7	52.8	69.1	111.2	67.1	56.2	87.7	110.5	90.9	96.2	50.5	55.6	102.8	77.1	88.9	57.8	87.9	66.3	67.6	78.2	68.4	74.3	59.7	94.4	47.6	53.2	84.4	71.6	79.0	61.4	92.0	116.5	122.4	49.3	53.2	63.0	15.1	5.6	7.1	8.1	6.0	8.7	6.9	6.4	8.4	7.6	6.5	7.0	7.2	9.8	6.7	4.6	6.4	4.8	5.7	39.1	40.7	40.0	48.4	37.9	41.3	38.1	41.0	39.1	33.9	39.3	44.3	23.3	35.3	21.2	56.8	29.0	23.2	18.4	15.5	26.7	21.4	26.1	24.9	11.4	11.5	16.0	16.5	39.6	26.7	29.4	22.6	17.6	15.7	41.8	17.1	21.7	22.6	22.2	20.0	29.8	13.8	17.5	20.7	22.4	21.3	23.5	26.6	22.9	27.2	19.6	32.0	31.0	21.9	16.2	31.0	19.0	29.1	27.4	23.4	3.6	37.5	39.7	24.2	22.6	31.7	39.8	19.5	13.6	25.2	28.6	25.0	22.3	14.3	19.9	21.7	39.5	28.8	22.6	37.5	27.1	25.0	26.3	27.5	22.1	17.7	23.0	23.0
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 110.0;Hepatocytes: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		45000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	24.3	27.7	16.0	22.3	18.4	38.9	22.7	20.2	17.3	20.4	32.0	67.4	70.7	25.1	7.3	22.0	25.4	27.7	25.4	14.7	17.7	38.4	67.9	25.3	15.9	20.6	22.0	18.3	23.6	27.6	14.3	18.4	19.3	20.3	44.6	22.6	26.0	21.9	9.9	17.0	71.3	34.9	15.9	27.4	35.6	13.5	22.1	14.0	15.4	14.3	12.3	18.7	18.0	13.9	29.4	50.9	7.3	48.6	31.2	28.0	2.1	22.9	18.8	17.7	3.6	2.0	96.0	0.1	82.2	60.4	62.2	93.5	63.9	13.6	5.3	46.8	6.3	71.5	52.3	24.0	46.4	41.9	82.6	29.2	6.6	35.5	21.4	24.1	63.5	28.2	7.6	56.8	16.5	83.6	34.4	73.7	0.8	149.7	53.2	94.7	1.2	127.1	41.7	71.7	1.0	31.8	63.0	119.9	20.2	4.8	107.4	40.0	64.5	38.3	0.9	77.7	33.5	43.9	60.1	29.2	40.3	30.3	42.8	8.2	6.6	9.5	7.3	7.7	4.2	1.9	4.4	4.4	4.4	2.0	2.7	5.5	3.2	4.9	6.7	10.4	2.8	2.7	16.0	18.4	20.2	17.3	14.7	17.7	20.6	22.0	19.3	15.9	22.1	13.9	44.4	38.5	28.8	35.6	13.5	9.4	11.0	9.0	28.5	4.8	9.6	7.6	25.5	22.8	18.0	23.9	64.6	15.9	39.3	110.0	19.6	13.8	14.7	33.2	22.6	30.4	16.2	30.9	5.6	9.5	3.9	16.6	31.1	56.7	29.7	23.0	40.7	108.3	15.7	1.7	5.7	48.9	10.2	39.1	11.5	43.9	9.6	24.6	0.0	28.1	31.4	12.7	23.7	7.1	1.7	8.5	43.4	32.0	28.6	9.6	83.4	11.8	23.8	43.0	39.5	18.3	21.1	14.5	10.0	14.8	7.7	7.8	24.0	17.3	67.4	9.2
CPT1B	"CPT1-M, M-CPT1"	ENSG00000205560	"Carnitine palmitoyltransferase 1B"	Q92523	22	50568861-50578465	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 242.7;skeletal muscle: 144.5;testis: 80.7;tongue: 228.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 45.4;Late spermatids: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA079265	Enhanced					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA079265: "	"unprognostic (1.66e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.76e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.15e-5)"	10.3	9.3	13.8	11.4	15.5	13.4	15.7	17.4	17.4	7.7	12.2	14.0	13.5	4.6	10.3	16.6	7.3	6.1	242.7	13.6	14.7	25.1	25.6	10.5	14.4	16.7	14.6	5.0	18.3	34.1	23.5	8.1	15.8	15.7	10.6	17.1	13.1	3.4	144.5	14.1	22.2	3.6	13.6	27.5	13.0	80.7	16.1	9.8	26.7	228.0	13.1	9.9	10.3	17.8	8.2	7.7	24.5	9.0	5.3	3.1	17.5	0.3	3.1	4.1	4.5	3.6	7.2	16.3	2.2	2.0	6.0	13.6	12.9	2.9	3.6	6.5	14.2	8.0	26.2	3.9	1.4	8.5	22.3	1.8	22.0	2.9	4.8	15.0	0.7	11.4	2.9	27.8	3.9	11.9	2.9	16.3	5.2	4.3	4.9	15.2	7.8	3.5	10.3	19.6	6.6	12.7	5.7	9.7	10.9	14.8	10.8	17.9	1.6	11.4	11.4	7.4	2.8	22.3	5.5	8.7	4.9	15.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.8	15.5	17.4	17.4	13.6	14.7	16.7	14.6	15.8	13.6	16.1	17.8	0.5	0.0	11.0	0.0	0.8	0.3	0.0	1.0	1.8	1.9	2.2	1.0	3.7	1.5	1.5	3.7	2.1	0.5	0.2	5.6	0.0	2.2	45.4	0.9	0.1	1.0	0.0	0.0	0.0	2.1	0.6	1.4	5.6	0.4	7.0	0.1	0.4	2.1	0.6	3.3	0.0	5.2	0.0	0.6	0.8	109.3	0.3	1.0	1.8	0.0	6.3	0.4	0.0	0.0	0.0	1.0	6.4	0.7	0.4	0.0	3.5	0.5	3.7	2.0	0.0	0.9	0.3	16.3	2.4	1.0	0.3	0.4	1.2	0.0	4.2	0.1
CPT1C	"CATL1, CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;pituitary gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.4;Excitatory neurons: 34.0;Horizontal cells: 32.0;Inhibitory neurons: 28.1;Late spermatids: 29.7;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.2;AN3-CA: 33.2;SCLC-21H: 27.4;SH-SY5Y: 70.1;U-87 MG: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome		"HPA014529: AB_1847206, HPA063621: AB_2732706"	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	5.3	14.0	1.6	14.8	0.0	2.1	8.5	19.1	6.5	18.8	2.6	1.3	8.1	2.3	1.0	4.9	4.4	3.8	19.2	15.6	1.7	0.8	2.1	1.3	10.1	9.2	5.1	1.4	1.4	28.4	0.7	10.3	3.4	0.6	12.4	1.0	2.5	0.7	1.0	1.8	4.6	4.9	4.9	1.5	3.5	12.9	0.2	2.4	0.2	0.6	2.7	3.7	14.4	0.0	0.0	40.2	33.2	14.0	11.0	0.0	12.6	25.2	16.2	22.4	0.7	0.0	0.8	0.0	12.7	2.0	3.0	0.0	0.0	8.5	0.6	0.1	0.0	0.1	0.0	22.7	0.0	0.0	12.7	0.0	13.3	0.1	4.3	22.2	0.1	0.1	0.0	0.9	0.7	0.2	0.0	1.8	2.7	8.8	0.0	0.0	0.0	0.9	0.0	27.4	70.1	0.1	0.1	0.0	0.6	0.1	0.1	18.3	1.0	0.2	7.7	6.7	0.2	3.2	0.4	29.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	14.8	8.5	19.1	19.2	15.6	10.1	9.2	10.3	4.9	12.9	14.4	3.8	0.0	0.0	7.5	0.4	2.2	3.1	0.5	3.4	43.4	0.9	1.3	1.4	1.5	0.0	0.0	16.7	1.1	0.3	0.1	0.0	0.0	8.9	0.5	14.1	7.4	0.0	0.0	34.0	0.0	4.4	6.0	0.0	1.2	0.0	1.9	5.0	0.1	0.3	32.0	28.1	0.1	0.0	0.9	1.2	29.7	3.4	0.8	0.0	7.5	0.0	18.3	0.0	21.1	14.9	0.3	0.0	13.2	1.4	2.1	0.0	0.0	0.0	19.1	0.0	5.8	6.3	3.1	7.0	1.0	1.8	1.1	0.7	4.4	0.2	1.6
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CPTP	"GLTPD1, MGC10334"	ENSG00000224051	"Ceramide-1-phosphate transfer protein"	Q5TA50	1	1324756-1328896	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.5;Late spermatids: 167.1;Proximal enterocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056832	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA056832: AB_2683251"	"unprognostic (9.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.27e-2)"	15.7	19.5	14.1	6.0	13.0	2.8	16.9	13.1	22.1	17.6	14.0	28.3	19.8	14.2	8.5	48.9	12.5	3.7	92.8	15.0	10.9	28.4	69.9	12.6	5.4	16.0	13.8	10.8	18.6	14.1	8.0	4.6	17.1	19.1	4.8	2.0	37.2	6.5	55.2	33.0	23.2	2.7	12.3	21.2	31.3	70.7	15.4	4.0	14.2	22.8	4.4	14.7	24.8	11.8	36.0	12.7	6.0	11.0	5.7	4.8	9.7	18.4	9.8	17.1	11.1	17.4	19.6	14.2	20.9	8.5	11.3	26.3	4.8	10.9	6.2	16.8	16.5	10.6	13.6	17.7	14.4	10.3	10.3	9.3	8.3	18.0	5.0	8.3	9.1	9.0	15.8	8.3	5.7	13.3	11.4	12.1	5.5	9.3	55.1	14.0	9.8	41.1	14.0	9.5	14.2	14.9	14.8	46.3	32.8	3.1	16.5	7.1	15.5	18.3	12.8	20.1	15.2	18.1	14.8	14.8	17.6	15.1	5.6	1.8	1.2	6.1	1.6	0.6	0.9	2.9	1.9	1.5	0.8	1.5	1.1	0.9	1.6	1.2	1.2	1.2	5.1	1.4	14.1	13.0	13.1	22.1	15.0	10.9	16.0	13.8	17.1	12.3	15.4	11.8	20.0	0.0	3.2	2.0	7.2	0.0	7.8	0.0	5.2	9.7	15.8	8.6	22.6	12.8	1.3	7.3	0.0	18.6	10.8	35.3	39.2	25.9	72.5	5.9	4.9	13.8	6.1	5.5	3.0	24.3	21.3	7.0	26.5	9.4	0.0	9.1	13.9	31.5	16.4	23.5	3.3	14.0	0.0	7.6	0.0	167.1	12.2	6.3	0.0	5.6	15.8	16.3	18.6	2.0	2.7	49.3	13.3	9.8	18.6	12.0	72.0	18.2	0.0	7.0	13.1	4.7	6.8	52.3	4.8	14.0	0.0	19.6	7.5	9.8	18.4	9.1
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 81.3;intestine: 75.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 106.8;Late spermatids: 202.5;Oligodendrocytes: 35.6;Peritubular cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 18.4;fHDF/TERT166: 71.8;SuSa: 28.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA		62000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	29.1	6.4	3.9	5.9	7.2	0.0	20.8	9.2	2.6	5.8	81.3	75.4	6.2	10.2	59.8	18.4	16.0	11.2	18.0	3.5	7.2	11.2	2.4	7.0	2.7	16.1	10.7	16.7	5.2	2.5	10.9	1.2	11.6	15.1	7.0	0.5	9.3	12.7	3.8	7.3	14.9	56.9	20.0	16.8	19.9	9.6	10.4	7.8	15.0	7.9	6.6	28.3	9.2	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.7	1.1	0.1	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	28.0	0.5	0.0	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.2	9.2	2.6	3.5	7.2	16.1	10.7	11.6	20.0	10.4	18.3	22.3	0.0	0.6	0.3	0.1	2.2	0.0	0.2	6.2	0.0	0.3	0.4	2.4	0.0	0.0	1.8	0.0	8.3	0.1	0.2	1.9	0.4	106.8	0.2	0.2	26.1	0.0	0.0	5.0	0.2	0.3	23.0	1.1	0.3	0.0	0.1	16.8	0.0	0.3	1.7	0.5	0.7	0.0	0.0	2.7	202.5	10.8	0.6	3.6	0.0	0.0	0.0	0.0	1.0	35.6	0.1	0.1	79.0	1.4	0.0	0.4	0.0	0.0	0.1	0.0	1.6	2.0	1.3	1.9	0.6	2.0	5.1	0.2	0.0	2.7	0.2
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"bone marrow: 1.5"	"Cell type enriched"	"Detected in some"	18	"Erythroid cells: 128.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 1.3;HMC-1: 2.9;K-562: 1.6"									HPA049348	Approved				"Secreted in other tissues"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.5	0.0	0.3	1.8	0.0	0.1	0.0	0.0	5.9	0.4	0.2	6.9	0.2	1.8	0.0	128.6	0.4	0.0	0.1	0.2	0.0	1.0	0.0	0.0	3.6	0.2	1.2	0.0	0.4	0.0	2.0	0.3	0.3	0.4	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.0	0.2
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 174.0"	"Group enriched"	"Detected in some"	17	"B-cells: 54.9;Plasma cells: 14.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.1;stomach cancer: 5.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.0;JURKAT: 4.0;MOLT-4: 13.4;RPMI-8226: 4.7"	"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced					NA	NA		220000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favorable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	2.0	0.0	0.1	53.1	0.1	0.8	0.6	0.0	0.2	0.0	0.0	5.1	0.9	0.4	0.0	0.7	0.1	2.0	0.1	0.2	0.0	6.2	0.4	1.1	174.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.1	1.1	4.0	0.0	4.3	0.0	0.2	0.0	16.7	0.4	0.0	73.2	6.9	0.5	0.1	15.2	0.8	0.0	171.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	13.4	0.0	2.1	0.0	0.3	0.0	0.2	4.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	17.5	1.0	0.6	0.0	20.3	2.4	2.2	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 544.1;thyroid gland: 173.2"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.9	1.7	14.2	2.5	24.8	0.2	56.1	25.6	26.4	1.3	28.5	6.9	0.8	2.3	2.0	0.6	0.3	1.6	0.4	9.6	39.6	15.5	0.0	0.7	0.2	61.7	62.6	0.4	0.7	0.0	27.6	15.0	58.4	2.6	1.7	544.1	1.1	47.4	0.2	26.7	5.0	1.8	23.8	75.2	7.1	0.5	86.2	1.7	173.2	0.2	1.2	0.6	2.5	13.7	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	24.8	25.6	26.4	9.6	39.6	61.7	62.6	58.4	23.8	86.2	13.7	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CRACD	"CRAD, KIAA1211"	ENSG00000109265	"Capping protein inhibiting regulator of actin dynamics"	Q6ZU35	4	56049073-56328625	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;intestine: 19.7;testis: 29.6"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.7;SH-SY5Y: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		59000		"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	0.5	2.3	6.6	3.1	9.6	3.9	0.3	8.7	5.6	1.6	0.0	9.5	13.8	3.5	4.2	0.5	2.9	11.3	0.8	5.7	12.8	0.7	0.6	1.0	2.2	18.8	13.3	1.2	1.8	6.3	0.9	0.6	19.1	1.7	8.1	4.1	1.0	3.5	0.0	0.5	19.7	4.4	8.7	2.5	2.7	29.6	11.9	0.6	0.1	0.2	1.9	1.3	1.2	6.2	0.0	2.9	11.2	0.9	0.3	0.0	4.1	0.1	0.4	0.5	1.2	3.4	0.4	10.2	0.3	0.0	9.1	0.0	9.6	0.2	0.3	0.9	5.6	5.7	5.1	0.5	1.6	4.8	0.8	0.4	0.2	0.0	0.1	3.6	5.3	9.1	0.0	9.8	0.1	1.4	7.1	0.4	6.0	8.7	7.2	6.8	6.1	0.2	0.1	2.6	26.7	56.7	1.0	0.3	6.9	9.4	2.4	0.5	2.1	0.3	2.8	0.7	2.6	9.7	6.9	0.1	2.8	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.6	8.7	5.6	5.7	12.8	18.8	13.3	19.1	8.7	11.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CRACDL	"C2orf55, KIAA1211L, MGC42367"	ENSG00000196872	"CRACD like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 31.6"	"Cell type enriched"	"Detected in some"	9	"Adipocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	5.0	0.9	12.8	1.5	20.0	0.5	5.1	0.0	30.8	5.1	0.0	5.9	8.0	2.1	31.6	11.2	22.6	2.9	3.4	29.7	0.0	4.1	0.3	6.0	0.8	0.0	0.0	0.6	4.7	7.7	6.6	4.5	0.0	2.3	4.6	0.1	11.0	4.6	1.7	6.4	7.5	2.3	0.0	1.3	8.3	6.2	0.0	1.0	5.0	1.5	1.8	2.2	5.5	3.6	8.4	0.4	0.2	3.2	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	10.4	0.0	0.2	7.4	0.3	0.4	0.0	61.7	1.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	2.3	0.1	1.2	0.1	2.5	0.0	0.0	17.4	0.0	16.3	0.2	1.3	0.1	8.3	0.9	0.0	0.0	0.8	3.2	6.5	5.8	0.9	17.3	22.5	0.1	0.0	8.7	1.4	10.7	0.0	1.3	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	20.0	0.0	30.8	29.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CRACR2A	"EFCAB4B, MGC4266"	ENSG00000130038	"Calcium release activated channel regulator 2A"	Q9BSW2	12	3606633-3764819	"Predicted intracellular proteins"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.0;intestine: 13.5;salivary gland: 38.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.9;Intestinal goblet cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038686	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA038686: AB_10671748"	"unprognostic (6.78e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.96e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.85e-6)"	"unprognostic (4.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.04e-2)"	1.4	0.2	0.2	3.6	1.0	17.0	5.0	0.1	0.3	2.1	0.7	9.1	4.5	0.7	0.1	0.5	0.5	1.7	1.9	0.2	0.1	0.2	1.0	1.3	4.0	0.6	0.3	1.1	3.3	0.1	0.2	0.2	0.4	4.2	13.5	0.1	38.6	0.7	0.3	1.8	8.4	1.1	0.3	2.9	3.5	1.1	0.6	6.1	0.6	0.4	3.6	2.8	0.3	0.4	13.2	4.4	0.9	0.2	1.7	5.1	10.1	1.4	1.2	3.7	5.1	8.9	2.6	19.5	0.5	5.1	0.2	0.0	14.7	0.0	5.2	29.4	3.3	17.1	0.0	0.0	2.9	23.9	0.4	3.9	1.5	11.4	0.1	0.0	10.7	18.4	12.0	8.4	4.8	10.7	22.0	11.6	5.3	24.6	0.0	11.7	11.9	3.8	0.0	16.6	9.5	2.2	3.0	3.1	0.1	0.9	0.6	13.4	15.6	0.0	15.3	12.6	0.0	0.1	0.0	24.9	0.0	11.1	0.0	16.9	1.0	2.5	5.0	1.0	5.0	2.6	2.5	4.0	0.8	0.9	1.4	2.5	1.1	3.5	0.2	0.3	1.0	1.7	0.2	1.0	0.1	0.3	0.2	0.1	0.6	0.3	0.4	0.3	0.6	0.4	0.9	0.0	0.6	1.0	6.1	0.0	1.3	0.0	0.6	1.1	12.8	9.4	3.8	0.0	3.1	0.0	2.1	0.1	14.9	4.3	0.0	1.6	1.5	0.4	5.5	1.2	0.0	3.0	3.4	2.9	0.6	3.1	6.1	0.3	0.0	13.2	2.2	0.5	2.0	0.0	5.5	46.0	0.0	2.5	0.0	2.9	1.8	3.1	0.0	4.7	3.2	0.1	8.2	0.0	0.6	1.9	5.3	4.5	8.6	4.7	3.2	0.2	2.9	0.2	0.0	4.2	2.0	1.2	2.9	0.2	0.0	0.0	12.1	2.6	8.1	1.8
CRACR2B	"EFCAB4A, MGC45840"	ENSG00000177685	"Calcium release activated channel regulator 2B"	Q8N4Y2	11	826144-831991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 208.7;salivary gland: 223.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 180.4;Breast myoepithelial cells: 116.3;Gastric mucus-secreting cells: 178.9;Hepatic stellate cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.4;eosinophil: 3.7;memory B-cell: 3.9;naive B-cell: 3.0;NK-cell: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.9;granulocytes: 3.7;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"NB-4: 35.2;OE19: 29.6;SK-BR-3: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046217	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA046217: AB_10960833"	"unprognostic (8.87e-2)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (4.47e-3)"	"unprognostic (8.20e-3)"	"unprognostic (5.27e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.49e-3)"	"unprognostic (9.25e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-1)"	"unprognostic (5.15e-3)"	11.9	8.4	1.5	3.3	1.6	13.3	65.8	3.1	2.1	8.3	3.5	43.6	22.4	4.6	1.0	6.7	6.4	6.8	22.4	1.3	1.5	27.0	3.4	14.9	2.4	1.8	1.5	1.3	208.7	6.8	23.3	2.7	1.8	44.9	13.6	1.0	223.6	5.2	4.3	21.9	28.5	1.2	1.1	13.9	81.0	2.4	1.9	0.6	6.4	1.7	2.0	19.6	3.9	1.0	3.6	3.1	0.6	1.5	0.2	0.0	11.5	0.3	0.0	0.1	0.0	3.8	12.0	0.0	4.7	0.0	0.3	3.2	2.1	0.1	0.0	26.2	1.1	13.3	3.1	8.8	0.0	10.9	0.5	0.2	0.5	0.0	0.0	2.2	0.5	1.4	17.3	10.7	0.0	8.0	0.3	35.2	0.9	29.6	0.4	2.4	0.6	22.5	8.7	2.8	2.8	1.5	0.4	111.6	0.0	0.6	17.5	9.0	0.3	1.7	0.6	0.4	0.2	26.3	2.4	3.8	5.5	14.4	0.1	3.4	0.5	3.7	0.1	0.0	0.0	3.9	0.0	0.3	0.0	3.0	0.0	0.0	0.1	1.7	0.3	0.5	0.0	0.2	1.5	1.6	3.1	2.1	1.3	1.5	1.8	1.5	1.8	1.1	1.9	1.0	61.5	6.4	19.8	3.3	16.8	0.0	6.6	0.0	1.8	2.4	180.4	116.3	8.8	22.8	27.2	12.9	0.0	3.8	6.4	18.8	15.6	15.0	2.6	11.6	1.9	34.8	12.2	6.1	0.1	37.1	1.7	2.5	178.9	16.2	1.3	0.6	85.3	2.0	3.5	0.0	0.1	71.9	0.0	5.0	0.0	5.0	2.5	3.8	0.0	3.7	1.2	11.4	0.0	0.0	0.0	25.8	40.5	1.9	24.2	29.6	46.2	4.3	13.1	7.2	13.1	2.4	4.4	2.1	6.5	4.2	0.0	1.8	5.0	1.8	43.6	66.5
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.3;Early spermatids: 164.5;Inhibitory neurons: 122.3;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 287.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	10.0	19.3	9.1	5.0	10.5	9.3	11.2	9.9	9.1	12.8	12.8	13.6	16.9	13.0	12.6	13.0	9.9	10.4	41.2	8.7	10.1	17.9	37.3	9.9	7.3	9.7	9.9	10.3	12.7	18.6	15.3	7.2	9.8	11.4	8.2	12.8	11.0	8.9	28.2	11.4	18.0	8.2	8.7	10.4	12.9	13.7	10.0	13.3	9.6	30.0	6.2	12.7	11.3	10.3	7.8	17.4	8.4	9.6	11.8	21.2	10.6	8.8	10.7	7.6	8.9	16.4	3.2	13.9	5.3	10.2	5.8	8.0	9.3	11.5	9.3	14.7	12.3	7.4	7.0	12.2	12.2	6.8	6.8	19.8	17.4	12.2	9.5	8.0	9.3	15.2	21.3	6.4	9.1	12.6	10.1	12.3	10.6	8.9	13.2	16.8	4.3	19.3	7.4	5.7	12.9	12.5	12.0	11.7	21.3	8.1	20.5	13.2	10.0	17.5	8.7	8.4	9.0	15.0	8.7	12.9	8.2	10.0	8.4	62.7	11.6	45.5	23.8	14.7	21.1	15.1	16.5	24.8	9.7	13.5	17.6	13.0	33.9	20.6	23.2	13.1	20.9	12.0	9.1	10.5	9.9	9.1	8.7	10.1	9.7	9.9	9.8	8.7	10.0	10.3	7.8	9.6	6.3	161.3	7.8	7.4	9.3	21.1	6.2	6.4	8.9	7.2	38.7	7.2	18.0	7.3	8.4	14.5	9.0	19.1	23.5	16.8	164.5	11.8	8.7	11.9	7.8	9.1	62.8	22.4	12.7	10.3	10.2	6.7	4.5	3.7	10.0	41.9	11.5	23.5	122.3	14.6	26.4	10.6	6.1	35.2	17.7	16.0	3.6	96.5	9.5	16.9	15.5	174.4	287.2	19.5	19.8	23.7	8.4	10.1	58.5	63.1	20.0	15.5	6.6	15.0	11.4	25.6	11.7	10.1	8.1	10.8	10.2	8.3	13.9	10.1
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612337-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.0	7.5	7.4	5.6	6.2	13.5	9.0	15.0	6.9	11.1	5.9	10.9	8.1	10.3	6.2	9.0	10.7	5.4	8.3	6.6	4.6	9.4	6.3	9.9	7.6	5.4	5.2	12.5	8.8	5.7	12.4	6.9	5.3	12.0	5.4	9.9	8.4	6.4	7.9	11.0	9.5	6.7	3.2	11.0	9.0	22.9	5.5	10.7	12.7	4.8	6.0	9.6	9.5	7.1	8.5	15.5	15.6	14.5	9.8	9.7	20.3	14.4	7.5	11.5	8.2	11.2	14.0	12.0	12.3	9.9	7.1	15.3	18.7	10.0	10.3	12.7	22.6	14.2	16.0	6.9	7.1	19.0	20.6	8.5	12.6	14.5	12.1	11.2	12.4	17.9	19.6	7.1	6.3	12.4	14.8	10.6	14.9	4.9	8.7	51.2	8.4	16.1	8.2	7.5	16.6	14.0	15.8	11.3	8.3	10.9	9.9	24.3	15.2	11.9	12.8	11.4	13.9	15.0	23.3	24.3	3.7	13.0	10.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	7.4	6.2	15.0	6.9	6.6	4.6	5.4	5.2	5.3	3.2	5.5	7.1	10.4	16.0	17.0	0.0	2.7	0.0	5.2	0.0	12.0	8.6	9.3	8.0	0.0	4.3	8.6	9.2	18.8	4.7	12.8	6.1	1.9	5.5	28.0	11.1	14.5	6.8	2.4	4.6	0.0	2.0	3.0	5.4	5.1	15.3	5.1	11.0	6.8	4.3	5.6	3.3	0.0	6.6	0.0	8.2	0.0	9.6	4.4	4.3	0.0	0.0	6.6	6.2	4.1	0.0	0.0	7.1	4.7	6.8	4.7	9.9	6.0	1.6	2.9	17.9	6.6	7.1	5.2	17.3	18.4	9.4	0.0	5.3	5.2	5.6	5.5	5.9
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs cell polarity complex component 1"	P82279	1	197268204-197478455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.3;retina: 74.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 7.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	8	"HeLa: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Secreted in brain"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	0.1	0.1	15.7	0.0	17.6	0.4	0.1	19.8	20.5	0.0	9.6	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.2	15.8	14.2	0.1	0.0	0.1	0.1	18.7	18.4	0.7	0.4	0.0	2.2	0.0	17.5	0.0	0.0	74.7	0.0	0.0	0.7	0.0	0.0	0.0	18.9	0.0	0.2	2.9	16.1	0.0	0.2	0.5	0.0	0.0	0.0	21.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.7	17.6	19.8	20.5	15.8	14.2	18.7	18.4	17.5	18.9	16.1	21.3	0.0	0.0	0.0	469.5	0.0	0.3	0.2	0.3	0.0	15.0	0.2	0.1	1.1	0.0	0.2	0.0	164.7	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.7	0.0	11.6	53.2	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.7	130.1	0.0	2.0	0.0	0.5	1.6	1.8	0.0	0.0	24.4	0.0	79.7	0.0	280.0	105.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	149.3	0.0	0.2	0.1	1.8	0.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0
CRB2	"FLJ16786, FLJ38464"	ENSG00000148204	"Crumbs cell polarity complex component 2"	Q5IJ48	9	123356170-123380324	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Gastrulation, Sensory transduction, Vision"	"Developmental protein"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.9;choroid plexus: 14.1;retina: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 40.5;Bipolar cells: 29.7;Cone photoreceptor cells: 118.9;Oligodendrocytes: 26.8;Rod photoreceptor cells: 110.1"	"Group enriched"	"Detected in some"	7	"glioma: 9.4;ovarian cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043674	Approved	Supported			"Intracellular and membrane"	NA	NA		210000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA043674: AB_10962974"	"unprognostic (1.38e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.56e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.38e-1)"	1.6	0.0	14.5	0.5	21.5	0.3	0.1	11.0	12.5	0.0	14.1	0.7	0.1	1.5	0.1	0.0	1.0	0.0	0.1	13.8	13.7	5.8	0.0	0.0	0.7	24.0	20.3	0.2	0.0	0.0	1.4	0.0	14.9	0.0	0.4	8.1	0.0	0.0	0.0	0.1	0.3	0.3	22.2	0.5	0.2	0.5	24.9	0.2	0.1	0.0	0.6	0.2	0.0	23.0	0.0	0.1	32.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.6	0.0	0.0	4.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	21.5	11.0	12.5	13.8	13.7	24.0	20.3	14.9	22.2	24.9	23.0	0.0	0.0	0.0	40.5	0.5	0.3	0.1	0.0	0.0	29.7	0.0	2.2	2.8	0.0	0.0	1.8	118.9	0.1	0.0	0.7	0.0	0.0	3.9	0.4	1.3	0.4	3.0	0.0	4.2	0.0	0.1	2.5	0.0	0.1	1.3	0.0	0.0	0.0	0.2	3.3	0.4	2.8	0.0	0.0	1.0	7.7	1.8	0.1	0.0	0.0	0.1	6.1	1.0	2.0	26.8	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	110.1	0.0	0.5	0.3	0.1	0.3	0.0	0.6	0.3	0.1	0.1	5.3	0.1
CRB3	MGC17303	ENSG00000130545	"Crumbs cell polarity complex component 3"	Q9BUF7	19	6463777-6467221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 160.9;Pancreatic endocrine cells: 149.9;Paneth cells: 177.3;Suprabasal keratinocytes: 139.5;Urothelial cells: 243.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 9.2"	"Group enriched"	"Detected in many"	20	"B-cells: 3.1;T-cells: 9.2"	"Cell line enhanced"	"Detected in some"		"A-431: 57.9;BEWO: 35.1;CACO-2: 38.1;HaCaT: 36.9;hTCEpi: 27.8;OE19: 33.1;SK-BR-3: 29.5;T-47d: 25.8"	"Low region specificity"	"Detected in many"							HPA013835	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA013835: AB_1847214"	"unprognostic (3.25e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (8.06e-5)"	0.8	0.4	0.3	4.0	0.7	0.3	5.1	1.2	0.5	9.3	6.1	26.9	36.9	2.2	4.6	54.5	8.2	8.2	0.3	0.3	0.2	34.1	32.5	19.0	0.9	0.4	0.2	0.4	44.0	20.7	15.9	3.5	0.5	9.1	10.5	0.4	24.8	8.9	0.1	41.9	30.6	0.5	0.1	0.8	31.1	0.4	0.2	0.8	16.2	0.0	5.4	6.4	17.6	0.5	57.9	7.0	0.0	0.2	0.0	0.1	35.1	0.0	0.0	0.0	0.0	38.1	23.8	0.3	22.1	0.0	0.3	36.9	0.4	12.5	0.0	0.0	0.4	0.1	0.2	21.5	0.0	0.1	0.1	0.0	27.8	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	15.1	0.2	0.4	1.3	33.1	0.0	0.0	0.0	0.7	16.5	24.0	0.0	0.1	0.2	29.5	0.1	1.7	25.8	0.2	0.0	0.1	0.4	0.2	0.1	0.7	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.3	3.1	4.6	2.2	0.0	1.0	9.2	3.6	0.3	0.0	0.0	0.0	3.4	1.9	0.3	0.7	1.2	0.5	0.3	0.2	0.4	0.2	0.5	0.1	0.2	0.5	0.2	35.3	38.0	0.0	2.2	72.1	64.6	81.3	21.1	0.0	43.6	19.9	0.3	71.4	64.0	31.3	0.0	28.1	0.9	160.9	46.9	113.0	0.0	43.8	4.0	1.8	16.8	3.2	0.1	101.5	9.8	2.0	34.7	58.3	1.3	0.1	0.4	31.8	2.5	0.0	0.0	60.2	63.1	1.0	6.2	0.0	0.0	1.3	7.2	0.0	2.7	0.9	0.0	0.0	0.1	149.9	177.3	0.0	3.1	94.4	86.8	44.5	36.3	0.5	0.0	0.0	4.2	1.1	0.4	45.0	139.5	56.2	3.2	0.2	52.0	243.6
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	25.1	20.9	25.6	17.1	30.2	44.0	33.8	32.7	41.6	22.9	42.0	21.4	21.8	26.2	23.9	20.6	21.7	21.0	30.9	29.2	28.5	31.0	35.4	24.4	28.6	33.7	26.8	32.1	21.9	29.9	11.1	29.5	35.5	23.5	22.9	26.8	36.3	23.6	41.8	24.8	22.8	24.8	22.9	30.6	22.9	48.2	29.1	23.5	31.9	38.5	21.6	20.0	14.6	48.1	12.9	10.5	32.5	14.4	38.8	37.3	13.6	14.3	23.9	18.4	24.6	15.6	18.7	13.9	19.4	17.8	22.3	12.2	19.9	24.1	20.0	24.0	30.9	35.9	20.1	19.4	26.0	32.5	22.4	28.7	31.1	19.9	15.1	36.1	25.2	29.9	21.5	29.4	16.1	18.7	28.6	32.5	27.3	17.8	24.8	25.9	19.5	30.5	21.8	20.0	16.3	23.7	15.9	21.6	35.7	24.1	28.9	24.0	16.3	18.8	9.8	30.0	18.6	33.2	55.8	35.2	29.2	29.5	23.5	314.2	44.3	99.3	61.6	53.6	65.2	46.4	82.6	66.8	39.8	36.9	84.3	72.4	28.1	103.6	58.1	21.4	63.0	96.1	25.6	30.2	32.7	41.6	29.2	28.5	33.7	26.8	35.5	22.9	29.1	48.1	89.7	44.8	39.1	30.3	46.5	36.1	35.5	70.9	33.0	61.5	30.6	43.4	73.5	38.6	45.2	38.6	27.1	52.6	81.2	21.4	72.4	33.3	184.2	23.9	31.7	72.0	15.6	54.5	72.6	21.2	35.3	47.9	17.3	22.3	140.4	50.2	68.6	35.0	36.0	43.7	74.1	24.6	54.9	52.7	33.4	56.6	62.7	54.8	33.8	28.1	68.8	66.4	121.5	42.7	74.0	20.4	33.5	66.5	34.1	26.0	53.4	73.2	36.4	64.5	59.2	58.0	46.2	206.2	96.2	19.2	38.5	50.2	70.9	49.4	30.5	24.7
CRCP	"C17, CGRP-RCP, POLR3I, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006883, HPA007216"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA006883: , HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	13.5	15.3	10.8	13.8	11.4	37.5	17.6	12.7	14.1	14.7	11.2	18.3	16.8	14.7	11.3	20.0	17.3	13.1	17.5	11.3	13.7	16.5	26.5	14.5	16.4	11.6	12.2	16.9	20.6	21.2	11.1	13.7	14.1	17.3	19.6	14.2	16.1	15.8	14.8	16.1	14.7	18.2	11.3	17.4	17.9	8.3	13.9	15.2	20.0	13.6	16.6	16.6	14.4	12.4	44.0	26.9	19.5	26.4	27.0	33.7	19.0	29.9	31.9	43.7	33.7	43.5	34.6	40.6	35.7	29.0	37.0	32.4	26.7	35.9	46.1	26.0	27.3	23.1	19.1	20.9	19.4	47.6	32.6	27.0	30.9	38.3	71.6	27.8	23.7	23.1	49.3	28.8	30.0	35.0	36.7	37.7	39.8	58.7	33.6	38.4	30.1	37.8	27.8	40.5	46.1	60.3	34.3	95.2	29.2	22.8	73.6	24.0	27.6	63.4	33.6	36.5	56.3	35.4	70.0	54.3	35.9	36.8	51.6	25.9	12.0	20.4	17.6	11.1	17.1	14.4	15.4	14.9	9.1	13.4	14.5	17.3	20.9	10.9	17.0	12.0	16.0	12.0	10.8	11.4	12.7	14.1	11.3	13.7	11.6	12.2	14.1	11.3	13.9	12.4	24.8	28.9	32.5	12.1	30.4	13.4	22.2	13.9	24.5	29.9	19.7	19.2	25.7	12.8	23.0	16.5	22.9	12.6	47.8	15.5	35.2	21.3	4.4	27.7	30.3	18.1	16.1	12.2	19.5	24.8	11.8	20.5	27.5	29.4	34.1	22.8	9.7	25.2	12.1	30.3	20.5	15.4	8.2	13.6	9.2	4.3	18.6	17.7	16.0	12.2	20.6	23.0	22.6	12.5	17.2	29.8	10.2	22.2	26.5	26.2	10.5	17.6	32.8	25.8	6.6	27.2	18.5	24.5	16.7	20.9	14.8	11.5	27.3	28.6	14.7	32.1
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207605988	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 417.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	13.0	8.7	10.6	15.3	11.4	22.4	14.7	17.5	11.1	15.8	11.9	11.4	10.0	15.7	10.8	15.0	13.1	14.0	11.5	10.3	10.7	12.4	11.6	13.6	22.1	10.6	9.9	17.2	8.7	15.6	6.9	18.0	10.4	13.0	14.0	17.8	8.9	12.6	6.7	11.5	10.6	16.3	9.7	17.1	12.1	32.4	9.9	28.7	18.1	14.6	25.0	16.8	9.6	15.0	24.9	20.9	38.6	15.6	22.9	22.4	21.8	15.9	23.5	26.6	26.5	21.6	22.9	15.4	19.8	21.1	29.8	19.5	34.8	20.4	37.7	25.1	13.2	29.2	18.9	23.0	18.7	27.7	20.0	16.0	16.3	21.1	31.1	25.4	34.9	28.9	20.5	22.5	30.4	16.8	41.0	16.1	27.8	24.2	13.1	31.4	22.1	20.2	25.1	24.6	27.1	23.4	21.6	16.2	18.1	35.5	16.5	30.1	18.5	21.8	22.6	22.1	20.5	19.6	27.5	36.4	25.2	25.3	22.0	33.6	28.2	28.2	27.0	29.2	23.7	36.7	25.3	26.2	34.1	34.8	30.0	20.7	56.1	45.6	34.9	18.6	38.6	26.7	10.6	11.4	17.5	11.1	10.3	10.7	10.6	9.9	10.4	9.7	9.9	15.0	46.7	19.2	18.2	47.0	52.3	70.9	47.1	33.3	34.1	38.9	25.3	18.5	26.3	17.2	29.0	12.9	33.3	29.1	35.5	25.3	23.5	23.6	417.8	19.6	39.2	47.2	32.4	54.7	56.1	20.3	24.9	35.8	18.8	21.0	43.7	41.5	35.7	15.8	29.4	40.4	51.1	28.2	30.5	48.8	75.9	47.2	26.1	35.8	44.4	68.4	60.9	42.1	33.0	66.9	70.7	26.4	27.5	29.3	29.1	56.5	22.8	19.7	18.9	40.2	39.5	37.4	40.7	44.5	29.4	33.5	57.8	18.6	42.6	19.6	25.7	62.6
CREB3L1	OASIS	ENSG00000157613	"CAMP responsive element binding protein 3 like 1"	Q96BA8	11	46277662-46321409	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.9;salivary gland: 83.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 89.2;Gastric mucus-secreting cells: 105.0;Glandular and luminal cells: 120.5;Intestinal goblet cells: 280.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 87.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 134.3;BJ hTERT+: 130.7;BJ hTERT+ SV40 Large T+: 120.6;fHDF/TERT166: 321.8;OE19: 129.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA024069, CAB026151"	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB026151: , HPA024069: AB_1854750"	"unprognostic (2.46e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (1.12e-2)"	8.6	15.1	4.3	8.0	3.3	0.1	10.7	0.9	4.2	43.2	2.1	41.2	27.7	20.4	2.4	3.2	5.2	25.0	15.6	7.2	3.4	2.8	1.1	14.8	0.7	1.9	5.1	9.3	133.9	2.3	10.7	26.7	4.1	42.3	43.3	0.1	83.0	26.8	4.4	5.6	30.6	13.3	1.1	3.2	68.0	3.9	8.4	1.0	4.5	4.2	4.7	21.4	15.3	2.4	0.9	0.8	1.3	26.1	81.9	77.9	0.6	134.3	130.7	120.6	83.3	13.7	0.3	0.0	0.7	321.8	8.3	0.0	1.6	0.4	66.6	0.1	1.5	2.0	0.8	0.0	113.5	0.0	1.9	75.2	0.0	68.6	2.5	109.0	1.0	0.5	11.2	0.0	102.5	0.0	0.1	0.4	17.0	129.0	13.7	0.1	18.0	0.2	0.2	0.0	0.0	0.2	0.9	3.4	0.2	23.3	0.1	4.9	0.0	62.7	18.3	48.6	83.4	0.1	0.1	0.0	75.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.3	0.9	4.2	7.2	3.4	1.9	5.1	4.1	1.1	8.4	2.4	10.3	0.0	46.4	0.3	0.6	1.5	44.4	2.6	0.0	0.0	52.0	5.1	15.9	25.8	10.0	29.5	0.0	1.2	0.1	56.8	3.9	42.0	2.1	37.2	24.1	9.0	9.1	0.0	2.1	89.2	2.3	49.4	105.0	120.5	4.5	1.9	3.3	0.0	1.9	0.0	1.0	280.5	6.1	0.0	3.5	6.6	83.6	1.0	10.6	2.8	2.0	0.0	0.0	19.6	0.1	49.2	59.8	44.4	0.2	40.4	9.5	0.7	3.6	0.0	0.0	0.7	29.3	1.0	1.5	0.6	2.3	3.4	1.8	10.7	57.7	51.3
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
CREB3L3	"CREB-H, CREBH"	ENSG00000060566	"CAMP responsive element binding protein 3 like 3"	Q68CJ9	19	4153631-4173054	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	71	"intestine: 257.2;liver: 415.5"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 111.9;Proximal enterocytes: 426.0"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 91.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;HDLM-2: 49.0;Hep G2: 15.6;HMC-1: 8.5;U-266/70: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040671, HPA056228"	Enhanced					NA	NA		32000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA040671: AB_2677072, HPA056228: AB_2683072"	"unprognostic (1.86e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.41e-4)"	"unprognostic (1.79e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.53e-6)"	"unprognostic (3.18e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.35e-2)"	0.0	4.7	0.3	0.3	0.4	0.3	0.0	0.1	0.6	0.0	0.0	2.0	243.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	1.3	415.5	0.0	0.1	0.7	0.4	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	257.2	0.3	0.1	0.2	1.8	0.5	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	15.6	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.0	0.4	0.0	0.1	0.0	2.0	0.0	1.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	10.1	4.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.1	0.6	0.3	0.3	0.7	0.4	0.7	0.1	0.6	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	15.1	3.3	111.9	0.0	0.0	0.5	13.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	14.6	0.0	0.0	0.0	426.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	8.2	0.0
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974361	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 106.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	6.3	8.5	3.5	4.5	3.8	7.6	48.2	4.6	4.7	30.5	4.4	11.5	11.4	12.9	13.0	8.2	19.2	6.7	5.0	3.3	3.5	10.5	14.0	5.8	5.9	3.9	4.1	17.4	13.2	6.7	6.1	6.3	3.7	106.2	15.2	4.9	43.9	7.6	5.6	10.2	9.0	5.7	3.9	7.5	29.3	5.3	3.6	12.0	11.3	5.3	7.4	6.8	6.9	4.7	7.5	10.6	9.8	10.9	6.9	10.0	24.7	6.2	7.2	8.3	7.3	5.1	31.0	13.9	31.7	2.6	6.1	12.0	14.5	9.7	4.5	11.4	5.9	10.3	11.7	8.9	5.6	4.9	8.5	10.9	9.2	7.9	17.9	7.5	7.4	16.5	8.1	16.9	3.8	81.8	9.3	3.8	6.7	82.7	12.7	20.9	10.3	26.1	9.0	5.3	18.5	20.1	6.6	174.6	16.8	12.8	139.9	14.9	4.5	2.5	7.3	5.2	4.9	31.4	17.3	10.6	5.3	8.5	8.2	1.5	2.9	2.2	3.4	1.2	4.5	4.5	1.9	2.4	5.0	4.8	1.8	3.5	0.1	9.4	1.7	5.7	1.8	2.5	3.5	3.8	4.6	4.7	3.3	3.5	3.9	4.1	3.7	3.9	3.6	4.7	7.2	6.4	13.1	3.6	6.2	2.9	13.1	10.1	6.8	5.3	49.9	40.1	2.0	7.2	20.3	1.8	2.1	12.9	5.6	3.6	9.8	14.0	0.4	10.6	5.2	6.9	9.0	8.6	0.4	13.3	17.0	4.8	10.7	13.5	5.7	8.7	4.2	14.2	5.4	0.0	0.4	56.9	6.1	7.5	2.0	0.6	7.2	5.1	5.4	0.0	2.8	6.6	8.2	1.5	2.2	7.9	4.3	2.2	5.3	49.3	4.0	4.1	16.6	8.8	19.7	3.1	5.0	7.4	10.6	6.3	3.0	4.2	4.5	7.6	10.9	7.0
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.6"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	39.8	130.6	24.7	30.4	26.3	5.3	31.9	22.8	29.2	26.4	29.5	23.4	23.1	19.0	28.8	17.1	24.6	28.2	22.5	26.2	28.8	49.7	50.1	32.5	37.5	24.6	24.5	37.2	24.7	56.3	32.2	24.2	24.6	28.2	23.8	35.2	26.4	23.0	10.1	24.6	23.6	18.9	24.8	37.5	25.1	20.9	29.1	24.7	44.3	15.6	29.8	28.0	15.1	27.7	12.5	15.9	13.6	15.5	46.9	47.0	26.3	24.0	40.4	17.3	23.7	11.5	17.9	10.8	9.1	29.3	26.2	10.3	20.7	18.4	29.1	61.0	12.6	8.5	15.1	14.2	30.7	12.2	15.2	30.8	32.2	20.3	33.1	58.7	25.7	8.5	8.7	16.5	29.4	20.1	6.4	9.9	40.8	11.9	14.4	8.7	23.6	6.9	33.1	35.7	16.0	18.2	24.4	11.7	43.3	58.5	6.5	13.6	20.8	23.7	15.1	23.7	23.9	13.9	19.7	2.7	28.1	10.3	24.9	1.1	2.5	2.6	1.7	5.6	3.1	0.9	3.4	2.7	2.8	1.1	3.3	2.7	0.4	1.1	2.6	1.4	5.6	1.5	24.7	26.3	22.8	29.2	26.2	28.8	24.6	24.5	24.6	24.8	29.1	27.7	18.0	25.6	26.5	23.5	14.8	22.2	18.6	11.1	18.8	17.5	23.5	15.9	14.6	30.0	12.2	33.1	2.1	18.1	15.7	17.7	41.1	21.6	40.4	14.2	10.4	19.1	30.0	27.8	15.9	21.8	19.3	25.3	17.9	10.6	10.2	12.1	23.2	48.4	39.3	37.0	17.7	16.4	26.4	120.0	83.0	12.1	36.1	58.2	33.8	33.7	45.6	38.0	10.3	28.6	18.6	21.8	15.0	35.3	17.3	29.5	29.3	58.8	19.9	11.8	39.5	13.7	12.4	45.8	20.8	18.0	29.1	27.5	23.3	11.5	17.6	28.1
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85657990-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HeLa: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	17.1	12.4	9.8	12.9	11.1	9.7	16.8	18.3	15.4	15.9	11.3	12.8	14.1	21.3	12.2	10.1	15.1	10.3	8.2	10.1	9.9	8.8	10.8	15.4	18.7	10.6	10.0	21.7	14.8	11.8	8.7	13.2	11.1	12.9	13.7	27.9	16.4	10.2	9.9	17.2	16.4	10.3	10.5	17.2	12.7	6.1	10.3	13.6	16.3	6.8	15.3	12.1	14.9	13.5	5.6	12.4	18.4	7.6	8.4	8.8	13.7	9.8	6.0	8.4	11.0	15.6	22.5	16.4	9.1	5.8	22.1	19.6	12.7	6.2	14.1	9.3	11.9	14.9	53.1	7.2	5.7	14.1	8.0	7.8	12.2	8.5	11.8	11.5	5.3	10.8	11.7	18.6	10.1	7.9	12.0	27.5	6.8	16.3	8.7	19.2	15.7	10.1	9.2	10.7	14.5	12.4	12.6	19.3	4.2	11.6	20.8	20.8	6.3	17.4	10.7	24.3	11.0	6.4	7.6	16.8	4.1	10.4	10.9	0.3	0.1	0.1	0.4	0.1	0.7	0.2	0.3	0.3	0.2	0.2	0.4	0.4	0.2	0.4	0.3	0.2	0.6	0.1	9.8	11.1	18.3	15.4	10.1	9.9	10.6	10.0	11.1	10.5	10.3	13.5	30.3	19.2	21.5	58.1	41.9	41.3	21.6	12.4	31.3	97.5	35.1	20.6	13.9	17.2	17.9	22.0	91.8	16.9	53.1	30.0	9.8	13.2	34.5	27.6	31.1	25.1	39.4	30.1	57.6	8.6	14.9	34.7	46.9	34.0	22.2	64.3	23.2	29.5	9.9	90.9	60.7	23.8	10.2	19.2	27.3	16.6	30.7	15.6	33.8	25.3	24.8	47.9	46.4	56.8	114.5	9.2	22.8	33.4	39.1	29.5	29.8	8.0	22.5	113.5	13.1	34.6	30.9	27.4	11.4	27.7	41.3	14.4	43.0	51.9	25.7	26.5
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345550-101387503	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"brain: 27.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 66.0;Inhibitory neurons: 27.6;Oligodendrocytes: 12.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"amygdala: 8.7;basal ganglia: 17.2;cerebral cortex: 26.3;hippocampal formation: 27.8;white matter: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HaCaT: 6.3;HeLa: 2.5;OE19: 7.1;PC-3: 2.4;RT4: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.0	0.1	8.7	0.0	17.2	0.1	0.0	0.0	26.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	27.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	9.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	17.2	0.0	26.3	27.8	0.0	1.3	0.0	0.6	0.0	1.4	9.0	0.0	0.0	0.0	2.9	0.0	0.0	0.6	0.5	0.0	0.8	0.1	0.1	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.5	0.0	0.0	66.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.1	2.0	0.0	0.0	6.5	0.0	0.2	0.0	6.5	0.0	0.8	0.0	2.5	12.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.5	0.0	0.2	0.1	1.5	5.6	0.5	0.0	0.1	0.0	0.2	0.0	1.5
CRELD1	"AVSD2, CIRRIN"	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933816-9945406	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.3;hTERT-RPE1: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	32.7	37.3	63.6	11.4	63.5	9.3	24.8	69.1	94.4	27.7	59.1	57.5	14.0	31.3	17.0	18.0	34.9	16.5	73.2	63.9	65.7	43.0	57.1	27.5	12.4	64.7	63.0	32.5	27.6	22.7	70.9	17.9	66.3	47.6	12.1	16.4	26.3	34.5	48.9	20.1	25.9	22.2	58.6	28.6	35.6	23.6	65.5	10.5	67.6	26.4	9.2	33.6	24.4	68.2	6.4	8.1	19.3	8.8	30.1	17.6	110.3	26.7	8.0	6.1	11.7	11.1	20.7	8.4	57.6	17.7	27.7	4.5	10.4	17.6	4.9	15.2	9.2	7.3	15.2	28.2	68.7	3.3	29.3	21.7	32.3	15.2	13.6	77.2	28.8	11.1	9.5	10.4	6.1	15.5	3.6	19.3	5.7	30.1	6.6	4.8	3.1	21.6	25.9	9.9	6.9	26.7	12.6	10.3	24.3	27.5	27.9	17.0	21.7	12.1	19.5	16.2	6.3	10.7	14.2	15.2	27.3	7.8	13.0	12.3	10.2	9.3	11.9	9.8	12.2	7.9	8.9	11.5	6.9	8.7	11.3	10.4	1.8	13.8	12.9	12.3	7.2	9.5	63.6	63.5	69.1	94.4	63.9	65.7	64.7	63.0	66.3	58.6	65.5	68.2	24.7	19.2	17.5	43.4	14.1	9.7	26.2	48.5	15.9	21.5	17.5	15.0	41.9	31.5	24.0	16.5	16.7	23.7	15.1	10.9	7.9	19.6	6.8	10.3	7.0	20.2	27.0	7.8	38.0	4.4	11.5	20.1	19.4	12.9	21.0	18.8	19.2	14.9	20.6	32.0	37.1	19.1	38.7	8.8	9.0	10.1	32.0	10.0	12.4	15.0	13.9	18.3	27.8	14.6	21.7	8.7	20.4	26.4	15.3	31.4	18.8	11.1	13.2	15.8	26.3	11.0	17.1	68.0	26.5	9.6	12.4	22.2	15.4	11.2	15.4	20.2
CRELD2	MGC11256	ENSG00000184164	"Cysteine rich with EGF like domains 2"	Q6UXH1	22	49918167-49927540	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 349.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000603, CAB025604"	Approved				"Intracellular and membrane"	NA	NA		480000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB025604: , HPA000603: AB_1078565"	"unprognostic (1.12e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (5.04e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (1.34e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.02e-1)"	29.0	28.5	17.7	25.8	20.6	18.1	24.1	19.3	20.1	25.4	19.2	29.6	26.4	31.5	41.8	26.6	28.2	13.6	33.0	18.3	21.4	26.7	97.8	31.5	19.1	22.1	19.9	23.5	123.3	13.0	65.5	14.4	21.5	27.3	16.4	7.7	39.5	17.1	15.8	17.0	26.8	15.8	19.0	40.3	46.0	43.2	24.9	15.4	67.4	7.6	15.2	27.1	21.3	21.9	37.5	25.5	29.3	96.6	30.6	34.6	39.1	76.4	46.0	41.9	35.5	44.7	44.0	20.4	59.6	66.2	42.3	36.4	37.1	38.3	18.0	11.0	60.1	11.2	37.3	55.8	126.1	44.1	41.4	31.8	33.6	36.4	30.6	29.5	42.9	21.8	16.5	79.5	31.8	119.3	17.2	46.2	21.1	73.9	54.7	41.1	51.9	46.4	20.3	33.6	19.0	53.5	64.9	75.2	32.0	19.3	30.8	51.8	32.7	35.5	59.2	33.1	23.9	65.4	16.9	17.9	52.6	32.5	57.3	33.5	12.4	17.2	17.2	14.9	17.7	29.2	14.9	23.2	13.7	28.1	12.4	10.2	6.4	35.4	8.9	52.2	11.3	12.9	17.7	20.6	19.3	20.1	18.3	21.4	22.1	19.9	21.5	19.0	24.9	21.9	42.4	6.4	16.1	12.7	82.6	32.8	34.4	49.0	10.2	34.7	35.3	34.2	17.7	31.5	39.6	9.2	25.0	32.4	65.6	45.6	7.9	41.2	112.5	28.4	41.5	32.2	39.9	12.4	9.7	63.2	120.5	56.8	50.4	37.0	36.2	27.0	47.2	63.9	74.6	25.2	10.9	136.3	26.4	25.7	47.0	25.8	44.1	33.8	96.0	6.5	27.8	41.7	80.3	9.5	16.2	51.2	35.1	41.3	349.6	82.4	28.2	16.6	37.4	32.0	13.1	25.7	39.7	143.5	104.8	21.6	30.7	55.1	53.0	41.0	55.7	43.8
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 216.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	54.9	137.4	31.9	51.0	34.3	22.0	27.1	31.3	39.2	26.4	38.6	24.5	8.9	30.3	11.4	17.6	29.2	44.5	50.5	33.6	42.9	58.8	60.5	30.5	17.6	36.7	35.5	60.6	16.0	24.5	59.5	100.3	36.0	32.0	13.6	23.5	13.4	23.3	30.0	9.0	15.9	24.5	34.1	25.3	20.7	216.6	35.8	29.3	22.3	31.3	16.9	60.5	19.1	33.5	24.8	39.0	32.3	33.2	22.2	23.0	32.2	31.8	24.8	19.6	27.0	4.6	10.2	42.0	30.2	18.7	21.2	5.6	28.0	20.8	28.5	103.8	20.6	14.9	25.7	18.6	26.5	3.6	15.2	20.4	25.9	38.3	11.7	17.2	55.3	31.1	44.3	16.9	30.4	20.0	26.1	10.8	9.6	9.2	88.6	16.0	16.9	7.8	34.8	9.7	7.5	20.4	15.1	13.1	88.7	36.5	7.2	11.0	74.0	14.9	19.1	41.4	21.3	7.4	10.9	14.6	35.6	33.1	13.0	5.3	3.5	11.5	11.5	5.5	14.6	7.0	12.6	10.4	4.1	6.8	9.0	10.4	9.7	10.2	4.2	12.4	16.2	8.5	31.9	34.3	31.3	39.2	33.6	42.9	36.7	35.5	36.0	34.1	35.8	33.5	98.7	19.2	47.9	42.7	301.8	143.4	58.0	30.9	18.8	18.3	32.1	32.4	62.3	20.0	33.2	165.5	6.2	98.7	819.1	16.8	97.8	40.6	2013.6	32.6	27.6	118.7	69.0	5.7	50.1	44.4	109.1	140.6	29.0	44.2	347.7	14.5	17.9	37.6	120.6	10.1	34.3	17.9	32.6	61.4	1094.0	814.3	26.1	286.1	247.3	30.0	187.4	39.0	65.9	113.1	34.9	30.6	19.7	32.7	109.4	49.5	15.3	64.2	46.1	19.5	46.0	45.5	232.8	464.7	156.8	15.9	108.4	230.0	612.4	46.4	13.6	52.7
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76953045-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 166.5"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 480.8;Hepatic stellate cells: 1319.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		69000000		"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	22.2	13.7	4.1	0.7	5.6	3.2	6.2	3.2	7.5	3.7	2.2	0.4	0.6	2.6	0.9	0.2	1.8	0.8	7.4	5.8	15.8	36.5	166.5	0.5	0.9	7.0	9.1	1.3	0.1	0.6	0.1	10.2	11.9	1.1	0.4	0.1	1.1	4.1	0.9	0.5	0.7	1.5	3.7	37.2	0.3	0.8	20.1	0.5	4.1	1.3	0.6	0.9	0.8	7.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	4.4	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	7.6	4.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.1	5.6	3.2	7.5	5.8	15.8	7.0	9.1	11.9	3.7	20.1	7.0	134.9	0.0	0.0	1.3	8.8	0.4	0.0	0.0	0.0	0.0	0.4	1.1	0.7	17.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	45.9	0.0	39.4	0.8	0.2	0.2	0.3	0.0	0.0	0.0	480.8	1319.7	9.9	1.8	0.0	32.4	0.0	0.0	75.0	2.1	1.0	0.3	3.8	0.0	4.7	0.3	0.0	0.0	0.5	11.1	0.0	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.0	0.1	2.3	0.5	1.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.4;pituitary gland: 22.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 41.0;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 10.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SH-SY5Y: 1.8"									CAB025251	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"			"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.2	0.0	4.1	0.0	1.7	0.0	0.4	10.4	4.8	2.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	1.9	0.4	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	22.6	0.0	0.2	0.6	0.0	3.5	0.2	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.2	2.8	0.0	0.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.7	10.4	4.8	1.9	0.4	0.0	1.5	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.8	1.1	1.3	1.2	10.2	0.7	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	53.4	0.6	0.3	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	0.4	3.2	1.6	0.1	0.1	0.4	0.5	0.0	0.5	1.6	5.1	1.5	9.9	3.3	0.0	2.5	0.0	0.1	1.7
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355778-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 163.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Hepatic stellate cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 466.5;fHDF/TERT166: 462.5;TIME: 651.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"	NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	88.3	14.6	27.0	18.8	28.1	3.5	58.9	9.4	23.5	26.7	51.4	28.7	14.9	26.6	16.7	30.5	34.4	32.2	34.5	20.3	28.8	70.0	16.0	50.1	14.8	23.5	21.9	36.9	23.5	29.2	7.4	163.8	21.2	25.8	23.2	29.5	31.1	32.6	50.1	27.2	18.2	35.7	22.1	47.1	17.5	12.4	36.1	9.9	33.8	36.5	8.7	38.9	22.2	17.1	100.9	75.4	15.2	17.5	69.1	78.0	125.0	466.5	244.7	255.4	133.4	95.3	34.2	0.2	297.9	462.5	166.1	42.8	11.4	75.2	206.5	1.1	8.7	3.2	96.7	55.5	221.5	2.2	0.6	110.1	55.2	102.4	182.4	238.4	361.9	1.9	4.7	0.7	271.6	9.2	0.2	1.2	11.9	5.2	22.1	5.4	19.6	15.5	159.8	41.1	1.8	0.2	81.5	26.4	3.4	56.2	72.3	2.0	651.1	321.7	116.1	40.4	229.1	25.5	0.5	0.9	94.7	0.4	100.8	1.4	0.1	0.5	0.6	0.0	0.4	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.2	0.4	0.6	2.1	0.2	0.0	27.0	28.1	9.4	23.5	20.3	28.8	23.5	21.9	21.2	22.1	36.1	17.1	262.9	12.8	43.3	100.2	5.4	66.0	38.5	30.1	43.9	12.0	55.6	72.9	34.4	47.1	26.5	132.4	2.1	111.9	27.1	49.5	3.9	33.5	1.0	37.1	27.7	159.8	31.8	10.7	85.1	2.6	40.6	41.0	10.2	75.9	1.3	27.4	207.1	3.6	27.7	0.0	57.5	37.7	36.7	7.7	32.5	2.0	19.0	8.2	39.2	135.9	7.1	18.5	6.2	65.9	17.2	26.5	30.9	19.9	6.9	75.5	11.5	38.4	28.9	42.5	46.0	18.4	164.6	2.1	9.4	22.0	30.1	173.5	17.1	5.7	33.2	58.3
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 1113.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6"	"Group enriched"	"Detected in all"	30	"B-cells: 109.9;T-cells: 115.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA		160000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	177.6	44.7	160.4	31.3	172.0	1.5	162.5	137.7	259.5	101.6	124.2	101.9	27.0	138.1	36.4	127.3	130.0	47.9	1113.7	172.7	186.4	205.1	52.7	185.7	30.0	157.3	158.7	51.2	46.1	19.2	175.0	49.6	158.6	89.0	8.3	4.1	100.0	72.9	52.5	128.9	82.8	32.0	145.0	104.1	66.1	92.8	191.9	10.4	155.6	42.7	16.5	121.4	100.4	140.8	2.5	201.2	37.9	98.3	4.3	19.9	10.0	17.5	1.9	2.8	1.0	7.1	44.2	0.2	321.9	73.8	4.5	166.8	3.6	50.8	0.1	2.3	1.9	0.2	132.5	73.8	24.3	0.0	25.5	10.5	4.4	5.2	26.2	38.4	192.7	0.2	0.5	1.4	26.8	306.5	0.5	0.6	10.0	45.7	143.4	0.4	7.7	9.9	140.1	0.6	61.6	175.3	30.0	303.7	1.9	4.9	266.4	0.1	259.3	82.7	38.8	2.3	50.5	0.7	0.6	0.9	24.3	0.3	179.3	0.2	1.9	0.0	7.5	0.9	6.8	52.1	80.4	17.2	3.6	109.9	17.8	4.5	1.0	3.7	0.5	0.5	115.6	10.4	160.4	172.0	137.7	259.5	172.7	186.4	157.3	158.7	158.6	145.0	191.9	140.8	459.4	157.0	33.7	17.9	15.0	153.2	96.7	206.4	29.0	2.7	110.0	140.7	863.3	107.2	127.1	189.4	4.2	2.6	8.2	0.9	154.6	106.8	37.9	125.1	28.8	510.4	25.2	9.7	16.4	87.6	30.5	132.9	32.1	126.6	7.6	0.4	346.3	30.4	3.0	94.2	3.0	0.3	81.4	11.8	92.6	84.0	28.0	9.3	156.5	27.2	2.5	57.2	1.0	4.5	3.1	48.9	0.1	14.7	7.0	37.4	0.2	17.0	155.7	4.0	276.1	108.1	339.5	27.8	46.1	20.1	196.8	32.0	32.5	5.9	0.2	103.2
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.3;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	16	"myeloid DC: 44.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 44.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.8	0.6	10.1	1.7	10.2	2.6	0.9	11.3	16.5	2.4	8.1	1.1	2.0	1.3	1.6	0.7	2.0	0.6	24.3	10.1	10.4	5.3	10.4	0.6	5.4	9.4	9.4	2.1	1.6	2.1	2.3	0.2	9.4	5.7	0.4	2.5	0.8	8.0	0.4	1.8	3.5	0.6	9.0	7.9	0.8	25.7	10.0	1.6	2.0	0.0	5.9	1.1	1.4	10.4	0.0	0.8	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.6	2.8	0.1	0.0	0.0	3.3	0.0	3.5	6.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.7	0.9	0.0	1.7	0.0	2.3	0.0	0.0	44.6	2.6	0.0	0.0	0.8	0.3	2.3	0.4	0.0	1.8	10.1	10.2	11.3	16.5	10.1	10.4	9.4	9.4	9.4	9.0	10.0	10.4	0.2	0.0	0.0	9.4	2.8	0.6	0.3	0.0	0.0	0.9	0.1	0.8	3.2	5.7	0.1	0.0	0.0	0.0	0.1	0.3	9.8	1.1	3.9	1.1	0.2	0.2	0.0	0.8	4.7	0.2	0.0	0.2	0.0	0.1	0.0	12.5	0.0	2.9	0.2	0.0	3.5	0.1	0.0	0.9	3.4	7.9	1.2	0.7	0.0	1.0	1.4	0.5	1.0	6.6	3.4	0.3	0.1	0.0	0.1	0.1	0.7	4.5	0.3	0.8	0.0	0.3	0.4	5.3	1.6	0.0	0.0	0.0	0.3	1.0	0.4	0.1
CRIPT	HSPC139	ENSG00000119878	"CXXC repeat containing interactor of PDZ3 domain"	Q9P021	2	46616416-46630176	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046080, HPA056765"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA046080: AB_2679529, HPA056765: AB_2683230"	"unprognostic (3.38e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.42e-2)"	7.0	7.7	4.7	2.2	4.6	6.0	6.6	7.6	6.0	5.9	5.3	7.2	3.0	5.9	5.5	6.3	5.5	1.8	11.9	4.8	4.1	7.2	6.1	4.3	3.3	5.5	4.3	7.2	5.4	2.7	6.0	2.1	5.0	5.6	2.8	10.7	7.0	1.9	12.3	6.1	5.6	2.2	3.6	4.7	6.3	5.8	4.6	2.4	4.7	2.8	3.1	6.3	6.3	7.8	3.8	2.5	2.3	2.4	2.7	2.9	3.4	2.7	1.8	1.7	1.7	2.9	2.7	2.9	5.7	2.9	2.4	2.6	2.3	2.4	3.3	4.4	2.6	3.6	3.4	3.8	3.1	2.8	2.2	3.3	2.9	2.4	1.7	3.2	2.7	1.6	3.7	3.4	2.1	2.4	1.9	3.5	3.0	3.6	2.5	1.7	4.6	4.4	3.2	2.7	4.2	6.7	3.1	2.4	3.2	2.3	2.0	2.1	3.5	2.7	2.6	2.7	3.0	3.7	3.1	2.8	4.1	3.1	2.3	6.3	2.6	3.8	2.9	2.3	2.6	3.6	3.0	2.6	2.1	3.5	3.0	2.9	5.8	3.0	2.4	3.2	3.6	1.9	4.7	4.6	7.6	6.0	4.8	4.1	5.5	4.3	5.0	3.6	4.6	7.8	28.6	19.2	13.7	19.2	34.5	43.1	65.5	71.3	28.5	28.9	56.5	54.4	60.4	45.8	51.8	31.3	25.0	56.7	48.4	38.5	68.4	64.5	41.8	46.4	33.7	29.5	65.1	91.8	22.5	39.8	81.4	35.1	20.4	37.7	28.5	28.3	38.6	57.5	48.1	16.8	25.7	39.9	42.7	38.9	30.2	15.9	36.4	29.3	30.2	20.6	48.7	40.4	51.5	44.2	31.2	67.6	58.4	25.6	46.2	58.6	81.0	102.6	48.7	51.2	19.7	26.0	48.0	56.0	49.6	39.1	53.0	95.6	35.8	26.2	32.6	74.9
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"epididymis: 1573.9"	"Group enriched"	"Detected in some"	29	"Early spermatids: 45.5;Late spermatids: 71.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"	NA	NA		35000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA028445: AB_10670428, HPA030534: AB_2732459"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1573.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	71.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"testis: 505.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 5765.5;Late spermatids: 21517.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"	NA	NA		820000		"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.1	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	1.9	0.7	0.0	0.1	0.2	0.9	3.6	17.6	7.7	0.1	0.0	0.2	0.8	0.2	1.2	0.0	0.1	0.1	0.1	0.6	0.0	2.0	0.0	0.0	1.2	0.0	0.1	15.6	2.5	0.2	0.5	0.3	0.0	0.0	0.5	0.1	505.0	0.1	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5765.5	17.8	0.5	6.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21517.6	133.9	6.1	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	83.8	0.0	2.8	0.2	0.1	24.1	0.0	65.7	0.0	0.0	409.8	65.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727376-49744437	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 1203.8;salivary gland: 2310.0"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"neutrophil: 2.5;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	19	"granulocytes: 2.5;monocytes: 1.2"	"Group enriched"	"Detected in some"	20	"HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		420000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.3	0.6	0.0	0.0	0.0	381.8	3.9	0.0	0.0	61.0	0.0	0.1	0.4	1.7	0.1	266.8	1203.8	23.1	0.8	0.0	0.0	0.1	0.9	1.3	0.0	0.0	0.0	0.5	5.5	0.0	0.5	0.6	0.0	2.9	0.0	0.0	2310.0	111.9	0.3	3.9	0.2	0.0	0.0	2.5	0.3	0.2	0.0	0.3	0.2	0.0	4.0	4.7	140.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	9.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	2.1	5.6	0.0	21.5	13.1	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	182.2	47.2	0.8	0.0	0.4	0.0	3.7	0.0	0.2	0.0	551.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	26.8
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984505-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 29.4"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA		8200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	2.7	1.3	3.9	2.5	4.0	1.5	29.4	3.4	3.1	6.3	3.4	2.7	0.7	8.6	4.9	5.0	7.4	10.0	8.8	4.3	8.0	2.1	2.1	2.3	2.8	5.8	10.4	5.7	2.4	19.3	1.2	7.8	8.3	24.6	1.6	3.1	19.3	2.6	0.5	2.3	1.2	7.0	6.3	2.0	0.9	3.8	4.1	9.4	15.1	1.2	1.1	2.5	1.1	10.7	0.0	1.7	134.4	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.9	0.8	0.0	0.0	19.0	0.0	2.2	0.1	11.3	0.1	0.0	0.1	5.2	0.2	5.1	0.0	3.0	0.0	1.0	7.2	0.3	0.1	1.0	16.6	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.2	13.9	0.0	5.0	0.0	18.5	0.2	0.0	0.0	0.8	72.0	0.0	0.1	8.0	27.5	10.4	6.4	0.0	3.8	19.6	0.2	0.5	2.4	0.9	0.0	4.6	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.9	4.0	3.4	3.1	4.3	8.0	5.8	10.4	8.3	6.3	4.1	10.7	1.0	3.2	0.0	12.7	0.0	0.8	6.1	1.4	17.6	1.6	10.3	36.1	0.4	0.0	5.4	1.8	0.0	22.7	0.3	0.0	0.0	0.0	15.3	62.2	4.9	3.2	0.0	3.0	15.7	0.0	3.8	9.2	0.0	22.4	3.8	1.8	23.6	0.1	2.0	0.0	11.1	0.0	0.0	0.9	0.0	1.5	4.1	0.4	7.2	1.9	0.0	8.8	0.0	81.4	0.9	0.0	0.0	1.5	0.0	9.4	0.0	0.2	22.5	0.9	0.0	0.4	1.5	1.3	6.0	2.5	1.0	12.0	0.4	6.3	0.0	2.3
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819985-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 87.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 87.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 15.6"	"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	113.4	29.0	3.3	46.6	4.9	8.1	64.2	3.9	4.6	112.9	2.6	88.9	10.8	115.7	20.3	39.9	129.0	104.0	36.6	3.7	5.2	40.9	17.1	92.7	7.3	5.9	5.5	80.7	23.5	2.5	19.3	122.7	5.9	98.9	18.1	2.4	18.1	27.7	15.0	36.7	58.5	95.0	4.4	24.9	65.9	21.5	4.3	8.2	47.9	12.2	3.7	119.9	69.8	5.7	0.9	2.2	0.6	6.0	43.7	16.2	69.2	34.5	30.4	27.2	19.1	4.7	2.9	0.1	3.0	30.5	8.0	1.0	0.1	0.1	27.3	0.0	0.2	0.5	0.9	0.1	161.4	0.0	0.3	68.0	0.1	8.0	0.1	9.0	0.2	0.0	0.3	0.3	3.1	1.4	0.3	1.7	2.0	4.6	2.0	0.1	0.3	0.4	0.2	5.5	6.7	0.5	8.1	3.5	0.7	9.4	13.7	0.9	3.8	0.4	1.8	28.3	1.0	0.4	0.1	5.8	0.2	0.5	4.1	14.8	20.2	0.7	0.0	1.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.0	87.2	0.0	0.0	0.1	0.0	4.2	3.3	4.9	3.9	4.6	3.7	5.2	5.9	5.5	5.9	4.4	4.3	5.7	5.9	3.2	2.3	0.7	0.7	46.1	8.6	0.6	9.6	0.5	3.9	7.6	8.6	2.8	1.6	0.0	0.0	7.4	0.8	1.8	0.0	1.4	12.6	7.0	137.3	21.7	3.0	0.0	2.2	0.5	42.4	185.5	27.0	6.3	7.0	11.5	38.6	0.8	4.7	1.7	1.5	4.1	0.0	36.6	39.6	19.6	271.5	14.8	48.0	9.4	41.5	5.1	3.1	54.3	0.6	0.9	0.3	265.9	0.9	17.1	0.2	0.1	0.9	0.7	92.1	146.2	341.2	1.0	1.9	3.7	42.8	9.0	5.4	5.7	2.2	6.5
CRK		ENSG00000167193	"CRK proto-oncogene, adaptor protein"	P46108	17	1420689-1463162	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010485, HPA068087"	Approved		Approved	"Plasma membrane"		NA	NA		400000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010485: AB_2085043, HPA068087: AB_2685950"	"unprognostic (6.82e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.70e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.93e-2)"	48.2	23.2	27.9	20.8	28.3	5.7	30.6	28.1	27.8	26.4	25.2	34.1	26.8	28.2	32.1	26.9	21.0	29.7	27.7	28.2	28.5	31.5	50.1	30.2	17.3	29.6	29.7	24.8	27.3	25.3	11.2	42.2	29.4	23.9	34.4	22.6	23.8	27.0	32.0	20.4	24.2	35.6	30.1	20.4	26.1	20.5	31.2	17.6	36.7	37.9	20.1	31.6	21.8	29.3	45.9	69.8	50.8	54.6	83.7	70.2	47.5	77.3	64.8	59.7	55.3	90.7	26.3	22.0	37.6	89.1	41.7	69.1	68.2	55.8	87.2	11.1	46.6	24.5	43.7	50.2	77.9	10.6	20.9	68.3	64.7	61.9	77.1	45.8	74.3	20.2	42.1	20.3	84.4	46.3	11.5	12.1	46.3	50.4	34.6	24.3	25.7	20.1	78.4	48.4	18.8	49.2	73.5	45.2	54.6	47.7	44.5	17.7	79.8	59.7	33.9	63.8	77.3	9.6	15.8	13.5	50.4	20.6	66.6	6.2	3.9	5.3	3.0	4.2	3.0	3.6	3.2	2.7	4.4	5.2	2.4	3.5	13.9	2.7	4.4	3.9	2.6	1.7	27.9	28.3	28.1	27.8	28.2	28.5	29.6	29.7	29.4	30.1	31.2	29.3	89.5	67.3	51.5	12.7	34.6	149.5	68.8	29.6	50.7	43.8	62.7	45.5	35.2	48.6	33.8	33.1	27.1	63.3	22.1	92.6	41.1	62.1	4.3	55.2	64.5	89.7	49.8	39.5	17.5	65.3	61.6	52.7	47.4	94.1	7.6	33.0	92.8	65.6	45.3	53.8	17.6	61.9	22.4	47.1	91.6	8.3	43.8	46.3	53.4	19.7	45.3	43.5	24.7	12.5	13.6	76.7	60.5	44.0	25.7	77.9	58.3	39.7	32.6	38.9	46.0	59.6	72.9	29.0	58.6	62.8	167.8	85.0	29.9	35.4	66.4	92.2
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917407-20953747	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 344.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.7	14.8	34.5	18.4	34.9	53.7	16.3	34.6	35.7	17.5	26.0	18.4	22.0	19.4	13.0	26.6	20.4	14.3	25.1	33.7	33.5	17.1	27.3	20.7	25.5	36.8	37.0	27.4	23.5	19.1	16.1	25.9	34.0	16.5	19.6	22.4	14.8	19.0	54.3	24.9	19.7	19.5	38.8	22.4	14.7	13.3	38.9	33.3	14.8	43.0	27.6	18.9	18.4	36.0	43.9	25.8	56.7	44.8	37.5	23.9	61.0	29.0	35.5	43.7	49.1	42.8	19.2	56.1	22.9	30.8	30.0	54.8	67.2	46.3	51.7	47.7	65.5	77.7	28.6	47.3	37.4	83.5	38.0	24.3	60.3	38.1	64.6	35.7	39.1	44.3	344.9	44.8	35.7	41.2	49.0	39.0	44.8	45.5	27.7	62.7	89.9	13.5	29.2	37.8	36.5	46.9	48.6	42.4	36.4	67.7	36.4	45.9	31.9	69.0	77.8	26.2	37.2	42.7	44.4	64.1	51.1	34.8	43.3	16.2	15.0	22.1	18.5	13.9	19.3	12.1	16.2	18.4	16.5	11.4	19.7	18.9	15.9	12.9	26.1	8.3	14.4	21.2	34.5	34.9	34.6	35.7	33.7	33.5	36.8	37.0	34.0	38.8	38.9	36.0	11.8	9.6	17.8	17.3	18.6	54.2	13.5	15.2	29.6	17.8	19.7	14.2	23.1	7.2	12.2	5.5	14.6	19.6	26.4	19.6	1.9	7.7	30.4	19.3	15.3	15.0	20.4	28.6	23.9	8.6	42.4	16.5	10.2	18.4	1.3	15.8	20.7	25.0	17.5	18.5	18.6	19.9	8.2	19.5	20.8	52.5	15.2	15.2	24.9	9.4	19.0	17.5	21.6	16.6	25.0	11.2	11.8	15.4	14.1	19.0	18.5	10.7	14.8	13.2	13.1	15.7	12.1	12.7	11.0	40.2	60.4	27.2	17.8	12.7	18.5	18.6
CRLF1	"CISS, CISS1, CLF, CLF-1"	ENSG00000006016	"Cytokine receptor like factor 1"	O75462	19	18572220-18607741	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 88.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Basal keratinocytes: 9.7;Fibroblasts: 16.0;Respiratory ciliated cells: 11.9;Skeletal myocytes: 19.9;Smooth muscle cells: 10.5"	"Group enriched"	"Detected in all"	4	"lung cancer: 27.4;thyroid cancer: 36.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"ASC diff: 1048.7;Hep G2: 458.8"	"Region enriched"	"Detected in many"	7	"hippocampal formation: 21.1"	"Group enriched"	"Detected in some"	6	"cerebellum: 2.3;spinal cord: 8.6"	"HPA041493, HPA041793"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041493: AB_10795637, HPA041793: AB_10804117"	"unprognostic (1.97e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.95e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.27e-3)"	40.1	14.5	18.7	0.9	24.6	0.0	18.7	22.4	51.7	25.7	11.2	8.9	0.5	12.8	0.9	17.4	11.3	1.4	88.5	22.0	13.5	7.7	1.5	16.0	0.4	24.3	28.0	4.5	8.9	0.5	8.9	11.3	17.8	8.9	0.4	0.1	14.9	6.2	21.4	27.3	5.0	1.5	18.7	2.4	7.5	1.3	13.4	0.3	50.3	0.9	0.2	9.3	15.5	25.5	0.0	0.0	0.0	10.7	1048.7	15.3	5.2	5.4	0.0	0.0	0.0	0.1	0.0	0.0	66.5	33.2	1.9	0.4	10.8	0.2	0.0	0.0	1.4	0.0	18.1	458.8	7.5	0.1	0.5	12.0	1.0	0.2	0.3	1.6	0.3	0.0	0.1	0.2	0.3	16.6	0.0	0.0	1.2	0.1	0.3	0.0	9.1	0.1	0.0	0.5	0.0	0.1	14.2	0.0	0.0	2.0	13.0	0.6	1.3	0.1	11.1	0.8	0.4	0.1	0.0	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	24.6	22.4	51.7	22.0	13.5	24.3	28.0	17.8	18.7	13.4	25.5	0.4	0.0	0.0	15.3	0.3	9.7	0.6	6.8	0.0	0.2	0.7	4.2	2.5	0.0	2.6	0.0	0.0	0.1	0.3	0.1	5.9	0.3	6.9	2.6	1.9	0.5	0.0	0.0	7.8	0.2	1.3	16.0	0.5	0.5	0.0	0.2	0.4	0.1	0.3	0.0	1.0	0.0	2.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	0.1	0.9	1.0	0.5	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.3	11.9	1.3	0.0	19.9	10.5	0.2	2.2	0.6	4.5	0.3	0.6	0.2	0.1	0.3
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	7.5	4.9	3.5	21.5	3.2	20.6	7.0	10.5	4.4	7.6	0.2	7.8	6.1	5.3	2.8	12.8	4.9	7.5	4.3	4.5	2.7	4.2	5.4	9.1	35.5	1.8	1.9	4.3	4.4	7.9	4.7	12.6	2.4	4.7	7.9	9.5	5.9	3.8	3.8	11.1	9.7	6.5	1.3	23.4	6.6	10.3	3.7	33.4	4.3	4.4	32.7	11.0	8.0	3.0	11.3	12.2	7.5	15.6	13.4	10.3	11.1	10.4	10.1	19.8	20.6	13.5	7.4	36.8	15.2	13.0	19.3	19.2	12.8	8.6	23.6	17.6	23.3	15.7	9.9	10.3	7.4	21.0	11.2	6.1	11.8	16.0	13.4	7.4	19.4	32.9	40.1	37.6	12.6	6.8	46.6	21.8	14.9	18.7	7.4	20.0	24.2	22.2	13.1	9.4	5.3	12.5	10.6	16.1	11.6	15.6	12.5	10.3	10.4	11.4	13.9	18.5	25.8	15.7	14.2	24.9	10.9	16.6	12.9	53.7	57.9	139.9	37.0	59.5	39.3	46.7	52.2	42.4	43.0	46.8	99.9	75.6	117.3	40.3	72.1	22.0	63.7	84.5	3.5	3.2	10.5	4.4	4.5	2.7	1.8	1.9	2.4	1.3	3.7	3.0	10.4	0.0	12.5	17.6	50.9	22.6	8.0	5.4	16.5	17.9	7.0	4.3	4.5	2.8	4.6	7.3	14.6	18.7	36.2	9.2	5.9	5.1	13.5	6.1	8.4	10.6	3.6	46.9	54.8	5.3	17.6	7.7	13.3	9.1	22.8	5.5	8.9	4.2	16.8	6.7	56.5	3.9	8.2	26.1	25.0	21.3	6.5	26.7	5.4	42.2	39.9	4.7	47.4	38.7	38.0	9.1	3.4	4.1	25.7	8.4	2.6	5.3	8.9	25.2	13.1	9.2	7.5	27.5	27.3	11.4	27.8	45.8	47.1	5.3	4.2	7.8
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.7;pituitary gland: 67.3;retina: 57.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.9;Excitatory neurons: 40.8;Horizontal cells: 210.3;Inhibitory neurons: 44.5;Muller glia cells: 78.4"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.0;HAP1: 117.2;NTERA-2: 84.3;REH: 229.4;RH-30: 129.6;SCLC-21H: 167.2;SH-SY5Y: 105.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	9.8	53.0	2.7	55.9	0.1	0.9	45.0	58.0	9.6	10.7	4.4	1.3	21.9	0.1	2.7	4.9	5.1	2.8	59.7	57.9	2.1	0.3	5.7	1.9	31.0	35.2	7.9	5.7	0.7	67.3	5.4	41.0	3.2	1.6	57.6	2.7	3.1	0.5	3.7	2.9	14.5	30.8	1.1	3.7	3.0	47.1	1.2	2.4	1.1	1.0	2.6	2.9	38.2	1.3	2.7	81.0	2.8	0.1	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	27.2	1.9	117.2	0.0	0.0	2.2	0.9	0.0	4.0	0.6	1.4	0.1	0.7	1.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.3	1.3	0.0	0.4	0.0	84.3	0.0	2.6	229.4	129.6	20.2	0.0	0.2	167.2	105.8	0.0	0.6	1.4	54.2	0.8	0.1	6.8	3.8	27.3	2.3	2.6	14.8	2.2	0.1	9.8	0.9	69.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	55.9	45.0	58.0	59.7	57.9	31.0	35.2	41.0	30.8	47.1	38.2	1.0	0.0	1.1	23.8	0.0	0.4	0.0	1.5	0.0	148.9	0.0	0.0	1.5	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.1	2.2	0.4	13.6	6.3	2.4	1.3	40.8	0.0	0.2	3.5	3.1	0.5	0.0	2.4	0.0	0.0	0.5	210.3	44.5	0.0	0.0	0.0	0.0	5.5	0.6	0.2	1.8	6.5	0.0	78.4	0.0	33.2	2.9	0.4	0.0	0.4	0.0	0.4	0.0	0.0	0.0	22.8	6.6	0.4	6.2	1.0	12.4	1.1	0.1	0.3	0.2	1.5	0.0	0.1
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5346.2;vagina: 1691.7"	"Cell type enriched"	"Detected in some"	24	"Squamous epithelial cells: 79.9"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					NA	NA		100000		"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								1.0	0.9	0.1	0.0	0.1	0.0	0.7	0.0	0.2	865.3	0.0	0.6	0.0	0.8	0.0	5346.2	0.7	1.1	1.8	0.1	0.1	0.6	1.4	0.4	0.0	0.1	0.1	1.2	3.0	0.0	3.5	0.0	0.1	0.8	0.0	0.0	906.9	0.0	1.4	8.2	1.2	0.1	0.1	0.9	5.0	0.8	0.1	0.0	0.6	0.0	249.8	1.2	1691.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.9	0.0	0.0	0.0	0.0	0.0	0.0
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972964	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	7.6	7.6	5.2	2.3	5.5	1.6	8.0	10.1	7.2	13.5	29.0	10.2	1.7	10.4	0.7	10.0	22.7	1.4	6.2	5.8	6.2	8.3	3.3	8.4	2.4	9.5	11.5	13.3	10.7	1.7	10.2	1.3	6.1	10.4	0.4	11.3	7.6	1.8	6.2	14.3	7.9	1.1	6.2	10.2	8.9	5.3	6.6	2.8	8.1	1.2	0.7	9.2	11.4	6.9	4.1	1.7	3.1	3.1	2.1	1.9	1.2	2.9	0.9	0.9	1.0	0.2	1.8	10.9	2.7	1.3	0.3	4.9	0.7	2.2	0.1	0.9	5.6	5.0	6.1	0.8	3.7	0.3	4.9	1.7	5.0	0.9	0.8	1.7	1.5	7.7	0.7	2.7	0.3	3.5	3.4	1.2	11.1	0.9	2.6	3.1	4.1	3.8	0.7	1.1	9.4	10.2	3.1	2.0	9.7	0.9	4.1	1.4	4.3	2.6	3.4	6.8	2.3	4.7	3.7	2.2	2.6	0.7	3.3	0.0	0.0	0.3	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.1	5.2	5.5	10.1	7.2	5.8	6.2	9.5	11.5	6.1	6.2	6.6	6.9	9.0	0.0	4.6	14.0	5.4	6.2	4.1	4.4	17.1	26.3	7.9	7.7	5.8	5.7	4.1	5.5	27.1	1.3	8.2	2.3	0.0	4.7	5.5	35.2	6.3	7.1	3.6	2.5	27.9	2.3	6.5	11.3	6.1	5.9	1.3	28.2	6.4	1.8	2.4	3.3	24.0	4.3	4.1	1.6	5.3	2.6	19.3	3.4	5.4	11.2	3.1	11.7	12.3	13.0	19.9	2.4	1.9	12.8	2.1	2.0	0.8	1.5	34.0	109.7	0.0	12.8	9.4	1.2	12.8	13.1	5.1	1.1	8.0	3.5	2.7	2.2
CROCC2		ENSG00000226321	"Ciliary rootlet coiled-coil, rootletin family member 2"	H7BZ55	2	240906330-240993311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	5	"brain: 6.7;choroid plexus: 23.6;fallopian tube: 7.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 9.7;Endometrial ciliated cells: 43.6;Respiratory ciliated cells: 13.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 6.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;RPMI-8226: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048678	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA048678: AB_2680491"	"unprognostic (4.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.68e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.75e-4)"	"unprognostic (2.84e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.90e-3)"	"unprognostic (7.19e-2)"	0.0	0.0	0.6	0.1	0.4	0.0	0.0	0.2	0.1	1.2	23.6	0.0	0.2	0.1	0.0	0.0	7.0	0.0	0.0	1.9	0.8	0.1	0.2	1.5	0.6	3.0	6.7	0.1	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	2.3	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.4	0.2	0.1	1.9	0.8	3.0	6.7	2.5	1.6	1.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9388.5"	"Group enriched"	"Detected in some"	16	"Ductal cells: 1087.7;Hepatocytes: 4142.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	3.4	0.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	3.1	0.0	0.5	0.4	111.7	0.7	0.0	0.0	0.7	9388.5	0.5	0.1	0.0	0.0	0.4	118.5	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.6	0.5	0.0	0.0	6.1	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.8	0.0	11.7	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1087.7	1.4	0.0	0.1	6.3	0.0	163.2	0.0	63.2	0.0	0.0	0.0	0.2	0.0	0.0	89.6	4142.7	0.1	0.0	0.0	0.0	0.0	98.8	0.3	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.6;fallopian tube: 38.2;lung: 50.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008175	Enhanced				"Secreted to extracellular matrix"	NA	NA		550000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favorable (1.51e-4)"	4.4	0.8	8.7	1.1	23.7	0.0	2.4	10.9	20.1	6.4	0.9	11.5	0.5	1.3	3.8	8.3	38.2	0.3	10.6	9.1	8.1	4.3	0.4	50.0	0.4	45.1	10.2	0.7	1.3	0.8	5.3	0.0	45.6	2.3	0.4	11.3	3.4	33.6	1.1	4.1	2.3	0.8	12.6	0.1	1.8	3.9	18.5	0.2	4.7	1.5	0.3	30.2	4.9	15.5	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	3.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.7	1.1	0.5	0.0	7.7	0.3	0.0	0.0	9.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	23.7	10.9	20.1	9.1	8.1	45.1	10.2	45.6	12.6	18.5	15.5	1.9	22.4	119.5	2.9	0.0	1.5	2.7	1.3	5.7	10.1	2.6	2.8	7.1	1.5	36.4	9.2	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.5	0.1	8.8	1.8	0.0	22.9	0.7	0.0	2.3	0.0	0.6	5.1	0.0	5.7	0.1	0.0	0.0	63.6	0.0	0.0	0.6	0.9	0.6	0.0	0.2	8.8	2.8	0.0	14.1	0.0	54.8	6.2	0.6	0.0	0.4	1.2	1.3	0.0	0.0	0.9	5.3	0.0	3.5	0.3	1.5	1.9	13.1	0.4	0.0	0.4	0.0	0.0	1.7
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33114014-33147773	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 377.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 306.9;monocytes: 377.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 795.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	157.2	106.5	65.2	38.7	69.2	43.2	123.9	51.9	54.8	211.2	52.9	145.1	35.0	170.1	57.1	58.7	138.3	80.5	83.9	49.6	64.9	67.9	44.6	92.3	37.3	65.2	62.4	131.4	36.0	45.7	22.8	69.9	63.9	90.7	51.6	19.3	54.0	106.5	54.4	84.1	65.6	115.0	67.5	48.2	78.9	25.0	65.3	23.7	77.2	68.9	38.1	142.7	135.8	69.5	64.1	123.3	37.8	119.2	795.0	516.6	219.0	136.1	294.0	160.6	151.9	42.1	35.1	44.4	147.6	259.3	129.9	80.2	68.0	103.9	115.5	110.1	106.0	69.2	87.6	43.7	237.4	45.4	54.8	415.3	208.5	145.0	183.2	311.7	172.0	27.0	60.3	82.1	164.6	54.7	16.5	46.3	45.5	67.5	165.7	59.4	111.0	86.1	127.8	42.0	7.9	61.0	92.0	79.8	201.1	87.3	85.9	109.3	113.0	209.1	89.1	115.4	145.9	59.0	214.3	6.7	164.3	89.7	117.1	13.4	377.6	28.5	35.8	147.7	52.5	39.9	51.4	40.2	306.9	39.2	29.2	27.8	30.5	42.1	46.0	82.5	74.0	200.5	65.2	69.2	51.9	54.8	49.6	64.9	65.2	62.4	63.9	67.5	65.3	69.5	74.0	9.6	42.8	15.3	29.0	60.4	41.1	39.5	150.8	17.9	32.7	43.7	34.7	25.8	22.0	38.6	8.4	49.0	37.1	14.8	11.7	25.0	1.2	17.4	135.7	72.7	6.0	46.0	10.0	32.0	81.6	142.3	29.0	31.2	48.1	58.4	122.4	53.2	107.0	35.3	14.5	26.0	10.2	181.1	91.1	6.3	142.9	108.6	80.0	10.3	134.1	15.9	22.6	17.1	11.6	18.4	16.3	144.8	58.1	24.5	24.4	52.7	6.8	10.1	111.7	78.4	120.9	1.6	15.9	95.1	46.7	28.0	26.5	89.9	36.1	30.0
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683678-18782333	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	203	"amygdala: 14.2;basal ganglia: 11.4;cerebellum: 27.1;cerebral cortex: 24.3;hippocampal formation: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.8	11.3	14.2	5.2	11.4	2.1	8.2	27.1	24.3	11.3	0.0	8.9	4.0	9.3	3.4	5.2	10.3	3.2	10.5	24.5	0.0	12.8	10.4	7.9	4.1	0.0	0.0	9.4	9.8	4.7	23.7	3.9	0.0	11.6	1.5	4.4	7.3	5.1	14.4	7.4	8.5	2.5	0.0	9.6	9.9	11.3	0.0	3.6	14.4	3.6	2.2	9.7	7.4	0.0	5.2	7.9	6.7	10.7	6.3	4.5	18.6	5.4	3.6	5.3	4.8	5.1	6.6	7.1	11.6	5.2	3.9	5.5	2.1	3.5	1.3	3.1	15.1	6.0	7.8	9.3	5.5	8.3	16.3	7.8	2.9	4.4	1.3	6.8	3.1	7.2	4.8	6.3	3.0	15.2	5.7	10.0	8.8	2.7	13.1	8.7	2.9	8.1	3.2	8.0	12.1	10.7	6.0	5.8	7.0	2.2	6.6	5.2	5.4	6.0	9.1	10.8	6.4	4.4	3.6	4.6	6.9	8.6	4.6	0.3	0.6	0.4	0.4	0.2	0.3	0.5	0.5	0.6	0.7	0.7	0.5	0.3	0.2	0.3	0.4	0.8	0.4	0.4	14.2	11.4	27.1	24.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	5.3	31.0	6.9	2.7	8.9	7.8	5.7	29.1	5.8	6.1	17.7	10.0	3.5	18.4	27.1	9.7	7.9	6.8	11.7	4.6	1.1	9.6	14.0	5.6	19.2	3.6	37.4	6.0	2.7	7.5	8.6	9.8	2.5	14.7	3.9	4.7	8.8	43.7	26.7	7.1	12.2	6.0	4.0	3.2	9.3	6.3	3.6	10.3	5.5	9.1	8.2	12.1	20.2	3.5	9.6	4.9	2.0	3.0	6.1	5.0	4.8	14.7	0.0	14.2	6.6	2.9	8.8	2.4	2.0	10.4	5.1	8.3	5.2	3.6
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958615	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	32.9	28.6	26.1	20.5	28.1	27.9	29.6	26.6	30.2	33.7	24.3	28.5	11.1	27.2	15.7	25.7	29.2	13.7	26.0	25.2	26.6	31.1	35.1	38.8	28.8	29.2	28.0	40.5	26.3	21.0	24.9	15.8	26.9	29.0	12.6	10.0	27.0	16.7	36.6	34.8	34.7	17.2	25.5	55.9	27.9	21.4	28.2	23.6	32.3	18.5	25.3	28.5	29.2	28.7	24.2	17.9	17.1	19.6	27.2	19.8	25.2	12.8	27.2	24.9	20.3	18.5	24.0	22.8	20.4	23.2	16.8	27.0	20.5	26.8	13.9	29.5	25.7	11.2	18.8	14.4	27.4	19.0	18.7	26.1	25.5	27.6	22.3	19.7	23.3	12.8	19.2	27.1	18.0	38.4	20.6	29.9	12.8	26.1	19.5	15.5	11.7	19.6	26.3	19.4	14.2	23.2	21.5	43.3	32.7	16.5	20.9	37.3	17.7	20.0	17.9	21.7	22.9	43.6	30.7	15.7	18.4	15.9	15.1	3.2	2.2	5.0	2.3	3.5	2.0	2.5	2.5	2.6	1.9	3.2	1.6	2.0	5.7	2.9	2.7	2.6	1.9	1.0	26.1	28.1	26.6	30.2	25.2	26.6	29.2	28.0	26.9	25.5	28.2	28.7	17.8	6.4	10.0	10.4	22.3	24.6	6.9	11.1	13.6	6.3	14.6	12.8	6.0	11.5	8.7	12.9	4.2	9.7	23.0	15.9	1.9	9.0	1.4	13.4	15.0	13.7	16.1	9.7	7.4	10.2	9.4	11.1	14.3	27.7	8.2	6.1	12.5	12.8	10.9	1.7	6.9	13.8	6.1	14.6	23.6	1.2	12.2	17.4	3.6	6.5	11.8	4.8	19.6	6.0	11.1	15.0	5.0	15.1	20.6	12.6	9.8	4.0	7.3	6.9	6.6	9.3	12.1	17.0	12.0	12.7	22.6	12.2	19.6	6.1	7.9	13.0
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529923-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	27.0	15.5	16.8	14.2	25.3	10.7	21.7	20.0	19.8	26.3	10.1	28.4	7.3	26.0	10.9	12.5	23.8	14.8	19.8	17.0	16.4	14.5	13.2	23.2	15.8	21.8	23.1	36.8	10.7	13.8	9.9	17.1	21.1	18.8	9.4	13.5	17.4	17.0	19.9	19.1	16.6	20.9	16.3	13.3	15.2	16.8	23.2	15.0	22.3	17.4	15.7	28.4	18.3	31.6	9.6	15.1	9.7	16.7	21.6	15.7	46.0	11.7	16.0	17.6	15.9	12.4	9.3	0.2	8.3	23.8	14.9	15.2	15.1	9.8	13.2	16.3	18.8	23.7	83.9	6.1	24.8	6.5	38.8	17.2	16.3	14.5	19.3	13.2	12.5	10.2	12.8	5.5	13.6	11.5	2.6	9.7	3.7	2.7	7.2	8.3	16.3	0.5	6.6	20.3	18.5	16.5	34.7	11.6	19.3	10.8	11.2	12.2	16.4	19.7	14.9	19.0	14.0	7.3	10.2	7.2	8.0	12.6	9.8	21.4	2.6	1.5	3.5	0.8	3.8	2.9	4.3	3.7	1.6	5.0	6.1	3.9	0.5	3.3	0.3	2.1	4.4	3.4	16.8	25.3	20.0	19.8	17.0	16.4	21.8	23.1	21.1	16.3	23.2	31.6	17.9	6.4	9.2	44.1	35.6	23.6	27.8	8.0	13.1	24.9	15.7	12.7	17.0	14.3	7.8	12.9	27.1	14.8	30.0	8.6	1.9	14.9	29.3	6.6	18.5	20.4	15.6	17.1	70.1	10.7	43.3	23.2	14.8	12.7	23.5	34.8	24.7	16.2	15.3	57.2	72.4	9.1	6.1	18.2	18.8	24.3	26.8	21.7	17.8	39.4	20.6	17.7	58.7	75.4	160.8	11.1	10.9	43.6	21.3	26.2	6.4	11.0	2.8	59.7	46.0	30.5	45.8	10.2	17.8	11.4	24.0	17.8	36.0	13.7	11.3	38.2
CRX	"CORD2, CRD, LCA7, OTX3"	ENSG00000105392	"Cone-rod homeobox"	O43186	19	47819779-47843330	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Cone-rod dystrophy, Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	136	"retina: 238.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 136.5;Cone photoreceptor cells: 285.7;Rod photoreceptor cells: 501.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036762, HPA036763"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA036762: AB_10673663, HPA036763: AB_10670922"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-2)"		"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.82e-2)"		"unprognostic (1.33e-2)"	"unprognostic (1.95e-10)"	"unprognostic (9.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-3)"	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	238.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.6	0.1	0.1	0.2	0.0	0.1	0.3	0.8	6.4	14.3	0.0	0.6	0.9	2.3	0.1	0.0	136.5	0.3	0.4	0.5	1.5	13.6	0.0	285.7	0.2	1.7	0.1	0.0	0.0	0.7	0.5	0.5	5.5	0.0	0.0	0.4	0.0	0.2	3.9	0.0	0.8	10.1	0.1	1.8	0.5	0.2	32.0	0.3	0.2	0.0	1.0	1.8	0.5	4.7	2.2	0.0	0.0	0.2	59.3	0.0	0.0	0.1	0.0	0.0	0.7	0.3	1.3	0.2	0.0	9.7	501.5	0.0	0.9	0.3	0.2	0.6	0.0	1.1	0.0	1.3	0.1	0.1	1.7
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	13.3	12.4	8.5	7.6	9.8	12.4	11.2	16.2	10.9	11.1	16.7	12.6	11.5	14.2	6.4	11.0	16.4	16.7	11.7	8.4	9.0	13.7	13.6	19.3	5.8	9.8	10.1	9.0	13.5	8.8	8.4	12.1	9.9	11.3	8.6	21.3	9.0	11.5	10.9	9.0	12.7	16.8	9.7	8.7	16.2	37.3	9.9	19.0	17.0	11.0	6.7	15.6	8.6	12.5	17.3	16.9	20.6	23.0	14.6	9.1	36.9	17.9	19.1	36.0	24.2	19.9	10.1	0.0	11.1	16.7	22.7	11.6	26.8	9.3	39.6	17.3	16.6	16.9	15.3	13.8	18.6	17.3	14.2	8.6	9.6	26.4	24.9	17.8	30.5	31.4	19.3	14.6	22.7	12.1	39.2	19.7	25.1	16.5	24.6	34.5	52.3	6.1	25.3	20.2	37.1	19.2	33.6	22.1	10.9	20.0	15.6	9.6	13.5	20.9	22.2	14.6	16.2	26.6	26.6	7.8	10.2	16.3	17.5	12.0	3.2	5.8	12.8	4.7	16.1	1.9	9.6	8.2	4.3	1.9	8.9	8.8	1.4	6.4	8.9	2.8	13.5	5.7	8.5	9.8	16.2	10.9	8.4	9.0	9.8	10.1	9.9	9.7	9.9	12.5	16.3	16.0	16.2	20.5	9.7	69.2	47.9	4.3	55.2	16.8	30.4	14.7	11.1	11.5	6.1	11.0	20.9	8.3	29.1	12.7	17.6	11.4	12.8	27.3	19.3	20.1	19.6	11.2	22.4	16.3	13.4	24.5	45.9	33.2	5.1	6.2	12.1	20.2	6.3	26.9	38.4	9.7	6.1	7.3	21.0	4.8	11.5	8.8	16.0	13.1	16.3	22.8	19.6	35.2	32.8	21.5	7.0	17.3	15.3	29.7	7.7	16.1	18.7	13.7	6.6	24.3	19.2	108.0	32.4	24.3	59.5	15.1	29.7	5.7	6.8	27.0
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 141.9;Horizontal cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favorable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	31.8	22.3	33.3	8.9	35.3	29.4	27.1	36.4	36.9	24.4	22.8	26.5	10.8	23.3	16.9	15.9	29.1	17.4	60.0	36.6	29.3	22.5	62.7	22.9	10.4	27.4	31.5	38.7	34.7	22.4	30.8	13.5	28.5	25.3	9.9	52.8	21.7	22.1	96.7	50.4	16.7	17.1	28.8	14.0	24.6	34.4	35.2	12.6	34.0	64.8	10.3	26.0	18.4	31.4	1.4	4.2	6.3	7.5	16.7	8.4	13.8	5.0	8.9	6.2	4.5	6.8	3.3	9.8	3.8	10.5	5.9	8.5	6.0	5.2	4.3	9.8	5.5	6.4	8.2	9.4	6.4	8.0	8.5	9.9	7.5	4.8	7.6	7.0	4.4	7.5	12.7	16.2	5.6	5.3	6.8	9.4	17.1	17.8	5.0	11.5	9.1	4.6	4.5	7.8	10.1	3.8	8.3	7.5	4.5	8.0	10.0	5.5	5.5	8.7	5.3	13.5	3.6	15.0	10.8	7.9	5.3	3.5	5.3	4.1	3.5	5.4	5.7	4.8	4.7	5.0	5.5	6.1	3.6	4.6	6.6	6.9	1.8	7.5	8.0	2.6	4.9	5.3	33.3	35.3	36.4	36.9	36.6	29.3	27.4	31.5	28.5	28.8	35.2	31.4	11.7	12.8	18.2	48.0	12.6	17.0	9.7	5.1	8.0	141.9	10.6	8.6	34.7	14.3	11.6	7.3	27.1	8.0	10.0	17.2	29.4	5.4	24.2	28.1	7.5	9.2	7.1	3.0	30.3	4.7	5.6	19.8	12.8	15.4	14.7	10.8	8.6	47.3	3.6	101.0	26.0	7.4	6.1	8.5	12.5	8.7	31.4	7.2	16.0	10.3	6.2	34.4	10.3	13.0	13.6	6.0	6.0	39.9	8.5	11.6	10.5	11.6	23.8	27.5	19.7	14.5	14.6	29.1	15.0	4.4	17.5	9.3	9.1	8.4	6.0	9.8
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"	A0A140G945	21	6560714-6564489	"Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	136	"kidney: 125.7;liver: 42.1;retina: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	207	"Hep G2: 37.5"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"		Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	125.7	42.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908564-111923722	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5623.2;heart muscle: 10683.1;skeletal muscle: 6972.0;tongue: 9406.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"ASC diff: 2663.1;fHDF/TERT166: 775.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.70e-5)"	1035.0	106.6	2466.0	113.9	3113.8	0.4	592.2	3032.2	5623.2	439.1	2077.7	678.9	24.6	351.4	179.1	312.2	204.0	71.7	10683.1	2424.9	2666.2	2123.2	37.2	253.4	15.0	3215.2	2856.7	136.0	50.6	24.9	209.2	107.8	3147.1	317.9	78.2	478.7	428.7	358.5	6972.0	317.3	158.5	338.1	2877.3	88.5	263.8	23.5	2815.5	20.9	477.7	9406.7	34.4	490.0	477.5	4060.6	0.1	0.5	0.1	45.0	2663.1	90.9	15.0	54.5	2.5	0.8	2.5	1.7	0.2	0.0	41.7	775.8	0.2	2.0	1.8	2.3	1.4	0.3	0.0	0.0	11.9	3.9	16.9	0.4	0.7	77.1	11.1	0.6	6.2	44.3	0.2	0.0	4.6	2.5	169.5	0.1	0.1	1.1	0.5	0.0	1.0	0.2	0.0	0.6	29.8	0.8	0.1	0.4	5.3	9.1	39.8	63.5	4.9	0.0	1.7	310.1	105.0	6.5	4.1	0.5	0.1	0.6	7.1	0.4	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2466.0	3113.8	3032.2	5623.2	2424.9	2666.2	3215.2	2856.7	3147.1	2877.3	2815.5	4060.6	38.4	83.3	4.1	96.0	51.3	174.9	2889.5	32.1	72.8	16.2	334.4	696.1	6878.2	84.4	15.2	1338.9	18.8	3.9	6.8	0.4	677.0	320.3	24.7	345.4	265.3	88.4	7.1	0.0	6.7	11.5	7.4	880.6	0.0	1008.4	0.0	16.1	35.7	0.7	5.8	10.1	12.6	2.4	8.2	0.3	85.8	12.6	228.6	67.7	483.8	11.2	3.6	1664.3	0.0	7.5	615.7	12.1	0.0	187.7	1.6	855.4	0.0	7285.9	23.2	59.4	138.1	799.9	1053.3	21.6	1.4	56.5	155.1	33.4	55.4	6.7	1.2	249.0
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246859-29254494	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 2.1"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 1.1;Syncytiotrophoblasts: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 3.2;BEWO: 4.1;SuSa: 1.0"	"Group enriched"	"Detected in some"	7	"hippocampal formation: 2.7;hypothalamus: 1.2;thalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA022016	Supported					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	0.1	0.7	0.1	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.4	0.6	0.2	0.3	0.9	0.4	0.9	0.3	0.8	2.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.1	0.0	0.0	0.0
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993422	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;pancreas: 16.6;pituitary gland: 13.7"	"Cell type enriched"	"Detected in some"	34	"Enteroendocrine cells: 860.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Region enhanced"	"Detected in many"		"midbrain: 11.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 69.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.3"	"Low region specificity"	"Detected in some"			HPA062293	Supported					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favorable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.8	0.0	0.3	2.1	2.8	0.0	0.2	0.2	0.0	0.0	0.1	0.5	0.9	0.2	0.0	0.0	0.0	2.0	11.1	0.0	16.6	1.4	13.7	0.0	5.0	0.8	2.2	0.2	0.1	0.0	0.1	0.2	2.7	0.0	0.4	0.0	4.5	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	10.3	2.5	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.2	0.1	0.1	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.7	0.8	0.5	0.9	2.0	11.1	5.0	0.4	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.8	0.0	0.0	0.1	860.9	0.0	0.1	1.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	25.0	0.0	0.0	0.4	10.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	7.5	17.5	0.0	0.0	1.0	3.9	0.0	0.0	0.9	0.0	0.0	0.0	0.6	4.5	0.0	0.3	0.3	0.1	0.0	1.7	0.0
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621963-26630669	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 4.3;hippocampal formation: 4.0"	HPA071178	Supported					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.3	0.1	0.0	0.5	0.1
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618027	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 9.6"	"Cell type enriched"	"Detected in some"	21	"Hofbauer cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 10.3;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 10.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 43.3;RPMI-8226: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003448, CAB010058"	Supported					NA	NA		89000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB010058: AB_668166, HPA003448: AB_2732396"	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	1.3	1.6	1.5	0.9	1.6	0.6	0.6	1.6	2.4	0.6	1.3	0.5	0.4	0.3	9.6	0.4	0.4	1.2	0.4	1.6	1.6	0.2	0.4	0.5	1.2	1.9	1.8	0.2	0.2	0.3	0.5	3.3	2.3	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.4	0.9	1.9	1.6	0.3	0.3	2.2	0.4	0.2	0.2	0.5	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.3	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	0.0	82.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.2	0.5	0.0	0.0	0.7	0.2	1.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	10.3	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.5	7.5	0.0	0.0	0.6	1.5	1.6	1.6	2.4	1.6	1.6	1.9	1.8	2.3	1.9	2.2	2.1	0.1	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.1	1.3	0.0	0.0	0.2	82.6	0.0	0.2	0.0	0.0	3.5	0.8	0.6	0.0	2.8	1.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.2	0.0	0.0
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25212564-25231870	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.6;Breast myoepithelial cells: 12.8;Distal tubular cells: 27.4;Melanocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.1"	"Region enhanced"	"Detected in some"		"hippocampal formation: 1.7"	"Low region specificity"	"Detected in many"			HPA043749	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.2	0.4	2.7	0.0	2.6	0.0	0.3	2.0	4.5	0.3	2.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.2	2.7	2.3	0.5	0.3	0.3	0.0	2.1	2.2	0.1	0.2	0.0	1.4	0.0	2.5	0.6	0.3	0.4	0.3	0.1	0.5	0.4	0.3	0.2	2.0	0.1	0.2	1.7	2.9	0.0	1.0	0.0	0.0	0.2	0.4	2.5	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	2.7	2.6	2.0	4.5	2.7	2.3	2.1	2.2	2.5	2.0	2.9	2.5	0.9	0.0	0.0	2.0	1.0	5.4	0.6	6.7	0.6	0.3	10.6	12.8	1.4	1.5	1.5	1.8	0.0	0.1	0.9	1.7	27.4	0.1	3.0	1.7	1.2	2.9	0.0	8.0	2.4	0.2	0.1	3.4	0.0	2.5	0.0	3.1	4.6	3.2	0.2	0.0	0.4	0.3	0.0	1.2	3.1	9.6	2.5	0.8	12.4	1.9	0.0	0.4	0.0	0.5	0.3	0.5	0.1	8.2	0.0	0.4	0.0	9.7	0.6	0.1	0.0	6.2	2.1	2.6	3.3	0.4	3.8	0.1	1.3	7.6	0.2	0.6
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199858-25207359	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.2	0.5	0.9	0.1	0.6	0.0	0.7	0.0	1.0	0.5	0.0	0.6	0.3	0.3	0.2	0.6	0.4	0.4	0.5	0.9	0.0	2.0	2.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.8	0.4	0.7	1.0	0.4	0.7	0.9	0.7	0.1	0.0	0.1	0.5	0.2	0.5	0.2	1.3	0.1	0.3	0.1	0.4	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	1.4	0.8	0.6	0.0	0.0	1.4	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.7	0.4	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.0	0.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.6	0.3	0.4	1.5	0.1	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.3	10.5	0.4	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.3	0.1
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
CRYGA	"CRY-g-A, CRYG1, CRYG5"	ENSG00000168582	"Crystallin gamma A"	P11844	2	208160740-208163589	"Predicted intracellular proteins"		"Eye lens protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA043386	Supported		Uncertain	Vesicles,Cytosol		NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"HPA043386: "					"unprognostic (1.49e-1)"													0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.7	0.6	0.3	0.2	0.3	0.2	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.1"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0"					HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGC	CRYG3	ENSG00000163254	"Crystallin gamma C"	P07315	2	208128137-208129828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8;ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2"	"Group enriched"	"Detected in some"	14	"cerebral cortex: 1.2;hippocampal formation: 1.5"	HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (1.89e-1)"					"unprognostic (2.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"ovary: 8.0"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 140.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 10.0"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.0	0.0	0.5	0.0	0.4	1.3	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.5	0.7	8.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.6	0.5	0.7	0.6	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	4.6	0.3	0.0	0.1	0.9	0.0	0.0	0.0	140.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	34.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	0.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428832-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"thyroid gland: 15.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Breast myoepithelial cells: 1.1;Endometrial stromal cells: 1.4;Oligodendrocyte precursor cells: 1.0"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;white matter: 11.4"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.8	0.2	0.9	0.1	0.6	0.1	0.5	0.2	0.7	1.7	1.4	0.9	0.1	0.9	0.1	0.1	0.9	0.2	0.1	0.9	0.3	0.4	0.0	0.1	0.6	0.2	0.1	0.7	0.2	1.3	1.2	0.3	0.1	0.7	0.0	0.2	0.2	3.3	0.0	0.0	0.3	0.1	0.1	1.0	0.2	0.1	0.3	0.1	15.4	0.0	0.0	1.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.2	0.7	0.9	0.3	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CRYGS	CRYG8	ENSG00000213139	"Crystallin gamma S"	P22914	3	186538441-186546702	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 5.2;Excitatory neurons: 5.4;Inhibitory neurons: 6.0;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035103, HPA063539"	Supported		Uncertain	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA035103: AB_10696367, HPA063539: "	"unprognostic (5.52e-4)"	"unprognostic (1.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.72e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.67e-1)"	"prognostic favorable (2.73e-4)"	1.1	2.0	6.5	1.0	6.9	2.8	1.6	8.0	10.5	1.8	6.9	1.7	1.1	1.6	1.5	1.2	1.5	0.8	2.1	6.5	7.2	2.3	2.1	1.5	2.2	6.5	6.8	1.2	2.1	0.7	1.4	0.9	7.0	1.5	2.0	8.1	1.2	1.4	1.1	1.1	1.9	1.3	6.3	2.8	1.5	2.1	6.8	4.8	1.2	0.6	1.7	1.7	1.6	7.3	0.3	0.7	1.5	1.1	1.5	1.7	0.0	0.2	0.4	0.5	1.0	0.2	0.6	1.5	1.3	1.2	0.6	1.0	0.8	1.1	1.6	1.0	1.8	1.7	0.2	1.1	0.6	1.1	1.3	1.9	1.2	0.3	0.8	1.7	1.5	1.6	0.4	0.8	1.2	0.4	0.8	0.5	0.0	0.5	0.3	1.7	0.2	0.8	0.5	1.0	0.5	0.6	0.2	0.7	0.3	1.0	0.9	0.9	2.2	0.4	0.3	0.5	1.0	1.7	1.1	1.8	0.7	0.5	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	6.9	8.0	10.5	6.5	7.2	6.5	6.8	7.0	6.3	6.8	7.3	1.2	0.0	1.7	5.2	0.7	0.3	0.3	0.7	0.6	1.1	0.9	1.5	3.0	1.5	0.9	0.0	2.1	0.2	0.6	0.5	0.0	0.6	0.2	0.3	0.6	1.0	0.0	3.2	5.4	0.2	0.2	0.9	2.6	0.5	1.3	0.9	2.5	1.3	0.4	1.7	6.0	0.8	2.0	0.3	1.2	1.3	0.3	1.1	0.0	5.6	0.1	0.5	1.0	6.0	7.6	0.2	0.4	0.7	0.1	0.3	0.8	0.2	0.5	3.2	0.0	0.8	0.8	2.4	0.9	0.4	0.1	0.3	0.8	0.9	1.2	0.2
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 331.0;liver: 282.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	19.8	34.2	19.2	12.9	19.8	2.2	39.0	19.3	36.0	54.6	54.2	21.4	51.2	40.8	120.6	29.0	50.0	68.9	45.6	21.6	23.3	331.0	282.9	32.4	24.4	21.3	24.9	31.6	64.6	52.9	17.0	16.8	24.4	38.8	22.0	15.3	25.0	56.9	25.1	22.2	44.0	40.1	21.1	19.4	25.1	9.2	24.5	33.9	44.5	23.0	23.8	40.8	21.7	24.9	12.1	112.2	57.6	16.3	64.4	70.2	38.6	36.5	57.1	51.8	57.4	88.9	46.1	64.9	62.0	71.3	92.2	31.0	47.2	46.0	83.6	75.2	19.2	27.0	32.2	179.0	33.8	23.1	52.6	33.1	40.0	82.8	15.1	49.1	43.7	35.9	85.9	22.8	109.2	27.0	42.3	38.6	43.1	93.6	72.6	26.8	53.6	23.7	439.4	36.0	15.9	27.9	8.5	60.1	41.2	64.3	54.0	7.7	21.9	12.3	30.7	38.8	55.7	16.2	33.3	32.1	99.4	9.0	35.6	13.1	9.4	1.9	32.1	15.1	26.2	32.8	31.6	30.3	17.1	26.5	27.4	29.5	1.5	30.3	17.9	14.4	42.3	18.8	19.2	19.8	19.3	36.0	21.6	23.3	21.3	24.9	24.4	21.1	24.5	24.9	6.9	28.9	22.6	4.9	20.4	17.8	28.0	32.4	24.5	4.0	16.8	16.8	32.3	84.4	15.7	160.0	2.1	13.5	8.6	6.6	226.9	53.8	0.2	54.8	7.8	8.0	6.7	8.4	4.5	32.4	18.1	20.7	20.9	27.0	14.5	7.8	12.8	200.6	18.5	0.0	4.4	12.0	8.2	15.7	13.7	2.1	20.8	11.4	10.6	4.7	7.1	7.7	11.3	7.1	9.1	31.2	14.5	20.7	20.5	10.2	79.1	526.6	17.3	2.9	0.0	10.6	16.2	1.7	7.4	19.7	21.2	7.3	16.9	13.8	16.2	17.0
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	22.4	18.6	23.7	16.4	26.4	22.4	21.1	31.4	33.5	19.2	23.7	28.2	15.0	22.6	19.0	18.8	20.2	16.3	20.0	24.8	25.9	23.5	18.0	16.2	17.7	24.7	26.0	22.0	15.2	22.3	14.2	21.7	25.1	18.3	20.3	29.2	18.0	22.3	19.2	22.9	15.8	21.2	22.5	15.6	17.6	34.0	25.2	18.1	24.5	15.4	14.0	21.0	18.0	34.2	38.0	16.4	45.7	33.8	24.3	35.0	24.0	26.3	37.8	33.0	29.1	24.5	29.0	26.4	23.0	32.5	25.6	20.5	24.6	27.2	30.0	24.6	24.8	49.9	35.5	22.2	38.4	31.0	29.8	32.7	23.4	34.9	27.2	43.1	42.4	42.6	36.8	26.6	31.3	19.3	30.2	31.8	32.3	38.8	21.9	28.5	36.8	36.6	47.1	33.7	19.8	31.2	34.6	17.5	39.7	37.8	34.3	23.1	44.8	26.3	25.3	22.0	20.5	43.4	64.7	29.1	34.4	22.7	30.1	36.1	34.5	36.2	31.7	37.5	34.3	38.2	33.4	29.9	43.3	40.4	43.3	35.3	18.3	47.1	35.6	34.3	29.9	26.8	23.7	26.4	31.4	33.5	24.8	25.9	24.7	26.0	25.1	22.5	25.2	34.2	25.6	32.1	17.3	40.1	25.9	23.6	43.9	58.9	19.9	47.8	22.1	25.1	28.0	31.5	36.0	31.3	31.3	70.4	21.3	20.2	49.0	37.6	90.4	19.6	14.4	29.9	21.0	25.4	42.4	29.1	40.5	28.1	13.3	14.4	65.2	34.5	27.5	15.0	33.5	47.1	47.2	22.5	46.8	26.0	25.7	28.0	44.1	24.6	37.4	26.2	36.1	49.4	41.2	32.2	56.7	28.6	30.3	41.0	11.3	23.3	33.7	44.8	35.0	51.1	19.7	23.7	41.5	139.4	19.4	15.9	21.5	44.6	28.4	27.3	29.4	40.5
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300391	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 550.1;tongue: 600.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		670000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	154.2	93.6	29.2	61.7	30.0	111.0	66.3	33.7	49.9	55.4	40.5	110.1	97.7	56.4	32.2	95.6	58.3	42.4	319.3	30.9	34.6	86.6	39.0	58.0	67.2	39.4	32.0	56.0	61.5	127.6	28.9	45.7	39.4	59.0	124.1	128.9	73.7	60.5	550.1	70.5	81.2	77.5	22.5	49.0	66.5	24.4	41.0	69.4	53.0	600.7	106.1	70.2	58.2	31.6	168.9	176.8	141.6	198.2	188.4	173.8	93.3	136.9	132.0	231.1	160.6	271.2	158.2	322.9	128.2	172.6	99.3	182.1	396.8	200.8	234.9	109.3	200.2	222.9	136.1	261.4	107.3	288.4	166.6	188.2	201.6	182.4	232.0	202.2	268.6	163.7	233.2	193.7	214.7	160.8	229.8	121.9	117.5	128.0	247.8	222.3	167.1	247.6	166.2	194.6	189.3	125.2	175.2	251.7	157.7	137.5	297.6	174.3	178.3	127.1	165.3	167.4	147.4	124.5	200.4	206.2	120.4	206.4	119.5	59.6	73.3	205.7	47.0	93.0	61.9	60.6	56.5	45.1	119.3	51.8	59.2	47.9	31.3	51.6	94.0	65.6	63.4	71.2	29.2	30.0	33.7	49.9	30.9	34.6	39.4	32.0	39.4	22.5	41.0	31.6	14.5	16.0	39.5	32.3	31.6	39.0	23.5	26.9	46.7	22.8	38.3	29.7	239.9	15.7	21.5	12.9	62.6	18.5	24.1	66.9	35.2	32.5	6.6	25.1	31.5	27.2	16.9	36.0	21.5	45.1	31.3	25.8	42.3	53.5	27.9	21.3	18.9	29.7	34.3	10.1	24.6	43.9	20.3	39.4	35.0	4.8	20.2	34.6	10.6	9.4	44.8	16.7	16.5	18.6	18.8	44.6	35.7	19.9	46.7	33.1	50.4	22.0	14.9	38.3	13.1	27.8	38.2	29.7	25.8	74.8	52.1	16.8	25.8	32.0	71.3	34.5
CSAD	"CSD, PCAP"	ENSG00000139631	"Cysteine sulfinic acid decarboxylase"	Q9Y600	12	53157663-53180925	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in all"		"ASC diff: 84.5;T-47d: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039487	Approved				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA039487: AB_10672776"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (1.57e-1)"	"unprognostic (7.99e-2)"	"prognostic favorable (6.33e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.46e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (4.59e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.81e-6)"	68.0	28.3	24.3	15.9	25.4	39.1	62.4	25.2	25.7	54.9	33.8	34.3	17.3	31.2	52.3	29.3	41.5	19.2	25.2	24.0	24.5	39.2	101.7	30.8	19.1	26.1	23.0	54.0	35.9	14.9	40.9	13.0	24.8	50.3	16.0	16.8	34.7	19.8	19.6	59.6	28.5	19.6	20.2	37.5	31.9	27.7	24.7	14.2	36.0	7.7	14.1	25.8	37.6	36.7	3.7	6.8	16.0	6.8	84.5	34.4	5.7	14.5	3.2	6.0	5.0	4.1	8.8	4.9	10.6	7.7	2.0	12.6	7.1	11.2	3.5	6.6	8.6	7.8	19.4	8.8	7.6	3.3	4.9	42.6	13.8	9.0	11.2	30.8	5.6	10.4	8.4	42.8	5.7	30.8	1.8	9.2	3.1	1.9	6.3	6.6	1.0	11.4	8.0	9.6	8.0	6.3	14.3	19.9	5.7	9.9	52.7	6.5	12.6	17.5	3.4	5.2	4.2	12.2	3.4	2.6	14.7	8.3	7.1	3.7	2.0	2.5	1.3	1.1	0.8	1.1	1.8	0.8	1.0	1.8	2.4	1.4	16.3	1.6	1.3	2.3	3.4	0.5	24.3	25.4	25.2	25.7	24.0	24.5	26.1	23.0	24.8	20.2	24.7	36.7	23.5	3.2	22.0	40.1	15.6	16.6	28.3	18.3	4.0	29.0	27.9	43.4	8.9	20.0	17.4	23.9	16.7	12.2	18.5	19.3	3.9	12.6	0.7	11.6	20.4	22.5	14.4	0.4	47.0	9.1	6.9	23.0	19.4	14.3	9.5	22.0	21.4	38.2	8.4	26.9	51.1	21.3	14.2	11.9	12.8	3.5	27.1	11.1	14.2	30.0	15.6	18.3	20.6	34.2	62.4	10.0	25.5	30.9	6.9	28.8	22.5	5.1	15.4	30.0	39.5	22.5	27.9	48.0	64.4	5.5	18.3	8.9	13.0	17.9	15.4	24.2
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41561010-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 143.8;heart muscle: 288.2;ovary: 133.6"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 12.4;U-2 OS: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	6.8	143.8	29.4	1.6	21.8	0.1	3.2	64.5	32.1	69.9	4.1	16.5	0.8	83.5	1.4	3.2	24.1	2.3	288.2	30.5	35.3	40.4	2.6	11.5	0.2	44.4	41.0	133.6	51.1	0.0	20.5	0.4	36.9	26.2	0.5	5.2	1.0	10.4	2.7	2.1	3.2	10.9	26.1	1.1	4.5	31.3	44.9	0.0	2.5	2.7	0.0	27.4	29.0	22.7	0.0	0.2	1.5	0.2	0.0	0.0	0.1	3.4	0.2	0.1	0.1	0.9	0.0	0.0	0.5	4.7	0.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	12.4	1.5	3.5	0.0	0.0	1.9	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.1	1.1	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.1	41.8	0.3	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	29.4	21.8	64.5	32.1	30.5	35.3	44.4	41.0	36.9	26.1	44.9	22.7	0.1	0.0	0.0	4.6	0.5	0.3	0.2	0.3	0.6	9.9	0.1	0.6	75.0	0.0	0.0	7.3	2.1	0.1	0.0	0.0	19.6	0.3	1.5	0.2	6.0	0.9	0.0	0.0	6.8	10.4	0.1	5.1	0.0	0.1	0.0	30.7	0.4	0.2	0.2	6.7	11.0	0.0	0.0	0.0	0.0	5.1	5.3	0.3	1.8	0.0	0.0	51.7	0.0	1.0	0.6	2.4	0.0	2.6	0.0	0.2	0.0	42.5	0.7	3.2	72.3	0.4	19.9	2.1	0.3	0.0	0.1	0.3	0.2	0.3	0.0	0.0
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2403.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	412.5	166.8	149.0	170.9	168.8	276.4	241.9	160.5	170.8	193.8	163.5	300.1	187.3	226.7	196.2	247.2	162.9	172.0	414.8	137.6	169.8	228.2	233.6	182.8	172.4	166.4	169.5	258.8	216.2	273.8	85.8	182.4	172.6	229.8	199.6	177.6	230.0	245.6	1408.6	201.6	196.1	236.4	172.2	176.5	201.7	257.4	164.7	218.8	262.6	1039.4	208.2	238.4	137.0	187.3	658.8	226.6	395.5	396.1	440.7	561.4	550.1	566.7	420.5	373.0	301.1	334.0	193.7	514.9	465.6	543.1	217.0	272.3	442.4	439.6	539.2	632.1	302.8	506.1	390.3	299.9	388.2	380.7	288.7	414.7	468.2	447.0	583.2	502.2	433.5	426.5	523.3	327.3	458.9	2403.4	513.8	242.0	755.0	274.0	302.5	378.4	1221.9	244.0	295.4	508.4	485.6	320.7	553.9	455.8	433.3	411.9	234.5	599.4	526.9	437.8	597.3	579.6	629.1	495.7	587.9	567.7	564.9	422.2	1365.1	217.2	241.4	230.8	146.4	233.1	199.7	161.6	186.5	180.7	226.8	130.4	219.3	189.1	155.2	191.0	270.8	87.2	222.2	389.4	149.0	168.8	160.5	170.8	137.6	169.8	166.4	169.5	172.6	172.2	164.7	187.3	193.2	198.7	194.2	41.8	198.3	216.2	219.7	149.0	235.6	134.0	218.2	161.5	572.0	160.2	181.1	128.8	58.4	172.4	155.2	160.8	226.9	198.2	405.5	130.4	178.8	191.3	219.9	232.8	70.8	202.9	208.2	181.7	143.2	174.3	219.1	234.7	156.4	189.1	156.8	99.3	73.7	220.3	120.1	277.9	202.0	639.7	161.8	216.8	220.5	55.3	241.8	195.5	117.4	54.3	86.5	213.8	150.6	225.7	283.6	269.0	240.1	235.5	143.2	121.3	164.3	232.4	274.2	263.3	189.8	247.2	234.0	272.9	193.3	208.2	210.5	283.8
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor subunit alpha"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 248.5;Extravillous trophoblasts: 124.6;Langerhans cells: 365.1;Macrophages: 114.5;monocytes: 575.2;Syncytiotrophoblasts: 312.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 320.2"	"Group enriched"	"Detected in all"	30	"dendritic cells: 170.7;granulocytes: 320.2;monocytes: 161.1"	"Group enriched"	"Detected in some"	7	"BEWO: 194.0;HMC-1: 58.3;SK-MEL-30: 142.0"	"Low region specificity"	"Detected in single"							CAB016148	Uncertain				"Secreted to blood"	NA	NA		13000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favorable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	10.0	5.5	4.2	25.4	4.4	21.7	6.8	5.2	4.8	5.1	5.4	5.8	5.8	2.5	1.7	5.3	4.1	12.6	2.5	4.0	5.4	2.3	4.6	14.2	20.9	8.5	6.6	1.8	3.3	3.1	1.4	64.4	8.3	2.5	7.4	0.7	3.0	3.0	0.6	4.0	6.6	7.1	7.2	14.9	5.0	1.1	9.0	9.4	1.6	2.0	23.5	12.7	1.5	11.9	0.3	11.5	0.5	0.0	0.0	0.0	194.0	0.3	0.5	0.4	0.1	4.2	1.0	0.2	12.6	0.0	10.3	0.2	0.1	0.0	0.0	3.9	0.1	0.2	8.0	0.1	0.0	4.6	58.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.4	18.8	1.6	1.8	0.4	0.2	0.5	0.3	0.0	0.5	0.1	0.3	3.7	0.1	142.0	15.1	9.4	16.8	0.0	0.2	5.5	0.1	0.0	0.1	0.1	0.6	0.0	18.5	0.1	17.4	161.1	200.3	0.4	94.9	1.0	2.3	0.3	0.3	170.7	0.6	0.4	0.3	320.2	7.3	48.7	164.0	1.1	65.5	4.2	4.4	5.2	4.8	4.0	5.4	8.5	6.6	8.3	7.2	9.0	11.9	1.2	0.0	7.3	1.3	5.5	7.8	0.9	0.1	0.6	0.6	6.3	2.5	1.2	2.8	3.6	1.8	0.0	248.5	38.3	0.0	0.0	0.3	0.6	7.8	1.2	5.3	0.0	1.3	1.4	1.8	124.6	3.4	0.0	14.7	10.1	0.5	0.7	0.1	75.5	0.0	1.7	0.0	2.0	74.8	365.1	0.3	0.9	114.5	8.8	66.5	575.2	0.3	0.0	1.5	0.9	0.2	0.0	0.4	1.0	0.5	0.0	0.1	2.7	1.5	6.6	1.8	1.4	0.2	0.4	0.0	5.3	312.5	3.3	0.1	0.0	2.5
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 379.7;lung: 136.7;lymphoid tissue: 375.6;placenta: 105.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 230.8;Cytotrophoblasts: 423.8;Kupffer cells: 177.7;monocytes: 197.6;Syncytiotrophoblasts: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1962.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1962.3"	"Group enriched"	"Detected in some"	18	"BEWO: 70.8;NB-4: 20.3;THP-1: 50.3;U-937: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	36.2	7.1	5.8	148.2	5.6	379.7	13.0	6.7	19.0	5.2	6.3	6.4	2.6	3.1	0.4	5.6	31.5	15.8	14.6	5.5	7.3	9.7	22.9	136.7	7.3	10.3	7.8	3.2	4.9	1.6	5.5	105.1	11.4	7.5	1.8	0.1	7.4	1.8	3.6	1.6	9.8	12.2	9.6	375.6	9.9	1.2	10.7	5.7	5.8	21.7	2.7	22.2	6.2	11.9	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	1.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.5	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	47.8	0.0	1.1	280.8	8.7	0.2	56.8	0.6	0.1	0.4	0.2	97.2	0.4	0.1	0.3	1962.3	3.4	24.1	3.3	0.6	158.4	5.8	5.6	6.7	19.0	5.5	7.3	10.3	7.8	11.4	9.6	10.7	11.9	0.7	25.6	230.8	0.0	3.3	1.0	0.5	0.0	0.0	0.0	5.9	4.7	1.8	0.0	10.0	0.0	0.0	423.8	2.9	0.0	0.0	0.0	0.4	0.3	6.4	4.8	0.0	4.6	0.2	0.0	47.3	8.0	1.5	0.2	18.9	1.1	3.9	1.2	64.1	0.0	0.2	0.0	0.0	177.7	39.2	0.7	0.3	111.5	0.0	77.8	197.6	0.2	6.2	0.5	0.3	0.1	0.0	0.0	0.7	0.3	0.0	0.5	6.6	0.2	0.0	0.3	1.0	0.0	0.4	0.2	0.1	1194.8	4.0	0.0	0.0	3.0
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138445-43185302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 133.9"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 121.6;Macrophages: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	19.7	10.6	8.8	24.1	10.8	133.9	12.9	15.1	13.3	15.1	12.6	15.1	9.2	19.5	8.4	10.5	15.5	25.4	12.8	8.5	10.8	8.8	13.9	26.8	22.5	10.7	9.7	17.0	7.8	8.0	11.6	26.4	11.1	13.4	11.6	9.8	7.9	10.9	14.6	11.0	11.5	20.8	9.4	26.5	10.1	9.2	9.9	27.9	9.9	17.2	17.4	24.0	12.1	13.5	12.6	8.2	15.1	14.4	23.0	38.5	3.7	44.7	59.8	19.3	30.0	2.9	12.7	20.8	10.8	40.6	9.2	11.4	12.6	16.8	31.3	24.9	9.3	10.8	7.9	8.6	50.0	25.3	21.8	38.6	18.1	43.1	89.3	24.3	25.0	30.7	4.6	60.1	39.9	6.5	19.3	15.1	6.5	4.2	10.7	11.9	15.0	8.8	17.1	6.6	13.6	26.8	11.6	11.9	28.8	13.0	15.7	20.5	37.3	16.5	26.2	52.3	30.4	15.4	23.2	10.9	35.1	60.8	7.9	14.7	11.9	19.4	7.3	14.2	6.4	3.0	5.5	5.7	14.4	3.0	6.4	5.4	11.2	11.3	21.8	4.1	7.1	6.9	8.8	10.8	15.1	13.3	8.5	10.8	10.7	9.7	11.1	9.4	9.9	13.5	16.3	16.0	18.7	23.8	20.5	17.7	13.3	7.0	6.2	13.1	10.7	8.5	10.9	5.7	9.6	11.0	10.4	2.1	47.8	1.7	0.0	5.9	2.1	12.0	22.0	16.8	9.0	18.5	42.5	6.9	6.1	31.4	4.6	11.3	48.1	23.5	11.4	11.9	16.4	8.4	41.1	1.6	4.1	68.6	121.6	1.4	17.1	82.6	8.8	16.9	41.5	4.1	35.0	45.2	54.5	13.7	3.1	12.4	33.8	12.7	1.5	4.4	5.8	8.5	26.3	27.7	25.3	17.8	18.3	3.6	12.1	1.5	37.4	7.2	1.6	7.0
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"placenta: 9786.7"	"Group enriched"	"Detected in some"	24	"Extravillous trophoblasts: 542.0;Syncytiotrophoblasts: 1092.3"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 11.8;SuSa: 17.0"									"CAB026374, HPA043715"	Enhanced				"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB026374: , HPA043715: AB_2678632"															"unprognostic (6.99e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	6.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.7	3.9	0.0	0.2	9786.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	39.6	0.0	26.1	19.9	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	542.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1092.3	0.0	0.0	0.0	0.0
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	218	"placenta: 3289.0"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 275.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BEWO: 9.3;SuSa: 13.1"									HPA043715	Supported				"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	1.1	0.0	1.9	3289.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	15.0	0.0	8.6	5.2	0.2	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	275.5	0.0	0.0	0.0	0.0
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"placenta: 150.0"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025646, HPA043715"	Enhanced				"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"		"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB025646: , HPA043715: AB_2678632"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	150.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.6	0.0	0.0	0.0	0.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CSKMT	"CS-KMT, METTL12, U99HG"	ENSG00000214756	"Citrate synthase lysine methyltransferase"	A8MUP2	11	62665309-62668496	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.4;Alveolar cells type 2: 41.4;Breast glandular cells: 65.9;Breast myoepithelial cells: 68.5;dendritic cells: 46.3;Endometrial stromal cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"							"Low region specificity"	"Detected in all"			HPA038533	Approved					NA	Yes			"Cluster 30: Non-specific - Translation"		"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"			"HPA038533: AB_10697392"	"prognostic favorable (8.73e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.43e-5)"	"unprognostic (1.55e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.28e-1)"	0.3	0.3	0.4	0.1	0.3	0.1	0.4	0.3	0.7	0.5	0.3	0.4	0.5	0.4	0.1	0.5	0.5	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.6	0.7	0.1	0.2	0.5	0.4	0.4	0.4	0.1	0.3	0.4	0.9	0.3	0.2	0.1	0.3	0.2	0.4	0.0	0.4	0.2	0.2	0.2	0.3	0.4	0.5	0.4	0.9	0.9	0.3	0.4	2.6	1.0	0.4	0.3	0.6	0.7	0.9	0.7	0.9	1.6	0.4	1.2	0.2	1.7	1.6	0.8	1.4	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.6	0.9	2.7	0.2	1.0	0.7	0.2	0.2	0.7	0.0	1.0	0.8	0.5	0.7	1.6	0.0	0.8	0.8	0.4	0.2	0.3	0.1	0.0	0.0	0.8	1.0	0.9	0.4	2.0	0.2	0.0	0.2	0.9	2.4	0.0	0.3	0.0	0.0	0.2	0.4	0.4	0.7	1.1	0.1	0.8	1.8	1.7	2.9	2.4	1.1	1.1	1.5	2.9	2.5	0.0	0.5	1.3	1.3	1.3	1.4	0.4	0.3	0.3	0.7	0.3	0.4	0.4	0.3	0.4	0.3	0.4	0.4	40.4	12.8	41.4	0.0	25.0	0.0	0.0	0.0	0.0	0.0	65.9	68.5	0.0	0.0	21.1	18.4	0.0	27.7	46.3	0.0	5.9	7.4	0.0	17.5	37.7	10.1	0.0	0.0	0.0	5.6	20.0	13.2	0.0	23.0	27.8	15.3	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.8	0.0	0.0	9.8	6.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	26.5	24.4	13.5	0.0	0.0
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113436939	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 6.8"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 915.9;Inhibitory neurons: 867.9;Oligodendrocyte precursor cells: 1761.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029007, HPA029008"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029007: AB_10601802, HPA029008: "	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	0.0	0.0	6.8	0.0	4.3	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	4.8	0.0	0.0	0.0	0.0	1.9	2.7	0.0	0.2	0.0	0.1	0.0	1.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	4.3	0.0	6.0	5.7	4.8	1.9	2.7	1.6	0.8	5.0	0.7	0.0	0.0	3.0	21.5	0.2	0.3	0.1	0.0	0.0	7.3	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.5	0.1	0.4	0.0	0.0	915.9	0.0	0.0	0.9	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	867.9	0.0	0.0	0.0	0.8	6.3	0.0	0.3	0.0	19.7	0.0	0.5	0.0	1761.3	92.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.2	17.1	8.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931068-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"breast: 1391.5"	"Cell type enriched"	"Detected in some"	47	"Breast glandular cells: 8261.0"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			16.0	0.0	0.1	0.5	0.0	0.0	1391.5	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.4	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.2	0.0	0.1	0.0	0.4	0.1	28.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	8261.0	172.2	2.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.1	0.3	0.0	2.1	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.0	0.0
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"breast: 307.2"	"Cell type enriched"	"Detected in some"	97	"Breast glandular cells: 33136.9"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	307.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	33136.9	340.4	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	0.8	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 378.1"	"Cell type enriched"	"Detected in some"	48	"Breast glandular cells: 2554.0"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 35.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.0	0.0	0.0	0.0	0.0	0.0	378.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2554.0	52.2	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	3.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492982-149551471	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	77.0	67.6	49.0	67.3	53.9	210.8	97.8	60.0	52.7	67.9	61.5	83.2	56.6	73.7	60.2	142.4	56.6	79.7	87.6	48.6	55.9	50.3	68.2	69.6	60.0	61.3	56.4	53.2	55.0	99.4	48.8	71.7	56.6	88.3	68.2	57.6	71.3	69.2	104.1	121.4	63.1	82.9	57.9	60.7	73.5	45.6	57.8	81.0	76.9	59.5	81.8	94.8	82.3	66.3	154.4	106.4	151.0	144.1	143.6	191.4	185.0	189.7	176.8	146.0	153.5	194.1	187.0	71.6	221.3	183.3	140.7	153.9	101.2	292.5	184.1	124.6	78.0	96.9	96.6	87.8	143.1	163.9	148.4	158.5	313.4	148.1	269.0	163.9	184.7	137.2	102.2	116.0	140.7	104.4	152.2	66.6	71.4	167.6	247.3	129.0	96.1	98.9	112.3	248.3	123.5	110.5	151.1	193.3	200.8	135.6	194.1	134.4	164.6	168.6	83.6	118.2	197.1	117.0	149.2	100.6	169.2	95.6	216.9	106.0	72.6	66.6	47.5	68.9	51.6	50.2	58.1	49.7	80.0	39.9	61.4	55.2	61.1	63.7	67.8	47.4	76.7	94.7	49.0	53.9	60.0	52.7	48.6	55.9	61.3	56.4	56.6	57.9	57.8	66.3	169.7	147.4	176.7	137.1	101.8	684.5	583.1	270.0	187.8	135.8	257.0	158.4	63.5	90.1	298.1	115.8	64.6	171.2	135.6	126.8	92.0	167.1	95.7	195.8	193.5	191.1	129.9	146.7	108.4	184.1	223.7	159.8	124.4	285.2	117.6	114.0	216.4	108.9	136.1	151.4	115.4	141.9	154.6	167.8	311.5	87.5	104.1	183.8	152.9	119.0	156.6	156.9	108.1	168.4	198.1	197.2	113.9	111.7	105.4	368.6	120.4	102.8	276.7	109.6	157.8	190.2	216.1	181.9	88.9	272.4	847.7	350.9	133.5	177.0	115.7	485.2
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 280.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	87.1	52.8	81.1	41.2	82.6	51.6	88.3	80.8	95.1	93.6	66.0	73.0	41.4	82.7	52.5	69.0	83.3	48.7	80.9	82.9	73.7	70.2	37.4	92.2	40.3	78.9	78.6	109.5	64.9	74.1	85.1	71.2	79.5	80.3	35.5	47.3	71.6	44.9	60.5	94.8	50.9	45.3	70.2	63.6	58.0	29.5	83.2	33.3	64.4	47.2	37.8	65.7	88.4	93.9	101.5	57.4	121.6	114.7	61.5	88.3	92.1	126.9	168.6	116.7	114.3	63.9	76.7	74.2	53.0	120.7	70.7	77.9	96.1	177.9	79.2	123.0	215.2	23.9	181.2	47.4	123.7	48.3	61.9	90.2	143.8	171.7	220.3	141.0	121.1	60.6	50.9	155.0	110.8	68.4	71.1	60.9	87.2	67.3	69.1	130.8	90.1	123.4	99.0	92.4	181.6	69.3	102.9	109.3	124.7	68.0	59.5	73.0	134.3	94.0	111.3	58.7	102.1	61.2	105.2	104.5	151.0	56.9	176.3	4.8	1.6	3.6	3.0	0.8	3.8	2.1	3.4	3.0	1.8	3.1	1.9	2.5	3.8	5.7	0.5	15.9	1.6	1.2	81.1	82.6	80.8	95.1	82.9	73.7	78.9	78.6	79.5	70.2	83.2	93.9	73.4	38.5	21.7	0.0	32.3	78.6	158.8	89.1	68.9	132.6	53.7	42.4	49.8	34.3	73.9	23.9	60.5	35.2	42.3	28.4	7.9	30.8	46.0	94.3	72.5	76.4	62.8	12.6	0.0	41.8	49.2	60.8	39.8	126.5	3.8	46.6	45.0	21.3	23.1	72.3	0.0	46.0	46.8	17.6	54.1	69.1	85.4	21.8	60.5	0.0	13.3	117.9	28.8	0.0	0.0	57.5	33.1	66.2	83.5	160.5	9.0	6.5	62.8	60.7	72.3	85.7	98.0	8.0	20.0	50.3	104.7	125.5	26.0	34.9	37.6	280.8
CSNK1G2	CK1g2	ENSG00000133275	"Casein kinase 1 gamma 2"	P78368	19	1941172-1981338	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 254.8;Late spermatids: 613.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA034868: AB_10671235, HPA056572: AB_2683178"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.51e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.83e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-2)"	37.1	52.7	19.3	40.5	17.9	47.3	38.3	22.8	28.1	35.1	18.3	35.0	29.5	34.5	6.5	50.6	35.7	20.6	33.8	21.6	16.6	42.6	41.6	53.5	41.8	20.8	19.2	39.5	39.8	13.3	51.5	17.7	18.1	41.3	8.7	9.8	38.1	14.0	39.4	45.1	46.9	10.3	12.8	69.2	35.5	99.9	18.3	23.5	35.8	12.3	18.7	32.3	37.8	18.1	71.2	37.3	51.0	80.1	17.5	32.6	42.7	43.1	28.0	32.0	39.1	31.0	37.8	44.3	35.2	27.6	17.8	50.1	27.6	52.5	14.0	40.5	60.4	31.2	65.0	52.9	28.2	50.7	76.3	32.5	33.8	33.4	21.3	24.7	38.4	54.2	67.1	146.5	21.4	41.3	101.0	66.8	92.7	19.7	41.8	86.8	32.3	72.7	24.3	73.2	81.9	67.4	32.2	52.7	48.2	18.8	33.6	81.8	46.6	40.2	31.5	85.3	50.6	94.8	54.5	55.5	40.7	47.6	42.8	2.8	3.6	4.7	4.2	5.8	3.0	3.4	3.1	3.6	3.6	3.3	2.4	3.4	10.0	3.5	14.4	5.4	2.4	2.4	19.3	17.9	22.8	28.1	21.6	16.6	20.8	19.2	18.1	12.8	18.3	18.1	37.5	16.0	17.9	10.1	36.5	21.9	17.8	14.9	10.8	43.6	28.9	26.8	14.2	10.0	14.9	11.0	41.7	12.2	91.7	36.9	9.8	17.1	254.8	37.7	32.5	24.7	30.5	12.6	10.8	29.5	18.9	21.6	31.1	32.4	29.9	41.8	16.8	16.4	14.9	25.2	9.8	26.6	6.1	21.9	30.3	613.6	20.5	32.3	14.2	14.0	16.4	21.6	41.2	5.5	6.2	30.1	24.0	18.8	38.2	28.8	15.0	14.6	22.8	39.3	13.1	26.4	23.0	16.0	13.2	19.0	25.3	18.2	46.2	51.7	24.8	32.8
CSNK1G3		ENSG00000151292	"Casein kinase 1 gamma 3"	Q9Y6M4	5	123512099-123617045	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027010	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA027010: AB_10602803"	"unprognostic (1.28e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.92e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.38e-1)"	13.5	12.0	8.1	13.6	9.5	11.6	15.2	13.5	9.7	12.2	6.5	21.9	21.4	15.7	10.5	16.3	12.6	15.2	10.1	9.4	9.9	14.2	25.2	13.6	14.4	6.9	7.9	15.0	9.9	15.1	6.4	14.6	8.3	10.9	24.1	7.6	9.1	9.2	5.7	9.4	23.1	16.3	7.3	13.0	16.6	15.3	9.7	14.4	14.2	8.0	16.3	20.1	10.1	7.7	28.3	26.7	39.2	37.4	39.0	43.3	19.4	29.9	35.7	32.4	48.2	24.0	44.0	0.0	37.9	36.2	37.7	20.1	31.7	59.2	55.6	42.7	21.8	19.9	29.8	25.6	34.7	10.5	19.7	37.1	37.7	36.7	68.8	38.5	35.9	13.7	11.3	22.2	27.7	19.6	14.2	13.0	22.1	22.2	18.2	15.8	41.4	27.0	24.3	30.6	33.9	24.5	33.3	21.8	50.1	32.4	28.6	29.1	33.2	47.5	35.6	29.1	33.5	24.7	29.0	25.1	28.4	29.8	31.4	12.4	5.7	2.5	6.3	5.4	8.6	12.4	5.3	5.6	5.2	11.9	5.4	5.8	4.4	13.4	6.1	4.5	7.3	4.9	8.1	9.5	13.5	9.7	9.4	9.9	6.9	7.9	8.3	7.3	9.7	7.7	42.4	22.4	14.1	40.5	54.9	20.6	25.6	19.6	33.0	30.1	25.3	22.2	20.6	7.2	18.0	11.0	8.4	8.6	38.3	35.2	21.5	23.7	10.9	26.3	29.9	30.7	32.8	5.9	75.4	25.0	15.2	31.8	25.5	31.8	5.7	29.9	29.3	23.4	9.6	90.9	74.8	27.2	22.4	17.3	18.0	15.8	19.9	20.5	16.0	65.6	32.0	26.2	39.1	97.0	54.5	30.5	42.8	19.5	38.5	28.5	33.9	22.2	18.8	3.3	0.0	28.2	27.8	26.6	53.7	24.8	18.8	6.7	32.7	21.7	23.9	43.2
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSNK2A3	CSNK2A1P	ENSG00000254598	"Casein kinase 2 alpha 3"	Q8NEV1	11	11351942-11353250	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.4;Cholangiocytes: 4.3;Smooth muscle cells: 6.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;SK-BR-3: 1.3"									"HPA059206, HPA061698"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.25e-4)"	"unprognostic (4.36e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.38e-2)"	0.5	0.5	0.7	0.2	0.1	0.0	0.5	0.4	0.6	0.4	0.0	0.5	0.3	0.6	0.0	0.7	0.4	0.0	0.8	0.9	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.5	0.5	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.6	0.0	1.8	0.7	0.4	0.2	0.0	0.2	0.5	0.9	0.1	0.0	0.5	0.0	0.0	0.4	0.5	0.0	2.1	0.4	0.1	0.6	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.3	0.2	0.3	0.2	0.2	0.5	0.3	0.6	0.1	0.9	0.4	0.1	0.3	0.2	0.3	0.1	0.5	0.6	1.3	0.3	0.0	0.4	0.1	0.3	0.3	0.4	0.1	0.2	0.2	0.3	0.3	0.9	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.5	0.0	0.5	1.8	1.0	0.7	0.0	1.2	0.6	0.9	12.4	4.3	1.0	3.7	0.0	0.7	0.5	0.4	0.0	0.7	2.5	0.1	0.3	2.0	1.2	0.0	0.0	0.8	0.5	0.9	0.0	0.4	1.3	0.6	1.8	0.3	0.3	3.3	0.0	0.3	0.0	1.6	0.8	1.9	0.6	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.5	1.2	0.0	0.1	1.2	0.6	0.7	0.9	0.5	0.0	2.3	6.9	0.9	0.9	0.0	1.0	1.0	0.6	1.1	0.6	0.6
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665227-31670343	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved					NA	NA		83000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	155.8	157.4	15.8	31.9	24.6	62.2	150.2	17.6	54.1	147.9	16.8	142.2	27.8	126.7	183.7	166.6	130.1	33.1	178.9	15.9	16.4	172.1	163.7	133.0	72.5	16.3	17.5	161.2	142.3	69.3	130.0	68.2	17.8	120.3	50.4	41.4	131.9	57.6	232.0	294.2	126.5	66.3	15.4	146.0	146.7	257.9	17.1	56.5	132.4	94.8	30.1	126.2	139.8	17.4	0.9	95.5	2.5	164.9	97.4	158.0	120.8	200.9	350.2	407.6	377.9	0.2	129.3	302.5	127.9	196.8	146.0	0.1	1.0	374.5	409.4	153.1	322.6	4.3	0.6	1.1	260.0	341.5	0.9	257.8	1.5	0.8	0.2	0.2	4.7	208.3	1.7	1.7	0.8	2.9	237.1	2.2	102.0	240.0	0.0	221.1	2.3	247.7	222.3	136.5	1.2	243.0	1.8	0.9	175.8	101.0	7.4	1.3	118.8	210.3	203.9	198.0	1.3	167.3	285.9	267.6	122.3	1.6	196.1	87.3	114.8	121.8	80.1	125.9	80.5	113.7	81.7	85.1	111.0	99.1	71.4	61.9	95.2	90.8	83.2	131.7	113.4	95.0	15.8	24.6	17.6	54.1	15.9	16.4	16.3	17.5	17.8	15.4	17.1	17.4	114.3	51.3	67.0	11.1	124.4	186.1	125.1	196.1	138.9	56.8	135.5	196.3	91.3	105.8	116.5	101.2	12.5	211.8	106.4	185.6	270.1	184.7	452.7	75.1	71.7	122.7	125.7	103.5	14.1	175.2	252.7	118.3	93.3	68.2	129.5	102.3	125.7	126.6	296.2	48.8	14.3	175.4	138.4	204.4	218.5	270.7	153.7	146.2	152.9	8.4	181.1	168.3	121.5	14.6	19.1	182.9	248.1	125.3	152.1	154.3	283.1	397.5	91.3	47.8	138.1	107.9	152.2	485.6	186.5	142.7	186.3	282.1	111.5	116.8	184.3	150.6
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562238-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 83.2;choroid plexus: 65.2;retina: 28.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.6;HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	0.9	0.8	58.3	0.2	62.4	0.1	0.6	33.6	83.2	0.3	65.2	1.1	0.0	0.3	0.1	0.3	0.3	0.1	0.5	62.5	49.7	0.2	0.2	3.2	0.2	41.2	45.6	0.2	0.3	0.3	1.7	0.8	45.8	0.4	0.2	28.3	0.3	0.0	0.5	1.1	0.3	0.4	37.0	0.0	0.4	1.9	48.0	0.1	0.4	0.0	0.1	0.1	0.2	46.1	0.3	1.7	32.6	5.7	0.6	0.0	0.9	0.6	0.1	1.2	0.3	0.3	2.0	0.1	2.5	0.1	2.4	0.5	2.7	0.3	0.3	0.0	8.8	0.5	1.4	0.0	0.0	0.4	1.4	0.0	1.1	0.1	0.0	0.9	0.1	1.1	6.6	0.3	0.1	1.5	0.2	0.4	3.1	2.4	3.3	0.5	0.2	0.7	1.4	1.1	3.4	1.5	2.1	4.1	0.1	0.9	1.6	3.1	0.3	0.1	6.5	0.1	1.9	0.8	0.8	0.0	0.5	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	62.4	33.6	83.2	62.5	49.7	41.2	45.6	45.8	37.0	48.0	46.1	0.7	3.2	2.0	67.6	0.1	0.8	0.1	0.0	0.0	28.6	2.2	1.8	1.3	0.0	0.0	0.0	6.2	0.2	0.0	0.5	0.0	0.2	2.0	0.6	0.6	0.3	1.8	0.0	18.6	0.0	0.2	0.5	0.0	2.0	0.0	6.1	0.0	0.5	0.2	6.7	25.0	0.3	0.0	0.0	0.2	0.6	0.3	0.2	0.0	7.5	0.0	94.7	0.0	233.7	9.9	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	22.7	0.0	0.8	0.8	13.5	3.3	0.0	0.6	0.1	0.2	0.2	0.4	0.1
CSRNP2	"C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12"	ENSG00000110925	"Cysteine and serine rich nuclear protein 2"	Q9H175	12	51061205-51083664	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018503, HPA019914"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA018503: AB_1845535, HPA019914: AB_2670315"	"unprognostic (8.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.74e-2)"	"prognostic favorable (2.78e-4)"	12.2	10.4	19.1	7.4	19.3	3.3	11.1	15.5	21.9	13.4	13.3	11.9	6.7	13.7	11.9	7.7	11.2	11.6	12.7	19.3	19.7	12.2	6.8	10.8	8.3	14.1	15.4	12.4	9.3	11.8	17.6	11.4	14.2	11.6	7.0	20.5	9.9	10.5	16.8	9.5	8.8	14.6	12.0	10.0	10.0	26.2	19.2	13.9	11.4	14.7	7.0	12.3	9.7	16.5	9.0	10.2	30.2	27.1	22.8	16.0	31.5	17.3	19.9	23.8	16.3	19.6	6.4	7.5	16.2	18.7	16.2	10.8	14.9	9.5	18.8	15.4	10.4	8.9	12.1	6.1	24.7	6.2	12.8	19.6	26.4	27.6	15.6	25.9	23.6	34.0	12.5	13.1	27.8	15.6	21.3	8.6	24.8	4.2	14.3	12.5	19.1	6.0	13.6	11.6	21.2	25.1	25.1	20.0	25.9	21.2	12.7	17.2	21.4	23.6	12.4	15.8	11.9	13.5	16.0	6.9	14.5	8.1	7.7	0.0	0.3	1.0	0.7	0.0	0.2	0.4	0.7	0.4	0.4	0.2	0.7	1.0	1.0	2.2	0.2	0.1	0.5	0.2	19.1	19.3	15.5	21.9	19.3	19.7	14.1	15.4	14.2	12.0	19.2	16.5	17.8	3.2	6.8	13.1	9.4	17.8	11.4	7.1	8.0	6.8	14.1	20.2	19.5	5.7	5.4	5.5	25.0	6.6	13.8	15.4	3.9	6.9	23.5	10.3	14.4	12.7	8.3	4.0	39.9	5.0	9.2	15.6	63.2	10.0	11.4	13.1	13.6	2.6	6.5	6.7	32.3	10.8	8.2	4.4	14.8	14.8	6.2	9.7	16.0	11.2	4.2	5.4	5.2	23.6	20.7	8.0	7.5	7.9	10.8	10.0	8.6	4.2	7.4	7.6	0.0	20.2	17.3	28.6	13.8	6.8	16.1	15.1	12.5	5.9	5.7	6.6
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 358.3;Inhibitory neurons: 315.3;Oligodendrocyte precursor cells: 344.8;Oligodendrocytes: 95.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.8;PC-3: 2.4;SCLC-21H: 7.1;SH-SY5Y: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Approved		Uncertain	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	0.9	2.3	9.4	0.4	9.3	0.0	3.2	0.0	14.4	2.3	7.0	0.8	0.7	2.7	0.8	0.7	0.9	0.9	1.4	10.6	10.5	1.5	0.6	0.4	0.2	0.0	0.7	3.4	3.7	1.1	3.4	0.2	0.0	1.5	0.9	6.4	2.2	2.1	0.1	0.7	0.6	2.5	0.0	0.8	0.7	0.6	8.6	0.5	2.3	0.7	0.2	0.6	1.0	6.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.4	0.0	0.3	0.1	0.5	0.0	0.2	0.0	0.7	0.4	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.0	0.6	0.5	0.0	7.1	5.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.3	0.0	14.4	10.6	10.5	0.0	0.7	0.0	0.0	8.6	6.5	2.5	3.2	5.1	81.6	0.2	5.2	4.0	2.3	6.8	55.7	16.2	13.5	8.7	5.7	1.6	11.0	70.9	0.3	0.0	0.7	3.9	2.7	2.9	2.3	9.6	3.6	7.7	0.0	358.3	2.3	0.1	8.2	2.0	2.3	0.0	47.9	1.4	3.6	2.6	11.8	315.3	4.7	4.1	0.3	1.6	1.7	7.5	0.4	7.2	7.5	0.0	19.6	0.0	344.8	95.4	0.9	1.9	8.2	0.0	0.6	1.7	7.2	0.5	20.4	6.6	4.4	23.0	0.6	1.6	6.3	4.5	0.3	0.2	13.2	2.6	2.0
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 2743.3;seminal vesicle: 2571.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		11000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	344.5	127.2	713.6	224.5	871.4	41.0	321.8	742.5	717.3	542.4	467.6	2743.3	180.6	1904.4	308.4	884.1	1025.6	152.7	194.2	647.3	735.1	192.5	114.7	386.0	64.9	840.1	837.4	319.0	114.6	188.0	117.0	118.3	719.0	947.2	432.0	24.2	250.1	2571.3	64.0	219.8	503.6	2009.6	713.5	165.6	748.3	44.2	848.5	48.0	186.4	53.8	65.7	1494.5	469.1	766.6	83.0	195.3	52.0	116.4	83.2	107.7	273.6	605.7	514.3	455.3	360.9	211.1	57.7	78.7	36.1	325.0	96.7	144.7	32.7	120.3	321.2	169.5	29.3	90.7	220.1	30.7	387.4	72.1	10.2	99.3	105.3	373.0	163.1	253.1	508.1	34.9	4.5	71.9	302.1	232.9	46.6	11.8	0.8	99.0	73.2	18.3	304.9	266.8	212.6	129.7	27.1	22.5	238.0	503.8	163.9	25.6	87.0	74.3	610.6	303.7	195.7	206.6	250.6	40.5	82.6	30.6	303.5	137.6	202.6	75.5	49.8	65.6	37.4	49.3	36.9	25.0	35.8	34.9	65.0	18.1	20.5	25.2	5.0	34.3	54.2	5.2	54.1	46.5	713.6	871.4	742.5	717.3	647.3	735.1	840.1	837.4	719.0	713.5	848.5	766.6	151.8	38.5	47.8	86.5	21.8	49.2	341.2	24.6	207.7	3.4	123.7	737.5	24.8	21.5	36.9	47.8	0.0	88.8	23.3	96.6	49.0	165.1	21.5	30.1	73.6	86.9	57.9	19.1	2.4	171.7	388.5	86.7	36.7	38.9	27.9	13.9	91.1	28.3	66.0	0.0	2.1	80.0	14.2	29.1	55.8	44.9	41.0	37.0	126.3	10.3	73.5	137.4	15.5	6.6	114.8	140.5	71.4	292.3	61.5	113.8	97.2	28.4	25.2	3.1	144.7	37.7	419.9	2.4	3.2	75.3	34.9	160.9	31.2	30.4	69.7	103.6
CSRP2	"CRP2, LMO5, SmLIM"	ENSG00000175183	"Cysteine and glycine rich protein 2"	Q16527	12	76858709-76879023	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 275.3;Muller glia cells: 625.9;Smooth muscle cells: 268.4;Squamous epithelial cells: 271.2"	"Cancer enhanced"	"Detected in all"		"glioma: 24.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 336.2;BEWO: 177.9;fHDF/TERT166: 184.9;HEK 293: 186.4;NTERA-2: 181.4;WM-115: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		63000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (9.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (8.52e-4)"	"prognostic unfavorable (4.48e-5)"	"unprognostic (3.55e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.45e-1)"	68.9	8.2	52.7	32.6	55.5	0.3	52.2	56.9	70.0	77.4	54.4	34.2	17.2	54.3	27.1	98.0	55.8	61.6	37.4	51.6	62.6	88.3	45.2	57.7	27.8	55.5	56.6	30.1	16.6	11.6	28.7	84.0	57.7	48.5	16.3	64.9	29.9	15.9	15.3	24.1	39.0	37.2	55.5	19.4	45.8	23.7	61.4	26.9	50.0	34.4	37.5	47.4	62.6	61.4	26.0	23.0	336.2	67.7	15.0	3.3	177.9	43.7	52.5	39.3	108.2	15.3	1.1	0.3	17.5	184.9	30.9	31.4	75.3	44.5	63.0	3.2	186.4	0.3	46.4	14.9	3.7	0.0	0.7	18.0	29.5	31.8	5.6	67.8	8.1	12.9	1.2	1.0	68.8	8.3	3.8	0.3	181.4	1.6	39.1	39.5	90.9	0.3	130.3	61.7	17.4	111.8	74.3	2.7	17.9	92.5	0.1	0.8	1.9	34.3	44.4	8.5	32.6	2.2	1.9	3.7	10.5	0.6	188.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	52.7	55.5	56.9	70.0	51.6	62.6	55.5	56.6	57.7	55.5	61.4	61.4	93.8	0.0	1.7	6.2	1.8	78.5	105.5	24.3	133.7	16.7	12.7	57.0	14.4	20.0	8.5	14.7	10.4	275.3	2.7	0.8	215.2	28.5	35.3	107.1	16.1	119.1	0.0	0.0	4.7	4.4	156.7	116.6	7.7	82.4	0.0	61.7	13.2	25.7	28.8	0.0	2.1	2.5	2.0	1.0	43.7	21.0	3.7	5.3	49.8	13.1	76.1	625.9	0.0	2.5	0.6	5.5	1.4	9.1	8.1	72.7	0.4	140.8	2.7	19.4	210.4	138.0	268.4	81.2	44.8	271.2	61.9	117.9	5.9	25.1	3.8	55.0
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000		"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.3	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.0	39.6	0.0	0.5	2613.3	0.1	0.2	0.2	0.2	1.2	1.2	0.2	0.1	0.5	2.6	0.0	0.1	0.1	0.2	32.8	0.0	0.0	24.8	0.0	1649.3	0.4	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.7	579.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747562-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	119	"salivary gland: 28401.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Collecting duct cells: 79.1;Glandular and luminal cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 1142.2"									"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA		6300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"prognostic favorable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.3	0.1	1.1	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.0	3.7	0.4	0.1	0.2	238.8	8.0	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.7	7.1	37.3	0.0	0.1	4.1	1.4	13.0	0.2	0.0	28401.8	0.6	0.0	3.2	0.0	0.0	0.4	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.7	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	172.6	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.4	0.0	0.1	0.0	0.1	0.0	51.2	0.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	45.3	0.1	0.0	0.0	0.0	4.4	1142.2	0.7	0.0	0.1	0.0	0.3	5.6	0.0	0.0	223.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.7	1.4	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	14.3	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.7	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	31.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.5
CST11	"CST8L, CTES2, dJ322G13.6"	ENSG00000125831	"Cystatin 11"	Q9H112	20	23450403-23452876	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	473	"epididymis: 210.7"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Endometrial stromal cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053399	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 36: Stromal cells - Cell proliferation"			"HPA053399: AB_2682136"						"unprognostic (9.42e-2)"				"unprognostic (2.21e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	210.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.3	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST2		ENSG00000170369	"Cystatin SA"	P09228	20	23823769-23826729	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	637	"salivary gland: 5987.1"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 5.2;Melanocytes: 16.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 24.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RT4: 67.7"									"CAB024963, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (1.57e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.82e-3)"	"unprognostic (6.43e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-11)"	"unprognostic (1.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.1	0.2	0.1	0.0	0.2	4.8	2.4	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	1.6	9.3	0.1	2.0	1.0	0.0	2.5	0.0	0.0	5987.1	1.3	0.0	0.4	0.2	3.8	0.0	0.1	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.8	67.7	0.0	0.0	0.0	0.0	5.4	0.9	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	16.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689038	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	514	"salivary gland: 29036.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.7;Collecting duct cells: 9.2;Glandular and luminal cells: 3.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.5;RT4: 13.6"									"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	NA	NA		2800000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavorable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favorable (2.88e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	56.4	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	29.9	0.0	0.0	3.8	0.0	2.4	0.0	0.0	29036.2	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	13.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875934-23879748	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	959	"salivary gland: 2156.1"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 9.6;Langerhans cells: 3.4"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 11: Alveolar cells - Smell perception"			"CAB024944: , HPA061449: AB_2684523"	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.3	0.4	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2156.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"skin 1: 761.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	3.2	0.3	0.1	0.3	0.1	0.2	28.5	0.8	0.4	7.4	0.8	0.4	0.0	0.3	0.6	34.6	14.9	0.5	2.8	0.1	0.3	2.6	0.3	18.3	0.0	0.2	0.2	0.7	0.7	2.1	1.6	8.1	0.1	0.9	0.0	0.0	7.4	4.9	2.0	761.4	0.3	0.1	0.1	0.2	0.6	1.8	0.4	2.7	21.4	0.0	2.2	1.2	22.5	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.2	0.2	0.1	0.1	0.4	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949269-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 1095.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 1287.0"	"Group enriched"	"Detected in all"	27	"granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		26000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	18.0	3.6	1.3	24.2	1.6	1095.6	5.7	2.8	5.1	4.5	1.7	5.7	5.9	4.6	4.8	5.4	10.4	17.7	5.6	1.5	1.4	5.4	12.7	49.3	73.4	2.4	1.4	2.5	3.9	1.0	2.2	4.4	2.0	4.3	5.1	0.2	6.6	2.0	1.9	4.5	13.9	5.0	1.6	148.1	8.7	1.7	1.6	17.3	5.6	4.4	16.4	19.2	5.2	1.4	0.3	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.3	1.7	0.0	0.4	0.0	77.8	204.6	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	2.8	0.0	0.2	2.0	212.1	0.1	0.0	0.2	0.5	7.7	0.1	0.0	0.1	0.3	0.2	0.0	0.1	1.0	0.1	0.0	13.3	0.2	0.1	0.8	0.2	0.5	0.1	0.1	0.2	0.1	380.4	0.1	74.3	3.0	10.4	1287.0	3.4	720.2	3.7	186.8	904.7	28.4	3.9	38.8	531.2	342.2	655.3	3.5	7.2	123.0	600.8	1.3	1.6	2.8	5.1	1.5	1.4	2.4	1.4	2.0	1.6	1.6	1.4	8.1	9.6	14.1	0.0	14.5	22.8	0.3	0.0	0.0	0.0	2.5	2.4	1.4	4.3	0.6	0.0	0.0	0.2	1094.4	0.3	0.0	1.3	0.0	1.3	0.7	3.2	0.0	46.7	0.0	3.7	0.1	5.2	11.2	1.2	60.0	0.0	11.0	3.8	1.4	0.0	0.0	0.1	0.0	16.2	541.7	0.0	0.0	61.9	24.9	1.9	659.7	0.0	1385.2	0.0	0.1	0.2	0.1	0.0	90.9	0.1	0.4	2.3	2.2	0.0	0.0	2.2	3.6	0.0	0.2	0.5	23.9	1.1	544.5	0.0	0.6	0.6
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605917	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"breast: 1.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted in female reproductive system"	NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 35: Glandular cells - Unknown function"			"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5912.9;vagina: 1853.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	30.7	4.7	0.8	27.1	0.9	297.8	56.3	1.0	3.7	961.0	1.4	3.8	1.1	2.2	10.3	5912.9	4.6	7.2	5.9	0.8	1.0	2.4	38.9	26.0	25.1	1.5	0.9	21.1	3.7	0.8	5.0	19.0	1.3	19.7	3.6	0.3	996.1	9.6	4.6	369.1	5.8	6.3	1.1	20.4	30.3	1.3	1.4	46.5	2.7	2.8	941.0	39.1	1853.3	1.6	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	0.9	1.0	3.7	0.8	1.0	1.5	0.9	1.3	1.1	1.4	1.6	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776330	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"esophagus: 11304.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 2798.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		8700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	224.3	165.6	254.1	141.6	253.6	73.8	161.9	255.4	314.6	585.8	275.2	243.8	122.9	90.1	175.0	11304.7	154.1	150.7	192.2	252.8	263.0	144.7	189.4	290.1	176.4	258.4	257.8	136.1	116.2	154.4	70.1	132.1	259.6	137.3	194.7	78.9	738.3	138.6	100.1	256.9	135.6	110.4	257.5	125.8	249.9	71.7	262.8	268.2	147.9	197.4	1484.9	611.8	1001.9	262.9	1573.6	495.5	146.3	188.1	874.5	742.6	379.6	310.1	431.0	230.7	230.6	401.6	868.6	123.0	245.8	570.1	1814.0	260.5	384.4	405.7	153.5	529.0	388.4	332.4	385.3	473.8	753.0	85.5	267.1	754.5	439.6	621.2	314.7	389.3	331.2	111.8	276.9	681.1	359.7	431.4	100.1	267.6	336.0	1052.6	791.5	169.7	80.5	1472.0	669.1	2798.2	141.8	121.6	420.2	229.2	928.8	75.7	210.4	214.0	426.3	347.7	162.7	305.5	211.8	148.5	347.4	251.1	1432.5	430.2	242.3	390.1	505.5	313.1	242.9	840.3	224.5	198.5	315.4	255.4	766.1	172.7	221.0	217.6	445.6	152.4	1322.9	93.4	406.9	475.2	254.1	253.6	255.4	314.6	252.8	263.0	258.4	257.8	259.6	257.5	262.8	262.9	210.1	176.3	298.4	43.4	140.5	385.3	460.6	5910.7	191.2	69.8	317.8	345.1	105.7	268.8	4352.8	415.6	35.5	310.4	126.5	803.9	538.1	588.4	10.4	388.8	205.1	307.8	239.3	61.4	17.0	488.2	1199.4	238.6	297.7	458.8	228.2	131.5	250.6	464.5	2827.7	67.3	18.4	308.6	1462.8	483.4	1256.2	40.8	381.1	806.9	471.4	24.4	915.9	160.6	255.4	11.1	32.4	810.9	735.6	330.2	167.7	674.3	524.9	469.9	1997.3	72.9	118.3	86.5	320.0	33.7	111.7	4910.2	596.0	402.5	202.8	170.9	367.2	3198.3
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406362	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	6.3	6.4	4.1	8.1	4.7	5.1	11.1	6.1	5.0	7.3	5.0	7.9	5.3	8.2	8.0	8.8	9.5	7.7	8.0	4.5	4.4	9.6	10.9	8.5	12.4	4.3	4.1	11.8	10.0	11.4	4.8	9.4	4.8	8.5	8.0	14.9	10.3	7.0	9.4	8.4	5.9	8.8	3.9	7.6	7.8	17.6	5.6	14.3	10.0	14.7	14.4	8.9	5.7	6.1	18.9	17.4	22.1	15.6	22.6	20.2	23.7	25.2	27.8	49.2	36.7	37.6	26.9	39.1	26.7	19.1	31.5	31.2	35.7	43.4	57.8	12.4	12.6	38.1	29.3	23.3	13.4	32.2	23.6	19.4	24.5	27.6	23.8	19.1	30.2	24.3	32.6	18.5	30.2	44.6	36.2	17.0	20.3	37.2	23.2	26.5	47.7	34.6	23.9	19.3	24.5	17.0	34.5	93.1	25.6	25.3	37.1	22.9	17.1	39.9	25.3	16.9	24.9	13.0	21.5	42.0	32.0	21.3	19.4	11.4	16.9	13.6	20.7	14.6	26.0	21.1	25.9	23.4	21.5	24.3	28.4	24.9	13.3	31.2	13.1	23.7	33.3	20.4	4.1	4.7	6.1	5.0	4.5	4.4	4.3	4.1	4.8	3.9	5.6	6.1	8.4	9.6	13.1	4.2	11.6	9.2	10.8	29.3	12.5	9.2	9.9	8.3	8.9	14.3	16.8	18.4	14.6	30.9	11.5	7.3	19.6	17.9	25.9	7.1	9.4	13.3	4.9	21.0	4.2	14.7	21.1	12.1	9.7	6.0	17.7	12.6	11.7	22.6	15.3	5.0	4.2	9.4	14.2	16.7	7.8	7.5	13.7	8.4	5.4	9.4	18.4	14.2	12.3	5.5	6.7	11.9	11.8	12.8	10.8	12.3	8.5	21.1	12.9	14.7	19.7	11.1	9.9	84.3	30.5	11.3	8.8	21.1	14.9	16.7	9.8	8.8
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100841520	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	6.3	7.2	5.7	9.9	6.0	10.5	7.7	6.7	6.3	7.0	5.0	12.0	8.6	7.5	8.2	19.2	8.1	6.4	6.1	5.9	6.4	8.0	5.3	6.3	12.5	5.4	5.4	7.1	4.7	8.9	5.3	7.2	5.3	7.5	13.1	8.5	7.9	8.4	4.5	8.4	8.2	7.6	5.3	7.0	6.6	12.7	6.6	12.0	6.7	5.1	19.9	10.0	8.4	6.3	36.0	41.7	27.5	24.9	14.7	11.4	37.2	29.6	24.0	47.6	68.0	45.4	32.1	35.6	35.2	19.1	61.2	35.1	64.2	35.3	57.2	36.5	39.9	32.8	38.8	29.8	19.4	46.9	33.8	11.3	16.5	49.8	32.6	12.7	29.0	31.3	56.2	33.7	29.2	41.9	38.4	31.8	76.8	55.7	39.9	35.8	46.3	42.3	17.5	34.4	24.1	30.4	49.1	20.5	20.4	27.6	20.5	20.3	25.8	26.2	42.3	38.1	37.8	22.8	52.3	45.9	22.5	48.6	32.4	20.0	16.1	11.1	23.4	18.9	17.9	17.4	21.1	21.8	23.3	16.9	19.0	17.8	2.6	23.9	25.8	16.7	24.2	15.3	5.7	6.0	6.7	6.3	5.9	6.4	5.4	5.4	5.3	5.3	6.6	6.3	4.1	3.2	1.1	3.9	8.2	4.2	4.6	20.7	9.6	2.2	3.1	3.0	4.9	2.8	12.9	0.0	2.1	16.7	3.6	5.9	5.9	12.5	13.3	6.3	4.9	4.6	4.2	12.8	10.4	8.3	18.4	4.3	6.1	4.3	3.8	5.5	2.5	1.5	10.8	3.3	10.8	3.7	14.2	2.5	3.7	2.4	4.7	4.3	1.8	1.0	5.9	4.5	4.1	7.1	5.7	15.4	6.7	4.1	6.2	2.0	5.4	4.0	9.9	2.9	6.6	2.7	5.7	18.8	25.5	14.4	4.1	7.7	7.1	5.0	6.4	5.0
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695486-51699595	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	13.5	13.2	10.6	17.4	13.1	13.6	11.7	13.4	13.4	11.0	11.2	10.4	11.7	11.7	10.3	9.0	14.8	10.2	14.4	10.4	11.5	11.9	12.6	9.6	19.6	13.3	12.6	17.9	12.3	18.0	6.0	11.9	13.1	11.9	10.6	13.8	10.7	9.3	22.2	10.9	11.6	12.2	13.9	17.6	11.1	9.5	12.0	21.5	11.5	22.8	19.4	12.4	6.3	18.4	16.2	18.9	27.9	29.4	38.5	26.2	1.9	22.5	20.7	25.4	24.7	25.3	23.2	46.5	12.7	19.7	15.4	24.8	21.2	23.6	22.9	27.1	24.0	26.8	19.9	4.7	18.6	10.5	23.6	38.0	18.0	22.4	25.8	16.1	19.3	26.9	29.3	25.6	22.2	13.9	42.9	16.8	10.3	19.7	40.3	33.7	56.2	9.9	19.6	13.4	23.3	30.1	18.8	19.4	20.4	28.9	36.2	19.2	20.7	16.2	22.1	15.1	28.5	32.5	13.0	32.9	33.7	24.1	14.3	2.8	4.1	4.5	3.5	3.8	4.9	1.7	2.6	2.8	4.3	3.0	4.4	4.0	1.1	10.9	2.8	2.7	4.6	2.9	10.6	13.1	13.4	13.4	10.4	11.5	13.3	12.6	13.1	13.9	12.0	18.4	13.4	9.6	7.5	2.9	15.8	9.1	7.1	15.7	12.5	18.2	8.7	5.6	14.3	8.6	11.1	9.2	8.4	24.1	13.7	7.5	23.5	16.4	1.7	9.2	13.5	17.7	6.1	17.7	4.6	15.3	14.6	12.4	9.7	7.8	20.3	10.9	17.9	16.7	15.4	20.2	5.7	8.7	10.2	14.8	8.3	2.7	23.9	8.9	0.0	3.7	22.5	13.2	33.0	3.0	19.3	13.9	6.1	19.9	7.1	4.1	9.3	13.6	17.8	13.7	6.6	16.1	9.1	37.0	15.7	8.5	6.5	6.2	17.2	12.0	11.2	5.1
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	13.8	21.2	28.5	20.8	30.9	12.7	19.5	34.7	39.8	24.2	30.5	20.3	19.1	19.8	61.1	26.7	21.2	14.9	17.1	30.0	32.4	28.9	34.6	21.3	26.6	26.3	26.8	25.9	21.1	18.2	57.6	19.1	27.4	30.4	20.0	31.9	20.6	15.0	16.9	26.1	20.2	13.7	26.1	25.5	18.6	32.9	31.1	23.8	29.8	11.8	21.5	22.0	24.7	32.9	45.8	43.3	82.8	56.4	22.0	38.7	59.8	44.2	28.5	48.5	66.2	31.7	34.9	49.3	31.2	28.5	32.4	58.5	73.8	42.9	77.5	52.7	128.3	50.6	109.1	58.2	24.9	66.5	30.9	28.2	30.6	37.6	36.7	39.1	64.4	39.2	67.9	34.2	66.4	32.3	66.8	35.7	40.3	34.6	54.0	52.2	80.5	39.7	54.6	58.2	61.4	34.9	50.9	29.9	37.6	52.7	54.4	44.1	39.5	40.3	49.7	64.5	59.7	32.3	46.8	41.9	47.4	68.9	40.2	4.6	4.8	7.0	5.8	6.9	6.8	6.5	7.2	5.8	7.7	5.0	7.5	7.9	1.9	6.9	8.3	5.7	9.1	3.7	28.5	30.9	34.7	39.8	30.0	32.4	26.3	26.8	27.4	26.1	31.1	32.9	12.8	19.2	18.7	38.5	19.0	18.9	50.6	50.1	10.2	33.3	22.3	19.9	21.8	17.2	43.5	58.8	6.2	63.0	12.7	15.1	62.6	24.3	37.6	31.4	20.7	21.2	31.8	34.9	75.2	16.9	32.0	23.1	15.3	18.9	14.5	29.0	11.0	57.3	28.4	13.5	59.1	30.0	77.3	22.0	21.1	10.3	29.8	17.0	28.4	42.2	28.1	35.7	14.4	62.4	56.9	20.8	18.6	29.7	14.0	33.0	20.6	47.0	68.0	25.2	26.3	26.1	25.4	77.3	57.6	19.1	19.5	33.8	18.3	25.3	29.6	55.6
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.8"	"Group enriched"	"Detected in some"	50	"Spermatocytes: 3.5;Spermatogonia: 6.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 246.0;Karpas-707: 112.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	246.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	112.8	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.5	0.0	0.3	1.7	33.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 47.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	85.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	94.7	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	18.5	88.6	0.1	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.2	1.3	0.4	1.5	0.6	2.0	0.6	1.3	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 9.5"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 94.7;T-47d: 63.5;U-266/84: 308.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.7	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.4	0.0	0.0	2.3	0.0	0.0	0.4	308.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.1	0.8	0.8	1.2	0.8	1.0	0.6	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pituitary gland: 1.9;testis: 3.5"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Spermatogonia: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 195.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	9.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	6.4	0.0	0.1	2.0	195.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	1.0	0.5	1.2	0.6	2.8	1.7	0.3	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794685-135802787	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;HMC-1: 3.0;Karpas-707: 2.6;RPMI-8226: 4.5;U-266/84: 13.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.9	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 70.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	70.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846497-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HMC-1: 115.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863418-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	49.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A1	CT47.1	ENSG00000236371	"Cancer/testis antigen family 47 member A1"	Q5JQC4	X	120982476-120985788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"U-266/70: 2.2"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA					"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A10	CT47.10	ENSG00000224089	"Cancer/testis antigen family 47 member A10"	Q5JQC4	X	120938701-120942023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A11	CT47.11	ENSG00000226929	"Cancer/testis antigen family 47 member A11"	Q5JQC4	X	120933840-120937158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-266/70: 1.7"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A12	CT47.12	ENSG00000226685	"Cancer/testis antigen family 47 member A12"	Q5JQC4	X	120930250-120932301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A2	CT47.2	ENSG00000242362	"Cancer/testis antigen family 47 member A2"	Q5JQC4	X	120977606-120980928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A3	CT47.3	ENSG00000236126	"Cancer/testis antigen family 47 member A3"	Q5JQC4	X	120972746-120976068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A4	CT47.4	ENSG00000230594	"Cancer/testis antigen family 47 member A4"	Q5JQC4	X	120967886-120971208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A5	CT47.5	ENSG00000237957	"Cancer/testis antigen family 47 member A5"	Q5JQC4	X	120963026-120966348	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A6	CT47.6	ENSG00000226023	"Cancer/testis antigen family 47 member A6"	Q5JQC4	X	120958165-120961487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA						"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A7	CT47.7	ENSG00000228517	"Cancer/testis antigen family 47 member A7"	Q5JQC4	X	120953282-120956600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A8	CT47.8	ENSG00000230347	"Cancer/testis antigen family 47 member A8"	Q5JQC4	X	120948422-120951744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A9	CT47.9	ENSG00000226600	"Cancer/testis antigen family 47 member A9"	Q5JQC4	X	120943561-120946883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47B1	CT47.13	ENSG00000236446	"Cancer/testis antigen family 47 member B1"	P0C2W7	X	120872603-120875929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 6.8"	"Group enriched"	"Detected in some"	42	"Spermatocytes: 112.2;Spermatogonia: 76.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	76.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAG1A	"ESO1, LAGE2A"	ENSG00000268651	"Cancer/testis antigen 1A"	P78358	X	154585133-154586816	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	67	"testis: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	173	"U-266/70: 749.2;U-266/84: 332.1"									CAB013061	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"				"CAB013061: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	749.2	332.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAG1B	"CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1"	ENSG00000184033	"Cancer/testis antigen 1B"	P78358	X	154617609-154619282	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-266/70: 671.4"									CAB015453	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"				"CAB015453: AB_784921"																		0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	671.4	41.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 5.4;testis: 10.4"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 77.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.8	1.5	0.0	5.4	0.0	0.0	3.4	0.7	0.3	0.0	0.1	0.0	0.5	2.0	0.0	0.3	2.6	0.1	0.3	0.0	0.0	0.1	0.0	3.3	0.4	0.2	0.0	0.0	0.4	0.5	10.4	0.0	3.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	2.9	0.0	0.0	0.2	0.0	0.0	203.6	0.0	0.0	0.0	311.3	0.0	0.0	0.4	0.0	0.0	195.4	0.3	0.0	0.2	0.6	0.3	6.3	0.2	0.7	0.2	2.6	356.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.2	0.9	0.0	3.9	0.0	0.2	0.0	1.8	0.2	0.0	0.0	0.5	0.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	1.2	0.5	0.0	0.0	0.6	18.5	77.3	0.0	0.0	1.1	0.1	0.0	0.0	0.0
CTAGE1	"CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2"	ENSG00000212710	"Cutaneous T cell lymphoma-associated antigen 1"	"Q96RT6, Q9HC47"	18	22413599-22417915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	103	"testis: 10.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 117.4;Spermatocytes: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922, CAB016204"	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581"					"unprognostic (1.41e-1)"		"unprognostic (5.65e-2)"	"unprognostic (2.34e-1)"		"unprognostic (1.81e-2)"	"unprognostic (1.52e-1)"		"unprognostic (1.70e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.62e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.3	16.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.5	0.5	36.1	0.8	0.0	0.3	0.1	0.1	0.1	0.0	0.6
CTAGE15	CTAGE15P	ENSG00000271079	"CTAGE family member 15"	A4D2H0	7	143571801-143574387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"testis: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (2.82e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.32e-1)"		"unprognostic (2.44e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.52e-2)"		"unprognostic (9.94e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.39e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.0	1.4	0.2	0.0	0.1	0.0	0.0	1.6	0.8	0.4	0.0	0.0	0.0	0.3	0.7	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	1.7	0.5	0.0	0.0	0.2	0.6	8.1	0.0	0.0	1.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CTAGE4	"cTAGE-4, FLJ43692"	ENSG00000225932	"CTAGE family member 4"	Q8IX94	7	144183466-144186053	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.6;Club cells: 1.3;Early spermatids: 1.1;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.3;hTCEpi: 12.9;RPTEC TERT1: 11.6;T-47d: 8.3;WM-115: 8.0"									"HPA000387, HPA000922"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 71: Testis - DNA repair"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.17e-2)"		"unprognostic (2.80e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.15e-1)"		"unprognostic (1.26e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.68e-1)"	1.5	0.5	0.2	0.4	0.3	0.6	4.5	0.2	0.2	2.7	1.1	4.5	4.7	0.8	3.0	8.6	1.5	2.6	0.8	0.1	0.2	10.5	5.7	2.9	0.7	0.4	0.4	1.8	5.6	0.7	2.7	1.5	0.3	4.3	4.0	1.2	4.6	1.0	0.1	11.9	3.9	0.3	0.2	1.6	4.1	14.9	0.3	0.5	10.0	0.1	0.6	1.5	4.0	0.2	15.3	0.1	0.0	0.0	0.0	0.0	6.2	0.4	0.2	0.0	0.1	1.4	4.9	0.0	0.0	0.5	0.3	0.4	0.0	2.7	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.3	12.9	0.4	4.0	0.7	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	11.6	3.7	0.0	0.0	6.1	5.8	0.4	2.3	8.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.1	0.2	0.4	0.4	0.3	0.2	0.3	0.2	0.0	3.2	5.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.1
CTAGE6	"CTAGE6P, MGC41943"	ENSG00000271321	"CTAGE family member 6"	Q86UF2	7	143755089-143757696	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	43	"testis: 14.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.1;Microglial cells: 1.0;Spermatocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA000387: AB_1078582, HPA000922: AB_1078581"		"unprognostic (1.51e-2)"											"unprognostic (8.90e-12)"	"unprognostic (1.73e-2)"			"unprognostic (2.86e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
CTAGE8		ENSG00000244693	"CTAGE family member 8"	P0CG41	7	144266701-144269288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 10.8"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.6;Club cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.8;CAPAN-2: 3.7;HaCaT: 4.5;OE19: 7.1;RT4: 4.5"									"HPA000387, HPA000922"	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (4.80e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-1)"			"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	1.0	0.3	0.3	0.6	0.2	0.6	2.1	0.2	0.2	1.5	1.8	2.7	2.3	0.7	0.4	5.3	0.9	1.0	0.6	0.1	0.3	9.2	3.5	1.9	0.3	0.3	0.4	1.4	3.4	1.9	1.8	0.6	0.3	3.1	1.1	0.6	3.2	0.6	0.1	7.8	2.9	0.2	0.2	1.0	2.9	10.8	0.3	0.2	7.0	0.2	0.5	1.0	2.4	0.2	9.8	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.1	2.2	3.7	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	1.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	7.1	0.0	0.0	0.0	0.0	1.0	4.5	0.0	0.0	2.2	2.2	1.8	0.6	1.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.1	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.0	6.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CTAGE9		ENSG00000236761	"CTAGE family member 9"	A4FU28	6	131708441-131711017	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 8.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.6;Spermatocytes: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (3.92e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.48e-2)"			"unprognostic (1.92e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.36e-1)"		"unprognostic (5.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.74e-4)"	"unprognostic (3.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Nucleoplasm		NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161"	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favorable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	27.1	25.4	21.4	17.1	23.7	17.2	30.6	32.9	20.1	47.9	47.8	36.7	33.3	46.8	21.0	30.4	37.3	22.1	19.9	22.8	25.5	31.7	5.7	33.1	9.4	24.3	24.1	41.8	40.7	21.9	23.6	24.7	22.0	38.6	29.2	55.4	36.7	24.0	22.8	16.7	33.4	30.0	22.1	21.6	36.9	19.7	28.8	9.0	53.9	19.8	9.1	29.9	30.9	23.7	87.3	96.5	83.6	70.2	43.9	43.0	46.1	66.4	77.0	61.2	69.3	60.4	99.7	0.1	33.6	66.9	38.6	67.2	83.8	106.5	45.8	0.3	63.8	63.8	61.6	1.3	91.7	27.2	48.9	37.1	82.7	63.5	125.5	80.9	79.1	4.9	2.6	0.5	38.7	96.5	3.0	27.8	63.0	90.3	61.3	77.4	35.0	0.8	72.5	38.8	25.5	73.1	64.7	56.0	86.5	64.7	39.7	43.9	64.4	36.8	46.2	53.0	57.9	1.4	5.3	0.3	46.1	0.3	37.1	30.8	8.5	16.4	8.5	9.0	1.1	0.5	0.4	2.3	11.2	0.3	0.5	3.6	14.3	34.6	22.4	9.4	0.3	4.7	21.4	23.7	32.9	20.1	22.8	25.5	24.3	24.1	22.0	22.1	28.8	23.7	64.7	32.1	27.2	72.1	4.0	47.2	83.4	41.5	33.6	182.5	75.8	59.8	32.7	55.8	53.2	38.6	158.4	22.3	50.7	81.7	68.4	69.3	29.9	125.0	65.1	63.0	55.0	42.3	41.8	60.8	70.5	42.3	40.2	163.0	17.7	43.1	61.4	1.2	29.6	107.7	35.0	93.9	50.8	49.3	46.9	38.1	60.3	47.0	58.7	127.4	60.6	63.2	124.6	44.2	87.1	83.8	61.6	77.8	6.9	89.3	45.1	31.6	94.1	107.5	59.2	59.6	67.0	12.7	45.5	42.1	39.8	19.3	15.3	81.3	106.1	102.7
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549611-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"basal ganglia: 7.4"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		370000000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	1.5	1.4	0.4	1.4	0.8	3.3	1.6	1.0	0.6	1.2	2.1	1.2	0.9	1.5	3.1	1.0	1.1	1.2	1.0	0.2	0.6	1.7	3.7	1.4	1.6	1.3	0.9	0.8	1.7	1.6	0.5	1.2	1.5	2.2	1.4	1.4	3.3	0.8	0.8	2.4	1.2	1.1	0.5	2.5	1.4	0.5	0.8	1.0	1.3	0.9	1.0	1.0	0.5	1.3	0.9	0.3	0.2	0.2	2.7	3.2	0.6	0.6	2.2	0.3	0.8	0.1	1.1	1.2	0.2	1.4	0.3	0.4	0.0	0.9	0.9	1.1	0.3	0.8	0.1	0.1	1.6	0.8	0.4	2.4	1.6	0.8	1.2	1.9	0.9	0.5	0.7	2.2	0.6	0.0	0.5	0.9	0.2	0.2	0.3	0.2	0.3	0.8	1.9	0.4	0.1	0.4	0.2	0.9	1.1	0.5	0.5	0.9	1.5	1.1	0.1	1.5	0.7	0.6	0.2	0.3	0.8	1.1	0.8	0.5	0.1	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	0.4	0.8	1.0	0.6	0.2	0.6	1.3	0.9	1.5	0.5	0.8	1.3	43.6	9.6	23.4	10.4	37.4	30.3	30.2	28.0	34.1	5.9	33.1	15.6	5.8	31.5	25.5	23.9	41.7	26.8	25.4	30.2	43.0	20.2	3.3	24.1	24.4	29.9	23.0	14.1	6.2	19.2	24.2	28.1	25.0	19.4	43.8	9.7	49.6	70.8	48.2	3.3	4.3	18.9	16.2	75.5	27.9	3.7	21.1	58.8	7.2	20.6	56.5	21.8	18.6	5.5	9.0	19.1	25.2	24.5	59.8	36.7	30.0	44.4	38.2	41.9	13.1	20.2	16.6	10.4	12.8	27.3	24.7	25.6	26.8	25.3	18.4	29.9
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 61.3;Spermatogonia: 143.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HMC-1: 79.6;K-562: 116.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.1	0.2	0.4	0.2	0.5	1.0	0.2	1.2	0.6	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.5	0.2	0.4	0.2	0.4	0.1	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.9	0.1	0.1	0.2	0.5	0.3	0.1	0.0	0.3	0.2	11.0	0.3	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.4	0.2	0.1	0.0	0.4	0.2	0.3	0.7	0.1	0.2	0.2	79.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	116.1	0.6	0.0	0.1	0.3	0.4	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.3	0.1	0.2	0.3	0.4	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.3	0.1	2.9	0.3	0.3	0.4	0.5	0.1	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.2	0.2	0.1	0.0	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.0	0.1	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.0	0.0	6.6	0.1	0.2	61.3	143.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	99.7	94.2	53.0	41.4	52.5	48.8	91.4	49.2	55.1	102.4	51.2	89.8	36.4	97.6	37.1	105.2	88.2	32.1	119.0	49.9	49.0	85.5	69.1	91.6	45.9	55.9	52.7	103.4	98.5	44.4	83.8	41.1	51.2	81.8	46.7	29.7	82.6	33.6	410.0	114.7	93.8	45.0	50.5	115.9	95.4	66.5	55.8	56.2	81.2	179.2	61.8	88.2	87.0	52.8	86.2	123.9	68.4	73.7	105.0	128.0	52.5	62.4	102.8	97.4	83.1	59.6	57.7	80.6	65.6	111.5	68.6	70.5	90.8	95.4	108.6	118.5	74.6	55.2	79.7	104.1	96.5	63.3	100.3	103.4	113.8	111.9	118.3	99.9	105.2	76.2	50.9	56.3	93.3	53.4	77.3	67.0	48.3	75.7	50.9	85.3	61.3	62.6	77.9	44.1	26.3	75.5	49.8	48.9	69.8	67.6	46.3	51.5	61.6	70.9	61.3	57.5	119.4	49.2	46.0	40.6	91.5	85.8	75.1	4.2	6.3	11.0	5.5	6.7	4.4	7.8	5.2	5.9	4.6	7.4	4.0	5.9	8.4	4.1	4.5	9.7	5.7	2.3	53.0	52.5	49.2	55.1	49.9	49.0	55.9	52.7	51.2	50.5	55.8	52.8	48.0	25.6	23.2	12.7	47.1	47.2	42.4	36.1	19.9	44.8	73.9	70.1	13.1	37.1	33.5	40.5	22.9	66.1	68.3	84.5	11.7	63.7	4.8	50.0	59.9	47.2	73.7	18.5	14.7	85.2	129.9	43.5	22.4	68.5	20.3	71.3	44.6	35.6	90.6	30.3	17.0	79.6	22.4	104.4	62.2	7.9	57.8	69.8	28.4	14.0	69.2	47.9	59.8	11.6	21.9	84.5	52.1	47.0	41.3	58.3	62.8	34.8	25.8	35.4	26.3	42.5	51.4	23.7	35.5	32.5	67.1	83.2	41.3	68.3	69.6	61.8
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679803-79754510	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 113.1;Late spermatids: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	9.3	7.4	3.8	7.2	3.9	13.7	8.9	3.3	4.2	7.8	4.1	11.1	7.2	10.4	1.4	10.7	8.1	4.0	7.2	3.3	3.3	7.9	9.5	9.3	8.7	5.3	4.2	5.0	9.0	3.3	6.9	4.2	4.0	8.2	3.1	1.5	9.5	3.9	11.9	20.5	10.9	3.1	3.3	13.5	9.9	22.2	4.0	6.5	8.0	3.1	3.7	9.6	8.6	4.4	13.4	14.0	7.7	11.0	6.0	5.0	25.9	9.6	6.1	7.6	7.5	9.4	8.0	17.2	4.2	5.6	9.1	16.4	6.6	8.8	3.1	16.9	12.4	8.5	6.6	12.9	8.7	37.6	20.5	8.4	8.3	8.1	3.8	4.6	9.2	12.2	11.2	8.1	3.0	11.5	25.4	29.5	12.7	4.2	19.1	20.7	10.1	20.0	5.6	13.1	12.0	12.4	10.2	9.8	13.9	5.8	8.0	21.7	12.9	12.9	19.4	5.3	9.7	7.4	27.6	16.1	11.0	18.8	9.3	0.0	0.4	3.2	0.5	0.4	0.4	0.2	0.4	0.8	0.6	0.1	0.5	0.3	1.0	1.1	0.4	0.1	0.1	0.2	3.8	3.9	3.3	4.2	3.3	3.3	5.3	4.2	4.0	3.3	4.0	4.4	7.4	0.0	4.1	3.6	9.2	8.5	5.0	4.0	11.4	9.5	7.7	6.5	3.8	4.3	4.5	3.7	14.6	8.8	24.2	20.0	1.9	5.4	113.1	18.6	8.0	7.5	6.0	13.5	7.7	7.2	8.0	4.8	19.9	24.0	7.0	7.8	6.4	5.7	8.8	23.5	6.6	16.6	6.1	7.5	9.5	123.2	7.8	13.8	7.2	6.5	6.5	6.5	19.6	3.0	8.9	10.2	14.9	10.5	15.2	11.8	10.0	6.8	9.6	14.8	0.0	5.9	7.4	18.0	10.5	10.5	10.1	19.0	18.3	8.0	11.7	12.6
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 1208.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	90.9	82.5	66.8	65.4	80.0	45.7	81.8	79.7	69.3	84.0	61.0	108.9	54.3	96.4	51.4	67.0	89.9	64.7	72.4	64.6	63.0	66.2	58.8	113.9	66.1	90.7	80.6	107.3	119.4	68.2	40.3	94.3	76.5	70.1	83.2	30.1	109.1	82.8	122.3	88.9	77.0	94.8	71.4	75.5	89.9	32.3	74.3	104.8	68.1	102.8	77.5	85.2	71.8	83.4	83.1	35.4	165.6	105.8	145.6	248.8	55.0	87.4	165.1	85.2	75.4	45.6	131.5	101.3	98.1	187.5	33.2	64.8	70.0	85.3	88.8	34.2	29.7	140.3	54.4	37.0	135.4	64.3	78.3	239.7	88.9	77.3	65.1	181.9	135.0	60.6	74.5	172.9	43.4	38.2	69.1	38.3	84.3	52.5	44.4	91.0	1208.7	133.2	66.2	118.6	31.1	68.3	122.1	69.4	105.3	100.2	125.8	110.4	109.3	75.0	80.8	85.6	31.5	51.4	59.6	120.3	84.4	58.5	59.7	12.6	9.1	14.4	6.1	8.5	7.2	6.6	8.6	7.1	8.7	6.0	9.8	7.6	17.2	8.2	7.6	7.2	6.2	7.4	66.8	80.0	79.7	69.3	64.6	63.0	90.7	80.6	76.5	71.4	74.3	83.4	50.9	73.7	42.7	31.3	28.5	67.6	45.2	34.6	51.8	19.0	51.2	36.6	34.0	78.6	27.6	47.8	16.7	43.7	48.8	151.1	15.6	72.9	52.2	33.4	51.2	59.3	48.7	50.1	15.8	135.0	41.4	51.0	20.4	50.1	24.7	44.2	86.4	59.1	42.3	20.2	11.0	39.4	16.2	76.1	43.5	151.9	51.9	39.5	42.7	16.9	81.9	44.4	42.2	17.6	27.9	105.8	49.3	48.5	30.3	70.4	57.5	30.6	18.4	11.2	72.3	49.2	53.3	6.3	25.1	39.6	76.1	56.2	34.3	34.8	37.3	99.2
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861880-37984469	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 132.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	21.1	9.2	19.4	6.3	20.6	10.0	28.1	24.3	23.2	20.3	17.1	33.4	14.3	20.2	14.0	23.8	17.9	29.3	29.4	18.8	17.3	39.7	21.5	27.2	4.1	19.2	17.7	19.6	15.8	12.0	10.7	31.7	16.6	26.5	30.2	3.2	27.1	31.3	21.2	52.9	17.6	23.2	18.1	17.3	31.7	10.6	19.5	7.2	14.0	19.9	5.5	26.4	19.1	17.3	44.5	18.9	7.6	24.0	29.2	41.0	57.2	30.0	37.0	20.1	23.5	27.4	35.3	0.2	17.9	36.9	8.4	36.3	19.2	56.1	16.0	0.1	15.1	27.2	18.8	63.1	26.4	0.0	6.4	21.5	132.3	21.2	25.5	22.4	28.2	12.0	8.9	0.0	33.7	13.7	11.1	0.1	31.5	17.7	2.7	12.3	14.9	0.2	63.3	28.7	6.3	19.9	16.5	28.7	33.5	30.5	28.1	7.3	23.2	14.4	20.4	27.3	19.1	0.6	0.2	0.2	15.8	14.8	27.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.1	19.4	20.6	24.3	23.2	18.8	17.3	19.2	17.7	16.6	18.1	19.5	17.3	26.8	67.3	27.6	170.4	1.2	30.1	17.0	17.7	27.9	10.1	25.7	59.4	42.2	65.8	25.7	23.9	0.0	34.7	1.0	35.6	23.5	14.2	21.5	7.6	17.6	22.4	45.2	7.8	189.3	4.7	9.9	32.4	10.2	27.2	1.3	15.7	22.9	18.1	7.2	10.1	126.3	18.5	2.0	13.3	6.5	51.3	71.7	11.3	8.8	22.5	1.4	9.5	1.0	87.4	48.8	14.2	17.9	98.2	0.4	15.5	9.1	19.7	12.4	1.7	26.3	55.4	40.4	10.0	16.9	17.7	28.7	9.4	2.0	65.8	42.0	14.4
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427622-44529038	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.5;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	9.1	7.4	2.9	12.9	3.6	20.5	14.1	12.8	5.3	14.0	3.4	10.8	10.0	17.5	7.0	12.5	11.1	11.9	9.5	3.4	4.4	10.7	10.3	10.4	19.4	3.4	2.7	19.1	11.5	11.1	4.0	15.8	3.1	10.2	11.3	15.1	9.1	10.2	5.4	8.1	12.7	13.9	3.0	13.3	9.8	21.0	2.9	25.3	15.0	9.4	19.0	12.2	6.2	6.0	28.6	14.2	57.7	29.4	9.1	19.9	31.9	29.1	25.4	37.3	46.8	29.3	26.4	30.1	27.7	20.3	20.6	39.2	33.4	19.6	42.6	30.9	16.1	37.4	34.8	17.6	12.3	65.7	33.5	15.7	14.0	25.6	33.4	15.8	28.4	37.9	44.2	34.0	26.7	12.1	78.2	23.1	31.2	30.4	20.3	86.7	80.5	28.0	19.4	38.9	26.7	38.5	36.0	28.5	16.2	21.2	38.7	57.7	24.9	46.0	49.5	44.3	49.4	19.3	79.2	93.9	22.2	50.4	36.0	7.4	10.8	9.2	10.3	11.3	9.4	10.6	9.8	9.3	13.8	10.5	10.4	11.8	7.7	15.7	8.9	8.8	14.9	9.4	2.9	3.6	12.8	5.3	3.4	4.4	3.4	2.7	3.1	3.0	2.9	6.0	34.4	19.2	35.7	26.4	25.4	24.6	14.7	14.5	27.9	23.7	24.5	21.0	23.1	11.5	31.3	12.9	10.4	18.9	40.9	16.9	17.6	12.5	165.5	18.3	35.4	27.2	9.0	16.2	41.8	14.6	18.4	30.2	11.7	29.6	36.0	26.7	20.3	13.6	14.0	30.3	41.2	13.9	20.3	22.2	20.9	166.9	20.2	22.1	16.0	49.6	23.8	19.2	39.1	50.3	65.7	17.7	10.4	13.2	24.0	18.0	17.2	14.5	19.5	31.1	26.3	30.4	34.2	23.7	31.4	19.6	21.9	14.6	31.4	21.9	15.3	16.8
CTF1	"CT-1, CT1"	ENSG00000150281	"Cardiotrophin 1"	Q16619	16	30896614-30903547	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.4;Cardiomyocytes: 11.4;Distal tubular cells: 31.3;Muller glia cells: 21.1;Proximal tubular cells: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.6;ASC TERT1: 14.7;fHDF/TERT166: 11.9;HHSteC: 13.0;HSkMC: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025853	Uncertain				"Secreted to blood"	NA	NA	11900		"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB025853: "	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (7.22e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.79e-1)"	6.4	8.1	4.8	1.3	4.7	1.5	6.7	4.1	5.2	14.7	5.3	13.4	0.8	17.3	4.2	5.3	12.1	3.8	16.0	4.5	4.5	10.2	1.2	7.4	1.3	5.3	5.8	18.4	3.6	10.0	5.2	2.0	4.7	12.2	1.0	2.1	5.7	12.7	14.1	2.7	4.6	7.6	5.5	1.7	7.6	3.4	5.0	2.1	8.5	10.9	1.1	14.0	9.6	5.0	2.0	0.3	2.6	5.7	13.6	14.7	4.5	4.3	8.5	4.4	5.6	2.4	0.4	0.1	8.3	11.9	0.4	1.5	0.0	3.0	4.4	0.1	0.2	0.1	0.2	0.9	13.0	0.2	0.8	13.9	3.8	3.3	8.0	4.9	1.2	0.2	3.7	0.4	7.9	0.3	0.3	0.4	0.8	1.2	0.8	1.6	3.9	0.0	0.7	0.9	0.2	1.4	0.0	0.1	0.0	4.0	6.9	0.3	0.9	4.2	5.2	0.2	0.1	0.1	0.1	0.2	3.3	0.5	0.0	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.4	0.1	0.1	0.3	0.0	0.0	4.8	4.7	4.1	5.2	4.5	4.5	5.3	5.8	4.7	5.5	5.0	5.0	0.8	3.2	6.4	2.6	0.8	0.4	16.4	1.8	2.2	0.3	6.2	7.1	11.4	2.8	1.8	7.3	0.0	0.3	1.2	0.0	31.3	1.0	0.6	7.1	2.9	1.1	0.0	0.4	0.3	0.4	0.2	3.9	0.0	2.4	0.0	3.8	0.0	0.4	0.6	0.0	0.6	0.2	0.0	0.6	0.8	0.7	2.1	1.1	0.0	1.0	0.4	21.1	0.0	1.0	0.4	0.4	0.0	2.6	0.6	2.7	0.2	14.4	2.5	0.9	0.0	4.6	3.0	0.8	0.4	1.9	0.3	0.4	0.7	3.9	0.2	7.4
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 122.9;ovary: 34.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	4.3	12.9	3.4	1.3	3.1	3.4	2.9	3.3	4.0	2.5	4.5	5.1	5.2	2.2	1.6	4.5	3.8	1.8	2.4	3.3	3.6	13.5	122.9	3.1	0.9	3.4	3.7	34.4	17.0	1.4	2.9	1.1	3.4	4.3	6.2	8.1	2.5	2.1	3.6	1.2	5.3	1.3	2.7	1.0	7.4	4.1	3.7	0.6	7.7	2.9	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.1	3.3	4.0	3.3	3.6	3.4	3.7	3.4	2.7	3.7	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
CTHRC1		ENSG00000164932	"Collagen triple helix repeat containing 1"	Q96CG8	8	103371538-103382989	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.1;gallbladder: 87.8;placenta: 90.1;urinary bladder: 84.6"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 95.2;Fibroblasts: 181.6;Langerhans cells: 45.9;Melanocytes: 49.8;Smooth muscle cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 294.6;fHDF/TERT166: 138.1;HHSteC: 197.1;HSkMC: 406.6;WM-115: 386.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059806, HPA061896"	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		420000	"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA059806: AB_2684130, HPA061896: AB_2684633"	"unprognostic (2.04e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.22e-14)"	"unprognostic (2.33e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.37e-3)"	69.1	2.8	1.6	15.4	1.8	0.5	39.0	5.7	6.3	12.8	0.4	6.6	6.3	18.7	3.3	9.7	5.3	87.8	8.9	1.5	2.3	2.3	0.8	8.9	13.8	2.0	1.6	4.2	3.7	2.2	3.7	90.1	2.5	4.7	6.2	2.4	17.0	5.6	3.6	32.5	3.5	19.7	1.8	2.6	3.6	3.6	1.5	6.2	9.1	4.1	16.0	84.6	6.6	3.3	12.1	0.9	3.3	0.8	90.6	294.6	0.2	34.8	9.3	3.7	5.0	1.1	8.3	1.5	36.6	138.1	0.2	0.4	0.1	0.2	17.7	0.5	0.0	0.5	0.6	19.2	197.1	0.9	0.7	406.6	0.5	30.7	0.4	1.4	60.2	2.3	0.5	91.6	18.7	1.7	17.2	41.1	11.0	0.4	58.0	35.8	30.9	1.1	2.9	0.2	5.7	4.3	0.1	0.2	110.8	12.6	0.1	0.2	49.0	4.6	1.8	4.8	0.4	3.0	0.8	0.6	2.2	0.2	386.9	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.2	0.0	0.1	1.6	1.8	5.7	6.3	1.5	2.3	2.0	1.6	2.5	1.8	1.5	3.3	36.9	3.2	2.3	1.0	6.7	32.0	0.2	12.1	0.0	0.3	0.9	1.4	0.8	1.5	3.6	3.7	0.0	5.6	0.9	0.0	0.0	4.1	0.5	6.4	9.8	95.2	1.2	0.8	2.3	0.6	11.3	181.6	0.0	11.5	0.0	0.5	17.5	0.1	8.0	0.0	2.0	0.0	4.1	0.3	45.9	0.8	12.5	0.9	49.8	3.7	0.6	5.5	1.0	4.5	1.8	1.8	0.0	0.4	24.2	0.8	0.0	0.5	0.8	1.2	0.0	4.7	77.4	4.3	16.5	0.3	27.3	16.6	3.5	1.2	0.2	0.5
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539031-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	35.3	20.0	15.7	3.3	13.9	2.0	24.3	10.7	23.2	14.0	0.0	26.0	2.5	21.5	2.6	11.4	16.3	7.5	24.8	16.0	15.5	11.1	24.8	14.3	1.3	20.7	17.4	28.0	9.8	4.6	12.4	4.3	23.3	13.9	1.6	7.4	11.0	5.4	15.8	14.0	9.9	7.0	9.1	6.7	19.6	7.3	19.0	1.4	10.7	4.3	1.0	26.1	12.6	16.7	3.2	3.4	4.5	5.8	11.3	6.0	2.5	15.9	13.2	12.4	11.2	3.5	1.9	0.0	3.5	22.0	5.2	6.7	3.3	9.0	5.3	0.0	2.7	1.4	7.9	8.4	21.6	2.6	4.5	8.4	14.5	7.8	13.8	8.9	8.9	4.1	4.0	9.8	8.0	1.7	0.9	2.0	2.2	3.4	2.8	1.6	5.2	4.2	3.7	4.3	9.6	9.7	5.6	6.0	4.5	3.8	3.8	3.1	18.1	11.4	10.5	3.4	2.9	3.3	4.2	0.0	10.1	1.6	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	13.9	10.7	23.2	16.0	15.5	20.7	17.4	23.3	9.1	19.0	16.7	7.3	35.3	3.7	94.7	1.9	3.3	2.1	3.5	2.8	25.6	11.2	8.4	16.0	5.7	5.6	7.3	16.7	1.9	0.8	4.6	7.9	5.1	11.1	1.7	7.7	8.5	3.5	0.4	76.4	4.8	2.8	13.1	7.1	3.6	4.5	19.5	7.5	23.0	4.2	11.8	80.6	3.5	4.1	6.4	2.7	19.3	25.1	5.0	3.6	30.0	1.5	3.6	3.1	75.9	59.7	5.7	2.7	50.8	4.8	3.0	5.9	5.8	4.7	8.8	6.6	8.8	9.4	2.3	1.8	3.5	2.3	1.2	0.7	34.7	3.3	3.3
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		57000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	144.4	137.1	88.3	65.9	110.4	33.1	126.4	102.9	100.6	110.9	103.2	155.8	115.5	99.2	115.7	208.9	113.4	95.6	190.7	83.7	91.3	151.8	82.4	134.4	35.6	106.8	99.4	101.5	83.8	120.4	54.3	124.6	105.2	96.3	122.9	54.0	127.7	104.0	87.1	140.6	115.2	115.5	95.9	66.0	125.3	35.0	100.2	33.0	122.9	62.0	69.3	126.8	126.3	139.0	225.3	161.1	237.9	353.6	202.2	220.8	362.0	222.0	277.9	208.1	261.1	337.9	297.4	0.8	182.9	334.3	228.0	167.7	165.9	366.0	240.0	129.6	144.0	94.3	245.7	206.5	243.6	1.7	88.2	140.5	286.0	249.1	269.6	230.6	397.7	66.0	52.9	94.3	227.2	199.4	2.3	28.9	96.2	237.4	3.6	88.8	138.0	135.7	441.9	295.5	94.9	124.8	409.7	568.2	344.3	503.4	201.5	64.4	341.1	217.1	117.4	136.5	156.5	33.8	69.9	13.5	207.0	40.3	286.7	5.1	37.8	3.4	5.8	46.4	3.8	7.9	4.1	4.3	32.3	6.6	0.3	2.1	20.9	0.6	46.8	7.9	11.1	17.8	88.3	110.4	102.9	100.6	83.7	91.3	106.8	99.4	105.2	95.9	100.2	139.0	137.3	259.6	161.0	57.1	19.4	78.5	119.5	134.4	82.0	7.3	74.6	52.3	230.8	87.2	201.8	121.4	20.9	124.8	21.1	320.7	68.4	184.9	17.2	158.0	67.9	141.1	51.0	41.7	37.6	175.5	137.8	97.1	167.1	206.9	40.5	83.3	92.4	66.6	92.8	3.3	31.5	139.0	87.5	80.5	80.9	23.6	77.9	77.9	78.2	104.0	158.5	46.2	6.2	66.4	159.7	328.7	201.4	84.7	24.8	128.7	165.6	140.1	210.1	24.5	98.6	74.9	109.1	18.1	21.0	111.3	77.3	189.9	20.4	44.4	130.6	181.4
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.0;epididymis: 67.0;retina: 80.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	96	"basophil: 55.3"	"Lineage enriched"	"Detected in single"	553	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	0.1	4.7	74.1	0.5	82.5	0.1	0.0	51.8	99.0	0.4	28.5	1.9	0.3	3.3	67.0	0.2	1.9	0.2	0.2	78.8	59.3	0.1	0.1	0.0	0.0	47.0	71.2	0.1	0.8	0.0	7.1	0.0	50.8	1.0	0.9	80.4	0.2	0.7	0.2	0.1	0.7	0.5	36.6	0.0	1.1	17.4	78.9	0.0	0.0	0.0	0.0	0.1	0.4	62.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	3.8	10.7	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.4	0.7	0.2	0.0	2.3	0.0	0.0	2.7	0.0	2.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	74.1	82.5	51.8	99.0	78.8	59.3	47.0	71.2	50.8	36.6	78.9	62.0	0.0	0.0	0.0	3673.8	0.0	0.0	0.0	0.0	0.0	17.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	560.8	12.9	7.0	0.5	0.0	0.0	1358.5	0.0	0.0	0.1	0.0	34.3	0.0	4.7	0.0	0.0	0.0	5.0	1056.9	0.0	0.0	0.0	0.0	144.4	2.5	0.5	0.0	187.4	0.0	112.1	0.0	1304.4	230.7	0.3	0.0	3.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.2	10.3	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912523-67696195	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 176.3"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 4054.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;Karpas-707: 1.5;NTERA-2: 1.7;RPMI-8226: 2.4;SCLC-21H: 1.5;U-266/70: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	0.7	0.5	31.8	0.6	96.9	0.1	0.5	49.3	49.7	1.4	0.0	2.0	0.3	1.3	0.1	1.4	0.7	0.6	18.7	30.3	51.6	0.5	8.5	0.1	0.2	90.9	66.8	1.7	0.1	0.2	0.2	0.4	95.3	0.4	0.6	0.4	0.3	0.2	12.0	0.2	0.8	2.6	52.4	0.3	1.2	2.2	69.7	0.1	0.3	23.4	0.3	0.6	0.6	176.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.7	0.6	0.7	0.1	0.0	2.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	6.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.8	96.9	49.3	49.7	30.3	51.6	90.9	66.8	95.3	52.4	69.7	176.3	0.4	0.0	0.0	24.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	75.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.8	0.0	1.5	1.2	0.0	0.0	49.8	0.0	0.0	2.5	0.0	0.1	0.0	2.6	0.4	5.7	0.0	0.0	50.6	0.0	0.0	0.8	0.3	275.5	4.4	0.3	0.0	30.0	0.0	1.4	0.0	50.3	4054.6	0.0	0.1	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	9.3	4.0	1.6	0.0	0.1	0.0	0.1	4.6	0.1	0.0
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 539.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		2000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	130.8	112.2	106.7	98.7	85.3	162.4	194.3	147.8	87.5	179.4	94.7	141.2	136.9	149.4	84.4	113.7	131.0	121.8	109.9	88.1	105.3	106.5	147.9	132.9	81.9	101.3	112.9	173.9	93.3	137.2	84.7	200.0	94.0	132.3	134.5	88.8	110.9	126.3	87.3	99.0	142.9	178.4	104.9	92.5	81.8	59.5	129.4	95.6	140.6	89.9	99.5	158.3	109.3	108.4	161.6	210.0	423.6	242.8	226.9	184.7	333.8	179.6	249.7	288.2	284.3	146.3	224.0	131.7	157.8	314.1	129.0	119.6	315.8	510.0	306.2	123.3	215.7	215.5	261.0	523.7	169.5	121.8	99.1	271.6	226.7	345.5	208.7	235.7	258.1	63.0	153.7	80.3	324.1	161.8	87.3	68.3	397.2	211.0	159.3	64.9	281.9	88.3	177.9	494.8	102.9	172.4	296.2	147.1	809.4	509.8	242.1	248.6	340.8	217.1	163.6	139.3	264.0	50.7	82.7	138.4	221.5	150.5	369.7	4.7	7.3	6.4	9.2	12.3	10.9	7.7	8.6	10.1	11.8	8.0	8.6	9.4	6.6	9.6	12.6	10.0	10.8	5.6	106.7	85.3	147.8	87.5	88.1	105.3	101.3	112.9	94.0	104.9	129.4	108.4	171.7	137.8	179.5	58.1	71.7	213.5	130.1	75.3	116.1	40.7	232.5	168.1	84.7	90.1	119.2	62.5	33.3	318.9	99.0	251.6	35.2	132.2	11.0	90.3	125.9	187.3	93.8	43.8	50.9	78.5	115.6	116.8	53.0	95.5	116.6	137.0	139.2	172.5	115.1	13.5	82.4	145.9	42.7	154.6	228.1	9.5	59.7	161.1	202.7	124.6	98.3	89.2	49.4	70.9	62.9	139.8	249.5	86.9	55.5	128.3	160.3	93.2	96.1	62.0	46.0	175.6	137.3	78.4	40.1	70.9	174.9	539.5	77.0	245.6	189.6	127.9
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979688-41012565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	9.1	8.1	4.8	11.1	4.7	6.8	6.7	4.0	5.8	9.3	7.9	8.7	4.4	23.6	5.7	14.9	11.1	10.6	5.3	4.9	5.3	12.4	73.4	7.6	12.4	4.6	4.9	3.4	4.7	47.6	0.0	7.8	5.8	13.5	12.0	2.4	50.6	24.8	7.7	4.6	8.4	51.9	4.7	5.0	4.1	14.7	4.9	17.3	4.8	7.6	17.8	17.7	0.3	5.0	77.8	68.5	95.3	60.5	22.9	30.9	138.5	138.8	57.0	141.2	92.0	131.5	66.6	149.8	55.6	61.7	39.4	38.6	91.5	97.0	139.5	66.5	78.0	87.3	72.3	43.3	87.8	128.0	56.8	34.0	49.2	148.5	103.0	23.0	64.1	102.2	84.7	51.5	99.4	42.9	125.0	38.1	126.8	66.4	81.3	100.9	120.0	93.7	71.4	69.4	118.4	61.7	79.2	77.7	33.9	90.8	30.1	152.9	53.5	78.2	119.6	61.7	167.2	36.8	50.8	134.5	59.8	84.5	97.4	0.0	3.5	0.0	3.6	6.5	5.7	5.2	4.1	4.3	11.0	4.0	3.7	6.1	0.0	6.9	5.9	11.9	6.3	3.4	4.8	4.7	4.0	5.8	4.9	5.3	4.6	4.9	5.8	4.7	4.9	5.0	5.4	6.4	18.4	4.9	10.9	8.0	14.3	9.1	9.6	12.5	4.6	4.7	5.7	21.5	7.0	5.5	6.2	15.4	26.4	2.2	1.9	19.2	32.4	4.7	10.8	8.5	3.0	22.5	14.1	17.2	26.4	8.7	7.1	7.3	1.3	15.8	2.2	29.0	11.0	11.8	18.7	3.4	6.1	2.8	6.2	27.9	10.8	6.8	1.8	7.5	8.7	5.4	7.2	7.1	10.3	19.3	1.1	24.8	15.1	19.3	25.2	12.8	2.8	4.3	39.5	9.3	17.5	11.1	40.6	11.8	7.4	5.6	9.9	20.7	5.8	7.3
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16587999-16712936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Approved		Approved	Mitochondria,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	5.5	7.0	5.6	4.3	7.2	6.9	10.4	7.6	6.3	9.5	6.0	8.1	12.3	10.3	6.7	5.1	9.0	6.8	4.4	5.1	6.8	6.0	7.5	6.5	6.6	8.0	6.3	13.2	9.2	12.1	4.0	6.6	8.0	9.5	9.5	9.9	7.4	7.0	4.3	7.1	10.3	7.4	6.5	4.4	8.3	2.0	6.3	6.1	6.8	4.6	8.2	6.2	6.2	9.4	13.7	12.6	20.3	16.9	10.1	7.6	0.2	7.3	6.2	12.1	11.0	13.0	14.2	0.4	23.2	7.9	11.0	11.0	28.9	13.9	14.3	0.1	18.9	7.9	17.0	19.2	5.3	5.7	0.2	8.4	4.7	11.3	9.5	13.6	16.5	0.3	11.1	0.5	11.2	18.9	0.2	4.6	34.7	5.2	14.6	0.3	11.6	4.4	13.3	15.5	12.5	22.8	23.5	1.8	14.2	21.9	32.8	16.2	10.3	6.2	3.3	16.5	6.6	0.3	0.2	45.6	5.0	4.9	7.0	0.1	0.6	0.5	0.4	0.3	0.9	0.6	0.8	0.5	1.3	0.5	0.6	0.6	0.0	1.7	2.7	0.9	0.9	0.6	5.6	7.2	7.6	6.3	5.1	6.8	8.0	6.3	8.0	6.5	6.3	9.4	6.7	9.6	6.7	13.4	3.4	3.2	6.0	4.8	4.6	5.4	8.0	6.5	6.0	8.6	8.9	5.5	0.0	3.5	4.4	5.5	3.9	9.8	4.0	7.2	6.4	5.4	11.3	3.8	10.4	9.4	7.9	5.9	6.1	9.0	6.3	9.1	6.8	7.9	5.3	6.7	18.2	7.5	4.1	4.4	2.7	8.6	9.0	3.3	8.8	24.4	6.0	4.4	1.0	26.2	35.5	11.3	9.0	4.1	4.0	3.9	19.2	3.0	6.1	5.1	6.6	4.1	6.6	0.1	0.3	3.7	3.8	1.5	2.7	4.3	8.8	5.8
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10751246-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	15.4	20.6	10.0	21.0	10.2	23.7	18.8	9.9	11.3	19.9	13.4	16.9	16.2	22.2	48.0	17.5	16.8	15.3	17.2	10.4	10.8	22.5	25.2	17.2	26.3	10.0	12.0	22.0	13.3	30.0	12.5	20.3	10.5	17.6	18.1	29.2	18.3	16.1	17.9	19.2	16.8	16.4	9.7	22.5	17.2	27.0	10.4	30.3	23.2	15.1	26.0	21.8	11.8	11.0	40.5	30.9	43.5	41.4	93.1	37.0	21.2	43.9	29.2	34.8	36.5	51.1	83.9	36.7	23.6	36.6	42.3	40.9	54.0	36.2	56.7	56.7	64.6	186.6	31.0	29.2	29.7	74.1	98.8	34.6	28.8	22.5	30.1	32.1	40.6	34.5	77.0	43.2	42.6	18.3	47.5	28.9	36.0	48.7	38.2	43.6	52.9	25.1	29.9	54.8	19.9	47.4	39.6	38.9	31.3	41.5	34.6	32.3	40.2	29.2	30.0	51.7	24.0	23.6	59.8	39.5	31.2	49.5	30.5	54.4	15.4	31.3	20.0	17.7	26.3	16.7	21.4	19.7	18.1	17.0	20.1	19.6	11.3	26.7	18.3	9.0	19.4	15.8	10.0	10.2	9.9	11.3	10.4	10.8	10.0	12.0	10.5	9.7	10.4	11.0	51.5	57.7	48.8	14.7	49.0	87.2	46.2	29.7	64.3	34.0	30.2	31.6	49.2	31.5	41.7	25.8	56.3	37.9	42.7	30.7	19.6	26.9	28.5	34.0	38.0	37.7	26.9	25.5	16.5	24.5	24.8	36.4	15.8	52.4	85.9	33.2	28.5	38.6	29.1	63.9	21.4	45.1	32.6	32.3	23.6	13.1	33.5	36.1	12.4	15.0	31.8	31.1	29.9	20.6	18.6	26.9	17.5	31.2	37.2	26.1	22.8	18.3	33.7	45.9	26.3	47.8	33.1	100.3	71.3	51.1	81.1	45.7	48.0	56.4	25.3	31.5
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438442-15449242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	3927	"pancreas: 25708.5"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 6566.4"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	6.5	1.2	0.2	0.2	0.2	0.7	2.9	0.7	0.3	2.7	0.2	1.2	1.1	1.3	0.1	1.9	0.8	0.0	2.3	0.3	0.1	1.2	3.5	1.0	0.3	0.1	0.1	5.6	25708.5	0.0	1.5	0.7	0.2	1.8	0.0	0.1	2.1	0.0	1.0	2.1	1.7	0.0	0.0	2.0	2.3	1.0	0.2	0.0	1.0	0.0	0.0	0.6	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	17.3	0.0	0.6	1.0	0.7	0.0	0.0	0.2	6566.4	0.1	0.2	0.0	2.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.1	1.8	0.0	24.3	0.0	1.0	0.0	0.0	673.8	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.3
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932365	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1154	"pancreas: 7481.6"	"Group enriched"	"Detected in some"	20	"Exocrine glandular cells: 224.2;Pancreatic endocrine cells: 58.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	1.2	0.7	2.9	1.1	3.1	6.1	0.9	3.8	4.2	1.1	2.1	0.8	1.8	0.6	0.2	0.5	0.7	0.7	1.7	3.0	2.8	0.8	1.0	1.7	2.5	3.5	3.0	6.4	7481.6	0.0	1.7	0.7	3.7	1.2	0.5	0.3	1.1	0.2	0.6	1.0	1.7	0.4	2.8	3.5	1.0	0.6	3.3	1.9	0.7	0.7	1.0	0.7	0.7	3.5	0.4	2.1	0.6	0.2	0.1	0.0	0.9	0.3	0.4	0.7	1.0	1.9	1.0	0.5	0.3	0.4	0.6	0.7	4.1	0.7	2.0	0.8	4.6	0.5	0.9	1.9	0.2	0.3	1.4	0.7	0.1	2.5	0.7	0.3	0.0	1.0	1.0	1.1	0.3	0.7	0.4	2.2	4.1	1.1	1.9	2.0	0.3	3.1	0.0	0.8	1.9	1.1	0.7	0.7	0.4	0.4	0.9	2.5	0.9	0.1	1.4	0.2	1.0	3.8	1.7	2.2	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	2.9	3.1	3.8	4.2	3.0	2.8	3.5	3.0	3.7	2.8	3.3	3.5	0.6	0.0	0.0	1.6	0.2	0.5	0.0	0.0	2.2	0.0	0.2	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.3	224.2	0.0	0.5	1.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.4	2.0	1.2	0.3	0.0	0.0	0.5	0.0	1.0	2.1	0.0	0.0	0.5	1.6	58.5	1.4	0.0	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	0.6	6.9	0.5	0.1
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	318.6	734.6	147.0	204.9	181.9	499.0	244.0	186.0	156.5	270.8	672.7	298.0	387.6	170.7	82.8	319.4	171.6	438.4	444.1	187.8	223.6	691.6	464.8	539.6	241.0	247.6	206.6	130.7	284.8	137.3	131.5	180.7	228.6	138.2	153.4	48.3	422.1	231.7	590.3	340.9	398.3	105.0	188.9	442.0	287.2	88.9	334.4	78.1	182.1	178.2	123.1	296.4	307.5	367.1	204.6	578.9	51.4	246.2	586.5	206.3	112.1	149.4	362.2	161.8	182.8	147.5	2596.6	49.2	376.8	285.8	1265.6	1072.2	63.7	142.6	35.8	206.7	222.9	70.4	92.5	196.5	736.2	171.4	787.7	350.9	621.6	82.5	136.9	2780.1	128.2	62.1	89.2	267.6	263.3	832.6	47.0	110.9	153.1	719.7	247.9	62.5	72.5	191.2	586.6	610.8	84.2	94.8	173.3	2488.5	535.0	68.6	1022.8	232.6	170.3	556.8	92.9	79.0	216.7	432.0	382.3	26.8	867.7	468.6	509.6	211.2	578.7	170.1	156.5	309.9	90.6	28.8	72.1	110.3	144.5	18.8	82.5	107.4	319.5	192.3	265.2	120.3	89.2	489.1	147.0	181.9	186.0	156.5	187.8	223.6	247.6	206.6	228.6	188.9	334.4	367.1	139.3	112.2	228.6	48.3	62.8	72.0	223.5	473.2	71.7	168.6	108.9	113.8	251.9	314.5	459.5	548.1	110.5	211.7	156.1	1475.9	109.5	911.4	3.3	118.1	67.4	128.3	159.6	132.6	18.3	370.1	165.0	157.0	237.5	203.4	474.3	119.4	695.7	678.9	3763.5	264.2	25.2	418.2	498.5	1187.8	67.5	14.6	108.4	1512.6	227.7	20.6	382.6	179.0	256.4	27.2	42.2	392.3	832.5	128.2	122.5	111.7	1699.4	311.8	270.3	102.1	111.7	70.7	135.2	26.6	63.5	141.2	82.1	471.3	155.0	96.0	399.1	357.8
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206008535-206023909	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 1168.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"OE19: 1799.1"	"Not detected"	"Not detected"							"HPA012674, HPA012940, CAB032687"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.3	0.0	0.1	9.5	0.1	30.0	0.0	0.5	0.3	0.0	0.1	15.3	229.8	0.3	1.7	0.8	1.1	15.0	0.3	0.1	0.1	0.2	0.2	49.7	0.5	0.3	0.1	0.1	3.7	0.0	1.1	1.3	0.3	0.2	25.7	0.1	0.0	1.6	0.0	0.1	55.5	0.3	0.1	0.6	1168.3	0.1	0.3	0.5	8.9	0.0	10.7	5.8	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	3.8	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.4	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.8	1.5	0.7	1799.1	0.1	0.4	0.0	0.8	0.7	39.4	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.1	0.1	0.3	0.1	0.3	0.1	0.3	0.5	0.0	105.8	27.9	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	10.0	42.3	0.0	0.0	0.0	0.0	34.1	0.0	52.0	0.0	0.3	0.0	0.3	2.4	60.6	0.0	262.8	0.1	14.7	553.5	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	21.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.1	260.0	208.9	0.0	0.7	0.1	4.0	0.1	7.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	10.4	0.4
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563464-66568879	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 320.9;Muller glia cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 23.1;SK-MEL-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	57.8	70.0	68.1	0.8	76.3	0.3	62.2	74.5	74.0	78.8	90.2	76.7	3.0	89.2	21.9	15.6	70.8	10.0	100.2	63.2	74.2	46.9	66.0	32.9	3.6	75.0	70.3	99.1	31.7	20.0	43.3	3.8	68.4	53.5	3.5	26.2	55.7	17.1	91.9	44.4	29.5	12.2	77.2	25.0	54.3	109.7	71.0	3.0	40.6	27.6	3.0	56.6	58.7	86.6	0.0	17.0	3.1	5.4	14.2	8.6	3.4	13.0	11.4	6.3	2.3	0.0	2.2	0.0	21.3	10.4	0.0	1.2	6.8	2.6	4.8	3.7	0.0	0.5	7.0	0.0	9.9	0.3	4.4	22.3	9.1	0.8	1.6	13.7	3.8	2.0	5.4	1.6	5.2	4.6	0.1	1.7	0.9	3.7	9.7	0.0	0.0	1.5	7.1	0.3	4.3	6.9	23.1	0.3	59.5	0.3	7.4	0.6	3.3	1.8	2.9	1.5	1.2	21.2	0.2	0.0	2.2	0.0	2.9	0.0	0.4	0.3	3.9	0.6	4.1	1.5	3.5	4.6	0.6	1.4	6.4	4.1	0.1	4.6	0.2	0.9	1.3	2.2	68.1	76.3	74.5	74.0	63.2	74.2	75.0	70.3	68.4	77.2	71.0	86.6	36.6	12.8	15.6	31.3	5.9	39.8	62.4	8.5	37.5	107.9	45.3	80.6	57.9	41.5	7.4	36.8	41.7	31.6	9.6	0.6	15.6	13.1	163.3	1.7	22.8	27.2	12.0	11.4	26.5	7.5	9.5	118.1	8.2	5.3	9.5	52.1	56.0	67.8	14.9	134.6	31.3	3.1	18.3	21.5	32.8	320.9	145.7	13.1	156.5	12.2	3.1	196.6	17.5	21.6	29.4	5.9	3.2	121.9	12.9	50.5	1.3	44.7	3.3	77.9	78.9	62.0	45.9	169.6	43.3	3.6	25.3	23.7	9.5	30.7	4.3	32.9
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573518-24576250	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	154	"bone marrow: 5352.9"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 534.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 8681.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		330000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	23.4	0.1	0.0	13.5	0.0	5352.9	25.4	0.0	0.0	16.6	0.0	25.5	5.8	9.6	10.2	22.1	2.7	25.9	3.7	0.0	0.0	2.3	3.6	11.6	6.5	0.0	0.0	0.5	3.5	1.5	1.0	2.9	0.0	3.7	25.5	0.0	11.5	4.8	1.8	28.0	18.1	7.7	0.0	16.9	4.9	3.2	0.0	26.0	0.8	7.6	6.0	34.8	4.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	303.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	3.6	41.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.2	0.0	3.6	0.0	0.0	8681.4	0.0	0.0	0.3	0.0	5.3	0.0	0.8	2.8	0.0	1287.5	0.1	0.0	6.0	0.0	1.1	1.0	0.0	0.0	0.9	3.4	5.4	0.0	0.0	1.7	7.3	5.0	0.0	6.5	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	33.3	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	534.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	11.1	9.1	0.0	1.5	5.4	0.0	1.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.3	0.3	1.7	0.0	4.0	0.0	5.1	0.0	0.4	0.0
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87724051-87731469	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 563.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 128.1;non-classical monocyte: 195.2"	"Lineage enriched"	"Detected in many"	12	"monocytes: 195.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2305.0;HSkMC: 1061.0"					"Low region specificity"	"Detected in all"			"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	232.4	86.6	49.2	136.0	55.4	84.8	110.0	52.9	67.5	69.5	67.9	110.3	39.7	108.1	81.6	33.3	108.4	85.0	112.5	47.0	52.3	207.3	333.5	154.9	101.1	54.4	54.0	96.4	61.9	151.1	69.5	563.6	57.5	68.2	58.8	32.3	77.6	91.7	71.9	39.8	57.1	125.2	52.4	124.4	71.4	80.1	112.2	33.0	76.1	79.8	49.4	209.8	48.0	59.6	88.1	423.0	32.6	55.3	514.0	2305.0	198.4	267.2	781.8	232.2	300.6	43.0	86.3	0.0	128.9	355.4	754.0	67.5	49.8	86.0	198.4	1.9	37.8	18.1	111.2	105.1	352.6	0.1	51.4	1061.0	138.9	373.7	134.9	186.6	194.9	0.0	162.5	0.7	326.6	115.6	0.5	9.9	67.7	128.6	77.5	21.6	21.5	0.6	158.6	39.0	42.8	50.6	62.1	133.5	312.3	177.9	14.5	97.9	296.9	190.8	104.7	750.6	125.9	18.5	84.1	0.9	692.6	0.2	67.9	0.3	13.5	0.6	0.3	128.1	0.0	0.0	6.6	0.1	7.9	0.1	16.7	1.3	0.5	0.2	195.2	0.3	1.7	10.1	49.2	55.4	52.9	67.5	47.0	52.3	54.4	54.0	57.5	52.4	112.2	59.6	86.1	41.7	52.9	15.3	11.2	37.7	82.1	58.0	15.4	43.8	12.2	33.4	96.8	87.2	46.4	75.4	18.8	1081.6	0.3	16.3	27.4	91.8	5.3	48.1	119.9	110.0	11.5	251.2	18.6	93.4	1012.3	261.7	10.2	27.6	29.7	63.6	580.4	122.6	1105.7	13.5	24.0	8.5	20.3	206.9	105.4	17.4	156.9	537.2	64.0	14.0	16.2	79.5	0.0	17.6	31.7	67.2	5.6	187.3	1.9	34.5	8.0	138.3	67.3	45.4	92.1	176.9	136.3	207.4	60.5	6.8	34.0	1543.6	10.8	30.8	11.7	44.8
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155921580-155953912	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1;HSkMC: 44.6;Karpas-707: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"	NA	NA		25000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	19.1	31.5	8.0	17.8	8.0	5.0	31.9	6.2	11.8	36.7	7.9	19.6	32.8	37.2	36.1	16.7	36.9	40.7	20.2	7.8	7.6	34.5	98.8	36.8	24.5	7.1	7.5	28.0	19.9	24.5	9.6	41.2	6.9	29.8	23.2	5.2	22.1	32.2	6.7	10.0	34.0	30.7	7.0	39.7	15.5	9.4	7.4	14.1	34.5	17.8	17.9	28.0	15.4	7.6	0.8	0.6	4.1	3.7	17.3	37.1	0.2	1.6	18.3	3.3	5.7	0.4	14.4	0.2	1.2	6.8	1.2	0.1	0.2	0.1	2.6	1.6	0.1	0.4	0.5	0.2	18.1	1.4	0.2	44.6	3.5	2.2	1.8	25.6	3.5	0.7	0.3	85.8	11.7	0.7	1.1	0.4	0.7	0.6	0.7	4.8	0.5	1.0	16.8	7.5	0.5	4.3	2.4	9.3	2.3	2.0	4.2	2.6	3.0	13.3	0.7	0.4	2.3	8.3	0.2	0.2	24.4	0.3	18.6	5.3	0.9	0.6	1.2	0.7	3.0	1.2	1.4	0.8	0.4	1.5	1.6	2.0	0.7	3.0	0.9	1.0	3.3	1.4	8.0	8.0	6.2	11.8	7.8	7.6	7.1	7.5	6.9	7.0	7.4	7.6	29.3	38.5	20.8	15.0	19.9	10.5	13.1	11.3	12.0	10.4	20.1	13.0	5.0	44.3	14.3	25.8	2.1	20.5	19.6	15.6	13.7	24.6	0.4	20.9	34.6	28.2	6.7	8.6	1.7	20.7	7.7	51.5	8.6	27.3	8.8	25.0	43.2	58.1	16.3	5.0	1.7	7.9	8.2	29.2	23.7	1.5	30.4	21.4	30.2	7.5	26.5	17.0	22.6	36.7	5.4	12.7	6.3	25.2	7.0	17.5	21.1	10.7	14.5	1.9	19.7	34.0	24.6	0.3	2.1	5.9	9.1	10.5	14.5	14.3	6.6	9.5
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730079-150765957	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.0;lymphoid tissue: 164.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 698.6;Kupffer cells: 2230.8;Macrophages: 1316.2;monocytes: 2312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 2483.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 81.6;HMC-1: 187.5;U-698: 387.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		23000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	40.0	16.7	4.0	87.8	4.5	137.0	20.3	4.8	7.1	9.4	8.0	83.6	60.2	7.8	5.7	16.5	17.8	29.1	10.6	3.4	5.5	9.3	40.4	88.4	71.7	11.8	8.0	4.9	11.3	2.3	4.7	23.6	11.2	9.1	59.4	3.4	23.9	7.3	4.1	7.1	64.6	16.3	7.7	164.8	42.6	3.8	10.4	20.1	11.5	9.0	38.5	42.9	10.0	16.1	3.7	10.9	0.2	0.3	1.2	1.4	0.7	0.4	8.6	0.9	1.3	1.2	81.6	44.3	5.7	1.2	15.3	2.1	0.2	0.7	0.5	26.9	0.2	29.0	1.1	0.8	0.2	33.6	187.5	2.6	0.1	6.6	1.5	0.5	6.3	0.6	3.4	45.0	2.4	0.3	0.4	22.5	0.2	0.1	0.3	14.9	4.6	49.8	10.7	8.7	0.3	0.4	1.1	2.3	0.8	0.3	0.4	49.8	9.1	6.2	1.3	0.8	1.2	27.8	2.2	387.3	28.5	35.2	2.3	20.9	2483.4	218.0	41.3	1735.3	51.1	139.5	46.6	50.9	571.0	138.8	45.0	40.8	1022.2	41.8	1655.1	106.8	77.4	2577.6	4.0	4.5	4.8	7.1	3.4	5.5	11.8	8.0	11.2	7.7	10.4	16.1	37.6	109.0	158.7	1.6	255.3	17.0	31.3	72.0	4.6	2.3	21.0	8.9	5.3	74.4	143.4	42.3	12.5	3.7	198.0	549.2	0.0	183.6	6.6	126.9	8.6	44.1	42.4	22.5	10.3	177.0	5.7	34.4	71.9	39.0	106.8	9.5	60.3	30.6	698.6	0.0	9.5	205.7	73.2	2230.8	316.4	3.0	5.3	1316.2	56.9	27.2	2312.9	0.5	137.0	0.5	0.9	200.9	466.5	2.2	121.4	20.6	210.8	4.7	488.9	4.9	19.7	5.6	13.3	0.2	0.5	12.4	15.5	6.2	108.9	66.0	237.8	113.3
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 450.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	91.7	142.5	28.3	15.6	30.0	4.9	82.9	29.7	32.3	112.3	28.5	84.9	28.4	117.8	18.7	131.6	85.0	35.1	106.9	27.7	28.2	109.6	66.9	74.8	9.0	33.2	30.8	112.9	79.5	18.1	94.1	23.9	30.9	101.6	23.8	8.4	92.9	27.0	65.7	104.4	70.9	31.8	29.5	53.3	92.2	62.0	30.3	8.7	89.5	14.5	12.7	88.1	101.2	32.5	450.2	97.2	32.0	37.2	53.2	81.9	52.5	93.8	92.5	80.7	63.4	129.5	110.3	17.5	90.6	121.1	86.3	97.3	38.6	98.7	58.7	35.5	39.1	1.7	73.6	61.1	113.9	0.4	22.6	116.6	68.0	89.4	50.2	84.4	68.8	0.5	51.3	3.3	80.9	122.9	0.9	6.4	35.0	163.4	58.6	0.2	39.3	14.3	90.5	143.7	26.3	44.9	68.3	93.2	158.0	57.2	75.8	1.9	86.8	70.8	45.3	111.2	63.6	7.4	5.2	1.0	141.1	0.4	98.9	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.1	0.4	0.0	6.8	28.3	30.0	29.7	32.3	27.7	28.2	33.2	30.8	30.9	29.5	30.3	32.5	95.3	44.8	51.8	61.7	4.0	151.9	102.8	85.8	46.1	39.4	81.0	57.9	64.1	80.1	95.4	134.3	18.8	83.8	1.6	224.4	64.6	146.5	12.4	86.4	84.8	89.9	74.4	18.9	93.4	221.5	95.6	89.1	76.0	116.1	6.3	117.7	78.9	44.1	10.4	38.7	65.4	123.8	57.0	8.9	34.1	26.1	103.2	38.6	122.7	28.1	5.9	42.5	0.0	40.2	145.8	260.6	177.8	98.9	3.1	153.5	108.4	164.3	89.4	32.5	59.2	61.0	87.5	32.0	47.0	76.7	174.9	106.3	5.4	91.4	111.9	258.1
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CTU1	"ATPBD3, MGC17332, NCS6"	ENSG00000142544	"Cytosolic thiouridylase subunit 1"	Q7Z7A3	19	51097606-51108409	"Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 45.9;Theca cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.5;PC-3: 20.5;U-266/70: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053797	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA053797: AB_2682266"	"unprognostic (2.07e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.85e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (5.73e-5)"	3.1	3.2	3.8	0.9	4.0	0.3	2.2	3.7	4.5	4.0	2.8	3.3	1.3	4.4	0.5	4.5	4.2	0.4	3.3	3.8	3.4	5.0	4.1	2.3	0.9	4.9	3.9	6.3	4.2	1.1	2.9	0.9	4.3	3.8	0.4	0.5	2.4	0.6	2.9	3.6	2.7	0.7	3.7	3.8	3.0	2.8	3.8	1.0	3.5	0.6	0.7	3.9	3.4	4.9	5.4	5.0	0.8	2.5	2.4	1.6	2.4	4.1	0.7	1.4	1.6	1.9	1.6	5.6	5.0	1.0	1.2	8.4	4.2	1.2	0.9	6.5	43.5	2.1	4.5	1.5	1.7	4.1	4.3	1.2	3.1	1.1	2.7	2.1	1.2	1.9	9.5	2.4	1.2	1.6	5.3	8.6	4.5	6.4	20.5	6.7	3.1	7.2	1.4	1.2	4.5	5.2	2.5	3.8	6.4	1.0	1.5	3.7	2.8	1.4	5.8	2.1	5.9	18.9	13.1	4.6	1.8	5.0	1.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.8	4.0	3.7	4.5	3.8	3.4	4.9	3.9	4.3	3.7	3.8	4.9	11.3	0.0	0.0	2.0	5.2	19.5	45.9	0.4	9.1	2.6	11.4	13.5	3.0	7.2	0.3	12.9	8.4	6.6	10.1	7.4	33.2	1.2	3.8	8.1	12.3	8.0	3.5	13.2	2.5	0.8	8.7	10.7	5.1	8.1	0.0	20.3	10.4	5.9	5.3	6.7	2.8	7.8	0.0	5.9	7.6	2.3	9.3	8.0	3.6	1.9	3.3	4.0	6.2	1.0	3.5	0.6	3.4	6.0	4.4	32.3	2.6	27.5	0.2	3.9	6.6	8.7	9.7	2.1	1.9	10.8	31.0	6.2	8.7	36.5	7.2	32.5
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706483-88715396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	9.7	9.6	8.8	5.0	8.7	6.2	8.8	7.9	13.8	10.2	6.5	9.9	4.2	11.6	2.0	8.7	9.5	3.5	11.8	9.1	7.5	9.7	12.5	7.9	6.1	9.6	8.1	10.5	11.3	3.6	11.3	3.2	8.5	8.8	1.6	1.4	8.0	3.7	19.1	8.7	7.6	3.4	7.5	9.4	9.6	10.9	8.2	4.0	10.3	5.4	3.4	9.9	8.1	10.5	14.9	22.9	8.8	19.4	7.3	7.5	21.8	15.2	11.4	16.6	8.1	27.2	14.0	21.7	19.8	9.8	7.8	14.7	14.8	14.9	4.5	6.8	44.6	14.9	9.8	27.8	12.4	15.1	10.8	8.5	10.8	13.1	13.9	6.0	14.1	13.1	56.5	6.3	6.3	40.0	42.0	34.9	13.7	12.9	36.9	33.0	6.6	23.4	5.8	5.8	29.0	14.0	24.2	4.6	9.7	5.3	13.8	15.6	15.9	17.5	22.1	19.2	16.8	19.4	10.5	61.7	15.1	32.1	19.6	1.1	5.5	0.0	7.3	6.9	6.0	5.5	6.6	7.3	6.8	5.8	6.4	5.5	0.4	7.5	6.0	6.4	4.1	4.2	8.8	8.7	7.9	13.8	9.1	7.5	9.6	8.1	8.5	7.5	8.2	10.5	6.5	0.0	4.4	2.3	10.0	13.8	12.2	7.8	5.2	12.5	7.3	7.2	2.5	10.0	7.8	1.8	6.2	11.0	15.7	8.4	11.7	8.8	12.1	4.0	7.1	6.6	5.4	3.8	2.9	13.6	16.2	8.6	11.2	4.9	0.0	9.9	3.6	6.7	9.9	13.5	2.3	7.1	4.1	1.9	4.0	7.0	8.1	6.7	5.4	1.0	5.0	4.4	7.2	0.5	2.7	8.9	8.2	9.8	15.5	17.2	9.6	7.8	4.7	8.7	0.0	8.9	11.1	25.6	25.7	6.5	10.7	8.1	9.5	10.8	10.5	8.9
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 275.1;endometrium 1: 85.7"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	6.5	12.5	176.3	0.9	275.1	0.1	3.2	0.0	173.0	36.9	0.0	61.3	0.9	85.7	2.9	2.6	43.0	0.2	1.0	199.1	58.0	11.7	0.4	7.0	0.0	0.0	21.3	6.2	2.2	1.1	57.0	0.3	1.0	16.3	0.4	0.2	6.4	12.4	0.5	4.1	4.7	4.9	0.0	1.4	8.8	27.8	85.5	0.3	2.8	0.1	0.0	21.2	13.2	40.7	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.3	275.1	0.0	173.0	199.1	58.0	0.0	21.3	1.0	0.0	85.5	40.7	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
CTXN2		ENSG00000233932	"Cortexin 2"	P0C2S0	15	48178122-48203758	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;choroid plexus: 1.6;pituitary gland: 1.1;retina: 1.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 43.4;Late spermatids: 34.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053168	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA053168: AB_2682066"	"unprognostic (1.90e-1)"			"unprognostic (3.85e-3)"	"unprognostic (7.43e-2)"					"unprognostic (2.18e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"		"unprognostic (4.61e-2)"			0.0	0.1	2.6	0.0	2.4	0.0	0.0	2.3	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	3.1	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.1	0.0	1.1	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	2.4	2.3	3.9	2.3	3.1	2.8	2.7	3.1	2.2	3.1	2.2	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	43.4	0.4	0.0	0.0	4.9	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	34.0	0.9	0.0	0.0	1.9	0.0	2.0	0.0	5.5	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.0	0.0	8.2	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CU639417.1		ENSG00000274559	"Histone H2B type F-S-like"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Intestinal goblet cells: 1.4;Paneth cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;T-47d: 2.2;U-2 OS: 1.6;U-266/70: 1.2;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.5	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.6	0.0	0.4	0.1	0.5	0.5	0.6	0.3	1.3	0.4	0.0	0.1	0.7	0.9	0.5	0.7	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.4	0.4	0.0	0.0	0.6	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.0	0.2	0.6	0.0	0.5	0.3	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	1.1	0.3	0.0	0.4	0.1	0.0	0.4	0.1	0.0	2.2	0.0	0.0	0.0	1.6	0.1	0.2	1.2	2.2	0.2	0.3	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823966-17129811	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 140.4"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 257.7;Proximal tubular cells: 325.0"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.8;ASC TERT1: 3.0;SK-MEL-30: 2.8;WM-115: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.7	0.8	0.8	0.4	0.9	0.4	0.8	0.8	0.7	1.2	1.3	0.5	0.2	0.7	3.1	0.2	2.1	0.3	0.6	0.8	0.8	140.4	0.1	0.6	0.8	2.5	1.7	2.5	0.5	0.6	2.2	2.6	2.4	1.1	0.2	3.0	0.7	0.4	0.3	0.8	28.0	0.4	1.7	0.9	0.4	2.0	1.0	1.7	3.8	0.5	0.7	0.4	0.7	0.6	0.0	0.0	1.5	14.8	0.5	3.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.6	1.5	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.1	0.0	0.1	1.6	0.1	0.2	0.3	0.1	0.5	0.0	0.0	0.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.9	0.8	0.7	0.8	0.8	2.5	1.7	2.4	1.7	1.0	0.6	3.2	0.0	1.5	23.8	3.7	0.5	0.4	0.2	0.6	2.9	0.6	0.6	1.7	0.0	3.2	5.5	2.1	0.0	3.3	0.1	13.7	0.0	37.3	3.1	2.2	5.7	0.0	0.0	8.4	0.2	0.0	2.3	0.0	2.2	0.0	2.2	1.4	0.0	0.1	0.0	9.0	3.7	0.0	0.3	0.4	31.8	2.8	3.1	7.2	7.5	0.1	6.5	1.0	9.0	5.5	0.1	5.0	1.2	1.6	0.4	257.7	325.0	3.5	4.0	0.0	19.0	1.6	1.1	0.9	0.1	0.9	0.1	2.9	1.2	1.2	0.2
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Oligodendrocytes: 117.9;Rod photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 21.7"	"Cell line enhanced"	"Detected in many"		"T-47d: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	20.5	19.2	19.1	13.9	29.5	8.6	17.2	23.2	22.8	31.5	20.6	40.9	7.6	24.7	7.9	32.4	32.4	19.7	38.8	16.6	22.5	25.1	6.1	21.2	7.5	29.5	27.5	9.5	19.0	11.3	21.6	11.9	24.0	24.4	10.6	30.4	30.9	26.3	86.6	11.7	13.2	25.6	21.9	10.6	23.2	3.2	27.8	5.5	18.2	39.7	5.5	31.3	21.2	33.8	27.1	81.7	83.7	15.1	13.5	24.4	2.8	18.8	37.6	38.5	27.7	15.1	100.9	0.4	74.3	36.2	32.6	21.2	9.3	40.1	13.7	52.8	15.8	0.9	58.4	12.6	32.1	0.3	6.3	25.2	23.7	22.5	18.9	33.8	18.8	0.5	1.1	0.4	35.8	15.2	1.4	0.6	2.9	30.7	22.5	2.8	21.6	4.0	25.8	17.5	34.5	18.9	7.9	8.4	32.0	14.2	116.8	2.9	24.2	101.9	63.4	28.2	42.4	0.0	0.4	0.4	44.3	3.7	83.3	0.7	0.5	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.2	1.9	21.7	0.0	0.2	19.1	29.5	23.2	22.8	16.6	22.5	29.5	27.5	24.0	21.9	27.8	33.8	14.1	19.2	5.9	22.5	0.9	4.1	15.6	6.5	13.1	47.1	11.5	11.6	16.1	17.2	10.4	22.0	64.6	0.7	30.9	6.2	7.9	20.3	0.4	24.6	6.3	10.7	3.5	0.0	4.8	26.3	0.4	15.8	10.2	22.9	0.0	10.0	3.9	3.4	17.3	10.1	13.0	4.5	18.3	11.3	7.3	2.9	6.8	12.9	5.4	30.9	4.3	31.8	0.0	31.2	117.9	27.7	2.1	5.3	0.1	21.8	0.7	8.6	17.6	64.8	6.6	26.6	15.3	0.0	1.3	19.0	2.4	0.7	0.7	1.6	4.2	17.3
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432584	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	45.6	66.6	84.3	28.3	86.0	29.8	42.3	89.4	91.2	49.5	80.5	64.7	19.8	53.4	33.7	30.7	48.3	31.5	91.8	84.4	89.0	55.8	44.9	38.1	33.2	85.1	84.1	56.3	41.0	58.9	45.5	27.8	86.2	48.1	23.3	31.1	40.8	37.3	119.4	37.5	34.2	42.5	83.8	42.8	48.0	38.4	88.1	43.2	42.2	119.2	30.4	48.2	37.7	87.2	53.8	58.2	98.3	120.0	77.3	95.8	35.8	42.4	147.8	95.6	71.6	18.9	56.5	94.4	91.7	76.3	41.7	54.7	65.0	97.3	50.5	75.5	66.4	58.7	50.1	20.8	130.4	45.2	38.0	116.2	89.9	93.6	95.3	187.0	100.1	108.5	46.6	96.5	109.4	58.8	110.2	101.6	35.4	44.1	37.9	124.6	115.0	49.9	101.9	24.8	49.7	113.0	29.6	31.6	96.8	41.5	94.3	71.7	59.5	48.2	45.4	60.6	62.9	112.3	93.2	63.3	84.4	154.2	41.4	98.9	111.5	84.4	69.2	91.5	77.3	80.5	66.9	72.4	112.0	89.5	66.2	63.2	43.0	93.0	58.0	97.9	84.3	86.7	84.3	86.0	89.4	91.2	84.4	89.0	85.1	84.1	86.2	83.8	88.1	87.2	56.6	32.1	21.9	10.7	36.1	31.7	49.0	73.1	44.9	54.7	58.8	81.0	56.8	40.0	37.4	46.0	25.0	66.9	40.6	24.0	80.3	70.0	21.0	28.3	52.9	46.4	55.7	35.7	12.2	46.6	33.2	58.5	31.6	26.6	51.4	89.6	59.3	49.9	75.1	67.3	16.0	36.4	63.1	49.1	47.7	42.2	57.2	44.3	51.6	3.7	97.0	94.7	44.3	13.6	23.4	40.0	32.0	60.2	45.4	38.3	34.5	151.7	28.1	47.5	39.5	46.5	164.9	56.6	31.3	42.6	33.8	45.6	38.7	92.5	39.3	41.9
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUL2		ENSG00000108094	"Cullin 2"	Q13617	10	35008551-35090642	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 319.6;Late spermatids: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002677, HPA024578"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB002677: , HPA024578: AB_1847338"	"unprognostic (8.11e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (8.24e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.29e-1)"	15.3	13.3	10.5	16.2	11.7	20.1	15.5	11.9	13.1	13.0	9.8	14.7	14.5	14.8	10.4	16.8	11.0	12.0	19.2	12.2	12.2	14.3	21.0	13.4	19.8	10.8	11.2	12.7	13.4	22.1	8.8	18.8	11.4	15.3	15.2	13.2	11.5	15.7	45.2	13.4	13.9	19.1	11.5	15.0	14.0	35.8	12.3	18.2	16.2	37.6	20.8	17.0	10.1	12.2	50.4	29.2	37.7	32.5	42.0	46.0	39.8	57.8	32.1	56.1	56.2	38.7	47.0	39.9	31.0	61.6	41.1	45.3	55.4	53.4	63.9	46.9	35.9	51.8	29.0	34.8	46.0	28.6	32.6	44.5	43.7	61.6	21.4	43.3	63.6	41.5	60.5	35.2	62.2	34.4	47.7	15.9	13.8	34.4	117.3	39.4	61.0	25.0	51.3	38.9	18.4	24.4	32.4	40.3	47.0	41.6	30.7	32.4	58.6	34.5	38.3	59.6	38.4	14.7	21.2	47.4	66.4	63.2	24.8	12.8	9.9	11.6	12.3	14.9	17.4	10.9	13.5	14.6	12.6	12.6	16.1	15.2	4.8	13.3	15.3	5.7	17.8	8.5	10.5	11.7	11.9	13.1	12.2	12.2	10.8	11.2	11.4	11.5	12.3	12.2	24.8	22.4	12.6	21.9	23.0	12.0	8.6	13.1	9.6	13.1	12.0	12.4	26.4	5.7	20.7	9.2	10.4	24.7	27.8	9.9	15.6	18.4	319.6	17.5	25.4	22.3	10.7	9.4	39.7	17.8	20.1	15.7	9.2	20.5	20.3	19.2	16.4	18.2	20.1	23.5	35.6	10.6	14.2	17.2	12.3	181.0	14.0	20.3	10.6	27.2	23.0	16.0	27.8	30.7	41.7	17.5	6.9	11.7	17.3	8.3	15.2	15.0	19.9	13.7	0.0	16.1	26.9	40.1	32.8	14.4	13.1	37.1	25.3	23.0	13.1	9.9
CUL3		ENSG00000036257	"Cullin 3"	Q13618	2	224470150-224585397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, ER-Golgi transport, Mitosis, Transport, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 224.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 309.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002678	Supported					NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002678: "	"unprognostic (1.22e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.74e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.87e-2)"	30.6	33.6	26.7	36.3	28.2	62.5	40.6	30.4	34.7	35.3	31.0	38.2	36.1	33.6	41.8	54.2	28.7	32.8	39.0	28.6	30.2	49.4	52.4	31.2	55.5	25.9	26.0	33.2	34.3	56.5	25.2	37.1	26.2	33.4	39.4	46.3	36.1	28.6	112.6	54.1	34.2	33.5	27.0	33.8	35.5	224.8	26.6	48.4	45.7	81.8	75.7	40.6	36.5	31.1	61.7	61.3	87.8	72.6	71.9	62.7	82.7	73.9	74.3	72.6	67.7	72.7	60.2	67.0	44.5	76.1	70.3	53.6	99.8	85.0	112.0	66.5	54.5	95.9	61.3	100.7	87.6	95.1	69.3	62.6	68.9	67.7	74.0	72.2	74.3	61.9	90.2	67.0	96.9	104.5	88.5	91.5	90.4	100.9	38.0	76.5	109.8	50.0	108.5	141.0	79.9	58.6	51.1	73.7	85.7	124.5	58.6	79.3	66.2	77.2	58.5	52.1	74.1	69.2	55.3	115.3	59.9	58.2	83.7	9.4	2.8	7.6	3.5	3.5	4.6	5.3	3.9	5.4	3.0	6.5	4.7	5.2	6.6	8.7	4.2	3.6	7.6	1.7	26.7	28.2	30.4	34.7	28.6	30.2	25.9	26.0	26.2	27.0	26.6	31.1	48.3	51.3	69.6	92.1	73.9	28.3	67.8	25.1	20.5	48.5	40.8	34.7	39.9	30.0	49.7	27.6	29.2	25.7	85.3	46.7	35.2	20.2	211.2	58.9	66.9	35.2	40.9	30.9	86.7	24.9	17.8	35.0	32.6	76.2	38.0	37.1	28.5	39.6	20.7	60.6	93.4	39.2	20.3	43.2	28.3	309.7	27.4	45.2	24.9	95.5	39.4	48.4	28.8	107.1	126.4	34.5	39.3	27.4	58.1	59.8	43.8	43.2	38.7	41.3	52.6	71.8	41.5	116.4	50.7	35.7	32.7	39.5	61.2	40.1	34.0	90.1
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120505920-120604074	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Late spermatids: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm		NA	NA		18000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868"	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	18.7	20.5	15.3	14.4	16.5	9.8	20.0	18.2	19.3	24.6	15.7	20.0	12.3	18.7	27.3	23.4	19.6	15.5	15.5	16.0	19.2	18.1	19.5	14.5	20.5	14.4	16.4	25.2	17.0	24.2	26.9	15.5	15.7	18.2	13.5	19.9	15.1	22.5	10.0	15.2	15.4	15.6	13.7	17.7	15.5	28.0	16.2	25.3	15.8	12.5	21.8	18.2	20.3	16.1	41.9	37.3	28.7	31.4	129.5	57.0	22.4	89.8	104.1	71.3	69.4	30.4	110.6	40.1	35.5	206.8	127.7	29.9	61.1	27.7	84.8	26.1	26.6	20.5	42.1	25.9	50.6	22.6	28.1	65.6	22.2	45.1	37.5	134.8	133.2	22.6	33.6	31.7	78.4	24.5	30.7	19.0	45.4	52.6	39.5	23.4	27.1	43.4	23.2	19.5	32.9	27.4	74.2	36.8	36.5	35.0	28.8	20.9	177.6	57.1	30.5	76.3	88.6	21.2	50.0	52.2	59.9	28.2	55.2	6.6	3.8	8.1	5.6	3.1	6.1	5.7	5.2	5.2	4.4	4.4	6.0	6.2	14.4	4.4	2.4	7.0	6.9	4.1	15.3	16.5	18.2	19.3	16.0	19.2	14.4	16.4	15.7	13.7	16.2	16.1	18.7	22.4	14.4	11.8	15.5	15.2	9.6	12.9	12.5	15.7	17.3	14.7	14.6	8.6	11.7	14.7	14.6	10.1	19.9	14.7	13.7	10.1	106.9	12.4	15.6	18.2	24.6	13.3	18.4	8.9	25.0	21.2	14.3	15.8	14.0	20.5	40.7	16.4	17.5	25.2	20.9	13.9	8.2	30.5	13.9	169.3	21.5	18.4	12.4	14.0	17.6	15.0	7.2	23.1	21.0	16.7	7.3	21.4	18.9	9.5	11.0	14.4	17.8	14.1	13.1	17.0	16.6	12.6	13.9	23.0	13.8	10.0	14.1	21.7	12.7	9.5
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008898-108107761	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	9.8	11.5	6.8	9.5	7.0	28.3	13.0	10.9	9.1	11.8	7.3	9.1	9.0	13.1	9.9	10.6	9.6	8.5	15.2	6.8	8.0	16.3	14.2	8.8	11.2	6.4	6.8	12.4	8.9	13.4	5.7	11.4	6.5	12.1	9.1	12.7	8.5	9.5	46.4	11.4	8.6	10.5	7.4	9.8	9.4	6.5	6.8	12.7	14.4	37.5	10.3	10.0	7.0	10.3	14.4	6.6	19.6	15.1	12.5	20.2	9.7	15.0	16.3	13.4	15.0	21.3	16.5	20.1	27.3	18.8	14.0	18.0	18.4	12.3	19.4	13.2	11.1	18.9	6.2	15.7	21.1	21.8	14.9	15.8	16.1	14.1	18.6	17.5	18.7	16.2	25.0	7.2	21.4	7.9	20.9	18.1	10.3	18.4	11.6	15.0	14.6	21.8	16.4	21.2	13.9	19.6	20.4	21.1	12.3	12.0	31.1	17.0	19.7	24.6	11.4	17.6	16.2	7.2	6.2	26.5	9.6	24.0	16.0	1.2	2.3	1.6	2.1	2.1	2.0	1.7	2.1	1.9	2.3	2.2	2.3	2.3	0.4	1.6	2.2	2.5	1.7	1.3	6.8	7.0	10.9	9.1	6.8	8.0	6.4	6.8	6.5	7.4	6.8	10.3	50.2	57.7	42.5	66.3	49.0	29.8	29.3	26.0	44.3	52.7	35.1	25.7	111.9	37.1	39.2	31.3	66.7	37.6	49.2	21.8	50.9	29.6	6.0	45.4	48.7	41.3	17.6	34.3	84.9	23.5	23.6	42.6	33.1	40.9	43.1	42.8	40.0	54.8	27.1	55.5	83.8	28.7	22.4	41.6	20.3	8.0	30.7	41.2	14.2	61.8	51.7	31.5	30.9	74.4	101.7	29.1	29.0	38.0	48.4	36.6	27.9	76.7	36.6	59.4	19.7	56.0	53.1	35.5	44.0	43.9	30.3	35.8	38.8	48.0	30.3	32.9
CUL7	"dJ20C7.5, KIAA0076"	ENSG00000044090	"Cullin 7"	Q14999	6	43037617-43053943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015449, HPA030095, HPA030096"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 51: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997"	"unprognostic (2.32e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (8.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.35e-1)"	7.5	13.7	5.0	6.6	5.0	4.4	8.8	5.7	5.3	14.4	7.9	7.6	7.7	11.7	9.0	6.9	14.2	7.6	5.9	5.4	7.0	11.0	9.7	7.4	6.2	3.8	4.4	15.9	15.7	6.9	26.0	10.2	4.9	11.0	5.4	5.5	8.5	8.7	13.2	7.5	8.0	9.2	3.5	9.7	9.4	5.7	6.9	6.1	12.9	10.7	5.4	8.9	9.6	4.0	10.6	8.2	27.1	32.0	27.9	40.7	2.2	15.7	21.0	18.8	19.0	18.0	7.9	4.9	35.2	27.0	19.1	3.9	9.9	13.9	8.8	12.4	10.5	12.2	9.1	25.5	23.2	4.4	14.2	42.5	13.1	16.2	17.4	33.7	18.0	5.6	10.7	12.3	24.1	21.8	5.6	10.9	4.5	32.2	6.7	9.1	6.5	12.7	16.6	14.4	14.6	18.2	12.2	11.3	11.1	12.4	16.6	8.3	18.9	28.1	12.0	9.1	6.9	25.6	7.0	12.9	11.2	4.8	16.5	0.0	0.7	0.4	0.6	0.6	0.4	0.5	0.4	0.2	0.7	0.7	0.2	0.4	0.2	0.6	0.5	0.9	0.3	0.6	5.0	5.0	5.7	5.3	5.4	7.0	3.8	4.4	4.9	3.5	6.9	4.0	3.9	6.4	10.5	6.5	4.5	2.5	1.7	5.2	4.0	6.0	7.2	6.0	4.6	1.5	4.6	3.7	6.2	4.8	1.7	3.8	0.0	6.4	0.6	8.4	7.7	5.8	7.2	2.1	6.0	4.8	3.7	6.9	10.7	6.3	4.5	15.9	5.7	2.2	5.0	1.7	5.9	8.2	6.1	2.2	1.8	0.2	9.3	2.7	1.8	5.6	1.2	4.1	1.0	3.0	3.1	4.6	2.6	7.5	3.9	2.2	6.4	4.9	12.9	7.8	0.0	7.5	4.9	0.8	2.5	4.2	1.7	4.4	2.8	17.3	4.6	1.5
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		26000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	129.0	268.0	155.3	60.3	165.9	93.9	132.4	166.2	177.1	159.6	196.0	156.7	104.5	158.7	184.8	106.4	144.4	95.1	151.1	159.6	169.9	200.3	217.8	118.3	99.0	166.1	158.3	193.8	186.3	177.2	346.6	81.5	169.6	153.8	71.2	60.3	179.2	113.0	142.8	149.5	129.1	80.1	161.9	147.1	177.5	74.2	160.9	82.7	201.6	89.2	82.5	128.2	121.9	173.0	244.5	142.0	242.7	293.8	177.6	173.9	109.7	224.0	430.1	433.1	462.7	147.5	154.1	166.1	162.2	269.1	316.0	152.4	154.5	231.3	248.9	153.2	295.1	171.8	228.9	397.0	226.3	134.2	135.9	224.7	195.8	209.8	179.8	303.7	118.8	180.9	212.9	348.7	325.1	187.2	222.0	305.1	213.8	222.6	187.5	235.9	141.8	456.4	310.1	112.3	451.7	225.4	136.2	231.3	425.8	135.5	170.8	308.7	121.3	222.6	190.0	166.5	229.8	341.7	363.9	189.5	202.9	304.9	189.3	207.8	179.2	103.6	225.8	138.1	335.1	315.7	360.7	274.6	163.6	266.5	366.5	279.2	25.6	306.9	97.2	120.0	421.9	400.4	155.3	165.9	166.2	177.1	159.6	169.9	166.1	158.3	169.6	161.9	160.9	173.0	109.5	131.4	119.3	14.0	209.5	230.6	287.9	424.5	266.9	92.6	401.0	488.6	138.2	237.4	239.7	316.3	68.8	361.6	186.2	154.0	283.7	188.3	85.4	181.8	177.9	114.7	292.1	111.7	13.0	141.0	235.5	181.4	105.5	156.8	169.9	122.6	134.2	340.1	328.6	77.4	17.4	320.1	360.1	167.1	197.1	345.2	200.0	139.2	316.6	10.3	140.0	179.7	216.3	14.1	31.2	113.3	223.9	191.5	375.7	243.3	306.6	559.1	229.5	85.9	92.1	131.1	226.7	111.0	106.4	203.5	230.4	242.9	242.4	217.8	341.3	268.4
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 35.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	30.5	18.0	23.8	24.8	33.6	33.4	17.9	54.0	48.2	35.5	28.0	40.5	33.7	60.9	16.9	32.6	35.3	31.7	82.8	21.5	23.3	40.0	23.2	33.1	19.4	30.8	27.5	46.9	63.3	46.0	24.6	23.1	27.4	30.7	25.3	19.2	36.1	23.2	45.5	24.0	37.3	40.8	26.2	16.9	35.3	9.6	29.3	34.7	49.4	38.8	20.6	32.4	24.8	30.5	41.8	44.0	30.3	37.7	24.1	49.3	18.4	41.1	43.0	17.0	10.9	26.2	26.2	53.6	64.2	40.8	31.3	33.4	19.4	32.9	10.1	25.9	21.8	18.8	32.8	22.2	63.7	24.7	9.9	34.6	65.9	13.1	29.5	48.7	22.3	34.0	44.5	44.2	16.3	85.9	80.8	30.1	12.3	64.0	45.4	52.6	25.1	64.4	27.6	46.5	27.7	82.6	35.8	88.4	35.4	25.1	17.4	29.0	33.5	71.2	47.8	54.4	23.7	28.8	14.5	114.7	65.8	22.3	50.8	3.3	13.9	2.3	3.1	13.4	3.0	2.9	2.3	3.1	10.8	2.4	2.2	3.1	7.0	4.5	35.0	18.2	2.2	8.4	23.8	33.6	54.0	48.2	21.5	23.3	30.8	27.5	27.4	26.2	29.3	30.5	33.7	99.3	60.5	78.4	35.3	26.3	30.9	30.9	33.6	67.2	23.9	17.1	110.5	31.5	40.3	40.5	68.8	54.6	59.6	69.2	9.8	34.4	9.5	50.6	165.2	42.1	42.5	50.0	129.0	24.0	55.5	51.8	62.2	85.0	12.0	97.8	37.5	36.1	32.8	53.8	116.2	48.7	38.7	70.2	42.5	9.4	41.3	75.4	17.8	139.6	65.2	47.7	32.0	96.0	117.5	34.1	50.2	60.9	46.0	55.5	42.9	64.5	37.9	57.3	26.3	105.2	56.6	13.5	14.4	39.9	43.3	88.0	25.7	34.7	46.0	43.8
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832158-122846175	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1631	"pancreas: 2414.2"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 266.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 1.9;U-937: 1.2"	"Not detected"	"Not detected"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles		No	No				"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.4	0.2	0.2	0.2	0.3	0.8	0.4	0.2	0.5	0.6	0.2	0.6	0.5	0.4	0.4	0.5	0.4	0.0	0.4	0.3	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.0	2414.2	0.0	1.4	0.1	0.4	0.7	0.0	0.4	0.5	0.0	0.1	0.7	0.9	0.0	0.2	1.1	0.4	1.0	0.2	0.3	0.5	0.0	0.0	0.5	0.5	0.3	0.3	0.5	0.1	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.1	0.2	0.3	0.3	0.3	1.0	0.1	0.4	0.3	0.4	0.4	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.2	0.3	0.0	0.3	0.5	0.4	0.6	0.5	0.0	0.5	0.2	0.0	0.0	0.4	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.7	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	2.8	0.1	0.1	0.1	0.0	0.4	0.0	266.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.3	0.3	6.7	0.3	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0	43.6	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.7	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.1
CWC15	"AD002, C11orf5, Cwf15, HSPC148"	ENSG00000150316	"CWC15 spliceosome associated protein homolog"	Q9P013	11	94962620-94973586	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 883.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039878	Supported		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles, Mitochondria"		"HPA039878: AB_2676722"	"unprognostic (1.97e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.81e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.84e-3)"	"prognostic favorable (9.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (5.23e-2)"	23.1	21.8	37.3	14.2	37.5	32.3	30.5	38.5	46.3	22.5	33.9	20.4	16.0	20.8	34.1	23.6	21.3	13.9	35.0	37.1	39.1	31.2	37.6	17.3	25.1	38.3	39.8	27.0	22.4	25.9	15.7	25.6	38.5	19.9	19.4	25.2	27.0	19.7	68.7	18.1	18.3	17.4	38.6	18.9	21.7	40.0	38.0	30.8	25.1	60.1	24.4	22.0	20.7	39.4	27.1	16.5	63.3	32.3	54.4	50.1	33.0	40.1	52.4	59.9	51.0	80.6	62.4	40.3	76.2	51.1	41.2	28.9	33.8	47.3	66.3	50.7	30.5	51.3	20.5	40.0	45.3	65.9	31.8	47.9	54.1	36.7	54.0	50.2	59.5	44.3	58.2	37.2	56.1	29.4	65.2	87.6	32.0	66.6	42.9	43.7	38.2	44.2	61.1	30.2	35.2	28.8	42.0	44.7	35.9	53.3	72.1	50.8	35.8	44.4	35.2	60.7	41.0	16.9	41.2	57.4	25.5	73.4	44.8	45.9	22.6	33.9	23.6	28.1	32.3	28.7	31.3	29.0	29.6	25.2	29.7	30.7	27.4	26.8	35.9	28.7	34.4	23.7	37.3	37.5	38.5	46.3	37.1	39.1	38.3	39.8	38.5	38.6	38.0	39.4	67.1	73.7	63.9	12.4	69.3	59.3	84.6	150.1	54.7	59.3	56.1	80.0	170.3	92.9	112.2	51.5	14.6	146.7	75.5	62.4	221.1	122.2	883.6	57.7	60.9	74.3	28.4	96.2	15.4	144.0	126.3	80.0	42.8	57.9	104.4	68.6	96.0	121.3	128.7	40.4	17.0	68.3	83.4	69.5	62.4	203.6	112.8	68.8	71.2	14.0	109.1	142.6	104.0	13.0	21.5	125.7	85.4	92.9	59.2	90.9	99.0	245.9	89.1	59.1	138.1	72.5	98.8	267.7	196.2	80.2	63.9	119.3	71.3	69.9	65.2	70.9
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	12.7	10.2	7.1	13.1	7.8	16.0	15.0	13.5	10.1	14.1	7.1	11.9	10.1	16.9	10.4	12.5	12.0	12.1	10.1	7.6	7.2	13.4	16.8	11.5	18.5	6.4	6.9	19.3	9.2	13.5	8.2	14.5	7.0	12.5	11.8	12.4	10.2	10.9	13.6	11.0	10.4	13.9	7.1	14.7	11.0	9.0	7.0	21.8	16.0	14.5	18.2	14.1	12.1	8.9	19.1	11.2	31.6	21.1	22.7	26.7	24.1	24.5	28.7	29.4	28.7	25.9	23.1	36.7	21.6	17.9	25.6	20.5	30.4	23.1	44.2	33.0	26.2	49.1	15.1	35.4	22.0	69.6	26.2	17.5	27.1	37.4	49.8	19.3	22.3	25.2	54.6	21.9	19.7	18.9	36.5	34.7	48.8	22.5	18.3	32.8	38.9	27.7	20.2	23.5	21.6	28.8	20.3	15.9	28.5	33.8	11.8	42.2	19.0	25.1	21.2	16.8	25.7	19.2	21.5	44.3	22.6	27.2	26.1	49.7	13.3	31.4	16.1	16.7	16.3	17.4	17.3	19.5	13.9	14.5	21.1	16.7	22.0	16.0	13.3	8.6	16.5	11.5	7.1	7.8	13.5	10.1	7.6	7.2	6.4	6.9	7.0	7.1	7.0	8.9	38.0	19.2	33.8	20.5	38.0	19.1	29.2	16.9	22.2	19.5	12.9	19.8	26.6	22.8	27.0	11.0	25.0	18.3	36.5	11.8	9.8	23.4	1.6	24.2	31.9	27.2	15.6	14.9	35.8	19.1	17.5	32.5	19.9	25.1	27.3	24.7	16.8	12.8	13.7	13.5	28.4	16.4	14.2	20.6	12.1	2.4	23.3	24.2	3.6	15.0	31.6	17.3	30.9	35.2	35.1	18.7	17.6	18.4	20.8	16.8	15.7	20.3	34.4	19.1	46.0	40.3	25.1	22.8	21.3	14.1	18.6	24.8	32.5	18.6	15.6	19.5
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800441-38825355	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	13.3	12.6	7.9	9.9	8.9	62.2	12.3	8.5	9.7	11.6	8.8	11.1	10.3	10.3	5.4	12.5	11.9	7.6	9.0	8.2	8.5	11.6	16.2	13.0	12.6	8.7	8.5	11.2	12.6	7.2	11.0	6.7	8.5	11.7	6.1	8.6	10.9	4.5	12.7	17.4	13.1	6.8	8.0	16.8	11.6	18.4	8.5	14.2	11.3	7.1	9.0	10.9	11.5	9.4	11.2	13.1	8.2	14.1	10.9	7.1	8.3	11.5	7.9	12.0	11.0	8.4	11.7	12.7	7.8	9.2	9.2	25.3	8.2	7.7	14.5	12.0	8.7	9.9	14.9	10.4	10.8	25.2	15.6	8.4	12.3	11.8	9.7	12.7	9.8	13.5	15.5	15.0	10.2	6.2	26.4	25.6	8.5	8.2	6.4	20.0	12.1	11.4	12.0	10.7	9.3	8.2	10.7	7.6	13.8	12.2	12.0	19.8	10.2	10.8	9.9	14.3	17.9	11.9	9.3	18.8	11.4	12.1	10.9	18.0	4.1	10.6	4.6	3.9	4.0	4.5	4.3	4.8	3.5	6.0	4.9	3.7	28.7	5.9	8.1	1.7	2.9	3.0	7.9	8.9	8.5	9.7	8.2	8.5	8.7	8.5	8.5	8.0	8.5	9.4	50.7	57.7	69.5	10.4	54.2	63.9	61.2	45.9	39.9	37.2	40.8	31.2	18.3	21.5	46.3	23.9	83.4	35.1	60.6	56.6	29.4	27.5	118.4	63.8	51.7	45.3	41.8	34.5	10.0	23.6	35.2	43.8	52.0	100.2	58.9	23.8	37.9	27.2	28.6	26.9	7.9	51.9	26.4	27.0	37.9	31.9	37.3	38.2	26.6	5.6	38.7	30.1	41.2	5.5	8.1	29.3	70.9	34.6	43.2	51.4	61.5	27.2	41.9	43.4	39.5	57.0	45.7	93.9	33.6	30.5	76.7	79.1	54.6	28.8	32.6	72.4
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like cell cycle control factor 1"	Q69YN2	10	100232298-100267680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	8.1	6.9	5.9	11.4	6.3	18.8	11.6	7.5	7.6	7.9	5.1	7.2	6.8	8.2	5.7	6.9	8.7	6.7	7.4	5.9	6.5	7.8	8.2	7.5	16.4	6.0	5.8	10.3	8.0	9.0	6.1	9.0	6.3	6.8	8.6	10.3	8.6	6.5	10.1	11.2	8.1	9.3	6.3	11.8	6.6	14.3	6.0	14.8	8.1	10.2	16.9	8.5	6.6	8.4	29.1	18.8	18.7	29.2	9.1	10.8	20.7	17.2	23.8	37.5	30.6	21.5	22.6	30.5	19.4	16.6	16.3	27.9	42.2	24.9	39.6	19.4	20.8	17.5	15.8	20.6	15.8	44.7	19.6	15.2	10.4	28.0	26.2	14.2	26.6	30.8	20.7	26.8	21.9	18.3	36.2	32.4	14.7	15.0	23.2	12.6	29.2	21.2	15.0	16.5	9.4	16.8	20.6	10.3	26.0	12.6	37.3	19.1	18.6	15.8	21.5	18.3	32.8	23.9	29.6	17.9	20.1	39.1	11.4	10.0	17.0	22.7	12.8	15.9	16.3	14.0	13.3	14.4	14.9	13.0	14.9	15.0	9.6	18.1	14.7	6.8	17.7	13.8	5.9	6.3	7.5	7.6	5.9	6.5	6.0	5.8	6.3	6.3	6.0	8.4	8.0	19.2	10.8	14.0	16.2	4.5	7.7	6.8	4.6	9.5	4.8	3.9	8.0	5.7	11.3	5.5	4.2	10.4	13.5	4.3	7.9	6.0	23.6	6.8	6.4	8.3	4.2	11.2	26.8	7.7	11.0	6.7	4.6	6.3	17.7	8.3	7.5	5.9	9.5	10.1	24.3	4.2	10.2	13.1	5.7	5.3	6.8	11.3	8.8	14.0	15.5	5.1	19.6	18.6	24.0	7.2	6.7	4.1	11.3	5.3	4.5	6.2	12.5	12.3	0.0	8.4	6.9	18.4	12.2	5.8	7.7	10.9	12.8	6.7	5.3	4.4
CWF19L2	FLJ32343	ENSG00000152404	"CWF19 like cell cycle control factor 2"	Q2TBE0	11	107326345-107457844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038166	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA038166: AB_10669518"	"unprognostic (1.38e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.76e-2)"	8.8	5.8	15.4	6.2	16.6	8.2	11.3	20.3	30.9	8.8	16.8	7.3	5.0	10.9	8.2	6.4	7.5	6.0	5.4	14.7	16.7	11.2	8.5	7.1	10.4	16.1	15.9	14.2	5.9	7.8	4.7	8.4	16.2	8.3	6.2	8.6	6.2	8.5	7.0	7.3	5.5	6.9	15.8	9.8	6.7	5.9	16.1	11.8	9.7	8.4	11.0	6.9	6.7	17.7	7.4	5.9	12.5	6.0	10.2	11.5	9.4	9.5	8.8	7.3	9.7	13.9	17.0	12.8	17.7	6.7	9.3	17.6	14.0	7.3	12.7	14.4	7.8	14.2	6.6	9.1	6.6	16.9	11.5	5.9	12.6	8.5	12.7	8.4	10.0	7.6	21.9	7.2	10.7	5.5	13.1	15.3	11.9	12.2	8.3	11.3	11.9	17.3	8.6	9.0	7.2	6.0	13.9	10.3	5.4	10.5	13.8	8.0	9.1	12.1	9.7	6.4	8.6	3.8	7.5	12.3	3.5	16.4	11.3	45.6	10.1	19.3	14.2	9.3	15.7	29.4	16.5	14.4	4.5	27.6	19.9	15.3	19.4	17.4	10.4	19.2	15.7	4.3	15.4	16.6	20.3	30.9	14.7	16.7	16.1	15.9	16.2	15.8	16.1	17.7	56.2	38.5	53.2	38.5	66.1	17.8	16.1	19.1	18.2	97.2	24.2	21.0	28.9	57.2	33.2	82.8	95.9	24.0	57.9	18.3	33.2	22.1	3.1	31.8	39.8	40.8	13.1	23.8	42.3	18.4	22.8	29.3	17.3	34.0	46.2	35.2	51.4	56.1	15.8	69.0	37.4	27.0	14.2	33.7	15.4	9.5	54.3	24.5	14.2	43.1	32.7	47.5	69.0	42.3	68.1	16.3	31.6	63.9	36.1	6.7	25.6	60.5	18.3	131.8	39.5	41.1	30.8	48.0	47.2	9.1	13.4	17.0	55.3	21.4	21.3	7.8
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372477-57385044	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis, Host-virus interaction, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 104.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal prostatic cells: 50.8;Basal respiratory cells: 51.8;Breast glandular cells: 62.3;Breast myoepithelial cells: 51.1;Club cells: 54.8;Endothelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 30.1;HDLM-2: 86.0;Hep G2: 63.8;RPTEC TERT1: 36.5;SK-BR-3: 21.5"	"Low region specificity"	"Detected in all"							"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	1870000	370000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	68.3	4.8	36.4	5.7	39.5	0.1	104.8	11.9	44.8	17.6	19.8	14.3	5.1	13.7	8.7	14.4	18.2	21.0	43.0	46.9	26.4	41.9	14.9	98.8	8.5	25.1	24.8	8.3	13.1	7.1	11.2	3.9	23.6	42.2	5.4	4.3	70.8	45.3	15.0	27.3	12.8	10.6	21.8	1.4	14.5	5.7	30.5	5.2	29.7	19.2	6.2	33.0	17.3	31.2	0.0	0.8	8.0	6.8	0.3	0.1	2.0	0.1	0.0	0.0	0.1	3.1	0.0	0.0	30.1	0.1	4.3	0.3	0.0	0.1	0.0	86.0	0.4	0.0	0.0	63.8	0.9	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.8	0.1	0.0	0.1	1.1	0.2	36.5	0.2	0.2	7.1	0.0	21.5	1.9	5.1	0.1	0.2	0.1	0.3	4.7	0.2	2.1	0.1	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	36.4	39.5	11.9	44.8	46.9	26.4	25.1	24.8	23.6	21.8	30.5	31.2	115.4	3.2	4.6	3.3	1.2	4.5	50.8	51.8	31.9	9.8	62.3	51.1	8.3	21.5	54.8	3.7	4.2	0.0	0.8	0.5	0.0	35.1	0.4	12.9	3.3	50.7	1.8	0.0	28.1	1.8	0.1	9.0	0.5	27.3	1.3	0.2	6.1	11.7	0.0	5.0	20.5	0.3	20.3	0.8	4.7	0.5	4.7	0.6	0.0	16.9	0.6	0.8	0.0	13.0	3.2	4.3	0.6	27.8	0.0	29.7	0.2	11.8	28.8	2.2	13.1	2.8	15.7	0.1	0.1	10.3	2.6	0.3	0.8	0.3	1.0	32.6
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263495-39281735	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.4"	"Group enriched"	"Detected in some"	5	"Microglial cells: 177.1;NK-cells: 350.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 449.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"RPMI-8226: 589.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	6.2	6.9	6.4	1.1	5.1	8.6	6.0	2.7	1.7	1.1	1.2	2.7	4.2	0.8	6.1	2.6	2.4	7.7	8.4	2.5	2.0	9.9	2.1	17.3	14.8	1.6	0.7	4.5	1.0	4.6	18.9	3.5	1.1	0.5	7.6	7.2	6.5	2.3	0.9	3.5	21.5	11.9	1.4	1.8	17.4	2.0	2.4	2.2	5.3	2.4	0.3	26.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	6.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	24.5	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.2	0.1	589.8	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.2	0.1	16.5	0.0	0.0	0.1	0.1	0.0	0.5	1.0	0.1	0.0	28.6	0.0	7.7	99.6	1.8	264.0	261.2	3.4	0.8	55.9	145.2	94.4	0.7	19.0	122.4	20.8	39.7	449.2	7.1	1.5	232.7	6.2	6.4	8.6	6.0	7.7	8.4	17.3	14.8	18.9	21.5	17.4	26.4	0.8	0.0	0.5	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.8	3.8	0.4	0.0	0.6	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.2	0.2	0.1	3.5	0.0	2.1	0.3	0.0	0.0	0.3	0.0	0.0	5.1	0.1	0.7	0.3	4.1	0.0	0.6	0.0	0.0	15.0	28.0	0.3	0.3	43.2	0.0	177.1	50.3	0.1	350.1	2.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.7	0.2	6.6	0.4	1.3	0.7	0.2	0.0	0.6	0.0	22.6	0.1	0.1	0.0
CXADR	CAR	ENSG00000154639	"CXADR Ig-like cell adhesion molecule"	P78310	21	17513043-17593579	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4"					"Low region specificity"	"Detected in all"			"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted - unknown location"	NA	NA		18000	"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	3.6	2.9	7.0	2.8	8.7	2.6	9.8	6.6	10.8	7.7	22.8	22.5	42.3	5.3	15.2	14.5	10.6	18.3	9.3	8.9	7.1	8.3	49.3	13.6	0.7	10.4	6.8	0.4	15.8	6.8	4.7	0.3	9.3	15.1	25.6	4.9	15.4	14.2	0.4	53.4	42.6	3.3	9.7	2.4	30.9	12.5	7.3	1.5	22.1	0.0	4.1	25.6	10.9	17.7	16.8	9.0	44.6	0.1	0.0	0.0	26.7	0.2	0.2	0.7	2.7	93.4	14.6	6.2	19.7	0.0	13.3	28.1	22.8	6.2	1.0	9.3	19.0	0.1	24.1	63.0	2.9	1.8	0.1	0.0	24.6	1.3	0.4	10.8	9.0	5.5	0.3	0.4	0.0	1.1	3.7	0.1	109.1	15.2	0.0	0.1	15.2	12.5	38.7	104.4	18.5	12.3	10.9	12.6	6.7	45.8	25.4	0.3	0.5	0.2	25.8	0.4	6.6	4.5	7.7	0.4	3.6	0.1	0.6	1.0	0.1	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.6	0.2	0.3	0.2	0.0	0.0	0.1	0.2	7.0	8.7	6.6	10.8	8.9	7.1	10.4	6.8	9.3	9.7	7.3	17.7	0.2	141.1	79.0	2.6	1.0	323.4	172.7	110.6	132.6	16.9	58.6	28.2	29.8	161.5	106.6	103.0	27.1	0.8	0.3	238.4	5.9	130.0	5.3	118.9	8.3	4.8	80.8	9.9	60.4	93.7	0.2	8.6	94.3	128.9	5.7	1.1	47.8	127.7	0.6	0.0	43.0	107.5	81.4	22.9	13.1	7.7	2.1	3.3	23.2	40.3	0.7	13.4	0.0	78.9	161.4	93.4	155.3	0.0	1.6	125.1	263.0	4.0	85.6	11.2	6.6	0.2	5.3	6.4	24.5	117.0	343.8	0.7	4.3	0.5	107.0	202.7
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Human disease related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Basal prostatic cells: 2.6;Basal respiratory cells: 2.9;Distal enterocytes: 2.7;Exocrine glandular cells: 3.6;Macrophages: 4.3;Prostatic glandular cells: 3.7;Proximal enterocytes: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 3.4;BJ hTERT+ SV40 Large T+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 5.3;GAMG: 1.4"					"Region enhanced"	"Detected in single"		"spinal cord: 1.2"	CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000			"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	1.6	0.4	1.5	11.1	1.3	0.3	3.7	1.1	3.5	2.5	1.0	1.7	0.8	1.5	0.2	1.0	1.6	1.2	1.2	1.2	1.2	1.3	2.4	6.0	11.9	2.3	1.4	0.5	8.9	0.1	0.3	3.6	2.2	5.2	4.3	0.0	3.1	0.3	0.3	0.3	1.2	1.7	1.6	5.8	6.3	0.9	2.0	6.3	1.2	0.0	1.4	4.6	0.6	1.3	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.4	5.1	5.3	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	1.1	3.5	1.2	1.2	2.3	1.4	2.2	1.6	2.0	1.3	0.5	3.2	0.0	0.0	0.2	0.1	2.6	2.9	0.0	0.0	0.2	0.3	0.2	1.5	0.2	0.0	0.0	0.0	0.0	2.7	0.0	2.0	0.0	0.7	0.9	2.2	0.0	0.0	0.0	3.6	0.0	0.5	0.0	1.6	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.1	0.0	2.1	0.3	0.0	0.0	4.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	2.8	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.2	1.4
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"	NA	NA	1030000	560000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	366.8	82.6	19.4	143.8	20.2	35.1	237.4	19.1	28.1	268.4	24.5	124.3	53.6	360.7	54.3	138.5	122.1	263.3	190.3	19.4	18.6	124.8	252.8	71.0	215.8	22.3	21.1	112.3	131.2	126.7	21.3	8.5	19.1	47.8	115.5	2.1	116.3	66.2	158.9	99.4	96.5	343.5	19.9	356.6	45.4	19.4	21.0	142.6	103.4	181.3	119.7	107.0	174.3	17.7	0.0	0.0	0.4	0.6	509.6	78.9	0.4	187.7	303.5	294.9	441.2	0.0	0.1	0.2	1.9	501.8	0.0	0.1	0.8	0.2	97.1	187.2	2.4	0.0	0.0	0.0	172.8	0.4	0.9	1293.8	0.0	63.8	0.1	0.0	0.2	0.1	0.1	0.0	1.0	0.4	0.7	0.6	32.2	0.0	0.6	0.8	0.3	224.3	0.2	0.0	0.6	0.6	0.3	0.7	0.0	63.6	272.2	0.4	0.4	0.4	0.5	205.0	0.2	0.2	0.1	0.1	0.6	0.3	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	20.2	19.1	28.1	19.4	18.6	22.3	21.1	19.1	19.9	21.0	17.7	347.2	0.0	1.1	1.3	1.4	76.3	0.3	0.0	9.6	1.5	8.1	14.0	25.0	10.0	0.6	5.5	0.0	0.3	2.1	0.0	172.1	0.8	2.2	1.7	46.8	134.1	0.0	0.0	0.6	20.5	0.3	566.4	1.5	1.0	0.0	0.4	55.6	2.5	2.6	0.0	6.6	3.9	0.0	191.8	110.1	3.7	70.2	27.9	135.2	74.0	0.0	1.9	0.0	12.1	0.1	3.0	0.0	8.6	1.0	1.0	0.1	25.5	0.0	0.8	85.5	43.7	146.1	1.8	5.9	6.3	62.7	0.7	9.6	33.2	0.5	0.5
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 523.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 242.2;Breast myoepithelial cells: 72.4;Endometrial stromal cells: 101.0;monocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700			"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	2.6	0.4	0.1	127.7	0.4	0.1	15.4	0.4	0.3	1.4	0.1	13.3	1.9	3.6	1.6	2.4	0.8	5.8	1.2	0.1	0.1	0.6	28.5	2.9	523.1	1.1	0.1	0.7	0.3	0.2	3.1	0.6	0.1	27.3	16.5	0.2	8.5	1.4	0.0	0.6	68.5	1.2	0.4	338.6	34.9	1.5	0.1	16.2	2.4	0.0	441.3	30.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.1	0.1	1.1	0.1	0.1	0.4	0.1	0.2	0.9	0.0	0.5	1.3	0.3	0.1	15.8	3.9	0.0	0.0	242.2	72.4	0.0	1.5	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.6	101.0	1.7	0.0	10.7	1.9	0.2	0.3	6.3	0.5	1.8	1.3	0.0	3.6	21.3	10.2	0.0	3.9	0.0	0.0	3.4	0.0	0.0	0.0	0.9	0.0	1.9	38.8	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	7.8	0.0	0.1	4.5
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 780.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3435.4;Basal squamous epithelial cells: 3284.9;Breast myoepithelial cells: 1544.3;Fibroblasts: 2220.8;Glandular and luminal cells: 1201.1;Proximal tubular cells: 3662.8;Suprabasal keratinocytes: 2115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HAP1: 61.6;hTCEpi: 79.9;RPTEC TERT1: 222.2;SuSa: 115.2;U-2 OS: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 33: Fibroblasts - ECM organization"			"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	366.1	5.2	77.6	76.2	84.5	0.6	229.1	70.6	102.7	166.3	74.8	152.4	214.0	6.9	66.6	92.9	32.9	19.8	14.0	83.7	73.8	345.6	58.5	7.4	90.7	72.4	91.0	5.5	11.6	1.9	122.0	170.7	72.4	10.1	181.3	17.5	293.5	17.6	81.1	780.3	247.0	6.3	68.7	87.5	107.3	3.7	90.2	26.6	55.2	36.5	128.5	76.6	96.3	77.9	0.0	0.0	2.7	0.0	0.2	0.2	0.7	2.9	0.8	0.2	0.0	0.0	9.1	0.0	2.7	0.1	3.8	0.2	61.6	1.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	79.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.0	0.0	0.0	0.2	0.0	1.1	222.2	0.0	1.1	0.7	0.2	0.2	0.0	115.2	0.1	0.0	0.0	0.1	84.9	0.4	0.1	0.3	0.0	0.0	1.4	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	77.6	84.5	70.6	102.7	83.7	73.8	72.4	91.0	72.4	68.7	90.2	77.9	123.8	0.0	1.1	32.7	13.1	3435.4	14.4	276.9	3284.9	245.7	47.5	1544.3	4.1	0.0	5.1	283.3	0.0	35.9	6.1	0.0	563.4	0.0	0.8	45.0	140.8	45.9	0.0	0.0	1.0	0.0	25.4	2220.8	0.5	1201.1	0.0	0.0	43.5	0.2	63.6	6.7	150.8	0.0	240.1	0.9	887.9	1.3	20.8	35.3	439.4	8.4	0.0	6.7	0.0	4.5	4.2	0.1	0.0	0.4	13.3	10.6	0.0	3662.8	2.1	19.0	0.0	889.8	99.2	0.4	5.2	69.3	2115.0	77.2	43.4	0.3	0.1	9.3
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733533-4739928	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 4051.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6"	"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	6800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	27.6	18.1	18.7	56.0	19.4	70.4	29.3	20.0	30.7	19.8	20.8	21.9	45.7	11.7	15.3	24.6	24.0	54.0	7.8	17.4	23.0	19.6	52.6	106.0	23.7	32.5	22.7	10.5	20.8	61.8	14.4	31.1	27.9	16.3	25.8	10.2	47.1	14.4	2.6	21.8	39.3	17.6	25.2	43.8	41.2	112.6	28.7	12.5	10.5	3.3	17.9	60.6	14.3	34.2	86.5	12.4	0.4	44.7	0.7	3.1	11.5	1.1	8.9	11.2	15.6	63.5	58.4	0.1	10.0	1.5	8.6	97.9	20.0	14.1	5.3	8.9	14.8	0.4	1.7	29.5	8.5	0.1	15.8	0.7	26.6	5.9	1.3	7.4	3.1	0.9	0.4	0.7	0.8	20.9	0.3	1.8	0.4	42.1	7.2	1.2	0.0	13.2	30.4	15.8	0.4	1.4	17.6	11.3	5.5	2.3	57.4	1.4	0.4	1.5	6.8	2.2	5.3	3.0	3.9	0.1	0.5	2.9	2.4	0.6	63.3	16.7	0.5	107.5	0.7	9.5	1.1	0.8	38.2	13.0	0.8	1.2	103.2	0.6	141.6	16.0	0.1	29.2	18.7	19.4	20.0	30.7	17.4	23.0	32.5	22.7	27.9	25.2	28.7	34.2	9.7	73.7	46.6	1.6	17.4	70.1	130.4	133.4	40.5	2.6	64.8	50.3	0.8	58.6	132.4	40.5	2.1	3.4	11.1	28.1	3.9	151.0	795.4	22.1	4.1	25.4	30.9	2.7	0.1	145.9	2.5	14.2	36.7	32.7	74.1	2.3	132.1	9.0	196.4	3.3	0.3	32.2	44.7	231.6	406.3	4051.5	24.5	270.6	26.6	15.0	556.1	13.2	1.0	5.0	1.2	188.1	44.5	30.1	2.2	277.2	51.3	17.4	62.4	1.3	19.7	3.4	14.4	22.7	11.5	33.7	76.4	2.9	11.7	1.6	23.7	272.7
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998677	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 35.9;salivary gland: 50.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 56.2;stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6"									HPA065474	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1110000	1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	2.1	0.2	1.5	35.9	0.9	1.2	3.2	0.6	8.8	7.7	0.4	0.7	0.8	0.2	0.0	0.1	0.2	4.8	0.6	0.8	2.6	0.2	1.3	10.0	6.3	1.4	2.1	0.0	0.5	0.0	0.1	0.2	3.1	1.3	0.3	0.0	50.2	0.5	0.1	0.0	2.1	0.2	1.1	2.1	8.5	0.4	5.7	0.6	0.0	0.2	0.6	8.4	0.0	0.7	0.1	191.9	0.7	0.0	0.3	6.9	0.0	3.5	2.9	1.5	3.0	0.6	1.6	0.0	157.0	0.1	34.0	0.4	0.0	0.0	17.6	0.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	111.4	0.0	81.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	603.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.0	1.5	0.9	0.6	8.8	0.8	2.6	1.4	2.1	3.1	1.1	5.7	0.7	0.2	3.2	0.0	0.0	0.0	0.9	0.7	64.6	0.0	0.0	8.0	4.4	1.2	15.7	33.2	0.0	0.0	0.0	0.1	1.3	0.0	94.0	0.7	0.7	0.1	1.8	0.0	0.0	0.3	1.4	0.1	3.6	15.3	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.7	4.1	0.3	30.4	0.3	0.0	222.6	0.0	1.0	2.1	0.0	0.0	0.0	0.1	245.4	0.0	0.0	0.3	3.1	0.0	0.1	4.3	0.0	0.0	0.6	4.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	1.1	2.0
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740541-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3301.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"cerebral cortex: 136.1"	"Immune cell enriched"	"Detected in some"	451	"neutrophil: 483.0"	"Lineage enriched"	"Detected in single"	788	"granulocytes: 483.0"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 4072.6;GAMG: 1080.2"					"Not detected"	"Not detected"			HPA057179	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7260		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	67.9	13.5	1.8	209.9	2.8	3301.3	3.6	1.7	136.1	54.5	7.6	10.6	3.6	41.0	0.2	3.7	8.9	177.2	33.8	1.7	1.6	10.8	77.7	91.2	1.2	2.1	1.6	6.0	16.1	1.8	3.2	41.1	15.1	9.6	7.3	0.9	25.4	1.5	1.3	3.2	4.9	12.7	1.9	10.3	8.8	0.7	4.9	15.2	3.4	8.1	8.7	456.7	4.0	1.9	2.7	1.4	0.0	0.1	3.9	19.4	0.2	25.7	4072.6	35.9	117.0	0.2	13.0	0.2	547.6	1.3	1080.2	48.2	0.0	1.0	562.3	1.8	0.2	0.9	0.4	6.5	6.8	41.0	2.5	12.4	1.7	119.0	2.9	12.9	124.9	0.0	1.4	0.8	0.7	0.0	0.0	55.7	0.0	14.7	20.3	0.3	0.5	0.9	317.3	17.2	0.1	0.0	1.9	0.1	61.1	0.8	0.1	5.6	308.3	56.8	5.1	15.1	55.0	0.4	0.7	1.7	252.5	30.9	88.2	1.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	483.0	0.0	0.0	0.0	0.0	0.1	1.8	2.8	1.7	136.1	1.7	1.6	2.1	1.6	15.1	1.9	4.9	1.9	28.6	51.3	254.1	0.0	26.4	0.0	13262.1	0.0	164.4	0.5	40.2	15.4	23.8	127.2	426.5	0.0	0.0	4.3	17.7	14.4	0.0	1695.0	3.2	717.6	257.1	712.2	19.1	8.0	0.0	260.7	5.2	1475.1	54.0	1708.7	51.2	0.5	15.7	3.6	367.1	0.0	0.0	26.4	0.0	543.0	0.0	1.9	0.6	3685.4	0.0	0.0	1178.5	0.5	0.0	0.0	0.0	584.9	0.3	0.4	27.3	8869.1	0.9	1.0	178.6	1.1	39.5	44.3	263.0	0.3	2.5	124.9	0.0	21.3	138.8	0.0	18.5	13149.4
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162841-218166962	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.1;dendritic cells: 5.2;granulocytes: 2.5;NK-cells: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	14	"neutrophil: 1472.7"	"Lineage enriched"	"Detected in many"	62	"granulocytes: 1472.7"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 5.8"	"Not detected"	"Not detected"							HPA031991	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA031991: AB_2674103"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	13.2	0.5	0.3	25.1	0.5	9.5	0.4	0.3	1.7	0.7	0.5	0.4	0.2	0.2	0.0	1.6	2.9	4.1	1.8	0.3	0.3	0.5	2.0	9.7	0.3	0.4	0.4	0.1	1.5	0.3	0.2	2.6	1.2	0.3	0.2	0.0	0.5	0.1	0.4	0.3	0.6	1.8	0.3	40.5	0.9	0.2	0.5	1.8	0.4	12.0	0.6	5.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	2.3	2.9	23.7	0.8	0.3	0.2	2.1	6.1	0.7	0.1	0.4	8.7	1472.7	1.5	3.2	0.9	0.3	8.3	0.3	0.5	0.3	1.7	0.3	0.3	0.4	0.4	1.2	0.3	0.5	0.3	0.0	0.0	5.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 306.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7"	"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"	0.6	0.8	0.1	5.9	0.1	7.2	0.5	0.2	0.3	0.5	0.0	1.6	5.4	0.4	0.0	0.6	0.5	1.4	0.4	0.2	0.0	0.5	0.5	3.3	16.3	0.2	0.0	0.4	0.5	0.0	0.1	0.1	0.0	0.4	1.0	0.0	1.8	0.3	0.1	0.6	6.4	0.4	0.0	7.5	2.9	0.3	0.1	3.0	0.9	0.1	5.3	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.1	0.0	0.4	0.3	0.2	80.4	0.2	40.9	45.3	90.3	124.7	8.4	9.9	5.5	51.6	1.9	198.9	0.2	306.7	89.4	35.3	0.1	0.1	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	13.9	0.3	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	87.6	3.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	3.2	0.0	0.2	0.0	0.3	3.1	0.3	1.3	0.0	0.7	0.3	0.3	0.0	0.0	1.8	0.0	0.8	6.1	0.0	0.0	4.0	1.8	0.0	2.1	0.0	15.5	0.0	0.0	0.2	5.3	0.0	36.5	0.0	17.6	0.5	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.6	0.1	48.3	1.5	3.1	0.1
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883892-118897787	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"B-cell activation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 10.6;intestine: 10.2;lymphoid tissue: 28.9"	"Cell type enriched"	"Detected in some"	13	"B-cells: 83.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"memory B-cell: 67.7;naive B-cell: 92.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 92.4"	"Group enriched"	"Detected in some"	11	"Daudi: 18.9;U-698: 65.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026149, HPA042432"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB026149: , HPA042432: AB_2677995"	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	0.5	1.9	0.4	11.2	0.3	10.6	0.2	0.7	0.5	2.7	0.0	4.4	0.4	0.3	0.1	2.5	0.1	1.0	0.9	0.4	0.2	2.1	1.5	1.4	28.9	0.3	0.4	0.7	0.9	0.0	1.0	0.2	0.3	3.7	0.4	0.6	1.3	0.0	2.1	1.9	10.2	0.0	0.1	21.1	2.0	0.3	0.5	1.9	0.8	0.0	15.9	2.3	1.4	0.0	0.1	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	18.9	0.5	0.0	0.7	2.1	0.0	0.0	0.0	0.4	0.3	3.9	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.6	0.0	1.1	0.8	1.6	0.0	0.7	0.0	0.8	0.1	0.3	0.0	0.0	0.6	0.5	0.0	0.1	0.9	0.2	0.4	0.8	0.0	0.6	0.9	0.0	0.2	0.3	0.0	65.2	0.1	0.7	0.0	0.1	0.1	0.0	1.0	0.0	0.9	67.7	10.9	3.0	0.1	92.4	1.1	1.0	0.1	0.2	0.1	0.1	1.7	6.2	0.4	0.3	0.7	0.5	0.4	0.2	0.3	0.4	0.3	0.1	0.5	0.0	0.1	0.0	1.8	0.0	83.0	0.1	0.0	0.0	1.2	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.2	1.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.9	0.6	0.3	6.1	0.1	0.1	0.1
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA050120: AB_2681024"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favorable (1.44e-8)"	9.0	8.2	5.1	11.5	5.9	10.5	8.2	5.8	5.3	8.0	4.5	7.6	8.3	7.3	4.6	6.1	10.0	6.4	4.8	4.9	5.3	8.1	8.0	10.2	16.1	6.2	5.6	9.5	6.0	9.5	4.8	6.8	6.3	6.3	7.7	5.7	6.5	6.1	5.0	7.9	9.7	5.8	5.8	14.4	6.6	2.1	5.9	13.2	11.1	4.1	13.4	7.2	7.0	7.0	11.3	5.9	6.2	4.9	6.5	10.8	3.3	7.5	10.5	9.1	9.1	7.7	15.8	18.5	6.4	11.2	15.2	7.4	7.6	12.5	8.3	25.7	11.4	12.5	7.1	4.6	10.8	22.0	18.6	9.6	9.0	12.7	12.5	8.7	10.4	15.8	5.3	13.7	17.0	10.5	15.4	16.7	5.6	8.2	12.8	12.7	13.2	14.4	10.7	17.0	7.0	9.6	15.1	7.5	8.9	11.6	11.4	10.1	13.0	11.9	6.8	8.7	6.5	14.7	5.5	7.9	15.4	11.4	8.0	9.3	16.0	22.1	9.2	15.8	9.7	6.9	8.7	7.4	14.2	9.6	7.6	7.8	19.7	7.3	25.1	5.9	10.9	10.3	5.1	5.9	5.8	5.3	4.9	5.3	6.2	5.6	6.3	5.8	5.9	7.0	19.8	9.6	9.1	10.1	26.9	3.6	11.3	6.3	10.8	12.6	10.5	8.0	6.4	18.6	7.6	16.5	18.8	9.2	48.3	15.1	7.9	27.7	1.0	25.2	15.0	14.0	7.3	6.3	11.9	30.1	9.7	8.9	9.7	21.6	17.1	16.5	10.4	10.8	36.6	15.2	13.1	12.7	8.2	30.7	9.8	1.3	9.6	29.5	3.6	8.4	61.9	10.2	41.2	12.1	17.8	40.5	17.2	5.3	16.4	14.7	15.8	14.4	7.8	7.6	6.6	13.5	9.2	6.5	7.4	9.7	5.4	8.2	31.2	20.6	13.3	28.3
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	11.6	9.8	8.2	7.6	8.6	16.2	12.5	8.3	9.2	10.1	7.1	10.0	7.7	11.6	9.0	9.4	9.9	6.1	10.5	8.2	9.4	11.6	8.8	8.8	10.7	7.9	7.9	13.7	8.8	11.7	7.2	10.2	8.7	8.8	8.7	11.5	9.9	8.8	13.0	12.3	9.0	8.7	8.0	9.8	9.0	6.7	9.3	11.5	11.8	13.2	11.6	9.3	9.0	9.7	27.3	26.2	16.8	19.8	17.9	12.5	22.9	17.1	15.4	22.3	20.7	23.4	26.7	41.3	43.2	16.9	53.9	16.9	40.1	21.0	30.5	24.8	30.3	14.9	25.2	16.2	13.8	41.3	22.1	14.7	17.9	29.1	24.0	14.2	16.3	24.0	32.2	25.4	11.1	40.5	24.8	24.7	27.3	33.4	28.4	23.9	19.0	29.9	15.8	19.8	12.1	22.0	35.9	19.3	25.3	18.0	15.0	17.9	20.4	16.9	12.0	31.2	39.6	21.9	42.7	42.0	14.2	39.7	20.3	5.0	10.3	13.9	9.0	12.6	8.2	10.9	7.7	9.5	9.5	15.6	7.9	7.7	4.8	6.4	11.9	8.7	10.4	9.4	8.2	8.6	8.3	9.2	8.2	9.4	7.9	7.9	8.7	8.0	9.3	9.7	2.6	3.2	13.9	1.6	10.6	6.2	8.0	4.8	5.7	15.7	4.8	5.0	13.4	7.2	5.4	3.7	6.2	20.5	3.5	8.3	21.5	9.2	1.3	8.7	10.3	7.5	8.5	10.3	9.4	6.6	20.1	5.3	4.1	10.5	17.2	7.7	6.8	6.4	10.1	8.4	10.8	6.0	8.2	12.9	8.3	1.2	9.6	6.5	12.4	2.8	17.1	15.8	6.2	7.5	6.8	6.8	6.5	11.3	7.8	5.2	9.8	13.2	6.8	11.3	13.1	9.5	11.1	5.4	10.0	6.5	5.8	35.6	9.2	7.6	7.9	8.6
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23908006-23939509	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	8	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 33.3;Late spermatids: 6.9;Respiratory ciliated cells: 5.5;Spermatocytes: 19.7;Spermatogonia: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"GAMG: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031542, HPA031543, HPA031544"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929"	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	3.9	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.0	0.2	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.2	33.3	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	1.0	0.6	0.7	0.0	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.2	5.5	2.8	0.0	0.0	0.1	19.7	8.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0
CXorf65		ENSG00000204165	"Chromosome X open reading frame 65"	A6NEN9	X	71103889-71106788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 22.4"	"Group enriched"	"Detected in some"	154	"Early spermatids: 432.7;Late spermatids: 1481.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047396	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA047396: AB_2680028"	"unprognostic (7.81e-3)"	"unprognostic (8.43e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-8)"	"unprognostic (1.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	2.3	0.1	22.4	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.8	0.0	0.0	432.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.6	0.0	0.0	0.4	0.0	0.6	2.1	1481.8	4.4	0.5	1.8	1.0	0.2	0.0	6.2	0.0	0.0	0.0	0.2	6.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.7	0.0	0.0	1.1	3.2	0.0	0.1	0.1
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50287839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	18.1	26.7	24.4	22.8	25.4	45.9	19.3	29.8	30.5	28.0	25.9	23.6	27.3	23.3	10.3	23.6	24.9	17.5	19.9	24.6	24.6	25.5	24.5	19.2	34.3	24.6	24.5	30.0	38.7	20.3	21.0	16.0	25.2	24.4	15.9	13.6	32.4	21.4	20.2	29.5	23.5	14.9	22.8	29.6	25.7	22.8	25.0	30.7	23.2	13.1	21.1	25.6	23.7	26.3	24.6	31.9	33.4	46.9	28.9	16.2	46.9	34.3	28.4	38.5	32.1	21.6	19.6	60.2	17.6	22.0	18.5	44.6	51.6	37.0	21.7	51.9	33.0	57.9	42.3	39.5	19.6	126.4	68.7	19.5	32.9	38.0	51.0	26.0	25.0	58.8	29.9	63.8	27.3	37.7	71.6	67.7	47.8	16.9	22.4	74.5	26.9	56.5	26.8	13.9	48.4	47.2	18.0	17.8	21.6	21.2	22.9	56.9	29.2	45.1	28.4	18.4	29.6	119.1	87.7	52.5	28.4	58.6	35.5	24.7	18.8	34.0	24.0	22.0	25.0	26.9	21.6	23.6	21.9	27.5	23.1	18.9	8.1	22.6	18.8	15.5	26.4	20.6	24.4	25.4	29.8	30.5	24.6	24.6	24.6	24.5	25.2	22.8	25.0	26.3	18.1	19.2	27.4	21.9	27.8	26.8	13.1	21.7	21.1	15.3	20.2	17.4	7.3	18.6	23.8	18.4	14.6	34.5	23.7	31.4	13.7	19.4	13.8	20.9	13.8	18.3	35.3	14.9	10.2	21.8	39.2	16.6	33.1	17.6	8.2	20.5	16.8	15.3	22.0	8.4	8.7	25.0	26.4	20.2	17.2	9.8	19.9	21.0	8.8	7.5	21.3	19.3	43.3	9.5	9.4	21.8	26.1	19.5	41.5	13.3	26.5	14.9	21.4	13.5	6.6	19.5	16.9	49.4	22.1	24.5	30.1	37.1	27.7	18.3	26.5	12.0
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468308-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 16.1;retina: 7.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	0.6	1.3	4.9	0.1	3.9	0.0	1.4	3.0	16.1	0.7	0.2	1.3	1.8	0.4	1.7	0.1	2.3	0.3	1.9	4.3	10.1	0.4	0.8	0.6	0.0	5.0	6.1	1.8	3.0	0.7	4.4	0.3	4.5	0.5	0.8	7.3	2.9	0.4	0.3	0.2	1.9	0.4	4.4	0.4	1.3	1.6	11.9	0.5	2.4	0.1	0.0	0.2	0.3	4.8	0.0	0.2	7.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	9.0	0.0	0.0	2.7	0.0	2.5	0.1	0.1	0.0	0.0	5.5	0.0	0.1	12.0	2.2	0.0	0.6	0.0	2.8	0.3	0.0	0.0	0.0	1.5	0.0	0.1	9.7	2.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.9	3.0	16.1	4.3	10.1	5.0	6.1	4.5	4.4	11.9	4.8	12.4	0.0	6.4	10.4	0.1	0.3	1.0	0.8	1.2	48.0	8.4	5.6	15.9	2.8	2.2	0.0	31.3	0.2	0.8	0.4	0.0	0.1	0.3	13.0	0.9	2.9	102.1	0.0	23.8	3.3	0.0	1.0	0.0	0.6	0.0	1.2	1.1	2.7	0.1	45.4	27.5	6.2	0.0	0.3	0.3	0.9	0.3	0.1	1.8	0.0	0.0	13.8	1.0	64.3	30.8	1.5	1.2	10.9	0.3	0.6	10.2	1.1	12.6	26.7	0.0	15.6	0.9	0.0	4.8	0.1	0.0	0.3	0.5	0.1	2.6	0.5
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 210.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	26.5	20.6	48.9	17.6	65.6	46.9	21.5	103.6	64.5	29.2	36.4	17.5	10.8	15.1	30.0	25.6	29.8	20.1	30.4	56.2	48.2	70.7	88.1	16.1	30.2	91.5	65.1	5.0	61.2	28.0	43.6	15.9	84.0	15.3	11.6	38.7	53.9	18.3	80.1	24.8	22.5	9.1	66.5	34.5	21.0	51.8	61.4	34.3	22.5	21.5	24.7	14.8	23.9	106.4	36.5	30.1	32.6	12.3	44.5	60.6	12.7	23.3	35.3	9.9	19.5	66.8	36.0	47.4	101.0	62.5	59.7	40.5	6.7	17.9	4.7	5.2	11.5	70.5	25.8	47.0	19.2	16.0	1.8	21.8	4.0	16.7	4.8	95.6	2.7	1.5	67.8	7.6	72.6	94.7	17.2	51.1	39.4	39.2	8.5	30.8	66.5	73.5	75.3	26.0	103.0	106.3	8.3	210.6	18.0	71.2	115.5	74.2	14.6	80.2	15.6	38.8	21.4	27.3	62.4	89.9	121.2	5.3	45.6	1.1	6.6	0.6	9.7	1.4	30.0	85.1	0.9	6.8	5.5	96.7	0.5	2.6	1.8	71.9	0.6	59.0	1.4	10.7	48.9	65.6	103.6	64.5	56.2	48.2	91.5	65.1	84.0	66.5	61.4	106.4	22.9	48.1	18.8	24.5	120.4	26.3	14.8	41.9	8.6	232.0	41.0	67.8	49.3	105.8	32.5	147.1	25.0	2.9	90.2	18.6	317.0	125.1	714.2	47.1	53.9	43.6	18.6	52.2	18.7	144.9	23.9	47.8	24.5	53.7	21.5	41.9	36.0	131.8	38.4	541.8	8.7	50.7	61.1	35.6	92.1	200.3	39.1	32.2	60.5	15.0	40.9	220.5	195.7	16.6	44.3	93.9	17.5	30.5	114.1	34.1	22.6	200.0	38.6	49.1	13.1	150.9	48.5	14.2	13.9	15.7	20.9	37.6	21.1	25.1	27.0	21.4
CYB561	"CYB561A1, FRRS2"	ENSG00000008283	"Cytochrome b561"	P49447	17	63432304-63446354	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons: 124.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014753	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA014753: AB_1847364"	"prognostic unfavorable (8.89e-5)"	"unprognostic (2.90e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-5)"	"unprognostic (1.81e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.89e-1)"	14.8	125.6	22.2	12.3	24.4	4.1	32.8	6.8	23.1	45.0	70.6	26.4	36.6	12.3	57.2	51.9	55.8	17.3	16.2	20.4	33.2	24.5	21.0	30.9	8.3	17.2	23.2	9.4	118.0	76.1	74.1	16.2	124.7	63.3	21.1	9.8	85.0	37.8	6.0	37.3	31.9	9.2	9.8	8.7	48.1	6.0	28.0	3.5	40.8	4.6	12.8	16.4	27.4	17.9	99.3	31.9	2.6	20.5	11.5	52.7	43.3	10.3	12.0	12.3	4.9	29.2	96.9	0.2	23.0	75.5	3.3	83.1	20.3	8.0	4.8	26.1	8.7	12.7	20.4	2.0	21.7	1.3	4.3	8.6	84.1	11.2	1.5	17.9	23.9	0.1	41.2	17.7	4.0	140.3	0.5	4.9	20.9	80.5	49.9	0.3	0.2	31.0	40.0	49.8	73.7	432.2	26.0	209.2	10.4	7.3	168.6	6.2	3.6	25.9	29.4	60.6	3.1	0.4	0.4	0.1	22.6	5.1	14.0	0.3	2.0	0.2	19.2	5.7	24.6	0.6	14.4	13.2	2.1	0.6	1.3	4.2	5.2	20.3	7.7	0.1	0.0	5.8	22.2	24.4	6.8	23.1	20.4	33.2	17.2	23.2	124.7	9.8	28.0	17.9	14.6	28.9	37.8	3.6	3.5	16.4	23.7	16.0	26.2	6.1	37.4	24.6	12.8	20.0	36.7	23.9	0.0	25.1	7.0	22.2	3.9	41.1	6.9	74.5	12.5	18.3	21.6	3.4	14.1	50.5	29.2	15.0	30.1	53.9	15.9	7.3	11.4	11.1	4.7	0.0	10.7	31.7	18.3	7.0	9.8	6.2	3.7	4.1	3.6	9.4	6.0	5.2	2.1	0.5	0.6	30.8	11.4	3.4	15.3	41.6	32.1	11.9	68.5	26.8	6.6	5.1	7.6	6.9	7.2	34.2	27.8	24.8	11.4	0.4	26.2	22.6
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348754-61362283	"Predicted membrane proteins"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 251.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4"	"Group enriched"	"Detected in all"	9	"B-cells: 386.6;dendritic cells: 841.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles	Nucleoli	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	19.5	251.4	10.2	32.6	11.5	26.0	17.3	10.5	10.7	17.1	17.4	33.3	19.2	24.1	18.7	19.6	30.4	27.5	12.3	11.0	10.1	15.3	31.0	21.3	70.3	13.0	13.7	27.1	24.4	21.5	13.8	17.3	12.6	20.9	27.8	11.4	21.8	19.8	26.1	76.0	27.8	18.8	12.3	49.7	20.8	13.6	12.1	28.1	18.5	17.7	70.4	22.9	16.2	14.0	50.2	80.6	13.4	40.6	67.8	41.9	11.3	26.0	37.3	29.8	28.9	22.6	54.3	98.1	42.1	46.2	24.0	67.5	13.6	72.2	20.1	64.5	28.5	18.3	53.6	16.5	32.0	24.9	42.3	63.4	95.7	65.3	30.0	25.0	44.1	46.1	55.5	57.3	51.2	53.3	45.7	11.4	24.5	44.7	51.9	52.2	14.0	72.6	35.2	48.1	16.2	26.1	54.7	71.5	60.5	9.6	58.6	29.3	31.7	34.2	17.8	34.2	35.6	34.3	49.9	56.8	50.6	44.2	46.4	19.4	66.4	35.5	31.0	53.8	28.6	314.5	22.1	29.2	63.5	386.6	23.5	24.6	21.8	31.5	64.0	841.4	23.6	84.8	10.2	11.5	10.5	10.7	11.0	10.1	13.0	13.7	12.6	12.3	12.1	14.0	13.0	6.4	22.8	6.8	96.2	28.3	18.3	86.6	19.9	15.9	19.6	18.7	1.9	10.0	30.0	12.9	31.3	49.9	145.1	53.6	11.7	26.2	53.6	15.4	12.0	13.5	19.2	14.1	4.3	38.8	39.5	16.4	21.4	7.5	8.8	13.0	15.4	21.0	51.4	18.5	4.1	28.9	22.4	23.8	21.2	14.2	20.8	47.9	320.2	8.4	57.1	23.7	28.8	5.5	7.2	26.6	48.9	20.7	10.5	15.9	55.6	13.7	72.0	56.2	13.1	14.8	15.8	7.2	11.5	18.4	24.0	39.5	18.7	128.9	30.7	16.2
CYB561D1	"FLJ39035, FLJ44753"	ENSG00000174151	"Cytochrome b561 family member D1"	Q8N8Q1	1	109494052-109502932	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027028	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027028: AB_1847365"	"unprognostic (2.15e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (4.68e-4)"	"unprognostic (4.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.16e-6)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.82e-2)"	4.8	7.3	6.3	8.0	6.0	8.4	5.3	7.9	7.0	3.9	4.4	6.2	5.6	4.7	11.1	7.1	5.1	3.9	4.2	7.1	4.6	6.8	2.9	5.8	11.0	4.8	5.4	6.8	11.1	8.5	8.0	3.1	4.8	4.5	5.8	4.3	6.1	6.0	6.8	17.8	9.0	5.1	4.4	8.7	7.3	2.7	5.6	7.8	7.8	3.6	10.3	4.7	3.5	5.8	9.4	5.4	3.9	4.5	13.1	9.4	9.9	8.0	6.1	9.0	6.4	5.2	4.0	8.3	8.2	10.3	5.7	10.4	5.1	6.4	5.8	6.9	4.7	5.4	8.6	4.3	6.2	11.6	16.8	10.2	15.8	8.7	4.5	5.5	6.3	8.1	3.6	3.7	5.8	11.7	4.1	6.2	1.8	6.9	8.2	6.9	15.6	3.3	8.2	15.6	5.7	5.1	9.1	8.9	8.6	5.4	5.9	6.3	8.5	8.8	10.2	12.0	6.6	4.3	3.3	4.0	8.9	9.4	9.9	2.5	2.4	3.6	3.7	2.6	3.3	2.5	3.9	3.4	1.7	2.5	4.9	3.4	6.7	5.6	2.9	1.9	3.1	2.5	6.3	6.0	7.9	7.0	7.1	4.6	4.8	5.4	4.8	4.4	5.6	5.8	2.5	0.0	4.7	2.3	7.1	2.3	1.7	2.9	1.8	7.7	4.2	2.3	3.7	7.2	4.4	3.7	2.1	2.5	5.3	10.6	0.0	3.3	0.0	2.6	3.0	2.6	4.2	0.4	10.4	8.0	1.1	2.9	4.6	3.0	1.3	3.7	0.7	2.2	1.3	3.3	6.4	2.9	2.0	4.1	3.2	0.4	2.5	2.5	1.8	3.7	3.7	2.4	28.8	3.5	9.1	5.8	0.8	4.1	3.5	1.9	10.2	2.6	4.3	6.4	0.0	5.6	2.2	0.9	2.0	3.4	3.0	1.1	8.3	1.9	3.5	2.5
CYB561D2	"101F6, TSP10"	ENSG00000114395	"Cytochrome b561 family member D2"	O14569	3	50350845-50358460	"Enzymes, Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071862	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA071862: "	"unprognostic (4.89e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.41e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (3.26e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.57e-2)"	13.3	20.7	8.1	16.7	9.8	22.0	13.9	9.7	9.2	10.6	10.5	19.7	22.0	7.6	25.8	14.6	9.7	14.6	10.1	8.3	8.6	19.8	34.3	14.1	22.2	9.8	9.6	7.0	19.5	18.2	13.8	11.1	9.8	16.3	18.0	3.1	20.3	11.5	10.0	9.8	22.7	7.1	9.6	24.7	21.7	10.5	9.2	13.2	20.3	3.5	15.3	12.3	9.3	11.3	16.2	33.5	8.4	15.8	17.2	14.7	19.2	27.4	20.4	24.5	28.0	24.1	25.3	25.3	29.3	33.8	29.8	16.5	12.8	25.2	10.7	38.5	31.9	23.7	40.7	22.5	24.2	26.3	52.3	23.0	11.3	29.3	13.5	12.4	21.1	19.1	10.5	32.3	19.7	30.3	17.0	22.9	13.4	24.6	52.1	11.6	5.8	50.2	26.3	27.0	8.4	23.7	13.7	56.1	17.5	8.4	19.8	30.9	23.1	22.5	18.9	37.6	35.8	24.6	26.2	16.8	30.2	32.1	24.4	145.8	113.9	176.1	144.3	140.1	95.6	88.4	96.1	115.7	86.3	79.3	67.1	99.6	110.8	109.3	136.2	89.0	114.7	112.4	8.1	9.8	9.7	9.2	8.3	8.6	9.8	9.6	9.8	9.6	9.2	11.3	13.3	6.4	21.7	5.5	24.4	5.0	12.0	37.4	8.6	6.8	26.5	12.3	0.0	0.0	30.9	25.8	6.2	35.0	40.2	47.1	11.7	44.9	19.9	19.7	14.7	9.1	31.8	6.7	6.7	68.1	46.0	13.0	31.1	18.4	21.5	8.4	0.0	0.0	57.3	8.4	5.8	47.0	46.8	0.0	12.3	9.1	8.7	29.1	19.6	6.5	36.2	22.2	45.3	6.0	13.3	43.3	49.4	7.9	36.7	17.9	55.6	22.3	38.4	8.2	13.1	8.0	15.6	6.1	14.1	14.0	7.4	55.1	32.9	15.9	28.1	18.4
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	17.2	13.0	8.6	5.5	9.4	7.8	12.1	9.6	9.7	10.2	16.0	9.4	6.2	10.1	15.2	8.2	26.4	8.7	15.0	9.0	10.1	17.9	12.6	8.3	4.8	10.0	10.8	13.0	11.4	10.8	16.6	6.6	9.0	11.3	7.1	30.0	10.3	11.6	10.6	9.6	6.3	8.7	9.3	6.0	8.8	8.8	11.5	7.5	21.3	13.6	5.4	7.4	7.8	8.0	24.6	17.9	8.5	22.4	14.8	13.0	5.0	12.5	12.2	13.0	12.4	11.3	4.6	10.5	8.6	10.0	7.6	21.3	18.9	16.1	19.4	7.1	21.9	6.9	24.6	16.3	6.7	12.4	4.7	11.2	19.9	22.8	20.2	8.0	14.0	25.3	5.2	7.0	7.3	10.7	19.5	5.0	10.7	16.0	18.2	13.2	3.9	10.7	20.4	4.7	11.4	7.6	19.9	10.8	11.6	8.5	12.6	5.0	9.9	9.9	8.7	17.8	15.9	3.7	9.7	5.8	20.8	6.7	6.5	0.3	0.9	0.0	1.0	0.7	1.1	1.2	0.8	0.5	1.2	0.5	2.1	1.1	0.9	0.6	0.4	0.5	0.8	0.7	8.6	9.4	9.6	9.7	9.0	10.1	10.0	10.8	9.0	9.3	11.5	8.0	21.8	12.8	19.5	5.9	4.5	5.1	6.7	4.9	1.8	4.8	22.2	18.4	0.3	7.2	11.0	5.5	20.9	4.2	7.7	5.0	13.7	4.2	71.9	45.5	16.3	14.7	6.0	0.8	6.8	3.1	2.7	13.2	13.3	27.2	10.8	4.6	6.8	8.3	3.9	1.7	5.9	8.5	4.1	1.6	4.3	42.6	4.7	29.1	5.4	2.8	0.3	6.7	0.0	0.5	2.2	7.7	4.5	3.8	5.1	7.8	4.5	11.9	47.3	20.3	6.6	41.9	7.5	4.4	2.7	8.5	6.1	2.6	4.4	2.9	8.3	2.5
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	19.0	21.7	17.4	6.1	17.3	4.3	18.2	17.4	20.1	15.9	14.2	10.7	15.2	15.6	28.5	10.9	18.7	16.3	14.0	16.7	19.6	25.5	29.0	9.7	9.3	18.1	17.6	20.8	19.7	30.9	24.1	10.8	17.8	13.5	7.4	9.2	20.0	17.6	16.2	14.4	12.1	8.4	17.6	9.6	16.0	29.3	17.9	10.2	22.7	14.9	7.2	12.9	11.7	18.7	16.2	21.6	11.8	12.7	74.7	22.5	5.2	15.7	31.5	11.0	10.9	6.3	10.3	5.3	13.6	17.4	9.2	22.5	4.9	7.1	4.4	17.9	25.7	5.0	13.5	10.5	13.7	2.1	9.5	28.8	17.0	6.2	11.7	22.3	20.1	11.5	5.1	31.2	8.3	20.6	7.8	3.4	4.3	13.7	11.5	9.2	10.6	12.5	25.1	8.5	9.3	8.1	17.2	9.9	23.5	13.1	25.6	3.2	28.5	15.7	4.0	14.5	8.0	5.8	4.9	3.9	19.9	4.5	6.2	0.6	10.8	13.6	5.9	9.2	6.7	8.1	9.3	7.4	10.5	7.1	8.6	8.0	9.5	5.5	8.7	11.3	11.2	8.2	17.4	17.3	17.4	20.1	16.7	19.6	18.1	17.6	17.8	17.6	17.9	18.7	57.4	12.8	10.3	9.1	17.2	53.7	18.4	36.0	12.5	26.9	35.4	36.7	9.8	45.8	21.8	31.3	58.4	55.7	11.4	18.5	52.8	34.3	28.5	36.6	20.0	34.4	13.8	33.3	7.6	27.0	29.1	23.8	19.4	23.4	11.4	22.3	41.0	32.9	21.4	40.4	10.4	16.0	36.7	24.0	23.8	30.6	28.9	17.3	14.2	4.7	15.4	37.6	15.5	8.5	10.0	26.9	18.9	28.6	17.6	8.3	39.7	55.7	38.5	30.4	0.0	15.2	20.1	130.3	29.2	9.5	42.9	38.6	15.8	39.3	16.6	15.8
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961873-202967275	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 605.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 187.3;hTCEpi: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	38.6	57.3	37.4	23.0	38.8	19.7	43.7	41.1	40.5	49.7	57.3	35.7	19.3	41.2	131.4	61.6	68.2	27.2	154.8	38.3	48.0	64.5	50.2	44.0	25.2	45.4	49.4	41.7	45.1	82.9	46.1	66.6	55.7	41.1	21.2	34.3	56.9	40.0	605.2	123.8	25.7	37.5	39.9	39.1	92.8	50.7	41.4	40.1	40.5	308.0	38.8	52.7	45.8	43.6	34.8	21.3	18.3	37.7	166.0	37.9	178.5	68.3	63.4	43.2	38.4	17.5	39.9	21.5	56.5	68.1	24.0	187.3	14.9	58.0	28.2	31.2	37.8	12.4	24.0	20.4	59.7	10.5	29.6	61.2	188.3	47.5	25.8	36.4	28.9	25.8	37.0	37.6	157.8	40.4	13.6	9.5	12.1	31.0	40.1	21.9	87.6	45.7	41.1	40.8	15.7	19.1	38.0	124.0	57.4	39.4	57.7	23.4	28.5	49.0	20.8	18.7	38.3	34.9	44.5	10.0	53.6	16.2	37.1	24.4	56.7	46.6	27.4	42.6	36.3	23.4	30.9	28.9	37.6	35.0	41.9	29.6	46.0	32.2	29.4	25.9	34.2	52.6	37.4	38.8	41.1	40.5	38.3	48.0	45.4	49.4	55.7	39.9	41.4	43.6	33.0	22.4	29.8	10.1	15.5	187.2	38.5	89.5	42.1	21.0	46.1	41.9	119.3	37.1	60.5	29.5	29.2	171.1	15.8	10.6	7.9	38.3	5.0	58.7	17.3	30.0	19.2	30.7	8.9	48.3	196.5	28.9	31.6	34.9	28.5	13.6	32.9	44.6	63.5	10.1	11.3	10.8	105.8	45.4	29.7	8.6	29.8	39.5	64.0	8.4	20.9	65.9	11.3	11.6	8.1	72.8	11.3	31.2	12.5	25.8	16.0	38.9	75.9	35.0	13.1	49.1	30.0	23.0	4.3	40.6	157.4	293.5	19.5	27.9	14.7	48.2
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 139.2;testis: 133.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 10.6;granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3"	"Low region specificity"	"Detected in single"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	8.8	3.6	17.2	5.7	23.1	4.1	15.6	18.7	25.3	15.6	13.2	4.6	2.4	22.8	25.5	19.6	10.1	6.8	4.7	18.2	19.7	5.9	5.1	11.5	2.7	19.5	22.5	29.3	4.3	29.0	1.3	13.8	19.2	19.5	5.3	139.2	35.7	22.3	1.7	51.1	4.3	13.2	16.9	3.0	5.6	133.6	21.8	0.9	5.1	1.7	10.5	13.3	17.7	28.0	7.1	3.6	1.5	0.0	0.3	1.7	22.8	43.9	125.1	65.9	59.4	0.7	9.4	0.2	10.3	22.7	20.2	0.8	0.1	0.3	52.0	0.1	0.2	0.0	3.8	0.9	35.0	0.4	6.6	17.7	1.4	0.3	3.7	0.1	5.6	0.0	6.9	0.1	0.5	0.0	0.0	0.1	69.8	7.4	3.4	34.1	0.1	0.0	0.0	4.4	0.0	0.7	0.3	28.0	1.9	11.1	4.8	9.4	0.0	6.1	0.1	0.3	3.4	0.2	0.0	10.7	0.5	0.0	96.3	0.0	0.9	6.1	0.0	0.5	0.0	10.6	0.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	17.2	23.1	18.7	25.3	18.2	19.7	19.5	22.5	19.2	16.9	21.8	28.0	0.6	22.4	5.1	0.0	2.3	7.0	8.4	12.3	8.6	1.3	8.8	12.8	3.0	1.5	6.3	3.7	20.9	5.3	0.1	0.6	0.0	1.4	268.0	5.5	11.2	1.7	0.0	0.0	0.0	4.7	20.0	8.1	1.5	14.3	2.5	0.5	0.4	1.8	2.5	0.0	0.1	1.8	6.1	0.0	0.5	601.1	4.7	1.5	5.4	1.9	0.5	0.8	0.0	0.5	8.5	6.0	1.4	6.0	2.9	11.2	0.3	0.4	10.2	35.2	13.1	2.3	7.5	115.6	9.8	12.8	10.1	4.5	0.2	1.8	1.8	11.4
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649392	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 830.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	404.4	310.5	147.1	87.4	152.9	82.7	272.2	145.7	189.9	237.3	115.0	192.4	94.8	248.4	58.8	152.4	174.0	139.5	374.3	138.7	163.9	182.9	279.4	201.3	76.3	194.7	174.2	218.3	89.1	62.0	137.4	107.8	169.9	181.4	74.9	27.3	149.8	239.3	203.0	233.6	138.1	200.2	154.8	101.4	182.0	142.7	156.7	54.0	157.8	140.5	72.3	216.7	210.0	160.2	125.5	78.6	126.6	78.6	830.9	654.7	74.4	359.2	330.0	262.2	232.4	104.0	95.6	58.8	156.6	668.8	113.8	112.4	85.3	178.0	133.7	63.9	187.3	83.6	127.3	202.4	211.0	118.4	149.5	397.4	138.1	188.9	124.5	190.8	220.0	74.0	73.5	296.3	361.9	137.9	116.8	108.4	51.0	129.2	142.7	84.9	153.8	131.3	202.0	90.6	56.1	73.2	118.6	113.2	134.0	92.6	90.6	112.0	340.9	282.0	175.3	192.3	137.9	78.3	91.2	72.4	328.8	67.8	237.9	126.3	104.0	300.3	75.9	135.3	76.6	110.1	72.8	83.9	154.0	102.7	50.8	54.0	53.8	63.5	176.7	140.8	95.0	86.4	147.1	152.9	145.7	189.9	138.7	163.9	194.7	174.2	169.9	154.8	156.7	160.2	238.5	86.6	62.2	17.0	51.7	110.1	95.5	184.8	27.3	16.7	52.3	73.2	106.4	105.8	100.9	60.7	4.2	110.0	37.0	90.5	49.0	216.4	4.8	51.4	82.9	161.5	83.7	113.9	12.3	107.0	199.3	183.4	38.2	65.4	62.8	57.8	180.2	230.4	108.3	16.8	16.1	45.8	142.4	50.6	112.0	17.0	253.9	67.7	176.1	25.3	112.5	91.0	33.0	7.1	26.4	156.8	85.6	280.6	36.7	82.3	116.9	110.8	53.3	18.4	190.7	62.5	202.5	23.8	45.5	57.5	112.7	117.9	43.0	233.1	55.2	96.4
CYB5R4	"b5+b5R, dJ676J13.1, NCB5OR"	ENSG00000065615	"Cytochrome b5 reductase 4"	Q7L1T6	6	83859656-83967423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 179.2;Late spermatids: 364.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 199.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018992	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA018992: AB_1847371"	"unprognostic (4.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.77e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.44e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.15e-2)"	5.1	3.1	4.0	12.0	4.4	17.0	3.6	9.8	6.0	2.4	1.0	7.1	6.5	3.0	3.2	4.5	2.3	3.2	4.2	3.7	4.0	4.0	3.9	5.1	9.8	4.0	2.9	2.5	5.6	2.6	1.9	3.4	4.7	3.0	5.0	5.4	3.6	2.5	6.3	3.1	7.3	3.5	2.6	8.8	7.0	12.1	4.1	6.6	2.3	4.4	7.1	5.3	3.1	8.2	10.6	9.2	6.5	8.1	3.4	4.6	12.0	7.0	10.9	10.4	14.8	12.7	6.8	19.9	10.8	4.7	27.7	8.8	6.1	10.1	7.5	75.1	14.2	47.0	5.2	7.0	6.4	28.5	40.0	6.1	2.8	7.3	7.1	4.2	5.8	17.2	17.1	14.1	7.7	4.5	7.4	9.6	3.6	8.5	8.9	12.3	23.3	6.9	5.6	10.9	17.4	9.6	8.7	8.2	9.5	3.9	5.0	16.3	7.2	10.2	8.5	21.2	22.4	16.4	27.0	10.7	11.8	19.2	11.7	104.0	59.0	177.3	16.6	50.4	13.6	27.4	14.6	15.0	46.6	26.9	9.4	14.7	199.1	14.2	58.1	19.7	23.9	29.3	4.0	4.4	9.8	6.0	3.7	4.0	4.0	2.9	4.7	2.6	4.1	8.2	9.9	6.4	13.9	31.3	46.5	11.1	14.4	17.5	8.0	15.5	8.5	5.8	15.4	11.5	18.3	7.3	16.7	5.9	31.3	22.0	11.7	25.7	179.2	8.4	9.2	9.7	16.2	10.1	46.6	25.1	20.5	9.2	21.9	13.5	25.3	6.0	4.2	11.3	45.1	13.5	51.0	14.8	28.5	56.6	49.7	364.5	8.4	59.4	16.0	37.5	74.4	5.8	47.4	48.7	85.8	28.4	17.3	7.5	27.1	13.6	15.7	21.6	14.8	18.7	6.6	16.9	13.1	25.7	27.3	12.5	14.8	11.5	28.2	8.3	13.3	23.6
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	2.1	4.4	1.6	1.4	1.8	2.3	2.5	1.7	2.0	2.4	2.7	2.5	2.7	2.7	2.5	2.3	2.8	2.2	3.4	1.7	1.2	2.5	2.9	1.8	2.6	1.4	1.4	4.4	4.2	2.9	3.7	1.6	1.4	2.4	2.8	2.7	3.7	1.7	4.1	3.8	2.1	2.5	1.2	3.1	3.1	1.4	1.5	1.7	3.1	4.1	2.6	2.0	1.9	1.8	3.6	4.7	6.3	6.6	5.0	4.8	2.2	2.8	4.0	5.3	5.7	4.4	3.9	6.0	3.2	1.9	12.1	3.3	10.1	2.9	6.0	6.8	4.1	6.8	8.0	4.7	3.8	5.8	3.4	2.6	3.8	6.3	2.8	3.7	4.7	5.3	7.5	2.8	3.9	4.3	5.9	3.2	6.4	4.1	3.7	9.3	7.8	5.6	2.4	4.0	9.3	4.6	1.9	6.3	5.7	5.1	4.4	4.4	2.1	4.0	3.3	6.0	5.0	4.3	7.1	8.5	4.5	12.2	6.3	0.7	0.4	0.4	0.2	0.9	0.1	0.2	0.3	0.1	0.4	0.3	0.2	0.2	0.5	0.8	0.2	0.4	0.1	0.3	1.6	1.8	1.7	2.0	1.7	1.2	1.4	1.4	1.4	1.2	1.5	1.8	1.6	0.0	7.2	1.3	1.3	0.1	1.1	0.9	0.0	4.0	2.3	2.4	5.1	2.8	3.0	3.7	4.2	1.9	0.4	1.1	7.9	3.0	0.1	3.6	2.0	6.1	2.4	6.1	2.4	4.2	2.3	2.4	1.1	2.1	2.5	4.8	3.9	2.9	5.3	0.0	2.2	1.2	4.1	1.6	0.4	1.0	1.5	1.2	0.0	2.8	1.2	1.9	4.1	2.5	3.1	1.4	0.8	1.9	2.0	0.8	1.4	2.7	5.9	4.0	0.0	2.6	1.4	1.2	5.1	0.8	0.9	0.3	1.6	2.9	2.3	0.9
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643289-88651054	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 742.0;lymphoid tissue: 693.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1632.1;Hofbauer cells: 2171.9;Kupffer cells: 1734.2;Macrophages: 1682.8;monocytes: 1688.5;NK-cells: 1805.4;Plasma cells: 1990.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 733.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 1058.3;RPMI-8226: 1631.2;THP-1: 1231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009492: AB_2090309"	"prognostic favorable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	149.9	68.0	40.3	344.4	41.8	742.0	93.3	46.0	58.0	81.9	62.4	200.9	196.6	60.8	38.5	80.9	95.4	122.5	93.2	38.6	55.0	187.7	71.5	234.6	333.8	73.8	49.3	40.0	108.6	13.4	40.6	54.9	64.1	75.2	79.9	1.8	116.7	26.6	41.8	39.4	245.3	51.3	65.4	693.1	236.0	10.4	62.4	87.1	136.5	19.9	192.8	144.6	74.1	92.2	2.5	663.0	2.6	1.5	1.3	0.4	329.5	155.7	77.3	39.3	24.1	447.2	819.6	510.5	420.7	56.4	0.0	250.5	21.4	0.9	5.8	146.1	564.1	99.0	217.7	694.9	75.7	156.3	397.6	80.7	0.0	1.6	0.3	1.9	23.9	103.6	278.5	567.5	3.2	1058.3	147.9	822.3	106.2	248.7	1.5	437.9	1.6	1631.2	324.9	490.9	84.2	76.5	482.7	78.8	138.5	60.8	1.4	1231.3	129.8	1.5	6.1	1.8	2.2	362.9	459.9	543.6	195.5	464.9	53.4	120.2	103.8	733.7	76.7	150.1	55.8	109.8	36.7	70.4	107.0	110.7	28.9	36.7	192.3	36.4	143.3	196.3	41.2	47.3	40.3	41.8	46.0	58.0	38.6	55.0	73.8	49.3	64.1	65.4	62.4	92.2	157.8	16.0	12.4	0.0	1290.9	119.4	233.4	420.8	53.5	0.4	131.7	133.2	12.8	368.9	487.1	285.1	2.1	45.3	1632.1	807.2	127.2	636.8	4.2	219.5	137.5	137.1	230.5	162.7	0.2	155.3	299.0	184.8	285.4	312.5	279.0	104.3	317.0	23.9	2171.9	0.0	0.2	540.3	233.9	1734.2	1370.8	14.0	50.1	1682.8	1152.6	32.8	1688.5	1.6	1805.4	1.0	0.2	682.8	1045.8	21.4	1990.6	191.8	390.4	1057.4	529.7	2.7	59.2	44.0	164.3	0.9	15.6	75.2	85.7	118.2	838.6	20.5	805.2	436.9
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYBC1	"C17orf62, Eros, FLJ90469, MGC4368"	ENSG00000178927	"Cytochrome b-245 chaperone 1"	Q9BQA9	17	82442586-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 47.4;Ductal cells: 39.7;Granulosa cells: 56.1;Hofbauer cells: 80.2;monocytes: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cell Junctions"	"HPA045696: AB_2679421"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	39.2	35.7	34.4	70.1	36.1	37.2	37.4	36.7	42.6	40.9	36.3	33.8	24.6	33.7	23.7	34.1	34.9	46.0	30.7	33.2	35.6	51.2	64.9	41.4	110.5	41.8	37.8	33.8	45.0	24.5	25.9	30.7	37.7	43.4	27.7	9.9	30.8	23.2	14.9	29.4	49.3	40.7	37.1	117.4	36.9	17.8	36.7	63.3	28.9	13.6	72.1	49.7	28.2	40.6	48.5	67.4	37.1	61.4	57.9	60.6	35.0	42.2	51.6	61.8	73.1	26.2	47.8	122.4	37.8	60.6	75.4	48.3	25.7	32.4	42.6	87.4	21.1	33.4	19.2	30.6	59.3	38.1	94.4	68.5	45.7	53.1	29.3	59.0	81.5	90.3	28.4	88.2	52.9	50.8	160.2	33.0	27.5	65.0	35.3	120.1	22.7	93.1	44.8	60.7	31.7	60.7	77.0	88.1	55.7	66.3	91.4	148.3	27.9	46.7	46.0	79.3	45.9	157.8	58.3	93.1	61.2	61.0	42.5	223.8	136.7	182.9	96.3	181.3	74.7	114.8	88.2	93.6	125.2	115.9	73.0	71.1	300.6	104.5	169.4	130.9	101.1	161.4	34.4	36.1	36.7	42.6	33.2	35.6	41.8	37.8	37.7	37.1	36.7	40.6	35.6	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	19.0	17.1	0.0	0.0	0.0	22.0	0.0	27.6	47.4	0.0	9.8	39.7	0.0	11.9	21.9	12.9	0.0	0.0	0.0	33.6	36.1	10.9	0.0	12.4	0.0	56.1	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	54.8	0.0	0.0	0.0	0.0	34.9	0.0	0.0	11.1	0.0	0.0	19.6	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	27.6	19.5	23.8	0.0	0.0
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558129	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	166.7	97.5	32.6	24.4	38.8	18.3	148.7	33.9	34.1	140.0	32.6	68.7	197.7	100.2	49.7	70.6	88.2	153.7	128.6	28.2	45.9	32.0	21.7	129.9	33.8	45.2	38.7	180.9	21.6	12.0	26.1	38.1	40.5	70.6	39.0	22.2	63.7	76.7	23.3	85.0	233.4	87.9	35.6	30.6	53.3	23.8	35.9	27.9	231.0	82.8	30.1	84.3	90.4	43.0	24.8	18.1	10.1	19.2	1064.0	453.8	1.3	88.3	408.2	45.0	56.4	1.1	33.8	0.0	14.8	214.2	46.2	12.2	8.4	7.2	53.2	18.9	2.2	20.7	26.1	0.4	222.7	22.0	1.9	327.3	68.8	70.5	13.7	276.3	29.6	12.4	7.0	0.2	128.3	0.0	7.1	20.4	5.1	0.0	4.6	2.5	125.3	1.5	7.0	1.4	1.3	4.7	104.2	0.2	56.5	3.6	35.8	13.5	59.5	101.0	14.4	96.1	38.3	0.3	0.4	0.2	49.5	18.3	55.6	0.0	17.4	0.8	1.6	17.7	0.3	0.0	0.3	0.2	16.8	0.0	0.0	0.0	9.8	3.6	13.7	0.7	0.0	7.5	32.6	38.8	33.9	34.1	28.2	45.9	45.2	38.7	40.5	35.6	35.9	43.0	37.6	221.2	109.0	45.1	0.9	121.2	47.3	20.3	38.7	0.0	54.7	48.0	18.4	37.1	34.7	25.8	0.0	1.9	3.4	16.1	0.0	1.0	1.5	4.2	35.6	33.9	0.0	85.0	0.9	6.4	2.3	243.4	13.3	8.3	2.5	1.6	73.5	2.4	48.5	0.0	1.5	22.2	2.0	60.7	92.0	6.1	202.0	28.4	44.4	36.5	29.3	27.9	4.1	12.1	54.2	1.8	16.2	221.5	2.2	22.5	689.4	0.3	6.9	1.5	19.7	89.6	49.9	1.2	1.2	7.0	60.1	1.4	5.9	2.8	27.6	18.2
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095039-144097525	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 730.0;tongue: 724.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 817.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 1125.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	Mitochondria		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	84.7	173.2	92.1	62.4	97.2	104.4	72.7	115.4	103.8	71.4	102.4	162.6	171.2	75.9	35.7	155.5	67.8	39.5	527.7	92.3	105.3	152.6	180.4	56.7	55.8	99.8	96.9	63.6	101.2	163.3	58.2	45.8	103.1	67.8	111.0	42.0	104.4	70.0	730.0	106.5	127.5	59.9	94.9	70.1	139.6	38.9	106.9	63.4	64.8	724.9	61.0	92.0	86.5	99.6	172.0	381.4	98.9	208.4	80.5	88.5	189.6	96.7	116.7	240.2	156.9	269.4	208.2	241.0	210.8	129.8	116.2	247.3	217.9	191.2	89.8	148.2	289.2	259.7	306.5	250.4	143.1	154.7	162.5	129.4	234.9	153.2	301.4	80.6	141.3	163.7	240.4	208.2	127.7	616.8	292.0	143.5	115.1	476.8	1125.5	253.7	132.4	422.1	199.7	273.0	263.3	117.2	267.8	365.7	200.0	54.0	302.5	233.2	108.8	152.1	321.6	169.6	299.7	229.1	179.7	183.8	193.2	261.9	198.4	185.7	340.4	95.7	131.6	360.4	139.8	208.7	108.1	141.5	444.1	180.3	104.9	134.6	32.7	187.8	278.8	251.0	158.2	397.1	92.1	97.2	115.4	103.8	92.3	105.3	99.8	96.9	103.1	94.9	106.9	99.6	77.0	19.2	29.3	23.5	94.0	156.1	191.9	394.8	62.6	113.6	110.7	102.6	402.3	181.6	156.0	79.1	81.3	263.6	61.7	516.1	817.8	239.9	81.2	59.1	68.1	88.0	146.4	130.6	14.4	289.1	257.1	102.8	144.8	60.2	59.7	89.2	62.4	239.4	246.3	87.5	21.6	390.4	272.6	104.8	139.4	88.6	88.9	101.4	179.7	12.2	208.4	115.2	92.7	12.1	17.5	290.6	332.5	90.7	149.9	237.9	570.0	468.6	86.1	100.9	72.3	109.4	250.6	83.1	116.7	212.9	163.7	236.8	63.8	197.5	602.6	258.3
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25118656-25125260	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 799.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	86.0	115.6	65.8	89.2	70.4	85.0	59.2	79.8	101.7	45.3	87.6	263.6	150.1	42.3	41.5	105.9	43.0	52.9	476.8	72.1	82.8	174.6	115.7	54.3	63.8	71.0	72.9	48.1	38.5	226.2	57.0	43.0	69.4	54.3	238.8	153.9	58.0	60.1	483.7	47.6	120.1	91.1	70.2	48.0	108.1	61.1	83.4	74.0	74.6	799.8	89.4	119.8	60.1	71.7	336.4	185.1	195.0	273.7	108.7	83.1	199.6	314.4	128.0	229.2	264.5	307.4	222.2	383.8	152.9	138.5	678.3	385.8	396.5	295.0	401.2	115.0	179.1	318.6	208.9	218.7	170.2	739.0	271.1	111.2	257.5	230.9	492.9	99.4	209.5	232.2	597.1	397.9	246.0	155.1	408.6	284.4	365.1	746.3	343.0	282.1	235.3	364.5	360.9	322.5	392.6	190.3	164.5	689.0	267.9	338.7	359.5	436.6	152.8	209.3	383.3	329.8	591.8	401.4	507.3	860.5	281.0	526.4	606.7	65.3	56.2	42.8	68.0	106.0	82.5	102.5	62.2	71.6	105.7	90.0	58.6	70.2	8.2	73.3	96.8	81.5	87.5	83.0	65.8	70.4	79.8	101.7	72.1	82.8	71.0	72.9	69.4	70.2	83.4	71.7	244.3	83.3	118.6	42.4	337.6	689.8	818.3	698.5	237.9	163.1	210.6	179.6	770.0	144.4	314.2	183.9	77.2	192.6	304.4	827.5	1663.0	278.3	496.4	154.8	120.2	183.3	384.9	162.6	53.2	216.0	351.0	257.3	287.5	197.5	212.6	68.7	81.0	210.8	353.0	132.9	64.6	522.5	502.5	141.5	715.2	161.8	90.1	329.2	590.5	16.9	245.8	220.9	197.8	17.1	24.2	303.8	570.5	93.6	358.7	551.9	392.8	638.6	146.1	195.2	138.1	294.7	962.3	423.1	211.1	402.7	715.2	349.3	349.7	146.9	600.2	884.1
CYFIP1	"KIAA0068, P140SRA-1, SHYC"	ENSG00000273749	"Cytoplasmic FMR1 interacting protein 1"	Q7L576	15	22867052-22981063	"Predicted intracellular proteins"	"Cell shape, Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 253.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 23.5;intermediate monocyte: 24.9;myeloid DC: 22.0;non-classical monocyte: 12.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.0;monocytes: 24.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA068106	Approved					NA	NA		1100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA068106: AB_2685955"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.93e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-3)"	41.2	26.0	16.6	19.8	16.9	4.7	36.4	15.8	20.0	33.2	16.7	37.7	31.5	33.8	23.8	46.2	24.7	24.0	21.8	15.5	17.9	25.9	26.1	40.5	19.2	20.7	19.5	28.9	41.7	37.3	13.3	39.5	23.1	29.3	28.1	4.4	39.3	24.6	21.2	39.7	29.3	24.9	23.5	26.5	33.8	15.9	21.7	10.2	27.5	14.4	16.2	29.9	36.6	28.6	67.6	74.8	35.5	72.2	42.7	49.3	49.7	47.5	35.7	32.1	31.7	70.0	32.9	0.2	34.1	50.0	32.9	64.2	31.9	58.8	29.7	36.2	45.5	41.3	40.9	51.9	37.3	14.4	29.5	39.3	43.1	25.4	29.7	33.6	48.3	37.0	20.0	23.4	37.8	58.1	1.5	25.7	25.1	87.1	61.8	18.3	45.7	16.6	81.4	114.3	43.1	44.3	40.9	67.2	46.3	35.0	53.1	30.3	49.5	58.7	47.2	24.3	69.6	3.4	7.7	0.7	56.6	32.5	33.7	0.0	23.5	0.4	0.5	24.9	2.4	2.0	2.1	1.0	22.0	0.3	0.4	0.1	0.7	4.3	12.5	3.3	1.6	8.2	16.6	16.9	15.8	20.0	15.5	17.9	20.7	19.5	23.1	23.5	21.7	28.6	56.7	35.3	37.9	18.6	5.7	20.0	27.3	33.8	23.9	2.3	28.9	29.8	7.4	17.2	37.9	18.4	2.1	38.6	4.1	78.7	11.7	33.5	4.5	33.8	35.8	50.7	17.4	9.2	41.8	35.0	40.0	32.2	42.8	50.6	8.8	99.1	35.3	31.5	108.7	5.0	46.1	34.0	28.5	104.5	29.5	5.3	36.4	73.8	28.4	253.9	43.3	17.9	0.0	19.6	16.0	43.2	43.2	32.4	6.3	33.2	41.9	21.8	39.6	2.0	26.3	29.5	40.8	9.0	17.9	40.4	26.3	31.7	4.8	38.5	33.0	34.8
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.2;kidney: 139.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Collecting duct cells: 158.2;Distal tubular cells: 174.1;Excitatory neurons: 117.7;Inhibitory neurons: 147.5;Oligodendrocyte precursor cells: 120.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 202.4;JURKAT: 145.2;MOLT-4: 204.8;U-266/70: 153.6;U-698: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	3.2	12.3	61.0	30.8	54.4	55.5	2.8	23.6	103.8	3.1	16.3	8.9	6.3	6.6	25.1	3.8	9.2	8.8	10.4	112.2	25.6	139.9	18.3	12.2	57.1	8.4	33.4	4.8	7.1	64.9	40.1	9.3	6.6	5.8	9.8	35.4	4.0	5.0	7.0	2.8	17.5	5.6	0.0	35.0	20.9	5.3	67.7	85.9	9.9	1.7	55.3	8.3	2.3	37.7	0.3	31.8	47.3	28.8	1.1	1.3	81.5	6.1	9.6	2.5	6.8	6.2	0.6	202.4	14.5	3.4	7.4	0.4	38.0	27.1	5.8	48.8	60.8	28.4	42.3	24.9	4.1	29.1	71.8	5.4	10.9	8.1	0.5	18.8	8.8	145.2	0.4	81.1	7.0	7.7	204.8	5.5	22.3	0.5	8.5	50.6	1.4	102.3	24.5	30.2	70.5	27.4	0.6	28.3	4.6	46.8	19.9	0.8	11.3	2.0	21.4	7.1	5.4	153.6	40.2	142.8	21.4	33.5	11.8	64.8	12.6	90.1	85.9	57.4	61.0	35.8	60.6	75.7	17.8	35.9	63.2	73.2	41.0	53.9	133.7	43.9	53.5	78.0	61.0	54.4	23.6	103.8	112.2	25.6	8.4	33.4	6.6	0.0	67.7	37.7	1.8	3.2	26.9	133.5	76.6	1.1	2.2	2.8	3.4	62.0	3.5	3.4	17.9	8.6	7.4	158.2	16.7	37.2	78.8	6.0	174.1	9.7	15.3	2.8	1.8	2.6	14.4	11.6	117.7	1.6	43.0	3.6	6.1	6.2	2.5	23.1	5.7	30.8	5.3	90.9	147.5	5.6	4.1	6.5	11.4	24.2	1.8	15.7	7.2	23.4	20.3	14.0	101.0	120.6	33.8	1.9	9.9	6.8	41.1	1.3	5.4	55.0	4.7	35.2	0.0	12.2	11.0	3.2	13.1	0.8	1.4	21.1	88.8	2.1	9.1	1.7
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
CYHR1	"CHRP, KIAA0496, MGC13010"	ENSG00000187954	"Cysteine and histidine rich 1"	Q6ZMK1	8	144449582-144465667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053653, HPA059543"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA053653: AB_2682219, HPA059543: AB_2684056"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.58e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.54e-2)"	33.6	57.9	61.2	9.2	60.3	11.1	37.1	58.2	76.1	50.5	57.1	46.8	15.8	41.0	22.8	34.7	43.1	16.0	58.9	61.7	59.5	43.1	48.8	26.6	15.3	63.7	59.9	44.7	60.9	28.9	67.5	10.2	58.6	70.5	8.8	11.2	40.5	27.6	45.9	41.5	30.0	12.0	60.5	35.0	42.1	69.8	59.6	13.7	44.1	22.6	8.5	48.9	40.3	61.2	23.0	27.6	18.3	22.6	30.8	20.7	22.9	15.5	15.9	14.6	18.4	12.8	30.6	10.4	32.5	23.3	18.1	34.0	14.4	22.6	5.6	25.3	23.9	23.6	33.7	22.1	42.9	6.0	12.4	35.6	29.9	18.2	22.7	32.2	16.9	29.0	34.8	27.7	14.0	51.5	28.9	16.6	12.0	34.5	57.5	27.3	7.7	29.6	22.5	19.5	26.7	16.4	33.5	27.9	36.6	13.9	37.5	23.8	20.1	18.4	21.5	20.5	15.6	14.0	9.9	8.4	26.5	20.2	15.2	2.9	11.7	7.0	9.5	8.4	15.5	12.9	11.9	7.8	12.7	14.0	22.2	12.5	5.8	5.3	9.5	27.0	5.0	9.6	61.2	60.3	58.2	76.1	61.7	59.5	63.7	59.9	58.6	60.5	59.6	61.2	32.6	35.3	26.5	52.5	18.5	30.5	46.2	31.8	43.9	75.6	68.7	69.6	19.0	45.8	28.7	58.8	25.0	29.2	33.3	43.2	43.0	28.1	12.5	37.2	37.3	28.9	33.7	23.4	45.9	28.7	20.1	36.4	32.6	32.7	5.1	42.9	37.9	45.6	25.6	90.9	39.4	44.0	36.7	26.7	23.2	44.1	50.7	23.0	26.6	18.7	31.0	120.5	22.6	31.7	37.2	23.2	42.9	39.9	26.2	48.5	47.6	35.0	41.7	59.0	39.5	37.4	35.5	45.8	32.3	36.8	38.8	16.7	24.3	82.2	47.3	35.6
CYLC1		ENSG00000183035	"Cylicin 1"	P35663	X	83861126-83886699	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	312	"testis: 31.2"	"Group enriched"	"Detected in some"	72	"Early spermatids: 499.8;Late spermatids: 1411.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA070355, HPA078303"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA070355: AB_2686261, HPA078303: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	499.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1411.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367646	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"adrenal gland: 1009.9"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 345.1;Peritubular cells: 173.8;Syncytiotrophoblasts: 1452.0;Theca cells: 637.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 10.2"	"Group enriched"	"Detected in some"	5	"BEWO: 55.2;HEL: 46.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1.8;hippocampal formation: 1.1;hypothalamus: 1.3;midbrain: 4.5;pons: 1.1"	HPA016436	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	2.0	1009.9	2.0	0.6	2.1	0.1	1.9	2.3	2.0	2.0	3.5	0.8	0.3	1.6	0.8	6.3	2.4	0.4	1.4	2.0	2.1	0.6	3.6	0.6	0.1	2.8	2.5	38.9	0.3	0.0	2.8	25.2	2.8	1.2	0.2	0.7	1.2	0.5	2.5	0.6	0.8	0.9	2.6	4.9	0.9	23.0	1.9	0.3	0.3	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.0	0.2	0.0	0.4	55.2	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	46.8	1.2	0.5	0.2	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	11.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	2.1	2.3	2.0	2.0	2.1	2.8	2.5	2.8	2.6	1.9	1.9	0.1	0.0	0.0	6.2	0.0	0.3	0.0	0.0	34.1	0.1	0.6	0.9	1.2	2.8	0.0	0.0	0.0	144.6	0.0	0.0	1.9	0.0	1.6	0.2	4.9	0.8	0.0	0.0	0.2	0.0	345.1	10.0	0.0	0.2	0.0	41.3	0.0	3.6	22.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	48.7	0.4	0.0	1.0	0.6	6.2	0.0	0.0	0.2	0.5	0.0	173.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.2	4.6	2.8	8.7	0.0	1452.0	0.0	637.4	0.0	0.0
CYP11B1	"CPN1, CYP11B, FHI, P450C11"	ENSG00000160882	"Cytochrome P450 family 11 subfamily B member 1"	P15538	8	142872356-142879846	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	877	"adrenal gland: 3686.5"	"Group enriched"	"Detected in some"	113	"Early spermatids: 53.3;Late spermatids: 83.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049171, HPA049565, HPA056348, HPA057752"	Supported		Approved	Mitochondria		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516"																		0.2	3686.5	0.1	0.9	0.6	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.4	0.3	0.0	0.9	0.5	0.3	0.0	0.1	0.1	0.3	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.4	4.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP11B2	"ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo"	ENSG00000179142	"Cytochrome P450 family 11 subfamily B member 2"	P19099	8	142910559-142917843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	603	"adrenal gland: 179.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049171, HPA049565, HPA056348, HPA057752"	Supported		Uncertain	Mitochondria		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria		"HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516"																		0.0	179.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"adrenal gland: 8229.5"	"Cell type enriched"	"Detected in some"	17	"Theca cells: 1871.0"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.4	8229.5	0.0	2.1	0.0	0.0	0.4	0.1	0.1	1.1	0.0	0.5	0.0	0.8	0.1	0.9	1.0	0.4	1.0	0.0	0.0	52.9	6.7	1.4	0.0	0.0	0.1	16.6	1.7	10.5	0.7	0.0	0.0	0.7	0.0	0.2	3.4	0.0	1.0	0.7	0.6	0.0	0.0	0.9	1.3	98.3	0.0	0.0	2.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.7	0.0	0.0	1.8	0.0	0.4	0.1	0.1	21.5	0.0	41.6	0.1	0.0	0.7	0.0	2.7	0.1	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.4	6.1	0.1	1.7	0.1	0.0	0.0	0.6	0.7	10.6	1.8	0.9	0.0	0.0	0.1	0.2	3.1	0.5	0.1	0.7	0.0	0.0	0.0	0.3	0.0	104.3	0.0	1.2	0.0	1.2	0.6	0.3	0.1	0.0	0.0	0.3	0.4	1871.0	0.0	0.1
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338601	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 124.4"	"Cell type enriched"	"Detected in some"	10	"Syncytiotrophoblasts: 2007.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Group enriched"	"Detected in many"	4	"amygdala: 4.8;hypothalamus: 4.1;medulla oblongata: 1.4;midbrain: 2.0;thalamus: 3.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 92.8;HDLM-2: 17.5;HSkMC: 31.4;SuSa: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	8.3	9.0	4.8	0.4	0.6	0.2	2.1	0.1	0.5	0.6	0.0	0.2	0.7	0.3	0.0	0.1	0.3	0.5	1.2	0.3	4.1	0.1	0.1	0.7	0.0	1.4	2.0	3.2	1.3	0.2	0.0	124.4	0.7	0.6	0.1	0.6	0.9	2.7	0.6	1.8	0.2	1.3	0.2	0.6	0.2	6.5	3.7	0.2	2.4	0.3	0.0	3.5	0.5	0.7	0.1	0.0	0.0	0.0	1.7	92.8	6.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	17.5	0.0	0.6	0.2	8.1	0.6	0.0	0.1	31.4	0.0	0.3	4.0	0.3	0.0	0.0	0.0	0.8	0.4	0.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.4	0.2	16.3	0.0	0.5	0.1	0.3	0.1	0.2	0.0	3.0	1.6	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.1	0.5	0.3	4.1	1.4	2.0	0.7	0.2	3.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	7.9	1.5	0.0	0.0	0.0	191.3	0.0	0.0	14.0	0.0	0.3	0.0	0.0	0.9	0.0	5.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.9	12.3	0.3	0.0	0.0	2007.5	0.0	22.2	0.0	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725536	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.1;urinary bladder: 63.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	18.5	0.6	0.2	0.0	0.2	0.0	14.7	0.1	0.3	3.6	0.0	2.0	0.6	2.4	0.6	1.9	1.2	0.7	10.7	0.2	0.4	1.4	66.1	12.2	0.0	0.3	0.4	0.5	0.6	0.0	0.5	0.3	0.3	0.7	0.1	0.3	1.8	0.6	4.1	13.9	19.8	0.0	0.1	0.1	1.8	0.3	0.2	0.2	2.0	0.2	0.1	63.6	2.2	0.1	0.3	2.1	0.2	0.0	0.5	0.1	11.7	0.0	0.1	0.7	0.3	36.9	1.6	0.3	9.6	0.0	8.8	11.4	0.7	7.3	0.3	0.0	1.0	0.5	2.6	5.5	0.2	0.3	11.5	0.0	19.5	0.3	1.4	0.4	19.1	0.3	2.3	0.3	0.1	0.7	0.1	0.4	0.2	12.1	2.9	1.2	0.0	0.4	0.0	2.4	0.6	0.3	1.7	14.7	3.8	35.6	0.4	0.2	1.0	1.6	0.5	5.2	0.0	0.7	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.4	0.3	0.4	0.3	0.1	0.2	0.1	21.9	0.0	0.0	0.0	0.1	0.5	2.4	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.4	1.1	13.7	0.0	0.0	0.1	0.2	0.0	0.2	0.0	5.9	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	16.4
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748845-74756607	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	313	"liver: 513.4"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 85.7"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.2	0.3	0.5	0.2	0.5	1.0	0.1	1.6	0.8	0.0	0.2	0.0	0.2	0.2	0.4	0.1	0.2	0.2	0.1	0.5	0.5	0.2	513.4	0.4	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.7	0.6	0.1	0.1	0.4	0.2	0.3	0.3	0.6	0.2	0.0	0.1	0.3	0.2	0.3	0.6	0.1	1.4	0.0	0.1	0.1	0.0	1.3	0.4	0.3	0.8	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.4	0.8	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.3	0.1	1.3	0.7	1.3	0.0	0.2	0.9	0.3	0.4	0.3	0.2	0.9	0.8	0.3	0.1	0.7	0.7	0.3	0.6	2.3	0.1	0.6	0.5	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.5	0.3	0.9	0.3	1.5	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.2	2.1	0.4	0.2	0.4	0.1	0.1	0.5	0.5	1.6	0.8	0.5	0.5	0.6	0.5	0.6	0.1	0.6	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.7	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease variant, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 170.8;Prostatic glandular cells: 747.6;Urothelial cells: 498.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"classical monocyte: 156.9"	"Lineage enriched"	"Detected in many"	24	"monocytes: 156.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 128.7;ASC TERT1: 136.8;HSkMC: 551.3;hTERT-RPE1: 128.9;SiHa: 270.0;U-87 MG: 142.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 34.6"	"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	28.4	12.0	2.7	31.9	6.2	2.0	29.4	1.6	8.9	34.9	10.4	3.7	2.2	41.0	19.5	7.6	44.9	23.8	29.2	2.5	2.3	24.1	7.0	16.8	11.6	3.6	2.9	5.6	7.2	0.9	14.8	4.5	3.0	34.7	2.1	1.2	4.3	39.2	3.4	6.3	5.8	35.1	3.6	27.3	15.9	8.0	7.3	28.3	8.7	5.5	1.9	35.0	6.7	1.5	7.0	71.9	2.3	0.0	128.7	136.8	0.4	0.6	4.4	1.3	12.3	0.2	30.1	0.0	19.1	17.8	3.1	58.7	0.3	4.0	2.3	5.5	3.8	0.0	21.2	0.0	36.0	0.2	0.1	551.3	55.3	30.7	1.4	128.9	0.0	0.3	0.7	0.2	0.7	29.2	0.3	22.5	7.5	10.4	14.2	0.1	0.0	0.2	13.4	0.9	0.5	2.1	270.0	38.8	0.0	7.5	49.4	10.8	0.0	1.1	0.2	107.9	0.1	0.3	0.2	0.0	142.2	0.1	11.8	1.6	156.9	0.0	0.1	23.2	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.1	6.5	0.1	18.6	0.7	0.1	70.2	2.7	6.2	1.6	8.9	2.5	2.3	3.6	2.9	3.0	3.6	7.3	1.5	56.8	19.2	66.3	0.0	1.7	17.7	118.4	86.9	8.0	0.7	18.3	42.0	3.4	0.0	79.7	46.0	0.0	0.3	1.1	0.9	15.6	6.0	15.1	11.7	100.4	103.8	1.8	0.0	4.5	0.5	0.8	114.1	3.6	28.2	3.8	0.1	7.5	12.2	12.6	0.0	0.3	1.3	4.1	103.0	50.6	12.1	159.7	112.2	17.8	64.6	140.1	1.6	3.1	0.0	0.2	0.6	0.1	170.8	0.3	747.6	0.1	1.6	11.2	0.5	19.7	4.5	32.7	12.6	2.6	2.4	14.2	0.3	2.4	1.3	1.0	498.7
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238977-203306026	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: AB_2682951, HPA058461: AB_2683725"	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	3.1	3.2	3.1	2.1	4.3	2.2	2.4	4.1	3.4	2.7	4.2	3.6	2.1	2.3	2.4	2.4	1.9	3.2	1.7	2.7	3.0	6.1	4.6	3.5	3.9	4.5	3.8	3.8	3.1	2.9	0.9	3.4	3.8	3.5	3.2	1.7	2.3	2.1	2.6	3.8	2.6	3.2	2.9	3.7	3.7	2.9	4.2	2.2	8.0	1.3	2.9	3.2	1.0	5.7	2.8	4.7	2.9	2.9	12.1	2.9	2.5	5.0	3.3	2.4	1.7	9.1	5.2	1.9	3.8	4.8	4.4	4.0	1.9	2.7	4.6	2.9	1.0	6.1	3.0	3.5	7.2	6.4	3.3	5.5	2.2	5.7	4.9	2.1	6.4	2.8	8.0	9.9	5.1	4.2	4.3	3.7	7.7	2.3	4.2	3.5	3.7	4.5	3.2	9.2	2.0	2.2	0.4	4.0	5.5	3.3	2.7	4.8	8.5	8.4	2.5	4.0	4.1	5.2	4.4	2.3	6.4	2.8	3.6	5.7	5.2	2.1	6.5	5.6	7.1	6.1	8.0	5.9	2.3	9.6	5.9	3.5	3.0	4.9	6.5	7.4	8.0	4.3	3.1	4.3	4.1	3.4	2.7	3.0	4.5	3.8	3.8	2.9	4.2	5.7	41.2	16.0	33.2	24.2	55.5	12.4	41.6	20.2	29.6	42.0	17.1	17.8	33.6	50.1	33.8	16.5	58.4	33.4	55.8	40.3	11.7	18.3	96.6	24.2	33.6	40.5	45.4	45.5	12.1	20.3	23.0	49.0	53.0	23.7	29.1	65.4	88.2	50.4	37.9	50.5	20.5	33.0	22.4	38.1	22.5	21.9	123.0	35.8	7.2	34.7	44.5	32.4	74.2	24.1	39.1	15.2	30.6	83.8	51.7	33.6	30.8	26.2	23.5	70.5	65.7	76.6	45.7	104.5	64.1	25.4	13.4	40.8	54.4	59.7	32.8	28.7
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	2.0	2041.7	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.9	0.0	2.5	0.0	1.5	0.6	0.6	2.4	0.0	2.9	0.0	0.0	7.0	44.8	0.8	0.0	0.0	0.0	4.3	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.7	1.1	0.0	0.0	5.5	0.8	0.8	0.0	0.0	2.3	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72147862	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;skin 1: 31.4"	"Group enriched"	"Detected in many"	4	"Leydig cells: 75.8;Peritubular cells: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	26.2	4.3	12.0	1.9	3.3	0.1	15.0	12.3	7.0	5.0	0.4	3.2	3.7	2.5	1.5	3.9	5.5	1.1	8.5	6.7	1.3	8.8	1.0	2.7	4.9	48.0	10.4	4.5	0.6	0.8	9.3	3.3	49.9	2.6	1.2	4.2	9.9	7.3	5.9	31.4	4.7	1.6	0.0	3.5	1.2	13.8	0.7	19.3	14.4	2.3	2.9	3.2	4.2	3.5	0.6	5.9	0.0	0.1	9.8	4.0	5.9	0.9	0.1	0.2	0.2	1.8	0.5	0.0	0.5	0.7	3.0	14.8	8.5	0.0	0.1	0.0	2.7	0.0	7.0	0.9	0.2	0.0	0.3	0.0	0.5	0.0	0.3	3.0	1.1	4.0	0.6	0.1	0.9	2.9	0.0	0.1	0.0	0.1	1.0	0.1	18.4	0.0	0.0	1.3	0.6	0.1	3.0	0.0	3.5	1.2	0.3	0.9	0.0	1.6	19.3	9.0	3.0	0.1	1.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.3	12.3	7.0	6.7	1.3	48.0	10.4	49.9	0.0	0.7	3.5	2.4	0.0	0.0	2.0	1.2	14.7	1.1	0.8	0.6	0.2	2.3	0.8	1.4	4.3	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	4.1	0.2	0.2	19.0	1.8	5.3	5.3	0.0	0.9	15.6	0.0	0.3	0.0	1.5	34.6	0.8	0.1	0.0	0.7	0.0	0.0	6.1	19.1	9.6	75.8	0.4	7.2	0.0	0.0	7.4	0.0	2.0	0.5	0.4	1.5	229.9	0.0	0.5	0.2	0.1	0.2	0.3	0.0	5.7	20.7	1.5	3.8	1.6	9.7	0.1	0.8	7.5	0.1	0.4
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088451-41096195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"liver: 2.0"	"Group enriched"	"Detected in some"	8	"Club cells: 2.0;Early spermatids: 4.2;Late spermatids: 3.7"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 34: Spermatids - Unknown function"			"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843541-40850447	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	171	"liver: 1612.0"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 322.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.6	0.2	0.0	0.0	0.1	0.0	9.4	0.0	0.2	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	1612.0	0.3	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.2	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	11.4	322.3	0.0	0.0	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.5
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	71	"liver: 152.5"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 195.3"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.6	2.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	152.5	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	24.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	11.0	195.3	0.0	0.0	0.1	0.8	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.9
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94855547	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 190.2"	"Group enriched"	"Detected in some"	11	"Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, HPA074424"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA015066: AB_1847433, HPA074424: "			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.2	0.1	0.2	32.4	0.0	0.1	1.6	0.0	1.7	0.0	0.1	0.0	0.0	190.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.6	13.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.4	9.5	0.0	0.0	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2156.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.3	1.8	1.7	0.0	1.9	0.2	0.3	1.4	2.1	0.3	1.4	0.4	0.2	0.1	0.3	0.1	1.1	4.6	0.3	1.8	2.2	1.4	2156.6	0.4	0.1	1.7	2.2	0.1	1.7	0.5	3.1	0.1	1.8	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.4	1.0	6.0	4.0	2.1	0.2	0.9	0.0	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.4	2.1	1.8	2.2	1.7	2.2	1.8	1.4	2.1	1.8	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1719.9"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	1.2	0.0	2.7	87.8	0.0	0.0	7.7	0.0	7.9	0.0	0.0	0.0	4.3	1719.9	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.2	0.1	0.0	0.5	18.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130865	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 320.0"	"Group enriched"	"Detected in many"	35	"Hepatocytes: 512.8;Proximal enterocytes: 465.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.8"					"Low region specificity"	"Detected in many"			HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.2	0.0	0.3	0.3	0.1	0.8	0.2	0.1	0.3	0.3	3.7	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.3	320.0	0.1	0.1	0.2	0.0	0.2	0.8	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	11.7	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.0	1.1	5.5	0.7	0.5	0.7	1.3	2.8	7.3	1.1	1.4	0.4	2.8	0.7	1.8	2.1	0.1	0.6	2.9	1.9	0.7	3.1	0.8	0.6	0.6	1.2	0.0	6.5	0.6	0.1	0.3	4.1	1.4	0.0	0.7	5.7	512.8	0.1	11.8	9.4	7.6	0.0	5.6	0.0	13.6	0.0	0.4	0.0	0.0	0.1	0.7	0.0	5.0	4.9	0.7	11.3	1.5	0.4	0.6	465.2	0.5	1.3	2.3	0.0	0.4	2.1	0.8	0.4	0.6	1.1	0.4	1.0	0.1	3.4	0.3
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	309	"liver: 10379.8"	"Cell type enriched"	"Detected in many"	58	"Hepatocytes: 6272.7"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5;myeloid DC: 6.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 6.2;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	2.8	2.9	5.4	0.6	5.4	0.8	3.0	9.1	7.5	4.9	3.0	5.0	1.4	4.5	8.3	16.7	5.5	2.5	2.1	5.5	5.5	9.1	10379.8	2.6	2.0	6.1	5.5	4.1	12.4	0.6	4.1	1.4	6.7	5.3	1.2	11.5	3.6	6.1	2.8	13.8	2.2	2.2	5.0	7.2	6.7	3.7	6.3	1.7	4.0	0.9	33.6	3.5	3.2	7.5	0.1	0.0	0.3	1.0	3.5	1.9	0.7	1.6	4.5	0.0	0.3	0.0	2.7	1.4	0.2	0.5	0.0	11.0	0.0	0.2	0.4	0.3	1.5	1.8	0.2	1.3	0.6	8.9	8.9	1.0	0.2	0.0	0.7	1.9	0.0	3.1	0.6	0.4	1.0	0.7	0.6	24.0	6.4	4.3	0.4	0.4	6.1	0.0	2.0	0.0	0.0	0.0	4.2	0.0	0.6	0.2	0.3	0.9	0.0	1.4	0.4	2.3	1.0	2.2	1.0	3.0	1.5	7.4	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.6	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	5.4	5.4	9.1	7.5	5.5	5.5	6.1	5.5	6.7	5.0	6.3	7.5	0.8	0.0	1.1	5.5	9.2	2.3	0.2	0.7	0.6	5.7	0.6	0.5	2.8	48.6	1.9	0.0	2.1	0.0	0.4	0.1	0.0	1.6	2.1	0.6	0.8	4.6	0.0	67.6	6.7	1.3	0.1	1.1	1.5	0.5	1.3	0.7	67.1	6272.7	0.0	8.4	5.3	0.0	0.0	108.0	2.8	2.1	1.5	0.3	0.0	1.9	0.4	0.7	0.0	2.0	2.2	3.2	0.0	2.6	0.3	0.6	0.0	0.6	2.2	5.8	0.0	0.2	0.6	4.1	4.2	2.0	7.5	0.1	5.7	0.2	0.0	0.0
CYP2R1		ENSG00000186104	"Cytochrome P450 family 2 subfamily R member 1"	Q6VVX0	11	14877440-14892231	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 176.3;Late spermatids: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 26.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042949	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA042949: AB_2678237"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	2.5	1.8	1.6	3.1	1.9	3.0	4.1	4.9	2.4	2.6	0.5	3.7	4.6	2.2	3.2	4.6	1.8	1.6	2.2	1.6	2.1	1.8	2.2	2.5	3.0	1.7	1.5	2.0	5.2	1.5	2.6	1.0	1.8	2.8	3.3	3.3	4.5	1.4	2.8	6.9	4.4	1.5	1.5	3.0	5.0	4.3	1.6	2.4	1.9	1.6	2.9	3.0	3.3	2.3	6.1	3.7	3.6	1.5	1.5	2.5	0.0	2.1	1.1	1.2	1.3	4.3	6.8	7.6	1.6	0.4	4.7	0.0	1.2	2.8	0.5	6.3	5.8	3.4	4.7	0.3	5.4	5.9	3.4	2.4	10.6	0.0	4.4	1.1	1.4	9.3	5.1	26.0	0.8	1.6	6.5	11.9	3.4	4.4	3.5	4.6	2.6	11.6	1.4	0.7	3.0	4.7	4.5	5.4	5.2	2.3	4.0	2.2	3.8	3.6	4.4	2.2	2.7	12.8	16.1	9.0	5.0	7.6	3.3	2.4	2.0	1.6	3.0	1.9	4.7	1.6	2.5	1.9	1.7	2.8	3.5	3.0	0.3	2.1	2.3	2.0	3.6	1.2	1.6	1.9	4.9	2.4	1.6	2.1	1.7	1.5	1.8	1.5	1.6	2.3	4.4	12.8	4.8	8.5	15.4	5.9	13.9	9.3	12.5	1.9	7.0	5.8	4.3	8.6	7.4	5.5	6.2	0.3	9.8	10.1	5.9	8.1	176.3	1.9	3.3	6.7	6.7	4.6	13.1	16.9	0.2	4.4	14.8	3.9	3.8	7.8	5.0	6.0	5.9	1.7	18.4	5.5	0.0	7.6	12.6	106.7	2.1	7.7	14.2	13.1	6.1	5.0	13.4	14.6	13.3	11.3	2.9	4.1	11.9	6.4	12.6	6.2	2.8	5.0	13.1	3.2	4.9	23.8	20.2	20.4	6.7	0.0	16.4	6.7	8.8	6.1
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193210-41207539	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 101.3;stomach 1: 120.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 24.7;myeloid DC: 84.4"	"Group enriched"	"Detected in many"	131	"dendritic cells: 84.4;monocytes: 24.7"	"Cell line enhanced"	"Detected in many"		"A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.8	1.1	1.4	6.7	1.4	1.8	0.9	3.1	1.5	2.7	1.2	26.7	101.3	0.5	0.2	14.5	6.3	5.5	0.5	1.3	4.1	1.1	1.4	7.1	1.7	6.3	10.0	0.3	0.6	0.7	1.2	1.6	6.1	1.3	18.6	0.2	5.0	0.9	0.2	3.7	65.3	1.7	2.2	6.1	120.4	0.8	3.6	3.2	0.6	0.2	13.2	3.6	4.0	2.5	3.8	99.4	0.0	0.1	0.0	0.0	4.5	0.6	0.8	1.0	0.2	49.8	13.6	0.2	10.4	0.7	0.1	50.3	16.6	25.0	0.4	0.0	0.3	12.9	5.1	19.1	19.4	0.0	0.4	0.8	1.4	1.4	0.8	0.2	0.8	4.3	5.8	0.2	0.0	2.0	0.3	0.2	69.6	158.6	12.5	0.2	0.0	0.9	1.5	20.4	0.1	0.6	9.1	0.0	0.0	27.8	12.2	4.7	10.6	0.1	4.0	1.7	0.0	0.5	0.0	0.0	0.5	2.1	0.1	0.0	24.7	0.0	0.0	5.9	0.4	0.0	0.0	0.1	84.4	0.0	0.0	0.0	0.2	0.1	3.7	3.2	0.0	11.4	1.4	1.4	3.1	1.5	1.3	4.1	6.3	10.0	6.1	2.2	3.6	2.5	0.3	0.0	6.9	1.0	0.7	2.5	2.0	18.2	23.3	0.0	0.1	0.3	1.2	0.0	7.6	1.8	0.0	24.9	0.1	31.0	0.0	0.7	0.3	7.4	0.3	0.4	0.0	0.0	0.4	1.0	1.1	0.8	110.6	0.3	1.3	0.1	0.4	0.0	14.5	0.0	0.5	29.2	0.0	5.7	73.0	0.0	0.0	16.0	0.0	1.0	7.2	0.0	0.0	0.5	0.1	23.7	22.3	0.0	0.4	0.5	50.7	0.2	10.8	0.0	0.0	0.3	0.9	0.1	0.4	4.0	2.8	10.3	0.3	0.0	14.1	0.5
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	44.7	0.1	0.1	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 242.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1227.5;Club cells: 405.1;Respiratory ciliated cells: 763.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 286.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	81.8	4.9	0.3	0.0	0.3	0.0	62.0	0.2	0.6	13.4	1.2	14.6	1.3	9.5	1.7	44.0	48.0	0.5	40.2	0.2	0.3	2.4	0.1	242.2	0.5	0.3	0.3	1.7	3.4	0.7	9.3	1.2	0.3	22.7	0.7	0.0	16.6	15.8	24.0	42.7	15.2	0.1	0.3	0.4	11.5	0.5	0.4	3.1	22.3	24.6	15.2	81.7	30.5	0.3	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	286.7	0.1	0.0	0.0	11.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.3	60.8	1227.5	89.3	0.0	0.0	0.5	139.6	111.5	36.5	0.0	2.0	1.5	6.4	1.5	405.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	93.8	12.5	23.5	0.0	0.0	0.1	0.0	0.2	47.9	1.1	8.5	6.3	0.0	1.4	0.0	0.6	0.0	0.1	0.0	48.8	0.0	0.3	0.9	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	6.9	0.0	1.1	763.9	0.0	0.0	3.0	23.3	0.1	0.1	71.4	4.1	0.8	1.8	0.0	0.0	163.0
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.9;liver: 72.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 15.6;Hepatocytes: 62.9;Prostatic glandular cells: 36.3;Urothelial cells: 26.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.1;CAPAN-2: 50.4;EFO-21: 18.5;Hep G2: 25.0;RPMI-8226: 13.5;RT4: 15.2"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.3	2.9	5.2	0.6	5.3	0.6	2.1	5.1	5.3	1.6	0.0	3.5	10.7	0.5	16.4	13.0	3.0	18.7	0.2	4.3	5.5	6.4	72.3	0.6	0.4	9.3	9.6	0.1	5.1	0.1	0.5	0.1	6.3	3.8	2.6	1.6	3.8	4.3	0.5	1.0	23.9	0.1	4.8	1.0	4.1	1.1	6.6	0.0	3.0	0.0	0.9	5.7	3.4	5.0	13.1	2.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	50.4	0.1	18.5	0.0	10.5	1.5	0.0	6.6	0.0	0.0	0.1	0.1	4.2	25.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	10.0	0.0	1.9	0.1	0.3	0.1	11.4	0.0	0.1	0.1	13.5	3.4	15.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.6	0.2	0.4	1.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.3	5.1	5.3	4.3	5.5	9.3	9.6	6.3	4.8	6.6	5.0	0.1	0.0	0.0	9.1	0.2	0.1	7.7	5.3	0.0	0.0	1.4	1.7	0.4	10.0	4.4	9.2	0.0	0.0	0.0	6.9	1.9	15.6	0.0	2.8	0.6	0.3	1.2	2.7	0.0	11.5	0.0	0.3	0.0	4.4	0.0	0.3	0.4	62.9	0.0	0.0	0.0	2.0	2.0	2.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.8	9.2	3.2	0.0	0.0	36.3	11.7	8.3	7.6	0.1	0.0	0.6	0.6	0.0	0.0	0.5	0.3	0.0	0.1	0.1	2.7	26.1
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"	Q9HCS2	19	15673018-15697174	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.5;liver: 40.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 58.8;Gastric mucus-secreting cells: 57.6;Paneth cells: 51.9;Proximal enterocytes: 125.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	54	"basophil: 6.1;eosinophil: 14.8"	"Lineage enriched"	"Detected in single"	88	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 17.6;HaCaT: 32.0;Hep G2: 9.8;Karpas-707: 20.9;OE19: 46.3"									HPA058960	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	3.2	1.1	0.6	1.2	0.9	0.9	2.7	0.6	1.5	6.0	0.4	15.1	39.1	1.5	0.5	18.1	3.2	2.4	1.5	0.9	2.4	1.8	40.1	1.2	0.5	0.9	1.1	1.6	0.3	0.0	0.5	0.5	1.1	5.0	7.8	0.1	4.3	1.0	0.6	21.1	41.5	1.9	0.7	1.0	12.0	0.2	0.7	0.8	0.9	0.9	2.6	10.5	11.2	1.9	0.0	4.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.6	0.5	0.0	0.0	0.3	32.0	0.0	0.0	0.0	2.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.1	0.0	46.3	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.1	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.1	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.6	1.5	0.9	2.4	0.9	1.1	1.1	0.7	0.7	1.9	6.3	0.0	1.8	2.6	0.5	14.0	10.0	8.3	13.1	0.0	0.5	0.3	1.0	5.7	7.1	0.0	0.0	0.1	0.0	58.8	0.0	0.6	1.6	0.2	0.1	3.0	7.8	8.0	0.2	0.0	0.1	3.8	57.6	0.3	0.0	0.0	1.4	30.3	0.4	0.0	0.2	24.8	2.0	0.9	1.6	3.2	4.1	0.3	1.8	0.0	0.0	2.7	0.0	0.0	0.4	1.9	51.9	1.2	0.2	3.5	125.3	2.2	4.9	0.1	0.0	0.3	2.5	0.4	0.1	20.5	21.2	0.3	0.5	0.1	29.6	24.8
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508525-15552317	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.8;skin 1: 58.6;vagina: 22.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1"	"Group enriched"	"Detected in many"	8	"monocytes: 14.1;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.7;T-47d: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"			"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	10.5	0.0	0.0	0.2	0.3	0.0	18.8	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.3	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	3.2	6.4	0.2	58.6	0.1	0.0	0.0	0.3	1.4	1.0	0.0	0.1	0.0	0.0	1.7	6.3	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	6.1	4.3	0.0	0.5	1.5	0.2	0.0	0.0	0.4	0.0	1.1	14.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	8.8	5.5	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	3.0	0.0	1.8	0.0	0.0	0.3
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 80.2;liver: 235.8"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 562.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	63	"neutrophil: 84.1"	"Lineage enriched"	"Detected in single"	177	"granulocytes: 84.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058960	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	1.6	0.1	0.9	1.2	3.3	80.2	0.2	2.3	1.3	6.9	0.3	2.1	9.4	0.1	0.8	26.7	1.1	15.5	0.3	1.8	2.2	27.3	235.8	2.3	0.1	2.8	3.0	0.0	0.6	0.0	0.5	0.4	2.9	0.6	1.8	0.0	3.4	0.6	0.1	3.9	15.0	0.3	1.9	7.8	5.1	0.3	1.9	0.7	0.1	0.6	0.7	2.9	9.0	4.1	0.3	7.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.0	0.1	14.9	0.0	0.2	0.0	0.6	0.0	0.1	3.5	18.3	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	49.3	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	84.1	0.0	0.1	0.0	0.0	0.1	0.9	3.3	2.3	1.3	1.8	2.2	2.8	3.0	2.9	1.9	1.9	4.1	0.0	9.6	3.7	0.7	2.0	1.0	2.1	2.5	1.2	0.0	0.1	0.1	0.9	62.9	5.0	0.0	0.0	0.0	1.4	10.0	0.0	2.3	0.1	0.9	0.2	0.7	53.1	17.3	0.0	0.2	0.2	0.8	7.7	3.1	1.3	0.0	8.2	562.4	0.0	0.0	0.0	14.4	8.2	11.4	0.3	0.7	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.0	7.4	0.0	0.0	3.2	69.9	32.1	1.9	0.0	0.0	0.7	1.3	0.0	0.3	25.7	6.5	0.0	1.1	0.0	10.9	13.1
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630639	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"seminal vesicle: 215.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.2;Breast glandular cells: 1.7;granulocytes: 1.3;NK-cells: 1.0;Prostatic glandular cells: 1.3;Skeletal myocytes: 1.7;Urothelial cells: 2.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 10.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.1"					"Low region specificity"	"Detected in all"			HPA058960	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.2	215.6	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.4	1.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.3	2.5
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191567-186213463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;SK-MEL-30: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	7.4	16.4	5.1	5.2	6.8	2.1	5.7	5.6	5.0	8.6	17.9	9.6	16.5	5.6	2.6	5.0	6.1	14.7	9.2	4.8	5.1	33.9	113.5	10.8	5.6	5.3	6.0	5.7	15.6	33.4	3.7	3.5	5.3	8.2	11.9	14.2	7.0	7.5	4.5	1.3	16.7	7.1	5.4	11.2	6.2	3.2	5.6	6.5	17.3	5.0	4.9	6.4	2.3	6.3	3.4	1.8	0.8	0.0	15.2	6.3	0.2	4.4	9.9	1.7	1.9	0.0	13.0	1.1	0.5	3.5	5.9	1.6	1.9	1.7	0.3	6.0	2.2	4.7	0.8	0.5	5.6	2.6	1.9	5.8	0.8	1.9	1.0	5.9	0.1	6.4	1.4	14.3	6.8	2.9	3.6	1.3	1.5	1.6	0.0	3.1	0.7	1.0	7.4	6.1	4.0	4.9	1.1	0.0	27.5	0.3	2.6	4.6	4.1	3.6	0.7	3.5	1.6	0.1	0.0	0.5	10.9	11.0	4.7	0.0	0.6	0.0	1.8	1.9	1.0	0.4	1.4	1.8	0.7	1.0	1.3	1.3	0.0	0.8	3.1	1.3	1.1	0.9	5.1	6.8	5.6	5.0	4.8	5.1	5.3	6.0	5.3	5.4	5.6	6.3	9.0	6.4	11.5	31.3	13.8	2.5	4.5	5.1	9.6	33.6	9.3	7.2	18.8	42.9	8.7	14.7	31.3	2.0	9.6	14.7	9.8	24.2	2.7	6.7	5.1	7.7	16.9	16.4	15.4	22.4	2.1	14.2	12.8	7.6	7.0	6.5	8.9	103.7	13.5	5.0	23.4	16.5	2.0	14.8	6.0	2.1	5.0	11.3	3.6	6.5	3.5	52.2	4.1	15.6	11.0	9.6	9.0	6.4	12.3	3.8	47.2	28.5	11.9	27.4	0.0	10.1	10.6	8.9	6.3	6.8	3.1	1.0	17.2	6.7	10.5	5.7
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023669-47050751	"Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 37.1;salivary gland: 31.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.5;Club cells: 59.0;Excitatory neurons: 37.4;Respiratory ciliated cells: 104.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 24.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.6;CACO-2: 4.6;NTERA-2: 2.1;SCLC-21H: 2.7;T-47d: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017661	Approved					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	11.6	3.2	8.2	0.7	8.5	0.1	14.9	5.2	10.2	37.1	2.8	1.6	1.7	2.1	2.7	14.7	9.3	1.6	8.6	8.7	12.1	5.9	10.5	8.8	1.9	4.5	5.6	1.2	1.7	1.7	3.8	1.1	5.7	8.0	1.9	2.3	31.1	2.9	4.6	7.1	1.4	1.9	4.1	0.6	22.3	4.0	9.2	1.1	5.0	4.0	9.1	3.3	7.2	6.4	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.3	0.0	0.4	0.2	2.7	0.0	0.0	0.2	0.0	0.1	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	8.5	5.2	10.2	8.7	12.1	4.5	5.6	5.7	4.1	9.2	6.4	4.4	22.4	17.0	2.3	0.0	2.5	26.9	37.5	25.0	2.4	31.0	0.9	0.8	1.5	59.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	8.4	7.6	0.8	4.0	0.0	0.0	37.4	0.7	0.0	7.1	4.1	1.4	0.0	0.0	1.1	2.8	3.9	0.0	29.3	0.2	18.3	0.6	0.7	8.6	10.5	0.5	5.4	4.7	0.0	0.1	0.0	1.0	2.0	0.1	0.0	20.7	0.0	8.4	0.5	1.7	104.6	0.8	0.0	2.0	19.1	0.5	3.6	21.4	1.4	0.1	0.5	0.1	1.9	31.8
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112153-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 204.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 169.7;Early spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 481.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	19.4	58.2	22.3	20.6	24.9	30.3	30.6	39.8	32.3	26.4	21.0	52.7	86.6	21.2	35.8	43.7	16.7	24.3	20.7	24.2	39.0	38.7	204.7	53.2	13.1	60.1	42.3	29.0	48.7	59.6	17.1	21.9	50.6	43.8	41.5	31.4	20.3	17.5	7.9	26.5	40.0	20.4	46.6	13.4	45.1	86.4	31.8	6.6	33.6	11.7	16.6	21.3	26.2	57.0	113.7	54.3	134.0	86.4	92.0	149.6	18.7	37.7	112.7	47.1	128.8	131.8	201.7	98.1	57.9	65.3	481.6	96.2	118.1	237.0	55.3	40.3	82.6	27.9	51.1	99.7	125.7	56.0	39.4	109.1	105.7	185.6	194.0	42.2	49.4	19.8	108.2	217.8	56.4	115.6	12.5	53.8	100.7	45.9	53.4	40.3	27.8	222.8	216.7	187.9	94.1	62.5	80.0	156.3	117.2	60.6	56.9	69.5	59.5	65.0	70.6	95.2	49.8	72.8	70.5	88.1	49.8	75.5	85.2	2.8	11.1	3.9	11.6	16.3	7.7	15.6	8.0	8.9	16.3	12.3	7.1	9.6	1.5	7.8	10.3	14.3	6.7	8.2	22.3	24.9	39.8	32.3	24.2	39.0	60.1	42.3	50.6	46.6	31.8	57.0	3.1	67.3	169.7	35.9	24.0	2.5	1.6	4.6	48.9	2.6	6.7	3.7	1.6	7.2	44.5	1.8	2.1	1.5	8.9	20.3	1.9	10.7	74.4	10.7	8.1	7.7	10.8	11.6	34.3	19.8	1.0	9.1	43.3	16.4	28.5	4.1	5.3	45.2	1.5	0.0	39.6	13.1	2.0	5.6	1.9	34.4	3.7	9.2	0.0	15.9	1.3	2.4	0.0	39.2	53.1	14.2	11.7	1.5	34.3	1.4	9.6	1.5	15.7	1.9	0.0	4.0	6.5	7.8	4.2	51.4	5.4	4.4	12.2	9.3	11.9	2.5
CYP7B1	SPG5A	ENSG00000172817	"Cytochrome P450 family 7 subfamily B member 1"	O75881	8	64587763-64798737	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.7;Oligodendrocyte precursor cells: 94.5;Oligodendrocytes: 119.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 2.5;eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	4	"HSkMC: 16.5;SH-SY5Y: 5.5;WM-115: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017761	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA017761: AB_1847455"	"unprognostic (3.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.80e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.75e-3)"	8.4	5.4	5.7	5.6	11.4	0.3	6.3	8.2	6.6	5.7	8.6	2.3	1.8	2.8	2.0	7.3	2.7	5.8	3.6	5.3	6.8	7.9	21.5	4.6	2.4	11.8	7.3	4.2	6.7	11.4	0.8	0.5	11.4	4.4	3.5	1.9	4.6	5.6	0.2	5.9	1.8	4.3	8.4	9.2	2.4	1.7	8.1	2.1	12.2	1.7	2.9	7.9	3.0	27.2	1.5	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	5.5	0.0	0.0	2.2	0.8	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.7	11.4	8.2	6.6	5.3	6.8	11.8	7.3	11.4	8.4	8.1	27.2	3.3	0.0	3.4	93.7	0.1	10.6	6.6	1.0	7.4	4.9	4.2	5.5	3.0	2.8	0.9	7.3	2.1	0.1	0.4	0.0	3.9	4.4	7.4	0.2	6.9	2.1	1.8	1.3	29.3	4.9	0.2	15.9	0.5	0.1	12.7	0.6	2.5	8.2	0.2	3.3	30.6	0.5	0.0	0.3	4.9	8.6	5.9	0.5	17.8	30.0	1.0	6.9	0.0	94.5	119.2	1.2	0.0	4.9	0.0	4.2	0.0	2.9	0.8	0.5	13.1	1.1	16.8	4.1	3.4	6.2	12.6	0.0	1.3	7.6	0.0	3.1
CYREN	"C7orf49, FLJ22450, FLJ27285, MGC5242, MRI, MRI-2"	ENSG00000122783	"Cell cycle regulator of NHEJ"	Q9BWK5	7	135092363-135170795	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 69.1;Distal tubular cells: 72.4;Ductal cells: 51.0;Extravillous trophoblasts: 65.6;Hofbauer cells: 41.3;Proximal tubular cells: 47.3;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020060	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA020060: AB_2290651"	"unprognostic (3.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (8.89e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.69e-1)"	16.2	20.1	11.8	15.4	15.7	16.5	16.2	15.0	13.1	16.4	18.9	14.5	13.7	18.5	16.6	18.6	21.1	11.6	15.9	11.5	13.1	30.1	14.1	13.9	19.3	18.7	14.6	18.3	21.0	26.2	16.3	20.6	17.4	15.4	13.9	6.6	22.5	22.8	33.4	13.6	13.6	18.1	13.8	17.2	18.5	13.9	14.6	19.5	15.0	18.9	23.7	16.6	14.8	18.9	59.9	62.7	29.4	46.0	24.9	23.7	49.1	38.3	38.8	49.0	38.1	40.1	42.0	48.3	42.2	39.2	52.1	32.8	42.2	69.6	31.6	62.1	27.1	32.0	34.2	37.2	35.4	64.0	37.4	27.6	68.4	38.3	44.0	22.5	21.2	37.4	117.5	31.9	40.3	60.4	60.6	44.0	67.8	50.5	46.1	44.1	36.4	64.1	57.1	35.4	34.7	53.4	43.4	37.7	42.5	32.1	30.0	57.4	18.4	43.8	24.6	39.0	66.3	56.8	69.8	65.8	60.7	62.5	90.9	32.2	27.5	27.9	12.3	24.5	13.4	18.3	10.8	16.7	30.3	19.4	15.8	15.9	6.1	27.2	24.1	25.8	5.4	20.9	11.8	15.7	15.0	13.1	11.5	13.1	18.7	14.6	17.4	13.8	14.6	18.9	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	15.2	13.8	0.0	0.0	0.0	31.3	0.0	69.1	9.9	0.0	72.4	51.0	0.0	11.8	13.4	6.3	0.0	0.0	0.0	35.4	65.6	8.0	0.0	25.6	0.0	17.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	32.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	2.2	0.0	0.0	47.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	46.7	4.3	17.8	0.0	0.0
CYRIA	"CYRI-A, DKFZP566A1524, FAM49A, FLJ11080"	ENSG00000197872	"CYFIP related Rac1 interactor A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 46.4;Extravillous trophoblasts: 102.6;Hofbauer cells: 37.1;Macrophages: 24.0;Syncytiotrophoblasts: 150.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.1;HUVEC TERT2: 43.1;RH-30: 95.6;SK-BR-3: 28.2;TIME: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB017847: , HPA060398: AB_2684275"	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.46e-4)"	13.9	11.0	29.8	21.1	34.2	23.2	8.8	4.6	37.9	15.8	2.5	7.9	3.4	10.1	2.2	5.1	9.1	10.9	4.1	37.2	18.3	1.9	7.6	13.0	19.2	9.9	20.6	11.9	2.8	1.1	6.4	20.0	13.2	8.2	6.3	6.4	4.1	8.6	8.4	3.6	6.5	10.7	14.5	27.8	4.2	1.9	24.1	5.0	40.9	7.3	18.1	10.3	9.4	19.6	0.5	0.0	6.1	0.3	6.2	1.8	18.0	0.0	0.1	0.0	0.0	0.1	0.0	2.9	1.0	0.0	4.2	3.7	1.5	2.4	0.0	6.8	0.2	3.8	0.1	0.0	3.3	0.1	53.1	3.1	2.3	0.5	0.0	4.9	43.1	0.1	0.4	4.8	3.8	0.4	0.1	12.9	2.7	0.3	0.0	2.1	95.6	0.4	5.1	24.4	1.0	3.6	0.0	28.2	0.0	7.4	1.1	1.7	34.1	0.4	5.4	0.0	0.2	2.8	0.1	3.4	13.9	2.8	2.0	0.2	100.1	140.5	21.6	129.7	2.5	37.2	1.0	11.3	66.4	32.3	0.8	8.1	195.4	58.1	159.2	33.0	0.4	43.2	29.8	34.2	4.6	37.9	37.2	18.3	9.9	20.6	13.2	14.5	24.1	19.6	12.2	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	46.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	102.6	4.7	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	150.0	0.7	0.0	0.0	0.0
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271468-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 68.4;B-cells: 64.1;dendritic cells: 44.7;granulocytes: 78.6;Plasma cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 85.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 19.8;Karpas-707: 12.4;NB-4: 27.1;RPMI-8226: 41.9;THP-1: 25.2;U-937: 28.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010546	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA010546: AB_1078268"	"unprognostic (9.48e-2)"	"unprognostic (6.01e-5)"	"unprognostic (4.72e-3)"	"unprognostic (3.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.41e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.94e-2)"	4.7	1.7	0.6	7.6	0.6	3.5	2.3	0.7	0.8	2.6	0.8	3.6	2.4	1.7	0.7	7.3	1.7	5.6	1.7	0.6	0.8	1.0	1.6	7.3	9.5	1.0	0.7	0.4	0.6	1.4	0.3	3.5	1.0	2.3	4.9	0.3	1.9	1.0	0.5	3.3	3.9	4.5	1.0	10.6	2.9	0.2	0.7	4.1	2.0	1.8	11.6	6.9	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	19.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	27.1	0.1	0.0	0.0	5.7	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	28.1	0.0	19.5	15.1	85.8	0.0	26.5	0.1	19.1	5.5	0.2	11.7	15.2	8.3	0.1	45.2	10.6	31.2	18.0	1.4	6.9	0.6	0.6	0.7	0.8	0.6	0.8	1.0	0.7	1.0	1.0	0.7	0.9	20.4	67.3	68.4	0.7	64.1	3.7	3.7	0.6	5.2	3.7	1.6	0.9	1.4	0.0	36.7	0.0	6.2	0.3	44.7	1.1	0.0	0.2	0.0	0.3	0.3	21.5	0.0	3.8	0.5	0.2	0.3	7.6	0.0	0.3	78.6	1.3	5.7	0.3	29.8	0.0	0.3	0.3	2.0	39.3	14.7	0.0	0.6	37.5	7.2	16.9	21.4	0.5	23.7	0.0	0.0	0.2	0.0	0.0	44.9	1.4	1.7	0.5	35.9	0.7	0.0	0.7	3.2	0.1	0.3	1.4	3.7	0.8	20.6	0.2	0.5	3.4
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 25.8;seminal vesicle: 17.5"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 9.3;Macrophages: 13.1;Melanocytes: 5.4;monocytes: 4.8;NK-cells: 5.2;Sertoli cells: 13.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"eosinophil: 100.6"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 100.6"	"Cell line enriched"	"Detected in some"	47	"HDLM-2: 89.9"									HPA046528	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.4	7.2	3.1	3.0	3.0	1.1	1.1	2.6	4.0	0.8	2.3	1.2	2.4	1.5	1.3	0.8	3.8	1.8	10.0	3.1	3.9	1.9	1.3	1.8	4.7	3.7	3.2	1.8	0.5	0.6	1.3	25.8	3.7	0.8	1.2	1.0	0.3	17.5	0.4	1.3	2.9	0.8	2.4	8.3	1.3	0.9	3.4	1.8	1.3	0.0	1.8	0.9	0.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.8	2.5	100.6	0.6	8.0	0.0	0.0	1.1	0.2	2.5	0.0	1.1	0.4	0.3	1.1	5.8	0.0	0.9	1.0	3.1	3.0	2.6	4.0	3.1	3.9	3.7	3.2	3.7	2.4	3.4	2.9	0.3	0.0	1.1	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	3.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.0	0.1	2.0	0.0	0.8	0.0	0.0	1.5	3.8	0.0	0.1	1.3	0.3	9.3	0.0	0.6	0.0	0.0	0.0	0.0	4.7	0.8	0.4	0.3	13.1	5.4	0.0	4.8	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	13.1	0.0	3.7	0.0	0.2	0.0	0.0	2.9	2.9	0.1	0.0	0.0
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"	A8MQ03	9	137224635-137226315	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 239.5"	"Group enriched"	"Detected in some"	10	"Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.6	1.1	0.6	0.2	0.4	0.4	1.5	0.3	1.6	43.1	0.0	0.6	0.4	0.5	0.4	239.5	1.8	0.7	0.9	0.8	0.8	3.7	1.7	1.1	0.7	1.4	1.3	0.3	1.5	0.6	7.3	0.3	0.6	2.6	0.1	0.6	29.9	0.5	0.4	34.4	0.8	0.0	1.0	0.7	2.0	4.1	0.9	0.3	2.4	0.0	14.3	1.2	57.7	0.5	25.1	2.4	1.8	3.9	0.0	0.1	5.3	0.4	0.4	0.5	0.2	1.3	28.9	1.3	1.2	0.3	0.7	33.3	0.5	7.0	0.0	2.7	1.8	0.3	30.6	16.8	0.9	0.2	1.4	0.4	3.5	0.9	0.2	1.3	0.3	1.4	0.6	3.1	1.6	49.5	0.7	1.0	0.7	4.8	3.0	2.4	2.8	3.5	0.6	1.6	0.4	1.8	4.5	3.5	0.9	1.5	7.7	0.4	1.0	1.1	0.9	3.2	0.6	1.9	1.7	1.2	1.4	1.3	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.6	0.4	0.3	1.6	0.8	0.8	1.4	1.3	0.6	1.0	0.9	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.5	0.4	1.5	2.5	5.5	0.0	0.6	0.1	0.4	0.0	4.6	0.5	2.1	0.2	0.3	0.0	0.0	0.3	5.8	0.2	0.1	3.1	1.7	0.0	0.6	0.7	0.8	0.2	0.0	0.3	0.6	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	58.0	1.1	0.4	0.1	0.2	1.6	0.9	0.0	0.6	0.0	0.3	0.3	3.0	1.1	66.0	0.0	0.0	0.1	0.9	0.5	1.7
CYSTM1	"C5orf32, ORF1-FL49"	ENSG00000120306	"Cysteine rich transmembrane module containing 1"	Q9H1C7	5	140175156-140282052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 1317.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2568.9;Gastric mucus-secreting cells: 2148.3;Late spermatids: 1327.7;Pancreatic endocrine cells: 1331.5;Proximal tubular cells: 1301.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 425.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 425.2"	"Cell line enhanced"	"Detected in all"		"OE19: 773.7;RPTEC TERT1: 364.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050930	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA050930: AB_2681278"	"unprognostic (7.39e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (7.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.14e-2)"	86.3	187.3	111.3	53.7	112.6	161.2	61.1	114.2	131.5	48.5	148.6	184.3	320.5	36.6	53.9	28.3	139.6	150.8	114.6	110.2	121.1	264.8	74.4	96.6	23.4	117.9	117.4	29.1	141.3	128.6	53.9	64.6	119.3	31.3	166.2	35.2	81.7	41.7	293.5	23.8	168.0	60.0	112.7	33.4	1317.5	35.7	116.4	31.7	87.2	360.0	20.9	158.1	21.9	112.5	68.5	118.8	10.1	65.8	152.5	118.2	51.0	26.7	77.1	34.5	67.8	142.0	115.1	28.4	92.2	44.8	180.1	42.8	55.7	70.8	27.5	54.3	74.6	2.7	50.4	92.3	119.1	9.1	63.5	31.4	92.2	42.2	77.0	62.7	67.5	91.1	48.7	68.4	8.2	66.2	31.4	16.6	16.4	773.7	44.5	7.0	12.4	51.4	364.9	284.0	25.4	16.6	45.8	28.8	280.6	33.3	96.9	27.0	16.0	17.0	17.1	12.8	31.8	62.5	48.6	26.4	87.9	8.9	32.8	15.6	32.4	22.4	4.3	37.3	8.1	18.2	11.5	7.2	41.3	14.4	3.1	4.8	425.2	4.5	39.1	64.0	17.2	16.4	111.3	112.6	114.2	131.5	110.2	121.1	117.9	117.4	119.3	112.7	116.4	112.5	259.9	317.3	115.2	34.6	52.8	169.5	525.6	252.8	51.2	5.6	85.5	77.8	107.2	424.7	186.1	573.8	2.1	422.8	42.8	1024.7	2568.9	674.9	444.3	469.0	60.8	147.8	435.8	47.4	10.6	846.6	53.6	174.0	2148.3	218.9	119.2	9.4	120.0	88.5	205.2	11.8	12.5	285.8	205.4	45.3	150.0	1327.7	101.5	77.1	394.8	13.1	105.5	153.3	3.1	4.5	11.1	1331.5	1148.5	116.6	37.4	365.1	727.1	1301.6	576.5	18.8	144.7	115.6	190.6	208.6	81.4	28.4	113.7	393.1	53.9	30.2	429.3	736.7
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469208-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: AB_2732652"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.21e-4)"	8.1	12.1	17.2	11.4	17.8	8.1	14.2	20.3	19.0	15.9	15.4	9.3	21.5	10.7	13.6	15.3	7.6	23.2	7.4	16.2	17.1	21.0	7.2	11.2	8.2	18.1	19.1	7.5	16.6	19.6	14.8	16.3	17.4	15.0	8.3	39.0	22.6	9.1	3.6	15.1	21.3	8.2	15.3	10.6	17.5	35.6	21.2	14.9	52.5	5.7	8.8	10.9	10.6	21.2	24.7	36.8	107.9	24.7	16.2	13.9	19.6	18.9	17.3	19.9	18.7	20.1	32.9	16.1	19.2	16.6	16.5	30.4	21.1	23.1	12.5	24.6	28.1	22.5	52.6	22.0	14.6	14.0	29.7	18.0	38.5	24.6	15.9	90.2	26.0	23.4	22.9	55.0	26.6	20.0	23.9	102.5	11.8	22.1	14.9	29.6	15.9	11.2	34.2	52.1	31.9	30.9	20.7	57.6	16.8	34.0	27.1	18.8	28.3	42.6	21.3	10.3	27.8	54.1	30.8	10.8	15.5	27.1	30.7	2.8	2.7	2.3	2.6	2.1	1.8	2.6	3.2	3.7	2.4	1.8	2.8	2.0	7.2	1.4	2.7	3.9	3.6	2.1	17.2	17.8	20.3	19.0	16.2	17.1	18.1	19.1	17.4	15.3	21.2	21.2	48.5	28.9	33.5	15.0	18.7	45.9	115.0	81.1	26.7	35.6	47.6	28.7	11.5	55.8	63.2	40.5	25.0	51.2	42.6	35.0	35.2	82.7	285.9	85.3	26.5	56.0	26.0	4.6	5.7	93.6	47.0	33.5	55.0	56.3	17.7	32.5	50.3	8.3	43.7	21.9	6.8	29.3	67.1	27.9	39.7	163.0	37.3	34.9	35.6	9.4	52.0	42.6	22.6	4.5	12.0	136.6	36.2	36.9	23.2	77.1	57.9	53.3	80.6	59.5	52.6	42.9	70.9	63.5	53.2	23.2	47.5	142.7	33.2	26.0	25.4	139.2
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1"	"Cancer enriched"	"Detected in all"	5	"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	28.8	9.5	16.9	5.4	17.7	7.7	26.5	16.3	20.9	16.4	11.8	18.3	16.5	17.5	6.6	14.0	15.6	11.8	28.5	18.5	15.3	14.2	4.1	19.7	5.4	14.4	15.5	13.9	7.5	11.5	9.8	31.7	15.4	10.2	6.9	5.7	11.9	8.6	15.2	21.6	16.7	12.1	14.2	10.9	13.9	18.6	16.6	5.8	27.7	19.7	4.7	13.8	15.9	17.5	64.7	16.1	15.0	10.4	68.4	80.0	21.2	37.4	32.3	36.1	34.2	25.0	31.3	8.7	22.1	75.5	46.4	59.5	10.4	27.1	23.8	0.6	14.8	2.4	19.8	3.2	32.4	2.7	4.0	57.0	12.1	19.3	27.6	16.2	6.4	12.6	10.3	1.4	26.7	10.6	2.2	11.5	10.4	8.6	21.5	11.5	40.0	5.0	28.0	7.7	9.6	18.4	23.2	79.7	67.0	12.7	4.8	18.1	23.3	24.6	64.4	26.9	23.2	2.9	1.1	9.1	7.9	6.9	102.8	0.3	0.2	0.0	0.9	0.0	2.5	0.1	0.4	1.0	0.1	0.2	0.0	0.6	0.1	1.5	0.2	0.8	0.3	0.2	16.9	17.7	16.3	20.9	18.5	15.3	14.4	15.5	15.4	14.2	16.6	17.5	40.1	16.0	5.8	14.7	3.1	15.2	2.1	1.8	4.0	6.5	9.2	7.5	17.4	2.8	3.2	3.7	8.4	15.4	8.7	9.7	5.9	4.1	14.1	9.4	10.2	14.6	3.0	2.1	66.5	2.8	9.1	24.0	8.2	15.9	12.7	15.8	18.5	1.4	11.9	15.2	96.5	5.5	4.1	4.1	10.9	16.7	16.4	5.9	32.0	57.1	1.9	10.8	3.1	23.1	10.8	10.0	5.4	13.2	4.4	3.9	14.6	1.4	3.7	2.0	39.5	6.1	39.2	24.3	11.2	7.0	11.4	15.2	10.2	10.9	7.1	2.1
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315341	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.3;lymphoid tissue: 67.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	21.5	8.8	4.9	67.3	4.5	58.3	5.1	4.4	8.5	5.3	6.0	10.7	8.5	4.4	1.6	6.1	4.8	16.4	5.6	4.7	5.6	4.1	5.7	18.9	57.0	8.8	7.4	3.4	2.5	2.1	2.9	28.0	7.8	3.6	10.0	0.3	7.3	4.3	2.2	2.2	15.2	12.9	6.7	59.2	11.5	2.7	9.7	25.6	3.0	5.1	40.3	23.2	2.5	9.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	9.3	0.3	0.0	2.5	0.1	0.0	0.6	0.0	5.3	0.0	9.8	0.0	0.0	0.0	34.1	141.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	23.2	0.0	0.0	0.5	13.5	0.0	0.1	1.0	1.3	0.2	19.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	95.2	0.3	0.0	0.1	0.1	0.0	28.4	4.0	4.5	18.5	11.5	0.2	15.8	62.6	87.5	55.4	102.5	39.0	30.3	30.5	44.8	47.5	31.8	30.0	38.3	199.1	45.0	129.4	113.8	30.7	76.2	4.9	4.5	4.4	8.5	4.7	5.6	8.8	7.4	7.8	6.7	9.7	9.1	1.1	3.2	8.4	0.0	37.0	2.4	0.8	0.0	0.6	0.1	0.7	1.5	2.0	0.0	1.8	0.0	0.0	0.5	117.5	0.1	0.0	0.0	0.4	0.1	0.2	2.5	0.0	2.5	0.2	0.2	0.6	1.9	2.0	0.1	57.0	0.0	2.2	1.1	76.8	0.0	0.2	0.2	0.0	71.5	87.5	0.9	0.6	55.0	7.2	24.4	42.7	0.0	120.5	0.5	0.0	0.8	0.0	0.0	25.1	0.3	0.0	0.8	0.0	0.1	0.0	0.9	1.0	0.0	0.2	0.3	2.3	1.0	43.9	0.0	0.2	0.5
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.2	2.7	1.4	70.0	1.7	105.6	7.7	1.5	3.7	5.7	4.0	12.8	27.3	3.2	2.1	6.9	3.4	11.8	4.1	1.4	1.9	5.2	12.3	26.1	91.5	3.1	1.8	1.5	3.4	0.9	1.4	4.4	2.6	3.3	14.6	0.5	14.3	3.9	1.1	2.8	23.1	7.0	2.5	42.2	41.6	2.5	2.3	53.6	4.0	2.2	114.3	20.8	3.7	3.2	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	54.6	0.1	0.6	0.0	0.1	0.0	0.0	0.1	44.3	0.0	0.3	0.0	0.0	0.0	7.8	6.4	0.0	0.0	0.2	0.0	4.0	0.0	0.2	0.0	146.4	0.7	0.0	0.0	6.3	0.3	0.8	0.1	0.0	0.1	46.9	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	2.0	0.2	246.5	99.8	24.1	2.4	6.8	0.0	248.9	37.6	109.9	121.8	122.5	122.5	91.5	127.9	115.7	56.1	91.6	205.5	161.0	203.6	90.2	247.9	28.1	136.5	154.8	1.4	1.7	1.5	3.7	1.4	1.9	3.1	1.8	2.6	2.5	2.3	3.2	3.2	3.2	12.2	0.0	240.4	20.9	1.0	0.0	0.6	0.0	24.4	2.5	2.1	5.7	1.3	1.8	0.0	0.7	244.3	0.6	15.6	0.3	1.4	0.3	0.4	4.5	1.8	14.9	0.1	1.9	13.6	6.4	29.0	0.8	7.0	0.0	6.8	1.7	25.2	0.0	0.1	3.7	0.0	86.1	552.9	2.0	0.0	164.0	83.6	12.2	490.1	0.0	181.3	0.0	0.0	0.3	0.3	0.0	392.5	0.7	0.4	1.1	0.0	0.1	0.0	1.5	4.5	0.0	0.6	1.2	17.8	3.0	366.6	0.0	3.8	0.5
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	38	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in some"		"AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	36.4	46.4	9.7	8.1	9.0	7.8	30.2	8.7	11.4	16.4	8.4	8.4	6.1	19.2	8.1	9.0	12.9	16.1	22.3	8.1	9.4	12.7	4.8	23.7	6.0	9.9	10.5	4.5	5.5	15.5	3.8	36.3	10.6	9.5	6.6	0.9	6.8	11.4	15.1	8.2	9.6	23.6	9.6	32.5	7.7	1.9	10.8	6.0	14.1	31.8	4.6	12.6	9.5	9.4	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.4	0.0	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.1	39.2	0.0	11.0	0.0	16.6	0.0	1.7	0.0	33.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	31.4	0.0	0.1	9.7	9.0	8.7	11.4	8.1	9.4	9.9	10.5	10.6	9.6	10.8	9.4	200.0	0.0	0.6	1.6	1.5	11.7	2.0	10.2	27.3	0.1	14.9	15.0	6.7	0.0	1.7	14.7	0.0	0.1	14.9	0.0	3.9	0.0	0.7	0.4	6.9	150.0	0.0	11.1	1.6	0.0	0.2	8.3	0.0	0.4	0.0	3.7	79.9	0.4	0.3	0.0	4.6	0.0	2.0	3.2	8.0	1.5	2.1	1.4	7.2	58.1	0.7	0.5	0.0	0.0	0.7	0.1	0.0	0.0	2.5	1.1	0.0	6.8	1.1	0.3	0.0	13.3	4.4	0.2	1.3	4.9	5.4	0.3	1.5	0.4	0.0	0.7
CZIB	"C1orf123, FLJ20580"	ENSG00000162384	"CXXC motif containing zinc binding protein"	Q9NWV4	1	53214099-53220634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	55.8	35.5	56.1	22.3	58.0	21.9	49.4	57.2	74.6	53.6	56.9	66.5	22.5	57.1	39.8	32.3	52.3	30.2	52.5	57.7	56.6	39.4	43.5	33.1	30.0	57.9	56.6	47.2	25.1	34.6	28.5	30.6	57.0	41.0	34.8	21.6	24.8	45.4	76.5	26.2	31.6	59.2	57.1	32.5	40.3	31.0	57.4	36.3	35.1	65.3	29.7	57.7	37.6	59.0	32.6	34.7	44.7	41.0	101.6	129.1	39.4	47.8	50.4	47.3	50.8	29.6	27.5	50.1	39.0	58.1	45.8	12.6	27.9	46.9	57.0	65.0	47.5	51.0	24.9	45.0	100.0	59.5	32.1	84.6	50.3	50.6	53.3	71.5	78.5	61.0	53.7	13.7	60.1	54.6	73.5	55.6	74.8	39.7	54.3	52.8	56.8	39.7	55.8	32.6	37.6	36.1	45.1	40.9	47.7	72.2	29.2	59.8	49.3	54.5	31.9	38.2	47.2	19.5	30.7	57.3	43.9	58.5	42.8	60.7	56.6	58.6	50.9	72.3	46.9	46.9	49.8	53.6	68.8	45.1	55.0	54.9	22.8	59.0	60.3	46.3	68.2	51.1	56.1	58.0	57.2	74.6	57.7	56.6	57.9	56.6	57.0	57.1	57.4	59.0	29.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	60.7	8.2	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	76.7	22.2	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	46.7	1.3	0.0	0.0	0.0
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734602-241768816	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;T-cells: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA056216: AB_2683070, HPA060548: AB_2732650"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	11.5	17.7	6.9	11.2	8.0	18.6	7.6	6.2	7.3	10.5	14.9	16.6	11.4	11.8	13.0	15.0	16.1	14.1	11.4	6.6	6.1	15.9	19.1	10.6	12.0	8.4	6.9	14.8	16.6	15.2	10.5	8.9	6.6	14.6	14.6	3.2	18.7	14.9	33.8	39.4	14.9	9.3	6.1	15.1	14.7	4.9	7.3	7.4	18.0	23.7	11.5	8.9	9.6	8.6	10.2	10.5	6.2	9.6	14.7	7.9	21.5	9.7	12.2	9.6	7.7	11.8	21.9	8.3	4.4	9.7	11.0	23.2	5.9	7.8	4.0	8.8	5.7	15.9	11.3	20.5	8.2	19.0	12.1	14.1	13.7	7.6	7.3	18.5	9.5	13.1	20.7	5.3	8.6	16.8	16.0	19.7	3.0	13.8	20.8	19.5	6.9	16.2	17.6	36.7	20.4	7.2	9.4	23.8	6.6	4.1	14.7	6.7	4.1	14.9	5.6	7.9	5.8	9.9	1.9	13.4	10.3	20.8	10.0	0.0	0.2	0.0	0.2	0.2	0.4	2.5	0.1	1.0	0.4	0.1	0.6	0.2	0.0	0.0	0.3	0.1	0.8	0.1	6.9	8.0	6.2	7.3	6.6	6.1	8.4	6.9	6.6	6.1	7.3	8.6	10.4	9.6	14.3	33.3	10.4	19.8	23.5	13.7	25.6	14.3	22.8	22.7	10.6	25.8	16.3	18.4	14.6	44.0	13.0	40.9	23.5	10.5	3.6	12.5	13.2	9.7	31.8	6.9	7.1	8.7	15.9	15.7	23.0	19.2	5.7	28.0	13.2	46.0	18.2	11.8	9.9	56.4	14.2	10.8	7.5	4.8	16.8	12.6	3.6	15.9	5.3	37.4	8.2	28.6	12.8	6.7	32.0	18.0	15.0	19.3	26.4	31.4	13.9	12.0	6.6	14.0	11.7	2.1	7.0	25.7	14.8	22.6	14.0	27.0	49.9	22.2
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		9700	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	14.5	6.2	13.0	6.8	13.6	5.4	10.4	12.6	12.8	13.6	22.8	13.5	4.8	13.5	5.6	19.0	7.7	5.9	19.3	11.8	14.8	6.9	12.6	10.5	11.1	7.9	8.1	8.0	9.3	20.6	5.3	9.1	8.3	11.9	8.5	24.9	9.4	11.0	5.6	30.9	7.2	10.9	7.8	13.1	7.0	6.9	11.2	4.8	7.4	4.7	15.6	9.5	15.1	10.7	18.2	1.9	13.1	3.5	7.8	5.8	17.1	2.5	2.3	4.7	4.8	9.4	16.6	20.4	4.4	5.6	9.6	39.7	11.8	10.0	4.0	9.0	4.1	6.8	4.8	11.8	4.8	7.9	3.8	3.9	10.6	3.9	4.7	10.8	11.3	10.2	11.9	9.9	2.8	17.0	6.9	4.9	7.5	12.9	5.6	6.3	11.1	2.0	6.8	13.5	20.3	4.8	15.8	23.1	16.1	8.7	30.5	2.1	10.8	3.9	7.4	8.4	2.2	2.2	2.7	22.1	5.0	1.5	8.7	7.7	2.0	2.6	2.3	2.4	3.0	10.8	3.0	2.3	2.2	4.6	2.4	2.6	2.8	6.7	3.5	18.3	4.0	1.9	13.0	13.6	12.6	12.8	11.8	14.8	7.9	8.1	8.3	7.8	11.2	10.7	62.2	35.3	27.0	160.6	37.8	467.3	172.4	128.6	30.7	110.7	56.8	40.6	149.3	38.6	82.3	29.5	308.6	33.0	66.9	47.0	23.5	63.8	40.0	68.4	142.9	71.9	87.7	140.0	143.7	93.1	27.6	67.3	21.9	54.6	26.0	155.2	102.4	47.2	32.8	195.2	202.0	56.7	73.2	16.3	55.8	16.6	60.3	36.1	90.7	66.5	25.2	96.5	16.5	74.9	24.3	191.4	45.1	74.1	30.8	104.2	24.7	12.8	102.4	168.7	32.9	84.6	66.3	51.3	46.3	52.8	332.0	34.2	25.1	25.1	38.1	84.2
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 245.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2"	"Group enriched"	"Detected in all"	5	"glioma: 15.0;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	33.7	22.5	179.4	9.0	229.4	1.8	23.3	175.8	159.3	15.7	65.1	18.9	9.8	14.0	10.4	36.6	18.5	7.4	13.5	144.0	170.5	9.3	4.8	12.4	3.6	234.8	195.8	10.0	7.5	4.1	5.1	12.2	205.0	11.0	8.7	1.6	7.6	21.7	38.3	8.5	20.9	18.3	194.3	40.2	18.9	12.3	187.7	2.5	13.1	38.1	2.3	9.9	11.3	245.9	0.1	0.0	5.8	0.1	12.2	0.3	0.2	9.8	13.1	2.2	1.2	0.9	0.0	0.1	0.5	14.7	4.5	0.1	0.0	0.0	0.8	0.0	2.4	0.0	0.0	0.1	8.8	0.0	0.1	54.9	0.0	0.3	0.0	15.6	0.0	30.4	0.0	0.1	55.8	0.2	1.5	0.1	1.6	3.1	0.1	0.0	10.0	8.1	0.0	0.0	2.0	2.3	0.0	0.7	68.7	11.7	0.0	0.1	0.6	20.8	6.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	179.4	229.4	175.8	159.3	144.0	170.5	234.8	195.8	205.0	194.3	187.7	245.9	11.2	9.6	12.2	275.6	0.1	1.8	0.9	0.0	0.0	1.3	1.5	1.5	2.5	1.5	3.8	0.0	0.0	0.5	0.1	0.0	0.0	0.5	3.8	1.2	10.4	9.0	0.0	2.7	1.4	3.3	0.5	11.8	0.5	2.3	0.0	1.9	2.5	1.2	0.2	0.0	5.8	0.0	0.0	31.5	2.4	6.4	23.6	6.2	8.8	21.5	0.0	5.8	1.0	8.5	449.8	0.3	0.0	22.2	0.0	0.8	0.0	0.1	1.5	1.6	151.2	12.7	48.8	1.0	1.9	0.4	1.1	0.3	0.7	55.9	0.0	1.2
DAB1		ENSG00000173406	"DAB adaptor protein 1"	O75553	1	56994778-58546734	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8;intestine: 22.3;seminal vesicle: 10.0"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 460.3;Inhibitory neurons: 1170.3;Oligodendrocyte precursor cells: 814.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 54.0;HeLa: 18.6;NTERA-2: 23.4;RT4: 32.0;WM-115: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	2.0	1.7	4.3	0.4	5.3	0.0	0.3	16.8	8.8	1.6	0.0	0.8	15.8	0.5	0.4	0.6	1.6	0.7	1.8	10.6	5.4	0.3	7.7	0.4	0.2	2.1	3.9	1.2	0.4	0.0	0.2	0.0	2.0	3.9	0.3	5.4	0.9	10.0	0.1	0.1	22.3	0.3	2.3	0.2	1.0	0.4	5.1	0.1	0.3	0.1	0.1	1.2	0.9	1.9	0.0	0.0	10.6	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.1	23.4	0.0	0.0	6.0	0.0	0.2	0.0	32.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	4.3	5.3	16.8	8.8	10.6	5.4	2.1	3.9	2.0	2.3	5.1	1.9	0.7	0.0	0.0	30.0	0.1	0.0	0.1	0.1	0.0	23.7	0.1	0.3	3.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.6	8.2	0.6	0.3	0.0	0.0	460.3	0.0	0.0	0.4	4.6	12.8	0.0	0.0	0.7	5.1	0.1	21.9	1170.3	1.9	6.1	0.3	0.0	4.7	3.4	0.1	0.0	22.5	0.0	1.0	1.0	814.8	26.5	0.0	0.0	2.6	0.0	0.1	101.1	0.2	0.0	0.8	0.0	0.1	0.9	0.2	0.5	0.0	0.0	0.7	0.6	0.0	2.1	0.0
DAB2	DOC-2	ENSG00000153071	"DAB adaptor protein 2"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 179.1;placenta: 226.6"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1756.4;Proximal tubular cells: 1653.7;Syncytiotrophoblasts: 1324.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"plasmacytoid DC: 48.7"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 48.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.1;ASC TERT1: 234.5;fHDF/TERT166: 356.8;TIME: 211.1;U-138 MG: 237.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA		130000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	76.9	113.6	7.3	33.1	8.3	4.1	48.2	13.4	13.1	48.4	26.2	33.2	13.5	32.5	116.8	16.8	21.6	50.1	20.0	7.5	7.7	179.1	27.3	53.3	33.2	14.6	10.0	34.0	22.8	10.1	7.9	226.6	12.6	13.0	54.5	11.6	24.2	19.8	11.4	21.2	25.6	47.8	7.8	58.5	16.6	10.6	20.1	20.9	23.5	16.4	19.0	44.6	20.6	10.8	0.2	8.3	12.9	27.9	220.1	234.5	16.0	145.7	149.5	56.3	92.5	108.1	0.5	0.1	8.8	356.8	54.8	0.3	2.0	5.2	78.9	0.2	4.2	19.9	191.1	35.5	52.4	0.2	24.3	146.5	0.2	91.7	16.5	87.2	172.4	9.9	0.0	5.0	95.2	0.6	2.1	0.3	8.9	4.1	15.8	5.4	32.7	0.0	37.8	3.2	0.1	0.4	17.4	9.3	79.2	20.4	0.6	4.9	211.1	237.9	26.1	27.7	11.9	0.2	0.1	0.3	82.6	18.1	31.5	5.8	2.3	0.5	2.1	4.6	0.1	0.1	0.3	1.4	6.3	0.2	0.2	1.7	3.2	1.7	1.3	48.7	0.4	12.7	7.3	8.3	13.4	13.1	7.5	7.7	14.6	10.0	12.6	7.8	20.1	10.8	100.2	38.5	42.2	0.0	14.5	14.5	1.2	15.3	3.4	1.1	38.3	26.7	55.1	70.1	9.9	95.6	70.9	170.8	83.8	29.6	197.6	75.7	1.4	31.7	161.0	116.9	9.7	10.1	11.0	2.0	20.1	139.5	3.6	36.4	25.3	50.6	187.4	3.7	1756.4	8.4	2.8	7.6	2.0	175.2	77.9	4.5	122.4	287.4	12.4	92.8	10.9	81.5	63.8	27.2	0.3	6.5	10.2	64.3	1.4	7.0	33.8	1653.7	7.5	3.5	6.6	62.4	50.4	0.5	4.8	3.5	13.4	1324.5	13.4	104.8	27.5	1.3
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867204	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 38.8"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.2"	"HPA012672, HPA012938, HPA073222"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA012672: AB_1847466, HPA012938: , HPA073222: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.4	11.1	2.3	1.2	14.0	6.0	4.0	1.6	2.9	9.7	0.3	3.1	5.2	3.8	1.3	0.9	2.8	7.2	2.2	1.0	4.6	8.9	2.0	5.9	0.5	7.0	9.3	0.5	1.9	6.6	3.5	6.9	5.9	7.0	3.3	16.7	2.0	2.3	1.9	1.8	6.7	2.0	2.6	5.4	1.9	6.3	4.3	3.5	0.2	1.2	0.4	2.0	2.7	2.4	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	22.5	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.4	37.9	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.9	16.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.9	29.5	0.0	0.0	0.0	0.1	0.9	26.9	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.2	4.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	4.2	0.0	6.4	0.0	0.1	2.3	14.0	1.6	2.9	1.0	4.6	7.0	9.3	5.9	2.6	4.3	2.4	36.4	0.0	0.6	15.7	0.5	1.7	3.6	0.0	0.0	15.4	19.4	9.3	2.1	1.5	0.0	7.3	4.2	0.0	12.5	0.9	5.9	1.0	88.5	5.0	4.7	34.2	34.1	2.5	77.0	0.0	0.0	4.6	1.1	3.2	5.1	0.3	2.9	0.0	0.2	87.5	28.2	21.4	0.0	1.2	1.2	103.7	3.4	2.5	0.0	143.4	1.1	143.8	0.0	6.6	3.9	0.6	0.3	1.9	0.0	5.8	3.5	6.9	0.7	6.9	13.1	1.5	4.3	58.8	10.2	0.2	1.3	0.0	1.0	1.3	12.6	2.7
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
DACT1	"DAPPER, DAPPER1, FRODO, HDPR1, THYEX3"	ENSG00000165617	"Dishevelled binding antagonist of beta catenin 1"	Q9NYF0	14	58633967-58648321	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003016, HPA074619"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA003016: AB_1078623, HPA074619: "	"unprognostic (2.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	8.6	7.9	5.2	4.1	4.2	1.5	6.5	17.4	3.3	12.0	0.6	6.3	5.9	7.6	5.8	2.9	5.9	24.9	8.0	3.6	2.5	5.5	2.7	9.3	4.1	1.6	3.2	24.4	2.3	8.0	3.8	12.1	2.0	11.8	6.7	2.0	3.5	13.1	2.4	2.7	3.9	8.9	2.0	7.2	6.9	9.8	2.4	3.6	10.7	4.4	2.3	14.0	6.6	3.4	0.0	0.0	4.0	0.1	4.5	5.0	0.1	2.3	2.9	2.4	2.1	0.3	0.2	0.0	0.1	6.9	4.0	3.6	11.5	0.0	1.3	2.7	2.4	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.3	9.0	0.0	9.0	0.1	0.8	0.0	0.0	1.6	0.0	0.9	0.1	3.8	0.2	0.9	4.9	5.6	0.0	0.0	0.0	0.1	0.0	6.5	0.0	13.5	17.2	0.0	0.4	0.0	31.7	10.8	0.5	8.5	4.4	1.8	0.0	3.4	1.4	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	4.2	17.4	3.3	3.6	2.5	1.6	3.2	2.0	2.0	2.4	3.4	1.1	0.0	0.0	0.3	1.0	0.8	1.2	0.0	1.2	0.4	0.3	1.5	3.9	7.2	0.0	1.8	0.0	0.2	0.2	0.3	0.0	1.7	56.0	0.4	9.3	1.4	0.0	0.0	2.7	2.3	0.8	11.7	2.0	0.3	0.0	2.3	4.2	0.0	1.2	0.0	4.0	1.0	0.0	2.9	2.1	17.9	12.2	0.6	1.8	6.5	0.0	4.5	0.0	1.5	0.8	3.1	0.0	27.8	0.6	0.4	0.0	1.0	0.0	0.5	0.0	2.9	15.7	12.6	8.6	0.3	1.3	0.1	0.5	3.6	0.5	0.4
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;placenta: 12.9"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	2.3	3.3	3.7	0.4	19.4	0.0	0.6	2.9	6.2	1.7	1.4	1.0	0.8	2.7	0.1	1.5	1.7	0.4	5.2	2.7	2.7	3.6	5.8	1.6	0.4	4.1	3.5	0.1	2.9	0.0	0.6	12.9	4.6	7.3	0.3	5.8	6.5	0.4	0.2	5.7	0.6	0.2	2.8	0.0	0.7	1.0	4.1	1.9	0.3	0.0	0.6	1.1	1.2	3.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	19.4	2.9	6.2	2.7	2.7	4.1	3.5	4.6	2.8	4.1	3.0	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647551-46661182	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.5;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	9.1	3.3	42.1	5.9	42.0	1.4	5.4	41.1	54.4	34.7	3.6	53.9	3.9	48.2	14.3	7.4	37.4	7.2	27.5	48.6	33.4	5.9	2.6	14.0	1.1	45.4	40.1	17.0	1.1	1.9	4.1	1.7	39.9	19.7	6.7	5.8	1.7	24.6	2.2	4.1	13.0	31.6	34.7	6.8	18.0	18.7	46.3	0.5	4.8	2.9	0.9	39.0	15.9	58.0	0.2	0.2	5.6	5.3	1.9	1.5	0.5	3.1	5.2	1.0	1.5	0.2	0.3	0.5	2.0	10.5	1.0	0.3	3.6	0.1	1.0	0.3	1.9	1.2	0.8	0.2	2.7	0.1	2.1	4.9	0.1	1.3	0.1	0.6	0.4	0.7	1.8	1.8	0.9	0.4	0.2	1.4	2.2	0.0	0.8	4.6	1.3	0.3	0.2	0.3	2.1	24.6	0.4	0.2	0.4	5.7	0.4	0.5	0.4	2.6	3.2	2.6	0.5	1.6	0.5	0.8	0.5	0.8	1.9	2.6	0.3	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.2	1.6	0.7	0.2	0.3	0.2	0.1	42.1	42.0	41.1	54.4	48.6	33.4	45.4	40.1	39.9	34.7	46.3	58.0	1.9	6.4	5.5	13.7	0.2	2.3	1.5	0.0	0.0	16.5	1.0	2.4	17.8	1.5	0.7	0.0	2.1	5.4	0.5	0.3	0.0	0.0	23.9	0.4	9.3	3.1	1.8	0.0	9.2	0.0	2.6	7.4	0.0	0.8	6.3	0.5	1.8	0.2	1.1	1.7	16.7	0.2	2.0	1.6	9.2	8.6	7.8	1.4	3.6	7.5	1.2	9.2	2.1	15.1	27.2	0.1	1.2	14.7	0.1	1.0	0.2	0.3	0.2	6.3	6.6	2.3	22.9	2.3	2.5	0.4	3.3	9.9	1.0	4.3	0.2	1.0
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564907-22589224	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Endoplasmic reticulum"	"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	204.0	229.3	209.2	159.1	224.4	129.0	224.0	236.2	259.4	229.6	252.2	197.7	165.8	184.3	473.8	187.0	230.5	190.8	202.6	211.4	238.0	296.8	275.7	183.4	169.6	240.2	218.7	174.5	200.2	254.1	201.6	141.8	238.7	145.5	209.9	86.2	286.3	205.5	156.6	137.2	173.8	206.6	237.2	165.3	197.0	150.7	219.2	211.6	272.8	197.5	191.0	200.0	163.4	252.0	373.3	344.7	274.6	375.8	740.2	529.9	238.3	387.0	473.0	340.5	478.1	219.6	520.1	233.7	242.1	453.1	381.4	330.0	291.1	375.7	543.3	319.8	265.1	228.5	180.9	886.0	514.5	321.2	315.8	395.8	498.7	356.0	454.4	383.1	506.2	220.9	176.4	532.1	509.9	459.3	153.6	391.4	169.7	816.1	557.8	211.7	232.4	306.7	503.2	306.1	211.5	263.4	294.9	416.1	445.9	328.7	251.4	323.1	381.1	291.8	232.2	358.2	248.3	391.2	502.6	308.5	263.8	225.5	431.0	532.4	421.9	460.9	528.4	371.9	518.9	527.2	543.8	501.4	401.0	477.1	564.8	497.6	481.5	437.2	332.3	783.9	560.3	941.8	209.2	224.4	236.2	259.4	211.4	238.0	240.2	218.7	238.7	237.2	219.2	252.0	357.9	160.3	161.7	15.0	183.9	198.3	188.3	581.8	149.7	25.1	201.0	274.6	173.8	187.3	315.2	255.6	27.1	260.9	204.6	174.8	215.2	525.4	196.8	270.3	242.9	267.8	135.7	130.2	10.6	415.2	383.1	276.5	145.2	255.6	302.6	150.8	187.7	231.9	350.3	21.9	11.0	242.3	360.1	146.2	224.8	101.5	214.3	166.8	330.8	8.4	217.3	216.8	198.8	18.1	42.5	396.8	160.7	199.0	408.6	172.5	244.8	420.8	393.7	42.6	151.2	141.5	291.0	300.3	128.1	179.6	215.8	289.0	211.7	266.6	183.8	174.4
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DAGLA	"C11orf11, DAGLALPHA, KIAA0659, NSDDR"	ENSG00000134780	"Diacylglycerol lipase alpha"	Q9Y4D2	11	61680391-61747001	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.7;Excitatory neurons: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.5;T-47d: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062497, CAB078793"	Approved	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB078793: , HPA062497: AB_2684784"	"unprognostic (2.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.99e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-2)"	1.7	1.4	3.0	1.3	4.2	0.3	2.6	0.3	12.5	1.9	0.0	3.8	2.2	2.4	1.7	3.8	2.2	1.3	2.7	9.1	2.0	1.5	0.3	1.9	0.5	0.0	2.6	0.6	5.3	0.8	3.0	0.7	0.0	2.4	1.7	0.6	3.9	1.8	3.3	0.6	2.4	1.3	0.0	1.7	1.8	2.0	5.5	0.1	1.2	1.1	0.2	0.7	0.9	4.2	5.6	6.4	4.9	1.0	1.1	1.7	0.7	2.6	0.7	2.9	3.1	3.7	11.5	0.0	2.6	2.4	4.5	3.3	0.8	0.0	1.2	0.0	3.3	0.0	5.0	5.8	1.8	0.0	0.8	0.9	0.3	3.7	0.0	1.7	0.7	0.4	0.0	0.0	1.3	2.3	0.1	0.0	9.4	1.9	6.2	0.0	0.7	0.0	0.9	1.3	10.0	5.5	1.4	2.0	1.2	1.2	12.5	2.5	3.5	1.6	8.5	5.2	3.2	0.0	0.0	0.0	5.2	1.5	2.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	4.2	0.3	12.5	9.1	2.0	0.0	2.6	0.0	0.0	5.5	4.2	2.9	3.2	0.5	12.7	0.1	0.4	0.3	1.3	1.8	1.6	3.2	2.2	1.0	1.5	2.8	3.7	0.0	0.1	0.0	4.0	0.0	1.8	0.1	0.7	3.9	1.2	4.2	0.0	14.8	2.3	0.1	1.2	3.1	0.5	0.0	0.5	1.8	0.1	2.5	0.0	8.3	6.1	4.1	4.4	4.7	0.4	1.8	2.9	0.0	3.7	0.9	1.9	0.0	3.5	1.1	2.2	1.5	4.1	0.0	0.5	3.6	0.4	1.7	0.6	0.0	3.1	0.8	1.8	3.0	2.5	0.3	0.0	0.2	0.7	4.9	0.2
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 158.9;Late spermatids: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	11.8	18.5	11.2	6.0	10.9	5.4	14.2	10.6	12.4	14.1	14.5	10.1	7.8	9.8	13.1	18.3	36.9	10.5	10.0	10.8	10.8	21.4	9.0	9.9	9.1	11.5	12.6	15.2	38.7	13.9	14.4	9.6	10.9	10.2	7.9	6.5	11.6	9.5	11.0	18.8	9.6	6.9	12.0	10.8	14.7	51.0	11.2	9.4	19.2	6.9	12.3	10.7	11.5	10.8	12.0	16.6	10.2	20.0	28.5	37.8	12.4	9.9	27.5	16.5	15.8	11.7	14.9	4.9	13.7	27.3	14.3	7.8	13.4	26.1	11.5	7.0	9.1	5.3	13.9	22.0	18.7	15.0	10.5	25.7	26.6	20.9	46.1	42.0	26.0	11.2	4.3	12.0	16.4	20.8	6.6	10.1	16.8	25.3	15.5	3.5	1.5	35.7	44.4	19.0	6.5	21.1	10.9	30.1	23.7	16.8	21.3	16.2	15.9	6.4	9.7	22.6	9.2	37.8	21.9	3.0	24.2	8.3	12.9	12.0	11.1	5.5	13.9	13.7	25.0	23.9	22.4	17.1	11.7	21.1	18.7	12.5	10.9	22.6	12.8	8.1	29.5	12.8	11.2	10.9	10.6	12.4	10.8	10.8	11.5	12.6	10.9	12.0	11.2	10.8	26.8	16.0	12.2	8.5	27.3	25.6	21.6	28.5	22.8	30.2	35.5	40.5	1.2	27.1	20.8	27.6	18.8	28.2	30.0	25.0	37.2	40.7	158.9	61.2	21.5	16.3	19.1	11.1	10.7	39.4	40.0	19.8	28.5	24.6	24.7	32.4	15.0	5.9	19.2	40.4	9.5	22.3	20.3	12.9	24.5	306.6	24.2	16.8	21.4	2.8	23.5	25.8	13.4	6.6	5.5	21.5	21.3	18.4	18.2	10.0	50.4	49.9	75.3	58.4	46.0	19.1	19.0	110.7	33.4	26.5	34.1	18.3	27.1	29.7	30.0	17.3
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974760	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 8.5"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 17.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 19.8"	"Not detected"	"Not detected"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.1	0.9	0.4	0.1	0.4	0.7	0.3	0.9	0.4	0.1	1.6	2.0	0.2	0.1	0.2	0.1	0.1	0.3	8.5	0.4	0.3	0.1	0.0	0.1	0.1	0.5	0.2	0.1	0.2	0.8	0.1	0.0	0.7	0.1	0.3	0.7	0.4	0.0	0.1	0.3	0.3	0.3	0.2	0.0	0.3	0.3	0.5	0.1	0.2	0.2	0.0	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.8	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.7	0.4	1.2	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.0	1.0	19.8	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.4	1.5	0.4	0.1	0.4	0.0	0.1	0.4	0.4	0.9	0.4	0.4	0.3	0.5	0.2	0.7	0.2	0.5	0.8	0.5	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.7	1.3	17.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.5	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.3	0.3	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.6	0.0	2.1	0.5	0.1	0.2	0.3	0.3	0.0	0.1	0.1	0.5	0.1
DAO	"DAAO, DAMOX"	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 71.4;kidney: 90.3;liver: 149.9"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 46.1;Proximal tubular cells: 86.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Group enriched"	"Detected in some"	10	"cerebellum: 66.4;pons and medulla: 20.2"	"Low region specificity"	"Detected in all"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.1	0.0	0.9	0.0	6.9	0.0	0.0	71.4	1.6	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	90.3	149.9	0.2	0.0	41.9	14.8	0.0	0.2	0.0	0.0	0.0	29.5	0.0	2.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	44.0	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.9	71.4	1.6	0.8	3.3	41.9	14.8	29.5	44.0	4.3	59.1	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.7	0.0	4.6	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	46.1	0.2	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	86.8	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.2	0.0
DAOA	G72	ENSG00000182346	"D-amino acid oxidase activator"	P59103	13	105465867-105491034	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Schizophrenia	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053114	Uncertain					NA	NA									"HPA053114: AB_2682048"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAP		ENSG00000112977	"Death associated protein"	P51397	5	10679230-10761234	"Predicted intracellular proteins"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA029456	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Vesicles, Mitochondria"	Nucleoplasm	"HPA029456: AB_10601262"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (2.04e-2)"	54.5	103.7	34.8	47.0	33.6	44.5	69.0	30.6	38.8	75.1	91.0	65.8	93.8	59.0	68.6	39.0	63.1	83.3	60.9	35.4	32.9	99.0	161.8	64.9	45.6	39.9	37.1	75.0	241.4	82.9	80.9	64.1	33.1	76.7	69.1	13.8	129.4	92.2	9.4	46.9	87.0	63.6	34.7	46.3	106.3	27.3	36.6	41.2	92.9	14.7	50.8	87.9	49.0	32.5	107.3	76.3	92.6	86.3	169.6	203.6	102.8	255.3	394.4	189.5	217.8	54.7	88.9	46.3	163.8	318.4	119.6	20.6	58.3	151.7	205.1	245.3	42.5	62.2	137.9	136.0	159.7	117.7	44.6	105.4	51.9	124.5	223.3	109.1	358.4	51.1	73.5	152.5	188.2	85.0	63.1	74.9	33.7	143.9	172.9	86.0	40.9	76.8	250.1	195.2	62.7	84.3	261.2	105.2	69.6	70.6	83.4	170.4	177.4	116.8	125.9	78.1	137.6	85.1	118.6	68.3	115.4	225.3	179.3	40.7	78.0	45.0	32.7	70.7	38.5	39.8	33.6	29.0	76.8	25.9	24.4	24.4	63.4	33.1	72.1	62.3	39.3	62.2	34.8	33.6	30.6	38.8	35.4	32.9	39.9	37.1	33.1	34.7	36.6	32.5	29.0	16.0	44.7	8.5	36.7	19.2	62.6	14.1	19.9	8.9	90.4	39.2	12.3	72.9	27.3	53.3	6.2	66.2	42.3	75.6	133.1	97.3	13.3	45.0	31.7	38.4	44.3	23.4	5.5	193.0	98.5	45.1	61.7	58.1	35.0	68.9	41.0	109.1	52.3	5.0	7.8	115.3	10.2	49.9	34.2	33.4	29.8	56.5	28.4	35.6	44.2	29.8	32.0	22.6	6.2	124.8	69.0	34.3	74.8	78.6	133.5	100.5	15.1	8.1	0.0	18.6	41.8	30.7	7.1	15.7	18.2	101.0	24.1	43.0	70.4	108.8
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	57.0	63.6	32.5	54.7	34.9	66.7	66.2	33.6	38.8	43.3	32.5	55.7	58.7	46.0	52.3	54.5	41.9	38.6	88.1	36.1	37.5	63.1	88.2	44.6	69.3	36.1	35.8	38.1	69.3	49.4	42.4	41.2	38.9	50.7	61.4	71.9	53.3	49.4	129.9	60.1	47.6	53.2	32.1	51.3	59.1	42.3	37.1	80.8	48.9	89.4	78.6	58.4	45.3	41.6	144.9	91.9	73.5	116.7	105.9	133.0	180.0	118.8	124.8	119.4	103.8	170.7	172.4	204.1	235.0	97.3	76.5	143.1	110.3	103.7	129.8	128.6	80.4	124.7	80.5	156.5	144.5	173.3	106.4	112.1	145.8	152.2	199.4	93.3	119.2	185.2	274.5	141.2	125.6	192.0	152.6	200.9	130.1	225.2	146.9	124.2	92.1	218.9	142.5	136.0	84.9	150.4	113.9	331.9	211.6	135.1	206.4	279.8	102.8	100.5	106.1	126.0	202.6	152.9	245.9	235.3	100.2	151.6	132.7	65.4	110.5	61.6	110.1	134.2	179.0	141.5	155.8	133.9	152.0	121.1	192.5	167.5	47.8	136.0	128.0	99.1	173.1	162.1	32.5	34.9	33.6	38.8	36.1	37.5	36.1	35.8	38.9	32.1	37.1	41.6	31.8	44.8	43.6	34.0	59.2	54.9	67.2	94.2	52.9	28.2	54.6	43.8	106.2	51.5	68.3	16.5	20.9	76.2	45.0	33.2	66.5	79.8	19.0	44.9	40.5	38.1	25.7	63.8	52.7	78.6	98.5	41.3	35.7	38.7	62.1	34.9	33.2	57.4	77.8	13.5	57.4	41.9	59.0	59.4	62.9	15.3	32.3	53.0	35.6	30.9	83.7	22.2	55.6	26.7	47.1	73.8	30.8	25.2	52.4	81.7	41.7	78.0	61.2	46.4	13.1	33.7	45.1	48.3	29.3	51.1	63.1	141.6	66.4	73.3	62.5	73.5
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708634	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 139.1;Excitatory neurons: 120.2;Inhibitory neurons: 155.9;Kupffer cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.7;eosinophil: 8.7;intermediate monocyte: 14.0;myeloid DC: 4.8;non-classical monocyte: 15.2;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 6.2;granulocytes: 8.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 97.6;HUVEC TERT2: 56.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	22.9	5.9	12.1	11.8	16.4	5.4	5.9	2.2	20.5	9.6	12.6	27.1	10.1	7.9	18.8	5.5	15.2	28.0	5.2	22.8	7.6	22.0	27.6	37.5	12.5	7.6	7.6	46.0	29.2	6.7	23.4	27.3	13.8	5.2	9.2	11.5	13.7	8.5	1.8	5.0	14.4	9.4	7.8	22.8	19.5	8.1	8.6	41.8	9.8	2.3	6.8	14.5	3.8	7.5	0.0	47.5	22.5	15.8	0.7	0.3	35.4	3.1	4.4	18.3	20.4	6.8	0.3	0.4	4.7	1.0	0.2	43.9	13.9	1.0	7.9	0.4	11.4	23.4	6.6	23.7	19.5	0.0	97.6	1.4	7.5	3.5	1.4	28.5	56.3	6.5	17.8	9.6	15.4	1.5	7.0	0.0	25.4	44.4	0.0	2.0	19.8	0.1	50.6	47.6	10.2	11.3	0.0	4.6	20.1	32.7	0.0	15.2	0.4	0.1	0.3	0.1	0.1	36.9	8.1	0.0	0.2	6.4	3.0	1.7	6.7	8.7	0.0	14.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	2.0	0.1	15.2	6.2	0.0	3.0	12.1	16.4	2.2	20.5	22.8	7.6	7.6	7.6	13.8	7.8	8.6	7.5	8.8	51.3	72.2	139.1	2.7	3.6	0.8	1.2	0.6	19.4	1.3	2.3	2.4	31.5	24.3	22.0	2.1	6.8	9.5	1.1	1.9	33.8	1.8	30.2	7.9	17.3	0.0	12.8	120.2	23.0	19.0	12.3	26.5	58.6	24.1	22.1	68.9	20.8	22.7	18.5	155.9	9.3	0.0	85.7	18.3	3.1	14.9	57.1	12.4	18.7	41.2	14.6	2.1	6.6	4.7	35.8	1.9	13.5	6.2	3.2	9.6	7.0	10.2	2.9	0.0	1.5	3.9	3.4	7.2	1.6	3.1	14.2	2.8	3.4	3.7	14.9
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028569	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"HPA028569: AB_10794319"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	49.9	25.4	15.0	29.0	15.2	18.9	47.2	14.3	27.9	58.3	18.9	92.2	30.9	85.0	8.2	37.0	55.4	36.0	106.2	16.8	13.9	27.6	30.4	72.5	21.2	16.2	15.4	48.4	36.4	19.0	38.5	31.9	18.8	53.3	11.0	9.0	41.3	39.3	113.6	51.2	44.4	36.6	11.9	29.6	61.4	42.6	17.4	15.4	31.0	21.1	11.3	59.5	45.3	17.3	79.2	61.1	37.5	47.6	27.5	30.9	57.8	106.0	84.5	84.7	55.5	113.4	23.3	43.4	50.8	93.8	59.6	61.7	36.9	60.3	30.7	64.0	61.2	17.5	76.7	65.9	87.2	42.7	63.1	70.6	73.6	77.0	44.0	50.8	71.2	29.2	56.3	73.2	52.5	51.0	42.4	31.9	58.5	31.8	48.6	52.5	55.3	40.5	51.0	60.9	59.1	41.1	71.4	84.9	61.1	43.8	61.4	33.1	134.8	108.3	49.3	98.1	134.5	81.1	72.4	50.7	86.3	44.0	59.0	32.5	18.0	32.5	23.0	20.3	16.7	15.9	17.8	21.6	16.2	16.6	13.1	12.9	29.8	24.3	14.3	18.6	23.6	14.6	15.0	15.2	14.3	27.9	16.8	13.9	16.2	15.4	18.8	11.9	17.4	17.3	24.1	25.6	10.5	6.5	17.0	100.7	99.7	84.1	27.9	15.2	23.9	15.6	29.2	24.3	35.0	11.0	2.1	50.5	14.5	69.2	17.6	90.3	40.3	27.9	28.2	38.3	27.4	7.0	9.6	88.2	79.1	27.8	40.8	37.5	20.3	24.8	21.4	7.9	22.9	11.8	7.1	48.2	48.8	13.6	22.8	23.6	22.7	16.6	37.4	8.4	25.7	12.8	30.9	6.0	6.7	117.7	49.9	22.6	13.3	46.1	59.6	14.3	18.8	10.7	32.9	19.9	53.0	34.6	15.7	24.4	71.7	93.2	15.1	26.2	29.7	46.3
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 196.9;esophagus: 242.0;skin 1: 301.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4"									"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies, Microtubules"		"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	1.9	56.0	1.6	0.1	1.8	0.8	28.7	1.6	6.6	47.6	1.2	2.9	0.5	0.6	196.9	242.0	80.5	0.6	0.5	1.3	9.3	3.6	0.2	1.6	0.6	1.5	5.3	1.0	22.8	0.0	24.4	0.1	2.4	9.2	0.7	115.6	30.2	1.1	1.0	301.0	1.0	0.5	1.3	0.3	1.5	1.5	4.3	4.8	34.3	0.0	25.0	8.6	108.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.1	0.2	23.2	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.6	0.0	0.7	1.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.8	0.5	0.1	0.6	0.2	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.5	0.7	0.1	1.2	0.4	0.1	1.6	1.8	1.6	6.6	1.3	9.3	1.5	5.3	2.4	1.3	4.3	1.2	0.6	0.0	0.0	0.0	4.1	106.9	51.8	74.8	212.9	7.2	15.0	19.6	0.1	2.8	29.8	9.2	6.2	6.0	4.9	2.0	3.9	7.6	13.8	5.6	2.2	2.0	3.0	0.0	0.2	6.0	12.8	2.4	0.0	5.4	4.5	148.1	0.7	14.3	14.7	3.3	0.4	2.0	14.2	9.1	9.3	56.1	4.1	5.0	12.4	0.0	5.4	913.0	2.1	1.0	0.1	5.8	7.1	2.2	3.4	11.8	5.9	13.3	4.8	23.8	0.0	1.9	10.9	10.8	4.2	736.5	126.6	4.5	3.1	1.7	2.3	67.4
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816827-99870190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		56000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	1.6	1.0	0.5	22.6	0.9	15.5	3.7	0.4	0.5	6.9	0.6	3.1	2.1	8.4	1.0	29.2	5.2	11.9	0.5	0.5	0.6	0.7	1.5	6.3	34.6	1.0	1.0	0.4	0.4	0.2	0.2	6.8	1.1	2.8	3.2	0.1	8.6	0.8	0.9	13.7	6.3	13.5	0.8	16.6	6.5	0.4	0.7	10.2	0.6	1.3	38.5	14.9	12.9	1.5	22.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	23.8	0.3	0.0	0.1	12.8	0.0	25.3	0.0	61.2	0.0	24.3	0.0	0.0	0.0	9.4	1.0	0.0	11.3	0.0	7.5	0.0	0.0	1.0	1.2	21.7	0.0	0.2	0.1	6.7	0.0	0.0	0.4	0.1	0.1	70.2	4.6	16.3	0.1	0.0	0.0	30.6	0.0	0.2	0.4	10.1	0.0	0.0	0.4	0.0	0.1	8.3	3.2	46.4	0.1	6.5	0.0	25.0	70.2	71.0	2.3	62.6	2.5	90.9	11.4	4.0	75.9	98.7	12.5	4.5	138.1	17.8	57.3	32.4	25.2	65.3	0.5	0.9	0.4	0.5	0.5	0.6	1.0	1.0	1.1	0.8	0.7	1.5	0.3	3.2	3.0	0.0	92.0	61.8	30.2	51.4	16.5	0.1	10.1	5.0	0.8	2.8	43.2	9.2	0.0	2.6	13.3	8.4	0.0	6.2	0.3	37.1	0.8	1.2	1.2	9.4	0.4	3.1	14.1	1.4	14.8	9.0	8.2	0.2	0.7	0.7	25.1	0.0	0.1	1.8	22.4	32.0	188.5	0.9	0.0	86.0	12.4	5.6	235.5	0.0	7.2	0.0	0.1	18.9	17.6	0.0	60.2	24.3	0.2	0.1	88.6	0.2	0.0	0.9	4.2	0.2	0.5	40.4	70.3	3.4	17.2	0.1	2.2	221.2
DARS1	DARS	ENSG00000115866	"Aspartyl-tRNA synthetase 1"	P14868	2	135905881-135986100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 85.1;Cytotrophoblasts: 115.4;Extravillous trophoblasts: 157.9;Hofbauer cells: 94.2;Syncytiotrophoblasts: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	37.5	42.1	30.1	41.2	31.2	34.0	48.7	33.3	52.1	34.7	28.0	38.5	23.5	38.4	22.8	46.0	37.8	25.8	42.3	29.5	35.2	47.3	44.2	27.8	48.3	32.6	31.2	47.2	36.1	38.4	24.6	44.4	35.6	33.6	26.6	87.1	32.5	36.5	82.8	40.2	28.0	39.3	34.0	32.3	33.3	17.8	30.7	63.1	43.4	60.1	55.4	40.0	36.4	35.3	201.6	77.0	73.4	66.3	61.0	78.1	141.6	99.8	92.6	92.2	91.1	163.0	84.0	210.0	159.8	78.4	86.6	111.7	94.9	114.9	170.3	95.6	86.0	134.0	76.8	185.6	83.9	188.3	90.8	84.5	75.6	109.1	99.8	122.9	46.8	106.3	131.6	66.0	66.6	87.3	139.2	117.4	77.8	85.3	66.9	179.3	157.9	139.0	91.8	76.9	40.3	89.6	75.0	63.5	74.8	72.2	66.8	118.2	38.2	86.0	87.4	64.5	92.8	194.9	123.3	250.2	144.1	132.3	51.0	33.7	85.4	51.2	115.2	82.6	174.7	219.9	172.6	151.4	133.7	198.8	175.2	154.2	31.7	171.9	67.4	130.4	168.9	153.3	30.1	31.2	33.3	52.1	29.5	35.2	32.6	31.2	35.6	34.0	30.7	35.3	29.4	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	115.4	20.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	157.9	18.2	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	136.4	4.4	0.0	0.0	0.0
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.6	0.0	4.3	0.1	5.3	0.3	0.4	2.9	4.7	0.7	25.7	0.2	0.0	0.1	0.3	0.5	32.6	0.3	0.5	4.5	4.5	0.2	0.4	3.0	0.2	7.3	8.8	0.1	0.0	0.2	0.2	0.8	5.5	0.0	0.0	0.7	0.1	0.0	3.6	0.2	0.0	0.1	6.8	0.2	0.1	51.3	5.4	0.4	0.1	0.0	0.2	0.1	0.0	5.4	0.8	0.0	0.1	0.0	0.3	1.2	0.6	0.8	0.4	0.9	0.6	5.4	0.5	0.2	0.0	0.2	8.8	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.7	0.0	1.0	0.7	5.8	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.1	0.3	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.2	0.0	0.5	2.2	0.2	2.0	40.7	0.0	0.0	0.1	0.3	3.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.3	2.9	4.7	4.5	4.5	7.3	8.8	5.5	6.8	5.4	5.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.7	0.0	11.5	0.0	4.2	0.2	0.0	0.0	0.0	0.2	106.7	11.2	0.0	0.2	0.0	0.0	6.2	0.0	2.8	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	8.2	0.0	0.0	215.3	3.4	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	3.0	0.2	2.6	0.0	0.1	0.0	0.1	113.9	0.3	0.0	0.7	2.1	177.1	4.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	27.5	33.6	6.4	4.0	6.2	8.1	25.3	5.0	12.0	28.4	2.9	27.9	8.1	27.8	18.9	30.8	28.6	7.2	22.3	6.8	5.8	23.2	25.0	24.0	8.7	6.9	5.9	23.8	23.1	19.3	22.1	7.9	5.5	25.1	10.8	5.2	24.2	9.3	35.4	28.8	30.4	10.6	4.8	44.3	25.0	36.7	6.7	23.5	24.2	12.5	27.3	27.2	25.9	9.0	20.8	0.1	38.0	15.6	16.0	16.0	30.1	27.4	76.7	61.5	43.6	1.6	11.8	58.5	14.8	33.3	65.5	11.8	0.3	46.1	62.5	29.9	39.6	52.0	29.9	39.9	26.5	37.0	17.0	27.0	32.5	25.8	31.0	22.7	15.5	16.2	39.1	21.2	32.1	23.2	29.7	54.1	1.2	0.2	9.1	35.2	5.6	41.8	11.7	1.6	49.7	20.2	0.0	0.9	22.7	14.8	17.5	0.5	22.9	26.3	29.1	0.5	0.3	35.4	58.3	66.4	23.3	23.0	27.7	24.1	22.5	47.3	55.6	28.9	54.9	58.8	48.3	61.3	28.2	56.8	44.5	49.6	22.9	62.9	35.1	27.0	59.0	70.5	6.4	6.2	5.0	12.0	6.8	5.8	6.9	5.9	5.5	4.8	6.7	9.0	18.4	6.4	22.8	5.2	45.3	58.5	23.5	36.2	48.3	19.2	25.8	19.4	7.9	18.6	27.6	12.9	18.8	25.2	41.3	23.3	23.5	38.5	15.7	14.5	54.8	23.9	21.0	27.1	3.7	38.3	35.9	25.2	16.8	23.6	37.9	12.9	16.4	14.5	24.3	15.2	3.8	21.2	12.2	17.2	42.5	7.6	17.7	19.7	24.9	6.5	48.8	29.9	52.5	5.0	4.6	45.4	21.8	23.3	38.7	31.8	20.3	14.4	15.6	111.1	13.1	18.7	19.9	63.8	41.5	45.9	60.9	24.8	42.8	24.1	22.0	35.7
DAZ1	"DAZ, SPGY"	ENSG00000188120	"Deleted in azoospermia 1"	Q9NQZ3	Y	23129355-23199094	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.0"	"Cell type enriched"	"Detected in single"	38	"Gastric mucus-secreting cells: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"U-266/70: 15.3;U-266/84: 24.5"									HPA047113	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZ2	"MGC126442, pDP1678"	ENSG00000205944	"Deleted in azoospermia 2"	Q13117	Y	23219434-23291356	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"stomach 1: 14.3;testis: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SK-MEL-30: 1.8"									HPA047113	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	14.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZ3		ENSG00000187191	"Deleted in azoospermia 3"	Q9NR90	Y	24763069-24813492	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047113	Approved					NA	NA				"Cluster 27: Brain & Skin - Unknown function"					"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZ4		ENSG00000205916	"Deleted in azoospermia 4"	Q86SG3	Y	24833843-24907040	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"stomach 1: 23.7;testis: 11.8"	"Cell type enriched"	"Detected in single"	40	"Gastric mucus-secreting cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	124	"U-266/70: 153.6;U-266/84: 153.1"									HPA047113	Approved					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	23.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	153.6	153.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	44.2	34.7	20.5	55.9	21.4	69.3	37.2	22.8	23.5	31.9	23.1	45.1	45.3	33.5	10.5	64.7	32.1	13.3	55.0	19.7	20.7	40.6	51.2	37.0	49.8	23.6	21.2	32.3	48.0	20.3	22.6	22.2	22.3	33.0	23.6	20.1	32.4	17.1	65.2	42.3	46.9	19.5	18.2	49.3	39.0	77.5	25.2	47.7	32.1	21.4	34.4	42.2	36.7	27.0	275.7	98.0	64.3	117.9	27.8	33.5	183.9	120.7	59.6	95.7	78.2	98.0	132.3	320.8	72.1	58.7	47.4	151.2	84.9	114.5	80.7	225.9	135.2	165.4	95.2	101.3	64.3	203.1	136.1	33.7	73.8	65.4	119.0	41.1	85.0	133.7	251.5	164.1	60.6	111.9	357.5	178.3	198.7	99.6	97.1	254.3	102.4	199.3	72.9	91.7	127.3	114.2	79.9	124.0	149.3	83.1	113.1	266.8	93.7	79.0	107.5	139.7	267.9	192.9	212.2	256.0	95.6	194.4	123.8	1.5	2.3	1.9	2.7	3.4	2.9	3.1	2.4	2.9	2.2	2.1	2.4	2.6	1.0	3.0	2.4	2.7	2.7	1.3	20.5	21.4	22.8	23.5	19.7	20.7	23.6	21.2	22.3	18.2	25.2	27.0	57.1	9.6	27.6	29.7	50.3	69.3	90.9	37.6	34.1	55.7	46.9	33.3	40.0	38.6	28.8	25.8	35.5	43.5	68.7	60.0	23.5	44.4	49.8	26.3	37.0	45.0	33.0	96.6	17.1	55.1	108.6	39.7	46.9	34.0	26.6	58.0	36.0	41.6	47.7	26.9	16.8	71.6	28.5	49.2	54.9	65.7	28.0	50.3	40.9	16.9	36.0	35.1	34.0	18.6	45.2	63.5	49.4	23.7	73.6	110.3	50.4	48.2	23.5	45.4	26.3	50.5	58.9	111.6	41.0	67.0	74.9	69.0	53.0	41.8	81.5	107.9
DAZL	"DAZH, DAZL1, DAZLA, MGC26406, SPGYLA"	ENSG00000092345	"Deleted in azoospermia like"	Q92904	3	16586792-16670306	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"testis: 79.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 64.1;Late spermatids: 41.2;Spermatocytes: 257.9;Spermatogonia: 143.1"	"Cancer enriched"	"Detected in single"	51	"testis cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HAP1: 18.8"									"HPA019777, HPA047113"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA019777: AB_1847495, HPA047113: AB_2679936"	"unprognostic (5.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.80e-1)"			"unprognostic (5.85e-2)"		"unprognostic (2.32e-3)"	"unprognostic (2.60e-2)"	"unprognostic (6.34e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.69e-2)"		"unprognostic (7.79e-2)"	"unprognostic (2.04e-1)"		"unprognostic (3.47e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	79.6	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	41.2	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	257.9	143.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 272.7;brain: 236.6"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Region enriched"	"Detected in many"	8	"pons: 236.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	272.7	0.1	1.0	0.2	0.2	0.1	0.0	0.8	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.2	1.3	36.1	0.8	2.3	9.8	29.4	0.4	4.3	0.0	1.4	1.4	236.6	0.4	0.0	0.1	0.6	0.2	0.1	0.2	0.6	0.0	0.0	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.3	0.2	9.8	29.4	236.6	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2215.1;Proximal tubular cells: 2834.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 2479.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051428	Approved					NA	NA		9100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051428: AB_2681482"	"unprognostic (1.24e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	358.3	153.9	486.0	158.7	470.8	121.9	717.3	495.6	726.7	218.6	452.3	322.8	312.8	73.5	653.7	667.7	85.8	129.7	515.4	493.0	498.5	536.2	971.1	236.0	182.9	499.4	495.1	86.0	143.8	866.9	76.9	116.3	510.0	451.5	297.3	116.3	369.9	215.1	273.0	451.0	229.6	97.2	512.7	115.5	185.1	201.3	487.6	173.3	133.7	460.5	324.5	136.5	327.7	516.4	543.0	276.9	557.1	257.2	1339.7	1131.9	350.7	281.3	708.7	387.0	746.1	580.6	427.8	747.3	312.1	440.6	938.5	277.9	397.0	588.3	345.9	498.2	262.1	641.4	279.9	775.8	335.6	206.1	2479.2	648.2	376.5	596.2	222.1	255.4	464.3	358.8	77.0	679.2	558.8	559.1	436.5	585.9	370.2	349.7	429.7	157.4	541.4	658.5	948.1	816.5	263.2	210.1	235.3	548.5	634.9	388.8	338.0	952.8	332.5	259.3	329.8	288.8	346.3	220.9	170.5	610.0	365.7	364.8	315.3	1180.7	439.9	1077.9	472.9	489.1	347.3	461.4	367.8	465.2	748.8	505.3	279.1	419.2	285.8	450.7	402.5	791.0	615.7	792.2	486.0	470.8	495.6	726.7	493.0	498.5	499.4	495.1	510.0	512.7	487.6	516.4	505.2	150.6	613.0	46.0	256.7	289.2	249.4	724.2	190.1	37.9	806.5	1025.9	1079.6	663.4	390.0	310.8	14.6	796.5	395.6	737.5	1197.4	466.9	844.4	154.8	194.7	206.2	371.3	108.8	5.2	670.3	643.2	258.2	243.1	185.6	433.4	219.4	167.8	2215.1	1069.4	30.3	3.9	495.0	524.9	305.0	785.7	325.7	152.2	476.1	1058.3	15.0	871.5	928.6	552.0	33.2	25.0	372.7	612.0	127.5	192.0	355.0	753.6	2834.8	340.5	59.1	151.2	267.2	289.9	462.0	30.1	972.6	684.9	516.3	260.8	456.0	673.2	361.0
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.1;Pancreatic endocrine cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		2000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	59.4	9.3	44.8	17.6	52.5	6.4	36.5	19.3	71.7	59.7	18.6	67.6	9.5	84.4	10.2	30.9	44.7	24.4	39.7	70.1	45.4	52.0	4.0	24.7	9.0	33.8	25.4	34.8	16.9	17.1	45.8	7.1	32.3	29.7	5.9	5.5	33.1	23.9	27.6	36.6	25.0	28.6	24.0	14.2	47.4	27.0	39.7	14.6	33.4	9.0	4.4	61.0	33.1	35.5	17.4	56.1	182.0	319.1	42.4	66.2	56.5	198.6	50.3	113.4	94.5	193.9	59.0	0.3	139.5	155.1	39.0	27.0	80.9	144.0	53.6	5.2	70.4	111.6	72.9	82.0	149.3	43.0	20.5	87.1	37.1	127.3	38.0	113.3	189.4	131.4	54.0	26.0	84.2	25.1	115.1	63.8	264.1	5.7	123.4	338.1	197.2	34.5	85.3	23.7	213.7	289.8	67.0	28.8	111.5	58.4	78.7	42.6	298.6	126.7	169.3	28.2	94.9	6.3	3.1	177.5	53.2	40.5	80.5	9.4	1.4	1.1	10.3	0.8	14.0	0.3	0.3	7.2	1.8	0.4	0.4	5.2	3.2	0.3	0.8	5.8	0.2	2.2	44.8	52.5	19.3	71.7	70.1	45.4	33.8	25.4	32.3	24.0	39.7	35.5	44.2	3.2	1.5	8.1	1.2	10.3	13.7	24.6	9.1	7.0	7.6	9.1	5.1	2.8	11.1	9.2	4.2	1.0	4.5	1.4	1.9	87.1	16.9	8.4	44.0	43.2	40.7	4.8	15.7	43.4	2.8	56.1	11.7	18.4	10.8	49.4	20.7	0.0	1.7	42.1	13.0	2.4	40.7	1.8	8.9	41.6	50.1	6.1	8.8	2.8	2.4	13.4	1.0	5.0	1.0	64.5	0.6	41.0	4.0	16.9	0.6	6.3	5.2	4.5	19.7	10.8	43.4	6.5	26.7	20.1	7.2	0.8	10.4	8.1	3.9	7.5
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004871-90019890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.0;skeletal muscle: 48.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive B-cell: 12.9"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	1.8	7.4	47.1	2.5	35.3	0.3	4.4	27.5	60.6	4.1	11.6	2.9	1.6	0.9	10.0	28.2	3.6	3.8	4.6	35.2	40.7	13.3	6.5	3.5	4.7	50.6	55.3	3.1	19.5	9.6	7.7	0.1	50.8	3.8	1.4	7.4	15.5	3.1	48.0	6.0	1.7	1.3	30.3	1.2	7.7	1.0	92.0	1.4	5.2	4.8	5.1	1.7	7.3	38.6	22.8	34.7	3.5	44.7	0.9	0.4	24.7	4.9	6.6	10.5	5.3	32.1	19.7	0.0	2.7	1.1	10.2	24.0	41.3	1.2	10.7	0.1	65.4	0.0	4.4	58.6	1.5	0.3	4.7	1.0	3.3	18.8	0.1	25.2	47.3	0.8	6.7	0.4	4.1	139.7	0.1	33.5	59.5	18.6	13.9	14.5	32.3	0.6	64.2	4.5	51.2	53.0	5.6	5.3	44.8	10.2	34.6	4.8	36.2	7.4	15.1	0.4	24.1	0.3	0.3	0.4	3.5	3.9	20.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.6	0.5	0.0	12.9	2.9	0.5	0.0	0.0	0.0	0.1	0.0	1.0	47.1	35.3	27.5	60.6	35.2	40.7	50.6	55.3	50.8	30.3	92.0	38.6	0.3	3.2	2.0	2.9	6.0	0.4	0.6	0.6	0.0	1.8	13.5	7.5	2.5	22.8	2.0	9.2	0.0	0.2	0.1	1.4	9.8	16.0	0.0	5.7	0.7	1.1	6.0	0.0	6.1	18.8	0.3	0.2	2.6	7.8	0.0	3.4	1.4	2.5	0.3	30.3	3.6	1.5	2.0	0.0	0.7	0.0	1.2	0.1	3.6	2.8	0.2	10.4	0.0	1.5	0.7	15.0	2.9	0.4	0.5	4.3	0.2	10.8	2.7	1.8	0.0	1.4	1.2	0.1	2.0	8.1	1.0	0.0	1.4	0.3	0.8	1.3
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		3500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane"		"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	58.1	51.6	44.2	62.8	45.1	76.6	51.3	41.7	50.4	72.4	39.9	54.6	34.7	56.0	20.2	189.0	47.8	47.2	49.2	45.8	45.2	50.7	51.1	57.8	99.6	46.2	44.8	38.0	44.3	38.4	47.8	34.9	48.4	57.0	30.6	9.4	57.5	38.0	34.3	59.9	64.7	44.8	44.3	119.5	54.7	20.8	44.6	64.8	47.6	16.4	89.1	60.3	92.0	43.4	57.6	89.1	60.5	56.6	77.0	49.7	46.0	95.9	93.6	111.5	91.5	90.0	82.5	132.3	70.0	126.1	133.6	101.9	35.6	130.6	40.7	70.6	38.9	51.9	73.8	52.4	78.5	75.8	70.3	46.6	53.3	107.1	35.2	71.5	74.1	83.9	63.8	49.3	105.5	91.5	136.5	85.3	43.1	72.9	73.0	69.4	48.1	64.5	69.8	90.5	65.6	89.8	69.6	121.5	24.4	43.8	94.0	99.4	121.1	82.7	75.5	49.5	113.6	102.7	49.4	81.2	78.3	83.2	183.8	263.3	377.1	295.0	190.3	422.7	148.3	253.9	138.0	155.0	362.5	261.7	136.5	145.1	357.4	192.4	437.9	376.6	183.1	558.8	44.2	45.1	41.7	50.4	45.8	45.2	46.2	44.8	48.4	44.3	44.6	43.4	49.9	44.8	36.2	10.7	105.4	17.6	34.1	62.9	19.4	33.0	26.7	24.0	30.6	25.8	42.2	31.3	35.5	78.9	101.6	58.5	45.0	87.0	10.3	30.7	39.3	44.8	37.8	45.8	7.4	73.2	146.4	39.3	54.6	50.7	65.9	42.3	32.5	22.5	176.0	40.4	6.7	50.0	38.7	129.6	48.6	10.6	37.0	113.4	55.2	7.5	338.3	42.5	112.3	5.5	11.4	105.9	74.0	33.8	50.2	31.5	49.0	33.6	21.6	38.6	6.6	29.0	54.6	24.4	12.8	64.4	26.7	87.3	69.5	51.9	44.0	51.1
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138160988-138174921	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	6.6	6.7	4.4	6.7	5.1	15.3	7.6	5.4	4.8	6.2	5.8	6.4	5.3	7.4	8.2	6.6	6.5	5.6	6.0	4.2	5.1	7.2	6.1	7.7	9.0	5.1	4.8	8.2	7.3	7.4	5.6	5.6	5.4	6.7	6.2	5.1	7.0	6.1	6.7	7.6	7.2	6.9	5.4	9.6	11.3	3.0	4.8	9.7	8.2	6.5	9.0	6.2	5.5	5.9	24.5	9.9	17.7	19.7	9.6	9.0	18.4	14.2	10.4	15.1	18.2	16.9	10.6	22.3	26.4	12.9	22.8	17.8	20.6	7.0	19.7	19.2	17.1	24.2	12.3	13.9	11.8	31.5	20.5	12.4	11.6	14.0	13.1	8.9	12.6	19.1	16.0	4.7	15.4	18.9	31.2	18.5	20.4	18.9	11.4	19.3	20.1	20.4	13.2	23.6	17.1	22.0	38.0	13.1	21.1	14.4	24.6	25.5	11.9	12.6	8.8	23.6	16.7	7.1	10.5	46.6	8.2	22.4	16.8	4.2	7.1	13.3	8.4	9.7	11.1	7.0	9.6	8.1	8.6	7.4	9.6	10.7	2.9	8.4	8.4	5.2	8.4	6.2	4.4	5.1	5.4	4.8	4.2	5.1	5.1	4.8	5.4	5.4	4.8	5.9	7.5	6.4	12.9	6.5	8.2	5.2	3.4	6.2	6.2	5.9	6.9	11.9	6.1	7.2	5.9	9.2	0.0	11.3	14.7	4.7	9.8	10.8	0.1	6.1	9.8	6.7	6.0	16.2	4.2	9.0	8.6	8.6	9.2	9.5	5.7	8.7	6.1	6.9	10.4	6.7	4.8	6.6	6.1	16.7	4.8	0.5	8.7	10.2	3.6	8.4	9.0	8.0	6.2	8.5	7.8	8.2	5.6	8.2	7.0	3.7	3.9	5.3	5.5	5.1	0.0	10.0	8.7	4.3	2.1	5.6	4.1	4.5	12.9	6.5	7.3	2.9
DBT	"BCKAD-E2, BCKDH-E2, BCOADC-E2"	ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	11.1	13.6	4.4	5.9	5.2	4.6	11.8	4.3	4.9	11.3	3.7	9.2	8.0	8.2	6.0	12.8	11.1	6.3	25.9	4.2	5.0	30.3	43.4	7.4	7.5	5.6	4.6	11.1	15.4	19.4	2.3	10.0	4.5	15.9	10.2	5.9	12.8	11.2	13.4	7.4	7.1	8.0	4.6	6.1	17.3	4.7	5.2	9.9	17.2	19.2	8.9	9.4	4.0	7.1	18.5	8.2	9.5	17.4	23.9	17.6	20.6	13.1	12.3	13.9	15.6	17.7	7.4	17.1	18.3	9.3	8.1	18.7	20.3	17.7	16.8	18.2	11.5	12.1	16.3	9.5	18.0	16.1	6.1	18.2	18.1	10.6	17.9	11.4	12.4	17.9	20.9	19.2	11.1	4.9	14.4	4.1	18.6	14.8	18.4	14.1	30.3	14.2	15.3	15.9	15.8	8.7	27.5	25.4	23.7	16.7	20.9	11.9	10.8	12.1	7.6	15.9	11.0	12.7	14.1	9.1	13.8	10.7	5.3	2.1	1.2	0.8	2.2	1.5	2.4	1.9	2.0	1.9	1.2	2.1	1.8	1.9	1.1	2.0	1.4	1.3	1.5	1.1	4.4	5.2	4.3	4.9	4.2	5.0	5.6	4.6	4.5	4.6	5.2	7.1	9.6	22.4	36.4	29.0	9.6	6.8	6.5	9.8	13.6	22.2	11.9	8.5	65.9	18.6	11.3	12.9	39.6	19.8	10.9	11.4	50.9	10.0	0.8	18.5	20.5	11.7	9.1	8.2	24.0	8.5	11.6	11.3	15.8	15.4	2.5	19.6	15.4	53.2	8.7	15.2	25.2	12.0	14.2	8.8	5.0	1.7	15.2	7.3	3.6	3.7	10.3	14.5	12.3	22.1	26.1	6.4	6.0	21.1	7.1	9.4	9.9	32.1	18.0	22.4	6.6	15.0	12.9	2.8	6.1	18.7	7.2	8.2	9.7	17.3	15.1	5.5
DBX1		ENSG00000109851	"Developing brain homeobox 1"	A6NMT0	11	20156155-20160475	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039802	Uncertain					NA	NA					"Cluster 5: NTERA-2 - Transcription"				"HPA039802: AB_10795256"					"unprognostic (3.76e-1)"										"unprognostic (5.64e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBX2	FLJ16139	ENSG00000185610	"Developing brain homeobox 2"	Q6ZNG2	12	45014672-45051099	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"brain: 9.3"	"Group enriched"	"Detected in some"	9	"Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	32	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065045, HPA066053"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065045: , HPA066053: AB_2685605"	"unprognostic (1.13e-4)"			"unprognostic (9.99e-2)"	"unprognostic (7.82e-3)"	"unprognostic (5.24e-2)"				"unprognostic (5.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.22e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.19e-1)"		0.4	0.0	3.6	0.0	4.0	0.0	0.2	3.7	3.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	3.6	0.1	0.0	0.0	0.0	8.2	4.6	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	9.3	0.0	0.0	0.6	5.2	0.0	0.2	0.2	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.0	3.7	3.7	3.4	3.6	8.2	4.6	5.6	9.3	5.2	7.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCAF10	"FLJ23201, MGC10765, WDR32"	ENSG00000122741	"DDB1 and CUL4 associated factor 10"	Q5QP82	9	37800554-37867666	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 182.4;Late spermatids: 325.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024160	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA024160: AB_1858802"	"unprognostic (2.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.05e-2)"	7.0	11.2	3.3	4.5	3.7	6.1	7.7	5.1	4.1	7.0	5.1	8.0	5.4	7.5	7.6	7.8	6.5	4.5	5.6	3.5	3.5	8.5	11.4	5.5	5.1	3.1	3.4	7.1	8.4	14.1	5.5	6.2	3.1	7.0	6.4	7.2	7.3	7.0	9.9	7.2	5.5	7.5	3.3	5.2	6.4	17.6	3.5	5.2	9.0	5.7	5.2	7.4	6.8	3.7	11.7	5.7	7.1	6.1	12.2	16.4	7.1	9.6	10.6	5.8	7.3	2.2	4.4	12.2	4.0	12.7	6.6	4.5	6.7	7.9	8.3	9.4	5.3	5.6	9.8	4.1	21.0	7.4	4.2	14.9	17.4	6.4	26.0	13.2	10.3	7.8	17.9	5.9	10.7	4.9	7.1	3.9	6.1	18.2	4.0	6.6	3.4	6.2	11.1	5.9	6.8	9.5	9.1	11.9	8.5	8.5	8.1	16.1	11.1	6.1	3.7	8.1	6.7	5.4	9.2	6.8	10.2	8.1	8.8	0.3	0.3	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.2	0.6	0.6	0.5	0.7	0.6	0.8	0.3	0.3	0.1	3.3	3.7	5.1	4.1	3.5	3.5	3.1	3.4	3.1	3.3	3.5	3.7	21.4	16.0	28.7	54.2	21.4	40.8	28.3	24.6	28.5	28.6	26.9	17.5	16.5	17.2	27.4	12.9	25.0	17.8	15.9	21.8	9.8	22.7	182.4	18.9	26.8	26.8	19.2	41.9	89.9	21.9	17.1	26.5	21.4	23.9	5.1	35.7	23.6	43.0	15.3	25.2	90.2	20.7	24.4	15.5	23.3	325.7	28.0	16.4	26.6	38.4	19.3	23.4	22.6	82.4	80.6	22.9	16.1	38.4	18.3	42.4	20.5	28.7	18.3	27.3	39.5	32.5	24.0	100.9	11.3	31.7	52.4	22.8	17.7	40.4	25.2	30.1
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003583: AB_2667001, HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favorable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	15.4	41.6	21.5	13.4	21.7	39.5	17.1	19.7	23.0	15.4	19.9	24.5	29.3	17.1	23.2	29.8	15.6	13.6	38.1	22.3	19.9	35.8	107.2	17.5	15.6	21.0	20.3	23.1	59.7	28.2	25.6	9.2	19.8	23.6	16.6	17.6	25.9	17.5	62.3	20.1	37.5	11.7	19.2	28.9	34.3	16.5	22.0	19.0	26.4	50.0	16.1	20.3	16.2	21.1	12.5	18.3	12.3	10.9	10.7	8.8	16.6	9.1	10.7	16.0	19.5	12.0	21.3	19.4	10.3	12.2	13.3	16.1	15.8	9.6	7.4	23.1	9.5	15.6	19.7	67.3	14.3	27.7	31.0	5.3	23.1	6.7	16.7	13.1	12.3	31.6	15.0	23.0	9.7	39.2	23.7	28.5	7.2	35.0	17.0	25.1	16.0	28.2	12.2	28.1	22.1	17.0	5.3	29.9	13.4	12.7	15.4	19.6	5.1	12.5	10.0	13.6	13.2	38.6	36.2	25.3	6.0	17.7	10.9	14.0	13.8	20.5	13.8	15.8	11.7	12.1	12.5	13.5	17.1	11.5	12.2	11.4	11.7	23.0	13.9	8.6	16.7	15.2	21.5	21.7	19.7	23.0	22.3	19.9	21.0	20.3	19.8	19.2	22.0	21.1	18.2	28.9	45.4	10.4	30.5	8.8	22.2	18.7	31.3	34.1	34.8	20.7	41.2	44.3	23.9	38.6	47.9	34.6	34.2	76.1	46.9	41.6	19.3	22.0	10.8	15.2	28.9	201.2	9.2	46.2	31.5	14.1	29.0	22.5	12.6	26.5	22.1	156.0	37.4	16.8	6.9	40.7	20.3	27.0	12.8	26.6	9.0	24.1	17.8	9.4	39.2	38.8	55.6	7.1	9.7	31.9	34.6	14.7	26.6	25.0	147.9	56.0	22.3	29.4	26.3	15.9	14.5	23.7	12.4	32.6	11.4	50.5	31.2	60.7	49.0	22.7
DCAF12	"CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A"	ENSG00000198876	"DDB1 and CUL4 associated factor 12"	Q5T6F0	9	34086387-34127399	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.9;Erythroid cells: 315.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062279	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA062279: AB_2684734"	"unprognostic (9.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (2.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	16.2	32.3	10.4	20.0	10.2	33.7	21.7	9.9	10.8	20.3	13.6	22.2	17.1	17.3	16.8	29.4	18.4	16.9	12.7	9.6	10.1	17.4	23.2	17.3	37.0	11.8	10.7	16.0	15.8	22.7	10.0	28.6	11.2	16.2	25.9	17.4	16.8	14.4	18.2	16.6	17.3	17.5	10.9	17.5	17.3	62.4	10.5	30.0	19.5	23.3	42.2	24.1	16.8	11.4	45.1	29.2	58.1	26.1	24.9	21.6	33.0	24.5	31.4	43.8	37.6	25.6	21.4	88.6	20.7	27.7	15.2	19.6	64.4	28.7	37.6	40.3	34.6	70.1	58.6	36.1	36.4	86.5	41.7	21.6	54.8	28.0	53.1	33.7	35.3	48.9	70.2	30.0	28.6	18.5	55.3	85.8	29.9	29.5	28.3	51.8	31.6	39.3	46.0	32.5	57.0	48.9	49.6	42.0	20.2	30.6	23.5	134.4	25.4	20.8	25.3	17.8	33.5	19.6	38.8	68.7	19.8	65.2	51.2	36.4	28.6	28.3	12.3	24.0	18.5	1.2	12.2	14.1	25.3	0.4	9.8	11.4	27.6	16.0	20.4	20.4	22.9	20.2	10.4	10.2	9.9	10.8	9.6	10.1	11.8	10.7	11.2	10.9	10.5	11.4	13.8	6.4	20.0	7.5	5.9	38.5	18.8	13.3	21.1	6.9	20.3	14.7	6.7	8.6	13.4	5.5	6.2	21.5	27.6	22.0	25.4	16.0	165.9	27.3	13.7	18.2	25.2	315.8	10.0	18.2	25.2	14.5	16.3	19.3	17.7	20.6	15.0	21.9	31.4	10.1	10.4	22.3	10.2	63.9	16.2	63.0	20.2	32.1	17.8	12.2	22.4	7.5	11.3	11.6	8.8	18.0	15.7	21.1	29.6	28.6	13.1	21.5	23.4	7.0	13.1	13.8	17.5	40.1	43.2	33.1	38.6	22.4	16.7	30.0	19.6	38.4
DCAF12L1	"KIAA1892L, WDR40B"	ENSG00000198889	"DDB1 and CUL4 associated factor 12 like 1"	Q5VU92	X	126549383-126552814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.9;testis: 6.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 20.7;Late spermatids: 44.4;Spermatogonia: 14.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"EFO-21: 15.2;U-2 OS: 8.4"									"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"				"unprognostic (2.62e-5)"						"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	2.5	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	0.8	6.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.7	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	3.8	14.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166289	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.3;epididymis: 21.4"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	0.8	0.9	1.9	0.0	2.0	0.0	0.4	0.1	2.2	1.4	0.0	0.7	0.0	2.4	21.4	0.1	2.3	0.1	0.0	2.5	3.5	0.2	0.0	0.0	0.1	9.3	1.5	1.4	0.0	2.5	1.3	0.0	4.2	1.5	0.0	0.2	0.3	4.3	0.1	0.2	0.2	1.3	1.6	0.0	0.3	5.5	3.1	0.0	0.1	0.9	0.2	1.2	0.5	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.1	2.2	2.5	3.5	9.3	1.5	4.2	1.6	3.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	16.7	19.2	10.3	22.9	11.0	15.2	23.9	11.3	15.6	17.7	12.8	20.7	16.1	16.2	19.1	21.3	18.0	12.7	16.2	10.9	11.1	32.4	20.7	12.9	24.7	10.8	13.7	13.6	18.5	20.0	15.6	18.7	11.4	14.7	21.4	13.8	14.3	12.8	18.8	15.7	14.5	18.2	11.3	14.3	15.6	32.2	10.4	24.7	18.1	16.0	30.5	33.6	14.6	11.9	96.5	84.2	76.9	79.0	54.7	62.7	57.6	70.1	53.2	64.4	65.9	83.1	90.9	132.2	116.1	73.3	64.0	69.9	105.8	89.0	124.1	127.7	74.9	183.0	48.0	95.9	62.2	76.1	75.7	51.8	59.9	95.9	157.5	40.3	91.4	89.6	125.3	56.7	99.9	78.0	144.9	79.3	118.0	268.9	129.6	92.6	93.3	136.4	95.3	78.6	97.6	92.3	43.5	67.3	83.1	67.4	103.9	51.2	60.6	65.3	105.3	85.5	94.7	61.7	116.5	188.0	88.0	162.8	85.7	19.6	37.6	22.1	35.5	46.5	48.8	60.8	37.5	38.2	54.4	50.8	37.0	38.2	4.2	52.8	35.2	28.3	58.0	44.9	10.3	11.0	11.3	15.6	10.9	11.1	10.8	13.7	11.4	11.3	10.4	11.9	40.0	16.0	17.0	9.1	39.7	79.5	76.6	92.4	38.1	19.6	21.6	24.9	20.8	12.8	53.8	33.1	25.0	57.9	34.8	11.0	39.2	55.0	54.6	26.9	35.4	39.9	14.5	22.1	9.5	48.4	75.0	37.4	17.9	24.7	40.6	49.3	17.5	16.9	42.7	16.8	9.0	17.5	69.2	14.8	23.9	16.7	24.2	22.9	26.6	11.2	28.5	28.8	27.8	16.1	20.0	43.6	12.3	17.7	30.3	51.1	24.3	79.1	36.0	23.7	13.1	50.2	48.0	102.0	86.3	37.1	77.0	33.9	33.1	41.7	28.1	56.9
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	9.6	8.2	4.5	8.0	7.0	18.1	13.0	6.4	6.7	12.8	2.9	10.4	7.9	13.8	10.2	7.9	11.9	6.6	8.4	4.2	7.4	9.2	4.8	9.1	11.9	6.1	5.8	19.4	11.3	12.3	13.3	9.8	5.7	10.6	9.5	13.3	10.9	7.9	8.2	15.0	10.2	8.9	4.5	8.9	8.8	10.9	7.8	12.0	10.1	4.4	11.4	10.0	10.2	9.4	21.7	4.6	24.3	25.5	6.8	11.9	13.2	13.9	16.3	16.2	19.1	13.1	17.2	24.2	10.8	12.9	13.1	10.7	14.4	14.7	23.9	8.3	13.2	34.2	16.0	21.5	16.3	30.4	13.4	15.5	11.8	20.6	20.3	10.8	11.3	23.6	37.4	39.3	9.4	8.2	33.4	29.0	20.0	6.3	13.1	35.0	27.8	15.7	7.1	16.9	36.0	28.9	14.8	3.9	16.9	12.2	14.3	8.1	14.5	18.7	14.7	20.8	17.8	17.3	7.4	29.4	15.4	20.6	12.8	7.8	1.4	2.1	2.5	1.6	3.3	2.0	2.7	2.8	0.9	2.9	3.4	3.2	1.0	2.1	1.1	1.8	2.1	1.3	4.5	7.0	6.4	6.7	4.2	7.4	6.1	5.8	5.7	4.5	7.8	9.4	11.6	19.2	24.8	13.1	17.6	25.4	24.3	9.4	25.6	12.2	16.3	16.9	21.9	12.8	14.4	9.2	6.2	17.6	27.0	8.6	13.7	9.9	19.6	12.9	18.4	13.0	17.5	21.7	20.2	7.7	10.0	15.9	14.3	13.3	17.1	24.8	11.4	6.4	7.7	15.2	20.2	12.5	14.2	11.9	11.3	11.5	21.1	9.4	10.6	15.0	10.2	27.5	7.2	29.1	36.7	11.8	7.6	22.2	27.6	14.6	9.2	5.1	17.1	14.6	13.1	21.7	16.2	28.8	17.3	19.5	21.2	12.3	20.3	19.0	13.9	19.2
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053339: AB_2682119, HPA055040: AB_2682680"	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (2.79e-2)"	3.9	4.5	5.2	5.4	6.6	3.4	6.4	6.6	6.1	6.1	4.3	5.6	4.5	6.2	6.3	4.4	4.6	3.8	3.5	5.1	5.7	5.6	4.5	3.8	7.2	5.5	5.2	7.1	5.0	6.0	3.8	5.3	5.8	5.0	4.6	13.9	4.3	4.5	3.9	7.2	4.7	4.6	5.5	6.4	4.4	5.7	6.9	7.8	10.2	4.3	6.0	5.6	5.4	10.6	8.5	6.9	8.9	10.6	11.0	11.7	13.6	7.3	7.5	7.3	6.8	8.3	5.5	24.4	5.4	9.1	5.5	8.2	9.1	9.0	9.9	11.4	6.2	11.3	6.2	15.0	11.2	16.2	7.9	9.2	11.6	9.3	20.7	8.6	8.0	7.6	17.9	8.2	10.1	5.2	17.9	14.9	13.2	6.2	4.3	13.4	11.7	13.4	6.2	7.6	7.8	11.3	6.9	5.8	7.4	8.3	4.5	8.3	9.6	8.4	7.6	4.8	6.4	12.4	18.3	20.5	8.9	8.2	8.8	1.1	1.3	0.5	2.3	1.5	3.4	1.3	1.8	1.7	1.0	1.8	2.0	2.5	0.0	1.1	1.3	0.8	1.8	1.6	5.2	6.6	6.6	6.1	5.1	5.7	5.5	5.2	5.8	5.5	6.9	10.6	5.8	0.0	7.5	17.9	8.9	4.7	4.7	4.2	8.6	10.1	7.8	6.0	5.0	7.2	3.1	7.3	12.5	6.5	6.0	4.4	9.8	4.8	2.2	6.2	10.7	5.2	10.2	6.9	18.0	3.9	5.7	5.8	8.2	4.9	3.8	8.2	2.5	7.7	5.6	8.4	23.5	4.5	6.1	8.4	4.6	3.6	6.2	5.0	3.6	15.0	4.4	8.8	5.2	24.6	56.5	6.6	2.0	6.0	6.4	6.3	5.5	6.2	6.1	15.2	0.0	6.7	7.2	13.5	17.1	8.7	5.1	5.6	7.5	9.0	4.3	5.0
DCAF4	"DKFZp434K114, WDR21, WDR21A"	ENSG00000119599	"DDB1 and CUL4 associated factor 4"	Q8WV16	14	72926377-72959703	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047276	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047276: AB_10959615"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.11e-2)"	6.8	7.9	5.9	4.8	6.0	4.9	7.1	5.2	6.6	7.8	4.6	7.9	4.1	7.0	5.3	7.6	5.6	3.7	5.5	6.5	6.6	9.1	7.4	4.5	6.5	7.4	6.2	9.1	12.5	5.5	3.7	9.3	7.6	6.9	6.5	2.6	6.8	5.2	12.8	12.8	6.9	6.0	5.2	6.7	8.0	7.0	6.1	3.9	11.4	5.1	7.4	8.1	7.5	6.6	20.7	9.4	2.3	10.8	9.9	12.5	19.0	11.6	11.6	14.9	17.4	11.3	8.9	26.0	8.5	21.9	13.6	15.6	16.0	18.2	25.5	13.2	8.9	10.8	4.4	15.1	13.9	7.4	17.8	21.9	17.4	15.5	29.1	10.0	5.2	25.1	16.2	16.1	12.1	35.3	12.7	18.4	6.3	20.2	20.3	8.9	12.2	15.2	22.5	12.3	12.5	4.9	7.0	37.4	14.1	10.4	12.5	9.9	7.8	8.0	18.5	22.6	5.7	22.8	23.5	17.7	11.0	6.1	4.9	0.4	1.6	0.3	4.1	2.5	6.1	11.6	5.0	4.6	3.3	8.7	5.7	6.0	0.9	9.1	5.4	2.5	7.2	3.0	5.9	6.0	5.2	6.6	6.5	6.6	7.4	6.2	7.6	5.2	6.1	6.6	2.9	6.4	5.3	3.3	10.8	6.1	7.3	5.8	8.0	3.4	5.8	5.1	4.0	2.8	8.3	3.7	4.2	20.9	4.4	4.3	3.9	6.7	3.8	4.3	6.6	4.4	4.2	4.2	5.7	5.6	15.3	4.9	12.8	7.5	0.0	10.9	1.1	4.7	5.8	0.0	4.7	4.3	6.1	2.2	4.2	2.6	3.7	1.9	1.8	3.7	4.1	2.1	4.1	3.5	5.8	4.4	7.0	5.7	4.7	4.0	2.9	6.6	2.6	3.5	0.0	4.4	4.0	7.5	18.6	6.4	6.7	5.6	5.3	11.8	7.1	3.3
DCAF4L1	WDR21B	ENSG00000182308	"DDB1 and CUL4 associated factor 4 like 1"	Q3SXM0	4	41981756-41986465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 24.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 35.4;Spermatocytes: 89.6;Spermatogonia: 128.4"	"Cancer enriched"	"Detected in single"	49	"testis cancer: 8.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.1"									CAB073535	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB073535: "	"unprognostic (6.24e-2)"	"unprognostic (7.52e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.64e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-4)"	0.2	0.2	0.5	0.2	0.5	0.1	0.1	0.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.4	0.3	0.4	0.4	0.3	0.1	0.4	0.3	0.1	0.1	0.0	0.8	0.0	0.5	0.2	0.0	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.3	0.6	0.1	24.7	0.5	0.0	0.2	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.2	0.6	0.7	0.1	0.0	0.7	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.2	1.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.6	0.2	0.9	0.1	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.7	0.7	0.4	0.3	0.4	0.3	0.5	0.3	0.5	0.6	0.8	0.0	0.0	0.7	0.5	0.4	0.3	0.2	0.0	1.2	0.9	0.5	1.2	1.5	0.3	0.0	0.0	0.2	0.6	0.3	0.0	0.3	35.4	0.9	0.9	0.9	0.0	0.4	1.4	0.6	0.3	0.5	0.0	1.2	0.0	0.1	0.0	0.6	0.3	0.0	0.8	0.4	2.0	2.2	0.3	8.6	1.2	0.8	3.6	0.0	0.7	0.7	2.1	0.5	0.6	0.9	0.1	0.4	0.9	1.2	0.2	0.1	0.5	1.6	0.0	2.9	0.7	89.6	128.4	0.6	0.9	0.5	0.6	0.2	0.7	0.6
DCAF4L2	WDR21C	ENSG00000176566	"DDB1 and CUL4 associated factor 4 like 2"	Q8NA75	8	87870747-87874015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	214	"testis: 21.3"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 68.6;Spermatogonia: 75.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 20.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"U-266/84: 7.5"									HPA067584	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA067584: AB_2685868"					"unprognostic (4.25e-1)"		"unprognostic (4.81e-2)"		"unprognostic (1.90e-1)"						"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCAF5	"BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22"	ENSG00000139990	"DDB1 and CUL4 associated factor 5"	Q96JK2	14	69050881-69153150	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041575, HPA048098"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA041575: AB_2677558, HPA048098: AB_2680263"	"unprognostic (8.12e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-1)"	30.0	22.5	16.1	23.4	15.9	30.2	27.2	16.4	16.5	29.3	17.0	34.0	21.6	28.3	22.3	30.9	28.8	24.4	31.3	16.5	16.6	24.6	31.4	31.0	27.6	15.8	15.0	28.5	22.0	36.4	28.8	25.4	16.0	29.8	21.2	20.8	27.2	25.1	74.3	30.5	25.9	32.7	14.1	27.7	26.2	60.5	17.2	39.4	30.1	51.7	25.6	29.2	28.3	14.5	48.3	15.0	34.7	32.5	37.7	32.9	22.7	22.2	32.1	24.9	31.2	19.4	29.9	26.4	19.9	34.7	18.8	23.0	24.7	33.2	23.2	36.0	13.7	28.4	15.8	14.0	28.6	10.9	33.2	37.3	34.0	22.3	31.1	43.0	37.7	31.1	22.4	21.6	25.1	28.6	34.7	19.0	15.6	22.6	23.7	22.8	32.9	10.6	33.1	37.0	24.7	27.8	29.7	30.7	19.4	29.7	37.5	22.0	34.4	42.2	39.4	19.6	13.2	28.4	9.9	23.9	28.1	13.0	13.0	21.1	4.3	16.4	31.0	4.0	26.3	8.2	16.7	23.0	5.7	8.6	15.7	19.7	5.4	32.3	3.0	6.0	8.2	13.1	16.1	15.9	16.4	16.5	16.5	16.6	15.8	15.0	16.0	14.1	17.2	14.5	28.8	44.8	57.8	71.8	24.9	26.3	19.1	21.4	38.1	18.5	23.3	19.0	58.8	32.9	39.4	14.7	27.1	19.4	43.6	20.9	1.9	25.1	149.9	28.7	30.6	32.1	23.4	25.6	88.8	24.9	19.3	27.2	32.1	31.9	37.2	28.0	26.0	33.2	19.6	18.5	85.6	22.0	22.4	19.7	23.7	89.3	31.1	24.3	10.6	74.9	21.8	22.3	52.5	76.9	61.6	29.2	16.0	34.3	35.8	19.9	20.9	14.0	41.2	24.9	46.0	29.1	26.6	75.2	19.8	37.9	19.9	15.3	38.0	31.2	21.3	23.5
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550477-63594279	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	12.4	13.6	23.3	22.6	23.1	9.0	15.5	20.1	21.0	19.8	17.8	23.9	25.9	16.7	18.8	17.5	19.3	16.7	18.1	22.2	23.0	26.5	14.3	21.6	29.1	22.7	22.7	16.5	18.4	37.4	12.4	26.7	22.8	21.9	25.7	29.9	18.1	23.3	13.3	14.0	25.0	18.9	24.9	25.4	20.8	14.8	23.6	37.2	22.1	15.3	32.4	22.3	12.8	23.2	33.2	46.4	79.6	51.0	26.9	22.2	20.9	32.6	28.7	35.3	29.7	34.2	35.2	61.2	25.7	32.7	36.9	34.7	67.0	45.8	45.0	23.7	42.7	79.9	29.3	40.3	27.7	89.7	44.4	18.6	29.7	20.6	46.8	42.5	55.8	50.9	85.7	27.8	45.3	40.9	97.7	43.0	25.9	57.5	61.7	77.1	94.5	34.9	51.4	49.7	76.4	141.0	29.4	56.2	38.9	70.0	41.5	72.1	59.3	58.0	26.4	29.6	54.4	28.9	39.6	32.2	33.0	57.1	35.2	10.9	11.3	12.6	11.2	13.1	9.0	8.1	7.7	8.7	10.6	8.3	6.9	7.5	4.7	8.9	16.2	7.8	5.9	8.6	23.3	23.1	20.1	21.0	22.2	23.0	22.7	22.7	22.8	24.9	23.6	23.2	28.5	44.8	45.9	30.3	57.4	31.4	30.5	49.8	46.7	55.4	29.3	25.1	30.8	38.6	38.1	68.0	77.2	51.7	49.0	47.2	23.5	50.1	95.5	30.5	38.0	43.1	72.0	62.6	42.3	45.2	47.7	33.8	31.1	30.1	60.2	67.1	48.9	40.2	55.4	65.6	41.1	49.0	52.9	64.3	45.2	27.6	35.1	61.9	26.6	43.1	72.9	53.1	69.0	36.2	40.5	55.0	41.2	38.0	45.0	45.3	67.7	52.0	43.7	54.0	59.2	23.2	35.8	96.5	35.0	51.6	34.8	21.6	53.1	49.8	57.2	47.6
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCAF8L1	WDR42B	ENSG00000226372	"DDB1 and CUL4 associated factor 8 like 1"	A6NGE4	X	27977992-27981449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 3.0"	"Group enriched"	"Detected in some"	23	"Spermatocytes: 8.0;Spermatogonia: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Karpas-707: 18.7"									HPA043787	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA043787: AB_10961430"															"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 1.8"									HPA048308	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nuclear bodies"	"HPA048308: AB_2680349"																		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		22000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	8.3	3.5	3.7	6.0	4.6	0.6	5.7	3.5	4.9	9.1	2.6	6.6	6.5	5.1	3.3	5.4	2.5	9.1	6.0	5.5	2.7	4.8	9.6	9.9	3.4	3.5	3.6	1.9	6.3	6.8	8.3	8.7	3.7	2.6	6.1	1.0	4.8	2.8	5.5	2.9	8.1	3.8	3.4	3.8	7.6	5.6	3.0	1.2	5.9	5.1	2.5	6.3	5.8	4.3	8.0	17.9	6.3	7.0	10.8	13.5	17.9	45.1	58.1	36.9	27.8	37.9	16.7	0.0	21.8	19.1	45.9	17.9	12.1	19.9	38.7	3.5	9.4	6.8	18.5	62.3	46.7	10.0	5.7	15.4	45.5	33.6	31.4	42.5	52.3	6.7	14.8	6.7	48.9	6.4	0.1	6.7	4.7	21.4	7.4	0.0	1.3	4.7	8.2	9.4	19.0	0.3	33.0	3.6	5.3	9.0	4.7	13.1	38.9	0.0	44.1	12.6	19.8	18.9	5.4	5.3	18.7	9.6	16.5	0.0	0.2	0.0	0.6	0.2	0.1	0.0	0.8	1.2	0.2	0.0	1.0	1.3	0.0	0.4	0.1	0.4	0.9	0.5	3.7	4.6	3.5	4.9	5.5	2.7	3.5	3.6	3.7	3.4	3.0	4.3	16.0	16.0	18.8	5.2	3.0	5.2	3.7	12.3	0.6	8.4	4.8	3.6	5.3	12.8	14.4	5.5	6.2	31.5	4.9	9.5	1.9	7.0	33.0	5.3	15.1	11.0	4.2	3.2	20.8	4.8	6.1	6.6	13.7	7.9	1.3	13.9	17.2	9.6	5.8	5.0	3.3	8.5	6.1	7.0	15.0	10.9	0.9	5.8	8.8	13.1	2.5	1.1	6.2	12.1	11.6	10.4	7.7	0.4	1.6	3.0	11.1	2.7	5.7	3.5	13.1	5.1	27.6	2.2	10.6	6.8	6.0	18.2	5.1	2.1	11.1	5.4
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901695	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		2200000		"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	12.2	13.3	4.0	4.5	3.8	1.2	8.2	8.1	5.8	8.3	6.6	11.5	2.8	14.6	8.0	6.4	14.5	12.5	27.6	3.4	5.9	11.0	9.8	11.5	3.6	6.5	6.9	17.8	5.8	13.2	6.6	8.0	26.7	11.5	7.0	22.4	10.1	14.9	5.2	8.3	4.1	16.3	4.8	1.6	6.5	23.8	7.3	6.9	15.7	8.4	3.9	7.8	5.1	5.0	55.3	397.0	52.3	41.2	67.8	160.1	22.7	122.0	57.9	81.4	91.9	33.9	171.6	0.1	373.7	211.5	249.0	50.3	24.1	198.8	186.2	0.8	8.4	19.4	12.1	51.5	41.6	9.3	8.7	63.8	30.3	234.3	455.0	648.9	54.6	7.1	4.0	5.0	776.8	14.6	7.7	5.5	36.5	0.4	135.6	8.1	98.2	4.8	479.0	14.4	14.0	24.3	33.5	6.9	145.9	35.2	26.4	7.3	90.4	208.0	166.6	53.8	433.0	6.3	9.7	7.4	581.3	3.4	92.8	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.0	3.8	8.1	5.8	3.4	5.9	6.5	6.9	26.7	4.8	7.3	5.0	5.9	32.1	52.8	18.3	2.7	22.8	15.5	18.2	17.1	12.9	15.5	16.3	83.8	17.2	19.0	18.4	77.2	12.4	1.6	4.3	0.0	30.5	3.1	32.2	39.5	7.7	3.6	5.9	51.6	8.0	9.7	33.8	6.1	38.3	38.0	52.2	6.8	20.5	4.0	13.5	51.3	8.0	20.3	3.2	6.2	5.8	22.1	4.0	8.8	25.3	1.4	40.9	2.1	88.4	38.9	26.3	4.6	50.4	1.6	11.9	0.7	7.9	22.8	48.9	0.0	12.3	31.3	15.8	24.2	14.1	15.6	4.0	1.8	34.4	8.2	7.1
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340197-53535903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;testis: 7.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Approved	"Golgi apparatus"		NA	NA		64000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA055376: AB_2682798, HPA069552: AB_2686151"	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.0	0.6	1.2	0.2	6.3	0.0	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	6.9	3.6	0.2	0.0	1.4	0.0	0.7	4.7	0.1	0.3	0.0	0.6	0.0	1.5	0.3	0.1	0.3	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.2	0.2	7.6	1.1	1.0	0.0	0.0	0.3	0.1	0.1	0.9	0.1	0.1	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	112.5	57.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.3	0.0	3.9	6.9	3.6	0.7	4.7	1.5	0.0	1.1	0.9	1.4	0.0	6.0	10.1	0.3	0.0	0.1	0.0	0.0	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	205.7	0.0	0.0	0.1	0.0	0.0	439.7	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	455.8	0.0	0.0	0.0	0.0	174.9	1.2	0.2	0.0	54.4	0.0	0.2	0.0	1305.9	58.6	0.0	0.0	1.2	5.7	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1	2.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 2476.8"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000	"Cluster 42: Non-specific - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				100.2	0.4	3.5	0.3	3.3	1.1	354.3	3.4	5.4	0.3	3.8	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.3	3.5	3.3	0.2	0.9	0.6	0.2	3.3	3.6	0.4	1.0	0.0	0.5	0.1	3.5	0.4	0.2	0.5	0.5	0.1	14.0	2476.8	0.7	0.1	3.0	0.4	0.7	1.1	3.2	0.3	0.5	0.0	0.2	0.2	0.7	4.1	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.5	3.3	3.4	5.4	3.5	3.3	3.3	3.6	3.5	3.0	3.2	4.1	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"fallopian tube: 27.6"	"Group enriched"	"Detected in some"	6	"Endometrial ciliated cells: 31.7;Respiratory ciliated cells: 112.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.4	1.1	0.0	0.0	0.3	0.0	0.0	27.6	0.3	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.5	1.0	0.1	0.0	0.0	4.4	0.0	2.8	0.2	0.4	0.0	0.0	7.9	1.8	4.2	0.1	0.0	0.1	0.0	0.0	7.4	31.7	0.5	0.3	0.0	0.0	1.3	0.0	0.0	0.5	0.5	0.5	1.3	0.1	0.0	0.0	0.0	3.3	1.1	0.1	10.2	0.0	0.0	11.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	112.0	4.6	0.0	0.2	1.9	2.5	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0
DCDC2C		ENSG00000214866	"Doublecortin domain containing 2C"	A8MYV0	2	3703575-3848008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 171.3;Late spermatids: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045848	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA045848: AB_10961120"											"unprognostic (2.63e-2)"	"unprognostic (1.81e-1)"		"unprognostic (3.81e-3)"	"unprognostic (6.98e-2)"			0.1	0.0	0.6	0.0	0.5	0.4	0.1	0.9	0.9	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.5	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	4.1	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.9	0.9	0.5	0.5	0.1	0.1	0.2	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.3	0.0	0.4	2.3	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	59.9	5.6	0.1	0.0	15.9	0.0	0.0	0.0	0.0	0.2	0.3	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621330-6655809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		4000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.4	2.5	7.4	8.4	6.8	0.7	9.3	6.1	6.3	19.5	0.9	19.0	4.1	28.9	2.4	5.0	13.2	8.3	9.2	6.6	10.1	4.6	2.0	10.1	4.0	7.6	6.3	11.6	3.3	2.0	3.2	10.1	5.7	9.3	3.4	0.6	3.5	11.5	4.2	3.7	8.3	16.2	4.7	12.9	8.2	3.0	8.7	3.8	4.1	4.6	2.2	14.8	9.3	3.8	0.0	0.1	33.5	0.1	0.0	0.1	0.3	1.2	8.7	5.4	6.0	0.3	0.0	0.1	5.1	9.9	0.4	0.0	2.7	0.1	3.7	0.1	0.9	0.7	0.0	0.0	0.3	0.2	0.0	1.0	0.1	2.5	0.0	0.0	47.1	0.1	0.2	0.0	2.0	0.0	1.2	0.6	5.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	2.4	32.4	0.0	0.3	0.2	3.5	0.0	1.3	20.4	0.1	10.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	7.4	6.8	6.1	6.3	6.6	10.1	7.6	6.3	5.7	4.7	8.7	3.8	34.8	0.0	0.5	12.1	0.2	2.9	0.3	0.0	0.0	1.5	1.7	3.0	3.8	4.3	0.0	0.0	0.0	0.2	1.4	0.2	0.0	1.0	3.1	0.8	17.3	29.0	0.0	2.7	2.0	0.4	0.3	17.0	1.1	0.7	0.0	19.3	61.1	0.2	2.2	0.0	7.4	0.7	0.0	4.7	4.2	3.4	1.2	2.4	16.0	4.7	0.2	0.9	0.0	10.1	1.4	0.1	0.1	1.9	0.2	0.3	0.1	0.1	0.0	0.5	0.0	7.4	4.9	4.9	0.6	0.5	1.7	0.3	1.2	4.6	1.1	0.1
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"	Q6V1P9	4	154231742-154491799	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 63.0;Early spermatids: 20.7;Excitatory neurons: 30.3;Horizontal cells: 25.2;Inhibitory neurons: 13.2;Late spermatids: 19.4;Microglial cells: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"U-2 OS: 4.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.0	0.1	0.6	0.0	0.8	0.0	0.1	0.3	0.5	0.9	0.0	1.7	0.0	1.4	0.0	0.0	0.9	0.1	0.0	0.4	0.8	0.1	0.0	0.1	0.0	0.5	1.3	0.7	0.0	0.0	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.2	0.3	0.1	0.7	0.0	1.2	1.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.5	0.4	0.8	0.5	1.3	0.3	0.7	1.1	1.4	0.0	0.0	0.0	63.0	0.0	0.4	0.2	0.8	0.0	0.4	0.8	0.6	1.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.7	0.1	0.5	0.3	6.7	0.0	30.3	0.0	0.0	1.8	3.6	0.0	0.0	1.2	0.0	0.0	0.1	25.2	13.2	0.1	0.0	0.0	0.7	19.4	0.6	0.0	0.0	13.1	0.0	0.2	0.0	6.6	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.2	0.0	0.3	0.5	1.7	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 105.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 105.7;Erythroid cells: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 232.9;U-698: 191.8"	"Low region specificity"	"Detected in all"							"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	11.1	15.2	10.1	36.3	11.2	43.9	12.5	9.7	13.6	9.9	11.0	15.7	13.7	13.4	7.2	14.6	9.8	12.4	10.4	10.7	10.7	9.8	9.2	13.4	92.9	10.9	10.4	10.6	8.3	8.8	3.5	15.3	10.8	10.2	18.9	17.1	7.7	7.1	9.5	14.7	15.9	13.9	11.4	32.3	14.2	9.0	9.7	105.8	15.7	12.1	79.6	14.2	6.1	13.4	25.8	17.2	38.5	23.9	12.4	20.4	21.0	65.3	25.6	53.3	43.6	11.3	56.1	232.9	24.7	28.3	31.0	14.8	34.6	21.4	71.0	43.5	16.2	46.6	18.6	20.5	11.8	95.8	58.5	11.2	25.5	32.2	19.5	26.0	31.0	64.4	19.0	93.2	62.0	15.5	126.6	39.5	17.2	45.6	15.6	96.0	74.0	18.6	26.6	18.8	35.1	31.8	24.9	49.6	29.7	17.4	22.3	54.3	22.0	60.1	41.8	47.6	37.1	31.7	21.2	191.8	40.7	60.0	45.0	25.6	17.2	28.9	24.2	20.5	32.0	44.5	33.0	30.6	23.8	41.1	34.2	34.2	8.1	34.4	21.0	63.6	41.2	45.1	10.1	11.2	9.7	13.6	10.7	10.7	10.9	10.4	10.8	11.4	9.7	13.4	16.4	0.0	8.6	6.8	105.7	43.0	10.1	11.9	27.9	16.1	10.4	5.2	6.5	7.2	7.5	12.9	6.2	11.9	97.7	10.4	29.4	19.2	0.7	5.9	7.0	16.3	21.0	284.8	17.1	6.2	19.3	11.0	8.6	7.4	22.9	7.5	22.9	7.2	38.2	18.5	21.0	16.4	22.4	63.2	74.5	2.3	8.4	56.0	46.2	18.7	61.4	15.8	84.5	8.0	11.1	10.5	8.0	10.1	24.6	11.6	7.1	10.0	4.7	10.7	6.6	9.3	15.9	52.0	33.9	28.0	43.3	4.5	62.4	4.8	16.5	8.4
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131382	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.0"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 970.6;Inhibitory neurons: 664.8"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	15.5	2.5	22.0	4.0	27.5	0.0	14.2	10.2	45.3	11.8	0.0	4.2	1.1	6.0	4.1	5.4	4.6	7.2	5.5	37.1	37.8	2.8	0.1	2.4	4.2	17.9	13.2	6.1	1.2	1.1	13.7	0.1	53.0	4.1	3.8	17.3	3.4	4.0	2.1	8.4	4.1	19.1	15.7	4.5	3.6	1.3	17.5	1.6	2.8	4.6	2.2	4.3	5.9	18.7	0.0	0.4	6.8	0.0	29.0	27.3	0.0	0.2	0.4	0.2	0.2	0.0	0.1	0.0	0.0	23.5	34.8	0.0	17.9	0.3	0.0	0.0	1.0	0.0	0.8	0.0	1.1	0.0	0.0	25.5	13.0	0.6	0.4	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	37.1	0.0	0.4	0.0	2.0	0.0	1.0	0.0	7.3	4.4	0.0	0.0	2.2	10.4	0.0	0.0	0.0	0.1	6.1	7.6	1.3	0.1	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	27.5	10.2	45.3	37.1	37.8	17.9	13.2	53.0	15.7	17.5	18.7	8.0	9.6	0.6	132.2	0.1	15.2	1.3	1.8	0.0	9.4	7.8	7.0	5.8	0.0	7.9	3.7	4.2	0.0	0.0	0.0	0.0	0.1	1.5	0.7	1.7	3.8	0.0	0.0	970.6	0.0	0.0	82.6	0.5	0.3	0.0	75.5	0.4	0.0	0.1	10.1	664.8	0.0	4.1	0.3	14.7	1.6	20.8	0.7	14.2	44.0	0.0	73.8	0.0	31.2	19.1	0.2	0.0	4.1	0.3	0.6	0.0	0.6	3.1	4.2	6.6	10.8	22.0	1.3	1.4	1.0	9.7	0.0	0.8	30.1	0.0	1.7
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078445-150257438	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0"	"Group enriched"	"Detected in many"	6	"Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	1.7	2.8	45.8	0.9	42.0	0.5	1.4	34.6	43.6	2.0	7.7	5.6	1.4	2.7	2.0	1.5	1.9	2.5	12.2	59.0	41.2	2.3	0.6	2.1	0.4	41.2	46.6	2.9	2.2	0.6	8.3	1.5	38.4	2.7	2.0	18.4	0.8	2.0	1.2	1.0	2.2	4.7	46.6	1.2	2.3	2.8	42.7	0.2	2.6	1.4	0.3	2.6	1.3	46.8	1.2	4.2	23.6	3.7	0.0	1.1	0.4	11.8	24.9	3.5	0.9	0.1	0.0	0.0	0.4	11.0	3.6	0.1	3.5	0.0	4.4	5.1	2.1	0.0	7.0	0.0	5.0	0.7	0.7	0.6	0.0	2.2	0.2	2.2	1.2	0.6	0.0	0.1	2.5	0.2	0.4	0.0	0.5	0.3	1.6	0.0	2.8	1.0	0.1	1.0	9.2	9.1	4.7	3.4	1.0	2.0	0.0	0.1	2.1	3.3	1.3	2.2	1.3	1.1	0.0	0.1	3.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	45.8	42.0	34.6	43.6	59.0	41.2	41.2	46.6	38.4	46.6	42.7	46.8	10.7	0.0	0.0	501.1	0.6	0.5	0.1	0.0	0.6	26.2	2.8	2.2	10.5	1.5	0.7	3.7	16.7	0.0	0.0	0.8	0.0	0.4	0.1	0.4	4.6	7.6	3.0	0.0	189.8	0.7	0.0	3.4	1.1	0.5	4.5	5.7	7.5	0.0	1.6	35.3	173.2	0.3	0.0	0.6	3.4	0.3	1.8	0.7	5.4	43.1	0.2	31.2	0.0	172.4	37.6	0.1	0.4	3.8	0.3	0.6	0.0	0.4	0.1	9.6	13.1	5.6	9.2	0.1	2.0	0.1	0.6	0.3	0.9	6.6	1.4	0.2
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 2.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040685, HPA053234"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA040685: AB_2732487, HPA053234: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	0.5	0.1	0.9	0.4	3.9	0.1	0.2	0.1	1.8	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.2	1.0	0.3	0.0	0.0	0.1	1.5	0.1	0.0	0.9	0.1	0.1	0.3	1.4	0.0	0.0	2.8	0.7	1.3	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	0.1	1.8	0.8	0.7	0.3	0.2	0.0	1.4	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	53.8	0.1	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.4	8.9	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	3.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	2.1	3.8	3.9	3.9	4.2	4.6	5.2	4.2	5.5	4.0	4.1	4.3	4.1	2.9	5.5	3.3	4.1	2.8	4.4	4.2	4.3	6.0	9.8	3.6	5.3	3.8	3.9	5.3	7.4	8.4	2.9	4.2	4.0	5.9	5.2	8.0	5.0	4.0	3.6	3.7	4.0	3.2	3.8	4.0	5.2	4.7	4.1	5.0	5.1	3.3	5.3	3.2	1.9	4.1	15.8	13.0	19.3	19.7	2.5	4.2	11.0	9.4	9.5	12.5	14.3	10.2	21.1	12.2	10.4	4.8	9.7	12.9	18.6	8.2	16.1	24.2	16.0	20.7	8.0	13.1	8.2	21.9	18.8	2.8	9.8	10.5	18.5	8.3	7.7	16.3	24.1	12.9	7.1	9.4	10.6	8.8	9.4	12.5	6.9	6.1	23.0	8.0	8.3	7.3	8.4	13.9	5.4	9.2	13.8	13.2	11.0	10.5	6.8	7.2	14.1	9.8	15.6	14.9	18.2	18.6	10.7	31.5	10.5	1.3	0.3	0.7	2.8	0.2	1.8	0.6	1.2	1.9	1.1	0.3	0.8	1.4	0.1	1.0	0.5	0.4	3.2	1.2	3.9	4.2	4.2	5.5	4.2	4.3	3.8	3.9	4.0	3.8	4.1	4.1	0.9	6.4	4.1	4.9	1.3	0.6	0.6	2.8	0.6	4.2	2.9	1.9	9.6	5.7	3.6	1.8	0.0	3.0	2.0	2.2	7.9	1.9	0.7	2.9	1.8	1.6	3.5	6.5	4.9	1.1	1.8	2.5	1.5	2.0	1.3	3.6	1.8	7.7	3.2	6.7	4.7	2.5	4.1	3.8	0.6	0.5	1.5	10.3	0.0	2.8	3.6	3.9	2.1	8.0	4.1	1.6	2.3	1.5	3.0	1.3	1.6	3.7	5.1	3.9	0.0	1.7	1.2	6.0	5.4	2.5	0.6	0.7	3.1	2.4	3.4	0.7
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283429-53347586	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	9.3	8.2	4.3	8.7	4.9	29.9	8.9	11.3	6.8	8.5	5.5	8.5	6.1	11.7	5.8	7.9	9.1	8.2	8.0	4.6	4.9	6.0	6.4	7.7	10.3	4.6	4.6	14.9	6.3	10.3	6.3	10.2	4.8	7.9	8.4	8.6	6.1	6.9	9.5	7.4	7.3	10.4	4.1	9.2	6.8	8.2	5.2	14.2	8.7	9.5	9.8	9.0	7.0	6.3	8.3	8.3	19.4	15.8	13.1	13.5	26.3	9.5	12.5	20.5	19.0	24.7	14.5	18.9	3.7	12.0	12.3	6.8	25.3	9.7	17.8	16.9	11.3	18.5	11.8	12.9	11.4	23.0	24.6	10.7	9.4	18.5	15.0	12.6	15.1	13.2	16.4	20.2	10.1	5.0	30.6	11.2	13.1	8.6	12.1	14.0	12.9	13.2	8.6	18.2	10.1	16.7	16.3	10.7	14.3	14.4	7.0	17.8	16.3	9.8	14.1	10.3	14.5	12.9	11.9	21.9	12.0	12.8	17.8	46.9	25.0	43.0	41.0	25.5	50.4	38.9	41.4	47.8	27.1	48.7	49.6	46.8	26.0	54.3	52.3	31.4	30.9	38.5	4.3	4.9	11.3	6.8	4.6	4.9	4.6	4.6	4.8	4.1	5.2	6.3	28.6	28.9	30.7	26.4	43.6	57.5	48.5	32.4	48.9	27.5	32.7	25.5	26.4	15.7	24.7	7.3	47.9	41.1	34.5	25.5	3.9	29.2	10.8	21.5	33.4	33.5	51.8	20.2	43.4	35.1	52.3	33.6	18.3	34.0	36.8	34.8	24.7	13.2	19.9	28.6	40.5	27.6	24.4	27.6	48.9	26.3	24.8	29.2	10.6	20.6	35.2	18.3	30.9	40.7	44.2	45.0	19.6	25.9	31.8	48.4	22.3	13.5	14.2	30.3	13.1	39.2	32.5	12.8	19.1	27.4	41.2	64.0	39.1	27.7	27.9	62.1
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946053-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 36.2;Early spermatids: 55.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 27.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039709	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	9.2	16.4	3.4	3.4	3.4	1.6	8.8	3.0	3.6	15.0	3.9	26.2	3.0	21.9	5.8	6.6	13.8	4.0	4.5	3.2	3.6	7.9	10.0	7.9	4.8	2.9	3.0	13.1	9.0	5.5	13.6	3.7	2.9	14.4	5.0	5.0	7.7	6.7	10.5	8.1	10.2	9.2	2.9	9.2	11.9	20.7	3.5	6.7	9.4	5.1	4.6	18.2	10.9	3.1	0.1	3.8	6.9	5.3	8.5	10.7	11.5	4.7	9.2	5.8	7.1	0.6	6.0	9.4	1.6	6.9	5.0	0.0	4.6	5.0	5.1	15.8	5.0	3.9	3.0	5.6	11.3	5.6	4.5	8.1	8.1	5.2	4.5	12.0	9.6	7.2	2.5	3.7	7.1	4.5	7.8	4.6	15.0	3.4	1.4	4.6	3.3	1.7	6.8	0.0	1.0	5.0	4.0	3.3	3.4	15.4	3.4	5.1	5.7	2.8	10.0	6.4	4.9	3.1	2.5	6.5	6.6	3.8	7.1	5.3	2.9	0.3	10.0	4.2	12.5	5.1	10.3	9.8	5.4	4.9	7.8	10.2	0.5	5.9	5.0	2.6	27.3	5.5	3.4	3.4	3.0	3.6	3.2	3.6	2.9	3.0	2.9	2.9	3.5	3.1	4.9	6.4	4.6	36.2	6.4	0.9	4.1	7.5	5.2	6.4	4.0	5.0	2.5	1.5	5.7	7.3	10.4	6.5	5.1	4.0	13.7	7.3	55.2	6.6	8.7	5.8	2.4	3.0	24.3	4.2	4.8	7.6	8.2	2.8	5.7	12.2	3.3	5.9	5.7	6.7	28.9	4.6	14.2	3.5	0.9	19.8	5.6	3.7	1.8	17.8	6.5	4.1	2.1	37.7	35.3	4.9	5.8	9.4	5.8	3.0	8.1	7.2	5.2	7.0	0.0	3.7	7.1	23.6	10.2	4.5	2.4	2.9	8.6	10.3	5.1	2.9
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.6;skin 1: 3.1;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 37.0;Late spermatids: 18.8;Rod photoreceptor cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;HeLa: 2.2;RPMI-8226: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA060314: AB_2684250"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.3	0.0	0.0	3.1	0.8	0.0	0.0	0.1	0.2	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	1.1	0.6	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	1.4	0.7	0.2	0.0	0.3	2.1	0.0	0.0	0.0	0.5	0.1	0.1	2.2	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.4	0.0	0.1	0.1	0.1	0.9	0.0	0.4	2.4	0.0	0.3	0.3	0.7	0.2	0.8	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.3	0.1	0.4	0.4	0.1	0.3	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.0	0.2	0.0	0.7	0.0	1.3	0.0	12.5	0.0	0.0	0.0	0.0	0.0	37.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	18.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	6.6	0.0	0.0	0.1	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436811-94479682	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"skin 1: 107.4"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 3552.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	272	"SK-MEL-30: 257.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.4	0.4	0.6	0.0	1.0	0.1	3.0	0.4	0.7	0.2	0.2	0.3	0.0	0.3	0.9	0.0	0.9	0.1	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.6	0.6	0.4	0.4	0.0	1.6	0.0	0.5	0.3	0.0	0.9	1.5	0.3	0.4	107.4	0.1	0.1	0.6	0.1	0.1	0.6	0.6	0.5	0.2	0.1	0.0	0.2	0.3	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	257.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.4	0.7	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.5	0.0	0.0	0.0	23.5	0.0	152.3	0.1	0.0	0.0	1.0	0.3	0.5	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.5	0.1	1.2	0.0	0.0	16.1	0.2	0.0	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	25.5	23.8	0.9	0.0	3552.1	1.9	0.0	3.5	0.0	6.6	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	1.0	0.5	0.8	0.0	33.4	0.0	0.9	0.1	0.0	0.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	50.8	83.8	39.0	41.6	40.3	29.5	46.7	40.1	44.8	48.9	51.1	41.4	33.1	47.8	29.7	61.2	49.0	54.7	40.6	39.8	43.6	48.9	79.8	41.2	45.2	43.0	42.8	65.8	54.9	61.8	46.9	36.7	40.2	39.9	40.9	25.1	44.6	41.7	41.7	39.3	36.3	46.4	43.8	50.3	54.1	21.8	42.6	42.2	100.8	32.9	49.6	50.1	45.6	46.0	97.8	87.4	88.4	81.3	129.6	176.7	115.0	184.1	163.0	128.7	79.7	89.2	183.0	33.5	44.3	179.9	87.1	47.3	65.5	114.9	117.1	163.8	50.4	155.9	50.4	109.1	139.5	153.3	93.3	149.8	120.8	113.6	117.8	129.6	112.2	73.1	157.4	324.5	175.6	71.5	100.1	94.7	70.0	39.8	79.3	107.3	62.2	65.8	107.9	115.1	86.7	54.3	86.7	73.8	87.4	81.2	56.7	78.8	131.7	105.7	81.7	52.0	142.0	124.5	72.9	42.8	117.4	98.5	127.1	68.6	47.9	45.2	61.0	58.8	76.8	71.0	52.6	62.7	55.0	48.6	51.6	54.6	3.3	73.7	60.2	42.4	50.6	55.6	39.0	40.3	40.1	44.8	39.8	43.6	43.0	42.8	40.2	43.8	42.6	46.0	31.6	12.8	19.5	8.8	31.7	25.4	34.4	35.4	37.5	4.9	39.4	34.2	24.3	38.6	21.5	33.1	4.2	19.0	26.6	16.8	37.2	68.8	7.0	19.7	41.6	30.9	14.5	27.1	10.7	54.5	26.8	42.3	15.8	22.3	22.8	36.2	30.0	45.2	53.8	3.3	11.7	28.5	18.3	38.8	32.1	18.0	44.1	29.4	26.6	9.4	34.8	37.4	25.7	3.0	3.1	75.5	18.5	35.3	27.6	46.1	19.3	45.8	18.7	5.5	32.9	25.8	34.6	10.2	15.4	54.5	23.0	7.3	27.6	42.4	31.3	42.3
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57529633-57547224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		630000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	85.7	99.7	76.3	40.7	80.5	44.6	76.7	88.6	86.1	91.3	62.5	104.6	44.6	98.3	61.8	120.2	71.9	43.6	102.3	81.4	87.9	84.9	50.7	71.7	43.3	91.1	85.1	75.8	116.0	78.2	75.7	52.4	95.5	66.4	73.5	61.3	82.9	65.4	155.2	103.7	75.9	93.3	82.1	64.2	94.9	51.9	82.7	61.4	69.9	102.7	71.4	79.6	89.8	89.9	94.9	109.4	129.1	90.3	194.7	200.0	69.4	104.7	191.7	205.0	149.6	87.2	79.0	95.5	114.1	172.5	83.8	70.8	106.0	136.4	162.0	108.7	119.1	84.8	48.4	69.9	139.3	58.7	60.0	186.3	213.8	131.5	225.1	245.6	201.9	102.0	127.7	126.6	189.5	107.4	89.3	71.8	62.4	56.2	124.0	77.2	101.0	91.4	158.1	92.3	173.2	125.8	98.3	85.2	96.7	104.0	138.5	54.4	153.5	110.6	95.6	69.1	66.7	94.6	91.6	93.8	106.4	73.8	121.2	47.9	48.5	43.7	38.0	54.2	39.3	32.9	37.9	38.0	49.2	30.3	28.1	34.3	22.5	35.1	50.3	37.5	45.5	62.8	76.3	80.5	88.6	86.1	81.4	87.9	91.1	85.1	95.5	82.1	82.7	89.9	82.6	48.1	30.2	20.2	47.5	64.9	87.2	105.1	58.6	84.3	64.7	76.7	70.9	65.8	60.0	35.0	31.3	118.2	53.5	83.4	80.3	162.7	105.5	42.9	58.6	74.0	49.1	53.6	27.9	227.5	122.1	73.6	80.5	52.4	36.2	70.8	69.9	31.7	102.6	72.3	32.6	70.3	83.4	51.8	54.2	265.5	77.9	52.8	76.5	15.0	153.5	141.9	57.7	23.1	28.2	200.4	85.5	73.0	60.9	85.3	121.1	115.8	40.9	67.8	92.1	59.4	107.6	122.7	37.1	93.6	68.5	163.4	52.6	92.3	94.5	89.5
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	72.9	87.9	98.3	33.7	104.6	107.3	72.2	97.0	123.5	80.6	92.9	81.1	42.0	72.9	46.8	98.5	66.4	38.7	127.1	106.0	103.3	88.6	67.0	60.8	48.0	97.1	97.2	78.7	76.5	94.4	108.4	40.7	102.4	68.2	39.0	57.0	69.2	51.4	152.5	111.1	51.1	53.6	94.1	58.7	75.6	36.3	100.3	81.3	71.5	114.4	59.0	69.5	79.2	95.6	147.1	120.7	110.1	115.6	95.1	132.3	45.1	122.7	112.8	166.4	130.2	77.7	53.8	67.0	74.6	161.8	58.4	57.4	101.0	128.3	105.6	211.9	126.5	44.9	202.9	68.5	102.6	118.8	131.3	117.5	109.4	115.6	75.0	81.4	111.1	123.6	54.2	135.3	147.4	120.9	151.4	320.0	33.4	61.0	192.7	75.2	59.7	93.4	81.5	51.2	36.5	93.3	90.9	82.7	48.0	32.2	110.6	134.5	102.7	104.6	84.1	120.1	121.0	90.6	126.0	45.5	164.1	68.6	217.4	235.2	131.1	187.4	99.9	139.4	92.1	88.4	106.0	106.8	133.8	94.7	83.6	98.9	114.4	102.2	150.3	136.1	179.1	152.5	98.3	104.6	97.0	123.5	106.0	103.3	97.1	97.2	102.4	94.1	100.3	95.6	103.7	32.1	38.3	13.1	61.3	101.6	111.8	180.7	82.0	83.2	97.3	146.9	86.1	77.2	91.8	80.9	25.0	128.8	105.6	74.1	207.4	127.5	14.3	78.6	98.8	79.2	74.7	115.7	16.8	154.6	111.9	97.9	56.6	67.1	87.5	82.4	88.5	84.9	133.8	74.0	16.2	64.9	91.6	88.8	99.0	21.1	103.5	76.8	149.4	5.6	94.9	212.9	125.7	7.5	16.8	126.7	84.5	122.6	89.1	54.7	89.0	240.2	95.0	96.7	59.2	82.0	150.5	82.2	72.9	109.9	142.6	99.7	95.7	143.2	61.6	96.6
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.6	31.8	29.4	16.5	30.1	56.5	30.1	30.6	36.2	21.3	24.1	18.9	19.2	24.2	30.7	23.5	21.0	19.2	25.4	29.9	30.2	23.3	26.6	21.3	14.0	32.1	28.3	29.4	38.1	28.7	20.5	31.3	33.6	27.4	21.6	58.7	18.3	25.0	47.5	22.7	17.0	25.1	29.9	15.0	21.8	28.0	30.4	20.1	29.3	36.8	17.2	19.9	16.2	41.2	25.2	29.3	53.1	87.5	62.8	60.9	43.2	43.1	43.9	52.7	51.9	55.6	30.5	24.9	58.5	53.1	46.2	29.4	67.3	51.6	63.3	48.3	52.5	31.6	32.3	33.8	57.3	38.9	42.5	61.8	45.0	45.9	82.5	53.2	37.4	30.4	48.9	30.3	68.3	26.0	23.6	20.5	26.2	30.1	47.3	20.5	32.1	27.8	38.7	42.4	117.8	49.5	46.0	62.0	66.9	34.0	59.8	51.0	40.8	56.8	30.3	37.7	47.2	26.3	36.8	14.3	65.6	51.2	48.1	3.2	11.2	11.1	5.0	7.8	5.2	4.8	5.7	5.1	11.0	3.8	5.3	6.5	16.1	3.2	6.8	5.1	4.6	5.7	29.4	30.1	30.6	36.2	29.9	30.2	32.1	28.3	33.6	29.9	30.4	41.2	19.3	48.1	29.2	43.4	29.4	17.7	13.2	12.6	52.3	20.8	33.7	21.3	37.2	32.9	13.7	16.5	20.9	22.4	26.8	23.2	11.7	11.8	2.6	23.9	32.7	19.7	37.7	47.3	41.3	16.5	18.0	26.0	40.8	32.2	12.6	32.4	20.7	39.4	31.5	30.3	43.7	27.2	16.2	48.8	19.1	4.7	22.1	35.7	12.4	35.6	20.7	26.4	9.2	46.8	56.2	18.4	19.7	19.2	27.0	17.4	14.7	22.7	20.6	31.9	13.1	15.0	19.5	18.4	24.0	38.6	20.5	29.7	26.2	23.7	19.5	17.9
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641466-23677472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	13.9	11.3	14.6	18.1	18.1	41.5	14.2	10.4	18.3	13.6	3.8	19.2	20.8	14.8	12.0	25.2	13.6	14.2	14.7	17.2	13.0	21.0	10.7	14.0	22.1	11.4	13.6	12.0	15.9	19.8	8.5	20.9	11.1	14.1	24.9	21.5	12.8	14.0	13.9	14.1	22.2	21.7	11.4	15.1	16.7	20.6	12.8	20.9	18.8	14.2	32.2	20.6	10.9	12.9	30.0	58.5	56.0	46.9	39.0	28.9	39.2	51.9	32.1	32.9	39.3	66.5	40.3	42.1	41.2	54.8	34.6	30.6	93.4	50.2	40.5	48.1	37.1	51.9	67.2	93.9	26.5	63.7	38.4	24.3	35.3	40.5	42.8	36.5	52.8	52.0	100.7	31.6	53.3	82.4	49.4	18.4	66.3	43.3	25.5	59.8	48.6	45.9	26.2	62.6	46.8	48.5	45.6	36.7	30.5	49.0	51.2	53.2	71.8	44.0	20.0	34.9	36.6	42.6	68.6	66.2	42.0	31.4	48.8	14.3	16.6	20.3	15.5	14.0	17.1	13.9	14.2	17.0	17.5	10.5	12.0	14.3	7.3	22.0	22.0	12.4	19.0	17.2	14.6	18.1	10.4	18.3	17.2	13.0	11.4	13.6	11.1	11.4	12.8	12.9	19.7	16.0	26.2	12.1	19.1	14.7	14.5	12.9	22.8	52.1	15.5	14.5	27.1	15.7	15.6	20.2	91.8	32.9	16.1	36.2	11.7	23.8	23.2	11.9	22.4	22.5	22.1	27.6	13.4	25.2	36.3	16.3	20.9	20.8	27.8	37.3	17.2	14.2	28.4	52.2	13.2	18.9	12.2	19.1	11.4	23.4	13.1	17.1	7.2	6.5	34.4	32.3	30.9	11.1	12.0	45.7	19.4	18.0	17.4	14.4	31.9	23.3	11.2	45.0	13.1	22.4	18.1	70.4	30.6	20.9	14.2	48.2	18.7	17.9	26.2	22.0
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156319-30183639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	50.6	54.1	48.0	26.6	51.1	43.7	53.0	51.8	74.1	32.3	42.3	37.5	23.8	38.2	43.5	34.3	30.1	32.8	75.6	50.4	54.8	54.2	46.7	34.0	28.3	50.8	49.8	41.5	32.0	72.8	29.7	53.6	51.1	34.7	36.2	42.4	33.6	36.7	36.6	29.0	26.1	42.6	52.9	27.6	31.9	21.9	50.5	37.8	54.6	43.5	31.2	45.8	31.6	58.6	53.6	51.9	64.4	33.8	59.3	80.7	42.1	72.8	87.0	70.4	74.9	33.6	35.8	41.0	76.0	78.8	64.9	39.6	46.1	64.2	83.8	32.4	34.3	57.8	40.9	54.5	45.8	33.6	47.4	68.2	90.4	51.2	54.8	61.5	65.2	58.0	66.4	44.3	77.0	41.7	62.4	53.0	51.6	93.8	32.0	32.4	48.7	35.3	104.6	54.1	105.4	60.0	42.7	53.0	77.9	32.4	50.4	48.3	60.8	37.4	128.9	31.9	52.4	18.1	22.2	51.8	69.7	38.1	68.1	16.7	13.5	5.0	8.1	15.8	9.1	7.1	7.5	9.8	15.9	5.3	9.5	11.4	3.7	11.2	15.9	20.8	8.1	6.8	48.0	51.1	51.8	74.1	50.4	54.8	50.8	49.8	51.1	52.9	50.5	58.6	61.3	25.6	39.7	19.9	34.9	57.2	91.3	127.1	25.6	36.4	45.4	43.2	83.4	47.1	85.3	44.1	14.6	88.5	48.9	28.1	123.3	94.5	18.0	32.5	37.2	58.7	40.8	28.2	19.0	84.5	87.7	56.6	25.0	39.6	46.9	44.0	45.7	42.7	71.4	26.9	17.3	31.6	91.6	43.9	54.8	12.5	80.8	43.2	69.4	15.0	58.4	63.3	17.5	17.6	21.3	91.1	43.1	75.2	32.3	48.8	36.3	147.1	71.6	40.3	52.6	63.1	66.0	44.2	47.3	38.0	63.5	203.6	59.8	49.5	33.0	95.0
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423615-30430030	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002832	Uncertain		Supported	Nucleoplasm,Cytosol		NA	Yes		61000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	21.0	21.4	17.6	27.4	18.4	22.2	30.5	18.7	22.5	18.6	18.9	56.4	32.0	18.6	20.0	28.3	28.1	19.5	31.1	18.4	19.5	39.7	21.8	16.2	35.5	18.1	17.6	14.0	24.9	32.1	10.3	16.0	19.0	21.8	58.4	12.2	25.5	19.3	44.7	25.1	27.7	20.5	18.4	27.8	24.3	9.1	18.1	24.5	20.1	36.9	35.7	27.0	19.1	19.4	124.7	149.8	66.8	85.8	18.4	24.1	61.9	58.4	35.1	87.4	87.9	114.7	103.4	168.1	119.1	36.8	54.9	95.9	141.4	115.1	103.5	89.2	221.0	98.3	61.5	150.3	24.1	177.0	144.2	28.6	64.8	96.4	55.6	25.4	88.7	88.2	125.8	57.4	61.5	217.8	210.0	189.9	88.8	124.2	119.2	293.1	74.8	218.1	98.9	80.2	141.4	80.4	39.0	137.7	55.3	41.5	118.4	73.9	45.9	66.0	59.1	85.8	107.2	36.9	118.4	217.5	43.8	145.7	79.6	70.6	36.7	38.1	54.0	70.0	75.8	146.7	68.4	61.4	86.7	128.7	60.9	59.0	4.6	76.1	79.2	94.6	76.4	81.0	17.6	18.4	18.7	22.5	18.4	19.5	18.1	17.6	19.0	18.4	18.1	19.4	34.0	19.2	15.2	0.7	38.2	90.2	53.3	92.5	33.6	23.3	45.8	48.9	34.8	51.5	37.9	44.1	8.4	103.2	22.7	130.3	127.2	135.6	13.4	32.6	29.9	47.4	38.5	29.6	2.6	124.8	101.0	28.3	27.5	66.5	31.1	40.2	31.1	23.2	76.9	15.2	2.7	142.3	73.2	21.0	49.1	45.1	19.6	26.9	48.0	1.0	73.2	25.0	23.7	2.5	4.4	89.0	115.8	19.9	24.1	86.9	68.8	76.7	27.8	21.4	19.7	23.7	40.0	3.3	44.8	39.4	80.3	27.8	28.3	53.8	168.5	45.7
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 246.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 13031.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	14.7	12.3	10.5	12.3	13.9	22.4	13.0	13.2	16.3	11.6	4.0	14.0	13.7	12.9	9.4	18.1	10.4	12.8	15.7	10.0	10.6	19.2	31.5	10.6	15.4	11.0	12.3	12.4	10.2	12.0	8.4	12.6	13.0	13.6	13.1	11.3	11.0	13.9	34.5	14.4	14.4	15.4	11.6	12.5	11.4	246.2	12.0	13.6	17.7	38.1	17.5	14.9	10.2	18.3	54.3	23.5	31.0	13.1	32.4	30.8	26.3	33.9	37.8	37.4	36.2	34.9	39.0	63.6	72.5	32.2	56.4	29.4	27.6	28.5	49.8	52.2	14.3	61.1	17.2	14.8	20.2	36.6	44.3	23.3	32.6	22.3	20.7	28.3	26.7	38.0	20.6	32.6	27.9	28.8	36.2	19.0	25.3	40.4	21.7	27.9	32.4	41.6	27.5	37.6	22.4	22.3	59.7	41.9	33.1	32.6	86.0	29.0	25.6	22.9	22.2	31.7	40.3	26.5	53.3	64.0	29.0	33.8	33.8	10.2	8.5	16.3	6.7	9.2	6.6	6.4	5.6	6.6	10.0	4.1	6.2	6.8	13.7	10.5	6.2	7.5	7.4	5.5	10.5	13.9	13.2	16.3	10.0	10.6	11.0	12.3	13.0	11.6	12.0	18.3	23.5	22.4	29.5	54.2	22.3	43.3	26.0	28.3	23.3	13.2	26.6	15.4	32.5	21.5	30.1	47.8	10.4	18.8	36.3	29.1	37.2	28.3	2437.8	24.0	29.9	23.7	26.9	98.1	52.7	30.5	18.7	29.0	18.3	26.3	29.8	22.1	17.9	52.6	28.6	18.5	40.9	19.6	30.5	45.9	54.2	13031.2	86.6	39.5	12.4	30.0	45.9	18.1	20.6	37.7	91.9	31.9	24.1	64.3	20.2	42.0	27.3	42.3	24.0	22.6	78.9	35.9	37.4	124.6	58.7	25.7	42.5	20.0	27.1	15.3	20.7	43.6
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490951	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.6;skeletal muscle: 108.7;tongue: 69.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 79.6;Excitatory neurons: 43.9;Inhibitory neurons: 37.9;Oligodendrocytes: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 11.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	8.1	8.4	9.7	4.4	8.8	14.0	7.6	23.4	14.6	8.9	30.1	9.2	4.6	9.4	9.4	6.4	7.7	5.4	98.6	8.5	9.7	8.3	8.5	7.7	7.2	12.6	9.9	8.1	7.1	5.9	10.5	7.4	13.4	7.5	6.4	16.8	9.0	4.8	108.7	14.4	8.3	7.4	8.5	9.4	8.3	9.0	10.2	8.1	4.5	69.1	7.3	7.0	7.4	15.3	13.3	7.5	13.0	9.5	9.8	8.3	10.6	10.0	11.4	9.0	10.8	27.4	7.3	9.8	3.4	11.3	13.9	17.2	13.8	7.1	12.5	6.7	23.4	15.6	40.9	7.5	6.0	24.5	11.2	12.0	11.6	9.8	9.0	6.2	8.3	12.9	9.2	8.4	8.6	9.0	16.6	38.1	8.9	9.7	11.8	16.9	20.8	11.2	6.4	8.3	54.7	12.2	6.9	24.6	7.0	8.8	14.1	10.6	12.7	11.3	16.4	9.0	14.3	25.5	11.4	19.2	25.3	10.4	7.7	11.3	1.5	2.2	2.0	1.0	2.5	1.9	1.8	1.4	1.6	0.9	1.8	0.9	0.8	1.9	1.5	0.2	2.0	1.5	9.7	8.8	23.4	14.6	8.5	9.7	12.6	9.9	13.4	8.5	10.2	15.3	7.6	16.0	15.6	27.4	2.4	5.9	2.0	2.3	1.8	9.0	6.7	4.3	79.6	0.0	8.4	3.7	16.7	2.4	2.5	4.8	1.9	1.7	5.9	5.0	6.5	7.1	6.6	3.0	43.9	1.3	1.4	6.6	8.2	6.0	5.1	4.6	5.7	3.9	1.4	18.5	37.9	4.4	0.0	3.5	4.4	8.3	7.2	4.2	5.4	18.7	2.2	4.8	3.1	30.2	42.8	2.1	1.3	5.7	2.0	3.7	3.4	2.5	4.6	9.6	0.0	3.5	3.7	3.8	4.2	4.3	7.4	2.6	3.5	5.2	3.9	3.2
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 58.6;Late spermatids: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.2;ASC TERT1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	20.6	9.5	3.9	6.3	4.3	2.8	9.3	5.5	4.6	8.3	4.1	6.2	3.3	6.2	2.5	8.3	6.9	9.7	7.1	3.4	4.8	5.2	11.9	9.9	2.6	4.0	4.0	5.0	6.8	4.4	4.7	7.9	4.0	5.4	3.9	12.6	3.7	4.1	28.5	7.1	4.0	8.6	3.7	4.4	5.9	8.3	4.8	3.2	4.4	4.0	2.6	8.3	9.4	7.2	4.8	8.6	4.2	8.7	52.2	38.9	5.4	16.1	13.6	7.9	10.5	10.7	8.5	3.0	12.6	15.8	4.7	6.1	4.8	6.7	10.6	4.0	2.9	2.5	7.1	15.8	13.6	3.7	23.9	25.9	9.0	15.2	8.5	8.4	22.2	2.9	2.9	7.4	16.4	6.6	3.4	5.5	9.9	4.1	2.7	6.1	4.5	2.6	7.0	5.0	3.6	4.8	6.2	6.2	3.6	4.7	4.2	1.8	10.9	16.5	5.4	6.9	4.4	6.9	4.3	2.0	17.1	4.1	8.3	1.3	0.3	0.2	0.4	0.6	0.3	0.2	0.2	0.6	0.4	0.3	0.3	0.6	0.3	0.6	0.5	0.2	0.2	0.2	3.9	4.3	5.5	4.6	3.4	4.8	4.0	4.0	4.0	3.7	4.8	7.2	25.6	12.8	19.3	4.6	2.9	31.4	11.7	7.5	19.4	12.4	19.0	10.8	5.2	2.8	7.2	9.2	35.5	3.6	8.2	6.3	0.0	3.8	58.6	14.5	16.2	18.4	20.3	1.3	10.6	5.2	2.0	16.5	5.6	34.3	0.0	4.2	9.7	16.3	2.3	13.5	9.7	4.3	6.1	5.0	20.6	48.5	10.8	15.8	12.4	1.9	1.8	5.2	1.0	10.6	10.8	4.9	1.2	9.8	3.3	6.1	3.0	5.2	4.3	24.8	6.6	20.1	19.6	6.4	3.7	10.7	22.6	5.1	5.9	4.1	4.7	18.3
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 111.9;Oligodendrocytes: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	14.0	17.8	14.5	7.3	14.1	2.8	9.8	14.4	20.3	13.3	8.1	15.0	5.9	13.6	11.5	10.4	12.7	11.4	12.1	13.4	17.3	14.9	28.9	9.1	7.5	16.0	16.2	16.0	9.1	9.5	15.7	6.9	17.2	12.0	8.5	15.7	13.4	16.9	11.8	7.7	9.7	17.3	14.2	9.4	13.3	17.0	18.9	6.5	13.2	11.4	6.1	16.9	10.9	16.4	10.6	18.9	25.5	36.7	25.6	27.5	9.8	31.1	23.2	18.0	15.9	11.8	12.1	8.1	20.1	35.2	23.5	11.2	31.0	19.8	27.8	4.9	9.5	13.8	14.9	28.7	54.9	20.4	17.9	25.1	23.7	19.6	17.9	27.0	19.2	7.4	15.6	5.9	35.3	15.2	24.1	13.6	14.5	21.1	15.1	11.4	12.2	4.4	23.1	12.4	14.4	15.6	13.1	17.8	28.9	13.9	18.4	12.3	28.8	24.0	19.7	19.7	25.7	11.1	18.1	7.3	16.6	18.8	14.4	6.8	3.6	8.8	5.7	3.3	8.5	3.6	6.4	6.5	2.5	2.4	6.0	6.8	1.4	3.7	2.4	1.5	3.2	4.4	14.5	14.1	14.4	20.3	13.4	17.3	16.0	16.2	17.2	14.2	18.9	16.4	13.1	6.4	14.1	86.2	9.7	37.2	19.2	16.5	16.5	23.3	18.1	11.7	40.6	14.3	13.2	16.5	16.7	5.0	9.8	14.9	13.7	10.6	76.3	10.7	16.1	17.9	6.7	11.8	90.9	12.2	8.5	23.1	21.9	10.0	13.3	18.9	17.2	35.8	8.2	30.3	88.6	7.2	12.2	7.3	18.4	111.9	14.9	7.2	32.0	51.5	5.3	14.9	15.5	69.4	131.4	13.3	10.9	25.9	6.3	17.2	8.9	24.1	18.1	17.8	0.0	13.4	20.8	24.6	25.5	17.3	33.2	3.4	11.1	12.4	8.9	15.0
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103050686-103092194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	15.8	14.6	11.9	4.2	12.7	4.7	13.2	16.6	17.5	11.3	7.9	11.3	1.4	11.1	3.8	21.4	10.3	1.8	23.9	13.3	12.8	14.3	13.7	11.0	5.1	11.8	13.0	9.1	14.2	3.0	13.0	3.3	12.1	11.3	2.2	7.5	12.2	3.0	31.3	11.8	9.4	2.7	13.2	12.3	13.3	18.5	13.5	4.5	9.2	7.7	4.1	11.9	12.1	13.0	18.2	14.5	18.8	16.3	11.6	13.2	10.0	17.9	6.8	9.0	12.7	51.2	24.8	8.0	32.8	13.3	29.0	21.3	24.3	24.0	16.1	9.7	22.4	21.6	16.2	22.3	18.7	33.7	12.4	7.6	23.8	17.7	22.8	18.3	18.1	32.6	26.3	0.1	10.5	21.6	24.4	46.5	24.5	33.6	32.9	9.5	15.1	22.4	15.4	33.9	12.8	11.0	10.0	21.8	21.4	25.1	20.4	22.4	4.0	12.4	14.8	16.6	17.6	7.8	12.5	33.0	7.9	31.4	13.0	12.8	6.6	6.5	8.7	8.5	10.2	11.3	10.8	9.5	9.5	9.3	9.3	10.3	2.5	15.1	7.1	11.1	11.8	9.3	11.9	12.7	16.6	17.5	13.3	12.8	11.8	13.0	12.1	13.2	13.5	13.0	24.9	16.0	11.0	26.8	30.2	79.5	63.2	101.6	38.1	11.7	34.4	36.2	30.7	15.7	42.8	9.2	8.4	57.2	29.3	8.2	49.0	59.5	5.0	26.5	38.2	27.2	14.4	52.1	50.7	55.6	88.6	35.6	21.9	25.3	15.8	37.3	16.1	25.3	44.7	6.7	39.6	17.9	67.1	29.8	32.4	8.4	14.3	22.7	30.2	15.9	26.5	18.9	15.5	25.6	27.5	63.1	12.2	19.5	52.8	92.6	8.6	39.2	28.0	14.1	26.3	31.5	74.6	121.6	119.8	59.0	83.7	43.8	30.9	59.8	23.2	73.0
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;endometrium 1: 1.4;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Inhibitory neurons: 90.2;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 52.5;SH-SY5Y: 22.1"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 74.0"	"Region enriched"	"Detected in all"	4	"olfactory bulb: 68.6"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.1	0.2	2.1	0.0	2.4	0.0	1.3	0.0	2.5	0.1	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	52.5	22.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	2.5	1.4	2.7	0.2	1.3	0.8	0.0	2.4	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.6	2.2	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	39.1	0.0	0.2	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	90.2	0.2	0.0	0.0	0.4	0.5	0.0	0.0	1.8	1.9	0.0	1.6	0.0	49.8	2.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.2	0.0	0.0
DCXR	"DCR, HCR2, KIDCR, P34H, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 1851.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4"	"Group enriched"	"Detected in all"	5	"liver cancer: 305.9;prostate cancer: 163.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 365.2;MCF7: 446.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	106.7	43.9	93.1	15.2	95.3	25.3	107.6	102.5	111.1	52.0	84.4	49.6	29.2	39.5	281.3	96.6	59.2	10.8	132.7	87.6	100.7	239.9	1851.6	61.0	16.6	102.4	98.0	70.0	71.6	46.1	63.9	20.2	105.9	138.0	20.9	9.7	103.4	33.6	187.3	87.6	44.4	10.4	91.8	35.8	167.0	44.8	105.9	26.1	60.7	80.6	19.6	48.9	62.1	94.9	50.3	68.2	32.8	56.4	123.2	31.8	80.4	25.0	33.9	68.5	48.4	122.0	21.3	100.3	47.4	35.9	9.4	57.4	59.6	52.6	24.1	21.4	145.9	96.9	48.8	365.2	143.2	75.6	114.5	44.6	62.2	22.7	79.8	16.0	41.1	61.1	112.4	76.3	36.5	446.2	63.7	184.1	35.0	242.9	71.3	57.9	42.0	135.3	53.3	71.9	85.5	51.0	35.5	287.5	46.0	19.7	213.4	74.5	20.5	36.6	45.0	48.9	48.2	73.7	56.2	50.2	31.4	83.0	26.7	49.5	92.6	77.9	66.5	92.0	64.1	86.8	83.0	64.7	151.3	99.2	117.7	85.4	47.2	108.9	88.1	121.6	98.9	110.1	93.1	95.3	102.5	111.1	87.6	100.7	102.4	98.0	105.9	91.8	105.9	94.9	29.0	51.3	198.2	16.6	133.6	58.5	200.3	113.5	109.8	16.0	301.8	269.2	120.7	183.0	123.4	178.4	18.8	372.1	116.6	152.9	812.0	41.4	6.0	67.0	50.9	44.6	54.7	335.7	4.7	42.6	450.6	65.0	151.4	102.3	64.7	62.7	138.5	3510.3	164.7	21.9	9.0	170.4	189.2	165.7	65.6	22.6	70.8	82.3	179.7	1.9	52.8	145.1	78.2	5.5	10.5	30.4	135.7	47.4	98.6	215.2	158.9	2919.4	55.4	26.5	19.7	40.6	79.6	10.3	48.2	219.9	73.2	342.6	135.7	118.6	154.6	178.8
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323298	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 416.9;Syncytiotrophoblasts: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	7.9	11.5	15.8	5.1	14.4	7.1	7.8	12.2	19.9	7.8	10.4	11.5	5.7	8.6	3.4	10.9	8.4	4.0	12.0	14.7	15.3	9.8	10.9	9.6	6.2	14.0	15.0	7.3	6.8	6.1	8.0	8.0	14.4	10.0	4.8	3.8	8.7	5.4	9.5	13.0	11.2	4.2	13.1	9.9	10.1	10.1	15.2	7.3	7.9	5.0	4.7	9.3	8.0	13.2	15.6	13.5	10.1	8.2	10.5	7.5	15.6	10.1	13.0	15.4	14.1	12.0	13.8	6.0	13.7	10.6	7.3	13.2	7.5	15.0	7.8	9.9	19.4	7.2	11.1	11.5	12.5	8.3	14.2	11.5	17.5	9.3	8.7	9.5	9.1	13.9	8.9	10.7	8.4	7.8	17.5	12.7	11.7	16.0	22.3	11.0	7.8	10.3	12.6	11.5	10.4	15.2	7.3	17.8	9.5	6.1	9.0	11.6	13.7	10.6	8.7	26.9	14.6	12.8	18.2	8.6	23.3	14.4	10.6	3.0	3.8	6.4	4.2	4.3	3.6	3.7	3.5	4.2	3.2	3.2	3.9	3.9	4.0	3.4	3.8	6.8	4.8	3.4	15.8	14.4	12.2	19.9	14.7	15.3	14.0	15.0	14.4	13.1	15.2	13.2	24.4	28.9	14.1	13.4	26.3	54.6	38.6	84.0	30.1	18.4	41.8	30.5	17.1	11.5	54.2	27.6	12.5	140.5	38.5	70.4	39.2	77.2	416.9	48.6	32.8	26.4	20.3	29.9	10.4	46.4	152.8	26.8	34.7	53.7	38.7	25.2	20.3	26.3	65.0	13.5	9.8	43.4	54.9	22.4	36.8	130.3	22.4	34.2	30.2	7.5	57.2	34.1	58.7	4.5	10.8	139.6	79.9	27.1	31.8	41.4	47.4	55.1	43.7	19.0	19.7	19.5	36.0	107.7	40.0	36.8	61.8	253.5	34.2	31.5	28.6	89.5
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239217	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;monocytes: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	13.2	22.5	2.6	8.2	3.2	11.6	13.5	3.4	3.6	12.5	3.4	12.8	7.6	12.7	11.7	24.8	17.6	12.5	6.8	2.5	2.4	4.4	27.0	12.2	14.7	3.4	2.7	11.6	14.4	4.8	4.7	6.8	3.5	9.7	14.9	2.3	14.4	11.7	6.2	46.7	10.2	13.9	2.7	11.3	9.5	4.5	3.2	23.5	5.5	6.9	17.0	11.2	14.1	3.6	23.7	62.3	25.9	19.3	16.6	32.7	29.9	26.0	58.8	32.0	37.1	10.1	14.1	56.6	5.3	23.2	23.6	40.8	14.6	51.8	15.7	14.5	27.5	13.3	55.7	46.7	15.8	15.9	34.4	43.4	58.0	15.9	35.2	10.2	94.2	14.7	3.5	27.0	52.7	44.4	60.4	7.7	8.4	31.1	22.3	30.3	5.6	30.6	13.5	22.7	13.2	16.7	31.2	8.7	8.1	30.8	56.1	5.5	41.2	96.8	44.1	21.3	12.6	27.6	22.4	12.5	37.0	20.2	35.9	9.8	12.8	20.2	19.3	18.4	18.8	18.3	20.1	18.8	10.4	14.5	14.8	15.7	3.7	14.1	15.8	0.3	47.7	15.9	2.6	3.2	3.4	3.6	2.5	2.4	3.4	2.7	3.5	2.7	3.2	3.6	13.8	16.0	22.2	7.8	25.1	38.9	39.7	28.1	75.1	5.0	18.0	25.8	7.8	11.5	16.3	5.5	10.4	3.6	21.3	11.1	9.8	12.5	1.5	5.2	8.1	19.5	7.7	19.1	6.6	13.8	9.0	16.0	18.3	9.5	22.8	31.2	15.0	16.6	17.5	1.7	1.4	12.6	16.2	17.5	12.8	2.1	19.0	16.8	19.6	24.4	135.5	9.6	35.0	1.0	10.6	19.9	9.8	10.5	34.1	8.9	15.7	7.7	13.9	12.8	0.0	12.1	14.0	3.1	8.6	34.5	30.3	1.5	34.3	25.4	16.5	26.5
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DDHD1	"KIAA1705, PA-PLA1, SPG28"	ENSG00000100523	"DDHD domain containing 1"	Q8NEL9	14	53036745-53153323	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 280.9;Excitatory neurons: 140.5;Late spermatids: 146.3;Oligodendrocytes: 177.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049870	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA049870: AB_2680925"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.14e-3)"	"unprognostic (9.40e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.67e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	4.5	3.6	5.7	6.0	6.6	8.7	3.9	9.7	10.1	5.3	0.8	3.8	2.5	5.0	2.2	2.5	3.7	4.6	5.1	6.8	6.9	2.3	2.6	5.2	10.0	6.9	6.6	5.1	2.9	4.4	5.3	7.5	7.6	3.7	4.6	16.7	2.3	4.1	3.1	3.3	4.7	5.1	4.2	6.2	3.8	30.7	6.6	6.6	3.5	5.3	8.5	5.4	3.4	10.3	8.7	10.2	32.5	12.7	14.0	12.7	6.7	13.0	9.8	9.4	10.3	2.4	1.7	23.3	6.4	9.1	8.7	3.7	15.8	3.6	11.3	12.8	7.0	3.0	8.7	4.7	12.1	10.6	10.3	6.9	4.3	10.0	8.4	6.7	7.1	7.9	5.9	19.6	11.0	9.2	12.6	5.4	6.7	5.6	8.4	9.6	34.0	4.0	5.0	11.3	14.5	9.3	15.2	4.2	4.4	5.7	5.9	6.9	10.5	8.9	13.9	13.4	9.6	9.1	6.3	15.3	4.7	9.6	5.0	1.6	1.4	1.2	4.6	2.2	4.4	3.2	3.7	5.1	1.7	2.6	3.2	3.9	0.8	4.6	3.7	1.5	5.3	1.3	5.7	6.6	9.7	10.1	6.8	6.9	6.9	6.6	7.6	4.2	6.6	10.3	12.0	6.4	15.4	69.9	40.4	6.1	7.1	3.5	23.9	64.2	9.3	7.0	13.2	7.2	3.6	9.2	87.6	17.6	46.5	3.2	0.0	6.8	280.9	8.7	38.7	19.1	8.4	27.8	140.5	6.7	7.4	25.4	7.7	15.3	7.6	20.0	5.3	5.8	16.2	45.4	120.6	5.0	2.0	18.5	13.3	146.3	13.7	31.5	5.4	38.4	22.1	19.1	49.4	104.0	177.9	5.1	3.4	20.7	42.7	8.2	1.9	4.9	6.7	35.0	19.7	17.1	15.8	57.4	46.6	9.7	6.0	17.4	42.4	24.9	5.6	5.9
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	28.9	18.1	27.3	14.4	32.1	14.9	19.4	33.8	39.7	22.0	23.5	20.1	19.6	20.9	23.3	20.9	19.1	17.5	27.7	30.1	29.3	21.6	12.1	16.9	19.8	32.1	27.7	28.9	22.2	21.1	18.3	15.2	35.1	22.6	16.7	31.7	18.3	29.3	32.0	16.8	22.2	18.2	30.7	17.2	15.0	22.7	32.4	19.5	18.7	35.8	22.3	17.6	17.7	38.8	57.7	26.1	58.3	28.3	21.8	30.6	18.4	18.1	33.0	42.5	38.4	30.8	22.6	22.8	24.1	32.8	26.3	22.7	33.9	34.1	64.9	19.8	22.6	83.0	36.0	29.9	19.6	9.6	12.8	16.0	26.4	26.4	26.8	27.0	51.5	31.2	59.6	24.5	27.3	12.3	66.6	14.7	13.2	9.5	15.1	34.0	50.1	16.5	22.5	34.8	21.2	32.0	44.4	21.9	22.2	18.2	26.3	26.1	46.6	24.8	31.1	24.3	28.4	25.7	25.8	54.0	39.5	18.4	35.3	2.5	3.9	4.7	10.6	4.9	11.8	9.8	9.6	11.9	6.5	15.2	10.2	7.5	0.3	16.5	3.5	3.8	15.6	7.3	27.3	32.1	33.8	39.7	30.1	29.3	32.1	27.7	35.1	30.7	32.4	38.8	15.4	22.4	7.0	20.5	17.3	13.8	10.6	8.2	14.2	27.9	12.7	7.4	23.9	8.6	8.4	20.2	18.8	12.1	16.2	7.2	23.5	11.6	4.5	9.7	13.4	13.8	15.7	25.2	51.3	11.0	11.5	13.6	12.8	12.4	21.0	22.8	12.5	5.5	7.4	53.8	51.2	9.3	6.1	8.4	11.2	10.8	20.2	7.7	19.6	21.5	13.0	19.9	16.5	35.7	46.9	16.2	6.2	20.7	24.0	10.2	23.8	10.0	5.4	5.9	6.6	17.6	13.6	30.9	35.3	8.7	10.7	6.4	17.9	13.4	8.9	7.7
DDI1	FLJ36017	ENSG00000170967	"DNA damage inducible 1 homolog 1"	Q8WTU0	11	104036640-104039196	"Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 25.5"	"Group enriched"	"Detected in some"	74	"Early spermatids: 409.1;Late spermatids: 921.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA079511	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA079511: "										"unprognostic (2.98e-1)"				"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	409.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	921.4	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617458-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	10.8	6.0	3.4	6.3	3.9	10.7	10.2	4.3	4.6	8.1	4.6	6.4	7.9	8.7	6.6	15.8	6.0	5.1	6.8	4.1	3.7	7.9	21.8	7.8	8.6	4.0	3.8	5.8	7.0	10.2	3.9	7.4	4.1	10.0	6.6	10.2	10.2	5.3	26.8	10.9	7.1	6.4	3.5	6.9	5.8	3.0	3.8	7.7	6.4	11.7	9.7	7.9	10.4	5.3	11.4	6.5	11.6	12.1	15.5	12.2	11.2	7.0	5.3	6.0	5.2	16.1	10.1	28.4	8.0	7.7	4.4	11.8	25.4	11.3	10.1	13.2	17.0	22.3	10.7	15.8	6.6	29.8	10.8	12.1	13.1	11.3	12.0	7.5	12.4	18.2	36.5	10.2	7.5	7.6	17.3	9.8	11.1	16.8	5.3	16.1	16.3	16.8	8.5	9.4	14.1	7.8	13.1	20.9	19.2	12.9	10.9	7.7	10.9	8.6	7.4	9.8	8.6	9.5	12.4	22.3	6.7	21.4	6.9	0.3	0.8	0.1	1.1	0.7	0.9	0.8	0.8	0.8	0.8	1.1	0.8	1.1	0.2	0.7	0.5	1.8	0.8	0.5	3.4	3.9	4.3	4.6	4.1	3.7	4.0	3.8	4.1	3.5	3.8	5.3	8.9	9.6	21.0	6.2	18.1	15.3	14.0	11.7	23.3	25.6	23.4	11.6	28.0	15.7	24.6	3.7	14.6	22.6	22.8	16.5	1.9	7.7	1.7	40.7	25.2	17.5	15.0	82.9	12.8	7.7	19.2	16.7	14.8	39.1	1.3	13.7	15.7	61.7	15.1	35.3	15.1	21.3	22.4	27.1	6.8	1.0	12.8	17.6	16.0	10.3	16.8	8.2	6.2	8.5	17.6	16.4	9.4	6.8	10.9	24.9	28.1	20.5	33.0	41.3	6.6	14.7	11.3	11.1	9.1	38.6	20.2	40.2	13.6	8.6	20.4	13.8
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;testis: 10.8"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	0.9	0.4	0.6	3.3	0.9	7.9	2.1	0.9	1.0	0.7	0.4	1.8	1.6	1.2	1.0	2.9	0.5	0.7	0.5	0.8	0.4	0.4	1.2	3.4	4.4	0.8	0.8	0.5	0.9	0.1	0.1	1.9	0.7	0.5	2.2	0.5	0.8	0.4	1.0	2.2	1.5	1.8	0.5	2.9	0.9	10.8	0.8	5.3	0.4	0.9	6.2	3.5	0.9	1.8	13.6	22.6	21.0	15.2	1.9	3.1	15.3	25.4	10.5	26.8	31.0	22.4	16.2	16.1	36.1	5.7	21.6	24.7	36.0	15.5	36.8	30.7	19.7	23.1	10.6	9.1	0.2	28.6	19.7	0.7	1.4	33.8	15.6	2.3	12.8	20.5	23.9	27.0	23.9	19.6	27.0	23.2	25.1	36.5	24.4	20.0	40.5	20.6	5.7	23.3	15.6	21.5	15.2	15.6	5.7	20.2	16.5	11.7	6.0	26.7	35.9	71.1	30.4	15.4	44.3	56.4	8.4	20.2	26.3	0.7	10.3	4.1	0.5	7.9	0.2	1.1	0.3	0.7	4.5	1.7	0.6	0.4	5.5	2.2	8.5	1.4	0.5	3.2	0.6	0.9	0.9	1.0	0.8	0.4	0.8	0.8	0.7	0.5	0.8	1.8	0.3	0.0	0.0	0.0	4.3	0.0	0.6	0.0	1.8	0.0	1.1	1.1	0.9	1.5	0.0	0.0	0.0	2.7	1.0	0.6	0.0	0.9	4.2	1.0	0.6	0.8	0.0	6.5	0.6	0.6	5.5	0.8	1.1	1.2	0.0	2.5	0.7	0.7	2.5	0.0	0.3	0.7	0.0	6.4	0.0	1.9	0.3	3.5	0.0	1.9	4.5	0.0	4.1	0.5	0.6	0.5	0.1	0.7	8.2	0.7	0.3	0.3	0.0	0.0	0.0	0.8	1.1	17.2	18.2	5.4	0.0	0.3	1.5	0.5	1.6	0.9
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 170.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058416: AB_2683712, HPA068416: AB_2685985"	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	65.3	66.2	90.6	16.1	97.8	196.5	64.3	97.4	145.5	51.0	92.9	52.0	20.7	39.1	109.3	31.6	41.2	32.1	85.1	89.0	99.2	106.4	81.7	55.4	18.8	95.9	98.4	57.4	37.3	80.5	81.4	37.6	97.1	45.5	26.6	123.1	43.3	25.8	44.8	48.7	28.0	29.2	95.5	34.2	44.4	40.9	106.4	17.8	182.1	55.4	17.5	56.2	49.5	129.5	17.8	16.1	10.1	34.5	90.7	61.0	53.8	48.2	106.0	70.1	65.4	57.2	45.7	25.3	46.9	14.3	186.7	21.4	38.5	7.3	72.2	21.0	15.5	19.9	19.9	42.3	784.2	31.8	29.3	175.7	152.7	118.6	399.9	81.7	16.9	26.5	86.4	94.0	31.2	10.8	21.1	41.5	19.7	37.3	37.5	11.8	220.7	22.3	25.0	22.3	20.9	15.3	14.2	16.2	409.0	37.2	34.4	82.8	9.9	47.5	20.2	45.4	42.0	164.4	60.3	26.8	57.4	29.1	85.8	121.1	17.9	48.8	25.1	16.6	22.7	48.3	17.9	23.6	12.8	44.8	34.1	31.1	170.7	35.6	19.4	15.9	23.8	18.0	90.6	97.8	97.4	145.5	89.0	99.2	95.9	98.4	97.1	95.5	106.4	129.5	237.9	19.2	55.1	17.0	96.6	56.3	176.5	93.1	177.0	114.9	86.3	265.7	177.9	37.1	56.7	22.0	91.8	42.3	101.8	265.7	115.4	43.3	9.5	111.3	39.4	62.3	230.7	12.8	9.6	16.0	17.5	115.7	74.5	82.4	204.0	26.3	27.5	20.1	45.7	55.5	14.5	218.4	101.7	30.4	81.6	6.3	28.0	81.5	88.9	6.5	8.2	156.1	17.5	14.1	23.0	33.0	300.0	38.0	43.2	115.1	61.7	61.6	38.1	160.0	13.1	56.9	122.2	77.7	15.6	91.5	45.7	107.8	89.7	37.2	127.2	65.1
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273919-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 776.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 657.6;hTCEpi: 2252.5;hTERT-HME1: 877.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	313.5	280.9	88.9	83.7	89.3	123.7	287.3	92.5	106.4	415.9	103.4	93.5	20.8	98.6	12.6	425.0	118.6	47.8	237.2	82.4	87.7	179.9	337.1	197.8	90.1	102.9	92.0	741.5	675.4	94.4	169.5	51.8	90.0	171.1	13.3	86.7	224.9	68.3	278.1	231.6	111.7	25.4	88.0	166.3	121.2	32.0	95.8	102.5	105.1	60.0	114.3	315.3	597.5	98.2	139.2	95.2	20.0	179.3	124.0	74.3	52.1	40.3	45.6	13.5	56.7	11.1	280.5	14.3	113.7	6.5	19.1	143.0	28.9	657.6	33.7	213.9	35.8	15.1	115.4	74.0	501.2	47.7	57.7	291.1	2252.5	59.2	877.9	127.1	60.1	33.9	135.3	347.2	51.5	58.7	28.5	62.1	4.2	67.6	22.2	15.2	22.4	265.7	115.9	30.9	33.2	46.2	98.3	152.0	583.9	43.0	20.9	104.4	118.7	4.6	35.4	8.7	22.3	234.3	135.1	42.3	252.9	99.9	29.8	68.8	7.6	51.1	236.4	14.5	249.6	97.4	163.8	141.3	40.3	122.4	274.5	213.7	17.1	408.1	13.0	197.4	136.9	215.0	88.9	89.3	92.5	106.4	82.4	87.7	102.9	92.0	90.0	88.0	95.8	98.2	366.5	12.8	27.1	136.1	290.6	228.5	383.5	534.1	290.8	87.8	129.8	112.5	16.1	77.2	226.6	60.7	79.2	9.9	680.2	109.2	60.7	310.7	3.1	46.4	101.8	177.9	75.1	129.0	2.1	165.3	141.1	203.8	116.2	69.2	415.0	30.8	249.1	83.8	89.7	30.3	3.8	105.6	173.0	102.4	485.9	7.0	88.3	280.5	396.6	5.6	38.9	682.8	249.3	7.1	5.5	131.5	177.7	128.2	776.1	143.5	41.6	19.3	100.6	143.3	72.3	124.2	338.3	2.1	5.7	519.6	251.5	19.0	537.4	126.0	70.6	359.6
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999375	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 165.7;skeletal muscle: 297.1"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Excitatory neurons: 5.9;Inhibitory neurons: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2;head and neck cancer: 2.6"	"Group enriched"	"Detected in many"	31	"amygdala: 142.5;basal ganglia: 115.5;cerebral cortex: 165.7;hippocampal formation: 126.2;white matter: 54.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.0;NB-4: 7.0;RPMI-8226: 23.3;SCLC-21H: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"amygdala: 165.3;basal ganglia: 212.8;cerebral cortex: 178.3;hippocampal formation: 171.2;olfactory bulb: 62.7"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.1	0.1	142.5	0.2	115.5	1.0	0.1	0.0	165.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	126.2	0.0	19.5	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	1.3	0.0	0.0	1.4	0.0	0.3	1.6	0.0	297.1	0.3	0.1	0.0	0.0	0.3	0.3	0.2	3.9	0.0	0.1	9.2	0.2	0.0	0.1	54.2	0.4	0.4	0.2	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	5.2	0.5	0.0	0.2	0.1	0.0	1.8	12.0	0.0	0.1	0.6	5.4	2.7	0.6	1.2	0.0	6.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	4.0	0.2	0.2	6.3	7.0	0.1	0.9	1.6	5.7	0.3	23.3	0.0	0.1	11.8	1.1	0.2	0.6	0.3	0.1	0.3	0.9	0.1	0.3	0.5	0.3	0.0	1.4	2.8	5.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.5	115.5	0.0	165.7	126.2	0.0	0.0	0.2	0.0	0.0	3.9	54.2	0.4	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.4	0.6	0.0	0.0	3.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.4;Muller glia cells: 8.2;Oligodendrocytes: 13.3;Paneth cells: 8.5;Proximal enterocytes: 8.5;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.3;myeloid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.5;RPMI-8226: 15.9;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	1.9	8.2	4.5	0.8	7.0	1.4	2.5	5.0	4.8	1.9	4.3	2.3	7.4	2.1	2.7	0.8	4.9	2.9	18.4	4.4	4.5	10.6	11.1	3.2	1.0	5.4	4.9	0.3	2.6	5.3	1.2	1.6	5.3	2.0	3.2	2.4	4.2	2.3	10.9	0.4	7.0	2.2	4.8	2.1	1.1	0.1	4.7	0.4	1.3	7.4	0.2	1.6	0.9	5.9	0.2	0.0	0.0	0.1	0.0	0.2	1.1	0.1	5.4	1.3	0.9	0.0	0.1	0.0	0.7	0.7	11.5	0.0	0.0	0.0	2.3	5.0	0.0	5.1	0.1	4.3	1.6	0.0	0.0	0.1	0.0	2.7	0.1	2.3	0.0	0.0	0.0	1.9	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.0	15.9	0.0	4.9	0.1	0.2	0.0	0.5	0.6	0.0	0.7	1.1	0.9	1.0	0.1	0.0	2.6	0.1	0.4	0.0	2.0	17.4	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	1.1	4.5	7.0	5.0	4.8	4.4	4.5	5.4	4.9	5.3	4.8	4.7	5.9	1.1	0.0	0.0	4.9	0.0	0.0	0.7	0.7	0.6	0.0	1.4	1.1	17.4	0.0	0.4	0.0	2.1	0.2	0.1	1.8	3.9	4.5	0.3	3.6	0.5	0.7	4.2	0.0	0.0	2.2	0.2	0.6	0.0	0.9	0.0	0.1	2.5	4.9	1.7	0.0	0.1	6.0	0.0	3.1	0.4	0.0	0.3	1.6	0.0	0.0	2.0	8.2	0.0	3.5	13.3	0.8	8.5	0.0	0.0	0.4	8.5	12.9	2.2	0.2	0.0	2.1	1.2	0.0	0.0	0.2	0.0	0.0	0.2	0.3	5.0	0.5
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	26.5	50.4	24.1	5.3	49.5	0.4	54.6	47.9	20.2	55.2	4.8	57.7	12.3	23.4	4.5	150.1	46.2	11.4	42.1	17.5	40.7	96.8	6.3	33.7	1.2	68.7	47.3	41.5	99.7	19.7	67.9	4.2	57.9	70.2	10.7	4.5	131.7	13.8	40.5	121.1	47.3	1.1	38.8	11.5	71.1	16.5	46.3	7.0	85.9	4.3	3.0	45.0	88.4	58.9	58.2	18.5	26.0	5.4	1.7	2.4	16.2	1.4	0.4	0.8	0.1	25.2	29.8	0.5	30.9	5.1	26.8	90.9	5.7	70.1	0.3	32.0	9.9	0.2	18.7	6.7	5.0	0.0	1.2	3.3	35.4	0.4	0.5	16.1	2.0	1.4	17.3	0.7	4.0	36.5	2.0	0.1	4.5	31.8	3.8	3.9	19.5	2.2	13.1	93.5	4.7	2.5	5.4	41.4	19.4	8.6	103.0	0.6	4.3	12.8	11.7	1.2	13.6	0.8	0.1	2.6	8.4	0.0	11.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	24.1	49.5	47.9	20.2	17.5	40.7	68.7	47.3	57.9	38.8	46.3	58.9	1.9	35.3	24.6	54.5	3.8	53.0	68.3	125.5	67.2	7.4	77.0	57.9	18.0	37.1	79.8	90.1	0.0	63.6	1.5	109.7	5.9	125.5	15.1	58.5	6.5	4.1	46.2	2.7	1.2	76.2	26.0	7.4	63.7	58.4	1.3	29.5	2.2	0.6	6.1	6.7	7.5	69.8	109.9	0.8	5.4	30.1	8.4	2.5	16.0	9.4	13.1	139.9	1.0	60.3	73.8	71.5	78.2	5.3	0.8	68.1	77.3	5.4	104.2	8.0	6.6	10.5	11.9	1.5	6.8	81.8	51.9	46.5	1.9	4.1	67.1	88.4
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: AB_2668872"	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	44.6	89.1	43.2	23.8	44.6	24.8	45.5	38.9	65.7	50.8	36.7	43.3	43.4	43.5	20.0	46.0	49.0	22.4	38.4	42.3	36.8	51.2	77.9	51.6	23.6	39.7	38.8	48.9	84.1	54.7	36.6	25.9	39.5	45.7	19.2	43.2	61.7	32.2	58.2	53.0	44.9	19.9	33.5	36.3	63.0	34.8	37.5	18.6	51.3	14.1	17.0	43.5	44.6	48.4	108.5	133.3	32.3	60.6	71.7	27.2	46.6	67.2	31.9	40.6	44.1	105.7	76.7	64.3	53.6	37.5	77.9	118.2	33.5	100.6	14.8	44.0	62.8	54.4	45.6	186.1	97.9	62.1	56.6	42.8	96.2	77.8	55.2	44.8	37.5	45.3	77.0	74.8	26.4	59.2	42.9	115.5	40.1	73.6	60.8	55.9	28.7	98.6	66.7	99.8	71.4	44.1	69.2	192.7	65.6	19.2	82.0	37.6	57.2	64.9	28.8	46.3	104.2	55.8	67.7	27.3	18.0	51.6	38.9	23.1	36.9	45.6	33.3	25.3	32.7	26.9	35.0	35.6	36.8	26.3	30.8	30.5	9.5	24.6	23.2	57.3	36.2	25.9	43.2	44.6	38.9	65.7	42.3	36.8	39.7	38.8	39.5	33.5	37.5	48.4	57.3	44.8	53.9	19.9	35.1	26.3	68.8	119.0	44.3	47.9	77.1	72.3	31.3	91.5	114.3	69.9	64.6	127.5	50.9	105.8	19.6	147.0	42.2	54.8	42.6	54.1	53.4	26.5	28.6	178.8	65.1	49.3	54.0	79.0	27.3	34.8	50.0	125.6	119.3	52.2	13.9	72.2	154.6	60.9	36.0	21.1	55.9	54.2	39.2	7.5	67.8	73.7	64.9	6.0	28.4	145.0	125.3	68.8	60.5	75.7	216.3	80.5	81.6	108.3	65.7	39.1	115.6	38.7	23.6	64.0	38.8	146.0	44.7	70.0	92.7	75.0
DDT	"D-DT, DDCT, MIF-2, MIF2"	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23979828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 835.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 4869.6;Proximal tubular cells: 1415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 262.9"									"HPA049871, HPA074115"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	125.7	126.7	29.6	15.1	30.6	39.6	99.0	33.1	38.0	69.6	28.7	128.5	44.2	62.6	16.2	119.1	67.3	6.3	167.0	28.9	32.2	218.2	835.9	69.2	13.7	30.7	29.6	83.0	260.9	24.3	47.7	10.7	30.7	109.0	24.2	12.8	82.7	15.7	129.3	89.8	120.7	8.6	30.7	66.3	176.2	39.2	32.9	12.3	80.1	15.7	11.9	86.8	76.4	33.9	107.6	44.8	15.4	34.9	29.0	24.9	92.6	30.4	20.7	26.1	27.1	39.8	30.6	101.9	27.8	16.1	37.7	86.3	38.3	38.1	17.1	43.6	262.9	60.8	58.9	88.3	28.9	136.2	58.8	25.5	28.5	26.3	23.1	27.9	28.7	16.0	56.8	40.2	26.9	53.0	30.1	123.1	46.2	94.4	134.2	65.3	27.0	148.9	46.4	39.2	51.7	49.2	62.8	117.7	95.9	20.6	30.8	42.3	33.1	26.8	59.9	27.8	32.2	122.6	43.9	65.1	53.1	49.7	52.5	63.5	92.9	72.4	46.0	82.8	47.5	75.3	55.3	49.1	87.8	70.7	49.2	48.9	58.3	61.6	79.1	130.4	74.5	78.8	29.6	30.6	33.1	38.0	28.9	32.2	30.7	29.6	30.7	30.7	32.9	33.9	116.9	83.3	86.3	11.1	178.3	138.9	220.5	278.8	176.4	58.4	266.6	379.7	21.3	499.0	153.2	242.8	89.6	202.6	134.1	533.1	718.1	237.2	202.1	150.8	126.4	103.4	259.6	230.2	9.1	375.7	288.2	103.9	163.1	260.3	129.4	97.1	154.9	4869.6	281.0	43.7	11.0	402.8	187.2	240.4	162.2	411.0	117.1	172.2	158.3	9.4	235.8	119.6	135.9	6.0	18.8	233.6	395.1	110.6	166.1	257.5	935.1	1415.8	97.6	100.0	78.9	109.5	127.6	117.9	43.8	280.6	188.0	299.8	140.3	212.5	558.7	291.3
DDTL		ENSG00000099974	"D-dopachrome tautomerase like"	A6NHG4	22	23966888-23972556	"Predicted intracellular proteins"		Lyase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 11.5;Distal tubular cells: 5.9;Hepatocytes: 6.4;Proximal enterocytes: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 14.9"									HPA074115	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA074115: "	"unprognostic (6.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (5.98e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.58e-3)"	4.2	5.5	0.1	3.8	0.5	5.6	4.1	1.3	0.5	4.6	0.5	7.3	6.3	3.7	1.3	6.6	4.1	2.4	8.0	0.3	0.1	11.3	58.6	4.1	5.1	0.9	0.4	6.3	15.3	1.3	4.2	2.2	0.8	8.4	1.8	5.1	5.2	0.3	4.1	5.2	8.1	0.4	0.0	7.4	9.5	3.6	0.7	0.2	5.8	3.2	0.1	4.5	5.0	1.8	4.6	3.1	3.5	3.8	0.0	0.3	4.4	2.5	0.0	0.0	0.0	6.9	4.5	7.8	1.6	0.0	3.2	11.6	1.2	0.0	0.0	2.9	14.9	4.4	13.6	6.7	1.2	11.1	4.7	0.0	0.0	0.0	0.0	4.7	0.0	2.6	4.5	5.6	0.0	3.5	1.2	6.4	1.3	3.5	2.6	6.5	3.7	1.0	2.1	6.4	3.8	1.9	3.4	6.4	11.4	4.1	5.2	0.8	0.0	6.6	5.1	2.0	1.8	4.2	1.3	2.2	1.5	5.4	2.4	6.8	1.0	1.8	1.4	1.6	1.6	1.4	1.0	2.1	0.9	1.4	0.7	1.2	0.5	2.3	0.3	1.3	1.1	0.8	0.1	0.5	1.3	0.5	0.3	0.1	0.9	0.4	0.8	0.0	0.7	1.8	0.3	6.4	3.1	0.0	0.6	1.0	1.3	0.1	1.2	0.9	0.9	1.7	11.5	2.8	1.4	0.0	4.2	1.2	0.7	3.0	5.9	1.0	1.6	0.1	0.5	1.3	1.2	0.4	0.3	0.4	1.4	1.7	0.0	0.4	1.3	0.4	2.5	6.4	1.0	0.0	0.4	1.2	0.0	1.2	0.8	0.7	0.6	1.5	0.0	0.0	0.6	0.4	1.0	0.0	0.5	1.2	2.2	1.2	0.7	0.9	7.6	5.1	0.3	0.7	0.0	1.1	1.4	0.2	0.6	1.5	0.9	2.5	1.0	0.0	2.5	0.7
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665069-108940927	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 162.3"	"Low region specificity"	"Detected in all"							HPA004691	Approved		Approved	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	7.3	6.8	3.7	6.8	3.9	6.3	9.2	4.2	5.1	7.9	1.6	6.6	5.0	10.4	7.3	7.3	8.5	5.0	6.1	4.4	3.0	11.7	7.0	5.3	8.5	2.2	3.3	10.6	7.5	7.6	4.5	7.8	2.8	7.0	7.7	11.1	6.2	6.8	7.1	7.6	4.7	9.9	2.0	7.2	5.8	15.8	3.7	8.4	7.8	4.7	8.8	10.3	6.9	4.0	21.3	20.7	19.3	27.0	18.5	15.0	20.0	22.6	12.2	26.7	26.3	59.3	30.6	71.8	41.3	17.3	28.7	23.5	55.4	27.3	37.8	27.8	25.0	48.5	11.6	22.3	33.0	49.9	22.4	13.5	21.0	30.4	37.6	15.9	24.6	18.4	70.0	7.8	26.7	14.0	42.7	42.5	24.8	40.0	31.0	35.9	31.3	67.9	16.3	18.2	35.2	18.4	31.7	27.4	12.3	25.4	33.4	17.7	26.0	27.8	28.3	26.8	30.9	11.7	22.0	162.3	9.5	59.7	28.7	1.6	4.4	1.2	7.8	6.7	10.8	10.5	7.0	9.6	8.5	12.0	7.4	7.2	0.4	10.1	6.8	8.0	6.3	4.4	3.7	3.9	4.2	5.1	4.4	3.0	2.2	3.3	2.8	2.0	3.7	4.0	20.2	16.0	28.8	29.0	23.7	28.4	24.5	11.0	28.5	21.1	14.9	11.9	20.5	12.8	17.6	3.7	95.9	24.3	19.8	9.7	19.6	18.7	47.2	16.9	31.4	24.3	15.0	11.6	84.7	21.3	21.3	26.3	15.3	23.3	14.5	28.1	10.4	11.0	14.7	18.5	75.9	9.7	6.1	8.8	12.0	10.9	29.5	15.4	7.2	51.5	20.6	8.9	27.8	67.3	59.5	17.2	5.7	21.4	13.2	24.8	3.7	133.3	13.1	25.1	13.1	32.6	20.3	63.0	45.8	19.3	29.0	25.9	17.7	26.6	15.6	14.8
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483438-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	181.2	172.4	142.0	124.3	160.1	74.5	198.5	150.9	178.4	248.7	174.8	233.8	107.8	216.1	255.3	150.4	248.1	121.1	168.7	143.5	152.1	247.2	152.8	202.2	186.4	152.8	149.4	298.8	214.0	144.7	309.9	158.8	155.3	234.4	114.2	342.0	188.4	123.3	184.8	197.0	227.2	119.7	146.8	293.0	192.1	91.1	148.2	215.2	300.0	106.6	158.2	204.4	201.5	196.5	122.0	79.9	237.6	141.8	148.2	166.0	120.7	104.3	85.9	118.3	121.2	89.0	100.5	225.8	65.8	119.5	82.9	133.2	212.5	127.9	145.9	202.5	142.1	140.4	175.8	133.5	153.4	192.9	170.8	122.3	183.7	86.8	142.9	211.7	153.3	109.6	139.7	255.3	116.0	75.6	128.7	164.0	148.0	172.1	51.6	218.0	122.9	137.1	141.2	132.6	134.1	75.3	155.0	125.9	161.2	180.5	110.0	148.4	140.8	125.7	77.6	80.0	79.3	203.7	130.3	183.4	156.7	123.1	154.2	6.7	8.1	9.5	7.6	7.9	8.9	9.0	7.1	7.3	7.0	7.2	5.7	6.8	16.6	5.1	8.7	10.5	9.1	6.0	142.0	160.1	150.9	178.4	143.5	152.1	152.8	149.4	155.3	146.8	148.2	196.5	252.6	214.7	325.5	483.8	241.9	223.6	206.1	129.3	158.2	448.3	300.7	195.3	147.2	180.1	223.5	283.3	352.3	127.6	297.5	172.8	33.2	111.7	44.4	280.0	293.4	250.4	236.1	177.1	198.9	90.2	99.9	207.5	216.1	234.2	200.7	505.3	233.8	205.3	113.9	321.4	242.1	191.6	146.5	200.6	194.8	49.1	323.7	197.7	154.7	253.9	235.1	223.4	304.9	334.3	553.3	104.7	153.1	278.7	213.1	193.5	154.8	89.8	270.8	559.4	289.3	260.5	213.6	136.4	74.2	120.4	279.9	139.4	218.6	293.7	147.0	255.3
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829756-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		21000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	33.2	30.7	28.7	36.9	30.8	26.5	33.1	29.7	29.6	35.3	33.1	39.3	33.5	35.1	25.0	37.5	35.4	25.4	30.1	28.0	29.9	33.0	43.0	33.8	46.6	30.7	29.9	40.6	36.7	34.5	28.4	33.7	29.7	36.1	37.6	27.8	37.3	29.7	54.4	39.2	41.2	34.0	30.1	47.6	38.3	26.7	30.8	63.3	32.9	35.8	48.1	36.1	34.7	30.4	74.0	165.1	76.6	81.5	74.7	51.4	81.3	89.1	68.1	98.9	62.5	162.0	95.7	92.5	95.6	74.4	93.3	64.9	168.1	81.1	84.0	146.1	89.2	122.7	139.0	73.8	40.3	125.3	106.9	49.9	71.7	105.1	62.6	67.6	82.4	80.4	165.6	80.3	72.9	102.1	119.8	118.2	114.4	104.0	77.4	125.9	90.7	73.5	58.3	101.9	94.1	54.9	89.4	101.0	38.4	78.0	99.0	113.7	74.5	74.4	54.1	37.2	71.8	60.1	89.8	109.5	63.3	86.8	41.8	20.9	11.8	21.9	19.3	13.6	19.6	12.6	14.1	17.5	11.3	10.5	13.5	16.6	12.2	12.8	9.8	11.9	14.3	12.0	28.7	30.8	29.7	29.6	28.0	29.9	30.7	29.9	29.7	30.1	30.8	30.4	22.7	25.6	36.5	11.8	25.5	12.9	13.7	12.7	25.6	17.5	18.6	19.4	20.0	22.8	25.8	12.9	25.0	25.9	30.7	33.0	15.6	25.9	14.4	24.4	25.2	27.2	13.9	21.7	6.9	38.9	29.1	19.2	25.5	26.6	18.3	29.8	17.9	18.7	19.1	15.2	8.7	26.6	16.2	13.2	10.3	6.3	24.5	16.5	14.2	9.4	25.5	26.2	35.0	7.5	8.4	33.9	32.3	22.2	32.0	26.7	24.3	12.5	34.4	26.1	19.7	20.8	20.0	43.8	33.1	24.4	15.2	26.5	28.6	21.1	27.3	21.6
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048287-94081212	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	80.7	130.5	23.3	3.9	24.2	23.5	75.2	25.9	29.7	80.0	24.5	85.8	3.7	93.1	37.2	48.9	81.4	6.7	114.3	24.3	23.9	61.2	43.4	69.4	10.4	31.2	25.2	87.3	49.8	7.0	109.0	2.8	25.4	69.9	3.8	8.0	53.9	4.9	123.9	67.4	59.6	4.1	23.9	75.9	66.1	114.3	25.2	8.0	73.5	4.2	9.1	80.2	65.9	26.2	6.5	1.8	11.5	7.5	6.8	8.8	2.7	17.6	14.5	22.4	20.0	2.2	4.0	29.8	6.4	3.9	6.7	4.1	11.9	1.1	24.5	13.0	0.7	15.8	4.3	9.9	5.7	23.0	6.8	1.4	6.6	4.1	3.9	7.5	3.7	5.6	8.5	8.2	9.6	18.2	7.0	19.6	7.6	1.9	0.2	9.3	26.6	3.5	17.0	2.4	9.1	8.4	17.3	4.2	8.5	1.8	6.8	8.1	11.3	6.4	4.4	8.2	5.3	3.4	24.8	31.5	9.2	12.3	5.1	9.5	2.1	1.7	3.0	1.7	0.8	1.7	1.6	1.8	1.2	2.3	3.0	3.0	1.5	3.8	1.8	1.9	2.1	3.0	23.3	24.2	25.9	29.7	24.3	23.9	31.2	25.2	25.4	23.9	25.2	26.2	164.7	169.9	160.6	45.4	245.9	182.8	186.6	147.4	171.4	184.7	86.6	94.7	228.3	64.3	146.4	147.1	131.3	94.0	332.8	74.1	272.0	147.0	98.2	244.0	248.2	142.2	97.5	75.5	62.9	98.9	72.6	189.0	95.8	201.0	154.9	251.5	109.6	103.4	85.1	232.2	73.6	89.0	118.0	92.1	147.4	67.4	231.5	143.5	99.6	45.0	158.0	133.4	122.6	31.7	56.1	91.0	67.4	244.8	225.6	116.4	70.7	242.3	160.4	200.5	164.3	185.0	198.0	506.5	435.9	127.6	145.6	157.1	342.1	305.9	74.9	123.7
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"		20	49219347-49244077	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047087, HPA053455"	Approved		Approved	Nucleoli		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli		"HPA047087: AB_10964059, HPA053455: "	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	20.4	20.9	15.8	25.8	16.0	46.5	19.5	19.5	20.5	20.4	15.5	21.0	22.6	21.3	15.1	20.7	17.5	19.4	15.6	15.9	17.2	20.7	17.2	18.0	34.3	16.7	16.8	27.3	24.5	20.4	15.4	20.3	17.1	18.7	20.8	10.9	20.5	15.9	24.8	25.0	26.8	18.5	15.5	24.7	20.4	24.4	16.9	29.9	19.1	16.7	35.6	27.6	18.0	17.7	75.2	69.7	34.9	27.4	38.3	35.1	99.6	48.6	39.9	149.7	69.3	228.3	82.2	88.8	88.1	40.0	129.7	103.7	79.1	77.8	111.0	31.6	46.1	67.6	58.4	113.2	55.7	86.1	76.0	37.0	90.2	87.5	67.3	34.0	25.1	67.5	93.7	47.6	49.8	50.6	90.9	114.0	66.9	91.3	89.2	77.6	87.0	82.4	54.9	57.1	45.8	54.0	135.8	194.2	83.0	48.5	102.5	98.5	31.0	96.0	84.3	80.8	102.9	54.1	62.6	115.6	61.4	67.5	63.4	21.1	32.8	39.4	34.2	36.8	36.0	48.6	32.3	31.5	39.2	50.8	41.1	31.4	13.6	32.6	45.7	45.4	46.3	33.9	15.8	16.0	19.5	20.5	15.9	17.2	16.7	16.8	17.1	15.5	16.9	17.7	33.9	28.9	44.7	7.8	93.3	35.7	55.1	41.8	30.7	25.7	28.0	32.3	25.7	21.5	45.7	33.1	14.6	58.1	114.0	45.8	19.6	54.0	176.7	45.4	58.4	28.6	31.0	41.2	10.0	43.6	50.5	44.7	27.0	67.4	113.4	42.2	21.0	23.1	33.7	28.6	9.1	44.3	20.3	25.1	54.1	145.7	39.7	48.5	19.6	5.6	42.9	29.9	63.8	4.5	5.4	55.4	44.6	33.8	57.9	38.2	55.0	44.9	35.4	29.4	26.3	52.4	41.7	69.1	56.6	29.5	32.1	74.6	67.9	37.3	50.7	42.1
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68020916-68023232	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	5.8	10.0	3.9	4.8	4.1	16.8	5.6	4.0	4.3	3.9	4.0	5.7	3.9	6.0	5.1	8.2	5.0	2.8	8.3	4.1	4.7	6.4	8.7	4.3	7.7	4.0	3.9	5.5	5.6	7.0	3.6	4.7	4.3	3.5	4.3	1.6	5.0	3.5	15.4	9.7	7.0	3.7	4.0	9.0	6.3	9.7	4.1	5.6	4.0	7.7	6.4	5.5	4.3	4.1	10.2	14.7	7.1	8.5	9.5	5.3	16.5	6.9	9.8	16.4	11.6	14.4	15.5	37.6	10.2	8.3	9.0	17.9	10.1	16.1	9.6	5.1	16.7	13.6	7.4	14.9	12.8	21.7	14.1	10.3	17.2	13.5	12.4	5.7	9.2	24.9	24.5	5.7	7.4	22.4	22.9	30.0	17.2	10.2	10.7	22.1	6.6	40.3	11.6	11.4	14.8	9.9	27.6	7.8	15.3	8.0	14.9	23.1	7.0	7.3	6.3	10.6	11.2	12.8	16.9	36.7	9.0	16.4	10.1	24.0	22.3	27.4	17.0	22.4	18.7	14.3	15.6	18.5	20.8	19.0	24.2	18.2	7.2	21.5	23.4	10.2	16.0	20.8	3.9	4.1	4.0	4.3	4.1	4.7	4.0	3.9	4.3	4.0	4.1	4.1	4.4	6.4	6.8	0.7	10.9	9.2	14.2	11.7	8.0	5.6	4.8	4.3	4.1	8.6	8.3	3.7	0.0	27.9	4.0	2.9	13.7	12.0	6.6	5.4	4.4	5.7	4.8	9.5	0.9	9.7	12.5	4.4	5.1	5.4	3.8	8.0	6.8	11.6	17.1	3.3	1.0	3.5	6.1	8.5	3.1	4.0	5.0	6.8	7.2	0.0	13.3	7.5	25.7	0.5	1.4	7.4	4.2	3.4	4.2	5.7	2.0	19.7	5.3	4.3	13.1	4.4	9.4	22.7	14.1	6.7	10.7	99.9	7.6	12.5	6.1	8.8
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408798-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 147.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	28.2	21.6	17.1	49.6	20.7	105.5	24.7	21.9	23.0	22.1	18.0	26.4	28.6	21.9	8.7	39.3	18.2	13.6	24.9	17.0	18.6	21.0	21.9	25.1	76.2	21.9	19.8	14.9	15.7	10.2	15.5	18.1	22.0	16.8	20.2	4.7	19.0	8.8	20.7	24.4	33.8	15.1	19.0	55.7	27.2	147.8	20.5	80.4	20.5	12.7	65.1	25.9	22.7	25.2	198.8	175.9	87.8	147.2	32.4	22.4	73.5	84.8	48.0	176.1	105.7	183.3	98.7	375.0	87.5	71.1	101.0	114.8	215.7	135.9	74.3	129.0	127.3	408.5	201.0	133.1	55.1	225.1	164.0	30.1	30.6	113.1	47.0	25.4	89.1	134.4	253.4	150.3	95.7	270.9	375.4	320.1	147.9	208.8	280.4	248.9	139.7	212.0	62.5	179.6	181.5	98.2	64.3	127.8	98.6	54.3	138.0	216.5	83.1	144.5	92.7	245.7	192.6	156.0	313.0	399.3	167.1	232.2	148.9	33.2	92.8	29.6	120.1	107.9	106.2	132.5	96.0	96.3	131.1	125.8	83.1	90.1	27.0	84.1	94.3	82.7	153.0	135.5	17.1	20.7	21.9	23.0	17.0	18.6	21.9	19.8	22.0	19.0	20.5	25.2	55.6	16.0	21.4	4.9	90.0	76.0	43.6	53.0	50.1	10.5	30.0	24.8	10.9	21.5	27.4	5.5	0.0	60.6	75.1	60.5	37.2	55.3	308.4	26.6	30.6	53.0	25.7	88.1	3.1	67.2	117.9	33.3	87.7	44.5	93.0	32.7	26.0	12.9	90.5	11.8	3.5	55.4	26.4	48.6	85.2	283.3	26.4	62.7	49.8	4.7	56.7	16.2	50.4	4.0	9.2	53.5	42.7	18.8	115.6	44.5	41.7	26.0	21.1	4.9	19.7	24.8	62.0	307.5	95.4	69.4	71.0	59.9	78.7	32.1	63.8	34.2
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 149.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	149.7	0.3	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.3	0.1	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394828-73417566	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"placenta: 4.9;testis: 19.5"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 41.5"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.0;CAPAN-2: 13.8;HHSteC: 3.7;MCF7: 2.6;U-2 OS: 8.7"									HPA031381	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.0	0.4	0.3	0.5	0.4	0.7	0.9	0.4	0.4	0.6	0.3	0.9	1.2	0.8	0.0	0.9	0.4	1.2	0.7	0.2	0.4	0.8	0.3	1.0	0.8	0.7	0.5	1.1	1.3	0.0	0.4	4.9	0.8	1.4	0.5	0.4	1.8	1.8	0.2	1.2	0.8	0.8	0.4	0.8	1.7	19.5	0.5	0.2	1.4	0.3	0.6	1.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.0	0.3	0.7	0.8	0.7	0.9	0.2	1.0	0.4	0.1	0.2	0.6	0.2	0.0	0.4	0.2	0.3	0.4	0.4	0.4	0.2	0.4	0.7	0.5	0.8	0.4	0.5	0.8	2.1	3.2	5.4	0.3	1.0	2.7	0.9	3.4	0.0	0.3	0.8	0.9	0.8	1.5	2.5	0.0	0.0	7.2	2.6	0.5	0.0	0.4	5.1	2.1	0.5	2.4	0.0	0.0	0.3	1.0	3.2	1.7	0.0	2.4	0.0	0.1	0.4	0.1	2.7	0.0	0.3	0.3	4.1	0.8	1.5	5.0	2.1	1.5	3.6	0.0	0.6	0.5	6.2	0.0	2.0	1.5	0.0	1.2	0.7	0.3	0.3	1.5	1.4	1.1	0.0	1.7	1.3	50.6	41.5	0.0	1.4	6.0	2.1	0.2	0.3	0.8
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	16.5	14.6	7.6	23.9	8.8	23.1	17.7	16.1	10.8	16.3	11.4	17.3	17.0	19.8	12.3	17.5	15.0	13.4	13.4	6.8	11.2	18.8	17.7	15.8	25.6	10.0	8.4	18.5	20.8	18.4	11.1	15.7	9.2	15.5	20.7	18.0	16.8	12.1	35.2	19.4	18.7	17.6	5.4	20.6	20.0	16.3	10.0	32.1	18.7	22.9	26.6	18.2	15.6	10.3	87.1	78.0	54.4	71.1	20.8	23.2	75.0	56.8	43.7	58.8	65.6	119.2	61.7	108.9	47.7	38.3	62.3	52.5	80.9	54.2	68.7	73.8	73.3	131.0	84.7	48.5	18.0	120.5	67.8	21.0	28.9	62.1	34.8	24.9	47.3	85.9	113.6	45.3	44.1	41.5	104.2	46.9	75.2	50.1	34.8	89.7	142.0	54.8	32.0	73.9	64.2	61.3	79.4	37.2	42.7	63.0	58.3	68.0	59.0	61.8	43.2	47.9	114.0	35.6	103.2	140.2	42.8	112.0	40.0	55.6	31.9	48.2	30.7	29.2	28.0	38.1	30.4	31.3	25.3	43.4	30.9	31.5	55.9	32.3	27.5	38.5	29.7	17.8	7.6	8.8	16.1	10.8	6.8	11.2	10.0	8.4	9.2	5.4	10.0	10.3	102.4	76.9	131.5	35.9	123.6	113.8	121.5	102.7	68.9	131.5	80.6	79.4	69.3	64.3	94.9	103.0	83.4	133.7	142.3	91.3	56.7	100.5	53.4	111.4	155.8	104.7	92.2	90.6	38.7	107.9	160.4	85.1	69.3	115.9	101.2	122.3	76.8	113.1	94.4	121.1	41.2	112.4	63.1	119.3	113.2	26.7	111.9	103.4	56.9	21.5	178.5	79.9	194.7	28.1	57.6	130.7	62.6	113.2	134.7	139.5	79.2	84.1	74.5	176.0	98.6	114.9	115.2	246.3	275.7	81.0	137.0	157.2	131.8	114.5	112.7	144.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919705-18929189	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	16.5	17.7	17.1	13.9	17.3	23.3	15.5	17.9	22.1	16.0	14.0	17.4	15.7	15.9	5.9	25.9	13.9	7.9	18.2	18.2	16.5	15.6	24.9	13.7	16.1	17.1	16.0	14.6	20.1	12.6	11.3	13.4	16.7	16.4	7.4	4.8	18.0	10.8	33.6	27.1	14.8	9.9	17.7	16.1	15.7	19.2	17.3	14.1	13.6	13.6	10.3	17.5	17.5	19.3	46.5	47.4	19.0	61.3	28.1	21.1	71.0	29.2	19.8	50.9	40.1	54.6	45.8	60.6	86.7	29.1	16.1	39.4	42.9	39.8	14.8	18.9	110.5	29.9	49.9	48.6	63.5	77.5	40.1	44.4	35.9	40.7	41.9	14.4	23.3	46.9	58.2	43.1	18.2	104.4	56.6	37.9	62.7	50.3	112.8	62.8	31.5	65.9	27.4	28.2	67.2	69.7	38.2	36.6	48.2	9.8	39.2	37.6	29.5	24.3	27.9	92.0	48.7	55.5	73.0	57.1	31.1	88.8	39.3	17.1	21.9	16.7	14.8	26.2	12.0	9.1	11.0	11.1	31.1	9.8	10.9	12.1	8.6	19.5	18.1	13.7	18.0	12.7	17.1	17.3	17.9	22.1	18.2	16.5	17.1	16.0	16.7	17.7	17.3	19.3	15.6	3.2	10.0	4.9	20.5	22.6	18.7	28.0	14.8	19.5	25.2	29.1	13.8	27.1	20.5	18.4	4.2	46.5	27.0	48.0	37.2	35.0	37.2	18.8	26.5	15.3	25.8	18.3	7.4	52.2	50.3	19.0	19.4	24.7	18.4	25.1	7.5	14.8	33.5	10.1	7.6	31.5	30.5	21.0	22.0	103.0	21.5	18.8	26.6	4.7	28.5	18.3	29.9	6.0	8.2	29.8	30.7	19.9	29.5	21.5	48.0	25.0	12.5	24.1	19.7	21.1	26.9	33.4	31.8	29.5	28.3	42.1	20.8	38.1	39.4	21.5
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144319	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	8.5	7.1	4.6	1.9	4.7	4.3	8.6	4.5	5.8	9.7	3.3	8.6	1.6	8.5	2.4	7.2	10.5	1.0	6.8	4.8	4.0	9.3	6.9	6.8	2.5	4.5	4.3	12.9	11.2	1.9	8.7	1.3	4.7	8.7	1.4	2.6	6.9	2.3	9.7	12.0	8.0	1.7	4.2	9.6	8.1	6.7	4.2	2.3	8.5	1.4	1.9	9.3	8.0	5.1	4.1	6.5	2.7	3.4	2.5	2.4	5.0	3.1	1.8	4.5	1.9	4.0	2.0	7.2	2.6	1.9	1.0	4.2	6.7	5.0	2.2	1.7	6.5	8.5	3.8	1.3	3.0	6.0	4.7	2.1	3.6	2.5	2.3	5.0	2.4	7.8	6.4	2.3	1.3	4.1	7.4	12.2	4.7	3.4	11.0	8.6	3.6	7.9	3.1	3.2	6.5	3.4	3.4	4.8	3.5	2.2	4.2	5.5	4.2	1.7	5.1	4.1	7.2	6.4	4.0	8.2	3.5	4.5	4.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	4.6	4.7	4.5	5.8	4.8	4.0	4.5	4.3	4.7	4.2	4.2	5.1	9.5	3.2	17.3	5.2	8.4	12.5	10.1	2.9	7.4	28.5	9.9	10.4	4.5	10.0	9.0	3.7	25.0	6.7	12.9	7.6	1.9	4.1	1.0	6.4	9.2	8.6	8.4	5.0	22.1	5.3	6.4	9.5	9.7	8.8	6.3	18.2	6.8	7.3	5.6	33.7	17.1	11.1	0.0	6.3	8.0	1.1	8.4	6.4	10.6	11.2	4.6	11.7	11.3	8.0	9.0	6.0	8.0	8.2	8.4	11.3	3.3	3.4	4.4	28.0	0.0	17.7	9.1	7.0	11.1	6.3	14.1	4.1	11.1	17.2	12.8	6.8
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643446	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.1;Glandular and luminal cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	1.8	2.5	1.6	1.0	1.6	4.2	1.7	2.3	2.0	2.0	2.1	2.2	2.0	2.2	3.9	3.1	1.6	1.8	1.8	1.6	1.7	2.6	2.8	1.8	2.1	1.7	1.6	1.5	2.9	2.2	1.4	1.7	1.9	1.7	2.2	2.1	1.9	1.7	2.5	2.8	3.3	1.8	1.4	2.0	2.4	1.8	1.7	1.5	1.3	1.8	2.1	2.4	1.9	2.2	4.7	10.2	1.0	9.4	5.2	4.6	4.0	6.3	5.4	8.1	7.7	6.6	1.7	2.8	4.2	4.3	1.5	4.4	10.5	7.2	11.0	6.5	12.8	5.9	6.6	4.6	5.1	7.8	3.1	4.5	7.6	5.5	6.3	4.1	9.4	2.7	0.9	1.7	4.7	1.6	11.9	4.3	5.4	2.6	0.8	7.3	8.4	4.9	9.9	5.8	6.6	5.5	7.5	1.8	5.2	5.0	3.3	6.1	6.7	6.6	4.2	3.6	7.3	2.2	3.8	4.9	5.3	4.6	5.2	0.9	0.5	0.7	0.8	0.7	0.6	0.6	0.8	0.6	0.4	0.6	0.7	0.9	0.4	0.8	0.4	1.2	0.5	0.2	1.6	1.6	2.3	2.0	1.6	1.7	1.7	1.6	1.9	1.4	1.7	2.2	28.5	41.7	19.7	17.3	29.4	34.5	33.9	41.2	26.2	34.0	25.4	22.7	33.3	18.6	41.4	27.6	33.3	35.4	47.4	28.7	35.2	76.6	245.1	105.8	77.7	32.3	26.3	42.7	19.4	52.3	31.1	28.1	29.6	360.4	27.3	40.8	28.5	37.2	26.1	47.1	19.3	30.1	34.6	25.8	12.6	97.8	24.5	24.1	17.8	19.7	53.8	26.0	33.0	29.7	23.0	56.8	20.5	24.0	25.4	35.8	35.7	40.2	32.0	36.0	26.3	26.7	34.1	29.6	56.0	33.4	33.2	25.0	30.3	43.7	46.8	49.5
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157173-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	19.6	21.7	7.4	28.9	8.6	38.8	18.7	8.0	9.7	20.0	12.0	17.9	26.8	21.4	5.6	24.0	21.1	13.3	17.8	7.4	7.3	16.2	20.8	17.0	28.5	8.9	8.1	23.2	30.3	20.7	8.4	16.8	9.3	16.2	11.4	7.3	19.7	15.8	53.9	24.7	21.0	13.5	7.7	21.5	21.8	9.2	9.2	21.3	19.0	20.4	16.5	19.9	18.2	9.0	82.7	84.0	30.8	57.1	20.2	24.1	79.3	43.8	40.3	58.3	31.9	87.1	39.0	105.8	49.7	36.8	43.4	59.8	55.0	56.8	22.0	61.3	67.7	64.0	45.1	60.3	35.3	107.5	72.1	39.8	44.1	56.7	34.7	47.7	48.4	63.2	94.2	37.1	30.4	75.8	93.0	152.4	72.1	57.6	59.2	68.2	45.6	107.8	31.7	84.3	39.8	36.0	61.8	93.4	39.9	25.2	80.4	82.6	36.3	49.2	54.8	59.1	92.7	53.3	66.4	119.5	43.4	59.0	52.9	13.0	11.3	2.9	12.6	16.7	13.1	12.4	11.5	12.6	14.5	11.3	11.6	12.9	0.6	13.1	11.7	10.9	10.1	12.7	7.4	8.6	8.0	9.7	7.4	7.3	8.9	8.1	9.3	7.7	9.2	9.0	19.1	32.1	29.8	6.5	39.4	17.3	35.9	26.4	34.7	20.5	28.2	24.3	14.5	21.5	24.1	12.9	2.1	63.9	30.6	29.2	25.4	44.5	1.2	23.3	21.8	25.7	28.2	33.4	5.9	49.9	57.2	23.2	26.0	28.5	25.3	35.6	17.9	38.2	38.6	26.9	4.3	31.5	24.4	35.9	20.9	2.4	29.5	22.3	12.4	6.5	29.5	26.8	51.5	2.0	4.8	43.0	33.4	24.0	35.0	52.9	49.3	50.5	12.8	18.1	6.6	28.7	24.9	14.8	20.1	39.5	19.6	72.4	33.3	56.8	43.8	38.0
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620943	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	11.0	10.3	11.1	10.4	11.1	20.3	11.1	13.2	19.5	12.1	11.2	9.7	7.6	9.6	7.7	11.1	12.2	5.6	6.9	10.7	11.4	12.3	14.7	8.4	13.8	11.5	10.8	13.1	15.4	6.5	11.3	7.7	11.6	11.4	8.8	12.6	9.5	6.3	6.4	13.6	10.8	7.1	9.9	14.9	9.7	9.6	11.3	10.3	9.1	3.4	10.7	10.7	11.1	12.9	20.5	28.4	21.4	21.7	18.0	14.2	32.2	24.8	9.1	21.6	14.8	32.5	14.6	30.2	19.3	10.9	19.5	24.4	32.8	18.4	25.1	22.8	29.7	40.8	34.0	24.3	13.7	50.7	30.7	12.0	19.2	25.7	29.5	16.7	15.8	23.9	42.3	15.5	15.5	21.1	50.0	68.2	33.3	23.6	27.9	37.1	22.7	19.7	15.2	34.8	25.3	21.0	20.2	25.9	35.0	17.7	46.2	32.4	16.3	18.6	24.5	30.6	31.2	28.4	37.4	54.2	17.7	35.8	32.4	3.4	9.1	7.8	11.4	10.6	12.4	13.9	11.1	12.3	7.7	10.7	14.9	13.9	5.2	13.3	6.4	13.2	9.9	8.6	11.1	11.1	13.2	19.5	10.7	11.4	11.5	10.8	11.6	9.9	11.3	12.9	13.3	22.4	13.9	15.7	14.2	11.0	13.4	13.9	9.6	20.2	9.6	14.9	2.5	8.6	11.7	7.3	22.9	13.8	26.3	5.9	7.9	12.2	45.1	9.0	18.4	12.0	7.2	19.6	13.4	12.0	17.4	12.0	11.2	7.2	25.3	16.4	7.1	9.4	14.3	15.2	16.5	15.9	10.2	7.1	7.4	74.8	17.1	9.0	7.2	12.2	9.9	16.1	15.5	6.6	14.3	13.3	7.6	14.7	13.8	13.3	5.9	6.3	12.3	28.1	6.6	10.5	14.1	21.9	18.6	12.5	16.9	7.7	14.2	14.0	10.2	11.0
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669907	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	15.4	16.1	13.5	14.2	15.4	33.1	26.5	17.1	18.8	16.2	15.6	14.2	10.2	17.6	20.0	13.5	15.5	12.2	13.3	14.0	14.7	16.4	17.8	14.5	17.0	16.0	15.0	17.6	18.8	15.0	11.3	18.7	17.3	15.2	15.0	17.4	14.4	13.2	32.8	26.2	14.3	14.1	16.3	22.4	12.1	11.0	15.1	22.0	16.2	20.1	16.9	15.0	14.7	17.8	17.5	20.1	22.6	19.0	10.1	17.4	49.9	19.1	17.4	20.5	16.5	6.3	20.2	17.9	9.5	15.7	16.4	16.2	13.0	19.4	14.5	56.8	13.3	13.6	26.4	18.6	20.2	19.5	24.0	18.8	29.1	15.4	41.7	16.7	15.9	24.8	17.4	25.9	20.1	20.0	12.0	29.0	23.8	10.5	16.3	10.1	15.5	34.7	21.9	19.8	13.8	35.7	30.8	31.7	35.6	28.8	27.3	27.3	14.4	17.1	9.5	16.8	20.0	19.5	27.2	23.5	16.3	12.2	30.0	33.3	12.4	24.7	15.1	11.1	12.4	14.9	12.5	13.8	10.6	14.8	12.7	11.8	22.9	16.4	22.0	11.8	19.8	10.2	13.5	15.4	17.1	18.8	14.0	14.7	16.0	15.0	17.3	16.3	15.1	17.8	22.5	19.2	20.1	8.8	19.9	16.2	13.1	16.1	24.5	4.3	10.0	13.2	18.4	7.2	10.6	7.3	2.1	22.2	14.6	9.8	15.6	8.8	2.4	14.6	13.3	16.7	1.2	10.5	4.5	8.2	28.0	14.9	6.6	12.8	20.8	7.1	14.3	7.3	13.0	6.7	6.1	11.0	14.2	12.0	13.0	1.1	8.1	16.1	5.4	8.4	18.5	8.3	25.7	19.1	10.3	8.8	7.9	13.5	13.1	12.0	8.0	11.6	10.8	6.7	0.0	22.8	15.7	14.2	20.0	12.9	15.6	43.8	18.9	9.3	8.5	11.1
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216291-168318883	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	8.2	6.0	2.3	9.8	2.6	5.6	7.2	2.0	2.4	9.6	2.6	17.4	13.3	7.7	4.8	3.5	7.1	9.7	5.9	1.9	2.4	6.7	9.4	11.4	9.8	4.8	2.3	11.0	4.0	6.4	4.0	11.5	2.9	6.0	15.7	3.3	21.3	5.8	2.4	6.5	12.3	6.1	5.1	17.4	40.8	3.4	3.2	15.4	6.3	3.5	6.8	6.8	5.6	3.1	8.3	1.1	4.2	1.4	2.9	10.4	5.3	2.3	14.9	27.4	26.1	0.0	20.2	0.0	1.4	3.1	12.6	6.6	0.5	4.1	8.7	6.1	0.3	12.9	7.3	0.0	9.9	3.8	3.3	7.2	1.7	6.7	1.2	7.1	10.1	4.8	0.0	2.0	3.4	0.3	6.2	2.5	0.4	0.4	2.1	5.1	1.5	0.0	5.3	4.6	0.8	0.7	5.4	1.3	18.8	0.3	1.0	5.1	8.9	2.1	1.5	0.9	2.0	1.6	0.3	0.0	6.6	6.1	6.1	1.6	1.2	1.2	4.2	2.5	4.8	1.4	3.2	4.1	1.1	1.4	3.3	3.7	0.6	3.7	3.0	0.0	3.0	1.8	2.3	2.6	2.0	2.4	1.9	2.4	4.8	2.3	2.9	5.1	3.2	3.1	32.4	35.3	6.5	14.0	12.2	4.2	4.8	6.2	5.7	0.8	3.9	3.2	8.6	11.5	11.5	12.9	0.0	7.6	13.4	57.6	5.9	8.2	3.3	11.8	10.5	22.8	3.0	8.4	0.7	6.8	10.4	11.6	90.2	10.2	27.3	16.2	14.3	4.0	6.2	0.0	1.3	22.4	2.0	4.1	2.8	2.2	8.1	13.5	3.6	25.3	9.3	7.4	17.5	27.6	1.3	12.0	14.9	9.4	3.1	4.1	11.0	4.2	15.3	2.9	6.6	10.0	9.0	1.1	1.0	2.2	2.7	2.9	17.2	18.4	6.0	3.7
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1 transcription factor"	O75398	11	644233-706715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: AB_2673421"	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	10.9	19.7	51.5	6.5	50.6	9.2	12.5	30.6	67.1	13.2	15.3	12.1	7.8	13.3	10.0	19.8	14.6	9.4	11.0	60.8	32.5	15.4	8.0	9.1	8.7	32.4	36.0	12.4	16.2	11.3	16.9	6.9	32.9	14.6	4.1	4.5	21.4	7.2	16.6	17.5	10.1	8.0	24.5	11.1	20.0	15.0	40.2	9.7	25.3	13.9	6.3	10.7	12.8	45.9	14.1	13.6	22.9	13.1	18.4	22.8	13.5	14.1	18.2	28.3	20.6	9.7	18.6	5.4	14.8	14.0	9.0	14.4	18.1	12.9	4.3	24.2	108.1	13.5	8.5	13.0	32.8	28.0	22.3	20.4	18.1	5.1	15.4	20.1	22.4	15.5	29.0	28.8	11.3	10.9	11.7	31.9	49.9	20.3	24.0	28.1	6.8	24.2	21.9	3.0	27.3	31.8	10.4	18.2	12.9	5.8	8.4	9.7	26.6	10.5	4.7	4.5	13.7	24.5	9.3	10.2	13.4	21.2	22.9	0.0	2.0	2.3	1.6	1.3	1.7	0.6	3.4	1.7	2.8	0.4	3.9	2.0	0.8	2.0	1.2	0.1	1.4	1.1	51.5	50.6	30.6	67.1	60.8	32.5	32.4	36.0	32.9	24.5	40.2	45.9	20.1	0.0	3.9	12.7	8.7	13.3	27.1	11.8	11.4	20.0	35.8	25.7	8.2	18.6	8.0	35.0	10.4	14.9	12.3	10.0	52.8	19.5	3.6	19.6	15.0	19.3	10.9	25.0	33.8	11.1	6.4	20.1	10.7	26.2	0.0	40.1	10.8	12.4	10.0	60.6	35.2	9.3	12.2	12.9	10.2	6.5	19.9	11.2	17.8	17.8	13.7	39.9	7.2	19.1	17.4	15.4	10.6	30.1	9.0	36.0	16.9	34.2	10.0	19.9	13.1	11.4	16.8	7.5	22.1	17.3	15.5	15.5	12.4	42.2	9.1	32.4
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90053633	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 290.1;liver: 272.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 399.2;Proximal tubular cells: 485.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	60.2	136.8	12.4	9.6	14.4	24.9	54.4	12.5	14.4	29.4	22.2	65.0	20.2	28.0	14.9	52.6	26.1	7.4	290.1	12.7	13.2	103.5	272.3	34.2	15.0	12.2	13.1	35.5	44.4	13.2	32.6	5.9	12.1	28.6	18.8	8.0	42.8	6.5	121.8	43.3	61.0	9.1	12.5	47.1	44.5	52.3	15.4	10.2	33.0	34.4	13.9	31.1	35.8	12.8	13.1	7.9	19.6	16.1	8.0	17.3	5.2	13.2	12.9	5.9	8.2	2.8	13.4	7.7	5.3	15.1	4.1	6.8	7.7	11.1	11.0	12.6	1.2	18.4	13.6	14.5	11.6	8.7	4.4	12.0	7.0	7.6	10.7	10.1	17.4	16.5	21.3	15.5	20.7	16.3	12.5	7.6	1.5	9.1	24.9	7.4	5.8	13.4	23.4	43.9	1.3	10.6	13.0	81.1	7.7	1.1	10.7	7.4	20.1	11.4	6.2	12.9	6.0	10.5	7.5	12.8	8.6	12.0	10.8	3.9	9.1	6.2	7.1	10.2	7.9	7.4	6.9	8.6	8.8	4.6	8.1	7.8	15.2	3.9	9.3	3.9	9.6	5.8	12.4	14.4	12.5	14.4	12.7	13.2	12.2	13.1	12.1	12.5	15.4	12.8	66.1	76.9	59.4	72.5	52.9	41.3	70.6	180.2	35.3	11.4	51.1	57.4	268.3	82.9	96.4	71.7	2.1	50.2	57.6	119.0	399.2	137.8	165.3	68.2	65.5	60.0	104.8	77.4	27.2	92.5	49.0	60.2	61.2	40.6	50.0	81.3	47.8	244.8	115.1	32.0	55.9	105.9	116.0	95.2	82.7	52.6	85.4	85.1	85.4	29.0	107.1	52.5	74.2	66.9	35.0	87.5	111.6	51.6	67.8	30.3	250.3	485.2	69.0	7.6	72.3	54.5	61.7	157.5	24.6	68.6	41.1	41.0	64.4	135.1	139.6	86.8
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064486, HPA065101, HPA073628"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA064486: , HPA065101: , HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	34.4	21.4	20.6	19.4	22.0	29.8	29.0	21.9	20.8	26.1	18.8	30.5	20.8	24.7	14.9	25.8	26.5	21.2	24.3	20.2	20.4	21.6	24.3	28.6	21.2	21.3	20.7	28.0	21.2	18.2	17.9	22.1	20.7	23.0	13.7	23.9	20.7	15.8	56.7	29.2	23.5	21.0	20.7	27.8	22.4	28.0	21.5	22.5	24.2	34.9	18.3	26.8	25.1	22.6	24.7	24.0	27.7	24.3	21.0	22.2	19.1	20.7	29.3	23.5	26.1	16.7	41.5	26.2	20.4	31.2	17.2	22.0	21.2	32.5	15.1	26.3	23.1	24.5	30.2	22.7	37.0	17.3	35.5	26.8	34.2	25.3	40.1	31.2	38.5	35.6	21.3	38.3	27.8	38.8	42.4	18.9	46.5	49.1	24.5	34.1	19.1	35.0	23.8	29.6	29.3	44.2	21.1	55.1	37.0	29.9	33.0	34.8	27.3	25.6	27.2	30.0	30.6	52.2	35.6	46.9	30.6	18.5	18.6	64.0	36.9	52.8	27.8	34.6	23.7	24.0	27.4	27.9	33.3	22.7	30.6	25.1	41.2	27.7	38.0	29.2	38.4	31.4	20.6	22.0	21.9	20.8	20.2	20.4	21.3	20.7	20.7	20.7	21.5	22.6	27.8	25.6	9.3	8.5	16.7	25.2	13.9	11.5	14.2	6.8	10.5	8.0	10.6	18.6	10.1	9.2	6.2	19.6	16.2	12.9	23.5	13.6	42.6	9.5	8.3	22.3	11.3	13.7	4.8	19.3	19.6	13.3	15.8	11.3	16.5	7.7	21.0	10.7	14.8	13.5	5.1	8.1	2.0	19.8	27.2	43.5	11.8	16.2	14.2	4.7	20.9	6.7	8.2	5.0	10.8	15.6	13.2	9.8	24.2	10.2	12.5	13.7	7.4	13.2	6.6	12.0	16.5	23.5	18.4	22.2	24.9	27.0	15.0	5.7	9.7	17.4
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89948697-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	37.0	40.3	58.3	38.0	59.4	45.4	36.2	60.0	68.5	41.2	38.1	52.4	20.0	45.9	19.4	45.5	42.1	25.4	49.4	57.5	54.7	45.3	35.2	40.8	72.6	71.6	62.1	47.4	51.2	32.3	50.6	17.1	66.9	42.5	13.5	26.9	37.7	27.5	40.8	48.9	33.7	27.7	50.6	45.6	45.9	14.1	62.6	9.8	41.6	24.8	52.0	44.6	36.4	62.4	54.4	107.7	47.0	65.1	46.9	47.4	56.6	82.9	68.1	117.9	53.8	114.9	64.0	66.8	61.2	54.6	47.1	34.6	55.4	94.1	51.4	16.0	164.6	29.5	62.3	167.4	49.6	21.3	44.9	56.0	77.3	84.1	46.3	48.3	87.1	58.2	97.6	21.8	70.7	198.3	41.4	64.2	60.8	24.6	110.2	86.9	35.8	55.3	62.0	50.0	72.1	74.2	131.5	48.3	44.6	24.3	45.4	67.1	89.9	68.9	73.3	36.0	88.3	40.5	31.3	85.1	72.5	54.2	82.1	8.2	39.3	80.7	26.6	33.1	24.0	49.3	21.8	19.6	26.2	61.1	14.5	14.1	52.6	13.1	18.9	69.1	29.6	27.5	58.3	59.4	60.0	68.5	57.5	54.7	71.6	62.1	66.9	50.6	62.6	62.4	27.7	0.0	14.8	31.0	32.6	44.7	22.1	33.0	15.4	24.1	20.1	22.2	33.9	21.5	20.4	14.7	27.1	29.3	30.7	20.0	29.4	42.6	6.5	12.0	25.5	27.8	21.6	9.1	19.2	92.3	48.2	31.5	11.7	15.6	10.1	20.3	20.7	23.9	63.5	30.3	19.3	17.9	42.7	33.5	62.7	23.3	21.1	30.1	46.2	14.0	56.1	17.8	21.6	15.6	22.6	112.4	20.4	33.4	65.1	46.6	16.9	47.7	16.4	26.3	19.7	20.4	40.7	6.2	11.2	19.9	54.7	32.4	17.5	33.3	15.8	30.1
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 18020.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"NB-4: 2.1"									"CAB032548, HPA052517"	Enhanced				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB032548: AB_2277258, HPA052517: AB_2681860"																		31.6	4.3	0.7	0.6	0.8	18020.9	16.8	0.5	3.0	4.0	0.6	4.1	0.0	11.3	0.0	3.2	2.2	1.3	62.5	0.5	0.6	15.0	91.6	560.5	3.5	0.7	0.7	4.1	5.5	0.1	20.6	11.4	0.7	2.7	0.0	0.3	14.5	0.0	16.8	40.3	2.3	0.0	0.8	1803.8	6.4	3.1	0.8	37.0	15.8	0.0	0.8	3.4	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	3.0	0.5	0.6	0.7	0.7	0.7	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 872.0"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052517	Supported				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 11: Alveolar cells - Smell perception"			"HPA052517: AB_2681860"																		2.3	0.3	0.1	0.8	0.1	872.0	1.1	0.1	2.0	0.0	0.1	0.2	0.0	0.9	0.0	0.1	0.1	0.0	3.8	0.2	0.1	0.9	9.1	52.1	0.0	0.2	0.1	0.3	0.1	0.0	1.4	7.2	0.4	0.1	0.0	0.1	9.4	0.0	0.8	0.2	0.2	0.0	0.1	150.4	0.6	0.1	0.4	27.8	1.2	5.8	1.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.2	0.1	0.2	0.1	0.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
DEFA3	"DEF3, HNP-3"	ENSG00000239839	"Defensin alpha 3"	P59666	8	7015869-7018297	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"bone marrow: 37615.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 854.3"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 854.3"	"Cell line enriched"	"Detected in single"	8	"NB-4: 1.5"									HPA052517	Supported				"Secreted to blood"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA052517: AB_2681860"					"unprognostic (8.21e-2)"													8.8	1.2	0.5	1.0	0.3	37615.2	5.0	0.2	1.2	2.0	0.3	1.3	0.0	5.6	0.0	1.0	0.7	0.2	16.1	0.2	0.3	4.4	26.1	180.2	5.3	0.4	0.6	1.3	1.6	0.0	7.6	18.8	0.5	0.8	0.0	0.2	24.2	0.0	5.0	42.1	0.7	0.0	0.5	589.4	1.8	0.6	0.6	147.9	4.5	1.1	1.3	1.1	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	24.4	3.6	44.3	1.2	1.6	2.3	1.0	0.8	1.0	1.1	6.9	0.3	854.3	0.4	2.6	1.4	0.3	6033.6	0.5	0.3	0.2	1.2	0.2	0.3	0.4	0.6	0.5	0.5	0.6	0.2	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.8	17.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0
DEFA4	"DEF4, HP-4"	ENSG00000164821	"Defensin alpha 4"	P12838	8	6935820-6938306	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"bone marrow: 2702.9"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Hepatocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	13	"neutrophil: 13.1"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 13.1"	"Cell line enriched"	"Detected in single"	8	"THP-1: 6.8"									HPA051266	Enhanced				"Secreted to blood"	NA	NA		98000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA051266: AB_2681414"																		0.7	0.1	0.0	0.2	0.0	2702.9	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	2.7	14.2	0.6	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.4	2.0	0.1	0.0	0.0	46.4	0.1	0.1	0.0	8.9	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056739	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	768	"intestine: 9759.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	Yes	NA		110000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.3	0.4	0.1	12.7	0.1	0.2	0.5	0.1	0.5	0.0	0.1	56.6	5185.1	3.9	0.1	0.8	0.0	0.0	0.4	0.1	0.2	0.2	1.1	0.4	6.0	0.1	0.2	0.4	0.8	0.0	1.1	0.0	0.2	0.7	0.2	0.1	0.7	0.0	0.3	0.3	9759.8	0.1	0.1	0.4	0.9	0.8	0.2	0.4	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	2.5	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	325.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	399.9	0.0	0.0	0.0	1740.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	1753.0	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924697-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	863	"intestine: 4819.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 448.9;Undifferentiated cells: 904.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 21.2;colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 14.7;NB-4: 15.9;RPMI-8226: 19.7;SH-SY5Y: 12.2;U-2197: 5.7"									HPA019462	Enhanced				"Secreted to digestive system"	NA	NA		260000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.2	0.0	5.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	25.7	2862.9	2.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.2	3.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.3	3.3	0.0	0.3	0.0	0.2	0.6	4819.9	0.0	0.0	0.2	0.4	0.6	0.0	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	448.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	904.1	0.0
DEFB104A	"DEFB-4, DEFB104, DEFB4"	ENSG00000176782	"Defensin beta 104A"	Q8WTQ1	8	7836436-7841242	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	763	"epididymis: 1308.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"					"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1308.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB104B		ENSG00000177023	"Defensin beta 104B"	Q8WTQ1	8	7470308-7475082	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"	NA	NA									"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB106A	"DEFB-6, DEFB106"	ENSG00000186579	"Defensin beta 106A"	Q8N104	8	7825139-7829053	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16935	"epididymis: 3003.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"NB-4: 2.2"									HPA045592	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"				"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3003.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB106B		ENSG00000187082	"Defensin beta 106B"	Q8N104	8	7482504-7486400	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	685	"epididymis: 68.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045592	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"					"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB107A	"DEFB-7, DEFB107"	ENSG00000186572	"Defensin beta 107A"	Q8IZN7	8	7811720-7815716	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	1392	"epididymis: 139.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB107B	HsT21816	ENSG00000198129	"Defensin beta 107B"	Q8IZN7	8	7495911-7509311	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5377	"epididymis: 537.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	537.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB115	DEFB-15	ENSG00000215547	"Defensin beta 115"	Q30KQ5	20	31257664-31259632	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"epididymis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-2 OS: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053160	Uncertain				"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"				"HPA053160: AB_2682062"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB116	DEFB-16	ENSG00000215545	"Defensin beta 116"	Q30KQ4	20	31303212-31308585	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047430	Uncertain				"Secreted in male reproductive system"	NA	NA									"HPA047430: AB_10964749"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB118	"C20orf63, DEFB-18, dJ1018D12.3, ESC42"	ENSG00000131068	"Defensin beta 118"	Q96PH6	20	31368601-31373923	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9912	"epididymis: 991.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							HPA042634	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA042634: AB_10797505"														"unprognostic (3.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	991.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390590	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"epididymis: 1925.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.6;Cone photoreceptor cells: 39.6;Early spermatids: 61.9;Late spermatids: 99.8;Rod photoreceptor cells: 150.2"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.5"									HPA043059	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	1925.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	155.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	331.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.1	0.0	0.0	0.0	0.0	99.8	12.5	0.8	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	150.2	13.1	0.0	0.0	17.4	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB121	DEFB-21	ENSG00000204548	"Defensin beta 121"	Q5J5C9	20	31404845-31412838	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11866	"epididymis: 2605.3"	"Group enriched"	"Detected in some"	22	"Early spermatids: 14.5;Late spermatids: 5.4;Spermatocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NB-4: 3.1"					"Not detected"	"Not detected"			HPA079460	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA079460: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2605.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB129	"bA530N10.3, C20orf87, DEFB-29"	ENSG00000125903	"Defensin beta 129"	Q9H1M3	20	227258-229886	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	585	"epididymis: 1943.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;SH-SY5Y: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014581	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"				"HPA014581: AB_2732410"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1943.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257724-261096	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 271.2"	"Cell type enriched"	"Detected in some"	7	"Collecting duct cells: 11.0"	"Group enriched"	"Detected in some"	4	"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						25.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.5	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DEFB136	DEFB137	ENSG00000205884	"Defensin beta 136"	Q30KP8	8	11973937-11974599	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"epididymis: 1.2"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068255	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 34: Spermatids - Unknown function"			"HPA068255: AB_2732780"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
DELE1	"DELE, KIAA0141"	ENSG00000081791	"DAP3 binding cell death enhancer 1"	Q14154	5	141923855-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	42.5	54.2	26.5	22.5	29.1	39.7	42.0	30.4	32.9	43.3	33.6	43.8	30.3	41.2	14.6	35.4	38.8	24.9	78.9	26.8	27.7	44.5	53.5	46.2	30.2	29.9	28.6	37.9	42.9	38.1	34.0	29.4	28.9	41.4	31.2	14.0	33.1	24.5	71.1	32.3	39.6	30.1	27.7	65.7	42.4	15.6	29.5	19.3	40.3	49.7	27.1	43.4	38.7	29.6	23.6	31.5	44.7	65.9	34.7	45.5	29.7	29.8	48.8	51.6	56.8	46.0	54.0	55.1	33.2	32.9	29.9	35.1	27.2	62.8	28.4	31.7	24.0	33.4	37.9	34.5	43.8	48.3	63.3	55.8	31.3	45.4	37.0	46.0	54.5	11.5	21.4	72.9	26.9	30.8	13.0	26.8	17.2	28.6	49.9	43.5	29.7	61.8	37.2	33.7	25.0	31.8	35.2	54.0	72.6	28.8	70.3	42.6	44.1	38.9	23.8	20.7	27.0	20.1	23.3	34.0	32.0	38.1	43.4	21.2	43.0	14.8	21.2	56.7	19.7	20.6	16.5	20.7	56.1	19.1	13.8	18.2	18.2	24.7	66.9	22.2	27.2	25.3	26.5	29.1	30.4	32.9	26.8	27.7	29.9	28.6	28.9	27.7	29.5	29.6	31.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	16.0	17.0	0.0	0.0	0.0	11.0	0.0	26.2	13.7	0.0	13.7	12.4	0.0	12.0	13.7	10.9	0.0	0.0	0.0	24.3	13.8	6.3	0.0	12.1	0.0	24.4	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	17.2	0.0	0.0	5.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	25.7	4.8	34.5	0.0	0.0
DENND11	"KIAA1147, LCHN"	ENSG00000257093	"DENN domain containing 11"	A4D1U4	7	141656728-141702166	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.2;B-cells: 3.8;Cardiomyocytes: 4.3;dendritic cells: 8.5;Hofbauer cells: 7.6;Plasma cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 5.5;HEK 293: 5.3;U-266/70: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029467, HPA061437"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA029467: AB_10602915, HPA061437: AB_2684517"	"unprognostic (1.27e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (6.24e-4)"	"unprognostic (6.49e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.78e-1)"	8.7	5.9	7.1	1.0	8.0	0.9	9.6	5.4	10.2	8.0	4.3	11.0	3.6	7.0	0.5	12.5	8.1	0.5	6.8	10.7	5.3	8.8	14.7	13.3	1.6	9.0	7.7	7.5	17.4	1.0	11.8	0.3	8.6	9.0	1.5	2.8	20.6	0.7	5.7	8.7	14.4	0.6	7.0	14.2	17.8	1.4	6.9	0.6	12.4	0.5	1.2	8.5	11.3	10.6	1.9	1.5	0.9	1.2	0.5	0.2	0.3	0.4	0.3	0.3	0.3	1.9	1.3	0.1	3.1	0.3	0.8	0.6	1.0	0.8	0.7	5.5	5.3	0.9	0.8	0.3	0.1	1.7	0.3	0.2	0.7	0.2	0.3	0.8	1.3	1.0	0.0	0.3	0.2	0.7	1.5	1.2	1.5	2.1	1.0	3.6	0.2	1.7	0.6	1.0	1.4	2.7	1.2	2.1	0.2	0.5	0.8	0.2	4.3	0.2	1.0	0.4	2.2	7.5	1.8	2.4	0.6	2.3	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.1	8.0	5.4	10.2	10.7	5.3	9.0	7.7	8.6	7.0	6.9	10.6	9.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	8.5	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.3;Inhibitory neurons: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nuclear speckles"	"HPA042586: AB_2678064"	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	2.0	2.7	2.4	3.8	8.3	5.6	5.7	3.9	3.0	3.1	1.5	6.0	5.7	2.1	4.0	4.4	2.0	3.4	5.8	2.1	4.4	5.6	5.0	4.3	6.5	2.9	5.3	4.0	5.8	5.9	2.5	1.5	3.6	3.8	5.7	5.9	4.5	3.2	3.9	1.9	6.9	1.9	1.9	4.3	4.8	2.2	4.5	6.6	6.0	5.9	6.5	4.0	2.8	2.6	7.2	1.8	2.0	3.4	0.9	5.0	3.0	5.4	3.7	3.3	2.0	1.9	4.5	13.0	2.7	8.3	1.9	3.6	3.2	3.9	2.9	10.0	3.4	4.7	3.7	0.9	2.7	15.5	5.6	1.7	5.2	1.3	3.6	10.0	1.4	7.4	3.6	19.6	3.3	1.3	8.3	7.9	0.7	1.8	1.7	5.1	1.7	10.3	7.9	6.6	3.4	5.3	8.3	5.5	1.5	3.1	2.3	13.4	4.0	0.4	3.1	0.2	3.2	9.8	0.0	6.4	3.4	6.2	6.2	2.3	0.1	1.1	0.9	0.3	0.4	1.2	0.6	1.4	0.7	0.3	0.3	0.6	0.4	2.7	0.3	0.9	1.8	0.3	2.4	8.3	3.9	3.0	2.1	4.4	2.9	5.3	3.6	1.9	4.5	2.6	9.1	41.7	16.2	46.4	24.1	8.4	23.6	9.2	12.0	18.3	28.9	11.9	28.3	15.7	17.3	14.7	25.0	10.4	22.1	65.5	17.6	9.7	26.8	7.9	5.7	6.5	14.4	8.0	101.3	23.1	9.7	10.9	20.9	17.1	64.7	12.8	9.3	15.3	18.9	5.0	138.5	27.4	4.1	18.9	82.4	26.8	23.9	30.0	16.0	42.2	15.8	8.6	28.8	75.4	5.8	22.5	54.5	13.2	50.7	21.9	59.9	16.4	9.6	14.0	0.0	13.9	6.3	8.1	13.9	22.9	12.1	7.4	42.5	5.7	27.9	53.5
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DENND2B	"HTS1, p126, ST5"	ENSG00000166444	"DENN domain containing 2B"	P78524	11	8693351-8910951	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 3.2;Cardiomyocytes: 6.2;Cytotrophoblasts: 3.7;Extravillous trophoblasts: 1.8;Fibroblasts: 7.1;Hofbauer cells: 5.8;Smooth muscle cells: 5.7;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046796	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA046796: AB_2679812"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	26.3	60.0	22.0	19.2	20.4	3.4	26.6	26.6	23.2	72.7	38.2	85.4	28.8	130.3	33.2	62.7	104.6	34.6	35.0	19.1	22.3	29.4	27.4	28.8	12.1	29.7	32.6	69.2	27.5	15.4	21.5	26.4	18.3	45.4	26.7	36.5	37.5	62.9	21.9	22.2	30.3	117.2	21.3	59.7	56.9	41.0	28.0	17.5	36.6	11.1	15.1	65.0	50.4	17.1	32.6	4.9	51.8	9.0	16.8	17.6	2.5	28.9	95.8	27.5	25.4	6.8	34.0	1.0	17.2	52.7	12.1	32.2	10.0	41.7	10.8	4.4	12.7	0.0	16.7	22.8	26.9	0.2	0.2	60.8	11.6	15.6	20.1	56.0	5.5	5.0	6.7	2.8	45.4	3.5	1.8	1.5	7.9	32.2	7.7	1.1	31.5	2.0	37.5	23.4	9.8	31.7	25.7	32.1	19.8	17.7	5.4	1.1	14.9	15.8	24.7	50.6	22.8	8.0	15.5	0.2	24.1	0.2	30.4	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.0	2.9	0.0	0.1	0.4	22.0	20.4	26.6	23.2	19.1	22.3	29.7	32.6	18.3	21.3	28.0	17.1	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	7.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.7;skeletal muscle: 41.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 11.8;U-266/70: 25.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	0.9	0.5	0.8	0.3	0.8	1.0	1.9	0.9	0.9	4.2	2.2	0.6	0.7	1.5	0.8	17.7	0.9	1.2	1.1	1.1	0.4	0.6	2.0	1.5	0.4	0.6	0.6	1.1	1.2	1.7	0.6	0.1	0.7	1.4	0.6	1.5	2.7	1.4	41.6	12.4	0.6	1.1	0.3	0.4	0.9	5.5	0.6	0.4	1.4	1.7	3.4	2.6	7.0	0.5	2.1	0.0	0.1	1.4	1.7	1.8	0.4	0.6	1.1	0.7	1.1	0.3	0.0	0.1	0.9	4.1	1.4	7.4	1.4	4.6	0.7	0.1	1.8	1.2	0.4	0.1	0.5	0.0	1.8	1.8	4.4	2.7	2.3	0.1	0.2	0.5	0.2	0.3	2.4	6.0	0.2	0.1	0.9	0.0	1.1	0.0	6.2	0.1	0.1	5.7	0.0	0.0	4.5	0.1	0.5	1.1	0.9	0.3	0.3	1.0	1.5	11.8	0.2	25.4	4.8	0.0	1.0	0.0	0.8	3.0	0.0	0.9	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.8	0.8	0.9	0.9	1.1	0.4	0.6	0.6	0.7	0.3	0.6	0.5	6.6	28.9	2.2	3.3	3.3	109.1	138.2	32.5	60.3	20.4	5.2	5.3	8.7	11.5	21.3	7.3	20.9	0.1	1.9	1.1	0.0	7.2	29.5	100.3	15.7	8.6	0.0	0.0	2.8	7.5	0.1	6.9	5.6	192.7	2.5	8.1	15.4	11.7	0.3	0.0	0.8	0.9	4.1	2.2	9.3	12.9	5.0	14.0	7.2	9.4	1.1	2.3	1.0	5.0	3.5	33.0	0.2	2.2	17.6	79.5	0.1	0.8	46.8	10.3	0.0	21.7	6.6	47.9	59.7	114.9	171.8	0.0	3.7	1.3	1.5	340.4
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111185969-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 93.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.2;NK-cells: 232.8;T-cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"gdT-cell: 236.8;MAIT T-cell: 204.4;memory CD4 T-cell: 172.0;memory CD8 T-cell: 243.8;naive CD4 T-cell: 265.5;naive CD8 T-cell: 256.8;NK-cell: 278.3;T-reg: 79.5"	"Group enriched"	"Detected in all"	6	"NK-cells: 278.3;T-cells: 265.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;MOLT-4: 154.0;SK-BR-3: 96.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	9.1	13.0	0.8	39.3	0.7	11.8	12.0	0.7	1.3	10.9	3.7	19.2	19.2	3.5	9.6	25.2	18.6	10.8	1.8	0.5	1.0	14.3	12.1	16.5	93.8	1.8	1.1	6.5	7.8	33.4	9.8	9.0	1.3	7.6	19.7	0.3	19.0	7.6	0.6	14.2	22.5	3.3	1.6	40.1	26.8	9.7	2.7	41.6	11.4	2.2	79.5	29.2	11.6	2.7	32.6	1.4	0.1	0.0	7.3	3.0	0.3	1.9	0.1	3.4	0.8	9.9	14.8	34.4	11.0	4.9	0.2	10.2	0.1	1.7	3.3	61.2	0.0	10.1	2.4	0.0	11.3	0.1	10.1	8.9	7.0	1.0	0.0	10.2	0.3	11.1	0.2	10.3	1.0	27.8	154.0	0.9	0.0	40.8	4.4	4.0	0.0	46.0	10.9	33.6	11.2	0.0	11.4	96.5	3.6	0.2	30.3	32.0	0.0	0.0	0.1	0.0	0.2	9.5	4.1	25.8	0.0	27.1	0.2	5.3	21.0	15.0	236.8	15.5	204.4	42.6	172.0	243.8	19.7	46.3	265.5	256.8	20.7	278.3	11.9	15.1	79.5	197.5	0.8	0.7	0.7	1.3	0.5	1.0	1.8	1.1	1.3	1.6	2.7	2.7	2.1	6.4	16.8	0.3	24.7	5.0	17.9	24.1	9.6	0.1	14.9	8.6	1.2	8.6	23.8	20.2	0.0	1.7	71.2	22.8	19.6	38.0	35.4	8.9	1.4	3.7	6.0	8.2	0.2	15.9	3.1	3.7	25.5	11.3	17.7	4.6	7.5	5.3	57.1	0.0	0.2	34.6	14.2	32.4	2.5	49.2	1.2	17.2	7.2	1.9	11.9	0.0	232.8	0.0	0.1	12.7	18.2	0.4	12.3	35.4	20.4	28.7	20.7	0.4	0.0	1.2	1.8	25.4	0.7	17.7	4.0	11.5	83.2	10.2	21.0	31.3
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 59.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA065343: AB_2685476"	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	6.2	9.8	4.0	11.4	6.5	33.8	6.8	29.9	7.5	7.4	11.2	6.6	5.8	8.8	5.1	6.6	7.2	11.2	5.1	5.6	5.1	7.9	16.8	9.5	19.7	3.5	4.7	12.8	15.5	10.1	8.4	8.5	4.7	6.0	6.8	59.3	6.1	5.6	9.2	6.5	6.3	7.4	4.2	12.4	8.9	7.9	3.3	12.7	9.3	7.8	18.2	10.2	4.5	7.6	9.9	9.6	4.9	5.1	14.3	15.9	5.9	10.1	13.9	6.8	9.9	5.5	7.8	52.0	6.8	15.1	8.4	18.1	9.7	9.2	12.0	56.7	11.2	49.4	11.7	10.4	8.3	16.8	16.7	10.6	10.3	9.5	20.0	12.0	18.5	11.4	15.2	31.5	7.9	5.2	8.1	9.1	1.5	30.5	6.9	3.9	17.2	45.1	8.0	19.0	7.7	7.0	9.8	6.9	8.9	5.8	6.7	43.1	19.6	9.3	10.3	16.7	14.2	16.8	20.1	19.3	13.1	36.2	7.8	3.2	2.6	5.2	3.6	1.0	5.5	5.4	3.1	4.6	2.3	6.1	3.2	3.1	1.4	3.5	0.9	0.9	3.3	1.5	4.0	6.5	29.9	7.5	5.6	5.1	3.5	4.7	4.7	4.2	3.3	7.6	22.7	16.0	23.1	126.7	81.5	27.9	29.8	7.9	36.5	73.8	23.9	12.2	12.3	20.0	15.2	9.2	60.5	5.6	47.8	5.8	0.0	10.1	2.4	29.3	22.2	23.7	17.4	83.1	195.4	13.0	6.8	22.4	25.0	46.1	48.8	10.5	21.0	25.9	20.4	111.0	140.3	9.7	0.0	19.0	47.5	3.0	13.1	42.2	24.9	145.2	24.5	26.9	20.6	176.5	180.2	12.0	10.1	12.4	55.1	20.2	6.4	9.8	18.1	155.9	6.6	37.9	15.7	11.3	10.9	18.7	17.0	12.6	56.5	13.2	10.0	17.3
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946718	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	18.2	13.4	10.9	24.3	11.1	37.1	15.7	2.3	19.1	17.1	0.0	15.6	9.5	16.3	3.4	10.2	16.2	10.0	21.3	10.2	6.5	13.8	11.4	24.2	30.1	12.0	7.8	19.6	15.5	7.7	13.1	10.3	13.0	13.0	6.0	9.5	11.7	7.0	49.2	11.0	22.0	8.9	3.1	41.0	12.9	7.6	9.8	14.6	15.2	29.5	17.3	15.1	12.9	10.0	12.0	22.7	17.1	17.3	10.0	9.7	17.8	11.5	12.4	17.8	16.6	13.8	13.4	29.9	19.1	7.8	13.5	20.9	15.5	10.6	8.0	27.5	14.0	26.5	26.1	13.3	13.9	28.0	51.5	8.8	18.3	16.6	17.8	14.8	12.8	32.3	28.7	16.4	10.3	24.6	34.2	25.7	23.8	14.1	21.8	36.2	11.5	17.3	8.5	17.6	20.3	24.9	12.1	28.4	16.7	17.0	20.6	68.0	13.5	19.2	18.5	16.1	18.7	49.3	37.7	39.5	13.2	21.7	23.5	1.5	1.6	0.4	1.1	2.4	1.4	1.0	0.9	0.7	1.4	0.9	0.4	1.0	1.5	0.7	1.9	1.9	0.7	1.5	10.9	11.1	2.3	19.1	10.2	6.5	12.0	7.8	13.0	3.1	9.8	10.0	14.7	9.6	10.3	18.6	20.3	4.7	3.7	4.6	1.2	22.3	7.1	6.9	22.9	8.6	5.7	7.3	6.2	4.6	31.9	4.8	5.9	5.2	1.2	4.0	8.0	11.8	4.9	9.5	21.8	6.5	4.7	7.2	13.7	7.4	17.2	12.5	10.8	9.2	18.0	35.3	23.6	4.6	2.0	30.2	11.7	1.9	7.5	31.1	5.4	18.7	22.5	5.8	30.9	19.1	27.9	6.1	4.8	7.9	7.1	6.8	7.6	2.7	4.4	17.8	6.6	7.9	6.0	6.4	8.1	5.7	3.4	3.4	17.0	9.2	7.1	5.2
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19374281	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	21.7	11.9	5.9	9.2	7.0	10.6	21.7	14.1	6.3	17.2	8.0	17.4	25.1	17.2	14.3	14.5	16.4	13.8	14.5	5.3	5.6	13.9	15.2	18.0	11.8	5.9	5.7	21.4	12.9	19.0	8.7	19.6	5.7	16.1	19.8	11.8	15.1	13.4	10.6	29.6	22.4	14.6	5.8	12.7	19.8	11.2	7.2	17.7	17.3	12.4	11.2	16.6	16.0	6.6	17.7	17.5	11.7	15.3	26.6	28.5	21.4	10.0	14.9	10.2	13.7	8.4	11.6	7.5	8.3	13.6	11.8	9.4	13.7	9.4	12.0	47.2	7.8	34.4	18.5	10.4	13.4	8.3	18.8	11.7	18.7	9.0	15.5	21.6	20.2	9.9	9.4	8.5	13.1	7.4	13.8	18.8	9.0	24.7	8.5	12.6	6.6	10.9	29.2	34.1	10.9	8.5	8.4	20.1	7.4	11.0	12.1	11.3	18.5	8.9	5.2	10.0	10.5	5.8	14.9	4.0	7.7	7.6	5.2	8.3	1.6	1.9	5.4	0.8	7.0	1.7	4.6	5.5	3.1	2.3	4.3	5.0	0.9	6.4	0.9	3.2	3.8	2.4	5.9	7.0	14.1	6.3	5.3	5.6	5.9	5.7	5.7	5.8	7.2	6.6	28.6	9.6	11.5	85.8	21.3	51.2	16.7	18.0	65.4	20.9	16.0	11.0	12.4	14.3	21.6	16.5	60.5	29.4	22.6	26.6	1.9	9.8	7.7	12.7	15.5	22.9	19.8	9.7	78.6	12.5	13.5	24.0	47.4	20.4	27.1	24.8	51.0	11.5	19.0	23.5	87.2	22.6	24.4	23.9	22.0	5.2	18.6	32.2	21.4	120.9	8.5	13.6	27.8	107.1	69.1	12.1	20.9	20.3	14.1	19.4	26.4	4.9	21.6	16.3	0.0	19.5	16.2	3.3	6.8	30.9	49.3	16.1	28.2	12.0	23.3	23.2
DENND5A	"FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1"	ENSG00000184014	"DENN domain containing 5A"	Q6IQ26	11	9138825-9265959	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052923, HPA055009"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA052923: AB_2681989, HPA055009: AB_2682669"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (9.86e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.40e-2)"	45.8	23.5	72.4	23.2	90.5	21.7	36.3	85.0	80.7	36.1	45.5	44.2	5.8	38.5	14.1	17.4	37.5	23.3	58.0	65.1	85.4	25.5	15.7	46.1	16.8	81.5	86.6	30.2	23.2	18.5	20.5	28.8	77.0	24.5	12.9	34.7	19.5	40.0	26.7	17.3	20.2	47.5	74.9	31.4	23.7	15.8	87.3	28.0	22.0	33.7	15.9	40.4	25.1	81.3	18.8	23.3	63.7	56.1	113.0	92.0	61.7	69.2	99.8	85.7	104.5	16.4	13.6	0.0	30.5	129.0	82.4	12.7	64.3	22.5	111.4	73.0	30.9	6.2	32.2	34.5	61.0	34.4	13.9	76.8	11.5	51.1	74.6	59.7	83.8	21.9	33.6	0.3	101.9	11.0	19.4	15.1	19.7	3.2	28.6	34.2	46.1	0.3	41.6	13.4	15.9	32.1	65.8	29.7	27.2	70.4	15.7	24.6	59.2	63.0	41.0	78.7	47.3	1.4	0.4	18.7	63.4	14.1	51.9	4.4	5.0	5.7	0.1	6.3	0.6	1.8	1.3	1.3	4.6	0.2	3.8	1.9	10.8	1.0	9.2	1.1	0.0	1.9	72.4	90.5	85.0	80.7	65.1	85.4	81.5	86.6	77.0	74.9	87.3	81.3	34.1	19.2	14.5	43.8	7.4	21.7	19.3	10.3	10.2	9.7	15.3	13.8	33.2	14.3	8.0	14.7	60.5	15.9	6.4	0.3	0.0	7.3	1.1	26.3	31.8	31.3	6.6	7.8	47.7	6.7	20.1	27.1	3.1	57.8	2.5	11.6	21.4	10.9	21.8	13.5	74.2	2.2	4.1	36.3	63.4	2.0	21.5	48.9	19.6	68.4	41.1	11.6	3.1	136.2	287.1	8.4	1.4	20.7	0.9	32.5	0.1	10.3	4.8	10.5	26.3	34.4	31.6	7.9	12.3	6.3	8.2	11.2	6.3	16.0	0.8	15.0
DENND5B	MGC24039	ENSG00000170456	"DENN domain containing 5B"	Q6ZUT9	12	31382226-31591136	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 152.8;Excitatory neurons: 217.3;Inhibitory neurons: 246.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 121.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SuSa: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038865	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoli	"HPA038865: AB_2676245"	"unprognostic (5.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.60e-2)"	4.0	6.4	6.3	5.4	7.8	2.1	3.2	20.1	12.3	4.8	2.9	4.2	9.2	6.9	2.0	2.4	3.9	4.2	10.9	6.1	8.4	7.6	12.5	2.6	7.3	7.7	5.2	21.7	5.7	2.7	4.7	4.9	7.7	2.9	4.3	15.9	2.0	3.1	7.1	1.3	10.4	7.2	2.0	6.7	5.0	16.1	7.1	2.4	2.9	13.1	8.4	3.7	3.1	6.1	2.8	27.9	20.1	7.7	7.1	8.8	3.0	6.8	7.4	16.9	12.1	18.9	11.1	10.4	11.1	14.8	18.5	0.8	4.0	1.9	16.7	0.0	8.5	0.1	21.2	11.3	6.5	9.6	0.2	5.5	6.0	11.3	18.5	15.5	15.7	5.7	4.0	20.6	10.6	2.6	5.7	10.0	20.4	6.5	4.9	5.4	27.8	0.2	14.2	3.6	6.4	9.5	17.0	1.9	15.0	57.3	2.8	5.2	16.5	6.3	16.0	11.4	14.4	10.9	13.0	10.5	10.7	1.1	10.7	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.1	6.3	7.8	20.1	12.3	6.1	8.4	7.7	5.2	7.7	2.0	7.1	6.1	6.7	3.2	0.5	152.8	43.9	2.9	3.5	0.9	2.8	42.4	5.3	4.1	44.0	17.2	2.1	7.3	31.3	0.6	7.0	13.3	3.9	1.8	19.6	6.1	10.1	7.4	8.4	6.3	217.3	9.3	2.9	13.0	4.6	4.4	0.0	45.0	25.0	34.2	4.5	28.6	246.4	3.1	2.0	4.5	5.8	8.3	8.4	3.8	23.2	74.9	2.5	12.9	1.0	144.3	121.0	7.9	3.6	10.5	72.6	2.4	33.2	12.0	2.2	26.8	6.6	12.9	10.0	32.0	18.2	0.2	1.4	0.7	2.3	15.5	4.4	1.2
DENND6A	"AFI1A, FAM116A, FLJ34969"	ENSG00000174839	"DENN domain containing 6A"	Q8IWF6	3	57625454-57693077	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 18.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062618, HPA069725, HPA071711"	Approved		Supported	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435"	"unprognostic (6.20e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.76e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.77e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.94e-1)"	11.6	7.3	3.4	8.8	4.6	12.6	12.9	12.9	7.1	11.8	3.8	10.7	7.1	12.7	9.9	11.4	10.3	8.3	8.0	3.0	5.5	8.9	7.7	10.5	12.6	4.2	4.8	20.9	5.3	11.4	6.6	11.8	5.3	9.9	9.2	10.0	8.4	11.7	7.1	8.6	9.2	11.3	4.7	12.9	9.7	8.0	4.7	11.8	14.0	9.8	10.5	10.7	10.5	8.4	16.8	13.5	18.0	11.0	9.4	10.6	10.2	8.6	11.0	10.5	8.2	8.7	18.4	19.9	3.6	8.9	9.2	8.8	14.4	18.2	8.9	5.1	12.9	15.7	15.1	6.7	9.0	12.1	8.9	11.3	13.0	7.2	18.7	10.6	15.2	21.1	10.8	21.1	7.6	7.3	26.2	14.9	10.2	10.6	9.3	10.9	10.7	14.8	12.8	28.1	6.1	22.0	17.1	13.9	12.5	7.7	9.1	14.7	16.7	12.7	6.8	13.6	22.8	15.7	22.2	20.7	14.8	19.9	18.9	18.7	1.0	1.4	2.4	1.1	2.9	0.8	2.3	2.4	1.3	1.2	3.4	2.6	1.5	1.9	1.4	1.0	1.3	1.0	3.4	4.6	12.9	7.1	3.0	5.5	4.2	4.8	5.3	4.7	4.7	8.4	28.8	19.2	8.2	31.3	14.5	12.9	11.8	10.6	12.0	16.2	9.9	9.1	20.8	11.5	10.0	5.5	8.4	6.4	21.4	5.7	3.9	8.1	22.2	10.1	25.6	16.0	3.0	16.2	66.9	10.9	4.4	15.7	10.2	17.1	2.5	24.1	20.7	11.1	11.1	10.1	65.4	5.5	12.2	34.3	9.9	11.3	11.8	16.8	3.6	47.8	16.8	10.2	20.6	42.3	74.3	18.9	3.5	14.3	9.5	8.4	6.5	8.9	8.0	14.5	6.6	19.2	18.3	13.3	5.0	14.1	10.7	2.3	19.6	16.7	6.1	13.0
DENND6B	"AFI1B, FAM116B, MGC33692"	ENSG00000205593	"DENN domain containing 6B"	Q8NEG7	22	50309030-50327012	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 42.1;Late spermatids: 58.7;monocytes: 39.4;Respiratory ciliated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.9;RPMI-8226: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018934, HPA021653, HPA029570"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131"	"unprognostic (2.50e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic favorable (5.93e-5)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	2.4	3.8	10.6	2.3	10.8	1.0	3.4	8.0	14.4	6.2	8.6	3.9	1.1	5.2	2.5	2.5	13.4	3.2	1.7	10.3	9.5	7.6	1.7	4.7	2.9	9.4	9.1	4.0	5.4	2.7	13.6	1.0	9.5	5.5	0.9	4.2	3.6	3.6	0.7	2.6	3.9	1.7	6.9	4.5	3.3	6.7	9.6	0.8	6.7	0.6	1.7	2.6	3.5	7.7	0.5	1.8	3.9	4.3	1.0	3.7	0.0	0.8	1.9	0.5	0.3	0.1	2.8	6.9	1.7	1.9	0.2	3.4	0.1	0.1	0.2	1.7	1.0	1.2	3.5	0.2	0.9	0.2	3.0	3.1	4.2	0.1	0.6	3.8	0.8	0.1	1.5	1.2	0.9	3.0	0.0	0.6	0.3	2.0	0.2	1.0	0.0	10.0	4.9	1.6	1.7	3.1	2.1	2.7	0.3	0.2	4.3	1.0	0.9	0.7	0.6	0.6	0.1	1.0	0.2	1.0	1.7	0.8	0.8	0.2	0.8	0.0	0.1	1.0	0.2	0.2	0.1	0.2	0.5	0.2	0.1	0.2	0.1	0.3	1.3	0.4	0.1	0.3	10.6	10.8	8.0	14.4	10.3	9.5	9.4	9.1	9.5	6.9	9.6	7.7	4.5	3.2	4.1	16.3	14.9	1.1	3.6	6.1	5.7	6.2	5.4	5.8	1.3	11.5	8.3	5.5	22.9	0.3	9.5	3.9	3.9	6.5	24.7	42.1	4.6	5.7	10.2	4.4	20.3	1.8	0.6	4.2	9.2	5.7	5.7	2.8	4.2	1.0	13.7	1.7	13.7	3.3	4.1	24.2	7.8	58.7	2.5	20.0	5.4	2.8	39.4	5.6	5.2	9.0	2.5	2.6	2.1	2.6	33.2	2.4	14.0	17.8	65.5	17.5	0.0	2.5	3.0	24.7	22.2	1.6	0.6	1.0	8.4	3.1	3.6	2.3
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752824-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 227.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021783	Approved		Approved	Cytosol		NA	NA		200000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	25.4	22.6	19.0	27.0	19.6	27.5	29.6	15.3	23.6	22.2	15.1	25.5	26.7	23.7	22.1	32.5	21.7	22.1	24.4	19.4	20.2	25.5	27.6	18.8	36.2	16.8	21.6	19.2	21.2	59.0	17.1	31.6	19.5	28.0	26.0	16.5	28.4	24.8	60.2	29.6	25.0	24.5	15.2	28.0	23.3	14.6	18.9	38.9	29.8	44.7	35.5	30.0	20.4	16.7	113.1	62.1	77.7	80.1	48.7	71.9	67.6	100.5	56.1	87.6	60.6	86.9	40.6	99.9	103.4	72.5	66.6	84.0	93.8	89.5	117.6	90.9	67.3	122.8	36.2	63.8	63.5	139.6	97.4	62.8	86.9	79.3	107.4	81.6	86.4	109.7	129.8	35.8	94.8	74.9	137.7	134.1	159.2	67.2	128.4	120.6	91.2	63.7	85.3	99.9	89.3	63.4	139.2	40.8	107.3	79.1	129.5	78.1	82.2	81.2	95.9	91.7	102.1	58.8	145.8	160.4	76.4	100.1	90.9	227.9	35.0	58.1	38.8	53.3	45.3	45.5	41.9	39.4	47.3	41.4	48.5	43.4	42.2	47.3	69.9	42.1	49.2	44.5	19.0	19.6	15.3	23.6	19.4	20.2	16.8	21.6	19.5	15.2	18.9	16.7	43.4	70.5	40.1	31.0	59.8	71.9	65.9	55.4	59.7	37.7	66.2	69.8	66.3	45.8	47.7	47.8	41.7	73.0	60.8	40.9	64.6	68.6	17.9	67.7	83.5	51.4	84.8	53.8	39.0	61.8	130.3	48.3	40.8	70.7	43.1	50.4	42.1	54.3	57.4	55.5	36.2	53.6	44.7	50.1	42.4	8.0	50.4	49.3	26.6	25.3	60.2	47.3	75.2	48.2	31.3	88.0	44.6	45.9	47.9	73.2	40.3	67.3	49.5	35.9	19.7	46.2	62.5	120.3	136.8	72.8	64.9	60.6	54.7	47.3	58.8	51.3
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.1;testis: 8.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	0.3	0.1	0.0	2.6	0.0	5.0	0.6	0.0	0.1	0.4	0.0	2.9	2.5	0.5	0.1	2.4	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.2	4.8	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.1	2.1	3.5	0.0	0.3	0.1	0.0	1.6	2.4	1.5	0.0	0.6	1.2	8.1	0.2	8.1	0.3	0.2	4.8	0.9	0.7	0.2	47.2	21.5	40.0	18.5	2.5	5.6	31.3	58.9	26.9	49.1	42.1	17.9	19.3	0.0	42.8	24.4	78.6	30.8	58.6	30.7	82.4	41.2	38.2	38.3	35.9	10.5	0.6	33.4	0.0	2.1	1.6	56.3	31.2	10.0	36.0	16.5	26.6	36.1	88.3	10.7	0.1	12.5	34.6	19.5	28.9	0.0	118.7	15.3	19.8	12.7	44.8	20.7	59.0	24.9	30.3	25.6	22.5	16.6	21.3	31.5	35.5	56.0	69.2	22.5	52.2	0.5	29.7	11.4	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	3.3	0.8	3.3	1.2	0.4	1.3	1.8	0.8	0.0	0.5	1.8	0.0	20.6	0.4	2.1	0.0	0.2	44.9	4.0	1.6	1.6	0.0	31.8	0.5	0.0	35.2	4.4	8.2	2.0	0.0	17.5	2.2	1.2	8.6	0.0	2.2	5.3	4.1	3.5	1.0	73.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	6.9	2.2	0.5	0.1	0.9	0.2	0.0	0.6	4.0	86.8	19.6	12.2	1.3	2.9	1.6	0.5	8.8	1.7
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPDC4	"DEP.4, FLJ33505"	ENSG00000166153	"DEP domain containing 4"	Q8N2C3	12	100203669-100267079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.7;Late spermatids: 19.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039323	Uncertain		Approved	Microtubules		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039323: AB_10674283"	"unprognostic (8.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.09e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-2)"	0.2	0.3	0.2	0.3	0.2	0.6	0.8	0.2	0.6	0.3	0.0	0.6	1.2	0.4	0.5	0.7	0.4	0.4	0.3	0.2	0.6	1.7	1.3	0.3	0.3	0.3	0.2	0.7	0.7	0.5	0.5	0.7	0.2	0.7	0.8	0.4	0.7	1.0	0.2	0.4	0.5	0.2	0.3	0.2	0.6	3.9	0.2	0.6	0.5	0.2	0.3	0.3	0.3	0.3	1.3	1.8	3.4	0.9	0.1	0.4	2.1	1.8	1.2	3.7	2.2	2.9	0.7	1.4	1.1	0.9	1.1	2.0	2.9	1.5	4.0	1.5	3.2	4.9	0.8	3.3	0.4	1.6	1.9	0.3	0.9	1.3	0.3	0.7	0.9	2.5	2.9	0.6	1.7	1.3	1.0	2.9	1.6	1.6	1.9	2.0	3.4	3.3	1.7	0.8	0.9	2.0	1.0	1.4	1.1	2.0	2.8	1.7	0.2	2.5	1.0	1.0	1.4	1.5	1.7	3.0	0.7	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.3	0.2	0.2	0.3	0.2	0.3	0.5	0.0	4.4	6.2	0.7	0.9	1.4	1.8	3.4	2.1	1.0	1.5	0.9	0.0	2.2	5.5	4.2	3.5	0.2	0.5	5.9	0.6	13.7	0.9	0.9	0.7	0.0	2.1	3.3	1.3	2.0	3.6	0.0	0.9	0.0	1.1	0.4	1.1	1.1	0.0	3.4	0.5	0.0	0.3	1.1	19.2	1.2	0.5	1.8	1.0	0.1	1.3	0.0	3.5	6.5	0.5	0.3	0.0	0.2	0.6	1.4	5.3	1.8	4.8	0.0	1.4	1.2	8.0	6.2	0.7	0.3	1.2	0.7	2.4	1.5	0.9
DEPDC5	"DEP.5, KIAA0645"	ENSG00000100150	"DEP domain containing 5, GATOR1 subcomplex subunit"	O75140	22	31753867-31908033	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 31.9;Inhibitory neurons: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"U-698: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054969, HPA055619"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA054969: AB_2682655, HPA055619: AB_2682864"	"unprognostic (5.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.64e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (5.66e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (4.86e-5)"	6.3	7.7	6.4	5.1	6.5	4.4	5.6	8.7	10.8	8.7	5.8	7.4	3.0	6.0	3.4	7.2	6.6	3.5	4.8	6.5	6.3	5.5	9.9	5.3	6.3	6.0	5.8	11.3	4.2	4.9	6.2	3.6	6.2	5.5	5.2	4.0	6.0	3.0	5.9	6.4	8.5	3.7	5.3	9.4	6.2	7.4	6.5	4.9	5.7	3.8	9.7	6.6	7.1	8.6	5.7	5.0	9.1	5.7	4.5	4.7	7.4	3.9	6.4	5.1	6.8	6.8	3.4	13.0	1.5	5.5	4.1	5.8	6.3	6.3	9.1	6.7	5.8	6.1	6.1	6.7	4.4	20.6	19.0	5.2	3.2	9.6	4.8	4.3	9.3	4.8	4.3	3.9	7.3	5.5	5.8	5.8	4.6	9.9	2.1	11.2	10.0	7.4	6.0	12.0	6.0	6.7	7.8	4.2	5.2	6.6	4.4	11.5	8.0	5.0	6.0	5.2	3.8	5.8	5.7	31.5	5.5	6.0	5.1	34.8	2.9	15.2	2.6	3.4	3.0	6.8	1.9	1.5	2.5	4.2	3.0	3.8	1.8	4.2	3.7	1.8	2.3	1.3	6.4	6.5	8.7	10.8	6.5	6.3	6.0	5.8	6.2	5.3	6.5	8.6	4.7	0.0	3.9	20.5	12.0	2.7	1.8	3.0	5.2	4.9	4.5	2.9	4.3	2.8	5.5	7.3	2.1	3.8	4.5	10.4	3.9	5.1	1.3	4.2	6.1	5.1	13.2	2.1	31.9	4.9	3.1	4.3	6.6	6.5	5.7	18.2	4.2	4.9	3.5	16.8	29.6	6.2	6.1	3.1	2.2	2.2	1.8	6.9	3.6	24.4	3.9	4.2	5.2	23.1	24.3	4.7	5.6	2.6	4.4	1.6	4.7	2.8	5.2	5.6	6.6	3.1	3.1	4.8	5.2	4.3	2.3	2.3	5.3	11.4	5.0	1.8
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1 autophagy regulator"	Q9NTK1	10	44970981-44978809	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 889.5;breast: 697.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavorable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	889.5	48.4	62.3	19.4	71.4	4.5	697.2	59.5	71.8	153.0	50.3	145.7	16.7	168.5	16.5	65.7	334.2	68.5	260.6	55.5	71.9	95.4	131.6	508.6	63.0	175.9	72.3	297.8	349.7	23.0	85.2	76.5	93.4	82.6	12.0	28.2	119.7	22.8	165.8	165.0	94.8	68.8	101.6	32.8	104.6	19.3	87.4	25.2	200.5	52.2	47.6	177.6	139.1	90.6	30.2	0.2	0.5	0.4	143.2	69.5	7.4	0.2	10.2	0.4	1.8	1.1	11.2	0.0	1.6	13.5	7.1	1.2	1.2	9.1	0.7	106.7	4.0	0.1	0.1	11.0	258.2	0.1	0.1	201.6	0.4	0.1	1.4	24.9	165.0	0.0	0.2	63.2	0.6	0.0	0.1	1.7	0.2	0.6	0.9	5.1	1.7	25.7	0.5	10.9	5.6	0.3	0.0	1.3	5.8	17.0	0.2	7.0	1.6	7.8	5.6	0.5	7.3	1.7	2.8	0.4	44.2	2.6	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.4	62.3	71.4	59.5	71.8	55.5	71.9	175.9	72.3	93.4	101.6	87.4	90.6	192.0	0.0	24.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	47.0	27.8	0.0	0.0	6.2	31.3	0.0	53.8	1.4	0.0	37.2	146.3	0.0	61.3	33.2	60.0	0.0	0.0	0.0	113.0	14.7	79.3	0.0	87.1	0.0	8.4	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	65.0	0.0	0.0	0.5	0.0	0.0	25.5	5.8	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	300.2	1.8	0.8	0.0	0.0
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.2;tongue: 122.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 20.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria	"Nucleoplasm, Nuclear bodies"	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	14.4	52.8	12.0	3.0	16.7	2.0	20.7	12.6	11.9	39.2	3.8	23.3	16.9	16.5	11.1	15.2	27.1	10.8	5.1	9.7	23.2	40.0	16.3	5.3	10.1	15.8	12.5	24.7	11.9	16.9	11.4	4.9	15.3	12.1	9.9	2.0	106.3	15.6	158.2	6.6	14.5	15.5	14.8	9.5	40.0	2.9	16.3	5.1	98.0	122.3	2.9	5.6	7.0	24.2	0.1	3.5	0.3	1.1	21.0	6.2	0.3	0.1	0.3	0.6	0.5	2.4	0.4	105.1	2.3	1.2	0.3	0.3	5.4	0.2	0.4	2.3	2.7	14.2	0.9	0.6	12.8	3.0	23.7	5.5	9.5	0.8	0.6	0.1	0.0	1.8	0.1	16.9	0.3	7.1	0.1	2.5	1.3	45.5	3.7	0.4	4.9	193.2	149.3	4.1	3.2	0.7	1.7	11.0	3.2	2.8	9.6	0.5	0.0	0.4	0.9	21.4	0.5	45.4	11.4	55.2	6.5	3.9	0.6	0.0	0.9	0.0	0.2	1.7	0.8	0.1	0.4	0.7	20.3	0.1	0.8	0.6	0.3	0.4	0.2	1.0	0.4	1.0	12.0	16.7	12.6	11.9	9.7	23.2	15.8	12.5	15.3	14.8	16.3	24.2	23.1	6.4	9.3	4.9	2.9	5.2	15.4	3.8	27.3	2.1	16.5	10.4	2.4	15.7	8.4	25.8	0.0	0.6	0.8	2.7	86.1	5.7	2.2	19.0	9.7	7.5	16.7	12.4	14.5	11.8	4.1	10.0	29.6	66.1	12.0	5.4	2.5	12.7	3.3	0.0	31.0	7.7	0.0	16.0	39.5	2.2	11.8	14.9	14.2	46.9	1.5	1.2	2.1	9.5	123.9	1.1	36.5	3.4	6.4	7.1	21.0	33.6	1.1	0.7	0.0	8.1	5.7	3.6	3.8	16.5	5.5	0.4	1.3	6.0	16.5	21.9
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013170-123042302	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 225.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 825.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	69.1	47.6	15.2	53.7	16.4	104.1	34.1	20.2	18.2	26.6	26.6	50.0	47.9	29.4	31.4	35.4	29.4	32.9	41.3	17.9	18.3	30.8	77.5	37.1	48.7	15.7	16.4	38.1	31.6	26.9	23.0	28.0	15.7	27.0	42.8	29.6	29.6	28.7	73.3	23.6	47.0	34.4	16.7	40.0	38.5	32.1	18.0	27.2	42.4	49.1	55.5	41.8	22.5	19.5	130.8	93.9	55.7	72.6	98.3	72.8	47.1	108.9	72.1	68.7	85.1	59.7	126.9	150.7	129.8	87.4	81.2	107.0	51.8	69.3	97.4	174.9	57.6	157.2	62.9	51.6	89.2	62.2	111.0	66.9	87.8	76.0	89.8	62.5	62.8	60.6	95.9	193.7	78.7	254.8	68.5	39.4	42.1	166.4	82.5	68.3	46.2	252.1	182.2	92.1	60.5	89.8	109.9	825.1	68.6	59.6	97.3	55.4	74.2	82.2	154.1	74.1	102.1	239.5	444.6	136.5	135.4	76.4	79.4	73.1	60.7	72.6	89.3	75.7	93.0	69.8	59.5	74.0	49.5	56.1	41.0	64.0	42.1	77.8	77.9	56.6	80.0	83.3	15.2	16.4	20.2	18.2	17.9	18.3	15.7	16.4	15.7	16.7	18.0	19.5	38.6	32.1	25.9	12.4	78.3	42.3	41.8	57.3	26.7	22.6	38.3	21.3	28.1	17.2	44.8	29.5	20.9	41.0	67.6	43.3	9.8	87.7	85.5	18.9	32.3	39.2	30.5	41.0	11.5	75.4	71.4	43.8	26.5	31.2	42.6	24.0	39.3	75.9	68.0	18.5	12.8	62.2	42.7	49.4	44.2	19.9	24.5	45.6	60.5	14.0	47.6	25.5	59.8	17.6	19.1	68.4	40.6	25.6	225.0	63.7	56.6	28.0	31.3	25.6	46.0	32.7	77.6	75.4	40.3	41.0	50.7	78.0	69.8	34.8	37.5	64.4
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471254-5486811	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171"	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	14.5	18.8	5.7	16.4	6.0	33.9	12.9	6.3	7.6	13.1	7.0	12.9	14.9	12.8	29.6	15.3	14.0	17.3	10.2	5.4	6.2	14.0	28.0	11.3	18.2	6.4	6.4	12.8	28.5	14.7	12.1	13.4	6.6	14.0	12.3	8.1	28.3	11.4	10.6	10.1	17.5	12.4	6.2	15.1	15.5	24.4	6.1	10.8	24.6	4.9	15.4	14.9	11.1	7.6	32.0	40.4	18.8	31.7	31.5	23.6	24.0	44.5	36.1	30.0	36.4	27.8	27.9	22.0	39.2	28.5	33.6	35.0	13.2	25.7	29.9	29.3	27.6	10.8	25.8	30.0	43.4	8.1	25.2	22.0	21.0	40.6	34.9	26.4	31.4	22.4	12.0	37.5	40.9	16.5	17.3	12.3	18.2	20.7	16.0	20.8	26.6	16.3	32.5	16.2	7.9	23.2	27.1	18.5	47.6	20.6	24.8	11.8	23.9	35.4	23.9	21.8	43.3	26.0	31.4	20.0	37.0	20.1	28.4	71.9	62.6	77.0	64.6	70.4	67.2	66.5	61.2	68.7	48.2	65.5	48.3	59.3	59.9	60.4	56.4	69.2	81.0	117.5	5.7	6.0	6.3	7.6	5.4	6.2	6.4	6.4	6.6	6.2	6.1	7.6	36.1	12.8	23.9	12.4	46.4	34.3	50.5	157.7	27.9	17.7	48.4	48.5	31.3	35.8	82.7	44.1	22.9	70.6	70.5	28.1	15.6	79.9	259.2	32.5	41.7	35.7	18.5	35.3	8.1	89.7	103.6	51.3	22.4	41.6	49.4	38.8	30.4	57.5	74.5	11.8	9.0	37.2	89.5	33.6	44.8	63.4	43.8	37.8	46.2	6.5	64.7	35.1	48.4	6.6	16.2	86.7	25.2	35.3	119.9	68.7	37.1	50.4	55.6	24.8	59.2	33.9	54.3	126.4	45.4	26.2	31.1	96.2	47.7	45.8	30.4	62.8
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 1428.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"plasmacytoid DC: 187.4"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 187.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favorable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favorable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	2.6	3.2	1.4	4.3	1.4	1.8	5.4	1.3	2.2	6.1	1.9	30.6	10.0	3.7	0.2	4.3	7.1	2.3	7.7	1.3	1.6	5.7	9.1	9.2	9.2	1.8	2.2	2.0	60.8	0.8	8.1	0.8	1.7	3.3	10.9	0.2	51.1	3.8	2.7	0.8	33.7	0.7	1.7	61.6	29.4	24.8	1.7	1.6	14.6	0.2	17.6	3.6	2.3	1.5	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.5	4.8	0.9	0.0	1.4	0.0	1.1	1.3	0.0	0.5	4.8	0.4	4.6	0.0	0.7	3.2	0.6	0.0	0.2	0.5	0.0	0.1	0.1	0.5	0.8	26.9	0.0	0.0	1.3	2.2	1.0	2.3	0.3	4.2	0.0	23.6	0.9	0.3	0.6	0.1	0.1	0.0	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.4	0.1	48.5	6.3	8.3	0.8	6.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	13.8	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.0	0.0	187.4	0.0	1.3	1.4	1.4	1.3	2.2	1.3	1.6	1.8	2.2	1.7	1.7	1.7	1.5	0.5	0.0	1.1	0.3	183.8	1.8	1.5	3.7	0.6	1.1	19.3	1.8	3.5	1.5	4.1	0.0	2.1	0.8	141.7	2.7	0.0	0.5	113.2	33.8	0.9	1.1	1.8	8.2	0.3	5.8	6.2	2.2	7.7	1.7	2.5	15.7	4.6	7.8	3.4	0.0	1.7	7.9	4.1	2.2	2.1	158.2	2.5	5.4	224.1	1.9	0.5	0.8	0.0	1.0	0.5	1.1	0.5	4.1	1428.8	2.5	0.8	0.5	30.3	0.6	0.0	0.8	2.6	67.0	32.9	1.3	2.0	15.5	17.9	2.1	10.7	2.0
DERPC		ENSG00000286140	"DERPC proline and glycine rich nuclear protein"	P0CG12	16	69118010-69132151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 26: Non-specific - Cell cycle regulation"		Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"																		6.7	10.6	13.3	15.3	12.7	9.3	13.3	12.1	14.2	11.7	13.1	10.2	6.6	8.8	25.9	11.6	16.0	10.8	8.9	12.4	12.4	10.4	10.5	9.0	17.8	13.6	12.5	16.3	10.2	11.7		18.8	12.4	10.2	10.6	9.8	9.5	13.7	2.1	13.2	7.2	11.3	13.2	10.2	6.1	11.0	13.3	17.6	10.0	10.1	18.4	13.0		13.1	15.9	13.1	50.5	39.4	29.0	27.4	24.8	15.3	25.8	54.2	37.6	23.2	50.3	15.8	19.1	27.4	30.5	22.9	62.0	44.9	34.4	7.4	10.8	25.3	8.3	14.4	27.4	16.3	28.7	22.0	41.3	33.1	23.4	35.1	44.2	25.2	25.9	13.1	41.0	11.9	36.5	39.8	51.6	43.8	12.1	65.0	14.6	40.3	35.7	8.6	31.2	28.9	21.8	19.8	38.5	37.3	34.3	69.6	10.9	34.5	20.3	17.2	22.3	9.6	15.3	46.2	31.4	27.6	45.4	2.4	5.3	3.2	2.8	6.0	4.0	2.6	2.7	2.6	5.5	3.1	2.6	3.3	1.3	4.0	6.3	5.1	4.0	4.2	13.3	12.7	12.1	14.2	12.4	12.4	13.6	12.5	12.4	13.2	13.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DESI1	"D15Wsu75e, DESI-1, FAM152B, POST, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621043	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 761.4;Late spermatids: 415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	11.9	18.5	34.3	10.4	36.0	7.5	10.9	37.1	36.6	10.7	23.6	13.3	11.6	11.2	11.3	26.4	10.2	8.9	38.1	34.4	37.5	22.3	47.3	14.7	11.6	36.1	37.9	12.4	12.5	13.1	12.2	9.3	35.5	13.0	10.6	12.9	12.0	10.6	16.1	15.5	12.6	11.3	34.9	13.5	16.4	18.7	38.6	8.8	9.2	17.6	13.6	12.7	11.9	35.3	16.7	17.4	17.0	23.4	23.5	28.0	9.6	33.0	21.0	30.0	21.9	23.2	10.4	63.2	22.2	38.2	15.7	23.8	45.7	36.8	31.1	28.6	34.7	14.2	32.5	19.7	28.8	56.4	18.4	24.1	42.2	36.8	34.1	24.3	45.8	21.7	42.0	69.5	24.0	21.2	12.9	17.2	16.8	62.2	26.0	17.3	7.2	65.2	38.0	10.5	12.1	6.3	31.8	34.5	23.0	19.3	11.4	18.3	46.8	22.0	16.0	23.4	16.3	25.4	21.1	29.7	54.4	24.4	29.7	9.1	6.6	7.8	3.3	9.0	4.3	4.1	4.0	3.9	5.2	3.7	3.5	4.3	3.8	2.1	6.2	3.0	5.3	4.2	34.3	36.0	37.1	36.6	34.4	37.5	36.1	37.9	35.5	34.9	38.6	35.3	21.2	9.6	18.9	10.7	27.1	8.7	36.6	42.1	13.1	19.8	29.7	29.8	55.2	18.6	21.7	9.2	6.2	31.1	15.0	29.0	39.2	50.8	761.4	29.5	24.7	24.1	19.7	11.8	13.9	30.2	39.5	17.6	19.4	55.0	10.8	27.6	19.6	72.9	50.4	21.9	18.1	19.9	22.4	28.1	18.6	415.8	19.0	33.8	14.2	6.5	49.4	18.6	30.9	11.6	13.3	50.0	29.5	10.5	46.5	111.0	80.1	53.7	10.8	11.4	26.3	14.3	24.3	149.4	30.7	43.6	13.2	83.6	22.4	28.9	26.3	72.3
DET1	FLJ10103	ENSG00000140543	"DET1 partner of COP1 E3 ubiquitin ligase"	Q7L5Y6	15	88494440-88546681	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	3.7	5.2	2.5	2.0	2.8	1.2	3.6	2.7	2.7	6.0	3.2	4.2	3.5	6.7	5.4	2.2	5.6	3.0	5.6	2.5	2.6	3.2	2.7	2.1	2.9	2.7	2.5	10.3	3.6	3.7	3.7	3.5	2.8	4.1	3.2	5.0	4.1	3.8	9.7	2.6	3.2	5.5	2.4	2.5	3.4	1.5	2.6	5.6	4.1	11.7	3.0	4.5	3.3	3.2	1.7	6.2	8.6	6.0	3.4	6.0	1.1	5.4	6.1	4.5	5.1	1.0	4.8	3.3	4.1	7.3	4.5	2.4	8.7	1.3	3.9	0.2	5.9	6.9	3.1	1.5	6.7	2.5	1.1	5.0	5.9	1.9	6.9	4.4	3.8	2.9	8.5	3.8	6.7	2.6	3.2	2.8	3.6	2.6	1.8	4.2	6.9	3.8	2.4	5.3	3.0	4.9	6.5	2.0	14.9	5.6	2.9	5.2	3.0	5.1	3.7	4.8	5.4	2.3	1.4	2.1	5.4	4.3	4.5	0.0	2.3	1.6	2.2	3.4	1.4	1.8	1.7	1.9	3.7	2.2	2.6	1.9	0.3	1.4	2.3	1.9	2.4	1.3	2.5	2.8	2.7	2.7	2.5	2.6	2.7	2.5	2.8	2.4	2.6	3.2	3.5	3.2	2.7	6.8	3.5	0.6	2.0	3.7	4.6	11.5	4.3	3.8	2.3	1.5	2.1	3.7	10.4	7.2	1.7	2.1	1.9	3.4	1.2	3.4	6.1	2.3	3.0	5.5	5.7	3.9	6.3	4.9	2.0	2.4	0.0	10.6	2.2	2.8	4.4	6.7	6.8	2.7	2.0	1.6	2.2	0.6	4.4	2.5	3.6	3.7	4.7	7.1	2.1	6.0	9.5	3.1	1.0	3.8	1.6	1.5	3.1	2.6	3.1	7.9	0.0	5.6	4.5	8.1	9.9	1.5	1.3	4.1	2.7	8.4	3.3	1.4
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942468	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	34.7	82.2	52.6	10.8	54.2	5.5	29.3	59.3	60.1	35.3	44.3	46.8	14.6	34.5	23.4	25.0	34.1	11.2	101.6	43.0	54.0	33.1	91.3	27.3	12.5	58.7	55.6	34.6	29.8	20.9	38.0	13.0	62.2	39.1	7.9	6.2	23.5	20.3	128.4	27.6	24.9	15.5	51.8	30.5	34.0	14.8	67.9	11.6	28.4	58.7	10.5	33.5	28.9	45.5	18.1	25.9	13.6	24.1	54.1	29.5	12.5	27.2	28.0	17.4	16.5	12.2	18.5	21.4	39.9	31.0	19.0	22.9	16.2	29.3	14.9	50.4	36.4	10.7	17.1	52.3	30.9	18.3	19.3	30.2	33.1	17.1	19.7	28.2	25.3	29.7	24.5	20.8	19.6	31.9	22.9	19.9	19.1	22.3	26.5	21.2	18.0	32.8	21.9	13.3	28.0	24.7	26.0	28.2	22.6	11.4	22.5	31.6	28.1	17.5	18.7	41.9	18.0	27.2	22.6	6.2	15.4	38.7	20.2	1.3	0.5	7.2	4.6	0.6	4.2	0.5	4.0	5.4	0.3	4.1	4.7	4.6	0.5	3.0	0.2	2.0	3.3	1.0	52.6	54.2	59.3	60.1	43.0	54.0	58.7	55.6	62.2	51.8	67.9	45.5	23.3	6.4	12.1	10.1	12.4	33.3	40.5	9.7	21.6	18.8	19.1	26.0	0.0	41.5	5.9	27.6	12.5	28.1	11.5	8.5	76.3	24.8	8.1	10.5	21.4	27.1	14.9	15.6	8.0	36.2	21.4	33.8	10.7	7.4	1.3	30.4	46.1	106.3	41.2	23.5	13.3	14.5	14.2	15.5	15.8	14.9	75.2	14.6	16.0	8.4	10.7	57.0	18.6	3.5	6.7	31.2	10.1	85.7	14.9	70.7	17.8	70.9	8.8	14.8	19.7	29.9	26.1	3.8	3.7	18.4	32.5	11.6	19.2	38.4	17.5	39.0
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	1.3	1.1	0.6	1.2	0.7	1.0	1.1	0.5	0.9	1.7	0.0	1.5	4.6	1.6	0.0	0.8	1.3	1.4	0.7	0.7	0.5	0.7	0.4	1.0	1.6	1.5	0.9	1.7	2.4	0.5	0.6	1.3	0.7	0.8	0.8	0.2	1.3	0.7	0.5	0.6	2.0	0.4	0.4	1.9	1.2	0.4	0.6	1.2	0.8	0.5	0.9	1.4	1.0	1.5	3.2	3.3	2.0	4.7	0.6	1.6	1.1	2.7	1.2	4.1	2.8	2.6	2.8	2.6	2.2	0.5	0.8	1.7	0.7	3.2	0.2	9.0	9.7	10.7	1.2	3.2	3.3	8.7	7.9	0.4	0.8	2.4	1.9	0.8	4.1	7.5	7.4	1.6	0.1	1.8	6.1	4.8	2.2	3.9	7.4	4.9	1.2	4.4	1.3	0.6	3.3	5.1	2.3	6.5	10.7	0.0	1.1	3.8	4.1	1.5	1.1	6.5	2.5	2.9	4.6	5.4	1.2	9.0	2.0	3.6	3.7	5.0	3.4	3.8	2.0	2.1	2.5	3.1	5.1	1.0	2.1	3.2	1.2	2.3	7.4	0.0	4.7	2.9	0.6	0.7	0.5	0.9	0.7	0.5	1.5	0.9	0.7	0.4	0.6	1.5	3.3	3.2	4.6	4.2	3.0	0.6	1.0	1.4	1.8	5.5	1.9	2.7	1.3	2.8	1.7	1.8	45.9	3.5	7.3	1.6	1.9	1.9	1.4	3.3	4.6	3.1	2.4	2.5	17.0	1.6	29.5	3.2	1.5	2.5	0.0	4.6	2.5	1.8	2.9	15.2	18.0	4.2	0.0	5.4	1.4	1.2	1.2	3.7	0.0	8.4	2.5	3.9	15.5	5.5	22.7	1.8	1.5	4.9	3.1	0.6	5.0	2.4	1.1	17.9	0.0	1.7	3.2	1.7	2.5	1.7	0.3	1.4	6.0	3.3	4.4	0.7
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 213.5;Proximal enterocytes: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;PC-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Nucleoli rim,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Nucleoli, Nucleoli rim"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	15.0	24.7	4.6	1.8	4.6	5.1	11.8	5.5	5.6	6.1	4.1	16.7	37.0	5.6	1.0	8.6	5.1	2.0	11.7	4.7	4.1	7.9	16.5	6.9	1.8	4.5	4.6	4.3	6.5	3.9	6.5	1.5	4.2	6.6	4.2	1.6	7.4	2.4	11.7	6.9	40.6	1.6	4.1	9.3	8.7	14.7	4.4	2.3	7.4	3.5	1.4	6.7	6.4	4.5	5.2	4.9	2.2	4.1	3.5	1.5	2.9	3.4	3.1	2.9	2.0	11.2	3.1	2.1	12.4	1.9	1.6	4.0	1.8	4.3	0.6	3.7	5.1	3.3	4.2	18.4	2.5	1.0	3.4	2.1	3.2	2.0	2.1	2.1	2.3	7.3	2.9	5.2	1.9	3.7	6.8	4.1	1.1	10.9	21.2	7.7	0.9	3.4	2.8	2.5	2.6	4.2	4.7	5.2	2.3	0.8	2.9	3.3	2.0	1.6	5.6	3.6	2.8	2.3	0.6	0.8	1.8	6.3	3.2	0.0	0.4	0.7	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.2	4.6	4.6	5.5	5.6	4.7	4.1	4.5	4.6	4.2	4.1	4.4	4.5	34.0	16.0	19.0	15.7	8.5	8.0	12.5	6.3	4.0	24.6	21.6	16.0	20.8	12.8	8.7	18.4	29.2	11.3	17.6	213.5	1.9	9.4	19.2	12.3	13.7	26.5	23.4	17.7	11.2	11.9	10.3	9.3	48.4	21.3	7.0	23.9	12.5	57.4	18.8	18.5	12.8	93.6	4.1	25.5	11.8	25.8	6.8	22.8	5.4	8.4	9.2	21.3	4.1	17.6	7.0	13.3	113.4	6.8	18.8	8.1	700.1	7.4	5.6	23.6	0.0	11.9	12.3	27.7	17.4	12.3	9.2	16.4	12.3	41.1	108.0	20.7
DGCR2	"DGS-C, IDD, KIAA0163, LAN, SEZ-12"	ENSG00000070413	"DiGeorge syndrome critical region gene 2"	P98153	22	19036282-19122454	"Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000873	Uncertain					NA	NA		84000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000873: AB_1847632"	"unprognostic (1.68e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.72e-7)"	"unprognostic (3.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.28e-3)"	25.3	28.6	45.7	14.9	40.4	7.4	26.4	34.6	48.9	30.0	24.7	34.0	26.2	32.9	12.9	46.5	27.7	19.0	33.6	44.1	42.8	31.1	30.6	28.6	16.8	45.2	43.3	35.9	44.6	26.3	33.1	16.4	43.6	34.7	16.0	9.1	33.7	23.5	27.2	61.3	28.8	15.6	38.3	25.5	30.2	25.3	52.0	16.7	39.8	19.5	12.5	31.2	32.1	38.6	43.2	26.5	32.6	58.3	57.9	23.2	31.8	28.3	34.8	27.2	26.8	45.7	47.9	22.7	38.7	30.7	19.4	79.7	24.2	27.2	11.4	19.4	44.4	15.3	16.0	37.0	35.1	28.8	33.4	33.3	61.6	21.1	24.3	23.4	30.3	14.2	115.6	19.3	14.0	45.0	15.2	31.0	27.3	67.8	19.1	26.5	34.4	8.9	46.2	46.8	44.4	32.8	52.1	36.0	32.6	17.6	33.5	25.9	27.0	50.0	25.6	26.3	23.1	21.5	8.5	14.9	23.7	16.5	38.9	9.5	10.3	16.5	6.1	5.3	5.3	4.3	6.5	6.1	6.8	4.7	7.8	6.4	23.5	4.6	3.9	4.0	9.5	11.3	45.7	40.4	34.6	48.9	44.1	42.8	45.2	43.3	43.6	38.3	52.0	38.6	16.4	19.2	27.0	34.3	10.0	9.7	10.8	17.1	17.6	30.1	23.4	20.6	18.0	30.0	23.3	27.6	14.6	17.2	9.5	59.7	0.0	24.9	13.7	9.6	11.2	13.7	19.9	4.2	35.7	21.9	19.0	13.5	27.0	16.9	8.2	24.5	21.4	27.3	12.1	37.0	43.7	30.3	18.3	18.5	4.7	22.2	17.1	10.4	8.8	22.5	16.4	18.5	11.3	54.8	32.6	30.9	24.0	22.6	11.1	18.8	27.7	10.6	14.0	23.0	13.1	14.4	15.1	12.6	12.9	22.1	12.4	10.8	11.8	17.7	28.4	16.8
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 101.5;lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 49.0;Squamous epithelial cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 86.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 130.4;hTERT-HME1: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 58: T-cells - T-cell receptor"	Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	12.7	12.8	7.6	50.0	9.8	31.9	11.0	6.6	9.2	22.9	7.0	25.6	51.2	13.1	9.9	101.5	11.4	15.8	8.5	7.2	5.2	7.9	3.7	18.6	95.5	5.2	5.0	10.9	14.6	12.0	6.9	14.9	5.3	24.8	26.9	2.8	35.5	9.6	2.3	84.7	64.8	14.1	4.8	53.8	12.4	12.3	5.0	198.1	10.5	4.2	101.8	28.4	39.0	6.8	22.2	13.2	9.3	12.4	22.4	29.0	2.8	47.2	47.8	18.2	13.5	6.9	35.2	13.5	11.1	31.5	6.2	38.7	10.3	130.4	21.4	14.4	2.5	21.1	26.8	3.6	19.1	6.7	20.9	25.1	68.4	25.2	133.9	60.6	37.9	78.8	2.4	18.7	49.4	2.3	54.3	8.6	2.0	18.1	15.5	23.8	2.9	2.0	43.7	60.9	1.6	5.6	15.5	0.9	1.7	23.8	9.3	6.4	34.0	12.0	8.4	2.8	1.7	2.9	1.2	32.4	13.8	17.5	3.4	17.0	7.4	15.3	18.5	5.2	35.5	20.4	70.6	33.0	10.5	16.2	86.9	51.5	13.3	14.1	3.5	10.5	86.7	36.2	7.6	9.8	6.6	9.2	7.2	5.2	5.2	5.0	5.3	4.8	5.0	6.8	4.5	3.2	6.5	1.6	25.7	15.0	9.7	21.1	26.7	1.2	4.0	4.6	2.9	4.3	19.1	5.5	0.0	16.3	12.2	35.4	0.0	5.1	9.4	1.9	6.5	5.3	2.4	11.2	11.2	9.4	4.3	8.2	15.3	3.0	7.0	2.4	4.2	0.2	4.2	0.0	5.2	7.7	2.0	6.9	21.6	7.0	3.7	14.0	0.0	5.6	15.7	2.6	10.3	9.0	0.8	25.3	14.4	3.0	14.8	8.2	49.0	0.3	5.2	0.5	6.6	1.5	4.2	6.6	4.2	40.4	13.9	26.4	37.4	1.6	9.7	20.1
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354494-233472104	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 30.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 143.2;Inhibitory neurons: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.3;HeLa: 21.8;U-698: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027530: AB_2672320, HPA049101: AB_2680630"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.2	3.4	4.3	1.9	5.5	12.0	5.9	20.5	6.2	4.5	3.2	9.0	1.6	5.9	1.6	2.2	5.7	1.0	7.6	5.8	4.0	2.5	3.6	10.6	4.3	6.5	3.9	8.9	2.7	0.4	3.7	2.9	7.4	5.7	2.3	5.4	5.9	0.5	30.4	3.0	12.9	0.7	4.1	11.4	25.2	9.6	4.4	1.0	8.3	0.9	4.5	5.3	2.6	8.8	1.7	8.5	2.1	1.5	1.5	1.4	3.0	2.4	1.0	0.6	0.5	9.7	1.9	10.3	1.1	2.4	4.5	2.0	2.4	1.0	3.2	17.3	11.3	4.7	21.8	5.8	0.9	11.7	7.2	2.3	2.2	1.1	2.1	1.8	0.8	2.1	7.8	1.8	1.6	3.1	9.2	3.3	1.6	2.8	6.9	14.5	5.7	1.6	0.9	3.3	2.1	2.2	1.4	2.3	1.0	1.8	0.6	5.2	1.0	1.2	3.0	1.2	1.7	7.1	6.2	22.7	0.8	5.6	0.6	1.7	1.6	5.6	2.1	0.6	1.1	4.8	0.5	1.5	0.4	5.0	1.7	2.4	1.2	0.6	1.0	0.4	0.2	1.7	4.3	5.5	20.5	6.2	5.8	4.0	6.5	3.9	7.4	4.1	4.4	8.8	18.9	32.1	46.2	27.1	61.1	8.9	6.4	5.6	4.6	33.8	19.6	11.6	21.0	0.0	13.8	0.0	62.6	14.6	62.0	40.6	0.0	3.6	14.9	23.4	12.5	19.1	2.4	5.0	11.1	4.4	1.2	9.7	143.2	38.1	5.7	13.1	4.6	7.0	6.8	8.4	137.9	32.8	8.2	10.4	13.8	38.7	6.5	28.7	8.8	11.2	17.5	13.9	49.4	43.2	81.5	26.0	13.5	4.5	34.7	17.6	29.6	2.6	4.8	44.3	19.7	49.4	21.2	14.4	29.3	4.5	3.7	2.5	32.5	7.6	20.1	9.9
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834107-56869567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.1;Cone photoreceptor cells: 189.7;Inhibitory neurons: 90.0;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 84.8;MOLT-4: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	4.1	2.2	5.4	4.5	6.9	3.1	3.0	9.4	7.4	4.9	7.7	4.9	2.6	6.5	4.2	2.6	4.8	4.6	2.9	5.8	8.1	2.6	2.8	5.2	5.0	3.3	4.7	3.5	3.9	4.1	6.2	2.7	3.4	4.1	3.3	34.5	2.5	3.3	1.2	1.9	4.4	4.3	2.7	6.9	3.7	6.5	6.9	9.8	4.0	2.2	4.3	3.8	4.2	5.8	3.5	3.3	3.0	0.3	0.6	1.0	1.4	5.8	4.7	3.9	4.5	7.7	4.2	5.1	7.0	3.1	1.9	4.2	7.2	3.2	7.8	16.5	9.5	6.6	8.9	5.1	3.3	12.7	8.9	1.9	4.0	4.1	8.0	3.6	5.4	14.7	5.5	84.8	4.8	5.1	30.3	7.1	2.3	4.6	10.0	9.4	12.4	12.2	3.9	7.6	4.7	3.2	4.7	2.5	0.2	1.9	5.3	6.0	5.0	1.1	5.4	1.7	0.9	11.3	25.3	3.4	3.3	7.3	0.3	0.1	0.2	0.0	1.0	0.1	0.7	0.9	0.6	0.7	0.2	0.3	0.7	0.9	0.3	0.7	0.2	0.8	1.7	0.3	5.4	6.9	9.4	7.4	5.8	8.1	3.3	4.7	3.4	2.7	6.9	5.8	51.2	3.2	6.0	10.4	11.3	8.9	13.5	3.1	21.6	181.1	5.0	6.3	6.3	10.0	4.0	16.5	189.7	6.6	16.3	5.6	0.0	7.4	18.3	9.0	9.9	30.6	11.3	2.1	66.0	4.7	3.0	6.9	9.7	19.3	0.0	13.1	29.3	4.0	2.2	8.4	90.0	7.7	8.2	5.0	9.3	9.2	4.4	7.4	3.6	32.8	6.3	18.6	14.4	32.6	14.4	6.0	6.4	5.3	15.1	21.3	1.9	0.1	2.8	165.4	6.6	11.8	10.7	28.5	20.7	9.7	6.7	3.4	18.9	5.7	5.8	13.4
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362234	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	1.6	4.2	14.2	0.8	17.4	9.3	1.1	28.2	11.9	2.2	0.0	3.2	1.4	1.2	8.0	4.6	4.1	0.9	9.1	20.4	3.6	1.3	0.8	3.8	0.9	20.1	6.5	1.2	0.5	5.7	6.0	7.8	20.8	1.3	0.8	1.7	0.8	1.8	1.8	0.8	1.7	2.4	0.6	0.9	2.1	0.3	9.6	0.5	1.8	1.0	0.8	3.4	1.7	13.2	3.2	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.7	0.0	3.3	0.2	0.0	0.0	0.0	23.9	0.0	3.2	0.0	3.5	0.0	7.7	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.6	0.0	0.4	0.4	0.1	0.1	2.6	0.4	0.0	1.4	1.7	0.0	2.6	0.0	0.0	0.6	0.0	0.9	0.0	2.0	0.0	0.1	4.9	0.0	0.0	0.8	2.4	2.9	0.0	9.4	0.0	14.3	7.0	2.6	0.0	2.1	1.2	0.0	1.2	0.0	0.3	0.0	0.0	1.5	0.1	0.0	0.0	2.6	0.0	1.5	0.2	0.0	0.7	14.2	17.4	28.2	11.9	20.4	3.6	20.1	6.5	20.8	0.6	9.6	13.2	0.1	0.0	1.7	223.0	3.1	0.4	0.2	0.0	0.6	0.1	0.1	0.4	19.4	1.5	0.0	1.8	0.0	0.1	0.0	0.0	0.0	1.4	2.6	0.3	0.1	5.0	0.0	0.4	111.0	1.2	0.0	0.5	0.5	0.1	0.0	0.3	22.1	0.0	2.1	1.7	63.5	0.1	0.0	3.2	1.4	4.2	1.8	3.4	0.0	12.2	5.2	6.8	0.0	334.8	7.8	1.0	0.1	0.4	0.2	0.4	0.1	0.9	0.0	0.1	13.1	1.8	14.5	0.0	0.2	0.4	0.4	0.1	0.1	0.9	0.1	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 137.8;Urothelial cells: 147.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 25.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	3.7	1.3	4.5	2.0	25.8	1.3	3.5	8.7	5.4	4.4	0.0	3.7	1.5	6.4	6.9	4.1	4.3	2.5	3.0	7.3	4.4	3.3	1.0	7.8	2.2	0.0	7.4	2.8	1.0	0.7	2.6	4.5	0.4	2.8	3.3	2.6	3.0	2.1	1.5	3.2	2.7	4.0	0.2	1.7	2.6	2.3	9.7	2.7	2.5	2.2	1.3	5.3	4.6	2.8	5.6	6.6	4.3	3.6	1.9	4.2	0.5	3.4	2.7	2.2	2.8	0.6	4.7	4.3	4.1	3.7	8.3	11.8	3.8	7.7	3.3	3.4	12.4	7.6	3.6	0.4	2.4	3.3	2.0	1.6	7.7	4.3	17.0	3.4	9.9	5.3	3.0	2.9	3.8	5.1	3.4	1.7	1.9	5.2	4.3	5.0	3.8	2.9	7.4	16.7	2.5	2.6	3.1	4.0	3.0	1.8	3.4	8.9	9.8	4.1	3.8	4.5	4.7	1.5	1.5	4.8	2.4	2.9	3.1	0.6	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.4	0.0	0.2	0.2	0.4	0.9	0.1	0.1	0.3	0.3	0.1	4.5	25.8	8.7	5.4	7.3	4.4	0.0	7.4	0.4	0.2	9.7	2.8	64.8	22.4	20.1	8.8	1.9	61.7	58.1	61.1	15.9	44.5	13.6	8.9	8.5	24.3	44.7	11.0	4.2	3.7	2.2	29.0	1.9	11.3	25.9	64.1	26.0	50.8	47.4	2.7	85.4	7.2	2.2	17.5	15.3	46.2	7.6	5.7	23.2	3.2	6.8	1.7	60.2	18.7	14.2	5.6	43.1	20.1	3.4	8.0	8.8	56.2	8.6	18.8	1.0	54.3	11.0	27.6	19.2	9.1	6.2	137.8	13.1	8.4	91.8	2.6	26.3	16.2	54.1	3.8	3.8	19.7	33.1	2.9	13.0	11.5	22.0	147.3
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.5;Intestinal goblet cells: 21.6;Paneth cells: 33.1;Proximal enterocytes: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.5	8.2	11.7	9.2	11.4	9.8	6.7	15.4	15.8	9.0	3.6	20.0	22.2	7.9	2.6	10.8	7.6	5.1	6.0	14.0	10.9	8.3	8.1	9.5	11.0	14.3	8.6	6.5	9.9	3.7	10.5	3.2	10.1	9.3	6.5	1.0	9.4	4.0	3.6	13.2	23.6	2.7	6.1	15.4	8.4	9.0	11.8	7.5	8.7	1.3	4.4	8.4	9.7	7.0	5.7	9.1	3.9	13.2	4.7	3.8	14.5	10.7	6.0	6.0	5.9	6.5	11.1	7.6	8.8	6.8	12.2	6.5	2.2	7.5	1.4	6.0	6.9	11.8	10.3	11.6	8.0	5.1	15.2	7.2	12.5	4.9	2.3	5.1	7.3	15.6	9.1	0.9	4.7	8.6	10.7	29.6	6.9	15.9	15.3	17.0	1.1	0.9	6.5	7.9	2.4	6.6	3.7	4.1	11.3	3.0	9.9	12.3	10.8	10.3	4.8	11.7	7.2	20.2	9.4	6.0	8.9	10.9	9.5	2.9	0.5	1.3	2.0	0.5	0.9	0.5	0.7	1.7	0.4	0.4	0.7	1.3	0.3	2.4	0.4	0.8	0.5	0.8	11.7	11.4	15.4	15.8	14.0	10.9	14.3	8.6	10.1	6.1	11.8	7.0	4.3	3.2	3.1	8.5	3.6	2.8	1.3	2.9	1.2	3.6	3.5	3.9	3.0	4.3	2.9	3.7	4.2	0.5	15.1	33.5	0.0	3.0	0.6	2.6	3.3	3.3	7.7	5.7	12.4	4.9	2.1	2.9	3.1	4.1	0.0	6.2	2.5	5.8	2.5	3.3	11.8	21.6	0.0	4.1	2.3	1.3	4.1	4.6	3.6	5.6	4.5	3.0	10.3	3.0	3.2	5.7	33.1	2.6	4.6	3.1	29.1	0.9	4.4	1.0	0.0	2.6	2.8	3.2	4.3	2.9	3.8	0.7	6.7	3.6	14.5	3.8
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 146.2"	"Cell type enhanced"	"Detected in all"		"NK-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	27	"amygdala: 46.5;basal ganglia: 75.1;cerebral cortex: 146.2;hippocampal formation: 133.8;white matter: 51.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	20.7	14.2	46.5	21.6	75.1	54.6	19.4	3.3	146.2	16.5	0.0	20.3	36.4	16.8	4.0	19.5	15.3	11.1	46.5	133.8	0.0	18.3	10.5	18.3	39.9	0.0	0.0	12.4	31.5	10.0	58.7	14.1	0.0	18.6	6.6	2.5	43.4	10.7	95.7	22.3	41.2	9.1	0.0	36.1	22.2	15.4	1.4	34.0	12.5	25.1	17.1	18.2	15.3	51.0	38.1	33.2	22.1	33.2	11.5	12.8	102.1	29.0	21.5	30.0	26.3	39.8	17.1	48.4	20.5	30.1	33.0	43.3	26.7	42.0	10.6	48.8	62.5	31.7	25.2	29.5	20.5	60.5	61.2	17.3	19.3	16.5	22.2	15.3	33.4	39.3	45.1	29.1	21.5	99.8	58.6	94.3	64.3	54.5	50.3	69.0	38.2	20.6	9.1	36.6	150.3	25.6	33.2	109.6	23.0	13.8	78.8	75.2	37.9	39.2	42.4	62.6	52.9	19.1	23.4	40.3	53.8	54.0	37.2	12.4	13.5	6.0	6.8	5.6	4.1	0.3	4.3	5.9	12.0	0.8	4.3	4.6	9.5	7.6	6.4	5.7	4.4	10.5	46.5	75.1	3.3	146.2	133.8	0.0	0.0	0.0	0.0	0.0	1.4	51.0	46.0	3.2	6.6	44.7	16.4	13.3	22.3	16.3	14.2	27.6	24.6	19.8	24.4	8.6	8.7	9.2	20.9	14.6	95.8	37.7	9.8	13.2	6.1	9.9	15.2	34.2	51.5	23.4	114.0	47.8	105.1	12.4	34.1	14.1	21.0	25.7	56.7	7.1	51.2	16.8	45.0	26.3	22.4	46.1	26.9	11.4	13.1	34.0	12.4	31.9	50.6	6.4	129.8	8.5	24.7	33.5	41.0	8.2	25.3	16.6	97.0	20.2	8.2	9.9	32.9	17.8	16.8	7.0	12.2	12.3	9.2	27.4	71.8	19.4	29.9	17.2
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 163.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 200.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA041423: AB_10795540, HPA052932: AB_2681991"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favorable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	23.9	32.2	38.5	21.4	46.0	21.7	16.7	53.5	49.2	25.0	76.1	33.5	25.1	26.0	17.2	28.4	38.6	22.6	122.3	36.6	39.8	35.6	24.9	25.0	21.6	45.5	51.3	22.9	16.8	47.9	21.5	16.6	42.1	22.8	30.4	8.3	32.2	34.1	143.0	25.6	23.7	32.0	38.0	33.6	38.1	19.0	45.4	27.3	30.1	163.6	19.9	31.9	20.2	45.2	6.2	16.4	8.0	20.1	32.8	30.6	21.0	6.6	17.7	19.3	19.6	10.9	46.7	41.3	46.0	18.8	24.9	18.0	23.0	24.7	7.9	22.8	9.5	27.7	9.1	13.8	47.8	28.5	38.2	47.5	10.5	10.6	4.0	25.3	34.6	22.8	14.0	54.4	18.4	1.4	22.7	27.0	16.4	0.8	1.4	38.2	15.7	30.9	32.7	25.9	22.4	11.2	10.4	17.8	7.3	8.4	32.0	24.5	24.7	5.7	4.8	17.1	5.9	30.9	23.8	14.0	29.6	36.8	3.8	67.5	48.8	30.8	30.1	69.4	30.3	34.0	19.3	24.5	72.9	22.4	15.9	20.0	200.5	21.0	60.7	22.0	45.2	29.0	38.5	46.0	53.5	49.2	36.6	39.8	45.5	51.3	42.1	38.0	45.4	45.2	19.2	28.9	16.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	11.5	13.2	0.0	0.0	5.6	29.5	0.0	30.9	12.5	0.0	21.5	17.6	0.0	29.4	14.8	6.2	0.0	0.0	0.0	5.8	15.8	7.4	0.0	25.0	7.6	49.8	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	6.3	0.0	0.0	2.7	0.0	0.0	17.0	5.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	16.8	8.7	35.6	0.0	0.0
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA034766: AB_10669850, HPA057246: AB_2683381"	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (7.47e-4)"	20.8	30.0	37.1	20.3	39.2	27.1	28.1	36.5	48.4	23.0	36.8	25.0	17.7	23.1	34.4	21.8	31.3	19.4	23.0	38.5	42.8	24.6	30.5	17.7	36.8	37.9	37.7	30.0	16.3	11.0	41.3	21.5	39.1	24.5	29.1	34.5	19.8	22.5	17.1	26.5	20.2	21.9	37.9	25.9	21.0	32.8	38.8	36.3	22.6	17.7	40.9	22.2	20.9	38.8	45.1	72.5	74.4	67.9	47.8	53.8	37.1	29.3	56.0	66.7	61.1	91.2	51.5	83.0	27.4	42.1	74.1	34.7	85.4	57.1	79.3	47.1	53.6	65.8	25.4	107.5	70.5	62.1	66.0	49.7	51.3	50.4	58.9	48.6	48.3	91.4	67.2	37.0	78.8	54.4	59.6	101.2	76.7	60.5	53.9	73.8	73.1	59.7	55.8	49.6	85.0	82.6	27.9	28.2	77.1	35.5	34.0	34.8	45.3	43.3	68.8	37.8	52.6	32.3	31.4	86.1	62.2	65.9	95.1	129.8	70.9	138.7	62.3	87.3	72.4	108.5	77.0	69.6	81.6	114.5	98.6	79.6	56.4	79.4	84.7	91.3	79.9	91.3	37.1	39.2	36.5	48.4	38.5	42.8	37.9	37.7	39.1	37.9	38.8	38.8	72.5	32.1	42.8	14.7	103.4	74.2	138.7	249.6	88.2	52.3	85.0	128.1	19.1	78.6	108.6	60.7	6.2	159.4	89.7	58.9	84.1	102.6	12.3	82.3	69.1	74.1	113.1	67.1	17.5	149.1	165.4	88.3	40.2	82.6	57.6	87.4	76.1	69.9	90.9	52.2	21.1	100.1	158.7	88.3	112.3	15.1	93.5	80.2	110.3	15.9	151.9	89.5	118.4	12.5	27.2	173.0	88.1	86.9	70.2	146.2	88.2	119.7	87.2	40.4	92.1	55.3	89.3	105.3	129.4	88.3	83.3	124.5	101.4	124.5	104.9	142.9
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849627-54887195	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1129.5;liver: 623.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 298.1;Alveolar cells type 2: 682.3;Hepatocytes: 1091.4;Theca cells: 442.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1031.9"	"Low region specificity"	"Detected in all"							"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	58.3	1129.5	35.7	19.8	58.5	1.6	104.8	125.3	73.0	54.9	30.4	55.6	62.2	13.1	1.6	296.1	60.4	42.2	18.0	55.9	63.9	48.6	623.5	215.9	9.4	216.2	91.3	28.5	30.5	157.9	17.0	21.6	158.9	128.6	40.5	15.8	136.2	8.3	197.7	247.6	29.6	12.6	129.3	134.1	98.9	74.2	87.9	10.1	15.4	11.1	33.9	13.5	103.9	280.7	342.1	58.5	210.6	257.1	1031.9	219.0	50.5	94.8	160.3	130.7	268.6	341.6	210.2	55.3	191.5	82.4	427.4	319.2	250.5	501.3	118.3	8.3	159.6	303.3	131.8	421.7	168.9	126.7	68.2	161.0	429.0	397.6	74.7	66.7	67.2	124.5	224.7	0.2	50.2	143.5	25.8	111.4	592.0	90.7	164.2	0.3	54.2	166.3	735.3	257.1	144.5	53.2	185.0	337.5	123.1	221.6	441.5	143.3	62.2	45.3	130.0	66.1	183.9	22.7	55.0	91.2	32.8	215.3	60.4	5.1	1.5	0.7	6.0	1.8	0.3	3.7	2.5	2.6	5.2	1.3	2.2	2.9	0.0	2.7	0.7	3.0	0.4	4.4	35.7	58.5	125.3	73.0	55.9	63.9	216.2	91.3	158.9	129.3	87.9	280.7	6.2	298.1	682.3	12.4	13.3	31.5	17.3	150.6	79.1	9.7	87.9	33.1	15.3	145.8	205.2	68.0	0.0	35.2	6.4	133.3	3.9	55.3	22.9	14.5	5.8	13.5	24.0	71.6	14.5	76.5	34.4	17.5	38.7	44.7	32.2	26.4	111.0	1091.4	28.0	5.0	8.7	39.2	69.2	68.9	8.2	77.2	14.0	9.4	14.2	1.9	6.8	3.6	2.1	5.5	62.6	48.6	27.7	7.9	1.8	52.4	22.6	14.4	136.3	6.4	0.0	1.5	23.2	5.4	14.7	145.4	80.4	30.6	10.6	442.4	35.2	45.2
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	23.7	97.2	28.1	13.0	35.4	46.7	36.3	42.4	37.0	16.2	15.6	21.1	48.1	10.6	59.2	42.2	12.5	8.9	28.8	28.8	35.8	16.3	161.1	21.8	6.0	55.3	38.8	54.4	16.6	24.4	18.4	8.3	55.8	21.6	14.4	8.7	27.8	7.1	13.6	68.2	19.3	9.9	34.4	9.6	19.1	31.0	38.0	4.7	11.9	13.2	9.4	7.9	22.7	58.9	126.4	112.3	106.7	118.9	49.0	75.8	33.7	50.9	134.1	43.1	114.5	419.8	401.5	87.1	79.0	48.6	376.2	235.9	128.8	276.7	44.5	33.5	98.7	33.4	89.3	183.1	127.8	63.7	15.6	89.2	122.1	159.3	108.4	34.6	63.8	112.7	159.6	180.7	43.2	341.1	52.4	72.6	154.1	124.9	67.4	46.9	150.6	377.3	162.3	187.3	144.7	53.9	48.4	157.6	113.9	51.4	153.2	34.5	60.4	11.5	62.4	3.7	61.5	59.3	78.7	95.8	33.8	110.9	48.9	5.6	2.1	1.9	10.5	1.4	12.6	6.5	8.9	9.8	2.8	5.4	11.0	13.0	1.1	5.8	1.5	7.1	6.0	6.9	28.1	35.4	42.4	37.0	28.8	35.8	55.3	38.8	55.8	34.4	38.0	58.9	7.1	3.2	19.1	7.2	7.1	0.8	10.1	77.9	3.4	8.4	21.8	14.9	13.1	15.7	39.2	22.0	12.5	15.5	11.9	9.9	7.9	36.9	0.1	3.9	1.5	11.8	9.5	5.2	3.2	49.9	27.6	12.8	11.7	9.3	0.0	81.3	7.9	156.1	11.9	0.0	4.5	12.3	54.9	3.8	3.3	1.7	8.4	5.6	5.4	1.0	5.8	21.2	4.1	5.0	14.7	26.7	11.5	4.9	10.0	16.5	8.9	3.8	7.6	8.7	13.1	3.9	9.0	0.5	7.0	11.9	1.1	54.2	13.8	103.6	15.0	9.5
DHDDS	"DS, FLJ13102, hCIT, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471306	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 256.5;Early spermatids: 99.1;Rod photoreceptor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	57.3	19.6	12.3	18.9	11.8	12.4	22.7	32.5	14.0	14.6	14.6	37.3	19.1	13.5	38.5	26.3	12.9	15.9	19.8	12.8	13.3	25.5	22.0	13.9	17.6	15.5	16.9	11.4	18.5	39.8	20.9	12.6	18.8	14.1	38.8	37.8	43.3	14.0	13.5	21.2	18.2	18.4	9.0	14.1	23.3	12.3	14.1	14.1	19.1	11.8	20.8	18.1	14.4	12.2	34.2	24.8	20.6	23.8	36.1	28.2	28.4	54.9	33.4	44.0	41.6	37.4	34.6	38.4	33.3	57.2	30.0	24.1	25.4	42.8	42.9	22.7	13.9	38.0	66.9	30.8	39.3	41.4	51.5	40.3	27.6	59.1	32.2	29.4	51.2	26.7	27.3	41.0	39.7	19.4	23.1	20.2	26.3	53.1	36.2	25.3	33.4	31.2	25.4	28.8	24.4	19.4	36.4	38.0	26.6	26.8	29.8	20.9	63.0	30.1	26.3	60.4	32.0	48.1	72.4	39.5	43.0	54.0	26.8	9.4	16.1	9.6	13.8	23.6	9.8	13.2	9.0	9.1	13.6	10.2	7.4	10.9	13.0	10.1	23.1	11.5	8.3	10.5	12.3	11.8	32.5	14.0	12.8	13.3	15.5	16.9	18.8	9.0	14.1	12.2	9.4	9.6	7.8	7.8	13.5	4.6	9.6	12.0	10.8	29.6	9.6	7.4	15.5	15.7	13.8	14.7	256.5	18.3	13.7	76.3	11.7	19.3	99.1	11.6	12.9	11.1	20.9	5.7	26.9	14.5	23.4	11.1	33.6	20.0	19.0	14.4	10.0	13.2	24.5	15.2	28.5	46.3	14.2	11.5	7.1	23.4	10.5	10.5	10.6	10.3	34.4	16.3	14.4	9.0	11.4	17.6	40.3	7.5	18.7	10.6	24.7	29.3	11.5	106.1	0.0	8.4	14.5	13.2	13.5	12.4	5.1	25.4	10.3	15.8	26.0	12.2
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933699-48944969	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 17.3;kidney: 18.0"	"Group enriched"	"Detected in many"	11	"Proximal enterocytes: 213.7;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.2"	"Group enriched"	"Detected in many"	33	"granulocytes: 4.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.2	0.4	1.6	0.0	1.6	0.1	0.2	1.9	3.3	0.3	1.0	0.3	10.5	0.1	0.0	0.8	0.3	0.2	0.1	1.7	1.7	18.0	0.4	1.1	0.2	1.2	1.3	0.6	0.4	0.5	1.8	1.3	1.2	3.2	0.0	1.7	0.4	0.1	0.2	0.2	17.3	0.0	1.3	1.7	0.7	1.9	2.7	0.1	0.1	0.0	0.2	0.3	0.4	1.6	1.4	0.0	0.1	0.7	0.4	0.3	0.5	0.0	0.2	0.2	0.7	1.4	1.1	0.0	0.2	0.0	0.9	0.4	0.5	1.0	0.4	0.5	1.1	2.0	0.5	0.5	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.3	0.0	3.2	0.7	0.2	0.0	0.3	0.0	0.1	0.3	2.1	0.9	0.7	0.1	1.0	0.1	0.4	2.1	1.1	0.2	0.1	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.3	0.0	3.2	2.8	0.8	0.7	0.0	0.2	4.2	0.0	0.5	0.7	0.0	0.4	0.0	0.8	0.3	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.6	0.2	1.6	1.6	1.9	3.3	1.7	1.7	1.2	1.3	1.2	1.3	2.7	1.6	0.5	3.2	6.4	1.0	1.0	0.8	2.4	3.3	2.2	2.4	1.0	3.4	0.7	1.5	4.6	3.7	0.0	0.2	0.4	1.5	9.8	2.2	0.7	0.3	0.5	0.8	0.0	0.4	1.0	0.4	0.2	0.5	4.1	0.8	1.3	0.1	0.0	0.0	12.9	0.0	1.2	5.0	2.0	0.8	0.0	2.4	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	1.5	3.6	0.0	0.0	3.5	213.7	77.8	0.5	4.5	0.0	1.2	0.4	0.0	0.8	3.1	0.1	0.1	0.6	0.4	2.7	3.2
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626226-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.8;Spermatocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	25.2	5.3	15.3	20.7	16.5	54.3	12.0	15.8	21.9	8.0	13.3	21.4	24.5	8.6	7.0	14.1	7.4	8.5	7.2	13.8	15.5	21.3	60.1	7.5	41.5	16.6	16.6	6.6	3.2	9.1	6.3	14.4	16.6	8.9	25.3	10.3	6.8	9.5	19.6	9.8	25.1	12.0	16.5	10.3	12.2	18.5	15.8	60.7	8.2	25.8	39.5	10.3	5.7	17.7	98.1	66.6	164.8	122.7	30.7	32.0	60.6	76.5	58.1	130.2	149.0	63.8	114.6	196.9	32.5	44.6	106.0	67.0	214.4	98.6	208.5	88.2	132.1	94.8	104.5	59.5	6.6	111.7	40.3	22.3	9.9	116.9	13.0	22.2	63.9	142.0	108.3	146.7	133.5	98.2	276.5	44.9	83.6	48.3	38.5	176.7	323.3	194.1	75.1	61.5	134.3	93.7	107.9	49.9	54.6	83.5	98.5	108.6	38.5	41.0	62.0	116.0	148.3	68.2	146.6	210.3	91.5	222.1	107.7	0.2	0.3	0.2	0.5	0.6	0.2	0.5	0.6	0.8	0.5	0.5	0.5	0.6	0.8	0.5	0.5	0.8	0.9	0.6	15.3	16.5	15.8	21.9	13.8	15.5	16.6	16.6	16.6	16.5	15.8	17.7	4.1	6.4	11.7	4.9	21.4	6.9	6.5	6.0	4.0	3.5	8.9	8.9	13.0	4.3	6.1	14.7	2.1	35.2	7.4	19.3	9.8	7.4	7.4	10.8	7.7	7.7	4.9	145.8	7.3	3.7	47.3	12.0	11.7	8.0	2.5	22.0	10.0	48.3	44.7	3.3	7.2	19.1	4.1	18.9	4.4	6.4	14.0	12.8	0.0	4.7	7.1	14.5	13.4	3.5	6.0	4.7	10.3	16.1	60.9	2.9	26.6	40.0	6.9	3.2	13.1	9.0	12.5	132.2	49.8	21.2	5.5	13.3	11.8	12.3	38.1	12.1
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Ductal cells: 6.3;Respiratory ciliated cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"hTERT-RPE1: 154.6"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	3.3	4.9	3.9	3.8	5.2	1.8	5.3	6.0	5.2	5.2	4.8	4.2	4.1	7.9	6.4	3.5	6.3	5.1	3.7	4.1	4.1	5.9	6.7	4.5	5.7	4.8	4.2	10.1	5.3	6.5	2.5	3.2	5.0	6.4	4.6	3.2	4.4	4.9	1.4	4.2	4.9	5.4	4.2	4.9	4.7	4.7	4.4	5.7	6.7	2.1	4.6	3.3	2.4	6.5	3.8	6.5	4.2	4.4	5.7	7.2	1.7	5.7	6.0	2.8	3.2	1.4	5.7	2.5	3.8	3.0	3.7	5.0	3.3	3.9	4.4	8.5	1.8	3.1	2.9	3.4	6.0	2.2	3.6	7.6	5.1	3.3	4.2	154.6	2.9	11.9	1.6	5.6	3.7	4.5	10.8	1.2	3.7	10.8	6.7	2.7	5.7	4.1	4.1	1.9	5.4	5.3	8.3	2.2	9.6	3.3	5.6	3.1	4.8	4.4	7.4	1.8	2.2	4.1	4.4	3.5	4.4	5.5	6.2	2.2	1.1	2.0	1.8	1.7	3.3	1.8	2.4	2.9	0.7	2.2	3.2	3.0	1.7	1.4	1.8	2.1	3.2	1.3	3.9	5.2	6.0	5.2	4.1	4.1	4.8	4.2	5.0	4.2	4.4	6.5	2.8	12.8	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.6	3.4	0.0	0.0	1.8	3.7	0.0	2.4	2.3	0.0	3.9	6.3	0.0	3.5	4.4	2.5	0.0	0.0	0.0	5.5	1.7	2.5	0.0	2.9	2.5	4.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.6	8.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	1.3	3.5	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.4	4.8	3.1	4.2	3.6	3.9	5.8	3.7	3.7	4.0	3.7	5.4	3.9	5.4	2.8	4.2	6.1	2.3	13.8	2.9	2.5	8.0	105.9	3.9	4.2	3.4	3.3	4.9	4.2	6.2	2.5	2.7	3.3	4.0	5.8	3.2	5.4	4.5	10.0	4.5	3.1	5.7	2.1	4.1	4.1	3.6	3.4	3.9	4.1	8.1	5.5	3.9	3.4	5.2	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	3.1	3.6	3.7	3.7	2.9	2.5	3.4	3.3	3.3	2.1	3.4	5.2	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	30.6	43.2	44.6	23.9	48.1	21.7	29.6	51.0	57.5	35.7	50.0	40.9	28.0	33.2	15.6	29.5	38.6	20.1	41.0	46.5	48.6	34.2	41.0	29.6	32.7	46.4	45.1	40.6	49.7	47.0	52.8	19.7	50.0	34.8	29.5	69.1	34.1	27.9	92.6	41.3	32.8	29.1	47.7	31.6	44.2	16.0	45.9	45.2	28.7	70.5	34.7	36.7	33.1	56.2	70.8	50.8	80.8	41.5	34.2	57.7	18.6	44.0	64.9	82.8	82.9	35.4	33.8	71.7	49.4	48.2	75.6	41.0	55.7	63.0	57.4	64.2	37.8	48.8	51.4	47.1	43.8	57.2	72.1	47.2	74.8	49.7	85.2	82.9	59.1	141.5	45.1	49.5	61.5	137.0	105.1	83.3	64.2	90.3	85.1	65.8	29.1	106.6	63.5	34.6	106.7	144.4	44.0	64.2	76.0	48.1	59.0	96.5	29.8	94.4	38.2	93.5	69.2	160.0	184.9	49.9	59.7	66.2	94.5	37.0	58.8	82.7	51.0	54.1	53.0	86.2	59.0	52.8	63.4	82.1	77.7	56.8	18.2	64.2	72.8	64.9	77.6	70.0	44.6	48.1	51.0	57.5	46.5	48.6	46.4	45.1	50.0	47.7	45.9	56.2	40.3	41.7	30.7	10.1	54.8	55.6	79.2	93.0	38.7	75.8	48.3	64.5	8.6	37.1	49.1	33.1	45.9	47.1	52.2	35.2	86.1	53.7	20.9	38.2	24.5	35.0	41.3	26.7	11.9	37.6	55.1	35.0	33.6	27.9	24.1	46.0	30.4	34.6	42.8	42.1	12.5	60.8	79.3	37.6	42.5	27.5	45.1	35.3	49.8	6.5	62.7	115.2	53.5	8.0	14.7	48.7	70.1	34.6	51.1	73.3	87.9	84.1	49.6	129.2	46.0	39.6	53.8	33.3	62.3	39.7	51.0	71.8	51.1	37.4	54.3	71.0
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591879-36600804	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"intestine: 216.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 129.3;Distal enterocytes: 317.3;Paneth cells: 154.2;Proximal enterocytes: 527.9;Undifferentiated cells: 148.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted to digestive system"	NA	NA		42000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Golgi apparatus"	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	10.0	10.5	6.9	5.4	7.9	4.4	10.9	6.7	9.8	9.5	9.0	74.3	216.0	5.7	1.9	14.6	7.3	2.4	17.2	8.6	9.0	21.9	14.8	4.3	2.4	7.4	7.5	5.1	15.4	9.5	13.3	2.0	7.9	8.0	57.1	22.4	10.3	4.5	16.7	14.4	177.0	6.3	6.6	4.7	11.7	17.0	8.2	2.1	11.9	9.9	3.6	6.8	10.5	7.7	13.9	10.0	3.6	13.8	1.2	2.5	10.6	3.8	2.6	11.9	10.7	22.2	10.1	0.8	1.9	4.0	4.8	13.9	11.5	6.7	10.5	7.1	15.2	3.7	10.1	35.6	5.5	3.0	1.2	2.2	7.3	8.6	6.5	1.9	8.8	11.2	36.1	9.3	5.9	12.5	12.6	5.5	4.5	14.2	0.4	15.2	12.8	22.0	9.9	11.4	10.4	4.9	16.0	12.9	33.3	6.6	19.1	3.6	4.8	1.6	18.2	7.6	10.0	14.1	16.7	4.4	6.5	9.3	5.5	0.1	0.1	0.4	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	6.9	7.9	6.7	9.8	8.6	9.0	7.4	7.5	7.9	6.6	8.2	7.7	9.1	0.0	1.5	4.2	3.3	4.2	8.9	2.8	4.0	20.7	14.6	13.3	9.6	2.8	2.4	7.3	129.3	7.9	1.4	317.3	58.7	10.7	22.9	10.2	5.0	6.7	12.1	31.5	8.2	11.4	4.7	3.4	8.6	6.8	0.0	5.3	5.3	12.7	3.5	16.8	9.6	72.2	2.0	1.9	4.2	30.5	4.1	2.6	19.6	2.8	3.6	15.8	1.0	4.0	2.0	7.5	154.2	5.3	9.1	11.7	527.9	43.1	3.8	71.0	0.0	5.9	5.9	27.7	6.5	12.0	6.0	7.0	3.1	9.3	148.5	15.2
DHRS12	"FLJ13639, SDR40C1"	ENSG00000102796	"Dehydrogenase/reductase 12"	A0PJE2	13	51767993-51804162	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"pancreas: 66.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 69.1;Proximal tubular cells: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB034238, HPA057028, HPA058315"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678"	"prognostic favorable (1.41e-4)"	"unprognostic (1.98e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.44e-1)"	22.7	10.6	7.8	2.9	7.3	4.5	20.5	8.9	7.8	13.9	6.5	14.0	5.5	13.1	5.0	10.3	14.5	6.1	14.3	7.3	6.7	24.6	28.9	11.7	5.3	7.2	6.6	18.4	66.8	6.6	18.7	3.6	7.0	15.4	3.7	5.9	15.0	5.9	16.0	14.1	12.5	4.0	7.6	15.7	15.0	8.2	7.0	2.3	18.8	4.1	3.5	13.2	11.2	8.3	1.1	2.5	3.8	5.6	1.2	2.6	4.4	1.6	4.1	1.8	1.3	4.5	8.6	4.2	1.2	2.5	2.5	2.0	0.0	0.3	0.3	4.2	3.4	0.6	1.1	3.2	6.6	0.4	0.7	2.7	3.9	0.6	2.4	4.5	5.2	4.0	2.0	3.0	1.3	5.5	1.0	3.5	6.1	4.2	0.6	0.5	0.8	5.8	5.6	3.2	3.4	6.9	2.9	2.5	7.1	5.0	2.8	2.8	3.7	1.3	1.5	0.1	1.7	1.4	1.8	1.9	2.3	1.4	3.7	6.6	16.6	0.5	14.0	14.2	24.1	13.7	19.7	16.9	9.0	13.4	16.4	12.9	31.4	3.8	16.5	10.6	19.8	13.5	7.8	7.3	8.9	7.8	7.3	6.7	7.2	6.6	7.0	7.6	7.0	8.3	14.1	12.8	14.8	11.1	11.4	11.3	12.1	22.2	10.8	11.9	23.5	22.9	15.7	18.6	13.3	16.5	8.4	24.9	8.0	7.8	52.8	12.5	26.1	5.6	7.7	10.1	10.3	2.1	4.9	16.7	17.5	17.1	7.1	6.4	12.0	6.8	8.6	30.7	17.1	3.3	5.4	12.4	22.4	11.2	11.6	69.1	11.1	10.1	14.2	3.7	10.5	32.4	8.2	24.6	12.9	12.6	21.9	9.8	4.8	12.2	25.5	83.5	19.5	18.5	0.0	14.2	11.4	1.4	8.2	10.5	14.9	23.8	13.7	13.4	11.0	12.2
DHRS13	"MGC23280, SDR7C5"	ENSG00000167536	"Dehydrogenase/reductase 13"	Q6UX07	17	28897781-28903079	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 55.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022991	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA022991: AB_1853865"	"unprognostic (8.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.55e-1)"	3.1	7.0	9.9	5.7	8.6	41.8	5.4	17.1	9.6	6.4	11.8	4.8	4.4	3.0	6.6	8.8	4.1	2.9	2.8	8.6	15.3	12.2	23.6	4.7	6.6	13.0	14.9	3.5	6.6	7.9	6.3	4.5	14.0	19.4	3.6	8.3	12.7	10.6	1.3	7.4	4.0	2.2	10.1	10.2	5.9	3.0	13.0	4.6	4.7	2.3	6.9	9.5	6.3	9.5	12.1	7.6	17.4	22.2	2.6	3.8	16.8	6.4	8.3	11.6	17.7	23.5	7.1	32.8	10.7	1.4	13.4	10.5	24.8	7.1	4.9	33.5	23.9	18.4	13.9	13.0	6.5	9.5	2.1	2.8	6.3	7.3	7.7	8.1	3.6	22.7	42.3	11.0	2.3	21.7	20.9	15.9	10.7	31.4	1.0	32.8	16.4	25.5	21.8	20.2	24.8	20.8	10.1	69.5	13.9	9.1	46.4	15.2	1.2	3.7	11.1	9.0	8.9	25.5	25.7	20.7	11.0	11.9	9.4	0.9	4.4	3.1	8.5	6.9	10.4	7.1	10.8	10.7	5.9	8.6	10.9	8.1	55.3	9.4	6.8	3.2	11.4	5.8	9.9	8.6	17.1	9.6	8.6	15.3	13.0	14.9	14.0	10.1	13.0	9.5	2.4	3.2	4.2	2.3	6.7	1.5	10.2	12.3	12.0	6.1	7.1	5.7	0.4	8.6	5.4	7.3	2.1	27.7	4.4	4.3	9.8	10.6	11.9	3.4	1.1	4.5	3.0	106.1	0.7	2.7	22.2	2.1	7.7	6.3	1.3	1.2	6.4	5.5	6.2	5.0	4.4	4.2	2.0	0.8	3.0	5.2	1.2	2.1	5.4	1.0	15.5	8.2	10.3	3.0	1.0	2.5	2.4	0.4	12.8	11.5	2.8	3.2	2.2	5.0	6.6	0.9	1.1	6.1	22.5	9.4	1.7	13.5	7.0	0.5	6.4	5.8
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 336.3;urinary bladder: 392.6"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	1.2	1.6	0.3	0.1	0.2	0.0	336.3	0.2	0.4	1.9	0.2	0.2	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4	1.2	1.6	23.6	0.2	0.0	0.4	1.2	25.5	10.3	2.1	2.5	3.2	1.7	3.3	0.4	0.4	97.7	3.1	0.0	3.4	0.1	0.2	0.3	19.0	4.7	3.4	1.1	0.0	0.1	0.0	0.0	392.6	13.6	0.3	1.2	2.2	0.2	199.9	0.3	0.3	3.1	0.3	0.2	6.4	0.1	14.4	1.1	0.8	1.9	0.3	10.4	2.0	0.7	1.2	1.4	289.5	21.6	2.8	1.0	719.8	0.0	4.3	25.1	1.7	0.2	2.5	1.7	0.0	0.1	0.4	1.8	0.7	1.4	8.0	2.5	0.3	1.1	6.9	31.7	2.6	6.3	2.7	0.0	828.1	3.5	5.0	5.9	4047.2	4.9	0.7	3.9	1.0	0.0	2.4	1286.3	7.7	4.3	2.0	0.6	11.3	1.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.4	1.2	0.4	1.2	1.7	0.3	1.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	2.1	0.2	0.0	0.8	7.4	1.3	0.4	0.0	0.0	0.0	0.0	7.9	0.1	0.1	7.9	0.1	5.0	0.1	0.0	0.2	3.5	0.0	0.1	0.2	15.1	3.5	0.0	0.0	0.0	1.4	0.0	4.9	1.7	0.0	0.1	0.2	0.0	0.3	0.8	3.7	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	4.8	0.2	1.2	0.0	0.3	0.0	0.2	0.0	1.2	6.6	0.0	0.7	0.3	7.4	0.0	0.1	24.8	0.2	12.6	0.7	30.6
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12618210	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 323.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 409.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 86.8;MAIT T-cell: 63.1;memory CD4 T-cell: 46.9;memory CD8 T-cell: 41.0;myeloid DC: 24.0;naive CD4 T-cell: 79.2;naive CD8 T-cell: 50.1;NK-cell: 41.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.0;NK-cells: 41.1;T-cells: 86.8"	"Cell line enhanced"	"Detected in many"		"A549: 107.4;CAPAN-2: 206.9;hTERT-RPE1: 196.7;SK-BR-3: 104.6;WM-115: 192.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	150.9	21.6	38.3	18.6	37.8	13.8	115.8	34.8	41.1	89.8	96.3	60.8	50.2	34.6	25.3	117.1	53.9	33.5	73.2	38.0	38.0	87.8	323.7	56.4	18.0	57.2	37.8	38.8	108.4	31.3	48.8	19.6	40.1	169.6	21.2	8.6	67.0	48.2	76.2	71.9	52.5	16.8	40.6	27.0	87.1	20.2	41.3	10.4	121.2	24.7	8.9	73.0	107.0	44.2	18.1	107.4	0.1	42.7	54.9	5.0	11.9	6.2	0.3	0.2	0.4	11.8	206.9	0.1	5.2	57.7	17.6	79.9	21.4	10.6	0.2	0.1	36.3	16.5	11.3	57.3	8.5	0.3	0.3	27.9	13.5	0.3	0.5	196.7	18.0	0.7	24.3	0.3	0.3	3.0	4.4	1.0	6.8	18.5	40.3	0.5	0.1	20.2	0.1	36.6	1.3	2.0	35.0	104.6	6.6	13.2	10.3	4.8	13.5	0.5	2.2	30.3	0.4	3.3	0.2	0.2	23.9	1.4	192.8	9.2	0.8	0.1	86.8	0.5	63.1	0.6	46.9	41.0	24.0	0.7	79.2	50.1	4.7	41.1	1.1	3.0	1.4	48.2	38.3	37.8	34.8	41.1	38.0	38.0	57.2	37.8	40.1	40.6	41.3	44.2	139.5	96.1	55.9	26.8	3.4	25.6	136.0	114.8	59.2	2.0	17.5	22.6	42.3	45.8	93.4	20.2	18.8	34.4	35.5	83.8	23.5	99.3	99.6	69.8	50.2	54.1	25.1	23.6	3.7	163.1	45.0	56.4	32.1	83.7	15.8	2.6	73.5	181.3	67.1	0.0	3.3	33.0	42.7	69.6	8.4	409.5	22.7	43.6	7.2	17.8	11.5	15.3	38.1	1.0	0.6	129.6	69.5	9.8	3.5	76.2	112.6	52.9	82.8	2.4	0.0	10.5	30.8	1.9	1.4	51.7	27.0	26.3	28.3	7.9	33.0	156.8
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953734-23969279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	34.1	45.8	8.6	10.4	9.2	6.9	34.5	8.8	9.7	30.5	10.1	43.5	34.0	27.1	5.2	45.8	23.6	5.9	49.1	8.3	8.6	92.0	109.7	28.0	10.2	9.2	8.6	33.0	40.3	8.8	19.3	5.3	9.2	31.9	13.5	3.9	31.2	8.4	62.2	44.7	38.6	8.3	8.6	32.2	33.7	37.9	9.0	9.6	25.4	14.0	8.5	30.5	33.1	9.5	15.1	29.6	10.4	17.2	16.6	18.5	0.1	27.4	15.3	11.5	9.1	6.5	16.5	13.3	14.3	14.6	7.6	18.1	8.6	12.3	10.1	34.6	16.5	7.8	23.5	36.6	9.5	11.6	45.2	18.0	14.8	9.2	20.8	12.3	14.4	19.6	11.8	30.4	15.8	52.3	21.1	10.7	9.9	18.9	30.3	33.8	18.0	41.4	12.1	17.1	19.9	16.1	27.7	17.6	13.8	6.8	16.0	14.6	25.5	13.3	13.8	13.9	9.0	22.8	22.8	3.5	11.8	12.6	13.6	5.4	54.4	6.0	18.0	45.8	21.4	21.5	20.3	18.2	47.4	18.5	20.1	19.5	2.3	18.1	25.5	39.4	19.4	36.2	8.6	9.2	8.8	9.7	8.3	8.6	9.2	8.6	9.2	8.6	9.0	9.5	16.6	16.0	30.5	6.2	12.5	12.5	10.4	15.7	55.2	5.1	22.2	31.9	35.4	17.2	21.3	14.7	0.0	9.6	17.8	34.2	78.2	6.4	50.4	13.1	11.6	14.6	19.2	20.8	2.6	9.8	6.0	23.7	34.7	7.8	13.9	10.5	20.0	68.1	30.4	6.7	2.1	50.1	8.2	29.2	13.5	66.1	11.1	35.9	5.4	3.7	33.2	18.1	47.4	4.0	5.0	5.3	22.3	17.3	24.6	11.2	51.8	235.4	23.2	1.8	6.6	13.5	18.1	59.4	1.9	61.6	13.4	3.8	18.1	22.9	71.8	9.0
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	27.2	39.5	28.8	14.6	29.6	11.5	30.5	28.3	38.4	26.9	30.8	34.7	34.4	19.7	12.8	38.4	18.6	10.6	45.9	28.5	27.8	122.5	136.2	22.5	14.6	29.3	28.7	25.2	34.0	24.5	16.7	10.0	28.7	32.5	26.6	6.7	24.7	20.7	50.7	37.1	42.0	18.4	28.6	29.3	27.9	41.4	29.4	16.9	21.5	28.5	16.5	26.0	26.1	29.9	18.7	29.0	4.9	24.4	46.2	47.9	0.6	17.3	34.3	24.8	18.4	8.4	22.5	12.6	11.5	35.3	16.0	20.6	22.3	29.1	20.6	43.3	13.3	3.1	24.8	52.4	34.0	15.3	47.9	50.0	36.4	16.3	23.7	17.0	29.5	40.0	10.1	44.9	26.7	61.5	40.4	16.5	9.7	45.9	31.8	64.9	19.9	38.2	35.6	23.7	26.0	15.7	24.5	21.5	15.0	10.3	25.2	24.5	20.8	12.9	13.4	15.4	8.8	25.5	21.1	3.8	11.1	23.7	18.8	4.8	56.3	6.9	19.4	47.2	20.1	21.9	20.9	22.2	45.4	17.4	21.0	19.1	2.6	17.2	29.3	37.4	21.8	33.6	28.8	29.6	28.3	38.4	28.5	27.8	29.3	28.7	28.7	28.6	29.4	29.9	39.3	16.0	29.6	10.4	17.8	27.8	46.1	56.8	27.9	9.9	45.5	54.4	17.2	47.1	34.3	25.8	2.1	21.2	22.9	37.9	127.2	40.0	20.7	20.6	20.1	32.0	37.3	24.2	7.3	55.7	7.3	36.4	13.3	16.5	17.7	31.8	50.0	204.2	146.1	11.8	6.7	61.7	42.7	55.9	42.8	35.4	43.8	41.9	51.6	10.3	65.0	79.5	35.0	10.1	8.5	30.4	54.9	37.2	10.8	32.5	326.4	581.7	28.6	8.3	32.9	24.2	32.7	17.2	1.7	42.1	40.2	13.0	21.3	37.5	78.1	42.4
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144119-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 840.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	62.1	103.4	50.8	43.8	53.9	61.0	58.5	59.2	75.4	48.9	50.2	73.0	108.9	49.8	96.5	44.3	45.9	59.1	47.1	49.9	55.1	100.5	146.4	64.2	45.5	62.3	54.9	64.9	76.8	226.8	54.7	29.6	63.3	409.9	69.5	111.1	317.5	134.6	615.8	46.6	181.0	51.0	57.8	45.4	182.3	9.8	52.0	39.2	120.3	136.0	49.4	51.7	41.1	65.6	221.3	52.9	41.8	89.3	219.6	74.4	42.8	74.3	186.4	26.5	59.0	37.3	149.8	21.5	41.7	76.8	78.0	92.7	57.2	108.3	34.5	156.1	36.0	53.7	28.7	60.9	110.1	71.8	1.7	63.3	116.7	47.6	153.0	50.8	52.5	66.2	18.2	52.6	61.4	59.2	40.9	67.2	18.6	151.2	55.4	42.7	50.8	24.4	118.3	70.5	83.4	99.8	72.6	118.0	168.2	52.7	72.7	32.5	35.8	126.6	38.7	36.9	44.2	18.3	7.9	45.0	62.6	64.8	93.5	743.5	213.1	519.6	335.7	159.1	340.6	184.4	238.9	298.5	185.0	167.0	134.6	258.5	835.4	294.7	224.0	388.8	215.5	450.2	50.8	53.9	59.2	75.4	49.9	55.1	62.3	54.9	63.3	57.8	52.0	65.6	109.6	54.5	102.5	16.0	72.2	34.0	70.3	233.2	52.3	25.7	81.2	57.4	27.6	160.2	138.4	86.5	83.4	29.6	210.4	101.3	19.6	222.5	2.1	56.2	55.5	89.7	46.5	20.4	12.2	165.9	88.7	87.9	120.8	120.0	178.5	22.9	48.5	166.4	94.4	42.1	19.0	102.2	386.6	54.5	70.6	3.5	82.3	98.7	108.5	16.9	172.5	94.4	299.7	26.2	20.1	210.6	114.5	84.2	99.0	263.4	840.4	44.1	57.0	70.7	85.5	66.4	73.7	1.6	2.9	47.0	25.4	20.8	152.1	19.7	79.2	47.1
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.9;intestine: 70.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 229.3;Distal enterocytes: 261.2;Early spermatids: 153.2;Paneth cells: 299.9;Respiratory ciliated cells: 155.9;Syncytiotrophoblasts: 267.5;Urothelial cells: 249.2"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 258.3;eosinophil: 99.2;neutrophil: 77.3"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 258.3"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 22.8;HUVEC TERT2: 21.5;NB-4: 33.7;THP-1: 98.0;TIME: 49.9;U-2197: 31.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	10.0	0.2	2.2	12.5	2.4	8.5	5.1	3.0	2.6	8.6	1.6	70.4	1.9	1.2	0.9	28.2	1.0	5.7	53.9	2.5	2.3	0.3	3.1	7.1	20.2	4.2	3.2	0.7	0.4	0.2	0.4	2.8	4.3	0.8	46.2	1.2	6.1	0.5	0.3	3.3	5.7	4.2	3.8	7.6	10.8	11.3	3.2	2.2	0.3	0.8	26.8	17.5	10.1	4.5	0.0	0.7	0.0	0.0	2.5	10.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	6.5	1.7	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	1.0	0.4	0.5	1.3	6.1	22.8	21.5	0.0	1.0	0.0	0.0	0.0	0.1	33.7	0.0	0.3	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	98.0	49.9	0.1	0.2	31.4	0.2	0.1	0.0	0.0	0.8	18.9	0.0	258.3	21.0	99.2	0.0	25.0	0.6	6.5	0.0	0.0	21.6	5.0	0.1	0.0	77.3	0.4	5.1	1.6	0.0	5.9	2.2	2.4	3.0	2.6	2.5	2.3	4.2	3.2	4.3	3.8	3.2	4.5	0.3	0.0	1.3	0.0	1.4	1.7	19.3	72.4	0.0	0.0	0.1	0.4	24.4	0.0	229.3	0.0	0.0	2.5	0.0	261.2	0.0	4.6	153.2	0.5	0.0	0.6	1.8	0.8	0.2	25.3	1.3	1.5	7.7	0.1	91.0	0.0	0.0	0.6	25.0	0.0	0.2	51.6	36.7	10.2	38.8	45.5	1.2	16.6	0.0	19.7	3.5	3.9	0.0	0.0	0.2	68.6	299.9	0.4	6.4	6.5	1.5	0.1	155.9	0.1	6.6	0.2	10.9	1.1	0.6	0.3	1.4	267.5	3.8	0.0	8.2	249.2
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219506-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	13.1	16.2	7.0	4.8	8.2	5.2	12.2	6.7	7.7	13.3	11.9	12.7	6.5	13.0	8.0	6.0	11.0	8.8	19.9	6.1	6.8	14.7	30.6	10.3	5.6	11.5	10.1	12.6	21.9	11.5	10.6	8.2	8.4	13.2	8.3	2.2	14.7	7.0	12.4	9.0	10.8	6.9	8.5	10.1	16.5	6.4	10.9	6.1	13.3	7.0	3.9	11.2	9.3	8.2	8.1	35.7	23.9	11.0	28.8	18.0	18.5	17.8	29.9	13.3	17.9	26.9	16.8	12.6	22.6	21.5	31.4	3.9	16.4	14.3	9.4	24.1	26.1	12.2	17.9	21.2	33.8	6.6	9.5	22.3	17.7	11.6	11.4	22.7	10.9	13.9	14.0	6.1	21.7	9.2	28.5	9.7	6.9	10.6	9.9	10.4	12.4	3.5	14.5	19.3	24.3	22.9	17.0	20.3	14.2	14.8	8.7	10.8	15.6	14.5	3.6	8.4	10.6	7.1	0.1	33.2	9.7	8.7	6.7	14.9	38.3	34.6	15.1	30.6	16.0	25.0	13.5	12.7	35.1	20.1	12.3	10.6	56.4	17.7	19.5	28.3	18.2	21.0	7.0	8.2	6.7	7.7	6.1	6.8	11.5	10.1	8.4	8.5	10.9	8.2	8.7	19.2	9.3	64.3	19.2	10.6	22.9	58.0	20.5	9.5	19.3	16.9	23.4	25.8	24.4	25.8	10.4	42.9	17.0	32.9	13.7	52.3	0.6	16.1	15.9	14.8	19.2	13.7	41.2	81.2	43.5	26.9	21.4	14.4	17.8	27.1	15.0	50.6	38.4	3.3	42.7	21.4	32.6	20.8	30.7	3.0	24.2	26.3	12.4	61.8	35.9	9.4	14.4	46.3	31.9	71.0	28.8	25.2	29.1	65.3	49.2	43.7	14.8	6.2	19.7	12.0	18.3	12.0	21.2	11.3	6.5	107.3	14.0	14.6	24.1	29.2
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256055-55307694	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	10.6	10.6	5.3	9.7	5.7	6.7	12.0	9.1	7.0	12.5	6.7	12.1	7.2	11.4	6.8	12.7	9.5	8.9	10.7	5.7	5.1	16.9	13.1	9.4	9.5	5.0	5.0	8.9	11.7	18.7	10.4	11.4	5.1	13.4	9.8	8.7	10.3	12.0	24.2	11.6	8.4	12.6	5.5	7.9	10.4	7.4	5.1	10.0	15.4	14.8	9.7	12.0	10.3	7.1	36.7	25.5	20.9	27.2	32.3	28.2	25.6	38.9	30.9	28.2	28.7	21.3	23.0	20.7	34.9	44.5	35.8	26.0	34.0	37.1	40.5	9.1	19.4	18.8	21.6	14.6	18.3	13.3	19.6	23.8	23.0	29.9	17.2	18.5	37.9	16.5	24.4	15.0	33.4	25.9	21.4	11.1	17.5	10.5	27.1	10.9	31.8	35.7	23.0	25.3	19.6	12.5	37.4	21.3	18.6	20.5	28.7	21.7	32.9	25.9	20.2	22.8	27.4	13.2	24.1	29.0	29.9	23.0	29.1	68.6	22.5	24.3	18.0	24.4	20.4	27.3	22.5	20.0	17.5	26.3	25.0	21.6	20.6	24.5	30.1	36.8	21.9	8.9	5.3	5.7	9.1	7.0	5.7	5.1	5.0	5.0	5.1	5.5	5.1	7.1	44.5	70.5	42.6	34.0	35.2	37.6	37.5	71.8	39.3	81.6	44.9	49.8	73.6	41.5	69.4	64.4	41.7	68.3	39.5	34.4	54.8	61.4	54.8	37.4	61.5	40.7	38.4	68.4	47.3	61.7	54.6	52.7	35.7	36.5	31.6	39.0	22.9	45.0	41.2	42.1	46.9	36.4	63.1	26.0	26.6	16.6	46.6	41.5	28.4	28.1	50.7	35.7	35.0	42.7	54.9	61.9	27.3	53.0	57.0	53.2	35.2	105.2	35.9	83.6	52.6	52.8	54.2	117.5	108.1	50.1	47.5	81.3	36.1	106.4	39.9	43.3
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.6	23.7	17.1	23.3	22.2	22.9	21.4	26.3	26.4	24.8	26.8	16.2	27.6	10.4	23.6	24.8	14.9	28.8	23.5	22.4	26.8	25.2	21.3	20.1	24.0	23.5	27.9	24.1	28.9	32.1	17.5	24.6	26.6	10.9	12.7	21.6	18.2	37.1	27.6	22.3	15.9	20.3	27.3	25.2	54.2	23.8	23.3	24.8	21.0	14.3	25.2	22.8	24.2	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	23.7	23.3	21.4	26.3	23.5	22.4	24.0	23.5	24.6	20.3	23.8	24.2	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DHX32	"DDX32, DHLP1, FLJ10694, FLJ10889"	ENSG00000089876	"DEAH-box helicase 32 (putative)"	Q7L7V1	10	125836337-125896436	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048872	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA048872: AB_2680540"	"unprognostic (1.05e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (9.49e-5)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	12.6	18.5	11.5	9.0	12.9	7.2	20.6	12.7	12.8	14.9	23.6	30.6	17.5	11.6	13.7	25.2	12.7	10.9	35.5	11.0	12.2	16.4	15.3	14.6	6.9	12.9	12.5	25.7	30.4	20.1	10.0	15.4	12.8	17.8	36.0	21.6	23.8	11.9	21.3	24.8	17.8	12.5	12.8	9.4	33.7	33.0	13.6	8.9	14.7	21.3	12.7	17.2	16.4	14.7	70.0	37.8	25.0	51.6	32.4	29.9	44.6	30.3	69.8	27.1	30.2	8.9	67.4	0.3	22.2	35.4	29.9	49.9	11.5	50.9	22.2	35.2	22.5	8.6	18.3	13.6	36.0	17.0	27.4	29.6	52.3	26.6	59.3	48.4	39.9	0.4	24.3	0.3	26.3	31.5	0.3	26.7	19.0	34.2	25.9	0.3	40.6	15.1	39.4	32.1	3.4	18.2	28.1	49.7	42.6	32.5	18.3	14.9	36.0	21.0	12.8	27.0	27.0	26.4	27.5	0.6	37.9	0.4	11.0	0.1	1.7	1.8	1.4	1.8	1.1	4.6	0.6	0.5	1.2	2.0	2.7	1.1	0.0	2.7	0.9	0.7	0.2	0.5	11.5	12.9	12.7	12.8	11.0	12.2	12.9	12.5	12.8	12.8	13.6	14.7	11.7	16.0	17.2	31.3	6.5	5.0	14.8	10.0	9.6	13.5	12.0	9.9	25.4	12.8	15.3	7.3	22.9	19.4	4.0	41.8	15.6	32.4	101.8	19.7	20.2	13.9	4.2	16.2	20.3	37.7	29.8	9.8	38.2	24.7	11.4	27.1	6.8	10.6	12.1	11.8	27.9	48.2	14.2	6.7	2.4	28.3	10.5	7.4	7.2	9.4	8.2	29.1	2.1	23.6	30.2	54.5	22.2	17.0	9.0	25.0	14.6	13.9	22.1	15.2	13.1	14.4	11.2	51.3	5.9	13.2	7.0	44.2	4.6	22.9	22.5	26.1
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440917-5468982	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	6.2	5.9	5.5	6.3	5.8	4.4	7.0	5.1	6.0	5.4	3.9	5.3	4.8	6.4	4.1	6.2	5.8	4.1	4.5	5.7	4.9	5.2	7.8	4.4	6.0	4.9	5.2	5.6	6.7	7.6	3.9	6.3	4.8	5.4	5.6	6.4	5.6	5.4	8.0	6.9	5.0	5.9	5.0	6.0	5.5	4.5	5.7	5.2	5.1	5.6	5.9	6.5	5.4	5.5	19.0	27.7	17.4	31.1	7.2	14.4	21.6	18.4	11.4	27.6	22.1	17.6	8.1	46.7	12.5	15.1	11.0	22.0	35.4	28.7	35.3	15.0	34.1	18.5	22.4	30.0	14.1	24.9	15.9	12.2	17.3	29.8	40.4	8.3	20.9	22.0	24.9	22.3	15.5	13.4	25.5	13.6	38.5	12.5	14.0	33.5	25.5	25.3	12.8	14.7	15.1	21.7	19.2	16.4	28.0	14.6	12.8	12.9	19.5	19.0	20.2	15.3	39.6	8.3	9.5	23.5	13.6	29.1	27.7	0.2	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.3	0.4	0.8	0.6	0.6	0.6	0.8	0.3	0.9	0.4	0.2	5.5	5.8	5.1	6.0	5.7	4.9	4.9	5.2	4.8	5.0	5.7	5.5	11.4	12.8	8.6	6.5	8.6	21.0	15.3	8.6	19.9	15.6	18.3	15.7	16.3	17.2	9.9	7.3	20.9	8.3	10.2	8.5	1.9	9.3	81.8	7.6	23.3	16.2	9.1	23.3	14.5	15.3	10.1	13.7	10.7	12.7	3.8	21.0	13.2	28.1	6.3	13.5	15.2	10.9	2.0	16.9	8.7	11.3	7.8	9.9	14.2	6.5	6.8	13.3	9.2	11.6	13.0	12.1	5.1	9.8	10.4	20.9	5.9	5.9	6.1	10.5	0.0	25.1	11.5	10.6	15.7	22.0	19.9	5.1	6.6	19.7	11.9	14.9
DHX34	"DDX34, KIAA0134"	ENSG00000134815	"DExH-box helicase 34"	Q14147	19	47349315-47382704	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 65.8;Spermatocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042159, HPA043558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA042159: AB_10963066, HPA043558: AB_10961262"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (8.63e-6)"	"unprognostic (9.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (7.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.21e-3)"	5.8	6.7	6.2	5.6	6.3	11.3	5.8	6.7	10.4	9.0	6.0	6.0	3.7	6.7	2.3	7.6	7.9	2.6	5.4	6.1	5.7	7.6	10.1	8.6	4.2	6.9	6.0	10.3	6.8	3.1	9.1	3.2	6.0	8.1	1.9	2.9	5.8	3.6	7.4	7.5	5.7	3.0	5.0	12.0	5.6	22.1	6.2	3.7	8.4	2.2	2.9	7.7	7.5	7.7	10.8	27.8	6.7	13.1	5.7	3.9	12.7	8.4	2.8	8.5	7.6	17.8	10.3	16.5	8.3	4.7	9.1	15.4	9.3	11.1	4.3	13.8	25.4	17.3	16.1	13.7	6.4	13.5	7.1	5.0	8.8	14.3	8.0	5.4	5.7	7.4	29.2	6.9	5.7	12.8	13.5	33.6	13.9	14.0	16.4	14.6	5.3	10.0	4.6	14.3	11.9	7.3	10.3	10.1	6.8	7.5	9.2	8.6	6.5	9.9	12.7	6.3	15.0	10.5	15.5	15.1	7.9	9.7	11.8	1.0	1.8	0.7	1.0	1.8	1.0	0.9	0.8	1.5	1.7	1.1	1.2	0.5	11.7	0.8	1.5	1.3	0.6	1.1	6.2	6.3	6.7	10.4	6.1	5.7	6.9	6.0	6.0	5.0	6.2	7.7	1.8	6.4	5.8	8.5	4.4	7.5	5.7	2.4	4.0	8.1	5.4	3.0	3.6	2.8	3.5	7.3	2.1	4.9	8.6	4.2	0.0	4.8	26.1	5.9	4.4	3.6	3.6	4.2	11.0	3.3	5.7	3.6	6.6	7.3	3.8	10.5	2.9	6.6	7.6	0.0	10.1	4.7	4.1	8.2	18.1	65.8	5.3	13.3	1.8	2.8	5.4	1.6	1.0	7.1	10.4	3.6	2.2	4.9	3.5	7.4	4.1	1.9	6.0	5.7	6.6	3.4	4.0	39.1	16.9	4.3	7.2	5.1	3.9	4.3	6.3	6.4
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565558-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	17.9	22.0	14.9	12.9	15.7	26.5	26.9	16.9	16.6	22.1	25.1	15.4	14.6	25.7	21.1	17.4	27.3	17.1	18.2	14.3	17.7	32.9	14.9	18.7	16.3	15.1	16.9	32.3	21.1	57.7	21.7	19.7	16.0	21.3	17.1	21.5	17.0	21.6	17.4	21.2	13.9	20.8	15.5	15.5	16.7	29.8	15.1	25.0	30.6	22.3	18.4	19.2	13.5	20.9	28.7	51.7	64.0	42.5	39.4	39.5	36.0	25.3	48.2	37.9	42.8	20.5	28.0	37.7	69.3	37.2	40.0	20.9	46.5	36.2	58.6	29.9	68.8	34.3	35.1	23.4	30.7	42.3	15.3	31.2	33.1	32.3	31.4	62.3	42.0	36.2	29.3	33.9	26.5	53.5	51.8	26.4	24.8	36.0	37.8	48.8	45.1	42.3	39.0	22.9	45.5	113.5	45.7	18.4	48.6	31.3	58.4	24.8	34.5	45.8	56.3	16.6	25.2	41.2	47.5	23.9	53.5	28.9	32.0	9.2	6.8	11.6	7.9	6.6	10.3	4.7	5.6	5.6	7.1	4.9	5.5	6.6	19.4	4.5	4.9	3.7	6.2	7.5	14.9	15.7	16.9	16.6	14.3	17.7	15.1	16.9	16.0	15.5	15.1	20.9	27.3	9.6	20.9	10.1	19.7	19.4	10.4	16.7	26.2	12.6	31.9	26.7	24.3	28.6	25.3	47.8	18.8	8.8	35.5	14.2	11.7	18.4	43.0	68.8	37.8	22.4	18.5	29.8	10.9	16.9	9.3	21.1	20.9	41.8	3.8	41.8	27.5	25.0	9.2	50.5	14.3	19.0	8.2	21.6	14.7	16.7	25.1	18.8	19.6	3.7	14.8	21.7	14.4	7.1	14.6	13.2	11.9	26.7	18.0	13.4	12.6	46.2	57.7	14.6	32.9	17.4	22.8	103.9	51.4	15.3	22.0	12.6	19.1	36.5	17.8	10.9
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 136.3;Late spermatids: 352.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	6.1	9.2	6.6	5.2	6.9	4.8	6.5	6.4	8.8	8.1	6.9	7.1	2.2	7.7	10.3	5.4	6.6	4.2	5.3	7.1	7.2	6.8	5.3	4.9	6.2	5.8	6.5	7.8	7.0	9.7	10.0	5.8	6.0	6.2	5.5	8.5	5.6	6.3	9.1	7.1	5.2	7.3	6.0	5.9	5.7	23.4	6.6	6.7	7.2	5.5	6.3	7.4	6.2	6.5	23.4	19.3	21.0	15.8	13.5	16.6	16.2	15.5	15.9	15.2	14.7	15.7	7.2	7.1	15.6	16.9	17.1	11.8	23.6	18.2	24.9	28.0	18.4	13.3	11.5	21.3	12.2	14.5	7.3	16.0	10.8	20.0	12.5	10.8	20.7	5.2	17.8	9.5	16.7	17.7	14.7	12.9	25.1	10.1	11.4	7.0	27.7	13.9	14.2	8.6	16.8	24.8	15.8	16.4	17.4	14.7	11.7	8.0	15.4	15.1	16.5	10.9	17.7	9.3	12.2	2.8	11.4	10.1	10.2	1.6	6.3	1.2	2.8	4.5	3.6	3.8	2.3	2.1	3.2	4.6	2.9	1.7	0.4	2.3	5.6	1.2	2.5	2.9	6.6	6.9	6.4	8.8	7.1	7.2	5.8	6.5	6.0	6.0	6.6	6.5	6.2	3.2	10.9	24.2	8.8	2.7	2.7	5.9	6.2	24.7	5.2	7.6	6.2	10.0	10.9	23.9	56.3	7.2	4.7	2.5	0.0	7.7	136.3	18.0	13.4	6.3	11.9	8.2	36.7	7.6	6.7	9.3	7.1	6.2	10.8	19.4	9.7	6.2	7.0	18.5	38.0	5.7	4.1	11.7	3.8	352.8	15.8	8.5	1.8	25.3	23.9	9.5	8.2	33.2	20.9	8.5	3.1	13.9	8.1	2.0	2.1	6.0	27.3	27.7	0.0	8.8	6.0	19.3	9.8	5.3	2.6	2.9	7.9	14.7	5.0	2.2
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112714	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	8.9	11.9	5.5	10.2	6.1	12.3	7.6	4.7	7.4	7.7	4.9	7.0	8.5	7.0	5.9	6.4	11.5	12.1	4.9	4.6	4.8	7.3	14.5	11.8	12.5	6.9	5.4	11.9	6.0	7.2	6.9	7.0	6.2	8.7	5.1	0.6	18.6	8.2	3.7	7.5	8.5	7.3	7.5	18.4	9.3	10.8	5.4	12.5	5.5	4.3	7.4	8.0	5.9	6.7	2.5	0.0	0.1	1.3	11.3	9.9	0.3	3.3	22.4	45.5	52.9	0.3	14.6	0.2	3.4	5.4	10.2	2.0	0.2	3.5	1.7	9.3	0.3	3.9	2.6	0.9	12.6	3.6	8.6	15.9	5.9	4.0	3.9	8.0	5.5	23.5	0.0	12.8	2.5	0.0	21.7	4.5	0.4	0.6	0.0	7.8	0.0	1.2	5.2	8.6	0.4	0.0	1.5	5.9	27.0	0.0	7.9	3.8	2.4	2.3	0.1	0.8	1.1	4.3	3.8	0.2	4.6	3.3	2.6	2.3	7.7	6.9	3.1	9.7	4.8	4.6	4.7	2.9	5.9	3.5	5.1	3.8	3.2	6.8	8.6	2.0	4.4	5.0	5.5	6.1	4.7	7.4	4.6	4.8	6.9	5.4	6.2	7.5	5.4	6.7	9.1	9.6	3.4	6.8	4.8	1.5	3.9	6.2	3.4	1.0	3.5	3.7	1.7	8.6	7.6	7.3	0.0	4.0	4.7	2.3	1.9	7.0	9.0	4.5	2.9	7.0	0.0	0.4	1.9	6.9	4.6	4.1	3.6	4.0	1.3	7.5	3.3	14.0	9.8	0.0	2.4	3.2	4.1	7.0	0.7	12.1	8.7	7.4	3.6	8.4	39.9	2.4	2.1	4.0	1.8	5.7	4.3	9.1	1.3	5.4	3.9	5.7	11.6	0.6	0.0	3.7	3.8	18.1	1.0	2.3	1.6	0.8	6.6	8.2	1.9	2.9
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 564.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004916, HPA076913"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		2000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	27.9	20.3	21.0	42.1	22.5	90.2	24.2	18.3	20.9	24.4	40.0	31.0	40.6	18.5	44.3	58.0	25.2	30.0	34.9	21.5	25.7	38.1	91.7	51.3	67.0	18.8	19.9	12.9	37.3	44.6	24.5	25.1	20.1	14.7	31.1	28.4	36.1	19.3	172.0	47.3	36.5	18.7	18.0	36.3	45.1	19.9	27.4	68.5	33.1	55.7	66.4	47.1	30.4	18.6	147.8	92.6	53.2	68.4	40.4	54.5	71.3	59.5	62.2	67.7	70.2	318.1	131.6	156.5	88.1	85.5	103.0	157.9	116.9	191.5	84.8	88.9	66.6	282.6	121.4	103.6	37.7	198.9	564.7	34.4	102.1	94.5	95.5	30.5	87.0	234.8	101.2	106.9	67.7	141.5	217.2	256.8	51.6	75.2	61.6	240.1	87.1	87.6	129.8	158.5	69.4	37.3	146.2	184.6	59.5	47.5	77.5	92.1	52.8	93.9	49.9	52.1	119.9	54.2	94.4	111.7	50.2	153.7	57.8	23.6	12.8	29.8	32.6	14.0	21.2	9.3	20.3	25.3	12.6	9.1	14.8	23.9	13.7	13.7	15.1	10.0	18.7	15.4	21.0	22.5	18.3	20.9	21.5	25.7	18.8	19.9	20.1	18.0	27.4	18.6	33.9	48.1	46.8	11.8	40.0	52.6	60.8	22.4	21.6	17.3	35.1	23.1	18.6	22.8	48.0	44.1	54.2	20.9	96.9	60.5	5.9	62.7	27.9	42.3	18.9	39.0	5.4	52.6	44.1	98.0	31.9	25.9	76.0	83.0	46.9	14.5	16.8	91.6	17.1	6.7	33.6	23.1	12.2	38.4	60.6	9.0	11.8	78.5	19.6	24.4	54.6	12.1	115.4	25.6	9.1	122.9	35.7	10.9	54.1	77.3	35.2	13.9	30.4	69.0	13.1	15.4	26.4	18.3	26.1	38.7	59.7	52.1	92.8	18.3	30.1	91.2
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	10.7	3.3	3.7	6.4	6.4	17.7	7.0	0.0	4.3	10.6	17.3	8.6	4.3	5.5	3.5	7.7	6.7	5.7	5.4	6.4	3.1	3.1	12.3	8.2	3.8	0.6	0.9	7.7	4.9	7.0	2.0	12.5	1.0	6.1	8.7	3.0	6.6	7.6	12.0	5.3	5.3	7.4	0.2	3.8	7.4	9.4	1.5	6.0	3.9	9.1	3.9	7.4	9.8	1.8	0.0	6.5	3.1	6.3	17.1	28.3	0.0	11.2	11.8	5.9	12.4	5.5	12.3	18.5	8.7	9.7	11.3	0.0	16.6	1.7	7.6	0.5	9.5	0.0	7.4	5.9	14.2	24.3	8.2	14.3	6.0	8.0	24.6	8.0	11.6	13.6	0.0	14.9	11.2	5.3	9.2	10.0	24.4	0.1	9.4	0.0	16.5	0.0	3.4	9.8	0.0	6.3	0.0	3.2	9.0	18.8	2.7	13.2	14.8	12.6	5.8	10.6	7.3	0.2	0.0	15.3	10.7	24.1	7.6	0.0	3.1	3.3	1.1	2.8	0.9	1.7	1.2	1.4	2.3	1.3	0.8	0.7	0.3	0.7	2.5	2.2	0.7	0.6	3.7	6.4	0.0	4.3	6.4	3.1	0.6	0.9	1.0	0.2	1.5	1.8	61.7	32.1	51.1	21.2	18.8	10.8	6.8	11.9	11.4	5.5	9.9	8.1	20.2	15.7	15.0	20.2	0.0	65.2	21.5	36.6	7.9	18.6	80.5	51.2	46.2	31.2	24.6	6.1	171.0	23.4	16.8	35.2	41.8	41.7	7.6	36.1	8.2	26.1	21.0	0.0	90.0	32.3	4.1	29.6	19.3	177.8	45.1	34.7	8.8	301.7	32.7	13.0	10.3	281.0	41.2	38.4	39.3	20.3	11.6	8.0	11.9	9.4	57.1	13.7	26.3	46.7	32.7	7.5	12.9	17.6	18.3	118.3	19.0	19.0	32.5	6.0
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	30.4	20.1	15.7	21.5	17.6	29.1	31.0	22.4	17.8	33.8	23.3	36.3	19.6	38.2	26.8	27.1	36.8	17.5	27.6	15.4	17.2	25.5	24.7	30.9	31.6	16.4	16.4	39.5	24.6	28.5	28.1	24.8	16.6	34.0	19.7	19.9	33.2	24.9	32.5	39.5	36.5	20.9	14.0	35.9	28.8	27.9	17.3	30.8	33.0	22.8	26.9	32.6	31.5	22.2	29.6	22.5	36.7	21.0	18.4	22.6	19.6	21.9	18.5	79.4	22.8	96.4	29.9	29.0	29.4	26.9	46.1	45.2	33.8	42.4	51.1	16.1	22.9	41.9	40.2	69.6	23.5	37.8	41.6	23.3	57.0	27.5	15.4	18.1	22.1	54.6	41.7	25.8	20.5	28.7	76.9	33.1	29.4	35.7	32.2	53.7	47.0	18.5	13.1	26.0	45.2	26.7	43.8	41.9	28.9	21.9	41.8	42.7	27.8	64.3	44.8	21.7	31.5	17.1	11.9	38.2	29.3	18.8	23.7	32.6	7.2	20.2	15.0	9.5	15.9	11.7	13.4	14.8	5.1	9.8	17.6	16.5	10.6	13.8	7.6	10.7	11.8	9.6	15.7	17.6	22.4	17.8	15.4	17.2	16.4	16.4	16.6	14.0	17.3	22.2	24.8	25.6	30.1	37.9	28.4	24.2	35.3	17.8	25.6	25.6	23.1	19.6	27.5	22.8	23.8	25.8	33.3	28.6	49.0	32.3	23.5	18.0	42.8	32.1	26.1	26.2	19.2	21.0	44.9	13.8	15.7	24.2	30.1	34.3	22.8	33.8	20.7	19.6	14.5	38.7	46.0	23.2	14.2	16.8	13.7	13.0	35.1	20.2	21.4	32.8	26.8	16.7	42.2	40.7	47.4	22.2	20.2	33.8	30.0	26.3	25.3	9.6	45.8	23.4	6.6	35.4	23.4	26.1	32.1	26.0	25.6	19.7	32.1	25.6	21.1	34.4
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIMT1 rRNA methyltransferase and ribosome maturation factor"	Q9UNQ2	5	62347284-62403943	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.3	13.6	6.5	13.3	6.5	9.1	19.7	6.7	9.6	17.2	6.4	10.9	8.5	14.6	13.9	17.5	14.5	14.2	17.7	6.6	6.8	10.6	15.4	9.8	15.9	6.7	6.7	15.5	19.3	13.3	10.3	17.3	6.7	15.9	12.0	2.9	15.2	16.2	9.7	8.5	8.8	21.0	6.7	13.3	8.5	8.2	6.6	15.0	13.4	12.8	16.8	26.0	11.4	6.7	33.1	19.9	24.2	44.1	37.7	57.4	35.0	57.3	33.7	57.3	55.8	45.1	36.3	61.4	48.4	61.9	45.4	20.2	38.7	35.8	61.3	46.4	34.0	27.2	15.0	33.8	48.1	32.4	34.7	46.7	31.1	54.1	57.3	28.1	46.1	37.0	49.3	27.9	47.3	43.5	50.1	58.6	36.1	18.9	49.7	28.2	33.3	119.2	45.8	29.9	31.5	19.8	38.5	32.2	35.5	19.6	27.0	29.2	40.3	21.0	29.5	33.7	71.2	27.4	46.7	62.6	27.0	61.6	45.1	7.9	5.3	2.7	6.7	9.1	12.7	10.4	11.2	9.1	9.3	6.1	11.6	9.7	0.1	7.7	6.8	12.1	7.8	6.3	6.5	6.5	6.7	9.6	6.6	6.8	6.7	6.7	6.7	6.7	6.6	6.7	25.3	3.2	9.5	6.5	37.8	50.9	90.3	54.8	69.4	6.2	29.9	20.2	35.3	17.2	36.3	14.7	10.4	45.3	21.9	5.0	21.5	28.6	10.1	23.8	28.3	32.0	4.8	20.4	11.1	22.5	48.1	35.6	13.7	23.2	13.3	13.3	17.5	13.4	33.1	0.0	10.5	12.1	32.6	16.4	22.8	4.4	28.9	18.5	28.4	2.8	19.7	7.4	13.4	8.0	12.9	19.8	7.5	20.3	29.3	104.3	4.0	32.5	24.0	4.7	6.6	51.8	49.8	16.5	20.4	58.7	37.8	35.7	31.1	28.6	18.3	76.6
DIP2A	"C21orf106, Dip2, KIAA0184"	ENSG00000160305	"Disco interacting protein 2 homolog A"	Q14689	21	46458891-46570015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 159.6;Oligodendrocytes: 143.0;Rod photoreceptor cells: 206.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052516	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052516: AB_2681859"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-3)"	5.6	5.4	4.1	6.1	7.7	9.8	5.2	5.0	6.8	6.5	2.9	6.1	6.6	5.8	2.1	6.6	6.3	4.5	8.4	6.0	6.4	3.5	2.9	5.5	7.2	7.6	6.4	7.2	6.7	5.1	4.9	5.9	7.7	6.9	4.1	10.6	6.9	4.0	6.8	6.7	7.4	5.0	3.4	8.9	7.2	7.3	7.8	6.4	5.2	6.6	4.8	5.1	6.1	15.8	14.3	9.5	17.4	8.2	7.9	7.4	10.8	9.7	7.4	9.5	7.7	17.0	10.5	5.9	9.1	10.1	9.8	7.3	7.9	13.4	5.6	23.4	11.1	20.1	15.8	10.1	5.4	7.3	10.3	6.8	8.8	10.2	11.2	7.3	14.1	11.4	13.4	13.9	7.9	13.3	11.7	10.9	9.5	12.6	9.4	11.6	7.0	12.4	5.6	13.2	9.3	5.8	15.0	9.8	8.4	4.6	10.3	7.0	19.0	7.8	5.5	11.2	7.2	13.9	7.6	5.4	8.3	12.3	12.8	11.9	5.2	12.4	14.4	6.5	9.4	3.3	6.5	9.9	2.9	3.6	4.5	9.3	10.3	10.1	7.4	10.6	5.8	4.6	4.1	7.7	5.0	6.8	6.0	6.4	7.6	6.4	7.7	3.4	7.8	15.8	35.3	41.7	19.2	40.8	18.6	14.7	9.3	13.8	23.9	55.9	18.0	16.6	30.7	18.6	20.5	14.7	116.7	11.3	97.0	23.9	9.8	10.7	18.8	21.3	32.8	33.2	24.0	12.8	86.9	11.0	9.5	23.2	50.0	25.7	13.3	34.9	34.2	11.2	18.0	18.5	101.8	21.7	4.1	39.9	17.3	25.6	23.9	26.5	7.2	119.9	21.4	16.3	159.6	68.9	143.0	20.9	15.7	22.2	58.4	19.3	23.4	8.0	26.4	206.8	26.3	31.4	18.3	54.2	38.3	20.7	17.6	11.2	63.1	19.1	23.1	13.3
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748657	"Human disease related genes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.4"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 188.3;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 634.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	6.6	8.7	22.8	8.9	46.0	12.1	10.5	35.0	28.2	7.1	6.9	9.5	6.2	6.2	3.4	14.6	4.3	7.0	5.7	22.5	31.0	6.0	11.3	6.7	9.9	36.1	40.0	9.3	7.6	11.0	6.1	10.3	38.0	6.5	10.7	16.4	8.5	4.1	5.1	17.3	6.5	7.1	26.4	14.9	6.9	7.6	37.0	12.9	8.2	6.3	11.7	7.3	8.8	61.4	20.0	12.0	17.9	12.6	10.0	9.7	25.0	11.3	13.1	10.6	8.0	21.8	11.0	13.4	13.4	12.4	10.9	20.5	28.8	21.1	12.6	15.9	10.7	21.3	10.1	27.6	15.7	25.7	12.4	11.0	18.1	11.8	17.1	18.6	20.4	12.0	30.3	12.5	9.4	15.7	19.9	12.9	10.2	11.4	22.0	23.4	17.6	6.4	12.0	15.5	16.9	11.8	28.3	16.4	17.3	20.6	23.0	17.7	21.6	8.6	10.1	7.9	9.3	9.0	16.0	15.4	11.9	11.7	12.0	1.0	1.2	2.7	0.4	1.4	0.6	1.4	0.9	0.3	1.4	2.2	1.6	1.3	4.9	0.5	3.9	0.4	1.0	0.7	22.8	46.0	35.0	28.2	22.5	31.0	36.1	40.0	38.0	26.4	37.0	61.4	15.4	6.4	10.5	74.1	26.3	54.9	30.2	14.7	12.5	31.5	15.0	11.4	9.0	17.2	10.5	9.2	64.6	13.3	9.2	25.2	0.0	10.9	1.4	14.3	12.9	15.5	31.3	13.7	121.1	17.4	17.6	11.2	20.4	15.1	10.8	25.0	15.0	18.2	20.4	11.8	125.3	18.3	10.2	37.4	15.7	3.3	10.2	24.5	16.0	188.3	18.7	14.4	11.3	144.8	634.8	22.0	14.0	10.1	15.4	28.1	8.4	6.7	8.8	31.9	0.0	8.0	10.0	12.4	17.7	34.6	66.9	38.0	13.3	34.3	12.4	24.4
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	12.7	7.7	13.8	3.7	18.3	0.2	8.3	18.8	19.9	11.0	0.0	22.1	4.5	12.1	5.4	9.1	8.8	8.6	14.1	13.6	10.7	14.7	8.9	4.9	2.4	16.8	14.6	13.3	8.0	8.1	6.2	4.6	17.4	8.4	4.4	9.4	4.2	9.1	34.5	4.8	7.0	12.4	7.2	3.3	7.3	7.2	18.1	2.1	5.3	20.8	1.5	10.5	7.5	32.6	0.7	6.3	11.5	6.1	19.0	20.5	9.5	13.9	8.6	10.5	8.5	1.8	1.9	0.5	3.6	22.5	2.7	0.1	7.1	1.2	6.4	0.3	6.4	0.1	4.5	2.0	9.2	0.0	8.6	16.9	5.5	6.6	0.0	16.4	2.3	0.1	0.0	1.2	8.0	17.4	0.7	0.0	3.0	5.4	2.6	9.9	4.8	2.0	7.5	7.2	5.8	8.2	2.4	5.0	20.1	6.0	6.6	0.0	0.1	11.1	2.9	33.3	4.6	0.8	14.3	7.2	13.9	0.3	6.4	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	13.8	18.3	18.8	19.9	13.6	10.7	16.8	14.6	17.4	7.2	18.1	32.6	12.6	9.6	5.8	125.4	4.0	7.9	5.4	2.2	7.4	18.6	11.8	10.0	30.3	17.2	4.7	3.7	22.9	5.2	0.6	2.2	0.0	8.5	19.0	7.9	18.5	7.8	10.8	0.0	219.3	4.0	5.8	15.4	10.2	8.8	20.3	16.3	10.4	24.2	6.2	1.7	269.9	6.2	2.0	3.5	5.2	6.1	11.5	3.6	23.2	44.0	0.6	19.4	1.0	216.2	421.7	7.7	1.3	19.5	0.9	7.7	10.2	17.0	5.3	20.5	6.6	22.7	17.6	21.7	22.5	4.3	3.8	3.8	2.0	5.6	5.7	8.9
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DIPK1C	"C18orf51, FAM69C"	ENSG00000187773	"Divergent protein kinase domain 1C"	Q0P6D2	18	74434775-74457944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.6;choroid plexus: 11.3;retina: 16.5"	"Cell type enriched"	"Detected in single"	27	"Cardiomyocytes: 22.1"	"Group enriched"	"Detected in some"	18	"glioma: 11.1;melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SK-MEL-30: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048928	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA048928: AB_2680560"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.91e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.40e-3)"	0.3	0.1	19.6	0.0	26.4	0.0	0.3	21.4	25.8	1.6	11.3	1.4	0.0	0.2	0.1	0.1	0.2	0.4	8.4	18.6	20.6	0.1	0.3	0.0	0.0	19.7	24.4	0.0	0.1	0.0	0.3	0.1	19.2	0.4	0.1	16.5	0.3	0.6	1.1	4.2	0.3	0.1	16.5	0.1	1.5	6.8	26.0	0.7	0.0	2.0	0.0	0.1	0.4	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	26.4	21.4	25.8	18.6	20.6	19.7	24.4	19.2	16.5	26.0	28.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DIPK2A	"C3orf58, DIA1, HASF, MGC33365"	ENSG00000181744	"Divergent protein kinase domain 2A"	Q8NDZ4	3	143971823-144048719	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.5;Cardiomyocytes: 19.6;dendritic cells: 11.3;Fibroblasts: 22.6;Hofbauer cells: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 147.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048992	Approved				"Secreted in other tissues"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA048992: AB_2680591"	"unprognostic (5.96e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (2.92e-7)"	"unprognostic (4.82e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.50e-2)"	9.8	7.4	10.3	10.5	14.5	32.4	15.7	24.5	17.9	13.6	3.8	8.2	6.8	14.2	6.0	14.1	12.7	14.2	7.0	9.1	10.9	6.8	18.9	12.9	11.3	12.6	11.0	20.2	4.5	15.0	3.4	38.1	11.9	11.5	8.8	5.8	9.0	12.6	4.6	24.4	5.9	15.1	9.7	10.7	8.4	8.0	10.6	16.6	12.7	7.2	11.0	11.5	9.7	23.9	24.9	9.9	24.8	147.9	22.6	20.4	13.5	17.7	17.2	16.6	17.6	6.7	9.8	15.5	13.6	6.8	11.9	13.9	37.2	14.3	25.9	7.3	13.5	23.0	9.4	10.1	9.8	21.3	10.3	17.0	7.5	10.2	15.4	16.7	26.1	7.0	4.1	43.9	21.2	6.7	7.7	10.4	15.7	10.3	6.2	11.3	12.8	17.2	10.3	29.1	16.5	0.0	12.7	5.8	5.8	6.7	15.5	11.5	12.5	14.6	7.0	22.9	20.6	17.4	6.5	22.1	23.6	10.0	19.3	24.9	11.9	20.1	3.5	7.8	5.8	8.2	4.2	3.7	14.9	7.1	3.6	3.6	3.3	9.5	10.6	9.3	3.9	6.0	10.3	14.5	24.5	17.9	9.1	10.9	12.6	11.0	11.9	9.7	10.6	23.9	23.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	1.6	11.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.4	2.6	0.0	0.0	0.0
DIPK2B	"CXorf36, DIA1R, FLJ14103"	ENSG00000147113	"Divergent protein kinase domain 2B"	Q9H7Y0	X	45148373-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Adipocytes: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		940000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	40.8	5.3	14.4	6.1	15.0	0.8	36.9	11.7	13.9	19.6	7.8	9.1	2.6	20.5	6.9	6.5	18.0	8.8	27.3	11.4	13.1	7.0	1.4	14.1	5.7	14.4	14.2	6.9	3.5	4.6	3.3	40.5	14.1	11.3	3.8	1.4	6.8	7.2	16.6	7.4	7.7	20.7	12.4	3.1	6.3	1.5	14.8	2.7	18.5	16.6	3.4	14.3	13.9	15.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	81.7	0.1	0.0	0.5	0.0	0.1	0.0	0.3	0.1	1.4	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	15.0	11.7	13.9	11.4	13.1	14.4	14.2	14.1	12.4	14.8	15.4	96.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045886-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 143.9;ovary: 60.1;pituitary gland: 52.5"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 64.6;Theca cells: 206.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.4	20.1	25.3	0.5	18.7	0.1	5.0	2.2	11.5	5.2	3.0	3.3	7.5	2.5	10.6	1.7	3.3	10.2	11.3	7.0	143.9	6.9	9.5	5.1	0.2	39.6	49.2	60.1	20.0	7.5	52.5	0.6	18.5	2.9	0.8	4.0	2.3	2.6	1.1	2.1	1.4	1.2	7.8	2.5	4.2	5.5	104.7	1.6	3.8	1.9	0.3	3.1	6.4	8.0	0.0	1.5	1.6	0.0	5.2	3.9	0.6	4.6	1.6	0.3	1.2	0.0	0.8	0.0	0.2	4.8	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.6	0.0	8.2	0.0	0.0	17.2	0.1	0.7	0.0	0.0	1.0	0.2	0.3	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	11.2	0.0	0.5	0.2	9.1	2.7	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	25.3	18.7	2.2	11.5	7.0	143.9	39.6	49.2	18.5	7.8	104.7	8.0	0.3	0.0	1.8	5.2	0.0	3.2	25.0	0.6	0.6	1.1	5.4	6.5	5.9	7.2	2.5	3.7	10.4	1.1	0.0	0.4	64.6	3.7	0.1	0.7	0.7	1.7	16.2	0.0	2.2	18.7	0.1	10.3	4.1	1.8	0.0	0.8	3.3	3.9	0.1	0.0	8.8	2.3	0.0	0.0	4.8	0.8	6.8	0.3	5.4	0.0	0.0	0.7	1.0	5.0	0.2	2.9	0.1	1.5	0.0	5.3	0.1	11.1	0.9	6.1	0.0	16.9	1.7	0.0	1.4	1.7	2.8	0.4	0.7	206.2	0.7	2.4
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.2;Late spermatids: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	13.8	9.9	5.3	12.4	5.7	20.4	15.8	9.1	6.7	11.3	7.1	10.0	8.5	11.2	11.5	12.4	9.9	10.4	11.6	5.2	5.9	12.8	16.6	11.4	17.6	5.2	5.6	13.4	8.9	11.9	8.9	12.0	5.3	12.3	10.9	12.1	9.4	10.5	10.2	11.1	9.9	11.0	5.5	12.2	9.9	21.3	6.3	14.1	15.0	10.4	17.3	14.1	10.8	6.9	29.5	13.4	25.9	21.9	26.9	31.9	17.0	25.5	31.0	25.6	31.1	20.7	23.8	35.6	21.6	26.3	16.2	23.8	35.7	29.4	40.9	29.3	26.3	41.8	27.8	18.7	33.4	71.4	23.2	33.4	20.1	29.0	37.9	25.5	27.8	26.6	28.3	14.4	31.4	10.3	30.5	34.8	24.3	44.7	15.7	24.2	19.7	16.2	25.4	23.2	23.3	30.8	20.9	17.3	25.4	26.8	16.7	32.1	26.1	15.4	12.5	17.5	27.4	27.6	33.2	28.0	42.9	33.2	22.7	8.4	3.6	5.2	4.0	6.3	5.6	4.2	5.0	4.5	4.3	3.7	4.9	4.5	2.1	6.9	5.2	2.7	6.7	3.2	5.3	5.7	9.1	6.7	5.2	5.9	5.2	5.6	5.3	5.5	6.3	6.9	51.6	35.3	37.2	12.4	35.3	25.5	36.5	24.5	18.2	38.8	27.6	26.4	27.6	21.5	40.2	9.2	29.2	23.8	45.0	19.0	23.5	21.7	169.2	26.2	37.6	41.2	30.5	18.7	21.5	20.1	23.5	33.3	19.9	45.6	33.6	26.3	26.7	23.7	14.4	32.0	24.0	17.2	18.3	19.2	13.8	135.5	28.9	21.4	12.4	24.4	38.2	23.6	25.7	17.6	24.2	25.4	8.1	28.2	30.2	27.4	16.3	17.2	35.4	41.6	6.6	58.3	27.0	28.9	37.7	31.4	31.3	22.6	33.7	29.1	21.2	53.9
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	11.0	11.8	7.9	6.2	9.8	7.6	9.3	8.9	8.6	10.3	7.7	11.1	5.1	11.1	9.5	7.5	9.6	5.5	12.7	8.0	9.1	8.3	11.0	5.9	7.6	8.7	9.4	11.1	12.8	15.8	10.0	5.4	9.6	8.7	6.0	11.4	8.9	9.0	23.2	7.4	7.7	8.8	8.8	8.7	9.0	9.8	8.9	7.8	11.0	28.3	7.2	9.6	8.1	12.2	14.0	32.6	10.6	14.1	12.2	16.4	12.4	9.5	11.1	14.3	13.2	17.6	10.1	51.6	10.3	13.4	14.9	23.3	25.7	9.2	9.2	12.0	24.1	26.7	25.1	20.1	9.5	27.7	10.1	6.9	9.7	4.5	14.8	9.7	13.1	17.7	18.6	12.6	14.4	12.3	13.8	17.3	15.4	12.7	20.0	18.3	42.1	30.0	5.7	18.9	17.1	15.7	22.3	7.6	11.4	10.0	10.6	21.8	14.4	18.7	16.8	7.4	18.7	10.1	36.9	24.0	6.4	35.9	7.8	8.5	5.1	4.3	7.6	6.1	10.2	6.5	7.7	10.0	8.5	7.8	8.8	7.3	0.6	11.7	13.2	6.7	8.0	6.7	7.9	9.8	8.9	8.6	8.0	9.1	8.7	9.4	9.6	8.8	8.9	12.2	7.1	6.4	16.2	22.5	14.6	4.2	5.5	4.0	17.1	15.6	9.4	7.6	30.3	15.7	7.1	3.7	4.2	17.0	9.6	5.0	5.9	6.5	7.1	8.3	14.6	10.2	3.0	24.2	11.4	3.5	4.5	12.4	10.7	7.3	16.5	25.1	7.1	19.2	9.6	10.1	17.2	10.6	8.2	12.3	7.8	9.9	19.9	10.1	1.8	13.1	14.4	17.7	12.3	22.6	23.1	3.3	5.1	20.3	18.4	4.8	5.4	9.8	8.1	23.2	19.7	9.5	10.1	28.5	17.2	12.1	5.4	3.7	16.0	16.5	14.0	3.8
DIS3L2	"FAM6A, FLJ36974, MGC42174"	ENSG00000144535	"DIS3 like 3'-5' exoribonuclease 2"	Q8IYB7	2	231961245-232344350	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 93.4;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035796, HPA035797"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA035796: AB_2674786, HPA035797: AB_10669978"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (2.21e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.97e-1)"	8.9	10.2	10.7	7.8	11.1	10.5	10.7	14.2	12.8	13.9	13.2	10.4	7.0	11.3	9.2	16.3	12.7	7.7	10.1	10.6	11.1	12.3	10.7	9.6	10.5	11.8	10.7	14.6	11.3	12.3	12.1	9.2	11.1	13.1	8.5	15.3	10.4	9.0	9.1	15.7	9.4	8.9	9.1	11.3	10.6	14.1	11.9	14.6	15.1	7.3	9.6	11.3	12.3	15.2	12.6	13.1	19.8	11.8	11.1	11.4	18.8	11.5	11.6	12.8	11.8	10.9	17.1	10.5	9.5	12.3	17.0	15.3	11.7	15.2	13.3	16.9	12.9	16.2	15.7	22.4	10.3	14.7	15.7	9.0	16.7	11.1	11.7	13.3	16.6	17.0	17.6	7.2	11.1	16.9	20.4	27.8	13.6	12.0	6.9	17.1	24.4	9.6	16.0	21.4	15.9	23.2	10.1	20.6	14.3	13.3	11.3	18.3	16.3	16.5	17.0	14.5	12.9	19.3	10.0	11.8	12.5	10.6	15.8	0.1	3.7	3.0	4.8	4.3	5.1	4.8	4.3	4.4	3.8	9.2	4.5	5.1	0.4	4.0	3.4	5.7	5.1	2.3	10.7	11.1	14.2	12.8	10.6	11.1	11.8	10.7	11.1	9.1	11.9	15.2	12.9	3.2	9.1	64.6	19.5	9.9	17.8	11.4	19.9	33.7	7.9	7.4	9.3	11.5	17.4	12.9	66.7	14.2	9.0	13.0	3.9	15.1	82.3	23.7	15.7	12.1	8.4	12.0	82.6	10.6	14.2	10.1	12.2	13.7	1.3	22.8	10.0	7.4	8.6	40.4	93.4	10.9	12.2	12.8	8.7	30.7	10.5	9.7	5.4	42.2	10.6	15.4	20.6	57.8	150.8	15.0	10.2	10.5	11.1	10.0	11.0	10.9	19.0	56.0	19.7	22.2	11.6	20.6	13.0	15.0	9.7	9.9	17.0	15.5	13.8	15.6
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222815022-223005995	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	6.8	5.7	1.7	1.5	2.0	0.2	3.0	4.0	2.5	3.2	3.7	9.0	2.6	4.3	2.0	1.9	2.4	4.6	3.9	1.6	1.9	5.2	2.7	9.2	1.1	1.2	0.9	4.5	2.4	5.1	2.5	4.6	1.1	2.4	2.1	1.3	1.9	2.0	4.1	3.3	3.7	4.2	0.7	2.5	5.3	6.5	1.5	1.4	5.2	3.1	1.4	5.4	2.5	2.6	0.9	2.2	5.6	3.8	10.1	6.1	2.4	3.2	2.7	1.1	1.1	2.6	1.6	0.1	4.2	1.5	2.2	0.6	1.6	1.3	1.6	8.1	2.4	1.1	6.3	1.2	4.4	0.2	1.1	4.8	1.9	2.3	0.9	5.8	2.3	1.2	0.0	0.1	3.9	1.5	1.4	0.3	4.0	6.1	1.3	1.7	15.1	0.2	6.8	0.8	1.6	2.5	1.8	0.7	2.3	2.7	2.7	1.4	4.2	2.3	1.5	3.9	3.6	1.2	0.5	0.3	3.2	0.8	5.1	0.3	0.2	0.0	0.7	0.4	1.6	0.5	0.6	0.7	0.6	0.9	0.6	0.5	0.1	1.0	0.2	0.3	0.5	0.4	1.7	2.0	4.0	2.5	1.6	1.9	1.2	0.9	1.1	0.7	1.5	2.6	4.6	6.4	1.7	42.7	3.6	0.5	0.6	1.2	5.7	2.7	3.4	1.5	7.8	7.2	3.3	11.0	0.0	1.4	2.1	1.0	0.0	1.9	2.1	1.9	3.4	4.9	0.0	0.0	47.7	2.8	1.8	5.6	48.4	4.1	0.0	15.8	6.8	3.3	5.9	0.0	54.4	2.6	4.1	1.6	0.9	3.7	1.5	4.1	0.0	204.2	1.4	0.9	5.2	199.6	15.4	1.3	3.1	3.4	0.7	0.7	6.4	5.8	2.7	2.3	0.0	4.0	3.7	2.1	2.3	5.4	1.1	0.8	1.7	2.8	1.6	0.3
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358219-40378621	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 17.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.0;Distal enterocytes: 16.8;Horizontal cells: 18.5;Intestinal goblet cells: 18.2;Proximal enterocytes: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.2;HaCaT: 6.6;SCLC-21H: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA059903: AB_2684156"	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.2	0.7	5.1	0.4	4.7	0.3	0.1	17.6	5.7	0.3	0.0	1.5	1.1	0.2	0.1	0.1	0.2	0.2	0.1	3.6	3.9	0.0	0.1	0.1	0.4	5.5	1.6	0.3	0.3	0.1	1.3	0.2	5.8	0.1	1.2	1.6	0.3	0.4	0.1	0.3	1.2	0.3	0.4	0.2	1.2	0.7	4.5	0.2	1.4	0.0	0.0	0.1	0.1	1.9	1.3	0.5	0.3	2.0	0.1	0.0	0.7	0.2	0.1	0.8	1.2	1.9	0.6	0.2	1.3	0.8	4.2	6.6	0.2	1.1	0.5	0.1	0.4	0.3	0.4	0.1	0.0	0.4	1.1	1.4	0.0	0.2	0.1	0.2	0.4	0.7	0.5	0.8	1.1	0.3	0.2	0.3	0.3	1.7	0.9	0.2	0.3	0.4	0.2	1.7	13.4	1.9	0.2	0.1	0.2	0.3	0.3	0.2	0.4	0.9	0.7	0.2	0.2	0.2	0.1	0.2	0.3	0.5	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.0	0.0	5.1	4.7	17.6	5.7	3.6	3.9	5.5	1.6	5.8	0.4	4.5	1.9	0.9	3.2	3.6	1.0	0.5	0.0	1.9	0.0	0.0	19.0	0.8	1.3	1.7	1.5	4.4	3.7	10.4	0.2	0.2	16.8	0.0	0.4	1.3	0.3	0.6	1.4	9.6	2.7	5.1	0.4	0.3	1.6	5.1	0.5	8.8	0.4	0.4	0.4	1.0	18.5	7.0	18.2	0.0	0.6	0.0	1.8	1.2	1.1	0.0	1.0	0.3	2.3	4.1	4.0	0.3	0.3	3.2	0.0	0.3	1.2	12.1	0.2	2.2	7.6	0.0	3.1	0.8	4.1	6.1	0.0	0.0	0.3	1.1	0.8	8.6	1.1
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479155-11537551	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 9.8;pituitary gland: 3.5;retina: 4.6;testis: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA054579: AB_2682529"	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.0	0.3	7.1	0.1	9.4	0.0	0.0	4.1	9.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.6	6.9	0.1	0.0	0.1	0.1	3.3	5.7	0.1	0.5	0.0	3.5	0.0	4.6	0.5	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.3	0.1	6.3	7.8	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.5	0.0	1.3	0.0	0.1	2.0	6.8	1.6	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	9.4	4.1	9.8	8.6	6.9	3.3	5.7	4.6	3.7	7.8	3.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DIXDC1	"Dixin, KIAA1735"	ENSG00000150764	"DIX domain containing 1"	Q155Q3	11	111927144-112022653	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Horizontal cells: 121.1;Oligodendrocytes: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 42.7;TIME: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039424, HPA039658, HPA061366"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039424: AB_2676500, HPA039658: AB_2676611, HPA061366: "	"unprognostic (1.93e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (6.89e-5)"	"unprognostic (4.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (4.19e-5)"	17.8	17.7	16.4	8.6	23.2	0.7	15.0	36.8	22.6	18.7	22.8	29.5	5.6	24.8	18.6	12.7	20.4	12.6	23.3	17.0	16.9	11.4	7.0	9.4	2.6	20.1	21.8	15.8	3.8	17.1	7.1	10.8	19.1	23.4	10.0	22.0	7.8	35.8	13.7	5.4	9.1	25.6	18.0	2.9	14.9	19.1	19.7	2.6	10.7	12.3	2.5	25.3	12.0	34.4	0.8	3.7	9.9	18.5	29.9	17.5	2.1	7.7	5.3	2.9	5.2	0.6	2.0	1.6	2.0	21.5	3.4	0.9	4.4	2.4	2.9	6.4	3.7	0.8	5.8	10.3	4.6	5.3	0.7	14.2	19.3	6.3	42.7	21.5	30.6	4.0	5.2	0.6	11.9	0.9	3.3	4.6	5.9	0.8	6.6	1.6	2.9	6.1	12.1	0.3	8.0	16.7	5.7	4.6	2.5	4.3	6.8	2.0	50.4	13.1	5.6	2.4	12.9	1.2	5.5	0.8	7.2	13.5	4.7	0.0	0.1	5.2	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.1	16.4	23.2	36.8	22.6	17.0	16.9	20.1	21.8	19.1	18.0	19.7	34.4	12.8	16.0	10.3	40.1	0.4	6.4	16.3	4.1	11.4	22.3	23.7	28.8	35.6	7.2	10.1	18.4	104.3	1.4	0.9	2.6	15.6	6.4	23.1	32.1	48.6	28.1	2.4	2.1	47.7	7.7	5.1	32.8	11.7	11.3	1.3	6.3	62.8	19.3	1.7	121.1	83.8	13.9	6.1	3.4	5.3	17.5	39.7	1.5	12.4	20.6	1.0	30.2	0.0	34.7	140.4	7.0	6.2	36.9	2.0	10.8	2.7	15.4	35.5	69.2	13.1	25.3	31.8	62.3	16.4	3.3	4.1	1.4	2.0	3.5	4.5	3.1
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 707.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		34000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (2.94e-4)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	23.5	20.4	17.1	29.9	18.1	68.8	35.3	18.3	20.5	21.3	18.9	28.5	24.2	23.2	22.3	36.4	24.4	15.3	19.4	17.0	18.4	21.7	22.6	16.5	40.2	17.9	18.2	30.8	32.6	26.5	17.6	23.2	18.8	22.2	34.8	19.8	22.0	18.9	31.2	30.6	21.3	22.8	18.0	25.7	21.5	25.3	18.1	39.4	27.8	23.2	47.8	36.8	23.8	19.7	236.5	129.3	77.4	111.4	47.2	48.2	114.9	87.2	60.5	127.2	118.9	164.3	114.2	447.2	221.3	74.7	119.4	123.5	239.6	144.8	189.3	108.8	132.9	223.4	131.1	143.3	66.9	304.6	131.2	46.3	135.6	141.1	320.8	46.6	89.7	146.2	210.1	108.0	88.0	137.7	201.5	233.7	130.2	234.0	158.8	177.1	174.1	230.3	80.4	132.0	170.0	84.4	77.8	133.3	122.7	75.0	68.1	120.8	70.8	91.4	138.2	119.3	292.6	199.8	290.5	707.7	62.2	316.5	102.0	10.8	25.0	33.1	38.6	30.1	48.8	44.2	31.1	41.6	35.5	31.3	40.7	39.1	7.4	41.2	31.2	25.5	26.5	30.3	17.1	18.1	18.3	20.5	17.0	18.4	17.9	18.2	18.8	18.0	18.1	19.7	21.6	25.6	32.3	5.9	47.6	99.7	76.2	45.4	60.3	31.6	39.2	34.0	32.0	25.8	35.2	25.8	14.6	56.6	34.8	17.7	41.1	62.8	2.7	22.4	39.8	39.7	34.1	84.1	6.4	45.3	74.8	36.4	23.0	24.1	56.8	70.0	13.6	26.0	44.5	23.5	7.1	35.9	54.9	21.6	36.4	7.9	25.7	25.8	49.8	7.5	36.4	34.8	29.9	7.5	7.7	47.3	14.8	28.6	45.1	131.2	9.5	25.6	26.7	28.5	13.1	37.8	42.6	41.0	87.2	69.9	98.3	34.2	35.9	59.6	49.9	57.9
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7"	"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	1.4	0.8	0.4	0.4	1.4	0.0	3.0	0.0	1.5	15.2	1.2	1.7	0.0	1.0	0.4	1.2	0.5	0.7	2.2	0.7	0.6	0.2	0.2	5.3	0.7	0.9	4.5	4.4	0.2	0.6	1.5	2.8	0.3	2.3	0.5	0.4	1.3	1.7	1.9	4.7	0.3	0.6	0.2	1.3	0.1	0.1	2.3	1.0	0.9	1.2	3.0	0.2	0.8	0.8	0.0	0.0	3.6	0.0	0.6	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	1.5	0.7	0.6	0.9	4.5	0.3	0.2	2.3	0.8	2.6	0.0	0.0	0.3	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.1	5.4	0.0	0.0	5.2	0.0	0.2	18.7	0.0	0.1	0.0	0.0	3.3	0.0	16.8	0.0	32.5	0.0	0.0	0.3	11.8	0.0	4.1	0.3	7.2	2.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	7.4	0.0	0.8	2.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374063-42377229	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 4.9"	"Group enriched"	"Detected in some"	5	"Basal prostatic cells: 5.2;Early spermatids: 2.1;Pancreatic endocrine cells: 4.4;Prostatic glandular cells: 3.7;Spermatocytes: 2.2;Urothelial cells: 5.3"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.7;midbrain: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052916	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	0.8	3.7	0.1	1.0	0.0	0.0	2.4	0.0	0.7	4.9	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.9	0.0	0.6	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.8	1.4	0.5	0.3	0.0	0.0	0.4	1.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.7	3.1	0.6	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.3	5.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.1	0.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	5.3
DKKL1	"CT34, SGY-1"	ENSG00000104901	"Dickkopf like acrosomal protein 1"	Q9UK85	19	49361783-49375116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	277	"testis: 344.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2188.8;Late spermatids: 2340.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;AN3-CA: 9.8;HeLa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025410, HPA047194"	Enhanced		Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB025410: , HPA047194: AB_2679979"	"unprognostic (1.64e-1)"	"unprognostic (5.30e-1)"	"unprognostic (5.39e-4)"	"unprognostic (1.85e-4)"	"unprognostic (3.79e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.52e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.57e-2)"	0.7	0.5	0.3	0.5	0.3	0.0	0.5	0.2	0.5	0.7	0.4	0.5	0.3	1.1	0.3	0.2	1.2	0.7	0.4	0.2	0.1	0.6	0.3	0.3	0.5	0.4	0.3	0.8	1.0	0.1	0.1	0.3	0.2	0.6	0.1	0.3	0.9	0.6	0.2	0.2	0.3	0.4	0.3	0.4	0.3	344.8	0.2	0.0	0.2	0.4	0.2	0.4	0.4	0.3	0.0	1.2	5.1	9.8	0.0	0.3	0.4	0.9	0.0	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.7	0.0	2.9	0.2	0.0	0.0	0.9	0.7	0.3	0.2	0.3	0.9	0.8	0.0	1.2	0.3	0.1	0.4	0.0	0.0	2.0	0.5	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.9	0.0	0.5	1.0	1.0	2.0	1.2	1.0	0.6	0.6	0.0	0.4	0.6	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.2	0.1	0.4	0.3	0.2	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.6	0.6	1.2	2.2	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.4	2188.8	0.5	1.0	1.9	0.0	0.0	0.2	0.5	0.2	0.7	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	2340.4	16.8	1.4	1.8	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.4	6.6	0.7	0.9	491.0	15.2	0.2	0.0	0.0	0.1	0.5	0.2	0.2
DLAT	"DLTA, E2, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112025408-112064404	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 89.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.5;Distal tubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA		44000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	24.7	16.5	7.7	13.3	8.3	7.9	14.5	9.5	9.3	11.0	10.4	24.7	18.3	10.0	13.4	19.5	13.0	8.5	69.4	8.1	11.1	33.8	15.5	11.7	16.1	8.3	8.9	9.5	6.8	31.7	8.5	13.1	9.7	14.5	26.0	10.8	16.8	14.8	75.4	10.3	16.5	13.4	8.2	9.9	14.3	9.9	9.4	12.7	20.2	89.4	18.2	14.2	8.1	8.0	18.7	16.4	28.2	34.4	41.6	30.5	26.5	26.6	18.2	34.8	38.7	52.8	56.7	85.4	46.0	28.7	42.6	41.0	65.7	34.2	38.9	27.3	30.2	51.9	17.9	39.2	29.0	64.9	26.6	36.9	37.7	32.0	35.2	24.2	33.9	41.7	88.4	42.6	41.2	16.6	25.4	66.9	30.3	58.6	35.4	45.4	38.0	93.3	64.4	21.4	51.2	27.8	30.7	93.4	20.5	30.9	67.4	42.9	17.8	29.1	29.1	29.1	33.0	11.1	19.4	127.5	7.7	73.0	22.7	9.1	3.8	3.0	4.3	5.8	5.4	5.6	4.9	5.1	5.8	4.0	5.6	5.1	0.3	4.7	6.1	4.5	5.8	5.0	7.7	8.3	9.5	9.3	8.1	11.1	8.3	8.9	9.7	8.2	9.4	8.0	7.6	12.8	14.5	15.3	13.8	11.2	9.2	18.2	14.2	8.1	9.2	5.8	100.5	15.7	13.2	11.0	0.0	21.2	6.4	26.3	74.3	18.7	3.9	15.8	11.6	9.6	17.3	18.1	18.0	11.4	39.6	11.7	11.7	12.1	3.8	13.5	7.5	15.5	18.7	8.4	24.4	17.8	24.4	8.8	7.5	3.2	6.2	9.5	17.8	9.4	16.7	10.4	4.1	11.1	19.7	14.1	9.2	10.9	19.4	7.0	19.0	37.6	30.3	11.1	0.0	14.2	19.9	25.1	18.3	21.1	9.8	17.4	8.5	26.3	26.7	9.3
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLEC1	"CFAP81, DLC1, FAP81"	ENSG00000008226	"DLEC1 cilia and flagella associated protein"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 14.7;fallopian tube: 27.9;testis: 13.2"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019077	Enhanced		Supported	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	1.2	0.3	2.3	0.3	2.1	0.9	0.4	1.6	1.2	3.5	14.7	0.3	0.4	0.5	4.1	0.1	27.9	0.6	0.2	2.5	2.9	0.3	0.1	4.8	0.4	6.6	8.6	0.9	0.1	0.1	9.6	0.1	4.7	0.9	0.4	0.0	0.9	0.5	0.0	0.4	0.4	0.1	5.3	0.5	0.3	13.2	3.2	0.1	1.1	0.0	0.3	0.2	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.6	1.2	2.5	2.9	6.6	8.6	4.7	5.3	3.2	2.5	0.0	3.2	3.0	2.9	0.4	0.5	0.5	3.0	1.2	1.2	0.4	0.4	0.7	0.0	14.1	0.0	0.0	0.1	0.4	1.2	0.0	0.1	4.5	45.0	1.2	0.6	1.2	0.8	1.1	0.2	0.1	1.3	0.0	1.4	2.5	0.2	0.0	0.3	0.5	0.0	0.9	0.7	6.1	0.6	1.2	6.6	0.9	1.1	0.0	2.8	0.8	0.2	2.1	0.5	0.3	0.1	1.4	0.0	2.8	0.5	0.7	0.5	74.4	0.8	0.0	0.7	1.5	6.7	1.3	1.0	0.3	0.1	1.3	0.4	0.2	0.4
DLEU7	FLJ44882	ENSG00000186047	"Deleted in lymphocytic leukemia 7"	Q6UYE1	13	50519364-50843939	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 5.0;choroid plexus: 2.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 25.9;Excitatory neurons: 26.8;Inhibitory neurons: 44.9;Kupffer cells: 35.6;Microglial cells: 35.6;Oligodendrocyte precursor cells: 21.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"NTERA-2: 10.4;U-698: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA053750	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053750: AB_2682249"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.03e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	0.0	0.1	4.3	0.0	4.3	0.0	0.0	3.5	4.8	0.1	2.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.4	3.7	0.1	0.0	0.0	0.0	4.2	4.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.4	5.0	0.6	0.3	0.1	0.0	0.0	0.1	4.8	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	10.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	4.3	4.3	3.5	4.8	4.4	3.7	4.2	4.4	4.0	3.9	5.0	4.8	0.1	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	25.9	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	26.8	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	6.8	0.0	44.9	0.0	0.0	35.6	1.4	0.0	0.0	7.1	0.0	35.6	7.6	0.2	0.0	21.1	1.9	0.0	0.0	1.5	0.3	0.0	0.0	0.9	0.0	1.8	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299330	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 422.9;Oligodendrocytes: 1542.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	20.7	14.5	26.4	14.7	57.0	16.2	18.4	33.2	36.4	23.8	15.4	24.2	24.0	19.7	11.6	37.6	16.1	17.1	19.4	25.4	29.3	27.6	25.9	18.0	14.7	36.9	43.3	23.3	17.2	31.7	14.4	21.3	34.8	15.9	26.3	38.8	20.2	18.6	25.2	18.8	25.4	21.2	19.9	13.0	22.9	15.5	50.3	27.1	43.3	28.2	20.6	20.3	20.5	73.5	128.0	20.0	40.3	75.7	34.2	36.2	40.7	52.2	46.2	49.2	59.0	60.4	59.8	41.5	127.1	47.7	95.7	86.4	39.3	76.4	97.7	10.9	22.5	35.2	31.1	40.5	35.2	35.0	33.3	27.8	43.3	49.1	101.3	163.1	64.8	32.2	26.7	51.4	125.6	41.5	51.3	12.9	35.3	71.1	35.4	26.7	51.6	26.8	51.9	55.3	19.7	32.3	72.9	49.5	49.4	46.7	108.8	26.0	62.5	127.5	33.5	36.1	79.9	76.0	50.6	50.6	50.3	51.8	40.0	2.5	0.7	1.2	0.8	0.7	1.3	1.6	1.3	0.9	0.8	1.2	1.3	1.3	2.4	1.1	0.4	1.1	1.0	0.8	26.4	57.0	33.2	36.4	25.4	29.3	36.9	43.3	34.8	19.9	50.3	73.5	24.0	25.6	25.7	113.3	28.5	53.3	52.3	45.5	40.5	42.0	29.6	23.0	25.6	35.8	44.6	49.7	95.9	48.9	25.2	72.4	5.9	22.8	12.9	51.8	37.4	28.1	28.9	17.5	422.9	20.2	19.5	27.7	51.5	68.5	12.0	29.9	27.8	54.6	14.9	37.0	117.8	34.4	28.5	26.4	26.0	19.2	28.6	19.2	37.4	165.8	18.3	71.9	43.3	257.3	1542.2	30.3	48.0	25.6	34.1	52.3	50.6	20.8	66.3	101.7	13.1	40.5	25.5	31.2	37.9	66.7	70.8	25.0	30.6	29.3	38.8	106.8
DLG2	"chapsyn-110, PPP1R58, PSD-93, PSD93"	ENSG00000150672	"Discs large MAGUK scaffold protein 2"	Q15700	11	83455012-85627922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021307, HPA023896, CAB072341"	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Vesicles	"CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353"	"unprognostic (2.61e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.84e-1)"	"unprognostic (7.66e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.89e-2)"	1.6	11.0	29.5	1.1	48.7	0.3	2.1	3.6	55.8	1.8	0.0	2.3	1.2	2.9	4.1	7.5	5.7	2.1	3.0	64.4	18.1	3.6	2.8	1.7	1.1	13.5	8.2	5.7	3.3	7.3	10.0	2.4	10.3	4.0	1.4	25.4	3.1	4.6	0.8	20.2	1.2	2.2	11.9	2.5	1.5	8.1	10.5	7.3	15.5	0.7	2.9	1.7	2.6	88.4	0.6	0.3	0.9	0.5	0.6	0.7	8.2	0.2	0.5	0.4	0.3	7.4	1.1	1.3	1.3	0.4	0.5	0.8	2.3	0.7	0.4	0.8	0.9	1.3	5.0	0.2	0.1	0.4	1.1	0.5	0.5	1.0	1.0	0.4	0.5	1.9	1.2	3.5	0.7	0.9	0.6	1.3	6.0	0.8	1.3	1.4	2.0	0.9	0.4	0.3	5.9	8.1	0.8	5.1	0.4	7.2	21.2	0.0	0.3	2.2	1.8	2.1	0.3	0.8	2.9	5.6	0.8	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.2	0.0	0.6	0.6	0.2	0.0	0.0	0.1	0.5	0.0	0.0	29.5	48.7	3.6	55.8	64.4	18.1	13.5	8.2	10.3	11.9	10.5	88.4	7.0	3.2	10.4	742.8	1.3	3.3	3.6	0.3	9.1	298.1	4.4	5.2	8.3	2.8	1.8	7.3	275.2	7.9	1.8	1.5	9.8	0.7	21.5	1.3	2.7	3.6	4.2	0.0	3292.3	0.4	0.5	7.4	1.1	2.4	0.0	1.6	2.2	4.6	4.0	23.5	2602.7	1.1	0.0	0.3	0.0	16.4	7.8	0.8	1.8	487.2	0.6	11.0	0.0	2331.8	4213.8	0.4	0.1	6.4	0.1	2.0	0.6	2.7	0.9	48.2	6.6	7.1	4.1	11.3	3.2	6.2	8.5	2.1	1.7	12.1	0.9	0.8
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444835-70505490	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	3.6	3.7	14.6	4.9	16.0	0.6	11.7	8.3	19.2	10.9	9.5	18.6	13.4	8.3	25.5	20.4	19.1	10.7	7.9	19.7	10.1	16.7	1.7	8.8	3.6	6.1	9.5	11.9	35.2	36.3	11.6	5.9	9.0	11.4	18.9	10.5	23.2	10.8	1.2	11.8	16.0	9.0	6.6	20.0	17.3	1.8	10.9	4.6	15.3	2.0	7.4	10.3	12.2	12.9	6.9	3.1	18.9	8.1	4.8	5.8	13.2	4.0	4.5	2.2	2.2	19.4	15.8	0.0	9.1	4.0	1.6	14.5	37.1	8.8	1.4	8.1	11.3	0.0	17.4	10.7	9.4	0.2	2.6	6.1	5.7	2.8	6.1	19.4	0.8	12.9	3.7	26.5	2.1	24.1	15.8	0.1	31.9	55.5	22.3	14.7	9.3	3.0	12.8	20.7	8.9	0.5	3.2	36.9	7.3	15.6	19.4	0.0	1.5	2.5	2.5	2.4	3.0	17.3	13.9	8.4	3.7	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.0	0.7	0.1	14.6	16.0	8.3	19.2	19.7	10.1	6.1	9.5	9.0	6.6	10.9	12.9	2.2	19.2	22.5	4.6	1.7	0.8	5.5	10.8	7.4	20.2	16.8	10.4	17.2	22.8	17.5	9.2	0.0	6.3	7.0	36.7	11.7	15.0	0.0	27.7	5.7	1.8	25.7	0.8	24.8	24.9	2.6	7.4	17.9	15.8	1.3	6.4	3.6	0.3	0.6	5.0	24.5	23.7	4.1	0.3	1.2	0.3	1.5	1.3	1.8	7.5	1.8	11.6	3.1	20.1	5.4	21.6	19.3	6.4	5.7	13.9	26.1	6.0	31.5	6.3	6.6	4.0	11.1	2.9	2.9	13.1	2.0	1.6	8.1	2.5	21.4	10.5
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7187187-7219841	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 112.4;pituitary gland: 62.8;retina: 223.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Cone photoreceptor cells: 102.2;Rod photoreceptor cells: 62.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0;hTERT-RPE1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122, HPA071006"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB001999: , CAB002000: , HPA010122: AB_1855169, HPA071006: "	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	13.1	19.1	41.9	9.3	49.6	3.6	10.0	32.1	112.4	23.5	0.0	18.5	4.9	23.1	6.9	6.3	20.7	10.8	19.6	86.3	17.5	10.3	7.1	14.7	4.4	7.2	0.4	30.3	6.3	7.2	62.8	8.9	5.6	16.6	3.5	223.2	7.2	12.8	6.1	4.7	8.4	11.1	0.0	13.9	10.3	18.9	7.7	8.7	11.0	2.8	2.9	13.3	16.4	36.2	0.5	15.2	29.4	9.1	8.4	14.6	1.5	14.1	12.5	10.8	11.3	0.7	4.0	2.4	6.4	12.1	1.6	1.8	1.1	6.7	3.3	17.6	6.0	9.4	35.1	1.4	8.0	0.3	40.0	17.5	0.9	7.7	11.0	45.5	11.5	10.1	3.1	10.1	15.2	1.0	9.3	5.1	3.8	0.8	1.6	10.5	1.6	1.0	6.6	0.3	12.4	10.5	0.4	0.8	2.6	7.0	6.5	7.2	16.4	30.6	12.6	7.4	7.8	1.5	0.9	2.1	19.3	6.9	8.5	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.0	0.1	41.9	49.6	32.1	112.4	86.3	17.5	7.2	0.4	5.6	0.0	7.7	36.2	3.4	0.0	1.5	14.0	1.5	2.7	2.2	1.8	6.2	41.8	4.8	3.7	3.2	1.5	2.2	3.7	102.2	0.6	3.3	0.4	0.0	0.9	1.8	2.4	9.5	7.0	15.0	0.8	22.8	0.2	0.4	5.5	2.0	3.2	7.0	3.4	10.0	2.2	3.9	20.2	17.5	0.8	4.1	11.0	10.3	1.3	7.2	7.8	3.6	8.4	5.5	11.1	0.0	4.5	4.2	0.2	0.1	10.1	0.2	1.7	1.3	0.3	3.0	62.6	0.0	1.4	4.5	6.5	2.9	3.2	1.8	0.5	1.1	6.8	0.5	1.1
DLGAP2	"C8orf68, DAP-2, ERICH1-AS1"	ENSG00000198010	"DLG associated protein 2"	Q9P1A6	8	737628-1708476	"Nuclear receptors, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 2.6;testis: 12.2"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 645.0;Inhibitory neurons: 467.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030320	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA030320: AB_10600904"	"unprognostic (8.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.81e-1)"	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	3.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	12.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	16.0	0.0	0.4	0.3	0.0	0.0	4.1	0.7	0.9	1.7	0.0	1.8	0.0	16.7	0.0	0.0	0.0	1.9	0.1	64.1	0.1	0.0	0.6	0.0	0.0	645.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	40.4	467.8	0.0	0.0	0.0	0.3	31.9	0.9	0.2	1.8	35.6	0.0	1.9	0.0	12.1	9.1	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.7	2.5	0.0	0.3	0.2	8.2	6.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLGAP4	"DAP4, KIAA0964, SAPAP4"	ENSG00000080845	"DLG associated protein 4"	Q9Y2H0	20	36306336-36528637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 213.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054105, HPA056378"	Approved		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA054105: AB_2682381, HPA056378: "	"unprognostic (1.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (1.23e-1)"	"prognostic favorable (9.88e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	55.4	47.5	39.0	23.5	31.4	7.5	40.3	2.8	45.9	51.7	2.6	71.4	21.2	64.5	12.5	31.7	45.2	26.4	58.4	39.3	12.3	34.3	37.3	60.5	16.6	5.4	18.1	48.4	47.8	13.8	36.4	26.5	10.5	44.7	15.0	25.4	37.8	30.6	130.8	86.8	37.1	42.5	2.8	32.9	36.5	29.3	29.1	14.7	43.3	45.9	14.8	56.2	46.6	20.6	49.9	44.2	53.0	44.1	49.0	79.9	53.2	73.2	66.5	70.0	48.2	67.4	30.9	14.0	38.5	103.3	61.9	46.7	14.3	75.1	51.8	22.5	5.2	31.8	22.7	46.2	70.9	12.9	26.5	52.9	57.0	83.1	57.6	54.2	69.7	19.5	22.5	37.2	53.6	37.0	26.3	49.0	23.2	36.2	93.4	26.1	14.0	19.4	33.0	24.3	34.8	47.9	48.0	96.0	60.0	53.7	55.3	22.3	71.2	212.1	64.6	92.6	40.9	12.7	9.8	15.1	84.9	16.2	85.4	2.7	16.5	26.9	15.0	17.3	11.9	19.5	13.5	10.7	14.5	20.8	10.1	8.1	23.6	9.6	17.9	17.4	11.9	12.6	39.0	31.4	2.8	45.9	39.3	12.3	5.4	18.1	10.5	2.8	29.1	20.6	30.4	16.0	20.5	34.0	25.2	66.4	53.8	30.6	9.1	34.9	30.2	21.0	27.9	22.8	22.9	12.9	8.4	23.1	23.7	27.2	7.9	53.0	69.9	25.9	47.7	36.6	63.3	4.4	77.9	55.7	52.3	40.1	23.4	29.4	12.6	35.7	27.8	17.5	27.2	74.0	93.4	35.0	20.3	22.4	54.4	213.4	29.8	23.9	10.6	37.5	47.5	38.7	21.6	81.4	13.2	84.4	25.0	26.4	8.9	72.9	25.8	20.4	28.3	29.5	72.3	28.8	51.0	13.7	30.3	13.2	71.7	55.1	20.7	29.8	20.6	52.3
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 1330.8;pituitary gland: 772.9;placenta: 1631.2"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1;testis cancer: 25.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 163.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 41.2;midbrain: 156.8"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		2600000		"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			3.1	1330.8	3.4	6.1	1.9	0.1	7.1	0.0	0.8	9.4	0.3	0.2	1.8	0.7	0.2	2.6	3.1	2.2	45.7	0.5	163.3	0.6	1.8	0.8	0.5	15.4	38.7	277.2	21.2	0.0	772.9	1631.2	81.7	1.4	0.0	0.0	26.9	0.0	17.5	1.2	1.3	0.2	2.1	1.1	1.0	40.9	14.7	1.7	0.2	83.1	0.0	1.0	1.5	0.9	0.0	0.0	120.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	12.6	0.3	419.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	1.4	0.1	0.0	0.5	33.7	473.8	0.0	0.1	0.0	2.9	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	1.9	0.0	0.8	0.5	163.3	15.4	38.7	81.7	2.1	14.7	0.9	0.4	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.3	1.0	2.6	0.0	0.0	0.0	0.0	55.2	0.2	0.0	0.0	4.8	7.1	0.0	0.0	6.7	0.0	0.0	0.0	576.5	45.3	699.3	0.0	0.0	0.0	0.8	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.3	35.0	1357.0	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	172.6	0.0	1.3	0.0	0.2	0.0	0.0	59.2	2360.1	3.0	13.5	69.9	0.0	0.4	105.8	0.8	63.2	0.0	0.2
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.3;prostate: 12.9;skin 1: 12.7"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	0.8	0.5	3.8	0.7	4.5	0.9	2.9	6.9	7.0	2.9	1.8	0.4	0.4	0.6	2.0	12.3	0.6	0.3	1.7	4.4	4.2	0.5	0.7	0.5	0.9	2.7	2.6	1.1	0.8	0.1	0.8	0.6	2.7	12.9	0.0	0.6	8.1	5.2	0.2	12.7	0.6	0.1	2.6	0.7	0.4	1.0	3.5	2.3	0.7	0.0	0.9	0.8	6.7	3.2	7.9	2.8	0.8	11.3	0.0	0.6	2.5	2.8	3.0	3.1	1.4	2.7	0.4	1.5	1.7	0.5	3.8	24.1	8.0	13.1	0.7	1.5	3.0	0.6	1.5	4.2	0.8	0.5	1.6	1.3	38.5	0.9	7.1	1.0	0.0	4.5	0.7	1.1	1.2	3.0	0.6	0.6	1.0	3.0	2.9	1.6	1.4	0.7	0.4	2.6	8.3	0.8	0.9	0.3	0.4	0.6	0.7	2.4	0.8	1.1	3.6	0.8	5.6	1.8	0.4	2.5	0.1	1.1	0.8	0.3	0.1	0.1	0.1	0.0	0.8	0.1	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.8	0.1	0.5	0.0	0.1	3.8	4.5	6.9	7.0	4.4	4.2	2.7	2.6	2.7	2.6	3.5	3.2	0.3	0.0	0.5	0.3	0.4	10.1	96.9	56.8	64.3	1.3	0.6	26.7	0.6	0.0	6.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.3	0.1	3.0	0.7	1.2	0.0	6.1	0.0	2.7	0.4	0.0	0.2	0.0	4.7	0.0	0.0	0.1	11.8	2.8	0.0	2.0	0.0	0.4	0.5	0.3	0.6	1.8	2.8	0.0	0.6	0.0	3.0	0.9	0.1	0.0	0.0	0.1	12.9	0.0	0.0	1.1	1.2	0.0	0.5	1.1	1.7	7.0	6.7	2.6	0.3	1.3	0.4	0.0	8.3
DLL4		ENSG00000128917	"Delta like canonical Notch ligand 4"	Q9NR61	15	40929340-40939073	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Distal enterocytes: 24.2;Endothelial cells: 48.6;Hepatic stellate cells: 30.4;Intestinal goblet cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BJ hTERT+: 59.4;HUVEC TERT2: 15.7;SCLC-21H: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023392	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023392: AB_1847740"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (7.52e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.51e-3)"	25.2	2.6	6.9	2.9	6.1	0.3	21.2	6.5	7.0	8.0	4.9	7.6	4.0	8.8	1.0	3.7	7.6	3.7	23.8	5.8	6.0	10.0	3.5	22.5	5.0	7.1	6.5	4.1	2.9	2.9	5.6	19.8	7.5	7.9	3.0	0.9	4.3	2.7	10.0	5.5	6.8	4.2	6.6	4.6	4.8	1.5	8.4	5.0	15.4	10.6	1.7	8.7	7.6	6.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.9	59.4	0.2	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.7	0.0	0.4	1.1	0.1	0.1	0.0	0.6	0.0	0.9	0.0	1.4	0.5	1.6	0.0	0.1	32.5	0.0	0.3	0.7	0.0	0.0	0.0	3.5	0.9	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	6.1	6.5	7.0	5.8	6.0	7.1	6.5	7.5	6.6	8.4	6.2	70.7	0.0	2.7	0.0	1.7	1.3	0.2	0.2	4.0	4.9	1.6	2.8	3.2	1.5	0.9	0.0	0.0	1.5	0.2	24.2	0.0	0.2	0.2	1.9	0.7	48.6	17.4	0.0	0.9	0.2	0.6	3.1	13.3	2.6	2.5	0.0	30.4	0.1	0.2	0.0	0.6	36.3	6.1	1.6	0.8	0.3	0.0	0.8	1.8	11.2	0.0	0.2	0.0	0.5	0.5	0.2	16.7	0.0	3.5	2.3	9.2	0.0	0.2	1.4	0.0	0.9	3.8	0.8	2.0	1.0	1.6	1.9	0.4	0.4	12.0	0.6
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.7;skin 1: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 77.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.9;CACO-2: 16.8;GAMG: 15.3;HAP1: 11.2;K-562: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.2	0.2	0.8	0.0	0.3	0.2	0.1	3.7	0.5	0.2	0.1	0.0	1.1	0.2	0.0	3.0	0.2	0.0	0.2	0.4	0.1	0.3	0.2	0.1	0.3	0.0	0.5	0.2	0.5	0.2	0.5	1.4	0.0	0.1	0.1	0.0	22.9	0.1	0.1	0.1	0.3	16.8	1.0	0.7	3.3	0.3	15.3	2.3	11.2	0.4	0.1	4.5	5.9	0.4	5.7	1.7	0.0	0.9	3.7	0.0	2.8	0.1	0.0	0.2	0.0	3.5	13.5	0.0	0.0	2.9	0.4	6.0	0.2	3.1	0.0	0.0	5.1	0.6	0.1	0.8	1.9	0.1	0.4	1.9	1.1	3.4	4.1	4.0	0.0	0.0	1.0	0.2	0.0	0.9	0.2	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.0	6.4	0.0	0.0	0.2	2.5	0.4	1.0	2.2	0.0	0.5	0.3	1.9	0.0	0.1	0.0	0.0	12.7	0.1	0.1	0.0	0.3	0.1	1.5	0.1	0.2	0.0	0.0	0.3	0.2	77.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.0	1.1	0.4	0.6	16.8	0.1	0.2	0.2	0.3
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020396-97024950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 14.1;placenta: 11.7;skin 1: 21.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 53.7;HAP1: 27.2;SuSa: 13.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory bulb: 29.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.5;olfactory bulb: 18.0"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.3	2.1	0.2	3.9	0.0	0.9	0.2	3.4	7.6	0.4	0.6	0.3	14.1	1.0	1.9	1.3	0.4	0.5	1.5	4.5	0.5	0.0	0.2	1.7	0.2	0.3	1.6	0.0	0.2	0.8	11.7	0.3	1.7	0.0	0.0	3.3	2.8	0.3	21.2	0.1	0.9	0.3	0.1	0.1	0.9	1.5	1.8	1.5	0.0	2.1	0.7	3.0	1.3	0.0	0.0	0.0	8.2	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.2	27.2	0.0	0.0	0.0	4.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	3.6	1.5	2.1	0.2	0.0	0.0	13.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.2	3.4	1.5	4.5	0.2	0.3	0.3	0.3	1.5	1.3	1.4	0.0	0.0	0.0	0.0	9.8	1.1	1.7	0.6	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.2	217.8	13.3	2.9	0.0	0.0	0.1	0.0	245.2	1.5	0.0	191.2	0.0	1.6	0.0	0.0	16.9	0.0	12.8	0.0	0.0	0.0	1.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	59.2	0.2	8.0	4.2	11.6	7.9	20.6	314.8	1.6	0.1	0.0	1.6
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005553-97011040	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 27.0"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.4	0.0	2.1	0.0	7.3	0.3	0.1	0.0	4.3	2.0	0.0	0.2	0.0	2.5	0.8	0.0	0.4	0.0	0.1	0.8	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	3.0	0.0	0.3	0.0	0.0	1.1	0.9	0.1	1.5	0.0	0.2	0.0	0.1	0.0	5.5	1.2	0.3	0.4	0.1	0.2	0.3	0.2	0.4	0.0	0.0	0.0	10.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	1.9	15.3	0.0	0.0	0.0	3.9	0.0	5.9	7.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	2.6	1.6	0.0	0.0	0.0	0.0	2.2	7.3	11.0	1.0	0.0	0.3	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.9	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	7.3	0.0	4.3	0.8	4.7	0.0	0.0	0.0	0.0	1.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	32.9	0.1	0.0	0.0	0.0	22.6	37.3	2.2	0.2	0.0	0.0	0.0	0.0	70.4	0.2	0.0	27.5	0.0	0.0	0.0	0.0	3.3	0.0	8.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.8	6.8	10.2	0.0	0.0	17.4	0.3	0.0	0.0	0.1
DMAC1	"C9orf123, MGC4730, TMEM261"	ENSG00000137038	"Distal membrane arm assembly complex 1"	Q96GE9	9	7796500-7888380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 500.8;Hofbauer cells: 221.7;Proximal tubular cells: 254.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA014585	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"			"HPA014585: AB_1845803"	"unprognostic (1.48e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.23e-3)"	"prognostic favorable (4.15e-4)"	"unprognostic (2.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.96e-11)"	"unprognostic (1.75e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.41e-2)"	10.6	11.9	16.8	7.7	17.0	6.2	12.4	17.5	21.0	9.3	9.0	12.6	9.8	10.0	11.8	9.3	11.0	6.3	25.4	16.3	17.8	15.9	10.2	7.2	10.0	15.2	15.0	13.2	9.2	21.8	12.3	8.1	15.6	11.9	9.9	9.0	14.3	11.6	43.1	8.5	9.1	8.1	15.1	10.4	10.7	7.0	16.0	20.6	11.8	29.8	8.9	11.5	8.3	16.9	18.5	21.8	19.7	12.3	15.4	19.1	13.3	11.0	7.7	11.5	10.4	9.9	11.3	27.1	5.6	9.8	15.0	9.8	21.2	18.8	11.6	16.2	24.3	49.3	32.7	31.8	15.6	17.2	6.7	24.1	13.2	9.1	13.9	10.6	11.0	24.3	9.2	5.6	12.2	15.7	25.1	39.7	17.5	15.6	10.5	19.0	11.1	16.4	13.2	17.6	31.5	17.6	12.0	8.0	14.1	13.5	10.5	10.5	14.0	8.8	14.2	11.6	7.7	7.0	12.0	14.5	7.4	14.3	9.0	2.0	10.1	4.5	11.5	12.2	17.4	26.5	15.7	12.3	12.6	22.5	20.5	16.5	1.6	20.8	9.8	13.1	19.9	19.6	16.8	17.0	17.5	21.0	16.3	17.8	15.2	15.0	15.6	15.1	16.0	16.9	42.2	70.5	48.5	0.0	15.7	0.0	0.0	0.0	0.0	0.0	69.5	81.5	0.0	0.0	24.1	101.2	0.0	113.6	13.9	0.0	500.8	94.2	0.0	81.4	64.3	30.0	0.0	0.0	0.0	90.7	96.3	32.8	0.0	58.6	27.8	127.7	0.0	0.0	221.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	25.8	0.0	0.0	0.0	0.0	62.4	0.0	0.0	3.1	0.0	0.0	254.7	70.7	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	55.4	17.3	79.3	0.0	0.0
DMAC2	"ATP5SL, FLJ10241"	ENSG00000105341	"Distal membrane arm assembly complex 2"	Q9NW81	19	41431318-41440717	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Distal tubular cells: 39.2;Ductal cells: 44.0;Exocrine glandular cells: 40.5;Extravillous trophoblasts: 67.9;Hofbauer cells: 40.4;Proximal tubular cells: 46.3;Syncytiotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041427	Approved		Approved	Mitochondria		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA041427: AB_2677473"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (4.37e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (4.07e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.29e-3)"	27.3	33.2	29.3	16.1	29.5	18.2	26.2	30.6	34.7	27.6	26.1	41.1	44.9	31.5	10.4	34.5	27.0	14.1	110.1	29.5	30.7	40.8	36.2	32.6	20.5	31.4	31.4	24.4	35.9	33.2	16.2	18.8	31.0	27.5	17.9	18.7	26.4	20.2	68.4	30.8	42.6	22.3	29.8	26.7	38.2	13.9	31.7	25.7	26.9	80.1	17.2	37.1	26.2	30.5	39.1	134.9	48.4	32.4	33.2	32.9	28.8	31.9	36.9	55.7	49.5	96.7	43.5	40.4	47.8	47.3	30.1	28.6	36.9	59.0	28.4	37.3	47.4	38.1	35.2	70.8	49.5	64.6	36.8	52.5	53.3	44.6	31.3	37.9	66.2	54.7	52.3	39.2	38.0	48.4	59.2	26.4	60.5	55.7	40.3	48.7	38.1	35.8	53.8	53.4	34.6	57.1	51.4	41.9	35.0	38.4	39.2	72.3	50.0	47.7	52.0	29.3	55.7	41.0	41.7	36.6	42.5	46.5	35.0	15.0	28.4	24.2	22.0	25.7	22.9	16.8	16.7	22.2	40.3	19.7	17.7	17.2	9.3	22.9	22.8	26.6	21.0	23.2	29.3	29.5	30.6	34.7	29.5	30.7	31.4	31.4	31.0	29.8	31.7	30.5	25.4	28.9	16.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	25.7	19.7	0.0	0.0	5.6	12.9	0.0	47.9	9.6	0.0	39.2	44.0	0.0	10.3	17.3	11.6	0.0	0.0	0.0	40.5	67.9	9.3	0.0	14.7	7.6	22.4	0.0	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	31.6	0.0	0.0	0.0	0.0	29.2	0.0	0.0	1.4	0.0	0.0	46.3	2.9	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	46.4	6.5	21.0	0.0	0.0
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018, HPA069527"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	19.3	53.8	31.7	13.2	32.3	14.6	20.6	32.4	37.4	22.8	30.1	21.1	13.5	20.3	9.7	18.9	20.0	11.7	26.5	32.6	31.0	26.0	28.7	17.9	16.9	30.9	31.2	26.6	33.9	25.5	25.1	14.6	31.0	24.3	11.7	19.5	21.3	13.2	36.1	21.3	22.0	10.7	30.2	27.6	24.2	25.2	32.0	20.9	23.4	25.2	14.4	21.6	19.5	32.8	21.1	22.2	30.6	16.0	15.5	14.6	35.0	18.3	24.4	43.3	37.2	35.7	25.9	31.5	24.1	29.7	16.9	17.0	27.4	23.6	22.8	25.0	44.3	29.0	41.2	36.2	28.0	28.7	21.2	23.0	25.8	35.8	20.5	27.9	28.3	29.5	20.6	28.2	25.7	24.5	40.4	35.9	43.6	10.8	27.0	40.5	30.8	34.5	23.1	26.2	28.0	23.3	34.4	24.3	35.8	29.1	20.1	32.8	27.5	12.2	36.5	28.5	37.6	33.9	21.8	25.4	23.1	28.2	20.6	45.0	23.1	23.1	30.8	20.9	31.9	27.7	31.2	32.2	24.0	28.3	27.8	27.5	9.9	43.8	17.6	19.2	37.5	24.6	31.7	32.3	32.4	37.4	32.6	31.0	30.9	31.2	31.0	30.2	32.0	32.8	23.4	32.1	23.8	11.1	23.6	19.2	25.9	36.4	19.4	43.0	18.6	22.2	22.8	18.6	24.5	11.0	25.0	72.6	30.9	32.8	29.4	31.9	41.9	15.4	14.1	23.9	54.4	25.7	10.4	41.5	34.4	20.5	28.5	14.8	27.3	38.1	23.6	19.1	32.6	23.5	12.1	32.0	44.7	22.3	12.7	69.2	18.0	15.4	17.8	4.7	26.3	46.3	25.7	9.0	9.6	22.9	38.6	17.7	26.8	9.7	46.9	36.2	26.8	56.1	6.6	23.9	25.1	24.5	47.2	15.7	17.8	52.4	25.5	29.3	29.8	16.3
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	19	"intestine: 1651.4;salivary gland: 519.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 192.9;Intestinal goblet cells: 113.4;Paneth cells: 388.2;Proximal enterocytes: 167.8;Undifferentiated cells: 314.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 47.6;stomach cancer: 76.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 9.9;LHCN-M2: 16.4;RH-30: 40.3"	"Not detected"	"Not detected"							HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	NA	NA		5200000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Centriolar satellite"		"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.5	0.2	0.6	45.3	2.9	0.1	0.3	4.4	1.5	12.8	0.0	55.6	1651.4	1.7	0.0	1.6	3.9	45.7	0.1	0.5	2.3	0.1	0.1	58.4	1.0	6.1	5.2	0.1	1.8	0.0	0.2	0.0	7.2	1.7	17.0	0.0	519.1	0.0	0.3	0.1	518.7	15.3	2.3	0.0	3.8	1.5	4.2	0.1	0.0	0.2	0.2	15.4	0.0	7.8	0.2	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.5	0.2	1.1	0.0	0.4	0.0	0.2	0.0	0.0	3.2	0.5	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	1.3	0.5	9.9	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	40.3	6.0	0.0	0.0	0.1	3.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.8	0.5	2.3	5.7	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	4.4	1.5	0.5	2.3	6.1	5.2	7.2	2.3	4.2	7.8	0.0	6.4	192.9	0.7	1.1	0.0	7.0	0.4	0.0	0.0	1.5	0.9	0.7	0.0	3.8	0.0	0.0	0.0	0.0	52.4	0.0	2.1	2.9	1.1	0.2	7.3	0.0	0.0	0.0	15.1	0.0	0.4	0.0	3.5	10.1	0.0	0.0	0.0	0.0	0.0	0.1	113.4	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.7	388.2	0.0	0.0	1.7	167.8	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.8	0.0	0.0	0.0	1.8	0.0	314.4	20.3
DMC1	LIM15	ENSG00000100206	"DNA meiotic recombinase 1"	Q14565	22	38518948-38570204	"Predicted intracellular proteins"	"Cell cycle, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 109.3;Spermatogonia: 36.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001232, CAB015397"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB015397: AB_629406, HPA001232: AB_1078683"	"unprognostic (1.29e-2)"	"unprognostic (3.11e-3)"	"unprognostic (4.48e-3)"	"unprognostic (5.71e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.99e-1)"	0.7	0.2	0.4	1.3	0.4	2.3	0.9	1.2	0.7	1.0	0.4	0.9	0.2	2.5	0.9	0.9	0.8	0.4	2.3	0.4	0.2	0.5	0.3	0.4	2.8	0.5	0.2	1.2	0.5	0.3	0.4	0.7	0.5	1.2	1.1	0.8	0.3	0.7	1.3	1.6	0.7	0.7	0.1	0.5	0.6	12.3	0.1	3.4	0.3	0.5	3.1	0.6	0.7	0.5	7.1	2.6	5.0	0.1	0.4	2.1	0.2	7.4	1.0	11.7	8.1	0.2	0.8	3.5	0.3	2.0	0.0	1.2	2.0	0.3	13.1	25.5	0.5	13.6	2.0	0.2	0.2	1.2	2.7	0.5	0.0	17.4	0.0	0.1	0.9	11.2	10.5	3.5	4.1	3.9	2.8	10.3	9.0	3.5	0.2	6.2	0.0	5.2	1.5	0.9	9.7	0.5	12.5	1.1	0.1	1.1	2.1	2.9	0.3	0.1	0.8	0.1	0.1	9.8	21.4	6.4	2.0	2.8	0.9	0.4	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.4	0.4	1.2	0.7	0.4	0.2	0.5	0.2	0.5	0.1	0.1	0.5	0.6	0.0	2.3	3.6	0.7	2.3	1.0	0.4	1.8	0.7	2.7	2.4	2.5	0.0	2.7	3.7	0.0	1.9	0.4	1.3	1.9	0.2	2.9	0.9	0.8	0.8	0.0	11.8	1.1	0.0	1.7	1.4	0.0	1.3	1.3	1.1	0.4	0.1	1.0	0.0	1.4	1.6	0.0	0.0	1.2	3.0	1.5	1.1	0.0	1.9	0.1	4.8	1.0	2.5	0.6	0.1	0.5	1.5	3.8	0.2	0.1	0.4	0.9	0.2	13.1	1.3	0.9	109.3	36.0	0.3	0.6	0.8	0.9	0.3	2.5	0.5
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"skin 1: 4799.0"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	13.8	9.3	6.5	1.1	11.7	1.7	195.4	7.3	7.0	262.7	16.1	11.0	5.6	16.1	14.4	221.3	73.9	1.8	11.9	5.9	7.0	50.3	4.7	22.3	1.2	18.4	7.2	35.0	59.7	87.1	58.1	2.2	17.8	19.3	4.9	1.9	69.5	14.6	20.1	4799.0	8.4	4.2	6.6	2.9	19.9	4.1	6.6	12.2	60.0	0.2	50.6	14.1	378.5	6.2	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.5	11.7	7.3	7.0	5.9	7.0	18.4	7.2	17.8	6.6	6.6	6.2	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650280-87664361	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"	NA	NA		64000			"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DMRT1	"CT154, DMT1"	ENSG00000137090	"Doublesex and mab-3 related transcription factor 1"	Q9Y5R6	9	841690-969090	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	94	"testis: 26.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 44.0;Spermatogonia: 153.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027850	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA027850: AB_10600868"	"unprognostic (3.23e-1)"	"unprognostic (1.91e-1)"		"unprognostic (9.75e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.50e-1)"		"unprognostic (3.08e-1)"		"unprognostic (1.45e-1)"			"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.02e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	17.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.9	153.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.2;lymphoid tissue: 20.9;parathyroid gland: 46.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 3.0;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"HPA003498, HPA029297"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Vesicles, Centriolar satellite"	"HPA003498: , HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	4.7	0.1	1.7	0.1	3.4	0.0	5.3	3.1	2.7	0.1	0.2	1.6	0.0	0.1	1.1	0.3	0.6	0.0	0.1	1.9	1.9	41.2	0.0	3.1	0.2	3.0	3.1	0.0	0.0	46.4	0.5	0.2	2.9	0.3	0.9	0.4	1.3	1.4	13.3	0.3	0.1	0.0	1.7	0.0	0.0	0.8	2.8	20.9	0.1	2.5	0.1	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.0	19.4	0.0	0.8	2.9	0.0	0.0	0.0	5.2	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	3.1	2.7	1.9	1.9	3.0	3.1	2.9	1.7	2.8	8.5	0.5	0.0	0.0	0.3	0.2	0.5	0.6	1.8	0.0	0.1	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.1	0.1	1.8	115.4	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	46.8	0.0	1.1	0.4	0.6	0.2	3.6	0.0	0.0	0.3	0.0	0.5	11.1	0.0	1.9	0.0	0.4	0.2	0.0	0.4	0.6	2.4	0.0	22.7	0.7	4.0	3.0	0.2	0.1	0.1	0.1	0.0	1.8	0.4
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976655-991732	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 10.2;parathyroid gland: 26.9;testis: 10.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.8;Smooth muscle cells: 2.3;Spermatocytes: 13.9;Spermatogonia: 5.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 1.4;hTERT-RPE1: 2.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	HPA077685	Approved					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	3.3	0.0	0.7	0.0	0.2	0.0	1.7	0.0	1.0	0.0	10.2	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.2	0.2	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.6	0.0	0.2	0.1	0.0	0.0	10.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.0	1.4	0.0	0.2	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	13.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446824-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 8.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Distal tubular cells: 15.6;Glandular and luminal cells: 14.5;Hepatocytes: 30.8;Proximal tubular cells: 29.2;Squamous epithelial cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.3;hTERT-RPE1: 7.4;LHCN-M2: 2.9;RPTEC TERT1: 3.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	1.8	0.0	0.4	0.2	0.4	0.0	0.4	0.3	0.3	1.6	2.4	0.4	0.6	0.3	1.2	1.7	0.3	0.9	0.3	0.6	0.3	3.4	8.4	0.9	0.4	0.4	1.6	0.2	1.4	2.2	0.7	0.0	0.4	1.4	0.3	0.1	3.5	0.4	0.7	0.2	0.5	0.1	0.4	0.2	2.0	0.1	0.7	0.5	1.8	1.1	0.8	0.4	0.1	0.4	0.2	0.3	0.0	0.0	0.2	0.1	0.1	0.0	6.3	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.2	1.2	1.7	0.2	0.0	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.1	7.4	0.4	0.0	0.0	2.3	2.9	0.6	0.0	0.0	1.2	0.3	2.1	0.0	0.1	0.9	3.0	0.0	0.1	0.0	0.8	0.5	1.4	1.4	0.0	0.0	2.1	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.6	0.3	0.4	1.6	0.4	0.4	0.7	0.4	0.1	0.0	2.7	2.0	0.1	0.0	4.8	7.2	19.4	0.5	1.9	1.0	1.9	5.7	5.6	5.5	0.0	0.0	0.0	1.1	15.6	6.9	0.1	10.7	1.4	0.3	2.4	0.0	0.0	6.7	0.0	0.8	10.2	14.5	0.0	0.6	0.0	30.8	0.3	0.0	0.0	0.7	8.2	0.3	0.3	0.1	0.3	0.4	0.0	1.0	0.0	5.4	0.0	0.0	0.0	7.8	0.2	0.0	0.1	6.3	4.1	29.2	5.9	0.1	0.0	2.9	0.6	0.2	1.2	26.5	0.4	0.1	0.3	0.0	1.9	8.2
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423443	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.6;esophagus: 1.5;pituitary gland: 2.0;testis: 1.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.9;Basal squamous epithelial cells: 17.6;Early spermatids: 10.8;Squamous epithelial cells: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Region enhanced"	"Detected in single"		"white matter: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HBEC3-KT: 3.3;RH-30: 11.7;SH-SY5Y: 2.4;SiHa: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 61: Squamous epithelial cells - Keratinization"	Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	1.4	0.0	0.9	3.3	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.4	2.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.4	0.3	0.2	0.6	0.5	0.3	0.2	0.8	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.6	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	10.8	0.1	0.1	0.1	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.2	1.3	1.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0
DMRTB1		ENSG00000143006	"DMRT like family B with proline rich C-terminal 1"	Q96MA1	1	53459399-53467488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 62.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.3;Late spermatids: 120.2;Spermatocytes: 222.5;Spermatogonia: 138.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036490, HPA058553"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA036490: AB_10671844, HPA058553: AB_2683753"										"unprognostic (2.20e-3)"					"unprognostic (1.36e-1)"	"unprognostic (1.67e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	222.5	138.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	0.5	1.5	0.1	1.3	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.7	0.2	0.0	1.0	1.8	0.1	0.0	0.1	0.3	0.4	0.2	0.5	0.2	0.2	1.8	0.0	0.5	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.6	1.3	0.2	0.7	0.0	0.3	0.1	0.1	2.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	2.5	1.0	1.8	0.4	0.2	0.5	0.0	1.3	2.4	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;pituitary gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.3;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.2	3.2	17.5	0.8	17.9	0.0	0.6	11.6	22.5	1.1	10.7	1.0	0.4	1.6	6.7	0.2	2.3	0.4	0.2	18.7	19.7	1.4	0.0	0.8	1.0	13.7	14.3	8.2	3.8	1.5	25.3	0.0	13.7	2.7	0.5	9.7	0.8	1.2	0.0	0.3	1.0	0.4	11.9	1.0	1.0	8.9	20.5	1.2	3.3	0.0	1.5	0.3	0.8	16.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	17.5	17.9	11.6	22.5	18.7	19.7	13.7	14.3	13.7	11.9	20.5	16.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DMRTC2		ENSG00000142025	"DMRT like family C2"	Q8IXT2	19	41844743-41852333	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	106	"testis: 40.9"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045016	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA045016: AB_10960404"	"unprognostic (6.80e-3)"			"unprognostic (4.38e-2)"								"unprognostic (5.36e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.02e-1)"			0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	40.9	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	162.6	38.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DMTF1	"DMP1, DMTF, hDMP1, MRUL"	ENSG00000135164	"Cyclin D binding myb like transcription factor 1"	Q9Y222	7	87152409-87196337	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 176.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023846	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023846: AB_1847779"	"unprognostic (3.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.77e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (6.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-3)"	20.2	15.7	17.5	16.2	23.3	28.6	20.6	21.7	22.8	24.4	17.2	23.2	16.8	26.0	37.8	13.6	22.7	15.3	16.0	16.8	20.4	21.5	11.5	21.2	20.2	21.4	19.3	29.0	17.1	16.7	23.4	18.0	20.3	19.5	19.4	36.2	15.9	17.4	12.1	19.5	21.3	19.8	16.5	20.4	15.9	50.0	20.2	21.1	27.5	12.9	18.6	20.1	19.6	30.8	27.7	13.3	58.9	50.5	17.1	28.8	25.6	33.6	13.6	19.2	30.3	12.2	25.8	34.3	23.3	20.7	23.2	15.1	40.2	22.9	37.2	17.8	20.4	24.3	40.4	18.6	16.9	23.2	26.3	26.9	19.0	37.4	37.8	32.3	26.2	35.2	44.2	39.8	32.2	25.4	40.5	29.0	45.9	18.0	23.6	34.6	31.3	21.0	18.7	23.1	40.6	50.5	41.6	17.8	29.6	74.1	25.2	15.0	32.8	35.7	18.1	47.0	30.5	29.6	45.4	59.9	20.6	18.7	32.1	14.6	3.5	7.1	7.4	4.0	6.9	8.4	5.7	5.3	2.9	6.5	6.8	6.2	5.3	5.3	4.2	4.6	7.6	3.1	17.5	23.3	21.7	22.8	16.8	20.4	21.4	19.3	20.3	16.5	20.2	30.8	20.9	22.4	31.7	91.1	38.0	13.0	16.6	8.7	12.5	28.5	11.3	9.4	11.8	17.2	16.4	3.7	37.5	15.0	43.8	20.5	3.9	10.0	24.5	15.3	26.6	20.9	19.7	12.6	82.6	8.2	8.8	21.7	23.0	23.0	37.2	42.9	20.0	9.7	11.0	18.5	88.6	14.1	12.2	19.2	11.7	14.1	23.3	18.7	0.0	81.5	20.7	10.4	30.9	132.7	176.5	9.4	20.4	22.6	33.8	21.6	17.8	5.3	21.6	25.6	32.9	18.0	17.8	51.5	19.5	11.1	12.6	7.7	34.4	16.5	11.1	18.1
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 192.5"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024290, HPA058487"	Uncertain					NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA024290: AB_1847601, HPA058487: "	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	35.7	29.8	104.2	6.1	134.6	136.6	21.8	0.0	192.5	13.5	0.0	33.1	9.2	15.3	14.4	18.9	30.4	13.5	71.5	142.1	36.9	67.5	28.2	20.1	3.4	27.0	14.0	3.4	29.6	54.9	109.6	7.4	27.1	25.0	15.2	23.0	22.9	20.4	66.4	24.3	14.0	14.0	0.0	19.3	23.8	11.7	32.4	3.0	39.1	41.4	3.7	12.9	12.4	90.5	44.1	68.9	0.5	1.4	1.1	0.3	5.4	4.6	4.3	14.5	4.3	29.9	26.7	0.4	43.8	0.8	0.9	14.8	2.1	2.7	6.5	0.4	13.0	225.9	5.3	63.9	1.3	0.1	65.6	0.7	29.3	0.2	0.3	8.5	14.7	2.0	21.7	2.2	0.1	18.9	5.7	0.5	1.8	67.3	6.1	0.0	0.6	3.1	87.2	12.3	15.6	21.8	7.3	0.9	3.2	3.5	11.2	2.2	26.1	0.0	22.0	0.3	24.0	0.1	0.2	0.7	0.3	0.2	15.4	0.0	0.1	0.2	1.7	0.0	1.7	0.0	3.8	1.6	0.1	0.0	1.5	1.5	1.2	0.0	0.0	0.3	3.3	9.3	104.2	134.6	0.0	192.5	142.1	36.9	27.0	14.0	27.1	0.0	32.4	90.5	9.3	3.2	10.7	10.7	1.5	2.3	4.0	3.9	1.2	34.6	9.9	5.7	37.8	0.0	5.1	7.3	12.5	0.1	2.7	15.3	19.6	11.4	12.7	11.2	1.7	10.2	20.5	248.6	45.7	11.4	1.7	2.4	7.7	12.7	0.0	4.1	3.9	15.8	0.5	28.6	29.7	8.7	0.0	1.0	1.6	7.7	0.3	44.5	14.2	5.6	1.3	2.6	0.0	1.5	4.3	18.2	10.0	2.6	1.4	3.7	1.8	29.6	9.3	7.3	0.0	1.4	5.7	1.4	2.4	3.8	5.7	0.1	6.4	0.3	13.3	4.8
DMWD	"D19S593E, DMR-N9, gene59"	ENSG00000185800	"DM1 locus, WD repeat containing"	Q09019	19	45782947-45792845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068172, HPA069843"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Actin filaments"		"HPA068172: AB_2685964, HPA069843: AB_2686212"	"unprognostic (6.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (5.11e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.59e-2)"	24.6	19.1	27.7	12.3	23.4	7.3	23.0	10.5	31.7	29.1	10.8	40.3	9.7	39.6	6.7	18.2	29.4	11.8	43.1	30.0	18.6	18.7	10.2	22.6	11.2	17.5	19.9	29.1	18.1	10.3	29.6	15.0	15.1	25.2	7.4	11.9	17.1	12.2	44.0	15.5	18.3	14.8	8.9	17.0	25.0	36.5	20.2	10.3	23.1	20.1	7.1	30.6	23.2	14.5	31.6	34.3	30.4	21.2	18.1	22.9	23.3	26.9	18.8	23.5	21.2	20.6	17.1	13.2	15.4	30.4	28.8	23.4	16.1	13.4	12.3	38.6	30.0	11.4	37.3	18.2	22.4	1.4	17.6	21.5	16.2	22.0	31.2	26.7	20.3	8.3	28.2	28.9	18.6	25.8	16.0	9.0	13.8	20.6	22.2	16.3	11.0	14.5	14.6	29.7	30.4	33.6	28.9	22.2	19.5	13.4	19.4	7.7	43.3	27.0	26.6	18.1	40.7	41.1	27.4	15.0	28.1	2.1	31.8	0.6	0.2	0.2	1.4	0.6	1.1	0.6	1.2	1.1	0.2	1.4	0.4	0.8	0.6	1.8	0.8	0.2	0.7	0.3	27.7	23.4	10.5	31.7	30.0	18.6	17.5	19.9	15.1	8.9	20.2	14.5	18.8	6.4	4.7	8.1	6.9	8.4	13.9	4.5	2.2	34.5	11.8	9.8	28.5	10.0	4.4	9.2	60.5	7.3	10.6	10.4	5.9	7.3	17.2	12.4	18.9	16.2	26.3	9.3	8.1	10.6	9.6	15.3	6.1	11.2	11.4	23.3	20.0	4.6	2.0	52.2	7.5	7.9	10.2	4.8	11.4	57.7	17.1	2.6	5.4	5.6	0.9	23.3	14.4	10.1	5.8	13.8	7.2	17.0	6.8	11.5	5.6	7.1	8.9	41.2	13.1	24.5	19.0	10.8	15.7	4.6	7.0	5.5	9.0	20.6	8.1	11.5
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.3;Inhibitory neurons: 147.3;Oligodendrocytes: 224.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: AB_2675120"	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	7.0	4.8	3.1	7.3	7.0	25.9	9.2	7.8	5.1	7.4	11.9	6.8	6.2	8.7	5.7	8.2	6.6	7.5	6.1	3.5	5.3	13.8	7.1	6.6	10.1	7.4	4.5	10.4	12.0	11.8	2.6	7.2	8.0	27.2	7.1	9.0	8.0	5.8	4.1	8.4	6.1	8.2	6.3	8.2	7.9	5.8	5.6	10.3	13.4	7.3	9.7	6.2	4.5	15.2	10.4	8.0	8.8	9.0	9.3	12.2	9.4	8.4	8.4	8.3	9.6	9.6	6.2	20.2	8.5	10.8	12.9	6.1	9.9	10.0	10.7	15.6	9.9	14.2	14.0	3.4	7.8	9.4	11.8	9.8	5.5	9.6	7.9	8.5	11.0	12.4	12.1	13.3	6.7	6.5	12.6	5.3	4.8	3.6	4.7	9.8	16.3	7.9	6.4	11.9	8.2	8.3	14.5	5.2	12.6	9.4	8.6	10.7	10.7	9.8	8.2	9.9	9.0	12.4	9.4	17.6	12.2	9.1	8.0	4.1	4.9	3.6	2.4	4.4	3.0	8.8	1.9	2.0	3.4	9.1	3.0	1.8	3.8	1.3	8.9	8.3	2.6	2.7	3.1	7.0	7.8	5.1	3.5	5.3	7.4	4.5	8.0	6.3	5.6	15.2	23.7	28.9	20.1	93.4	56.5	13.6	16.5	17.7	22.8	36.8	22.8	15.4	25.7	7.2	17.6	16.5	25.0	12.6	27.5	16.2	17.6	12.0	10.2	19.8	21.1	16.7	6.0	19.1	122.3	20.1	10.3	20.4	27.5	25.0	14.0	15.6	11.0	15.6	16.6	21.9	147.3	12.2	10.2	21.9	19.9	12.1	15.2	31.0	33.8	68.4	29.1	16.9	25.7	111.6	224.0	14.1	11.6	15.4	27.2	36.0	15.8	32.5	13.9	22.6	13.1	28.6	24.7	28.0	23.2	35.0	18.8	16.3	24.3	17.8	11.3	15.0
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAAF1	"CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.7;testis: 45.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 3.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.3	0.7	1.4	0.1	1.2	1.2	0.3	1.1	1.9	2.2	9.7	0.3	0.0	0.5	1.4	0.4	22.7	0.0	0.4	1.6	1.5	1.0	0.8	3.5	0.0	4.1	7.3	0.4	0.3	0.3	2.4	0.2	4.3	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	3.0	0.7	0.2	45.3	1.6	0.0	1.6	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	4.0	2.8	0.4	0.1	0.0	0.0	1.3	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.3	0.3	0.1	0.4	1.0	0.3	1.4	1.2	1.1	1.9	1.6	1.5	4.1	7.3	4.3	3.0	1.6	1.3	1.1	0.0	12.4	1.6	5.7	0.6	1.5	9.6	0.0	1.4	4.5	1.5	0.7	1.5	67.2	3.7	54.2	0.2	0.5	0.1	0.0	1.3	116.2	311.3	4.4	1.9	0.0	0.0	9.6	0.4	0.4	2.4	0.5	14.6	3.8	2.6	2.2	0.6	1.9	0.0	5.2	0.0	18.3	7.0	1.5	26.7	1.2	21.6	87.2	0.0	0.8	2.4	1.0	0.5	0.6	0.9	0.0	0.4	225.4	1.4	0.0	1.7	494.5	51.0	0.0	1.6	7.3	116.2	17.0	0.2	0.3	0.4	4.5	1.2	0.3	0.9
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favorable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"	3.8	4.6	3.2	4.4	3.1	3.4	5.7	3.8	3.3	4.3	6.0	5.4	7.6	4.0	4.1	4.4	8.6	3.7	4.3	3.0	3.5	6.8	9.3	3.7	5.5	3.5	4.3	3.5	6.9	3.9	3.4	3.4	3.5	4.0	4.7	4.8	5.5	3.0	5.0	3.2	6.2	3.3	3.6	4.1	5.1	6.3	3.4	4.7	5.3	5.3	4.6	4.6	3.3	3.6	14.2	8.3	18.0	14.1	8.6	9.9	17.1	7.5	8.3	8.2	9.0	8.1	13.4	20.7	11.6	5.0	6.7	15.3	15.0	10.6	10.2	14.6	8.9	10.6	6.2	14.1	6.7	17.3	8.6	6.6	11.3	7.0	9.5	8.4	8.5	11.3	16.0	13.8	8.2	17.7	11.4	17.8	19.6	14.7	15.1	14.0	13.9	7.0	11.7	11.8	27.4	20.4	11.2	12.0	13.8	11.3	13.7	6.9	7.0	7.6	21.7	7.9	9.5	27.5	18.4	17.1	2.9	10.5	8.5	7.8	4.9	6.8	7.4	4.5	8.9	11.6	8.2	9.9	5.7	9.3	7.9	7.8	1.8	12.4	5.8	5.1	8.5	4.8	3.2	3.1	3.8	3.3	3.0	3.5	3.5	4.3	3.5	3.6	3.4	3.6	9.8	3.2	5.6	5.9	38.5	41.0	25.0	38.9	41.5	7.0	21.4	20.3	10.6	15.7	14.6	12.9	0.0	21.6	16.2	13.0	31.3	28.4	25.9	30.3	22.9	17.1	9.6	13.9	6.8	24.0	29.4	17.6	19.4	13.8	12.0	12.2	19.2	26.6	14.0	3.3	8.0	15.3	48.8	9.2	21.1	7.5	18.3	10.2	19.6	2.8	10.5	11.3	19.6	6.6	6.2	25.7	13.0	16.6	43.7	36.2	30.8	37.9	27.2	11.9	6.6	16.0	15.4	22.4	17.9	38.6	44.0	12.4	28.0	30.2	22.8	20.0
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.0	2.0	4.7	1.1	4.7	1.2	3.3	3.6	6.8	2.8	8.4	0.9	0.6	3.7	10.6	1.2	11.1	2.2	1.0	4.8	5.8	5.0	0.5	4.3	1.1	5.1	5.0	2.6	2.1	8.5	3.5	0.7	3.8	2.0	0.9	27.5	1.5	2.0	0.8	1.7	0.8	2.0	3.6	1.3	1.0	11.3	6.7	0.7	8.6	0.5	0.9	1.4	0.7	3.7	7.0	4.8	4.9	10.4	2.0	3.5	1.5	1.0	2.6	3.2	3.6	1.0	2.9	0.6	4.4	2.1	5.2	2.1	1.9	2.7	3.7	2.4	2.5	2.6	3.2	1.7	1.8	5.4	4.2	2.2	5.7	7.6	2.9	5.1	7.2	2.2	0.8	0.3	4.8	2.9	1.3	4.7	2.9	11.0	3.7	1.1	2.3	0.9	17.6	2.3	4.9	10.7	4.3	1.3	6.5	4.2	6.2	1.4	2.5	5.0	2.5	4.4	5.2	2.1	5.4	1.7	8.3	1.3	1.5	0.1	0.7	0.5	0.3	0.5	0.3	1.4	0.5	0.5	0.6	1.3	0.7	0.5	1.4	0.4	0.5	1.9	0.7	0.3	4.7	4.7	3.6	6.8	4.8	5.8	5.1	5.0	3.8	3.6	6.7	3.7	4.1	12.8	15.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.9	9.8	0.0	0.0	15.5	12.9	0.0	2.0	0.4	0.0	5.9	13.6	0.0	171.5	9.0	2.8	0.0	0.0	0.0	5.1	1.5	3.4	0.0	13.3	2.5	9.7	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	34.4	102.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.7	7.2	0.0	0.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNAAF6	"CXorf41, MGC35261, NYSAR97, PIH1D3, TWISTER"	ENSG00000080572	"Dynein axonemal assembly factor 6"	Q9NQM4	X	107206611-107244247	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 12.1;testis: 12.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 3.0"	HPA072496	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"					"HPA072496: AB_2732202"	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.3	0.2	0.3	1.0	0.0	0.0	0.1	0.6	0.0	12.1	0.0	0.0	0.3	0.4	0.1	0.0	1.5	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	12.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.3	0.4	1.6	1.2	0.9	0.7	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH1	"DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1"	ENSG00000114841	"Dynein axonemal heavy chain 1"	Q9P2D7	3	52316319-52400491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 21.5;Respiratory ciliated cells: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"HPA036805, HPA036806"	Uncertain					NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036805: AB_10670924, HPA036806: AB_10670849"	"unprognostic (8.34e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.60e-4)"	"unprognostic (1.54e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.59e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.84e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.80e-5)"	2.1	1.4	0.2	2.1	0.7	6.2	1.7	0.0	1.1	1.4	2.1	1.4	1.3	1.5	1.3	1.3	4.0	1.6	1.0	0.3	0.5	1.5	2.4	2.4	3.1	1.3	1.7	1.9	1.5	1.4	1.8	1.0	0.8	1.6	1.3	2.5	1.5	0.7	1.1	1.7	2.9	1.7	0.3	2.9	1.6	4.1	0.6	1.9	1.5	0.5	2.4	1.1	1.1	1.8	0.1	0.7	1.0	1.0	1.2	4.6	0.5	0.6	1.0	0.2	0.2	0.0	0.6	0.3	0.6	0.8	0.1	0.1	0.0	0.2	0.4	0.8	1.4	2.0	0.1	0.2	0.6	1.5	1.3	2.0	0.3	0.8	1.0	2.1	0.8	0.8	0.2	1.7	0.8	0.2	0.4	1.4	0.5	0.1	0.9	0.7	0.0	0.6	0.3	0.8	0.1	0.5	1.0	0.1	0.7	0.3	0.2	2.4	1.0	0.3	0.2	0.9	0.2	1.8	1.8	0.5	0.3	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.1	0.3	0.5	1.3	1.7	0.8	0.3	0.6	1.8	2.2	6.4	3.7	9.1	3.2	0.5	0.4	2.0	0.6	1.8	1.7	1.8	4.4	0.0	2.7	0.0	4.2	0.6	3.1	2.3	0.0	0.3	9.7	6.9	1.6	2.1	5.4	2.7	13.8	0.6	0.2	1.2	8.2	3.8	3.8	3.2	2.2	3.9	1.2	5.0	10.0	2.6	8.2	3.5	1.6	21.5	1.2	3.2	1.8	3.7	3.4	0.9	4.1	2.5	10.7	0.3	2.1	0.4	2.4	0.9	4.8	0.9	35.5	5.2	0.0	1.4	1.9	6.9	1.5	1.1	0.3	0.8	3.3	1.7	2.2	0.6
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123935720	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;choroid plexus: 2.6;fallopian tube: 4.1;testis: 3.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 35.5;Endometrial ciliated cells: 88.5;Late spermatids: 68.9;Respiratory ciliated cells: 88.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039066	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.2	0.0	1.0	0.0	0.7	1.2	0.0	0.8	0.4	0.6	2.6	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.1	1.0	1.3	0.1	0.0	1.1	0.0	4.6	4.9	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	3.3	0.1	0.0	3.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.5	0.9	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.4	1.0	1.3	4.6	4.9	2.5	3.3	1.1	1.2	0.0	0.0	5.5	2.0	0.7	0.0	0.0	1.6	0.0	1.2	0.1	0.3	2.3	0.0	12.9	0.0	0.0	0.0	0.6	0.0	1.9	0.0	35.5	88.5	1.2	0.3	0.0	0.4	7.2	0.0	0.0	0.8	0.0	2.1	0.0	0.1	0.4	0.0	0.1	0.0	6.1	0.2	0.0	0.0	0.0	68.9	0.0	0.3	0.0	0.0	0.4	1.0	1.0	2.0	5.0	0.1	0.0	0.0	0.0	0.0	1.2	2.9	88.0	1.4	13.1	0.6	1.0	9.9	2.1	0.0	0.0	0.0	0.4	0.9	0.4	0.1
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543039-21901839	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 36.2;parathyroid gland: 71.3"	"Group enriched"	"Detected in many"	10	"Endometrial ciliated cells: 136.7;Oligodendrocyte precursor cells: 57.3;Respiratory ciliated cells: 128.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.9;U-2 OS: 1.0;U-2197: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 6.7"	"HPA045880, HPA056474"	Approved					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	0.1	1.8	1.5	0.0	1.5	0.0	0.0	0.7	0.3	0.4	36.2	0.1	0.0	0.3	0.3	0.6	5.2	0.1	0.4	2.0	1.8	0.2	0.3	1.1	0.0	8.9	5.6	0.3	0.1	71.3	0.1	0.3	4.1	0.4	0.0	0.0	0.1	0.1	0.3	0.7	0.3	0.0	6.4	0.0	0.1	0.5	1.8	0.3	1.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.3	0.5	0.0	0.7	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.3	1.0	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.7	0.3	2.0	1.8	8.9	5.6	4.1	6.4	1.8	3.2	0.2	6.4	3.9	4.6	0.4	2.4	4.2	6.4	1.2	0.2	0.7	0.3	3.6	5.7	10.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.8	136.7	1.0	0.8	0.0	0.4	3.0	0.0	2.1	0.7	0.0	3.9	0.0	0.1	0.0	0.3	0.1	6.7	3.5	0.0	4.1	0.3	1.1	2.3	0.3	0.6	1.8	3.7	0.6	0.0	1.0	57.3	7.3	0.1	0.0	0.4	0.0	8.3	0.0	0.1	128.8	0.1	0.0	3.8	1.9	0.7	1.9	0.3	0.3	1.6	0.3	0.1	0.1	1.5
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 5.0;choroid plexus: 7.1;fallopian tube: 10.3;lung: 3.5;testis: 8.9"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 230.5;Respiratory ciliated cells: 318.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.6"	"HPA037493, HPA058203, HPA061365"	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.0	0.2	1.2	0.0	1.0	0.0	0.2	0.7	0.7	0.9	7.1	0.0	0.0	0.3	0.1	0.0	10.3	0.2	0.0	1.3	1.3	0.1	0.1	3.5	0.0	4.5	5.0	0.1	0.7	0.0	0.9	0.0	2.9	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.1	8.9	1.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	1.0	0.7	0.7	1.3	1.3	4.5	5.0	2.9	2.8	1.2	1.6	0.2	3.2	1.1	13.7	0.2	0.0	0.2	5.4	0.0	0.3	0.8	0.6	1.1	0.0	42.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	49.8	230.5	1.3	0.1	1.8	0.0	3.9	0.0	0.0	1.2	0.0	4.6	1.3	0.3	0.0	0.0	0.1	0.0	3.8	0.0	6.1	0.0	0.0	9.8	0.9	0.7	0.0	2.8	0.1	1.7	0.0	5.0	15.8	0.1	0.0	0.4	0.0	0.1	0.0	0.5	318.9	0.2	0.0	0.7	1.6	28.4	2.7	0.0	0.0	0.0	0.5	5.4	0.1	0.1
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Excitatory neurons: 65.4;Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 48.8"	"Low region specificity"	"Detected in many"							"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851"	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.1	3.2	4.2	0.7	3.5	1.9	3.2	0.9	3.4	1.8	4.4	1.9	1.0	1.9	3.6	1.1	1.6	1.6	1.3	3.4	9.2	5.4	5.7	2.3	0.4	3.8	4.3	3.7	5.6	2.1	6.6	1.5	3.9	3.2	2.3	2.7	1.5	1.4	0.1	0.4	0.6	1.1	2.9	0.4	2.6	22.1	8.8	1.4	4.4	0.2	0.2	1.8	1.1	2.9	19.7	9.9	8.9	9.8	3.5	7.1	21.3	4.0	3.7	7.2	6.3	15.6	21.1	0.0	9.7	4.1	0.0	0.2	13.8	3.8	12.2	0.0	23.0	9.4	7.2	3.4	4.3	19.6	3.1	6.9	8.3	10.0	6.9	7.7	2.4	13.5	48.8	0.0	12.4	5.2	3.6	20.3	25.1	22.1	12.0	0.0	33.8	18.0	6.7	9.0	14.9	16.9	15.4	11.5	32.1	14.8	21.2	16.9	0.4	0.1	14.4	0.3	0.1	20.9	14.1	0.2	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.2	0.0	4.2	3.5	0.9	3.4	3.4	9.2	3.8	4.3	3.9	2.9	8.8	2.9	2.5	12.8	11.5	2.3	0.6	2.0	14.0	6.0	3.4	28.1	10.1	6.2	6.5	10.0	5.7	20.2	33.3	10.6	1.3	2.1	7.9	11.2	135.0	13.1	13.2	3.4	8.3	6.7	65.4	10.0	12.4	4.5	6.6	12.2	14.0	23.3	1.4	7.7	3.4	28.6	44.0	5.2	4.1	0.0	1.2	45.9	2.8	1.2	3.6	6.5	1.0	8.0	1.0	23.6	8.4	9.4	1.1	3.4	1.2	11.2	0.5	8.4	6.7	3.9	6.6	0.5	2.7	74.5	24.9	2.8	0.9	11.5	1.4	10.1	5.0	7.1
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DNAH2	"DNHD3, FLJ46675, KIAA1503"	ENSG00000183914	"Dynein axonemal heavy chain 2"	Q9P225	17	7717354-7833744	"Predicted intracellular proteins, Predicted membrane proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 13.1;parathyroid gland: 10.5;retina: 21.1"	"Group enriched"	"Detected in many"	4	"Respiratory ciliated cells: 43.0;Rod photoreceptor cells: 123.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.6;CACO-2: 4.0;CAPAN-2: 2.4;OE19: 1.8;SCLC-21H: 2.3;SiHa: 2.3"	"Low region specificity"	"Detected in some"							HPA067103	Enhanced		Approved	Microtubules		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA067103: AB_2685778"	"unprognostic (2.03e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.50e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.60e-2)"	0.4	0.1	1.5	0.1	2.4	0.5	0.5	1.0	1.1	1.2	7.1	0.2	0.2	0.5	1.6	0.1	13.1	0.4	0.1	1.8	1.1	0.1	0.4	1.9	0.1	5.6	6.8	2.5	0.5	10.5	0.4	1.7	2.8	0.3	0.2	21.1	0.1	0.0	0.1	0.2	0.1	0.2	3.5	0.2	0.2	6.5	1.1	0.3	0.3	0.0	0.1	0.2	0.1	1.8	2.6	0.1	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	4.0	2.4	0.1	1.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.1	0.0	0.3	0.1	0.6	0.1	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.5	0.1	0.2	0.2	1.8	0.8	0.1	0.2	0.0	0.0	0.7	2.3	0.1	2.3	0.0	1.2	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.0	0.0	1.5	2.4	1.0	1.1	1.8	1.1	5.6	6.8	2.8	3.5	1.1	1.8	1.1	0.0	1.1	1.3	0.7	0.3	1.0	1.7	0.0	2.7	0.6	1.0	1.9	0.0	3.6	0.0	2.1	0.0	0.0	0.0	0.0	0.4	6.2	20.2	0.6	1.2	6.7	0.0	6.1	0.0	0.0	0.8	0.0	0.8	0.0	2.3	0.4	0.1	0.1	1.7	4.9	0.5	8.2	0.3	0.7	2.3	0.3	0.2	0.0	1.0	0.0	4.6	0.0	3.0	2.1	0.1	1.1	0.0	0.0	0.7	0.0	0.4	43.0	123.9	0.0	1.0	1.0	9.6	2.6	0.0	0.1	0.0	0.2	0.5	0.2	0.9
DNAH5	"CILD3, Dnahc5, HL1, KTGNR, PCD"	ENSG00000039139	"Dynein axonemal heavy chain 5"	Q8TE73	5	13690328-14011818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7;choroid plexus: 14.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 61.7;Endometrial ciliated cells: 190.3;Respiratory ciliated cells: 258.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;LHCN-M2: 1.1;PC-3: 2.7;RPTEC TERT1: 1.3;TIME: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037469, HPA037470"	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037469: AB_10672791, HPA037470: AB_10672348"	"unprognostic (3.85e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.94e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-3)"	"unprognostic (8.87e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	0.0	0.1	0.9	0.0	1.1	0.0	1.5	0.5	0.3	0.3	14.0	0.1	0.0	0.1	0.1	0.0	3.8	0.1	0.0	1.0	1.7	0.8	1.0	1.7	0.0	4.2	6.7	0.0	0.9	0.0	2.0	0.0	4.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	0.3	1.8	0.0	1.1	0.0	0.0	0.8	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.0	0.5	0.0	0.5	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	1.3	0.4	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.5	0.3	1.0	1.7	4.2	6.7	4.0	2.1	1.8	1.4	0.3	3.2	24.4	7.2	0.2	0.0	1.7	5.6	0.0	0.0	11.7	7.0	1.5	14.3	61.7	5.5	0.0	0.0	0.1	0.0	0.0	6.7	7.3	190.3	1.9	1.2	1.8	0.0	12.9	3.6	0.2	1.8	0.0	12.4	2.5	0.0	0.0	10.9	0.0	0.0	7.8	0.0	6.1	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	4.0	0.4	2.6	0.0	0.0	0.1	14.8	0.0	4.3	258.7	0.0	0.0	1.6	2.6	2.6	3.6	0.0	0.0	0.0	0.4	0.1	0.0	3.8
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;choroid plexus: 12.1;fallopian tube: 5.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 77.5;Endometrial ciliated cells: 98.2;Excitatory neurons: 94.2;Respiratory ciliated cells: 143.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036391, HPA061401"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036391: AB_10672220, HPA061401: "	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	0.3	0.2	1.4	0.1	2.4	0.0	0.4	0.0	1.7	0.2	12.1	0.1	0.0	0.5	1.2	0.0	5.4	0.1	0.0	1.5	1.1	0.4	1.1	0.8	0.1	4.4	4.6	0.3	0.2	1.6	0.4	0.0	2.4	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.0	0.5	2.7	1.6	0.5	1.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.4	2.4	0.0	1.7	1.5	1.1	4.4	4.6	2.4	2.7	1.6	1.6	0.6	6.4	4.1	18.6	0.6	0.1	2.2	5.4	0.0	0.8	1.4	1.8	1.2	1.5	13.7	0.0	2.1	0.9	0.3	0.3	0.0	0.3	77.5	98.2	1.5	0.9	0.0	0.4	94.2	0.9	0.2	2.7	4.1	3.0	0.0	1.6	0.0	6.9	0.1	0.0	28.2	1.0	10.2	0.3	0.2	25.0	0.6	0.3	1.8	9.4	0.0	2.0	0.0	5.5	13.7	0.3	0.3	0.7	0.1	1.0	0.2	1.0	143.6	4.8	0.0	2.1	1.7	23.3	5.1	0.0	0.0	0.3	1.3	0.3	1.1	0.3
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068837	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.9;choroid plexus: 29.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 197.2;Cone photoreceptor cells: 70.9;Early spermatids: 59.3;Endometrial ciliated cells: 103.5;Excitatory neurons: 93.0;Respiratory ciliated cells: 139.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.9;RPTEC TERT1: 2.8"					"Region enhanced"	"Detected in many"		"midbrain: 4.4"	"HPA034724, HPA044070"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA034724: AB_10670977, HPA044070: AB_2678798"	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	0.3	1.0	8.2	0.2	7.9	0.0	0.6	3.6	10.1	2.5	29.8	0.7	0.1	0.8	1.7	0.2	9.8	0.6	0.4	8.0	7.1	3.4	0.3	2.3	0.1	10.2	12.9	0.5	2.6	2.0	7.2	0.1	8.0	1.1	0.5	8.9	0.8	0.9	0.0	0.2	0.7	0.3	7.6	0.1	0.6	10.8	9.0	0.1	3.2	0.0	0.2	0.2	0.3	6.7	0.3	1.3	0.3	0.1	0.7	0.4	0.1	0.1	0.8	0.3	0.3	0.2	1.0	0.0	0.3	0.3	1.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	1.7	0.4	0.1	0.0	0.1	0.2	0.2	1.1	0.2	1.7	0.0	0.0	0.3	1.8	0.5	1.4	0.0	0.0	0.3	0.7	5.9	0.0	0.3	0.5	2.8	0.2	0.6	1.0	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.7	0.2	1.1	0.3	1.4	1.4	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	8.2	7.9	3.6	10.1	8.0	7.1	10.2	12.9	8.0	7.6	9.0	6.7	0.5	0.0	6.1	197.2	0.0	0.9	1.2	3.3	0.0	1.9	2.1	1.3	1.3	0.0	12.3	1.8	70.9	0.0	0.1	4.4	0.0	2.9	59.3	103.5	2.8	1.8	0.0	0.0	93.0	0.7	0.0	1.0	1.5	3.0	0.0	0.8	0.7	0.0	0.1	1.7	25.6	1.0	4.1	0.0	1.2	27.8	0.6	0.4	1.8	13.1	0.0	2.9	0.0	5.5	2.2	0.6	0.2	1.5	0.1	1.8	3.7	2.6	139.5	36.8	0.0	2.1	1.1	28.0	5.7	0.0	1.3	0.1	0.2	0.8	0.7	0.7
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715311-39030792	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.6;prostate: 2.1;testis: 7.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 47.1"	"Not detected"	"Not detected"							HPA028447	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.1	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.9	0.1	7.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.2	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	33.3	5.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0
DNAH9	"DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357"	ENSG00000007174	"Dynein axonemal heavy chain 9"	Q9NYC9	17	11598470-11969748	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 28.2;choroid plexus: 27.6;fallopian tube: 35.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.7;Endometrial ciliated cells: 97.5;Excitatory neurons: 26.8;Late spermatids: 56.5;Respiratory ciliated cells: 110.5"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.1;glioma: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.1;WM-115: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052641	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA052641: AB_2681895"	"unprognostic (4.16e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.31e-2)"	"prognostic favorable (6.79e-5)"	"unprognostic (8.37e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-3)"	"unprognostic (5.31e-2)"	2.1	0.8	9.7	0.3	8.1	0.0	1.5	9.2	8.0	1.7	27.6	0.2	0.0	1.4	2.2	0.1	35.4	0.4	0.2	12.1	10.4	1.7	0.1	2.8	0.0	24.0	28.2	1.4	1.8	3.6	3.2	0.3	18.1	0.8	0.0	6.6	0.3	2.0	0.2	0.3	0.1	0.5	19.5	0.1	0.3	6.3	12.1	0.1	0.9	0.0	0.0	0.3	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	8.1	9.2	8.0	12.1	10.4	24.0	28.2	18.1	19.5	12.1	11.6	0.1	3.2	1.1	8.5	0.0	0.8	0.9	3.6	1.2	2.0	0.2	0.4	1.7	0.0	6.1	3.7	2.1	0.0	0.0	0.6	1.9	1.4	48.7	97.5	2.0	0.3	0.0	0.0	26.8	0.2	0.0	1.5	0.0	2.1	1.3	1.2	0.0	0.0	0.1	0.0	17.6	0.2	2.0	0.0	0.4	56.5	0.6	0.2	0.0	3.7	0.0	1.8	0.0	11.1	8.3	0.1	0.0	3.0	0.1	0.6	0.0	0.2	110.5	8.2	0.0	1.5	2.5	5.3	2.4	0.6	1.1	0.1	0.3	1.4	0.0	0.6
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520988	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.9;choroid plexus: 28.3;fallopian tube: 33.9;pituitary gland: 9.5;testis: 33.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 29.6;Endometrial ciliated cells: 48.8;Late spermatids: 35.0;Respiratory ciliated cells: 132.2;Spermatocytes: 56.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HDLM-2: 1.4;SK-BR-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021649, HPA021843"	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	2.7	0.0	3.2	0.0	0.5	2.3	2.5	2.2	28.3	0.0	0.0	0.9	0.2	0.0	33.9	0.1	0.1	2.8	3.1	1.3	0.1	4.5	0.0	7.3	9.9	0.1	0.9	1.2	9.5	0.0	4.8	0.2	0.0	2.7	0.0	0.1	0.1	0.0	0.0	0.0	5.5	0.0	0.2	33.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	2.3	2.5	2.8	3.1	7.3	9.9	4.8	5.5	3.2	2.4	0.0	0.0	0.5	3.9	0.1	0.0	0.0	5.0	0.0	0.0	0.5	0.3	0.4	0.0	11.0	0.0	4.2	0.2	0.0	0.0	1.9	0.0	29.6	48.8	0.5	0.2	0.0	0.0	9.4	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	2.0	0.0	0.0	35.0	0.3	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.4	132.2	1.3	0.0	0.0	1.4	56.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DNAI2	"CILD9, DIC2"	ENSG00000171595	"Dynein axonemal intermediate chain 2"	Q9GZS0	17	74274234-74314884	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.4;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.7;Endometrial ciliated cells: 51.3;Late spermatids: 16.4;Respiratory ciliated cells: 68.1;Spermatocytes: 41.7"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.2;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.8"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB006245, HPA050565"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB006245: AB_426059, HPA050565: AB_2681177"	"unprognostic (6.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.62e-3)"	0.0	0.0	0.6	0.1	0.4	0.0	0.0	0.2	0.1	1.8	6.5	0.0	0.0	0.3	0.0	0.0	30.4	0.0	0.0	0.9	0.9	0.0	0.0	3.0	0.0	3.0	4.3	0.0	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	19.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.6	0.4	0.2	0.1	0.9	0.9	3.0	4.3	2.1	2.3	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	21.7	51.3	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.0	4.4	16.4	0.6	0.3	0.0	1.0	0.6	0.0	1.0	1.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	68.1	0.0	0.0	0.0	0.9	41.7	0.5	0.0	0.0	0.0	0.4	0.6	0.2	0.0
DNAI3	"DIC3, FLJ30067, NYD-SP29, WDR63"	ENSG00000162643	"Dynein axonemal intermediate chain 3"	Q8IWG1	1	84999147-85133138	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 21.9;choroid plexus: 23.9;fallopian tube: 14.5;testis: 18.9"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.3;melanoma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.4;HBEC3-KT: 4.4;HSkMC: 5.6;hTCEpi: 6.9;LHCN-M2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038526	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA038526: AB_2676063"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-4)"	"unprognostic (1.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.14e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	0.2	21.9	1.8	0.4	1.8	0.0	0.2	1.6	0.9	0.9	23.9	0.7	0.2	0.6	4.1	0.3	14.5	0.4	0.8	2.4	2.6	0.7	0.1	1.8	0.4	7.7	10.0	0.1	0.5	5.7	3.0	0.5	5.7	0.3	0.5	0.7	0.8	0.2	0.1	2.1	0.1	0.4	6.6	0.2	0.1	18.9	2.5	0.8	1.1	2.2	0.2	0.5	0.1	4.0	0.1	0.4	0.1	0.3	3.0	8.4	1.6	1.7	3.4	0.5	0.9	0.0	0.5	0.4	0.0	0.3	2.0	0.0	0.3	4.4	0.7	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	5.6	6.9	2.9	0.2	0.3	0.1	0.5	0.0	0.0	6.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.1	0.0	0.0	0.2	1.1	1.6	0.0	2.9	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.3	3.3	0.1	1.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	1.8	1.8	1.6	0.9	2.4	2.6	7.7	10.0	5.7	6.6	2.5	4.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025273-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	Yes		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	102.6	134.7	143.9	83.9	154.7	148.8	65.8	147.4	438.9	83.7	142.7	61.9	44.5	81.0	80.4	51.7	102.7	83.6	72.9	154.1	159.8	114.6	216.9	94.4	80.6	147.7	152.8	83.5	59.7	105.2	80.7	108.3	160.9	85.8	63.5	78.2	61.0	64.7	47.3	43.8	50.1	87.2	155.3	72.0	67.7	135.0	164.6	95.7	66.0	61.5	89.1	130.7	57.3	174.0	255.6	447.5	353.7	123.6	240.2	155.1	202.4	256.5	205.9	451.2	348.2	299.2	115.0	259.5	191.6	175.4	254.9	113.1	515.7	154.7	386.1	368.2	150.2	208.3	537.3	382.7	115.1	242.5	234.2	96.1	156.1	170.4	53.9	218.4	273.6	110.9	330.5	109.7	262.0	208.6	407.7	530.3	345.3	254.2	308.2	294.7	126.6	132.9	254.1	148.8	223.8	243.5	345.4	220.6	120.0	262.5	103.5	231.5	236.1	160.0	273.1	184.6	346.2	69.9	233.3	271.7	209.9	208.3	140.9	154.1	140.8	160.9	93.3	202.0	111.1	127.5	116.8	105.7	127.8	119.7	119.6	113.4	176.2	117.8	268.3	213.4	110.4	209.9	143.9	154.7	147.4	438.9	154.1	159.8	147.7	152.8	160.9	155.3	164.6	174.0	1110.8	214.7	154.9	7.8	368.7	264.6	942.8	245.3	327.8	209.3	307.8	513.5	187.7	95.8	257.7	82.8	208.5	274.0	619.1	287.9	172.1	247.7	536.4	549.2	348.2	427.8	391.1	198.9	16.2	181.1	341.6	392.8	188.6	526.1	424.7	127.6	133.2	129.6	231.1	121.1	16.7	327.3	213.6	156.0	497.4	222.2	99.1	402.3	284.6	22.5	243.7	150.5	91.6	8.0	22.5	189.8	334.7	94.8	195.8	393.8	134.7	178.1	417.8	161.7	105.2	391.1	476.0	492.7	209.4	238.5	265.4	464.9	678.9	179.2	273.3	636.8
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973674	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		67000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: AB_2680883, HPA060538: AB_2684315"	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	20.7	25.2	30.5	14.2	32.6	23.9	19.7	33.9	40.5	17.9	32.2	21.3	20.0	22.0	28.6	21.5	17.4	16.4	36.0	32.3	31.9	28.0	36.0	16.6	19.7	29.8	30.2	22.0	17.0	29.2	16.4	19.9	30.5	21.8	19.0	29.5	17.1	20.6	37.1	21.1	20.5	17.0	31.0	22.7	19.2	24.9	31.2	20.3	22.2	38.7	21.4	21.6	18.2	30.5	23.1	26.9	26.6	22.8	35.7	34.1	40.3	29.4	35.4	43.4	20.5	23.7	23.6	37.1	23.2	31.9	18.6	35.0	43.0	30.2	49.8	8.8	36.0	27.2	12.8	50.7	42.7	41.7	36.3	36.5	34.6	25.2	23.7	37.9	30.4	14.7	31.7	12.0	37.0	25.4	30.1	57.5	40.6	21.1	39.6	34.3	48.7	44.1	52.7	24.1	36.1	23.1	34.9	52.1	33.4	26.1	20.3	32.2	31.6	25.4	16.0	18.5	25.1	29.3	21.7	49.0	26.9	35.5	21.8	13.1	10.3	13.5	9.8	12.7	12.9	11.3	13.2	11.2	9.4	8.4	12.9	13.1	10.7	12.8	11.3	6.7	17.2	9.7	30.5	32.6	33.9	40.5	32.3	31.9	29.8	30.2	30.5	31.0	31.2	30.5	64.3	51.3	35.9	11.8	78.4	126.9	75.1	56.4	101.3	38.8	37.5	28.4	100.3	40.0	48.2	40.5	18.8	85.2	76.1	67.6	90.1	73.4	93.3	86.9	76.8	52.2	52.0	49.4	16.6	62.2	72.5	66.2	54.0	72.1	53.9	52.7	31.1	54.9	56.5	37.0	15.3	55.6	52.9	42.5	86.4	56.8	50.1	65.1	72.9	12.2	72.3	60.5	45.3	10.1	11.0	71.2	64.2	59.0	70.7	61.6	83.3	111.4	67.6	43.7	52.6	63.4	99.4	177.7	106.0	111.1	120.5	172.4	89.6	131.4	62.6	87.3
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA		16000	"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	18.9	44.3	15.7	11.8	16.3	6.4	18.3	17.5	18.7	19.9	15.3	25.2	17.5	18.6	6.8	27.8	18.0	8.1	43.6	16.0	16.8	26.7	65.7	15.8	13.3	16.5	16.1	20.7	26.5	23.9	20.2	12.3	17.2	18.7	12.6	8.7	20.2	12.4	90.5	22.7	21.2	10.4	16.6	19.3	23.9	23.6	17.5	11.5	18.7	48.3	11.9	23.8	20.5	16.8	26.4	53.7	16.1	33.1	20.5	18.8	34.6	34.2	22.9	45.1	36.1	40.2	38.7	50.2	32.9	20.3	31.3	38.4	55.7	39.7	24.8	42.2	35.8	25.4	48.8	40.4	50.8	47.5	24.4	22.6	46.6	40.0	66.1	20.5	20.4	36.7	63.1	39.7	27.8	60.9	39.6	33.8	35.6	48.2	43.2	51.5	27.6	92.7	32.5	28.0	43.7	17.3	38.2	77.6	62.0	13.7	46.7	38.3	22.2	35.8	24.5	80.1	44.4	38.5	56.6	69.7	17.9	45.0	39.8	1.4	5.3	3.2	10.3	8.7	12.4	12.1	9.6	9.8	7.6	10.0	12.9	10.4	0.8	11.1	6.9	5.4	10.8	10.5	15.7	16.3	17.5	18.7	16.0	16.8	16.5	16.1	17.2	16.6	17.5	16.8	10.9	12.8	8.1	11.4	23.7	15.7	18.5	12.6	25.0	23.0	14.8	10.8	36.3	14.3	13.0	25.8	10.4	42.8	8.2	17.9	45.0	21.8	62.6	8.9	13.5	13.3	17.5	18.7	19.4	12.2	34.3	13.6	18.8	10.0	12.7	17.9	8.9	46.1	16.6	23.5	20.4	17.5	16.2	10.1	7.0	30.5	19.3	10.0	21.4	6.5	15.2	18.5	16.5	10.6	15.2	13.9	15.5	22.2	19.9	28.9	21.5	25.9	9.2	23.2	13.1	14.2	14.2	50.5	33.7	23.5	16.9	28.5	17.5	29.8	32.7	16.7
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 138.4;tongue: 144.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 673.9;Late spermatids: 1608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	16.5	20.0	60.6	14.0	67.7	63.7	12.6	62.6	138.4	14.1	45.6	18.0	13.8	8.3	20.2	15.8	38.9	11.2	123.3	68.6	93.1	26.7	3.3	19.7	11.3	65.7	73.3	12.1	6.6	7.4	30.9	9.5	89.8	26.7	18.5	33.0	15.6	15.6	123.2	28.6	16.3	19.6	59.8	13.5	24.2	78.3	73.5	9.4	9.6	144.6	12.4	29.6	13.6	71.3	33.6	0.2	0.0	0.0	0.0	0.0	0.1	4.1	0.0	1.1	0.5	0.0	43.3	0.0	0.3	3.2	0.0	31.3	0.0	0.0	0.1	0.1	0.0	19.9	47.3	0.0	9.4	0.0	20.6	3.6	4.1	2.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	33.6	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.1	85.2	53.3	0.0	42.7	8.6	3.6	2.3	32.4	39.8	0.5	0.0	8.7	4.0	0.4	0.6	2.4	0.0	0.1	4.2	0.0	0.0	0.3	1.1	0.6	0.3	1.0	0.7	0.9	0.9	0.4	0.1	1.7	1.4	0.0	0.1	0.4	0.2	0.5	0.6	60.6	67.7	62.6	138.4	68.6	93.1	65.7	73.3	89.8	59.8	73.5	71.3	41.9	6.4	4.8	12.7	10.0	28.8	209.9	14.0	2.2	19.6	44.6	29.2	43.6	2.8	33.5	7.3	81.3	1.9	6.7	55.5	1.9	1.3	673.9	124.0	11.4	18.9	100.3	92.8	16.6	2.4	3.8	18.3	21.4	41.8	36.9	7.5	6.8	0.2	16.5	6.7	24.0	34.9	10.2	9.5	81.7	1608.0	10.2	51.7	51.6	6.5	3.5	10.3	6.2	15.1	19.0	5.1	55.3	11.3	3.7	115.8	15.8	7.2	138.9	22.6	6.6	17.4	20.2	33.8	27.7	16.9	46.7	6.8	37.1	6.9	42.1	190.1
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514769-14560391	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1705.1"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1392.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 1705.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm		NA	Yes		23000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: AB_2684971"	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	206.0	216.1	228.5	40.9	241.7	133.8	62.0	320.9	1705.1	188.1	259.4	86.7	35.2	54.0	40.8	439.9	75.3	183.7	182.8	243.8	240.2	245.0	230.3	286.0	42.0	250.4	251.8	231.9	89.8	66.4	148.4	123.4	285.4	73.9	48.4	81.2	109.7	127.1	51.2	128.5	62.7	54.5	240.6	104.5	149.1	149.4	241.8	107.3	97.2	208.0	76.5	133.6	257.7	323.4	192.5	212.5	80.8	81.7	146.8	114.1	45.6	125.9	99.9	210.4	158.8	126.3	106.7	54.8	135.4	121.0	135.5	144.9	169.1	96.7	150.3	55.0	76.1	86.7	115.0	275.6	94.6	57.9	78.5	61.0	237.5	85.3	73.4	114.7	71.6	35.7	131.2	471.6	123.6	130.5	102.2	60.1	80.4	285.9	228.3	73.7	106.3	121.7	101.8	62.4	67.0	51.1	121.1	233.7	127.1	90.8	60.3	60.6	64.7	156.4	98.0	184.1	264.8	193.5	141.7	65.7	114.4	109.2	151.1	68.8	92.4	116.2	171.6	159.0	184.8	93.7	244.5	214.9	76.0	92.0	281.6	219.9	137.6	125.1	172.2	45.1	270.9	322.6	228.5	241.7	320.9	1705.1	243.8	240.2	250.4	251.8	285.4	240.6	241.8	323.4	750.2	157.0	95.4	32.3	248.7	425.8	1142.1	148.0	719.3	60.9	468.8	476.4	367.1	72.9	118.6	23.9	118.9	135.6	214.2	459.6	41.1	132.8	491.8	374.8	339.3	397.3	407.3	60.0	10.2	162.6	199.3	661.2	408.7	552.8	339.4	100.2	86.7	59.9	158.1	52.2	8.9	420.1	81.4	85.1	1392.1	475.3	63.3	559.3	503.4	23.4	31.3	160.7	25.7	3.0	16.5	123.8	380.7	36.9	697.0	461.1	117.3	59.1	138.0	164.7	26.3	398.9	673.3	290.2	53.4	1186.0	478.9	274.9	948.4	104.8	393.7	606.2
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	36.1	26.3	17.3	51.5	18.8	50.1	28.2	20.1	19.8	30.3	21.0	38.9	35.2	31.5	36.7	33.2	28.7	28.1	42.9	17.9	20.1	33.0	81.8	35.8	34.5	21.1	19.8	20.5	62.3	31.7	27.0	46.2	20.2	23.3	37.2	16.1	34.3	23.1	22.9	23.9	38.4	30.9	19.3	41.7	37.8	27.1	20.0	30.7	53.2	15.8	36.5	40.6	26.1	21.6	154.5	60.5	87.5	150.5	69.6	53.1	142.4	166.5	98.5	138.6	145.9	187.0	100.5	109.4	326.7	113.3	199.6	139.1	96.0	88.0	135.6	123.7	81.7	97.8	57.0	128.8	150.8	116.8	149.0	46.6	85.5	78.0	130.6	76.4	116.7	59.0	55.8	263.9	93.6	117.4	77.6	85.7	83.1	211.8	76.3	78.1	96.8	187.8	87.7	66.4	73.3	101.3	108.2	181.4	123.2	103.2	209.3	177.6	89.5	76.6	97.1	100.7	244.5	202.9	159.0	175.8	102.3	141.6	169.8	37.4	37.3	39.8	44.0	45.9	37.2	37.2	22.9	36.5	46.2	21.8	21.8	29.2	17.2	50.2	35.4	84.8	33.9	38.4	17.3	18.8	20.1	19.8	17.9	20.1	21.1	19.8	20.2	19.3	20.0	21.6	42.2	19.2	20.9	12.1	78.1	145.3	212.5	104.3	48.9	22.9	38.3	22.7	152.0	67.2	61.4	14.7	18.8	88.7	75.0	93.5	3.9	109.2	41.5	58.2	44.9	63.6	142.1	37.6	10.8	85.7	173.0	63.3	41.3	77.5	54.7	29.4	61.1	105.0	149.4	23.5	11.6	122.8	67.1	65.3	130.3	10.8	31.4	59.4	103.2	14.0	33.3	48.5	63.8	12.1	24.5	86.9	88.2	25.9	251.1	136.6	74.6	18.9	47.3	28.4	65.7	63.7	61.3	190.6	100.7	51.1	112.2	195.1	61.7	28.4	106.8	155.8
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355149	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.1	29.8	18.3	18.1	19.5	27.6	24.5	20.0	20.4	21.6	19.5	23.3	21.4	24.0	23.4	23.2	20.8	17.5	26.8	19.0	18.1	23.9	28.0	21.1	16.4	20.0	18.8	22.6	26.9	32.9	23.7	20.3	19.1	23.4	14.7	16.6	28.4	17.7	37.5	28.5	20.7	19.0	18.4	24.8	23.9	21.4	18.9	17.3	23.5	23.5	16.0	21.6	20.6	20.0	37.4	38.3	23.4	39.3	30.5	31.1	29.6	36.6	63.8	49.5	45.9	44.7	64.3	27.2	28.8	45.1	31.3	61.4	22.2	33.0	26.9	29.9	29.4	14.7	23.0	29.6	68.5	30.1	54.2	39.6	67.6	44.1	55.8	45.0	35.1	25.6	23.2	40.2	43.3	36.7	26.0	26.3	10.8	29.1	11.1	23.4	17.8	18.9	37.7	21.7	16.1	23.0	20.0	74.0	36.8	12.9	28.2	34.2	39.1	24.6	33.4	28.0	46.7	33.8	27.3	16.0	40.6	32.6	17.1	18.7	29.2	18.7	12.8	31.5	11.4	11.5	12.5	9.6	24.6	11.1	10.3	10.2	36.6	13.9	28.9	16.4	13.8	17.5	18.3	19.5	20.0	20.4	19.0	18.1	20.0	18.8	19.1	18.4	18.9	20.0	30.3	28.9	29.3	10.1	30.1	13.4	30.6	38.6	25.6	33.3	36.1	29.6	23.3	50.1	44.3	23.9	22.9	41.1	37.7	38.1	11.7	34.2	122.2	25.1	26.1	25.3	29.4	31.2	12.7	64.3	41.1	28.6	23.4	29.3	40.0	26.4	21.0	29.6	38.1	30.3	13.0	28.8	12.2	36.0	16.0	235.7	36.4	37.6	10.6	7.5	39.6	33.6	35.0	12.1	15.2	34.9	38.1	35.0	34.2	27.4	62.2	34.4	26.8	35.6	52.6	27.4	34.4	32.4	10.9	28.1	15.5	68.0	22.8	37.0	25.9	35.2
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.2;testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	1.5	1.2	1.5	4.4	0.2	1.0	1.4	5.5	12.2	0.1	0.6	2.0	5.2	0.1	53.2	2.2	0.1	2.0	1.9	1.0	0.1	3.1	2.1	4.8	5.7	0.3	0.8	0.1	1.1	0.5	3.6	0.9	0.0	0.4	0.6	2.9	0.3	0.1	2.9	0.1	4.0	1.3	0.2	18.9	2.4	0.0	0.2	0.0	0.0	0.2	0.1	1.8	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	1.5	1.5	1.0	1.4	2.0	1.9	4.8	5.7	3.6	4.0	2.4	1.8	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DNAJB14	FLJ14281	ENSG00000164031	"DnaJ heat shock protein family (Hsp40) member B14"	Q8TBM8	4	99896248-99946618	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036016	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"			"HPA036016: AB_10670594"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.12e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	13.4	11.6	9.0	9.6	12.1	17.7	11.6	7.4	15.3	10.8	5.4	13.8	9.4	11.5	10.7	9.8	7.8	10.3	7.8	14.3	13.7	13.8	10.9	12.2	15.3	9.7	11.1	11.9	7.9	14.8	8.5	16.5	11.9	12.0	9.8	18.5	8.3	10.3	5.0	10.2	9.8	10.2	7.7	14.3	12.0	4.4	11.8	11.2	17.3	6.2	10.9	10.8	8.5	13.7	14.4	36.9	12.6	14.0	22.6	23.8	12.5	35.6	21.2	11.2	10.3	25.2	33.0	13.8	19.7	15.5	7.2	12.0	9.5	15.7	18.2	35.2	11.3	22.3	21.8	20.7	20.0	19.6	32.9	19.6	18.2	12.0	12.2	19.6	22.0	14.7	20.2	18.8	26.1	30.2	23.0	11.4	7.0	9.3	18.6	21.6	14.6	12.0	20.5	28.7	7.1	16.4	19.4	28.0	19.4	11.2	15.6	9.2	31.6	19.6	16.6	13.8	12.1	23.4	55.1	18.4	16.4	8.2	23.6	39.0	14.5	17.5	18.6	16.2	16.7	16.8	14.7	17.1	13.1	17.5	16.9	15.5	22.3	16.3	25.6	15.1	20.1	13.6	9.0	12.1	7.4	15.3	14.3	13.7	9.7	11.1	11.9	7.7	11.8	13.7	78.6	64.1	57.5	61.0	76.5	45.0	50.8	40.3	44.9	92.3	36.7	35.1	20.9	37.1	46.5	40.5	54.2	47.2	100.1	50.9	33.2	31.0	4.4	32.2	60.0	55.0	35.4	15.8	125.4	30.1	31.0	54.9	36.2	42.2	41.1	45.0	47.5	30.3	31.5	111.0	114.8	30.3	30.5	52.7	76.8	4.2	49.7	49.4	44.4	53.4	68.3	64.5	64.9	70.9	107.5	32.1	36.5	53.4	55.7	63.5	34.3	41.8	31.5	95.3	26.3	69.0	54.3	20.3	14.1	32.7	36.9	48.2	83.4	43.0	27.4	54.7
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279342-219286898	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 366.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"		NA	NA		9900	"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	41.9	106.9	264.5	17.7	290.6	26.6	45.7	276.0	323.5	63.8	232.0	48.9	23.2	46.2	45.2	54.1	48.2	26.6	85.4	266.6	270.7	81.0	72.1	45.8	26.0	281.8	281.8	65.0	84.8	54.3	112.1	27.1	279.7	73.9	15.8	63.9	62.3	35.5	135.6	108.1	36.0	15.8	269.7	46.7	54.8	86.0	280.5	28.4	71.0	56.5	20.5	52.8	59.0	366.0	34.9	14.2	21.9	20.7	45.6	22.1	29.3	32.8	27.2	29.0	24.2	66.2	21.3	21.4	39.7	31.6	66.3	49.1	27.9	36.3	16.3	45.3	12.2	41.7	28.0	32.0	30.8	7.1	36.5	21.3	103.3	31.8	38.4	51.3	12.9	23.5	7.4	23.7	21.4	18.0	13.0	8.4	12.9	30.2	26.4	13.4	17.9	13.5	31.7	24.5	20.6	26.0	38.0	38.4	64.9	57.5	28.6	14.9	17.5	41.6	82.3	12.0	28.6	26.2	8.4	35.0	42.8	6.5	31.1	0.0	0.4	2.1	0.7	0.4	0.6	0.5	0.7	0.6	0.2	1.7	1.0	0.9	0.4	1.3	1.2	0.6	1.0	0.4	264.5	290.6	276.0	323.5	266.6	270.7	281.8	281.8	279.7	269.7	280.5	366.0	24.6	19.2	31.4	35.6	30.9	28.6	40.9	17.1	9.1	97.9	61.9	33.9	77.4	25.8	18.0	38.6	56.3	36.1	24.0	41.5	78.2	60.0	43.8	43.5	16.2	22.3	53.7	69.9	17.9	33.5	34.7	27.5	22.4	27.9	24.8	22.1	20.7	20.5	28.2	80.8	26.5	47.5	10.2	19.7	28.2	70.9	36.4	28.0	32.0	11.2	21.6	84.8	15.5	16.6	144.2	68.9	23.6	39.1	28.5	39.8	31.7	56.5	39.0	87.3	19.7	27.3	28.3	56.5	20.6	18.9	50.4	69.0	30.2	23.1	25.5	25.8
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 119.0;HUVEC TERT2: 182.3;LHCN-M2: 312.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		9500	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	31.6	49.7	21.9	11.1	24.2	6.7	15.4	24.4	74.6	24.0	19.9	14.3	6.4	21.3	10.8	26.4	13.9	32.3	50.4	23.1	27.1	20.6	20.0	17.0	9.7	23.0	24.8	16.0	22.8	14.1	11.6	26.0	23.0	23.3	11.2	15.0	7.6	14.1	44.1	9.6	9.6	29.9	23.3	42.2	12.3	7.9	25.9	10.5	44.5	71.4	6.2	23.6	12.8	35.3	6.2	11.8	14.5	8.6	61.8	115.0	6.7	119.0	28.8	50.8	56.8	3.9	8.0	8.9	19.4	55.5	20.7	9.2	18.7	10.1	86.1	10.1	5.3	4.5	32.9	28.7	84.1	2.5	2.4	47.9	27.9	66.5	18.9	28.4	182.3	2.9	19.6	6.1	312.1	0.7	3.0	6.6	9.4	1.8	5.6	5.0	25.2	5.9	12.0	3.1	10.8	3.4	13.3	10.0	11.7	15.0	3.9	3.7	88.7	72.5	17.8	51.2	15.9	5.5	1.8	7.9	9.9	5.3	12.9	3.3	0.7	1.2	1.1	0.8	1.8	1.6	1.3	1.3	0.7	1.3	3.0	2.1	0.2	1.6	0.9	2.3	1.9	0.9	21.9	24.2	24.4	74.6	23.1	27.1	23.0	24.8	23.0	23.3	25.9	35.3	81.5	60.9	6.3	35.9	23.9	41.7	112.5	16.3	48.3	29.3	90.9	57.1	98.7	18.6	20.0	18.4	68.8	51.2	15.3	40.9	37.2	11.2	144.7	55.1	37.3	84.4	21.4	42.1	41.6	14.7	23.2	87.3	45.9	51.9	56.6	16.7	42.8	22.3	19.4	30.3	39.0	37.9	12.2	18.3	70.1	62.6	24.5	33.7	65.8	21.5	5.1	40.5	8.2	28.6	53.8	11.4	27.3	35.0	70.6	33.9	16.8	31.0	34.7	56.5	26.3	82.8	120.3	23.1	12.0	55.5	39.2	181.0	52.7	32.1	30.9	43.2
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.5;tongue: 218.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 5.5;neutrophil: 5.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.5;granulocytes: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	14.7	12.5	18.5	11.0	18.7	1.5	8.7	23.0	27.7	14.0	14.8	63.0	7.7	56.0	11.8	32.5	29.6	12.7	64.8	24.0	20.1	8.5	4.4	12.3	4.6	20.3	21.0	8.6	6.1	4.0	25.3	2.4	19.4	27.5	12.2	10.1	6.3	52.1	164.5	5.1	17.9	64.3	18.1	12.2	26.8	16.0	19.3	5.8	10.9	218.5	5.0	33.7	11.5	18.8	4.7	3.8	23.7	12.7	13.6	10.4	2.6	20.1	14.5	30.3	26.8	2.8	1.0	4.5	4.9	22.2	31.7	0.6	9.1	15.8	25.5	6.4	2.9	1.6	5.6	1.3	15.6	0.5	14.2	15.2	1.1	18.0	8.9	13.4	19.6	8.3	0.4	9.3	24.7	3.3	7.8	6.7	11.2	2.1	8.1	6.0	24.4	2.5	4.4	0.4	10.1	16.4	10.8	0.6	2.4	20.2	3.8	1.4	8.8	14.4	31.4	7.6	6.3	3.4	2.5	3.3	16.6	1.8	15.9	0.0	1.0	0.0	0.2	0.3	0.9	0.4	0.2	0.0	5.5	0.2	0.3	0.7	5.2	0.4	0.1	0.1	1.0	0.5	18.5	18.7	23.0	27.7	24.0	20.1	20.3	21.0	19.4	18.1	19.3	18.8	1.9	6.4	1.5	8.5	0.9	2.0	2.3	4.7	1.8	6.0	1.7	1.4	42.9	1.5	1.8	0.0	6.2	0.1	0.5	0.5	0.0	2.8	8.0	1.7	4.8	4.5	0.0	0.0	4.9	3.4	0.7	6.7	2.0	2.2	0.0	1.7	3.6	1.2	4.7	1.7	3.3	0.3	2.0	1.9	11.1	6.7	1.5	3.6	5.4	1.9	1.2	12.0	2.1	6.6	3.2	4.3	0.0	7.9	0.7	1.5	1.6	4.4	1.0	2.7	6.6	14.7	16.8	6.3	1.3	1.8	3.0	0.8	1.4	1.5	0.3	0.7
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	82.7	66.0	112.4	55.9	119.0	183.2	87.0	124.0	219.8	76.0	125.6	103.7	43.5	81.5	109.4	117.0	73.8	50.5	121.0	119.5	122.2	73.3	49.8	69.9	54.8	122.8	122.8	76.6	43.6	57.6	65.2	73.7	123.7	58.1	49.2	87.4	74.8	70.5	328.3	132.7	56.9	73.3	120.3	59.3	62.1	118.2	118.5	81.1	52.6	177.5	68.0	92.7	90.8	139.5	179.8	106.7	127.0	130.9	126.3	113.1	117.6	196.2	159.8	179.1	194.4	146.4	176.0	68.7	359.2	146.9	162.4	111.9	87.3	137.8	275.3	138.3	119.6	123.1	61.7	104.6	116.1	92.4	99.4	100.2	130.7	136.1	64.2	178.9	135.6	72.2	203.8	66.9	232.5	121.7	232.4	181.0	255.7	126.1	141.2	122.7	91.1	96.0	148.9	108.1	76.5	201.2	153.5	119.3	151.2	259.6	87.2	129.8	170.0	113.0	85.4	270.6	172.0	126.1	193.1	80.9	160.1	208.7	146.4	345.1	160.8	201.9	133.8	168.2	135.2	134.8	120.8	138.4	120.2	124.0	152.0	141.7	287.8	148.0	206.3	109.9	159.6	247.0	112.4	119.0	124.0	219.8	119.5	122.2	122.8	122.8	123.7	120.3	118.5	139.5	225.2	48.1	62.7	41.1	150.9	756.7	640.9	632.6	182.7	100.4	281.8	175.9	115.0	62.9	206.8	97.5	81.3	276.9	287.0	143.0	193.7	134.9	105.8	225.6	125.2	178.8	193.5	131.1	49.4	69.4	241.8	159.8	66.8	296.3	212.7	70.5	101.4	46.7	164.7	94.2	56.4	149.8	223.8	133.7	803.5	126.4	151.0	339.2	282.8	60.9	313.6	122.7	173.0	37.2	73.5	138.5	132.4	202.3	132.9	413.2	82.4	196.1	253.8	104.0	98.6	146.0	198.8	319.4	504.8	204.1	960.5	508.1	288.0	111.4	155.1	876.8
DNAJB7	HSC3	ENSG00000172404	"DnaJ heat shock protein family (Hsp40) member B7"	Q7Z6W7	22	40859549-40862113	"Predicted intracellular proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"testis: 10.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 553.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA000534	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA000534: AB_1078693"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.46e-4)"	"unprognostic (3.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.45e-2)"	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.8	0.7	0.2	0.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	10.4	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.4	0.4	0.2	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.7	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	0.4	0.8	0.0	0.0	553.5	1.5	0.8	0.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.4	4.5	0.2	0.0	0.0	0.1	1.7	0.5	0.4	0.0	0.0	0.0	98.5	2.8	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.7	0.0	0.0	2.6	0.1	0.1	6.0	0.0	0.0	11.2	0.0	0.3	0.1	2.9	1.5	0.0	0.0	0.3	0.2	0.2	0.9	0.1
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569867-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 350.9;Plasma cells: 409.3;Syncytiotrophoblasts: 569.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 116.5;Karpas-707: 109.3;U-266/70: 191.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	21.9	58.4	16.2	21.5	17.1	40.8	29.9	18.0	22.5	34.8	27.0	20.6	23.4	23.9	62.8	13.3	19.4	22.3	45.3	16.8	23.5	63.2	103.8	21.4	21.1	18.8	21.3	27.9	71.6	21.4	43.5	41.6	20.8	28.4	19.4	23.1	41.7	44.6	34.8	10.9	20.7	21.9	19.6	17.6	25.7	33.7	18.5	15.9	77.8	26.3	31.1	28.9	11.5	20.0	9.4	10.6	14.2	16.3	38.6	27.6	31.2	33.6	40.8	18.2	21.8	10.7	17.5	12.4	36.6	10.7	56.6	11.2	16.0	8.3	18.7	13.2	8.7	6.6	7.2	33.0	116.5	9.8	12.3	19.5	63.2	10.8	58.6	41.1	19.3	7.0	9.7	109.3	29.0	14.0	9.3	11.5	14.2	11.0	5.9	6.0	14.3	65.8	15.1	6.1	9.8	20.5	12.4	55.7	65.2	39.4	10.4	13.6	22.4	19.1	9.0	24.0	11.8	191.8	66.0	14.0	16.8	12.7	17.6	75.9	19.3	9.4	34.1	15.0	59.0	24.5	36.2	34.2	14.3	21.2	20.2	23.5	5.3	26.0	17.0	78.1	22.6	30.3	16.2	17.1	18.0	22.5	16.8	23.5	18.8	21.3	20.8	19.6	18.5	20.0	65.7	3.2	28.8	10.1	110.3	185.6	102.4	123.1	71.7	40.3	129.4	58.9	65.6	44.3	75.1	53.3	8.4	106.7	95.0	28.0	49.0	47.5	350.9	46.1	38.1	55.3	66.6	44.9	14.5	45.7	123.0	121.2	51.0	92.5	92.1	16.2	33.5	185.9	40.1	20.2	15.6	76.8	69.2	37.8	190.5	211.4	38.2	60.2	339.7	11.2	16.0	90.4	23.7	8.5	11.2	33.0	32.3	46.3	409.3	144.7	31.3	155.6	35.4	33.3	39.5	49.4	129.0	157.0	89.9	39.4	158.7	569.4	115.1	18.6	28.8	79.5
DNAJC1	"DNAJL1, ERdj1, MTJ1"	ENSG00000136770	"DnaJ heat shock protein family (Hsp40) member C1"	Q96KC8	10	21756548-22003769	"Predicted membrane proteins, Transcription factors"		"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013432	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA013432: AB_1847797"	"unprognostic (7.00e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (4.44e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.22e-2)"	17.6	16.9	9.9	16.3	11.2	18.3	20.0	10.6	13.1	17.8	15.0	20.6	28.3	15.5	13.4	16.3	14.2	17.7	15.8	9.0	12.9	23.0	36.9	24.0	15.6	12.1	11.1	14.0	38.5	45.6	19.6	19.9	12.4	23.7	18.7	7.1	40.7	16.3	12.7	14.3	22.4	15.8	11.5	15.2	28.6	9.4	11.3	13.1	29.0	11.2	13.0	26.5	15.2	12.7	38.5	24.5	53.9	20.1	49.3	34.9	23.4	50.9	22.1	20.8	32.7	33.8	33.1	16.9	21.9	31.2	31.2	36.1	12.3	25.7	11.5	88.6	41.1	40.3	18.8	20.3	119.5	3.0	16.5	35.8	46.5	24.7	28.3	30.4	27.8	16.4	42.7	93.6	23.8	39.2	9.6	12.9	7.1	33.2	20.3	13.8	18.8	62.3	29.1	9.1	11.3	17.1	37.7	62.2	38.1	58.7	19.8	42.8	42.7	20.3	43.5	34.4	29.3	29.8	10.0	11.7	30.3	126.1	12.3	11.8	16.6	7.0	36.2	16.6	36.5	8.4	20.2	29.1	15.3	12.3	12.9	16.5	9.3	34.2	30.9	39.6	15.8	15.0	9.9	11.2	10.6	13.1	9.0	12.9	12.1	11.1	12.4	11.5	11.3	12.7	56.4	35.3	26.9	73.4	46.7	38.7	64.8	26.6	30.1	27.9	67.9	76.1	16.9	57.2	31.0	31.3	45.9	16.7	92.9	52.4	27.4	73.6	47.6	40.9	74.6	54.7	38.3	49.0	134.4	74.2	92.6	67.4	59.7	58.3	41.8	14.3	52.8	84.5	55.0	38.7	77.1	75.8	28.5	43.7	52.5	19.6	94.8	44.2	67.6	112.4	46.9	37.4	99.9	91.5	137.7	80.6	49.2	67.0	202.7	71.2	57.9	80.1	23.9	149.1	59.2	49.3	56.7	232.2	109.5	45.3	44.2	35.3	81.5	41.0	55.8	71.9
DNAJC10	"ERdj5, PDIA19"	ENSG00000077232	"DnaJ heat shock protein family (Hsp40) member C10"	Q8IXB1	2	182716255-182794464	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 113.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031111	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"			"HPA031111: AB_10601211"	"unprognostic (3.29e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.10e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (2.19e-7)"	"unprognostic (2.91e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.87e-2)"	21.2	15.0	5.5	30.1	6.4	8.4	22.5	5.9	6.3	29.0	7.7	20.5	19.4	40.4	113.9	13.6	30.2	27.3	18.2	6.5	10.0	19.7	15.0	18.5	32.4	7.9	7.4	24.6	33.0	28.5	20.2	24.6	7.6	24.0	28.0	15.6	24.1	28.9	9.2	8.3	20.3	28.0	7.1	26.1	35.2	38.9	6.6	18.7	37.0	10.8	40.1	22.6	12.3	9.5	25.6	29.0	42.8	28.5	60.2	72.7	45.4	49.6	85.5	34.9	49.4	43.6	65.9	126.0	50.0	58.0	53.1	29.4	26.5	47.4	64.4	44.5	22.4	23.5	35.1	43.9	55.6	68.0	51.4	41.3	57.3	47.3	109.0	70.1	87.7	23.9	32.3	52.4	41.1	16.4	21.0	10.8	48.5	46.3	46.0	28.6	31.7	114.9	48.2	38.4	30.6	33.1	35.1	42.6	28.5	69.9	21.0	21.9	79.6	70.8	44.9	36.0	39.8	32.5	51.0	45.2	83.0	43.7	58.5	1.7	12.3	0.9	5.5	10.6	7.2	22.4	5.8	6.5	15.7	16.7	4.7	5.7	0.9	7.2	9.8	5.9	4.8	9.3	5.5	6.4	5.9	6.3	6.5	10.0	7.9	7.4	7.6	7.1	6.6	9.5	49.6	44.8	22.0	34.3	79.9	17.2	21.1	18.8	18.2	36.0	38.6	27.8	44.1	34.3	39.5	57.0	18.8	11.7	22.9	12.5	5.9	45.3	219.8	103.0	61.5	51.9	32.4	23.4	46.2	61.9	41.5	49.4	43.8	115.5	30.9	46.0	34.6	23.4	38.7	23.5	38.3	117.3	40.7	29.3	29.1	55.1	36.4	40.6	19.6	48.7	41.2	22.8	27.8	37.7	47.2	44.0	19.9	44.4	67.9	38.8	6.8	19.4	132.0	30.5	46.0	40.2	53.8	112.6	41.7	20.6	14.8	10.8	28.8	32.8	21.5	18.6
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023707, HPA028705"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA023707: , HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	16.9	28.3	15.8	19.1	16.3	14.5	16.3	14.5	20.0	15.2	11.9	28.6	27.2	17.2	12.7	24.2	15.5	12.5	37.2	17.7	15.1	54.5	28.8	13.6	19.0	17.9	16.5	18.7	19.0	24.5	12.7	17.7	18.1	15.4	31.7	16.5	17.1	13.8	44.0	20.3	23.3	17.6	13.5	23.3	21.7	16.5	17.8	15.4	14.6	35.9	18.5	18.6	16.2	17.7	44.5	41.5	47.6	44.3	40.5	28.6	44.7	42.6	36.5	82.7	58.9	51.2	61.7	70.0	41.2	49.2	35.3	58.1	82.9	69.1	72.1	40.0	57.6	71.0	84.1	51.4	40.7	85.4	37.6	42.3	19.0	74.8	48.7	29.2	39.6	52.2	92.6	29.7	42.3	35.5	53.6	45.1	49.9	60.2	71.9	60.0	41.7	50.9	53.0	37.3	64.9	46.0	49.3	98.2	55.4	39.9	39.1	44.6	40.5	48.9	26.1	40.9	51.7	34.5	40.7	91.2	48.1	93.5	25.0	10.2	9.6	3.4	8.7	12.8	8.8	7.5	6.2	9.4	12.1	8.4	6.6	5.2	0.3	10.0	14.4	5.3	7.6	9.2	15.8	16.3	14.5	20.0	17.7	15.1	17.9	16.5	18.1	13.5	17.8	17.7	11.9	9.6	11.8	17.3	9.7	19.6	4.4	9.1	4.6	18.5	8.6	9.8	9.7	2.8	9.7	12.9	29.2	21.4	5.3	33.4	35.2	14.2	14.9	8.6	13.1	9.3	14.6	25.2	28.6	13.7	22.8	10.3	23.0	10.5	5.1	27.4	5.0	14.1	16.7	20.2	35.8	22.9	14.2	8.2	24.2	9.3	8.1	9.6	28.4	18.7	8.4	11.8	6.2	15.6	23.3	11.1	19.6	4.5	13.3	6.5	37.2	32.4	12.0	17.7	6.6	11.8	13.7	17.0	11.6	14.5	18.3	23.8	8.9	24.9	36.4	5.3
DNAJC12	JDP1	ENSG00000108176	"DnaJ heat shock protein family (Hsp40) member C12"	Q9UKB3	10	67796669-67838188	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.3;liver: 67.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 7.7"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 7.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036289	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA036289: AB_10670794"	"unprognostic (1.52e-2)"	"unprognostic (3.65e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (7.31e-3)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (7.35e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.81e-3)"	"unprognostic (7.99e-2)"	2.0	70.3	23.3	2.3	26.3	1.5	30.2	36.5	28.5	6.0	12.8	9.1	3.2	7.3	5.9	1.2	3.4	5.4	6.6	26.3	29.1	29.5	67.5	1.6	0.6	22.5	50.1	15.0	37.0	6.6	41.1	0.1	29.0	7.6	14.2	13.6	5.4	4.8	10.9	0.3	4.7	6.0	19.7	1.2	6.6	7.0	23.2	2.1	1.5	9.9	0.7	4.4	3.3	23.4	0.0	32.9	5.3	0.9	7.5	6.1	0.1	0.1	2.0	1.1	6.8	0.5	0.0	91.5	13.4	0.1	0.4	0.0	0.9	1.2	0.3	4.4	36.9	21.9	26.9	8.5	7.9	41.7	0.5	19.3	7.6	3.2	1.9	0.1	11.4	2.6	40.5	1.2	3.2	1.8	2.0	76.0	1.5	0.4	36.4	1.2	3.0	48.2	0.8	0.0	72.0	41.1	0.5	14.4	1.3	0.3	0.7	0.4	0.0	3.5	1.0	0.8	1.0	8.6	1.0	68.2	6.6	49.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	23.3	26.3	36.5	28.5	26.3	29.1	22.5	50.1	29.0	19.7	23.2	23.4	1.5	0.0	1.1	2.9	2.1	0.3	2.2	1.4	0.6	31.9	75.9	35.6	9.3	1.5	13.0	5.5	6.2	0.1	0.6	7.2	9.8	1.5	5.6	2.2	24.8	2.3	166.2	9.1	12.3	55.9	0.1	8.7	6.1	1.6	0.0	2.0	1.4	74.5	0.6	38.7	14.8	98.0	8.2	2.6	0.4	4.2	16.1	3.1	0.0	1.0	3.7	13.5	0.0	11.6	13.6	43.4	4.1	21.4	0.4	26.3	1.1	163.2	20.3	5.5	0.0	4.6	5.3	2.8	0.7	0.2	0.1	0.0	0.9	21.6	4.4	1.3
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417502-132539032	"Human disease related genes, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	11.7	9.4	5.9	12.4	6.5	15.5	11.4	6.0	6.3	12.9	8.2	14.4	10.9	13.8	11.7	10.7	9.9	9.9	12.9	5.9	6.9	16.0	9.8	11.3	11.0	7.7	6.9	11.7	6.8	12.6	5.9	15.4	7.1	10.8	14.3	10.7	9.1	12.1	12.5	9.8	10.4	16.7	6.3	12.2	9.7	7.8	7.5	12.0	15.7	14.2	10.6	12.4	10.3	7.8	31.0	18.0	22.2	10.9	54.3	46.7	13.7	32.3	62.5	31.4	33.8	20.4	18.2	15.7	20.5	46.3	41.1	24.1	22.1	24.3	43.5	18.3	6.4	20.6	17.1	13.6	27.6	21.1	18.3	34.2	16.4	28.5	35.1	22.7	44.6	26.0	11.4	25.6	43.7	24.1	16.8	9.1	12.7	26.7	15.8	15.9	16.5	13.0	27.7	32.4	7.9	11.9	31.6	16.7	36.1	19.0	24.7	17.8	40.9	34.7	17.8	33.3	13.9	14.8	15.7	21.5	36.8	13.6	25.2	2.0	2.6	0.4	0.8	2.2	0.7	1.0	0.9	0.7	2.8	0.4	0.6	0.8	0.5	0.7	4.0	1.4	0.4	0.8	5.9	6.5	6.0	6.3	5.9	6.9	7.7	6.9	7.1	6.3	7.5	7.8	16.8	12.8	21.9	45.7	14.4	6.6	7.3	7.3	6.8	10.8	8.9	7.2	47.2	8.6	11.3	12.9	33.3	7.9	13.2	21.5	1.9	9.0	1.7	10.3	31.3	17.1	14.4	12.8	48.7	9.1	7.7	20.2	16.8	18.7	12.0	18.9	13.2	8.5	20.5	67.3	48.7	12.5	0.0	34.2	9.2	3.6	15.2	26.5	28.4	60.0	25.1	13.3	6.2	46.8	64.7	11.7	12.5	21.4	13.9	10.5	17.0	18.7	13.1	11.5	6.6	22.3	19.7	5.3	13.7	15.4	7.5	5.1	10.8	22.5	13.4	11.0
DNAJC14	"DNAJ, DRIP78, FLJ32792, HDJ3, LIP6"	ENSG00000135392	"DnaJ heat shock protein family (Hsp40) member C14"	Q6Y2X3	12	55820960-55830824	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017653	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"			"HPA017653: AB_1847799"	"unprognostic (2.54e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.91e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.92e-2)"	14.0	13.2	14.2	15.4	14.8	16.3	15.6	13.4	14.2	16.0	14.2	14.2	13.8	15.4	16.9	11.3	17.4	12.6	12.2	14.0	13.3	16.4	16.9	15.2	16.9	14.5	14.6	12.8	13.5	24.6	11.5	16.2	13.8	14.8	15.0	12.3	15.5	13.4	11.2	13.2	15.0	16.1	13.8	17.6	14.6	18.6	14.6	23.6	17.7	11.3	19.0	14.2	10.4	16.2	25.0	29.7	31.9	32.3	31.3	29.5	36.1	27.6	35.8	35.2	25.5	24.2	41.5	31.5	51.9	31.4	24.3	26.9	28.7	34.4	32.1	50.8	20.6	43.6	28.0	20.4	32.4	26.5	35.9	26.5	28.3	35.4	32.8	52.4	38.7	45.7	34.0	36.4	40.6	29.5	48.8	26.3	25.1	24.8	24.8	39.6	28.5	27.6	32.4	21.3	43.1	40.2	22.2	30.5	21.0	30.6	64.1	40.1	33.6	33.2	30.6	31.2	22.6	43.7	40.7	27.7	33.7	24.1	42.1	14.8	9.5	16.1	12.9	8.4	10.2	10.3	9.6	11.6	9.1	7.4	8.4	10.5	7.8	11.3	11.5	11.6	8.4	11.1	14.2	14.8	13.4	14.2	14.0	13.3	14.5	14.6	13.8	13.8	14.6	16.2	9.2	6.4	7.7	1.6	6.8	4.0	4.0	8.1	5.7	7.1	7.5	4.2	0.8	7.2	9.0	11.0	10.4	10.0	6.7	9.6	3.9	9.8	4.5	7.1	7.7	8.1	7.2	10.8	3.9	7.7	14.1	6.4	7.7	6.8	1.3	9.7	5.3	7.4	9.8	1.7	3.8	5.2	0.0	12.5	10.7	4.7	9.6	9.2	7.2	3.7	8.6	7.9	13.4	1.5	5.5	9.3	7.7	9.1	8.5	5.6	8.0	7.5	6.9	5.2	6.6	7.4	11.5	6.8	10.0	5.1	4.1	13.0	6.3	7.7	7.2	3.5
DNAJC16	KIAA0962	ENSG00000116138	"DnaJ heat shock protein family (Hsp40) member C16"	Q9Y2G8	1	15526813-15592379	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043643	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA043643: AB_10796794"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (4.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.74e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.70e-2)"	4.9	5.2	4.5	5.5	5.3	2.2	6.5	5.4	6.5	5.0	7.8	6.0	6.5	5.6	7.6	5.4	6.8	4.5	5.1	5.3	4.9	11.5	10.1	4.8	6.2	4.2	4.4	5.7	6.4	10.0	5.3	5.8	4.8	5.5	5.9	9.0	7.0	4.8	11.9	5.6	5.8	6.3	4.1	5.7	5.4	6.3	5.0	5.1	7.4	6.3	6.4	5.2	4.6	6.4	8.8	8.7	6.7	12.4	18.0	14.5	6.3	10.4	10.7	10.2	10.9	7.1	12.7	7.6	6.8	10.3	13.3	10.7	8.3	9.2	14.3	9.0	4.0	7.8	9.6	12.2	17.8	12.2	8.7	10.5	10.6	16.4	9.2	12.7	11.6	6.3	16.9	6.7	11.8	3.6	6.2	6.2	6.5	7.9	5.6	7.3	8.6	8.5	12.6	6.0	7.5	7.0	10.6	10.1	9.0	9.6	6.3	4.8	15.7	17.9	6.4	16.7	5.7	9.1	13.8	6.6	11.1	6.9	8.7	2.0	2.1	1.5	2.6	2.0	3.9	3.4	2.8	2.4	2.1	3.1	3.5	3.0	1.1	1.6	1.5	1.9	2.8	1.9	4.5	5.3	5.4	6.5	5.3	4.9	4.2	4.4	4.8	4.1	5.0	6.4	11.6	0.0	8.7	25.5	12.4	5.1	4.3	13.8	9.6	14.9	16.1	8.4	16.9	22.8	14.9	25.8	22.9	12.8	11.5	13.7	1.9	9.1	11.6	25.5	19.0	12.0	11.5	4.6	33.5	6.9	7.7	10.5	11.7	17.6	8.2	14.0	16.4	20.5	10.9	18.5	28.6	9.7	18.3	20.6	5.5	5.8	12.5	9.5	7.2	17.8	11.4	12.8	12.3	19.1	28.8	9.3	7.5	11.3	6.8	12.6	10.6	19.0	37.5	16.0	6.6	11.7	7.8	24.7	15.7	13.0	5.8	22.0	7.1	11.4	13.4	8.2
DNAJC17	FLJ10634	ENSG00000104129	"DnaJ heat shock protein family (Hsp40) member C17"	Q9NVM6	15	40765161-40807478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040914, HPA041187"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA040914: AB_10794072, HPA041187: AB_10794192"	"unprognostic (9.79e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.58e-2)"	13.2	11.1	6.9	9.9	6.7	6.3	13.4	9.3	9.3	12.5	4.6	13.8	8.2	14.6	9.6	12.5	14.2	10.1	8.8	6.5	6.4	12.0	14.8	11.1	13.6	6.5	6.5	17.1	9.8	16.8	8.9	13.9	6.6	9.7	11.4	5.4	9.2	11.2	8.0	12.2	10.8	12.7	5.8	12.2	10.6	4.5	6.7	16.2	11.8	11.2	16.8	10.9	10.7	7.3	10.8	9.6	23.8	23.1	10.5	26.2	10.1	19.9	19.5	32.7	26.7	7.7	15.1	16.6	21.5	23.9	15.0	22.2	24.4	32.6	28.9	30.8	15.3	28.1	19.2	7.6	29.8	14.7	24.0	26.2	20.6	25.8	46.2	18.2	30.5	28.0	20.0	8.6	25.3	13.6	21.5	19.7	8.6	25.3	14.1	15.7	19.8	8.6	33.2	19.5	15.0	9.6	14.4	13.4	10.2	16.8	17.0	29.1	30.0	18.5	16.0	21.0	17.1	9.6	31.0	36.5	11.9	37.1	15.9	30.0	21.5	28.9	24.5	28.6	17.6	19.8	21.2	23.7	24.3	19.4	22.4	21.8	7.9	13.3	17.0	19.8	39.2	14.1	6.9	6.7	9.3	9.3	6.5	6.4	6.5	6.5	6.6	5.8	6.7	7.3	26.6	12.8	16.4	9.4	16.5	5.6	19.2	40.6	8.6	15.0	24.3	14.7	5.8	22.8	33.2	25.8	12.5	25.1	15.5	17.5	19.6	18.9	3.2	13.4	15.8	16.2	7.8	9.4	13.0	17.5	15.8	14.7	12.8	16.9	22.1	13.6	19.6	14.4	22.5	13.5	15.0	16.1	20.3	10.3	10.6	2.0	15.2	13.1	7.2	12.2	13.0	8.5	36.0	11.6	16.1	16.9	24.6	16.1	9.9	12.8	30.6	27.2	20.2	10.4	0.0	14.5	22.6	5.6	4.7	16.3	5.3	17.2	16.7	16.6	16.9	20.6
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 77.9"	"Group enriched"	"Detected in many"	21	"Early spermatids: 529.9;Late spermatids: 1332.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions"	Cytosol	"HPA036538: AB_10670802, HPA060154: AB_2684212"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	6.1	3.1	7.7	1.5	7.4	0.9	5.2	7.9	9.5	6.9	4.5	5.8	0.7	6.5	2.3	2.4	6.6	2.1	6.6	7.2	8.3	5.1	1.0	6.8	1.7	8.3	7.2	7.5	1.9	3.6	8.0	2.1	8.6	4.5	1.3	7.6	3.0	2.9	7.5	2.4	3.4	3.5	6.6	2.8	3.5	77.9	7.6	1.6	4.3	4.3	1.2	5.4	4.7	8.1	1.2	1.2	7.9	7.4	4.3	4.5	0.9	2.4	5.3	4.2	7.6	2.9	0.9	5.4	6.4	3.8	9.2	2.1	4.5	7.3	4.4	12.5	5.9	3.7	2.6	1.3	3.4	0.4	1.7	6.1	0.9	7.0	4.3	7.1	5.8	2.0	1.7	5.1	6.3	0.6	1.6	1.7	5.4	0.4	1.8	4.5	8.5	0.9	2.5	1.3	7.3	7.6	2.5	0.9	5.8	10.1	1.1	2.7	7.5	5.5	0.0	1.7	5.2	6.0	8.6	2.8	2.9	2.7	2.4	0.5	0.4	0.5	0.5	0.3	0.7	0.8	0.7	0.9	0.3	0.9	0.7	0.4	0.1	1.4	0.2	0.5	1.7	0.3	7.7	7.4	7.9	9.5	7.2	8.3	8.3	7.2	8.6	6.6	7.6	8.1	14.9	3.2	3.9	12.7	5.0	1.5	8.3	9.4	7.4	29.4	2.2	5.5	11.0	2.8	5.8	1.8	10.4	4.7	7.0	0.7	1.9	4.9	529.9	2.1	11.0	15.2	12.6	1.7	33.1	1.1	3.4	11.3	2.0	2.3	9.5	14.4	13.6	0.2	2.9	16.8	39.0	2.1	0.0	3.5	2.4	1332.4	14.0	3.4	5.4	8.4	3.7	13.7	3.1	17.6	22.1	2.0	1.7	18.8	7.6	3.9	0.8	3.6	3.3	20.1	19.7	21.1	14.2	43.8	12.9	2.6	1.1	4.7	4.2	9.8	1.3	3.4
DNAJC19	"Pam18, Tim14, TIMM14"	ENSG00000205981	"DnaJ heat shock protein family (Hsp40) member C19"	Q96DA6	3	180983709-180989774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	Cardiomyopathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 471.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037782	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA037782: AB_10672611"	"unprognostic (4.52e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (8.53e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-3)"	22.7	44.1	26.1	11.1	27.1	10.8	26.4	27.2	39.7	19.4	28.8	27.5	21.4	18.9	33.0	22.9	21.3	11.8	73.4	27.2	28.0	50.2	48.9	14.7	16.3	26.4	29.3	26.5	27.9	34.7	30.9	14.2	26.3	22.6	17.7	27.2	28.1	18.2	65.8	15.0	18.1	11.8	27.6	18.5	26.2	11.6	26.8	20.7	25.6	77.8	13.4	23.5	18.4	28.1	53.9	14.0	38.8	29.6	45.6	27.0	35.4	30.2	18.2	29.1	25.5	49.0	26.2	23.0	63.9	25.5	70.9	26.8	37.8	36.5	35.9	36.5	49.1	27.0	24.5	48.3	48.9	64.9	27.5	25.9	29.8	24.4	43.0	37.9	34.0	55.2	42.8	35.8	23.0	44.2	48.5	54.6	51.2	75.9	44.8	31.4	26.9	69.6	43.3	24.8	38.7	20.6	30.8	75.8	82.3	44.0	85.2	45.2	16.8	18.5	27.1	26.3	54.4	47.7	60.7	80.1	19.0	49.9	22.9	33.6	20.4	31.5	33.3	22.3	39.8	34.7	38.5	34.7	28.6	29.8	39.8	40.6	4.4	26.8	27.3	36.4	35.0	30.8	26.1	27.1	27.2	39.7	27.2	28.0	26.4	29.3	26.3	27.6	26.8	28.1	68.3	38.5	52.5	11.1	66.3	56.6	68.6	105.4	56.9	31.7	138.6	183.0	151.7	120.1	70.1	77.3	14.6	116.6	67.4	57.9	471.6	83.9	9.1	57.4	50.4	61.4	45.2	48.8	18.7	109.3	111.2	71.7	30.1	42.7	110.7	79.7	68.6	167.0	68.0	48.8	20.5	90.7	91.6	35.5	59.8	13.2	85.1	42.8	74.7	9.4	58.6	91.4	74.2	13.0	21.4	79.9	66.1	72.6	47.7	91.5	101.0	216.8	58.7	67.6	85.5	80.3	108.8	82.1	56.3	73.9	60.1	68.7	68.4	121.4	86.7	69.2
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312289-103344830	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	15.7	13.4	10.2	12.2	10.7	42.0	13.4	12.7	19.2	13.1	10.5	11.9	14.7	12.8	9.7	13.8	12.1	9.8	13.5	10.5	10.4	16.4	15.7	11.2	16.8	10.0	10.7	15.7	13.4	9.0	12.6	11.9	10.3	12.3	11.9	8.7	12.6	7.7	32.5	13.6	11.9	7.4	9.3	12.2	12.9	31.3	11.4	12.3	12.7	12.7	13.2	18.8	12.8	11.8	52.7	38.1	21.4	38.7	16.1	22.6	41.6	35.1	25.8	38.5	28.6	52.9	37.2	74.9	53.7	24.4	55.2	35.5	57.5	25.7	58.4	40.6	43.4	55.1	38.7	47.3	28.6	97.9	41.2	19.6	21.9	44.9	39.4	16.2	25.6	27.8	128.3	46.2	32.0	83.8	95.0	102.1	75.9	56.8	57.0	59.7	43.0	70.1	22.8	24.8	40.6	38.7	47.7	66.2	39.7	39.6	28.1	49.8	30.8	37.5	59.9	83.3	68.1	48.9	67.8	146.0	27.3	97.9	47.6	61.3	9.0	9.3	10.9	10.3	12.1	11.7	10.9	11.7	9.4	13.7	12.5	12.5	3.6	16.4	15.3	11.2	12.8	5.9	10.2	10.7	12.7	19.2	10.5	10.4	10.0	10.7	10.3	9.3	11.4	11.8	31.3	25.6	47.0	10.7	46.1	64.6	78.7	37.3	35.3	27.1	26.3	36.6	32.3	22.8	50.2	22.0	41.7	43.7	45.9	31.1	35.2	45.0	248.5	43.8	50.1	39.6	35.3	29.9	24.7	46.0	75.5	41.0	42.8	44.2	53.7	50.1	18.5	30.6	39.6	21.9	17.9	39.0	26.4	24.5	41.3	37.3	39.4	37.8	19.6	13.1	42.9	19.3	44.3	24.1	20.6	50.2	32.9	31.2	36.9	79.2	36.4	31.0	43.4	29.0	39.5	63.7	64.8	238.7	131.9	33.5	62.1	55.4	43.2	58.3	51.9	91.5
DNAJC21	"DNAJA5, GS3, JJJ1"	ENSG00000168724	"DnaJ heat shock protein family (Hsp40) member C21"	Q5F1R6	5	34929559-34958964	"Disease related genes, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040789	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA040789: AB_10794147"	"unprognostic (1.37e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.77e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.68e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.02e-2)"	18.2	12.7	9.5	13.8	10.9	24.1	16.1	10.0	12.1	22.2	9.9	20.1	15.2	16.3	14.3	20.7	11.4	13.6	32.0	8.3	11.0	23.0	23.0	17.5	18.5	10.7	10.5	11.8	20.0	19.4	8.1	24.5	10.7	18.1	18.5	9.3	15.8	17.5	58.4	15.1	15.8	18.2	10.2	12.6	18.8	61.4	10.6	18.0	18.0	42.3	19.7	20.8	16.7	11.0	36.2	25.3	32.0	41.6	39.1	46.4	57.1	47.4	38.9	37.7	25.2	41.6	42.8	75.9	20.1	44.3	46.6	24.3	37.9	49.0	43.8	45.2	27.8	41.7	90.7	35.2	64.6	60.7	37.7	33.2	44.8	41.6	67.7	26.2	35.3	27.8	65.6	59.7	28.1	30.4	51.3	45.2	22.6	39.8	21.4	45.5	79.2	33.7	37.9	44.9	16.5	17.5	128.1	59.4	40.2	35.2	40.1	64.4	43.4	46.5	44.7	27.8	37.7	40.2	40.0	51.0	37.6	71.8	25.1	2.2	1.5	4.7	1.7	1.2	2.5	3.1	2.5	1.6	2.5	2.0	2.5	2.5	0.4	4.0	2.0	2.3	3.4	1.0	9.5	10.9	10.0	12.1	8.3	11.0	10.7	10.5	10.7	10.2	10.6	11.0	53.5	76.9	111.3	23.8	42.0	37.0	73.9	22.4	33.6	52.6	57.0	56.6	151.1	47.1	36.1	36.8	43.8	51.2	59.1	34.6	88.0	21.5	117.5	49.2	77.8	44.9	18.0	40.0	26.9	30.5	25.7	44.4	32.6	68.4	8.2	42.0	37.5	59.5	24.3	75.7	40.4	36.9	6.1	31.4	32.9	47.7	40.4	38.8	37.4	15.0	50.8	31.2	45.3	20.1	32.1	26.6	27.7	38.0	41.4	85.8	28.2	62.5	22.8	73.0	13.1	57.0	44.0	117.4	50.3	43.4	46.7	65.7	52.7	51.4	41.4	77.1
DNAJC24	"DPH4, JJJ3, ZCSL3"	ENSG00000170946	"DnaJ heat shock protein family (Hsp40) member C24"	Q6P3W2	11	31369840-31432835	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 204.8;Late spermatids: 223.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020025, HPA025237"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA020025: AB_1847801, HPA025237: AB_1847802"	"unprognostic (2.07e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-1)"	7.2	6.3	6.7	5.4	6.7	1.9	6.8	8.5	8.9	4.8	5.8	4.8	4.4	5.9	6.4	5.3	3.1	4.9	11.8	7.0	7.4	6.4	6.0	4.3	6.8	6.7	7.0	4.6	7.3	4.7	4.6	5.0	6.7	5.7	4.4	8.3	5.8	5.9	17.0	8.8	4.5	6.3	6.5	5.8	5.0	4.4	6.9	5.2	6.6	11.3	5.7	5.6	3.4	7.1	4.8	6.4	11.2	8.2	8.7	10.9	4.9	12.7	8.0	7.0	7.3	5.2	4.5	6.3	6.7	8.6	10.4	6.2	6.4	8.2	12.2	14.8	11.9	6.9	10.2	5.3	11.1	14.0	10.9	10.3	10.4	4.3	13.8	10.2	9.5	10.7	13.3	10.9	14.0	5.0	10.8	9.4	5.7	7.0	6.7	6.7	18.8	6.5	10.3	4.5	4.9	6.9	11.0	7.5	11.0	6.3	10.5	9.1	10.0	13.1	8.9	16.3	15.8	13.3	11.3	7.6	19.3	6.6	14.9	4.5	1.0	0.9	2.2	1.8	3.1	1.5	2.2	1.9	0.8	1.6	2.8	2.9	0.7	1.3	1.1	1.6	1.5	1.3	6.7	6.7	8.5	8.9	7.0	7.4	6.7	7.0	6.7	6.5	6.9	7.1	7.5	3.2	7.4	14.0	14.4	12.1	7.0	9.2	6.8	11.9	9.1	7.2	20.3	1.5	9.3	3.7	10.4	8.6	15.5	5.6	3.9	9.1	204.8	6.4	11.0	7.7	7.2	5.2	40.7	9.1	9.4	10.4	7.1	6.3	5.1	5.3	9.3	10.5	8.2	23.5	28.9	5.1	4.1	6.9	10.3	223.9	9.0	8.5	12.4	25.3	7.1	26.2	9.2	41.2	29.9	11.7	6.2	9.4	18.5	7.2	5.2	11.4	4.4	14.6	0.0	9.6	8.3	28.2	18.2	9.5	8.2	6.3	13.5	7.1	5.9	9.1
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631334-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 32.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	3.3	5.2	1.0	2.3	1.1	1.0	2.0	1.0	1.9	1.5	2.5	3.0	2.9	1.7	4.4	1.5	1.8	2.1	2.5	1.1	1.0	5.1	32.1	1.3	0.7	1.4	1.2	1.4	2.9	4.2	1.5	2.7	1.2	3.7	1.6	0.6	4.2	2.2	2.2	1.0	2.4	1.7	0.9	0.7	2.4	1.4	1.0	0.2	2.2	1.7	0.8	3.0	1.3	1.0	2.7	2.0	1.3	2.3	14.1	6.2	5.3	10.4	4.8	3.9	3.7	3.7	1.6	2.4	4.0	7.0	6.1	8.5	1.5	2.9	3.7	1.9	2.0	2.4	0.0	8.0	4.5	4.5	3.3	5.3	8.2	3.0	5.6	3.0	3.3	1.3	4.9	1.8	5.0	2.9	1.3	0.2	2.3	5.1	4.9	2.3	7.3	2.2	8.2	2.8	2.3	1.2	5.7	7.7	3.6	2.3	4.1	0.8	6.5	4.7	2.3	12.9	6.0	3.6	6.0	1.3	8.1	2.1	4.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.0	1.1	1.0	1.9	1.1	1.0	1.4	1.2	1.2	0.9	1.0	1.0	9.9	6.4	11.9	0.0	8.3	10.6	16.2	13.8	6.8	7.9	14.1	12.4	13.9	8.6	16.0	11.0	20.9	14.2	16.7	16.2	13.7	17.1	10.8	18.6	18.2	7.9	17.3	3.0	0.0	16.3	24.7	15.3	10.2	19.5	1.3	8.8	6.4	85.3	12.1	13.5	0.0	21.3	6.1	6.4	10.2	2.5	10.2	10.0	12.4	0.0	6.7	4.6	5.2	0.0	0.0	11.7	7.3	10.1	22.6	29.4	21.7	13.5	18.9	19.9	13.1	13.3	15.7	29.5	16.6	7.0	9.2	13.8	8.8	10.6	15.0	22.7
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favorable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	5.6	3.4	4.3	2.1	5.6	3.8	3.7	7.1	7.0	3.7	4.1	3.7	1.9	4.2	5.0	2.2	4.6	3.0	4.9	4.6	8.7	3.8	2.0	2.7	2.7	7.5	6.5	7.0	2.7	5.1	6.1	2.9	8.2	3.3	2.7	13.3	2.2	3.1	4.6	2.9	2.7	3.0	5.7	2.9	2.9	22.2	6.0	3.5	3.3	7.0	2.4	3.1	2.9	6.5	2.8	1.2	2.6	2.6	3.6	3.0	2.0	2.1	3.2	2.2	1.9	1.3	1.3	2.6	0.5	1.5	1.8	2.2	1.9	1.3	2.3	1.1	1.6	1.6	1.6	1.2	2.3	1.5	2.2	2.3	2.2	1.7	3.5	2.5	0.9	3.1	1.1	2.4	2.4	1.0	2.7	2.6	1.7	1.0	1.1	1.6	5.1	1.4	2.1	1.5	0.9	3.2	2.0	1.5	3.0	2.7	1.3	1.1	0.8	2.9	2.0	1.5	2.0	6.1	2.3	3.1	1.5	2.4	1.3	0.0	0.2	0.9	0.2	0.1	0.5	0.4	0.3	0.2	0.2	0.3	0.4	0.5	0.0	1.3	0.3	0.1	0.3	0.2	4.3	5.6	7.1	7.0	4.6	8.7	7.5	6.5	8.2	5.7	6.0	6.5	7.8	9.6	10.0	19.2	11.2	2.0	5.6	3.6	8.0	24.1	9.8	8.5	25.4	4.3	3.0	7.3	37.5	3.6	10.8	4.5	3.9	2.6	59.8	12.5	9.7	7.7	15.5	11.8	18.2	2.5	2.0	8.8	8.2	5.2	10.8	9.5	6.1	3.4	3.3	37.0	22.1	5.9	6.1	3.2	4.6	32.5	8.7	5.9	1.8	7.5	4.3	12.2	4.1	12.1	24.1	1.7	0.9	6.4	8.8	4.6	4.3	3.1	17.3	25.1	0.0	12.8	23.9	70.7	17.0	8.3	3.3	4.2	11.3	23.2	5.4	3.8
DNAJC28	"C21orf55, C21orf78"	ENSG00000177692	"DnaJ heat shock protein family (Hsp40) member C28"	Q9NX36	21	33485530-33491716	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.0;Early spermatids: 33.3;Proximal tubular cells: 10.4;Spermatocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018003, HPA030076"	Approved					NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA018003: AB_1845695, HPA030076: AB_10602218"	"unprognostic (9.63e-3)"	"unprognostic (4.44e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.92e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.23e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.14e-9)"	"unprognostic (1.84e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	0.6	2.2	0.8	0.1	0.8	0.4	0.7	0.9	1.2	0.5	0.7	1.1	0.3	0.5	1.2	1.1	0.3	0.5	2.9	0.8	0.7	2.6	2.6	0.6	0.2	0.8	0.7	0.4	1.3	1.4	1.5	0.5	0.8	0.8	0.7	1.7	1.4	0.6	2.8	0.6	1.1	0.3	0.5	1.2	1.5	7.0	0.8	0.1	2.5	2.0	0.1	0.7	0.6	0.9	0.3	0.1	1.2	0.4	3.1	0.8	0.3	0.6	0.6	1.2	0.5	0.1	0.5	0.3	0.1	0.0	0.6	0.1	0.1	0.1	0.3	0.1	1.3	0.7	0.2	0.8	0.7	0.0	1.2	0.6	0.6	0.6	0.1	1.0	0.7	0.6	0.4	0.1	0.4	0.4	0.1	0.3	0.6	0.4	0.0	0.3	1.3	0.1	0.6	0.1	0.9	0.6	0.1	0.0	0.3	0.4	1.1	0.2	0.2	0.5	0.2	0.1	0.1	0.5	0.5	0.1	1.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.8	0.9	1.2	0.8	0.7	0.8	0.7	0.8	0.5	0.8	0.9	1.3	0.0	2.2	0.3	0.7	0.4	0.3	1.1	1.8	1.7	1.2	0.9	14.0	1.5	0.5	3.7	0.0	1.3	0.9	1.3	3.9	2.2	33.3	0.7	0.8	1.4	1.2	4.0	2.5	1.3	0.4	1.1	1.1	0.9	3.8	0.8	1.4	4.7	1.0	1.7	2.3	1.1	0.0	2.4	0.3	7.6	0.6	0.9	0.0	1.9	1.3	0.9	0.0	1.0	1.2	1.7	1.2	1.2	2.0	0.6	1.8	10.4	2.4	2.2	0.0	1.1	1.2	13.4	2.0	0.6	0.0	2.3	0.8	3.0	0.6	0.2
DNAJC3	"ERdj6, HP58, P58, p58(IPK), P58IPK, PRKRI"	ENSG00000102580	"DnaJ heat shock protein family (Hsp40) member C3"	Q13217	13	95677139-95794988	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Antiviral defense, Stress response, Translation regulation, Unfolded protein response"	"Chaperone, Repressor"	"Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039336, HPA041326"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		4900000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA039336: AB_2676451, HPA041326: AB_2677412"	"unprognostic (1.44e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.12e-2)"	"prognostic favorable (3.47e-5)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.30e-3)"	"unprognostic (8.18e-2)"	21.0	20.0	10.7	22.5	13.0	45.6	21.3	13.0	11.4	35.1	22.3	25.2	23.8	20.4	38.9	15.9	20.4	22.0	16.6	10.0	14.1	25.5	41.8	22.9	15.0	15.1	12.5	15.8	36.0	24.4	16.2	24.7	15.5	34.5	26.4	9.9	36.3	26.0	9.3	10.9	24.0	22.3	13.4	19.8	28.8	12.7	14.6	11.3	52.8	11.2	17.8	22.1	11.9	16.4	32.4	18.0	14.2	40.7	57.7	28.6	42.6	44.6	40.3	20.2	18.4	22.7	66.5	29.5	41.5	45.0	28.5	32.3	18.7	34.1	30.7	28.8	8.4	40.7	24.6	36.5	79.1	49.8	51.6	34.3	35.7	29.7	68.2	36.9	44.4	13.2	13.9	0.3	34.4	13.1	17.0	17.8	10.6	75.2	13.9	17.1	24.8	22.9	44.9	39.5	8.2	15.6	31.6	74.9	22.5	32.4	37.3	54.6	50.8	39.0	13.3	26.2	23.3	60.6	28.4	13.4	65.6	29.6	54.9	64.7	25.5	86.2	23.9	32.1	25.3	11.2	19.6	20.1	17.2	9.0	13.7	18.7	77.1	22.8	36.0	45.9	13.4	15.7	10.7	13.0	13.0	11.4	10.0	14.1	15.1	12.5	15.5	13.4	14.6	16.4	81.7	80.1	71.3	47.3	61.1	94.1	88.5	81.1	33.6	25.7	65.2	35.9	58.2	81.5	83.4	47.8	27.1	57.1	109.6	69.0	21.5	98.8	160.5	58.0	87.5	64.8	41.9	33.7	30.1	118.7	135.5	99.6	56.6	94.5	67.8	34.4	68.6	140.7	78.8	25.2	37.3	84.9	69.2	70.5	130.2	33.6	71.7	82.0	119.2	47.8	63.1	38.7	51.5	53.3	58.9	97.6	52.4	75.6	214.3	151.2	58.1	71.1	96.7	19.6	92.1	80.8	104.5	47.1	79.9	38.1	92.9	189.8	67.0	53.3	63.8	124.4
DNAJC4	"HSPF2, MCG18"	ENSG00000110011	"DnaJ heat shock protein family (Hsp40) member C4"	Q9NNZ3	11	64230278-64234286	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 240.9"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 3342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011947	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA011947: AB_1847803"	"unprognostic (8.99e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.69e-1)"	38.4	80.5	48.3	25.0	48.9	43.2	38.8	47.9	51.0	52.0	52.3	53.2	39.0	37.8	35.6	44.1	40.2	23.9	94.3	44.5	48.5	71.1	71.8	38.5	35.0	50.7	48.7	61.4	98.5	33.3	54.6	16.4	50.8	58.5	22.8	11.3	59.9	23.2	64.2	55.1	53.7	16.1	47.6	70.4	62.3	240.9	52.8	29.0	57.2	49.2	33.3	43.0	40.4	46.3	12.4	11.6	26.9	39.9	32.0	56.0	18.8	17.9	30.2	10.9	15.0	11.6	17.6	14.9	57.6	32.1	6.4	9.7	13.5	16.2	6.3	31.6	15.9	18.5	12.2	31.8	39.0	13.9	42.3	58.4	42.9	17.3	20.2	51.5	26.1	16.4	12.7	76.2	7.1	30.4	5.6	33.2	7.8	29.1	22.3	38.7	7.1	101.1	45.4	8.2	23.4	37.9	18.0	20.2	68.8	25.6	48.8	24.6	24.3	12.6	12.6	19.4	10.2	74.8	32.8	18.6	11.1	17.3	36.8	48.2	57.6	42.7	21.9	52.2	27.7	47.6	21.8	25.6	80.4	49.1	30.9	24.8	31.2	41.6	42.7	129.8	22.4	36.4	48.3	48.9	47.9	51.0	44.5	48.5	50.7	48.7	50.8	47.6	52.8	46.3	29.8	12.8	30.5	11.4	69.5	43.7	58.2	54.5	95.0	21.1	93.8	119.9	22.3	34.3	37.8	27.6	8.4	80.1	58.1	47.6	160.4	37.6	667.3	22.1	27.3	35.1	81.3	28.2	5.0	38.5	60.2	34.4	45.9	24.9	46.3	41.6	43.2	32.4	53.0	25.2	6.9	74.1	69.2	69.5	63.8	3342.9	62.7	66.0	48.0	4.7	112.4	35.0	55.6	3.0	5.5	28.7	55.6	46.6	96.3	43.4	115.0	101.7	15.1	14.5	19.7	29.0	30.3	28.4	28.8	60.1	51.1	54.5	46.6	61.9	68.9	64.9
DNAJC5	"CLN4, DNAJC5A, FLJ00118, FLJ13070"	ENSG00000101152	"DnaJ heat shock protein family (Hsp40) member C5"	Q9H3Z4	20	63895126-63936031	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012139, HPA012737, HPA013154"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane"	Vesicles	"HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292"	"unprognostic (9.96e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (3.04e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (2.24e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.08e-2)"	12.6	22.1	30.8	10.7	33.0	16.9	11.1	10.2	39.1	11.4	2.1	17.6	11.5	12.1	5.7	42.0	11.6	7.4	25.8	36.2	31.0	17.7	12.8	18.0	9.9	27.9	23.9	8.8	22.7	21.2	28.5	8.4	30.4	16.7	6.9	28.1	16.2	11.5	14.5	19.2	17.5	8.6	13.8	22.2	20.8	10.7	26.8	8.4	16.8	9.5	8.5	13.4	16.9	25.7	25.2	23.7	19.8	18.8	19.4	15.9	14.6	28.6	27.4	49.4	23.8	52.7	30.2	9.8	31.6	28.2	22.7	36.4	15.9	53.6	16.0	8.2	11.3	19.3	17.4	25.8	18.1	19.2	43.5	18.0	39.9	22.9	11.7	19.1	24.2	16.5	19.2	8.9	22.6	17.3	21.1	30.9	7.1	21.0	26.5	21.0	10.9	10.7	16.4	22.6	21.4	13.9	30.8	48.7	17.8	11.6	23.5	75.9	43.7	42.6	14.4	20.4	21.5	11.1	5.6	13.6	42.9	25.3	25.4	0.7	3.2	2.6	3.2	3.7	1.8	1.6	1.8	2.7	2.5	1.4	2.5	2.5	3.1	1.5	3.1	3.9	3.1	2.6	30.8	33.0	10.2	39.1	36.2	31.0	27.9	23.9	30.4	13.8	26.8	25.7	12.8	6.4	17.8	19.2	10.4	20.8	18.5	25.5	20.5	60.7	17.4	14.1	31.7	14.3	23.2	23.9	62.6	18.5	19.1	71.7	13.7	20.5	48.9	23.9	8.5	18.7	32.4	10.3	37.1	37.6	18.4	12.4	27.0	23.5	1.3	12.1	23.9	27.8	43.5	79.1	38.8	33.3	14.2	51.0	24.8	123.5	7.2	31.4	14.2	25.3	36.9	27.9	22.6	19.1	26.2	59.0	41.1	12.4	17.3	39.5	62.0	22.9	29.4	47.0	13.1	9.0	13.1	13.5	13.2	28.0	22.9	30.2	15.0	13.3	28.4	64.5
DNAJC5G	"CSP-gamma, FLJ40417"	ENSG00000163793	"DnaJ heat shock protein family (Hsp40) member C5 gamma"	Q8N7S2	2	27275433-27281499	"Predicted membrane proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	14	"epididymis: 46.9;testis: 22.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 69.1;Late spermatids: 83.6;Spermatocytes: 105.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041445	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041445: AB_2677485"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.97e-2)"	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.0	2.5	0.4	0.0	0.1	0.0	0.4	46.9	0.0	0.4	0.0	1.3	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.0	2.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.1	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	83.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	105.1	19.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976421-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		22000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: AB_2681811"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	41.7	50.5	122.8	43.5	126.4	40.4	39.6	125.0	204.0	39.5	124.2	46.5	37.3	28.3	50.5	66.7	33.8	26.2	85.3	126.8	128.6	65.4	67.0	38.9	53.4	127.6	127.1	43.0	54.9	54.5	55.2	35.9	127.2	37.4	45.4	49.2	39.2	25.0	99.8	48.2	38.1	27.6	124.1	45.1	49.1	46.0	125.5	56.5	38.2	73.0	67.7	40.7	41.3	128.1	99.2	129.6	130.8	100.1	68.5	106.5	120.0	103.6	98.8	139.7	110.6	143.5	93.9	142.0	118.2	113.2	118.4	140.6	192.3	127.9	169.7	123.6	220.1	102.6	116.0	189.7	100.8	185.0	102.7	92.4	82.3	131.5	104.4	101.5	114.8	122.4	160.7	98.9	122.2	66.5	210.8	155.0	139.4	92.3	87.1	124.0	175.4	123.6	116.9	104.8	117.7	104.7	84.9	243.6	126.1	128.7	139.3	177.8	110.3	80.1	105.0	100.1	163.3	72.0	159.4	122.9	103.0	124.0	97.1	49.7	55.9	35.9	30.9	57.8	35.2	39.6	36.3	36.1	57.7	41.9	33.4	32.6	19.8	49.4	59.8	98.5	43.8	38.8	122.8	126.4	125.0	204.0	126.8	128.6	127.6	127.1	127.2	124.1	125.5	128.1	62.2	35.3	38.3	39.2	87.1	65.4	94.4	107.8	37.5	80.5	46.7	43.4	57.6	61.5	54.0	66.2	135.5	108.6	139.0	81.1	115.4	107.6	108.3	83.7	77.8	71.8	111.4	52.4	33.9	132.5	103.8	50.9	38.7	70.6	57.0	105.5	71.4	56.4	102.4	63.9	37.3	63.4	67.1	102.1	99.6	52.3	67.4	94.6	48.0	34.7	166.5	100.0	121.5	36.7	142.0	125.2	62.1	61.3	79.7	77.4	79.2	155.8	61.7	143.5	46.0	78.9	78.5	104.7	111.9	49.3	68.8	126.8	81.9	127.2	79.1	94.6
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233029	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	32.1	29.2	21.7	27.8	22.5	30.1	31.2	22.8	27.6	27.2	21.3	27.4	20.9	31.6	22.9	25.2	22.6	20.2	38.4	22.6	24.3	28.2	27.3	21.9	40.3	22.7	22.8	28.2	25.2	23.2	13.6	30.6	23.1	21.7	23.0	26.2	23.0	22.8	41.2	21.6	23.6	31.0	21.8	26.7	29.0	13.8	22.1	42.7	26.2	29.9	42.2	28.1	23.4	22.9	76.6	38.9	58.9	68.4	70.6	57.8	53.0	61.7	77.2	122.6	111.7	41.2	60.1	87.0	62.4	69.4	60.2	45.3	88.4	61.1	128.6	68.5	65.9	112.0	54.0	73.1	63.5	111.8	88.3	44.3	53.6	77.0	40.6	57.2	82.5	70.6	106.4	59.3	90.6	44.5	84.6	77.3	107.6	47.1	44.2	96.0	87.7	84.4	78.1	62.3	21.1	55.1	81.8	33.2	74.4	43.2	49.7	89.9	63.4	54.4	58.4	123.1	93.9	55.5	78.9	138.3	72.9	133.4	75.8	64.2	53.6	53.1	60.4	53.6	61.6	60.5	54.5	60.2	59.8	59.6	54.3	54.8	28.6	57.1	60.0	61.3	66.3	91.8	21.7	22.5	22.8	27.6	22.6	24.3	22.7	22.8	23.1	21.8	22.1	22.9	133.2	76.9	91.4	9.4	119.4	129.8	148.3	181.2	80.8	96.0	66.6	87.1	149.6	78.6	116.2	106.7	25.0	188.7	156.7	56.4	270.1	150.9	55.3	100.9	127.5	127.9	46.0	128.7	19.5	98.1	159.7	132.4	48.9	106.1	141.0	93.8	93.5	77.9	181.2	69.0	16.6	58.1	111.9	71.9	146.3	40.3	120.5	121.1	103.2	21.5	153.5	167.4	183.4	19.6	23.4	117.3	68.2	144.0	74.6	121.1	65.2	199.3	87.8	103.1	85.5	108.0	144.9	153.1	91.7	74.7	110.2	224.1	132.7	98.8	76.7	112.3
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73247255	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	9.2	10.6	17.1	17.6	17.5	91.9	15.4	19.2	21.5	11.2	15.4	16.0	14.6	12.8	12.4	16.9	9.7	6.9	8.6	16.9	17.0	10.0	13.4	9.6	28.2	16.4	16.5	15.3	8.7	10.2	10.6	17.6	16.9	11.4	18.0	25.1	11.3	11.2	11.5	17.7	13.9	11.8	15.7	14.8	12.2	12.4	17.0	35.8	8.4	13.1	32.3	11.5	11.9	17.6	135.0	77.3	93.8	68.4	16.1	19.3	45.7	101.5	59.4	101.1	106.1	130.8	89.4	86.9	33.5	43.6	43.7	83.1	92.9	67.5	118.1	98.5	63.8	188.3	79.4	93.4	14.8	173.1	71.0	14.8	33.2	107.1	93.4	36.4	66.2	112.1	168.3	103.0	81.4	118.4	155.0	124.7	36.3	64.4	215.1	114.2	85.1	47.6	52.9	61.5	44.3	73.4	73.5	114.5	52.9	43.7	62.1	76.8	48.0	65.2	118.3	71.3	168.0	45.0	70.6	141.8	64.8	162.9	45.9	23.9	3.7	29.1	25.5	10.7	29.2	32.8	31.3	28.2	6.5	28.3	30.3	26.9	4.5	24.8	10.9	20.3	36.8	18.0	17.1	17.5	19.2	21.5	16.9	17.0	16.4	16.5	16.9	15.7	17.0	17.6	17.3	9.6	12.3	11.1	39.5	47.7	34.1	31.9	33.0	26.1	21.5	24.8	2.7	17.2	24.8	9.2	8.4	107.8	44.6	18.3	21.5	31.5	80.4	15.9	14.0	20.6	12.0	173.8	11.8	31.4	111.4	17.6	12.2	19.0	42.3	26.0	13.9	9.8	61.9	15.2	12.8	25.6	54.9	10.9	19.6	43.3	14.0	17.4	32.0	6.5	23.0	29.5	32.0	7.5	6.5	44.1	16.7	20.3	49.7	27.6	18.2	16.3	21.9	43.2	26.3	17.7	28.3	28.7	65.4	38.2	43.5	58.0	45.2	19.7	38.0	37.5
DNAL1	"1700010H15RiK, C14orf168, CILD16, MGC12435"	ENSG00000119661	"Dynein axonemal light chain 1"	Q4LDG9	14	73644875-73703732	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 335.4;Endometrial ciliated cells: 104.0;Respiratory ciliated cells: 141.4;Spermatocytes: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053129, HPA060974"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite"		"HPA053129: AB_2682051, HPA060974: "	"unprognostic (1.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.17e-8)"	"unprognostic (9.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	7.5	6.2	8.3	6.2	11.0	6.1	5.1	12.2	10.0	5.9	18.5	4.7	2.7	7.9	12.2	4.6	23.7	9.3	9.2	13.0	9.6	11.2	3.7	7.7	5.2	8.8	11.0	7.5	6.1	14.7	8.4	4.7	8.9	5.7	5.5	18.1	4.4	7.0	5.2	3.0	3.0	9.5	7.6	4.7	5.6	55.2	11.2	6.1	16.4	5.9	4.5	6.1	3.3	8.8	15.4	11.2	13.5	12.3	9.3	11.8	10.7	15.2	11.6	19.3	20.0	11.7	23.9	6.1	11.1	16.2	18.4	9.2	12.8	11.7	28.0	9.0	5.3	5.1	16.7	4.3	9.7	5.9	5.8	9.0	9.0	21.3	15.2	14.8	12.7	9.7	5.8	13.7	23.8	25.2	15.4	7.0	6.3	12.7	10.9	10.7	20.2	2.6	16.1	16.1	20.7	9.8	25.0	4.8	12.2	10.3	26.7	3.9	12.0	24.1	43.8	18.2	14.3	7.8	18.2	13.4	19.9	3.1	17.2	4.3	2.3	2.5	2.7	2.5	3.8	2.7	2.6	2.7	2.1	4.1	2.3	2.6	2.1	2.1	2.1	5.9	2.6	1.3	8.3	11.0	12.2	10.0	13.0	9.6	8.8	11.0	8.9	7.6	11.2	8.8	10.8	19.2	14.9	11.4	6.3	3.2	7.4	19.8	2.2	16.0	9.4	5.7	14.4	15.7	23.1	18.4	60.5	5.4	5.4	5.7	9.8	15.5	335.4	104.0	20.4	11.2	10.2	4.8	21.7	14.0	9.3	12.9	7.7	16.4	10.1	11.8	11.0	5.3	8.4	15.2	15.5	6.1	18.3	6.7	7.9	57.8	17.4	6.9	12.4	6.5	6.5	19.9	12.3	10.1	5.8	12.3	4.1	16.6	5.8	5.9	1.7	24.9	141.4	40.2	13.1	21.6	12.4	187.7	24.7	2.1	2.0	2.5	6.2	11.9	5.6	5.0
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 124.1;Late spermatids: 210.7;Spermatocytes: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 64.0"					"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	11.3	18.0	29.1	6.7	32.3	4.4	14.5	21.0	36.5	18.3	23.2	12.9	7.9	12.2	15.0	18.9	35.4	12.9	13.7	29.2	28.3	24.4	11.1	13.9	8.1	22.1	23.3	17.5	21.3	31.1	30.9	9.9	22.1	18.3	9.6	13.8	18.1	12.1	7.0	17.5	9.8	7.5	22.0	11.4	16.4	65.5	28.0	14.3	25.4	6.2	8.3	14.2	15.5	24.5	17.9	8.9	17.5	15.5	21.8	21.7	0.0	7.5	14.0	11.4	12.2	5.7	20.1	4.5	15.7	10.7	13.1	8.3	11.0	20.5	7.7	11.4	14.8	2.6	2.5	6.6	34.9	14.5	3.7	17.1	64.0	14.9	26.8	29.7	16.6	22.1	5.3	8.5	13.8	21.9	13.6	14.0	6.8	26.3	7.4	12.8	7.5	5.9	23.7	10.8	24.3	13.5	15.4	11.5	30.7	12.1	20.7	13.7	9.8	10.1	10.1	15.5	7.5	5.3	1.8	2.1	29.9	4.9	9.8	15.0	8.5	11.9	11.2	8.9	13.8	7.1	9.3	10.2	8.7	10.6	10.5	9.0	15.0	16.2	11.3	13.2	9.3	7.5	29.1	32.3	21.0	36.5	29.2	28.3	22.1	23.3	22.1	22.0	28.0	24.5	8.2	6.4	10.5	5.5	5.1	5.6	13.4	18.9	10.2	15.0	20.6	17.8	4.3	14.3	15.2	3.7	2.1	27.6	9.7	10.9	31.3	28.4	124.1	56.4	11.8	8.5	12.6	11.2	11.0	15.5	21.2	10.1	6.1	10.5	15.2	20.3	12.8	3.8	13.7	11.8	10.6	14.7	14.2	4.4	2.8	210.7	11.8	6.5	8.8	4.7	5.7	18.9	8.2	6.6	5.1	18.4	9.1	7.5	1.3	9.8	8.5	20.0	41.0	15.4	6.6	6.6	11.6	77.7	20.0	9.1	10.5	19.8	6.0	20.1	13.2	12.0
DNALI1	"dJ423B22.5, hp28, P28"	ENSG00000163879	"Dynein axonemal light intermediate chain 1"	O14645	1	37556919-37566857	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 54.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 664.5;Endometrial ciliated cells: 302.8;Late spermatids: 1051.9;Respiratory ciliated cells: 484.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.3;ASC TERT1: 12.1;hTERT-RPE1: 18.8;RPTEC TERT1: 16.9;SH-SY5Y: 11.7;T-47d: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028305, HPA031633"	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028305: AB_10601807, HPA031633: "	"unprognostic (1.21e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.52e-2)"	2.7	6.1	14.5	0.7	14.2	0.0	7.4	14.1	15.4	9.2	27.2	5.2	1.2	8.6	14.3	2.7	54.5	9.1	3.5	13.6	17.8	12.2	12.0	10.5	0.8	18.3	22.1	13.9	9.1	9.1	12.6	1.6	18.6	6.7	2.3	11.8	4.5	7.2	1.1	0.7	2.3	4.1	17.3	1.0	6.4	29.4	16.5	0.7	10.7	1.3	0.6	3.8	2.0	17.9	0.0	0.0	14.3	1.3	2.9	12.1	0.2	1.8	3.9	0.1	0.5	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.3	9.3	0.0	0.1	5.5	0.0	9.3	0.0	18.8	1.5	0.0	1.0	0.0	7.5	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.0	16.9	0.0	1.6	11.7	0.0	0.0	0.0	2.2	30.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	14.2	14.1	15.4	13.6	17.8	18.3	22.1	18.6	17.3	16.5	17.9	1.9	19.2	32.4	6.8	1.0	0.9	22.6	42.3	1.2	2.7	19.6	15.9	5.6	21.5	48.5	20.2	8.4	2.7	0.3	0.8	29.4	34.0	664.5	302.8	12.2	4.7	20.9	0.0	2.6	10.2	8.5	15.7	20.4	16.7	2.5	38.9	8.6	9.4	2.8	3.3	2.8	11.5	46.8	0.6	0.6	1051.9	13.7	2.0	0.0	0.0	0.0	18.7	0.0	3.0	1.7	12.5	1.0	12.0	0.0	21.0	1.0	43.3	484.1	19.6	6.6	17.5	18.5	140.0	18.5	0.3	0.6	3.4	1.1	21.0	4.9	9.3
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DNASE1L1	"DNAS1L1, DNASEX, DNL1L, XIB"	ENSG00000013563	"Deoxyribonuclease 1 like 1"	P49184	X	154401236-154412112	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072635	Approved				"Intracellular and membrane"	NA	NA		96000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA072635: AB_2686542"	"unprognostic (5.27e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.98e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.75e-2)"	18.7	26.6	12.6	13.0	12.1	24.1	17.8	11.7	14.1	15.8	26.6	15.2	15.2	15.8	22.5	21.6	14.0	13.0	43.2	13.5	14.3	20.9	18.8	22.0	16.4	12.2	13.4	13.7	12.8	22.7	20.1	16.1	12.6	15.1	12.3	3.9	22.0	11.3	147.0	11.3	19.3	11.3	13.0	28.5	18.1	7.7	13.6	8.9	24.1	94.8	13.2	13.5	16.9	11.9	19.7	19.6	6.3	12.2	56.6	74.5	7.7	54.5	85.3	17.6	34.6	5.7	28.0	32.9	68.2	103.0	67.4	9.6	7.6	31.0	12.8	9.9	13.0	4.8	20.6	7.1	38.8	8.6	33.4	55.6	35.7	39.6	40.0	47.9	76.4	5.3	6.5	34.0	61.1	33.0	3.6	4.2	5.0	35.5	22.1	7.3	28.5	52.9	31.0	9.7	20.2	12.0	17.1	29.9	22.5	13.9	11.9	7.8	112.9	17.7	20.3	25.6	10.9	64.2	15.4	34.4	26.6	14.4	22.4	13.0	12.0	17.1	3.5	21.6	4.0	6.2	3.3	3.1	14.5	4.1	2.4	2.2	7.0	4.6	20.9	8.3	4.9	6.4	12.6	12.1	11.7	14.1	13.5	14.3	12.2	13.4	12.6	13.0	13.6	11.9	20.1	6.4	6.5	3.3	8.0	1.3	7.1	11.1	9.6	1.8	5.1	3.8	2.0	5.7	5.4	5.5	0.0	5.3	6.7	15.5	9.8	6.1	0.1	5.8	5.7	17.7	6.1	6.5	3.2	10.2	23.3	5.2	11.7	7.5	13.3	4.9	23.2	8.6	29.1	0.0	2.2	10.4	6.1	36.6	11.7	1.2	3.4	25.4	16.0	4.7	22.9	12.8	7.2	0.0	0.5	13.5	18.1	2.6	6.8	5.9	27.0	9.6	7.0	1.4	0.0	16.7	3.3	0.4	0.4	10.4	1.7	8.9	6.0	3.2	10.9	10.9
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Necrosis"	"Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 271.4;lymphoid tissue: 263.5"	"Cell type enriched"	"Detected in many"	6	"Hepatic stellate cells: 1670.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 424.7"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 424.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;Karpas-707: 1.1;RPMI-8226: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA019955: AB_1847805"	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	20.6	41.0	0.6	38.0	0.5	2.9	10.3	1.5	0.7	4.4	5.4	31.4	29.7	1.7	1.5	16.9	2.8	7.9	14.7	0.6	0.5	47.7	271.4	18.0	38.7	0.6	0.5	1.1	1.1	1.7	20.3	7.1	0.8	1.8	42.2	0.5	8.7	1.4	1.0	4.5	42.5	3.5	0.5	263.5	5.9	3.8	0.8	22.6	16.5	0.3	54.0	12.0	9.4	1.2	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.3	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	20.4	0.1	0.1	40.4	20.7	0.1	0.0	0.6	0.5	0.2	424.7	0.0	3.4	0.6	0.5	1.5	0.7	0.6	0.5	0.6	0.5	0.8	0.5	0.8	1.2	126.6	0.0	9.8	0.3	25.7	9.2	0.3	1.1	12.0	0.1	0.9	1.4	1.2	35.8	2.0	0.0	0.0	0.1	76.3	0.5	3.9	0.0	1.9	0.4	0.2	239.9	0.0	85.5	0.1	0.4	1.2	6.1	0.0	0.8	1.3	0.1	1670.9	27.1	0.5	1.7	0.1	0.2	0.0	127.1	144.3	3.2	4.1	18.6	3.6	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.2	0.3	0.1	3.3	0.0	0.2	0.0	0.3	1.3	0.3	0.2	59.3	16.3	0.3	3.8	2.6	0.0	1.0
DNASE2	"DNL, DNL2"	ENSG00000105612	"Deoxyribonuclease 2, lysosomal"	O00115	19	12875209-12881466	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Developmental protein, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 226.7;Paneth cells: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066185	Enhanced				"Intracellular and membrane"	NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA066185: AB_2685632"	"unprognostic (9.62e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.42e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.98e-1)"	27.0	26.7	17.1	24.0	17.5	9.6	23.3	17.2	19.1	22.7	19.7	24.7	23.7	25.1	29.5	18.9	25.3	25.3	22.7	16.5	17.6	19.2	36.0	37.7	42.2	18.7	18.2	26.1	41.7	43.1	23.8	20.6	19.4	27.7	19.2	5.6	33.0	26.1	19.7	29.2	22.7	22.0	19.3	26.2	30.0	5.9	17.8	20.8	38.7	13.1	26.5	24.3	19.9	23.0	63.7	36.3	2.9	80.8	86.8	46.2	55.0	34.4	87.2	33.2	79.6	3.8	43.6	27.9	97.3	54.9	73.0	71.8	30.7	33.2	16.2	89.8	41.0	13.1	36.8	17.5	68.3	26.5	119.8	46.5	74.5	24.8	36.7	80.2	50.2	42.4	14.0	112.1	20.3	82.7	27.3	14.1	6.1	66.3	60.8	17.1	14.2	64.3	32.9	29.7	17.3	28.6	46.1	65.8	123.5	11.8	98.5	23.4	32.5	67.8	21.4	70.3	31.1	139.9	153.6	35.7	112.9	24.6	34.4	73.5	71.0	10.9	64.5	95.8	53.5	31.1	56.1	68.8	14.0	35.6	49.0	53.7	40.6	70.9	114.2	28.3	85.8	66.4	17.1	17.5	17.2	19.1	16.5	17.6	18.7	18.2	19.4	19.3	17.8	23.0	18.7	25.6	22.4	7.5	25.5	14.5	23.6	56.9	14.2	6.7	22.7	18.5	10.6	28.6	31.0	36.8	4.2	60.0	23.5	17.3	3.9	67.1	0.5	24.1	15.1	21.4	16.4	5.7	1.3	58.3	96.2	27.9	13.7	25.4	22.2	23.8	28.9	26.4	226.7	5.0	1.7	15.0	83.4	87.5	6.8	2.5	32.0	55.5	46.2	2.8	28.4	32.2	33.0	3.0	1.7	39.5	125.0	33.4	36.6	15.1	10.8	6.8	29.9	3.3	13.1	16.5	16.9	0.6	4.8	12.4	12.4	48.0	23.9	23.0	26.2	18.5
DNER	"bet, UNQ26"	ENSG00000187957	"Delta/notch like EGF repeat containing"	Q8NFT8	2	229357629-229714555	"Cancer-related genes, Predicted membrane proteins"	"Notch signaling pathway"	"Activator, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 73.0;brain: 147.5;choroid plexus: 143.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 123.3;Inhibitory neurons: 333.0;Oligodendrocyte precursor cells: 435.8;Oligodendrocytes: 247.7"	"Cancer enriched"	"Detected in many"	32	"glioma: 73.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"GAMG: 368.0;hTERT-HME1: 149.7;hTERT-RPE1: 409.5;U-138 MG: 252.2;U-87 MG: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017320	Enhanced					NA	NA		7900000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017320: AB_1847808"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (2.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.13e-3)"	2.0	73.0	88.3	1.3	121.0	0.0	2.3	139.7	82.9	2.0	143.8	5.2	0.4	2.8	5.7	0.3	4.1	0.2	11.8	72.3	130.9	11.2	0.1	1.0	0.3	121.3	121.0	0.6	0.9	8.9	30.3	0.4	117.8	1.9	1.1	60.5	43.4	0.4	0.8	10.3	1.6	1.2	124.7	0.1	10.7	1.0	147.5	0.5	0.1	0.5	1.2	0.8	1.1	137.2	0.4	1.9	3.9	0.3	0.6	0.5	0.0	0.2	1.4	8.6	2.6	0.0	1.1	0.0	0.4	0.1	368.0	0.1	0.3	1.2	4.3	0.0	0.1	0.0	12.4	0.0	1.4	0.0	0.1	2.6	9.3	6.5	149.7	409.5	0.0	0.0	0.0	0.3	2.3	0.1	0.0	0.0	2.5	0.2	14.0	0.1	1.6	0.0	14.6	0.0	30.3	2.5	0.8	0.1	0.8	0.4	0.1	0.0	0.0	252.2	0.0	8.5	39.7	0.0	0.0	0.0	149.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.3	121.0	139.7	82.9	72.3	130.9	121.3	121.0	117.8	124.7	147.5	137.2	0.1	0.0	0.0	68.9	0.0	0.4	5.9	1.9	1.8	123.3	1.6	0.6	12.2	0.0	1.4	3.7	14.6	0.0	0.0	0.0	1.9	0.2	7.3	4.1	1.5	0.6	28.7	0.0	24.1	1.3	0.2	4.3	0.0	6.7	0.0	1.6	0.0	0.0	0.1	11.8	333.0	0.0	6.1	0.0	0.8	1.9	5.9	0.9	19.6	8.4	0.1	52.0	0.0	435.8	247.7	0.3	0.0	6.0	0.0	4.5	0.0	1.2	34.1	55.0	0.0	0.1	0.8	1.2	1.1	0.5	0.0	0.1	0.2	0.6	0.1	0.5
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	2.2	1.7	2.6	1.5	3.3	4.5	2.2	2.1	4.3	2.9	2.3	3.3	1.6	2.5	2.1	1.6	2.6	1.4	2.0	2.1	3.2	2.5	2.8	3.3	2.5	4.7	2.8	3.3	1.7	0.4	2.2	0.8	5.0	2.4	1.4	4.0	1.8	1.3	2.0	2.3	3.3	1.4	2.4	2.8	2.0	10.3	3.5	2.1	2.4	0.8	2.0	2.4	2.5	6.2	2.1	2.0	2.4	1.9	2.0	2.9	2.6	1.0	1.2	0.7	0.9	1.3	2.3	2.4	0.4	1.0	1.8	3.7	1.1	1.1	0.9	1.5	2.3	1.8	3.7	1.5	1.3	2.1	0.8	2.0	1.8	2.2	3.6	1.2	0.6	3.1	2.0	2.3	1.0	0.6	0.9	3.0	2.6	0.7	2.0	1.4	0.9	1.5	1.3	1.6	1.1	2.2	0.8	2.2	1.9	1.8	1.3	2.5	1.2	1.3	1.4	1.8	1.4	6.6	5.0	3.0	1.3	2.6	1.7	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.1	2.6	3.3	2.1	4.3	2.1	3.2	4.7	2.8	5.0	2.4	3.5	6.2	2.3	0.0	3.4	69.5	3.8	0.9	1.2	1.9	0.6	9.9	2.7	3.0	3.8	0.0	4.3	0.0	4.2	0.3	4.0	2.2	0.0	0.3	12.7	4.0	1.5	2.8	0.0	35.6	41.4	0.4	0.2	2.2	2.6	3.6	1.3	4.7	3.3	4.8	0.8	10.1	32.8	1.7	0.0	2.5	1.5	13.9	0.9	4.0	0.0	19.7	2.2	3.4	3.1	36.2	67.4	0.4	1.6	1.2	1.7	1.8	2.2	0.6	7.3	9.5	0.0	2.1	1.7	19.5	2.0	1.5	3.8	0.7	2.4	1.8	2.1	1.8
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009947	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	13.6	6.0	3.6	5.5	3.7	10.3	10.2	6.2	5.3	15.8	8.6	17.7	22.5	9.6	12.5	10.2	11.3	11.0	7.5	4.7	4.2	20.6	13.1	8.4	4.6	3.7	3.6	11.5	17.6	31.7	3.9	10.5	3.8	8.9	20.7	15.8	8.4	12.8	13.4	27.4	27.2	8.8	3.0	7.7	23.8	6.9	5.2	20.1	8.1	11.1	5.2	19.8	17.7	3.1	25.7	20.7	18.4	29.2	32.9	27.4	4.4	45.2	43.6	21.5	20.7	14.2	38.0	26.6	18.9	34.9	11.8	19.9	21.6	26.1	29.9	1.4	6.7	3.8	23.7	10.0	17.1	2.6	1.8	13.0	5.7	26.6	23.4	75.5	52.1	8.5	3.6	0.0	44.1	3.2	4.5	5.1	17.7	18.0	12.3	5.5	18.7	1.4	36.6	21.9	3.1	4.2	7.4	1.9	5.7	25.3	1.5	2.4	63.4	16.0	15.3	13.1	29.8	2.1	1.7	36.3	15.2	8.4	12.2	0.0	0.8	0.2	0.7	1.2	0.7	1.2	0.1	0.4	0.3	1.9	0.1	0.3	0.7	2.1	1.2	0.3	0.0	0.6	3.6	3.7	6.2	5.3	4.7	4.2	3.7	3.6	3.8	3.0	5.2	3.1	6.8	9.6	11.0	11.1	14.8	35.1	7.2	5.0	5.2	6.3	9.3	6.3	6.1	12.8	11.2	12.9	35.5	7.7	4.4	36.7	3.9	7.5	1.0	27.0	11.0	12.6	3.6	0.0	15.9	14.3	1.4	17.6	26.0	43.9	2.5	4.1	11.4	12.8	4.7	13.5	24.8	25.0	6.1	10.7	9.6	3.2	13.7	20.5	3.6	23.4	3.3	4.3	0.0	10.6	2.6	19.3	23.6	9.1	6.1	4.0	36.5	3.7	19.9	26.6	0.0	4.3	6.9	4.2	9.3	9.0	45.6	3.7	4.3	15.0	28.4	21.8
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.8	0.6	1.2	0.8	1.5	3.6	1.3	2.4	1.6	1.3	1.0	0.7	0.8	1.0	3.1	0.8	0.7	0.8	1.0	1.2	1.6	1.7	1.2	0.7	0.9	1.4	1.3	0.8	6.0	1.1	0.6	2.0	1.3	0.8	0.7	3.0	1.2	0.6	0.5	3.8	0.8	0.9	1.0	1.0	0.9	5.8	1.4	3.7	1.7	0.2	0.9	1.3	1.1	1.4	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.5	2.4	1.6	1.2	1.6	1.4	1.3	1.3	1.0	1.4	1.4	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.9"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 20.8;Proximal tubular cells: 29.1"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219372043-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.4;Late spermatids: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	25.8	18.9	15.4	25.0	15.8	18.0	23.6	14.8	18.6	24.9	14.7	34.5	56.5	22.4	21.5	25.1	25.1	22.6	39.9	16.2	16.9	22.1	32.0	27.6	23.4	15.8	15.0	30.2	27.2	25.8	13.0	37.1	15.2	22.6	30.8	9.5	26.2	24.4	64.5	31.7	56.2	19.9	16.0	24.7	25.4	58.5	17.4	17.5	15.2	46.4	16.2	29.6	21.6	14.7	47.5	25.8	15.4	45.7	39.7	32.2	122.0	23.0	46.5	59.3	62.5	72.6	61.2	27.2	48.7	49.5	76.0	45.0	18.6	53.6	21.3	56.4	12.5	46.6	25.0	79.8	107.2	38.9	32.2	54.4	55.4	61.8	50.2	37.9	41.2	38.6	53.8	45.3	31.0	103.7	60.8	44.5	25.5	67.7	15.1	77.2	35.7	36.5	33.0	74.0	19.1	26.0	27.1	86.5	34.5	26.9	25.8	43.3	23.5	55.4	46.1	31.4	33.7	49.6	31.8	21.3	80.0	37.7	24.1	8.7	17.2	7.3	16.1	19.7	18.8	13.2	13.2	18.3	20.8	16.2	14.0	18.7	1.6	21.2	17.0	7.2	16.6	14.8	15.4	15.8	14.8	18.6	16.2	16.9	15.8	15.0	15.2	16.0	17.4	14.7	43.1	12.8	18.2	8.8	35.6	38.6	74.1	55.1	52.9	19.3	41.2	36.7	33.6	55.8	27.2	25.8	33.3	90.4	26.7	70.4	49.0	62.9	364.4	16.5	36.5	41.8	48.0	19.8	3.1	66.3	96.9	43.4	29.0	19.6	24.1	39.1	30.4	47.9	51.0	10.1	5.2	110.3	38.7	31.5	26.8	462.0	52.5	26.2	32.0	4.7	53.0	29.8	45.3	3.0	3.3	52.3	75.6	41.0	38.3	113.1	202.6	79.6	16.3	37.6	26.3	31.9	120.0	20.1	20.1	43.4	44.8	66.4	34.1	36.9	70.9	74.6
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866284-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	5.0	3.7	4.9	3.5	5.2	15.3	5.0	10.3	6.7	3.5	5.6	3.4	2.7	4.0	6.3	4.4	3.5	4.5	4.5	5.5	5.4	4.2	5.0	3.7	5.5	4.8	4.9	4.3	3.4	3.8	2.1	4.6	5.1	3.7	3.6	4.2	2.9	3.0	8.9	5.5	2.7	3.7	3.8	4.5	3.6	4.5	5.3	4.3	4.7	5.0	5.2	6.5	2.8	6.8	14.3	6.6	7.2	7.8	6.9	6.2	11.1	9.4	6.6	11.0	9.4	7.3	6.1	18.8	12.2	9.9	13.8	7.7	11.9	11.2	15.6	11.4	6.6	15.4	11.3	11.0	7.2	17.4	5.3	6.8	11.9	11.9	9.8	5.5	7.9	6.0	18.6	6.0	15.1	6.3	12.2	11.3	14.2	6.3	10.6	7.0	15.6	7.2	11.3	10.8	8.7	7.7	9.8	14.4	10.5	9.2	6.2	12.6	7.7	8.8	9.2	10.2	15.9	6.4	9.3	15.3	5.1	13.6	5.9	9.7	5.7	11.6	6.4	8.3	7.7	8.2	5.8	5.8	5.1	8.4	5.3	6.9	8.0	9.6	8.5	3.5	6.4	6.8	4.9	5.2	10.3	6.7	5.5	5.4	4.8	4.9	5.1	3.8	5.3	6.8	98.9	57.7	78.2	3.6	66.7	54.4	163.0	57.9	43.3	33.9	27.5	38.9	73.0	11.5	91.2	12.9	58.4	52.0	110.2	17.3	21.5	74.3	53.8	85.1	72.0	74.2	8.4	20.6	6.8	60.3	44.4	54.3	38.2	122.4	119.4	36.6	25.7	19.4	38.1	20.2	7.7	14.5	46.8	29.5	72.1	11.0	25.7	75.8	23.2	8.4	52.1	29.2	48.4	3.5	7.2	88.6	20.1	25.9	50.1	96.7	17.2	19.6	85.1	34.4	19.7	90.7	79.0	62.8	65.9	40.0	50.6	55.8	87.7	44.4	23.1	112.0
DOC2B	DOC2BL	ENSG00000272636	"Double C2 domain beta"	Q14184	17	142789-181650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;retina: 24.6"	"Group enriched"	"Detected in many"	5	"Adipocytes: 49.4;Cone photoreceptor cells: 175.2;Muller glia cells: 146.7;Rod photoreceptor cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 37.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 56.1"	HPA043168	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA043168: AB_2678349"	"prognostic favorable (3.45e-4)"	"unprognostic (2.28e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.87e-3)"	15.9	4.5	11.6	3.0	12.7	6.2	13.9	18.6	21.1	3.7	1.3	4.0	0.0	4.0	0.0	14.4	5.8	0.0	5.3	22.5	6.5	8.7	0.7	3.4	1.3	8.7	11.7	1.1	10.0	0.2	6.7	1.4	10.8	3.6	1.1	24.6	2.1	0.6	2.7	4.4	4.5	1.5	12.6	3.3	3.4	0.3	12.2	0.8	3.0	0.1	2.5	4.4	5.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	12.7	18.6	21.1	22.5	6.5	8.7	11.7	10.8	12.6	12.2	0.9	49.4	0.0	2.3	0.3	0.2	0.0	0.8	0.0	2.2	10.1	1.5	1.3	2.0	0.0	0.0	9.2	175.2	0.0	0.0	0.2	0.0	0.2	1.1	0.7	4.6	22.8	0.0	0.0	3.8	4.2	0.0	2.3	9.2	0.8	0.0	0.1	18.5	0.2	0.1	1.7	2.3	0.0	0.0	0.3	0.0	2.5	0.0	0.5	0.0	1.0	0.6	146.7	0.0	1.5	0.1	4.3	0.0	0.0	0.0	0.9	0.0	0.5	1.5	100.7	0.0	2.3	0.8	0.2	0.1	1.8	0.0	0.3	0.1	0.8	0.2	3.6
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097"	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	19.9	8.2	38.1	7.3	54.3	0.7	19.9	39.1	34.6	23.3	22.5	17.7	13.4	19.6	15.5	16.1	18.1	17.2	14.2	29.9	37.2	19.3	9.6	13.7	4.6	44.7	51.8	24.7	14.1	25.6	5.6	19.6	44.5	16.5	13.8	2.3	17.7	18.4	5.2	33.4	15.1	19.2	35.6	9.9	13.3	6.9	45.3	8.5	26.6	10.6	5.7	16.5	18.9	50.1	16.1	29.8	57.2	41.2	29.2	38.7	12.6	31.5	66.2	21.9	23.1	18.8	18.0	0.0	10.3	47.4	19.8	18.0	18.4	23.8	25.4	0.3	17.9	10.0	18.8	22.7	28.9	0.0	14.2	31.8	7.0	22.7	49.3	53.0	51.3	0.0	0.0	0.1	33.1	16.4	0.0	0.0	14.1	12.4	13.5	0.0	37.3	0.4	22.1	17.5	3.4	24.5	32.9	18.6	28.9	40.6	4.7	0.1	54.2	39.7	15.3	9.8	30.7	0.0	0.1	0.0	31.3	0.0	25.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	38.1	54.3	39.1	34.6	29.9	37.2	44.7	51.8	44.5	35.6	45.3	50.1	55.9	32.1	20.3	186.4	0.4	17.2	15.5	9.5	43.9	0.5	18.5	17.3	11.8	12.8	17.9	22.0	0.0	14.1	3.2	28.0	0.0	14.7	11.3	20.2	36.8	35.2	5.4	1.7	2.4	7.1	11.5	27.7	16.8	17.1	0.0	33.3	26.4	7.8	5.7	0.0	4.8	15.3	6.1	4.6	5.9	24.5	32.6	5.1	7.2	105.9	2.8	6.6	0.0	331.3	429.1	13.6	9.4	36.5	0.1	13.7	17.5	11.5	20.6	1.2	13.1	30.5	24.1	2.0	6.7	21.5	16.2	12.6	1.1	35.4	12.3	10.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;lymphoid tissue: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.5	8.2	22.6	18.8	49.2	10.2	3.8	33.7	33.4	8.7	9.7	6.3	4.1	3.2	1.1	3.2	2.4	6.3	1.6	28.7	35.1	3.2	5.5	7.6	27.8	45.5	38.4	17.7	1.7	2.0	1.0	2.3	48.9	1.6	6.5	5.7	2.5	1.7	1.2	5.0	12.5	4.3	32.0	29.8	6.7	2.2	37.9	32.1	2.7	0.8	19.9	6.4	4.4	83.1	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	22.6	49.2	33.7	33.4	28.7	35.1	45.5	38.4	48.9	32.0	37.9	83.1	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495815-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 100.4;Kupffer cells: 47.5;Macrophages: 45.7;Microglial cells: 67.5;NK-cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.3;HMC-1: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA059695: AB_2684104"	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	54.3	8.2	5.7	15.4	11.2	33.6	34.9	4.1	6.8	17.1	4.7	26.0	3.1	12.6	9.7	6.1	13.7	8.5	6.9	5.6	9.9	10.8	3.5	25.8	23.7	6.3	6.8	4.2	2.3	4.4	28.3	12.8	7.1	6.7	5.7	1.2	7.0	3.1	3.8	8.2	19.9	8.9	5.8	34.1	12.3	2.6	5.6	21.0	18.3	4.8	17.8	16.6	14.3	7.7	0.1	5.9	4.8	4.5	63.3	26.8	12.7	6.7	14.5	5.5	14.2	0.7	0.1	18.2	0.6	24.3	6.5	0.2	8.5	0.0	4.8	22.7	7.4	39.8	6.2	0.2	20.4	24.3	92.3	18.9	0.4	5.8	6.4	3.8	0.2	15.6	12.3	32.0	3.5	4.1	14.6	32.2	5.0	5.3	9.2	9.7	12.3	0.6	0.1	1.3	1.7	11.3	20.3	18.7	6.6	3.7	2.2	20.3	0.3	4.4	1.4	25.5	3.0	9.8	15.7	16.6	9.5	38.1	2.3	5.7	3.3	6.2	6.4	4.9	4.1	3.7	5.4	5.2	3.6	3.8	4.8	6.1	10.1	5.9	6.2	2.8	9.1	1.8	5.7	11.2	4.1	6.8	5.6	9.9	6.3	6.8	7.1	5.8	5.6	7.7	10.9	28.9	3.7	6.8	38.3	2.9	0.1	0.4	0.6	0.5	0.7	0.9	2.7	0.0	7.7	7.3	0.0	3.0	34.5	0.3	0.0	0.2	0.5	0.4	5.4	7.4	4.2	14.7	4.4	0.0	3.2	18.7	5.1	0.3	44.4	0.2	2.9	1.1	20.6	0.0	100.4	3.2	2.0	47.5	24.9	0.6	12.2	45.7	8.8	67.5	38.6	0.3	52.5	20.6	14.8	0.7	1.5	4.9	22.7	0.4	3.0	6.3	1.2	0.4	26.3	4.3	14.0	3.8	3.3	0.6	1.8	6.8	36.6	0.2	1.3	0.4
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 61.6;lung: 16.4;lymphoid tissue: 51.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.7	3.6	1.4	34.4	2.4	61.6	3.6	1.9	2.6	3.1	2.8	7.6	5.0	2.3	1.3	3.3	2.4	9.6	1.6	1.8	2.5	1.2	5.5	16.4	42.5	6.4	3.7	1.6	1.9	1.5	0.8	7.3	4.6	1.8	7.8	0.2	2.6	1.9	0.9	1.2	9.6	7.0	4.6	36.5	8.1	1.7	6.3	51.4	1.5	1.4	46.9	9.9	1.1	8.4	0.4	0.3	0.0	0.0	0.0	0.4	0.0	3.3	0.0	8.2	14.3	0.0	0.0	123.4	4.5	13.0	3.9	0.1	0.1	0.6	19.5	172.7	0.3	71.0	3.4	0.0	0.2	132.7	135.8	0.4	0.0	6.3	0.0	5.5	0.5	65.1	1.4	60.3	8.7	0.0	94.5	27.0	0.2	0.0	0.0	59.9	4.8	49.3	3.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	64.8	0.4	5.9	6.8	4.1	9.1	18.6	40.9	112.4	7.3	85.1	0.2	19.7	28.6	22.0	12.3	48.6	12.6	13.2	11.3	12.6	29.8	9.7	7.8	9.5	29.4	13.5	72.1	10.9	11.7	24.0	1.4	2.4	1.9	2.6	1.8	2.5	6.4	3.7	4.6	4.6	6.3	8.4	1.4	0.0	3.9	2.0	53.3	0.9	0.2	0.0	0.0	0.0	0.7	2.3	1.7	0.0	2.5	0.0	0.0	0.3	78.1	0.2	0.0	0.0	5.9	0.3	0.3	1.5	0.0	15.1	9.6	0.0	0.3	1.3	1.5	0.3	33.6	0.8	1.8	1.3	42.6	0.0	4.9	0.0	0.0	93.2	31.1	5.6	0.3	78.0	5.4	173.3	72.5	0.0	47.4	4.0	21.7	0.2	0.1	0.0	39.6	0.1	0.0	0.2	0.7	0.1	6.6	0.7	0.6	2.8	1.4	0.2	2.0	0.8	50.8	0.3	0.1	0.1
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50674927-51384198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.5;thyroid gland: 12.2"	"Group enriched"	"Detected in some"	11	"Astrocytes: 223.6;Excitatory neurons: 777.2;Inhibitory neurons: 837.1;Oligodendrocyte precursor cells: 445.4;Oligodendrocytes: 814.7"	"Group enriched"	"Detected in many"	4	"glioma: 2.7;thyroid cancer: 7.6"	"Group enriched"	"Detected in many"	8	"amygdala: 9.9;basal ganglia: 12.8;cerebral cortex: 17.5;hippocampal formation: 13.4;white matter: 17.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.1;GAMG: 5.9;HMC-1: 4.9;JURKAT: 5.8;U-87 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	0.8	3.3	9.9	0.2	12.8	0.2	0.3	0.9	17.5	0.9	0.0	3.1	0.2	0.7	0.7	2.1	0.8	0.3	2.9	13.4	0.8	0.8	0.1	0.5	0.3	1.3	0.4	0.4	0.4	5.3	6.4	0.1	1.2	2.0	0.3	10.1	1.5	1.9	1.9	2.4	0.8	1.0	0.0	0.5	1.4	5.9	1.7	0.0	12.2	1.8	0.3	2.0	0.6	17.2	0.1	0.2	0.2	6.1	0.0	0.0	2.6	0.1	0.1	0.3	0.2	0.1	0.4	0.0	0.5	1.9	5.9	0.4	4.1	0.0	0.1	3.7	4.3	0.1	1.2	0.1	0.0	0.1	4.9	0.0	0.1	0.2	0.0	0.3	0.0	5.8	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.3	1.9	0.0	0.6	0.0	0.3	0.6	3.7	0.0	0.3	3.4	0.0	4.1	0.1	0.0	0.4	0.2	1.6	0.2	2.2	0.3	0.0	0.0	7.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	9.9	12.8	0.9	17.5	13.4	0.8	1.3	0.4	1.2	0.0	1.7	17.2	0.0	0.0	0.6	223.6	0.0	0.0	0.2	0.0	0.0	22.0	0.3	0.4	7.5	0.0	0.7	0.0	2.1	0.1	0.4	0.1	1.9	0.0	11.4	0.3	0.2	0.4	0.0	0.0	777.2	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.5	33.7	837.1	0.0	0.0	0.0	0.0	6.0	0.0	0.4	0.0	52.5	0.0	3.1	1.0	445.4	814.7	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.1	5.1	0.0	1.1	1.2	6.0	4.1	0.4	0.1	0.0	1.1	0.1	0.0	0.1
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184689-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.0"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 789.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA017719: AB_1847820, HPA056837: AB_2683253"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	4.9	3.4	17.1	7.5	56.6	17.0	4.8	33.4	30.0	4.4	25.2	8.4	10.6	4.1	5.1	3.4	6.2	5.8	7.8	19.5	29.1	4.3	15.2	9.3	1.8	43.4	39.9	6.8	4.7	2.6	8.2	10.2	43.6	7.9	9.4	2.5	6.7	5.6	2.6	5.4	12.9	3.3	19.3	19.3	6.6	6.2	40.7	1.9	15.5	2.8	1.6	4.1	4.9	86.0	19.8	43.2	4.1	0.3	9.8	10.6	14.2	45.5	26.5	12.4	9.6	6.3	15.5	0.4	4.0	40.3	13.7	34.6	4.9	32.5	19.9	6.2	6.1	20.2	40.5	15.8	11.1	5.0	21.6	7.3	12.9	13.6	20.3	13.6	10.7	0.8	0.3	0.8	12.2	11.5	0.7	9.5	4.1	24.4	11.9	0.3	9.0	0.5	9.1	12.0	3.0	1.4	24.0	14.5	4.7	3.4	4.5	4.0	32.1	21.1	13.6	25.5	17.1	0.7	0.2	0.3	27.4	10.2	27.4	14.6	2.5	3.8	0.4	5.5	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.3	30.7	0.4	6.8	0.4	0.0	0.3	17.1	56.6	33.4	30.0	19.5	29.1	43.4	39.9	43.6	19.3	40.7	86.0	2.7	44.8	41.5	96.6	2.2	18.5	13.2	30.5	2.2	9.6	12.8	5.8	13.4	31.5	31.4	14.7	2.1	28.3	20.1	50.6	0.0	10.3	0.9	16.3	10.0	10.6	17.5	9.9	4.9	12.0	100.2	28.1	32.1	53.1	31.0	52.8	8.2	35.0	13.3	1.7	3.6	26.7	8.2	60.3	51.0	5.6	28.9	41.3	85.4	38.4	24.5	20.0	22.6	61.3	789.8	48.9	27.4	48.2	13.4	36.0	60.0	6.2	20.9	2.3	13.1	4.0	12.1	0.9	5.6	5.8	7.2	20.5	10.8	25.1	27.7	16.8
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.3;Cardiomyocytes: 185.4;Endothelial cells: 64.8;Hepatic stellate cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 68.2;TIME: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA049423: AB_2680760, HPA049424: AB_2680761"	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	31.2	9.9	7.4	5.4	6.3	0.4	27.5	4.5	9.7	15.4	3.6	16.8	14.2	14.7	4.6	16.8	11.6	12.0	29.6	4.6	5.1	26.3	13.2	46.3	4.9	7.8	7.1	12.0	14.4	5.4	11.9	15.0	6.9	14.8	6.2	1.8	11.4	7.5	15.1	25.2	15.4	7.1	5.7	14.5	15.8	5.8	11.4	2.1	29.0	9.3	2.6	14.2	16.6	5.6	14.6	8.9	9.9	8.1	7.3	10.5	15.9	4.2	6.9	4.1	6.3	16.9	11.2	0.9	25.4	7.1	3.9	8.3	4.3	22.3	2.5	12.4	7.0	2.8	2.2	12.8	11.8	4.3	13.7	8.1	13.0	7.5	17.0	7.9	68.2	0.3	15.7	0.0	9.1	32.7	0.1	14.7	12.5	13.2	16.6	0.9	6.7	14.0	6.8	20.0	0.6	17.6	4.2	4.2	7.6	6.5	4.9	7.6	68.8	7.5	7.8	17.1	7.6	1.2	0.2	14.1	6.3	3.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.3	4.5	9.7	4.6	5.1	7.8	7.1	6.9	5.7	11.4	5.6	70.3	3.2	12.6	6.8	0.9	6.5	6.2	8.5	4.6	1.4	4.3	3.8	185.4	5.7	11.3	25.8	0.0	0.3	0.9	15.6	1.9	5.4	3.5	3.9	8.9	64.8	12.1	0.0	2.9	6.8	1.3	19.6	35.2	7.2	5.1	4.7	55.3	5.6	4.6	0.0	5.9	15.9	8.2	2.5	4.4	1.3	22.4	1.6	3.6	35.6	0.0	4.6	0.0	7.1	3.5	11.9	10.9	9.4	1.9	8.4	11.9	1.9	9.2	2.6	19.7	8.4	30.8	1.5	4.3	7.4	11.5	0.5	1.2	7.8	9.7	9.0
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.0;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 506.8;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	11.0	13.3	4.3	35.7	4.4	42.2	7.3	5.2	3.9	4.3	45.0	7.3	7.3	3.0	2.9	7.2	4.3	14.6	2.0	4.0	5.9	16.5	6.1	19.7	51.1	8.8	7.6	2.0	4.2	7.7	2.6	15.3	9.1	5.1	7.3	4.5	4.6	2.8	1.0	3.0	15.4	6.2	9.3	45.6	9.5	7.5	8.8	64.8	4.9	2.5	49.6	14.8	3.3	12.8	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	1.6	1.4	52.9	3.9	0.0	0.0	2.3	0.8	0.3	0.0	18.2	2.3	0.1	0.0	0.2	0.0	53.3	7.1	0.2	9.3	0.0	0.2	0.0	0.0	0.0	11.8	25.9	0.0	3.2	50.1	83.7	0.2	0.2	0.7	61.9	0.1	21.3	0.2	54.3	0.1	0.0	0.0	0.6	3.6	1.0	1.4	158.0	10.2	0.0	0.4	0.7	0.1	10.3	0.1	0.0	0.1	33.3	0.9	65.1	56.9	73.5	12.2	52.0	10.2	25.2	15.7	13.8	53.0	23.2	11.3	11.1	173.6	24.1	84.2	13.8	15.6	22.6	4.3	4.4	5.2	3.9	4.0	5.9	8.8	7.6	9.1	9.3	8.8	12.8	5.0	9.6	33.5	2.3	112.6	6.4	2.5	1.2	45.5	3.6	12.3	10.8	2.3	18.6	4.9	7.3	77.2	70.9	101.9	1.5	1.9	1.0	33.4	1.9	0.7	9.8	8.4	35.1	1.9	6.5	4.3	5.3	12.8	3.2	24.6	12.7	2.9	2.6	58.4	0.0	4.2	12.9	2.0	115.0	49.4	14.8	3.1	107.7	8.8	506.8	134.3	1.1	74.2	4.5	2.2	1.4	24.9	0.4	94.6	1.5	1.2	12.8	8.0	4.2	13.1	30.2	20.6	22.1	13.3	9.4	3.8	42.7	111.6	1.1	1.3	3.4
DOCK9	"KIAA1058, ZIZ1"	ENSG00000088387	"Dedicator of cytokinesis 9"	Q9BZ29	13	98793429-99086625	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 216.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 158.7;Excitatory neurons: 150.6;Inhibitory neurons: 202.2;Microglial cells: 148.0;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 402.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 2.0;MAIT T-cell: 4.8;memory CD4 T-cell: 5.2;memory CD8 T-cell: 2.1;naive CD4 T-cell: 6.0;naive CD8 T-cell: 4.0;NK-cell: 7.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	11	"NK-cells: 7.3;T-cells: 6.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 200.8;hTERT-HME1: 435.4;HUVEC TERT2: 180.9;TIME: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034061, CAB034065, HPA043940"	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: AB_2678741"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.79e-1)"	"unprognostic (7.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.31e-2)"	83.2	22.4	82.6	21.4	137.2	6.0	71.1	96.6	91.0	42.9	30.8	44.4	15.7	31.3	35.5	93.1	30.3	36.6	58.9	72.8	93.8	21.9	15.8	93.0	33.8	116.6	112.1	27.4	19.9	41.8	21.1	98.2	123.4	23.0	20.8	39.5	51.2	21.7	25.9	76.9	35.2	36.9	86.6	16.8	24.7	16.2	110.4	47.8	62.6	64.3	40.4	29.0	49.6	216.7	61.6	19.4	10.6	14.2	10.6	8.3	200.8	17.2	14.2	12.1	10.7	127.4	47.7	51.3	39.8	16.6	21.8	59.5	27.4	54.3	21.8	52.2	15.2	0.0	37.6	2.1	14.0	0.1	2.9	9.0	37.2	12.4	435.4	27.9	180.9	33.0	10.6	11.6	52.1	20.2	35.5	0.3	4.9	84.6	14.2	2.1	39.3	2.7	38.3	50.8	22.4	24.3	26.4	63.4	15.7	85.9	16.9	0.4	179.7	9.7	11.4	6.5	28.5	17.6	14.8	8.6	15.6	0.0	16.0	0.0	0.0	0.0	2.0	0.0	4.8	0.6	5.2	2.1	0.0	0.2	6.0	4.0	0.1	7.3	0.0	0.0	2.4	1.5	82.6	137.2	96.6	91.0	72.8	93.8	116.6	112.1	123.4	86.6	110.4	216.7	158.7	16.0	39.5	37.5	3.4	15.3	7.1	14.7	10.2	37.9	15.4	6.5	9.4	11.5	12.5	9.2	50.1	35.6	7.0	11.9	1.9	5.4	1.7	10.5	5.3	90.2	6.7	3.6	150.6	6.6	8.3	17.2	2.6	21.4	2.5	18.0	47.8	8.4	5.0	25.2	202.2	6.0	10.2	1.9	7.4	3.3	7.8	1.7	1.8	148.0	0.4	12.9	4.1	238.8	402.2	14.7	5.6	14.7	2.8	10.1	10.6	3.8	7.1	23.9	0.0	122.6	12.4	7.2	5.4	25.6	32.0	17.2	11.0	2.4	5.9	10.5
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490821-3500674	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	7.5	8.8	15.6	4.4	18.9	8.9	6.8	18.9	18.3	6.2	9.9	8.2	17.8	7.6	0.5	11.0	6.7	1.2	12.6	14.7	15.2	11.1	10.9	6.4	3.2	20.6	19.2	6.5	8.5	2.5	8.4	2.2	18.8	7.5	1.0	1.3	6.9	2.1	18.9	10.5	11.5	1.3	16.5	7.9	8.7	8.1	17.6	2.1	5.9	2.2	1.6	8.3	6.9	24.0	18.6	22.4	3.1	7.1	1.6	2.0	15.0	17.4	3.6	8.0	6.5	31.9	7.6	15.3	13.2	2.4	7.5	19.3	4.6	6.1	1.5	21.5	24.5	15.1	13.3	37.7	6.7	20.7	19.9	2.3	5.7	8.2	3.3	2.8	4.3	15.6	34.1	16.4	3.7	22.3	20.3	23.3	19.1	7.1	29.2	25.4	7.6	21.3	5.3	11.1	20.0	15.5	12.7	10.8	18.4	1.3	15.0	11.0	9.9	10.9	14.4	29.0	31.7	21.9	17.4	20.1	12.4	46.6	12.7	1.2	6.7	2.4	7.6	8.1	9.4	11.1	10.1	14.9	11.0	16.5	14.1	12.3	0.4	10.0	8.9	14.1	13.2	5.9	15.6	18.9	18.9	18.3	14.7	15.2	20.6	19.2	18.8	16.5	17.6	24.0	9.5	6.4	2.2	2.0	15.5	23.6	22.6	13.2	12.5	17.2	12.4	10.0	7.7	11.5	7.1	5.5	10.4	30.9	7.6	27.9	21.5	22.2	8.6	10.9	7.9	13.2	13.1	23.2	4.9	21.3	29.9	13.6	16.3	7.8	13.4	10.5	11.7	10.0	21.6	25.2	5.1	17.6	24.4	7.9	9.3	23.8	14.0	9.3	19.6	1.9	16.9	12.7	15.5	4.5	30.0	24.7	17.2	15.1	16.0	28.4	10.8	28.9	4.6	12.4	0.0	16.2	13.6	12.6	12.7	14.5	27.6	34.8	12.1	13.6	27.2	18.7
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"granulocytes: 36.8;Hofbauer cells: 48.6;Macrophages: 31.2;monocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol		NA	NA		80000	"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB004224: AB_627447, HPA048561: AB_2680443"	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	10.8	3.7	8.8	10.2	8.3	13.7	4.7	8.2	9.0	6.6	7.6	5.2	4.4	4.9	0.7	1.4	6.3	3.2	2.8	7.8	8.7	2.7	1.5	6.6	12.3	10.7	8.7	4.2	3.7	6.3	2.2	4.0	9.2	3.1	3.8	0.9	3.0	4.0	1.1	1.6	5.8	4.8	9.2	11.6	6.7	1.7	9.4	7.6	3.9	1.7	10.1	4.7	2.7	9.0	5.3	2.0	6.0	3.0	13.9	16.8	4.2	12.8	10.0	5.2	8.5	1.6	6.1	3.3	18.0	12.3	11.3	0.7	6.1	2.8	1.9	76.3	5.7	43.1	4.4	0.3	10.0	22.0	41.0	12.5	0.0	28.5	14.7	21.7	6.2	13.8	12.7	9.5	10.5	5.6	15.8	45.7	11.1	10.8	1.6	13.0	12.9	3.5	2.7	4.5	2.0	10.0	2.5	0.7	6.7	1.7	3.3	24.1	11.7	32.7	15.1	15.3	2.9	12.6	9.6	0.1	32.9	35.3	5.5	39.0	52.3	38.9	17.3	51.4	13.9	22.9	14.1	15.4	51.3	26.3	10.3	10.3	52.9	27.4	59.3	10.8	24.3	39.8	8.8	8.3	8.2	9.0	7.8	8.7	10.7	8.7	9.2	9.2	9.4	9.0	6.7	9.6	8.8	2.9	15.0	2.0	1.1	3.7	1.2	0.5	2.2	2.8	1.8	4.3	2.0	5.5	0.0	1.9	13.6	8.7	0.0	11.9	0.3	7.4	5.8	7.2	3.0	12.4	0.1	9.1	4.2	6.5	6.1	5.6	36.8	5.8	9.7	0.6	48.6	1.7	0.5	5.9	2.0	26.3	24.2	1.0	5.0	31.2	3.6	4.7	41.1	9.8	16.5	0.5	0.6	10.2	10.0	6.0	6.3	2.4	8.1	3.9	1.7	0.5	6.6	4.1	8.3	0.5	2.1	0.3	1.6	2.3	13.5	7.0	6.8	1.6
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.6;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1565.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		220000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	9.5	5.0	1.1	26.5	1.2	19.5	5.0	1.2	2.3	1.9	2.5	5.5	7.0	2.2	0.5	2.3	3.5	6.5	3.5	1.3	1.3	3.0	6.1	25.6	26.3	1.4	1.5	1.4	1.9	0.5	1.1	7.9	1.5	2.3	3.6	0.0	3.4	1.5	2.0	2.3	9.5	6.9	1.2	40.9	6.8	1.6	4.5	16.4	2.4	1.6	7.8	8.4	2.3	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	54.3	0.0	0.1	0.0	0.4	119.8	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.8	5.0	0.0	0.0	0.9	8.7	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.3	1.4	42.0	0.2	577.6	484.3	1565.6	398.3	624.0	184.5	14.5	274.3	304.8	421.9	6.6	151.0	185.9	37.2	307.6	580.7	7.6	597.2	810.3	1.1	1.2	1.2	2.3	1.3	1.3	1.4	1.5	1.5	1.2	4.5	1.5	2.0	3.2	18.1	0.0	13.2	11.5	0.6	0.0	0.0	0.0	1.2	1.8	2.1	0.0	1.3	3.7	0.0	0.7	130.6	0.3	0.0	0.1	0.2	0.2	0.5	2.8	0.0	10.5	0.1	0.0	1.0	2.6	3.1	0.4	36.3	0.1	5.7	1.1	131.8	0.0	0.0	0.2	0.0	171.8	288.4	0.6	0.3	181.5	19.6	0.0	74.8	0.0	344.0	0.0	0.0	0.0	0.0	0.0	15.4	0.2	0.0	0.7	1.5	0.0	0.0	0.6	2.5	0.2	4.3	0.7	8.5	1.0	147.4	0.0	0.2	0.8
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK4	FLJ10488	ENSG00000125170	"Docking protein 4"	Q8TEW6	16	57471922-57487327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008348, HPA055849"	Supported		Approved	Cytosol		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA008348: , HPA055849: AB_2682942"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.18e-3)"	10.5	9.2	12.0	9.6	12.2	1.8	8.8	12.2	12.7	20.7	9.0	43.9	46.1	16.9	12.1	32.8	15.2	17.5	14.8	11.1	11.8	42.0	33.7	23.3	4.3	8.3	11.0	19.8	17.6	12.0	19.8	10.9	13.0	18.3	31.3	4.1	12.6	25.8	3.0	43.2	49.9	12.2	7.5	10.5	37.3	7.0	10.8	3.8	10.7	3.9	7.4	16.7	21.6	9.4	10.3	94.2	15.0	26.8	20.6	22.6	16.7	17.7	23.5	12.4	3.8	107.8	53.1	1.1	75.4	37.2	7.3	21.0	9.2	4.9	5.3	2.7	6.9	22.3	28.2	63.2	29.3	0.3	2.3	15.8	14.2	16.4	1.8	27.6	19.0	3.8	7.3	4.3	14.9	9.9	1.1	4.1	9.6	46.1	4.0	8.9	7.8	1.2	64.8	3.9	73.6	239.9	14.5	6.3	4.5	66.0	5.6	4.2	20.5	2.1	15.1	6.1	0.8	2.9	4.1	0.8	6.7	4.7	9.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	12.0	12.2	12.2	12.7	11.1	11.8	8.3	11.0	13.0	7.5	10.8	9.4	8.3	12.8	14.0	0.7	1.4	7.9	7.2	3.6	5.2	15.5	3.7	5.0	2.4	30.0	3.3	14.7	0.0	0.9	1.8	127.9	5.9	15.0	1.2	2.1	5.3	11.3	3.6	1.3	5.0	23.7	7.6	7.9	36.2	2.9	0.0	19.6	6.8	20.4	0.9	8.4	7.1	30.3	2.0	0.8	1.6	2.0	13.4	1.0	3.6	1.0	0.7	2.2	0.0	2.0	0.4	30.8	99.9	12.0	1.4	7.1	96.6	46.9	2.5	0.8	6.6	1.1	6.9	0.2	4.1	11.6	18.0	0.5	2.5	4.8	34.1	6.1
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475593-54651169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.0;tongue: 24.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	2.9	1.9	14.6	1.7	14.2	0.0	1.9	13.4	15.6	1.1	13.0	1.4	0.3	1.7	0.3	1.7	12.2	9.8	18.4	15.4	16.9	5.2	2.3	1.0	0.6	15.9	14.7	0.9	1.2	0.2	1.1	1.8	18.6	0.9	0.7	11.7	1.4	0.8	46.0	0.5	0.7	2.8	13.9	0.3	0.8	1.7	15.3	0.4	5.1	24.3	0.4	4.7	0.9	13.3	0.0	0.0	32.9	0.0	13.1	11.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.3	0.0	13.7	0.0	0.6	1.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.6	7.0	0.0	8.6	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	51.3	3.2	1.4	0.0	0.0	0.0	0.1	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	14.2	13.4	15.6	15.4	16.9	15.9	14.7	18.6	13.9	15.3	13.3	4.8	0.0	0.0	110.7	0.3	0.3	2.3	0.0	0.0	12.3	6.7	6.2	7.3	12.8	0.0	11.0	6.2	0.3	0.1	0.0	39.2	17.7	2.3	0.4	1.5	3.3	0.0	0.0	49.7	1.2	0.6	14.4	0.0	10.6	0.0	28.6	17.5	0.0	29.0	38.7	79.6	0.0	0.0	0.6	2.5	4.5	2.5	0.6	0.0	9.4	14.5	63.9	0.0	58.3	2.1	2.2	0.0	1.2	0.1	2.0	0.0	0.2	0.0	8.1	0.0	2.8	5.3	3.7	1.5	0.0	0.4	0.8	0.2	1.6	0.0	0.9
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69400888-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;parathyroid gland: 12.5;retina: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	1.1	0.7	8.8	0.7	10.3	0.1	0.5	0.9	14.0	1.8	0.0	0.6	0.3	1.5	0.5	0.7	0.7	3.2	6.2	17.8	10.6	4.9	2.4	2.4	0.5	10.9	11.6	2.2	0.2	12.5	0.7	5.9	9.7	1.3	0.5	22.3	0.8	2.1	0.1	0.5	0.5	2.5	4.1	0.9	0.7	1.5	6.5	0.1	2.2	0.6	0.5	3.1	1.1	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.0	11.1	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.7	10.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	4.0	0.6	0.0	1.5	0.3	0.0	0.0	3.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.3	0.9	14.0	17.8	10.6	10.9	11.6	9.7	4.1	6.5	5.8	0.5	0.0	0.0	9.8	0.0	0.3	0.1	0.0	0.0	230.4	0.1	0.0	9.1	0.0	1.3	0.0	14.6	0.0	1.2	0.0	1.9	0.0	45.3	0.4	13.3	1.5	0.0	0.0	236.8	0.0	0.0	6.7	0.0	0.3	0.0	17.2	0.0	0.9	0.0	10.1	259.1	0.0	0.0	0.3	0.8	30.6	1.5	2.1	0.0	8.4	0.1	6.9	2.1	178.4	6.4	0.0	0.0	6.8	0.7	0.1	0.0	9.6	0.0	14.6	0.0	0.4	5.5	0.9	1.1	0.1	0.6	0.0	1.2	4.9	0.0	0.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081111-129090438	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.1;Proximal enterocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	5.6	11.4	12.2	6.3	13.4	8.1	5.8	13.0	13.8	6.6	8.7	15.5	26.2	5.3	6.0	19.2	5.5	5.8	4.6	12.1	12.5	6.0	22.4	5.0	6.6	13.3	13.4	5.2	10.4	8.7	6.2	7.6	14.3	8.5	12.5	3.8	9.9	4.7	4.9	10.5	22.6	5.3	13.1	7.8	10.8	8.1	13.5	10.1	5.4	4.8	6.6	6.0	8.3	15.2	8.7	33.6	31.4	29.6	10.3	9.1	36.2	20.9	12.2	39.3	22.0	42.9	28.4	16.7	18.2	13.0	30.2	61.8	32.6	17.8	16.6	19.9	20.6	22.0	22.3	34.5	18.8	23.0	26.4	9.5	24.4	25.5	20.3	8.9	17.5	30.7	37.3	16.2	11.4	44.7	26.5	24.8	27.4	64.7	28.2	30.8	25.3	31.2	14.2	14.1	35.9	24.2	27.1	24.1	9.4	18.4	44.8	15.0	14.5	33.5	16.4	33.4	29.0	20.3	41.6	25.3	15.3	4.6	22.8	7.9	8.2	12.6	10.2	10.5	25.2	11.4	12.6	12.6	10.5	7.7	12.5	11.9	1.7	11.2	11.0	15.8	13.6	8.9	12.2	13.4	13.0	13.8	12.1	12.5	13.3	13.4	14.3	13.1	13.5	15.2	3.1	6.4	6.3	4.2	3.9	2.3	3.0	6.9	1.2	3.7	7.3	5.2	2.1	10.0	6.3	1.8	6.2	18.8	2.8	29.1	1.9	7.1	0.5	3.9	5.0	3.4	3.6	13.0	3.1	9.6	14.2	3.9	10.2	5.4	5.7	3.8	5.3	18.3	7.5	3.3	4.4	10.1	6.1	2.9	1.9	0.5	2.1	2.7	5.4	1.0	4.2	8.6	6.2	3.5	6.4	6.6	16.2	4.1	6.7	3.8	42.0	4.1	3.2	3.7	0.0	3.1	4.0	6.3	9.7	11.0	4.0	16.4	4.4	8.1	13.5	4.1
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DOP1A	"dJ202D23.2, DOPEY1, KIAA1117"	ENSG00000083097	"DOP1 leucine zipper like protein A"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	5.2	4.9	5.0	6.2	5.7	4.9	10.9	8.7	6.4	8.9	3.5	8.0	7.9	10.4	7.4	7.1	9.4	7.2	9.0	5.1	4.2	6.9	6.2	6.8	7.2	3.8	3.7	13.8	9.1	11.6	7.7	6.0	3.7	9.6	8.8	24.0	9.5	10.7	6.3	13.6	8.9	7.5	5.0	8.2	7.2	12.7	4.1	10.6	13.6	9.4	7.5	6.2	5.0	11.0	4.2	3.0	9.8	8.9	8.7	9.1	4.6	7.0	5.9	4.7	6.8	6.4	1.0	8.2	4.9	7.7	5.9	5.5	10.0	7.6	5.9	7.2	11.3	6.8	4.2	2.4	4.7	10.1	6.9	7.3	10.4	6.6	17.0	6.2	7.0	12.6	14.4	5.9	5.1	3.9	3.0	4.5	2.0	3.1	6.1	8.2	7.4	3.0	6.1	11.7	17.6	3.2	5.2	3.3	1.3	7.0	5.3	5.7	11.8	5.9	2.1	6.0	5.5	7.3	5.7	4.6	3.2	4.6	4.7	0.0	0.3	0.4	0.5	0.4	0.4	0.6	0.4	1.1	0.7	0.4	0.8	0.4	0.0	0.4	0.3	0.3	0.4	0.4	5.0	5.7	8.7	6.4	5.1	4.2	3.8	3.7	3.7	5.0	4.1	11.0	5.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2163933-2232578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 99.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	11.4	12.9	3.7	10.5	7.6	22.1	8.9	9.9	9.1	8.8	4.9	12.1	12.5	10.0	1.1	14.7	8.6	5.2	9.7	5.1	3.7	19.7	15.1	18.3	8.0	7.5	4.9	10.5	15.4	2.0	13.9	5.4	6.2	9.7	3.9	8.5	9.9	1.9	12.2	14.5	17.6	3.4	1.7	17.3	12.7	99.7	7.9	7.0	15.6	2.8	5.0	7.2	9.8	11.2	27.7	14.4	48.4	26.5	3.5	5.2	63.5	15.2	3.4	8.3	6.6	18.4	10.1	31.6	7.3	10.0	7.0	24.0	16.1	8.6	3.9	16.4	20.0	29.6	26.7	18.3	5.5	42.8	52.6	5.0	6.3	15.9	8.1	6.8	6.7	17.8	36.2	32.7	6.6	15.6	34.1	46.4	37.4	17.4	25.2	34.8	13.6	21.8	4.6	12.9	31.9	24.7	10.7	31.8	20.2	12.7	14.3	32.4	9.6	22.9	20.7	34.2	30.1	29.9	42.8	22.0	22.6	28.6	13.7	0.1	0.1	0.8	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.2	3.7	7.6	9.9	9.1	5.1	3.7	7.5	4.9	6.2	1.7	7.9	11.2	9.3	32.1	16.3	12.4	9.5	17.7	14.7	4.7	10.2	27.2	12.7	8.4	7.1	11.5	7.2	9.2	66.7	6.1	15.9	29.1	3.9	11.5	37.6	14.2	10.7	10.2	20.8	8.6	7.8	12.2	13.8	11.0	27.5	28.2	6.3	15.9	5.3	14.4	9.9	13.5	6.8	12.0	4.1	12.3	30.4	18.2	3.1	19.0	12.4	10.3	8.5	5.5	8.2	10.6	15.0	13.9	28.6	3.4	8.6	12.9	35.6	3.1	7.6	28.1	0.0	14.2	10.3	32.4	23.0	12.2	19.9	16.3	6.3	15.3	15.9	15.3
DPAGT1	"ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT"	ENSG00000172269	"Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1"	Q9H3H5	11	119096503-119108331	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053878	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053878: AB_2682288"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.53e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.08e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.57e-2)"	11.3	14.1	13.0	13.7	13.3	9.1	14.8	13.9	22.4	16.1	17.6	17.7	16.8	10.2	21.8	12.4	17.3	14.5	8.6	13.5	14.1	12.8	21.2	11.4	11.5	14.2	14.4	9.0	27.1	18.6	4.4	15.8	14.2	14.3	20.0	7.4	27.8	16.3	5.6	9.0	14.9	17.7	13.4	9.8	14.4	4.8	14.6	8.2	15.5	8.5	14.3	16.8	6.2	14.9	22.0	39.2	22.2	55.7	60.0	37.0	24.6	33.7	38.3	25.7	32.2	43.4	88.3	41.5	62.8	45.4	57.7	77.1	42.0	60.7	31.1	29.4	23.8	83.5	14.1	51.6	50.7	53.9	47.4	40.3	48.7	62.4	85.3	29.9	53.3	25.2	51.7	84.1	50.9	67.7	19.5	39.9	22.5	148.3	49.4	26.2	26.6	61.3	60.3	44.7	23.0	30.1	30.7	99.3	17.1	32.3	116.8	19.4	29.1	57.3	24.5	30.3	23.7	19.6	32.2	13.9	14.3	68.3	48.9	28.4	35.7	4.4	25.2	35.5	28.4	24.5	20.1	24.8	43.3	25.6	16.6	15.8	3.0	20.7	32.7	37.5	19.6	20.2	13.0	13.3	13.9	22.4	13.5	14.1	14.2	14.4	14.2	13.4	14.6	14.9	11.5	6.4	8.1	7.2	10.7	13.3	15.2	34.4	13.1	6.1	18.4	12.1	5.0	14.3	22.8	14.7	14.6	34.2	9.6	10.3	3.9	32.9	0.9	15.6	12.3	16.0	10.2	8.6	7.3	13.3	44.4	11.0	14.3	11.2	12.7	12.7	15.7	23.1	28.8	3.3	5.7	19.8	32.6	13.0	11.4	1.9	14.0	14.1	8.8	5.6	20.9	6.2	13.4	7.5	5.4	13.9	11.1	8.2	33.2	14.5	19.3	11.3	37.2	4.6	0.0	6.0	10.7	6.8	10.3	14.1	12.5	23.5	10.0	15.9	20.7	12.9
DPCD	"DKFZP566F084, RP11-529I10.4"	ENSG00000166171	"Deleted in primary ciliary dyskinesia homolog (mouse)"	Q9BVM2	10	101570560-101609662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 132.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 579.4;Late spermatids: 1068.7;Respiratory ciliated cells: 329.7;Spermatocytes: 313.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 20.2;intermediate monocyte: 22.2;myeloid DC: 29.6;non-classical monocyte: 9.5"	"Group enriched"	"Detected in all"	14	"dendritic cells: 29.6;monocytes: 22.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036603, HPA036604"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA036603: AB_2675212, HPA036604: AB_10673503"	"unprognostic (1.22e-2)"	"unprognostic (1.73e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.90e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.83e-2)"	"unprognostic (7.54e-2)"	10.5	18.7	35.1	8.7	37.2	11.8	19.4	31.5	42.0	21.8	55.1	17.3	6.8	16.7	41.3	20.4	73.3	15.5	29.6	37.4	39.1	30.9	10.4	14.0	6.2	36.2	37.1	23.5	14.7	49.3	49.5	10.6	36.5	16.1	13.5	55.8	21.2	15.7	19.2	13.2	7.1	18.0	33.3	4.5	14.4	132.4	39.7	6.6	33.0	18.3	8.2	14.4	14.9	33.4	97.1	53.4	37.9	77.2	35.2	61.7	15.6	44.5	53.6	59.4	55.1	38.8	51.4	9.0	74.6	42.7	25.2	54.0	55.4	65.3	61.2	23.0	57.5	11.3	49.8	56.7	20.3	58.8	8.1	42.3	54.8	72.0	56.1	153.7	50.8	14.0	32.4	12.6	45.1	122.9	0.0	48.1	28.7	26.9	41.6	0.0	51.8	20.5	92.6	25.3	37.1	63.3	36.5	23.4	31.3	34.1	71.2	23.9	35.5	27.3	24.9	55.7	62.3	37.9	45.9	16.9	94.7	13.7	11.7	0.0	20.2	1.0	1.8	22.2	1.7	1.3	1.4	1.4	29.6	0.7	1.5	1.8	0.9	1.6	9.5	4.1	0.6	8.1	35.1	37.2	31.5	42.0	37.4	39.1	36.2	37.1	36.5	33.3	39.7	33.4	6.9	35.3	12.4	4.9	2.1	9.7	29.5	89.2	9.6	16.4	25.4	29.5	33.7	30.0	56.6	49.7	18.8	24.6	0.9	10.5	95.9	63.3	579.4	136.5	23.5	11.1	23.9	14.1	7.7	27.5	16.7	21.2	10.2	20.2	1.3	19.2	11.4	10.9	24.0	11.8	6.2	12.5	52.9	4.4	14.6	1068.7	23.6	8.7	16.0	3.7	6.9	27.8	2.1	4.0	1.4	33.9	12.4	27.8	5.6	18.6	3.5	117.3	329.7	49.1	0.0	12.4	29.0	313.8	77.4	8.7	14.2	10.7	2.9	25.3	22.1	23.9
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 29.9;Kupffer cells: 55.0;Macrophages: 34.6;monocytes: 28.6;NK-cells: 25.7;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 410.0;eosinophil: 841.1;neutrophil: 358.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 841.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.1;HMC-1: 18.1;NB-4: 4.1;U-937: 6.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 12.3"	HPA035644	Approved					NA	NA		330000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	6.0	0.9	4.3	12.6	4.4	23.3	2.8	4.3	9.3	2.3	4.1	4.1	3.3	1.4	0.6	1.8	2.8	6.2	2.4	4.1	4.8	1.8	3.8	18.5	18.8	6.3	4.9	0.6	1.0	0.9	0.7	13.4	5.1	1.5	4.1	0.2	1.7	1.2	1.4	1.2	11.9	4.0	5.1	28.6	3.2	2.8	5.6	9.0	2.5	3.3	18.3	8.1	1.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.1	0.0	0.1	18.1	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.3	0.1	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.0	6.3	0.0	410.0	82.6	841.1	17.0	101.9	19.8	30.3	29.5	13.7	33.0	35.9	34.7	17.8	358.8	44.7	126.7	5.3	31.8	48.9	4.3	4.4	4.3	9.3	4.1	4.8	6.3	4.9	5.1	5.1	5.6	6.6	0.9	0.0	7.9	0.0	20.4	2.0	0.0	0.3	1.2	0.0	0.2	0.3	1.8	0.0	1.7	0.0	0.0	10.0	8.7	0.1	0.0	0.1	0.2	0.1	0.1	4.8	0.0	2.1	0.1	0.0	0.7	1.0	0.5	0.1	2.5	0.0	18.9	0.1	29.9	0.0	0.2	0.0	2.0	55.0	21.0	1.1	0.0	34.6	3.6	10.3	28.6	0.0	25.7	0.0	0.1	0.0	0.0	0.4	3.4	0.0	0.0	0.3	8.6	0.0	0.0	0.3	0.8	12.0	9.4	0.1	1.3	54.0	13.1	0.0	0.0	0.1
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980549	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 47.0"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 290.4;Spermatogonia: 289.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 6.7;NK-cell: 1.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 6.7;NK-cells: 1.8"	"Cell line enriched"	"Detected in single"	10	"U-266/70: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced					NA	NA		27000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.4	0.1	0.2	0.2	0.2	1.7	0.0	0.2	0.4	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.3	2.0	0.3	47.0	0.3	0.1	0.0	0.6	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.5	0.5	0.2	6.7	1.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	41.3	4.4	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	0.1	0.7	0.0	26.3	0.0	0.0	290.4	289.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 25.4;Excitatory neurons: 24.6;Horizontal cells: 45.4;Inhibitory neurons: 16.3;Late spermatids: 23.4"	"Group enriched"	"Detected in some"	5	"glioma: 5.6;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	0.1	0.3	12.7	0.4	14.9	0.1	0.1	2.2	23.4	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.4	16.9	9.9	0.1	0.0	0.3	0.1	1.9	4.4	0.3	0.1	0.0	2.5	0.1	2.4	0.1	0.0	2.4	0.2	0.0	0.2	0.3	0.1	0.2	2.0	0.1	0.1	2.4	9.5	0.2	0.0	0.0	0.1	0.1	0.1	14.8	4.6	3.8	15.8	11.7	1.1	0.8	1.6	4.8	2.7	8.0	6.7	2.7	0.4	7.5	3.2	3.7	3.2	2.8	19.7	2.6	3.6	7.2	3.9	2.5	2.0	1.1	0.4	1.9	2.1	0.9	0.1	4.7	1.5	1.0	1.5	5.5	5.6	0.4	7.7	6.4	4.1	0.5	2.9	1.3	4.4	7.5	8.0	1.6	0.8	1.4	22.9	7.8	5.4	0.5	1.0	1.9	2.4	0.4	1.8	11.5	3.7	2.8	4.4	2.9	10.3	9.9	6.1	2.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	14.9	2.2	23.4	16.9	9.9	1.9	4.4	2.4	2.0	9.5	14.8	0.4	0.0	0.0	3.3	0.1	2.3	0.1	1.1	0.0	17.9	0.2	0.6	1.2	0.0	0.1	0.0	8.4	0.1	0.0	0.1	0.0	0.0	25.4	1.5	2.2	0.9	0.0	0.0	24.6	0.0	2.0	1.5	0.0	0.7	0.0	4.3	0.4	0.0	0.2	45.4	16.3	0.0	0.0	0.3	0.4	23.4	0.6	0.1	0.0	1.0	0.0	3.3	0.0	12.5	4.8	0.1	0.0	2.6	0.0	0.1	0.0	0.1	1.4	3.1	0.0	0.7	1.9	6.7	12.6	0.0	1.1	0.1	0.2	1.6	0.0	0.1
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333852-65354262	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020880: AB_1847845, HPA056786: AB_2683235"	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	21.2	21.0	41.3	14.2	45.1	24.7	21.6	43.6	43.3	35.0	35.2	36.1	13.1	37.6	22.8	23.1	31.3	14.7	34.2	39.5	42.2	20.8	16.8	19.5	22.3	43.1	43.7	40.9	20.5	19.7	20.1	17.6	42.8	28.6	13.8	17.6	21.1	25.8	38.6	19.3	24.3	27.8	43.7	29.7	24.2	37.7	43.0	37.6	22.5	29.2	24.5	34.2	24.1	48.7	29.9	36.4	45.9	40.5	39.7	39.8	25.5	25.0	35.1	53.5	38.6	36.0	34.8	39.5	40.8	34.0	46.6	31.2	52.2	31.9	37.7	47.6	23.1	50.4	24.6	37.7	61.1	47.0	36.5	35.0	30.4	48.4	86.6	40.1	43.3	47.0	48.7	51.0	35.2	47.3	60.0	49.3	51.6	31.9	37.4	65.1	29.9	46.8	34.0	24.1	29.9	27.3	32.1	45.7	47.0	29.7	59.0	26.2	25.8	35.2	31.3	38.9	25.9	62.7	78.8	51.1	21.6	30.6	40.4	186.4	75.4	141.1	79.7	70.8	87.0	102.0	76.9	78.4	76.2	109.1	78.6	71.9	161.5	125.8	83.0	70.6	107.3	108.4	41.3	45.1	43.6	43.3	39.5	42.2	43.1	43.7	42.8	43.7	43.0	48.7	19.2	6.4	10.1	14.0	35.7	22.7	21.8	41.7	23.9	42.2	20.1	24.9	12.7	27.1	24.2	33.1	47.9	27.2	42.0	11.5	19.6	21.2	5.2	18.3	29.5	24.2	17.4	32.8	18.5	17.4	22.9	27.2	15.3	18.5	16.5	31.8	24.3	13.3	19.5	30.3	19.9	16.8	32.6	17.5	33.8	12.3	58.7	16.9	19.6	15.0	30.0	22.8	35.0	24.1	32.3	19.3	8.6	53.4	21.6	22.6	23.7	22.0	19.3	50.5	32.9	28.8	32.2	60.2	63.5	15.4	23.2	26.5	30.6	28.7	17.9	19.7
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;retina: 18.0;skeletal muscle: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 49.5"	"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.3	1.4	2.8	0.5	6.7	2.6	0.4	35.5	5.1	0.4	0.0	2.0	0.2	0.2	0.0	0.6	0.3	0.3	14.2	10.2	3.8	1.4	3.0	0.2	0.8	12.0	5.9	13.7	0.3	5.1	0.6	0.3	12.6	0.1	1.5	18.0	0.4	0.2	26.5	0.5	1.3	0.5	4.4	1.0	0.5	3.5	5.7	0.3	0.4	9.1	1.0	0.2	0.2	7.7	2.1	0.0	1.6	0.1	0.2	2.9	17.7	5.4	5.1	12.2	4.7	0.1	0.2	0.2	0.3	1.7	0.2	0.1	1.7	0.8	7.4	0.3	0.6	31.5	0.2	0.0	0.5	0.2	0.5	0.7	0.3	2.8	2.0	2.0	4.0	3.4	2.8	12.4	3.9	0.1	2.7	0.3	0.0	0.0	1.8	6.9	0.8	0.4	2.1	0.0	1.2	0.7	0.0	0.1	0.0	0.5	0.0	0.0	8.7	6.0	0.0	2.2	0.6	4.3	1.2	0.4	0.5	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.7	35.5	5.1	10.2	3.8	12.0	5.9	12.6	4.4	5.7	7.7	0.8	0.0	0.0	104.5	6.0	0.6	0.1	0.0	0.0	10.5	1.1	0.9	38.4	1.5	0.0	0.0	108.4	2.6	2.6	7.5	1.9	0.1	58.5	0.1	0.8	2.9	0.0	8.6	17.7	0.4	1.3	2.8	0.0	0.1	4.5	43.2	1.1	4.4	0.4	6.7	21.7	3.4	0.0	0.8	0.7	34.3	0.3	1.7	0.0	8.4	0.1	8.6	2.1	123.1	115.7	0.7	5.1	4.9	2.6	0.1	2.7	10.7	0.0	85.5	0.0	2.6	3.5	4.5	1.2	0.3	0.3	0.1	3.8	14.5	7.4	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
DPH2	DPH2L2	ENSG00000132768	"Diphthamide biosynthesis 2"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	8.2	11.5	9.3	10.8	9.6	7.0	7.9	9.0	10.2	7.2	9.0	9.7	7.3	7.7	6.1	11.8	8.2	5.5	11.6	9.1	8.5	13.2	12.6	7.1	12.4	8.7	9.2	7.2	15.9	10.2	8.8	6.6	9.0	8.1	9.2	3.5	9.5	6.7	32.8	10.5	9.0	8.9	8.6	11.8	9.7	7.2	9.4	8.8	7.4	17.0	10.9	12.3	6.7	9.5	25.0	28.5	12.2	26.8	9.2	9.6	41.6	13.0	13.9	32.9	26.9	36.1	23.8	41.4	21.4	13.3	17.0	28.1	41.7	36.8	18.4	28.0	36.1	42.4	36.1	37.9	24.1	49.9	23.4	14.9	40.6	39.2	21.0	10.0	23.2	32.0	55.4	23.1	16.8	28.6	44.6	28.3	86.3	40.5	31.4	37.6	28.2	67.4	20.6	19.5	42.8	49.3	17.2	43.1	32.6	16.3	18.2	34.3	15.4	16.1	36.7	28.6	52.4	55.3	98.7	43.0	14.2	55.0	24.1	0.0	6.6	0.4	6.1	9.4	9.0	8.3	6.4	6.5	10.1	8.8	6.4	9.3	0.6	10.3	4.8	8.4	6.6	6.3	9.3	9.6	9.0	10.2	9.1	8.5	8.7	9.2	9.0	8.6	9.4	9.5	5.8	0.0	4.8	5.2	14.4	22.9	13.2	8.9	8.6	6.8	10.3	10.0	9.3	7.2	5.2	1.8	10.4	14.8	8.8	4.8	5.9	16.5	0.3	4.0	5.6	7.6	12.0	6.3	6.9	18.8	16.2	6.2	8.6	4.3	4.5	6.9	2.5	5.7	8.6	3.3	6.5	8.1	4.1	3.7	7.1	1.0	8.4	4.4	5.4	0.0	9.2	4.4	12.3	4.0	6.9	15.2	3.0	3.8	11.5	23.6	3.8	9.0	6.0	6.0	0.0	6.5	8.0	9.4	24.9	10.3	27.1	8.6	6.9	12.7	13.7	9.0
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257061-16264969	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	14.2	11.9	12.7	9.6	13.5	8.4	10.3	14.3	14.3	10.2	13.6	11.5	10.7	10.0	11.0	9.4	8.9	10.2	13.9	12.2	15.6	13.1	15.3	11.1	8.9	15.4	14.4	6.1	7.8	9.0	8.5	13.2	15.0	9.3	8.7	13.4	5.7	11.1	29.4	4.9	13.3	15.2	14.7	9.1	9.4	8.5	13.6	11.5	12.4	20.1	8.1	12.4	5.8	15.5	10.5	14.6	31.9	18.9	58.9	39.7	24.8	29.9	24.4	28.0	31.3	18.1	5.8	10.0	9.3	37.5	24.0	6.2	29.4	17.7	32.6	50.5	20.4	16.6	11.5	21.0	36.7	24.5	15.6	28.6	23.6	36.0	15.2	17.6	25.5	17.4	26.9	16.4	39.9	14.1	19.0	16.5	25.6	15.9	14.7	12.9	20.7	15.4	24.9	8.0	7.2	20.2	13.8	6.7	35.4	25.6	12.5	23.9	29.9	22.9	15.0	41.7	24.0	12.6	44.5	12.8	33.6	27.2	20.7	27.1	16.7	25.7	11.3	22.8	14.0	10.1	11.9	13.8	15.9	9.9	9.9	11.9	35.5	10.7	21.6	6.2	11.9	12.7	12.7	13.5	14.3	14.3	12.2	15.6	15.4	14.4	15.0	14.7	13.6	15.5	32.3	19.2	22.4	10.1	31.0	51.6	42.9	41.0	29.0	11.6	32.9	34.7	34.9	25.8	32.4	16.5	12.5	47.9	28.1	43.0	41.1	49.5	109.1	27.5	35.3	32.5	17.9	32.0	12.0	57.2	80.6	34.4	30.1	33.3	52.0	11.2	26.7	41.6	101.6	6.7	10.3	22.6	26.4	45.5	61.7	63.3	20.5	46.4	28.4	3.7	71.5	24.8	29.9	6.6	9.2	66.6	32.4	15.8	42.2	42.6	79.1	45.4	33.9	15.1	13.1	33.4	36.7	80.4	40.1	31.3	52.4	80.9	34.5	18.7	19.0	47.1
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.5	23.2	17.2	8.4	17.8	10.7	28.8	17.3	22.5	23.2	18.3	14.6	7.1	17.2	23.8	13.7	26.2	11.6	23.5	17.4	18.7	19.5	25.3	10.1	18.1	17.8	18.0	49.8	31.4	20.0	15.5	12.3	17.8	15.0	17.5	8.8	11.9	17.1	20.8	15.0	11.2	19.7	17.6	15.4	14.1	9.8	19.0	29.0	20.7	25.0	25.4	14.7	13.3	18.0	28.1	30.1	40.1	37.0	48.3	154.7	34.9	24.9	42.9	41.0	34.5	35.3	7.7	46.0	33.2	22.2	23.1	20.0	47.5	41.1	62.6	20.0	35.8	22.1	26.7	71.4	84.1	33.4	13.8	97.1	63.9	38.8	118.6	67.4	64.8	33.4	62.6	16.7	70.3	26.3	40.7	36.7	31.5	15.2	46.4	37.8	51.1	32.6	50.0	25.7	44.2	22.2	13.7	36.2	114.0	29.6	27.3	18.3	25.1	23.0	28.7	28.8	34.4	20.0	24.1	31.9	31.5	29.6	7.9	5.7	7.5	4.6	16.1	8.9	21.7	19.2	17.9	17.7	13.6	15.1	24.0	20.9	2.7	24.7	10.6	9.8	12.8	10.2	17.2	17.8	17.3	22.5	17.4	18.7	17.8	18.0	17.8	17.6	19.0	18.0	8.1	6.4	14.6	17.0	30.3	15.8	17.0	24.2	19.9	5.3	18.7	12.3	23.8	21.5	12.7	7.3	0.0	26.2	10.1	4.7	23.5	14.0	1.8	14.2	19.6	11.2	10.2	17.7	12.0	18.4	27.8	13.5	5.6	8.2	25.4	29.0	12.1	29.3	18.9	1.7	14.6	15.0	22.4	28.4	13.1	3.0	27.1	14.0	12.4	8.4	27.7	16.5	27.8	27.2	28.3	8.9	12.9	13.9	10.3	10.8	8.1	30.9	16.8	6.5	6.6	16.6	12.5	15.7	17.6	17.0	18.0	13.0	19.4	33.4	23.7	11.3
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.7;Oligodendrocytes: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	8.6	7.5	3.7	4.9	4.7	5.4	10.8	4.6	5.0	6.8	3.6	6.7	6.1	7.9	10.7	9.6	8.1	6.0	10.2	3.6	4.7	10.4	8.1	5.3	5.3	4.6	4.4	9.7	14.3	8.7	5.9	8.1	4.8	5.8	7.0	8.9	6.7	6.1	10.8	9.7	6.6	6.4	4.3	6.3	6.8	5.9	3.9	7.0	10.8	6.9	7.4	8.0	7.1	5.7	16.9	8.9	14.7	12.5	2.6	11.7	14.3	6.2	10.8	14.7	7.6	11.9	15.5	5.2	14.8	5.7	17.9	19.0	17.2	17.9	17.5	4.1	10.7	19.6	9.9	18.9	15.3	10.6	12.1	9.9	22.2	5.9	28.5	9.0	14.4	11.0	21.8	20.6	13.6	6.6	13.0	9.8	13.0	25.4	8.1	16.0	13.7	7.2	12.9	21.0	10.7	10.4	11.6	12.8	10.7	8.5	44.6	14.4	4.4	14.2	13.8	14.4	10.0	18.2	31.3	13.4	12.3	17.7	13.9	0.0	6.7	0.3	6.0	6.7	7.7	8.9	8.1	8.4	6.7	6.3	10.3	9.3	0.3	14.7	6.2	5.8	5.8	4.5	3.7	4.7	4.6	5.0	3.6	4.7	4.6	4.4	4.8	4.3	3.9	5.7	15.9	16.0	7.5	91.7	18.7	31.0	20.0	19.8	24.5	29.2	12.0	16.6	15.8	18.6	17.2	9.2	39.6	26.7	9.3	7.5	13.7	16.3	2.2	10.7	13.7	10.0	5.4	16.8	28.0	24.1	23.5	12.0	21.4	13.3	3.8	21.1	5.7	7.4	17.5	18.5	47.0	7.4	14.2	10.3	12.9	3.3	14.0	9.8	16.0	44.0	14.3	15.0	11.3	71.9	101.5	18.7	7.1	6.8	6.9	8.9	13.4	19.9	7.6	24.2	0.0	18.9	14.0	9.8	14.0	21.2	23.2	22.6	9.9	21.9	10.5	13.4
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	40.9	53.4	23.0	34.3	23.9	59.3	42.7	24.4	31.9	31.5	26.1	38.6	36.9	39.4	47.6	45.3	32.6	36.1	60.6	24.4	24.5	47.0	63.1	29.7	56.0	23.3	22.8	38.7	48.6	43.0	25.4	45.1	23.5	34.3	42.7	27.2	38.5	31.0	57.3	34.6	39.0	37.4	23.8	37.1	38.1	39.7	23.1	43.9	48.4	55.2	53.6	51.6	33.3	27.6	139.9	55.4	83.6	50.5	72.1	80.8	92.1	52.6	62.1	102.9	80.7	252.1	110.2	84.1	112.9	71.1	141.9	156.2	68.5	129.0	103.9	40.7	53.9	87.7	69.5	171.2	101.6	141.4	50.5	70.0	187.0	71.5	73.7	66.4	80.1	89.0	135.3	104.2	103.3	61.3	127.6	148.9	85.3	131.8	124.8	69.7	120.7	112.6	102.6	83.4	62.5	68.5	135.8	203.8	189.1	64.2	138.8	164.5	66.1	130.8	109.2	76.6	112.6	74.2	99.7	122.0	143.7	92.4	60.4	13.5	16.3	17.6	16.4	18.5	20.0	17.9	18.6	17.9	20.3	16.1	20.0	22.4	20.0	19.1	18.6	21.7	19.5	16.1	23.0	23.9	24.4	31.9	24.4	24.5	23.3	22.8	23.5	23.8	23.1	27.6	36.8	19.2	42.3	27.1	37.3	116.5	143.4	248.4	29.0	11.7	37.1	24.9	48.8	35.8	119.5	31.3	2.1	153.1	46.4	31.7	117.4	75.9	207.8	49.3	38.0	53.0	23.4	30.7	35.6	73.8	104.9	53.7	18.8	57.5	74.3	25.1	49.2	67.9	87.9	5.0	31.0	52.5	144.5	42.0	58.4	43.8	56.8	36.7	49.8	18.7	65.8	27.3	43.3	20.1	34.2	70.5	50.2	51.6	33.2	73.7	40.7	96.4	135.7	12.6	72.3	50.4	71.5	109.9	103.6	32.0	105.6	245.4	47.8	36.5	55.3	125.9
DPM2	"MGC111193, MGC21559"	ENSG00000136908	"Dolichyl-phosphate mannosyltransferase subunit 2, regulatory"	O94777	9	127935099-127937854	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 202.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064623	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA064623: AB_2685303"	"unprognostic (8.30e-3)"	"unprognostic (1.07e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (2.20e-4)"	"unprognostic (3.67e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	21.4	20.6	54.1	19.4	53.2	39.6	27.4	50.5	66.8	31.4	50.0	27.6	23.9	17.9	38.1	25.5	43.1	19.7	16.0	56.0	52.7	22.0	29.7	29.2	24.0	53.2	55.0	20.7	58.6	53.4	12.2	26.9	52.7	24.5	25.7	13.2	50.1	26.8	8.2	29.5	20.1	28.4	50.7	18.5	39.9	15.4	54.2	26.6	38.2	12.0	29.3	25.0	9.6	52.2	49.5	85.5	42.1	57.2	75.1	59.4	40.6	61.3	55.7	63.9	44.2	58.1	79.7	38.8	38.0	90.1	91.8	85.4	47.3	88.1	31.2	71.7	74.5	46.4	98.5	66.1	88.8	75.4	51.1	57.5	78.0	93.5	101.2	44.9	65.8	67.2	106.2	84.9	76.7	161.8	55.8	78.0	79.1	169.7	79.4	43.0	54.6	212.7	79.1	28.8	39.3	95.8	63.8	75.4	53.0	27.3	95.1	48.2	43.5	56.1	43.4	72.0	64.5	93.3	134.4	32.5	113.1	52.8	76.6	52.3	67.8	57.6	86.6	75.7	72.8	99.3	62.1	75.9	77.3	94.3	47.8	61.6	28.1	77.5	73.0	88.5	55.2	60.9	54.1	53.2	50.5	66.8	56.0	52.7	53.2	55.0	52.7	50.7	54.2	52.2	29.9	28.9	42.5	6.5	27.5	27.0	34.1	58.2	18.8	25.3	52.4	57.7	12.4	38.6	42.8	40.5	16.7	86.9	25.1	40.6	45.0	61.2	9.6	28.3	39.9	33.1	32.4	202.7	9.7	59.4	105.8	38.6	44.9	33.5	29.2	31.1	33.9	33.2	83.7	38.7	9.2	53.6	42.7	25.0	22.1	11.6	26.4	30.0	32.0	7.5	49.8	35.0	39.1	6.0	10.0	58.7	36.2	20.3	62.0	64.5	44.5	47.3	24.9	22.1	6.6	16.6	32.5	19.1	22.5	36.8	34.5	65.0	28.5	41.2	43.8	40.7
DPM3	"MGC125904, MGC125905, MGC34275"	ENSG00000179085	"Dolichyl-phosphate mannosyltransferase subunit 3, regulatory"	Q9P2X0	1	155139891-155140595	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014667	Approved					NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA014667: AB_1847848"	"unprognostic (6.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.83e-3)"	"unprognostic (4.71e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (1.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.64e-4)"	74.0	135.0	62.4	24.0	63.6	51.2	80.5	67.1	101.5	87.0	78.7	89.2	62.5	89.5	57.3	57.5	81.2	37.4	84.6	62.1	64.1	106.0	145.5	67.5	37.8	61.9	61.2	79.5	127.0	58.8	128.7	18.3	61.7	87.5	18.6	10.4	93.2	55.6	77.1	61.0	72.2	19.7	64.8	82.7	90.7	59.9	67.8	24.9	95.9	34.3	13.4	72.3	67.7	63.9	97.5	106.6	32.6	79.0	59.2	54.9	35.3	31.1	39.9	41.5	44.0	34.1	113.8	31.3	93.3	26.4	14.2	68.6	12.7	37.8	5.4	44.7	219.2	34.4	156.2	120.8	57.0	31.2	44.9	54.8	68.4	30.1	13.3	19.5	50.3	77.7	40.7	165.9	31.8	239.1	71.0	71.3	81.3	110.5	80.5	60.6	36.8	189.2	52.6	67.4	57.2	117.6	71.4	86.0	116.1	11.9	58.9	148.6	39.3	25.8	62.4	37.4	46.2	138.4	75.8	101.6	68.6	68.1	20.0	57.2	101.3	101.0	86.8	69.0	95.8	109.3	91.0	85.3	104.2	99.6	86.6	82.0	57.3	95.6	69.6	118.2	81.1	86.6	62.4	63.6	67.1	101.5	62.1	64.1	61.9	61.2	61.7	64.8	67.8	63.9	99.3	51.3	75.4	4.2	59.4	27.4	63.6	101.6	52.3	31.6	108.0	116.1	120.7	95.8	80.1	176.6	10.4	69.4	46.4	137.8	66.5	60.3	56.7	115.2	116.1	68.3	99.2	56.4	5.5	162.4	70.6	72.5	63.7	111.6	71.0	53.4	84.3	279.1	87.6	13.5	6.1	213.9	77.3	58.6	59.9	18.8	92.6	60.5	97.8	7.5	44.3	115.1	53.5	3.0	9.5	61.0	176.7	97.8	101.2	58.1	178.3	152.2	107.3	31.5	39.5	54.7	75.8	62.2	9.6	56.5	33.8	40.8	53.9	76.7	157.2	63.3
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845780	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.7;brain: 20.2;pancreas: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.2	10.7	12.4	0.3	20.2	0.1	0.0	0.0	16.6	0.3	0.0	2.2	1.2	0.4	0.0	0.0	0.1	0.8	0.1	19.3	0.5	0.2	0.1	0.2	0.0	1.9	3.1	0.0	17.3	0.0	0.8	0.8	2.0	0.0	2.8	4.1	0.2	0.0	0.0	0.1	1.2	0.8	4.5	0.0	1.0	1.0	6.0	0.0	0.6	0.0	0.0	0.3	0.0	11.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	3.9	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.2	0.0	16.6	19.3	0.5	1.9	3.1	2.0	4.5	6.0	11.7	0.0	0.0	0.0	4634.9	0.0	0.0	0.0	0.0	0.6	21.7	0.0	0.0	1.5	4.3	0.6	0.0	0.0	1.5	0.0	2.3	0.0	0.0	12.4	0.1	0.1	0.1	4.2	2.1	3067.4	2.7	10.2	0.5	0.0	0.3	0.0	5.8	0.7	0.0	0.3	5.0	3258.7	1.4	0.0	0.0	0.0	5.7	0.3	0.0	1.8	58.1	0.0	1.4	0.0	990.7	48.3	0.8	1.9	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.1	1.6	2.6	0.3	0.0	4.4	0.0	0.4	3.2	0.0
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		3200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	11.6	17.5	8.2	21.4	9.1	20.7	11.2	10.2	10.4	11.0	5.4	30.2	24.8	11.7	7.8	23.5	9.8	14.5	10.3	8.4	8.9	17.1	18.6	14.3	21.8	10.2	8.8	6.8	17.3	11.9	8.7	14.3	10.8	14.4	26.3	15.9	18.8	12.9	26.5	13.6	20.5	16.2	8.6	15.4	19.2	9.8	10.2	18.6	11.7	7.4	23.3	17.3	13.5	9.9	84.1	71.6	32.5	36.3	26.4	28.3	50.4	46.5	61.8	61.4	40.7	90.8	68.4	48.7	154.0	52.9	52.2	73.6	52.1	57.0	39.4	92.5	23.8	63.1	32.1	54.2	40.7	77.6	101.1	40.5	54.5	46.2	22.8	26.5	47.8	50.1	45.1	28.2	56.7	95.3	91.0	78.7	55.5	82.0	43.2	63.1	32.7	79.6	52.6	71.7	61.1	52.2	39.7	45.6	62.5	30.3	70.8	44.7	50.1	36.5	39.4	40.7	46.2	23.3	46.6	56.6	48.5	36.5	45.9	20.7	18.8	21.3	21.4	40.0	13.3	11.5	15.8	17.7	32.3	11.1	9.4	13.9	3.2	30.8	27.9	22.5	29.6	17.7	8.2	9.1	10.2	10.4	8.4	8.9	10.2	8.8	10.8	8.6	10.2	9.9	5.8	16.0	13.2	6.8	11.6	6.0	17.4	34.8	8.6	11.4	7.1	3.8	3.0	10.0	27.0	23.9	10.4	46.9	11.5	41.6	13.7	45.6	24.6	8.7	6.2	10.5	18.6	3.4	3.4	61.3	34.2	7.4	29.0	11.5	1.3	9.9	3.6	14.7	37.4	6.7	4.0	19.5	63.1	7.9	9.0	7.0	2.1	10.8	16.0	3.7	31.3	21.6	18.6	4.5	5.6	40.8	25.2	5.3	15.7	11.0	26.4	28.7	17.3	72.9	13.1	4.4	16.2	8.8	20.7	14.4	6.0	36.0	13.1	20.1	29.5	19.5
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110546-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 997.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.0;THP-1: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	60.2	98.8	42.1	28.0	43.2	45.8	56.8	43.4	64.9	45.4	83.6	65.3	28.4	46.3	16.7	46.0	53.6	31.3	116.4	43.8	52.0	58.7	70.0	57.3	41.7	53.4	48.0	37.7	82.8	54.3	112.3	26.7	45.7	81.1	7.3	8.0	92.3	46.2	52.8	56.6	51.7	12.8	45.6	79.0	69.4	75.3	48.3	19.8	83.7	21.4	14.4	59.3	48.0	49.2	28.0	43.1	3.5	3.6	51.1	40.5	5.7	42.2	66.2	26.6	17.4	41.0	22.2	56.2	44.4	27.2	1.2	60.3	30.7	8.2	1.3	54.8	2.1	26.4	63.6	1.3	113.5	69.1	135.5	50.0	31.7	11.6	24.1	38.3	35.1	65.8	57.5	41.2	18.0	76.4	35.7	65.7	14.8	99.9	42.8	52.8	0.5	232.0	43.3	30.5	67.7	46.7	47.8	122.6	118.9	0.8	43.5	218.1	44.1	67.4	23.5	43.4	29.5	51.7	31.8	14.9	80.9	41.1	31.1	40.2	194.8	59.2	148.8	176.2	151.8	86.6	131.4	127.9	190.6	83.4	117.1	106.2	12.0	95.0	110.6	276.6	173.6	204.1	42.1	43.2	43.4	64.9	43.8	52.0	53.4	48.0	45.7	45.6	48.3	49.2	80.5	54.5	80.9	54.9	96.8	67.0	103.2	109.2	59.7	74.5	90.3	82.2	66.5	94.4	76.8	53.3	35.5	55.2	129.2	28.2	37.2	121.0	288.7	35.9	40.7	58.2	88.1	35.9	31.4	68.1	115.3	97.2	33.6	47.3	74.3	178.7	64.6	77.1	315.7	121.1	27.9	32.3	107.8	171.7	106.2	997.8	155.4	150.1	167.2	9.4	165.5	123.9	122.6	16.6	26.4	58.2	54.3	169.2	190.2	108.5	97.3	84.9	75.4	83.6	52.6	57.4	58.4	106.2	46.2	47.3	64.9	51.4	115.4	19.0	43.1	90.4
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	12.7	10.2	7.0	12.1	8.5	14.9	11.8	9.3	11.3	11.8	5.5	11.4	14.4	11.7	9.7	10.0	8.3	9.7	14.9	8.3	9.2	12.7	7.9	11.1	12.9	7.3	8.3	10.8	7.4	15.2	5.7	11.2	7.2	10.8	12.9	15.4	9.5	11.5	27.5	9.8	13.5	13.1	8.5	14.8	11.0	26.1	9.7	13.8	14.1	30.6	11.3	11.2	8.3	9.7	14.1	24.4	15.7	15.8	17.4	25.2	12.8	22.5	28.4	21.1	20.3	10.6	12.6	25.1	16.3	30.3	14.5	25.9	30.6	17.6	26.0	20.9	17.2	24.2	18.1	10.4	17.9	34.3	23.8	18.6	18.3	17.0	16.0	18.5	23.2	19.2	16.4	24.1	26.5	12.5	17.1	12.0	9.9	15.7	11.1	22.6	27.9	24.7	19.8	32.7	10.5	17.0	14.3	15.8	25.3	15.6	14.4	22.5	28.6	28.2	19.2	12.7	25.5	26.9	42.2	25.8	21.3	32.8	20.4	30.5	11.7	15.1	12.1	11.7	12.6	11.8	10.0	11.2	10.9	12.2	9.5	10.6	20.9	8.2	15.8	8.6	11.3	7.2	7.0	8.5	9.3	11.3	8.3	9.2	7.3	8.3	7.2	8.5	9.7	9.7	39.1	35.3	27.9	65.6	30.0	13.4	15.0	20.4	15.9	24.1	21.1	14.2	43.4	21.5	25.4	14.7	37.5	20.4	35.3	25.8	23.5	22.7	57.4	17.3	19.3	39.5	25.9	17.9	50.1	30.0	15.2	22.3	31.1	17.5	27.8	24.7	46.1	18.2	21.5	28.6	58.6	27.0	16.2	36.0	15.1	59.7	29.2	31.9	23.2	38.4	47.6	32.3	45.3	36.2	57.1	38.4	25.8	29.3	24.7	19.3	24.2	27.5	25.9	28.1	19.7	29.9	22.1	69.3	24.4	21.9	20.2	17.6	28.5	46.5	26.7	23.6
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 203.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA036059: AB_10671240"	"prognostic favorable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.38e-8)"	"prognostic favorable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	19.6	16.2	12.2	24.5	13.8	32.8	19.4	12.9	13.7	20.1	25.0	24.2	20.1	20.3	5.9	24.5	16.3	13.5	32.2	13.2	11.7	16.9	57.2	27.4	24.9	14.8	14.3	17.3	20.6	10.1	12.7	12.9	14.3	18.9	13.8	9.5	17.7	12.8	71.0	23.8	26.3	15.3	12.3	28.4	21.1	9.0	16.1	17.9	16.9	23.0	17.1	23.2	20.2	15.4	77.5	60.4	17.6	27.5	26.2	36.3	31.7	44.3	58.5	73.1	47.4	54.3	58.2	36.5	32.8	57.7	49.1	51.7	35.9	203.9	44.5	47.3	34.8	26.8	33.6	47.2	40.0	47.2	55.8	27.9	46.6	114.4	67.2	62.2	66.8	25.0	37.4	78.3	64.1	21.2	54.2	30.0	36.0	30.4	89.0	34.0	37.4	42.4	38.3	52.5	24.8	22.2	38.2	67.8	29.5	18.1	18.8	38.2	54.5	64.9	28.0	101.6	89.6	54.6	62.3	36.8	63.4	53.7	55.7	10.8	7.1	7.7	10.6	8.3	7.9	8.0	4.7	8.5	7.1	4.8	4.5	7.3	3.7	11.4	6.5	3.3	9.7	7.7	12.2	13.8	12.9	13.7	13.2	11.7	14.8	14.3	14.3	12.3	16.1	15.4	21.8	28.9	25.8	14.4	18.8	7.9	13.6	10.2	10.8	18.6	12.2	12.3	14.6	10.0	11.2	3.7	37.5	11.7	22.7	37.4	3.9	12.4	2.0	12.7	14.6	19.4	12.5	7.6	10.1	12.8	18.3	10.7	36.2	22.8	17.1	13.3	17.2	39.5	19.0	23.5	10.2	21.3	6.1	20.4	17.6	3.9	9.9	22.0	5.4	16.9	42.2	9.0	25.7	7.5	13.7	26.6	28.4	9.4	32.9	15.6	20.1	5.1	9.5	30.8	19.7	21.7	12.4	7.5	6.9	12.4	5.5	15.6	21.2	12.8	20.6	16.7
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.3"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 12.0;Spermatogonia: 14.5"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.4	0.0	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	0.0	1.6	0.0	0.1	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353063-73354276	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 2.4;Spermatogonia: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"SuSa: 6.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DPRX		ENSG00000204595	"Divergent-paired related homeobox"	A6NFQ7	19	53632056-53637009	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.2;skeletal muscle: 1.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.6;Cytotrophoblasts: 1.2;Early spermatids: 1.1;Late spermatids: 2.0;Oligodendrocyte precursor cells: 1.0;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	20	"thyroid cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA043682	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"		"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA043682: AB_10963073"												"unprognostic (2.47e-1)"			"unprognostic (1.89e-1)"			0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 206.2;Excitatory neurons: 132.8;Late spermatids: 72.0;Oligodendrocytes: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA059139: AB_2683921"	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	10.8	13.2	16.5	12.1	18.6	11.2	6.4	22.2	22.3	15.9	11.0	10.6	5.3	18.9	4.1	7.6	10.7	15.2	14.9	18.0	23.2	7.0	19.5	14.7	10.7	23.6	22.9	9.0	5.6	4.1	6.2	21.6	22.0	9.0	12.1	27.9	7.1	8.4	3.5	4.6	6.2	19.3	25.2	15.7	10.1	38.1	21.5	4.8	11.4	6.1	9.8	16.5	5.5	33.4	16.7	64.6	36.2	46.3	69.7	55.3	7.5	36.6	30.7	22.4	29.3	15.5	42.4	24.2	52.1	38.2	92.4	29.1	27.2	20.1	50.1	12.4	22.2	35.3	40.2	25.7	24.5	33.6	31.6	27.3	16.5	29.7	20.1	63.1	93.5	11.9	26.9	95.8	79.3	8.1	0.3	33.3	23.3	39.2	28.9	24.7	47.8	34.8	85.0	57.4	16.7	43.4	32.8	4.2	19.4	56.5	32.6	38.6	109.1	44.3	53.1	30.9	50.2	42.3	99.9	27.6	54.9	30.5	126.2	0.9	0.5	0.0	1.2	0.7	1.3	0.4	0.5	1.0	0.5	0.7	0.1	0.5	0.1	0.6	0.2	0.5	0.3	0.3	16.5	18.6	22.2	22.3	18.0	23.2	23.6	22.9	22.0	25.2	21.5	33.4	12.1	28.9	16.4	42.7	3.9	7.1	5.6	4.4	2.2	8.4	7.4	5.8	13.3	5.7	10.0	7.3	18.8	14.5	10.2	11.2	0.0	7.7	206.2	17.0	23.4	13.9	14.9	8.2	132.8	16.4	4.1	11.3	10.7	16.9	27.3	6.5	20.3	15.4	8.7	11.8	35.1	5.1	4.1	11.1	7.5	72.0	9.3	8.0	5.4	30.0	4.4	8.6	3.1	30.2	95.5	24.0	4.5	10.1	8.0	9.5	1.0	1.9	12.4	12.8	0.0	7.5	8.5	9.1	4.6	3.2	4.8	21.2	6.9	4.4	8.5	13.7
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 9.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	6.7	5.3	4.0	0.5	3.9	3.0	4.7	7.0	6.9	11.4	6.6	5.2	0.6	7.8	4.1	1.4	6.4	2.8	19.2	3.0	4.3	12.7	0.2	1.3	0.9	2.4	3.0	11.0	2.7	9.0	10.5	1.2	1.5	9.3	1.3	14.4	1.6	4.7	0.5	1.6	1.7	3.5	0.8	1.7	2.9	65.6	3.3	0.7	13.1	0.6	0.6	6.3	5.1	4.2	1.0	2.6	2.2	5.4	0.6	0.0	0.2	1.8	1.8	2.4	3.1	0.4	0.8	2.8	1.8	0.7	2.9	0.4	2.7	0.3	3.6	1.5	1.7	4.6	1.4	1.7	0.5	3.4	1.4	1.5	0.1	1.1	0.0	6.1	0.8	2.2	1.9	2.9	3.9	1.7	0.2	1.4	2.1	0.4	2.4	0.0	1.8	0.0	4.6	0.5	7.0	0.7	0.6	0.2	1.0	0.9	1.9	0.9	0.5	3.2	4.2	0.5	4.6	7.5	9.3	0.0	3.4	1.6	3.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	4.0	3.9	7.0	6.9	3.0	4.3	2.4	3.0	1.5	0.8	3.3	4.2	6.7	3.2	0.0	23.2	0.2	0.5	2.9	0.1	2.2	49.6	1.9	1.8	32.3	1.5	3.8	12.9	14.6	2.0	0.3	0.1	5.9	0.4	329.9	5.6	7.1	1.7	0.0	7.2	124.1	0.0	1.3	2.2	0.5	2.1	2.5	1.2	1.4	0.1	0.3	3.3	137.2	0.1	6.1	0.0	0.4	363.0	7.2	0.4	7.2	11.2	0.1	9.2	0.0	124.1	5.0	0.2	0.0	8.6	0.5	2.9	0.0	6.4	11.6	6.7	26.3	3.8	19.9	143.3	4.9	0.2	0.4	1.4	0.8	3.6	0.1	1.1
DPY19L3		ENSG00000178904	"Dpy-19 like C-mannosyltransferase 3"	Q6ZPD9	19	32405543-32485895	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Horizontal cells: 79.1;Oligodendrocyte precursor cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008325	Approved		Approved	Microtubules		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Microtubules		"HPA008325: AB_1847853"	"unprognostic (9.58e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	5.9	7.3	10.9	5.2	12.6	8.9	6.9	12.1	11.2	8.1	13.5	4.4	2.9	7.2	6.1	4.2	6.0	6.9	3.6	14.4	13.1	5.7	5.2	5.3	4.7	10.7	11.4	13.0	5.0	8.2	6.4	8.3	9.9	10.8	4.6	9.2	7.9	5.6	1.9	3.0	4.2	5.3	8.7	6.6	6.8	8.9	10.5	5.6	10.4	3.0	4.6	5.3	3.5	10.5	4.6	8.7	32.9	15.0	32.9	16.8	16.4	14.2	10.1	5.8	10.5	10.5	5.4	18.6	8.7	10.5	4.2	2.4	13.8	6.5	11.2	9.1	8.6	24.5	9.1	9.6	21.6	13.0	13.9	17.6	3.4	7.1	6.9	11.0	13.9	8.6	17.7	5.9	15.1	7.8	3.4	6.4	13.7	9.0	3.5	9.1	13.1	5.7	10.9	11.4	7.3	19.4	7.0	6.7	7.8	18.1	5.3	15.1	15.4	11.9	8.3	7.1	15.1	8.6	19.0	12.5	16.5	15.3	19.5	5.3	1.6	5.2	1.1	1.3	0.6	1.3	1.0	1.1	1.4	1.7	0.8	0.9	5.8	0.9	1.9	1.0	1.6	0.6	10.9	12.6	12.1	11.2	14.4	13.1	10.7	11.4	9.9	8.7	10.5	10.5	8.1	6.4	15.1	71.5	4.8	2.0	3.8	2.7	5.2	15.2	8.3	5.5	3.3	4.3	5.2	14.7	10.4	6.8	4.7	4.3	1.9	2.4	2.1	13.0	16.6	8.4	3.6	6.1	30.1	3.9	5.5	11.9	9.2	17.1	1.3	21.1	20.3	5.8	5.8	79.1	35.6	8.9	6.1	19.5	3.4	2.7	10.8	4.7	1.8	25.3	4.1	22.1	9.2	97.5	24.8	2.6	5.4	11.7	6.4	11.9	5.5	3.0	6.5	13.3	0.0	12.5	6.7	11.5	18.7	4.5	3.0	14.9	2.9	11.5	3.5	3.5
DPY19L4		ENSG00000156162	"Dpy-19 like 4"	Q7Z388	8	94719703-94793836	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024339, HPA024780"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA024339: , HPA024780: AB_10600869"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.28e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	11.5	12.3	7.3	6.6	10.5	5.1	12.5	9.7	9.4	13.6	8.0	8.6	6.7	12.3	10.5	7.6	11.2	10.0	15.4	6.5	10.1	14.5	15.8	9.1	6.9	9.9	9.0	16.7	9.4	26.4	6.4	12.6	10.3	11.6	9.0	13.0	10.2	9.0	7.2	9.4	7.9	9.5	9.6	11.1	13.1	9.6	8.9	7.0	16.1	9.3	5.8	8.6	8.5	14.4	24.4	15.5	26.1	16.4	25.9	33.3	14.4	21.5	20.3	19.8	19.4	7.3	35.0	5.4	25.8	20.8	13.3	25.0	16.0	16.9	32.7	12.2	12.8	25.3	15.1	12.2	30.1	10.9	5.1	22.2	14.0	16.8	16.2	23.2	24.3	16.0	18.0	9.0	23.3	15.3	20.9	20.5	10.2	27.9	17.2	14.8	17.9	10.9	19.1	18.9	12.8	28.7	17.2	3.6	16.8	15.9	22.8	13.6	24.0	20.5	12.6	23.1	18.1	9.9	13.1	14.8	15.4	18.7	29.6	0.7	0.5	0.0	1.0	0.6	1.4	1.2	1.0	1.6	1.0	0.3	1.1	1.4	0.4	1.4	0.6	1.2	0.4	0.7	7.3	10.5	9.7	9.4	6.5	10.1	9.9	9.0	10.3	9.6	8.9	14.4	21.1	16.0	16.3	20.5	6.3	9.8	14.1	11.6	15.9	19.6	16.2	12.1	26.0	11.5	13.0	40.5	4.2	16.7	3.7	8.5	1.9	8.9	2.1	13.7	20.3	19.0	7.3	9.7	13.2	10.0	11.9	20.4	12.2	13.7	3.8	23.1	65.0	27.5	9.6	13.5	18.3	11.5	10.2	14.8	11.9	5.0	17.4	8.3	10.6	25.3	5.5	11.9	9.2	23.6	39.7	13.0	6.4	18.4	7.9	15.6	10.7	10.7	18.8	17.6	6.6	13.4	14.9	11.9	9.8	16.6	12.1	9.2	7.8	32.6	12.0	14.1
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30 histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		29000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	40.2	75.2	66.9	34.3	68.6	31.4	61.3	72.1	84.4	53.2	73.6	50.9	43.4	38.3	78.3	60.2	90.5	42.4	46.7	68.4	73.6	79.1	84.8	44.1	51.8	71.6	71.5	42.7	48.1	58.3	50.9	43.9	73.6	57.3	46.4	33.3	64.6	47.0	48.8	49.7	44.4	37.4	73.2	36.1	46.8	22.6	69.1	52.3	81.6	45.4	49.3	51.8	50.0	77.5	201.8	136.8	100.8	78.1	86.7	128.8	134.9	102.1	90.8	81.2	79.5	197.2	158.3	123.2	102.2	90.8	148.3	79.9	93.1	118.6	88.1	146.4	149.5	110.8	89.7	225.5	76.5	114.3	66.8	87.4	135.6	87.4	76.9	109.1	130.4	55.1	132.5	85.3	125.6	219.4	128.8	228.9	139.2	184.3	140.5	104.0	118.9	155.7	144.2	137.1	162.5	115.9	101.2	141.1	143.6	118.2	98.3	82.1	100.5	73.9	119.1	69.2	125.4	99.9	161.3	166.2	77.6	123.2	91.7	177.6	101.0	150.8	95.5	99.9	116.5	165.9	133.5	119.4	100.5	135.6	118.1	112.0	117.3	105.8	112.8	91.5	200.3	130.6	66.9	68.6	72.1	84.4	68.4	73.6	71.6	71.5	73.6	73.2	69.1	77.5	65.7	51.3	61.5	10.1	61.7	98.0	107.7	233.5	53.5	17.9	110.5	135.1	71.3	80.1	140.8	103.0	0.0	190.2	41.0	84.2	283.7	114.3	64.5	388.8	59.7	62.9	92.1	55.5	16.0	117.2	252.4	63.1	44.4	107.3	46.9	65.1	63.1	102.7	123.5	21.9	17.7	107.6	175.0	65.4	67.2	18.5	72.4	58.7	65.8	13.1	106.8	50.8	55.6	13.6	26.7	125.7	117.8	88.0	40.6	130.5	138.4	296.7	396.4	26.8	85.5	52.4	108.4	65.7	57.4	72.0	122.6	138.7	67.3	67.7	109.0	127.5
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.5"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1712.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	22.2	13.2	7.2	22.6	12.8	10.3	16.7	5.7	10.4	18.8	2.4	11.9	21.9	14.9	8.4	17.1	14.3	25.7	8.9	7.4	12.9	12.6	68.5	29.6	16.6	12.4	9.4	24.0	11.8	9.2	6.2	4.5	12.1	9.9	10.1	3.3	15.0	13.4	5.8	7.1	19.4	18.2	6.9	24.7	8.4	3.7	12.9	17.0	10.3	10.1	12.0	18.2	14.2	24.4	22.2	6.2	7.8	0.2	42.4	72.5	0.1	35.2	31.9	32.1	23.6	0.0	9.2	11.7	50.6	32.9	5.1	5.2	0.0	8.3	58.7	11.6	7.3	10.0	11.1	0.2	18.8	4.5	0.6	57.5	3.0	25.7	29.3	67.7	26.8	6.8	0.4	36.4	17.0	0.0	23.6	6.4	0.9	0.2	7.5	0.1	37.1	18.6	39.4	0.1	11.1	8.8	30.1	2.5	0.3	0.8	0.0	10.2	30.9	69.2	5.0	56.4	70.6	3.0	0.1	0.2	10.2	12.6	56.2	18.2	61.1	4.1	11.6	29.5	14.8	2.2	13.3	11.0	32.7	4.9	12.5	11.1	59.8	13.3	27.1	0.9	15.8	21.9	7.2	12.8	5.7	10.4	7.4	12.9	12.4	9.4	12.1	6.9	12.9	24.4	25.5	16.0	39.1	23.8	15.4	7.6	8.8	9.4	18.8	2.5	8.4	8.3	5.3	40.0	11.5	7.3	0.0	0.2	19.2	3.3	5.9	2.5	7.0	1.5	15.2	14.7	3.0	13.3	258.6	6.4	0.2	30.0	10.7	1.7	9.5	4.5	17.2	54.2	17.1	0.0	30.5	5.5	6.1	130.4	27.0	4.0	33.5	73.7	3.6	105.9	98.1	4.8	27.8	34.2	1712.3	5.3	2.1	18.8	17.0	4.9	21.0	6.6	8.6	0.1	13.1	16.0	17.7	1.2	3.1	19.7	5.5	0.1	31.4	5.1	6.8	9.3
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467055	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 199.6;liver: 477.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 459.5;Proximal tubular cells: 518.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 57.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024785, HPA070814"	Enhanced					NA	NA		820000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024785: AB_1847856, HPA070814: "	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	8.6	2.8	0.6	0.1	0.6	0.0	0.4	0.2	1.7	1.2	0.2	0.2	0.0	0.1	0.6	0.1	0.7	6.5	0.1	0.6	0.5	199.6	477.6	0.6	0.3	0.5	0.7	0.2	0.1	0.6	0.2	0.6	0.6	4.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.9	1.2	5.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	1.7	0.6	0.5	0.5	0.7	0.6	0.3	1.2	0.5	0.1	0.0	0.0	1.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	40.0	0.0	20.2	0.0	0.0	0.0	0.0	27.4	0.1	12.8	0.3	0.1	1.0	0.0	16.0	11.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	11.7	459.5	1.4	0.0	4.6	0.0	0.0	11.1	0.3	13.5	0.9	10.6	0.0	14.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	518.8	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514031-26658178	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 549.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 362.9;Oligodendrocytes: 367.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 65.8;intermediate monocyte: 74.5;myeloid DC: 71.2;non-classical monocyte: 48.8;plasmacytoid DC: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 71.2;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 263.7;Karpas-707: 279.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (5.41e-5)"	60.0	34.8	252.6	22.5	348.0	3.5	48.0	332.4	266.7	25.3	0.0	44.8	10.4	24.9	11.4	18.3	29.6	29.4	58.6	276.1	263.2	21.3	17.6	78.2	17.4	362.4	296.0	40.8	11.0	7.1	22.1	43.7	389.9	19.7	19.0	64.0	18.5	14.9	19.2	25.8	27.6	32.9	257.9	33.6	21.5	11.2	305.0	19.3	22.5	25.8	20.1	35.6	26.9	549.9	22.0	104.1	100.2	53.9	263.7	120.6	9.8	41.9	97.0	39.2	50.6	41.0	31.0	32.7	29.7	131.7	78.8	20.9	106.6	42.0	37.1	74.2	9.2	37.0	36.9	57.9	168.5	8.0	14.5	150.8	59.5	107.1	61.9	125.5	80.0	24.9	1.1	279.1	39.9	13.9	64.3	8.1	78.8	69.9	20.0	84.3	40.3	21.8	66.2	25.0	45.6	95.8	51.0	0.5	28.6	65.7	7.8	14.8	145.0	88.2	34.8	74.3	18.5	39.1	43.3	24.8	127.7	48.1	46.0	1.3	65.8	0.6	9.1	74.5	3.3	8.5	8.1	6.2	71.2	4.4	4.0	5.2	1.7	11.3	48.8	42.2	13.3	30.3	252.6	348.0	332.4	266.7	276.1	263.2	362.4	296.0	389.9	257.9	305.0	549.9	362.9	131.4	71.7	193.9	11.5	40.4	1.0	13.2	2.2	111.4	44.4	58.4	105.0	84.4	19.4	22.0	31.3	15.1	64.8	4.5	3.9	21.4	3.1	41.6	154.3	154.6	60.7	22.3	191.9	2.0	9.1	144.9	6.1	33.6	20.8	33.0	211.3	22.8	51.1	141.3	157.0	87.0	4.1	223.5	192.3	10.6	109.0	111.1	120.9	81.5	163.5	165.2	22.6	102.1	367.2	12.6	6.2	89.5	6.5	1.1	4.7	24.4	10.5	38.6	138.1	51.8	110.6	3.8	17.0	1.6	33.8	4.5	14.8	16.8	12.1	1.2
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
DPYSL4	"CRMP3, DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186948-132205759	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;heart muscle: 33.7;retina: 15.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Mitochondria"		"HPA049066: AB_2680619"	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.11e-4)"	1.3	2.2	18.4	0.7	18.6	0.1	1.5	10.3	25.9	2.5	2.4	1.6	0.1	3.3	0.7	0.6	1.5	0.7	33.7	20.3	12.6	0.6	0.3	1.2	0.3	14.8	15.0	5.3	0.9	0.0	10.4	0.2	15.1	4.9	0.0	15.9	2.6	2.0	2.0	1.2	0.9	1.1	12.1	1.2	1.3	7.9	16.4	0.0	1.0	0.2	0.2	1.0	1.3	18.1	0.1	15.2	53.2	70.0	0.1	0.4	0.0	4.6	0.6	2.9	0.6	0.0	0.4	0.0	1.8	2.4	5.1	0.0	10.4	10.3	0.3	0.0	2.0	0.0	0.1	5.7	9.3	0.0	10.6	4.7	4.9	1.7	0.2	0.9	5.4	0.0	0.0	0.5	7.7	4.5	0.0	0.0	9.1	0.9	5.1	0.0	0.0	8.7	0.0	1.1	8.3	72.0	1.7	0.1	9.7	3.1	0.2	0.1	9.0	13.1	21.7	0.0	12.8	0.1	3.9	0.0	22.0	0.0	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.1	18.4	18.6	10.3	25.9	20.3	12.6	14.8	15.0	15.1	12.1	16.4	18.1	0.3	0.0	0.0	7.2	0.1	0.5	0.5	0.1	0.6	64.9	0.4	0.6	20.1	0.0	0.1	0.0	58.4	0.0	0.1	0.0	0.0	0.3	5.3	0.1	5.0	1.2	1.8	0.0	12.2	0.0	0.1	2.7	2.0	0.3	0.0	0.7	0.0	0.0	0.2	33.7	13.6	0.0	0.0	0.0	0.8	9.0	4.1	0.1	1.8	0.0	0.1	7.5	0.0	12.1	18.4	0.5	0.0	4.5	0.0	0.7	0.0	0.0	0.0	13.8	0.0	1.0	5.7	7.0	5.2	0.3	0.1	0.0	0.5	4.5	0.0	0.2
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 111.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	22.6	0.3	49.4	0.0	0.0	59.4	41.7	0.1	3.8	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.6	42.1	0.1	0.0	0.0	0.0	79.6	50.2	0.1	0.0	0.0	7.8	0.0	65.5	0.1	0.2	15.8	0.0	0.0	0.1	0.0	0.3	0.3	54.8	0.0	0.1	7.8	60.2	0.0	0.0	0.0	0.0	0.0	0.1	111.5	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	49.4	59.4	41.7	17.6	42.1	79.6	50.2	65.5	54.8	60.2	111.5	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526281	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039158, HPA046763"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA039158: AB_10960125, HPA046763: "	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.0	6.3	16.4	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	5.6	0.0	0.4	0.0	0.0	1.1	13.9	0.5	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	1.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.8	0.1	0.0	0.0	0.5	0.2	18.4	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	15.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.5	0.1	4.5	4.6	0.4	0.1	0.0	0.3	1.5	3.5	0.0	2.1	1.6	0.0	17.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.0	0.6	0.0	0.8	0.6	13.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	13.9	0.0	0.4	0.0	44.2	0.0	5.0	0.9	0.0	0.1	0.1	0.6	0.3	3.1	0.0	1.1	0.1	0.0	12.5	0.2
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	21.8	18.9	9.8	28.8	9.6	59.1	16.8	12.5	9.3	17.7	23.7	18.2	27.2	21.0	11.1	30.0	14.2	23.1	27.0	8.7	10.8	21.8	20.4	19.6	43.3	9.9	9.8	15.9	18.8	16.9	12.1	32.0	9.5	17.1	16.3	14.1	19.5	14.0	50.4	29.4	22.4	19.2	10.3	27.0	30.2	55.7	10.5	47.7	18.7	42.9	30.8	27.3	22.6	10.5	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.8	9.6	12.5	9.3	8.7	10.8	9.9	9.8	9.5	10.3	10.5	10.5	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
DRAP1	NC2-alpha	ENSG00000175550	"DR1 associated protein 1"	Q14919	11	65919274-65921563	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 813.2;Suprabasal keratinocytes: 1015.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 1032.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006790	Uncertain		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"HPA006790: AB_1078702"	"unprognostic (1.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.58e-2)"	"unprognostic (8.47e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.96e-5)"	"unprognostic (1.62e-1)"	87.4	86.4	119.0	71.0	120.8	96.8	80.3	121.2	162.8	91.0	103.7	104.4	56.1	89.3	27.9	107.5	74.0	34.9	129.2	120.3	132.4	75.0	76.2	75.1	71.0	119.9	119.6	67.4	73.3	62.6	81.2	43.1	121.5	73.1	21.1	25.1	58.3	48.0	197.1	112.5	62.9	40.2	118.1	85.6	69.9	173.1	120.7	96.6	118.9	78.5	39.2	84.2	83.4	131.6	578.7	226.8	108.3	200.0	99.9	195.3	75.9	634.9	273.2	344.1	223.6	85.6	302.7	142.2	277.3	420.3	395.5	222.7	42.7	292.0	138.2	187.7	70.1	173.4	103.8	85.4	186.0	145.8	228.2	123.7	126.6	365.8	246.7	191.4	142.2	138.9	78.5	223.6	377.4	301.9	255.0	263.6	167.5	73.1	575.9	216.3	107.1	305.4	113.6	82.3	122.2	137.7	149.6	137.8	348.9	46.1	188.2	104.8	413.0	470.1	461.4	1032.4	556.2	201.8	186.6	149.9	490.1	91.4	650.8	146.5	118.9	290.5	131.0	311.9	117.5	139.5	116.3	136.6	183.2	124.2	114.6	123.3	164.6	194.6	538.9	136.8	148.5	112.7	119.0	120.8	121.2	162.8	120.3	132.4	119.9	119.6	121.5	118.1	120.7	131.6	116.7	6.4	30.5	9.1	131.8	813.2	199.3	238.8	139.5	56.9	122.9	189.0	32.9	64.3	89.8	130.6	35.5	136.6	166.9	111.7	283.7	202.8	128.9	78.6	142.8	110.6	151.9	195.7	11.5	170.7	161.9	130.2	58.1	98.9	238.0	78.9	92.1	96.4	298.5	63.9	10.8	120.4	142.4	152.4	462.0	85.7	179.3	208.1	247.3	14.0	241.9	79.9	286.3	11.6	22.9	289.9	126.2	173.0	131.7	423.3	144.8	257.8	54.4	47.9	92.1	90.1	194.1	131.0	171.1	163.8	1015.8	174.4	197.2	107.1	125.0	425.3
DRAXIN	"C1orf187, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691710-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.5;NK-cells: 3.1;T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 27.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA014302	Uncertain				"Secreted in brain"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.0	0.0	1.6	0.2	1.4	0.5	0.0	1.1	1.3	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.2	1.0	0.0	0.0	0.1	0.2	2.7	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.3	3.9	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.6	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	5.7	0.0	0.2	0.0	0.1	0.0	0.2	2.1	0.3	27.9	0.0	0.1	6.4	0.2	0.0	0.0	0.0	1.8	0.7	0.1	0.0	0.1	4.6	0.0	0.2	0.2	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.4	2.5	0.3	0.1	0.5	0.1	0.2	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.8	0.2	0.2	0.1	0.2	0.1	1.6	1.4	1.1	1.3	1.2	1.0	2.7	0.6	0.5	0.4	3.9	1.3	0.1	0.0	0.5	0.0	1.2	0.5	2.9	0.6	0.0	0.7	0.4	0.4	1.1	1.5	0.1	0.0	2.1	0.1	5.5	0.1	0.0	0.1	0.7	0.4	0.4	0.6	0.0	0.0	0.4	0.2	0.2	0.6	0.0	0.4	1.3	0.1	1.1	0.2	0.4	0.0	0.5	0.7	0.0	0.8	1.9	2.1	0.6	1.2	1.8	0.0	0.3	0.2	3.1	1.5	0.4	0.2	0.2	0.0	1.5	2.1	0.0	0.1	0.0	0.7	0.0	2.3	0.7	0.6	1.7	0.0	0.3	0.0	4.6	0.1	0.1	2.2
DRC3	"CFAP134, DKFZP586M1120, LRRC48"	ENSG00000171962	"Dynein regulatory complex subunit 3"	Q9H069	17	17972813-18016889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 125.1;Early spermatids: 41.8;Endometrial ciliated cells: 121.8;Respiratory ciliated cells: 130.4;Rod photoreceptor cells: 88.7;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036040, HPA036041"	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036040: AB_10602349, HPA036041: AB_2674915"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-3)"	"unprognostic (9.48e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.64e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.33e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-2)"	0.8	1.0	1.8	0.2	2.1	0.1	2.4	1.6	1.7	5.0	18.7	1.0	0.9	4.5	11.9	0.6	61.4	2.4	1.1	3.0	4.2	4.4	1.1	5.3	0.5	9.1	11.4	3.3	4.1	6.6	9.9	0.4	5.9	2.0	0.5	9.1	1.5	2.1	1.5	1.2	0.3	1.3	7.1	0.8	0.7	11.9	3.2	1.0	8.5	0.7	0.3	0.8	1.1	3.1	0.5	2.1	0.3	1.0	0.2	0.7	0.1	0.5	0.2	1.0	1.0	0.3	2.2	0.0	1.7	0.3	0.6	1.8	0.6	0.2	0.5	0.1	1.5	0.1	0.1	0.0	0.7	0.3	0.1	0.6	0.6	1.6	0.2	1.1	0.3	0.2	0.0	0.2	1.2	0.6	0.1	0.0	0.4	0.1	0.4	0.1	0.6	0.0	3.1	0.6	0.6	1.7	0.8	0.0	1.9	1.2	2.0	0.0	0.5	0.5	0.4	0.1	0.2	0.3	0.1	0.1	2.7	0.0	1.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.6	1.7	3.0	4.2	9.1	11.4	5.9	7.1	3.2	3.1	1.9	3.2	3.1	0.0	0.6	0.0	3.6	0.0	1.8	10.7	6.6	7.2	0.0	2.8	13.6	11.0	125.1	0.5	1.5	0.1	5.9	3.0	41.8	121.8	5.3	3.4	0.0	0.0	0.0	0.8	2.7	3.1	3.6	5.4	0.0	3.3	4.6	0.2	0.4	20.2	0.0	0.3	0.0	3.5	0.0	11.1	5.0	0.8	0.0	0.0	0.8	8.6	0.0	0.0	0.0	1.1	1.1	4.5	0.0	1.7	0.5	10.6	130.4	88.7	0.0	8.2	1.3	48.7	13.3	0.9	0.0	0.8	1.4	2.7	0.5	1.1
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409605-113475691	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 77.8;pituitary gland: 59.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 60.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 77.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 88.3"	"Region enriched"	"Detected in many"	10	"basal ganglia: 205.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 146.3"	"HPA015139, HPA015691"	Supported	Supported				NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.3	8.4	6.1	0.1	77.8	0.0	1.3	0.2	18.3	1.6	0.0	0.4	0.0	1.1	0.1	0.5	1.3	0.2	0.1	1.4	13.6	1.2	0.0	0.2	0.0	3.9	40.7	0.2	0.2	0.0	59.6	0.0	21.1	0.9	0.3	11.7	11.9	0.7	0.8	0.9	0.2	1.5	0.7	0.0	0.1	1.0	14.8	0.0	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.6	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	1.0	0.1	0.0	0.0	9.6	0.0	0.0	0.1	88.3	10.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	77.8	0.2	18.3	1.4	13.6	3.9	40.7	21.1	0.7	14.8	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	60.6	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781634-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Dystonia, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;stomach 1: 4.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Horizontal cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 7.0"	HPA048930	Supported					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048930: AB_2680562"		"unprognostic (2.03e-2)"			"unprognostic (2.63e-1)"	"unprognostic (9.73e-2)"		"unprognostic (4.27e-2)"		"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-4)"	"unprognostic (5.09e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.36e-3)"	0.0	0.0	3.2	1.4	6.6	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	0.0	0.4	0.0	2.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.6	0.0	3.3	1.6	1.6	2.0	1.1	2.2	1.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087892-18107970	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.3	19.1	14.2	12.8	14.8	15.9	19.6	14.8	15.0	21.6	13.6	19.4	14.8	22.3	12.9	21.6	19.8	12.6	19.8	14.9	15.7	18.5	16.6	15.7	18.4	15.2	15.4	22.5	19.6	15.8	17.8	12.3	16.1	20.1	10.0	5.2	17.0	15.2	36.6	20.3	17.4	13.7	15.4	19.8	17.9	8.9	14.9	16.0	18.4	16.5	14.9	20.0	18.3	16.5	37.1	51.1	17.4	17.3	31.1	31.7	33.1	24.8	24.7	40.0	37.0	55.5	21.8	35.5	31.8	29.4	21.2	38.9	28.5	35.1	27.4	32.1	74.2	16.0	26.5	31.5	33.4	14.3	24.2	36.4	30.5	39.1	33.0	22.9	38.5	46.8	27.6	13.7	23.6	42.5	38.7	25.8	12.9	51.4	36.1	41.5	41.8	66.7	24.3	21.6	9.9	28.0	25.2	15.2	31.9	102.8	30.0	21.4	29.2	19.6	18.3	23.0	42.8	15.5	19.4	20.1	27.9	26.2	36.6	17.7	21.1	23.6	24.6	23.3	20.2	14.9	17.8	20.0	24.6	17.7	16.9	18.7	2.8	28.2	30.5	13.8	24.9	19.3	14.2	14.8	14.8	15.0	14.9	15.7	15.2	15.4	16.1	15.4	14.9	16.5	23.8	0.0	12.4	8.5	19.5	16.7	19.9	21.2	11.4	14.9	18.8	23.0	3.9	24.3	13.2	7.3	2.1	37.5	26.3	20.1	29.4	29.4	7.3	12.8	19.3	20.8	21.6	10.1	11.9	27.1	40.8	19.4	17.9	12.9	12.0	32.6	16.4	19.4	32.2	6.7	10.0	19.7	16.2	21.4	12.2	14.2	21.5	18.0	12.4	8.4	23.9	19.6	23.7	4.0	8.0	24.8	16.2	24.5	22.9	17.4	31.4	31.8	9.3	13.4	6.6	22.0	21.7	12.1	13.0	18.2	11.6	39.3	21.9	33.9	24.5	14.4
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364066-49396089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	19	"adrenal gland: 5.4;brain: 10.4"	"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.2;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7"	"Region enriched"	"Detected in single"	6	"pons and medulla: 3.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7"	HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.1	5.4	0.0	0.2	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	10.1	0.7	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	8.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	17.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	10.1	0.7	10.4	8.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.8	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 228.8"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 166.5"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 2.7;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075379	Enhanced					NA	NA		27000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"			"HPA075379: AB_2732290"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.2	0.0	0.0	0.1	0.0	0.2	9.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	228.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	2.6	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	14.1	0.3	0.0	2.2	0.9	0.1	0.4	29.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.4	0.0	0.0	3.6	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.5	166.5	0.4	0.6	0.0	0.0	0.3
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102522	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 164.0;vagina: 97.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 28.9;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011911, HPA012615"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		24000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	Cytosol	"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (3.01e-4)"	5.5	1.8	1.3	12.7	1.4	0.7	22.2	1.3	1.6	59.2	1.9	50.5	41.6	1.5	5.9	164.0	6.1	3.7	10.6	1.2	2.0	5.9	7.3	7.9	3.7	2.6	1.5	0.6	10.5	27.0	0.5	21.3	2.2	15.8	44.5	1.0	46.8	1.0	0.3	11.9	42.9	4.0	1.8	3.0	43.2	0.8	1.6	6.6	4.0	3.1	62.2	3.6	97.4	2.3	18.1	1.9	2.9	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	9.8	48.3	0.0	0.7	0.0	0.9	71.1	11.8	4.9	0.0	0.0	6.9	27.1	8.4	16.9	0.3	0.2	0.5	0.4	76.0	0.0	7.3	6.1	0.0	0.0	13.4	0.0	0.0	14.7	0.0	1.1	11.3	60.7	17.4	13.2	0.0	0.2	0.1	0.7	0.0	0.1	0.0	44.4	0.0	43.4	12.2	18.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	28.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.4	1.3	1.4	1.3	1.6	1.2	2.0	2.6	1.5	2.2	1.8	1.6	2.3	25.1	28.9	5.6	3.3	1.0	83.7	44.5	16.4	67.7	0.8	75.3	65.7	33.8	32.9	11.1	7.3	0.0	100.8	1.0	384.0	0.0	83.5	0.1	19.1	4.0	6.7	69.4	0.4	3.3	33.2	186.6	5.9	47.4	43.8	0.0	2.7	8.2	16.0	24.8	0.0	1.5	83.1	20.3	48.8	29.3	0.2	0.3	35.3	14.2	4.7	25.2	11.2	0.0	2.0	0.2	155.7	324.8	0.7	0.3	140.6	118.2	9.7	3.8	0.7	0.0	1.2	3.0	0.1	1.3	705.6	55.0	83.9	2.0	0.3	114.0	76.1
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30989365-31042815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 99.2;skin 1: 372.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 500.7;Basal squamous epithelial cells: 214.5;Squamous epithelial cells: 419.6;Suprabasal keratinocytes: 688.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 246.2;HBEC3-KT: 54.6;hTCEpi: 156.7;hTERT-HME1: 103.6;REH: 44.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.3"					"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		6000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	4.8	0.1	0.1	0.5	0.0	0.2	12.5	0.1	0.0	23.8	0.0	0.3	0.4	0.1	1.2	99.2	1.3	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.4	0.2	3.4	0.2	12.5	0.0	6.0	0.1	0.1	19.6	1.3	1.0	372.6	0.3	0.5	0.0	0.0	0.1	0.1	0.0	7.7	0.1	0.0	24.7	3.5	48.5	0.0	17.2	1.8	0.2	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	246.2	0.0	54.6	0.0	0.1	14.6	0.9	4.7	0.4	9.7	0.1	0.2	10.2	156.7	0.0	103.6	19.6	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.9	0.1	21.8	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.1	0.3	0.0	500.7	62.0	49.5	214.5	0.0	3.1	8.0	1.3	0.0	30.3	0.0	0.0	73.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.3	2.4	0.0	0.3	0.0	14.2	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.3	0.0	0.3	0.2	12.2	0.0	34.8	0.0	0.0	0.6	39.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	32.1	0.0	0.1	10.2	0.0	0.0	0.0	3.4	0.1	0.1	419.6	688.8	25.0	2.3	0.0	0.1	89.1
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.6;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.4	0.0	5.8	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.6	4.2	0.0	0.1	0.0	0.0	2.3	2.8	0.0	0.1	0.0	4.2	0.7	3.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.8	0.1	6.6	5.6	4.2	2.3	2.8	3.5	2.9	4.1	4.1	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
DSCAML1	KIAA1132	ENSG00000177103	"DS cell adhesion molecule like 1"	Q8TD84	11	117427772-117817525	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.0;retina: 20.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 87.9;Excitatory neurons: 178.8;Inhibitory neurons: 232.4;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 465.3;Rod photoreceptor cells: 137.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HDLM-2: 1.7;RPTEC TERT1: 4.8;T-47d: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035230	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035230: AB_2674527"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.27e-5)"	"unprognostic (8.48e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-2)"	1.5	0.3	8.4	0.1	12.6	0.2	0.4	4.3	12.4	1.0	0.0	2.0	0.4	2.0	0.5	0.2	2.7	1.2	1.0	11.0	10.2	3.0	0.4	0.7	0.3	13.2	12.7	5.0	0.9	0.0	4.3	0.1	12.3	0.8	0.6	20.1	1.1	0.3	0.5	0.2	0.7	0.8	2.9	1.0	0.7	2.1	14.9	0.5	0.7	0.3	0.4	1.2	0.7	27.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.9	0.1	0.0	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	8.4	12.6	4.3	12.4	11.0	10.2	13.2	12.7	12.3	2.9	14.9	27.0	0.4	0.0	0.0	23.8	0.1	0.1	0.1	0.1	0.6	87.9	0.0	0.0	2.7	4.3	0.1	0.0	41.7	0.0	0.0	0.3	0.0	0.4	6.1	2.1	0.3	0.7	6.7	0.0	178.8	0.0	0.0	1.3	0.0	0.4	0.0	0.2	0.7	0.0	0.1	3.3	232.4	3.7	0.0	0.0	1.2	10.5	1.2	0.2	0.0	3.7	0.0	4.0	0.0	352.8	465.3	0.0	0.1	1.9	0.0	0.2	0.0	1.8	5.5	137.7	0.0	1.2	1.2	0.3	0.8	0.0	0.0	0.1	0.3	0.1	0.9	0.1
DSCC1	"DCC1, hDCC1, MGC5528"	ENSG00000136982	"DNA replication and sister chromatid cohesion 1"	Q9BVC3	8	119833976-119855894	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.6;Extravillous trophoblasts: 17.6;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023780, HPA024401"	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023780: AB_2671311, HPA024401: AB_2671557"	"unprognostic (7.36e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.92e-6)"	"prognostic unfavorable (3.93e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.12e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.32e-9)"	"unprognostic (2.75e-2)"	"unprognostic (5.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (8.18e-2)"	1.8	1.8	1.3	3.7	1.6	6.1	2.4	2.1	2.0	2.6	1.1	2.7	2.4	2.4	1.3	2.4	1.5	1.0	1.5	1.4	1.4	0.9	1.1	1.4	7.1	1.5	1.5	1.5	2.8	0.5	0.5	2.3	1.6	1.9	3.5	0.3	3.7	1.2	2.1	2.6	2.3	2.7	1.5	1.3	1.7	2.6	1.4	9.9	1.0	3.4	5.7	1.5	2.1	1.8	34.3	16.6	32.1	29.4	4.6	8.3	13.8	23.1	4.7	16.3	16.9	15.2	20.4	61.7	19.7	6.9	10.1	24.8	36.7	14.4	17.5	42.2	33.3	78.7	16.2	17.9	1.5	31.2	26.4	3.8	2.2	20.1	9.7	3.8	4.7	40.5	27.2	26.9	19.9	33.8	82.4	19.2	47.2	90.4	41.2	29.1	30.4	29.9	12.7	21.3	28.7	17.6	12.4	96.7	15.8	25.0	18.1	17.0	3.2	17.7	48.0	17.2	33.9	36.5	58.2	65.4	9.0	49.2	26.2	0.0	0.0	0.0	0.9	0.0	0.7	0.3	0.2	0.4	0.0	0.1	0.1	0.3	0.0	0.8	0.0	0.2	0.3	0.2	1.3	1.6	2.1	2.0	1.4	1.4	1.5	1.5	1.6	1.5	1.4	1.8	4.7	0.0	0.5	2.6	1.2	3.4	2.2	2.1	4.6	0.7	2.2	3.2	0.8	1.5	0.2	0.0	0.0	7.9	1.6	1.0	0.0	1.6	0.1	0.8	2.8	3.0	0.0	24.6	6.4	2.4	17.6	4.3	1.5	1.3	4.5	3.7	4.6	0.9	4.7	0.0	5.2	1.2	2.0	1.0	1.2	0.2	1.2	0.9	3.6	1.0	0.0	1.5	1.0	7.5	5.3	0.5	0.3	2.6	5.2	1.7	0.2	1.5	1.7	0.3	0.0	2.3	3.3	1.1	18.8	6.0	3.3	1.4	3.0	2.0	3.8	1.5
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 112.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA014764	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014764: AB_1856587"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	27.8	10.7	3.6	26.8	4.5	18.4	18.3	3.9	4.4	13.8	10.4	7.7	6.4	10.5	8.3	13.7	14.6	14.9	12.4	3.2	4.3	8.6	11.3	15.3	16.4	7.0	5.8	13.8	3.8	11.1	6.0	23.1	5.6	8.5	8.0	3.5	6.9	10.2	6.9	13.8	9.0	15.0	4.6	18.6	6.4	6.1	8.5	10.3	6.6	10.7	9.7	19.7	14.3	5.9	32.7	7.0	23.6	22.2	62.0	40.7	26.5	37.6	88.2	46.4	67.4	0.2	8.9	0.9	3.3	66.3	46.4	60.8	3.3	88.7	60.1	33.9	14.6	2.2	9.8	0.3	69.0	1.5	1.7	86.8	37.4	51.5	50.0	24.0	27.7	8.3	0.8	14.4	22.4	1.0	4.4	1.8	12.7	0.2	1.8	5.6	21.6	15.6	30.4	2.2	7.8	5.9	36.4	0.1	0.8	16.2	0.3	3.9	10.5	46.4	13.4	11.8	30.6	3.1	1.1	1.6	24.6	4.0	5.5	0.4	2.0	0.1	0.6	2.5	0.3	2.0	0.5	0.3	5.9	2.1	0.6	0.3	1.6	0.1	1.6	2.7	0.1	0.8	3.6	4.5	3.9	4.4	3.2	4.3	7.0	5.8	5.6	4.6	8.5	5.9	9.4	16.0	4.1	64.9	15.4	52.0	26.4	42.2	78.6	6.3	7.4	10.7	8.3	2.8	20.7	3.7	0.0	2.9	16.5	0.3	7.9	4.8	52.2	11.0	21.9	15.4	1.2	11.4	46.8	8.5	7.0	73.7	3.6	3.1	22.8	100.9	56.4	5.7	39.8	1.7	48.9	0.6	8.2	83.6	77.1	24.9	55.0	112.2	10.6	51.5	79.4	3.4	5.2	73.4	86.4	13.6	0.4	30.1	8.9	32.0	0.4	7.7	30.3	3.0	32.9	16.4	33.4	6.1	5.5	76.6	39.9	4.9	14.0	17.2	1.0	51.0
DSG1	"CDHF4, DSG"	ENSG00000134760	"Desmoglein 1"	Q02413	18	31318160-31359246	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"skin 1: 564.4"	"Group enriched"	"Detected in some"	25	"Basal keratinocytes: 117.4;Suprabasal keratinocytes: 315.7"	"Group enriched"	"Detected in many"	10	"head and neck cancer: 57.0;melanoma: 16.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"hTCEpi: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA022128, HPA074188"	Enhanced					NA	NA		130000000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA022128: AB_1847620, HPA074188: "	"unprognostic (2.55e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.22e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.44e-1)"		"prognostic unfavorable (2.99e-4)"	0.4	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.1	1.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.6	0.0	2.0	564.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	2.1	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.0	0.6	0.0	3.3	0.9	1.7	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.1	0.0	0.0	8.6	3.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.2	6.5	315.7	0.0	0.2	0.0	0.1	0.0
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447741-31478702	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 313.9;vagina: 119.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 197.6;Basal squamous epithelial cells: 101.9;Squamous epithelial cells: 470.6;Suprabasal keratinocytes: 206.4;Urothelial cells: 87.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.0;head and neck cancer: 183.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	53	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.2"	"Group enriched"	"Detected in some"	7	"HaCaT: 204.4;hTCEpi: 494.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046864, HPA056863, CAB069880"	Enhanced					NA	NA		190000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.90e-4)"	0.3	0.0	0.1	0.2	0.1	0.2	3.9	0.1	0.2	71.1	0.1	0.0	5.4	0.0	0.0	313.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.0	43.6	0.0	0.1	39.9	3.9	0.0	0.0	0.0	0.2	0.1	0.2	14.8	0.0	0.0	72.7	1.2	119.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	204.4	0.0	46.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	494.7	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.2	28.9	18.5	0.0	0.2	197.6	17.4	32.2	101.9	0.3	0.5	5.0	0.3	0.0	21.1	0.0	0.0	0.4	1.5	0.2	0.0	0.2	0.6	0.1	0.3	2.7	0.0	0.0	2.7	0.4	0.4	2.2	0.0	0.1	12.6	0.0	0.4	0.3	0.4	0.0	0.1	1.3	2.0	0.3	7.7	0.5	0.0	3.2	7.2	0.0	0.7	0.1	0.0	0.0	0.1	1.3	2.5	0.7	1.2	12.3	7.1	0.1	15.9	0.8	6.6	0.0	1.8	3.3	2.8	470.6	206.4	0.3	1.3	0.0	6.5	87.2
DSG4	"CDHF13, LAH"	ENSG00000175065	"Desmoglein 4"	Q86SJ6	18	31376777-31414912	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"skin 1: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.4;Squamous epithelial cells: 1.0;Urothelial cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	133	"HaCaT: 37.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059456, HPA079244"	Enhanced					NA	NA		320000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA059456: AB_2684025, HPA079244: "	"unprognostic (9.86e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"		"unprognostic (5.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.11e-2)"			"unprognostic (6.00e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.58e-1)"	"unprognostic (2.14e-1)"		"unprognostic (1.79e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.2	1.3
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616873	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036230	Uncertain				"Secreted in other tissues"	NA	NA		27000							"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17570075-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 1690.3;SK-BR-3: 1421.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037094	Approved					NA	NA		3700000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	306.9	232.5	134.0	136.7	150.8	53.3	287.0	144.0	178.0	336.8	144.5	1146.3	136.1	636.1	297.1	535.6	449.9	297.4	411.6	150.0	158.2	269.0	141.3	315.8	60.2	146.7	150.3	236.8	268.9	180.0	127.1	162.3	154.4	559.2	306.8	114.0	274.6	758.3	87.2	227.8	285.6	695.0	147.6	75.2	486.8	82.0	140.4	47.8	273.0	111.4	79.0	704.4	312.7	164.1	323.0	431.3	161.5	160.5	399.8	391.5	303.8	397.7	616.4	248.1	221.7	200.4	348.6	50.1	97.7	587.8	458.5	305.3	149.4	606.5	281.9	28.0	125.5	131.9	247.2	295.3	426.2	102.9	86.5	357.9	563.1	239.3	275.9	609.0	360.6	85.4	63.4	65.7	468.1	251.7	42.2	121.6	110.4	1690.3	322.3	28.9	248.4	103.5	686.4	291.9	244.6	72.9	363.0	1421.1	441.9	263.7	654.3	55.9	345.3	294.9	93.2	324.1	276.8	39.7	52.2	134.6	139.9	43.8	250.8	33.8	17.6	59.2	55.9	32.2	46.8	11.9	56.9	52.0	22.1	9.0	37.0	47.0	11.8	48.8	46.4	51.1	46.7	45.3	134.0	150.8	144.0	178.0	150.0	158.2	146.7	150.3	154.4	147.6	140.4	164.1	372.8	1442.3	667.9	25.1	84.9	1151.6	697.0	796.7	542.4	101.5	925.2	762.2	1131.3	739.2	696.8	678.6	50.1	576.4	336.9	549.2	1457.6	1022.2	295.0	558.3	447.3	481.7	546.5	83.1	54.7	1468.6	1165.0	533.5	275.7	540.2	183.8	199.4	425.9	602.4	222.2	176.7	43.1	643.2	533.0	147.8	361.5	111.2	496.8	133.0	610.1	57.1	191.7	779.1	224.6	30.7	44.0	1018.6	572.8	1266.8	172.4	640.3	304.4	1491.4	912.0	153.1	1216.2	271.1	1745.4	390.0	298.9	515.2	1043.5	549.5	161.6	252.0	545.8	680.2
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5, SPG23"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 89.2;Melanocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	4.5	7.2	11.5	3.8	11.1	19.2	6.7	11.5	12.1	6.4	6.8	6.0	2.7	7.9	5.8	5.5	7.2	4.5	4.9	11.8	11.3	7.5	2.2	6.1	4.0	13.5	10.7	11.1	4.5	13.1	5.5	6.0	13.7	5.6	3.6	13.5	4.4	6.9	9.6	12.0	4.1	7.1	9.9	6.2	4.2	5.1	11.5	6.2	6.8	6.8	4.5	5.2	5.4	13.5	9.9	6.3	6.6	8.1	9.5	15.9	4.7	12.0	12.1	12.4	8.4	2.9	5.3	7.3	3.5	20.6	6.9	6.9	7.3	7.8	12.4	3.5	7.8	13.3	8.1	3.1	8.5	3.7	6.8	9.4	11.6	12.7	12.0	14.7	9.2	5.2	17.4	4.8	10.0	6.8	2.9	3.3	7.2	1.8	7.4	2.6	12.1	6.5	8.4	6.1	3.7	7.2	10.3	10.5	34.5	7.7	7.8	4.9	9.2	7.7	7.7	11.8	8.2	4.8	3.7	4.1	9.0	5.1	28.2	8.1	1.9	3.6	2.4	1.5	2.3	1.5	1.8	2.0	1.7	1.7	2.6	1.9	2.7	2.8	1.0	1.2	1.1	1.0	11.5	11.1	11.5	12.1	11.8	11.3	13.5	10.7	13.7	9.9	11.5	13.5	15.8	28.9	15.5	26.4	15.3	14.9	7.2	10.5	14.2	48.0	14.5	13.6	13.6	12.8	15.1	16.5	33.3	6.8	15.1	3.8	5.9	12.5	11.3	16.3	37.7	16.1	12.7	31.6	35.1	9.1	6.1	19.4	8.2	11.6	24.1	43.2	28.5	6.9	8.8	89.2	36.6	6.2	6.1	23.6	15.6	25.2	16.4	11.4	90.7	21.5	20.6	45.1	23.7	17.1	43.0	10.6	5.0	18.0	11.1	10.7	6.1	6.9	24.7	37.3	26.3	22.4	16.4	22.3	13.0	10.1	13.9	2.6	15.1	27.8	7.5	6.7
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-aminoacyl-tRNA deacylase 1"	Q8TEA8	20	18587942-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA		350000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	23.5	21.1	7.0	3.7	7.0	4.5	21.5	7.2	7.6	18.9	7.1	15.6	2.7	19.7	4.8	26.6	18.6	3.2	17.5	7.1	7.6	25.6	10.8	16.0	4.1	7.3	6.9	17.6	20.4	7.7	33.8	3.4	7.4	13.7	4.2	6.6	21.9	3.1	29.1	27.4	13.7	4.0	7.2	15.3	16.2	19.1	7.3	2.1	19.3	6.7	4.5	17.1	19.4	7.3	10.1	15.7	15.8	16.2	8.8	12.2	9.1	4.3	12.3	10.5	11.3	10.0	11.4	0.1	4.1	13.6	13.9	5.3	13.1	25.0	10.4	6.8	3.2	10.2	4.0	18.7	22.8	9.4	8.2	10.2	22.4	11.8	42.1	8.7	16.5	3.0	7.0	22.5	15.3	24.9	1.7	23.8	11.0	13.5	9.9	0.0	16.6	11.1	16.6	8.2	16.6	13.0	4.4	20.4	23.6	7.1	12.3	9.2	10.2	14.3	3.8	17.7	14.5	5.5	10.2	4.6	8.6	13.9	11.1	1.7	0.7	0.4	1.8	1.0	0.8	1.1	0.6	1.0	1.5	0.7	0.5	0.5	0.9	1.4	1.0	0.2	0.4	0.6	7.0	7.0	7.2	7.6	7.1	7.6	7.3	6.9	7.4	7.2	7.3	7.3	35.5	35.3	24.0	32.0	26.8	23.6	40.9	48.3	22.2	42.4	27.9	33.0	18.8	28.6	23.1	42.3	2.1	26.7	24.7	9.9	43.0	71.9	38.4	16.2	33.1	36.4	23.3	22.1	41.9	87.4	37.8	29.9	13.7	17.8	42.5	24.6	35.7	11.2	47.8	43.7	60.6	23.5	28.5	23.5	35.9	21.8	18.0	27.1	42.7	12.2	42.8	58.2	38.1	53.3	52.2	90.6	19.1	19.5	24.6	50.6	9.3	73.8	22.8	34.9	0.0	30.1	27.5	93.5	124.2	33.2	35.7	12.4	35.5	42.7	26.8	31.9
DTD2	"C14orf126, MGC9912"	ENSG00000129480	"D-aminoacyl-tRNA deacylase 2"	Q96FN9	14	31446036-31457506	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001117	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA001117: AB_2666204"	"unprognostic (2.56e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.28e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (5.74e-6)"	8.6	6.3	4.7	4.9	6.8	2.3	7.1	5.2	6.5	4.0	5.2	4.8	3.9	5.2	5.0	5.7	4.9	3.5	3.1	5.3	5.3	5.8	8.1	5.8	5.5	5.5	5.9	5.3	6.3	6.1	4.4	4.3	5.9	5.7	5.4	5.0	6.0	3.9	1.6	5.6	3.7	5.5	4.9	4.9	4.0	4.0	6.2	5.0	6.2	1.6	5.5	4.7	3.8	8.1	11.4	9.5	8.1	10.6	14.6	12.3	5.5	10.3	10.0	8.0	7.1	5.2	10.7	21.6	6.8	11.8	8.6	10.8	13.0	11.6	13.6	11.7	5.7	6.2	6.5	29.0	15.7	12.6	7.3	14.0	12.9	7.1	15.9	6.7	11.8	12.8	12.3	9.9	10.7	13.7	18.3	11.3	11.0	19.6	9.7	12.3	6.0	11.3	15.0	9.8	12.1	8.0	16.8	21.6	12.4	6.9	19.8	6.5	8.6	8.7	7.7	7.1	9.1	12.3	24.5	20.7	3.8	11.4	14.3	2.5	2.6	1.0	2.0	2.2	2.9	2.7	3.0	2.2	3.7	3.2	4.5	3.0	1.5	3.7	1.2	2.2	1.6	2.8	4.7	6.8	5.2	6.5	5.3	5.3	5.5	5.9	5.9	4.9	6.2	8.1	2.9	9.6	9.0	10.1	7.6	5.2	5.7	5.1	13.1	5.9	6.1	4.3	4.8	15.7	4.9	3.7	8.4	9.1	4.9	3.3	3.9	5.7	4.4	6.8	7.2	3.8	3.0	8.0	9.2	6.2	6.3	6.2	5.1	3.0	1.3	5.9	3.9	11.6	5.1	5.0	12.7	6.7	14.2	5.5	3.7	6.6	7.5	4.0	3.6	2.8	4.8	9.5	7.2	35.2	40.2	5.2	3.9	8.2	7.1	6.0	3.3	9.7	6.2	9.2	0.0	7.4	6.8	10.1	2.7	16.2	5.4	2.7	5.4	10.3	7.2	4.2
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.8;Inhibitory neurons: 214.1;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA061357	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	2.1	2.1	7.8	1.6	6.7	2.9	9.7	3.4	12.1	4.2	0.0	1.7	1.2	2.8	10.1	4.5	4.6	3.3	2.0	12.4	3.6	4.2	3.4	4.3	2.5	4.9	1.7	4.4	7.7	9.9	5.8	1.9	4.5	8.4	1.0	5.0	36.0	5.1	2.7	4.5	1.6	1.2	0.1	2.7	5.6	6.7	2.9	4.0	11.1	1.5	1.9	3.5	4.0	5.6	10.7	9.1	6.6	7.5	4.0	5.2	0.2	3.2	4.2	4.0	5.3	3.5	2.6	5.5	1.3	2.5	5.0	3.7	4.6	13.1	2.2	8.2	11.1	4.5	2.9	10.0	2.9	5.4	4.1	3.6	10.9	4.2	7.2	4.9	5.5	10.5	0.4	8.0	3.0	10.9	8.5	4.6	7.3	2.9	5.4	7.0	11.5	9.7	4.9	9.7	8.9	13.7	10.3	16.2	12.9	3.6	8.7	3.3	2.3	1.6	7.3	2.4	5.7	14.6	6.8	10.0	4.6	9.5	5.7	0.4	1.6	5.7	4.1	0.9	4.4	4.4	5.0	3.7	0.5	5.8	5.0	3.3	3.2	4.1	0.4	0.9	5.2	2.0	7.8	6.7	3.4	12.1	12.4	3.6	4.9	1.7	4.5	0.1	2.9	5.6	3.9	9.6	12.8	53.2	12.6	8.0	26.6	16.4	44.3	9.4	20.3	18.9	2.3	7.2	9.3	14.7	6.2	3.7	4.2	0.9	11.7	4.0	3.1	7.2	4.2	4.7	3.0	4.4	176.8	11.6	1.5	3.2	15.8	12.1	1.3	4.6	5.0	5.6	33.6	21.9	214.1	2.8	14.2	7.8	1.7	6.9	1.5	4.9	12.4	83.4	3.2	18.5	7.2	137.7	343.3	9.5	1.4	2.6	8.7	17.9	0.3	9.3	2.2	9.9	6.6	1.9	3.2	12.6	27.9	15.7	2.0	2.1	10.8	2.3	1.3	17.7
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49621037-49656232	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"HPA042214: AB_2677903"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.6	11.8	7.7	13.0	10.1	5.4	18.2	8.2	9.1	27.4	6.5	21.1	7.4	22.6	16.8	13.3	21.1	23.0	11.0	9.0	8.9	11.0	11.5	10.9	12.9	5.7	6.9	22.7	33.3	11.5	9.2	12.8	6.0	15.7	11.9	8.8	21.5	14.7	10.3	12.2	9.1	20.5	6.4	9.0	14.9	9.5	9.9	11.7	17.6	21.1	10.0	20.4	15.9	9.8	10.0	11.9	21.2	11.5	41.3	84.1	16.6	29.3	28.6	36.8	27.5	4.2	8.3	16.7	20.3	38.7	16.8	17.8	15.6	15.8	37.7	10.8	11.2	13.8	23.5	14.5	29.1	18.0	11.1	38.8	20.4	24.3	29.7	32.9	15.5	19.3	26.3	17.3	41.7	23.3	12.3	15.1	12.4	22.6	15.7	17.4	44.7	64.9	12.3	7.1	18.6	14.4	34.7	11.5	27.3	22.1	12.1	25.4	10.7	43.6	17.3	25.6	32.3	13.2	22.2	10.0	37.5	53.9	28.3	8.7	9.7	5.2	6.8	11.7	9.8	9.7	10.3	11.6	12.8	10.1	12.0	11.5	2.6	13.9	15.3	25.3	8.9	6.0	7.7	10.1	8.2	9.1	9.0	8.9	5.7	6.9	6.0	6.4	9.9	9.8	39.9	19.2	15.0	36.6	16.6	19.2	15.4	31.9	18.2	41.8	23.0	34.0	18.8	12.8	22.1	35.0	31.3	23.4	27.1	4.7	31.3	20.1	21.0	27.8	88.1	23.6	15.5	20.8	57.2	21.0	27.7	49.9	20.4	14.1	7.0	29.3	25.4	14.9	19.5	18.5	55.2	19.2	40.7	16.4	14.9	11.2	37.9	16.7	16.0	18.7	10.4	20.3	18.6	33.7	66.1	20.8	10.3	28.2	27.0	21.5	9.5	22.0	37.9	40.0	6.6	35.5	46.7	51.2	44.3	19.6	19.0	9.7	16.2	35.4	17.1	12.7
DTWD2	FLJ33977	ENSG00000169570	"DTW domain containing 2"	Q8NBA8	5	118836074-118988547	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.4;Inhibitory neurons: 61.8;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053173, HPA054864"	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"		"HPA053173: AB_2682068, HPA054864: AB_2682629"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.59e-1)"	3.1	3.3	1.3	2.3	1.3	1.2	3.6	2.3	1.8	5.1	2.2	3.3	3.2	2.6	2.3	4.2	2.3	3.2	6.5	1.2	0.8	6.5	4.5	2.4	2.3	1.1	1.4	1.7	3.0	4.7	0.8	1.8	1.2	3.4	3.3	3.4	3.2	2.7	10.5	3.3	2.7	3.2	1.0	3.0	2.7	2.4	1.3	2.0	9.1	6.3	2.3	2.9	1.3	1.4	4.3	2.6	3.6	5.3	2.0	1.0	3.6	3.9	2.7	5.5	6.3	1.8	3.2	3.6	6.9	3.4	2.6	4.8	6.0	4.4	6.9	1.2	4.2	4.9	4.3	2.9	1.7	5.9	6.1	1.5	7.4	2.4	2.4	3.2	1.8	6.4	3.8	5.5	3.7	4.2	4.9	3.6	3.8	3.1	1.4	2.0	3.3	1.9	7.0	6.2	1.8	3.3	3.9	4.2	5.4	2.9	9.7	3.9	2.2	6.9	5.1	2.3	5.7	3.8	6.6	2.8	4.0	3.5	3.4	0.9	0.3	0.1	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.6	0.4	0.4	0.6	0.5	0.3	0.5	0.1	0.4	1.3	1.3	2.3	1.8	1.2	0.8	1.1	1.4	1.2	1.0	1.3	1.4	2.7	9.6	3.6	33.6	5.7	2.8	2.7	3.9	8.6	12.0	5.4	2.8	11.7	8.6	4.7	7.3	16.7	2.7	3.7	4.0	9.8	2.9	12.8	4.2	1.9	2.0	4.2	12.6	70.4	8.3	1.1	3.0	9.7	3.6	0.0	4.5	1.8	5.6	3.9	20.2	61.8	2.0	4.1	2.6	2.5	20.3	2.5	4.5	7.2	21.5	4.6	7.3	4.1	49.3	43.9	1.9	5.2	2.2	8.0	2.1	3.7	12.1	3.1	9.1	0.0	4.5	2.8	12.7	17.4	10.0	3.7	0.7	2.8	7.3	3.4	3.4
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;lymphoid tissue: 11.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 48.3;Horizontal cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 109.1;REH: 45.1;U-698: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.0	1.7	6.5	5.7	6.8	2.7	6.4	3.2	5.9	2.4	0.2	0.8	1.3	1.5	0.3	0.9	1.8	0.8	1.2	5.2	11.1	3.5	8.9	0.8	11.1	5.2	8.8	0.4	1.6	0.0	3.3	0.3	5.1	0.8	0.1	2.9	2.6	0.3	0.5	1.0	3.5	0.3	3.7	11.8	0.9	1.9	10.5	0.5	2.2	0.1	6.0	0.5	0.6	2.4	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	109.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.3	4.6	0.0	2.0	0.2	0.0	45.1	0.2	2.6	0.0	0.0	2.7	7.1	0.4	0.4	2.5	0.0	0.1	0.2	1.2	0.0	4.0	0.0	0.1	0.5	0.2	110.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	6.8	3.2	5.9	5.2	11.1	5.2	8.8	5.1	3.7	10.5	2.4	0.7	0.0	0.0	48.3	8.8	1.0	0.0	0.0	0.0	4.7	0.2	0.6	0.7	0.0	0.0	1.8	8.4	0.0	0.3	0.1	7.9	2.5	0.7	0.7	17.5	1.7	0.0	0.0	10.6	0.0	0.0	4.5	0.5	0.4	7.0	0.0	0.4	12.4	0.8	171.6	13.8	0.1	0.0	0.3	0.6	1.7	7.8	0.2	3.6	2.8	0.0	11.4	2.1	13.0	1.0	0.2	0.1	7.5	2.5	0.0	0.0	0.2	0.0	2.8	0.0	0.4	1.3	0.8	2.4	0.0	0.4	0.0	2.2	0.8	0.0	0.0
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 67.7;CAPAN-2: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	10.0	5.0	5.6	12.3	6.3	5.1	10.3	3.3	10.1	17.4	13.8	15.8	10.2	9.3	1.1	54.0	10.5	9.3	6.8	4.3	5.9	5.4	8.7	10.3	10.9	11.1	8.1	8.1	10.5	8.4	6.7	5.3	8.1	13.7	8.1	4.4	30.4	3.9	12.5	31.0	13.3	4.3	3.8	13.3	14.2	28.1	13.5	9.0	7.9	2.7	10.1	12.1	27.2	12.8	31.8	67.7	9.9	14.7	5.5	5.4	21.2	6.8	5.7	7.2	9.9	19.1	110.9	9.8	4.7	6.8	38.1	23.2	5.3	32.1	4.5	22.1	11.3	5.6	14.4	16.9	7.4	8.2	13.7	9.6	19.1	18.7	10.0	5.6	5.5	17.2	17.3	14.3	8.8	15.3	12.6	28.6	14.4	23.8	10.2	13.8	9.1	17.7	3.4	24.4	3.9	8.2	10.9	18.4	9.3	8.6	18.5	21.6	5.8	40.5	19.0	13.8	27.1	10.7	13.7	11.2	8.8	8.8	21.3	17.7	11.6	17.2	8.6	13.3	6.2	6.6	7.1	8.5	10.1	7.3	7.1	7.9	22.8	4.2	18.8	17.8	11.0	8.4	5.6	6.3	3.3	10.1	4.3	5.9	11.1	8.1	8.1	3.8	13.5	12.8	7.3	6.4	5.0	5.2	13.1	33.9	19.5	87.2	23.3	2.6	7.1	4.8	2.3	4.3	59.2	7.3	8.4	18.5	12.0	39.1	3.9	19.4	33.0	8.1	3.1	5.9	9.1	3.8	5.7	10.8	13.5	6.5	61.2	10.7	3.8	3.2	7.1	4.3	21.6	3.3	5.2	25.6	22.4	11.0	7.7	10.4	5.6	14.5	7.2	19.7	10.0	5.7	8.2	18.1	10.0	23.1	37.9	4.9	13.9	20.0	21.0	3.2	62.8	9.2	6.6	3.0	7.3	11.0	11.0	27.0	35.4	37.6	9.7	1.9	26.1	62.5
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Cancer enriched"	"Detected in all"	4	"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	36.6	58.2	117.1	15.8	120.2	7.2	36.4	117.5	138.2	97.6	115.0	117.4	11.5	95.5	50.7	24.2	92.0	24.5	67.6	124.5	111.4	63.8	12.3	37.2	21.2	107.8	112.1	124.3	41.9	39.4	145.1	28.1	108.6	82.1	16.8	80.8	31.4	48.2	21.0	21.1	46.2	48.5	105.3	46.0	51.0	29.0	112.6	23.6	75.9	16.6	15.5	65.0	60.7	119.0	8.8	22.7	65.9	0.1	0.0	0.1	0.4	13.8	35.4	29.7	30.0	11.8	36.5	12.3	20.5	30.0	0.3	14.2	0.0	1.7	20.9	31.1	4.1	7.1	39.4	12.5	49.4	0.0	0.1	24.5	16.7	22.8	0.3	84.4	33.6	0.1	0.0	40.9	23.1	19.2	38.4	0.3	52.1	7.2	2.0	0.0	55.1	0.7	2.8	22.7	47.7	75.5	10.9	3.1	7.0	15.8	38.4	18.9	0.1	38.6	15.3	17.9	20.2	66.2	53.6	0.2	24.8	0.1	20.6	0.0	0.0	0.0	2.5	0.0	0.6	0.1	0.9	1.2	0.1	0.1	0.8	1.6	0.0	1.0	0.0	0.3	2.2	1.2	117.1	120.2	117.5	138.2	124.5	111.4	107.8	112.1	108.6	105.3	112.6	119.0	4.9	16.0	15.6	25.8	2.9	6.2	10.0	8.7	21.1	47.8	12.2	19.9	11.0	11.5	10.5	12.9	50.1	0.5	10.6	0.5	13.7	8.2	0.9	17.8	17.4	8.5	15.6	4.4	29.9	1.9	0.3	15.1	6.1	5.5	5.7	17.2	15.0	0.6	0.6	70.7	29.3	0.9	10.2	2.0	2.1	2.8	34.2	1.6	3.6	8.4	0.8	27.4	36.0	25.1	19.0	2.6	0.0	31.6	5.8	7.1	0.0	4.6	30.9	42.0	46.0	11.5	37.5	4.6	5.7	2.8	2.8	1.2	10.4	16.8	0.7	3.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564338-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 91.6;BJ hTERT+ SV40 Large T+ RasG12V: 112.3;GAMG: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	11.1	9.2	5.5	24.4	6.0	12.8	10.8	5.0	6.4	10.1	4.8	15.5	20.6	12.3	6.5	11.4	11.4	15.3	7.3	4.6	6.1	9.9	32.1	20.8	21.8	11.1	6.6	9.4	17.8	11.1	5.3	16.3	7.4	12.3	16.2	2.6	20.3	8.6	7.8	8.1	18.7	14.8	8.3	26.6	15.9	3.6	8.3	17.4	11.9	9.2	20.9	18.2	8.2	7.2	31.2	9.4	2.6	7.9	12.0	27.6	10.2	7.9	29.3	91.6	112.3	9.2	31.2	3.6	15.1	13.2	87.8	30.5	9.2	12.8	20.1	26.3	3.4	27.1	7.2	9.8	23.7	14.0	20.2	23.8	14.8	13.7	7.8	17.4	17.6	16.9	3.5	18.8	6.9	9.6	34.3	9.9	1.7	9.7	17.2	37.5	21.0	6.0	23.4	19.8	3.8	4.1	16.6	7.4	59.5	1.8	8.5	17.5	21.6	10.4	14.5	1.0	10.2	6.8	4.0	16.4	17.9	17.9	10.9	21.4	11.3	12.0	11.6	18.1	12.5	7.5	9.5	12.4	8.7	7.9	8.4	9.3	28.2	10.5	19.4	0.9	9.9	9.9	5.5	6.0	5.0	6.4	4.6	6.1	11.1	6.6	7.4	8.3	8.3	7.2	31.3	32.1	28.1	3.9	19.7	8.9	10.2	10.4	9.1	0.3	12.9	8.1	5.1	15.7	15.0	7.3	0.0	4.1	15.3	46.3	0.0	23.1	2.5	17.2	26.7	24.1	18.5	16.2	0.0	32.5	15.2	13.3	30.5	27.5	15.8	17.5	25.4	56.7	28.4	0.0	0.3	26.6	10.2	38.6	5.8	1.1	8.4	26.1	5.4	13.1	38.2	5.1	40.2	0.5	1.1	32.4	15.0	9.1	11.8	20.1	24.2	15.1	17.0	0.4	32.9	10.0	10.7	1.8	0.5	12.4	6.0	1.8	19.2	8.3	20.6	20.1
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208588	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.6;Oligodendrocytes: 33.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 34.5;CAPAN-2: 37.7;OE19: 35.4;RT4: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA056760: AB_2683228, HPA059294: AB_2683969"	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.57e-3)"	10.4	1.9	13.9	5.5	21.2	9.3	9.5	21.4	20.0	8.0	8.2	17.5	16.4	3.8	1.9	4.7	5.8	4.9	3.2	13.2	21.2	8.5	32.5	18.1	5.3	30.2	22.4	15.0	7.9	1.0	4.1	14.8	27.0	7.5	17.2	10.4	21.7	3.1	1.4	3.9	14.4	2.5	33.5	6.7	11.6	1.7	25.6	1.5	10.2	1.7	6.5	15.0	3.9	50.5	4.8	5.7	30.5	0.6	8.5	0.5	62.8	0.4	2.7	0.3	0.4	34.5	37.7	11.6	2.1	0.7	1.2	16.5	9.5	11.8	0.1	0.8	0.5	0.1	6.6	11.2	2.4	0.9	2.3	1.4	19.3	0.1	0.5	2.1	0.0	2.1	0.1	1.1	1.4	2.7	0.5	0.1	16.1	35.4	1.5	4.1	27.1	1.3	2.6	95.2	0.0	0.1	24.3	6.4	0.8	7.7	4.9	0.5	0.3	0.1	4.9	0.1	0.0	0.4	0.1	1.1	0.2	2.8	2.6	0.7	0.4	0.4	0.0	0.4	0.0	1.0	0.0	0.0	0.6	1.3	0.0	0.0	1.5	0.0	0.2	2.8	0.0	0.1	13.9	21.2	21.4	20.0	13.2	21.2	30.2	22.4	27.0	33.5	25.6	50.5	8.9	19.2	16.8	9.4	3.1	1.7	3.2	7.9	2.2	2.0	2.9	3.9	1.4	28.6	21.8	7.3	0.0	15.0	6.9	33.6	0.0	10.2	0.4	1.5	8.1	3.6	4.9	0.0	12.0	4.9	19.2	7.2	12.2	3.0	1.3	4.9	5.7	23.1	3.7	0.0	8.4	10.5	2.0	2.5	2.5	0.4	4.1	2.7	5.4	3.7	0.9	30.3	0.0	7.5	33.9	10.8	16.3	3.4	0.0	3.1	19.8	9.1	14.9	2.0	0.0	22.1	3.6	0.4	1.7	1.8	1.3	5.5	1.2	5.9	18.5	22.5
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675747-241686944	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 108.6;Extravillous trophoblasts: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA		7000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.2	16.0	15.6	15.6	17.1	37.0	11.8	16.2	19.8	11.2	16.5	15.1	13.2	10.8	6.1	19.1	10.2	8.6	10.6	14.5	15.0	14.9	18.8	9.7	24.8	16.8	16.0	8.2	9.5	7.5	5.0	11.1	16.1	11.1	12.2	4.3	9.8	7.4	8.1	18.8	14.0	13.4	15.3	17.2	13.3	8.2	16.8	24.1	8.7	6.4	19.2	10.6	11.2	17.2	102.6	112.3	93.6	120.1	30.2	33.3	103.2	82.1	63.2	110.8	125.6	54.8	120.1	48.3	24.6	66.8	126.8	84.4	87.8	102.2	56.7	118.8	104.6	103.9	88.3	105.1	26.3	69.1	83.1	23.7	27.3	102.7	42.4	32.1	104.8	74.4	123.6	38.4	114.1	112.6	132.2	125.0	100.7	113.1	94.2	111.4	139.8	71.8	62.3	59.5	115.0	74.0	53.4	81.5	67.9	27.0	74.2	120.0	66.5	147.5	110.4	99.0	152.5	47.3	49.1	144.6	122.4	112.2	184.9	20.5	26.2	17.4	30.4	46.7	29.6	35.6	28.5	32.6	19.7	36.7	28.1	25.0	4.2	32.6	37.1	38.5	42.1	28.5	15.6	17.1	16.2	19.8	14.5	15.0	16.8	16.0	16.1	15.3	16.8	17.2	28.9	9.6	5.8	8.1	21.4	15.2	17.7	47.7	16.5	19.1	36.3	44.8	11.0	24.3	22.2	25.8	2.1	79.5	24.0	22.9	21.5	39.6	2.1	17.6	25.0	29.2	14.4	108.6	3.3	34.1	149.1	26.9	25.5	22.3	15.2	52.3	23.9	22.3	84.9	5.0	4.7	35.7	36.7	17.0	13.9	2.1	16.4	21.7	23.2	5.6	39.3	23.0	38.1	6.0	9.2	33.7	10.6	19.2	37.6	21.7	12.7	37.7	12.9	17.4	26.3	21.4	31.2	27.5	63.4	32.6	11.9	27.5	17.4	28.2	52.2	19.5
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.5;skin 1: 81.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Group enriched"	"Detected in many"	6	"cerebellum: 12.4;white matter: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.6"	HPA023544	Approved					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	1.5	14.1	0.7	1.0	1.0	0.2	4.5	12.4	1.2	44.5	0.0	1.0	0.6	3.0	50.0	108.5	14.0	3.3	3.3	1.0	0.3	0.7	0.4	70.1	0.3	0.3	0.3	1.8	0.5	5.2	1.3	1.5	0.6	13.8	0.3	0.6	18.7	13.0	0.4	81.7	0.7	0.4	0.1	0.3	64.3	1.6	0.4	1.1	70.4	0.0	14.7	11.1	42.0	3.2	8.3	0.1	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	64.4	0.0	6.1	0.0	0.8	0.4	0.0	0.9	0.1	0.0	0.0	0.3	0.0	30.5	0.0	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.1	0.0	0.0	36.3	0.8	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.0	12.4	1.2	1.0	0.3	0.3	0.3	0.6	0.1	0.4	3.2	0.9	83.3	168.6	4.2	4.5	11.1	14.3	22.8	11.4	21.3	4.7	2.8	2.4	8.6	32.5	3.7	8.4	5.3	7.6	2.5	0.0	3.8	0.7	67.1	9.4	3.8	21.7	2.7	5.1	5.4	0.6	5.1	17.9	88.5	8.2	7.9	7.9	1.5	1.2	6.7	3.9	4.0	16.2	3.1	43.5	0.3	3.4	3.3	16.0	1.0	3.2	3.5	33.0	9.5	10.6	4.7	4.0	3.8	0.1	9.5	6.8	0.5	64.9	4.4	0.0	8.5	4.7	11.5	7.5	36.4	18.0	3.7	4.5	0.4	5.6	30.0
DUOXA1	"FLJ32334, mol, NIP, NUMBIP"	ENSG00000140254	"Dual oxidase maturation factor 1"	Q1HG43	15	45117367-45129938	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 189.0;skin 1: 91.6;thyroid gland: 111.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041578	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041578: AB_10795691"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.36e-2)"	1.1	5.0	0.2	1.3	0.5	0.1	4.0	0.7	1.1	32.1	0.0	0.9	0.8	4.6	49.3	189.0	5.7	4.3	2.1	0.5	0.3	0.8	0.3	64.3	0.1	0.6	0.1	1.1	0.4	5.0	0.7	0.8	0.8	21.6	0.5	0.1	27.5	12.0	0.5	91.6	0.8	0.2	0.1	0.1	43.6	0.2	0.7	0.7	111.1	0.0	17.9	23.3	77.4	2.9	10.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	103.9	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.5	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.1	0.5	0.3	0.6	0.1	0.8	0.1	0.7	2.9	0.0	60.9	118.0	1.0	0.0	9.4	18.8	26.9	18.2	0.6	1.4	1.7	0.5	0.0	35.5	0.0	2.1	2.4	0.0	3.3	0.0	2.0	0.1	28.7	4.0	0.8	3.0	0.0	0.7	3.1	0.1	1.6	8.6	47.7	1.3	0.3	0.0	0.0	0.3	0.0	0.4	0.1	4.1	0.0	1.2	0.0	0.3	0.8	0.0	0.0	0.6	0.1	0.0	0.5	1.8	1.9	3.3	0.0	0.0	13.4	0.0	0.0	36.9	0.1	0.0	0.7	1.1	0.0	0.9	53.6	21.9	3.0	0.6	0.1	0.4	44.2
DUOXA2		ENSG00000140274	"Dual oxidase maturation factor 2"	Q1HG44	15	45114326-45118421	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Protein transport, Transport"		"Congenital hypothyroidism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 63.9;urinary bladder: 41.9"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 856.3;Exocrine glandular cells: 178.0;Pancreatic endocrine cells: 696.7;Urothelial cells: 552.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 27.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063548	Enhanced					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA063548: AB_2685037"	"unprognostic (1.87e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-4)"	"unprognostic (9.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.54e-2)"	0.1	0.3	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.4	0.0	0.0	5.6	0.0	63.9	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.9	0.1	0.0	1.5	0.0	0.0	0.0	2.1	0.2	0.0	0.0	15.9	0.0	0.0	0.0	11.4	0.0	0.6	41.9	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.1	0.0	2.2	0.0	28.1	46.4	0.0	0.0	0.0	0.0	0.9	12.8	32.7	0.0	0.0	0.0	0.0	85.2	0.0	856.3	0.0	0.3	0.1	1.0	0.0	0.0	0.0	178.0	0.0	0.5	57.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	4.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9	0.0	0.0	0.0	0.1	696.7	61.8	0.0	0.0	14.2	0.9	0.1	106.7	0.0	0.0	0.0	7.1	0.3	0.2	0.0	0.0	0.0	0.6	0.2	23.8	552.0
DUS1L	"DUS1, PP3111"	ENSG00000169718	"Dihydrouridine synthase 1 like"	Q6P1R4	17	82057506-82065887	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023384	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA023384: AB_1847879"	"unprognostic (4.42e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (4.17e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.70e-3)"	83.3	86.7	38.2	51.1	38.0	94.2	89.0	35.2	49.7	85.3	40.6	101.3	66.6	74.0	23.0	117.8	81.8	27.0	93.1	38.4	34.9	90.4	174.3	80.5	64.8	40.4	36.4	82.3	148.3	32.0	99.7	27.0	37.0	118.8	29.8	16.9	105.8	30.4	144.3	127.1	107.2	18.9	35.2	131.3	119.4	93.6	38.5	37.7	93.6	27.3	33.3	87.9	85.0	38.6	169.4	109.0	37.7	44.3	28.9	28.4	115.0	57.5	26.8	56.5	40.2	99.7	77.9	133.7	65.3	33.0	39.8	112.0	46.1	60.9	21.9	54.6	263.1	89.2	167.3	178.8	65.3	138.8	101.0	43.1	75.1	37.3	46.4	27.0	64.1	124.8	147.1	69.4	28.5	268.6	192.9	114.9	43.7	87.6	151.7	143.7	43.1	151.7	42.3	114.3	193.9	118.7	45.2	192.6	127.1	35.8	112.3	133.1	49.1	91.7	89.0	79.3	150.1	164.5	48.9	113.0	58.8	102.2	65.0	3.0	3.5	5.0	4.0	3.9	6.0	3.9	4.0	5.0	3.6	3.3	6.5	5.6	1.2	5.9	5.3	7.9	7.6	2.0	38.2	38.0	35.2	49.7	38.4	34.9	40.4	36.4	37.0	35.2	38.5	38.6	36.8	28.9	19.1	17.6	30.0	22.0	20.0	10.0	10.8	28.3	78.3	69.8	21.3	24.3	15.0	11.0	29.2	16.1	60.1	65.2	7.9	12.1	87.2	30.5	28.4	21.0	43.2	21.7	15.9	39.1	19.1	19.1	37.2	37.6	3.8	46.3	13.9	77.8	21.0	18.5	15.8	58.1	8.2	26.8	14.3	146.2	14.3	27.0	10.6	10.3	19.2	17.8	27.8	10.1	18.2	32.0	32.2	13.5	33.7	40.9	32.4	24.5	15.3	47.8	13.1	18.0	23.9	43.3	9.6	23.3	28.4	15.6	28.4	52.2	75.4	37.5
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.1;Late spermatids: 94.1;Spermatocytes: 53.1;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	5.8	6.8	5.2	12.6	5.8	9.6	5.8	6.8	7.5	6.1	4.6	8.6	5.7	5.3	4.9	12.2	5.1	5.5	6.1	5.3	6.1	5.9	9.2	6.8	18.8	6.8	5.8	4.8	4.4	7.5	4.9	9.9	6.6	5.4	8.4	5.3	5.9	5.0	9.6	10.8	10.4	7.9	5.0	15.9	6.4	27.5	6.4	7.6	5.4	8.9	20.2	7.0	7.4	7.8	17.1	25.5	11.0	17.1	8.8	14.8	20.4	16.1	15.6	33.4	23.7	27.5	29.9	39.7	14.3	17.0	9.8	22.8	26.6	28.5	25.5	6.1	16.0	13.4	15.6	20.6	14.9	15.1	18.4	14.5	21.9	27.5	26.8	12.8	21.3	29.9	16.1	6.5	16.0	24.9	16.0	22.5	12.2	16.9	13.5	26.8	12.5	28.3	18.4	11.8	13.0	11.3	31.8	12.3	7.1	14.1	25.1	8.4	11.7	14.8	13.3	12.9	13.6	18.4	24.5	36.6	10.6	19.7	8.8	12.1	29.2	89.9	9.5	25.8	9.2	56.9	6.5	10.3	21.9	48.4	9.4	8.5	27.8	21.3	37.7	8.6	13.5	17.2	5.2	5.8	6.8	7.5	5.3	6.1	6.8	5.8	6.6	5.0	6.4	7.8	2.5	9.6	4.6	6.8	17.1	2.7	2.0	12.8	4.6	3.9	2.4	2.2	2.6	4.3	6.2	7.3	8.4	29.2	6.0	5.7	5.9	10.4	118.1	1.7	3.5	5.3	4.2	3.0	7.2	5.4	17.3	3.8	4.6	2.6	7.0	7.2	9.3	7.9	13.4	15.2	8.0	5.5	6.1	11.9	2.3	94.1	3.7	6.2	3.6	2.8	13.5	4.5	9.2	5.5	7.3	9.5	3.6	7.9	7.7	3.4	4.2	10.8	4.1	2.9	6.6	3.4	4.7	53.1	15.0	5.2	2.6	61.4	4.2	10.0	6.0	2.1
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791225	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	14.5	15.3	7.1	8.4	7.4	20.7	15.6	6.8	10.2	16.9	7.2	15.4	11.4	16.3	1.6	20.6	17.1	4.1	13.4	7.0	6.6	16.7	25.2	11.7	9.5	8.9	7.3	18.2	24.1	3.9	13.7	5.4	7.3	18.9	2.8	3.0	17.7	5.0	16.7	24.6	18.4	2.8	7.0	19.6	16.9	40.2	7.7	8.1	18.6	3.7	3.7	15.5	16.8	9.4	29.9	28.3	8.1	29.0	2.3	3.7	26.9	9.8	5.7	9.9	7.6	44.4	13.9	30.2	36.1	3.9	11.5	18.9	7.3	9.5	1.5	22.7	63.6	20.3	15.4	16.9	14.2	45.0	56.2	8.6	10.0	11.3	7.8	1.3	6.8	19.8	53.2	0.0	5.4	38.0	38.8	45.9	28.4	10.7	76.9	19.4	17.0	38.1	4.2	20.7	27.9	28.6	10.3	17.0	19.7	1.9	12.1	36.1	9.4	14.3	25.2	43.1	42.6	83.4	66.9	29.3	13.9	46.1	16.4	8.3	20.1	5.8	21.5	30.2	24.7	15.2	16.4	20.3	29.8	19.0	21.2	21.5	2.2	27.9	25.3	30.9	20.1	16.3	7.1	7.4	6.8	10.2	7.0	6.6	8.9	7.3	7.3	7.0	7.7	9.4	7.2	9.6	10.0	2.6	19.9	14.7	19.3	16.7	25.6	6.6	7.7	10.2	3.0	7.2	9.7	1.8	12.5	18.3	9.3	14.4	7.9	12.4	48.8	6.7	8.3	9.2	7.7	25.2	4.2	22.4	17.7	10.9	18.3	8.2	35.5	7.7	4.6	7.5	14.8	11.8	5.0	12.8	4.1	7.2	9.1	10.9	12.8	10.6	5.4	1.9	6.9	4.3	14.4	1.5	4.8	12.0	10.3	6.4	12.3	8.6	12.8	7.2	6.2	11.1	19.7	15.8	9.8	55.0	10.7	16.1	12.8	21.8	13.5	9.8	15.9	12.7
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578523	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	1.5	1.9	1.1	0.5	1.2	0.4	1.5	1.2	1.5	1.6	0.9	1.4	0.6	1.5	1.7	1.7	1.3	0.6	2.7	1.1	1.2	2.7	2.0	1.0	0.8	1.2	1.2	1.8	1.7	1.2	1.5	0.6	1.3	1.5	0.8	1.0	1.6	0.5	1.7	1.5	1.3	0.5	1.2	1.3	1.6	2.3	1.1	0.7	1.6	1.1	0.8	1.7	1.5	1.4	4.1	1.6	1.6	1.0	0.5	1.0	2.3	0.9	1.4	1.7	1.5	2.1	3.6	4.6	2.1	0.6	4.6	1.2	1.7	2.4	2.3	1.2	1.3	1.2	0.9	2.6	1.6	3.0	0.2	1.2	3.5	1.6	5.7	1.8	2.4	3.9	5.4	1.7	2.7	3.0	4.3	5.8	2.8	3.3	3.4	2.3	1.7	5.3	3.2	2.1	1.6	4.4	1.9	4.2	3.6	2.3	1.9	2.6	1.7	2.5	2.0	1.8	2.6	3.0	3.8	4.9	2.3	4.3	2.9	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	1.1	1.2	1.2	1.5	1.1	1.2	1.2	1.2	1.3	1.2	1.1	1.4	4.5	6.4	3.9	4.6	7.6	5.1	11.0	5.6	10.2	10.0	8.6	10.2	9.2	5.7	6.6	11.0	4.2	9.1	4.5	3.3	7.9	13.3	32.8	11.3	7.2	4.6	9.6	5.0	3.5	16.2	8.8	4.6	5.1	11.0	13.4	10.2	4.2	9.3	6.7	3.3	5.1	5.0	10.2	5.0	3.7	24.9	4.4	5.6	3.6	5.6	5.2	15.4	11.3	4.5	9.7	15.7	6.8	3.8	5.6	8.1	7.7	17.3	15.3	9.8	13.1	3.4	5.7	12.4	11.0	11.2	4.0	3.7	6.7	7.6	6.3	6.9
DUS4L-BCAP29		ENSG00000288558	"DUS4L-BCAP29 readthrough"	Q9UHQ4	7	107563971-107623317	"Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 18.7"									"HPA029215, HPA044301, HPA049694"	Approved		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"		"Cluster 11: RPE1 & U-87MG - Synaptic function"		Cytosol		"HPA029215: AB_10602331, HPA044301: AB_10967460, HPA049694: AB_2680854"																		3.4	2.0	6.7	2.0	7.7	2.9	2.8	7.4	11.4	4.0	4.5	2.6	1.2	4.2	2.0	2.1	1.7	1.3	3.3	7.6	6.3	2.0	2.5	3.9	1.3	6.9	6.5	2.1	0.8	2.4		1.7	7.0	2.0	3.4	3.3	0.8	2.5	5.7	5.8	1.3	3.6	6.7	2.1	1.5	2.4	7.0	1.9	4.3	4.9	1.9	2.0		7.8	7.2	2.8	4.0	1.3	3.0	4.9	1.3	5.7	6.1	4.6	2.9	2.2	3.6	1.9	3.5	5.8	2.1	2.4	3.1	5.1	5.5	2.4	4.3	5.0	2.5	2.0	4.6	6.7	3.2	2.9	3.0	7.4	2.7	5.2	7.2	3.3	7.6	1.8	6.0	3.0	4.9	7.1	2.2	1.7	3.0	3.1	4.4	6.1	5.3	2.0	1.2	6.1	5.3	5.1	4.9	2.1	1.5	6.5	8.8	9.1	2.3	11.0	13.2	2.4	5.0	3.3	18.7	6.3	5.3	5.8	0.4	1.0	0.3	1.1	0.4	0.3	0.4	0.6	0.8	0.5	0.3	0.6	0.0	0.3	1.5	0.5	0.7	0.3	6.7	7.7	7.4	11.4	7.6	6.3	6.9	6.5	7.0	6.7	7.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742089	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 19.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 102.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	3.8	2.4	4.3	5.2	7.4	25.0	6.0	7.7	5.3	4.5	4.7	8.0	1.4	3.6	1.2	6.0	6.4	6.6	2.6	4.5	4.5	1.4	32.9	6.2	9.1	7.1	6.0	1.6	17.0	1.2	1.2	3.8	5.8	2.7	4.1	14.9	6.3	0.9	22.9	6.1	3.9	8.9	3.8	6.1	2.5	3.1	9.0	5.6	4.4	3.6	7.6	6.1	2.7	13.5	15.2	6.4	0.5	0.4	45.4	22.6	0.5	10.1	25.9	16.2	12.5	0.3	4.2	11.6	3.3	26.1	11.9	102.3	2.2	9.8	14.0	30.5	1.2	20.4	3.0	1.8	10.6	9.1	13.3	31.9	7.0	17.6	17.8	7.5	0.6	3.0	2.1	4.0	16.0	0.3	1.8	7.2	1.5	3.2	0.7	1.1	28.5	0.9	5.7	9.1	37.4	3.0	1.3	1.2	43.6	5.6	2.1	5.5	3.6	8.1	2.2	12.6	12.4	6.8	5.1	6.2	12.8	4.1	8.9	8.2	5.5	0.3	4.5	4.6	3.9	0.8	2.9	3.1	7.0	0.9	1.0	1.7	0.5	19.7	1.9	0.2	16.9	2.2	4.3	7.4	7.7	5.3	4.5	4.5	7.1	6.0	5.8	3.8	9.0	13.5	4.9	0.0	1.7	2.6	21.7	50.9	13.5	13.6	25.6	6.0	42.4	18.7	4.7	14.3	19.2	3.7	20.9	2.8	39.0	3.1	0.0	35.9	61.1	57.9	6.6	6.7	43.9	2.5	0.3	9.1	3.7	7.9	4.6	53.7	133.5	0.2	1.8	53.6	22.3	1.7	30.9	17.7	69.2	9.7	46.9	7.1	24.8	26.0	23.2	2.8	14.1	14.3	17.5	17.1	50.5	26.2	0.8	12.8	9.9	11.0	0.4	1.1	18.5	34.2	0.0	33.7	5.3	9.7	3.2	16.7	41.3	3.4	47.0	28.7	3.6	16.5
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	13.3	9.6	12.1	9.1	12.5	30.9	14.1	14.3	14.6	13.8	12.1	12.9	7.6	14.3	8.9	10.3	12.5	6.7	9.4	12.0	12.4	14.4	9.4	11.4	13.8	12.2	12.2	13.6	13.6	8.2	9.5	11.2	12.3	11.0	10.5	13.2	10.9	9.5	7.4	10.9	12.4	11.0	12.3	14.1	11.5	6.7	12.0	11.7	12.1	7.3	13.0	13.1	11.5	13.3	32.6	28.2	33.1	21.7	17.2	18.5	30.4	25.9	33.7	39.2	29.9	42.1	28.2	19.9	25.7	31.9	24.4	22.7	26.0	32.0	38.0	25.5	22.0	17.8	27.7	28.4	36.4	38.6	17.1	25.4	34.6	34.1	61.0	22.2	27.6	27.2	31.7	20.9	28.3	30.0	22.7	43.2	52.1	35.2	43.1	32.2	32.0	32.9	22.2	39.3	20.6	43.6	21.9	36.2	44.1	36.2	31.3	43.6	19.3	33.3	30.8	26.3	55.6	35.3	31.0	47.0	20.3	38.1	33.3	32.0	16.9	13.7	18.4	19.5	22.9	19.2	20.8	17.8	22.0	20.0	19.6	21.8	6.8	28.4	12.2	10.0	19.5	12.9	12.1	12.5	14.3	14.6	12.0	12.4	12.2	12.2	12.3	12.3	12.0	13.3	22.9	19.2	12.8	8.1	25.5	13.6	14.4	25.9	25.6	15.9	13.4	16.1	5.0	8.6	15.6	7.3	8.4	21.7	26.4	4.8	21.5	22.2	4.2	7.4	13.7	18.4	11.3	16.2	11.9	24.3	22.7	17.3	11.7	7.2	18.3	18.7	18.5	8.2	20.5	10.1	14.8	9.8	8.2	20.6	16.2	1.2	8.7	15.4	10.6	10.3	22.1	15.8	33.0	12.1	14.4	21.2	6.5	17.7	27.5	17.1	8.6	18.5	7.0	19.6	0.0	13.2	24.5	13.9	12.6	18.2	13.1	17.6	23.5	16.4	12.1	12.0
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 210.5"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 273.9;Early spermatids: 288.8;Late spermatids: 979.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;REH: 16.0;SH-SY5Y: 4.3;SK-MEL-30: 4.0;U-2 OS: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.7	5.9	5.3	0.2	7.6	0.1	3.4	10.7	7.5	5.9	4.9	1.8	0.5	3.4	9.0	1.0	1.5	0.7	7.8	4.8	7.7	50.0	0.7	1.6	0.6	17.1	8.7	5.2	2.4	13.0	8.7	0.7	8.1	6.6	0.1	0.6	2.1	3.0	0.9	1.2	1.5	0.3	7.8	2.7	2.3	210.5	7.6	0.3	9.6	0.3	0.2	2.5	2.7	8.8	0.2	0.2	0.1	1.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	4.8	0.1	1.0	1.9	0.2	2.6	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	16.0	1.8	0.1	0.0	0.0	2.1	4.3	2.6	0.0	4.0	0.1	1.1	0.9	0.0	0.0	3.6	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.6	10.7	7.5	4.8	7.7	17.1	8.7	8.1	7.8	7.6	8.8	2.9	0.0	0.0	1.3	0.8	0.6	1.3	0.0	0.0	0.6	3.6	4.4	2.5	1.5	0.0	18.4	4.2	0.0	0.4	0.1	273.9	2.4	288.8	0.6	4.0	2.2	1.8	0.0	1.7	1.0	0.1	2.9	1.5	0.6	0.0	7.0	1.8	0.1	0.6	6.7	2.6	0.4	0.0	0.6	1.9	979.4	8.7	1.2	7.2	0.0	0.6	2.9	0.0	3.0	4.7	0.6	0.0	10.9	0.0	0.9	0.0	55.3	0.1	0.3	0.0	2.5	3.3	121.5	6.0	0.3	0.1	0.1	0.3	7.5	0.7	0.4
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12473282-12562863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 114.9;Oligodendrocytes: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.7;RT4: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	9.3	47.8	4.9	7.8	8.3	3.6	15.0	7.7	5.3	12.2	6.3	11.3	13.6	11.3	6.2	12.7	10.5	8.0	7.2	4.8	6.0	7.6	33.3	12.0	6.4	7.3	8.1	10.7	18.8	8.0	12.9	5.5	6.2	19.7	10.9	7.5	14.6	3.4	11.3	11.1	13.1	4.9	5.4	6.8	13.2	7.1	6.7	15.2	8.8	4.7	9.0	10.7	17.0	11.8	4.5	6.5	7.6	4.2	2.8	3.3	13.6	2.6	5.8	6.4	9.1	18.1	8.6	0.4	1.4	2.9	11.3	2.9	14.1	2.4	8.6	14.4	7.0	0.7	6.8	19.2	5.4	1.3	3.0	2.8	6.7	5.1	16.3	6.8	5.0	7.3	4.0	11.8	0.4	8.6	1.7	0.9	37.7	11.1	1.9	2.0	2.6	8.6	3.6	34.3	12.3	11.5	10.6	13.6	6.7	28.2	5.5	2.2	4.5	2.9	8.3	1.8	2.9	8.3	10.6	1.5	3.8	2.9	4.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	1.6	0.7	0.1	0.0	0.5	0.3	0.8	0.0	0.0	0.0	3.9	0.3	4.9	8.3	7.7	5.3	4.8	6.0	7.3	8.1	6.2	5.4	6.7	11.8	9.6	28.9	55.5	30.3	3.3	2.8	14.9	1.5	3.4	4.8	23.8	13.1	11.5	20.0	9.7	3.7	2.1	10.5	5.6	35.7	0.0	14.3	1.3	15.1	10.2	9.2	49.6	0.0	19.5	24.6	4.1	9.9	11.7	19.9	23.5	114.9	7.5	34.2	5.3	6.7	24.8	10.0	2.0	9.4	1.9	2.3	5.9	5.7	5.4	38.4	2.9	36.8	0.0	56.3	196.3	20.9	25.3	6.8	4.3	34.3	25.4	5.2	10.4	4.8	0.0	11.1	10.3	3.0	5.8	6.2	1.8	30.1	27.9	9.9	18.7	24.5
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	1.1	1.4	1.3	0.8	2.4	0.3	1.1	0.0	2.7	1.2	0.1	1.4	1.4	1.4	3.5	1.4	3.2	1.3	3.1	3.8	0.1	1.8	1.1	1.3	1.0	0.1	0.0	1.6	0.9	1.6	1.2	1.0	0.0	1.5	1.0	1.2	0.9	1.9	1.6	1.3	1.1	1.9	0.0	1.6	3.9	3.7	0.0	1.2	1.7	1.7	0.7	1.1	0.6	0.4	0.1	1.6	1.8	0.9	2.5	1.4	0.0	0.7	1.1	2.9	1.0	1.5	1.9	0.6	3.8	0.8	2.1	0.2	3.8	0.5	2.3	3.9	1.8	7.1	1.1	1.0	1.0	1.8	4.2	1.1	0.3	1.3	0.7	1.8	1.5	0.0	2.2	1.0	1.8	0.6	3.4	1.6	1.5	0.6	1.2	3.3	2.9	0.2	0.6	0.7	2.3	0.9	2.6	1.1	2.0	0.1	0.5	0.6	1.3	1.6	1.3	1.1	0.6	1.3	1.6	0.0	2.0	0.3	2.4	0.7	0.1	0.6	0.6	0.2	0.6	1.1	0.5	0.8	0.1	0.5	0.7	0.7	0.3	0.7	0.1	0.4	1.0	0.3	1.3	2.4	0.0	2.7	3.8	0.1	0.1	0.0	0.0	0.0	0.0	0.4	2.5	0.0	3.2	0.7	1.6	1.0	1.3	1.1	3.4	1.8	2.1	2.7	8.3	1.5	1.8	1.8	2.1	2.0	0.8	1.5	5.9	0.9	15.2	17.7	2.3	3.3	2.4	0.0	9.9	0.7	1.5	1.7	3.6	1.5	1.3	3.0	2.9	1.9	0.6	1.7	7.8	1.9	0.0	0.8	0.3	6.0	1.8	2.2	0.0	1.0	1.1	4.8	2.1	4.0	3.1	0.6	3.4	2.6	0.3	0.7	2.2	2.9	15.7	1.5	0.0	1.9	4.4	15.5	3.8	2.3	1.6	0.7	1.2	3.6	1.8	1.1
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 270.6;U-266/70: 130.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	36.9	16.4	25.6	27.7	29.1	23.7	33.0	27.4	28.8	31.6	21.2	47.8	22.5	28.9	12.2	45.7	25.9	21.3	42.1	25.1	27.1	32.4	32.7	38.5	32.4	32.3	28.5	19.6	40.8	13.2	21.2	27.3	30.3	23.2	16.1	7.8	30.4	15.1	52.3	41.4	33.7	22.0	28.0	43.9	32.7	44.9	29.3	15.0	28.1	37.7	30.5	30.3	36.8	42.7	13.7	8.3	17.3	25.9	19.5	21.5	22.8	9.9	8.0	8.6	10.3	8.8	15.1	28.4	23.3	10.3	18.3	9.4	21.9	18.3	6.1	68.6	25.1	19.3	7.1	24.7	9.9	7.0	24.4	16.2	54.1	6.2	11.3	14.1	24.8	24.0	18.3	92.2	7.2	8.2	10.3	25.1	10.4	10.0	18.7	20.2	11.7	270.6	16.2	5.8	29.7	11.6	8.5	3.4	29.6	37.4	17.6	8.9	34.2	7.7	10.1	7.8	6.0	130.0	98.6	40.0	3.0	19.0	17.7	36.4	32.5	13.6	8.6	26.5	6.2	40.4	6.7	9.1	33.5	33.3	6.1	8.8	21.8	5.9	25.1	28.8	15.9	19.6	25.6	29.1	27.4	28.8	25.1	27.1	32.3	28.5	30.3	28.0	29.3	42.7	45.5	16.0	21.3	5.5	53.7	26.5	22.0	33.3	14.2	5.7	19.4	17.5	40.8	10.0	30.7	5.5	0.0	10.8	51.1	11.7	21.5	24.2	13.4	18.6	8.2	33.4	9.5	8.2	8.5	51.4	7.7	21.9	15.3	12.9	33.0	8.8	21.8	25.0	30.1	0.0	6.1	14.7	32.6	38.6	43.0	20.5	15.5	47.1	46.2	21.5	78.4	14.9	36.0	7.1	25.9	29.2	12.4	9.4	59.7	16.5	23.2	18.2	39.7	3.2	26.3	11.6	22.8	34.5	73.8	42.5	37.1	6.6	21.3	6.8	15.4	27.9
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	75.0	122.4	29.1	15.4	31.5	20.5	99.9	32.0	38.5	57.6	30.0	46.3	26.7	55.0	15.5	82.0	52.3	13.4	36.1	31.8	31.4	199.1	189.3	55.3	10.4	32.0	30.1	35.6	76.8	34.6	20.8	5.9	32.1	55.3	13.9	8.1	152.4	15.3	65.4	61.1	42.9	12.0	32.8	39.2	39.7	18.2	31.3	15.2	58.8	16.6	9.1	45.1	53.6	31.0	39.5	42.2	0.3	0.2	39.5	33.5	0.4	15.8	13.0	18.4	14.3	17.3	44.7	0.1	90.9	17.6	4.2	1.5	10.8	14.5	10.0	9.9	4.6	54.4	14.7	0.0	58.6	33.3	40.4	142.8	38.3	12.1	43.0	13.2	71.0	0.1	25.2	19.4	26.3	72.5	3.5	1.4	71.3	71.6	58.7	0.1	0.0	18.8	22.7	6.9	17.8	39.4	28.6	63.0	78.5	7.3	40.6	51.7	51.7	15.3	0.8	1.9	0.2	13.5	34.8	0.5	25.8	26.5	11.7	111.8	181.7	229.1	97.9	153.4	54.6	60.5	72.7	92.8	261.3	43.7	44.0	65.1	185.6	100.5	105.6	59.2	70.8	112.2	29.1	31.5	32.0	38.5	31.8	31.4	32.0	30.1	32.1	32.8	31.3	31.0	100.4	41.7	58.7	3.3	23.8	74.6	129.2	151.8	100.7	8.5	110.6	112.1	29.5	95.8	122.2	51.5	6.2	16.1	28.4	97.7	262.2	210.7	48.3	47.5	30.8	155.8	35.4	37.5	1.4	458.5	29.2	31.2	32.1	130.9	54.5	66.1	75.0	249.4	170.3	1.7	0.5	124.9	91.6	94.3	72.9	8.4	26.4	92.2	42.7	4.7	58.9	74.8	69.0	1.0	4.4	208.4	112.2	15.8	14.6	121.5	140.4	800.7	54.8	10.0	13.1	16.0	34.9	5.4	19.9	123.2	74.4	5.7	43.6	72.3	109.5	116.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240565256	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 39.7;Spermatocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 8.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.5	2.4	1.6	1.3	1.7	5.4	1.7	3.0	1.8	2.2	0.5	2.5	1.1	2.1	1.7	3.1	2.6	0.8	3.4	1.3	1.7	3.2	3.2	2.2	1.9	1.7	1.2	2.2	3.0	0.9	3.9	0.6	1.4	3.5	1.0	1.2	2.8	0.8	9.8	2.0	3.6	0.6	1.1	4.7	2.7	6.2	1.5	1.1	3.5	4.0	1.5	2.3	2.2	2.0	1.0	0.8	1.1	1.4	0.7	0.4	1.3	1.0	0.6	0.8	0.5	0.5	2.4	1.7	0.6	0.6	1.3	3.1	0.9	0.3	0.7	2.2	4.0	2.1	2.2	1.3	0.5	1.6	3.7	1.0	0.9	0.6	0.6	1.6	0.4	2.3	1.6	1.9	0.7	1.1	1.7	2.5	0.9	1.4	0.9	2.3	2.4	2.1	0.6	1.6	2.8	1.5	0.9	1.1	1.3	0.7	1.2	2.2	1.0	1.9	1.6	1.3	1.0	8.2	2.1	2.8	1.2	1.0	1.5	8.9	1.1	0.5	1.2	0.7	1.4	1.0	1.2	1.3	0.6	1.8	1.4	1.2	1.9	1.5	0.7	1.9	0.9	0.9	1.6	1.7	3.0	1.8	1.3	1.7	1.7	1.2	1.4	1.1	1.5	2.0	5.7	0.0	4.5	1.3	11.4	3.7	7.7	4.7	6.2	6.7	12.3	10.0	13.8	10.0	3.8	12.9	4.2	7.8	18.4	11.0	15.6	5.1	35.2	11.2	5.5	4.1	8.4	8.8	3.8	5.8	4.8	4.3	14.8	10.2	7.0	6.2	3.3	8.6	11.5	8.4	4.9	9.8	6.1	10.0	6.1	39.7	3.1	13.6	7.2	1.9	10.5	9.9	23.7	2.5	3.6	4.4	10.4	1.5	16.8	8.0	15.7	15.6	11.7	6.8	6.6	4.1	7.2	45.8	18.7	10.7	5.4	7.0	14.9	7.6	11.2	8.7
DUSP29	"DUPD1, DUSP27"	ENSG00000188716	"Dual specificity phosphatase 29"	Q68J44	10	75037836-75058514	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 71.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042964	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"					"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.9	0.0	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056571	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 109.8;hTERT-HME1: 92.6"	"Low region specificity"	"Detected in all"							HPA073007	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	13.1	10.0	23.3	7.6	28.4	3.6	11.5	19.5	27.5	27.0	7.5	8.4	4.1	14.6	3.9	64.1	10.1	8.7	22.2	24.2	21.2	10.6	5.2	24.9	10.2	25.8	27.2	8.7	7.0	6.2	7.2	14.1	22.3	11.5	3.8	2.6	13.2	7.9	23.1	65.6	7.9	6.7	19.5	26.2	9.1	12.0	27.2	8.1	9.1	20.5	10.8	13.5	45.5	38.4	21.3	4.4	5.2	11.9	16.4	14.1	6.2	21.0	39.8	20.4	14.7	5.8	10.6	5.8	5.7	31.3	10.3	24.6	19.8	76.0	13.8	5.0	8.1	27.8	10.9	10.3	13.3	25.1	16.2	14.8	109.8	26.5	92.6	14.1	19.8	16.8	16.2	16.4	16.5	5.9	18.7	35.2	12.9	5.9	37.6	15.5	4.5	15.6	8.5	9.1	6.5	19.0	9.4	8.5	14.9	4.2	3.0	59.4	26.0	39.1	25.3	41.7	65.4	7.9	7.9	9.3	21.7	41.5	12.7	0.9	3.4	1.7	5.3	10.3	7.2	0.9	6.3	3.8	4.7	0.5	4.5	4.1	1.3	2.5	10.3	7.1	4.5	1.7	23.3	28.4	19.5	27.5	24.2	21.2	25.8	27.2	22.3	19.5	27.2	38.4	17.0	9.6	1.1	0.0	2.9	117.3	31.5	13.5	21.1	4.9	6.6	7.2	18.9	0.0	5.2	0.0	0.0	0.6	13.4	1.6	1.9	3.1	1.7	2.9	8.1	18.7	2.4	1.7	5.5	2.6	4.3	7.8	0.5	2.8	0.0	1.3	23.6	0.9	8.1	0.0	4.4	2.5	0.0	16.7	12.0	0.5	8.7	9.0	21.4	5.6	10.3	0.9	9.2	5.5	20.2	12.1	1.3	4.9	1.6	17.5	0.6	1.3	1.5	1.0	26.3	3.3	8.6	3.5	5.5	51.6	135.2	1.2	7.3	4.1	3.4	29.3
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554051-1572271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.6	2.1	3.5	0.2	3.0	1.0	6.0	0.3	8.1	5.1	0.0	11.3	0.0	8.4	0.6	1.4	8.7	0.5	17.0	5.0	0.1	5.4	3.6	9.5	0.3	1.9	0.4	2.4	15.7	0.2	25.5	0.1	0.1	5.1	0.3	1.6	6.1	0.2	13.3	4.3	6.8	1.2	0.3	3.1	8.3	3.1	0.7	0.2	3.7	0.0	0.1	3.6	4.2	2.0	0.6	0.3	0.4	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.6	0.6	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.1	0.3	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	2.5	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	1.4	1.7	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.3	8.1	5.0	0.1	1.9	0.4	0.1	0.3	0.7	2.0	14.9	3.2	1.1	0.0	6.3	9.8	8.1	2.7	2.8	113.6	32.1	24.3	6.0	14.3	3.2	12.9	47.9	0.3	11.1	57.8	1.9	7.7	0.3	31.5	24.7	6.5	42.3	0.0	11.1	11.3	0.5	4.3	8.6	65.6	0.0	0.4	1.4	0.6	0.5	90.9	11.3	32.6	6.1	0.0	3.4	0.2	0.6	4.7	5.4	2.8	1.0	22.3	1.0	3.0	5.2	11.0	22.4	0.4	4.7	17.4	19.1	1.6	2.8	35.5	6.6	8.0	15.1	0.8	0.6	2.2	4.8	5.9	10.5	0.7	25.0	14.2
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
DUXA		ENSG00000258873	"Double homeobox A"	A6NLW8	19	57154021-57167485	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059358	Uncertain					NA	NA						"Cluster 34: Spermatids - Unknown function"			"HPA059358: AB_2683989"															"unprognostic (2.34e-1)"			0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.3	0.3	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349418	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 230.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011538, HPA073607"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB011538: AB_2093326, HPA073607: "	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	32.8	49.9	50.6	11.8	44.4	9.6	34.0	32.0	71.4	42.9	23.1	50.4	28.8	37.6	8.3	65.0	42.7	11.7	74.9	51.6	31.9	38.2	56.8	35.4	9.5	42.2	37.7	43.0	63.9	21.2	43.7	15.0	35.4	39.4	5.8	8.1	61.8	14.3	230.1	51.5	32.4	7.9	31.9	28.9	53.1	61.9	37.9	6.8	38.3	69.9	4.7	43.6	46.2	41.1	81.5	40.7	16.5	35.2	15.7	19.1	40.5	48.3	22.8	37.3	18.7	31.7	99.3	25.3	70.8	21.5	20.6	48.9	13.2	49.1	5.8	31.4	76.6	14.4	78.4	58.1	33.6	22.5	21.7	16.3	29.6	50.2	34.2	31.7	12.9	33.9	56.5	17.5	15.6	32.6	21.8	37.4	26.3	29.0	154.3	36.9	13.0	44.7	27.5	12.6	64.3	43.8	23.3	62.6	66.6	5.9	34.8	37.4	25.8	21.2	55.0	82.4	82.2	27.6	12.1	32.1	62.2	31.3	13.7	0.1	0.3	0.0	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.1	50.6	44.4	32.0	71.4	51.6	31.9	42.2	37.7	35.4	31.9	37.9	41.1	20.5	19.2	14.8	12.1	4.4	13.8	5.5	8.8	6.2	33.2	19.0	16.3	25.5	8.6	10.1	7.3	6.2	10.7	6.9	32.1	3.9	11.3	1.1	13.4	14.2	12.0	12.1	1.3	11.0	20.4	14.9	11.5	31.6	18.8	1.3	15.8	6.1	21.8	5.1	32.0	10.2	17.6	4.1	5.7	6.8	3.0	13.1	4.9	7.2	9.4	2.6	23.5	1.0	6.0	14.3	52.3	20.8	10.5	5.1	16.6	21.0	5.8	9.1	22.1	13.1	12.2	10.8	14.2	13.3	15.3	15.5	11.4	4.5	25.4	24.3	12.6
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225342-7234517	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	18.2	20.7	15.1	11.4	17.2	14.8	18.1	15.6	17.9	31.7	15.2	22.6	12.9	29.6	10.5	23.0	22.3	14.1	13.8	14.7	14.9	16.3	10.6	15.0	16.7	17.1	16.3	33.9	12.8	17.6	26.0	14.7	16.2	24.7	8.6	14.4	17.8	18.0	16.5	28.8	16.7	18.1	15.0	16.1	14.4	16.4	16.1	22.2	20.1	11.5	13.0	22.1	25.9	19.0	31.0	43.9	52.2	52.0	39.0	35.0	22.5	21.1	38.1	50.0	63.7	37.5	25.6	43.8	31.3	23.5	39.0	43.5	43.5	28.6	19.0	43.6	50.3	28.5	46.0	40.0	68.0	16.0	23.7	52.5	48.2	47.2	25.7	35.0	20.9	50.5	24.6	20.0	30.6	28.9	61.6	16.1	17.8	20.7	17.1	89.5	33.8	26.8	27.8	26.9	22.9	46.4	38.3	18.9	46.7	23.5	27.4	22.1	17.6	28.0	25.1	52.8	39.6	31.1	28.0	20.4	32.6	23.8	44.4	13.5	4.2	10.2	10.0	4.9	8.3	8.5	7.0	9.0	5.0	9.3	8.0	8.5	1.9	7.2	4.9	7.0	4.5	6.2	15.1	17.2	15.6	17.9	14.7	14.9	17.1	16.3	16.2	15.0	16.1	19.0	11.7	9.6	12.1	12.4	13.1	17.5	22.6	20.9	21.6	15.7	13.2	14.4	7.7	5.7	15.0	18.4	25.0	21.3	11.8	11.2	5.9	11.3	0.9	8.8	12.9	10.5	13.2	6.5	11.2	10.4	15.9	15.7	7.7	13.5	14.7	18.4	9.7	4.9	14.6	10.1	9.4	14.3	24.4	6.0	9.4	1.9	26.1	7.6	10.6	2.8	9.3	13.1	14.4	10.6	10.4	7.2	9.9	22.2	5.9	17.1	10.8	5.5	9.3	30.0	13.1	16.0	14.9	18.4	34.2	21.7	19.2	36.5	11.5	18.4	19.6	15.0
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155377-184173614	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	35.2	28.1	16.4	18.7	17.4	18.6	29.8	17.4	18.9	39.0	15.9	46.0	17.2	44.7	16.1	30.3	34.5	22.6	35.0	16.4	17.1	25.7	20.0	31.7	13.9	18.1	17.3	42.0	25.6	17.9	24.4	38.3	17.6	29.1	16.1	22.8	25.6	25.8	34.9	33.8	27.1	31.7	16.6	25.6	27.9	15.1	17.0	12.4	30.0	22.3	15.9	36.6	31.6	18.3	47.9	13.6	36.4	41.4	37.5	37.8	95.0	28.4	28.9	32.7	27.6	43.6	18.3	33.6	73.3	37.0	32.4	40.8	29.6	22.2	23.4	54.0	32.2	38.1	21.3	28.2	56.6	21.2	27.8	38.4	39.9	23.4	27.3	55.9	24.6	21.6	38.9	44.2	35.5	46.5	28.3	25.2	32.8	34.6	22.1	49.9	42.7	30.0	31.7	36.2	36.3	51.0	34.9	39.8	67.4	35.8	98.7	26.8	25.0	29.5	28.5	31.0	43.8	48.3	38.8	37.0	30.0	22.4	23.6	0.1	0.6	1.3	0.6	1.0	0.8	0.7	0.4	0.7	0.6	0.5	0.5	0.3	0.9	0.4	0.3	0.8	0.2	0.4	16.4	17.4	17.4	18.9	16.4	17.1	18.1	17.3	17.6	16.6	17.0	18.3	15.9	25.6	14.1	16.6	10.8	18.7	15.7	12.9	15.9	20.1	23.5	16.5	26.9	12.8	17.2	22.0	27.1	34.4	14.6	40.8	23.5	13.3	12.8	23.2	30.9	15.9	34.3	6.9	11.4	16.6	21.6	22.6	32.6	27.7	17.1	29.7	19.2	20.5	20.3	62.2	11.8	22.3	12.2	16.2	14.4	47.5	33.5	17.4	12.4	14.0	10.8	19.7	14.4	9.0	11.5	20.7	18.9	37.2	13.9	20.8	25.2	18.3	13.4	18.5	19.7	23.6	27.1	10.6	12.4	20.4	21.7	52.1	10.3	21.9	21.5	25.7
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
DYDC1	"bA36D19.5, DPY30D1"	ENSG00000170788	"DPY30 domain containing 1"	Q8WWB3	10	80336105-80356755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 126.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA037790, HPA037791"	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA037790: AB_10805351, HPA037791: AB_10796215"	"unprognostic (8.95e-2)"	"unprognostic (8.28e-3)"		"unprognostic (7.11e-2)"			"unprognostic (3.12e-1)"	"unprognostic (1.87e-1)"		"unprognostic (1.90e-1)"				"unprognostic (9.96e-2)"	"unprognostic (7.95e-2)"			0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.1	0.1	0.2	2.2	0.0	0.0	0.2	1.5	0.0	5.6	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	126.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.2	0.5	0.1	0.1	0.2	0.2	0.5	0.7	0.2	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	15.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	83.5	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	36.3	0.0	6.6	0.0	0.3	349.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"fallopian tube: 97.4"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 182.5;Respiratory ciliated cells: 324.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;NTERA-2: 3.2;SCLC-21H: 2.9;SH-SY5Y: 1.9;U-2197: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.1	0.1	1.6	0.1	2.6	0.8	0.3	1.7	2.1	2.2	5.3	0.3	0.1	1.8	4.5	0.5	97.4	0.3	0.0	2.1	2.4	0.3	0.6	4.6	0.0	5.5	5.7	0.1	0.8	0.3	0.8	0.3	3.7	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	5.9	0.0	0.3	10.8	3.7	0.2	0.2	0.0	0.1	0.0	0.1	3.6	0.1	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.8	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	3.2	0.0	0.0	0.9	0.2	0.8	0.0	0.0	2.9	1.9	0.0	0.0	0.3	0.8	0.0	1.4	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	2.6	1.7	2.1	2.1	2.4	5.5	5.7	3.7	5.9	3.7	3.6	0.0	0.0	3.1	0.3	0.0	0.0	0.1	20.6	0.0	0.0	0.3	0.1	0.2	0.0	29.6	0.0	0.0	0.0	0.1	0.1	1.9	0.5	61.4	182.5	1.6	0.1	0.0	0.0	0.8	0.5	0.0	0.9	0.0	2.4	0.0	1.3	0.0	0.6	0.1	0.0	0.3	0.0	14.2	0.0	0.3	30.4	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.3	0.0	0.1	324.1	0.0	0.0	0.2	4.3	8.5	3.1	0.1	0.0	0.0	0.4	0.2	0.0	0.1
DYM	"DMC, FLJ20071, SMC"	ENSG00000141627	Dymeclin	Q7RTS9	18	49036387-49461347	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043551, HPA049187"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus"		"HPA043551: AB_2678547, HPA049187: AB_2680668"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (3.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (5.26e-5)"	17.9	19.2	17.3	14.8	19.6	24.0	23.3	24.9	20.4	24.9	24.4	20.7	15.8	19.8	20.2	25.3	18.6	17.7	21.1	16.7	20.4	21.1	19.7	15.7	17.0	22.8	21.1	29.4	80.7	28.6	9.9	14.6	24.5	20.6	16.8	36.0	36.6	22.0	49.6	18.2	14.1	25.1	19.0	12.7	16.6	44.0	19.1	33.0	32.6	46.0	20.7	23.2	22.3	23.9	32.9	19.8	30.6	47.0	56.9	63.9	24.1	32.2	42.1	37.7	36.8	14.6	20.7	102.1	27.8	60.1	27.9	41.0	48.1	42.1	46.0	38.6	24.7	23.8	16.9	43.4	56.7	83.5	41.5	50.1	49.1	44.1	112.7	63.3	59.0	51.6	25.7	60.5	30.4	35.0	56.5	35.5	9.8	27.1	15.2	29.2	39.2	48.3	34.8	37.2	56.5	36.5	21.9	26.1	30.2	34.5	36.7	29.8	32.6	35.6	16.9	15.5	18.9	67.8	52.7	57.4	19.1	51.6	40.5	20.9	26.9	32.7	20.2	23.4	27.2	17.0	19.3	18.7	29.2	13.9	19.6	15.2	11.9	30.6	20.6	8.4	21.4	21.4	17.3	19.6	24.9	20.4	16.7	20.4	22.8	21.1	24.5	19.0	19.1	23.9	16.0	6.4	6.9	113.6	29.1	11.6	20.4	8.1	29.0	20.1	17.9	15.4	24.5	17.2	8.4	3.7	6.2	19.5	17.4	10.5	13.7	18.1	353.4	11.6	17.2	16.3	16.2	17.9	173.2	20.3	22.2	20.6	17.3	14.8	16.5	23.3	14.3	11.5	16.7	21.9	204.1	15.1	6.1	23.0	15.1	176.1	27.7	20.5	3.6	149.9	19.7	16.1	24.7	167.9	299.4	14.7	11.4	27.1	23.8	25.0	16.1	22.5	13.4	24.9	13.1	22.4	15.4	49.8	16.2	19.4	11.4	35.2	21.6	18.1	16.2	20.2
DYNAP	"C18orf26, FLJ39106"	ENSG00000178690	"Dynactin associated protein"	Q8N1N2	18	54587757-54599493	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"esophagus: 29.3"	"Cell type enriched"	"Detected in single"	4	"Squamous epithelial cells: 1.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011148	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA011148: AB_1845609"		"unprognostic (9.88e-2)"		"unprognostic (2.51e-2)"		"unprognostic (1.75e-3)"				"unprognostic (1.45e-1)"					"unprognostic (8.09e-3)"			0.8	0.4	1.7	0.6	1.3	2.2	0.6	2.2	2.4	0.6	0.0	0.6	0.6	1.0	2.1	29.3	0.5	0.6	1.0	1.4	1.8	0.9	0.8	0.5	1.1	0.9	0.4	0.8	0.4	0.3	0.0	0.4	1.2	0.3	0.7	2.6	1.9	0.5	0.8	1.1	0.5	0.8	0.1	2.4	0.4	1.0	1.5	0.3	0.5	0.4	1.9	0.3	0.2	2.4	0.5	0.2	1.3	0.6	0.6	1.4	1.3	0.3	0.5	1.0	1.0	0.7	0.5	0.7	0.5	0.6	1.1	0.5	0.9	0.0	0.5	0.2	0.2	0.2	0.9	0.4	0.5	0.7	0.6	0.6	0.1	0.9	0.3	0.3	0.2	0.6	1.0	12.9	0.1	0.2	0.5	0.4	2.0	0.2	0.3	0.5	1.5	0.6	0.3	0.7	0.5	0.7	0.2	0.3	2.4	0.9	0.4	0.8	2.2	0.4	2.4	0.5	0.4	0.5	0.4	1.0	0.6	0.3	0.3	0.3	0.3	0.6	0.2	0.3	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.8	0.2	0.8	0.2	0.0	0.0	1.7	1.3	2.2	2.4	1.4	1.8	0.9	0.4	1.2	0.1	1.5	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964573-102056443	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		490000	"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	22.4	19.3	7.8	4.9	7.2	9.2	18.2	16.1	10.9	17.2	0.0	29.1	3.6	24.6	5.0	18.5	17.5	4.0	29.7	9.2	1.1	12.6	9.4	19.9	4.4	5.2	4.3	21.0	15.8	2.0	20.9	3.0	9.0	14.5	3.1	13.2	19.9	2.9	53.1	27.6	19.2	3.1	0.6	14.2	19.7	13.0	2.1	2.0	17.6	1.2	2.4	23.4	18.0	9.2	3.3	6.6	5.0	4.6	3.0	5.0	3.2	3.0	1.8	5.1	4.5	2.6	4.5	4.2	3.4	5.4	4.9	4.0	8.2	5.3	3.6	3.4	3.5	4.1	15.1	3.3	2.7	3.6	6.4	6.4	6.3	14.1	4.9	3.2	3.9	8.0	3.0	8.9	4.5	4.2	5.6	4.1	5.1	2.1	10.2	4.6	3.3	1.6	5.2	7.6	8.4	2.8	3.2	2.2	3.4	4.9	2.5	1.5	11.5	6.8	4.1	11.5	5.1	4.3	7.6	4.9	9.1	2.9	3.0	1.3	0.6	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.5	0.3	0.5	1.2	0.4	0.6	0.6	0.4	0.3	7.8	7.2	16.1	10.9	9.2	1.1	5.2	4.3	9.0	0.6	2.1	9.2	102.1	125.0	84.7	83.9	55.9	52.4	46.4	75.0	51.2	126.4	63.1	55.5	182.9	31.5	89.1	77.3	139.7	49.6	106.3	94.2	13.7	112.6	14.8	123.6	131.0	93.7	71.3	38.1	127.3	81.2	42.9	86.5	86.6	134.6	33.5	117.9	46.1	36.7	40.2	183.4	131.0	68.0	75.3	52.7	123.6	16.8	70.5	90.7	71.2	51.5	99.2	63.3	73.2	51.8	93.3	131.3	73.6	71.5	100.0	47.6	82.6	48.5	90.7	115.4	85.5	81.4	106.1	87.1	72.2	59.2	64.1	37.4	91.3	86.1	64.4	46.5
DYNC1I1	"DNCI1, DNCIC1"	ENSG00000158560	"Dynein cytoplasmic 1 intermediate chain 1"	O14576	7	95772506-96110322	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 457.5;Inhibitory neurons: 374.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 213.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 14.0;SH-SY5Y: 10.3;U-266/84: 9.5;WM-115: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061689	Enhanced	Supported				NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA061689: AB_2684586"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (3.79e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-4)"	"unprognostic (2.25e-4)"	"unprognostic (1.63e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.10e-2)"	2.5	12.7	27.0	1.5	30.2	1.1	2.7	36.3	53.8	2.4	18.5	19.1	1.4	2.7	5.0	3.4	2.6	2.0	19.0	30.9	34.2	2.2	0.3	1.0	0.8	36.1	41.6	7.8	2.0	0.6	19.6	0.8	52.5	7.4	3.0	27.4	1.4	8.2	9.6	2.6	2.3	3.6	7.6	1.4	5.5	2.4	13.4	3.8	2.9	12.4	0.6	19.8	3.5	31.0	0.4	0.3	0.1	1.3	0.2	0.1	0.5	0.2	0.0	0.7	0.2	1.7	1.1	0.5	14.0	1.9	1.0	0.6	4.9	0.3	0.3	0.1	1.1	3.5	0.6	0.0	0.1	0.4	4.6	0.2	0.3	0.3	0.5	0.6	0.3	2.1	0.6	0.5	2.2	3.2	0.4	0.6	0.9	0.3	2.9	0.8	0.4	2.0	1.8	1.6	1.8	10.3	0.1	0.2	2.3	7.5	1.0	0.9	0.4	4.0	2.8	2.2	2.2	7.3	9.5	0.4	4.6	0.5	9.2	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.2	1.4	0.6	0.1	0.8	0.2	0.2	27.0	30.2	36.3	53.8	30.9	34.2	36.1	41.6	52.5	7.6	13.4	31.0	1.6	0.0	0.0	21.5	0.2	0.8	1.3	0.0	1.2	49.6	3.6	1.3	30.9	0.0	0.0	0.0	50.1	1.3	0.0	0.0	0.0	0.3	6.8	22.3	1.7	4.2	1.8	0.0	457.5	1.1	0.1	6.7	0.0	24.4	0.0	3.8	15.0	0.5	0.5	1.7	374.1	0.0	0.0	0.3	0.8	5.2	19.0	3.0	21.4	30.9	0.1	83.5	0.0	91.0	213.8	0.9	0.0	11.7	1.4	0.7	0.0	0.3	0.0	24.8	6.6	19.4	9.1	1.2	4.0	0.4	1.1	0.1	0.4	1.2	0.0	0.6
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171750158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	65.1	58.5	89.2	44.4	121.1	23.1	65.3	122.6	185.9	62.3	70.4	62.3	54.3	74.5	51.0	68.3	47.1	58.6	65.9	89.2	101.4	80.0	41.3	51.7	38.7	130.5	116.2	71.7	38.7	68.2	29.4	76.2	124.1	59.9	64.7	63.5	46.7	60.3	51.0	48.8	51.0	80.4	104.0	41.4	49.3	55.9	112.9	60.0	56.3	57.7	47.4	72.3	53.3	155.5	87.5	55.0	167.0	61.9	151.2	144.0	94.2	149.2	115.7	122.9	133.7	96.5	84.4	79.2	127.7	178.8	168.0	86.2	132.5	143.5	159.8	30.1	59.7	69.3	65.7	109.6	75.5	80.0	71.7	113.0	133.4	152.3	97.3	171.7	219.1	76.5	112.1	21.3	246.1	54.4	68.9	65.7	77.0	127.0	55.5	68.7	149.8	58.3	163.3	138.0	105.8	116.6	82.7	65.6	90.6	126.0	64.1	77.3	238.3	185.9	91.9	75.2	90.9	26.3	54.0	64.5	126.8	64.2	139.2	209.6	93.9	49.2	50.7	98.0	54.3	77.2	58.1	59.4	68.7	71.1	51.7	49.5	5.8	64.4	100.1	111.8	66.2	39.6	89.2	121.1	122.6	185.9	89.2	101.4	130.5	116.2	124.1	104.0	112.9	155.5	146.2	198.7	60.6	30.3	49.2	50.6	59.2	138.5	19.9	73.1	101.7	87.1	75.4	158.7	124.8	169.2	64.6	101.9	46.3	169.5	131.0	207.6	129.5	118.2	147.3	117.1	84.3	95.2	102.4	161.5	107.5	91.2	42.8	172.6	102.3	69.3	174.9	150.7	101.1	80.8	104.9	140.0	116.0	148.1	39.8	48.0	128.6	75.9	35.6	45.9	156.2	91.3	70.0	35.7	182.4	189.2	126.9	138.0	22.7	44.7	139.2	270.3	108.0	128.9	111.7	61.4	111.0	248.4	95.2	43.2	60.0	115.6	46.7	60.6	123.9	58.5
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525974-32570858	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol		NA	NA		23000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	17.9	11.3	16.3	17.8	17.3	37.4	21.3	23.9	23.2	15.3	12.9	15.6	13.6	18.6	12.4	15.7	16.3	16.1	48.6	17.0	20.7	21.2	18.7	19.2	20.4	19.2	17.0	16.6	17.8	21.4	13.6	13.0	22.7	20.6	15.7	39.7	11.8	13.8	46.6	35.0	15.0	22.4	14.8	19.5	14.3	40.8	18.2	22.7	14.5	35.2	20.6	19.9	14.1	17.5	40.1	42.2	64.5	40.7	36.2	42.4	177.7	60.4	82.8	106.4	86.9	45.2	33.7	49.7	39.9	61.5	50.6	20.1	65.4	47.3	100.8	47.7	45.5	66.2	28.9	40.7	44.4	75.6	36.9	34.5	37.1	75.3	58.4	38.8	69.8	55.9	75.8	44.6	57.9	32.0	58.2	33.7	66.8	38.1	56.1	50.7	34.4	51.8	44.2	36.0	27.6	41.1	42.4	52.1	47.0	51.2	43.7	43.9	52.3	58.2	48.9	51.2	61.6	32.0	87.1	80.7	32.7	64.5	46.6	33.1	29.5	26.6	10.3	35.4	11.0	13.0	11.1	11.7	33.0	13.4	7.8	10.3	62.7	16.4	59.0	18.0	13.7	28.9	16.3	17.3	23.9	23.2	17.0	20.7	19.2	17.0	22.7	14.8	18.2	17.5	48.6	25.6	28.3	20.5	49.4	43.0	30.9	40.7	40.5	48.0	30.9	28.8	95.7	11.5	40.2	14.7	18.8	34.9	53.8	14.2	46.9	50.5	102.6	65.8	54.9	39.3	30.9	48.8	43.6	46.5	36.6	37.6	25.0	66.8	17.1	29.2	23.6	28.8	39.4	65.6	55.0	23.0	26.4	35.9	54.2	39.9	26.1	50.7	28.4	28.1	80.0	37.2	34.0	25.6	33.5	56.1	20.0	28.6	28.7	23.4	18.9	61.9	44.3	81.9	46.0	36.7	44.9	192.0	169.5	23.7	50.2	11.1	40.8	39.9	16.8	15.0
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751609	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 311.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049538, HPA057201"	Approved		Approved	Centrosome,Cytosol		NA	NA		21000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome	Cytosol	"HPA049538: , HPA057201: AB_2683366"	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	60.9	44.9	225.7	39.2	240.6	42.4	44.1	207.1	311.6	46.2	131.4	70.5	43.3	50.7	40.6	50.6	37.7	48.7	59.4	184.1	202.3	43.0	29.1	45.9	27.0	228.5	228.0	45.5	44.7	65.7	35.6	46.8	226.2	52.7	61.1	37.3	48.6	49.9	42.3	51.3	44.6	64.9	244.5	36.3	50.2	34.1	221.3	24.6	61.6	49.9	28.8	45.7	40.8	265.1	52.5	54.0	79.1	71.0	100.1	98.3	71.6	84.5	67.1	67.5	87.0	73.4	50.6	21.9	64.6	83.3	49.1	74.1	61.2	60.4	98.2	14.9	43.9	27.0	68.1	70.6	55.5	29.0	38.5	64.8	80.6	77.8	53.4	94.3	96.2	22.4	44.4	28.0	88.8	37.5	18.1	37.5	47.5	58.4	93.0	39.4	166.3	26.5	67.2	73.3	78.8	54.9	152.1	32.6	100.6	56.5	39.7	28.8	123.2	86.9	43.3	43.0	58.2	35.3	27.4	43.0	74.6	27.7	55.8	13.6	16.6	16.6	12.3	9.9	14.2	4.8	10.4	10.2	12.2	9.4	8.7	8.4	15.7	9.3	14.5	7.6	11.4	8.7	225.7	240.6	207.1	311.6	184.1	202.3	228.5	228.0	226.2	244.5	221.3	265.1	117.9	102.5	120.4	44.1	29.5	66.2	63.1	66.1	52.3	82.5	54.8	51.2	48.3	54.3	93.8	27.6	33.3	61.3	47.2	114.0	7.9	85.7	112.6	77.6	68.5	97.6	106.1	28.4	50.9	58.1	62.0	66.7	52.5	87.4	36.7	87.5	62.4	33.3	30.6	107.7	45.4	78.6	65.1	39.9	53.7	66.8	63.3	36.8	69.4	34.7	37.8	116.0	35.0	51.3	106.9	101.7	56.7	80.5	37.3	83.6	60.0	49.4	105.0	61.4	118.3	93.4	87.0	103.0	51.1	53.6	69.9	84.8	32.2	61.2	66.7	95.8
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109410-103479863	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	4.2	3.0	5.0	1.2	5.2	0.3	3.5	5.6	10.2	5.1	14.6	3.2	1.6	4.6	3.7	1.6	6.5	3.2	2.0	4.1	6.1	3.7	0.8	2.8	0.9	8.3	8.9	5.6	2.9	6.7	6.8	1.4	6.3	2.6	0.7	10.5	2.6	2.5	0.8	2.8	2.1	2.3	5.5	1.9	2.2	7.9	6.7	1.8	4.6	1.5	0.7	3.3	3.0	5.9	1.3	2.7	7.0	3.3	9.5	21.2	0.4	4.0	6.4	6.5	7.0	1.6	1.5	0.0	5.5	8.0	3.1	5.5	5.5	7.7	5.3	0.0	4.6	1.2	4.8	0.2	9.3	2.2	1.3	13.6	2.8	14.9	16.9	10.3	2.7	1.4	0.2	0.0	8.6	5.4	0.7	0.7	1.9	0.0	7.7	0.0	5.9	0.1	7.5	0.9	4.6	3.6	6.5	1.7	3.1	1.7	6.8	1.5	6.4	7.9	3.3	7.7	3.0	0.0	0.0	0.1	2.3	6.7	2.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	5.0	5.2	5.6	10.2	4.1	6.1	8.3	8.9	6.3	5.5	6.7	5.9	12.7	0.0	13.1	173.7	2.3	6.6	13.4	17.3	9.6	25.9	8.2	9.7	10.1	4.3	18.0	27.6	112.6	0.3	2.1	0.2	1.9	7.0	26.1	124.0	43.7	11.1	17.3	1.3	164.7	3.4	0.5	32.0	5.6	7.5	3.8	15.4	9.3	0.8	2.5	32.0	101.8	1.0	4.1	0.8	5.8	11.1	20.8	3.1	8.8	45.0	0.9	16.5	1.0	86.0	72.6	10.5	2.9	18.4	3.3	4.9	0.9	16.9	171.0	85.1	19.7	40.8	18.5	90.6	11.6	5.0	5.5	0.5	5.0	23.5	1.7	5.9
DYNC2I1	"CFAP163, DIC6, FAP163, FLJ10300, WDR60"	ENSG00000126870	"Dynein 2 intermediate chain 1"	Q8WVS4	7	158856558-158956747	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 45.7;Cardiomyocytes: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020607, HPA021316"	Approved		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA020607: AB_1858817, HPA021316: AB_2215577"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	13.0	7.4	5.7	5.5	4.0	5.6	9.9	6.5	12.3	9.4	16.3	13.4	9.2	9.1	9.3	6.5	13.6	7.0	15.1	3.9	3.7	8.2	3.7	8.8	5.3	5.5	2.5	9.8	5.9	12.8	9.0	6.8	4.7	6.8	6.1	14.1	8.2	6.3	24.1	7.0	10.2	7.3	0.2	7.5	8.0	40.1	4.7	5.8	10.9	10.0	3.5	9.7	7.7	9.1	15.2	15.0	10.4	25.0	7.9	7.6	4.6	9.4	8.3	7.6	8.2	7.3	13.5	6.0	14.3	5.8	9.3	7.1	4.8	10.1	8.5	6.5	9.6	8.0	10.2	3.3	8.0	9.2	17.8	6.3	7.4	5.9	2.5	17.9	6.3	4.3	24.4	3.3	8.9	8.9	15.4	8.2	9.1	5.7	9.7	13.7	10.7	7.3	12.7	7.7	20.8	14.7	19.1	11.5	11.4	9.0	8.4	5.6	7.8	9.5	3.4	31.2	6.9	8.7	10.2	12.9	26.0	8.8	14.4	49.8	8.6	4.7	13.5	5.7	11.9	21.5	10.5	11.3	5.4	22.7	10.1	10.3	5.3	10.3	5.8	42.6	5.4	2.6	5.7	4.0	6.5	12.3	3.9	3.7	5.5	2.5	4.7	0.2	4.7	9.1	45.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	15.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	13.7	11.7	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	11.5	1.8	0.0	0.0	0.0
DYNC2I2	"bA216B9.3, CFAP133, DIC5, FAP133, MGC20486, WDR34"	ENSG00000119333	"Dynein 2 intermediate chain 2"	Q96EX3	9	128633653-128656847	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Cytotrophoblasts: 89.8;Extravillous trophoblasts: 95.3;Hofbauer cells: 21.9;Syncytiotrophoblasts: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 35.8;naive B-cell: 52.9"	"Lineage enriched"	"Detected in all"	5	"B-cells: 52.9"	"Cell line enhanced"	"Detected in all"		"MCF7: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	14.4	49.9	15.7	11.4	15.4	33.2	20.1	14.3	20.1	28.2	30.5	26.7	22.2	22.4	8.9	37.9	30.5	11.1	41.4	15.4	18.9	61.8	39.1	25.1	12.0	17.0	19.4	19.1	36.7	21.2	36.1	11.0	16.4	31.0	10.3	4.5	31.9	14.0	11.1	24.0	27.7	6.3	16.5	23.6	26.3	69.8	16.6	23.8	55.6	4.3	9.5	19.2	23.7	14.7	112.7	202.8	49.8	78.8	11.4	16.1	141.4	46.2	32.9	66.5	42.8	96.6	197.3	40.4	32.4	30.8	62.0	169.4	47.5	50.8	16.6	93.5	40.1	24.0	134.8	52.0	13.9	41.5	39.4	8.0	25.0	66.3	18.9	24.0	46.5	112.6	83.5	34.0	36.4	432.4	151.3	106.1	63.7	97.3	121.0	157.2	66.6	136.8	42.1	36.0	125.1	100.1	143.9	135.9	36.8	13.7	230.5	40.7	28.3	75.9	114.8	95.6	90.7	34.6	100.7	39.6	71.4	41.9	74.0	1.7	1.1	0.4	1.4	1.6	2.3	35.8	2.9	3.9	2.8	52.9	1.1	1.7	0.8	4.5	5.7	11.0	5.7	3.8	15.7	15.4	14.3	20.1	15.4	18.9	17.0	19.4	16.4	16.5	16.6	14.7	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	89.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	95.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	37.4	0.2	0.0	0.0	0.0
DYNC2LI1	"CGI-60, D2LIC, DKFZP564A033, LIC3"	ENSG00000138036	"Dynein cytoplasmic 2 light intermediate chain 1"	Q8TCX1	2	43774039-43810010	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 197.5;Respiratory ciliated cells: 133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062905	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA062905: AB_2684899"	"unprognostic (3.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.60e-2)"	16.2	23.2	20.2	7.5	21.3	6.8	32.6	16.1	23.6	28.3	34.9	15.4	19.0	35.6	46.6	11.0	53.4	20.7	15.5	20.0	21.9	50.2	13.4	23.4	10.2	20.4	19.3	39.7	16.2	42.2	31.2	13.6	18.7	20.8	17.9	44.0	16.3	20.0	10.2	15.8	16.3	19.8	17.9	11.0	17.1	44.9	21.3	10.8	34.3	8.5	9.7	15.0	13.9	20.6	21.2	12.0	20.5	13.1	32.5	64.5	17.6	11.5	24.8	13.3	12.4	4.0	14.4	12.0	24.8	15.2	17.0	13.8	9.9	16.5	15.4	15.4	21.1	9.4	5.5	15.3	31.3	18.7	14.8	38.3	23.4	26.5	12.1	40.6	18.5	14.1	29.0	5.6	18.7	10.8	9.2	20.6	9.4	27.3	12.0	12.2	19.0	3.8	110.1	18.0	14.0	25.1	13.0	7.1	15.5	19.4	19.7	16.9	13.1	11.6	10.5	14.4	9.8	21.0	12.3	3.0	25.8	4.7	12.6	14.8	2.3	2.1	1.7	3.9	1.8	3.7	2.2	2.4	3.1	2.1	2.7	2.3	0.8	2.6	3.1	1.8	1.4	1.4	20.2	21.3	16.1	23.6	20.0	21.9	20.4	19.3	18.7	17.9	21.3	20.6	11.9	19.2	16.8	58.1	6.4	9.7	18.2	42.9	7.4	21.7	19.3	22.4	13.9	21.5	31.3	53.3	29.2	19.7	2.3	10.2	90.1	21.7	197.5	71.7	42.2	8.1	12.7	5.5	96.8	22.0	9.1	27.8	15.3	24.2	17.7	26.2	14.6	7.3	12.4	16.8	64.9	20.3	50.8	4.5	5.3	39.4	33.2	5.9	23.2	22.5	3.3	29.3	4.1	33.7	43.4	14.5	32.1	33.8	4.7	9.6	52.4	84.1	133.8	36.9	19.7	14.8	14.8	102.1	15.9	9.1	9.1	9.3	4.9	30.1	17.5	12.8
DYNLRB1	"DNCL2A, DNLC2A, ROBLD1"	ENSG00000125971	"Dynein light chain roadblock-type 1"	Q9NP97	20	34516414-34540958	"Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009845	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB009845: AB_2093671"	"unprognostic (2.23e-1)"	"unprognostic (7.60e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (9.10e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.00e-1)"	168.7	208.4	430.4	96.9	440.2	113.7	163.7	416.5	552.8	163.7	400.8	228.4	113.8	193.0	204.9	155.4	198.5	117.1	275.7	448.5	454.1	265.8	122.0	169.4	123.9	444.7	443.3	153.9	115.0	222.9	204.3	154.6	436.7	180.9	128.2	171.7	142.1	170.7	222.8	222.1	156.4	158.7	416.1	143.0	166.7	66.6	422.8	154.3	174.4	224.5	135.1	191.4	158.8	458.8	244.4	317.6	259.4	207.3	307.5	294.9	175.4	264.1	393.5	399.2	340.7	853.3	231.1	135.6	327.4	402.0	385.5	215.3	282.2	391.6	265.9	164.5	198.8	463.2	286.8	679.1	345.7	217.5	249.6	251.4	250.4	320.2	245.7	306.2	282.2	255.8	195.1	249.0	415.5	313.4	314.7	427.4	148.6	284.7	345.2	158.6	359.6	220.2	618.7	160.8	264.2	273.9	382.9	631.9	359.4	249.2	362.5	240.7	251.9	500.8	122.4	351.2	295.8	208.8	310.3	157.3	430.1	186.7	225.0	225.4	112.5	221.2	88.0	123.1	88.8	144.2	145.6	117.2	128.8	127.3	101.4	102.1	111.4	132.4	144.3	161.2	238.7	135.0	430.4	440.2	416.5	552.8	448.5	454.1	444.7	443.3	436.7	416.1	422.8	458.8	188.4	169.9	106.5	26.1	107.9	146.8	176.8	215.9	100.2	105.4	136.0	200.3	125.5	170.1	157.4	292.4	58.4	297.8	112.9	283.9	481.3	264.4	34.0	266.4	139.5	170.9	226.7	98.2	34.7	223.4	211.4	149.1	85.1	208.5	159.0	149.8	162.4	104.1	287.9	80.8	30.0	284.6	256.3	127.8	131.5	51.0	234.9	139.1	193.9	19.7	236.2	435.8	148.3	20.1	61.4	317.5	379.3	240.3	117.0	240.4	388.9	781.8	253.1	127.6	203.8	101.8	210.8	65.6	77.2	106.3	150.0	342.3	124.9	90.9	160.5	184.3
DYNLT3	"TCTE1L, TCTEX1L"	ENSG00000165169	"Dynein light chain Tctex-type 3"	P51808	X	37836757-37847571	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 738.3;Glandular and luminal cells: 265.2;Late spermatids: 445.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003938	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"			"HPA003938: AB_1847920"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.69e-2)"	29.0	60.8	25.9	17.7	27.7	27.1	24.4	26.4	35.1	33.3	22.4	23.7	12.1	32.7	25.4	63.6	18.7	37.4	32.0	30.4	39.1	50.3	44.9	24.7	14.7	35.0	33.4	23.0	13.9	40.3	23.4	26.4	38.1	27.2	22.2	33.1	19.2	27.7	12.6	11.4	14.9	37.2	26.5	18.4	23.5	16.9	30.1	14.8	26.5	18.2	21.9	32.8	30.7	26.6	48.2	13.9	1.4	0.1	58.1	67.0	7.5	32.0	35.0	17.7	29.2	25.8	25.2	16.9	15.5	65.5	51.2	18.9	20.1	27.5	34.8	28.7	23.4	13.4	66.0	13.6	29.1	0.0	9.5	29.3	38.4	43.2	19.1	53.0	55.3	0.0	6.9	23.9	82.5	15.7	0.4	20.8	8.1	24.7	69.2	24.0	0.1	27.9	32.4	34.7	30.8	13.1	58.9	12.0	97.7	2.8	14.7	14.3	29.8	36.7	19.9	43.0	36.7	15.9	15.4	19.7	88.8	22.0	46.4	20.6	9.5	7.3	17.2	14.0	35.9	17.5	24.0	22.9	6.3	12.3	20.5	20.2	7.6	16.5	8.7	7.3	14.7	14.7	25.9	27.7	26.4	35.1	30.4	39.1	35.0	33.4	38.1	26.5	30.1	26.6	62.0	38.5	28.9	6.2	37.8	15.4	121.8	48.7	10.8	28.2	38.9	20.8	31.8	25.8	46.8	64.4	2.1	12.5	31.9	26.0	133.1	53.8	738.3	80.4	75.6	47.4	55.7	8.6	22.9	46.9	29.1	64.7	42.8	265.2	87.6	15.4	42.8	34.0	38.2	70.7	24.8	18.4	85.5	31.5	80.0	445.7	44.1	42.5	42.7	12.2	49.0	57.2	28.8	7.1	7.6	102.1	28.0	103.4	22.9	116.7	20.2	143.6	53.0	50.8	39.5	53.2	81.6	13.1	5.8	74.7	22.7	45.4	68.0	27.4	17.7	118.8
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 156.7;Inhibitory neurons: 158.4;Microglial cells: 176.1;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	23.1	20.4	17.8	22.5	19.9	71.4	22.3	29.9	20.7	23.9	22.2	22.2	18.7	26.6	22.0	18.8	22.6	19.9	28.9	21.3	19.2	19.9	19.8	22.3	30.1	12.1	14.7	29.6	21.5	27.8	20.2	23.0	13.3	18.8	21.6	27.8	21.3	19.2	49.4	24.2	21.7	24.1	12.8	30.4	22.8	29.9	18.6	45.8	25.7	45.2	26.7	24.3	21.1	20.9	23.5	18.2	36.3	25.6	17.1	18.8	32.7	20.8	26.0	20.3	22.0	25.7	19.7	31.7	13.8	37.0	27.1	15.8	27.3	21.2	24.4	49.7	11.6	93.6	30.9	16.1	26.5	36.9	32.3	18.7	24.3	26.5	41.2	23.5	22.3	44.2	36.4	70.4	22.2	23.6	49.3	25.9	38.5	24.1	10.8	62.8	19.7	29.6	22.3	30.4	36.5	20.4	47.1	31.6	33.2	12.2	29.9	34.8	27.8	27.6	8.3	17.2	17.4	47.7	41.6	44.9	22.0	41.8	30.7	3.1	0.5	0.8	1.2	0.8	0.7	1.1	1.3	1.0	0.7	1.0	1.4	1.3	2.3	0.5	1.1	1.3	1.3	0.3	17.8	19.9	29.9	20.7	21.3	19.2	12.1	14.7	13.3	12.8	18.6	20.9	36.8	19.2	25.5	114.3	28.8	37.5	24.1	15.7	18.2	32.7	28.3	18.0	73.0	20.0	23.0	11.0	27.1	10.3	43.0	30.1	0.0	13.5	29.7	44.2	39.3	31.9	21.4	26.1	156.7	14.6	12.4	25.2	21.4	71.4	24.7	35.9	27.1	18.1	15.8	47.1	158.4	18.8	14.2	25.0	27.7	22.2	16.1	32.4	24.9	176.1	18.8	16.4	21.6	158.3	157.2	21.2	22.4	19.5	33.8	29.8	17.1	9.9	27.9	21.8	13.1	38.4	32.5	15.3	24.7	24.6	31.7	15.3	36.8	21.3	19.3	37.2
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 133.1;Horizontal cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	9.9	4.6	2.9	14.2	3.3	14.9	6.3	2.3	6.1	7.8	3.2	25.7	20.4	13.1	6.2	10.7	10.0	14.3	24.4	8.6	2.3	4.7	4.2	9.1	21.6	3.4	2.3	8.7	8.6	4.9	3.0	14.1	2.7	6.5	21.9	14.8	5.4	8.8	39.4	7.5	28.0	13.0	3.1	14.7	20.6	5.0	2.7	24.1	6.9	10.4	14.2	11.9	7.6	3.5	24.5	13.4	19.8	14.4	9.7	13.2	15.8	24.2	15.7	11.6	6.6	17.9	13.2	45.3	29.2	35.3	7.1	27.8	16.0	9.6	12.4	19.6	20.9	7.3	9.5	6.9	3.8	16.8	15.2	11.0	13.3	31.4	24.8	19.6	6.6	18.9	9.2	22.9	15.1	13.9	14.4	8.2	17.2	15.8	21.5	37.9	19.7	20.0	13.6	30.2	26.0	30.7	10.1	13.4	13.9	13.3	9.2	13.9	10.0	18.4	17.3	12.8	19.4	10.9	1.9	24.9	17.6	11.1	19.4	2.0	0.3	4.0	3.2	0.7	2.3	1.8	2.3	4.2	1.2	2.0	1.9	3.7	0.4	4.7	0.9	0.5	2.0	1.1	2.9	3.3	2.3	6.1	8.6	2.3	3.4	2.3	2.7	3.1	2.7	3.5	13.0	9.6	10.2	3.9	14.4	11.3	11.9	6.7	8.6	18.0	7.4	8.1	44.5	20.0	11.2	1.8	22.9	3.5	28.6	133.1	0.0	19.0	0.6	28.0	35.9	12.1	24.6	4.8	11.0	18.2	7.9	18.9	25.0	15.6	5.7	13.3	6.4	6.1	17.0	80.8	11.4	62.0	4.1	15.7	22.5	2.0	11.5	15.5	8.8	13.1	12.0	16.7	42.2	6.0	9.1	17.7	61.3	13.2	9.0	16.1	62.9	11.3	30.3	23.3	13.1	53.5	33.6	2.7	10.1	15.6	16.2	4.5	31.0	17.9	32.3	34.4
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 392.2;Late spermatids: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	2.1	4.2	3.9	3.4	4.2	4.6	6.4	5.1	7.6	5.9	4.2	5.4	4.6	5.0	17.0	4.0	5.0	4.4	4.7	4.2	4.4	3.5	4.2	4.7	5.9	4.4	4.5	5.1	3.0	5.0	3.6	6.8	4.8	5.0	6.2	7.7	3.7	7.2	2.2	4.9	4.0	5.1	4.1	6.2	3.2	36.7	4.8	4.3	9.1	4.1	5.4	4.7	2.0	5.7	2.0	3.2	3.9	4.3	5.8	7.1	4.7	2.4	4.8	5.4	5.9	0.6	3.2	6.1	0.3	6.9	3.7	4.2	3.0	4.5	4.2	4.7	6.8	4.2	1.0	3.6	16.4	3.7	3.3	4.9	9.6	3.8	12.4	10.1	7.8	6.5	1.8	6.7	4.9	4.3	3.5	9.1	5.3	1.0	1.8	0.7	2.8	2.6	6.7	1.9	0.0	1.5	0.5	2.4	3.3	8.4	1.9	3.3	0.5	6.3	4.9	0.6	3.1	1.9	2.6	3.8	3.3	5.8	3.3	0.3	1.7	0.8	0.5	1.3	0.6	4.4	0.8	0.9	1.6	3.0	0.8	0.9	0.0	0.7	3.5	0.8	0.7	0.8	3.9	4.2	5.1	7.6	4.2	4.4	4.4	4.5	4.8	4.1	4.8	5.7	13.0	12.8	16.2	11.1	15.8	8.9	13.2	31.2	14.8	20.7	21.2	30.4	23.8	7.2	19.9	16.5	10.4	15.7	16.7	5.2	31.3	25.1	392.2	14.0	22.5	15.5	5.4	12.2	10.3	27.1	12.0	17.3	14.3	13.3	17.7	19.0	8.2	9.8	49.7	13.5	10.4	75.4	14.2	16.1	9.3	393.1	15.2	18.7	16.0	9.4	14.5	19.4	13.4	14.1	16.1	20.1	14.2	31.6	22.9	16.4	7.3	35.6	13.9	21.7	6.6	15.2	17.6	23.7	39.0	20.4	7.5	9.9	12.7	40.6	17.3	11.8
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
DZANK1	"ANKRD64, bA189K21.8, C20orf12, C20orf84, dJ568F9.2, FLJ10600, FLJ30892"	ENSG00000089091	"Double zinc ribbon and ankyrin repeat domains 1"	Q9NVP4	20	18383367-18467281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.8;Endometrial ciliated cells: 35.5;Excitatory neurons: 32.2;Inhibitory neurons: 27.0;Respiratory ciliated cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"THP-1: 25.4;U-266/84: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059478, HPA064255"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA059478: AB_2684033, HPA064255: AB_2685228"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.78e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.81e-3)"	1.2	1.3	3.2	0.8	3.1	2.8	2.7	3.2	4.2	2.2	3.3	1.0	0.4	1.0	0.9	1.0	3.5	0.4	0.7	3.0	3.1	3.3	1.0	1.8	1.0	2.9	3.6	2.1	1.7	1.0	5.7	0.5	3.0	1.7	0.6	3.4	1.2	0.4	0.7	1.7	1.2	0.3	2.3	1.8	1.1	4.9	3.0	0.4	3.8	0.2	0.8	1.2	1.1	3.3	0.3	1.7	1.7	1.5	1.6	1.0	0.3	0.9	0.4	2.4	1.5	6.4	0.8	3.3	0.4	0.8	1.0	0.6	5.5	0.6	1.8	0.4	1.1	1.6	0.9	0.8	1.2	2.6	1.1	0.6	1.0	4.4	0.8	0.6	0.8	1.1	0.1	1.1	0.6	2.7	0.2	1.2	3.6	1.0	0.2	0.8	0.7	0.2	3.4	1.5	1.6	2.2	2.6	1.3	3.1	1.3	1.0	25.4	0.1	2.1	0.4	1.8	1.2	3.6	27.9	3.8	0.7	3.1	0.8	2.6	0.3	0.5	0.1	0.9	0.1	1.1	0.1	0.4	0.3	0.3	0.2	0.2	1.0	0.5	0.7	0.4	0.4	0.2	3.2	3.1	3.2	4.2	3.0	3.1	2.9	3.6	3.0	2.3	3.0	3.3	1.7	0.0	3.6	12.1	6.1	1.5	1.1	1.6	1.8	4.3	7.7	9.7	1.6	1.5	8.8	3.7	16.7	0.5	2.3	1.5	1.9	2.1	25.8	35.5	5.1	1.5	0.0	0.4	32.2	1.1	0.8	2.3	1.5	5.1	3.8	3.8	1.4	0.3	2.3	6.7	27.0	1.2	8.2	3.8	1.8	19.3	0.3	2.5	5.4	5.6	1.1	4.0	1.0	9.0	16.7	2.5	0.3	1.9	4.0	0.7	0.6	4.1	41.9	18.0	0.0	2.6	2.6	11.6	12.4	0.8	1.4	0.3	2.6	3.2	1.9	0.6
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	4.9	1.4	1.7	2.2	2.2	8.8	4.7	5.9	2.1	8.6	15.3	5.0	2.2	8.1	1.9	2.5	12.8	5.7	3.3	2.2	2.3	5.6	1.0	5.7	0.9	5.7	7.4	7.0	6.3	2.7	2.1	2.0	4.2	4.1	1.5	4.6	2.1	3.3	1.0	7.8	2.1	4.6	4.3	2.6	7.2	4.1	2.6	0.4	3.6	0.9	0.7	6.1	5.3	2.2	5.4	3.1	6.1	5.1	3.8	5.1	1.4	8.6	5.1	5.0	6.3	2.0	0.4	0.0	4.3	8.0	7.0	1.7	4.5	2.0	2.4	1.2	4.4	2.4	7.5	0.3	3.1	1.8	4.0	5.4	2.0	5.5	2.6	5.1	2.8	1.4	1.8	0.0	6.9	0.3	0.0	0.8	7.4	0.0	1.1	0.0	7.1	0.0	2.3	8.5	2.1	4.8	8.9	0.0	4.3	3.4	2.3	3.7	2.2	12.3	5.6	6.0	4.5	0.0	0.0	0.1	4.9	2.6	4.8	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.2	5.9	2.1	2.2	2.3	5.7	7.4	4.2	4.3	2.6	2.2	1.4	3.2	2.0	4.2	0.0	3.6	0.6	1.9	7.4	8.6	0.2	2.5	2.9	7.2	7.7	1.8	8.4	0.1	0.0	0.0	5.9	3.8	17.4	58.8	8.5	2.6	0.0	1.3	4.0	1.2	0.1	6.5	7.1	1.1	0.0	7.4	0.0	0.0	1.4	3.3	2.9	0.0	2.0	3.2	2.6	1.8	6.2	3.5	0.0	3.7	0.6	2.7	0.0	2.5	0.2	5.9	0.0	4.1	0.0	0.4	0.0	0.8	74.0	19.4	0.0	7.2	9.8	0.6	2.3	1.7	4.3	0.0	0.5	1.7	0.0	0.1
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589705-108694840	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	5.2	9.7	15.6	4.9	19.4	4.0	5.3	11.8	18.6	5.3	22.6	5.1	3.0	7.9	10.1	3.9	18.7	5.9	11.7	18.8	18.5	10.9	4.3	6.5	10.2	13.3	14.9	10.5	5.3	7.8	24.5	4.9	12.4	9.7	4.7	29.8	3.6	7.0	12.4	3.7	3.9	5.2	10.4	8.3	6.6	34.6	15.5	8.5	12.8	16.2	8.0	5.2	3.4	15.0	9.8	8.2	24.8	14.7	10.7	10.8	8.6	6.1	12.2	10.1	13.9	12.1	6.8	18.0	12.8	6.6	20.9	3.5	13.7	5.3	21.0	6.6	6.1	8.1	3.4	8.5	6.3	3.3	4.5	11.8	2.8	9.4	11.4	10.2	6.4	10.9	8.0	8.7	19.6	8.6	8.2	3.5	15.5	5.0	6.2	10.4	20.5	1.8	8.4	4.7	17.0	16.2	9.8	1.0	11.1	21.6	15.1	2.8	7.6	9.0	13.7	1.8	5.3	9.6	6.0	34.7	6.8	2.7	11.3	6.5	0.5	1.2	4.1	0.8	5.0	6.3	4.2	5.1	0.5	4.6	3.6	4.8	0.1	10.6	1.5	1.5	6.0	1.5	15.6	19.4	11.8	18.6	18.8	18.5	13.3	14.9	12.4	10.4	15.5	15.0	7.3	12.8	12.8	86.8	14.8	7.5	8.6	16.3	9.1	67.8	9.6	8.3	45.0	4.3	26.6	33.1	327.4	21.9	17.1	4.1	13.7	12.9	28.4	106.1	16.0	8.7	52.8	11.1	145.2	9.0	8.8	18.2	9.2	9.2	8.8	30.9	7.5	4.4	9.4	77.4	103.4	6.9	34.6	5.7	7.5	59.9	17.4	5.7	7.2	37.5	10.5	32.9	11.3	79.4	80.6	8.9	4.6	17.7	9.0	6.9	4.5	20.6	218.2	33.7	19.7	16.6	17.7	351.3	112.5	4.4	7.4	14.8	29.4	35.4	7.4	5.6
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675477-33686385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	1.8	5.5	7.1	5.6	7.1	34.3	1.6	5.2	9.2	1.8	3.9	3.8	3.2	1.2	0.2	5.7	1.3	0.7	1.4	6.1	5.6	0.9	1.8	3.7	8.7	7.6	6.4	3.5	1.0	1.3	0.6	2.4	6.5	1.9	3.9	0.7	1.9	0.9	1.6	4.7	4.1	2.8	7.0	5.0	3.7	10.4	6.9	10.7	0.8	0.8	6.9	2.4	2.5	8.3	48.1	45.4	52.0	40.5	5.2	3.6	39.3	45.0	21.4	55.9	46.7	81.1	48.0	87.3	44.2	20.2	67.7	35.4	25.3	23.8	24.8	26.4	36.5	71.6	71.9	47.7	0.4	34.0	43.6	2.8	1.4	30.6	5.4	5.7	14.6	54.4	19.3	60.0	34.9	42.3	72.8	71.6	15.6	47.9	64.6	71.4	140.7	36.2	9.6	28.7	76.7	54.1	54.6	37.6	22.7	14.8	47.3	42.4	7.9	65.0	37.7	45.8	64.8	58.1	42.0	72.6	54.1	20.0	39.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.1	0.1	0.1	7.1	7.1	5.2	9.2	6.1	5.6	7.6	6.4	6.5	7.0	6.9	8.3	1.1	0.0	1.1	0.7	3.6	2.9	1.7	0.5	0.0	2.3	3.1	4.3	0.4	0.0	1.4	0.0	0.0	5.0	2.9	2.4	0.0	0.9	1.0	0.3	1.0	1.6	0.0	25.0	1.5	0.2	9.6	3.0	7.7	1.2	0.0	11.4	0.7	0.8	4.4	0.0	0.5	4.6	2.0	0.6	2.1	3.1	2.1	3.1	1.8	1.0	0.1	1.5	1.0	1.0	3.4	0.6	0.5	1.2	9.7	0.5	1.4	0.1	0.2	2.3	0.0	1.0	3.0	7.5	32.9	3.7	1.7	1.8	3.3	1.2	7.0	3.5
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506438-23531233	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 25.1;esophagus: 8.7;lymphoid tissue: 15.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 50.2;Erythroid cells: 45.7;Late spermatids: 110.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.7;Karpas-707: 38.9;U-266/84: 37.2;U-698: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB016313	Uncertain					NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.2	0.2	0.0	1.8	0.0	25.1	0.1	0.1	0.1	0.9	0.1	3.4	1.5	0.1	0.0	8.7	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.8	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.1	2.1	0.0	0.8	0.0	0.1	3.5	2.1	0.3	0.0	5.1	0.7	3.6	0.1	15.8	0.2	0.0	3.7	0.3	1.9	0.1	5.4	3.9	6.4	10.2	0.2	0.2	4.5	2.5	1.2	2.4	3.1	2.5	3.1	46.7	3.0	1.3	1.1	10.6	12.9	0.6	2.2	11.8	4.2	7.4	10.7	2.8	0.0	5.4	9.3	0.0	0.1	1.7	0.2	0.3	0.7	21.4	5.8	38.9	1.1	3.2	24.3	5.0	1.4	5.8	1.9	26.4	13.7	15.7	0.9	1.4	8.3	11.6	4.3	5.4	1.3	0.8	4.0	3.9	0.5	2.2	6.1	7.0	3.6	28.5	37.2	38.0	2.1	5.8	4.3	4.1	0.2	0.8	0.0	0.6	0.0	0.4	0.3	0.2	0.5	0.3	0.0	0.0	0.1	0.1	0.9	0.4	1.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.8	0.2	0.2	1.8	0.0	1.0	1.3	0.6	0.0	0.3	1.8	0.0	3.4	0.7	14.5	0.0	0.1	50.2	0.3	0.3	0.6	1.2	45.7	0.1	0.0	4.8	1.1	3.1	1.1	0.0	4.2	0.4	0.4	2.3	0.0	0.1	5.9	0.0	3.1	0.8	110.3	0.3	2.7	0.0	1.0	1.4	0.0	0.0	0.5	0.1	0.1	7.3	0.4	14.5	0.6	1.8	0.1	0.0	0.0	0.0	0.1	0.8	2.5	5.2	10.2	1.0	0.5	1.7	0.7	9.5	1.3
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223580-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favorable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	13.5	16.0	7.9	6.6	8.6	11.3	15.1	10.2	13.5	17.5	4.8	16.5	6.2	18.7	1.9	16.1	15.2	3.3	15.3	8.1	7.0	16.1	19.0	13.4	6.8	10.2	8.1	15.9	15.2	4.4	19.0	5.3	10.0	21.3	1.8	3.0	16.0	5.5	19.0	23.6	15.0	2.7	6.1	20.5	14.8	14.4	8.3	6.4	22.6	4.3	2.8	16.1	16.4	9.4	10.9	20.2	8.3	16.4	4.8	4.4	20.0	14.8	6.6	10.0	6.7	32.7	16.2	15.8	15.8	5.7	5.6	14.6	6.8	7.6	1.8	17.2	25.6	11.2	36.1	18.0	9.3	14.2	19.1	6.6	8.5	9.0	4.1	5.6	6.9	13.5	26.7	10.6	3.8	30.1	18.8	30.6	18.7	6.6	18.8	34.7	9.1	27.9	6.2	7.6	21.4	15.5	18.4	21.9	10.7	3.0	19.4	20.0	12.3	12.0	15.7	12.0	12.4	20.7	10.9	32.0	5.0	10.0	12.3	6.8	8.1	11.7	10.2	9.8	8.8	8.2	8.4	9.7	8.8	8.0	9.0	8.4	11.4	6.9	11.8	5.2	11.4	7.5	7.9	8.6	10.2	13.5	8.1	7.0	10.2	8.1	10.0	6.1	8.3	9.4	9.1	16.0	8.2	8.5	14.4	7.1	7.9	12.2	9.1	13.8	12.3	10.8	4.9	5.7	13.9	11.0	37.5	20.4	18.5	26.5	11.7	11.1	19.6	12.6	10.2	10.3	25.8	6.5	8.1	10.5	17.2	8.7	31.1	11.6	2.5	12.3	6.8	10.5	12.6	30.3	7.2	19.8	20.3	7.3	7.8	5.0	11.5	7.3	7.2	10.3	9.1	11.3	13.4	5.0	5.5	11.1	14.5	16.1	13.2	9.7	15.4	8.0	12.0	15.7	13.1	9.6	11.2	19.0	16.1	7.6	8.9	13.4	11.8	12.6	15.3	6.4
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427598-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.1"	"Group enriched"	"Detected in all"	6	"Early spermatids: 268.7;Late spermatids: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	12.9	9.0	9.2	10.5	8.9	57.1	9.1	7.2	9.4	7.2	7.7	9.0	10.6	7.9	7.6	9.8	7.0	10.4	5.1	10.3	11.1	11.2	19.0	8.3	10.7	9.6	10.3	5.6	9.8	11.8	8.6	10.2	12.3	10.0	9.9	7.7	6.9	6.8	5.3	10.7	10.0	8.3	7.8	9.8	11.4	7.3	10.6	10.6	10.5	5.8	11.1	11.5	5.8	7.9	10.3	16.6	17.1	17.6	9.8	8.3	137.4	14.7	10.5	16.7	16.3	22.7	11.4	28.7	9.3	10.9	10.9	8.6	22.5	13.2	19.2	23.6	16.2	24.8	14.5	20.8	22.1	23.6	19.2	11.0	22.8	24.3	16.2	12.8	16.8	23.1	26.9	20.6	14.1	21.2	23.6	13.2	30.7	19.3	16.9	21.3	14.2	16.0	14.5	17.8	17.6	30.6	18.2	16.7	17.6	21.9	25.2	18.5	16.6	17.5	12.8	15.6	21.8	27.1	58.3	29.7	17.0	27.7	21.1	8.0	7.1	4.6	11.1	5.4	14.3	4.9	9.1	8.7	4.2	3.6	5.4	8.7	6.5	8.1	6.9	9.8	10.9	4.4	9.2	8.9	7.2	9.4	10.3	11.1	9.6	10.3	12.3	7.8	10.6	7.9	11.5	9.6	17.3	6.8	14.2	46.9	9.1	6.0	14.2	8.1	15.8	7.7	4.8	15.7	9.0	12.9	6.2	8.0	29.1	15.5	9.8	8.6	268.7	10.8	16.0	11.8	34.3	7.8	16.4	8.2	14.6	13.9	16.3	14.1	10.2	9.9	12.1	30.4	15.8	21.9	14.0	12.5	12.2	30.7	31.6	389.5	11.5	37.6	23.2	3.7	19.4	5.5	22.6	5.5	10.7	15.6	10.3	12.0	12.2	16.1	16.0	29.7	8.6	6.4	26.3	13.6	11.0	21.5	11.6	17.7	54.3	35.8	22.0	4.3	12.8	19.9
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 71.8;lymphoid tissue: 53.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 104.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA008411	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favorable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	4.3	2.6	2.3	19.5	2.0	71.8	10.0	2.1	3.1	5.5	1.5	10.3	8.9	2.0	4.9	2.7	1.4	5.0	1.7	2.7	2.4	30.2	3.5	4.3	53.6	2.1	2.4	1.0	4.2	3.1	3.3	2.9	2.2	21.0	11.6	1.7	7.6	8.4	0.8	1.0	7.7	3.5	1.4	16.9	8.2	4.6	3.0	7.7	1.7	1.3	43.4	7.8	1.4	2.0	3.5	3.0	2.0	2.5	0.7	2.1	6.0	1.3	0.8	2.4	4.4	5.8	2.0	73.5	1.5	0.3	7.7	5.7	5.0	3.0	6.0	35.8	2.9	42.4	3.0	11.1	1.0	114.9	44.7	1.0	6.9	2.8	2.6	0.0	2.3	10.0	5.0	14.2	1.1	1.0	16.3	15.1	2.9	13.8	2.5	17.1	6.4	11.2	2.4	4.3	2.5	0.6	2.1	2.0	5.7	5.5	1.8	59.9	0.7	1.5	2.4	1.4	3.4	25.4	12.2	93.5	2.8	64.0	4.7	11.9	18.8	42.8	1.4	41.2	2.8	104.4	2.2	1.5	22.5	97.4	2.9	1.6	3.5	1.8	54.7	30.5	2.7	13.1	2.3	2.0	2.1	3.1	2.7	2.4	2.1	2.4	2.2	1.4	3.0	2.0	4.5	3.2	4.2	48.0	73.7	2.4	6.9	25.0	6.2	1.3	5.9	6.6	4.3	0.0	16.5	1.8	4.2	15.5	15.3	2.9	17.6	4.4	36.4	4.3	2.0	2.5	1.2	10.3	17.3	17.6	2.2	4.9	7.7	7.7	10.1	2.5	3.9	1.6	16.5	0.0	28.6	5.7	16.2	32.4	15.7	4.6	5.0	29.8	16.0	8.4	29.5	9.4	6.2	12.1	7.7	4.2	4.7	3.0	144.1	11.1	2.4	128.0	9.1	5.3	0.0	4.5	4.6	37.6	18.1	2.3	2.4	7.7	11.1	2.2	3.5	5.9
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515938-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (3.24e-2)"	37.3	35.8	26.3	24.6	27.0	89.2	51.0	29.7	35.5	33.3	27.1	50.8	35.7	35.0	44.7	29.0	39.4	28.1	29.0	27.1	28.6	42.4	50.2	29.5	37.2	25.9	26.5	49.7	26.7	54.7	21.6	35.2	26.3	33.7	51.7	37.1	36.4	31.2	37.0	46.9	45.6	29.2	28.1	31.3	29.3	23.5	27.1	49.1	45.5	29.3	37.1	31.1	30.0	30.0	37.7	45.1	41.3	24.4	47.8	48.7	64.1	33.8	51.6	41.5	43.1	21.6	48.6	39.1	46.6	41.5	24.7	34.5	30.8	45.1	48.3	49.1	27.1	28.7	31.6	91.7	65.1	51.5	30.4	56.3	56.7	23.8	60.9	54.6	41.7	54.1	28.9	42.0	39.1	88.0	71.4	41.5	24.3	69.4	50.0	44.8	49.5	39.5	50.2	50.3	33.1	36.5	47.8	45.6	76.4	39.4	79.7	32.3	45.2	21.4	18.1	28.1	22.0	52.8	63.1	41.5	20.1	28.0	27.6	139.9	61.9	134.3	65.3	57.8	79.1	107.7	81.9	75.0	54.9	101.0	82.7	75.8	140.2	100.6	80.9	47.8	124.4	80.0	26.3	27.0	29.7	35.5	27.1	28.6	25.9	26.5	26.3	28.1	27.1	30.0	59.8	22.4	53.3	17.0	78.6	46.4	67.2	145.0	74.6	75.6	60.0	70.1	35.4	60.1	78.8	82.8	31.3	125.3	76.3	91.8	174.1	86.6	20.9	82.0	59.6	57.8	66.0	66.7	20.5	84.5	76.5	67.6	26.5	54.8	73.5	98.7	57.5	109.0	58.8	25.2	21.3	112.8	87.5	50.6	33.9	14.9	89.5	47.5	90.7	16.9	71.3	122.0	87.6	17.6	23.1	59.8	102.5	94.4	46.8	61.4	131.5	164.8	102.0	75.7	72.3	69.9	78.7	103.3	38.3	63.8	66.5	189.4	74.2	101.2	98.0	58.2
EARS2	"KIAA1970, MSE1, mtGlnRS"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23520754-23557731	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	3.7	7.6	3.3	1.2	3.5	1.5	4.0	2.7	4.0	2.9	3.6	3.7	1.1	3.7	3.0	5.2	3.0	1.0	5.3	3.3	3.6	4.9	9.9	3.1	1.8	3.3	2.5	3.3	5.6	4.8	3.5	2.5	2.6	3.0	2.3	1.9	4.6	1.4	4.2	5.6	2.9	2.0	1.5	3.3	4.1	3.8	3.5	2.5	4.3	3.8	2.4	3.3	3.3	3.2	2.6	8.3	2.4	4.8	2.9	3.8	3.9	3.2	3.1	3.6	2.4	5.0	2.9	4.8	2.6	3.3	1.8	2.9	9.6	6.4	4.7	2.9	7.7	2.4	5.3	7.1	2.4	3.4	2.1	3.2	4.4	2.4	4.7	4.5	1.4	5.2	7.0	2.5	2.6	5.5	2.1	2.3	7.5	4.4	2.8	4.1	4.5	8.0	5.5	3.8	5.0	4.1	2.1	5.0	2.7	6.3	5.9	3.0	2.3	3.1	2.1	3.1	3.4	5.1	3.7	3.4	4.1	4.0	4.3	0.1	0.8	0.0	1.0	1.5	1.6	0.8	1.4	1.1	1.7	1.0	1.3	1.1	0.4	1.8	1.1	1.6	1.7	1.3	3.3	3.5	2.7	4.0	3.3	3.6	3.3	2.5	2.6	1.5	3.5	3.2	1.8	9.6	5.9	5.2	3.8	2.2	4.0	4.0	4.0	3.8	6.2	4.7	11.6	2.8	2.9	3.7	2.1	15.1	2.3	2.5	5.9	7.0	2.9	3.3	4.9	3.2	5.4	9.4	8.3	3.5	12.3	4.3	4.1	3.4	5.7	6.5	3.6	11.4	7.1	8.4	7.9	4.3	2.0	3.2	2.5	2.5	2.5	3.4	5.4	3.7	5.3	2.6	4.1	4.0	4.7	3.7	1.7	1.9	8.8	4.9	1.6	8.6	5.3	3.9	0.0	2.7	3.4	5.8	9.8	6.5	3.0	11.4	3.3	12.6	6.2	3.2
EBAG9	"EB9, RCAS1"	ENSG00000147654	"Estrogen receptor binding site associated antigen 9"	O00559	8	109539711-109565996	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021153, HPA021154, CAB072810, CAB072811, CAB072812"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"		"CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152"	"unprognostic (3.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.71e-2)"	23.3	28.4	18.6	17.6	19.9	16.9	32.4	23.4	26.3	36.1	19.8	28.6	23.5	22.8	44.7	17.0	27.6	19.4	24.7	19.1	20.5	37.0	45.2	28.1	25.4	18.9	19.0	22.2	36.7	34.9	20.5	18.1	19.0	23.3	31.2	32.5	42.9	27.6	53.2	17.9	21.0	17.0	19.1	20.7	27.2	25.3	19.3	20.6	57.4	42.3	27.0	17.2	15.3	20.2	36.7	25.2	25.3	17.3	15.3	24.9	19.7	19.5	14.6	27.0	25.4	25.7	38.1	51.7	33.0	13.8	21.8	25.2	24.4	31.3	28.5	57.6	26.9	56.9	15.8	39.6	34.3	20.0	16.1	19.9	60.1	23.4	47.2	21.9	25.7	45.8	59.8	37.0	24.0	55.8	58.2	31.5	15.8	70.1	25.2	30.9	20.1	43.7	31.4	23.7	27.6	22.1	21.3	22.6	27.6	18.4	44.7	25.6	17.5	20.9	15.0	19.1	14.4	54.9	38.3	48.7	21.2	52.7	19.6	5.8	13.4	14.7	19.3	19.5	34.1	40.7	27.1	27.0	22.5	40.3	33.5	30.4	2.8	29.4	17.3	23.8	33.4	14.7	18.6	19.9	23.4	26.3	19.1	20.5	18.9	19.0	19.0	19.1	19.3	20.2	32.0	121.8	102.4	12.7	40.2	21.7	28.6	51.8	44.9	34.5	36.8	46.0	37.6	54.3	65.1	29.5	6.2	50.2	24.0	33.6	64.6	47.3	134.7	42.9	26.7	34.5	31.8	36.0	16.1	65.8	34.0	28.8	22.4	33.0	46.9	16.0	23.2	48.8	32.7	50.5	16.1	39.4	50.8	24.7	22.1	115.0	29.2	27.9	19.6	11.2	25.3	53.4	27.8	18.1	16.1	38.5	41.3	23.0	53.8	36.8	50.5	58.5	61.8	34.7	32.9	35.1	32.1	101.6	50.4	40.5	19.9	22.2	28.5	34.7	46.0	31.7
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229523-4237528	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 147.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 485.6;monocytes: 505.7;Syncytiotrophoblasts: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 4.8;memory B-cell: 18.7;naive B-cell: 14.7;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	14	"B-cells: 18.7;monocytes: 6.3"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 218.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046635	Enhanced				"Secreted to blood"	NA	NA	203000	1400000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA046635: AB_2679729"	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	4.7	4.7	3.8	14.6	3.3	1.2	1.7	3.4	5.3	1.5	3.2	3.0	4.3	1.1	0.1	1.0	2.4	5.4	1.4	3.8	3.7	2.1	3.3	2.9	20.2	5.7	4.2	1.3	2.5	0.4	1.7	147.6	5.2	1.8	1.6	0.1	1.8	1.4	0.2	0.6	8.4	2.1	4.5	34.0	3.7	0.9	5.8	9.4	0.9	0.4	7.3	4.8	1.0	6.1	0.1	1.7	0.1	0.0	0.0	0.0	7.3	0.7	4.2	0.4	0.2	1.3	1.2	4.2	16.4	0.0	2.0	0.1	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.2	0.3	0.0	7.7	0.4	0.0	2.1	0.6	1.6	0.1	0.0	0.4	0.5	0.1	0.1	0.0	3.0	0.4	0.0	0.0	0.0	0.6	0.3	2.6	0.0	0.2	0.4	0.0	0.0	0.0	2.7	0.2	0.2	0.9	0.3	5.1	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.1	0.0	0.0	4.8	0.0	18.7	0.0	0.0	0.8	14.7	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.6	3.8	3.3	3.4	5.3	3.8	3.7	5.7	4.2	5.2	4.5	5.8	6.1	0.5	0.0	0.5	0.3	8.4	0.4	0.0	13.3	0.0	0.0	0.2	0.6	0.1	1.5	10.7	0.0	0.0	10.6	0.5	0.0	0.0	2.8	0.0	0.3	0.4	1.3	0.0	0.0	0.6	0.9	485.6	0.7	0.0	0.3	11.4	0.0	1.1	0.1	9.6	0.0	0.4	0.0	6.1	102.6	11.3	0.0	0.0	19.0	0.0	5.6	505.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	2.6	0.1	0.0	0.6	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	336.4	1.0	0.1	0.0	0.1
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.3	1.2	0.5	2.3	1.7	15.4	2.3	1.0	1.1	2.5	1.9	1.8	1.3	2.6	2.4	1.6	2.6	1.3	1.9	0.6	1.2	0.9	1.7	2.7	2.0	1.7	0.9	3.7	2.2	0.7	1.2	2.0	1.9	1.5	2.4	2.7	2.7	0.8	1.4	2.2	2.1	1.5	0.8	2.4	1.9	1.1	1.3	1.5	2.1	0.3	1.7	1.8	2.5	4.4	0.6	0.4	2.6	2.3	0.6	1.4	1.9	1.0	0.2	0.6	0.5	1.3	2.1	1.7	0.4	1.4	0.6	0.9	1.0	1.1	1.3	0.6	0.6	1.1	3.0	1.1	0.3	2.2	2.4	1.4	0.8	1.3	1.3	1.2	0.9	1.4	0.8	2.5	0.7	1.4	1.0	3.0	1.6	0.5	0.7	2.7	0.6	1.0	0.7	2.8	0.6	1.2	0.6	1.1	0.3	1.8	1.7	0.8	1.7	0.7	1.4	2.0	1.6	2.5	1.3	1.3	0.7	2.3	1.3	0.1	0.7	3.3	1.6	0.2	1.3	0.7	1.4	1.4	0.2	1.2	1.2	1.7	1.5	0.5	0.3	1.0	1.9	0.1	0.5	1.7	1.0	1.1	0.6	1.2	1.7	0.9	1.9	0.8	1.3	4.4	4.3	0.0	2.2	0.0	5.8	5.7	12.6	6.7	1.8	5.3	3.2	3.0	1.1	12.8	6.2	3.7	8.4	9.7	5.9	6.8	0.0	3.2	1.8	4.0	4.4	4.6	4.2	6.1	0.0	1.6	6.2	3.9	4.1	7.4	1.3	9.2	10.8	5.1	2.8	3.3	0.0	4.0	4.1	5.1	11.5	0.8	8.4	5.4	1.8	0.0	5.2	2.0	5.2	0.0	0.0	3.9	4.1	3.8	5.2	9.3	6.2	0.5	6.3	6.0	6.6	8.0	4.8	3.5	5.0	1.1	6.3	14.6	6.8	6.7	5.1	13.2
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"EBP cholestenol delta-isomerase"	Q15125	X	48521799-48528716	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease variant, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 328.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 674.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	10.2	73.3	16.7	17.1	17.2	48.3	17.4	18.5	17.8	19.4	22.0	50.6	85.5	11.0	17.3	41.3	14.3	10.5	32.5	16.8	18.7	44.0	328.5	24.4	18.8	24.4	16.6	12.7	26.0	44.0	7.2	8.2	24.2	40.6	57.5	10.7	25.0	11.7	9.5	27.8	54.2	14.9	15.8	16.9	31.6	14.2	15.9	28.2	14.4	10.6	32.7	14.1	23.3	16.0	224.5	96.4	107.4	77.0	74.5	39.2	50.5	48.2	43.6	64.3	93.9	169.9	382.7	115.9	35.2	41.3	83.5	230.3	217.5	293.8	49.8	85.8	149.7	50.1	115.2	139.3	57.8	179.2	138.2	51.3	108.6	112.9	86.4	22.5	46.5	98.1	77.6	119.5	50.7	163.7	119.1	199.9	118.2	88.3	199.1	93.8	10.3	363.7	175.6	68.8	110.0	59.6	175.4	122.6	31.2	91.5	122.9	71.1	46.6	33.1	56.2	132.9	63.1	47.5	72.1	107.7	78.7	239.7	40.6	96.1	37.7	97.1	129.4	53.4	104.5	71.5	90.5	116.7	53.5	57.2	76.5	99.7	7.3	63.9	57.2	105.4	103.1	93.6	16.7	17.2	18.5	17.8	16.8	18.7	24.4	16.6	24.2	15.8	15.9	16.0	15.2	32.1	49.8	2.9	38.9	37.1	58.2	245.6	23.3	23.8	57.8	26.2	49.9	77.2	116.6	53.3	8.4	55.9	74.5	140.3	39.2	91.7	10.5	30.5	14.7	26.1	30.0	48.8	7.4	239.1	113.0	21.4	36.2	56.5	40.6	41.2	27.1	674.6	65.0	8.4	10.3	96.8	93.6	30.2	36.0	11.8	13.4	31.9	37.4	4.7	34.8	19.3	101.0	5.0	5.1	156.7	137.3	14.7	54.4	46.4	171.9	99.7	34.8	23.3	13.1	12.5	23.6	8.7	22.7	47.6	45.5	37.5	57.1	128.7	149.1	71.1
EBPL	EBRP	ENSG00000123179	"EBP like"	Q9BY08	13	49660674-49691486	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049891	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	21.9	59.7	6.6	12.1	6.5	20.0	23.2	7.0	8.9	37.0	7.5	24.1	14.2	20.4	6.6	62.3	25.5	11.1	8.7	6.7	7.3	14.8	99.3	19.1	11.0	6.8	6.8	33.3	47.7	10.5	10.3	11.2	6.9	21.3	16.3	4.4	27.9	13.5	5.2	33.7	14.3	13.3	7.8	14.4	27.5	11.0	7.9	10.3	16.1	2.5	11.0	23.8	47.6	8.4	46.7	34.9	21.0	88.5	26.0	66.4	37.5	48.5	33.1	30.9	25.0	66.8	65.1	57.9	21.6	23.7	27.1	93.7	38.3	47.4	45.0	46.4	126.8	43.7	23.4	83.3	75.2	69.4	35.0	77.7	100.4	25.6	68.1	49.9	53.6	61.5	36.7	23.0	40.2	25.0	27.4	124.8	72.4	153.2	78.2	58.5	11.7	89.0	66.4	15.2	19.5	50.1	18.0	62.1	21.6	21.7	54.4	54.0	24.6	23.4	23.2	20.2	40.7	14.9	41.2	46.7	11.2	68.6	21.6	2.4	3.0	0.8	2.4	3.6	6.8	4.3	4.8	5.0	5.0	5.4	7.1	4.1	6.4	4.1	3.9	3.3	3.7	1.4	6.6	6.5	7.0	8.9	6.7	7.3	6.8	6.8	6.9	7.8	7.9	8.4	75.5	35.3	23.1	9.8	46.5	108.6	157.6	17.4	115.5	7.9	139.8	192.1	5.4	104.4	17.4	23.9	8.4	32.3	25.5	26.5	41.1	61.2	13.3	61.5	90.6	76.8	27.8	65.6	8.0	52.1	37.1	56.9	56.6	50.0	17.8	64.9	78.9	305.3	38.5	1.7	11.6	80.1	8.2	45.8	36.5	10.0	94.1	27.4	46.2	8.4	30.9	23.6	36.0	8.0	5.1	41.0	42.0	70.0	79.3	116.6	16.5	62.3	8.5	8.4	19.7	57.7	52.7	26.9	17.2	208.6	154.6	15.2	40.3	194.2	133.6	108.9
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	13.8	17.2	8.0	14.6	11.2	31.9	17.9	12.7	10.7	14.8	10.2	13.1	12.1	16.0	16.2	15.2	11.9	15.9	12.8	8.5	7.7	17.4	18.9	12.6	17.7	7.4	7.1	13.9	16.7	22.8	11.3	17.8	7.5	16.5	13.9	17.0	14.4	14.3	13.8	15.3	11.7	14.7	7.2	14.4	13.1	19.2	7.6	21.0	19.0	14.3	18.4	20.0	12.5	12.5	41.0	28.8	32.0	48.1	28.8	28.2	26.3	31.1	48.5	49.9	57.8	52.0	41.4	31.8	29.9	30.5	36.7	33.0	34.6	36.9	50.3	26.1	33.5	39.9	21.2	38.0	43.7	48.3	25.3	31.5	30.9	41.6	51.7	37.9	53.3	29.3	42.1	21.4	47.6	34.8	44.5	28.6	33.0	37.7	81.8	32.1	35.6	17.6	40.4	29.5	13.9	26.5	28.4	62.5	40.3	32.6	36.1	23.0	33.3	21.1	42.8	23.3	36.2	25.2	18.1	54.5	40.1	40.4	18.5	21.0	23.3	26.3	24.7	24.9	26.4	24.3	23.0	24.4	20.3	21.2	29.9	21.5	27.5	32.5	34.7	13.8	24.8	20.3	8.0	11.2	12.7	10.7	8.5	7.7	7.4	7.1	7.5	7.2	7.6	12.5	21.2	28.9	12.1	13.1	22.7	11.0	27.9	16.6	24.5	13.9	11.9	10.3	12.5	8.6	23.0	7.3	25.0	22.7	22.7	9.0	7.9	15.8	39.4	15.3	15.5	17.4	10.8	21.8	17.3	12.2	15.7	15.7	23.4	24.8	19.6	12.2	15.0	8.8	16.6	20.2	16.3	11.8	8.2	12.4	10.1	11.5	15.8	16.0	14.2	9.4	10.8	10.3	14.4	11.6	18.6	14.7	5.7	13.2	16.7	13.1	9.8	12.2	10.5	13.1	6.6	17.8	18.2	32.9	16.0	19.2	10.9	33.2	22.1	11.6	9.2	24.7
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345572	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 29.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 673.8;TIME: 588.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		1300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	87.3	123.2	26.5	47.7	29.4	48.1	79.4	23.0	30.1	61.4	12.6	71.0	30.1	42.4	10.0	26.7	46.9	36.8	70.9	21.3	33.7	38.1	54.0	72.1	35.7	34.4	25.7	71.0	91.8	125.0	47.4	66.5	30.4	53.1	34.7	14.7	33.6	25.1	19.8	34.3	46.1	42.3	21.2	48.5	43.3	22.7	28.1	21.1	51.4	33.2	34.9	58.8	43.8	27.5	93.0	60.1	77.9	38.3	111.0	116.4	44.1	135.4	236.8	72.9	66.6	44.1	275.8	34.0	323.6	138.8	157.7	38.4	32.6	64.9	63.5	83.0	27.2	48.7	89.9	34.8	144.3	7.1	11.8	61.6	74.3	112.6	55.8	199.2	673.8	27.6	10.0	17.7	62.9	19.4	14.6	11.4	23.2	26.3	46.5	17.5	45.0	49.2	114.0	17.0	26.4	63.1	134.3	79.2	57.4	42.5	55.9	20.2	588.7	160.7	77.9	73.3	79.9	26.4	49.0	39.1	332.6	16.5	196.6	0.2	8.4	3.3	2.9	10.0	4.2	6.1	6.1	4.6	0.7	4.1	4.0	2.7	29.8	1.5	7.8	2.8	8.6	7.2	26.5	29.4	23.0	30.1	21.3	33.7	34.4	25.7	30.4	21.2	28.1	27.5	164.0	19.2	7.5	46.4	25.1	20.3	19.7	81.6	18.8	5.0	71.3	44.7	18.9	10.0	54.7	23.9	0.0	6.0	12.4	105.8	5.9	25.8	1.5	19.6	35.2	106.1	25.2	20.2	19.2	56.7	35.0	51.8	20.9	51.8	18.4	35.4	97.1	36.0	3.3	0.0	14.8	13.0	57.0	9.6	14.3	4.2	43.5	17.3	7.2	31.9	25.5	50.4	8.2	13.6	22.5	100.4	106.5	55.3	29.4	34.9	45.7	7.5	24.2	4.4	39.5	72.7	47.5	1.3	5.9	8.5	16.1	10.5	17.9	80.6	21.6	40.8
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487834	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.9;ovary: 99.7;pituitary gland: 27.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 106.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 44.1;HeLa: 21.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 70.7"	"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	1.8	10.0	5.2	1.0	5.5	0.0	1.7	1.2	31.6	1.0	3.4	0.8	0.1	2.2	0.0	0.4	3.5	0.5	0.2	0.5	106.9	4.1	2.5	0.4	0.3	20.9	11.3	99.7	0.7	1.2	27.6	0.3	17.1	0.4	0.0	13.4	0.6	1.5	3.0	0.6	0.4	1.4	2.4	4.5	0.9	1.9	44.2	0.2	1.4	0.0	0.4	0.4	1.1	4.5	0.0	0.1	0.1	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.5	1.2	31.6	0.5	106.9	20.9	11.3	17.1	2.4	44.2	4.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	33.5	0.5	0.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	1.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.0	0.0	100.3	0.0	0.0	0.0	0.1	0.0	21.1	0.0	0.0	0.0	0.1	0.0	3.7	0.0	1.0	2.3	0.5	1.6	0.0	0.0	0.0	0.1	0.6	0.0	0.1
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38831841	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 749.9;skeletal muscle: 906.9"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 796.9;Proximal tubular cells: 880.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		720000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	216.0	343.0	51.2	47.6	53.7	62.3	194.2	54.1	60.3	124.9	58.6	232.9	93.5	115.3	32.3	168.4	114.0	66.8	749.9	49.3	52.5	271.6	556.1	122.1	67.8	51.8	51.8	107.2	141.4	56.0	77.1	67.1	53.4	99.5	99.9	12.8	138.6	43.3	906.9	149.0	167.4	59.7	50.6	192.3	180.5	100.7	55.0	51.0	117.9	455.1	65.7	142.4	132.4	53.3	64.0	273.8	42.0	68.8	161.0	82.0	61.8	31.7	53.2	26.6	27.1	178.8	124.8	98.6	117.2	72.8	24.1	30.1	70.9	72.9	21.1	345.3	37.7	120.7	76.5	146.1	161.3	131.9	116.9	109.0	186.6	35.1	61.2	52.3	63.4	127.3	58.4	160.8	59.6	120.0	91.8	82.2	27.8	278.8	65.9	101.8	126.2	199.0	168.7	142.6	51.4	67.2	161.0	77.1	86.5	27.3	106.4	288.4	53.7	45.5	39.3	46.5	29.6	121.0	153.2	96.4	71.4	164.9	90.7	316.1	312.9	268.0	253.6	248.2	237.2	368.4	243.5	249.1	308.6	361.3	216.5	242.4	41.6	342.7	212.8	221.5	391.8	541.8	51.2	53.7	54.1	60.3	49.3	52.5	51.8	51.8	53.4	50.6	55.0	53.3	125.4	86.6	104.7	13.1	111.1	82.2	220.0	320.8	80.8	22.4	124.0	143.8	302.7	205.9	203.2	145.3	16.7	796.9	103.4	257.7	510.6	195.4	64.5	95.7	56.9	96.4	189.2	99.9	7.1	90.1	370.6	104.1	112.7	77.0	120.9	177.6	90.7	549.4	277.6	37.0	8.6	298.9	193.3	99.0	85.2	56.7	130.8	97.5	145.9	8.4	205.1	53.0	113.3	7.1	16.0	97.0	257.5	143.0	122.1	100.1	383.0	880.0	182.6	21.4	78.9	88.4	119.7	73.3	51.3	121.6	90.8	580.9	118.6	624.2	350.0	218.1
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288712-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA		56000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	92.9	29.4	21.8	36.8	24.5	16.2	37.3	26.4	28.6	36.4	32.3	58.4	46.8	21.4	23.0	33.5	23.2	27.5	42.6	22.0	27.0	92.5	93.8	56.8	41.3	28.1	24.7	21.1	27.9	26.2	14.1	36.2	28.5	33.8	53.8	30.0	46.3	28.4	39.3	22.7	40.7	33.4	24.4	28.4	37.0	18.2	24.7	41.1	38.7	52.2	42.6	43.4	23.4	32.3	58.3	45.6	64.0	59.3	92.9	87.7	54.1	92.7	112.1	78.0	99.0	79.7	43.1	87.6	77.8	88.6	88.4	46.9	0.1	69.6	98.3	52.4	43.3	116.9	58.4	128.3	82.6	158.0	63.4	99.6	81.9	73.1	61.6	70.6	71.8	63.2	147.6	51.6	105.7	55.1	105.7	73.5	52.9	29.0	55.8	49.0	78.7	72.3	142.8	70.8	73.3	71.2	52.1	1.8	131.3	48.3	1.8	182.6	75.2	47.8	76.9	121.8	104.8	65.7	141.0	116.3	87.2	136.4	114.7	19.0	71.6	24.0	23.4	57.5	24.7	28.6	19.8	22.9	66.6	29.2	23.7	24.2	28.6	15.3	43.1	50.5	22.1	43.9	21.8	24.5	26.4	28.6	22.0	27.0	28.1	24.7	28.5	24.4	24.7	32.3	37.0	96.1	114.0	32.3	59.7	26.1	42.3	94.2	35.3	26.4	30.8	28.3	60.8	32.9	102.4	31.3	31.3	106.8	49.3	35.6	127.2	76.1	64.7	47.0	48.3	32.6	13.8	22.9	47.4	79.5	85.6	45.8	38.2	40.2	43.7	32.9	26.0	68.8	85.8	28.6	41.0	35.7	59.0	48.4	38.7	24.4	32.9	55.9	35.6	40.3	55.3	33.5	47.4	55.3	95.0	54.4	41.1	31.2	48.3	31.1	74.4	230.3	47.0	42.3	26.3	55.7	33.0	27.6	28.6	34.7	22.9	65.5	46.3	88.2	56.9	52.7
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 174.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 875.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;HHSteC: 11.0;THP-1: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		NA	NA		240000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favorable (2.70e-4)"	24.1	35.2	5.9	1.2	6.0	2.7	24.9	7.5	7.9	18.1	7.2	18.0	16.7	17.2	5.5	28.2	23.1	5.1	27.6	5.6	5.7	50.6	174.3	12.8	2.3	5.6	5.8	29.1	23.2	14.3	14.6	4.5	5.7	24.0	3.5	5.0	19.0	8.4	29.9	17.1	17.3	2.4	5.5	9.3	29.1	7.0	6.1	3.0	38.9	26.8	1.5	18.2	16.8	5.7	0.0	1.8	0.0	0.0	1.1	0.5	15.8	1.2	7.6	1.6	2.4	0.0	1.5	0.0	7.7	1.2	0.0	0.8	0.0	1.2	0.3	0.0	8.1	0.0	3.1	3.6	11.0	0.0	1.8	1.6	3.2	1.0	1.1	2.4	4.5	0.0	1.2	0.2	0.0	4.2	0.0	0.9	0.2	7.0	1.7	0.0	0.2	0.7	5.2	6.4	0.8	0.3	2.3	6.3	0.1	0.9	1.3	10.2	2.3	0.0	0.0	0.7	0.2	0.3	0.6	0.0	0.5	0.0	0.4	0.0	2.1	1.8	12.1	1.4	9.1	6.9	9.9	11.4	9.5	3.3	10.7	6.6	0.4	6.1	0.8	2.4	13.6	4.0	5.9	6.0	7.5	7.9	5.6	5.7	5.6	5.8	5.7	5.5	6.1	5.7	23.9	54.5	92.0	161.3	17.9	30.7	85.6	67.2	83.1	32.3	96.4	86.7	61.5	153.0	71.1	86.5	327.4	206.0	26.7	96.4	178.1	59.3	150.2	54.9	19.5	18.7	52.1	29.9	26.0	59.4	18.0	64.6	94.3	41.3	29.8	50.6	30.4	875.3	31.8	42.1	34.9	78.3	40.7	27.6	13.8	180.6	154.1	12.8	40.9	51.5	7.6	60.0	23.7	54.8	6.9	44.6	115.7	112.5	10.0	66.5	172.6	284.7	62.5	160.6	19.7	118.3	39.5	17.0	16.7	66.9	29.5	124.0	36.1	23.7	64.7	80.0
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.6;skeletal muscle: 128.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 81.2;Distal tubular cells: 144.8;Hepatocytes: 152.0;Proximal tubular cells: 209.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 52.9;BEWO: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					NA	NA		120000	"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (3.91e-4)"	71.7	29.3	2.6	3.2	2.4	7.0	52.8	2.5	2.5	15.9	17.5	6.7	1.8	11.0	2.2	22.9	11.1	1.8	67.0	2.6	4.3	63.0	161.6	17.5	3.7	3.0	2.7	10.5	29.7	1.8	10.8	7.9	2.9	13.7	3.6	2.0	28.6	13.7	128.4	21.7	6.0	4.4	2.9	15.7	26.6	14.3	3.8	2.8	17.9	60.1	5.5	9.3	17.8	3.3	52.9	7.6	0.1	0.0	0.0	0.0	28.7	6.3	0.0	4.6	4.0	19.1	0.4	0.0	5.8	14.1	1.3	12.5	11.9	1.9	2.0	0.1	0.5	0.0	7.6	0.0	20.5	0.0	7.4	14.1	11.8	4.8	0.0	0.4	9.3	0.0	19.6	0.0	1.4	7.3	0.0	0.2	13.3	0.1	0.0	16.3	0.0	0.0	3.6	0.0	5.5	8.4	0.0	13.1	0.0	16.5	20.5	2.6	2.8	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.6	2.9	1.7	15.4	0.0	0.6	0.0	0.2	0.1	0.5	1.7	1.7	0.3	0.0	3.6	0.5	0.7	0.6	0.0	0.3	2.6	2.4	2.5	2.5	2.6	4.3	3.0	2.7	2.9	2.9	3.8	3.3	2.7	19.2	11.8	0.0	3.6	4.5	13.8	2.7	0.0	0.9	16.7	27.2	42.2	17.2	6.4	16.5	2.1	81.2	0.1	1.3	144.8	33.6	4.0	2.3	5.9	3.5	0.0	1.7	0.3	29.8	32.9	6.0	16.3	4.6	0.0	49.5	4.6	152.0	13.1	0.0	0.2	0.6	6.1	14.1	2.2	6.3	2.8	10.6	8.8	1.0	6.8	13.1	0.0	0.0	0.5	13.6	1.2	3.4	6.4	26.1	0.9	209.9	0.4	2.7	19.7	12.0	12.0	22.1	9.6	0.4	5.7	28.9	1.5	4.9	1.9	6.8
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362485-133373354	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1128.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1476.3;Proximal tubular cells: 2336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	302.4	127.1	127.7	53.7	127.8	43.9	116.9	131.3	136.1	59.8	149.7	143.1	171.6	47.0	89.3	107.9	90.5	66.7	226.4	133.1	129.9	481.7	1128.7	48.5	52.4	129.4	129.9	71.3	96.8	98.7	74.3	73.6	128.8	102.0	104.6	39.8	163.4	123.2	294.3	68.2	153.6	59.4	130.3	48.4	84.5	52.6	134.6	40.0	88.5	271.6	59.0	87.4	57.8	136.0	185.1	229.2	120.4	303.4	173.0	111.4	110.5	132.2	175.9	183.2	154.1	509.5	174.0	139.2	111.9	151.4	94.4	167.7	160.2	136.1	132.0	107.4	281.2	138.5	128.1	367.2	145.0	180.4	93.5	124.5	115.9	121.2	153.6	160.8	165.1	98.3	127.8	117.4	181.6	443.9	90.7	352.0	84.4	289.8	272.1	152.8	146.4	74.6	227.8	236.0	78.1	123.4	137.0	224.1	178.9	69.4	174.8	171.5	132.1	81.3	115.9	169.9	177.4	87.0	58.8	159.8	192.4	98.8	68.7	96.1	184.7	86.8	105.5	212.2	137.6	178.7	117.8	115.8	242.6	148.9	119.3	115.8	19.8	166.0	168.1	104.9	123.0	233.0	127.7	127.8	131.3	136.1	133.1	129.9	129.4	129.9	128.8	130.3	134.6	136.0	99.2	44.8	82.7	16.3	60.5	68.2	86.9	271.8	62.6	57.0	98.5	119.6	255.2	210.1	161.5	174.7	6.2	470.2	34.0	298.6	565.4	162.8	29.9	148.9	92.7	71.4	131.7	72.2	11.6	101.1	163.5	92.5	87.7	226.4	91.2	120.0	88.5	1476.3	221.1	45.4	11.0	223.0	175.0	92.1	61.5	39.1	77.6	88.0	135.2	10.3	113.0	145.2	45.3	10.6	24.3	107.8	248.6	91.7	57.5	88.0	486.2	2336.5	93.2	55.2	85.5	57.0	98.8	52.9	66.1	125.2	76.3	299.1	62.5	220.0	317.2	127.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239402-2252300	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 301.3;Hepatocytes: 246.5;Proximal tubular cells: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		7300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	51.5	57.3	35.9	12.7	39.2	19.6	52.0	38.6	45.9	46.2	61.6	74.0	59.9	44.9	10.6	57.0	50.7	11.3	189.7	32.1	38.0	123.2	235.7	37.2	13.8	39.1	37.8	38.6	74.7	43.8	50.4	14.6	35.0	56.6	15.0	12.8	78.7	24.2	220.6	49.7	58.8	9.3	37.3	35.3	69.5	18.2	42.0	13.4	105.0	87.8	9.5	50.3	43.6	36.5	29.5	68.0	25.7	107.4	9.6	13.6	96.6	29.5	19.1	23.1	33.7	120.0	88.0	42.3	71.2	17.7	16.9	71.6	29.6	27.5	3.2	74.2	157.1	12.9	61.7	151.7	87.3	38.6	6.0	25.2	63.1	18.9	41.7	16.4	23.6	1.1	71.7	87.1	8.0	119.1	4.0	57.8	60.1	46.8	68.8	134.3	27.7	207.1	45.5	32.5	88.8	56.2	70.0	131.4	92.7	12.6	84.7	67.7	19.6	18.4	68.0	19.9	33.0	95.8	61.0	72.2	23.9	35.4	26.2	1.7	3.6	1.6	1.9	3.8	3.1	4.4	2.8	1.6	3.0	4.9	3.4	2.9	2.0	3.6	2.5	3.6	4.0	0.8	35.9	39.2	38.6	45.9	32.1	38.0	39.1	37.8	35.0	37.3	42.0	36.5	47.1	3.2	28.2	13.4	28.0	21.3	115.6	11.3	21.1	53.2	77.2	95.1	92.3	94.4	15.0	77.3	43.8	179.6	20.5	151.7	301.3	35.1	10.9	128.2	54.8	28.2	45.5	61.7	4.2	36.9	80.7	33.1	33.1	122.8	5.7	62.2	34.2	246.5	47.9	21.9	6.7	105.9	20.3	31.0	23.8	5.3	24.5	29.8	39.2	4.7	17.5	89.9	5.2	13.0	10.0	33.2	91.1	24.0	36.8	72.8	176.1	272.3	14.6	77.6	0.0	73.4	42.7	6.3	19.6	32.9	22.3	109.9	21.7	50.2	104.7	110.5
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115693-4135597	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 422.7"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	53.6	123.6	43.9	21.0	47.7	21.5	65.0	46.5	63.7	60.0	50.5	53.3	64.0	44.9	102.1	26.7	49.2	40.1	150.9	42.4	47.8	236.0	422.7	28.6	20.0	45.0	45.6	71.4	159.8	53.2	52.6	37.7	44.2	45.2	55.4	31.8	29.9	36.3	198.4	22.7	59.6	35.5	45.3	30.1	103.5	30.9	49.0	33.5	37.0	236.4	21.8	31.6	26.8	45.5	82.8	45.1	72.8	161.0	89.7	131.4	8.8	114.0	116.7	122.1	107.7	34.0	12.4	3.6	139.6	126.0	111.0	41.6	83.6	67.4	179.5	30.4	95.8	44.0	59.7	186.8	51.3	40.4	20.7	90.6	40.6	106.2	58.4	166.0	262.9	136.2	146.2	31.1	118.6	33.4	113.9	100.7	49.5	8.1	158.7	108.8	90.8	1.5	67.2	16.8	1.8	33.7	6.8	48.2	107.6	131.0	109.8	18.9	268.6	92.4	49.8	82.7	69.8	46.8	88.7	8.4	47.9	34.7	73.0	19.2	36.4	17.4	41.5	28.4	57.1	45.8	48.8	58.3	58.9	51.9	59.8	59.2	1.2	66.0	43.3	45.3	57.9	41.1	43.9	47.7	46.5	63.7	42.4	47.8	45.0	45.6	44.2	45.3	49.0	45.5	61.0	28.9	25.2	17.0	24.4	18.2	48.6	50.3	22.2	14.3	33.3	41.0	165.8	78.6	40.1	36.8	12.5	293.6	29.3	32.0	428.4	53.2	63.1	60.8	43.1	48.0	52.1	77.6	10.7	175.5	29.0	55.2	34.7	57.0	23.4	68.6	53.9	162.2	64.3	18.5	11.9	41.6	20.3	22.0	19.2	50.6	63.3	23.5	35.6	14.0	34.7	77.7	21.6	8.5	18.2	80.4	37.5	50.8	28.3	24.7	120.6	577.0	83.6	46.4	26.3	46.8	33.9	46.5	35.6	24.9	12.8	101.9	41.2	224.0	60.8	22.3
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No		5400	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	41.6	34.1	33.8	23.5	43.7	28.6	31.8	33.9	52.9	31.6	31.6	34.0	32.1	28.4	23.6	28.7	26.5	19.9	44.4	52.7	30.6	31.0	28.2	31.0	21.6	32.0	31.9	33.0	38.4	40.6	32.7	24.0	33.7	34.3	29.6	28.3	32.0	25.6	245.0	32.4	29.6	28.5	26.1	22.4	31.2	35.6	31.4	16.2	32.4	97.1	21.2	31.6	30.9	40.1	58.9	53.1	35.0	37.7	81.6	81.1	57.5	70.8	60.4	57.0	39.1	49.7	35.6	59.3	32.5	62.6	46.5	83.7	45.1	47.4	52.7	65.4	28.3	36.6	64.5	72.0	60.4	68.9	38.2	74.2	48.8	57.3	84.4	64.6	58.8	14.7	85.4	81.1	47.1	49.5	0.3	39.9	68.6	74.7	44.1	33.4	107.2	35.7	48.9	52.2	66.7	31.7	60.5	64.1	46.2	37.6	50.5	36.4	64.7	38.1	43.6	57.5	65.5	71.2	144.9	71.3	55.7	27.8	36.0	2.7	5.8	1.9	4.6	6.0	5.3	3.9	4.7	5.3	8.1	4.2	2.8	4.9	1.7	4.8	4.5	3.6	4.1	2.9	33.8	43.7	33.9	52.9	52.7	30.6	32.0	31.9	33.7	26.1	31.4	40.1	24.6	57.7	63.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	19.0	14.7	0.0	0.0	32.8	12.9	0.0	17.3	11.6	0.0	9.8	21.0	0.0	19.3	32.0	12.1	0.0	0.0	0.0	21.7	11.4	12.5	0.0	26.2	24.0	30.6	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	25.7	0.0	0.0	4.9	0.0	0.0	14.4	24.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.2	6.5	29.2	0.0	0.0
ECRG4	"augurin, C2orf40"	ENSG00000119147	"ECRG4 augurin precursor"	Q9H1Z8	2	106063246-106078155	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 225.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 87.6;Fibroblasts: 25.3;Smooth muscle cells: 19.1"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 72.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 8.5;naive CD8 T-cell: 7.2"	"Lineage enriched"	"Detected in single"	83	"T-cells: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008546	Uncertain				"Secreted to blood"	NA	NA		330000	"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 33: Fibroblasts - ECM organization"			"HPA008546: AB_2066524"	"prognostic favorable (4.58e-4)"	"unprognostic (3.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.30e-4)"	66.7	27.6	5.3	1.1	6.0	0.0	49.6	9.6	5.3	73.8	225.3	47.6	5.3	24.6	28.4	20.2	47.5	9.4	25.7	12.0	13.0	47.1	3.2	27.6	1.7	14.9	21.5	13.2	5.9	0.7	96.2	8.5	15.4	55.1	5.6	0.1	20.4	101.8	10.3	14.1	19.2	9.0	19.4	25.8	165.8	27.0	12.2	2.8	101.1	6.9	0.3	79.6	58.2	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	2.0	1.3	0.0	0.0	8.5	7.2	0.0	0.0	0.0	0.0	0.8	1.4	5.3	6.0	9.6	5.3	12.0	13.0	14.9	21.5	15.4	19.4	12.2	11.7	87.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0
ECSIT	SITPEC	ENSG00000130159	"ECSIT signaling integrator"	Q9BQ95	19	11505929-11529172	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	26.2	38.0	28.5	14.9	28.4	24.7	26.8	32.4	38.5	32.2	29.6	42.2	39.5	29.7	9.4	29.2	28.5	15.0	128.5	28.7	29.3	36.6	51.6	20.8	18.0	30.5	28.2	43.1	56.3	30.6	24.3	9.8	31.6	29.8	18.9	12.9	45.7	16.0	124.7	29.6	28.3	16.5	26.1	21.8	48.9	15.0	30.8	15.6	26.2	130.4	13.3	34.3	27.5	30.0	40.0	35.8	20.4	29.2	30.0	33.6	23.1	21.1	26.4	41.8	33.4	52.6	26.4	58.7	42.0	25.4	38.0	52.1	51.6	42.6	14.6	33.2	42.7	54.5	21.6	48.1	29.7	31.5	42.8	35.9	46.0	35.0	38.1	22.1	31.8	53.7	59.2	56.2	15.6	55.2	53.7	48.6	54.6	51.8	91.4	53.3	22.0	77.1	22.3	24.2	77.3	50.2	24.6	38.7	42.4	9.6	45.9	46.3	16.2	44.4	31.2	64.4	38.5	52.7	106.5	28.7	37.0	46.9	32.2	4.1	32.5	12.0	26.6	41.1	30.8	41.7	28.8	25.1	42.3	39.2	31.9	29.3	6.1	26.1	38.3	23.5	35.4	29.7	28.5	28.4	32.4	38.5	28.7	29.3	30.5	28.2	31.6	26.1	30.8	30.0	19.7	9.6	15.7	13.1	25.2	44.5	61.6	48.3	40.9	23.2	38.7	44.2	74.7	52.9	28.3	20.2	12.5	34.5	18.0	44.3	82.2	42.1	18.0	10.2	16.3	23.4	37.3	31.1	15.3	78.5	45.7	27.5	29.6	9.5	22.9	47.1	27.5	49.4	31.1	18.5	19.4	49.3	16.2	29.6	23.5	52.2	34.5	19.5	28.4	3.7	22.2	30.4	29.9	8.0	9.9	38.4	34.8	32.0	21.0	55.9	70.0	101.5	18.5	30.6	32.9	32.7	36.4	17.6	45.1	37.6	41.9	25.2	20.3	53.7	84.6	56.3
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795911-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 8.7"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.1	0.3	1.2	0.1	0.4	0.3	0.3	0.8	0.7	0.4	1.7	0.1	0.0	0.2	0.0	0.1	8.7	0.0	1.7	1.3	0.4	0.0	0.0	1.5	0.1	1.9	1.6	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.4	0.2	0.0	0.2	0.4	0.0	0.1	1.2	0.1	0.1	0.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.8	0.7	1.3	0.4	1.9	1.6	0.6	1.2	0.5	0.7	0.2	0.0	1.1	2.3	0.1	0.5	0.7	1.6	0.0	2.1	0.3	0.1	2.3	0.0	12.7	0.0	2.1	0.1	0.6	0.1	0.0	0.0	5.1	15.0	0.5	0.8	0.0	0.0	6.1	0.0	0.0	0.9	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	0.4	5.4	0.0	0.1	0.0	1.0	0.0	2.0	0.0	2.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	91.4	3.2	0.0	1.2	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.3
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 3.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Macrophages: 1.1;Squamous epithelial cells: 5.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 7.5;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	75	"T-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;HaCaT: 10.2;OE19: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA042292	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.0	0.2	0.6	0.0	1.3	1.1	0.5	0.2	3.6	0.2	0.9	0.0	0.1	0.0	0.6	0.9	0.2	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.7	1.9	0.0	0.6	0.1	0.0	1.4	1.0	0.0	0.0	0.2	0.9	0.1	0.1	1.2	0.0	0.0	1.2	1.5	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.7	0.0	0.4	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	7.5	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.4	0.0	0.1	0.6	0.5	0.0	0.8	0.0	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.8	0.0	0.3	0.8
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 8.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.7;granulocytes: 22.7;Syncytiotrophoblasts: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 49.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.9;HDLM-2: 13.2;HMC-1: 52.7;RT4: 45.3;T-47d: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.4	0.1	0.2	0.4	0.1	0.4	4.8	0.1	0.1	0.7	0.0	0.3	0.4	0.4	5.2	3.3	1.2	0.8	0.9	0.1	0.1	1.1	0.3	0.7	1.2	0.2	0.2	0.4	3.8	0.1	0.1	4.9	0.1	3.6	0.3	0.0	1.4	6.1	0.0	5.8	0.3	0.1	0.1	1.2	6.3	3.4	0.2	2.3	6.4	0.0	2.6	8.7	1.0	0.1	0.0	3.8	0.3	0.0	0.0	0.0	15.9	0.0	0.0	1.3	0.8	1.0	0.0	0.0	0.0	0.2	4.3	8.8	6.5	9.6	1.2	13.2	7.6	0.1	0.1	1.4	0.0	0.4	52.7	0.0	2.7	0.9	0.8	0.0	0.0	1.8	0.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	3.4	0.1	0.0	0.0	45.3	0.4	0.3	0.0	1.2	0.2	0.3	12.6	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	49.5	0.3	0.1	3.1	0.4	4.1	0.1	4.7	6.1	0.5	0.2	0.4	3.2	0.3	5.3	0.2	0.1	5.1	2.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.0	1.3	0.0	0.4	6.9	7.3	16.3	13.1	0.0	7.1	7.4	4.1	5.7	8.4	0.0	0.0	26.7	3.0	0.1	3.9	1.7	10.6	0.2	1.2	1.2	0.0	2.5	0.5	0.9	14.2	1.1	5.1	0.4	22.7	2.8	5.0	0.5	3.4	0.0	0.6	0.1	8.2	1.5	8.9	9.3	0.3	0.6	12.4	1.0	3.7	0.6	0.0	1.0	0.4	0.6	0.0	0.4	1.8	4.2	0.1	0.4	3.2	0.1	0.0	1.4	6.1	13.4	3.7	6.5	5.3	22.6	6.2	0.3	0.0	5.3
EDC3	"FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2"	ENSG00000179151	"Enhancer of mRNA decapping 3"	Q96F86	15	74630558-74696292	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 117.2;Late spermatids: 192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040650, HPA044206, HPA066137"	Uncertain		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytoplasmic bodies"		"HPA040650: AB_2677061, HPA044206: AB_2678857, HPA066137: AB_2685625"	"unprognostic (4.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.81e-2)"	12.8	8.7	14.3	11.7	15.6	7.9	13.8	18.1	16.6	13.0	15.6	12.4	10.4	15.2	11.0	15.5	16.4	10.2	10.5	14.0	15.3	12.9	11.2	10.5	15.1	15.2	15.0	18.6	10.5	13.4	11.9	12.4	14.9	14.3	13.8	11.8	10.3	10.8	14.8	15.3	12.3	17.0	12.7	12.9	11.5	34.8	15.0	18.5	13.1	11.5	18.1	13.0	10.7	18.6	24.9	20.8	39.0	34.9	24.6	22.5	35.7	26.1	30.5	42.4	40.6	58.9	30.2	39.6	24.1	35.8	39.2	50.6	99.0	40.4	29.5	33.7	54.3	41.0	46.9	30.8	29.4	47.8	24.4	23.0	36.9	36.8	39.0	26.8	38.9	45.7	59.3	30.4	30.5	39.8	32.8	26.7	39.2	34.0	22.9	40.8	42.7	40.0	19.4	42.7	42.5	38.8	38.8	33.5	41.8	51.8	34.6	34.6	24.3	36.7	20.3	22.2	38.4	31.9	65.2	44.3	29.1	46.6	29.5	6.1	5.8	4.6	9.6	5.9	10.3	8.3	6.8	7.9	6.8	6.3	6.9	7.5	1.9	13.7	5.0	6.7	8.5	7.1	14.3	15.6	18.1	16.6	14.0	15.3	15.2	15.0	14.9	12.7	15.0	18.6	10.8	6.4	7.8	21.9	7.2	4.7	5.0	7.6	9.6	9.7	6.8	6.2	6.3	8.6	6.7	7.3	0.0	9.7	8.4	7.0	3.9	11.4	117.2	10.2	7.5	9.6	15.6	7.8	19.5	8.1	12.1	7.9	9.7	9.4	4.5	10.2	8.2	8.2	7.6	5.0	18.0	6.8	8.2	7.1	2.4	192.2	9.0	4.6	8.8	17.8	11.5	5.2	11.3	18.6	19.0	9.5	11.1	6.4	14.0	7.6	6.6	5.8	11.3	6.3	13.1	4.6	6.8	12.8	16.3	7.7	2.8	9.3	7.4	7.6	6.0	8.1
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745887-20748380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 636.1"	"Cell type enriched"	"Detected in some"	26	"Collecting duct cells: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049952	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA049952: AB_2680970"	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	636.1	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
EDDM3B	"FAM12B, HE3-BETA"	ENSG00000181552	"Epididymal protein 3B"	P56851	14	20768404-20770948	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	279	"epididymis: 2563.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;NB-4: 2.6"	"Not detected"	"Not detected"							HPA001323	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA001323: AB_1848377"	"unprognostic (2.40e-2)"																	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2563.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219958	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 184.4;U-698: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	11.2	11.3	5.5	31.3	6.6	66.5	14.4	3.7	6.2	11.6	4.4	15.6	14.1	11.9	12.6	16.7	10.7	12.2	7.2	5.2	5.6	12.5	59.3	29.8	41.4	6.5	5.2	13.1	24.9	17.2	9.4	14.0	4.9	12.4	16.9	5.6	13.3	10.7	5.7	17.2	18.7	12.5	5.4	24.4	17.7	10.5	6.7	79.1	17.6	5.4	42.5	16.7	13.2	6.4	18.0	17.8	11.1	11.1	14.3	31.6	35.1	28.8	38.8	19.5	25.5	8.2	23.4	95.9	15.2	28.6	42.3	13.9	12.1	39.8	29.6	184.4	7.1	32.7	16.9	18.7	66.2	39.0	91.8	28.7	47.4	41.6	45.5	26.4	39.2	122.1	8.7	128.2	24.4	10.6	78.9	14.9	5.6	8.2	13.4	113.2	19.6	90.0	22.4	37.0	1.4	14.5	20.8	29.6	44.4	9.8	15.2	123.3	38.7	37.2	25.7	32.1	33.6	75.1	49.4	162.3	61.8	37.1	31.8	2.9	2.6	3.1	4.0	3.7	5.7	6.7	5.9	4.4	3.3	4.4	5.2	4.1	3.0	2.1	4.6	7.5	6.7	2.0	5.5	6.6	3.7	6.2	5.2	5.6	6.5	5.2	4.9	5.4	6.7	6.4	11.8	60.9	100.7	10.7	51.1	20.6	7.0	15.5	10.2	5.3	17.2	11.0	3.1	20.0	19.9	16.5	10.4	10.0	29.1	23.8	0.0	7.0	14.4	11.4	14.8	12.6	8.4	12.6	17.4	12.2	32.8	11.3	20.9	20.0	23.5	8.1	12.8	76.2	17.0	1.7	15.4	26.4	14.2	32.9	194.0	63.1	8.4	44.3	16.0	14.0	43.1	3.3	12.3	11.1	10.3	15.2	4.7	9.1	135.5	12.5	16.1	8.5	11.0	4.0	0.0	9.4	13.6	7.8	5.5	23.1	27.3	40.9	25.5	5.1	12.3	20.7
EDEM2	"bA4204.1, C20orf31, C20orf49, FLJ10783"	ENSG00000088298	"ER degradation enhancing alpha-mannosidase like protein 2"	Q9BV94	20	35115364-35147336	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 137.9;Plasma cells: 89.0;Syncytiotrophoblasts: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037238, HPA048353"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB037238: AB_1840826, HPA048353: AB_2680369"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (4.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.29e-2)"	21.1	26.9	10.3	16.2	11.4	27.7	17.9	16.0	12.8	18.5	13.6	19.5	20.0	11.6	44.9	14.5	16.2	14.7	15.0	9.8	10.7	19.1	38.9	26.7	20.1	13.4	11.4	10.4	32.4	13.2	24.5	28.1	12.9	16.0	21.8	10.7	19.1	15.5	7.5	13.9	19.4	15.4	11.0	32.5	16.4	6.6	14.8	16.8	15.3	5.9	21.7	16.4	12.2	12.5	18.6	54.4	8.6	34.0	98.0	33.9	49.2	20.8	70.5	24.4	34.4	61.3	47.7	16.0	61.3	40.9	77.0	37.6	31.5	43.3	19.6	12.3	8.8	31.6	11.8	58.7	54.1	23.2	117.6	41.3	59.4	23.5	58.2	60.2	91.9	30.3	14.9	66.5	33.9	20.6	18.6	28.9	9.7	52.8	35.0	15.5	29.5	33.6	54.6	16.0	7.1	11.1	21.8	55.8	53.9	36.3	26.2	38.5	41.0	36.9	22.0	21.9	25.6	34.5	23.2	9.7	64.7	29.2	31.4	35.9	96.9	75.3	39.9	72.4	78.4	42.3	36.4	39.6	101.4	42.0	26.0	32.9	67.2	42.9	72.9	59.1	47.7	79.9	10.3	11.4	16.0	12.8	9.8	10.7	13.4	11.4	12.9	11.0	14.8	12.5	16.7	16.0	17.4	6.8	27.5	4.0	14.6	34.7	6.2	3.7	12.0	9.3	4.6	24.3	18.9	12.9	2.1	72.9	27.4	14.7	11.7	35.5	2.5	11.4	13.8	16.4	4.8	13.3	5.2	29.1	137.9	14.1	7.7	16.6	55.1	13.6	13.9	23.3	72.2	0.0	6.5	13.8	32.6	21.3	7.9	1.2	7.8	28.3	12.4	9.4	26.8	7.9	14.4	1.5	6.9	28.9	16.1	5.3	89.0	12.8	43.6	18.9	15.3	6.5	13.1	7.9	19.0	8.7	11.2	8.9	4.7	94.7	18.7	15.7	17.3	12.7
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690237-184754907	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	14.3	12.4	3.8	13.8	4.8	8.2	10.9	6.6	5.1	13.7	4.3	20.6	18.8	8.8	8.0	9.2	6.6	11.7	7.2	4.1	6.5	10.6	20.3	11.2	10.2	4.7	5.7	5.7	15.7	13.0	7.1	20.8	4.6	13.5	24.0	11.4	13.2	8.7	12.2	6.6	16.3	12.0	4.5	10.5	35.8	7.4	5.5	10.8	11.8	11.4	10.7	13.6	5.8	6.3	15.1	11.2	15.0	13.4	53.8	55.0	24.5	29.9	20.7	11.1	11.6	5.9	42.4	10.5	31.8	22.8	11.3	20.1	14.6	15.6	16.4	10.3	11.9	13.8	11.7	8.5	20.7	36.4	19.5	31.6	18.8	27.1	24.2	21.0	30.4	27.4	36.8	47.4	21.6	12.5	29.3	18.8	21.2	34.1	10.2	12.7	11.6	36.2	16.1	10.4	16.9	23.9	14.7	25.2	20.8	24.9	23.7	56.3	36.1	16.1	7.2	34.3	25.5	72.1	29.8	13.6	21.3	40.7	35.6	5.0	3.5	2.2	1.4	3.5	2.5	1.3	2.2	1.7	3.1	0.9	3.0	1.6	3.6	2.2	3.6	1.6	1.5	1.8	3.8	4.8	6.6	5.1	4.1	6.5	4.7	5.7	4.6	4.5	5.5	6.3	35.1	19.2	19.3	41.4	19.9	16.7	8.4	9.8	19.9	26.1	20.4	11.4	16.0	12.8	21.8	14.7	25.0	13.8	13.2	55.1	0.0	14.0	16.0	14.3	21.2	25.9	30.6	32.4	58.2	35.6	10.9	28.0	96.8	17.0	21.0	12.9	19.2	47.0	13.0	21.9	62.8	76.5	2.0	40.1	30.3	7.1	20.5	33.0	19.6	36.5	31.0	7.8	11.3	47.3	61.6	20.0	28.1	18.0	73.6	27.1	21.4	9.7	28.1	15.2	19.7	20.3	18.7	15.0	8.7	18.2	20.5	19.4	24.9	53.8	32.4	19.1
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866308	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 2662.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	305.1	423.1	401.9	234.1	403.4	299.6	315.7	408.4	511.3	359.2	392.1	355.4	494.2	280.8	211.9	462.9	281.6	192.2	519.3	404.5	420.1	430.0	668.7	279.5	273.3	415.5	412.3	394.2	715.5	289.9	395.9	202.8	412.2	430.3	206.9	105.1	497.8	230.7	497.6	407.3	486.4	162.7	401.3	309.8	399.1	179.5	405.5	231.3	396.3	321.6	242.2	286.6	343.4	418.0	496.0	646.9	355.3	361.3	342.6	358.5	693.9	555.9	370.3	438.7	339.8	528.1	335.9	429.6	503.5	484.3	392.3	585.0	277.0	424.5	159.7	467.6	338.4	300.4	784.0	727.5	680.2	518.7	394.9	357.4	533.8	344.9	396.9	408.1	426.7	382.7	443.0	540.6	379.7	1071.4	465.6	818.8	375.6	761.1	548.0	404.2	517.5	875.8	592.2	515.4	450.8	433.3	579.8	807.6	587.1	231.9	781.1	715.8	526.6	477.5	363.8	524.5	528.0	311.5	555.7	366.6	625.8	305.7	448.8	290.4	378.6	327.2	351.6	334.9	388.7	430.9	373.6	364.9	379.2	400.3	328.8	343.7	149.3	396.7	282.8	621.6	471.0	544.4	401.9	403.4	408.4	511.3	404.5	420.1	415.5	412.3	412.2	401.3	405.5	418.0	375.9	227.6	290.8	27.1	357.5	522.1	601.8	717.4	314.1	139.5	530.5	691.1	336.9	480.4	421.8	314.5	39.6	683.0	405.4	1157.4	1154.3	668.1	148.4	266.8	317.2	365.7	443.4	277.0	19.1	1274.9	768.6	332.7	349.7	320.2	291.1	386.5	404.8	822.2	571.2	94.2	20.8	1032.8	376.4	394.7	535.9	292.1	581.6	323.0	526.5	15.9	787.1	352.5	460.3	23.1	39.0	1103.5	1413.9	426.5	409.6	625.2	2662.5	1566.5	314.5	155.6	276.1	389.0	469.0	238.7	237.4	408.3	620.3	1127.5	377.8	364.3	764.7	682.5
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384880	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 256.8"	"Group enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 561.4;Oligodendrocytes: 2119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 547.0;LHCN-M2: 169.8;TIME: 203.3;U-2 OS: 163.2;U-87 MG: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA020415: AB_2670434"	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	13.9	21.7	55.3	13.6	126.6	0.2	6.2	93.9	105.1	17.5	7.6	37.0	17.0	26.8	44.9	17.0	10.9	34.0	20.6	68.1	90.1	10.7	0.7	20.9	0.8	118.1	89.3	10.1	3.4	4.2	2.9	4.6	121.0	13.5	38.4	40.2	3.9	22.1	0.8	9.7	26.2	25.8	99.1	3.2	19.7	2.3	82.3	0.3	4.0	0.7	3.6	15.7	9.5	256.8	0.1	1.5	1.4	0.0	3.7	0.2	0.1	4.8	0.0	12.6	16.9	0.0	21.2	0.0	0.1	0.1	8.8	19.6	0.0	0.8	9.3	0.1	9.2	0.0	54.5	0.0	99.9	1.0	0.2	25.6	2.6	61.0	8.5	547.0	21.7	0.0	0.0	0.3	169.8	0.1	0.1	0.3	8.7	0.0	39.4	0.1	41.4	0.1	28.2	0.0	4.5	0.5	0.0	0.3	0.1	26.1	0.2	0.2	203.3	60.8	163.2	2.1	56.6	1.6	0.0	0.1	112.6	0.1	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	126.6	93.9	105.1	68.1	90.1	118.1	89.3	121.0	99.1	82.3	256.8	3.1	9.6	6.0	14.0	0.1	12.1	1.7	13.7	14.8	179.2	0.3	11.7	13.3	0.0	4.5	3.7	2.1	0.3	0.1	5.9	0.0	0.1	32.8	0.4	7.2	10.4	22.9	0.0	219.9	0.0	0.0	34.8	0.0	0.3	5.7	1.3	1.4	0.1	0.3	5.0	216.5	9.2	2.0	0.0	3.3	19.8	2.5	0.3	3.6	32.8	0.0	5.4	0.0	561.4	2119.7	0.4	8.1	3.8	0.0	0.9	0.0	0.9	1.2	11.6	6.6	0.2	40.2	1.9	1.5	9.3	16.1	0.4	0.6	16.2	8.4	0.7
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290361-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 44.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 4.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	44.6	1.8	14.7	7.3	13.8	4.7	23.6	13.6	18.2	6.2	9.7	10.6	10.4	7.0	6.3	12.1	9.4	13.5	7.8	12.6	12.2	7.7	3.1	36.6	5.6	15.1	13.6	2.6	9.6	1.4	1.1	18.5	15.2	5.5	14.5	1.0	12.1	8.9	7.6	11.8	9.8	11.3	13.1	12.3	10.4	4.7	15.7	1.7	3.4	6.4	2.4	9.9	5.9	14.2	10.3	57.6	1.1	0.1	0.3	0.2	0.2	18.2	16.0	15.0	12.4	74.6	8.6	0.0	660.4	7.2	9.2	5.4	0.0	10.6	11.0	0.8	0.0	0.0	2.1	2.3	0.8	0.0	0.0	0.4	6.2	3.0	2.1	4.7	446.8	0.0	0.0	0.0	56.8	1.6	0.2	0.3	0.6	10.4	0.7	0.2	5.1	0.1	35.3	9.4	0.6	0.0	1.8	53.1	0.1	117.2	137.5	0.8	334.3	37.1	30.1	0.7	23.5	0.3	0.4	1.3	0.3	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.0	14.7	13.8	13.6	18.2	12.6	12.2	15.1	13.6	15.2	13.1	15.7	14.2	190.7	173.1	23.8	2.9	0.8	189.9	749.7	99.9	151.4	0.2	68.7	26.8	2.2	8.6	110.6	38.6	0.0	1.8	0.8	189.7	3.9	316.3	13.3	187.2	16.3	236.8	15.6	2.7	3.6	218.9	0.4	9.0	22.4	289.7	1.3	0.8	169.2	1.8	1.8	1.7	3.0	43.8	12.2	5.0	6.7	19.8	5.6	5.3	8.8	6.5	10.9	0.3	0.0	3.5	0.6	268.5	145.7	0.4	0.4	185.8	119.6	8.3	27.4	0.4	6.6	1.8	21.8	1.0	0.6	53.7	64.5	0.8	9.7	0.1	196.6	141.8
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484683	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.1;esophagus: 20.8;vagina: 32.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.3	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	26.1	1.0	1.9	3.9	3.1	4.7	20.8	1.6	0.2	1.4	0.1	0.0	7.4	1.2	3.7	0.0	0.1	0.1	0.1	2.4	0.0	2.1	0.0	0.1	7.5	0.9	0.2	8.0	0.5	0.2	15.0	17.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.0	0.3	2.4	32.7	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	13.8	0.0	35.9	0.0	0.0	1.7	0.0	0.1	0.0	4.2	0.0	0.0	13.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.8	0.4	0.0	0.0	1.3	8.4	9.4	0.9	16.8	0.0	0.3	41.2	0.0	0.9	0.8	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	6.4	1.5	0.0	0.0	30.3	239.7	137.3	8.6	0.1	2.5	1.3	0.7	2.8	146.1	69.9	0.0	0.2	0.1	23.3	0.0	8.8	0.0	36.9	0.5	0.6	1.8	0.0	0.0	1.0	0.0	1.8	3.1	6.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	4.2	38.7	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.9	2.7	0.0	0.1	62.5	91.7	1.6	20.9	0.0	0.0	0.4	3.5	0.0	0.2	2.4	29.1	0.0	0.7	0.8	8.2	45.2
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 120.5;Astrocytes: 126.3;Hepatic stellate cells: 112.5;Melanocytes: 110.3;Muller glia cells: 116.2;Sertoli cells: 216.9;Skeletal myocytes: 81.3;Smooth muscle cells: 102.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 127.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 68.0;ASC diff: 50.5;SK-MEL-30: 66.0;U-266/70: 40.7;WM-115: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	58.8	41.2	34.7	19.5	50.8	0.9	39.8	44.6	26.1	18.7	6.7	13.0	20.0	13.1	3.7	8.2	14.1	14.9	28.1	27.5	51.6	33.0	50.9	51.2	10.4	76.2	66.0	4.7	11.4	15.3	9.6	127.8	47.9	25.3	13.2	17.9	27.0	6.9	11.3	12.5	21.9	12.9	97.2	16.8	10.6	2.3	64.9	4.0	31.8	18.8	4.7	23.6	15.5	78.7	5.7	0.0	68.0	0.0	50.5	2.0	1.0	0.0	0.1	0.0	0.0	25.9	0.0	0.0	2.6	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	3.5	0.0	0.2	13.2	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.5	0.1	0.0	66.0	8.9	0.0	0.3	0.3	0.6	0.1	0.0	0.4	40.7	24.9	0.1	1.2	0.0	131.8	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.7	50.8	44.6	26.1	27.5	51.6	76.2	66.0	47.9	97.2	64.9	78.7	120.5	12.8	51.0	126.3	0.2	14.8	1.0	0.0	1.2	5.8	1.2	2.8	10.8	0.0	2.5	0.0	6.2	14.7	0.3	0.1	0.0	0.0	2.9	2.9	20.7	73.3	0.0	0.0	1.3	0.0	13.9	51.1	1.1	35.9	6.3	2.1	112.5	1.1	13.4	0.0	1.6	0.0	0.0	18.7	10.6	2.2	79.9	5.2	110.3	6.5	0.1	116.2	0.0	48.2	0.9	0.1	0.0	2.6	0.1	2.6	0.0	0.1	1.5	4.4	216.9	81.3	102.1	0.4	2.1	0.2	7.2	5.7	1.6	2.5	0.0	1.5
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles		NA	NA		20000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	11.4	6.6	2.8	6.7	3.0	3.7	7.2	6.6	4.3	9.3	0.0	8.2	6.7	8.7	4.1	13.1	4.8	7.3	7.8	2.7	3.8	6.6	9.5	7.1	5.6	5.3	4.3	8.9	6.0	8.1	2.8	9.4	5.5	7.3	7.0	13.7	7.0	5.7	9.6	10.2	6.6	8.4	3.2	7.3	7.0	5.3	3.5	4.1	8.1	10.4	5.5	8.5	6.8	4.4	14.9	4.9	7.2	5.1	30.1	30.1	16.4	28.8	16.6	15.0	10.6	17.1	4.0	15.2	5.1	20.3	21.3	17.5	16.0	8.1	23.0	10.2	7.8	16.2	5.9	15.7	16.7	11.6	7.3	19.7	11.7	16.1	24.0	16.7	25.3	4.2	12.2	5.0	15.7	6.9	8.4	7.9	7.2	6.0	10.5	9.2	18.2	10.1	7.7	20.4	6.0	4.4	21.2	13.7	12.9	9.9	18.2	10.1	34.4	21.0	8.0	16.8	11.2	5.4	10.1	10.2	7.8	10.1	11.6	0.0	0.6	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	0.8	0.5	0.5	0.2	0.9	0.5	0.1	0.2	2.8	3.0	6.6	4.3	2.7	3.8	5.3	4.3	5.5	3.2	3.5	4.4	58.3	99.3	59.8	60.7	36.4	37.9	57.6	25.2	35.9	53.1	26.5	24.9	93.0	17.2	32.8	25.8	37.5	65.5	39.4	35.7	43.0	59.0	15.1	37.1	85.7	58.9	16.8	14.9	58.5	34.7	45.8	81.1	29.0	53.6	32.9	29.8	31.4	37.4	36.4	183.4	76.2	26.6	14.2	38.6	36.8	9.5	61.8	44.5	48.0	68.4	44.0	60.0	28.8	94.5	102.5	40.4	35.9	68.1	19.8	50.0	26.3	35.3	26.4	68.4	46.0	104.4	71.0	131.1	30.0	91.3	50.3	113.6	29.8	35.5	30.7	78.1
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244753-86278813	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	9.3	9.0	13.2	16.3	13.1	9.2	11.4	15.0	15.8	13.8	13.1	12.1	12.1	11.5	15.2	12.7	10.6	9.3	8.9	12.8	13.5	11.5	11.9	8.5	28.8	12.9	12.8	12.1	10.5	9.1	9.4	14.5	13.1	11.7	11.9	16.4	10.3	10.6	10.5	12.1	11.6	10.2	12.9	14.4	10.9	10.3	13.6	17.8	10.7	11.1	32.1	13.0	12.1	13.9	34.2	37.8	40.9	16.8	22.6	20.2	47.0	49.2	22.6	46.3	46.8	121.0	64.4	79.8	50.6	15.8	44.2	41.4	48.7	26.8	43.2	79.7	22.7	51.4	38.7	36.3	19.8	54.2	33.4	12.4	18.0	46.8	20.1	17.5	20.9	34.7	58.8	16.2	39.0	55.2	51.5	55.4	30.4	107.8	18.4	56.2	49.1	38.8	29.1	55.4	27.5	22.4	63.5	29.6	14.5	29.1	49.2	22.6	19.0	48.1	44.1	70.0	43.2	9.2	32.1	63.9	13.7	46.6	36.8	31.0	9.1	15.0	25.4	15.3	22.1	45.0	33.2	32.0	13.9	47.3	26.4	29.6	3.9	19.3	16.8	9.2	58.6	19.1	13.2	13.1	15.0	15.8	12.8	13.5	12.9	12.8	13.1	12.9	13.6	13.9	15.4	6.4	9.3	28.1	32.7	25.6	11.6	27.5	25.0	26.4	13.3	11.8	9.5	11.5	15.4	7.3	18.8	45.2	31.0	16.1	19.6	14.5	7.7	17.6	17.1	16.6	7.2	15.8	35.0	10.2	36.8	14.8	16.3	15.5	15.9	15.0	13.2	11.4	16.9	32.0	45.6	12.8	12.2	14.5	32.5	3.6	22.7	15.2	19.6	37.5	30.4	11.5	25.7	31.2	38.9	11.9	11.1	17.3	17.6	11.9	11.7	8.6	21.3	18.3	6.6	14.3	24.5	18.7	20.0	16.9	16.8	24.9	31.6	17.5	15.0	20.9
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73489308-73525587	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA		82000000	"Cluster 30: Non-specific - Translation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	7265.1	5743.3	2531.3	4576.8	2717.1	10489.1	10504.6	2524.2	2783.1	7953.2	2902.2	6991.5	4783.5	7397.5	7203.8	6302.2	9034.9	4902.1	4074.6	2309.3	2687.4	7520.3	6459.1	4891.3	8813.5	2792.2	2572.6	12627.2	10370.0	6942.9	3776.4	5545.3	2828.4	5639.5	6936.4	2200.9	8381.0	6045.9	1682.1	7151.8	5076.6	7695.8	2980.6	5912.7	5776.4	1701.2	2687.7	8091.2	8348.4	1938.8	11294.9	6993.4	6470.3	2900.2	5218.1	8235.8	8697.0	13940.8	18183.0	32963.3	7874.7	7061.7	21384.2	10632.9	10044.2	12591.7	8020.5	20786.6	9976.7	13824.2	6089.1	5849.1	11729.0	15249.9	9969.0	3868.8	7099.6	7824.7	6142.2	13619.5	14708.8	15773.6	9201.9	26454.1	27514.4	7357.6	24803.6	17437.1	14783.4	8434.8	15242.2	7357.1	13131.5	8385.7	7184.5	17411.3	10348.2	6259.3	4400.0	14212.5	15389.7	26105.5	12201.5	14719.8	8337.9	8853.1	3931.6	10026.7	17535.8	9067.6	6928.7	24671.0	11535.0	4637.5	6195.9	3343.0	9206.4	7296.2	6913.1	5011.8	4780.9	12625.1	7404.1	2888.1	8472.3	895.8	7474.9	7600.7	14243.9	10580.7	12006.0	10174.3	8618.3	8426.8	13912.6	12049.7	681.7	9555.0	7680.9	6461.2	9278.5	26796.5	2531.3	2717.1	2524.2	2783.1	2309.3	2687.4	2792.2	2572.6	2828.4	2980.6	2687.7	2900.2	4915.6	3169.9	6059.2	107.4	11291.6	9829.9	12187.6	10417.5	11667.5	978.9	10528.4	9476.3	160.6	6258.2	5739.8	2637.3	546.3	9401.2	8653.6	2189.4	10344.0	5796.3	1373.9	4535.2	6754.2	5952.7	3862.8	6396.8	84.5	10404.1	12700.2	5756.1	4472.5	5831.2	3736.3	5732.4	6124.7	3323.0	6415.2	494.6	109.3	6969.3	3289.7	7779.7	8970.1	2325.8	8931.5	6705.0	5112.0	175.2	18016.6	3733.0	8468.7	76.9	162.0	7231.8	5821.6	7213.5	6811.7	11638.2	7494.7	14215.0	2974.6	1469.9	3536.8	7040.7	7075.1	1092.8	703.6	12784.4	10055.1	11086.8	9616.5	6982.9	8574.9	16180.0
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773961	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	9.6	10.3	11.1	5.3	11.6	3.4	9.8	11.8	16.8	11.2	10.5	9.5	4.5	10.8	14.3	5.8	11.1	6.3	9.9	11.2	12.6	9.5	13.5	6.4	6.8	11.1	11.6	10.4	6.3	9.5	9.9	6.5	11.8	10.2	6.0	10.2	7.9	8.9	11.1	5.9	5.6	9.2	12.0	5.8	7.1	4.3	12.0	9.2	9.5	12.2	6.8	8.8	7.5	12.3	11.1	8.5	6.9	11.4	28.3	29.2	16.9	14.4	11.0	12.4	6.4	11.9	12.1	18.0	10.5	15.8	5.8	9.0	9.4	12.2	12.8	11.7	8.4	23.3	3.8	22.8	15.6	46.3	4.6	20.1	10.7	9.2	20.4	13.8	22.4	15.7	13.6	2.4	35.5	30.7	15.6	41.0	12.0	20.2	6.2	19.2	7.6	3.5	17.8	12.7	15.8	9.4	12.5	6.1	16.5	5.9	6.4	42.4	13.3	8.5	0.0	19.1	6.4	3.3	6.7	19.9	7.3	31.4	6.1	0.0	5.2	0.9	8.6	4.1	9.6	13.1	10.3	9.0	8.9	5.4	13.0	11.3	0.7	16.3	4.4	10.8	12.0	6.7	11.1	11.6	11.8	16.8	11.2	12.6	11.1	11.6	11.8	12.0	12.0	12.3	15.0	22.4	9.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.3	19.9	0.0	0.0	8.1	7.3	0.0	19.8	3.1	0.0	27.4	12.6	0.0	20.9	16.2	6.0	0.0	0.0	0.0	10.4	15.2	8.9	0.0	7.0	3.8	13.2	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	36.5	7.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	15.7	2.2	9.9	0.0	0.0
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791887	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	4.8	3.8	3.0	2.1	3.3	3.6	5.3	4.8	4.2	4.6	3.0	3.7	1.8	4.0	4.6	4.0	3.8	2.1	4.1	3.1	3.0	4.9	5.2	3.3	2.5	2.8	3.1	5.5	4.4	4.5	4.3	2.7	2.8	4.3	3.8	2.5	5.1	2.8	4.0	5.0	3.5	2.6	2.7	3.5	3.7	5.6	2.8	3.3	5.1	3.3	3.1	3.4	4.2	3.6	12.6	3.3	4.8	8.0	3.1	8.0	3.1	5.8	7.6	7.4	6.5	4.3	7.1	8.4	3.0	4.7	2.5	3.8	6.8	4.2	11.5	7.0	2.5	6.8	4.2	3.9	6.0	10.9	4.1	3.9	3.9	4.1	9.9	6.2	4.7	7.0	7.6	9.3	9.3	3.7	5.2	8.5	5.9	4.6	4.8	2.3	5.7	2.6	4.6	2.7	1.5	3.8	3.7	6.2	8.7	3.3	5.4	8.5	5.8	2.7	2.9	4.5	8.8	4.3	3.7	6.8	4.9	5.7	3.9	0.8	1.0	1.6	1.6	1.1	2.5	1.9	1.6	2.0	1.2	1.3	2.2	1.6	0.1	4.4	0.8	1.5	1.9	1.1	3.0	3.3	4.8	4.2	3.1	3.0	2.8	3.1	2.8	2.7	2.8	3.6	23.2	3.2	11.3	0.0	8.9	0.0	0.0	0.0	0.0	0.0	20.5	22.4	0.0	0.0	2.5	11.0	0.0	29.1	13.4	0.0	66.5	20.0	0.0	11.4	11.8	7.5	0.0	0.0	0.0	20.4	29.8	10.4	0.0	10.5	2.5	17.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	11.4	0.0	0.0	0.0	0.0	19.8	0.0	0.0	2.8	0.0	0.0	30.5	3.6	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.1	7.1	14.7	0.0	0.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"RH-30: 152.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome,Centrosome"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nucleoplasm, Mitotic chromosome"	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	7.5	6.2	2.5	3.6	2.3	2.6	9.2	4.1	2.7	10.5	2.6	5.6	3.9	9.3	9.6	5.6	8.4	5.4	3.7	2.4	1.8	11.6	6.5	5.3	3.6	2.6	2.4	11.4	21.7	6.4	3.7	4.6	2.7	8.2	4.6	3.7	19.4	8.7	2.9	7.3	3.8	7.6	2.1	4.0	7.2	4.2	2.4	1.9	10.1	3.1	3.1	6.3	7.3	3.1	5.4	11.0	4.6	5.9	12.8	12.0	4.0	5.8	10.9	8.9	9.0	5.6	9.5	3.1	7.4	7.6	7.2	5.2	3.7	3.3	9.3	4.0	5.6	14.9	6.6	9.2	11.3	3.7	6.6	12.6	8.7	9.3	9.8	15.2	9.7	13.2	8.9	22.6	5.4	3.8	4.7	11.0	3.4	4.3	8.0	8.5	152.1	10.0	6.0	5.3	4.4	6.0	10.0	7.5	6.2	4.1	11.9	10.0	9.5	13.7	7.7	5.8	6.4	5.7	2.3	3.8	11.3	15.4	10.0	0.4	3.0	0.1	1.8	1.1	7.8	0.5	3.5	2.2	3.1	0.4	1.7	1.4	0.7	1.5	4.6	1.5	2.2	2.3	2.5	2.3	4.1	2.7	2.4	1.8	2.6	2.4	2.7	2.1	2.4	3.1	3.9	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	7.6	0.0	0.0	1.8	1.8	0.0	3.4	1.3	0.0	5.9	5.5	0.0	2.0	6.0	1.9	0.0	0.0	0.0	12.7	4.9	3.4	0.0	2.5	2.5	5.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	16.4	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	4.7	0.0	0.0
EEF1AKNMT	"CGI-01, DFNM1, FEAT, KIAA0859, METTL13"	ENSG00000010165	"EEF1A lysine and N-terminal methyltransferase"	Q8N6R0	1	171781660-171814023	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.1;Cytotrophoblasts: 16.9;Extravillous trophoblasts: 22.3;Hofbauer cells: 17.5;Syncytiotrophoblasts: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA044498: AB_10960884, HPA053705: AB_2682235"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	10.5	12.6	8.0	11.3	8.6	8.2	11.1	9.4	8.3	10.5	8.2	10.7	12.1	10.2	18.6	9.8	12.1	7.1	9.4	7.8	8.4	10.0	10.4	9.6	13.8	9.1	8.3	11.0	10.0	10.6	5.4	9.0	8.3	9.4	11.4	6.2	10.2	10.4	16.4	11.2	11.2	11.5	8.7	11.3	10.0	13.0	8.9	13.2	9.3	13.1	14.2	10.1	8.5	9.2	27.3	63.3	16.7	17.2	23.1	20.7	44.7	33.5	26.2	39.5	30.7	48.2	27.5	49.5	39.3	22.9	26.0	27.3	51.3	26.8	31.2	32.4	29.1	34.3	33.0	21.3	17.0	46.2	33.4	18.5	24.5	41.1	17.7	18.1	23.9	26.6	69.7	16.6	30.3	20.7	36.9	31.3	63.6	54.0	84.1	33.3	21.9	45.8	22.7	27.7	27.3	37.5	25.3	56.8	31.0	40.3	42.0	39.8	19.8	26.6	24.4	27.6	40.0	42.7	51.2	56.7	20.2	31.5	24.5	1.6	8.0	3.0	8.3	7.7	9.6	8.4	8.3	7.1	7.7	6.1	7.4	10.0	2.3	10.5	7.1	8.9	6.7	7.5	8.0	8.6	9.4	8.3	7.8	8.4	9.1	8.3	8.3	8.7	8.9	9.2	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	16.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		840000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: AB_2674422"	"prognostic favorable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	586.3	402.8	181.5	255.4	188.7	685.9	567.1	177.3	262.6	586.6	236.1	512.2	341.2	453.9	131.2	768.3	515.6	144.0	357.5	171.5	181.9	416.1	445.8	357.3	460.2	185.0	181.1	807.9	1586.9	95.6	219.8	139.5	188.0	357.5	292.3	53.0	468.0	147.5	1038.4	764.6	574.1	192.1	192.7	576.2	491.0	163.3	185.5	346.3	266.6	372.2	444.7	487.7	572.5	190.1	278.2	330.0	377.0	357.3	542.8	914.1	816.4	584.5	556.7	560.1	367.4	733.1	454.2	792.3	358.8	648.9	310.4	352.7	520.1	647.3	509.3	245.8	469.2	562.2	442.9	998.5	719.8	1189.2	483.1	932.9	755.6	418.1	939.0	545.0	605.2	629.9	782.8	644.2	628.0	568.2	946.5	916.2	552.5	628.0	565.3	731.7	796.0	1007.4	606.0	521.8	384.1	395.2	211.1	461.8	588.8	439.8	283.3	1349.0	431.1	290.9	403.6	391.7	529.1	681.5	631.0	918.3	338.7	751.5	224.1	93.9	357.8	44.1	432.5	370.9	794.4	1075.6	761.7	576.5	676.4	848.7	1075.2	897.6	47.9	609.1	298.1	650.3	448.7	1770.3	181.5	188.7	177.3	262.6	171.5	181.9	185.0	181.1	188.0	192.7	185.5	190.1	614.8	198.7	346.8	9.4	2022.8	1142.4	1787.7	737.1	1367.0	114.5	1353.8	2138.0	164.5	619.1	474.5	163.7	27.1	853.8	1097.6	591.9	688.7	756.0	187.8	284.9	1021.6	596.6	445.0	1188.1	13.0	1883.8	1657.1	597.5	575.4	403.4	547.2	1584.1	461.2	682.3	823.0	52.2	12.6	1316.9	270.6	826.2	1008.4	463.5	866.7	868.0	533.6	11.2	1049.6	193.2	924.8	6.0	15.4	890.3	990.9	483.7	1393.5	1529.4	1952.4	1222.5	228.5	117.9	269.5	615.5	748.0	153.7	287.4	2237.4	1259.6	950.5	1228.8	1381.0	1734.8	1525.9
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: AB_2681305"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	556.9	600.9	278.8	254.4	299.8	474.5	552.1	276.4	339.0	638.4	302.9	716.0	205.3	497.5	228.5	524.8	523.0	179.7	795.4	267.2	277.0	491.3	582.9	435.3	380.0	303.4	283.3	979.4	1349.3	160.2	328.0	147.2	292.4	609.2	148.3	67.1	577.0	201.9	916.1	615.8	505.9	179.9	281.5	609.6	634.3	288.1	281.7	338.7	504.0	433.0	307.3	538.2	554.0	322.1	454.8	644.8	284.2	246.0	251.0	307.0	314.2	344.2	438.4	536.7	424.0	886.7	420.0	345.5	352.2	386.6	160.4	441.8	295.3	556.0	231.7	274.8	487.6	340.6	1211.8	881.5	373.6	214.1	276.9	594.8	796.6	325.1	367.8	309.6	364.5	282.0	325.2	497.6	309.3	1456.4	838.7	539.7	300.3	580.3	852.3	367.2	204.4	681.0	466.3	757.9	280.0	301.6	300.1	726.3	762.5	174.1	544.3	535.7	285.2	309.9	914.8	465.5	757.5	335.2	142.9	380.2	348.4	431.6	275.3	268.2	535.1	259.6	880.1	503.5	1128.3	1400.1	1110.3	922.6	619.1	1461.9	1365.3	1110.3	408.6	864.7	458.9	874.2	1191.8	2020.0	278.8	299.8	276.4	339.0	267.2	277.0	303.4	283.3	292.4	281.5	281.7	322.1	652.3	163.5	415.9	47.7	1397.8	1846.0	1620.8	1277.4	1438.7	75.7	1568.2	2028.8	3.9	732.0	600.3	342.1	20.9	665.5	942.8	718.8	855.0	751.4	413.0	173.0	441.3	705.7	343.3	639.1	11.3	1793.7	822.0	699.2	520.9	263.8	446.1	931.0	871.7	792.9	799.6	79.1	13.0	971.5	526.9	1361.3	1492.3	1087.1	891.3	823.6	1085.1	17.8	1400.9	502.7	1071.1	15.6	30.2	938.4	799.5	633.1	1098.8	1566.2	998.9	1552.3	241.7	88.9	479.9	1005.6	844.4	34.0	142.2	969.5	1648.6	712.5	1297.8	573.3	870.0	1619.4
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102559	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 244.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	15.5	29.6	26.6	21.5	26.4	57.8	26.5	33.5	33.4	14.9	24.2	18.4	12.0	19.3	26.3	22.6	15.0	13.6	19.1	27.0	31.5	50.6	20.3	13.8	31.7	30.7	34.6	14.7	28.3	31.3	23.9	17.3	31.6	17.8	20.9	25.4	20.0	18.2	22.8	12.3	12.7	19.2	26.7	16.4	23.0	57.5	30.5	25.9	20.6	24.7	31.2	26.4	13.9	30.0	129.5	67.1	104.8	71.9	35.0	56.5	63.6	105.7	67.0	94.4	97.0	111.8	52.5	140.9	229.3	69.8	169.8	51.9	122.3	123.9	156.8	79.6	160.6	113.9	92.0	196.4	63.9	228.2	79.2	47.4	113.5	117.4	116.2	66.4	136.2	113.8	283.3	35.9	91.2	54.0	98.0	183.2	95.8	123.9	107.8	117.9	61.0	221.0	156.3	98.5	156.7	48.0	45.6	100.5	131.9	141.5	79.7	75.7	70.2	77.0	76.7	70.7	156.3	58.4	290.7	199.3	43.1	95.8	126.0	16.2	22.2	14.2	25.7	31.8	36.8	42.9	34.4	34.8	61.2	46.9	38.1	39.5	2.3	30.7	25.5	26.8	45.8	29.3	26.6	26.4	33.5	33.4	27.0	31.5	30.7	34.6	31.6	26.7	30.5	30.0	31.9	16.0	30.0	0.0	39.7	65.9	61.4	99.1	60.3	34.4	43.1	54.1	23.5	21.5	63.4	60.7	10.4	78.7	23.5	11.8	140.8	67.9	244.3	59.0	31.0	34.1	40.1	43.5	0.0	89.0	76.6	30.8	32.1	71.0	15.8	45.4	24.3	30.0	49.7	30.3	0.0	36.6	75.3	31.1	33.4	231.1	26.4	31.3	42.7	0.0	32.6	44.7	29.9	0.0	0.0	69.0	12.9	23.7	48.0	81.3	7.5	186.7	45.9	21.8	13.1	32.8	38.9	131.2	92.2	59.3	76.1	32.3	34.1	69.9	42.0	44.8
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559596-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040688, HPA055316"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		2500000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus"	"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	1237.6	883.6	646.7	951.1	663.7	1897.3	1890.9	640.9	722.0	1595.1	659.8	1229.0	1094.9	1078.6	1079.3	1634.9	1555.9	749.8	1089.3	616.4	690.9	1162.4	885.3	818.1	1532.7	678.1	661.0	2604.5	2191.5	835.7	708.1	780.5	675.9	1219.1	1272.4	416.0	1588.0	875.6	4810.2	2215.7	1098.5	991.5	690.1	1073.0	1090.2	441.9	677.4	1281.7	1050.2	3030.5	1951.7	1173.7	1440.6	676.7	1773.6	1824.3	1859.1	2656.2	2742.6	3529.1	1866.2	1505.0	2692.9	1830.1	1392.3	2045.9	2161.9	5161.2	2365.4	2392.2	1048.0	2018.3	2229.8	2200.1	1663.3	1693.2	2071.2	1348.7	2061.8	2120.7	2974.2	2810.2	1523.6	4060.8	3913.9	1812.1	4419.8	3014.9	2562.7	1777.2	2755.8	2451.2	2190.6	3611.0	3035.5	4895.3	2304.9	1546.3	1575.0	2545.1	2390.9	4978.7	2454.9	2276.4	1608.2	2002.3	901.7	3010.3	4214.5	1179.1	3496.3	3012.0	1759.8	1057.1	1476.4	2070.0	1338.6	1680.0	1783.1	2609.2	1210.8	2005.2	1517.1	883.9	2365.5	589.6	2182.3	2151.6	4333.1	5399.6	4153.2	2825.0	3623.0	5080.7	6117.7	4188.5	320.6	3285.2	1837.0	2869.7	3307.5	11090.3	646.7	663.7	640.9	722.0	616.4	690.9	678.1	661.0	675.9	690.1	677.4	676.7	2.8	150.6	366.9	14.4	403.6	7.9	2.5	8.8	1021.0	0.5	21.9	10.3	0.0	14.3	300.8	1.8	2.1	17.7	9.6	63.7	3.9	124.8	4.3	2.2	7.2	70.2	148.5	405.0	8.4	188.5	26.8	149.5	252.8	3.5	375.6	1.8	11.0	4.9	12.5	0.0	13.8	152.0	4.1	8.8	4.9	18.8	3.1	134.7	1.8	24.4	126.4	0.8	16.5	6.0	13.0	114.9	121.0	2.2	770.5	3.0	132.1	12.1	152.0	0.5	0.0	1.6	43.9	1.4	0.8	1166.7	6.1	21.1	235.3	1.1	223.8	2.3
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985463	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	1022.6	1037.0	771.8	507.3	755.2	920.3	946.7	737.2	1059.6	966.7	807.6	1122.4	821.4	887.6	563.7	1062.3	857.3	501.2	1396.6	740.9	729.1	843.2	1152.9	666.9	685.4	775.4	769.6	1627.6	3194.1	494.0	838.0	386.2	782.3	819.2	344.5	224.7	1276.4	500.3	2322.6	1142.7	798.9	385.4	758.3	721.6	1266.6	490.5	762.7	541.0	793.6	1112.4	499.0	927.8	797.7	745.1	1456.8	1018.4	579.3	1539.4	1515.6	2706.7	830.9	1110.4	1479.8	1036.7	1012.7	1618.1	652.7	3000.6	644.1	1032.3	461.1	1069.8	919.4	1719.4	544.2	755.0	1533.0	768.5	919.9	1677.0	2204.8	1668.0	1277.6	3515.5	1777.2	916.0	1404.1	1497.5	1086.6	1434.4	1526.7	2145.4	642.1	2095.7	1510.1	1266.3	1537.0	518.3	1015.7	1654.2	860.3	1938.3	871.2	1270.2	1575.4	1466.4	699.0	1377.1	2058.3	543.1	1344.7	1992.7	1321.8	738.2	765.7	1521.4	1738.7	2276.4	1644.3	1485.3	1100.4	2065.8	986.6	81.2	455.7	64.1	259.8	333.1	460.2	578.5	453.0	344.6	430.7	478.1	497.2	404.1	43.1	355.3	342.1	358.7	429.4	756.5	771.8	755.2	737.2	1059.6	740.9	729.1	775.4	769.6	782.3	758.3	762.7	745.1	323.1	221.2	392.2	24.5	1125.5	1321.1	1071.3	754.3	1269.7	212.6	981.3	694.3	627.9	597.7	448.3	255.6	77.2	958.1	535.9	556.9	986.1	716.0	799.2	318.2	675.4	568.2	744.2	934.8	23.2	1816.8	1305.0	679.7	619.3	428.5	373.4	596.1	656.8	690.6	610.1	203.6	28.9	982.1	411.0	885.4	859.5	1195.6	1008.4	514.2	645.7	36.5	907.5	429.1	614.8	27.2	42.2	868.2	815.5	832.8	992.8	1010.5	1562.7	1078.8	194.5	134.1	585.1	797.7	697.3	371.5	308.4	1343.0	1347.1	1243.1	727.1	1044.3	1168.4	1051.6
EEF2K	"CaMKIII, eEF-2K"	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206278-22288738	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 69.1;Late spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;HL-60: 1.6;HMC-1: 1.8;NB-4: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	19.8	7.1	1.0	0.4	0.9	0.7	15.9	1.5	2.2	17.2	0.7	20.1	0.3	14.3	0.7	9.1	13.1	0.3	9.2	0.9	1.2	3.6	7.8	9.0	0.5	1.1	0.9	8.2	12.9	0.0	5.2	0.4	1.2	19.6	0.2	0.3	15.0	0.2	24.9	49.0	8.1	0.3	0.9	8.0	9.8	2.3	1.4	0.0	6.3	0.0	0.2	18.8	15.4	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.6	0.2	1.0	0.0	1.6	1.8	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.2	1.3	0.0	0.0	0.1	1.6	0.1	0.4	0.0	0.4	1.0	0.2	0.4	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.2	0.5	0.5	0.7	0.3	1.4	0.0	0.3	0.1	0.3	1.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.1	0.0	1.0	0.9	1.5	2.2	0.9	1.2	1.1	0.9	1.2	0.9	1.4	1.1	43.7	22.4	13.3	22.5	7.3	12.6	9.6	3.9	31.3	69.1	15.4	9.3	17.3	12.8	9.8	9.2	14.6	16.3	12.7	24.2	0.0	4.9	42.9	42.4	12.6	18.4	3.0	7.6	21.2	13.4	11.7	19.2	26.0	34.9	29.2	12.0	22.5	17.7	18.7	1.7	37.4	12.3	4.1	15.3	16.2	76.6	14.3	8.7	8.8	15.9	7.9	6.1	6.2	31.7	8.6	10.2	26.3	15.8	19.6	6.6	12.5	4.0	14.9	21.6	6.6	43.5	10.0	1.3	4.2	16.9	23.0	7.8	7.8	5.7	8.1	6.7
EEF2KMT	"EFM3, FAM86A, MGC19636, SB153"	ENSG00000118894	"Eukaryotic elongation factor 2 lysine methyltransferase"	Q96G04	16	5084284-5097795	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 189.0;Late spermatids: 393.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 104.8"	"Low region specificity"	"Detected in all"							HPA041610	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA041610: AB_2677581"	"unprognostic (4.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"prognostic unfavorable (8.85e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (2.35e-4)"	4.6	5.9	3.2	4.0	3.2	1.1	4.9	2.9	3.4	5.0	3.3	5.0	5.1	6.6	2.7	6.0	4.9	2.8	5.7	2.7	3.4	6.8	8.2	3.7	4.5	3.4	3.5	3.7	6.8	5.8	5.0	2.3	3.4	4.8	3.5	1.1	5.4	4.3	8.5	4.3	4.1	5.2	2.9	4.7	5.3	10.6	3.9	2.4	4.9	3.4	3.5	6.0	4.5	2.9	6.3	20.1	8.9	16.5	9.2	7.3	11.3	11.8	6.7	11.6	7.3	15.1	18.2	17.9	7.6	12.2	15.1	13.5	14.5	14.6	8.5	18.7	15.3	7.7	8.6	25.5	11.5	16.4	9.5	8.4	10.9	13.5	23.6	5.4	11.6	21.3	13.8	16.1	9.6	42.0	7.7	9.8	16.3	33.7	13.6	17.9	9.9	104.8	12.6	8.1	11.0	9.2	14.4	20.0	8.6	6.9	14.0	5.7	7.1	18.7	12.6	59.8	12.3	10.3	13.8	11.8	5.4	12.9	18.3	10.1	7.2	0.7	10.7	13.7	15.8	12.8	10.4	11.6	9.7	9.5	7.9	11.9	0.9	10.5	17.2	2.8	17.8	8.3	3.2	3.2	2.9	3.4	2.7	3.4	3.4	3.5	3.4	2.9	3.9	2.9	7.2	3.2	3.7	0.3	8.6	0.0	9.1	0.0	8.0	2.6	9.7	11.4	1.1	7.2	2.5	5.5	0.0	6.0	3.6	1.8	31.3	18.5	189.0	6.8	14.7	7.3	3.6	3.8	0.7	18.3	12.5	6.0	6.1	4.2	1.3	9.9	6.4	9.9	14.6	6.7	0.9	4.6	0.0	4.1	0.0	393.3	7.8	5.8	0.0	1.9	5.7	7.3	6.2	0.5	1.5	17.0	2.9	3.8	10.2	23.4	3.4	19.6	7.3	2.8	0.0	5.3	6.4	5.8	16.8	12.8	0.0	4.1	5.9	16.2	5.3	8.5
EEFSEC	"EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153481-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	13.5	8.2	0.2	0.2	0.2	0.1	12.5	0.2	0.6	14.2	0.1	11.3	0.0	15.6	0.0	12.3	13.9	0.1	25.5	0.2	0.3	14.3	21.8	9.6	2.2	0.4	0.2	12.3	11.7	3.0	8.8	1.6	0.3	12.1	0.6	0.5	9.7	1.9	24.0	16.5	10.7	0.0	0.2	13.4	11.0	19.3	0.4	0.1	9.9	0.0	1.2	12.7	12.3	0.2	0.5	0.1	4.1	1.7	0.1	0.2	0.5	0.0	0.3	0.2	0.2	0.3	6.9	15.2	0.1	3.8	12.3	1.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.1	5.7	0.3	0.3	0.1	0.1	4.0	0.1	0.2	0.3	0.0	0.1	0.2	3.5	0.2	7.9	0.4	0.4	0.1	0.1	0.3	0.2	1.0	0.0	0.0	0.3	10.4	0.0	17.7	15.4	0.3	9.6	0.7	0.0	0.1	0.0	0.2	0.2	0.4	0.7	0.4	0.1	0.4	0.2	0.4	6.3	6.1	5.0	6.0	3.9	5.4	4.4	4.4	8.7	3.9	4.0	5.0	0.0	7.5	4.8	3.7	5.7	4.3	0.2	0.2	0.2	0.6	0.2	0.3	0.4	0.2	0.3	0.2	0.4	0.2	9.4	0.0	6.0	15.0	17.2	6.4	9.3	9.1	7.4	7.8	6.9	8.6	10.1	8.6	4.4	16.5	2.1	22.3	15.7	6.4	15.6	7.9	27.7	3.1	12.5	8.2	11.4	5.9	25.3	7.1	18.3	10.0	10.2	4.5	28.5	10.0	8.9	14.8	14.6	13.5	36.6	11.7	18.3	7.9	8.2	71.6	13.1	11.4	12.4	28.1	9.8	9.3	17.5	45.8	27.1	5.6	2.7	8.6	17.1	9.4	8.6	25.7	2.7	8.2	26.3	9.0	9.1	27.9	16.9	10.8	9.9	29.7	13.7	11.9	10.6	6.0
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 91.6;testis: 37.5"	"Group enriched"	"Detected in many"	19	"Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.3	1.5	3.1	0.1	4.7	0.7	3.0	1.9	2.5	11.4	22.4	0.5	0.6	12.4	2.5	0.7	91.6	0.6	0.2	3.7	4.9	0.5	0.7	10.6	0.1	13.5	12.1	19.3	3.2	0.0	3.1	0.5	7.0	5.4	0.4	0.0	2.0	5.9	0.0	4.7	1.0	2.9	9.1	0.3	0.6	37.5	5.7	0.4	0.1	0.2	0.2	2.3	3.4	8.5	6.5	0.0	0.8	0.0	2.6	6.2	0.0	0.1	0.6	0.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	1.7	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.2	2.6	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.5	4.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.0	3.1	4.7	1.9	2.5	3.7	4.9	13.5	12.1	7.0	9.1	5.7	8.5	0.4	0.0	5.9	0.0	0.0	6.8	9.7	14.7	4.0	0.0	0.4	9.1	0.4	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	538.8	159.1	4.7	1.2	0.0	0.0	0.7	1.5	0.1	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.2	0.0	0.3	552.0	4.7	0.8	1.8	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	5.7	0.0	3.4	0.0	0.3	310.7	0.0	0.0	0.7	6.2	16.9	4.5	0.1	1.8	0.3	0.4	3.9	0.0	2.5
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.7;testis: 23.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 205.9;Endometrial ciliated cells: 138.5;Late spermatids: 78.7;Respiratory ciliated cells: 243.9;Spermatocytes: 96.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA019751	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.5	0.5	1.0	0.6	2.0	2.4	0.5	1.7	1.3	1.6	11.1	0.6	0.5	1.0	0.2	0.8	29.7	0.2	0.5	1.7	2.3	0.9	1.0	3.2	0.8	5.4	6.9	0.9	1.4	0.0	2.1	0.2	3.8	0.9	0.3	1.3	0.8	0.0	1.2	1.1	0.7	0.0	3.8	1.1	0.6	23.5	3.0	0.1	0.7	0.0	0.1	0.5	0.6	2.4	1.4	3.8	2.0	1.3	0.3	0.1	0.8	1.8	0.0	0.0	0.1	0.7	0.9	1.9	1.6	0.0	0.3	0.5	0.0	0.0	0.0	0.7	3.4	0.9	3.0	2.1	0.2	1.2	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.9	2.8	1.5	0.0	2.9	1.3	2.5	3.4	0.9	1.4	0.9	2.1	4.1	0.2	0.8	1.8	2.5	1.1	3.9	0.6	2.5	0.7	1.4	1.0	1.9	1.3	4.0	1.2	2.1	2.7	1.7	1.1	1.9	0.9	1.0	0.3	0.2	0.4	0.2	0.4	0.3	0.4	0.3	0.1	0.6	0.6	0.5	0.3	0.3	0.2	0.4	0.3	0.1	1.0	2.0	1.7	1.3	1.7	2.3	5.4	6.9	3.8	3.8	3.0	2.4	0.1	0.0	4.4	0.3	0.2	0.0	0.1	11.8	0.0	0.7	0.2	0.3	0.3	0.0	13.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	205.9	138.5	1.2	0.3	0.0	0.0	3.4	0.0	0.1	0.3	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	6.1	0.0	0.0	78.7	2.5	0.4	0.0	0.0	0.0	0.1	0.0	1.5	0.7	0.0	0.0	1.5	0.8	0.2	0.0	0.5	243.9	0.2	0.0	0.6	3.5	96.3	2.5	0.0	0.0	0.1	0.5	0.1	0.0	0.1
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 20.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 169.8;Late spermatids: 185.7;Spermatocytes: 64.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	3.2	2.6	1.3	3.2	2.3	3.9	4.2	3.7	2.0	3.8	0.9	2.9	4.8	6.0	4.0	1.6	3.5	2.9	2.5	1.1	2.9	5.4	3.5	3.1	4.5	2.9	2.5	3.8	1.8	3.2	2.5	3.6	3.3	2.7	3.3	3.9	2.3	1.9	0.8	2.2	3.3	2.4	1.7	4.4	3.6	20.5	2.8	1.8	14.2	0.4	3.2	2.6	2.4	4.3	0.9	3.7	1.5	0.2	1.8	6.4	2.8	2.1	0.4	0.6	1.0	1.7	5.2	0.3	5.8	0.7	0.0	1.0	0.0	0.4	3.5	0.1	0.5	4.9	3.4	0.5	1.8	3.8	0.5	1.2	1.7	2.4	0.0	4.4	4.1	3.8	1.5	9.0	2.2	0.1	1.7	2.1	0.8	2.6	2.9	4.5	1.1	1.8	8.3	3.0	1.1	0.5	1.1	0.1	2.5	1.1	6.0	4.5	1.5	0.2	1.1	0.3	1.0	9.4	6.9	0.9	5.5	7.3	3.8	2.8	1.0	0.3	0.5	0.6	0.4	2.2	0.4	0.3	0.5	2.6	1.2	0.7	0.0	0.5	0.4	0.3	0.1	0.3	1.3	2.3	3.7	2.0	1.1	2.9	2.9	2.5	3.3	1.7	2.8	4.3	5.3	9.6	2.2	7.2	7.9	0.8	1.8	0.9	0.6	2.5	2.3	2.4	6.2	1.5	1.3	0.0	0.0	0.3	1.3	0.4	0.0	1.0	169.8	1.9	2.5	6.0	3.0	1.3	8.0	0.9	0.1	4.1	2.6	5.4	6.3	1.3	4.6	0.5	1.9	3.3	10.1	0.4	2.0	2.9	2.0	185.7	1.8	2.6	0.0	32.8	2.7	1.0	0.0	13.0	19.5	1.1	0.3	3.8	1.4	1.1	1.2	1.6	3.3	2.9	0.0	3.2	4.0	64.1	24.5	0.0	0.6	0.0	2.3	1.2	0.7	1.3
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46674659-46719146	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 159.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		110000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	49.8	23.8	26.0	25.4	35.5	8.5	30.5	31.9	21.3	42.4	15.5	37.4	30.2	31.7	24.7	39.6	38.4	33.3	36.1	21.3	28.1	44.2	30.6	43.0	26.2	37.5	33.7	35.8	23.1	159.5	18.0	43.6	33.4	30.7	39.3	12.3	30.5	40.1	34.6	28.7	31.5	38.9	29.9	31.7	65.9	27.3	29.9	34.1	43.9	45.9	35.2	40.1	27.1	38.2	34.9	20.3	13.4	23.8	75.2	48.6	37.3	35.4	56.7	40.3	40.6	22.4	23.1	26.5	38.5	51.6	53.7	41.0	28.1	41.3	51.7	62.4	16.9	33.8	15.1	8.7	26.9	44.3	67.1	43.9	61.5	31.4	28.2	37.4	52.6	26.3	23.5	37.9	37.7	12.4	30.6	10.6	22.2	39.8	21.1	22.1	45.9	25.2	37.6	68.4	7.4	9.9	47.7	64.2	29.9	43.3	29.0	38.6	46.0	33.1	16.8	38.1	37.0	38.0	65.2	22.7	43.6	34.5	25.9	23.4	22.6	36.8	25.3	28.0	34.0	18.0	23.0	22.9	19.5	17.0	21.0	21.7	15.4	21.8	26.3	14.1	21.1	24.3	26.0	35.5	31.9	21.3	21.3	28.1	37.5	33.7	33.4	29.9	29.9	38.2	152.3	73.7	84.6	31.3	45.9	31.7	52.3	32.0	44.9	31.6	56.3	34.0	44.9	47.1	46.1	114.0	31.3	40.6	64.4	80.8	31.3	36.2	70.6	36.1	37.4	74.8	37.8	31.1	20.3	38.4	32.0	48.8	79.0	52.2	101.8	27.4	50.7	57.9	42.2	47.1	27.8	64.6	54.9	75.5	44.0	18.9	47.2	52.0	26.6	29.0	65.0	50.6	84.5	29.7	46.2	48.5	61.3	49.7	34.8	73.8	50.5	34.4	49.9	18.6	26.3	50.2	49.9	51.3	27.7	46.5	43.5	59.0	52.0	30.4	46.2	128.4
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.1;THP-1: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	13.0	10.6	11.5	6.7	13.8	14.4	16.0	14.4	21.9	8.7	26.7	6.8	3.3	21.2	17.5	10.5	36.1	14.7	15.0	11.4	14.4	11.1	5.6	12.6	9.6	18.1	16.9	11.3	9.0	15.4	8.5	16.8	13.9	8.9	12.4	17.7	8.8	13.1	19.7	6.9	7.4	11.4	14.9	7.5	12.4	28.0	12.9	7.4	26.8	7.5	10.7	8.2	4.9	16.3	7.3	9.1	20.3	5.2	7.2	16.7	24.7	9.2	9.7	11.5	10.6	23.5	19.5	25.3	19.2	11.6	12.2	5.7	8.2	5.3	7.1	2.7	5.0	12.4	41.3	10.7	15.2	12.8	77.1	14.6	11.0	15.5	14.4	13.7	18.0	0.7	48.0	20.1	10.0	7.6	2.6	34.6	26.0	10.4	6.9	48.4	3.1	6.8	29.0	12.3	15.9	21.4	16.0	6.1	13.6	22.7	5.9	70.5	2.8	14.1	5.3	7.9	33.7	6.9	12.4	17.2	11.2	35.9	11.7	0.9	1.3	2.3	0.4	1.4	0.5	3.1	0.5	0.3	4.3	3.3	0.4	0.4	3.8	2.3	1.1	8.7	0.6	1.0	11.5	13.8	14.4	21.9	11.4	14.4	18.1	16.9	13.9	14.9	12.9	16.3	13.3	3.2	14.5	76.0	11.5	5.1	11.8	17.2	10.2	12.6	11.6	11.0	58.6	8.6	23.0	23.9	14.6	16.3	9.3	5.4	50.9	8.2	112.3	103.1	18.5	11.7	18.8	17.2	54.6	10.8	46.3	15.5	11.2	11.1	0.0	13.6	12.5	7.3	11.2	5.0	90.3	6.5	22.4	21.3	6.5	132.5	9.0	13.2	7.2	42.2	6.6	19.2	1.0	74.9	75.9	5.6	6.6	6.4	12.0	7.1	2.7	35.6	177.2	19.1	6.6	15.5	15.8	115.9	30.6	5.4	3.0	34.2	7.5	8.3	6.9	10.6
EFCAB3	FLJ25818	ENSG00000172421	"EF-hand calcium binding domain 3"	Q8N7B9	17	62343941-62416480	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 6.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 74.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046862	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA046862: AB_2679844"													"unprognostic (2.99e-6)"					0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.2	0.4	0.4	0.0	0.0	1.3	0.0	0.2	0.4	0.0	0.3	1.3	0.3	0.4	0.3	0.0	1.7	0.9	0.0	0.0	0.0	1.1	8.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.3	0.0	0.2	0.1	0.1	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.3;Excitatory neurons: 58.9;Inhibitory neurons: 47.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	2.7	5.3	7.3	2.2	7.6	2.0	6.0	8.9	10.3	5.8	10.1	3.4	2.0	6.1	6.2	2.9	8.1	4.6	6.5	7.4	9.3	5.6	1.7	4.0	3.6	6.8	7.2	8.0	2.9	10.4	5.9	3.2	7.0	5.4	3.0	8.9	3.1	5.0	6.7	3.1	2.1	4.7	6.5	2.7	3.2	14.6	8.2	7.3	5.9	3.9	3.3	3.7	2.8	8.3	6.5	5.7	7.1	4.5	7.5	11.0	3.6	4.1	4.6	7.2	8.8	1.7	5.0	4.4	9.6	2.5	14.5	6.0	6.1	4.1	8.5	8.6	4.3	3.6	10.4	3.9	4.6	5.1	3.2	6.1	9.9	8.6	5.6	11.4	6.1	8.2	4.8	7.3	4.7	1.5	9.9	3.5	3.1	4.6	5.6	6.2	10.7	4.6	11.1	3.6	15.2	5.8	8.1	4.5	10.5	9.6	4.5	3.8	1.7	4.1	3.5	12.1	4.0	4.7	8.7	5.0	7.4	3.5	6.0	10.1	0.4	0.1	1.2	0.3	1.6	1.8	1.4	1.4	0.8	1.9	1.4	1.3	0.0	1.3	2.6	1.0	1.6	0.6	7.3	7.6	8.9	10.3	7.4	9.3	6.8	7.2	7.0	6.5	8.2	8.3	3.1	12.8	4.1	23.2	6.0	3.1	5.6	7.0	5.7	7.7	2.6	3.9	7.8	2.8	5.6	5.5	4.2	3.7	2.1	0.6	7.9	3.8	55.3	19.9	8.0	3.2	1.8	1.3	58.9	0.7	2.0	5.6	3.6	3.4	2.5	7.9	2.2	1.2	2.6	0.0	47.7	1.3	8.2	2.5	1.6	8.8	10.8	1.8	1.8	14.0	1.9	5.2	2.1	41.7	21.9	1.4	0.3	13.5	6.0	1.4	0.5	5.5	27.5	11.3	26.3	11.8	5.3	73.4	22.7	3.8	2.3	1.2	3.4	5.8	2.1	1.6
EFCAB8		ENSG00000215529	"EF-hand calcium binding domain 8"	A8MWE9	20	32858923-32961609	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.7;Late spermatids: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034246, HPA042751"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"CAB034246: AB_1565078, HPA042751: AB_2678145"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.10e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.44e-10)"	"unprognostic (1.66e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.74e-3)"	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	3.4	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001629-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Endothelial cells: 6.5;Enteroendocrine cells: 9.5;Fibroblasts: 10.7;Microglial cells: 9.4;Peritubular cells: 7.5;Sertoli cells: 6.6;Theca cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 1.3;HL-60: 3.7;U-266/84: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042798, HPA050888"	Uncertain					NA	NA				"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA042798: AB_2678173, HPA050888: AB_2681263"	"unprognostic (1.74e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.70e-4)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.20e-1)"	1.7	0.4	0.8	0.4	0.2	0.1	1.8	1.8	1.0	1.2	0.0	3.5	1.9	1.9	0.1	0.9	1.6	0.5	2.3	2.2	1.4	1.2	0.5	5.6	0.1	1.7	1.0	3.4	0.5	0.1	1.3	0.3	1.8	2.0	0.4	0.0	0.7	0.2	1.0	1.1	2.5	0.1	0.5	2.7	2.1	0.4	1.1	0.2	2.2	0.5	0.0	2.0	1.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	1.8	1.0	2.2	1.4	1.7	1.0	1.8	0.5	1.1	0.0	7.1	0.0	1.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	1.4	0.2	0.3	6.5	9.5	3.6	1.3	0.6	0.0	10.7	0.0	0.2	0.0	0.4	3.6	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.8	5.3	4.7	0.1	1.8	9.4	0.0	0.0	2.1	0.0	0.1	0.1	0.0	7.5	0.0	0.1	0.0	0.2	0.0	0.0	6.6	1.1	2.4	0.2	0.4	0.0	0.4	0.1	0.3	22.0	0.2	0.1
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 122.8;Leydig cells: 93.5;Muller glia cells: 84.8;Peritubular cells: 107.2;Smooth muscle cells: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 159.7;fHDF/TERT166: 232.6;HSkMC: 155.3;hTERT-RPE1: 159.1;LHCN-M2: 134.5;U-138 MG: 114.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	38.4	18.0	19.8	13.8	21.1	2.8	29.5	18.8	26.7	46.6	22.1	39.6	9.3	55.2	8.3	12.8	35.8	33.5	61.6	19.1	20.4	26.8	7.0	32.1	9.1	24.9	20.0	47.0	19.9	26.8	15.2	22.4	21.4	31.1	6.5	5.9	17.4	35.2	21.2	14.9	16.2	32.3	20.3	16.1	20.6	8.2	21.4	5.6	39.1	22.0	5.0	33.1	30.7	19.1	0.5	0.2	2.1	47.3	54.3	108.0	0.8	125.8	159.7	48.1	44.8	0.0	4.3	0.7	9.3	232.6	0.7	0.9	0.0	1.3	12.1	5.4	0.1	1.1	3.2	8.0	89.1	0.0	0.4	155.3	0.4	18.9	1.0	159.1	28.5	1.0	0.3	8.0	134.5	0.4	0.2	20.7	1.6	0.2	0.6	0.4	0.3	3.2	1.6	0.6	0.7	14.1	0.2	1.3	1.5	6.6	1.5	10.0	64.6	114.2	24.7	52.6	0.6	10.9	0.7	0.3	42.6	0.8	19.7	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	0.2	19.8	21.1	18.8	26.7	19.1	20.4	24.9	20.0	21.4	20.3	21.4	19.1	30.8	35.3	7.4	29.0	1.5	13.5	38.9	33.9	8.6	7.7	10.2	27.6	46.0	15.7	11.4	18.4	0.0	2.4	2.3	0.3	7.9	28.7	15.6	3.4	57.1	27.9	0.0	0.4	1.1	0.2	3.9	122.8	2.6	4.1	0.0	74.3	42.8	1.8	9.8	6.7	2.9	0.3	4.1	3.5	19.1	33.3	93.5	3.0	24.9	9.4	0.7	84.8	2.1	9.5	1.6	2.6	0.1	107.2	1.4	30.1	0.2	21.2	9.0	4.8	39.5	41.1	113.2	35.9	3.3	1.1	10.1	5.9	2.4	78.5	0.3	14.2
EFHC1	"EJM, EJM1, FLJ10466, POC9, RIB72"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 34.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 242.0;Endometrial ciliated cells: 227.5;Respiratory ciliated cells: 529.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035307	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.4	3.9	4.4	1.9	6.6	3.6	5.4	4.9	5.8	8.8	24.6	5.4	2.1	6.8	6.7	3.3	34.6	3.6	3.8	4.4	4.5	5.6	2.5	6.5	2.4	8.1	8.3	7.3	4.5	5.6	15.5	3.6	5.2	5.6	3.3	21.7	5.1	3.8	2.1	5.7	3.9	3.4	5.6	3.4	4.2	17.6	5.2	2.0	9.3	1.3	2.0	4.7	5.4	6.7	3.5	3.9	9.3	6.4	9.0	15.3	1.8	4.1	10.6	5.5	8.6	2.4	4.1	1.5	9.0	6.8	10.5	3.6	2.7	7.6	7.1	0.8	3.3	1.4	11.0	3.3	6.2	1.5	1.6	7.3	4.2	7.8	7.2	25.9	11.7	1.7	3.1	2.4	8.4	3.1	1.7	2.3	2.8	2.7	1.5	2.3	5.1	1.9	7.4	1.3	18.5	5.2	1.0	1.8	8.4	11.8	6.5	1.6	3.8	4.0	5.3	1.5	3.2	2.1	2.8	2.7	11.2	0.5	7.3	0.7	0.6	1.5	0.7	0.2	0.3	3.8	0.3	0.6	1.4	3.9	0.3	0.6	2.0	1.5	0.3	6.1	0.2	0.4	4.4	6.6	4.9	5.8	4.4	4.5	8.1	8.3	5.2	5.6	5.2	6.7	14.5	6.4	14.9	32.7	24.2	18.1	36.0	49.5	53.5	23.1	31.3	19.2	4.5	17.2	44.7	42.3	60.5	12.6	10.2	9.9	0.0	18.8	242.0	227.5	19.0	15.0	25.0	6.5	25.6	8.0	17.8	27.1	14.3	15.3	8.2	22.6	17.5	5.6	7.8	13.5	26.3	14.9	69.2	10.6	14.5	73.8	28.3	6.9	16.0	14.0	8.8	10.9	20.6	22.1	23.8	11.0	15.9	22.2	13.8	17.4	24.8	6.9	529.7	47.5	32.9	29.3	21.3	93.5	22.8	13.2	12.1	4.5	9.0	28.8	10.1	27.8
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147872-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 17.1;fallopian tube: 14.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 16.4;NK-cell: 5.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.4;NK-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.4	0.3	1.5	0.3	1.9	1.4	0.7	1.0	1.4	2.7	17.1	1.1	0.3	3.7	3.4	1.8	14.7	1.4	3.7	1.5	2.1	1.8	0.0	2.0	0.2	5.2	3.9	1.7	0.1	0.2	3.1	0.8	2.8	1.9	0.3	2.0	8.2	3.6	0.0	3.5	0.5	1.6	2.7	0.3	0.9	6.7	2.5	0.5	2.3	0.1	0.4	0.5	0.9	2.6	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	12.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.5	0.0	0.6	0.1	0.6	0.1	0.3	0.1	0.5	0.7	1.5	5.8	0.0	0.0	0.0	0.9	1.5	1.9	1.0	1.4	1.5	2.1	5.2	3.9	2.8	2.7	2.5	2.6	0.1	0.0	3.9	32.0	0.0	3.1	6.0	9.6	1.2	0.2	0.4	0.5	10.8	4.3	5.1	0.0	2.1	0.0	1.6	1.2	1.9	0.9	78.6	55.3	6.0	0.3	0.0	1.7	7.2	5.9	0.1	0.8	0.0	17.1	16.4	3.8	0.4	0.0	0.3	0.0	1.7	1.5	4.1	0.0	0.4	19.0	6.8	4.9	0.0	0.0	0.4	5.3	3.1	1.5	0.2	1.0	0.0	7.2	0.2	1.0	3.8	0.7	79.6	0.1	6.6	0.1	3.7	11.3	10.5	7.3	2.8	0.3	1.6	0.4	5.2	6.0
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 414.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA		14000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	86.3	7.0	199.7	3.7	303.2	0.8	180.7	244.9	261.3	86.9	129.9	16.9	4.4	72.4	33.7	9.6	73.7	12.0	46.0	196.6	217.4	186.2	54.6	15.3	3.9	253.6	258.7	76.5	86.5	10.5	16.5	77.9	261.8	25.6	5.7	9.5	22.2	27.7	35.5	30.9	16.2	20.6	201.4	52.5	17.6	20.1	237.8	3.0	32.7	42.7	2.4	22.0	44.5	414.6	0.0	3.4	5.7	1.4	2.2	0.1	125.8	26.8	2.1	2.3	1.9	0.9	0.6	0.1	2.0	11.6	2.9	0.2	19.0	0.0	0.3	0.5	9.2	0.0	2.4	1.9	0.0	0.1	0.3	1.0	0.4	0.2	0.0	0.4	0.0	5.5	3.9	0.5	0.5	2.3	0.6	0.2	8.4	0.0	0.2	0.6	7.2	0.4	68.6	0.7	0.3	3.2	9.1	301.8	18.3	42.3	236.9	2.6	0.0	0.0	1.8	0.4	0.8	0.2	0.1	0.1	0.3	0.1	13.4	1.0	0.2	0.1	0.2	0.1	0.4	0.3	0.3	0.4	0.1	0.1	0.6	0.6	2.2	0.1	0.1	0.2	0.1	0.1	199.7	303.2	244.9	261.3	196.6	217.4	253.6	258.7	261.8	201.4	237.8	414.6	15.6	0.0	0.0	37.5	1.5	3.6	2.8	1.3	1.2	0.5	241.8	129.0	7.4	1.5	4.6	35.0	0.0	112.0	3.0	0.3	393.2	0.0	9.0	1.1	37.8	16.8	0.0	2.7	2.6	0.0	19.7	41.1	0.0	1.7	0.0	3.2	6.4	89.4	8.7	0.0	5.3	0.1	59.0	1.3	3.0	7.0	44.4	2.1	8.8	18.7	0.0	48.0	0.0	1.5	173.4	0.0	0.0	57.2	0.1	4.6	0.0	116.5	1.9	1.4	197.2	8.7	130.9	17.3	13.6	0.4	3.1	263.9	2.5	1.5	0.3	2.0
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409888-15430339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 372.4;NK-cells: 416.1;Pancreatic endocrine cells: 481.2;Urothelial cells: 431.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 133.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 370.3"	"Low region specificity"	"Detected in all"							HPA048961	Enhanced		Approved	Cytosol		No	No		220000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA048961: AB_2680572"	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (2.70e-4)"	"prognostic favorable (3.60e-5)"	37.7	78.9	52.5	77.7	56.8	174.3	27.5	31.6	76.9	32.8	20.4	74.3	83.3	33.7	5.9	58.7	29.3	32.9	28.5	75.4	34.9	23.0	33.3	60.0	46.3	100.2	31.4	26.9	75.7	10.7	28.6	21.4	101.7	44.6	29.6	2.7	27.3	19.0	6.4	35.9	96.4	17.3	29.6	140.0	92.0	95.2	36.1	25.2	41.6	4.9	29.5	62.6	40.5	62.9	370.3	91.8	8.8	23.8	14.1	30.0	46.8	46.0	43.4	42.7	40.5	35.5	98.8	79.6	141.6	32.1	54.8	88.1	24.5	80.9	27.0	99.8	47.8	19.1	21.6	57.4	22.5	98.1	160.1	23.9	27.2	87.0	21.9	19.9	55.5	35.5	46.4	37.6	26.6	36.8	50.8	188.6	11.6	50.1	112.9	67.2	82.1	63.4	25.3	76.2	20.1	15.6	40.5	34.3	76.8	6.9	15.1	104.8	105.4	62.5	66.9	196.7	74.8	25.4	63.8	34.9	87.4	193.2	86.8	16.3	33.8	52.5	44.0	34.4	12.7	3.9	9.8	20.9	29.5	4.2	4.6	18.0	133.2	28.5	30.0	10.3	7.6	17.0	52.5	56.8	31.6	76.9	75.4	34.9	100.2	31.4	101.7	29.6	36.1	62.9	54.2	3.2	12.2	5.9	44.1	66.2	123.7	25.2	26.7	1.8	21.3	23.0	7.2	32.9	24.4	22.0	10.4	23.7	372.4	280.0	19.6	69.6	93.6	55.4	28.8	52.6	61.7	28.0	33.9	259.4	222.8	31.1	157.0	69.4	44.5	49.4	23.6	20.9	219.3	0.0	21.9	160.8	24.4	217.1	188.2	221.2	9.9	246.9	23.2	13.1	171.3	4.9	416.1	0.5	3.7	481.2	190.5	6.8	62.9	112.2	305.8	28.1	25.7	5.0	46.0	26.7	28.5	5.4	5.7	48.9	68.5	53.4	120.1	178.3	117.8	431.4
EFL1	"EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1"	ENSG00000140598	"Elongation factor like GTPase 1"	Q7Z2Z2	15	82130233-82262734	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Elongation factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039654, HPA047110, HPA052345"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.92e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (8.58e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.05e-2)"	6.2	7.4	5.0	8.2	5.3	8.8	9.9	4.9	5.4	7.3	6.7	13.3	11.6	7.1	7.5	8.3	7.7	7.0	7.3	4.6	5.4	8.6	9.3	6.9	9.6	5.0	5.1	4.9	6.2	14.7	4.6	6.9	5.7	7.2	16.5	7.2	6.7	6.8	11.6	9.0	12.8	8.8	4.8	7.0	8.3	11.2	5.3	16.6	7.8	12.4	10.8	8.1	7.2	6.0	9.8	24.5	18.0	14.9	11.7	16.1	11.6	28.0	33.1	19.9	26.1	12.2	16.7	24.0	11.4	21.4	25.2	24.9	47.5	18.5	31.8	21.8	23.1	26.8	20.2	9.3	18.3	17.0	18.3	7.9	28.9	20.5	46.0	23.7	27.0	30.8	20.5	10.8	23.6	14.1	22.5	13.9	16.0	17.5	12.6	23.8	26.4	13.3	14.1	29.7	15.8	16.8	17.7	20.5	21.6	30.7	15.6	15.1	22.9	28.1	18.5	71.6	28.6	13.4	54.9	20.1	25.1	32.2	10.5	23.1	5.7	14.6	8.6	8.2	6.9	9.4	8.0	7.5	7.0	9.9	6.9	6.0	1.0	6.5	9.9	3.3	7.9	4.8	5.0	5.3	4.9	5.4	4.6	5.4	5.0	5.1	5.7	4.8	5.3	6.0	4.1	3.2	5.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.7	3.9	0.0	0.0	4.3	0.0	0.0	7.1	5.5	0.0	3.9	6.8	0.0	9.2	5.1	1.4	0.0	0.0	0.0	6.0	4.0	2.5	0.0	9.5	5.1	16.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.4	0.0	0.0	5.5	7.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.8	2.9	4.9	0.0	0.0
EFNA1	"ECKLG, EPLG1, GMAN, LERK1, TNFAIP4"	ENSG00000169242	"Ephrin A1"	P20827	1	155127876-155134899	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 472.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 942.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 11.4;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in single"	23	"T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 266.5;HaCaT: 95.5;SiHa: 156.9;SK-BR-3: 227.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069549	Approved				"Secreted to blood"	NA	Yes		2800000	"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA069549: "	"unprognostic (5.14e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	43.2	24.0	25.6	4.9	30.0	1.3	64.7	27.2	33.9	31.7	21.8	42.5	57.9	23.7	28.5	54.7	23.2	24.5	47.1	25.5	25.9	73.8	472.8	86.7	8.1	31.0	29.0	17.5	53.6	29.7	19.5	109.9	29.8	79.5	51.6	7.8	66.6	22.1	18.5	123.1	69.3	13.4	27.8	8.6	40.7	4.1	27.6	21.0	79.9	38.6	12.5	36.9	55.5	35.2	15.1	5.9	0.9	11.5	2.1	0.1	266.5	0.0	0.5	0.2	0.3	13.9	32.0	0.0	26.3	0.0	9.0	95.5	6.6	35.3	0.2	9.8	2.2	0.1	19.0	76.1	0.9	0.2	1.5	4.9	84.5	0.0	30.2	7.3	53.6	0.9	2.8	0.3	0.0	52.2	0.3	1.1	1.7	52.3	17.7	6.1	1.5	9.3	66.4	22.4	9.8	14.2	156.9	227.1	6.0	48.8	51.1	0.0	6.7	0.1	9.1	0.6	1.5	2.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.7	0.0	0.3	11.4	5.9	0.4	0.4	0.0	0.0	0.0	1.6	25.6	30.0	27.2	33.9	25.5	25.9	31.0	29.0	29.8	27.8	27.6	35.2	116.8	198.7	113.1	0.7	2.3	127.7	103.7	91.6	327.8	3.0	198.3	151.9	47.8	95.8	101.2	18.4	0.0	195.6	4.4	265.0	13.7	130.1	0.3	100.4	19.1	148.9	18.6	4.0	0.7	63.9	942.6	23.2	124.9	163.5	6.3	0.1	106.4	133.2	28.2	5.0	0.8	114.1	101.7	4.3	19.5	0.7	4.7	4.2	62.2	2.8	0.6	5.7	0.0	3.5	28.7	73.9	205.5	0.4	4.1	197.8	238.6	34.5	54.5	1.1	0.0	6.5	35.9	0.8	2.6	253.2	217.8	254.2	7.5	1.3	95.9	135.9
EFNA3	"Ehk1-L, EPLG3, LERK3"	ENSG00000143590	"Ephrin A3"	P52797	1	155078837-155087538	"Predicted membrane proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.9;skin 1: 102.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.2;Basal squamous epithelial cells: 44.3;Extravillous trophoblasts: 30.0;Squamous epithelial cells: 32.6;Suprabasal keratinocytes: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 46.3;SCLC-21H: 26.8;T-47d: 25.3"	"Low region specificity"	"Detected in all"							CAB010494	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"			"CAB010494: AB_2097783"	"unprognostic (3.75e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.66e-10)"	"unprognostic (2.83e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-3)"	1.3	2.1	14.0	0.7	15.1	0.2	5.2	7.4	23.3	13.1	5.0	3.5	1.0	1.3	3.8	30.9	0.8	0.6	1.0	17.9	12.3	1.6	3.4	0.7	0.6	13.9	10.6	1.6	1.1	5.6	14.5	0.8	13.3	2.3	3.6	3.2	5.5	0.5	0.8	102.4	1.5	0.7	8.7	1.2	1.1	3.6	12.5	1.1	1.0	0.6	2.4	0.9	28.0	15.4	6.1	1.5	2.6	16.6	2.9	1.5	1.9	0.3	0.5	0.7	1.0	1.0	2.6	4.7	2.7	0.6	1.5	10.0	18.4	3.7	0.6	2.8	4.0	0.6	0.6	1.3	0.3	0.7	3.3	0.8	4.5	0.3	1.1	7.7	1.4	3.0	3.0	2.9	0.6	8.3	0.9	2.5	1.8	46.3	4.8	6.0	1.5	15.6	2.0	0.2	26.8	8.2	1.0	17.7	0.5	2.3	25.3	0.9	0.5	1.8	5.1	0.8	0.5	5.6	2.6	1.1	3.1	2.4	0.2	0.0	0.6	0.8	0.8	0.8	0.8	1.0	0.6	0.4	1.4	1.2	0.9	0.5	0.0	2.7	0.3	1.1	1.6	0.4	14.0	15.1	7.4	23.3	17.9	12.3	13.9	10.6	13.3	8.7	12.5	15.4	3.8	0.0	0.6	2.0	2.1	63.2	3.8	13.6	44.3	1.5	16.9	12.2	0.2	0.0	4.4	0.0	0.0	1.1	3.5	8.6	1.9	3.9	0.6	1.6	0.7	4.2	1.2	0.0	6.5	2.9	30.0	1.5	0.0	1.6	0.0	1.6	1.1	1.1	2.1	3.3	7.9	9.1	2.0	1.2	6.8	1.1	1.2	1.3	8.8	1.0	0.8	9.6	3.1	0.0	1.3	3.2	7.4	0.4	0.4	9.9	6.1	1.3	1.1	1.3	0.0	1.1	8.8	6.5	9.3	32.6	108.8	2.9	2.2	10.1	7.4	3.8
EFNA4	"EPLG4, LERK4"	ENSG00000243364	"Ephrin A4"	P52798	1	155063737-155069553	"Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 86.1;Theca cells: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB021350	Uncertain				"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB021350: "	"unprognostic (4.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.97e-3)"	"prognostic unfavorable (3.14e-4)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.29e-2)"	3.7	12.0	3.2	4.5	3.3	1.3	9.4	3.3	3.4	11.1	4.5	11.7	10.5	6.5	12.4	18.6	4.9	5.2	3.5	3.3	3.0	6.9	8.3	4.5	5.1	3.6	3.4	9.9	5.7	7.9	2.5	4.5	3.5	9.1	12.1	0.9	13.1	4.3	1.3	30.2	10.7	4.3	3.4	6.5	5.9	2.3	3.3	3.8	6.2	1.8	7.3	4.8	14.2	3.5	11.4	8.5	20.4	30.4	11.8	7.5	17.0	5.1	9.6	9.7	9.0	12.5	18.5	14.6	28.2	5.1	7.7	26.2	12.3	7.6	3.9	6.9	3.7	1.4	7.7	17.8	4.3	3.3	22.0	4.5	23.2	4.9	5.7	8.4	19.7	11.9	6.2	9.5	5.5	25.2	7.5	8.3	37.6	43.3	17.5	26.0	8.1	14.3	15.2	9.6	4.9	22.3	10.1	37.1	4.5	14.7	24.3	10.2	10.2	5.8	17.0	11.7	7.8	9.7	11.0	14.6	5.5	7.8	5.9	0.1	10.1	7.3	7.7	9.2	8.0	22.9	8.5	8.8	8.3	17.3	11.8	8.1	10.9	3.9	13.7	25.2	8.9	6.6	3.2	3.3	3.3	3.4	3.3	3.0	3.6	3.4	3.5	3.4	3.3	3.5	2.5	0.0	6.3	2.0	9.0	25.1	8.6	21.2	19.4	0.2	20.7	15.6	1.3	8.6	12.1	16.5	0.0	9.2	12.3	23.9	1.9	32.4	0.1	4.9	4.5	6.8	3.0	2.1	0.2	14.0	86.1	8.4	3.6	6.6	1.3	15.6	5.7	3.6	12.8	0.0	0.2	18.7	8.2	6.3	6.8	0.4	7.8	5.3	17.8	1.0	5.9	5.6	4.1	0.0	0.8	21.5	37.0	5.7	2.2	21.2	38.3	4.4	6.5	0.2	0.0	1.7	6.0	0.5	4.1	15.4	32.7	9.9	7.2	73.3	28.3	10.8
EFNA5	"AF1, EPLG7, LERK7"	ENSG00000184349	"Ephrin A5"	P52803	5	107376894-107670937	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 35.2;RPTEC TERT1: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013282, HPA054047"	Approved		Approved	Vesicles,Cytosol		NA	Yes		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"CAB013282: AB_2533353, HPA054047: AB_2682355"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.98e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.46e-3)"	"unprognostic (4.92e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.92e-7)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.27e-1)"	4.1	1.1	4.5	2.0	6.5	0.1	4.0	1.3	13.6	10.1	0.0	2.3	0.8	1.1	2.0	7.1	2.9	2.7	6.8	3.1	10.2	3.4	0.3	2.4	0.8	0.9	0.3	4.0	0.5	2.5	2.7	2.4	0.6	4.3	2.3	2.5	5.6	4.7	0.5	9.7	0.8	2.2	0.0	5.3	2.5	1.4	2.1	1.4	1.0	1.4	2.5	3.5	4.8	5.4	12.7	22.2	35.2	0.0	16.7	14.2	3.6	0.3	6.3	4.5	11.6	0.2	13.9	0.0	20.5	2.4	7.1	13.1	19.4	18.0	3.6	0.0	12.9	0.1	11.9	0.0	3.1	0.6	0.0	16.0	15.4	0.0	14.4	3.9	13.8	0.0	0.0	0.0	8.3	12.0	0.0	0.0	4.6	0.1	1.9	0.0	16.9	0.4	50.9	15.5	5.8	14.7	6.0	8.9	3.8	11.2	3.9	2.2	0.2	28.3	5.0	17.4	7.1	1.2	0.0	8.3	12.4	0.8	31.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	4.5	6.5	1.3	13.6	3.1	10.2	0.9	0.3	0.6	0.0	2.1	5.4	1.1	9.6	24.4	291.2	0.0	15.9	22.5	18.5	6.2	4.3	11.8	8.5	30.6	11.5	26.0	14.7	0.0	20.3	3.3	4.3	23.5	1.7	1.8	3.2	14.8	8.2	12.0	0.0	798.5	1.3	3.3	16.9	5.6	6.3	0.0	0.1	9.7	0.0	1.7	6.7	373.1	8.5	18.3	0.3	7.0	3.7	18.3	0.4	8.8	37.5	3.6	4.7	2.1	26.2	8.7	13.9	4.9	21.8	1.7	14.1	0.0	0.1	19.6	1.4	0.0	1.3	3.7	0.1	4.0	14.9	24.2	3.8	2.2	2.3	5.9	23.1
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68829021-68842160	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	47.0	23.7	9.3	8.2	9.5	2.3	41.2	8.7	11.8	27.1	8.7	27.6	19.1	19.4	10.7	32.0	19.6	18.3	32.5	9.1	8.9	44.0	11.6	41.6	4.3	9.4	9.1	14.3	7.6	16.5	10.3	25.4	8.9	19.8	13.2	1.2	11.2	16.2	9.1	52.5	20.6	8.8	9.6	26.1	18.1	6.3	9.7	5.6	19.6	9.5	4.8	25.9	27.9	9.3	10.4	5.3	41.9	15.6	21.7	13.4	21.9	8.7	9.5	3.8	2.8	4.8	19.0	2.5	56.7	3.3	5.0	54.3	40.0	97.0	2.1	4.3	10.2	2.6	2.3	8.5	20.0	1.9	21.3	25.0	74.1	9.4	42.4	3.4	29.3	5.3	2.8	0.2	3.3	8.5	4.2	2.0	29.0	63.5	70.9	18.6	4.4	16.6	15.9	36.1	15.6	7.5	6.7	2.0	2.6	31.7	1.6	3.6	49.7	7.2	8.9	19.6	3.3	0.1	2.3	2.5	3.6	11.3	4.7	0.0	0.6	0.3	0.4	1.7	0.3	0.3	0.4	0.4	3.5	0.2	0.3	0.2	0.1	0.7	1.1	0.5	0.2	0.5	9.3	9.5	8.7	11.8	9.1	8.9	9.4	9.1	8.9	9.6	9.7	9.3	81.1	3.2	1.1	2.6	3.2	117.3	66.2	60.7	93.4	3.3	3.6	11.2	8.2	20.0	12.8	22.0	0.0	11.4	5.9	59.4	0.0	16.4	0.4	2.6	7.6	42.4	8.4	2.7	1.0	15.6	75.9	20.5	21.4	4.5	4.5	134.5	143.5	4.8	12.4	1.7	1.0	27.6	8.2	9.1	23.8	1.3	27.4	8.6	21.4	2.8	5.9	12.5	2.1	0.5	0.6	46.3	52.6	8.2	2.3	40.2	28.6	5.7	2.8	1.3	13.1	8.7	12.5	2.0	3.8	76.2	120.5	11.2	4.7	116.2	29.8	93.6
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489745-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 239.7;Hepatic stellate cells: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		940000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	20.7	6.1	3.8	4.3	5.9	0.2	17.1	1.3	6.2	11.0	0.0	22.1	7.9	10.2	0.7	12.1	8.8	4.2	15.5	5.5	4.9	11.2	4.8	23.4	3.2	0.1	0.1	7.2	3.9	3.2	6.3	15.4	0.3	12.5	9.9	3.2	14.0	10.6	6.5	17.2	14.4	5.5	0.1	7.4	15.0	5.4	1.6	3.6	11.9	8.0	3.2	6.5	14.1	4.3	23.3	1.8	76.5	0.1	0.2	0.7	0.3	10.8	5.4	8.2	4.7	19.1	28.7	0.0	11.0	2.5	0.6	28.4	2.9	10.9	8.9	0.0	24.3	0.1	6.0	0.0	1.5	6.9	0.6	3.5	19.0	0.4	16.1	4.1	10.4	0.2	0.1	0.0	9.1	3.3	0.2	0.1	4.7	45.5	5.0	21.9	3.3	0.1	11.9	2.5	5.8	42.7	3.6	1.7	0.1	21.4	1.0	0.2	9.6	16.3	0.0	0.5	23.8	0.4	0.0	0.0	34.5	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.9	1.3	6.2	5.5	4.9	0.1	0.1	0.3	0.1	1.6	4.3	239.7	6.4	35.7	38.8	4.4	83.2	52.9	15.4	13.1	10.4	39.8	45.3	8.8	5.7	13.2	25.8	0.0	1.4	8.6	114.6	0.0	6.8	0.4	24.7	69.8	106.5	50.6	0.0	49.3	1.4	3.1	15.4	69.3	42.1	17.8	11.8	187.4	1.3	1.1	6.7	29.7	59.8	26.4	5.8	11.9	1.0	0.3	4.0	32.0	48.7	0.0	89.1	0.0	3.5	13.9	46.3	64.3	0.4	1.0	25.1	15.9	0.2	8.7	3.4	0.0	33.1	22.8	0.7	3.3	41.1	86.0	1.9	7.9	6.4	71.5	72.0
EFNB3	"EPLG8, LERK-8"	ENSG00000108947	"Ephrin B3"	Q15768	17	7705202-7711372	"Cancer-related genes, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.6;Early spermatids: 9.2;Excitatory neurons: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.9;AN3-CA: 32.3;hTERT-RPE1: 32.6;SH-SY5Y: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001623	Approved					NA	NA		11000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA001623: AB_1848026"	"unprognostic (5.17e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.20e-2)"	3.5	2.0	23.1	0.7	25.8	0.0	3.5	0.1	25.3	7.4	5.6	0.7	0.3	10.3	0.5	2.0	5.5	1.2	1.1	23.0	37.3	1.2	1.7	1.0	0.3	9.2	10.7	4.7	1.2	12.0	5.7	1.2	8.7	2.1	0.6	3.6	1.4	0.5	0.3	5.9	0.9	3.7	5.8	0.1	0.8	3.6	38.2	0.4	0.7	0.1	0.9	1.0	2.4	10.7	0.0	1.0	53.9	32.3	1.0	0.7	0.4	0.6	7.2	4.8	3.1	2.0	3.4	0.0	1.1	2.1	0.3	0.4	13.9	6.9	2.8	0.0	6.8	0.2	0.0	0.1	1.5	0.0	0.0	3.1	1.4	1.5	1.1	32.6	0.3	0.5	0.0	0.0	0.9	5.4	0.0	0.0	4.8	0.0	1.0	0.2	0.1	0.0	7.4	0.7	3.4	28.1	0.0	0.0	1.1	9.4	2.9	0.0	0.1	3.2	10.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	25.8	0.1	25.3	23.0	37.3	9.2	10.7	8.7	5.8	38.2	10.7	2.1	0.0	0.0	1.0	0.2	4.1	3.8	4.6	6.8	2.2	5.9	11.6	1.7	1.5	0.9	0.0	0.0	0.3	0.0	0.1	0.0	1.1	9.2	2.5	5.9	1.3	6.7	2.7	9.1	0.2	1.0	4.6	0.0	0.7	1.3	3.3	2.2	0.0	0.4	5.0	6.8	0.3	4.1	0.0	0.4	5.6	4.7	0.2	0.0	1.0	0.0	1.4	0.0	0.5	1.3	0.2	0.0	3.4	0.0	1.6	0.0	0.0	6.0	0.7	0.0	0.0	2.2	0.7	0.7	1.8	2.8	0.3	0.1	1.2	0.0	1.6
EFR3A	KIAA0143	ENSG00000132294	"EFR3 homolog A"	Q14156	8	131904093-132013642	"Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 121.6"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 358.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022859, HPA023092, HPA023402"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031"	"unprognostic (4.79e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-3)"	21.7	20.8	22.7	20.8	28.6	14.5	20.0	36.4	35.7	28.3	13.2	21.2	23.2	23.4	38.0	27.5	24.2	21.8	33.9	29.5	9.3	29.8	44.5	27.8	25.3	52.7	13.6	19.3	18.6	33.6	12.0	20.4	59.0	26.9	18.4	121.6	17.3	29.3	41.6	21.2	23.5	36.1	7.0	23.5	22.8	22.1	16.1	24.3	37.8	49.1	27.9	26.9	14.0	23.9	55.3	49.0	15.0	12.4	59.9	68.8	29.9	38.6	54.0	31.5	41.3	10.8	40.4	33.8	35.5	87.6	41.8	17.9	23.9	52.9	38.3	78.3	13.1	33.7	22.7	22.0	57.5	13.0	34.1	58.6	29.6	31.2	49.0	52.2	40.2	16.4	18.7	44.3	56.5	36.1	36.5	11.9	8.5	47.3	30.4	14.5	29.4	16.1	38.0	34.1	10.0	34.6	76.9	10.8	30.6	39.3	34.4	22.0	56.3	55.6	50.9	27.4	40.9	31.3	28.8	20.9	41.2	31.0	29.0	12.0	16.8	17.4	16.2	23.3	14.5	12.6	13.0	13.3	17.3	11.2	11.6	12.0	10.1	15.5	40.9	4.0	11.3	15.8	22.7	28.6	36.4	35.7	29.5	9.3	52.7	13.6	59.0	7.0	16.1	23.9	32.6	41.7	42.8	90.8	40.7	21.2	25.3	29.5	25.0	358.8	29.9	16.6	57.4	28.6	37.5	51.5	91.8	22.8	34.1	33.5	21.5	28.7	4.5	25.9	35.1	29.1	11.4	13.3	126.8	30.9	22.2	34.4	29.0	20.7	25.9	19.8	25.0	79.9	44.5	26.9	122.6	18.7	26.4	59.4	25.0	8.0	19.9	52.9	8.8	60.0	53.3	42.3	42.2	77.9	55.6	25.5	36.0	44.4	32.6	55.8	39.9	58.4	27.7	107.5	19.7	32.3	41.4	52.9	30.9	39.1	31.4	37.1	37.3	36.8	17.0	36.7
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042076-25159135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.1;skeletal muscle: 20.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	0.8	1.6	23.0	0.6	53.1	0.3	0.5	22.4	29.5	0.5	0.0	1.1	0.4	0.7	5.1	0.3	0.6	0.5	4.5	51.7	19.0	1.3	0.2	2.5	0.3	45.3	24.0	0.8	0.4	3.9	9.3	1.7	47.5	0.5	0.6	11.0	0.3	0.8	20.0	0.6	0.5	1.2	9.8	3.4	0.9	2.5	27.7	0.3	3.4	3.8	0.2	0.5	0.4	12.1	0.2	8.3	9.5	10.3	0.5	0.1	12.0	1.0	0.2	0.5	0.1	6.7	0.4	0.1	0.6	1.4	3.3	0.6	7.5	0.0	0.1	1.6	1.8	1.6	0.3	0.6	0.0	0.1	0.8	0.1	0.0	2.3	0.1	0.7	0.3	0.2	0.1	0.4	0.2	0.9	0.2	0.5	1.9	0.1	6.6	0.8	9.1	0.3	0.1	0.3	4.0	10.7	1.2	18.0	5.9	5.3	0.9	0.1	0.5	0.5	2.7	4.1	2.0	0.7	0.9	0.1	7.3	0.1	1.9	1.3	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	23.0	53.1	22.4	29.5	51.7	19.0	45.3	24.0	47.5	9.8	27.7	12.1	3.1	28.9	1.1	127.0	0.0	0.0	0.8	0.0	0.0	9.9	0.3	1.0	9.7	0.0	0.0	9.2	22.9	0.1	0.1	0.7	0.0	0.3	20.6	1.3	0.3	6.7	3.6	0.0	58.5	0.8	0.2	1.0	0.0	0.3	0.0	1.1	2.9	0.0	0.9	5.0	110.7	0.1	0.0	0.0	0.3	46.0	1.2	0.1	0.0	54.4	0.0	22.0	0.0	19.6	51.2	0.7	0.0	2.6	0.1	0.6	0.5	0.1	0.0	10.7	0.0	1.6	1.4	2.4	2.2	0.0	0.1	0.1	0.1	0.2	0.3	0.4
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569601-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 645.2"	"Cell type enriched"	"Detected in many"	8	"Fibroblasts: 214.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 4.3;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA001838: AB_2666457"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	20.1	0.0	0.4	0.6	0.5	0.0	3.2	0.1	0.3	1.0	0.1	0.2	0.5	1.8	0.0	4.3	2.2	1.1	0.3	0.3	1.2	0.7	0.0	25.6	0.3	0.9	1.3	0.3	1.2	0.6	2.6	645.2	0.4	1.1	0.3	2.3	0.4	0.1	0.0	0.5	0.4	0.5	1.6	0.3	1.3	0.3	0.4	0.2	0.3	1.6	1.6	10.7	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.3	0.3	1.2	0.9	1.3	0.4	1.6	0.4	0.2	1.3	0.0	2.0	0.0	0.0	1.0	1.2	22.0	1.2	6.3	0.1	0.5	0.4	0.0	11.9	0.0	0.0	12.4	0.0	0.5	0.0	0.0	0.3	4.2	5.6	6.0	0.0	0.0	0.3	0.0	9.8	214.7	0.0	3.7	0.0	0.0	0.0	0.0	17.3	0.0	2.0	0.1	4.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	1.0	0.0	0.0	23.9	0.1	1.1	14.9	0.4	26.4	0.9	4.9	0.1	3.7
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 806.1;Endothelial cells: 436.5;Hepatic stellate cells: 511.5;Hofbauer cells: 290.3;Spermatogonia: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.1;eosinophil: 3.5;intermediate monocyte: 6.2;non-classical monocyte: 5.5;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 5.9;granulocytes: 3.5;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 183.9;HUVEC TERT2: 329.0;RPMI-8226: 136.8;TIME: 312.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA050716: AB_2732562"	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	195.6	50.2	108.8	13.4	90.4	14.4	192.3	85.0	144.3	112.9	74.4	49.1	13.4	104.3	9.8	39.8	98.5	27.4	243.3	89.8	86.5	144.3	56.1	204.2	20.8	102.0	96.9	37.8	28.2	18.5	51.3	181.6	100.9	74.9	3.5	1.0	39.4	13.2	60.5	47.8	51.4	13.4	89.9	191.7	40.7	43.3	111.7	5.6	105.5	25.2	2.9	87.5	86.3	85.2	0.1	45.7	14.6	52.7	1.2	1.0	33.4	12.9	2.3	7.3	2.3	16.2	42.4	0.3	183.9	4.3	11.9	6.5	3.7	8.3	0.3	77.2	14.1	28.8	3.4	1.3	11.4	0.0	40.1	1.5	3.2	3.7	0.0	2.5	329.0	2.1	104.9	0.1	2.5	83.5	0.5	0.7	21.1	64.3	2.6	91.4	5.9	136.8	4.6	1.1	9.3	31.0	6.3	5.9	12.2	4.2	15.5	43.6	312.6	1.8	37.2	4.4	2.5	0.4	0.1	0.5	0.2	0.1	38.4	0.0	2.1	3.5	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.8	0.2	5.5	5.9	0.0	2.4	108.8	90.4	85.0	144.3	89.8	86.5	102.0	96.9	100.9	89.9	111.7	85.2	806.1	0.0	26.5	2.3	6.2	11.9	5.6	5.5	9.6	2.0	5.9	6.7	23.7	5.7	4.2	3.7	0.0	3.1	5.9	1.4	7.9	19.4	2.7	1.4	3.4	436.5	1.2	58.9	15.0	2.0	17.8	18.5	0.5	1.9	20.3	2.0	511.5	20.5	290.3	3.3	10.1	4.6	2.0	24.5	14.2	9.2	8.7	18.7	19.6	102.1	1.2	1.9	0.0	3.5	1.8	5.8	3.7	6.0	4.0	19.1	22.5	25.2	0.2	2.3	13.1	13.0	18.4	18.9	179.8	2.7	9.5	6.0	2.9	4.8	0.5	3.5
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164595-32168281	"Metabolic proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Granulosa cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.2;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	13.3	7.2	3.8	0.5	3.5	1.1	13.6	3.6	5.7	23.4	4.1	19.8	0.6	10.0	0.8	12.3	16.3	3.0	14.2	3.9	3.9	16.3	7.4	9.4	0.3	3.8	3.9	31.2	5.1	0.4	8.2	2.9	3.7	16.9	0.5	0.0	7.9	1.4	3.8	12.8	8.8	0.3	3.8	7.9	10.2	4.4	4.1	0.6	8.7	2.5	0.2	13.5	17.2	3.8	0.2	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.5	0.0	0.3	3.2	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.2	0.7	0.5	0.0	0.0	0.6	1.0	1.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	3.4	0.0	1.0	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.5	3.6	5.7	3.9	3.9	3.8	3.9	3.7	3.8	4.1	3.8	1.2	6.4	4.1	0.0	0.3	1.5	0.6	0.3	4.6	1.5	0.5	0.3	0.1	0.0	1.6	1.8	2.1	0.8	0.6	0.2	0.0	0.4	0.1	1.0	1.9	1.7	0.0	1.7	0.0	0.2	0.4	1.5	4.6	1.3	0.0	10.4	3.3	0.3	0.2	0.0	0.0	1.1	0.0	0.6	1.6	0.2	3.7	0.7	0.0	0.0	0.0	0.9	3.1	0.0	0.0	0.3	0.2	1.2	2.1	0.7	0.4	0.1	1.6	1.5	0.0	2.0	1.5	0.5	0.4	4.0	2.3	0.8	0.9	1.5	1.3	0.5
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 121.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	41.7	19.8	2.0	2.8	2.5	0.2	47.1	1.9	2.3	15.6	3.5	6.1	1.9	5.6	6.8	4.0	8.2	4.9	26.2	1.5	2.4	6.9	4.7	2.9	14.2	3.2	4.2	23.7	3.1	4.0	5.8	51.6	3.6	14.2	3.2	66.7	6.9	20.6	72.0	5.9	4.7	6.7	1.6	9.8	3.4	15.0	3.6	20.4	9.0	121.2	9.1	7.7	13.0	2.5	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.9	2.3	1.5	2.4	3.2	4.2	3.6	1.6	3.6	2.5	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 287.9;Skeletal myocytes: 251.2;Syncytiotrophoblasts: 376.8"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"A-431: 5282.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	88000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	27.9	11.4	12.6	4.0	18.3	0.0	20.0	16.6	9.7	20.4	10.5	12.2	5.7	11.4	10.3	23.5	13.9	9.0	7.1	6.3	10.3	11.6	35.3	14.9	2.5	10.4	19.0	15.1	15.8	3.5	2.9	67.9	8.9	16.2	10.7	10.2	22.1	15.0	10.9	51.0	9.5	9.3	7.5	5.1	11.1	4.2	22.6	12.8	20.6	20.6	8.3	14.7	24.1	6.3	5282.1	61.9	16.5	22.4	102.7	63.5	16.7	47.9	68.7	30.8	23.8	11.5	54.2	2.7	11.4	43.8	130.7	197.1	0.4	230.2	37.1	2.2	3.6	0.1	27.3	3.4	27.0	0.0	0.2	31.2	205.4	74.1	409.9	45.5	4.0	0.0	0.0	0.5	68.0	3.0	0.1	0.1	5.1	21.2	30.4	0.1	9.1	0.2	38.1	52.6	0.8	20.0	42.7	50.6	9.3	16.8	4.9	12.0	15.6	27.1	7.2	215.7	45.8	0.1	4.8	3.1	37.9	1.6	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	16.6	9.7	6.3	10.3	10.4	19.0	8.9	7.5	22.6	6.3	16.4	96.1	49.9	147.6	1.2	85.8	77.1	101.5	116.1	3.5	12.1	30.4	11.1	47.1	50.6	22.0	6.2	287.9	0.0	45.9	0.0	32.9	4.9	25.9	57.2	12.5	4.2	8.0	1.2	24.3	37.1	91.6	22.4	39.8	0.0	50.6	6.8	79.5	28.3	0.0	107.5	21.6	48.8	7.7	11.6	5.8	128.3	1.9	17.8	40.3	1.6	90.0	0.0	63.3	1.4	54.8	19.9	133.5	0.0	75.4	14.1	13.4	21.7	3.8	78.9	251.2	34.7	2.4	2.5	73.3	89.9	376.8	2.2	41.9	24.9	55.8
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231422287	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 190.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 29.1"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 29.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	32.8	35.6	37.5	18.1	40.8	20.0	23.9	38.8	43.2	26.3	31.6	30.0	34.0	30.8	24.5	33.6	24.2	28.2	58.7	39.9	37.2	38.8	56.5	19.1	21.1	41.6	39.0	37.5	40.0	39.0	9.3	42.6	36.8	23.8	26.1	49.9	22.0	30.3	190.7	48.6	35.5	27.6	40.9	27.6	19.1	17.1	43.4	16.7	25.5	153.4	21.3	27.0	12.0	40.9	54.2	59.9	17.5	33.7	44.8	29.4	15.8	22.7	42.2	36.3	49.4	41.3	48.0	15.5	41.7	42.4	31.7	25.1	26.8	30.1	61.0	18.6	42.5	6.7	23.5	37.7	31.5	38.5	8.1	25.4	27.5	24.9	34.2	58.6	49.3	18.5	33.9	37.9	38.3	12.2	8.9	14.4	18.4	33.4	21.0	20.0	21.7	22.7	48.0	23.4	15.9	45.3	32.9	41.4	83.1	11.2	22.4	112.8	54.3	44.3	20.8	40.5	47.2	65.7	46.4	14.7	60.4	14.0	59.4	4.2	0.5	3.1	1.2	1.0	0.7	0.7	0.9	0.8	0.8	0.7	1.0	1.8	29.1	1.6	1.8	0.7	0.5	0.4	37.5	40.8	38.8	43.2	39.9	37.2	41.6	39.0	36.8	40.9	43.4	40.9	64.7	19.2	23.2	36.6	19.8	58.5	15.0	10.7	33.0	32.3	19.4	13.3	111.9	67.2	11.6	18.4	37.5	16.2	16.6	57.6	35.2	37.8	1.2	18.5	20.2	60.6	12.7	8.2	43.9	36.2	34.2	25.9	15.3	21.2	10.1	55.6	28.9	70.6	16.9	62.2	52.6	24.6	16.2	24.1	45.3	5.0	16.1	29.8	26.6	44.0	19.0	56.9	12.3	46.3	48.3	36.6	30.9	23.0	23.9	15.1	43.2	52.3	13.5	44.0	19.7	36.4	36.6	13.1	20.9	24.9	57.5	10.4	24.9	16.0	23.5	21.3
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465479-138469303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 1113.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 133.1"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 7.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.1;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	565.5	354.0	7.5	135.4	15.9	176.7	173.9	133.1	70.1	302.5	10.0	246.5	54.8	197.6	13.5	370.9	911.7	345.2	258.8	20.7	30.4	173.2	149.5	173.4	145.2	9.9	13.2	974.6	137.0	93.5	243.3	54.2	12.9	309.7	161.1	56.0	140.9	84.4	66.0	363.1	107.2	474.3	4.4	77.5	254.5	26.9	10.4	301.5	584.4	354.9	19.1	191.4	115.9	19.5	21.8	0.9	45.0	67.6	119.6	192.0	5.1	36.7	22.7	48.4	39.0	26.4	18.9	1.1	5.9	80.2	165.8	10.1	2.6	74.5	22.2	1.1	3.3	3.0	11.5	7.6	15.5	8.0	57.8	15.2	286.6	43.2	9.8	37.6	4.2	53.9	112.5	26.0	14.3	108.2	3.2	34.1	4.1	80.3	0.1	0.8	6.7	4.1	36.8	13.1	56.5	6.4	44.7	120.1	106.6	43.3	1.5	6.6	1.8	17.5	22.6	8.7	14.2	60.1	478.8	8.6	20.3	103.5	5.2	0.0	2.6	0.3	0.1	3.6	0.0	0.7	0.1	0.0	0.7	0.2	0.1	0.1	7.1	0.1	1.2	0.0	0.2	0.5	7.5	15.9	133.1	70.1	20.7	30.4	9.9	13.2	12.9	4.4	10.4	19.5	920.4	275.7	485.6	6.8	116.4	181.8	719.6	207.4	816.1	43.5	550.0	459.0	652.4	420.4	124.0	29.5	64.6	159.5	46.2	645.2	7.9	255.4	1.4	356.0	836.5	383.1	960.5	27.3	20.3	101.7	110.1	989.9	736.0	645.4	354.0	274.8	347.0	183.1	131.4	3.3	2.7	747.6	93.6	218.6	109.7	3.8	164.7	300.7	106.7	20.6	8.6	191.6	0.0	1.5	2.4	135.3	380.8	53.0	67.2	405.1	224.8	5.7	127.4	101.3	223.5	1113.1	613.2	3.2	2.9	644.8	200.3	129.7	83.4	104.9	480.2	145.4
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;skin 1: 45.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 47.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favorable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	29.0	24.5	7.7	19.0	9.9	10.1	10.3	0.6	47.2	9.5	0.0	4.6	1.5	5.6	0.4	5.9	17.3	30.0	12.1	16.1	0.0	5.8	2.9	5.8	11.4	5.1	0.0	15.3	4.5	13.8	6.8	1.0	2.0	14.4	3.2	4.5	3.1	0.9	1.9	45.6	3.9	12.5	1.3	3.3	6.5	5.4	0.0	19.5	8.4	3.2	5.9	14.8	3.6	5.8	0.2	0.0	0.2	0.3	1.8	5.5	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.4	0.5	0.2	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.5	0.6	0.2	0.2	0.0	0.8	0.1	0.2	0.3	0.1	0.0	31.9	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.5	0.0	22.5	0.3	1.4	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.1	0.0	0.9	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	9.9	0.6	47.2	16.1	0.0	5.1	0.0	2.0	1.3	0.0	5.8	80.2	6.4	11.2	0.3	46.7	23.1	31.9	43.8	39.3	2.3	73.0	68.2	47.1	0.0	12.2	0.0	0.0	1.3	9.3	3.5	0.0	3.3	18.4	47.1	52.7	36.5	284.3	0.0	16.0	4.2	1.3	33.9	35.2	116.6	108.7	21.8	37.5	0.5	4.7	0.0	0.9	19.2	8.2	19.0	20.3	11.6	3.1	27.8	21.4	3.7	0.0	5.1	0.0	1.0	0.7	4.5	2.2	0.4	3.7	16.1	0.2	0.1	5.7	1.3	0.0	41.3	35.9	0.3	0.2	16.5	50.0	9.7	11.5	6.5	7.0	9.8
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 54.0"	"Cell type enriched"	"Detected in many"	6	"Enteroendocrine cells: 99.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"cerebellum: 31.4;cerebral cortex: 54.0;hippocampal formation: 22.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028983	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	0.2	0.1	2.6	0.1	5.5	0.1	0.0	31.4	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.1	1.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.5	31.4	54.0	22.1	1.6	0.0	2.4	2.4	0.0	1.5	2.6	1.3	0.0	0.0	0.0	2.6	2.7	13.2	0.6	0.6	3.0	6.8	7.2	1.2	0.0	0.2	0.0	0.0	0.1	5.0	0.4	0.0	0.2	0.0	2.9	7.0	1.0	99.5	0.0	3.8	1.0	0.3	0.7	5.1	15.9	8.9	16.1	0.0	0.0	0.2	0.0	0.5	0.6	2.0	0.6	5.3	0.6	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	1.1	0.0	1.0	10.8	0.0	0.0	0.1	0.8	0.0	0.2	5.7	0.2	13.2	1.7	2.3	0.8	1.5	3.4	0.8	0.2
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 203.4;Early spermatids: 220.3;Excitatory neurons: 262.3;Inhibitory neurons: 245.4;Late spermatids: 495.6;Oligodendrocyte precursor cells: 226.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (1.95e-8)"	30.0	17.2	15.1	10.7	16.3	6.4	17.4	27.7	19.3	29.0	11.7	41.9	9.7	31.1	7.9	29.5	21.3	20.4	11.7	20.0	16.5	17.1	53.9	11.6	8.8	13.3	22.1	48.0	15.9	15.2	12.2	11.9	14.1	16.0	14.2	20.9	15.7	18.6	8.0	13.0	14.9	30.0	10.9	8.1	17.5	37.4	22.6	13.4	14.4	13.1	10.2	18.1	21.6	16.2	49.7	66.9	26.8	16.4	46.1	89.0	27.2	43.6	42.4	31.6	25.9	80.4	36.2	34.2	15.4	79.8	47.5	29.1	35.1	30.5	51.9	36.3	16.5	29.7	22.9	95.2	31.5	17.5	21.5	40.9	54.1	31.6	61.9	31.3	20.5	26.7	20.6	19.1	51.1	19.4	20.0	10.9	26.3	40.8	26.2	17.8	33.8	14.9	20.8	16.1	29.6	23.6	35.1	25.9	43.0	28.5	12.6	17.0	15.2	33.3	34.4	55.8	23.0	21.5	16.2	32.7	33.3	26.3	69.4	0.2	2.2	2.5	4.1	2.4	4.0	6.3	4.2	3.9	3.7	4.9	4.2	3.6	0.8	3.4	1.3	2.4	2.5	2.2	15.1	16.3	27.7	19.3	20.0	16.5	13.3	22.1	14.1	10.9	22.6	16.2	29.0	38.5	18.8	203.4	10.4	15.6	12.0	27.1	43.3	39.7	10.5	12.8	15.2	22.8	20.7	14.7	4.2	10.9	9.9	5.3	15.6	22.1	220.3	10.3	45.4	19.9	16.2	8.8	262.3	40.5	30.1	36.6	9.2	12.1	2.5	15.2	30.0	59.6	5.0	18.5	245.4	5.4	6.1	8.6	11.4	495.6	58.4	7.6	10.6	119.0	6.5	20.1	13.4	226.7	98.7	41.7	5.0	40.3	9.6	13.9	11.4	15.1	14.5	17.8	6.6	33.1	19.4	53.7	31.1	55.4	14.2	2.9	12.7	18.2	8.1	13.1
EHBP1L1	"DKFZp762C186, TANGERIN"	ENSG00000173442	"EH domain binding protein 1 like 1"	Q8N3D4	11	65576046-65592650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 255.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039479, HPA073476"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		110000		"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Plasma membrane"		"HPA039479: AB_10795678, HPA073476: "	"unprognostic (1.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.10e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.10e-1)"	27.2	9.9	7.5	51.9	6.2	59.7	21.5	5.9	9.4	35.9	7.3	108.1	26.0	56.1	5.7	45.4	48.0	18.0	45.6	7.1	6.3	17.7	10.8	39.6	30.7	9.8	8.1	19.6	8.1	4.1	9.8	16.3	7.7	45.2	12.2	0.4	22.9	39.5	255.7	22.6	46.6	32.8	8.0	73.3	41.0	7.3	9.4	14.5	13.0	70.7	16.6	71.3	40.8	9.0	40.6	41.0	1.3	21.8	10.5	26.4	8.2	31.4	22.9	14.8	7.8	13.7	34.9	14.0	52.4	45.8	41.2	55.9	7.6	29.7	3.4	39.3	1.2	32.4	51.0	12.0	10.0	7.1	30.1	22.7	19.8	37.2	6.8	26.9	15.2	20.8	50.5	55.9	13.8	34.5	12.4	27.5	1.8	15.1	34.8	33.6	0.2	46.8	13.7	20.0	0.9	17.2	17.4	15.2	32.9	3.0	21.9	33.7	26.3	40.3	42.9	57.3	0.6	98.5	66.6	7.3	60.2	18.8	23.9	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	7.5	6.2	5.9	9.4	7.1	6.3	9.8	8.1	7.7	8.0	9.4	9.0	33.1	0.0	6.9	6.2	23.9	10.1	8.5	2.9	15.9	1.4	12.2	14.2	22.0	7.2	7.4	1.8	0.0	3.4	27.3	79.1	0.0	3.6	0.2	11.9	12.2	26.0	4.2	61.6	4.4	5.1	1.4	13.8	61.2	14.2	2.5	5.3	18.9	5.7	32.6	0.0	2.2	16.3	2.0	79.7	33.9	1.7	11.5	67.6	7.2	15.0	49.1	0.7	20.6	1.5	1.3	27.8	53.0	38.0	19.5	11.6	19.5	0.4	8.6	1.1	26.3	27.3	30.7	2.7	5.9	15.3	14.8	2.6	23.2	23.0	21.9	17.0
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 151.6;testis: 159.9"	"Group enriched"	"Detected in all"	10	"Early spermatids: 1033.0;Late spermatids: 1950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"		NA	NA		10000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	39.7	25.4	21.5	59.7	26.6	151.6	21.8	38.6	32.6	26.2	18.2	32.3	33.8	28.1	8.4	26.0	27.0	25.0	39.3	24.9	26.8	31.2	22.0	44.7	65.6	32.7	28.2	13.6	11.1	8.9	7.0	35.4	29.9	18.8	14.5	3.0	16.6	20.9	32.1	34.4	38.5	28.3	31.0	74.4	29.3	159.9	30.5	28.9	19.3	31.5	50.3	55.3	23.0	33.4	109.4	74.1	26.2	28.9	31.2	50.2	15.4	108.2	97.4	89.5	51.8	96.5	66.2	142.0	37.8	129.9	76.5	86.6	27.3	108.9	34.5	89.5	15.2	94.8	37.1	49.1	36.8	30.9	24.6	22.8	22.9	138.7	43.2	40.6	89.8	27.6	39.6	243.8	68.7	57.8	62.5	51.4	17.5	27.5	95.9	24.8	83.5	49.9	84.5	35.7	18.6	16.6	60.8	109.3	48.6	29.5	149.2	21.8	127.9	39.6	35.4	106.0	52.6	100.2	48.5	112.1	103.3	40.1	22.0	18.0	13.9	99.6	39.0	16.1	39.2	24.0	27.3	33.8	7.2	18.2	16.2	23.1	57.1	25.4	33.7	8.7	31.8	30.7	21.5	26.6	38.6	32.6	24.9	26.8	32.7	28.2	29.9	31.0	30.5	33.4	31.2	76.9	30.3	4.2	46.0	67.3	52.8	39.4	17.6	3.8	28.8	24.8	29.2	18.6	22.9	14.7	2.1	88.6	76.5	75.9	7.9	29.4	1033.0	41.9	24.4	29.3	6.6	19.8	1.7	40.8	24.5	32.4	25.5	54.9	93.8	37.2	10.4	10.9	32.2	5.0	3.5	27.7	12.2	37.4	61.0	1950.6	30.1	79.6	26.6	1.9	34.3	5.9	78.2	2.5	12.2	101.5	47.7	27.1	50.8	28.2	38.9	41.9	16.5	2.8	78.9	47.9	53.5	55.0	27.4	19.9	49.2	137.0	71.7	19.8	22.1	42.7
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713422-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		1500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	195.0	59.9	18.4	32.8	17.6	0.4	133.9	16.5	21.2	110.3	11.9	116.1	14.3	119.9	13.2	53.5	75.4	31.2	85.9	15.9	17.1	24.4	14.4	102.8	9.1	23.3	19.3	68.3	28.2	6.2	12.6	50.3	20.0	62.2	14.7	3.0	34.2	51.1	39.6	54.7	54.5	79.6	17.2	40.3	56.3	11.2	24.1	5.1	49.5	28.2	8.3	112.3	88.8	15.8	62.7	142.7	0.1	1.7	312.2	236.0	0.2	238.5	114.0	86.0	70.0	9.3	31.2	0.0	0.3	258.6	20.3	78.1	1.5	126.5	51.9	0.1	0.8	8.4	78.4	0.7	197.0	0.0	16.6	230.1	109.5	72.5	70.6	113.7	168.4	0.7	26.6	0.2	91.7	11.4	13.3	0.7	1.8	9.2	25.9	1.4	10.0	0.2	69.5	2.9	0.1	0.8	212.5	8.2	6.2	19.1	20.2	4.3	192.6	128.0	27.8	112.5	52.2	0.2	0.2	0.2	119.3	3.3	27.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	18.4	17.6	16.5	21.2	15.9	17.1	23.3	19.3	20.0	17.2	24.1	15.8	161.9	60.9	20.6	10.7	0.3	20.3	29.4	31.0	12.5	5.5	7.3	10.8	11.6	10.0	22.5	5.5	0.0	1.1	0.8	0.1	0.0	21.2	0.6	3.4	60.5	75.4	0.0	8.6	4.0	14.1	1.6	55.8	5.1	4.5	2.5	24.7	48.9	3.1	1.9	0.0	0.9	0.0	2.0	1.3	8.8	4.3	99.1	1.6	8.8	7.5	0.6	1.8	0.0	3.5	0.3	31.1	0.0	107.2	0.1	28.8	0.0	0.1	5.5	0.8	236.7	24.8	139.4	0.9	3.0	15.8	13.5	1.5	1.5	27.2	0.0	33.4
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234152-31269451	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.7;esophagus: 43.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 5.6"	"Lineage enriched"	"Detected in many"	7	"B-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		15000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.5	9.1	20.5	5.9	29.5	1.9	3.2	10.5	38.7	5.5	1.1	2.5	1.6	4.4	3.0	43.9	4.5	3.4	15.9	29.5	18.5	20.0	11.0	5.7	6.8	11.7	17.8	2.5	1.3	21.1	9.1	11.7	13.9	5.5	1.7	9.0	5.9	4.4	2.3	3.1	3.7	4.6	9.6	7.3	2.2	1.3	31.1	2.7	3.2	5.1	11.1	6.6	6.0	26.2	1.8	8.4	4.5	3.9	7.5	11.3	0.7	79.7	192.2	7.5	6.9	0.0	0.9	0.6	2.9	26.0	6.5	0.8	0.2	5.2	5.3	3.2	7.1	77.4	0.4	0.0	25.7	0.0	0.2	18.1	2.3	7.3	3.0	20.0	0.1	0.2	0.3	0.4	5.6	12.6	1.0	0.1	17.7	0.0	4.3	2.8	0.3	1.8	5.8	8.9	2.2	12.1	0.8	1.3	0.0	14.1	1.2	0.0	0.0	5.8	5.4	0.3	6.5	48.7	6.5	0.1	14.8	0.0	12.4	0.6	0.5	0.5	2.1	1.0	1.1	20.8	1.0	1.4	0.5	5.6	0.9	0.5	1.2	0.8	2.8	0.0	0.5	10.2	20.5	29.5	10.5	38.7	29.5	18.5	11.7	17.8	13.9	9.6	31.1	26.2	1.9	0.0	0.0	2.6	16.2	0.8	1.8	1.7	10.2	9.7	0.6	6.2	24.3	5.7	0.9	0.0	0.0	4.1	0.6	0.0	0.0	0.5	0.1	0.7	2.3	8.4	1.8	6.1	17.1	0.2	8.4	3.3	1.1	0.5	0.0	0.4	120.3	5.0	1.7	0.0	11.1	0.1	0.0	16.1	0.4	0.0	1.2	5.9	0.0	4.7	1.1	9.0	0.0	22.6	5.4	0.2	0.1	3.0	5.8	2.6	0.0	0.2	0.4	5.9	19.7	3.0	7.0	0.6	2.7	10.7	0.9	43.9	1.4	0.7	0.1	4.7
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895933-41972557	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 189.5;Urothelial cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 103.8;TIME: 172.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		440000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	21.6	4.6	3.1	11.8	3.2	10.9	16.4	7.5	3.5	9.4	5.3	12.1	5.5	9.6	10.5	15.0	9.8	15.2	27.8	3.3	3.8	14.3	9.6	15.0	12.8	4.8	4.0	5.6	14.3	12.8	5.8	8.3	4.8	9.5	10.2	6.1	10.4	9.7	4.4	14.3	12.4	12.9	5.2	7.4	9.9	2.8	4.0	5.3	18.4	4.7	8.8	23.8	9.0	6.6	28.7	9.8	9.3	9.6	4.6	6.5	8.1	14.9	31.4	25.9	36.1	41.4	16.1	5.9	39.2	18.8	51.6	28.4	13.9	32.6	19.0	35.7	11.7	8.7	13.5	7.1	11.3	4.0	24.4	5.5	12.6	26.3	28.8	9.9	103.8	8.7	9.2	6.6	21.1	12.2	4.2	4.5	7.1	27.8	33.5	0.1	24.5	9.4	23.4	57.0	15.4	6.5	10.9	23.2	17.0	9.0	22.9	5.6	172.8	8.1	15.7	30.5	73.1	18.1	30.9	12.4	10.3	9.4	71.6	1.1	14.0	9.0	4.0	12.4	6.1	2.1	6.2	5.0	14.9	2.6	2.6	3.8	2.3	4.4	5.2	2.5	7.9	8.0	3.1	3.2	7.5	3.5	3.3	3.8	4.8	4.0	4.8	5.2	4.0	6.6	94.9	6.4	44.2	3.9	20.0	81.6	189.5	68.1	34.1	4.9	31.4	20.1	36.6	30.0	69.0	44.1	31.3	10.1	22.2	96.0	7.9	71.3	16.1	66.1	9.7	114.9	22.6	5.7	1.2	62.6	20.4	21.3	25.5	72.4	61.6	16.2	54.7	8.7	89.0	1.7	0.7	22.5	28.5	35.6	52.7	34.7	7.5	46.3	19.6	12.2	53.5	37.5	4.1	26.7	2.7	75.1	70.9	4.9	31.5	49.9	71.4	4.6	60.8	27.8	13.1	8.0	29.0	5.4	8.2	29.3	79.8	17.4	27.8	21.2	37.3	200.1
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 144.3;liver: 344.5"	"Group enriched"	"Detected in many"	10	"Hepatocytes: 289.0;Proximal tubular cells: 147.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	10.8	4.3	2.1	3.0	2.9	1.2	4.1	3.9	2.7	3.5	9.2	14.2	21.5	2.8	3.5	5.5	3.6	4.4	10.7	2.1	3.1	144.3	344.5	4.3	2.1	3.2	4.1	2.6	9.9	7.8	1.5	3.2	3.0	6.3	10.8	1.6	5.7	2.2	1.7	4.5	12.9	3.7	2.5	3.7	10.4	2.7	3.1	2.1	6.5	5.6	2.8	3.6	2.1	2.8	12.3	5.0	1.4	0.0	7.3	6.1	1.5	5.7	1.8	3.7	4.1	21.9	7.5	0.0	22.1	5.7	1.4	5.8	0.0	4.8	7.6	16.2	5.2	8.6	1.3	22.5	4.7	1.0	0.2	8.7	6.0	3.7	3.4	5.0	5.5	0.0	5.7	6.1	7.2	6.4	0.2	5.1	3.0	4.3	6.3	0.0	9.9	0.5	15.4	6.8	4.4	6.4	11.2	6.4	10.5	12.1	23.7	10.1	2.6	2.4	3.6	1.9	0.5	1.7	5.6	0.5	0.8	3.9	4.0	0.1	0.9	0.0	0.6	0.8	0.4	0.5	0.4	0.9	2.4	0.0	0.6	1.0	0.0	1.2	0.8	1.0	0.6	0.4	2.1	2.9	3.9	2.7	2.1	3.1	3.2	4.1	3.0	2.5	3.1	2.8	4.9	16.0	10.9	20.9	4.5	1.5	1.4	1.9	1.2	0.7	3.2	2.3	19.2	17.2	3.9	20.2	4.2	8.9	0.4	17.8	19.6	2.1	0.2	6.5	5.1	3.9	7.7	9.7	4.9	6.8	2.9	1.6	8.6	3.1	0.0	6.1	13.6	289.0	4.4	0.0	5.7	12.8	0.0	10.5	1.0	0.7	0.6	2.7	3.6	4.7	9.4	1.9	0.0	3.5	8.0	3.7	9.3	0.4	0.8	2.5	15.0	147.1	4.0	1.2	0.0	1.1	2.4	3.7	4.2	4.9	0.4	1.4	2.2	3.6	10.8	1.8
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	8.6	9.6	0.5	0.3	0.4	1.0	8.7	0.4	0.5	15.1	0.2	12.9	2.4	19.8	1.7	10.1	12.8	0.0	5.7	0.4	0.4	7.1	4.6	7.3	1.0	0.4	0.5	16.1	7.8	0.6	12.8	0.7	0.4	10.3	0.3	0.6	9.5	1.3	5.5	9.3	10.5	1.4	0.4	11.5	9.4	12.6	0.5	1.5	10.3	0.4	1.0	13.1	11.3	0.4	0.0	4.5	7.8	0.0	3.4	1.8	5.0	3.5	2.8	3.9	3.2	0.0	0.0	0.0	7.6	5.7	4.0	0.0	0.0	8.6	1.8	5.4	11.8	0.0	0.0	0.1	0.0	13.3	0.0	4.6	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	9.4	0.0	19.3	0.0	0.0	8.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	6.5	3.1	0.0	0.0	3.8	4.1	3.1	6.9	0.0	11.0	16.1	3.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	16.9	16.0	12.0	22.9	20.3	8.4	6.3	11.9	26.2	60.6	15.9	17.8	6.6	17.2	18.9	25.8	41.7	24.6	13.4	9.2	7.9	15.7	41.5	10.1	19.1	16.1	22.6	19.3	16.6	12.2	15.0	16.0	13.3	11.8	14.5	33.8	22.1	7.5	16.3	38.7	24.4	16.4	12.2	12.9	7.3	60.0	27.4	12.1	19.6	9.4	19.9	26.8	25.7	20.1	23.9	10.8	9.1	23.0	16.5	6.2	12.5	10.1	10.8	48.2	26.3	16.3	15.0	20.8	33.7	23.5	11.1	5.6	18.3	19.9	19.0	5.2
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48878134-48880173	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051122: AB_2681350, HPA051123: AB_2681351"	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	128.6	206.3	96.9	95.4	103.7	61.0	112.0	98.7	153.6	149.8	107.2	143.9	81.6	161.0	132.1	96.6	134.9	120.9	280.1	103.9	111.3	147.9	125.1	99.5	112.0	102.6	101.7	186.7	102.0	144.8	130.1	93.3	100.5	156.1	71.3	158.4	98.3	147.3	278.8	57.6	79.0	141.8	102.1	115.3	84.2	67.9	104.5	117.2	138.5	227.6	83.9	113.1	81.4	123.2	131.5	109.1	260.9	231.6	239.9	316.9	16.4	337.6	304.5	220.3	294.3	95.0	58.0	174.9	305.3	207.0	155.5	115.4	130.2	130.8	247.9	484.1	127.1	300.6	235.8	4.1	186.0	183.0	132.2	278.1	115.1	146.1	91.9	221.4	262.8	151.2	182.3	162.6	258.5	188.7	134.6	174.1	0.5	98.9	97.4	185.1	302.6	290.6	287.4	142.3	233.8	234.6	210.2	80.2	401.2	212.7	145.0	240.6	262.9	322.4	177.7	305.6	299.3	208.4	616.7	125.1	264.6	410.0	230.0	345.0	311.5	275.5	221.3	285.3	209.2	168.3	249.4	231.8	358.1	183.2	179.6	165.3	40.4	230.0	297.5	354.9	332.4	440.1	96.9	103.7	98.7	153.6	103.9	111.3	102.6	101.7	100.5	102.1	104.5	123.2	327.4	387.8	207.7	31.3	127.5	175.5	139.9	459.5	138.9	345.3	188.5	286.4	480.8	183.0	329.9	261.1	120.9	351.6	168.0	46.0	606.5	386.5	17.5	116.0	324.4	356.8	233.7	219.2	38.0	268.0	151.2	443.4	88.2	116.7	188.0	173.8	339.8	166.2	211.3	238.9	43.5	114.0	301.1	208.1	262.0	49.2	702.4	189.7	487.4	30.9	302.2	844.1	213.1	28.6	80.9	191.0	102.1	651.4	134.3	81.4	91.9	446.5	240.2	329.9	322.1	350.7	379.1	98.6	75.0	125.9	145.6	109.6	180.7	463.2	101.5	96.9
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538707-39540161	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045477	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	10.5	17.9	13.3	8.8	14.5	6.4	8.5	13.3	19.5	7.7	11.9	9.1	6.8	11.0	8.1	9.2	8.4	6.2	10.1	14.3	15.6	12.6	10.8	8.4	9.1	13.8	11.8	8.4	7.8	12.6	13.0	14.3	14.1	9.0	6.6	15.7	7.7	8.0	11.1	7.4	9.0	9.8	12.5	9.5	8.8	9.0	12.8	14.2	8.3	10.4	8.4	7.8	6.5	12.6	25.0	33.4	31.1	21.2	24.7	15.3	4.6	29.3	22.0	22.5	23.2	21.2	7.7	25.4	23.5	20.6	15.1	10.5	29.0	21.3	29.0	24.6	36.5	11.4	19.1	25.5	24.5	19.9	16.1	18.0	13.3	18.7	14.4	17.8	26.6	49.0	18.8	17.2	19.8	16.5	29.0	17.5	17.4	30.1	14.0	26.6	29.7	11.9	28.9	22.8	29.0	20.6	31.8	12.6	21.0	20.9	17.1	12.9	19.2	14.3	51.0	19.1	22.3	26.9	33.8	32.1	13.3	18.5	11.8	0.0	0.4	0.7	0.8	0.5	0.8	0.5	1.0	1.0	0.5	0.5	1.0	1.4	0.1	0.3	0.5	0.5	0.2	0.4	13.3	14.5	13.3	19.5	14.3	15.6	13.8	11.8	14.1	12.5	12.8	12.6	16.4	19.2	9.2	2.6	7.3	10.1	4.5	2.4	6.2	23.9	11.2	15.6	19.1	17.2	4.0	14.7	10.4	48.9	14.0	6.5	1.9	5.2	3.2	18.3	23.3	14.4	7.2	4.2	7.4	5.0	5.3	10.0	5.1	12.4	1.3	14.4	13.2	12.9	10.8	26.9	8.0	5.3	0.0	8.1	6.5	1.3	10.2	7.8	8.8	3.7	7.5	31.1	12.3	5.0	8.6	6.2	7.4	13.2	7.2	5.3	5.9	9.5	5.5	20.7	6.6	9.7	12.7	11.3	8.8	5.2	7.5	19.4	11.3	25.2	7.5	2.6
EID2B	"EID-3, FLJ38944"	ENSG00000176401	"EP300 interacting inhibitor of differentiation 2B"	Q96D98	19	39530987-39532852	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.1;Horizontal cells: 32.0;NK-cells: 27.8;Rod photoreceptor cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA064185	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA064185: AB_2685207"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.08e-3)"	"unprognostic (4.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.92e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.20e-2)"	2.4	3.6	7.2	2.0	6.9	1.2	2.0	7.8	7.1	3.9	4.5	3.7	1.3	4.1	2.6	1.1	4.1	1.2	3.0	6.4	9.4	2.6	1.0	2.2	3.1	5.1	5.7	5.1	1.4	1.8	10.3	1.1	5.8	2.9	0.9	9.4	1.3	2.0	2.1	1.0	2.5	1.5	4.7	3.3	1.9	5.2	8.1	2.5	3.6	1.2	1.5	3.0	2.3	5.5	2.0	4.1	4.6	5.1	2.9	2.7	1.0	3.1	2.4	5.0	4.5	0.6	1.3	4.0	1.7	1.9	2.5	0.6	2.3	2.1	3.7	6.3	6.3	1.8	5.3	2.5	2.5	1.8	3.1	2.7	1.5	2.8	1.4	1.9	2.2	8.9	2.0	5.6	2.5	1.8	3.6	3.1	1.2	0.7	2.2	4.6	4.2	2.0	2.5	0.6	6.3	3.9	6.1	0.2	2.5	1.8	0.5	1.0	1.5	3.7	6.6	3.6	4.1	4.0	6.1	3.0	2.0	4.3	2.0	0.4	1.9	3.9	2.8	2.1	2.7	3.6	3.5	4.1	2.4	3.1	6.5	4.3	0.6	4.6	2.2	2.4	2.4	2.1	7.2	6.9	7.8	7.1	6.4	9.4	5.1	5.7	5.8	4.7	8.1	5.5	3.9	6.4	1.1	3.9	8.5	1.5	1.3	3.5	1.8	30.1	1.6	2.7	5.5	7.2	6.3	9.2	25.0	3.0	6.4	0.2	11.7	4.0	1.8	5.3	6.0	4.3	6.1	4.6	9.0	3.0	1.2	6.3	2.0	0.7	4.5	9.1	3.3	1.8	3.7	32.0	9.2	0.5	4.1	4.1	5.3	1.2	15.2	4.6	8.8	4.7	5.5	23.2	27.8	3.0	5.5	1.8	1.3	11.3	5.6	0.6	0.2	4.9	10.8	30.2	13.1	3.5	5.3	22.1	8.8	0.5	0.6	0.8	7.8	8.0	0.1	0.4
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 61.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9"	"Not detected"	"Not detected"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	2.8	3.1	1.8	3.5	1.7	5.3	2.4	2.1	2.2	3.2	2.8	3.1	0.8	2.7	2.7	1.8	3.1	2.7	2.0	1.9	2.4	1.8	1.4	3.0	6.2	6.6	3.1	4.1	2.5	1.2	3.7	1.7	2.2	3.3	0.9	6.6	1.4	5.5	0.6	2.7	2.7	2.3	1.6	3.0	2.2	61.2	2.4	3.7	1.5	0.9	3.9	2.4	2.1	2.0	0.3	9.1	0.3	0.9	2.0	2.0	1.7	8.5	6.9	4.0	6.8	0.2	0.5	0.1	0.0	1.9	1.8	0.2	0.3	0.7	5.9	0.5	0.1	1.7	8.9	1.4	2.9	0.1	0.5	2.7	0.0	2.5	0.5	0.4	0.6	0.4	0.1	0.5	2.5	0.1	3.1	1.3	0.4	0.1	1.8	0.2	0.0	0.1	2.2	0.3	0.1	0.0	5.6	0.4	0.2	0.2	0.0	0.0	1.3	0.1	0.3	2.0	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	4.4	1.4	4.6	2.3	5.6	5.4	0.2	2.3	7.9	5.0	0.7	6.2	0.9	0.5	7.3	2.2	1.8	1.7	2.1	2.2	1.9	2.4	6.6	3.1	2.2	1.6	2.4	2.0	4.7	0.0	6.0	0.0	5.9	13.4	78.5	5.9	1.8	4.9	2.4	3.9	1.4	2.8	2.7	1.8	27.1	2.4	11.1	2.4	0.0	3.5	72.8	13.8	9.6	14.0	0.0	6.6	0.0	1.3	1.6	12.7	5.1	21.1	1.3	6.1	5.3	3.0	1.9	11.8	0.0	1.2	4.1	4.7	26.8	23.5	8.7	6.8	1.8	0.0	4.0	7.5	6.2	0.0	0.0	4.9	4.5	4.5	4.3	47.6	1.2	1.7	7.5	18.6	6.6	7.6	8.4	306.8	44.3	1.4	7.7	2.5	11.1	15.6	1.0	46.9
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"	Cytosol	"HPA054991: AB_2682664, HPA058735: AB_2683802"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	15.7	17.7	15.3	19.9	15.8	44.6	16.0	18.7	19.8	13.1	14.4	15.8	15.1	15.9	16.2	21.0	15.3	13.0	17.1	16.4	17.7	15.2	17.3	15.0	23.4	16.1	15.7	20.4	19.2	17.1	16.6	21.1	16.3	13.4	14.7	16.6	16.8	14.9	27.2	23.1	16.9	14.8	14.8	20.0	16.1	19.4	17.3	19.9	13.8	23.3	27.6	17.1	14.5	18.4	51.0	43.9	35.0	35.9	27.6	28.8	32.8	36.4	34.6	44.2	37.7	44.8	47.5	38.2	62.6	41.2	38.0	34.9	42.2	48.8	41.5	35.1	21.7	54.4	52.0	46.4	33.7	50.3	41.8	24.1	41.9	65.3	44.1	31.2	31.0	40.9	81.1	54.4	64.7	68.7	46.6	55.1	25.9	23.3	47.5	50.3	35.9	75.0	25.6	31.8	26.5	31.2	39.3	54.7	41.5	28.1	53.1	31.0	36.5	59.7	39.9	47.8	36.1	66.7	85.5	79.8	42.9	33.8	39.5	52.6	20.5	13.5	17.7	16.6	13.6	19.4	15.0	13.0	21.3	19.0	14.1	13.5	13.1	16.4	21.3	12.7	15.3	13.3	15.3	15.8	18.7	19.8	16.4	17.7	16.1	15.7	16.3	14.8	17.3	18.4	8.2	3.2	5.4	3.3	16.2	37.7	12.2	13.4	12.5	7.2	14.2	9.1	16.2	14.3	7.3	5.5	14.6	16.3	17.7	11.6	15.6	12.7	18.3	9.0	8.3	11.6	2.4	21.0	3.0	13.1	23.0	11.4	7.1	10.5	12.7	31.7	16.4	16.5	24.5	11.8	2.8	11.2	6.1	10.4	29.5	14.3	12.2	14.4	12.4	1.0	17.6	10.5	17.5	5.5	4.5	29.0	15.2	5.7	22.6	13.2	13.8	15.7	10.6	18.5	6.6	9.8	27.0	31.3	23.2	15.7	48.9	25.3	16.2	7.4	10.9	13.2
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A X-linked"	P47813	X	20124525-20141838	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	61.2	42.9	27.1	47.9	29.2	61.6	58.2	36.8	38.3	45.1	23.0	46.5	43.9	57.9	28.5	49.7	42.2	26.7	47.4	27.9	29.3	58.0	62.0	35.0	44.5	29.3	28.9	66.9	50.6	46.6	19.8	40.1	28.3	36.2	31.6	45.3	49.9	30.8	80.0	42.1	37.3	49.6	32.2	33.7	45.7	30.4	30.4	41.4	48.4	50.4	33.9	42.6	49.2	35.7	233.3	128.4	96.9	129.8	92.5	124.8	78.8	202.6	73.9	108.3	84.9	186.2	108.2	215.5	132.2	134.9	101.4	97.6	172.8	175.9	167.8	88.8	284.5	95.7	148.9	160.1	64.5	257.8	129.5	59.1	105.2	167.4	260.2	71.4	153.3	68.9	252.3	117.6	107.9	113.2	160.3	160.6	252.1	97.5	211.0	129.8	222.3	232.0	85.1	127.7	112.1	124.9	215.0	165.8	139.0	138.8	134.6	108.0	88.3	130.8	81.6	430.8	153.6	79.9	163.3	255.7	89.5	116.1	101.2	36.3	41.0	27.4	47.8	46.5	64.1	69.0	54.4	57.2	41.2	66.4	62.6	52.8	10.7	64.5	47.1	68.1	47.6	52.6	27.1	29.2	36.8	38.3	27.9	29.3	29.3	28.9	28.3	32.2	30.4	35.7	205.4	105.8	116.7	22.2	167.5	474.9	354.9	172.6	178.2	164.0	226.5	212.2	100.2	161.5	154.5	115.8	93.8	191.4	231.5	131.6	187.9	213.6	450.5	210.5	310.1	161.2	167.2	135.2	40.5	230.4	453.8	208.6	107.6	321.9	164.0	140.7	137.4	329.9	196.3	102.6	43.2	213.5	120.1	137.9	230.1	132.2	144.1	157.3	154.7	35.6	118.2	181.3	68.0	23.6	48.0	251.0	140.1	145.2	176.7	469.7	152.2	301.4	93.2	140.4	144.7	288.6	213.9	52.9	101.1	245.4	570.1	227.0	170.5	149.6	288.5	377.0
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A Y-linked"	O14602	Y	20575776-20593154	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 121.3;tongue: 131.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 378.0;Erythroid cells: 538.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 34.9"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 180.2;HEL: 220.6;U-266/84: 161.1;U-698: 349.8"					"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	17.4	22.2	3.3	11.4	3.6	59.8	14.6	3.6	34.9	0.0	3.5	20.8	14.6	0.0	20.6	14.8	0.0	8.9	121.3	3.2	4.4	26.2	25.3	14.9	9.7	4.2	4.4	0.0	13.7	13.3	27.8	16.2	4.3	26.9	25.2	11.6	13.7	20.2	85.2	11.7	28.9	0.0	3.6	31.9	16.5	21.4	3.6	0.0	11.3	131.5	27.7	18.4	0.0	4.6	0.5	26.4	0.0	0.0	0.0	0.0	52.7	57.4	39.1	39.5	39.1	0.0	0.1	180.2	0.2	32.0	0.0	0.0	0.0	0.0	55.0	97.4	0.0	220.6	0.0	65.8	38.4	0.4	0.0	21.1	44.2	0.0	0.0	0.0	0.0	59.4	0.3	0.0	65.1	0.0	144.7	0.2	37.8	0.0	0.0	0.0	70.9	71.9	56.5	67.6	50.1	0.1	0.1	0.3	42.4	71.9	0.0	30.9	56.8	29.9	0.9	0.3	63.1	103.9	161.1	349.8	11.6	0.1	0.0	48.8	20.4	28.3	14.2	21.8	19.7	53.2	25.9	16.8	16.7	55.3	31.2	25.2	125.8	21.6	22.1	66.2	31.7	21.5	3.3	3.6	3.6	34.9	3.2	4.4	4.2	4.4	4.3	3.6	3.6	4.6	0.0	32.1	49.9	2.9	122.1	54.7	68.5	123.8	26.7	19.6	0.0	0.0	378.0	35.8	63.3	53.3	10.4	123.0	51.8	6.8	88.0	47.7	59.6	0.0	0.0	31.3	17.8	538.5	2.0	0.4	45.6	33.1	27.5	0.1	91.7	0.0	57.8	16.5	38.9	6.7	2.4	23.3	61.1	67.9	43.7	16.7	42.9	43.0	67.6	1.0	88.7	92.2	59.8	3.0	2.5	21.5	9.6	43.6	101.2	63.3	28.9	123.6	64.2	26.3	39.5	23.5	31.7	85.0	90.4	29.9	50.6	92.8	48.3	0.0	18.8	73.2
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150586016	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Uncertain	Mitochondria,Cytosol		No	No		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	57.0	54.0	14.5	47.8	18.5	86.8	103.4	27.2	25.4	63.9	21.9	57.8	65.5	69.7	46.9	64.7	62.7	55.8	72.3	16.6	18.4	72.2	75.2	47.7	68.4	17.1	15.3	94.9	107.2	62.8	32.8	52.4	18.5	52.8	70.8	52.3	77.2	47.0	87.3	74.0	55.3	68.4	18.1	47.4	59.7	24.3	15.1	68.7	92.1	76.7	83.4	67.5	43.4	22.8	158.0	69.4	76.6	79.9	100.8	234.3	105.0	97.3	158.0	134.1	143.0	202.5	168.9	212.0	142.4	134.3	160.1	125.1	149.9	152.9	193.5	81.3	91.6	129.4	76.1	130.9	101.1	155.0	113.0	151.4	153.6	97.2	221.9	200.7	180.3	112.3	109.8	116.5	105.5	121.3	109.6	70.6	108.4	161.3	98.7	97.5	101.1	238.8	119.9	116.9	93.7	102.1	62.6	88.0	144.5	91.6	130.9	127.3	99.9	76.3	69.3	109.2	186.6	194.9	119.6	195.0	96.4	130.5	39.5	23.6	47.2	10.4	27.9	49.5	46.1	36.2	40.6	35.7	54.2	34.7	51.5	41.6	3.7	46.1	56.9	26.5	37.0	44.4	14.5	18.5	27.2	25.4	16.6	18.4	17.1	15.3	18.5	18.1	15.1	22.8	77.7	35.3	67.1	14.4	91.4	140.1	157.3	109.8	109.3	30.6	86.0	76.5	102.4	58.6	69.2	35.0	27.1	84.1	85.7	43.1	137.0	76.1	21.5	39.6	64.3	67.5	56.8	80.3	30.4	108.3	113.6	63.8	64.7	51.4	75.5	45.0	60.0	30.6	62.4	23.5	33.1	81.7	54.9	96.4	82.8	6.6	61.5	72.7	69.4	19.7	97.4	37.2	73.2	32.6	34.7	64.0	57.7	56.4	112.1	79.6	77.0	138.4	41.7	31.2	78.9	95.4	77.9	40.4	41.9	102.3	122.9	120.3	95.0	55.1	99.0	130.4
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022247-6059175	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	27.2	39.4	28.1	27.7	28.9	105.9	35.9	30.6	36.1	29.0	34.9	48.8	37.1	25.0	37.4	30.4	31.0	23.8	33.8	28.1	30.6	43.8	65.1	30.3	35.2	30.5	28.9	29.3	44.3	78.0	25.9	52.3	31.6	35.0	47.3	29.0	46.8	24.2	38.3	33.3	37.2	23.8	29.1	26.6	49.1	19.5	29.8	43.6	39.3	34.4	40.4	27.2	22.4	33.7	144.5	90.5	71.2	108.8	66.4	59.6	92.4	73.0	66.8	64.2	80.8	83.7	96.2	112.5	77.4	81.3	115.5	100.4	93.1	67.1	82.2	69.8	140.3	115.9	91.6	127.3	54.3	100.8	102.0	48.1	82.8	60.7	64.9	67.7	69.4	88.1	189.0	106.8	61.4	146.5	55.6	128.6	88.5	84.6	99.7	120.0	74.6	134.0	82.3	70.3	87.3	156.5	139.3	186.6	63.8	98.6	141.0	122.4	65.9	37.0	134.2	65.3	78.2	106.5	114.8	115.6	73.9	129.8	108.7	11.1	6.9	17.3	8.2	5.5	5.6	12.3	6.5	9.3	6.9	9.5	7.5	6.6	3.7	10.2	6.2	6.0	8.9	4.8	28.1	28.9	30.6	36.1	28.1	30.6	30.5	28.9	31.6	29.1	29.8	33.7	23.1	38.5	43.7	14.4	42.8	23.8	34.9	34.3	41.5	29.7	52.5	34.9	49.6	45.8	37.7	44.1	16.7	219.1	52.5	57.1	66.5	55.0	8.8	59.5	42.3	27.5	38.5	422.0	21.8	44.8	82.1	29.7	64.7	48.1	20.8	44.9	21.0	63.2	53.8	32.0	21.9	68.7	54.9	39.0	29.9	16.1	34.5	65.2	24.9	13.1	62.8	46.4	70.0	19.1	26.9	53.0	47.0	37.6	60.1	43.3	47.5	66.1	48.3	26.5	13.1	32.0	26.0	33.7	34.5	45.5	22.4	371.0	38.0	57.1	52.7	32.3
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157522	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	11.1	9.0	7.2	10.5	8.1	30.1	8.6	7.4	9.5	9.8	8.6	8.8	7.6	10.5	8.0	6.3	8.3	9.5	6.3	7.8	11.1	8.5	7.7	8.9	8.0	10.9	8.1	10.8	7.4	11.1	6.6	11.2	10.9	10.1	8.6	6.6	17.7	8.4	4.5	4.6	9.9	11.1	15.6	11.9	9.5	3.3	13.0	11.7	10.0	5.8	7.1	8.0	5.9	8.7	38.4	22.1	16.7	17.4	21.5	28.3	20.1	21.2	29.1	56.3	41.1	23.0	23.2	27.4	27.0	29.8	66.2	27.4	24.2	27.1	29.5	45.7	12.0	33.8	19.2	18.7	17.9	32.2	0.2	22.5	13.1	23.7	19.3	17.7	18.0	10.7	19.1	23.6	20.3	13.4	35.5	17.0	15.8	8.4	10.8	27.6	40.9	12.1	15.3	18.7	14.1	20.4	32.0	24.0	50.7	12.7	9.2	9.0	31.4	25.7	24.9	15.1	36.2	19.0	30.8	0.3	15.9	20.0	23.1	10.7	5.3	6.3	5.4	7.9	5.2	5.3	4.5	5.2	4.8	4.2	3.0	4.3	15.7	6.5	8.0	3.1	6.5	2.1	7.2	8.1	7.4	9.5	7.8	11.1	10.9	8.1	10.9	15.6	13.0	8.7	94.5	67.3	34.0	25.1	35.9	19.5	42.3	33.0	31.3	38.8	26.6	26.0	29.9	32.9	46.0	22.0	14.6	47.8	44.8	32.2	21.5	40.2	2.4	55.8	68.7	76.3	15.0	36.0	39.6	48.5	89.2	52.6	22.4	41.7	41.1	93.5	33.5	21.9	38.2	47.1	42.9	24.0	16.2	29.9	20.8	4.2	57.2	50.7	21.4	48.7	47.1	50.9	45.3	51.3	16.8	54.7	21.8	84.2	46.0	39.5	33.6	33.0	48.9	24.8	39.5	60.5	45.9	2.4	5.5	22.5	10.1	40.8	40.0	61.3	28.6	40.5
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627464	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.6"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.8;U-266/70: 44.0;U-698: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	3.3	3.1	0.8	4.0	1.1	2.6	1.6	1.6	1.4	2.3	1.6	4.7	6.2	1.9	1.0	1.6	1.3	1.4	1.5	0.8	1.5	2.0	1.9	1.8	3.2	1.0	1.2	1.9	19.6	3.4	1.1	3.2	0.9	4.0	1.8	0.1	9.7	1.2	2.0	1.4	5.0	0.9	1.5	3.1	12.3	1.0	1.2	1.3	3.5	0.0	2.3	1.9	1.8	2.1	8.7	3.3	1.2	4.3	2.8	2.0	15.9	12.4	1.1	0.7	2.1	3.5	2.9	46.8	8.0	1.3	3.1	7.2	1.6	1.3	1.1	25.3	7.1	4.6	1.7	2.0	1.1	3.9	12.3	0.1	1.5	0.7	2.0	0.8	1.4	4.9	3.0	8.7	0.6	4.4	5.5	2.2	6.2	2.7	7.2	25.1	7.0	8.2	1.3	5.0	5.6	9.9	6.3	6.5	8.2	1.7	2.2	4.4	3.9	2.5	5.5	10.8	7.1	44.0	24.4	31.0	4.6	4.2	6.2	0.0	0.1	0.1	0.3	0.0	0.2	1.0	0.2	0.8	0.1	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	1.1	1.6	1.4	0.8	1.5	1.0	1.2	0.9	1.5	1.2	2.1	9.2	9.6	7.5	14.7	43.8	20.3	8.9	7.2	26.7	8.4	14.7	8.9	8.2	17.2	7.2	12.9	8.4	4.1	13.4	14.0	0.0	3.7	0.1	18.4	18.3	7.6	13.7	1.7	31.3	6.5	6.9	15.2	40.2	39.2	1.3	4.4	8.9	11.8	4.6	1.7	39.0	30.1	14.2	5.1	41.2	0.7	7.5	27.7	32.0	21.5	3.9	3.0	9.2	20.1	26.2	7.0	7.7	5.7	121.3	13.0	5.4	2.9	7.7	2.3	0.0	13.4	9.4	3.1	3.6	23.8	18.3	6.7	12.8	3.5	6.8	16.6
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934115-40035591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 66.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.1	14.6	21.5	12.2	22.4	18.7	17.6	27.2	23.7	14.6	16.8	15.5	11.3	30.5	15.4	16.0	16.1	17.0	17.7	21.2	22.0	13.4	21.3	16.9	16.9	20.3	20.2	17.1	14.1	17.7	24.1	19.0	20.5	19.8	12.9	13.1	13.9	11.5	18.9	19.0	11.3	15.6	18.9	15.7	15.2	8.9	22.1	13.1	21.8	11.0	11.6	17.2	12.4	28.9	37.1	17.5	30.3	46.3	49.0	81.7	28.9	51.0	58.1	40.8	40.0	25.2	15.6	19.6	25.9	69.3	54.7	38.6	41.1	61.4	56.6	92.8	20.4	41.6	30.8	30.7	42.1	25.6	27.8	65.3	41.2	39.0	69.8	57.3	58.0	40.5	31.3	18.1	81.7	12.3	21.7	34.6	18.8	32.8	38.2	25.4	42.2	33.1	51.4	24.7	16.1	24.4	36.4	22.2	32.3	29.5	30.7	43.4	61.6	54.3	40.9	27.3	33.6	24.6	47.8	6.0	38.1	34.4	77.4	11.6	10.8	8.6	6.8	14.1	5.7	7.1	7.6	7.9	17.6	9.2	8.3	8.2	3.3	8.5	20.5	66.5	5.8	4.9	21.5	22.4	27.2	23.7	21.2	22.0	20.3	20.2	20.5	18.9	22.1	28.9	47.9	16.0	31.1	28.7	29.3	12.0	27.5	17.8	43.3	29.9	45.0	45.2	32.3	32.9	21.4	16.5	12.5	37.5	32.2	21.1	13.7	23.7	1.5	19.3	52.7	35.3	14.4	37.4	42.7	25.4	34.8	36.5	23.4	27.0	24.1	35.0	22.9	27.8	30.7	28.6	53.9	25.9	12.2	33.7	55.4	4.3	42.3	52.1	32.0	29.0	41.1	30.4	16.5	30.2	26.3	47.6	16.2	39.9	115.6	30.7	6.4	18.2	12.9	23.9	46.0	43.6	35.6	8.6	29.8	47.0	14.5	15.2	18.2	64.0	29.6	18.4
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034258, HPA049509"	Approved		Approved	Cytosol		NA	NA		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034258: AB_2095995, HPA049509: AB_2680797"	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	32.9	32.1	23.5	33.0	25.7	36.4	31.5	27.8	27.9	33.1	23.9	33.2	27.6	34.0	29.5	33.8	31.1	22.0	26.3	24.8	23.7	28.7	29.0	24.4	40.4	25.4	23.8	34.1	32.9	21.7	28.2	31.0	27.4	29.4	30.8	23.5	28.8	26.2	43.1	51.1	29.2	31.5	23.9	33.4	28.7	22.6	25.7	30.0	27.4	27.3	43.1	32.5	31.2	32.2	55.6	47.9	50.0	53.1	45.8	46.2	52.5	66.8	38.2	64.3	46.7	62.8	34.0	104.2	77.3	51.1	28.6	54.3	79.0	52.0	67.3	85.4	87.8	74.9	68.3	55.6	43.3	106.9	90.2	42.0	63.3	55.4	38.9	54.0	59.6	66.8	136.4	34.2	60.2	50.4	86.1	113.3	82.4	59.5	64.1	89.5	61.1	79.2	43.2	46.0	61.9	69.9	49.4	48.7	63.3	46.7	88.5	63.2	56.8	43.8	52.9	63.2	62.4	90.9	102.1	153.6	63.6	71.7	63.9	113.2	87.3	119.3	56.3	104.2	51.3	60.1	57.2	58.9	95.7	53.2	58.0	53.9	9.8	64.8	101.6	59.9	73.2	100.7	23.5	25.7	27.8	27.9	24.8	23.7	25.4	23.8	27.4	23.9	25.7	32.2	29.0	16.0	19.6	10.7	29.3	20.4	17.5	28.3	24.5	19.8	16.0	17.3	20.0	25.8	19.0	18.4	8.4	69.0	33.8	18.3	29.4	33.0	7.6	15.0	28.3	26.0	21.7	21.9	23.4	40.1	58.8	23.6	15.3	14.2	41.2	24.4	22.1	13.1	37.8	16.8	21.2	15.4	18.3	18.6	18.5	5.3	25.1	26.0	19.6	14.0	30.6	34.4	35.0	16.1	21.9	32.8	23.8	16.6	30.7	14.8	26.1	23.9	14.3	21.6	32.9	18.5	29.8	49.2	38.7	27.3	20.5	51.6	26.7	29.3	21.7	14.6
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002921-75012366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		12000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	2.7	5.3	4.0	2.9	4.5	3.2	3.6	8.7	4.8	3.9	2.2	3.0	3.0	3.6	4.9	3.8	3.1	4.0	3.9	3.6	6.1	4.9	3.3	2.7	4.0	4.5	4.2	2.9	4.0	8.5	3.5	4.8	4.5	4.1	3.8	6.8	2.8	4.5	5.5	4.0	2.8	3.4	2.9	2.7	2.6	3.9	4.8	3.9	11.5	7.1	4.2	4.0	2.6	6.9	5.9	7.0	5.6	6.4	6.3	5.2	7.4	3.7	6.1	7.1	8.2	9.0	5.9	5.2	2.3	5.8	4.5	4.4	8.8	8.7	10.6	3.2	6.5	4.6	6.3	6.2	8.2	3.4	5.3	4.8	8.2	9.1	9.3	6.1	24.8	4.5	4.2	4.9	15.5	17.4	5.5	4.3	4.0	7.3	10.3	3.4	6.6	4.3	10.1	7.0	6.0	4.8	3.9	5.5	8.4	6.9	9.0	3.2	6.4	5.4	5.2	2.4	4.8	8.4	7.5	6.2	5.9	4.3	4.2	4.2	1.8	1.4	3.0	1.9	2.5	2.1	2.6	2.5	2.4	2.0	1.9	2.0	1.0	3.3	1.8	2.0	4.0	2.5	4.0	4.5	8.7	4.8	3.6	6.1	4.5	4.2	4.5	2.9	4.8	6.9	18.9	19.2	11.5	6.2	14.1	17.7	19.5	28.9	18.2	28.2	15.4	17.0	18.2	22.8	21.5	25.8	45.9	51.5	16.1	15.3	41.1	36.2	12.1	17.0	14.5	32.1	15.6	20.8	5.3	33.1	56.5	18.3	12.8	12.8	21.5	17.5	13.2	11.9	33.7	28.6	5.4	9.0	20.3	19.1	11.9	12.7	15.8	18.8	14.2	1.9	28.0	27.3	28.8	2.5	8.5	28.1	11.7	16.1	11.3	17.5	19.0	50.8	17.2	29.4	26.3	16.9	27.9	84.2	27.4	27.3	21.9	165.5	14.9	30.5	19.7	19.2
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	23.6	27.2	11.4	11.6	10.9	10.9	21.9	13.2	15.6	18.7	10.1	17.5	8.6	17.0	12.5	17.4	16.3	9.6	40.6	11.2	11.6	15.4	24.7	13.5	14.3	11.9	12.1	18.2	16.9	30.0	15.8	9.7	12.8	15.0	13.4	19.0	25.1	13.7	77.0	17.6	10.7	19.4	11.0	14.9	14.2	19.3	11.2	13.3	12.5	48.0	14.5	17.7	17.1	14.0	35.4	26.9	30.9	25.5	36.3	43.1	36.2	56.1	42.2	56.5	52.9	39.0	20.7	90.6	39.9	43.2	45.0	20.6	65.3	48.6	69.5	32.5	58.1	44.3	29.3	38.4	46.2	71.2	24.3	29.3	25.8	61.0	69.9	26.5	52.8	30.1	106.1	31.6	62.3	23.1	69.7	30.2	42.0	38.8	52.7	54.7	51.3	65.7	28.7	15.7	53.2	20.5	55.1	63.8	37.4	40.7	24.7	32.8	28.3	35.9	42.9	53.4	73.7	31.6	37.9	68.9	27.9	59.5	43.1	1.6	23.4	3.9	18.6	37.2	22.8	14.8	18.3	21.1	37.0	18.9	22.9	23.6	2.1	25.5	33.1	25.3	17.6	21.4	11.4	10.9	13.2	15.6	11.2	11.6	11.9	12.1	12.8	11.0	11.2	14.0	13.9	6.4	22.0	24.8	15.8	13.8	19.0	33.0	10.8	15.1	15.8	16.8	79.2	15.7	24.9	5.5	20.9	25.1	12.1	4.5	29.4	18.9	26.1	17.0	23.0	14.4	3.6	15.3	39.9	15.8	22.6	22.6	13.7	11.5	25.9	21.1	3.9	22.6	24.8	21.9	44.5	7.0	20.3	10.7	11.2	11.3	26.4	15.4	17.8	26.2	30.1	21.7	10.3	29.1	35.7	13.7	6.9	25.2	22.6	17.1	5.7	23.1	34.2	21.8	26.3	19.7	45.4	45.5	23.6	17.1	14.9	14.9	13.5	40.4	9.4	13.9
EIF2B4	"DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta"	ENSG00000115211	"Eukaryotic translation initiation factor 2B subunit delta"	Q9UI10	2	27364352-27370457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 196.4;Late spermatids: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032234, HPA039993, HPA068855"	Approved		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Actin filaments"	"CAB032234: AB_668909, HPA039993: AB_2676790, HPA068855: "	"unprognostic (2.26e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (5.46e-8)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-2)"	21.4	24.8	23.3	15.2	24.3	10.7	20.7	24.0	23.8	21.3	22.5	31.7	14.6	21.0	16.9	27.8	20.3	13.4	28.0	23.2	23.7	18.2	21.5	18.1	17.2	24.4	24.3	19.8	31.4	20.4	20.3	18.8	24.0	25.4	18.4	19.3	24.6	20.8	51.8	29.3	18.4	22.8	23.2	18.6	24.7	38.1	24.4	18.9	18.1	35.2	22.9	24.1	21.4	24.1	38.7	59.8	44.3	34.6	58.4	42.7	48.4	41.0	43.7	55.7	37.3	89.2	16.9	49.7	38.7	48.7	46.6	27.6	62.5	50.8	36.2	37.4	40.7	61.7	39.3	104.5	51.1	58.2	23.0	41.3	51.1	69.2	51.6	40.4	53.3	37.2	59.5	24.9	53.0	35.2	28.8	61.7	49.1	59.8	38.9	52.9	69.9	43.2	50.0	32.7	34.3	37.4	34.1	53.8	42.6	39.6	31.3	23.4	52.8	40.1	47.0	35.4	49.7	50.9	65.7	74.7	33.9	47.9	38.6	56.6	53.9	38.8	32.1	48.1	44.6	31.1	31.6	32.6	52.5	25.3	30.2	32.9	7.7	30.8	52.2	38.6	43.8	43.2	23.3	24.3	24.0	23.8	23.2	23.7	24.4	24.3	24.0	23.2	24.4	24.1	19.9	12.8	14.8	9.8	17.5	35.9	18.9	32.0	15.4	22.6	28.0	18.7	33.0	14.3	27.0	22.0	66.7	40.9	27.8	23.4	19.6	29.0	196.4	22.3	23.9	19.9	24.0	8.2	6.6	33.4	25.0	24.6	14.8	17.6	31.6	16.9	25.7	34.4	24.3	10.1	6.5	24.8	28.5	20.7	28.0	299.6	23.3	16.5	23.2	2.8	29.5	23.2	16.5	6.0	8.8	26.7	27.1	24.8	28.4	21.2	23.0	27.6	24.9	58.9	19.7	17.0	34.9	71.5	38.9	14.5	34.8	46.1	24.3	23.8	20.5	14.4
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184146127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	16.1	18.9	10.1	8.2	10.1	5.3	17.6	11.2	12.5	17.2	13.0	19.6	9.4	15.3	5.6	24.7	14.9	6.5	22.3	9.8	11.7	15.5	20.1	15.8	9.7	11.2	10.1	14.9	19.0	22.1	18.0	11.8	10.6	18.1	13.8	2.3	23.9	11.2	53.9	24.7	19.4	11.6	10.9	20.3	21.0	10.1	10.8	18.2	16.7	33.6	19.0	18.8	19.6	9.3	60.7	25.4	24.3	25.4	32.4	23.4	28.0	29.1	36.2	51.7	42.4	41.5	24.5	48.6	37.8	32.5	65.0	34.7	56.6	39.1	47.7	39.7	55.4	75.6	28.4	42.4	24.8	61.8	32.9	19.6	32.1	28.7	24.1	19.5	37.3	49.7	46.7	29.2	35.2	49.5	49.5	34.3	39.9	76.1	49.3	45.1	37.6	61.3	43.1	38.6	35.2	34.2	27.9	91.9	41.5	20.3	83.6	60.8	33.6	22.9	35.4	28.5	62.7	24.3	61.2	69.6	33.0	58.8	35.2	9.5	10.0	14.7	8.7	9.1	11.5	15.4	12.2	13.3	11.8	16.9	18.1	11.5	1.3	14.3	9.8	5.1	11.6	7.6	10.1	10.1	11.2	12.5	9.8	11.7	11.2	10.1	10.6	10.9	10.8	9.3	19.8	25.6	22.7	8.8	31.6	30.8	36.6	18.2	29.6	18.5	33.1	30.1	25.8	17.2	28.4	36.8	8.4	39.3	25.4	32.0	52.8	27.5	3.7	20.5	17.7	24.0	45.9	27.6	14.6	36.0	28.8	17.8	35.2	23.3	16.5	21.3	13.6	27.1	24.9	35.3	18.6	28.0	24.4	18.5	22.6	2.7	18.3	18.2	19.6	12.2	30.8	14.5	22.6	18.1	15.3	26.3	17.9	14.7	19.0	34.6	27.2	30.0	21.9	16.7	13.1	17.5	22.8	17.7	17.0	31.2	29.0	38.6	26.5	34.2	34.7	44.9
EIF2D	LGTN	ENSG00000143486	"Eukaryotic translation initiation factor 2D"	P41214	1	206571292-206612465	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028220	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nuclear bodies"	"HPA028220: AB_10602022"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.09e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.13e-2)"	32.7	32.5	18.1	18.8	20.4	33.0	43.3	19.0	21.0	37.8	22.0	37.9	21.9	35.5	31.9	32.4	42.7	23.9	25.6	17.5	19.1	31.0	31.3	24.4	32.7	19.9	19.7	60.3	41.3	43.6	23.5	27.4	20.1	30.0	32.6	9.8	47.1	30.1	54.1	34.0	24.3	38.1	19.3	23.4	35.7	18.3	19.6	37.0	35.6	51.7	38.6	31.7	31.8	22.1	63.4	38.3	30.6	26.7	88.2	115.1	37.2	34.9	71.7	61.8	60.4	31.3	53.6	106.7	26.5	71.5	19.7	43.6	50.3	78.8	54.4	35.2	66.2	37.5	44.4	59.5	97.2	68.6	36.9	105.9	103.2	49.1	96.9	78.4	79.4	77.0	88.8	48.5	54.5	49.6	61.8	31.7	25.1	46.9	57.9	49.4	65.5	118.4	63.0	23.2	28.6	26.3	30.7	80.9	76.4	45.5	62.0	52.9	56.1	33.9	34.0	15.9	47.2	44.1	26.3	74.4	45.7	45.7	25.9	15.1	17.6	2.8	19.2	16.7	25.9	32.7	26.4	23.6	28.9	26.9	33.7	24.7	0.4	30.0	25.1	15.3	26.3	17.7	18.1	20.4	19.0	21.0	17.5	19.1	19.9	19.7	20.1	19.3	19.6	22.1	18.1	16.0	17.5	15.0	24.1	14.4	37.6	24.3	23.3	10.6	24.6	22.9	10.1	20.0	19.1	11.0	4.2	40.7	15.2	9.4	25.4	19.9	41.3	18.8	17.5	20.9	4.9	26.9	11.4	20.0	26.6	21.6	17.3	12.6	17.7	24.8	23.6	11.4	22.1	3.3	10.7	14.8	24.4	17.2	11.7	16.1	28.9	12.7	17.8	6.5	23.3	12.0	14.4	14.1	17.6	14.4	15.0	27.4	22.9	23.7	15.2	28.8	17.1	14.3	19.7	23.3	23.3	26.4	10.4	31.5	23.2	25.6	20.6	32.7	27.6	30.5
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67360328-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		210000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	28.3	24.5	12.5	29.9	14.0	25.0	25.7	15.1	17.8	18.1	10.4	25.0	21.5	19.4	19.6	38.8	15.8	21.5	28.7	14.6	14.1	24.5	35.3	18.4	30.4	13.7	12.7	17.1	26.3	22.9	9.4	26.3	13.6	22.1	26.7	21.2	18.3	22.3	49.4	23.7	21.5	27.0	13.8	19.8	19.8	33.4	13.5	27.9	27.9	40.6	33.5	39.1	19.0	16.6	265.7	86.4	59.8	92.3	56.4	63.4	127.8	115.5	68.3	127.4	110.7	101.6	92.2	118.7	57.0	87.4	85.7	100.4	139.1	110.3	192.7	86.9	51.9	76.9	80.0	70.4	59.2	82.7	71.9	52.4	62.6	113.9	172.5	49.8	105.4	73.8	132.6	89.6	127.3	131.3	113.7	64.7	61.1	157.9	142.9	85.7	99.0	84.6	78.2	120.0	85.9	60.7	83.0	96.5	91.1	52.3	164.5	70.8	81.3	167.4	180.7	82.0	124.4	77.0	90.4	180.7	97.1	145.3	110.2	51.4	50.6	33.0	47.4	71.0	58.4	55.4	54.5	51.7	70.1	45.8	50.3	51.5	6.9	58.6	62.8	48.0	64.3	70.7	12.5	14.0	15.1	17.8	14.6	14.1	13.7	12.7	13.6	13.8	13.5	16.6	64.1	28.9	40.2	17.3	44.1	142.8	88.2	77.2	37.5	22.1	32.0	30.1	92.8	30.0	55.8	22.0	12.5	78.7	38.0	23.3	70.5	89.6	81.0	34.6	48.9	60.3	13.1	64.2	21.7	63.0	104.7	51.2	34.1	44.8	35.5	35.7	26.4	39.8	70.4	37.0	20.9	30.6	61.1	37.9	51.3	33.4	31.1	40.7	51.6	15.9	61.3	32.2	36.0	15.1	23.8	70.8	18.3	40.6	56.7	79.9	26.6	65.1	35.0	35.2	26.3	60.7	85.9	204.9	96.3	49.7	130.4	93.4	46.1	57.9	39.7	79.1
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088309-34112243	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	50.7	49.2	40.1	44.0	42.1	45.0	42.3	43.1	54.5	34.8	39.8	45.8	38.3	33.7	37.9	61.2	30.6	32.5	46.2	39.0	41.7	54.0	59.2	46.8	52.8	44.3	41.3	32.0	81.4	35.8	27.7	54.2	43.9	35.0	42.8	23.7	43.5	33.9	100.8	39.0	37.6	40.5	43.6	37.9	50.8	37.1	41.6	46.6	42.4	64.0	56.3	63.1	37.9	48.4	211.9	139.1	103.4	125.5	99.1	149.3	196.6	188.7	180.2	184.1	184.6	493.4	144.5	188.5	135.1	171.9	204.1	194.5	169.7	310.6	222.0	61.0	92.3	373.8	110.0	254.5	254.7	241.9	116.7	153.6	259.1	182.7	270.2	125.8	195.5	273.7	223.6	174.8	153.5	135.8	226.0	201.3	100.6	243.7	251.1	128.2	176.0	176.2	145.5	174.2	104.7	71.3	209.3	125.2	403.7	119.2	189.9	282.4	132.8	208.7	129.0	132.5	179.8	162.4	153.8	195.9	196.5	185.0	155.1	54.2	77.1	64.8	54.7	89.0	68.1	84.8	77.2	77.2	75.8	71.2	72.0	72.8	47.3	74.9	83.8	105.3	96.1	64.0	40.1	42.1	43.1	54.5	39.0	41.7	44.3	41.3	43.9	43.6	41.6	48.4	157.4	169.9	162.1	13.7	167.8	180.5	326.3	384.9	81.4	60.5	171.7	154.6	145.1	223.1	241.7	139.8	31.3	359.2	139.6	145.7	307.2	344.2	314.9	182.9	160.1	199.2	126.7	300.7	17.6	529.2	394.4	128.5	110.6	139.1	144.4	80.1	253.4	497.1	243.0	42.1	17.1	229.6	215.7	223.1	119.3	163.7	126.5	147.0	119.2	16.9	286.8	92.8	126.7	17.1	25.2	519.3	133.8	129.4	182.6	292.7	141.5	335.0	207.7	95.3	111.7	102.6	226.6	446.4	211.6	132.7	174.5	641.7	124.0	220.6	200.4	343.8
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054946-24078810	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"	"Disease variant, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB012471	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	65.5	51.8	31.9	71.8	33.5	76.2	82.9	35.7	35.4	78.0	42.5	67.2	66.4	83.8	45.0	62.5	79.9	53.3	57.1	31.4	33.0	69.6	74.6	50.7	113.3	35.9	32.2	131.3	94.8	49.6	30.1	46.4	35.7	51.7	66.3	46.9	69.7	41.7	66.7	71.8	53.0	74.3	35.8	72.1	66.7	18.6	34.8	97.6	69.9	51.8	111.6	66.4	65.6	41.4	261.0	256.0	110.3	182.7	113.5	235.5	73.2	142.3	127.4	114.8	130.6	290.8	174.3	449.5	141.0	104.9	251.9	165.1	344.7	271.3	140.8	147.8	203.7	177.2	467.8	164.3	126.2	304.0	219.4	206.9	169.2	129.6	269.7	152.9	166.2	176.0	275.4	176.0	127.7	124.8	170.6	278.8	268.2	118.1	146.5	169.5	215.2	271.4	155.4	241.5	60.2	130.8	232.3	224.7	239.8	205.5	289.6	205.1	140.2	97.1	66.7	177.3	125.3	156.6	322.4	240.9	120.9	193.1	113.7	64.4	141.1	27.9	84.9	151.9	147.8	156.0	148.8	113.9	123.9	120.6	187.5	156.6	51.2	106.3	132.6	97.4	124.2	127.2	31.9	33.5	35.7	35.4	31.4	33.0	35.9	32.2	35.7	35.8	34.8	41.4	76.5	44.8	54.5	48.0	187.6	126.6	98.0	51.8	145.1	25.3	128.4	91.2	49.1	74.4	49.0	40.5	25.0	59.6	127.5	35.2	111.6	67.9	0.5	67.3	109.4	67.5	44.9	92.5	19.0	57.6	122.1	72.3	78.5	90.9	100.8	84.6	84.3	58.8	89.1	20.2	20.1	65.0	32.6	138.9	91.9	3.5	67.7	109.7	55.2	36.5	134.5	30.4	78.2	23.6	31.4	59.5	68.9	61.3	99.3	70.2	72.3	135.2	40.6	33.3	72.3	85.0	87.4	10.2	21.9	130.7	151.2	71.0	117.9	76.2	100.4	92.9
EIF3A	"EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	83.0	53.2	27.5	73.7	30.9	120.7	62.5	28.4	31.8	48.8	38.0	62.9	65.8	60.1	34.9	69.3	44.8	50.1	69.0	25.7	33.7	58.1	77.9	49.5	75.1	34.8	30.0	61.7	155.1	70.2	24.4	57.0	35.4	55.5	63.9	31.6	73.3	46.3	178.2	69.9	60.0	62.8	31.6	57.4	72.8	44.8	32.4	78.3	70.3	89.8	74.6	76.4	51.8	32.4	258.5	190.9	154.0	211.6	163.6	235.0	119.4	228.9	235.9	144.0	143.7	181.2	165.5	300.2	83.2	190.3	113.3	252.0	202.5	175.7	203.5	166.1	166.3	258.3	143.6	203.2	186.2	382.3	183.9	204.6	193.0	212.7	362.8	240.7	165.7	119.8	269.7	191.9	188.7	152.5	159.4	179.8	147.8	99.4	96.3	162.1	332.1	143.7	137.0	213.9	71.6	151.3	180.2	166.9	244.9	132.0	107.2	241.1	245.6	138.7	128.0	147.1	335.8	164.9	194.0	286.9	147.2	368.2	97.6	49.0	38.2	23.9	27.4	41.8	31.7	25.6	33.1	25.2	36.1	24.7	22.6	24.7	10.0	26.6	58.1	20.5	50.9	28.3	27.5	30.9	28.4	31.8	25.7	33.7	34.8	30.0	35.4	31.6	32.4	32.4	122.1	233.9	323.8	24.5	147.3	304.2	279.1	129.0	203.7	60.1	155.8	133.7	320.7	111.5	198.5	64.4	62.6	169.1	181.1	130.2	27.4	157.2	199.4	230.3	248.6	145.3	141.2	270.0	32.7	185.4	159.5	152.5	159.0	371.8	145.4	132.6	74.3	184.5	126.3	43.7	34.9	168.2	87.5	200.3	169.0	119.1	108.7	196.5	147.7	29.0	235.9	78.2	135.9	24.6	38.9	192.8	105.4	117.8	258.6	253.6	98.5	58.7	158.3	54.1	59.2	209.7	221.6	158.0	112.9	255.3	363.8	252.3	171.1	145.0	227.7	302.3
EIF3B	"EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	59.3	54.8	29.4	49.5	31.5	88.8	55.1	31.8	31.7	49.6	31.4	74.3	39.5	55.3	28.4	78.2	53.3	34.8	55.1	31.2	32.1	44.7	60.4	42.2	58.9	33.4	32.6	51.0	83.1	39.6	37.9	51.9	33.6	50.3	44.6	17.7	63.4	42.9	155.2	82.9	48.9	52.5	32.6	56.6	59.1	60.8	32.0	53.5	37.0	65.8	64.6	69.4	53.3	35.2	510.8	253.3	102.9	280.4	113.5	102.4	254.4	174.5	130.2	193.8	180.5	334.4	193.2	293.9	139.8	186.2	273.5	269.9	287.1	229.0	212.5	88.6	334.6	224.8	240.8	227.0	159.2	277.0	159.8	127.5	147.9	210.1	219.2	101.8	157.9	133.9	580.9	133.2	179.7	358.4	134.7	306.9	322.6	176.2	224.4	163.3	208.3	304.2	123.4	228.9	233.9	174.9	184.5	403.4	102.8	178.8	270.0	301.3	169.0	149.0	326.9	231.7	319.4	145.7	210.6	295.6	169.3	303.9	372.5	2.1	7.2	4.0	7.5	7.2	9.4	6.5	7.0	8.2	8.0	6.1	8.4	8.5	0.6	16.9	6.6	8.2	9.5	4.8	29.4	31.5	31.8	31.7	31.2	32.1	33.4	32.6	33.6	32.6	32.0	35.2	43.3	25.6	64.1	19.6	35.9	64.2	55.6	25.4	34.1	37.9	74.0	62.4	37.4	30.0	38.8	27.6	64.6	64.9	52.6	49.0	3.9	35.5	11.6	37.1	57.0	50.9	47.8	56.8	20.1	62.6	63.4	47.6	48.9	48.1	17.1	77.0	63.5	67.0	47.4	52.2	19.5	63.0	14.2	39.5	32.3	23.3	43.8	34.3	16.0	8.4	32.6	45.6	38.1	15.6	19.9	70.9	28.9	37.2	42.3	68.8	33.6	31.0	27.4	44.3	26.3	69.2	48.5	34.4	39.4	63.5	78.3	82.6	34.7	119.4	77.0	50.6
EIF3C	"eIF3-p110, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735727	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	174.0	99.7	86.7	113.5	94.3	149.8	185.7	77.4	92.6	136.9	83.2	189.7	148.6	138.0	51.7	159.7	185.9	86.7	135.3	98.1	89.2	172.8	143.1	104.6	124.8	87.4	91.6	236.4	219.6	227.9	86.8	122.8	92.8	115.2	166.1	94.8	187.6	112.9	360.1	188.3	145.0	149.0	80.2	116.2	124.4	140.8	84.2	91.0	175.7	291.9	189.0	144.8	104.2	89.3	182.1	321.5	419.3	481.5	368.0	453.1	627.7	444.1	380.9	587.7	425.4	620.6	333.9	461.7	556.7	322.2	366.5	214.5	361.4	618.1	650.0	188.4	376.0	518.9	466.8	860.4	471.9	791.3	344.6	521.4	367.4	370.4	582.8	253.6	679.5	439.3	595.7	394.5	314.5	783.0	622.0	299.2	652.8	304.0	491.2	638.8	612.7	447.0	317.8	406.4	379.1	573.2	396.8	531.0	478.0	263.3	551.6	356.6	570.3	372.3	370.1	180.4	299.9	325.8	279.0	860.7	378.7	320.4	398.7	54.5	198.1	90.2	122.0	204.0	140.6	114.3	131.8	129.1	213.2	113.9	127.4	120.5	14.3	163.8	220.5	98.3	147.2	267.3	86.7	94.3	77.4	92.6	98.1	89.2	87.4	91.6	92.8	80.2	84.2	89.3	5.0	67.3	101.4	1.0	9.6	11.9	10.0	3.9	15.4	7.0	5.3	3.0	157.0	5.7	91.1	5.5	41.7	3.7	6.2	4.6	1.9	3.3	2.8	8.7	7.7	16.0	6.0	17.5	1.4	3.5	3.1	33.2	10.2	12.9	39.1	7.3	7.9	4.8	3.1	0.0	1.5	5.9	2.0	5.0	8.4	3.5	6.5	12.6	5.4	5.6	3.9	1.9	2.1	4.5	1.0	4.1	5.2	5.3	21.4	5.7	7.1	5.2	168.1	16.2	0.0	6.9	18.5	3.9	4.6	16.9	13.8	5.6	11.2	6.1	6.3	8.8
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403841	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.0;Cardiomyocytes: 35.1;Club cells: 37.9;Respiratory ciliated cells: 38.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 50: Non-specific - Ribosome"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	40.8	35.4	19.9	1.0	20.2	6.2	41.2	20.4	33.5	37.9	16.6	37.1	1.3	29.4	3.5	44.3	33.8	1.9	47.4	20.9	19.7	43.0	39.9	30.7	1.6	21.3	20.2	50.5	72.9	4.0	32.1	2.4	21.9	35.6	2.3	5.4	38.5	3.3	98.6	52.3	30.3	2.0	18.0	32.1	43.1	30.7	19.9	1.8	40.6	6.9	2.9	37.7	35.8	21.2	3.0	6.9	6.6	5.5	9.1	5.2	4.3	3.8	4.6	9.5	8.2	7.7	3.5	4.1	6.8	5.8	7.6	5.5	11.0	10.9	14.1	1.9	6.5	4.7	12.7	15.3	2.7	6.9	8.3	5.7	7.3	5.7	6.0	5.7	3.6	6.8	7.6	7.8	3.6	9.4	8.2	17.3	15.1	5.7	4.0	10.9	8.0	7.4	8.1	5.1	13.1	8.5	3.2	6.4	6.0	1.8	16.4	6.8	5.2	4.2	7.9	5.2	7.6	4.2	3.8	7.2	7.3	7.2	7.7	2.9	1.3	0.7	1.1	1.8	1.3	0.9	1.4	1.2	1.7	0.9	1.2	1.6	0.1	1.1	2.3	0.8	1.2	1.3	19.9	20.2	20.4	33.5	20.9	19.7	21.3	20.2	21.9	18.0	19.9	21.2	0.1	22.4	44.0	0.7	2.2	1.3	2.0	0.3	1.8	0.0	0.5	0.6	35.1	0.0	37.9	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.1	0.2	0.2	4.9	0.0	8.4	0.5	1.2	0.6	10.5	3.1	0.1	10.1	0.0	1.8	0.2	0.5	0.0	0.6	0.7	0.0	1.3	2.3	0.7	0.3	5.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.1	1.7	0.4	5.2	1.1	0.9	1.7	38.2	0.0	0.0	0.5	7.4	0.3	0.6	2.5	1.6	0.8	2.6	0.1	0.7	1.0
EIF3D	"eIF3-p66, eIF3-zeta, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510855-36529184	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol		NA	NA		36000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637"	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	121.7	84.3	46.1	105.2	48.9	176.9	184.5	48.6	48.2	127.8	59.0	118.7	107.3	121.7	123.7	144.5	158.1	84.6	95.0	46.2	48.0	88.4	88.0	87.5	174.1	51.1	48.6	193.3	228.0	108.1	55.3	109.8	51.3	97.8	135.5	45.6	132.8	102.2	152.1	153.4	100.1	118.7	48.9	138.6	129.3	63.5	50.8	162.6	113.5	93.1	211.8	134.7	116.2	52.2	312.4	171.3	172.2	197.2	237.8	462.3	287.8	235.2	321.2	319.5	313.7	270.7	171.1	395.3	173.4	271.8	202.4	230.9	295.1	374.5	320.7	215.7	313.6	215.4	151.9	209.6	428.2	507.5	214.4	419.6	427.7	357.1	515.0	365.1	347.5	128.0	238.3	195.9	363.6	194.0	180.3	281.0	188.5	484.9	141.6	318.1	278.0	305.0	314.2	214.9	135.9	190.7	153.6	311.3	337.4	180.0	196.7	472.5	243.9	247.9	222.6	188.3	333.6	247.5	171.8	316.9	252.1	318.1	242.7	166.7	383.7	141.3	320.3	353.5	520.4	518.1	461.1	381.1	528.9	509.2	558.2	455.7	95.1	402.3	348.9	303.3	608.7	826.1	46.1	48.9	48.6	48.2	46.2	48.0	51.1	48.6	51.3	48.9	50.8	52.2	115.6	60.9	92.0	13.7	184.7	212.9	287.1	299.1	134.9	37.3	231.9	216.8	67.9	130.1	167.1	46.0	31.3	224.2	151.5	68.2	150.6	191.7	126.3	108.4	95.3	141.7	112.7	101.4	8.5	207.8	240.4	99.4	78.0	88.1	187.3	128.9	126.7	41.0	219.7	25.2	8.7	149.1	109.9	211.0	176.1	46.4	138.5	121.7	129.9	8.4	275.1	75.6	137.0	10.6	12.5	185.6	134.7	108.3	72.5	230.6	176.5	160.1	119.9	46.2	72.3	147.9	260.8	106.0	83.2	140.3	215.8	246.1	159.8	162.2	219.7	288.0
EIF3E	"eIF3-p48, EIF3S6, INT6"	ENSG00000104408	"Eukaryotic translation initiation factor 3 subunit E"	P60228	8	108162787-108443496	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023973	Approved		Supported	Cytosol		NA	NA		21000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA023973: AB_1848083"	"unprognostic (8.18e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.52e-3)"	"unprognostic (6.93e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (3.06e-7)"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-2)"	269.0	201.4	104.7	94.2	107.2	251.7	418.1	113.6	178.1	360.4	110.9	281.2	93.5	232.5	243.3	256.3	263.0	163.5	187.7	104.6	110.0	178.0	199.1	174.2	231.1	107.7	108.9	449.4	409.1	138.5	157.2	161.1	111.2	204.8	155.7	63.6	214.1	186.4	343.2	230.9	181.7	135.6	107.3	157.6	237.0	83.9	107.6	283.0	183.9	241.1	208.9	248.7	267.2	112.7	339.4	208.1	211.3	193.3	518.2	1098.8	139.9	193.0	430.3	415.4	443.0	238.0	260.1	653.0	213.0	288.6	134.2	187.6	421.1	507.6	502.6	216.1	485.0	595.8	218.6	472.3	357.6	287.5	169.0	813.2	745.9	272.8	678.6	534.7	636.8	405.6	477.5	196.8	469.6	453.7	384.2	898.4	196.2	577.7	403.6	300.6	278.8	436.6	520.0	305.2	223.5	192.2	122.0	78.0	363.2	288.2	263.8	413.7	279.1	131.7	241.7	139.9	201.9	167.4	171.6	426.5	171.6	483.1	149.8	79.5	165.6	32.6	104.0	161.0	197.1	214.7	205.5	148.4	218.7	178.0	301.0	225.9	14.6	166.8	153.1	116.6	202.5	317.3	104.7	107.2	113.6	178.1	104.6	110.0	107.7	108.9	111.2	107.3	107.6	112.7	216.8	134.6	204.6	36.9	565.3	1036.0	1105.8	1174.4	805.3	64.5	569.8	274.2	93.1	317.4	463.5	158.2	54.2	614.4	288.0	101.3	606.5	332.3	377.4	173.8	399.2	365.6	297.5	319.8	36.3	354.3	770.9	366.9	196.7	220.5	378.3	277.1	403.4	212.6	424.2	58.9	36.2	400.5	443.5	662.4	875.2	73.8	454.2	368.7	517.6	37.5	621.8	154.8	268.8	59.8	69.2	272.3	279.1	327.6	251.0	728.2	273.8	799.7	201.7	74.6	190.7	434.6	564.5	276.7	102.8	532.6	1117.1	620.3	488.1	490.0	568.6	914.3
EIF3F	"eIF3-epsilon, eIF3-p47, EIF3S5"	ENSG00000175390	"Eukaryotic translation initiation factor 3 subunit F"	O00303	11	7970251-8001862	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Ubl conjugation pathway"	"Hydrolase, Initiation factor, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049250	Approved					NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"			"HPA049250: AB_2680692"	"unprognostic (1.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.36e-2)"	"unprognostic (8.78e-2)"	225.1	160.8	7.8	10.2	7.4	21.7	216.8	8.6	7.6	249.1	5.1	248.9	10.5	206.8	10.1	227.3	213.3	16.7	186.2	7.6	6.6	165.8	160.3	157.0	24.7	7.9	6.8	353.9	361.3	8.0	126.6	11.7	7.7	170.0	12.6	15.5	175.5	12.9	374.0	333.1	188.6	21.2	6.7	201.6	238.9	132.7	7.3	11.8	153.7	12.8	25.4	218.7	212.9	8.2	23.6	9.3	12.7	11.3	23.5	52.6	39.9	16.1	28.1	20.3	19.4	9.6	23.0	70.4	6.7	15.7	9.1	12.5	9.9	27.7	20.4	23.1	32.4	24.8	9.5	11.1	38.7	26.9	10.0	32.2	32.7	7.9	18.7	18.6	20.7	12.6	21.5	16.1	22.2	9.6	15.8	25.5	13.1	9.5	22.6	17.7	17.3	22.4	11.0	15.8	29.2	50.6	15.2	6.7	19.3	7.7	11.9	18.6	19.3	9.5	11.0	6.9	11.7	11.8	21.1	29.0	6.4	16.8	12.6	37.5	92.4	41.7	81.5	99.7	112.1	174.6	130.5	96.4	130.9	161.6	155.4	114.5	11.7	95.8	93.6	87.7	177.6	246.5	7.8	7.4	8.6	7.6	7.6	6.6	7.9	6.8	7.7	6.7	7.3	8.2	179.9	109.0	145.4	11.1	355.2	349.1	364.1	411.0	266.9	72.2	271.6	285.6	96.8	264.5	197.2	79.1	52.1	631.3	283.7	121.1	293.5	277.0	424.5	113.8	204.9	218.3	210.2	221.7	11.5	442.8	670.6	216.3	139.7	112.1	164.8	335.7	256.6	170.6	344.2	45.4	10.9	262.0	140.4	423.1	398.1	913.3	246.0	263.4	247.3	8.4	471.1	141.5	362.5	7.5	18.8	322.2	242.2	196.7	237.6	247.4	312.9	286.9	115.1	87.1	98.6	222.4	374.3	197.0	124.8	358.3	440.4	563.4	319.3	264.8	392.2	426.0
EIF3G	"eIF3-delta, eIF3-p44, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115014-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1509.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 1471.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol		NA	NA		64000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	193.6	153.1	91.9	97.0	98.6	127.9	188.0	97.9	110.3	211.3	91.2	219.0	94.9	190.6	61.3	144.2	189.7	68.1	212.6	88.1	93.5	152.7	134.3	135.4	125.4	100.6	94.6	280.0	324.5	116.2	119.6	90.8	99.9	172.0	54.3	24.8	182.2	102.2	529.8	212.4	148.0	73.8	98.4	168.9	207.6	176.3	96.8	124.9	139.2	221.1	98.8	183.5	171.9	103.1	211.5	175.5	130.1	174.9	170.8	216.6	169.2	175.6	242.3	269.0	247.7	289.2	111.1	214.9	245.1	210.8	121.9	158.4	159.7	265.0	111.1	196.0	491.8	379.8	179.0	293.2	283.7	303.8	192.7	262.7	191.0	191.6	181.0	172.2	195.7	263.1	349.2	249.6	164.3	282.3	333.2	1471.2	323.1	131.9	372.0	265.3	129.2	287.2	173.4	181.8	170.0	328.9	117.6	152.0	287.9	73.2	133.4	264.4	196.1	233.0	132.6	256.1	339.1	726.8	567.8	240.2	175.6	328.5	227.9	199.9	319.1	139.5	267.6	238.7	348.0	244.5	287.0	291.8	303.2	255.3	287.5	262.4	60.3	458.6	200.3	240.7	351.5	457.0	91.9	98.6	97.9	110.3	88.1	93.5	100.6	94.6	99.9	98.4	96.8	103.1	183.9	44.8	94.5	7.2	219.3	228.2	271.7	185.8	191.2	41.5	276.0	342.9	43.3	164.5	118.1	108.5	18.8	470.9	273.6	146.4	187.9	182.7	438.1	99.7	141.5	160.6	129.9	131.1	4.2	309.1	328.2	159.1	122.3	108.9	129.3	197.3	167.4	98.9	225.1	21.9	4.1	231.1	81.4	288.5	268.9	1509.3	237.9	198.9	145.9	4.7	351.7	85.5	557.1	6.6	10.8	205.3	198.8	177.1	192.6	241.0	277.0	320.1	100.6	56.6	164.3	189.9	243.8	221.1	142.4	152.9	238.7	527.2	261.5	209.6	235.4	263.2
EIF3H	"eIF3-gamma, eIF3-p40, EIF3S3"	ENSG00000147677	"Eukaryotic translation initiation factor 3 subunit H"	O15372	8	116642130-116766925	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1808.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023117, HPA023553"	Approved		Approved	Cytosol		NA	NA		38000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA023117: AB_1848076, HPA023553: AB_1848077"	"prognostic unfavorable (5.26e-4)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-1)"	212.3	164.1	111.0	168.6	119.8	341.1	246.8	114.8	138.5	270.2	104.2	233.1	172.7	212.7	180.0	232.0	211.3	159.2	223.6	106.9	121.0	184.2	181.0	149.2	283.2	118.4	113.7	392.6	249.9	184.0	147.6	161.7	120.6	179.5	201.9	131.0	219.9	158.1	372.6	201.8	167.9	182.5	124.2	171.4	195.2	144.4	111.9	291.0	215.5	278.3	307.1	221.7	237.0	130.2	455.0	256.2	302.2	264.9	390.3	678.0	300.4	292.5	374.4	316.7	306.5	266.1	521.6	719.4	288.6	307.2	230.4	284.4	335.5	445.2	395.5	468.5	271.9	636.0	212.0	400.6	487.8	278.1	325.7	630.0	606.4	287.0	659.5	536.4	348.8	555.5	548.2	370.1	360.4	335.7	778.2	388.1	308.6	995.6	404.5	443.6	201.8	517.6	479.8	327.8	341.6	412.4	153.5	1808.1	504.9	294.8	538.3	550.5	322.5	201.8	374.5	301.5	388.8	591.3	574.4	591.3	280.2	483.4	281.8	165.2	361.6	132.2	217.9	356.8	358.9	438.1	393.5	317.9	468.6	381.4	511.0	432.1	74.4	314.6	366.1	260.9	477.7	585.7	111.0	119.8	114.8	138.5	106.9	121.0	118.4	113.7	120.6	124.2	111.9	130.2	138.9	182.7	210.7	42.4	314.6	337.5	423.7	444.2	266.9	62.7	317.2	273.4	160.8	191.6	253.0	93.8	12.5	488.0	211.4	117.0	448.0	290.5	387.2	81.2	196.0	185.8	201.0	215.8	47.8	380.5	551.0	183.7	125.9	159.2	194.4	166.2	168.8	104.6	332.4	26.9	49.9	301.6	170.9	386.6	402.8	265.0	331.5	261.5	209.9	51.5	509.9	136.0	224.6	58.3	70.3	292.9	240.5	220.1	166.7	338.5	260.2	443.9	92.9	76.8	197.2	251.5	504.1	233.0	176.0	317.4	356.5	577.2	287.5	241.4	345.5	481.2
EIF3I	"eIF3-beta, eIF3-p36, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221077-32245397	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	123.4	146.6	69.2	109.3	70.2	103.5	164.5	76.9	87.3	126.4	78.7	137.2	96.4	104.4	162.3	154.7	141.7	93.7	127.0	68.6	71.8	123.8	152.8	99.6	134.0	72.8	71.2	154.1	134.8	141.9	78.3	116.2	73.3	113.2	163.5	52.5	127.2	120.4	247.3	119.8	91.0	144.9	72.7	84.7	118.8	48.9	73.6	164.5	131.8	220.5	187.1	158.0	107.1	79.0	404.3	293.3	207.4	463.5	326.9	427.2	209.3	301.3	514.2	517.2	401.5	317.1	418.3	533.0	320.7	514.0	315.9	265.9	498.6	549.9	667.0	234.4	348.1	288.9	245.8	362.7	352.5	559.1	295.4	413.1	471.2	528.0	569.5	363.4	478.8	363.8	699.1	223.4	502.4	276.3	469.3	370.2	624.2	445.4	339.4	344.1	356.3	509.0	515.9	300.9	325.6	343.4	276.6	351.7	562.1	366.6	282.9	270.7	286.4	333.2	360.3	523.8	653.5	377.7	495.7	487.4	365.2	419.6	440.2	113.8	196.6	93.7	164.4	206.7	180.4	182.1	171.8	160.5	235.8	164.9	148.4	140.5	15.2	183.0	162.0	177.0	219.6	299.8	69.2	70.2	76.9	87.3	68.6	71.8	72.8	71.2	73.3	72.7	73.6	79.0	136.9	51.3	76.7	6.8	114.5	136.6	227.6	275.6	84.8	38.0	123.6	114.7	41.9	87.2	136.4	51.5	10.4	300.8	118.2	90.1	133.1	295.4	60.8	79.2	114.2	163.5	138.6	69.0	6.8	272.8	341.4	125.6	71.9	85.1	115.3	120.3	89.6	77.1	224.1	13.5	8.2	184.0	148.5	108.1	131.5	29.5	172.4	108.8	144.1	5.6	190.8	69.9	112.3	7.1	10.7	284.4	115.6	139.2	107.5	173.9	125.9	216.2	99.2	41.8	92.1	108.0	338.3	76.5	76.6	121.8	141.4	342.3	115.1	192.3	213.5	219.9
EIF3J	"eIF3-alpha, eIF3-p35, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537125-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 209.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050977	Approved		Approved	Cytosol		NA	NA		280000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA050977: AB_2681297"	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavorable (4.96e-5)"	48.2	34.2	40.0	40.8	42.3	38.7	39.9	41.5	51.7	26.8	34.7	36.2	36.2	26.8	30.8	48.8	22.0	26.1	40.1	39.8	45.0	46.4	58.7	25.8	38.9	44.6	47.9	22.3	65.5	34.9	22.9	44.8	46.1	32.3	37.1	21.2	56.3	29.8	209.6	37.1	31.4	35.5	41.0	30.5	35.3	31.6	44.4	34.0	35.9	104.0	49.8	49.6	31.6	47.0	103.5	55.7	88.4	55.5	60.7	60.0	113.1	161.0	46.9	108.5	72.9	165.6	59.6	96.0	184.6	67.1	102.5	192.3	137.7	99.5	129.5	114.5	79.8	222.5	129.4	108.6	115.1	239.2	98.4	54.6	130.7	72.8	141.6	65.1	117.2	111.1	294.9	119.8	97.8	73.1	124.0	160.8	55.4	190.5	92.9	141.2	145.4	146.1	122.4	118.0	118.4	74.9	150.6	137.1	89.7	69.3	118.0	196.6	140.3	117.6	140.7	127.9	216.4	145.5	302.4	244.8	80.9	249.0	114.0	64.3	40.3	40.7	35.6	41.6	40.8	59.2	45.9	43.7	46.8	53.4	44.1	47.5	18.3	60.4	40.7	76.7	52.9	13.1	40.0	42.3	41.5	51.7	39.8	45.0	44.6	47.9	46.1	41.0	44.4	47.0	92.8	60.9	54.6	16.3	93.1	175.1	112.6	86.5	49.5	56.2	174.6	114.2	95.2	108.7	79.7	145.3	20.9	148.7	122.8	148.0	193.7	145.2	149.7	118.6	141.0	92.2	117.3	139.5	22.0	149.6	170.8	69.2	50.0	175.5	127.4	73.1	99.2	404.3	110.7	43.7	24.1	172.9	61.1	98.7	106.6	103.4	91.0	78.5	60.5	18.7	108.5	50.1	109.2	16.6	27.4	152.3	118.6	71.1	91.9	119.0	94.9	266.4	43.1	66.8	46.0	74.1	94.3	205.4	153.4	70.6	172.0	247.1	88.5	54.7	180.6	102.8
EIF3K	"ARG134, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favorable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	233.4	177.9	98.8	83.6	100.4	172.7	228.3	104.9	114.2	214.3	113.1	285.5	142.0	186.6	110.2	286.1	188.4	73.2	591.7	98.9	100.9	313.3	189.0	169.3	142.0	103.2	101.7	214.8	262.2	179.6	173.0	72.0	101.0	172.1	165.7	57.9	197.5	100.4	682.7	290.7	219.1	113.7	102.1	222.5	265.7	66.5	103.7	143.7	168.6	462.4	182.1	218.4	216.6	105.3	135.3	421.3	110.1	175.4	196.5	197.7	134.3	104.2	180.7	220.9	192.5	272.0	118.6	300.2	121.2	174.2	128.7	122.4	221.2	280.8	165.1	145.7	184.6	214.0	134.4	197.2	201.0	345.1	170.7	219.6	252.3	151.4	269.6	118.8	242.3	156.6	217.9	250.8	188.8	215.2	185.3	158.6	103.5	474.4	211.4	222.7	197.0	235.7	225.3	311.0	141.5	139.4	114.8	377.1	174.0	117.3	145.9	260.3	133.9	135.0	134.8	81.3	185.9	246.4	276.3	255.6	114.9	321.6	155.0	154.8	267.8	138.2	182.8	297.8	232.1	252.0	222.3	213.2	359.0	218.0	228.9	204.0	72.4	201.2	305.7	209.4	296.4	441.8	98.8	100.4	104.9	114.2	98.9	100.9	103.2	101.7	101.0	102.1	103.7	105.3	372.1	93.0	166.1	26.4	430.3	395.6	547.4	674.4	345.4	83.6	477.2	755.1	502.5	320.3	331.0	217.0	66.7	422.9	376.3	466.2	1097.6	345.5	160.6	182.0	231.8	309.3	326.1	284.2	23.8	453.2	484.8	267.7	231.9	180.6	248.2	239.0	311.7	278.6	660.9	23.5	25.0	567.7	305.2	640.7	552.1	274.4	265.3	470.7	466.0	10.3	572.6	276.9	415.1	14.6	24.7	330.2	487.2	199.7	386.6	461.9	874.5	974.2	198.3	174.9	203.8	331.4	450.3	109.0	83.4	594.2	457.0	454.1	424.0	319.1	719.5	622.7
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	97.1	80.1	22.7	37.1	22.8	86.3	149.4	25.4	33.6	113.2	22.8	105.4	56.9	85.1	41.9	84.0	100.4	21.2	76.6	23.4	22.2	101.2	64.4	56.9	52.1	22.5	22.8	200.2	257.9	36.7	64.0	52.8	22.7	71.5	63.4	26.8	92.2	78.3	162.0	123.7	73.3	42.2	22.0	57.6	143.9	34.8	23.4	44.3	87.3	43.1	82.1	90.1	86.8	24.0	74.9	44.1	113.7	83.4	107.4	238.0	81.5	69.4	165.4	109.1	147.5	71.6	53.5	253.7	19.2	81.5	38.3	46.1	127.2	96.0	127.1	34.1	211.2	90.0	56.6	33.4	66.9	240.5	73.6	128.8	106.9	81.7	120.7	189.5	138.1	82.4	75.5	67.6	127.4	30.2	65.5	112.0	65.5	90.0	106.7	73.1	156.0	76.0	82.2	44.3	82.4	129.1	68.9	80.1	88.7	127.6	60.7	95.4	67.4	68.3	81.6	42.1	57.1	40.5	68.3	97.0	64.0	103.9	57.1	46.5	162.0	42.4	81.4	148.1	134.2	131.7	116.9	98.2	241.1	113.1	161.8	125.5	22.8	111.3	129.4	116.9	124.2	299.1	22.7	22.8	25.4	33.6	23.4	22.2	22.5	22.8	22.7	22.0	23.4	24.0	128.9	118.6	210.9	16.6	299.0	397.0	491.6	449.3	278.9	61.3	366.9	299.8	2.5	217.3	238.0	66.2	29.2	699.0	255.0	77.5	416.7	234.3	137.6	94.8	159.4	171.1	197.3	277.2	18.9	461.8	628.9	166.1	101.9	108.3	222.3	318.1	183.1	116.1	256.6	25.2	23.2	236.3	187.2	299.7	418.0	341.2	222.4	229.8	227.7	11.2	447.0	149.1	216.3	11.6	19.3	212.4	211.4	212.1	170.5	306.2	180.7	328.2	90.2	51.1	164.3	278.3	267.4	121.9	128.5	301.9	429.6	703.2	221.6	239.9	378.4	435.0
EIF3M	"FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606264	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031063	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	96.9	105.0	49.5	72.4	53.0	141.4	135.1	51.9	71.6	89.6	51.1	80.6	77.1	96.5	106.6	95.0	146.4	70.8	86.1	52.0	56.1	112.7	108.4	60.1	122.7	52.3	49.5	162.9	131.6	64.7	49.4	79.8	51.5	71.3	98.4	43.3	78.6	82.3	103.1	102.5	60.2	98.3	52.7	71.1	88.0	74.3	51.7	131.2	107.6	82.4	146.6	113.6	79.5	55.9	173.6	219.0	171.0	218.8	222.7	318.2	251.5	176.1	242.7	264.5	255.6	284.5	124.1	445.6	118.1	201.6	226.7	214.1	301.1	319.4	328.2	151.4	372.3	201.2	164.5	303.4	322.1	473.9	276.4	287.4	355.1	178.8	434.6	221.5	301.3	234.6	403.8	151.2	293.8	204.1	238.3	494.4	188.4	230.8	334.2	192.0	430.7	209.9	291.4	321.4	131.3	203.0	125.2	233.5	279.9	187.0	259.3	279.6	142.1	164.6	188.0	353.0	540.2	183.5	248.8	324.0	148.2	284.3	166.1	71.9	211.7	65.7	99.7	189.3	137.6	144.9	136.9	127.3	258.4	117.9	141.1	129.9	24.8	142.3	142.8	154.8	156.5	186.0	49.5	53.0	51.9	71.6	52.0	56.1	52.3	49.5	51.5	52.7	51.7	55.9	82.7	83.3	66.4	19.2	147.5	212.9	256.2	372.8	189.0	44.7	112.9	132.3	41.1	81.5	168.0	60.7	20.9	261.8	127.8	47.1	131.0	187.3	154.9	76.4	168.8	106.3	72.4	148.5	23.8	250.7	284.0	121.9	103.0	104.3	158.4	123.6	98.6	73.3	197.1	10.1	23.5	132.3	156.6	250.6	209.6	55.2	133.9	153.6	110.3	12.2	283.6	70.0	131.8	20.1	21.6	171.8	87.4	120.4	132.4	212.0	86.3	220.6	87.6	42.5	72.3	140.1	254.9	109.4	72.6	159.5	225.0	243.0	154.1	228.3	169.9	252.9
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789897	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1600000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	178.4	288.5	277.5	105.8	302.9	7.3	243.4	328.0	388.2	274.5	251.6	282.5	143.3	325.0	196.3	178.1	322.0	205.3	383.9	309.0	331.3	287.8	202.6	156.2	192.3	275.4	254.5	606.8	272.1	189.2	292.5	218.8	290.2	249.7	179.7	310.3	213.5	262.9	675.3	93.7	165.7	252.8	270.6	159.0	196.0	155.3	316.9	178.0	293.8	553.2	170.0	224.3	186.8	275.6	95.4	44.6	179.1	30.2	624.9	589.3	59.3	158.9	138.5	159.1	202.1	159.9	34.2	200.0	812.8	213.7	283.4	146.8	255.2	66.5	272.0	182.6	134.8	304.8	54.4	214.5	249.6	68.3	209.0	402.5	291.8	47.8	368.3	764.1	275.2	161.6	109.6	311.9	496.8	14.2	112.5	31.2	183.7	337.0	199.4	143.3	124.1	122.2	305.9	110.4	331.8	71.9	241.4	175.4	356.9	427.3	269.6	244.3	205.6	122.8	63.0	123.9	87.7	252.1	374.8	85.9	86.9	71.0	63.9	233.4	78.5	88.5	125.8	87.5	200.8	245.4	183.2	154.5	91.0	203.0	273.4	224.2	50.5	169.6	125.3	85.4	187.3	282.3	277.5	302.9	328.0	388.2	309.0	331.3	275.4	254.5	290.2	270.6	316.9	275.6	265.3	118.6	220.2	68.6	416.9	690.3	770.9	595.8	412.6	267.4	396.7	308.2	271.3	327.5	447.9	261.1	64.6	450.1	370.8	306.7	661.2	254.3	33.0	287.9	297.5	319.2	407.8	221.4	146.8	94.5	251.2	367.8	250.2	344.2	312.1	267.2	258.1	142.4	226.6	390.3	138.0	372.9	455.7	228.6	385.2	56.8	385.8	242.9	345.1	92.8	318.1	383.9	256.4	73.9	118.7	136.0	410.8	472.8	235.7	737.4	567.9	665.2	337.8	192.8	236.7	409.7	489.9	223.8	165.4	314.8	618.0	615.5	449.2	345.6	380.1	879.5
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4B		ENSG00000063046	"Eukaryotic translation initiation factor 4B"	P23588	12	53006282-53042215	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039072, HPA046164"	Approved		Enhanced	Cytosol		NA	NA		340000	"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA039072: AB_2676333, HPA046164: AB_2679567"	"unprognostic (1.91e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.44e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.69e-1)"	"unprognostic (8.20e-3)"	181.5	173.3	92.3	137.5	110.4	226.6	251.5	117.5	100.2	222.2	111.1	167.1	192.4	251.8	135.3	165.1	270.5	165.7	179.4	79.9	103.3	200.1	218.2	135.3	233.6	108.0	95.4	637.4	278.8	202.8	90.7	155.5	112.3	152.5	173.0	114.5	262.7	142.3	510.5	178.1	161.6	177.2	120.4	177.9	163.1	80.2	103.2	287.9	233.9	361.4	293.2	186.8	148.3	116.4	214.9	341.1	233.9	296.6	416.3	787.8	300.6	204.0	492.1	188.9	170.8	352.0	340.4	1318.2	296.3	311.4	160.4	234.2	420.0	460.4	238.3	256.6	244.3	503.4	450.6	401.5	320.0	723.3	282.4	787.1	473.2	219.2	682.1	1144.5	377.1	385.9	561.1	515.8	319.6	468.0	443.5	488.4	438.3	232.9	178.6	447.7	321.9	558.8	267.8	347.1	238.8	326.7	213.7	456.4	432.2	298.9	521.9	485.3	339.6	128.6	272.0	142.8	184.6	450.2	529.3	330.0	219.3	318.7	180.7	40.8	76.2	40.8	105.0	79.0	152.5	96.1	126.9	116.3	94.9	69.9	159.2	148.3	19.7	100.0	97.9	61.3	114.2	146.9	92.3	110.4	117.5	100.2	79.9	103.3	108.0	95.4	112.3	120.4	103.2	116.4	140.5	147.4	227.1	20.2	283.6	207.9	244.9	179.3	270.4	86.8	246.1	177.4	144.2	215.9	166.5	93.8	31.3	139.7	220.6	108.7	181.9	131.7	242.5	120.6	186.1	168.5	186.3	209.4	33.0	174.6	244.5	145.4	154.5	124.8	235.5	201.5	208.1	211.3	109.4	63.9	35.5	188.0	71.2	276.1	185.3	638.6	202.3	182.9	140.5	18.7	254.0	127.0	178.2	22.6	37.7	129.2	117.6	195.6	227.5	214.8	204.1	257.6	121.6	85.5	111.7	205.1	160.7	79.6	48.6	281.3	235.8	178.7	243.3	203.7	234.0	244.0
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
EIF4E1B	FLJ36951	ENSG00000175766	"Eukaryotic translation initiation factor 4E family member 1B"	A6NMX2	5	176630618-176646644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.1;epididymis: 1.1;retina: 2.7"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 8.5;Cardiomyocytes: 12.8;Cone photoreceptor cells: 16.7;Excitatory neurons: 7.1;Horizontal cells: 11.8;Inhibitory neurons: 8.4;Rod photoreceptor cells: 17.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"T-47d: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045045	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA045045: AB_2679197"	"unprognostic (6.54e-2)"				"unprognostic (1.53e-2)"					"unprognostic (7.44e-2)"	"unprognostic (5.26e-2)"				"unprognostic (1.86e-1)"			0.0	0.2	1.1	0.0	1.4	0.2	0.0	1.5	3.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.5	3.1	1.3	0.8	1.1	0.9	1.1	0.6	0.7	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	12.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	8.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
EIF4E3	MGC39820	ENSG00000163412	"Eukaryotic translation initiation factor 4E family member 3"	Q8N5X7	3	71675414-71754773	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 14.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 14.7;monocytes: 4.2;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 36.3;U-937: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058649, HPA076465"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoli fibrillar center"		"HPA058649: AB_2683785, HPA076465: "	"unprognostic (3.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.31e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (3.10e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.16e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (6.99e-5)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.83e-2)"	27.5	12.0	13.5	12.7	17.5	26.6	13.9	10.7	18.3	11.5	1.7	18.0	14.2	14.5	9.8	19.6	15.7	10.6	29.9	17.5	12.3	13.9	11.7	16.1	12.7	8.7	10.0	22.7	15.9	24.5	9.8	6.3	8.1	16.0	17.0	8.2	14.3	18.2	61.8	9.7	18.6	17.3	10.6	17.7	12.7	5.6	15.7	15.8	17.4	54.5	10.9	15.1	9.9	15.5	0.6	2.5	2.4	7.8	2.3	5.9	3.0	2.1	2.3	2.1	1.2	1.3	1.2	0.0	5.1	2.0	13.4	2.8	8.6	12.1	1.7	28.0	2.7	0.0	0.2	0.2	8.2	4.3	4.6	5.3	7.5	0.6	6.4	1.1	6.7	4.9	0.9	36.3	0.4	9.4	3.9	1.0	18.9	0.9	4.3	2.1	9.4	1.2	25.9	13.3	4.8	12.9	14.4	3.1	0.3	7.4	13.6	0.2	1.8	1.2	5.9	16.6	2.0	25.2	25.0	0.0	0.9	50.3	4.8	2.0	4.2	6.1	2.1	1.8	3.2	0.2	2.9	3.5	0.9	0.1	2.1	2.5	14.7	1.1	2.6	0.0	5.7	1.7	13.5	17.5	10.7	18.3	17.5	12.3	8.7	10.0	8.1	10.6	15.7	15.5	16.6	28.9	14.5	5.5	1.9	10.1	10.3	2.0	5.2	9.4	14.5	10.3	39.3	11.5	7.4	11.0	0.0	3.7	20.3	41.0	3.9	5.2	1.0	8.6	19.0	11.0	9.1	1.7	37.0	5.8	3.0	12.5	7.1	35.2	7.0	6.4	17.5	7.3	3.9	1.7	32.0	10.8	2.0	19.5	6.2	1.7	12.8	15.8	3.6	11.2	31.2	13.0	17.5	11.6	11.9	8.6	17.1	9.4	10.9	12.2	40.0	14.9	8.1	0.5	0.0	11.5	14.1	0.6	1.3	8.3	13.5	1.5	20.8	2.6	10.1	9.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030534-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 188.9;salivary gland: 164.2"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		44000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	60.9	12.6	7.7	16.9	8.0	35.0	53.6	8.0	10.9	24.9	12.7	25.3	18.5	19.7	2.2	86.0	21.7	8.9	32.7	8.0	9.8	19.5	63.5	25.0	10.3	9.8	8.5	22.2	188.9	7.8	9.2	28.6	9.8	19.2	15.4	1.5	164.2	17.0	98.1	20.8	23.1	14.4	8.5	23.9	43.8	5.5	10.1	9.6	9.6	27.2	10.4	33.6	26.5	10.8	146.9	113.2	32.4	193.2	41.3	32.3	77.0	130.5	111.9	128.4	203.5	74.8	56.3	46.3	101.5	121.3	77.1	85.1	109.1	197.5	74.8	36.0	190.9	269.6	52.0	104.9	423.6	98.8	60.4	100.0	314.9	142.0	264.1	40.1	208.2	57.7	152.7	221.8	54.8	141.7	95.9	297.8	186.0	112.9	243.7	80.3	80.4	197.4	49.3	22.3	281.6	200.8	26.1	78.8	534.8	20.3	105.8	192.2	105.2	76.1	167.1	179.9	137.8	185.1	121.6	72.1	173.4	213.4	169.1	51.1	416.3	258.3	27.9	336.6	27.3	130.7	32.8	30.9	335.0	103.3	26.2	26.0	39.4	35.0	268.3	242.6	66.0	258.3	7.7	8.0	8.0	10.9	8.0	9.8	9.8	8.5	9.8	8.5	10.1	10.8	23.6	9.6	8.3	1.6	25.2	74.4	42.4	114.8	51.8	3.6	84.8	72.8	41.7	57.2	97.3	20.2	2.1	41.3	27.3	70.1	29.4	226.1	17.0	11.6	39.0	54.6	40.2	79.9	0.8	730.0	224.2	68.6	35.7	12.5	18.4	76.0	65.3	103.4	223.4	0.0	1.3	138.2	79.3	108.6	82.2	106.2	43.5	83.9	72.9	1.9	101.9	19.2	21.6	4.0	0.4	277.9	64.5	19.2	38.7	100.2	19.5	103.1	33.5	2.2	13.1	17.6	85.2	1.9	25.5	209.3	85.4	38.6	19.8	69.3	83.8	58.9
EIF4EBP2		ENSG00000148730	"Eukaryotic translation initiation factor 4E binding protein 2"	Q13542	10	70404145-70428618	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019415, HPA037410, HPA061665"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580"	"unprognostic (9.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.61e-2)"	67.7	27.6	27.8	23.2	25.2	30.4	44.8	21.8	23.6	29.0	28.9	41.2	40.4	25.1	16.5	31.9	25.8	23.8	40.8	21.0	23.9	57.3	50.5	30.5	26.2	28.9	26.6	34.9	30.2	27.5	11.2	43.8	21.7	24.7	39.6	34.9	28.2	33.6	64.2	35.0	47.3	27.2	23.6	26.7	30.9	18.2	34.7	34.5	23.2	67.4	29.2	36.2	28.2	20.1	56.3	17.8	93.7	92.0	176.9	66.8	51.8	33.5	40.5	24.0	25.9	77.5	48.1	57.2	20.1	48.6	14.9	35.6	46.2	30.4	26.9	63.6	24.0	41.4	21.1	30.8	41.5	74.4	28.4	74.8	30.8	29.4	26.4	48.4	36.8	46.0	69.0	50.7	37.5	31.5	64.3	76.3	80.7	54.2	31.8	66.3	37.6	37.4	30.7	56.3	51.1	77.6	45.7	103.0	44.5	63.8	47.2	65.3	40.6	15.6	20.0	25.8	30.2	35.5	73.2	66.5	18.1	108.2	16.3	20.8	19.2	28.7	16.4	16.8	13.2	9.0	13.1	13.8	17.2	8.2	10.9	11.4	21.1	11.6	23.0	5.7	15.7	19.2	27.8	25.2	21.8	23.6	21.0	23.9	28.9	26.6	21.7	23.6	34.7	20.1	72.5	25.6	37.6	21.9	31.9	52.9	53.5	25.4	27.9	46.8	42.9	32.5	147.0	68.6	29.1	36.8	20.9	47.3	45.2	196.7	43.0	43.9	25.9	33.1	52.1	41.4	26.5	70.5	13.0	59.3	119.1	49.9	34.7	57.8	11.4	39.0	61.8	157.4	46.0	23.5	17.5	73.6	34.6	95.4	45.1	59.0	65.9	50.9	21.4	24.4	92.9	73.1	76.2	22.1	9.1	59.5	94.7	61.3	33.8	63.4	195.2	137.0	23.4	17.2	78.9	46.4	37.1	43.7	47.1	39.1	70.0	57.3	43.0	47.0	73.1	109.4
EIF4EBP3	4E-BP3	ENSG00000243056	"Eukaryotic translation initiation factor 4E binding protein 3"	O60516	5	140547662-140549576	"Metabolic proteins, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 59.2;Exocrine glandular cells: 29.0;Gastric mucus-secreting cells: 26.5;Proximal enterocytes: 43.3;Squamous epithelial cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 25.1;JURKAT: 42.3;Karpas-707: 28.9"	"Low region specificity"	"Detected in some"							HPA045537	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA045537: AB_10965796"	"unprognostic (7.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.82e-2)"	"unprognostic (3.75e-1)"	43.7	66.1	23.2	6.4	24.2	12.5	45.6	24.9	29.6	27.0	25.4	38.4	12.7	21.8	6.9	36.8	36.9	17.0	42.8	22.8	25.5	41.1	55.4	26.0	12.1	25.2	23.9	30.0	49.0	2.9	17.0	7.0	25.1	41.3	17.4	2.6	54.2	15.5	121.8	49.2	39.9	8.6	25.0	31.1	59.1	32.1	23.4	12.6	35.6	55.7	9.2	30.0	28.7	25.6	0.4	1.7	1.5	2.3	18.4	19.2	3.4	1.6	0.4	0.9	1.6	3.4	1.4	0.9	8.7	3.6	1.3	1.3	0.7	1.8	1.1	3.1	5.6	0.2	3.8	6.3	25.1	10.3	4.9	23.6	2.3	1.5	1.2	4.5	2.8	42.3	0.6	28.9	1.1	0.0	7.9	18.6	2.2	5.3	6.3	8.3	1.2	0.3	2.9	3.6	9.1	1.3	2.8	23.1	7.6	2.0	3.1	11.9	2.2	7.8	1.5	5.0	1.2	2.6	2.3	0.9	5.4	20.0	2.1	9.4	43.6	1.4	11.3	51.2	14.1	41.3	20.5	10.3	37.7	37.1	41.7	34.1	22.3	24.1	38.6	117.5	17.6	24.3	23.2	24.2	24.9	29.6	22.8	25.5	25.2	23.9	25.1	25.0	23.4	25.6	0.8	0.0	13.7	0.0	8.0	0.3	0.6	0.7	59.2	0.0	6.5	3.2	0.2	7.2	4.6	0.0	0.0	0.8	1.5	13.0	3.9	8.6	1.1	4.9	0.9	2.8	8.5	11.8	0.0	29.0	0.9	8.0	26.5	1.5	12.0	0.1	2.2	7.2	2.4	0.0	0.0	15.1	0.0	5.7	0.2	1.1	1.8	9.0	0.0	0.0	7.1	0.0	1.0	0.0	0.0	14.2	19.4	0.0	0.9	0.8	43.3	7.9	7.8	0.0	0.0	0.6	1.2	2.6	0.6	42.3	0.6	1.0	3.4	0.2	18.8	0.4
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.6;Late spermatids: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	12.5	11.9	14.3	10.4	14.8	14.3	11.9	19.7	17.3	15.9	11.4	19.4	11.4	15.0	13.0	14.0	13.8	7.8	13.2	15.3	15.0	12.3	8.4	12.1	12.6	13.6	14.7	15.0	10.5	16.7	10.8	13.6	14.3	13.5	11.5	18.0	12.1	13.2	20.2	15.7	11.8	12.1	11.6	12.3	12.3	34.7	13.8	12.9	13.5	14.5	14.9	15.6	14.3	17.3	19.8	11.6	29.4	16.0	16.1	14.2	11.7	13.7	16.8	21.4	19.8	13.4	7.0	25.3	7.9	20.7	14.3	19.1	26.9	12.5	19.7	20.2	27.0	10.3	20.0	15.4	16.7	41.0	17.9	16.6	16.9	15.8	17.8	19.5	18.4	14.8	25.4	27.0	20.3	22.4	27.8	20.3	13.5	18.3	9.5	31.1	24.5	26.0	21.7	14.7	22.6	20.9	18.9	15.4	14.5	19.4	16.4	16.1	20.5	14.3	18.6	14.4	15.5	19.3	20.4	25.1	13.7	14.8	17.1	1.3	2.4	1.2	3.4	3.0	3.5	4.8	1.8	3.3	2.2	2.0	1.8	3.2	2.0	1.0	8.1	4.4	1.4	1.9	14.3	14.8	19.7	17.3	15.3	15.0	13.6	14.7	14.3	11.6	13.8	17.3	8.4	12.8	15.2	23.2	10.6	7.4	7.3	6.2	15.4	18.0	9.6	8.9	22.7	10.0	8.5	12.9	12.5	9.8	13.8	8.6	9.8	8.9	54.6	8.0	12.8	10.2	12.0	12.4	21.0	6.4	5.5	8.1	12.2	13.0	6.3	23.1	11.0	8.9	8.0	18.5	20.5	10.8	8.2	9.5	6.2	98.9	14.6	7.5	7.2	13.1	14.5	8.1	14.4	20.1	20.2	10.2	3.6	15.4	10.3	10.7	5.7	9.4	6.3	13.7	6.6	11.8	11.0	38.7	13.3	10.7	10.5	6.7	8.2	9.0	8.1	8.0
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 348.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	86.2	91.8	24.8	75.7	22.2	84.0	69.0	17.9	22.2	66.6	34.1	81.8	62.0	71.3	32.7	126.8	59.6	50.9	90.8	23.3	29.8	53.9	113.0	74.2	55.7	38.5	36.1	57.5	96.2	99.3	57.4	59.4	32.4	62.2	56.5	22.3	93.1	59.2	348.3	116.7	67.2	74.7	24.4	58.2	79.9	64.8	37.4	49.1	71.3	177.0	63.2	76.0	85.3	16.6	559.0	232.3	173.1	205.7	196.9	192.5	322.5	298.6	204.1	315.4	238.8	486.5	173.7	348.4	381.9	367.6	358.5	292.7	322.6	365.8	230.5	375.1	345.8	321.3	226.1	206.4	173.4	321.4	212.2	199.6	206.8	292.4	268.8	152.8	278.3	128.8	239.6	267.2	205.7	403.4	219.7	105.3	368.9	241.3	180.8	221.7	183.4	281.9	156.8	331.8	197.7	174.6	258.1	415.6	187.6	144.6	445.2	206.5	364.1	227.2	228.9	297.3	567.9	203.8	263.2	629.0	260.5	271.4	258.3	8.3	16.0	6.7	11.7	14.4	10.8	7.7	7.8	9.6	12.8	9.2	6.9	7.6	5.6	8.7	21.0	18.1	6.0	12.7	24.8	22.2	17.9	22.2	23.3	29.8	38.5	36.1	32.4	24.4	37.4	16.6	63.9	76.9	72.6	23.8	41.7	59.1	78.2	58.0	70.6	24.2	69.3	46.2	109.4	50.1	72.3	62.5	14.6	64.0	37.6	135.5	13.7	98.8	151.6	53.0	67.1	69.3	55.7	82.7	10.8	135.3	74.8	64.5	75.4	85.6	48.0	163.8	43.5	152.8	66.8	21.9	12.9	97.2	50.8	40.8	39.9	202.7	73.0	48.9	33.8	14.0	53.0	23.2	30.9	4.0	10.1	149.0	69.0	56.1	112.9	96.8	77.0	45.4	51.4	23.2	78.9	81.6	78.9	24.8	41.4	120.7	91.8	79.6	46.0	94.8	108.4	95.6
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10808940	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol		NA	NA		48000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	307.1	259.9	177.4	278.4	178.0	516.4	213.7	182.9	197.9	281.1	260.2	329.2	217.0	310.5	310.1	372.0	265.0	290.0	377.9	165.0	195.9	321.8	288.7	312.8	286.6	190.0	226.5	247.1	259.6	368.6	160.2	406.4	196.9	276.2	318.6	258.5	231.1	305.5	456.4	299.5	216.3	395.9	186.5	249.5	245.4	226.4	193.0	384.8	349.7	372.4	369.3	430.0	203.0	191.1	933.5	715.1	958.4	527.9	668.2	712.0	668.4	848.9	841.7	713.1	483.6	790.1	1064.3	525.7	474.1	1029.4	545.2	537.8	1048.1	781.0	970.8	820.1	489.0	676.3	427.7	607.2	580.2	1041.8	545.9	582.3	601.0	444.6	577.3	657.1	830.2	483.5	527.8	570.5	935.1	481.8	691.7	377.9	702.1	646.8	756.0	690.3	563.8	336.1	630.7	1328.3	357.9	584.6	966.5	658.7	516.7	640.7	561.1	474.5	805.5	916.1	614.8	793.4	711.4	281.5	841.5	766.9	531.5	600.2	998.7	343.1	331.3	498.6	212.1	382.2	277.0	251.3	237.3	250.1	304.6	212.9	205.8	212.9	244.6	262.4	422.3	162.3	295.9	767.1	177.4	178.0	182.9	197.9	165.0	195.9	190.0	226.5	196.9	186.5	193.0	191.1	306.7	323.7	284.4	48.6	273.6	633.2	372.0	213.4	285.1	128.1	236.0	196.0	382.6	198.8	243.4	147.1	123.0	321.8	289.0	422.3	244.6	325.2	163.7	213.4	247.1	302.9	247.8	169.1	48.1	368.1	373.7	250.1	263.5	269.3	199.5	271.3	209.9	209.0	272.2	164.9	53.8	279.7	191.2	240.1	417.9	152.0	208.8	312.7	250.8	54.4	279.7	197.3	224.6	36.7	53.3	582.5	260.6	240.7	262.0	307.1	205.6	329.5	225.3	142.8	131.5	328.1	363.1	203.6	197.6	320.3	630.1	1056.1	267.7	281.2	289.0	518.3
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA		68000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	21.3	20.7	5.2	20.5	6.2	32.3	17.9	1.6	19.7	18.5	57.9	22.7	15.0	21.1	17.1	19.8	18.8	19.9	18.3	4.8	12.7	16.1	14.9	16.4	17.4	5.0	1.5	17.2	12.1	39.5	26.5	15.6	4.9	17.4	24.4	26.4	12.6	20.6	42.2	18.5	17.4	27.5	0.0	17.1	17.3	74.3	3.7	17.1	35.7	23.4	19.9	22.6	16.7	16.6	31.8	25.2	78.3	32.0	80.1	77.9	16.4	66.8	70.4	46.5	46.1	27.2	33.4	60.7	41.1	73.2	42.6	34.5	48.4	53.9	64.3	50.4	48.2	31.6	47.7	18.9	38.5	53.1	56.5	86.4	39.9	47.8	61.2	69.0	59.2	22.3	23.9	42.0	66.3	25.1	16.6	19.2	23.3	36.7	21.3	31.7	29.8	21.4	40.8	16.4	46.1	35.4	70.0	29.6	35.9	46.3	20.7	58.0	60.7	51.4	19.1	73.5	30.2	18.8	22.5	0.3	63.5	78.7	48.4	0.5	0.5	0.9	0.7	0.0	0.3	0.6	0.3	0.3	1.0	0.8	0.2	0.3	1.2	0.4	0.3	0.6	0.5	0.5	5.2	6.2	1.6	19.7	4.8	12.7	5.0	1.5	4.9	0.0	3.7	16.6	50.9	19.2	30.5	181.5	29.5	20.6	19.9	15.0	17.1	52.0	19.2	17.4	44.5	14.3	28.2	16.5	66.7	4.6	51.1	51.3	0.0	20.6	173.9	66.6	81.2	42.7	16.3	26.1	515.2	19.4	8.8	33.8	46.4	46.8	26.6	44.9	46.1	14.7	23.1	50.5	464.4	21.6	4.1	31.5	11.3	121.8	44.7	39.3	14.2	255.8	18.0	18.6	28.8	425.8	483.4	24.8	32.1	44.8	27.3	21.0	15.7	10.3	51.1	40.5	32.9	36.6	31.3	100.6	51.2	33.8	26.3	3.4	23.7	68.4	29.6	28.0
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
EIF5		ENSG00000100664	"Eukaryotic translation initiation factor 5"	P55010	14	103333544-103345025	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 787.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000867, CAB004226"	Supported		Enhanced	Cytosol		NA	NA		77000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB004226: AB_627507, HPA000867: AB_1078731"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.47e-3)"	"unprognostic (6.33e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.70e-2)"	"prognostic favorable (5.67e-7)"	"unprognostic (2.76e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.14e-2)"	90.5	60.4	82.6	54.5	86.9	194.4	72.1	89.7	90.9	48.7	73.7	81.6	79.5	56.3	54.9	74.4	66.2	63.3	85.2	87.8	92.7	92.4	151.4	64.6	62.3	88.1	93.0	45.6	78.1	81.7	40.8	66.3	93.4	54.9	77.9	50.4	63.5	75.1	163.6	56.8	67.4	71.0	96.3	55.3	65.3	94.9	87.4	61.6	93.4	144.5	80.1	62.9	46.0	103.2	132.9	149.4	174.0	79.1	147.0	129.1	182.3	190.7	205.1	192.5	145.3	223.7	137.3	136.4	117.2	172.4	165.0	173.3	220.9	193.3	325.6	111.9	87.4	121.9	76.3	119.6	152.8	222.1	100.6	139.7	127.0	170.8	230.6	160.2	196.9	98.9	255.8	126.7	161.3	188.7	152.7	73.4	90.5	251.7	285.8	127.4	226.1	85.1	112.8	423.7	153.7	107.7	191.6	141.3	155.9	161.0	135.5	100.8	149.7	152.8	103.3	196.3	201.5	376.2	787.9	287.4	150.5	154.3	182.4	356.8	245.1	323.9	235.1	249.1	265.2	335.0	239.4	224.3	241.5	334.1	283.0	236.8	266.1	315.1	273.0	329.2	221.1	401.0	82.6	86.9	89.7	90.9	87.8	92.7	88.1	93.0	93.4	96.3	87.4	103.2	282.4	144.2	158.6	56.5	269.5	340.1	346.0	216.0	362.0	196.8	260.5	252.3	307.3	101.5	172.4	73.5	185.6	233.0	298.1	221.9	215.2	243.8	280.6	182.0	162.9	227.9	199.6	408.1	47.3	282.3	212.1	267.6	137.1	252.4	278.7	218.7	134.6	255.5	173.1	176.7	40.9	220.3	187.2	158.4	313.2	683.5	128.0	282.5	152.9	30.9	238.7	167.7	129.8	24.6	60.6	247.8	161.7	173.8	414.4	260.4	233.7	272.3	179.8	212.9	118.3	460.0	372.7	507.8	367.8	323.2	265.2	493.8	281.7	213.1	232.0	254.0
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888418-170908644	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 353.0;Late spermatids: 977.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	4.1	2.7	1.9	3.1	2.8	4.2	2.9	5.8	6.1	3.1	1.9	3.4	1.7	4.5	1.3	2.9	2.4	3.5	4.0	1.9	5.4	5.0	1.6	2.2	2.8	7.2	4.6	4.4	3.3	3.7	1.8	1.8	8.2	2.6	2.6	2.8	1.9	3.0	1.3	1.9	1.6	7.2	4.1	2.3	9.1	28.3	5.5	4.3	2.2	3.1	3.1	3.5	2.0	7.2	22.7	11.6	4.2	5.9	21.7	14.2	10.0	17.1	22.3	17.4	25.1	23.6	14.4	14.2	30.9	23.4	38.9	7.4	13.4	6.0	21.9	15.8	5.8	6.9	4.6	7.5	14.6	18.2	19.9	16.6	8.7	26.3	21.4	24.2	9.1	3.7	5.8	0.1	28.7	7.6	8.1	7.9	8.1	17.5	7.8	0.0	12.0	0.0	7.3	4.0	3.4	6.4	17.7	4.6	14.4	6.5	10.0	11.9	12.0	21.2	15.0	44.8	38.9	21.6	0.3	33.3	7.2	6.2	15.4	14.9	1.4	1.5	12.4	1.5	8.7	2.2	8.4	11.9	1.0	3.5	5.0	8.3	0.7	8.8	1.4	1.0	11.3	5.0	1.9	2.8	5.8	6.1	1.9	5.4	7.2	4.6	8.2	4.1	5.5	7.2	16.6	0.0	0.5	4.9	4.4	17.1	8.5	7.8	10.8	2.5	2.1	2.7	9.5	0.0	1.8	1.8	0.0	1.2	18.1	1.6	1.9	6.4	353.0	0.9	7.7	12.8	4.9	2.1	7.1	7.5	1.9	11.7	8.6	0.6	2.5	2.6	3.3	2.5	8.9	0.0	8.8	0.8	2.0	3.8	7.2	977.9	12.8	4.5	10.6	3.7	7.9	8.0	28.8	4.0	10.1	19.6	6.1	11.3	3.7	8.2	1.7	21.1	3.4	2.7	46.0	9.6	11.6	54.3	10.0	2.3	21.6	0.7	15.7	2.2	1.8	5.7
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337371-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		210000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	39.4	31.6	50.3	32.8	53.5	20.8	33.9	50.8	88.8	31.3	51.1	56.3	23.1	35.2	41.7	44.4	29.6	18.5	89.6	48.8	55.3	50.9	38.4	30.9	32.6	54.1	52.5	27.0	48.6	32.1	28.2	29.6	55.0	44.0	30.0	23.8	36.5	33.5	102.9	39.4	29.1	28.7	52.8	30.7	42.1	48.6	53.6	26.2	29.3	56.2	36.6	47.8	33.7	53.0	117.0	57.2	63.8	83.5	75.5	88.7	105.4	100.4	62.9	65.3	64.6	132.5	80.9	132.5	84.6	75.2	77.4	64.9	112.6	97.3	114.6	80.8	67.4	159.6	57.7	175.9	59.7	158.0	94.3	60.2	66.8	91.0	92.1	55.9	96.6	80.0	179.6	64.4	95.2	94.9	100.8	145.7	99.5	76.2	83.0	86.8	94.7	108.2	134.9	96.2	53.8	50.9	54.6	123.8	85.3	120.4	50.5	103.0	106.9	100.7	99.3	53.2	90.7	47.4	72.0	106.0	73.3	172.0	75.9	19.8	11.0	13.7	15.5	12.5	18.2	20.9	16.3	15.5	8.4	19.8	15.9	17.0	2.9	18.3	17.3	26.2	12.5	6.4	50.3	53.5	50.8	88.8	48.8	55.3	54.1	52.5	55.0	52.8	53.6	53.0	121.7	109.0	219.6	23.8	152.4	321.3	200.4	209.0	84.8	103.8	159.1	112.1	579.1	135.8	198.6	343.9	50.1	143.7	142.9	135.0	144.8	210.5	769.9	143.1	175.0	153.2	157.9	154.2	27.4	235.1	205.3	130.4	82.0	157.5	172.7	90.0	146.3	480.9	134.7	77.4	28.3	206.7	144.5	123.5	128.9	144.0	124.5	95.7	142.3	18.7	157.7	91.8	145.2	21.6	36.7	282.6	93.8	175.7	183.2	253.9	102.7	226.2	165.4	111.3	276.1	167.3	157.7	575.3	505.0	99.1	324.8	181.4	133.4	101.7	185.1	244.7
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278907-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 700.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040873	Enhanced		Supported	Nucleoplasm		NA	NA		260000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA040873: AB_2677182"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	66.5	99.4	55.8	61.7	56.9	75.8	87.3	58.2	64.9	91.0	64.4	120.2	142.6	80.3	80.7	242.6	99.1	64.7	51.8	57.6	64.4	129.6	172.4	64.0	75.5	59.9	58.3	67.4	73.7	93.1	56.4	68.2	61.6	76.7	122.8	21.6	88.7	84.2	52.2	169.0	119.4	92.9	58.0	68.8	83.3	71.8	57.9	78.9	64.8	56.9	120.4	146.5	125.6	60.1	338.1	447.4	115.3	137.1	136.9	161.9	148.6	205.5	250.8	431.5	322.3	864.0	306.2	232.1	251.2	258.2	326.7	261.8	234.6	671.8	299.9	60.0	154.8	397.5	188.7	752.0	262.6	225.1	177.1	162.8	430.3	331.3	680.3	185.8	298.1	131.4	253.1	116.6	459.7	325.8	128.2	285.5	151.2	367.4	375.3	173.1	203.9	207.1	590.5	243.6	194.2	178.3	163.4	675.6	266.5	93.3	314.7	177.0	248.2	478.8	211.7	244.0	326.3	135.0	149.4	221.8	243.2	216.7	274.6	420.1	267.8	230.4	166.0	278.1	182.5	261.7	165.1	183.9	318.5	263.4	132.7	158.1	89.6	247.4	316.1	291.0	196.8	353.2	55.8	56.9	58.2	64.9	57.6	64.4	59.9	58.3	61.6	58.0	57.9	60.1	80.8	64.1	54.2	4.9	75.7	281.3	270.0	333.6	95.6	32.6	81.9	102.4	27.8	114.4	201.0	165.5	10.4	237.5	82.5	363.7	197.6	375.8	68.9	92.3	60.1	90.3	105.7	50.9	5.7	378.8	217.7	78.5	73.9	90.2	99.0	62.2	60.7	216.0	176.6	25.2	5.0	150.7	193.3	78.6	169.8	94.5	81.7	89.9	106.7	1.9	226.8	68.3	81.4	2.0	6.2	700.9	468.3	67.0	53.9	213.1	373.0	527.0	116.8	32.2	65.7	70.7	170.7	130.5	77.8	197.3	346.5	256.0	70.0	120.4	215.0	468.0
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	8.5	15.2	24.8	13.8	25.6	18.2	9.8	24.3	27.3	9.3	20.5	13.6	12.2	9.9	19.4	19.7	13.2	7.7	11.9	26.0	26.2	17.9	16.5	9.3	19.2	22.2	23.2	6.9	10.5	15.8	27.8	9.1	23.9	9.5	11.8	15.9	11.2	7.8	14.0	13.9	10.6	10.6	22.9	14.6	10.8	11.6	25.1	22.2	22.4	15.2	18.0	10.8	11.1	23.6	25.4	48.2	25.9	28.2	15.7	21.1	56.2	26.8	27.8	32.0	24.2	32.5	32.6	45.3	46.8	28.3	30.1	25.9	20.9	39.3	17.3	35.5	37.5	40.7	28.4	76.2	29.9	40.2	49.9	19.5	35.1	32.2	43.6	17.6	41.9	79.0	45.2	30.9	29.7	48.5	37.6	57.9	29.4	61.5	38.1	43.6	26.6	61.6	39.6	35.7	54.5	62.6	18.5	31.7	30.1	13.8	29.0	36.9	29.9	25.3	13.1	21.2	36.9	34.9	88.0	37.8	30.0	40.8	24.1	22.2	15.2	12.8	19.7	17.9	19.6	16.8	16.1	20.6	27.4	20.6	17.6	18.8	6.5	22.2	16.7	30.3	22.2	18.6	24.8	25.6	24.3	27.3	26.0	26.2	22.2	23.2	23.9	22.9	25.1	23.6	5.6	3.2	9.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	8.5	7.0	0.0	0.0	6.2	20.2	0.0	48.6	7.0	0.0	50.9	28.7	0.0	14.9	7.5	7.0	0.0	0.0	0.0	16.0	36.9	5.0	0.0	11.5	3.8	13.7	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.3	0.0	0.0	41.6	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	26.7	5.7	24.5	0.0	0.0
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	5.1	7.2	4.2	5.4	4.4	2.3	6.2	3.9	6.0	5.0	4.8	6.2	5.0	4.4	12.8	4.4	6.4	4.1	3.3	4.4	5.2	8.0	9.9	5.1	6.7	3.8	3.9	5.5	8.7	11.8	5.7	5.6	4.0	6.2	7.0	5.0	6.6	6.1	3.1	4.6	6.5	4.3	3.3	6.9	6.3	7.2	5.2	7.2	10.2	2.8	6.9	4.7	3.4	5.1	9.1	6.1	16.0	13.6	17.5	7.4	6.8	9.8	12.7	9.0	6.3	2.3	7.9	7.0	6.5	9.1	7.2	8.8	5.0	10.3	6.1	15.4	1.3	8.6	2.3	1.6	10.4	22.1	5.8	9.3	8.1	4.8	11.0	7.2	9.5	10.0	8.9	16.9	16.0	4.1	7.8	6.4	8.0	7.6	3.1	8.6	5.6	13.0	10.4	3.8	9.4	10.7	8.2	1.4	15.5	6.6	7.5	16.6	8.4	11.6	6.0	3.4	6.7	15.8	14.4	9.3	10.7	7.3	14.9	5.0	9.6	10.0	15.4	11.5	17.1	18.6	14.7	14.9	15.4	16.8	14.0	18.1	0.9	20.8	11.4	13.0	12.8	10.0	4.2	4.4	3.9	6.0	4.4	5.2	3.8	3.9	4.0	3.3	5.2	5.1	5.9	6.4	6.5	7.2	7.6	2.4	5.6	14.5	4.6	7.3	8.7	10.4	8.6	12.8	8.0	3.7	2.1	23.3	4.0	8.5	19.6	14.6	21.4	8.8	6.3	7.9	10.3	5.5	4.1	13.5	13.3	8.1	3.1	4.8	8.2	11.4	10.0	15.2	15.4	5.0	5.3	8.2	14.2	8.9	2.8	22.8	5.0	6.3	5.4	2.8	10.2	15.8	23.7	7.5	8.4	10.4	9.1	7.2	5.6	8.1	15.9	25.5	11.8	8.2	0.0	8.5	6.4	29.1	12.9	5.6	3.4	18.9	6.8	11.1	10.5	4.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"bone marrow: 3894.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.1;monocytes: 4.0"	"Cell line enriched"	"Detected in some"	91	"THP-1: 3105.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced				"Secreted to blood"	NA	NA		370000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	3.4	1.0	0.3	0.0	0.3	3894.9	3.4	0.1	0.7	0.5	0.2	2.0	0.4	1.0	0.0	1.1	1.4	0.1	4.0	0.3	0.2	0.7	3.3	19.4	0.6	0.1	0.2	0.5	0.5	0.0	1.2	0.8	0.1	2.9	0.0	0.0	2.4	0.1	1.5	5.4	1.8	0.1	0.1	42.6	1.4	0.4	0.2	6.3	3.1	0.0	0.0	2.1	1.0	0.2	2.0	0.1	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3105.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.0	34.0	0.0	0.0	4.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	27.2	0.3	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	4.2	0.1	0.0	1.3	16.2	0.0	0.1	0.0	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.0	3.4	11.1	0.0	6.2	1.1	7.2	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	0.0	0.0	7.4	0.0	0.7	0.2	0.0	0.0
ELAPOR1	"EIG121, KIAA1324, maba1"	ENSG00000116299	"Endosome-lysosome associated apoptosis and autophagy regulator 1"	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 156.7;salivary gland: 166.1;stomach 1: 88.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;dendritic cells: 1.2;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 65.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 20.8;SCLC-21H: 16.8;SK-BR-3: 17.6;T-47d: 59.1;U-87 MG: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.8	3.2	3.6	4.1	4.4	0.5	56.7	0.0	4.9	70.1	0.0	28.3	45.5	12.8	9.7	1.6	23.9	5.6	0.2	4.4	13.2	0.1	0.2	5.1	2.5	0.2	0.1	0.1	156.7	9.2	32.9	0.2	0.7	48.6	27.8	0.4	166.1	0.3	0.0	3.9	35.3	1.1	0.0	0.8	88.2	18.3	10.0	0.8	9.0	0.1	1.9	0.4	0.1	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.7	1.3	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	1.0	0.0	0.0	0.5	20.8	0.2	0.3	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	16.8	0.4	0.1	17.6	0.0	0.1	59.1	0.0	0.4	0.0	2.1	0.2	0.2	1.3	3.6	0.0	12.4	0.0	0.1	0.0	0.1	0.0	4.6	0.0	7.6	0.4	7.5	3.2	0.0	0.1	3.3	1.5	65.2	0.5	0.0	0.0	9.8	2.2	3.6	4.4	0.0	4.9	4.4	13.2	0.2	0.1	0.7	0.0	10.0	1.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0
ELAPOR2	"EIG121L, FLJ31340, KIAA1324L"	ENSG00000164659	"Endosome-lysosome associated apoptosis and autophagy regulator family member 2"	A8MWY0	7	86876906-87059654	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.9;Cardiomyocytes: 2.8;Endothelial cells: 2.2;Fibroblasts: 2.3;Smooth muscle cells: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.3;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 31.2;hTERT-HME1: 36.0;HUVEC TERT2: 30.8;K-562: 49.6;SCLC-21H: 38.7;SuSa: 33.8;TIME: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (2.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.37e-1)"	10.3	3.6	10.5	2.0	26.6	0.9	4.5	17.1	14.4	3.0	0.0	4.3	1.4	3.5	0.5	3.7	3.2	4.3	4.8	7.7	16.2	2.3	1.2	21.8	3.4	19.3	16.3	2.0	4.6	8.3	3.0	7.8	20.5	6.1	5.4	5.8	2.3	5.0	2.3	2.2	2.4	5.4	15.5	5.8	3.2	3.1	22.9	3.7	5.1	4.0	3.5	5.2	1.6	51.7	1.9	0.0	31.2	0.0	0.4	0.0	8.2	0.7	0.0	0.1	0.0	0.1	0.5	0.3	7.8	0.7	0.3	0.0	3.4	0.0	0.1	7.8	0.7	24.8	8.6	2.9	0.3	0.2	3.1	2.5	0.1	0.0	36.0	0.2	30.8	12.1	49.6	0.8	3.4	9.9	0.7	0.0	17.1	0.1	7.9	0.0	2.2	5.2	3.2	14.3	38.7	28.9	8.5	11.1	3.6	33.8	3.3	0.6	36.5	0.4	11.9	0.3	0.0	17.2	10.9	0.2	9.1	0.0	0.4	0.0	0.0	0.2	0.3	0.0	2.7	0.4	0.9	0.6	0.2	1.9	0.9	0.5	0.0	2.3	0.0	0.4	0.4	0.3	10.5	26.6	17.1	14.4	7.7	16.2	19.3	16.3	20.5	15.5	22.9	51.7	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
ELAVL1	"Hua, HUR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958573-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		230000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	27.5	27.7	14.5	33.1	15.6	27.8	25.0	16.0	15.7	29.4	19.5	27.9	25.2	31.6	25.9	30.0	34.3	22.4	34.0	15.3	15.9	24.8	29.0	24.2	40.2	13.7	15.6	31.8	28.4	37.5	21.4	32.7	13.8	26.9	27.2	19.0	29.6	29.4	37.7	24.9	25.1	35.9	16.2	30.1	24.6	46.1	15.1	52.7	27.9	32.2	44.1	37.4	25.2	16.6	127.5	84.1	137.9	104.5	52.9	52.7	76.5	89.5	78.4	136.9	106.3	122.4	73.2	153.2	125.5	104.0	76.9	86.0	155.2	107.9	114.8	134.9	131.8	135.5	58.9	115.7	77.4	129.9	103.1	65.8	63.6	95.7	57.7	64.8	106.2	115.6	140.7	112.6	95.7	95.8	215.3	103.7	122.1	96.4	101.6	239.0	89.6	100.9	87.5	93.9	98.0	70.8	88.9	89.1	71.7	82.6	101.8	101.4	79.7	127.3	87.3	119.2	161.8	109.8	114.7	161.9	71.3	154.2	112.2	29.9	19.7	37.2	16.4	17.2	17.0	20.8	24.0	26.3	25.0	27.7	21.8	16.6	5.3	33.1	22.1	12.5	20.9	16.3	14.5	15.6	16.0	15.7	15.3	15.9	13.7	15.6	13.8	16.2	15.1	16.6	45.7	25.6	23.1	18.6	56.0	72.4	79.5	29.0	51.2	47.2	54.9	37.2	31.3	30.0	20.7	47.8	56.3	86.8	48.1	32.9	66.5	37.1	227.7	41.6	46.5	52.2	42.0	95.7	20.3	33.8	102.3	53.1	40.2	47.2	21.0	59.5	47.2	89.2	64.2	60.6	21.5	52.9	18.3	57.5	79.2	164.1	50.4	47.3	51.6	23.4	43.9	43.4	57.7	33.7	26.9	35.3	45.7	56.8	88.7	98.2	38.3	65.8	27.3	55.7	52.6	45.5	71.0	164.7	61.2	72.0	71.0	74.8	50.9	44.7	60.2	84.6
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 31.8;testis: 43.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	0.1	1.3	12.4	0.1	15.8	0.5	0.2	1.5	31.8	0.1	0.0	0.4	0.1	0.5	0.5	0.2	0.1	0.2	0.1	10.9	23.2	0.5	0.0	0.2	0.2	15.7	13.0	1.1	0.0	0.1	1.0	0.1	15.3	0.3	0.5	5.0	0.1	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	43.1	15.0	0.0	0.3	0.0	0.1	0.4	0.2	9.4	25.4	0.3	37.2	0.2	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	7.8	9.9	15.9	0.2	0.0	7.1	0.0	0.1	0.3	0.0	0.2	0.6	0.5	9.6	0.0	11.0	0.0	0.3	0.1	0.9	1.2	5.3	0.0	0.1	0.1	9.8	0.0	11.8	0.1	13.3	0.2	0.0	0.0	119.6	11.5	0.3	0.3	0.3	9.4	0.6	1.9	0.0	0.2	7.9	0.2	0.2	0.1	0.1	0.1	1.3	0.1	1.4	1.1	0.3	0.5	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.5	0.3	0.4	1.5	0.4	0.2	0.3	0.2	0.0	12.4	15.8	1.5	31.8	10.9	23.2	15.7	13.0	15.3	0.1	15.0	9.4	0.9	0.0	0.0	7.8	0.0	1.0	0.4	0.4	0.6	8.8	0.9	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.9	0.1	62.2	0.5	0.2	1.8	4.2	0.0	135.5	0.0	0.0	0.8	0.0	0.2	0.0	10.6	0.0	0.0	0.1	16.8	390.6	1.2	0.0	0.0	0.7	39.5	3.1	0.2	0.0	7.5	0.0	2.8	0.0	5.5	5.5	0.0	0.2	1.5	0.0	0.4	0.0	0.1	0.0	10.6	0.0	1.4	1.0	13.9	159.2	0.5	0.9	0.0	0.1	0.7	1.3	0.6
ELAVL3	"DKFZp547J036, HUC, HUCL, MGC20653, PLE21"	ENSG00000196361	"ELAV like RNA binding protein 3"	Q14576	19	11451326-11481046	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.9;Bipolar cells: 26.9;Excitatory neurons: 78.1;Inhibitory neurons: 91.0;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 120.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 80.9;SH-SY5Y: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013066	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB013066: AB_221448"	"unprognostic (1.47e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.60e-3)"	0.0	1.2	46.8	0.5	62.8	0.0	0.0	89.7	69.3	0.0	0.0	0.6	0.1	0.1	0.5	0.1	0.0	0.0	0.7	54.1	47.8	0.8	0.1	0.1	0.0	60.0	54.8	0.1	0.1	0.1	5.5	0.0	64.9	0.4	0.2	6.0	0.0	0.2	3.2	0.0	0.2	0.2	50.9	0.1	0.2	0.9	55.6	0.0	0.0	0.1	0.0	0.0	0.1	106.4	0.0	0.2	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	80.9	46.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	62.8	89.7	69.3	54.1	47.8	60.0	54.8	64.9	50.9	55.6	106.4	1.0	0.0	0.0	36.9	0.0	0.6	0.4	0.0	0.6	26.9	1.3	3.3	12.4	0.0	0.0	0.0	4.2	0.2	0.1	0.2	0.0	0.0	3.5	0.2	0.5	1.8	0.0	0.0	78.1	0.0	0.1	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.1	5.0	91.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	4.7	0.0	3.0	1.0	36.2	120.1	0.1	0.0	0.0	0.0	0.5	0.2	0.2	0.0	7.4	0.0	1.7	2.2	2.9	4.2	1.1	0.1	0.0	0.1	0.5	0.2	0.3
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50024029-50203772	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 52.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4"	"Cancer enriched"	"Detected in some"	4	"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Cell line enriched"	"Detected in some"	17	"SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.1	11.2	13.9	2.4	18.0	0.0	0.2	7.4	52.8	0.0	0.0	2.2	1.4	0.0	0.0	0.2	0.1	0.1	0.2	20.0	18.5	0.1	0.1	0.3	0.2	36.5	14.0	0.0	2.3	0.0	3.4	0.2	31.7	0.1	2.8	3.9	0.2	0.1	0.0	0.4	2.2	1.1	2.0	0.2	1.0	8.5	11.4	0.9	0.0	0.0	0.2	0.1	0.2	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.2	157.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	13.9	18.0	7.4	52.8	20.0	18.5	36.5	14.0	31.7	2.0	11.4	17.4	0.1	0.0	0.0	7.2	0.1	0.8	0.0	0.0	0.0	3.9	0.1	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	155.5	0.0	0.0	0.3	32.9	0.0	158.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	109.7	0.1	4.1	4.0	5.0	159.4	1.5	3.1	1.8	22.5	0.0	1.5	0.0	75.4	5.9	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.1	8.9	11.8	0.0	0.9	0.1	0.2	0.0	0.1	0.1
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40931924-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 200.9"	"Cell type enhanced"	"Detected in all"		"T-cells: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 271.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	64.2	22.5	8.8	64.3	14.5	200.9	45.3	13.8	9.9	45.8	11.1	45.6	53.4	35.3	28.9	52.6	41.1	59.6	29.1	8.9	12.4	31.9	50.4	47.3	95.3	19.7	14.1	34.6	56.1	39.8	9.7	48.6	19.5	35.2	48.3	4.2	35.3	33.9	21.3	38.5	57.8	43.9	13.7	68.3	49.7	15.1	14.9	134.5	54.9	25.9	96.9	61.3	36.5	21.0	35.5	20.5	15.3	15.3	68.6	72.6	57.2	35.9	84.9	48.7	55.1	51.2	90.9	199.7	22.1	60.4	36.5	78.7	2.9	45.4	30.8	44.9	23.7	179.6	16.3	36.5	50.9	103.3	271.2	75.1	78.5	32.9	62.0	32.8	69.2	93.1	45.0	51.7	32.4	32.5	136.6	63.1	12.1	117.7	15.8	179.2	25.1	58.7	49.9	54.8	6.1	21.3	31.0	31.0	62.9	21.2	22.0	132.8	63.8	21.5	12.4	17.7	13.0	23.7	14.8	131.2	29.0	65.0	45.9	265.9	60.4	134.2	70.0	66.1	73.8	63.0	79.3	77.9	58.6	65.1	84.8	75.9	97.4	73.0	98.4	38.9	86.8	80.1	8.8	14.5	13.8	9.9	8.9	12.4	19.7	14.1	19.5	13.7	14.9	21.0	156.8	76.9	68.0	51.6	326.8	108.8	188.2	86.0	90.0	2.8	71.5	37.7	41.3	52.9	86.1	57.0	10.4	35.7	292.0	62.9	19.6	70.2	47.7	121.6	69.5	122.0	58.1	78.8	8.2	69.4	55.8	79.0	64.2	126.0	323.1	8.1	91.4	25.2	97.5	3.3	8.6	57.0	95.6	115.4	206.3	21.9	42.9	244.1	120.9	125.5	123.5	8.1	133.9	52.8	138.7	65.9	54.4	43.2	211.5	150.4	58.7	28.3	84.6	3.7	39.5	52.7	52.8	7.7	11.2	95.6	114.8	53.5	365.3	26.9	56.0	221.9
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017183	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	1.6	0.2	0.2	12.7	0.1	0.8	79.2	0.8	0.4	55.3	0.1	161.3	142.9	12.9	4.5	237.0	35.5	77.6	5.0	0.1	0.2	66.7	79.2	59.8	0.3	0.0	0.0	1.2	120.7	8.4	3.9	6.1	0.1	58.7	127.5	1.0	147.1	14.8	0.2	14.5	145.6	7.3	0.0	0.5	122.7	0.2	0.1	1.6	6.6	0.0	16.0	165.2	93.6	0.2	56.1	209.6	0.0	0.4	0.0	0.0	63.5	0.0	7.9	0.0	0.1	47.3	296.0	0.3	24.0	0.0	1.7	53.8	0.0	0.2	0.0	6.7	0.2	0.0	38.3	9.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.3	0.7	3.3	196.3	17.6	0.1	0.1	3.0	78.3	215.3	0.3	0.4	2.4	405.7	0.2	9.2	28.8	0.0	0.1	0.0	0.7	0.4	0.5	1.2	3.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	2.7	294.9	422.9	0.0	12.2	5.1	691.3	879.7	113.8	1.5	470.3	180.3	1.5	586.2	1130.0	329.2	18.8	76.6	9.5	1599.6	41.1	792.7	0.0	812.3	90.8	16.4	452.2	2.7	0.4	641.0	122.2	15.9	1390.9	1127.5	40.6	0.2	0.4	38.6	9.3	0.0	0.2	1225.3	1102.7	2.5	2.7	0.0	0.0	18.6	8.8	0.0	15.4	2.6	1.0	0.5	0.1	512.5	1506.1	0.0	6.0	1014.2	1476.3	147.1	888.2	67.3	0.0	0.8	46.3	0.0	0.3	418.5	8.4	257.2	18.7	0.3	983.0	1628.9
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130063955-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 34.3;Granulosa cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	12.2	3.7	1.8	14.6	1.6	53.1	9.6	2.8	2.0	9.4	2.6	18.1	14.2	10.6	2.0	11.7	12.1	9.3	5.6	1.8	2.4	6.0	2.8	15.9	18.3	2.8	2.4	17.5	2.6	4.8	4.2	23.7	2.4	6.1	17.7	0.6	5.5	4.1	2.0	10.9	17.0	10.6	1.5	18.1	20.3	2.6	2.9	19.6	3.9	3.6	18.0	18.8	9.1	3.1	56.0	20.7	3.7	0.4	9.1	19.3	52.6	25.3	32.1	30.4	33.4	28.7	38.9	28.6	49.5	34.8	42.3	35.2	20.5	30.0	29.9	31.0	16.8	56.7	27.3	13.6	20.2	49.7	69.3	20.4	32.6	49.1	48.0	19.0	30.0	6.5	22.0	7.7	16.5	32.8	8.2	28.2	2.4	28.4	19.4	17.6	6.5	12.2	18.3	63.9	13.6	6.0	22.8	21.9	6.9	19.1	11.0	46.9	27.6	21.2	16.6	39.5	47.7	4.2	1.8	22.6	24.6	44.8	5.0	1.6	4.0	5.8	7.1	7.6	5.6	2.6	4.2	6.1	4.5	2.7	4.2	4.8	6.9	6.5	5.5	2.7	4.8	4.2	1.8	1.6	2.8	2.0	1.8	2.4	2.8	2.4	2.4	1.5	2.9	3.1	10.7	9.6	4.4	0.0	8.0	13.6	8.2	2.9	9.1	0.0	2.1	1.5	0.8	0.0	4.4	0.0	0.0	10.6	12.2	24.1	0.0	2.3	0.1	8.9	3.8	8.4	9.0	7.4	0.2	4.0	34.3	6.4	17.9	17.1	1.3	27.5	6.4	1.0	9.7	0.0	0.3	8.3	2.0	12.2	9.2	0.6	1.8	14.8	3.6	5.6	13.1	0.0	16.5	0.0	1.2	9.1	17.4	1.2	2.0	7.5	11.6	0.3	5.4	0.0	6.6	2.6	2.5	0.0	4.0	6.5	10.4	11.2	9.5	5.2	7.1	18.9
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427479	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.2;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 45.5;Excitatory neurons: 11.6;Inhibitory neurons: 16.2;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 18.2;basal ganglia: 13.8;cerebral cortex: 17.5;hippocampal formation: 16.6;white matter: 4.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.0;CAPAN-2: 11.2;GAMG: 12.3;RPMI-8226: 11.7;RPTEC TERT1: 21.5;U-2 OS: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	0.0	0.6	18.2	0.0	13.8	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	16.6	0.9	0.2	0.2	0.6	0.0	2.7	2.7	0.0	0.2	0.0	0.0	0.0	1.9	0.6	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.1	1.7	2.2	2.2	0.0	0.0	0.0	0.0	0.0	4.8	12.0	4.9	0.0	0.0	0.0	0.9	0.0	5.3	2.8	1.2	0.1	1.9	11.2	0.2	6.8	3.8	12.3	8.2	0.6	1.1	0.1	0.2	0.1	0.0	5.7	0.0	0.2	0.0	0.1	0.9	0.1	0.4	1.6	4.5	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.3	7.1	10.6	0.1	0.1	11.7	21.5	0.1	1.0	0.0	4.9	6.2	0.0	0.1	0.0	0.1	0.5	0.0	24.1	0.2	3.5	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	13.8	0.0	17.5	16.6	0.9	2.7	2.7	1.9	2.8	2.2	4.8	0.1	0.0	5.1	1.3	0.5	0.1	0.0	0.9	0.0	45.5	0.0	0.0	0.0	1.5	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.2	0.0	0.0	11.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.3	16.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	1.9	0.0	0.9	0.0	36.7	0.9	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.6	2.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	16.8	30.7	71.7	12.4	53.1	13.7	12.0	37.1	62.5	15.0	19.9	12.8	9.0	17.0	17.4	15.0	18.6	10.1	19.3	58.5	32.8	12.6	26.4	16.2	12.3	26.7	26.2	54.2	12.9	17.0	12.7	9.2	27.5	15.4	9.6	7.7	13.1	11.2	32.9	15.2	12.9	10.9	23.4	18.9	13.6	21.2	52.2	12.9	10.5	18.5	12.3	14.8	11.9	40.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	71.7	53.1	37.1	62.5	58.5	32.8	26.7	26.2	27.5	23.4	52.2	40.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
ELK4	SAP1	ENSG00000158711	"ETS transcription factor ELK4"	P28324	1	205597556-205632011	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	9.0	4.9	7.4	11.5	11.0	11.7	8.1	12.2	7.5	8.2	7.0	6.9	6.1	7.7	7.2	8.0	6.7	9.2	7.0	6.0	6.4	7.8	13.2	9.7	17.5	8.5	8.8	6.7	8.1	7.8	5.5	7.9	9.9	26.0	6.8	9.3	8.2	5.7	10.6	13.5	9.6	6.1	9.1	15.8	7.7	7.3	8.5	14.1	6.9	8.7	16.8	9.6	9.3	14.1	14.9	13.2	5.1	13.3	11.9	15.2	12.9	9.8	10.1	7.6	8.9	5.7	14.6	31.3	9.0	12.2	5.7	18.0	10.9	12.0	13.1	35.9	7.7	13.6	22.0	12.2	16.1	25.7	51.8	13.4	14.5	12.0	24.4	14.7	32.3	14.8	12.7	25.6	10.7	20.1	21.3	9.5	8.5	3.4	7.8	15.7	31.2	25.4	10.2	32.0	5.9	7.0	25.2	13.7	17.3	8.9	12.7	8.5	23.5	15.3	17.8	13.7	18.8	19.1	18.9	21.1	13.3	10.3	18.2	6.6	0.4	0.7	0.8	0.5	1.1	0.7	0.9	1.1	0.6	1.1	1.1	1.6	0.2	0.6	0.3	0.8	1.0	0.4	7.4	11.0	12.2	7.5	6.0	6.4	8.5	8.8	9.9	9.1	8.5	14.1	50.7	9.6	16.2	7.2	39.3	39.4	35.3	19.0	9.6	104.8	15.1	11.9	20.8	34.3	17.8	31.3	12.5	15.6	34.0	13.8	3.9	14.7	17.4	37.7	37.4	40.1	13.1	21.4	22.8	17.8	6.2	23.2	18.3	82.5	28.5	12.8	36.4	30.2	10.0	25.2	11.7	18.3	14.2	23.5	39.1	19.5	25.4	22.3	30.2	27.2	22.3	11.2	39.1	17.6	28.0	17.5	9.0	15.4	18.6	71.3	14.4	17.5	24.9	26.9	26.3	28.5	21.4	24.6	11.6	19.2	48.6	18.3	32.6	16.7	17.5	103.1
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522116	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 297.2;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.1	7.7	4.0	9.0	6.2	29.8	11.8	8.4	7.0	11.2	5.0	10.6	6.5	11.0	2.0	10.3	10.6	5.7	10.5	3.6	4.2	12.6	14.1	16.6	7.6	4.7	4.2	13.0	10.0	4.1	11.3	10.0	3.8	9.9	2.3	1.2	8.3	3.6	20.1	15.3	12.8	3.6	4.0	17.3	10.1	38.5	6.1	6.8	8.2	9.9	4.3	10.5	11.0	3.9	12.7	5.7	3.2	6.8	3.4	4.2	22.7	10.0	8.8	7.5	7.1	7.1	9.8	15.6	11.8	6.7	5.2	8.6	4.7	11.1	3.8	13.3	10.9	9.4	5.9	6.3	5.2	10.3	11.8	8.6	9.3	9.8	7.7	5.6	5.4	8.5	13.5	21.8	4.0	10.3	12.5	11.9	10.6	7.8	16.8	10.9	4.8	17.4	5.3	8.8	5.7	6.4	7.4	12.3	11.0	4.1	6.4	12.4	9.0	8.6	6.6	11.6	9.3	34.8	23.4	11.7	11.4	17.6	12.5	0.3	5.9	4.5	4.5	4.1	7.3	2.9	2.6	3.9	5.0	2.1	1.7	2.7	18.1	2.3	2.1	8.6	3.1	4.1	4.0	6.2	8.4	7.0	3.6	4.2	4.7	4.2	3.8	4.0	6.1	3.9	12.3	6.4	6.1	9.1	16.3	28.0	26.4	11.9	23.3	4.5	19.7	10.7	5.1	11.5	7.2	3.7	4.2	47.5	29.5	15.2	11.7	8.7	297.2	22.9	16.0	11.4	19.7	10.3	9.1	8.0	17.6	17.2	12.8	37.7	11.4	5.1	7.5	15.5	19.3	1.7	11.2	10.1	6.1	12.8	21.7	235.9	6.5	20.4	7.2	9.4	13.8	5.3	4.1	7.1	8.0	10.8	3.7	3.0	53.6	14.2	11.8	7.0	8.4	3.4	19.7	13.0	16.7	18.2	24.7	19.4	30.4	68.7	19.2	5.9	7.1	19.9
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
ELMO2	"CED-12, CED12, ELMO-2, FLJ11656, KIAA1834"	ENSG00000062598	"Engulfment and cell motility 2"	Q96JJ3	20	46366050-46432985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018811	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA018811: AB_1848126"	"unprognostic (1.19e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (8.81e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (6.10e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.20e-2)"	20.4	25.6	47.9	15.9	50.1	41.0	20.0	50.7	52.7	29.1	39.7	22.3	9.9	24.1	20.7	32.4	21.3	11.6	24.5	59.1	46.1	22.9	18.5	25.3	21.2	48.1	48.4	17.6	28.1	27.6	26.2	16.6	46.5	29.1	11.2	25.7	20.7	26.7	35.2	25.0	20.1	24.1	48.6	35.2	18.9	31.3	51.4	15.8	20.4	23.2	21.2	23.5	29.4	53.5	10.0	29.0	33.7	27.9	57.8	37.0	17.3	22.7	31.1	31.2	30.2	39.5	11.0	12.4	35.5	38.2	52.6	23.2	29.0	33.9	24.1	20.5	12.9	20.2	18.7	29.2	43.5	11.3	41.1	36.5	29.7	33.2	23.4	21.4	25.5	29.8	20.4	40.0	29.4	26.3	22.4	29.1	13.0	18.8	28.1	18.8	32.8	25.0	30.7	22.9	20.3	18.3	32.8	28.7	44.2	31.8	22.2	44.6	29.9	64.0	36.0	26.5	15.0	16.0	25.8	12.6	26.5	17.8	19.9	121.8	25.0	42.1	42.0	47.9	51.7	9.9	37.8	40.6	23.6	13.4	23.9	27.2	26.9	58.2	73.3	32.7	27.2	43.9	47.9	50.1	50.7	52.7	59.1	46.1	48.1	48.4	46.5	48.6	51.4	53.5	5.7	3.2	12.5	33.3	5.3	4.8	5.0	2.3	5.2	9.7	7.3	4.8	10.9	8.6	3.6	1.8	29.2	6.0	14.6	2.3	0.0	4.3	6.3	3.9	6.8	6.4	8.3	4.8	15.2	3.3	5.2	7.3	6.1	6.0	8.8	5.3	5.0	2.9	13.7	11.8	13.9	2.9	16.2	8.2	5.3	5.6	11.1	6.1	7.2	15.0	8.0	15.2	18.6	14.1	31.0	4.7	3.4	12.8	6.4	8.7	2.9	4.7	1.7	8.5	26.3	4.7	12.6	11.0	14.5	5.2	6.7	4.1	11.8	6.3	2.7	3.9
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 63.9;Paneth cells: 50.3;Proximal enterocytes: 100.3;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.1;CAPAN-2: 49.3;HaCaT: 46.9;T-47d: 45.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favorable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	2.8	1.8	1.5	4.3	1.4	5.6	8.8	2.4	2.6	6.4	0.3	24.3	33.1	2.0	4.1	25.8	8.5	8.6	1.9	1.1	1.7	21.4	8.1	8.3	2.9	2.1	1.0	1.8	41.0	8.5	29.8	7.1	2.8	19.3	9.1	0.7	20.3	9.6	1.2	33.5	26.3	0.8	0.4	5.6	26.0	13.0	1.3	2.1	19.3	0.3	2.6	8.5	13.2	1.5	22.1	2.5	2.4	3.0	0.4	0.6	33.1	1.3	0.7	1.6	1.4	14.2	49.3	3.0	1.5	0.7	0.7	46.9	2.2	21.6	0.3	1.4	2.9	3.2	4.8	4.7	1.0	1.9	7.5	0.5	15.6	1.2	1.1	1.6	1.7	2.6	3.1	1.5	0.9	18.4	2.0	9.3	3.2	20.7	1.9	4.6	2.3	4.9	2.0	2.9	16.2	3.6	3.2	14.4	1.5	1.3	45.8	3.4	2.8	3.7	4.5	2.3	2.3	4.9	1.7	5.8	1.9	4.4	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.5	1.4	2.4	2.6	1.1	1.7	2.1	1.0	2.8	0.4	1.3	1.5	1.8	0.0	13.1	0.0	2.0	8.8	11.9	21.9	13.1	0.9	20.6	16.3	1.2	15.7	12.6	20.2	0.0	33.8	1.0	63.9	17.6	20.1	22.9	8.8	1.7	1.6	13.1	6.9	0.4	24.0	15.0	1.7	47.4	12.2	4.5	1.3	1.4	3.6	3.6	0.0	0.3	33.8	22.4	1.6	3.1	36.3	0.9	2.6	3.6	1.9	2.8	0.4	0.0	0.0	1.0	24.8	50.3	0.7	1.4	7.9	100.3	28.6	12.3	1.5	0.0	0.4	1.6	14.5	5.9	14.4	13.5	16.8	2.3	5.0	52.3	13.0
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524168-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	10.7	13.8	6.8	8.7	7.4	8.6	14.2	9.7	6.9	9.9	12.3	12.2	12.9	10.9	13.2	8.6	10.7	9.1	11.4	6.0	7.8	14.5	15.6	8.5	8.8	8.3	7.6	8.5	8.8	15.5	7.4	9.6	8.0	13.0	13.0	18.0	9.2	9.7	4.3	9.4	15.3	10.2	8.7	7.6	10.3	8.0	7.2	12.5	16.8	5.3	10.2	9.4	6.0	10.6	11.3	12.4	24.9	19.1	25.4	29.2	16.0	26.3	24.7	14.3	17.1	12.2	23.7	18.5	11.3	16.5	17.3	10.1	23.8	16.7	17.6	18.1	14.2	15.3	10.2	16.0	23.1	23.6	13.0	20.1	27.2	12.2	12.5	22.6	15.9	22.2	19.9	29.6	24.8	8.2	25.6	8.1	13.2	16.4	10.1	29.7	19.2	12.0	20.7	17.9	11.8	43.6	17.3	17.5	19.3	27.7	17.1	9.7	16.3	32.7	11.6	15.5	27.6	30.8	47.1	23.1	23.9	18.2	25.3	2.3	6.6	8.0	6.6	7.1	7.4	3.2	5.8	7.2	5.6	6.0	5.9	5.9	15.3	7.5	5.7	9.8	7.3	4.4	6.8	7.4	9.7	6.9	6.0	7.8	8.3	7.6	8.0	8.7	7.2	10.6	14.6	28.9	17.7	22.5	13.1	9.2	11.0	30.3	11.4	20.7	14.7	10.5	14.3	7.2	26.4	18.4	18.8	23.2	19.9	17.6	1.9	22.2	3.9	29.0	24.4	14.5	9.1	7.4	20.2	26.5	8.7	15.5	9.2	15.7	19.7	17.8	11.4	27.1	19.0	15.2	15.6	10.9	22.4	16.4	11.0	1.5	13.1	13.8	17.8	19.7	14.1	16.3	9.2	20.6	35.3	25.6	12.9	10.9	21.7	10.3	27.1	15.9	44.9	24.7	6.6	10.0	18.3	26.9	19.1	12.4	11.6	20.1	13.9	10.9	12.0	8.6
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	11.1	8.2	7.0	3.7	7.4	2.7	8.7	6.6	8.0	7.2	5.1	7.6	4.9	5.6	5.9	5.0	6.9	6.1	5.3	5.9	6.4	6.0	8.8	4.9	5.4	6.9	6.8	6.5	6.0	8.9	6.6	6.1	6.2	8.4	4.9	3.1	6.2	7.0	12.1	5.1	5.6	6.7	6.4	6.6	7.1	2.7	6.7	5.4	6.3	10.2	5.0	7.3	6.3	7.0	4.9	6.0	6.7	10.0	20.9	9.2	4.0	8.6	6.7	12.6	11.7	5.0	2.4	3.7	6.7	7.2	15.9	5.1	9.7	11.9	11.4	13.0	6.7	6.5	3.4	3.7	10.9	4.9	8.2	9.6	10.6	12.1	13.6	10.6	9.1	7.4	6.6	4.2	11.9	3.9	7.2	2.9	3.3	9.8	6.4	5.2	13.9	3.5	5.8	3.0	6.3	3.3	5.3	7.3	7.9	7.6	4.0	3.5	4.8	9.1	4.9	7.9	8.0	5.0	9.9	4.9	9.1	5.7	9.4	6.5	2.7	8.0	5.0	1.9	2.7	3.1	3.2	2.0	3.2	2.6	2.7	4.8	2.5	5.0	4.5	0.9	5.5	2.8	7.0	7.4	6.6	8.0	5.9	6.4	6.9	6.8	6.2	6.4	6.7	7.0	9.0	6.4	8.4	36.9	15.7	4.7	10.0	13.0	8.6	27.2	10.7	7.6	5.2	10.0	16.7	11.0	29.2	15.2	9.8	17.3	7.9	8.6	5.6	4.6	6.9	9.5	8.4	7.4	24.3	9.1	5.9	10.0	12.8	4.0	8.9	20.7	12.5	7.5	8.6	30.3	21.4	11.4	14.2	10.0	9.3	5.6	19.3	9.5	17.8	18.7	16.5	14.1	28.8	28.6	49.7	10.4	15.3	23.7	7.7	10.8	24.9	7.1	11.7	30.9	19.7	10.0	8.0	19.7	10.9	6.7	6.5	12.4	14.0	18.3	12.7	9.4
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.7	12.7	9.8	18.8	10.8	33.4	16.5	13.0	11.5	15.7	10.4	14.8	12.6	13.3	10.1	23.8	12.9	15.4	15.5	10.1	10.9	14.4	29.6	25.8	17.7	10.9	10.6	16.1	42.4	27.0	11.5	19.2	11.0	14.9	16.5	12.7	17.4	13.3	33.2	20.1	13.9	16.8	9.7	16.2	26.5	18.9	11.1	21.6	21.3	26.4	23.6	24.5	14.6	11.8	52.0	28.3	40.2	34.6	46.2	28.6	25.3	52.4	46.9	76.2	66.1	34.9	44.1	27.0	62.7	53.3	42.8	48.5	83.0	55.2	84.4	77.8	41.1	60.9	42.2	41.1	40.9	64.7	35.3	30.6	43.6	83.3	63.2	28.2	46.4	43.7	91.8	45.3	61.6	39.3	33.5	26.1	46.8	57.7	42.4	49.8	50.9	51.3	35.8	34.8	76.2	42.9	47.7	47.5	58.5	44.3	34.4	23.5	49.5	59.5	52.8	106.9	62.5	46.8	56.4	59.2	52.1	63.2	60.7	28.2	24.6	19.6	16.5	24.9	16.3	23.5	13.8	15.1	22.6	18.5	11.2	14.9	6.5	13.7	24.1	18.4	17.1	17.7	9.8	10.8	13.0	11.5	10.1	10.9	10.9	10.6	11.0	9.7	11.1	11.8	24.1	28.9	83.9	0.0	7.9	0.0	0.0	0.0	0.0	0.0	19.6	16.0	0.0	0.0	18.0	18.4	0.0	28.1	17.5	0.0	5.9	41.3	0.0	15.4	27.4	12.5	0.0	0.0	0.0	32.7	35.7	10.1	0.0	23.3	13.9	21.5	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	35.2	0.0	0.0	0.0	0.0	37.9	0.0	0.0	4.9	0.0	0.0	19.0	16.8	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	41.3	9.6	32.5	0.0	0.0
ELOA2	"HsT832, TCEB3B, TCEB3L"	ENSG00000206181	"Elongin A2"	Q8IYF1	18	47032572-47035621	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	33	"brain: 2.3;choroid plexus: 3.4;testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"			Nucleoplasm	Cytosol	"HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "	"unprognostic (2.38e-1)"	"unprognostic (4.47e-1)"		"unprognostic (2.54e-4)"	"unprognostic (2.39e-1)"			"unprognostic (8.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.64e-1)"			"unprognostic (5.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.97e-2)"		0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.8	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.8	1.1	0.7	0.6	2.0	2.3	1.9	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3CP	ELOA3C	ENSG00000275553	"Elongin A3 family member C, pseudogene"		18	46968695-46969912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	28	"brain: 2.2;choroid plexus: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"			Nucleoplasm	Cytosol	"HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.2	0.0	1.7	0.0	0.0	0.6	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.6	1.1	0.8	0.7	2.0	2.2	2.0	0.9	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOB	"SIII, TCEB2"	ENSG00000103363	"Elongin B"	Q15370	16	2771414-2777280	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1279.6;Exocrine glandular cells: 911.2;Pancreatic endocrine cells: 1027.1;Proximal tubular cells: 1789.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064006	Approved					NA	NA		82000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA064006: "	"unprognostic (1.77e-1)"	"unprognostic (5.27e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.15e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.32e-2)"	234.7	293.3	355.3	130.9	359.6	289.7	235.0	363.3	479.4	217.1	339.1	275.5	141.6	214.1	80.8	297.1	217.7	180.2	485.0	365.8	363.9	301.6	340.1	206.6	185.6	356.8	360.3	187.8	207.5	203.4	279.9	109.8	358.2	233.8	83.2	51.4	332.2	112.9	573.1	254.5	203.5	89.5	362.8	208.8	255.6	428.5	366.5	154.6	199.4	266.2	93.4	220.1	228.6	367.5	185.8	559.0	254.5	407.0	263.5	354.6	265.7	233.1	242.6	254.3	210.0	408.8	372.6	288.6	309.4	256.7	275.1	206.6	146.4	403.4	61.9	349.4	593.0	188.5	773.6	578.7	410.1	276.9	286.6	362.8	517.3	242.4	180.6	254.7	225.8	420.1	258.4	465.0	265.5	1212.8	459.7	708.6	331.4	363.2	570.0	487.9	248.3	636.9	311.8	404.2	461.4	335.2	310.0	472.3	320.1	79.0	434.1	506.3	303.5	323.4	308.9	232.4	277.7	382.8	503.1	619.8	152.5	279.6	347.2	3022.8	1566.1	2928.2	711.2	1154.9	687.1	877.6	741.7	760.1	951.3	757.8	638.9	671.0	1519.2	892.1	1236.0	848.6	1046.2	2212.0	355.3	359.6	363.3	479.4	365.8	363.9	356.8	360.3	358.2	362.8	366.5	367.5	401.9	182.7	218.4	0.0	89.7	0.0	0.0	0.0	0.0	0.0	633.1	738.0	0.0	0.0	131.8	505.8	0.0	562.9	243.1	0.0	1279.6	752.8	0.0	641.0	734.0	188.1	0.0	0.0	0.0	911.2	689.1	219.6	0.0	551.8	107.2	339.5	0.0	0.0	719.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	304.4	0.0	0.0	419.2	0.0	0.0	0.0	0.0	1027.1	0.0	0.0	46.1	0.0	0.0	1789.2	241.9	0.0	0.0	0.0	233.3	0.0	0.0	0.0	0.0	496.8	132.1	310.6	0.0	0.0
ELOF1	"ELF1, MGC4549"	ENSG00000130165	"Elongation factor 1 homolog"	P60002	19	11551147-11559236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 497.5;Late spermatids: 1414.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045606	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA045606: AB_10965133"	"unprognostic (4.32e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (4.38e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.12e-2)"	42.7	65.7	78.3	33.3	81.2	62.2	40.8	91.9	95.2	63.1	82.6	57.4	31.3	68.9	43.4	51.4	60.2	29.4	54.4	81.2	89.1	54.9	80.3	40.9	45.3	76.3	77.9	60.3	79.7	48.6	74.4	25.5	83.9	64.1	25.0	22.2	56.4	45.1	57.9	48.1	48.9	34.8	75.5	56.0	66.4	205.2	81.0	47.1	47.4	47.8	38.6	53.2	47.7	101.5	138.7	94.7	63.7	88.0	78.0	78.5	32.8	87.2	73.0	117.1	117.6	94.4	37.1	88.1	83.5	79.3	76.3	63.5	78.2	121.2	81.2	70.2	79.6	110.8	61.8	90.5	87.6	72.5	72.9	76.8	88.7	103.6	74.8	83.7	57.9	82.8	156.1	111.8	71.0	177.8	108.2	84.1	166.1	69.9	172.3	79.2	54.5	93.2	97.6	63.2	80.2	101.4	70.3	83.6	85.2	58.1	70.2	57.5	40.6	120.3	45.5	127.6	133.0	129.0	188.5	75.1	112.1	101.0	61.5	99.6	130.4	144.2	99.5	128.8	92.5	195.5	104.0	93.5	115.0	160.4	92.8	83.4	87.1	106.1	147.3	189.4	153.0	146.4	78.3	81.2	91.9	95.2	81.2	89.1	76.3	77.9	83.9	75.5	81.0	101.5	15.4	16.0	23.9	7.8	50.5	84.9	53.4	74.7	43.9	24.7	47.9	39.2	31.9	50.1	37.7	33.1	8.4	83.6	52.3	59.9	105.7	80.1	497.5	38.9	30.3	32.4	60.3	67.8	10.0	103.0	80.8	42.2	19.4	20.2	22.2	29.5	44.3	37.0	76.7	15.2	10.3	47.1	59.0	53.0	68.9	1414.3	74.0	39.7	69.4	6.5	87.4	45.7	80.3	3.0	9.0	96.1	68.7	71.5	36.5	49.5	80.9	90.7	51.0	17.6	26.3	31.8	38.3	206.3	80.4	32.2	81.3	72.7	47.5	33.7	46.6	43.5
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363398-43368074	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	78.5	54.7	77.2	39.8	115.6	52.9	66.6	121.1	116.9	57.1	61.4	63.9	51.6	46.5	30.6	176.6	38.9	42.4	47.2	76.8	93.2	59.7	45.8	59.6	40.1	152.0	110.1	28.9	55.4	46.2	27.2	51.0	140.7	58.7	48.6	8.4	72.7	48.8	24.1	201.9	55.4	50.8	114.8	57.1	70.6	18.6	107.7	22.2	66.8	28.0	55.7	68.5	86.8	165.7	108.0	119.5	22.6	44.8	148.4	138.2	70.2	125.2	154.5	153.5	122.4	105.9	182.5	73.9	94.3	193.6	130.3	119.4	79.7	152.2	93.2	94.6	53.9	96.6	77.3	77.1	128.2	84.2	98.0	106.2	168.2	180.9	198.4	114.8	155.0	27.7	68.1	54.8	178.5	79.5	19.9	69.5	33.5	136.9	120.2	43.6	59.9	89.7	195.5	128.7	27.4	28.8	73.7	258.4	105.8	66.8	121.2	82.4	132.2	129.7	82.5	161.2	161.3	26.6	31.2	35.4	127.8	85.2	120.1	134.9	189.6	172.7	105.1	180.0	93.4	109.0	98.4	103.2	212.8	94.2	63.5	88.0	133.0	114.7	179.6	148.8	113.8	203.1	77.2	115.6	121.1	116.9	76.8	93.2	152.0	110.1	140.7	114.8	107.7	165.7	44.0	19.2	12.5	7.5	28.1	15.6	25.9	61.1	29.6	5.7	60.3	37.5	4.7	34.3	40.2	40.5	10.4	93.4	36.0	114.0	7.9	91.5	3.4	22.9	26.3	43.6	19.2	67.8	3.8	100.1	127.4	26.1	48.4	45.2	21.0	52.6	24.7	16.7	74.9	3.3	3.4	33.8	46.8	46.3	37.5	4.6	20.2	41.5	12.4	7.5	92.5	13.7	32.0	3.0	66.1	133.3	63.9	25.6	19.0	44.7	66.0	23.3	14.5	9.5	19.7	10.0	39.7	8.4	11.2	70.1	31.0	95.9	31.5	50.8	47.2	49.2
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226299-102229589	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 30.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.0;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	3.2	0.7	1.0	0.3	0.8	1.8	3.5	0.5	1.3	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.2	1.0	0.4	0.8	0.0	1.0	0.1	0.4	0.9	0.1	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.1	0.3	0.1	0.2	30.5	0.2	0.0	0.4	0.8	0.1	1.2	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.5	3.2	0.2	0.2	7.8	9.5	9.4	2.8	0.1	0.3	0.4	0.5	0.5	3.0	0.0	0.3	0.0	0.0	0.1	5.9	0.1	0.5	0.0	0.0	0.2	0.4	0.8	0.3	0.0	0.1	13.9	1.6	3.6	0.0	0.0	0.0	0.9	0.1	3.5	0.8	0.0	0.0	11.6	0.1	1.1	1.0	0.0	5.1	0.0	2.0	0.1	0.0	0.4	22.6	0.9	0.7	0.6	8.1	2.7	0.0	1.5	0.0	0.3	0.3	0.5	7.2	0.0	3.4	6.5	0.0	0.0	7.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	1.7	1.0	0.8	0.5	1.3	1.0	0.4	0.4	0.9	0.4	0.4	0.4	0.5	2.5	0.0	1.1	0.0	0.2	0.4	0.5	0.6	0.6	0.0	1.1	3.2	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	1.3	1.9	0.0	0.0	0.3	0.0	0.7	1.3	0.0	0.2	0.0	0.0	1.4	0.4	0.2	0.0	0.0	0.2	0.0	1.5	0.8	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	5.0	1.2	0.1	3.4	0.6	0.1	0.3	0.3	2.2	0.2	0.1
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.4;Hepatocytes: 102.0;Inhibitory neurons: 78.5;Oligodendrocytes: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.4;MAIT T-cell: 2.6;memory CD4 T-cell: 1.0;memory CD8 T-cell: 1.3;naive CD8 T-cell: 1.0;NK-cell: 3.3"	"Group enriched"	"Detected in many"	21	"NK-cells: 3.3;T-cells: 2.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	12.2	8.7	4.6	2.9	5.2	4.0	7.4	5.2	7.9	4.2	1.5	11.5	8.5	3.1	2.1	18.0	2.1	3.2	4.2	4.9	5.0	4.0	36.2	3.1	0.7	5.8	5.4	1.5	2.0	6.4	4.0	1.7	6.0	1.9	10.2	12.1	4.1	2.3	1.0	15.3	6.3	3.7	5.8	1.6	13.6	0.9	5.3	1.8	1.8	0.5	2.3	6.8	5.7	7.8	24.1	14.5	57.8	12.9	31.6	32.6	24.6	16.8	9.5	6.4	16.4	7.6	45.5	2.5	1.3	13.3	22.0	21.5	46.8	52.2	13.6	9.5	14.8	33.9	17.3	17.9	19.6	30.4	18.8	30.0	10.2	34.9	13.5	21.5	11.9	3.4	33.8	57.0	12.6	10.5	7.1	2.6	25.0	15.3	7.2	4.3	24.1	7.2	37.2	20.3	11.0	23.3	9.9	57.9	9.1	24.3	10.0	0.3	5.9	13.2	15.5	20.4	21.4	2.7	11.3	57.9	20.8	0.0	2.8	0.1	0.0	0.0	2.4	0.0	2.6	0.0	1.0	1.3	0.0	0.0	0.3	1.0	0.1	3.3	0.0	0.0	0.1	0.4	4.6	5.2	5.2	7.9	4.9	5.0	5.8	5.4	6.0	5.8	5.3	7.8	2.1	0.0	7.8	51.2	1.6	1.8	3.0	8.6	2.8	24.4	3.8	2.8	3.2	8.6	9.8	11.0	37.5	2.5	8.9	38.1	5.9	13.0	7.6	3.5	11.1	2.2	3.0	34.9	83.4	8.2	26.8	6.9	30.5	6.3	6.3	8.3	4.2	102.0	1.9	26.9	78.5	14.4	8.2	3.0	0.3	3.9	1.2	0.7	0.0	18.7	0.1	5.5	18.6	56.3	77.3	16.6	24.8	1.2	2.9	2.5	7.1	6.9	2.9	16.3	6.6	6.4	7.5	0.2	1.5	19.9	7.0	2.1	9.6	11.8	22.4	5.1
ELOVL7	FLJ23563	ENSG00000164181	"ELOVL fatty acid elongase 7"	A1L3X0	5	60751791-60844274	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 190.2;Oligodendrocytes: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.9;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 41.9;HDLM-2: 29.3;HEL: 37.3"	"Low region specificity"	"Detected in all"							HPA036337	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA036337: AB_10670797"	"unprognostic (6.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.54e-9)"	"unprognostic (6.95e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.30e-3)"	10.5	5.5	23.1	2.2	24.9	1.0	22.1	29.5	26.5	3.6	36.2	8.8	11.8	2.2	0.9	5.0	2.8	19.3	0.9	18.3	30.0	16.2	1.0	3.8	2.5	31.8	26.3	0.5	8.5	21.0	2.7	0.8	32.9	22.0	11.5	10.5	4.7	1.2	0.5	26.2	21.3	3.7	30.1	0.5	3.3	0.8	32.9	1.8	16.8	1.0	4.0	7.6	6.7	32.2	20.7	7.6	0.1	0.5	0.0	0.0	18.6	0.0	4.3	2.5	8.4	9.6	21.4	0.0	9.1	0.0	41.9	1.2	11.9	8.3	3.8	29.3	6.9	37.3	0.9	3.2	0.2	3.0	15.2	0.1	14.6	0.3	12.3	0.9	0.0	6.5	5.9	7.2	0.0	17.8	0.1	0.3	2.4	1.9	0.1	1.6	1.9	1.2	19.4	18.5	7.8	1.2	10.9	8.8	5.0	2.0	14.2	0.6	0.2	1.5	9.0	0.2	7.2	18.5	19.7	0.3	13.2	0.8	0.4	1.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.5	23.1	24.9	29.5	26.5	18.3	30.0	31.8	26.3	32.9	30.1	32.9	32.2	14.5	12.8	3.1	4.9	0.5	31.1	13.1	1.4	4.6	2.3	3.1	1.4	0.7	20.0	4.8	12.9	0.0	0.2	0.3	8.8	5.9	6.8	0.1	6.5	1.6	21.1	4.8	1.3	29.5	3.1	0.0	2.0	5.6	20.4	12.7	0.4	0.4	0.0	0.1	0.0	26.0	17.0	0.0	0.0	16.6	0.0	0.0	4.9	10.6	190.2	2.0	3.5	0.0	6.0	90.8	7.1	13.3	0.0	0.1	23.4	29.7	8.9	1.7	6.7	0.0	1.0	0.8	0.2	1.1	2.9	38.2	2.9	0.9	0.2	15.9	8.6
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108866898-108934328	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 36.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	13.6	39.7	5.8	6.5	6.2	6.5	13.6	6.9	8.1	21.5	8.4	17.5	5.8	17.1	9.5	13.0	19.9	6.7	18.2	5.9	7.8	14.4	18.4	15.2	9.6	6.6	6.5	29.9	17.6	29.3	38.1	6.8	7.9	18.0	8.1	24.8	14.8	8.3	15.7	15.9	15.9	8.9	5.9	18.2	15.5	12.0	6.9	9.5	20.1	11.4	8.8	15.5	18.3	6.3	15.6	26.7	19.7	12.8	21.7	21.1	21.1	23.4	15.1	20.8	16.9	31.5	9.2	31.0	12.0	20.2	27.5	35.7	40.7	29.8	25.8	28.6	26.6	15.2	38.2	63.3	18.6	28.7	13.7	18.7	19.1	34.5	26.7	18.0	20.9	33.6	43.1	17.9	22.9	25.3	21.2	13.6	32.1	41.0	34.4	20.7	31.9	18.3	17.3	16.1	26.6	23.9	27.8	23.3	15.7	22.4	33.3	14.1	15.4	10.4	16.2	26.0	25.1	15.5	47.2	13.8	20.0	20.2	19.1	36.6	1.4	2.8	2.9	2.2	4.4	2.2	3.4	4.6	2.4	1.2	3.1	4.0	0.2	4.5	3.3	1.6	2.6	2.1	5.8	6.2	6.9	8.1	5.9	7.8	6.6	6.5	7.9	5.9	6.9	6.3	7.3	12.8	18.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	7.7	7.0	0.0	0.0	3.1	14.7	0.0	6.9	5.8	0.0	0.0	5.8	0.0	9.9	10.6	4.7	0.0	0.0	0.0	21.1	6.2	3.8	0.0	9.6	2.5	11.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	0.0	0.0	2.7	0.0	0.0	6.3	6.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.6	2.8	24.4	0.0	0.0
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180557	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	17.7	20.7	12.1	12.3	13.2	13.2	35.3	12.4	11.9	23.5	12.3	19.1	15.2	27.3	31.0	15.9	28.8	20.3	23.6	11.4	14.2	18.9	46.2	16.6	19.9	12.1	12.1	48.6	24.4	24.8	20.7	20.8	12.6	29.4	16.2	21.2	19.1	26.3	32.4	21.5	14.0	22.5	12.2	16.7	16.5	22.2	13.4	23.6	21.8	32.3	23.3	22.5	16.9	16.0	23.7	16.7	30.8	27.8	42.7	63.9	33.9	47.9	69.3	39.6	52.5	17.6	21.5	49.6	32.6	40.4	26.5	32.9	39.7	35.8	55.8	22.6	21.1	19.2	27.4	31.0	46.6	63.0	19.6	52.3	40.2	39.4	63.6	59.5	45.0	33.8	32.9	25.4	42.4	28.4	30.6	27.0	36.7	18.2	12.6	48.7	37.0	34.9	35.7	54.4	24.2	46.3	45.1	17.6	73.0	44.0	22.5	31.2	26.8	35.6	20.5	13.2	24.8	30.4	25.6	46.2	30.0	33.2	31.3	22.0	12.1	10.0	12.6	17.6	17.9	20.0	17.0	15.0	17.6	16.3	21.5	18.9	2.2	22.2	24.8	17.5	18.4	14.0	12.1	13.2	12.4	11.9	11.4	14.2	12.1	12.1	12.6	12.2	13.4	16.0	25.0	48.1	28.8	34.3	46.3	32.9	49.4	33.8	39.9	50.1	42.1	28.6	48.5	22.8	29.2	35.0	43.8	39.5	45.9	10.9	29.4	26.4	55.0	29.9	33.1	29.4	24.7	21.7	61.7	22.2	42.3	39.2	17.3	29.5	36.7	39.9	24.7	75.3	22.8	33.7	60.7	20.3	20.3	28.0	24.8	90.4	43.5	20.8	23.2	34.7	39.1	26.9	41.2	52.3	77.4	18.7	12.1	36.5	34.2	60.9	24.3	19.0	36.5	45.4	6.6	40.8	30.6	40.0	33.2	25.0	36.7	39.8	39.7	28.0	26.9	50.7
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.3;Glandular and luminal cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	13.6	13.0	17.3	11.0	19.0	6.6	16.6	19.0	20.3	26.1	14.1	13.8	9.7	22.6	11.3	12.2	16.1	15.4	16.3	19.2	19.8	17.5	21.0	12.1	16.3	18.2	17.4	16.1	10.9	16.8	11.6	12.0	18.5	13.4	15.6	12.4	9.8	19.2	27.9	12.0	11.1	14.9	18.0	13.7	10.7	14.2	20.1	14.6	18.3	26.5	19.5	13.6	10.6	19.6	34.5	36.3	26.1	21.7	28.9	27.8	17.6	17.7	26.6	31.9	31.2	23.9	14.7	60.0	24.6	27.7	31.3	21.5	26.3	34.3	41.2	11.2	12.4	38.0	21.9	41.3	27.7	21.4	27.5	32.7	48.4	24.4	36.5	26.2	32.4	41.3	46.2	34.8	32.9	20.9	47.3	30.1	28.9	29.5	12.0	34.4	24.4	24.2	33.8	25.5	13.6	25.5	18.1	14.4	28.4	21.3	29.2	24.2	25.7	23.6	35.2	26.8	26.5	14.4	25.9	45.2	26.7	24.7	26.8	20.2	16.1	12.9	25.0	22.2	28.7	17.9	21.8	26.0	18.3	21.2	18.7	22.1	3.8	25.0	27.0	17.3	23.5	19.1	17.3	19.0	19.0	20.3	19.2	19.8	18.2	17.4	18.5	18.0	20.1	19.6	8.8	3.2	12.7	26.4	14.4	2.7	7.1	10.2	10.8	8.5	6.8	8.9	16.6	7.2	11.1	7.3	22.9	15.1	12.5	6.3	7.9	12.5	7.4	74.3	25.0	10.1	1.2	9.4	32.2	9.9	14.8	9.5	9.7	125.2	8.2	12.8	10.4	19.0	14.9	15.2	38.7	7.0	0.0	13.2	4.0	4.8	8.4	9.6	1.8	31.9	9.6	8.7	24.7	49.3	45.9	9.3	11.3	10.1	11.0	7.6	9.9	13.1	10.6	12.2	0.0	9.5	8.4	20.2	17.7	6.9	2.4	10.4	13.7	15.6	10.5	5.4
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA038572: AB_2676090, HPA038573: AB_2676091"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	7.1	7.2	14.6	7.4	16.4	8.6	6.8	37.9	19.0	7.4	13.3	9.0	4.6	6.8	8.3	9.7	7.3	7.2	10.2	14.0	13.3	10.2	9.6	7.3	9.7	13.6	14.3	7.5	9.4	8.1	5.4	7.8	14.7	6.7	7.7	12.7	6.9	7.4	8.3	9.6	6.5	7.6	13.6	6.4	6.5	8.3	15.2	15.1	6.6	8.3	8.4	7.8	7.3	18.2	13.2	11.2	12.0	14.4	10.9	14.9	4.6	11.5	12.3	16.7	18.4	10.4	11.5	18.0	9.7	10.3	20.9	23.3	16.5	14.4	18.3	15.1	18.3	5.9	13.2	16.0	11.2	12.6	11.2	14.9	8.7	7.2	19.5	13.2	20.4	22.9	27.4	15.7	10.7	20.3	21.4	14.9	6.9	38.9	13.7	12.8	25.7	12.0	25.6	13.0	13.8	6.4	22.3	13.4	10.0	11.7	25.4	18.2	8.2	15.3	13.5	25.3	15.2	6.1	12.9	22.0	10.8	17.6	13.4	5.9	8.0	8.1	6.7	9.2	8.3	9.1	7.6	7.9	9.3	5.9	8.5	7.4	2.1	7.5	9.5	8.3	10.1	6.6	14.6	16.4	37.9	19.0	14.0	13.3	13.6	14.3	14.7	13.6	15.2	18.2	13.9	12.8	10.5	153.5	11.4	8.3	11.0	20.2	6.8	4.9	7.7	8.5	7.7	5.7	14.5	7.3	4.2	20.2	11.4	4.3	29.4	9.1	18.0	11.0	14.0	7.5	6.7	4.6	93.6	11.3	15.6	10.5	4.1	8.3	10.8	12.8	3.9	5.5	11.5	15.2	90.2	6.0	12.2	5.7	2.4	3.6	5.0	8.5	3.6	91.8	7.7	16.5	8.2	129.2	123.4	6.1	3.9	6.4	14.3	2.9	4.0	33.1	8.6	6.1	6.6	8.3	12.9	23.5	10.2	9.4	8.2	18.9	11.4	11.6	6.4	6.9
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 171.6"	"Group enriched"	"Detected in all"	4	"Early spermatids: 405.3;Late spermatids: 699.6;Spermatocytes: 226.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	30.6	47.9	21.1	10.0	22.0	14.1	26.7	22.0	23.8	30.0	22.0	36.4	11.5	31.8	12.8	27.9	28.7	9.3	59.7	21.0	21.8	39.6	57.1	22.7	16.7	21.7	21.6	33.7	28.0	19.9	39.7	10.4	21.6	35.4	10.8	18.9	26.1	11.8	57.3	21.2	31.2	17.8	21.2	35.0	29.0	171.6	21.9	22.9	29.3	77.9	16.9	30.9	24.8	21.6	22.4	61.7	27.3	24.9	46.8	36.8	11.9	19.5	23.1	30.7	28.2	62.0	14.3	44.0	21.1	31.3	53.7	16.4	69.6	46.1	22.0	27.4	98.2	40.7	20.5	57.3	23.2	29.2	15.4	26.2	34.0	21.0	41.1	19.4	26.5	54.9	28.6	11.5	48.4	37.5	74.4	55.4	22.5	23.4	42.5	63.0	30.6	23.9	34.5	20.7	13.3	26.4	38.0	11.5	30.9	27.0	16.3	20.9	30.4	17.6	20.6	34.1	31.7	13.3	19.4	51.8	32.0	28.1	23.3	28.6	30.7	16.1	32.3	37.8	41.0	39.3	28.9	30.1	37.4	39.5	30.2	35.9	5.3	38.7	26.1	45.9	44.7	28.6	21.1	22.0	22.0	23.8	21.0	21.8	21.7	21.6	21.6	21.2	21.9	21.6	30.4	9.6	11.7	10.7	38.3	22.0	47.7	47.8	27.9	21.5	27.8	36.6	64.3	12.8	39.9	46.0	20.9	36.1	45.1	29.7	97.8	38.3	405.3	20.5	28.1	26.5	41.6	14.1	9.4	13.6	78.1	28.6	9.7	21.5	7.0	30.1	18.2	24.2	41.4	28.6	9.7	37.0	57.0	13.5	28.8	699.6	34.2	22.8	21.4	10.3	29.0	32.7	29.9	10.6	10.5	19.3	32.9	33.1	26.7	73.5	46.9	107.0	23.1	33.6	39.5	27.1	35.9	226.4	40.8	21.0	21.7	57.9	29.9	29.0	46.5	51.6
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
ELSPBP1	"E12, EDDM12, HE12"	ENSG00000169393	"Epididymal sperm binding protein 1"	Q96BH3	19	47994632-48025154	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"epididymis: 2828.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 22.0;Cone photoreceptor cells: 16.7;Early spermatids: 32.0;Horizontal cells: 18.5;Late spermatids: 28.8;Muller glia cells: 20.4;Rod photoreceptor cells: 120.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 10.1;NB-4: 5.5"					"Not detected"	"Not detected"			"HPA044256, HPA050341"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044256: AB_2678879, HPA050341: AB_2681097"					"unprognostic (1.51e-1)"				"unprognostic (1.11e-1)"						"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2828.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0	0.0	0.0	28.8	0.6	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	120.5	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215660-19251527	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA048904: AB_2680552"	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.43e-4)"	15.4	11.2	10.1	11.7	11.6	9.2	11.1	11.7	14.0	12.2	2.1	12.8	8.7	12.2	13.1	10.7	12.0	8.2	12.5	11.8	16.0	10.8	15.5	12.0	9.0	8.3	9.5	14.1	10.6	16.3	10.0	24.0	11.3	13.2	14.1	51.9	10.7	11.0	19.9	11.6	9.1	18.9	5.1	9.7	11.0	13.1	12.4	9.4	14.0	14.3	10.5	11.7	9.8	8.8	41.1	36.5	40.3	105.4	63.6	49.3	78.3	65.1	60.8	88.3	86.8	38.4	92.5	36.5	84.1	100.6	57.1	45.4	56.7	73.0	102.1	31.0	29.6	44.0	46.3	45.5	46.2	56.9	50.7	52.7	46.4	104.6	86.2	82.2	75.6	31.2	55.1	53.7	69.1	23.5	23.3	27.9	24.4	47.2	33.9	34.4	49.7	64.2	35.8	18.8	49.6	33.9	71.5	37.0	54.6	47.2	40.5	35.3	67.3	79.5	51.7	61.2	75.2	29.7	67.0	46.3	75.4	73.5	108.4	5.2	12.7	3.1	8.1	9.6	9.0	6.2	8.1	9.2	12.6	7.0	8.0	8.0	0.5	21.7	12.8	6.1	6.2	9.1	10.1	11.6	11.7	14.0	11.8	16.0	8.3	9.5	11.3	5.1	12.4	8.8	13.0	16.0	14.6	8.1	12.4	11.6	10.1	16.9	8.0	20.3	11.2	11.7	15.7	11.5	10.5	22.0	10.4	40.4	9.9	11.4	0.0	14.3	1.2	10.0	18.0	16.1	19.7	6.9	12.9	8.5	41.0	19.2	9.7	15.0	8.2	23.2	14.3	25.6	19.4	15.2	14.5	11.4	14.2	12.3	7.3	2.6	14.9	11.5	10.6	8.4	12.0	19.0	4.1	15.1	10.9	10.6	9.4	14.3	14.5	10.3	6.4	9.0	7.8	63.4	6.6	20.1	13.5	12.9	19.3	13.0	9.2	36.0	8.9	18.6	12.7	6.7
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490871	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 185.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 193.0;PC-3: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053905, HPA062723"	Approved				"Secreted to blood"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA053905: AB_2682303, HPA062723: "	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	24.3	63.9	29.1	11.4	41.5	19.7	27.6	38.4	38.2	34.1	46.7	36.1	23.8	38.8	15.3	36.0	32.0	13.5	50.7	27.2	29.4	76.3	63.0	32.1	9.7	38.8	35.0	49.6	55.2	44.3	106.4	9.5	36.0	38.3	7.1	8.7	55.7	16.9	185.8	31.7	36.0	6.6	32.7	27.8	47.8	45.6	36.0	6.9	82.4	9.0	6.8	31.0	27.3	49.5	66.2	80.1	3.0	30.8	8.8	10.8	0.8	62.9	11.4	5.4	5.9	0.7	44.4	21.6	0.8	11.3	9.9	55.1	3.7	10.3	2.0	84.2	193.0	4.6	33.9	0.0	14.7	19.1	123.2	13.3	11.3	5.6	4.3	5.2	13.5	18.5	42.7	44.9	11.3	46.0	30.3	0.6	0.3	26.0	137.6	51.7	9.7	71.7	25.0	59.2	48.5	107.9	92.5	29.6	36.1	3.6	31.0	34.8	26.2	3.8	83.1	23.0	34.4	49.5	132.7	17.9	24.8	13.2	30.8	6.2	6.9	8.1	5.0	5.6	4.3	6.4	5.3	5.3	5.3	8.5	6.2	6.0	3.0	3.1	4.3	7.0	4.7	5.2	29.1	41.5	38.4	38.2	27.2	29.4	38.8	35.0	36.0	32.7	36.0	49.5	30.3	64.1	111.1	15.7	65.6	29.7	53.4	60.9	31.3	82.3	72.5	53.8	11.3	81.5	64.0	69.9	81.3	129.5	71.0	103.6	23.5	181.8	177.7	52.1	49.4	46.0	212.2	21.7	7.9	112.3	155.0	46.6	71.9	79.8	53.2	80.3	55.6	79.4	133.8	37.0	11.8	117.7	59.0	109.2	36.7	39.1	69.0	67.7	83.6	9.4	103.1	101.2	90.6	44.2	78.3	114.4	144.9	115.1	80.2	66.4	158.2	66.8	28.6	71.7	6.6	93.3	43.7	18.0	56.2	50.3	31.3	151.0	67.4	78.5	130.5	66.5
EMC2	"KIAA0103, TTC35"	ENSG00000104412	"ER membrane protein complex subunit 2"	Q15006	8	108443601-108489196	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022838	Approved					NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022838: AB_2670967"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.15e-3)"	40.8	38.2	20.1	5.3	21.4	3.5	36.7	20.7	25.3	33.9	19.7	42.9	6.0	27.7	10.1	39.8	31.0	6.7	49.0	19.3	20.4	40.1	34.6	35.5	6.2	21.9	20.2	29.5	41.0	9.6	32.3	9.3	21.3	27.2	8.5	10.2	33.0	7.5	57.3	30.9	27.6	7.3	21.0	26.6	35.1	38.7	20.0	4.6	30.2	10.9	6.1	33.7	33.8	26.3	10.5	5.8	5.0	6.0	9.0	10.1	4.5	4.1	6.5	7.1	6.5	4.8	6.7	4.9	8.7	6.8	5.2	4.6	9.8	10.7	9.0	10.4	9.7	7.9	12.0	7.0	13.7	4.6	4.8	10.7	13.2	6.1	12.0	10.9	9.3	5.6	7.3	5.2	9.4	11.8	6.4	7.0	4.6	17.1	9.9	2.8	6.0	8.0	16.0	5.6	5.4	3.4	4.8	1.3	10.0	7.4	8.3	7.7	5.4	5.0	4.4	9.2	5.4	5.3	11.8	4.9	12.6	10.8	7.7	11.6	6.1	10.4	9.0	5.9	8.1	6.3	8.1	10.7	6.3	6.0	9.6	9.6	7.9	6.9	6.8	10.3	8.5	5.6	20.1	21.4	20.7	25.3	19.3	20.4	21.9	20.2	21.3	21.0	20.0	26.3	47.3	32.1	49.5	50.9	22.8	27.5	52.5	157.7	27.3	17.9	18.6	20.8	66.8	37.1	98.7	36.8	14.6	57.2	25.8	19.8	86.1	52.0	72.8	48.4	28.4	37.4	21.1	9.9	30.9	46.5	47.6	43.9	17.3	28.7	35.5	20.8	32.9	24.7	47.7	18.5	37.8	23.6	93.6	20.5	16.1	24.6	36.7	21.3	32.0	24.4	38.6	57.9	16.5	44.7	102.1	34.2	27.5	37.2	27.6	31.4	40.3	102.4	98.6	30.5	65.7	39.3	64.6	190.8	71.6	20.5	27.3	73.5	24.4	45.9	22.2	42.5
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	71.1	41.1	26.5	28.9	27.6	65.7	33.3	28.5	29.9	26.1	29.7	40.6	37.4	23.2	26.9	46.1	28.9	27.9	34.3	29.2	29.4	40.3	65.7	36.1	22.7	31.0	29.5	22.5	43.6	70.5	17.2	20.3	30.4	25.8	36.0	24.2	42.8	32.0	78.5	33.6	37.3	32.0	28.3	23.1	35.3	48.5	28.8	27.2	39.9	46.7	28.5	40.7	25.1	30.4	48.9	100.7	37.4	22.5	232.6	90.3	125.1	98.1	84.6	60.1	64.8	69.5	75.6	38.7	69.8	111.9	115.2	66.7	64.2	58.3	61.7	105.2	64.3	63.6	69.9	46.5	100.4	71.8	68.2	107.4	102.5	104.9	60.1	76.5	75.6	41.8	82.0	109.2	90.2	119.5	38.3	35.6	41.5	103.2	68.7	49.0	52.4	115.7	72.8	86.7	26.4	53.1	69.9	103.3	63.4	39.1	87.5	58.0	87.6	59.8	49.6	65.0	100.8	58.3	165.6	79.0	126.2	52.0	76.4	119.7	115.1	108.5	64.5	93.6	66.8	65.6	63.7	74.5	88.3	71.2	45.8	61.5	103.5	77.3	95.3	79.1	107.3	156.1	26.5	27.6	28.5	29.9	29.2	29.4	31.0	29.5	30.4	28.3	28.8	30.4	59.1	54.5	72.9	19.9	45.3	50.6	59.9	178.0	24.5	40.6	43.0	39.9	108.1	57.2	121.4	46.0	39.6	49.5	52.7	58.6	46.9	100.6	360.7	61.6	50.2	59.2	21.1	240.2	25.4	119.9	51.8	51.1	38.7	64.0	34.1	36.5	46.1	105.0	97.8	23.5	21.1	40.2	109.9	51.0	66.6	109.3	50.4	101.7	58.7	9.4	97.5	65.2	57.7	21.1	17.8	107.4	71.3	37.6	55.6	58.7	92.6	76.9	99.1	63.5	59.2	44.7	60.7	199.7	63.0	49.6	60.7	85.8	52.7	60.6	52.0	80.2
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34225013-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053440	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA053440: AB_2682151"	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	76.1	68.1	83.8	48.8	86.5	58.7	68.4	90.3	103.7	69.3	92.0	69.1	55.1	67.0	102.9	78.3	67.8	52.3	86.4	87.6	88.8	67.9	91.3	57.3	55.4	87.2	85.2	66.2	90.7	83.0	60.3	59.2	88.4	62.3	58.2	65.4	79.0	63.7	214.4	63.9	57.1	58.8	86.9	49.1	69.8	49.4	85.7	58.1	60.6	136.7	54.2	59.2	71.4	95.2	123.1	248.2	103.9	135.1	133.2	119.6	95.0	137.7	156.9	166.0	143.4	162.0	106.1	48.5	177.7	160.0	145.6	229.4	107.0	135.3	118.7	148.3	103.7	91.9	219.4	154.8	161.0	139.8	87.8	121.4	126.3	121.4	136.0	118.1	139.8	144.6	117.0	186.6	147.1	137.9	109.9	149.9	116.9	165.0	163.5	102.0	94.7	138.3	161.0	186.9	137.1	166.4	101.7	148.3	77.6	74.8	99.3	164.7	106.5	151.3	103.8	131.8	142.7	162.8	251.5	122.0	184.5	164.1	131.1	256.5	158.6	176.9	154.5	173.9	170.0	237.2	170.6	185.8	162.6	187.7	172.2	168.8	88.5	197.8	200.2	166.6	216.1	277.6	83.8	86.5	90.3	103.7	87.6	88.8	87.2	85.2	88.4	86.9	85.7	95.2	75.3	54.5	67.7	8.8	67.9	91.5	103.7	206.5	55.8	35.8	83.7	104.1	58.7	58.6	132.4	66.2	18.8	150.6	62.5	39.5	125.2	180.3	121.8	67.6	55.1	86.1	52.0	38.7	14.1	172.3	173.6	87.8	36.7	69.1	88.0	63.2	64.2	78.6	113.7	18.5	15.4	62.8	166.8	48.5	73.2	27.4	100.6	56.5	101.4	13.1	87.9	98.4	76.2	15.1	16.9	184.0	65.4	90.7	117.9	89.6	71.8	117.5	133.3	42.8	85.5	81.4	123.2	169.7	91.9	60.2	110.0	141.7	68.8	69.7	66.4	125.4
EMC6	"MGC2963, RAB5IFL, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668812-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 185.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	35.6	58.2	35.1	14.7	36.0	30.3	31.4	38.9	40.2	24.7	40.1	40.8	20.0	29.1	11.3	49.3	27.0	5.2	91.0	34.8	37.2	53.2	75.8	29.2	13.3	36.2	35.3	23.4	44.3	18.5	27.7	13.5	35.9	33.0	10.3	17.2	35.5	10.6	185.0	36.9	35.3	9.0	38.5	37.8	47.4	63.3	37.3	15.5	29.6	60.7	12.6	32.8	30.4	37.8	92.8	88.6	38.1	40.1	26.9	21.4	73.2	64.7	31.4	51.7	47.5	54.1	33.8	57.6	91.6	30.3	45.9	87.2	44.5	45.6	37.2	56.0	166.2	41.9	65.4	76.2	38.7	29.3	41.6	27.1	50.6	47.8	33.2	40.9	39.8	68.0	53.4	40.6	38.6	56.2	60.5	86.2	55.0	55.9	99.1	55.7	35.5	55.3	74.2	25.9	31.3	56.7	53.1	41.2	75.6	37.8	48.0	31.1	44.2	43.3	54.4	65.9	96.5	39.5	47.1	38.4	67.7	38.0	53.3	91.6	83.1	87.1	66.1	83.8	61.1	74.6	73.6	73.4	72.7	72.0	75.2	68.5	62.8	56.5	60.7	114.3	92.5	87.4	35.1	36.0	38.9	40.2	34.8	37.2	36.2	35.3	35.9	38.5	37.3	37.8	40.1	16.0	25.9	9.4	60.3	89.0	127.1	144.2	42.1	41.8	82.9	87.8	0.2	82.9	74.8	58.8	35.5	118.4	68.1	55.7	166.3	126.2	252.2	90.0	42.7	56.6	51.4	46.7	7.4	142.8	148.6	40.8	48.4	58.0	55.2	59.8	47.5	148.7	102.5	33.7	8.4	74.7	105.8	57.1	49.6	176.1	38.5	56.6	67.6	3.7	83.3	125.9	77.2	5.5	17.9	164.8	71.6	34.3	81.9	179.9	84.6	203.8	82.2	52.9	39.5	43.3	111.7	151.0	91.6	81.1	101.9	129.0	52.7	65.0	72.6	169.5
EMC7	"C11orf3, C15orf24"	ENSG00000134153	"ER membrane protein complex subunit 7"	Q9NPA0	15	34084017-34101862	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010029	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA010029: AB_1078335"	"unprognostic (2.16e-1)"	"unprognostic (8.16e-3)"	"unprognostic (5.28e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (9.25e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.47e-3)"	65.4	86.5	74.2	48.3	78.2	75.2	58.5	82.6	92.9	47.2	91.4	61.3	52.1	49.6	104.4	47.6	45.9	50.4	70.4	74.1	85.7	90.7	103.8	54.4	43.8	78.5	79.2	43.1	79.1	93.2	54.7	77.3	79.7	62.2	64.8	67.2	59.9	57.0	91.0	56.0	46.8	58.8	82.1	42.5	57.7	76.9	79.6	40.1	71.0	70.9	46.2	63.0	44.0	87.0	68.1	185.7	62.2	84.2	249.3	143.3	69.3	190.4	199.3	174.8	181.0	170.6	79.7	40.4	187.4	189.5	181.3	128.9	94.7	96.3	128.5	99.7	96.5	99.4	273.6	147.3	229.1	101.2	135.0	155.1	181.5	125.0	178.7	117.3	110.3	75.9	99.5	259.9	170.7	79.8	54.5	115.2	58.1	157.2	122.3	69.5	76.2	140.3	187.3	119.1	107.2	78.2	114.0	151.8	97.7	75.5	110.0	161.2	94.9	185.8	71.6	123.7	144.4	172.4	219.7	86.2	187.8	153.3	154.8	316.0	161.1	178.1	139.7	184.2	136.9	137.0	138.6	144.0	150.6	102.9	100.4	124.1	143.8	122.7	206.2	242.6	195.8	196.4	74.2	78.2	82.6	92.9	74.1	85.7	78.5	79.2	79.7	82.1	79.6	87.0	65.5	28.9	36.1	20.2	51.7	86.9	56.8	194.6	40.9	58.6	44.0	50.3	92.9	54.3	117.9	103.0	45.9	127.5	92.1	56.5	39.2	124.4	117.3	52.4	66.2	67.3	45.6	48.0	15.5	172.4	153.4	90.1	32.6	52.6	45.1	40.2	60.3	78.6	112.6	30.3	17.8	57.6	146.5	65.2	60.1	81.6	90.1	61.2	103.2	12.2	70.9	112.4	40.2	17.6	27.7	137.9	63.0	104.2	97.1	61.3	72.5	90.8	94.5	62.9	118.3	65.4	136.5	257.9	57.4	43.1	86.4	160.1	65.8	100.4	61.3	55.2
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	13.5	12.9	13.9	8.3	14.7	17.4	12.7	14.7	13.6	9.7	13.2	12.5	10.6	12.7	7.2	13.1	9.2	6.3	19.5	13.9	13.9	13.8	12.8	9.3	10.1	14.8	14.3	8.2	10.9	11.0	10.2	9.3	13.8	9.9	8.7	7.1	9.9	8.7	20.8	10.5	10.5	9.3	15.1	10.9	11.7	12.2	14.8	10.3	9.6	12.5	9.5	11.7	9.4	16.0	29.8	34.1	21.3	19.5	22.6	21.6	41.4	28.7	28.4	46.9	20.8	54.7	33.5	25.6	32.5	29.1	21.0	33.3	32.0	30.1	41.5	10.9	45.7	21.1	17.3	50.3	34.2	21.7	13.7	23.8	20.1	35.7	41.5	20.2	27.1	30.9	48.6	9.6	29.2	50.7	34.5	61.4	42.5	27.4	43.3	50.0	17.4	21.8	29.9	20.7	35.9	21.4	52.8	17.1	33.9	18.9	33.9	38.1	23.8	28.1	28.7	24.9	37.1	26.6	27.3	102.8	24.1	41.3	30.2	17.9	18.1	25.6	10.9	19.2	12.7	11.1	11.8	14.8	24.2	15.6	14.7	14.4	7.5	19.2	19.5	17.8	12.3	12.3	13.9	14.7	14.7	13.6	13.9	13.9	14.8	14.3	13.8	15.1	14.8	16.0	60.1	6.4	8.6	10.4	25.0	61.3	30.1	28.9	25.0	33.7	26.7	26.0	19.9	15.7	18.5	25.8	12.5	48.5	25.0	28.8	60.7	46.9	230.2	37.1	28.3	33.6	46.6	21.5	6.1	42.1	60.7	26.2	18.8	40.9	9.5	25.1	23.6	23.3	47.0	15.2	7.8	27.4	26.4	28.0	38.0	55.0	24.8	27.1	28.4	8.4	41.9	27.8	27.8	8.0	12.2	50.0	27.2	31.6	33.3	51.1	29.1	46.5	12.5	18.6	26.3	22.5	28.9	54.2	56.5	33.5	54.6	51.0	22.4	37.0	35.6	41.9
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141591	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078254	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	10.4	30.2	9.5	2.7	9.5	6.0	10.4	9.7	10.9	11.4	11.7	14.9	9.9	11.0	4.8	14.5	11.5	2.5	17.6	9.5	10.4	22.2	26.8	10.1	4.2	9.9	9.1	13.3	20.8	5.0	31.9	3.0	10.1	19.5	3.4	12.5	14.4	5.2	39.6	16.6	14.4	3.1	8.8	17.3	13.8	16.3	9.6	6.1	14.4	18.4	3.6	13.2	11.9	9.1	14.1	32.6	9.0	25.0	4.7	2.5	8.3	8.7	7.0	12.5	12.5	14.2	10.5	11.6	7.5	7.0	9.7	12.6	7.4	13.8	7.4	9.3	18.0	2.7	13.2	63.3	5.8	10.3	5.7	3.4	5.6	6.8	11.9	10.0	14.1	16.3	2.7	14.9	9.9	33.0	10.2	8.8	10.4	14.3	23.7	6.4	22.3	12.1	9.8	16.7	15.7	12.7	16.3	28.9	7.7	4.4	16.1	5.2	7.1	5.4	15.0	8.0	14.7	18.7	17.7	13.5	8.4	4.4	8.8	0.8	4.2	3.5	3.7	2.3	4.2	4.6	5.1	5.0	4.3	4.8	2.5	3.4	0.4	3.4	2.1	10.2	7.5	3.5	9.5	9.5	9.7	10.9	9.5	10.4	9.9	9.1	10.1	8.8	9.6	9.1	14.1	0.0	7.0	3.9	17.3	18.1	10.4	24.7	24.5	46.4	23.3	23.1	19.7	17.2	15.5	23.9	18.8	33.0	17.3	22.1	56.7	17.6	83.3	12.6	12.3	12.3	21.0	32.6	6.1	11.7	24.2	16.6	6.1	12.9	5.1	24.2	8.6	26.1	30.5	11.8	6.6	29.6	24.4	14.0	19.6	155.7	11.5	11.4	16.0	3.7	15.4	21.2	9.2	4.0	3.2	9.7	14.0	21.8	21.6	17.9	75.9	61.0	18.6	54.4	13.1	15.5	18.5	20.9	5.6	18.1	23.9	24.5	13.4	32.0	30.9	10.3
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA		470000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	46.3	20.2	6.7	9.6	7.1	0.2	38.2	7.1	11.2	37.1	7.8	10.3	6.8	27.9	9.9	12.7	19.2	31.4	38.5	6.3	7.5	79.7	7.5	48.4	6.6	8.1	7.0	6.9	6.2	19.2	9.6	0.8	9.0	12.7	8.1	1.5	9.2	25.6	18.5	9.0	8.3	38.8	7.0	3.5	8.2	2.3	9.4	8.7	43.6	40.2	4.9	24.9	13.9	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	7.1	7.1	11.2	6.3	7.5	8.1	7.0	9.0	7.0	9.4	7.4	409.0	6.4	6.0	0.3	14.0	16.6	0.5	0.1	6.2	0.1	2.1	3.0	14.1	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.0	0.1	0.7	0.6	0.6	261.7	0.0	8.0	1.3	0.0	0.0	16.2	0.0	0.3	0.0	0.1	175.3	1.1	0.2	0.0	0.2	0.0	0.0	5.5	21.4	1.3	1.2	1.7	16.0	111.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	2.6	1.0	0.0	0.2	0.0	0.4	0.0	5.8	21.4	0.2	0.5	1.1	14.6	0.3	2.4	0.7	0.0	1.0
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379273-154381523	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		240000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	"Endoplasmic reticulum"	"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	32.8	32.5	27.4	15.4	27.4	26.5	33.2	27.8	31.8	46.6	26.6	45.7	14.7	58.2	16.0	35.0	56.2	11.2	46.2	26.0	30.1	48.7	30.6	33.3	13.8	28.5	28.6	63.9	50.5	21.3	42.6	15.5	28.2	36.5	11.1	12.9	33.5	21.8	80.3	36.3	27.2	19.9	29.2	26.9	38.5	17.3	29.7	13.0	40.6	29.7	15.4	51.2	36.1	31.4	121.3	42.4	29.0	32.7	26.3	50.6	54.7	58.1	58.2	68.5	72.4	37.9	22.6	99.6	92.2	56.2	143.5	65.5	55.8	67.4	29.5	60.6	116.8	43.7	58.4	22.5	67.9	42.9	46.8	44.1	53.2	60.4	75.0	46.5	48.3	37.5	37.0	39.0	47.9	49.2	74.4	78.1	51.3	66.3	128.9	62.1	45.9	92.4	38.4	21.9	37.9	47.8	29.8	47.6	74.2	27.8	33.6	31.2	43.5	35.7	69.6	80.2	84.2	131.4	100.6	179.3	42.3	70.9	38.1	35.5	29.5	46.4	45.2	37.3	41.8	37.8	43.1	43.6	24.8	37.0	37.7	37.7	31.0	28.7	28.1	54.9	43.3	30.6	27.4	27.4	27.8	31.8	26.0	30.1	28.5	28.6	28.2	29.2	29.7	31.4	30.3	32.1	39.5	8.1	93.1	71.8	74.8	60.9	84.2	35.1	53.4	60.1	22.3	35.8	40.4	27.6	12.5	60.7	87.4	16.6	70.5	43.5	16.3	46.5	51.8	36.2	23.9	46.7	9.6	55.0	66.4	52.9	53.5	64.4	55.1	40.9	27.1	38.8	52.2	30.3	8.8	37.0	28.5	25.2	93.0	15.4	40.7	69.4	67.6	10.3	50.2	46.9	34.0	5.5	10.8	47.7	31.3	44.8	125.8	86.4	30.9	49.5	27.9	32.6	26.3	49.5	60.1	25.4	36.2	99.3	77.0	125.1	92.7	42.3	30.4	68.3
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.4;epididymis: 6.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 18.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	0.5	0.3	0.2	1.7	0.3	4.4	0.6	0.1	0.4	0.5	0.0	0.9	0.8	0.4	6.3	1.1	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.4	2.3	0.3	0.2	0.5	0.2	0.1	0.1	1.4	0.3	0.2	1.3	0.4	0.5	0.1	0.2	1.1	0.7	0.6	0.1	0.9	0.5	5.7	0.3	3.3	0.2	0.0	2.6	0.4	0.5	0.4	13.9	20.0	26.2	13.7	1.2	2.6	18.8	14.2	5.4	19.3	17.7	31.7	11.0	11.0	18.3	5.7	12.0	10.7	24.5	11.3	27.3	21.7	19.3	26.3	23.3	14.8	0.1	10.9	8.4	0.5	0.8	22.3	9.2	2.6	4.5	31.2	16.3	25.6	11.6	15.2	25.0	13.9	15.1	14.2	13.6	25.5	50.7	15.4	4.3	5.6	10.1	20.2	8.7	4.8	8.1	20.9	16.8	12.3	3.1	24.8	14.9	16.6	19.7	16.0	17.4	10.5	7.8	12.2	15.6	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.2	0.3	0.1	0.3	0.4	0.1	0.0	1.1	0.3	0.8	0.1	0.3	0.5	0.6	1.5	0.5	0.3	0.4	0.0	0.7	0.0	0.0	4.6	0.5	0.6	0.0	0.3	0.5	0.8	0.7	0.4	0.0	3.8	0.1	0.0	4.8	0.8	2.0	0.5	0.0	4.5	0.0	0.3	2.2	0.0	0.1	0.9	0.0	0.0	1.4	0.6	0.6	0.8	0.0	0.0	1.0	0.5	1.0	0.0	0.3	0.1	0.0	0.0	2.5	0.1	0.1	0.0	0.9	0.3	0.0	0.6	1.0	13.2	9.1	1.5	0.1	1.1	0.5	0.6	1.3	0.2
EME2	"FLJ00151, SLX2B"	ENSG00000197774	"Essential meiotic structure-specific endonuclease subunit 2"	A4GXA9	16	1772810-1781708	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 3.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.1;Gastric mucus-secreting cells: 15.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.5;REH: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045770	Uncertain					NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA045770: AB_2679447"	"unprognostic (2.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.86e-4)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (6.76e-7)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.32e-5)"	0.7	1.1	0.5	0.5	0.7	0.2	0.8	0.4	0.9	0.8	0.2	0.9	0.6	1.1	0.1	1.2	0.9	0.0	0.4	0.8	0.2	0.8	0.4	0.7	0.2	0.9	0.3	0.5	0.8	0.1	3.9	0.1	0.9	2.1	0.0	0.0	1.0	0.4	0.4	0.9	1.2	0.0	0.0	1.1	1.1	0.9	0.3	0.1	1.7	0.0	0.0	0.9	0.8	0.1	0.5	0.1	0.0	0.4	0.1	0.0	1.1	1.8	0.0	0.1	0.1	0.4	0.8	1.8	1.1	0.0	0.0	1.9	0.0	0.0	0.0	2.4	7.5	0.4	0.8	0.1	0.0	0.9	2.1	0.0	0.3	0.0	0.0	0.0	0.2	0.7	2.4	0.1	0.0	0.2	0.5	0.6	1.0	0.1	1.0	4.1	0.3	2.1	0.1	0.1	3.4	0.6	1.7	0.8	0.2	0.0	1.2	0.7	1.2	0.2	1.1	0.5	0.9	2.5	0.8	2.1	0.0	0.4	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.2	0.5	0.7	0.4	0.9	0.8	0.2	0.9	0.3	0.9	0.0	0.3	0.1	2.8	3.2	8.2	0.3	4.5	2.7	1.2	2.4	2.2	14.1	4.3	3.9	1.3	0.0	6.0	3.7	8.4	2.1	3.3	8.9	0.0	1.6	2.1	2.7	2.8	2.2	6.7	0.8	0.0	2.2	1.2	2.7	15.3	3.1	0.0	4.2	2.5	2.7	3.6	5.0	0.0	3.6	0.0	5.5	2.3	1.4	1.2	4.6	3.6	0.0	4.4	2.4	3.1	0.0	0.1	3.6	1.7	1.5	2.7	2.0	5.6	1.5	3.0	7.1	0.0	4.0	2.4	1.5	1.9	4.6	2.8	2.5	3.6	8.5	6.7	1.4
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205896-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;lymphoid tissue: 54.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HEL: 28.8;NB-4: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	29.0	34.5	4.2	35.0	14.8	2.5	27.7	49.5	6.5	24.4	5.7	5.1	10.0	1.7	1.3	10.4	4.8	2.3	36.8	29.4	15.0	3.3	13.0	7.5	30.1	30.4	7.0	14.0	12.4	2.0	4.9	28.3	6.1	3.4	0.3	3.6	3.9	0.8	6.3	8.3	2.3	27.0	54.8	7.7	2.3	27.8	4.8	13.2	0.3	2.3	4.9	2.2	32.4	0.0	0.2	4.9	10.5	0.0	0.0	0.7	0.0	0.0	0.4	0.3	5.7	0.7	0.0	4.7	0.1	0.0	0.0	2.5	0.1	0.0	11.5	8.6	28.8	0.1	1.1	0.7	4.1	2.2	0.3	0.2	0.2	0.0	0.0	0.0	6.4	2.5	0.0	0.0	8.0	0.2	102.0	1.1	0.1	0.4	0.0	0.2	11.3	0.0	0.1	13.2	6.3	0.4	0.1	0.2	0.8	4.2	5.4	0.0	0.0	8.0	0.0	0.1	0.5	0.0	0.0	0.0	14.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	34.5	35.0	27.7	49.5	36.8	29.4	30.1	30.4	28.3	27.0	27.8	32.4	0.4	0.0	2.5	92.1	0.1	2.8	1.0	0.1	0.0	1.7	5.3	3.9	0.7	4.3	0.6	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.2	10.8	22.6	6.2	0.0	18.5	5.6	1.3	0.1	11.8	0.5	20.0	11.4	32.7	11.4	2.1	0.3	0.0	6.2	0.4	0.0	0.3	5.2	0.5	3.1	0.6	0.0	10.3	0.6	1.1	0.0	51.8	1.0	0.4	0.0	1.9	1.0	1.9	0.1	1.9	0.0	0.4	0.0	17.5	4.0	0.1	1.5	0.0	2.0	0.3	1.1	151.0	0.3	0.4
EMILIN1	"DKFZp586M121, gp115"	ENSG00000138080	"Elastin microfibril interfacer 1"	Q9Y6C2	2	27078615-27086403	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 64.5;Fibroblasts: 111.3;Hepatic stellate cells: 45.0;Leydig cells: 85.1;Peritubular cells: 167.3;Sertoli cells: 72.3;Smooth muscle cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.2;BJ hTERT+: 65.0;HHSteC: 99.0;HSkMC: 109.6;SH-SY5Y: 129.4;U-138 MG: 63.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002822	Supported				"Secreted to extracellular matrix"	NA	NA		4300000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA002822: AB_1078738"	"unprognostic (3.14e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (8.13e-9)"	"unprognostic (8.96e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.70e-3)"	55.5	55.7	6.9	47.0	7.1	1.9	43.6	6.4	7.1	139.8	4.6	223.5	24.9	206.3	7.4	23.3	129.2	35.4	68.9	5.9	7.5	55.5	42.4	100.7	11.7	13.0	7.6	172.4	21.2	1.4	26.9	16.2	9.5	96.4	7.9	0.3	17.5	52.1	10.3	19.1	72.0	50.3	8.3	118.1	87.6	16.9	10.4	2.4	29.7	2.6	2.2	142.9	70.2	8.6	0.9	0.7	5.9	0.9	35.8	49.0	1.1	98.2	65.0	20.7	29.7	0.5	0.8	0.6	0.9	56.6	0.1	0.9	0.2	0.2	3.8	3.1	1.3	1.8	0.5	43.9	99.0	1.5	27.0	109.6	0.1	14.2	0.0	0.2	0.2	1.3	1.0	0.9	4.3	1.1	0.9	28.8	3.2	0.5	0.7	15.6	1.3	1.2	0.0	0.4	1.6	129.4	0.3	0.5	1.1	0.4	0.4	2.5	11.9	63.6	2.0	7.6	0.4	1.7	1.8	1.1	0.7	1.3	17.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	6.9	7.1	6.4	7.1	5.9	7.5	13.0	7.6	9.5	8.3	10.4	8.6	5.2	0.0	0.5	6.5	0.4	3.3	0.2	0.0	0.0	0.6	0.8	7.1	2.9	1.5	0.0	0.0	0.0	1.6	0.6	0.2	0.0	0.4	0.6	1.9	64.5	6.3	0.0	4.0	0.2	0.4	1.5	111.3	0.5	1.3	4.5	0.2	45.0	1.0	6.4	0.0	0.3	0.3	0.0	2.5	5.8	10.0	85.1	4.1	10.6	8.4	0.5	3.6	0.0	0.5	0.3	0.8	0.1	167.3	0.8	0.2	0.5	1.0	0.0	1.1	72.3	35.3	52.4	0.6	0.4	0.4	3.1	2.9	1.3	10.7	0.1	0.1
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359962-41366818	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 53.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2"	"Group enriched"	"Detected in many"	5	"glioma: 10.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0"	"Region enriched"	"Detected in single"	30	"cerebellum: 3.3"	"Region enriched"	"Detected in single"	4	"spinal cord: 4.1"	"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	Yes	NA		1200000		"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.6	1.4	2.5	0.1	2.4	0.0	3.5	2.3	3.8	8.6	1.8	4.9	0.6	2.3	53.6	0.8	4.2	0.3	7.8	2.1	2.2	1.0	0.6	0.3	0.1	3.7	2.7	8.9	0.2	0.1	1.8	0.0	3.0	6.7	0.3	0.0	1.0	9.9	0.9	3.9	1.7	0.9	2.5	0.1	2.0	1.7	2.6	0.5	0.3	2.6	0.2	2.3	4.7	3.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	11.1	0.0	0.2	0.0	1.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.0	1.3	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.4	2.3	3.8	2.1	2.2	3.7	2.7	3.0	2.5	2.6	3.0	0.6	0.0	0.0	0.7	0.0	0.9	0.2	0.0	0.0	0.3	1.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.7	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	1.8	0.1	0.0	4.7	0.0	0.1	0.0	3.5	0.1	0.0	1.2	4.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1
EML1	"ELP79, EMAP, EMAPL, HuEMAP"	ENSG00000066629	"EMAP like 1"	O00423	14	99737693-99942060	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033137, HPA049105"	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB033137: AB_2098052, HPA049105: AB_2680633"	"unprognostic (9.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.81e-3)"	"unprognostic (7.03e-3)"	15.5	6.4	8.6	9.1	25.5	0.3	9.7	7.3	12.7	13.2	15.0	35.5	6.8	16.1	10.8	24.1	15.1	18.6	17.2	8.6	7.9	8.6	5.5	13.2	3.3	9.2	9.0	3.8	8.7	28.3	9.2	27.2	10.7	9.6	14.9	50.1	5.0	16.9	47.5	9.4	10.1	31.0	9.4	3.9	14.9	8.0	8.9	1.3	14.8	34.4	4.4	17.1	10.3	22.8	0.0	44.9	36.8	12.9	20.1	39.5	0.3	35.9	67.3	25.2	8.4	5.1	0.9	0.0	22.2	22.6	30.3	0.2	26.7	3.1	11.5	89.5	13.6	0.0	7.9	0.8	4.8	0.1	0.9	11.6	4.9	31.0	11.7	16.0	44.5	0.7	0.1	0.0	10.4	21.3	0.1	0.1	14.5	0.1	17.2	5.4	13.5	0.2	56.2	0.6	14.1	20.9	11.8	1.8	0.0	24.1	13.7	1.2	42.3	22.8	4.1	104.3	14.9	0.5	0.0	0.3	57.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	25.5	7.3	12.7	8.6	7.9	9.2	9.0	10.7	9.4	8.9	22.8	22.8	16.0	7.0	17.3	0.3	2.8	1.2	0.4	1.2	9.2	1.0	1.3	15.0	1.5	4.5	3.7	158.4	2.7	0.1	0.1	0.0	4.6	29.1	15.9	14.2	30.1	0.0	0.0	57.5	4.9	0.6	20.6	4.1	4.7	0.0	1.6	40.0	1.3	1.3	1.7	29.9	0.6	0.0	2.5	4.7	61.3	7.2	1.9	7.2	69.3	0.6	8.8	1.0	17.6	61.8	0.8	0.0	6.0	1.2	1.4	0.0	2.5	11.8	113.6	0.0	20.8	8.7	4.8	11.3	0.4	4.0	2.9	0.7	1.2	0.0	0.7
EML2	"ELP70, EMAP-2, EMAP2"	ENSG00000125746	"EMAP like 2"	O95834	19	45606994-45645602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 153.1;Syncytiotrophoblasts: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012757	Approved		Approved	Vesicles		NA	NA		180000	"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA012757: AB_1848145"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.48e-2)"	"unprognostic (7.03e-2)"	11.2	32.7	23.2	13.6	41.7	14.1	12.9	43.2	37.6	16.4	9.7	21.3	11.5	9.1	6.8	40.2	12.0	10.9	20.4	19.5	36.1	17.5	7.9	13.6	13.4	57.6	35.4	5.2	21.1	55.1	14.3	19.8	52.8	15.8	14.4	49.0	29.0	18.3	5.7	38.6	11.9	7.1	27.9	12.9	18.9	3.5	40.3	16.5	20.9	4.9	12.5	19.5	24.9	57.9	47.6	16.2	3.2	1.1	25.0	13.6	17.4	29.2	37.0	12.6	14.8	6.2	39.5	14.6	17.0	15.4	4.0	39.7	6.0	57.4	4.0	56.7	15.0	5.7	19.5	12.4	47.1	18.5	13.4	21.1	74.5	15.1	74.1	10.5	9.4	28.0	18.3	38.5	10.0	49.9	10.3	4.2	1.9	75.7	14.3	2.3	5.6	18.9	33.3	61.2	17.8	3.3	16.4	32.0	22.1	17.0	18.7	18.9	15.1	0.0	5.4	4.8	0.3	66.2	43.9	7.9	20.4	20.9	38.7	7.8	3.7	5.7	6.5	4.8	5.1	5.5	4.4	6.7	4.4	2.2	2.9	3.9	1.0	2.6	5.2	6.4	5.8	3.9	23.2	41.7	43.2	37.6	19.5	36.1	57.6	35.4	52.8	27.9	40.3	57.9	10.6	3.2	13.1	8.5	15.7	18.6	42.9	40.3	27.3	32.2	13.2	14.2	9.0	14.3	25.5	35.0	14.6	66.4	24.5	34.1	37.2	16.8	72.1	28.6	9.0	13.8	17.5	5.5	29.7	20.8	20.4	7.6	38.7	20.1	19.1	6.7	20.3	6.4	15.8	28.6	46.0	32.6	26.4	8.8	9.6	27.0	4.1	8.7	19.6	5.6	13.1	16.4	12.3	15.1	68.0	17.9	29.1	7.2	25.0	23.7	11.0	7.5	40.7	153.1	0.0	6.8	16.4	3.5	6.1	29.6	14.3	101.0	23.2	39.1	31.9	41.9
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"EMAP like 4"	Q9HC35	2	42169353-42332548	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	Microtubules,Cytosol		NA	NA		25000	"Cluster 13: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Microtubules	Cytosol	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.2	13.7	1.5	32.4	2.5	41.1	14.1	1.0	1.4	11.7	3.9	23.6	38.8	11.1	4.6	11.1	9.9	19.9	4.6	1.6	1.0	19.4	38.1	24.3	28.3	2.2	1.6	8.9	24.3	13.8	4.3	35.6	1.6	9.7	23.7	10.3	21.0	8.0	2.4	18.3	36.5	14.1	2.0	28.3	20.9	20.4	3.7	14.9	21.5	3.9	30.0	27.3	5.7	2.8	45.1	76.7	43.7	34.9	15.6	25.4	47.7	27.3	21.4	29.7	28.5	80.8	55.1	41.1	18.5	26.9	45.6	22.7	38.0	26.3	51.3	80.8	31.8	37.7	23.5	186.3	19.7	28.8	37.1	27.9	9.8	39.4	26.5	14.4	20.9	14.0	37.9	40.3	32.5	26.4	27.3	7.7	44.8	57.8	21.9	27.8	69.2	24.3	24.2	64.3	42.9	86.3	26.9	27.7	20.8	39.6	14.4	11.4	24.6	30.1	39.9	24.3	24.9	44.9	33.3	34.6	26.3	27.0	21.6	5.6	4.7	9.9	9.0	13.7	19.0	13.9	15.0	14.8	4.1	9.1	12.8	9.6	12.3	11.9	14.6	5.3	22.3	7.6	1.5	2.5	1.0	1.4	1.6	1.0	2.2	1.6	1.6	2.0	3.7	2.8	47.0	60.9	107.3	37.9	137.6	67.3	74.3	60.5	75.1	35.1	53.5	45.7	7.0	51.5	60.9	40.5	47.9	143.0	120.8	57.0	17.6	34.0	33.1	33.4	50.1	50.8	102.3	20.8	54.2	75.4	47.5	55.3	76.0	86.6	48.1	80.7	43.9	61.9	65.6	16.8	60.0	69.3	34.6	40.3	56.6	31.0	23.9	74.8	16.0	119.9	38.4	35.1	47.4	62.8	32.9	38.1	58.9	23.0	139.5	65.4	51.3	41.3	28.6	47.3	6.6	25.0	47.6	46.5	39.4	73.4	79.7	118.9	223.8	42.0	85.0	96.4
EML5	"EMAP-2, FAP16, HuEMAP-2"	ENSG00000165521	"EMAP like 5"	Q05BV3	14	88612431-88792752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;ovary: 17.4;retina: 9.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Excitatory neurons: 79.5;Granulosa cells: 98.7;Inhibitory neurons: 106.8;Oligodendrocyte precursor cells: 98.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 17.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.5;SH-SY5Y: 23.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 41.5"	"HPA054019, HPA055379"	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA054019: AB_2682345, HPA055379: AB_2682799"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.53e-3)"	0.4	3.8	3.3	0.7	2.8	0.3	0.8	17.7	2.8	0.7	0.0	1.3	0.2	0.4	0.2	0.8	1.1	0.1	0.2	3.4	2.4	1.4	1.6	0.6	0.2	0.5	5.5	17.4	0.9	2.4	3.9	0.0	1.5	4.4	0.3	9.5	0.8	0.2	0.1	0.5	0.8	0.2	0.3	0.9	0.6	2.7	2.7	0.7	1.6	0.1	0.6	0.8	0.5	1.1	1.3	0.5	0.0	1.0	0.0	0.0	2.6	0.4	0.3	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.2	3.5	4.1	0.1	0.1	2.2	2.2	1.1	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.5	11.5	0.1	1.2	2.9	0.0	0.2	0.4	1.0	1.4	0.0	0.4	0.1	3.1	3.9	23.8	1.1	1.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.7	4.7	1.0	3.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.8	17.7	2.8	3.4	2.4	0.5	5.5	1.5	0.3	2.7	1.1	0.2	0.0	5.8	31.3	3.5	0.5	1.0	0.0	0.6	28.2	2.0	0.9	1.5	1.5	1.3	0.0	60.5	0.2	0.7	1.2	0.0	0.9	3.1	2.0	1.2	0.8	10.7	2.1	79.5	0.4	0.1	1.2	3.1	1.9	1.3	98.7	0.0	0.1	0.0	20.2	106.8	0.3	0.0	0.0	0.0	2.9	0.6	0.3	3.6	17.8	0.2	3.6	0.0	98.0	34.5	0.3	1.1	1.2	4.5	5.7	0.0	0.4	4.6	30.1	0.0	1.9	7.4	13.6	8.1	1.5	0.4	0.1	1.7	5.1	0.1	0.6
EML6	FLJ42562	ENSG00000214595	"EMAP like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.3;retina: 13.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.0;Excitatory neurons: 372.7;Inhibitory neurons: 265.1;Oligodendrocyte precursor cells: 95.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 10.9;SCLC-21H: 34.0;U-698: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Vesicles	"HPA062808: AB_2684872, HPA068759: AB_2686027"	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.3	3.0	1.6	4.0	1.8	0.7	0.7	1.4	3.8	0.2	0.2	0.7	0.7	0.3	1.1	0.5	0.4	0.2	0.1	2.2	2.1	1.7	0.5	0.4	7.0	1.3	1.4	0.1	0.8	1.9	3.2	1.4	1.3	0.6	0.8	13.9	0.5	0.5	1.0	0.9	2.0	0.4	0.6	2.6	0.5	1.3	1.4	0.6	2.6	0.5	10.3	0.6	0.4	2.9	0.7	2.0	0.2	1.5	1.0	0.3	2.0	0.2	0.3	0.2	0.2	0.8	0.3	10.9	0.2	0.7	0.4	0.3	1.4	0.5	0.4	1.0	0.4	0.6	0.9	5.1	0.0	0.3	0.0	0.1	0.1	0.6	1.1	0.2	0.2	6.2	0.0	2.0	0.0	1.1	2.1	0.4	0.5	0.2	2.3	0.9	0.7	0.8	0.1	1.4	34.0	4.2	0.5	0.1	0.0	0.2	0.1	0.1	0.3	0.4	2.1	0.5	0.6	7.8	2.2	35.0	1.8	3.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	1.4	3.8	2.2	2.1	1.3	1.4	1.3	0.6	1.4	2.9	0.9	0.0	1.1	145.0	7.3	3.7	1.9	0.6	1.8	28.0	1.1	0.8	2.0	0.0	3.5	3.7	56.3	0.4	0.4	0.5	0.0	0.2	24.6	2.9	0.6	1.3	2.4	0.0	372.7	0.4	0.6	1.0	2.0	1.2	0.0	0.8	1.4	0.6	1.3	38.7	265.1	3.6	0.0	1.0	2.3	11.2	0.6	0.6	0.0	19.7	0.0	14.3	1.0	95.5	30.2	0.1	0.1	0.7	8.4	1.6	1.1	0.7	7.0	32.7	0.0	2.2	1.5	5.1	2.6	0.6	4.4	0.1	0.8	0.9	0.4	2.3
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.0;epididymis: 104.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	10.4	0.1	23.2	0.2	25.6	0.2	2.8	16.9	31.3	58.2	16.7	0.4	0.1	79.0	104.3	0.4	53.0	1.5	0.8	26.9	16.5	39.1	0.1	0.1	0.6	15.8	18.0	11.9	0.0	0.1	1.8	0.4	16.4	1.1	0.1	0.3	2.4	52.6	10.8	10.5	0.1	45.0	14.7	0.2	0.1	1.2	19.6	0.1	0.3	5.2	0.4	4.7	4.4	22.9	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	23.2	25.6	16.9	31.3	26.9	16.5	15.8	18.0	16.4	14.7	19.6	22.9	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		15000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	26.3	20.2	30.3	16.5	25.9	0.5	13.4	21.1	20.3	13.5	2.0	30.9	12.5	23.6	13.7	16.2	15.0	23.6	25.2	27.2	35.7	7.0	7.5	17.3	4.7	35.5	34.2	22.6	22.3	17.9	6.5	18.2	28.1	21.4	10.1	8.1	20.9	30.6	20.4	10.6	10.8	57.6	22.4	24.8	23.3	25.0	40.9	9.0	7.3	11.5	4.6	30.1	13.8	28.7	91.6	71.9	87.1	79.0	33.3	43.7	111.9	99.1	47.3	58.4	43.9	46.4	33.0	38.7	256.8	153.9	52.5	79.0	102.7	37.4	55.2	0.6	63.4	40.3	62.4	63.1	99.4	4.8	1.5	67.9	44.2	75.9	96.2	47.8	47.0	10.7	2.7	1.9	58.6	17.7	18.5	4.7	146.8	23.9	64.3	27.6	122.9	1.1	26.9	69.5	85.3	68.9	194.6	73.3	63.3	66.1	87.5	5.9	92.2	150.4	109.8	126.8	198.6	4.2	11.4	25.7	82.7	5.0	78.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.3	25.9	21.1	20.3	27.2	35.7	35.5	34.2	28.1	22.4	40.9	28.7	117.0	12.8	37.3	81.9	3.8	129.0	172.5	64.4	26.2	11.2	96.2	57.9	119.3	54.3	56.5	22.0	62.6	65.0	1.7	14.8	3.9	84.7	74.8	127.2	60.5	79.3	41.4	0.0	86.3	100.5	18.5	71.6	63.2	75.0	5.1	194.2	23.9	12.9	11.2	16.8	155.0	27.3	26.4	1.6	29.7	24.3	58.1	4.3	83.6	41.2	3.8	32.6	3.1	160.4	151.3	61.5	16.5	168.9	1.6	133.1	3.5	19.6	137.8	19.0	92.1	69.4	166.1	13.4	37.2	25.6	134.1	60.5	4.8	220.7	31.3	100.3
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089846-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	21.9	17.3	32.6	10.7	56.4	5.8	16.7	48.0	38.5	22.2	12.8	34.7	10.8	17.6	15.1	24.7	18.5	15.8	13.1	30.3	43.2	24.3	5.9	13.9	10.2	48.2	49.9	14.6	5.7	36.3	14.9	15.9	55.8	47.5	38.6	3.4	17.1	28.3	52.3	30.1	19.4	20.8	43.4	32.5	10.3	10.3	47.4	4.0	16.2	34.7	8.8	13.6	23.4	77.9	3.7	5.8	7.0	4.3	194.4	61.9	29.3	27.2	6.0	7.2	7.4	28.3	48.8	26.4	32.7	21.7	16.0	36.0	6.9	37.3	2.8	21.3	5.2	57.4	2.6	12.1	21.3	10.7	71.0	56.3	47.6	4.1	13.3	48.5	24.9	24.8	11.8	16.7	26.8	9.9	4.5	0.4	1.6	41.2	18.2	19.5	0.0	11.1	21.0	30.6	3.7	2.9	11.5	11.4	21.2	9.6	11.6	2.9	17.9	38.6	11.3	26.1	11.7	13.8	11.0	2.2	11.7	5.6	87.8	1.2	0.8	0.6	3.6	2.2	3.4	4.6	2.3	3.1	1.9	4.7	1.9	2.3	0.4	2.2	3.9	0.8	1.5	4.2	32.6	56.4	48.0	38.5	30.3	43.2	48.2	49.9	55.8	43.4	47.4	77.9	34.1	9.6	19.4	22.9	15.6	8.0	18.9	14.9	7.4	2.4	8.4	15.9	10.9	20.0	16.2	11.0	0.0	3.6	9.9	99.5	1.9	5.5	2.7	7.1	13.8	32.4	16.2	29.9	24.9	8.9	7.8	16.9	10.2	22.9	14.5	93.4	43.2	3.9	3.1	0.0	30.2	22.2	8.2	3.4	4.9	4.4	10.2	15.6	28.4	16.9	4.3	2.2	23.7	19.1	122.9	7.9	44.5	15.1	3.3	17.7	26.9	9.2	5.8	0.8	39.5	15.9	34.5	0.4	2.5	27.8	12.5	12.4	8.8	18.5	21.0	8.8
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818500-128822676	"Plasma proteins, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 111.4;Late spermatids: 147.4;Respiratory ciliated cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	11.2	18.8	19.7	2.9	20.0	4.4	11.9	23.7	25.1	9.3	27.0	16.8	12.5	9.3	1.8	17.5	12.6	1.7	52.2	20.1	22.5	24.3	52.9	9.9	3.3	23.4	20.8	8.1	22.5	12.0	13.7	3.6	19.5	14.9	5.7	2.0	14.9	7.0	135.2	13.6	11.5	3.0	20.3	9.2	18.4	20.6	22.6	3.8	11.9	59.1	3.1	11.8	11.0	22.9	14.2	15.3	3.9	20.7	10.0	8.5	17.5	13.4	6.9	12.4	8.6	9.3	11.2	4.6	11.9	8.8	7.7	39.6	12.5	11.8	2.2	9.0	22.4	8.0	14.6	16.7	4.5	24.8	29.3	8.9	14.1	7.5	5.1	7.6	9.6	15.2	25.4	7.1	7.9	20.9	19.4	51.1	9.7	24.6	56.4	22.9	4.5	48.2	18.8	5.1	34.0	33.8	30.0	27.2	7.4	2.6	26.1	12.2	9.8	8.7	5.2	12.5	10.2	22.2	3.3	8.9	17.5	17.6	9.1	0.0	1.1	0.7	1.3	2.0	1.2	1.5	1.3	0.6	1.8	2.8	1.2	1.4	0.0	1.3	0.9	3.6	0.6	0.6	19.7	20.0	23.7	25.1	20.1	22.5	23.4	20.8	19.5	20.3	22.6	22.9	19.0	9.6	5.5	13.1	11.4	8.8	26.9	12.8	6.2	14.0	28.7	21.7	0.6	20.0	16.8	23.9	4.2	31.9	26.9	55.1	101.8	6.0	97.1	111.4	15.1	9.3	14.4	16.8	4.6	7.9	34.4	14.9	21.4	30.1	1.3	93.0	10.0	80.3	20.0	11.8	8.3	27.2	18.3	17.7	7.7	147.4	18.6	15.6	10.6	4.7	6.4	37.2	10.3	3.0	7.8	7.8	24.1	18.8	11.0	18.4	52.0	108.2	115.1	13.1	6.6	23.7	19.0	74.9	6.6	19.1	14.5	10.1	14.5	44.5	36.6	23.3
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 82.9;vagina: 31.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.9;Glandular and luminal cells: 9.6;Squamous epithelial cells: 5.2;Suprabasal keratinocytes: 9.1;Syncytiotrophoblasts: 34.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;SK-BR-3: 4.9;SuSa: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"	NA	NA		14000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	1.8	0.1	2.5	0.1	2.8	0.2	1.7	2.6	3.1	19.5	1.8	0.7	0.1	0.5	1.0	82.9	0.9	0.5	0.6	2.8	2.1	1.1	0.1	0.7	0.3	2.5	2.6	1.8	0.2	0.0	0.5	2.5	2.7	0.4	0.1	0.1	23.2	0.2	0.5	21.1	0.4	0.5	2.2	0.3	0.6	0.3	2.7	0.1	0.9	0.1	8.8	0.7	31.0	2.3	0.0	0.0	0.0	0.0	0.3	1.1	0.7	0.2	0.9	0.8	0.7	0.1	0.0	2.2	0.5	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	4.6	0.1	0.0	0.1	0.2	0.0	0.6	0.1	1.2	1.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.8	2.6	3.1	2.8	2.1	2.5	2.6	2.7	2.2	2.7	2.3	6.9	0.0	0.0	2.0	0.1	1.7	0.2	0.0	0.0	0.2	0.4	0.4	1.2	0.0	0.7	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.1	2.4	0.8	3.5	0.0	0.0	0.1	0.0	1.0	0.8	0.0	9.6	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.5	0.1	3.6	1.0	0.1	0.1	0.0	0.5	0.5	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.2	0.0	0.0	5.2	9.1	34.3	0.0	0.2	0.0	0.1
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074824-79088599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	9.3	8.4	8.4	8.2	9.4	7.2	9.1	8.6	11.5	11.9	10.2	14.5	14.3	9.6	2.0	5.4	10.7	5.9	9.1	8.3	9.9	7.6	8.8	9.4	9.2	10.0	10.7	13.7	7.9	6.7	7.1	5.6	10.1	10.8	9.2	6.1	9.1	4.3	24.0	9.6	14.9	5.2	8.4	20.0	11.0	3.4	11.0	7.2	11.8	10.4	5.8	11.6	9.5	12.3	6.3	12.8	5.7	10.0	4.4	2.5	9.6	5.6	3.5	4.6	3.9	7.2	6.4	0.0	5.9	5.1	6.2	9.7	7.2	5.4	2.3	4.3	12.5	5.9	14.8	4.2	4.2	6.7	11.2	5.8	7.9	3.4	3.3	7.8	4.9	14.7	9.1	3.6	2.5	5.1	0.6	7.3	2.7	15.4	12.1	12.7	16.8	5.3	2.4	16.4	4.2	9.2	7.3	33.5	4.2	6.8	10.8	7.8	6.4	6.8	6.1	6.4	4.4	10.9	1.9	2.9	4.0	13.6	5.1	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.7	0.1	8.4	9.4	8.6	11.5	8.3	9.9	10.0	10.7	10.1	8.4	11.0	12.3	6.9	0.0	16.0	18.3	6.1	4.5	5.6	3.4	3.4	11.1	7.5	7.4	6.3	5.7	5.7	11.0	35.5	5.3	7.1	23.3	0.0	4.2	1.8	3.9	6.3	7.6	26.2	3.8	5.4	4.3	5.4	6.7	18.8	4.8	5.1	11.5	8.2	11.5	8.6	8.4	10.1	18.6	0.0	13.2	9.8	1.3	3.4	15.5	0.0	14.0	8.8	5.3	6.2	3.5	11.0	2.5	10.7	1.9	5.7	5.3	16.5	2.9	2.9	24.5	13.1	7.9	8.3	1.9	1.6	4.1	5.8	6.7	7.4	7.5	27.5	4.4
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521043-34522990	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	16	"brain: 475.8;choroid plexus: 256.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.2;Muller glia cells: 145.1;Oligodendrocyte precursor cells: 28.6"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"myeloid DC: 28.1"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 28.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.7;NTERA-2: 22.9;SCLC-21H: 11.6;SH-SY5Y: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted in brain"	NA	NA	4240000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"			"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	0.8	385.2	0.9	422.3	0.8	4.4	360.6	475.8	2.0	256.0	5.9	2.2	0.4	0.2	0.4	2.8	0.7	2.1	344.8	364.6	1.0	23.5	1.5	0.3	400.8	408.7	0.6	1.6	2.3	11.4	0.1	373.1	8.9	2.3	5.7	1.7	0.5	1.0	5.5	4.7	0.2	380.4	0.6	5.5	16.0	459.9	0.2	0.5	0.5	0.2	1.3	1.5	321.5	0.2	1.2	6.5	16.7	0.2	0.0	0.4	0.0	0.0	2.6	2.7	0.7	0.3	2.9	4.5	0.0	5.3	0.2	7.6	0.5	0.6	0.4	7.4	0.0	0.1	1.6	0.2	0.0	3.6	0.0	0.1	0.0	0.3	0.0	0.0	5.4	0.0	2.4	0.6	0.4	0.0	0.0	22.9	1.2	4.7	0.1	0.1	0.4	0.6	0.0	11.6	11.0	0.9	5.2	0.6	0.8	0.3	2.2	0.0	0.5	2.4	0.1	0.1	1.4	1.7	0.1	0.6	0.0	3.9	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	3.6	1.0	1.5	0.0	0.7	385.2	422.3	360.6	475.8	344.8	364.6	400.8	408.7	373.1	380.4	459.9	321.5	0.2	0.0	0.5	71.2	0.3	2.8	2.3	0.0	0.0	4.6	12.0	11.7	0.7	1.5	0.1	0.0	2.1	0.2	0.3	0.0	0.0	0.8	1.0	0.2	7.0	0.7	1.8	1.7	6.4	0.2	0.4	15.5	1.1	0.1	0.0	2.3	1.1	4.8	2.9	5.0	13.6	0.0	0.0	1.0	9.3	5.4	0.3	8.3	1.8	3.7	7.8	145.1	0.0	28.6	7.2	0.0	15.0	0.4	0.0	8.4	0.3	0.5	0.0	4.1	0.0	0.4	0.8	0.7	14.9	0.1	3.1	0.0	0.7	0.1	0.4	0.7
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
ENKUR	"C10orf63, CFAP106, enkurin, MGC26778"	ENSG00000151023	"Enkurin, TRPC channel interacting protein"	Q8TC29	10	24981979-25062279	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;choroid plexus: 13.6;fallopian tube: 43.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 73.9;Endometrial ciliated cells: 143.5;Respiratory ciliated cells: 288.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.1;glioma: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.5;CAPAN-2: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037593, HPA037594, HPA061503"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543"	"unprognostic (2.33e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.69e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-6)"	"unprognostic (3.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.43e-3)"	0.1	0.4	8.7	0.5	8.3	0.4	0.1	9.8	9.1	1.4	13.6	0.3	1.3	1.6	0.2	0.0	43.6	0.3	0.1	9.1	12.6	0.4	0.7	4.4	0.0	14.2	14.4	0.2	0.0	0.0	5.5	0.6	13.8	0.1	0.1	1.9	0.1	0.0	0.2	0.1	1.5	0.2	12.0	0.3	0.3	6.9	9.7	0.1	0.5	0.1	0.1	0.0	0.0	12.4	0.1	0.4	0.4	1.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.7	0.2	0.3	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.8	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.3	0.0	6.2	8.7	8.3	9.8	9.1	9.1	12.6	14.2	14.4	13.8	12.0	9.7	12.4	0.2	0.0	1.1	19.2	0.6	0.0	0.7	10.7	0.0	0.3	0.1	0.4	0.3	0.0	27.3	1.8	0.0	0.4	0.2	4.0	0.0	2.5	73.9	143.5	2.3	1.0	2.4	0.0	8.1	5.1	1.8	1.4	3.6	1.8	1.3	0.3	0.0	0.2	0.0	0.0	3.3	0.6	8.2	0.0	0.0	12.6	1.2	25.0	0.0	2.8	2.0	18.7	4.1	2.0	3.1	11.2	0.1	0.7	0.0	0.7	2.0	0.9	288.8	1.6	0.0	0.7	2.9	35.8	4.9	0.0	0.1	0.3	0.3	0.7	0.5	0.2
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879190	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394, CAB080034"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		310000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	463.4	418.4	552.9	553.3	591.7	792.8	409.1	679.7	749.9	370.7	585.6	382.6	401.2	321.7	125.7	1049.4	281.6	302.0	328.2	638.1	599.6	1063.6	612.2	453.2	492.4	624.1	607.7	295.0	220.8	347.2	245.7	362.7	602.9	279.2	358.3	741.5	581.3	354.2	231.0	548.1	382.3	471.3	583.4	394.9	321.6	217.7	585.3	455.6	271.4	146.5	695.4	485.9	519.7	571.5	3637.0	3088.4	1461.8	1258.6	1194.2	1323.8	1316.6	1919.1	2110.9	4044.1	3767.4	1986.9	2041.5	2586.5	2496.8	2328.5	1651.8	1736.8	2511.5	5127.7	4081.0	1780.5	2645.9	2191.3	2848.0	2511.0	1789.6	4421.6	1290.1	1377.4	1526.1	3208.9	4825.9	3045.2	2630.1	1294.6	2444.4	982.3	2664.2	1784.1	1685.2	2354.5	1600.3	1290.4	3063.4	1712.4	2172.9	4259.0	4815.0	843.6	1961.4	1211.1	2251.0	3232.5	2407.8	1748.4	1621.8	1302.1	2424.7	2774.5	2444.5	2402.3	3328.3	2771.0	2120.4	3906.9	4313.8	3556.1	2388.6	195.9	1198.7	232.3	528.4	822.7	597.3	411.2	552.5	543.2	1216.4	386.1	443.4	466.0	230.6	635.3	830.6	336.1	700.0	2171.2	552.9	591.7	679.7	749.9	638.1	599.6	624.1	607.7	602.9	583.4	585.3	571.5	140.0	278.9	499.1	99.6	222.3	416.5	570.9	1939.8	348.8	178.2	242.7	324.6	69.6	283.1	657.4	606.9	70.9	1045.4	194.0	455.9	925.4	2259.3	281.3	205.3	227.7	314.3	189.0	145.4	32.0	1399.1	2078.5	303.5	144.8	248.4	297.2	408.6	133.5	351.7	1147.4	482.9	33.2	297.3	787.3	356.4	524.5	699.6	171.5	454.2	448.2	30.9	1558.2	2624.9	279.1	28.6	26.9	1433.6	366.9	135.1	211.0	555.7	742.2	1005.4	245.7	216.6	151.2	156.1	402.5	215.1	154.3	468.1	349.6	1001.8	285.6	609.8	528.4	444.2
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 1695.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5"	"Group enriched"	"Detected in many"	7	"B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 537.4;U-87 MG: 398.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		55000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	25.6	46.7	280.8	20.0	289.7	9.6	20.2	291.2	400.7	55.9	97.5	74.0	10.2	40.1	12.6	15.3	40.2	17.9	53.7	295.0	289.4	27.8	7.7	33.8	26.3	289.4	189.9	29.7	9.0	43.6	124.4	10.4	282.2	34.9	15.5	1695.6	13.8	34.4	7.4	19.3	37.1	35.0	164.3	26.4	30.4	9.6	259.0	26.7	42.0	6.4	24.4	57.4	44.1	306.2	74.3	45.3	16.2	0.5	23.7	26.0	1.5	56.5	37.3	82.0	125.9	8.6	5.8	103.9	9.5	24.3	108.8	11.0	173.0	15.4	116.1	211.9	16.6	141.0	47.7	60.3	17.4	8.3	161.2	13.0	0.7	61.1	11.5	537.4	17.5	137.9	9.5	1.1	56.3	10.3	66.9	8.8	84.9	31.7	27.2	75.0	13.9	22.9	38.5	9.8	128.3	94.0	14.3	1.0	96.3	76.4	4.5	3.9	20.9	69.4	73.7	95.7	73.0	73.3	79.5	15.4	398.4	0.3	15.2	2.1	0.0	0.2	9.9	0.0	11.3	6.8	13.1	11.4	0.1	4.4	8.2	8.6	7.0	0.4	0.3	1.2	7.5	6.1	280.8	289.7	291.2	400.7	295.0	289.4	289.4	189.9	282.2	164.3	259.0	306.2	3.2	35.3	27.4	54.2	11.2	6.2	2.3	45.2	1.8	318.2	5.2	4.3	16.1	1.5	17.2	12.9	312.8	0.3	7.5	0.3	0.0	17.0	0.5	9.6	2.1	9.9	23.9	7.0	96.2	1.8	1.1	8.3	2.0	2.7	67.2	1.0	5.3	0.2	1.7	429.0	89.4	0.5	18.3	0.6	6.9	0.3	5.6	5.9	12.4	25.3	3.5	146.1	0.0	23.6	31.5	9.3	1.2	9.8	9.2	2.5	0.1	0.2	32.2	787.2	13.1	8.1	20.2	1.5	2.5	1.1	2.3	0.3	17.1	0.3	0.4	2.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase 4"	A6NNW6	10	116849499-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;choroid plexus: 4.7;fallopian tube: 5.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.2	0.3	1.7	0.0	5.3	0.0	0.4	1.7	3.4	0.4	4.7	0.3	0.0	0.6	1.3	0.1	5.0	0.3	0.1	2.1	2.6	0.6	1.3	0.6	0.1	4.8	4.5	0.5	0.6	1.0	1.0	0.0	3.5	0.3	0.1	2.0	0.2	0.4	0.0	0.2	0.2	0.2	2.6	0.2	0.3	2.5	4.0	0.1	0.7	0.0	0.0	0.1	0.2	11.5	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	5.3	1.7	3.4	2.1	2.6	4.8	4.5	3.5	2.6	4.0	11.5	0.0	0.0	0.0	16.3	0.0	0.1	0.3	0.8	0.6	4.9	0.4	0.3	0.3	0.0	0.4	0.0	22.9	0.3	0.0	0.2	0.0	0.5	15.5	15.8	0.7	0.1	1.8	0.0	12.2	0.2	0.2	0.7	0.0	1.1	0.0	0.5	0.0	0.0	0.0	5.0	18.4	0.0	0.0	0.0	0.6	15.8	1.2	0.2	0.0	8.4	0.6	1.3	0.0	4.5	62.4	0.2	0.1	0.7	0.0	0.1	0.3	0.8	30.2	8.4	0.0	1.0	0.5	9.4	2.9	0.1	0.0	0.1	0.0	1.0	0.3	0.1
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENOSF1	"FUCD, HSRTSBETA, rTS, TYMSAS"	ENSG00000132199	"Enolase superfamily member 1"	Q7L5Y1	18	670318-712662	"Enzymes, Predicted intracellular proteins"		"Isomerase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 216.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA047829	Enhanced					NA	NA		7300	"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA047829: AB_2680170"	"prognostic favorable (2.27e-4)"	"unprognostic (8.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.44e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-2)"	8.4	25.0	3.1	3.2	4.4	7.7	9.3	3.3	7.2	10.0	5.5	12.0	5.5	6.6	2.1	12.0	10.6	3.2	11.0	2.9	4.2	28.0	29.3	8.1	2.8	3.8	3.4	8.6	15.8	5.0	11.3	4.0	3.7	13.3	3.9	5.9	14.9	2.5	5.0	7.5	11.0	2.3	3.2	9.5	14.6	5.3	4.0	3.2	18.6	1.6	1.9	9.0	8.1	5.3	3.5	9.6	6.0	5.8	1.6	2.1	5.2	4.9	5.4	1.0	3.6	10.6	10.5	3.8	1.8	0.8	4.1	4.1	8.0	3.7	2.2	2.6	4.4	7.2	12.0	5.4	6.9	11.8	3.2	3.2	8.5	1.7	5.7	1.7	5.7	10.5	6.2	9.6	2.0	8.8	13.8	7.3	2.6	13.1	5.0	4.7	2.2	12.7	5.3	14.0	7.6	3.1	7.7	8.4	2.7	2.2	3.2	14.2	2.9	2.8	5.4	5.5	2.6	14.0	15.2	8.1	12.8	8.3	2.6	0.0	0.5	1.4	3.5	1.6	2.7	0.8	2.3	1.9	0.8	0.5	3.3	3.4	0.1	1.2	0.6	2.4	1.7	0.9	3.1	4.4	3.3	7.2	2.9	4.2	3.8	3.4	3.7	3.2	4.0	5.3	17.9	35.3	99.5	36.9	10.1	11.9	29.5	29.6	24.5	35.2	38.4	36.4	19.6	28.6	44.7	47.8	116.7	44.6	25.6	36.7	115.4	32.4	7.0	61.6	32.2	19.6	24.7	73.2	4.2	14.4	27.7	26.5	61.2	40.1	22.2	26.2	23.9	56.6	39.1	0.0	7.6	36.0	38.7	12.6	8.8	6.8	23.6	20.9	19.6	30.0	12.1	30.9	24.7	38.2	143.6	21.9	36.2	28.2	25.2	25.9	50.9	216.9	78.3	98.8	13.1	38.7	15.8	14.7	29.3	39.8	12.1	37.8	22.0	67.8	49.4	20.8
ENOX1	"cCNOX, CNOX, FLJ10094, PIG38"	ENSG00000120658	"Ecto-NOX disulfide-thiol exchanger 1"	Q8TC92	13	43213518-43786908	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.3;Early spermatids: 190.8;Excitatory neurons: 452.3;Inhibitory neurons: 692.0;Late spermatids: 264.8;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 771.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.3;RH-30: 24.1;TIME: 17.8;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038355	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA038355: AB_10673171"	"unprognostic (9.64e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.42e-2)"	3.4	1.0	7.8	2.5	12.5	0.3	1.8	4.6	9.2	3.3	0.4	8.5	0.6	5.0	0.9	1.0	2.7	1.6	4.7	7.7	7.9	3.5	0.4	0.9	2.2	10.0	6.9	6.4	1.3	0.7	1.9	4.4	10.3	3.0	1.5	2.0	0.4	3.7	8.1	0.5	1.4	4.2	7.4	0.7	2.3	9.0	8.9	2.8	0.4	0.7	1.4	3.1	2.1	14.1	0.2	0.3	3.4	0.0	3.4	13.2	0.7	1.6	3.8	5.7	5.4	2.4	0.4	0.0	0.2	5.1	0.6	0.1	0.7	0.4	2.5	4.2	5.6	0.7	4.0	0.1	2.1	0.1	0.9	12.7	1.2	17.3	8.7	0.9	0.4	2.8	0.0	0.8	3.5	0.3	5.9	0.2	3.8	0.1	1.5	0.0	24.1	0.0	3.0	0.7	11.8	4.5	2.1	3.5	0.9	2.6	0.7	0.1	17.8	1.9	0.6	17.9	1.9	0.0	0.1	0.1	8.3	0.0	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	12.5	4.6	9.2	7.7	7.9	10.0	6.9	10.3	7.4	8.9	14.1	1.5	3.2	0.0	173.3	0.0	0.6	1.3	0.0	2.2	4.3	1.2	0.6	3.0	0.0	2.5	0.0	0.0	0.1	0.0	0.1	5.9	0.6	190.8	0.1	1.9	0.4	0.0	0.0	452.3	0.4	0.0	2.5	0.0	0.1	0.0	2.3	0.0	0.0	0.2	1.7	692.0	0.0	0.0	0.0	1.8	264.8	12.2	0.4	0.0	15.0	0.0	0.3	0.0	167.9	771.1	0.1	0.0	4.5	0.0	2.7	0.0	1.1	5.3	0.4	6.6	6.1	5.1	3.8	7.3	0.3	0.3	0.3	0.1	12.3	0.0	0.5
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130622325-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	6.4	7.6	6.4	5.6	9.2	3.3	6.4	5.5	6.9	6.9	5.0	4.9	4.1	8.8	5.4	7.2	7.6	6.6	10.8	6.1	8.0	4.3	5.4	5.1	8.2	7.5	6.7	7.9	3.8	7.8	1.7	5.9	6.4	6.1	5.3	2.8	4.6	8.0	6.7	4.4	4.7	8.2	6.2	7.3	5.6	5.9	7.6	8.6	6.3	8.3	9.5	6.9	3.0	9.2	15.7	12.9	16.2	7.4	15.3	13.2	7.3	12.6	15.3	8.5	5.3	6.0	12.9	11.3	30.1	11.6	11.4	10.9	11.4	13.0	10.7	15.3	12.1	24.6	7.4	6.6	10.6	20.2	16.6	10.7	19.3	10.1	11.3	4.0	12.8	9.9	17.1	8.6	7.0	21.4	13.2	3.7	9.0	20.8	16.0	8.7	10.4	12.9	10.0	10.5	5.5	9.6	12.2	7.2	17.0	6.1	4.6	10.1	10.5	8.3	4.9	13.2	26.4	9.2	4.9	7.6	23.6	19.2	13.8	7.0	11.1	12.9	9.4	14.1	9.6	11.7	10.5	9.7	10.8	11.9	11.2	9.7	1.8	10.8	7.7	5.8	12.4	9.3	6.4	9.2	5.5	6.9	6.1	8.0	7.5	6.7	6.4	6.2	7.6	9.2	11.8	3.2	7.4	15.0	11.5	4.2	6.9	5.1	19.4	4.4	8.1	5.3	13.0	5.7	7.5	3.7	0.0	6.2	7.9	4.9	7.9	8.0	1.0	8.3	13.3	8.6	4.8	11.6	18.7	9.3	5.5	9.7	10.7	5.4	6.3	7.4	7.5	12.3	6.9	3.3	31.2	6.7	14.2	21.3	7.7	2.2	5.6	12.6	8.8	23.4	18.4	4.3	19.6	51.3	132.2	10.1	2.6	6.4	11.9	6.4	4.5	8.4	13.1	8.3	6.6	11.6	9.5	11.4	10.6	13.8	4.8	7.3	11.1	7.6	5.7	5.7
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 383.3;choroid plexus: 753.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	104.7	46.7	98.9	62.0	208.4	2.7	89.7	188.1	150.1	73.6	753.4	32.6	67.5	139.2	20.2	9.0	55.7	39.9	9.9	111.0	133.0	76.6	28.5	42.7	109.8	246.2	164.4	15.2	15.9	20.2	11.8	252.3	244.4	26.4	32.3	6.9	9.9	27.3	8.9	17.5	45.8	85.1	147.8	51.4	26.9	31.3	153.7	20.8	10.8	23.9	85.8	45.1	18.1	383.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	98.9	208.4	188.1	150.1	111.0	133.0	246.2	164.4	244.4	147.8	153.7	383.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129989-46146688	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.9;U-266/84: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	15.1	13.6	11.7	7.3	20.9	38.0	7.8	19.5	19.5	10.3	6.4	12.1	10.9	4.0	11.6	5.1	10.8	8.0	15.1	10.8	16.0	18.4	8.2	20.7	7.7	20.5	19.3	2.1	11.9	22.3	9.0	3.5	19.9	16.4	12.8	12.2	21.3	19.7	22.1	2.3	10.1	7.0	18.5	13.9	14.8	8.3	17.5	8.5	12.5	25.3	6.5	6.8	2.1	30.2	0.1	1.1	0.7	1.5	0.0	0.0	0.1	1.7	1.6	4.0	0.3	1.9	13.4	15.2	12.7	2.1	9.9	0.2	4.1	0.6	0.8	18.5	11.1	8.5	0.0	0.0	0.5	10.5	14.9	2.1	0.0	0.1	0.0	1.1	1.4	10.5	0.0	0.0	1.5	1.8	7.8	1.0	2.7	16.9	0.5	5.9	2.7	5.7	8.3	1.7	18.0	0.0	0.0	2.8	0.0	4.1	7.6	4.3	0.0	0.0	6.7	0.3	11.2	21.9	26.6	5.2	10.3	0.0	1.4	0.0	0.4	0.9	9.2	1.1	5.4	2.8	3.4	6.8	1.5	1.2	3.2	5.8	0.3	4.4	2.6	1.6	1.2	3.0	11.7	20.9	19.5	19.5	10.8	16.0	20.5	19.3	19.9	18.5	17.5	30.2	43.5	76.9	27.0	23.5	11.6	0.9	3.2	2.3	0.6	9.3	11.0	2.4	23.1	14.3	25.4	29.5	14.6	0.5	23.5	27.2	0.0	12.9	18.3	28.8	2.0	16.0	15.7	3.0	26.4	12.2	0.3	8.5	10.7	17.3	15.8	4.5	6.1	8.6	5.8	26.9	19.2	13.8	4.1	24.8	11.0	26.0	1.2	19.0	3.6	6.5	15.2	21.6	34.0	32.2	125.3	9.7	16.1	11.3	10.3	12.6	16.3	12.6	70.6	6.2	0.0	22.1	5.4	9.1	9.8	0.3	0.6	0.3	14.7	3.7	11.3	14.8
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4;kidney: 30.6;ovary: 12.5"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		290000		"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.2	0.3	2.7	0.8	11.8	0.9	0.8	14.2	5.5	0.2	2.3	1.0	1.7	0.2	6.1	1.0	0.3	0.5	0.2	2.7	6.1	30.6	0.1	0.3	0.9	20.4	9.6	12.5	0.0	0.0	4.2	0.1	18.1	2.2	1.0	0.1	0.7	6.1	0.2	0.1	2.2	0.1	12.5	1.0	1.2	2.4	11.1	1.9	0.1	1.3	2.8	0.6	0.3	29.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	2.7	11.8	14.2	5.5	2.7	6.1	20.4	9.6	18.1	12.5	11.1	29.4	0.5	0.0	0.0	5.9	0.1	0.0	0.2	0.9	0.6	0.0	0.1	0.5	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	3.9	1.1	1.0	0.0	0.0	0.5	0.0	0.0	4.3	0.2	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.4	4.1	0.6	1.8	4.7	1.1	0.0	0.0	6.6	119.9	0.0	0.0	35.3	0.5	0.1	0.0	31.3	0.2	0.0	0.0	5.1	0.6	0.1	1.6	0.0	0.0	0.0	0.3	23.9	0.0	0.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730943-79742219	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 104.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		450000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	9.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	11	"U-698: 8664.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	140.5	106.6	151.2	115.1	156.7	219.8	154.9	133.6	188.2	145.2	132.6	135.9	133.6	117.8	183.3	288.0	100.5	94.9	120.2	161.6	144.1	118.8	148.8	124.0	128.4	137.2	135.6	102.4	108.5	173.0	92.0	103.7	134.2	97.7	123.9	121.8	122.9	94.6	301.0	241.3	132.7	105.8	136.9	99.7	124.1	45.2	147.4	157.8	134.4	212.3	146.7	147.0	165.6	157.0	287.1	170.8	236.9	206.9	149.7	126.8	220.7	141.0	148.4	199.9	171.7	207.3	216.6	288.9	196.8	122.1	125.1	238.3	198.5	325.4	160.1	415.1	277.4	434.3	239.6	158.2	108.3	372.1	462.6	100.5	202.0	214.1	293.6	118.8	206.2	224.8	321.7	551.8	140.9	775.5	302.3	272.6	431.2	386.2	211.1	298.6	199.9	328.0	299.2	306.0	303.8	193.3	201.6	385.6	222.1	200.8	533.9	442.9	208.2	143.9	261.9	171.8	340.3	309.4	441.4	8664.2	197.1	357.6	191.8	67.3	54.4	94.3	55.6	62.9	52.2	64.3	46.3	57.5	70.7	55.3	37.7	56.0	53.0	68.8	64.3	58.3	58.2	75.1	151.2	156.7	133.6	188.2	161.6	144.1	137.2	135.6	134.2	136.9	147.4	157.0	103.1	41.7	166.1	20.9	132.9	190.3	225.1	303.9	124.7	59.7	152.7	117.1	102.6	98.7	172.9	82.8	45.9	286.5	148.9	170.7	254.3	160.3	9.7	109.1	68.5	114.2	130.8	178.2	44.7	152.4	184.2	85.9	71.9	93.7	224.3	51.1	80.3	86.9	203.3	67.3	29.3	169.1	211.6	101.1	171.4	17.7	86.0	123.3	103.2	19.7	409.7	83.6	184.4	21.6	19.3	91.5	146.8	104.2	135.6	128.0	187.2	186.0	128.8	50.0	72.3	85.5	94.4	27.6	25.0	269.7	286.8	382.8	140.4	87.9	163.9	253.7
ENTHD1	FLJ25421	ENSG00000176177	"ENTH domain containing 1"	Q8IYW4	22	39743044-39893864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 11.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.2;granulocytes: 8.9;Late spermatids: 17.5;Spermatocytes: 37.4;Spermatogonia: 6.7"	"Cancer enriched"	"Detected in single"	30	"melanoma: 7.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SK-MEL-30: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019800	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA019800: AB_1848842"	"unprognostic (5.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.97e-4)"	"unprognostic (6.02e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-4)"	"unprognostic (3.60e-2)"	"unprognostic (7.75e-10)"	"unprognostic (3.68e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	17.5	0.6	1.1	0.0	0.0	0.7	0.0	0.0	1.5	0.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	37.4	6.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
ENTPD2	"CD39L1, NTPDase-2"	ENSG00000054179	"Ectonucleoside triphosphate diphosphohydrolase 2"	Q9Y5L3	9	137048107-137054061	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 192.3;Paneth cells: 35.5;Peritubular cells: 96.7;Proximal enterocytes: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 24.3;hTCEpi: 12.7;MCF7: 16.7;OE19: 26.6;SK-BR-3: 21.6;T-47d: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017676	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA017676: AB_1848179"	"unprognostic (1.64e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.71e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (3.51e-6)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.51e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.12e-3)"	1.0	0.8	17.5	0.9	13.0	0.2	5.0	13.3	14.8	5.9	4.3	6.8	12.2	1.8	1.6	3.3	6.1	4.5	3.4	12.5	28.1	4.7	0.9	0.4	0.1	15.9	31.7	0.7	1.8	0.9	3.0	0.7	17.1	7.3	3.8	1.0	5.5	1.6	2.0	10.2	7.8	1.0	16.7	0.1	6.1	3.5	26.4	0.2	0.6	3.4	0.3	1.2	3.6	14.5	6.5	1.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.0	1.2	1.9	0.0	1.4	0.0	0.0	5.1	0.5	3.7	0.0	0.0	0.2	0.0	0.8	24.3	0.0	0.0	0.3	0.0	12.7	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	26.6	3.6	0.0	1.1	2.5	2.8	0.6	3.5	0.1	0.3	21.6	0.0	0.1	23.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	13.0	13.3	14.8	12.5	28.1	15.9	31.7	17.1	16.7	26.4	14.5	1.1	0.0	0.0	19.2	0.5	1.7	1.9	2.8	4.0	0.2	8.0	13.2	0.5	11.5	1.8	0.0	0.0	0.3	0.0	26.2	0.0	6.2	1.4	12.1	1.5	1.2	25.2	0.0	0.2	4.3	1.1	1.5	5.1	2.8	0.0	0.0	0.4	1.1	0.2	0.0	0.1	9.4	6.1	0.0	0.0	6.2	192.3	0.3	5.4	1.9	0.6	6.8	0.0	0.5	0.1	6.0	35.5	96.7	0.0	4.4	61.8	8.6	3.2	0.1	0.0	0.4	4.1	1.2	4.4	1.8	1.4	1.0	0.2	0.0	16.0	1.5
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017655	Supported		Approved	Vesicles		NA	NA		82000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	8.6	24.2	10.5	30.5	14.8	11.1	16.2	17.0	8.1	19.8	18.1	16.8	17.3	12.6	13.7	14.6	21.2	10.8	12.3	12.2	13.7	20.0	29.3	13.1	9.2	13.5	21.4	27.2	18.3	17.2	12.8	16.8	20.3	32.7	22.0	13.4	15.2	12.4	26.2	16.5	7.6	25.4	20.3	19.9	12.5	14.5	14.7	15.9	29.8	16.7	16.6	11.6	20.8	28.7	34.0	23.5	29.0	36.8	35.0	33.1	30.4	21.3	33.2	40.3	26.4	35.5	22.9	32.8	32.9	24.5	15.8	29.0	40.3	8.6	11.5	18.4	18.1	14.2	23.7	9.8	34.8	22.8	34.7	28.4	29.9	51.9	31.2	26.7	13.2	30.6	36.4	9.3	14.8	11.9	20.1	26.2	10.2	14.3	34.6	10.8	27.0	24.1	27.2	26.6	12.0	17.0	23.7	67.0	12.9	13.6	38.6	39.1	38.3	43.7	24.1	24.7	11.5	45.5	51.3	11.5	39.4	17.0	5.7	13.4	7.4	8.6	8.8	8.7	7.3	8.1	7.5	6.5	9.2	7.3	14.4	4.8	7.0	6.8	6.3	6.9	8.6	10.5	11.1	16.2	10.8	12.3	13.1	9.2	12.8	7.6	12.5	11.6	15.9	19.2	34.5	10.7	25.8	6.5	12.0	17.6	8.6	32.1	11.4	8.6	24.6	7.2	27.3	14.7	14.6	16.1	33.4	25.1	0.0	15.6	8.6	13.6	21.6	15.8	17.3	10.3	31.4	16.9	16.9	16.9	23.9	23.9	17.7	18.9	12.1	11.5	12.3	47.1	37.4	19.7	20.3	14.2	15.5	19.2	7.2	18.2	12.4	19.7	19.4	15.2	18.6	23.1	23.1	21.8	13.3	8.6	46.9	18.9	18.8	5.0	15.0	35.9	13.1	14.3	14.6	21.5	22.8	9.5	5.5	20.2	21.3	11.7	12.4	18.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6"	O75354	20	25195693-25228075	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 289.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		41000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	24.8	55.4	54.3	22.8	64.0	15.2	27.7	39.7	65.9	22.9	26.5	61.0	60.0	21.8	18.4	25.3	23.2	26.5	75.9	56.0	49.8	40.4	38.9	25.4	16.1	29.6	32.2	36.2	49.6	23.5	60.0	25.2	45.2	55.7	44.9	15.7	71.2	17.2	38.7	19.4	63.0	18.6	25.7	19.8	47.2	36.3	48.5	29.8	28.8	21.9	13.0	24.5	21.8	38.9	78.8	122.8	32.9	64.0	41.0	50.8	70.8	63.0	45.0	54.0	48.3	65.5	60.0	47.6	91.4	60.9	104.7	100.3	40.1	96.2	35.5	29.2	36.2	38.3	18.2	150.4	60.7	52.7	57.3	47.4	53.1	67.7	51.4	39.4	43.7	46.1	51.5	78.8	40.0	75.6	49.2	32.6	20.8	63.9	96.0	27.1	102.9	108.4	67.8	46.3	52.0	26.7	17.7	105.1	289.4	29.6	75.3	43.4	48.6	61.9	63.7	51.6	75.7	50.5	43.8	21.0	44.5	34.1	116.3	0.1	25.2	4.9	18.8	17.0	25.6	8.7	16.5	15.0	26.4	11.0	16.9	15.5	1.1	14.1	7.6	18.5	17.2	22.1	54.3	64.0	39.7	65.9	56.0	49.8	29.6	32.2	45.2	25.7	48.5	38.9	6.4	19.2	28.5	12.4	9.9	9.8	16.2	23.6	6.2	19.2	25.8	21.8	5.8	25.8	14.8	18.4	10.4	63.2	11.0	81.4	9.8	42.5	22.1	10.5	7.6	7.6	34.0	4.2	18.6	40.1	21.7	12.8	52.5	15.4	3.8	65.2	14.3	15.0	26.7	25.2	19.4	57.5	26.4	17.7	17.4	65.2	20.5	17.6	10.6	11.2	16.0	4.2	10.3	13.0	9.2	33.8	59.8	42.2	16.5	27.9	68.4	13.5	10.7	9.1	6.6	6.3	9.6	3.0	8.8	8.6	6.0	59.8	12.0	25.8	72.6	12.1
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659509-99711241	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 17.5;Urothelial cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	1.8	3.7	0.4	4.2	0.5	7.0	2.2	1.7	0.7	3.2	3.9	3.7	14.6	2.1	2.2	4.4	1.8	4.5	1.3	0.7	0.2	2.7	6.3	1.9	2.2	0.3	0.4	1.0	6.9	2.9	1.7	6.5	0.2	2.7	3.8	2.7	2.9	2.3	0.5	2.9	14.6	2.7	0.3	2.1	3.9	1.4	0.3	1.6	2.2	0.4	2.7	10.2	2.6	0.5	5.4	5.9	8.0	14.4	4.0	3.6	8.4	10.0	19.1	11.4	9.2	11.1	5.2	4.8	5.4	14.0	3.6	13.6	6.0	4.0	9.6	2.3	5.6	4.0	4.4	11.2	5.8	13.4	7.8	3.5	6.7	14.1	15.3	14.1	11.8	5.1	6.1	4.7	4.8	4.6	2.6	3.9	4.7	6.0	2.4	0.3	6.2	2.4	15.8	16.7	3.4	6.9	6.7	2.7	9.5	5.4	7.1	5.9	8.5	11.0	6.2	7.0	8.4	4.7	7.3	4.1	11.0	4.4	2.7	0.3	0.6	0.9	0.6	0.7	0.5	0.2	0.3	0.5	1.3	0.1	0.4	0.3	0.5	0.8	0.4	2.3	0.2	0.3	0.4	0.5	1.7	0.7	0.7	0.2	0.3	0.4	0.2	0.3	0.3	0.5	1.2	0.0	0.0	2.9	1.3	8.2	17.5	4.6	10.8	0.7	2.0	1.1	0.8	1.5	2.2	5.5	2.1	6.3	3.2	3.7	0.0	2.3	1.5	6.0	2.8	1.7	5.4	1.3	9.5	5.0	5.3	2.4	9.2	5.3	0.0	0.7	0.7	4.7	1.9	0.0	7.9	4.2	0.0	0.6	2.7	2.7	0.9	2.6	0.0	6.5	4.9	0.4	0.0	10.1	3.2	4.5	3.1	0.7	7.6	2.6	11.4	1.3	3.6	1.9	0.0	1.1	1.7	1.2	0.8	6.9	7.4	5.1	1.2	3.9	2.4	23.6
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 27.6;liver: 14.5"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	1.4	0.0	0.4	0.4	0.2	0.2	0.6	0.0	21.3	27.6	0.1	0.0	0.3	0.7	3.7	0.0	0.0	0.0	3.1	14.5	0.1	0.1	0.2	0.1	0.1	3.1	0.1	5.1	0.1	0.0	0.4	11.2	0.0	6.3	0.2	0.0	0.1	27.2	0.1	0.0	0.2	8.9	0.5	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	5.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.2	0.0	0.0	5.3	0.7	0.0	0.2	0.5	0.1	0.0	0.1	0.4	2.8	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.7	1.5	0.4	11.5	0.3	20.2	0.0	0.0	0.1	194.5	0.0	1.3	0.0	3.0	0.4	0.1	3.6	0.0	0.0	7.5	0.2	0.1	31.6	4.7	0.0	0.1	0.4	10.1	0.1	0.0	0.0	181.0	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	174.3	0.0	0.2	0.6	167.3	5.9	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.3	0.1	15.6	1.7
ENTR1	"NY-CO-3, SDCCAG3"	ENSG00000165689	"Endosome associated trafficking regulator 1"	Q96C92	9	136401922-136410614	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Breast glandular cells: 15.7;Breast myoepithelial cells: 21.5;Endometrial stromal cells: 22.5;Granulosa cells: 18.7;Hofbauer cells: 18.2;Pancreatic endocrine cells: 18.3;Theca cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029303	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA029303: AB_10602222"	"unprognostic (8.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.35e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.23e-2)"	19.5	18.0	11.5	14.2	12.4	10.5	18.0	12.5	13.7	18.9	13.9	21.4	14.3	17.3	4.2	20.7	17.9	10.9	17.0	11.5	11.6	17.8	46.9	16.6	21.0	13.0	11.9	18.5	25.4	7.9	13.5	8.6	12.8	17.9	9.0	5.1	15.1	8.6	26.8	22.0	20.7	11.0	11.5	27.7	19.8	33.2	14.2	10.9	17.4	10.6	13.2	21.3	18.3	14.6	39.0	47.7	30.4	63.6	29.8	27.7	61.6	36.2	21.1	36.6	23.2	61.2	29.3	32.8	29.4	28.6	45.3	94.0	57.5	42.0	21.4	63.7	39.0	28.5	87.3	42.4	41.1	46.0	31.1	25.9	59.5	35.1	74.1	19.1	28.8	49.3	66.9	23.6	33.8	72.2	19.6	48.1	107.4	101.5	49.3	36.7	33.2	130.8	30.2	31.7	60.3	49.4	38.6	61.2	60.5	23.1	88.2	50.7	31.0	55.5	33.1	72.9	71.6	18.1	36.1	48.9	47.6	56.5	56.5	0.0	0.6	1.0	0.6	0.2	1.9	2.3	1.0	0.8	0.3	1.2	1.1	1.3	0.4	1.0	0.6	0.9	1.1	0.5	11.5	12.4	12.5	13.7	11.5	11.6	13.0	11.9	12.8	11.5	14.2	14.6	20.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	15.7	21.5	0.0	0.0	0.0	9.2	0.0	4.3	12.8	0.0	0.0	9.3	0.0	10.9	22.5	4.9	0.0	0.0	0.0	13.6	6.0	6.2	0.0	11.7	0.0	18.7	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	2.9	5.0	24.0	0.0	0.0
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2 transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345954	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	54.4	55.5	28.1	44.7	29.1	87.6	57.0	29.3	45.3	44.2	32.9	59.5	54.5	37.9	53.8	48.2	36.1	29.9	64.2	29.1	32.2	74.4	101.3	40.4	49.6	31.5	30.5	29.5	44.9	47.2	34.4	41.3	30.1	39.0	55.1	24.5	43.7	36.0	71.7	34.7	47.9	44.1	29.8	47.7	47.9	34.8	29.7	60.3	38.0	68.5	53.8	48.4	38.9	30.9	180.3	145.9	213.6	97.1	79.5	101.0	61.4	140.0	89.9	141.2	177.2	109.0	109.1	115.3	127.9	110.9	63.6	89.7	96.8	99.5	171.7	184.1	113.9	223.5	106.7	227.4	85.4	78.3	133.5	77.5	66.7	92.5	87.3	102.2	215.1	111.5	216.5	63.7	162.7	289.9	235.9	175.5	156.1	207.1	140.3	148.4	93.2	144.5	192.5	134.7	128.9	137.5	87.7	109.3	127.2	117.0	138.6	132.3	146.9	94.1	158.9	97.8	144.7	107.9	125.6	222.2	95.2	128.3	112.7	65.6	102.5	93.5	28.9	112.8	36.7	41.4	39.0	35.6	93.8	27.3	31.9	35.8	56.8	42.4	121.8	80.3	42.3	74.5	28.1	29.1	29.3	45.3	29.1	32.2	31.5	30.5	30.1	29.8	29.7	30.9	231.3	70.5	93.8	16.3	135.0	185.6	196.3	305.7	159.9	63.8	149.2	192.7	170.6	138.7	184.6	145.3	123.0	263.3	157.0	171.5	381.5	214.3	173.3	146.4	134.7	226.3	154.2	160.1	22.7	200.0	284.5	161.0	88.7	144.8	91.8	99.3	142.5	371.1	276.8	45.4	23.9	245.1	225.9	230.3	265.7	111.0	148.2	205.0	158.3	17.8	260.9	112.4	126.7	19.6	27.6	251.2	237.1	112.5	147.2	230.3	264.5	546.1	125.0	139.9	78.9	163.9	262.9	208.7	130.4	151.0	174.6	167.3	132.4	143.9	209.1	208.0
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975217-69013684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	19.4	9.1	7.2	12.8	7.2	5.9	19.5	6.7	10.9	14.0	22.4	25.8	7.4	29.9	9.8	17.5	18.5	17.8	28.5	7.1	7.0	10.2	5.7	28.7	8.2	7.7	7.6	11.6	12.6	5.0	9.3	22.3	8.0	27.9	8.6	8.8	16.4	33.7	20.0	9.7	11.4	25.4	7.8	10.0	15.5	8.9	7.8	11.1	7.9	15.2	8.8	24.7	13.7	7.5	19.0	7.1	12.5	14.4	16.6	32.2	8.6	25.4	31.5	16.0	21.0	9.1	10.2	1.1	3.8	28.1	13.6	6.0	8.3	32.3	19.9	62.3	5.6	20.2	15.5	13.5	18.7	11.5	8.2	26.8	29.4	20.6	25.1	19.4	86.2	0.8	5.9	11.1	53.7	5.5	2.0	3.8	13.5	6.2	3.5	0.8	12.4	8.2	13.9	43.4	1.2	6.3	29.1	1.7	23.5	12.8	6.0	15.9	44.6	40.6	13.4	5.1	24.3	6.0	20.5	9.3	16.3	17.1	23.8	5.4	1.5	0.0	2.0	1.4	2.3	1.1	3.0	4.3	2.4	0.7	2.5	2.7	0.2	2.4	0.5	0.4	6.6	1.3	7.2	7.2	6.7	10.9	7.1	7.0	7.7	7.6	8.0	7.8	7.8	7.5	29.6	12.8	10.3	14.0	3.5	7.1	11.4	13.2	16.5	2.2	7.5	11.7	20.7	4.3	14.5	1.8	16.7	0.9	3.1	5.1	0.0	4.6	16.5	15.3	7.5	23.7	6.0	3.8	11.2	8.2	5.3	9.3	9.2	15.4	0.0	9.4	20.3	3.6	6.7	0.0	21.4	4.5	2.0	6.8	9.8	15.1	3.1	8.6	8.8	30.9	6.5	1.4	1.0	9.5	12.2	12.4	3.4	40.6	5.4	8.3	2.1	1.9	13.2	5.6	0.0	26.8	15.2	5.5	2.5	14.8	4.5	0.8	7.0	6.9	3.4	8.6
EOLA1	"CXorf40, CXorf40A"	ENSG00000197620	"Endothelium and lymphocyte associated ASCH domain 1"	Q8TE69	X	149540355-149550510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 27.2;Cytotrophoblasts: 26.9;Extravillous trophoblasts: 8.5;Hofbauer cells: 10.9;Syncytiotrophoblasts: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060897	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA060897: AB_2684381"	"unprognostic (1.37e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.16e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.06e-2)"	14.7	53.0	17.4	15.7	18.8	29.1	21.2	19.2	22.8	13.1	21.7	19.6	15.9	12.7	31.5	15.5	13.3	10.7	31.7	21.7	19.0	26.0	24.7	13.4	17.6	18.1	19.6	21.2	23.8	38.4	34.3	15.9	18.0	17.8	20.5	23.3	22.5	16.4	32.3	16.6	17.4	13.2	17.9	25.5	22.3	8.0	18.6	17.8	19.0	27.1	19.0	14.1	13.8	20.3	17.4	22.7	10.9	15.8	18.4	19.1	11.4	16.6	16.5	17.1	22.1	7.7	13.6	35.9	48.8	16.6	18.8	19.0	26.5	15.1	15.7	31.0	26.0	8.8	38.9	10.5	21.0	25.6	25.0	19.7	24.3	19.3	19.3	21.9	19.8	18.2	7.7	29.6	15.5	70.2	20.3	31.7	4.5	30.7	35.2	16.3	17.5	36.2	16.6	21.3	22.1	11.8	7.6	22.6	21.7	8.5	10.9	18.4	15.3	10.2	7.1	29.3	32.4	21.7	17.2	52.1	21.0	35.4	12.7	31.5	14.4	10.0	21.6	15.1	17.0	15.5	16.7	17.7	15.1	11.5	20.3	14.5	13.4	34.5	13.8	42.3	22.0	16.7	17.4	18.8	19.2	22.8	21.7	19.0	18.1	19.6	18.0	17.9	18.6	20.3	1.3	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.0	26.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	8.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	54.2	0.6	0.0	0.0	0.0
EOLA2	CXorf40B	ENSG00000197021	"Endothelium and lymphocyte associated ASCH domain 2"	Q96DE9	X	149929527-149938700	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 47.3;Extravillous trophoblasts: 21.8;Hofbauer cells: 12.5;Syncytiotrophoblasts: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060897	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA060897: AB_2684381"	"unprognostic (5.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.14e-3)"	27.4	71.5	18.5	18.2	19.9	60.3	36.7	19.0	20.2	26.3	22.8	24.4	18.7	24.4	25.7	29.0	26.2	18.7	32.8	19.4	19.2	34.6	41.3	28.8	25.6	18.9	19.6	42.6	40.9	23.0	38.8	25.5	18.9	32.0	18.9	24.9	30.4	19.3	22.8	38.7	27.6	18.9	18.9	36.3	30.6	18.5	19.0	18.4	29.9	16.4	26.1	27.8	27.1	20.9	32.8	46.6	26.6	22.8	24.3	35.1	28.1	32.9	34.3	39.3	48.6	35.6	27.1	43.5	88.2	34.7	33.6	17.3	37.8	35.3	28.8	27.3	38.8	19.9	58.1	36.4	45.3	39.8	36.1	36.1	48.2	48.0	47.6	27.7	39.9	26.6	23.8	53.9	36.1	86.9	31.3	41.7	19.1	41.3	55.7	28.6	26.4	53.1	24.5	45.3	20.8	18.0	14.5	34.9	39.1	23.9	23.4	27.0	30.9	31.3	19.1	53.3	67.3	40.3	22.8	105.9	34.3	51.7	28.7	38.6	25.9	36.2	35.7	21.4	32.9	27.7	26.6	34.5	28.3	27.4	25.9	31.5	10.9	58.6	18.3	36.8	36.5	30.4	18.5	19.9	19.0	20.2	19.4	19.2	18.9	19.6	18.9	18.9	19.0	20.9	3.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	47.3	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	91.4	0.8	0.0	0.0	0.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41092592-41180077	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	15.7	13.7	6.8	17.7	8.9	65.1	14.2	20.5	10.8	16.0	6.1	16.6	13.6	17.2	13.5	16.3	16.4	14.2	11.5	7.1	9.4	13.1	15.5	14.7	17.6	10.6	7.8	23.9	18.0	23.2	13.4	19.3	7.7	15.0	14.5	17.8	15.0	15.6	20.4	18.9	16.0	16.4	5.3	17.0	14.5	19.6	8.6	27.2	20.2	23.4	17.9	15.4	14.8	11.2	31.6	21.7	35.4	23.0	22.2	23.3	32.3	15.0	21.8	21.0	21.0	27.8	12.0	32.7	12.2	28.4	18.7	24.1	48.1	20.8	23.5	30.5	32.2	24.4	25.4	22.3	26.9	59.3	26.5	24.8	22.2	30.0	27.0	19.3	24.9	18.7	26.3	43.9	18.3	12.5	16.2	18.9	27.5	38.3	15.2	33.7	16.7	21.3	20.3	40.4	11.3	11.9	51.1	26.0	25.6	29.5	17.8	33.9	31.3	20.3	24.8	16.3	20.8	28.5	14.1	47.9	16.3	17.4	21.5	3.6	1.7	1.6	1.6	1.9	1.5	2.2	1.7	1.7	2.1	1.4	1.4	1.1	4.9	2.7	1.0	1.6	1.4	1.2	6.8	8.9	20.5	10.8	7.1	9.4	10.6	7.8	7.7	5.3	8.6	11.2	45.4	67.3	49.2	58.1	53.8	24.6	22.9	11.6	40.9	44.6	35.1	25.8	31.6	38.6	15.8	25.8	35.5	18.4	63.2	37.0	3.9	16.1	15.3	55.1	56.4	36.2	24.7	60.4	71.8	18.7	17.9	32.0	27.5	72.5	25.3	36.1	32.9	29.2	18.4	25.2	73.6	24.2	2.0	60.7	25.7	6.4	28.9	60.5	8.8	45.9	52.0	27.7	40.2	81.4	80.3	25.8	28.9	30.5	51.2	30.8	20.2	10.8	22.8	30.9	26.3	47.6	36.7	22.8	31.2	35.3	25.9	30.2	46.0	36.7	23.7	36.3
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949942-132080460	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA016704: AB_1854888, HPA049013: AB_2680598"	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	11.9	14.0	18.5	7.6	15.6	12.2	11.9	15.0	18.1	16.8	9.3	15.7	6.0	14.4	13.2	11.4	15.0	5.9	11.6	18.2	14.6	15.4	11.7	11.3	11.4	14.0	12.1	19.5	12.5	9.5	17.4	6.4	13.1	14.3	6.6	18.1	10.3	8.8	19.3	15.4	13.1	7.3	8.7	18.6	11.7	14.6	15.5	11.7	14.3	8.9	8.6	13.1	12.6	16.5	23.5	30.6	28.3	14.2	16.6	16.3	22.3	13.0	9.9	9.8	8.4	18.3	7.1	19.9	11.8	16.2	11.1	17.6	13.7	13.0	13.2	8.3	20.6	28.5	10.8	20.8	13.7	30.9	21.3	14.0	12.1	18.1	16.3	16.7	16.9	12.7	28.3	5.5	14.3	29.6	23.5	42.1	22.6	12.7	26.3	24.6	19.0	8.1	13.3	28.3	22.8	19.2	15.1	10.4	15.0	20.4	17.4	24.1	25.4	15.6	24.3	17.6	18.9	14.1	11.6	19.8	16.2	17.0	16.0	0.7	0.7	0.6	1.1	0.6	1.1	4.0	1.0	0.9	0.6	4.0	1.2	1.7	0.6	0.6	0.6	4.7	0.7	0.6	18.5	15.6	15.0	18.1	18.2	14.6	14.0	12.1	13.1	8.7	15.5	16.5	19.1	3.2	17.9	44.4	27.8	9.9	10.5	11.0	17.1	34.2	14.0	10.5	13.9	7.2	14.3	16.5	39.6	12.6	22.4	13.2	1.9	11.3	12.5	21.3	25.5	18.6	14.4	14.9	59.6	10.4	11.4	17.3	14.8	21.8	6.3	34.1	15.7	12.1	15.0	25.2	56.4	13.8	12.2	14.1	7.6	6.8	16.4	17.9	7.2	24.4	16.7	15.7	29.9	55.8	48.9	15.3	14.0	17.0	24.3	17.8	8.8	4.2	35.9	37.2	19.7	31.2	20.2	62.8	54.3	20.0	13.1	17.8	26.5	26.9	13.5	13.4
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	55.1	122.1	68.6	8.1	73.8	0.4	25.7	66.0	97.2	37.7	0.0	31.2	13.8	27.9	31.0	46.3	45.3	40.3	21.3	64.7	81.7	64.7	8.9	30.1	4.4	101.5	80.3	41.8	29.3	37.0	21.1	21.8	94.0	26.9	20.9	39.5	56.6	42.6	12.0	14.2	16.7	27.2	53.0	8.1	64.2	18.3	75.0	4.5	24.8	15.4	14.0	40.7	31.7	79.9	53.5	163.5	57.7	21.5	36.8	22.8	53.8	16.8	37.7	35.1	27.9	108.7	93.7	3.0	26.4	52.7	71.7	237.9	26.7	19.6	26.2	0.5	14.9	0.4	52.7	107.6	11.3	0.2	19.4	19.9	9.4	32.9	2.7	44.7	8.6	13.0	2.7	41.5	30.5	34.2	1.8	0.9	21.4	192.9	49.9	2.6	16.0	66.3	30.5	84.6	20.1	24.5	74.9	185.6	6.4	43.9	45.8	2.4	7.3	40.9	43.0	20.8	3.7	50.3	19.0	0.6	71.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	68.6	73.8	66.0	97.2	64.7	81.7	101.5	80.3	94.0	53.0	75.0	79.9	14.5	16.0	22.1	27.7	0.4	2.9	5.0	11.1	30.7	31.9	12.8	9.4	8.5	28.6	16.5	47.8	156.4	1.5	0.8	23.8	19.6	22.2	2.9	10.6	8.7	9.2	15.5	0.0	56.8	10.8	0.5	11.0	50.4	7.5	52.5	13.3	10.0	3.7	6.9	32.0	75.7	6.0	4.1	1.3	2.2	2.7	15.8	6.0	3.6	3.7	0.0	22.7	0.0	24.6	73.1	31.6	15.7	42.2	2.1	5.1	8.0	37.1	21.9	8.7	32.9	6.8	35.1	4.6	7.1	43.2	1.7	1.1	0.8	7.1	13.2	18.0
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 12.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	27.6	28.1	5.8	27.4	5.3	4.1	11.7	17.9	49.9	6.4	0.0	17.7	49.6	7.8	5.6	10.7	13.6	9.3	6.5	7.1	24.8	33.9	4.8	13.9	7.9	59.6	14.7	11.4	6.9	59.6	10.4	21.1	53.3	5.8	13.1	45.8	4.0	7.3	6.1	4.0	47.7	13.4	7.7	12.2	3.2	62.3	29.1	6.5	4.6	10.7	3.9	10.3	5.7	29.8	0.3	0.9	3.9	0.0	54.5	62.8	43.7	12.8	0.0	0.0	0.0	0.7	0.1	0.1	0.1	39.8	23.2	0.2	38.6	0.0	0.0	0.0	34.2	0.1	0.4	0.0	0.2	0.1	4.6	33.3	0.0	12.3	0.1	16.2	59.5	0.0	0.4	0.4	0.1	0.0	0.5	0.7	7.9	0.2	12.5	0.3	0.0	0.2	0.4	4.8	65.5	0.5	0.1	0.5	25.9	31.2	0.7	4.8	164.8	0.3	57.7	57.1	71.6	0.1	0.1	0.0	0.2	5.4	6.8	0.0	4.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.7	0.0	12.4	0.0	0.0	0.7	5.8	5.3	17.9	49.9	7.1	24.8	59.6	14.7	53.3	7.7	29.1	29.8	18.2	19.2	6.4	28.7	1.3	15.9	4.1	0.0	3.4	75.6	5.3	1.7	3.5	2.8	1.9	7.3	77.2	98.6	0.2	44.0	15.6	0.4	171.9	2.2	10.1	21.9	9.1	3.2	306.8	0.7	44.2	27.7	0.0	2.1	0.0	0.0	7.1	0.8	58.8	3.3	237.4	10.0	0.0	82.2	66.7	291.6	22.4	81.9	10.6	103.0	50.9	3.3	2.1	44.2	159.2	0.8	8.3	7.9	1.6	3.8	91.2	68.4	1.6	14.7	0.0	3.0	13.1	2.7	11.5	2.3	8.4	214.0	2.6	0.2	12.3	1.7
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPB41L4B	"EHM2, LULU2"	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171974-109321059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.9;pancreas: 149.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	21.0	9.7	6.0	4.5	8.7	0.0	15.3	2.0	12.2	4.1	11.8	57.6	47.6	1.2	17.9	1.5	10.8	4.2	8.8	10.7	6.4	6.4	88.9	6.3	0.2	2.7	5.3	13.8	149.1	11.1	1.6	2.5	3.7	7.6	56.7	3.0	26.9	9.1	6.1	15.5	51.9	1.9	7.2	0.1	30.6	7.5	10.9	0.6	44.7	0.7	1.6	2.2	3.4	4.3	8.7	10.8	0.7	0.8	0.8	0.0	31.7	1.1	0.4	3.7	1.9	18.5	8.5	0.0	2.3	1.0	8.9	13.9	21.5	11.5	3.9	9.2	5.1	0.0	3.4	26.5	2.2	0.4	0.0	0.3	49.8	1.5	17.0	1.1	0.2	8.0	0.3	0.0	5.2	22.3	0.4	0.2	13.8	62.8	15.7	0.0	0.0	0.6	12.9	13.1	13.1	1.4	3.4	22.2	0.0	6.3	5.2	0.1	0.5	7.5	7.6	2.5	3.1	0.1	0.1	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.7	2.0	12.2	10.7	6.4	2.7	5.3	3.7	7.2	10.9	4.3	0.2	6.4	5.1	2.6	0.4	11.5	5.4	6.0	1.2	7.5	22.7	10.4	18.5	20.0	9.6	7.3	0.0	4.1	0.0	134.8	0.0	3.5	11.7	23.8	2.3	0.8	51.6	0.0	79.7	20.8	2.1	2.5	26.0	20.7	0.0	6.2	5.0	125.2	0.6	38.7	58.9	51.4	12.2	1.6	1.5	1.9	13.4	0.4	1.8	3.7	0.0	1.9	0.0	12.1	3.8	10.2	54.4	2.6	0.0	7.2	79.2	0.8	39.2	1.1	0.0	0.8	1.0	1.4	17.2	0.9	24.0	1.9	0.5	6.8	46.5	6.5
EPB41L5	"BE37, FLJ12957, KIAA1548, LULU, LULU1, YMO1, YRT"	ENSG00000115109	"Erythrocyte membrane protein band 4.1 like 5"	Q9HCM4	2	120013077-120179119	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 55.5;MCF7: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037563, HPA037564"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA037563: AB_2675546, HPA037564: AB_2675547"	"unprognostic (1.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (5.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.20e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.61e-1)"	5.7	6.0	9.0	3.0	7.3	1.0	15.7	43.4	10.6	7.2	4.5	9.9	14.0	7.5	5.8	8.8	12.8	7.4	6.3	7.1	11.1	32.7	56.8	29.9	2.5	8.9	11.1	11.6	26.2	25.1	8.2	9.8	9.0	12.4	8.8	27.8	15.3	6.1	10.1	8.3	11.7	6.5	8.7	2.5	9.1	30.5	12.4	3.6	32.9	8.9	6.6	6.1	8.4	8.1	18.0	6.1	23.8	18.5	16.4	11.8	20.8	3.8	3.7	7.8	7.0	55.5	11.7	0.3	12.9	4.8	9.7	12.1	32.4	14.9	11.5	3.6	10.1	5.2	2.8	31.1	19.1	2.3	5.3	10.6	27.6	14.6	10.4	6.7	22.1	10.4	12.4	1.3	15.6	83.4	4.3	7.9	21.5	8.3	5.6	0.0	7.1	5.0	24.2	17.1	12.3	23.5	16.5	29.0	8.2	32.5	14.0	4.3	18.4	0.7	11.2	12.3	3.9	1.9	3.5	9.2	2.0	0.1	4.5	0.1	0.5	0.6	0.4	0.1	0.1	1.7	0.4	0.4	0.1	1.3	1.1	0.8	0.7	0.6	0.3	0.0	0.2	0.4	9.0	7.3	43.4	10.6	7.1	11.1	8.9	11.1	9.0	8.7	12.4	8.1	6.0	218.0	41.9	61.0	11.1	24.5	28.9	9.7	21.6	33.9	28.0	14.1	13.2	24.3	22.5	33.1	25.0	14.9	4.3	20.6	21.5	18.8	38.0	25.8	12.6	6.8	15.5	5.7	68.4	22.3	12.1	13.1	56.1	45.8	0.0	12.0	17.9	54.2	3.2	8.4	79.8	12.7	22.4	2.1	6.8	20.6	9.0	2.8	14.2	26.2	1.1	15.8	0.0	89.5	25.9	23.2	21.7	9.4	5.9	29.1	20.9	29.0	17.5	35.7	19.7	11.7	9.8	43.5	48.6	18.3	21.7	26.4	6.2	5.7	12.9	39.4
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221018	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 98.9"	"Cell type enriched"	"Detected in many"	33	"Erythroid cells: 480.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"HEL: 85.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	3.1	0.0	0.0	0.0	0.0	98.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	1.9	1.5	0.5	0.0	4.0	0.0	0.0	0.6	1.5	0.5	0.0	6.2	4.5	0.0	1.5	0.0	0.0	14.4	0.0	0.0	1.2	0.0	480.0	0.1	0.0	2.3	0.8	0.0	0.0	4.5	0.0	2.5	1.1	1.1	6.7	0.1	0.9	4.1	2.2	2.8	10.5	2.8	1.1	1.8	0.0	3.6	2.5	14.4	0.0	0.0	0.0	1.7	0.7	0.4	1.5	2.4	0.0	0.6	8.4	6.6	1.0	1.0	13.5	4.6	0.0	2.8	6.7	3.8	0.0	0.8	2.0
EPC2	DKFZP566F2124	ENSG00000135999	"Enhancer of polycomb homolog 2"	Q52LR7	2	148644440-148787569	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 125.7;Oligodendrocytes: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036759	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036759: AB_10672365"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	16.4	14.0	9.6	13.5	10.9	50.3	17.2	22.0	13.4	18.2	7.8	12.4	9.7	25.5	14.1	12.2	15.3	15.3	15.5	9.9	11.3	12.9	12.7	14.6	18.0	9.6	9.9	31.9	9.8	12.1	9.9	18.5	9.9	16.2	13.9	14.0	11.5	15.5	15.9	11.7	10.5	19.1	9.7	15.9	12.0	14.2	11.5	23.1	19.3	18.5	15.9	15.6	14.0	14.5	9.2	7.0	23.8	14.8	15.7	19.5	17.9	15.9	21.4	25.3	21.2	14.1	12.0	19.8	7.8	18.7	10.9	12.1	20.7	12.7	31.1	17.6	15.4	38.9	11.0	19.8	16.0	29.7	22.7	20.5	22.1	25.8	25.3	15.6	15.9	15.9	20.9	33.4	16.0	14.7	20.2	19.8	24.3	8.7	13.6	20.7	22.1	18.2	12.7	25.6	32.5	23.6	19.6	12.0	29.8	16.6	7.7	25.8	19.2	20.2	17.7	14.0	13.6	20.3	17.0	25.0	16.0	17.4	21.9	0.1	0.9	1.2	0.9	0.7	1.3	0.8	1.4	0.8	0.9	0.8	1.5	1.1	4.5	0.3	2.0	1.0	1.4	0.5	9.6	10.9	22.0	13.4	9.9	11.3	9.6	9.9	9.9	9.7	11.5	14.5	24.2	25.6	13.6	60.1	21.1	14.0	26.4	4.8	4.0	19.6	15.4	17.1	22.0	8.6	15.1	9.2	6.2	11.3	27.5	8.4	3.9	9.1	28.5	23.5	25.9	17.0	18.0	15.8	79.2	8.8	11.7	20.7	8.6	27.3	6.3	15.6	7.9	5.0	8.6	8.4	75.3	9.2	2.0	16.1	10.2	5.5	23.9	17.7	12.4	70.3	11.3	14.1	20.6	125.7	99.3	9.3	9.1	23.0	10.7	20.3	6.3	6.7	9.8	15.7	13.1	44.4	25.4	19.3	18.6	7.8	15.6	20.1	25.2	16.3	8.1	23.6
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 806.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2317.0;Ductal cells: 999.6;Intestinal goblet cells: 1378.2;Paneth cells: 2437.0;Proximal enterocytes: 2681.1;Undifferentiated cells: 1607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 538.9;CACO-2: 680.9;CAPAN-2: 944.4;OE19: 911.8;RPTEC TERT1: 398.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA		22000		"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	4.4	12.2	3.1	77.0	4.0	10.2	99.7	1.5	3.1	116.2	1.0	806.0	726.5	33.0	238.9	10.8	114.3	71.1	0.6	3.3	9.2	223.1	3.1	74.7	0.9	2.8	3.2	1.2	125.4	219.5	86.9	1.7	3.4	60.5	751.0	0.6	119.8	52.8	0.1	8.8	769.6	22.2	2.6	1.4	172.4	21.7	10.4	6.4	286.8	0.1	2.8	30.9	4.2	2.6	538.9	5.4	0.4	1.2	0.0	0.0	321.3	0.2	0.0	0.6	0.0	680.9	944.4	0.1	141.5	1.0	0.4	247.3	4.6	62.2	2.0	0.1	56.3	0.3	2.5	261.6	0.1	0.3	0.4	0.0	17.6	0.0	0.0	0.0	0.8	0.0	160.9	0.0	0.3	269.7	0.5	24.0	164.3	911.8	31.4	0.3	0.0	136.9	398.6	231.3	354.0	3.2	4.3	187.7	0.6	132.7	158.3	1.0	0.7	0.3	6.3	2.0	1.1	39.2	0.6	0.8	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	4.0	1.5	3.1	3.3	9.2	2.8	3.2	3.4	2.6	10.4	2.6	3.7	310.9	148.1	1.3	7.0	9.3	227.6	127.4	14.2	0.5	184.7	112.9	2.0	243.1	222.8	448.8	0.0	16.4	2.3	2317.0	76.3	999.6	8.6	434.7	35.3	5.8	498.1	23.1	1.1	402.8	6.5	6.3	150.3	445.3	32.5	11.8	1.4	0.6	2.9	0.0	0.4	1378.2	486.2	0.0	5.2	5.6	20.5	5.6	35.6	0.0	11.5	15.7	0.0	0.5	1.2	617.5	2437.0	18.8	1.8	257.9	2681.1	195.9	219.0	0.7	13.1	0.5	13.7	83.5	130.3	33.3	10.4	6.0	9.4	70.3	1607.7	230.7
EPDR1	"EPDR, MERP-1, MERP1, UCC1"	ENSG00000086289	"Ependymin related 1"	Q9UM22	7	37683843-37951936	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 95.5;Peritubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-937: 122.2;WM-115: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026298, HPA072321"	Enhanced				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"CAB026298: AB_425991, HPA072321: "	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.00e-4)"	23.1	40.3	46.3	4.2	41.4	4.5	11.3	38.4	82.3	38.5	27.3	10.5	13.4	41.7	13.6	8.4	28.1	10.1	27.4	45.4	67.5	16.4	10.9	27.1	4.9	81.9	50.4	34.0	9.4	8.0	9.4	4.9	83.2	34.5	8.4	14.3	13.8	41.0	122.9	3.2	13.2	29.9	50.9	17.2	5.7	13.0	58.5	11.4	31.0	72.1	3.0	8.8	17.0	38.9	0.2	77.9	6.4	0.1	57.9	20.8	0.1	5.9	0.0	3.0	9.1	7.7	5.1	0.0	84.2	86.0	88.7	0.2	1.8	0.7	0.0	0.1	9.8	34.9	10.2	49.5	0.5	29.1	0.2	35.1	0.0	21.1	0.4	20.0	0.0	34.3	0.0	25.2	51.6	5.1	11.3	25.1	24.0	0.0	11.6	35.2	22.3	30.6	47.3	19.3	8.4	29.3	0.0	3.8	28.2	15.3	0.1	20.4	0.0	16.6	27.8	46.6	36.7	33.8	15.4	0.5	75.5	122.2	114.7	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.8	0.0	2.2	0.0	0.1	46.3	41.4	38.4	82.3	45.4	67.5	81.9	50.4	83.2	50.9	58.5	38.9	6.4	32.1	46.2	12.7	1.4	1.3	7.8	3.5	1.2	5.7	1.1	10.5	20.7	7.2	12.7	1.8	0.0	0.5	6.8	5.1	17.6	10.0	0.3	5.5	31.8	2.4	3.6	25.6	36.9	8.0	0.2	15.0	1.5	5.9	2.5	95.5	7.5	10.7	3.1	11.8	39.3	5.1	0.0	1.6	2.0	2.1	28.3	3.1	28.4	14.0	14.2	13.3	2.1	24.6	13.0	19.7	6.9	98.9	0.2	14.6	19.3	14.8	5.7	7.2	6.6	46.4	23.9	0.3	1.8	0.5	0.3	0.1	1.2	28.7	6.4	2.6
EPG5	"hEPG5, KIAA1632"	ENSG00000152223	"Ectopic P-granules autophagy protein 5 homolog"	Q9HCE0	18	45847609-45967329	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 53.1;Oligodendrocytes: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 55.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031689	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA031689: AB_10609997"	"unprognostic (3.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.66e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (5.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.18e-1)"	6.6	6.8	5.8	4.4	6.0	13.8	6.8	6.3	6.2	7.1	5.1	5.8	3.2	6.1	5.8	7.1	6.0	3.2	8.4	6.2	5.3	6.6	6.0	8.8	5.7	5.1	8.1	8.9	6.3	6.9	7.6	4.5	5.3	5.9	4.0	8.6	6.0	3.7	8.6	10.1	6.0	4.1	4.5	9.5	5.6	4.8	5.8	8.4	9.3	6.7	5.9	5.4	6.6	6.3	5.3	4.1	4.1	3.0	13.8	16.6	4.1	33.2	13.7	18.7	19.4	1.2	3.9	5.4	2.0	25.0	22.5	4.9	5.5	6.6	23.7	4.5	2.3	4.2	4.7	4.2	13.1	7.2	10.4	11.2	6.0	20.6	14.0	16.5	9.4	4.7	3.7	2.8	55.8	3.7	3.2	6.9	2.0	1.9	2.5	3.0	5.1	3.8	8.8	7.3	4.4	3.4	5.9	2.4	7.0	5.8	3.4	5.1	23.0	23.2	4.9	3.4	9.2	5.7	4.3	3.0	9.9	6.2	7.7	0.4	0.7	0.7	1.5	0.7	1.4	0.4	0.9	0.8	0.5	0.6	0.7	0.9	0.8	0.4	0.6	0.6	0.5	0.3	5.8	6.0	6.3	6.2	6.2	5.3	5.1	8.1	5.3	4.5	5.8	6.3	8.8	19.2	10.5	24.5	9.0	10.3	4.6	6.8	8.0	16.7	11.9	8.3	17.1	10.0	7.4	11.0	25.0	7.6	15.7	5.8	1.9	6.5	4.6	9.0	9.8	9.3	8.3	11.4	53.1	3.6	4.4	7.8	6.1	16.9	7.0	14.4	13.6	10.3	12.2	13.5	46.5	6.9	6.1	16.0	6.2	3.0	12.5	11.5	14.2	40.3	16.6	6.5	27.8	40.2	51.4	7.8	6.5	11.7	10.0	9.1	6.2	8.3	10.5	17.4	13.1	9.8	6.7	8.4	7.1	5.9	13.2	9.0	15.4	9.8	6.5	9.4
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408856	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 57.2;parathyroid gland: 206.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Gastric mucus-secreting cells: 13.3;Proximal enterocytes: 13.2;Squamous epithelial cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.9;naive CD4 T-cell: 3.8;naive CD8 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 17.9;HaCaT: 16.6;HBEC3-KT: 13.5;MCF7: 15.0;NTERA-2: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB026144	Uncertain					NA	NA		32000000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.1	0.0	0.0	1.3	0.0	0.3	2.2	0.4	0.1	11.2	1.2	3.7	8.4	0.3	1.2	57.2	3.4	1.5	0.0	0.0	0.0	5.8	15.6	2.3	2.0	0.0	0.0	0.0	5.7	206.5	2.5	0.6	0.0	4.0	1.6	0.0	11.0	1.2	0.0	19.7	6.2	0.1	0.0	0.9	4.2	1.9	0.0	3.4	5.4	0.0	3.5	1.9	25.8	0.1	8.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	17.9	7.1	0.0	0.1	0.0	0.0	16.6	0.0	13.5	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.8	0.1	0.0	4.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	15.0	0.0	1.9	54.4	8.8	0.0	0.0	0.0	0.0	1.1	6.7	0.3	0.0	0.0	8.2	0.0	3.2	3.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.0	3.8	2.9	0.1	0.1	0.0	0.4	0.1	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.2	0.3	0.1	2.0	6.3	6.5	6.8	0.0	3.3	5.0	1.0	2.8	9.9	7.3	0.0	2.0	0.2	4.2	0.0	4.4	23.3	4.0	1.0	0.2	1.2	0.0	0.6	4.3	2.6	0.5	13.3	6.6	0.0	0.0	0.4	8.8	0.4	0.0	0.3	4.7	2.0	0.3	0.3	9.9	0.6	0.3	0.0	1.0	0.0	0.3	0.0	0.5	0.2	6.3	8.8	0.0	0.6	2.0	13.2	1.5	2.1	0.2	0.0	0.4	0.4	0.5	1.9	28.7	3.7	1.0	4.4	0.0	7.6	5.5
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;intestine: 13.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 91.8;Early spermatids: 59.1;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;HDLM-2: 19.4;SCLC-21H: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027497	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.0	0.4	4.2	0.9	4.4	0.3	0.9	0.0	7.6	0.2	0.0	13.4	3.5	0.1	3.9	0.4	0.9	1.0	0.1	4.3	2.1	0.2	0.0	0.1	0.2	1.9	0.4	0.0	2.6	1.3	6.7	0.0	0.7	0.6	6.3	3.1	1.4	0.2	0.0	0.2	6.7	0.4	0.0	0.1	3.1	13.4	4.1	0.1	0.4	0.0	0.1	0.2	0.2	1.8	1.5	1.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.0	19.4	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.0	1.0	0.0	0.1	0.7	2.0	0.6	0.0	0.0	0.4	0.3	1.7	8.6	0.4	1.1	0.0	0.0	0.2	2.8	0.1	0.0	0.0	0.9	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	4.4	0.0	7.6	4.3	2.1	1.9	0.4	0.7	0.0	4.1	1.8	0.0	0.0	0.5	0.3	0.2	0.1	0.0	0.0	0.0	5.6	1.3	0.9	1.5	0.0	0.1	0.0	91.8	0.0	0.0	23.8	0.0	0.4	59.1	0.0	0.0	0.1	18.7	0.0	24.5	2.5	0.0	0.3	1.5	0.1	0.0	0.1	0.0	0.0	0.0	11.8	15.8	10.5	0.0	0.0	0.0	183.7	1.8	0.1	0.0	1.0	0.0	0.4	0.0	2.5	2.2	2.3	21.1	0.4	0.0	0.2	7.8	0.0	0.0	3.1	0.0	0.0	0.1	18.2	2.6	0.0	0.0	0.0	0.1	0.0	11.0	0.2
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 39.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 317.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 23.8;hippocampal formation: 20.9"	"Group enriched"	"Detected in many"	9	"basophil: 1.6;gdT-cell: 1.7;MAIT T-cell: 1.7;memory B-cell: 1.3;memory CD4 T-cell: 2.5;memory CD8 T-cell: 1.7;naive B-cell: 1.2;naive CD4 T-cell: 1.0;NK-cell: 3.5;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 77.0;ASC diff: 33.9;CACO-2: 59.3;U-2197: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		9300000	"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.8	1.6	0.0	1.9	3.9	3.7	3.9	0.0	23.8	4.5	39.7	4.6	1.0	6.4	2.8	4.8	4.9	3.1	17.4	20.9	0.0	4.8	0.8	3.6	2.7	0.0	1.5	11.1	1.1	1.9	0.6	1.6	0.0	5.3	4.5	4.2	2.6	6.1	2.7	12.9	2.8	8.0	0.0	3.4	2.3	11.7	3.7	3.8	9.5	4.0	3.2	3.6	3.5	0.0	2.6	2.4	77.0	0.0	33.9	20.9	0.1	18.2	8.3	16.9	6.2	59.3	0.9	0.0	0.1	26.7	0.0	7.0	12.3	0.1	7.0	9.7	6.4	0.0	0.9	0.0	0.9	0.0	1.4	8.5	4.2	5.3	0.1	10.3	14.9	0.0	0.0	0.0	4.4	9.5	0.2	0.0	5.6	5.9	1.7	0.1	8.5	0.0	25.8	4.3	13.2	0.0	6.2	1.3	1.3	6.2	2.9	0.0	0.0	1.7	3.2	38.4	1.0	0.0	0.1	0.0	6.9	0.0	3.6	1.6	0.0	0.0	1.7	0.0	1.7	1.3	2.5	1.7	0.0	1.2	1.0	0.2	0.1	3.5	0.0	0.1	1.2	0.4	0.0	3.9	0.0	23.8	20.9	0.0	0.0	1.5	0.0	0.0	3.7	0.0	36.3	0.0	6.4	51.9	8.2	6.1	0.7	9.7	2.8	9.8	4.3	6.0	31.6	7.2	13.7	9.2	0.0	0.1	12.2	4.7	7.9	0.2	3.9	1.9	5.7	26.3	3.5	0.0	317.9	0.2	0.0	5.1	4.6	5.2	1.3	9.0	20.0	0.4	0.3	1.7	68.8	12.8	8.2	0.0	1.5	5.8	1.2	0.9	7.2	70.3	0.2	7.2	3.1	8.0	7.9	30.9	3.6	8.6	2.1	1.4	0.1	1.7	4.5	3.2	0.0	3.6	10.2	10.0	1.9	4.1	12.5	0.0	5.4	11.3	6.6	2.4
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 24.2;ovary: 6.3;testis: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 24.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 9.3;U-266/70: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.2	0.0	6.5	0.0	12.7	0.0	0.2	24.2	10.9	0.8	0.0	3.2	0.1	0.9	0.3	0.8	1.9	0.9	0.3	11.4	0.0	0.4	0.0	0.1	0.0	0.0	0.2	6.3	0.5	0.1	0.1	0.0	1.1	1.0	0.7	1.1	0.1	0.6	0.0	0.0	0.3	1.4	0.1	0.0	0.6	8.4	3.5	0.2	2.0	0.1	0.1	1.4	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	9.3	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.4	0.0	0.9	28.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	12.7	24.2	10.9	11.4	0.0	0.0	0.2	1.1	0.1	3.5	0.0	0.0	0.0	0.0	421.5	0.1	0.3	0.3	0.0	5.2	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.8	0.1	1.4	0.1	0.0	0.0	423.8	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	879.2	0.0	0.0	0.0	0.0	208.7	3.1	0.2	0.0	30.0	0.0	1.0	0.0	31.2	9.0	0.1	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.3	0.0	0.2	0.1	14.7	2.7	6.0	0.0	0.1	0.0	0.4	0.0	0.1
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419687	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.6;parathyroid gland: 69.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 138.6;Inhibitory neurons: 172.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		660000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	0.3	0.0	1.2	0.4	3.4	0.0	1.2	3.4	5.1	1.4	0.0	24.6	1.5	0.9	0.2	0.2	0.5	2.2	3.6	4.9	2.6	5.9	0.0	0.2	0.0	1.2	2.2	1.9	0.1	69.9	1.2	0.4	1.5	9.7	2.5	1.8	5.4	0.9	0.1	0.2	4.4	2.1	0.4	3.9	10.3	0.9	0.6	0.0	0.1	0.1	0.0	8.2	1.8	1.2	0.0	0.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	35.1	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	1.0	5.4	31.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	3.4	5.1	4.9	2.6	1.2	2.2	1.5	0.4	0.6	1.2	0.2	0.0	0.0	4.2	0.0	0.4	0.4	0.0	0.6	18.5	3.1	1.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	13.1	1.3	1.4	1.8	0.0	0.0	138.6	0.0	0.0	5.9	0.0	3.8	0.0	3.7	0.0	0.0	0.1	11.8	172.0	0.0	0.0	0.0	0.4	3.3	0.9	0.1	0.0	11.2	0.0	0.4	0.0	4.5	8.3	0.1	0.0	0.0	0.0	0.4	0.0	11.8	0.0	1.0	0.0	0.2	0.5	0.2	1.1	0.2	1.0	0.0	0.2	0.9	0.0	0.1
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563489-22603595	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 27.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.2;Cone photoreceptor cells: 2.1;Early spermatids: 2.8;Horizontal cells: 3.3;Late spermatids: 5.8;Rod photoreceptor cells: 8.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 59.6"	"Region enhanced"	"Detected in many"		"cerebellum: 13.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 11.7"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.0	3.5	2.7	0.0	2.3	0.0	0.0	1.5	2.3	0.0	27.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	0.0	0.0	0.0	0.0	1.9	3.1	0.0	3.3	0.0	1.5	0.0	2.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	2.3	4.6	0.0	2.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.6	4.8	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	1.5	2.3	4.9	5.3	1.9	3.1	2.0	2.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561785-184582408	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 51.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 38.1;Breast myoepithelial cells: 50.8;Enteroendocrine cells: 71.5;Intestinal goblet cells: 43.3;Squamous epithelial cells: 44.3;Undifferentiated cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.8;HaCaT: 40.2;OE19: 28.3;SK-BR-3: 30.9;T-47d: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					NA	NA		100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.7	0.7	3.0	3.7	2.7	0.1	10.4	5.8	4.1	22.7	1.0	10.3	6.4	10.1	1.8	30.6	4.0	2.8	1.9	2.9	2.4	5.8	0.9	3.4	0.9	5.7	3.4	8.3	14.9	1.1	2.0	5.7	6.1	10.0	10.9	0.5	31.7	3.5	0.5	51.5	6.3	3.8	2.3	1.0	22.8	0.9	4.0	0.7	0.9	0.4	2.4	4.0	20.9	2.7	6.6	2.3	14.8	1.6	4.5	0.3	28.8	1.1	1.9	2.2	1.2	2.0	0.2	0.0	2.8	6.3	1.0	40.2	5.4	1.9	0.6	0.2	1.1	0.0	0.3	0.0	0.3	0.0	0.2	1.2	13.0	1.8	0.2	0.7	0.0	0.0	0.0	0.0	1.0	17.6	0.0	6.4	1.4	28.3	2.5	1.5	9.0	0.0	0.0	5.8	1.9	2.2	1.2	30.9	1.3	7.8	20.5	0.1	0.0	3.6	5.1	1.8	2.5	0.0	0.0	0.1	0.3	0.0	14.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	5.8	4.1	2.9	2.4	5.7	3.4	6.1	2.3	4.0	2.7	0.9	3.2	2.7	11.1	0.2	24.1	7.6	5.3	17.1	0.9	38.1	50.8	1.8	2.8	4.6	0.0	0.0	10.1	1.1	21.5	1.9	0.5	0.6	3.7	4.0	1.4	71.5	0.0	4.6	1.6	18.7	6.9	27.0	7.5	4.5	2.1	1.8	0.0	23.5	15.2	5.8	43.3	10.2	0.3	9.8	0.4	2.8	2.4	0.0	1.0	0.8	0.1	0.0	5.0	0.3	3.2	7.2	6.0	0.0	6.0	1.7	0.2	1.4	1.0	0.0	4.5	2.9	0.4	0.6	44.3	35.8	16.3	0.8	1.6	55.0	20.7
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827523	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.0;neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013537	Uncertain					NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	26.4	49.8	5.0	8.0	4.3	5.6	32.6	4.6	4.8	45.6	6.8	20.7	8.3	61.5	3.8	24.7	27.1	18.0	26.1	4.1	4.1	28.3	33.3	28.2	5.8	5.5	5.1	36.0	26.8	10.1	6.3	35.5	5.3	28.9	10.2	0.3	24.2	22.4	7.7	35.8	17.5	22.2	5.1	47.9	21.4	12.3	6.3	3.1	17.6	13.3	4.9	17.3	28.1	4.8	37.7	33.1	32.5	94.2	20.4	13.0	94.7	14.1	31.2	22.3	29.0	27.4	28.3	4.8	63.6	15.3	31.3	38.2	14.3	38.3	11.9	6.2	25.6	1.3	19.0	43.2	11.8	0.7	0.9	15.3	56.7	14.2	33.1	24.8	84.0	1.5	71.9	1.8	18.4	66.4	0.7	15.0	54.7	56.3	47.5	51.4	15.6	8.9	28.6	19.9	0.2	27.4	22.0	10.4	22.1	45.1	26.1	6.7	71.3	27.6	42.6	51.3	21.4	0.2	0.8	1.7	4.0	12.0	51.2	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.7	5.0	4.3	4.6	4.8	4.1	4.1	5.5	5.1	5.3	5.1	6.3	4.8	47.1	9.6	12.6	1.6	1.9	20.5	10.3	13.9	15.9	0.1	22.0	19.7	5.7	7.2	8.5	5.5	0.0	68.5	1.1	9.1	0.0	12.3	28.5	4.8	21.8	51.2	3.0	10.8	0.3	6.6	11.2	6.5	12.8	8.0	1.3	10.7	113.2	22.4	9.0	0.0	0.2	17.4	8.2	4.1	3.4	9.9	8.1	1.3	3.6	1.9	1.5	1.7	0.0	0.0	1.0	20.6	7.6	4.1	1.4	13.3	1.3	4.0	4.2	0.2	6.6	5.7	6.3	1.4	10.2	12.1	17.8	206.5	1.2	2.9	19.9	8.0
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810124-225845563	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1178.6;liver: 1705.1"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1161.8;SiHa: 413.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	245.8	1178.6	233.5	23.6	252.5	22.7	163.7	239.0	249.3	188.3	345.8	82.0	102.2	108.1	97.6	159.6	153.8	96.5	94.0	221.3	233.7	110.7	1705.1	146.8	39.1	225.3	234.9	329.1	536.1	147.7	105.8	32.9	223.6	113.2	52.5	30.7	143.6	128.1	142.5	71.5	52.8	109.6	210.1	55.7	99.9	74.3	258.4	25.9	171.1	95.6	33.4	135.4	140.4	227.2	32.1	202.3	12.3	108.5	1161.8	120.2	24.3	29.7	49.2	28.1	35.1	38.8	293.6	1.3	128.7	147.3	30.6	38.1	32.7	16.8	12.1	7.8	46.5	21.8	83.5	282.7	129.8	12.9	15.1	109.2	40.0	74.6	6.3	116.5	22.1	13.4	14.5	27.3	50.4	30.3	13.5	31.0	61.6	178.1	79.4	27.8	15.2	92.9	91.1	132.5	98.3	13.0	413.0	192.1	51.3	32.1	131.7	43.5	46.8	41.9	35.4	54.5	59.0	9.1	38.9	4.1	63.5	14.2	59.5	0.0	2.6	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.6	0.2	0.5	0.3	0.2	0.7	0.3	0.9	0.3	0.8	233.5	252.5	239.0	249.3	221.3	233.7	225.3	234.9	223.6	210.1	258.4	227.2	196.9	0.0	14.0	41.1	5.7	19.6	121.8	244.2	74.0	8.8	29.7	27.4	1.2	102.9	255.5	51.5	29.2	46.6	3.4	34.5	17.6	95.3	10.2	142.9	32.2	82.7	10.8	7.0	3.1	73.0	7.6	175.6	30.5	93.4	5.7	349.9	88.2	757.6	149.1	1.7	5.0	17.5	103.7	30.9	28.7	28.4	311.3	25.8	42.7	23.4	9.6	99.2	0.0	7.1	19.4	45.5	27.2	159.1	9.5	40.4	63.4	128.9	174.3	10.1	223.5	29.3	146.9	4.4	5.1	129.0	17.6	22.8	4.7	1042.6	31.5	108.5
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.9;skin 1: 76.5;vagina: 36.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.5	0.3	0.8	0.2	0.8	0.2	1.5	0.6	0.9	14.7	0.7	0.2	0.2	0.4	0.3	68.9	1.7	1.3	0.5	0.7	0.9	3.3	0.3	1.7	0.1	0.9	0.8	0.7	0.2	3.0	1.8	0.4	0.8	1.5	0.2	0.2	7.6	0.9	0.4	76.5	0.3	0.4	0.8	2.6	0.8	2.1	0.9	1.7	0.4	0.1	26.7	8.6	36.6	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.8	0.8	0.6	0.9	0.7	0.9	0.9	0.8	0.8	0.8	0.9	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
EPHX4	"ABHD7, EH4, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029985-92063538	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;choroid plexus: 5.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 55.3;Inhibitory neurons: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 12.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.4;CAPAN-2: 13.0;EFO-21: 25.9;RPTEC TERT1: 36.1;U-251 MG: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	0.5	0.5	4.0	0.5	9.2	0.0	1.4	1.9	10.9	0.9	5.7	0.6	0.6	0.6	0.5	0.8	0.4	0.4	0.5	6.9	2.3	0.4	0.0	0.6	0.2	3.1	2.3	0.1	0.0	0.4	1.1	0.8	3.1	0.9	0.5	2.1	0.2	1.8	0.1	0.5	0.4	1.1	1.8	0.0	0.3	1.2	2.8	0.0	1.8	0.1	0.2	0.7	0.2	5.5	15.4	0.5	2.9	0.0	0.0	0.0	0.7	0.3	5.5	0.5	0.3	0.0	13.0	0.0	25.9	0.0	3.9	0.2	0.5	1.2	0.5	0.0	8.0	0.0	0.1	0.0	0.2	1.1	0.0	0.9	0.7	0.0	0.0	9.4	4.5	0.0	0.1	0.0	0.4	0.9	2.2	0.6	2.8	0.0	5.2	0.5	0.3	0.0	36.1	3.0	1.8	2.2	9.1	0.0	2.9	0.2	0.0	2.2	0.2	0.0	0.1	0.0	10.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	2.0	0.1	1.4	3.0	0.0	0.0	0.3	2.8	0.0	0.5	0.0	0.0	0.0	1.5	4.0	9.2	1.9	10.9	6.9	2.3	3.1	2.3	3.1	1.8	2.8	5.5	2.0	0.0	0.0	4.9	0.0	0.1	0.1	2.0	0.0	2.0	6.7	4.6	1.0	0.0	1.5	0.0	2.1	0.4	3.2	0.1	0.0	0.4	1.7	1.0	0.1	6.2	0.0	0.0	55.3	0.9	0.7	0.3	0.0	1.3	0.0	0.3	0.4	0.0	0.2	1.7	32.5	0.0	0.0	0.0	0.4	0.1	0.0	0.2	3.6	4.7	0.1	8.6	0.0	5.5	2.7	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.6	0.0	0.1	0.8	6.0	0.7	0.1	0.4	0.0	1.1	0.2	0.3	0.3
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
EPN2	"EHB21, KIAA1065"	ENSG00000072134	"Epsin 2"	O95208	17	19215615-19336715	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Oligodendrocyte precursor cells: 868.6;Oligodendrocytes: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.9;eosinophil: 29.0;neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.0"	"Cell line enhanced"	"Detected in many"		"SuSa: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049809, HPA053360"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA049809: AB_2680893, HPA053360: AB_2682126"	"unprognostic (1.38e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (8.15e-5)"	20.5	13.9	62.1	9.7	64.9	11.5	16.7	50.4	62.8	36.3	32.7	28.3	9.6	29.5	11.5	40.3	26.6	14.6	32.5	62.6	56.2	21.3	9.3	18.6	6.5	61.6	63.6	22.5	14.6	15.3	18.1	21.6	57.5	23.6	9.5	19.1	17.9	23.4	22.4	50.1	13.3	22.5	46.6	14.3	15.9	19.7	63.6	4.7	17.8	17.0	8.4	27.0	33.8	91.6	31.3	30.4	43.9	19.2	22.8	36.3	34.5	29.4	18.9	17.9	15.3	20.2	9.2	4.9	28.2	29.5	16.8	29.0	19.8	22.1	21.9	23.6	21.2	3.2	20.3	9.2	23.7	1.4	13.1	20.5	19.5	28.3	22.7	23.2	38.8	6.6	8.6	3.9	15.8	22.5	1.3	2.1	11.1	41.3	19.8	7.1	18.8	8.1	21.0	8.6	13.0	28.8	20.9	13.9	14.7	127.9	21.0	4.0	35.6	19.7	22.3	30.9	12.9	6.7	4.3	3.9	54.0	0.5	31.1	10.9	1.3	29.0	1.6	0.8	1.2	3.0	1.1	1.3	0.5	3.4	1.3	1.2	9.0	0.7	1.0	0.6	1.0	0.7	62.1	64.9	50.4	62.8	62.6	56.2	61.6	63.6	57.5	46.6	63.6	91.6	60.0	54.5	29.3	74.4	13.7	24.1	36.6	21.2	43.9	68.3	32.8	33.4	44.5	25.8	25.0	38.6	47.9	27.6	3.3	7.2	27.4	22.5	36.8	69.2	35.0	42.5	6.0	13.5	51.3	8.4	39.8	36.1	15.8	40.6	14.0	37.3	15.0	10.4	8.4	35.3	45.0	16.8	10.2	5.1	6.2	72.7	46.6	5.9	5.4	54.4	1.6	38.3	2.1	868.6	258.3	23.3	14.9	39.5	14.4	32.0	7.0	14.2	43.2	82.3	26.3	50.5	63.7	45.8	38.3	63.9	48.9	21.9	7.4	35.0	7.8	40.1
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532682-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;stomach 1: 37.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.2	8.9	2.3	0.8	1.3	0.6	2.3	6.4	6.0	6.5	1.2	7.1	6.8	0.4	3.2	35.9	7.5	5.9	7.1	0.7	2.1	6.0	0.1	0.3	0.0	11.5	5.4	13.5	23.0	21.2	0.8	4.2	13.6	9.9	4.4	0.2	11.1	5.6	0.1	30.5	3.2	0.1	0.5	0.0	37.3	2.8	13.4	3.2	1.1	0.0	3.7	5.5	12.9	1.8	20.5	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	14.7	12.1	0.0	0.2	0.0	0.1	28.6	0.0	40.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.1	21.8	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.0	66.4	0.3	0.0	0.0	62.8	0.4	0.0	0.0	0.1	0.2	50.2	0.4	0.0	0.0	25.8	0.0	0.4	57.4	0.2	1.5	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	6.4	6.0	0.7	2.1	11.5	5.4	13.6	0.5	13.4	1.8	0.2	0.0	0.0	0.0	0.4	2.3	4.4	4.1	10.8	2.9	6.5	3.4	5.4	8.6	8.3	18.4	0.0	77.9	0.0	27.6	5.9	9.2	1.0	3.8	0.6	0.4	3.6	0.0	1.0	11.5	7.4	0.8	44.9	5.5	0.0	3.1	0.0	0.0	5.9	0.0	1.7	24.9	2.0	0.0	0.0	2.1	2.8	0.5	0.0	1.0	0.6	0.6	0.0	0.0	0.0	3.4	10.3	0.0	1.3	4.9	2.1	0.3	4.3	0.9	0.0	0.0	0.8	0.0	0.5	30.0	5.5	10.7	0.2	12.4	19.3	7.8
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720468-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.9;Exocrine glandular cells: 4.2;Extravillous trophoblasts: 14.0;Hepatocytes: 19.5;Pancreatic endocrine cells: 3.7;Syncytiotrophoblasts: 2.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.6;Hep G2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.3	2.9	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.4	0.1	0.4	3.1	47.2	0.1	0.0	0.2	0.1	0.2	8.3	0.0	0.0	0.0	0.2	0.5	0.0	0.2	1.4	0.5	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.2	14.0	0.0	0.0	0.0	0.0	0.1	1.4	19.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	2.9	0.0	0.0	0.0	0.0
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38674957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4;testis: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.5;basal ganglia: 8.8;cerebral cortex: 10.4;hippocampal formation: 7.7;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.9;Hep G2: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.6	2.2	4.5	1.7	8.8	0.5	1.1	0.9	10.4	0.9	0.5	0.8	0.3	1.2	0.8	1.9	1.1	0.9	1.2	7.7	0.9	1.6	3.8	1.1	2.7	1.4	1.7	0.8	3.7	4.8	0.8	1.3	1.6	1.4	0.4	2.2	0.8	0.9	0.6	3.3	0.9	0.7	1.3	1.1	1.3	10.0	1.7	1.5	0.6	0.3	3.5	2.9	0.7	5.4	9.2	10.8	6.8	47.9	1.5	0.4	11.7	1.9	0.7	2.1	3.3	10.8	3.3	17.1	11.6	1.2	6.1	7.3	22.6	4.6	3.7	18.2	17.1	3.8	1.5	57.3	3.1	2.1	9.0	1.0	8.0	2.3	4.6	4.4	1.6	18.8	12.0	25.9	1.4	14.4	15.8	5.1	1.5	6.0	9.6	37.3	3.9	37.8	1.3	2.4	10.4	15.8	6.0	7.8	2.1	11.0	11.4	7.2	2.7	2.0	2.0	2.2	1.8	13.5	16.1	21.7	3.9	25.4	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.8	0.9	10.4	7.7	0.9	1.4	1.7	1.6	1.3	1.7	5.4	4.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	19.3	13.6	0.0	0.0	1.3	1.8	0.0	1.7	3.5	0.0	0.0	4.2	0.0	3.4	4.8	1.8	0.0	0.0	0.0	4.0	1.5	1.0	0.0	6.4	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.1	0.6	0.8	0.0	0.0
EPPIN	"CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7"	ENSG00000101448	"Epididymal peptidase inhibitor"	O95925	20	45540626-45547752	"Predicted intracellular proteins, Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"epididymis: 327.9;testis: 84.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 30.0;Granulosa cells: 13.6;Late spermatids: 29.2;Respiratory ciliated cells: 32.5;Sertoli cells: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.8;U-87 MG: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067335	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA067335: "	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"		"unprognostic (3.08e-3)"				"unprognostic (1.06e-2)"		"unprognostic (3.75e-2)"				"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.00e-2)"		0.3	0.3	0.7	0.3	1.1	2.4	0.2	1.9	2.4	0.5	0.1	0.4	0.7	0.7	327.9	0.3	1.3	0.2	0.1	0.9	0.0	0.2	2.3	0.4	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.6	0.2	0.4	1.2	0.3	0.8	0.2	0.8	0.7	0.1	0.0	0.4	0.2	84.2	0.4	0.0	0.7	0.0	0.2	0.1	0.0	2.0	0.8	0.1	0.3	0.3	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.5	0.3	0.6	0.3	0.0	0.6	0.3	0.1	0.0	0.0	0.5	0.1	0.3	0.5	0.4	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.6	1.8	0.0	0.4	0.2	0.7	0.8	0.1	0.2	0.7	0.2	0.5	0.1	0.2	0.3	0.5	0.3	0.1	0.3	0.3	0.4	0.4	0.7	0.7	0.6	0.9	0.5	0.6	0.8	0.3	2.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.7	1.1	1.9	2.4	0.9	0.0	0.1	0.0	0.6	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.1	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	30.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	29.2	4.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	32.5	0.0	13.1	0.0	0.4	5.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	"EPPIN-WFDC6 readthrough"	O95925	20	45534196-45547662	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"epididymis: 63.6;testis: 53.6"	"Cell type enriched"	"Detected in single"	6	"Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067335	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA067335: "										"unprognostic (1.46e-3)"					"unprognostic (6.38e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	63.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"	P58107	8	143857324-143878467	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 16.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 137.1;Suprabasal keratinocytes: 274.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;EFO-21: 13.3;HaCaT: 13.8;HeLa: 26.8;MCF7: 20.2;SK-BR-3: 9.3"	"Not detected"	"Not detected"							"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA		1200000		"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.2	0.0	0.4	0.3	0.4	0.1	0.9	3.9	0.5	0.5	1.3	3.3	2.1	2.4	0.3	1.7	2.0	0.2	0.1	0.8	0.6	1.2	0.3	0.9	0.1	2.5	2.7	0.0	0.7	0.2	0.2	0.2	1.7	1.4	0.6	0.0	2.2	1.4	0.2	16.1	2.7	0.9	1.6	1.2	2.1	1.8	0.7	0.1	0.2	0.0	0.2	1.8	0.9	0.4	7.9	0.1	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	7.4	0.5	0.0	13.3	0.0	0.0	13.8	1.4	0.1	0.0	0.0	3.4	0.0	26.8	4.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.2	0.0	0.0	1.4	1.8	0.0	0.0	0.1	0.0	0.0	4.9	2.3	0.0	2.2	9.3	0.0	1.2	7.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	3.9	0.5	0.8	0.6	2.5	2.7	1.7	1.6	0.7	0.4	0.7	19.2	9.2	1.0	1.1	137.1	20.3	8.2	8.0	0.6	32.7	25.0	27.9	11.5	4.4	14.7	0.0	2.5	0.0	48.1	0.0	11.3	0.5	12.6	0.5	3.2	6.0	0.0	0.3	14.7	0.3	2.4	12.2	10.1	0.0	0.6	0.7	4.4	0.3	0.0	0.0	14.5	12.2	0.0	8.2	0.3	0.0	0.4	16.0	0.0	0.0	0.6	0.0	0.0	0.1	31.9	21.7	0.0	0.2	8.6	28.2	7.0	24.2	0.2	0.0	0.0	5.2	1.5	1.0	10.6	274.3	6.2	1.2	0.1	28.4	31.5
EPRS1	"EARS, EPRS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase 1"	P07814	1	219968600-220046530	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	28.8	24.7	18.1	34.4	19.6	26.6	35.7	22.8	24.8	30.5	17.6	36.1	27.7	25.6	25.2	30.6	26.2	20.6	31.8	17.7	21.8	31.6	27.9	24.3	36.5	21.6	20.5	34.7	49.0	54.5	22.5	23.8	22.9	23.6	39.0	43.8	83.4	26.4	52.2	28.9	29.7	32.5	22.4	27.4	35.9	20.5	21.7	34.8	43.0	55.9	42.5	30.4	18.6	27.8	125.9	78.4	55.7	152.3	114.9	126.7	138.0	160.1	111.7	102.1	113.4	93.3	98.1	239.3	86.7	170.4	41.3	130.3	140.9	129.4	136.2	117.9	88.9	130.2	97.6	80.2	125.1	217.6	106.7	92.1	161.7	130.3	161.6	84.8	113.4	113.2	228.0	182.9	100.8	61.8	94.7	53.1	107.4	146.8	159.6	98.5	98.0	236.2	92.8	54.4	128.6	101.3	93.7	152.6	166.5	78.9	141.2	235.1	101.1	48.3	88.1	149.6	151.1	122.8	150.1	197.1	111.4	153.9	156.4	8.8	17.8	10.0	19.7	24.6	27.8	21.0	19.7	22.1	23.2	18.5	22.0	22.9	0.6	22.5	22.1	7.6	20.8	17.2	18.1	19.6	22.8	24.8	17.7	21.8	21.6	20.5	22.9	22.4	21.7	27.8	22.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.7	0.0	0.0	0.0	0.0	40.8	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	59.3	17.1	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	36.5	2.6	0.0	0.0	0.0
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519266	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	31.9	35.1	40.3	25.5	48.2	20.7	25.6	38.8	55.7	23.9	25.7	19.1	15.8	22.8	17.6	21.0	18.3	26.1	26.5	43.9	39.1	24.5	26.4	26.9	46.0	38.6	44.1	28.8	14.7	29.0	15.5	31.5	40.7	26.7	20.5	23.4	16.7	20.9	47.6	24.2	17.7	24.3	40.1	34.1	21.3	46.9	45.0	27.6	25.3	40.5	45.6	22.8	20.9	57.2	35.4	10.4	22.0	20.8	49.6	49.2	54.5	24.2	37.9	19.4	28.4	14.4	19.2	71.8	24.3	38.1	39.5	32.7	28.7	23.1	29.1	81.8	18.0	64.1	16.9	17.1	46.7	36.9	56.4	40.3	21.0	34.0	45.7	33.5	36.5	25.2	40.4	31.7	29.8	17.5	29.9	19.8	30.2	24.6	16.7	24.1	33.3	15.9	25.5	43.2	15.0	20.9	28.8	50.4	42.1	60.2	20.5	25.7	51.1	18.0	19.1	36.3	20.5	37.6	41.0	47.6	26.6	41.0	16.1	18.8	10.4	12.1	9.4	10.7	14.2	15.6	11.2	14.9	10.8	9.0	6.6	9.6	7.8	10.8	13.0	7.1	19.0	8.7	40.3	48.2	38.8	55.7	43.9	39.1	38.6	44.1	40.7	40.1	45.0	57.2	51.5	35.3	41.0	142.4	78.3	43.0	32.1	16.4	30.1	18.1	28.2	15.6	59.8	24.3	22.7	44.1	31.3	22.8	65.0	28.5	19.6	15.2	27.0	22.1	50.1	43.3	28.8	81.0	77.1	19.0	18.9	52.5	41.3	35.6	24.6	36.0	61.4	37.7	83.4	28.6	60.6	30.7	12.2	80.9	61.9	61.7	65.9	67.0	103.2	110.5	57.6	38.4	27.8	29.7	314.1	23.3	19.8	48.2	78.4	62.1	20.7	28.1	31.9	26.6	39.5	45.1	38.0	74.4	44.5	33.8	51.0	28.5	74.3	28.5	21.4	50.8
EPS15L1	eps15R	ENSG00000127527	"Epidermal growth factor receptor pathway substrate 15 like 1"	Q9UBC2	19	16355239-16472085	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019237, HPA055309"	Approved		Approved	Vesicles		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA019237: AB_1848223, HPA055309: AB_2682780"	"unprognostic (3.06e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.54e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.47e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-1)"	15.3	17.6	33.4	11.8	32.4	23.6	14.2	39.6	40.5	22.4	21.5	17.0	8.3	18.1	5.9	25.2	18.7	9.6	42.4	35.6	29.1	20.5	17.9	14.6	13.9	29.3	33.4	19.1	15.5	18.2	22.6	13.9	30.8	19.5	9.2	14.0	14.9	12.9	67.6	23.3	14.3	14.1	23.5	19.8	16.8	22.9	41.0	11.8	17.5	25.7	13.0	17.6	19.7	27.6	27.3	12.8	25.8	20.4	27.4	21.1	40.3	17.8	14.9	28.8	25.1	15.3	18.2	29.2	30.4	26.1	22.8	26.6	36.3	20.8	25.1	15.8	36.8	24.7	17.4	29.8	27.7	22.8	26.7	17.6	21.1	31.9	22.3	28.6	23.6	24.5	20.1	31.2	24.5	53.9	25.4	32.5	17.7	36.4	41.7	32.2	12.5	24.3	19.8	27.9	23.3	15.3	18.6	17.5	17.7	19.2	58.3	21.3	24.5	18.2	12.2	57.3	31.4	8.8	19.4	27.7	20.2	31.9	24.5	53.5	11.9	35.9	11.1	12.0	10.5	20.8	9.8	12.0	9.2	19.3	10.1	7.8	56.2	19.1	14.4	8.6	10.7	9.0	33.4	32.4	39.6	40.5	35.6	29.1	29.3	33.4	30.8	23.5	41.0	27.6	10.8	9.6	9.8	62.3	22.1	16.6	14.0	12.0	12.0	30.7	9.5	8.1	20.4	7.2	10.9	9.2	50.1	21.7	30.8	11.7	9.8	11.0	74.9	10.7	13.0	11.8	11.3	13.9	49.7	5.7	19.7	16.0	16.3	12.1	12.0	22.3	11.0	8.2	20.0	11.8	63.4	10.7	24.4	10.6	14.8	15.1	18.6	13.8	3.6	30.9	13.0	9.9	34.0	36.2	35.6	9.3	9.1	20.3	18.7	15.0	9.0	12.9	14.7	25.9	19.7	20.3	13.9	18.5	16.7	22.3	24.4	10.9	15.8	18.7	9.8	22.2
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620134-15882329	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 22.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 253.0;HHSteC: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA		17000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	62.3	13.0	12.9	16.1	17.4	0.6	33.7	15.3	14.0	53.9	14.1	49.7	37.6	46.2	47.1	20.5	20.1	56.0	26.4	11.1	17.2	55.8	37.8	29.0	9.4	18.5	20.1	49.2	15.1	21.6	3.5	53.1	19.7	16.4	53.7	39.8	13.4	39.8	13.8	11.9	42.7	53.7	15.5	11.9	32.0	15.6	16.1	4.8	22.8	24.3	5.2	51.7	21.4	20.8	65.0	38.8	37.7	1.4	253.0	177.6	53.1	73.6	59.8	34.5	46.1	33.3	97.3	0.0	2.4	140.4	114.4	16.4	11.3	9.5	52.4	0.2	12.6	5.7	11.2	34.7	218.1	4.4	0.2	159.8	42.8	91.7	115.7	44.6	17.7	0.2	0.1	0.2	169.0	17.5	0.2	2.8	5.2	50.3	30.8	0.0	109.5	0.8	97.7	92.5	3.1	4.9	21.4	12.4	91.5	6.2	34.2	4.3	28.7	54.7	14.3	32.4	30.7	3.6	0.4	0.1	32.1	10.7	160.0	0.0	2.7	0.2	0.2	10.8	0.1	1.3	0.9	0.4	5.5	0.3	1.1	0.5	4.4	1.0	22.2	0.4	0.1	1.7	12.9	17.4	15.3	14.0	11.1	17.2	18.5	20.1	19.7	15.5	16.1	20.8	121.4	12.8	175.9	91.1	11.6	17.0	39.6	32.0	13.6	9.7	28.7	42.8	27.6	87.2	58.3	23.9	66.7	33.0	15.2	317.0	60.7	69.4	67.6	87.4	72.0	61.4	38.3	0.4	2.2	68.9	7.3	73.4	81.1	152.2	6.3	139.4	36.0	36.0	65.8	6.7	31.1	54.5	67.1	54.1	35.6	49.4	134.8	46.2	35.6	148.0	8.6	15.4	0.0	121.2	96.9	97.0	217.8	43.6	5.2	26.9	69.0	114.6	104.8	153.7	401.0	18.1	313.1	10.9	4.2	22.8	13.1	21.1	11.8	40.0	80.0	97.6
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 124.3;skin 1: 59.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 104.1;Gastric mucus-secreting cells: 108.1;Paneth cells: 110.2;Syncytiotrophoblasts: 428.0;Urothelial cells: 189.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 17.6;BEWO: 58.8;SK-BR-3: 19.6;T-47d: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA041851: AB_2677706, HPA043545: AB_2678544"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	4.5	0.2	0.0	0.9	0.1	0.1	4.0	0.0	0.1	24.0	0.0	3.5	2.3	1.5	0.0	124.3	14.8	0.9	0.6	0.1	0.0	25.1	0.7	3.9	0.0	0.1	0.1	0.5	5.6	2.1	2.1	5.4	0.1	9.2	0.6	0.0	20.4	2.5	0.5	59.7	2.0	0.0	0.0	0.6	27.0	0.6	0.2	0.1	17.4	0.0	1.6	2.7	37.1	0.2	17.6	0.7	0.6	0.4	0.0	0.0	58.8	1.5	0.1	0.0	0.1	7.6	13.7	0.3	3.4	0.0	0.1	9.7	0.4	2.1	0.0	0.3	1.6	1.3	0.6	0.5	0.2	2.6	10.8	0.0	3.6	0.0	0.0	0.0	0.0	1.2	6.2	0.1	0.0	8.0	0.9	2.6	0.8	12.7	0.0	0.1	0.0	5.4	2.7	3.6	0.2	3.8	1.0	19.6	0.8	0.6	28.9	3.2	1.3	0.0	0.7	0.0	0.0	2.4	3.1	1.6	3.3	0.9	2.0	1.1	0.2	2.3	0.3	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	4.0	9.6	6.1	0.3	0.8	2.0	28.4	39.5	8.6	0.0	16.3	15.1	2.6	8.6	92.2	31.3	0.0	55.1	4.0	104.1	13.7	20.4	1.6	29.1	6.3	10.7	3.0	0.0	0.1	10.2	26.8	4.7	108.1	41.7	10.2	5.4	10.0	0.1	8.9	0.0	0.1	39.0	24.4	1.9	3.4	4.5	1.2	2.6	21.4	0.0	5.2	0.2	6.2	0.0	0.1	94.5	110.2	0.7	1.0	48.7	12.7	1.1	53.6	0.6	26.3	0.5	21.6	1.6	3.6	6.6	4.0	428.0	2.8	0.3	22.1	189.4
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 188.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 9.2"	HPA041143	Approved		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	7.8	11.2	5.2	5.7	4.8	0.0	27.0	8.9	5.5	49.4	4.9	42.7	100.8	11.4	3.5	188.5	19.2	13.3	4.3	4.5	6.8	98.4	101.7	32.4	0.7	10.9	9.2	11.8	43.7	3.8	11.5	17.7	6.2	29.3	15.5	1.0	94.6	15.2	1.3	76.3	105.0	2.9	7.1	1.4	48.1	3.2	7.1	2.0	70.2	0.4	10.9	17.5	80.1	6.5	234.3	68.6	0.2	1.6	2.7	14.4	220.8	20.1	20.3	29.2	12.5	51.4	206.6	0.4	81.6	21.4	5.4	122.4	0.6	117.8	6.4	0.6	5.4	0.0	27.7	94.7	16.3	0.3	0.4	8.1	77.8	8.0	18.7	12.3	0.2	0.1	1.8	1.1	3.2	72.1	0.5	1.3	2.7	71.5	24.0	0.5	0.8	1.8	103.8	55.2	0.8	0.8	75.9	257.5	0.5	14.3	94.9	0.2	1.5	11.2	27.3	7.2	1.6	0.9	1.0	0.8	6.1	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.1	5.2	4.8	8.9	5.5	4.5	6.8	10.9	9.2	6.2	7.1	7.1	6.5	1.8	141.1	51.8	3.9	11.2	19.8	26.2	48.8	51.8	0.6	39.1	37.0	4.5	57.2	62.4	90.1	0.0	47.9	21.6	211.4	27.4	55.2	1.0	47.3	7.1	4.7	43.8	1.3	3.1	80.0	33.4	11.5	131.0	60.8	7.0	0.4	0.7	59.4	4.7	0.0	3.8	76.8	32.6	2.1	7.8	2.3	18.0	2.7	14.2	2.8	3.1	10.0	16.5	2.0	0.7	83.2	175.3	11.7	7.6	33.6	235.9	108.2	60.9	1.5	0.0	0.9	7.5	1.1	4.8	74.9	24.4	92.5	18.6	0.9	77.2	32.1
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 35.7;intestine: 142.1;stomach 1: 50.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.0	0.0	1.3	0.0	77.1	141.8	0.2	0.9	0.1	0.1	35.7	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	77.1	0.0	0.0	0.2	0.0	0.0	142.1	2.9	0.0	0.0	50.7	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.6	14.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	67.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	14.3	0.3	0.0	0.0	0.0	0.0	254.4	0.0	11.6	28.0	0.7	0.1	0.3	51.4	0.0	0.0	23.9	0.0	0.0	80.5	1.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	103.4	0.0	0.0	0.0	144.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	257.8	0.4	0.3	0.0	285.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.6	112.6	1.8
EPSTI1	"BRESI1, MGC29634"	ENSG00000133106	"Epithelial stromal interaction 1"	Q96J88	13	42886388-42992271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 168.1;monocytes: 144.2;Proximal enterocytes: 156.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 99.6;HDLM-2: 74.2;RPMI-8226: 35.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017362	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA017362: AB_1848226"	"unprognostic (2.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (7.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.13e-2)"	7.5	7.7	3.7	31.6	4.1	33.6	4.8	3.1	5.1	5.7	2.8	12.6	33.7	6.0	1.6	5.0	3.7	18.1	4.7	3.1	3.6	8.0	12.9	16.8	34.2	7.8	4.6	3.1	3.5	7.6	2.7	16.8	5.2	2.7	11.0	0.3	18.5	4.8	2.2	1.5	32.0	9.7	5.5	31.3	15.8	7.4	4.4	27.7	3.1	2.5	20.7	13.1	3.6	4.5	2.8	0.1	0.0	0.0	0.1	5.2	3.0	2.3	26.0	95.8	99.6	23.2	5.7	3.7	0.8	3.4	10.1	11.4	0.2	3.9	12.2	74.2	0.2	11.9	0.0	0.1	22.9	0.0	2.0	17.4	5.2	7.7	0.5	1.4	1.4	5.7	0.0	17.9	2.5	0.2	19.0	2.9	0.5	1.9	0.1	0.2	0.1	35.7	16.1	0.7	2.0	0.0	0.3	0.0	1.9	0.4	0.6	1.9	3.9	0.0	0.0	1.0	0.0	0.8	0.6	0.0	1.9	0.0	1.0	52.3	34.4	29.4	10.8	59.3	11.4	26.7	22.3	12.3	31.1	23.7	10.4	7.8	16.1	24.4	39.3	3.8	59.0	22.5	3.7	4.1	3.1	5.1	3.1	3.6	7.8	4.6	5.2	5.5	4.4	4.5	26.5	19.2	10.9	1.3	40.0	4.2	1.7	4.1	0.6	0.0	1.2	1.8	2.9	12.8	9.2	5.5	0.0	10.9	27.1	26.5	1.9	40.9	89.0	10.2	18.8	18.8	24.6	31.5	0.3	39.0	168.1	15.9	15.3	20.7	10.8	22.4	12.5	6.3	84.2	0.0	11.6	25.1	2.0	39.2	28.3	27.1	14.9	68.7	10.6	84.3	144.2	0.2	37.0	4.5	0.3	51.2	55.4	4.9	23.6	3.6	156.0	39.1	6.5	0.1	0.0	2.6	10.6	2.6	1.7	2.8	3.8	14.5	37.0	43.9	37.6	3.7
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192726-58205174	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"bone marrow: 33.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;Inhibitory neurons: 1.2;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	68	"NB-4: 248.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.0	0.1	0.0	0.2	0.2	33.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.1	0.0	0.0	1.3	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	248.2	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963682-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"placenta: 6.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"breast cancer: 2.4;ovarian cancer: 7.7;pancreatic cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 3.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.7;basal ganglia: 2.9;cerebral cortex: 2.7;hippocampal formation: 2.2"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284654-27297150	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 37.8"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 739.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA015089, HPA015504"	Enhanced		Approved	"Plasma membrane,Actin filaments"	"Secreted in male reproductive system"	NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Actin filaments"		"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.2	0.0	0.4	0.0	1.2	0.0	0.2	0.8	0.6	0.2	0.2	0.3	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.2	1.5	0.9	0.5	0.4	0.0	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.8	0.2	0.2	37.8	1.6	0.0	0.2	0.1	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.8	0.6	0.2	0.4	1.5	0.9	1.3	0.8	1.6	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	739.3	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	67.8	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.7	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	16.2	2.4	0.0	0.3	0.1	0.0	0.1	0.2	0.1
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28855010-28861061	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	20.3	32.5	47.6	17.5	47.7	18.5	23.4	48.4	61.7	20.9	44.7	25.8	22.0	22.1	22.7	28.8	26.2	15.1	41.0	48.0	48.0	29.2	41.2	18.3	22.0	47.9	47.3	25.6	23.6	36.2	18.9	24.5	48.1	21.0	28.1	16.9	22.6	23.9	52.7	26.3	19.9	26.5	47.7	21.0	26.3	17.9	48.4	23.8	19.2	51.8	29.6	22.1	20.6	48.9	50.4	96.2	55.9	63.1	59.1	40.6	53.4	40.1	56.2	117.1	95.9	94.5	31.7	64.1	47.0	68.8	87.9	55.2	102.0	90.0	97.5	63.6	119.8	52.2	60.6	95.8	75.5	63.0	45.7	53.5	78.1	95.3	89.3	46.1	97.2	80.4	104.4	39.9	66.4	78.7	66.1	98.4	50.6	91.8	46.0	59.7	87.6	83.4	71.3	56.1	58.6	47.1	64.5	155.6	51.6	82.2	110.0	71.8	39.7	48.1	53.1	52.9	84.6	32.0	62.3	69.9	51.4	54.4	49.1	25.5	34.2	14.4	32.2	44.6	24.2	38.9	26.9	23.5	54.9	36.3	30.8	32.2	2.6	42.8	31.6	28.7	32.1	30.8	47.6	47.7	48.4	61.7	48.0	48.0	47.9	47.3	48.1	47.7	48.4	48.9	12.4	6.4	2.8	5.9	14.0	8.0	12.7	33.9	12.0	10.9	14.9	18.3	8.0	17.2	13.9	11.0	6.2	69.1	9.9	13.4	37.2	28.1	1.0	11.1	14.0	14.4	21.6	20.4	7.2	21.6	55.2	15.8	19.9	13.3	5.1	24.8	14.3	21.7	35.6	11.8	7.8	15.0	26.4	8.5	6.7	5.4	14.3	12.4	10.6	3.7	66.6	16.4	9.2	5.5	4.3	21.1	12.9	15.8	29.2	15.1	20.0	33.3	9.7	9.0	19.7	11.0	15.6	22.3	21.7	25.4	11.6	51.7	10.4	25.0	26.6	9.9
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.8;Inhibitory neurons: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		30000000	"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	51.5	15.8	3.7	37.0	4.3	27.9	25.5	3.1	5.6	21.8	2.3	37.9	63.4	22.0	14.4	13.2	25.5	23.7	17.1	3.4	5.2	16.4	32.9	31.2	38.2	8.4	5.7	20.7	13.7	19.1	8.2	47.0	7.0	18.6	43.7	12.4	19.3	22.0	20.9	36.5	55.1	21.7	5.0	30.8	33.7	9.1	6.6	63.7	17.5	19.6	36.8	27.3	11.7	6.8	25.9	14.1	21.3	20.0	114.7	111.5	61.4	18.3	59.6	44.0	76.2	17.6	91.1	75.3	37.6	36.0	61.8	25.7	17.8	38.1	27.3	139.8	7.5	24.7	10.0	13.9	130.9	12.0	44.1	46.8	16.2	50.6	15.5	64.3	61.1	48.8	12.9	74.7	26.7	11.6	113.2	12.4	10.6	3.1	10.4	82.4	28.8	38.4	32.8	39.0	7.8	5.5	29.6	19.8	28.6	14.6	17.1	57.0	48.8	37.4	12.6	6.2	31.1	26.9	53.9	57.8	40.2	40.2	22.5	28.8	15.2	18.0	22.6	12.3	20.2	14.8	19.2	19.1	10.5	18.3	22.3	18.1	15.8	23.1	20.6	16.7	13.9	13.7	3.7	4.3	3.1	5.6	3.4	5.2	8.4	5.7	7.0	5.0	6.6	6.8	11.1	9.6	16.3	34.0	15.3	25.0	14.2	19.2	8.6	13.6	6.6	3.9	10.6	10.0	16.9	9.2	2.1	9.6	21.1	24.4	0.0	12.4	27.0	12.7	15.0	16.3	10.3	14.1	72.8	15.5	11.9	18.4	16.3	19.8	15.2	13.9	16.8	28.0	17.6	3.3	79.3	23.9	4.1	29.9	16.1	7.3	9.9	22.9	7.2	24.4	32.5	9.0	20.6	32.6	70.1	12.3	14.1	16.1	32.3	13.5	47.3	6.9	23.1	7.6	0.0	10.3	22.6	1.4	1.8	9.8	11.1	9.2	21.8	5.7	27.3	14.9
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875986-96919703	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 176.1;GAMG: 105.0;hTEC/SVTERT24-B: 83.2;MOLT-4: 98.8;TIME: 188.7"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		11000000	"Cluster 15: NK-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	7.8	7.1	3.0	31.5	3.0	7.5	11.9	2.3	4.3	12.2	3.0	16.2	32.6	8.4	17.5	10.5	7.0	11.0	7.5	2.9	2.5	11.3	14.5	18.1	46.4	4.3	3.3	8.5	2.9	3.7	3.6	11.0	3.5	10.3	6.2	2.3	6.6	7.0	8.9	10.1	21.5	3.4	2.7	36.7	19.0	1.7	3.8	49.9	5.6	9.9	29.7	14.7	6.8	3.5	2.1	2.4	1.7	0.9	1.9	3.8	0.6	8.1	13.8	7.3	12.3	7.9	176.1	12.2	35.1	11.5	105.0	2.9	0.9	65.4	5.8	4.3	7.9	0.6	3.0	8.5	2.7	43.2	19.2	25.3	12.8	83.2	0.6	1.2	4.9	27.4	0.2	25.8	20.8	1.4	98.8	22.5	0.2	0.0	3.7	45.7	16.2	29.3	55.2	15.4	3.5	0.2	1.1	0.9	16.5	0.4	6.5	1.7	188.7	3.9	1.1	10.0	24.6	26.2	23.2	4.2	50.8	5.8	0.9	23.0	12.1	15.4	24.8	27.5	31.3	28.5	34.6	30.6	19.8	17.7	37.4	28.9	4.2	45.4	28.5	6.9	34.6	27.6	3.0	3.0	2.3	4.3	2.9	2.5	4.3	3.3	3.5	2.7	3.8	3.5	46.7	32.1	20.0	11.8	62.6	5.7	11.2	24.4	12.0	1.5	3.1	5.8	4.4	8.6	15.9	44.1	0.0	11.5	35.6	48.1	0.0	5.3	0.3	7.0	10.6	34.1	1.8	15.8	2.5	25.5	17.0	23.4	17.3	7.4	7.0	33.4	31.4	16.3	12.3	0.0	2.1	23.3	8.2	29.4	14.2	0.7	10.5	33.0	7.2	21.5	19.4	6.5	20.6	7.1	4.9	22.1	27.6	7.9	56.0	4.3	52.4	6.2	15.7	2.8	0.0	12.2	12.2	0.9	0.8	10.0	3.0	6.7	54.2	9.3	34.2	10.5
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025331, HPA045396, HPA070524"	Approved		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312, HPA070524: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	2.4	2.6	34.4	8.0	69.2	0.9	56.5	45.9	62.0	20.9	10.9	62.9	88.5	5.5	12.3	82.0	12.1	30.6	9.0	39.2	43.1	36.2	98.6	29.3	0.6	59.4	54.4	1.6	57.0	23.8	2.4	13.0	54.7	37.8	64.1	1.3	83.0	18.2	2.4	75.7	82.5	3.8	36.2	0.6	74.7	2.3	55.9	1.0	9.4	1.7	12.5	21.8	44.2	104.9	39.8	2.1	3.2	1.4	0.2	0.1	63.2	3.9	7.2	4.5	4.1	20.4	70.4	0.2	0.8	1.0	0.6	32.2	5.0	7.7	2.3	0.7	3.0	0.1	1.1	116.4	0.1	0.1	0.5	1.3	9.3	0.7	0.3	0.7	0.1	0.8	2.6	1.0	0.4	71.6	0.4	1.3	10.4	119.1	1.9	0.4	7.4	2.1	7.9	89.7	3.3	1.3	2.6	106.5	149.5	9.1	122.2	0.7	0.3	0.5	4.0	1.9	0.5	0.9	0.6	0.6	0.4	0.3	153.4	2.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	1.0	0.4	0.2	0.2	0.3	0.1	34.4	69.2	45.9	62.0	39.2	43.1	59.4	54.4	54.7	36.2	55.9	104.9	0.8	118.6	81.0	1.0	1.5	18.2	15.3	21.6	19.4	1.5	106.4	47.8	1.9	171.6	74.6	35.0	2.1	52.6	2.0	254.3	1.9	60.1	1.3	36.1	10.9	2.7	93.1	2.7	0.7	88.1	84.6	4.5	96.4	95.9	1.3	0.7	5.0	112.0	6.1	0.0	2.0	145.2	40.7	1.9	3.7	0.5	1.5	1.5	55.2	1.0	1.7	7.7	0.0	49.8	187.0	94.8	184.6	0.0	0.3	103.3	240.2	30.0	54.8	1.1	6.6	4.5	3.4	9.5	13.4	87.7	36.9	100.6	2.5	0.1	136.9	135.4
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;fallopian tube: 11.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.3	0.4	10.0	0.0	13.3	0.0	5.6	10.5	11.5	2.9	0.0	0.1	0.0	0.2	0.0	0.1	11.2	0.0	3.0	9.9	12.7	5.1	0.0	0.8	0.0	4.9	16.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.7	1.2	1.5	0.3	0.0	0.0	4.3	0.0	0.4	3.3	8.0	0.0	1.6	1.7	0.0	0.1	0.1	6.1	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.3	10.5	11.5	9.9	12.7	4.9	16.9	7.6	4.3	8.0	6.1	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926556-66082546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;dendritic cells: 61.3;Endometrial ciliated cells: 62.3;Glandular and luminal cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA		39000	"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles, Plasma membrane"		"HPA048606: AB_2680461, HPA059863: AB_2684146"	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	15.7	14.5	65.2	29.5	109.6	30.0	24.7	64.2	67.6	23.2	19.0	27.8	24.5	22.6	27.0	20.1	20.0	28.4	16.9	56.2	91.6	29.5	33.3	21.5	40.6	91.3	88.0	20.0	18.8	22.6	8.3	16.4	106.0	26.4	26.3	28.1	21.8	20.2	19.8	32.8	44.1	19.7	64.4	31.4	40.3	27.5	86.6	48.7	29.9	20.7	39.0	28.5	13.0	119.1	97.8	32.2	41.5	49.6	30.0	36.0	31.5	61.5	62.6	85.3	94.3	31.5	113.8	82.2	58.8	95.3	67.2	31.7	26.5	45.1	149.4	36.3	12.0	28.3	41.3	24.7	39.5	22.0	26.3	39.4	29.2	47.2	67.5	50.0	32.1	37.1	29.4	54.6	58.1	33.5	59.0	25.1	10.1	9.7	9.5	53.7	33.0	45.8	49.9	65.6	20.0	18.7	65.0	21.7	46.4	30.9	38.4	53.8	29.8	48.3	85.9	29.8	80.8	47.2	31.7	69.8	31.6	35.9	28.1	13.1	4.1	5.5	5.2	5.8	4.8	4.7	3.9	4.6	3.5	3.7	4.5	4.8	9.2	3.9	5.1	2.2	3.8	2.8	65.2	109.6	64.2	67.6	56.2	91.6	91.3	88.0	106.0	64.4	86.6	119.1	53.0	70.5	57.5	0.0	13.2	0.0	0.0	0.0	0.0	0.0	39.4	24.8	0.0	0.0	31.6	53.3	0.0	6.5	61.3	0.0	11.7	26.7	0.0	62.3	50.0	26.1	0.0	0.0	0.0	24.9	11.2	16.2	0.0	101.9	27.8	47.8	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	50.3	0.0	0.0	13.3	0.0	0.0	41.7	24.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.9	20.0	51.4	0.0	0.0
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 292.3;Horizontal cells: 185.1;Inhibitory neurons: 487.0;Microglial cells: 213.6;Oligodendrocyte precursor cells: 230.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	10.4	9.7	12.2	6.8	14.4	7.3	8.0	38.1	12.8	8.9	8.0	11.8	3.5	9.0	4.8	11.8	8.2	7.5	13.9	15.2	18.5	9.2	6.5	7.3	4.8	13.7	14.8	10.5	7.6	15.4	8.1	11.8	13.7	9.5	6.2	7.0	8.4	12.1	9.4	9.4	5.8	12.9	11.9	5.8	7.2	7.5	17.7	7.9	13.4	9.0	5.3	13.4	9.0	12.6	8.2	20.1	10.3	7.1	27.8	22.2	14.2	25.0	20.0	17.0	15.3	17.7	10.0	12.5	3.4	33.2	16.8	13.3	22.1	19.7	23.1	25.9	11.6	30.3	20.1	9.3	21.1	16.1	6.9	18.7	17.0	30.0	55.6	20.7	22.3	7.9	9.6	23.9	12.9	9.2	5.2	3.5	16.8	8.1	9.7	9.9	38.9	3.8	16.9	14.2	6.3	12.3	38.8	9.3	13.9	37.6	9.3	7.0	39.6	29.6	29.0	21.6	24.0	6.4	13.1	18.1	19.2	9.4	12.9	1.5	3.1	2.3	1.7	1.2	2.4	12.7	2.7	2.7	2.7	5.6	3.8	2.7	2.4	1.4	4.8	3.4	2.8	0.7	12.2	14.4	38.1	12.8	15.2	18.5	13.7	14.8	13.7	11.9	17.7	12.6	36.9	25.6	25.1	155.4	21.2	21.0	25.6	9.4	29.0	39.2	13.2	14.1	56.4	17.2	17.4	20.2	47.9	34.1	12.6	12.7	1.9	20.3	34.3	31.2	43.4	34.6	30.0	7.6	292.3	13.4	18.0	32.3	23.9	53.9	14.5	59.2	24.3	17.3	12.4	185.1	487.0	11.9	2.0	12.6	16.5	35.2	24.8	17.0	14.2	213.6	18.4	34.8	6.2	230.7	171.1	18.5	10.3	30.9	39.1	30.8	6.1	4.1	13.2	33.4	19.7	35.5	33.1	18.5	28.8	33.8	27.4	78.7	15.8	18.7	10.3	29.4
ERC2	"CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110"	ENSG00000187672	"ELKS/RAB6-interacting/CAST family member 2"	O15083	3	55508311-56468467	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 11.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 818.5;Inhibitory neurons: 674.8;Oligodendrocyte precursor cells: 304.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Group enriched"	"Detected in many"	32	"amygdala: 7.9;basal ganglia: 11.7;cerebral cortex: 11.1;hippocampal formation: 7.6;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.4;HUVEC TERT2: 2.1;Karpas-707: 7.9;SH-SY5Y: 2.0;U-266/70: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073739	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA073739: AB_2732240"	"unprognostic (2.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.09e-2)"	0.0	0.3	7.9	0.0	11.7	0.0	0.1	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	7.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	0.2	0.0	1.7	0.1	0.0	0.3	0.0	2.6	0.2	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.0	0.0	7.9	0.0	0.8	0.0	0.0	1.7	0.0	0.2	0.0	0.1	0.0	1.6	0.0	0.9	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.7	0.0	0.2	6.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	11.7	0.0	11.1	7.6	0.0	0.0	0.2	0.0	0.0	0.0	3.1	0.1	3.2	0.5	22.9	0.0	0.1	0.2	0.0	1.2	11.3	0.4	0.5	3.4	0.0	1.3	0.0	25.0	0.0	0.0	0.0	0.0	0.4	6.2	0.4	0.3	0.5	0.0	0.0	818.5	0.6	0.1	0.6	0.0	1.2	0.0	0.9	0.0	0.0	0.7	5.0	674.8	0.0	0.0	0.0	0.0	2.5	1.5	0.2	0.0	30.9	0.0	1.3	0.0	304.6	102.4	1.6	0.0	0.7	0.0	0.8	0.0	0.6	1.5	10.8	0.0	0.1	0.1	1.5	2.9	0.4	0.1	0.0	0.0	1.2	0.0	0.3
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407334-45478828	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044"	"unprognostic (1.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.57e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	47.0	49.8	34.7	28.0	33.9	31.4	50.7	37.6	42.6	50.5	44.8	45.1	26.2	47.9	40.2	43.1	43.7	30.3	109.1	35.9	37.2	57.8	38.3	40.4	30.0	38.7	35.5	54.2	57.1	48.9	56.9	22.9	37.3	55.2	20.8	23.2	70.6	29.2	84.0	63.3	40.1	33.4	35.4	43.1	42.9	27.8	36.2	24.1	46.9	83.1	30.5	41.5	44.3	36.6	61.1	104.0	84.2	125.8	57.8	108.1	27.3	90.1	119.1	106.4	141.4	12.0	58.8	34.5	24.9	94.2	57.2	45.0	26.0	277.7	65.1	79.1	28.6	57.9	39.3	36.2	120.2	55.9	96.8	81.0	60.3	111.7	99.5	89.0	117.3	40.8	33.8	69.8	167.9	40.3	50.9	44.4	20.9	54.4	42.4	77.7	40.5	46.3	78.5	36.7	36.6	76.2	58.4	47.3	79.6	27.7	55.0	103.7	70.3	97.7	91.4	59.2	93.8	49.5	43.2	39.5	105.3	45.8	296.6	30.7	131.9	26.3	61.3	142.8	41.7	75.8	37.3	48.6	134.7	84.1	29.4	47.4	17.8	60.6	107.9	315.8	49.8	90.2	34.7	33.9	37.6	42.6	35.9	37.2	38.7	35.5	37.3	35.4	36.2	36.6	43.2	22.4	36.3	13.1	53.4	70.9	109.7	82.7	41.5	0.0	73.9	76.8	39.1	37.1	43.9	20.2	0.0	36.1	67.8	26.9	90.1	54.5	27.1	50.4	43.5	37.5	39.6	20.2	32.9	65.9	33.3	62.4	22.4	24.5	50.0	103.4	38.9	29.6	96.2	0.0	21.9	41.2	34.6	61.5	71.7	107.1	79.2	69.6	67.6	17.8	49.0	0.0	38.1	16.6	13.8	85.3	33.5	57.2	49.1	94.9	69.2	73.1	67.5	0.0	46.0	60.5	60.0	37.0	37.1	51.4	52.8	35.6	36.0	98.6	43.2	89.0
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102845831-102875995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045845, HPA050374"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA045845: AB_2679471, HPA050374: AB_2681106"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavorable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.82e-4)"	14.1	11.1	7.8	10.9	8.6	16.3	14.5	8.9	11.8	12.2	10.5	14.5	20.1	9.2	13.4	10.7	9.7	10.8	9.8	8.1	8.2	12.6	21.8	12.8	15.2	8.5	8.2	12.5	11.3	12.3	3.7	11.3	8.5	11.7	14.3	12.6	10.5	10.8	9.5	13.2	17.1	9.6	8.0	15.2	16.3	7.0	8.4	21.3	13.5	10.8	16.5	11.2	3.9	8.4	21.5	10.5	15.4	7.4	34.4	30.5	8.9	24.5	31.1	13.6	16.7	10.8	37.9	19.3	10.4	23.4	9.4	23.8	14.3	19.6	10.1	19.4	9.7	16.6	23.7	13.3	15.9	50.9	26.3	26.1	19.2	15.7	25.6	19.6	23.1	23.4	9.5	16.5	23.9	8.0	18.7	23.5	7.7	30.2	9.9	14.9	10.9	17.9	19.3	15.7	9.0	14.1	12.6	25.0	8.8	13.6	13.9	43.4	21.4	7.5	5.5	3.7	13.1	16.1	5.0	9.4	41.3	20.7	10.9	19.2	11.9	20.4	16.2	15.0	14.6	8.9	17.1	19.8	14.3	8.8	18.4	18.2	3.5	20.5	21.1	7.4	20.7	17.7	7.8	8.6	8.9	11.8	8.1	8.2	8.5	8.2	8.5	8.0	8.4	8.4	2.2	3.2	9.5	0.0	22.2	7.1	4.7	11.5	16.5	0.0	2.0	2.0	28.6	14.3	14.0	0.0	0.0	9.6	7.3	17.6	0.0	1.6	60.7	2.4	4.8	8.6	4.9	24.8	0.0	1.2	7.5	11.0	44.9	2.1	19.0	1.7	13.2	21.2	10.5	0.0	0.0	22.3	10.2	17.2	6.5	28.3	22.1	14.0	7.2	0.0	12.6	0.0	19.6	0.0	0.0	1.7	16.7	15.8	21.5	4.0	26.6	1.5	11.4	0.0	19.7	10.6	6.7	11.6	6.3	19.1	7.0	5.7	31.3	1.7	18.2	5.0
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.1	0.1	0.1	1.3	0.2	3.2	0.4	0.8	0.2	0.4	0.1	0.9	0.7	0.2	0.2	1.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.1	0.1	1.1	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.7	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.6	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
ERCC6L2	"C9orf102, FLJ37706, HEBO, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95871264-96121154	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021259, HPA021260, HPA021271, HPA022422"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"		"HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	3.2	3.8	3.3	2.6	4.6	5.1	4.1	5.8	4.2	4.4	3.6	4.0	2.6	4.7	3.5	3.2	3.2	3.4	2.9	4.3	3.8	3.8	3.6	3.2	4.4	3.3	3.4	5.0	2.9	5.5	2.1	3.8	4.1	4.3	3.5	5.4	2.8	4.1	3.7	3.0	2.7	4.2	3.0	4.7	4.2	4.5	3.4	6.8	5.5	3.8	3.9	3.4	2.7	6.9	5.4	8.5	8.3	9.0	5.2	4.3	3.7	5.9	7.8	8.1	5.9	8.9	4.4	6.6	2.6	9.5	10.5	8.0	12.0	5.0	8.6	3.9	3.8	8.2	7.5	5.4	4.8	9.4	6.0	5.2	2.9	8.2	6.0	3.4	6.0	7.9	8.2	3.7	4.5	6.4	8.2	4.9	6.0	6.1	5.1	6.3	14.5	2.7	5.3	5.7	7.7	6.0	5.8	4.3	4.1	4.9	5.6	4.0	7.6	8.1	6.7	9.3	6.8	3.0	4.0	3.6	6.5	5.8	7.0	1.2	1.9	2.0	3.7	1.7	4.8	2.6	4.2	3.9	2.0	4.3	5.1	5.1	1.5	2.7	3.0	5.4	3.2	1.1	3.3	4.6	5.8	4.2	4.3	3.8	3.3	3.4	4.1	3.0	3.4	6.9	20.2	16.0	16.2	105.8	13.8	5.0	12.6	7.2	12.5	0.0	6.6	6.2	18.8	8.6	13.5	0.0	0.0	6.3	18.3	7.5	0.0	8.8	7.8	9.0	32.4	12.9	4.9	12.4	90.1	8.2	3.5	19.3	11.7	11.3	15.2	24.9	8.6	6.6	6.3	0.0	88.5	8.4	6.1	11.1	3.8	3.8	26.8	10.8	3.6	62.8	13.7	0.0	12.3	130.7	117.9	8.3	4.5	27.8	13.5	9.7	7.2	4.0	15.5	0.0	19.7	26.1	19.9	17.0	11.1	12.2	4.4	4.8	15.7	45.9	6.4	9.5
ERF	"PE-2, PE2"	ENSG00000105722	"ETS2 repressor factor"	P50548	19	42247569-42255128	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058532, HPA067952"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA058532: AB_2683744, HPA067952: AB_2685932"	"prognostic favorable (8.07e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.27e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.54e-2)"	38.2	31.8	21.1	21.9	23.7	15.2	35.1	16.5	24.3	35.8	10.4	37.1	34.4	48.2	17.4	25.6	49.9	50.1	37.8	19.5	23.9	37.5	43.4	41.6	20.0	22.3	22.5	43.0	29.1	21.0	40.3	18.5	19.5	30.9	10.0	14.6	26.4	17.2	11.6	33.5	34.4	19.9	17.5	31.4	29.8	32.8	21.9	24.2	38.7	18.0	15.6	29.7	31.3	37.7	57.6	136.4	57.7	65.8	12.7	32.4	16.4	53.3	37.4	53.5	54.0	63.2	65.1	47.4	32.9	49.3	48.0	61.7	42.1	124.4	39.2	23.5	29.1	28.5	82.9	80.1	34.3	33.2	45.5	37.1	41.3	41.4	45.5	69.6	45.0	37.9	62.0	38.4	29.8	115.8	38.0	25.0	48.5	54.4	29.3	46.6	21.0	20.1	33.5	49.1	26.6	54.2	59.4	43.4	61.8	39.1	43.6	58.7	54.2	78.4	112.9	27.4	100.0	43.2	53.1	39.0	76.9	35.3	108.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	21.1	23.7	16.5	24.3	19.5	23.9	22.3	22.5	19.5	17.5	21.9	37.7	63.3	3.2	1.7	7.8	25.0	157.0	30.2	19.8	77.4	14.1	95.0	57.9	7.3	25.8	6.3	9.2	22.9	7.2	21.7	21.6	7.9	19.1	9.4	35.1	20.5	43.7	26.4	7.8	4.2	15.8	4.9	27.2	13.7	23.4	11.4	10.0	41.4	30.2	11.7	10.1	1.5	22.9	2.0	14.5	58.6	4.1	11.1	22.9	55.2	7.5	7.3	19.0	3.1	3.5	8.5	15.3	27.2	10.1	11.2	18.8	34.6	23.3	11.9	12.3	13.1	61.0	39.8	3.0	16.2	37.9	109.7	14.8	25.5	10.2	21.7	17.6
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ERG28	"C14orf1, NET51"	ENSG00000133935	"Ergosterol biosynthesis 28 homolog"	Q9UKR5	14	75649791-75660876	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 152.0;Ductal cells: 95.4;Exocrine glandular cells: 110.3;Extravillous trophoblasts: 154.2;Syncytiotrophoblasts: 116.3;Theca cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043172	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA043172: AB_10793942"	"unprognostic (2.68e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (4.30e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.20e-1)"	9.8	27.7	24.0	9.1	23.3	13.2	17.3	24.6	26.2	16.9	25.1	16.5	21.6	14.9	40.6	34.6	16.9	11.9	13.6	24.6	25.0	18.5	70.2	22.6	11.5	26.2	25.2	20.0	16.1	29.7	17.4	14.9	25.4	21.2	15.5	19.4	19.9	13.8	10.3	24.8	14.5	14.6	25.4	8.3	13.6	47.1	25.8	10.2	21.5	11.3	14.6	12.5	20.1	27.5	39.2	21.6	42.7	33.5	28.6	53.1	26.6	15.6	48.2	29.9	51.0	33.8	91.4	16.6	22.3	19.6	59.7	42.4	38.5	67.0	34.0	31.2	25.4	17.8	20.5	48.4	41.4	19.7	25.5	66.5	56.7	42.9	23.8	24.0	35.3	44.7	16.0	39.3	20.9	77.7	30.2	21.8	41.8	62.5	34.7	23.9	28.7	33.0	99.8	50.5	36.6	20.1	39.2	33.5	24.1	37.8	56.1	28.3	25.1	16.1	32.0	15.8	15.8	25.3	32.5	36.1	25.7	28.5	27.7	33.5	12.3	20.0	40.0	12.7	39.5	39.4	43.1	41.8	29.8	34.5	39.1	38.5	6.6	31.8	13.2	38.4	42.7	31.9	24.0	23.3	24.6	26.2	24.6	25.0	26.2	25.2	25.4	25.4	25.8	27.5	18.8	22.4	57.5	0.0	9.3	0.0	0.0	0.0	0.0	0.0	74.7	57.7	0.0	0.0	11.2	60.7	0.0	152.0	23.6	0.0	49.0	95.4	0.0	43.4	11.5	18.0	0.0	0.0	0.0	110.3	154.2	21.4	0.0	30.3	5.1	63.2	0.0	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	37.7	0.0	0.0	0.0	0.0	76.9	0.0	0.0	3.5	0.0	0.0	47.1	18.2	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	116.3	12.4	121.2	0.0	0.0
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834251-172952683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 247.8;Intestinal goblet cells: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	67.3	147.8	33.4	49.1	31.2	44.9	60.3	47.4	35.4	127.2	26.7	97.7	79.5	67.4	75.3	55.0	72.4	50.2	60.9	35.8	31.8	66.1	193.2	77.8	40.8	41.4	36.4	56.9	80.6	50.7	48.5	47.9	38.1	146.8	102.7	21.6	97.6	69.8	92.3	46.7	79.4	64.1	33.0	69.2	107.1	25.3	41.3	83.1	75.2	91.9	55.0	58.3	54.3	34.0	120.2	112.8	95.0	211.6	353.3	262.0	51.9	239.5	179.3	105.5	97.4	159.5	120.4	114.8	166.9	406.4	181.7	43.2	68.5	316.8	123.3	92.0	67.5	70.7	156.1	86.1	258.9	33.3	21.6	223.8	128.6	155.8	143.8	173.8	171.0	117.8	42.6	156.8	177.1	150.4	96.5	57.6	56.0	283.7	101.4	327.4	62.9	358.5	245.2	68.6	52.9	96.0	82.7	234.7	120.6	91.1	98.0	37.4	132.4	171.3	69.1	165.9	99.2	246.8	294.0	47.5	236.9	78.3	76.2	3.7	7.5	19.2	3.1	10.5	5.2	9.3	1.6	2.1	6.1	6.2	1.0	2.3	30.6	14.3	14.3	3.1	1.0	5.1	33.4	31.2	47.4	35.4	35.8	31.8	41.4	36.4	38.1	33.0	41.3	34.0	41.9	57.7	29.5	22.9	62.0	22.8	32.1	22.7	14.8	37.2	51.2	35.1	32.9	68.6	29.4	49.7	16.7	20.7	44.3	83.6	21.5	101.9	11.5	36.2	48.0	33.5	26.0	25.9	35.4	60.8	90.3	47.2	49.5	77.9	23.5	64.4	37.5	247.8	41.1	21.9	41.8	202.9	36.7	77.0	105.2	33.8	65.0	54.8	7.2	30.0	91.1	39.0	36.0	47.7	30.6	86.9	59.3	58.3	96.2	74.2	95.0	38.5	28.4	12.6	39.5	56.1	41.1	1.9	10.5	27.2	26.9	9.0	25.1	103.5	73.3	47.8
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	38.5	32.5	22.7	37.8	24.6	10.5	46.0	25.1	29.0	34.4	20.8	37.1	34.4	34.4	50.1	46.0	24.2	33.1	52.4	22.6	25.9	30.6	47.6	26.3	33.8	24.9	23.9	26.9	40.2	47.2	20.7	53.1	24.3	39.5	33.7	29.4	49.2	34.5	33.8	19.2	34.9	39.3	25.4	26.7	32.6	57.8	24.4	35.0	45.1	47.0	43.6	50.1	22.1	34.4	96.7	87.0	69.1	46.8	94.8	111.5	170.1	153.1	123.4	92.7	98.3	115.7	157.6	51.3	149.1	120.7	168.7	98.7	66.0	98.3	146.4	112.6	69.4	84.0	114.6	68.3	55.7	121.2	70.0	79.1	75.9	115.8	116.7	169.3	71.8	69.8	70.5	144.6	122.6	52.3	60.3	126.2	98.9	101.3	235.0	54.9	189.9	107.6	75.5	140.1	26.5	43.2	77.2	86.5	91.5	145.9	168.0	96.7	81.8	124.1	108.1	169.1	167.6	106.4	145.5	106.0	103.7	87.3	105.3	92.3	50.2	70.6	84.7	79.9	102.9	83.2	107.6	101.2	55.1	71.0	106.6	90.3	181.1	72.1	101.1	120.9	130.8	90.1	22.7	24.6	25.1	29.0	22.6	25.9	24.9	23.9	24.3	25.4	24.4	34.4	54.6	28.9	28.6	20.9	74.3	57.9	68.9	144.1	39.9	54.8	57.2	55.1	61.7	38.6	99.0	53.3	54.2	119.2	60.8	19.4	49.0	72.7	383.0	48.7	66.5	43.7	41.8	44.8	39.2	62.8	120.6	73.0	25.5	54.6	55.8	44.2	34.6	50.2	56.4	48.8	37.8	33.5	87.5	25.5	40.2	51.9	52.5	37.1	62.2	14.0	41.6	69.5	52.5	32.2	48.3	58.1	20.5	59.8	154.0	85.7	32.4	49.5	64.6	60.0	32.9	58.5	105.7	75.0	36.3	49.4	66.3	156.2	68.0	54.0	34.7	78.8
ERGIC3	"C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84"	ENSG00000125991	"ERGIC and golgi 3"	Q9Y282	20	35542038-35557634	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 711.0;Late spermatids: 708.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015242, HPA015968"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA015242: AB_1848238, HPA015968: AB_1848239"	"unprognostic (4.36e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (2.20e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.64e-2)"	123.3	167.5	123.4	77.7	124.6	164.5	174.9	124.4	180.6	161.8	183.3	154.6	124.2	127.4	456.9	146.9	325.4	135.1	123.8	123.8	131.5	145.3	181.0	115.1	99.4	128.2	129.9	188.3	270.3	188.0	86.9	151.3	128.2	125.9	190.9	67.0	196.9	142.3	103.5	151.4	110.4	142.6	124.7	108.3	162.0	211.6	133.9	119.9	199.8	95.2	154.6	154.0	137.5	128.2	173.2	317.5	161.8	282.4	553.6	417.1	210.1	234.4	503.7	378.3	374.0	726.9	354.2	127.4	214.4	495.4	332.8	249.5	137.7	371.9	279.0	62.8	252.5	272.6	221.1	453.2	285.2	240.1	193.2	462.8	578.1	235.1	298.7	432.5	251.1	163.0	189.8	399.3	307.0	379.1	191.4	354.0	93.4	645.1	305.1	143.1	378.8	365.5	315.6	298.7	155.4	225.5	353.4	286.0	284.7	159.8	276.5	389.0	209.8	429.5	169.0	178.0	208.1	164.7	107.0	102.5	461.2	126.4	235.5	98.5	188.7	106.7	117.9	182.2	143.3	157.9	139.2	130.4	228.7	146.6	136.0	139.9	62.0	150.7	158.9	226.6	177.0	237.8	123.4	124.6	124.4	180.6	123.8	131.5	128.2	129.9	128.2	124.7	133.9	128.2	48.1	35.3	79.9	14.4	107.1	184.2	209.7	289.4	150.2	27.1	194.3	150.2	37.1	153.0	190.7	62.5	18.8	476.5	80.6	224.5	117.4	210.6	711.0	215.5	99.4	101.8	112.6	93.2	8.9	269.8	490.7	122.7	114.7	77.5	78.0	94.7	146.3	146.4	208.1	16.8	10.1	246.9	152.5	148.2	192.5	708.4	105.3	100.4	190.3	8.4	126.7	76.8	82.4	8.0	13.6	185.0	283.1	94.0	344.1	189.8	213.4	207.5	340.2	31.3	118.3	100.5	122.0	415.9	170.5	172.6	200.6	589.4	86.8	111.3	264.6	292.3
ERH	DROER	ENSG00000100632	"ERH mRNA splicing and mitosis factor"	P84090	14	69380128-69398299	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	107.7	113.7	143.3	119.0	146.2	144.4	119.3	145.1	186.7	97.0	146.9	110.5	110.0	111.9	150.3	75.5	112.8	70.1	100.2	145.4	159.1	118.3	142.5	76.3	147.1	142.8	146.8	107.0	66.7	128.2	58.3	98.1	147.6	87.0	122.9	116.7	110.0	84.3	107.0	58.1	99.1	114.8	153.7	96.5	88.7	91.1	149.6	212.2	97.6	85.8	168.4	117.0	51.2	154.5	972.7	574.9	704.6	409.1	271.8	201.1	356.9	450.7	261.3	401.3	372.0	598.5	403.1	879.9	224.3	305.3	340.3	296.1	563.4	376.9	484.2	437.9	428.3	441.4	366.1	731.8	419.6	389.3	334.6	227.1	203.0	355.9	317.2	239.2	337.8	584.5	454.0	301.6	335.7	1043.2	714.1	750.8	537.2	525.6	686.0	558.9	599.9	320.6	415.4	672.8	449.1	439.8	442.1	464.6	355.6	330.8	539.9	564.4	351.4	425.7	699.7	286.7	480.0	351.7	336.2	1096.1	345.1	417.5	442.4	76.6	101.4	80.9	76.6	98.9	77.5	122.2	100.0	88.0	107.4	94.3	92.7	88.2	45.3	121.5	95.1	122.8	116.5	147.0	143.3	146.2	145.1	186.7	145.4	159.1	142.8	146.8	147.6	153.7	149.6	154.5	231.2	60.9	54.3	22.2	189.1	273.1	225.0	702.7	180.4	126.4	244.2	314.2	118.9	181.6	282.2	253.8	37.5	455.3	179.4	117.5	673.1	363.8	100.4	238.1	198.9	211.9	188.5	252.6	23.9	275.3	560.3	237.0	120.3	158.7	127.6	186.7	169.6	239.9	341.5	74.0	23.1	244.0	510.6	147.5	215.2	51.3	270.9	162.5	307.7	16.9	302.3	350.3	174.0	19.6	34.6	289.8	183.9	259.2	237.9	288.9	203.9	508.5	278.4	119.8	190.7	177.7	273.8	321.5	230.9	251.0	318.8	279.9	165.3	281.4	265.9	230.6
ERI1	"3'HEXO, THEX1"	ENSG00000104626	"Exoribonuclease 1"	Q8IV48	8	9002147-9116746	"Predicted intracellular proteins"	"RNA-mediated gene silencing, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033838, HPA055548, HPA056074"	Uncertain		Approved	Vesicles,Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	Vesicles	"CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029"	"unprognostic (2.49e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.36e-2)"	5.3	3.1	3.1	6.5	3.8	13.0	4.8	3.7	4.1	4.3	3.5	3.8	4.7	4.7	2.5	4.3	3.9	3.9	2.8	3.0	3.5	4.2	4.4	5.1	7.4	4.5	3.9	4.2	3.0	4.2	2.5	6.7	3.7	3.2	4.6	11.3	3.8	3.2	2.4	3.2	3.8	5.1	3.8	5.0	3.6	9.1	3.8	6.9	2.9	2.7	7.4	6.2	3.5	4.1	32.3	19.9	17.2	13.1	13.4	21.7	23.5	27.4	14.4	19.6	24.1	14.8	14.4	36.7	7.0	15.7	32.7	11.2	15.1	18.5	27.3	15.1	10.8	20.3	15.8	11.5	13.7	15.6	28.6	12.9	6.1	16.3	14.4	10.9	26.8	21.6	23.3	22.6	22.8	10.5	47.2	19.3	20.0	24.2	12.1	20.1	25.1	13.7	25.2	45.6	2.4	18.8	16.4	12.5	13.8	12.1	9.3	13.9	23.2	20.7	21.4	39.5	21.6	4.9	18.1	31.9	15.3	22.2	16.5	6.4	4.6	3.4	4.2	5.1	4.3	5.3	4.9	4.4	3.9	3.9	3.8	3.6	3.3	6.0	3.5	2.9	9.8	3.5	3.1	3.8	3.7	4.1	3.0	3.5	4.5	3.9	3.7	3.8	3.8	4.1	9.2	3.2	8.1	17.6	9.7	18.2	9.6	6.7	3.4	17.4	8.6	5.0	5.7	2.8	10.1	3.7	14.6	25.3	11.3	7.4	3.9	9.0	46.9	14.8	14.4	8.6	3.6	18.7	11.4	12.0	27.6	9.1	8.6	23.3	8.2	7.7	11.4	4.8	13.5	5.0	9.7	5.2	8.2	9.7	15.9	16.7	6.5	12.9	10.6	9.4	11.9	8.0	6.2	9.5	16.7	11.2	5.6	9.1	11.2	6.3	4.3	8.2	9.1	21.6	13.1	7.8	7.5	43.6	45.6	6.1	10.1	20.8	11.7	5.9	6.8	3.8
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	4.7	6.8	4.3	3.7	4.9	6.4	9.2	4.4	5.5	3.9	4.8	7.4	8.1	4.1	7.6	6.7	5.7	4.5	4.4	4.1	4.4	6.5	12.1	4.7	3.8	4.9	4.4	4.5	7.4	14.0	5.0	5.4	4.9	7.5	10.2	4.2	5.1	4.8	5.1	7.1	7.8	4.6	4.6	3.6	8.4	13.1	4.7	7.5	6.2	3.7	4.4	4.5	4.7	5.7	17.1	7.9	21.6	9.5	6.5	8.3	13.0	13.3	7.9	11.8	14.9	10.2	17.0	4.8	14.6	7.3	8.2	12.7	21.8	13.7	21.8	15.3	11.4	11.5	9.7	17.6	6.0	22.3	9.0	7.5	16.7	15.9	13.2	6.3	7.2	0.0	37.1	13.5	20.0	15.3	3.2	19.8	13.4	17.5	4.5	25.5	17.7	10.5	11.0	13.4	11.0	13.5	8.5	16.0	10.3	11.4	33.7	24.7	5.5	12.5	7.0	12.2	17.9	8.3	13.4	2.9	11.9	17.9	17.6	13.8	1.8	1.7	0.4	1.3	0.3	0.5	0.4	0.4	1.9	0.0	0.3	0.2	0.1	0.5	2.6	0.6	0.8	0.4	4.3	4.9	4.4	5.5	4.1	4.4	4.9	4.4	4.9	4.6	4.7	5.7	4.0	16.0	6.7	18.3	1.0	5.0	5.3	5.6	8.0	5.3	11.3	5.8	7.3	5.7	8.5	9.2	0.0	8.3	0.9	8.0	9.8	4.1	22.5	6.9	5.5	3.0	0.0	22.7	10.4	5.2	9.1	4.3	9.7	6.0	0.0	7.1	2.9	10.9	8.4	3.3	10.6	9.6	6.1	8.2	4.1	14.7	6.2	5.8	1.8	5.6	6.7	5.0	3.1	10.6	20.3	4.7	6.6	5.3	2.8	4.5	7.5	6.8	12.6	3.5	0.0	5.6	3.5	39.3	20.0	9.7	3.7	3.7	2.5	4.5	8.5	5.7
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	31.1	34.8	105.3	15.5	105.9	24.6	30.5	92.0	140.3	30.1	92.2	34.4	20.6	33.3	34.2	27.9	37.2	20.5	51.7	111.9	98.7	59.8	41.8	25.6	19.3	99.4	108.1	32.4	35.0	45.2	45.1	23.3	122.2	38.8	23.2	22.4	27.8	25.2	77.2	36.1	22.7	28.6	97.2	26.4	28.9	63.3	105.7	24.1	31.2	60.2	20.4	32.2	27.2	103.4	73.6	56.5	69.3	77.7	44.9	55.5	46.0	44.0	61.4	82.1	75.1	37.8	78.3	52.3	76.4	58.7	42.2	41.2	62.6	80.6	55.9	56.9	115.8	60.0	90.2	52.0	67.9	59.3	32.8	57.9	76.9	66.2	91.3	61.0	57.3	59.5	56.4	43.9	55.2	51.2	68.7	57.0	82.2	72.2	83.7	62.6	62.4	75.3	65.2	38.9	120.5	54.9	52.5	71.3	87.7	55.1	46.6	50.1	34.1	54.3	56.5	60.7	72.0	37.7	50.1	56.4	67.7	52.4	70.4	17.6	25.8	15.8	25.5	36.4	27.2	30.8	21.1	24.5	40.3	30.9	24.8	26.0	2.4	26.1	37.3	30.3	29.4	26.2	105.3	105.9	92.0	140.3	111.9	98.7	99.4	108.1	122.2	97.2	105.7	103.4	35.4	25.6	16.5	74.4	26.2	31.6	36.5	64.7	27.3	22.6	36.2	51.3	15.1	15.7	26.2	29.5	2.1	93.2	19.3	31.2	97.8	56.9	202.7	35.3	30.7	27.4	118.3	26.5	36.7	62.5	85.9	39.8	25.0	23.1	15.2	62.8	18.9	22.3	45.0	25.2	34.0	99.1	46.8	19.2	27.2	943.6	36.4	20.1	48.0	38.4	27.9	42.6	15.5	66.4	54.5	37.7	22.2	36.5	28.3	51.0	17.0	167.3	20.4	16.4	6.6	28.5	52.0	68.0	51.4	29.4	34.5	61.6	20.2	54.0	37.1	30.7
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	15.9	8.7	7.3	17.2	6.5	23.0	13.7	6.4	8.2	10.7	8.3	11.0	8.4	10.1	6.6	10.4	10.5	9.1	10.7	6.9	7.1	22.5	11.6	14.6	21.1	9.0	7.1	11.6	9.0	7.9	11.5	10.1	8.4	9.1	7.2	5.1	9.8	5.8	10.8	13.0	12.4	7.9	6.0	15.3	10.5	8.0	8.4	11.8	13.2	5.5	10.7	12.7	11.6	7.1	15.8	22.2	11.7	14.0	12.4	15.0	24.3	14.9	7.9	13.3	14.6	14.4	9.9	36.0	6.9	12.5	25.3	26.0	21.7	22.9	9.4	15.7	28.1	25.1	15.1	20.8	13.9	15.5	22.6	17.4	14.5	10.1	13.0	13.7	14.7	31.2	26.3	20.2	13.5	13.2	30.0	27.5	18.6	17.6	9.9	27.0	7.6	25.0	14.9	28.7	5.4	15.0	10.9	13.8	20.2	19.2	5.8	18.4	23.7	9.7	4.6	0.6	16.2	13.1	36.7	38.9	19.9	24.6	10.5	24.7	33.0	12.5	8.4	32.3	7.5	17.9	9.7	8.4	17.1	20.1	8.1	7.1	30.0	12.3	29.8	12.7	7.5	10.4	7.3	6.5	6.4	8.2	6.9	7.1	9.0	7.1	8.4	6.0	8.4	7.1	71.0	44.8	36.1	17.9	75.3	36.6	47.0	47.9	32.5	23.3	32.6	32.5	23.0	27.1	31.2	33.1	12.5	62.0	55.4	49.2	109.5	38.4	16.1	35.9	52.2	65.8	19.7	43.9	24.4	36.6	60.4	40.7	66.8	57.4	41.1	48.3	62.4	31.9	41.9	48.8	21.0	50.4	32.6	70.9	68.0	9.2	60.3	69.9	35.6	23.4	126.9	18.2	78.2	11.1	22.5	55.4	54.3	40.6	34.6	51.5	33.3	58.9	26.9	22.1	39.5	33.6	35.6	48.5	58.4	23.2	40.9	54.0	68.3	27.0	39.8	37.0
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568117-74673792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.3;testis: 24.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 326.4;Endometrial ciliated cells: 139.8;Late spermatids: 326.9;Respiratory ciliated cells: 234.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028655, HPA072916"	Approved					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favorable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.0	2.5	3.1	0.0	3.5	0.0	0.8	0.2	5.4	5.4	0.0	0.0	0.0	1.0	0.0	0.0	17.3	0.0	0.0	3.4	1.8	0.0	0.0	2.7	0.2	0.0	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.1	3.2	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.5	0.2	5.4	3.4	1.8	0.0	0.3	0.0	0.0	3.2	0.2	0.0	3.2	3.1	3.6	0.3	0.0	0.0	0.0	0.0	3.5	2.8	0.3	0.6	0.0	28.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	326.4	139.8	1.0	0.4	3.5	0.0	56.8	0.0	0.0	0.5	0.0	3.2	1.3	0.0	0.0	0.1	0.0	0.0	51.8	0.0	0.0	0.0	0.0	326.9	3.1	0.7	0.0	1.0	0.0	0.1	1.0	24.6	3.2	0.0	0.0	3.8	0.0	0.6	0.0	0.0	234.6	0.5	6.6	0.0	0.1	32.9	1.5	0.0	0.0	0.1	0.3	0.1	0.0	0.3
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.1	1.5	0.3	2.4	0.0	1.0	0.9	1.4	2.5	1.2	1.9	5.3	1.3	0.6	0.7	11.1	12.3	5.3	1.0	2.4	5.6	10.2	0.9	1.0	1.8	2.1	0.9	34.2	2.2	1.3	0.2	1.9	2.7	3.3	2.3	1.3	2.3	0.0	0.7	1.5	0.5	1.1	0.2	12.6	2.4	4.7	0.7	0.6	0.0	0.7	1.9	0.5	1.3	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.4	0.9	1.4	1.0	2.4	1.8	2.1	1.9	1.1	4.7	1.3	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ERICH6	"C3orf44, ERICH6A, FAM194A, MGC39662"	ENSG00000163645	"Glutamate rich 6"	Q7L0X2	3	150659885-150703971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 29.7"	"Group enriched"	"Detected in some"	25	"Early spermatids: 96.1;Late spermatids: 56.0;Spermatocytes: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;SH-SY5Y: 1.6;U-266/70: 1.7;U-266/84: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA048373	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA048373: AB_2680375"	"unprognostic (7.38e-2)"	"unprognostic (3.89e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-2)"	0.3	0.2	0.1	0.2	0.4	0.3	0.1	0.1	0.3	0.0	0.9	0.1	0.5	0.4	1.7	0.2	0.3	0.3	0.3	0.3	0.6	0.6	0.1	0.2	0.6	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.3	29.7	0.4	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.6	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.0	0.7	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.7	1.6	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.2	0.5	0.6	0.1	1.7	2.8	0.3	0.2	0.0	0.0	0.0	0.1	0.1	2.6	0.0	5.1	1.9	1.6	2.0	0.1	2.0	2.2	2.3	0.0	4.2	0.0	2.4	1.9	1.4	0.1	0.4	0.1	0.3	0.3	0.6	0.1	0.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	96.1	0.3	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	56.0	2.1	0.2	0.0	1.9	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.0	1.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0
ERICH6B	"FAM194B, FLJ32682"	ENSG00000165837	"Glutamate rich 6B"	Q5W0A0	13	45534522-45615739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 2.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 39.7;Late spermatids: 19.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA043559	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA043559: AB_2678552"	"unprognostic (6.77e-3)"	"unprognostic (3.52e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.81e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.70e-8)"	"unprognostic (4.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (7.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ERLEC1	"C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB"	ENSG00000068912	"Endoplasmic reticulum lectin 1"	Q96DZ1	2	53787044-53818819	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031501, HPA031502, HPA031503"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425"	"unprognostic (1.27e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.92e-2)"	38.4	51.0	30.2	31.3	32.1	33.8	48.7	29.3	41.9	66.4	39.3	45.8	37.7	40.9	93.9	26.1	36.2	41.0	45.2	32.9	39.2	38.1	43.4	44.1	32.4	28.7	31.1	38.0	67.1	57.3	59.4	56.6	31.5	72.8	50.2	54.5	54.0	55.9	32.1	20.1	34.0	38.5	30.1	33.1	55.3	42.4	31.5	28.1	72.5	39.5	41.2	44.7	27.2	34.4	42.1	47.3	44.4	27.4	123.3	111.3	65.5	100.5	109.1	49.0	51.4	31.3	55.7	29.4	94.5	106.3	86.3	29.7	29.2	42.3	62.1	67.0	38.7	36.1	29.1	93.8	84.4	60.2	63.9	70.5	69.4	51.6	83.3	99.4	58.1	28.6	39.0	115.8	73.6	35.3	27.7	48.0	34.1	67.1	30.4	24.9	53.1	82.7	57.7	39.3	26.5	46.3	36.6	79.0	64.6	50.3	38.0	45.9	63.3	53.9	47.2	44.0	60.3	170.1	120.3	16.5	88.2	35.8	64.5	77.0	25.1	30.7	41.4	27.8	45.8	36.8	36.3	39.9	28.0	28.6	33.9	39.0	9.6	45.4	33.3	40.1	36.6	41.5	30.2	32.1	29.3	41.9	32.9	39.2	28.7	31.1	31.5	30.1	31.5	34.4	57.2	89.8	116.7	22.2	86.3	25.1	42.5	88.0	34.1	77.0	76.3	54.6	83.5	52.9	93.5	66.2	31.3	100.2	60.9	43.4	33.2	76.1	168.4	67.7	77.5	63.8	55.1	23.1	24.0	115.7	105.8	99.7	54.6	101.7	74.1	36.6	68.6	81.8	60.1	95.9	28.5	169.7	107.8	39.7	31.5	117.9	88.3	41.7	80.0	17.8	61.7	79.7	72.1	20.6	25.3	90.2	42.8	84.2	394.0	113.4	32.3	51.4	118.2	68.6	52.6	55.6	109.5	146.1	65.3	40.3	33.4	183.6	57.0	48.3	57.1	67.5
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.4	14.2	8.6	21.4	10.5	76.2	21.4	9.5	10.1	27.5	10.3	37.0	40.4	21.8	17.6	32.8	31.6	16.3	11.0	9.6	9.4	27.2	114.1	19.1	14.5	8.6	8.2	30.4	19.2	19.4	5.4	42.2	9.0	17.7	38.2	10.8	15.1	16.4	8.6	22.5	30.2	22.4	8.8	16.6	36.8	28.0	9.0	15.6	26.2	13.6	21.2	28.6	19.1	9.7	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.6	10.5	9.5	10.1	9.6	9.4	8.6	8.2	9.0	8.8	9.0	9.7	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736601-37758422	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	20.3	17.8	15.7	14.6	17.3	14.4	25.0	16.5	16.8	20.0	27.2	24.2	17.7	21.2	32.3	17.9	30.1	19.8	17.8	14.2	16.3	40.4	40.8	15.5	11.5	18.0	18.5	30.8	26.2	41.4	8.3	21.2	17.7	25.4	25.0	21.6	29.4	23.8	18.9	15.3	23.6	19.5	17.9	14.6	24.9	17.0	15.6	14.7	46.5	14.1	12.6	16.8	10.3	18.6	39.0	38.5	43.0	31.4	47.3	33.9	47.2	59.1	51.9	31.8	33.2	20.1	50.8	18.9	95.8	63.4	30.3	41.4	31.2	48.4	46.8	11.2	24.2	27.8	22.7	22.7	31.5	17.8	34.1	43.3	49.1	46.3	48.1	39.6	30.7	17.2	51.1	17.7	47.4	18.3	25.8	14.7	45.9	53.8	17.7	17.9	29.9	15.2	42.8	41.9	7.7	20.7	39.3	12.6	35.6	50.1	62.0	27.1	31.1	30.9	26.4	56.8	31.1	24.3	41.0	24.2	55.0	28.4	40.7	1.3	6.5	13.4	4.4	7.0	3.6	4.5	2.7	3.5	5.4	2.3	4.1	3.8	6.1	2.5	9.6	7.6	5.5	3.1	15.7	17.3	16.5	16.8	14.2	16.3	18.0	18.5	17.7	17.9	15.6	18.6	14.7	12.8	14.3	21.5	7.1	9.7	10.0	18.5	13.1	25.2	24.9	20.7	30.2	25.8	22.8	33.1	20.9	17.9	6.0	19.0	9.8	23.8	21.3	31.3	18.5	13.6	11.4	8.0	3.7	22.1	27.0	18.8	17.3	27.8	3.8	14.4	17.5	41.0	20.6	16.8	6.4	24.3	20.3	23.9	6.6	16.8	11.8	16.1	14.2	7.5	12.3	23.5	5.2	11.6	16.7	18.8	17.4	17.7	16.8	15.2	25.4	19.8	47.6	18.7	19.7	19.1	14.8	47.4	18.5	21.9	7.4	15.7	7.1	12.9	25.4	12.8
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817122-42844991	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 38.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	8.0	9.2	3.9	4.7	4.2	30.5	8.3	3.8	4.6	8.6	4.8	7.3	6.5	6.0	15.8	7.2	10.1	7.5	4.3	3.8	5.0	7.1	13.2	7.2	4.9	5.0	4.5	5.5	9.5	8.4	5.8	5.9	4.4	7.8	8.1	4.3	8.6	6.2	2.3	9.3	6.1	6.3	4.4	5.2	7.8	4.1	4.8	5.3	13.0	3.6	5.4	5.5	3.9	5.0	5.2	7.1	2.1	7.0	7.7	22.4	2.0	10.5	17.8	9.3	9.3	2.9	9.6	4.6	3.5	11.2	4.4	6.5	2.4	3.2	8.3	7.8	8.2	38.3	5.2	2.3	9.5	5.2	18.8	13.7	11.8	4.3	9.9	16.8	6.1	5.6	26.4	4.7	8.6	3.6	2.3	1.6	5.1	3.3	3.8	2.6	2.8	4.3	8.0	8.1	4.7	3.2	9.0	3.3	4.0	3.7	6.6	19.6	9.6	6.9	3.9	5.9	4.8	1.8	4.4	2.0	5.6	5.8	4.4	0.0	4.3	2.1	1.2	4.5	0.6	1.3	1.2	0.9	5.1	0.7	1.0	1.0	1.3	2.2	3.0	1.0	3.2	1.9	3.9	4.2	3.8	4.6	3.8	5.0	5.0	4.5	4.4	4.4	4.8	5.0	2.4	12.8	10.9	9.8	2.9	3.8	2.9	3.2	6.2	1.8	6.6	6.3	2.2	4.3	6.2	3.7	22.9	3.1	4.4	4.8	1.9	3.6	4.3	4.7	6.2	3.3	5.4	81.7	5.5	7.2	1.6	3.6	6.1	5.6	2.5	10.4	3.6	12.9	7.8	11.8	2.2	4.4	0.0	11.7	2.9	25.7	2.8	7.4	5.4	14.0	7.1	4.8	1.0	9.5	10.6	4.8	3.9	4.1	2.1	2.9	3.5	4.0	6.5	4.5	0.0	4.7	2.6	0.1	0.7	5.7	3.8	2.9	2.3	7.4	5.5	2.3
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781600	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 49.9;Late spermatids: 48.5;Spermatocytes: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	13.8	14.6	5.3	8.4	7.1	10.1	13.1	5.4	6.7	13.7	5.6	11.2	6.3	13.8	20.5	10.5	13.2	7.7	6.8	5.3	5.9	16.1	18.6	9.7	13.8	6.9	6.1	17.4	11.4	6.9	15.4	7.4	7.2	12.7	7.4	14.6	11.0	8.6	14.9	18.7	13.6	6.4	6.5	17.3	10.9	22.1	6.1	9.9	13.2	2.5	13.6	11.2	10.8	9.1	5.1	7.5	9.7	14.8	6.9	11.4	5.1	5.3	7.7	5.0	6.3	2.0	8.3	8.0	4.8	6.5	6.1	13.3	4.0	10.3	4.4	8.6	4.4	11.5	9.9	3.0	13.7	16.1	7.6	13.4	10.4	6.1	15.5	12.8	3.4	14.0	8.0	11.4	6.5	7.7	6.8	14.4	3.2	5.7	5.4	7.5	6.0	13.0	6.2	4.0	3.8	7.0	9.0	9.0	4.9	6.3	7.1	12.8	5.3	5.7	3.4	9.1	6.5	13.1	17.5	6.7	7.2	9.7	6.6	1.6	4.2	1.8	5.2	7.9	5.2	5.1	6.0	5.9	4.4	6.0	4.7	4.4	0.4	5.2	9.7	3.7	7.6	3.9	5.3	7.1	5.4	6.7	5.3	5.9	6.9	6.1	7.2	6.5	6.1	9.1	8.5	3.2	11.1	20.2	6.2	4.1	4.4	7.7	5.2	12.0	5.9	5.1	2.8	5.7	7.7	5.5	10.4	12.2	4.7	3.0	11.7	9.8	49.9	10.8	9.4	5.0	6.0	4.6	9.3	8.5	8.3	7.0	5.6	6.9	2.5	11.7	7.9	10.1	5.9	5.0	11.8	2.9	6.1	5.7	4.4	48.5	4.4	6.1	3.6	8.4	5.6	14.6	5.2	17.1	20.7	5.3	2.4	4.5	4.4	2.5	5.7	9.5	15.5	10.8	6.6	5.5	5.8	37.8	18.0	5.5	3.1	7.1	4.7	10.3	3.4	3.4
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 498.6;choroid plexus: 136.2"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	212.4	2.3	342.3	18.8	0.5	312.8	386.9	0.5	136.2	0.7	0.5	0.4	0.1	0.4	0.4	0.8	0.3	208.7	266.4	0.5	0.5	2.4	3.3	408.3	313.2	0.2	0.3	0.0	0.4	0.1	391.8	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	266.5	4.7	1.3	0.5	300.8	1.6	0.4	0.0	3.0	0.7	0.3	498.6	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	212.4	342.3	312.8	386.9	208.7	266.4	408.3	313.2	391.8	266.5	300.8	498.6	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.8;RT4: 154.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	3.9	7.9	4.2	3.7	10.4	2.0	6.3	10.9	3.7	10.8	14.4	11.3	4.4	5.6	2.6	14.9	6.4	11.3	10.0	2.9	6.1	24.9	4.6	6.3	3.5	10.1	10.3	4.5	3.9	50.1	1.5	7.8	8.8	6.0	11.4	2.2	19.1	4.1	7.6	9.3	6.5	3.8	6.5	3.1	13.3	4.7	8.9	4.6	26.6	9.9	6.4	17.1	4.8	13.1	45.1	43.1	1.8	5.2	22.6	20.7	22.6	5.1	11.1	2.3	1.9	10.4	27.2	10.7	19.2	8.4	25.9	32.2	9.6	29.4	3.3	55.6	7.6	56.2	20.0	20.4	4.8	16.0	21.3	10.5	12.9	2.1	13.3	28.6	30.1	4.6	6.9	9.9	2.8	20.7	0.6	6.2	6.6	28.0	8.4	1.7	5.3	14.1	76.8	154.6	9.9	3.3	7.1	52.2	8.1	24.5	33.7	20.5	18.0	1.5	5.0	3.4	16.1	8.9	13.6	5.5	6.7	13.0	4.1	0.2	0.1	0.3	0.4	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.1	0.1	4.2	10.4	10.9	3.7	2.9	6.1	10.1	10.3	8.8	6.5	8.9	13.1	3.4	6.4	1.1	24.8	2.2	2.9	18.3	13.3	2.8	4.0	11.1	5.8	13.7	12.8	22.8	73.5	10.4	6.8	5.2	32.1	0.0	4.6	22.3	11.4	10.9	6.3	11.4	6.3	21.0	3.0	7.1	4.6	13.7	13.8	8.9	53.4	2.9	6.1	5.7	3.3	32.8	8.9	10.2	1.6	2.2	41.8	3.1	4.5	1.8	24.4	2.1	3.0	8.2	22.1	88.8	3.5	22.5	4.9	4.1	7.0	9.2	3.3	16.6	2.9	6.6	5.8	4.3	8.8	4.6	17.5	4.5	4.1	5.9	39.8	15.7	66.9
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039080-64130819	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 53.0;pancreas: 66.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported					NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	9.5	53.0	1.5	5.4	1.7	13.4	7.5	2.6	3.2	22.6	2.1	7.7	6.3	10.1	6.4	9.5	14.3	6.2	6.1	1.6	2.4	5.6	23.5	16.5	5.8	1.7	1.0	16.9	66.7	4.3	19.5	5.6	1.3	9.9	4.5	8.8	15.7	7.1	6.8	11.3	10.6	5.6	1.0	15.8	16.2	2.8	1.6	6.8	10.2	2.4	6.6	8.3	11.7	1.7	4.0	4.0	2.2	4.8	4.8	4.4	9.8	4.1	9.7	2.8	1.3	2.5	2.3	6.6	3.2	2.8	3.5	3.6	1.9	4.5	6.1	1.6	1.5	6.0	3.2	2.4	19.6	3.2	2.1	3.8	8.1	6.4	21.5	3.5	5.0	4.7	4.2	74.6	2.8	3.9	4.5	1.0	0.6	3.6	3.2	4.2	4.2	40.2	1.1	5.5	7.1	3.5	4.3	6.1	5.7	3.5	3.8	5.9	5.9	2.5	4.1	6.4	2.7	77.4	23.9	4.8	4.0	2.1	4.2	17.9	0.9	0.4	4.9	0.4	9.0	0.2	3.3	4.1	0.4	0.3	0.9	0.9	4.9	2.5	0.3	7.7	0.8	1.0	1.5	1.7	2.6	3.2	1.6	2.4	1.7	1.0	1.3	1.0	1.6	1.7	31.9	0.0	36.1	7.2	27.8	22.0	54.3	8.3	15.4	4.0	35.0	29.7	8.6	11.5	8.6	12.9	6.2	8.1	106.4	10.0	1.9	12.6	2.3	26.1	49.1	18.3	79.7	11.2	8.6	27.3	8.8	42.2	52.0	79.4	8.2	11.8	13.9	26.8	8.0	3.3	6.1	8.2	8.2	15.7	71.3	1.7	4.7	60.4	74.7	12.2	10.2	3.5	28.8	6.0	4.6	17.9	7.3	6.0	325.8	44.7	7.9	4.4	6.1	26.5	0.0	19.0	25.7	4.0	4.1	27.7	45.0	54.9	88.2	12.0	9.6	60.1
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690310-23713226	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9"	"Cell type enhanced"	"Detected in some"		"Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.0;pancreatic cancer: 19.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 43.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076875	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum, Cytosol"		"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.4	0.1	3.0	0.1	0.0	0.1	0.6	0.4	19.5	0.2	28.9	12.9	0.0	0.0	0.9	0.4	17.0	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.2	3.5	23.0	0.0	22.9	0.1	0.0	0.2	12.4	0.9	0.0	0.0	51.9	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.8	0.0	1.5	6.8	0.0	0.0	0.0	0.0	0.5	20.0	38.4	0.0	0.0	0.5	0.0	80.2	0.0	2.3	0.1	0.5	0.2	0.1	10.8	0.0	0.2	1.9	0.0	0.1	193.7	1.6	4.5	0.1	0.0	0.0	0.1	0.0	0.1	143.9	6.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	33.1	37.2	0.0	0.5	1.3	6.1	0.1	16.9	0.0	0.0	1.7	1.6	0.0	0.2	0.0	0.0	0.1	0.4	0.0	70.9	11.1
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639915-52695900	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 172.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	NA	NA		110000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.59e-4)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	17.9	8.6	12.2	20.4	11.7	47.0	16.4	11.8	12.9	59.0	11.3	18.5	17.9	12.0	15.1	172.5	10.0	18.9	15.5	12.1	16.6	14.6	31.2	15.2	14.9	11.7	13.3	8.5	18.9	11.1	12.6	44.4	12.8	9.6	17.8	30.6	37.4	14.0	9.1	18.9	16.5	12.0	9.9	14.6	29.0	5.4	15.1	8.3	13.4	8.2	30.4	32.6	62.4	10.9	100.6	24.2	19.9	21.4	54.4	61.3	38.0	42.4	52.7	34.1	56.9	33.4	158.0	26.3	50.7	28.3	42.0	61.1	27.1	84.1	84.9	22.0	14.5	3.6	25.1	42.1	46.2	60.2	72.1	54.5	54.2	43.9	44.5	79.9	48.2	32.3	18.1	50.8	46.2	15.8	36.0	37.8	11.8	46.5	15.5	21.5	59.8	38.1	52.3	97.1	18.5	49.6	28.9	17.8	39.4	25.7	24.8	22.3	40.0	60.7	29.5	49.6	37.4	26.9	28.8	22.7	88.0	30.3	28.7	20.6	5.9	11.7	5.0	6.9	11.0	4.6	9.4	6.3	4.9	3.1	5.5	5.5	14.7	6.7	9.4	3.7	11.9	2.5	12.2	11.7	11.8	12.9	12.1	16.6	11.7	13.3	12.8	9.9	15.1	10.9	33.8	16.0	27.6	0.0	18.8	0.0	79.2	0.0	19.4	23.4	29.7	11.8	0.0	38.6	15.5	38.6	16.7	24.3	23.3	33.4	3.9	221.3	0.6	32.4	23.8	32.6	10.9	9.9	0.0	130.6	215.8	20.5	56.1	64.0	6.3	10.9	21.0	62.5	42.9	42.1	0.0	10.7	0.0	42.7	0.0	1.6	6.2	49.7	0.0	0.0	45.0	12.2	15.5	0.0	0.0	264.7	18.1	12.8	60.0	171.4	29.0	15.1	13.1	26.4	19.7	14.6	20.9	0.6	3.6	25.7	0.0	91.4	32.1	10.4	20.3	145.8
ERO1B	"ERO1-L(beta), Ero1beta, ERO1LB"	ENSG00000086619	"Endoplasmic reticulum oxidoreductase 1 beta"	Q86YB8	1	236215101-236281958	"Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 153.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;Early spermatids: 133.4;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 6.0;granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028085	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA028085: AB_10601214"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.53e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.09e-3)"	5.8	5.5	4.2	5.6	4.1	7.3	7.7	8.5	5.1	5.1	4.3	5.1	10.2	5.1	21.3	2.8	4.9	9.1	4.9	4.5	4.8	8.3	18.8	5.2	7.0	3.7	3.6	6.4	153.9	14.8	9.7	5.2	3.4	5.8	3.2	17.3	8.0	5.4	3.3	3.3	5.4	5.0	2.9	8.3	46.8	28.3	3.1	5.7	27.2	3.9	6.3	4.7	4.0	5.1	2.0	2.3	3.9	3.4	3.0	1.8	4.5	3.1	2.9	2.2	1.7	0.7	2.2	5.5	8.2	4.8	8.3	1.0	1.8	2.8	3.0	5.8	11.1	1.6	0.3	2.1	7.9	2.1	0.9	3.5	5.6	3.8	7.3	4.5	2.6	5.0	0.8	14.2	2.7	1.1	0.9	0.9	1.5	0.3	0.7	11.3	2.6	1.5	4.0	4.7	7.8	4.6	10.2	3.3	8.7	2.0	7.9	9.5	2.5	3.2	2.8	3.2	4.2	9.3	0.6	3.4	4.3	3.1	5.0	15.4	1.5	3.0	2.2	1.6	1.9	1.5	1.2	1.5	1.6	2.1	1.7	1.7	3.1	1.1	0.7	6.0	1.2	0.8	4.2	4.1	8.5	5.1	4.5	4.8	3.7	3.6	3.4	2.9	3.1	5.1	33.4	9.6	9.4	0.0	47.8	0.0	17.9	0.0	45.5	20.7	27.9	23.7	0.0	27.1	3.1	16.5	14.6	12.7	72.8	0.2	1.9	5.3	133.4	1.7	13.2	12.8	14.6	5.5	0.0	16.9	5.1	16.9	32.1	3.9	5.1	9.6	17.5	26.4	6.9	25.2	0.0	5.3	0.0	21.5	0.0	25.6	19.3	34.5	0.0	0.0	11.9	12.2	29.9	0.0	0.0	9.9	0.2	11.3	69.5	18.4	2.7	7.7	1.5	55.4	0.0	36.0	15.1	94.3	14.9	13.6	0.0	22.6	43.8	2.8	1.8	11.0
ERP27	"C12orf46, FLJ32115, PDIA8"	ENSG00000139055	"Endoplasmic reticulum protein 27"	Q96DN0	12	14914039-14938537	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"pancreas: 1802.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Collecting duct cells: 40.5;Distal tubular cells: 164.4;Endometrial ciliated cells: 40.7;Exocrine glandular cells: 39.7;Theca cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RT4: 102.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA039636, HPA052851"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039636: AB_10795403, HPA052851: AB_2681972"	"unprognostic (9.02e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.45e-2)"	0.9	0.8	1.2	3.7	0.3	5.3	6.7	0.0	1.4	6.7	0.2	0.8	1.1	1.1	2.1	1.4	77.4	1.0	1.0	0.9	0.0	27.0	0.6	11.9	5.0	0.1	0.0	1.6	1802.9	1.4	1.0	2.5	0.1	2.0	1.3	0.7	5.7	2.8	0.3	2.0	2.5	0.8	0.1	4.2	3.7	0.4	0.0	2.5	8.3	0.4	3.8	18.0	0.9	0.0	3.4	0.0	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.0	0.0	1.1	19.5	1.6	2.0	0.0	0.0	4.0	0.0	0.2	0.0	0.1	0.0	4.5	0.1	19.3	0.0	1.5	2.2	0.1	0.0	0.0	0.0	0.1	0.5	4.9	0.0	0.9	0.0	7.0	3.2	5.9	0.0	0.2	0.0	1.8	0.0	0.4	0.6	102.3	0.1	0.0	0.0	15.8	0.0	1.8	0.7	4.8	2.4	0.3	0.1	0.0	0.0	0.1	0.1	3.1	0.0	1.4	0.0	3.0	3.4	4.1	4.8	3.8	6.3	1.5	4.3	3.4	2.5	1.5	5.4	5.8	1.5	1.3	4.6	0.2	5.9	2.6	1.2	0.3	0.0	1.4	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	41.7	20.8	0.0	1.6	0.4	2.7	0.2	0.0	0.2	8.7	2.2	0.2	0.0	17.9	40.5	0.0	5.9	2.4	0.2	164.4	25.0	0.0	40.7	1.1	0.8	1.8	0.0	0.0	39.7	14.1	1.1	0.0	8.7	1.3	0.2	0.4	0.0	1.5	0.0	0.0	0.0	0.0	1.9	1.2	0.0	1.8	1.1	0.0	3.7	2.5	3.1	4.1	0.0	0.0	18.9	3.5	0.0	1.3	1.8	0.0	8.6	18.0	0.2	0.0	0.0	1.0	0.0	0.0	0.4	0.4	0.8	3.9	104.3	0.3	14.3
ERP29	"C12orf8, ERp28, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013348-112023449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"	NA	NA		900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	62.7	100.9	56.9	77.9	58.0	202.3	84.0	65.1	62.0	78.4	91.1	94.5	100.7	60.5	109.8	91.5	74.8	64.1	59.0	56.0	68.7	93.0	179.9	78.8	123.8	61.1	62.6	78.9	174.6	123.6	99.1	73.0	64.2	93.4	91.3	68.3	122.7	87.4	34.3	113.3	96.1	47.1	57.8	118.3	131.4	57.6	60.8	107.6	90.4	34.3	111.2	75.9	71.0	61.6	145.4	137.2	98.8	194.2	367.4	143.7	211.3	139.2	163.7	108.5	139.3	215.2	164.4	152.7	106.4	244.5	117.8	175.4	187.8	181.2	89.3	133.7	104.2	174.3	150.1	239.2	246.8	432.1	164.0	207.5	227.6	178.4	201.6	287.4	156.1	157.9	203.2	277.3	84.7	166.6	140.9	765.7	161.5	513.1	102.5	114.2	120.9	501.2	229.8	213.5	88.6	119.8	173.6	140.1	426.1	187.4	177.1	575.7	116.5	92.6	142.7	88.8	103.3	303.4	379.8	128.0	157.8	268.5	73.2	96.2	241.4	346.2	131.6	178.8	140.4	259.1	170.7	164.1	229.7	264.1	186.5	154.9	47.5	86.5	170.9	455.8	179.6	307.4	56.9	58.0	65.1	62.0	56.0	68.7	61.1	62.6	64.2	57.8	60.8	61.6	102.6	83.3	183.4	13.7	324.8	141.4	205.5	249.3	132.6	125.3	207.8	199.9	91.6	198.8	178.0	185.8	110.5	497.7	396.6	210.1	93.9	239.5	7.7	142.1	84.9	114.9	197.9	134.4	14.4	211.8	405.3	118.3	131.5	149.9	88.8	164.4	146.3	346.6	373.1	80.8	20.6	280.6	343.8	306.9	192.6	16.6	128.9	230.4	168.9	12.2	269.0	152.8	160.6	11.6	22.8	128.7	288.0	106.8	350.1	195.4	355.5	274.6	187.0	164.9	52.6	79.2	112.2	100.3	195.3	143.1	161.0	441.6	221.7	252.4	285.2	219.8
ERP44	"KIAA0573, PDIA10, TXNDC4"	ENSG00000023318	"Endoplasmic reticulum protein 44"	Q9BS26	9	99979185-100099000	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001318	Supported				"Intracellular and membrane"	NA	NA		5300000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001318: AB_1080427"	"unprognostic (8.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.31e-1)"	18.4	17.3	8.1	17.7	8.5	21.3	16.2	12.9	10.5	19.5	10.1	22.0	22.4	15.2	39.3	17.8	13.7	16.7	15.9	8.2	9.1	18.0	34.2	18.6	17.9	8.0	8.7	12.4	27.4	18.7	13.3	32.6	8.5	18.9	23.6	15.8	20.8	18.3	11.6	12.9	23.8	16.8	8.4	18.4	24.1	10.6	8.6	14.6	27.1	11.6	18.6	19.3	14.1	9.0	18.5	14.7	20.7	23.6	73.5	34.9	37.6	39.9	54.2	27.6	36.3	31.2	52.4	47.3	25.7	45.5	41.1	65.9	25.7	28.1	24.9	24.5	14.4	17.8	14.3	22.8	64.3	32.2	27.0	39.4	41.5	24.2	34.7	26.2	34.2	15.7	34.7	35.7	22.7	28.8	22.1	22.6	21.5	72.0	18.9	19.2	34.7	32.9	35.9	20.9	16.2	18.9	32.8	40.2	28.9	30.5	15.0	32.8	23.8	20.5	19.2	27.4	17.7	20.5	19.3	15.8	31.3	21.0	28.3	32.8	45.7	42.7	20.2	49.2	19.5	28.1	19.9	22.1	37.4	26.5	15.1	17.6	41.5	27.4	62.3	23.4	23.5	37.7	8.1	8.5	12.9	10.5	8.2	9.1	8.0	8.7	8.5	8.4	8.6	9.0	72.3	54.5	41.8	38.8	77.5	43.3	80.3	146.6	29.0	34.3	33.9	25.3	34.7	54.3	84.6	33.1	18.8	141.4	72.5	90.0	17.6	104.4	8.4	42.2	61.4	62.5	53.1	38.3	69.4	111.8	150.5	72.0	57.1	62.3	71.0	54.2	64.6	73.3	165.7	30.3	70.0	118.1	73.2	79.5	101.9	7.7	61.2	102.2	64.0	85.3	128.5	32.7	61.8	45.8	68.9	92.8	90.0	67.7	97.9	75.9	111.2	51.4	60.2	30.6	72.3	48.9	95.9	83.3	41.4	40.0	49.6	229.3	60.3	87.5	88.9	84.2
ERV3-1	"envR, ERV-R, ERV3, H-PLK, HERV-R"	ENSG00000213462	"Endogenous retrovirus group 3 member 1, envelope"	Q14264	7	64990356-65006743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.7"									"HPA017209, HPA046508"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA017209: AB_2732419, HPA046508: AB_2732525"	"unprognostic (2.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.88e-2)"	22.8	33.0	4.8	8.5	4.5	9.3	15.0	4.1	6.4	10.0	5.1	5.7	3.5	10.0	32.5	15.2	8.0	16.4	6.2	4.7	6.2	4.8	3.2	9.7	5.7	6.2	7.9	7.3	5.3	15.3	8.2	13.4	5.4	7.3	5.7	13.5	12.1	7.5	3.6	12.3	4.5	7.6	4.8	6.9	6.3	8.7	5.9	6.6	7.6	1.8	7.4	6.2	11.5	5.1	3.3	1.0	17.4	27.7	11.3	4.7	12.4	5.7	6.3	2.0	4.6	1.2	20.5	5.5	5.3	2.2	4.0	3.9	2.6	1.5	3.2	4.1	1.5	2.8	1.6	11.5	1.0	6.7	3.7	5.1	1.6	1.8	0.6	10.4	11.6	6.0	12.7	10.3	8.1	8.1	4.9	5.0	5.1	10.8	1.2	11.4	0.7	3.7	3.5	6.8	3.6	16.8	6.2	1.9	0.7	18.9	4.7	16.4	9.2	6.7	1.0	5.1	2.8	3.2	7.8	1.6	5.7	20.8	4.1	0.0	1.0	2.4	0.6	1.8	0.5	0.4	0.1	0.4	0.8	0.5	0.3	0.4	7.0	1.1	0.5	0.4	1.2	0.6	4.8	4.5	4.1	6.4	4.7	6.2	6.2	7.9	5.4	4.8	5.9	5.1	7.1	3.2	13.1	17.9	32.5	4.2	15.6	17.0	7.4	24.8	13.7	10.4	2.1	24.3	25.5	16.5	29.2	16.5	21.6	4.4	9.8	14.4	7.3	6.2	8.6	10.9	13.8	19.4	12.2	17.9	12.7	8.3	12.8	5.9	8.2	20.4	13.6	3.6	9.7	18.5	13.0	9.1	16.2	21.8	16.5	4.8	11.5	19.8	10.6	14.0	16.7	11.3	36.0	24.1	14.0	17.6	7.8	9.8	10.0	12.5	15.4	4.9	14.0	21.4	6.6	7.6	8.7	12.2	11.8	8.6	5.7	40.2	20.5	10.7	6.7	31.1
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751586	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.9;placenta: 10.8"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		6000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.1	0.5	1.0	0.2	0.7	0.0	0.9	0.7	1.2	0.8	0.7	0.2	0.2	0.6	0.6	1.2	0.5	0.2	2.6	0.8	0.8	3.5	0.1	0.6	0.2	0.9	0.7	1.3	0.5	12.9	0.0	10.8	1.0	0.4	0.4	0.0	0.4	0.8	0.0	0.3	0.1	0.2	0.9	0.5	0.4	0.7	0.8	0.0	0.4	0.0	0.4	0.5	0.6	1.0	7.6	0.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	46.9	9.9	0.0	1.0	0.1	0.7	0.5	0.0	3.4	0.0	0.0	0.4	0.0	0.1	0.5	0.6	0.0	0.0	2.1	32.5	0.0	4.8	0.0	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	3.1	3.0	1.4	0.0	0.0	0.0	24.2	0.7	2.0	0.4	3.1	1.3	0.0	4.7	4.1	0.7	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	1.2	0.8	0.8	0.9	0.7	1.0	0.9	0.8	1.0	0.1	0.0	0.0	0.0	0.5	0.5	1.8	2.3	2.2	0.0	2.2	1.9	2.9	0.0	0.6	7.3	0.0	74.4	0.0	0.1	0.0	2.5	4.2	0.6	0.9	1.3	0.0	0.0	0.4	0.8	102.9	1.5	0.0	1.7	0.0	2.6	0.0	0.0	7.4	0.0	0.2	0.3	2.0	0.0	0.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	3.7	0.0	3.0	0.1	0.0	0.0	0.2	0.5	0.2	0.4	2.8	0.1	17.4	0.0	0.2	0.4	1.4
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
ESCO1	"EFO1, ESO1, KIAA1911"	ENSG00000141446	"Establishment of sister chromatid cohesion N-acetyltransferase 1"	Q5FWF5	18	21529284-21600884	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042497	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA042497: AB_10794278"	"unprognostic (8.12e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.80e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.72e-2)"	6.0	5.3	5.8	6.1	6.4	16.3	10.4	10.0	8.8	8.0	5.3	6.7	6.3	6.8	10.1	7.5	5.6	5.2	5.7	5.4	7.3	8.0	9.9	5.3	10.1	6.1	6.2	7.4	7.2	10.1	9.0	8.7	6.5	7.2	5.9	7.8	8.0	6.6	10.3	7.8	7.0	4.8	5.9	8.3	6.9	20.2	6.3	11.1	7.3	5.3	9.9	6.9	7.2	7.0	9.3	4.3	9.3	4.7	8.3	8.8	9.6	5.6	10.7	7.9	11.1	8.8	6.3	16.3	12.5	7.1	8.7	13.3	11.6	7.9	10.9	17.1	7.8	12.7	6.1	14.9	13.5	21.3	12.3	7.4	16.6	6.1	15.9	10.4	10.9	11.9	17.7	16.4	10.9	10.7	15.9	22.4	19.3	17.7	9.9	10.2	11.9	18.3	15.7	13.9	14.4	10.3	10.5	13.2	24.3	14.6	9.7	14.4	6.1	10.1	10.2	7.4	7.0	38.8	24.0	18.8	10.0	12.2	10.1	4.9	0.5	3.9	3.3	1.1	2.8	2.2	2.7	3.1	1.1	1.9	2.6	3.3	3.2	2.2	0.9	0.8	3.1	1.0	5.8	6.4	10.0	8.8	5.4	7.3	6.1	6.2	6.5	5.9	6.3	7.0	29.1	12.8	29.5	29.0	35.5	10.7	21.0	24.4	17.1	43.1	22.6	17.4	36.2	10.0	24.2	11.0	20.9	26.0	47.0	15.8	19.6	26.2	14.4	28.6	23.9	18.5	11.4	13.7	48.8	13.4	16.2	20.1	27.5	36.7	29.2	24.4	16.8	7.6	13.7	30.3	55.2	19.4	24.4	9.5	12.4	9.2	21.1	21.3	16.0	31.9	24.1	17.0	46.4	35.7	50.1	18.8	23.6	22.6	31.6	23.5	19.9	15.7	19.7	35.5	26.3	23.1	20.4	119.1	93.6	15.7	12.5	37.6	38.4	37.4	14.1	27.3
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784919	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA047083: AB_2679924, HPA050396: AB_2681111"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.0	9.6	11.2	9.6	12.4	7.9	10.8	11.5	13.3	8.6	8.7	8.3	7.5	10.2	10.3	9.1	6.9	8.5	9.5	9.8	12.4	9.7	13.9	6.6	10.8	12.8	12.3	12.5	6.5	10.0	5.3	11.3	14.2	9.5	9.8	9.0	6.2	7.3	12.6	10.8	6.8	8.8	12.8	9.9	7.8	14.1	12.6	9.7	10.5	12.2	9.7	12.3	7.1	13.4	30.4	24.3	24.1	13.0	18.8	23.3	14.9	28.9	18.5	21.5	19.4	26.0	29.2	38.4	15.1	14.5	40.2	45.9	36.0	30.3	41.4	11.1	18.1	49.5	10.2	64.2	25.4	59.4	13.2	18.7	23.0	33.1	28.2	16.0	17.0	18.7	70.9	17.9	27.1	22.6	46.7	39.8	25.9	27.0	17.1	30.6	61.1	30.4	16.7	22.3	25.9	16.2	23.8	41.8	42.4	22.1	20.5	27.3	23.2	36.2	24.2	25.7	59.1	17.9	43.4	45.7	14.7	27.2	33.2	2.7	8.7	2.7	10.5	11.1	12.3	18.2	12.2	11.6	8.9	17.4	14.9	13.8	0.5	15.1	14.0	19.3	10.0	4.6	11.2	12.4	11.5	13.3	9.8	12.4	12.8	12.3	14.2	12.8	12.6	13.4	71.5	22.4	45.0	36.6	60.4	61.8	63.8	50.5	44.3	92.8	31.4	53.2	61.7	50.1	47.6	33.1	45.9	47.8	55.3	53.8	33.2	55.0	80.5	35.3	61.4	50.8	48.5	34.5	56.2	42.1	39.2	48.5	32.6	34.0	26.0	55.4	45.0	51.5	45.1	95.9	59.7	49.7	28.5	35.3	22.4	30.2	65.3	35.3	26.6	34.7	57.6	58.0	33.0	53.8	63.6	56.0	48.8	73.7	26.8	62.8	47.6	38.4	34.6	81.9	32.9	117.0	78.0	210.4	175.5	31.5	53.6	41.5	40.8	71.9	61.5	42.2
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977867-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 19.9;thyroid gland: 17.3"	"Cell type enriched"	"Detected in some"	8	"Endothelial cells: 142.4"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 302.2;TIME: 568.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB047364	Approved				"Secreted to blood"	NA	NA	1540000	340000	"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB047364: "	"unprognostic (4.70e-2)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.3	4.2	0.4	0.7	0.7	0.6	0.5	0.2	1.1	2.0	0.8	0.2	0.7	3.6	0.4	0.2	0.2	1.3	3.6	0.3	1.3	19.9	2.6	11.3	1.2	0.5	0.5	0.7	2.3	6.0	2.2	0.4	0.3	3.5	0.0	0.1	6.3	3.7	0.2	0.1	0.8	0.7	0.8	0.9	0.3	0.6	1.6	0.2	17.3	0.2	0.6	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	79.8	9.5	4.1	1.0	0.0	0.0	0.1	7.4	5.7	2.3	0.0	0.0	1.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.7	0.4	8.5	302.2	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	568.0	4.7	13.7	39.2	21.3	0.1	0.0	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.4	0.7	0.2	1.1	0.3	1.3	0.5	0.5	0.3	0.8	1.6	0.4	6.3	0.0	0.6	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	16.1	0.0	0.1	0.1	142.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	2.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.5	1.7	0.1	0.3	0.0	0.1	0.1	0.6	1.1	0.0	0.7
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 129.1;retina: 117.8;testis: 145.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.4;thalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	5.7	0.4	2.6	1.0	28.0	9.2	13.4	1.0	30.3	0.2	28.2	90.4	2.4	39.9	34.3	18.6	0.3	0.9	0.4	1.7	63.4	129.1	3.2	0.3	0.6	1.3	0.4	0.9	26.8	42.1	0.9	1.1	10.0	6.8	117.8	9.4	6.2	0.8	91.7	89.5	0.8	0.3	0.9	2.7	145.3	6.1	1.6	0.4	0.0	1.7	1.3	22.3	0.5	14.1	0.7	0.6	0.1	0.0	0.0	48.9	0.0	0.0	0.2	0.0	29.9	1.5	0.5	6.5	0.0	0.1	32.6	2.3	0.1	0.0	2.0	0.7	0.4	0.7	81.5	0.0	0.6	2.7	0.1	0.6	0.0	0.0	0.0	0.0	1.0	17.6	0.0	0.0	28.2	0.2	1.0	0.6	3.8	12.2	0.0	0.4	10.9	0.2	0.1	21.0	0.7	3.7	160.1	5.0	0.3	53.6	7.4	15.6	0.1	0.8	0.6	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	13.4	1.0	0.4	1.7	0.6	1.3	1.1	0.3	6.1	0.5	0.2	0.0	0.6	0.0	0.8	7.8	2.4	4.5	12.5	5.6	10.7	3.9	1.4	11.5	3.8	9.2	68.8	3.0	0.2	175.5	13.7	0.2	137.5	19.1	0.9	0.8	6.0	8.2	0.2	3.1	0.5	0.3	5.6	12.4	0.0	0.0	3.9	109.4	0.2	0.0	0.2	36.3	8.2	3.2	0.9	461.6	3.7	1.5	0.0	0.0	0.0	272.5	0.0	0.0	0.1	0.1	186.3	2.2	0.0	1.6	512.1	102.2	9.0	72.5	0.0	0.0	0.2	12.3	3.9	17.6	22.7	6.6	1.5	0.0	35.3	2.9
ESPNL	FLJ42568	ENSG00000144488	"Espin like"	Q6ZVH7	2	238100340-238133287	"Predicted intracellular proteins"	Hearing	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;intestine: 3.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.8;Cardiomyocytes: 2.5;Granulosa cells: 2.0;Muller glia cells: 1.4;Proximal tubular cells: 3.4;Skeletal myocytes: 1.6;Theca cells: 2.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 5.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.8;Daudi: 2.6;fHDF/TERT166: 2.3;HHSteC: 2.6;THP-1: 1.8;U-87 MG: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055103	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA055103: AB_2682694"	"unprognostic (8.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-6)"	"unprognostic (3.49e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.67e-2)"	0.4	0.3	0.4	0.1	0.2	0.0	0.4	5.0	0.2	0.8	0.9	0.8	0.3	1.0	0.0	0.2	1.5	0.1	0.7	0.4	0.3	0.3	1.6	0.2	0.5	0.2	0.3	2.2	0.3	0.0	2.1	0.1	0.4	0.6	0.0	0.0	0.0	0.8	0.2	0.2	3.5	0.4	0.0	1.1	0.2	0.4	0.2	0.3	1.0	0.0	0.2	0.6	0.4	0.3	0.0	0.0	0.0	1.8	0.3	0.6	0.3	1.0	0.4	0.8	0.8	0.0	0.0	2.6	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.9	2.6	0.0	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.0	1.0	0.0	0.0	1.1	0.1	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	5.0	0.2	0.4	0.3	0.2	0.3	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.6	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	2.0	0.0	0.5	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.6	0.3	0.0	0.6	0.0	0.0	0.0	0.4	2.2	0.0	0.0
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.8;endometrium 1: 110.9;fallopian tube: 64.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.2	1.8	3.2	1.5	1.3	0.8	29.1	2.9	1.3	83.8	3.2	0.9	0.4	110.9	1.2	0.5	64.9	1.2	1.8	0.6	6.7	2.8	16.9	2.0	1.6	0.4	0.5	9.0	1.0	0.2	6.6	0.4	0.3	6.1	0.5	3.5	0.9	9.8	5.8	1.1	0.8	50.4	0.2	1.7	0.6	2.3	5.9	1.0	3.4	2.6	2.3	2.1	46.9	0.3	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.3	2.9	1.3	0.6	6.7	0.4	0.5	0.3	0.2	5.9	0.3	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 6.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.1"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	1.5	6.1	1.2	1.2	0.6	1.0	0.9	3.0	0.8	1.4	3.5	0.9	1.0	1.2	0.4	0.7	1.0	0.5	0.6	0.5	0.9	1.5	0.7	0.6	2.1	0.7	0.6	5.4	2.1	0.1	0.8	0.2	1.0	1.5	1.0	2.0	0.8	0.2	1.4	1.0	1.3	0.3	0.3	1.8	1.0	5.7	1.7	2.5	0.6	0.2	1.6	1.1	0.6	0.9	0.8	0.4	0.7	0.6	0.0	0.1	1.5	0.2	0.0	0.1	0.1	0.3	0.9	3.1	0.1	0.1	0.4	1.0	0.8	0.0	0.1	0.7	0.4	0.3	1.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	1.1	0.5	4.2	0.2	0.8	0.5	0.2	0.7	0.6	0.4	0.5	0.4	0.3	0.1	1.3	2.2	0.6	0.4	0.2	1.1	0.4	0.7	0.1	0.5	0.4	1.0	0.2	0.1	9.8	3.1	16.4	0.2	0.1	0.8	0.3	0.1	0.5	0.3	0.2	0.2	0.5	0.2	0.4	0.0	0.7	0.4	0.3	0.6	0.2	0.3	1.1	0.2	0.1	1.2	0.6	3.0	0.8	0.5	0.9	0.7	0.6	1.0	0.3	1.7	0.9	0.9	6.4	0.0	6.8	5.5	0.3	2.2	0.4	2.8	1.6	0.3	0.1	0.9	4.3	0.9	0.0	6.2	0.7	5.2	0.1	0.0	0.3	61.4	3.5	0.9	3.0	0.0	0.4	12.4	0.7	0.5	2.2	0.0	4.9	1.3	26.6	1.1	0.1	0.1	0.0	17.9	0.8	0.0	0.0	0.3	93.7	0.9	0.2	1.8	7.5	0.1	0.9	6.2	10.6	7.6	0.5	0.1	1.2	16.6	3.8	0.4	0.1	1.7	35.6	0.0	1.5	1.4	28.0	1.4	0.5	0.1	1.1	3.0	16.4	0.8	1.8
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229033-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.3;Gastric mucus-secreting cells: 44.9;Late spermatids: 82.4;Syncytiotrophoblasts: 58.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.5;MCF7: 113.2;RT4: 60.4;SK-BR-3: 59.8;T-47d: 90.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.6	0.1	0.2	2.2	0.1	0.0	9.6	0.5	0.3	7.6	0.7	18.1	9.9	1.1	7.4	55.2	4.9	4.1	0.1	0.2	0.0	9.9	38.8	13.3	0.0	0.1	0.1	0.2	28.9	13.4	3.3	8.0	0.1	11.6	14.7	0.0	17.8	2.6	0.2	36.5	8.2	0.5	0.0	0.0	27.0	10.8	0.3	3.4	16.7	0.0	7.1	13.0	19.2	0.2	38.6	0.2	0.1	0.0	0.0	0.0	55.5	0.2	0.0	0.1	0.2	36.7	19.1	0.0	1.7	0.0	0.0	40.4	0.1	30.1	0.0	0.1	24.1	0.1	12.5	30.9	0.6	0.0	0.2	0.0	43.4	0.0	16.4	0.1	0.0	0.1	0.1	0.0	0.0	113.2	0.0	0.3	4.1	31.4	12.0	0.1	0.0	0.2	14.5	60.4	4.2	0.0	19.6	59.8	0.1	5.4	90.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	19.2	17.2	0.0	0.3	6.4	5.3	6.8	5.7	0.8	10.7	6.9	1.0	20.0	11.1	23.9	0.0	36.3	0.3	18.8	0.0	11.0	29.1	7.3	1.4	0.4	8.4	0.0	0.0	14.0	5.5	0.5	44.9	13.8	0.0	0.6	0.4	31.1	2.7	0.0	0.0	25.3	8.2	0.8	0.8	82.4	0.9	0.2	1.8	0.0	0.6	0.3	1.0	0.0	0.0	13.7	8.5	0.0	0.3	7.9	5.1	5.6	4.2	0.2	0.0	0.2	0.7	10.4	1.2	27.2	8.5	58.4	0.5	0.0	18.3	8.9
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 23.0;SH-SY5Y: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.4	6.4	1.1	0.2	3.1	0.0	3.6	16.9	12.3	1.5	7.4	0.5	5.3	0.4	0.9	1.6	2.5	0.7	10.6	4.4	2.3	29.0	0.7	0.5	0.2	45.4	4.9	0.7	5.7	46.3	1.5	10.6	49.6	3.1	0.3	36.1	16.0	0.7	5.8	0.8	5.0	0.2	1.6	1.1	35.1	1.1	3.5	0.6	5.9	10.2	0.3	0.7	0.2	6.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	23.0	3.4	2.5	8.1	42.4	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	3.1	16.9	12.3	4.4	2.3	45.4	4.9	49.6	1.6	3.5	6.1	0.2	0.0	1.8	330.7	0.2	0.3	3.8	0.6	0.6	29.5	9.5	5.2	51.2	10.0	1.8	23.9	58.4	35.4	0.0	0.0	54.8	5.0	5.1	15.9	2.0	1.3	8.3	0.0	415.2	2.4	4.7	3.0	70.3	3.5	0.0	0.5	1.1	0.6	4.8	48.8	495.5	1.7	14.2	0.3	0.4	8.1	0.3	0.5	8.8	36.5	0.0	13.3	0.0	391.6	218.7	0.4	1.3	0.7	0.1	4.9	16.3	29.0	16.0	41.3	0.0	10.3	0.4	1.6	0.3	0.8	0.3	214.9	0.3	1.1	2.6	1.7
ESS2	"bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2"	ENSG00000100056	"Ess-2 splicing factor homolog"	Q96DF8	22	19130279-19144684	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.7;Distal tubular cells: 13.7;Syncytiotrophoblasts: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 9.4;RH-30: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001221, HPA001222"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA001221: AB_1078645, HPA001222: AB_1078647"	"unprognostic (8.31e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.71e-3)"	0.6	0.4	3.2	0.6	3.2	0.2	0.5	4.9	3.3	1.2	1.9	2.2	0.4	1.4	0.5	1.0	0.9	0.5	1.3	2.9	2.9	0.9	0.4	0.5	0.8	3.2	3.2	1.3	0.7	0.7	1.1	0.5	3.3	1.0	0.4	1.3	0.6	1.2	1.6	1.4	0.9	0.9	2.8	0.9	1.1	2.0	3.0	0.8	0.8	1.6	0.8	1.7	0.9	3.4	1.6	3.0	1.7	1.9	2.7	0.5	0.7	1.5	0.9	2.6	2.1	2.4	0.6	2.3	0.5	0.7	0.6	2.8	5.1	0.8	1.3	3.4	5.8	0.6	2.7	0.4	0.7	2.8	2.0	0.4	3.0	1.8	0.5	0.7	0.5	1.6	9.4	0.3	1.2	1.7	1.7	1.6	1.5	1.8	2.3	2.6	8.3	0.0	0.7	1.2	4.3	0.9	0.7	1.3	1.9	1.1	0.9	1.3	0.4	2.2	3.2	2.2	1.2	1.1	2.5	0.8	0.7	1.7	1.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.0	0.2	0.0	0.1	3.2	3.2	4.9	3.3	2.9	2.9	3.2	3.2	3.3	2.8	3.0	3.4	6.3	6.4	4.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	6.1	6.7	0.0	0.0	1.8	9.2	0.0	15.7	8.3	0.0	13.7	13.2	0.0	7.5	6.9	4.0	0.0	0.0	0.0	10.4	12.4	3.7	0.0	7.5	5.1	10.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	10.3	0.0	0.0	0.0	0.0	13.4	0.0	0.0	2.3	0.0	0.0	12.7	4.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	16.3	4.0	10.2	0.0	0.0
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 8.9"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144674	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	107.9	39.3	15.2	38.5	14.4	18.7	72.7	18.5	18.9	36.6	19.8	45.9	17.2	53.4	22.2	29.2	47.1	27.8	24.5	13.5	23.0	26.8	46.7	45.0	45.9	34.2	21.7	38.8	39.5	40.7	11.7	38.7	36.2	30.5	36.2	8.9	28.0	47.2	54.2	26.1	30.7	74.4	22.5	37.2	29.3	12.1	23.6	36.6	27.8	33.3	49.8	44.7	32.3	24.0	107.0	78.1	62.2	158.2	90.8	67.3	53.4	117.4	129.3	136.2	94.4	72.4	114.3	40.8	92.2	201.3	50.7	118.7	73.7	120.4	121.6	58.8	54.2	244.7	56.0	58.5	125.9	193.2	371.6	76.7	125.5	147.1	81.3	145.3	117.8	39.2	153.6	263.9	124.4	81.2	70.4	116.4	78.9	44.6	102.5	105.4	85.0	107.3	113.7	89.0	52.4	54.8	174.1	52.9	80.5	71.3	111.1	128.4	154.5	104.8	94.7	59.7	85.7	62.3	99.0	58.7	97.3	79.6	111.7	423.2	37.4	423.0	127.2	69.4	157.2	62.4	129.4	129.5	87.2	48.2	102.3	120.2	9.3	84.2	85.6	29.7	139.6	177.8	15.2	14.4	18.5	18.9	13.5	23.0	34.2	21.7	36.2	22.5	23.6	24.0	44.4	9.6	9.3	4.6	25.9	16.3	19.8	23.5	14.2	5.5	20.5	21.3	8.2	14.3	12.9	31.3	10.4	31.9	22.3	6.1	0.0	36.8	2.0	20.5	15.1	28.2	25.2	17.9	10.2	26.8	18.1	17.6	9.2	19.3	62.7	24.7	27.1	37.8	46.4	0.0	7.1	12.0	22.4	21.3	24.8	2.1	17.4	22.9	35.6	6.5	50.6	5.7	60.8	2.0	4.1	26.2	3.5	25.2	18.5	19.9	2.2	4.4	10.7	5.9	52.6	14.3	22.0	3.9	2.9	18.0	11.9	37.9	40.3	12.5	10.8	12.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002132, HPA070823"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		24000	"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA002132: AB_1078807, HPA070823: "	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	53.9	37.0	24.0	25.6	25.0	34.8	33.9	21.8	28.7	30.8	22.7	38.4	22.3	36.1	30.1	45.0	34.4	32.2	35.1	27.7	25.3	27.2	24.5	33.4	27.5	22.1	24.6	48.1	29.2	30.9	20.6	43.3	24.6	25.3	30.3	14.2	32.1	30.5	44.9	31.0	27.6	38.7	21.7	21.4	25.5	15.8	30.7	37.0	39.3	41.8	25.4	35.8	29.3	19.4	92.9	57.8	19.5	19.8	62.2	72.6	55.3	47.5	48.9	36.7	40.6	29.7	106.1	27.5	52.2	86.2	66.6	46.0	27.8	50.2	35.1	31.5	28.3	26.2	44.0	32.2	64.1	95.0	55.8	53.4	51.8	41.8	55.2	73.1	44.8	81.9	56.4	97.8	61.9	71.7	96.0	66.7	29.2	53.9	56.7	82.4	37.0	38.8	58.6	38.4	46.8	30.2	151.6	109.7	66.7	43.4	37.7	96.3	69.3	40.3	18.8	178.7	60.5	68.6	17.3	27.5	102.4	93.8	121.5	1.7	1.4	1.2	6.1	1.8	3.4	1.1	5.1	4.3	2.8	0.6	4.6	5.5	0.9	5.4	1.2	1.8	4.2	2.3	24.0	25.0	21.8	28.7	27.7	25.3	22.1	24.6	24.6	21.7	30.7	19.4	65.7	38.5	32.4	55.5	18.1	46.1	12.9	22.6	19.4	15.0	32.6	21.6	30.8	21.5	33.7	47.8	16.7	31.6	54.0	41.0	3.9	15.3	18.0	60.6	17.8	48.5	21.1	17.7	137.1	20.0	26.1	44.2	15.8	47.0	12.6	36.8	23.2	20.9	20.2	13.5	119.3	31.2	24.4	20.2	83.6	5.3	35.1	27.7	51.6	185.5	21.9	12.1	43.3	67.3	61.4	29.9	14.1	54.5	36.2	23.2	28.0	8.7	61.8	10.8	32.9	42.6	60.4	10.6	10.2	22.0	51.7	40.8	43.4	19.5	26.0	25.8
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.3"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"			"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.1	0.1	2.5	0.0	2.0	0.0	0.7	5.1	2.2	0.8	0.2	3.8	0.0	2.2	0.0	0.4	0.2	0.3	0.5	2.1	2.3	0.9	0.0	4.7	0.0	2.2	2.1	0.5	1.0	0.8	1.9	0.3	2.5	0.2	0.2	0.1	0.3	0.0	0.4	7.7	0.3	1.5	1.3	0.0	1.7	0.5	2.4	0.0	4.7	0.0	0.4	1.0	0.7	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.8	0.8	0.1	0.2	1.3	0.0	0.0	0.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	1.2	0.1	1.7	1.4	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.0	5.1	2.2	2.1	2.3	2.2	2.1	2.5	1.3	2.4	1.5	0.1	38.5	37.7	4.2	0.1	0.8	0.8	0.5	1.2	1.9	0.9	1.3	2.5	1.5	4.5	1.8	4.2	0.8	0.0	0.1	0.0	1.0	0.2	1.5	0.8	0.7	0.0	0.0	9.4	0.9	0.4	0.9	3.6	2.2	0.0	0.5	0.4	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.4	0.2	0.3	0.2	1.8	1.0	0.0	0.3	0.0	2.0	0.5	0.7	0.1	0.0	0.0	1.1	0.0	0.3	0.8	3.9	0.0	1.4	0.3	1.5	1.7	0.5	1.6	0.7	0.1	0.7	0.2	0.1
ETAA1	ETAA16	ENSG00000143971	"ETAA1 activator of ATR kinase"	Q9NY74	2	67397322-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	4.7	11.1	2.7	4.3	3.1	3.9	7.1	4.0	3.3	6.7	3.9	5.0	3.6	6.9	6.2	5.9	6.6	4.3	3.9	2.4	2.7	6.1	5.3	5.4	6.5	2.9	2.8	7.3	8.2	6.1	3.3	4.2	2.9	5.0	4.4	5.7	6.2	3.9	3.5	6.2	5.5	5.1	2.7	5.5	5.2	4.6	2.8	6.3	6.3	3.1	5.0	5.1	6.6	3.5	7.9	5.9	10.2	9.0	7.6	10.4	8.0	8.2	10.8	8.7	8.3	4.8	9.3	14.8	4.4	6.8	12.1	9.5	8.9	10.0	12.3	8.6	6.8	8.1	14.7	7.1	7.2	8.3	7.4	8.3	13.8	6.4	9.7	13.7	13.8	11.8	6.8	6.1	12.0	3.5	12.3	9.0	10.3	12.7	6.3	8.6	16.0	6.8	10.5	5.1	8.5	16.7	8.4	7.6	8.0	9.9	6.6	4.0	9.6	11.6	8.9	5.6	9.8	6.8	6.5	11.6	10.9	8.6	9.0	1.3	1.1	0.9	2.2	1.8	2.4	3.5	2.0	1.3	1.4	3.6	2.7	2.4	0.1	2.0	2.6	2.0	3.2	1.3	2.7	3.1	4.0	3.3	2.4	2.7	2.9	2.8	2.9	2.7	2.8	3.5	7.7	22.4	21.0	10.4	7.6	2.4	7.9	8.3	6.8	5.1	8.8	8.4	10.1	15.7	9.1	12.9	0.0	6.6	9.1	3.5	11.7	17.8	0.6	15.0	15.0	7.8	10.7	13.7	6.3	18.4	6.3	10.9	6.6	11.1	6.3	15.4	10.4	8.9	4.8	5.0	6.6	7.1	2.0	5.1	1.5	1.9	12.2	4.8	1.8	2.8	9.4	6.5	15.5	15.1	13.6	20.4	4.7	13.2	7.0	8.0	5.9	15.0	16.6	4.6	0.0	8.9	7.3	12.7	8.2	7.9	2.6	2.1	7.2	14.1	7.0	6.1
ETF1	"ERF, ERF1, RF1, SUP45L1, TB3-1"	ENSG00000120705	"Eukaryotic translation termination factor 1"	P62495	5	138506095-138543236	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 456.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011686, HPA037511"	Approved					NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"			"CAB011686: AB_732263, HPA037511: AB_2675516"	"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.63e-2)"	68.3	46.5	26.9	47.1	27.3	169.5	51.9	26.7	31.3	37.4	34.0	46.2	33.7	41.7	36.7	88.2	33.9	49.1	48.3	29.4	30.0	46.2	58.9	56.8	40.3	28.6	29.2	29.4	48.4	54.6	33.0	59.8	28.4	39.1	45.6	27.3	37.7	46.3	98.1	61.1	33.6	51.6	28.8	31.1	41.6	59.1	29.7	35.5	49.1	74.2	57.8	70.1	39.5	29.3	137.9	132.2	92.0	151.4	120.5	112.5	161.4	148.1	152.2	172.4	199.7	321.5	123.3	171.6	125.1	151.2	243.6	112.4	218.0	277.2	258.0	96.7	117.2	137.2	142.9	128.8	162.0	117.3	110.5	117.8	158.5	176.4	231.2	90.4	141.4	110.4	180.1	101.9	179.0	102.9	146.3	104.4	113.5	104.8	75.8	123.5	152.2	139.7	119.0	191.7	119.6	120.6	164.8	110.8	264.0	238.4	129.6	138.3	117.4	136.1	78.2	108.9	218.4	211.9	215.0	249.2	122.2	173.4	131.1	17.7	22.9	14.4	17.0	27.1	19.7	17.2	17.5	19.7	23.8	10.8	12.3	16.3	15.1	16.7	25.6	16.9	19.9	17.1	26.9	27.3	26.7	31.3	29.4	30.0	28.6	29.2	28.4	28.8	29.7	29.3	54.8	160.3	62.4	14.4	57.2	209.3	179.0	70.4	85.4	16.1	78.9	63.6	63.3	41.5	77.9	57.0	14.6	118.0	80.0	51.0	62.6	77.9	456.1	110.3	74.9	54.1	39.9	63.7	18.6	75.0	90.1	68.5	44.4	128.4	54.5	32.1	26.0	50.8	76.5	25.2	18.1	47.4	26.4	62.5	146.6	178.4	23.3	116.1	72.9	13.1	71.4	25.6	34.0	10.1	17.8	91.3	39.6	27.1	64.2	109.2	36.9	54.5	72.1	19.9	59.2	118.4	79.8	46.3	52.7	98.1	202.0	285.5	67.6	40.5	58.9	181.5
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein subunit alpha"	P13804	15	76215353-76311472	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 389.7;tongue: 493.5"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 402.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		680000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	93.0	112.3	33.8	55.0	36.0	63.0	70.4	36.0	54.6	38.7	40.3	131.4	135.6	27.0	30.6	85.1	30.1	44.7	243.0	34.2	37.6	180.0	389.7	39.0	60.9	35.6	35.7	25.6	81.6	71.0	13.9	70.9	36.0	42.2	123.5	34.3	49.3	38.2	300.8	40.1	116.3	65.7	35.5	38.8	67.7	28.4	38.2	54.5	38.7	493.5	65.9	74.0	33.1	36.9	122.4	196.7	128.2	134.8	141.7	149.1	201.0	144.4	166.2	183.0	162.8	175.3	221.3	203.5	141.3	144.3	138.5	304.6	502.7	200.2	211.9	245.8	98.0	222.2	131.4	205.2	114.7	214.5	158.7	112.7	185.9	93.1	153.5	100.0	187.8	64.7	214.1	205.2	190.3	191.2	44.9	178.2	99.9	225.3	58.4	192.8	158.6	272.8	202.1	386.9	133.3	67.2	218.2	492.2	205.0	294.4	254.1	223.4	111.4	178.2	119.5	157.0	177.4	99.0	221.0	255.9	127.8	281.1	128.5	50.0	120.3	82.7	65.4	110.3	61.7	77.3	60.6	67.6	159.4	67.3	48.8	60.1	30.2	122.9	96.1	63.4	95.8	141.9	33.8	36.0	36.0	54.6	34.2	37.6	35.6	35.7	36.0	35.5	38.2	36.9	65.7	57.7	41.6	45.1	54.3	53.4	110.8	151.5	44.9	13.1	47.2	46.4	352.9	65.8	84.5	36.8	22.9	277.4	61.1	250.9	209.4	106.5	11.7	29.5	45.1	51.8	65.4	117.8	26.0	84.1	180.8	66.8	90.2	37.0	38.6	53.1	48.9	348.8	132.3	53.8	31.5	141.6	89.5	79.0	84.5	7.9	59.4	103.0	56.9	28.1	129.0	26.7	85.5	37.2	46.9	92.1	176.2	58.3	87.8	92.4	231.1	402.9	50.2	20.4	46.0	44.0	113.7	66.4	40.5	79.5	57.1	300.2	55.5	123.4	187.3	162.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	159.1	171.5	121.1	44.0	134.4	70.2	115.3	134.8	145.5	55.7	123.0	97.6	136.3	48.9	16.9	140.7	53.3	62.7	387.8	112.8	120.6	144.5	493.6	50.4	58.2	129.8	124.8	55.2	81.9	106.3	73.1	39.0	125.7	55.2	41.2	24.1	172.2	37.9	280.7	79.0	129.7	31.7	119.9	64.5	90.0	53.6	132.4	81.4	70.3	280.3	36.9	65.6	69.0	137.0	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	121.1	134.4	134.8	145.5	112.8	120.6	129.8	124.8	125.7	119.9	132.4	137.0	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
ETFBKMT	"C12orf72, DKFZp451L235, METTL20, MGC50559"	ENSG00000139160	"Electron transfer flavoprotein subunit beta lysine methyltransferase"	Q8IXQ9	12	31647160-31673114	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 7.3;Distal tubular cells: 7.9;Endometrial ciliated cells: 10.3;Proximal tubular cells: 18.1;Theca cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039024	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"			"HPA039024: AB_10670917"	"unprognostic (1.05e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.77e-1)"	"unprognostic (6.12e-5)"	"unprognostic (3.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.32e-2)"	2.4	3.8	2.0	1.6	2.3	2.3	2.9	3.1	2.7	3.7	0.7	2.4	2.9	2.8	5.4	2.5	4.4	2.7	3.7	1.8	1.8	6.1	9.7	2.1	1.6	1.6	1.7	4.8	3.8	4.7	2.6	2.1	1.7	2.6	2.5	6.1	2.2	2.7	7.6	2.5	2.0	3.0	1.8	2.4	2.7	3.7	1.7	1.0	3.7	7.8	1.4	2.1	1.6	2.9	1.8	1.1	1.6	2.3	6.8	4.7	1.4	1.7	1.7	1.9	2.1	2.1	3.2	0.8	1.6	1.2	1.7	0.4	1.0	1.2	2.0	1.3	1.2	1.3	1.6	0.6	2.4	0.8	1.8	4.4	2.1	2.3	2.1	1.8	3.0	2.5	1.5	2.9	2.4	1.7	0.8	0.8	1.8	1.5	1.9	1.2	2.0	2.2	2.7	0.6	1.0	1.0	1.6	1.2	2.6	4.1	5.1	1.6	2.3	1.9	1.7	5.0	1.4	5.3	3.2	1.4	1.6	1.5	1.5	7.8	1.7	2.1	0.9	1.0	0.8	2.0	1.1	1.5	1.2	2.3	1.8	1.6	4.5	1.6	1.2	2.5	1.3	0.9	2.0	2.3	3.1	2.7	1.8	1.8	1.6	1.7	1.7	1.8	1.7	2.9	5.9	6.4	3.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	7.3	6.3	0.0	0.0	0.6	3.7	0.0	3.0	2.5	0.0	7.9	2.9	0.0	10.3	5.2	2.1	0.0	0.0	0.0	2.6	2.6	2.1	0.0	5.3	2.5	5.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.0	18.1	3.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.7	1.6	7.6	0.0	0.0
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease variant, FDA approved drug targets, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 196.4;tongue: 186.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	34.6	38.0	13.3	10.7	14.8	9.4	16.0	13.9	15.1	10.2	25.5	32.6	63.7	10.4	8.4	25.0	9.3	11.1	93.3	12.8	14.5	46.5	196.4	9.2	8.7	12.3	13.8	10.8	20.4	32.8	9.8	13.0	12.8	13.7	26.9	15.8	21.8	13.2	111.0	18.7	51.4	14.8	12.5	9.5	26.9	11.2	15.0	9.4	13.2	186.9	14.3	12.9	12.8	15.1	13.2	9.2	12.2	21.4	47.2	28.8	6.6	21.3	19.4	13.9	14.3	3.7	24.6	27.8	4.6	24.1	15.8	13.8	22.1	20.9	19.2	51.5	20.3	26.5	17.3	8.0	20.8	24.0	23.4	26.5	23.8	15.8	12.8	20.8	27.3	20.7	15.6	53.8	22.2	14.7	22.7	11.0	5.0	33.2	19.4	18.4	4.3	21.9	21.2	10.6	18.7	8.0	21.0	39.5	21.8	10.0	30.4	17.6	13.6	11.9	6.7	18.5	12.2	31.3	42.1	20.3	24.6	19.2	13.5	3.7	21.5	41.5	10.1	22.6	12.7	10.3	9.8	10.4	18.3	9.6	11.6	9.9	7.8	10.5	20.9	13.1	16.1	9.5	13.3	14.8	13.9	15.1	12.8	14.5	12.3	13.8	12.8	12.5	15.0	15.1	18.1	12.8	10.3	55.2	18.5	33.0	46.0	27.2	29.6	29.2	12.6	13.8	146.6	14.3	22.8	18.4	64.6	24.9	18.0	34.4	29.4	14.4	4.2	12.5	12.5	17.7	18.0	30.7	43.2	11.7	9.9	23.9	44.4	14.2	5.1	19.2	12.8	85.7	13.4	25.2	71.9	22.5	30.5	14.4	15.8	4.7	23.0	13.3	8.8	15.0	12.2	13.9	10.3	55.8	58.0	11.7	29.4	23.7	30.1	21.3	58.3	26.8	13.1	43.9	32.9	27.4	30.4	43.2	29.8	32.7	36.9	43.0	19.7	15.7	26.2	38.7
ETFRF1	LYRM5	ENSG00000205707	"Electron transfer flavoprotein regulatory factor 1"	Q6IPR1	12	25195216-25209645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 305.2;Proximal tubular cells: 183.8;Theca cells: 69.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044255	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA044255: AB_10967895"	"prognostic favorable (9.63e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (9.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-3)"	28.2	46.3	43.9	13.5	48.3	12.9	35.0	49.5	69.8	25.7	41.2	17.9	33.4	19.6	35.6	22.5	18.3	22.5	53.1	43.4	47.4	55.9	121.3	21.7	17.9	50.0	46.4	20.6	24.1	37.2	15.1	17.5	49.5	26.4	19.4	30.4	30.4	20.6	89.1	24.2	23.9	18.3	49.7	18.3	30.3	56.3	45.8	18.9	43.2	101.5	16.5	18.1	12.0	57.0	13.4	12.6	16.8	11.1	25.4	40.4	12.1	14.7	21.4	15.1	17.4	6.0	15.0	4.3	10.2	23.4	9.6	9.4	14.2	14.9	17.0	15.9	12.1	21.5	13.8	7.9	27.3	19.4	12.1	26.1	48.9	13.8	23.5	46.5	23.9	23.9	25.5	13.5	24.1	14.1	16.9	50.1	26.8	29.6	16.1	11.2	19.8	26.2	40.8	10.4	17.3	12.2	13.4	14.1	40.2	42.5	21.7	27.1	14.0	6.0	8.1	33.1	9.2	16.6	10.9	16.6	26.2	15.2	18.7	24.9	8.5	7.8	8.5	9.5	12.1	21.3	15.2	11.6	8.9	16.8	27.7	22.6	15.6	17.1	6.2	13.3	7.7	12.3	43.9	48.3	49.5	69.8	43.4	47.4	50.0	46.4	49.5	49.7	45.8	57.0	38.0	19.2	24.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	39.1	48.8	0.0	0.0	9.3	27.6	0.0	56.2	11.9	0.0	305.2	31.0	0.0	36.8	17.0	13.8	0.0	0.0	0.0	45.8	19.2	12.1	0.0	36.1	11.4	14.2	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	25.6	0.0	0.0	3.0	0.0	0.0	183.8	4.4	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	65.5	9.0	69.1	0.0	0.0
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1 persulfide dioxygenase"	O95571	19	43506719-43527230	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 256.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 222.6;OE19: 360.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	24.4	27.9	16.1	34.8	17.0	45.8	26.7	16.5	17.3	28.7	15.8	256.1	85.5	18.3	29.8	81.0	20.6	21.0	18.8	15.6	17.4	40.4	52.7	30.5	23.4	17.3	17.2	13.5	28.9	16.1	19.1	26.3	16.6	27.1	226.6	3.2	40.1	18.5	22.8	27.2	77.0	35.6	17.1	27.8	37.8	3.0	18.2	19.8	24.1	21.9	41.7	34.4	39.1	17.2	54.1	68.9	14.1	49.6	75.1	50.9	5.5	82.1	222.6	69.8	71.1	21.1	54.3	0.2	60.0	79.8	22.2	42.9	20.6	123.4	19.6	26.2	6.2	13.8	29.7	59.2	34.0	19.3	18.4	52.2	95.1	26.9	76.0	92.2	52.0	49.8	9.0	87.6	35.1	35.7	22.2	18.9	3.8	360.5	32.9	26.6	6.1	12.0	153.0	110.9	0.2	16.6	20.8	74.8	50.6	23.6	22.4	34.3	41.6	10.9	46.9	13.1	15.3	23.1	20.2	1.4	48.4	83.8	57.7	24.2	63.3	1.6	41.1	34.5	48.3	20.5	47.6	39.4	95.8	7.5	36.4	35.0	2.1	29.3	22.8	17.9	50.4	40.2	16.1	17.0	16.5	17.3	15.6	17.4	17.3	17.2	16.6	17.1	18.2	17.2	32.0	22.4	23.4	3.9	25.5	34.5	82.2	242.5	57.5	9.8	85.8	95.2	9.8	47.1	84.5	55.2	0.0	191.6	38.0	1037.7	54.8	71.7	0.9	31.0	41.2	44.9	63.7	17.4	6.2	63.6	95.7	42.1	53.5	68.2	38.0	12.6	42.1	89.2	115.1	5.0	6.8	324.2	79.3	105.0	78.5	2.1	17.7	74.6	80.0	3.7	78.5	11.7	63.8	4.0	5.6	102.7	788.4	16.1	34.9	75.0	376.3	136.4	23.1	5.8	19.7	32.0	45.1	2.1	6.2	82.8	23.2	92.5	50.4	15.8	447.5	146.5
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 299.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	10.1	14.4	13.7	14.5	15.2	12.2	13.7	9.0	15.9	10.8	16.4	27.2	23.3	10.2	19.6	10.8	10.1	14.0	7.3	14.7	28.1	18.4	18.2	12.6	17.4	12.0	14.2	11.7	10.7	10.8	13.7	11.3	15.8	10.9	15.3	18.2	12.4	6.2	6.2	15.3	15.5	7.6	11.1	16.7	45.0	17.8	19.3	23.1	14.5	5.6	14.3	10.8	9.5	17.5	14.8	27.9	30.4	27.5	21.2	21.3	21.7	15.6	12.2	17.4	16.0	20.6	33.3	41.1	14.7	11.6	16.5	10.7	27.1	7.6	28.2	36.8	23.7	34.7	11.5	18.9	20.6	33.9	29.4	13.7	7.2	21.9	17.4	25.8	20.3	15.7	41.8	17.2	22.3	7.7	38.8	67.1	59.3	17.9	20.1	32.7	28.1	32.9	25.6	16.5	9.8	17.8	18.9	13.9	27.1	41.1	24.1	32.1	17.5	12.2	19.9	18.6	25.0	12.9	18.1	46.8	16.2	21.0	23.9	44.0	14.3	15.9	15.4	22.0	15.2	22.2	16.4	14.4	14.1	15.3	17.7	17.7	14.6	17.7	23.4	12.6	20.5	19.2	13.7	15.2	9.0	15.9	14.7	28.1	12.0	14.2	15.8	11.1	19.3	17.5	33.6	48.1	32.2	48.0	55.9	144.3	75.7	34.7	64.9	41.0	56.8	42.2	10.1	45.8	43.8	44.1	50.1	30.1	57.6	116.1	27.4	30.7	299.0	64.2	49.1	34.8	108.3	48.8	104.4	44.5	24.2	38.2	230.4	51.4	34.8	40.9	28.2	41.5	42.9	26.9	104.3	60.7	46.8	88.3	60.0	43.5	24.2	57.0	67.6	84.3	39.1	17.7	43.3	121.2	152.9	39.5	62.9	21.4	63.7	73.8	57.7	33.2	81.6	39.5	39.5	23.3	38.9	49.1	18.5	51.9	170.2	75.4	49.0	41.5	47.8	90.3
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152044	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 108.1;liver: 235.5;testis: 125.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 417.0;Late spermatids: 1337.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.8;MCF7: 55.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.6"	HPA057167	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	14.4	6.1	12.8	2.1	12.5	2.8	17.4	7.9	12.0	18.8	28.3	5.7	1.9	10.8	29.9	23.9	13.1	5.3	6.3	10.6	14.0	108.1	235.5	3.3	2.1	10.5	13.4	36.1	9.5	18.5	25.6	4.3	11.1	13.7	2.1	5.7	27.7	16.2	2.0	20.3	3.7	6.5	8.5	7.2	4.9	125.0	15.1	3.7	10.6	4.1	9.3	10.0	26.0	7.5	11.3	3.8	11.0	20.9	4.0	1.3	10.9	11.4	25.2	15.6	6.8	19.2	5.4	0.4	18.4	2.8	18.2	9.9	19.7	15.9	10.7	0.4	17.3	0.2	2.5	30.6	16.2	0.5	0.7	5.4	53.8	3.2	0.7	8.0	11.1	11.9	1.6	0.4	2.0	55.1	3.2	0.3	23.0	0.4	8.4	0.8	13.0	0.4	13.4	4.3	2.9	15.4	7.2	33.6	5.4	35.1	32.5	0.7	0.7	4.4	23.8	1.0	8.4	0.5	0.2	0.5	0.3	0.6	6.3	0.0	0.1	0.0	2.2	0.0	2.1	0.0	0.5	1.3	0.0	0.1	1.3	1.6	0.1	0.8	0.0	0.0	0.3	0.6	12.8	12.5	7.9	12.0	10.6	14.0	10.5	13.4	11.1	8.5	15.1	7.5	1.3	0.0	0.0	1.3	1.0	4.1	13.8	8.2	1.8	4.2	12.3	11.6	1.1	4.3	2.5	3.7	4.2	6.1	1.6	0.1	39.2	9.5	417.0	4.5	1.9	2.1	1.2	13.5	1.2	6.3	9.2	6.4	1.1	3.2	8.9	47.4	6.8	196.9	0.8	0.0	2.9	0.1	2.0	6.5	1.1	1337.3	29.2	1.6	10.6	0.0	0.0	3.8	1.0	2.5	0.2	4.5	0.0	42.2	0.0	14.9	0.3	147.2	3.1	0.8	0.0	4.1	4.4	11.0	7.4	16.1	2.4	9.4	2.9	34.1	0.2	13.5
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETV3	PE-1	ENSG00000117036	"ETS variant transcription factor 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 361.2;monocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	13.7	7.7	6.6	11.1	6.6	24.0	12.1	7.9	20.1	8.3	5.3	8.7	15.1	9.3	7.5	15.6	7.8	12.7	7.4	8.3	8.1	6.6	6.6	12.6	10.1	7.7	6.5	11.5	6.4	23.9	5.0	12.8	7.0	10.2	9.5	5.7	9.2	8.5	9.4	31.5	14.6	10.1	7.1	10.0	10.0	9.4	7.4	10.8	7.9	8.8	12.5	17.6	11.4	7.1	11.9	11.4	11.6	10.1	17.3	11.3	9.9	10.9	11.4	10.5	9.7	12.2	11.6	14.2	13.4	13.4	5.6	18.0	12.8	16.7	13.8	31.0	8.1	11.9	12.2	6.7	10.3	19.0	18.1	12.5	19.2	15.7	13.3	8.5	11.1	8.8	13.9	10.2	12.0	15.7	5.8	10.7	38.6	16.9	8.7	8.7	13.8	16.3	8.1	43.9	9.8	19.0	11.9	28.1	29.5	20.7	14.4	20.7	18.8	13.5	11.9	13.2	13.7	24.6	13.5	16.7	15.5	10.9	45.2	6.3	4.6	3.3	4.5	4.2	6.2	2.1	3.9	4.5	4.5	2.4	3.9	3.5	5.4	4.2	4.2	1.2	3.3	2.6	6.6	6.6	7.9	20.1	8.3	8.1	7.7	6.5	7.0	7.1	7.4	7.1	22.9	35.3	16.2	3.6	20.4	70.4	18.4	20.2	71.7	2.3	18.2	14.4	9.4	5.7	24.3	12.9	10.4	7.5	37.2	22.1	0.0	6.4	9.4	18.1	18.0	19.4	10.7	5.9	8.1	6.3	9.0	16.3	15.3	29.5	22.2	6.4	15.4	8.3	8.7	1.7	6.9	12.5	10.2	13.2	361.2	7.3	4.1	69.0	16.0	5.6	97.0	3.9	10.3	6.0	4.4	10.4	13.4	4.5	25.3	16.5	16.0	3.2	29.7	6.3	13.1	16.4	15.4	10.2	9.4	64.2	78.7	14.9	40.4	6.0	14.4	51.4
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant transcription factor 4"	P43268	17	43527844-43579620	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 80.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.5	2.4	1.2	1.0	1.6	0.0	7.0	0.8	2.2	3.6	0.0	2.0	6.1	2.4	1.0	9.2	2.5	6.4	3.1	1.3	0.8	5.4	1.2	2.2	0.6	1.0	0.9	0.4	7.8	7.9	14.7	5.2	1.4	4.5	1.7	3.0	4.6	3.6	1.3	6.4	4.2	1.4	0.3	0.4	3.8	1.2	0.7	0.3	6.9	2.5	4.8	2.1	5.3	0.9	24.5	67.0	80.4	177.7	3.1	20.1	17.9	7.9	21.1	14.9	15.2	38.1	33.9	0.1	4.3	4.1	36.6	43.6	2.7	40.2	13.2	0.8	0.5	2.3	10.7	173.0	4.3	47.0	20.9	3.6	1.4	56.8	35.0	16.8	32.1	0.3	48.9	0.1	31.0	9.8	0.2	82.9	116.9	123.1	110.9	99.8	9.8	58.9	33.0	17.3	0.1	71.4	2.1	4.5	197.0	43.8	0.8	13.9	15.1	10.6	52.0	15.7	22.1	7.3	47.8	0.1	18.9	8.9	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.8	2.2	1.3	0.8	1.0	0.9	1.4	0.3	0.7	0.9	0.2	0.0	0.0	1.3	0.0	1.9	2.5	3.6	23.3	3.2	10.4	12.3	1.1	17.2	2.4	0.0	0.0	2.3	0.1	1.1	17.6	6.5	3.1	0.7	0.3	1.5	14.9	0.0	1.6	1.0	19.8	1.9	3.1	1.6	0.0	0.2	0.7	0.0	0.8	0.0	1.0	4.0	2.0	0.3	0.3	6.0	0.3	0.2	3.6	1.0	0.0	10.9	0.0	1.0	0.0	3.7	3.3	0.4	0.0	0.9	1.9	0.1	1.0	0.3	0.0	2.1	1.7	0.0	1.3	3.6	1.1	14.9	0.3	0.1	7.7	4.3
ETV5	ERM	ENSG00000244405	"ETS variant transcription factor 5"	P41161	3	186046314-186110318	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 50.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065, HPA073889"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	6.8	39.3	17.1	6.9	22.4	1.4	15.0	17.7	24.4	4.9	9.4	3.4	6.1	8.1	7.3	4.2	5.1	5.6	11.5	17.8	16.8	8.9	7.9	29.6	5.2	20.5	17.1	2.2	17.5	42.2	25.4	17.1	17.7	7.4	3.2	15.9	6.5	5.8	11.9	6.4	3.0	7.4	14.7	10.9	14.8	9.3	17.2	4.8	21.9	7.0	4.2	4.3	4.1	19.6	42.4	28.6	36.1	79.2	21.9	22.7	2.6	35.7	39.7	27.7	29.6	31.7	25.4	1.1	46.4	34.7	41.3	7.1	0.8	27.2	40.7	9.3	1.0	12.4	1.0	36.4	36.3	31.2	22.1	19.9	4.4	44.3	53.7	32.9	41.0	4.4	11.6	14.6	47.5	19.8	4.1	47.7	54.2	12.1	32.4	86.6	36.0	28.7	23.0	9.9	1.6	45.8	8.7	0.4	178.3	14.4	0.1	17.3	40.0	15.0	24.3	38.2	70.5	11.1	49.9	0.3	45.8	24.6	91.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.1	17.1	22.4	17.7	24.4	17.8	16.8	20.5	17.1	17.7	14.7	17.2	19.6	5.7	3.2	68.5	26.1	5.6	15.7	10.6	8.2	45.5	17.8	9.4	30.4	5.7	17.2	2.4	0.0	12.5	57.6	3.1	0.6	3.9	9.4	24.6	2.0	4.3	9.2	10.7	1.7	94.0	9.4	18.8	12.5	15.8	4.7	8.2	0.8	10.4	9.0	56.4	5.0	43.7	2.8	0.0	64.4	19.4	49.0	9.0	27.1	16.0	45.9	2.1	60.4	1.0	169.9	47.5	12.5	1.1	15.4	4.9	3.6	1.5	22.9	1.3	18.8	0.0	25.4	13.6	16.9	14.4	8.7	5.3	88.8	1.9	3.1	1.5	2.7
ETV6	TEL	ENSG00000139083	"ETS variant transcription factor 6"	P41212	12	11649674-11895377	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.2;Microglial cells: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.1;NB-4: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Cytosol	"HPA000264: AB_611466"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.54e-5)"	16.9	8.8	4.8	16.3	4.4	40.9	20.0	4.8	5.6	9.4	3.6	15.2	7.5	7.9	11.1	9.5	8.0	9.7	6.6	4.2	4.7	9.2	9.3	16.2	12.8	9.2	6.0	5.0	9.6	5.6	5.3	8.1	6.9	13.5	11.2	2.6	33.3	6.8	5.5	24.3	14.1	9.2	6.8	16.7	8.4	3.5	6.8	17.3	8.9	2.7	14.7	15.0	8.4	6.3	5.6	7.5	6.7	11.6	5.0	4.7	8.1	4.1	6.9	5.2	6.1	0.5	25.9	4.7	4.0	7.0	6.1	7.1	3.0	12.4	6.2	85.1	1.4	29.9	4.0	2.8	6.2	32.0	31.2	9.3	7.5	5.1	10.5	9.9	15.9	21.3	2.3	15.3	4.7	3.6	18.1	45.3	10.9	5.9	2.0	5.1	6.3	12.3	11.9	34.8	1.3	6.8	8.1	7.7	7.7	10.6	2.6	19.9	18.1	11.6	9.8	3.9	8.8	6.7	5.5	2.6	7.6	0.2	13.6	6.2	4.5	5.9	1.1	5.6	1.6	2.3	1.7	1.1	3.5	1.7	1.0	0.6	9.8	2.1	6.8	5.3	1.2	1.2	4.8	4.4	4.8	5.6	4.2	4.7	9.2	6.0	6.9	6.8	6.8	6.3	38.3	6.4	9.6	84.2	37.7	14.9	31.8	27.2	10.8	3.1	66.7	57.8	9.1	21.5	30.7	14.7	6.2	15.0	21.5	45.7	1.9	17.9	17.6	45.3	17.5	37.5	32.4	33.6	63.6	35.9	4.3	12.9	20.9	69.7	10.8	24.0	38.6	10.9	18.3	0.0	117.7	28.9	22.4	53.3	137.2	4.5	7.8	62.6	28.4	216.4	55.7	4.3	8.2	106.6	37.0	38.6	31.6	10.9	71.4	34.2	15.4	11.5	39.3	3.9	19.7	17.6	34.2	0.6	5.4	17.3	22.4	8.6	20.9	21.5	22.5	71.8
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	1.9	2.1	1.5	6.9	1.5	0.9	2.1	1.0	1.7	2.1	1.4	3.3	16.0	1.0	1.3	3.6	2.2	3.4	0.4	1.5	1.4	2.3	2.9	4.9	5.3	2.2	1.2	1.5	1.6	2.2	3.8	3.6	2.1	2.9	2.6	0.4	8.6	1.5	0.2	15.4	12.7	1.0	2.1	3.1	6.2	1.1	1.4	4.0	1.2	0.3	3.9	5.5	2.5	1.4	3.2	0.0	0.2	0.1	0.0	0.2	27.1	0.0	9.2	14.7	27.8	0.5	6.2	0.1	0.7	0.2	2.3	3.3	0.4	1.7	0.7	59.7	0.5	0.5	0.0	0.0	1.8	0.0	0.3	1.2	2.4	0.7	0.2	0.0	0.4	0.0	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.3	0.1	6.1	0.1	0.2	0.2	1.1	0.8	0.0	0.6	2.1	0.5	0.0	3.1	0.6	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	2.7	0.4	0.0	3.7	0.3	1.6	5.7	3.9	3.3	5.4	2.2	0.9	2.4	1.0	1.4	18.9	0.6	1.9	0.0	16.3	2.5	1.5	1.5	1.0	1.7	1.5	1.4	2.2	1.2	2.1	2.1	1.4	1.4	1.4	19.2	14.8	0.3	1.2	2.0	2.2	8.0	6.2	0.2	2.5	2.7	0.5	7.2	7.1	0.0	0.0	28.8	0.7	6.6	0.0	12.4	0.4	0.4	1.4	1.1	3.6	0.0	0.5	23.8	6.6	2.7	8.2	0.7	2.5	1.7	0.0	0.4	2.9	0.0	0.3	6.5	6.1	1.3	1.6	0.5	1.5	1.0	3.6	0.0	6.5	3.1	1.0	0.0	0.3	13.4	7.8	1.2	5.6	4.8	21.5	1.3	3.0	0.6	0.0	1.0	5.5	0.9	26.8	6.4	3.7	8.5	3.6	0.7	7.6	4.8
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 191.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.7;U-138 MG: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	Yes				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	1.1	0.5	0.2	1.1	0.9	0.1	3.4	0.6	0.5	9.8	0.2	0.7	1.7	2.8	9.6	0.4	3.7	1.2	1.6	0.2	0.3	20.0	191.6	20.7	0.4	1.1	0.5	0.5	23.8	7.6	1.1	17.3	0.9	0.9	0.7	0.5	8.9	2.2	1.2	2.7	1.8	2.0	0.7	10.8	0.6	2.9	0.8	5.1	1.8	1.6	0.3	0.8	0.8	0.8	1.0	14.5	1.5	0.4	3.1	21.2	1.4	68.0	45.3	59.2	30.1	0.5	1.2	0.1	6.3	85.7	54.2	9.4	1.7	14.4	36.8	0.0	1.1	0.0	2.5	45.7	2.2	0.0	0.1	15.0	8.3	73.2	33.3	59.0	37.2	0.0	0.0	0.0	46.1	0.0	0.1	0.0	3.3	0.2	23.5	7.9	0.1	0.0	32.5	0.5	0.9	1.6	6.2	0.4	53.7	2.2	0.2	0.3	31.0	110.3	46.3	2.0	71.9	0.7	0.1	0.3	62.5	0.0	59.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.5	0.2	0.3	1.1	0.5	0.9	0.7	0.8	0.8	6.1	41.7	35.4	1.0	0.9	2.8	13.7	14.3	3.4	1.2	11.7	12.3	0.3	1.5	23.0	11.0	0.0	43.3	0.4	0.1	27.4	30.5	12.2	13.3	1.4	4.8	1.8	0.0	1.1	16.1	25.9	4.7	0.0	11.4	0.0	0.0	2.2	78.1	3.5	0.0	0.9	1.1	4.1	0.8	1.2	9.4	0.3	0.6	28.4	2.8	0.1	0.0	0.0	1.5	0.9	9.7	0.0	0.7	0.0	12.3	0.5	77.3	1.7	0.1	0.0	2.2	9.0	2.2	0.9	1.1	0.9	124.8	1.1	0.0	1.6	10.5
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA041928: AB_2677752, HPA043537: AB_2678538"	"prognostic favorable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	26.8	19.4	5.5	3.4	5.4	2.0	35.8	5.5	6.4	41.8	7.5	19.8	2.5	34.0	0.6	12.2	21.9	1.3	19.9	5.0	5.9	39.2	8.5	26.1	1.9	6.8	6.4	30.2	7.8	1.9	9.4	9.0	6.0	29.0	0.4	0.0	28.7	2.9	5.7	24.0	15.8	1.6	7.0	37.6	14.2	7.5	6.6	0.5	33.9	1.0	0.5	22.0	30.1	5.7	0.7	2.7	1.6	3.0	7.9	23.3	6.8	29.0	22.4	5.4	6.3	0.2	2.1	0.0	8.5	9.2	1.0	0.2	0.2	1.1	1.1	3.3	6.0	3.6	0.6	1.3	17.4	0.1	0.6	20.4	0.0	6.9	0.3	0.9	8.7	0.1	1.4	1.0	3.6	0.2	0.1	41.7	1.7	0.0	10.4	1.5	0.3	7.1	4.6	0.0	0.1	3.9	2.8	1.1	13.3	1.1	0.0	2.7	12.7	7.9	0.0	10.5	2.7	0.3	0.0	0.1	2.9	1.8	7.1	4.0	0.9	0.0	0.2	0.3	0.6	0.0	0.3	0.5	0.5	0.0	0.0	0.0	1.7	1.6	0.1	0.0	1.2	0.1	5.5	5.4	5.5	6.4	5.0	5.9	6.8	6.4	6.0	7.0	6.6	5.7	82.8	0.0	0.0	2.3	6.2	16.2	19.3	7.3	0.0	0.0	143.9	90.6	2.2	1.5	5.1	7.3	0.0	54.7	8.4	0.3	1.9	20.2	7.1	9.4	88.4	53.9	0.0	0.8	0.0	15.2	250.3	56.6	0.0	15.2	4.5	15.7	84.9	0.9	48.7	0.0	0.0	0.1	6.1	41.3	28.8	24.8	50.7	30.4	12.4	5.6	10.2	14.1	4.1	0.0	0.1	28.9	1.1	48.5	7.9	56.6	0.4	7.7	5.6	0.9	26.3	7.8	98.4	8.4	3.3	0.7	12.4	161.3	9.7	58.2	0.5	30.3
EVA1C	"B18, B19, C21orf63, C21orf64, FAM176C, PRED34"	ENSG00000166979	"Eva-1 homolog C"	P58658	21	32412006-32515397	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 156.1;Late spermatids: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.1;gdT-cell: 3.1;MAIT T-cell: 3.8;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.2;naive CD8 T-cell: 1.6;NK-cell: 3.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.1;NK-cells: 3.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 24.5;CAPAN-2: 22.4;HBEC3-KT: 18.1;hTCEpi: 18.1;HUVEC TERT2: 18.7;SK-MEL-30: 19.1;U-87 MG: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015720, HPA029944, CAB034174"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092"	"unprognostic (7.55e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.40e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.25e-3)"	25.8	3.1	4.9	3.7	5.6	1.1	20.4	5.3	6.4	14.0	5.3	11.6	1.3	22.1	6.3	11.1	23.9	11.9	13.5	4.7	5.8	6.8	2.0	17.3	4.7	5.8	5.5	12.5	5.2	7.2	7.6	7.1	5.7	20.0	2.4	0.4	14.4	22.0	6.1	18.5	6.7	13.0	4.9	5.8	9.7	9.6	6.0	2.3	10.6	5.2	8.9	18.4	17.1	6.4	0.0	24.5	0.1	1.1	7.2	4.1	0.4	4.5	2.2	1.5	0.5	0.0	22.4	0.1	0.3	0.2	2.3	0.0	0.7	18.1	0.5	2.2	0.0	0.0	10.9	0.6	6.7	0.0	0.0	1.5	18.1	3.4	13.2	3.8	18.7	1.7	0.0	0.0	1.8	0.1	0.1	0.0	0.8	1.1	4.4	0.0	0.4	0.0	0.4	0.3	6.8	1.1	13.4	1.0	19.1	0.1	0.8	0.0	15.4	1.9	0.5	2.6	1.0	0.3	0.1	0.1	19.9	0.1	5.6	1.1	0.0	0.0	3.1	0.1	3.8	0.0	3.2	3.2	0.1	0.0	0.6	1.6	0.0	3.2	0.3	0.0	0.4	1.2	4.9	5.6	5.3	6.4	4.7	5.8	5.8	5.5	5.7	4.9	6.0	6.4	77.1	19.2	16.0	19.9	1.3	42.7	94.3	156.1	83.6	6.8	22.4	32.4	7.1	42.9	72.2	9.2	0.0	0.3	14.4	3.3	0.0	77.7	84.6	22.6	62.9	68.8	1.8	19.4	24.6	10.2	0.2	18.5	12.2	12.3	6.3	1.1	36.8	1.4	0.5	6.7	37.6	4.8	10.2	1.9	21.3	227.2	14.6	4.9	23.2	49.6	3.1	28.2	16.5	32.6	86.3	8.2	2.6	14.7	6.6	53.6	7.5	2.3	70.0	2.0	19.7	9.4	27.5	15.2	2.1	22.0	29.5	0.7	13.0	0.2	6.8	60.0
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711201-5814305	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Microglial cells: 10.3;Skeletal myocytes: 10.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 16.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 62.3;hTERT-HME1: 60.7;hTERT-RPE1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	6.6	3.3	2.2	3.0	2.4	0.1	5.4	1.5	1.4	10.3	4.4	8.4	1.9	13.7	8.3	8.1	13.9	14.1	7.2	1.6	2.1	26.0	2.8	8.3	2.8	3.7	2.4	33.5	9.3	18.8	1.9	3.6	1.7	11.4	3.4	1.7	9.6	9.8	1.4	7.8	3.0	11.7	2.5	3.0	4.6	3.5	2.7	4.2	9.4	3.3	2.8	7.0	6.0	1.3	7.5	9.4	5.1	13.4	32.6	46.7	1.8	16.3	62.3	18.6	23.9	0.0	0.0	0.0	5.1	26.2	31.0	8.7	5.4	13.5	15.2	12.4	3.7	0.0	5.6	2.5	24.1	0.0	1.4	23.2	19.4	24.8	60.7	53.0	13.1	0.0	0.1	0.1	43.6	0.0	0.0	0.0	5.6	0.0	8.6	11.4	14.1	0.2	6.4	1.3	2.9	8.7	0.0	0.0	6.4	4.9	3.4	0.6	22.9	15.8	3.0	11.3	14.5	9.9	8.6	0.8	45.2	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	1.5	1.4	1.6	2.1	3.7	2.4	1.7	2.5	2.7	1.3	0.5	3.2	2.3	26.4	0.1	3.4	1.9	3.6	2.2	0.5	0.5	1.1	2.0	1.5	2.2	3.7	0.0	0.1	0.0	0.0	1.9	0.6	0.5	0.8	6.6	0.7	0.0	0.4	1.2	0.0	0.0	6.5	1.5	4.5	0.0	1.5	0.7	0.8	0.0	0.0	1.1	0.0	2.0	0.0	1.0	0.2	0.9	0.2	5.4	10.3	0.0	2.0	0.0	2.0	0.1	0.3	0.0	0.7	0.4	0.9	0.0	1.5	1.5	0.1	0.0	10.5	2.6	0.0	0.0	2.0	2.8	0.1	0.9	2.4	0.0	1.2
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31316410-31321749	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.7;lymphoid tissue: 105.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 81.4;Hofbauer cells: 114.2;Kupffer cells: 240.6;Langerhans cells: 112.5;Macrophages: 112.0;monocytes: 195.8;NK-cells: 87.6;Oligodendrocytes: 218.9;T-cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;Karpas-707: 99.1;RPMI-8226: 160.7"	"Low region specificity"	"Detected in all"							"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nuclear bodies"	"HPA045033: AB_2679191, HPA057051: AB_2683321"	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	10.9	7.9	72.3	47.9	106.9	31.2	8.1	98.9	126.4	8.1	53.3	11.3	11.0	3.6	1.4	6.0	2.8	17.9	4.2	73.2	82.1	2.9	9.6	20.1	53.6	105.0	89.1	2.4	2.8	2.3	1.4	21.0	109.1	3.8	13.6	0.9	4.0	3.2	0.9	1.9	12.2	7.1	88.3	38.2	12.8	1.8	83.3	105.1	2.5	3.7	40.8	20.3	2.8	155.7	0.1	0.1	0.0	0.0	4.9	30.0	0.1	4.1	6.6	5.0	17.3	0.0	1.5	26.2	0.0	5.3	29.0	0.1	0.0	0.3	14.3	0.0	0.2	0.1	0.1	0.1	57.1	31.5	33.4	37.6	0.0	7.2	20.0	7.7	1.8	24.7	1.1	99.1	39.4	0.6	22.9	35.3	0.0	0.0	0.0	23.8	3.9	160.7	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	34.5	11.6	21.5	0.6	0.9	14.8	44.2	0.0	30.1	17.1	23.0	18.1	6.0	91.0	3.6	36.0	44.6	44.0	28.5	51.0	42.6	62.4	14.7	60.4	53.8	177.1	32.4	35.8	20.4	60.9	95.1	72.3	106.9	98.9	126.4	73.2	82.1	105.0	89.1	109.1	88.3	83.3	155.7	1.2	0.0	5.6	1.3	48.3	4.0	0.4	0.4	0.0	0.3	0.7	0.9	0.7	0.0	1.3	0.0	0.0	0.7	68.7	0.1	0.0	0.2	2.8	0.3	0.5	2.7	0.0	8.8	0.8	0.0	0.8	2.2	4.1	0.9	81.4	0.0	6.1	1.6	114.2	0.0	0.8	0.1	2.0	240.6	112.5	1.6	0.3	112.0	14.2	9.4	195.8	0.5	87.6	1.0	218.9	0.0	0.0	0.0	53.6	0.3	0.0	0.6	1.6	1.0	0.0	0.7	1.2	0.2	0.3	0.4	3.1	1.4	116.0	0.1	0.6	0.4
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303770-31314105	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.0;lymphoid tissue: 169.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 233.2;Kupffer cells: 522.3;Langerhans cells: 169.8;Macrophages: 271.9;monocytes: 426.4;T-cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1366.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1366.0;monocytes: 381.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 87.9;HL-60: 99.9;HMC-1: 133.3;Karpas-707: 96.4;NB-4: 79.4;RPMI-8226: 147.7;THP-1: 124.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007346, HPA053383"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA007346: , HPA053383: "	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	24.6	11.0	6.4	100.9	7.3	189.0	13.8	7.3	11.6	13.1	8.7	27.9	23.7	7.4	4.3	11.8	7.8	30.5	6.7	6.3	8.4	5.1	24.9	61.1	159.5	13.3	10.3	5.5	3.0	3.8	1.8	15.4	10.8	7.4	30.5	1.2	11.8	6.1	2.0	5.1	39.2	17.0	7.7	158.8	33.7	3.7	8.5	76.4	5.3	12.2	169.8	38.5	4.1	11.1	0.6	0.7	0.0	0.0	6.5	8.3	0.1	0.8	5.8	6.7	12.4	0.0	3.4	87.9	0.1	5.5	26.4	0.6	0.0	1.2	7.5	0.1	0.0	2.1	0.0	0.0	66.0	99.9	133.3	15.3	0.0	3.9	5.3	2.2	6.9	7.3	1.4	96.4	19.8	0.0	29.4	79.4	0.1	0.0	0.0	51.0	0.4	147.7	0.3	0.2	0.0	0.1	0.4	0.2	0.5	0.0	0.0	124.8	7.2	1.9	0.2	0.7	7.0	18.4	0.9	18.9	8.6	34.0	2.2	1005.3	328.9	798.7	79.2	240.1	76.8	183.6	120.8	102.8	149.9	146.2	91.9	87.5	1366.0	44.2	381.9	86.3	173.6	251.4	6.4	7.3	7.3	11.6	6.3	8.4	13.3	10.3	10.8	7.7	8.5	11.1	2.1	0.0	14.8	0.7	233.2	5.4	0.7	0.7	1.8	0.2	1.5	1.7	1.0	2.8	6.7	1.8	0.0	0.6	129.0	1.3	0.0	0.3	8.3	0.1	0.3	5.6	0.0	6.5	2.7	0.0	0.8	4.0	1.5	0.4	82.2	0.0	7.5	2.3	89.1	0.0	3.1	0.1	2.0	522.3	169.8	9.0	0.0	271.9	37.4	11.2	426.4	0.0	117.4	4.0	31.7	1.0	0.0	0.4	110.4	0.4	0.1	1.1	2.4	0.8	19.7	1.2	1.9	0.4	0.4	0.4	3.7	0.3	170.9	0.0	1.3	1.1
EVI5	NB4S	ENSG00000067208	"Ecotropic viral integration site 5"	O60447	1	92508696-92792404	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027339	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027339: AB_1848308"	"unprognostic (1.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.04e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.35e-2)"	5.7	8.1	5.9	4.5	8.3	2.7	4.4	8.5	5.8	5.9	8.2	4.8	4.3	6.4	4.6	4.0	5.1	5.8	7.1	4.2	7.7	5.0	16.4	7.1	3.2	8.1	6.2	3.8	3.8	7.9	3.9	12.1	6.8	5.3	5.5	4.9	4.5	5.6	2.9	5.0	4.0	7.1	8.6	4.5	6.4	9.6	6.3	1.3	6.6	3.6	3.3	5.5	3.8	10.9	5.4	5.9	9.1	8.9	14.5	18.2	8.6	12.2	18.5	8.2	9.4	10.4	1.4	2.4	16.8	14.0	15.2	6.1	8.6	9.0	14.6	0.2	3.3	4.3	5.6	6.2	14.2	3.1	4.8	11.5	7.2	14.2	8.5	23.9	17.9	0.2	7.7	3.8	13.9	2.7	0.3	3.6	2.6	3.5	4.8	2.2	21.7	3.2	6.3	15.5	3.4	7.0	14.4	7.4	16.6	9.8	3.6	7.1	11.8	9.1	6.6	12.2	8.1	5.5	3.4	3.8	6.0	5.0	7.6	0.9	2.7	2.8	0.1	1.9	0.0	1.2	0.1	0.0	1.3	1.2	0.0	0.0	3.4	0.1	2.9	0.8	0.0	0.4	5.9	8.3	8.5	5.8	4.2	7.7	8.1	6.2	6.8	8.6	6.3	10.9	27.2	60.9	29.9	91.4	18.7	43.5	29.3	23.0	18.2	24.5	20.5	17.7	51.8	22.8	32.3	16.5	25.0	48.4	7.5	22.9	17.6	27.9	3.0	67.8	39.4	31.2	22.1	11.4	158.4	29.9	26.0	42.5	42.3	26.2	13.3	21.9	43.2	52.4	32.2	30.3	149.3	27.0	14.2	54.0	27.0	5.8	28.3	45.1	26.6	114.3	48.9	28.5	5.2	112.6	199.6	68.4	19.3	54.2	28.8	28.1	21.8	20.1	46.9	25.4	13.1	51.4	56.4	37.4	42.4	21.2	50.0	65.5	5.5	60.9	20.0	32.1
EVI5L		ENSG00000142459	"Ecotropic viral integration site 5 like"	Q96CN4	19	7830233-7864976	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.5;Horizontal cells: 33.7;Late spermatids: 32.6;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043099, HPA043563"	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"		"HPA043099: AB_10796685, HPA043563: AB_2678556"	"unprognostic (3.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.97e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.04e-2)"	6.8	10.4	29.5	5.0	30.2	3.1	6.6	23.0	35.2	9.4	2.5	13.4	4.9	11.2	4.6	10.6	8.4	5.1	17.1	30.5	27.6	11.6	6.3	7.2	4.2	34.1	28.5	7.3	6.3	8.8	16.4	7.9	29.8	12.1	4.1	11.1	7.5	9.1	20.5	13.7	6.9	8.7	21.3	8.1	9.3	36.1	32.1	6.4	8.6	14.9	4.4	11.1	9.0	41.1	13.5	2.7	10.5	15.4	18.8	15.7	29.5	19.7	20.5	13.8	14.7	1.1	5.0	3.4	23.1	26.9	7.3	9.1	3.8	13.4	12.7	19.6	12.7	2.6	6.3	2.2	23.7	3.1	6.7	14.7	15.9	6.8	31.9	11.4	16.9	17.5	3.1	17.8	14.4	13.8	10.8	6.8	3.9	10.0	28.4	13.0	8.7	10.0	8.3	11.3	4.3	10.3	18.3	8.1	5.8	7.0	6.8	9.9	16.7	9.4	4.4	53.6	7.4	25.7	6.2	4.6	15.9	7.5	8.3	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.1	0.1	1.1	0.1	0.2	0.0	29.5	30.2	23.0	35.2	30.5	27.6	34.1	28.5	29.8	21.3	32.1	41.1	3.6	0.0	5.1	13.1	1.6	3.8	2.2	2.4	2.2	30.5	3.6	3.3	4.0	2.8	1.8	9.2	18.8	3.7	1.6	7.4	0.0	2.4	14.8	2.2	4.3	3.8	5.4	1.3	16.3	2.6	16.9	3.1	6.1	4.2	0.0	5.7	3.6	2.0	3.8	33.7	19.7	4.2	6.1	2.5	1.1	32.6	4.1	2.8	3.6	9.4	1.1	7.1	1.0	50.3	69.8	3.0	3.5	4.5	2.0	2.5	1.7	4.1	1.8	18.8	6.6	2.0	4.0	18.3	7.3	3.6	4.1	3.4	2.2	8.2	3.4	5.1
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 291.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	38.8	31.3	130.5	91.9	135.1	50.1	58.1	105.0	185.5	44.4	66.3	46.6	29.2	64.8	49.5	30.6	63.7	42.0	53.0	136.9	108.8	42.6	90.3	63.2	159.0	103.1	110.1	51.6	40.8	19.7	98.6	29.1	106.1	52.1	24.2	204.6	41.2	32.0	33.2	41.0	69.9	62.0	92.5	107.7	43.3	31.6	115.5	179.4	37.9	28.8	126.2	43.1	32.8	121.2	15.2	14.2	107.1	30.3	22.4	58.5	59.7	18.9	26.5	14.2	18.7	0.8	11.4	30.9	24.9	19.2	10.5	0.4	49.0	36.3	16.8	30.4	32.6	51.9	11.5	8.4	18.0	16.2	116.7	31.6	18.9	9.1	35.8	29.3	38.3	117.3	25.5	2.3	15.7	22.7	291.7	89.6	19.7	13.1	21.8	65.4	58.7	5.5	17.2	0.6	120.8	73.1	14.3	22.0	7.2	24.6	17.7	47.4	27.7	11.2	16.5	66.9	12.8	55.3	44.1	87.9	14.9	27.1	19.7	2.3	2.6	27.4	20.2	13.9	15.1	9.6	22.6	19.2	4.3	13.2	26.3	24.4	0.6	18.0	16.5	0.8	41.4	10.6	130.5	135.1	105.0	185.5	136.9	108.8	103.1	110.1	106.1	92.5	115.5	121.2	26.4	28.9	42.3	45.1	155.2	20.8	22.2	10.8	12.0	125.4	70.4	50.5	4.7	22.8	14.2	12.9	402.4	22.6	215.3	1.0	31.3	12.9	4.2	40.1	51.9	47.5	8.4	31.1	119.9	14.0	12.0	30.5	20.4	26.2	17.1	45.1	39.3	102.2	144.8	77.4	121.1	3.7	8.2	82.5	76.6	12.0	24.8	92.5	26.6	100.2	42.0	89.1	591.2	86.0	66.1	11.6	2.9	49.7	53.3	17.4	2.6	14.2	41.9	438.0	6.6	29.8	33.9	14.1	28.4	8.7	31.4	14.6	373.3	13.5	3.8	15.9
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027306	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 281.2;skin 1: 147.4;vagina: 101.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	1.3	0.3	0.6	1.0	0.6	2.5	2.6	1.1	1.0	47.5	0.8	8.9	11.0	1.5	1.7	281.2	2.1	1.7	0.2	0.6	0.3	17.0	0.3	9.4	0.6	2.8	1.3	0.3	4.0	3.4	1.5	0.3	2.8	8.0	1.5	0.6	42.3	1.8	1.4	147.4	9.1	1.0	0.5	0.3	5.2	0.8	0.6	0.4	10.7	0.1	7.9	12.7	101.9	1.5	28.1	23.4	0.0	0.3	0.2	0.0	9.6	0.2	0.0	0.0	0.0	2.6	16.7	0.0	0.1	0.0	0.0	59.8	0.1	7.8	0.1	0.1	0.2	0.7	19.4	17.4	0.0	0.2	4.2	0.2	12.3	0.2	0.0	0.0	0.0	3.7	0.1	1.1	0.0	40.4	1.0	3.6	0.1	11.9	10.5	11.5	0.1	0.4	16.7	87.8	1.1	0.0	11.4	43.2	0.0	0.2	54.1	0.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.6	0.6	1.1	1.0	0.6	0.3	2.8	1.3	2.8	0.5	0.6	1.5	0.2	19.2	19.5	0.0	0.0	11.7	4.7	10.5	26.7	0.3	5.1	2.9	3.7	4.3	16.5	5.5	0.0	0.2	0.2	10.8	1.9	4.4	0.0	4.3	0.6	0.3	20.4	1.3	0.3	0.5	0.2	0.5	12.8	8.9	12.6	0.2	0.0	0.0	0.0	0.0	0.1	5.7	2.0	0.6	2.1	0.1	0.9	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.1	8.4	7.4	1.9	1.2	4.6	19.3	3.4	13.1	0.1	0.0	0.7	0.7	0.1	1.2	94.1	25.9	0.0	0.4	0.4	15.5	12.9
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377778-18389647	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.9;skin 1: 6.0;vagina: 8.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.1;Basal squamous epithelial cells: 8.0;Spermatogonia: 5.8;Squamous epithelial cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;HaCaT: 1.1;HeLa: 2.4;hTCEpi: 7.1;RT4: 2.5;SiHa: 1.3;T-47d: 2.1"									HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.1	0.1	0.0	0.2	16.9	0.1	0.0	0.0	0.0	0.0	1.2	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	1.9	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.4	1.1	0.0	0.1	2.2	8.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	1.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.5	1.6	1.3	8.0	0.0	0.1	0.6	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	5.8	10.9	1.3	0.0	0.0	0.0	0.2	1.0
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 1.4;prostate: 1.3;seminal vesicle: 1.6;testis: 3.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Enteroendocrine cells: 2.4;Late spermatids: 4.7;Paneth cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"midbrain: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			HPA041576	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	1.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	8.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.3
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.0	6.9	16.0	5.0	17.2	2.5	9.7	16.7	18.8	13.6	15.0	9.5	6.8	9.6	12.1	10.4	13.1	8.1	8.7	15.8	15.7	10.4	5.9	8.6	4.2	17.3	16.4	11.0	18.1	16.0	10.0	7.5	17.4	10.2	9.2	13.0	15.4	10.5	11.0	6.6	6.5	10.1	17.1	5.8	9.7	19.9	16.2	7.2	11.5	9.7	4.5	8.4	7.4	18.9	29.6	13.6	10.3	15.3	6.2	7.4	13.0	14.4	12.1	13.1	17.3	11.6	20.3	0.0	10.4	15.1	8.0	16.4	11.5	14.5	14.7	7.4	13.7	8.6	5.2	6.8	24.2	6.4	7.9	15.1	23.5	13.4	8.7	8.1	18.9	7.4	5.5	11.0	12.7	14.8	3.6	9.6	11.2	15.8	13.5	0.0	9.9	10.4	19.5	10.8	20.0	17.8	10.8	22.2	10.6	11.0	29.8	5.5	15.0	12.2	8.5	9.9	7.5	8.3	12.0	0.1	0.1	6.9	9.3	12.2	2.5	2.2	2.2	1.4	4.2	2.9	2.3	2.3	5.4	1.5	2.8	4.1	0.3	2.9	1.4	4.2	1.8	2.3	16.0	17.2	16.7	18.8	15.8	15.7	17.3	16.4	17.4	17.1	16.2	18.9	7.2	12.8	10.9	15.7	4.3	3.2	4.9	6.2	14.2	9.9	9.9	7.2	12.1	7.2	9.0	0.0	8.4	8.5	2.5	4.7	5.9	10.7	3.2	7.7	8.4	6.0	6.1	7.8	27.4	8.8	4.4	6.5	8.2	11.1	1.3	9.6	10.8	5.4	6.8	10.1	22.6	8.4	8.2	6.3	2.2	2.3	6.2	3.3	3.6	11.2	6.8	7.5	2.1	21.6	19.1	8.8	6.2	12.0	5.6	5.6	3.6	4.8	11.0	9.3	0.0	7.2	7.4	36.1	8.1	12.6	4.3	2.9	2.6	6.1	7.9	4.3
EXD3	"FLJ20433, LOC54932, mut-7, Nbr"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423211	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 73.2;Paneth cells: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"					"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.4	10.1	6.2	3.5	6.8	3.5	10.8	5.9	11.0	11.5	6.6	16.0	9.4	9.9	1.5	11.6	12.3	4.2	11.2	6.5	5.8	12.2	8.1	10.2	3.8	7.2	6.1	10.7	9.8	3.7	13.5	3.4	6.4	14.5	3.6	0.8	10.1	3.7	9.5	10.2	11.3	1.4	5.5	14.8	12.3	4.8	6.1	1.1	11.4	2.6	2.3	10.9	11.2	6.3	8.3	7.0	3.3	9.5	2.8	4.0	7.8	4.0	4.5	3.5	5.3	4.8	17.5	3.5	9.1	3.1	8.7	14.5	1.0	4.4	1.1	8.2	8.1	2.6	13.0	7.9	8.5	1.9	29.4	4.8	6.0	3.1	2.8	10.2	11.9	0.0	7.0	6.4	3.0	22.3	0.1	6.9	3.8	18.1	4.7	6.3	2.6	25.3	7.1	4.7	4.5	7.7	4.0	8.4	3.8	3.8	13.6	9.3	15.0	4.8	4.4	7.5	6.2	8.1	4.1	3.0	8.7	6.4	7.4	10.7	3.4	7.8	2.2	4.5	2.7	2.6	4.0	2.1	3.9	2.4	3.1	2.5	0.8	4.1	4.4	2.5	6.1	2.3	6.2	6.8	5.9	11.0	6.5	5.8	7.2	6.1	6.4	5.5	6.1	6.3	17.6	0.0	6.3	24.2	5.3	5.9	10.0	8.9	13.6	14.6	13.5	17.0	5.2	10.0	11.2	7.3	14.6	9.9	8.1	46.4	9.8	6.8	17.9	11.5	6.5	14.1	7.3	5.0	21.6	11.3	3.3	7.3	19.4	13.1	61.7	10.5	17.2	7.2	9.2	21.9	24.1	27.6	16.2	5.4	7.3	73.2	5.9	6.9	3.6	13.1	6.2	10.0	12.3	26.2	14.6	6.4	178.2	7.9	6.6	10.0	31.3	11.9	9.3	10.4	13.1	5.5	9.9	2.3	8.9	9.9	8.9	4.0	6.4	19.5	39.0	9.2
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184379-67190185	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.4;Endothelial cells: 19.6;Granulosa cells: 20.8;Hepatic stellate cells: 28.9;Leydig cells: 15.5;Peritubular cells: 18.4;Theca cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HUVEC TERT2: 3.5;SCLC-21H: 6.4;SuSa: 2.1;TIME: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	6.4	4.6	0.5	1.8	0.5	0.0	4.1	1.0	0.8	2.6	0.0	1.6	0.9	2.8	0.1	1.3	1.8	1.1	5.4	0.5	0.5	7.3	2.1	10.0	1.4	0.8	0.2	3.6	1.6	0.8	2.0	5.9	1.1	2.4	0.4	0.2	1.6	0.6	2.1	1.2	1.7	0.9	0.1	44.7	1.5	2.1	0.4	0.1	7.1	0.8	0.2	1.7	1.3	0.1	0.1	0.0	0.7	0.2	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.5	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.4	0.8	0.7	0.1	0.0	0.1	6.4	0.8	0.8	0.1	0.0	2.1	0.6	0.0	2.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.0	0.8	0.5	0.5	0.8	0.2	1.1	0.1	0.4	0.1	26.4	0.0	0.0	0.3	0.3	0.9	2.1	2.8	5.7	1.5	3.0	5.2	1.6	0.0	0.4	3.7	0.0	0.6	0.2	4.6	7.9	1.0	2.0	0.1	0.3	19.6	1.2	2.7	0.1	3.7	4.3	2.6	1.5	0.4	0.0	20.8	28.9	1.4	0.8	3.3	0.3	3.4	2.0	1.9	0.2	5.5	15.5	1.8	0.0	1.0	4.0	0.3	0.0	1.0	0.0	0.6	3.1	18.4	0.0	0.4	8.9	0.2	0.3	0.9	0.0	0.3	1.1	4.0	8.6	1.2	2.0	0.8	0.2	32.5	2.7	1.6
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"		19	45212370-45245407	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"kidney: 19.0;thyroid gland: 17.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 19.1;K-562: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		4.3	8.3	0.3	2.1	0.6	1.6	2.9	0.5	0.4	4.0	1.6	2.7	2.4	4.9	0.4	1.9	2.8	2.3	2.3	0.4	0.3	19.0	2.7	2.7	1.1	0.7	0.5	0.9	2.7	3.3	5.0	0.4	0.5	5.2	0.7	0.1	1.8	2.2	0.9	2.1	3.2	1.9	0.3	8.3	2.9	3.3	0.4	0.4	17.9	0.3	0.5	3.2	2.4	0.7	0.1	0.3	2.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	19.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	16.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.0	0.1	0.3	0.6	0.8	1.5	0.2	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.4	0.4	0.3	0.7	0.5	0.5	0.3	0.4	0.7	15.3	0.0	1.3	0.7	0.7	0.4	0.3	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	17.7	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.4	51.4	0.3	0.0	0.0	1.1	0.6	0.0	1.6	0.0	0.0	1.8	2.8	0.0	0.0	0.1	0.2	2.1	0.5	0.7	0.0	0.0	1.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.6	0.4	6.2	0.2	0.9	0.0	0.1	21.2	0.0	0.3
EXOC3L4	C14orf73	ENSG00000205436	"Exocyst complex component 3 like 4"	Q17RC7	14	103100144-103110559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 19.1;liver: 41.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 8.6;Gastric mucus-secreting cells: 21.9;Hepatocytes: 25.1;Proximal enterocytes: 30.2;Proximal tubular cells: 12.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.4;HEL: 3.8;Hep G2: 2.7;RPMI-8226: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043661	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA043661: AB_10965693"	"unprognostic (8.71e-2)"	"unprognostic (7.42e-3)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.81e-4)"	0.7	0.3	0.0	2.7	0.0	0.2	0.2	0.0	0.1	0.5	0.1	2.8	19.1	0.2	0.0	0.5	0.4	3.0	0.8	0.0	0.0	3.9	41.1	1.7	6.5	0.0	0.0	0.3	1.5	0.0	0.2	0.9	0.0	1.3	1.3	0.0	0.7	0.3	0.3	0.1	9.7	0.2	0.0	5.1	4.6	0.2	0.0	3.7	0.3	0.0	2.8	0.8	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	3.8	0.0	2.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.2	1.3	0.0	0.0	0.2	0.1	1.1	8.6	0.6	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.1	0.3	0.2	0.3	1.2	0.0	0.0	4.1	3.2	2.2	21.9	0.3	0.0	0.8	0.4	25.1	0.2	0.0	0.0	5.3	0.0	0.8	0.3	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	1.5	2.1	0.2	30.2	12.3	1.5	0.0	0.0	6.4	0.8	0.1	2.0	0.0	0.4	0.3	0.2	2.2	5.1	0.7
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	20.7	21.1	18.7	13.8	20.2	13.8	21.4	19.3	20.3	22.6	24.3	19.7	13.1	21.5	13.6	24.4	27.3	17.8	15.3	20.9	19.4	17.7	17.8	17.7	16.4	18.4	20.3	30.6	27.3	27.3	16.9	19.6	19.9	18.3	21.5	53.1	16.3	20.5	68.4	25.4	13.5	23.9	18.8	21.0	17.3	18.7	19.1	28.1	26.4	38.5	20.3	21.1	18.6	20.8	40.1	32.2	43.3	43.3	49.7	51.6	15.0	28.6	47.2	25.4	33.2	18.8	54.7	29.8	20.1	54.1	36.9	24.7	23.7	38.8	41.8	45.6	28.2	24.0	31.5	19.9	54.7	32.0	25.1	50.4	47.6	36.3	66.5	55.7	43.5	38.6	35.1	28.8	47.7	26.1	58.5	35.2	32.8	47.5	29.8	25.7	38.7	54.2	40.7	35.2	33.9	53.2	43.0	39.1	46.3	48.9	25.8	29.3	47.9	28.1	14.6	30.0	31.5	45.0	29.4	28.1	82.9	36.4	43.8	10.3	12.0	7.2	11.2	12.9	10.0	8.3	11.6	11.9	16.3	8.1	9.4	9.6	4.0	19.6	11.4	7.2	12.9	11.2	18.7	20.2	19.3	20.3	20.9	19.4	18.4	20.3	19.9	18.8	19.1	20.8	22.9	22.4	22.3	238.6	27.3	18.9	16.3	16.6	25.6	39.9	16.8	15.4	30.9	11.5	18.0	14.7	93.8	17.5	26.7	21.5	3.9	15.0	29.6	27.0	21.2	23.0	17.4	18.7	334.2	18.2	16.6	21.2	34.1	21.0	8.2	32.4	23.2	15.9	18.1	50.5	306.8	21.0	26.4	27.3	14.5	27.6	17.4	20.4	14.2	341.0	23.9	20.4	23.7	395.6	345.9	15.4	17.4	18.8	27.7	13.2	16.3	16.9	29.8	231.5	13.1	26.0	15.3	20.5	13.1	28.2	17.0	11.2	26.2	26.4	21.9	20.1
EXOC5	"SEC10, SEC10L1, SEC10P"	ENSG00000070367	"Exocyst complex component 5"	O00471	14	57200507-57268905	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060837	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA060837: AB_2684375"	"unprognostic (2.95e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.98e-2)"	9.0	6.3	4.9	6.6	6.2	5.1	5.1	6.4	6.5	4.5	7.5	4.8	5.6	4.7	4.9	6.5	4.5	4.7	5.2	5.3	6.4	7.7	8.4	6.6	7.2	6.2	7.5	4.6	3.7	6.9	3.4	7.7	7.4	5.6	4.5	9.8	5.4	4.9	5.7	5.6	5.9	6.4	5.5	7.9	5.7	11.1	6.0	8.7	7.4	5.9	6.6	5.7	3.7	8.4	21.7	13.4	26.3	13.4	17.4	17.1	20.1	33.1	15.6	12.3	14.3	12.6	13.4	31.9	19.6	17.9	12.5	17.3	16.3	13.5	19.1	37.7	9.6	20.4	9.9	9.6	16.1	25.2	25.7	10.3	14.0	12.1	13.5	16.2	22.6	22.4	19.9	23.5	25.0	9.8	34.2	5.7	14.2	12.4	23.8	23.9	38.7	11.8	15.4	17.7	20.4	17.5	26.8	10.7	16.4	22.1	19.9	12.2	24.9	26.7	29.9	17.1	16.5	12.0	15.9	26.7	24.5	14.1	17.5	6.8	5.1	6.1	4.8	5.5	5.9	5.6	4.9	5.2	6.3	5.8	5.4	4.7	2.8	6.3	5.2	3.2	6.3	6.8	4.9	6.2	6.4	6.5	5.3	6.4	6.2	7.5	7.4	5.5	6.0	8.4	32.1	25.6	18.6	34.3	26.7	22.6	23.1	18.8	22.2	32.2	23.4	13.2	28.3	21.5	24.2	14.7	29.2	17.4	24.2	17.1	17.6	18.6	130.7	29.4	32.5	35.7	34.6	34.7	56.2	17.3	19.4	27.5	21.9	23.2	34.9	20.6	45.0	38.6	21.6	63.9	56.5	17.0	32.6	31.5	34.1	108.6	23.6	31.4	21.4	38.4	34.3	28.6	23.7	49.3	71.9	25.2	10.8	35.7	27.7	24.7	11.1	41.1	29.4	30.2	19.7	31.1	33.9	128.6	53.2	32.8	30.0	18.7	26.0	34.6	15.3	20.1
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92826831-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 164.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	8.7	14.4	5.9	8.2	7.5	12.9	8.0	7.7	8.6	6.5	8.0	9.6	8.1	6.1	5.7	4.2	5.8	10.1	7.1	8.2	6.0	6.4	10.1	10.7	9.5	3.4	2.4	3.9	10.0	6.3	6.1	37.4	3.7	8.6	10.2	164.2	5.6	4.3	31.8	5.0	9.5	7.7	3.3	9.1	7.0	9.9	6.1	8.5	28.4	19.7	8.2	10.1	3.5	7.1	19.8	24.3	25.7	16.8	1.3	1.6	9.1	9.0	24.9	8.1	9.7	9.1	16.5	22.5	19.0	4.3	6.6	12.3	20.8	5.7	10.1	20.1	20.9	35.1	8.3	11.7	9.6	36.4	30.6	2.2	3.0	7.2	4.8	14.6	113.8	14.6	29.2	14.5	4.0	10.7	15.3	23.2	3.5	40.2	7.0	22.5	11.2	11.6	17.4	13.2	8.5	11.9	9.2	9.2	11.8	6.4	18.2	18.8	22.4	0.6	8.2	7.5	14.7	10.8	12.4	18.1	2.8	41.6	9.3	6.2	4.9	15.2	3.0	3.9	3.0	6.7	3.4	2.8	5.1	6.6	2.7	3.2	30.6	2.8	3.9	11.1	3.3	2.4	5.9	7.5	7.7	8.6	8.2	6.0	3.4	2.4	3.7	3.3	6.1	7.1	28.3	16.0	16.7	33.6	27.6	3.3	10.7	8.6	3.4	40.2	9.8	6.5	12.0	20.0	15.0	16.5	39.6	22.9	24.1	14.3	5.9	28.3	5.4	8.8	3.0	53.1	25.6	39.2	181.7	15.4	7.8	7.8	13.7	16.5	10.8	24.3	77.1	14.2	21.4	23.5	100.3	16.6	14.2	18.2	12.5	12.6	4.4	18.9	5.4	146.1	22.8	27.1	19.6	157.3	84.7	14.1	10.3	14.7	13.8	14.1	10.8	8.4	10.0	177.8	13.1	13.6	9.0	25.0	25.5	4.9	4.8	20.5	18.4	29.8	11.9	15.8
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	11.3	13.4	22.3	4.2	32.7	1.2	8.6	18.8	23.9	12.6	3.2	8.6	7.3	10.1	6.0	15.1	7.8	6.5	50.7	20.7	25.7	7.2	3.8	7.2	3.1	23.9	25.7	15.0	5.0	13.2	6.1	13.0	23.3	8.0	5.7	14.1	7.7	8.9	11.1	26.5	9.1	10.0	16.4	5.2	6.9	6.9	22.2	4.4	10.2	11.5	6.4	9.7	13.0	40.9	21.7	16.3	14.7	17.8	41.2	16.9	25.3	15.6	21.9	13.2	8.6	22.3	3.3	5.6	9.5	26.2	19.6	35.4	12.4	25.7	18.9	4.2	10.1	16.7	11.0	12.8	22.2	2.4	5.5	14.6	36.6	14.9	23.1	20.6	21.8	8.7	1.8	0.0	17.6	7.5	6.4	2.9	15.3	14.9	9.0	3.4	26.4	2.3	12.7	50.1	7.3	6.3	26.7	8.2	10.9	16.1	5.7	2.3	24.3	15.2	12.8	13.1	9.6	5.5	5.9	0.0	17.7	1.2	12.4	1.3	0.5	0.0	0.7	0.4	0.5	0.7	0.5	0.4	0.4	0.7	0.6	0.9	0.0	0.5	0.6	0.1	0.8	0.4	22.3	32.7	18.8	23.9	20.7	25.7	23.9	25.7	23.3	16.4	22.2	40.9	17.8	0.0	4.1	210.3	4.1	26.1	10.2	9.8	14.8	17.4	5.2	5.2	87.1	12.8	5.1	9.2	25.0	15.1	5.0	10.2	5.9	9.3	62.9	5.6	14.5	14.1	3.0	2.1	351.1	11.5	13.2	12.4	30.5	9.2	8.2	11.6	11.4	5.6	4.6	16.8	393.6	6.0	4.1	12.0	7.1	8.2	8.4	5.0	5.4	286.7	2.0	9.9	1.0	288.5	863.3	11.0	8.6	7.5	3.7	8.1	28.2	5.5	8.4	11.1	0.0	13.5	14.7	12.0	4.9	13.1	37.4	24.6	4.7	5.5	4.5	10.7
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081016-76121576	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	40.4	31.4	36.0	32.7	37.0	53.2	31.2	31.4	36.7	39.3	34.1	40.1	32.5	40.1	33.1	52.3	52.3	35.4	47.2	36.8	35.5	31.9	30.2	35.9	32.7	35.4	34.3	49.6	41.1	61.2	41.0	35.3	36.5	48.1	27.9	24.7	50.6	43.1	43.0	37.0	34.7	43.5	31.9	32.4	30.3	24.9	36.4	43.5	43.0	41.4	32.3	44.3	30.1	34.8	65.6	79.4	71.9	58.5	66.6	47.0	74.5	58.9	77.6	103.9	74.7	67.5	43.0	33.7	42.0	103.0	65.6	52.7	43.9	57.1	69.0	29.3	59.1	55.8	64.0	72.3	46.4	62.9	55.7	66.1	44.3	80.5	39.2	73.5	116.9	59.8	38.1	33.7	65.6	59.8	102.1	27.8	37.8	49.5	83.4	54.0	123.3	34.6	59.7	133.6	38.9	91.4	66.5	48.6	44.6	68.8	79.7	51.0	77.5	111.3	66.3	74.1	65.8	46.0	18.2	31.2	66.4	28.0	59.0	55.1	41.1	66.1	35.5	57.4	24.4	26.7	26.9	30.4	28.9	26.9	27.7	23.9	46.2	36.4	79.7	12.3	32.0	44.9	36.0	37.0	31.4	36.7	36.8	35.5	35.4	34.3	36.5	31.9	36.4	34.8	31.0	19.2	35.0	36.6	37.7	19.8	40.1	40.8	31.3	87.6	30.2	28.8	7.5	28.6	41.4	40.5	143.9	51.5	37.5	47.6	33.2	38.3	22.4	35.1	25.8	27.1	48.9	48.6	26.2	37.1	29.0	31.6	27.0	34.4	41.1	65.0	30.7	27.0	37.7	67.3	31.1	43.8	54.9	29.6	21.3	52.2	37.3	26.9	24.9	15.0	36.8	52.1	56.7	44.2	35.0	44.6	41.4	38.4	15.7	41.5	62.8	35.3	43.7	108.8	46.0	27.8	49.5	32.1	16.6	20.3	19.9	71.1	35.8	56.6	29.8	44.8
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	6.1	5.4	3.0	7.9	3.1	16.9	6.7	4.8	3.9	5.2	2.9	5.0	5.9	4.5	4.8	5.5	4.8	5.0	5.2	3.3	4.2	5.9	6.2	5.9	9.2	3.1	2.7	7.0	6.3	8.7	2.9	6.5	3.4	5.5	4.7	7.5	5.4	3.8	14.1	5.9	6.3	4.4	2.5	8.3	6.8	4.1	3.7	7.4	8.4	9.8	9.1	5.3	3.7	3.7	8.2	9.0	5.4	5.4	13.9	11.2	13.0	10.0	8.4	7.4	7.0	8.6	8.1	9.4	8.6	10.1	6.6	13.2	7.9	10.8	8.1	12.2	19.0	5.7	11.8	5.5	7.8	10.1	15.2	11.3	11.7	11.0	10.4	8.7	9.2	9.6	10.6	21.9	12.0	4.3	9.4	6.2	8.2	10.4	7.6	6.1	8.3	12.0	9.3	9.5	7.1	7.6	10.1	13.1	10.1	4.3	12.5	14.5	12.6	9.9	7.0	13.3	17.7	16.2	9.9	10.1	11.3	8.9	12.7	1.7	0.7	1.3	0.4	0.8	0.5	0.4	0.6	0.5	0.5	0.5	0.7	1.2	2.2	0.8	1.6	0.7	0.6	0.5	3.0	3.1	4.8	3.9	3.3	4.2	3.1	2.7	3.4	2.5	3.7	3.7	10.0	9.6	9.8	2.0	10.9	18.5	5.6	4.0	8.0	4.3	8.1	5.5	8.9	11.5	8.3	9.2	6.2	4.6	10.4	6.7	1.9	3.3	1.6	8.1	9.0	9.3	4.8	7.4	5.3	3.5	2.8	8.2	14.3	10.4	2.5	4.3	6.8	9.6	5.8	3.3	5.9	3.7	2.0	13.3	7.1	1.1	4.1	7.6	3.6	3.7	5.7	5.8	5.2	2.5	6.6	5.0	1.2	5.7	7.9	6.0	6.9	5.2	5.6	12.3	0.0	8.4	5.2	5.1	5.0	11.0	14.8	9.3	10.0	4.6	4.2	8.6
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 59.8;Rod photoreceptor cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA012531: AB_2732403, HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (1.92e-5)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	3.9	5.1	5.5	4.0	5.4	3.9	3.4	7.9	7.0	5.2	3.4	4.9	2.0	4.7	3.5	2.6	3.8	3.5	12.9	5.9	5.1	3.7	3.4	3.8	6.0	5.1	5.7	3.9	3.9	3.3	5.6	2.9	4.5	4.8	3.2	5.3	3.2	3.6	3.2	1.9	4.4	4.5	4.1	5.5	3.6	3.9	5.9	5.0	4.5	3.2	4.7	4.4	3.5	6.4	4.3	7.6	8.7	7.6	5.7	8.4	3.5	13.9	8.7	11.6	12.9	6.8	4.3	15.1	3.5	5.5	3.3	4.3	11.0	4.7	9.8	17.5	10.2	11.4	12.7	7.6	7.0	12.7	9.5	6.4	5.2	10.3	5.4	5.5	16.2	8.6	5.2	9.9	18.2	2.9	8.6	4.2	8.3	3.7	9.8	5.8	4.6	6.7	6.0	5.5	4.0	2.0	8.5	2.1	3.8	3.9	2.9	6.1	13.3	9.5	7.2	10.8	11.2	5.7	10.3	13.3	7.4	10.9	7.1	0.9	10.0	4.5	26.6	9.8	23.8	60.3	25.8	26.4	7.2	47.1	25.9	25.2	0.6	27.8	11.6	14.4	12.9	5.5	5.5	5.4	7.9	7.0	5.9	5.1	5.1	5.7	4.5	4.1	5.9	6.4	9.8	6.4	4.5	15.3	24.9	2.9	6.5	13.4	8.0	49.9	4.4	3.7	33.0	7.2	5.8	11.0	56.3	12.3	23.8	5.4	0.0	8.5	3.7	3.2	9.7	12.9	16.9	13.7	23.5	5.3	2.1	10.8	4.6	3.6	1.3	14.0	9.7	5.7	7.0	40.4	29.1	7.5	10.2	8.3	6.2	3.7	27.1	6.0	12.4	15.0	16.0	13.0	59.8	31.7	23.5	6.4	7.4	17.7	19.1	5.5	4.3	4.0	8.0	78.3	13.1	11.6	9.5	36.5	28.0	4.6	1.0	1.9	22.9	14.0	9.7	6.3
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97435909-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	21.9	25.4	31.4	23.5	34.3	28.7	22.4	50.4	39.9	25.5	27.7	25.6	24.3	24.0	42.6	28.4	22.2	17.0	23.5	29.7	33.6	25.3	26.9	20.5	32.3	33.3	32.2	23.6	38.8	21.1	24.2	17.6	32.6	24.5	23.5	21.2	26.6	17.3	29.0	23.5	22.3	22.1	32.6	30.3	31.2	15.2	32.8	32.5	21.6	14.8	31.9	25.3	22.9	36.3	62.9	49.6	34.8	61.7	42.1	44.3	47.0	52.2	73.9	57.2	64.4	86.5	62.1	60.4	59.0	50.2	44.1	64.0	52.5	58.9	56.6	77.3	61.3	39.5	48.0	68.9	74.5	94.2	46.1	45.8	77.9	69.6	101.3	70.2	66.3	90.5	45.6	108.0	43.2	70.3	88.0	153.3	58.1	64.7	43.2	65.8	43.4	106.4	39.4	32.8	20.4	38.3	38.6	30.0	87.6	44.1	71.2	113.2	43.6	31.9	40.1	50.4	117.6	72.5	103.1	119.5	54.3	113.2	26.3	79.0	91.0	93.5	75.5	132.8	96.5	109.6	93.1	87.9	96.4	94.7	89.4	78.1	35.7	57.9	121.7	82.9	144.0	86.4	31.4	34.3	50.4	39.9	29.7	33.6	33.3	32.2	32.6	32.6	32.8	36.3	22.5	25.6	24.6	15.0	42.4	19.1	35.7	59.3	18.2	31.0	22.5	27.3	20.5	27.1	35.8	44.1	27.1	48.6	41.2	15.4	39.2	36.0	17.4	22.6	24.1	27.7	14.3	23.8	24.7	41.8	58.1	27.0	21.9	16.7	25.3	31.0	34.6	25.3	50.9	30.3	22.2	28.1	36.7	31.4	20.7	17.0	32.6	28.7	30.2	17.8	61.0	29.1	61.8	12.1	25.5	35.9	20.0	24.0	43.6	24.9	30.1	53.8	47.1	48.1	26.3	20.7	35.2	35.8	39.1	27.6	24.4	41.2	44.3	26.4	25.7	31.7
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37759234-37832117	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	9.9	12.3	5.4	9.7	5.7	6.5	9.1	8.7	6.3	10.4	5.6	9.1	7.2	9.7	4.3	14.4	8.8	4.1	7.8	5.4	5.4	10.5	10.1	7.5	11.1	4.9	5.4	10.3	7.9	6.9	8.5	6.6	5.0	9.4	6.2	5.2	9.3	6.5	11.4	8.2	8.9	5.1	5.7	10.8	8.9	21.6	5.5	12.9	8.4	5.3	11.8	10.2	11.5	7.1	69.2	46.8	25.1	32.5	16.5	13.4	33.7	38.5	15.0	31.7	29.6	63.0	11.1	52.3	29.0	14.3	36.2	26.2	28.3	27.3	35.7	75.1	46.9	43.4	57.5	59.3	19.4	66.7	38.5	9.1	13.5	24.0	15.2	10.2	17.0	38.1	108.7	24.7	22.8	40.9	59.3	53.1	69.6	61.7	53.9	53.9	31.2	29.2	17.9	22.0	36.8	36.4	21.9	18.0	26.3	19.8	23.7	48.0	19.7	25.4	47.1	32.0	62.2	16.5	45.4	70.7	25.7	51.2	28.9	34.1	44.4	36.8	35.6	53.9	45.7	53.1	42.9	47.8	42.4	49.1	43.0	41.3	27.8	40.2	49.3	50.4	51.2	55.6	5.4	5.7	8.7	6.3	5.4	5.4	4.9	5.4	5.0	5.7	5.5	7.1	14.7	22.4	19.9	3.3	25.8	54.2	32.7	47.2	8.6	7.4	17.1	19.3	7.8	22.8	24.0	7.3	0.0	58.0	22.6	13.5	33.2	40.6	74.3	19.2	20.1	14.6	10.7	29.5	4.3	34.9	76.7	20.9	8.6	13.2	29.2	23.7	12.8	13.1	45.4	6.7	4.1	14.9	22.4	19.9	17.9	16.4	16.8	17.6	19.6	1.9	26.3	11.2	20.6	2.5	5.9	34.9	17.7	13.2	19.9	27.6	15.7	32.7	21.9	7.5	26.3	17.6	30.6	132.4	53.1	20.0	54.1	31.5	19.6	28.9	20.2	27.2
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078648-144080648	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 94.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 320.6;Late spermatids: 856.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 430.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024792, HPA065103"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA024792: AB_1848325, HPA065103: "	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	19.3	31.2	15.1	11.4	16.5	14.9	16.9	16.0	23.4	13.1	16.1	18.8	15.4	17.0	5.0	27.5	16.1	7.2	23.7	15.6	15.0	23.6	35.0	16.0	12.1	16.8	14.9	12.3	18.8	10.3	17.6	9.2	15.5	18.8	5.7	3.5	26.6	12.5	21.2	22.1	15.2	6.1	15.4	23.8	24.0	94.9	15.8	10.1	13.9	8.2	6.6	17.4	15.2	15.9	51.8	104.8	18.1	44.2	15.6	11.7	51.8	39.9	15.2	28.9	28.9	73.4	33.4	28.9	54.6	15.5	21.0	40.4	33.8	40.5	8.3	42.5	117.8	42.7	77.9	83.3	25.9	31.4	48.6	16.9	40.9	33.2	26.2	11.4	14.8	32.0	68.8	19.8	23.8	177.8	51.4	62.0	47.6	51.2	430.6	21.7	30.2	74.8	27.7	48.3	57.6	75.4	46.6	59.7	95.4	9.3	68.1	49.0	15.2	29.9	66.3	73.6	68.1	52.4	67.8	37.5	43.1	50.8	47.7	61.5	78.3	34.1	37.4	76.6	38.7	59.7	29.3	37.4	75.0	60.2	37.7	36.2	22.9	45.6	43.0	97.4	36.1	49.5	15.1	16.5	16.0	23.4	15.6	15.0	16.8	14.9	15.5	15.4	15.8	15.9	16.3	9.6	21.3	2.9	17.8	94.4	45.2	58.6	45.5	10.0	40.7	41.4	22.3	24.3	31.9	27.6	8.4	48.2	17.2	46.6	123.3	50.6	320.6	23.8	28.3	25.5	25.9	24.6	3.2	46.3	44.2	24.7	25.0	18.8	14.0	21.0	19.2	54.9	44.7	6.7	3.3	35.6	48.8	29.8	40.7	856.7	18.6	29.9	35.6	0.0	45.7	23.5	14.4	3.0	3.6	61.7	52.4	21.1	32.5	55.5	41.0	102.5	31.7	8.2	13.1	14.7	43.5	97.0	34.7	48.1	87.9	48.2	12.8	37.8	47.1	48.7
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397359	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	12.9	19.4	18.6	14.1	20.2	17.4	14.0	18.9	26.1	12.5	15.1	13.3	11.4	11.3	4.2	21.4	15.1	6.6	16.8	18.8	17.8	9.9	21.7	7.3	22.0	20.8	18.4	14.3	28.6	5.9	7.2	7.4	19.2	11.0	7.2	2.3	16.4	8.4	41.7	23.0	10.8	7.2	19.0	14.3	13.6	11.4	18.3	14.8	11.6	23.1	11.8	14.7	13.9	22.1	58.2	123.5	15.1	48.8	10.7	13.5	39.4	24.5	13.1	44.6	37.0	72.5	47.5	92.9	64.8	12.9	22.8	25.1	33.1	31.3	12.2	66.7	117.3	42.7	45.5	55.7	32.1	76.7	41.8	16.3	69.0	35.6	33.8	12.1	21.1	57.7	57.5	70.2	14.2	88.1	70.2	58.6	56.6	85.2	59.9	66.9	40.9	94.8	17.6	43.1	64.4	47.8	34.6	62.4	68.2	10.5	31.1	95.6	16.2	45.9	37.4	30.1	76.9	109.6	138.5	106.3	34.9	116.0	39.0	15.2	68.2	1.9	41.3	77.7	47.9	66.0	43.3	40.9	110.1	74.0	63.2	55.4	5.0	62.1	48.6	118.7	37.0	48.6	18.6	20.2	18.9	26.1	18.8	17.8	20.8	18.4	19.2	19.0	18.3	22.1	16.1	3.2	4.8	2.3	21.3	30.5	29.0	29.6	44.9	5.5	30.1	44.2	8.4	22.8	16.9	18.4	4.2	28.4	23.5	12.7	37.2	21.7	9.1	5.5	16.7	11.1	8.5	28.0	5.0	21.4	124.0	13.1	16.3	9.1	5.1	24.7	7.1	20.3	28.8	6.7	4.8	18.4	20.3	11.8	13.3	8.5	16.8	18.9	14.2	2.8	18.9	7.0	18.6	4.0	4.3	17.2	15.3	12.4	21.3	28.0	6.6	34.9	12.7	4.1	6.6	17.8	16.0	17.0	33.1	47.4	33.2	21.2	17.0	31.5	34.2	23.8
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: AB_2683571"	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favorable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	17.5	44.1	9.5	12.5	9.5	17.2	18.4	10.0	10.4	23.5	10.7	15.3	11.6	20.4	7.0	27.2	17.0	9.1	27.0	9.5	10.9	22.2	18.1	15.0	19.6	10.4	9.8	19.0	18.6	20.1	17.3	15.4	10.1	15.9	10.8	5.9	17.5	15.9	43.8	44.6	13.2	11.2	9.7	15.3	20.0	23.2	10.5	20.2	19.9	36.4	16.8	22.7	22.2	9.8	61.5	55.7	44.9	37.3	45.9	50.0	40.5	26.2	42.2	56.0	57.7	93.3	47.8	77.4	40.3	45.6	42.6	33.9	55.9	72.2	46.0	52.3	49.2	67.5	64.5	91.5	88.7	95.3	26.5	44.1	45.6	61.2	123.6	36.5	54.8	84.9	107.4	37.8	40.3	63.2	68.6	167.9	54.3	55.2	78.4	33.8	41.7	117.7	51.0	85.5	20.9	31.4	37.0	31.6	39.7	38.4	46.7	77.9	39.3	28.8	43.0	48.3	71.7	47.1	47.5	92.6	42.4	131.6	26.2	6.8	41.3	7.6	38.8	41.5	43.6	71.3	44.6	40.2	66.0	59.7	51.8	41.4	2.1	58.3	31.5	40.2	47.7	45.4	9.5	9.5	10.0	10.4	9.5	10.9	10.4	9.8	10.1	9.7	10.5	9.8	25.0	35.3	30.1	16.0	23.2	61.8	68.8	97.2	47.3	29.5	23.9	43.2	39.0	21.5	46.5	35.0	18.8	67.8	22.1	8.6	135.0	51.7	3.9	23.7	34.8	24.0	13.1	19.6	19.9	46.7	62.4	32.7	23.0	21.7	15.2	33.0	18.2	28.6	46.5	20.2	22.5	19.3	79.3	14.2	22.6	8.3	47.8	17.4	26.6	8.4	20.6	37.6	33.0	10.6	14.0	41.7	10.3	41.0	19.4	74.8	17.7	47.4	34.3	23.4	13.1	25.7	53.9	53.7	66.3	35.5	74.2	63.1	26.2	52.2	24.3	56.3
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.2	16.6	19.1	17.6	27.5	18.8	17.9	24.3	16.8	16.6	17.0	12.6	14.2	14.4	18.2	16.8	8.4	19.4	16.9	17.8	17.9	19.8	13.5	21.2	17.5	17.1	16.4	13.9	11.6	10.8	15.6	18.1	14.2	19.0	15.3	11.3	13.2	24.2	16.6	14.0	16.6	17.3	17.5	15.3	27.8	17.0	31.5	12.3	24.8	25.1	16.2	14.7	19.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	16.6	17.6	17.9	24.3	16.9	17.8	17.5	17.1	18.1	17.3	17.0	19.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111826	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 229.6;Inhibitory neurons: 421.4;Microglial cells: 144.3;Oligodendrocyte precursor cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.5;fHDF/TERT166: 82.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					NA	Yes		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.85e-1)"	5.1	4.2	2.0	5.2	2.5	1.1	4.3	2.3	2.3	7.6	3.9	7.7	14.1	4.9	2.9	5.5	3.8	5.8	7.0	3.4	1.3	3.8	13.3	7.9	3.0	1.1	2.1	5.0	5.5	3.3	1.8	11.1	1.0	5.0	8.2	2.7	3.2	7.7	1.5	7.8	11.7	6.1	1.4	5.1	5.3	2.4	1.2	3.0	5.2	2.4	3.8	11.8	4.2	1.9	29.3	8.5	13.5	5.5	22.8	23.0	5.9	51.5	95.5	40.9	39.4	10.0	3.1	0.5	24.8	82.1	24.0	19.8	5.0	31.4	55.7	12.5	9.9	1.5	5.9	6.5	10.0	0.0	1.6	10.8	10.8	38.8	38.5	47.7	28.1	2.9	0.9	7.4	18.7	3.2	1.8	0.2	4.6	13.7	10.1	0.0	4.1	1.3	23.1	7.6	4.5	4.0	8.0	3.9	9.2	32.6	5.3	0.5	32.0	35.2	28.7	32.0	15.8	5.5	5.1	2.4	36.5	0.0	9.2	0.1	0.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.3	0.1	2.0	2.5	2.3	2.3	3.4	1.3	1.1	2.1	1.0	1.4	1.2	1.9	21.1	19.2	6.0	127.3	3.0	54.8	23.0	27.7	10.2	23.6	7.8	10.8	6.5	24.3	13.7	7.3	14.6	6.5	5.1	49.2	0.0	37.3	1.8	17.7	37.1	25.9	4.8	1.7	229.6	20.1	3.9	32.6	11.7	18.2	7.0	108.3	16.8	32.9	2.5	10.1	421.4	25.5	4.1	37.9	13.9	2.7	17.4	9.6	19.6	144.3	8.1	5.9	4.1	162.8	101.8	27.4	16.1	36.1	5.3	19.3	44.9	4.9	14.2	22.4	0.0	17.1	36.4	0.6	5.1	12.6	47.3	12.2	4.2	35.0	26.3	26.8
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.2;skeletal muscle: 12.7;tongue: 29.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.3;Breast glandular cells: 8.8;Excitatory neurons: 22.7;Horizontal cells: 10.1;Melanocytes: 7.2;Oligodendrocyte precursor cells: 10.6"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Group enriched"	"Detected in many"	11	"amygdala: 10.3;basal ganglia: 9.8;cerebral cortex: 14.2;hippocampal formation: 11.5;white matter: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 150.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010726, HPA037749"	Uncertain		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		79000		"Cluster 47: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.2	1.0	10.3	0.0	9.8	0.0	0.8	0.0	14.2	0.4	0.0	1.0	0.1	3.6	0.1	0.5	0.7	0.3	3.5	11.5	0.0	0.4	0.0	0.2	0.2	0.1	0.6	1.1	1.5	0.0	0.9	0.3	0.4	0.4	0.0	0.8	0.5	0.2	12.7	2.3	0.3	1.3	0.0	3.5	0.3	0.6	0.9	0.0	0.2	29.8	0.0	0.3	0.4	6.9	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.2	0.6	0.0	0.2	2.4	0.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	150.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	9.8	0.0	14.2	11.5	0.0	0.1	0.6	0.4	0.0	0.9	6.9	0.1	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	15.3	8.8	1.8	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	22.7	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.1	10.1	5.1	0.0	0.0	0.0	0.3	0.6	1.5	0.0	7.2	2.8	0.0	0.4	0.0	10.6	1.9	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.4	0.4	0.2	0.2	0.0	0.0	1.0	0.0	1.1	0.1	0.1
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895179	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 214.1;Theca cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		80000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	8.8	24.6	11.4	5.0	15.0	2.2	11.5	12.0	16.4	13.9	19.1	10.8	4.8	18.1	13.7	6.5	10.9	11.4	9.2	10.3	15.4	12.9	12.6	8.4	4.2	12.9	14.9	19.6	9.0	14.6	12.9	24.9	13.7	13.4	7.6	13.9	7.1	11.9	6.9	6.5	5.4	17.0	11.2	6.5	7.3	10.7	17.8	8.2	10.1	7.1	3.7	9.2	6.9	11.3	13.0	6.9	50.2	50.7	53.2	39.3	31.4	23.2	37.5	17.5	39.4	6.1	9.9	15.2	21.8	20.9	13.5	12.7	18.3	19.6	35.4	31.8	13.4	19.0	23.6	18.3	17.5	28.9	9.3	47.3	6.8	35.9	6.6	36.5	65.0	19.2	23.9	2.0	45.1	6.9	15.5	15.5	62.2	12.2	15.5	11.2	51.5	12.1	18.4	9.7	20.6	57.5	17.4	4.6	42.0	35.8	10.9	12.7	27.7	44.0	25.8	27.8	24.4	15.5	15.0	9.8	69.2	29.3	14.4	2.0	0.5	0.0	3.4	0.7	1.5	1.2	1.1	2.3	1.7	1.7	1.2	2.7	0.1	3.9	0.5	4.6	0.0	1.2	11.4	15.0	12.0	16.4	10.3	15.4	12.9	14.9	13.7	11.2	17.8	11.3	12.3	12.8	8.4	39.8	4.9	8.5	10.2	13.8	21.1	20.7	13.2	13.5	12.7	10.0	11.0	14.7	35.5	214.1	5.0	3.3	11.7	5.8	45.3	20.3	28.7	13.1	9.5	16.2	47.1	2.1	36.9	36.0	15.3	11.0	17.7	35.3	13.6	16.4	24.3	3.3	49.9	5.6	12.2	7.3	5.7	34.9	25.1	5.8	23.2	12.2	7.4	18.8	8.2	40.7	32.9	2.4	2.6	34.6	5.9	6.2	2.9	11.9	25.3	19.7	13.1	25.4	22.4	37.1	12.3	8.5	8.1	74.3	6.1	328.5	7.1	4.9
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 38: Heart - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	10.8	16.5	11.3	7.2	12.0	3.8	6.3	7.6	13.7	8.9	5.8	11.1	5.5	13.8	5.4	12.3	11.3	7.9	31.1	14.7	10.4	7.0	6.2	8.6	5.4	10.7	14.3	10.0	11.9	18.9	10.3	13.8	7.2	8.5	5.4	11.2	8.1	11.8	20.8	11.1	6.7	17.9	8.9	8.6	9.0	10.3	23.4	6.4	7.7	22.7	4.8	10.6	7.2	12.7	45.3	33.6	70.1	37.0	18.8	18.5	15.6	33.7	32.6	20.3	16.4	28.9	15.9	12.2	46.6	40.1	28.2	29.7	34.5	55.1	22.4	8.9	18.9	17.2	15.7	14.3	9.8	8.6	46.9	22.2	36.7	15.9	14.6	16.9	44.3	17.4	16.2	15.4	16.5	8.5	15.5	4.7	49.2	13.3	13.6	18.4	31.3	7.1	31.2	29.0	15.2	26.6	14.3	8.6	17.3	22.0	8.4	9.4	34.9	26.6	62.7	25.4	28.9	7.9	17.9	13.5	22.5	10.3	23.7	3.0	1.3	2.0	1.7	0.9	0.8	0.3	0.7	0.9	1.3	0.4	0.5	0.4	5.7	0.5	1.4	1.1	0.3	0.8	11.3	12.0	7.6	13.7	14.7	10.4	10.7	14.3	7.2	8.9	23.4	12.7	6.3	3.2	4.4	10.4	2.4	5.0	2.9	8.7	6.8	17.5	4.8	4.2	26.8	7.2	5.0	1.8	25.0	3.7	7.1	4.9	3.9	9.7	32.0	4.2	7.0	7.3	4.2	1.3	20.0	10.6	16.9	6.5	4.1	5.9	5.7	3.0	8.2	9.0	4.4	8.4	19.0	2.4	2.0	6.6	2.5	10.1	9.9	6.1	5.4	16.9	5.7	6.7	23.7	13.0	16.6	12.3	2.4	14.3	4.2	6.3	2.1	3.5	4.9	16.2	26.3	8.4	9.6	4.3	9.1	4.3	3.0	2.2	4.5	8.6	3.1	3.1
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 133.4"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 258.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	39.6	18.1	35.0	14.4	37.4	15.2	34.1	42.4	41.5	41.5	29.4	31.6	13.0	31.1	26.5	21.6	35.6	12.8	31.8	33.9	33.9	28.6	13.4	25.7	20.5	37.7	36.5	47.8	18.3	25.5	26.3	12.5	40.2	26.0	15.4	133.4	20.2	23.8	43.8	26.1	30.6	20.4	32.3	37.8	20.7	12.0	35.8	22.9	28.4	33.2	20.4	29.2	31.4	41.5	8.9	9.3	12.4	8.5	48.4	29.1	10.4	14.0	12.7	11.4	11.6	4.4	10.8	13.4	8.6	15.0	11.2	19.8	8.1	9.2	16.3	15.0	14.5	4.7	19.7	5.4	16.6	10.2	10.8	16.7	16.6	8.6	20.8	20.0	9.4	13.4	12.5	18.5	10.2	3.7	16.6	12.9	3.4	8.2	4.7	10.7	12.4	14.5	11.7	9.3	8.4	6.8	7.8	3.8	9.5	17.5	13.2	6.5	9.8	12.2	5.0	14.4	8.9	19.3	10.4	8.0	8.8	10.4	6.4	14.2	5.2	7.8	6.0	5.4	8.2	5.8	5.3	6.1	2.0	6.3	7.7	5.8	19.7	5.8	3.6	6.3	6.4	2.6	35.0	37.4	42.4	41.5	33.9	33.9	37.7	36.5	40.2	32.3	35.8	41.5	34.2	9.6	20.8	41.1	23.6	5.2	14.2	6.6	8.6	71.7	8.7	13.1	39.3	20.0	14.1	12.9	66.7	7.9	24.6	9.3	9.8	11.2	0.7	21.8	23.2	20.7	13.1	36.4	36.8	7.5	3.2	25.3	8.6	25.5	20.3	19.4	15.4	7.8	9.0	47.1	34.0	4.9	12.2	17.1	7.2	2.8	31.1	14.7	1.8	15.0	24.1	30.8	33.0	20.6	58.9	12.1	7.7	34.3	15.9	9.1	12.9	10.7	28.0	258.1	52.6	32.7	24.1	10.7	10.6	6.6	6.1	10.8	21.8	26.2	7.4	9.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
EZHIP	"CATACOMB, CXorf67"	ENSG00000187690	"EZH inhibitory protein"	Q86X51	X	51406948-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 32.8"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.6	0.6	0.2	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	1.4	0.2	0.0	0.1	0.0	0.5	0.3	0.4	0.1	0.0	1.0	0.9	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	5.9	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.6	0.6	0.2	1.4	0.5	0.3	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021343	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Urothelial cells: 242.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 165.5;neutrophil: 113.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 165.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 205.4;OE19: 202.4;SuSa: 232.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		1900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	21.1	24.5	6.6	20.8	6.3	21.3	26.8	6.0	8.2	24.2	9.6	52.6	55.9	11.9	21.1	85.5	33.1	28.7	12.8	6.3	6.5	40.4	73.6	67.1	13.2	7.8	7.5	14.0	41.7	36.3	18.8	50.7	7.5	28.7	51.7	2.2	49.4	21.2	6.1	48.2	64.0	9.0	7.2	21.5	52.6	13.0	8.6	16.5	39.2	6.3	32.0	52.2	44.1	7.1	122.9	15.5	4.7	1.4	3.3	0.2	95.5	0.6	0.1	4.0	4.1	113.5	155.9	8.9	78.6	0.2	22.6	205.4	25.3	105.2	6.4	6.9	17.8	25.8	6.2	52.3	4.8	24.2	72.6	1.4	132.5	0.6	32.7	24.1	98.6	18.8	35.6	2.5	0.6	53.5	7.6	13.6	80.1	202.4	21.9	11.3	0.0	39.2	67.2	94.4	34.3	8.8	29.2	123.4	26.2	232.8	132.6	41.7	58.8	0.3	3.0	0.4	1.2	28.2	59.3	3.1	18.0	23.4	7.5	34.6	31.0	165.5	12.6	16.3	6.7	4.7	11.7	8.0	24.6	2.9	11.1	8.8	113.4	8.2	13.0	18.7	5.7	25.1	6.6	6.3	6.0	8.2	6.3	6.5	7.8	7.5	7.5	7.2	8.6	7.1	27.7	253.2	137.2	0.0	9.8	35.2	119.7	86.2	64.3	0.9	35.0	15.5	3.3	67.2	136.2	77.3	2.1	78.6	10.2	154.9	7.9	76.8	7.2	120.8	13.9	41.5	62.2	10.3	2.7	71.0	176.2	9.1	66.8	150.9	18.3	13.7	34.2	68.8	31.0	0.0	1.1	71.5	46.8	14.4	25.5	2.1	2.1	24.7	8.8	7.5	48.7	1.5	13.4	3.0	0.4	91.4	114.1	0.7	10.8	135.3	82.5	12.6	178.8	2.4	0.0	5.1	6.2	13.4	2.9	102.3	50.6	63.1	12.3	8.1	50.7	242.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.4	0.1	1.4	0.1	1.2	2.6	0.3	0.1	1.3	0.4	0.1	0.5	0.5	0.2	0.0	1.9	0.3	0.1	0.4	1.5	0.8	0.8	604.6	0.6	0.0	0.8	0.6	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.4	1.0	0.1	1.2	0.8	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.4	1.2	0.1	1.3	1.5	0.8	0.8	0.6	0.9	0.4	0.8	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 232.8;placenta: 489.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 863.3;Langerhans cells: 205.1;Macrophages: 232.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.1;myeloid DC: 179.6"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.6;granulocytes: 50.2;monocytes: 141.1"	"Cell line enhanced"	"Detected in some"		"AF22: 24.0;LHCN-M2: 8.9;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 4: Macrophages - Innate immune response"			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	232.8	57.9	2.6	52.3	4.2	16.1	46.9	1.3	13.0	50.4	28.5	45.9	9.7	18.5	5.6	51.2	29.1	52.7	39.2	2.1	3.6	21.0	3.0	38.7	30.0	8.3	4.6	10.7	10.0	13.3	8.1	489.2	6.9	8.8	63.9	21.6	18.8	13.4	10.3	22.7	22.0	89.6	2.6	8.8	25.4	17.8	3.7	20.9	17.1	32.8	12.5	144.5	12.1	4.0	0.0	0.1	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	43.8	0.8	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	50.2	141.1	1.4	0.5	25.4	0.6	0.4	0.3	0.4	179.6	0.4	0.4	0.2	32.9	0.3	0.7	12.5	0.3	364.9	2.6	4.2	1.3	13.0	2.1	3.6	8.3	4.6	6.9	2.6	3.7	4.0	2.0	0.0	1.9	0.3	1.8	18.7	0.0	0.0	0.6	0.1	0.3	0.4	10.6	5.7	0.0	0.0	0.0	5.0	4.5	0.0	0.0	0.0	5.1	0.6	10.6	3.8	0.0	1.3	3.9	0.0	5.6	13.7	0.0	0.4	1.3	0.0	2.9	0.9	863.3	0.0	1.4	0.0	0.0	92.4	205.1	5.8	4.4	232.0	19.6	64.6	53.1	0.9	6.2	0.5	0.7	0.1	0.0	0.7	1.2	0.0	0.0	11.0	2.2	6.5	59.2	2.5	3.3	1.6	0.9	1.2	15.2	10.1	2.6	0.4	0.0	0.1
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	211	"liver: 200.2"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 54.9"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	200.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	54.9	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1518	"liver: 1217.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1217.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716126-76735770	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.5"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 307.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 25.4"	"Group enriched"	"Detected in many"	14	"NK-cells: 7.0;T-cells: 25.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 196.9;HUVEC TERT2: 366.2;WM-115: 345.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB008973: , CAB012962: AB_2533198"	"unprognostic (3.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (2.21e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.74e-3)"	14.5	13.5	1.2	12.1	1.4	4.0	18.3	1.6	1.5	15.4	1.6	10.0	14.2	23.2	4.2	11.1	3.9	39.5	30.4	1.2	1.5	19.1	23.9	22.8	16.2	2.5	2.6	2.9	9.9	7.3	4.3	10.5	2.1	7.2	11.6	0.7	30.5	12.0	3.6	45.7	18.8	18.8	1.8	69.5	10.3	8.8	1.9	4.9	15.2	11.9	8.6	15.4	4.5	1.5	5.7	17.5	53.3	8.8	98.4	170.5	2.6	30.3	102.5	19.5	69.8	3.9	47.0	0.1	50.1	13.0	88.1	13.2	23.1	18.1	36.6	4.4	19.3	120.2	3.8	14.7	147.7	0.6	4.9	96.9	60.2	37.2	10.5	196.9	366.2	21.4	22.8	22.1	40.1	2.4	9.6	0.4	17.0	0.3	93.5	17.1	31.9	4.3	91.2	0.8	6.3	28.7	8.9	0.2	45.2	48.0	0.7	1.3	169.0	121.8	26.7	1.3	56.7	59.0	18.5	0.2	32.4	2.3	345.5	1.1	0.2	0.4	25.4	0.5	6.5	0.6	5.7	17.7	0.0	0.2	0.9	12.7	1.1	7.0	0.1	0.3	0.6	11.2	1.2	1.4	1.6	1.5	1.2	1.5	2.5	2.6	2.1	1.8	1.9	1.5	25.8	0.0	9.2	1.6	4.4	17.2	0.7	9.3	1.2	3.5	3.4	2.4	2.6	7.2	4.5	7.3	0.0	0.2	56.2	0.3	0.0	2.0	10.7	2.8	47.1	51.8	6.6	11.6	1.0	2.2	0.4	39.5	8.2	5.4	6.3	13.0	307.0	4.3	2.1	0.0	3.3	3.9	16.2	16.6	10.7	6.0	0.9	5.4	12.4	5.6	1.1	0.1	54.6	0.5	0.1	10.8	0.2	10.5	35.8	1.4	0.5	3.4	4.2	1.4	0.0	8.1	24.9	12.7	5.4	1.5	40.1	0.3	40.1	9.5	1.3	0.4
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.2"	"Group enriched"	"Detected in many"	10	"Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"	NA	NA		25000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	29.4	15.2	7.8	2.5	8.6	2.1	19.3	7.4	11.2	7.5	9.9	9.6	2.9	10.9	9.1	4.0	7.9	5.0	53.2	8.2	8.5	14.1	20.1	16.7	4.7	8.6	8.4	14.5	11.6	5.6	6.4	3.3	8.6	9.0	3.8	6.2	4.7	7.5	20.6	3.6	5.0	6.3	7.8	17.9	5.7	6.1	8.9	3.2	10.9	28.1	3.7	8.1	3.7	7.8	6.1	4.5	0.9	2.1	6.5	10.1	0.7	2.9	1.8	2.0	3.4	0.3	6.8	12.0	9.5	3.0	4.7	0.8	1.0	1.0	1.8	5.1	1.9	2.4	2.8	0.2	3.0	2.1	5.6	7.2	0.6	1.8	2.4	3.5	1.2	5.7	1.1	9.0	10.0	2.7	1.7	1.9	1.6	1.8	4.5	1.4	1.5	1.8	1.8	1.3	3.7	2.8	7.0	0.8	3.9	1.0	2.1	4.9	1.5	10.3	5.5	16.6	3.7	5.3	5.1	6.0	9.4	12.3	5.5	4.6	2.8	0.9	5.2	2.4	10.3	2.1	3.1	5.5	2.7	1.9	1.6	4.1	4.4	3.3	2.4	0.4	4.6	2.7	7.8	8.6	7.4	11.2	8.2	8.5	8.6	8.4	8.6	7.8	8.9	7.8	118.6	0.0	6.3	13.1	2.3	1.8	2.5	1.6	4.0	8.1	3.7	4.2	17.7	7.2	1.9	3.7	2.1	0.9	2.0	0.6	7.9	3.1	1.4	1.5	1.5	120.4	0.0	8.4	7.2	0.7	0.7	6.8	0.0	1.5	1.3	8.2	371.2	11.8	3.2	6.7	5.0	0.6	0.0	19.9	1.1	3.3	11.5	3.0	0.0	8.4	2.4	6.8	2.1	7.5	6.0	4.5	0.1	5.3	2.0	1.4	0.9	11.4	2.4	3.5	6.6	11.1	13.0	2.3	3.4	1.5	1.1	0.1	4.0	4.3	0.4	2.1
FA2H	"FAAH, FAXDC1, FLJ25287, SPG35"	ENSG00000103089	"Fatty acid 2-hydroxylase"	Q7L5A8	16	74712955-74774831	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 183.9;stomach 1: 61.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 85.1;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 307.9;Paneth cells: 75.2;Urothelial cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 38.1;HAP1: 48.6;JURKAT: 89.8;OE19: 61.5;SK-BR-3: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056614, HPA077840"	Approved		Uncertain	"Nuclear membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear membrane"		"HPA056614: AB_2683191, HPA077840: AB_2686858"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (6.01e-2)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.11e-3)"	0.3	0.3	41.7	4.3	89.1	0.3	2.8	77.9	63.0	1.9	11.7	21.2	10.3	0.2	2.2	7.9	1.8	17.8	0.3	46.1	56.1	8.2	0.2	1.4	0.7	129.2	79.6	0.0	8.4	10.1	0.6	0.7	106.0	1.9	19.4	0.4	11.0	0.7	0.0	8.5	14.4	1.1	65.2	0.5	61.1	2.9	75.2	4.7	2.0	0.1	5.9	26.3	2.2	183.9	9.2	38.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.0	20.8	21.0	0.0	0.2	0.0	2.0	3.6	48.6	0.6	0.1	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	89.8	0.0	0.0	0.0	15.2	0.8	0.0	0.9	61.5	2.1	0.0	0.0	1.6	23.4	15.6	6.5	0.0	0.0	28.8	0.0	1.3	8.6	0.0	0.0	0.0	0.1	0.0	0.2	1.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	89.1	77.9	63.0	46.1	56.1	129.2	79.6	106.0	65.2	75.2	183.9	0.0	0.0	1.3	1.0	2.6	0.5	11.1	8.5	1.8	0.0	5.0	3.3	0.2	8.6	14.6	0.0	0.0	0.5	0.2	43.0	7.9	13.5	10.8	2.4	0.5	0.2	6.7	0.0	0.7	14.2	0.2	1.1	85.1	4.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	34.8	4.1	0.0	0.0	4.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	61.3	307.9	38.4	75.2	0.4	6.2	22.9	17.6	0.2	10.5	0.0	0.0	0.0	0.6	2.4	3.3	12.4	0.9	0.1	0.2	0.0	15.3	192.8
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394317-46413848	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 128.5;Proximal enterocytes: 87.4;Spermatocytes: 89.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.5;OE19: 18.8;RT4: 42.4;SK-BR-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	7.5	14.2	23.5	2.9	28.4	10.4	9.5	25.6	29.6	7.5	29.3	18.9	22.0	3.9	9.1	8.7	12.0	5.2	5.0	24.6	23.3	20.0	32.8	7.8	2.5	32.1	25.4	3.9	22.4	24.6	19.0	3.4	28.7	44.1	15.2	5.5	17.4	7.1	9.5	12.1	22.0	2.3	27.9	3.3	17.1	46.8	26.4	7.1	38.6	5.6	2.7	6.9	8.2	45.8	5.0	1.2	0.8	1.0	1.2	0.8	37.5	1.0	0.5	0.5	0.8	7.3	11.4	0.3	3.9	0.7	0.4	16.2	0.7	2.3	0.2	2.2	5.4	0.1	0.2	3.5	0.8	1.4	2.8	0.6	10.7	0.4	1.3	0.4	0.0	0.9	0.1	0.8	0.0	10.7	0.8	2.2	3.2	18.8	0.4	0.9	0.4	0.2	9.0	42.4	4.8	3.6	5.6	21.2	0.2	0.9	14.6	14.5	0.0	0.1	0.6	1.1	0.7	2.1	1.0	0.6	0.1	13.4	0.4	0.0	6.9	29.1	0.4	1.9	0.2	0.1	0.4	0.2	8.2	0.1	0.6	0.6	0.4	0.5	1.0	8.8	0.2	1.4	23.5	28.4	25.6	29.6	24.6	23.3	32.1	25.4	28.7	27.9	26.4	45.8	1.2	22.4	13.2	6.5	2.4	5.2	29.0	6.8	10.2	15.5	15.4	9.0	2.9	27.1	11.0	22.0	43.8	16.3	7.3	51.6	0.0	12.4	50.7	9.5	1.9	1.8	15.5	6.6	15.7	6.4	8.7	3.7	37.8	6.0	0.0	6.3	0.4	37.1	2.8	1.7	11.4	38.2	10.2	2.5	4.2	128.5	7.5	3.3	5.4	1.9	2.5	7.3	0.0	7.5	45.1	4.2	41.3	4.5	0.7	20.1	87.4	22.6	5.2	14.5	0.0	2.9	3.2	89.0	23.0	6.4	6.0	12.4	1.2	1.3	55.2	18.9
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"FA core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	14.7	16.8	6.7	13.8	7.0	10.1	15.9	14.7	9.5	18.6	6.8	15.8	12.0	17.3	3.1	16.2	18.8	9.5	16.3	6.7	6.4	21.2	22.7	16.0	15.9	8.1	6.5	19.5	26.6	7.8	22.4	7.2	6.3	20.7	4.9	3.7	14.6	7.8	13.2	16.1	18.8	6.9	5.1	38.1	15.5	13.3	7.3	8.8	24.1	6.0	7.3	17.9	15.5	8.8	11.7	21.3	9.4	26.8	11.0	11.5	14.6	11.2	5.9	14.3	8.9	14.5	14.0	21.0	8.6	15.5	13.8	15.0	4.9	14.5	3.3	6.1	13.9	13.5	23.3	20.0	11.6	15.4	16.0	14.0	10.7	10.4	11.7	17.6	27.0	22.0	20.7	16.5	7.0	23.0	24.4	25.8	11.3	13.6	7.7	22.1	9.4	19.3	10.4	21.1	20.5	17.1	8.5	24.4	10.4	9.7	26.2	20.7	22.8	30.6	18.8	8.3	18.9	18.3	1.5	10.7	8.0	9.9	14.3	0.0	3.0	1.2	2.4	2.8	1.9	3.0	1.6	1.6	2.9	2.0	1.5	1.2	0.4	2.4	1.4	3.2	1.6	2.2	6.7	7.0	14.7	9.5	6.7	6.4	8.1	6.5	6.3	5.1	7.3	8.8	11.4	3.2	7.5	0.0	7.5	0.0	3.5	0.0	4.6	10.3	9.8	10.9	8.9	10.0	2.5	14.7	4.2	6.1	8.5	7.1	3.9	8.2	1.9	4.5	7.3	7.5	7.3	11.8	0.0	6.9	4.8	8.3	15.8	6.8	0.0	14.9	6.8	11.7	8.4	6.7	0.0	6.2	0.0	14.1	0.0	3.0	5.0	7.0	0.0	0.0	8.9	6.2	4.1	0.0	0.0	8.9	4.4	5.3	6.6	5.3	12.7	6.8	1.5	4.9	0.0	7.4	6.4	7.3	7.5	9.5	0.0	3.1	6.2	10.7	7.3	3.6
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"FA core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 337.5;Proximal tubular cells: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	39.3	57.5	18.1	3.2	18.9	5.6	41.2	20.8	28.0	52.5	20.5	48.5	4.6	50.0	1.3	38.8	37.8	1.5	50.0	14.5	19.6	64.8	52.1	37.9	3.6	24.6	18.9	45.3	38.7	5.1	75.5	3.2	19.6	61.1	1.8	3.7	30.7	7.1	26.4	42.7	31.8	1.8	20.2	45.0	47.3	54.8	26.9	2.9	52.9	4.0	3.1	43.7	40.7	18.9	27.7	4.4	5.8	7.3	3.6	4.7	34.8	30.4	11.0	9.6	12.9	6.7	18.0	31.7	43.7	4.8	9.0	13.5	4.2	4.6	4.9	68.3	61.0	26.5	6.8	14.4	13.5	18.7	24.8	8.1	9.8	5.8	6.3	5.9	11.9	24.6	37.1	7.6	6.7	11.6	27.0	57.6	20.8	5.4	55.6	36.0	18.1	30.7	4.6	4.5	47.4	63.5	19.8	8.6	58.5	5.3	8.5	7.5	25.6	15.1	35.8	18.7	17.4	68.9	39.9	48.2	28.0	11.4	6.4	9.8	16.4	63.4	18.4	16.9	18.1	28.3	16.5	19.8	17.0	25.7	22.2	18.6	20.6	10.8	15.6	42.4	16.2	10.6	18.1	18.9	20.8	28.0	14.5	19.6	24.6	18.9	19.6	20.2	26.9	18.9	71.7	6.4	11.9	0.0	82.3	0.0	97.7	0.0	79.6	29.1	120.9	138.2	22.1	62.9	6.8	97.5	4.2	119.7	83.6	14.5	170.2	128.5	102.7	44.3	77.2	62.1	43.7	36.8	0.0	110.8	144.1	65.3	64.7	49.9	7.6	74.8	84.6	94.5	134.0	15.2	0.0	56.0	0.0	110.8	0.0	337.5	86.0	82.3	0.0	0.0	178.9	84.7	91.6	0.0	0.0	141.1	40.8	82.8	60.9	152.8	56.2	290.1	8.0	29.5	65.7	63.3	68.8	101.5	38.3	88.4	0.0	89.8	62.4	102.5	42.2	113.2
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"FA core complex associated protein 24"	Q9BTP7	19	32972209-32978229	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 14.6;Spermatocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	1.7	1.4	0.8	2.6	0.7	3.5	1.8	1.2	1.1	1.0	1.1	1.7	1.8	1.3	2.4	1.8	1.4	2.3	0.7	0.8	0.6	1.2	1.4	1.4	3.1	1.4	0.6	2.5	0.9	0.4	0.8	1.6	1.0	4.8	2.5	0.5	1.2	1.1	0.5	2.8	2.2	1.5	0.4	2.4	1.4	6.2	0.9	2.6	1.8	0.2	3.5	1.5	1.2	2.2	6.0	15.0	5.7	9.3	3.2	6.3	4.9	7.7	8.2	14.5	18.8	10.3	9.7	7.0	11.2	3.2	11.4	4.2	11.7	5.9	11.5	19.4	5.4	15.3	5.8	7.6	1.7	5.2	7.5	3.5	3.5	9.0	5.3	2.3	5.9	11.2	8.2	7.1	11.1	6.7	11.6	7.1	2.6	8.7	6.7	10.2	5.1	3.9	2.9	3.6	5.9	4.9	8.7	9.9	6.1	6.2	6.6	13.7	3.5	14.2	6.6	6.2	7.2	5.5	12.4	9.6	10.1	11.9	9.6	15.3	5.7	8.8	3.2	6.9	3.8	6.4	4.0	4.9	3.6	6.2	3.6	5.2	13.9	7.1	7.8	6.9	5.6	3.2	0.8	0.7	1.2	1.1	0.8	0.6	1.4	0.6	1.0	0.4	0.9	2.2	1.7	3.2	1.1	0.0	3.0	0.0	3.3	0.0	1.8	1.5	3.9	3.6	0.5	2.8	1.3	3.7	2.1	11.1	6.5	1.2	1.9	1.6	7.2	4.4	3.0	2.1	1.2	7.4	0.0	8.0	14.6	3.1	0.5	6.3	1.3	7.1	3.6	0.4	8.2	5.0	0.0	2.4	0.0	5.1	0.0	12.3	3.4	3.5	0.0	0.0	7.0	0.6	2.1	0.0	0.0	4.2	2.4	3.4	2.6	3.2	3.5	1.0	0.0	1.0	0.0	2.7	2.2	22.6	8.3	2.7	0.0	5.1	2.5	5.8	2.7	2.6
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP12		ENSG00000197416	"Fatty acid binding protein 12"	A6NFH5	8	81524981-81531378	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 72.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 83.1;Late spermatids: 150.3"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044041	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 34: Spermatids - Unknown function"			"HPA044041: AB_10962213"		"unprognostic (1.18e-1)"			"unprognostic (7.31e-3)"	"unprognostic (3.07e-1)"									"unprognostic (2.63e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	72.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	83.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	150.3	0.6	0.0	0.0	0.0	0.0	4.1	0.0	2.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.5	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365253-31376850	"Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"ASC TERT1: 215.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	3000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	31.4	63.5	33.7	2.1	39.2	1.6	95.4	42.3	51.5	40.4	14.8	16.3	0.8	93.9	6.4	9.5	37.2	3.7	5666.1	52.0	37.3	229.8	6.6	26.4	3.4	50.5	38.3	20.3	2.2	0.3	9.0	2.8	55.2	48.9	4.8	17.8	46.5	52.2	2202.5	16.3	7.5	44.2	31.4	28.8	60.3	15.3	36.1	2.3	6.8	1442.4	1.4	12.5	32.5	36.8	1.0	0.4	8.8	1.1	50.6	215.0	2.0	2.6	17.3	0.3	6.6	1.3	1.9	1.6	17.8	5.2	0.3	2.1	2.5	0.0	0.5	0.8	3.7	1.8	2.7	5.3	2.2	1.7	0.5	16.9	0.0	3.9	0.0	2.5	0.0	1.4	2.2	0.5	2.2	0.5	0.7	1.5	11.4	0.9	3.1	0.4	5.7	0.6	4.1	0.7	2.1	0.5	1.5	0.7	28.4	13.2	0.9	3.1	1.7	1.0	1.0	6.0	1.3	1.0	2.3	1.3	2.9	1.5	1.7	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.1	33.7	39.2	42.3	51.5	52.0	37.3	50.5	38.3	55.2	31.4	36.1	36.8	4.9	0.0	1.7	2.9	7.7	3.6	1.5	0.4	0.0	6.1	629.8	13.2	2495.2	2.8	1.3	27.6	2.1	3.8	2.1	0.4	452.0	0.4	2.5	0.4	0.5	25.6	0.0	0.0	16.1	0.4	1.4	67.2	1.1	3.1	1.3	43.8	2.2	0.1	114.7	8.4	14.6	0.1	0.0	27.8	10.3	5.4	6.8	19.1	8.8	3.7	0.0	2.6	0.0	3.5	8.9	0.3	12.3	7.9	0.1	6.8	0.1	703.6	1.5	10.2	0.0	14.9	40.7	2.9	0.2	0.2	3.0	1.6	5.1	97.9	0.3	36.5
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3787.4;breast: 2195.7"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3787.4	42.2	0.8	46.7	1.1	2.8	2195.7	0.9	1.6	9.9	34.8	52.9	2.8	4.6	0.6	15.1	10.9	68.1	121.8	1.2	0.8	7.0	5.1	113.5	13.6	0.8	0.8	4.2	16.6	59.1	1.4	186.9	0.8	4.3	33.5	2.6	58.8	5.0	66.7	65.2	44.7	14.2	0.7	6.7	26.5	1.1	3.8	29.8	83.0	166.7	2.0	242.7	18.9	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	1.6	1.2	0.8	0.8	0.8	0.8	0.7	3.8	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"intestine: 4531.3"	"Cell type enriched"	"Detected in some"	23	"Proximal enterocytes: 52213.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	NA	NA		890000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.0	14.4	7.9	2.5	8.1	0.1	0.2	8.3	11.7	3.1	8.7	3.3	4.9	1.9	0.0	1.2	53.9	0.2	2.2	7.4	11.2	0.2	0.1	5.3	4.2	8.9	8.5	0.1	0.1	0.0	0.7	0.1	10.4	0.2	0.0	0.9	0.2	0.2	0.0	0.4	4531.3	3.4	9.4	1.5	0.4	3.1	9.4	5.6	0.1	1.4	3.5	2.7	0.4	7.7	0.3	0.6	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	8.1	1.3	31.6	30.5	0.0	0.3	0.0	0.0	0.0	0.0	13.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	2.3	1.2	0.4	0.0	0.0	0.0	17.0	0.1	0.0	2.9	0.0	1.0	17.2	0.0	15.2	2.8	0.7	0.0	8.8	0.2	0.1	0.2	0.2	0.0	0.0	0.1	15.3	1.7	1.7	6.9	4.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.1	8.3	11.7	7.4	11.2	8.9	8.5	10.4	9.4	9.4	7.7	0.0	0.0	1.5	1.3	0.2	0.5	0.3	7.8	0.6	0.2	0.1	0.1	3.4	0.0	21.9	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.4	110.2	0.6	0.1	0.0	0.0	1.6	0.0	0.3	0.6	0.0	1.4	0.0	0.6	0.0	0.0	0.1	1.7	2.2	2244.4	2.0	0.0	4.2	0.2	0.3	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.3	2080.0	0.0	0.0	0.1	52213.9	0.1	134.9	0.7	0.0	0.0	1.2	0.1	2.1	2.0	0.1	0.0	0.1	1.7	1304.0	1.4
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FABP9	"PERF, PERF15, T-FABP"	ENSG00000205186	"Fatty acid binding protein 9"	Q0Z7S8	8	81458253-81461579	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"skin 1: 40.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073619	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA073619: AB_2732229"															"unprognostic (2.99e-1)"			1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	40.9	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203296-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 75.0;Ductal cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 331.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (7.29e-2)"	9.8	13.8	10.6	14.0	10.5	8.8	13.6	10.9	10.1	13.1	10.6	14.8	14.1	12.6	17.6	14.3	13.2	12.1	8.4	9.9	10.8	14.2	16.0	10.6	16.9	12.6	10.8	12.5	8.2	9.1	6.4	15.3	11.6	9.2	12.8	4.0	11.3	13.4	10.9	12.5	13.9	10.3	11.2	13.2	14.8	5.7	11.4	20.3	11.3	9.0	16.9	11.4	9.2	11.3	331.2	54.7	26.6	24.3	31.6	25.4	23.8	55.3	43.6	47.5	31.6	47.1	52.3	48.7	51.9	37.1	44.8	47.7	26.3	49.3	36.8	45.7	28.8	22.3	30.6	24.3	28.5	28.0	28.4	25.4	34.5	51.4	64.7	38.1	45.3	26.7	37.0	24.4	42.1	48.5	34.4	49.5	42.1	75.1	89.1	26.3	64.3	47.0	46.8	24.1	23.5	22.3	41.0	38.0	117.1	30.3	41.3	30.7	51.0	36.6	35.7	56.7	53.9	33.8	27.8	28.6	53.2	28.0	52.6	37.1	36.2	28.2	41.7	38.4	47.5	38.7	44.1	48.9	37.1	33.9	44.6	40.7	88.6	37.7	45.3	33.7	45.7	36.1	10.6	10.5	10.9	10.1	9.9	10.8	12.6	10.8	11.6	11.2	11.4	11.3	7.8	0.0	5.3	0.7	12.1	11.9	14.8	18.1	6.2	6.8	14.0	15.7	0.1	14.3	7.7	18.4	0.0	75.0	9.3	22.9	21.5	55.9	0.7	7.3	11.7	15.6	2.4	19.8	1.4	34.7	37.3	10.0	12.8	10.6	1.3	13.8	14.6	8.5	31.2	3.3	1.6	14.3	0.0	11.0	8.8	2.4	13.4	10.8	32.0	2.8	20.9	10.0	18.6	0.5	1.4	49.0	15.3	16.6	9.6	11.8	24.5	33.7	5.4	4.1	0.0	5.2	14.5	10.4	14.2	14.4	10.5	30.8	13.3	18.9	17.4	14.4
FADS1	"D5D, FADS6, FADSD5, LLCDL1, TU12"	ENSG00000149485	"Fatty acid desaturase 1"	O60427	11	61799627-61829318	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 521.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042705	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042705: AB_10795709"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.95e-9)"	"unprognostic (2.29e-2)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (2.79e-4)"	"prognostic unfavorable (1.33e-4)"	26.2	67.7	43.1	19.8	39.2	9.7	13.6	38.4	40.7	19.6	70.7	9.5	5.5	21.3	6.6	5.2	17.4	14.5	22.6	39.3	58.5	9.7	52.8	20.3	9.8	57.9	62.1	27.5	10.0	27.2	21.3	21.1	52.2	19.6	4.9	35.1	6.4	15.8	17.5	15.5	6.7	20.5	46.4	8.0	9.4	11.9	68.7	8.1	6.0	7.8	9.2	12.7	10.2	56.0	66.3	170.1	159.1	41.1	313.2	521.2	46.4	42.0	204.5	69.9	118.9	53.3	143.2	2.3	43.4	60.5	177.2	84.7	130.8	114.1	51.7	12.2	18.4	107.9	191.2	98.9	169.1	23.4	10.4	238.1	38.3	154.7	74.7	73.8	64.1	104.7	59.9	118.6	70.1	18.6	78.6	23.6	94.2	5.5	63.0	85.4	162.5	231.2	81.5	29.0	80.7	89.6	106.7	1.7	90.0	58.4	38.6	98.6	62.1	71.8	70.8	74.2	50.6	112.9	111.3	55.4	42.6	108.9	61.4	7.5	33.2	6.2	12.1	40.4	2.6	2.5	4.0	4.9	28.0	8.7	2.3	5.4	2.6	6.9	17.4	23.6	2.9	15.7	43.1	39.2	38.4	40.7	39.3	58.5	57.9	62.1	52.2	46.4	68.7	56.0	10.3	6.4	77.9	28.7	3.2	2.7	2.5	48.5	1.2	78.9	2.6	3.7	30.4	8.6	25.3	12.9	27.1	9.5	12.4	0.9	0.0	15.2	8.7	4.9	30.7	16.6	9.7	46.3	9.4	33.4	50.0	34.9	6.1	7.8	37.9	65.3	9.3	74.5	37.2	69.0	14.7	0.6	16.2	21.7	21.0	16.4	29.8	27.6	32.0	12.2	32.0	70.5	6.2	13.6	27.4	7.6	0.0	21.4	2.1	6.4	0.1	1.1	8.0	91.9	0.0	40.3	31.9	6.5	17.5	2.3	1.4	9.3	5.5	75.2	1.4	1.6
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 364.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Endometrial stromal cells: 57.7;Hepatocytes: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1141.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.42e-4)"	23.7	364.1	140.2	34.7	126.7	28.0	59.6	128.5	135.0	68.0	157.0	24.2	31.9	86.3	27.7	10.6	34.6	20.2	27.7	131.8	164.8	20.3	126.7	33.4	16.5	175.1	186.2	29.1	9.8	80.0	50.8	40.6	155.1	97.7	13.2	41.5	24.3	188.7	12.3	131.6	15.9	125.3	152.0	11.5	14.1	27.8	222.9	34.1	10.4	8.8	31.2	24.6	27.9	134.2	14.6	492.6	655.8	345.0	551.3	1141.8	167.2	86.3	658.3	109.0	288.2	31.4	149.6	3.8	11.4	172.3	167.8	15.7	436.4	709.5	52.7	6.9	11.8	297.9	106.5	72.0	421.9	18.9	15.9	430.9	25.8	383.4	39.1	170.3	324.4	254.4	17.9	212.1	52.0	13.5	166.4	104.7	291.5	0.7	150.1	206.1	13.9	663.1	392.1	4.4	197.4	260.8	49.9	1.4	23.5	164.0	21.5	197.7	139.2	14.0	120.5	9.8	13.1	115.7	110.3	39.7	13.0	96.3	131.2	4.4	6.0	6.9	8.5	8.7	2.0	1.4	3.1	4.6	10.1	3.7	1.8	3.8	2.8	6.6	7.4	13.0	2.9	4.9	140.2	126.7	128.5	135.0	131.8	164.8	175.1	186.2	155.1	152.0	222.9	134.2	3.2	9.6	18.8	69.9	2.0	1.7	1.3	26.9	0.0	9.1	4.7	3.0	4.2	1.5	15.1	3.7	4.2	1.7	5.2	0.5	0.0	6.9	2.2	4.7	57.7	12.2	5.4	26.7	7.4	17.8	22.0	21.0	5.1	9.5	5.1	28.3	2.5	55.8	20.5	5.0	7.7	0.2	22.4	7.2	3.1	5.3	25.7	7.0	8.8	15.0	20.7	32.1	8.2	38.7	11.9	5.1	0.0	23.7	1.4	16.9	0.1	0.7	5.4	13.2	0.0	23.8	29.5	1.3	0.5	1.2	0.6	3.1	2.5	28.3	2.0	0.9
FADS3	"CYB5RP, LLCDL3"	ENSG00000221968	"Fatty acid desaturase 3"	Q9Y5Q0	11	61873519-61892051	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.6;Extravillous trophoblasts: 138.4;Rod photoreceptor cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.7;naive B-cell: 8.7"	"Group enriched"	"Detected in many"	4	"B-cells: 8.7;granulocytes: 5.7;T-cells: 2.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 283.2;HHSteC: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045224	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"		"HPA045224: AB_10967570"	"unprognostic (4.69e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (1.76e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.50e-9)"	"unprognostic (1.14e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-1)"	105.0	72.3	37.1	23.4	37.3	5.1	72.5	29.6	50.7	31.2	55.3	27.5	4.8	27.9	31.7	9.5	26.7	12.1	88.9	36.9	35.2	29.4	23.7	45.4	21.6	34.8	33.7	35.7	25.4	11.4	14.1	64.0	38.9	21.3	4.6	15.0	14.3	13.1	45.2	13.4	28.1	19.4	29.8	22.3	22.7	13.4	37.3	4.3	18.1	14.8	20.9	36.7	21.4	35.3	37.3	11.4	3.6	22.5	283.2	57.0	71.5	73.1	177.9	77.0	73.7	16.2	13.3	27.5	46.5	147.1	60.0	20.1	13.7	199.4	40.8	7.9	7.6	22.7	48.9	32.8	243.6	2.1	4.5	62.5	85.2	92.4	175.4	46.8	90.1	14.3	22.2	50.8	132.6	42.7	8.3	11.3	10.7	4.1	29.4	46.4	142.8	76.8	86.0	13.0	5.7	7.2	83.4	11.2	77.9	29.9	16.4	5.0	61.2	74.5	51.1	22.0	32.6	15.5	8.0	35.0	62.4	11.2	55.2	0.0	0.7	5.7	1.6	1.2	1.4	7.7	1.4	2.1	0.6	8.7	0.1	0.5	0.3	0.6	0.8	0.0	0.4	0.6	37.1	37.3	29.6	50.7	36.9	35.2	34.8	33.7	38.9	29.8	37.3	35.3	164.6	32.1	5.2	54.5	39.0	6.8	8.2	15.6	2.8	11.2	23.3	26.2	19.5	18.6	2.0	5.5	8.4	38.9	15.2	35.7	1.9	46.4	17.4	8.2	31.2	57.7	6.7	13.0	31.6	20.6	138.4	31.3	16.8	13.1	7.0	12.4	20.3	9.8	19.7	1.7	10.0	21.0	0.0	3.9	43.0	14.0	28.6	16.5	35.6	8.4	8.0	48.5	5.2	17.1	17.6	16.4	6.7	17.7	13.1	10.7	6.3	13.9	2.9	120.3	19.7	97.3	90.2	2.0	5.5	3.5	5.5	68.0	17.6	16.1	15.8	4.3
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877302-74893781	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 10.7;epididymis: 18.2;intestine: 14.8"	"Cell type enriched"	"Detected in some"	13	"Proximal enterocytes: 72.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.2	7.1	4.5	0.5	3.5	1.5	0.5	6.6	9.1	0.6	0.0	0.8	7.5	0.2	18.2	3.2	0.1	0.0	0.2	2.0	2.0	1.1	6.1	0.2	0.6	10.2	2.4	0.3	0.4	0.5	0.1	0.2	10.7	0.1	0.7	1.2	0.3	0.3	0.4	7.7	14.8	0.2	0.9	4.1	0.2	0.7	5.1	0.4	0.4	0.2	0.8	1.2	1.1	3.6	0.2	0.3	0.5	0.4	0.0	1.0	0.7	0.5	0.0	0.1	0.2	0.8	0.3	0.3	0.1	0.5	0.3	0.3	0.7	0.0	0.2	0.1	0.0	0.5	1.6	0.6	0.3	0.4	0.4	0.3	0.0	1.1	0.4	0.2	0.0	0.4	0.4	1.4	0.6	0.6	0.3	1.1	0.3	0.2	0.5	0.2	0.1	0.5	0.3	0.3	0.4	0.4	0.5	0.2	0.1	0.5	0.2	0.5	0.3	0.3	0.7	0.6	0.5	0.5	0.2	0.3	1.0	0.3	0.5	1.1	0.6	0.4	0.2	0.6	0.2	0.3	0.3	0.3	0.1	0.5	0.3	0.4	2.0	0.8	1.5	0.5	0.2	0.0	4.5	3.5	6.6	9.1	2.0	2.0	10.2	2.4	10.7	0.9	5.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	1.8	1.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	3.7	0.0	0.0	0.8	0.0	0.1	0.3	0.0	0.0	5.2	0.2	0.1	0.3	0.0	0.2	0.0	1.1	0.4	4.0	0.3	1.7	5.4	1.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	5.1	0.0	0.0	1.1	72.2	1.9	0.0	0.5	0.0	1.1	0.4	0.0	2.0	1.7	0.6	3.8	0.2	0.4	0.7	1.3
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636"	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	15.5	19.7	13.5	15.0	14.1	21.7	17.5	15.0	17.0	16.9	18.1	16.8	15.0	18.6	17.5	16.7	17.3	14.6	11.4	14.0	14.9	14.7	21.0	15.4	16.3	13.5	14.4	20.0	16.2	24.9	14.7	16.7	14.6	18.2	19.2	22.6	16.4	14.7	11.6	19.4	14.7	18.8	13.3	14.9	14.5	21.0	14.7	23.1	19.5	12.8	18.7	18.0	13.1	13.5	36.9	41.1	39.9	44.4	55.4	43.9	54.6	47.2	53.8	52.7	56.6	53.9	64.9	32.1	52.0	50.2	95.6	55.5	57.8	119.6	72.3	128.7	31.8	21.1	40.7	26.4	56.3	46.2	26.4	58.1	51.6	64.5	53.2	34.0	44.3	35.8	30.7	42.6	50.8	61.2	40.6	24.2	32.4	39.8	34.4	39.5	34.7	35.9	44.7	48.0	35.3	37.7	57.5	49.4	52.9	34.1	58.1	36.2	49.9	71.9	38.8	40.1	63.8	36.2	41.6	41.2	45.4	32.5	64.2	9.0	6.8	4.7	6.8	5.6	8.3	4.9	5.6	7.3	8.0	4.8	7.1	6.4	5.6	9.2	12.1	5.3	9.8	5.7	13.5	14.1	15.0	17.0	14.0	14.9	13.5	14.4	14.6	13.3	14.7	13.5	26.4	28.9	54.5	26.8	19.6	5.4	34.4	49.7	16.5	46.3	18.6	18.7	13.4	15.7	44.9	18.4	45.9	34.8	19.2	17.6	11.7	34.0	12.1	24.6	41.0	29.0	19.9	17.5	29.0	37.2	40.8	32.6	23.4	27.6	32.2	32.6	28.2	24.3	22.5	15.2	34.2	15.1	34.6	16.1	8.0	5.6	30.4	17.9	12.4	14.0	23.3	39.6	26.8	31.7	36.1	59.1	12.0	31.2	22.0	32.3	17.3	9.3	41.3	29.9	26.3	36.3	36.6	59.8	51.3	16.6	8.5	57.9	18.4	43.2	17.1	29.0
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAHD2A	CGI-105	ENSG00000115042	"Fumarylacetoacetate hydrolase domain containing 2A"	Q96GK7	2	95402708-95416616	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 101.7;Hepatocytes: 99.3;Proximal enterocytes: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042145, HPA044987, CAB045971, CAB045972"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB045971: AB_11126570, CAB045972: AB_11140511, HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.52e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.77e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.55e-2)"	21.0	22.1	22.6	8.7	24.2	14.7	21.8	25.5	29.7	18.4	18.8	18.3	32.4	19.0	5.3	13.3	17.8	10.9	39.3	23.5	22.4	28.6	114.8	13.9	10.9	22.3	22.4	22.6	30.0	18.1	12.3	10.8	22.7	15.5	13.9	5.9	86.2	12.2	37.8	18.5	25.4	15.3	21.2	14.6	26.1	29.9	23.3	18.6	37.8	57.9	12.2	14.3	15.7	27.6	30.2	27.9	31.7	20.4	34.4	31.1	22.4	28.2	47.5	32.5	51.6	17.6	12.9	18.5	12.1	29.1	41.0	16.2	22.8	25.7	32.3	16.0	27.9	14.9	13.2	29.1	44.3	22.8	8.2	29.9	28.6	30.0	37.9	51.6	43.2	35.6	21.6	41.1	41.6	36.6	40.6	31.1	10.2	17.6	27.2	29.9	20.0	52.0	36.3	12.1	18.9	9.3	16.8	27.0	33.2	39.3	16.9	9.0	20.4	41.2	28.3	17.6	19.6	44.0	20.3	18.8	28.0	20.5	20.9	3.3	15.7	8.1	18.2	17.8	20.7	15.5	16.7	17.6	23.3	10.4	16.8	14.2	1.0	12.3	9.0	27.3	19.6	14.4	22.6	24.2	25.5	29.7	23.5	22.4	22.3	22.4	22.7	21.2	23.3	27.6	14.6	9.6	12.5	10.7	13.8	9.8	13.8	14.6	21.1	17.6	26.6	26.4	36.8	28.6	16.8	29.5	10.4	30.3	16.6	14.4	70.5	29.5	101.7	11.2	10.5	13.9	4.9	14.5	15.2	23.1	14.7	21.4	21.9	7.7	4.5	32.7	16.4	99.3	26.0	16.8	13.2	17.3	10.2	12.0	8.3	87.1	37.0	11.0	17.8	2.8	19.8	22.2	13.4	3.5	10.8	18.7	17.3	52.3	23.9	15.4	104.6	52.7	15.0	18.8	13.1	15.3	21.3	49.1	19.1	19.0	7.7	17.1	12.4	36.5	23.9	12.1
FAHD2B	DKFZp434N062	ENSG00000144199	"Fumarylacetoacetate hydrolase domain containing 2B"	Q6P2I3	2	97083583-97094882	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 235.0;Late spermatids: 212.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.8;NK-cells: 16.2;T-cells: 15.5"	"Low cell line specificity"	"Detected in many"											"HPA042145, HPA044987"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.55e-3)"	"unprognostic (5.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (9.03e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.84e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.04e-1)"	10.7	7.1	24.5	3.2	28.2	3.5	12.8	29.5	25.2	16.6	21.1	14.5	2.5	17.6	38.1	7.4	17.2	4.2	30.0	23.7	28.8	12.6	4.0	7.9	5.7	27.8	25.8	23.6	14.4	11.1	10.3	1.7	28.9	10.9	5.5	6.8	10.8	6.8	30.3	13.6	8.2	11.2	29.6	6.8	24.7	46.8	28.6	4.2	3.9	45.9	7.7	14.3	12.2	33.1	5.0	6.0	8.2	16.8	8.0	9.5	13.0	4.3	5.0	7.3	6.7	5.6	7.7	9.6	3.7	1.7	13.7	5.2	12.0	9.6	4.1	12.5	22.1	10.5	7.6	4.5	25.6	11.9	6.5	12.8	10.0	0.9	15.5	3.4	7.8	37.0	18.3	22.9	0.5	0.0	14.5	35.5	8.1	2.2	16.7	14.0	2.3	34.5	8.1	8.3	1.8	7.1	14.7	3.8	21.5	15.3	16.1	9.4	1.3	0.8	13.7	1.0	4.2	15.1	21.1	25.4	1.2	30.5	10.1	0.0	0.2	0.2	11.3	0.3	15.5	8.8	11.0	11.1	1.8	4.2	7.5	9.7	0.2	16.2	0.1	2.9	15.0	4.8	24.5	28.2	29.5	25.2	23.7	28.8	27.8	25.8	28.9	29.6	28.6	33.1	8.2	6.4	11.1	11.1	6.1	6.5	11.5	5.9	9.6	6.3	17.9	21.0	42.3	4.3	8.0	5.5	2.1	2.1	5.8	1.1	27.4	7.3	235.0	2.3	6.5	7.8	1.8	5.5	10.4	4.3	1.0	13.5	30.1	1.2	5.7	18.5	8.2	2.3	3.5	5.0	12.1	3.3	6.1	1.6	2.6	212.6	17.1	2.2	30.2	2.8	1.6	21.7	9.2	2.5	8.0	6.9	1.2	17.0	17.3	7.7	0.2	3.8	4.6	5.8	0.0	9.7	10.5	24.5	7.3	7.3	7.1	1.0	8.2	11.1	4.4	8.3
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 235.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 173.3;Rod photoreceptor cells: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 135.7"					"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	18.3	8.6	16.8	6.9	17.9	4.1	15.6	17.5	21.3	31.7	14.9	9.3	6.4	12.6	19.5	12.2	38.2	12.1	6.4	16.2	18.6	15.3	8.2	10.5	10.8	18.9	17.7	10.8	38.1	8.5	10.4	8.4	19.4	14.9	7.9	235.0	9.6	21.7	5.4	8.5	6.1	9.7	19.2	4.9	9.8	7.3	17.1	19.8	20.3	5.5	13.7	13.5	10.4	19.9	80.8	15.5	1.7	13.9	14.7	27.2	55.4	24.4	14.7	25.2	21.5	26.8	23.2	0.2	21.0	32.0	29.0	20.9	66.8	13.9	28.2	66.2	69.8	15.1	42.9	39.1	16.3	0.0	4.8	38.4	26.5	9.4	14.4	15.4	27.5	5.7	10.0	20.0	15.8	30.7	0.4	68.3	30.1	2.5	15.3	81.4	18.0	2.1	40.4	39.5	26.0	22.1	43.2	23.8	64.6	16.4	40.1	20.0	16.9	5.1	11.9	25.9	12.0	0.0	0.4	135.7	20.8	0.2	21.0	16.8	2.9	2.2	10.5	3.3	9.6	17.0	5.8	8.4	6.3	12.0	3.8	9.8	0.4	18.8	2.2	4.3	6.9	4.3	16.8	17.9	17.5	21.3	16.2	18.6	18.9	17.7	19.4	19.2	17.1	19.9	16.4	19.2	22.9	9.1	12.7	10.8	30.3	35.2	14.2	31.9	14.3	21.5	5.3	68.6	32.4	25.8	66.7	42.0	14.7	5.9	31.3	63.1	12.0	173.3	29.8	14.5	21.1	7.2	7.7	50.0	33.3	16.8	8.2	41.3	41.2	17.2	8.9	9.4	25.2	15.2	6.1	8.8	14.2	3.2	5.7	16.5	17.4	6.5	16.0	1.9	15.6	45.3	21.6	11.1	16.5	31.3	4.4	19.9	14.2	22.1	2.2	28.1	77.5	228.3	0.0	25.0	22.6	14.1	4.2	16.6	13.1	14.6	10.8	14.6	11.7	21.6
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 44.8;testis: 153.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1305.1;Late spermatids: 1771.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	16.6	11.7	13.1	14.1	13.0	44.8	15.3	16.9	14.0	14.4	11.1	14.7	12.6	11.7	12.5	17.8	11.1	10.4	12.4	12.9	11.3	10.8	13.9	12.8	17.8	12.0	11.5	12.2	15.0	12.2	16.0	17.8	11.5	14.1	12.4	14.0	12.3	11.1	17.1	21.6	12.8	11.2	11.4	17.0	21.7	153.0	12.6	20.9	11.8	12.0	16.9	13.4	14.8	13.7	41.8	33.5	16.7	31.0	24.7	23.1	54.1	33.4	34.7	35.9	36.9	28.3	26.3	24.3	26.7	32.2	35.0	26.0	21.4	24.3	38.7	28.6	28.7	35.4	29.1	43.5	32.9	31.1	58.1	24.6	31.6	31.9	23.2	23.7	42.6	28.8	28.0	39.6	43.6	28.5	55.7	21.5	22.9	30.7	42.5	30.1	46.3	23.5	27.6	33.7	27.3	36.1	19.6	28.2	36.7	31.0	39.4	31.8	29.8	42.3	49.1	29.1	39.4	38.5	41.5	29.8	37.9	33.7	31.9	72.4	49.4	87.7	57.1	44.6	55.5	53.5	69.6	65.7	48.8	55.8	50.1	60.9	81.9	68.9	49.8	31.7	128.5	82.5	13.1	13.0	16.9	14.0	12.9	11.3	12.0	11.5	11.5	11.4	12.6	13.7	37.1	9.6	10.2	7.5	24.2	57.0	20.7	42.3	17.6	17.7	22.5	21.1	5.6	22.8	26.9	22.0	6.2	122.3	23.0	20.8	31.3	32.7	1305.1	21.9	16.0	23.9	19.8	103.6	14.2	25.3	70.1	19.4	28.5	24.6	29.2	20.4	18.2	18.5	35.6	26.9	14.1	22.9	26.4	21.8	34.2	1771.9	35.1	25.5	24.9	10.3	32.2	20.2	33.0	10.6	11.3	32.1	20.1	24.0	30.4	32.8	26.4	18.9	27.4	19.7	6.6	14.8	43.7	277.3	60.7	29.9	65.8	324.9	32.7	21.3	20.7	51.8
FAM104B	"CXorf44, FLJ20434"	ENSG00000182518	"Family with sequence similarity 104 member B"	Q5XKR9	X	55143102-55161310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 238.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049082	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA049082: AB_2680625"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.23e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.35e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.81e-3)"	"unprognostic (9.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-3)"	11.1	16.1	28.1	10.9	30.9	12.6	17.1	29.8	37.8	23.2	26.0	20.4	8.4	20.3	49.0	14.7	46.0	10.3	16.5	28.2	29.3	37.8	18.9	14.1	15.2	29.7	28.8	18.4	10.5	27.7	15.1	11.3	29.9	13.5	16.3	30.6	10.8	16.8	20.5	17.5	10.5	16.4	28.9	10.7	13.5	15.0	29.4	19.9	33.8	22.4	16.3	16.6	13.3	33.0	26.9	20.9	24.3	22.2	16.4	21.3	7.2	13.8	10.2	14.2	12.2	12.4	23.9	12.8	28.5	12.6	25.4	18.6	36.7	21.4	22.7	12.1	36.7	17.5	23.7	14.9	13.2	23.1	14.4	18.6	18.7	22.7	17.5	16.7	17.3	26.3	22.7	17.7	18.2	23.9	30.9	21.7	36.1	25.1	37.4	17.6	30.8	30.5	41.1	29.0	31.3	25.3	23.0	17.9	28.0	35.4	34.4	15.2	17.2	16.5	21.7	40.8	18.2	13.1	12.6	12.2	21.0	40.3	14.5	12.7	16.1	11.0	14.5	22.6	15.7	17.8	16.6	17.5	22.6	14.9	18.9	18.6	7.9	17.9	19.5	21.9	19.1	12.7	28.1	30.9	29.8	37.8	28.2	29.3	29.7	28.8	29.9	28.9	29.4	33.0	13.3	41.7	17.2	6.5	12.2	15.2	19.2	60.3	18.8	8.0	22.6	26.7	49.0	22.8	24.4	25.8	0.0	35.9	10.6	21.3	45.0	35.6	134.0	63.6	19.9	16.7	18.8	51.1	7.4	29.4	52.8	23.0	9.2	18.5	50.0	14.2	16.4	26.0	33.3	5.0	7.3	25.3	26.4	16.2	15.4	238.3	19.6	14.3	26.6	8.4	12.7	27.2	20.6	10.6	10.7	18.4	47.6	22.2	11.5	15.3	12.2	115.4	96.9	12.5	19.7	17.1	23.4	31.6	22.2	23.6	25.3	27.2	13.8	27.7	26.6	20.9
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 1923.8;choroid plexus: 1389.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.3;Astrocytes: 81.9;Endothelial cells: 121.3;Hepatic stellate cells: 150.6;Muller glia cells: 125.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 20.7;HUVEC TERT2: 64.9"	"Low region specificity"	"Detected in all"							HPA055888	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA055888: AB_2682957"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	73.2	7.5	1824.7	8.3	1801.2	0.3	58.6	1490.8	1923.8	34.5	1389.1	36.9	5.4	36.3	53.3	29.2	87.0	16.0	140.4	1745.7	1736.7	45.0	5.5	93.2	3.1	1611.9	1644.5	11.8	23.3	5.9	109.6	29.4	1613.0	80.5	16.0	85.1	40.6	38.0	26.3	23.3	45.2	42.5	1564.5	25.7	37.7	5.7	1698.7	43.9	51.4	32.8	8.6	68.9	41.6	1770.4	0.0	0.0	0.9	0.0	20.7	1.3	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.1	5.8	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.1	0.1	0.3	64.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	3.6	0.3	0.2	0.2	0.1	0.1	0.0	0.1	1.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1824.7	1801.2	1490.8	1923.8	1745.7	1736.7	1611.9	1644.5	1613.0	1564.5	1698.7	1770.4	196.3	6.4	5.5	81.9	0.5	2.2	50.8	0.3	2.2	5.2	2.3	1.3	26.5	4.3	3.2	38.6	52.1	0.1	0.4	0.0	9.8	1.1	14.5	23.2	2.4	121.3	3.6	2.7	1.4	0.2	0.0	18.4	0.0	39.3	1.3	5.9	150.6	1.6	0.0	3.3	5.3	0.0	0.0	2.2	3.7	32.4	32.9	1.9	5.4	14.0	0.0	125.0	0.0	2.0	0.6	0.3	0.0	11.7	1.3	7.3	0.2	4.5	2.3	50.2	6.6	6.6	10.4	0.7	0.4	0.4	2.7	0.0	1.0	0.5	0.0	2.2
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 526.5;Proximal tubular cells: 359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2"	"Cell line enhanced"	"Detected in all"		"Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4"	"Low region specificity"	"Detected in all"							"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		15000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	48.4	44.7	82.3	90.2	150.8	171.5	44.3	112.4	112.5	42.2	90.8	64.2	32.7	48.2	11.4	22.8	20.6	66.1	11.1	84.2	102.1	119.6	147.3	64.8	152.3	136.8	125.9	7.3	70.6	70.0	21.3	22.2	130.7	27.6	42.5	15.2	68.6	113.7	3.5	22.2	55.9	31.4	95.5	50.6	122.8	37.3	118.7	48.0	12.6	9.3	134.0	66.7	17.1	223.6	60.8	129.1	50.3	3.4	7.6	1.7	21.3	59.7	85.8	35.9	25.6	79.9	49.9	373.0	52.8	27.5	13.4	18.6	16.1	36.4	63.5	449.6	13.9	10.3	55.6	95.0	26.7	136.6	23.3	4.2	28.0	14.9	7.2	42.4	154.6	72.5	1.1	309.6	28.2	15.6	33.6	39.5	12.5	72.7	28.2	240.8	39.1	140.2	81.9	39.0	18.7	53.5	23.6	12.4	39.0	44.7	46.0	294.4	50.8	37.0	31.2	118.3	20.3	136.2	131.7	241.3	6.5	117.5	10.1	52.3	6.0	63.8	100.2	7.1	97.7	12.4	79.4	85.0	5.2	12.6	105.7	106.2	25.2	53.8	14.9	3.5	78.0	74.8	82.3	150.8	112.4	112.5	84.2	102.1	136.8	125.9	130.7	95.5	118.7	223.6	12.8	105.8	44.4	7.2	203.6	89.7	147.1	25.4	16.5	4.8	94.6	30.4	4.1	134.4	52.5	286.9	2.1	18.1	194.7	65.9	223.0	44.3	27.0	234.9	98.7	37.8	14.3	22.7	1.6	106.8	38.2	49.7	175.3	268.2	119.2	32.7	72.8	177.4	37.1	201.9	7.3	110.5	36.7	53.9	120.9	53.2	2.5	110.7	51.6	15.0	68.8	13.6	198.8	11.1	526.5	90.3	44.3	4.9	176.6	139.6	25.9	359.9	85.3	15.0	0.0	5.4	64.6	56.2	35.7	8.3	82.3	62.5	237.7	3.8	39.9	240.2
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 71.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 543.5;monocytes: 248.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 84.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB034110: AB_1562838, HPA069240: AB_2686103"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	4.2	5.5	4.2	5.9	5.2	8.8	9.0	3.1	3.6	10.1	3.9	5.5	10.0	2.5	4.7	39.3	2.5	2.3	4.0	2.8	3.4	8.8	3.6	12.3	6.7	5.5	5.3	2.8	5.5	11.0	7.9	6.6	5.6	19.3	3.2	1.2	18.4	3.6	4.0	71.2	9.7	1.1	3.3	23.4	6.1	3.7	6.6	6.9	7.6	0.6	7.8	9.2	18.4	3.6	27.7	7.3	4.1	7.6	4.4	1.9	27.8	8.5	4.7	5.3	4.7	16.0	16.9	8.9	3.7	5.3	7.6	43.7	3.3	22.2	4.4	7.3	2.3	18.6	4.9	4.2	2.0	5.1	6.3	1.2	27.1	7.3	7.1	1.6	3.6	8.1	10.2	21.5	4.9	16.4	14.3	13.8	5.3	17.7	12.3	14.1	7.0	11.7	4.1	19.6	7.7	9.1	7.4	84.0	3.8	1.7	34.9	7.5	4.8	12.6	9.1	11.5	9.6	7.8	7.3	3.8	2.0	13.2	9.2	543.5	28.3	163.4	13.2	160.6	11.7	7.0	23.7	27.2	36.2	11.7	28.1	27.9	15.3	6.9	248.6	3.9	43.0	24.2	4.2	5.2	3.1	3.6	2.8	3.4	5.5	5.3	5.6	3.3	6.6	3.6	3.5	0.0	7.0	0.0	18.5	32.6	17.0	31.6	71.7	0.3	26.7	20.1	2.9	7.2	15.7	11.0	0.0	41.5	24.3	5.1	1.9	10.1	9.9	3.0	1.7	8.0	10.8	16.2	0.5	6.0	138.2	3.6	5.1	5.2	51.5	1.4	17.2	0.7	20.0	5.0	0.4	8.8	16.2	36.7	74.2	24.3	3.4	70.0	7.2	1.9	29.9	0.3	25.7	0.5	0.1	13.4	7.8	1.9	3.5	20.9	16.1	2.4	7.4	2.6	6.6	1.1	4.3	3.4	4.9	57.7	36.8	31.3	26.1	14.2	10.4	24.6
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Inhibitory neurons: 195.6;Oligodendrocyte precursor cells: 253.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 13.4;intermediate monocyte: 3.5;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.4;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favorable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.6	1.3	14.1	1.9	11.5	2.2	5.2	18.1	12.0	7.9	8.1	6.6	0.8	5.7	2.2	1.3	5.0	2.7	15.7	15.2	18.1	5.6	5.6	3.8	0.7	11.7	11.2	5.3	1.6	10.9	3.8	2.7	14.0	5.3	1.4	4.0	5.8	6.7	12.0	2.8	3.2	6.0	8.2	20.5	4.6	6.1	11.9	0.7	6.1	6.0	0.7	6.3	4.9	7.4	0.0	1.1	3.9	0.1	1.7	0.6	1.5	7.5	8.6	5.1	2.3	0.0	0.1	0.0	1.4	5.3	4.6	0.0	3.5	0.0	3.9	0.0	3.6	0.7	1.1	4.5	5.8	1.0	0.2	6.1	1.4	0.2	3.2	0.6	0.0	1.7	0.0	0.1	3.9	0.1	0.0	2.7	3.7	5.3	1.6	0.0	4.3	0.0	12.8	0.8	3.7	4.1	0.0	0.5	0.2	4.5	3.4	0.4	0.0	3.6	2.3	0.0	2.6	1.6	0.0	0.0	1.7	0.0	4.3	0.0	1.4	13.4	0.0	3.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.0	6.8	0.0	0.1	0.7	14.1	11.5	18.1	12.0	15.2	18.1	11.7	11.2	14.0	8.2	11.9	7.4	4.2	0.0	5.5	39.2	0.5	9.8	22.8	0.2	3.4	10.6	8.9	6.6	27.7	1.5	0.9	23.9	2.1	1.7	0.1	0.1	7.9	8.7	5.8	1.0	10.9	7.5	7.2	0.0	37.5	2.9	21.9	28.1	9.2	2.5	4.5	5.4	14.6	8.0	4.9	6.7	195.6	0.2	4.1	8.7	10.2	2.2	9.9	6.6	16.0	43.1	1.3	20.1	0.0	253.8	9.2	1.7	0.1	14.7	0.2	17.4	0.0	8.8	0.7	6.6	32.9	38.1	19.8	1.2	2.5	1.0	4.1	1.5	1.0	0.5	0.0	6.7
FAM110C		ENSG00000184731	"Family with sequence similarity 110 member C"	Q1W6H9	2	38814-46870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 248.8;Basal squamous epithelial cells: 90.0;Endometrial ciliated cells: 85.6;Glandular and luminal cells: 158.2;Urothelial cells: 236.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.3;HBEC3-KT: 10.3;hTCEpi: 10.1;RPTEC TERT1: 17.3;RT4: 24.5;SK-BR-3: 10.9"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.9"	"Low region specificity"	"Detected in some"			"HPA036144, HPA036145"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA036144: AB_10670710, HPA036145: AB_2674968"	"unprognostic (4.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.47e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.68e-1)"	11.1	3.4	2.0	1.8	3.2	0.1	5.3	0.0	2.5	8.7	3.3	8.4	10.9	3.9	20.7	32.8	8.7	8.4	3.2	2.5	0.5	16.5	17.5	3.3	0.2	1.1	0.5	6.5	14.3	5.3	4.0	0.2	0.7	4.2	10.1	1.1	5.8	19.8	0.1	9.9	9.6	1.8	0.6	0.3	7.5	3.6	1.2	1.9	5.8	0.3	2.2	11.1	15.4	1.7	5.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	8.3	0.0	6.3	0.0	0.3	13.3	0.0	10.3	0.0	0.8	0.4	0.0	1.8	1.1	0.0	0.0	0.0	0.0	10.1	0.0	1.7	0.0	0.0	9.1	0.0	0.0	0.0	9.0	6.0	0.1	1.2	6.1	3.2	0.0	0.0	0.0	17.3	24.5	0.6	0.0	0.0	10.9	0.0	1.0	3.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	2.0	3.2	0.0	2.5	2.5	0.5	1.1	0.5	0.7	0.6	1.2	1.7	0.1	0.0	5.8	2.3	0.2	22.9	248.8	12.1	90.0	0.1	9.5	4.7	5.8	27.1	17.4	35.0	0.0	0.0	0.7	40.1	19.6	13.5	0.2	85.6	14.2	1.6	29.8	0.0	2.7	5.3	0.0	4.4	10.2	158.2	0.0	57.3	0.7	13.4	0.1	3.3	0.7	35.8	6.1	0.3	0.7	0.9	2.1	1.6	0.0	0.0	0.0	2.2	1.0	0.0	0.3	9.0	38.6	1.9	1.4	23.1	14.6	13.3	4.3	0.1	0.0	0.1	3.4	0.5	0.2	71.8	30.1	0.0	2.6	0.1	11.1	236.0
FAM110D	"FLJ14050, GRRP1"	ENSG00000197245	"Family with sequence similarity 110 member D"	Q8TAY7	1	26159079-26163962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 82.7;Endothelial cells: 63.5;Hepatic stellate cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"TIME: 1.2;U-2 OS: 1.4;U-937: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013664	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013664: AB_1234332"	"unprognostic (7.53e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.16e-3)"	"unprognostic (7.67e-5)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (9.87e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-1)"	10.9	1.3	4.1	0.6	3.0	0.8	8.5	3.1	3.7	4.8	2.0	2.9	1.1	7.9	0.8	1.9	7.4	2.3	6.2	3.1	3.2	4.0	0.4	4.2	1.1	4.7	3.6	1.3	2.2	1.1	1.3	0.6	4.1	3.1	0.5	0.3	2.4	0.7	4.2	3.0	3.1	2.8	4.5	0.8	3.3	0.6	4.1	0.9	4.7	2.1	0.4	4.0	3.6	3.3	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.5	0.1	0.0	0.1	0.4	0.1	0.2	1.2	0.1	1.4	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.0	1.3	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	1.0	0.4	0.1	0.2	0.0	0.0	4.1	3.0	3.1	3.7	3.1	3.2	4.7	3.6	4.1	4.5	4.1	3.3	82.7	0.0	3.4	0.3	0.9	1.0	0.9	0.0	2.2	2.3	1.3	1.8	3.1	2.8	1.3	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.4	0.2	0.5	63.5	0.0	2.7	0.4	0.0	0.0	2.5	0.0	0.2	0.0	0.3	34.6	0.0	0.0	1.7	0.7	0.0	0.0	1.3	1.8	0.5	0.6	0.4	0.0	4.7	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	1.4	1.8	0.2	0.7	0.8	0.9	0.3	0.3	0.5	0.0	0.3
FAM111A	"FLJ22794, KIAA1895"	ENSG00000166801	"Family with sequence similarity 111 member A"	Q96PZ2	11	59142748-59155039	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	"DNA-binding, Hydrolase, Protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039529, HPA040176"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039529: AB_10795149, HPA040176: AB_10793958"	"unprognostic (4.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.39e-4)"	14.8	18.9	7.0	23.1	7.0	20.3	16.0	6.7	9.6	20.8	12.9	17.1	22.5	13.8	17.3	12.8	16.5	18.7	11.6	6.6	7.6	23.7	17.9	25.2	36.1	9.0	7.7	14.6	15.0	16.9	14.3	19.5	8.1	33.2	19.3	9.1	19.0	10.7	5.5	18.8	27.6	10.9	7.8	42.5	22.5	7.1	8.2	42.3	26.6	4.1	30.1	14.8	17.4	8.4	66.0	16.2	7.9	7.5	16.9	21.4	5.1	91.6	50.8	38.5	56.3	24.9	59.0	94.3	37.1	29.7	51.2	21.9	26.9	40.4	47.4	86.0	1.2	36.3	22.7	7.6	17.8	58.7	45.7	14.5	9.6	36.2	11.1	22.0	37.7	57.2	4.8	76.7	42.2	18.0	85.6	36.9	3.5	19.5	17.5	59.9	28.7	22.8	25.4	57.6	0.2	2.3	48.6	38.5	17.5	4.1	80.1	24.7	37.0	61.9	55.5	42.5	42.7	39.0	43.4	15.3	34.3	39.5	75.9	6.0	5.0	4.8	4.2	3.4	5.3	2.6	2.7	3.2	4.6	2.6	2.4	2.5	5.4	5.0	1.9	1.2	3.1	2.2	7.0	7.0	6.7	9.6	6.6	7.6	9.0	7.7	8.1	7.8	8.2	8.4	38.9	64.1	43.7	14.4	27.4	8.5	10.7	21.3	26.2	1.7	24.2	24.3	5.5	14.3	24.7	16.5	0.0	11.1	40.5	20.8	9.8	13.8	0.2	31.5	26.0	25.9	6.0	42.5	0.2	7.7	1.4	22.7	30.5	20.7	27.8	83.9	30.0	8.1	28.2	0.0	0.2	24.8	22.4	31.3	19.5	1.8	13.1	39.2	7.2	21.5	40.2	25.2	47.4	12.1	3.9	7.5	17.6	6.8	29.7	14.2	19.4	10.3	36.9	7.3	0.0	17.0	14.3	0.4	2.1	24.3	8.8	4.4	41.3	48.8	18.6	14.0
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127412	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3;naive B-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	0.9	0.5	0.5	5.9	0.6	4.8	2.7	2.8	1.8	1.0	0.1	5.6	3.4	1.0	0.5	3.4	0.5	0.8	0.3	0.6	1.1	0.4	2.5	1.1	12.3	0.5	1.0	0.2	0.6	0.9	0.0	1.7	0.7	1.0	5.8	1.3	0.8	0.4	0.4	4.4	4.0	2.0	0.1	1.8	3.2	0.8	0.6	18.0	0.9	0.1	13.3	1.7	1.0	2.1	72.6	18.5	26.6	0.4	2.7	4.9	0.3	53.5	26.7	31.2	46.1	38.7	28.0	89.8	35.4	15.7	26.3	54.7	39.5	36.2	55.2	46.8	9.5	9.8	32.3	16.9	0.1	0.3	11.1	1.2	1.2	30.3	2.4	6.0	16.9	24.1	2.8	81.9	37.2	27.3	57.7	0.6	0.3	43.2	21.0	60.1	39.7	34.7	16.8	61.2	5.2	16.9	44.4	50.8	8.7	9.7	56.2	5.0	9.4	24.1	52.4	73.5	49.6	62.6	48.4	0.6	35.0	0.4	35.4	0.2	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.3	0.1	2.6	0.1	0.1	1.6	0.0	0.1	0.1	0.7	0.1	0.5	0.6	2.8	1.8	0.6	1.1	0.5	1.0	0.7	0.1	0.6	2.1	0.7	0.0	0.0	0.0	12.8	4.2	2.2	4.2	1.8	0.0	2.5	4.2	0.3	0.0	1.4	0.0	0.0	1.1	1.4	4.0	0.0	0.8	0.0	0.9	1.6	1.2	0.0	9.1	0.0	0.0	0.4	1.5	3.6	1.9	0.0	6.3	0.0	0.2	3.9	0.0	0.0	4.4	2.0	0.3	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	1.3	0.0	8.8	0.7	0.5	0.1	1.6	0.0	0.0	1.3	1.8	0.1	1.0	7.1	2.7	0.1	3.2	1.1	10.4	1.6
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		96000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	28.4	48.1	7.9	23.6	11.8	2.0	20.2	7.8	9.2	48.4	23.7	34.6	22.9	29.2	17.8	35.1	19.5	36.4	23.7	9.9	11.4	11.8	54.2	21.2	8.9	13.7	12.5	41.5	25.6	22.4	18.5	35.6	11.2	35.5	33.7	3.1	61.2	27.8	16.6	15.6	24.4	61.7	9.0	8.8	34.4	12.5	12.1	4.3	17.6	22.7	19.5	35.6	26.4	13.4	43.5	30.7	18.5	21.9	197.4	204.7	6.1	167.9	244.1	69.7	105.8	8.1	33.0	0.0	23.0	273.8	118.8	11.9	0.1	53.7	80.1	0.2	4.6	3.1	30.3	40.6	70.6	0.1	5.8	122.1	17.0	101.2	23.3	157.2	101.4	0.1	3.4	0.2	102.9	11.0	0.1	2.3	3.8	18.3	15.6	0.8	90.9	3.2	23.4	8.7	0.7	9.4	33.8	0.7	33.8	42.8	20.8	3.8	156.3	75.4	34.8	95.3	39.5	0.7	0.2	0.3	123.3	3.3	63.0	0.6	3.2	0.0	0.1	3.6	0.0	0.4	0.1	0.1	2.6	0.1	0.1	0.1	2.4	0.0	1.4	0.3	0.0	0.9	7.9	11.8	7.8	9.2	9.9	11.4	13.7	12.5	11.2	9.0	12.1	13.4	28.1	16.0	13.2	5.9	2.2	12.2	47.4	43.7	15.4	0.3	29.9	21.2	17.2	14.3	56.0	7.3	0.0	2.2	0.2	46.8	9.8	45.6	1.0	17.5	88.6	35.2	15.7	3.6	1.0	61.0	47.0	94.9	35.7	39.1	1.3	30.4	31.1	68.3	16.1	0.0	1.8	78.7	83.4	7.2	15.0	6.3	110.9	8.7	21.4	17.8	6.4	12.2	0.0	14.6	31.0	47.6	41.6	116.2	8.5	92.6	39.0	11.7	47.8	1.2	19.7	49.4	44.3	1.2	5.5	23.6	10.2	3.4	3.1	94.1	32.0	82.7
FAM114A2	"133K02, C5orf3"	ENSG00000055147	"Family with sequence similarity 114 member A2"	Q9NRY5	5	153990148-154038936	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035869, HPA035870"	Approved		Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA035869: AB_10669534, HPA035870: AB_10673222"	"unprognostic (1.81e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.37e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.85e-2)"	14.1	12.6	7.6	13.8	7.7	9.1	12.6	7.1	7.7	10.7	9.3	9.9	12.1	10.8	16.6	13.4	9.6	10.2	19.3	6.7	9.7	15.4	16.2	11.7	15.9	8.5	8.8	10.1	14.6	22.1	8.5	13.4	8.7	12.1	10.8	13.2	14.3	11.6	19.9	9.3	11.8	15.4	8.4	14.3	12.8	37.6	9.9	14.2	13.5	16.1	17.2	12.0	8.1	8.1	15.7	20.4	21.5	33.8	29.6	27.5	19.5	37.1	25.8	26.9	37.2	15.2	22.6	19.7	34.7	27.5	18.8	13.1	18.8	36.1	32.5	22.1	21.0	25.2	12.2	11.1	34.8	22.3	25.0	24.9	22.0	24.3	43.5	19.7	38.3	25.6	16.2	30.1	35.3	15.1	25.5	9.2	9.7	16.7	9.9	21.9	29.6	30.4	20.5	10.8	5.0	17.8	26.8	28.7	38.2	22.6	38.5	16.1	35.7	24.9	17.6	23.0	22.5	45.4	39.7	27.9	29.5	30.4	27.3	38.1	14.6	35.7	15.6	18.2	17.9	15.5	12.6	18.2	14.5	17.9	16.0	15.4	7.2	17.6	23.3	13.2	16.0	11.9	7.6	7.7	7.1	7.7	6.7	9.7	8.5	8.8	8.7	8.4	9.9	8.1	22.6	9.6	11.5	9.1	14.9	6.2	5.7	9.5	11.4	10.5	9.2	6.5	26.9	10.0	8.2	11.0	4.2	22.4	8.5	4.8	7.9	12.3	45.3	9.6	13.1	19.8	5.4	24.0	10.4	12.5	16.2	15.0	11.7	8.7	17.2	12.9	10.4	19.8	17.7	10.1	12.9	8.2	6.1	17.7	8.7	14.8	11.1	11.5	14.2	15.0	13.2	25.0	12.3	18.1	11.7	9.1	2.9	9.8	19.2	5.4	12.4	15.4	12.3	15.6	6.6	10.4	14.5	109.6	38.5	11.4	6.8	18.3	11.2	14.1	6.0	3.6
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.4;Erythroid cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 50.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 82.0;U-266/84: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	13.5	7.3	7.6	14.8	6.8	76.5	12.5	10.0	5.9	12.6	37.4	22.8	10.6	20.4	9.6	9.4	16.7	10.4	18.9	9.6	4.8	9.0	11.7	12.1	22.9	6.3	4.6	21.6	16.0	18.6	14.6	5.4	6.1	10.0	8.5	8.0	13.5	11.3	4.0	19.1	18.7	16.7	3.3	34.2	13.3	19.0	6.7	23.5	14.5	6.3	17.4	20.2	10.5	5.0	7.2	1.7	11.4	0.2	5.0	1.0	20.2	2.4	4.0	4.3	7.1	51.2	11.8	34.4	12.4	1.4	19.1	4.1	9.0	8.5	3.3	2.4	14.5	37.9	0.1	16.6	5.6	5.8	29.1	4.9	7.1	7.1	3.9	4.4	7.8	28.9	46.9	28.1	4.1	18.6	37.5	31.1	17.0	10.0	5.7	11.6	9.6	18.4	6.7	6.4	11.1	7.5	2.4	1.1	8.5	11.1	16.7	21.5	0.7	4.2	3.4	4.6	2.0	82.0	60.2	23.0	3.6	8.4	3.5	50.4	1.7	9.1	8.5	1.1	9.2	23.6	5.5	7.2	1.3	15.3	4.5	6.2	3.6	12.8	0.3	3.6	5.9	3.4	7.6	6.8	10.0	5.9	9.6	4.8	6.3	4.6	6.1	3.3	6.7	5.0	15.5	6.4	9.3	5.2	19.5	9.1	1.3	2.1	7.4	15.1	14.6	21.7	22.2	1.5	4.1	7.3	14.6	1.1	56.4	2.2	5.9	2.0	4.1	4.2	5.9	9.9	10.7	104.4	4.5	3.5	1.9	9.3	9.2	7.9	2.5	2.9	7.1	8.6	1.2	5.0	4.0	4.9	6.1	2.9	4.5	5.6	14.3	7.6	7.2	1.9	13.0	3.5	37.0	2.0	2.3	3.8	1.0	15.4	34.9	2.6	0.5	3.6	1.5	4.0	0.0	14.2	10.2	15.5	14.5	8.8	14.1	0.8	27.9	5.5	2.7	1.1
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202634969-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.8;Inhibitory neurons: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	3.1	7.5	5.1	4.5	5.4	2.9	3.3	7.0	7.1	2.7	0.7	4.9	4.3	2.9	2.9	5.4	3.8	3.0	1.8	5.0	6.3	4.9	1.9	2.9	7.2	3.1	3.8	5.1	4.6	7.3	3.5	6.9	3.6	5.1	4.7	2.6	3.3	3.0	1.5	5.0	3.7	2.0	3.3	5.4	4.1	5.8	6.4	9.6	2.8	1.8	7.4	3.8	3.2	4.1	2.0	2.4	10.5	7.2	3.5	1.9	10.2	0.6	0.9	0.6	1.1	3.1	4.2	8.2	6.5	1.2	1.6	1.9	9.0	4.6	1.7	0.2	7.2	6.9	4.3	11.6	2.8	5.9	3.0	2.6	6.3	1.3	1.9	4.7	2.8	10.8	10.1	1.6	0.6	3.9	16.1	12.1	10.7	5.8	4.5	12.5	2.1	9.8	5.5	5.2	17.7	15.4	8.0	5.3	3.9	8.7	2.2	8.1	1.7	1.2	2.4	1.9	1.1	5.9	3.6	10.8	2.4	4.5	1.3	0.4	3.9	1.5	1.3	8.2	3.4	8.1	3.0	2.7	4.5	7.7	8.2	5.7	2.2	4.4	9.1	1.5	1.2	3.1	5.1	5.4	7.0	7.1	5.0	6.3	3.1	3.8	3.6	3.3	6.4	4.1	9.7	3.2	7.5	13.1	21.5	17.2	2.9	3.0	12.0	4.9	8.1	4.3	4.9	12.8	2.6	18.4	4.2	8.4	8.8	11.7	0.0	10.2	2.2	8.6	6.5	4.9	25.8	3.0	45.8	6.4	6.3	6.1	7.1	10.1	5.7	15.3	8.2	2.2	2.8	6.7	49.7	11.8	2.0	27.4	13.9	1.4	13.1	17.1	3.6	23.4	17.1	1.7	3.1	29.1	29.4	5.8	9.7	23.7	5.2	6.7	4.9	5.9	3.0	2.7	6.6	2.0	4.1	5.0	16.3	29.2	19.9	2.7	10.1	11.1	13.8	6.0
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 104.0;Early spermatids: 125.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	14.1	11.8	14.9	23.7	16.9	21.5	23.3	22.0	17.1	21.9	25.5	23.3	19.9	17.7	66.5	18.6	12.2	24.4	24.5	17.2	15.6	22.9	17.1	19.3	49.1	14.4	15.3	21.7	14.3	38.3	37.6	18.3	14.4	41.7	12.4	9.5	18.4	9.3	30.5	39.7	24.8	10.3	11.4	25.9	21.3	22.7	17.9	13.6	23.7	6.5	27.6	29.7	22.8	15.8	10.9	7.8	11.0	11.9	9.3	8.9	24.0	8.1	13.4	11.5	11.2	25.6	10.1	48.6	6.5	7.5	6.5	40.7	14.3	10.3	11.5	10.6	31.9	26.3	13.2	18.7	12.8	24.8	7.2	9.5	12.3	17.6	10.8	8.0	7.1	14.6	39.5	52.6	5.9	26.1	14.7	51.3	8.2	49.8	10.4	19.0	7.1	17.4	6.6	28.9	21.8	25.6	8.9	19.0	23.9	18.0	8.2	14.4	9.2	8.8	28.8	10.8	10.8	29.0	5.5	24.7	11.9	17.1	16.0	7.1	7.1	2.2	5.8	6.2	4.7	4.3	7.3	7.2	8.8	6.5	11.5	8.6	5.8	5.6	5.0	13.5	10.9	4.4	14.9	16.9	22.0	17.1	17.2	15.6	14.4	15.3	14.4	11.4	17.9	15.8	12.5	9.6	17.0	23.8	21.2	22.6	36.9	18.8	10.8	18.3	10.9	6.6	11.3	8.6	16.6	7.3	18.8	104.0	83.1	21.4	0.0	7.0	125.0	6.7	15.5	20.7	32.9	14.5	23.1	6.2	8.5	19.2	10.2	7.4	1.3	8.8	23.9	14.5	12.9	6.7	18.3	20.5	12.2	13.0	29.9	75.6	35.8	19.8	1.8	62.8	69.5	16.4	39.1	22.6	21.5	4.8	17.7	23.7	25.8	22.6	13.4	3.9	14.6	22.3	0.0	33.6	14.7	72.5	38.8	8.8	9.9	120.9	55.2	7.3	17.5	35.4
FAM118B	FLJ21103	ENSG00000197798	"Family with sequence similarity 118 member B"	Q9BPY3	11	126211724-126262984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041644, HPA042100"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041644: AB_10794303, HPA042100: AB_10795394"	"unprognostic (8.11e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.13e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (6.67e-7)"	"unprognostic (1.85e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.44e-2)"	9.3	10.5	15.1	10.3	19.2	4.3	7.6	15.7	20.4	10.4	20.2	24.0	18.5	10.0	12.3	7.6	6.7	10.5	18.2	15.5	16.2	10.3	8.9	16.3	12.7	15.1	15.3	6.2	5.7	7.7	9.0	11.1	15.3	7.3	23.6	9.0	8.0	9.3	22.0	5.4	13.1	14.2	16.0	10.5	14.9	21.4	15.6	14.1	10.2	16.3	14.0	13.6	6.2	16.3	11.7	14.3	31.5	23.6	43.4	28.5	14.0	18.5	33.2	20.4	21.2	29.0	18.5	13.0	19.2	23.5	42.4	15.2	33.5	19.7	24.8	21.2	14.5	41.3	6.8	19.5	33.7	20.7	13.0	23.7	19.9	25.0	23.0	20.5	46.8	24.9	25.8	17.8	29.6	10.9	27.8	16.2	25.6	63.3	26.4	24.1	25.1	11.6	34.4	18.3	14.5	15.2	21.5	14.0	26.8	36.8	27.3	12.4	29.2	20.7	15.2	17.9	16.3	9.3	11.7	22.0	8.9	31.0	26.9	33.8	43.4	21.9	14.6	58.8	18.6	15.2	14.4	18.9	48.1	15.9	12.9	16.0	9.0	18.9	59.6	21.9	18.0	25.2	15.1	19.2	15.7	20.4	15.5	16.2	15.1	15.3	15.3	16.0	15.6	16.3	8.6	3.2	16.4	14.4	5.6	4.1	4.2	21.9	1.2	3.1	3.3	3.6	10.4	4.3	9.6	12.9	4.2	9.3	5.0	21.9	5.9	16.0	7.5	5.0	6.0	12.4	3.6	8.6	19.1	17.2	12.4	8.3	21.4	4.1	10.8	9.1	9.7	5.5	24.2	1.7	17.6	11.4	12.2	16.7	9.4	9.2	7.8	11.0	3.6	12.2	16.9	13.5	13.4	16.1	12.7	14.0	12.8	21.8	9.5	4.1	11.4	12.9	6.8	5.7	6.6	3.4	10.2	46.0	20.6	3.5	3.4	13.0	5.3	11.0	16.6	5.7
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451685-93566112	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA		12000	"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	48.1	47.8	26.7	59.7	30.8	49.9	37.8	25.8	27.0	45.0	55.0	74.4	59.0	39.2	36.0	46.6	50.8	42.3	60.9	26.0	24.2	47.7	55.7	42.0	56.5	32.6	29.3	39.1	57.9	87.3	26.8	60.3	28.8	42.7	69.1	30.6	56.2	40.8	81.7	41.9	58.4	50.9	25.3	49.0	69.3	17.4	30.3	45.5	49.0	71.4	45.6	53.4	33.0	28.7	179.7	145.4	32.0	92.8	93.7	116.6	100.3	123.2	107.8	92.9	68.0	47.5	108.2	116.1	68.9	156.2	73.7	188.8	86.5	144.3	71.1	117.0	62.8	63.8	126.1	75.3	104.6	109.0	83.5	114.3	87.2	105.7	166.3	90.9	133.7	81.0	74.4	94.9	101.3	202.8	108.2	61.4	41.2	212.7	134.3	62.1	85.6	97.4	112.3	107.2	85.8	52.5	139.5	166.4	86.0	31.4	91.0	70.6	140.6	99.6	71.6	123.8	136.4	74.2	78.6	44.8	107.9	96.6	90.9	3.1	6.6	5.2	4.9	7.5	4.1	4.4	4.3	4.8	6.1	3.5	3.0	4.4	13.1	4.3	9.3	3.9	8.3	4.1	26.7	30.8	25.8	27.0	26.0	24.2	32.6	29.3	28.8	25.3	30.3	28.7	64.0	44.8	93.9	67.9	42.7	102.2	49.6	56.6	70.6	30.0	86.5	49.0	112.3	77.2	75.2	75.4	50.1	73.8	49.2	164.3	21.5	50.1	26.1	77.5	76.2	64.9	91.8	60.2	92.1	74.7	104.9	60.5	123.8	92.3	48.8	66.1	63.1	186.6	71.0	40.4	62.5	176.8	36.7	146.4	78.6	9.8	66.8	103.4	53.4	80.6	111.0	35.7	35.0	64.3	80.9	86.4	92.0	65.5	60.8	125.8	81.0	75.7	87.8	33.7	39.5	63.5	68.6	12.3	12.4	91.1	114.2	103.4	49.3	94.4	177.2	109.0
FAM120AOS	C9orf10OS	ENSG00000188938	"Family with sequence similarity 120A opposite strand"	Q5T036	9	93431441-93453581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 155.5;Syncytiotrophoblasts: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021475	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA021475: AB_2670718"	"unprognostic (1.20e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (3.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (6.04e-4)"	"unprognostic (2.33e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.42e-1)"	21.5	19.0	27.7	14.7	27.4	12.2	23.5	27.3	34.2	18.0	27.1	25.1	14.5	18.0	35.4	16.7	16.4	16.7	22.7	27.7	27.4	23.4	18.4	17.7	17.2	28.5	27.1	18.8	23.5	27.9	32.3	23.6	27.3	23.5	24.4	23.6	20.1	20.3	20.8	19.9	16.6	16.0	27.4	14.4	24.2	8.6	28.1	18.6	29.1	19.8	18.8	21.2	15.6	28.9	31.3	29.0	20.2	22.5	28.1	12.1	31.6	19.1	19.8	20.7	15.8	21.5	24.1	26.7	23.8	21.8	29.8	39.1	20.2	20.1	18.9	43.5	16.0	27.6	26.5	24.5	28.6	22.3	17.1	15.6	28.1	20.6	33.2	23.2	22.5	23.5	29.1	37.5	20.0	74.4	30.6	12.1	27.3	42.9	31.0	24.5	27.5	27.8	28.3	27.8	42.1	20.3	28.7	30.8	28.9	22.9	33.0	18.0	15.0	13.1	21.0	45.6	27.2	26.1	37.6	11.6	21.2	13.5	27.6	12.9	9.0	6.7	4.1	8.9	5.8	11.8	6.5	5.8	7.3	8.8	7.9	6.0	10.5	8.0	11.3	8.0	6.8	4.4	27.7	27.4	27.3	34.2	27.7	27.4	28.5	27.1	27.3	27.4	28.1	28.9	29.8	35.3	45.4	22.2	30.8	12.6	45.8	21.6	40.5	25.4	47.6	37.6	38.9	14.3	46.1	18.4	14.6	100.9	25.8	60.6	39.2	37.5	0.5	31.0	31.2	28.4	28.3	26.1	22.2	47.8	155.5	37.3	55.0	45.1	22.8	15.1	24.3	22.3	41.2	6.7	17.5	42.8	14.2	31.8	20.0	3.4	23.9	29.7	12.4	12.2	36.6	30.8	19.6	7.5	17.5	37.9	41.0	33.4	37.0	38.9	33.2	33.9	24.7	32.7	26.3	31.6	36.0	13.7	17.1	34.8	25.9	249.0	30.6	21.3	30.6	59.4
FAM120B	"CCPG, KIAA1838, PGCC1, SAN1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407067	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 556.1;Late spermatids: 1847.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	12.3	12.2	9.3	5.7	8.7	4.5	12.5	11.2	11.2	11.6	9.9	11.5	6.2	12.1	8.9	10.0	12.2	6.1	10.7	7.7	9.0	8.3	8.8	9.4	7.1	10.0	9.8	11.0	9.6	7.1	11.4	6.6	10.3	11.0	8.6	9.2	13.8	6.2	17.4	12.3	10.1	7.6	7.7	10.1	10.2	14.4	9.1	7.4	9.8	6.8	6.6	10.9	10.4	10.5	7.0	7.1	8.7	12.7	15.4	14.2	6.2	6.4	13.4	8.5	7.2	6.4	5.2	8.0	5.2	14.2	9.2	8.2	11.0	13.1	13.0	9.0	5.2	10.5	6.5	8.4	10.5	10.5	6.5	14.0	11.2	9.2	12.2	14.6	15.7	6.3	9.5	7.8	17.0	13.7	6.3	11.8	5.3	12.5	4.8	6.5	9.8	10.3	10.3	6.2	6.0	9.6	6.2	8.7	2.9	13.0	7.0	20.6	13.4	4.2	6.3	11.3	6.4	6.6	7.3	9.9	11.6	7.4	15.9	16.5	5.9	7.5	5.4	6.4	6.3	4.4	5.1	6.1	6.4	5.3	6.4	5.3	10.0	11.9	10.1	3.5	6.6	6.7	9.3	8.7	11.2	11.2	7.7	9.0	10.0	9.8	10.3	7.7	9.1	10.5	17.8	22.4	17.6	36.9	13.2	3.6	5.2	11.1	16.5	16.7	13.7	13.6	15.7	11.5	13.0	14.7	33.3	10.5	7.3	11.8	0.0	8.4	556.1	18.8	16.7	15.4	9.6	11.1	48.8	9.1	7.6	13.1	14.3	22.5	10.1	14.1	10.4	10.7	11.0	6.7	53.2	12.5	12.2	9.8	5.6	1847.0	19.3	10.2	19.6	40.3	8.8	7.7	8.2	50.3	62.6	9.2	6.5	14.3	12.0	9.3	10.1	5.4	19.9	14.2	32.9	12.9	10.1	18.4	12.7	10.8	5.8	13.4	13.9	11.2	8.8	6.4
FAM120C	"CXorf17, FLJ20506, ORF34"	ENSG00000184083	"Family with sequence similarity 120C"	Q9NX05	X	54068324-54183281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047677	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"HPA047677: AB_2680118"	"unprognostic (4.70e-2)"	"unprognostic (2.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.86e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.28e-2)"	3.1	3.7	8.3	1.8	9.9	3.4	2.9	8.1	8.9	3.9	2.3	2.9	1.3	3.7	5.1	3.5	3.5	1.7	2.6	7.5	9.0	3.0	3.1	2.4	2.9	11.3	9.2	4.6	2.6	4.0	4.3	2.2	8.7	3.3	1.7	5.8	2.7	3.1	5.9	3.2	2.4	2.8	9.3	3.4	2.1	2.6	9.0	4.1	3.4	2.9	3.1	3.3	3.4	11.0	4.0	7.2	3.6	8.3	8.2	5.9	6.7	3.8	6.3	5.7	6.1	3.4	4.2	5.6	2.5	3.3	8.4	10.7	10.6	2.8	5.0	4.4	11.6	3.0	11.3	5.6	3.7	2.7	3.0	4.1	3.5	5.0	5.8	6.6	3.6	5.7	3.2	4.5	4.6	10.9	4.5	10.8	6.8	2.3	15.9	5.3	5.8	5.9	4.7	2.2	5.0	5.0	9.8	7.4	2.7	8.8	8.8	2.4	6.5	5.0	6.5	6.6	3.1	5.4	5.6	4.2	5.7	8.2	6.1	0.0	1.4	0.1	1.3	0.8	1.1	2.6	1.2	1.0	2.5	2.1	1.3	1.5	0.0	0.9	0.3	3.1	0.4	0.9	8.3	9.9	8.1	8.9	7.5	9.0	11.3	9.2	8.7	9.3	9.0	11.0	4.5	3.2	2.6	21.9	7.8	5.9	5.4	5.0	15.4	10.5	5.5	3.7	5.7	8.6	2.5	0.0	4.2	8.9	4.6	0.8	9.8	3.0	0.1	7.0	7.2	5.5	4.8	7.4	18.1	2.7	5.5	5.5	3.1	7.7	2.5	9.2	5.3	6.1	4.1	6.7	19.0	1.1	2.0	3.2	4.7	0.7	6.5	5.3	1.8	10.3	3.5	5.1	8.2	33.2	32.9	1.5	1.6	4.9	3.0	3.3	0.8	5.6	3.9	8.6	0.0	9.0	5.4	2.0	6.9	12.0	4.7	2.5	5.6	8.7	2.5	3.4
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780065-68785566	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	9.9	9.3	4.6	5.8	4.9	5.3	9.7	8.2	6.3	9.7	15.0	7.9	4.4	9.3	6.7	8.3	8.5	5.6	9.0	5.4	5.4	9.7	9.9	6.8	7.4	5.1	5.4	10.5	8.9	11.0	6.8	10.2	5.1	7.7	6.5	6.8	8.2	8.4	8.9	7.6	7.4	7.8	4.4	8.3	7.4	4.9	5.0	6.5	8.5	8.6	7.2	7.2	8.0	5.0	5.2	3.4	4.8	4.1	15.9	10.3	6.4	7.3	6.9	6.3	5.0	1.2	2.5	11.0	3.5	7.7	4.5	9.6	5.3	4.9	7.8	11.9	5.6	6.1	6.0	4.4	9.7	11.2	4.1	8.4	11.0	5.8	4.5	7.1	6.3	7.8	6.5	12.1	6.8	2.9	6.3	2.9	6.0	12.4	6.2	7.6	6.6	3.4	5.7	4.3	7.6	3.4	5.4	4.5	3.8	6.6	2.7	4.8	8.0	5.8	4.2	11.0	5.5	14.2	6.1	4.4	6.3	6.9	6.7	1.9	2.0	1.5	1.7	1.9	1.4	1.5	1.7	1.8	2.2	2.5	3.5	2.0	1.1	1.8	1.9	2.6	2.0	1.0	4.6	4.9	8.2	6.3	5.4	5.4	5.1	5.4	5.1	4.4	5.0	5.0	10.0	3.2	9.8	0.0	19.6	23.6	18.7	13.3	20.5	18.8	18.2	17.0	15.9	10.0	13.1	5.5	16.7	28.2	11.8	11.3	66.5	18.3	32.0	10.4	20.2	17.2	18.0	27.0	0.0	13.8	17.0	13.9	14.3	8.1	17.7	12.7	17.2	18.6	21.6	8.4	0.0	17.0	10.2	22.3	17.0	15.4	15.2	15.0	14.2	0.0	16.8	38.3	24.7	0.0	0.0	12.9	15.8	17.0	18.3	11.9	11.1	27.2	23.0	19.8	46.0	18.8	43.9	52.4	21.3	19.5	23.7	30.6	16.8	23.1	15.3	17.8
FAM122B	"DKFZp686L20116, RP11-308B5.5"	ENSG00000156504	"Family with sequence similarity 122B"	Q7Z309	X	134769566-134797232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000266	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA000266: AB_1078801"	"unprognostic (2.10e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.19e-3)"	16.0	19.5	23.9	18.4	25.4	31.6	15.8	20.6	32.8	18.7	27.1	18.1	15.4	20.8	26.0	17.6	22.6	13.1	14.6	23.9	24.3	20.1	11.2	17.6	29.8	22.8	23.5	28.8	16.8	21.1	21.3	15.5	22.1	17.6	22.7	8.8	18.8	16.0	7.8	19.4	22.1	19.5	24.3	27.4	20.1	35.3	29.2	25.9	21.0	7.1	27.3	18.8	17.6	25.2	51.0	46.2	36.2	25.9	18.2	23.6	25.4	39.5	34.5	43.9	41.3	41.1	44.3	49.7	76.2	28.9	61.3	33.5	54.0	32.6	79.2	61.8	37.4	50.2	94.6	13.4	11.2	92.9	61.2	15.5	31.6	48.3	21.0	28.5	25.9	50.0	33.2	61.9	46.8	68.8	58.1	80.1	19.8	58.3	49.1	58.0	39.5	43.6	26.6	52.1	32.9	23.3	21.2	28.3	14.8	31.1	15.2	47.4	18.6	36.4	23.5	93.3	87.1	34.1	42.2	63.2	39.0	105.8	46.2	0.0	0.4	2.6	0.8	0.2	1.1	0.7	0.7	1.0	0.5	0.6	0.9	1.2	0.5	1.2	0.5	1.5	0.8	0.5	23.9	25.4	20.6	32.8	23.9	24.3	22.8	23.5	22.1	24.3	29.2	25.2	4.7	12.8	10.4	6.2	17.4	13.5	15.0	9.2	12.0	4.0	11.8	7.6	10.8	2.8	11.7	16.5	12.5	9.3	15.3	14.4	17.6	8.0	1.3	10.4	6.7	12.5	6.0	32.6	15.2	13.8	10.2	11.0	15.3	11.5	23.6	32.9	9.7	7.4	14.7	13.5	10.5	13.2	18.3	21.4	21.7	5.8	10.5	17.9	17.8	12.2	16.6	6.4	20.6	8.0	16.8	12.2	20.2	6.4	13.8	14.7	12.9	8.0	8.2	5.5	0.0	6.6	8.8	3.7	4.4	14.4	11.2	8.8	20.1	17.7	12.2	19.1
FAM122C	RP3-473B4.1	ENSG00000156500	"Family with sequence similarity 122C"	Q6P4D5	X	134796395-134854835	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 12.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.8;Granulosa cells: 39.0;Theca cells: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059961	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059961: AB_2684181"	"unprognostic (1.32e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.50e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-3)"	2.3	1.8	2.1	2.6	1.9	5.8	1.2	2.7	3.5	1.7	4.0	1.8	0.9	3.8	1.8	1.8	2.5	1.8	1.5	2.0	2.0	1.5	1.8	2.1	4.3	2.1	1.7	12.5	0.7	1.5	1.5	1.6	1.8	1.8	1.6	5.7	4.0	1.6	1.6	1.7	1.4	3.1	1.7	3.9	2.8	6.1	1.7	4.3	1.6	1.4	2.2	2.0	1.1	3.3	1.1	1.3	4.1	4.2	1.0	1.6	2.4	3.6	3.1	3.2	4.3	3.0	4.2	1.4	5.3	1.5	6.8	1.6	3.4	1.3	2.3	3.7	1.4	2.5	15.3	1.3	1.2	3.8	2.1	1.6	0.6	3.1	1.9	2.0	2.7	11.0	10.8	8.1	2.3	6.5	3.9	3.1	2.2	1.1	3.1	6.7	2.8	3.2	1.0	0.9	1.6	2.8	2.2	0.6	3.4	2.9	1.0	1.0	0.8	1.9	1.2	2.9	2.3	3.0	3.0	6.1	2.6	4.2	2.1	1.8	1.2	3.5	1.1	1.4	1.2	2.3	1.3	1.7	0.9	1.6	1.6	1.4	2.1	2.2	3.0	3.3	1.2	0.9	2.1	1.9	2.7	3.5	2.0	2.0	2.1	1.7	1.8	1.7	1.7	3.3	2.9	6.4	4.5	14.7	4.8	1.3	2.1	1.8	0.0	4.1	1.9	1.9	2.1	0.0	2.9	1.8	14.6	1.7	2.9	1.7	1.9	1.3	57.8	4.4	3.9	6.5	1.2	6.9	6.7	1.8	2.7	4.3	6.6	6.9	12.7	39.0	7.5	0.9	2.2	3.3	7.0	3.0	0.0	4.1	3.0	9.6	4.1	3.4	3.6	12.2	3.8	3.8	3.1	11.1	12.1	1.9	1.7	2.2	5.9	1.5	4.5	1.7	8.8	14.1	0.0	3.2	3.9	10.4	2.6	1.5	1.1	1.9	11.7	35.5	1.8	2.8
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 59.1;choroid plexus: 26.7;retina: 25.7"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 232.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HAP1: 18.0;HUVEC TERT2: 10.6;NTERA-2: 35.1;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	4.6	1.8	13.2	2.7	32.1	0.2	2.9	24.0	22.0	2.2	26.7	8.1	0.6	3.1	4.6	1.2	3.1	2.4	4.9	14.8	20.8	3.7	0.7	1.9	0.8	33.8	27.4	0.8	1.4	0.6	1.3	3.6	31.3	4.6	1.3	25.7	7.3	4.4	1.0	1.0	2.0	5.2	18.4	8.3	3.3	1.2	25.9	3.1	2.4	1.3	0.5	4.5	1.6	59.1	0.0	1.7	1.2	1.1	0.3	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.6	0.6	0.0	0.0	2.2	0.1	18.0	0.2	0.1	0.1	2.7	0.1	0.5	0.0	1.4	0.9	1.1	0.4	0.2	0.5	0.0	0.0	10.6	4.8	0.1	0.1	0.0	0.3	4.6	0.3	35.1	0.3	2.8	1.0	0.1	2.6	0.0	0.1	2.5	13.3	0.6	2.2	2.0	2.6	0.3	1.1	0.2	0.1	1.2	0.9	1.3	0.3	0.0	0.0	1.6	3.2	1.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	13.2	32.1	24.0	22.0	14.8	20.8	33.8	27.4	31.3	18.4	25.9	59.1	8.5	0.0	0.0	17.6	0.4	0.8	2.1	0.0	0.6	10.2	1.1	1.8	10.8	0.0	0.0	1.8	50.1	0.0	0.8	0.2	3.9	2.6	4.7	0.8	3.5	9.3	0.0	0.0	12.0	0.8	0.0	2.2	0.0	1.6	1.3	0.6	8.6	0.1	0.2	6.7	4.8	0.0	0.0	0.6	0.3	5.8	0.6	1.4	3.6	9.4	0.0	3.6	0.0	10.6	232.9	0.7	0.0	0.4	0.0	2.3	0.0	11.7	1.5	43.6	0.0	1.8	2.0	1.7	1.6	0.1	0.1	0.0	0.6	0.7	0.1	0.5
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	14.9	4.7	5.0	8.5	6.9	4.2	12.2	4.4	6.5	9.7	7.9	9.7	9.4	8.7	1.4	12.2	6.7	11.4	10.5	12.1	4.5	4.7	8.5	13.7	11.5	5.0	5.9	6.6	6.2	2.3	5.0	14.8	5.4	5.9	4.4	4.9	6.8	4.8	25.0	4.9	6.9	11.5	4.5	11.8	4.6	12.0	6.3	4.2	6.6	15.3	9.2	9.4	11.2	7.8	22.4	12.4	63.6	22.3	61.3	100.9	10.6	103.0	101.8	41.6	63.9	19.8	10.6	13.3	15.9	82.6	87.2	7.7	44.3	14.7	72.6	6.6	22.4	14.7	18.1	13.0	48.0	19.3	15.7	41.1	9.2	85.0	61.3	83.4	42.5	7.5	30.4	58.6	77.5	7.9	10.8	24.2	63.0	0.1	22.9	15.7	63.5	9.5	13.1	11.2	10.4	0.1	38.1	0.4	19.2	52.5	8.2	20.4	51.0	150.0	18.3	71.8	37.4	67.2	30.6	60.9	91.1	12.5	112.6	4.7	2.9	13.7	1.4	7.8	1.3	6.4	2.6	1.3	3.9	7.4	0.9	1.5	0.3	2.1	9.8	1.6	4.0	2.5	5.0	6.9	4.4	6.5	12.1	4.5	5.0	5.9	5.4	4.5	6.3	7.8	27.8	3.2	15.1	19.6	29.1	25.5	5.1	8.3	15.9	60.3	5.4	32.4	21.9	2.8	4.2	3.7	2.1	11.8	28.8	0.5	0.0	6.8	49.0	12.5	22.4	31.4	7.7	19.8	13.6	4.8	15.5	42.9	2.6	11.3	8.2	8.6	26.0	17.7	15.2	16.8	13.6	3.0	2.0	25.1	55.2	22.4	20.2	31.5	35.6	47.8	24.0	6.8	11.3	23.6	133.2	3.6	1.4	19.5	26.4	4.7	8.3	5.7	2.4	4.6	19.7	24.0	31.7	72.2	11.1	35.0	24.0	6.0	20.6	12.2	4.7	6.5
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 25.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.7"	"Cell line enhanced"	"Detected in all"		"U-266/84: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	7.8	4.5	4.7	6.3	5.2	17.4	4.8	15.9	8.1	4.0	2.3	7.2	6.8	3.9	4.0	8.2	3.2	4.3	3.4	6.5	3.1	7.8	7.4	5.4	5.9	3.3	3.2	3.8	4.9	4.9	3.8	5.0	3.3	3.7	6.4	10.4	4.3	2.7	3.0	7.1	6.6	3.9	0.6	6.8	7.5	4.5	5.2	5.9	6.9	3.6	6.1	3.8	4.4	6.1	5.4	2.8	3.9	4.2	4.0	5.3	8.2	5.0	3.0	4.0	3.7	7.2	6.2	4.9	4.8	5.1	3.7	6.5	8.1	3.1	6.0	7.1	4.9	14.3	7.6	6.7	3.3	17.6	11.9	2.3	3.9	5.5	3.3	3.1	3.9	5.2	13.4	17.6	4.1	3.3	10.5	11.4	2.8	3.5	4.7	6.1	5.9	4.6	3.7	5.9	7.7	3.8	5.3	6.0	4.7	5.1	4.2	7.7	7.9	7.5	5.3	3.7	4.6	13.1	58.8	10.5	4.3	6.7	5.4	2.6	1.8	6.3	3.8	2.4	4.0	2.6	3.2	3.0	1.6	2.7	3.1	3.7	25.7	3.1	2.7	1.1	2.4	1.9	4.7	5.2	15.9	8.1	6.5	3.1	3.3	3.2	3.3	0.6	5.2	6.1	21.5	28.9	23.9	45.1	29.3	52.6	10.7	17.0	23.3	52.9	16.3	9.4	17.2	27.1	20.4	20.2	164.7	16.6	38.3	59.1	17.6	10.6	9.1	12.7	16.4	22.7	37.1	23.1	113.4	10.5	10.1	15.9	24.5	16.2	24.7	19.9	35.3	21.0	12.0	26.9	98.3	23.4	22.4	33.9	51.6	6.6	31.7	21.1	30.2	45.0	41.5	20.3	73.2	57.8	64.6	21.3	31.1	25.6	34.0	13.2	47.3	16.4	23.1	42.7	19.7	14.8	15.9	32.8	22.9	31.6	74.2	17.4	35.6	15.3	22.0	19.6
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	15.6	22.7	42.8	5.4	51.1	3.2	13.5	25.0	57.6	17.3	20.5	26.4	7.5	19.1	5.0	13.2	20.6	10.2	29.6	68.2	39.2	13.3	5.5	16.9	4.4	29.5	27.5	24.1	13.7	14.5	54.8	5.8	29.9	17.0	3.7	4.8	10.8	12.3	17.3	30.1	13.8	10.0	22.5	10.7	16.6	16.4	38.8	3.1	12.8	18.0	2.9	17.1	15.2	40.1	14.5	6.1	9.5	16.3	12.1	10.2	8.8	6.5	13.7	9.6	7.5	4.7	5.1	2.1	25.9	6.0	20.7	13.5	0.0	11.8	5.8	15.7	16.0	0.1	9.4	10.2	12.4	0.3	10.8	7.3	1.9	8.4	19.2	9.2	19.4	9.7	3.2	2.1	3.3	11.3	5.6	0.3	16.1	8.7	11.8	10.4	4.0	14.0	9.8	0.5	28.2	29.3	4.1	10.5	14.7	5.9	31.9	3.3	20.2	12.1	9.3	9.9	20.0	22.9	15.4	1.5	38.5	2.1	8.3	1.5	3.8	4.8	1.1	4.9	1.2	1.4	0.8	1.1	4.2	1.4	0.9	1.1	8.3	1.2	2.7	1.7	1.7	2.2	42.8	51.1	25.0	57.6	68.2	39.2	29.5	27.5	29.9	22.5	38.8	40.1	15.5	6.4	5.0	13.7	5.5	11.1	20.0	6.1	5.7	24.0	8.0	11.0	7.6	14.3	4.1	14.7	14.6	9.0	4.6	11.6	1.9	6.0	4.4	6.5	10.5	11.5	9.6	6.1	30.8	3.5	3.5	9.7	5.1	11.0	7.0	55.9	13.6	1.4	7.9	23.5	16.6	7.5	6.1	5.7	14.2	2.5	18.6	7.7	1.8	11.2	9.6	13.1	6.2	6.6	11.9	10.7	9.6	20.7	2.5	15.2	15.7	3.4	15.8	15.9	6.6	13.0	14.4	12.9	7.1	3.5	14.6	33.2	5.0	20.0	8.7	15.9
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.3;kidney: 14.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 9.2;Distal tubular cells: 19.6;Horizontal cells: 38.7;Muller glia cells: 31.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.8;HEK 293: 5.3;PC-3: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.3	6.9	10.3	0.0	13.8	0.0	0.2	40.3	12.3	1.1	3.3	0.3	0.0	0.5	0.2	1.5	0.5	0.3	5.6	8.5	15.3	14.9	0.5	0.0	0.0	15.9	14.4	0.4	3.5	3.3	9.4	0.0	18.4	0.2	0.0	3.1	1.9	0.3	0.1	2.7	0.9	0.1	13.5	0.1	1.0	0.7	13.5	0.1	1.2	0.2	0.3	0.2	0.9	20.8	3.3	7.8	0.2	0.4	0.0	0.0	0.0	0.7	0.6	0.8	1.9	0.2	1.7	0.0	0.3	0.4	1.9	0.9	1.0	0.2	0.2	0.0	5.3	0.0	1.6	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.6	2.6	0.5	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.3	1.6	6.0	0.0	0.0	3.5	0.6	0.0	1.1	2.3	0.2	0.9	0.2	0.0	0.2	0.0	1.2	0.1	2.7	0.0	0.0	1.3	0.1	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.8	40.3	12.3	8.5	15.3	15.9	14.4	18.4	13.5	13.5	20.8	0.1	0.0	0.0	4.9	0.0	0.3	0.4	0.3	0.0	6.5	0.6	1.0	2.1	1.5	0.3	9.2	4.2	0.1	0.0	0.0	19.6	2.6	1.3	0.3	0.1	0.3	3.5	0.0	0.7	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.7	0.4	0.0	38.7	8.9	0.0	6.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	31.8	0.0	0.0	7.1	0.3	0.0	0.0	0.4	0.5	0.0	0.8	0.2	2.4	0.0	2.3	0.4	0.7	3.5	0.2	1.1	0.0	0.1	0.0	0.1	0.5
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	2.6	2.8	2.5	4.8	3.6	1.3	2.5	8.1	3.3	4.9	0.6	10.7	13.6	6.3	2.5	29.8	4.1	7.0	4.1	3.2	2.1	4.9	2.4	4.2	3.8	2.4	2.3	6.3	6.0	9.7	1.9	4.0	2.4	16.1	11.1	8.2	4.5	3.5	2.6	9.6	11.5	3.7	1.2	3.5	10.7	10.1	2.2	2.9	3.8	6.5	6.4	4.9	7.1	3.7	7.9	4.8	9.5	6.1	4.5	3.2	8.9	2.5	5.0	2.6	4.3	8.9	6.2	14.3	18.1	1.9	12.6	7.3	9.6	5.6	4.6	6.8	8.2	6.2	4.6	8.0	5.5	12.3	6.4	2.9	13.8	5.0	13.4	3.1	7.2	4.4	10.6	6.8	3.1	0.8	2.2	5.5	6.4	9.2	3.9	6.8	31.3	6.8	9.8	4.0	10.1	3.1	2.9	2.6	3.0	6.3	1.8	5.2	3.6	2.2	5.7	2.2	5.8	8.5	10.3	5.5	1.6	10.4	4.2	1.8	2.3	0.1	0.8	2.0	0.9	1.6	0.7	0.3	3.5	2.0	1.1	0.7	0.6	2.7	3.3	0.5	0.9	0.9	2.5	3.6	8.1	3.3	3.2	2.1	2.4	2.3	2.4	1.2	2.2	3.7	12.0	28.9	12.5	85.8	10.8	15.9	12.9	8.3	31.3	20.8	4.5	4.1	11.5	17.2	8.9	20.2	29.2	2.9	4.7	49.9	5.9	6.7	30.4	13.9	15.6	13.0	23.4	1.7	170.1	12.4	1.5	10.2	45.9	21.4	8.8	13.5	9.7	6.5	5.6	238.9	172.8	29.2	16.2	10.6	15.5	23.8	15.5	11.9	5.4	132.1	11.9	13.8	4.1	219.2	121.3	18.4	31.7	13.2	6.4	35.4	24.0	10.0	9.9	26.4	6.6	11.6	9.3	33.2	10.5	71.4	33.5	8.2	4.6	10.9	25.5	15.8
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138497261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.7;retina: 9.1;testis: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 64.3;Early spermatids: 157.1;Excitatory neurons: 229.3;Inhibitory neurons: 267.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RH-30: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.1	2.6	4.8	0.1	4.8	0.0	0.0	6.1	10.7	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	6.8	1.1	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.4	0.0	1.3	0.0	5.1	0.2	0.6	9.1	0.0	0.2	0.0	0.0	0.3	0.0	1.8	0.0	0.6	3.8	3.4	0.1	0.0	0.3	0.0	0.4	0.1	5.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.8	6.1	10.7	6.8	1.1	5.0	3.0	5.1	1.8	3.4	5.7	0.0	0.0	0.0	64.3	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	1.4	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.1	1.8	0.0	229.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	267.0	0.0	0.0	0.0	0.4	32.7	1.5	0.1	0.0	8.4	0.0	2.9	0.0	34.2	17.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.3	0.1	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM136A	FLJ14668	ENSG00000035141	"Family with sequence similarity 136 member A"	Q96C01	2	70295975-70302090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030103, HPA030104"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria		"HPA030103: AB_10600194, HPA030104: AB_10600534"	"unprognostic (2.81e-1)"	"unprognostic (5.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (4.95e-3)"	"unprognostic (3.03e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.00e-3)"	10.7	12.2	16.0	17.8	16.4	20.4	16.8	16.4	19.4	15.2	16.1	25.9	26.1	10.0	14.6	19.2	14.3	9.7	21.5	16.0	17.8	20.1	32.5	10.5	17.5	17.0	17.0	10.6	31.4	20.6	10.3	18.0	17.9	15.8	27.1	16.4	27.1	14.1	24.5	14.7	21.6	14.0	15.8	13.6	19.6	8.9	17.9	17.7	20.6	22.2	21.4	17.8	10.5	15.5	94.8	83.4	51.5	72.4	26.5	39.1	78.4	50.2	47.7	67.8	46.8	222.0	53.3	64.9	44.5	43.6	58.9	42.5	106.8	40.0	69.2	67.1	121.3	99.7	62.1	138.8	38.1	166.5	62.7	27.0	27.3	63.9	54.0	36.3	73.8	93.0	161.1	51.0	51.0	138.0	107.6	143.9	129.2	127.7	88.7	71.2	96.2	107.1	104.9	65.4	119.7	52.3	37.7	90.6	76.1	47.3	37.6	47.9	44.9	28.9	85.1	44.7	96.2	42.3	70.0	75.2	72.0	93.2	50.1	35.8	27.9	21.0	21.3	39.8	31.9	37.0	23.6	25.9	37.8	33.2	27.3	27.6	2.6	53.4	27.9	24.8	20.5	29.6	16.0	16.4	16.4	19.4	16.0	17.8	17.0	17.0	17.9	15.8	17.9	15.5	16.7	41.7	31.6	8.8	49.5	28.0	35.4	41.3	35.3	26.3	46.6	46.1	54.7	11.5	38.9	33.1	25.0	89.5	46.0	52.3	70.5	71.8	1.3	39.3	28.3	20.1	32.9	50.5	8.6	99.1	107.5	31.9	40.8	47.1	27.9	46.1	18.9	59.3	69.8	8.4	9.4	61.2	44.7	22.4	29.2	3.6	13.4	31.9	28.4	3.7	42.0	29.1	49.4	6.0	3.6	95.0	58.1	18.4	88.6	54.8	69.7	73.5	31.8	26.7	13.1	19.8	32.5	14.0	53.8	49.8	41.9	29.6	36.8	49.2	66.7	45.7
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM13B	"ARHGAP49, C5orf5, FAM13B1, KHCHP, N61"	ENSG00000031003	"Family with sequence similarity 13 member B"	Q9NYF5	5	137937960-138051961	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 140.6;Inhibitory neurons: 140.0;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036525, HPA041819, HPA071936"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474"	"unprognostic (8.09e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (3.55e-5)"	"unprognostic (9.56e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	13.4	22.6	14.4	15.7	18.5	24.0	15.9	18.7	15.7	15.4	7.9	14.1	9.8	22.4	14.0	14.0	14.7	14.8	20.6	13.8	22.0	13.7	8.6	13.7	21.4	14.8	14.3	24.6	9.5	15.6	8.7	16.2	15.9	24.4	12.2	12.6	11.3	35.7	4.4	11.1	10.9	32.4	8.9	17.8	11.6	34.0	21.3	17.7	15.1	7.6	23.4	17.1	11.6	18.7	18.1	9.0	26.2	21.6	34.3	10.7	20.6	39.1	31.7	29.3	33.8	24.1	16.0	40.7	12.8	34.3	37.4	13.8	16.3	12.6	38.0	30.9	17.6	18.3	21.7	7.6	11.6	30.0	24.3	13.7	6.9	22.4	13.0	15.4	10.2	14.6	10.7	20.2	27.4	13.3	30.5	16.4	10.4	14.0	10.7	21.7	26.1	8.1	17.7	31.6	29.6	26.0	30.5	9.3	38.8	37.6	25.4	30.2	13.5	31.3	13.5	23.2	29.9	16.2	42.2	38.2	17.6	24.3	27.3	10.7	2.2	8.6	4.6	3.3	3.9	5.3	3.3	4.2	1.7	5.6	3.4	4.5	7.1	6.0	5.9	2.9	3.5	1.7	14.4	18.5	18.7	15.7	13.8	22.0	14.8	14.3	15.9	8.9	21.3	18.7	21.2	22.4	19.8	63.6	56.7	15.4	15.7	10.0	64.9	19.4	23.2	20.7	43.3	14.3	15.2	5.5	20.9	12.4	44.9	8.7	3.9	6.8	40.8	28.1	25.2	17.8	10.3	18.5	140.6	3.5	4.0	21.7	16.8	36.0	30.4	29.2	18.9	5.4	13.9	11.8	140.0	9.9	6.1	24.6	28.9	30.5	16.1	31.2	12.4	73.1	17.6	5.9	28.8	130.2	227.6	6.4	7.0	25.6	37.5	12.5	7.6	5.6	12.9	15.2	26.3	29.8	24.8	29.9	21.7	39.6	13.8	5.2	46.9	49.6	8.4	12.8
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246130-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.0"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 477.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	13.5	16.2	20.8	3.9	45.8	0.0	9.3	33.2	32.4	8.7	3.7	7.7	4.2	8.7	8.0	13.8	14.5	11.5	8.1	21.3	34.3	3.4	2.1	9.9	4.7	49.3	36.3	21.2	2.2	4.7	4.7	2.6	40.9	17.2	6.2	9.9	5.6	7.9	17.1	7.2	5.9	12.2	35.5	5.1	3.8	5.2	37.6	5.2	6.3	22.9	2.3	4.4	7.9	68.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.2	0.1	0.0	1.2	0.0	4.1	1.9	0.1	0.0	0.0	5.1	0.6	0.2	0.0	3.4	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.8	0.0	0.0	1.3	8.6	5.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	2.5	2.2	0.1	2.1	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	45.8	33.2	32.4	21.3	34.3	49.3	36.3	40.9	35.5	37.6	68.0	47.8	0.0	0.0	33.6	0.1	4.8	9.3	0.3	8.0	10.5	0.7	2.7	2.5	0.0	0.7	0.0	6.2	0.0	0.4	0.1	7.9	0.0	49.0	18.6	1.5	35.2	0.0	0.0	66.8	0.0	0.0	19.8	0.5	5.3	0.0	26.9	3.9	0.5	0.0	3.3	73.2	0.2	20.3	0.0	2.5	22.1	23.0	0.7	3.6	7.5	0.0	8.8	0.0	56.8	477.1	0.0	0.0	21.1	0.1	5.4	0.0	0.6	20.7	13.6	39.5	23.4	36.2	1.4	0.7	2.4	6.3	0.0	1.2	17.4	0.2	1.1
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Microglial cells: 41.2;Muller glia cells: 29.1;Rod photoreceptor cells: 35.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.1;JURKAT: 8.3;MOLT-4: 8.5;RT4: 9.6;SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA044019: AB_2732513, HPA055004: AB_2682667"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favorable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	11.8	5.1	22.7	1.6	25.5	0.1	6.0	20.1	26.5	7.4	25.9	13.0	5.7	7.4	11.9	11.2	13.7	14.8	7.2	28.7	22.0	35.7	50.4	5.4	1.4	23.4	22.7	7.5	25.7	9.4	5.7	2.2	23.2	9.5	7.6	26.6	9.9	16.0	10.0	2.7	5.2	7.2	23.0	2.3	14.8	5.2	24.7	2.1	3.4	11.4	1.7	11.1	5.4	23.2	0.0	3.3	2.9	0.1	11.1	4.5	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	2.9	0.0	5.3	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.7	0.1	0.2	2.0	0.3	0.2	0.0	1.1	0.0	8.3	0.0	2.5	1.3	1.7	8.5	0.4	5.1	0.0	0.0	0.3	0.0	2.1	1.7	9.6	14.2	3.9	0.1	0.0	4.7	0.9	1.0	0.0	0.9	0.2	1.6	0.0	1.7	0.0	0.1	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.2	0.0	22.7	25.5	20.1	26.5	28.7	22.0	23.4	22.7	23.2	23.0	24.7	23.2	1.8	0.0	1.5	8.1	0.5	0.5	2.4	0.4	1.2	11.8	0.6	1.0	8.5	22.8	4.4	5.5	45.9	0.7	0.0	1.6	5.9	9.5	15.3	17.4	3.7	1.8	9.5	2.7	8.8	5.4	0.9	5.0	4.1	16.7	0.0	0.4	1.4	13.8	0.2	1.7	12.4	3.7	2.0	1.3	1.8	5.6	3.4	2.6	3.6	41.2	0.0	29.1	0.0	7.5	0.5	5.0	4.0	4.1	2.9	2.3	0.8	8.5	11.1	35.5	6.6	2.5	3.3	1.0	4.7	1.6	0.3	0.8	1.1	0.1	3.3	2.8
FAM149B1	KIAA0974	ENSG00000138286	"Family with sequence similarity 149 member B1"	Q96BN6	10	73168119-73244504	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039189, HPA039859"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039189: AB_10805355, HPA039859: AB_2676712"	"unprognostic (2.23e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.24e-2)"	12.3	10.6	20.7	6.4	23.1	5.2	12.4	22.8	22.9	14.1	18.9	9.2	7.7	11.5	12.6	11.7	13.6	12.6	12.6	19.2	21.3	21.8	19.1	10.4	9.4	21.6	22.1	15.0	12.2	13.9	6.2	13.3	22.8	10.9	9.9	11.8	11.3	10.6	13.6	7.8	8.9	11.5	21.1	8.0	9.9	21.9	21.3	12.4	12.3	17.2	9.7	10.6	7.6	25.3	8.7	8.4	19.8	19.0	45.9	28.5	13.9	12.5	28.6	9.8	17.1	2.5	23.6	8.1	5.8	25.8	10.8	10.1	12.6	18.4	11.7	11.1	4.7	6.3	5.6	7.4	23.8	10.2	6.1	24.6	13.4	12.6	48.6	44.5	24.9	11.7	5.8	15.2	18.0	10.4	7.7	12.9	8.7	29.8	19.7	4.3	11.2	9.9	26.4	12.1	3.3	20.1	11.1	30.1	19.6	17.8	18.6	9.9	12.7	8.2	6.6	8.2	12.6	20.0	8.8	4.4	15.9	11.3	7.0	0.7	0.2	0.6	0.3	0.6	0.2	0.3	0.1	0.2	0.4	0.4	0.5	0.4	0.5	1.0	0.2	0.6	0.1	0.1	20.7	23.1	22.8	22.9	19.2	21.3	21.6	22.1	22.8	21.1	21.3	25.3	5.4	3.2	3.1	24.8	3.9	2.0	3.5	4.6	6.8	6.7	5.3	5.2	12.2	5.7	5.4	1.8	6.2	7.4	2.4	4.6	1.9	3.9	21.8	6.1	7.0	6.2	7.7	3.0	19.7	3.6	5.8	7.2	5.1	6.1	2.5	8.2	7.1	4.0	5.4	3.3	24.9	5.0	6.1	6.3	3.1	27.6	8.4	4.0	1.8	12.2	4.1	4.6	1.0	23.6	41.3	4.2	2.2	4.5	1.8	4.6	6.6	6.9	9.8	11.4	13.1	5.9	5.0	13.4	5.1	5.3	3.7	8.2	3.4	7.2	5.4	4.3
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609181-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 66.3;kidney: 174.5"	"Group enriched"	"Detected in some"	15	"Proximal enterocytes: 478.5;Proximal tubular cells: 294.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"CACO-2: 78.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA		10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.6	0.3	0.5	0.6	1.5	0.2	0.1	1.6	0.9	0.0	5.9	2.4	2.4	0.1	0.0	0.3	0.0	0.1	3.0	0.6	0.5	174.5	16.7	0.0	5.3	2.7	2.8	0.3	0.6	0.0	0.1	0.0	1.5	0.1	1.3	0.3	0.5	0.0	1.0	0.1	66.3	0.0	0.4	0.8	0.7	0.6	2.2	0.2	0.4	0.0	1.8	0.1	0.0	0.6	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	78.9	0.9	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.7	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.5	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	1.6	0.9	0.6	0.5	2.7	2.8	1.5	0.4	2.2	0.6	0.0	0.0	0.0	3.6	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	9.3	13.7	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.4	16.8	0.0	0.3	0.0	14.3	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	25.0	0.0	0.0	0.0	478.5	294.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.1	18.1	0.0
FAM151B	UNQ9217	ENSG00000152380	"Family with sequence similarity 151 member B"	Q6UXP7	5	80487969-80542563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043805	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA043805: AB_10794287"	"unprognostic (1.29e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.28e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.46e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.63e-1)"	0.7	1.0	0.7	0.7	0.9	4.7	0.7	0.4	0.9	0.8	0.4	0.4	0.4	0.6	0.9	0.5	1.3	0.9	0.9	1.0	0.5	1.1	0.8	0.7	0.3	0.6	0.4	0.6	0.6	1.1	0.7	1.8	0.2	0.8	0.6	1.0	0.4	0.5	0.3	0.3	0.3	0.9	0.5	0.7	0.5	0.7	0.9	0.2	0.8	0.3	0.4	0.7	0.5	0.7	0.1	1.5	0.7	3.2	2.6	3.7	1.0	1.3	1.9	1.1	2.4	0.1	1.2	0.0	0.2	3.4	3.4	0.8	1.1	0.2	0.9	0.3	0.7	0.3	0.5	0.3	1.1	0.5	1.7	1.8	1.1	1.2	0.1	2.1	1.7	0.4	0.1	0.5	1.8	1.1	0.2	0.2	0.1	0.3	0.6	0.4	2.6	0.4	1.3	0.5	0.3	0.7	0.4	1.2	1.1	0.3	1.7	1.4	0.7	0.2	0.2	0.0	0.5	0.0	0.7	0.0	1.8	1.4	1.1	0.0	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.9	0.4	0.9	1.0	0.5	0.6	0.4	0.2	0.5	0.9	0.7	0.3	0.0	0.0	3.6	0.4	0.3	0.5	2.2	0.6	1.0	1.4	0.8	1.8	2.8	1.7	3.7	0.0	7.9	0.1	0.3	0.0	1.5	4.1	3.9	1.3	0.9	0.0	0.0	17.8	2.1	6.7	2.0	1.5	2.6	1.3	1.1	0.4	0.3	5.1	1.7	21.6	0.5	0.0	4.8	1.2	1.9	1.2	3.6	0.0	6.5	2.2	1.5	0.0	18.6	8.5	0.3	0.3	0.4	1.3	0.7	0.6	4.3	3.7	0.8	0.0	1.2	0.8	4.7	0.9	1.0	1.0	7.9	0.1	1.3	0.2	0.6
FAM153A	NY-REN-7	ENSG00000170074	"Family with sequence similarity 153 member A"	Q9UHL3	5	177707981-177783398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.0;testis: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.5;Excitatory neurons: 45.2;Inhibitory neurons: 20.6;Late spermatids: 20.0;Peritubular cells: 22.2;Sertoli cells: 39.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 2.3;cerebellum: 7.0;cerebral cortex: 5.6;hippocampal formation: 5.8"	"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.9"	"Not detected"	"Not detected"											"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836"	"unprognostic (5.92e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	0.5	0.4	2.3	0.5	1.1	0.7	0.0	7.0	5.6	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.4	0.2	0.3	5.8	0.0	0.3	0.1	0.3	0.8	0.0	0.0	2.4	0.7	0.2	3.2	0.0	0.0	1.3	0.0	0.3	0.4	0.2	0.1	0.9	0.2	0.0	0.0	2.2	0.3	19.5	0.0	0.3	0.7	0.0	0.8	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.9	0.8	0.0	0.0	0.0	0.1	0.1	0.1	2.3	1.1	7.0	5.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	2.6	0.1	0.6	3.3	1.0	5.2	2.7	0.2	0.1	2.2	1.5	1.7	0.0	4.2	0.0	1.4	0.0	0.0	1.0	73.5	0.2	0.2	1.1	0.0	0.0	45.2	0.0	0.4	3.5	1.1	0.2	2.5	2.9	0.7	0.0	0.1	0.0	20.6	0.0	0.0	0.0	2.6	20.0	14.0	0.3	0.0	1.0	0.2	0.2	1.0	3.0	0.8	0.6	0.0	22.2	0.1	1.3	0.0	0.1	2.1	0.7	39.5	0.1	4.6	1.0	0.6	0.9	0.6	0.0	2.0	0.2	0.1	0.3
FAM153B		ENSG00000182230	"Family with sequence similarity 153 member B"	P0C7A2	5	176060689-176116015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.5;ovary: 7.2;pituitary gland: 6.7;testis: 22.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 285.8;Excitatory neurons: 59.6;Leydig cells: 101.2;Peritubular cells: 51.6;Sertoli cells: 309.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.5"									"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836"	"unprognostic (1.08e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.66e-2)"	"unprognostic (3.62e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-1)"	0.2	0.9	8.4	1.4	2.6	0.9	0.1	13.5	12.9	0.6	0.0	0.1	0.1	0.3	2.2	0.2	3.0	1.3	0.8	7.3	0.0	0.2	0.1	0.5	2.9	0.0	0.0	7.2	1.7	0.5	6.7	0.0	0.0	2.4	0.2	0.9	0.6	0.7	0.3	0.8	0.3	0.0	0.0	1.1	0.6	22.0	0.0	0.3	1.2	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	1.2	1.0	0.2	0.2	0.0	1.0	0.2	0.1	8.4	2.6	13.5	12.9	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.2	0.1	2.0	3.2	0.9	2.2	7.1	0.1	0.1	1.8	2.8	0.3	0.0	2.1	0.0	1.3	0.1	0.0	0.8	285.8	0.2	0.2	1.8	0.0	0.4	59.6	0.2	0.2	3.9	0.0	0.1	0.0	8.0	1.8	0.3	0.0	0.0	32.7	0.0	2.0	0.0	4.1	31.3	101.2	0.9	1.8	0.0	0.2	1.3	0.0	0.5	0.3	0.2	0.0	51.6	0.0	3.1	0.1	0.0	2.8	1.0	309.0	2.1	7.0	3.7	2.3	0.7	2.7	0.0	1.8	1.4	0.0	1.3
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107867496	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.7;pituitary gland: 5.4"	"Group enriched"	"Detected in many"	6	"Astrocytes: 918.7;Excitatory neurons: 3051.8;Inhibitory neurons: 2146.4;Oligodendrocyte precursor cells: 2307.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.3;RPTEC TERT1: 11.4;SCLC-21H: 7.2;SH-SY5Y: 16.6;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039453: AB_10795290"	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.4	1.1	7.5	0.1	8.6	0.0	0.2	5.9	10.7	0.5	1.0	0.2	0.1	0.6	1.7	0.2	0.2	0.4	0.2	9.3	10.5	0.1	0.0	0.4	0.1	6.0	7.1	0.2	0.1	0.0	5.4	0.4	7.1	1.1	0.2	2.0	0.0	1.6	0.0	0.0	0.2	0.4	4.9	0.1	0.2	1.0	8.4	0.0	0.4	0.0	0.3	0.5	0.3	8.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	2.4	0.0	5.3	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	4.5	0.0	0.0	0.2	0.0	11.4	1.9	7.2	16.6	0.0	0.0	0.0	0.2	4.2	0.0	0.2	5.0	2.1	1.7	0.2	0.0	0.0	0.0	10.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.6	5.9	10.7	9.3	10.5	6.0	7.1	7.1	4.9	8.4	8.3	2.8	3.2	24.6	918.7	0.0	0.1	0.3	0.0	0.0	19.7	0.9	0.3	0.8	0.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	1.3	62.3	8.9	39.5	4.4	0.0	0.0	3051.8	0.0	0.1	3.7	0.0	20.7	0.0	0.5	8.2	0.0	0.2	37.0	2146.4	0.0	0.0	0.0	0.4	22.7	1.8	0.2	0.0	306.3	0.0	6.8	0.0	2307.6	37.2	0.5	0.0	1.2	0.0	0.9	0.0	0.1	0.0	1.6	6.6	0.3	1.5	1.1	2.0	0.1	0.0	0.0	0.4	1.0	0.0	0.3
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69504326-69532508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 43.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 23.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036093: AB_10673613"	"prognostic unfavorable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (1.83e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.1	0.8	2.2	0.0	2.1	0.0	0.2	3.0	2.6	0.2	0.5	0.3	0.1	0.3	0.4	0.1	0.7	0.2	43.5	2.1	2.7	0.9	0.2	0.1	0.1	2.4	3.1	0.1	1.8	3.1	2.4	0.0	3.4	0.9	0.2	0.4	1.1	4.9	0.1	0.0	0.2	0.1	2.0	0.7	1.1	1.5	3.5	0.1	8.0	0.0	0.1	0.2	0.1	2.3	0.0	2.7	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	5.2	0.0	0.0	0.0	16.2	0.6	0.0	0.0	5.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.2	0.0	0.0	24.3	6.5	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.8	0.1	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	3.0	2.6	2.1	2.7	2.4	3.1	3.4	2.0	3.5	2.3	0.2	0.0	0.0	1.3	0.0	0.0	0.3	1.6	0.0	0.4	0.6	0.1	23.7	0.0	0.8	1.8	0.0	0.0	0.0	0.5	0.0	0.5	0.0	2.0	0.5	0.7	1.2	0.0	0.8	1.2	0.0	0.4	0.0	4.4	0.0	0.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.2	0.0	0.0	1.2	0.0	0.5	0.3	0.8	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3
FAM156A	"PRO0659, TMEM29"	ENSG00000268350	"Family with sequence similarity 156 member A"	Q8NDB6	X	52926402-52995472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Excitatory neurons: 9.6;Gastric mucus-secreting cells: 11.2;Inhibitory neurons: 11.1;Microglial cells: 8.4;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056640, HPA056643"	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA056640: AB_2683200, HPA056643: AB_2683201"	"unprognostic (1.80e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.60e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.49e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-13)"	"unprognostic (6.42e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.90e-2)"	36.1	35.1	13.3	10.6	10.4	9.7	33.2	14.6	16.7	35.6	9.6	28.6	11.9	29.6	6.0	22.8	34.1	4.1	23.2	10.6	13.1	26.5	24.8	27.5	5.9	13.0	11.9	34.6	25.9	11.4	61.3	20.6	12.4	32.4	7.3	6.7	21.2	9.1	12.1	44.8	26.6	8.2	6.5	37.3	24.8	22.5	10.7	6.8	34.2	3.7	6.6	27.3	28.5	16.1	16.8	22.6	13.1	19.5	5.9	24.6	66.8	26.4	11.4	21.5	11.7	13.3	6.9	22.3	11.8	19.7	9.3	27.2	11.8	15.4	9.1	21.1	24.4	14.5	71.9	23.9	8.9	13.6	9.4	15.2	5.8	19.0	5.9	10.1	7.1	17.9	14.0	6.3	17.3	27.1	14.7	24.1	11.2	8.4	31.7	20.8	18.5	21.6	6.6	16.8	12.6	14.1	23.2	12.2	7.4	12.9	25.5	8.3	5.6	18.1	17.9	45.5	9.8	34.2	42.0	17.0	24.1	18.8	16.6	0.0	8.5	1.4	5.5	5.8	4.5	4.3	4.6	4.7	13.8	4.4	7.6	3.4	2.4	7.2	6.5	7.8	3.8	5.3	13.3	10.4	14.6	16.7	10.6	13.1	13.0	11.9	12.4	6.5	10.7	16.1	0.2	0.0	1.1	16.0	2.1	0.0	0.2	0.0	4.6	0.4	0.2	0.0	4.3	0.0	0.6	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.8	0.0	1.3	9.6	0.0	0.7	1.5	11.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	11.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	8.4	0.3	0.3	0.0	11.1	11.0	0.1	0.0	0.0	2.9	0.1	0.5	0.0	0.0	0.5	0.0	0.4	0.7	0.0	0.1	3.3	0.1	4.4	1.3	0.2	0.1	0.1
FAM156B	TMEM29B	ENSG00000179304	"Family with sequence similarity 156 member B"	Q8NDB6	X	52891306-52908560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 80.8"									"HPA056640, HPA056643"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056640: AB_2683200, HPA056643: AB_2683201"		"unprognostic (2.91e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.66e-1)"			"unprognostic (3.24e-5)"	"unprognostic (2.97e-1)"				26.7	39.7	33.6	12.0	34.1	13.6	25.7	34.3	38.2	23.0	38.4	19.8	18.4	17.4	18.5	17.5	22.5	17.1	25.2	34.3	33.9	33.2	27.3	19.0	20.4	34.0	32.9	23.5	23.2	10.6	48.1	50.0	33.7	25.7	18.7	14.2	15.7	19.9	7.9	49.0	18.3	18.0	31.8	31.9	19.8	24.2	36.2	10.6	22.4	5.6	13.2	22.5	17.8	33.8	5.0	8.4	11.9	29.1	14.2	29.2	37.2	10.5	16.5	13.0	18.4	10.9	18.9	4.4	3.5	35.1	11.5	9.2	25.3	19.5	16.6	3.7	10.6	3.4	80.8	18.0	26.9	8.0	8.6	37.5	15.3	20.3	13.1	43.0	12.4	16.0	10.8	19.5	32.9	10.2	8.3	33.3	13.8	8.4	14.2	14.4	9.9	13.4	14.3	9.6	10.2	12.6	3.3	22.7	9.4	31.8	9.5	11.2	15.8	47.7	8.5	20.1	12.0	5.5	8.4	13.2	21.6	29.3	8.2	0.0	4.0	1.0	0.9	5.5	1.3	0.8	0.6	0.9	6.1	1.6	1.8	0.6	0.8	2.5	5.4	3.5	2.0	2.7	33.6	34.1	34.3	38.2	34.3	33.9	34.0	32.9	33.7	31.8	36.2	33.8	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409176-151670503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	11	"cerebellum: 13.8"	"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	0.6	1.3	0.8	0.3	0.7	1.8	4.4	13.8	1.2	3.2	32.3	3.3	1.9	1.6	4.0	7.8	2.7	0.9	3.4	1.2	0.0	3.4	0.7	1.9	0.2	0.6	0.6	2.4	10.2	8.3	1.3	0.5	0.8	2.2	3.4	6.7	4.7	1.5	34.5	13.4	2.0	1.1	0.3	0.5	2.5	3.4	0.4	1.5	6.8	16.5	2.3	2.2	3.4	0.2	8.6	0.7	0.0	0.2	0.0	0.1	2.9	0.3	1.4	0.8	0.2	3.6	3.0	0.0	0.8	0.3	2.6	7.4	2.1	6.1	0.9	0.0	3.3	0.0	10.0	0.9	0.0	0.0	0.2	0.2	7.0	0.0	9.2	2.4	0.2	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.8	2.8	0.8	0.0	2.0	0.2	5.1	5.5	1.2	0.4	8.9	7.8	0.2	2.2	3.3	0.0	0.0	0.4	3.7	0.2	1.4	0.0	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	13.8	1.2	1.2	0.0	0.6	0.6	0.8	0.3	0.4	0.2	0.1	3.2	2.0	1.3	0.0	11.9	6.6	2.9	10.8	0.1	2.7	1.9	1.8	0.0	5.2	0.0	0.0	0.3	0.5	5.9	0.0	1.6	3.3	5.9	0.6	0.4	0.0	0.0	15.8	1.8	0.6	0.6	6.1	10.8	1.3	0.3	0.0	0.5	0.3	8.4	2.4	2.3	0.0	0.0	2.1	1.5	0.0	0.6	0.0	1.0	0.0	2.5	0.0	19.1	1.3	1.9	0.3	0.0	1.4	7.9	2.2	0.7	1.3	4.7	0.0	1.0	0.4	6.1	5.8	11.6	14.5	1.6	0.2	0.3	1.8	8.6
FAM160A2	"C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759"	ENSG00000051009	"Family with sequence similarity 160 member A2"	Q8N612	11	6211345-6234711	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055994, HPA063987"	Approved		Approved	Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA055994: AB_2682999, HPA063987: AB_2685166"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.85e-1)"	16.5	14.5	6.2	14.2	6.5	42.3	18.1	6.8	7.2	20.1	9.5	29.8	34.1	21.6	9.5	13.2	20.2	17.8	12.4	6.4	3.8	13.8	20.8	16.0	13.3	4.0	4.4	21.3	24.7	16.3	14.9	12.1	3.5	15.7	27.7	9.6	18.6	14.7	14.0	23.5	33.8	15.8	2.9	14.2	18.9	27.2	4.4	11.3	22.7	10.5	8.9	16.5	16.5	4.4	13.5	13.1	9.0	13.4	11.9	12.8	19.5	7.6	9.1	11.1	10.6	11.2	24.4	10.5	8.2	8.9	18.3	17.4	9.2	13.8	6.7	11.6	13.1	3.6	24.1	6.0	9.8	8.9	11.6	11.7	17.0	10.0	17.7	14.5	11.4	16.2	11.5	12.7	7.0	10.7	8.5	17.0	13.4	17.5	12.2	9.3	4.7	8.6	10.4	9.6	12.0	7.9	10.9	12.7	6.9	9.3	8.7	12.4	9.8	13.6	10.4	20.4	8.1	17.0	15.7	8.1	15.0	7.0	12.3	1.3	3.1	3.4	3.0	1.3	1.8	1.3	1.2	2.2	2.0	1.3	0.9	1.6	3.3	1.1	1.0	0.6	0.2	2.0	6.2	6.5	6.8	7.2	6.4	3.8	4.0	4.4	3.5	2.9	4.4	4.4	19.0	19.2	16.2	28.1	10.1	12.5	11.1	12.5	10.8	12.6	17.8	12.3	4.5	14.3	12.2	12.9	16.7	13.5	15.9	76.8	7.9	11.4	24.2	15.6	10.1	15.2	25.0	18.5	21.3	11.3	10.1	12.9	33.6	11.2	7.0	27.6	9.3	23.7	9.6	6.7	15.8	37.9	16.2	17.6	28.5	6.5	9.9	12.3	14.2	11.2	16.9	7.6	37.0	14.1	15.6	17.6	47.8	7.5	8.3	10.8	65.0	8.8	18.6	24.4	13.1	10.6	11.6	38.5	21.7	8.5	14.9	11.5	14.7	21.9	39.5	10.4
FAM160B1	"bA106M7.3, KIAA1600"	ENSG00000151553	"Family with sequence similarity 160 member B1"	Q5W0V3	10	114821744-114899832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043624	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA043624: AB_10797145"	"unprognostic (2.61e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.43e-2)"	"unprognostic (9.87e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (3.41e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.25e-2)"	15.0	11.7	8.7	10.0	8.4	53.3	11.9	6.1	8.4	12.1	6.1	10.7	12.7	16.0	10.0	7.3	12.3	10.5	14.2	7.8	6.5	7.9	19.0	11.6	12.6	5.6	6.5	14.3	9.8	11.9	7.4	14.9	6.1	10.5	8.1	11.5	8.5	11.3	20.3	8.6	13.2	16.9	5.3	11.4	10.1	18.8	6.9	11.2	11.7	12.3	9.6	11.9	10.0	5.2	16.7	8.9	9.6	14.3	22.9	26.0	11.2	29.7	28.8	16.8	13.4	3.1	6.3	9.9	9.1	27.2	4.3	11.0	4.7	11.9	19.8	36.2	10.2	3.9	16.5	7.2	16.7	10.6	12.8	20.4	11.3	12.5	20.2	36.0	22.9	20.0	5.6	24.4	31.7	7.7	19.0	10.5	6.3	4.8	6.6	16.3	16.3	6.6	11.3	9.9	2.1	8.6	13.2	13.6	15.5	11.3	5.4	6.0	23.1	10.4	6.6	30.7	10.4	10.0	3.0	11.2	13.4	26.0	10.0	19.9	3.2	4.7	5.4	2.4	4.0	3.7	7.4	9.2	3.6	3.6	4.0	5.5	15.2	4.9	2.8	3.7	10.5	2.7	8.7	8.4	6.1	8.4	7.8	6.5	5.6	6.5	6.1	5.3	6.9	5.2	25.9	16.0	8.1	20.5	10.9	7.0	7.9	8.0	14.8	13.9	9.4	6.7	19.5	4.3	8.4	3.7	12.5	12.7	14.1	9.0	1.9	10.2	26.7	12.0	26.2	19.8	7.8	9.9	26.5	9.6	10.2	19.2	23.0	16.8	2.5	29.6	23.9	31.3	6.3	10.1	27.4	9.2	4.1	15.6	6.8	36.0	28.6	11.3	3.6	25.3	11.4	8.3	25.7	28.1	13.8	15.1	3.7	22.2	20.1	19.5	20.8	6.6	8.7	16.9	6.6	13.2	14.4	14.9	6.4	8.9	4.8	12.6	17.5	15.0	5.8	14.8
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089150-22104911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	13.9	11.5	4.5	3.9	4.1	3.6	15.8	3.5	5.5	12.5	3.5	16.2	5.8	12.3	4.9	13.6	12.7	5.6	21.7	3.6	3.5	14.6	10.5	10.6	6.3	4.8	4.2	10.0	22.3	8.2	13.2	5.2	4.1	14.6	2.5	3.0	16.7	10.6	17.7	14.0	13.5	6.9	3.7	11.4	17.4	6.1	4.8	4.2	15.4	7.2	2.2	16.2	12.0	4.6	4.4	8.7	4.3	6.8	9.2	8.1	7.8	8.0	13.6	8.6	5.8	3.9	4.7	4.9	7.7	19.7	7.8	6.3	3.3	9.3	1.9	4.1	4.2	7.3	2.8	2.2	12.4	1.9	5.7	13.6	6.9	6.6	4.4	8.9	9.1	8.8	4.6	3.3	8.3	8.0	5.0	2.9	2.1	8.0	3.8	5.1	3.7	2.5	7.4	8.9	1.8	5.8	4.6	6.6	5.2	4.5	4.3	3.2	10.3	8.4	7.2	8.0	4.6	3.5	0.9	0.9	9.0	3.1	9.7	0.0	0.4	0.1	0.8	0.2	0.5	0.7	0.5	0.6	0.2	0.5	0.4	0.7	0.0	0.4	0.4	0.2	0.0	0.7	4.5	4.1	3.5	5.5	3.6	3.5	4.8	4.2	4.1	3.7	4.8	4.6	16.4	12.8	17.2	17.0	11.6	5.9	10.1	9.9	12.5	22.0	16.4	13.5	26.1	12.8	8.8	12.9	27.1	8.5	10.1	15.5	0.0	9.7	3.7	8.9	14.5	16.8	13.2	1.3	12.3	15.0	15.5	12.5	23.0	11.8	7.0	19.1	16.8	13.6	7.4	23.5	12.0	10.8	0.0	9.4	4.7	2.5	10.8	8.2	1.8	8.4	4.4	8.7	9.2	12.1	11.0	17.1	17.1	5.7	6.3	15.1	14.7	5.0	10.8	23.8	0.0	11.0	14.7	1.5	7.0	16.1	7.5	14.9	11.2	9.6	9.9	12.4
FAM161A	"FLJ13305, RP28"	ENSG00000170264	"FAM161 centrosomal protein A"	Q3B820	2	61824848-61854143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 100.1;Early spermatids: 183.2;Late spermatids: 293.1;Rod photoreceptor cells: 417.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032119	Approved					NA	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA032119: AB_10602806"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-5)"	"unprognostic (7.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.93e-1)"	"unprognostic (8.08e-3)"	"unprognostic (7.04e-2)"	0.9	1.2	0.8	0.5	1.1	0.3	1.1	0.6	1.6	2.1	2.4	1.0	0.4	1.6	1.2	1.1	4.0	1.4	1.5	0.9	1.1	1.9	0.7	1.0	0.7	0.8	0.9	5.2	2.3	1.9	2.4	1.1	0.8	1.0	0.6	28.9	0.7	1.1	1.2	0.6	0.7	0.6	0.6	0.7	2.6	5.5	1.0	1.6	3.6	0.3	0.6	1.1	1.1	0.9	3.4	3.1	7.1	3.3	3.4	3.2	2.1	2.9	1.5	3.4	4.2	2.1	1.7	6.6	1.5	0.5	6.1	1.6	4.3	0.5	8.0	4.5	4.7	2.4	2.8	3.3	2.9	2.7	0.5	1.3	0.0	6.6	1.9	4.0	3.7	6.4	0.9	2.5	2.4	1.3	4.9	5.2	11.0	4.2	3.3	8.4	12.1	3.3	2.4	0.8	8.7	7.3	6.2	0.8	4.7	6.7	1.5	1.8	0.7	5.9	5.2	4.2	6.7	3.8	3.1	8.1	4.2	4.5	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.8	1.1	0.6	1.6	0.9	1.1	0.8	0.9	0.8	0.6	1.0	0.9	3.9	3.2	9.7	20.2	3.7	5.5	9.4	10.2	6.2	49.7	4.8	7.0	14.5	7.2	10.5	20.2	100.1	14.0	2.3	1.5	1.9	4.3	183.2	42.7	11.0	6.7	6.0	5.5	16.6	3.8	7.7	10.7	5.1	4.8	4.5	42.7	4.2	3.8	3.6	16.8	19.0	2.5	14.2	1.2	3.6	293.1	20.8	2.3	8.8	4.7	2.0	42.4	2.1	11.1	33.0	1.3	0.3	16.6	4.0	4.7	0.0	13.0	47.1	417.2	0.0	14.2	9.0	98.0	39.3	5.3	4.1	11.1	3.6	16.4	3.5	3.4
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 625.3;Distal tubular cells: 540.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA075611"	Approved		Supported	Mitochondria		NA	NA		19000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA035856: AB_10611965, HPA075611: "	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	49.0	105.7	54.8	31.3	60.2	39.9	43.9	57.3	82.2	84.5	57.1	145.9	56.1	49.5	59.4	207.6	49.7	46.2	174.2	57.1	58.5	107.6	200.3	32.0	32.9	55.9	57.2	84.3	133.9	116.6	51.0	17.6	55.6	74.6	149.0	83.5	59.8	49.2	141.0	89.8	56.3	44.6	56.6	31.7	93.2	43.6	58.8	34.7	44.1	142.6	42.7	76.9	131.5	55.6	132.0	27.7	40.4	75.6	72.1	66.4	20.7	52.9	46.8	49.0	123.9	69.4	58.7	142.1	89.2	18.2	40.3	89.8	73.5	128.1	130.0	74.0	55.1	115.6	44.0	125.8	47.4	114.0	39.6	77.3	65.5	46.7	97.9	164.3	66.0	137.7	79.2	55.6	71.1	52.0	116.9	137.9	59.5	294.9	144.4	69.5	57.8	186.9	144.3	314.9	60.1	48.1	39.4	92.4	114.3	59.9	57.9	55.7	47.0	48.4	34.6	28.7	55.6	108.8	39.9	144.8	143.3	109.7	22.8	9.9	25.8	75.7	58.3	68.2	86.9	75.3	79.5	74.0	84.6	68.1	85.1	88.6	8.5	50.6	75.9	70.4	80.4	38.8	54.8	60.2	57.3	82.2	57.1	58.5	55.9	57.2	55.6	56.6	58.8	55.6	55.7	28.9	46.0	41.1	68.2	128.1	155.3	625.3	82.0	31.5	80.6	109.5	338.4	84.4	188.6	130.6	47.9	51.4	47.9	477.5	540.0	148.2	102.5	82.0	30.1	49.8	106.9	47.7	33.0	177.6	47.8	78.7	84.6	79.2	85.7	59.3	44.6	280.4	92.7	38.7	30.4	374.3	240.1	66.7	108.9	33.1	134.5	61.2	104.9	7.5	108.9	79.7	45.3	22.1	21.6	141.6	313.2	148.6	61.2	121.4	186.2	466.2	95.5	29.9	105.2	83.2	315.3	146.4	68.3	315.1	132.8	47.2	66.0	121.1	358.4	210.9
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765719	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 65.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036112, HPA060342"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	14.7	14.9	3.3	0.8	4.4	0.0	10.9	1.9	7.0	13.2	2.5	3.3	0.9	5.8	7.5	4.4	10.1	5.2	9.1	4.6	2.7	4.5	0.9	17.9	1.5	3.0	2.5	5.7	1.7	3.7	6.6	65.2	2.7	6.2	2.1	0.2	8.2	13.4	5.4	3.0	2.3	3.7	2.7	0.1	3.5	2.5	2.8	1.8	9.7	10.6	1.2	7.9	9.9	4.7	0.0	0.0	0.0	0.0	2.3	0.1	0.0	8.7	23.5	3.7	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.4	1.9	7.0	4.6	2.7	3.0	2.5	2.7	2.7	2.8	4.7	34.6	0.0	0.0	1.3	0.0	1.3	0.1	0.0	1.2	0.0	0.9	0.8	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	16.9	0.7	15.7	13.7	0.0	0.0	14.8	0.0	0.2	14.1	0.0	0.4	0.0	0.1	3.6	0.0	0.5	0.0	6.9	0.0	0.0	0.0	2.1	2.2	2.1	0.7	1.8	3.7	0.0	0.0	0.0	6.6	0.5	0.2	0.0	5.3	0.0	0.2	0.0	0.1	0.0	0.1	65.7	2.2	105.1	10.3	5.9	0.6	0.9	0.5	2.3	0.1	0.0	0.0
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133577081-133609389	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.1"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"SH-SY5Y: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	10.0	26.5	0.0	44.4	0.0	0.0	0.0	60.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.4	5.2	38.2	0.0	0.8	8.7	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.5	0.8	7.3	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	0.0	6.0	0.2	0.4	2.4	0.0	0.2	0.2	0.0	0.0	1.1	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.7	0.2	0.1	0.0	0.0	2.4	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	44.4	0.0	60.1	38.2	0.0	0.0	0.0	7.3	6.0	0.0	32.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM166A		ENSG00000188163	"Family with sequence similarity 166 member A"	Q6J272	9	137243584-137247770	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 60.8"	"Group enriched"	"Detected in some"	121	"Early spermatids: 626.7;Late spermatids: 1323.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023307	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA023307: AB_1848930"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.67e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.18e-3)"	0.5	0.4	0.0	0.2	0.1	0.1	0.5	0.2	0.2	0.3	0.0	0.2	0.2	0.3	0.7	0.4	0.3	0.0	0.5	0.1	0.1	1.1	1.9	0.2	0.1	0.1	0.1	0.1	0.5	0.0	0.9	0.0	0.1	0.5	0.0	0.4	0.4	0.1	0.2	0.3	0.4	0.0	0.1	0.2	0.3	60.8	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	626.7	0.3	0.1	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	3.8	0.1	0.7	0.8	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1323.3	5.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.2	0.1	0.2	1.6	0.6	0.0	0.3	0.3	8.0	4.8	0.0	0.3	0.3	0.3	0.2	0.0	0.2
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 270.0;fallopian tube: 83.1;skeletal muscle: 185.9"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 108.0;Respiratory ciliated cells: 126.4"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045540	Enhanced					NA	NA				"Cluster 39: Non-specific - Mitochondria"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	5.2	270.0	1.9	0.0	1.5	0.0	2.5	1.2	1.2	3.6	8.8	0.3	0.0	1.3	9.0	0.6	83.1	0.1	0.5	1.7	2.3	0.7	0.6	4.2	0.1	4.7	7.0	0.3	0.2	0.1	0.4	0.0	4.5	0.3	0.2	0.1	0.7	0.6	185.9	0.6	0.6	0.1	5.5	0.2	0.4	0.2	2.2	0.0	0.3	18.3	0.3	0.2	0.2	2.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.5	1.2	1.2	1.7	2.3	4.7	7.0	4.5	5.5	2.2	2.7	0.3	0.0	0.5	0.0	0.0	4.7	1.2	9.2	2.2	0.0	0.3	2.4	0.3	0.0	10.1	0.0	2.1	0.2	0.3	0.0	0.0	0.2	0.3	108.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	24.4	0.0	0.7	0.3	0.3	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	3.3	126.4	0.2	0.0	3.1	3.3	0.2	0.2	2.0	2.0	0.0	0.3	2.1	0.2	0.5
FAM166C	"C2orf70, LOC339778"	ENSG00000173557	"Family with sequence similarity 166 member C"	A6NJV1	2	26562585-26579532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.6;testis: 26.6"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062453	Enhanced		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane, Vesicles"		"HPA062453: AB_2684769"	"unprognostic (5.44e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.40e-6)"		"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (4.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.08e-3)"	0.1	0.1	0.8	0.1	0.7	0.0	0.2	0.5	0.6	0.3	4.1	0.6	0.1	0.2	0.3	0.1	7.6	0.0	0.4	0.8	2.5	1.0	0.0	0.4	0.0	2.0	2.0	0.0	0.7	0.1	0.7	0.0	1.2	0.2	0.4	0.1	1.9	0.2	0.1	0.1	0.1	0.1	1.5	0.0	4.8	26.6	2.9	0.0	1.1	0.0	0.0	0.1	0.0	1.0	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	3.7	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	0.6	0.8	2.5	2.0	2.0	1.2	1.5	2.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM167A	"C8orf13, DIORA-1"	ENSG00000154319	"Family with sequence similarity 167 member A"	Q96KS9	8	11421476-11475908	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.1;thyroid gland: 53.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 28.4;Distal tubular cells: 13.7;Early spermatids: 24.8;Enteroendocrine cells: 19.1;Late spermatids: 41.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.6;RPMI-8226: 61.5;SH-SY5Y: 44.4;U-698: 44.8;U-87 MG: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023915, HPA030426"	Approved		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA023915: AB_1845768, HPA030426: AB_10601318"	"unprognostic (8.51e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (3.08e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-2)"	0.6	0.8	25.8	1.2	25.1	0.7	1.3	23.9	25.3	0.8	17.0	0.7	0.3	0.1	0.5	0.9	1.3	1.0	0.2	26.6	26.7	6.4	0.3	10.2	2.4	29.8	27.6	0.0	2.1	1.7	17.4	0.9	27.9	1.5	0.7	5.2	2.6	4.6	0.0	11.8	1.3	0.0	26.6	1.2	2.0	3.8	31.1	3.0	53.2	0.1	3.0	0.3	1.6	25.1	4.8	3.0	6.1	0.6	0.4	2.5	0.2	16.8	16.0	10.1	4.4	0.2	1.5	57.6	0.9	18.3	4.7	1.6	0.1	4.0	11.9	24.8	0.8	0.0	0.1	0.0	20.8	0.0	0.1	2.9	2.6	5.3	32.2	32.3	0.0	0.0	0.2	2.2	6.0	1.8	0.1	0.0	1.6	0.1	0.1	0.3	0.0	61.5	5.1	0.5	26.3	44.4	0.8	4.7	2.2	0.8	1.8	0.1	28.5	1.0	1.6	25.8	0.2	17.7	14.0	44.8	36.3	0.1	1.6	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.0	25.8	25.1	23.9	25.3	26.6	26.7	29.8	27.6	27.9	26.6	31.1	25.1	0.0	16.0	1.8	28.4	5.4	5.9	0.6	0.5	0.0	0.1	1.2	1.3	0.7	1.5	0.5	5.5	10.4	0.0	1.1	0.2	13.7	2.1	24.8	2.1	0.2	0.2	19.1	0.0	0.6	1.8	0.0	0.3	2.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.4	1.3	0.0	0.3	0.3	41.1	0.3	0.3	0.0	3.7	0.3	1.7	0.0	0.0	1.3	1.1	2.4	0.4	0.9	0.8	0.1	0.2	1.9	1.8	0.0	0.3	0.2	3.9	2.2	0.0	3.4	0.0	1.0	0.1	0.1	0.2
FAM167B	"C1orf90, DIORA-2, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247222-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.0"	"Group enriched"	"Detected in many"	14	"Adipocytes: 68.5;Endothelial cells: 102.5;Hepatic stellate cells: 200.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.6;EFO-21: 12.0;SK-MEL-30: 30.9;U-2197: 29.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"		"HPA029398: AB_10602807, HPA062074: AB_2684677"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	19.9	19.7	4.3	4.1	3.8	0.2	10.0	3.8	6.3	14.3	4.3	7.4	2.8	12.9	0.5	4.0	10.3	4.2	11.0	3.8	4.5	44.0	10.7	20.5	2.7	4.5	4.1	4.1	8.4	4.3	14.4	4.2	4.5	16.5	2.1	1.4	4.7	5.9	3.0	2.4	8.1	5.8	4.4	1.9	7.5	0.9	5.1	0.8	19.9	1.1	1.5	13.2	7.7	4.3	0.9	1.8	0.6	0.0	1.2	1.1	0.0	4.3	9.6	1.9	2.7	0.1	0.9	0.2	12.0	7.3	2.2	1.4	0.3	0.0	0.6	0.1	0.0	0.0	4.6	0.5	0.4	0.0	0.1	1.0	0.7	1.4	0.4	2.6	3.5	0.6	0.0	0.1	0.2	0.6	0.2	0.0	0.3	0.2	4.1	0.9	0.0	1.2	1.2	0.4	1.8	0.4	2.8	0.2	30.9	0.8	0.5	0.1	3.2	0.8	0.9	29.9	0.1	0.1	0.3	0.7	0.3	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.7	0.2	4.3	3.8	3.8	6.3	3.8	4.5	4.5	4.1	4.5	4.4	5.1	4.3	68.5	0.0	1.1	0.3	3.2	0.3	0.5	0.2	0.0	0.4	2.8	2.8	0.4	0.0	0.1	5.5	0.0	0.1	2.7	1.3	0.0	0.5	0.0	1.3	3.5	102.5	0.0	8.0	0.0	0.8	0.2	3.7	1.5	1.0	0.0	0.2	200.3	1.7	0.6	0.0	0.1	1.3	0.0	8.5	2.2	0.0	2.8	1.4	1.8	2.8	0.0	0.0	2.1	0.5	0.4	0.2	1.2	1.2	0.6	0.6	0.0	0.1	1.3	0.5	0.0	0.6	1.6	0.0	0.3	0.3	1.0	0.3	2.1	0.9	0.7	0.3
FAM168A	"KIAA0280, TCRP1"	ENSG00000054965	"Family with sequence similarity 168 member A"	Q92567	11	73400487-73598189	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 125.0;Excitatory neurons: 171.0;Inhibitory neurons: 161.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037580	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA037580: AB_10672906"	"unprognostic (2.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (4.60e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.41e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.70e-4)"	13.5	10.9	43.7	10.8	44.9	11.0	13.3	48.8	48.8	14.6	2.3	16.0	8.1	15.3	18.0	8.9	14.1	13.9	13.6	42.6	50.0	12.1	11.3	10.4	9.0	59.1	48.3	16.7	9.7	21.9	12.4	9.8	54.0	12.9	9.6	49.7	12.7	15.7	19.9	8.7	12.0	18.1	49.7	9.4	10.7	8.5	56.0	13.2	14.8	15.3	8.3	12.8	8.8	46.8	13.4	15.6	33.6	19.0	24.2	27.0	5.1	19.6	22.5	21.5	20.5	17.6	17.4	14.9	16.9	34.9	20.1	12.3	19.4	19.3	26.3	10.3	14.3	17.1	17.3	9.6	9.4	9.2	30.8	25.3	13.5	21.3	11.2	29.2	13.8	23.9	4.3	10.9	22.3	20.2	21.4	9.4	11.5	27.4	19.7	30.3	56.7	8.1	12.8	12.0	22.3	34.6	23.1	17.5	37.8	12.3	28.4	10.7	17.8	24.5	20.6	31.9	16.2	24.9	18.7	25.7	13.0	11.3	22.9	6.0	1.3	0.9	0.8	2.3	0.4	0.4	0.3	0.6	1.1	0.5	0.6	0.6	2.9	0.5	1.5	1.4	0.6	0.3	43.7	44.9	48.8	48.8	42.6	50.0	59.1	48.3	54.0	49.7	56.0	46.8	18.3	3.2	8.2	125.0	4.0	3.8	2.3	7.1	3.4	21.8	11.0	9.7	20.3	15.7	9.9	7.3	45.9	2.3	5.7	5.2	0.0	3.3	22.4	13.1	12.5	9.7	12.7	2.1	171.0	2.7	3.6	9.4	5.6	19.2	22.9	31.9	11.0	16.6	9.8	3.3	161.2	8.6	2.0	14.8	6.8	25.4	7.5	10.0	5.4	59.0	7.3	26.7	5.2	166.9	149.1	3.4	2.8	12.8	2.9	1.8	8.4	4.2	7.2	24.4	6.6	12.3	19.1	7.0	6.1	5.3	3.8	2.7	4.9	6.9	6.7	1.7
FAM168B	"KIAA0280L, MANI"	ENSG00000152102	"Family with sequence similarity 168 member B"	A1KXE4	2	131047876-131093460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043778, HPA061659"	Enhanced					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043778: AB_10964889, HPA061659: AB_2684577"	"unprognostic (8.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.30e-5)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.35e-3)"	41.5	33.7	55.5	26.8	67.7	46.2	32.1	49.8	60.1	35.4	32.6	54.2	26.3	51.4	26.5	34.4	37.9	23.7	43.4	57.5	52.1	38.4	30.9	27.6	27.8	51.4	53.6	46.9	30.1	46.7	20.3	29.4	54.0	37.5	31.9	48.6	28.1	46.8	69.9	29.9	34.3	40.8	54.7	24.2	36.3	26.8	60.1	38.5	36.2	52.9	31.3	47.6	28.0	55.8	74.1	47.6	98.2	67.7	82.2	62.4	74.0	75.2	54.9	46.3	39.7	88.1	40.0	78.6	61.1	79.8	31.8	57.1	83.8	83.8	66.2	64.8	62.3	72.1	49.8	67.4	83.0	84.8	58.6	63.6	82.4	94.5	81.0	62.3	65.5	72.3	70.3	28.9	72.2	53.4	68.0	55.3	61.6	60.2	57.5	85.0	82.5	70.2	63.7	84.0	71.3	100.0	58.2	58.8	80.1	46.0	52.4	79.2	70.8	77.3	78.9	58.0	73.9	67.9	81.2	98.1	65.9	49.3	70.7	2.5	2.2	4.3	4.4	1.5	4.0	3.0	3.6	3.7	2.0	3.0	4.7	3.4	2.1	2.5	3.4	3.3	3.2	2.8	55.5	67.7	49.8	60.1	57.5	52.1	51.4	53.6	54.0	54.7	60.1	55.8	24.4	35.3	27.4	25.1	19.0	22.8	18.3	24.5	16.5	32.2	28.6	23.6	51.4	24.3	21.6	35.0	37.5	27.0	22.5	38.8	5.9	24.8	12.3	28.0	21.6	22.8	31.8	13.3	47.9	30.8	24.8	23.8	19.4	29.0	19.0	34.7	22.1	39.8	20.1	30.3	52.2	29.8	14.2	25.1	16.0	11.1	29.2	19.2	24.9	28.1	20.9	27.0	14.4	18.6	38.8	38.0	25.3	49.7	25.1	33.3	27.3	26.8	19.5	42.3	13.1	27.5	27.4	18.2	22.8	20.0	25.1	38.3	19.0	23.2	36.7	31.0
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;retina: 71.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.9;Hep G2: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.1	2.8	13.2	0.7	14.7	1.1	0.5	4.4	12.9	1.0	0.0	1.3	0.3	2.4	18.0	0.3	2.6	2.1	1.3	9.4	27.2	4.7	2.2	0.3	1.5	14.1	10.6	2.1	1.3	5.1	2.1	0.7	9.6	4.5	2.0	71.4	1.4	4.6	0.1	0.2	0.3	0.3	17.0	1.7	1.4	12.4	17.0	5.1	7.1	0.1	1.6	3.1	0.2	17.1	8.0	7.2	4.8	6.7	0.0	0.0	31.9	1.3	2.5	5.1	5.1	3.0	5.2	0.0	3.4	0.1	13.9	5.4	10.2	15.3	5.5	5.7	11.9	2.2	1.3	23.4	0.2	0.0	0.1	0.1	16.2	1.3	7.2	0.8	0.0	7.3	0.0	0.1	3.0	2.2	7.4	0.1	12.8	1.8	4.1	10.9	3.2	0.5	4.8	12.8	2.8	3.8	12.9	5.5	1.0	21.5	5.6	1.4	0.0	0.3	4.8	0.0	5.5	17.7	18.5	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.0	1.4	0.2	0.6	0.9	0.0	0.4	1.2	1.3	0.0	0.3	0.0	0.2	0.3	0.6	13.2	14.7	4.4	12.9	9.4	27.2	14.1	10.6	9.6	17.0	17.0	17.1	0.3	0.0	0.0	32.0	5.7	0.3	6.5	2.8	1.2	138.0	1.2	1.5	1.6	1.5	3.5	49.7	141.8	5.4	14.2	1.6	3.9	1.9	15.5	8.5	1.9	2.6	3.5	1.3	103.4	0.0	0.5	1.5	6.6	10.9	1.3	24.7	0.0	4.1	0.5	85.8	101.3	1.3	2.0	1.9	0.0	29.0	5.0	0.7	1.8	14.0	0.9	191.3	11.3	67.3	58.2	2.9	0.5	4.1	4.8	8.1	2.2	2.8	2.8	179.7	0.0	0.3	1.5	25.2	13.4	1.4	0.1	0.3	7.8	5.7	1.4	4.4
FAM170A	ZNFD	ENSG00000164334	"Family with sequence similarity 170 member A"	A1A519	5	119629559-119635822	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 11.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.5;Late spermatids: 11.7;Sertoli cells: 6.6;Spermatocytes: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037900, HPA037902"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA037900: AB_2675728, HPA037902: AB_2675730"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"		"unprognostic (9.70e-3)"			"unprognostic (1.89e-1)"					"unprognostic (1.06e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.12e-1)"		"unprognostic (2.25e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	54.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM170B	"AC084727.4, C10orf73"	ENSG00000172538	"Family with sequence similarity 170 member B"	A6NMN3	10	49131154-49134021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 6.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043899, HPA050610"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA043899: AB_2678721, HPA050610: AB_2681189"													"unprognostic (8.01e-2)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	19.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM171A1	"APCN, C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"TIME: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	11.0	5.0	60.1	7.5	73.2	0.5	8.8	69.8	56.4	11.8	22.7	21.6	19.1	12.8	6.4	6.4	15.6	12.9	10.6	68.5	49.5	31.9	15.4	7.4	6.0	79.6	64.8	14.2	22.4	10.9	3.7	4.1	75.6	11.2	17.6	2.6	14.1	11.9	7.6	4.2	13.0	12.3	59.3	12.4	13.3	3.5	68.7	3.9	6.9	6.1	6.6	9.0	6.3	86.7	0.0	16.2	33.3	12.6	13.2	24.9	0.4	19.5	3.9	10.2	8.8	3.0	19.2	0.1	21.5	53.4	22.7	1.4	24.0	0.2	11.5	5.9	33.4	46.7	5.2	48.1	14.3	0.0	36.0	19.7	4.9	27.8	4.0	36.8	51.4	6.8	17.5	0.2	32.8	1.4	7.7	0.1	30.4	9.3	7.8	30.4	17.0	5.1	12.7	0.0	22.4	27.6	10.9	0.2	0.1	35.0	0.2	0.6	105.6	13.9	53.6	50.4	20.8	6.3	2.1	0.1	30.3	0.0	10.8	0.0	0.0	0.0	1.7	0.0	4.4	0.0	2.5	2.2	0.0	0.0	4.7	2.4	0.0	0.2	0.0	0.0	0.5	0.9	60.1	73.2	69.8	56.4	68.5	49.5	79.6	64.8	75.6	59.3	68.7	86.7	11.1	0.0	0.0	263.8	1.0	1.3	4.0	3.1	8.0	4.0	7.6	5.7	6.8	98.7	1.7	14.7	0.0	0.1	0.2	25.4	3.9	21.1	0.7	5.9	12.5	43.7	21.0	6.5	166.9	12.2	0.2	12.3	35.7	14.6	1.3	14.4	49.2	24.7	0.4	6.7	76.6	23.7	4.1	2.8	1.7	1.1	5.3	0.3	1.8	33.7	0.7	1.5	0.0	44.2	214.4	17.5	16.1	5.7	5.2	16.5	7.3	4.5	2.4	1.1	0.0	7.5	5.9	2.3	5.7	8.0	1.8	0.1	2.0	11.4	38.8	3.6
FAM171A2	MGC34829	ENSG00000161682	"Family with sequence similarity 171 member A2"	A8MVW0	17	44353215-44363853	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3;pituitary gland: 7.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 40.1;Horizontal cells: 43.7;Muller glia cells: 131.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.9;REH: 23.2;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019770	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA019770: AB_1848383"	"unprognostic (1.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.14e-3)"	"unprognostic (8.47e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.62e-4)"	"unprognostic (5.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.76e-2)"	1.0	1.0	10.3	0.1	11.7	0.1	0.4	0.3	17.3	4.1	0.0	0.5	0.1	2.5	2.8	2.2	1.8	0.7	0.8	11.0	2.6	1.1	0.1	0.5	0.2	3.1	0.0	3.3	0.2	2.9	7.9	0.4	0.7	1.0	0.0	1.6	0.5	0.9	0.1	0.7	0.4	0.3	0.0	0.2	0.3	0.4	0.2	0.1	1.5	0.0	0.1	0.2	2.0	3.6	1.5	2.2	6.7	9.4	1.1	1.3	4.7	2.6	0.3	2.1	2.6	0.2	0.2	3.1	5.8	0.7	1.2	0.1	2.4	0.6	0.2	2.6	12.9	0.9	0.2	1.3	0.7	0.2	0.5	1.6	0.2	0.8	0.0	3.8	3.3	6.9	2.1	0.1	0.7	8.0	7.3	1.2	10.0	0.1	4.9	23.2	4.4	1.9	0.4	0.5	15.9	11.9	0.9	0.1	1.2	1.6	2.6	1.6	2.1	3.1	5.8	5.2	0.8	1.0	0.3	1.1	0.2	1.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	11.7	0.3	17.3	11.0	2.6	3.1	0.0	0.7	0.0	0.2	3.6	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	40.1	0.3	1.7	1.4	0.0	0.0	3.7	12.5	0.0	0.7	0.0	0.0	0.2	0.0	2.8	7.4	2.0	0.0	0.0	1.6	0.0	0.2	1.4	0.0	11.3	0.0	2.7	2.5	0.0	0.2	43.7	0.7	0.0	0.0	0.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	131.2	0.0	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.0	0.0	0.0	7.8	0.0	0.2	1.6	0.1	1.2	0.5	0.1	0.0	0.7	0.5	0.1	0.1
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186694060-186765959	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 258.6;Bipolar cells: 141.4;Excitatory neurons: 126.5;Inhibitory neurons: 114.2;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 78.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.7;U-138 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	2.9	14.4	36.1	1.5	52.2	0.5	3.4	8.3	54.8	6.6	0.0	1.8	1.0	7.5	2.1	1.9	2.7	4.9	1.4	52.8	33.0	1.2	0.3	1.4	1.2	15.0	16.9	10.2	1.0	7.6	10.7	3.3	17.6	2.7	2.0	24.1	23.0	2.3	0.7	3.7	1.4	4.4	17.2	1.5	2.0	0.9	28.3	2.8	2.2	3.6	1.1	2.2	2.2	30.1	4.2	4.9	7.2	22.6	20.9	15.7	0.1	4.5	8.0	5.5	7.8	13.6	21.9	0.0	1.6	12.9	9.3	0.5	9.9	4.3	7.8	0.0	5.7	5.1	2.1	0.0	1.6	1.5	1.7	20.2	1.8	4.2	3.4	7.1	12.1	3.9	0.0	43.7	10.5	2.9	3.0	0.0	9.6	0.0	4.9	0.0	13.9	1.0	8.5	15.8	22.4	12.2	2.3	1.4	6.1	4.2	1.7	1.0	7.1	29.7	3.9	0.5	2.9	11.5	12.0	0.0	9.2	0.0	4.2	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.2	0.0	0.0	36.1	52.2	8.3	54.8	52.8	33.0	15.0	16.9	17.6	17.2	28.3	30.1	9.1	0.0	0.0	258.6	0.1	8.9	2.8	1.2	4.0	141.4	10.7	5.7	0.8	5.7	5.7	0.0	14.6	11.4	0.5	0.0	0.0	1.0	1.3	1.5	13.0	14.4	4.8	1.3	126.5	0.4	0.8	14.1	2.6	4.7	0.0	0.8	6.8	0.1	2.0	23.5	114.2	0.0	4.1	0.3	2.8	4.0	7.8	1.0	3.6	18.7	0.7	16.2	0.0	102.1	78.5	0.7	0.0	13.9	0.2	1.4	0.0	0.2	2.6	17.0	0.0	8.6	4.5	0.4	1.5	0.6	5.3	8.2	0.9	2.6	0.0	1.1
FAM172A	"C5orf21, DKFZP564D172, Toupee"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93617725-94111699	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 174.3;Excitatory neurons: 259.9;Inhibitory neurons: 297.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	13.6	9.7	10.2	8.1	10.7	7.6	12.9	12.8	11.1	12.7	7.3	8.4	7.5	12.7	10.0	11.6	12.2	9.4	9.3	10.2	11.0	12.3	5.3	9.1	9.2	10.4	9.7	15.0	9.6	12.4	7.1	8.3	10.2	12.4	8.1	14.8	10.9	14.3	3.0	7.7	8.9	11.5	10.6	9.8	8.8	5.6	10.4	9.8	15.5	6.7	9.0	9.4	7.4	11.4	7.5	8.8	20.4	23.1	24.0	29.3	10.7	16.4	12.1	6.7	6.5	6.0	10.1	10.7	11.6	18.7	11.8	6.3	6.3	22.2	15.4	7.4	7.7	14.2	17.0	3.6	10.0	11.5	15.8	25.3	12.2	6.2	11.8	23.7	15.0	10.1	3.0	3.3	27.3	8.3	9.3	8.1	3.1	13.8	7.0	10.3	21.7	10.3	10.1	14.5	17.5	32.1	12.4	5.0	11.6	12.8	12.8	12.9	14.8	15.6	14.1	10.3	18.7	13.4	20.8	11.9	24.0	11.9	29.1	12.4	4.0	5.4	8.2	5.4	8.4	6.7	6.1	6.2	5.3	6.3	6.8	6.9	9.3	9.7	4.1	5.0	6.9	4.8	10.2	10.7	12.8	11.1	10.2	11.0	10.4	9.7	10.2	10.6	10.4	11.4	27.8	54.5	26.4	174.3	40.0	12.2	25.0	26.4	23.3	49.5	31.4	28.2	21.5	22.8	23.4	11.0	31.3	13.0	47.4	14.3	60.7	19.9	47.7	29.2	34.9	25.4	16.9	10.3	259.9	21.2	13.7	32.6	21.9	21.9	25.3	22.7	21.8	14.9	11.3	42.1	297.7	13.9	22.4	21.3	12.1	34.2	38.5	18.0	21.4	227.7	27.9	37.4	58.7	264.9	343.8	20.1	14.7	36.5	17.3	19.7	27.7	35.2	47.5	54.5	13.1	39.5	30.7	22.4	26.1	25.8	10.1	10.9	37.4	30.7	16.4	24.4
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535374-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 154.5;Respiratory ciliated cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 55.8"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.8"	"Cell line enhanced"	"Detected in all"		"U-266/84: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	16.1	23.1	13.0	8.1	14.4	2.8	15.3	13.4	16.5	11.4	23.3	12.6	11.2	12.1	12.1	24.3	34.8	7.5	19.5	13.8	18.6	17.3	15.7	17.2	5.6	13.9	14.0	10.1	22.6	29.3	27.4	15.1	14.9	18.2	8.5	16.8	17.4	11.8	42.8	30.3	10.3	8.0	13.9	10.2	15.5	22.0	14.6	5.3	13.6	24.7	5.4	13.0	16.9	14.6	10.3	10.7	4.3	13.6	10.3	8.4	15.1	23.1	12.9	9.3	12.7	2.2	13.1	1.8	46.2	10.1	16.2	8.6	3.6	15.1	7.0	12.8	10.9	1.3	18.6	6.4	13.9	5.3	12.4	10.7	35.4	7.2	5.5	21.3	14.3	5.3	3.8	13.7	15.9	20.7	1.6	11.1	2.4	1.2	29.1	3.6	16.2	18.2	17.0	12.3	8.6	23.4	16.2	14.5	13.7	5.0	13.9	11.5	16.1	11.7	7.4	19.0	18.5	44.3	61.5	2.4	14.5	7.1	10.4	7.9	4.9	7.1	3.3	5.5	5.1	2.8	3.3	4.0	4.4	3.3	2.9	3.8	55.8	5.5	5.7	4.4	4.4	3.3	13.0	14.4	13.4	16.5	13.8	18.6	13.9	14.0	14.9	13.9	14.6	14.6	40.8	32.1	31.8	13.1	13.8	88.1	31.4	80.3	43.3	29.7	57.3	31.2	17.4	34.3	54.7	29.5	4.2	44.5	10.0	17.8	43.0	30.6	33.2	154.5	13.8	27.1	34.8	20.6	26.0	30.0	40.3	26.9	18.8	25.3	13.3	8.1	35.0	30.6	23.5	30.3	38.3	32.3	85.5	16.8	22.1	10.1	18.0	14.1	49.8	15.9	17.1	75.4	6.2	19.1	25.1	30.2	23.3	24.5	60.7	28.1	23.2	40.0	222.5	42.3	13.1	48.7	24.3	91.5	20.7	59.6	115.1	50.3	13.8	18.4	18.9	43.1
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617448-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"		"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	5.6	5.6	13.8	5.9	13.2	1.1	27.2	9.7	14.6	16.9	9.1	10.7	6.3	8.2	7.2	8.4	24.0	6.1	10.5	13.9	14.5	5.3	6.9	21.0	8.5	14.0	16.0	16.2	76.6	2.9	26.5	6.7	14.6	32.2	15.2	6.4	52.5	16.2	16.2	8.4	8.5	4.9	7.8	4.0	35.0	17.9	14.9	8.0	37.2	15.9	7.4	26.3	6.6	19.5	0.3	12.2	8.0	2.4	0.0	0.2	1.0	4.6	21.8	0.2	0.0	74.3	8.6	1.2	20.6	0.6	5.8	0.4	13.9	0.5	0.0	0.5	6.5	0.7	1.4	1.0	1.3	1.1	3.2	1.0	0.3	0.2	0.2	0.5	10.5	6.8	1.2	54.7	12.2	91.8	2.7	0.1	39.2	76.3	0.0	8.9	22.5	109.6	5.4	221.3	4.9	3.9	6.4	42.7	14.3	22.7	33.8	7.9	0.0	0.0	1.6	0.3	10.3	1.7	17.2	2.6	0.2	0.8	5.3	0.9	0.6	0.8	0.1	0.7	0.2	0.3	1.8	0.0	0.5	0.3	2.0	2.6	2.9	0.7	0.0	3.5	8.9	0.6	13.8	13.2	9.7	14.6	13.9	14.5	14.0	16.0	14.6	7.8	14.9	19.5	8.5	105.8	22.2	13.7	1.7	2.3	14.7	1.7	5.7	7.0	26.3	11.3	5.2	5.7	12.6	7.3	8.4	1.4	2.3	3.7	7.9	5.5	22.6	17.8	4.2	10.3	42.1	0.8	24.0	14.6	21.2	4.9	19.4	23.4	18.4	1.3	22.1	7.0	5.4	11.8	24.4	60.9	24.4	3.8	4.8	57.8	5.9	4.9	12.4	22.5	0.4	3.9	0.0	17.1	44.8	19.1	1.6	1.9	6.6	24.2	3.0	1.5	14.5	3.7	0.0	7.7	3.7	1.0	5.0	3.9	3.0	0.7	3.4	1.8	5.5	24.3
FAM174C	"C19orf24, FLJ20640"	ENSG00000228300	"Family with sequence similarity 174 member C"	Q9BVV8	19	1275530-1279244	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 89.9;Extravillous trophoblasts: 148.9;Hofbauer cells: 121.6;Syncytiotrophoblasts: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043279, HPA047026"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Golgi apparatus"	"HPA043279: AB_10794656, HPA047026: AB_2679906"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-2)"	43.0	73.4	32.9	27.6	34.5	24.8	38.9	34.2	45.8	34.0	36.2	36.6	27.6	36.6	11.5	52.3	29.5	20.0	33.4	32.6	31.5	52.3	121.9	31.7	31.8	34.9	33.4	27.7	56.1	12.1	42.3	16.5	35.5	49.2	7.2	2.1	40.8	16.4	21.8	48.5	36.4	9.5	32.7	54.1	42.9	44.7	34.6	17.7	44.7	4.8	10.4	40.1	33.4	34.9	97.3	90.3	8.6	72.6	13.8	32.7	34.0	48.0	24.8	48.2	42.4	102.8	52.2	29.5	64.3	16.5	32.0	51.5	15.3	48.8	5.6	103.2	87.0	31.2	79.1	61.1	57.6	67.1	65.3	39.2	61.1	36.3	16.0	14.0	35.2	85.3	61.1	153.8	19.6	96.0	78.9	94.4	43.7	45.4	96.4	58.2	17.4	172.4	26.9	50.5	60.4	39.6	31.0	69.2	109.0	5.9	50.5	105.1	24.2	86.6	27.9	106.6	111.2	102.4	146.1	36.6	93.5	80.2	79.2	46.6	94.6	35.3	107.8	104.2	106.6	153.2	114.9	114.2	97.9	136.8	106.2	109.0	16.4	78.5	93.5	165.3	121.5	81.4	32.9	34.5	34.2	45.8	32.6	31.5	34.9	33.4	35.5	32.7	34.6	34.9	16.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	89.9	17.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	148.9	7.3	0.0	0.0	0.0	0.0	0.0	0.0	121.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	96.2	3.0	0.0	0.0	0.0
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 637.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	45.3	43.2	36.8	30.0	50.1	49.6	38.2	45.3	46.5	44.2	36.9	81.5	57.2	29.4	29.6	49.7	26.8	37.7	78.1	39.0	51.3	61.3	77.0	68.6	20.2	52.4	50.6	28.2	49.4	30.6	47.4	27.3	49.1	63.1	71.5	31.3	43.4	36.1	48.3	41.3	54.6	42.3	45.0	23.6	42.5	86.2	47.0	21.6	48.0	32.8	23.2	46.7	37.7	57.0	63.4	51.2	38.0	31.3	64.6	64.6	46.7	101.3	55.8	52.4	57.1	52.2	82.6	25.1	68.1	98.9	71.1	65.8	47.1	58.5	66.7	73.5	28.8	19.5	63.8	179.5	79.4	30.7	44.9	58.5	75.3	63.5	49.5	76.7	60.6	46.7	47.7	79.8	102.5	91.5	38.0	28.1	30.9	100.9	65.2	21.9	52.7	35.9	95.2	68.7	52.1	45.9	119.3	94.2	81.3	75.2	87.2	23.9	71.3	67.5	59.2	76.6	53.2	59.3	79.8	31.2	42.3	20.5	68.0	79.9	43.9	79.2	31.0	36.7	36.5	45.0	40.3	35.7	34.8	35.8	31.7	31.4	167.5	32.6	31.9	50.8	60.0	30.4	36.8	50.1	45.3	46.5	39.0	51.3	52.4	50.6	49.1	45.0	47.0	57.0	126.7	240.4	176.3	6.5	87.4	160.7	199.4	200.4	83.6	35.8	119.0	118.4	147.8	67.2	168.1	104.8	27.1	71.0	322.2	329.3	119.3	121.9	637.1	235.5	86.6	116.4	133.8	36.0	10.7	249.6	118.0	80.5	107.0	426.4	82.3	43.1	82.5	235.6	75.5	23.5	13.4	189.5	144.5	61.1	130.9	505.9	54.0	85.4	149.4	8.4	125.1	45.3	48.4	9.0	28.4	364.6	220.1	53.0	133.3	211.4	273.7	347.2	177.8	45.5	46.0	65.2	106.2	189.3	106.8	93.1	171.5	123.3	215.7	30.4	224.2	229.5
FAM177B	"FLJ43505, RP11-452F19.2"	ENSG00000197520	"Family with sequence similarity 177 member B"	A6PVY3	1	222737207-222750805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 49.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 22.8;Cardiomyocytes: 19.0;Gastric mucus-secreting cells: 53.5;Intestinal goblet cells: 58.6;Microglial cells: 32.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"memory B-cell: 40.9;naive B-cell: 53.6"	"Lineage enriched"	"Detected in many"	22	"B-cells: 53.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA063059	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"		"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA063059: AB_2684933"	"unprognostic (8.19e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.57e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-6)"	"unprognostic (5.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.29e-2)"	0.2	1.6	1.2	3.1	0.5	0.2	0.3	0.1	0.7	0.3	0.0	6.7	4.9	0.2	0.2	0.3	0.2	10.1	0.2	1.1	0.6	0.2	0.1	0.4	8.4	1.9	0.8	0.1	0.2	0.2	0.2	2.5	0.9	0.4	9.3	0.1	8.6	0.2	0.0	0.0	12.2	0.9	0.5	2.2	49.6	1.8	1.3	1.0	0.2	0.0	8.3	0.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	40.9	0.0	0.0	0.1	53.6	0.0	0.1	0.8	0.0	0.1	2.4	0.0	1.4	1.2	0.5	0.1	0.7	1.1	0.6	1.9	0.8	0.9	0.5	1.3	0.7	0.1	0.0	0.0	0.7	22.8	0.4	0.8	0.3	0.0	0.0	0.5	0.3	19.0	8.6	0.3	0.0	0.0	0.0	1.4	1.1	0.0	0.3	8.6	0.1	0.1	0.7	0.0	0.4	0.8	0.4	0.0	1.5	53.5	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.8	58.6	0.0	1.9	0.8	11.9	0.0	3.5	0.0	32.8	0.1	0.0	0.0	1.0	0.2	0.2	0.1	0.0	0.1	2.2	3.0	0.1	0.1	0.0	0.0	1.2	0.8	0.4	0.3	0.2	0.1	0.0	0.9	0.0	1.0	0.5
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 18.9;brain: 10.5;epididymis: 5.5;lymphoid tissue: 12.1;testis: 8.2"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 88.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 2.4"	"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	1.7	0.0	4.9	0.0	8.7	18.9	0.9	6.3	7.3	0.5	2.3	2.2	0.0	1.6	5.5	0.7	1.3	0.1	0.4	4.7	6.8	0.1	0.0	0.4	0.1	7.7	8.0	0.5	0.0	0.0	0.1	0.9	7.4	1.1	0.1	0.1	0.3	0.8	0.2	1.2	0.5	0.4	6.5	12.1	0.3	8.2	7.3	0.1	0.1	0.0	0.0	2.1	0.8	10.5	6.2	0.0	0.0	2.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	2.5	0.0	0.0	0.2	7.0	0.0	0.0	6.7	28.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.9	8.7	6.3	7.3	4.7	6.8	7.7	8.0	7.4	6.5	7.3	10.5	0.2	0.0	0.0	1.0	1.2	0.8	0.6	0.4	0.0	0.2	0.5	1.4	0.4	0.0	0.0	0.0	2.1	3.2	0.5	0.1	0.0	0.0	3.6	0.1	0.3	0.2	0.0	88.3	7.2	0.0	7.1	3.0	0.0	0.1	0.0	0.2	0.4	0.0	1.2	1.7	1.1	0.0	10.2	0.0	0.9	7.8	0.9	1.0	3.6	1.0	0.2	2.9	1.0	1.0	20.7	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	2.8	1.6	3.2	20.1	0.6	1.7	2.5	0.2	0.3	0.1	0.4
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748813	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;heart muscle: 15.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Cardiomyocytes: 6.6;Fibroblasts: 19.7;Hepatic stellate cells: 4.6;Langerhans cells: 9.5;Melanocytes: 7.2;Suprabasal keratinocytes: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2197: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	3.1	2.7	0.0	0.5	0.1	0.1	3.4	0.1	0.3	2.6	4.2	1.8	0.8	4.7	0.4	4.0	2.0	16.1	15.9	0.3	0.0	4.1	10.2	2.5	0.1	0.0	0.0	7.9	1.3	0.2	0.1	0.2	0.0	0.6	2.0	0.0	1.2	0.2	0.3	3.4	1.3	4.7	0.0	0.6	1.0	0.4	0.0	0.2	2.7	1.3	0.5	4.4	1.3	0.1	0.0	0.1	0.0	0.0	27.8	28.4	0.0	14.9	56.2	0.3	0.2	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.6	0.0	35.6	4.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	57.1	0.0	259.7	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.8	0.0	0.0	0.3	0.0	0.0	19.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	2.8	0.1	7.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	0.1	4.8	0.7	0.2	0.0	0.0	0.0
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"	Q6P0A1	11	47586678-47589194	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;brain: 5.9;breast: 5.2;choroid plexus: 5.1;skin 1: 6.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.4;Fibroblasts: 20.4;Langerhans cells: 11.9;Melanocytes: 5.4;Peritubular cells: 4.1;Suprabasal keratinocytes: 6.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA029408	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"			"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	6.5	0.1	0.8	0.0	2.0	0.1	5.2	5.9	1.7	0.4	5.1	0.6	0.0	0.2	0.0	0.1	0.4	0.4	0.7	0.6	0.8	0.0	0.0	0.2	0.0	1.9	1.3	0.1	0.1	0.0	0.2	0.0	1.5	0.0	0.0	0.1	1.1	0.0	1.0	6.3	0.2	0.1	1.3	0.1	0.5	0.5	1.6	0.7	4.3	2.9	0.1	0.4	0.2	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	5.9	1.7	0.6	0.8	1.9	1.3	1.5	1.3	1.6	2.6	0.8	0.0	0.0	1.0	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	20.4	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.9	0.3	2.5	0.3	5.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	6.3	0.1	0.3	0.0	0.0	0.0
FAM181A	C14orf152	ENSG00000140067	"Family with sequence similarity 181 member A"	Q8N9Y4	14	93918894-93929608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 32.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 48.9;Spermatocytes: 35.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"AF22: 4.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 31.9"	HPA001603	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA001603: AB_1078326"		"unprognostic (8.19e-2)"		"unprognostic (6.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.31e-1)"		"unprognostic (2.05e-2)"		"unprognostic (1.84e-2)"					"unprognostic (6.27e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.37e-2)"	0.0	0.0	6.3	0.0	6.0	0.0	0.0	6.0	7.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.8	6.8	0.0	0.0	0.9	0.0	7.7	7.0	0.0	0.0	0.0	2.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.9	0.0	0.0	32.5	6.4	0.0	1.2	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	6.0	7.5	5.8	6.8	7.7	7.0	6.8	6.9	6.4	6.4	0.0	3.2	3.1	8.8	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.4	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	6.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.7	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.1	35.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729940-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	0.5	0.6	18.0	0.2	20.3	0.1	0.4	19.8	14.3	1.3	5.9	1.4	0.2	0.7	0.1	0.3	1.0	0.0	1.7	14.5	14.7	0.7	0.0	0.0	0.0	26.9	20.8	0.8	0.5	0.1	1.2	0.0	16.3	0.6	0.0	0.6	0.8	0.5	0.2	0.3	0.4	0.1	23.9	0.0	0.4	0.2	19.9	0.0	0.8	0.1	0.2	1.1	0.7	23.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	20.3	19.8	14.3	14.5	14.7	26.9	20.8	16.3	23.9	19.9	23.6	0.7	0.0	0.0	56.2	0.0	0.3	0.2	0.1	0.0	0.8	1.0	3.6	2.9	0.0	0.1	5.5	0.0	0.0	0.0	0.0	3.9	0.1	0.0	24.1	1.8	1.3	0.0	0.0	0.4	0.0	0.0	1.2	0.0	2.4	0.0	0.6	0.0	0.0	0.1	0.0	0.6	1.5	0.0	0.0	0.3	0.4	0.6	0.2	1.8	1.9	0.0	18.4	0.0	22.1	19.0	0.0	0.0	0.4	0.0	0.2	0.1	0.4	0.1	1.1	0.0	1.6	7.0	0.1	1.6	0.3	0.0	0.0	0.1	2.2	0.2	0.1
FAM183A	"hCG23177, LOC440585"	ENSG00000186973	"Family with sequence similarity 183 member A"	A6NL82	1	43145153-43156396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"fallopian tube: 116.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 516.6;Late spermatids: 244.5;Respiratory ciliated cells: 1012.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 19.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;hTCEpi: 2.4;NTERA-2: 3.1;SCLC-21H: 2.7;SuSa: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043382, HPA049120"	Approved					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA043382: AB_2678456, HPA049120: AB_2680640"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.42e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.73e-2)"	0.0	0.0	1.3	0.0	1.2	0.0	1.0	0.5	0.3	2.5	9.2	0.2	0.1	2.1	0.5	1.0	116.9	0.0	0.0	1.2	2.1	1.3	0.1	6.9	0.0	8.1	7.2	0.2	0.2	0.9	5.5	0.6	3.9	2.0	0.3	0.2	1.4	0.2	0.0	9.7	0.0	0.2	4.2	0.0	0.1	6.9	1.4	0.3	0.0	0.0	0.3	0.5	1.1	2.3	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.6	3.5	0.0	0.4	0.2	0.3	0.4	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	1.4	0.6	2.7	0.0	0.0	0.1	0.0	5.2	0.7	0.0	0.5	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.5	0.3	1.2	2.1	8.1	7.2	3.9	4.2	1.4	2.3	0.0	0.0	7.4	0.0	0.0	1.9	14.0	66.1	3.4	0.0	1.4	2.3	0.2	0.0	109.2	3.7	0.0	2.1	0.1	0.4	3.9	0.0	107.7	516.6	3.5	1.3	4.2	0.0	0.0	0.0	0.2	1.2	0.0	5.7	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.4	54.9	0.0	0.0	244.5	1.8	0.7	3.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.7	0.0	3.9	0.0	2.0	1012.8	0.1	0.0	0.0	13.3	7.6	3.5	2.3	2.6	2.1	0.6	0.2	0.5	9.7
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781621	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.0;retina: 1.7;skeletal muscle: 4.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.0;Horizontal cells: 32.0;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 27.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA044119: AB_2678817, HPA048458: AB_2680401"	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	0.0	0.1	1.8	0.1	1.9	0.2	0.1	1.2	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.7	0.3	0.0	0.0	0.1	2.0	1.6	0.0	0.0	0.1	0.0	0.0	1.8	0.1	0.2	1.7	0.1	0.0	4.2	0.2	0.0	0.0	1.0	0.1	0.0	0.1	1.6	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.9	1.2	2.0	1.9	1.7	2.0	1.6	1.8	1.0	1.6	1.6	1.1	0.0	2.0	4.2	3.8	4.5	5.2	0.2	2.8	33.0	2.7	2.0	0.6	2.8	0.8	0.0	14.6	4.8	1.7	2.4	0.0	1.1	0.8	1.1	2.2	2.7	4.2	2.7	15.5	1.0	3.9	2.8	0.0	2.8	13.4	3.6	0.4	2.4	1.2	32.0	23.0	1.8	0.0	2.2	8.2	1.7	11.5	1.5	3.6	1.9	0.0	19.8	2.1	75.9	7.1	1.5	0.5	7.5	0.4	7.0	0.0	1.1	0.2	27.1	0.0	9.7	2.2	9.1	9.5	0.9	9.7	5.3	4.8	3.4	0.6	5.4
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 64.0;Excitatory neurons: 132.4;Inhibitory neurons: 134.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 70.9;Oligodendrocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	0.8	1.1	0.6	0.6	0.6	0.8	0.8	1.0	0.8	1.3	0.6	1.0	0.4	0.8	0.4	1.0	0.7	0.4	1.0	0.4	0.5	1.2	2.8	0.6	0.4	0.5	0.8	1.0	1.3	1.5	0.7	0.5	0.4	1.2	0.7	1.1	0.8	0.8	3.5	1.2	0.8	0.5	0.3	0.6	1.9	0.4	0.7	0.7	0.9	2.0	0.4	1.3	1.0	1.2	0.6	2.0	0.4	2.4	0.4	0.9	1.5	0.6	1.3	0.3	0.0	1.7	2.1	0.6	0.9	0.6	1.5	2.3	1.0	0.9	0.4	1.2	0.1	0.2	0.2	2.8	0.6	0.9	1.1	0.0	1.8	0.0	0.4	1.5	0.6	0.5	1.0	1.1	1.1	3.2	2.1	0.6	0.9	2.7	0.5	0.2	0.0	6.7	0.2	1.4	0.4	1.7	4.0	4.5	0.1	0.0	2.7	0.0	1.6	0.2	1.1	2.1	0.4	3.1	1.4	0.6	0.4	0.6	0.2	0.0	1.4	1.9	1.1	1.2	1.1	2.2	0.7	1.0	1.6	0.8	0.9	0.7	3.7	0.8	0.5	1.2	0.8	0.4	0.6	0.6	1.0	0.8	0.4	0.5	0.5	0.8	0.4	0.3	0.7	1.2	2.9	3.2	1.5	64.0	5.1	4.2	8.1	5.8	9.6	8.8	5.1	3.6	6.3	11.5	6.0	0.0	10.4	13.8	5.6	2.0	19.6	4.6	5.4	5.0	3.8	4.0	1.2	9.4	132.4	2.3	6.5	4.0	9.2	4.1	0.0	7.0	6.4	7.4	4.4	5.0	134.5	3.2	6.1	2.8	1.4	3.3	7.2	3.3	7.2	63.7	3.2	4.9	2.1	70.9	89.2	2.5	1.7	5.3	6.3	3.8	4.6	11.1	3.0	21.4	13.1	4.3	4.1	9.2	5.1	6.7	4.5	8.1	4.1	7.0	3.6	7.0
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 521.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047128, HPA064735"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA047128: AB_10967726, HPA064735: "	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.1	0.3	0.2	0.2	0.4	0.5	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.1	0.3	0.1	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.3	0.1	14.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	521.1	0.1	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	64.7	0.6	0.1	0.0	2.8	0.0	0.6	0.0	1.5	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM186B	"C12orf25, DKFZP434J0113"	ENSG00000135436	"Family with sequence similarity 186 member B"	Q8IYM0	12	49582885-49605639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 46.0"	"Group enriched"	"Detected in some"	17	"Early spermatids: 85.1;Late spermatids: 101.5;Spermatocytes: 38.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039736, HPA040028"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA039736: AB_10795295, HPA040028: AB_10795684"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.42e-5)"	"unprognostic (1.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.10e-5)"	"unprognostic (7.23e-2)"	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.9	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.4	0.5	0.8	0.2	0.6	0.2	0.0	0.8	1.6	0.9	0.3	0.1	0.0	0.3	0.1	0.6	0.4	0.2	0.6	1.2	0.3	0.1	0.1	0.3	0.4	46.0	0.4	0.1	1.0	0.3	0.2	0.3	0.3	0.6	0.3	1.4	0.1	0.4	0.1	0.0	0.7	0.0	0.1	0.0	0.1	1.8	0.5	1.0	0.3	0.1	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.6	0.9	0.2	0.1	1.1	0.3	0.0	0.3	0.2	0.7	0.1	0.1	0.4	1.0	0.8	0.2	1.0	0.1	0.1	0.2	0.4	0.5	0.4	0.1	0.4	0.5	0.4	1.1	0.3	0.5	0.2	0.8	0.3	0.6	0.5	0.5	0.1	0.5	0.4	0.3	0.5	0.4	1.8	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.9	0.5	0.3	0.4	0.2	0.0	0.0	0.1	0.4	0.6	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	85.1	0.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	101.5	1.2	0.2	0.0	1.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.2	38.2	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
FAM187B	"FLJ25660, TMEM162"	ENSG00000177558	"Family with sequence similarity 187 member B"	Q17R55	19	35224800-35228729	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"testis: 68.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 2682.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079535	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA079535: "	"unprognostic (3.34e-1)"			"unprognostic (4.96e-1)"				"unprognostic (2.40e-1)"		"unprognostic (2.84e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-2)"	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	68.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	548.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2682.3	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 5.3;thyroid gland: 3.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.6	0.4	2.2	0.0	1.8	0.0	0.1	0.0	2.4	0.3	0.3	2.6	0.1	0.2	0.0	0.0	1.0	0.0	0.8	2.5	0.4	2.1	0.1	1.1	0.0	0.2	0.3	0.2	5.3	0.4	0.4	0.0	0.2	0.4	0.5	0.1	0.6	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.4	2.0	1.2	0.0	3.2	0.0	0.1	0.9	0.2	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.1	12.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	2.4	2.5	0.4	0.2	0.3	0.2	0.0	1.2	0.8	0.5	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.3	0.8	0.0	0.0	0.4	3.0	0.0	202.9	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.0	198.0	2.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	29.0	0.0	0.2	0.0	59.8	8.1	0.2	2.6	1.5	0.0	1.0	2.2	0.8	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.0	0.0	0.0	0.0	1.0	3.2	0.4
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.3;thyroid gland: 58.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 157.0;Astrocytes: 256.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	6.0	4.7	12.8	0.4	15.0	0.0	13.7	15.8	11.2	26.0	9.2	7.1	1.2	6.8	1.7	5.2	6.8	1.6	13.3	12.2	15.7	4.7	0.2	22.3	0.6	20.1	16.7	24.6	7.3	6.0	7.6	1.5	17.1	11.1	1.1	4.4	6.2	3.4	48.3	12.4	4.0	4.9	16.3	0.4	13.7	1.3	19.8	5.6	58.2	9.0	0.9	7.9	4.6	15.1	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.7	0.7	0.0	0.0	0.6	1.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.0	1.8	2.3	0.0	0.0	0.0	0.0	5.0	1.9	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	15.0	15.8	11.2	12.2	15.7	20.1	16.7	17.1	16.3	19.8	15.1	12.1	157.0	23.3	256.3	0.4	3.3	4.9	1.9	7.4	2.1	18.4	39.6	14.6	0.0	26.9	1.8	0.0	1.2	0.4	1.5	0.0	0.9	0.1	19.9	2.8	8.0	0.0	0.0	0.7	0.6	0.1	1.7	11.7	33.0	0.0	2.0	2.2	0.0	0.3	0.0	3.9	0.4	0.0	0.3	1.3	0.0	0.0	0.4	19.6	20.6	0.0	35.1	0.0	7.1	2.1	3.5	1.2	0.0	0.2	3.7	0.2	0.2	2.3	1.0	0.0	3.8	3.8	0.1	0.6	1.9	2.4	0.3	1.0	0.7	0.7	1.8
FAM189B	"C1orf2, cote1"	ENSG00000160767	"Family with sequence similarity 189 member B"	P81408	1	155247205-155255483	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006659, HPA050674"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA006659: AB_1078339, HPA050674: AB_2681213"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.86e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.43e-7)"	"unprognostic (4.16e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.25e-2)"	12.1	14.5	7.3	3.6	5.1	1.7	11.1	6.8	14.9	13.5	0.2	22.0	5.3	17.1	0.6	17.5	12.3	1.9	11.3	5.9	4.6	11.3	8.6	10.6	2.2	12.5	4.8	12.0	9.2	4.5	14.0	3.2	15.7	13.9	1.3	1.4	11.1	4.1	28.4	13.5	11.4	3.3	5.9	8.9	15.6	13.1	14.9	1.4	9.8	5.7	1.4	21.1	14.1	6.3	22.4	18.9	9.2	31.1	9.6	14.8	4.2	20.9	10.5	10.9	9.8	21.5	13.6	21.9	27.0	11.2	7.8	21.2	12.1	16.7	2.4	27.5	39.6	17.3	12.3	11.0	16.4	4.7	18.4	16.5	10.3	10.5	6.4	11.4	15.3	14.7	13.3	7.2	8.8	14.0	19.9	8.3	20.6	13.0	39.2	21.3	14.5	24.7	7.2	8.9	19.9	30.1	8.9	25.5	23.8	4.9	27.5	16.7	17.4	14.5	18.3	15.4	21.7	16.1	17.4	10.5	17.1	9.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.3	5.1	6.8	14.9	5.9	4.6	12.5	4.8	15.7	5.9	14.9	6.3	10.1	3.2	2.2	7.5	6.1	6.0	12.8	10.0	17.6	18.0	10.8	9.7	12.2	8.6	5.3	12.9	18.8	12.9	3.9	8.0	1.9	13.7	3.7	4.8	9.2	13.3	6.7	9.2	14.8	10.5	15.1	9.2	8.2	8.0	5.7	13.9	13.6	7.5	8.0	40.4	14.5	10.2	12.2	11.2	4.7	8.0	9.6	6.0	7.2	4.7	6.0	7.5	8.2	8.0	8.5	11.9	5.2	9.1	4.3	19.2	12.3	5.9	6.0	19.3	0.0	8.5	9.6	23.2	13.6	13.3	8.2	14.4	4.3	12.6	9.6	12.6
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536647-2732573	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	14.3	11.7	9.7	7.6	9.3	13.0	13.2	15.1	11.5	14.8	9.6	13.4	7.9	13.8	6.8	9.6	12.9	6.0	9.7	9.5	9.7	11.9	11.6	10.1	9.6	9.8	9.0	15.0	11.1	9.2	15.5	7.6	9.3	12.1	6.0	8.9	10.1	7.0	15.1	13.2	12.3	8.0	6.9	12.0	10.5	21.1	10.5	12.4	12.2	8.7	6.7	11.5	11.2	11.8	8.7	10.7	20.0	11.3	12.0	12.2	10.5	13.1	11.3	12.7	10.8	10.9	13.9	17.1	7.7	14.7	15.7	7.4	14.0	9.4	10.8	10.3	8.9	25.7	14.3	11.5	14.4	15.8	17.2	13.3	9.8	12.7	13.0	11.6	12.8	10.0	18.2	18.5	10.8	9.4	25.5	25.6	15.9	8.9	11.8	24.7	10.3	8.4	8.7	11.1	17.1	14.6	11.2	7.8	11.3	10.9	14.3	15.9	17.4	19.2	11.3	10.5	17.5	18.0	14.5	16.1	10.7	12.8	13.8	3.3	0.9	0.8	0.8	0.6	0.6	0.6	0.7	1.2	0.6	0.9	0.7	1.1	1.8	1.3	3.1	1.7	0.6	0.5	9.7	9.3	15.1	11.5	9.5	9.7	9.8	9.0	9.3	6.9	10.5	11.8	21.8	12.8	18.2	62.7	11.2	9.4	6.7	6.5	9.1	25.7	10.5	9.0	14.7	4.3	15.6	1.8	47.9	7.3	20.0	12.9	1.9	9.4	8.9	19.8	21.8	19.4	14.4	17.9	62.4	7.5	7.1	13.2	15.8	27.1	8.8	30.2	11.0	6.3	8.7	15.2	70.8	11.1	8.2	7.6	11.6	13.4	17.1	15.9	14.2	51.5	11.1	15.8	11.3	45.8	58.3	10.1	11.0	14.7	12.4	11.3	11.4	2.8	5.6	26.2	6.6	20.5	17.5	36.2	32.4	9.6	9.9	5.6	14.4	13.6	9.6	9.2
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519789-177554563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	37.0	25.6	23.4	24.5	19.7	58.0	40.9	22.1	25.9	52.2	14.5	38.6	22.0	38.4	14.1	34.8	41.1	17.2	27.7	24.3	19.2	41.4	51.0	45.3	31.7	16.0	16.5	51.4	52.1	11.2	37.9	21.5	15.0	50.6	15.8	20.6	37.2	17.3	22.1	55.0	49.5	14.7	12.5	70.3	36.7	31.9	27.7	30.9	41.4	7.9	22.3	34.6	43.6	18.8	10.4	13.5	29.3	25.7	14.3	13.5	63.2	9.0	9.8	14.9	14.1	36.6	19.4	19.4	13.8	9.0	18.9	17.7	13.6	19.2	11.1	43.5	13.9	13.7	22.9	17.8	8.3	13.6	27.5	13.6	21.1	12.5	13.8	26.6	15.3	30.4	13.4	18.7	10.9	34.5	24.9	39.4	20.4	9.0	10.6	40.4	6.4	16.7	14.2	29.1	27.2	17.2	10.6	30.0	9.8	22.2	29.5	18.4	19.1	16.4	13.5	10.8	11.2	20.1	9.2	16.1	13.1	21.8	13.9	0.0	0.4	0.1	0.5	0.0	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.6	0.5	0.2	0.3	0.1	0.2	23.4	19.7	22.1	25.9	24.3	19.2	16.0	16.5	15.0	12.5	27.7	18.8	16.9	19.2	26.7	45.1	8.5	8.7	5.8	7.2	11.4	11.5	12.1	18.3	14.6	20.0	11.2	11.0	18.8	5.0	11.9	14.3	0.0	6.1	6.1	8.3	10.2	12.5	8.4	6.1	41.0	8.9	8.3	11.7	22.4	10.8	5.1	14.1	12.1	13.8	5.0	11.8	39.3	15.6	6.1	10.0	8.2	8.4	9.9	10.6	8.8	21.5	8.3	7.3	9.2	39.2	38.0	6.0	8.4	5.3	6.9	7.7	9.8	2.8	10.7	12.5	6.6	12.4	11.1	15.4	13.2	11.8	12.9	4.5	10.4	8.6	11.7	6.7
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166453-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.9	11.7	17.0	7.1	16.9	13.8	11.6	18.2	18.7	9.2	10.2	8.4	7.9	10.6	34.8	7.8	9.1	6.8	7.3	15.2	18.8	15.1	7.7	8.1	8.6	15.5	19.1	11.9	11.1	19.9	8.5	9.0	17.5	10.2	8.4	16.1	10.2	13.9	9.4	9.5	7.2	8.7	16.8	8.8	8.3	10.1	20.5	9.0	17.5	9.7	7.8	8.0	7.6	18.8	23.9	14.9	13.2	14.5	9.6	11.5	13.3	12.4	11.6	15.8	14.7	11.6	19.4	13.1	15.0	11.4	12.5	17.6	23.9	18.3	25.7	6.4	13.4	10.4	19.0	13.2	13.7	20.0	14.1	9.0	22.9	15.5	15.6	24.7	16.2	8.3	11.5	28.6	17.8	17.1	10.8	14.2	13.2	20.9	17.3	11.4	8.6	16.5	26.9	15.8	7.1	8.8	30.0	19.7	21.4	12.9	9.8	9.8	20.1	17.6	6.4	13.8	13.5	13.6	12.1	14.4	19.8	21.1	13.1	0.6	0.5	0.3	0.7	0.4	0.7	0.4	0.6	0.8	0.6	1.3	0.9	0.5	0.6	0.3	0.5	0.3	0.8	0.3	17.0	16.9	18.2	18.7	15.2	18.8	15.5	19.1	17.5	16.8	20.5	18.8	18.6	16.0	14.5	33.0	17.8	24.0	11.5	12.6	13.6	23.3	21.3	14.7	13.7	17.2	12.2	62.5	14.6	11.8	23.1	23.9	23.5	11.9	0.6	20.6	27.3	15.7	16.8	9.4	25.9	18.7	13.0	11.7	18.3	31.5	9.5	16.8	14.6	18.8	17.6	33.7	24.5	17.0	16.2	21.4	27.0	3.9	11.8	15.7	10.6	15.9	14.6	20.0	22.6	26.2	21.6	15.4	18.9	14.7	20.2	14.6	14.2	34.8	10.3	16.9	26.3	17.1	13.7	4.1	9.7	21.0	26.3	14.6	15.9	21.6	15.9	15.5
FAM200A	"C7orf38, DKFZp727G131, FLJ36794"	ENSG00000221909	"Family with sequence similarity 200 member A"	Q8TCP9	7	99546300-99558536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017855	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA017855: AB_1847703"	"unprognostic (3.98e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (2.38e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.17e-7)"	"unprognostic (8.38e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.41e-2)"	3.1	7.4	5.6	4.4	5.8	1.7	6.0	7.3	6.0	6.3	5.6	3.3	3.5	5.2	6.5	4.1	5.0	3.6	5.3	5.5	6.6	6.4	3.6	3.9	6.1	5.4	5.5	10.4	4.7	7.1	6.3	5.1	5.4	6.9	3.1	8.7	6.4	5.0	5.4	5.4	3.7	3.2	5.5	4.8	4.8	9.5	6.1	7.3	6.8	6.4	5.2	4.0	3.5	6.2	8.5	5.1	11.7	13.8	10.2	9.8	7.5	7.6	8.0	6.5	8.0	4.9	7.1	5.2	7.8	5.0	10.5	6.6	9.3	7.1	10.7	7.5	8.3	5.8	6.8	6.0	8.2	6.8	6.5	6.9	12.6	6.2	12.0	8.7	6.8	8.5	12.7	4.4	12.0	6.3	12.7	13.3	10.5	2.3	8.2	6.2	9.9	5.3	6.0	5.7	8.9	17.2	4.5	7.4	13.1	13.9	5.7	7.4	5.4	9.8	11.8	14.1	6.8	5.9	5.5	6.1	7.8	5.6	15.8	6.5	2.3	3.0	4.0	1.6	5.9	3.4	4.0	5.0	2.5	5.0	7.1	6.0	1.5	2.5	1.4	2.6	5.9	2.3	5.6	5.8	7.3	6.0	5.5	6.6	5.4	5.5	5.4	5.5	6.1	6.2	5.3	9.6	5.3	15.7	10.8	1.9	3.4	3.1	9.1	13.3	4.5	5.8	7.3	4.3	5.0	7.3	0.0	7.9	3.2	2.0	7.9	5.6	83.0	6.2	8.9	5.8	0.0	1.3	12.4	3.4	5.5	5.5	4.1	5.2	0.0	10.2	3.3	1.8	4.3	13.5	14.2	2.6	4.1	3.5	1.4	14.4	9.0	4.4	1.8	10.3	5.0	11.0	7.2	8.5	25.4	3.9	5.4	6.0	8.7	3.1	2.6	5.1	5.4	10.1	0.0	5.2	4.5	19.6	9.1	5.8	3.3	8.1	6.3	9.1	3.1	1.6
FAM200B	C4orf53	ENSG00000237765	"Family with sequence similarity 200 member B"	P0CF97	4	15681662-15690447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 406.9;Late spermatids: 306.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017855	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017855: AB_1847703"	"unprognostic (7.38e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.82e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (4.39e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.35e-5)"	6.4	6.8	12.8	5.1	13.7	3.7	7.2	13.7	17.2	6.8	9.7	5.1	6.6	6.4	9.3	4.7	6.2	5.0	5.2	12.8	13.4	10.3	8.9	4.2	5.5	12.0	13.0	8.5	5.5	5.8	6.5	6.5	12.1	6.1	5.6	8.9	4.6	6.0	5.5	4.8	5.7	3.8	12.4	5.4	4.4	4.8	15.0	9.6	8.9	6.6	3.9	4.1	4.9	15.0	6.3	9.2	14.6	8.0	10.2	13.5	5.2	7.7	4.3	10.0	9.0	6.8	4.3	7.4	3.9	8.4	13.1	4.4	14.5	7.4	15.6	3.7	8.0	5.7	12.3	10.7	8.1	5.4	2.4	7.9	8.4	9.7	6.1	16.9	5.7	4.7	7.6	4.4	22.1	3.6	5.6	5.9	19.4	3.6	7.3	5.0	22.5	1.1	9.2	4.9	20.0	11.0	5.6	1.6	13.6	12.8	3.3	6.6	8.1	10.3	8.1	8.4	10.5	2.1	4.6	3.5	6.4	7.2	23.5	3.7	6.7	6.8	1.4	3.0	1.9	0.8	1.7	1.3	3.3	1.3	2.9	2.3	15.1	1.1	2.4	1.1	2.1	3.7	12.8	13.7	13.7	17.2	12.8	13.4	12.0	13.0	12.1	12.4	15.0	15.0	35.2	28.9	47.5	16.0	21.7	53.8	61.8	80.0	76.8	53.4	72.8	96.1	94.9	78.6	52.4	77.3	12.5	72.4	34.8	54.3	406.9	50.1	224.1	64.6	46.1	42.9	66.0	27.1	23.4	58.7	60.2	59.0	17.9	62.9	13.3	64.5	44.3	91.9	68.2	53.8	23.5	68.5	97.6	77.3	48.6	306.0	93.8	60.4	62.2	5.6	84.7	133.3	59.8	10.6	39.4	51.9	79.3	70.0	8.5	45.4	105.2	233.8	55.1	21.1	46.0	48.1	56.7	113.4	38.0	45.4	51.1	34.6	38.8	71.2	66.7	64.7
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297925-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	27.9	19.3	15.7	22.5	16.9	54.4	31.4	13.4	23.6	22.2	11.5	27.5	20.9	26.6	32.2	26.1	20.0	21.8	35.3	17.1	16.1	27.7	29.0	25.0	27.4	15.8	14.8	28.4	24.8	30.3	14.1	20.9	14.8	20.7	24.1	15.9	25.3	22.1	36.7	18.7	18.5	26.5	15.0	24.8	21.7	49.2	16.0	28.4	29.3	27.6	27.9	25.8	17.1	15.8	56.4	24.9	40.2	56.2	39.1	42.4	22.8	43.6	81.4	61.6	55.4	29.4	51.2	39.7	26.3	47.2	27.7	47.3	34.0	45.5	55.6	62.8	42.0	33.0	23.4	26.2	58.4	86.7	44.9	29.4	54.8	45.3	94.3	51.7	53.3	50.2	35.3	45.5	51.6	31.5	53.6	80.1	28.6	24.7	22.0	45.2	77.7	29.3	56.0	28.2	25.8	40.5	29.9	27.7	66.8	19.6	44.0	61.7	37.4	32.2	30.1	28.8	67.4	32.4	31.0	57.0	62.8	92.2	33.3	73.5	57.5	70.4	36.9	64.2	39.0	50.6	41.8	34.4	59.6	35.2	35.6	41.8	32.0	34.4	69.3	43.0	51.5	57.1	15.7	16.9	13.4	23.6	17.1	16.1	15.8	14.8	14.8	15.0	16.0	15.8	71.9	60.9	55.7	54.5	66.0	55.6	63.0	60.9	63.7	38.8	61.0	67.4	78.6	52.9	47.3	44.1	73.0	39.5	84.8	30.2	135.0	85.5	255.8	62.5	79.4	67.8	41.9	59.5	49.9	113.7	49.8	72.4	41.8	60.3	68.4	140.6	64.6	49.8	62.4	33.7	48.3	56.0	63.1	69.4	76.2	132.0	76.4	73.0	60.5	27.2	77.2	62.5	92.7	53.3	45.4	95.3	68.9	70.0	62.9	54.6	35.4	115.7	44.2	55.4	26.3	73.7	78.3	258.5	170.3	55.6	50.6	30.6	62.8	62.6	48.4	61.6
FAM205A	C9orf144B	ENSG00000205108	"Family with sequence similarity 205 member A"	Q6ZU69	9	34723053-34729488	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"testis: 24.8"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 135.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA071267	Enhanced		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA071267: AB_2686376"	"unprognostic (2.25e-1)"					"unprognostic (3.66e-3)"		"unprognostic (6.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.78e-1)"		"unprognostic (7.34e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM207A	"C21orf70, PRED56"	ENSG00000160256	"Family with sequence similarity 207 member A"	Q9NSI2	21	44940012-44976989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034178, HPA036354, HPA036559"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: "	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (3.23e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.77e-2)"	19.8	20.9	9.8	11.3	11.0	12.6	17.6	13.9	16.1	14.3	5.7	22.3	11.1	15.1	2.1	17.9	14.5	2.2	53.6	10.6	9.8	20.3	31.1	13.0	9.3	11.1	10.8	11.6	21.5	6.0	9.4	5.3	10.7	14.2	3.7	6.1	15.7	5.7	43.3	18.5	14.3	4.8	7.7	23.8	20.2	27.3	12.3	9.4	10.5	14.4	6.5	21.4	13.4	10.0	48.4	51.9	17.2	22.2	8.3	11.4	40.9	32.4	8.7	24.4	19.6	88.1	14.8	49.0	68.7	11.5	35.5	31.8	23.9	35.5	9.7	35.9	72.8	144.6	36.4	75.2	33.1	47.7	18.1	19.9	20.4	22.0	19.2	10.5	26.7	41.6	83.9	33.5	18.6	86.7	45.2	74.3	58.2	36.0	72.1	44.0	18.4	85.7	23.5	19.0	84.0	35.7	43.0	50.7	51.4	12.2	35.4	33.8	35.2	20.4	42.3	27.5	70.8	70.0	65.5	47.6	16.3	81.1	29.1	3.1	4.0	4.1	1.8	4.1	1.8	7.7	3.2	4.3	3.8	5.0	3.5	3.5	2.4	4.4	4.7	8.9	4.0	2.3	9.8	11.0	13.9	16.1	10.6	9.8	11.1	10.8	10.7	7.7	12.3	10.0	13.8	0.0	7.5	5.5	25.6	19.2	31.7	35.3	27.9	22.7	41.4	57.7	22.6	34.3	22.7	18.4	4.2	36.9	28.8	60.0	46.9	68.1	14.8	30.6	30.1	23.3	26.4	29.2	3.2	63.5	70.7	23.3	16.8	20.9	10.2	48.6	26.4	56.3	68.4	6.7	3.8	34.3	12.2	33.3	18.4	38.5	14.6	24.9	24.9	1.0	51.7	36.9	41.2	6.0	2.9	59.3	34.8	12.8	29.4	77.9	84.1	90.2	15.2	18.3	32.9	17.7	36.2	82.0	42.0	35.1	21.0	30.8	19.5	70.7	44.3	39.9
FAM209B	"C20orf107, dJ1153D9.4"	ENSG00000213714	"Family with sequence similarity 209 member B"	Q5JX69	20	56533246-56536520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 114.4"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 1680.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/70: 2.0;U-266/84: 2.2"									HPA042144	Enhanced					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042144: AB_10794414"	"unprognostic (2.93e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.49e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.59e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.48e-4)"	0.9	0.2	0.5	0.6	0.5	11.8	0.7	0.5	0.9	0.6	0.6	0.5	0.2	0.4	0.0	0.5	0.5	0.3	0.5	0.5	0.6	0.7	0.8	1.0	1.3	0.6	0.6	0.2	0.6	0.3	0.9	0.1	0.6	0.7	0.4	0.2	0.7	0.3	0.9	1.2	0.9	0.2	0.5	2.6	0.6	114.4	0.6	0.6	0.4	0.4	0.9	0.5	0.5	0.6	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.4	0.7	0.9	0.3	0.7	0.0	0.1	0.7	0.4	0.2	0.6	0.5	0.3	0.8	0.2	0.4	0.4	0.0	0.2	0.1	1.1	1.6	0.6	0.9	0.1	0.5	0.0	0.0	0.7	0.0	0.9	0.0	1.1	0.4	1.0	0.2	0.0	0.5	0.3	0.2	0.0	0.6	0.3	0.6	0.1	0.3	1.4	0.2	0.2	0.6	0.2	0.0	0.1	0.2	0.6	0.0	2.0	2.2	0.3	0.1	0.4	0.1	0.0	0.3	1.0	0.6	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.5	0.5	0.9	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.3	0.0	1.9	0.0	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	0.0	0.9	1680.6	0.2	0.1	0.9	1.2	0.0	0.6	1.6	0.5	0.1	0.0	0.3	1.3	0.1	0.4	0.2	0.6	0.0	0.4	0.2	0.0	1.6	0.7	238.2	11.5	1.0	0.0	0.0	0.9	0.0	2.1	0.0	0.9	0.8	0.1	8.2	0.0	0.3	0.4	1.0	1.1	0.0	0.0	0.1	0.4	12.8	7.1	0.0	0.0	0.0	0.4	0.1	0.1	0.6
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601367	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 82.4;Early spermatids: 69.0;Hepatocytes: 66.8;Hofbauer cells: 94.0;Late spermatids: 189.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;BJ hTERT+: 27.3;HSkMC: 21.8;U-2197: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048964	Approved				"Secreted in other tissues"	NA	NA		13000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	7.5	1.6	0.4	2.7	0.3	0.6	5.4	0.3	0.6	17.5	2.6	1.6	0.6	12.5	0.1	3.1	6.0	1.3	3.1	0.1	1.1	12.9	50.2	12.6	1.6	0.8	1.7	8.1	1.0	0.3	6.3	2.2	0.7	2.5	0.4	0.1	11.6	0.6	1.6	2.5	2.0	2.3	0.1	4.5	7.8	6.5	3.6	0.4	6.8	0.1	0.5	2.2	5.7	0.7	0.0	0.2	0.0	0.2	1.1	10.1	0.0	0.5	27.3	0.0	0.0	0.0	0.1	0.0	2.0	2.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.0	21.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.1	0.0	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.3	0.3	0.6	0.1	1.1	0.8	1.7	0.7	0.1	3.6	0.7	1.4	16.0	82.4	0.7	1.1	2.3	0.1	5.2	0.0	3.2	5.3	0.9	5.2	7.2	21.3	44.1	0.0	0.6	0.4	0.0	0.0	1.2	69.0	6.1	44.4	3.6	0.0	2.7	3.8	0.5	2.2	18.1	42.3	9.7	1.3	2.9	7.5	66.8	94.0	42.1	8.2	0.0	2.0	27.4	3.5	189.3	11.1	26.8	1.8	16.9	1.3	0.2	0.0	4.0	2.1	0.8	0.0	14.7	0.2	0.0	0.0	15.3	0.8	2.8	6.6	3.4	3.0	1.2	0.6	1.2	1.8	2.7	1.0	13.6	0.0	0.1
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076567	"Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		14000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	20.9	22.4	15.0	11.2	17.2	11.7	15.9	12.7	17.1	16.1	7.7	22.2	9.9	18.0	15.4	17.6	15.4	13.6	23.4	18.0	17.2	17.3	16.5	16.3	11.3	14.0	14.6	19.9	11.4	21.4	14.4	17.0	14.5	16.5	14.4	28.7	11.8	19.4	19.6	12.8	11.5	19.4	13.5	12.4	13.6	8.0	15.3	11.5	17.9	25.6	10.8	16.2	12.3	14.7	41.4	37.1	28.2	30.0	49.1	51.4	31.2	33.7	38.3	23.2	20.7	18.7	40.1	21.3	43.2	59.7	19.1	29.3	29.0	24.8	33.8	27.3	19.5	67.9	34.8	23.9	24.5	45.5	41.1	30.1	26.5	31.7	24.5	35.4	29.0	29.2	77.0	30.2	37.5	23.1	19.9	16.4	37.1	46.2	7.9	24.1	29.7	28.4	19.5	46.1	37.5	91.8	35.5	39.7	34.5	39.8	34.4	32.8	30.8	36.7	32.2	51.1	46.0	24.5	48.5	18.2	36.5	21.7	37.3	0.9	0.6	0.2	1.3	0.6	1.3	1.4	0.7	1.1	0.8	1.5	1.1	1.0	0.6	1.6	0.8	1.2	1.0	0.5	15.0	17.2	12.7	17.1	18.0	17.2	14.0	14.6	14.5	13.5	15.3	14.7	16.8	6.4	11.4	16.0	7.5	15.6	12.6	8.9	4.6	15.7	12.2	9.3	40.1	12.8	9.0	18.4	25.0	9.0	9.0	10.6	3.9	8.8	5.2	8.8	17.8	13.8	14.4	43.3	28.3	13.0	7.7	14.6	9.2	14.5	17.1	20.2	9.3	14.2	7.6	38.7	32.0	7.9	10.2	11.6	8.1	5.1	17.7	9.6	16.0	19.7	14.1	9.0	2.1	17.6	32.5	13.7	3.8	21.4	6.2	19.7	5.0	5.9	8.8	21.0	13.1	20.0	17.7	17.6	13.8	9.6	12.9	7.5	8.0	24.1	8.5	24.7
FAM210A	"C18orf19, HsT2329, MGC24180"	ENSG00000177150	"Family with sequence similarity 210 member A"	Q96ND0	18	13663347-13726663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 33.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014324, HPA051564"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Golgi apparatus, Mitochondria"		"HPA014324: AB_2668972, HPA051564: AB_2681536"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.23e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.79e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.27e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.82e-2)"	6.1	4.7	4.7	5.5	4.5	3.5	4.8	5.8	7.1	4.2	8.0	6.9	9.3	3.9	2.9	8.8	4.2	4.0	21.8	4.6	5.3	9.4	13.2	4.0	6.4	5.2	7.0	5.6	3.3	6.4	2.6	7.5	5.6	4.4	6.4	11.5	5.1	4.6	25.5	3.3	6.2	6.2	5.1	3.7	4.7	8.4	6.3	5.3	6.3	33.1	7.3	6.3	5.0	5.7	24.6	13.6	9.4	8.8	10.9	11.2	13.6	16.5	15.3	18.2	21.1	18.4	11.6	24.9	20.2	11.8	33.6	11.5	18.2	20.6	29.5	17.4	8.4	17.7	9.7	13.0	12.9	30.3	15.9	9.7	15.9	17.5	61.6	12.7	11.9	14.8	24.2	13.4	21.2	16.8	18.7	19.5	10.6	47.7	13.5	15.2	22.3	29.1	15.1	15.3	6.0	10.1	14.5	21.1	40.0	13.4	10.8	14.2	13.2	46.4	45.7	29.1	20.6	15.1	20.1	28.8	24.6	15.6	18.9	3.5	5.3	3.3	6.2	8.0	6.8	5.7	5.2	5.4	6.4	6.3	6.4	6.2	0.8	6.0	4.2	4.0	5.4	3.8	4.7	4.5	5.8	7.1	4.6	5.3	5.2	7.0	5.6	5.1	6.3	5.7	14.9	9.6	8.3	13.7	29.8	55.3	14.8	28.3	12.5	63.2	11.0	11.2	66.4	12.8	14.6	7.3	20.9	20.6	11.6	9.1	21.5	18.6	20.5	16.7	21.6	18.3	11.4	5.9	18.0	8.8	39.0	17.4	10.2	32.7	7.0	36.7	6.8	20.7	20.0	30.3	23.5	10.0	10.2	9.5	43.4	6.1	9.3	26.5	8.8	15.0	11.4	19.0	15.5	18.6	24.8	12.6	4.1	10.1	14.2	19.9	12.1	29.8	5.0	29.9	6.6	16.3	15.4	31.4	32.3	20.6	57.3	25.7	16.8	45.6	20.5	14.8
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358974-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 449.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 299.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA042652: AB_2678098"	"unprognostic (3.29e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	38.2	87.6	32.1	13.9	34.1	85.2	62.0	30.0	33.6	43.7	37.7	39.8	24.7	36.5	45.7	31.1	40.1	40.6	43.9	33.9	32.6	34.6	100.3	28.2	13.9	29.6	33.8	108.9	41.5	32.7	28.1	36.7	29.9	66.8	30.6	30.0	54.9	58.7	75.2	36.5	23.3	34.2	29.6	19.6	34.2	14.1	35.9	20.6	28.4	102.2	20.0	32.5	32.7	29.1	19.9	7.5	29.3	71.6	83.2	93.4	57.1	23.8	53.4	42.6	48.7	13.9	9.6	1.6	12.1	40.9	24.6	56.2	15.9	68.7	71.0	2.9	24.9	12.2	16.9	132.0	54.4	1.3	7.4	80.2	75.2	24.1	34.0	49.3	69.4	10.2	93.6	12.7	52.7	20.6	10.4	5.4	24.9	29.0	46.7	0.1	60.4	15.9	21.9	22.9	40.4	72.9	57.9	124.6	299.1	62.3	55.0	11.1	48.4	37.8	25.2	61.0	14.7	9.9	10.9	0.4	30.0	7.7	25.2	2.3	2.3	6.9	1.7	3.3	1.3	1.1	1.9	2.3	1.7	1.3	2.0	1.9	1.0	1.4	1.5	1.5	2.3	1.0	32.1	34.1	30.0	33.6	33.9	32.6	29.6	33.8	29.9	29.6	35.9	29.1	30.3	16.0	29.3	4.2	7.4	24.9	85.4	28.2	70.6	10.3	57.5	98.8	56.8	54.3	19.3	16.5	39.6	77.7	13.5	23.8	64.6	27.9	1.0	41.4	49.0	28.8	50.9	449.3	5.7	19.5	26.3	46.1	44.9	37.4	19.1	47.5	46.1	154.5	28.0	1.7	6.6	28.6	20.3	44.1	21.2	4.7	66.8	26.2	37.4	5.6	36.6	27.8	14.4	4.0	8.4	35.7	15.3	155.7	9.4	48.7	34.1	46.1	15.6	19.2	19.7	28.1	37.1	1.1	9.4	68.6	32.5	41.9	14.6	123.4	33.4	56.3
FAM214A	"FLJ10980, KIAA1370"	ENSG00000047346	"Family with sequence similarity 214 member A"	Q32MH5	15	52581317-52709817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 63.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039369, HPA040180"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA039369: AB_10795250, HPA040180: AB_10794736"	"unprognostic (1.75e-1)"	"unprognostic (6.40e-2)"	"unprognostic (4.54e-1)"	"prognostic favorable (7.27e-6)"	"unprognostic (1.08e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.32e-3)"	"prognostic favorable (8.68e-4)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.94e-3)"	37.2	20.3	6.4	15.1	12.0	21.3	28.2	24.5	9.0	12.6	41.1	15.4	14.2	17.5	10.2	27.6	16.5	12.6	15.9	6.6	6.5	12.1	38.8	14.4	24.5	7.3	8.9	12.5	21.8	43.4	11.5	8.5	10.3	15.3	16.9	17.5	16.9	15.9	50.1	11.7	14.2	13.4	5.8	16.0	18.4	21.2	9.8	18.1	25.3	27.0	30.6	12.7	12.3	13.6	5.1	6.8	6.9	12.0	20.7	12.4	8.1	12.5	21.8	6.6	8.6	3.9	5.4	35.3	14.7	11.9	3.1	10.2	5.0	11.6	5.8	28.4	7.1	8.9	15.9	3.3	7.3	4.3	4.6	29.6	18.2	6.5	7.2	12.4	22.0	10.9	5.2	36.1	9.4	20.1	6.8	10.9	1.3	8.7	8.1	16.3	7.2	27.1	10.8	23.7	7.8	13.6	12.6	23.5	9.5	21.1	36.6	9.3	16.4	6.6	2.0	7.4	2.7	55.2	35.8	63.6	11.4	5.7	2.2	0.7	0.6	5.3	3.6	0.2	3.9	6.3	2.7	2.4	0.7	5.4	3.0	2.8	3.8	4.9	0.3	8.4	4.7	1.1	6.4	12.0	24.5	9.0	6.6	6.5	7.3	8.9	10.3	5.8	9.8	13.6	43.5	44.8	27.1	60.7	53.5	16.3	13.2	23.7	28.5	19.3	50.8	30.2	27.7	24.3	35.6	3.7	62.6	2.6	49.2	25.4	3.9	11.4	2.8	78.1	34.7	28.0	29.2	20.4	80.0	14.9	3.0	25.3	30.5	123.9	3.8	19.3	24.7	39.0	7.3	26.9	90.1	27.0	28.5	18.0	9.9	3.7	28.3	15.8	26.6	57.1	7.4	24.7	16.5	73.4	123.7	15.2	13.2	32.0	100.5	20.1	12.3	7.6	46.2	28.6	13.1	36.6	20.9	36.5	9.4	28.7	14.3	20.2	34.6	26.9	11.5	42.0
FAM214B	"bA182N22.6, FLJ11560, KIAA1539"	ENSG00000005238	"Family with sequence similarity 214 member B"	Q7L5A3	9	35104112-35116341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 54.1;Late spermatids: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.8;granulocytes: 16.3;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"TIME: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048831, HPA055751"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048831: AB_2680535, HPA055751: AB_2682906"	"unprognostic (2.91e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.15e-2)"	13.9	14.9	26.7	12.2	27.4	38.8	10.6	27.2	29.4	11.8	20.7	15.2	10.2	10.6	7.0	29.7	8.9	11.7	19.7	26.0	26.9	14.9	11.3	21.7	6.8	30.8	29.0	8.0	6.8	11.2	15.8	9.9	29.6	13.0	10.5	4.3	11.6	9.7	14.2	15.0	11.2	11.0	27.4	27.6	11.7	8.5	30.8	5.9	11.7	11.5	7.0	12.3	14.4	28.3	6.4	5.2	14.2	10.3	11.0	16.9	3.0	31.2	27.9	17.0	10.9	3.6	4.4	1.6	9.0	50.5	44.0	2.8	2.4	10.0	11.0	8.3	0.6	7.9	12.6	3.4	11.2	2.2	33.4	12.1	17.4	19.9	12.5	39.3	33.1	7.9	4.4	6.3	36.0	1.8	3.1	9.8	2.7	4.8	7.8	3.5	2.4	1.9	22.3	1.4	1.0	9.3	4.9	3.5	16.6	14.8	4.6	5.3	56.0	23.8	11.5	11.5	11.5	4.0	4.1	0.8	37.5	4.0	26.7	5.0	5.9	5.7	2.1	7.7	0.7	0.5	1.3	1.5	4.8	0.2	0.5	0.9	16.3	2.1	10.2	1.2	0.8	3.4	26.7	27.4	27.2	29.4	26.0	26.9	30.8	29.0	29.6	27.4	30.8	28.3	10.8	0.0	3.9	17.9	3.1	8.4	4.4	11.7	11.4	3.3	8.6	5.2	8.6	2.8	6.2	16.5	14.6	2.8	7.9	43.0	3.9	11.3	12.7	5.5	7.0	11.3	5.4	54.1	5.8	12.5	9.6	6.9	9.2	7.8	8.8	3.8	18.2	6.7	14.9	0.0	5.4	12.3	12.2	28.2	21.3	77.0	3.4	32.5	16.0	4.7	26.2	8.4	16.5	2.5	14.4	40.0	19.8	7.9	3.5	6.9	14.1	11.7	4.4	3.6	6.6	7.3	9.2	3.0	6.5	23.6	14.5	4.2	7.5	5.3	14.0	9.3
FAM216A	"C12orf24, HSU79274"	ENSG00000204856	"Family with sequence similarity 216 member A"	Q8WUB2	12	110468415-110490385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 15.5;testis: 59.4"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.7;Spermatocytes: 215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038286	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"		"HPA038286: AB_2675931"	"unprognostic (7.91e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (4.18e-10)"	"unprognostic (7.60e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.05e-1)"	3.4	7.5	9.4	6.6	9.6	4.1	3.8	12.9	15.5	4.8	4.7	3.6	1.1	5.8	2.0	3.2	4.5	4.3	9.1	9.7	12.7	3.0	3.2	2.1	7.4	10.4	9.4	7.0	2.0	5.5	5.2	3.6	10.3	3.9	2.2	8.8	1.7	4.4	3.3	1.4	3.2	6.0	8.9	3.9	2.3	59.4	11.1	7.3	3.2	4.3	4.5	4.8	3.2	9.7	31.1	25.8	21.6	28.5	13.7	25.9	3.5	57.3	14.4	63.9	28.3	27.5	8.5	101.2	13.1	24.2	18.1	19.9	38.1	33.3	77.9	30.0	72.8	49.9	17.6	23.4	22.8	68.3	39.1	25.1	7.8	32.5	71.6	47.8	20.5	39.5	63.1	26.7	48.4	11.2	50.4	106.4	64.6	13.6	41.9	24.4	29.6	68.9	24.7	0.9	77.4	27.5	24.4	18.4	14.2	7.8	43.6	49.2	18.9	22.4	7.5	19.9	58.8	41.7	38.9	79.7	31.7	61.0	37.7	0.9	3.6	1.0	1.9	3.1	3.7	7.3	3.7	3.6	4.5	8.2	9.3	5.6	2.9	2.8	2.6	2.4	2.4	3.9	9.4	9.6	12.9	15.5	9.7	12.7	10.4	9.4	10.3	8.9	11.1	9.7	2.4	0.0	1.5	7.8	9.6	1.7	6.0	8.7	7.4	11.6	3.0	7.5	20.1	0.0	3.6	3.7	2.1	0.7	1.4	0.1	0.0	4.1	38.6	3.2	17.5	4.4	1.2	17.2	20.4	0.9	3.0	10.8	1.1	0.7	10.2	6.6	3.9	3.4	8.1	13.5	21.6	0.1	2.0	4.4	2.1	54.7	9.6	3.7	3.6	5.6	4.2	4.2	6.2	14.1	8.9	2.8	0.0	5.7	3.9	8.0	0.1	4.4	5.1	5.1	13.1	8.4	9.3	215.9	21.6	5.1	2.0	0.5	3.6	12.2	0.4	1.5
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 77.6"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 162.2;Respiratory ciliated cells: 294.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.1	0.0	1.5	0.8	1.5	0.0	0.0	0.7	0.1	1.4	5.5	0.1	0.1	1.5	0.0	0.0	77.6	0.2	10.0	1.7	2.6	0.0	0.0	9.9	1.8	9.3	9.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.7	0.1	0.2	0.0	2.1	0.0	0.0	0.0	3.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.7	0.1	1.7	2.6	9.3	9.3	6.1	6.7	2.1	3.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	19.8	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	162.2	1.0	0.7	0.0	0.0	0.2	0.0	0.0	2.2	0.0	2.3	1.3	0.0	0.0	0.0	0.3	0.0	0.9	0.0	12.2	0.0	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	294.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
FAM217A	"C6orf146, MGC43581"	ENSG00000145975	"Family with sequence similarity 217 member A"	Q8IXS0	6	4049434-4087344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 14.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 246.0;Late spermatids: 418.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA035455	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA035455: AB_10669905"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.54e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	246.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	418.8	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	20.9	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041021: AB_10959734, HPA056698: AB_2683212"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	4.8	4.0	8.6	6.3	10.3	13.6	4.9	5.7	17.3	4.8	0.1	4.2	5.1	6.8	5.6	4.6	5.5	4.1	9.9	10.8	6.7	5.3	2.0	5.3	9.3	6.1	6.9	10.7	3.0	3.8	6.9	6.3	6.4	7.5	3.5	8.2	4.3	9.0	15.5	3.5	5.9	4.5	5.9	6.3	4.6	9.5	7.4	9.4	6.8	17.4	8.8	3.6	3.1	12.1	9.1	6.1	14.0	9.6	6.6	9.8	11.2	12.7	10.8	13.8	9.9	31.9	19.4	20.0	21.0	5.3	11.1	21.9	15.2	10.6	13.4	11.1	9.6	18.7	15.5	18.5	4.2	30.2	24.3	5.7	12.9	10.2	3.3	5.6	4.1	23.8	13.6	8.2	9.0	16.6	53.0	16.4	13.6	8.5	12.5	12.7	13.8	19.5	5.3	14.1	14.2	16.9	17.0	21.8	18.9	12.9	21.2	21.1	5.8	11.4	13.3	11.8	6.8	14.0	25.7	23.9	15.8	19.4	7.6	9.3	5.9	8.2	8.5	3.7	10.3	4.9	8.0	7.7	6.5	5.7	8.2	8.8	11.1	8.0	3.6	5.2	7.6	6.0	8.6	10.3	5.7	17.3	10.8	6.7	6.1	6.9	6.4	5.9	7.4	12.1	16.0	16.0	19.4	25.5	18.5	5.4	5.4	13.6	10.2	35.6	16.4	16.0	34.9	10.0	12.1	11.0	22.9	23.4	22.2	11.7	17.6	5.5	29.9	8.4	15.5	16.7	8.4	11.3	33.5	8.2	12.0	18.0	7.1	6.6	29.1	19.3	17.2	5.0	19.1	60.6	32.6	5.3	8.2	34.0	13.4	24.9	17.4	13.2	12.4	12.2	32.4	24.4	44.3	22.6	27.9	8.1	5.1	10.1	16.8	9.6	26.3	14.5	17.5	32.0	32.9	36.2	16.6	52.4	16.2	11.0	5.4	6.8	23.3	13.1	9.5	9.7
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 94.6"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8;Late spermatids: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: AB_2681986"	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	19.8	14.0	82.5	9.0	79.4	3.8	17.5	72.4	88.0	18.5	25.9	17.0	5.4	22.5	6.2	9.8	15.7	5.6	29.9	75.9	77.5	15.7	12.7	18.8	6.5	90.0	84.8	15.3	13.2	6.4	26.3	13.4	94.6	16.3	4.6	19.3	12.1	7.0	42.7	16.2	11.9	11.9	83.8	15.1	12.7	9.7	82.9	8.3	14.9	12.6	5.0	17.7	15.7	85.4	27.9	10.6	24.5	14.0	22.3	8.5	23.8	16.5	12.4	14.0	17.7	7.4	6.3	6.1	16.6	16.1	27.7	11.4	19.6	10.6	14.0	96.0	11.2	2.5	14.6	8.0	12.5	6.1	13.6	9.0	10.5	21.0	11.7	17.4	23.4	10.6	6.1	29.6	11.0	5.6	9.5	8.5	15.8	3.8	15.6	12.1	4.1	5.3	10.1	5.9	7.8	24.8	14.3	10.3	8.5	22.2	5.2	6.1	28.0	15.4	11.9	32.3	23.2	7.8	12.0	5.1	44.2	13.9	27.8	0.6	0.1	1.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.5	0.2	0.2	0.1	0.4	0.1	82.5	79.4	72.4	88.0	75.9	77.5	90.0	84.8	94.6	83.8	82.9	85.4	14.3	6.4	3.3	17.3	3.3	6.2	3.7	5.6	4.0	21.1	5.1	2.9	11.7	1.5	2.5	3.7	4.2	9.4	4.3	2.1	0.0	6.1	13.8	2.0	6.0	17.4	10.8	0.4	28.6	5.1	16.8	7.8	6.1	2.8	2.5	3.4	9.3	2.8	5.9	53.8	31.8	2.3	8.2	5.5	2.6	35.1	3.7	4.1	8.8	15.0	4.5	9.3	3.1	22.1	15.9	6.6	1.7	5.7	3.0	5.1	1.3	3.0	2.3	11.0	6.6	5.2	9.1	9.9	3.8	3.0	6.5	20.7	3.5	2.9	0.9	2.7
FAM219B	"C15orf17, FLJ00005"	ENSG00000178761	"Family with sequence similarity 219 member B"	Q5XKK7	15	74899992-74906883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048929, HPA058064"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA048929: AB_2680561, HPA058064: AB_2683592"	"unprognostic (1.12e-1)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.11e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.91e-3)"	21.9	19.8	31.5	9.9	30.8	6.4	13.7	31.9	35.5	15.4	32.5	17.1	12.0	16.8	22.5	23.6	22.3	10.6	30.3	31.6	36.3	16.1	6.6	16.9	15.2	32.7	33.6	19.5	13.0	32.4	28.1	13.3	35.0	24.0	14.6	44.7	18.2	17.0	18.7	22.0	13.9	17.8	31.6	24.3	15.3	6.3	34.4	8.5	18.2	25.1	17.4	20.1	16.0	31.3	6.6	9.6	25.9	11.4	42.9	31.6	11.6	18.7	9.8	16.7	10.5	9.1	18.0	12.9	10.4	13.0	16.8	16.8	35.9	10.3	9.1	32.5	20.4	12.3	22.9	7.7	20.3	11.9	16.2	19.2	47.3	7.3	13.7	36.0	18.7	9.6	9.6	15.4	17.1	5.5	7.1	10.4	14.3	19.4	14.4	19.0	9.0	9.7	25.7	21.1	21.7	14.1	20.9	11.6	33.7	27.1	23.3	14.0	21.7	13.5	7.3	11.4	15.2	11.6	12.1	5.5	17.1	24.2	13.8	3.8	1.0	6.9	1.4	0.9	2.4	2.2	2.1	1.2	1.0	2.0	0.9	1.5	1.2	1.8	1.3	0.1	0.2	1.3	31.5	30.8	31.9	35.5	31.6	36.3	32.7	33.6	35.0	31.6	34.4	31.3	13.3	19.2	20.6	22.5	18.4	6.4	21.2	17.9	13.6	41.6	16.2	13.5	5.1	10.0	18.9	27.6	58.4	17.1	22.3	23.3	13.7	14.4	1.0	22.9	14.8	16.0	20.9	7.6	23.9	10.5	11.4	17.4	9.7	13.9	24.7	15.0	17.2	5.8	17.9	23.5	20.8	16.0	28.5	13.3	8.5	4.7	23.3	13.0	14.2	13.1	19.8	26.7	30.9	11.1	9.4	17.5	16.2	28.6	15.7	19.9	23.3	11.9	30.6	69.2	26.3	15.8	15.2	9.1	17.5	18.2	7.7	8.3	16.0	15.0	14.0	22.6
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 69.2;Respiratory ciliated cells: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 19.3;GAMG: 26.5;MOLT-4: 27.4;SCLC-21H: 23.4;SH-SY5Y: 41.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	5.5	3.6	14.9	3.2	17.2	1.7	4.3	18.2	24.4	3.5	15.4	6.5	9.9	2.5	3.4	7.2	9.3	3.4	4.1	14.2	15.7	6.4	9.7	4.7	3.8	17.3	16.1	3.8	20.4	2.7	5.3	1.6	18.1	4.8	8.5	4.8	7.5	2.4	2.6	3.9	7.3	1.9	16.7	2.6	11.9	19.7	16.2	7.7	6.0	4.3	4.9	4.9	4.1	23.8	0.0	1.0	11.1	8.9	0.4	0.0	5.4	0.6	0.8	1.4	1.6	11.6	5.5	1.5	19.3	0.3	26.5	2.4	0.0	0.1	2.2	0.0	15.3	3.3	1.1	0.0	3.0	0.0	17.3	0.7	0.7	0.2	0.1	2.4	3.4	11.7	0.0	0.0	0.4	5.5	27.4	0.0	0.0	0.0	5.8	10.8	1.1	0.0	5.8	5.4	23.4	41.3	1.9	0.0	0.0	2.6	5.6	8.0	0.5	0.1	4.2	2.4	1.1	0.1	0.1	0.0	1.1	0.0	2.0	0.0	3.1	4.2	5.1	2.0	10.7	6.6	8.6	6.4	5.4	6.8	9.8	5.5	0.1	7.8	6.0	4.7	12.2	3.3	14.9	17.2	18.2	24.4	14.2	15.7	17.3	16.1	18.1	16.7	16.2	23.8	7.2	16.0	7.2	13.4	7.2	16.2	9.5	10.0	14.8	6.9	17.8	7.7	5.5	20.0	20.0	7.3	2.1	3.5	5.3	8.2	9.8	15.4	8.5	24.7	2.0	6.9	14.9	3.8	13.7	10.6	0.3	12.3	36.7	11.2	5.1	10.2	6.1	16.0	6.7	6.7	16.3	25.7	18.3	4.1	10.8	10.4	4.7	6.1	8.8	12.2	2.1	8.5	2.1	11.6	69.2	11.5	25.2	3.8	7.1	11.7	15.2	12.3	51.6	8.0	19.7	8.5	5.3	45.2	27.6	14.6	18.9	0.8	7.6	4.4	22.5	11.8
FAM221B	C9orf128	ENSG00000204930	"Family with sequence similarity 221 member B"	A6H8Z2	9	35816391-35828747	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 2.9;testis: 9.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 266.3;Late spermatids: 122.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA026577	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA026577: AB_1845810"	"unprognostic (1.23e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-3)"	0.1	0.1	0.2	0.4	0.3	2.9	0.4	1.2	0.4	0.2	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.3	0.2	0.2	0.1	0.0	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.7	0.5	0.6	0.5	0.0	0.3	0.2	0.0	0.1	0.3	0.3	0.4	9.8	0.3	0.2	0.1	0.0	0.5	0.2	0.0	0.6	0.0	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.9	0.0	0.0	2.9	0.1	0.0	0.2	0.3	1.2	0.4	0.2	0.1	0.5	0.2	0.5	0.3	0.3	0.6	0.0	0.0	3.1	0.3	0.4	0.0	0.4	1.0	0.0	4.1	0.8	0.4	0.4	0.0	1.8	0.0	0.0	0.1	16.1	0.3	0.0	0.1	266.3	0.5	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.4	1.2	2.0	0.3	0.0	122.0	2.1	0.4	0.0	0.0	0.2	1.9	0.0	1.0	0.7	0.2	1.6	0.7	0.3	1.3	0.0	0.1	2.7	5.5	0.0	0.1	0.2	6.0	1.4	0.0	0.0	0.0	0.0	0.1	0.2	1.3
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109713825-109770495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA075616"	Uncertain		Approved	"Golgi apparatus,Cell Junctions,Midbody ring"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Cell Junctions, Midbody ring"	"HPA040181: AB_10796448, HPA075616: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	0.7	19.0	23.7	0.7	45.2	0.6	1.2	36.7	34.2	0.6	5.6	1.9	4.8	0.3	0.8	2.3	0.4	0.8	8.9	20.0	27.6	10.6	4.0	2.1	0.4	41.2	43.1	13.4	3.9	0.7	22.4	0.1	37.7	1.8	1.0	22.1	3.4	0.5	4.3	3.2	2.2	0.4	29.0	6.2	7.2	23.4	48.4	0.4	0.7	0.6	0.6	0.9	1.8	65.6	2.0	3.1	1.6	3.7	1.0	0.0	1.1	0.6	0.3	1.6	0.2	28.1	0.5	0.3	2.2	0.8	1.7	1.2	1.9	0.1	0.6	16.8	4.0	3.5	0.9	6.5	0.2	2.8	3.6	0.2	0.2	0.3	0.0	0.4	0.1	2.0	1.2	0.6	0.3	11.5	0.7	3.6	3.0	3.3	5.3	2.3	8.0	1.2	3.5	1.5	19.2	116.4	2.5	3.7	8.2	0.5	4.5	3.0	0.2	0.5	3.2	1.3	2.4	2.9	4.0	2.4	0.3	2.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	45.2	36.7	34.2	20.0	27.6	41.2	43.1	37.7	29.0	48.4	65.6	2.1	0.0	0.0	2.3	3.6	2.2	0.9	0.1	3.4	23.4	7.4	6.1	8.1	1.5	0.8	1.8	33.3	0.3	10.4	1.2	7.9	1.7	29.1	1.2	0.5	1.3	7.7	0.0	1.3	0.8	0.2	1.5	1.5	1.8	0.0	0.7	0.7	1.3	0.3	77.4	6.7	5.8	0.0	0.0	2.1	13.4	1.2	1.9	7.2	0.0	0.1	11.2	0.0	9.5	78.5	1.1	0.2	0.4	1.3	1.7	0.9	0.7	0.6	50.3	0.0	2.6	1.5	1.1	5.7	3.3	1.8	0.8	3.7	6.0	1.6	0.4
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 84.7;Oligodendrocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051840: AB_2681633, HPA062239: AB_2684722"	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	8.6	6.3	6.9	6.9	7.3	7.0	8.4	14.1	9.5	9.3	18.8	11.2	12.3	7.5	7.8	11.1	7.0	8.6	10.9	6.6	6.8	10.5	7.7	8.0	6.6	8.7	6.8	8.4	8.0	10.5	10.2	9.9	8.1	9.3	10.0	10.0	14.2	8.8	43.4	7.9	11.0	7.1	2.8	6.6	8.4	27.5	9.8	7.9	8.5	16.2	7.1	10.7	9.8	7.1	13.1	25.1	21.2	24.4	17.7	12.3	23.2	9.1	8.5	12.5	12.6	32.4	12.6	13.3	17.9	10.2	16.0	16.2	17.7	20.4	10.4	18.7	24.1	15.0	12.9	24.9	20.4	9.9	23.1	12.9	19.8	17.7	15.7	12.6	25.2	15.5	29.1	9.2	26.4	16.5	16.9	7.9	24.3	17.5	9.4	7.9	20.1	13.4	22.4	16.4	23.0	16.1	12.9	24.8	31.8	44.0	18.9	9.3	28.8	8.3	17.1	9.4	14.5	18.5	24.9	8.8	11.4	6.8	15.5	15.9	3.9	9.5	6.4	5.0	7.6	6.2	5.4	6.6	5.4	4.6	7.3	6.3	4.5	3.9	7.9	4.9	5.2	4.2	6.9	7.3	14.1	9.5	6.6	6.8	8.7	6.8	8.1	2.8	9.8	7.1	10.3	3.2	7.3	49.3	12.0	9.4	7.7	14.7	9.1	14.8	14.7	10.3	13.6	31.5	9.1	7.3	27.1	7.9	6.5	22.9	3.9	18.1	56.9	11.0	10.8	13.7	25.9	14.7	73.8	13.3	10.6	7.9	11.7	17.1	10.1	8.1	31.4	11.4	8.7	25.2	84.7	17.3	20.3	8.4	5.7	45.3	12.5	6.8	7.2	41.2	8.3	6.2	8.2	64.3	79.0	24.1	12.7	7.9	8.6	14.0	18.3	11.2	10.0	8.0	0.0	9.5	6.5	51.9	34.8	9.2	6.7	6.0	10.7	8.1	19.0	10.4
FAM227A		ENSG00000184949	"Family with sequence similarity 227 member A"	F5H4B4	22	38578120-38656629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 7.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6;Early spermatids: 87.3;Endometrial ciliated cells: 72.4;Late spermatids: 57.0;Respiratory ciliated cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 10.4;Karpas-707: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003077	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003077: AB_1079264"	"unprognostic (7.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.91e-3)"	"unprognostic (4.79e-5)"	"unprognostic (5.91e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.62e-2)"	"unprognostic (6.46e-6)"	"unprognostic (3.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.35e-2)"	0.1	0.6	1.3	0.2	1.2	0.5	0.8	0.9	1.2	1.2	7.5	0.4	0.2	0.7	1.9	0.1	3.8	0.3	0.3	1.5	1.4	1.1	0.1	1.1	0.2	2.5	3.1	0.7	0.4	0.6	4.3	0.1	1.5	0.6	0.2	3.5	0.4	0.4	0.1	0.8	0.1	0.3	1.4	0.1	0.3	4.1	1.4	0.2	1.3	0.0	0.1	0.3	0.3	0.9	0.4	0.9	1.4	1.7	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.1	0.9	0.1	0.4	0.2	0.4	0.9	0.5	0.2	0.4	10.4	0.9	0.1	2.9	0.2	0.2	0.4	0.4	0.5	0.6	1.0	0.4	1.5	0.2	1.6	0.4	17.3	0.1	0.5	0.4	0.5	0.7	0.2	0.5	1.0	0.1	0.6	0.9	0.3	2.0	0.5	1.4	0.1	0.2	0.5	1.1	0.1	0.3	0.4	0.4	0.4	0.1	1.8	0.8	0.1	0.6	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.3	1.2	0.9	1.2	1.5	1.4	2.5	3.1	1.5	1.4	1.4	0.9	0.3	3.2	2.6	20.9	0.0	2.4	3.2	3.7	0.0	6.8	4.1	3.8	2.1	2.8	9.0	5.5	39.6	0.3	0.2	0.3	0.0	3.8	87.3	72.4	5.9	1.6	4.8	0.8	15.5	2.5	0.3	2.6	0.0	4.1	0.0	8.5	0.4	0.3	0.2	5.0	11.1	0.7	4.1	0.6	1.2	57.0	2.1	0.6	0.0	2.8	0.3	9.5	1.0	1.5	2.3	2.3	0.2	1.2	0.1	2.1	0.0	1.4	115.2	30.4	0.0	4.6	2.8	16.4	12.9	0.0	3.4	0.1	1.4	9.5	1.2	1.7
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620929	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.1	5.1	4.2	1.9	5.1	1.5	6.6	4.2	5.2	4.7	4.6	4.3	2.8	6.3	7.3	3.5	7.7	3.4	7.3	3.9	4.8	7.7	7.5	2.7	4.8	4.8	5.0	9.9	6.4	5.6	6.4	1.3	5.2	5.7	2.8	7.9	5.3	5.1	7.9	3.9	2.3	3.9	4.9	2.8	3.6	10.4	4.5	6.8	7.4	8.9	4.4	3.5	2.2	6.3	0.8	0.7	5.1	2.8	1.5	3.0	0.6	2.1	2.8	3.2	5.1	0.7	2.4	1.5	4.9	3.5	3.7	0.8	1.8	3.1	3.7	3.7	1.5	3.2	1.3	1.7	4.2	1.5	1.3	3.1	4.0	1.8	2.0	6.2	3.0	7.7	5.4	2.4	7.1	3.5	3.2	1.3	2.0	1.2	1.3	2.7	4.5	8.1	4.8	1.0	3.8	5.3	1.9	2.5	6.2	3.7	3.1	1.1	2.2	2.2	1.7	3.0	1.3	12.2	9.8	4.8	2.4	3.9	2.4	5.8	0.2	1.7	3.4	0.5	4.5	2.8	3.5	4.6	0.3	3.5	5.8	5.6	0.3	2.7	0.6	3.4	3.4	2.0	4.2	5.1	4.2	5.2	3.9	4.8	4.8	5.0	5.2	4.9	4.5	6.3	1.1	9.6	4.8	39.5	5.8	2.8	5.4	5.4	3.4	4.3	6.2	7.6	10.8	1.5	9.4	3.7	0.0	1.7	3.3	1.3	25.4	3.9	41.0	19.1	3.1	2.8	8.4	2.1	12.8	3.2	1.5	3.7	3.6	3.2	3.8	1.8	1.8	4.1	0.6	5.0	12.1	1.8	6.1	0.6	2.0	21.1	4.1	2.0	3.6	5.6	0.6	11.7	4.1	16.1	55.1	2.5	1.6	3.0	6.1	2.6	1.9	12.5	21.3	8.0	0.0	4.7	2.0	48.7	13.2	2.5	4.3	0.4	5.7	6.3	2.2	2.6
FAM228B		ENSG00000219626	"Family with sequence similarity 228 member B"	P0C875	2	24076526-24169640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.9;Late spermatids: 100.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052598, HPA063357"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus"		"HPA052598: AB_2681880, HPA063357: AB_2684994"	"unprognostic (2.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-5)"	"unprognostic (5.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.93e-2)"	21.8	15.0	44.4	2.9	48.1	7.9	17.1	53.2	63.6	21.1	33.8	20.7	1.7	12.2	19.2	6.8	18.4	9.2	26.0	40.4	47.3	17.0	4.9	11.0	5.5	45.3	43.8	21.4	8.3	14.9	30.6	6.5	45.5	21.6	4.3	8.9	7.5	12.4	13.2	8.2	10.4	7.8	45.6	12.7	11.4	33.4	45.1	6.2	14.0	9.7	5.0	16.9	14.5	54.9	2.6	1.9	3.7	13.9	9.6	12.5	0.4	6.3	5.9	2.3	1.5	0.2	1.6	3.3	3.1	4.8	4.6	0.2	0.9	0.7	2.2	5.0	6.1	4.0	0.6	0.7	18.6	2.0	1.0	11.7	6.5	1.0	9.3	15.5	5.0	3.0	0.4	4.0	3.1	4.1	0.6	9.4	1.2	0.3	5.4	3.2	1.7	1.5	6.8	2.7	1.3	10.0	2.0	0.0	11.3	5.9	3.8	9.3	5.2	4.2	0.4	0.8	2.1	6.7	2.2	3.9	9.2	7.1	2.9	9.4	5.0	10.1	5.2	3.5	2.6	7.4	3.7	4.2	6.0	4.8	5.5	5.7	4.1	4.5	3.3	9.9	3.8	3.1	44.4	48.1	53.2	63.6	40.4	47.3	45.3	43.8	45.5	45.6	45.1	54.9	19.1	51.3	35.3	49.9	10.7	6.4	9.5	8.8	5.2	24.7	11.5	18.7	24.7	10.0	34.9	14.7	8.4	9.7	17.2	1.6	31.3	5.4	116.9	13.2	11.8	17.4	9.6	6.9	52.1	5.5	4.2	20.1	2.6	5.5	25.9	22.3	20.7	3.5	10.4	37.0	52.1	3.2	10.2	12.8	21.7	100.5	42.3	13.2	10.6	39.4	14.7	39.0	21.6	41.7	78.3	3.8	1.1	38.4	4.6	4.3	2.4	12.3	41.9	27.7	52.6	24.3	21.6	39.4	11.4	2.6	7.4	3.3	13.2	17.4	3.1	5.4
FAM234A	"C16orf9, DKFZP761D0211, FLJ32603, ITFG3"	ENSG00000167930	"Family with sequence similarity 234 member A"	Q9H0X4	16	234521-272183	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA		5300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	59.5	57.9	22.5	25.1	38.7	19.9	46.5	41.1	30.5	38.3	41.3	71.2	101.2	52.5	21.5	59.7	40.8	37.6	116.8	21.9	25.7	57.7	51.5	36.6	19.2	59.0	37.2	39.5	68.4	48.2	58.1	38.6	54.8	52.5	30.1	9.8	41.2	39.4	175.7	49.1	64.7	40.6	35.7	30.2	59.8	45.1	37.1	16.7	50.5	77.0	15.0	60.1	38.3	71.1	29.5	67.1	72.3	152.1	110.2	66.3	39.2	71.5	92.7	41.9	54.2	67.6	76.9	30.2	104.2	90.8	37.3	55.2	27.6	48.4	35.7	40.5	48.5	35.7	38.8	53.2	81.0	21.4	22.5	74.4	58.7	67.1	48.1	119.8	74.1	39.1	42.1	6.0	44.9	140.0	22.1	25.2	89.1	44.2	31.1	66.5	48.0	120.5	73.9	29.6	83.1	73.9	107.9	58.3	61.5	63.3	81.5	31.4	63.3	76.7	25.2	43.8	21.3	15.6	7.1	37.6	54.4	30.1	104.9	11.7	17.7	13.3	10.1	17.7	5.2	7.1	8.9	10.0	18.0	9.5	10.0	11.3	6.1	15.8	17.2	6.5	9.4	13.9	22.5	38.7	41.1	30.5	21.9	25.7	59.0	37.2	54.8	35.7	37.1	71.1	20.2	9.6	12.6	0.0	7.4	0.0	11.3	0.0	9.6	8.9	23.9	19.7	0.0	21.5	5.0	31.3	25.0	58.7	8.8	25.2	7.9	49.4	27.9	22.2	26.8	18.1	35.2	14.5	0.0	26.1	48.8	21.0	23.4	33.2	8.8	59.2	22.9	23.5	25.7	10.1	0.0	26.4	0.0	14.4	0.0	78.1	16.8	10.9	0.0	0.0	39.6	11.1	10.3	0.0	0.0	18.4	41.5	21.8	5.7	14.8	102.1	18.6	6.6	12.0	19.7	16.9	20.1	29.2	30.8	18.2	0.0	66.2	6.8	73.3	40.4	10.7
FAM234B	KIAA1467	ENSG00000084444	"Family with sequence similarity 234 member B"	A2RU67	12	13044381-13142521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.8;Breast glandular cells: 16.8;Collecting duct cells: 18.4;Erythroid cells: 13.2;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010803, HPA010850"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	"Endoplasmic reticulum"		"HPA010803: AB_1079200, HPA010850: AB_2732402"	"unprognostic (1.85e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.03e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.62e-2)"	3.3	2.5	14.1	1.6	14.7	3.0	16.4	9.2	22.9	2.3	4.5	1.5	1.8	2.5	3.1	2.0	2.9	1.6	1.8	15.5	16.1	5.4	2.2	2.7	1.6	10.5	10.7	2.5	2.6	3.3	5.1	5.7	11.5	6.2	1.1	17.6	2.7	2.4	2.2	12.7	1.8	2.3	8.1	2.2	1.6	5.6	11.7	2.3	8.6	1.7	1.5	2.5	2.6	13.4	3.6	3.6	10.9	7.7	8.3	8.0	8.4	2.4	2.8	5.3	10.4	3.8	5.3	14.7	2.9	2.9	9.4	5.4	13.9	2.6	11.0	1.7	7.7	8.7	4.1	3.0	4.4	7.6	4.7	6.3	5.5	7.8	5.9	8.0	7.2	10.2	2.2	5.1	5.8	12.2	6.5	4.8	14.3	2.8	2.0	8.5	14.0	1.6	3.3	8.9	15.0	4.9	5.3	3.5	4.3	18.5	4.4	4.2	3.5	3.5	5.8	6.5	2.6	2.8	3.9	9.4	11.1	3.4	4.4	0.2	1.4	1.1	1.3	2.6	1.8	2.4	1.5	1.3	1.2	3.4	2.1	2.3	0.3	1.5	4.2	2.3	1.2	0.7	14.1	14.7	9.2	22.9	15.5	16.1	10.5	10.7	11.5	8.1	11.7	13.4	5.4	3.2	3.3	0.0	2.2	0.0	2.1	0.0	1.2	29.8	16.8	3.6	0.0	2.8	0.0	18.4	2.1	9.6	1.0	0.0	1.9	2.0	9.3	1.1	1.0	3.2	12.2	13.2	0.0	1.3	3.4	1.9	0.5	1.5	0.0	2.0	5.0	2.3	3.6	3.3	0.0	0.8	0.0	1.6	0.0	3.6	5.6	1.5	0.0	0.0	2.3	4.2	1.0	0.0	0.0	1.1	1.2	5.3	1.9	3.3	2.6	1.2	0.0	3.3	0.0	1.6	1.3	9.2	13.7	2.2	0.0	3.6	1.3	1.2	0.9	1.5
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145454-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 41.3;HUVEC TERT2: 28.0"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	16.7	4.1	7.7	5.3	8.6	7.2	11.2	16.6	15.5	2.8	0.5	2.8	2.9	3.8	3.8	4.3	2.3	5.1	7.2	6.7	1.7	4.5	4.6	5.1	5.2	1.6	2.3	2.8	2.2	3.9	1.5	10.8	2.9	3.8	2.8	10.5	8.8	2.9	6.0	6.3	3.4	5.1	0.4	5.0	7.3	6.0	3.9	3.2	4.2	5.0	4.1	5.1	2.5	13.7	6.3	2.4	2.5	2.1	12.5	7.1	3.7	5.3	1.2	1.0	1.6	1.9	7.9	41.3	4.9	2.9	3.5	3.1	3.9	5.5	1.8	19.7	6.6	4.4	6.4	3.4	7.4	10.3	2.7	7.8	8.7	1.5	9.1	2.0	28.0	5.8	8.4	19.6	3.1	6.5	3.8	7.4	3.2	10.3	5.9	8.6	4.2	8.5	4.2	6.1	4.6	3.8	5.0	9.0	2.7	3.6	6.5	4.4	17.9	3.2	9.7	2.1	1.9	8.2	11.3	19.1	7.3	5.1	4.1	2.8	0.6	0.6	0.5	0.5	0.4	0.6	0.5	0.4	0.3	0.9	0.5	0.6	1.5	0.6	0.6	1.0	0.6	0.3	7.7	8.6	16.6	15.5	6.7	1.7	1.6	2.3	2.9	0.4	3.9	13.7	272.0	60.9	69.9	0.0	4.9	0.0	0.0	0.0	0.0	0.0	87.0	42.2	0.0	0.0	36.5	33.1	0.0	1.6	9.2	0.0	7.9	12.0	0.0	4.6	3.9	44.0	0.0	0.0	0.0	17.3	2.8	13.8	0.0	12.0	32.8	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	28.2	0.0	0.0	4.0	0.0	0.0	3.5	42.3	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	2.5	9.8	1.3	0.0	0.0
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630247-69633596	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8"	"Lineage enriched"	"Detected in single"	25	"T-cells: 17.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 57.5"					"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavorable (8.64e-4)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.72e-4)"	1.6	3.0	26.3	1.9	27.3	1.1	4.7	30.4	40.3	2.2	19.2	6.6	2.7	3.2	11.1	4.8	4.3	2.0	6.6	35.5	31.7	10.7	3.7	4.0	2.9	21.7	24.2	2.1	8.2	8.2	12.7	1.2	28.2	7.8	2.3	11.3	5.5	4.7	4.7	3.4	3.5	3.8	21.5	1.4	5.8	22.2	26.4	2.8	5.8	1.2	2.3	5.8	3.0	22.2	29.4	31.9	3.9	31.8	0.0	0.0	13.6	2.9	0.8	5.1	5.6	23.4	23.6	0.0	42.8	0.6	18.6	11.8	16.6	9.6	7.1	29.4	22.8	0.0	6.7	8.8	8.1	0.0	10.0	0.0	9.4	0.2	4.8	3.8	0.0	43.8	11.1	0.1	0.5	39.9	0.3	0.0	19.1	11.8	57.5	0.0	0.0	0.4	10.9	16.6	16.0	22.2	12.1	29.6	19.0	7.8	20.5	5.1	1.4	0.8	19.4	0.1	8.5	5.1	15.2	0.1	0.4	0.0	0.8	0.0	0.0	0.0	4.3	0.0	10.9	0.1	10.5	7.0	0.1	0.4	17.2	5.7	0.6	0.2	0.0	0.1	7.8	3.1	26.3	27.3	30.4	40.3	35.5	31.7	21.7	24.2	28.2	21.5	26.4	22.2	1.4	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.3	19.4	0.0	0.0	3.1	16.5	0.0	7.5	0.6	0.0	11.7	24.3	0.0	5.7	0.4	0.7	0.0	0.0	0.0	18.4	5.6	0.6	0.0	5.0	0.0	8.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.3	0.0	0.0	13.5	4.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	2.8	3.7	0.0	0.0
FAM243A	C21orf140	ENSG00000222018	"Family with sequence similarity 243 member A"	B9A014	21	34400112-34401072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;hTERT-RPE1: 1.2;T-47d: 1.0"	"Not detected"	"Not detected"							HPA045123	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"				"HPA045123: AB_10961912"																		1.2	0.9	0.1	0.3	0.3	0.0	1.2	0.2	1.1	1.9	0.4	2.0	0.0	1.6	0.0	0.6	1.5	0.3	1.2	0.2	0.1	1.2	0.9	1.1	0.3	0.2	0.3	2.0	1.0	0.0	1.6	0.1	0.2	1.6	0.0	1.4	1.4	0.0	1.1	0.8	1.0	0.0	0.0	1.2	3.8	5.4	0.2	0.0	1.9	0.0	0.0	1.4	1.4	0.6	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.8	0.2	1.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.1	0.7	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	1.0	0.5	0.1	0.1	0.2	0.0	0.2	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.1	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM243B		ENSG00000277277	"Family with sequence similarity 243 member B"	P0DPQ4	21	7768884-7770591	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.4"									HPA045123	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"				"HPA045123: AB_10961912"																		1.1	0.9	0.1	0.4	0.1	0.0	1.1	0.4	0.5	1.5	0.5	1.5	1.1	1.3	0.0	0.7	1.4	0.8	1.1	0.6	0.0	1.0	0.7	0.8	1.1	0.0	0.0	1.7	1.2	0.0	1.2	0.3	0.1	1.2	0.0	2.4	1.4	0.0	1.5	1.2	0.9	0.0	0.0	0.9	4.6	2.1	0.1	0.0	1.7	0.0	0.0	1.1	1.1	1.0	0.3	0.7	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.3	1.0	0.0	1.0	0.5	0.3	0.5	0.1	1.4	0.4	0.1	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM24A	AC073585.4	ENSG00000203795	"Family with sequence similarity 24 member A"	A6NFZ4	10	122910610-122913111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	118	"testis: 17.6"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 303.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052490	Supported				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA052490: AB_2681851"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	303.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FAM24B	"AC073585.2, MGC45962"	ENSG00000213185	"Family with sequence similarity 24 member B"	Q8N5W8	10	122849078-122879641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 50.9;Early spermatids: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"hTERT-HME1: 135.5;LHCN-M2: 181.8;TIME: 58.3"									HPA052490	Supported				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA052490: AB_2681851"	"unprognostic (4.03e-2)"	"unprognostic (4.27e-2)"	"unprognostic (3.13e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.42e-7)"	"unprognostic (2.99e-1)"	"unprognostic (7.06e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.81e-3)"	2.1	1.3	4.9	2.6	5.0	2.6	3.0	4.9	6.4	2.8	3.7	2.8	2.3	2.3	2.9	2.4	2.2	2.1	1.5	5.2	6.3	15.0	0.9	2.4	5.9	5.3	5.0	2.9	7.8	1.0	10.9	0.4	5.2	3.0	4.0	5.9	1.9	1.4	0.9	4.2	3.6	1.6	4.9	3.8	3.1	9.2	5.2	4.9	2.4	0.2	4.7	2.6	2.3	5.8	8.1	12.8	3.1	0.1	1.9	3.7	4.0	11.8	11.1	4.8	4.4	14.2	16.6	3.0	3.6	6.5	1.4	5.2	0.0	7.1	13.1	14.0	5.3	23.8	18.4	7.6	10.4	0.0	13.8	4.3	0.9	10.4	135.5	0.9	12.6	15.5	9.5	6.0	181.8	7.3	13.9	13.9	5.0	8.1	13.3	0.0	18.5	2.8	8.6	7.2	8.6	3.7	5.5	2.9	15.0	7.7	4.7	14.1	58.3	1.4	6.7	5.0	1.2	6.5	7.1	18.0	9.7	23.3	0.0	2.2	1.5	1.0	1.7	1.5	0.6	4.2	3.4	2.4	2.1	2.3	3.5	2.1	1.0	2.1	1.5	8.1	3.6	1.2	4.9	5.0	4.9	6.4	5.2	6.3	5.3	5.0	5.2	4.9	5.2	5.8	2.5	0.0	0.5	0.0	7.1	6.6	1.6	4.2	14.2	3.6	3.7	5.8	0.2	2.8	1.2	9.2	0.0	0.1	7.7	1.6	50.9	4.3	28.2	0.5	0.7	1.9	4.8	6.5	0.0	7.3	0.2	3.8	2.0	0.6	8.9	0.5	1.8	0.8	1.2	1.7	0.0	3.5	12.2	4.1	2.9	4.1	3.7	3.3	1.8	0.0	3.5	2.9	8.2	0.0	0.0	8.7	2.7	4.1	2.7	2.0	2.3	1.8	1.2	4.3	0.0	1.7	2.3	12.9	4.6	5.5	5.4	0.0	6.7	0.2	3.5	1.2
FAM25A	bA96C23.5	ENSG00000188100	"Family with sequence similarity 25 member A"	B3EWG3	10	87020294-87024730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 143.3;esophagus: 519.5;salivary gland: 140.0;skin 1: 175.0;vagina: 193.1"	"Group enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 49.6;Syncytiotrophoblasts: 16.1"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 53.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A-431: 30.3;SK-BR-3: 70.0"	"Low region specificity"	"Detected in single"							HPA044808	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA044808: AB_2679096"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-1)"				"unprognostic (7.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.05e-5)"						"unprognostic (1.21e-1)"	0.3	2.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	143.3	0.0	0.1	0.0	0.1	0.0	519.5	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	1.5	0.0	0.1	0.0	0.0	140.0	0.0	1.2	175.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	1.4	0.0	0.0	63.6	0.1	193.1	0.1	30.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.3	0.0	0.0	0.2	0.0	0.0	9.0	0.1	0.0	0.0	0.2	2.0	0.0	0.3	0.0	1.6	1.2	0.0	0.0	0.0	70.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	2.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	49.6	16.1	0.0	0.0	0.0	1.9
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995322-47999791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 14.8;esophagus: 30.1;salivary gland: 15.4;skin 1: 43.6;vagina: 13.4"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 1.3;Basal respiratory cells: 3.0;Suprabasal keratinocytes: 3.1"	"Cancer enriched"	"Detected in single"	5	"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 10.7"									HPA044808	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.1	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	14.8	0.0	0.3	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	43.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.4	0.0	13.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	3.1	0.0	0.0	0.0	0.0	0.0
FAM25G	bA301J7.4	ENSG00000189090	"Family with sequence similarity 25 member G"	B3EWG6	10	47487219-47491693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 18.6;skin 1: 43.3"	"Group enriched"	"Detected in some"	4	"Pancreatic endocrine cells: 57.1;Spermatogonia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 13.8"									HPA044808	Uncertain					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA044808: AB_2679096"						"unprognostic (1.97e-2)"												0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	10.4	0.0	0.2	0.2	0.0	0.0	18.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.7	43.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	10.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.1	0.0	0.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	19.8	3.9	0.0	0.4	0.0	0.0	0.1	0.1
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	64.5	69.9	64.9	48.2	66.4	94.6	57.1	60.5	69.3	44.6	57.3	68.8	78.2	57.2	49.5	69.6	45.3	53.8	54.8	66.2	62.1	60.7	95.3	51.4	60.9	62.9	63.1	43.3	52.8	54.0	37.8	61.4	63.5	50.0	57.8	28.1	56.3	47.4	50.8	73.3	74.9	52.9	60.1	67.7	68.9	30.6	65.8	64.1	48.6	49.1	59.5	63.4	49.8	64.3	102.8	76.7	118.3	76.8	137.1	104.7	111.8	97.1	109.8	117.5	128.3	106.1	120.4	67.6	165.2	126.4	84.4	76.8	122.4	106.2	102.6	89.6	134.2	125.5	66.2	95.6	110.4	159.4	141.0	121.6	109.4	94.5	86.2	103.8	128.4	137.2	100.2	96.6	117.6	136.0	124.4	165.9	170.6	168.9	187.7	129.3	81.9	111.6	129.6	100.6	101.6	154.3	82.3	77.2	107.8	84.5	65.5	179.5	120.5	90.8	53.9	167.4	123.5	114.5	204.5	107.8	132.0	191.7	80.2	278.1	266.5	547.9	127.5	339.2	136.3	152.9	122.0	140.3	228.8	159.1	146.2	160.5	220.6	161.5	390.0	157.5	185.6	343.3	64.9	66.4	60.5	69.3	66.2	62.1	62.9	63.1	63.5	60.1	65.8	64.3	59.2	44.8	46.2	3.3	54.7	46.7	32.4	61.7	40.9	26.8	56.5	51.9	36.8	55.8	45.6	36.8	20.9	100.9	65.3	119.8	92.0	102.1	17.9	39.5	56.5	58.7	67.8	49.6	6.2	103.5	108.2	52.5	40.2	53.3	62.7	55.0	45.7	99.8	86.5	42.1	6.9	63.8	34.6	75.5	45.8	40.7	38.8	57.2	58.7	6.5	93.4	56.4	84.5	7.1	7.1	136.4	157.3	52.3	49.1	49.6	120.1	85.5	37.8	24.5	26.3	27.9	61.0	26.5	44.3	47.7	53.3	105.8	53.5	56.0	59.6	54.8
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"FAM3 metabolism regulating signaling molecule A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted to blood"	Yes	No		15000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	28.4	37.3	43.5	11.3	49.1	11.3	27.6	50.8	51.3	44.6	38.8	35.3	28.0	36.0	7.7	41.3	38.9	8.4	58.7	40.6	45.8	38.6	63.1	26.8	9.4	52.2	47.6	51.5	52.0	14.8	40.9	10.1	47.8	39.1	6.8	6.1	28.5	12.7	36.8	31.1	33.8	7.4	46.9	28.2	36.1	10.0	46.4	12.1	39.9	13.7	5.5	35.8	35.3	58.1	44.4	41.1	10.3	34.5	30.3	15.4	28.8	22.3	15.1	14.8	17.6	19.1	26.2	28.5	109.2	36.8	29.0	31.6	16.2	19.3	3.6	23.4	21.7	11.2	36.9	13.8	47.2	7.6	17.6	19.0	17.5	30.7	21.4	17.7	10.5	18.1	21.6	20.5	17.3	46.3	14.2	32.7	4.6	47.8	52.4	17.3	10.4	79.6	16.6	18.0	20.4	15.6	10.3	24.4	37.3	7.4	18.7	11.8	12.0	19.9	12.0	54.7	30.6	77.6	46.5	36.0	36.4	19.6	20.8	23.4	10.8	15.2	13.4	12.7	13.2	6.1	8.6	9.6	11.0	8.7	10.0	12.0	5.8	10.6	11.3	14.6	9.1	10.1	43.5	49.1	50.8	51.3	40.6	45.8	52.2	47.6	47.8	46.9	46.4	58.1	23.5	12.8	16.7	13.1	16.9	16.3	23.4	29.2	22.8	25.4	21.9	24.9	21.9	22.8	16.3	22.0	14.6	47.0	19.3	60.2	27.4	27.6	1.0	13.4	18.3	18.3	17.5	29.9	7.1	42.5	50.0	28.4	50.0	15.0	5.7	34.8	23.6	30.3	29.8	21.9	9.4	58.9	18.3	16.4	15.3	2.8	33.5	18.0	33.8	6.5	17.6	28.9	24.7	11.1	14.3	28.2	57.5	29.3	32.5	28.7	116.2	33.1	12.7	20.4	6.6	26.7	24.5	5.2	10.1	32.1	21.2	71.3	19.3	23.7	39.7	22.9
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"FAM3 metabolism regulating signaling molecule B"	P58499	21	41304212-41357727	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 142.6;pancreas: 212.3;salivary gland: 119.4;stomach 1: 114.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 304.6;Exocrine glandular cells: 399.9;Proximal enterocytes: 831.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.5;CAPAN-2: 11.7;Hep G2: 32.1;OE19: 27.3;RPMI-8226: 80.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777, CAB034131"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2080000	250000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	1.5	0.1	0.0	2.5	0.1	0.8	17.7	0.1	0.3	4.9	1.3	5.9	142.6	0.3	22.1	56.2	17.2	16.2	0.6	0.1	0.1	17.9	2.6	9.3	1.5	0.1	0.1	0.2	212.3	0.5	5.4	15.2	0.1	37.9	0.1	0.0	119.4	8.7	0.1	2.3	135.0	0.5	0.1	0.6	114.9	6.9	0.1	3.1	8.0	0.0	16.8	34.4	16.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.5	11.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.9	27.3	0.0	0.2	0.0	80.6	0.0	5.8	0.4	0.4	0.0	0.7	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.3	1.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	22.4	25.7	0.0	0.8	1.3	17.0	2.9	1.2	0.0	101.3	123.1	0.2	102.9	36.5	66.2	0.0	304.6	1.4	2.7	25.4	172.1	25.2	0.2	0.1	2.5	0.0	0.0	0.1	399.9	11.1	3.4	147.3	0.7	1.3	0.6	0.4	0.3	27.0	0.0	0.1	120.9	42.7	5.0	15.8	11.5	0.6	3.9	5.4	1.9	2.1	0.0	0.0	0.0	0.1	144.6	169.0	0.4	0.2	64.9	831.6	0.7	22.4	0.0	0.0	0.4	1.8	28.0	8.1	29.1	1.3	161.3	0.9	0.0	125.2	130.5
FAM3C	"GS3876, ILEI"	ENSG00000196937	"FAM3 metabolism regulating signaling molecule C"	Q92520	7	121348878-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 22.5;naive B-cell: 19.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 22.5"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 1257.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		48000000	"Cluster 37: B-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	40.4	45.9	23.8	38.5	26.8	9.6	42.1	20.4	46.5	96.5	15.9	46.5	177.0	51.4	57.5	32.0	34.5	35.3	64.0	33.8	22.6	62.9	49.5	34.5	44.6	29.3	20.7	36.7	74.0	57.3	29.6	44.5	30.4	31.7	54.0	47.8	38.1	32.3	19.0	32.2	158.2	44.3	19.1	47.4	61.8	24.5	21.8	17.1	111.1	24.5	44.8	56.6	31.3	25.4	133.1	33.2	60.7	64.9	100.3	164.2	55.6	139.7	61.5	41.2	52.1	26.4	1257.1	125.4	65.4	72.5	116.7	85.2	35.1	77.7	87.3	15.3	72.5	35.6	19.3	27.4	73.5	59.0	65.3	165.7	52.1	58.9	57.1	110.4	74.8	24.6	23.3	152.3	326.6	22.3	24.6	45.2	108.1	45.4	45.3	34.2	63.8	51.1	256.7	75.1	38.6	38.1	41.4	167.4	80.6	126.2	24.0	32.5	178.8	105.1	37.7	236.1	96.9	148.0	71.3	48.7	114.0	60.6	192.5	0.0	1.1	0.8	2.1	1.2	2.0	22.5	0.9	1.7	1.0	19.9	1.3	0.9	0.2	3.0	0.9	1.5	0.7	0.8	23.8	26.8	20.4	46.5	33.8	22.6	29.3	20.7	30.4	19.1	21.8	25.4	49.8	9.6	33.3	17.3	103.0	71.8	257.1	183.0	61.5	137.3	47.5	28.8	65.7	71.4	134.4	55.2	22.9	88.1	44.8	66.8	60.7	182.2	3.5	76.0	81.8	58.9	52.3	10.3	64.6	191.0	188.6	104.3	46.4	170.1	19.7	33.3	50.0	37.0	43.6	45.4	64.3	49.1	101.7	29.6	88.4	6.7	96.0	30.9	99.6	24.4	31.7	49.4	58.7	42.3	24.7	415.8	71.9	95.9	129.8	325.0	327.0	66.8	63.9	67.1	72.3	93.6	68.7	23.8	22.4	61.7	66.3	120.4	44.3	35.6	86.7	425.8
FAM3D	"EF7, OIT1"	ENSG00000198643	"FAM3 metabolism regulating signaling molecule D"	Q96BQ1	3	58633946-58666834	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 264.8;intestine: 488.7;salivary gland: 468.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 794.8;Intestinal goblet cells: 1150.1;Paneth cells: 776.7;Proximal enterocytes: 353.1;Undifferentiated cells: 760.0"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	65	"OE19: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013844	Approved				"Secreted to digestive system"	NA	NA		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.9	0.1	0.2	29.6	0.1	0.0	18.5	0.0	0.5	31.3	0.1	362.0	89.2	0.6	0.2	264.8	0.8	81.6	0.2	0.2	0.1	1.1	0.2	4.8	0.6	0.1	0.2	0.1	1.7	0.0	0.4	1.0	0.1	14.8	488.7	0.0	468.4	68.4	0.1	2.6	90.4	8.3	0.1	0.2	78.2	0.3	0.3	0.4	1.5	0.0	41.1	12.7	59.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.2	68.5	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.3	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.6	0.0	1.1	0.3	3.4	0.0	9.9	223.1	0.0	0.0	29.5	53.8	0.2	47.1	133.4	14.7	0.0	0.0	1.3	794.8	0.0	1.3	0.5	0.0	0.0	2.5	152.1	0.0	0.1	0.0	0.0	0.8	114.2	0.2	8.9	0.0	0.4	0.2	0.3	0.0	0.1	1150.1	18.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	776.7	0.0	0.2	68.2	353.1	1.2	43.1	0.0	0.0	0.0	4.9	0.1	0.6	7.9	0.1	0.4	2.0	0.0	760.0	245.0
FAM43A	FLJ90022	ENSG00000185112	"Family with sequence similarity 43 member A"	Q8N2R8	3	194685883-194689037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.2;Endothelial cells: 102.4;Extravillous trophoblasts: 83.3;Hepatic stellate cells: 97.1;NK-cells: 75.2;Syncytiotrophoblasts: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 123.7;NB-4: 72.8;PC-3: 56.9;TIME: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048345	Uncertain		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA048345: AB_2680367"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.71e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-3)"	"prognostic unfavorable (9.96e-4)"	25.2	4.8	8.3	5.1	5.6	3.7	15.7	6.9	14.1	16.1	4.0	15.7	1.4	13.0	1.2	15.4	15.1	4.0	30.3	11.7	6.5	41.4	5.8	9.7	10.0	33.2	9.6	4.5	3.0	1.4	8.7	11.2	34.8	22.1	2.3	0.8	8.0	2.7	6.0	25.2	11.6	3.7	7.3	54.9	8.3	4.4	8.3	1.3	8.0	4.0	6.3	17.2	25.1	6.9	0.3	1.8	1.4	1.1	23.3	11.4	10.4	3.8	8.6	0.1	0.0	0.8	0.3	1.3	37.4	11.6	8.5	3.8	2.3	1.0	0.1	0.9	6.4	4.7	10.8	1.3	1.8	1.2	13.5	3.0	4.8	0.5	0.1	0.6	123.7	0.2	2.8	2.5	0.3	1.9	0.0	72.8	6.0	12.8	56.9	6.0	0.4	0.6	0.1	0.2	35.6	3.0	2.4	2.3	7.5	2.4	1.5	15.7	66.3	1.2	1.9	1.6	0.8	0.2	1.5	3.5	0.7	34.3	24.0	2.2	0.6	1.3	0.5	0.5	0.7	1.2	0.3	0.5	0.8	2.5	0.0	0.2	0.9	1.6	0.5	4.5	0.2	0.3	8.3	5.6	6.9	14.1	11.7	6.5	33.2	9.6	34.8	7.3	8.3	6.9	89.2	0.0	2.5	0.0	26.7	4.0	21.4	6.7	4.6	16.0	10.6	7.0	35.1	0.0	4.0	1.8	8.4	21.1	38.3	39.6	7.9	7.8	0.3	3.2	19.5	102.4	6.6	0.4	3.5	1.8	83.3	30.1	8.6	4.0	15.2	3.8	97.1	1.4	6.0	0.0	7.3	8.0	24.4	13.1	3.9	1.3	16.4	9.3	12.4	28.1	7.7	2.2	75.2	0.0	2.6	7.0	19.1	9.8	8.5	20.3	1.0	0.4	1.4	2.8	26.3	5.2	20.8	0.6	14.2	6.5	4.0	162.4	16.0	3.0	11.0	12.6
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552573-20555020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 21.0;brain: 21.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Distal tubular cells: 3.9;Excitatory neurons: 2.6;Fibroblasts: 3.8;Inhibitory neurons: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;BJ hTERT+: 2.4;fHDF/TERT166: 4.9;Hep G2: 3.7;SCLC-21H: 4.3;SiHa: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050813	Approved		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	1.6	21.0	12.2	0.2	10.7	0.0	0.3	11.0	12.5	0.6	2.4	0.9	0.1	1.0	3.0	0.3	0.9	0.2	3.9	13.5	13.5	5.0	0.4	0.3	0.0	16.6	21.7	0.3	0.5	0.0	0.8	0.6	13.8	0.7	0.1	0.4	0.5	0.1	0.9	0.2	0.3	0.8	9.9	0.8	0.3	0.5	18.8	0.1	1.2	1.4	0.0	0.7	0.4	10.2	0.0	1.7	0.2	3.3	0.1	0.1	0.0	0.3	2.4	0.4	0.0	0.1	0.0	0.0	0.2	4.9	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	10.7	11.0	12.5	13.5	13.5	16.6	21.7	13.8	9.9	18.8	10.2	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.1	1.9	1.6	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.0	7.5	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.3	0.1	0.9	0.7	0.0	0.0	0.1	0.1	0.1	0.0
FAM47A	MGC27003	ENSG00000185448	"Family with sequence similarity 47 member A"	Q5JRC9	X	34129756-34132314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 3.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.1;Late spermatids: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000610	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA000610: AB_1078805"															"unprognostic (1.68e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM47B	FLJ35782	ENSG00000189132	"Family with sequence similarity 47 member B"	Q8NA70	X	34942796-34944915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"testis: 9.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 58.1;Late spermatids: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046829, HPA050996"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA046829: AB_2679828, HPA050996: AB_2681301"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283783	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"OE19: 28.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	6.2	4.9	7.6	0.4	8.3	1.0	6.8	7.5	8.8	2.9	7.9	2.6	3.2	1.7	11.0	1.3	19.6	4.0	1.9	8.0	8.4	7.3	9.1	4.0	0.5	8.1	8.5	0.8	9.1	7.6	8.5	1.5	7.8	4.2	2.9	8.8	4.4	2.7	6.4	1.3	3.5	1.1	7.8	1.2	5.1	8.0	9.5	0.7	9.7	3.2	0.4	1.9	0.7	9.1	0.6	2.1	2.1	0.6	1.6	0.2	0.5	0.2	2.0	0.4	0.4	2.6	2.2	0.1	0.6	0.7	4.5	0.6	0.9	0.5	0.7	2.1	0.1	0.1	1.3	3.6	0.9	0.5	0.3	1.0	0.5	0.6	0.5	0.9	0.2	0.3	0.2	1.5	0.6	3.1	0.2	0.2	0.4	28.0	1.0	0.3	0.5	0.3	3.4	1.8	3.7	2.9	1.0	1.6	0.3	0.5	1.7	0.2	0.5	0.4	0.5	1.2	0.5	5.5	1.2	0.1	1.6	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	7.6	8.3	7.5	8.8	8.0	8.4	8.1	8.5	7.8	7.8	9.5	9.1	1.6	9.6	2.6	4.2	0.4	0.6	2.5	5.1	0.0	12.9	7.7	9.1	7.9	8.6	8.4	0.0	12.5	3.3	0.1	6.2	9.8	7.5	47.3	34.0	0.6	1.8	7.7	0.8	1.0	7.8	1.6	1.5	3.1	2.0	0.0	1.5	1.8	3.6	0.8	1.7	1.1	5.7	14.2	1.0	0.0	6.2	0.6	0.7	1.8	1.0	0.0	4.7	0.0	0.0	2.9	5.8	3.0	0.4	0.4	2.8	13.0	10.3	91.4	7.4	0.0	2.0	2.2	8.8	4.3	0.3	0.3	3.4	0.2	0.8	3.1	1.9
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 41.5;skeletal muscle: 55.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 1.7;Astrocytes: 2.0;Excitatory neurons: 5.1;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.4;Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;OE19: 2.7"									HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	12.5	1.3	1.5	0.4	1.6	1.0	9.3	1.1	2.5	2.0	1.1	9.0	0.1	2.4	1.3	1.6	2.1	0.6	21.2	1.4	2.0	2.4	41.5	8.3	0.4	1.9	1.5	0.9	2.3	0.5	0.7	0.6	1.7	4.3	0.4	1.8	2.3	0.5	55.9	0.9	12.4	0.7	1.6	0.9	2.9	2.3	1.9	0.1	1.3	0.5	0.1	6.7	2.0	2.0	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.2	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.1	0.1	2.7	0.4	0.0	0.0	0.4	0.0	0.6	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.3	0.1	0.2	0.4	0.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.5	1.6	1.1	2.5	1.4	2.0	1.9	1.5	1.7	1.6	1.9	2.0	0.0	6.4	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444141-154450654	"Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favorable (2.05e-4)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	63.8	59.6	59.0	34.7	63.2	35.6	54.7	61.9	66.2	46.7	58.6	67.9	35.4	46.9	50.5	36.1	40.0	24.2	71.0	59.8	58.9	58.3	51.0	53.2	26.7	65.8	61.7	36.0	50.4	45.7	60.2	35.9	66.7	54.3	27.3	26.5	44.9	34.6	102.4	38.1	46.5	36.9	59.8	51.3	53.6	17.1	64.5	31.5	51.7	57.3	24.7	58.9	41.4	67.1	120.7	145.9	48.0	68.8	174.2	124.7	94.7	152.6	136.0	145.2	219.8	134.2	54.9	6.2	154.6	161.6	211.5	46.2	113.4	106.0	111.8	87.5	72.7	38.6	178.6	86.0	253.4	35.1	109.0	143.2	75.0	224.6	114.4	104.9	120.7	44.5	50.4	94.6	142.9	81.8	41.8	46.0	32.3	105.1	90.7	60.2	120.2	86.4	92.8	119.2	85.6	61.1	55.8	88.4	190.1	81.8	77.0	67.4	149.4	99.8	81.5	165.6	191.3	218.0	134.6	43.0	134.9	120.7	113.6	34.5	54.4	42.1	43.8	72.1	59.3	34.4	45.8	42.2	50.7	30.1	24.8	34.3	30.0	41.7	79.4	38.7	53.5	33.5	59.0	63.2	61.9	66.2	59.8	58.9	65.8	61.7	66.7	59.8	64.5	67.1	60.0	35.3	54.4	14.4	38.2	26.0	42.8	17.9	23.3	65.6	33.5	36.1	88.1	52.9	19.0	29.5	27.1	70.5	50.5	96.0	56.7	53.2	1.8	50.0	71.0	48.7	63.3	56.4	7.3	68.1	109.8	61.0	69.3	68.8	47.0	40.3	41.0	42.6	145.1	47.1	7.4	87.7	18.3	62.3	69.1	5.5	77.9	81.3	32.0	8.4	70.6	80.0	62.8	3.5	17.2	69.8	95.1	79.7	51.6	52.1	123.1	112.1	18.5	68.2	32.9	50.5	76.4	8.3	17.8	29.7	25.9	121.6	62.2	65.0	59.7	45.3
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.8;Oligodendrocytes: 14.8;Spermatocytes: 14.6;Spermatogonia: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.8;SCLC-21H: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036452, HPA058138"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.2	1.1	1.5	0.4	2.3	0.6	1.1	1.7	1.7	1.2	0.6	1.2	0.2	1.3	1.7	0.8	1.2	0.5	0.8	1.0	1.6	1.0	1.8	0.6	0.5	2.9	2.4	1.3	1.5	0.5	5.6	0.2	2.5	0.9	0.0	0.0	1.2	0.4	1.1	1.4	0.8	0.4	1.8	1.0	1.2	12.8	2.3	0.3	3.7	0.2	0.2	1.1	0.8	3.8	0.6	0.1	0.7	1.4	0.2	0.9	0.5	2.5	1.5	1.7	1.3	0.4	0.8	1.8	1.4	0.5	0.7	0.2	0.0	0.3	0.5	0.3	0.6	0.4	0.2	0.4	1.7	0.0	0.6	0.8	1.5	0.6	1.9	0.4	0.4	2.8	1.1	0.2	0.6	0.5	0.5	1.7	0.6	0.3	3.8	0.5	0.2	0.0	0.5	0.5	4.4	2.4	1.2	0.1	2.1	0.4	1.8	0.7	0.4	0.2	0.1	0.8	0.4	0.3	1.0	0.5	0.0	0.6	3.2	0.0	0.3	0.3	0.1	0.9	0.3	0.5	0.2	0.2	0.7	0.5	1.1	0.0	0.0	0.2	0.4	1.7	0.3	0.3	1.5	2.3	1.7	1.7	1.0	1.6	2.9	2.4	2.5	1.8	2.3	3.8	1.0	0.0	0.0	0.7	0.5	1.3	0.4	0.5	1.2	0.7	0.9	0.5	3.6	1.5	0.2	1.8	0.0	0.1	0.1	0.4	1.9	0.6	12.8	0.3	0.7	0.7	0.0	1.3	2.0	1.0	0.0	0.8	1.1	0.8	0.0	0.9	1.1	0.7	0.2	0.0	1.9	0.1	0.0	0.6	0.7	2.0	0.6	0.6	0.0	1.0	0.6	0.2	0.0	2.5	14.8	0.5	0.1	0.4	0.2	0.4	0.0	0.5	0.3	0.4	0.0	1.3	1.9	14.6	11.0	1.6	0.4	0.0	0.7	1.2	0.4	0.2
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744378	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA037751: AB_2675645, HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.81e-7)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.6	19.2	21.6	14.3	33.3	25.8	8.3	18.1	30.5	12.8	8.4	12.4	15.4	23.6	3.9	13.2	11.2	5.7	18.9	21.1	16.5	10.6	4.2	10.7	31.0	30.3	25.6	19.1	7.2	12.4	12.7	4.9	22.7	8.9	7.1	6.3	15.2	7.0	55.0	14.4	17.1	12.8	17.3	20.1	9.6	15.6	35.9	32.9	16.2	22.3	21.7	8.6	8.0	51.7	10.7	12.5	9.6	27.5	11.3	5.8	26.2	4.8	6.7	5.6	4.9	6.6	6.7	37.2	9.7	6.5	5.5	20.8	12.7	15.4	2.4	44.6	13.2	18.1	6.3	16.7	7.6	16.6	11.8	5.6	16.2	5.2	8.3	7.0	9.1	21.2	13.2	17.0	5.5	20.4	18.7	22.4	5.9	9.5	10.9	32.9	3.6	18.2	4.6	19.3	12.8	12.2	4.7	17.8	60.2	3.8	7.2	21.8	5.0	6.7	5.5	6.6	10.7	2.7	5.3	23.8	5.1	13.6	3.8	0.8	2.2	2.2	6.9	2.1	3.3	3.5	3.0	3.7	1.4	6.0	1.2	2.0	3.2	0.7	2.6	1.9	3.6	3.4	21.6	33.3	18.1	30.5	21.1	16.5	30.3	25.6	22.7	17.3	35.9	51.7	13.4	9.6	12.6	14.0	22.4	3.6	5.9	8.5	12.5	6.1	4.3	2.4	17.9	1.5	6.7	3.7	10.4	4.7	31.5	25.9	1.9	3.1	19.4	12.9	18.6	8.7	15.0	8.6	27.1	4.0	4.9	6.0	6.6	8.3	5.1	9.0	16.8	3.7	13.3	1.7	15.0	17.4	10.2	27.8	5.1	6.2	5.6	16.4	8.8	24.4	14.5	4.5	30.9	16.1	79.4	2.8	12.2	10.5	20.0	3.7	22.4	4.3	14.1	25.6	0.0	9.8	4.6	7.0	8.6	12.1	5.7	0.8	21.4	6.9	15.3	6.7
FAM53C	C5orf6	ENSG00000120709	"Family with sequence similarity 53 member C"	Q9NYF3	5	138331935-138349729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 311.8;Late spermatids: 588.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 29.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 29.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042796	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA042796: AB_10794158"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.95e-2)"	15.4	15.3	26.1	14.2	26.6	84.6	16.1	25.8	27.6	14.1	16.6	20.5	8.1	19.5	16.9	13.5	16.5	16.4	18.2	26.1	24.2	10.5	11.7	16.1	13.5	23.3	24.1	16.7	29.5	14.6	16.3	14.5	22.5	16.8	9.2	12.3	21.1	14.1	51.9	11.6	11.5	20.7	21.0	19.3	17.6	66.1	25.5	22.5	11.5	34.3	14.5	14.6	12.1	23.9	25.7	19.1	41.5	54.7	39.5	28.8	27.8	24.2	32.4	44.2	53.2	48.8	24.0	44.7	24.5	27.4	48.3	23.8	46.8	45.3	43.9	27.2	43.7	19.9	24.8	22.1	33.6	18.0	38.6	33.2	22.2	44.3	30.6	34.5	33.5	29.6	27.2	45.2	28.1	21.6	24.4	29.6	38.5	15.8	15.5	36.6	25.7	40.7	26.0	18.8	30.1	23.3	31.6	23.4	47.7	61.9	43.4	32.4	28.3	29.8	18.8	18.2	28.2	71.6	28.9	43.6	24.8	29.7	23.5	0.5	4.9	5.4	2.3	3.8	2.5	2.9	2.0	1.9	4.6	2.3	2.6	2.8	29.4	2.3	2.9	2.5	2.5	3.2	26.1	26.6	25.8	27.6	26.1	24.2	23.3	24.1	22.5	21.0	25.5	23.9	27.1	6.4	11.5	19.6	45.0	25.0	27.2	24.3	37.0	30.6	57.3	64.0	6.2	10.0	22.0	20.2	91.8	22.3	54.5	46.4	3.9	9.5	311.8	24.1	15.3	24.9	57.8	14.1	21.5	7.2	28.2	26.2	35.7	26.0	48.2	33.0	13.2	9.9	21.0	16.8	20.9	34.5	28.5	37.4	46.3	588.4	21.1	43.1	21.4	15.9	17.6	23.6	12.3	22.1	25.7	9.9	35.3	18.4	28.1	25.2	49.6	6.4	24.3	83.2	32.9	64.1	24.2	24.4	26.3	31.4	26.1	52.0	43.2	21.7	33.3	31.8
FAM71A	FLJ32796	ENSG00000162771	"Family with sequence similarity 71 member A"	Q8IYT1	1	212624474-212626775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	105	"testis: 78.7"	"Group enriched"	"Detected in many"	50	"Early spermatids: 1174.2;Late spermatids: 453.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028462, HPA060344"	Enhanced		Approved	"Nuclear speckles"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028462: AB_10601904, HPA060344: "																		0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.1	78.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	3.7	0.0	0.1	0.5	1.7	4.4	0.6	0.1	3.5	6.7	0.0	4.3	3.3	0.0	0.0	2.6	0.3	1.9	0.0	0.7	1174.2	7.2	2.8	1.6	1.2	0.0	0.0	1.2	1.5	1.8	9.7	16.0	1.3	0.0	1.8	0.4	1.2	0.0	0.0	2.8	0.0	0.0	0.3	453.8	5.3	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.8	2.6	0.6	2.5	0.4	0.0	1.5	0.0	0.0	3.2	2.7	3.9	2.4	0.8	0.1	2.9	0.8	0.1	2.0	0.5
FAM71B	MGC26988	ENSG00000170613	"Family with sequence similarity 71 member B"	Q8TC56	5	157161846-157166264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	316	"testis: 31.6"	"Group enriched"	"Detected in some"	167	"Early spermatids: 871.3;Late spermatids: 401.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039478, HPA040771"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039478: AB_10795106, HPA040771: AB_10805829"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	871.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.4	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 26.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 611.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.5	2.0	2.2	0.3	2.0	1.1	1.3	1.5	2.3	1.4	1.3	1.0	0.3	0.9	0.9	0.9	0.9	0.5	2.3	1.9	1.2	2.0	1.0	0.7	0.4	1.4	0.8	1.2	1.3	0.2	2.9	0.3	1.4	1.3	0.4	2.7	1.7	0.4	1.3	1.0	0.9	0.5	0.4	1.7	1.1	26.1	1.7	0.2	1.4	0.1	0.3	1.0	0.8	2.9	0.2	0.3	0.4	0.6	0.4	0.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.5	0.1	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.9	0.0	0.2	0.2	0.6	0.5	0.2	0.4	0.1	0.6	0.1	0.2	0.1	0.4	0.2	0.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.3	1.1	0.3	0.2	0.2	0.2	0.4	0.5	0.2	0.1	1.3	0.5	0.1	0.8	0.3	0.9	0.4	0.3	0.3	0.2	0.3	1.6	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.4	0.1	0.4	0.1	0.0	2.2	2.0	1.5	2.3	1.9	1.2	1.4	0.8	1.4	0.4	1.7	2.9	0.5	3.2	2.2	17.0	0.4	0.0	1.8	0.3	0.6	12.2	1.3	0.8	1.4	2.8	0.2	3.7	52.1	0.6	0.1	0.5	0.0	1.5	138.7	2.1	2.0	1.5	1.2	0.0	11.9	0.7	0.7	1.4	3.1	5.6	2.5	2.0	2.2	0.8	0.9	0.0	10.2	1.1	0.0	1.3	0.4	611.8	4.1	1.4	0.0	2.8	1.1	2.7	1.0	6.6	10.6	1.6	1.8	3.0	2.0	2.5	0.5	0.3	0.2	19.0	0.0	6.5	1.4	13.1	4.0	0.4	0.1	2.5	1.1	4.0	1.4	1.1
FAM72A	"LMPIP, MGC57827, p17, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	4.0	3.1	2.6	5.9	2.9	8.4	3.6	9.1	3.1	1.3	1.0	2.2	3.1	0.9	0.4	2.5	1.8	2.7	1.2	3.1	4.0	1.3	2.0	2.6	10.9	5.4	4.4	1.1	1.4	1.6	0.8	3.5	5.8	1.1	2.3	0.2	1.0	0.7	0.6	5.9	2.9	2.0	4.1	6.3	1.5	7.1	4.8	8.6	0.9	1.0	7.5	1.5	1.5	4.7	21.1	16.4	17.7	7.7	2.6	3.1	21.1	14.6	6.3	17.1	12.7	9.9	31.1	54.2	12.3	3.8	18.8	24.7	20.9	8.1	20.2	29.5	16.3	24.3	16.4	13.9	1.8	42.9	27.0	4.4	1.4	15.1	26.7	5.1	10.7	45.7	50.1	36.7	10.7	12.9	26.9	38.3	32.1	15.1	22.1	29.5	30.6	41.4	9.8	3.2	17.7	10.2	10.6	9.7	9.3	20.1	20.5	23.2	5.5	13.5	15.5	17.7	24.9	29.1	44.8	48.4	11.1	34.9	18.8	0.0	5.9	0.0	0.7	8.0	0.2	1.7	1.4	1.4	4.6	0.5	0.1	0.3	1.0	0.6	4.8	1.9	2.9	2.1	2.6	2.9	9.1	3.1	3.1	4.0	5.4	4.4	5.8	4.1	4.8	4.7	5.9	0.0	1.5	0.0	2.4	1.8	0.4	1.2	1.2	0.3	0.8	0.6	1.5	0.0	0.9	0.0	0.0	0.8	3.7	4.9	0.0	1.0	29.5	1.5	1.5	8.4	0.0	0.4	0.1	0.8	3.8	1.8	0.5	0.7	0.0	0.3	7.1	0.4	9.4	0.0	0.2	3.6	0.0	18.2	5.8	30.2	0.0	6.9	3.6	0.0	9.6	0.6	2.1	0.0	0.1	0.6	0.0	0.0	1.6	0.4	1.3	0.3	2.1	0.2	0.0	0.9	2.2	28.0	4.1	2.0	1.0	0.7	1.4	0.8	1.6	0.8
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.2;lymphoid tissue: 10.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.3;Early spermatids: 11.3;Erythroid cells: 5.9;Hepatic stellate cells: 6.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	0.8	0.6	1.2	3.7	1.0	6.2	0.8	2.0	1.1	0.5	1.3	1.1	1.3	0.5	0.4	1.6	0.4	1.0	0.3	1.2	1.2	0.4	0.4	0.6	8.1	1.6	1.4	0.4	0.2	0.7	0.2	1.4	1.6	0.2	1.2	0.1	0.4	0.2	0.1	1.9	1.1	0.7	1.3	2.0	1.0	2.3	1.3	10.3	0.3	0.2	6.6	0.8	0.7	1.4	28.6	10.3	16.5	8.2	1.6	2.4	13.3	14.7	6.2	16.8	14.1	0.1	14.5	62.9	19.9	2.7	16.4	17.1	23.1	8.3	25.9	41.1	17.3	27.2	12.0	12.5	1.0	47.7	23.2	1.3	0.9	13.0	26.5	4.2	10.3	51.0	36.1	37.3	12.4	12.1	24.1	39.1	31.6	14.9	20.6	35.8	35.8	28.7	6.7	3.2	18.0	10.4	11.1	8.6	8.6	16.9	11.4	36.5	3.6	13.8	23.5	27.3	26.6	32.6	44.1	61.3	12.4	50.8	32.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.4	0.3	1.2	1.0	2.0	1.1	1.2	1.2	1.6	1.4	1.6	1.3	1.3	1.4	1.3	0.0	0.0	0.0	1.6	1.0	0.1	0.2	0.0	0.0	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.8	0.1	7.3	0.0	0.2	11.3	0.2	0.4	2.5	0.0	5.9	0.1	0.2	2.3	0.6	1.1	0.2	0.0	0.5	6.4	0.0	1.1	0.0	0.3	4.9	0.0	1.9	2.8	3.0	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.1	2.3	0.0	2.5	0.0	2.1	0.0	0.7	0.0	0.0	0.3	0.9	17.0	3.1	3.5	1.0	0.1	1.2	0.2	3.6	0.0
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.9;lymphoid tissue: 5.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 7.8;Extravillous trophoblasts: 4.5;Sertoli cells: 6.6;Spermatocytes: 9.4;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 64.9"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.4	0.2	0.1	1.5	0.1	2.9	0.3	0.2	0.2	0.2	0.0	0.4	0.6	0.2	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	4.5	0.1	0.1	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.6	0.0	0.2	0.0	0.0	1.2	0.4	0.3	0.1	1.2	0.3	1.6	0.1	5.4	0.1	0.1	4.5	0.4	0.4	0.2	18.7	10.6	12.5	5.7	0.6	1.7	12.1	8.9	2.8	12.0	9.0	1.6	21.7	44.4	11.6	1.0	11.0	17.4	17.2	5.5	13.0	15.3	10.0	19.1	9.4	3.3	0.4	39.5	16.6	0.3	0.1	9.1	24.3	2.5	5.1	34.7	34.0	20.5	0.8	1.4	23.2	30.4	10.2	20.8	6.6	29.7	9.0	31.5	2.1	2.3	6.3	11.5	8.7	5.0	4.9	13.0	12.5	33.4	3.7	9.4	15.4	12.5	20.3	41.9	64.9	26.0	5.1	24.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.6	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	2.3	0.3	0.2	1.3	0.0	7.8	0.2	0.2	4.5	0.3	0.0	0.1	0.0	0.5	1.8	0.1	1.7	0.0	0.3	0.6	0.0	2.2	1.4	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.3	0.7	9.4	3.5	1.3	0.3	0.3	0.7	0.3	0.5	0.0
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145095974-145112696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.0;lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Erythroid cells: 9.7;Extravillous trophoblasts: 5.5;Spermatocytes: 15.4;Spermatogonia: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	0.7	0.3	0.4	3.0	0.4	4.0	0.5	0.7	0.5	0.3	0.2	0.8	1.0	0.3	0.1	1.1	0.2	0.5	0.2	0.4	0.8	0.2	0.3	0.5	4.8	0.6	0.7	0.2	0.1	0.2	0.1	1.1	0.6	0.1	1.0	0.1	0.2	0.1	0.0	1.9	1.3	0.5	0.4	1.2	0.6	2.1	0.7	6.7	0.2	0.1	4.5	0.6	0.4	0.5	16.6	10.4	11.7	4.5	0.5	1.0	12.4	9.8	3.0	11.1	7.1	7.5	14.7	26.6	9.3	1.5	11.1	17.3	13.6	3.0	12.8	22.6	14.1	13.6	5.8	9.7	0.6	24.0	14.2	0.8	1.1	9.4	16.9	2.0	5.6	33.0	26.8	34.9	7.2	12.4	16.6	22.5	21.1	20.3	14.4	13.9	14.3	30.7	4.0	2.2	10.9	9.1	7.3	6.3	4.4	13.9	17.2	15.7	2.7	8.3	9.6	7.3	16.7	27.0	46.5	39.3	0.2	18.7	10.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.4	0.7	0.5	0.4	0.8	0.6	0.7	0.6	0.4	0.7	0.5	2.0	0.0	0.0	0.0	0.8	1.0	0.0	0.2	1.2	0.0	0.2	0.4	1.1	0.0	0.2	0.0	0.0	1.2	0.1	0.8	0.0	0.1	7.3	0.2	0.3	2.1	0.0	9.7	0.3	0.0	5.5	0.8	0.0	0.2	0.0	0.3	0.4	0.1	1.5	0.0	0.5	0.8	0.0	1.0	1.0	0.6	0.0	1.8	1.8	1.0	0.8	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.8	0.2	0.3	0.1	0.3	0.0	0.0	0.5	0.8	15.4	4.5	1.6	1.0	0.3	0.4	0.1	1.4	0.1
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725961-27763116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.5;Late spermatids: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	21.0	5.8	5.9	8.5	6.5	13.7	11.7	8.3	8.9	9.3	10.1	10.1	8.7	12.9	10.0	11.7	9.7	10.8	10.1	5.5	7.4	11.6	12.0	10.5	10.7	6.9	5.7	9.6	11.3	13.7	7.8	11.1	6.5	10.0	13.4	15.4	7.9	10.4	40.4	12.0	8.8	10.3	4.5	11.0	11.7	18.6	6.9	8.0	15.9	12.8	10.9	7.1	8.0	12.3	10.0	7.8	8.8	9.1	10.9	9.4	15.9	9.1	9.5	13.1	12.9	9.1	13.0	18.1	5.9	10.2	12.5	12.8	11.2	10.1	10.2	9.4	8.2	5.6	11.7	10.7	8.7	8.9	8.4	9.7	10.8	14.6	14.5	6.7	6.7	9.5	10.9	16.5	9.6	9.5	21.4	8.3	13.9	9.6	7.8	12.8	10.4	10.3	10.6	14.1	12.7	5.7	10.5	11.1	11.3	10.7	7.8	3.5	7.3	15.5	6.7	18.1	6.4	14.9	17.7	14.6	9.7	11.5	6.7	9.8	8.8	11.0	10.4	9.4	11.3	9.2	10.8	10.2	8.1	9.7	10.1	11.2	6.1	9.4	10.1	11.3	8.9	5.3	5.9	6.5	8.3	8.9	5.5	7.4	6.9	5.7	6.5	4.5	6.9	12.3	20.0	28.9	17.0	9.4	20.3	19.1	9.4	8.1	23.3	28.5	14.8	12.1	15.9	14.3	8.8	23.9	27.1	31.3	26.7	12.1	21.5	11.7	131.5	19.6	19.6	14.8	4.2	13.5	15.9	9.7	11.5	26.0	17.3	13.9	11.4	8.5	22.1	18.4	11.8	28.6	15.2	10.4	6.1	15.8	25.2	110.7	16.8	15.2	39.2	13.1	11.4	19.1	16.5	5.0	11.6	9.6	9.1	37.2	10.9	5.4	10.3	20.1	25.3	39.6	19.7	25.4	27.6	35.3	55.4	17.3	27.0	45.4	18.9	11.0	9.2	5.3
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768953-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 261.6;Late spermatids: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	5.8	5.0	1.1	12.5	1.6	39.5	5.2	4.2	2.3	4.2	1.7	4.9	9.2	6.8	1.6	4.0	3.9	5.3	4.0	1.2	1.0	3.1	8.2	5.0	17.1	1.9	1.8	5.5	6.1	3.7	2.3	6.7	1.8	4.7	5.1	5.3	4.7	3.3	3.9	5.8	6.4	4.5	1.1	8.4	5.9	17.7	1.8	14.2	5.5	3.7	17.6	4.9	3.7	3.4	8.0	6.0	22.1	12.0	3.6	3.6	18.4	13.4	6.4	9.6	11.0	22.4	15.3	29.8	16.5	6.4	12.5	15.0	13.1	4.5	10.1	16.1	9.5	35.0	10.9	11.8	9.2	25.0	19.3	4.7	7.3	11.1	9.9	6.3	9.3	17.5	21.1	16.1	5.5	5.8	28.0	29.9	12.3	8.5	5.4	30.0	16.5	17.7	7.3	8.8	9.3	26.3	16.3	9.1	10.1	7.4	12.1	10.9	9.5	13.4	14.1	15.8	12.3	8.8	19.7	45.5	3.2	23.8	19.2	0.1	1.9	3.5	3.3	2.0	2.7	1.8	3.0	3.4	1.3	1.5	2.7	4.1	5.7	3.3	1.9	4.8	5.2	1.8	1.1	1.6	4.2	2.3	1.2	1.0	1.9	1.8	1.8	1.1	1.8	3.4	27.9	6.4	16.5	14.7	41.5	13.8	12.5	8.4	22.8	16.1	17.0	16.4	12.9	8.6	14.0	5.5	27.1	8.5	28.9	10.5	0.0	7.7	261.6	23.2	23.4	19.2	20.4	34.1	18.7	7.5	10.1	14.9	15.3	18.3	10.8	21.0	15.4	19.8	8.3	11.8	15.9	14.0	4.1	18.0	18.0	372.1	17.1	20.0	16.0	13.1	17.7	12.4	19.6	16.6	30.1	9.1	16.0	15.4	16.2	12.5	10.3	2.4	12.3	15.1	26.3	17.6	21.3	31.8	20.9	14.4	16.1	7.7	26.4	15.0	10.8	10.7
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.7;testis: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	2.9	2.0	3.8	13.8	5.6	21.7	1.7	3.6	6.3	1.4	1.8	2.4	2.7	1.5	0.3	1.7	1.3	3.1	26.5	5.1	3.7	1.6	1.5	6.1	24.5	5.6	4.1	1.4	1.1	1.1	1.2	5.3	4.9	1.4	1.6	4.6	2.7	0.9	53.7	1.2	8.9	1.8	4.6	21.6	3.8	31.9	5.8	21.1	1.6	20.2	14.9	3.5	1.1	5.7	0.7	0.3	2.5	5.6	1.7	0.5	39.3	0.3	0.3	0.5	0.2	0.3	0.2	17.1	0.2	0.3	0.8	0.1	16.0	0.2	0.1	4.4	1.4	38.6	0.6	0.3	0.6	38.7	1.5	0.4	0.8	0.0	0.1	0.5	22.2	10.8	13.8	4.7	0.5	6.0	1.7	60.7	2.6	0.3	0.6	4.0	2.3	23.7	0.2	0.1	1.5	2.1	2.3	0.8	2.4	0.9	1.4	53.5	0.6	2.3	2.4	1.3	0.1	3.4	1.9	9.7	0.3	35.9	0.6	0.5	9.7	17.6	9.2	12.6	7.4	14.2	8.9	10.1	6.0	15.9	11.0	9.3	9.8	3.1	9.9	2.7	9.5	8.7	3.8	5.6	3.6	6.3	5.1	3.7	5.6	4.1	4.9	4.6	5.8	5.7	3.2	0.0	1.5	0.0	15.5	0.9	0.0	0.0	0.0	55.7	0.4	0.5	17.6	0.0	0.0	1.8	0.0	1.1	19.0	0.0	0.0	0.1	90.6	0.1	0.2	6.8	0.0	3.4	5.0	0.0	37.6	3.1	0.5	0.1	1.3	167.2	6.4	0.5	25.7	0.0	1.7	0.0	0.0	21.7	10.6	120.3	5.0	14.8	1.8	15.9	15.6	0.8	30.9	1.0	0.1	0.1	0.0	3.4	12.0	0.0	0.0	0.2	0.0	1.8	0.0	0.6	6.3	2.2	1.2	0.0	0.9	1.4	17.4	1.0	0.0	0.1
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166167001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA052789: AB_2681949, HPA073246: AB_2686588"	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	0.7	0.2	0.9	0.0	0.7	0.0	0.5	0.5	2.6	1.1	0.0	0.5	0.2	0.7	0.0	0.4	0.2	0.1	0.6	1.0	0.1	0.2	0.7	0.2	0.1	0.6	0.1	0.3	0.4	0.1	0.5	0.0	0.1	0.4	0.1	0.8	0.3	0.1	0.7	0.5	0.1	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.4	0.1	0.1	0.8	0.5	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.6	0.0	0.0	0.1	0.3	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	4.9	0.8	0.5	0.0	0.1	10.1	0.0	0.3	0.2	0.1	0.6	2.6	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	2.6	1.0	0.1	0.6	0.1	0.1	0.2	0.1	0.5	1.2	0.0	1.7	5.5	0.4	0.5	0.5	0.0	1.8	15.5	1.0	0.8	9.9	2.8	0.0	0.0	87.6	0.0	0.0	0.4	1.9	0.7	2.5	0.1	1.7	1.6	0.0	0.0	55.4	0.2	0.0	1.6	0.0	0.1	0.0	1.1	0.4	1.6	0.0	82.4	85.0	0.6	0.0	0.3	0.6	2.6	1.2	0.1	1.8	5.6	0.6	2.2	0.0	45.8	5.7	0.3	0.3	0.7	0.0	0.2	0.1	1.3	0.0	12.9	0.0	4.5	1.0	0.6	4.4	0.6	0.1	0.0	0.7	0.4	1.1	0.2
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523555	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.1;plasmacytoid DC: 11.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.7"	"Cell line enriched"	"Detected in many"	4	"Daudi: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA001847: AB_2666462, HPA065797: AB_2685560"	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	0.4	0.1	7.0	2.4	10.5	0.2	1.4	0.0	17.0	6.7	0.5	4.3	2.4	2.4	4.4	0.4	6.1	1.6	1.5	11.0	3.2	6.8	0.4	0.7	4.9	0.0	0.1	0.6	1.9	1.1	2.6	0.8	0.1	2.3	5.2	1.3	2.6	1.5	0.5	0.9	1.4	1.2	0.0	1.4	2.4	1.8	6.0	0.4	2.1	2.8	5.5	0.4	0.4	8.3	10.5	15.0	1.1	0.2	0.4	0.2	6.0	0.6	0.0	1.0	2.8	1.8	1.7	66.5	0.3	0.2	14.1	7.8	8.3	2.5	1.9	0.7	4.3	0.0	10.6	0.8	0.0	5.7	1.3	0.0	1.5	0.4	0.8	0.8	0.1	2.7	0.1	0.0	1.0	3.5	0.1	0.1	0.9	2.7	5.4	1.5	14.8	1.7	3.3	3.8	3.0	0.8	6.0	0.3	9.9	0.6	2.5	3.4	0.3	2.4	7.4	2.9	11.4	0.1	0.0	0.8	2.5	2.2	6.7	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.1	2.3	0.0	0.0	0.3	0.1	0.0	11.7	0.0	0.3	7.0	10.5	0.0	17.0	11.0	3.2	0.0	0.1	0.1	0.0	6.0	8.3	0.2	0.0	1.3	11.4	2.5	0.5	1.4	0.2	0.6	0.0	2.4	2.4	6.9	0.0	1.0	31.3	0.0	0.1	0.0	1.7	5.9	0.5	0.5	11.2	0.9	0.7	1.2	1.3	83.0	0.2	1.6	0.6	1.1	1.5	1.3	0.2	0.4	0.2	1.3	10.1	67.0	1.9	2.0	0.6	1.5	1.4	0.3	0.7	8.8	4.7	0.7	1.1	0.0	2.5	8.1	0.4	1.9	0.0	1.2	1.4	0.8	0.3	8.4	0.2	0.0	1.1	3.1	0.2	1.6	1.5	0.4	0.0	0.4	0.2	4.0	1.0
FAM81B	FLJ25333	ENSG00000153347	"Family with sequence similarity 81 member B"	Q96LP2	5	95391366-95450454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 48.3;testis: 83.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 854.5;Late spermatids: 1757.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	61	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	61	"granulocytes: 6.7"	"Cell line enriched"	"Detected in single"	5	"CAPAN-2: 1.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA072554	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA072554: AB_2686533"	"unprognostic (2.22e-3)"	"unprognostic (8.86e-3)"		"unprognostic (2.61e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-1)"		"unprognostic (2.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	0.0	0.1	0.7	0.0	1.1	0.6	0.3	2.0	1.2	2.0	16.4	0.0	0.0	0.9	3.7	0.0	48.3	0.2	7.5	1.1	1.5	1.7	0.0	4.4	0.0	4.2	5.3	0.1	0.4	2.5	3.7	0.0	3.7	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	3.5	0.0	0.2	83.5	1.6	0.1	1.6	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	2.0	1.2	1.1	1.5	4.2	5.3	3.7	3.5	1.6	4.6	0.0	9.6	1.8	0.0	0.0	0.4	0.0	9.5	0.0	0.0	1.0	0.6	6.1	0.0	23.9	5.5	0.0	0.1	0.1	0.0	0.0	0.5	854.5	158.5	0.8	0.5	1.8	0.0	0.9	0.7	0.1	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	12.2	0.0	0.0	1757.9	8.4	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.0	3.0	0.0	0.6	0.0	0.3	227.1	0.0	6.6	0.5	2.4	18.0	6.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54945099	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 14.5;skin 1: 25.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 33.8;Basal prostatic cells: 32.5;Basal squamous epithelial cells: 43.3;Squamous epithelial cells: 31.9;Suprabasal keratinocytes: 41.1;Urothelial cells: 25.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.3;HaCaT: 18.1;HBEC3-KT: 9.8;hTCEpi: 19.7;hTERT-HME1: 23.8;RT4: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031464, HPA031465"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.0	0.0	0.1	1.0	0.1	0.1	2.2	0.1	0.1	3.8	0.0	8.0	7.4	0.3	1.2	14.5	1.6	2.1	1.1	0.0	0.0	2.5	0.1	0.1	0.0	0.0	0.7	0.0	1.5	0.0	0.0	4.3	0.1	1.8	8.2	0.1	4.7	1.1	0.7	25.9	7.4	0.2	0.0	0.0	3.9	0.6	0.0	2.3	3.6	0.1	3.6	4.3	9.8	0.2	13.3	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	6.5	3.6	0.0	0.0	0.0	0.1	18.1	0.0	9.8	0.1	0.0	2.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	19.7	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	9.1	19.2	0.2	0.0	2.9	0.6	0.0	3.3	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.8	32.5	6.6	43.3	0.0	1.5	3.0	3.1	5.7	6.5	7.3	0.0	11.2	0.1	9.0	0.0	6.1	6.3	8.8	0.8	0.3	1.2	0.0	0.2	3.5	11.9	0.4	9.2	8.1	0.0	0.0	0.4	0.0	0.6	0.0	0.1	5.4	6.1	0.0	1.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	17.4	0.0	0.1	9.1	12.6	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.6	31.9	41.1	18.7	0.1	0.0	8.8	25.4
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292425	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 33.3;skin 1: 42.3;vagina: 15.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 9.9;head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 28: Keratinocytes - Keratinization"			"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.2	5.3	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.2	0.0	0.1	42.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.1	0.6	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	27.9	1.1	0.0	17.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	6.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	26.1	64.2	0.0	0.0	0.0	0.1	1.9
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48599961-48615076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.9;OE19: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049305, HPA075968"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Vesicles	"HPA049305: AB_2680705, HPA075968: "	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.1	0.1	0.2	3.7	0.3	0.4	1.4	0.8	0.5	10.6	0.2	32.7	30.0	1.1	0.1	7.0	3.9	6.4	0.2	0.3	0.2	0.8	0.3	8.0	0.2	0.1	0.1	0.0	1.2	0.0	0.2	0.6	0.2	3.2	16.6	0.2	28.5	0.4	2.7	1.9	30.0	1.0	0.0	0.2	37.4	2.2	0.2	0.1	0.1	0.0	1.3	1.2	4.1	0.5	0.4	0.4	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	2.9	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.8	1.1	9.4	0.9	0.2	0.1	0.3	0.0	0.2	0.5	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.5	0.0	9.6	13.4	1.3	0.4	0.0	1.4	0.8	0.6	0.0	1.8	0.8	2.1	8.6	6.5	1.8	0.0	0.1	0.3	22.8	0.0	0.1	26.0	4.8	0.5	0.2	5.4	0.0	0.3	1.1	0.1	0.2	74.9	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	26.9	2.0	0.0	0.0	9.3	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	1.6	16.5	0.0	0.4	3.3	12.7	0.0	5.1	0.0	0.0	0.2	0.2	0.8	0.5	2.3	0.0	0.1	0.3	0.1	12.8	6.9
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994954-40043534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.3;testis: 40.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 68.1;Proximal enterocytes: 39.9;Suprabasal keratinocytes: 34.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 12.1;HaCaT: 12.8;HBEC3-KT: 15.5;hTCEpi: 37.9;hTERT-HME1: 11.8;OE19: 17.6;RT4: 18.6;SCLC-21H: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.2	0.1	0.2	0.5	0.1	1.2	4.7	0.3	0.2	2.6	0.1	5.3	3.2	0.2	2.5	20.3	1.2	0.5	2.0	0.2	0.1	4.0	2.9	0.2	0.0	0.1	0.1	0.3	13.5	5.4	1.2	0.1	0.1	9.0	3.2	0.4	8.2	6.6	0.1	18.8	7.6	0.1	0.0	0.0	6.8	40.8	0.3	0.9	5.9	0.2	1.1	2.6	7.0	0.3	8.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.1	2.3	0.0	0.0	0.0	0.0	12.8	0.0	15.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	37.9	0.0	11.8	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.1	2.1	17.6	0.0	0.0	0.0	0.1	0.3	18.6	39.8	0.0	0.3	3.4	0.0	1.3	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.5	28.7	14.5	18.0	23.9	1.2	19.1	10.4	5.2	12.8	7.4	23.9	0.0	0.2	0.0	33.1	3.9	9.6	28.4	6.2	0.5	1.0	13.1	0.4	0.2	15.1	0.2	1.0	10.7	6.5	1.3	0.2	0.0	2.2	0.2	0.0	0.2	21.0	14.2	0.6	2.9	68.1	1.8	0.5	1.8	0.0	0.0	0.9	0.0	0.5	0.1	12.5	21.6	2.2	0.2	16.3	39.9	5.9	6.4	0.6	0.0	1.1	1.3	12.4	1.8	30.6	34.5	1.4	0.8	0.4	15.6	17.8
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.3;skin 1: 67.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 77.8;Basal squamous epithelial cells: 39.3;Distal enterocytes: 46.5;Squamous epithelial cells: 55.3;Suprabasal keratinocytes: 68.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	2.3	2.2	0.8	2.9	0.8	1.4	2.8	0.8	1.2	10.8	2.1	8.2	10.8	2.5	0.9	51.3	1.6	6.4	17.2	0.8	1.9	7.1	21.7	3.2	3.0	1.6	1.4	1.4	9.5	6.4	4.3	0.7	2.7	3.5	5.3	0.2	10.9	2.2	6.9	67.3	11.3	1.5	0.9	2.0	9.8	1.0	1.4	3.7	5.6	0.8	5.7	2.5	17.0	0.7	24.7	22.4	0.2	0.0	0.7	2.0	35.9	25.2	11.0	21.0	15.7	28.7	8.8	16.1	15.1	16.7	17.1	28.6	3.6	21.1	9.6	13.2	8.1	0.4	11.2	15.9	15.3	2.9	7.9	2.8	38.9	13.6	22.3	7.9	7.6	2.5	7.7	0.5	6.0	15.0	0.7	6.0	11.0	34.1	0.1	0.1	0.0	7.8	10.1	6.2	11.2	0.0	8.7	5.3	1.5	29.1	9.2	3.6	14.2	12.9	21.6	6.1	29.8	2.2	4.0	4.1	10.1	0.1	8.6	1.1	0.0	0.0	0.7	0.0	0.3	0.3	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.8	0.8	0.8	1.2	0.8	1.9	1.6	1.4	2.7	0.9	1.4	0.7	0.6	3.2	2.2	0.0	2.5	77.8	12.2	9.9	39.3	0.2	7.1	2.9	5.1	11.5	6.3	7.3	0.0	0.4	0.7	46.5	0.0	15.8	0.1	2.4	1.0	1.9	7.1	2.7	0.1	10.0	9.7	2.6	17.3	5.0	8.9	3.5	1.1	20.9	1.2	0.0	0.1	17.7	8.2	0.3	7.8	1.9	0.0	1.0	5.4	0.0	1.0	0.2	3.1	0.5	0.0	24.3	22.8	0.0	3.0	13.2	15.3	4.4	2.5	0.4	0.0	1.3	2.0	0.1	1.0	55.3	68.5	1.9	2.6	0.0	17.1	9.1
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143738234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.5;skin 1: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 58.7;hTCEpi: 59.8;MCF7: 118.2;OE19: 62.4;RT4: 70.1;T-47d: 58.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	2.1	4.0	1.9	2.1	1.7	0.5	4.4	1.2	2.2	11.5	2.6	9.8	8.4	0.8	3.3	70.5	4.7	3.3	0.8	2.0	1.1	11.8	13.5	6.3	0.9	1.6	2.4	0.3	13.9	7.9	5.9	3.5	1.5	7.2	4.3	1.1	17.1	3.8	0.1	34.9	9.1	0.3	1.3	1.7	11.0	2.8	1.5	1.5	14.1	0.0	4.0	8.3	23.2	2.2	47.0	28.3	0.3	0.1	0.1	0.0	16.6	4.0	0.0	2.0	0.7	25.8	53.4	0.0	6.1	1.0	0.0	56.1	3.5	51.9	0.9	0.0	0.2	1.5	58.7	18.3	4.3	0.6	1.7	2.9	59.8	0.2	15.0	0.8	0.0	4.2	22.2	0.1	0.0	118.2	0.8	0.4	4.8	62.4	15.3	0.1	0.1	6.0	16.5	70.1	7.1	0.2	38.3	53.8	7.8	7.5	58.2	8.2	0.3	0.1	7.2	3.9	0.2	0.0	0.0	0.2	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	1.2	2.2	2.0	1.1	1.6	2.4	1.5	1.3	1.5	2.2	0.1	32.1	16.5	0.7	0.6	22.8	17.7	21.9	6.8	2.0	18.2	14.0	4.6	14.3	18.9	29.5	2.1	12.8	0.5	38.5	3.9	22.0	1.2	11.4	2.9	1.0	14.4	0.0	1.3	25.9	17.8	1.6	25.0	25.9	0.0	5.4	0.7	25.5	4.7	10.1	0.5	24.3	16.2	2.8	0.8	0.7	0.0	1.3	1.8	0.0	2.8	6.6	2.1	0.5	0.1	42.7	27.2	0.4	0.4	26.4	23.6	7.0	17.4	2.0	0.0	0.2	1.9	1.7	1.0	38.9	26.9	14.6	0.9	1.2	27.8	33.9
FAM86B1	MGC16279	ENSG00000186523	"Family with sequence similarity 86 member B1"	Q8N7N1	8	12182096-12194133	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 5.4;pituitary gland: 6.4"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5;Proximal tubular cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5"									"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA041610: AB_2677581, HPA055718: AB_2682895"	"unprognostic (1.90e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.58e-2)"	0.5	0.7	0.9	0.4	2.2	0.5	1.0	0.2	5.4	2.2	0.0	1.4	0.8	2.3	0.4	0.6	2.4	0.5	0.9	2.6	0.1	1.1	0.3	0.8	0.3	2.0	0.0	3.7	0.9	0.4	6.4	0.1	0.1	2.4	0.0	1.7	0.8	0.3	0.8	1.0	0.6	0.1	0.0	0.6	0.7	0.5	0.5	0.1	1.3	0.0	0.0	1.2	1.5	0.0	0.2	1.2	0.0	2.5	0.0	0.4	1.0	2.0	0.2	0.6	0.3	0.7	0.5	0.5	0.1	0.1	0.7	2.2	0.4	0.7	0.2	0.2	0.3	0.1	0.3	0.3	1.1	0.9	0.9	0.1	0.2	0.2	1.7	0.4	0.1	0.9	0.8	0.7	0.0	1.1	0.0	0.6	0.8	0.7	0.2	0.7	0.5	0.1	0.1	0.6	2.1	0.4	0.2	0.2	0.3	0.2	1.0	0.0	0.0	0.4	0.4	1.8	0.5	0.2	0.6	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.2	5.4	2.6	0.1	2.0	0.0	0.1	0.0	0.5	0.0	1.2	3.2	1.8	0.7	0.9	1.1	3.1	1.0	3.4	2.1	4.7	5.0	0.5	8.6	3.0	1.8	2.1	1.5	0.4	0.8	5.9	5.1	5.8	4.7	2.3	1.6	4.2	1.3	0.3	1.8	1.6	2.6	1.5	1.5	1.3	17.5	2.5	1.3	1.9	1.7	0.3	1.5	0.0	1.3	0.6	6.2	1.8	0.7	3.6	0.0	0.1	2.7	4.1	0.0	0.1	3.5	0.3	2.6	0.1	7.0	0.8	10.3	8.5	1.7	0.0	3.3	2.1	0.9	0.8	3.8	1.3	1.1	0.8	2.3	2.4	1.8
FAM86B2		ENSG00000145002	"Family with sequence similarity 86 member B2"	P0C5J1	8	12425614-12436343	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Early spermatids: 1.6;Granulosa cells: 2.7;Late spermatids: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTERT-HME1: 5.3;RPMI-8226: 12.5"									"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA041610: AB_2677581, HPA055718: AB_2682895"	"unprognostic (3.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.04e-4)"	"unprognostic (9.37e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.13e-2)"	0.3	0.4	0.1	0.1	0.2	0.0	0.4	0.1	0.3	0.6	0.1	0.3	0.1	0.5	0.0	0.9	1.4	0.1	0.1	0.2	0.2	0.5	0.3	0.3	0.0	0.2	0.3	0.6	0.6	0.4	1.0	0.0	0.1	0.4	0.1	0.1	0.3	0.4	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.9	0.0	0.0	0.4	0.4	0.1	0.2	0.6	0.1	0.0	0.2	1.1	1.3	0.2	0.6	0.4	1.0	0.4	1.1	0.7	0.0	1.2	0.3	0.2	0.9	1.5	0.0	0.0	0.0	0.2	0.9	0.0	1.0	0.0	0.0	0.3	1.3	1.3	5.3	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.3	1.0	1.9	0.4	0.1	0.1	12.5	0.0	0.9	1.6	0.0	0.4	1.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.1	0.0	0.2	0.1	0.1	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040254	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.0;placenta: 68.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 145.4;SK-MEL-30: 81.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	60.0	18.0	16.0	4.8	15.3	5.9	36.5	20.7	16.4	11.0	21.3	4.4	1.7	7.5	1.6	6.5	7.1	5.9	10.6	14.2	23.4	22.2	9.2	19.2	5.9	22.6	21.4	6.0	10.6	6.0	5.8	68.2	20.9	7.1	2.7	17.3	5.3	4.6	5.9	30.6	4.6	4.1	21.2	17.5	7.6	3.0	25.1	2.9	5.5	6.7	4.7	8.9	9.2	19.5	0.9	13.7	6.3	13.4	15.0	3.0	145.4	7.8	5.8	2.8	5.1	21.1	12.1	0.0	1.8	5.1	16.7	8.4	12.0	1.9	2.3	42.4	28.9	6.7	0.3	0.9	57.6	5.0	35.2	50.1	26.6	0.0	13.2	0.1	7.4	15.0	53.4	8.6	2.7	5.0	3.2	8.8	9.4	12.6	4.3	16.6	20.3	16.0	10.1	14.8	5.8	16.1	2.6	1.2	81.6	13.9	0.8	29.2	1.1	22.5	0.1	0.4	14.7	18.3	23.7	11.6	6.7	9.8	45.7	1.4	0.2	0.0	0.2	0.0	0.3	0.3	0.2	0.5	0.0	0.1	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.2	16.0	15.3	20.7	16.4	14.2	23.4	22.6	21.4	20.9	21.2	25.1	19.5	82.3	0.0	2.6	3.6	4.2	30.1	22.0	0.3	8.0	48.1	3.8	5.2	3.3	7.2	0.7	0.0	77.2	186.3	4.9	0.3	3.9	2.8	1.3	1.3	39.3	44.5	0.0	14.9	1.1	3.3	267.5	11.6	0.5	2.6	4.5	0.5	10.8	11.1	51.0	8.4	10.8	0.6	0.0	19.6	2.1	3.6	2.8	8.5	21.4	22.5	0.5	26.2	1.0	10.1	2.0	4.4	0.5	1.5	1.4	30.2	0.0	5.1	0.1	102.5	0.0	9.9	8.5	4.2	11.6	1.7	32.8	278.3	5.5	0.4	1.3	15.4
FAM89B	"LRAP25, MTVR1"	ENSG00000176973	"Family with sequence similarity 89 member B"	Q8N5H3	11	65572349-65574198	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046895	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA046895: AB_2679858"	"unprognostic (1.16e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.09e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.07e-3)"	"prognostic unfavorable (9.48e-5)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.12e-2)"	39.9	33.8	59.0	19.8	54.9	22.5	34.2	53.9	84.7	46.1	40.2	70.7	13.7	47.7	13.0	46.2	42.7	24.8	56.7	60.7	46.6	39.6	36.0	39.7	25.8	52.2	50.6	43.8	76.2	23.2	22.9	14.6	52.9	50.3	10.9	3.2	47.0	24.2	129.7	44.1	34.4	23.0	50.8	48.3	45.0	18.4	53.8	31.3	26.1	95.1	19.4	54.0	43.1	55.9	16.6	26.3	38.4	47.8	45.7	52.5	12.5	29.3	26.2	21.4	12.7	15.8	18.2	11.2	38.7	45.9	23.7	28.1	16.3	17.5	5.0	38.0	43.6	21.3	18.8	9.0	27.8	10.5	38.7	41.1	34.8	17.7	12.2	68.3	57.5	26.2	24.2	73.3	30.7	24.6	48.1	37.1	17.2	16.1	61.2	59.2	5.9	49.6	24.1	15.2	43.5	57.6	21.5	30.8	50.0	11.7	31.1	15.7	37.9	45.6	23.9	44.6	15.5	36.3	61.3	7.4	39.9	15.7	33.2	7.8	5.7	11.6	5.0	10.5	6.8	2.6	6.3	6.4	5.0	2.3	5.3	5.4	8.5	5.8	14.0	5.5	10.1	3.5	59.0	54.9	53.9	84.7	60.7	46.6	52.2	50.6	52.9	50.8	53.8	55.9	45.3	9.6	3.9	9.8	33.4	47.4	32.8	4.3	18.8	10.1	67.0	57.8	10.7	21.5	5.3	23.9	2.1	27.7	63.9	27.2	13.7	23.6	10.4	19.7	33.3	39.7	29.2	36.7	13.6	27.5	19.9	32.8	10.7	20.3	4.5	26.5	43.5	27.6	32.5	16.8	10.9	15.2	2.0	40.6	48.8	27.8	26.4	47.1	44.4	13.1	27.1	29.1	73.2	9.0	10.6	33.3	21.7	30.1	43.6	31.8	16.1	14.9	4.2	8.7	46.0	22.3	48.8	2.9	13.1	19.1	57.4	22.3	46.5	26.2	16.6	48.5
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600302-17611715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 759.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	18.6	16.1	16.3	10.7	17.3	31.6	19.1	19.0	19.5	20.4	16.6	19.9	16.9	27.3	18.9	13.9	20.6	21.1	14.8	17.4	20.3	24.0	77.9	18.9	10.4	18.2	17.2	27.8	15.0	22.3	13.0	14.9	18.2	20.9	22.8	27.1	23.0	22.3	18.9	14.0	16.7	24.8	20.2	14.3	12.7	17.2	21.1	17.1	23.2	21.7	8.2	14.5	12.6	20.6	9.5	3.7	13.5	32.3	45.6	42.6	11.1	15.0	20.4	7.6	13.1	21.4	3.1	8.1	35.2	25.6	8.3	7.6	20.5	13.0	9.9	6.9	29.1	9.8	12.5	46.2	20.1	6.2	9.6	22.6	20.7	8.7	6.0	24.2	17.0	8.9	20.2	16.2	12.0	11.7	4.6	19.2	5.6	11.6	5.6	12.1	13.0	25.0	25.6	7.5	4.1	21.4	11.7	25.0	23.7	23.1	29.0	9.5	13.3	9.7	3.4	14.9	5.5	13.4	12.0	8.0	8.8	7.1	13.4	2.6	0.3	1.0	1.1	0.4	1.2	0.0	0.5	1.0	0.2	0.1	0.7	1.1	5.5	1.5	0.2	0.2	0.4	0.3	16.3	17.3	19.0	19.5	17.4	20.3	18.2	17.2	18.2	20.2	21.1	20.6	16.8	19.2	27.1	8.8	7.0	13.4	9.7	6.6	14.2	27.6	15.1	13.5	15.3	21.5	12.1	29.5	14.6	10.0	15.7	63.4	5.9	9.2	759.2	26.4	24.0	14.1	12.0	4.2	17.1	7.9	12.0	23.0	10.7	20.6	1.3	8.6	25.4	77.5	6.2	15.2	17.9	10.8	8.2	24.4	6.4	187.8	36.7	8.6	5.4	3.7	8.7	19.3	14.4	8.0	13.8	7.5	25.7	30.9	12.8	7.5	30.4	12.4	20.5	16.7	32.9	20.3	18.7	46.6	18.0	14.3	15.9	12.2	14.0	9.7	16.7	7.8
FAM91A1	FLJ23790	ENSG00000176853	"Family with sequence similarity 91 member A1"	Q658Y4	8	123768439-123815452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027978	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Microtubules"		"HPA027978: AB_10600004"	"unprognostic (2.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	12.9	11.7	6.8	15.9	7.9	42.9	14.0	8.4	8.2	12.8	12.2	13.0	14.5	13.8	11.9	13.1	10.3	16.0	7.1	7.0	9.0	18.4	26.6	13.1	18.7	9.1	8.2	12.8	14.0	21.0	9.3	20.2	8.6	11.6	14.8	11.7	11.4	11.0	6.1	11.6	14.2	11.7	8.7	19.6	13.9	10.9	8.5	14.3	18.3	6.2	17.0	17.1	10.6	11.6	63.9	42.4	12.9	22.4	24.4	26.3	20.8	36.2	39.4	33.7	42.5	21.3	25.8	29.9	39.2	29.9	26.7	30.4	30.8	39.2	60.0	57.5	29.8	47.2	21.9	25.6	38.0	21.7	58.9	25.0	31.1	44.1	54.3	23.0	31.0	18.4	17.1	41.3	30.7	75.8	37.7	14.4	12.7	51.8	37.3	20.4	21.5	22.4	28.4	64.7	15.5	21.6	48.1	102.4	49.8	18.8	31.5	22.9	31.5	32.0	57.4	35.7	53.1	31.9	65.8	28.4	50.2	38.7	39.9	7.0	8.0	11.3	3.2	9.5	2.9	5.1	3.2	2.7	8.2	4.2	2.7	3.7	10.1	5.9	8.5	3.1	3.1	4.3	6.8	7.9	8.4	8.2	7.0	9.0	9.1	8.2	8.6	8.7	8.5	11.6	31.9	25.6	13.2	17.6	30.6	39.6	21.9	19.0	20.5	15.0	24.0	17.7	8.4	22.8	19.3	25.8	22.9	10.4	25.3	21.3	5.9	12.1	22.4	20.8	22.9	27.5	27.5	10.3	21.0	15.5	12.7	19.3	26.5	33.0	8.8	18.2	18.5	59.3	27.1	23.5	22.0	22.0	16.2	73.6	43.5	26.0	14.0	45.9	21.4	24.4	40.1	17.6	19.6	23.6	45.8	35.1	21.7	14.7	25.8	34.8	18.7	20.8	16.5	21.7	13.1	26.5	22.4	14.2	10.7	27.0	46.7	19.2	19.6	16.0	14.5	45.3
FAM98A	DKFZP564F0522	ENSG00000119812	"Family with sequence similarity 98 member A"	Q8NCA5	2	33583660-33599382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036250, HPA036251"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA036250: AB_2675020, HPA036251: AB_10673124"	"unprognostic (7.25e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (6.01e-2)"	29.2	21.5	21.4	20.5	26.5	7.2	16.3	28.6	30.4	21.7	27.9	20.7	13.6	19.1	19.3	19.9	12.2	15.7	40.6	30.8	25.7	27.4	25.5	11.5	18.4	25.1	24.5	16.5	14.6	51.2	20.5	20.6	29.5	23.0	17.1	17.2	28.0	16.7	61.3	14.9	12.1	36.4	27.7	14.3	19.8	49.4	26.4	17.4	19.2	62.4	22.6	27.5	12.9	39.7	93.4	47.2	25.5	43.9	99.4	108.3	41.9	224.1	81.6	62.3	80.2	49.8	18.8	144.5	41.3	101.8	55.3	41.3	84.8	60.8	84.2	67.7	56.3	119.7	46.9	69.3	47.2	95.5	44.7	56.1	42.2	83.9	52.1	63.5	83.3	15.5	84.4	43.8	108.7	46.1	53.3	28.5	64.4	83.2	59.9	41.1	82.5	51.9	65.0	72.2	45.6	26.1	60.0	89.5	27.0	40.7	36.2	15.6	135.7	39.5	66.1	82.9	89.2	80.2	106.6	142.4	91.2	68.2	56.8	1.3	4.1	2.3	6.4	7.2	6.9	10.7	5.4	5.8	6.1	5.5	6.9	5.7	0.1	4.0	4.6	3.5	9.0	4.1	21.4	26.5	28.6	30.4	30.8	25.7	25.1	24.5	29.5	27.7	26.4	39.7	19.0	22.4	11.5	6.8	17.4	20.4	19.0	12.2	18.8	16.8	15.0	14.0	74.6	11.5	19.8	7.3	2.1	25.5	9.8	6.9	25.4	20.3	14.9	16.7	29.9	21.1	5.4	12.8	22.8	29.2	33.2	31.9	17.9	18.9	2.5	44.4	17.2	23.4	16.4	47.1	15.7	15.1	8.2	7.7	11.8	13.8	22.4	8.7	8.8	6.5	5.9	17.4	16.5	9.0	36.1	26.0	8.7	21.8	40.3	22.6	9.3	46.2	16.5	15.7	0.0	21.7	27.1	41.5	40.1	26.1	20.5	40.0	13.7	54.9	12.1	23.4
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.6	9.6	14.5	5.5	13.9	8.7	12.3	12.3	17.6	14.8	7.2	14.6	13.8	10.7	2.6	17.7	12.3	5.3	11.6	13.8	11.7	12.2	13.3	9.1	6.2	18.9	11.6	12.5	18.6	8.4	11.6	2.3	13.5	13.4	4.7	1.7	13.9	5.8	3.3	25.2	15.4	3.3	12.7	11.8	14.4	9.0	14.4	4.7	11.4	2.5	3.8	12.7	14.6	14.3	15.6	16.3	1.9	9.4	2.0	6.8	8.2	8.8	7.3	8.5	8.9	2.8	11.0	13.9	9.7	5.2	3.0	7.5	3.7	6.3	1.4	22.6	7.6	4.6	2.9	6.5	9.0	3.9	8.1	6.6	13.0	4.3	7.8	4.7	5.0	22.5	12.9	15.0	5.1	17.2	5.9	3.1	1.4	25.5	17.5	11.6	3.9	8.4	10.4	8.0	3.3	9.6	8.8	15.6	5.6	0.9	11.8	12.3	6.7	3.8	10.4	11.9	10.7	16.1	8.8	6.1	9.9	9.2	6.2	0.0	1.9	10.8	2.4	2.7	3.2	2.0	4.2	3.4	2.6	6.5	3.3	2.6	1.7	3.0	2.7	1.0	3.9	1.4	14.5	13.9	12.3	17.6	13.8	11.7	18.9	11.6	13.5	12.7	14.4	14.3	19.8	9.6	8.9	3.6	17.5	21.5	22.3	23.7	14.8	15.1	21.1	26.3	5.4	10.0	21.2	23.9	12.5	11.8	22.1	41.4	21.5	22.2	6.4	18.2	9.1	12.0	25.7	9.7	11.7	32.9	10.9	13.9	17.9	18.0	15.2	8.6	11.4	12.5	11.0	11.8	9.5	32.4	22.4	13.2	18.2	2.4	18.6	14.3	23.2	2.8	14.4	14.6	34.0	5.5	8.5	23.8	42.8	18.4	12.7	12.2	100.4	22.6	22.4	12.5	13.1	13.5	13.8	37.4	37.4	22.3	29.8	6.2	21.8	12.9	34.8	23.4
FAM9A	TEX39A	ENSG00000183304	"Family with sequence similarity 9 member A"	Q8IZU1	X	8790795-8801383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 4.3"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 55.2;Spermatogonia: 36.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-266/84: 9.0"									HPA056076	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA056076: AB_2683030"															"unprognostic (3.43e-2)"			0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.2	0.0	0.4	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	55.2	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9295682	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.1;testis: 5.9"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 114.8;Spermatogonia: 96.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"U-266/70: 27.8;U-266/84: 32.1"									HPA035135	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.0	0.1	0.3	0.0	0.2	0.3	0.0	0.3	0.3	0.1	0.2	0.2	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.8	0.0	0.4	0.2	5.9	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	27.8	32.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.0	0.4	0.5	0.1	0.0	1.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	4.9	0.2	1.7	0.4	0.0	0.0	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.5	6.6	0.6	0.2	114.8	96.5	0.0	0.3	0.0	0.2	0.0	0.0	0.2
FANCB	"FAAP95, FAB, FLJ34064"	ENSG00000181544	"FA complementation group B"	Q8NB91	X	14835961-14873069	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;brain: 3.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 12.4;Oligodendrocytes: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003124	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA003124: AB_1078813"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.42e-3)"	"unprognostic (7.99e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.05e-5)"	"unprognostic (6.93e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.76e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-11)"	"unprognostic (4.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.96e-2)"	0.2	0.1	2.1	0.7	3.3	3.4	0.5	1.2	1.6	0.3	0.0	0.3	0.2	0.3	0.1	0.4	0.2	0.1	0.1	0.8	1.0	0.1	0.1	0.2	1.2	1.7	2.2	0.4	0.1	0.1	0.0	0.8	1.8	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.2	0.3	1.5	0.4	0.2	0.2	3.1	1.4	0.2	0.1	1.3	0.3	0.3	3.8	7.3	5.0	4.8	3.9	0.3	1.1	1.7	11.2	3.0	8.8	9.9	3.5	5.3	10.6	1.9	4.4	6.6	7.0	11.3	4.1	15.0	5.1	5.9	4.1	7.9	1.7	0.1	5.8	3.3	0.1	0.4	9.0	2.0	0.9	4.4	3.5	7.3	7.2	5.2	3.5	5.7	3.2	6.1	3.0	7.1	5.1	11.4	5.2	0.8	2.6	3.1	3.5	5.7	2.4	3.2	11.2	3.6	2.0	1.8	6.7	3.7	14.5	6.8	1.8	3.9	7.2	3.0	4.1	14.3	0.3	0.2	0.2	0.2	0.1	0.1	0.7	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	2.1	3.3	1.2	1.6	0.8	1.0	1.7	2.2	1.8	1.5	3.1	3.8	1.9	3.2	0.5	1.0	5.2	1.7	1.1	1.5	0.6	3.0	1.6	3.3	0.4	0.0	1.8	0.0	0.0	7.0	6.2	0.9	0.0	1.2	0.4	2.1	2.7	1.9	0.0	5.0	6.3	1.5	12.4	2.0	1.5	2.3	3.8	6.6	1.4	0.3	3.6	3.3	4.8	0.8	4.1	0.3	1.8	0.6	1.2	2.7	0.0	2.8	1.0	0.4	3.1	3.0	33.1	0.7	0.1	1.2	6.5	0.7	0.2	0.4	1.2	0.5	0.0	2.4	2.3	5.2	4.2	3.8	1.0	3.8	4.1	0.7	1.8	1.5
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.8"	"Cell line enhanced"	"Detected in all"		"RH-30: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	2.6	1.7	1.7	3.1	2.4	3.3	3.4	8.9	2.7	4.1	1.7	4.0	5.5	3.2	1.1	3.5	2.8	3.7	2.7	1.8	2.3	6.8	24.6	4.0	2.7	3.9	2.3	2.3	4.4	1.5	3.5	3.1	3.2	3.5	4.3	2.4	3.0	1.5	3.6	5.9	6.2	2.1	1.7	2.3	3.6	9.5	2.4	4.2	3.1	1.2	2.6	3.0	3.2	3.9	21.5	14.6	18.7	16.9	2.0	5.4	11.7	8.1	5.7	14.1	13.9	16.2	9.3	12.7	6.4	7.2	10.6	25.5	21.1	8.5	8.4	12.9	10.1	9.8	16.6	9.6	2.7	11.6	11.3	4.9	3.8	11.1	5.4	3.9	8.4	10.1	14.9	5.7	10.3	17.1	9.7	5.8	9.6	23.2	8.9	17.3	47.1	7.0	6.4	6.8	26.2	13.1	18.9	7.4	4.2	8.2	6.9	8.6	4.0	13.0	17.1	14.5	14.1	5.9	12.0	6.8	6.6	9.8	15.9	8.8	0.3	0.0	0.9	0.6	0.9	0.6	0.4	0.9	0.3	0.6	0.7	0.7	0.1	0.1	1.3	0.9	0.4	0.5	1.7	2.4	8.9	2.7	1.8	2.3	3.9	2.3	3.2	1.7	2.4	3.9	3.0	3.2	2.2	9.4	2.2	2.5	2.7	1.2	2.8	6.1	3.5	3.7	1.9	5.7	2.3	0.0	4.2	3.0	2.7	3.3	1.9	4.4	178.6	3.5	5.5	4.3	0.0	3.0	22.1	4.1	5.0	3.3	2.0	4.7	5.7	3.9	5.0	42.6	2.0	10.1	13.8	4.0	0.0	3.5	1.3	87.8	6.5	1.6	1.8	49.6	2.8	2.1	1.0	32.2	48.9	3.1	1.0	2.2	4.4	3.0	5.6	8.9	1.0	4.5	0.0	4.1	2.3	19.4	13.2	4.0	2.7	2.3	2.1	4.5	4.7	2.5
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026414-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 120.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	1.1	0.7	2.7	7.7	2.1	17.8	3.4	1.6	5.3	1.5	1.1	4.0	3.2	2.0	0.7	2.5	2.6	2.0	0.5	3.4	1.6	0.9	1.1	1.9	12.2	3.9	1.4	3.6	0.8	0.8	0.5	4.7	3.0	1.9	6.4	3.1	4.9	1.0	4.8	4.5	4.0	2.0	2.4	6.4	3.5	11.8	2.3	9.8	1.9	0.4	13.0	2.3	1.3	5.1	24.1	25.4	46.5	13.2	2.4	3.5	120.7	22.0	9.8	31.3	25.4	18.8	23.0	46.7	9.8	7.0	25.1	20.2	48.8	16.7	31.0	22.6	33.0	63.6	39.6	17.9	0.4	48.1	37.9	1.2	2.6	34.1	18.4	4.2	18.4	39.3	39.6	51.6	23.1	27.2	40.6	17.9	56.1	18.1	17.6	43.4	37.7	32.5	10.3	26.7	13.0	25.3	26.4	20.1	8.3	33.5	31.0	29.4	10.6	24.6	28.4	15.1	31.5	21.7	46.4	77.2	14.1	47.7	43.2	2.7	0.6	1.9	0.6	0.5	0.6	2.4	0.9	0.5	0.4	3.2	1.1	0.9	1.5	1.0	1.4	1.8	1.5	0.5	2.7	2.1	1.6	5.3	3.4	1.6	3.9	1.4	3.0	2.4	2.3	5.1	0.7	0.0	0.5	0.7	12.5	4.6	3.5	2.9	2.8	3.1	4.5	2.7	2.0	1.5	1.9	1.8	10.4	12.7	5.6	3.1	0.0	1.9	5.9	2.6	1.5	2.1	1.2	25.2	3.0	3.5	15.2	2.6	2.0	3.4	1.3	11.8	3.3	1.5	5.7	0.0	2.6	3.2	6.1	3.8	7.0	8.0	2.1	3.7	3.6	1.9	4.9	0.6	1.0	1.5	2.4	1.8	3.6	1.5	8.1	2.2	0.5	0.7	2.0	5.6	19.7	2.6	2.1	62.5	30.2	4.1	2.7	7.0	5.2	1.6	7.6	3.1
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
FANCG	"FAG, XRCC9"	ENSG00000221829	"FA complementation group G"	O15287	9	35073835-35079942	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 20.6;Spermatogonia: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: AB_2679292"	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	3.4	3.1	2.8	5.1	2.8	12.4	4.5	3.6	3.8	5.1	2.1	4.3	4.9	4.2	2.3	5.9	5.8	3.3	1.9	2.7	2.7	3.9	2.9	3.3	7.7	2.8	2.7	6.2	6.3	4.7	3.0	4.5	2.7	3.9	4.0	2.4	4.3	4.1	2.3	6.5	4.6	4.5	2.5	5.5	4.1	6.4	2.7	12.2	4.0	1.7	6.9	3.5	4.6	3.4	34.7	40.7	30.4	28.3	6.4	10.2	25.0	23.6	16.3	44.9	42.5	20.1	21.2	33.4	15.8	7.7	33.1	20.5	25.3	22.0	17.6	38.7	14.8	24.5	45.5	13.2	1.8	24.5	26.9	8.1	4.1	39.5	18.2	8.0	23.8	40.7	15.7	44.3	23.5	31.5	43.2	34.5	32.5	26.4	30.1	43.8	35.2	23.1	10.9	14.6	14.4	26.1	15.7	22.3	8.3	13.4	28.4	17.2	13.4	21.0	42.8	28.3	33.1	12.4	24.0	20.6	19.2	18.5	30.1	10.5	0.7	6.7	6.1	2.2	5.3	5.6	4.8	4.6	1.9	5.4	3.6	3.8	1.1	7.8	2.0	4.2	8.2	3.1	2.8	2.8	3.6	3.8	2.7	2.7	2.8	2.7	2.7	2.5	2.7	3.4	3.2	3.2	4.6	6.8	4.9	4.5	6.1	3.9	10.2	4.7	5.9	5.0	1.5	2.8	3.3	3.7	4.2	15.0	4.1	3.0	3.9	4.9	0.4	2.3	3.8	4.4	1.8	11.6	3.0	2.3	20.6	5.1	1.5	3.6	14.0	10.3	4.2	1.1	7.7	5.0	3.3	4.1	2.0	1.3	4.7	0.6	3.4	2.3	3.6	1.0	2.8	4.0	3.1	0.5	4.1	1.9	2.4	4.1	14.1	4.4	3.5	2.3	1.3	3.1	0.0	3.0	3.9	14.7	20.7	8.5	2.6	6.6	4.9	2.8	6.7	5.2
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.2	2.1	1.6	13.0	1.3	31.4	6.0	3.8	2.5	3.3	0.0	10.5	6.0	4.7	1.1	8.1	3.4	3.0	1.7	1.7	0.7	1.7	2.9	3.4	23.9	1.2	0.9	3.8	3.0	3.0	0.6	11.3	1.7	3.6	12.4	5.4	2.8	2.0	0.8	8.0	7.3	6.9	0.6	6.0	6.7	32.6	1.3	44.2	2.0	0.8	26.6	5.4	3.7	1.7	108.2	122.4	127.8	86.1	10.8	16.0	78.5	101.4	58.3	123.6	150.5	96.8	95.4	198.8	53.4	33.8	79.3	143.9	196.8	69.0	116.2	127.8	123.5	197.2	176.7	45.8	1.7	146.0	96.3	8.6	6.8	87.1	44.4	17.6	51.7	120.2	139.2	142.3	83.5	61.5	150.9	49.6	101.1	70.3	44.5	130.6	187.1	84.6	28.5	196.8	93.9	80.8	105.2	73.3	46.7	85.7	81.2	64.8	35.4	103.2	103.8	94.9	155.8	93.3	209.5	151.9	38.5	125.7	104.7	23.4	2.3	3.0	4.7	3.0	2.8	3.5	4.7	6.5	2.2	3.6	3.3	5.6	3.1	5.1	4.3	4.1	11.8	3.1	1.6	1.3	3.8	2.5	1.7	0.7	1.2	0.9	1.7	0.6	1.3	1.7	2.6	3.2	1.5	3.6	3.8	4.2	2.6	4.0	0.6	2.4	2.9	2.7	3.9	0.0	3.3	1.8	0.0	17.0	3.9	4.2	0.0	2.0	7.9	5.0	3.7	3.0	1.2	48.6	7.0	2.9	18.3	3.9	5.6	4.5	2.5	14.9	6.8	0.8	8.1	1.7	5.8	5.9	0.0	3.0	3.8	7.9	3.4	4.8	1.8	1.9	3.3	11.6	1.0	9.0	6.9	2.5	1.2	1.5	13.9	2.0	1.3	1.0	6.3	1.9	6.6	3.6	4.0	69.5	60.2	9.2	2.4	12.4	8.1	2.5	9.1	2.8
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"FA complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	8.5	35.3	39.4	11.0	49.5	15.1	19.5	35.3	39.4	18.6	27.2	12.1	11.5	19.9	18.4	11.5	13.9	12.0	13.0	34.1	45.1	12.2	21.7	9.6	14.8	51.6	40.3	24.8	14.5	14.0	44.3	12.5	55.4	14.7	14.8	24.6	18.7	10.7	9.1	17.9	12.8	13.5	40.9	16.8	13.1	19.1	41.2	13.2	17.1	9.1	12.6	11.7	14.6	68.6	48.6	35.0	69.4	34.0	11.9	15.1	36.9	34.8	21.5	33.8	43.5	30.9	59.4	33.4	43.8	11.4	46.3	27.5	39.0	26.4	56.0	78.8	61.7	54.8	49.5	42.1	13.0	53.3	29.0	11.8	12.4	24.8	9.7	29.9	27.0	23.5	51.9	29.6	23.2	24.6	18.9	65.8	75.2	77.4	7.2	35.2	52.5	26.1	29.9	47.2	78.1	39.3	49.5	20.2	33.8	37.0	18.7	35.4	15.9	30.0	45.0	22.3	39.0	30.4	20.6	19.7	63.7	35.7	46.6	3.2	3.0	4.9	3.7	5.6	3.0	9.1	3.2	4.2	5.9	9.3	1.0	2.3	0.8	7.6	4.3	5.3	4.8	2.2	39.4	49.5	35.3	39.4	34.1	45.1	51.6	40.3	55.4	40.9	41.2	68.6	16.7	19.2	20.0	18.6	9.4	10.3	13.9	26.1	11.4	16.6	12.5	15.4	16.4	8.6	16.1	9.2	4.2	29.1	4.8	7.2	11.7	9.7	2.5	11.1	15.8	14.8	9.0	14.5	45.0	4.2	14.0	12.2	15.3	6.2	10.8	25.8	13.2	12.5	10.9	8.4	38.4	15.0	30.5	6.3	4.6	3.6	10.8	7.0	26.6	34.7	6.8	22.8	3.1	81.4	188.9	4.6	13.3	14.3	9.7	6.2	21.7	5.7	23.2	18.7	13.1	10.8	12.4	52.6	37.9	9.5	6.8	7.4	5.6	13.2	16.0	9.3
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4;smooth muscle: 26.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.1;hippocampal formation: 2.4"	HPA059739	Uncertain				"Secreted to blood"	NA	NA	108000000	56000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	5.8	0.2	0.9	5.2	0.9	0.0	10.1	0.4	0.9	15.2	0.0	3.5	0.5	31.4	8.5	3.6	4.8	22.3	4.9	0.3	1.4	0.7	0.2	4.0	1.5	0.6	0.5	3.0	2.5	0.7	0.5	23.1	0.6	1.9	2.5	6.4	4.7	5.8	4.4	2.8	0.9	26.4	0.2	0.4	1.0	1.5	1.0	0.5	2.8	7.5	1.5	15.5	3.6	0.7	0.0	0.0	0.0	0.0	192.2	202.3	0.4	82.8	167.8	16.6	25.4	0.0	0.0	0.0	0.6	31.3	0.0	0.1	0.0	5.1	8.0	0.0	0.0	0.1	1.2	0.0	19.5	0.0	0.0	66.2	1.2	28.1	5.2	209.1	0.1	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.5	0.0	9.0	0.2	0.1	0.0	84.3	167.3	3.1	41.4	0.4	0.0	0.1	0.0	37.5	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.9	0.3	1.4	0.6	0.5	0.6	0.2	1.0	0.7	3.9	0.0	0.0	5.5	0.2	4.5	0.1	7.0	0.0	1.8	0.3	0.5	0.4	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.2	6.7	3.4	67.6	6.4	4.9	0.0	13.3	0.2	1.9	43.4	0.0	6.2	0.0	0.0	1.4	0.0	0.9	1.7	0.3	1.4	0.0	0.0	2.6	4.1	8.4	0.8	3.6	17.8	0.0	57.5	0.0	0.5	4.2	1.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	2.0	0.0	4.7	25.2	2.3	0.4	0.4	4.3	1.8	0.8	1.3	0.2	0.0
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668668-13732346	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 437.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	21.1	16.2	19.3	23.0	36.0	74.9	20.6	34.3	31.5	23.8	24.5	32.9	38.7	24.7	24.9	50.9	17.7	13.7	20.0	22.6	29.7	14.0	5.0	20.2	20.5	48.4	29.9	19.9	21.3	29.1	15.6	24.6	44.1	20.5	37.6	32.6	18.2	15.4	15.2	12.2	21.1	30.7	37.3	20.5	62.0	20.8	32.1	16.5	19.8	18.6	23.9	28.4	30.0	94.8	79.5	50.6	49.1	38.4	45.9	52.6	26.7	69.2	27.6	50.0	52.7	53.5	66.4	100.9	30.2	55.5	74.3	84.3	73.2	69.9	76.1	30.0	59.4	43.4	44.8	0.2	44.1	87.9	33.7	40.2	70.3	36.2	107.7	36.9	49.6	50.2	68.9	29.3	41.5	39.9	65.5	26.3	25.8	100.1	72.6	56.9	62.6	28.4	48.4	126.4	37.7	27.3	65.5	61.6	34.4	56.2	37.8	54.1	62.1	68.5	58.2	63.7	58.4	16.4	59.6	84.7	43.4	26.4	42.4	10.4	24.9	28.0	7.7	21.3	5.4	3.5	3.7	6.6	28.5	5.5	3.3	5.5	38.9	9.1	18.2	4.4	5.3	7.7	19.3	36.0	34.3	31.5	22.6	29.7	48.4	29.9	44.1	37.3	32.1	94.8	38.6	35.3	21.1	80.0	24.2	32.2	24.2	21.5	41.5	46.0	27.6	20.3	24.1	5.7	26.2	22.0	41.7	25.7	40.2	59.8	5.9	12.8	100.8	21.1	36.5	31.4	36.0	38.5	146.0	25.9	18.5	26.8	114.7	26.2	38.7	23.3	29.6	2.5	33.9	47.1	113.5	28.8	26.4	53.5	57.0	181.3	26.8	48.8	35.6	71.2	54.8	20.6	20.6	93.5	437.2	29.3	43.4	25.6	36.1	30.8	23.3	8.7	18.7	50.4	26.3	29.3	29.3	41.6	32.3	116.9	19.9	9.9	25.8	17.0	47.7	42.0
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 36.2;intestine: 34.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 114.3;Inhibitory neurons: 172.1;Microglial cells: 63.7;Syncytiotrophoblasts: 193.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 50.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 76.2;HUVEC TERT2: 84.0;NB-4: 74.2;SK-BR-3: 89.6;TIME: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	8.3	9.0	4.1	9.3	8.3	17.1	9.3	1.2	8.5	4.3	0.0	34.5	17.6	5.6	36.2	7.4	3.6	5.2	6.6	6.2	9.2	5.0	3.8	11.3	7.9	1.2	2.9	2.3	3.2	1.3	2.4	18.1	1.3	2.6	28.2	9.4	4.4	1.9	6.3	9.0	19.2	7.6	1.4	12.2	4.9	9.2	5.2	7.0	4.4	2.6	3.0	6.5	3.7	4.9	2.5	4.9	4.9	1.2	6.8	26.9	2.1	21.3	24.7	5.8	5.4	8.2	28.0	3.7	5.4	3.4	4.3	1.5	13.4	0.2	1.4	1.8	32.2	76.2	10.7	2.7	14.7	30.0	24.0	7.5	0.2	8.7	11.0	14.3	84.0	2.9	6.6	2.7	0.9	0.8	19.9	74.2	19.3	1.6	54.5	16.1	7.9	3.1	25.7	7.2	8.6	7.9	4.8	89.6	37.8	9.7	4.1	28.2	68.2	15.6	4.6	5.6	9.3	4.4	4.9	1.8	24.5	38.5	13.7	3.8	22.8	50.0	5.0	13.9	3.4	2.0	8.3	6.2	8.1	1.8	2.9	3.2	41.0	4.0	8.0	3.1	16.1	9.6	4.1	8.3	1.2	8.5	6.2	9.2	1.2	2.9	1.3	1.4	5.2	4.9	9.1	0.0	3.3	7.8	0.6	1.3	0.1	0.2	0.6	2.0	1.4	0.8	12.1	0.0	1.4	0.0	0.0	16.0	1.1	35.7	0.0	0.1	31.5	0.4	2.9	11.9	7.2	4.6	114.3	0.2	19.6	4.8	5.6	0.4	10.8	0.0	9.7	0.0	19.3	5.0	172.1	21.8	0.0	22.2	3.7	6.4	1.2	12.2	16.0	63.7	6.9	0.5	1.0	24.6	6.9	3.3	36.8	0.4	8.0	0.4	15.1	0.4	3.2	1.2	0.0	4.2	3.6	16.6	1.0	0.3	0.3	193.9	4.2	0.9	23.7	0.3
FARP2	"FIR, FRG, KIAA0793, PLEKHC3"	ENSG00000006607	"FERM, ARH/RhoGEF and pleckstrin domain protein 2"	O94887	2	241356285-241494841	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2;Oligodendrocytes: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031226, HPA055592"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA031226: AB_10602808, HPA055592: AB_2682856"	"unprognostic (3.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-1)"	9.6	10.3	13.8	11.4	16.8	5.4	9.0	19.3	16.0	10.0	9.8	22.6	20.2	10.6	7.3	14.1	9.2	10.0	7.6	13.2	12.9	11.0	17.1	10.4	11.9	15.6	15.2	11.0	11.4	13.2	8.4	9.0	15.6	10.1	21.3	10.1	9.2	10.0	10.6	22.6	18.9	11.6	11.7	11.6	20.3	28.1	16.2	8.5	6.8	9.9	13.8	14.2	10.1	21.3	20.0	14.3	25.8	17.7	21.9	29.1	23.1	19.7	16.3	20.0	20.6	15.3	23.4	8.5	5.2	38.8	14.1	22.4	35.0	20.6	30.4	13.3	18.1	18.8	25.4	20.3	16.0	17.0	14.1	29.3	15.2	29.2	23.7	9.3	18.4	16.1	21.7	7.6	16.3	16.7	18.3	12.5	12.8	35.3	11.1	20.3	58.2	25.7	25.9	41.0	30.5	20.3	22.1	15.4	59.5	14.9	8.1	16.8	27.9	18.8	14.3	23.8	16.0	13.0	10.0	18.8	17.2	11.5	39.0	6.1	2.1	7.3	1.3	5.1	1.2	4.4	1.4	1.5	3.1	4.9	0.9	1.0	1.3	1.7	2.8	6.4	2.2	1.6	13.8	16.8	19.3	16.0	13.2	12.9	15.6	15.2	15.6	11.7	16.2	21.3	8.9	28.9	5.9	27.4	23.9	15.4	11.4	8.0	16.5	12.7	11.1	8.3	29.6	14.3	12.3	18.4	18.8	5.8	9.7	36.3	3.9	9.3	42.7	12.0	10.6	10.5	28.1	3.4	43.1	12.3	5.4	12.9	45.3	14.0	6.3	15.9	11.0	11.6	4.2	20.2	36.7	38.7	10.2	8.4	9.4	25.0	14.9	11.9	39.2	38.4	8.5	4.9	2.1	128.2	114.0	12.6	24.1	10.5	14.4	12.8	20.9	7.1	17.3	15.1	19.7	21.4	14.1	45.6	19.7	13.8	15.2	11.1	6.0	11.3	26.2	22.4
FARS2	"dJ236A3.1, FARS1, mtPheRS"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5829192	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 110.4;Early spermatids: 77.4;Excitatory neurons: 217.0;Inhibitory neurons: 122.6;Late spermatids: 78.8;Microglial cells: 106.8;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favorable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	9.4	12.0	8.1	9.6	10.9	11.7	11.0	6.1	10.8	8.8	22.9	10.6	7.4	9.2	7.3	9.8	14.9	6.8	16.0	8.4	9.6	14.2	14.4	9.6	12.4	5.8	6.7	7.8	10.3	13.2	9.8	8.9	6.5	7.3	11.3	6.8	8.4	8.6	19.7	11.4	7.9	9.8	6.1	9.8	9.9	11.7	10.8	12.5	14.4	17.9	11.0	8.8	8.9	8.6	14.2	13.4	14.1	14.7	17.1	20.5	11.6	15.1	17.9	19.4	19.2	18.0	10.7	19.7	23.1	14.9	18.9	13.9	18.2	23.9	20.2	59.5	12.2	7.9	11.0	16.1	8.9	18.9	11.4	16.5	24.0	21.9	15.8	11.4	23.6	21.8	23.7	4.5	14.6	14.5	20.6	21.2	8.7	21.7	12.9	20.0	17.6	38.9	18.7	16.4	23.9	11.8	14.1	11.0	17.6	18.4	22.1	20.6	13.7	20.7	9.4	12.3	19.8	9.3	34.2	10.9	11.6	11.1	26.6	0.1	14.7	5.2	23.1	16.7	20.3	20.0	20.5	21.2	26.0	17.5	22.3	22.1	1.1	24.6	11.9	15.5	28.0	17.6	8.1	10.9	6.1	10.8	8.4	9.6	5.8	6.7	6.5	6.1	10.8	8.6	10.4	9.6	13.7	110.4	15.7	14.8	18.5	17.7	10.2	8.8	8.9	12.1	18.4	12.8	8.5	9.2	2.1	19.5	10.5	6.9	27.4	14.6	77.4	10.2	7.6	10.9	10.7	13.9	217.0	12.9	20.9	10.5	13.3	7.2	22.2	14.3	11.4	12.0	15.8	0.0	122.6	9.4	14.2	12.5	11.6	78.8	6.2	17.4	5.4	106.8	9.4	14.2	8.2	186.5	122.4	7.8	8.6	7.2	16.1	6.6	7.4	30.7	19.3	11.1	0.0	10.1	10.8	19.2	9.4	13.3	13.2	10.7	16.2	24.2	11.9	13.2
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase subunit alpha"	Q9Y285	19	12922479-12934037	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		55000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	26.4	32.5	30.1	29.4	32.2	31.6	25.0	28.1	40.0	21.8	19.4	29.1	26.2	24.3	12.1	39.2	24.0	16.4	37.4	33.4	32.7	29.1	40.6	20.7	36.0	32.6	31.8	23.1	36.3	30.4	32.1	22.5	33.4	25.5	17.1	14.7	30.4	21.7	57.0	33.3	26.5	17.7	24.3	32.0	30.6	22.6	30.6	33.0	25.5	30.6	25.4	30.6	25.6	31.1	135.7	125.6	49.3	106.9	33.4	31.4	88.9	93.6	60.8	133.0	103.9	154.2	56.1	148.7	147.1	54.1	53.9	101.9	121.0	108.4	48.1	87.9	183.7	117.0	106.8	124.2	108.4	227.7	147.8	43.4	78.7	102.8	82.1	43.8	73.1	148.7	179.6	30.6	56.7	181.5	273.4	283.5	154.2	83.4	210.6	139.5	51.2	191.4	70.5	78.7	153.8	141.4	64.2	109.2	69.0	23.0	85.9	137.5	71.3	108.0	47.8	165.6	180.6	199.6	186.5	156.8	97.7	203.4	114.1	66.6	111.0	86.3	87.1	119.0	108.2	88.2	85.1	81.4	120.4	94.5	85.4	82.3	7.0	118.0	92.8	97.0	87.6	130.2	30.1	32.2	28.1	40.0	33.4	32.7	32.6	31.8	33.4	24.3	30.6	31.1	15.0	9.6	21.4	9.1	24.7	25.4	28.0	63.4	20.5	25.1	18.8	18.5	25.7	14.3	35.4	23.9	10.4	87.5	17.5	26.7	58.7	55.4	5.8	16.0	18.6	20.0	22.8	61.8	12.1	46.4	78.7	18.4	27.5	15.8	23.5	26.3	21.0	25.8	62.9	18.5	12.8	32.6	69.2	23.5	21.2	9.4	19.0	19.7	33.8	1.9	45.5	23.6	25.7	8.5	7.5	47.0	26.3	13.2	40.9	32.6	30.4	55.7	22.3	17.1	6.6	16.5	24.3	20.2	41.9	26.3	29.5	96.7	22.5	28.9	44.7	26.8
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase subunit beta"	Q9NSD9	2	222566899-222656092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	12.8	10.9	9.5	7.6	10.0	8.0	12.8	10.4	11.3	13.1	6.5	14.7	9.1	13.5	6.5	20.7	11.9	3.9	16.7	10.2	10.7	11.8	14.1	9.4	7.4	9.6	9.4	14.3	15.6	8.0	13.2	5.0	10.8	11.2	11.1	10.0	10.4	6.1	31.9	14.9	10.8	8.1	8.4	9.7	13.9	13.5	9.9	7.7	9.7	13.2	8.3	13.1	13.7	9.4	31.1	17.8	20.7	27.2	18.0	26.3	31.0	31.0	19.2	29.4	23.9	45.3	16.6	15.3	22.7	22.6	24.7	25.8	39.7	34.7	43.0	22.8	20.7	35.1	18.9	28.8	27.9	51.9	14.0	17.6	27.0	33.9	51.2	10.5	28.3	26.4	53.5	30.3	36.1	28.9	31.2	29.2	26.6	37.0	22.0	30.2	49.4	49.8	24.5	19.9	33.4	11.2	12.9	22.4	27.6	24.7	20.9	21.3	15.8	25.5	21.1	37.8	38.5	14.8	15.5	54.5	20.8	34.0	27.2	0.5	7.6	1.2	9.6	9.4	14.3	15.1	12.8	11.9	14.4	12.7	16.4	14.2	0.9	17.4	11.3	7.2	12.5	13.7	9.5	10.0	10.4	11.3	10.2	10.7	9.6	9.4	10.8	8.4	9.9	9.4	10.2	6.4	6.4	21.2	25.2	12.4	19.5	32.7	19.4	17.9	16.3	18.0	28.6	5.7	18.5	22.0	4.2	37.0	7.5	18.1	35.2	24.7	57.5	17.3	15.8	13.3	20.9	24.2	50.2	30.4	43.3	18.0	32.6	18.6	5.1	21.8	7.5	17.8	27.4	3.3	56.7	19.9	20.3	10.1	9.7	73.1	15.2	11.8	7.2	26.2	11.3	13.2	15.5	38.7	38.2	22.8	11.3	19.9	27.3	18.1	9.9	31.0	16.8	19.5	6.6	17.6	34.4	67.4	33.7	28.8	14.2	22.2	16.9	24.3	45.8	14.3
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990531-89017059	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 114.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.7;T-cells: 96.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.4;Karpas-707: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	420000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	14.1	26.3	3.6	17.0	3.6	20.8	10.9	2.9	4.7	12.7	2.8	16.4	7.0	12.8	10.3	10.8	14.8	15.7	7.5	3.6	3.7	7.2	23.3	21.7	18.9	4.6	3.1	20.1	3.7	2.7	3.7	10.4	4.0	8.9	23.3	3.3	6.5	9.3	2.3	9.4	9.2	15.0	3.5	11.2	4.4	2.6	3.9	14.4	7.3	2.6	15.6	12.9	10.2	4.3	22.7	8.2	5.4	13.9	37.0	51.3	0.0	51.8	50.2	1.7	9.1	0.1	23.4	4.7	19.0	52.1	9.6	4.0	1.0	44.8	3.2	83.4	8.7	0.4	5.2	14.7	31.6	3.4	1.6	69.2	38.7	31.4	66.0	24.5	4.7	17.8	0.0	109.0	44.0	1.4	6.4	3.4	0.6	0.2	1.8	1.4	0.5	5.0	60.7	7.3	0.4	0.2	7.7	0.0	0.8	7.0	13.9	1.0	9.5	15.8	9.0	15.2	12.3	45.3	5.3	0.4	11.8	10.2	4.5	43.1	9.4	30.9	9.9	12.3	13.8	7.5	27.6	19.6	11.5	4.0	3.1	10.0	114.7	3.1	22.1	0.2	96.2	12.8	3.6	3.6	2.9	4.7	3.6	3.7	4.6	3.1	4.0	3.5	3.9	4.3	10.3	57.7	13.8	40.1	12.8	45.9	109.7	53.1	39.9	0.0	5.5	9.5	3.5	12.8	27.5	9.2	0.0	0.4	16.3	24.9	0.0	6.3	11.3	9.2	22.3	8.9	8.4	9.5	8.8	4.3	0.2	35.4	8.6	15.5	3.8	4.9	2.2	19.3	5.5	1.7	2.8	14.4	8.2	7.0	31.7	4.9	19.0	17.7	12.4	17.8	20.9	14.5	10.3	8.0	0.7	6.5	8.7	13.9	32.2	46.0	15.6	14.4	26.3	0.7	6.6	26.8	29.1	11.3	1.1	28.5	43.9	0.4	48.4	11.8	24.4	30.0
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	14	"dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.3	0.8	0.1	1.0	0.2	2.8	0.6	0.1	0.2	0.4	0.1	0.8	1.9	0.5	0.7	0.3	0.3	1.1	0.3	0.2	0.1	0.3	1.1	2.0	5.7	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.9	0.0	0.9	0.3	0.1	0.4	1.4	0.3	0.0	4.1	1.5	0.2	0.1	0.6	0.2	0.0	1.8	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	58.1	0.2	35.5	0.0	11.5	31.4	0.1	0.0	2.2	25.0	1.9	41.5	0.1	0.0	0.2	14.9	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.4	0.4	0.0	2.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	43.4	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.6	1.8	0.0	0.9	0.0	79.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	28.8	0.0	0.0	0.1
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	23.4	36.5	35.5	13.4	33.8	8.2	21.7	32.3	50.6	23.5	30.1	31.5	26.2	23.3	11.9	39.5	21.1	14.5	66.9	34.8	32.9	34.9	58.0	18.8	14.4	34.2	33.9	24.6	28.1	31.0	41.2	9.4	34.5	34.1	11.8	7.9	27.8	18.8	122.6	28.2	25.0	11.8	33.1	24.8	29.0	21.8	35.7	14.7	26.9	95.3	10.5	26.7	25.1	34.3	39.3	45.0	13.9	34.9	50.4	22.4	22.8	29.9	40.1	25.3	29.7	31.5	34.9	9.2	41.0	40.9	46.9	24.1	13.5	36.4	6.1	26.9	23.8	11.4	12.7	27.8	62.7	9.0	25.2	29.8	51.8	29.4	21.5	20.9	30.0	22.4	17.0	20.2	29.2	80.4	20.4	23.5	24.6	47.8	50.8	13.2	17.4	30.4	34.2	27.8	16.4	18.2	40.3	62.5	43.0	11.5	34.4	31.2	24.0	32.7	7.5	31.7	28.0	50.5	33.0	6.5	66.2	19.0	39.8	18.0	31.5	30.1	22.3	32.5	23.4	19.5	23.4	23.4	28.4	21.6	25.5	21.9	6.8	20.4	32.5	38.2	28.3	21.9	35.5	33.8	32.3	50.6	34.8	32.9	34.2	33.9	34.5	33.1	35.7	34.3	21.2	0.0	7.0	17.9	34.3	24.6	37.8	68.8	23.3	42.9	31.7	26.9	18.9	30.0	43.6	25.8	25.0	49.2	38.2	59.2	86.1	49.4	10.0	22.5	21.3	22.9	44.9	28.2	12.7	47.6	26.8	33.8	54.6	24.8	38.8	38.6	23.6	37.1	43.3	37.0	13.6	54.9	59.0	26.3	22.5	20.2	36.4	25.8	94.3	7.5	35.3	54.7	44.3	9.5	10.7	38.6	40.0	34.3	46.1	27.7	86.6	66.3	24.9	51.1	13.1	33.7	35.0	58.5	70.7	36.0	25.3	60.5	34.8	50.1	61.2	35.0
FASTKD1	FLJ21901	ENSG00000138399	"FAST kinase domains 1"	Q53R41	2	169528508-169573875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 91.8;Inhibitory neurons: 89.9;Oligodendrocyte precursor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043719	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043719: AB_2678635"	"unprognostic (3.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-3)"	"unprognostic (8.03e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.58e-2)"	"unprognostic (7.62e-3)"	6.0	7.8	8.2	10.0	9.2	7.1	7.7	15.2	12.6	4.4	20.5	17.5	17.8	6.4	10.5	11.9	5.3	5.3	27.2	8.6	8.4	10.8	10.1	6.5	10.2	10.0	7.6	2.5	8.7	15.4	8.2	8.3	10.4	5.6	22.1	17.8	9.8	6.3	15.4	7.3	16.8	9.0	7.5	8.9	9.7	10.5	7.0	10.0	10.8	26.4	12.4	9.1	6.5	11.3	10.9	12.2	15.6	18.1	10.4	14.6	27.0	18.2	10.5	14.4	17.5	19.4	17.5	33.6	16.8	11.4	25.0	29.4	43.9	19.8	23.2	30.7	23.6	48.6	18.8	22.7	7.9	45.7	14.7	10.0	17.3	21.9	12.5	12.0	20.9	28.7	36.0	18.6	18.9	7.8	35.9	37.5	30.9	30.6	14.9	28.2	17.1	40.8	21.2	18.4	34.3	11.2	16.4	30.9	26.8	26.9	5.7	42.7	14.1	16.8	16.8	16.7	18.7	16.5	34.3	24.8	14.3	39.5	11.6	20.6	4.7	2.2	3.3	5.5	4.7	4.9	4.4	3.7	6.3	4.3	4.7	4.0	0.5	7.1	2.6	6.2	3.1	2.5	8.2	9.2	15.2	12.6	8.6	8.4	10.0	7.6	10.4	7.5	7.0	11.3	5.2	16.0	8.7	46.0	12.7	5.4	6.4	9.8	13.1	16.5	5.7	4.3	30.4	10.0	9.2	3.7	25.0	10.1	10.6	18.3	1.9	6.1	13.4	6.9	8.8	6.6	15.0	21.7	91.8	4.8	10.2	4.7	13.3	7.2	18.3	10.2	5.7	8.0	13.1	11.8	89.9	12.1	10.2	10.0	4.2	5.1	0.9	11.3	1.8	36.5	10.6	3.7	5.2	64.8	46.3	5.8	13.1	2.6	52.9	5.6	16.7	7.4	5.4	19.4	0.0	7.3	3.9	27.2	6.5	19.4	4.4	8.1	9.6	9.0	17.2	7.7
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	3.5	5.4	2.5	3.8	2.6	4.4	6.2	2.4	3.4	4.0	3.2	5.6	5.3	3.3	4.0	3.1	3.1	3.2	3.2	2.4	2.5	9.1	6.7	3.6	5.5	2.4	2.4	4.5	3.0	5.8	2.8	3.3	2.6	4.2	6.6	3.5	3.3	3.4	5.7	4.7	5.9	3.9	2.5	4.6	4.8	2.7	2.2	5.2	4.1	4.3	6.5	3.4	2.6	3.0	10.5	9.0	8.5	11.1	5.2	6.6	16.8	8.5	7.2	13.0	9.9	13.6	10.8	36.0	16.6	9.3	16.5	10.8	21.5	12.0	18.7	9.9	11.1	12.6	28.7	10.7	7.2	21.0	9.8	7.7	5.0	12.3	7.3	5.8	7.2	14.1	17.5	6.1	10.0	7.6	14.2	12.2	7.8	10.9	12.7	16.0	10.4	8.3	10.8	11.1	5.9	5.6	25.9	11.1	12.6	7.7	10.0	9.5	4.8	12.8	13.2	13.6	14.3	7.0	7.2	22.9	8.7	18.9	10.8	2.9	4.2	5.9	4.6	5.7	6.1	7.7	6.6	4.8	5.2	5.7	7.2	6.8	0.2	4.2	4.7	3.0	8.1	3.6	2.5	2.6	2.4	3.4	2.4	2.5	2.4	2.4	2.6	2.5	2.2	3.0	5.3	16.0	5.9	3.9	5.7	2.5	2.3	11.6	1.8	3.3	5.4	4.7	5.0	5.7	5.1	0.0	0.0	7.8	8.8	6.5	5.9	9.1	0.4	3.1	5.4	5.3	7.2	4.6	5.6	11.8	7.1	4.8	4.1	3.3	3.8	4.2	6.4	9.7	8.4	5.0	4.9	6.5	12.2	7.0	5.1	1.1	5.3	5.2	1.8	0.0	12.1	3.5	10.3	2.0	5.9	11.6	4.4	4.5	4.9	3.0	12.4	21.3	6.5	5.3	0.0	3.5	4.0	4.0	6.0	6.6	5.5	4.2	6.8	8.0	7.7	2.1
FASTKD5	FLJ13149	ENSG00000215251	"FAST kinase domains 5"	Q7L8L6	20	3146519-3159865	"Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043833	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043833: AB_10962718"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.49e-2)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.95e-2)"	"prognostic favorable (8.19e-8)"	"unprognostic (6.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.04e-2)"	8.0	14.0	5.8	9.0	6.6	37.0	7.9	9.2	8.2	7.2	8.9	9.0	9.6	7.1	5.3	9.6	6.5	7.5	17.3	6.1	6.4	16.3	12.6	8.2	11.6	7.0	6.5	7.0	5.5	12.6	5.4	8.3	7.0	7.0	9.0	10.4	8.8	6.5	34.8	8.0	8.9	8.8	6.0	9.2	7.9	10.2	6.5	12.6	7.3	26.9	12.6	10.2	5.7	6.9	25.7	28.7	18.4	22.9	17.8	12.0	18.1	14.7	15.3	20.0	16.9	41.3	14.5	36.0	11.1	19.0	26.6	31.9	45.3	35.6	25.0	10.0	23.2	31.4	12.7	50.5	15.4	36.1	28.9	17.0	29.7	19.2	7.6	12.0	19.2	23.5	35.2	17.6	23.6	12.1	21.2	26.2	26.7	33.2	24.6	21.4	24.5	32.6	28.0	29.1	17.5	20.4	17.4	55.1	36.6	21.5	20.1	27.7	20.4	12.8	17.5	12.0	21.3	19.4	36.0	27.0	8.5	22.6	20.3	30.2	12.4	20.5	10.1	14.7	18.1	10.9	13.3	13.5	12.1	8.5	16.5	18.2	10.2	8.4	17.7	6.1	17.8	13.1	5.8	6.6	9.2	8.2	6.1	6.4	7.0	6.5	7.0	6.0	6.5	6.9	5.8	16.0	8.9	0.0	9.0	9.4	10.7	10.0	5.7	5.7	6.1	4.6	17.7	14.3	9.7	7.3	14.6	13.4	9.2	8.4	7.9	11.2	13.8	9.5	5.3	6.1	5.4	3.6	0.0	6.5	8.9	6.1	4.1	10.0	5.7	6.8	5.7	10.7	7.0	15.2	0.0	5.8	8.2	6.3	8.4	4.0	4.7	8.1	3.6	0.0	11.4	8.9	5.2	0.0	0.0	8.7	4.4	6.0	4.9	4.7	11.5	12.9	12.4	16.6	0.0	8.3	6.9	25.3	11.6	7.7	9.2	19.7	10.0	9.0	6.7	10.9
FAT1	"CDHF7, CDHR8, FAT"	ENSG00000083857	"FAT atypical cadherin 1"	Q14517	4	186587794-186726722	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 119.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 285.7;LHCN-M2: 206.7"	"Low region specificity"	"Detected in all"							"HPA001869, HPA023882"	Enhanced				"Intracellular and membrane"	NA	NA		4600000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA001869: AB_1078818, HPA023882: AB_1848429"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.80e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.25e-3)"	"unprognostic (4.27e-2)"	20.1	1.3	14.5	7.2	20.2	0.8	21.9	31.1	12.4	20.0	119.2	35.0	25.9	23.4	16.0	13.3	9.8	23.5	24.8	14.3	27.0	22.1	10.0	12.9	2.4	40.1	42.3	10.4	12.6	11.4	9.7	17.0	24.4	21.4	31.4	3.4	18.7	24.2	3.5	17.5	24.2	25.7	22.1	2.2	16.8	9.7	22.2	6.0	14.6	3.9	4.4	32.0	11.0	22.0	22.2	83.5	80.9	0.3	79.1	94.5	19.9	110.9	181.9	52.8	33.5	50.0	49.0	0.0	26.0	285.7	34.1	40.4	32.0	136.7	71.6	0.2	13.2	0.0	30.5	50.8	39.4	37.3	29.2	34.5	48.4	98.7	63.5	72.4	1.1	44.8	0.6	0.0	206.7	27.1	66.2	0.1	18.1	42.2	13.9	0.3	22.3	1.8	79.2	79.0	8.6	32.3	19.2	32.2	12.7	54.9	0.3	13.3	23.8	149.8	57.9	2.0	69.8	0.4	0.2	0.5	34.1	0.1	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	20.2	31.1	12.4	14.3	27.0	40.1	42.3	24.4	22.1	22.2	22.0	6.1	16.0	6.7	55.2	0.3	85.0	27.2	115.4	27.3	5.2	26.5	27.6	27.6	38.6	40.7	53.3	0.0	1.6	0.2	71.2	5.9	25.2	0.7	25.7	17.2	5.0	14.5	0.0	5.8	26.5	3.6	28.8	54.0	29.6	16.5	75.0	1.1	26.1	0.4	0.0	30.3	56.4	18.3	0.8	7.3	0.9	14.6	1.7	12.4	5.6	0.0	4.5	0.0	14.1	12.4	30.3	30.0	37.2	0.2	55.8	78.2	26.7	37.0	0.4	39.5	23.1	65.1	1.5	10.4	10.2	46.9	1.6	1.9	11.7	45.1	38.9
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 113.4;esophagus: 50.9;skin 1: 56.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in many"	7	"cerebellum: 113.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5"	"Region enriched"	"Detected in some"	18	"cerebellum: 32.0"	"Region enriched"	"Detected in many"	56	"cerebellum: 224.4"	CAB033680	Enhanced					NA	NA		300000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.2	0.4	0.0	3.8	0.1	3.6	113.4	4.8	11.5	0.0	0.1	0.1	0.1	1.7	50.9	1.0	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	15.1	2.8	0.1	0.2	0.2	0.5	0.9	17.2	5.3	0.0	0.1	8.9	4.8	0.2	56.0	0.2	0.0	0.4	0.1	0.1	13.2	0.5	2.2	0.1	0.0	3.4	2.9	24.4	2.2	1.7	0.0	0.0	0.1	0.0	0.0	35.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	21.0	0.0	0.2	51.7	0.0	23.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	70.5	0.0	3.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.1	0.0	0.1	1.1	0.2	0.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.8	113.4	4.8	0.5	0.4	15.1	2.8	17.2	0.4	0.5	2.2	0.1	0.0	0.0	0.7	0.0	18.0	5.8	31.6	27.9	0.0	3.4	12.8	1.9	0.0	11.1	1.8	0.0	0.4	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.3	0.0	0.0	5.0	0.0	20.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.0	1.5	7.8	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.1	3.0	0.0	0.0	0.0	0.4	0.5	0.1	53.2	19.6	1.0	0.1	0.0	0.0	13.0
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92224818-92896473	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 19.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026878, HPA074824"	Uncertain		Approved	"Cell Junctions"		NA	NA		4700		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA026878: AB_1848430, HPA074824: "	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.0	5.5	0.0	19.3	0.0	0.1	1.3	9.0	0.6	0.0	0.2	0.0	0.6	0.6	0.1	0.6	0.0	0.2	4.0	15.5	0.2	0.0	1.2	0.0	0.5	4.7	0.5	0.0	0.0	2.9	0.1	1.9	2.0	0.1	1.3	0.0	3.8	0.1	0.2	0.0	0.1	0.8	0.1	2.2	0.7	7.5	0.1	0.0	0.2	0.2	2.3	1.0	1.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	1.4	2.2	0.0	1.2	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	2.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	19.3	1.3	9.0	4.0	15.5	0.5	4.7	1.9	0.8	7.5	1.0	0.0	0.0	0.0	265.8	0.0	0.1	0.3	0.9	0.0	20.8	0.1	0.5	1.8	0.0	0.1	14.7	0.0	0.1	0.0	0.1	0.0	0.7	4.8	0.1	0.2	0.2	0.0	0.0	512.9	0.0	0.1	1.9	0.0	0.0	0.0	3.7	1.4	0.0	0.1	0.0	149.2	0.0	24.4	0.0	0.0	3.8	1.2	0.3	0.0	13.1	0.0	0.8	0.0	88.4	7.0	0.2	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.7	0.0	2.5	4.4	1.0	6.5	0.1	0.0	0.0	0.0	44.8	0.0	0.1
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125314918-125492932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Endothelial cells: 18.0;Fibroblasts: 17.9;Hepatic stellate cells: 33.2;Inhibitory neurons: 35.0;Microglial cells: 23.4;Oligodendrocytes: 54.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;ASC TERT1: 11.2;fHDF/TERT166: 11.4;HSkMC: 13.6;HUVEC TERT2: 14.3;TIME: 21.9"	"Low region specificity"	"Detected in many"							HPA052819	Approved		Approved	Cytosol		NA	NA		2300000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA052819: AB_2681963"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.3	1.0	3.2	1.4	4.1	0.0	2.7	1.2	2.7	4.0	0.7	6.4	0.9	3.0	1.3	2.3	1.9	4.3	4.0	3.8	2.0	2.8	2.5	4.5	0.8	3.1	2.8	4.9	0.9	3.0	0.6	2.9	2.8	3.7	2.3	0.5	1.0	2.6	1.6	1.4	2.2	3.5	3.5	2.7	2.0	0.7	3.3	1.1	4.0	4.8	0.8	2.5	1.8	4.8	0.0	0.9	7.4	0.8	15.5	11.2	0.0	2.6	3.0	1.2	1.2	0.0	0.4	0.0	3.1	11.4	1.5	0.0	2.8	3.2	0.7	0.0	1.3	1.7	3.3	0.1	5.4	1.1	0.0	13.6	1.9	0.7	7.0	9.1	14.3	0.0	0.0	1.9	6.7	0.1	0.5	0.0	0.5	0.0	0.3	0.9	1.5	0.0	0.1	0.0	0.2	1.5	0.4	0.0	0.0	0.4	0.0	0.0	21.9	7.8	2.2	2.7	1.1	0.3	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	4.1	1.2	2.7	3.8	2.0	3.1	2.8	2.8	3.5	3.3	4.8	19.3	6.4	0.0	8.8	0.0	1.7	0.2	1.5	0.0	3.7	0.3	1.3	6.9	0.0	0.3	5.5	0.0	0.1	0.9	0.0	0.0	0.7	0.9	0.6	8.8	18.0	0.0	0.0	9.4	0.2	0.0	17.9	1.1	1.0	0.0	1.2	33.2	7.4	0.2	0.0	35.0	0.0	0.0	2.2	2.2	0.2	5.9	0.3	3.6	23.4	0.0	1.1	1.0	6.0	54.4	0.3	0.0	4.9	1.4	0.4	0.0	0.7	0.1	0.2	0.0	5.3	4.1	0.1	0.6	0.5	0.6	0.0	0.3	5.7	0.0	0.1
FATE1	"CT43, FATE"	ENSG00000147378	"Fetal and adult testis expressed 1"	Q969F0	X	151716035-151723194	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 239.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 23.6;Late spermatids: 73.0;Sertoli cells: 13.1;Spermatocytes: 10.3;Theca cells: 9.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA034604	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA034604: AB_10602318"	"unprognostic (1.82e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.10e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (4.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.34e-2)"	0.4	0.3	0.5	0.1	0.5	0.0	0.2	0.3	1.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.9	0.4	0.4	0.5	0.1	0.2	0.1	0.3	0.3	0.0	0.1	0.1	0.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.3	0.0	0.3	0.1	0.2	239.0	0.3	2.3	0.6	0.3	0.1	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.0	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	3.8	1.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	73.0	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.3	0.0	10.3	5.9	0.0	0.0	0.0	0.0	9.6	0.0	0.1
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120630-65122177	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	817.0	787.0	976.0	655.4	1009.0	1898.7	878.5	956.5	1212.5	1024.2	887.1	905.9	604.0	780.6	535.3	720.0	907.5	590.1	862.2	928.0	953.5	632.1	756.3	614.0	1342.5	982.1	958.7	1403.7	1167.7	395.0	521.6	482.7	989.8	649.3	438.8	228.2	854.7	532.3	1191.2	905.1	712.9	441.6	1010.2	784.5	796.3	336.6	1011.9	843.5	619.9	642.1	818.5	796.7	794.0	1017.9	1305.1	1040.6	658.8	1067.9	766.4	1142.2	1033.3	727.3	887.7	1327.5	832.4	1258.7	1232.1	1782.0	1782.3	744.2	701.5	1101.2	821.5	1287.2	419.3	1075.4	1494.0	1428.1	907.1	1607.8	1612.2	1546.9	1184.9	1583.3	1944.0	1106.3	1286.5	842.2	998.5	1416.3	1334.4	1578.6	644.9	2003.0	1579.6	2925.2	1850.4	1007.2	2027.5	1464.8	622.2	2980.1	1036.0	744.3	1054.4	949.2	663.8	1490.6	2131.0	399.1	1393.3	1829.5	771.2	868.6	954.8	1327.5	1150.0	1629.0	1943.6	2802.6	1042.6	1285.4	979.3	2638.2	2997.4	1808.3	2906.6	2694.0	3986.3	7025.5	4689.8	3729.6	3181.0	6502.9	5484.9	4364.5	1905.5	2994.7	2398.9	4141.8	3794.9	10270.4	976.0	1009.0	956.5	1212.5	928.0	953.5	982.1	958.7	989.8	1010.2	1011.9	1017.9	2252.8	641.0	1035.7	17.6	3768.6	3773.3	3059.7	1883.6	2632.2	351.8	3483.5	5942.5	507.2	1712.8	1280.4	958.2	196.0	2277.7	2670.7	1454.5	2050.4	1540.6	875.1	954.7	1569.4	1671.7	1226.4	1786.0	15.9	2689.2	2487.3	1531.1	923.5	1298.4	1370.0	1483.3	1755.9	2176.7	2188.0	190.1	18.2	2143.3	907.3	2643.8	3977.8	2397.4	2285.9	2349.4	2123.8	16.9	3121.9	935.5	2472.7	15.6	40.8	2042.7	2666.5	1229.2	2317.3	3295.5	2501.4	2615.9	826.4	513.6	1117.5	2227.4	2678.6	654.4	590.6	2506.0	4195.9	2793.0	2897.4	1470.6	2184.8	3518.0
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog, metaxin like GST domain containing"	Q5TGI0	6	99271168-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	2.2	11.0	1.5	12.7	0.0	3.2	9.3	19.0	2.5	2.0	22.7	1.5	6.5	11.0	6.2	3.7	2.4	0.8	14.1	7.6	2.7	0.0	1.7	0.1	7.2	5.6	2.2	2.5	6.5	15.9	0.8	6.3	8.2	2.9	10.4	7.4	10.6	0.5	0.9	3.3	7.8	4.4	0.4	7.1	2.1	8.5	2.2	1.7	0.6	0.1	14.3	2.9	11.4	4.0	3.2	10.3	14.3	0.0	0.0	3.8	5.0	3.2	8.1	7.0	1.9	1.3	0.0	0.6	1.0	26.0	0.1	23.8	4.7	7.0	0.0	11.8	0.1	1.9	0.7	0.6	0.0	0.0	0.5	7.5	0.2	3.8	5.9	0.0	2.0	0.5	0.0	2.7	7.0	0.0	0.0	12.2	0.0	4.8	0.0	1.0	0.0	4.3	0.3	34.2	23.7	4.5	3.2	22.6	4.2	10.0	0.0	1.0	2.5	4.7	0.0	15.5	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	12.7	9.3	19.0	14.1	7.6	7.2	5.6	6.3	4.4	8.5	11.4	0.2	25.6	15.2	5.5	0.5	0.4	4.2	4.2	5.7	14.4	5.3	9.0	1.1	0.0	8.1	1.8	10.4	1.2	0.4	0.2	9.8	2.3	2.6	0.6	1.0	1.7	0.0	0.0	57.1	0.7	0.2	1.4	0.0	0.4	3.8	0.4	1.4	0.1	0.2	3.3	60.1	0.2	4.1	0.6	1.1	5.0	0.0	1.2	1.8	2.8	0.1	3.6	2.1	43.7	4.4	1.0	0.1	1.9	0.1	4.8	0.0	1.0	2.1	13.6	0.0	0.2	1.3	1.3	8.9	1.2	0.3	0.3	1.2	0.2	0.4	1.2
FBH1	"Fbx18, FBXO18, FLJ14590"	ENSG00000134452	"F-box DNA helicase 1"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	28.7	38.8	17.5	22.8	20.3	24.6	26.8	17.7	19.1	32.4	25.7	30.4	24.6	34.3	21.3	24.0	36.4	23.0	44.5	17.2	18.0	25.2	28.8	27.6	27.6	17.7	18.2	30.7	21.9	28.5	26.1	26.6	18.0	28.6	24.2	14.8	24.3	25.8	30.3	30.4	29.7	30.1	17.8	35.3	27.6	24.7	19.2	40.2	25.2	27.4	27.2	28.8	27.1	19.0	31.8	34.0	31.3	34.4	70.4	46.3	28.1	35.9	24.6	34.8	38.8	40.4	28.3	29.6	23.0	52.5	16.7	46.3	42.6	38.2	31.3	32.2	31.5	28.6	27.3	34.8	48.2	14.2	26.4	58.2	36.4	44.2	19.4	44.0	59.7	39.7	50.9	30.4	37.3	48.1	34.5	20.9	14.3	54.7	18.9	37.6	14.8	49.9	34.0	25.5	17.7	26.6	36.8	33.1	50.8	35.7	33.7	28.5	37.9	22.1	24.7	59.1	28.1	30.9	26.1	16.3	29.8	20.7	15.8	0.0	2.1	3.3	1.9	1.7	1.3	3.0	2.0	2.5	2.0	4.1	2.5	1.8	1.3	4.6	1.3	4.0	6.2	1.7	17.5	20.3	17.7	19.1	17.2	18.0	17.7	18.2	18.0	17.8	19.2	19.0	22.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	15.6	16.1	0.0	0.0	0.0	7.3	0.0	20.3	9.3	0.0	21.5	16.8	0.0	11.4	19.0	7.1	0.0	0.0	0.0	15.1	19.4	9.8	0.0	14.9	0.0	23.6	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	32.0	4.4	27.9	0.0	0.0
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846379	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 747.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546, HPA077724"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA		79000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: AB_2680811, HPA077724: "	"prognostic favorable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	130.3	86.7	30.0	66.3	31.0	124.9	147.8	28.4	34.0	186.5	28.8	112.1	52.2	136.9	61.2	191.5	145.3	32.8	72.8	27.5	28.4	93.3	73.4	88.2	99.2	30.6	29.4	255.1	155.9	50.1	66.0	42.9	30.2	109.9	85.6	23.3	110.5	48.2	127.6	221.8	113.4	67.3	30.0	130.8	104.8	77.2	31.1	103.0	89.5	57.2	157.3	125.6	156.2	31.5	248.5	510.6	208.0	237.2	82.6	140.5	125.0	137.5	122.8	237.6	225.9	301.8	142.8	555.9	125.9	119.7	72.0	98.3	308.2	295.4	290.8	101.2	405.3	225.2	181.9	276.8	106.5	528.3	169.1	114.2	105.9	190.3	395.0	107.4	184.2	239.5	361.8	228.0	133.2	340.3	468.9	232.7	206.4	353.8	156.1	256.3	209.7	282.5	131.4	282.1	280.2	163.2	133.5	210.9	87.7	116.2	107.1	190.6	99.8	112.3	177.2	156.8	324.8	155.5	176.1	374.1	113.4	341.6	105.2	2.7	41.8	6.4	70.6	36.3	101.7	83.5	73.9	70.3	74.8	84.5	100.6	97.3	3.2	92.5	40.5	78.1	58.3	71.6	30.0	31.0	28.4	34.0	27.5	28.4	30.6	29.4	30.2	30.0	31.1	31.5	45.9	32.1	48.1	2.3	166.6	350.3	323.8	150.2	200.9	18.8	168.3	177.3	37.5	105.8	77.4	40.5	25.0	130.7	118.9	88.5	74.3	108.8	361.1	43.4	97.9	105.4	92.8	129.3	2.7	190.9	283.2	84.2	65.7	53.7	95.9	139.0	105.7	54.1	104.8	15.2	2.6	170.0	46.8	104.3	169.8	747.7	118.1	66.5	97.8	2.8	135.8	33.3	151.4	1.0	4.1	94.5	95.6	78.6	102.8	266.6	59.1	78.7	43.7	24.9	72.3	193.9	122.8	41.7	83.4	201.8	330.7	121.6	123.3	157.3	265.3	240.1
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 207.3;Paneth cells: 153.6;Peritubular cells: 191.5;Proximal enterocytes: 145.9;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 255.9;TIME: 420.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	32.4	17.9	2.7	21.5	3.3	0.8	28.1	3.2	4.8	43.2	5.2	75.6	82.2	75.7	15.6	24.1	43.5	69.8	45.6	2.5	2.4	26.7	7.1	39.3	9.6	2.6	3.2	39.1	27.5	36.2	11.0	29.4	2.9	47.0	53.2	1.8	31.7	63.1	5.4	16.8	86.1	47.1	2.5	27.6	64.0	12.8	3.8	2.8	17.6	5.6	6.8	44.6	29.3	2.6	34.2	17.2	15.9	0.6	3.7	8.1	21.6	55.2	84.3	38.4	30.4	6.0	48.8	0.3	114.5	87.8	67.3	62.5	11.3	121.0	19.2	0.3	6.6	0.2	4.7	31.7	98.5	0.2	0.6	39.7	81.7	31.9	75.1	82.7	255.9	2.0	1.2	7.6	13.2	0.8	0.6	1.1	16.5	50.9	25.0	0.1	0.4	1.0	51.4	22.1	0.2	38.9	29.0	3.4	6.0	33.9	6.8	0.6	420.4	50.7	7.1	0.8	25.7	0.4	1.0	0.5	8.0	0.2	0.5	1.7	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.2	0.4	0.1	0.1	2.7	3.3	3.2	4.8	2.5	2.4	2.6	3.2	2.9	2.5	3.8	2.6	10.8	12.8	18.1	0.0	3.1	86.3	82.7	41.4	20.5	3.7	28.6	23.9	37.1	47.1	30.6	16.5	6.2	8.9	4.8	207.3	0.0	99.1	3.4	13.6	75.9	19.2	46.0	0.0	0.7	53.5	114.2	29.3	133.5	20.5	18.9	9.4	55.0	2.5	5.6	1.7	5.5	54.8	26.4	1.9	23.5	4.0	80.2	5.8	14.2	2.8	2.7	9.1	1.0	1.0	1.2	113.0	153.6	191.5	1.2	29.8	145.9	2.5	11.6	6.4	144.7	11.9	64.8	2.8	1.9	17.4	62.8	19.4	6.0	6.6	53.8	62.6
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529305-168530634	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.4;pituitary gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 24.2;SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.2	3.0	22.0	0.1	21.0	0.0	0.6	12.8	35.4	0.5	4.6	0.9	0.4	0.2	0.0	0.2	0.4	0.2	0.3	20.4	32.2	0.6	0.7	0.1	0.0	22.7	21.0	0.7	0.9	0.4	15.5	0.2	26.1	1.0	0.1	1.4	0.9	0.3	0.1	0.5	0.5	0.2	11.4	0.2	0.5	5.9	23.1	0.0	0.2	0.0	0.0	0.3	0.3	20.1	0.0	0.5	1.8	0.3	0.1	0.0	0.9	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	20.2	2.1	0.0	1.2	0.0	0.0	1.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	21.0	12.8	35.4	20.4	32.2	22.7	21.0	26.1	11.4	23.1	20.1	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.6	8.5	1.4	1.8	1.2	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	1.7	0.9	1.4	0.2	6.7	0.0	4.3	0.2	0.1	0.8	0.0	2.4	0.0	1.6	0.0	0.0	0.1	6.7	6.6	0.4	0.0	0.0	0.0	2.3	0.0	0.1	3.6	1.0	0.0	0.7	0.0	3.0	1.1	0.2	0.0	0.0	0.0	0.3	1.0	0.4	0.0	2.8	6.6	0.2	0.4	3.1	0.4	0.2	0.1	0.0	0.1	1.2	0.3	0.0
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549125-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 6.7;naive CD8 T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2"	"Group enriched"	"Detected in many"	4	"olfactory bulb: 12.4;white matter: 3.1"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	157.3	7.6	5.9	12.7	7.7	1.0	97.3	5.2	9.0	63.4	6.4	32.7	6.2	31.1	3.2	42.4	26.8	46.2	292.8	7.0	4.9	8.7	3.7	29.2	8.4	5.3	5.3	5.8	8.6	3.0	2.3	80.3	4.8	29.1	11.8	0.6	39.4	8.8	47.7	72.5	19.8	14.7	4.1	6.0	22.3	46.7	6.9	14.2	63.7	48.9	5.6	79.6	56.7	4.4	0.0	1.4	50.9	0.0	384.0	51.7	23.8	124.9	98.2	122.4	80.4	8.1	0.3	0.0	5.9	264.3	0.2	0.2	0.0	0.5	22.9	0.1	0.1	100.7	1.9	0.0	26.0	0.2	311.6	221.9	2.0	19.3	0.0	0.2	0.0	8.6	0.8	0.9	0.6	0.3	5.2	0.6	12.2	0.0	0.7	0.2	0.0	0.5	0.9	0.1	3.0	2.4	0.5	90.3	0.1	13.6	0.2	0.3	0.1	0.1	0.1	139.2	0.1	0.2	0.0	0.0	1.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.2	6.7	1.3	0.0	3.7	0.0	0.2	0.0	0.5	0.0	0.9	5.9	7.7	5.2	9.0	7.0	4.9	5.3	5.3	4.8	4.1	6.9	4.4	92.7	0.0	1.5	1.6	3.6	30.8	0.8	10.5	2.2	0.0	1.7	1.9	8.8	0.0	12.3	7.3	2.1	7.8	1.9	0.1	0.0	0.0	3.8	2.9	84.4	43.8	0.0	1.7	0.6	0.2	4.8	458.4	6.1	2.7	23.6	0.6	47.8	0.4	3.6	0.0	0.6	0.0	0.0	1.9	49.8	12.1	170.9	4.5	39.2	26.2	0.3	1.2	0.0	30.7	0.3	0.3	0.0	227.2	1.6	1.2	2.7	0.1	1.4	0.4	13.1	29.7	26.4	3.4	13.5	2.0	28.8	6.2	5.3	0.2	0.0	1.1
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 81.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		11000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.1	5.1	0.4	0.8	0.5	3.1	0.2	0.0	0.3	2.2	3.0	0.8	0.3	1.7	0.1	0.1	0.4	0.3	5.5	0.2	0.6	0.1	0.1	0.2	0.5	1.1	1.9	0.5	0.2	0.0	0.8	81.9	0.5	0.8	1.2	0.9	0.3	0.4	0.2	0.2	0.4	1.3	0.5	0.4	0.8	7.4	0.8	0.2	0.5	0.4	0.9	0.5	0.7	0.3	0.0	16.4	58.2	0.0	9.4	16.6	11.8	62.8	0.0	56.0	41.8	0.2	0.0	0.0	0.1	85.5	0.0	9.2	37.6	9.8	52.7	0.1	13.8	0.0	27.3	0.2	134.1	8.4	0.0	94.3	5.3	24.1	215.2	17.9	122.3	0.0	0.0	0.0	35.8	0.1	0.0	3.4	24.5	0.0	18.2	19.2	18.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.6	48.0	0.0	18.7	0.0	22.1	41.9	66.8	0.3	0.0	0.0	0.0	6.9	0.0	23.8	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.2	0.6	1.1	1.9	0.5	0.5	0.8	0.3	0.1	0.0	0.5	1.6	0.2	0.0	0.1	1.2	0.6	0.0	0.3	0.3	12.7	0.0	1.4	0.0	0.0	298.1	0.0	0.0	0.0	0.3	3.8	10.0	3.9	1.0	0.0	0.0	1.1	0.0	24.3	8.8	0.0	4.7	0.0	0.1	0.0	0.0	34.0	0.0	50.5	0.0	0.0	10.7	0.4	7.2	1.2	2.7	1.8	1.9	6.2	3.8	0.0	17.6	1.5	0.1	0.0	2.2	0.0	2.0	0.0	0.2	1.6	0.1	6.6	0.1	3.5	10.7	3.5	0.1	0.4	163.5	0.1	8.4	0.1	0.1
FBN3	KIAA1776	ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149592	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.4;salivary gland: 4.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 2.4;Inhibitory neurons: 3.4;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 3.7;NTERA-2: 12.3;REH: 18.6;SuSa: 4.5"					"Not detected"	"Not detected"			HPA049482	Uncertain				"Secreted to extracellular matrix"	NA	NA		2400000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.1	0.3	0.6	2.4	0.1	1.4	0.0	0.5	0.6	0.1	0.0	0.0	0.7	0.0	0.6	0.9	0.1	0.0	4.0	0.0	0.3	0.2	0.1	0.1	0.5	0.0	0.1	0.5	0.6	0.5	1.9	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.3	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.3	0.6	0.5	0.6	0.6	0.5	0.6	0.6	0.0	6.4	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FBRS	"FBS, FBS1, FLJ11618"	ENSG00000156860	Fibrosin	Q9HAH7	16	30658431-30670810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044117	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA044117: AB_10794394"	"unprognostic (1.87e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.01e-3)"	"unprognostic (6.32e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	25.6	34.3	23.0	24.4	22.2	55.9	25.8	21.5	24.6	34.2	14.9	39.1	21.2	35.6	5.5	57.2	36.0	9.4	28.7	22.9	19.7	33.3	29.9	29.2	21.8	24.7	20.9	33.8	29.8	16.6	57.6	12.6	19.4	37.3	6.5	6.5	30.2	15.6	38.4	53.5	40.0	9.7	16.8	53.4	33.8	117.3	22.9	21.3	36.6	11.4	15.9	34.7	33.2	23.0	28.8	30.2	15.6	12.9	15.3	15.5	39.5	20.9	16.9	17.7	13.3	17.8	25.9	26.8	34.0	17.0	16.0	23.6	16.6	19.9	8.3	72.7	41.5	36.0	29.3	33.0	37.4	26.5	52.3	23.1	26.4	34.3	16.6	19.8	22.0	24.4	32.0	50.2	13.1	59.1	33.7	51.7	4.4	12.9	19.0	48.5	11.8	29.4	18.8	21.2	21.8	24.5	16.4	31.2	22.9	6.7	70.5	34.6	34.3	40.0	24.2	25.0	27.8	58.6	30.5	25.4	38.4	25.6	24.1	0.0	1.0	0.8	0.8	0.4	0.8	0.6	0.7	0.8	0.5	0.7	0.2	0.9	2.1	0.5	0.6	1.0	0.0	0.9	23.0	22.2	21.5	24.6	22.9	19.7	24.7	20.9	19.4	16.8	22.9	23.0	21.2	16.0	21.8	9.8	30.0	18.7	15.9	13.2	38.7	22.3	26.8	19.3	9.3	11.5	11.0	7.3	33.3	10.2	38.1	36.3	5.9	11.0	82.2	33.4	25.1	18.2	16.8	4.6	9.5	14.7	9.3	15.8	29.0	32.2	19.0	21.5	19.2	9.4	14.0	43.7	8.7	21.5	10.2	15.8	22.0	109.9	17.1	25.8	10.6	7.5	20.1	14.7	15.5	7.5	14.5	21.1	26.3	16.1	13.3	22.2	33.5	8.9	24.4	25.7	0.0	19.0	17.7	69.1	23.9	37.8	24.3	33.0	28.8	22.2	19.3	27.9
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: AB_2680930"	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (9.82e-4)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (7.21e-4)"	12.3	19.2	16.3	8.7	13.1	10.1	13.2	20.7	21.2	17.8	7.2	20.5	11.2	18.6	7.7	15.6	18.7	4.1	31.1	16.2	6.7	19.3	26.8	16.2	8.5	10.0	7.7	22.3	39.2	7.3	28.7	5.7	8.0	22.0	3.6	5.9	14.7	7.2	31.9	19.4	23.3	4.1	4.7	28.3	21.4	29.1	9.6	6.2	15.7	9.4	4.7	17.8	15.7	10.2	11.7	18.5	8.7	14.8	3.7	4.5	64.4	10.9	3.1	7.1	4.3	32.7	6.9	19.0	18.4	3.6	6.1	22.6	9.3	6.1	2.3	14.7	47.6	23.2	11.0	25.0	8.0	24.7	23.4	4.1	10.7	6.6	4.8	6.5	7.0	15.9	49.9	3.8	3.1	29.8	33.7	90.0	22.7	8.4	33.4	50.9	9.3	13.2	6.2	11.2	33.4	28.0	10.2	15.8	14.1	3.6	18.6	23.7	11.1	7.6	18.5	13.7	13.9	24.6	13.0	12.0	8.8	23.8	9.4	1.2	0.4	1.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.6	0.3	0.4	0.5	0.2	0.7	1.0	0.6	0.3	16.3	13.1	20.7	21.2	16.2	6.7	10.0	7.7	8.0	4.7	9.6	10.2	14.9	3.2	5.2	24.2	12.8	9.2	7.1	3.3	11.4	28.9	20.7	18.5	13.7	4.3	4.0	11.0	41.7	6.9	19.8	24.0	7.9	6.2	1.4	16.8	17.9	8.8	31.0	12.0	17.0	7.6	5.8	11.8	15.3	22.0	1.3	22.6	7.5	22.2	6.9	11.8	17.1	21.7	0.0	11.6	11.1	2.0	16.1	16.4	5.4	15.0	7.7	9.3	6.2	12.5	16.8	9.0	15.0	15.4	11.9	16.0	13.3	6.4	6.4	22.7	6.6	12.7	11.5	5.7	8.0	10.8	10.4	11.5	10.9	12.7	18.7	10.4
FBXL12	"Fbl12, FLJ20188"	ENSG00000127452	"F-box and leucine rich repeat protein 12"	Q9NXK8	19	9810267-9827816	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002843	Approved		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"HPA002843: AB_2666679"	"unprognostic (7.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (4.07e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.77e-3)"	20.0	15.0	8.9	10.4	9.6	27.1	19.1	12.0	10.4	21.5	9.5	22.5	14.9	23.5	10.8	17.2	22.6	9.0	17.0	8.7	9.0	19.4	22.4	17.3	12.8	10.5	8.8	23.9	14.6	7.1	17.5	15.1	10.2	19.5	10.5	6.4	13.5	10.7	19.0	16.6	21.0	11.1	8.0	18.2	17.3	13.2	9.9	44.0	17.6	9.4	8.9	23.6	18.2	10.9	18.8	9.3	21.1	20.6	23.5	20.8	24.1	19.9	20.1	21.2	24.9	28.9	12.1	17.5	31.2	20.1	16.4	17.7	16.0	17.6	16.8	17.7	30.9	33.9	21.1	28.8	30.2	24.8	20.1	29.9	11.5	20.4	18.0	15.6	15.1	44.6	26.2	35.6	11.2	14.9	36.3	76.3	24.3	11.4	17.2	21.5	15.7	31.7	15.3	25.2	13.1	17.9	14.7	10.8	23.4	19.5	15.0	29.1	18.1	29.1	14.1	39.3	20.0	47.7	20.1	27.6	12.3	22.2	14.1	33.5	18.4	36.3	19.0	15.9	21.6	16.7	18.4	21.7	20.6	24.1	21.4	17.0	14.3	31.1	15.3	21.8	22.0	15.2	8.9	9.6	12.0	10.4	8.7	9.0	10.5	8.8	10.2	8.0	9.9	10.9	18.5	6.4	9.2	12.7	15.5	7.4	15.8	16.5	18.8	7.3	14.3	15.9	26.8	15.7	10.8	12.9	4.2	42.1	15.4	26.8	5.9	11.7	2.2	9.6	16.4	15.6	12.6	7.8	15.3	9.9	30.3	24.1	15.3	9.9	3.8	14.2	16.4	7.3	17.2	8.4	14.2	17.0	12.2	9.0	10.0	2.8	26.4	11.0	10.6	8.4	17.7	8.4	13.4	12.5	13.0	9.3	23.4	21.8	8.4	13.5	36.8	10.0	9.3	11.9	13.1	13.7	23.0	24.8	20.8	15.3	11.1	63.3	13.3	18.1	19.7	19.3
FBXL13	"CFAP169, DRC6, Fbl13, MGC21636"	ENSG00000161040	"F-box and leucine rich repeat protein 13"	Q8NEE6	7	102813230-103074843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.3;Late spermatids: 431.8;Oligodendrocyte precursor cells: 107.5;Oligodendrocytes: 88.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"eosinophil: 10.8;neutrophil: 38.4"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 38.4"	"Cell line enhanced"	"Detected in some"		"HEL: 7.6;HUVEC TERT2: 13.9;U-266/84: 18.1;U-87 MG: 9.5;U-937: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA057232	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA057232: AB_2683375"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.73e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.47e-1)"	0.2	0.8	0.4	0.3	0.7	0.3	0.2	0.2	0.8	0.4	4.4	0.1	0.2	0.6	0.7	0.2	5.0	0.3	0.1	0.2	1.1	0.4	0.1	0.5	0.2	2.2	2.2	0.8	0.4	0.5	0.6	0.2	1.1	0.4	0.3	2.4	0.2	0.3	0.0	0.4	0.2	0.3	1.4	0.2	5.0	20.7	0.9	0.6	0.6	0.0	0.1	0.2	0.1	1.5	0.6	0.1	0.2	1.2	0.0	0.2	0.1	0.4	0.4	0.2	0.2	0.5	0.5	1.0	0.5	0.3	0.8	0.4	0.0	0.0	0.5	0.5	0.2	7.6	1.2	0.2	2.4	7.0	0.3	0.0	0.1	3.9	0.1	1.2	13.9	0.8	2.3	0.3	1.0	0.5	0.5	6.4	1.0	0.1	0.4	0.3	0.1	0.5	1.7	0.4	0.5	0.5	0.3	0.0	0.1	0.3	0.1	0.2	0.4	2.0	3.9	1.6	0.2	0.9	18.1	1.8	9.5	12.3	5.9	0.0	0.0	10.8	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.2	38.4	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.8	0.2	1.1	2.2	2.2	1.1	1.4	0.9	1.5	1.7	0.0	1.1	49.0	0.4	1.8	1.0	0.9	1.2	1.0	0.8	1.8	0.7	1.5	1.7	0.0	12.5	0.2	0.2	0.5	3.9	1.3	179.3	12.2	1.5	1.4	1.8	0.4	61.8	1.1	0.1	1.1	13.3	1.3	0.0	2.1	1.1	0.0	0.1	0.0	53.9	0.1	0.0	0.0	0.9	431.8	0.6	0.5	0.0	48.7	0.1	2.5	1.0	107.5	88.0	1.6	0.1	3.4	0.1	0.8	0.0	1.5	25.8	9.6	13.1	1.6	21.9	23.3	6.5	0.2	0.9	0.1	0.4	1.1	0.3	0.8
FBXL14	"Fbl14, MGC40195"	ENSG00000171823	"F-box and leucine rich repeat protein 14"	Q8N1E6	12	1565993-1594581	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.4;Late spermatids: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053889	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA053889: AB_2682293"	"unprognostic (8.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.90e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (9.04e-6)"	"unprognostic (5.60e-3)"	"unprognostic (1.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.12e-3)"	5.2	4.3	7.9	5.9	10.6	5.8	4.6	8.7	21.4	3.6	2.4	8.4	4.9	4.5	1.6	6.0	5.7	4.8	5.2	10.6	7.8	4.6	3.9	5.7	7.5	7.8	8.1	4.7	11.3	7.1	8.7	4.2	8.3	3.7	3.5	4.2	6.2	4.0	3.3	3.4	6.2	2.1	7.4	6.4	9.7	21.1	9.0	8.3	6.4	2.5	3.3	4.7	4.3	8.6	11.8	16.3	4.8	8.4	4.0	4.1	14.3	2.6	4.7	2.4	2.7	17.1	14.8	15.8	3.1	2.9	4.0	8.1	3.9	6.0	0.4	27.2	19.0	19.6	4.7	5.5	5.3	15.0	14.4	6.5	2.7	4.4	3.7	4.3	4.3	13.4	8.3	43.2	2.9	12.4	15.9	7.4	21.2	6.4	6.7	13.5	7.8	9.9	3.8	10.3	9.2	9.1	6.3	9.5	9.8	4.9	7.5	12.1	6.4	5.3	17.5	6.8	9.5	5.3	6.1	19.7	11.3	8.7	8.2	0.7	0.1	0.0	0.1	0.1	0.1	0.2	0.4	0.4	0.2	1.7	0.4	0.2	0.3	0.6	0.2	0.2	1.6	0.1	7.9	10.6	8.7	21.4	10.6	7.8	7.8	8.1	8.3	7.4	9.0	8.6	1.9	0.0	0.0	11.4	1.1	0.0	0.3	0.5	1.8	4.2	1.1	0.9	0.9	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	0.2	47.4	1.7	0.8	2.3	0.0	0.4	12.3	0.5	0.1	1.3	1.5	0.9	0.0	0.5	2.9	1.1	0.6	10.1	13.4	0.7	2.0	0.8	0.8	103.7	0.3	1.2	0.0	12.2	0.8	2.7	0.0	10.6	17.1	0.1	0.7	1.5	1.8	0.8	1.4	0.8	1.0	3.0	0.0	1.7	1.1	10.4	0.5	2.9	0.0	0.1	1.8	0.9	1.2	0.3
FBXL16	"C16orf22, Fbl16, MGC33974"	ENSG00000127585	"F-box and leucine rich repeat protein 16"	Q8N461	16	692498-705808	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 287.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.4;Excitatory neurons: 29.2;Horizontal cells: 32.0;Inhibitory neurons: 20.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 155.1;basal ganglia: 287.6;cerebral cortex: 194.9;hippocampal formation: 156.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.4;GAMG: 12.3;MCF7: 15.5;SCLC-21H: 30.2;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 240.8;basal ganglia: 720.4;cerebral cortex: 384.6;hippocampal formation: 362.0"	"HPA039504, HPA056354"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA039504: AB_10794197, HPA056354: AB_2683105"	"unprognostic (5.51e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.34e-5)"	"unprognostic (1.62e-3)"	"prognostic favorable (1.87e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-2)"	0.3	4.6	155.1	0.6	287.6	0.1	0.9	0.0	194.9	0.5	0.0	1.5	0.8	0.1	0.0	2.0	0.5	0.0	0.4	156.5	0.0	1.1	0.3	0.4	0.3	0.0	0.0	0.2	2.4	1.2	32.5	0.0	0.0	0.9	0.0	3.3	4.9	0.9	0.3	4.1	1.3	0.0	0.0	0.6	1.4	11.6	8.8	0.3	2.3	0.0	0.2	0.1	1.0	37.6	0.6	0.9	0.3	18.4	0.0	0.2	0.6	0.6	0.1	3.4	0.2	1.8	0.2	0.3	5.0	0.0	12.3	3.4	1.4	2.0	0.2	9.4	0.4	0.0	4.7	0.8	0.0	1.9	0.4	0.0	2.8	0.0	1.6	1.6	0.0	0.7	1.0	4.5	0.0	15.5	0.4	0.0	0.8	0.2	5.8	0.0	0.0	10.8	0.2	0.0	30.2	22.7	3.1	0.5	0.3	0.0	1.7	0.0	0.0	0.1	6.2	0.0	2.4	0.8	5.6	2.4	2.5	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	155.1	287.6	0.0	194.9	156.5	0.0	0.0	0.0	0.0	0.0	8.8	37.6	0.1	0.0	3.7	6.5	0.8	1.0	0.7	1.1	2.2	44.4	3.8	3.7	1.2	0.0	3.9	11.0	2.1	0.6	1.6	0.3	1.9	0.2	1.2	1.6	0.4	0.2	9.6	0.0	29.2	0.0	0.2	0.8	0.0	3.9	0.0	0.0	0.4	0.0	0.1	32.0	20.2	1.0	2.0	0.0	0.3	0.6	0.6	0.1	0.0	6.5	0.1	3.1	0.0	9.0	2.5	0.3	0.1	0.0	0.4	0.7	1.0	0.2	0.1	5.7	0.0	0.1	0.3	5.0	4.6	2.7	1.6	2.5	3.5	0.0	0.4	0.2
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 270.0;Excitatory neurons: 568.2;Inhibitory neurons: 578.0;Microglial cells: 205.2;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA036410: AB_2675109, HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.35e-2)"	15.4	13.8	11.8	7.8	13.1	5.9	10.4	7.5	15.3	10.8	3.8	10.1	10.6	9.9	8.9	12.0	9.0	9.1	27.0	12.4	12.5	16.9	14.2	8.9	8.5	9.0	12.2	9.3	10.0	26.0	5.7	5.9	9.0	11.8	10.4	25.6	9.8	13.7	55.8	8.7	10.9	11.7	10.5	10.7	10.1	8.6	11.8	10.1	24.6	41.7	10.7	8.5	4.5	10.3	8.7	8.5	9.6	17.7	15.8	16.4	6.4	10.4	23.3	8.4	11.3	1.7	17.9	9.7	16.0	16.9	13.0	3.8	7.7	11.9	13.0	9.8	6.9	9.2	9.0	4.2	8.2	6.2	10.1	11.8	17.4	7.8	5.7	16.3	10.1	3.9	1.3	12.2	18.5	6.5	5.4	7.9	1.3	6.7	7.9	7.6	12.8	12.7	11.7	11.9	8.2	14.0	13.6	11.9	13.4	6.6	9.4	14.6	11.0	18.9	5.9	5.9	13.6	9.5	14.3	7.0	16.7	9.4	12.6	0.1	0.1	0.8	0.4	0.2	0.4	0.2	0.4	0.4	0.2	0.3	0.4	0.3	0.3	0.2	0.1	0.4	0.2	0.1	11.8	13.1	7.5	15.3	12.4	12.5	9.0	12.2	9.0	10.5	11.8	10.3	13.2	19.2	14.5	270.0	13.9	16.8	7.4	7.5	6.8	37.2	18.6	10.2	38.3	17.2	8.3	29.5	56.3	4.8	12.8	22.8	17.6	7.3	5.6	8.5	9.7	12.3	29.9	5.7	568.2	13.1	6.5	12.1	12.2	10.7	16.5	12.2	21.0	21.4	8.4	30.3	578.0	21.7	2.0	21.0	14.1	5.4	14.0	9.9	16.0	205.2	13.1	20.8	12.3	302.6	256.1	13.3	16.0	16.6	10.7	8.6	14.4	15.0	6.1	50.4	0.0	16.6	9.8	9.5	3.9	10.6	24.6	4.5	12.6	13.8	16.6	8.8
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.8;Excitatory neurons: 125.0;Inhibitory neurons: 92.8;Late spermatids: 50.7;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.7;LHCN-M2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003240, HPA061783"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003240: , HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	0.9	1.3	3.6	0.4	3.8	0.3	1.0	2.2	4.0	1.1	4.2	1.1	0.7	1.0	2.1	0.4	1.5	0.6	0.9	3.5	3.7	1.4	0.2	1.2	0.3	2.9	2.6	1.4	1.1	2.7	2.7	1.4	3.0	1.0	0.2	4.2	0.8	1.6	0.2	0.6	0.5	0.8	1.6	0.5	0.8	1.1	3.3	0.2	2.3	0.0	0.2	0.8	0.9	2.7	2.7	0.7	1.0	1.0	1.5	2.4	0.4	2.0	1.6	1.8	2.6	0.5	3.1	0.1	0.6	1.3	0.8	0.5	0.9	2.1	1.2	0.2	1.1	0.4	2.3	0.5	1.8	0.2	0.4	0.9	1.6	1.1	0.8	5.7	3.3	1.9	0.5	0.2	6.2	0.2	0.5	0.3	0.7	0.3	0.6	0.1	0.6	0.1	4.6	0.7	1.1	1.1	0.9	0.5	0.8	1.7	1.3	0.7	2.5	0.8	0.7	0.6	1.1	0.2	0.1	0.1	0.8	0.2	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	3.6	3.8	2.2	4.0	3.5	3.7	2.9	2.6	3.0	1.6	3.3	2.7	2.7	3.2	7.3	22.2	1.0	1.1	7.6	5.6	1.8	15.3	3.0	3.7	2.4	2.8	4.8	5.5	25.0	0.5	0.4	0.1	3.9	3.9	48.8	18.8	3.6	3.8	0.0	0.0	125.0	0.4	1.5	5.0	5.6	6.2	0.0	6.2	2.2	0.1	0.5	18.5	92.8	0.3	8.2	0.8	2.4	50.7	1.5	0.5	1.8	22.5	0.1	6.6	0.0	55.8	49.6	4.2	0.1	4.1	0.3	4.2	0.2	3.2	16.5	17.7	6.6	3.6	3.9	21.3	8.6	0.7	1.1	0.7	1.5	3.5	0.1	3.8
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252663-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.6;Inhibitory neurons: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA044748: AB_2679072, HPA050397: AB_2681112"	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	4.1	5.4	7.8	3.4	8.2	8.2	4.5	6.8	11.4	4.6	1.0	4.1	3.5	4.4	3.4	4.1	4.0	3.7	3.5	8.8	9.7	4.1	4.7	4.0	3.6	3.3	4.8	4.7	4.3	4.6	3.5	5.5	5.0	3.7	4.1	8.3	3.7	3.5	3.6	6.5	4.2	5.0	2.3	4.4	3.8	12.7	8.8	7.5	3.9	5.2	4.0	3.9	4.3	5.2	4.0	8.2	8.0	8.5	10.1	7.2	4.6	5.6	7.5	6.3	7.7	2.6	9.3	6.3	12.3	7.3	12.6	9.3	9.4	6.5	9.1	12.1	12.5	6.7	7.2	7.9	7.3	9.5	8.1	6.0	7.5	6.2	7.2	8.9	7.7	8.0	13.4	4.5	6.1	5.9	9.4	6.7	2.1	8.1	3.5	4.6	15.9	4.2	3.2	6.2	5.1	4.0	10.6	65.7	7.1	10.4	10.3	9.0	6.3	7.0	6.9	5.3	5.3	7.9	8.9	5.2	8.7	4.3	5.5	30.2	5.5	18.3	4.2	4.5	3.9	4.0	3.9	3.9	4.1	6.2	3.6	3.5	26.9	8.2	6.7	5.3	8.3	2.4	7.8	8.2	6.8	11.4	8.8	9.7	3.3	4.8	5.0	2.3	8.8	5.2	13.5	19.2	20.4	61.4	15.4	4.0	7.1	2.6	10.2	31.4	13.0	10.9	6.5	11.5	6.7	12.9	58.4	14.4	23.9	18.4	1.9	11.2	14.1	28.3	16.3	12.5	9.6	34.9	122.6	6.1	8.2	14.4	5.1	25.6	8.8	23.7	22.5	12.0	10.5	20.2	126.8	10.0	12.2	25.2	3.8	15.6	18.0	16.1	1.8	71.2	24.0	12.0	32.0	74.9	79.6	13.8	10.0	11.3	14.2	15.9	26.5	6.3	8.8	39.2	6.6	15.3	14.3	51.2	39.9	10.5	5.5	24.2	18.1	11.7	10.6	15.3
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.4;intestine: 60.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Cytosol"		"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	3.6	0.9	1.9	2.8	1.7	0.3	1.8	2.7	2.0	15.7	0.2	60.1	2.9	60.4	3.6	7.0	21.2	8.8	17.2	1.6	1.3	1.0	0.5	1.1	0.9	0.8	1.1	4.5	0.7	0.6	0.7	0.9	0.9	16.9	4.8	0.6	3.2	29.4	4.9	1.4	7.3	28.9	0.5	0.6	11.1	3.0	1.8	0.4	1.5	1.8	0.2	26.3	10.1	1.0	0.7	1.2	0.2	0.8	0.5	0.5	0.1	0.2	0.0	0.3	0.0	0.8	0.9	0.3	0.7	0.2	0.4	0.8	0.6	0.4	0.0	0.8	0.6	0.3	1.1	2.2	0.1	0.4	0.1	0.2	0.2	0.1	0.5	0.1	0.2	2.2	0.0	1.1	0.0	4.9	0.7	0.7	1.7	0.8	0.4	0.7	0.0	2.4	0.3	0.3	5.3	0.2	0.6	1.0	0.3	0.0	1.9	0.6	0.8	0.3	1.0	0.5	0.2	0.7	1.5	0.8	0.5	3.7	0.8	0.2	0.0	0.0	0.5	0.0	0.5	0.6	0.6	0.6	0.0	0.4	1.0	0.4	0.1	0.7	0.0	1.6	0.0	0.2	1.9	1.7	2.7	2.0	1.6	1.3	0.8	1.1	0.9	0.5	1.8	1.0	1.4	0.0	0.0	1.0	3.4	0.1	1.8	0.4	0.6	10.1	4.7	8.6	7.7	2.8	0.7	7.3	4.2	0.7	2.7	2.3	9.8	1.2	0.9	3.2	5.8	1.3	4.9	2.5	1.5	1.1	1.2	3.4	7.7	5.8	0.0	0.9	3.9	4.0	0.7	0.0	1.8	6.1	0.0	1.6	0.4	0.5	0.3	1.7	0.0	0.0	0.7	10.6	2.1	1.5	0.5	0.8	3.0	11.3	9.1	1.7	1.9	4.0	0.1	3.8	0.0	6.2	8.1	3.8	3.2	4.4	0.9	0.5	4.4	2.7	4.0	0.8
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868535-98948006	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	5.8	8.0	5.9	5.3	8.4	5.1	7.7	7.6	5.5	7.0	5.5	6.2	5.9	6.9	11.2	5.3	7.7	6.6	5.9	4.6	7.1	13.1	15.7	5.9	6.1	8.0	8.3	8.2	9.4	12.7	4.8	6.8	8.4	8.0	6.9	5.1	9.9	6.6	9.4	5.7	5.8	6.2	7.2	5.3	7.4	4.1	7.4	9.0	12.2	7.2	6.4	5.7	5.3	11.0	5.7	9.0	7.6	10.2	12.5	22.8	8.2	12.7	10.7	7.3	10.3	4.1	10.7	13.1	11.5	10.6	12.8	8.1	8.8	9.2	11.1	21.4	7.2	9.3	6.2	9.4	9.7	11.5	8.9	13.0	16.4	6.6	18.4	20.4	9.5	10.2	12.6	10.1	13.4	5.6	4.3	5.5	4.0	7.5	5.5	14.6	5.2	10.7	13.9	8.2	9.5	7.7	6.7	8.9	12.2	9.2	6.6	8.2	13.3	8.4	3.7	11.9	9.3	3.4	3.4	5.5	10.5	10.4	10.2	18.4	4.7	13.0	4.6	4.5	6.1	7.1	4.6	4.6	3.8	5.7	5.9	5.6	5.9	4.3	6.0	2.5	6.1	3.9	5.9	8.4	7.6	5.5	4.6	7.1	8.0	8.3	8.4	7.2	7.4	11.0	12.2	19.2	11.9	42.7	14.2	9.7	8.2	9.0	12.0	14.9	9.1	8.3	16.2	5.7	8.8	36.8	22.9	10.1	9.5	9.8	19.6	9.7	5.4	10.6	14.5	10.8	7.2	20.2	46.9	11.0	10.7	13.7	14.3	7.9	8.9	20.8	11.4	19.4	8.9	10.1	58.3	13.7	8.2	12.3	6.4	2.1	19.0	11.8	5.4	41.2	14.9	10.6	12.3	97.0	94.4	7.5	9.8	12.8	8.8	13.9	12.5	11.8	11.3	13.3	13.1	12.7	10.0	4.1	6.4	12.4	8.5	9.9	9.3	16.9	10.4	8.2
FBXL5	"FBL4, FBL5, FLR1"	ENSG00000118564	"F-box and leucine rich repeat protein 5"	Q9UKA1	4	15604381-15681679	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 407.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 108.2;granulocytes: 407.0;monocytes: 225.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002484	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002484: "	"unprognostic (1.53e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.70e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.18e-2)"	72.8	50.9	49.0	40.2	53.9	110.9	51.9	56.3	65.5	53.8	50.3	51.3	29.8	42.1	63.5	43.0	46.1	51.6	49.5	48.1	51.2	128.0	77.4	48.8	35.3	49.9	52.6	41.5	32.7	59.4	44.4	37.1	50.1	51.5	36.2	48.0	36.9	56.4	80.1	36.3	31.7	55.1	50.9	45.1	41.5	68.0	52.2	46.3	70.6	85.5	32.6	53.9	37.7	55.2	23.3	17.8	42.3	23.9	65.0	63.9	13.4	30.4	37.2	32.7	45.9	14.3	34.1	18.1	14.2	36.4	57.8	8.5	21.9	36.5	50.3	17.7	11.2	17.8	12.9	16.9	65.3	21.7	16.4	59.0	48.4	30.4	46.9	74.9	86.8	15.7	15.2	14.8	99.1	10.5	41.3	33.4	22.3	19.1	15.8	29.5	43.0	14.8	51.8	32.9	20.4	19.2	28.4	10.0	32.8	57.7	16.2	35.8	20.8	37.8	10.7	26.0	38.0	20.1	22.2	16.8	32.4	37.7	46.6	204.3	225.4	115.2	46.2	112.9	44.9	33.5	42.5	44.7	108.2	31.3	44.0	44.8	407.0	42.4	101.7	16.6	40.6	206.8	49.0	53.9	56.3	65.5	48.1	51.2	49.9	52.6	50.1	50.9	52.2	55.2	37.0	44.8	62.0	63.6	31.3	27.3	37.2	40.5	62.0	52.3	34.6	28.2	88.1	41.5	46.9	36.8	6.2	53.3	38.9	24.4	78.2	29.2	80.3	32.5	41.2	42.5	25.9	29.9	73.6	23.3	41.8	47.0	36.2	42.1	39.9	38.6	40.0	69.1	48.5	40.4	78.7	20.1	32.6	109.9	28.4	52.9	39.7	81.1	30.2	63.7	138.4	36.2	44.3	65.9	120.2	18.8	20.4	58.3	39.1	30.8	37.2	252.3	61.9	41.1	59.2	42.1	46.2	188.5	73.5	63.1	26.1	26.4	45.4	38.4	25.6	32.7
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500180-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 976.2;Inhibitory neurons: 295.1;Oligodendrocyte precursor cells: 335.8;Oligodendrocytes: 766.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055464	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055464: AB_2682822"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.94e-3)"	17.5	22.7	16.9	3.7	19.5	0.0	13.9	16.0	15.9	19.1	15.9	17.2	2.0	26.4	10.3	9.7	15.8	8.4	17.0	15.5	14.2	4.7	2.1	9.6	2.6	19.7	16.5	26.8	1.9	1.0	4.7	6.6	16.1	13.3	5.2	4.3	5.6	19.5	4.0	5.0	6.8	24.6	15.1	5.0	10.2	4.4	18.4	2.4	8.2	5.7	2.1	16.6	13.1	22.3	0.1	1.4	16.1	23.5	13.1	10.0	0.0	14.1	17.0	9.9	10.3	0.0	0.0	0.0	0.0	21.7	10.2	0.0	8.1	5.2	9.8	0.0	1.1	0.0	0.0	0.0	5.1	0.0	0.0	11.8	0.0	8.0	0.7	12.1	23.2	0.0	0.0	6.1	7.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	11.4	0.1	0.0	0.0	4.7	15.9	0.0	4.9	15.3	14.5	0.0	0.0	22.9	20.6	4.1	11.7	6.3	0.0	0.0	0.0	11.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.5	16.0	15.9	15.5	14.2	19.7	16.5	16.1	15.1	18.4	22.3	21.4	3.2	1.9	976.2	0.3	2.4	2.7	2.4	2.2	3.2	0.9	1.1	11.8	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	2.0	11.8	16.7	0.0	0.0	3.7	0.0	0.1	15.9	0.0	2.0	1.3	13.1	15.4	0.2	0.8	30.3	295.1	0.0	0.0	0.6	2.7	0.7	30.1	0.5	5.4	146.1	0.0	2.4	0.0	335.8	766.0	0.0	0.0	41.3	1.2	3.1	0.0	1.2	3.8	2.5	6.6	16.1	8.1	1.4	2.1	1.5	1.7	0.0	0.3	20.7	0.0	2.4
FBXL8	Fbl8	ENSG00000135722	"F-box and leucine rich repeat protein 8"	Q96CD0	16	67159932-67164570	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035587, HPA035588"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA035587: AB_2674690, HPA035588: AB_10670023"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.79e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.68e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	12.2	24.0	3.1	5.4	4.2	3.4	18.4	5.3	5.7	17.7	1.7	16.6	9.8	17.0	2.5	15.6	20.3	2.3	10.9	3.7	1.7	14.6	16.7	14.6	4.3	5.2	3.2	16.2	53.5	4.9	24.9	5.7	4.3	35.5	6.4	2.2	35.8	2.6	11.2	30.1	12.2	2.5	2.2	13.5	22.6	4.3	3.9	2.0	20.9	1.2	2.7	12.7	14.9	8.6	5.9	7.2	1.1	9.7	5.2	9.2	25.0	4.9	4.0	4.0	4.0	6.8	16.0	4.6	7.4	4.6	4.0	19.9	2.9	4.8	1.1	11.9	11.7	4.7	17.2	7.5	3.7	2.7	18.1	6.9	5.2	4.2	3.4	11.6	2.6	12.6	9.3	10.1	2.8	16.8	3.9	10.4	0.6	5.4	17.6	12.7	3.3	22.4	6.1	8.1	10.2	9.5	12.4	6.4	3.3	2.9	31.7	6.2	6.3	10.0	11.5	23.4	4.4	43.4	10.4	6.0	11.0	8.7	6.1	5.1	4.7	4.9	3.8	2.2	3.4	1.6	10.7	5.0	2.4	1.7	2.3	2.4	6.4	5.8	2.0	4.3	4.0	3.1	3.1	4.2	5.3	5.7	3.7	1.7	5.2	3.2	4.3	2.2	3.9	8.6	3.4	0.0	3.1	0.0	2.8	3.2	4.4	3.4	17.1	1.7	5.0	4.3	0.9	7.2	5.1	5.5	8.4	2.8	6.0	7.6	1.9	6.9	0.1	3.3	3.4	3.2	6.7	0.4	0.2	8.0	3.1	4.6	18.8	3.7	0.0	4.7	1.8	4.4	2.8	5.0	0.1	10.4	2.0	1.9	2.9	0.5	9.3	2.9	10.6	0.0	7.7	1.9	8.2	0.0	1.1	9.3	5.2	5.7	4.6	5.4	10.6	6.2	4.1	4.7	6.6	2.4	4.2	0.1	1.0	7.2	4.4	1.5	4.2	8.4	9.0	5.6
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576380	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 24.0;HHSteC: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	2.9	8.0	5.9	3.2	6.2	0.8	2.4	2.6	7.4	3.3	3.9	7.4	1.8	4.5	10.7	3.2	2.5	2.7	3.9	9.0	6.4	3.8	3.6	2.3	5.5	3.6	5.1	2.5	6.6	3.8	16.4	2.0	4.4	3.3	1.8	1.6	8.5	2.9	29.8	1.9	4.7	3.2	3.6	10.0	3.2	9.4	6.8	2.0	7.6	13.9	5.3	3.0	2.7	5.6	2.3	5.6	24.0	6.2	11.1	3.9	2.0	4.2	7.6	5.3	7.7	3.2	1.5	14.4	1.4	4.6	2.1	0.2	8.8	2.1	3.8	8.2	5.8	2.9	5.3	2.8	33.8	7.9	1.0	9.0	1.7	4.7	3.1	3.4	7.5	1.4	10.4	3.9	9.4	2.0	3.0	2.6	11.2	3.3	2.1	5.5	10.4	1.8	3.0	1.5	5.1	12.8	2.8	3.4	3.2	7.1	1.4	8.0	6.1	3.7	6.3	3.4	3.1	4.5	3.9	2.3	3.1	3.0	3.5	0.0	0.0	0.0	0.2	0.0	0.2	2.1	0.4	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.2	5.9	6.2	2.6	7.4	9.0	6.4	3.6	5.1	4.4	3.6	6.8	5.6	0.7	0.0	1.1	12.4	6.7	0.3	0.1	0.4	0.6	3.9	1.2	0.8	1.7	2.8	0.5	1.8	4.2	0.3	0.3	0.1	0.0	1.1	34.8	1.1	4.3	1.4	5.4	0.4	28.6	1.5	0.8	1.8	0.5	1.3	0.0	1.9	3.9	1.2	4.1	3.3	28.2	0.5	2.0	0.3	0.0	45.7	0.9	0.6	1.8	4.7	0.7	1.6	0.0	16.6	7.0	1.2	0.2	1.5	5.7	0.9	0.2	1.3	1.1	1.0	0.0	3.1	1.0	4.2	1.9	0.7	0.6	0.3	1.3	5.0	0.3	0.3
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490278	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.4;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 9.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 9.6"	"Cell line enhanced"	"Detected in many"		"AF22: 20.3;Karpas-707: 22.4"	"Low region specificity"	"Detected in all"							"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.5	1.8	3.9	0.9	5.0	2.2	2.6	6.8	7.0	4.1	2.9	1.6	2.0	1.1	18.4	0.7	4.4	1.4	1.4	4.6	3.9	3.2	6.0	1.5	1.4	1.1	1.7	0.7	4.7	7.1	17.3	0.6	2.0	3.5	2.0	14.3	3.4	5.1	1.1	0.4	2.9	0.7	0.3	1.2	2.2	4.2	3.5	0.6	7.0	0.9	2.8	1.2	0.7	4.3	16.5	2.9	20.3	7.5	0.5	0.0	0.3	0.2	0.5	3.0	5.5	3.1	4.6	5.8	7.2	0.1	8.1	5.1	2.3	3.5	3.0	2.6	3.6	2.7	0.3	1.7	0.0	3.5	1.9	0.2	10.8	0.7	3.2	1.5	0.0	5.6	1.1	22.4	1.0	5.7	0.5	5.0	3.9	2.2	4.5	0.2	4.5	8.2	3.9	2.4	13.1	5.4	0.4	3.3	9.5	3.5	13.8	5.9	0.6	1.6	5.8	3.2	3.0	5.2	5.0	5.2	6.8	0.7	3.5	0.3	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.1	0.2	0.9	0.0	0.1	9.6	0.2	0.1	3.9	5.0	6.8	7.0	4.6	3.9	1.1	1.7	2.0	0.3	3.5	4.3	0.0	3.2	4.1	7.5	1.7	0.1	3.0	10.9	5.2	8.2	3.9	3.4	2.1	8.6	7.9	3.7	35.5	0.6	0.0	0.5	7.9	5.3	12.1	13.5	1.3	0.2	10.2	0.0	44.4	4.6	0.4	0.9	1.5	6.4	0.0	1.9	0.4	1.9	2.7	5.0	43.6	3.9	4.1	0.8	2.3	12.4	1.2	0.4	0.0	2.8	0.0	9.3	0.0	23.6	3.2	3.1	0.4	0.7	11.1	1.7	0.2	4.7	23.4	48.6	0.0	0.5	1.8	10.5	5.6	1.2	0.0	0.0	0.5	4.2	1.0	1.7
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 238.9;choroid plexus: 125.3;pancreas: 86.9;pituitary gland: 118.3"	"Cell type enriched"	"Detected in many"	4	"Exocrine glandular cells: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	6.8	25.2	217.0	1.8	172.1	0.0	13.5	161.1	216.1	7.2	125.3	4.9	16.4	2.3	6.7	8.9	5.9	2.5	11.6	183.3	238.9	32.8	28.1	5.7	2.0	200.2	196.2	3.6	86.9	29.7	118.3	0.1	201.7	15.1	0.4	7.5	25.1	7.5	4.8	18.1	5.3	0.7	176.0	3.7	9.6	12.0	195.1	10.6	8.4	1.0	3.6	5.1	13.1	192.3	35.7	10.8	0.4	35.1	0.7	0.0	5.3	1.5	3.0	1.1	0.2	113.4	10.0	0.0	40.6	0.3	8.3	0.1	3.6	96.9	0.1	0.8	1.0	0.0	1.7	239.8	4.6	0.1	0.0	3.0	17.0	0.0	0.9	1.1	0.4	0.1	0.3	0.1	0.0	0.5	0.0	0.0	1.3	14.3	1.3	0.1	0.1	0.2	8.2	3.0	3.6	4.7	440.5	0.1	3.9	3.5	21.1	0.0	0.0	0.3	3.1	0.0	0.0	2.4	2.1	1.7	0.7	0.0	1.0	0.0	0.0	0.0	0.9	0.0	1.3	0.7	0.5	1.2	0.0	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.4	0.2	217.0	172.1	161.1	216.1	183.3	238.9	200.2	196.2	201.7	176.0	195.1	192.3	1.2	0.0	1.5	40.8	8.4	19.6	62.3	149.9	90.5	11.3	15.0	75.4	3.7	15.7	33.5	47.8	2.1	0.8	5.9	0.2	86.1	23.2	2.1	1.2	0.7	1.8	1.2	0.0	16.5	685.9	3.9	8.7	6.6	0.7	4.5	0.2	2.5	102.0	0.4	28.6	16.7	0.7	38.7	2.2	2.6	2.4	34.8	1.1	44.4	5.6	3.2	106.6	7.2	6.6	10.4	132.1	2.2	40.6	3.3	39.2	2.0	7.2	44.4	15.8	0.0	1.1	7.7	18.4	12.1	10.0	9.9	1.0	13.0	0.5	0.4	25.0
FBXO21	"FBX21, KIAA0875"	ENSG00000135108	"F-box protein 21"	O94952	12	117141991-117190471	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 128.9"	"Cell type enhanced"	"Detected in all"		"Peritubular cells: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062411, HPA071452"	Approved		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA062411: AB_2684755, HPA071452: AB_2686398"	"unprognostic (6.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.29e-2)"	12.2	40.9	21.7	10.7	23.0	8.5	17.5	22.2	24.7	18.5	25.7	15.6	16.5	25.0	110.8	15.4	128.9	17.0	31.1	27.2	29.7	53.7	27.5	17.5	13.7	17.5	18.7	60.3	30.7	24.8	20.2	19.5	17.2	26.5	14.6	24.3	16.5	29.3	23.8	16.9	14.3	19.5	20.4	15.2	18.7	42.2	30.2	13.7	28.3	28.5	14.1	16.2	13.8	23.5	20.3	47.3	29.2	16.2	23.5	24.4	33.4	26.6	28.6	24.3	19.7	30.8	14.0	26.5	25.7	27.3	18.2	27.0	34.7	26.6	29.1	15.0	31.2	1.3	24.9	25.0	21.3	8.7	9.0	24.1	25.1	19.5	31.0	39.7	34.4	23.0	10.7	8.6	21.2	33.0	25.0	6.3	43.7	30.9	30.6	29.3	42.5	27.8	24.4	47.7	57.6	34.9	66.4	17.3	14.5	23.3	40.6	3.5	26.8	16.1	20.7	19.1	17.4	15.0	16.6	34.4	23.5	13.5	23.1	1.2	7.0	4.5	11.6	12.2	12.1	10.4	12.0	12.1	9.7	14.3	13.6	12.6	0.6	11.4	12.7	6.6	13.6	8.8	21.7	23.0	22.2	24.7	27.2	29.7	17.5	18.7	17.2	20.4	30.2	23.5	28.5	32.1	35.4	44.1	44.0	37.2	49.1	29.5	40.5	44.3	32.3	26.7	65.4	42.9	39.6	51.5	41.7	58.3	26.3	16.4	45.0	62.5	37.2	108.6	38.3	46.2	39.0	12.0	50.7	50.5	38.0	44.3	24.5	113.1	3.8	57.0	60.0	38.9	15.6	74.0	51.4	23.7	54.9	22.3	17.2	60.4	99.7	17.3	23.2	23.4	18.4	54.1	16.5	41.7	67.5	36.9	16.4	222.3	23.4	48.8	19.0	95.4	29.9	34.1	105.2	35.3	40.6	21.6	43.9	33.9	45.3	65.5	34.1	44.2	27.2	38.3
FBXO24	FBX24	ENSG00000106336	"F-box protein 24"	O75426	7	100583982-100601117	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"testis: 81.2"	"Group enriched"	"Detected in some"	45	"Early spermatids: 517.1;Late spermatids: 594.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050951	Enhanced					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA050951: AB_2681286"	"unprognostic (3.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.48e-2)"	0.3	0.4	0.2	0.7	0.4	0.7	0.5	2.3	0.9	1.4	0.1	0.7	0.2	1.1	0.4	0.7	1.0	0.9	0.7	0.3	0.0	1.0	0.7	0.5	1.2	0.7	0.2	1.6	0.6	0.2	0.9	0.7	0.6	1.0	0.2	1.0	1.2	0.6	0.4	1.3	0.6	0.4	0.1	0.8	0.4	81.2	0.3	0.2	0.5	0.3	0.4	0.4	1.0	0.4	0.5	0.4	0.6	0.8	1.7	0.0	0.3	0.4	0.2	0.2	0.1	0.8	1.4	0.8	0.3	0.0	0.2	0.4	0.0	0.2	0.0	0.3	1.0	0.1	0.2	0.0	0.3	0.0	1.2	0.8	0.8	0.0	0.0	0.0	0.2	1.0	0.2	1.1	0.0	1.3	0.2	1.7	0.9	1.2	0.5	0.0	0.0	0.2	0.0	0.5	0.1	1.0	0.7	1.0	0.5	1.3	0.8	0.3	0.0	0.6	2.5	2.0	0.1	0.6	0.3	0.2	0.2	0.9	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.0	0.5	0.3	0.2	0.2	0.4	2.3	0.9	0.3	0.0	0.7	0.2	0.6	0.1	0.3	0.4	0.3	0.0	0.0	2.3	0.1	0.3	0.7	0.6	0.6	0.6	0.4	0.3	1.3	0.0	0.2	0.0	8.4	0.4	1.4	0.3	0.0	0.6	517.1	0.8	0.4	0.4	0.0	0.0	0.3	0.6	0.6	0.6	0.0	0.2	0.0	0.3	0.7	0.2	0.3	0.0	0.7	0.2	0.0	0.0	0.4	594.8	3.7	0.3	0.0	1.0	0.6	0.7	0.0	0.0	0.5	0.2	0.1	3.8	0.0	0.3	0.3	0.2	0.8	1.4	0.0	0.4	0.8	12.2	5.3	0.4	0.3	0.1	0.5	0.3	0.4	0.4
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 37.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 35.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	13.3	3.7	17.5	2.1	15.9	2.7	6.2	23.8	18.7	6.3	6.4	6.8	2.2	4.7	2.4	15.4	5.3	5.5	19.6	15.4	8.9	6.4	7.5	3.2	3.7	10.7	6.7	10.2	4.8	2.5	4.1	3.8	9.1	8.9	8.7	4.9	7.4	7.8	1.6	37.5	4.9	7.4	4.9	3.1	3.8	4.7	11.1	4.0	4.6	2.4	4.0	7.7	9.7	13.1	9.1	11.4	0.3	7.2	15.3	0.8	3.3	1.2	6.7	5.2	4.9	3.8	3.4	0.9	17.5	10.3	9.0	15.5	0.6	6.6	3.4	0.8	0.4	0.3	3.0	0.6	2.7	0.9	2.5	5.5	10.2	5.4	0.4	8.2	3.3	0.4	5.4	1.2	7.2	8.1	0.6	1.4	8.1	3.0	20.4	0.2	0.1	1.1	3.4	35.3	0.4	10.8	17.7	2.2	0.1	4.8	9.2	1.7	4.0	0.5	0.4	0.3	0.9	3.5	8.9	1.9	9.0	0.2	0.3	1.1	0.3	0.2	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.4	0.3	1.7	1.7	0.2	0.5	0.3	0.2	17.5	15.9	23.8	18.7	15.4	8.9	10.7	6.7	9.1	4.9	11.1	13.1	0.2	3.2	15.0	2.3	0.1	5.9	4.1	1.4	9.1	7.5	3.8	4.2	9.5	7.2	6.4	1.8	0.0	36.1	0.5	0.2	1.9	1.5	3.7	1.9	3.6	3.2	0.0	0.0	4.8	0.8	4.8	2.7	6.1	1.6	7.6	2.3	1.4	3.2	4.9	8.4	4.6	0.2	8.2	0.3	4.9	2.5	2.8	2.1	0.0	1.0	1.1	5.6	0.0	3.0	4.1	0.3	0.0	4.1	1.9	2.3	6.9	7.3	4.7	3.0	0.0	1.8	1.5	6.4	2.0	13.5	17.8	27.0	1.3	0.4	0.2	5.3
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114111-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003289	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	10.9	7.5	6.5	8.3	7.3	8.9	12.3	8.8	10.5	10.9	7.4	10.3	8.5	10.0	7.9	12.4	8.2	9.5	8.1	7.6	9.1	13.6	17.4	8.9	10.5	8.5	7.4	11.3	7.6	13.7	4.4	9.0	8.8	10.0	10.6	8.3	7.9	8.5	12.5	21.1	7.7	9.8	8.0	8.9	8.5	7.8	7.8	10.9	9.8	14.2	10.6	11.5	9.0	8.9	24.6	10.6	16.2	17.4	16.6	19.0	26.7	24.3	19.7	16.0	15.2	14.9	18.7	11.8	24.4	22.3	10.3	20.9	24.2	23.4	27.4	17.0	27.0	15.0	12.8	10.7	20.7	28.3	18.8	18.6	27.7	23.2	41.9	18.8	27.1	15.0	24.8	16.4	29.1	8.1	14.9	14.4	38.6	32.3	22.8	15.7	23.1	22.3	30.2	16.1	26.2	28.1	25.1	38.0	27.4	16.9	20.2	28.2	31.2	19.8	15.0	25.0	46.1	17.8	22.3	18.0	24.5	13.7	39.3	7.4	6.5	11.8	5.8	6.0	7.2	8.9	5.9	6.8	7.8	9.0	5.9	6.6	4.2	8.6	6.9	3.5	8.8	4.6	6.5	7.3	8.8	10.5	7.6	9.1	8.5	7.4	8.8	8.0	7.8	8.9	15.0	6.4	10.6	22.5	16.8	34.3	25.5	11.3	9.6	20.5	14.7	11.7	11.4	7.2	13.5	11.0	22.9	14.2	12.3	17.2	9.8	13.2	30.3	15.9	13.0	16.4	18.5	17.4	48.8	11.5	13.1	12.7	7.1	22.9	14.0	12.6	14.3	23.4	13.9	18.5	43.8	12.7	14.2	17.7	16.3	14.8	13.1	16.8	28.4	34.7	16.4	12.6	7.2	45.8	43.7	17.7	12.2	13.2	15.4	21.5	12.0	22.8	11.5	18.6	13.1	14.9	12.7	24.7	26.8	17.2	39.1	23.0	18.9	10.9	14.6	30.7
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814795	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583	Approved		Approved	Microtubules		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	4.5	4.0	3.8	4.2	5.0	7.2	4.0	4.6	3.9	4.1	2.7	9.7	4.1	6.7	3.1	9.6	3.2	5.6	7.2	3.1	6.0	4.1	3.4	3.2	4.3	4.5	5.5	5.9	3.8	4.0	1.6	4.8	4.7	6.0	4.7	5.3	4.4	6.8	11.5	2.6	3.5	8.0	4.2	3.7	3.7	6.5	5.1	2.9	8.0	9.1	4.1	5.7	2.9	5.3	3.7	6.9	9.7	13.2	9.9	8.8	9.9	10.3	9.6	6.9	6.8	8.7	3.3	17.0	7.8	11.8	12.6	5.7	8.4	7.5	10.4	10.0	5.8	10.8	9.1	8.8	17.8	14.1	10.8	14.6	8.3	8.6	11.4	9.0	10.1	4.1	12.6	11.9	13.6	2.9	6.4	7.5	11.2	2.4	5.1	8.2	21.7	5.9	7.2	3.8	4.3	6.9	12.6	6.5	6.1	9.6	3.0	13.8	13.4	7.1	6.0	9.1	10.4	8.8	7.2	6.8	11.4	6.0	7.7	9.3	1.3	1.6	0.4	1.1	0.3	0.6	0.4	0.8	1.6	1.3	0.6	0.6	1.2	0.5	0.9	0.5	0.3	0.6	3.8	5.0	4.6	3.9	3.1	6.0	4.5	5.5	4.7	4.2	5.1	5.3	11.1	3.2	5.9	7.2	5.4	14.3	5.3	4.2	12.5	8.8	10.5	8.3	22.9	10.0	4.7	3.7	4.2	5.8	5.7	4.9	11.7	4.7	10.9	4.1	13.7	13.8	6.0	36.7	5.3	3.2	3.4	15.4	7.1	6.2	12.0	37.1	11.4	9.7	7.5	26.9	6.4	5.0	2.0	11.9	20.8	4.4	11.1	10.2	7.2	7.5	7.5	12.0	0.0	5.0	7.6	5.1	3.2	10.1	11.1	7.1	4.3	8.2	2.8	8.7	0.0	26.5	18.4	19.7	10.5	12.4	17.3	5.6	6.2	7.2	5.0	5.0
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 65.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	33.7	12.8	6.8	6.0	8.5	5.7	24.3	39.0	14.5	14.9	0.0	20.9	8.6	21.7	4.4	10.2	16.8	6.2	18.2	11.9	13.4	5.3	15.9	8.7	6.4	8.3	5.5	15.0	13.1	8.2	19.4	4.9	11.1	10.2	5.8	8.1	11.1	10.7	65.3	17.0	15.9	11.1	2.7	5.2	11.5	18.7	9.5	5.7	8.7	36.8	4.6	21.8	13.0	7.6	7.0	13.1	4.3	11.7	21.6	12.9	12.5	12.0	11.9	11.6	6.1	11.9	5.8	16.3	12.9	12.7	5.9	10.6	8.3	10.0	7.7	7.5	15.5	5.5	8.7	34.1	12.1	5.3	4.4	15.4	8.3	15.2	14.3	7.6	7.2	8.3	15.9	6.3	6.3	10.1	13.0	7.3	8.4	7.3	11.5	16.1	5.1	7.0	5.2	4.9	20.0	9.7	26.7	5.4	8.3	3.1	8.5	4.6	10.1	11.2	8.5	10.8	9.6	14.4	12.0	20.1	9.0	9.8	7.0	0.5	0.1	0.0	0.2	0.1	0.4	0.6	0.4	0.6	0.1	0.3	0.4	0.5	0.2	0.0	0.2	0.2	1.1	0.4	6.8	8.5	39.0	14.5	11.9	13.4	8.3	5.5	11.1	2.7	9.5	7.6	61.3	0.0	4.6	13.1	7.3	14.7	5.1	3.3	17.1	13.8	6.4	6.7	20.6	2.8	2.1	5.5	33.3	10.8	4.6	19.3	0.0	3.6	9.2	18.0	10.6	16.0	9.0	9.5	21.6	5.1	3.1	10.1	6.6	11.1	0.0	5.3	5.3	29.5	4.0	0.0	21.9	11.7	4.1	4.4	7.7	26.3	8.1	2.9	3.6	10.3	4.1	5.3	3.1	8.5	13.6	3.5	17.2	11.3	7.2	5.4	33.6	5.5	11.7	11.9	19.7	8.6	9.8	17.9	6.1	14.6	12.9	7.3	9.0	5.9	16.5	4.5
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	7.0	9.6	12.2	8.1	12.6	52.6	6.5	10.8	16.2	8.0	16.7	5.9	7.2	6.5	10.1	5.2	6.0	7.3	5.3	14.9	12.9	7.3	6.9	7.9	9.4	12.4	10.8	6.1	5.9	13.2	10.8	7.8	12.5	7.5	5.7	8.4	6.7	7.4	3.0	5.7	5.6	6.6	9.8	7.8	6.0	12.1	11.6	11.8	11.6	6.7	9.8	7.2	4.9	12.5	12.8	7.8	7.0	10.8	24.7	11.5	11.6	12.6	16.9	6.9	8.0	4.7	11.1	14.3	15.2	19.7	6.9	6.4	18.3	12.4	12.3	13.7	11.8	5.7	10.5	12.2	7.0	21.7	20.9	10.7	13.2	11.8	3.8	11.9	5.8	14.0	5.0	12.6	13.6	13.7	19.4	13.5	7.2	11.5	11.6	16.6	11.4	13.0	13.2	16.1	12.1	5.5	11.3	11.8	14.0	10.4	8.7	13.7	7.5	11.6	10.4	17.4	10.1	17.0	21.6	22.6	9.0	10.1	8.8	0.9	0.9	1.8	1.6	1.1	1.4	1.2	1.6	1.7	0.8	1.1	2.2	2.1	3.9	2.8	1.1	0.7	1.7	0.6	12.2	12.6	10.8	16.2	14.9	12.9	12.4	10.8	12.5	9.8	11.6	12.5	14.7	9.6	20.1	21.9	25.7	34.5	13.6	6.4	27.9	24.0	19.1	16.4	8.9	4.3	8.1	9.2	43.8	8.4	40.8	18.0	7.9	8.1	42.1	25.7	14.3	14.7	23.9	16.2	82.6	9.3	9.5	14.8	12.8	39.8	10.2	10.1	13.9	10.6	10.5	28.6	46.7	14.2	2.0	19.2	23.3	10.7	8.4	22.6	19.6	23.4	14.8	12.4	10.3	34.7	36.7	14.0	10.1	5.3	32.7	21.5	13.9	4.0	8.4	17.9	0.0	18.8	17.8	28.5	12.2	24.0	56.4	21.2	31.4	8.0	13.7	24.7
FBXO34	"Fbx34, FLJ20725"	ENSG00000178974	"F-box protein 34"	Q9NWN3	14	55271344-55370053	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.2;Late spermatids: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052592	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA052592: AB_2681877"	"unprognostic (6.19e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.87e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	9.0	7.9	7.8	11.9	10.7	17.2	12.6	6.5	14.9	12.3	7.1	27.3	14.4	11.0	15.9	33.5	15.0	13.3	13.1	14.4	6.2	18.3	12.0	15.2	12.8	4.6	5.8	11.6	10.5	11.6	6.5	10.0	4.7	12.9	26.8	16.0	17.5	11.6	31.2	12.2	15.1	11.7	4.9	13.9	18.1	24.8	6.7	17.0	22.7	44.7	15.8	16.4	16.1	7.5	30.1	17.2	13.5	12.3	17.3	14.1	14.8	14.9	25.4	22.1	25.5	15.7	37.8	24.0	12.1	12.9	14.4	29.0	17.5	15.0	28.3	14.8	10.2	25.2	10.4	9.7	13.4	30.5	23.8	11.5	21.6	15.4	15.4	17.2	17.0	25.8	19.9	18.8	14.3	20.2	24.0	21.6	8.0	26.3	13.3	25.5	33.1	13.4	20.3	34.2	14.9	16.2	18.0	17.9	14.8	16.3	21.5	19.5	13.0	19.3	24.9	10.5	11.8	9.1	8.2	27.1	13.7	16.4	11.3	9.4	11.2	2.5	9.9	7.5	11.8	7.0	10.1	10.8	11.1	7.0	8.8	9.3	6.1	13.2	14.0	5.1	6.9	8.7	7.8	10.7	6.5	14.9	14.4	6.2	4.6	5.8	4.7	4.9	6.7	7.5	16.2	22.4	31.6	22.9	27.3	21.0	32.9	18.5	15.9	36.7	15.6	12.7	21.5	7.2	32.5	18.4	22.9	13.9	57.8	63.7	17.6	22.8	165.2	27.1	17.4	24.1	26.4	52.8	109.1	30.3	4.7	14.7	31.1	28.9	17.2	21.1	9.3	7.8	9.9	37.0	75.5	30.0	30.5	13.5	24.3	219.1	23.0	27.8	12.4	46.9	12.6	14.1	24.7	35.2	20.7	18.0	35.3	16.6	27.4	31.2	20.0	17.0	34.5	32.4	6.6	24.2	19.3	34.1	16.3	20.7	24.3	27.0	44.1	11.4	29.3	63.2
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246840-16352480	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	14.1	12.6	17.4	8.8	16.4	9.3	12.9	20.0	18.0	21.7	14.7	15.1	7.6	19.8	12.9	18.2	18.6	11.8	16.9	16.5	17.6	11.8	14.2	13.6	12.5	16.9	16.3	18.2	15.3	14.0	16.2	12.1	17.8	19.3	10.6	16.7	13.5	15.0	22.6	28.1	11.1	17.9	14.9	13.7	12.1	11.6	16.8	18.1	14.6	22.3	14.3	18.9	17.9	16.4	15.4	8.2	19.4	19.8	23.1	15.0	8.5	15.6	23.5	22.0	21.4	7.7	13.9	16.2	13.6	21.7	15.1	13.6	19.8	14.8	17.9	18.7	9.3	15.2	12.5	8.8	27.5	18.1	19.0	16.1	33.5	19.4	27.8	20.0	22.3	20.0	16.5	22.1	15.8	10.5	17.5	15.8	8.5	20.3	9.2	19.6	11.9	14.5	14.8	4.3	18.3	12.0	17.6	14.6	18.8	17.7	11.9	14.0	14.0	11.1	9.8	18.4	12.3	10.9	11.9	16.3	14.7	23.5	15.6	9.0	11.8	18.5	11.7	16.3	8.7	8.5	8.7	7.5	14.0	14.1	9.8	8.7	10.5	12.4	12.7	6.1	12.4	7.9	17.4	16.4	20.0	18.0	16.5	17.6	16.9	16.3	17.8	14.9	16.8	16.4	9.2	12.8	11.8	47.0	16.0	25.9	6.1	13.5	22.2	21.7	7.1	7.1	20.6	15.7	9.4	12.9	45.9	11.0	16.6	6.7	0.0	8.5	9.4	21.7	15.5	9.9	10.7	10.8	63.9	7.6	15.6	14.7	11.7	33.1	2.5	12.8	9.7	9.6	13.8	28.6	65.9	5.6	10.2	15.1	28.1	10.2	14.9	13.4	1.8	35.6	19.2	11.0	15.5	60.8	53.0	8.4	7.6	11.3	17.7	10.4	8.8	3.8	6.4	20.4	13.1	23.1	13.4	13.5	9.7	18.9	34.7	26.3	16.0	9.8	8.3	5.5
FBXO43	Fbx43	ENSG00000156509	"F-box protein 43"	Q4G163	8	100133351-100145817	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 3.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.6;Erythroid cells: 9.9;Late spermatids: 6.9;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.6"	"Not detected"	"Not detected"							"HPA024292, HPA024295, HPA024824"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464"	"unprognostic (4.94e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.07e-5)"	"unprognostic (4.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.09e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.7	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.1	1.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.6	0.0	0.3	0.6	0.0	0.9	0.2	0.0	0.1	1.4	0.0	0.0	1.5	1.1	0.0	0.1	0.2	0.0	0.6	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.2	0.5	0.6	0.8	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	1.8	1.6	0.3	0.9	0.6	0.3	0.6	1.4	0.5	0.6	0.4	0.0	3.2	0.0	0.0	0.6	0.4	0.2	0.0	0.0	11.6	1.5	0.4	0.6	1.2	9.9	0.3	0.4	0.3	1.4	0.0	0.3	1.3	6.2	0.0	0.2	0.5	0.0	0.4	0.1	2.0	0.3	1.1	6.9	0.0	0.7	0.0	1.0	0.1	0.6	1.0	0.5	0.5	0.1	0.1	0.4	0.8	0.3	0.2	0.2	1.2	0.8	0.0	1.4	0.5	43.8	4.5	0.7	0.4	0.3	1.6	0.3	0.4	0.2
FBXO44	"FBG3, FBX30, Fbx44, Fbxo6a, MGC14140"	ENSG00000132879	"F-box protein 44"	Q9H4M3	1	11654375-11663327	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 144.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 48.2;Inhibitory neurons: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003363	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA003363: AB_1078831"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (2.63e-4)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.29e-5)"	"unprognostic (1.34e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.02e-3)"	19.1	37.1	114.2	12.5	118.5	8.2	26.9	112.6	144.5	38.8	76.3	26.8	19.9	20.9	13.4	23.7	32.4	14.5	35.1	120.6	105.3	58.7	39.9	22.3	25.2	108.1	99.8	32.0	41.4	45.5	90.5	3.1	105.1	54.5	4.2	18.0	35.2	19.4	11.4	42.7	27.6	7.9	89.2	38.6	30.1	29.0	111.1	10.1	50.2	8.8	14.0	26.1	36.8	115.6	14.9	23.3	8.2	31.6	11.8	12.4	10.9	11.0	13.9	12.1	10.7	17.0	26.6	0.3	25.7	12.4	20.6	3.3	16.5	37.4	5.0	16.1	21.1	0.4	14.0	27.9	16.2	0.2	2.0	15.9	24.7	11.4	8.7	24.9	9.6	27.4	8.5	3.5	3.1	8.8	24.2	2.4	8.7	12.9	16.5	9.8	0.1	4.8	19.7	5.2	24.8	20.7	29.7	11.3	51.1	10.1	20.4	12.9	12.1	8.8	21.4	12.2	9.1	23.1	13.9	9.3	19.7	5.9	21.0	1.8	2.3	0.7	13.0	2.7	10.0	11.0	8.6	9.8	3.8	11.5	11.6	7.9	1.8	1.8	3.0	5.7	8.6	7.4	114.2	118.5	112.6	144.5	120.6	105.3	108.1	99.8	105.1	89.2	111.1	115.6	3.4	0.0	7.4	27.1	18.3	18.4	12.5	20.1	25.0	21.5	15.7	18.0	4.3	8.6	10.1	16.5	14.6	1.3	18.3	1.2	31.3	7.8	4.5	2.3	4.4	4.3	4.2	1.3	48.2	6.5	2.5	12.3	7.7	2.1	3.8	10.7	8.6	5.4	6.1	40.4	50.1	1.9	14.2	5.3	11.4	13.7	23.0	5.8	10.6	6.5	4.7	15.6	16.5	22.1	18.2	7.0	1.7	29.0	9.7	10.8	1.7	11.9	5.4	7.2	0.0	6.4	6.6	11.1	6.7	7.6	17.0	0.8	18.2	4.5	2.9	5.9
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	5.1	4.2	10.7	6.1	11.5	13.9	7.3	11.8	14.8	4.5	6.8	6.9	5.3	4.7	3.0	8.9	3.6	4.4	3.6	11.0	10.9	3.7	6.9	4.5	6.7	10.7	10.9	5.0	4.6	7.2	3.1	5.4	10.4	5.1	7.0	8.2	4.0	4.3	13.8	12.7	5.1	5.0	11.6	5.1	5.5	12.2	11.5	8.8	3.7	11.5	10.0	6.8	5.0	11.7	45.5	8.5	17.6	22.4	11.6	11.4	20.9	19.7	9.0	15.3	15.6	23.9	15.1	19.1	33.1	12.8	22.8	19.0	33.9	22.5	28.1	27.7	15.3	34.8	15.5	15.1	11.1	46.9	17.1	5.8	24.9	17.3	31.8	8.0	16.9	30.5	42.4	39.2	17.2	45.3	27.5	21.9	27.4	40.3	32.5	23.1	23.0	46.2	12.9	18.3	35.6	24.4	21.4	36.8	23.5	15.4	63.3	31.1	16.8	17.7	19.1	25.7	53.8	38.3	68.5	52.6	15.4	59.6	17.3	1.3	0.9	1.1	0.8	0.9	1.4	0.5	0.8	0.5	1.2	0.8	0.8	0.9	0.4	0.6	1.1	1.4	1.6	0.4	10.7	11.5	11.8	14.8	11.0	10.9	10.7	10.9	10.4	11.6	11.5	11.7	10.2	12.8	4.1	6.5	6.6	9.8	10.2	5.6	4.6	20.1	10.5	7.7	10.8	4.3	4.2	3.7	14.6	2.6	11.5	7.9	0.0	4.4	15.5	8.0	12.9	8.0	17.4	6.1	13.8	7.7	4.6	7.8	10.7	8.8	1.3	6.9	7.9	9.9	5.8	13.5	15.0	8.2	4.1	9.1	11.0	18.9	5.6	7.6	5.4	8.4	8.3	9.3	4.1	6.6	12.4	8.3	4.8	6.4	8.0	14.8	4.0	3.4	6.8	10.7	0.0	10.5	7.5	32.4	24.4	9.4	13.5	1.9	8.2	7.1	9.8	14.5
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730896	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: AB_2680742"	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favorable (5.44e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favorable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (5.09e-6)"	7.5	7.2	10.6	11.1	11.0	9.2	8.9	9.5	12.6	13.5	18.4	11.7	7.6	13.6	7.5	21.4	10.3	5.1	8.5	8.8	12.2	7.9	10.5	7.4	14.7	8.7	9.6	14.1	9.6	5.8	9.4	6.6	11.5	9.8	7.5	9.9	10.1	5.3	11.4	13.4	11.1	6.3	6.0	14.4	10.8	12.3	9.9	11.1	10.4	5.4	13.9	9.3	13.0	20.9	14.0	21.5	16.2	18.9	4.1	7.3	18.3	7.1	4.0	5.6	6.5	17.8	17.9	24.1	9.5	4.0	7.9	19.9	12.1	9.1	4.2	30.0	25.5	19.6	84.1	9.8	6.2	8.7	24.2	6.1	8.1	9.5	5.9	14.0	8.4	29.4	15.6	28.4	4.6	13.2	20.3	10.2	10.2	13.0	7.3	27.3	9.0	22.6	6.7	16.3	16.1	14.1	11.4	23.7	9.4	15.3	20.1	10.7	9.6	11.8	10.6	6.5	12.0	27.2	41.0	16.1	13.1	12.3	9.8	4.6	1.1	1.2	1.8	0.9	1.2	2.1	1.3	1.3	0.8	3.8	1.2	1.4	3.3	0.6	1.2	1.3	1.4	0.7	10.6	11.0	9.5	12.6	8.8	12.2	8.7	9.6	11.5	6.0	9.9	20.9	4.8	9.6	4.8	6.2	6.5	26.0	10.0	5.7	9.1	3.3	12.7	8.5	5.4	10.0	6.1	7.3	2.1	7.9	3.4	16.3	1.9	6.5	2.9	8.0	5.1	5.2	7.3	5.9	6.5	4.9	19.0	3.6	6.1	9.2	3.8	11.4	4.2	21.1	3.7	11.8	5.5	12.7	0.0	5.7	8.8	3.1	5.6	3.3	5.4	5.6	5.6	4.0	7.2	4.0	6.1	6.9	12.2	1.9	5.5	8.0	6.3	2.2	7.2	3.4	0.0	3.6	4.7	6.5	4.6	13.3	35.8	12.4	5.1	4.9	9.3	11.1
FBXO47		ENSG00000204952	"F-box protein 47"	Q5MNV8	17	38936432-38967403	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	39	"testis: 3.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 74.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057438	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA057438: AB_2683441"		"unprognostic (1.53e-1)"			"unprognostic (2.98e-1)"			"unprognostic (2.82e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-2)"		"unprognostic (2.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	74.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FBXO48		ENSG00000204923	"F-box protein 48"	Q5FWF7	2	68459422-68467294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Alveolar cells type 2: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049775, HPA054782"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"		"HPA049775: AB_2680874, HPA054782: AB_2682599"	"unprognostic (2.90e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.89e-2)"	1.1	1.2	1.3	1.4	1.8	0.7	1.3	1.5	1.5	1.1	1.2	1.1	1.8	0.8	1.1	1.1	0.7	0.8	0.7	1.3	1.2	1.4	2.0	1.0	1.7	1.5	1.4	1.7	0.8	1.3	0.5	1.2	1.7	0.8	1.2	3.0	1.3	0.7	3.1	2.5	1.5	0.6	1.2	1.8	1.3	1.0	1.7	1.2	1.1	1.8	1.8	0.7	0.9	2.7	2.1	0.7	1.3	0.9	1.6	1.8	0.9	1.5	1.8	1.4	1.6	1.0	0.9	2.6	1.0	0.7	1.9	1.1	1.2	1.2	2.7	3.5	1.3	1.3	0.7	0.5	0.7	0.6	1.5	0.8	2.1	2.0	1.7	0.7	0.6	4.3	0.6	4.9	1.1	0.4	1.5	1.9	0.7	1.4	1.0	1.3	2.3	1.7	1.1	0.6	1.3	0.9	0.7	0.3	1.7	1.1	0.4	0.6	0.6	1.6	1.5	2.0	1.6	3.9	2.5	1.1	1.0	1.1	1.2	2.6	0.7	0.9	1.0	0.7	1.0	0.9	1.7	1.0	0.4	1.0	1.2	1.2	1.4	1.0	1.3	0.9	2.1	0.6	1.3	1.8	1.5	1.5	1.3	1.2	1.5	1.4	1.7	1.2	1.7	2.7	9.1	32.1	52.0	1.3	6.4	7.1	5.0	3.1	9.1	3.9	7.7	10.4	11.7	7.2	16.3	5.5	2.1	4.2	4.5	7.1	11.7	3.2	1.7	4.0	3.1	8.2	3.0	4.0	0.8	3.3	3.5	6.8	3.1	4.1	12.6	2.1	5.3	7.1	4.1	3.3	0.8	6.2	0.0	5.1	6.6	1.0	4.1	8.7	1.8	0.0	2.5	2.2	2.1	1.5	1.7	3.1	2.7	1.5	5.8	3.4	7.4	9.2	12.9	5.7	0.0	5.5	3.9	18.0	11.1	6.7	8.0	1.6	8.1	2.8	3.5	3.9
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.1;lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	3.1	3.1	1.5	7.3	1.6	44.1	4.5	2.6	2.1	4.0	1.9	5.0	4.6	5.3	4.5	3.7	3.0	2.6	1.8	1.4	1.7	3.1	4.4	3.4	14.9	1.6	1.6	4.1	3.0	2.3	2.1	6.3	1.7	3.0	5.1	3.3	2.7	2.9	0.9	4.3	4.3	5.0	1.6	5.5	4.6	3.9	1.8	27.3	4.4	2.6	14.6	4.0	3.0	2.0	33.7	17.2	70.8	48.1	5.3	10.8	22.6	79.9	35.5	58.7	65.6	35.6	19.8	81.6	23.9	21.3	39.7	31.4	56.4	26.7	70.0	44.2	50.6	82.3	24.1	38.7	10.2	74.4	48.6	7.7	4.9	39.8	30.9	14.3	27.3	42.3	88.2	74.5	53.9	25.7	85.2	47.6	41.5	25.8	25.0	71.0	56.8	52.8	20.8	18.0	46.1	47.9	56.6	30.2	15.6	24.7	21.8	68.7	20.6	43.9	57.4	51.1	94.8	24.9	29.5	120.4	31.9	54.3	54.2	0.0	1.9	0.0	2.8	2.5	4.0	5.1	4.7	5.2	3.7	5.0	4.6	4.8	0.0	7.1	3.2	4.3	6.6	2.5	1.5	1.6	2.6	2.1	1.4	1.7	1.6	1.6	1.7	1.6	1.8	2.0	6.0	0.0	1.1	1.3	9.8	9.9	3.7	4.0	7.4	3.2	5.7	5.2	1.8	2.8	3.9	1.8	6.2	15.2	13.5	2.6	3.9	3.0	0.4	2.3	10.5	5.7	4.8	36.0	1.0	1.6	30.5	9.1	7.7	4.0	2.5	16.6	5.0	1.9	7.9	1.7	0.9	6.1	2.0	3.2	6.1	0.1	4.4	5.3	1.8	1.9	4.2	4.1	9.2	1.5	2.1	1.5	0.5	6.0	24.7	3.6	1.5	3.6	1.9	3.6	13.1	8.6	8.9	32.3	26.1	10.2	5.3	5.9	7.9	8.0	6.3	2.0
FBXO6	"FBG2, FBS2, FBX6, Fbx6b"	ENSG00000116663	"F-box protein 6"	Q9NRD1	1	11664200-11674354	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.6;Late spermatids: 117.8;NK-cells: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA051175	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051175: AB_2681372"	"unprognostic (3.23e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (2.65e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (5.90e-4)"	6.5	10.7	9.9	11.8	10.1	20.3	6.7	10.3	12.4	7.6	8.2	7.6	13.5	5.0	6.0	10.3	14.1	8.7	10.0	9.8	11.5	7.8	18.5	11.4	18.3	9.9	10.5	5.9	13.8	13.5	6.1	2.6	9.7	8.7	6.8	3.6	13.0	8.4	18.7	9.5	8.2	7.4	10.0	13.0	9.8	10.8	12.6	7.1	6.7	14.5	11.1	9.5	7.0	9.8	10.0	7.3	0.8	0.4	2.1	6.8	4.5	4.2	6.6	20.1	9.2	7.6	8.3	0.3	18.7	7.0	5.5	0.2	6.8	7.5	1.5	26.3	1.0	0.2	1.0	7.7	15.4	9.4	0.1	7.9	15.8	2.5	6.3	4.3	2.6	10.3	22.7	18.7	1.8	19.1	3.4	7.8	0.8	10.2	9.7	2.3	0.1	0.7	6.9	1.4	1.6	2.0	9.3	10.9	14.3	1.8	10.5	10.2	2.0	1.0	0.8	2.7	0.3	10.0	7.5	3.9	1.2	21.6	1.8	17.1	49.5	65.0	47.0	75.0	25.4	15.3	12.0	31.3	66.5	15.0	7.1	23.7	41.4	41.4	91.0	27.3	13.1	36.6	9.9	10.1	10.3	12.4	9.8	11.5	9.9	10.5	9.7	10.0	12.6	9.8	6.0	6.4	6.9	3.3	8.4	7.0	6.6	14.6	4.0	4.3	8.3	7.4	6.8	2.8	15.0	9.2	2.1	1.1	19.5	10.7	0.0	14.5	60.6	15.7	4.5	4.0	4.9	1.7	1.8	38.5	9.2	7.8	8.6	5.3	3.8	2.2	8.2	19.9	26.2	5.0	2.6	8.3	8.2	15.4	34.7	117.8	8.1	18.3	7.2	1.0	37.8	9.0	60.8	0.0	1.3	13.0	10.8	11.3	12.2	11.3	14.3	15.6	36.5	7.8	0.0	3.3	4.0	4.0	11.9	7.3	9.8	1.8	16.0	1.8	9.2	11.2
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 279.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 680.9;Late spermatids: 620.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		550000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	51.6	61.7	70.3	35.9	86.8	279.9	52.9	79.9	86.5	53.5	72.3	53.5	47.7	49.2	68.7	40.1	66.6	43.9	38.5	68.3	76.2	106.5	128.4	59.6	54.6	85.0	83.8	62.7	41.0	75.9	50.6	71.5	84.1	42.6	53.8	40.1	43.1	53.5	31.0	50.6	48.4	57.1	79.0	65.6	48.4	99.5	79.8	77.9	134.2	48.3	61.8	54.8	44.0	97.8	72.1	52.1	69.3	77.1	105.8	99.5	45.9	64.3	119.6	102.7	121.9	54.4	51.1	71.2	49.6	114.6	87.8	47.6	103.3	84.7	105.1	111.8	80.9	99.1	54.4	83.7	126.8	126.2	82.8	83.8	134.1	90.6	69.2	93.4	112.2	53.1	77.5	88.0	112.7	57.7	65.3	81.2	26.7	102.3	36.1	64.1	72.2	84.0	118.2	81.0	96.6	63.1	81.3	62.4	235.2	98.3	34.0	67.2	76.0	50.6	69.4	48.4	49.5	62.1	69.3	67.6	97.4	65.6	212.3	251.5	59.9	132.1	83.3	70.6	101.5	70.2	75.9	84.9	82.2	63.6	65.6	72.6	22.4	98.3	74.9	55.8	101.3	90.4	70.3	86.8	79.9	86.5	68.3	76.2	85.0	83.8	84.1	79.0	79.8	97.8	48.8	41.7	25.3	37.9	60.4	46.3	69.4	72.7	48.9	26.0	46.5	32.3	16.1	65.8	48.1	49.7	18.8	90.2	73.6	43.4	97.8	75.3	303.3	41.3	37.8	53.1	67.6	680.9	27.6	77.4	108.9	47.9	40.2	47.2	55.8	63.6	53.9	88.6	71.9	33.7	26.7	42.7	65.1	64.8	53.2	620.8	45.1	55.0	119.2	28.1	125.2	54.1	72.1	101.0	170.6	77.2	58.0	48.9	62.7	68.3	72.2	152.9	34.2	38.1	46.0	35.3	46.2	149.4	136.9	42.3	43.3	71.6	62.3	41.8	47.2	83.7
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174283667	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	15.7	18.6	13.8	10.5	15.3	10.2	17.8	15.7	17.5	14.3	13.8	18.4	16.3	12.5	19.9	17.0	15.5	15.5	21.2	13.5	16.6	22.9	47.5	14.0	12.9	15.8	14.7	17.0	14.2	21.2	14.2	30.9	16.1	14.7	16.1	17.8	15.2	12.6	6.7	16.1	16.4	16.3	15.1	13.0	15.0	11.2	14.8	15.8	22.2	10.1	12.6	16.0	13.7	17.8	10.0	6.3	12.3	4.3	31.5	33.2	9.8	18.8	19.2	13.3	13.6	5.2	19.9	6.9	19.5	15.7	12.2	6.7	9.2	11.7	13.8	22.5	20.9	7.2	10.4	7.4	23.5	8.5	7.5	19.1	24.5	12.9	13.4	20.5	13.4	8.0	14.9	40.5	18.3	7.9	9.8	8.6	4.4	15.4	7.6	4.9	8.2	12.5	17.8	4.1	13.9	80.8	8.7	16.1	22.4	11.8	11.0	11.0	17.0	9.1	7.3	23.5	11.3	18.5	9.7	6.2	25.2	6.4	13.0	29.4	6.5	14.0	12.1	8.4	15.2	13.2	13.7	12.1	9.0	11.9	12.7	11.6	6.6	10.5	10.0	9.1	16.6	8.4	13.8	15.3	15.7	17.5	13.5	16.6	15.8	14.7	16.1	15.1	14.8	17.8	18.9	3.2	10.0	6.5	15.8	20.6	17.0	26.0	19.4	13.2	16.9	11.4	10.8	15.7	19.5	22.0	6.2	36.6	10.1	20.3	50.9	19.0	20.5	24.9	13.2	15.8	12.1	11.2	10.1	10.9	60.6	32.7	14.8	16.3	2.5	5.3	21.0	58.1	21.2	18.5	13.0	21.5	28.5	19.6	8.2	5.5	17.4	12.2	10.6	11.2	16.3	29.1	9.2	9.0	17.8	12.4	21.4	26.4	9.1	16.8	21.5	44.6	26.2	18.1	13.1	14.9	18.4	34.7	17.6	19.8	31.4	89.6	14.3	10.3	13.7	22.7
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	19.5	20.4	33.3	13.6	38.2	8.2	17.0	34.7	41.6	19.9	27.4	14.6	12.6	22.9	12.4	24.2	27.0	17.5	36.1	38.0	35.5	23.0	20.7	17.6	16.7	33.3	34.4	25.6	29.1	33.1	14.2	13.9	33.1	19.0	16.0	37.2	13.5	20.3	34.5	13.7	13.2	26.1	34.4	18.1	20.0	14.3	37.7	17.3	21.1	35.6	22.0	19.2	15.8	42.4	35.4	35.6	52.0	45.2	39.9	40.2	26.4	37.1	51.7	45.0	54.9	36.7	23.1	32.5	44.3	46.4	72.0	22.8	37.6	56.3	74.6	42.7	37.3	26.2	35.0	28.5	35.4	29.8	36.0	28.5	38.2	36.8	59.8	48.5	38.6	27.3	16.6	31.7	55.7	26.5	20.7	15.3	19.8	20.8	39.5	30.1	43.7	22.0	34.8	29.2	21.6	37.2	32.9	27.3	70.8	38.7	34.2	31.0	33.8	44.3	22.0	27.4	37.2	31.8	38.9	22.2	31.3	27.8	34.6	25.4	7.3	7.2	5.8	5.1	6.1	8.5	4.8	5.7	7.3	8.4	4.3	5.7	7.1	14.1	5.7	8.6	5.7	6.6	33.3	38.2	34.7	41.6	38.0	35.5	33.3	34.4	33.1	34.4	37.7	42.4	35.4	25.6	21.2	75.4	52.7	19.1	15.6	21.8	32.5	43.5	26.4	22.1	59.1	42.9	20.8	27.6	8.4	8.5	49.8	25.1	43.0	33.7	32.9	42.0	47.9	26.3	28.8	27.4	86.5	36.9	7.8	24.7	38.2	51.0	20.8	25.8	29.3	43.1	12.8	35.3	85.3	21.6	20.3	29.6	25.3	34.3	29.5	26.6	12.4	62.8	24.6	63.6	16.5	75.9	94.4	54.1	14.9	28.6	36.5	30.2	21.5	52.4	17.1	34.3	46.0	28.2	33.5	34.5	16.0	28.7	23.7	12.0	28.8	17.2	15.0	32.9
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"pancreas: 6.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.4;Late spermatids: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA037491: AB_2675504, HPA037492: AB_2675505"	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.6	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1
FBXW2	"FBW2, Fwd2, Md6"	ENSG00000119402	"F-box and WD repeat domain containing 2"	Q9UKT8	9	120751978-120793416	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 177.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067878	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067878: AB_2685913"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (1.38e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.83e-2)"	23.7	21.7	10.0	21.0	10.3	37.4	20.1	10.5	10.6	21.7	11.7	18.0	16.7	19.9	15.4	21.3	16.5	14.7	23.5	11.8	10.9	18.0	22.2	23.1	22.1	9.5	10.5	16.9	18.5	22.7	13.0	17.4	9.4	18.4	19.8	15.2	19.0	18.8	16.1	21.4	16.0	22.7	9.5	22.5	18.7	17.7	12.2	26.3	19.9	21.7	25.3	22.4	16.7	11.4	30.1	37.3	27.5	46.5	50.7	41.4	25.4	39.5	45.1	42.7	41.3	29.8	35.4	44.9	20.4	51.8	43.1	64.4	39.9	39.4	53.0	60.6	17.2	29.1	64.8	43.5	28.6	65.6	38.6	30.3	47.9	47.2	50.0	40.1	50.8	45.7	39.4	47.5	37.4	48.2	47.3	19.6	41.0	50.8	35.3	36.1	43.8	45.1	29.5	33.5	21.9	33.0	55.3	40.6	29.5	32.2	66.5	18.7	38.1	36.3	28.9	59.3	49.6	34.1	74.2	38.5	38.4	28.7	38.1	15.3	12.0	17.2	17.3	11.4	13.1	10.0	12.3	16.3	11.0	6.2	10.0	13.8	12.4	15.5	13.7	9.6	13.0	9.8	10.0	10.3	10.5	10.6	11.8	10.9	9.5	10.5	9.4	9.5	12.2	11.4	32.3	25.6	56.9	17.3	17.6	22.7	26.4	27.3	13.1	20.0	23.5	16.6	21.9	12.8	28.7	11.0	12.5	18.5	50.9	27.1	21.5	27.1	38.8	14.5	22.7	31.9	27.6	24.0	34.0	34.0	29.2	23.2	28.1	17.8	15.8	27.2	33.5	33.9	25.2	33.7	29.0	19.0	28.5	25.0	30.0	177.2	26.4	21.7	48.0	23.4	38.0	16.5	36.0	27.6	37.0	32.5	19.4	35.7	24.5	34.9	22.7	24.7	21.0	25.1	6.6	20.4	36.1	40.5	53.7	21.9	32.0	17.8	31.2	31.0	23.2	28.1
FBXW4	"dactylin, Fbw4, SHFM3"	ENSG00000107829	"F-box and WD repeat domain containing 4"	P57775	10	101610664-101695295	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043496	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA043496: AB_2678514"	"unprognostic (4.31e-2)"	"unprognostic (5.43e-3)"	"unprognostic (8.40e-3)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (4.67e-4)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (2.94e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.85e-2)"	38.4	30.4	89.9	10.4	96.6	16.0	34.8	83.5	96.3	33.2	71.3	59.9	16.5	26.7	29.6	38.7	28.9	12.9	62.4	80.9	81.1	36.4	34.9	35.8	18.0	92.3	92.1	30.2	44.2	47.0	46.7	16.4	87.8	49.1	16.5	14.2	41.4	26.8	80.0	49.7	31.5	14.7	94.8	30.1	40.8	22.8	94.2	18.1	40.2	44.4	17.9	49.0	32.9	98.0	22.1	25.7	4.0	28.9	20.1	16.5	18.9	11.3	31.1	12.8	10.0	12.0	22.9	25.1	17.5	23.4	13.1	13.4	11.0	16.7	4.3	26.8	15.2	6.0	9.1	26.1	35.7	10.0	7.6	15.2	52.0	6.9	42.8	29.8	11.0	17.6	6.2	15.3	14.2	45.9	11.4	14.2	11.3	11.4	12.3	9.4	29.6	10.7	25.1	14.7	12.3	21.6	21.8	8.1	20.7	6.0	33.6	17.8	11.8	13.8	1.8	5.8	11.5	31.9	15.4	11.1	11.3	12.7	8.1	1.3	1.4	2.2	4.3	0.8	2.6	3.8	4.3	4.2	1.1	4.8	4.5	3.7	0.2	4.2	1.4	4.1	1.4	1.2	89.9	96.6	83.5	96.3	80.9	81.1	92.3	92.1	87.8	94.8	94.2	98.0	13.6	3.2	36.9	45.4	14.0	11.2	16.4	11.9	6.8	28.5	25.7	21.8	35.8	12.8	11.1	11.0	18.8	17.0	24.4	29.1	3.9	15.2	50.2	15.3	16.3	10.0	20.4	7.0	57.5	26.1	9.2	11.3	17.3	27.2	5.1	32.3	8.9	24.7	8.8	37.0	55.7	27.8	14.2	8.6	7.4	28.9	14.3	8.7	14.2	55.3	10.7	29.9	15.5	54.8	70.3	19.4	24.4	17.0	14.1	22.2	21.1	13.3	7.5	22.7	13.1	15.4	14.7	4.9	6.0	11.3	12.5	15.6	16.9	10.9	21.7	18.7
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944738	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 251.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 581.9;Late spermatids: 1900.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	54.7	58.1	27.6	23.3	23.0	28.7	47.4	23.4	32.4	36.2	23.4	73.9	42.9	44.1	9.4	70.8	33.9	17.7	117.1	34.7	23.5	54.3	132.4	37.5	22.1	27.0	27.2	29.1	75.7	19.0	41.1	15.5	28.3	56.3	13.4	3.9	54.8	26.9	188.7	42.6	59.3	17.2	24.3	47.6	65.0	251.8	33.0	24.7	42.5	66.0	17.6	59.4	41.5	23.7	39.2	65.5	14.9	36.7	36.6	23.6	85.7	40.6	27.5	27.7	15.3	42.9	48.8	27.0	46.0	42.0	21.5	48.0	13.6	35.3	4.6	35.4	47.2	22.9	88.8	46.8	40.0	34.2	55.2	26.9	31.0	25.4	21.1	21.9	28.9	19.5	46.0	42.7	21.3	98.3	26.2	36.4	26.7	48.1	70.6	28.7	22.5	46.3	24.5	37.9	30.9	30.0	49.0	52.8	54.4	5.7	60.3	52.4	55.8	39.5	35.1	75.1	35.1	33.6	45.1	17.0	55.0	29.7	30.5	62.8	62.1	88.0	97.7	74.3	75.3	39.2	73.9	83.3	59.6	31.1	32.0	53.7	32.9	55.4	61.2	98.8	96.8	72.8	27.6	23.0	23.4	32.4	34.7	23.5	27.0	27.2	28.3	24.3	33.0	23.7	61.3	19.2	45.4	13.1	40.7	28.7	44.5	129.0	26.7	29.9	50.1	48.8	86.9	50.1	72.8	23.9	16.7	68.3	108.0	336.5	74.3	111.7	581.9	29.1	27.5	53.6	67.3	36.8	15.9	148.1	132.9	38.9	98.4	38.6	28.6	116.2	46.1	113.3	88.0	60.6	15.3	153.7	65.1	62.6	49.3	1900.7	51.6	69.2	69.4	8.4	124.9	59.1	83.4	11.1	17.1	132.5	238.0	71.1	59.4	84.6	420.9	134.1	43.5	37.3	59.2	33.5	59.0	224.3	47.4	47.1	35.9	101.4	66.6	49.4	127.6	70.0
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536092	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 201.8;Excitatory neurons: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	14.2	9.5	37.9	15.0	43.1	19.8	14.2	54.3	66.9	8.7	6.7	9.5	7.8	8.6	24.3	14.3	15.6	9.2	24.7	48.2	23.0	6.7	11.2	11.4	16.1	17.1	20.9	9.1	12.8	7.8	9.2	9.4	18.1	7.8	10.3	18.0	11.8	7.5	26.0	63.1	10.4	9.1	11.8	16.2	13.0	22.8	29.4	14.7	10.3	19.7	20.3	11.9	10.7	47.4	9.8	8.0	19.1	14.2	12.2	9.4	16.2	13.4	12.9	8.5	8.1	15.7	12.0	24.7	3.9	13.7	6.5	5.2	16.9	30.9	12.1	16.2	8.0	11.9	10.7	10.9	12.7	29.2	10.6	14.8	45.7	15.2	24.4	8.4	15.2	20.5	19.2	25.7	10.8	13.7	34.9	10.6	9.7	8.0	6.1	32.2	8.0	5.3	9.8	17.0	12.7	10.2	8.5	11.3	7.5	21.6	6.4	12.6	15.6	11.3	12.6	5.4	8.2	79.0	47.5	24.4	9.4	9.2	8.3	23.5	2.7	1.6	4.0	3.0	2.7	2.8	3.1	2.7	1.6	1.8	3.4	2.5	4.8	7.1	2.2	2.1	2.9	1.3	37.9	43.1	54.3	66.9	48.2	23.0	17.1	20.9	18.1	11.8	29.4	47.4	29.5	9.6	22.9	80.0	48.1	201.8	36.5	29.9	120.1	74.9	32.1	30.9	61.8	12.8	15.1	9.2	31.3	10.9	54.7	22.2	3.9	14.3	17.4	37.7	37.3	36.1	14.5	30.1	529.6	13.5	39.9	27.2	21.4	61.6	15.8	19.1	17.9	18.3	10.5	11.8	186.5	16.4	32.6	18.8	47.0	10.2	15.2	33.7	28.4	172.4	28.0	37.0	35.0	102.5	99.8	18.7	18.2	11.3	174.5	36.3	8.9	7.5	11.9	41.4	13.1	33.2	25.5	74.1	87.2	57.0	174.9	31.2	46.2	18.7	14.9	70.5
FBXW8	"FBW6, FBW8, FBX29, FBXO29"	ENSG00000174989	"F-box and WD repeat domain containing 8"	Q8N3Y1	12	116910950-117031148	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Excitatory neurons: 40.6;Inhibitory neurons: 38.9;Late spermatids: 84.1;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038850, HPA038851"	Supported		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA038850: AB_2676238, HPA038851: AB_10673479"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.55e-1)"	5.3	4.9	2.5	4.7	9.5	3.5	5.9	1.5	3.0	5.8	10.1	4.9	3.6	6.5	3.9	5.3	6.3	4.1	4.7	4.1	3.0	4.0	4.0	4.5	5.6	2.9	2.3	8.6	7.1	8.5	8.2	7.6	1.9	4.8	4.9	4.4	6.6	5.2	5.3	5.8	4.3	5.8	1.3	4.1	5.9	4.9	3.7	5.5	9.4	3.4	6.6	5.2	5.0	2.6	8.6	15.5	13.4	10.8	12.1	16.9	8.8	16.0	16.6	11.8	11.4	4.9	5.9	13.0	5.9	21.1	6.3	9.1	10.1	6.3	9.5	20.6	7.3	6.3	7.1	5.0	20.7	8.1	4.7	17.6	5.4	11.0	24.7	16.7	13.2	11.7	8.2	6.0	10.7	22.3	6.4	5.5	15.7	3.9	9.4	10.0	6.1	11.2	9.5	14.6	12.0	33.4	11.5	4.1	7.9	11.3	15.2	7.1	16.7	10.4	4.3	10.8	5.0	19.0	12.6	12.2	14.2	4.9	17.2	0.2	0.8	2.0	1.4	0.8	1.3	2.4	0.8	0.9	1.1	1.9	0.5	0.8	0.0	3.9	1.0	1.1	1.2	0.7	2.5	9.5	1.5	3.0	4.1	3.0	2.9	2.3	1.9	1.3	3.7	2.6	3.2	0.0	6.4	21.9	5.4	1.9	3.0	1.4	5.2	9.1	3.5	4.2	3.1	4.3	5.6	1.8	25.0	9.4	5.5	1.4	1.9	4.2	53.5	4.1	6.6	3.6	9.1	3.8	40.6	4.5	6.5	5.4	8.6	3.6	2.5	11.1	0.7	3.0	4.3	1.7	38.9	4.2	0.0	3.5	0.8	84.1	9.3	2.6	0.0	33.7	2.3	3.1	5.2	38.2	28.3	2.4	3.3	5.3	7.7	5.4	1.0	2.2	4.7	15.2	0.0	7.2	4.2	4.6	6.7	3.5	1.4	6.7	4.5	11.6	3.7	3.2
FBXW9	"Fbw9, MEC-15, MGC10870"	ENSG00000132004	"F-box and WD repeat domain containing 9"	Q5XUX1	19	12688053-12696631	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.6;Respiratory ciliated cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042087	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA042087: AB_10794168"	"unprognostic (4.46e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.69e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.42e-3)"	4.2	7.9	4.4	2.1	4.4	4.2	5.6	2.9	5.8	5.2	9.0	5.2	4.4	4.9	2.0	10.3	13.1	2.9	2.9	4.7	4.3	8.6	5.1	4.5	3.0	4.1	6.3	4.0	7.3	4.3	7.4	2.6	4.2	7.2	1.7	2.0	7.6	3.5	2.7	9.4	4.0	1.7	4.0	3.9	5.6	14.9	4.4	2.9	7.5	0.8	1.9	4.6	5.8	3.2	16.6	11.1	7.2	10.6	3.1	5.2	8.7	5.3	5.4	11.1	9.1	6.2	10.0	4.1	13.5	4.8	2.7	14.7	6.9	10.0	1.9	2.9	18.5	4.9	13.2	10.4	7.0	12.3	2.9	7.0	15.8	7.7	3.8	6.6	8.8	9.4	11.9	2.7	2.5	34.5	13.4	16.1	12.2	8.8	10.4	7.0	5.0	23.2	10.0	4.9	16.5	19.6	7.9	16.5	7.6	2.3	16.5	9.3	4.3	6.5	6.0	8.1	8.5	16.4	7.3	4.5	8.1	4.5	4.3	0.0	7.4	0.0	2.7	7.1	4.6	2.8	2.9	2.1	11.1	2.5	2.8	2.0	0.3	4.7	4.9	3.1	5.7	5.0	4.4	4.4	2.9	5.8	4.7	4.3	4.1	6.3	4.2	4.0	4.4	3.2	4.8	3.2	5.4	1.3	1.3	6.0	5.2	18.6	8.0	2.0	12.1	13.0	0.7	8.6	14.3	1.8	6.2	14.4	1.5	5.7	5.9	18.1	6.4	65.6	6.9	4.2	4.8	11.8	3.7	16.0	8.4	4.4	5.6	6.8	0.0	10.7	4.6	3.6	7.0	0.0	3.1	9.2	22.4	4.5	3.7	8.5	2.5	5.9	3.6	0.0	4.2	4.9	1.0	1.0	1.2	11.6	5.6	4.5	1.7	4.2	5.5	17.4	80.3	7.1	6.6	4.4	6.5	30.8	17.3	9.2	8.2	6.4	2.4	20.3	12.5	4.9
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 38.1;lymphoid tissue: 26.2"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 32.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 2.4;renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056505	Enhanced					NA	NA		5300000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.1	7.9	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	26.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lung: 10.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 12.8;Macrophages: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.2;neutrophil: 4.0"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.5	0.3	0.0	1.0	0.0	26.1	0.7	0.0	0.3	0.2	0.0	0.6	0.0	0.2	0.0	0.3	3.4	0.0	1.5	0.0	0.0	0.5	1.7	10.5	0.0	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.1	0.0	13.5	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.1	0.3	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	12.8	0.3	0.0	0.0	18.0	0.0	1.0	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.7	0.5	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.6"	"Cell type enriched"	"Detected in many"	7	"Langerhans cells: 1962.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 21557.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 21557.7"	"Cell line enriched"	"Detected in some"	99	"HEL: 447.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	3.9	1.7	0.4	5.7	0.4	14.2	17.3	0.5	0.8	10.6	0.5	7.0	7.1	7.1	5.4	23.0	2.9	14.9	3.2	0.4	0.6	4.7	4.4	14.5	2.5	0.6	0.5	0.7	1.2	2.6	0.8	0.2	0.7	5.9	10.7	0.1	4.0	9.1	2.8	33.6	8.8	7.4	0.4	8.0	3.5	2.3	0.6	4.8	1.2	3.9	10.9	11.9	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	447.9	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21557.7	14.4	36.4	0.4	4.1	4.4	2.8	4.4	1.5	2645.6	3.1	2.3	3.4	17.2	14.6	11.0	361.0	2.8	132.1	0.4	0.4	0.5	0.8	0.4	0.6	0.6	0.5	0.7	0.4	0.6	0.5	1.6	6.4	33.1	0.3	5.5	37.7	0.1	0.0	0.6	0.0	0.6	1.8	0.6	0.0	1.8	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.3	0.1	0.0	3.4	0.0	37.8	0.0	0.0	0.1	4.2	0.0	0.1	270.7	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	4.0	1962.9	1.1	0.0	169.1	46.2	0.0	46.8	0.0	3.1	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.0	1.5	0.0	13.1	0.1	2.6	0.1	0.3	0.2	34.1	0.0	6.8	0.0	0.0	0.0
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.6;lymphoid tissue: 470.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	251.7	86.5	34.0	275.6	33.8	441.6	62.9	35.5	66.0	52.5	47.5	82.7	44.9	30.7	38.7	30.6	72.0	101.5	53.1	33.7	42.0	40.3	177.3	286.6	160.9	53.4	48.7	19.9	22.3	26.8	26.9	211.0	50.1	31.0	113.2	8.3	42.9	38.8	11.9	21.0	60.6	160.3	41.5	470.1	39.4	14.5	49.9	62.7	25.5	34.6	82.5	254.6	21.7	65.4	0.2	0.0	0.7	1.3	1.8	0.7	0.4	0.5	0.2	0.5	0.8	2.2	0.1	0.5	0.7	0.0	0.3	0.2	0.5	0.0	0.4	0.3	1.5	77.8	0.6	14.0	0.3	16.1	301.7	6.0	3.3	2.3	0.2	0.7	0.4	1.8	0.1	7.3	2.4	0.5	1.4	37.9	1.6	0.0	0.0	0.1	6.7	0.2	0.5	0.4	0.3	1.0	0.6	0.1	2.7	1.4	0.2	276.1	0.4	1.8	0.4	0.9	1.1	3.0	90.1	0.9	1.7	87.1	0.5	1987.3	3240.2	307.3	13.6	5333.6	15.9	28.2	10.6	10.6	2386.3	9.0	17.3	45.0	1831.0	1750.9	6984.5	3315.6	21.8	4265.5	34.0	33.8	35.5	66.0	33.7	42.0	53.4	48.7	50.1	41.5	49.9	65.4	12.8	86.6	147.7	0.7	35.9	39.6	1.5	0.2	1.8	0.1	5.2	22.1	6.8	15.7	27.3	18.4	0.0	14.5	726.6	1.0	0.0	1.9	3.0	1.0	0.9	38.6	1.8	79.3	0.1	1.0	18.8	18.3	1.1	1.0	705.6	0.5	41.0	13.6	2318.6	0.0	0.2	0.5	0.0	1950.8	1526.3	9.4	5.3	1971.3	80.0	12.2	808.9	0.2	1037.1	0.0	0.1	1.0	1.4	1.2	10.1	1.3	0.4	5.4	15.3	2.3	72.3	3.8	11.2	1.0	2.5	1.4	35.9	23.7	133.3	0.4	0.6	1.8
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 42.2"	"Cell type enriched"	"Detected in some"	16	"B-cells: 157.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in many"	24	"memory B-cell: 200.9;naive B-cell: 496.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 496.2"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 449.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"	NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	4.8	0.1	0.0	17.4	0.0	5.2	1.2	0.2	1.3	0.4	0.0	1.8	2.8	0.1	0.1	0.4	0.3	1.1	0.5	0.3	0.0	0.3	0.5	0.6	39.5	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.1	1.9	0.0	1.8	0.1	0.3	0.4	9.7	0.2	0.0	38.4	2.2	0.4	0.0	6.3	0.6	0.1	42.2	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	449.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	32.7	0.0	0.5	4.2	0.3	0.0	14.7	0.1	200.9	0.2	0.0	4.4	496.2	0.3	0.1	1.5	0.3	4.4	0.6	0.2	21.6	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	157.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.0	1.2	0.0	0.1	0.0	0.0	1.3	1.7	0.0	0.0	9.4	1.8	1.0	0.9	0.0	2.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.2	1.2	0.0	0.0
FCF1	"Bka, C14orf111, CGI-35, UTP24"	ENSG00000119616	"FCF1 rRNA-processing protein"	Q9Y324	14	74713144-74738620	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 104.7;Smooth muscle cells: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA046681	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046681: AB_10960541"	"unprognostic (1.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (5.54e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (7.79e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.47e-1)"	32.5	23.1	9.9	25.4	12.7	27.0	34.9	12.7	13.0	30.5	11.5	28.6	18.9	29.2	20.9	24.9	38.4	22.0	26.8	9.4	12.1	30.1	32.8	27.9	34.4	12.5	12.7	39.9	16.5	26.6	12.9	32.1	12.8	28.2	29.3	13.2	19.9	30.6	25.3	17.3	20.5	30.2	11.3	23.5	23.0	18.4	11.4	33.2	43.3	22.4	41.3	29.2	19.0	17.4	109.3	78.7	55.8	63.5	86.8	76.3	73.5	93.6	71.7	91.4	81.2	88.1	87.3	97.2	59.6	82.1	44.2	78.5	94.1	88.5	160.7	90.6	40.8	67.4	46.4	57.9	62.6	83.1	59.5	60.3	76.6	97.3	101.4	72.4	86.6	82.7	82.2	56.9	83.3	77.5	97.0	29.6	75.0	63.2	90.5	72.9	109.5	46.3	46.4	88.1	39.1	56.9	120.1	62.8	55.0	61.4	80.7	57.0	79.9	72.7	77.6	69.5	108.3	49.9	140.7	147.7	69.2	77.5	82.5	13.5	17.0	20.5	19.1	15.3	21.0	24.3	18.4	16.6	13.9	21.2	19.5	20.5	14.7	15.3	18.8	31.3	19.6	9.2	9.9	12.7	12.7	13.0	9.4	12.1	12.5	12.7	12.8	11.3	11.4	17.4	11.9	6.4	18.3	7.5	18.8	3.1	7.6	10.5	11.4	7.5	12.2	7.5	24.0	34.3	14.9	12.9	6.2	11.8	26.6	16.3	15.6	17.4	23.8	28.0	18.5	13.7	10.2	36.2	11.6	19.0	14.7	13.3	6.1	13.5	26.0	9.3	28.5	104.7	12.8	11.8	11.7	15.9	8.2	33.6	4.3	11.9	15.5	12.6	0.0	7.5	16.4	13.5	24.7	11.6	17.5	17.4	10.3	17.0	12.0	6.1	13.1	18.4	45.4	7.2	13.1	12.5	67.7	12.4	12.3	11.1	4.8	8.8	14.3	8.2	15.6	6.7
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 206.9;salivary gland: 85.4;stomach 1: 85.5;thyroid gland: 99.9"	"Cell type enriched"	"Detected in many"	9	"Intestinal goblet cells: 6081.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 63.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1"									"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	5.9	10.0	5.1	14.0	7.2	0.4	3.2	4.0	8.4	56.4	15.0	206.9	68.7	1.2	0.6	4.6	9.8	49.2	2.9	5.6	6.8	11.3	1.0	1.9	0.9	20.1	10.6	3.7	4.9	0.5	3.4	2.9	11.1	3.8	67.7	0.6	85.4	1.4	0.4	14.8	148.7	2.6	5.9	1.5	85.5	2.9	14.0	1.5	99.9	0.0	0.7	3.4	1.6	12.0	0.0	4.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	1.8	0.6	0.1	1.5	0.3	0.1	7.1	1.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.1	5.1	7.2	4.0	8.4	5.6	6.8	20.1	10.6	11.1	5.9	14.0	12.0	0.6	3.2	5.1	2.6	4.6	3.7	1.9	15.8	1.2	1.1	1.3	3.4	2.8	70.1	60.0	25.8	0.0	0.7	1.8	622.2	0.0	5.2	7.2	4.2	0.3	26.7	81.1	0.0	0.6	0.9	0.4	1.9	552.0	4.0	15.9	0.4	0.7	1.3	44.0	0.0	0.4	6081.9	2.0	30.2	12.6	9.2	0.9	21.6	8.8	15.9	0.9	0.4	1.0	0.5	0.2	3.9	253.6	0.0	2.1	13.8	413.5	1.2	11.0	2.0	59.2	0.5	1.1	0.5	2.4	0.4	6.8	0.4	5.6	0.9	191.4	164.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCGR2B	"CD32, CD32B, FCG2, FCGR2"	ENSG00000072694	"Fc fragment of IgG receptor IIb"	P31994	1	161663147-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"placenta: 398.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.0;Hepatic stellate cells: 333.8;Langerhans cells: 244.0;Macrophages: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 327.2;memory B-cell: 202.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 24.9;HMC-1: 31.2;NB-4: 7.3;RPMI-8226: 11.7"									"CAB007796, HPA014730"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.12e-2)"	"unprognostic (6.79e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.37e-1)"	30.4	7.5	0.9	12.2	1.3	1.7	15.4	1.3	3.3	9.7	4.2	10.3	3.0	2.6	2.8	11.4	4.4	13.0	7.9	0.7	1.1	4.2	42.4	21.7	15.8	4.5	1.1	4.8	4.7	2.8	1.4	398.2	2.2	1.8	11.0	1.1	7.0	2.8	2.2	4.8	16.0	16.6	2.2	25.5	4.9	2.5	1.4	7.4	4.2	13.7	29.6	18.7	3.1	5.8	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.8	0.0	327.2	8.5	26.4	1.4	9.7	0.6	202.8	0.7	1.1	72.4	160.4	0.1	1.4	53.6	0.7	9.5	0.1	0.1	13.0	0.9	1.3	1.3	3.3	0.7	1.1	4.5	1.1	2.2	2.2	1.4	5.8	2.2	0.0	3.9	0.0	75.0	5.4	0.1	0.0	0.0	0.0	0.3	0.9	2.1	2.8	1.3	0.0	0.0	0.2	5.6	0.0	0.0	0.0	4.8	0.0	0.0	49.8	0.0	3.2	0.0	0.0	0.2	1.7	1.1	0.0	2.5	0.2	333.8	8.2	7.6	0.0	0.0	0.0	0.0	47.4	244.0	4.2	0.6	145.5	23.2	0.0	9.5	0.0	5.2	0.0	0.1	0.0	0.0	0.0	45.4	0.0	0.0	0.3	0.0	0.0	0.0	1.7	2.5	0.3	0.2	0.7	3.1	0.4	5.8	0.1	0.1	0.0
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 206.3;lymphoid tissue: 306.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 333.4;Hofbauer cells: 193.1;Kupffer cells: 807.9;Macrophages: 300.0;NK-cells: 579.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1763.5;neutrophil: 1169.8;non-classical monocyte: 3948.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 1169.8;monocytes: 3948.7"	"Not detected"	"Not detected"											"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	52.9	41.9	18.4	99.8	20.4	27.3	14.7	19.3	27.2	8.2	26.5	12.5	5.8	5.9	5.9	4.9	9.1	24.5	22.3	16.9	22.0	7.9	111.5	206.3	37.1	37.7	27.9	6.6	7.8	13.6	11.3	71.0	30.6	6.9	12.6	6.9	14.7	7.6	3.3	2.2	5.7	68.4	31.7	306.8	6.8	7.7	28.8	9.3	7.0	4.3	3.9	32.5	3.5	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	26.2	9.6	513.6	1763.5	4.9	3.7	4.7	205.9	175.8	1.4	3.0	184.0	1169.8	136.2	3948.7	4.6	2.6	734.1	18.4	20.4	19.3	27.2	16.9	22.0	37.7	27.9	30.6	31.7	28.8	39.8	2.7	22.4	24.6	0.7	6.5	0.5	0.1	0.0	0.0	0.2	1.4	3.4	0.7	8.6	10.5	3.7	2.1	1.2	333.4	0.0	0.0	0.2	1.4	0.1	0.0	18.9	0.0	16.4	0.0	0.0	1.4	3.9	0.0	0.1	18.9	0.1	8.6	5.3	193.1	0.0	0.1	0.1	0.0	807.9	7.4	3.7	0.3	300.0	0.0	20.6	77.2	0.1	579.9	0.0	0.1	0.0	0.0	0.0	22.1	0.0	0.0	0.8	5.8	1.5	19.7	1.1	0.4	0.0	0.5	0.2	0.0	2.1	88.0	0.0	0.0	0.3
FCGRT	"alpha-chain, FCRN"	ENSG00000104870	"Fc fragment of IgG receptor and transporter"	P55899	19	49506816-49526428	"Predicted intracellular proteins, Predicted membrane proteins"		"IgG-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1362.6;Kupffer cells: 877.7;Paneth cells: 883.9;Proximal enterocytes: 1787.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2346.7"	"Group enriched"	"Detected in all"	17	"dendritic cells: 922.9;granulocytes: 2346.7;monocytes: 1364.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.7;Hep G2: 144.0;OE19: 165.4;THP-1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012122, HPA015130"	Enhanced					NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA012122: AB_1848474, HPA015130: AB_1848475"	"unprognostic (2.19e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-3)"	263.1	127.7	67.7	99.6	73.3	147.3	198.8	68.0	102.5	217.2	111.1	209.6	304.4	143.1	48.8	60.2	155.5	144.6	123.0	66.3	75.1	177.6	401.6	177.5	143.3	74.0	69.5	193.2	129.4	114.5	79.8	137.5	74.3	104.6	149.3	4.8	106.2	94.7	64.4	112.3	299.3	91.6	73.6	318.9	126.6	28.3	78.8	62.9	111.9	77.8	39.1	136.7	132.0	78.2	0.4	37.1	4.3	123.7	153.7	78.2	6.0	32.1	73.4	20.9	22.9	50.5	22.5	0.2	59.4	45.9	10.8	8.5	1.2	1.1	11.7	0.3	45.5	74.2	0.6	144.0	95.8	1.1	14.2	95.1	1.9	17.5	0.2	86.5	81.3	48.0	12.2	10.9	53.7	0.8	0.6	14.3	2.1	165.4	22.0	2.6	35.3	3.7	96.0	9.3	2.6	23.1	5.6	0.2	4.5	18.3	26.5	196.1	28.1	52.8	11.8	0.9	1.3	2.4	13.5	9.8	10.8	70.2	7.9	566.8	1364.4	1011.5	24.7	904.8	29.8	58.0	39.8	39.7	922.9	62.5	89.4	51.0	2346.7	28.6	630.2	536.4	28.2	1276.9	67.7	73.3	68.0	102.5	66.3	75.1	74.0	69.5	74.3	73.6	78.8	78.2	479.6	67.3	89.3	21.2	44.2	126.1	130.4	130.7	52.9	0.7	125.5	151.3	30.7	158.7	79.9	73.5	4.2	12.7	83.8	652.3	60.7	86.3	6.5	29.1	89.6	259.2	158.1	55.8	0.2	61.6	24.9	269.9	108.6	24.8	70.5	181.2	587.6	343.9	1362.6	0.0	0.2	349.0	57.0	877.7	438.1	21.8	362.2	608.6	186.7	24.4	190.6	13.4	11.3	10.1	0.2	90.6	883.9	183.6	63.2	87.9	1787.7	329.5	53.4	5.2	216.9	149.2	105.6	21.1	17.6	27.7	107.1	20.7	32.4	129.9	565.1	115.4
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FCHO2		ENSG00000157107	"FCH and mu domain containing endocytic adaptor 2"	Q0JRZ9	5	72956041-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 19.3;neutrophil: 20.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 20.6;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	16.6	9.8	5.1	11.3	6.5	10.7	15.0	9.8	9.1	14.5	11.4	16.3	17.1	16.1	9.0	29.6	11.3	16.9	10.6	5.2	5.0	19.7	17.9	21.8	11.0	6.7	5.6	14.9	9.1	15.3	4.1	21.2	6.4	13.0	17.1	9.1	11.6	12.6	10.4	12.3	18.6	13.4	5.3	17.1	13.6	7.2	8.8	5.2	24.0	12.2	9.2	14.9	16.5	9.5	15.0	11.8	11.3	9.9	15.6	20.5	33.0	12.9	19.0	9.6	15.1	6.0	25.6	3.5	17.6	18.0	17.8	11.1	9.6	22.6	13.0	3.8	11.3	7.3	9.9	7.6	7.8	1.5	7.3	13.8	11.5	12.8	20.6	21.9	22.3	3.5	8.4	6.2	20.2	7.0	0.0	7.3	3.6	3.0	6.1	3.2	10.8	4.4	23.4	20.8	4.5	7.1	17.7	12.6	8.3	15.7	15.1	10.4	23.1	12.5	5.8	13.9	9.3	2.2	4.4	0.7	8.1	1.1	15.8	19.3	3.2	8.8	1.5	4.6	1.0	0.4	0.5	0.6	1.4	0.9	0.2	0.5	20.6	0.9	6.6	0.5	0.4	0.8	5.1	6.5	9.8	9.1	5.2	5.0	6.7	5.6	6.4	5.3	8.8	9.5	51.8	57.7	44.3	34.9	3.8	10.5	15.6	12.0	12.5	11.1	16.5	12.3	15.1	14.3	23.1	35.0	4.2	14.2	7.0	25.6	13.7	16.0	2.4	24.3	17.0	36.8	14.9	12.6	78.2	17.5	8.9	22.8	17.3	38.3	18.3	9.5	52.1	11.0	19.8	11.8	51.5	14.8	8.2	81.0	13.0	2.8	13.4	45.8	16.0	71.2	12.9	15.4	3.1	62.4	59.1	30.7	29.4	13.9	3.5	22.5	21.0	21.8	21.5	8.9	26.3	25.1	21.3	16.9	14.3	15.0	15.3	13.7	4.4	9.1	14.0	30.2
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	8.3	6.7	4.0	19.6	5.2	19.7	8.8	5.7	5.3	16.0	2.8	9.2	11.1	12.5	3.4	9.0	11.0	11.3	5.6	3.1	7.5	7.5	2.8	10.7	23.0	7.2	6.0	17.4	7.7	50.8	13.1	6.7	7.6	10.5	5.2	3.6	11.2	6.3	1.9	21.3	17.2	6.1	3.7	22.2	11.7	3.9	7.1	11.0	11.1	1.9	16.9	11.7	14.3	7.3	13.5	8.3	11.0	23.1	9.2	11.5	19.3	28.5	14.5	25.1	39.3	15.7	28.1	5.6	14.0	22.1	4.0	7.5	3.5	15.8	11.2	23.9	6.0	11.7	12.9	5.8	7.0	3.7	38.1	14.2	12.3	19.8	6.4	21.1	14.6	0.4	7.4	10.3	2.9	11.8	3.0	7.1	3.2	4.7	7.6	0.1	0.1	5.5	8.6	19.8	1.2	12.2	0.5	10.6	16.5	8.3	12.9	11.0	29.8	0.4	6.9	10.3	12.1	12.2	4.4	2.9	21.8	13.1	12.2	5.8	1.2	4.0	4.3	1.3	3.3	3.3	2.4	4.6	1.2	1.7	2.2	3.1	6.5	1.6	2.1	1.2	3.5	2.4	4.0	5.2	5.7	5.3	3.1	7.5	7.2	6.0	7.6	3.7	7.1	7.3	4.0	0.0	2.2	5.5	11.6	2.7	3.7	4.7	9.6	4.9	3.5	4.1	0.6	2.8	3.6	3.7	12.5	1.1	11.4	6.3	0.0	4.7	7.1	1.8	2.9	3.8	4.2	1.3	1.7	6.5	4.3	5.3	9.2	3.4	8.9	4.9	3.9	0.6	5.6	53.8	3.9	4.6	8.2	1.9	1.9	6.6	4.1	5.6	3.6	4.7	3.5	1.9	15.5	0.5	8.6	7.4	3.4	3.8	8.2	2.4	4.3	0.7	3.6	1.7	6.6	2.4	3.8	2.3	4.0	4.4	2.8	1.4	14.4	3.5	2.6	2.3
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142318	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments"	"Nuclear speckles, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	22.2	19.2	43.3	33.4	47.9	28.6	16.8	31.5	38.7	14.9	34.6	14.5	8.9	16.0	6.9	11.7	13.8	22.6	25.5	37.0	44.5	13.0	17.6	23.9	45.2	36.6	36.4	32.3	10.4	9.9	8.1	31.2	35.4	11.6	14.4	19.6	9.3	13.8	8.8	9.0	17.7	17.2	32.5	42.3	13.1	22.6	41.3	28.5	14.9	14.7	46.1	21.6	11.7	45.0	14.2	12.3	26.0	31.3	9.8	23.9	21.8	26.7	50.6	14.8	12.0	9.6	21.0	76.3	31.3	31.0	15.6	20.0	15.3	14.1	21.0	27.2	7.0	64.2	14.3	33.4	25.7	30.6	7.6	14.6	15.6	15.1	17.7	33.4	35.7	26.7	13.7	49.6	19.5	16.1	36.4	54.7	5.5	15.6	13.8	56.4	39.8	164.1	24.8	21.4	13.1	16.9	9.6	16.2	31.9	12.2	12.4	23.7	47.9	45.9	18.5	32.9	7.5	46.8	29.4	71.2	8.4	51.4	13.8	18.3	8.4	18.7	2.8	5.1	1.9	22.2	2.8	3.2	8.1	26.9	3.2	4.1	19.9	2.0	3.0	32.3	3.2	3.6	43.3	47.9	31.5	38.7	37.0	44.5	36.6	36.4	35.4	32.5	41.3	45.0	47.3	9.6	14.0	114.9	76.7	8.5	5.2	3.6	9.1	13.5	5.9	4.7	16.0	8.6	6.1	3.7	25.0	12.4	39.4	1.9	1.9	4.1	6.2	6.6	8.3	30.2	4.8	19.4	79.4	6.2	9.2	9.4	7.7	5.4	2.5	33.6	46.1	11.3	19.9	10.1	219.6	7.7	4.1	30.8	29.9	10.0	10.8	32.8	5.4	387.8	20.6	10.6	5.2	471.0	198.1	5.3	5.7	16.6	70.1	3.8	1.8	3.5	3.9	17.0	6.6	13.0	26.1	9.6	13.0	7.1	5.8	12.0	14.9	6.0	3.7	4.8
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206903317-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 65.5;lymphoid tissue: 180.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 262.3;dendritic cells: 43.5;NK-cells: 108.1;T-cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 171.4;U-266/70: 73.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		5500000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	4.9	1.5	0.3	74.8	0.3	12.6	2.4	0.3	0.8	1.5	0.4	8.0	6.1	2.4	2.6	3.0	1.9	11.3	2.6	0.1	0.4	2.3	5.9	6.0	152.1	0.4	0.1	0.8	1.1	0.5	1.0	1.8	0.2	3.4	9.9	0.2	3.5	1.2	3.6	0.4	65.5	2.3	0.0	115.0	14.2	0.5	0.5	77.2	3.3	1.4	180.6	19.1	1.6	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.3	0.3	0.0	0.0	11.6	0.0	0.4	0.7	0.3	0.0	0.6	0.5	0.0	0.2	0.2	0.9	0.0	1.6	0.1	0.0	0.1	0.7	0.3	1.2	0.0	0.0	7.0	0.2	23.5	0.0	0.2	3.5	0.3	0.1	0.0	0.2	4.9	0.6	171.4	0.1	0.3	0.1	0.0	2.8	0.6	13.0	0.0	0.3	0.0	0.5	0.0	0.5	0.2	0.1	73.8	5.9	23.2	0.8	0.1	0.6	7.9	2.8	3.6	209.3	4.3	276.9	882.3	280.1	266.3	3.2	1057.5	483.2	336.0	56.0	218.8	4.3	13.7	687.7	416.6	0.3	0.3	0.3	0.8	0.1	0.4	0.4	0.1	0.2	0.0	0.5	0.6	1.3	0.0	3.9	0.0	262.3	0.0	4.9	0.0	1.2	0.0	3.5	3.0	3.6	5.7	1.3	0.0	0.0	0.1	43.5	0.9	0.0	1.7	0.2	0.8	0.7	1.7	0.0	8.4	0.0	2.9	0.1	3.4	4.1	0.9	0.0	0.6	4.6	1.4	4.4	0.0	0.0	0.6	0.0	5.7	0.0	0.4	0.3	8.1	0.0	0.0	3.6	0.0	108.1	0.0	0.0	1.2	0.3	0.0	30.5	2.9	0.1	1.0	0.7	0.0	0.0	0.2	2.9	0.1	2.3	1.7	0.0	0.0	74.9	0.0	1.9	6.8
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 158.9;lung: 46.2;lymphoid tissue: 96.3"	"Group enriched"	"Detected in many"	10	"Kupffer cells: 504.4;Macrophages: 542.4;monocytes: 1017.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1699.8;intermediate monocyte: 1195.1"	"Lineage enhanced"	"Detected in all"		"monocytes: 1699.8"	"Group enriched"	"Detected in some"	5	"NB-4: 4.7;U-937: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	36000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	15.9	1.4	0.6	47.7	0.5	158.9	5.1	0.8	0.7	2.0	0.5	3.2	0.5	1.5	0.0	1.6	6.4	3.9	5.1	0.5	0.3	4.1	7.2	46.2	3.2	0.5	0.5	1.0	2.5	0.1	1.0	2.4	0.6	2.3	1.6	0.1	2.8	0.5	1.6	1.2	2.8	12.1	0.2	96.3	3.7	0.7	0.7	2.4	2.2	1.1	1.3	10.1	2.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.1	0.0	7.2	0.1	9.3	1699.8	18.0	2.9	1195.1	3.5	5.9	1.4	1.6	492.6	1.5	1.7	1.6	277.1	2.8	582.2	13.0	2.1	1796.8	0.6	0.5	0.8	0.7	0.5	0.3	0.5	0.5	0.6	0.2	0.7	0.5	2.1	6.4	17.1	0.0	6.6	1.9	0.2	0.0	0.0	0.0	0.3	0.0	2.6	1.5	5.0	1.8	0.0	0.8	6.0	0.1	0.0	0.0	0.1	0.2	0.2	2.7	0.0	5.2	0.0	0.0	1.5	3.6	1.5	0.1	12.6	0.1	3.9	2.6	68.4	0.0	0.0	0.0	0.0	504.4	68.3	0.0	0.0	542.4	0.0	0.0	1017.8	0.0	27.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.1	0.7	0.0	0.0	1.0	0.5	0.0	0.1	0.2	0.4	1.1	6.1	0.3	0.0	0.2
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369110-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"liver: 278.3;lung: 724.6"	"Cell type enriched"	"Detected in some"	16	"Hepatic stellate cells: 2828.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	NA	NA	22800000000	14000000000		"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	62.6	35.9	1.1	5.7	1.0	0.0	40.8	1.1	1.6	2.7	10.0	4.1	0.8	3.9	0.1	2.8	3.0	1.6	62.1	1.4	1.1	55.2	278.3	724.6	4.3	1.2	1.2	2.4	12.5	2.7	6.6	22.6	1.2	5.3	0.5	0.0	2.5	0.5	9.0	1.9	6.7	1.8	1.2	11.3	8.4	2.4	1.2	0.4	20.4	7.5	0.3	3.0	1.9	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	1.1	1.6	1.4	1.1	1.2	1.2	1.2	1.2	1.2	1.0	94.1	0.0	9.3	0.0	16.6	0.8	0.6	0.5	0.6	0.0	0.8	2.8	2.4	52.9	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.5	0.4	0.2	155.1	0.0	136.4	0.1	0.0	0.0	3.8	0.5	0.2	3.8	0.0	2828.6	31.8	0.3	0.0	0.1	0.0	2.0	168.6	0.3	2.7	3.4	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.1	5.1	0.0	0.0	1.0	2.7	0.5	0.5	1.0	1.1	0.0	4.9	0.5	0.0	0.3
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820120	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"bone marrow: 8.0;intestine: 8.6;lymphoid tissue: 27.3"	"Cell type enriched"	"Detected in some"	26	"B-cells: 88.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 39.3;naive B-cell: 68.1"	"Lineage enriched"	"Detected in many"	62	"B-cells: 68.1"	"Group enriched"	"Detected in some"	26	"Daudi: 5.4;U-698: 17.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013323	Enhanced					NA	NA		290000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"	0.2	0.0	0.0	10.1	0.0	8.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.2	0.6	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.6	0.0	0.0	0.0	8.6	0.0	0.0	17.8	0.8	0.0	0.0	3.0	0.4	0.0	22.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	39.3	0.0	0.0	0.0	68.1	0.0	0.1	1.1	0.2	0.5	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 54.3;dendritic cells: 21.2;Early spermatids: 8.0;Late spermatids: 9.1;NK-cells: 30.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cell line enriched"	"Detected in some"	7	"Daudi: 9.9"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"	0.4	0.0	0.0	14.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.1	0.3	0.2	0.1	0.1	0.1	1.0	0.2	0.0	0.0	0.2	0.8	0.9	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.2	0.0	0.8	0.0	0.1	0.0	8.7	0.1	0.0	27.5	1.5	0.2	0.0	4.6	0.4	0.1	36.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	19.0	0.0	1.8	30.3	2.6	13.2	0.0	35.3	0.2	8.3	0.4	20.4	0.0	0.0	11.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.0	1.2	0.0	9.1	0.0	0.4	0.0	1.0	0.9	0.0	30.9	0.5	0.0	0.0	1.1	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573747-157598085	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in single"		"B-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"U-266/70: 4.6"					"Not detected"	"Not detected"			HPA054030	Approved					NA	NA				"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.3	0.0	0.0	0.2	0.0	0.0	10.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
FCRLA	"FCRL, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595"	ENSG00000132185	"Fc receptor like A"	Q7L513	1	161706972-161714352	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 98.4"	"Group enriched"	"Detected in some"	6	"B-cells: 124.2;Melanocytes: 67.6"	"Cancer enriched"	"Detected in many"	21	"melanoma: 38.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"memory B-cell: 368.0;naive B-cell: 341.5"	"Lineage enriched"	"Detected in many"	10	"B-cells: 368.0"	"Group enriched"	"Detected in some"	6	"Daudi: 484.1;SK-MEL-30: 197.8;U-698: 260.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016545	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB016545: AB_2247037"	"unprognostic (5.46e-4)"	"unprognostic (7.19e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.48e-4)"	"unprognostic (1.45e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.66e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.84e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-2)"	0.8	0.2	0.5	23.5	0.3	4.1	0.5	1.1	0.7	0.3	0.3	2.6	0.9	0.4	0.6	0.5	0.1	1.1	0.6	0.4	0.2	0.3	0.4	0.6	68.5	0.3	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.8	2.8	0.3	2.3	0.1	0.3	1.2	19.1	0.4	0.1	38.5	4.1	0.2	0.5	7.7	0.5	0.3	98.4	3.4	0.1	0.4	0.7	0.0	0.0	0.0	0.4	0.4	0.0	2.7	7.4	0.2	0.5	0.0	0.0	484.1	0.2	7.0	0.0	0.1	0.0	0.7	0.8	1.8	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.4	0.5	2.4	0.4	0.1	0.0	0.0	0.9	26.7	0.1	0.0	0.1	0.3	0.1	0.0	0.1	4.0	8.3	52.4	0.0	0.1	0.0	0.0	0.3	0.1	197.8	0.0	0.0	0.2	0.5	0.6	0.7	0.5	0.5	0.7	0.3	260.5	2.9	0.3	44.3	0.4	0.3	0.2	0.8	0.0	0.1	368.0	0.2	0.4	0.4	341.5	0.2	0.1	0.6	0.2	0.2	38.4	0.2	17.0	0.5	0.3	1.1	0.7	0.4	0.2	0.3	0.3	0.3	0.1	0.5	0.4	0.0	0.0	0.6	0.0	124.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.7	67.6	0.0	0.4	0.0	1.0	0.5	0.1	0.3	0.1	0.0	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.4	0.0	1.6	0.0	0.1	0.0
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 7.5;NK-cells: 11.3;Proximal tubular cells: 14.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.8;Daudi: 6.0;fHDF/TERT166: 8.8;HMC-1: 7.4;PC-3: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.2	0.1	0.5	0.7	0.4	0.0	0.1	0.5	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.4	0.7	0.3	0.1	0.9	0.5	0.5	0.1	0.2	0.1	0.0	0.1	0.6	0.1	0.1	0.1	0.3	0.9	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.1	0.4	0.0	0.1	0.0	1.8	0.2	0.1	0.6	0.6	0.1	0.0	0.3	0.4	0.6	0.0	3.7	4.8	1.2	1.2	0.1	0.1	6.0	0.2	8.8	0.2	0.0	0.2	0.3	3.1	0.1	0.3	0.2	0.1	0.1	0.2	0.0	7.4	1.1	0.0	2.1	0.1	0.3	1.1	0.0	0.3	0.3	0.1	0.3	0.0	2.1	0.1	0.0	4.4	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.2	0.0	0.0	0.6	1.3	0.6	1.3	0.7	0.0	0.0	2.3	2.5	0.4	0.6	6.4	0.1	1.8	1.8	0.0	0.6	3.4	1.1	1.0	0.4	4.7	0.5	0.8	1.0	3.7	0.2	0.0	0.0	0.5	0.5	0.4	0.5	0.7	0.5	0.4	0.5	0.5	0.6	0.4	0.4	0.6	2.8	0.0	0.0	0.3	2.9	1.1	1.1	1.0	0.6	0.2	1.5	1.5	1.5	0.0	1.2	3.7	0.0	2.1	3.9	0.1	5.9	1.3	0.1	0.3	1.3	2.3	1.2	5.3	0.9	1.1	5.6	1.1	0.0	0.4	0.0	1.2	7.5	1.2	1.4	0.0	1.2	0.0	0.0	1.9	1.2	0.2	0.0	3.4	1.8	0.0	0.7	3.4	11.3	0.0	0.3	1.0	0.1	0.4	3.0	0.6	0.0	14.7	0.7	0.7	0.0	0.2	1.6	2.7	1.4	1.3	0.4	0.8	2.4	2.2	0.0	1.1
FCSK	"FLJ39408, FUK"	ENSG00000157353	"Fucose kinase"	Q8N0W3	16	70454595-70480274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.7;Cardiomyocytes: 4.2;Cytotrophoblasts: 5.5;Extravillous trophoblasts: 3.0;Hofbauer cells: 5.0;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	3.9	7.2	5.4	5.4	7.1	5.0	4.9	8.2	7.7	5.6	7.5	7.5	10.1	4.9	2.4	5.6	5.5	3.8	4.3	5.3	5.0	8.9	8.2	4.8	5.4	6.4	4.6	6.6	8.3	9.1	9.8	3.6	5.7	6.3	3.9	2.9	5.9	4.4	5.5	7.2	7.4	3.1	4.5	6.4	6.6	4.5	5.7	3.8	7.9	2.3	2.8	4.8	4.8	11.1	3.4	4.6	2.5	5.8	1.5	1.8	10.0	1.8	2.8	2.2	3.0	4.2	10.0	2.3	8.8	1.7	0.7	4.8	1.8	4.7	1.6	4.4	6.5	2.9	8.9	4.5	3.7	3.8	2.3	3.0	5.4	2.1	4.4	3.3	4.3	4.6	5.9	2.6	1.8	10.3	4.6	9.2	1.6	5.5	2.7	7.0	0.6	10.4	5.9	5.5	4.0	5.3	10.1	3.7	5.3	1.9	14.8	7.5	5.0	1.8	2.4	4.0	2.2	9.5	5.1	4.8	3.3	3.8	4.2	0.2	1.9	0.8	1.9	1.0	1.6	0.8	1.9	1.9	1.1	1.5	2.6	1.2	1.6	1.2	1.2	1.3	1.4	1.2	5.4	7.1	8.2	7.7	5.3	5.0	6.4	4.6	5.7	4.5	5.7	11.1	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226124-70235252	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"lymphoid tissue: 3257.5;salivary gland: 6608.7"	"Group enriched"	"Detected in some"	25	"Breast glandular cells: 90.8;Breast myoepithelial cells: 87.9;Ductal cells: 75.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;GAMG: 7.5;HL-60: 1.5;K-562: 1.4;RH-30: 2.1;U-87 MG: 5.4"					"Not detected"	"Not detected"			"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"			"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favorable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	4.8	1.8	0.0	313.8	0.0	0.0	183.5	0.0	0.0	0.2	0.2	24.6	1.8	4.8	0.1	13.4	0.9	2.7	1.6	0.0	0.1	0.3	1.9	1.4	1052.7	0.1	0.6	0.5	2.7	0.0	0.5	0.7	0.0	1.6	18.3	0.0	6608.7	0.1	1.4	0.5	49.5	4.2	0.0	33.2	10.1	0.3	0.3	17.2	3.3	0.0	3257.5	11.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	90.8	87.9	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	75.6	0.0	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
FDFT1	SQS	ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839304	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Daudi: 133.1;RPMI-8226: 361.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	69.1	126.7	8.2	6.7	14.9	15.0	69.5	13.1	11.6	93.3	7.4	113.4	6.7	80.2	2.9	165.7	59.4	3.2	62.9	10.0	11.7	71.3	118.3	88.0	6.0	29.9	14.1	66.9	58.6	2.0	51.2	4.2	23.1	64.5	5.8	5.4	141.7	3.1	160.3	129.0	92.2	4.9	15.4	50.4	113.2	118.7	15.3	3.2	45.9	6.9	4.5	70.4	107.8	31.9	19.1	8.1	28.8	19.4	3.8	5.7	10.9	19.2	10.6	7.4	8.6	8.1	14.1	133.1	3.9	3.2	34.6	17.8	10.6	24.7	8.2	13.1	17.2	9.6	11.1	21.7	7.4	5.5	13.0	11.2	6.0	13.2	4.7	5.3	2.1	24.5	12.1	60.0	4.6	11.1	16.7	12.9	27.1	9.0	5.3	14.9	11.3	361.0	11.9	61.5	9.6	11.2	4.3	11.2	35.9	12.3	11.6	6.8	11.3	5.1	21.6	3.1	5.8	17.0	30.2	26.3	7.5	18.7	19.7	52.1	19.5	25.5	23.1	23.6	20.7	60.5	25.3	24.5	29.1	45.6	25.7	23.3	22.3	26.7	15.1	27.9	45.7	43.9	8.2	14.9	13.1	11.6	10.0	11.7	29.9	14.1	23.1	15.4	15.3	31.9	31.1	54.5	164.1	67.6	78.0	52.5	94.0	479.6	87.6	17.7	79.6	49.8	78.5	101.5	325.8	79.1	14.6	266.2	49.4	134.8	88.0	165.6	294.4	55.0	20.9	45.2	79.1	113.2	29.3	284.4	153.3	37.1	64.2	68.1	57.0	86.2	22.1	221.8	94.1	11.8	25.6	117.4	284.8	41.9	32.2	228.8	77.0	54.3	101.4	38.4	97.1	61.9	55.6	30.2	95.6	163.6	108.4	53.4	50.0	101.3	87.0	74.9	142.6	21.0	52.6	13.8	74.4	215.5	76.1	112.5	88.8	175.0	55.7	131.4	100.4	167.2
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429948-110464884	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"adrenal gland: 313.7"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1139.6;Theca cells: 745.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	9.0	313.7	6.9	6.8	7.5	12.1	8.5	7.5	8.6	7.4	8.7	12.9	22.0	6.2	8.2	9.3	5.9	9.1	16.3	6.8	7.6	29.6	44.3	10.8	7.9	7.3	7.8	5.4	13.4	9.3	6.1	17.7	7.6	8.2	10.7	5.3	8.6	26.3	20.6	6.2	18.4	6.1	7.5	6.7	13.5	7.6	7.9	12.0	20.3	18.5	7.5	10.5	5.5	8.8	10.2	7.0	10.6	11.6	10.1	17.8	23.5	9.2	11.2	8.0	13.5	24.1	16.7	23.8	26.4	11.9	14.2	11.8	12.4	13.9	10.8	22.9	15.8	12.0	12.0	14.8	17.7	12.7	18.8	31.3	11.4	7.3	17.1	13.8	16.5	16.2	12.2	34.4	17.3	11.3	18.2	28.3	9.5	19.3	13.1	26.4	10.1	22.1	17.4	18.1	14.4	7.4	17.5	19.7	12.5	12.3	11.7	8.7	9.8	8.0	9.8	9.8	9.9	7.7	6.4	71.7	6.0	25.5	10.5	1.8	4.5	2.8	3.8	3.3	4.1	9.7	5.2	5.4	5.2	7.5	6.2	4.4	0.5	3.4	4.6	4.0	7.4	2.6	6.9	7.5	7.5	8.6	6.8	7.6	7.3	7.8	7.6	7.5	7.9	8.8	53.2	19.2	38.1	15.0	68.6	68.3	104.3	45.4	42.7	33.0	40.3	37.0	57.1	102.9	28.3	80.9	8.4	174.3	65.7	109.5	244.6	71.4	53.4	49.6	35.6	36.7	47.9	28.8	22.6	144.8	169.4	48.1	61.2	42.0	45.7	36.3	45.0	192.7	113.3	42.1	25.8	56.2	34.6	58.4	68.3	11.0	46.9	77.3	69.4	15.0	57.3	42.3	50.4	22.1	19.6	78.5	76.5	45.5	102.7	114.2	183.9	338.7	18.6	17.3	26.3	50.6	43.6	48.0	67.0	75.3	97.5	1139.6	74.0	745.1	96.4	149.6
FDX2	"FDX1L, MGC19604"	ENSG00000267673	"Ferredoxin 2"	Q6P4F2	19	10310045-10316015	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Ductal cells: 38.5;Exocrine glandular cells: 30.3;Hofbauer cells: 37.0;monocytes: 31.6;Pancreatic endocrine cells: 30.2;Proximal tubular cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 266.8"									HPA043986	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA043986: AB_10960282"	"unprognostic (1.48e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	16.1	27.2	58.1	9.1	59.5	4.9	15.1	53.8	79.8	15.4	55.1	20.5	7.7	16.3	13.2	14.4	13.6	9.8	23.3	60.7	60.6	32.1	28.2	14.1	11.2	54.9	57.9	15.3	20.0	29.9	28.8	9.3	58.7	20.2	6.8	4.4	14.0	16.0	24.6	12.6	11.5	13.3	52.3	15.2	17.4	12.1	57.8	8.7	24.4	22.1	7.9	19.5	13.9	61.9	34.9	28.4	19.4	33.4	40.2	31.7	20.2	32.2	51.0	53.6	44.5	41.4	24.5	26.2	59.2	45.9	37.7	26.5	32.3	61.1	20.7	28.6	46.0	38.3	30.0	30.5	58.4	18.7	12.3	28.9	42.6	45.2	44.4	25.9	32.9	30.0	47.2	20.4	61.2	56.2	35.1	266.8	33.8	32.7	52.2	26.3	16.0	39.0	62.1	36.4	42.5	25.7	40.0	46.7	36.6	13.1	39.3	13.7	23.2	73.9	18.6	76.7	48.2	44.9	73.2	42.1	68.6	41.2	39.3	0.0	9.1	0.0	10.8	19.6	14.7	19.7	10.9	14.0	20.9	14.1	13.6	15.6	1.7	24.4	19.0	15.4	15.5	7.7	58.1	59.5	53.8	79.8	60.7	60.6	54.9	57.9	58.7	52.3	57.8	61.9	11.3	9.6	10.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	18.9	18.7	0.0	0.0	4.3	11.0	0.0	14.1	3.5	0.0	29.4	38.5	0.0	5.7	5.1	4.9	0.0	0.0	0.0	30.3	19.5	5.7	0.0	4.3	2.5	5.5	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	31.6	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.9	0.0	0.0	69.9	5.8	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	7.9	2.1	5.7	0.0	0.0
FDXACB1	"hCG_2033039, LOC91893"	ENSG00000255561	"Ferredoxin-fold anticodon binding domain containing 1"	Q9BRP7	11	111874056-111881243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.1;Late spermatids: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039012, HPA061375"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039012: AB_10670916, HPA061375: "	"unprognostic (2.91e-2)"	"unprognostic (3.32e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.81e-7)"	"unprognostic (1.32e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.95e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.79e-2)"	1.1	1.9	0.9	1.9	1.0	2.0	2.1	0.8	1.2	1.7	0.7	1.4	1.6	1.4	2.4	1.1	1.5	1.0	0.9	1.0	1.2	1.5	1.6	1.7	3.1	1.0	1.0	1.5	1.5	1.6	0.9	1.2	0.9	1.2	1.7	0.7	0.8	0.9	0.7	2.7	1.5	1.1	1.0	2.4	1.0	3.1	1.2	1.7	1.3	0.8	3.2	1.6	0.8	1.1	1.4	1.9	2.1	5.3	2.0	1.8	1.2	1.1	1.2	1.2	1.2	2.4	3.1	5.5	2.7	1.0	1.5	4.3	2.6	2.5	2.7	6.9	1.1	6.1	1.1	1.8	1.2	6.4	5.3	1.5	1.5	1.7	2.2	1.0	2.2	6.5	4.4	6.4	2.3	1.8	6.0	6.2	1.4	6.0	2.7	3.6	1.6	6.5	2.8	2.5	1.0	1.6	1.5	3.2	1.4	1.2	4.5	3.9	1.7	2.5	2.7	3.0	2.6	3.6	5.5	14.1	1.6	9.1	3.7	0.3	2.3	1.5	5.0	3.7	6.5	4.6	4.4	4.4	3.8	3.8	6.5	7.5	0.7	4.8	3.0	3.6	2.5	3.7	0.9	1.0	0.8	1.2	1.0	1.2	1.0	1.0	0.9	1.0	1.2	1.1	2.2	6.4	0.6	0.7	3.1	0.8	1.3	4.2	1.2	3.0	1.6	1.4	1.6	0.0	3.0	0.0	0.0	3.4	1.3	1.2	5.9	2.5	37.1	1.5	1.2	1.8	2.4	0.8	1.0	3.3	1.9	1.3	1.1	0.9	1.3	2.2	2.2	1.8	4.0	1.7	1.3	1.4	4.1	1.3	1.2	14.2	3.1	2.0	0.0	1.9	2.2	3.2	4.1	1.0	1.2	2.1	0.5	0.4	1.6	1.9	0.9	2.3	1.6	2.5	6.6	1.1	1.2	7.5	9.1	1.0	1.3	2.2	2.6	3.8	1.6	0.8
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57544377-57586702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Distal tubular cells: 156.5;Erythroid cells: 479.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 32.7;K-562: 31.4;U-266/70: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA044100: AB_2678809, HPA048177: AB_2680300"	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	9.3	14.7	5.2	1.9	6.3	39.6	8.8	4.7	6.3	7.8	5.8	10.0	1.8	9.2	2.9	12.0	7.6	2.6	17.0	4.8	5.2	20.9	22.0	6.5	1.9	6.3	5.3	8.4	9.2	4.3	8.9	3.2	7.2	9.5	2.4	3.6	9.0	2.4	32.2	8.4	7.2	2.8	5.3	10.0	8.4	4.7	5.3	5.0	9.7	7.4	1.8	9.9	8.5	9.7	5.3	15.1	4.3	8.2	2.6	7.4	4.2	4.5	3.4	2.9	4.0	7.3	3.0	4.8	4.3	6.8	3.9	3.5	4.2	3.8	3.7	6.6	19.0	29.5	12.8	10.5	4.9	17.7	32.7	5.4	4.0	4.0	1.4	4.2	5.3	8.0	31.4	10.9	2.1	10.1	7.8	3.8	4.3	1.9	8.7	6.3	19.7	4.7	8.6	19.1	2.5	8.4	4.8	7.4	3.4	2.5	4.6	2.8	6.8	3.3	1.9	1.4	3.2	33.4	12.4	6.3	3.5	5.6	3.9	3.7	3.8	8.1	4.5	5.0	3.2	2.4	3.0	4.9	6.6	1.0	2.8	3.3	0.6	6.9	5.2	4.3	3.2	3.8	5.2	6.3	4.7	6.3	4.8	5.2	6.3	5.3	7.2	5.3	5.3	9.7	4.9	6.4	10.6	10.4	5.6	2.5	6.7	8.6	5.2	3.8	7.8	6.1	24.5	15.7	7.2	5.5	4.2	36.6	15.4	6.7	156.5	16.4	0.4	6.6	7.9	7.3	2.4	479.7	20.3	16.3	16.5	10.3	4.6	9.7	16.5	11.8	4.2	26.3	33.4	8.4	14.6	4.1	8.2	10.6	4.9	1.1	9.9	12.7	1.8	12.2	15.4	15.1	9.2	12.1	45.5	12.4	6.4	7.2	12.5	6.5	7.0	18.2	9.8	4.1	0.0	9.0	6.8	4.1	5.5	14.2	3.1	24.2	8.1	19.1	5.7	5.0
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277745-68295862	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 835.0;Late spermatids: 289.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	17.3	13.6	15.1	16.2	16.8	60.1	23.7	21.3	18.7	18.0	6.9	17.5	15.4	26.8	14.6	24.6	15.3	14.9	19.8	17.3	14.7	13.7	20.1	16.4	15.8	12.9	12.5	20.0	11.6	18.0	9.0	18.9	16.2	18.6	16.4	22.6	12.7	20.8	49.3	23.3	16.6	30.2	13.8	17.2	12.9	71.7	14.3	18.9	17.1	27.4	18.6	22.0	16.1	23.1	17.3	31.2	31.7	29.9	27.8	25.6	21.1	24.1	25.1	24.5	22.3	21.1	22.7	39.8	17.1	33.2	17.6	61.6	66.5	30.7	20.3	19.1	26.3	43.7	36.8	13.4	24.1	35.8	26.1	23.8	64.9	29.6	71.3	34.9	19.5	19.9	37.3	47.2	20.9	20.1	26.0	18.2	32.2	13.9	10.0	37.1	35.5	51.6	15.5	62.1	42.2	26.6	25.0	25.6	67.4	39.8	23.1	33.0	25.6	42.2	37.1	14.8	22.3	30.7	71.2	42.4	24.1	38.3	25.6	0.0	3.1	2.0	3.0	4.2	2.8	2.0	2.9	3.2	2.4	2.3	3.5	2.7	2.3	3.7	3.6	1.7	1.6	2.0	15.1	16.8	21.3	18.7	17.3	14.7	12.9	12.5	16.2	13.8	14.3	23.1	25.2	22.4	35.4	12.7	16.9	98.7	56.3	32.1	48.3	31.5	29.2	25.7	51.6	21.5	23.7	18.4	12.5	17.1	20.8	25.8	0.0	23.4	835.0	21.7	34.3	24.4	19.9	21.4	33.4	12.0	12.7	26.5	15.3	25.6	14.5	26.9	16.1	30.9	31.8	38.7	29.4	23.2	12.2	27.3	33.4	289.6	24.5	24.9	40.9	30.0	22.4	17.6	10.3	17.6	33.5	20.8	17.9	27.8	14.9	37.0	22.2	13.3	29.4	13.1	26.3	26.7	31.3	25.2	8.9	49.5	111.2	16.8	17.2	23.6	20.3	59.3
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544775	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA059919: AB_2684161, HPA060977: AB_2684402"	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	13.6	5.6	6.1	7.9	9.5	63.2	10.6	13.4	10.7	12.5	1.1	13.3	11.1	9.8	6.1	14.7	6.1	12.3	15.7	5.3	4.4	7.4	15.7	11.1	6.9	6.3	7.2	7.6	11.0	5.5	4.2	6.2	5.4	9.7	12.2	17.1	5.8	6.9	20.6	10.1	12.1	10.3	4.8	8.5	10.6	13.6	9.5	6.6	8.2	21.3	6.6	9.8	7.7	7.9	11.8	7.0	9.8	15.3	17.3	24.1	7.9	18.3	14.5	13.5	15.6	7.7	10.2	12.0	12.2	13.5	15.5	9.0	8.0	15.2	19.7	18.6	7.6	6.3	9.7	5.9	11.5	4.2	8.2	15.9	12.6	16.8	15.1	12.5	13.4	9.8	4.0	15.3	20.5	5.1	11.0	7.1	6.9	7.5	8.7	9.3	17.9	13.1	14.9	22.1	8.0	6.5	11.8	8.1	20.1	7.8	10.5	8.4	23.7	23.0	12.0	21.3	16.4	12.0	9.4	9.4	13.4	11.6	9.5	2.5	4.7	5.0	2.7	6.9	3.9	2.3	2.8	2.0	4.6	1.3	3.1	2.6	4.8	2.2	8.8	1.2	3.4	2.8	6.1	9.5	13.4	10.7	5.3	4.4	6.3	7.2	5.4	4.8	9.5	7.9	35.4	22.4	13.6	28.4	15.3	26.5	15.8	7.8	18.8	17.2	17.6	13.0	31.5	20.0	14.8	11.0	20.9	4.4	15.8	64.7	5.9	11.6	48.1	31.1	33.0	18.8	16.7	12.2	13.3	8.4	8.6	27.5	23.0	36.9	13.3	29.6	17.9	47.0	7.6	5.0	7.2	27.5	8.2	15.8	52.9	80.7	8.7	22.5	30.2	5.6	9.7	23.1	5.2	15.1	18.2	17.1	53.2	6.8	19.4	18.9	31.7	12.3	18.3	28.2	0.0	24.0	22.8	16.5	6.3	25.4	24.7	5.1	16.7	8.0	21.5	40.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792911-61797238	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		160000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	5.9	10.4	7.8	21.3	7.8	39.5	10.2	10.9	9.9	6.2	9.6	15.5	11.2	6.3	7.1	14.2	5.7	4.3	6.6	8.0	7.7	5.8	9.9	5.6	34.0	10.0	8.3	3.9	6.8	5.6	8.3	12.9	10.7	6.2	16.1	17.4	6.1	5.9	13.1	9.6	11.4	8.9	6.8	12.8	8.4	19.1	9.1	46.0	4.8	9.6	37.4	8.1	4.9	8.1	154.6	139.7	149.3	81.3	14.9	18.0	94.9	133.3	76.1	160.9	181.4	123.4	112.8	222.6	100.3	57.3	150.5	158.3	214.3	117.7	163.3	117.8	117.6	117.6	187.7	127.3	11.0	184.7	115.4	12.7	15.8	148.1	39.0	23.3	63.1	122.1	181.3	155.1	136.0	195.4	259.7	165.4	165.3	120.3	134.7	173.8	173.7	228.9	64.4	144.7	170.0	140.7	89.6	115.0	79.1	70.1	167.4	127.1	43.2	141.5	178.1	182.3	134.6	120.4	204.3	228.9	98.4	121.9	124.6	24.7	6.7	14.2	16.2	12.9	16.8	14.4	12.3	15.1	8.0	14.8	14.0	13.8	2.7	20.0	12.9	24.5	25.2	10.3	7.8	7.8	10.9	9.9	8.0	7.7	10.0	8.3	10.7	6.8	9.1	8.1	2.7	0.0	2.2	0.3	14.0	10.3	5.2	18.2	7.4	23.8	7.4	7.4	5.8	5.7	7.7	0.0	12.5	53.0	15.9	6.7	7.9	17.3	21.7	4.2	5.5	5.5	4.8	87.5	2.0	12.2	70.9	8.6	7.1	6.3	0.0	18.6	1.1	7.2	25.7	15.2	2.4	8.0	18.3	5.4	6.8	14.4	5.6	6.2	5.4	0.0	12.4	31.3	13.4	1.5	3.1	12.2	9.4	7.2	45.3	6.5	3.7	5.7	6.4	23.3	0.0	6.8	12.2	61.0	62.1	11.3	6.1	30.9	11.0	9.0	22.0	5.2
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747841-109196841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Alveolar cells type 1: 80.1;Astrocytes: 207.3;Early spermatids: 158.1;Excitatory neurons: 266.3;granulocytes: 95.5;Inhibitory neurons: 313.8;Late spermatids: 182.4;Microglial cells: 227.7;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	4.2	3.7	3.4	3.0	3.2	1.6	3.6	2.8	3.4	3.8	0.6	3.9	1.7	3.7	2.9	4.2	3.0	3.3	3.0	3.1	3.9	3.5	2.3	3.7	1.4	3.6	3.7	4.6	1.9	9.4	2.5	4.2	3.8	3.0	2.4	5.7	2.5	3.9	1.3	4.5	2.0	4.9	4.1	2.7	2.2	6.7	3.1	2.8	6.4	2.0	2.0	3.5	3.2	5.0	9.8	3.4	11.0	18.0	6.6	10.1	7.2	11.4	11.0	6.5	7.6	19.0	5.5	15.3	6.9	13.8	8.4	6.3	6.2	14.4	14.7	6.5	8.4	9.8	14.5	7.0	4.4	5.6	8.2	6.2	7.9	15.8	17.5	6.4	9.8	14.6	12.9	11.1	8.4	2.7	4.4	1.7	1.6	0.9	7.0	3.3	10.7	91.7	6.4	3.3	3.8	5.6	18.6	1.0	11.4	7.0	4.4	2.4	14.7	12.5	10.2	6.5	9.0	9.4	14.9	5.9	7.4	1.9	6.0	8.9	3.7	4.6	1.2	2.5	2.1	10.3	0.7	1.4	2.3	3.4	1.2	1.5	0.3	1.1	2.0	4.5	1.7	0.9	3.4	3.2	2.8	3.4	3.1	3.9	3.6	3.7	3.8	4.1	3.1	5.0	23.8	80.1	28.3	207.3	9.5	29.2	15.8	9.5	25.6	17.6	6.6	8.5	21.9	10.0	21.8	14.7	18.8	3.9	7.5	4.9	1.9	13.6	158.1	13.1	17.2	19.7	8.4	10.7	266.3	6.0	10.7	31.4	16.8	12.6	95.5	21.8	18.9	2.3	8.2	18.5	313.8	4.5	8.2	9.5	13.4	182.4	19.3	14.1	14.2	227.7	12.0	10.5	4.1	284.0	216.0	9.1	4.7	17.7	13.7	12.1	1.7	6.9	27.9	16.3	6.6	30.7	23.8	7.7	11.5	13.2	17.6	3.1	10.4	10.2	4.1	6.9
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 10.8;stomach 1: 43.1"	"Group enriched"	"Detected in some"	9	"Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054117	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA054117: AB_2682387"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.0	5.0	2.9	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	4.5	0.1	0.0	0.0	43.1	2.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	15.8	0.3	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.4	0.0	0.0	0.0	30.5	0.9	0.0	0.0	1.9	0.0	0.0	0.0	1.0	1.0	10.8	2.2	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8
FERD3L	"bHLHa31, N-TWIST, NATO3"	ENSG00000146618	"Fer3 like bHLH transcription factor"	Q96RJ6	7	19144782-19145421	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"brain: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	109	"SCLC-21H: 10.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	16	"midbrain: 20.2"	HPA043494	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"				"HPA043494: AB_10964193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	5.3	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	1.8	5.3	1.9	0.4	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FERMT1	"C20orf42, FLJ20116, KIND1, UNC112A, URP1"	ENSG00000101311	"Fermitin family member 1"	Q9BQL6	20	6074845-6123030	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 121.3;Oligodendrocyte precursor cells: 229.7;Pancreatic endocrine cells: 384.1;Undifferentiated cells: 95.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HaCaT: 95.4;HBEC3-KT: 100.2;OE19: 75.1;RT4: 54.4"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"HPA039778, HPA041966"	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039778: AB_10805593, HPA041966: AB_10795387"	"unprognostic (1.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (4.38e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.33e-2)"	0.6	11.4	1.4	9.3	2.2	0.3	1.5	1.5	1.4	2.1	0.0	24.6	14.8	2.3	0.8	12.8	3.5	2.6	1.0	1.6	2.0	4.0	0.3	1.0	0.0	3.1	2.8	4.2	2.7	12.5	0.2	4.8	3.2	5.0	35.8	0.0	1.9	4.3	0.1	17.6	11.0	2.0	2.6	0.4	13.0	0.5	2.2	2.4	2.9	0.3	5.1	6.8	3.4	3.4	53.4	14.4	0.0	0.0	0.4	5.0	18.5	2.8	0.1	1.9	0.8	24.8	84.3	0.0	14.1	2.9	6.3	95.4	36.8	100.2	2.0	0.0	2.6	8.2	10.7	26.8	1.2	0.0	2.5	4.8	43.6	11.5	24.0	0.4	1.2	0.3	0.0	0.2	2.4	1.4	0.0	2.4	11.5	75.1	41.1	0.0	12.5	29.9	9.9	54.4	7.7	0.9	8.8	0.3	0.0	0.7	8.4	2.2	0.4	5.1	3.4	0.7	39.5	0.2	0.1	0.1	3.7	9.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.5	1.4	1.6	2.0	3.1	2.8	3.2	2.6	2.2	3.4	0.1	0.0	0.6	0.3	0.0	41.4	51.5	44.8	121.3	0.0	3.4	16.3	1.3	8.6	16.0	0.0	0.0	65.0	0.1	61.2	1.9	34.5	0.1	4.0	31.8	0.6	15.6	8.4	2.3	40.3	31.3	7.5	46.9	2.0	0.0	13.5	0.4	0.4	4.9	0.0	2.2	49.0	2.0	0.0	0.8	1.1	10.8	1.5	1.8	7.5	0.1	0.0	0.0	229.7	0.5	384.1	23.5	3.0	1.4	20.1	13.9	15.8	5.7	0.0	0.0	6.2	2.9	0.2	0.6	80.6	43.0	7.3	1.0	6.2	95.2	44.8
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 234.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.6	0.0	0.1	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.4	234.6	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.8	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125442881-125592568	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 23.4;MAIT T-cell: 15.5"	"Lineage enriched"	"Detected in many"	23	"T-cells: 23.4"	"Cell line enhanced"	"Detected in many"		"AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytosol"		"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	16.9	5.4	96.8	2.9	144.0	0.9	11.3	145.5	120.6	21.8	53.1	39.3	1.7	23.5	2.3	6.2	14.7	6.9	37.4	95.5	120.4	6.8	5.5	34.2	1.9	145.6	136.9	12.7	2.5	1.9	17.6	3.8	138.9	15.4	3.3	18.7	6.4	7.6	5.9	7.9	12.6	8.3	134.8	8.8	15.9	12.7	126.7	0.5	10.2	3.0	1.4	26.5	16.9	176.6	0.3	0.0	48.3	0.2	39.2	25.3	0.0	10.3	14.6	3.8	0.6	0.2	0.3	0.1	16.3	21.1	11.4	0.5	31.2	66.0	2.4	2.3	0.5	37.6	0.1	0.0	25.3	0.0	0.6	23.1	17.6	11.5	29.3	0.4	32.0	0.0	4.5	0.6	3.8	1.5	0.2	0.0	68.6	0.5	1.2	0.0	0.1	0.2	0.0	30.3	54.3	5.5	0.3	0.1	1.4	27.3	4.9	26.4	19.3	0.4	2.4	0.2	11.1	0.6	0.5	0.1	7.9	0.0	26.6	0.2	0.8	0.0	23.4	0.1	15.5	0.1	0.9	5.1	0.4	0.0	0.6	5.5	0.2	1.0	0.0	0.1	0.0	4.4	96.8	144.0	145.5	120.6	95.5	120.4	145.6	136.9	138.9	134.8	126.7	176.6	4.9	0.0	5.2	53.2	0.8	8.0	4.9	96.9	6.2	23.1	0.5	10.3	109.8	2.8	9.6	0.0	2.1	8.0	23.3	0.1	27.4	2.8	68.6	0.8	14.2	13.9	5.4	0.0	41.0	0.4	1.2	43.0	0.5	0.5	0.0	11.1	58.9	1.0	91.6	166.5	48.7	0.0	16.2	24.9	15.5	65.9	25.4	2.3	78.2	12.2	1.9	97.1	74.2	32.2	246.6	0.3	0.0	35.3	0.9	12.7	0.0	2.1	3.8	17.8	19.7	25.4	35.6	28.8	7.7	0.2	5.5	4.2	7.8	5.5	0.1	3.5
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	53.0	39.1	48.2	21.0	51.6	16.5	35.9	48.2	68.6	26.9	42.8	34.5	22.1	33.1	18.9	31.7	23.8	23.6	46.7	49.2	48.4	33.6	29.4	27.1	24.3	49.5	46.3	27.6	10.8	20.3	14.2	46.8	48.2	23.5	27.9	26.5	17.1	32.5	108.1	17.0	28.5	41.1	50.1	30.3	21.9	20.8	49.6	18.2	23.9	78.5	19.5	29.1	24.3	56.3	64.9	37.1	49.4	22.3	91.3	122.1	39.5	157.1	76.5	90.7	56.0	24.6	21.5	39.1	94.7	199.2	41.0	25.1	42.4	54.3	98.5	9.3	24.7	31.7	12.2	43.5	44.4	32.9	8.5	119.9	44.2	57.8	69.6	61.2	131.0	9.5	35.4	12.0	170.2	22.7	19.6	27.5	27.1	33.9	57.8	16.9	44.3	14.0	72.9	57.6	1.9	45.7	38.7	31.9	37.8	51.7	11.3	39.1	161.2	59.7	32.9	33.4	92.9	9.8	11.5	26.6	58.9	22.4	84.8	2.5	3.5	5.1	1.7	3.4	1.0	1.6	1.3	1.0	3.5	1.0	1.5	0.7	4.2	3.2	2.3	15.6	1.4	0.8	48.2	51.6	48.2	68.6	49.2	48.4	49.5	46.3	48.2	50.1	49.6	56.3	109.4	54.5	37.5	25.8	23.7	31.4	94.7	45.5	41.5	52.5	31.7	33.1	43.1	17.2	70.2	58.8	45.9	96.4	61.1	57.6	56.7	80.3	5.6	38.4	44.7	100.9	24.0	15.3	45.4	30.6	87.6	50.7	27.0	64.3	24.1	66.0	97.5	37.2	93.7	21.9	22.9	28.8	38.7	88.1	65.4	10.7	54.3	64.6	56.9	45.0	56.0	97.1	35.0	23.1	50.5	74.4	41.4	66.2	17.9	99.1	65.6	45.1	35.9	36.3	59.2	64.0	51.2	12.1	34.9	24.0	32.1	180.1	24.2	47.2	37.7	140.6
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.3;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 24.1;Intestinal goblet cells: 8.9;Kupffer cells: 11.9;Macrophages: 15.4;Prostatic glandular cells: 7.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"eosinophil: 85.0;neutrophil: 249.7"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 249.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;OE19: 1.8;SK-BR-3: 1.1;THP-1: 1.2;U-937: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023985	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA023985: AB_1849302"	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.9	0.3	0.2	17.8	0.4	20.3	2.3	0.2	0.4	0.2	0.6	0.8	3.3	0.1	0.0	1.3	1.0	1.4	1.0	0.2	0.2	0.3	1.5	7.5	0.1	0.4	0.4	0.0	0.6	0.3	0.1	1.6	0.5	1.1	0.7	0.1	0.7	0.0	0.2	1.1	4.6	1.3	0.2	22.2	1.2	0.0	0.4	0.7	0.4	3.7	0.7	6.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.1	2.1	85.0	0.0	5.6	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	249.7	0.0	6.5	0.1	0.0	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.4	0.4	0.5	0.2	0.4	0.8	5.6	0.0	3.2	0.0	0.6	0.1	0.4	0.3	0.0	0.0	0.2	0.3	0.4	0.0	2.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.1	0.8	24.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	5.1	0.0	0.4	0.0	5.0	0.0	0.0	8.9	2.0	11.9	2.6	0.1	0.0	15.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	7.7	1.1	0.0	2.2	0.0	0.0	0.4	2.4	0.1	0.2	0.0	0.6	0.1	1.3	0.1	0.6	1.5
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360489	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.1;lymphoid tissue: 2.5"	"Group enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 16.8;Macrophages: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.5;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Not detected"	"Not detected"											HPA044681	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 19: Lung - Lung function"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044681: AB_2679043"	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	4.1	0.1	0.3	2.5	0.5	0.8	2.3	0.3	0.6	0.0	0.5	1.3	0.3	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.4	0.2	0.2	0.4	0.2	1.2	0.5	0.2	0.4	0.1	0.4	0.4	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.4	1.2	0.5	0.1	0.4	0.2	0.6	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.3	0.6	0.5	0.4	1.2	0.5	0.5	0.4	0.4	1.1	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	16.8	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.6	1.8	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000911, HPA076516"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA000911: AB_1078853, HPA076516: "	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	3.9	5.1	8.2	1.6	6.2	0.0	3.6	5.3	7.6	7.0	2.4	5.6	1.0	7.1	1.6	5.8	5.1	2.2	5.0	8.3	5.2	3.5	1.1	2.8	0.5	3.8	4.1	7.4	3.2	3.6	3.6	3.4	3.7	4.3	1.6	1.6	3.4	3.3	1.3	5.4	2.8	5.4	3.5	2.4	3.5	2.4	4.9	0.4	3.3	1.0	1.0	4.8	5.4	4.6	18.5	6.9	13.2	19.3	7.8	13.8	6.2	10.4	12.8	10.6	8.5	0.6	0.4	0.0	8.2	19.9	9.6	5.3	14.6	9.0	5.8	1.0	8.9	0.0	5.0	2.2	8.3	0.0	0.0	11.3	5.6	16.1	7.6	9.4	9.7	2.3	2.0	0.0	8.4	2.4	0.7	0.0	12.6	0.0	10.2	9.4	6.7	0.0	9.1	0.3	13.1	11.9	10.3	0.2	16.6	21.0	10.3	0.4	6.9	10.5	8.7	23.0	9.4	0.1	0.2	0.1	11.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.2	5.3	7.6	8.3	5.2	3.8	4.1	3.7	3.5	4.9	4.6	3.2	0.0	0.0	4.6	0.0	2.9	1.2	2.0	5.2	2.5	3.2	3.9	3.4	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.0	1.6	0.4	1.3	7.0	4.2	1.2	0.0	16.1	1.1	1.0	5.1	1.5	2.1	0.0	12.6	2.9	0.3	0.4	1.7	15.2	1.0	0.0	0.0	1.0	0.6	2.8	0.1	7.2	5.6	0.0	2.3	0.0	7.1	1.8	0.5	0.5	4.1	0.1	1.6	0.1	1.4	0.3	3.5	0.0	2.3	4.0	0.3	2.2	5.5	4.1	0.3	0.1	2.9	2.8	1.0
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029069	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;dendritic cells: 29.7;Kupffer cells: 118.2;Langerhans cells: 49.3;Macrophages: 52.0;Microglial cells: 43.1;monocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 22.3;intermediate monocyte: 64.8;memory B-cell: 23.2;myeloid DC: 35.0;naive B-cell: 18.6;non-classical monocyte: 70.5;plasmacytoid DC: 27.4"	"Group enriched"	"Detected in many"	18	"B-cells: 23.2;dendritic cells: 35.0;monocytes: 70.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;Daudi: 11.5;HDLM-2: 11.3;U-698: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	6.1	3.3	1.0	14.8	1.3	6.0	2.6	1.2	1.3	1.5	2.3	3.4	3.7	1.3	1.5	2.4	2.8	4.1	1.6	1.0	1.6	1.4	2.5	8.0	22.5	3.2	1.7	1.0	1.3	0.3	1.1	2.7	1.9	1.5	2.7	0.1	2.3	1.8	0.6	2.1	11.1	4.7	2.1	39.7	3.8	0.6	2.1	5.5	2.7	0.9	9.8	4.5	1.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	22.3	2.3	0.1	64.8	0.1	23.2	0.0	0.0	35.0	18.6	0.0	0.0	0.3	0.4	70.5	27.4	0.1	7.5	1.0	1.3	1.2	1.3	1.0	1.6	3.2	1.7	1.9	2.1	2.1	2.0	0.3	6.4	7.4	0.0	53.7	2.0	3.0	1.0	0.6	0.3	0.7	0.6	3.2	2.8	0.5	0.0	0.0	0.3	29.7	0.3	0.0	2.8	11.9	0.5	0.2	1.2	0.0	1.3	0.1	0.9	0.4	1.0	1.5	1.2	7.6	0.0	2.5	0.6	17.7	0.0	0.2	0.1	4.1	118.2	49.3	2.1	1.5	52.0	1.8	43.1	51.8	0.4	2.1	0.5	0.2	1.0	3.9	0.0	14.2	1.6	0.1	0.2	3.2	0.2	0.0	2.3	0.5	0.0	0.1	3.3	2.3	0.4	3.0	0.1	0.4	5.6
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399558-32646050	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 232.5;Early spermatids: 196.3;Late spermatids: 250.1;Microglial cells: 203.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 14.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 8.4;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Approved	"Actin filaments"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	12.6	4.3	8.1	5.6	10.3	12.1	8.0	11.4	6.7	6.1	13.8	9.4	8.8	2.3	2.9	7.4	4.9	10.3	5.3	7.4	10.3	10.8	17.7	8.1	1.8	12.3	10.1	24.6	9.4	14.8	3.1	10.4	12.4	4.6	10.1	23.6	6.7	4.0	10.8	7.4	8.2	3.4	9.2	5.2	28.9	12.1	9.5	1.7	6.3	10.8	2.7	4.0	5.9	13.7	5.4	2.6	6.6	2.0	24.1	14.8	8.1	4.5	22.5	1.2	0.4	8.1	8.3	0.8	2.5	0.3	2.8	5.1	5.3	7.5	0.7	0.7	2.6	4.7	2.7	2.5	4.3	0.9	0.0	8.8	10.3	6.0	12.9	3.3	11.6	1.1	0.5	5.4	15.6	1.9	0.0	1.7	17.4	5.3	0.2	0.4	6.9	16.2	8.0	5.3	7.2	8.5	4.7	4.4	6.6	11.8	7.0	0.3	13.1	0.1	1.5	18.8	0.7	1.9	4.6	2.9	0.0	2.8	5.2	3.6	3.8	8.4	0.2	5.7	0.2	0.6	0.3	0.2	3.6	1.4	0.2	0.3	5.5	0.7	5.1	0.4	0.2	1.3	8.1	10.3	11.4	6.7	7.4	10.3	12.3	10.1	12.4	9.2	9.5	13.7	84.3	48.1	31.4	232.5	5.6	8.4	11.3	12.1	8.6	23.8	10.7	7.5	19.2	54.3	18.3	22.0	118.9	1.3	0.5	57.8	13.7	16.8	196.3	36.0	8.1	24.8	19.2	4.4	40.5	20.7	16.8	19.9	78.5	65.7	2.5	34.1	9.3	37.7	11.8	70.7	55.1	31.2	26.4	71.7	22.3	250.1	4.7	92.9	14.2	203.3	39.9	79.3	1.0	25.1	95.1	33.5	29.3	1.5	16.4	16.4	54.8	15.0	15.3	114.5	52.6	16.5	41.3	10.4	7.4	25.0	12.6	1.4	3.1	25.6	30.5	20.2
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934571	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.3;Endothelial cells: 44.7;Hepatic stellate cells: 55.6;Microglial cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 94.9;TIME: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.50e-4)"	19.8	4.4	4.8	5.6	4.3	0.3	15.0	4.1	4.9	10.4	3.4	5.3	9.2	11.3	2.3	5.7	8.5	11.9	11.5	3.0	2.9	10.1	3.1	20.6	4.2	4.5	11.5	5.3	2.2	3.5	3.2	17.7	4.8	5.3	4.6	0.2	3.7	4.4	6.8	5.4	7.0	11.4	3.2	25.0	4.6	4.3	6.7	2.0	7.5	13.4	3.6	7.7	5.6	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	94.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.4	0.0	81.1	0.0	6.6	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.3	4.1	4.9	3.0	2.9	4.5	11.5	4.8	3.2	6.7	3.0	51.3	0.0	4.6	0.0	0.9	3.1	0.2	0.0	1.2	0.1	1.3	1.9	4.4	1.5	0.6	0.0	0.0	0.3	0.4	0.1	1.9	0.2	7.3	0.4	5.3	44.7	0.0	5.3	3.4	0.2	0.1	11.3	1.1	0.3	0.0	0.0	55.6	1.3	10.5	0.0	8.6	0.2	0.0	2.2	5.9	9.9	11.5	3.3	1.8	25.3	0.0	0.0	1.0	0.5	0.3	4.8	2.5	4.5	0.0	0.3	1.0	7.0	0.0	0.2	0.0	4.9	2.4	0.2	3.6	0.1	1.8	0.5	0.7	2.3	0.5	0.2
FGD6	"FLJ11183, ZFYVE24"	ENSG00000180263	"FYVE, RhoGEF and PH domain containing 6"	Q6ZV73	12	95076749-95217482	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.0;Microglial cells: 90.9;Pancreatic endocrine cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007974	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA007974: AB_1848520"	"unprognostic (1.28e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.62e-5)"	"prognostic unfavorable (9.83e-4)"	"prognostic unfavorable (5.46e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.92e-1)"	1.8	3.3	3.3	5.1	5.3	1.5	2.9	0.3	5.2	3.3	4.0	4.5	1.3	3.4	1.2	3.3	1.9	4.9	3.6	3.2	0.4	3.3	3.1	5.2	5.5	2.0	1.7	4.5	3.4	1.2	1.1	4.3	0.3	3.3	4.2	2.2	2.2	4.0	1.6	7.8	3.5	3.5	1.8	3.3	1.8	3.0	2.9	2.5	5.2	1.3	9.7	3.3	3.5	1.6	22.5	20.1	18.2	2.0	1.9	1.8	9.5	3.1	4.4	1.1	1.8	7.7	15.0	23.8	5.1	2.0	1.3	8.9	3.3	18.7	2.6	2.5	2.0	1.1	3.2	3.8	2.5	2.5	0.2	7.5	8.4	2.2	22.1	7.3	11.9	3.2	5.1	0.4	0.6	1.2	2.0	0.5	7.5	2.8	6.9	5.5	3.6	1.9	12.8	7.1	3.0	4.9	9.0	4.6	0.4	9.1	2.1	0.2	16.4	0.7	2.0	0.9	2.4	2.2	5.3	6.7	0.9	1.6	1.4	0.2	1.6	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.9	1.4	0.1	0.0	0.1	0.1	2.0	0.0	0.0	0.6	3.3	5.3	0.3	5.2	3.2	0.4	2.0	1.7	0.3	1.8	2.9	1.6	12.4	16.0	17.0	109.0	3.9	48.6	21.9	18.6	29.0	3.8	11.0	10.5	22.2	10.0	14.0	9.2	4.2	4.5	1.5	26.5	0.0	22.6	1.7	10.9	17.3	22.3	12.5	1.7	23.9	21.9	8.8	7.3	6.6	22.1	1.3	10.6	16.4	5.2	11.7	1.7	22.4	15.5	10.2	16.1	11.8	3.1	12.5	11.0	1.8	90.9	12.6	1.9	1.0	4.0	4.1	78.1	17.0	10.5	3.5	19.3	14.9	5.2	12.0	9.7	0.0	3.5	6.1	4.8	16.0	28.3	24.9	43.8	1.7	4.9	5.5	30.7
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 295.2;choroid plexus: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	17.9	3.3	206.3	1.6	259.3	1.1	12.5	213.9	295.2	1.3	125.8	2.4	1.0	3.1	7.9	2.0	1.7	2.5	50.2	183.5	245.5	66.5	1.7	2.8	1.2	236.2	237.7	0.9	0.8	4.3	6.5	2.1	259.9	1.8	1.3	18.8	7.3	2.3	2.2	1.7	1.2	2.5	225.4	6.9	0.8	2.0	244.3	1.5	5.6	7.8	2.0	1.2	1.0	272.8	5.6	0.3	0.3	1.5	1.1	3.3	1.8	44.6	33.0	35.9	45.0	0.2	0.2	1.3	3.1	15.4	2.1	0.7	0.0	3.5	64.3	0.2	0.0	0.0	0.8	0.4	0.6	0.0	0.4	1.6	1.1	45.4	2.7	9.7	0.0	0.2	0.0	1.6	30.6	0.7	0.1	0.9	1.4	0.1	1.4	0.2	1.5	0.6	1.5	0.2	1.1	2.3	0.1	0.9	0.6	8.0	0.0	0.2	1.1	5.8	33.0	0.8	21.3	0.8	0.4	0.3	8.2	0.3	1.6	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.3	0.0	0.1	0.2	0.1	0.0	206.3	259.3	213.9	295.2	183.5	245.5	236.2	237.7	259.9	225.4	244.3	272.8	1.4	0.0	0.0	75.1	0.1	0.4	5.0	5.7	7.4	3.5	1.2	25.4	62.4	0.0	2.1	20.2	16.7	1.1	0.1	0.0	0.0	1.1	0.4	0.0	0.7	4.8	0.0	0.0	13.0	0.0	0.5	4.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	14.6	0.0	12.2	0.0	0.0	1.4	0.0	0.2	3.6	29.0	0.0	69.4	0.0	15.1	119.8	0.6	0.0	0.4	0.0	5.3	0.0	0.3	0.1	11.6	6.6	0.5	23.4	0.1	0.1	0.6	0.0	0.8	0.4	0.0	0.0	0.7
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44300247-44389706	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease variant, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 21.6;Fibroblasts: 14.6;Leydig cells: 8.4;Muller glia cells: 4.3;Peritubular cells: 10.5"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AF22: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010315	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	13.9	1.6	0.3	2.6	0.9	0.0	15.2	0.5	0.7	14.6	1.1	7.0	0.4	2.4	4.4	1.4	8.5	2.8	0.7	0.6	0.7	0.7	0.1	2.6	0.6	1.3	1.9	17.3	4.8	0.0	2.1	5.5	1.1	4.6	1.5	0.3	5.4	3.0	0.7	0.9	2.9	1.3	1.6	0.0	4.3	0.8	1.7	1.1	5.3	3.8	0.2	5.0	12.0	0.4	0.0	0.0	27.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.7	0.6	0.7	1.3	1.9	1.1	1.6	1.7	0.4	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	21.6	0.9	0.0	0.0	3.0	0.5	0.0	14.6	0.0	0.3	0.0	1.6	0.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.5	8.4	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.3	0.0	10.5	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 31.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.4;Basal respiratory cells: 10.2;Horizontal cells: 18.5;Muller glia cells: 15.2;Suprabasal keratinocytes: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.4;HaCaT: 18.4;LHCN-M2: 12.1"	"Low region specificity"	"Detected in all"							"HPA066605, HPA075188"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Centrosome		"HPA066605: AB_2685693, HPA075188: AB_2732283"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"	4.0	31.2	7.8	1.5	9.3	0.9	3.4	12.4	6.7	10.9	4.0	1.2	0.6	2.1	0.6	19.9	1.6	1.5	16.5	7.5	6.7	8.1	0.8	1.1	3.5	10.0	9.3	1.7	0.8	0.7	1.5	0.7	9.1	1.6	0.4	14.8	5.8	0.5	7.5	18.5	1.6	1.2	6.5	2.4	1.0	2.4	12.1	2.0	7.0	8.6	5.2	1.4	15.4	6.7	10.4	0.6	5.5	0.1	3.2	0.1	2.7	0.3	3.4	0.4	0.7	0.2	1.1	3.1	0.7	0.2	0.1	18.4	2.1	5.8	1.3	6.4	4.5	5.6	0.7	1.4	0.5	0.2	6.0	0.6	1.6	0.4	0.2	0.6	0.2	2.3	2.2	0.2	12.1	2.4	1.9	2.5	2.0	0.4	0.2	4.9	5.1	1.3	0.7	0.8	1.2	5.7	0.7	0.7	0.5	3.1	0.3	0.4	0.2	0.3	5.7	0.0	0.3	0.4	1.5	0.9	1.4	3.5	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.3	12.4	6.7	7.5	6.7	10.0	9.3	9.1	6.5	12.1	6.7	1.8	0.0	0.0	10.4	0.3	5.5	0.4	10.2	7.4	4.7	1.5	1.5	0.4	1.5	4.5	1.8	6.2	0.4	0.5	1.0	3.9	0.6	3.3	1.5	0.9	2.4	0.0	0.0	0.1	0.2	0.4	0.9	0.0	3.9	0.0	2.0	1.4	0.2	0.4	18.5	0.8	0.5	0.0	0.6	2.6	4.6	1.8	0.9	1.8	2.8	0.0	15.2	0.0	5.5	0.3	1.1	0.2	2.2	0.2	0.5	0.8	0.2	7.0	2.8	0.0	2.3	1.6	3.4	2.7	6.3	9.7	0.7	0.5	0.1	0.6	1.2
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;choroid plexus: 10.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.3;Cone photoreceptor cells: 14.6;Excitatory neurons: 10.6;Inhibitory neurons: 13.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6;testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;RPMI-8226: 1.8"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	HPA052600	Uncertain				"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.5	3.9	15.1	0.0	14.9	0.1	0.4	22.0	25.7	3.0	10.6	0.4	0.0	1.1	0.1	0.2	1.5	0.2	0.5	14.3	14.2	1.4	0.4	0.7	0.0	11.9	12.2	1.5	1.2	0.8	5.1	0.1	12.2	2.7	0.0	1.1	0.7	0.1	0.0	0.5	0.4	0.3	10.9	3.6	0.5	0.7	14.2	0.4	4.8	0.0	0.0	0.6	1.3	14.4	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	14.9	22.0	25.7	14.3	14.2	11.9	12.2	12.2	10.9	14.2	14.4	0.2	0.0	0.0	2.3	0.0	0.0	0.3	0.1	0.0	9.3	0.2	0.4	1.1	0.0	0.2	0.0	14.6	0.1	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.1	0.0	0.0	10.6	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	13.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	1.0	0.0	0.6	0.0	2.0	2.4	0.1	0.0	1.2	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.4	0.0	0.1
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419647-171457626	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 16.1"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"EFO-21: 188.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	HPA018795	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA018795: AB_1848523"	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	4.2	0.3	1.1	0.3	1.2	0.0	2.1	1.1	2.1	1.0	1.1	0.9	0.6	0.9	0.1	0.3	1.5	0.7	16.1	1.1	1.2	0.7	0.1	2.6	0.3	1.4	1.3	0.4	0.5	0.1	1.6	0.5	1.6	1.2	0.1	0.1	1.1	0.3	3.8	1.6	0.7	0.4	1.1	0.5	0.6	0.8	1.5	0.3	1.9	0.4	0.2	0.8	0.5	1.2	0.0	0.3	0.3	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.1	3.4	0.4	0.2	188.2	0.0	0.2	0.2	0.0	0.1	0.0	3.1	0.3	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.9	0.1	3.4	0.0	0.1	0.0	0.3	2.1	0.1	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.5	0.1	0.5	0.0	0.2	0.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.1	2.1	1.1	1.2	1.4	1.3	1.6	1.1	1.5	1.2	6.9	6.4	0.0	0.0	2.0	2.4	2.6	0.5	6.2	0.1	6.6	19.8	24.4	1.5	1.3	1.8	0.0	0.1	3.4	0.5	0.0	0.0	6.2	13.0	3.1	4.2	1.8	0.0	0.8	0.0	0.3	9.4	0.5	24.9	0.0	0.0	2.9	0.0	0.1	0.0	2.1	1.0	0.0	0.0	2.1	0.7	0.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.4	3.2	1.1	0.0	0.0	0.0	0.0	5.4	4.6	0.7	1.6	5.6	3.1	0.0	2.4	0.5	1.8	0.9
FGF19		ENSG00000162344	"Fibroblast growth factor 19"	O95750	11	69698238-69704022	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"gallbladder: 237.1"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 24.3;Ductal cells: 15.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CAPAN-2: 138.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036082	Approved				"Secreted to blood"	NA	NA	133000			"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA036082: AB_10669665"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.22e-1)"		"unprognostic (4.68e-3)"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-3)"		"unprognostic (2.26e-1)"	"unprognostic (6.39e-3)"			"unprognostic (1.66e-2)"	"unprognostic (8.82e-3)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.4	0.1	0.0	237.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	138.2	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.7	1.4	0.6	24.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.1	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	1.3	0.0	0.0	0.0	0.3	1.8
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	24.3	2.6	14.8	5.3	16.1	0.1	9.5	12.2	14.7	8.7	14.2	14.1	1.7	14.2	4.5	4.7	8.0	7.1	5.0	12.2	18.8	4.0	2.0	8.3	1.8	18.6	20.5	12.6	1.5	4.7	3.2	6.4	15.6	7.6	4.0	3.4	3.5	8.7	1.4	1.9	3.7	12.6	16.8	1.1	6.2	1.9	18.3	1.6	2.4	4.8	1.8	14.8	6.1	13.3	4.7	14.1	7.8	30.5	18.8	31.1	0.0	243.8	148.4	104.3	60.2	0.2	0.4	0.0	20.5	278.2	81.8	0.7	8.1	0.5	104.3	12.3	3.3	0.0	28.7	0.2	55.3	1.4	0.1	16.8	1.7	103.6	147.6	52.0	11.8	0.0	6.9	8.4	27.4	0.1	0.1	0.2	21.6	0.1	5.4	0.0	3.9	0.1	33.0	0.0	4.4	4.0	48.4	0.1	2.0	44.7	0.1	0.5	10.6	85.7	12.2	32.0	20.0	8.6	10.3	0.0	24.7	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	16.1	12.2	14.7	12.2	18.8	18.6	20.5	15.6	16.8	18.3	13.3	33.7	6.4	0.0	111.0	0.3	1.7	1.6	0.8	2.8	4.6	4.5	8.9	4.7	0.0	1.3	7.3	0.0	2.7	0.4	0.0	3.9	8.2	10.9	1.5	40.6	11.5	1.8	0.4	1.8	1.0	0.1	77.1	0.0	1.6	0.0	5.7	17.2	1.3	0.5	0.0	6.6	0.0	0.0	0.0	2.4	3.8	9.9	1.7	5.4	15.9	0.6	9.3	0.0	42.3	5.8	11.0	0.0	8.2	1.6	16.0	0.0	0.6	0.0	2.0	0.0	15.2	14.2	4.7	1.1	0.3	1.3	4.8	0.5	0.1	0.0	2.0
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755524-48758333	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	106	"liver: 84.1"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 116.4"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 1.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061286	Supported				"Secreted to blood"	NA	NA	254000	73000		"Cluster 62: Liver - Hemostasis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA061286: AB_2684466"				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809968-69819416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"brain: 3.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.1"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.1	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771022-69775341	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.1;Early spermatids: 3.1;Late spermatids: 1.4;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"NTERA-2: 16.1;SuSa: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423237-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 63.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 216.6;Leydig cells: 83.3;Proximal tubular cells: 53.4;Smooth muscle cells: 71.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 112.1;ASC TERT1: 66.1;BJ: 45.6;fHDF/TERT166: 50.3;HSkMC: 84.8;RH-30: 119.7;U-138 MG: 56.5"	"Region enriched"	"Detected in some"	6	"cerebellum: 8.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	43.8	4.5	3.4	31.5	3.9	0.1	8.5	4.2	5.2	29.4	2.1	11.1	3.7	29.2	4.3	9.5	15.4	46.0	10.5	3.3	4.8	4.5	1.4	12.9	8.3	4.6	4.6	13.4	2.2	3.6	2.2	23.5	5.1	16.2	9.6	8.4	5.1	12.0	2.2	2.6	3.6	26.9	4.1	1.8	5.5	2.3	4.5	3.0	7.4	23.8	4.8	63.3	10.3	4.5	0.2	0.0	0.2	0.3	112.1	66.1	0.1	45.6	25.7	0.0	0.1	0.0	0.3	0.2	0.2	50.3	0.4	0.9	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	10.6	0.3	0.1	84.8	0.8	9.4	0.0	0.3	0.0	0.0	0.1	0.3	5.4	0.1	0.0	0.1	0.2	0.1	0.3	0.1	119.7	0.1	0.1	0.1	1.8	0.6	0.4	0.0	0.4	0.2	0.2	0.2	0.2	56.5	0.5	1.1	0.2	0.5	0.4	0.0	13.3	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	4.2	5.2	3.3	4.8	4.6	4.6	5.1	4.1	4.5	4.5	16.1	12.8	19.3	2.0	2.2	14.4	16.8	1.3	1.2	7.9	11.1	9.5	46.8	7.2	0.5	9.2	2.1	6.2	3.2	0.2	119.3	2.0	3.3	8.8	46.2	5.2	0.0	2.7	1.9	0.6	3.3	216.6	2.0	29.2	1.3	0.6	1.8	2.7	2.0	3.3	3.3	0.0	2.0	1.6	15.9	4.0	83.3	1.9	7.2	1.0	0.2	9.8	2.1	1.5	2.9	0.6	0.0	4.9	0.7	9.4	0.0	53.4	0.3	6.1	6.6	43.6	71.6	0.6	0.7	1.8	12.6	2.9	2.9	2.9	0.1	8.4
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671073-21704498	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.7;retina: 8.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Excitatory neurons: 36.7;Horizontal cells: 40.4;Inhibitory neurons: 54.7;Muller glia cells: 138.8"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 3.7;ovarian cancer: 1.2;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HEK 293: 1.4;JURKAT: 2.1;RPMI-8226: 2.1;RPTEC TERT1: 3.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced	Approved			"Secreted in other tissues"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"			"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	2.4	4.0	1.1	0.1	1.4	0.2	0.2	5.8	4.7	1.5	0.2	0.8	0.7	1.6	0.2	0.2	0.4	0.4	2.7	1.3	1.9	10.7	0.0	0.9	0.1	3.7	1.6	1.0	0.5	0.1	2.2	0.1	4.3	0.3	1.2	8.2	0.3	0.5	0.5	0.1	1.8	0.3	1.2	0.1	0.8	0.5	3.0	0.1	0.1	0.5	0.0	1.2	0.8	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	2.1	3.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	5.8	4.7	1.3	1.9	3.7	1.6	4.3	1.2	3.0	2.1	0.9	9.6	5.6	12.1	1.8	1.7	0.2	0.6	0.0	14.4	0.7	2.7	25.7	0.0	1.3	3.7	0.0	0.1	3.2	1.7	39.2	0.4	9.4	13.1	2.6	1.6	18.6	0.0	36.7	0.0	0.0	3.9	0.0	26.6	0.0	1.2	0.0	0.0	0.1	40.4	54.7	2.7	0.0	0.0	1.6	2.9	0.6	0.5	1.8	1.9	1.6	138.8	3.1	9.5	1.7	0.2	0.5	0.0	1.9	0.1	10.9	1.1	0.0	5.9	0.0	1.0	0.7	6.3	6.2	0.1	1.4	0.3	3.2	0.1	7.5	0.1
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935577-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 117.1;esophagus: 421.8;vagina: 172.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1044.3;Basal respiratory cells: 596.2;Squamous epithelial cells: 528.5;Suprabasal keratinocytes: 786.2;Urothelial cells: 303.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 117.5;head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 556.3;HBEC3-KT: 968.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.6	0.1	0.0	1.7	0.0	0.1	13.5	0.0	0.0	117.1	0.0	22.1	1.8	0.5	0.1	421.8	1.2	0.3	0.2	0.0	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	1.1	0.0	1.7	15.6	0.0	59.7	0.1	0.1	91.2	7.0	1.1	0.0	0.1	2.0	0.0	0.0	0.3	0.7	0.0	38.4	14.9	172.3	0.0	150.7	10.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	189.0	0.0	10.9	0.0	0.2	556.3	0.0	968.2	0.0	0.0	1.2	0.0	2.0	0.0	0.2	0.0	0.4	0.1	141.0	0.0	17.7	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	7.9	75.2	0.0	0.0	0.0	93.4	6.7	0.0	0.0	0.2	0.0	0.2	0.0	0.9	0.5	0.1	0.2	0.3	0.0	0.3	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	8.4	0.0	0.3	1044.3	182.5	596.2	217.4	0.0	11.8	3.2	0.1	0.0	223.2	0.0	0.0	0.2	0.2	49.6	0.0	49.7	0.0	52.8	3.3	6.3	0.0	0.0	0.0	7.5	2.4	6.2	0.0	65.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.1	42.7	0.0	60.6	0.0	0.0	0.9	74.7	0.0	0.6	0.0	1.0	0.0	0.0	139.1	50.8	0.0	0.0	90.8	0.7	0.0	56.8	0.0	0.0	0.0	10.4	0.0	0.0	528.5	786.2	2.3	2.1	0.0	26.1	303.6
FGFBP3	"C10orf13, MGC39320"	ENSG00000174721	"Fibroblast growth factor binding protein 3"	Q8TAT2	10	91906584-91909486	"Predicted secreted proteins"		"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 19.6;Enteroendocrine cells: 46.2;Muller glia cells: 28.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	9	"AF22: 315.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA053943	Uncertain				"Secreted in brain"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA053943: AB_2682318"	"unprognostic (8.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.76e-3)"	1.0	1.4	3.9	0.8	3.6	0.6	1.1	3.0	4.4	1.5	2.0	1.0	0.6	1.4	1.5	0.9	1.1	0.2	0.9	3.3	4.3	1.6	0.6	0.7	0.8	4.1	3.7	1.4	1.9	0.9	2.2	0.4	3.7	1.7	1.0	4.5	1.5	0.6	2.0	1.3	1.1	0.4	3.3	1.3	1.2	0.5	4.0	0.8	2.3	0.6	0.6	1.5	1.1	4.0	0.3	2.5	315.8	4.7	1.3	0.4	1.1	0.2	0.2	0.6	1.0	0.8	1.2	0.4	0.4	0.6	0.1	1.3	2.2	0.3	0.8	1.2	3.4	6.5	2.6	3.8	0.7	35.5	0.9	0.9	0.4	1.6	1.5	1.0	0.2	4.1	3.4	1.2	0.1	2.7	4.1	14.2	23.4	1.3	1.1	10.5	2.0	0.5	0.5	0.8	3.3	4.3	0.8	0.1	5.7	1.8	1.3	0.7	0.3	0.3	2.3	0.4	1.1	0.8	2.0	1.3	0.3	4.1	0.6	0.6	0.1	0.0	0.5	0.0	0.1	0.8	0.3	0.2	0.1	1.7	0.5	0.4	0.0	0.3	0.0	0.1	0.0	0.0	3.9	3.6	3.0	4.4	3.3	4.3	4.1	3.7	3.7	3.3	4.0	4.0	2.8	0.0	2.0	2.6	2.9	1.3	5.1	0.3	1.2	13.0	5.4	5.1	3.2	4.3	2.9	5.5	2.1	2.9	4.4	1.7	19.6	2.0	0.3	1.4	1.9	2.6	46.2	2.1	1.9	3.4	1.1	3.8	5.1	1.3	0.0	3.2	3.3	1.5	1.4	6.7	2.7	7.6	0.0	3.4	2.6	0.5	5.9	2.5	3.6	1.0	2.5	28.2	10.3	5.5	2.6	0.6	2.4	3.8	3.1	3.2	1.0	3.2	4.9	15.9	0.0	4.6	3.1	0.3	1.0	4.7	2.7	1.0	6.4	2.6	3.8	4.3
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 508.7;BJ hTERT+: 278.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	95.1	12.8	27.5	15.9	24.6	14.1	87.1	48.8	22.4	79.8	37.2	97.2	8.8	74.2	15.8	35.8	85.9	57.1	89.9	30.9	28.8	40.1	9.1	55.7	16.6	35.9	37.3	108.2	98.6	20.4	57.1	51.3	63.7	60.5	17.9	15.8	31.4	53.6	24.8	35.6	41.7	57.1	30.3	9.9	40.4	20.4	33.4	17.1	33.7	23.3	16.1	79.3	63.9	29.6	12.9	42.0	198.0	508.7	120.1	91.2	142.9	136.7	278.8	90.0	95.8	27.3	6.5	1.8	38.3	127.7	103.9	0.2	90.0	6.8	104.3	39.2	24.1	0.0	7.7	27.8	69.7	31.1	0.6	80.5	0.7	70.9	13.3	45.6	86.9	6.0	11.9	0.4	40.5	12.5	91.5	9.2	145.9	1.6	21.6	86.3	21.1	0.4	35.6	0.3	7.9	19.4	23.4	1.0	5.1	93.4	9.3	5.4	51.4	49.2	28.9	149.6	29.7	2.4	4.1	0.5	60.3	1.7	27.1	0.2	0.3	0.1	1.7	0.1	1.1	0.3	0.7	1.2	0.0	0.6	0.5	1.5	0.6	0.4	0.2	0.2	1.0	0.1	27.5	24.6	48.8	22.4	30.9	28.8	35.9	37.3	63.7	30.3	33.4	29.6	101.0	3.2	15.8	55.8	1.8	31.5	95.9	1.1	37.0	4.4	28.7	77.7	52.5	24.3	5.1	9.2	4.2	8.3	6.3	0.4	0.0	27.3	15.3	48.2	40.6	75.5	25.0	3.6	25.4	65.2	80.5	176.7	3.1	75.3	8.2	40.4	47.5	0.8	25.3	21.9	21.1	0.6	4.1	5.6	75.2	15.0	192.0	11.7	33.8	19.7	1.7	88.1	6.2	166.4	14.2	21.6	0.3	99.6	6.4	94.7	0.1	7.9	1.0	3.3	13.1	118.9	59.9	1.6	14.1	4.8	19.7	10.4	14.1	2.1	0.7	11.7
FGFR1OP2	DKFZp564O1863	ENSG00000111790	"FGFR1 oncogene partner 2"	Q9NVK5	12	26938470-26966650	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038308, HPA038696"	Supported		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA038308: AB_10672524, HPA038696: AB_10675948"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-2)"	29.4	41.6	29.0	30.6	32.6	61.6	26.3	28.6	48.3	24.9	21.0	23.1	23.1	31.6	29.0	23.1	23.7	28.7	28.5	34.2	28.1	30.9	27.8	25.7	42.4	29.2	28.6	59.5	15.1	19.3	17.8	27.1	29.3	19.9	20.0	30.7	18.2	18.6	23.3	23.5	22.9	26.6	29.8	33.2	20.5	23.0	27.5	36.2	24.1	32.8	30.9	25.2	21.1	44.3	30.3	36.9	30.5	41.1	51.9	37.4	44.2	51.6	60.1	39.1	42.5	57.3	34.4	44.3	24.8	45.9	37.4	31.4	21.3	38.8	55.5	33.6	31.1	75.0	39.4	38.4	61.3	43.5	54.9	27.3	24.8	47.7	61.6	53.3	56.8	39.6	45.3	33.0	46.2	36.3	58.0	103.3	50.4	39.1	59.9	34.6	84.2	37.1	34.8	36.5	9.3	18.5	58.9	21.5	52.1	69.9	38.5	65.3	61.7	51.6	52.0	95.9	48.5	23.1	25.2	93.4	43.2	50.2	42.7	81.1	31.5	40.6	31.6	31.4	28.3	22.3	33.0	30.7	25.2	19.7	29.8	33.3	32.0	25.9	31.3	20.6	61.3	23.7	29.0	32.6	28.6	48.3	34.2	28.1	29.2	28.6	29.3	29.8	27.5	44.3	70.8	38.5	37.2	39.2	97.1	140.3	62.3	30.6	86.0	52.7	45.4	39.6	45.4	24.3	41.2	27.6	77.2	41.5	114.1	19.9	72.4	28.9	17.9	28.9	47.8	70.1	26.9	249.0	79.4	23.1	37.8	86.5	23.0	30.8	59.5	77.9	70.6	30.7	60.6	58.9	30.6	22.0	26.4	64.7	96.2	18.8	105.3	74.6	88.9	47.8	49.6	64.3	83.4	63.8	128.5	29.7	29.0	170.8	138.2	56.7	27.2	70.0	20.8	48.0	46.0	69.6	81.4	32.9	70.1	57.4	119.8	59.5	141.2	42.9	20.0	63.5
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 82.5;lung: 65.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	1.2	14.0	1.1	4.1	1.1	0.5	4.5	2.7	2.1	3.0	1.2	18.0	21.3	2.4	0.2	3.2	4.2	10.2	2.2	1.4	1.0	40.2	82.5	65.4	0.8	0.7	0.8	27.5	29.5	0.2	2.0	2.1	0.9	5.2	6.0	1.5	1.1	0.7	6.6	1.7	20.0	1.1	0.7	22.7	8.8	5.9	1.1	0.2	0.9	1.9	0.2	6.4	3.2	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	2.7	2.1	1.4	1.0	0.7	0.8	0.9	0.7	1.1	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.7	34.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.0	1.2	0.0	0.0	8.8	16556.3	50.2	0.1	0.0	0.0	1.4	15.8	0.0	0.4	6.3	0.0	0.4	0.0	0.0	0.4	0.3	0.4	0.5	0.6	0.0	0.0	9.1	8.7	3.0	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193369-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 162.5"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	45	"classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8"	"Group enriched"	"Detected in all"	59	"dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	7800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	48.5	24.4	3.3	89.4	2.7	5.8	35.1	5.3	3.5	17.2	6.1	44.9	43.7	17.8	7.6	38.5	22.1	45.4	21.6	2.4	5.4	44.9	43.5	32.7	56.5	7.7	5.9	10.9	8.3	5.2	7.9	21.6	6.7	10.5	57.2	0.8	14.8	11.7	8.8	13.9	69.8	45.7	6.2	162.5	23.5	6.2	3.9	30.1	18.8	24.6	27.5	73.3	7.1	9.8	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.2	0.3	5.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.0	5.7	2.8	256.5	226.3	3.9	380.6	1.2	4.3	2.5	3.4	160.0	2.0	1.8	3.0	294.7	2.5	379.8	6.2	4.7	174.0	3.3	2.7	5.3	3.5	2.4	5.4	7.7	5.9	6.7	6.2	3.9	9.8	102.0	6.4	12.1	0.0	26.2	38.1	1.1	0.1	3.4	1.1	1.4	3.0	4.4	0.0	5.0	88.3	10.4	1.3	60.3	17.3	5.9	1.9	7.5	2.6	0.7	50.6	0.0	7.0	0.3	0.0	1.4	102.8	2.0	5.0	10.1	0.6	45.3	5.2	36.2	1.7	0.4	0.3	0.0	466.3	571.0	9.4	27.7	430.3	49.8	33.7	463.1	13.6	39.1	0.0	0.9	0.1	10.9	19.5	82.6	1.1	42.5	5.9	2.2	7.4	0.0	166.2	8.2	0.4	0.4	2.1	31.3	3.7	24.1	0.2	0.8	1.5
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.8;fallopian tube: 15.2;testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 234.4;Endometrial ciliated cells: 179.0;Late spermatids: 244.9;Respiratory ciliated cells: 265.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;HMC-1: 80.4;K-562: 18.5;U-87 MG: 42.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.2	1.0	0.7	1.1	0.0	1.0	0.2	0.9	2.1	13.8	0.3	0.9	0.5	1.8	0.1	15.2	0.5	0.1	1.9	2.0	0.6	0.3	3.5	0.2	3.8	8.1	0.3	0.7	0.9	0.6	0.4	3.4	0.3	0.3	0.1	0.5	0.5	0.0	0.2	1.0	0.3	2.2	0.1	2.2	13.4	1.5	0.1	1.2	0.0	0.2	0.8	0.2	1.5	2.1	0.5	1.7	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	1.1	5.6	0.8	0.3	0.2	0.5	0.2	0.0	0.3	29.5	0.2	0.1	0.0	0.0	0.5	2.5	80.4	0.8	0.0	0.3	0.0	0.1	0.0	0.0	18.5	0.0	0.0	0.3	0.3	0.3	0.1	0.3	0.9	0.0	0.5	0.0	0.1	0.1	0.7	0.6	0.0	0.1	0.5	0.1	0.1	0.5	0.0	7.1	0.2	8.3	0.1	0.0	10.0	0.0	42.9	0.1	0.3	0.0	0.4	0.0	0.9	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.1	1.0	1.1	0.2	0.9	1.9	2.0	3.8	8.1	3.4	2.2	1.5	1.5	0.4	0.0	2.2	2.6	0.1	0.1	0.8	4.4	0.0	0.4	0.3	0.6	1.9	4.3	29.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	234.4	179.0	2.1	1.5	1.8	0.0	4.7	1.4	0.0	2.4	7.7	13.5	0.0	0.5	0.0	0.0	2.6	3.3	2.4	1.2	6.1	1.3	1.7	244.9	2.1	2.6	0.0	1.9	0.1	0.2	0.0	1.0	1.3	0.8	1.1	0.0	0.0	0.4	0.7	0.6	265.6	0.0	13.1	0.2	2.6	14.9	9.5	0.0	0.0	0.1	0.3	0.3	0.6	1.7
FHDC1	"INF1, KIAA1727"	ENSG00000137460	"FH2 domain containing 1"	Q9C0D6	4	152936323-152979671	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7;parathyroid gland: 17.6;thyroid gland: 15.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 85.9;Erythroid cells: 71.1;Syncytiotrophoblasts: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.6;RT4: 10.5;SK-BR-3: 14.4;WM-115: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008527	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA008527: AB_2104099"	"unprognostic (5.42e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.95e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.30e-1)"	0.7	0.3	1.0	1.2	3.7	14.7	2.1	2.1	2.2	1.6	0.5	3.9	3.5	0.6	1.2	4.9	1.4	1.8	0.3	0.5	1.7	2.0	0.4	8.6	0.8	2.4	1.5	0.3	1.0	17.6	1.5	6.7	2.4	7.2	4.7	1.0	3.9	0.8	0.3	7.9	4.1	0.6	0.7	3.5	4.7	1.2	2.8	0.4	15.7	0.3	2.1	1.6	2.8	1.2	5.7	0.5	1.0	0.8	0.4	0.3	30.6	0.4	1.1	1.2	0.1	0.3	3.4	0.2	0.2	0.5	1.0	1.1	0.3	2.3	0.4	0.6	0.3	0.6	3.5	0.4	0.1	0.2	0.9	0.2	2.8	0.0	0.7	1.2	0.0	0.5	1.4	0.6	0.4	3.5	0.1	0.1	6.3	0.5	0.4	0.1	0.3	0.1	5.6	10.5	5.5	0.2	1.9	14.4	2.1	6.9	2.2	0.4	0.2	0.4	0.9	2.6	1.3	0.8	0.5	0.1	0.2	0.1	10.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.0	3.7	2.1	2.2	0.5	1.7	2.4	1.5	2.4	0.7	2.8	1.2	0.5	16.0	85.9	5.5	0.5	5.9	2.8	16.3	3.4	0.1	4.8	4.1	0.9	2.8	18.8	3.7	2.1	11.9	0.3	11.1	0.0	0.9	2.0	4.5	2.4	2.0	13.8	71.1	10.7	3.1	13.1	2.6	15.3	15.6	3.8	0.5	0.0	0.0	2.1	0.0	13.7	9.3	4.1	0.0	0.8	0.2	0.9	0.6	0.0	7.5	0.0	0.0	0.0	13.0	8.7	7.5	6.2	0.7	0.1	4.7	7.7	0.1	9.3	0.1	0.0	0.5	1.2	1.1	0.8	4.7	7.1	80.0	0.6	1.5	7.6	3.2
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad diadenosine triphosphatase"	P49789	3	59747277-61251459	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 94.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"naive CD4 T-cell: 87.6"	"Lineage enriched"	"Detected in all"	12	"T-cells: 87.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/70: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		12000	"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	5.6	24.4	13.7	6.2	18.3	8.0	9.0	13.0	17.3	5.4	94.0	6.9	6.4	3.5	6.9	5.0	6.6	9.8	15.8	19.7	16.4	24.9	9.6	4.7	7.6	18.9	17.0	6.8	13.0	18.1	7.9	3.0	18.9	5.3	5.8	7.6	8.5	4.7	10.6	8.1	5.3	4.7	15.0	5.0	8.6	5.5	15.9	12.1	11.7	7.2	5.3	6.7	4.2	19.8	0.1	0.0	1.4	0.0	0.6	0.1	2.5	0.1	0.2	0.1	0.0	2.7	4.2	4.0	0.7	0.1	3.0	0.0	12.7	3.2	0.0	2.2	5.0	3.3	2.0	6.4	3.3	8.7	0.1	9.1	5.2	0.2	6.9	0.3	0.0	3.7	2.5	11.9	0.2	3.6	15.2	6.7	1.2	12.2	0.9	11.3	0.0	17.5	15.3	2.0	2.9	4.3	1.5	9.9	10.1	5.3	0.4	0.2	0.0	1.7	0.4	0.1	2.4	34.6	11.3	0.0	4.0	0.1	1.9	6.8	4.6	0.5	2.2	2.9	1.4	4.1	17.2	1.8	5.7	3.1	87.6	15.6	0.8	7.2	1.3	5.8	20.5	11.9	13.7	18.3	13.0	17.3	19.7	16.4	18.9	17.0	18.9	15.0	15.9	19.8	4.1	6.4	10.6	609.8	19.7	7.6	20.7	30.0	46.7	12.6	41.2	31.2	10.0	38.6	17.5	27.6	58.4	42.0	12.4	6.9	78.2	19.1	45.8	14.6	7.9	7.0	7.7	17.7	276.6	4.7	8.5	10.1	18.3	19.0	5.7	25.7	14.6	23.4	20.9	30.3	450.5	12.9	22.4	10.2	7.1	163.0	19.3	12.9	12.4	337.3	8.6	19.7	6.2	1086.7	1111.0	9.7	15.0	9.8	23.8	12.0	20.7	126.6	12.4	20.7	0.0	10.7	6.2	19.1	7.5	33.7	11.2	32.7	11.5	23.0	20.1	18.8
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 1421.4;ovary: 535.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1077.5;Extravillous trophoblasts: 585.9;Granulosa cells: 851.4;Leydig cells: 567.0;Peritubular cells: 1049.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.7;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 534.6;RPTEC TERT1: 489.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes		14000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	68.3	70.2	10.4	28.9	13.2	17.0	65.4	7.6	18.2	101.9	15.0	75.2	48.5	105.1	33.8	55.4	55.8	81.5	1421.4	18.9	7.4	55.2	22.1	17.5	17.2	6.7	7.2	535.4	9.1	8.2	29.3	79.3	7.0	88.8	56.8	8.5	45.3	63.8	67.5	44.2	50.4	91.5	7.5	20.1	94.9	50.9	7.9	22.8	41.3	118.6	13.9	105.5	47.2	12.2	156.8	36.1	20.9	0.8	65.2	81.7	196.4	289.3	75.9	182.2	216.7	65.6	237.6	0.4	23.7	353.6	223.8	47.7	31.4	262.4	204.2	6.5	23.9	108.7	42.9	49.0	257.6	0.4	23.5	171.7	142.2	286.0	188.1	360.8	374.4	18.0	29.0	8.9	534.6	5.6	25.8	1.0	44.1	108.3	113.2	0.4	31.6	4.3	489.8	108.4	1.0	6.9	109.2	48.1	76.9	20.5	60.7	3.9	183.1	130.4	134.1	146.4	236.0	3.3	0.6	0.7	208.1	0.6	138.5	5.7	0.4	0.4	1.1	0.2	0.7	0.6	0.9	2.0	0.4	0.5	0.7	1.5	2.2	0.7	0.2	0.6	2.7	1.5	10.4	13.2	7.6	18.2	18.9	7.4	6.7	7.2	7.0	7.5	7.9	12.2	15.7	9.6	5.1	0.7	1.0	468.5	1077.5	342.5	389.9	9.5	59.8	126.2	362.1	15.7	91.0	29.5	2.1	220.4	1.7	212.6	3.9	100.7	5.7	44.8	40.4	27.4	58.2	63.5	46.3	117.9	585.9	96.1	186.1	32.5	10.2	851.4	17.2	9.2	25.3	0.0	4.9	169.8	73.2	0.6	31.8	17.3	567.0	10.4	23.2	25.3	2.7	1.6	0.0	0.5	1.6	234.5	258.2	1049.0	6.7	198.2	51.7	28.1	19.1	13.0	216.9	60.6	171.0	9.1	17.7	124.5	296.9	178.7	7.7	193.5	55.8	536.2
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247481	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 88.1;skeletal muscle: 127.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 40.6;Theca cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 112.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	16.9	16.9	3.6	9.6	3.5	6.2	13.2	3.5	4.0	9.6	4.6	9.3	5.9	8.5	1.6	4.5	7.9	5.5	10.4	3.4	3.3	10.5	3.3	26.6	8.5	4.1	4.0	14.7	7.7	3.7	5.4	8.9	3.9	8.8	4.2	0.3	8.4	3.9	127.0	6.2	9.7	5.8	4.0	88.1	7.2	5.0	4.8	4.1	16.8	29.8	5.9	7.4	6.7	3.8	12.0	31.6	11.8	9.8	46.1	27.9	39.2	24.9	19.8	27.2	26.3	22.3	15.7	14.1	17.5	18.0	8.8	14.7	13.5	20.0	13.5	11.3	21.7	63.1	13.9	24.5	12.2	26.3	112.1	34.8	2.6	42.2	4.1	24.3	43.0	19.9	32.9	9.3	17.6	41.0	18.1	48.3	17.6	11.0	10.0	20.3	25.9	33.8	8.7	4.9	3.7	19.2	38.2	22.4	22.5	11.7	23.8	21.1	51.6	37.4	22.0	24.0	20.3	29.9	32.0	20.7	76.1	24.7	34.7	0.3	0.7	0.1	0.2	0.2	0.3	0.0	0.3	0.2	0.4	0.1	0.1	0.1	0.5	0.3	0.2	0.2	0.3	0.6	3.6	3.5	3.5	4.0	3.4	3.3	4.1	4.0	3.9	4.0	4.8	3.8	18.0	12.8	21.6	4.6	7.2	5.7	1.8	2.0	3.4	1.8	11.5	8.0	13.8	10.0	5.9	5.5	8.4	8.7	11.4	16.9	0.0	3.6	1.1	3.5	8.1	22.3	9.1	8.6	2.5	5.9	4.7	10.9	5.6	4.7	40.6	12.0	25.0	0.8	17.1	1.7	2.2	13.1	2.0	20.3	19.7	1.1	10.5	19.8	3.6	17.8	18.9	2.9	10.3	2.0	0.6	7.4	6.1	10.9	7.1	3.1	6.3	1.4	3.9	1.2	26.3	4.2	15.7	19.0	12.3	5.6	3.7	1.9	13.3	40.3	13.8	1.7
FHOD3	"FHOS2, FLJ22297, FLJ22717, KIAA1695"	ENSG00000134775	"Formin homology 2 domain containing 3"	Q2V2M9	18	36297714-36780055	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 87.6;Excitatory neurons: 132.2;Granulosa cells: 84.9;Inhibitory neurons: 186.5;Oligodendrocyte precursor cells: 114.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.3;HDLM-2: 80.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021827, HPA024696"	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021827: AB_1848571, HPA024696: AB_1848573"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.11e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.20e-1)"	3.4	32.1	13.2	2.4	14.3	0.1	6.1	8.7	17.7	5.6	13.9	14.5	1.6	3.0	42.2	9.4	11.2	7.2	172.8	13.8	12.3	23.2	1.4	1.5	1.3	37.9	15.1	6.9	2.1	1.0	10.5	1.3	36.8	27.9	3.4	36.1	11.3	62.8	49.5	6.5	5.5	10.1	11.5	1.3	3.2	4.1	8.5	2.4	3.6	20.5	4.0	14.6	5.2	13.5	15.5	5.4	34.3	8.2	0.2	0.0	2.6	34.1	72.3	6.7	6.5	0.0	24.5	2.8	8.9	16.3	19.2	19.5	11.4	14.8	4.0	80.1	4.0	0.0	1.0	0.1	0.4	0.0	1.1	4.5	7.1	3.6	1.5	36.6	0.2	0.0	0.0	0.2	8.0	0.0	0.1	0.2	7.5	0.0	4.9	0.0	0.0	18.9	32.5	17.0	19.0	44.6	7.4	0.1	4.6	3.0	0.2	0.1	39.6	21.3	1.6	0.9	29.5	31.8	0.0	0.0	23.8	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	14.3	8.7	17.7	13.8	12.3	37.9	15.1	36.8	11.5	8.5	13.5	0.4	0.0	0.0	104.5	0.0	3.2	0.9	8.9	14.8	6.5	2.3	11.4	38.0	0.0	2.7	12.9	87.6	0.1	0.0	0.2	3.9	1.3	1.7	10.2	1.7	0.6	0.0	0.4	132.2	0.9	11.3	7.9	1.1	0.6	0.0	84.9	0.0	0.0	0.2	0.0	186.5	0.2	6.1	0.0	0.6	0.4	0.0	0.3	10.6	11.2	0.0	7.3	0.0	114.1	3.4	3.3	0.1	0.4	0.0	0.6	0.0	7.9	15.3	33.6	0.0	11.2	6.3	2.2	2.8	1.6	0.6	0.4	0.4	29.9	0.3	0.3
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.9;brain: 26.7;parathyroid gland: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.6;Exocrine glandular cells: 30.1;Intestinal goblet cells: 24.5;Ionocytes: 26.4;Late spermatids: 36.1;Pancreatic endocrine cells: 28.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;MCF7: 32.8;OE19: 22.9;RPTEC TERT1: 24.4;THP-1: 12.5;U-2 OS: 14.1;U-251 MG: 13.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 17.6;hippocampal formation: 68.4"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 57.3"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.1	9.9	8.0	0.0	1.8	0.0	0.5	0.0	15.8	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	26.7	1.4	0.1	0.0	2.1	0.0	8.3	6.3	0.1	0.0	12.5	0.1	0.9	5.2	0.1	0.7	1.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.1	6.6	5.4	0.0	0.0	0.0	0.0	0.9	0.1	2.7	0.3	3.5	1.2	0.0	0.1	0.0	0.0	5.9	8.7	0.4	1.2	0.0	3.7	0.0	2.3	0.3	6.3	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.4	0.2	0.3	0.0	0.1	3.9	0.0	13.7	0.0	0.0	0.7	0.0	0.0	32.8	0.0	2.8	2.1	22.9	0.6	0.0	5.7	0.4	24.4	0.0	0.2	0.0	1.1	0.1	0.8	0.9	2.0	12.5	0.0	1.3	14.1	0.1	13.5	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	8.0	1.8	0.0	15.8	26.7	1.4	8.3	6.3	5.2	0.0	5.4	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.9	5.0	0.0	3.2	0.8	0.0	1.3	0.0	2.3	1.8	0.0	11.6	0.0	10.4	0.0	0.3	19.6	0.0	0.1	0.4	0.0	0.0	0.3	30.1	0.9	0.9	0.0	0.0	0.0	0.8	0.0	0.0	1.1	3.3	0.3	24.5	26.4	0.0	0.0	36.1	0.6	0.5	0.0	1.9	0.4	0.6	0.0	0.0	0.1	28.6	6.3	3.4	0.0	0.7	2.5	0.1	2.1	0.2	0.0	0.0	0.8	9.5	16.3	0.0	0.0	4.0	0.0	0.9	6.7	1.5
FIBIN	MGC24932	ENSG00000176971	"Fin bud initiation factor homolog"	Q8TAL6	11	26994112-26997087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 33.0;Fibroblasts: 80.8;Granulosa cells: 42.4;Leydig cells: 37.9;Oligodendrocyte precursor cells: 32.2;Peritubular cells: 35.0"	"Cancer enhanced"	"Detected in all"		"glioma: 48.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 65.2;ASC TERT1: 41.8;fHDF/TERT166: 22.1;HHSteC: 88.2;HSkMC: 89.5;hTCEpi: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040120	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA040120: AB_10795243"	"unprognostic (1.72e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.93e-5)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.02e-2)"	32.3	4.9	11.0	7.7	10.6	0.0	25.1	11.4	10.8	35.6	6.1	27.8	2.2	26.1	8.0	11.3	35.7	7.9	32.6	10.8	10.7	15.2	2.0	27.2	2.8	10.6	12.7	18.5	3.8	0.3	2.6	12.6	11.7	17.0	2.6	0.6	17.6	61.3	17.1	16.7	12.0	17.1	11.4	14.1	21.1	1.3	11.6	2.1	13.4	14.5	0.9	16.3	58.3	11.7	0.0	0.0	1.0	0.0	65.2	41.8	0.1	2.1	5.7	0.2	0.9	0.0	0.0	0.0	0.0	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	88.2	0.0	0.0	89.5	24.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.6	11.4	10.8	10.8	10.7	10.6	12.7	11.7	11.4	11.6	11.7	2.5	0.0	0.0	17.9	0.0	6.6	1.6	33.0	1.8	0.3	1.9	0.9	1.2	11.5	4.0	11.0	0.0	1.2	0.0	0.1	11.7	0.6	0.1	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.9	80.8	0.0	0.0	0.0	42.4	6.1	0.5	1.8	0.0	0.1	0.0	12.2	0.0	10.3	0.3	37.9	0.8	7.2	0.0	0.0	19.8	0.0	32.2	0.1	0.1	0.0	35.0	0.1	0.2	0.0	4.3	0.9	0.6	0.0	3.7	7.4	0.1	0.3	0.8	5.1	1.9	0.5	3.9	0.0	0.0
FIBP	FGFIBP	ENSG00000172500	"FGF1 intracellular binding protein"	O43427	11	65883740-65888531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011729	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA011729: AB_1848579"	"unprognostic (1.70e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.89e-2)"	34.1	48.4	48.0	26.8	49.0	32.2	33.0	48.0	55.1	31.1	41.8	30.8	30.4	35.9	29.4	35.6	37.2	22.3	56.8	51.0	50.5	48.3	37.1	31.6	35.6	53.3	47.6	28.6	39.0	32.8	31.2	25.1	54.3	30.6	27.3	19.8	27.9	24.6	53.6	45.7	35.3	30.9	46.6	43.3	37.7	64.9	49.9	40.3	35.9	56.1	42.9	29.7	28.3	47.8	61.0	86.9	48.3	118.6	72.8	91.2	35.9	54.8	110.9	74.3	62.0	36.1	83.1	79.7	98.2	124.1	35.9	65.2	48.5	121.0	48.1	93.7	62.2	77.3	84.1	54.7	99.8	100.7	64.4	73.8	68.3	54.1	114.4	60.0	93.7	61.5	27.4	139.4	98.9	198.2	78.9	88.0	47.8	61.5	130.7	104.9	45.6	196.3	88.5	79.6	87.8	80.4	60.3	110.6	110.5	32.5	113.0	58.1	86.3	79.7	66.4	130.9	40.3	73.8	87.6	48.4	101.1	73.6	30.7	123.5	121.2	98.9	71.1	136.9	74.4	100.7	67.2	64.9	164.7	83.1	52.7	57.0	20.4	101.1	150.0	84.1	100.6	109.4	48.0	49.0	48.0	55.1	51.0	50.5	53.3	47.6	54.3	46.6	49.9	47.8	55.8	12.8	28.0	4.9	57.0	47.3	51.7	105.7	38.7	47.7	66.9	85.6	44.7	42.9	55.7	44.1	31.3	79.4	41.1	61.6	93.9	114.2	176.7	45.3	59.8	52.6	93.5	39.1	7.1	149.3	125.7	50.3	37.2	39.6	67.2	68.6	45.3	36.5	115.0	42.1	7.3	49.2	57.0	75.3	75.9	608.0	36.1	67.9	51.6	3.7	129.3	47.1	101.0	3.5	5.6	98.9	68.8	39.5	60.1	56.1	185.8	150.1	54.9	52.8	19.7	39.2	77.2	100.5	84.0	51.5	52.1	71.8	54.6	79.6	58.8	61.5
FICD	"HIP13, HYPE"	ENSG00000198855	"FIC domain protein adenylyltransferase"	Q9BVA6	12	108515277-108525837	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	"Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.8;Late spermatids: 52.0;Syncytiotrophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021390, HPA071134"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA021390: AB_1851340, HPA071134: AB_2686347"	"unprognostic (1.00e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.61e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.65e-2)"	3.5	7.5	5.1	5.3	6.5	2.9	3.6	6.2	5.9	6.3	4.5	3.2	3.3	3.3	12.2	1.8	3.2	3.0	2.7	5.3	6.3	3.0	8.2	3.9	4.0	7.0	6.6	2.6	12.7	4.7	11.6	3.7	6.3	4.7	2.9	2.4	8.9	6.0	2.0	2.8	2.7	3.8	6.4	3.5	4.3	7.6	6.3	2.4	10.9	2.0	5.3	3.3	1.6	7.4	2.5	6.3	2.5	5.0	5.9	4.1	6.8	16.5	8.7	7.6	5.3	3.9	2.4	3.5	6.0	8.0	9.0	3.2	2.7	1.8	6.7	6.1	4.0	2.0	4.6	5.6	23.0	3.0	7.2	1.9	3.8	10.7	15.2	9.4	5.5	3.3	1.4	11.6	6.9	5.9	4.0	3.1	2.7	2.7	10.2	2.3	3.4	8.7	3.6	4.9	2.4	1.6	7.4	3.4	8.3	3.7	5.4	2.9	6.2	7.8	2.8	13.8	6.4	22.9	4.0	1.2	10.7	2.6	5.5	11.5	2.7	4.5	6.3	4.8	7.7	4.7	4.6	5.9	2.7	2.9	2.7	5.2	5.4	3.3	5.8	15.3	3.1	1.9	5.1	6.5	6.2	5.9	5.3	6.3	7.0	6.6	6.3	6.4	6.3	7.4	3.8	0.0	3.7	6.5	6.5	0.8	4.5	4.4	1.2	5.5	5.9	3.4	2.9	4.3	3.3	7.3	2.1	6.2	4.3	2.3	5.9	5.8	62.8	2.7	6.9	4.2	1.8	2.7	2.3	9.5	5.5	6.5	5.6	7.3	13.4	3.2	4.6	5.1	6.1	13.5	2.9	4.0	0.0	2.9	3.5	52.0	3.4	4.6	7.2	1.9	2.8	11.8	5.2	3.5	4.5	7.6	1.4	9.8	15.0	8.9	1.9	2.4	4.4	7.8	13.1	4.2	4.7	9.6	9.3	1.7	3.3	31.1	4.7	5.0	2.5	4.8
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109690609-109878098	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	9.3	10.2	5.5	7.1	7.2	5.6	8.1	5.9	7.7	8.2	12.9	10.1	5.0	8.5	7.8	9.4	7.2	7.6	7.7	6.0	8.8	9.5	6.1	13.4	10.1	6.4	7.3	8.2	7.5	17.4	11.9	8.8	8.9	7.7	9.5	10.8	10.7	7.8	10.6	7.6	9.1	10.3	5.6	13.8	8.7	8.2	6.1	12.3	9.3	8.3	10.1	9.2	8.4	7.0	8.3	8.4	11.7	14.9	11.8	17.2	7.8	9.9	14.1	8.3	23.2	4.6	7.2	23.2	5.8	18.9	14.9	5.2	12.6	8.5	20.7	13.3	16.5	10.9	5.9	5.5	11.4	9.5	10.0	8.8	9.9	12.8	10.6	22.8	18.3	13.9	6.8	8.8	12.7	6.8	12.0	8.4	5.9	12.0	4.7	7.9	6.1	7.3	13.3	18.4	12.8	11.7	7.1	10.7	21.1	15.6	6.0	23.1	11.2	4.2	3.8	5.4	9.5	3.4	2.6	7.9	27.3	8.5	4.6	15.4	24.9	14.2	8.8	24.5	7.7	18.9	6.3	8.5	19.2	21.2	7.5	7.5	7.4	10.0	15.2	8.1	9.4	11.7	5.5	7.2	5.9	7.7	6.0	8.8	6.4	7.3	8.9	5.6	6.1	7.0	4.9	16.0	9.0	24.5	15.7	4.6	7.1	7.3	5.2	8.8	5.4	3.3	6.7	2.8	6.9	9.2	2.1	13.4	9.5	7.0	5.9	9.8	18.0	7.5	5.3	5.2	10.2	3.0	49.5	11.4	7.0	6.0	8.2	7.9	8.8	8.6	7.1	4.1	23.3	1.7	32.4	8.6	8.2	19.2	6.8	17.7	3.4	17.3	8.8	29.0	16.4	8.5	11.3	46.8	37.4	7.6	6.3	6.8	6.5	4.0	6.3	8.2	9.1	7.6	0.0	5.1	6.6	5.5	12.1	8.3	4.4	12.3	9.3	5.6	6.4	8.9
FIGLA	bHLHc8	ENSG00000183733	"Folliculogenesis specific bHLH transcription factor"	Q6QHK4	2	70777310-70790643	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"retina: 1.1"	"Group enriched"	"Detected in some"	17	"Early spermatids: 1.9;Late spermatids: 6.4;Spermatogonia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071241	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA071241: "				"unprognostic (1.82e-1)"						"unprognostic (4.04e-1)"					"unprognostic (1.73e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	34	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	34	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"AF22: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	3.1	2.0	3.9	0.4	5.0	0.8	2.0	2.3	4.4	2.4	0.0	2.6	0.4	1.1	1.2	0.6	1.9	1.1	3.3	2.5	5.4	1.9	3.2	1.4	0.6	3.0	4.2	4.6	2.9	0.4	2.6	1.1	3.9	1.6	0.7	1.4	2.6	2.7	1.0	1.0	1.4	0.9	1.8	3.0	1.8	1.1	4.6	0.2	1.1	1.7	0.2	1.7	2.4	5.1	6.4	2.3	18.6	0.0	0.0	0.0	6.8	2.4	1.6	1.7	3.2	0.0	2.2	0.0	6.6	2.6	3.4	0.9	6.2	2.6	1.3	0.0	4.6	0.0	4.7	4.6	1.5	0.0	0.0	0.8	2.2	3.3	9.0	2.6	4.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	7.9	0.4	2.9	0.0	6.3	0.0	4.2	2.1	2.9	2.5	0.0	1.8	1.7	10.3	2.0	0.0	0.4	7.6	6.8	0.0	5.1	1.1	0.0	0.0	2.3	0.0	4.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.0	2.3	4.4	2.5	5.4	3.0	4.2	3.9	1.8	4.6	5.1	2.9	6.4	7.3	161.3	0.7	1.9	0.1	2.8	1.8	24.4	5.7	2.7	19.4	20.0	3.0	12.9	0.0	21.2	0.2	0.1	1.9	3.7	3.8	0.7	0.7	2.1	0.0	0.0	53.4	1.5	7.4	11.6	4.1	1.6	0.0	23.6	7.9	13.5	1.4	6.7	82.9	0.0	4.1	0.0	1.6	6.4	51.9	0.6	17.8	28.1	0.0	4.3	0.0	309.6	129.4	1.1	0.0	34.3	0.0	1.8	0.0	8.1	4.0	2.1	72.3	16.6	17.8	1.1	1.2	1.0	0.4	16.8	0.2	7.0	0.0	0.0
FIGNL1		ENSG00000132436	"Fidgetin like 1"	Q6PIW4	7	50444128-50542535	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA055542	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA055542: AB_2682841"	"unprognostic (4.62e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (9.54e-7)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	4.5	4.1	4.0	8.4	4.9	8.7	8.8	6.2	5.3	5.4	1.6	6.2	6.8	8.5	4.7	9.0	4.8	4.5	3.9	4.3	4.2	3.5	4.7	3.3	10.3	4.4	3.9	11.3	2.7	3.8	2.5	5.2	4.9	5.9	6.4	9.7	3.8	4.4	6.5	8.6	6.3	9.9	3.9	7.7	4.2	7.2	4.4	10.2	3.7	8.0	13.3	3.6	4.9	5.7	12.9	25.8	33.0	36.1	7.4	13.3	21.1	43.8	22.3	46.0	50.9	40.6	28.5	49.1	22.9	13.1	38.3	43.6	35.3	21.9	73.0	42.0	26.5	21.8	53.7	14.2	4.5	52.5	33.4	6.1	10.7	30.4	15.6	7.3	48.8	22.1	51.5	30.0	35.3	19.1	32.1	38.8	30.2	48.6	30.4	29.8	28.5	17.9	14.3	32.7	37.6	29.2	16.3	35.5	16.6	15.4	34.8	17.4	19.0	0.1	19.2	55.9	36.4	50.5	56.5	38.1	14.7	47.2	73.4	0.0	1.1	0.8	1.7	2.0	3.0	3.4	2.0	3.4	1.2	4.0	3.0	2.9	0.6	3.8	6.1	1.2	4.1	1.5	4.0	4.9	6.2	5.3	4.3	4.2	4.4	3.9	4.9	3.9	4.4	5.7	3.4	0.0	0.5	3.9	7.8	4.1	1.9	3.2	8.6	10.8	4.3	3.9	17.2	2.8	2.3	1.8	6.2	7.0	6.0	1.7	3.9	3.0	1.1	3.3	5.6	4.4	0.0	17.9	11.0	1.2	9.8	5.7	2.6	6.0	2.5	21.3	3.9	2.1	4.6	10.1	7.6	1.3	4.1	2.9	4.2	1.4	11.5	2.9	3.6	4.7	4.4	6.0	7.2	6.6	11.1	2.3	2.8	9.4	8.6	0.7	1.5	2.2	0.8	14.9	0.0	6.0	4.3	27.6	20.4	7.7	3.0	1.4	5.5	9.9	4.0	1.2
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.1;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 18.0"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	77.1	21.7	4.9	52.4	6.3	0.8	32.6	4.8	6.6	63.8	4.0	57.7	28.4	117.6	23.8	56.0	31.2	90.9	54.8	6.2	4.4	24.0	28.1	30.7	30.1	9.6	4.2	76.4	35.5	17.5	3.9	43.9	9.7	67.9	29.8	4.7	9.3	54.3	140.4	16.8	41.2	151.7	3.7	42.9	46.7	22.0	3.6	11.9	20.1	161.5	22.3	101.5	21.9	4.0	59.0	0.0	22.3	0.1	35.8	30.2	2.0	29.4	58.8	50.2	56.5	17.8	0.2	0.2	5.0	84.2	13.2	7.1	0.0	14.4	59.0	79.9	0.6	4.8	0.2	23.3	17.8	1.4	0.0	24.2	5.1	5.6	0.0	32.0	22.8	0.0	3.8	0.5	7.7	0.1	5.2	1.2	1.3	3.1	0.0	0.1	26.1	0.7	33.5	1.0	2.0	3.7	0.4	0.4	0.1	11.7	0.0	10.5	145.8	8.8	0.2	1.9	15.5	4.2	0.2	0.3	6.5	0.4	0.0	0.2	0.4	0.0	0.1	1.0	0.0	0.6	0.1	0.1	2.1	0.6	0.0	0.1	0.2	0.4	2.9	0.4	0.1	0.3	4.9	6.3	4.8	6.6	6.2	4.4	9.6	4.2	9.7	3.7	3.6	4.0	92.9	16.0	23.1	9.4	4.1	27.8	56.7	7.9	2.2	11.8	12.3	6.5	145.7	35.8	2.3	5.5	8.4	1.1	1.8	2.1	1.9	210.1	376.7	2.3	60.5	77.2	3.0	0.0	42.0	109.3	0.7	145.2	21.9	2.4	34.8	16.3	41.0	0.7	3.2	106.0	25.8	5.7	6.1	36.3	98.9	180.2	83.0	86.1	17.8	25.3	17.7	0.9	0.0	22.1	21.6	43.7	0.2	104.2	3.0	5.1	5.4	2.6	1.9	6.0	256.4	184.2	351.9	40.1	2.5	1.5	22.7	3.1	8.8	41.8	3.2	3.5
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377641-53460862	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	19.1	15.7	5.8	14.8	5.9	31.8	17.0	11.3	8.7	18.4	1.2	14.3	11.7	17.9	12.7	15.9	16.0	11.0	13.0	4.9	9.9	13.3	13.7	14.2	20.2	4.8	5.1	22.0	9.7	16.4	9.7	21.1	4.9	12.3	15.1	17.0	14.7	11.4	25.8	17.9	14.4	15.9	4.6	14.8	14.4	31.4	7.0	29.4	14.6	11.7	23.3	17.5	16.2	8.7	43.7	29.5	51.8	32.6	36.4	31.9	63.5	52.8	64.0	45.1	35.0	43.2	37.8	79.5	42.6	47.2	44.4	26.7	55.6	37.9	55.8	27.0	31.0	60.0	25.5	40.7	51.2	95.4	53.6	31.2	35.6	51.6	49.8	42.0	32.3	47.7	71.3	34.3	34.1	33.3	88.5	44.4	35.9	53.7	28.8	79.2	22.0	36.9	33.9	34.7	40.8	41.5	37.6	40.3	65.1	47.0	25.2	33.6	33.9	44.2	39.7	39.9	67.2	43.3	27.8	100.8	38.4	59.2	84.3	45.2	23.3	51.4	32.5	25.0	38.8	34.8	33.0	32.9	31.9	32.3	36.6	32.3	28.3	50.7	37.0	46.5	45.9	33.1	5.8	5.9	11.3	8.7	4.9	9.9	4.8	5.1	4.9	4.6	7.0	8.7	36.1	25.6	25.4	47.0	50.4	38.7	46.6	41.5	30.1	41.2	24.0	25.4	14.4	21.5	34.1	27.6	18.8	58.7	54.0	26.9	37.2	45.8	10.3	37.6	51.1	33.4	36.6	29.2	78.8	34.9	52.2	41.9	29.6	41.6	49.4	40.0	28.5	21.2	33.2	77.4	78.7	27.0	32.6	19.8	24.6	15.2	66.8	32.2	32.0	60.9	41.3	48.6	29.9	137.7	91.4	36.9	33.3	53.4	40.3	36.5	25.2	23.3	44.8	30.3	39.5	38.9	46.9	118.5	87.6	31.8	34.1	86.3	49.8	56.8	29.4	38.5
FIS1	"CGI-135, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 891.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017430	Approved		Supported	Mitochondria		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	205.8	227.6	202.4	60.0	231.0	110.2	195.2	234.0	230.7	149.5	194.5	211.0	83.0	168.1	100.5	155.9	166.0	70.9	382.2	198.4	213.5	250.5	294.9	140.4	73.2	238.9	222.7	152.3	208.7	201.1	209.3	75.4	237.8	160.3	69.5	34.8	142.4	90.0	475.6	174.3	137.3	83.7	223.9	163.0	194.4	145.5	217.6	84.0	178.9	284.2	63.8	163.2	141.1	256.0	110.1	124.3	94.7	133.6	103.6	136.6	63.5	118.1	139.0	103.2	88.3	81.7	173.2	107.4	145.7	159.4	98.1	64.0	65.8	184.5	56.8	87.9	101.0	49.8	154.7	100.6	124.5	93.1	75.0	131.9	172.5	73.4	111.5	117.2	185.6	60.3	109.0	142.9	155.0	445.1	145.1	160.4	100.8	221.2	123.0	70.7	53.4	235.8	155.1	107.5	120.6	141.9	57.0	261.5	83.0	81.3	88.0	101.5	159.6	120.6	76.6	127.9	125.3	122.2	98.6	61.6	111.7	103.0	159.0	153.9	137.7	135.9	122.3	141.7	126.4	152.7	115.5	115.9	149.6	152.8	115.0	120.5	104.5	126.3	131.6	123.2	155.6	207.9	202.4	231.0	234.0	230.7	198.4	213.5	238.9	222.7	237.8	223.9	217.6	256.0	301.0	102.5	119.1	16.0	127.5	104.9	158.6	158.4	114.4	48.2	220.5	309.2	349.4	207.3	114.8	229.9	16.7	259.8	120.7	334.5	561.5	263.5	208.5	145.4	120.7	205.8	219.4	423.7	13.6	293.4	309.2	166.7	110.1	126.4	136.3	132.4	182.0	384.9	297.0	35.3	13.2	317.9	128.1	170.9	133.5	730.3	193.9	136.0	218.7	15.0	214.1	281.5	171.9	6.6	83.1	232.2	460.4	179.0	184.8	221.0	603.6	891.2	130.9	59.6	98.6	161.1	233.3	188.0	201.2	192.7	135.7	324.1	127.5	247.4	277.5	192.5
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24130659-24132849	"Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 171.1;skeletal muscle: 224.1"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 281.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.0;HMC-1: 1.2;RH-30: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019842	Uncertain					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	1.0	7.3	0.7	0.2	0.8	1.7	1.2	1.1	1.1	0.9	0.6	1.3	0.9	0.8	0.5	1.3	0.8	0.2	171.1	0.6	0.7	1.8	27.0	1.4	0.5	0.8	0.7	1.4	15.5	0.1	1.5	0.1	0.8	3.3	0.3	0.8	7.4	0.4	224.1	1.6	2.3	0.0	0.6	10.2	1.3	2.2	0.7	0.4	2.0	1.7	0.2	0.7	0.9	1.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.1	0.2	2.0	0.2	0.0	1.2	0.2	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.3	0.3	2.0	0.0	0.1	0.3	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	1.1	0.6	0.7	0.8	0.7	0.8	0.6	0.7	1.0	2.7	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.0	1.8	1.3	0.9	281.6	1.5	0.2	0.0	0.0	0.2	1.1	1.9	0.0	1.0	2.2	0.5	0.3	5.0	1.2	0.0	0.3	3.0	0.2	12.2	1.1	0.9	0.0	0.6	1.1	37.4	0.2	0.0	0.2	1.1	0.0	0.8	0.3	3.9	0.0	0.4	0.0	0.0	0.9	0.9	2.1	0.0	0.4	0.8	0.3	0.7	0.2	0.3	3.8	0.6	0.3	0.7	0.0	56.8	7.5	1.5	0.3	0.7	0.6	0.7	0.8	12.3	0.9	0.2
FJX1	"FLJ22416, FLJ25593"	ENSG00000179431	"Four-jointed box kinase 1"	Q86VR8	11	35618460-35620865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 29.0;Cytotrophoblasts: 25.6;Endometrial ciliated cells: 30.6;Endometrial stromal cells: 35.4;Granulosa cells: 31.2"	"Cancer enhanced"	"Detected in all"		"glioma: 34.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 60.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059220	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA059220: AB_2683950"	"unprognostic (8.99e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.56e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.39e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (9.24e-9)"	"unprognostic (1.64e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (6.56e-4)"	8.9	5.9	8.4	1.7	10.4	0.1	3.5	6.8	9.2	7.8	4.4	2.1	0.3	5.2	1.5	3.8	4.9	2.3	2.5	10.2	7.1	9.5	2.2	2.8	1.1	8.2	13.1	9.2	3.5	0.6	2.3	3.4	6.6	5.2	0.2	0.7	2.5	2.2	1.1	6.0	1.3	1.6	9.6	5.0	1.6	0.7	12.0	1.0	2.9	0.3	1.7	3.8	3.3	10.1	23.3	11.4	12.0	3.8	4.1	12.6	3.7	25.4	17.3	24.1	17.2	14.5	7.1	0.0	5.7	10.2	49.6	24.3	4.2	42.6	20.4	0.3	33.0	2.1	4.4	0.6	9.7	2.7	0.1	4.8	31.8	12.7	38.1	3.9	11.1	1.2	12.5	0.1	23.6	5.4	0.8	0.0	16.4	0.1	33.6	1.4	26.6	5.4	18.6	28.5	11.2	6.4	2.7	2.1	7.5	8.7	48.2	0.5	21.7	19.0	35.5	3.7	60.9	0.0	0.0	0.0	33.9	1.1	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	10.4	6.8	9.2	10.2	7.1	8.2	13.1	6.6	9.6	12.0	10.1	7.8	0.0	0.0	9.4	0.2	17.5	15.8	14.0	29.0	1.8	5.3	13.3	1.2	0.0	3.9	0.0	12.5	25.6	0.0	0.1	1.9	7.6	0.3	30.6	35.4	11.8	0.0	0.0	6.6	0.2	13.9	7.2	0.0	6.5	0.0	31.2	17.9	0.4	3.6	0.0	3.9	0.0	2.0	0.6	1.7	0.1	0.6	1.1	0.0	1.0	0.0	12.5	0.0	6.6	1.7	1.4	0.0	0.7	0.0	22.9	0.0	8.0	4.3	0.5	0.0	6.0	22.3	0.6	1.0	5.6	9.5	11.9	0.4	3.1	0.0	2.5
FKBP10	"FKBP6, FKBP65, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FKBP prolyl isomerase 10"	Q96AY3	17	41812680-41823213	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 79.1;Fibroblasts: 100.0;Sertoli cells: 59.2;Smooth muscle cells: 65.3;Theca cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 22: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	39.4	39.5	20.9	27.1	22.2	0.5	33.5	21.7	26.1	64.0	22.0	29.1	7.6	61.5	16.9	13.9	50.9	46.0	45.6	20.3	22.1	17.7	7.8	37.8	10.9	24.6	21.6	58.4	15.1	48.5	56.7	60.7	22.2	32.6	10.8	6.0	14.7	30.8	7.6	20.4	19.1	55.6	21.9	14.3	18.5	9.0	24.2	4.9	34.9	9.3	4.4	42.2	39.1	21.6	0.7	119.6	110.7	363.3	379.3	441.7	92.0	490.4	497.4	185.6	159.0	62.1	4.8	0.3	6.6	551.9	45.9	0.8	66.7	133.4	77.9	33.0	99.9	48.6	132.1	181.0	411.4	0.0	0.6	476.1	0.5	150.3	115.5	352.6	158.8	0.0	1.9	16.7	157.0	163.2	0.3	0.1	85.4	258.0	38.3	9.9	125.2	15.7	31.7	0.1	26.7	92.1	0.7	349.3	166.0	137.4	54.1	3.1	181.0	219.0	111.5	145.8	76.0	0.8	0.2	0.3	299.7	0.0	213.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	22.2	21.7	26.1	20.3	22.1	24.6	21.6	22.2	21.9	24.2	21.6	14.9	0.0	4.8	38.2	0.2	8.5	11.5	2.7	1.2	0.6	10.8	13.2	2.3	1.5	1.4	0.0	0.0	6.1	0.2	0.1	0.0	8.7	0.7	3.0	79.1	34.9	0.0	0.0	0.3	4.7	30.8	100.0	1.5	4.6	0.0	32.9	30.4	0.0	4.7	15.2	0.3	1.3	0.0	0.0	9.7	2.9	46.9	1.5	16.0	15.0	0.0	32.0	0.0	17.1	0.1	2.2	0.1	44.8	0.5	8.2	0.0	0.0	0.1	1.1	59.2	35.2	65.3	0.9	7.6	0.5	5.1	11.9	2.1	54.0	0.6	1.6
FKBP11	FKBP19	ENSG00000134285	"FKBP prolyl isomerase 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 495.0"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 1153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 188.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 332.6;Karpas-707: 315.1;OE19: 527.2"	"Low region specificity"	"Detected in all"							HPA041709	Enhanced		Approved	Centrosome		NA	NA		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	25.6	17.6	4.0	60.2	4.1	34.5	34.5	3.7	4.9	42.4	5.6	57.2	70.8	17.4	86.4	16.2	19.1	25.4	13.1	3.8	12.0	13.8	59.4	23.9	55.4	5.7	6.3	13.8	495.0	4.7	47.2	15.6	5.2	28.9	53.3	2.1	160.2	32.7	2.4	8.0	55.9	26.2	3.8	76.4	70.6	6.1	9.6	16.4	22.9	0.4	77.4	49.2	17.3	4.8	13.6	24.7	3.0	4.5	116.0	141.3	3.8	123.2	183.3	128.0	154.5	78.3	88.3	192.8	2.2	226.8	1.1	60.6	31.6	60.4	77.0	39.1	7.7	6.6	24.7	0.3	332.6	3.2	3.3	165.0	109.8	99.2	171.4	67.2	75.4	53.1	3.0	315.1	49.9	44.7	26.3	5.1	7.4	527.2	33.9	76.5	3.3	280.7	21.0	2.3	35.0	10.6	36.6	66.5	24.4	4.0	2.0	7.0	49.2	21.0	2.8	2.1	2.3	132.3	122.2	108.1	16.1	3.9	33.0	6.0	1.0	2.8	115.7	1.3	188.3	50.5	80.5	92.7	1.9	25.7	38.8	69.9	4.1	26.7	1.1	39.3	33.4	36.3	4.0	4.1	3.7	4.9	3.8	12.0	5.7	6.3	5.2	3.8	9.6	4.8	22.3	16.0	19.1	5.2	229.8	28.3	56.0	48.6	39.3	5.5	45.0	43.3	2.3	30.0	42.8	9.2	39.6	21.5	130.9	23.1	7.9	23.7	18.4	19.2	117.8	32.3	25.1	20.6	5.3	171.7	80.7	64.1	31.6	31.0	12.7	34.0	40.4	96.6	10.9	1.7	3.7	227.7	16.2	15.1	26.1	17.4	27.7	10.1	272.1	0.0	8.0	1.8	158.6	1.5	1.8	59.8	14.3	13.9	1153.9	111.8	14.1	18.0	43.3	14.6	6.6	10.8	88.7	12.0	9.8	23.0	21.3	42.3	145.3	37.5	49.7	45.0
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FKBP prolyl isomerase 14"	Q9NWM8	7	30010587-30026702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	6.5	5.1	3.4	7.0	3.5	4.3	6.4	5.4	3.6	9.9	3.1	4.7	3.0	8.5	10.0	4.7	4.3	6.0	6.8	3.2	3.2	3.1	3.2	4.1	3.1	3.3	3.1	5.4	5.8	6.2	7.7	7.9	3.0	6.8	4.8	7.2	4.3	7.5	2.1	4.7	2.9	13.9	3.0	2.7	4.0	2.2	3.5	1.8	3.3	3.2	3.2	8.9	3.8	3.5	7.0	5.2	14.4	33.6	36.8	46.8	6.5	34.9	32.7	12.0	23.3	4.4	4.3	2.4	16.0	31.0	14.7	14.8	8.1	12.8	23.9	1.3	11.6	5.6	9.2	13.1	18.6	4.0	9.3	29.4	13.1	20.9	24.6	28.2	27.0	3.6	9.2	5.0	21.8	2.9	2.1	4.9	7.5	7.7	9.2	0.1	9.6	8.2	11.8	6.1	3.8	12.5	12.2	27.5	8.8	17.0	6.2	5.3	21.7	12.6	14.6	21.8	14.0	7.6	8.3	4.2	18.0	3.8	40.2	0.5	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	0.2	0.0	0.6	0.2	0.1	3.4	3.5	5.4	3.6	3.2	3.2	3.3	3.1	3.0	3.0	3.5	3.5	13.5	19.2	16.0	7.2	7.9	27.4	22.0	15.8	35.9	16.3	13.3	13.0	15.7	5.7	11.7	18.4	27.1	11.6	9.4	5.3	1.9	7.4	0.4	30.4	44.3	12.9	1.2	6.5	19.4	3.7	27.3	40.0	15.3	40.0	2.5	9.1	8.6	6.5	6.0	15.2	12.7	9.7	8.2	2.5	11.2	0.4	13.1	5.7	10.6	10.3	3.6	26.5	2.1	11.6	16.6	5.7	19.0	20.7	43.8	17.8	3.3	2.7	6.0	21.4	6.6	13.8	20.4	1.4	3.4	27.5	18.3	15.7	6.0	20.8	6.1	28.0
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FKBP prolyl isomerase 15"	Q5T1M5	9	113161006-113221318	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 23.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA		9800	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	17.8	14.8	7.0	17.0	10.5	13.1	15.3	8.7	8.9	17.0	8.1	15.0	9.6	14.8	8.5	16.2	14.7	8.3	14.9	7.8	8.8	12.2	15.2	23.9	15.9	12.5	9.4	14.9	13.4	12.0	15.4	14.2	11.6	14.9	10.2	12.5	17.1	7.3	18.1	20.3	16.7	10.9	8.7	31.0	14.1	5.9	10.9	11.0	15.7	7.6	13.5	16.3	16.4	15.4	13.4	13.2	9.4	8.8	15.6	14.8	12.1	16.6	20.8	15.6	14.2	8.1	13.3	21.7	7.1	18.6	31.2	30.0	10.4	14.0	15.3	16.6	7.1	8.8	16.3	8.0	12.7	18.7	20.9	15.0	13.8	16.1	17.4	18.3	15.1	13.3	10.9	13.4	15.7	19.2	13.8	9.7	8.8	17.4	10.6	12.5	19.1	7.5	11.2	12.2	8.0	8.1	19.5	15.5	8.5	11.6	17.7	6.2	19.9	18.4	6.9	19.2	16.9	12.2	13.0	9.4	19.7	10.3	14.9	2.5	11.3	1.8	3.2	13.9	2.7	1.8	1.9	2.0	7.9	3.1	2.4	1.9	6.4	4.4	23.3	3.3	2.0	4.7	7.0	10.5	8.7	8.9	7.8	8.8	12.5	9.4	11.6	8.7	10.9	15.4	11.1	16.0	26.7	23.5	14.9	5.7	6.2	9.6	11.4	13.7	7.0	5.6	15.4	7.2	14.3	14.7	27.1	13.8	17.3	9.7	1.9	12.7	1.2	13.4	13.9	12.5	4.8	14.7	25.1	13.6	12.4	14.7	11.7	10.0	11.4	13.3	17.2	9.3	61.3	11.8	25.0	8.6	8.2	58.4	13.6	1.7	16.8	57.5	7.2	27.2	31.2	8.0	18.6	21.1	30.1	17.3	8.1	15.8	8.8	6.1	9.2	5.4	15.9	16.1	19.7	10.0	9.2	7.1	10.5	11.1	4.1	12.2	14.9	14.5	8.2	10.5
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FKBP prolyl isomerase 1B"	P68106	2	24049701-24063681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.2;T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 47.9;NTERA-2: 42.9;SH-SY5Y: 30.7;SuSa: 46.1;TIME: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045572, HPA051798"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	5.6	4.4	32.5	2.2	36.1	1.6	5.5	26.5	47.9	6.7	23.0	7.1	19.6	4.8	2.7	8.3	3.9	5.4	5.1	39.2	30.9	8.7	6.6	10.5	1.5	27.7	27.6	5.5	7.5	7.0	6.4	4.0	30.3	7.2	3.3	7.7	6.6	6.3	1.4	6.5	6.8	2.7	25.9	2.8	15.0	1.6	32.7	1.6	6.7	1.2	2.3	5.6	8.1	30.5	0.2	2.0	17.2	0.0	10.9	4.7	6.2	5.8	6.0	2.5	3.6	1.2	2.0	0.0	4.3	10.3	15.4	6.8	25.7	20.2	1.6	3.0	16.1	6.0	0.2	47.9	4.5	0.0	14.1	3.9	4.6	5.9	1.1	14.7	16.5	6.8	1.5	0.1	5.9	0.2	2.0	0.0	42.9	1.7	3.0	3.1	1.5	0.2	2.0	1.3	4.1	30.7	0.3	0.1	5.8	46.1	1.2	2.2	38.0	0.0	5.2	0.2	1.4	1.1	0.5	0.0	6.4	0.0	1.3	0.4	0.4	2.2	0.1	0.4	0.0	0.1	0.2	0.2	1.0	1.2	0.0	0.1	0.0	0.1	0.0	0.2	2.8	0.5	32.5	36.1	26.5	47.9	39.2	30.9	27.7	27.6	30.3	25.9	32.7	30.5	9.3	0.0	6.8	2.9	1.8	9.2	14.0	13.7	11.4	2.1	6.5	13.7	0.9	22.8	4.7	7.3	0.0	4.9	2.7	15.8	13.7	27.6	0.6	3.5	5.0	10.9	9.5	7.0	16.9	38.2	31.9	6.9	16.3	7.1	1.3	3.4	15.7	10.2	7.5	1.7	7.8	8.9	2.0	4.0	17.4	2.9	2.8	9.1	28.4	4.7	13.0	31.4	1.0	2.5	1.3	49.8	25.4	4.1	2.4	15.5	10.6	6.8	2.0	3.6	26.3	2.9	10.6	1.6	5.4	9.1	7.4	5.2	4.9	1.4	4.5	19.3
FKBP1C	bA184C23.2	ENSG00000198225	"FKBP prolyl isomerase 1C"		6	63211446-63213024	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.9;Cardiomyocytes: 11.7;Langerhans cells: 12.0;Melanocytes: 8.8;Suprabasal keratinocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 4.4;monocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA051798	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA051798: AB_2681615"	"unprognostic (6.64e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.91e-5)"	"unprognostic (4.78e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.79e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	1.5	0.9	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.4	0.0	0.7	0.0	0.8	0.0	0.8	0.5	0.0	0.9	0.0	0.0	0.8	0.4	1.3	0.0	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.7	0.6	0.5	0.0	0.0	0.8	0.6	0.2	0.0	0.0	1.0	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.2	0.8	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	1.3	3.3	4.4	0.4	5.1	0.4	0.6	0.5	0.5	3.0	0.6	0.6	0.7	2.7	0.7	4.7	1.2	1.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.3	9.9	3.1	3.4	0.0	0.0	0.1	0.0	11.7	1.5	0.9	1.8	0.0	1.5	0.0	1.0	0.0	0.1	1.2	0.2	0.5	6.1	0.0	0.0	0.0	0.0	3.3	3.3	0.0	0.3	1.3	0.1	3.3	0.6	3.9	0.0	0.0	0.0	6.1	3.1	12.0	1.8	0.9	1.5	8.8	0.0	1.4	0.0	1.0	0.0	0.0	0.2	2.4	0.4	0.0	2.0	0.5	0.6	2.5	0.0	0.0	1.0	3.9	3.0	2.1	0.0	15.9	0.8	0.6	0.3	0.4	2.0
FKBP2	"FKBP-13, FKBP13, PPIase"	ENSG00000173486	"FKBP prolyl isomerase 2"	P26885	11	64241003-64244132	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 929.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		510000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	64.7	127.6	185.1	77.5	187.6	50.1	58.3	192.7	234.7	113.1	210.8	105.7	136.3	81.1	397.7	68.4	94.4	77.2	117.4	185.0	196.9	122.7	197.3	62.7	70.7	199.9	199.6	75.3	280.1	160.4	200.9	73.1	197.7	92.5	84.2	37.1	208.9	146.7	33.3	60.9	107.3	72.6	183.4	67.5	113.4	74.7	194.3	59.0	187.6	48.4	70.4	85.7	61.6	196.0	101.2	144.8	82.8	165.9	178.5	98.2	94.6	132.9	146.4	108.8	101.4	148.1	257.0	80.8	195.4	186.5	148.2	134.7	70.5	121.0	51.3	101.4	54.5	90.0	196.5	158.3	231.6	74.5	125.5	116.0	169.3	145.4	163.5	156.9	86.9	76.6	61.0	253.6	138.1	186.7	85.1	112.6	92.6	211.1	130.0	70.8	70.9	299.2	198.9	120.7	110.0	91.3	85.4	263.2	147.9	59.5	98.1	69.5	68.9	123.8	100.9	182.8	72.6	128.5	48.6	69.0	156.7	80.6	142.8	276.8	173.1	25.9	178.9	191.2	230.8	170.1	139.2	176.4	172.2	165.0	90.4	131.5	68.6	162.9	162.7	929.1	55.9	126.7	185.1	187.6	192.7	234.7	185.0	196.9	199.9	199.6	197.7	183.4	194.3	196.0	129.5	147.4	168.0	20.9	179.7	164.4	251.0	447.2	125.2	86.4	205.0	185.4	134.7	275.9	270.6	389.9	22.9	279.8	174.4	534.1	412.8	270.8	126.4	212.5	206.3	138.6	342.6	41.4	11.3	254.2	386.9	167.0	179.4	258.5	144.0	146.5	148.5	754.4	228.4	32.0	14.8	508.2	305.2	100.1	201.7	99.0	230.2	140.7	300.6	16.9	151.7	181.7	111.2	11.1	20.6	292.2	424.7	255.1	765.2	315.5	594.7	792.2	241.9	83.3	184.1	138.4	221.3	327.1	282.1	136.6	168.1	620.5	123.6	138.8	339.4	312.0
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FKBP prolyl isomerase 4"	Q02790	12	2794970-2805423	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 372.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		480000	"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	35.4	38.1	92.1	22.3	95.9	24.2	53.1	127.7	372.1	41.7	89.6	35.7	20.3	32.2	44.6	69.3	38.2	24.8	42.7	96.6	104.4	68.1	57.5	38.0	19.8	101.0	101.4	50.4	52.0	47.8	36.1	50.6	106.2	44.4	37.8	52.2	48.1	44.9	69.4	49.8	25.6	40.0	97.8	24.3	58.0	58.4	103.0	25.1	44.4	48.5	29.9	44.6	46.0	141.7	91.6	198.6	56.2	94.9	68.5	40.1	268.3	87.5	31.2	141.2	95.0	199.1	108.3	120.9	24.5	56.6	98.2	121.9	353.3	118.5	168.2	222.6	226.1	133.2	141.8	71.4	52.6	105.5	35.0	36.5	106.6	167.2	165.9	84.0	83.5	119.8	124.9	166.4	57.6	261.5	186.2	94.9	480.0	266.5	141.2	110.0	98.7	72.4	119.5	114.2	80.7	116.0	101.6	272.7	45.3	348.8	368.0	70.3	44.9	69.1	216.4	78.6	224.1	40.9	67.9	177.0	61.4	154.7	72.2	17.0	11.5	6.7	12.5	10.5	13.9	14.0	11.0	11.9	6.4	14.3	11.3	13.5	1.5	9.2	15.5	5.6	11.0	11.1	92.1	95.9	127.7	372.1	96.6	104.4	101.0	101.4	106.2	97.8	103.0	141.7	31.9	6.4	11.5	10.1	39.1	143.9	261.5	38.5	80.8	60.3	133.9	96.3	13.1	54.3	26.8	53.3	75.0	186.1	27.2	111.0	154.6	82.0	125.4	49.7	47.4	43.5	106.1	77.8	12.9	25.9	117.3	42.6	41.8	74.5	38.2	45.3	20.7	49.3	62.0	97.6	15.5	124.9	63.1	17.5	102.1	40.9	34.8	67.7	92.5	4.7	40.2	48.3	25.7	10.1	17.6	60.3	100.1	38.7	47.3	272.4	77.3	141.7	21.1	63.4	85.5	28.3	117.2	149.4	74.4	111.5	132.8	223.3	74.0	38.6	148.7	147.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FKBP prolyl isomerase 6"	O75344	7	73328161-73358637	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	222	"testis: 58.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 68.5;Late spermatids: 92.4;Spermatocytes: 142.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061109, HPA077010"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA061109: AB_2684430, HPA077010: "	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	58.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.6	0.0	0.6	0.0	0.3	0.5	1.5	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	68.5	5.2	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.2	0.3	0.0	0.3	0.0	2.0	1.3	0.0	92.4	3.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	1.2	0.0	0.0	0.0	0.1	12.6	0.5	0.0	0.3	0.1	142.0	37.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2
FKBP7	FKBP23	ENSG00000079150	"FKBP prolyl isomerase 7"	Q9Y680	2	178463664-178478600	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.3	5.4	1.5	3.9	1.6	1.4	11.9	2.6	2.8	23.1	1.5	8.3	2.8	27.8	11.3	5.9	15.1	15.4	12.3	1.6	1.8	5.2	8.3	7.8	2.9	1.6	1.5	50.0	2.8	2.7	5.0	13.0	1.5	9.3	6.2	2.1	5.0	13.3	3.8	4.2	4.4	19.2	1.2	3.0	5.4	4.4	1.5	2.5	6.6	6.5	2.8	11.6	10.2	2.1	0.2	1.9	18.5	27.8	155.0	96.7	1.7	33.3	55.0	5.9	19.0	0.3	1.9	5.4	7.3	60.9	5.5	0.3	7.1	2.8	10.3	4.5	3.9	5.7	7.3	5.5	23.7	3.5	3.8	64.7	1.4	24.0	3.4	44.2	19.8	6.6	2.5	3.4	25.2	0.3	6.1	6.0	3.6	3.5	2.9	7.8	31.9	7.7	8.4	0.6	9.7	32.0	7.0	0.2	6.2	12.7	0.5	6.8	18.2	11.0	6.8	12.8	3.2	6.3	7.2	2.6	19.9	8.7	24.3	0.0	0.4	0.0	1.0	0.7	1.2	1.1	0.9	0.7	2.6	0.7	0.9	1.0	0.0	0.6	0.0	2.1	1.1	0.4	1.5	1.6	2.6	2.8	1.6	1.8	1.6	1.5	1.5	1.2	1.5	2.1	16.2	6.4	4.1	2.9	5.4	7.0	9.3	19.6	7.4	4.2	6.7	13.6	16.1	2.8	5.2	7.3	0.0	7.6	2.7	0.7	1.9	10.9	149.1	3.4	54.8	19.3	1.2	4.2	1.6	8.4	22.4	67.6	4.1	3.5	14.0	19.0	15.7	11.9	5.8	5.0	3.7	5.6	14.2	4.4	13.6	27.1	64.0	3.8	17.8	4.7	1.6	4.2	1.0	7.1	4.2	3.9	0.7	48.5	10.3	3.4	0.4	3.7	2.1	3.6	6.6	31.1	37.7	8.5	5.1	3.7	5.8	5.1	5.5	30.4	3.1	4.1
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FKBP prolyl isomerase 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 719.1;Late spermatids: 1236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 93.4;neutrophil: 78.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA		10000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	206.9	161.5	426.8	79.8	423.7	272.9	197.3	359.7	645.5	235.3	332.7	311.1	85.5	188.6	59.0	238.3	198.1	85.5	244.3	427.4	395.7	194.8	233.7	187.6	97.9	427.6	405.1	263.6	167.2	109.1	312.3	91.2	406.1	249.4	33.6	51.4	200.0	115.3	202.7	185.9	159.2	62.5	381.7	193.6	189.3	378.4	423.4	86.2	205.9	105.5	52.7	228.3	222.4	437.8	196.3	139.0	106.0	201.7	106.2	165.6	266.8	155.0	163.1	116.5	160.2	133.3	259.1	111.6	245.0	191.7	77.7	104.4	65.0	216.5	31.4	136.6	316.5	105.3	175.4	162.3	183.3	105.5	220.6	217.3	204.8	104.0	65.4	216.1	121.9	213.2	222.4	254.8	102.1	329.1	190.4	313.1	216.3	174.6	200.2	197.8	88.4	387.3	154.9	126.6	117.1	213.2	108.8	87.7	197.5	77.8	104.5	299.4	143.2	143.2	130.3	282.1	120.0	194.6	118.2	130.8	321.5	166.7	130.8	18.1	14.7	93.4	14.2	15.5	13.3	10.2	14.6	16.3	11.1	9.8	11.1	12.6	78.0	8.8	19.0	11.3	15.8	30.1	426.8	423.7	359.7	645.5	427.4	395.7	427.6	405.1	406.1	381.7	423.4	437.8	115.9	9.6	1.1	35.3	115.1	95.3	164.1	118.4	68.3	64.8	110.9	107.4	2.0	115.8	58.0	101.2	14.6	246.4	107.0	287.7	248.4	178.4	412.3	65.6	59.2	92.3	205.9	719.1	32.0	126.9	234.8	126.5	80.5	64.6	52.8	125.0	99.6	66.4	237.3	99.3	33.2	156.8	126.1	184.1	145.0	1236.4	203.8	152.1	202.7	8.4	221.9	149.0	183.4	12.5	32.8	166.9	283.4	165.5	127.2	139.4	339.3	290.4	51.9	56.4	98.6	95.7	129.9	193.5	212.4	96.5	117.9	312.9	145.0	121.7	158.3	158.0
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FKBP prolyl isomerase 9"	O95302	7	32957404-33006930	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 108.6;Fibroblasts: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 379.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	80.7	44.8	23.9	16.8	24.0	2.3	59.1	26.5	25.3	65.9	28.1	44.8	19.7	55.7	22.4	35.6	50.6	44.4	77.1	21.4	32.1	38.2	21.1	49.6	13.6	28.9	30.2	46.3	40.8	25.1	34.8	77.4	29.3	42.3	45.3	11.7	36.0	52.1	35.0	64.4	31.0	74.4	28.0	23.7	41.0	11.4	34.2	8.2	40.8	49.7	15.8	43.3	52.2	27.9	38.9	71.4	27.6	113.4	254.1	290.2	36.4	202.6	209.9	65.5	103.9	31.6	89.2	0.2	80.7	379.5	105.1	73.3	40.8	100.0	75.2	0.1	11.9	6.6	72.3	31.6	105.6	0.4	10.8	191.8	59.6	59.0	56.9	156.3	83.9	0.1	15.0	7.7	137.3	37.1	0.2	19.4	5.8	76.6	37.3	0.3	73.7	0.3	73.0	13.0	25.7	62.4	115.6	58.4	73.4	69.6	41.1	18.7	112.8	107.0	99.8	67.4	46.8	23.9	48.9	0.2	104.4	0.3	218.5	0.9	2.2	0.5	0.0	1.6	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.0	4.0	0.1	0.4	0.1	0.0	0.6	23.9	24.0	26.5	25.3	21.4	32.1	28.9	30.2	29.3	28.0	34.2	27.9	108.6	12.8	21.7	22.9	0.6	34.3	12.7	31.4	10.2	8.2	15.7	16.5	46.1	17.2	10.3	18.4	10.4	18.8	0.6	23.2	5.9	19.5	0.5	22.6	25.8	80.1	12.2	1.7	9.8	41.5	27.7	89.1	17.9	23.0	5.7	81.0	60.0	18.0	7.6	11.8	10.2	25.4	10.2	8.6	23.5	3.2	36.7	5.4	60.5	15.0	2.9	30.5	0.0	8.5	8.8	36.5	22.1	55.3	4.4	8.1	18.8	8.1	11.0	5.2	46.0	21.2	45.8	1.0	1.3	12.1	28.6	13.1	3.1	12.3	27.7	10.5
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FKRP	"FKTR, LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	10.5	9.1	8.5	8.1	8.2	8.8	9.9	3.7	11.5	11.4	4.5	13.3	4.8	15.2	5.0	8.8	12.6	6.0	15.8	8.5	10.4	12.0	11.9	10.4	7.4	10.1	7.3	12.7	11.1	7.5	16.8	10.1	8.8	13.5	4.3	5.7	11.1	7.4	19.6	7.2	10.5	5.8	6.1	14.7	10.9	9.3	9.4	5.6	13.6	9.8	4.9	13.0	10.5	8.7	12.7	26.5	17.8	12.5	15.4	16.9	15.8	31.7	21.0	12.6	19.9	17.0	21.4	11.7	17.0	18.2	20.9	13.0	6.6	14.8	11.5	21.9	22.2	11.7	14.4	10.7	13.3	9.3	19.8	19.4	12.5	15.6	15.2	14.6	16.7	6.0	12.2	11.0	12.7	5.8	6.8	22.8	17.2	7.8	6.5	18.3	11.1	4.0	8.0	26.4	12.0	23.1	15.8	7.6	10.6	11.7	8.9	7.3	16.8	18.4	19.8	6.7	25.7	11.6	15.4	11.0	15.0	7.5	25.6	1.3	1.8	0.8	1.5	1.0	0.9	1.7	1.1	1.7	1.1	2.4	1.2	1.6	2.2	2.0	1.1	1.9	0.6	1.2	8.5	8.2	3.7	11.5	8.5	10.4	10.1	7.3	8.8	6.1	9.4	8.7	4.7	9.6	7.4	6.8	3.9	0.8	4.8	3.0	1.2	9.8	5.3	5.2	15.5	4.3	5.6	5.5	6.2	9.6	9.1	4.5	5.9	4.2	12.0	7.9	7.3	6.0	7.8	7.8	6.8	2.4	5.9	6.6	3.6	5.1	1.3	6.7	11.4	16.6	7.6	3.3	8.2	4.2	2.0	10.0	1.2	13.2	5.6	4.3	5.4	3.7	6.1	7.8	2.1	8.0	6.2	4.1	4.7	4.1	3.6	4.3	4.2	8.2	9.7	11.0	6.6	7.2	7.0	12.2	4.0	2.4	1.6	18.7	4.3	4.5	4.0	4.3
FKTN	"FCMD, LGMD2M"	ENSG00000106692	Fukutin	O75072	9	105558122-105653820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.4;Inhibitory neurons: 51.6;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012820	Approved					NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA012820: AB_1848478"	"unprognostic (3.48e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (2.41e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (3.02e-4)"	4.1	5.0	3.4	3.7	4.1	1.1	5.7	3.8	4.1	4.6	3.0	4.6	3.7	5.0	4.9	4.1	4.8	3.6	4.4	3.4	4.1	5.0	4.6	3.3	3.9	3.3	3.6	6.0	7.2	7.4	5.6	4.6	3.4	4.5	5.6	10.0	4.1	4.1	3.8	5.3	4.3	4.2	3.6	4.6	5.6	3.7	3.8	3.3	6.2	5.1	3.6	4.4	4.4	5.2	7.1	5.4	8.3	7.1	13.5	20.3	9.5	13.4	12.5	8.1	9.0	4.6	11.1	5.2	7.2	14.3	7.5	12.3	7.9	10.3	12.3	7.6	5.5	3.9	8.3	3.3	9.7	6.9	3.3	15.9	9.8	11.7	17.6	12.6	8.5	6.6	4.4	6.2	18.4	8.8	6.1	5.1	6.5	7.5	8.2	4.3	17.1	3.6	8.5	2.7	7.7	6.7	9.4	10.4	7.8	7.9	19.3	5.3	10.7	8.9	4.7	18.1	12.4	8.4	10.9	3.4	9.0	7.7	13.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.5	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	3.4	4.1	3.8	4.1	3.4	4.1	3.3	3.6	3.4	3.6	3.8	5.2	6.3	6.4	7.7	27.4	5.0	3.2	4.2	5.5	5.7	21.9	6.0	6.1	9.0	8.6	5.7	7.3	8.4	2.4	5.5	4.9	1.9	4.5	2.6	5.2	11.4	5.7	4.2	3.8	49.4	3.3	4.1	10.9	7.7	5.6	2.5	13.5	7.5	5.3	4.4	23.5	51.6	6.4	0.0	3.8	2.1	0.8	6.2	4.1	8.8	13.1	3.4	6.6	5.2	40.7	66.5	3.0	4.3	9.1	3.5	3.9	2.7	3.7	7.3	17.6	6.6	12.9	5.8	12.5	9.1	7.5	4.0	0.8	3.6	10.4	7.5	2.8
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	21.9	21.1	19.2	17.0	20.5	14.2	23.5	20.2	20.7	20.4	19.7	22.8	20.1	19.8	20.5	26.1	19.1	11.8	28.7	20.1	19.5	21.7	32.8	17.7	22.8	20.2	20.3	15.5	18.9	18.0	15.1	14.3	20.6	24.3	18.9	9.8	21.0	13.7	34.1	32.9	24.9	17.7	19.6	30.1	22.0	19.0	20.6	16.0	22.5	32.0	23.0	22.6	21.1	21.0	33.4	52.4	32.8	56.1	27.9	20.5	62.1	24.7	20.5	35.2	30.2	46.9	40.1	38.5	48.8	23.0	18.3	42.6	63.4	51.3	23.0	40.6	47.5	31.4	42.8	33.7	38.1	46.0	39.1	29.5	65.9	40.2	42.8	17.0	41.5	40.4	51.4	30.3	30.2	71.8	31.9	32.0	71.7	72.2	53.8	52.8	16.2	88.7	33.9	45.8	54.9	75.6	38.7	86.2	50.0	63.0	74.0	68.6	26.4	21.9	30.1	28.6	39.6	47.5	63.7	66.9	26.4	36.8	36.1	29.8	35.3	23.7	34.5	33.0	38.9	39.0	31.9	33.8	37.7	34.2	29.1	28.9	7.8	26.1	41.4	38.3	37.9	37.6	19.2	20.5	20.2	20.7	20.1	19.5	20.2	20.3	20.6	19.6	20.6	21.0	12.2	9.6	10.6	9.8	19.3	26.5	18.1	37.1	23.3	15.7	16.4	15.9	39.4	20.0	22.6	25.8	6.2	42.5	16.9	22.1	31.3	24.4	25.3	15.4	12.0	14.1	12.0	19.0	8.2	28.2	42.6	12.1	25.0	12.6	8.8	21.2	11.7	27.0	27.6	15.2	6.3	20.8	28.5	18.1	11.1	77.6	10.2	14.8	14.2	5.6	34.7	23.3	32.0	4.5	8.2	25.4	14.9	9.8	18.3	26.1	30.3	32.9	19.3	17.2	6.6	9.7	18.3	22.9	20.6	25.7	27.6	36.0	20.2	23.1	25.4	20.0
FLCN	"BHD, DENND8B, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 79.2;Erythroid cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	21.8	19.0	19.0	10.7	25.9	17.7	18.9	27.3	31.6	42.5	18.3	43.7	23.3	37.0	14.5	13.8	25.2	17.0	29.2	31.9	14.0	15.3	28.9	26.8	12.4	21.3	15.2	35.3	15.2	13.1	28.6	13.1	22.0	27.1	10.2	7.2	16.4	13.7	42.7	19.3	26.8	14.5	14.0	29.2	22.4	21.0	19.3	8.6	23.8	18.4	8.0	28.2	25.5	28.3	12.0	30.4	11.5	14.9	36.4	20.6	15.8	11.8	19.1	18.0	24.3	24.3	10.4	6.3	13.8	14.0	40.2	14.4	14.0	7.3	9.3	10.9	12.2	12.4	9.1	13.9	33.6	4.9	33.5	30.3	24.0	27.6	20.8	16.4	14.8	9.2	17.7	16.4	17.6	17.5	8.3	8.4	11.2	17.8	8.1	16.9	52.7	7.3	11.0	14.1	13.6	8.8	11.6	7.5	19.3	70.7	11.1	8.8	15.7	40.6	16.6	56.5	14.1	7.7	7.4	5.7	26.0	10.8	16.6	2.4	2.8	1.6	1.6	3.7	2.2	3.6	1.9	1.4	1.4	3.2	2.1	1.9	6.0	2.8	1.4	1.4	2.9	1.8	19.0	25.9	27.3	31.6	31.9	14.0	21.3	15.2	22.0	14.0	19.3	28.3	8.4	25.6	12.6	17.0	9.2	18.4	12.7	5.7	2.8	20.7	13.2	6.5	23.7	14.3	6.2	7.3	79.2	10.9	5.3	25.0	1.9	12.3	14.5	16.8	11.3	12.5	25.7	81.7	31.3	8.3	7.4	20.6	9.7	15.2	1.3	10.3	27.8	24.1	16.6	47.1	23.7	11.0	16.2	21.6	19.2	20.4	28.0	13.2	10.6	18.7	12.2	13.3	6.2	17.1	32.4	9.8	15.6	20.3	4.4	11.6	36.8	6.1	9.1	18.5	19.7	24.8	11.1	6.3	10.8	5.3	18.2	33.8	10.0	16.3	12.6	13.0
FLG		ENSG00000143631	Filaggrin	P20930	1	152302165-152325239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 458.2"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 44.0"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.1;NTERA-2: 3.1;TIME: 2.1;U-2 OS: 2.4;U-2197: 2.6;WM-115: 2.0"	"Not detected"	"Not detected"							"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		3800000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.3	0.4	0.7	0.1	0.3	0.1	15.7	0.3	0.4	6.5	0.0	0.2	0.0	0.5	0.0	12.0	0.4	0.1	0.4	0.3	1.4	0.4	0.2	0.2	0.0	1.6	0.9	0.9	0.4	0.0	0.2	0.0	1.2	0.2	0.0	0.2	2.7	0.0	1.8	458.2	0.1	0.0	0.8	0.1	0.2	0.3	0.8	0.5	0.3	0.0	0.5	0.1	4.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	10.1	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.1	0.8	2.4	2.6	1.9	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.4	0.3	1.4	1.6	0.9	1.2	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.0	44.0	0.0	0.1	0.1	0.0	0.0
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 483.9"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 24.2"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028699	Approved					NA	NA		21000000		"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.3	0.0	0.1	0.0	0.0	0.1	32.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	483.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.1	0.0	1.0	0.2	0.1	0.2	0.0	24.2	0.0	0.0	0.1	0.0	0.3
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII actin remodeling protein"	Q13045	17	18244815-18258738	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.4"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 198.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Enhanced		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	57.7	50.0	9.8	22.9	11.5	26.4	55.0	12.6	11.1	50.2	13.4	56.2	19.5	49.6	7.3	65.7	41.3	13.7	75.1	9.9	11.5	42.2	30.7	53.3	20.0	15.4	13.0	39.1	57.6	16.9	39.0	17.0	15.4	41.5	12.9	4.6	63.6	17.4	245.4	46.9	50.8	18.9	12.1	58.0	45.6	35.3	14.2	17.4	44.1	73.1	15.8	61.3	50.3	13.6	198.0	73.5	18.4	30.0	44.2	38.9	29.4	53.7	64.1	59.0	36.4	93.5	45.2	39.7	56.3	61.1	33.7	89.0	26.2	90.1	34.4	32.6	42.6	20.5	54.9	36.9	50.0	23.6	44.3	36.4	53.3	47.9	71.8	36.2	58.0	35.3	18.0	15.0	34.9	61.3	34.9	20.5	20.5	85.1	37.8	34.3	87.2	48.7	43.5	58.4	7.2	10.9	63.1	51.0	28.7	117.2	90.8	17.8	73.3	53.6	54.4	104.0	64.4	15.9	12.5	11.5	50.8	23.5	28.7	10.0	27.5	25.6	12.8	39.3	12.5	9.3	9.9	13.0	30.2	6.0	7.3	8.2	22.6	10.5	51.1	8.6	12.7	24.2	9.8	11.5	12.6	11.1	9.9	11.5	15.4	13.0	15.4	12.1	14.2	13.6	44.9	60.9	36.9	12.7	23.3	22.7	24.9	35.1	26.7	15.4	29.6	23.9	37.4	22.8	47.3	25.8	18.8	25.9	24.8	62.8	15.6	53.5	45.2	37.5	27.9	38.7	23.9	21.7	7.2	56.9	28.7	28.4	42.3	56.6	46.9	28.8	27.5	19.4	48.9	26.9	7.4	26.0	24.4	46.2	39.7	9.2	32.3	52.2	16.0	14.0	55.7	11.4	12.3	3.5	14.2	134.4	49.8	35.0	31.8	40.7	48.8	21.3	50.3	12.7	32.9	28.0	30.7	40.0	20.0	33.8	19.6	25.4	32.1	33.3	40.9	38.6
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897733	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	60.2	46.4	38.4	56.8	38.6	97.1	56.2	28.1	47.6	42.8	45.2	58.9	21.0	39.1	21.2	69.3	46.8	27.0	63.5	41.1	42.5	71.4	98.4	59.5	68.2	45.9	37.1	37.7	38.8	30.0	22.3	58.4	41.3	67.8	27.2	20.3	61.7	51.6	51.6	38.2	53.0	35.3	37.5	122.7	44.6	10.4	47.1	47.8	39.6	44.1	63.6	78.8	49.6	36.1	55.5	90.8	69.6	60.2	33.6	44.2	76.6	42.5	57.9	60.9	71.3	96.0	45.7	76.9	79.3	47.6	42.0	63.3	76.5	69.7	25.9	245.5	91.4	92.7	80.5	70.3	43.6	76.8	15.2	53.3	53.6	49.3	66.9	64.1	97.4	21.8	89.0	65.6	28.9	83.5	21.2	54.0	61.4	48.6	24.6	32.6	70.6	189.3	92.0	166.9	61.9	103.3	99.8	69.6	77.5	66.7	72.3	136.3	81.5	21.4	38.2	35.2	65.0	36.5	68.2	39.5	59.9	72.3	40.7	171.9	106.0	213.2	98.8	96.6	72.6	98.5	74.6	84.5	144.3	118.1	55.3	69.0	415.2	78.5	110.2	38.8	97.6	143.2	38.4	38.6	28.1	47.6	41.1	42.5	45.9	37.1	41.3	37.5	47.1	36.1	34.2	22.4	21.9	12.7	46.8	12.6	27.1	20.6	29.6	6.9	24.9	30.1	32.9	22.8	16.5	20.2	10.4	96.6	20.5	29.0	15.6	39.3	13.0	25.8	13.2	37.0	25.8	49.2	17.0	31.1	68.9	14.8	23.0	27.6	6.3	15.6	48.9	45.1	44.4	5.0	19.2	25.9	10.2	43.3	22.6	42.3	10.8	31.1	8.8	22.5	75.2	10.7	35.0	16.1	11.0	32.2	16.5	8.6	27.8	14.8	14.8	26.7	19.1	12.4	19.7	7.1	13.4	1.6	6.9	42.4	9.2	37.1	32.5	4.2	32.0	26.7
FLRT1	"MGC21624, SPG68"	ENSG00000126500	"Fibronectin leucine rich transmembrane protein 1"		11	64103188-64119173	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 8.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054589	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054589: AB_2682533"	"unprognostic (5.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.64e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.37e-2)"	0.3	4.4	7.0	0.3	8.4	0.0	0.4	1.6	6.8	2.9	0.0	3.9	0.5	1.5	0.0	0.8	0.6	0.5	1.2	7.1	3.0	2.5	0.9	0.2	0.0	1.5	4.3	0.5	1.0	0.0	1.2	0.1	0.6	1.2	0.3	1.6	0.7	0.9	0.2	1.0	0.9	0.5	1.6	0.3	1.1	0.3	8.5	0.0	2.2	0.1	0.0	0.7	1.1	7.4	0.4	0.7	2.7	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.4	0.0	1.1	0.6	3.7	0.0	0.0	0.7	0.2	0.0	0.9	0.1	0.0	2.1	0.3	4.0	0.0	0.5	0.1	0.6	1.2	0.1	0.2	0.8	0.2	0.1	0.0	0.3	5.4	13.5	0.3	0.3	0.4	0.0	0.4	11.3	0.1	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.2	3.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	8.4	1.6	6.8	7.1	3.0	1.5	4.3	0.6	1.6	8.5	7.4	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	6.2	0.0	32.2	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	17.2	11.3	3.5	4.7	4.6	0.8	14.7	2.6	3.4	9.0	2.6	4.9	2.8	8.0	3.0	4.4	9.8	3.8	9.7	5.1	2.6	20.1	6.2	16.9	5.5	3.4	3.0	4.5	2.0	2.3	7.8	6.4	3.6	5.6	1.3	0.3	2.0	2.5	4.7	4.0	7.2	4.1	2.8	17.6	3.5	3.1	4.2	1.0	25.7	4.1	1.4	5.6	5.5	2.7	0.1	2.5	3.2	10.1	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.4	0.3	0.3	0.9	0.1	0.6	0.4	3.4	0.2	0.3	0.1	15.6	1.2	0.5	0.5	0.1	9.5	0.3	0.2	0.1	0.2	0.4	0.3	9.9	12.3	0.4	0.4	2.1	5.6	0.1	0.5	7.0	0.3	0.6	8.2	0.1	0.1	0.1	0.3	0.3	1.1	0.1	0.2	0.1	3.1	14.6	0.3	15.7	0.2	6.9	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	3.5	4.6	2.6	3.4	5.1	2.6	3.4	3.0	3.6	2.8	4.2	2.7	27.4	0.0	1.7	0.7	0.7	0.9	0.2	0.0	1.2	0.2	1.4	1.4	4.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	27.1	0.0	0.0	0.2	0.0	37.1	0.8	0.0	0.1	2.5	2.4	64.6	0.6	1.2	0.0	0.1	0.0	0.0	3.3	0.8	0.7	0.3	0.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.7	0.7	0.1	5.2	0.1	1.1	1.0	1.8	0.2	0.0	0.1
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA, SLC49A1"	ENSG00000162769	"FLVCR heme transporter 1"	Q9Y5Y0	1	212858275-212899363	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	2.1	2.4	3.4	3.1	2.8	6.2	3.1	5.0	3.7	2.9	2.7	3.4	9.7	2.5	4.9	2.1	2.4	2.0	1.6	3.2	4.4	2.4	1.8	2.4	2.9	4.5	4.1	2.4	2.6	3.6	6.9	2.4	5.3	3.4	2.8	7.0	1.9	1.8	1.0	2.9	19.4	1.7	2.5	2.6	4.8	2.8	4.3	2.6	2.2	0.6	2.2	2.3	2.3	4.2	8.4	11.0	16.8	5.1	2.8	3.4	31.3	2.4	1.8	4.8	2.9	16.1	15.2	9.1	4.4	1.7	10.2	12.5	18.2	5.4	4.7	5.4	8.0	5.4	10.4	14.9	3.2	14.5	8.4	2.7	3.5	5.2	6.6	2.5	3.8	6.4	14.7	7.4	3.2	3.2	4.1	7.2	55.3	11.1	7.7	9.0	15.4	10.6	6.0	8.0	18.1	12.7	11.2	11.1	10.4	13.8	18.2	6.7	2.2	2.3	5.6	7.7	11.2	4.6	9.9	10.8	3.5	8.3	2.9	0.5	0.2	1.5	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.3	0.3	0.7	0.2	0.2	0.4	0.4	0.0	3.4	2.8	5.0	3.7	3.2	4.4	4.5	4.1	5.3	2.5	4.3	4.2	6.7	12.8	16.0	12.4	8.3	14.3	8.8	6.9	9.6	24.0	10.3	9.5	4.1	14.3	12.1	20.2	35.5	3.9	6.8	13.7	1.9	5.5	4.7	7.0	7.8	9.3	32.4	9.5	28.8	13.4	6.7	8.8	17.3	7.6	7.0	20.1	10.0	9.2	6.5	16.8	39.4	10.6	10.2	10.1	9.6	6.8	6.2	9.0	5.4	9.4	10.5	5.8	4.1	24.1	28.7	8.9	12.0	2.6	6.5	11.9	73.7	4.6	10.1	31.8	6.6	18.0	7.2	10.4	6.8	7.0	9.2	2.5	8.3	5.1	8.2	4.3
FLVCR2	"C14orf58, CCT, FLJ20371, MFSD7C, SLC49A2"	ENSG00000119686	"FLVCR heme transporter 2"	Q9UPI3	14	75578620-75663214	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 75.6;Kupffer cells: 44.9;Late spermatids: 142.5;Microglial cells: 41.2;Proximal enterocytes: 50.4;Syncytiotrophoblasts: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 14.0;intermediate monocyte: 14.6;myeloid DC: 7.6;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.6;monocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.8;ASC TERT1: 23.2;BEWO: 73.5;MCF7: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037984	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.1	13.6	3.5	9.3	3.7	5.4	2.5	3.2	3.8	2.1	16.2	8.4	17.4	1.0	1.4	2.9	1.9	3.5	2.2	2.9	2.7	11.3	20.5	16.2	5.3	4.7	3.7	2.2	0.6	2.1	3.4	10.3	3.9	2.3	7.1	0.7	12.7	1.7	8.3	5.7	24.4	4.2	5.2	13.8	0.9	21.1	4.8	1.2	3.2	1.6	5.0	4.9	2.6	5.5	3.7	2.8	0.8	4.0	53.8	23.2	73.5	0.7	3.1	3.3	2.6	6.2	0.4	0.0	0.2	0.2	5.4	0.4	9.8	0.2	1.3	19.3	0.6	0.1	2.8	13.3	4.3	0.1	0.6	10.9	7.7	4.0	2.4	0.1	0.8	0.3	0.2	0.5	10.1	26.4	0.2	1.9	1.6	1.1	4.4	0.1	2.6	0.0	3.5	5.1	0.0	0.1	2.0	8.1	1.6	4.6	4.5	10.1	8.8	4.0	1.4	2.0	0.1	0.6	1.1	0.0	11.4	2.5	0.7	0.0	14.0	0.7	0.4	14.6	1.1	0.0	1.1	0.3	7.6	0.1	0.8	0.2	0.5	0.5	11.8	0.1	1.6	4.1	3.5	3.7	3.2	3.8	2.9	2.7	4.7	3.7	3.9	5.2	4.8	5.5	0.3	6.4	6.4	2.6	0.5	0.6	0.3	0.4	0.6	0.0	1.5	0.6	0.8	0.0	3.2	3.7	0.0	23.2	1.7	14.0	0.0	0.1	75.6	2.1	3.9	2.5	0.0	0.0	0.2	0.2	31.0	2.2	0.0	2.7	1.3	0.2	1.8	21.1	16.4	0.0	0.2	2.2	4.1	44.9	5.6	142.5	3.4	19.0	0.0	41.2	10.1	1.3	2.1	0.0	0.2	0.1	3.2	1.9	0.5	0.8	50.4	7.0	0.3	0.3	0.0	0.4	0.3	2.4	1.3	0.2	0.9	54.5	1.2	2.3	5.5	0.2
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911931-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	16.0	14.6	22.6	11.7	22.4	12.5	14.2	22.6	28.7	18.6	15.9	19.3	12.9	17.7	4.8	12.8	17.0	13.0	19.0	18.9	20.8	12.8	8.3	14.0	11.3	33.2	23.3	20.6	10.7	14.7	16.4	8.2	30.0	17.2	3.7	13.3	13.7	12.5	32.8	20.4	14.4	7.6	19.2	18.7	13.4	4.0	27.3	9.1	15.5	10.7	6.2	21.8	16.2	23.7	10.0	34.8	7.8	23.2	12.4	12.5	23.6	18.2	14.1	9.0	9.2	5.8	31.8	24.4	47.3	14.0	14.7	20.5	6.5	12.2	1.8	40.8	19.6	8.2	30.9	19.5	27.7	10.9	27.3	11.2	37.9	19.1	13.8	16.7	12.9	16.0	18.6	25.0	7.0	23.8	25.1	13.3	12.7	7.5	23.6	43.5	11.6	44.0	10.6	6.7	16.7	15.5	19.1	20.6	24.1	4.3	16.1	19.6	24.4	15.0	13.6	29.4	12.4	37.1	34.5	22.7	16.4	17.8	17.9	1.2	0.8	0.3	1.3	0.4	2.3	0.9	2.1	2.7	0.8	2.6	1.7	1.5	0.1	0.5	0.4	0.5	1.1	1.1	22.6	22.4	22.6	28.7	18.9	20.8	33.2	23.3	30.0	19.2	27.3	23.7	16.7	0.0	4.2	34.3	10.4	12.4	9.3	9.2	23.3	42.1	8.6	11.3	12.3	8.6	5.1	22.0	35.5	21.2	14.3	6.5	1.9	6.1	0.4	6.0	7.7	13.4	2.4	6.5	26.9	6.5	8.5	13.9	12.2	8.9	0.0	48.3	11.0	6.8	8.5	33.7	29.0	4.9	4.1	9.9	5.1	1.2	11.1	8.9	8.8	13.1	7.9	18.8	9.2	18.6	25.6	7.1	2.9	14.3	10.4	5.3	8.9	6.3	8.3	39.3	0.0	16.6	20.9	0.9	3.2	13.1	13.9	8.8	11.9	5.3	7.4	5.6
FLYWCH2		ENSG00000162076	"FLYWCH family member 2"	Q96CP2	16	2883213-2899382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041354	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA041354: AB_10795007"	"unprognostic (3.57e-2)"	"prognostic favorable (9.38e-4)"	"unprognostic (7.33e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.40e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (5.50e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	26.1	44.8	27.0	10.2	25.8	7.6	26.5	31.3	33.2	21.9	21.9	24.9	15.7	27.2	5.7	24.1	21.8	11.0	34.9	28.8	32.9	27.6	11.7	21.5	10.7	37.8	31.4	27.3	14.1	17.6	34.8	7.7	33.2	30.3	5.3	5.8	26.1	14.0	31.5	19.5	17.4	10.1	27.8	35.2	20.2	24.2	30.6	11.6	30.6	17.7	6.9	19.3	21.9	25.8	23.0	44.7	18.9	45.0	17.4	26.2	27.8	18.0	13.7	19.0	13.2	20.9	28.7	23.1	67.0	16.0	17.7	15.0	10.8	25.5	3.4	38.7	28.5	24.9	45.3	17.1	53.3	14.7	23.9	36.5	18.8	15.1	7.4	23.5	15.1	40.5	17.7	24.1	12.9	110.1	37.4	63.8	20.9	22.1	47.3	72.4	20.8	50.7	13.7	6.7	29.2	38.1	50.5	53.2	38.4	7.1	63.2	45.5	20.7	31.7	26.0	50.0	18.6	39.9	38.1	32.6	18.9	21.8	22.9	8.5	19.2	16.2	21.7	28.2	23.1	22.9	24.7	20.7	27.7	22.0	26.7	23.4	7.9	16.2	28.7	38.0	25.3	20.2	27.0	25.8	31.3	33.2	28.8	32.9	37.8	31.4	33.2	27.8	30.6	25.8	62.3	12.8	11.2	7.5	21.9	20.4	40.4	60.0	29.6	19.9	45.5	50.5	15.0	14.3	31.8	44.1	8.4	21.5	25.9	32.8	84.1	45.5	12.6	34.1	46.0	45.0	33.6	11.1	10.5	55.6	46.2	38.3	15.8	31.6	14.5	31.3	18.2	5.5	34.5	15.2	14.0	42.2	61.1	9.2	25.3	12.2	21.1	25.1	42.7	5.6	27.2	54.1	32.0	7.5	7.2	43.8	34.4	25.2	12.8	30.5	29.3	60.2	24.5	19.3	32.9	25.9	46.3	84.8	69.3	34.1	28.4	12.0	22.0	60.5	35.2	34.7
FMC1	"C7orf55, HSPC268"	ENSG00000164898	"Formation of mitochondrial complex V assembly factor 1 homolog"	Q96HJ9	7	139339457-139346328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 84.6;Distal tubular cells: 199.6;Proximal tubular cells: 196.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045663, HPA050553"	Approved		Approved	Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA045663: AB_2679410, HPA050553: AB_2681173"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.19e-1)"	"prognostic favorable (5.63e-6)"	"unprognostic (1.04e-3)"	"unprognostic (2.39e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (1.50e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.02e-2)"	8.5	11.5	19.1	2.8	20.1	6.2	8.2	20.1	23.1	6.6	20.0	9.7	7.0	8.1	11.6	5.5	9.3	5.2	28.5	19.3	19.8	16.2	17.7	5.2	5.5	20.0	19.8	11.2	10.3	11.1	12.0	3.3	19.9	11.2	5.1	3.1	12.8	7.7	30.5	5.0	7.0	3.7	19.5	6.4	11.3	5.7	19.6	7.5	10.7	39.0	3.0	8.6	5.8	21.5	5.6	19.5	11.2	11.7	6.0	5.2	4.9	1.8	4.6	13.2	9.8	6.6	7.1	12.6	11.3	5.9	10.5	4.3	11.0	4.8	3.2	6.3	67.5	6.1	19.9	29.3	12.8	5.3	8.8	13.5	9.3	4.4	3.7	4.8	10.8	8.6	12.4	18.9	7.6	39.2	12.8	35.7	11.1	9.9	28.2	7.7	5.5	17.6	11.1	5.0	22.1	14.5	6.3	5.2	8.1	1.8	2.5	4.3	5.1	4.7	4.4	5.6	5.0	6.7	7.2	14.4	12.1	11.7	7.7	13.3	10.3	10.9	11.2	6.7	9.9	25.3	13.7	11.4	12.0	20.5	15.7	11.2	3.3	16.1	7.6	21.4	16.9	6.6	19.1	20.1	20.1	23.1	19.3	19.8	20.0	19.8	19.9	19.5	19.6	21.5	31.3	44.8	47.6	0.0	10.1	0.0	0.0	0.0	0.0	0.0	57.1	57.4	0.0	0.0	19.8	84.6	0.0	63.0	11.9	0.0	199.6	35.4	0.0	67.8	40.1	14.5	0.0	0.0	0.0	35.3	24.2	20.3	0.0	43.9	12.6	27.6	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	23.6	0.0	0.0	4.1	0.0	0.0	196.2	37.2	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	47.6	9.4	40.9	0.0	0.0
FMC1-LUC7L2	C7orf55-LUC7L2	ENSG00000269955	"FMC1-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		16.8	17.7	2.4	8.8	4.4	6.4	16.1	3.8	9.8	15.8	3.7	20.2	11.0	21.8	1.1	13.4	18.2	2.7	21.9	2.3	3.9	15.0	19.3	14.8	6.2	4.9	3.0	20.4	12.3	12.3	14.1	6.9	4.1	15.3	4.0	13.9	18.1	8.6	56.9	13.3	16.0	6.7	3.5	12.7	16.5	11.7	3.2	14.1	24.7	30.5	4.9	17.7	14.9	4.6	32.6	46.2	55.1	31.7	23.3	16.2	20.8	25.2	17.0	29.9	23.8	36.5	35.8	36.5	44.3	18.6	40.1	25.5	59.7	21.3	9.4	25.2	6.3	48.6	45.9	27.8	21.7	60.2	38.2	12.7	15.3	28.8	18.4	16.9	20.9	19.1	62.1	47.4	18.7	45.6	88.9	3.2	44.5	44.2	9.7	57.5	41.6	48.5	4.8	22.3	45.7	47.5	33.9	26.4	33.8	10.4	20.2	25.1	24.0	21.5	20.2	22.5	38.8	44.4	40.3	70.5	39.9	37.8	40.1	14.6	15.7	22.3	22.2	16.1	21.3	22.2	21.3	23.0	22.8	23.0	23.9	21.7	5.6	24.6	20.4	17.9	25.8	16.4	2.4	4.4	3.8	9.8	2.3	3.9	4.9	3.0	4.1	3.5	3.2	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765544-33194714	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;retina: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Region enriched"	"Detected in some"	7	"cerebral cortex: 16.9"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	1.8	0.8	0.0	2.4	0.0	1.2	3.0	0.0	16.9	5.3	0.0	5.7	1.3	1.0	0.7	2.0	3.1	2.4	0.9	0.0	0.0	2.8	0.5	3.4	0.9	2.3	0.0	0.2	1.2	1.4	3.7	3.7	0.0	1.8	4.4	30.0	4.2	1.2	0.7	4.2	1.8	2.2	0.0	1.0	7.9	10.2	1.7	3.8	2.5	0.5	0.6	1.3	3.6	0.0	3.8	4.0	0.8	0.4	0.1	0.4	4.9	5.4	4.1	1.5	4.0	0.6	5.0	0.6	1.8	6.1	3.4	3.7	0.1	3.7	3.9	0.0	0.2	3.1	0.8	0.4	0.2	0.0	0.2	1.5	0.2	7.9	0.1	3.1	0.0	0.1	0.0	21.4	8.8	3.9	0.1	0.0	1.1	7.0	0.3	0.6	26.9	4.9	1.8	1.5	0.3	0.9	0.0	3.3	28.7	0.9	24.8	0.0	4.9	17.2	2.7	17.9	1.6	0.0	0.0	0.9	7.3	0.2	10.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.4	41.7	46.9	10.1	1.6	3.7	3.2	2.0	3.4	117.0	7.7	5.1	3.1	14.3	17.3	0.0	221.0	12.0	5.4	13.3	11.7	5.7	16.5	17.4	2.4	2.7	9.0	0.4	439.4	1.8	5.9	2.6	97.9	7.0	24.0	1.8	0.0	0.4	10.9	47.1	340.0	16.8	16.2	28.0	3.9	12.8	0.9	29.6	33.8	64.6	5.8	6.9	0.0	8.0	61.9	11.4	11.4	0.7	2.2	4.5	4.0	1.6	29.4	102.4	0.0	13.0	1.0	18.4	16.0	7.3	3.4	18.3	5.0	0.1	9.9	5.7
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 277.6;lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.1;dendritic cells: 160.0;Kupffer cells: 77.4;Langerhans cells: 141.6;Macrophages: 115.5;monocytes: 132.8;NK-cells: 152.4;Plasma cells: 109.8;T-cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 190.8;MOLT-4: 138.4;U-266/70: 158.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	22.9	7.4	14.2	68.5	11.3	277.6	13.4	10.1	21.5	10.4	9.0	12.5	11.5	5.6	2.3	8.9	14.1	18.5	12.7	20.8	9.0	8.4	8.5	54.6	69.4	16.2	11.2	3.4	6.5	6.8	16.3	12.2	15.5	10.4	7.3	1.3	16.2	3.3	4.7	9.5	36.7	8.2	11.1	104.9	13.7	4.2	17.2	49.7	9.0	6.2	38.7	21.4	10.5	16.3	16.9	32.2	0.3	1.7	0.3	7.0	1.7	2.0	4.3	11.8	8.8	1.5	7.2	51.4	16.2	0.6	12.4	2.7	0.0	0.4	3.9	91.1	4.4	29.8	51.0	2.7	32.6	78.6	100.6	5.4	1.4	15.6	6.7	16.4	0.3	55.8	2.7	190.8	8.8	10.9	138.4	80.7	1.6	2.1	1.0	86.2	11.3	92.7	3.3	2.1	10.0	4.8	9.9	1.7	4.0	2.6	9.2	62.7	4.0	0.7	11.1	1.9	73.3	158.9	75.7	52.2	1.4	62.8	2.5	11.1	6.5	11.3	8.6	7.4	5.7	4.5	6.6	9.4	5.6	5.1	4.4	5.8	28.4	7.2	5.9	3.3	8.1	5.3	14.2	11.3	10.1	21.5	20.8	9.0	16.2	11.2	15.5	11.1	17.2	16.3	7.2	3.2	3.0	0.0	108.1	6.1	2.9	0.9	2.2	4.9	3.3	4.7	2.5	1.5	1.1	1.8	0.0	0.6	160.0	0.7	0.0	1.5	2.5	0.7	4.3	5.7	1.2	34.9	12.8	0.9	1.2	12.9	4.6	1.2	22.9	0.2	6.1	1.5	45.3	3.3	10.3	0.4	0.0	77.4	141.6	0.7	5.3	115.5	44.4	9.4	132.8	0.9	152.4	0.5	1.0	0.5	0.1	0.0	109.8	1.9	0.2	0.8	1.0	1.6	6.6	9.3	2.4	0.8	3.5	0.6	6.1	2.5	134.6	0.2	0.5	1.4
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335174-152649826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 223.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 668.0;Excitatory neurons: 574.9;Inhibitory neurons: 321.9;Oligodendrocyte precursor cells: 371.0;Oligodendrocytes: 2442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 191.4;hTERT-HME1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	26.4	25.2	88.9	11.1	152.3	0.7	20.8	135.2	119.3	18.1	73.6	15.2	8.9	20.7	14.9	8.5	15.3	16.8	12.0	92.9	102.6	22.2	8.1	32.2	14.2	172.3	136.3	54.0	18.1	23.1	28.4	58.2	165.5	15.2	12.3	10.6	32.1	11.7	24.1	11.3	11.6	16.3	121.6	19.8	17.3	9.0	128.5	14.8	33.1	19.3	8.4	19.3	18.3	223.5	14.5	15.1	45.9	25.5	54.5	58.3	191.4	14.4	29.4	24.9	34.8	16.3	0.9	0.3	29.8	12.6	53.7	16.2	22.4	45.8	39.6	0.1	23.4	0.2	10.0	70.2	15.7	4.0	0.8	38.4	27.8	48.2	123.5	48.3	44.7	6.6	0.6	0.3	13.9	4.0	0.8	4.5	29.5	12.4	30.0	25.9	9.9	20.9	72.9	9.9	46.6	38.0	12.2	4.5	51.4	38.7	1.1	1.5	49.9	37.4	1.0	12.7	25.0	1.3	0.5	0.1	34.7	3.3	77.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	88.9	152.3	135.2	119.3	92.9	102.6	172.3	136.3	165.5	121.6	128.5	223.5	21.5	25.6	25.9	668.0	2.7	26.4	23.0	14.0	19.4	23.8	11.4	10.0	3.8	1.5	16.4	11.0	0.0	36.1	4.5	2.6	13.7	20.4	24.5	14.1	10.8	29.1	8.3	0.4	574.9	6.9	17.8	36.2	8.2	27.0	1.3	36.0	20.0	1.3	40.6	0.0	321.9	3.3	10.2	64.8	53.0	10.5	35.1	31.5	7.2	245.4	4.4	3.9	1.0	371.0	2442.0	10.0	2.1	41.3	5.6	33.5	0.7	8.9	8.5	2.0	6.6	18.7	13.2	6.7	8.0	6.3	16.9	27.0	2.1	13.0	6.1	13.2
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	12.2	5.7	13.7	20.5	13.2	5.2	10.6	13.0	11.2	9.6	3.0	8.0	5.7	11.2	19.2	4.5	6.9	11.1	12.6	11.0	12.6	9.3	2.7	17.4	23.5	21.7	14.6	16.1	3.2	3.6	4.1	14.0	18.2	6.0	5.6	2.7	4.6	4.4	5.6	4.4	10.2	11.5	17.7	13.4	6.6	10.1	20.4	20.1	13.4	6.7	28.3	8.6	6.3	20.4	8.6	2.5	18.4	6.1	5.0	20.1	0.2	10.4	21.0	13.8	12.1	9.7	2.3	18.2	19.5	12.4	15.2	0.4	9.5	4.3	12.6	16.2	3.6	20.1	2.9	0.5	8.8	4.0	25.1	12.7	0.7	21.7	9.1	41.2	37.1	9.0	4.6	13.0	20.5	6.3	16.6	6.0	6.0	0.9	5.5	7.9	23.0	2.8	13.1	1.3	3.0	8.6	6.0	0.8	11.8	9.3	1.5	5.9	47.2	34.2	11.8	0.6	18.2	6.7	0.4	9.8	21.3	12.4	14.7	3.0	0.1	0.8	0.8	0.4	0.4	0.2	0.3	0.5	0.2	1.1	0.4	0.5	0.0	0.6	0.3	5.1	0.1	0.5	13.7	13.2	13.0	11.2	11.0	12.6	21.7	14.6	18.2	17.7	20.4	20.4	35.8	3.2	3.4	6.8	17.5	1.7	0.7	0.4	2.2	11.3	1.3	2.3	3.3	0.0	1.4	1.8	39.6	2.1	48.6	0.1	0.0	0.3	2.0	0.7	2.6	29.7	0.0	1.7	16.0	0.6	0.8	7.1	1.5	2.0	27.8	5.4	15.7	0.8	11.1	3.3	6.5	0.8	0.0	6.9	9.0	4.6	3.7	17.7	5.4	119.0	22.9	0.5	16.5	27.6	5.5	0.8	0.1	6.4	1.8	0.8	0.0	0.2	0.2	2.0	13.1	15.5	10.3	5.9	7.5	0.4	1.4	2.5	13.6	2.6	0.1	0.4
FMO1		ENSG00000010932	"Flavin containing dimethylaniline monoxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 199.0"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 97.9;Proximal tubular cells: 196.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078132	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	5.1	5.6	0.1	0.5	0.1	0.0	10.0	0.1	0.3	6.3	0.3	0.4	0.1	3.1	0.1	3.5	4.2	5.2	0.7	0.1	0.1	199.0	2.9	1.5	0.4	0.1	0.1	5.0	2.4	1.1	1.8	2.3	0.1	0.4	0.2	0.0	5.4	0.7	0.1	10.4	20.2	4.2	0.1	0.0	0.9	1.6	0.1	7.4	2.3	0.8	10.8	2.5	1.7	0.1	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.0	0.0	0.0	0.3	3.0	3.2	0.5	0.0	12.5	0.0	0.5	1.1	10.0	2.8	0.0	3.7	0.0	0.3	0.0	0.0	13.7	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	18.7	0.0	0.0	0.0	3.2	0.0	0.3	0.4	0.0	0.1	2.9	0.0	0.0	0.0	1.5	10.8	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	2.6	0.0	0.1	97.9	196.9	0.0	0.0	6.6	0.5	4.7	0.0	0.1	1.4	2.3	0.8	1.0	2.6	1.4	0.1
FMO2		ENSG00000094963	"Flavin containing dimethylaniline monoxygenase 2"	Q99518	1	171185249-171212686	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.7;lung: 93.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Alveolar cells type 1: 461.6;Club cells: 204.7;Fibroblasts: 98.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"ASC diff: 30.6;ASC TERT1: 13.7;HSkMC: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028261	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	69.7	24.0	1.5	1.3	2.4	0.1	47.8	1.3	1.4	6.6	2.9	6.5	0.9	5.1	7.7	65.9	33.3	4.6	50.0	0.8	4.1	10.4	4.3	93.9	11.6	2.2	1.7	4.3	5.5	4.9	6.3	0.3	1.7	5.5	1.7	0.9	36.5	2.9	17.6	4.5	4.2	3.9	1.5	0.7	6.8	1.1	4.7	8.6	12.0	20.3	11.8	4.5	11.6	1.1	0.0	0.0	0.0	0.0	30.6	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	37.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.4	1.3	1.4	0.8	4.1	2.2	1.7	1.7	1.5	4.7	1.1	187.0	461.6	21.7	2.6	0.1	0.4	4.4	36.0	2.8	0.4	14.5	69.1	9.2	0.0	204.7	1.8	0.0	0.0	0.5	0.0	0.0	0.5	5.5	0.1	0.1	69.1	0.0	0.0	0.1	0.0	0.0	98.7	0.0	0.0	3.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.7	2.8	0.9	1.8	0.0	37.5	0.0	0.2	0.0	2.0	0.1	1.3	0.0	0.0	2.5	3.7	0.0	10.2	36.0	0.6	0.0	9.7	48.5	0.3	0.1	7.4	0.0	0.0	1.1	1.6	0.0	1.2
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1123.3"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	27.2	12.4	2.5	0.9	2.7	0.4	6.8	2.5	3.6	1.2	2.3	1.4	1.8	1.3	3.0	5.1	13.3	1.8	4.2	2.3	2.6	14.0	1123.3	18.7	4.9	5.0	2.7	0.3	4.5	4.2	4.3	0.2	3.1	1.1	0.7	0.1	5.1	0.4	4.6	4.3	2.2	1.6	4.0	0.4	3.9	0.5	2.8	1.4	2.6	3.1	9.1	1.0	0.9	2.6	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	2.5	3.6	2.3	2.6	5.0	2.7	3.1	4.0	2.8	2.6	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
FMO4	FMO2	ENSG00000076258	"Flavin containing dimethylaniline monoxygenase 4"	P31512	1	171314183-171342084	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 48.6;liver: 61.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;HSkMC: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	3.7	2.6	2.2	1.9	3.1	0.9	4.1	2.8	3.0	3.3	3.1	5.0	5.4	2.7	6.3	2.3	3.5	4.9	5.2	2.1	2.6	48.6	61.3	3.2	2.9	3.1	2.8	3.8	2.4	4.7	1.9	2.3	3.3	3.1	4.8	0.7	2.0	2.2	1.0	3.4	9.2	2.0	2.6	3.1	5.0	1.7	3.1	3.6	3.2	2.1	3.3	2.4	2.9	3.5	0.1	0.1	0.3	0.4	4.1	3.4	0.2	0.8	3.7	1.1	1.2	0.6	5.3	3.7	5.7	0.1	2.0	0.2	0.7	1.0	1.6	1.6	0.8	0.0	0.0	0.0	0.6	0.7	0.8	6.6	2.4	0.4	1.0	0.4	0.2	1.7	0.2	2.3	0.5	0.7	1.6	1.3	0.4	0.9	1.2	0.4	0.4	2.1	2.6	0.0	0.1	0.0	1.2	1.0	2.4	4.1	2.2	1.0	0.1	0.9	0.3	1.0	0.7	2.9	1.0	2.2	1.8	1.1	0.8	0.2	1.0	0.3	0.9	1.6	0.7	1.2	0.8	1.3	0.9	1.8	1.2	0.9	0.1	1.7	1.1	1.2	2.1	0.8	2.2	3.1	2.8	3.0	2.1	2.6	3.1	2.8	3.3	2.6	3.1	3.5	2.2	0.0	2.6	7.2	3.2	2.8	4.6	5.0	2.8	0.0	2.3	2.0	3.7	2.8	3.7	9.2	0.0	2.8	0.6	7.1	29.4	2.3	5.7	3.8	1.7	1.4	1.2	0.0	0.1	1.4	1.2	6.6	8.2	1.7	1.3	1.5	2.9	22.1	3.7	0.0	0.1	3.2	2.0	5.9	1.3	1.3	1.5	2.7	5.4	2.8	1.6	1.8	1.0	0.0	18.5	1.1	0.7	0.4	1.1	0.9	16.5	49.5	7.3	0.0	0.0	1.8	2.1	0.3	0.5	1.9	1.6	1.9	1.7	2.0	2.8	1.8
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"FMRP translational regulator 1"	Q06787	X	147911919-147951125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	18.1	16.5	22.3	20.6	24.1	43.5	18.3	29.6	29.2	18.8	16.1	19.1	17.5	27.3	41.0	17.0	22.8	15.9	20.1	21.7	21.0	34.0	39.6	20.1	22.7	21.9	21.1	27.7	13.3	29.6	13.5	31.2	21.3	16.5	18.9	27.6	14.1	21.4	9.5	23.2	19.7	21.1	22.7	27.7	17.8	19.6	22.9	24.6	30.6	11.6	21.7	16.7	14.7	23.4	44.9	39.6	41.2	27.2	24.4	19.4	31.9	23.8	24.9	37.6	66.4	43.5	42.1	89.5	93.5	29.8	43.3	74.4	65.8	30.2	42.0	34.9	45.2	25.3	71.3	41.4	24.0	28.3	15.1	21.2	16.2	31.6	28.8	22.6	31.8	24.4	15.9	57.7	32.7	59.0	32.0	20.3	18.2	30.9	21.8	34.7	116.8	37.6	43.2	119.3	35.1	23.3	26.8	24.4	35.7	55.4	21.8	24.9	30.4	30.5	25.5	37.7	60.0	61.1	65.5	94.5	27.4	46.9	16.3	2.0	1.3	3.4	2.7	1.6	3.5	2.6	1.8	3.1	1.7	2.4	2.3	2.7	3.5	2.5	1.6	1.3	2.4	1.3	22.3	24.1	29.6	29.2	21.7	21.0	21.9	21.1	21.3	22.7	22.9	23.4	35.3	57.7	26.6	26.8	22.1	31.4	16.0	12.6	21.1	37.5	20.7	17.4	43.2	14.3	23.9	22.0	12.5	37.2	37.1	27.2	19.6	14.7	1.0	36.4	42.5	27.2	14.9	10.7	33.3	9.8	43.5	27.2	17.9	49.3	19.7	36.8	17.5	37.5	15.4	70.7	32.2	13.8	18.3	25.4	15.7	3.0	30.1	23.7	35.6	29.0	16.8	40.0	11.3	28.6	33.9	13.5	18.1	29.7	20.3	22.7	20.7	42.6	23.4	30.0	6.6	37.2	33.3	14.9	20.9	28.1	32.4	40.8	24.1	39.4	16.9	34.7
FMR1NB	"CT37, FLJ25736, NY-SAR-35"	ENSG00000176988	"FMR1 neighbor"	Q8N0W7	X	147981337-148026665	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	333	"testis: 58.1"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 502.2;Spermatogonia: 296.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"U-266/70: 67.5;U-266/84: 57.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA011284, CAB026403"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"CAB026403: , HPA011284: AB_1078898"				"unprognostic (2.22e-3)"			"unprognostic (1.05e-1)"			"unprognostic (1.83e-1)"					"unprognostic (4.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	67.5	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	18.4	5.6	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	39.5	0.0	0.0	502.2	296.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1725.9;placenta: 2928.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	151.1	31.4	37.8	131.9	44.8	0.6	76.5	36.3	51.2	135.9	85.9	444.0	33.8	156.1	61.3	251.6	174.5	187.1	410.9	38.9	41.1	42.9	1725.9	785.7	37.3	37.7	39.8	110.0	26.0	19.3	26.2	2928.1	43.5	105.6	237.2	6.0	67.0	428.9	37.7	52.7	103.4	722.6	36.2	14.3	127.2	25.8	112.1	133.8	40.4	148.4	23.9	361.7	87.1	35.3	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	44.8	36.3	51.2	38.9	41.1	37.7	39.8	43.5	36.2	112.1	35.3	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735615-82751196	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 34.3;Hep G2: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		180000		"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	14.4	47.3	47.4	2.9	64.3	12.0	8.4	64.4	56.6	10.4	36.8	15.5	22.4	9.4	7.0	4.6	12.5	6.9	47.5	46.5	54.3	49.6	48.1	7.8	2.4	63.3	56.8	22.3	18.1	21.9	22.4	5.3	62.7	12.5	9.5	13.8	28.5	12.1	23.5	5.3	14.5	6.6	49.4	4.6	17.4	5.2	55.6	1.0	10.2	10.9	2.3	8.8	7.9	79.8	1.3	16.1	4.4	23.2	6.9	5.7	2.9	2.9	2.2	5.4	2.7	21.0	3.3	0.2	3.9	2.6	4.5	0.6	34.3	2.5	2.0	1.0	2.4	12.5	12.9	66.2	18.8	0.3	10.1	4.9	9.0	2.1	0.0	5.7	10.6	1.0	22.4	0.6	1.1	1.8	0.2	0.2	2.9	7.6	13.0	2.1	0.3	0.1	11.5	4.5	7.0	22.7	5.3	1.2	15.8	3.8	15.4	4.5	2.5	0.4	1.6	5.6	4.3	1.2	0.3	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	64.3	64.4	56.6	46.5	54.3	63.3	56.8	62.7	49.4	55.6	79.8	3.9	3.2	2.0	8.8	1.9	1.5	3.7	1.5	14.8	41.9	4.5	3.7	5.8	4.3	2.5	31.3	47.9	11.7	2.6	5.7	90.1	3.2	0.2	11.6	3.0	5.2	5.4	49.2	10.2	1.2	2.6	8.6	47.9	25.9	1.3	6.9	4.2	5.4	8.2	32.0	13.0	10.4	6.1	1.0	3.4	0.4	5.3	5.7	12.4	5.6	1.2	36.2	1.0	6.0	17.1	1.7	7.3	3.0	9.1	3.9	28.2	167.2	2.5	72.9	0.0	6.1	9.8	0.8	4.1	12.8	1.8	8.3	3.1	18.6	9.5	3.5
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716706-82730328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	23.2	22.1	40.6	13.3	43.7	18.8	19.7	43.3	41.3	23.4	35.1	22.9	15.3	23.1	19.4	20.4	20.4	16.6	16.1	41.1	41.7	23.9	29.3	16.3	18.5	42.5	41.6	32.1	19.3	18.4	17.2	21.8	43.2	20.8	18.0	17.8	22.2	23.2	11.4	23.6	19.4	22.1	42.9	20.9	20.6	13.7	41.7	16.6	16.7	10.6	22.8	19.7	20.7	48.3	31.4	122.3	33.6	44.5	15.9	30.3	27.2	56.9	31.8	54.5	44.3	64.9	21.8	25.6	37.0	46.6	50.5	35.3	30.1	43.5	48.7	17.2	54.3	42.6	66.2	77.5	28.3	30.7	23.2	27.8	50.9	51.7	28.1	33.4	39.8	35.9	42.5	15.8	70.7	59.8	58.8	45.2	15.2	68.7	53.5	44.0	83.4	40.3	38.9	58.7	27.6	58.1	93.7	42.7	47.3	57.4	69.8	43.6	34.8	103.3	35.9	74.2	85.3	32.1	37.8	64.8	48.1	38.2	49.0	32.0	21.9	30.6	29.6	24.7	29.5	23.9	28.8	28.8	18.2	24.8	32.5	24.3	3.4	32.1	13.8	36.0	29.7	26.0	40.6	43.7	43.3	41.3	41.1	41.7	42.5	41.6	43.2	42.9	41.7	48.3	14.3	12.8	11.1	5.5	13.9	15.0	26.0	26.0	15.4	18.1	13.3	15.6	6.9	25.8	15.3	11.0	8.4	100.3	20.0	12.2	23.5	20.6	2.0	10.7	13.0	14.8	7.8	31.2	7.6	11.1	45.3	18.1	13.3	22.3	13.3	18.6	10.8	12.1	33.8	3.3	6.7	15.4	22.4	11.2	11.3	4.2	28.3	12.8	23.2	6.5	20.9	36.1	17.5	5.0	11.8	17.8	15.9	31.6	27.6	15.5	11.1	28.2	10.0	18.5	13.1	13.6	20.9	18.3	36.2	18.0	15.3	62.5	17.2	22.3	15.6	24.0
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	21.8	11.9	51.2	57.8	73.7	40.6	16.4	77.4	53.4	32.5	22.2	107.3	15.0	50.0	17.0	39.4	34.8	27.8	15.1	47.0	62.5	16.4	18.4	25.4	78.1	67.6	69.1	22.1	8.1	10.7	17.7	16.3	65.8	41.4	29.6	12.6	16.3	44.1	24.1	25.9	37.6	46.8	55.9	60.9	29.6	17.3	69.9	111.0	33.4	13.2	74.3	68.4	26.8	86.6	42.5	19.3	34.9	40.8	21.0	25.8	29.5	23.7	20.2	17.6	14.7	20.3	16.2	82.9	20.4	44.5	20.8	20.7	33.0	21.6	17.6	137.7	9.8	22.8	22.8	13.8	35.8	62.3	75.1	18.7	9.3	32.6	19.5	25.6	26.1	143.2	5.4	1.1	16.4	34.0	140.1	60.8	27.5	5.7	32.6	31.9	28.3	24.1	22.1	23.0	5.5	17.6	43.3	42.9	16.5	33.3	30.0	28.3	31.9	16.6	20.7	30.5	15.0	16.4	64.4	3.8	20.0	42.2	25.2	13.2	5.1	9.6	10.8	5.6	9.3	12.7	9.7	10.3	5.8	7.7	8.9	8.6	9.3	6.0	6.5	6.9	10.9	4.5	51.2	73.7	77.4	53.4	47.0	62.5	67.6	69.1	65.8	55.9	69.9	86.6	27.2	35.3	25.2	317.7	180.4	33.1	21.3	12.8	21.6	20.2	42.5	24.6	14.8	15.7	29.8	22.0	52.1	18.6	217.2	28.3	19.6	22.6	1.7	46.2	38.8	38.3	18.1	31.3	65.6	17.3	24.5	38.8	26.5	78.7	80.4	9.2	71.0	18.4	43.6	28.6	107.8	8.7	20.3	221.2	402.9	5.5	46.6	131.1	76.5	95.5	433.2	42.8	223.5	69.4	522.1	21.8	19.8	51.6	147.9	67.8	0.2	15.0	42.3	29.5	59.2	19.9	41.0	26.5	45.4	26.7	41.1	63.9	233.7	7.1	16.2	42.3
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448118-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065273: AB_2685452"	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	28.3	7.8	13.6	5.4	25.8	2.1	33.0	13.6	13.8	18.0	13.8	17.3	20.6	16.8	18.6	8.9	13.4	14.5	20.0	12.0	15.4	36.1	13.3	16.8	3.1	14.6	19.1	13.9	17.3	20.8	10.5	17.2	14.2	15.6	17.5	12.4	43.1	11.5	17.4	12.7	20.2	12.3	15.9	2.8	23.7	15.0	14.4	6.5	31.8	21.4	4.0	14.9	13.2	12.7	29.7	16.2	83.4	46.8	17.6	12.4	92.8	14.6	9.9	10.8	15.0	19.9	9.2	0.1	29.4	14.3	29.0	14.9	20.3	16.7	15.4	18.5	15.2	15.8	23.5	29.9	8.8	2.8	0.3	23.0	27.2	10.2	14.8	28.2	52.1	18.1	6.2	0.1	25.8	13.8	11.6	1.2	63.7	50.5	16.4	24.4	63.7	7.8	47.5	44.6	32.6	47.0	45.4	88.0	25.8	97.3	33.5	4.0	52.1	25.2	31.7	0.6	10.2	9.1	7.5	0.2	2.5	0.4	17.5	7.3	0.1	0.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.0	1.5	0.2	0.1	13.6	25.8	13.6	13.8	12.0	15.4	14.6	19.1	14.2	15.9	14.4	12.7	130.0	109.0	42.1	48.0	4.3	26.5	61.5	27.5	18.2	13.3	62.9	59.1	42.6	40.0	60.9	62.5	4.2	37.6	2.2	35.4	56.7	77.9	12.1	61.1	30.0	49.8	67.0	36.6	41.0	48.4	35.7	20.5	50.0	91.7	16.4	19.6	25.0	21.0	11.8	69.0	110.8	33.0	14.2	4.7	22.7	19.7	8.1	10.6	39.2	80.6	7.1	18.8	0.0	55.3	4.2	55.8	34.5	3.8	1.0	56.0	43.6	50.8	53.8	10.0	26.3	5.9	49.9	23.4	37.2	22.0	25.7	17.1	4.1	10.2	38.4	75.6
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716494-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	38.0	34.4	5.8	12.1	6.1	19.6	36.6	9.9	7.4	46.7	8.4	35.4	8.9	38.9	9.4	33.8	40.6	8.2	29.9	5.7	6.8	29.5	31.3	39.1	15.9	5.9	6.2	48.8	39.2	7.5	29.2	9.6	5.8	36.3	8.8	14.9	32.7	8.2	51.0	40.5	42.8	9.0	5.3	50.6	31.6	16.5	6.4	14.0	42.8	7.0	14.2	34.2	40.2	7.8	10.6	8.5	17.7	12.5	10.0	11.6	12.0	12.3	12.7	11.1	12.9	8.4	14.0	23.2	6.0	14.0	9.3	21.2	15.8	10.0	16.4	18.2	24.1	17.5	28.1	14.3	14.1	19.5	16.6	14.2	16.4	9.7	22.0	16.2	13.1	14.1	19.2	19.2	10.7	9.7	30.0	22.6	16.7	9.4	7.8	21.2	16.8	12.9	10.9	12.8	7.9	13.1	18.5	15.2	10.5	13.2	12.3	9.1	14.4	13.1	13.8	19.0	17.3	18.6	13.4	26.1	9.5	11.9	9.1	3.8	2.1	3.4	3.7	1.5	2.9	5.1	2.6	2.6	1.3	5.4	2.7	2.9	2.0	1.8	2.2	5.6	3.9	0.9	5.8	6.1	9.9	7.4	5.7	6.8	5.9	6.2	5.8	5.3	6.4	7.8	65.0	51.3	71.7	82.6	114.7	70.9	112.5	45.9	112.7	95.1	57.0	49.0	38.2	27.1	63.6	25.8	108.4	48.9	122.0	46.1	5.9	39.9	5.5	94.3	121.9	59.7	36.5	59.1	86.7	37.8	37.4	70.6	89.2	165.4	57.6	95.5	48.2	27.0	28.4	67.3	93.6	46.5	34.6	37.2	58.3	8.0	89.5	59.2	39.2	71.2	62.1	28.1	83.4	100.5	108.3	50.8	39.4	62.1	102.4	120.8	36.6	11.3	60.5	103.2	46.0	70.5	61.6	37.3	28.1	96.0	69.9	82.9	105.7	93.4	42.6	168.0
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169400-159272108	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 14.2;thyroid gland: 20.3"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 28.7;Smooth muscle cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 5.4;hippocampal formation: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.4	0.5	0.5	1.9	0.3	0.0	2.1	0.1	5.4	6.5	0.2	12.9	2.5	2.2	0.0	1.1	0.6	14.2	3.9	8.7	0.3	0.6	0.7	1.6	2.8	0.1	1.0	1.2	1.1	0.3	0.2	0.9	0.0	0.4	1.8	0.1	0.9	0.8	2.1	0.9	4.2	11.7	0.3	0.5	0.4	0.4	0.4	0.1	20.3	9.6	2.4	1.0	1.6	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	5.4	8.7	0.3	0.1	1.0	0.0	0.3	0.4	1.2	2.6	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.1	0.5	2.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.3	0.4	4.7	0.7	0.0	0.0	0.2	0.0	0.2	28.7	0.0	0.3	0.0	0.1	1.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	3.1	0.0	0.3	0.2	1.8	2.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	3.0	11.5	1.1	1.4	0.0	1.4	0.1	0.5	0.1	0.0	0.0
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012555, HPA012825"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus, Centrosome"	Cytosol	"HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	17.8	39.9	15.2	18.7	18.6	17.0	26.3	12.7	16.4	35.2	13.6	23.3	27.5	32.1	38.8	13.1	26.5	26.8	14.0	15.3	39.4	29.7	66.9	21.6	16.7	16.7	19.6	35.4	43.1	27.7	30.8	44.1	17.4	22.1	24.0	21.9	36.8	33.9	10.1	11.4	23.8	26.0	15.5	22.6	28.8	30.4	31.9	21.3	51.2	13.1	18.9	25.6	14.1	17.9	11.6	13.1	47.1	12.4	58.3	73.0	9.2	53.3	70.8	50.2	36.3	17.9	27.7	8.8	9.7	40.5	21.8	12.4	28.4	18.1	72.6	22.1	21.9	14.3	36.9	33.2	35.3	13.4	2.3	37.7	24.8	44.7	51.4	47.1	52.6	11.9	18.0	21.0	55.4	4.7	13.3	26.7	23.2	25.0	11.0	12.6	18.8	16.4	42.4	21.2	17.8	29.4	20.1	17.8	38.8	29.8	9.6	26.0	41.7	26.1	17.9	24.3	38.3	25.4	14.4	8.1	19.6	16.9	27.4	1.9	3.0	1.9	2.5	2.0	3.6	3.3	2.9	2.2	1.9	2.2	3.7	3.3	4.5	2.1	4.0	4.0	2.6	1.7	15.2	18.6	12.7	16.4	15.3	39.4	16.7	19.6	17.4	15.5	31.9	17.9	46.7	54.5	49.0	88.2	36.2	18.4	37.4	17.5	44.3	52.0	33.4	25.5	27.1	27.1	28.9	36.8	37.5	13.2	36.4	21.6	13.7	30.6	45.9	42.1	74.3	42.4	43.5	17.9	159.5	36.2	38.2	58.0	57.6	56.4	31.6	38.8	32.9	74.2	25.4	35.3	170.8	37.4	18.3	31.8	24.4	13.1	33.8	45.5	37.4	112.4	27.0	52.7	24.7	177.9	178.2	25.5	29.0	39.5	165.9	44.2	37.8	48.0	35.6	42.5	6.6	48.0	50.8	89.8	33.7	20.3	11.9	32.3	30.9	46.4	24.7	26.4
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039578-172401669	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 29.4;hypothalamus: 8.2;pons: 9.4;thalamus: 14.4"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 37.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	34.4	25.5	1.1	26.3	1.1	37.0	16.6	0.6	29.4	26.0	11.9	19.8	13.0	21.9	18.2	9.2	12.5	19.4	24.4	3.5	8.2	17.5	28.5	21.8	8.9	3.3	3.4	22.8	28.3	15.0	8.5	52.7	9.4	12.9	19.6	4.4	21.3	15.6	21.2	7.0	11.4	25.4	0.7	14.7	20.6	9.3	14.4	6.8	32.4	18.5	11.0	38.6	9.5	1.9	47.4	55.9	36.0	43.5	107.6	73.6	87.6	68.3	73.1	43.3	58.3	30.5	100.5	4.2	178.9	99.0	85.6	27.4	12.4	53.2	74.9	27.5	9.2	6.0	34.8	78.6	109.2	62.1	100.1	75.5	24.9	80.8	75.9	102.8	116.7	8.1	10.9	32.6	44.3	14.8	2.4	24.9	20.8	18.0	22.0	5.4	37.5	21.9	44.8	42.1	2.2	10.8	62.2	30.6	53.9	49.3	31.1	28.5	182.6	60.5	28.5	78.9	52.2	67.3	84.0	9.3	63.5	32.7	61.0	13.5	8.3	20.4	4.2	5.3	1.8	1.1	1.3	2.3	4.7	0.1	1.4	2.5	37.5	4.6	2.7	0.7	1.2	3.4	1.1	1.1	0.6	29.4	3.5	8.2	3.3	3.4	9.4	0.7	14.4	1.9	54.8	86.6	49.0	115.2	19.2	63.9	51.4	61.1	39.3	7.5	27.4	31.9	51.0	41.5	47.9	46.0	12.5	41.4	29.2	53.1	15.6	69.8	16.2	73.7	73.4	61.5	16.8	16.4	37.9	45.6	99.6	103.7	32.6	179.5	15.2	95.2	58.2	68.9	47.1	0.0	43.9	30.7	12.2	59.2	53.3	9.3	57.5	65.1	69.4	155.5	52.2	17.4	39.1	115.6	31.4	78.5	44.8	54.5	283.6	67.8	16.1	35.7	33.6	11.5	52.6	89.4	69.1	2.3	3.2	18.6	33.5	34.8	23.1	26.0	26.2	88.4
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 124.2;liver: 126.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.2;Hepatocytes: 130.9;Late spermatids: 557.6;Pancreatic endocrine cells: 89.2"	"Cancer enhanced"	"Detected in all"		"glioma: 39.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.3;ASC diff: 34.7;HUVEC TERT2: 43.3;SH-SY5Y: 33.2;TIME: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (6.11e-4)"	34.5	124.2	55.4	2.9	54.6	0.0	26.2	59.8	69.0	7.5	40.3	5.9	1.1	4.2	2.7	24.9	3.8	12.2	11.7	58.9	56.0	11.4	126.9	4.6	1.1	64.6	57.5	38.3	11.9	36.5	11.2	2.5	63.6	11.8	1.8	10.4	9.0	3.2	4.1	4.9	3.4	5.4	56.2	5.4	5.6	27.3	59.2	0.4	5.9	4.0	2.8	6.0	8.0	56.1	0.0	0.3	19.9	35.3	34.7	21.2	0.3	8.1	16.3	5.8	5.0	1.6	0.6	0.0	0.9	25.9	7.5	0.0	13.3	4.9	5.0	0.0	2.2	1.7	0.1	18.7	12.9	0.0	0.2	18.2	2.3	10.0	2.0	26.0	43.3	0.0	1.9	0.0	21.3	0.0	0.0	0.1	12.4	0.0	0.7	0.0	0.0	0.0	3.4	0.0	0.3	33.2	0.2	0.0	0.3	2.6	0.1	0.0	39.7	5.4	2.4	2.1	6.3	0.0	0.0	0.0	29.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	54.6	59.8	69.0	58.9	56.0	64.6	57.5	63.6	56.2	59.2	56.1	14.8	0.0	0.5	5.2	0.8	3.4	3.2	0.4	5.7	9.1	8.3	12.8	2.4	14.3	0.2	0.0	4.2	0.2	0.4	0.0	3.9	72.9	255.2	1.6	18.8	10.9	0.0	2.7	20.1	48.3	0.2	17.3	6.1	2.0	5.7	5.9	10.0	130.9	0.5	0.0	18.7	0.5	0.0	3.2	5.3	557.6	15.5	1.0	3.6	5.6	1.0	23.7	0.0	10.6	2.1	89.2	0.0	11.7	0.7	11.9	0.0	0.4	0.2	12.9	0.0	34.4	15.6	5.0	8.4	1.4	2.4	0.0	1.5	1.0	0.1	1.7
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 323.1;tongue: 478.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 71.3;Cardiomyocytes: 64.9;Early spermatids: 28.1;Granulosa cells: 38.6;Muller glia cells: 44.1"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.3	12.8	10.5	0.1	5.8	0.2	0.8	21.6	10.0	1.4	47.6	1.3	0.8	3.3	2.4	11.6	4.1	1.8	42.2	6.7	16.8	0.7	18.4	1.1	0.2	10.5	14.7	4.6	0.5	10.4	5.2	0.5	7.6	3.6	0.5	8.0	25.5	1.0	323.1	0.4	1.3	2.0	5.3	0.2	5.2	2.7	29.6	0.6	1.2	478.4	0.1	1.2	0.8	3.3	0.0	0.1	1.1	0.4	0.0	1.2	0.2	0.5	0.1	0.7	0.1	0.9	0.3	0.2	0.8	0.4	0.2	0.1	4.7	0.1	0.1	0.1	0.3	0.1	0.4	0.2	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.1	0.8	0.1	0.1	0.1	1.4	0.0	0.1	0.6	48.2	0.3	0.0	0.1	6.9	1.1	0.5	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.8	2.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	5.8	21.6	10.0	6.7	16.8	10.5	14.7	7.6	5.3	29.6	3.3	1.1	0.0	0.0	7.5	0.0	0.1	0.2	0.0	0.0	71.3	0.6	0.5	64.9	0.0	0.0	1.8	4.2	0.0	0.0	0.0	1.9	0.0	28.1	0.3	4.6	1.4	0.0	0.0	10.3	0.0	0.0	14.5	0.0	0.5	0.0	38.6	0.7	2.0	0.9	0.0	15.8	0.1	0.0	0.0	0.5	5.9	5.3	0.8	0.0	5.6	0.0	44.1	0.0	3.0	0.7	0.1	0.0	5.7	0.0	0.2	0.1	0.2	0.0	7.4	0.0	12.9	1.7	0.5	1.0	0.0	0.0	0.3	0.2	0.5	0.5	0.1
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712908-108742749	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 4.6;Late spermatids: 1.5;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.8	0.4	1.1	1.3	0.6	0.7	0.4	0.5	0.2	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.6	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.8	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1
FNDC8	DKFZp434H2215	ENSG00000073598	"Fibronectin type III domain containing 8"	Q8TC99	17	35121615-35130732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	474	"testis: 89.0"	"Group enriched"	"Detected in some"	73	"Early spermatids: 592.7;Late spermatids: 2294.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;JURKAT: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026521, HPA059803"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA026521: AB_2106163, HPA059803: "	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.10e-1)"		"unprognostic (5.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (9.02e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.7	0.3	0.7	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.7	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	592.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2294.8	7.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	7.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FNIP1	KIAA1961	ENSG00000217128	"Folliculin interacting protein 1"	Q8TF40	5	131641714-131797063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 398.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068099, HPA071213"	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA068099: AB_2685952, HPA071213: AB_2686362"	"unprognostic (1.91e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.41e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.13e-3)"	"unprognostic (4.47e-1)"	10.1	8.4	8.2	6.6	16.5	15.9	8.8	9.9	13.2	8.7	4.8	7.0	8.1	9.2	6.9	6.1	7.2	8.1	8.9	9.0	8.6	7.5	12.1	8.4	6.2	10.3	11.0	12.9	6.7	12.8	5.6	7.6	12.4	8.2	6.4	7.1	6.5	5.2	13.2	8.2	7.0	7.4	9.8	7.0	7.4	13.8	10.2	5.7	10.4	14.2	6.1	7.3	6.8	30.2	10.8	9.2	6.7	19.1	23.1	16.2	11.7	12.1	21.4	13.9	22.5	11.9	10.7	8.5	7.9	14.6	43.0	8.8	7.9	9.9	19.7	11.9	5.7	21.3	9.7	7.4	15.6	4.1	39.7	18.7	12.8	15.4	25.9	11.6	6.7	9.9	9.3	19.1	17.3	3.5	8.5	10.8	4.0	3.2	4.3	7.2	14.2	5.5	8.3	18.1	6.8	7.4	10.7	5.8	17.6	11.1	11.1	14.6	12.2	23.4	10.7	20.5	10.7	17.9	17.8	8.4	19.3	11.3	13.3	7.2	3.0	3.9	2.0	3.4	2.2	3.5	2.1	1.9	1.8	2.7	2.2	2.6	16.6	2.7	3.1	1.8	2.2	1.3	8.2	16.5	9.9	13.2	9.0	8.6	10.3	11.0	12.4	9.8	10.2	30.2	36.1	6.4	26.9	108.7	55.2	36.7	68.3	9.0	33.6	46.3	53.7	28.8	31.2	41.5	11.9	11.0	98.0	26.1	55.3	26.2	3.9	34.5	11.6	33.7	43.9	37.8	31.3	38.3	142.3	26.4	36.5	49.7	56.1	41.9	24.6	30.7	41.7	32.1	49.3	45.4	153.1	18.6	16.2	70.6	44.0	9.1	60.9	72.3	44.4	105.9	57.9	35.6	46.4	126.7	398.7	29.6	32.7	44.4	29.6	71.2	80.1	17.8	9.3	54.6	6.6	58.3	35.7	84.8	43.9	22.9	31.1	69.2	41.7	32.9	26.5	72.3
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769026-158908050	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.3;myeloid DC: 2.1;non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 179.0;U-266/70: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200"	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	26.3	7.7	6.7	10.1	13.2	8.9	12.1	6.5	12.8	12.7	4.4	21.8	7.4	11.1	9.3	14.5	8.0	20.4	25.3	12.3	8.3	47.8	58.3	24.9	7.7	10.3	10.1	10.7	19.4	15.9	3.2	30.1	8.8	10.8	22.3	8.8	13.9	11.3	11.4	10.1	9.3	17.9	7.3	13.3	22.8	10.0	22.5	7.2	18.5	20.0	5.5	13.6	5.2	18.6	4.0	4.5	19.2	10.1	14.1	8.9	21.0	8.6	9.1	8.7	9.8	5.3	4.0	0.2	2.1	31.2	10.7	3.7	18.4	8.9	10.5	179.0	6.6	18.7	2.5	7.3	8.8	7.9	36.0	6.5	7.3	5.9	7.7	12.8	9.9	9.8	11.4	0.8	14.6	1.3	18.4	1.0	6.1	12.7	4.6	10.8	9.5	5.1	7.0	10.2	12.3	10.9	4.7	3.2	19.5	6.1	4.0	4.3	12.5	14.0	8.7	9.6	6.5	57.3	26.0	3.8	13.9	9.5	10.0	0.4	0.7	0.2	0.5	3.3	0.3	0.0	0.3	0.2	2.1	0.0	0.2	0.6	0.1	0.6	7.2	0.4	0.1	0.4	6.7	13.2	6.5	12.8	12.3	8.3	10.3	10.1	8.8	7.3	22.5	18.6	93.7	19.2	129.2	20.9	6.5	35.6	30.9	7.2	14.2	17.7	18.4	16.4	55.4	58.6	23.2	40.5	54.2	13.1	17.8	80.9	23.5	38.5	17.6	51.6	13.8	78.1	62.4	25.4	109.0	79.9	7.4	35.1	30.1	82.0	27.9	15.7	95.3	114.7	65.4	10.1	95.5	44.9	8.2	90.6	288.0	9.9	13.4	101.5	40.9	64.6	28.4	4.9	11.3	56.8	151.8	80.5	77.2	9.8	5.4	55.7	11.1	72.9	15.3	27.9	52.6	72.3	34.0	25.8	22.8	13.6	36.8	8.2	13.0	10.4	46.8	41.2
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	53.6	33.4	57.7	26.3	69.3	26.8	46.1	74.0	74.0	41.3	52.7	46.3	35.9	34.0	43.2	45.4	33.4	27.1	48.1	54.2	63.7	37.4	47.2	34.7	45.5	75.1	64.8	33.0	43.9	34.3	36.6	50.0	73.6	38.3	32.5	33.8	36.5	34.1	74.3	51.0	32.9	31.4	73.2	36.7	35.4	26.9	61.9	39.9	31.6	64.7	44.2	40.9	43.1	87.6	78.8	37.5	50.9	16.7	88.6	112.5	43.4	44.9	52.4	50.1	46.3	62.1	56.9	88.5	35.5	54.1	67.6	41.9	63.1	71.5	59.4	26.2	42.2	70.9	25.5	54.2	112.7	30.4	35.8	87.6	119.0	36.3	104.2	74.4	89.4	47.9	86.1	50.4	58.5	9.9	72.3	47.1	91.3	66.4	27.1	63.1	83.0	47.8	70.5	58.4	29.7	47.4	56.6	47.3	78.9	59.1	59.1	55.3	69.9	17.9	22.1	68.6	48.0	47.7	46.2	89.2	43.0	56.4	41.3	3.1	7.7	14.3	9.5	10.7	11.3	14.1	9.7	12.6	13.3	15.2	12.9	12.9	4.3	16.1	7.8	12.6	14.3	6.4	57.7	69.3	74.0	74.0	54.2	63.7	75.1	64.8	73.6	73.2	61.9	87.6	68.7	57.7	20.3	33.0	57.4	87.7	82.3	55.3	58.1	22.5	35.5	34.8	44.9	34.3	41.2	33.1	37.5	135.6	69.1	29.6	70.5	73.0	41.2	40.7	55.1	55.8	32.2	38.9	27.9	70.1	124.4	58.7	28.5	46.2	32.4	58.6	56.0	25.9	80.5	20.2	31.9	39.6	34.6	47.5	60.7	52.8	48.1	49.2	94.3	33.7	75.7	42.8	69.0	25.6	79.8	69.4	41.2	60.2	40.8	109.3	67.0	54.8	46.7	57.5	52.6	56.2	47.2	65.9	37.1	73.9	95.6	207.6	60.4	69.6	49.1	76.6
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986895-65062652	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA062743	Uncertain		Approved	Centrosome		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Centrosome		"HPA062743: AB_2684861"	"unprognostic (2.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (6.21e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-3)"	8.7	8.7	15.9	5.1	30.2	2.9	7.8	40.7	20.1	7.7	13.5	6.5	5.9	6.6	8.4	13.3	9.5	5.9	12.9	14.5	20.7	8.2	5.8	6.7	5.7	55.0	34.2	7.3	5.6	13.0	7.0	8.7	46.5	9.1	7.7	6.1	9.2	9.3	18.1	11.8	5.2	11.6	36.7	4.7	5.5	9.5	30.7	6.5	5.8	19.7	8.3	7.6	8.9	70.0	37.1	31.9	20.4	12.5	13.9	11.9	14.6	20.2	14.7	22.4	23.0	15.9	14.6	6.0	12.0	21.1	13.2	24.1	47.5	15.1	18.3	9.0	15.9	23.2	8.0	28.1	9.0	8.3	32.2	9.7	14.3	9.4	5.7	22.4	19.1	10.9	13.7	8.4	13.1	30.9	13.3	22.6	8.4	23.1	29.9	12.2	17.6	7.6	16.2	15.7	12.0	13.5	11.9	24.4	30.2	15.9	22.7	14.0	15.2	16.2	34.7	8.4	14.2	5.7	5.6	6.6	18.3	10.3	39.4	21.9	12.8	11.5	3.8	9.9	9.6	2.5	6.2	5.1	7.4	1.7	4.7	3.7	3.4	4.0	5.1	5.8	6.2	7.4	15.9	30.2	40.7	20.1	14.5	20.7	55.0	34.2	46.5	36.7	30.7	70.0	3.9	12.8	2.2	0.0	1.6	2.4	3.5	4.3	2.8	4.6	6.2	6.6	8.3	2.8	5.6	3.7	2.1	15.9	2.4	4.3	0.0	6.6	9.2	3.9	3.0	4.5	7.7	7.8	0.0	4.8	15.3	4.9	4.1	4.8	0.0	12.7	5.0	8.0	8.1	5.0	0.0	5.9	6.1	8.1	2.5	6.0	5.6	15.7	5.4	0.0	7.5	7.6	2.1	0.0	0.0	4.2	1.9	8.6	2.1	4.7	4.0	6.0	4.0	4.1	19.7	5.1	5.5	2.7	4.7	6.7	3.7	8.2	2.5	7.3	5.3	3.3
FO681492.1		ENSG00000277758	Synaptotagmin-15		10	47749758-47763592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 11.3;lung: 12.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 68.9"									"HPA036971, HPA036972, HPA064559"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-5)"	"unprognostic (4.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.11e-2)"	2.7	0.7	2.1	1.2	2.4	0.1	2.2	0.0	11.3	2.3	0.0	0.8	0.3	1.3	0.5	2.5	2.1	1.1	1.3	5.0	0.0	0.5	0.4	12.2	3.7	0.0	0.0	0.7	4.1	0.8	0.3	2.5	0.0	1.1	0.6	0.5	1.8	1.3	0.6	3.2	0.8	0.9	0.2	0.9	0.6	0.3	0.2	0.8	1.1	0.6	1.9	1.1	2.0	1.0	0.4	4.1	0.4	0.5	0.2	0.3	0.2	2.8	0.4	0.3	0.3	4.5	4.0	0.1	0.3	2.2	1.3	0.5	0.0	0.1	0.4	0.1	1.6	0.0	0.8	0.4	3.9	0.3	0.8	0.4	0.2	0.3	0.7	0.4	0.3	1.9	0.1	0.4	0.2	7.6	0.2	0.6	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.2	0.6	0.2	5.2	68.9	0.2	0.2	5.4	0.3	0.5	0.3	0.7	0.3	0.2	0.3	0.3	0.2	0.4	0.1	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	11.3	5.0	0.0	0.0	0.0	0.0	0.2	0.2	1.0	0.1	3.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOCAD	"FLJ20375, KIAA1797"	ENSG00000188352	Focadhesin	Q5VW36	9	20658309-20995955	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"choroid plexus: 154.6"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 529.1;Inhibitory neurons: 314.2;Oligodendrocyte precursor cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055015	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA055015: AB_2682673"	"unprognostic (3.05e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.25e-4)"	"unprognostic (3.69e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.64e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.09e-8)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-2)"	7.3	19.4	15.0	6.1	14.7	5.2	7.7	12.7	21.9	8.5	154.6	9.5	4.5	9.0	11.2	8.9	13.2	5.2	12.5	23.0	20.6	9.5	4.9	8.6	5.3	10.7	8.1	7.4	12.8	12.3	25.1	8.3	10.5	10.5	10.4	7.1	11.9	7.1	11.2	8.5	6.4	9.0	5.2	6.2	8.2	7.7	15.8	14.5	20.4	11.8	6.2	7.3	7.7	17.5	32.8	22.2	23.7	17.8	21.7	24.7	12.5	19.1	30.2	13.3	15.1	14.8	11.0	13.4	9.9	27.4	11.1	11.2	20.8	37.8	23.0	59.8	15.4	10.5	25.3	18.5	11.2	17.5	13.0	22.9	25.5	13.2	21.6	18.5	51.3	11.1	0.3	19.2	22.3	12.6	13.3	33.0	18.7	17.4	22.2	0.1	10.7	9.0	20.6	13.9	15.7	7.9	12.6	21.3	5.2	31.5	13.3	10.2	31.7	0.1	8.7	14.7	17.5	4.7	28.3	15.0	0.0	24.3	8.0	6.8	1.6	4.9	2.9	3.3	3.8	1.5	2.5	2.8	4.0	2.6	2.2	2.7	1.2	2.7	1.9	1.6	2.6	1.7	15.0	14.7	12.7	21.9	23.0	20.6	10.7	8.1	10.5	5.2	15.8	17.5	7.0	9.6	14.7	85.8	5.2	2.9	2.8	4.5	6.8	5.8	5.8	5.1	14.9	4.3	8.6	16.5	4.2	4.7	4.1	7.9	1.9	8.1	16.6	21.2	6.7	6.0	17.5	5.5	529.1	8.6	7.6	8.7	12.8	6.8	5.1	13.9	9.7	4.0	5.1	11.8	314.2	10.1	10.2	4.4	3.5	5.0	5.0	5.3	8.8	74.9	2.8	7.9	2.1	140.8	59.0	8.9	3.4	3.8	10.7	5.8	2.5	4.8	25.0	4.0	6.6	11.2	6.7	13.7	7.5	11.2	3.7	3.3	5.7	7.0	10.4	3.0
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 266.4;prostate: 76.0"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.8	1.1	17.3	0.9	37.3	0.7	4.8	27.1	27.7	1.9	7.9	0.7	266.4	1.7	0.9	1.5	3.5	10.2	0.5	18.3	22.4	13.5	35.5	1.3	0.9	32.7	28.4	1.0	0.3	0.2	0.0	0.3	31.5	76.0	0.5	4.0	52.8	0.6	0.2	1.7	82.9	1.0	24.1	2.4	1.1	0.8	31.1	0.1	1.0	0.2	0.6	1.4	0.3	59.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.3	37.3	27.1	27.7	18.3	22.4	32.7	28.4	31.5	24.1	31.1	59.3	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278826-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 504.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 504.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 453.1;OE19: 170.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 80.9;spinal cord: 235.3"	HPA018531	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	1136.1	735.7	62.9	576.0	87.2	2270.6	477.4	184.8	113.1	700.5	111.5	479.5	235.3	410.4	58.4	1250.8	1777.3	1160.0	513.1	58.9	190.7	266.1	308.8	486.9	449.9	145.1	84.0	1188.7	298.4	264.7	452.3	417.4	92.0	791.1	627.4	233.3	555.6	462.3	99.1	1645.4	584.5	964.3	100.6	178.0	525.6	87.2	104.4	424.2	1007.6	1014.2	26.8	946.5	346.6	121.7	2.2	1.4	7.1	10.4	59.9	18.3	42.1	6.4	2.4	4.5	3.2	4.4	12.6	0.6	1.8	43.5	42.6	3.0	3.6	74.7	1.1	1.2	1.1	1.0	21.9	1.9	27.6	2.6	42.8	44.3	453.1	3.9	27.4	6.2	2.7	9.2	2.0	19.7	1.2	26.1	0.9	12.9	7.4	170.9	2.5	2.0	1.4	23.8	18.8	20.4	52.4	3.6	9.8	85.9	39.8	21.8	1.4	9.2	6.3	0.4	5.7	3.7	2.0	52.4	61.2	9.6	2.9	8.0	5.7	38.3	81.0	89.5	0.3	20.1	0.4	0.3	0.2	0.7	69.6	0.2	0.2	0.1	504.8	4.6	2.5	1.5	0.4	27.7	62.9	87.2	184.8	113.1	58.9	190.7	145.1	84.0	92.0	100.6	104.4	121.7	3911.0	1102.6	1859.4	137.1	1015.9	859.7	1644.7	1577.5	4336.7	106.1	3184.1	2874.6	1027.6	1416.9	752.7	191.3	129.3	1506.7	1323.5	1648.6	17.6	690.9	17.4	1834.4	3720.3	1624.0	1628.0	290.5	4.9	528.1	2694.6	4146.8	2049.5	3656.5	1630.6	751.3	1317.2	207.2	1693.8	35.3	3.0	1967.2	793.5	2600.2	1540.4	53.5	943.8	2910.7	855.6	58.1	269.5	1119.5	10.3	6.0	1.8	383.5	1507.8	178.3	1256.1	1115.7	1675.1	20.0	354.4	406.9	1209.6	3390.9	2705.7	10.0	10.5	2438.0	1092.4	2283.3	1497.0	417.4	1366.2	298.4
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 17.5;liver: 64.6;pancreas: 48.2;stomach 1: 36.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	1.4	0.0	17.5	10.6	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.8	64.6	0.3	0.1	0.0	0.0	0.0	48.2	1.1	0.0	0.0	0.0	0.5	17.1	0.0	2.1	0.4	0.0	0.0	12.8	0.7	0.0	0.0	36.8	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
FOXB2	bA159H20.4	ENSG00000204612	"Forkhead box B2"	Q5VYV0	9	77019655-77020953	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	64	"brain: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.6"	"Region enriched"	"Detected in some"	4	"hypothalamus: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 1.3"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.3;hypothalamus: 6.5;medulla oblongata: 2.8;midbrain: 2.8;spinal cord: 5.1"	HPA067947	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"				"HPA067947: AB_2685930"										"unprognostic (2.02e-1)"		"unprognostic (8.58e-2)"			"unprognostic (2.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	6.3	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63322567-63325128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 5.4"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.4"	"Group enriched"	"Detected in some"	13	"olfactory bulb: 8.6;spinal cord: 2.2"	CAB022455	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"			"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.8	0.0	5.2	0.2	0.2	0.0	0.4	0.4	0.1	1.6	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.1	0.2	0.1	0.0	0.1	0.0	0.4	1.4	0.2	0.0	0.4	0.5	1.4	0.6	1.3	0.1	0.2	0.0	1.1	1.5	0.0	0.0	0.2	0.2	0.0	1.5	1.5	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.7	0.0	11.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.0	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.0
FOXD4	"FKHL9, FOXD4a, FREAC5"	ENSG00000170122	"Forkhead box D4"	Q12950	9	116231-118417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;monocytes: 2.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 4.3"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.46e-2)"	"unprognostic (2.52e-4)"	"unprognostic (3.66e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-3)"	0.2	0.4	0.4	0.1	0.4	0.0	0.1	0.9	0.7	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.2	0.0	0.1	0.5	0.4	0.6	0.2	0.3	0.1	0.6	0.3	0.2	0.5	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.3	0.4	0.3	1.1	0.5	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.6	0.1	1.8	0.1	0.1	0.0	0.1	0.4	0.0	1.8	0.3	0.0	0.0	0.0	0.4	0.1	0.1	1.8	1.5	0.0	0.2	0.2	0.1	1.5	0.9	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.6	0.8	0.0	0.6	0.1	1.0	0.0	0.2	0.8	0.1	0.5	0.2	0.4	1.0	0.9	0.7	0.5	0.3	0.0	0.1	0.5	4.3	0.3	0.5	0.5	0.3	0.6	0.1	0.2	0.5	0.4	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.7	0.5	0.4	0.6	0.3	0.5	0.3	0.5	0.4	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.6	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.0
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68305084	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enriched"	"Detected in single"	5	"monocytes: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.2;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.2	1.6	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L4	"bA460E7.2, FOXD4L2"	ENSG00000184659	"Forkhead box D4 like 4"	Q8WXT5	9	65736555-65738784	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (6.92e-2)"	"unprognostic (5.48e-2)"			"unprognostic (5.19e-2)"						"unprognostic (7.78e-2)"		"unprognostic (7.93e-3)"	"unprognostic (7.14e-2)"				0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	1.1	1.2	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L5	bA15J10.2	ENSG00000204779	"Forkhead box D4 like 5"	Q5VV16	9	65282101-65285209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.26e-2)"	"unprognostic (6.95e-3)"									"unprognostic (1.58e-1)"			"unprognostic (5.76e-2)"	"unprognostic (2.57e-1)"			0.1	0.2	0.4	0.0	0.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.2	0.9	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.5	0.5	0.3	0.2	0.0	0.5	0.8	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.9	0.3	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.2	0.6	0.2	0.2	0.4	0.4	0.8	0.2	0.1	0.0	0.5	0.2	1.1	0.1	0.1	0.6	0.3	0.3	0.2	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.9	1.2	1.0	0.0	0.6	0.2	0.6	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FOXD4L6		ENSG00000273514	"Forkhead box D4 like 6"	Q3SYB3	9	41126435-41128681	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.5;hippocampal formation: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (2.41e-1)"			"unprognostic (3.41e-1)"									"unprognostic (3.61e-1)"				0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141245	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 43.4;choroid plexus: 80.1;fallopian tube: 53.2"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 29.9;CAPAN-2: 25.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 43.1"	HPA005714	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA005714: AB_1078902"	"prognostic favorable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.0	0.0	12.2	0.1	12.7	0.3	0.0	13.0	10.8	6.6	80.1	0.6	0.3	2.2	0.5	0.3	53.2	0.0	0.0	14.6	18.3	3.4	0.0	10.4	0.0	36.7	43.4	0.2	0.9	0.0	2.2	0.0	25.2	0.5	0.2	0.4	0.1	2.5	0.4	0.8	0.2	0.0	23.3	0.0	0.5	16.7	22.6	0.2	3.0	0.0	0.0	0.9	0.1	14.9	0.0	0.5	1.7	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	3.1	25.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.2	12.7	13.0	10.8	14.6	18.3	36.7	43.4	25.2	23.3	22.6	14.9	2.2	9.6	3.1	1.0	2.3	0.8	1.0	4.4	0.0	0.4	5.6	4.2	0.9	1.5	12.0	9.2	4.2	0.2	4.8	1.0	0.0	0.6	21.4	234.7	4.5	0.7	1.8	3.0	0.0	0.0	0.6	1.6	4.1	10.7	1.3	0.1	0.4	0.0	0.1	0.0	0.1	3.2	4.1	0.6	0.0	19.1	0.3	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.8	0.4	1.3	0.5	0.2	3.5	124.0	8.7	0.0	1.8	3.5	20.7	2.0	0.8	0.9	0.3	3.5	1.1	2.3	0.7
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682295-4771442	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	6.3	11.3	6.9	4.2	7.1	9.5	5.7	1.4	8.9	7.1	0.0	9.8	3.0	9.1	2.1	7.5	7.6	2.3	7.5	9.2	5.2	6.0	4.8	8.6	4.0	9.2	6.6	7.7	6.5	2.7	12.5	3.0	7.6	5.9	2.6	3.6	4.6	4.0	11.0	9.7	5.8	4.8	5.9	6.3	6.3	9.2	8.7	4.0	4.9	4.8	3.4	6.9	7.4	7.5	11.8	14.8	9.4	18.6	9.0	6.8	11.6	5.3	4.6	3.7	4.2	14.8	13.0	19.9	6.0	8.5	11.9	18.9	10.2	12.9	3.7	5.8	6.3	9.4	16.1	8.4	8.8	11.7	10.3	13.0	7.1	8.9	12.3	6.0	7.2	7.5	20.5	4.3	4.5	13.5	4.5	20.9	14.1	4.8	7.4	16.7	9.4	12.7	5.4	17.2	8.4	10.6	8.0	17.2	6.2	7.2	9.6	15.4	22.4	6.4	20.1	10.0	11.4	11.9	10.5	12.9	8.6	13.4	10.3	0.9	0.9	0.4	1.7	1.6	2.5	1.2	1.7	1.7	1.1	1.1	1.8	1.8	0.5	1.6	1.6	0.9	0.9	1.4	6.9	7.1	1.4	8.9	9.2	5.2	9.2	6.6	7.6	5.9	8.7	7.5	15.7	32.1	17.5	25.5	16.8	33.4	15.2	31.9	12.0	18.0	15.7	15.2	12.9	8.6	14.4	14.7	22.9	13.6	26.0	11.4	5.9	10.6	44.7	17.8	20.4	17.2	13.1	3.6	42.0	15.2	4.0	18.6	9.7	25.1	7.6	29.5	16.1	11.6	10.6	23.5	35.2	11.3	12.2	17.5	17.9	113.2	19.3	11.4	16.0	30.9	21.4	10.3	54.6	25.1	58.2	19.7	9.6	28.6	6.0	29.1	8.1	15.5	14.7	13.9	19.7	17.6	25.3	19.1	20.4	15.3	50.0	4.0	19.3	17.9	17.9	21.5
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	14.0	24.0	10.7	12.6	13.2	8.0	12.1	14.7	16.3	14.2	1.2	18.1	9.3	19.7	9.8	20.2	13.2	10.0	17.1	12.4	10.5	12.7	13.1	14.2	12.5	5.8	7.1	14.7	15.4	20.0	17.7	15.7	6.3	13.3	9.4	11.6	12.1	12.5	43.0	18.8	12.1	16.4	3.0	11.6	14.7	28.1	9.4	18.4	15.4	28.4	11.9	15.5	13.4	12.7	48.4	50.4	46.3	50.9	26.2	28.5	31.0	27.6	31.6	47.4	47.9	49.1	30.1	40.7	19.6	34.4	52.3	27.6	49.7	32.0	44.4	28.3	47.9	42.3	32.7	49.4	41.0	47.3	27.2	27.2	57.2	50.4	56.8	29.2	48.9	43.7	57.7	40.7	26.3	28.8	81.8	30.4	26.5	39.7	38.2	53.0	39.4	34.2	21.7	40.1	76.2	56.1	27.4	69.0	65.1	48.8	48.7	54.3	38.3	62.2	43.2	42.2	56.6	46.7	45.1	53.5	33.4	39.0	33.4	1.5	1.0	1.2	1.4	0.7	1.1	1.5	1.1	1.4	1.2	1.0	0.8	0.9	0.1	1.6	0.9	2.0	1.3	0.6	10.7	13.2	14.7	16.3	12.4	10.5	5.8	7.1	6.3	3.0	9.4	12.7	21.5	51.3	27.1	23.5	11.5	37.2	8.0	10.6	10.2	19.2	17.7	15.7	19.5	7.2	16.2	14.7	12.5	11.9	19.3	15.6	3.9	8.7	15.6	19.4	22.4	14.9	10.9	7.8	44.6	10.7	8.8	13.2	14.3	26.7	2.5	22.1	10.8	13.4	20.0	47.1	39.6	12.6	8.2	17.3	22.0	24.1	9.3	19.2	12.4	20.6	13.9	12.3	6.2	33.2	49.1	11.4	12.4	13.2	13.3	13.6	12.2	7.1	13.9	16.7	0.0	19.8	16.6	15.0	10.3	17.0	43.0	9.7	11.6	30.6	13.0	10.7
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947137	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 208.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069613	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	2.6	1.0	0.0	0.8	0.0	0.0	0.6	0.8	12.8	0.3	0.0	0.0	7.3	0.4	0.0	11.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.8	0.8	44.8	0.1	12.5	10.0	0.1	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.8	0.0	0.0	0.7	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.7	4.9	1.8	0.2	3.4	0.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.3	0.0	2.2	5.6	0.2	1.1	0.0	0.0	0.1	0.0	0.0	8.1	0.9	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.0	1.1	0.0	0.0	8.4	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.6	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.6	0.8	0.6	0.6	0.8	0.8	0.8	0.8	1.2	0.7	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	41.8	1.6	0.0	0.0	0.0	0.2	0.3	20.9	0.0	1.0	0.0	208.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.2	1.8	1.4	0.0	1.0	0.0	0.3	48.4	0.0	0.0
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857680-2877174	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.9	1.1	0.4	9.4	0.5	25.0	1.8	0.8	0.8	1.7	0.2	10.5	9.7	1.7	0.2	11.1	0.8	1.5	0.5	0.8	0.3	0.7	1.2	1.8	11.3	0.4	0.9	0.3	0.4	0.4	0.1	6.1	0.6	0.7	12.5	1.1	1.9	0.8	0.6	6.4	8.8	7.5	0.1	3.1	5.2	21.4	1.0	32.2	0.9	0.3	15.2	3.0	3.2	0.6	133.0	129.5	101.3	92.2	14.2	19.0	129.2	84.0	80.4	165.2	147.2	166.9	114.8	84.5	17.7	119.8	188.5	100.2	153.1	76.1	160.0	159.8	80.3	94.7	121.6	71.6	2.0	79.2	75.0	9.9	8.3	154.4	106.1	39.1	117.8	96.8	55.6	184.9	130.5	122.6	108.3	36.8	225.6	136.1	95.4	77.3	149.8	44.1	38.1	82.7	56.3	89.1	106.7	90.4	46.6	189.4	87.1	87.8	48.0	134.3	200.5	160.4	300.4	24.7	44.3	122.1	63.1	74.3	147.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.8	0.8	0.8	0.3	0.4	0.9	0.6	0.1	1.0	0.6	0.1	0.0	1.3	0.7	2.4	2.9	1.3	1.0	1.2	2.0	1.7	1.3	0.5	1.5	0.8	1.8	4.2	7.1	0.8	6.6	1.9	0.2	22.4	1.2	2.1	2.5	0.0	18.7	1.1	0.0	18.2	3.2	10.2	2.4	0.0	15.4	3.6	0.8	9.1	5.0	0.6	7.5	2.0	4.2	1.2	25.5	0.9	2.4	0.0	0.0	1.1	0.6	1.0	0.5	1.0	0.3	0.3	0.7	19.9	1.0	1.4	0.4	0.2	4.0	0.0	1.2	3.0	15.0	9.9	10.2	1.4	1.9	3.3	0.9	12.9	1.9
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379295	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0;brain: 53.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.9	5.5	13.3	15.4	30.3	54.0	8.0	25.3	19.0	7.7	4.2	7.7	8.3	6.7	4.2	9.3	5.5	9.7	8.6	13.9	16.3	6.6	19.8	9.5	19.4	24.1	21.0	5.9	8.9	9.5	3.0	13.4	21.9	5.0	8.0	3.4	5.5	4.2	4.8	3.6	10.3	9.8	20.0	18.1	7.9	6.3	19.2	14.9	6.9	6.4	17.1	10.6	3.9	53.3	13.1	19.5	22.2	19.6	17.2	12.7	24.3	14.4	15.8	11.9	13.2	17.3	15.9	28.4	18.7	17.0	14.5	16.2	13.7	16.5	17.2	22.3	11.7	56.1	13.3	17.4	30.0	30.9	42.1	11.4	6.9	12.9	22.3	9.6	12.8	11.6	26.6	32.7	19.5	10.1	34.4	20.3	16.8	9.8	10.2	17.0	46.5	23.2	10.2	16.5	12.4	12.6	6.9	13.2	24.9	7.5	5.7	18.0	15.0	16.0	16.1	15.2	15.2	17.8	14.2	40.5	13.9	27.5	22.2	120.9	32.4	129.6	24.0	26.2	27.4	21.2	23.1	22.4	33.6	20.6	17.2	17.7	40.8	25.7	36.4	20.8	28.8	17.2	13.3	30.3	25.3	19.0	13.9	16.3	24.1	21.0	21.9	20.0	19.2	53.3	22.1	0.0	7.4	66.6	31.3	15.6	27.5	10.0	15.4	6.7	5.4	5.6	11.1	14.3	6.1	1.8	0.0	6.7	28.3	7.0	5.9	6.0	4.8	8.9	17.2	21.8	2.4	22.5	28.1	5.4	32.1	13.3	14.3	13.3	22.8	1.2	20.7	19.7	17.9	13.5	25.2	8.0	8.2	39.5	47.3	4.7	12.2	44.4	12.4	35.6	44.1	7.8	26.8	152.3	282.0	11.0	7.1	11.3	31.0	35.2	11.3	4.8	3.3	3.6	6.6	17.8	27.4	22.7	13.1	11.9	21.2	16.6	38.3	2.8	8.9	35.9
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.2;U-266/84: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	46.5	27.0	17.8	23.6	17.9	83.7	22.8	76.2	15.1	24.9	33.4	28.8	36.7	26.5	9.2	39.4	23.2	22.9	38.2	12.2	15.8	12.8	30.8	23.9	29.1	20.5	18.3	50.6	24.8	46.9	5.1	22.7	21.5	20.2	21.8	16.5	18.4	22.1	79.6	41.4	35.2	35.1	19.3	21.6	29.0	16.8	21.5	41.6	9.5	72.6	30.9	25.5	20.6	18.3	0.5	7.7	19.7	11.3	78.1	24.8	14.2	15.7	15.4	13.8	22.7	7.8	6.3	24.0	7.8	25.0	9.5	5.6	33.5	22.3	20.4	109.2	6.2	8.3	14.6	25.0	25.3	16.6	14.1	59.4	12.6	1.3	9.4	16.6	30.2	34.1	10.0	69.0	22.9	9.4	32.2	16.6	21.2	14.2	13.8	51.4	67.0	22.8	1.7	26.6	10.7	35.1	23.0	21.9	6.4	64.8	12.8	45.3	55.0	23.5	32.1	23.6	23.6	58.4	112.6	44.6	8.5	28.2	13.8	48.8	23.8	35.8	41.9	25.7	33.3	13.5	27.8	35.9	35.2	16.4	35.8	34.6	9.6	32.2	17.3	7.9	35.9	31.2	17.8	17.9	76.2	15.1	12.2	15.8	20.5	18.3	21.5	19.3	21.5	18.3	108.7	32.1	33.9	229.5	65.4	89.3	22.4	27.4	41.5	123.2	21.0	21.7	103.2	47.1	53.4	9.2	0.0	36.9	105.9	37.2	21.5	11.5	86.2	38.8	36.3	67.3	59.3	52.5	125.6	20.9	21.3	75.2	45.9	36.4	12.7	112.4	55.6	92.9	43.5	79.1	195.2	37.5	30.5	100.3	174.9	38.5	96.3	87.9	32.0	517.2	65.3	38.6	94.7	291.6	143.8	15.5	32.1	85.4	71.3	16.8	77.4	12.2	16.0	9.9	39.5	133.6	57.9	4.3	11.6	51.4	147.6	29.6	85.0	37.2	46.6	29.1
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277978-109309284	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.2	1.8	0.5	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	11.4	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	2.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40555667-40666641	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 177.3;Endometrial stromal cells: 161.0;Granulosa cells: 177.9;Oligodendrocytes: 131.5;Skeletal myocytes: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;Daudi: 45.3;HSkMC: 53.6;U-698: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	43.2	9.7	11.2	13.1	16.1	13.8	27.6	10.0	10.9	19.1	16.7	13.8	5.0	39.1	6.5	13.0	25.7	14.5	13.9	9.1	11.8	11.8	38.5	16.8	23.8	14.1	12.7	65.6	16.5	5.3	7.6	11.2	12.7	10.1	9.6	3.9	9.8	10.1	91.0	18.0	10.9	27.0	10.5	15.7	9.5	8.9	11.3	11.6	19.0	22.2	24.0	13.4	17.4	14.3	0.7	1.7	12.4	0.3	40.4	7.9	11.8	1.8	2.5	0.5	0.3	3.7	3.0	45.3	8.1	1.2	1.9	10.7	9.8	5.3	0.7	20.9	10.1	0.0	1.4	10.1	19.1	0.4	1.2	53.6	35.5	0.2	6.7	2.5	31.7	3.3	0.9	14.0	3.1	1.6	0.1	0.6	18.0	6.2	3.1	32.4	14.3	3.6	22.9	5.8	2.6	0.6	1.6	8.5	1.8	14.1	1.5	1.1	18.6	0.3	2.3	0.1	1.1	7.9	3.3	57.8	1.2	2.1	5.7	0.9	0.6	0.5	1.3	0.8	1.8	3.7	3.6	2.2	0.4	5.8	5.5	4.3	2.5	1.4	1.4	0.0	5.1	1.0	11.2	16.1	10.0	10.9	9.1	11.8	14.1	12.7	12.7	10.5	11.3	14.3	57.9	0.0	4.4	177.3	29.3	29.3	19.1	13.0	27.9	3.7	12.9	17.3	11.5	10.0	9.9	9.2	12.5	0.5	22.9	27.5	0.0	11.1	7.2	55.4	161.0	50.2	52.2	3.2	7.4	18.0	3.8	40.8	18.8	118.8	1.3	177.9	84.3	47.9	6.5	5.0	23.0	21.0	8.2	14.6	26.9	4.0	18.6	18.6	12.4	117.1	18.4	5.5	8.2	47.3	131.5	19.5	16.3	13.2	32.9	10.1	7.7	8.8	9.2	9.8	6.6	131.7	31.3	6.4	14.6	25.3	26.7	0.8	40.3	64.0	12.5	13.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	46.7	11.4	14.7	13.4	15.1	68.5	43.1	34.0	19.6	28.1	19.3	21.7	12.4	23.5	15.3	35.4	25.4	28.2	18.6	14.3	9.8	16.3	23.1	30.3	12.8	17.4	15.5	43.0	86.9	30.2	8.6	21.3	13.3	20.0	17.0	28.7	25.1	11.5	84.1	30.6	16.9	21.1	11.5	18.8	22.2	11.9	17.1	18.5	18.0	51.4	15.8	23.2	27.4	17.0	21.6	6.8	9.1	20.4	41.2	48.4	16.1	17.0	17.7	13.5	19.9	11.9	19.5	11.7	14.8	20.0	22.3	15.0	12.1	20.8	20.4	12.9	18.3	32.5	6.2	9.8	47.4	8.6	24.8	56.0	43.2	29.3	40.4	19.8	10.3	10.2	21.8	94.5	26.9	12.2	9.4	12.6	6.1	10.1	11.6	12.1	32.4	48.7	30.7	16.5	23.4	59.9	12.7	11.8	16.6	18.1	12.1	27.7	18.3	24.9	12.9	13.8	20.6	0.9	16.8	13.5	13.4	16.2	16.4	7.8	2.8	6.1	3.2	1.5	3.8	0.8	1.7	2.6	1.7	1.7	1.4	2.0	15.6	3.7	5.3	2.7	1.9	1.1	14.7	15.1	34.0	19.6	14.3	9.8	17.4	15.5	13.3	11.5	17.1	17.0	88.2	44.8	46.0	112.6	41.2	67.7	73.3	34.4	91.6	63.4	64.1	46.9	31.6	71.4	44.4	25.8	70.9	25.4	41.4	86.9	17.6	50.4	19.9	91.2	41.8	55.6	66.9	246.9	102.7	30.9	36.9	105.8	46.9	105.6	15.2	46.2	84.6	77.7	46.4	52.2	99.9	55.0	20.3	85.2	83.3	17.7	106.6	96.6	56.9	160.2	55.9	78.9	22.6	108.6	133.2	73.3	44.2	100.4	83.3	122.2	28.3	21.1	57.7	68.6	32.9	236.6	81.6	9.1	17.8	61.1	46.5	41.2	37.6	30.6	34.5	184.2
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71095851-71103532	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 116.5"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 260.7;Syncytiotrophoblasts: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	6	"BEWO: 159.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA039560: AB_2676572, HPA040232: AB_2676894"	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	15.8	33.6	73.9	6.5	80.6	22.0	13.9	58.9	68.7	12.9	43.1	22.1	11.0	17.1	16.4	12.0	17.6	9.4	18.2	58.3	61.8	9.4	7.2	10.0	7.1	71.7	70.5	23.2	12.7	16.0	7.0	116.5	65.3	14.3	8.0	7.5	16.7	19.2	67.3	15.1	14.3	8.2	62.3	13.9	13.5	17.3	68.8	14.5	10.9	49.4	6.4	17.2	13.2	81.6	4.6	1.2	3.4	4.9	7.9	5.7	159.1	3.4	3.9	1.8	4.5	3.3	6.5	5.9	4.7	4.5	1.9	2.1	8.8	4.2	2.2	6.0	13.7	8.5	27.3	5.0	4.8	4.9	6.9	5.1	9.7	1.7	1.1	7.9	4.7	8.4	17.5	12.5	0.8	0.9	8.6	8.0	16.9	11.5	5.6	5.7	8.5	10.1	3.0	2.6	2.8	7.3	7.1	1.1	8.3	24.7	1.9	3.1	4.3	1.1	2.3	8.3	0.8	7.7	4.3	1.0	4.3	13.6	1.3	0.0	0.1	1.0	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.1	0.4	0.9	0.2	0.1	0.0	0.3	0.3	73.9	80.6	58.9	68.7	58.3	61.8	71.7	70.5	65.3	62.3	68.8	81.6	10.1	0.0	2.7	0.3	3.8	5.4	3.9	0.6	9.1	1.3	8.2	7.7	6.6	5.7	1.5	9.2	4.2	260.7	6.5	20.6	1.9	2.7	0.3	3.2	2.8	6.1	6.1	17.7	0.8	3.0	24.3	4.0	5.1	3.1	2.5	3.1	5.0	2.9	22.3	1.7	0.8	12.2	0.0	7.1	5.2	1.4	6.8	4.4	3.6	1.0	2.6	4.4	4.1	1.0	2.2	3.1	8.6	15.4	7.3	2.5	17.1	4.4	1.5	0.8	6.6	4.0	3.8	0.6	0.4	6.0	3.4	307.8	7.0	48.3	7.4	3.8
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70954708-71583989	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 41.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTEC/SVTERT24-B: 95.0"					"Low region specificity"	"Detected in all"			"HPA003876, CAB011501"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	16.5	3.8	5.0	20.3	41.1	38.5	14.5	0.3	12.5	11.2	9.9	28.7	12.2	15.3	6.5	23.0	14.3	21.0	12.7	7.8	0.0	7.0	13.0	22.9	22.2	3.1	6.7	32.4	16.8	6.5	9.1	13.7	0.9	21.2	23.4	2.6	29.7	9.6	8.2	10.9	15.3	22.7	0.1	17.8	20.6	14.4	6.6	26.3	14.5	11.1	25.4	21.6	14.2	8.1	9.6	8.0	16.8	13.2	8.4	21.3	8.2	26.3	30.9	22.0	17.4	51.9	11.2	31.1	4.3	12.9	17.6	6.9	31.0	22.8	40.3	7.8	11.7	13.0	17.0	52.7	20.5	25.7	31.6	21.7	10.3	95.0	42.1	18.3	36.6	15.4	13.6	36.7	10.8	42.6	11.9	9.3	19.7	7.2	39.9	38.0	30.7	4.7	18.8	30.1	14.5	27.6	32.6	7.7	1.9	15.9	5.6	21.9	47.7	34.9	14.3	48.9	42.2	9.0	7.1	41.8	22.5	35.7	7.5	46.9	15.3	15.2	18.3	13.1	19.4	58.1	38.7	22.6	13.0	62.2	60.8	40.0	27.0	22.2	25.3	21.7	35.9	28.8	5.0	41.1	0.3	12.5	7.8	0.0	3.1	6.7	0.9	0.1	6.6	8.1	158.8	73.7	121.3	130.9	266.5	183.0	170.6	58.2	176.4	30.3	98.5	115.1	42.1	148.7	72.0	33.1	18.8	47.2	122.9	118.1	31.3	79.0	156.0	116.3	48.2	184.9	271.6	111.5	391.0	95.1	12.6	90.4	95.8	128.0	219.8	117.7	184.9	72.3	49.5	6.7	139.9	231.2	154.6	117.6	209.0	89.6	42.0	101.3	37.4	414.1	120.3	15.5	116.4	184.5	286.4	124.8	102.8	24.8	66.0	178.8	91.7	19.4	83.7	42.8	92.1	102.9	119.4	13.7	33.6	111.5	101.4	52.4	168.1	33.1	157.2	146.3
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.8"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 186.8;Microglial cells: 288.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.0;RH-30: 37.3;THP-1: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.9	1.3	1.8	1.9	1.3	0.4	2.0	0.0	10.1	5.0	0.0	18.8	2.5	8.0	1.7	6.1	3.4	3.5	1.4	2.7	0.9	2.0	2.5	1.5	1.0	1.5	6.9	9.7	4.6	0.6	0.9	0.5	1.9	2.2	5.2	3.2	2.8	1.4	3.2	3.7	3.2	7.7	0.0	0.5	4.2	1.3	2.6	0.2	4.9	1.8	0.7	6.1	4.3	5.2	0.4	3.2	21.0	0.0	4.9	6.2	1.3	3.5	3.6	0.7	0.4	1.6	0.3	0.3	0.8	1.2	0.1	0.5	0.8	0.0	0.1	0.2	7.0	8.0	4.6	6.6	0.0	0.5	0.5	1.3	0.8	0.1	0.0	1.3	0.0	0.0	1.8	3.0	0.8	1.5	1.8	1.2	1.1	0.4	1.0	0.6	37.3	7.9	0.5	8.6	5.1	2.2	0.0	1.3	1.1	1.2	1.0	11.9	1.6	1.3	0.6	2.0	0.7	6.3	0.7	1.0	1.5	0.8	0.6	9.7	5.5	11.4	5.9	7.4	5.8	10.1	6.4	6.3	6.7	8.2	6.5	7.4	5.5	6.6	6.3	16.6	10.7	20.5	1.8	1.3	0.0	10.1	2.7	0.9	1.5	6.9	1.9	0.0	2.6	5.2	0.5	0.0	8.2	5.5	0.0	30.7	2.9	5.5	48.3	0.1	1.8	1.3	1.6	10.0	7.3	3.7	2.1	0.1	0.0	4.8	0.0	0.1	9.7	0.1	1.2	1.9	4.2	0.0	186.8	5.4	0.0	20.6	1.1	0.0	0.0	16.2	8.2	11.7	0.2	13.5	6.4	11.5	2.0	1.6	5.6	6.2	5.3	0.4	3.6	288.6	0.0	27.7	0.0	5.5	4.6	1.3	18.5	0.7	0.6	2.3	8.6	3.8	11.3	1.3	0.0	25.5	1.7	2.4	1.4	25.3	25.6	0.3	0.3	4.2	11.5	4.0
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250438-49270477	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lymphoid tissue: 7.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	11	"T-reg: 53.3"	"Lineage enriched"	"Detected in single"	394	"T-cells: 53.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.2	0.2	0.9	7.4	0.7	1.3	0.7	1.5	0.8	0.4	0.0	0.6	0.7	0.2	7.2	1.2	0.2	1.6	0.2	0.8	0.6	0.3	2.4	0.9	6.1	0.7	0.7	0.4	0.2	0.4	0.5	0.1	0.8	0.6	0.7	0.7	1.1	0.8	0.3	2.3	1.9	0.3	0.5	2.4	1.6	1.3	0.8	7.2	0.6	0.1	5.2	2.8	0.3	0.7	0.1	0.3	0.2	0.9	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.8	0.2	0.6	0.3	0.5	0.6	0.3	0.8	0.0	0.1	2.9	0.5	0.2	0.3	0.2	0.4	0.3	0.4	0.1	0.8	0.9	1.7	0.0	0.0	0.9	0.9	0.7	0.0	5.2	0.1	0.3	0.8	0.1	0.7	0.4	0.3	0.2	0.2	0.2	0.6	0.5	4.7	0.5	2.0	0.5	1.5	0.8	0.8	0.3	1.4	0.5	0.1	0.4	1.1	0.4	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	4.7	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	53.3	1.3	0.9	0.7	1.5	0.8	0.8	0.6	0.7	0.7	0.8	0.5	0.8	0.7	0.1	0.0	0.6	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.1	0.0	1.4	0.1	3.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.0	0.4	0.0	5.3	0.2	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546381-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.9;OE19: 118.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	15.9	10.6	7.7	11.0	6.6	4.9	18.6	3.6	10.4	33.0	1.9	22.7	19.9	32.5	2.0	15.3	16.3	9.1	21.3	10.1	12.0	19.9	28.5	17.3	9.5	13.1	8.6	16.7	34.8	6.3	19.9	5.1	11.8	33.5	6.0	2.9	31.6	10.3	14.3	12.5	18.7	9.1	3.4	8.0	50.1	27.9	12.8	6.8	32.0	4.3	5.9	16.8	15.6	11.4	25.8	36.2	41.2	45.7	7.1	2.5	44.0	14.5	6.8	11.2	7.8	113.9	8.0	29.9	25.7	7.8	33.3	19.3	11.4	13.2	4.1	25.1	20.7	24.2	20.1	74.9	14.1	15.1	19.3	6.6	14.1	10.4	5.6	15.8	10.9	17.6	30.2	11.6	5.0	70.5	17.5	22.4	10.8	118.6	11.7	19.3	13.8	20.9	8.6	22.2	11.9	17.0	15.2	35.4	23.3	10.5	20.0	35.3	17.0	15.1	37.3	24.0	24.0	9.1	6.2	40.9	12.3	25.8	14.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	7.7	6.6	3.6	10.4	10.1	12.0	13.1	8.6	11.8	3.4	12.8	11.4	1.1	0.0	11.7	4.6	6.2	9.2	5.8	5.1	2.8	5.2	19.2	15.2	21.0	7.2	4.8	5.5	2.1	2.6	4.3	22.0	0.0	8.7	26.9	6.3	1.9	3.4	40.2	0.8	2.5	16.1	3.4	4.6	56.6	9.5	3.8	15.0	13.6	21.0	4.1	0.0	1.9	41.7	8.2	4.2	7.0	21.0	4.1	4.4	1.8	1.0	5.4	1.2	7.2	6.6	3.5	20.9	20.3	8.6	3.6	14.7	15.8	8.8	3.4	2.7	13.1	4.8	8.4	2.2	13.1	7.6	7.7	4.4	4.0	0.6	17.4	10.2
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55626192	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	110	"NTERA-2: 10.8;SH-SY5Y: 9.9;U-266/70: 6.2;U-266/84: 16.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXRED1	H17	ENSG00000110074	"FAD dependent oxidoreductase domain containing 1"	Q96CU9	11	126269055-126278131	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039620, HPA046192"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA039620: AB_2676602, HPA046192: AB_2679580"	"prognostic unfavorable (7.36e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	8.1	13.8	13.6	5.9	14.6	12.1	7.6	15.3	16.6	5.8	17.1	12.0	10.4	6.7	6.4	9.2	7.5	5.6	21.2	15.0	14.7	14.7	37.4	5.3	10.4	15.3	14.3	4.8	7.8	9.7	8.1	7.1	15.3	6.9	12.9	3.7	7.3	6.8	17.8	7.5	8.6	7.9	14.7	11.1	10.9	8.7	15.8	11.5	6.1	29.4	10.6	7.1	6.0	14.8	23.5	26.6	19.5	24.3	14.2	6.8	26.1	11.6	14.9	22.1	22.1	40.0	24.1	38.2	32.3	9.8	28.7	38.5	51.7	31.5	13.8	20.4	14.3	79.7	16.7	48.2	18.8	19.7	16.4	6.3	12.1	14.9	26.5	6.0	24.7	40.2	46.6	20.6	18.7	32.7	23.1	35.3	16.0	61.8	45.2	37.0	34.1	45.2	20.5	11.9	25.0	21.5	23.8	35.7	13.1	12.2	85.9	33.4	9.0	13.1	10.7	23.8	19.4	12.2	19.0	31.9	16.2	66.5	18.7	1.6	10.1	5.9	6.7	13.4	7.0	7.1	5.3	8.9	12.1	6.2	7.4	6.7	2.0	9.9	9.9	16.8	7.6	8.1	13.6	14.6	15.3	16.6	15.0	14.7	15.3	14.3	15.3	14.7	15.8	14.8	6.1	9.6	11.5	19.6	13.5	3.6	6.2	14.9	8.0	24.8	7.3	7.0	21.7	10.0	10.7	3.7	27.1	27.7	12.2	12.6	7.9	13.6	4.2	7.4	8.7	7.6	13.1	14.9	24.7	13.8	24.1	9.8	17.9	7.8	9.5	17.8	10.0	28.2	20.4	13.5	27.1	12.6	8.2	7.1	5.1	7.2	5.6	8.0	8.8	4.7	7.1	18.6	9.2	14.1	16.1	10.7	5.9	11.3	24.4	4.6	8.9	21.0	6.7	32.2	6.6	8.9	9.6	24.5	24.0	11.0	5.7	21.1	8.9	25.0	14.9	4.8
FOXRED2	"ERFAD, FLJ23322"	ENSG00000100350	"FAD dependent oxidoreductase domain containing 2"	Q8IWF2	22	36487190-36507043	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in many"		"SiHa: 147.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031611, HPA031612"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA031611: AB_10599975, HPA031612: AB_10601887"	"unprognostic (3.66e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (6.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.66e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (9.42e-2)"	5.5	8.1	15.5	4.9	14.8	3.7	4.6	6.7	17.1	9.5	9.0	4.2	4.8	8.1	10.4	4.5	6.6	5.3	5.0	18.0	7.7	6.8	7.7	3.8	5.3	5.5	9.5	13.7	3.6	5.2	4.2	6.3	5.8	7.7	4.2	7.5	6.0	5.5	7.0	7.6	3.1	6.0	5.9	11.3	4.3	5.8	9.9	5.2	4.7	6.4	4.9	5.2	3.8	11.9	31.1	32.7	17.1	35.7	10.7	5.1	26.5	16.2	15.7	31.8	26.3	85.8	15.5	42.4	26.4	12.9	2.2	16.5	32.1	8.5	20.4	15.0	50.8	27.6	20.2	38.6	29.2	27.2	88.9	14.8	8.4	21.2	9.3	7.5	10.5	32.7	33.8	0.7	19.5	27.3	29.0	14.2	15.1	25.0	27.5	52.5	38.4	18.8	12.4	21.5	34.8	44.9	147.5	30.3	27.0	6.4	43.4	14.9	11.8	41.1	51.9	30.3	18.6	11.6	19.0	33.2	13.5	23.9	32.8	0.5	0.9	0.1	0.2	1.1	1.2	0.3	0.2	0.3	0.8	0.4	0.6	0.5	0.3	0.2	0.8	5.4	0.2	0.4	15.5	14.8	6.7	17.1	18.0	7.7	5.5	9.5	5.8	5.9	9.9	11.9	0.9	0.0	4.5	6.8	2.9	2.8	2.6	0.8	3.4	11.6	4.1	3.7	5.5	2.8	0.7	5.5	4.2	11.2	6.1	1.0	1.9	1.9	0.3	2.2	6.2	3.0	0.0	3.4	3.5	1.6	5.4	7.5	1.1	3.9	2.5	7.8	1.8	11.7	10.8	10.1	9.1	1.5	0.0	16.6	3.7	0.9	9.3	4.2	3.6	0.0	1.3	8.6	1.0	6.0	5.5	0.9	0.2	7.5	2.1	1.9	0.4	5.5	1.1	4.0	0.0	12.7	2.3	8.9	22.3	4.7	4.0	3.6	0.9	7.6	3.1	1.4
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844303-31845604	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	4.5	1.6	2.4	1.4	2.4	0.0	2.8	2.6	3.8	3.7	1.7	1.4	0.3	3.9	2.4	1.0	1.9	2.0	9.7	2.2	2.3	5.4	0.8	5.3	2.5	2.6	2.5	2.0	0.9	0.6	2.3	4.8	2.7	2.4	0.6	0.0	1.1	3.1	1.7	1.5	1.4	1.2	2.2	3.0	1.2	5.5	2.6	1.0	3.5	1.7	0.9	2.6	2.4	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	14.1	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.4	2.6	3.8	2.2	2.3	2.6	2.5	2.7	2.2	2.6	2.3	4.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	1.1	2.6	0.0	0.0	0.0	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	4.9	5.0	0.2	1.8	8.4	0.0	0.0	0.0	0.0	0.0	5.7	0.0	56.8	0.0	0.1	0.0	0.0	0.0	0.1	131.5	0.4	31.5	0.6	0.5	0.1	0.3	0.3	0.1	6.6	0.0	0.1
FP565260.1		ENSG00000275464	"Periodic tryptophan protein 2 homolog"		21	5130871-5154658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.4"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	9.2	9.2	6.4	9.9	8.8	12.1	7.4	7.2	8.0	5.9	4.9	8.5	9.1	6.8	1.7	8.3	7.8	7.3	7.5	7.1	6.8	9.0	6.8	7.1	13.4	7.6	7.2	6.7	7.7	6.5	6.0	7.9	9.1	6.5	8.4	3.5	6.7	4.7	10.1	8.6	8.2	7.3	6.8	11.5	7.6	7.1	7.2	6.7	6.6	3.2	5.3	11.4	7.1	13.7	32.0	24.0	15.4	24.2	6.6	5.0	9.1	0.2	0.0	0.1	0.1	0.4	20.1	0.3	14.1	10.5	20.8	21.0	42.9	19.0	0.0	7.4	15.1	102.4	12.4	11.9	10.4	47.6	29.1	17.8	22.5	25.5	20.1	5.0	20.1	16.5	56.8	11.6	6.6	28.4	34.4	33.1	60.4	36.5	29.3	54.0	14.2	28.8	13.5	25.3	16.6	27.3	25.5	38.4	14.9	4.2	31.5	24.9	10.2	12.0	29.7	0.3	32.9	13.9	16.0	63.5	20.4	62.3	16.7	3.3	7.3	6.9	18.5	12.6	21.2	11.0	11.3	13.5	8.7	11.2	11.1	15.2	4.1	9.9	18.2	5.5	8.5	11.6	6.4	8.8	7.2	8.0	7.1	6.8	7.6	7.2	9.1	6.8	7.2	13.7	0.9	0.0	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	1.9	0.0	0.0	2.5	0.0	0.0	2.7	1.1	0.8	0.0	9.3	0.0	0.8	1.1	0.9	0.0	0.0	0.0	8.0	1.4	0.9	0.0	0.9	5.1	0.6	0.0	0.0	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.3	1.2	0.4	0.9	0.0
FPGS		ENSG00000136877	"Folylpolyglutamate synthase"	Q05932	9	127794597-127814327	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050488	Approved				"Intracellular and membrane"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA050488: AB_2681143"	"unprognostic (6.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	37.3	49.1	8.7	15.5	9.7	19.7	32.6	9.1	9.3	26.6	9.2	19.5	10.5	29.6	8.4	22.1	35.5	9.1	31.2	8.3	9.2	24.8	66.1	30.6	17.7	10.3	9.6	55.4	28.0	10.2	18.0	7.7	9.3	26.6	6.9	2.2	20.4	11.6	48.2	15.5	22.8	9.4	10.2	29.9	25.8	12.9	9.2	13.4	22.1	19.0	13.2	25.6	18.2	10.1	36.2	24.4	14.2	29.7	21.2	23.1	42.6	28.0	33.0	34.4	28.0	26.4	56.7	44.4	35.8	38.9	24.4	67.0	17.7	39.4	11.4	48.5	22.6	34.5	30.4	32.1	50.5	64.2	28.1	32.2	21.2	34.7	43.8	29.4	43.3	41.6	39.8	27.7	36.2	45.8	56.6	47.8	39.9	39.2	74.0	116.0	23.0	77.7	52.2	29.3	20.5	35.0	80.1	38.6	5.8	5.7	23.7	26.8	65.4	18.6	26.0	54.1	56.8	31.0	14.2	36.0	40.7	29.4	26.7	0.2	15.4	2.3	38.8	23.9	35.1	23.2	22.9	34.0	30.8	27.6	18.5	25.2	0.8	43.6	23.9	38.9	26.6	22.4	8.7	9.7	9.1	9.3	8.3	9.2	10.3	9.6	9.3	10.2	9.2	10.1	11.3	22.4	28.1	8.8	28.6	10.5	23.7	31.1	8.6	5.5	15.7	13.3	19.5	34.3	21.6	9.2	14.6	15.5	21.8	11.6	11.7	49.6	5.0	18.0	19.9	18.7	22.9	26.7	5.8	52.9	22.0	18.0	31.6	23.9	31.0	14.6	19.2	73.2	29.8	5.0	6.4	13.8	16.2	19.5	18.4	2.2	19.0	18.9	8.8	4.7	46.2	6.5	22.6	6.0	6.2	66.9	9.9	7.2	32.7	30.8	22.1	20.1	11.2	8.5	13.1	21.9	15.2	6.0	16.0	19.9	8.8	14.8	22.2	14.5	24.2	36.5
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
FRA10AC1	C10orf4	ENSG00000148690	"FRA10A associated CGG repeat 1"	Q70Z53	10	93667883-93702592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039204	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA039204: AB_10794426"	"unprognostic (3.21e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.24e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	9.2	8.6	18.4	6.3	20.0	7.0	8.6	19.6	24.5	10.5	14.1	10.2	5.9	10.7	8.4	6.5	10.1	5.3	11.8	17.8	19.1	8.4	8.3	6.4	8.3	18.8	18.6	12.2	10.3	8.3	10.2	5.9	19.2	9.0	6.4	12.3	12.4	7.5	12.2	9.8	6.6	6.8	18.6	7.2	7.8	10.5	19.5	7.3	9.1	12.7	7.3	8.9	8.5	20.5	15.9	11.6	10.7	29.4	14.3	17.1	6.9	13.4	9.5	7.3	8.4	5.3	12.9	11.9	9.7	8.9	11.6	19.1	13.0	10.0	11.5	22.4	14.4	8.9	9.0	12.0	20.1	17.5	5.8	11.7	5.9	7.9	18.8	23.1	15.3	13.6	13.0	14.3	13.1	7.6	16.2	17.9	8.5	8.3	11.1	10.6	13.4	5.1	8.8	5.5	10.5	10.0	6.8	6.1	28.1	11.1	24.2	14.2	15.9	5.3	9.5	4.4	15.6	11.5	16.2	11.6	13.5	28.4	3.9	4.7	2.7	5.6	4.4	3.1	6.0	5.7	6.5	5.9	2.2	6.3	7.8	6.7	2.0	4.0	4.1	3.6	5.5	1.4	18.4	20.0	19.6	24.5	17.8	19.1	18.8	18.6	19.2	18.6	19.5	20.5	39.6	16.0	45.4	28.1	25.5	20.6	29.6	37.7	32.5	36.2	24.1	43.6	109.7	34.3	28.9	14.7	22.9	29.0	18.7	13.4	37.2	35.2	75.8	29.0	35.8	35.1	43.0	24.6	44.2	43.7	21.0	37.1	21.4	24.6	25.3	34.5	29.6	77.1	19.6	50.5	45.6	51.7	20.3	20.0	14.6	26.2	30.7	18.4	16.0	34.7	26.9	47.9	29.9	44.7	48.2	36.0	16.1	28.2	19.0	32.5	14.8	43.1	23.7	33.0	13.1	57.2	43.0	151.3	69.0	20.3	22.3	14.1	23.1	33.6	25.3	21.8
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057323-78544269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.8;thyroid gland: 12.0"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 204.9;Inhibitory neurons: 377.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 35.9;Hep G2: 21.9;RH-30: 20.1;SiHa: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051601	Approved				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	0.6	3.4	0.5	5.8	0.0	0.7	0.0	7.9	2.1	4.0	3.5	0.3	2.0	1.9	1.7	1.0	0.9	1.5	3.5	3.3	7.4	0.3	3.4	0.1	3.1	3.3	0.2	5.4	0.6	2.4	5.8	3.0	2.3	1.3	2.2	1.0	0.7	2.7	1.3	1.0	1.4	0.6	0.7	0.9	0.6	13.8	2.6	12.0	2.2	0.2	0.5	1.4	4.9	4.6	6.9	2.7	0.0	7.0	2.9	4.8	1.1	4.1	0.6	0.4	5.4	9.8	0.0	8.2	35.9	0.0	1.3	3.8	2.1	0.1	0.0	3.8	4.2	8.5	21.9	0.8	0.0	0.0	14.1	2.3	0.0	5.2	5.4	0.1	0.3	0.0	0.0	4.1	0.2	0.1	0.0	8.6	3.6	1.3	0.0	20.1	0.0	8.7	9.9	5.0	9.7	21.6	6.7	1.3	12.3	0.0	0.0	0.0	0.0	4.5	2.9	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.8	0.0	7.9	3.5	3.3	3.1	3.3	3.0	0.6	13.8	4.9	0.5	32.1	0.0	9.1	0.1	1.9	2.2	2.5	10.2	10.8	0.8	1.8	7.3	22.8	9.2	29.5	0.0	28.0	0.0	0.8	3.9	7.6	2.1	5.5	1.0	2.0	1.2	0.0	204.9	1.7	1.4	5.3	4.1	13.5	0.0	0.1	1.1	0.2	4.4	0.0	377.7	1.0	0.0	0.0	0.7	2.8	0.6	0.4	1.8	20.6	0.0	0.6	0.0	10.1	5.5	2.7	2.5	0.0	0.0	1.8	1.4	4.3	2.5	2.7	0.0	1.5	3.4	0.8	1.2	10.4	1.3	15.6	0.1	2.8	2.4	0.4
FRAT1		ENSG00000165879	"FRAT regulator of WNT signaling pathway 1"	Q92837	10	97319271-97321915	"Predicted intracellular proteins"	"Wnt signaling pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.2;Early spermatids: 31.3;Kupffer cells: 26.1;Late spermatids: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 8.7;neutrophil: 10.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB046472, HPA055258"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB046472: AB_1849131, HPA055258: AB_2682763"	"unprognostic (1.48e-2)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (6.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.43e-2)"	3.2	2.9	2.6	5.0	2.6	10.6	2.4	3.8	3.5	2.5	1.8	3.2	4.4	2.6	1.0	2.4	3.0	1.2	3.1	2.8	3.1	2.1	11.8	3.3	3.8	3.6	3.4	2.4	3.9	2.0	2.1	1.2	3.1	4.0	1.9	1.9	3.7	1.6	3.8	4.2	4.5	1.5	2.9	12.6	4.8	10.9	3.9	4.1	2.0	2.6	2.4	2.3	2.1	2.6	0.7	1.3	1.4	6.7	1.8	0.9	1.5	0.8	2.9	0.5	0.6	0.2	0.8	4.5	1.5	0.5	1.0	2.0	1.1	1.4	0.1	4.0	2.0	3.8	0.8	1.8	0.6	1.4	4.0	0.8	2.0	0.2	0.9	2.7	1.2	6.1	1.6	3.1	0.4	4.2	4.0	7.9	1.9	4.8	5.5	3.3	0.3	2.9	0.5	1.0	0.7	2.2	1.0	2.1	1.5	1.4	7.7	5.4	1.1	0.3	0.4	1.0	0.3	2.9	1.7	1.5	0.5	7.0	0.0	0.9	2.0	8.7	0.5	1.3	0.4	0.5	0.4	0.7	1.0	0.5	0.7	0.5	10.1	0.2	1.5	0.6	0.3	0.5	2.6	2.6	3.8	3.5	2.8	3.1	3.6	3.4	3.1	2.9	3.9	2.6	4.1	3.2	5.8	1.0	5.8	1.1	1.1	0.9	1.2	25.2	2.9	1.9	3.3	5.7	0.9	1.8	0.0	0.6	16.8	6.0	0.0	1.4	31.3	5.8	1.6	4.0	4.2	4.2	0.7	2.0	1.7	1.5	2.0	4.1	0.0	5.0	3.3	15.6	3.9	3.3	1.6	4.9	4.1	26.1	1.8	85.2	1.2	15.5	3.6	0.0	12.5	4.9	13.4	0.5	0.7	1.1	2.3	1.9	1.1	2.5	3.8	1.0	3.3	8.4	0.0	3.4	1.7	1.2	0.6	1.6	1.6	2.3	9.0	4.7	2.8	2.2
FRAT2		ENSG00000181274	"FRAT regulator of WNT signaling pathway 2"	O75474	10	97332497-97334729	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 15.0;neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.3	3.6	7.2	10.4	7.1	31.0	8.0	7.7	7.4	6.0	9.8	17.1	25.1	4.1	6.2	14.4	7.1	4.0	6.0	6.3	6.8	7.8	18.3	9.7	8.7	7.7	7.6	2.8	14.0	5.2	3.0	7.4	6.8	7.9	15.5	3.3	15.1	4.3	10.1	20.4	15.9	4.1	7.0	28.9	13.2	14.6	7.5	8.9	5.3	9.1	10.8	6.7	8.1	6.0	10.9	4.3	6.9	31.2	4.9	4.0	25.7	2.4	8.9	3.7	3.7	6.8	12.5	13.3	8.4	2.5	2.2	20.3	18.3	9.5	2.9	20.0	28.0	17.9	9.2	15.0	2.8	28.9	20.6	3.2	20.0	3.6	11.4	7.9	9.3	11.7	15.8	4.2	1.8	17.9	12.6	36.5	42.9	36.2	17.5	12.8	2.9	19.1	8.9	9.8	12.5	10.2	3.1	19.1	12.6	28.0	28.8	44.8	4.2	2.2	2.7	1.7	6.4	11.4	12.5	6.6	2.6	49.3	0.8	8.3	7.2	15.0	1.1	4.8	0.6	1.1	1.3	1.8	3.8	3.2	2.2	1.3	58.2	1.6	7.9	1.0	0.7	2.3	7.2	7.1	7.7	7.4	6.3	6.8	7.7	7.6	6.8	7.0	7.5	6.0	18.2	0.0	3.9	2.9	15.7	31.7	25.3	6.6	46.1	19.7	24.7	19.6	6.4	20.0	5.0	14.7	4.2	6.1	26.1	31.0	11.7	2.2	40.7	39.6	9.7	10.3	13.8	14.5	2.0	5.3	18.5	6.4	37.2	46.3	1.3	16.7	8.6	11.3	8.6	11.8	2.8	30.6	4.1	28.3	9.0	42.3	2.1	25.2	10.6	7.5	24.7	5.0	14.4	2.0	1.1	3.4	21.6	2.6	8.4	30.0	13.5	3.7	4.5	18.1	0.0	14.9	8.7	2.3	4.4	37.7	52.7	7.8	18.8	20.1	31.6	32.3
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix 2"	Q5SZK8	13	38687077-38887131	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 7.7;thyroid gland: 4.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.2;Astrocytes: 46.0;Cholangiocytes: 15.7;Endometrial ciliated cells: 18.6;Glandular and luminal cells: 48.6;Oligodendrocyte precursor cells: 15.6;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.6;MCF7: 7.8;RT4: 7.2;SK-BR-3: 6.3;SuSa: 29.7;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA028831	Uncertain		Approved	Cytosol		NA	NA		1500000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.2	0.1	0.3	0.0	1.1	0.0	0.2	0.2	0.9	0.3	0.1	0.5	0.1	0.5	0.2	0.0	0.4	0.8	0.0	0.6	0.0	7.7	2.0	2.2	0.0	0.0	0.4	0.7	2.7	0.0	0.3	1.4	0.0	1.8	0.1	0.3	0.0	0.7	2.8	0.1	0.2	0.3	0.0	0.1	0.9	0.3	0.0	0.2	4.9	3.6	0.0	0.2	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.3	0.0	0.2	0.0	1.4	0.1	2.3	7.2	0.2	0.1	0.0	6.3	0.3	29.7	1.1	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.9	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	27.2	46.0	0.0	0.6	0.1	0.7	0.0	0.2	0.4	0.5	2.7	15.7	1.4	1.8	0.0	5.9	0.0	0.3	5.9	3.2	0.5	18.6	4.5	0.6	0.0	0.0	0.5	0.2	0.4	0.4	0.0	48.6	0.0	0.5	0.0	1.3	0.8	0.0	9.1	0.1	2.0	0.3	0.0	0.1	0.0	0.2	0.0	3.7	0.0	3.3	0.0	15.6	9.7	1.0	0.1	0.0	0.0	0.0	0.0	24.8	2.9	0.3	0.0	3.1	0.7	0.2	0.9	0.0	0.1	1.9	0.5	2.9	0.1	0.1
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Excitatory neurons: 9.7;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.1;hypothalamus: 2.8;thalamus: 4.4"					HPA041641	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041641: AB_2677592"	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.3	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.2	0.6	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.0	0.0	0.0	0.0	4.5	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
FRG1	"FRG1A, FSG1"	ENSG00000109536	"FSHD region gene 1"	Q14331	4	189940870-189963202	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing"	"Actin-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA075683	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA075683: "	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.84e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.01e-1)"	36.8	25.7	6.0	6.4	6.0	16.6	33.9	6.1	13.0	29.5	6.1	35.0	6.6	32.9	9.6	30.7	27.6	5.9	31.9	6.0	6.1	29.2	24.8	23.5	7.9	6.0	6.0	32.0	30.6	13.1	18.5	5.9	6.0	21.7	7.7	3.6	24.9	7.5	31.1	28.6	26.7	8.6	6.0	29.0	30.0	19.8	6.0	13.0	23.4	9.4	8.4	28.8	28.3	6.1	12.2	8.5	21.5	19.0	11.0	16.4	14.6	18.0	13.4	23.3	15.6	6.1	20.1	21.9	8.5	13.5	8.8	7.3	20.3	13.8	24.6	13.3	9.6	39.4	9.3	4.3	18.8	28.9	14.9	12.1	15.5	12.9	4.2	15.8	15.5	19.1	25.4	42.4	19.0	6.9	38.6	42.7	4.4	5.4	12.8	27.2	4.9	14.4	16.3	6.9	15.8	15.7	11.4	13.0	21.1	11.8	6.7	20.3	15.4	8.8	11.6	6.5	13.4	15.4	12.8	17.6	15.7	18.7	13.1	30.7	13.4	19.7	13.6	18.0	13.8	16.9	16.0	15.1	12.1	15.4	13.6	14.8	13.3	16.9	19.1	13.4	20.1	13.6	6.0	6.0	6.1	13.0	6.0	6.1	6.0	6.0	6.0	6.0	6.0	6.1	69.3	80.1	52.9	6.5	61.9	33.4	42.5	62.9	18.2	43.1	47.6	56.9	70.6	64.3	52.9	33.1	16.7	77.0	82.2	45.6	131.0	106.0	50.4	42.4	51.4	61.1	44.9	94.1	12.5	121.9	65.2	50.9	18.8	40.9	84.2	34.8	83.6	133.8	68.1	32.0	11.6	53.9	50.8	92.6	46.7	20.4	76.1	57.4	21.4	4.7	107.6	61.1	124.6	12.5	17.0	88.4	48.9	72.6	41.9	20.7	60.8	126.2	51.7	52.0	52.6	50.7	84.6	75.9	70.6	27.5	28.1	53.5	64.6	42.8	52.9	32.4
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024367-190027257	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039264, HPA047769"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"			"Cluster 39: Non-specific - Basic cellular processes"			"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRG2B		ENSG00000225899	"FSHD region gene 2 family member B"	Q96QU4	10	133623895-133626795	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HDLM-2: 4.3"									"HPA039264, HPA047769"	Uncertain					NA	NA					"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRG2C		ENSG00000172969	"FSHD region gene 2 family member C"	A6NGY1	3	75664330-75667220	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 27.4;Early spermatids: 13.9;Late spermatids: 30.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"HDLM-2: 12.7"									"HPA039264, HPA047769"	Uncertain					NA	NA					"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039264: AB_2676420, HPA047769: AB_2680149"	"unprognostic (3.47e-2)"				"unprognostic (8.28e-2)"			"unprognostic (9.57e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.33e-1)"		"unprognostic (2.29e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	30.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;lymphoid tissue: 13.1;stomach 1: 5.7;testis: 5.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 68.9;Paneth cells: 167.2"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 1.9;RPMI-8226: 3.0"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA				"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			3.6	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.2	0.0	3.1	0.1	0.0	2.1	5.7	5.1	0.0	13.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.8	0.0	0.0	0.0	68.9	0.0	0.0	15.3	0.0	0.0	0.2	7.8	0.0	0.0	1.8	0.0	0.4	4.6	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	16.0	0.0	0.0	0.0	20.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	1.5	0.0	0.0	19.6	23.8	0.0	0.0	0.0	0.3	0.7	13.4	8.2	0.0	0.0	0.1	0.1	15.2	12.6	0.2
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69168782-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported	Approved	"Nucleoplasm,Golgi apparatus,Centriolar satellite"		NA	NA		17000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centriolar satellite"	"Nucleoplasm, Golgi apparatus"	"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	11.0	4.8	17.5	12.3	46.7	15.5	16.1	26.9	30.9	24.9	7.0	12.8	9.1	11.3	9.3	26.8	13.2	19.2	17.4	20.8	29.3	16.3	34.5	24.8	10.9	39.4	37.1	10.9	8.2	3.7	4.0	25.5	36.3	16.9	12.9	21.9	37.1	10.5	2.3	23.0	12.5	10.5	22.7	32.3	15.0	4.7	42.0	14.1	27.1	4.6	11.2	13.7	15.8	84.0	6.7	1.8	10.4	0.3	0.2	1.5	11.3	0.5	1.7	0.8	0.5	39.8	11.3	0.8	3.5	0.5	1.0	25.9	4.9	35.3	1.2	2.2	3.3	20.4	2.6	2.3	0.7	5.2	10.2	1.7	35.2	1.0	52.7	1.6	55.1	4.7	1.6	5.8	3.0	7.7	0.5	0.8	5.6	8.9	8.5	32.2	2.8	1.0	14.8	4.6	12.1	15.6	1.7	12.2	35.5	9.3	4.6	6.8	47.1	0.6	4.3	0.4	1.8	0.6	0.3	1.2	0.4	13.5	13.5	18.3	27.6	2.3	1.9	13.8	7.0	1.6	6.3	2.8	16.9	2.0	1.9	1.8	7.1	3.8	2.3	16.8	15.4	7.7	17.5	46.7	26.9	30.9	20.8	29.3	39.4	37.1	36.3	22.7	42.0	84.0	20.6	41.7	83.6	2.9	3.6	60.7	33.4	57.8	69.4	13.8	34.4	21.7	33.4	41.5	58.5	14.7	218.9	49.9	20.3	74.4	33.2	32.6	18.9	207.9	49.3	64.3	24.5	8.6	4.2	17.3	19.7	32.1	75.4	282.6	34.7	97.5	89.3	53.6	92.6	0.0	92.7	42.1	36.7	138.7	112.7	4.0	6.5	105.2	28.4	93.7	26.3	13.5	1.0	129.2	1209.1	24.5	67.0	18.4	6.9	61.1	10.7	55.6	38.2	109.2	6.6	11.8	21.0	0.0	3.5	79.9	51.4	58.3	44.6	32.1	32.2	172.8
FRMD6	"C14orf31, EX1, MGC17921, willin"	ENSG00000139926	"FERM domain containing 6"	Q96NE9	14	51489100-51730727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 160.6;Early spermatids: 219.1;Late spermatids: 473.0;Suprabasal keratinocytes: 137.5;Urothelial cells: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 351.1;fHDF/TERT166: 765.6;U-138 MG: 290.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001297	Uncertain	Supported	Approved	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA001297: AB_1078913"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.05e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.28e-4)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.20e-2)"	12.1	13.4	5.2	9.5	5.2	1.2	27.1	12.6	6.7	28.1	8.4	16.0	5.2	53.6	11.3	59.8	13.4	33.0	7.3	6.4	4.5	4.2	10.4	8.6	5.5	5.7	8.1	25.9	5.0	2.4	3.4	14.1	4.9	27.7	10.8	1.5	21.5	30.7	7.4	43.2	7.5	46.8	5.4	12.0	7.2	31.0	5.8	12.6	6.6	6.8	12.7	31.5	30.1	5.6	71.4	14.1	20.1	42.1	40.1	67.6	8.8	351.1	163.2	169.5	146.0	51.9	16.4	1.9	10.6	765.6	47.6	82.8	5.7	113.8	200.3	1.1	8.6	0.3	7.6	2.2	46.8	0.2	4.2	58.8	40.9	152.0	200.5	77.8	52.6	3.7	0.7	24.6	181.8	12.2	7.1	0.2	3.9	0.2	27.4	0.8	79.1	0.7	33.4	113.7	4.1	44.9	27.8	3.9	31.3	37.7	3.0	1.0	242.6	290.7	97.6	73.3	73.5	18.9	17.3	0.2	19.3	0.3	114.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.1	5.2	5.2	12.6	6.7	6.4	4.5	5.7	8.1	4.9	5.4	5.8	5.6	6.9	3.2	1.5	34.6	0.8	111.4	160.6	42.4	41.5	0.4	40.5	49.4	2.9	8.6	11.6	0.0	0.0	40.1	1.5	0.0	0.0	16.9	219.1	2.0	41.1	14.4	0.0	2.5	45.2	2.9	4.8	57.8	1.1	3.6	1.3	0.9	9.3	4.2	3.8	0.0	22.5	0.3	10.2	0.3	21.1	473.0	17.7	1.5	32.0	68.4	0.7	8.2	0.0	74.9	5.9	64.0	0.0	22.2	3.7	52.0	0.1	0.4	2.7	0.5	6.6	24.5	28.0	10.2	9.8	115.7	137.5	39.0	3.3	0.9	0.1	130.7
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMD8	"FKSG44, FLJ90369, iTAP"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386621-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002861	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA002861: AB_1078878"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	19.8	17.5	9.6	11.8	11.0	13.0	19.7	12.2	14.5	20.8	9.1	15.0	11.7	14.6	5.3	37.3	15.8	11.6	17.1	13.1	7.9	19.7	13.4	23.5	15.6	12.9	11.3	12.2	23.0	4.0	11.6	10.4	11.4	15.8	6.7	1.7	18.0	6.5	14.8	34.0	23.8	6.6	9.5	40.8	13.4	18.0	11.5	11.1	17.8	5.1	13.6	14.6	26.4	16.2	17.8	22.1	8.7	20.4	23.0	12.0	15.6	20.1	18.1	16.7	12.7	21.2	28.5	21.9	41.9	27.6	11.6	30.3	11.3	16.9	7.0	38.8	10.6	29.9	21.5	11.7	12.4	16.9	44.8	14.9	13.2	15.7	8.2	8.9	26.6	23.2	25.5	23.5	18.3	23.9	26.6	24.6	10.2	13.0	28.7	33.7	16.6	25.2	13.5	21.8	18.9	14.0	15.0	60.1	47.7	7.7	22.0	13.7	23.6	18.4	19.7	26.1	12.3	41.0	22.5	20.4	16.0	10.7	129.8	1.1	12.4	17.7	13.1	13.2	14.1	12.5	9.6	16.7	11.3	9.6	8.8	9.8	23.0	8.2	19.6	13.4	10.8	12.3	9.6	11.0	12.2	14.5	13.1	7.9	12.9	11.3	11.4	9.5	11.5	16.2	30.3	3.2	5.8	2.0	20.5	54.3	22.5	17.7	6.2	5.4	15.4	12.6	7.4	12.8	13.8	12.9	0.0	6.4	25.8	29.3	7.9	21.0	22.3	20.1	12.1	24.8	13.1	24.0	13.4	29.1	15.5	13.0	10.7	23.1	14.0	27.3	37.5	11.0	16.0	5.0	4.9	20.5	8.2	20.2	68.7	4.6	6.2	18.7	19.6	10.3	21.6	4.3	18.6	5.0	10.3	33.8	14.0	7.2	11.9	28.1	32.8	4.6	14.3	4.5	6.6	11.4	14.4	5.3	9.6	24.9	83.5	11.4	21.9	35.2	14.6	35.7
FRMPD1	"FRMD2, KIAA0967"	ENSG00000070601	"FERM and PDZ domain containing 1"	Q5SYB0	9	37650954-37746904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 68.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 47.8;Cone photoreceptor cells: 152.2;Inhibitory neurons: 24.3;Rod photoreceptor cells: 79.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.2;NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042934	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042934: AB_10960422"	"unprognostic (6.41e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.04e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.12e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.91e-2)"	0.4	0.5	3.1	0.8	3.8	2.9	0.9	2.9	4.1	0.3	0.4	0.5	0.7	1.0	0.6	1.6	0.8	1.6	0.7	2.6	2.9	0.5	0.5	0.7	1.3	3.1	4.8	0.3	0.9	0.7	0.8	0.4	2.6	0.5	0.5	68.9	4.1	0.5	4.2	6.4	1.1	0.4	2.2	0.4	0.6	9.4	5.5	0.2	1.0	1.2	1.1	0.5	0.1	4.5	0.2	0.3	1.2	0.1	0.0	0.0	1.5	0.5	0.0	0.1	0.1	0.6	0.5	0.3	0.2	0.3	0.5	0.9	0.9	0.5	0.3	0.4	0.3	0.1	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.5	0.2	0.6	0.0	0.9	0.5	0.2	0.2	0.3	0.1	0.2	0.7	0.1	0.6	0.6	1.0	0.1	0.0	0.9	2.5	1.7	0.0	1.6	0.8	0.4	0.8	0.3	0.0	0.3	0.5	0.5	0.4	0.4	0.7	0.6	0.4	0.3	0.4	3.2	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.0	1.3	0.4	0.3	0.2	0.1	3.1	3.8	2.9	4.1	2.6	2.9	3.1	4.8	2.6	2.2	5.5	4.5	0.2	3.2	10.5	11.1	0.3	0.1	0.3	0.0	0.0	47.8	0.5	0.3	1.1	4.3	1.8	0.0	152.2	0.2	0.0	0.4	0.0	0.1	4.8	0.2	0.1	1.4	0.0	0.0	3.7	0.2	0.5	0.8	0.0	0.4	5.1	0.2	0.7	0.8	0.1	1.7	24.3	0.3	0.0	1.3	2.1	1.3	0.9	0.8	0.0	1.0	0.3	9.0	0.0	13.6	6.7	0.1	0.1	0.4	0.1	0.2	0.0	0.0	1.5	79.8	0.0	0.8	0.2	0.4	1.7	0.0	0.4	0.7	1.0	0.1	0.1	0.3
FRMPD3	"KIAA1817, RP5-1070B1.1"	ENSG00000147234	"FERM and PDZ domain containing 3"	Q5JV73	X	107522450-107605251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;ovary: 5.6;thyroid gland: 4.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Cone photoreceptor cells: 4.2;Excitatory neurons: 3.8;Inhibitory neurons: 17.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.9;SCLC-21H: 1.7;U-698: 1.6;WM-115: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003164	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003164: AB_1078260"	"unprognostic (1.27e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.69e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-9)"	"unprognostic (4.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.26e-1)"	0.0	0.3	4.8	0.5	4.4	0.1	0.3	4.9	3.2	0.2	2.0	0.1	0.0	1.1	0.0	0.1	0.4	0.3	0.3	3.7	6.5	0.1	0.0	0.1	0.8	8.7	7.6	5.6	0.1	0.0	0.7	0.0	6.0	0.4	0.2	0.7	0.7	1.3	0.0	0.1	0.2	0.6	7.2	0.2	0.3	0.4	4.9	0.1	4.7	0.0	0.5	0.3	0.1	5.7	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.2	5.9	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.2	1.7	0.1	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.4	4.9	3.2	3.7	6.5	8.7	7.6	6.0	7.2	4.9	5.7	0.0	0.0	0.0	6.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.0	4.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.4	0.0	0.0	0.4	0.0	0.0	0.1	1.8	1.9	0.0	0.2	0.0	1.0	0.8	0.1	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.3
FRRS1	"SDFR2, SDR2"	ENSG00000156869	"Ferric chelate reductase 1"	Q6ZNA5	1	99703970-99766635	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 10.8;Microglial cells: 13.1;Squamous epithelial cells: 7.2;Theca cells: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"eosinophil: 12.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"HEL: 34.7;K-562: 23.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017883	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"			"HPA017883: AB_2294223"	"unprognostic (3.97e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.54e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.54e-2)"	1.7	3.2	0.8	1.2	1.2	2.9	3.3	1.0	1.1	2.9	2.2	4.3	3.1	1.8	7.3	6.0	2.2	3.3	1.7	0.9	1.1	1.6	28.6	2.5	1.1	1.4	0.6	2.4	1.1	1.2	0.3	10.1	1.2	2.4	4.1	1.1	1.5	2.6	1.0	9.2	2.3	1.9	0.2	1.2	4.8	1.1	1.3	1.2	2.2	1.6	2.4	2.6	3.8	2.4	6.9	1.2	2.9	2.7	8.5	4.3	14.2	1.9	3.2	1.8	6.8	8.1	9.0	3.8	6.9	2.0	3.0	16.0	4.3	6.8	2.3	8.1	2.9	34.7	3.9	8.7	1.2	4.4	9.2	6.6	8.6	4.0	1.7	0.5	0.4	2.6	23.4	2.0	1.3	2.2	1.4	2.7	2.1	15.2	5.9	0.3	10.8	1.7	1.2	17.3	0.8	0.3	3.0	13.1	6.9	2.1	5.0	4.9	0.8	3.8	5.0	3.3	2.0	3.1	0.4	6.7	8.1	1.9	1.9	1.3	1.0	12.6	0.3	1.4	0.2	0.9	0.2	0.3	1.3	0.6	0.2	0.5	0.8	0.6	0.3	1.0	0.3	0.3	0.8	1.2	1.0	1.1	0.9	1.1	1.4	0.6	1.2	0.2	1.3	2.4	1.1	0.0	0.0	0.0	1.2	1.9	1.9	1.9	10.8	0.1	0.9	1.3	1.5	0.0	1.2	1.8	0.0	3.1	0.3	1.3	0.0	0.3	0.2	1.9	6.2	0.5	0.0	2.1	0.5	0.0	1.8	4.0	6.6	3.1	0.0	6.2	0.4	2.8	1.0	0.0	0.6	0.4	0.0	2.2	0.0	0.4	0.9	2.1	0.0	13.1	1.1	1.0	0.0	1.0	0.2	0.4	1.4	0.0	3.1	1.2	1.7	0.3	2.2	0.1	0.0	0.5	1.1	0.0	0.2	7.2	2.7	3.7	0.3	12.3	0.5	3.1
FRRS1L	"C9orf4, CG-6"	ENSG00000260230	"Ferric chelate reductase 1 like"	Q9P0K9	9	109130293-109167249	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;ovary: 11.0"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 59.1;Excitatory neurons: 91.6;Horizontal cells: 97.6;Inhibitory neurons: 81.3;Oligodendrocyte precursor cells: 27.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071086	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA071086: AB_2686342"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.21e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.02e-2)"	"unprognostic (5.78e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.38e-3)"	0.1	7.8	15.1	0.3	16.6	0.3	0.3	9.2	17.3	1.3	0.0	0.7	0.4	1.5	2.8	1.9	1.4	1.0	1.0	18.6	15.4	0.1	0.1	0.2	0.2	2.5	6.3	11.0	0.6	3.0	7.2	0.0	6.2	3.1	0.3	7.8	0.2	1.7	0.1	0.2	0.5	1.5	6.9	0.2	0.8	0.7	15.4	0.0	0.2	0.1	0.1	0.1	0.2	7.1	0.0	0.2	1.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	15.1	16.6	9.2	17.3	18.6	15.4	2.5	6.3	6.2	6.9	15.4	7.1	0.1	3.2	0.6	1.3	0.1	0.4	1.5	0.0	0.6	59.1	0.7	0.4	5.0	0.0	0.6	0.0	2.1	0.4	1.5	1.6	0.0	0.0	7.9	3.2	1.6	0.8	1.2	0.0	91.6	0.0	0.2	4.3	0.0	1.8	1.3	16.3	0.4	0.1	0.1	97.6	81.3	0.8	0.0	0.6	1.2	4.6	13.1	0.5	1.8	4.7	0.2	16.6	0.0	27.6	5.9	0.1	0.4	17.0	0.0	1.1	4.1	0.1	0.0	7.0	0.0	1.6	1.5	0.3	1.2	0.0	0.6	0.3	0.3	10.8	1.3	0.8
FRS3	"FRS2B, FRS2beta, SNT-2"	ENSG00000137218	"Fibroblast growth factor receptor substrate 3"	O43559	6	41770176-41786542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 12.5;Spermatogonia: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030162, HPA030174"	Enhanced		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030162: AB_10599976, HPA030174: AB_10602093"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (4.23e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.29e-3)"	5.9	6.0	13.7	2.9	15.5	2.8	5.9	11.3	21.7	7.6	3.7	8.8	3.3	8.1	2.0	3.3	8.2	3.0	8.1	15.1	12.8	6.4	5.4	5.1	4.1	14.9	12.2	7.3	6.2	3.1	7.2	3.1	14.8	7.0	1.9	4.5	5.0	5.1	9.1	2.8	5.5	2.9	8.4	6.8	6.0	17.5	12.9	3.0	9.7	5.0	2.1	7.8	5.7	17.2	2.4	2.0	3.4	4.7	2.6	2.8	7.0	2.5	3.6	3.0	3.0	2.8	1.4	4.1	2.8	2.2	3.9	1.6	2.2	2.7	2.5	4.3	2.2	2.5	4.6	4.5	3.3	2.1	3.6	2.8	3.2	2.9	2.6	3.9	3.1	9.9	2.9	3.3	2.7	3.9	6.2	4.6	1.7	5.3	2.1	5.8	3.0	3.0	2.6	4.6	4.8	7.3	1.8	2.5	5.6	2.5	3.2	4.2	2.7	5.2	5.5	3.4	2.6	5.9	5.3	7.3	1.4	3.5	1.6	0.0	0.3	0.4	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	13.7	15.5	11.3	21.7	15.1	12.8	14.9	12.2	14.8	8.4	12.9	17.2	4.0	0.0	3.7	4.9	1.7	1.0	1.3	1.0	2.8	5.6	2.1	1.9	3.1	7.2	1.2	0.0	0.0	1.9	1.1	0.3	0.0	1.6	0.9	1.9	2.8	3.2	1.8	0.4	7.8	1.4	1.0	3.0	0.5	2.4	0.0	2.2	1.4	1.7	1.9	5.0	8.2	1.5	0.0	2.9	3.7	1.0	2.5	1.9	3.6	4.7	0.7	2.9	0.0	7.5	5.4	1.3	1.6	4.5	0.4	0.9	1.7	1.0	1.3	4.3	0.0	2.8	2.9	12.5	12.4	0.8	0.6	0.5	1.4	1.7	1.6	1.6
FRY	"13CDNA73, bA37E23.1, C13orf14, CG003"	ENSG00000073910	"FRY microtubule binding protein"	Q5TBA9	13	31846713-32299125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 26.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 185.6;Excitatory neurons: 259.2;Inhibitory neurons: 272.7;Oligodendrocyte precursor cells: 229.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 7.6;eosinophil: 11.8;neutrophil: 8.3"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 12.3;RT4: 25.1;THP-1: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041635	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041635: AB_2677588"	"unprognostic (4.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.25e-2)"	7.3	1.9	8.2	2.1	8.4	7.4	4.8	18.0	9.7	3.7	0.0	6.0	1.4	3.5	2.7	1.9	5.1	6.1	26.1	8.9	6.6	5.6	4.3	6.7	2.3	4.0	3.2	2.4	7.7	2.8	5.5	2.7	6.5	4.5	2.1	11.2	2.0	5.9	13.6	5.4	2.4	5.8	2.7	3.1	4.6	2.8	5.7	3.1	3.3	19.7	1.1	7.1	2.8	3.4	0.0	0.0	0.7	0.5	1.4	1.4	0.0	2.1	7.6	0.7	0.8	7.0	0.0	1.3	0.2	2.3	2.3	0.6	1.0	0.0	0.7	3.2	0.4	0.9	1.6	2.3	6.7	1.8	0.7	0.3	0.3	1.0	0.7	0.0	12.3	1.3	0.0	4.0	1.1	0.1	0.1	4.3	1.7	0.8	0.6	0.0	1.0	3.0	0.5	25.1	1.8	1.4	3.6	2.2	0.2	0.8	0.3	15.8	2.9	0.7	0.3	0.5	0.3	2.3	2.6	0.1	1.1	2.3	1.1	7.6	1.1	11.8	0.3	0.5	0.3	0.0	0.4	0.2	0.8	0.0	0.2	0.1	8.3	0.3	1.2	0.0	0.1	0.2	8.2	8.4	18.0	9.7	8.9	6.6	4.0	3.2	6.5	2.7	5.7	3.4	53.9	16.0	29.5	17.3	3.0	4.2	9.6	2.1	6.8	47.1	12.7	7.2	73.4	27.1	14.3	14.7	185.6	0.3	7.1	0.7	1.9	6.0	1.9	7.7	3.1	54.3	2.4	6.1	259.2	5.1	0.2	9.6	21.4	3.7	6.3	3.5	36.0	19.9	1.2	37.0	272.7	8.1	10.2	8.1	8.3	4.4	5.9	14.0	17.8	66.5	16.9	8.1	5.2	229.2	20.6	4.2	2.7	25.6	3.1	4.0	0.8	0.7	11.0	6.8	19.7	17.3	49.3	3.7	5.7	0.6	4.3	0.1	3.0	4.5	0.8	8.4
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.5"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.8	5.4	12.2	13.2	43.5	15.0	7.9	26.6	22.6	8.4	0.8	37.9	10.4	8.4	3.7	6.6	6.1	8.3	8.6	12.1	19.9	8.4	5.7	9.7	13.4	34.8	23.4	7.9	5.6	20.3	2.7	10.5	31.2	6.5	36.7	29.2	6.8	6.6	4.5	10.2	12.8	9.2	22.2	10.8	10.7	6.3	25.7	16.7	7.9	12.0	13.1	10.2	3.4	81.5	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	12.2	43.5	26.6	22.6	12.1	19.9	34.8	23.4	31.2	22.2	25.7	81.5	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
FSBP		ENSG00000265817	"Fibrinogen silencer binding protein"	O95073	8	94378377-94436952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Endometrial ciliated cells: 15.3;Glandular and luminal cells: 6.2;Rod photoreceptor cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025059, HPA026509"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025059: AB_2671718, HPA026509: AB_10602307"																		0.7	1.0	1.2	0.5	1.5	1.4	1.4	1.6	1.7	1.7	3.7	0.6	0.6	1.5	2.6	1.1	1.6	0.9	1.3	0.9	1.2	1.0	1.2	0.7	0.9	1.2	2.3	2.7	1.0	1.1	1.6	0.9	1.0	1.9	0.7	12.0	1.1	2.1	1.3	1.5	0.7	0.8	1.3	0.8	1.4	1.8	1.8	1.2	1.1	0.6	0.8	1.5	1.1	1.3	3.7	1.7	7.6	3.8	1.1	1.3	1.3	1.4	1.4	1.5	1.3	1.9	1.9	2.6	4.1	1.1	1.2	0.9	4.7	2.4	2.6	2.6	1.8	2.9	1.4	1.6	3.3	1.9	0.8	2.4	0.5	2.1	6.4	2.5	2.4	9.0	4.5	4.4	1.4	2.4	6.6	2.3	4.9	1.4	1.1	1.4	4.4	2.5	4.0	5.1	2.5	3.0	0.9	0.3	4.6	5.9	2.5	0.7	2.1	3.0	1.3	1.6	1.5	1.3	1.9	1.3	1.8	2.8	3.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	1.5	1.6	1.7	0.9	1.2	1.2	2.3	1.0	1.3	1.8	1.3	0.6	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	15.3	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.0	6.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.5	0.9	0.0	0.0
FSCB	"C14orf155, DKFZP434F1017"	ENSG00000189139	"Fibrous sheath CABYR binding protein"	Q5H9T9	14	44504149-44507283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 32.5"	"Group enriched"	"Detected in some"	69	"Early spermatids: 339.4;Late spermatids: 655.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA003546	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA003546: AB_1845561"															"unprognostic (8.13e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	339.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	655.2	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592816-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	27.5	39.7	41.5	31.1	62.2	8.3	24.9	26.3	57.2	33.7	10.7	12.1	4.4	19.7	0.7	69.4	15.6	7.6	15.8	39.4	28.2	17.3	8.3	27.6	14.5	49.4	42.7	47.7	5.5	2.3	20.2	27.9	22.8	10.3	1.7	3.4	23.8	2.4	7.3	56.3	12.6	5.7	20.9	55.6	9.3	42.5	79.0	9.0	25.6	2.1	8.3	20.4	41.6	77.1	62.3	139.3	91.2	326.3	34.8	65.4	600.3	144.2	62.4	24.2	26.1	98.5	15.6	1.3	172.0	63.5	24.3	231.3	52.2	229.9	2.1	70.6	28.7	4.8	142.0	464.9	18.0	0.2	13.9	40.8	66.6	46.1	37.2	40.4	118.3	0.7	533.6	0.9	31.6	6.9	2.0	600.9	238.4	4.2	508.2	140.0	22.3	2.3	34.9	5.9	73.1	482.4	121.0	2.6	5.3	58.5	3.9	38.4	246.4	167.4	289.3	99.1	151.0	0.9	0.8	0.7	107.8	0.6	317.2	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	41.5	62.2	26.3	57.2	39.4	28.2	49.4	42.7	22.8	20.9	79.0	77.1	90.0	3.2	4.1	1.6	8.3	181.2	26.7	75.1	189.5	9.4	32.3	44.3	10.4	1.5	13.4	1.8	0.0	6.7	10.8	3.9	0.0	12.8	14.3	8.0	37.8	120.6	42.1	28.0	12.1	5.1	110.8	48.9	10.7	10.1	16.5	256.5	84.6	0.8	274.2	0.0	10.9	5.4	8.2	28.0	136.1	12.3	25.4	27.4	51.6	23.4	1028.2	73.5	0.0	4.5	43.2	15.5	1.1	9.1	4.2	7.5	0.4	0.4	2.9	2.6	0.0	29.7	46.3	5.7	8.0	121.2	147.2	14.6	12.2	8.3	2.6	28.0
FSCN2	"RFSN, RP30"	ENSG00000186765	"Fascin actin-bundling protein 2, retinal"	O14926	17	81528377-81537130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 4.5;retina: 8.7"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 25.0;Exocrine glandular cells: 12.0;Rod photoreceptor cells: 25.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;T-47d: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079270	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA079270: "	"unprognostic (3.50e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.73e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.11e-1)"	0.2	0.2	0.4	0.2	0.5	0.1	0.5	1.2	0.6	1.1	0.2	0.5	0.2	1.3	0.5	0.6	0.8	0.1	0.3	0.1	0.2	0.9	0.1	0.5	0.2	1.0	0.3	0.9	4.5	2.0	1.0	0.1	0.4	0.8	0.1	8.7	1.8	0.4	0.1	0.5	0.5	0.1	0.6	0.6	0.8	0.5	0.3	0.1	4.2	0.1	0.2	0.3	0.5	0.5	0.7	0.4	0.3	0.5	0.1	0.0	0.5	0.3	0.5	0.0	0.0	0.4	0.5	0.5	1.9	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.2	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.6	0.6	0.1	0.1	0.2	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.2	0.6	0.1	0.2	1.0	0.3	0.4	0.6	0.3	0.5	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.2	0.0	3.8	0.6	0.4	0.9	0.0	0.0	0.0	25.0	0.1	0.0	0.1	1.9	0.4	0.5	0.1	0.1	0.2	0.0	0.0	0.7	12.0	0.5	0.1	1.1	0.1	0.0	0.5	0.0	0.0	0.1	3.3	0.9	0.0	0.0	0.0	0.0	3.2	0.3	0.3	0.0	0.0	1.0	4.9	0.0	3.5	0.3	3.0	0.1	0.0	0.2	0.1	0.3	0.1	0.0	25.7	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.0
FSCN3		ENSG00000106328	"Fascin actin-bundling protein 3"	Q9NQT6	7	127591409-127602144	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	138	"testis: 99.1"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 2359.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075174	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA075174: "	"unprognostic (7.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.68e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-5)"	"unprognostic (1.27e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.34e-2)"	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.7	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	99.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	1.1	0.0	0.0	0.8	0.4	0.3	1.2	0.0	0.4	0.4	0.5	1.5	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	333.6	0.2	0.5	1.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.5	1.3	0.2	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.3	1.3	2359.0	9.3	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.4	8.2	0.0	0.3	0.3	0.0	0.0	0.4	0.0	1.0	1.1	10.7	7.2	0.2	1.3	0.3	0.4	0.2	0.3	0.2
FSD1	"MGC3213, MIR1"	ENSG00000105255	"Fibronectin type III and SPRY domain containing 1"	Q9BTV5	19	4304598-4323843	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.0;testis: 7.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4"	"Group enriched"	"Detected in many"	6	"glioma: 9.2;testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 55.3;SH-SY5Y: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043141	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA043141: AB_10797137"	"unprognostic (8.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.29e-2)"	"unprognostic (9.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	0.3	0.7	11.9	0.7	12.7	0.7	0.0	9.3	15.6	0.6	2.5	0.6	1.0	0.5	0.1	0.2	0.1	0.3	0.1	13.9	12.1	0.3	0.4	0.2	1.1	14.7	10.4	0.2	0.1	0.0	2.0	0.8	16.0	0.3	0.1	1.8	0.1	0.1	0.0	0.2	0.9	0.4	7.7	0.9	0.3	7.6	15.5	0.9	0.1	0.0	0.4	0.1	0.3	11.7	0.1	6.7	18.6	9.7	0.1	1.8	7.9	7.9	3.2	25.0	19.3	15.6	0.5	24.3	6.7	5.5	13.1	1.6	17.0	12.8	8.0	15.6	24.9	6.8	5.6	0.5	9.9	0.0	1.6	4.2	0.1	14.6	0.9	10.1	13.5	21.5	1.1	0.0	1.2	18.4	11.2	0.0	23.9	0.1	12.7	0.0	8.8	0.0	0.1	0.6	55.3	57.6	2.1	0.9	1.7	3.0	0.2	0.2	15.3	3.9	17.6	7.3	7.3	13.7	18.4	6.1	9.4	0.0	9.7	0.0	0.0	0.0	0.5	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	5.4	0.0	1.4	0.4	0.7	11.9	12.7	9.3	15.6	13.9	12.1	14.7	10.4	16.0	7.7	15.5	11.7	0.2	0.0	1.1	2.0	0.4	0.1	0.7	0.0	0.0	12.6	0.1	0.0	0.5	0.0	0.6	3.7	2.1	3.2	6.1	0.3	15.6	0.1	4.0	0.1	1.1	0.5	2.4	2.7	26.6	0.0	1.3	1.4	0.5	0.2	2.5	3.5	0.7	0.4	0.8	16.8	19.7	0.4	0.0	0.0	0.0	5.3	0.9	0.3	0.0	3.7	0.1	1.7	16.5	8.5	9.5	0.0	0.1	0.4	0.5	0.3	0.0	0.3	0.0	7.1	0.0	0.9	1.6	3.7	30.4	0.0	0.0	2.7	5.6	0.1	0.3	0.4
FSD1L	"CCDC10, CSDUFD1, FSD1CL, FSD1NL"	ENSG00000106701	"Fibronectin type III and SPRY domain containing 1 like"	Q9BXM9	9	105447796-105552433	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 423.3;Early spermatids: 97.2;Excitatory neurons: 79.0;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035138	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA035138: AB_10601324"	"unprognostic (9.28e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.17e-5)"	"unprognostic (4.20e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.22e-3)"	1.2	3.5	8.4	2.1	9.4	2.4	1.6	7.8	10.0	1.7	6.3	2.6	4.5	2.1	3.3	0.9	7.1	1.4	4.1	8.9	12.3	2.1	0.7	2.2	1.4	13.2	11.4	1.4	1.4	2.0	3.3	0.9	11.5	1.6	2.4	43.2	1.1	1.6	7.3	1.1	3.7	1.5	11.7	1.4	2.2	5.8	12.5	1.6	2.0	13.3	1.5	1.1	0.9	12.0	3.3	3.8	5.6	3.9	1.6	3.2	2.0	3.1	1.8	2.5	2.5	1.7	1.4	8.3	1.2	2.7	3.0	1.3	3.6	1.6	3.5	11.1	1.3	1.4	5.3	2.3	2.5	4.9	3.4	1.5	1.6	3.6	5.5	3.2	2.4	3.9	1.8	5.1	2.5	1.1	8.4	3.1	3.5	0.4	2.2	10.6	3.8	0.7	2.6	0.7	12.3	5.9	3.5	0.9	3.0	2.3	3.7	1.7	3.2	4.4	2.7	3.7	4.2	2.6	9.9	2.2	3.1	3.0	1.6	0.4	0.9	0.0	0.5	0.6	0.2	1.8	0.7	0.5	0.6	0.6	0.0	0.3	0.2	0.5	0.4	0.6	0.2	0.2	8.4	9.4	7.8	10.0	8.9	12.3	13.2	11.4	11.5	11.7	12.5	12.0	2.9	3.2	1.1	23.8	4.2	1.0	2.0	2.5	0.0	23.1	2.3	2.0	6.0	1.5	3.5	7.3	423.3	0.3	3.4	3.0	1.9	22.7	97.2	47.5	5.7	3.3	10.7	1.7	79.0	3.8	1.3	5.2	2.6	15.1	14.0	10.4	1.1	1.3	3.8	52.2	59.2	6.3	2.0	1.2	3.5	68.2	5.0	5.3	10.6	16.9	21.0	12.7	1.0	21.6	66.9	5.2	7.1	6.8	3.0	1.1	7.8	2.4	44.9	121.1	13.1	6.3	4.1	26.0	26.1	0.3	0.9	0.0	2.8	2.2	6.8	0.2
FSHB		ENSG00000131808	"Follicle stimulating hormone subunit beta"	P01225	11	30231014-30235261	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	436	"pituitary gland: 239.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB023410, HPA069703"	Enhanced				"Secreted to blood"	NA	NA		78000		"Cluster 26: Pituitary gland - Hormone signaling"					"CAB023410: AB_324983, HPA069703: AB_2686176"												"unprognostic (1.04e-1)"						0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782841	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 10.9;testis: 7.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041002	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.2	0.2	1.6	0.2	1.8	0.6	0.9	0.0	1.6	0.2	1.7	7.3	0.1	0.3	0.3	0.1	1.2	0.2	0.2	1.2	1.8	0.8	0.1	0.2	0.1	1.1	1.3	0.1	0.1	0.8	1.4	0.3	0.9	0.2	10.9	0.9	0.1	0.2	0.2	0.9	0.1	0.3	0.3	0.2	0.5	7.2	2.0	1.4	0.4	0.1	0.1	0.3	0.1	0.4	0.4	1.3	3.4	0.5	0.6	1.1	0.0	4.1	0.8	0.6	1.2	1.0	0.3	0.2	0.3	1.2	1.7	0.8	0.5	0.7	1.0	1.4	0.3	2.5	0.9	0.0	0.3	0.5	2.7	0.7	2.8	1.5	0.6	0.8	0.7	1.4	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.2	0.6	0.3	0.7	0.1	1.3	1.5	0.8	2.5	0.8	0.1	0.1	0.3	1.1	0.3	0.6	1.6	0.9	0.9	0.4	0.7	1.6	0.2	3.3	0.9	0.8	0.4	0.3	0.4	0.7	0.2	0.5	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.4	1.6	1.8	0.0	1.6	1.2	1.8	1.1	1.3	0.9	0.3	2.0	0.4	0.7	0.0	0.5	8.1	1.1	0.6	0.6	3.4	0.0	1.1	14.5	7.9	0.8	2.8	2.9	1.8	12.5	0.9	1.4	17.5	1.9	1.0	67.1	10.0	2.1	1.0	0.0	0.0	28.2	0.4	0.1	1.5	0.5	0.6	15.8	0.4	0.4	0.0	0.1	0.0	21.5	3.5	0.0	0.0	0.3	48.3	1.2	0.6	0.0	7.5	0.1	1.0	3.1	3.0	3.2	0.1	6.6	0.7	0.4	0.7	0.0	3.2	12.6	6.1	0.0	1.2	1.5	35.3	8.3	0.2	0.0	5.6	3.3	0.7	2.9	0.3
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	26.1	6.2	0.8	3.0	0.5	0.4	15.2	0.4	0.7	7.7	0.7	9.8	1.8	4.2	3.7	6.5	11.8	7.2	9.4	2.0	2.0	2.9	68.7	8.2	1.6	1.8	1.0	9.9	2.6	0.5	5.9	24.1	0.9	15.5	3.0	0.3	11.3	10.8	9.2	18.0	8.8	4.7	0.5	0.3	11.1	5.0	1.1	2.3	4.0	7.7	12.9	40.4	7.5	0.7	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.4	0.7	2.0	2.0	1.8	1.0	0.9	0.5	1.1	0.7	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120450993	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 12.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		34000000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	432.4	134.3	20.5	116.3	18.1	2.2	166.1	22.8	22.7	279.9	83.0	156.4	37.1	157.5	50.8	126.1	150.6	257.0	242.7	20.6	22.8	45.4	35.7	120.7	50.3	28.5	44.6	90.3	37.3	35.5	25.7	442.0	23.1	188.3	90.4	29.8	59.3	184.4	31.8	64.2	69.1	409.6	22.7	63.1	68.6	33.5	22.7	24.2	78.8	89.8	38.8	260.4	104.3	20.6	81.0	21.2	222.9	91.8	1304.4	1782.4	1.3	2156.3	1208.9	1374.5	1211.0	0.1	178.5	0.8	178.8	2692.9	112.8	20.5	68.6	270.0	1741.5	1.1	32.5	0.4	159.8	0.3	286.0	1.2	0.9	1362.7	8.5	884.5	192.7	612.1	811.6	11.2	0.5	0.3	227.6	0.5	22.6	2.0	181.3	0.4	181.9	0.7	92.7	1.0	150.4	1.7	39.2	93.5	764.6	13.6	76.5	462.6	23.5	6.2	986.8	507.4	479.8	268.0	323.8	1.0	1.1	2.3	177.4	0.9	67.0	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	2.6	20.5	18.1	22.8	22.7	20.6	22.8	28.5	44.6	23.1	22.7	22.7	20.6	76.9	64.1	9.4	56.5	1.1	64.1	31.9	36.4	10.2	2.3	25.6	24.6	127.5	8.6	42.5	23.9	0.0	114.4	2.5	0.9	0.0	62.6	2.3	44.4	176.7	111.4	3.0	3.6	9.6	5.8	352.1	521.9	3.1	23.0	1.3	66.5	142.5	17.4	20.6	1.7	16.2	0.2	8.2	10.8	91.6	9.8	327.4	11.5	110.3	30.0	9.9	116.1	0.0	9.5	0.9	117.8	0.7	270.8	0.9	108.4	0.0	5.5	74.9	4.3	59.2	62.5	129.3	1.5	4.4	2.2	48.2	54.7	7.1	47.5	0.9	65.3
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676392-683392	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 3647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 164.7;hTCEpi: 181.2;SiHa: 341.5;U-2197: 173.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		7000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	82.9	163.3	16.6	24.1	15.3	13.3	62.4	13.3	19.8	75.6	16.0	82.7	7.7	62.0	6.1	22.0	70.2	16.5	124.1	16.4	17.3	55.9	26.2	132.7	5.5	22.6	16.0	63.8	49.3	3.2	28.9	179.4	17.9	74.9	5.9	2.4	21.1	22.1	11.7	32.3	36.5	42.4	16.7	22.6	43.2	75.2	18.1	2.3	37.9	4.9	1.6	70.5	63.1	18.9	9.5	74.0	5.1	3.7	22.3	56.4	164.7	126.1	18.5	30.7	11.3	27.1	14.4	4.1	49.4	84.7	17.6	65.2	4.1	106.4	10.1	7.8	8.7	3.5	110.2	22.4	95.6	6.7	12.0	70.7	181.2	34.0	140.2	79.3	5.5	3.9	8.2	5.3	46.7	33.1	2.4	4.0	6.2	62.0	26.2	7.2	3.4	8.7	43.1	1.7	3.3	5.7	341.5	6.9	4.3	6.4	6.2	3.5	75.5	30.6	106.6	173.4	46.9	8.5	4.4	2.3	4.7	20.0	14.2	0.0	1.9	0.0	0.4	1.8	0.0	0.1	0.6	0.4	0.9	0.3	1.0	0.6	0.0	0.2	1.4	0.3	0.0	0.9	16.6	15.3	13.3	19.8	16.4	17.3	22.6	16.0	17.9	16.7	18.1	18.9	4.6	19.2	1.9	40.5	1.5	14.5	31.0	11.7	1.8	1.3	11.3	7.9	16.7	32.9	4.4	9.2	0.0	53.9	1.0	1.1	7.9	86.1	8.8	6.4	14.8	8.7	1.2	1.7	9.8	64.3	3647.6	59.6	2.0	18.3	0.0	5.7	16.4	1.9	77.1	3.3	8.4	1.0	0.0	3.7	4.8	7.6	61.2	7.4	5.4	2.8	10.6	6.6	1.0	6.0	5.5	306.5	0.2	26.7	1.0	78.0	1.2	17.7	3.1	1.1	46.0	22.4	57.0	4.6	5.6	4.3	7.7	792.0	2.0	3.6	2.5	30.7
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612541	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 390.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 57.2;U-266/70: 19.3;U-266/84: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Uncertain	Mitochondria	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.1	1.3	5.5	0.6	5.5	1.9	0.6	8.5	11.2	0.3	0.0	1.1	0.7	0.2	1.5	1.9	0.9	0.5	0.3	3.1	3.2	2.8	0.1	1.2	0.3	0.0	6.2	0.4	1.9	3.1	2.3	3.8	0.0	1.6	1.1	3.9	0.7	0.0	0.9	3.4	0.8	0.2	0.0	0.4	1.4	1.7	21.4	1.3	0.8	0.5	1.1	6.0	0.9	7.8	7.5	13.1	1.4	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	12.5	1.7	0.7	10.5	0.0	1.3	0.2	1.7	0.5	0.0	0.9	0.6	0.6	13.9	1.1	0.0	0.0	0.7	0.3	1.8	0.0	0.1	0.3	0.0	0.5	5.9	7.0	0.0	12.7	1.5	0.6	14.4	14.2	1.6	0.6	1.3	14.1	0.0	15.0	57.2	1.6	2.9	2.4	0.3	12.2	4.6	0.5	0.3	0.6	2.4	0.8	0.4	19.3	20.7	0.5	0.2	0.1	0.4	1.1	0.2	0.1	0.2	0.0	0.5	0.6	0.4	0.3	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.3	0.3	0.3	5.5	5.5	8.5	11.2	3.1	3.2	0.0	6.2	0.0	0.0	21.4	7.8	0.0	0.0	3.1	21.5	1.0	1.7	2.5	0.2	4.0	10.1	0.6	0.3	9.6	0.0	4.4	0.0	14.6	0.4	0.1	0.0	0.0	0.2	35.9	1.2	0.2	0.6	9.0	0.0	390.3	0.0	0.0	0.4	0.0	0.1	0.0	1.4	0.0	0.0	0.1	1.7	57.9	0.4	0.0	0.0	0.0	20.4	0.3	1.2	10.6	8.4	0.0	3.0	0.0	21.1	4.5	0.6	0.0	0.7	0.0	0.4	0.2	2.5	3.7	2.6	6.6	0.0	1.1	0.5	0.7	3.3	1.6	0.0	0.4	0.9	0.1	2.9
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967634	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 49889.9;monocytes: 34409.9;Proximal enterocytes: 28837.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 23933.9;HHSteC: 24849.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008623	Approved					NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"			"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	6767.7	5191.4	5741.8	3546.9	5464.0	4734.2	5696.1	5591.9	7973.3	3973.1	4801.2	4701.2	1819.9	3712.8	2421.8	4025.0	3195.6	1995.6	4779.5	5252.8	5737.2	6092.3	3500.8	6057.7	1460.4	6416.7	5812.4	3069.9	3883.8	1696.4	2105.4	1800.3	6188.9	2778.8	3357.4	3123.7	3533.1	1514.8	4695.5	2125.0	4331.6	2040.7	6506.2	3496.3	4044.1	769.5	6153.5	1109.8	3167.6	2766.8	1291.2	4718.0	3163.8	6630.2	3029.8	8290.2	1236.6	3293.8	23933.9	11490.1	6794.4	2684.1	11547.3	2694.6	2698.6	1011.0	4065.8	345.3	16669.6	7830.0	10259.7	5035.8	1118.8	2235.9	1733.9	1439.0	542.9	1720.3	10802.1	6692.1	24849.2	821.6	2626.6	15711.1	10758.7	5384.0	10038.1	8476.6	3427.6	1970.7	2622.1	3874.4	9546.5	4080.7	935.3	1361.8	2114.6	10461.4	13675.6	914.9	1508.5	2502.3	13877.6	8068.8	1044.8	1325.0	9113.3	1005.9	4645.6	4045.3	1790.3	1098.4	3791.5	8310.7	1978.7	3727.4	1732.0	662.7	2516.5	1088.1	11353.7	363.1	2030.4	29466.0	19068.5	15453.6	2306.3	22407.8	2274.9	4088.8	3267.1	2296.9	9762.5	4113.3	2710.5	2108.2	45110.1	1981.1	27515.2	7217.1	4321.5	22214.4	5741.8	5464.0	5591.9	7973.3	5252.8	5737.2	6416.7	5812.4	6188.9	6506.2	6153.5	6630.2	3864.7	1317.3	2890.3	319.3	3200.9	5157.7	7723.2	23426.3	3495.0	881.7	9884.9	10192.4	11.7	4466.7	11711.1	1918.2	573.4	4541.1	4513.5	13653.9	10888.0	10748.7	274.2	4921.8	2908.5	4303.3	2520.6	6318.6	252.8	11073.9	6803.9	5931.3	2059.7	8005.0	6736.0	1798.6	3266.1	5199.9	18411.3	738.6	153.7	3927.4	10379.8	13784.1	49889.9	527.7	4666.1	22792.0	7116.5	183.6	34409.9	12189.1	1699.3	153.3	1031.0	7813.2	7936.8	3818.1	1789.1	12995.8	28837.7	21355.6	5978.6	3311.6	2084.0	2686.9	6139.1	585.4	927.1	1983.6	3555.6	4622.6	5225.4	2496.8	4921.7	18650.3
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965309-48966879	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 14422.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 125209.0;monocytes: 102128.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 24796.9;HSkMC: 20811.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020769, HPA041602"	Enhanced		Approved	Cytosol		NA	NA		170000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	6778.7	3262.2	6806.2	2353.2	7172.4	4213.8	4226.0	6782.1	10053.2	2094.3	6429.7	2451.1	2427.0	1523.4	1010.8	1306.2	2169.9	4298.0	2537.3	6497.7	6998.4	8845.6	14422.9	7261.1	3353.2	7250.8	6998.4	2455.3	2166.2	931.7	1730.4	3423.2	7218.5	1946.5	1800.0	684.9	1663.5	1390.4	1345.9	1449.7	2806.6	1842.3	7149.5	6751.4	3204.5	455.9	7581.8	1168.9	3000.4	1072.0	1334.6	4239.9	1804.7	7334.0	869.7	12906.5	949.6	1457.0	16013.9	16478.6	1693.1	2194.1	12820.0	3090.7	6903.8	2852.3	3413.2	656.4	4104.3	13203.9	6755.6	505.8	788.2	1301.8	2765.6	8895.0	507.6	1740.0	3222.8	18949.7	24796.9	4133.3	5591.2	20811.1	1735.9	5272.5	2301.6	4590.4	4549.8	774.6	3284.9	1328.2	6198.4	213.0	1152.1	2402.8	1729.8	15140.6	1306.9	947.6	643.0	6763.9	1989.7	545.0	1209.9	701.5	5761.7	313.4	1239.5	5104.1	183.2	8493.4	3438.3	3353.4	1740.1	4364.3	3083.1	5690.2	13742.1	625.1	3563.9	4334.7	6017.7	64938.4	71067.8	77353.0	6560.6	102128.9	7527.7	17097.3	7247.4	7054.3	25176.6	15607.2	8656.4	7466.9	125209.0	4978.3	91398.0	10579.6	9634.4	94147.5	6806.2	7172.4	6782.1	10053.2	6497.7	6998.4	7250.8	6998.4	7218.5	7149.5	7581.8	7334.0	2757.2	1125.0	3379.9	88.5	3311.5	2793.9	6799.5	2785.4	2159.8	474.7	2597.9	3977.3	777.8	4398.0	2550.4	2021.2	177.2	941.5	2199.4	2314.2	10704.0	4251.2	290.2	504.9	1413.1	4867.0	1613.4	4331.2	60.6	6134.8	1447.8	5703.3	1715.1	617.4	2365.7	942.2	4598.0	23702.0	74983.4	533.3	113.8	2368.8	3039.4	70127.1	16939.0	1601.8	4175.9	34584.5	5085.3	129.3	22965.8	3161.9	2020.6	55.8	309.7	6905.5	5604.7	2010.8	4884.7	9790.5	21474.5	58047.8	1908.0	682.6	1341.1	1643.8	3455.6	82.1	311.2	1985.5	2226.7	1502.7	2590.4	1492.0	2816.8	13083.6
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA 2'-O-methyltransferase 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 75.7;Pancreatic endocrine cells: 60.1;Plasma cells: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	14.6	15.2	5.7	14.5	6.8	16.0	13.8	6.5	9.0	16.0	5.2	10.2	8.2	13.8	4.6	14.9	12.1	8.6	11.4	6.6	6.7	10.1	9.8	13.3	16.2	6.0	6.2	12.7	16.8	12.4	12.2	8.4	6.2	10.3	7.7	5.7	15.4	12.8	14.8	14.2	10.2	12.3	6.2	13.7	13.7	9.8	5.8	14.8	14.3	10.9	13.4	14.3	14.1	6.6	75.9	51.1	19.1	76.4	27.1	27.9	31.3	36.0	34.3	51.4	40.5	30.8	102.6	43.6	26.3	55.4	32.4	49.8	38.3	127.3	23.1	33.4	36.3	27.8	62.5	35.5	75.8	38.5	67.4	26.0	63.0	64.8	63.2	28.5	36.4	49.2	24.1	35.2	67.4	42.6	50.4	27.3	43.2	32.1	86.6	40.4	62.7	91.2	48.3	25.4	26.0	25.5	57.4	31.1	27.5	22.1	35.7	21.7	35.8	40.6	54.9	85.3	44.9	47.6	39.8	31.4	89.6	71.3	43.6	19.5	23.7	19.1	34.6	27.1	43.0	27.2	29.5	35.4	28.3	31.5	26.8	34.5	3.4	30.3	27.8	19.1	30.2	27.8	5.7	6.8	6.5	9.0	6.6	6.7	6.0	6.2	6.2	6.2	5.8	6.6	15.1	6.4	11.0	3.9	20.6	12.7	11.4	30.7	14.2	4.5	8.5	8.8	6.7	4.3	23.8	7.3	2.1	5.3	19.7	6.6	17.6	21.2	49.5	11.1	11.8	13.4	5.4	14.7	4.4	18.2	28.7	12.4	16.3	15.2	8.8	9.2	6.4	5.9	17.0	3.3	4.3	11.3	10.2	8.4	10.6	75.7	10.8	11.0	5.4	5.6	8.9	5.7	19.6	3.0	5.8	60.1	2.7	8.6	59.5	17.0	4.8	11.3	14.0	6.5	13.1	9.6	16.7	7.5	10.1	15.0	10.9	5.7	17.0	10.7	9.4	26.5
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		300000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	29.6	37.8	13.4	35.5	15.3	79.6	30.9	24.0	17.9	28.1	18.5	24.3	24.9	36.4	36.8	24.8	28.5	16.8	29.7	13.8	15.9	39.3	17.1	31.6	42.8	15.6	13.4	46.9	33.7	23.0	41.7	23.0	15.7	24.1	27.5	57.2	30.5	13.3	33.8	27.5	27.5	19.0	15.1	35.2	26.1	17.0	15.3	35.7	36.9	15.2	38.6	25.3	27.4	24.3	49.4	36.5	106.9	40.0	11.9	19.0	77.6	53.5	23.4	35.8	29.2	34.7	49.1	91.3	22.1	31.9	49.1	51.4	54.8	45.4	48.1	91.6	38.5	58.8	87.4	56.9	25.8	104.9	22.8	25.2	35.5	39.7	36.4	39.6	29.2	59.1	65.8	45.1	31.0	39.0	74.0	60.4	75.7	38.0	26.2	94.6	78.7	30.9	35.2	49.0	54.2	61.1	41.5	42.8	44.2	44.7	52.9	38.7	50.7	50.7	66.0	14.7	62.5	44.8	39.4	106.1	21.1	45.3	44.5	6.5	10.5	12.3	20.5	17.0	23.3	19.0	19.6	20.8	9.3	14.7	19.4	23.6	5.3	29.4	19.1	15.4	24.5	15.3	13.4	15.3	24.0	17.9	13.8	15.9	15.6	13.4	15.7	15.1	15.3	24.3	38.6	73.7	57.5	48.0	70.7	84.8	107.0	49.5	39.3	44.7	48.7	31.2	76.4	24.3	71.0	33.1	41.7	46.8	68.2	27.1	43.0	59.5	33.3	54.8	50.7	52.0	55.1	43.1	48.8	72.1	66.2	49.0	28.5	60.5	77.8	59.4	30.4	23.4	33.4	18.5	53.6	35.9	36.7	32.1	37.0	19.8	48.1	41.8	39.2	61.8	61.5	32.5	52.5	56.3	88.3	69.2	33.5	30.1	68.9	54.2	23.6	28.9	73.2	40.5	32.9	70.3	65.7	33.2	41.3	40.9	63.1	35.7	72.1	38.0	37.8	72.7
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		63000	"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	29.9	23.6	20.4	20.9	23.7	12.4	21.5	22.2	25.3	23.3	16.4	26.1	21.4	30.4	20.5	24.8	21.8	20.4	26.7	19.4	21.0	22.9	40.4	21.3	21.9	24.2	22.5	24.9	22.9	33.7	17.5	28.5	23.8	26.6	20.9	20.2	23.7	24.7	16.0	22.1	22.4	27.0	21.5	22.9	22.5	17.0	22.1	25.8	41.5	13.6	20.9	22.8	22.6	24.5	47.3	42.4	61.1	50.8	43.2	48.7	76.8	67.1	59.0	51.9	40.3	62.0	42.3	45.8	34.5	63.4	45.7	80.3	51.5	56.1	61.1	51.2	45.7	50.3	66.8	46.1	59.2	76.4	54.5	47.6	44.1	54.5	51.1	43.8	43.7	37.2	82.1	27.5	54.7	63.3	59.3	38.8	78.2	74.4	54.5	52.6	75.4	61.7	45.6	49.2	39.5	66.4	70.5	51.8	44.4	45.7	71.0	57.9	55.4	93.9	44.4	63.5	78.4	25.1	44.8	57.9	52.8	33.0	68.2	0.0	2.1	1.2	2.4	2.5	3.6	2.3	2.6	2.9	3.1	1.6	3.1	2.7	0.5	4.0	2.0	2.7	2.3	1.5	20.4	23.7	22.2	25.3	19.4	21.0	24.2	22.5	23.8	21.5	22.1	24.5	26.1	19.2	20.6	45.4	19.5	33.4	20.6	17.6	24.5	26.2	23.0	13.6	20.4	20.0	15.2	16.5	14.6	28.3	18.1	21.1	29.4	19.0	5.1	18.0	24.3	23.9	21.7	20.2	49.4	18.9	31.8	25.0	20.9	26.2	7.6	26.6	26.4	52.0	26.7	32.0	54.1	17.2	20.3	25.4	20.4	9.6	20.5	17.6	37.4	30.0	18.1	59.1	12.3	41.2	56.9	25.7	17.0	27.8	22.8	28.3	15.5	35.9	22.8	28.0	13.1	29.3	29.9	16.8	12.4	31.4	40.9	45.8	19.4	20.7	17.7	26.0
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494812-143511720	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 165.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		56000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	28.9	41.4	13.5	25.4	16.4	25.8	26.3	16.0	15.3	29.2	30.2	41.5	42.6	25.6	44.9	14.2	23.7	27.8	27.9	12.4	16.5	54.8	52.3	28.9	17.2	17.1	14.2	30.4	34.6	165.8	15.8	50.5	17.8	21.9	52.8	6.1	25.4	25.8	6.9	12.3	39.3	27.6	16.4	24.6	38.3	12.6	15.9	6.6	32.0	11.6	17.0	33.5	20.4	20.9	97.4	55.7	47.6	86.9	69.0	134.4	90.1	89.9	95.4	108.1	182.0	107.1	94.8	0.2	66.1	120.8	33.9	0.6	24.1	11.7	148.9	87.2	92.6	32.6	100.1	163.2	99.3	0.3	15.8	72.3	69.4	96.6	41.5	91.6	111.4	0.2	117.6	49.3	123.2	114.6	0.2	75.9	62.1	44.2	76.0	0.2	99.7	72.1	129.0	59.5	36.0	23.6	98.7	65.3	82.3	36.3	32.1	79.6	65.9	64.1	54.0	161.6	175.4	18.3	21.3	0.7	74.1	59.1	22.5	38.8	84.9	26.2	13.2	84.0	15.0	11.3	9.8	11.3	65.4	8.3	4.4	7.9	5.5	29.6	62.0	10.3	19.8	51.9	13.5	16.4	16.0	15.3	12.4	16.5	17.1	14.2	17.8	16.4	15.9	20.9	27.3	41.7	35.9	9.1	13.5	11.2	12.6	30.3	9.1	3.7	19.2	12.6	28.0	38.6	37.9	25.8	0.0	52.5	10.3	47.6	11.7	81.9	2.0	26.8	55.2	25.0	9.6	18.7	8.7	124.9	109.8	62.6	34.7	28.9	37.4	38.1	23.6	35.2	110.3	1.7	11.8	38.1	46.8	57.5	29.2	2.6	66.8	51.7	42.7	9.4	49.1	11.1	13.4	5.5	14.5	74.6	38.2	45.5	47.7	13.8	60.3	51.4	34.8	1.1	6.6	33.8	35.0	4.8	4.6	13.2	8.0	46.4	11.5	78.8	50.4	18.4
FUNDC1	MGC51029	ENSG00000069509	"FUN14 domain containing 1"	Q8IVP5	X	44523639-44542859	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038773	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA038773: AB_10670789"	"unprognostic (1.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.88e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (6.67e-3)"	"prognostic favorable (2.58e-4)"	11.5	18.4	30.5	9.5	31.3	11.3	20.4	35.9	37.8	14.4	30.3	12.7	12.5	13.4	22.4	13.1	15.3	15.8	37.6	30.5	34.2	25.2	13.0	10.5	17.8	36.0	31.7	19.0	10.2	28.2	14.8	11.5	34.5	16.3	13.5	34.2	49.2	11.5	17.9	16.2	8.0	12.4	32.0	12.8	29.7	14.4	33.3	20.0	16.8	24.9	16.3	15.5	12.0	32.1	39.4	33.1	36.5	22.4	15.8	21.8	20.8	19.4	29.4	38.2	41.7	41.3	32.2	29.0	19.1	26.6	83.5	21.0	60.4	36.7	46.2	32.2	67.6	32.5	41.5	32.3	23.4	35.3	103.3	22.1	35.3	55.1	27.4	36.6	23.8	30.9	34.9	18.0	45.8	41.6	32.9	42.6	43.3	33.6	38.4	20.3	37.1	21.5	39.1	28.0	20.0	31.6	59.3	32.5	37.7	66.0	65.4	0.1	14.0	23.5	34.1	28.0	21.6	14.0	25.2	34.6	31.1	13.8	31.3	7.5	6.3	10.9	7.3	6.3	9.8	10.8	10.1	11.5	11.6	6.6	11.5	9.0	6.8	11.5	4.6	23.8	10.7	5.5	30.5	31.3	35.9	37.8	30.5	34.2	36.0	31.7	34.5	32.0	33.3	32.1	15.2	19.2	10.8	5.2	12.5	14.8	20.1	67.3	18.2	21.9	18.6	21.2	41.6	27.1	34.1	25.8	6.2	35.3	13.0	14.0	115.4	33.6	1.7	27.1	20.9	15.8	10.2	12.0	5.3	36.8	29.4	20.2	16.8	23.1	7.6	36.4	20.3	14.8	37.5	21.9	6.4	13.8	42.7	14.5	7.2	5.7	23.0	13.6	14.2	6.5	13.1	62.9	17.5	6.6	6.8	34.6	26.0	21.8	14.3	17.5	14.5	50.7	26.4	16.1	13.1	12.9	19.8	19.9	45.4	20.7	16.3	26.5	12.7	35.5	17.1	26.0
FUNDC2	"DC44, HCBP6"	ENSG00000165775	"FUN14 domain containing 2"	Q9BWH2	X	155025980-155060304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.3;tongue: 19.5"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1375.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059129	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA059129: AB_2683915"	"unprognostic (2.23e-1)"	"prognostic favorable (9.20e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.07e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (6.56e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.81e-1)"	3.7	3.6	3.3	1.6	3.6	3.3	3.2	4.4	3.5	3.6	3.8	4.0	2.0	3.3	3.5	2.4	3.7	2.8	10.4	3.4	3.6	4.4	2.5	2.5	2.5	3.9	3.6	6.5	7.7	4.3	3.0	2.5	4.0	3.3	2.5	3.1	3.3	2.9	18.3	1.5	2.1	4.0	3.8	1.9	3.2	2.5	3.9	2.8	3.1	19.5	2.2	3.0	2.5	3.4	5.3	2.7	4.9	3.7	6.5	5.0	3.7	3.1	3.6	3.8	7.7	2.8	2.1	7.0	7.7	4.0	2.9	2.2	5.3	4.3	2.6	3.6	6.2	2.2	3.8	1.6	2.9	4.6	2.8	5.6	6.5	3.1	2.7	2.5	2.6	3.0	2.9	4.9	4.0	2.4	3.4	2.6	3.3	4.3	6.4	2.9	3.5	7.0	3.9	2.1	2.6	5.5	2.6	2.7	3.9	2.4	2.8	4.4	2.7	2.8	4.0	5.1	4.9	3.0	5.4	7.3	2.8	5.7	2.3	1.5	2.1	2.1	2.5	2.3	2.3	2.5	2.3	2.4	2.7	2.2	2.4	2.6	0.1	1.7	2.8	2.4	2.6	3.3	3.3	3.6	4.4	3.5	3.4	3.6	3.9	3.6	4.0	3.8	3.9	3.4	92.7	44.8	43.5	8.8	77.4	72.3	109.7	85.1	68.3	39.6	65.1	77.8	141.8	85.8	46.8	64.4	6.2	71.1	67.4	28.7	223.0	116.3	297.0	43.4	49.9	73.8	47.8	84.6	5.5	113.7	95.3	109.2	35.7	45.2	68.9	69.8	48.9	76.1	81.8	45.4	7.1	48.8	61.1	55.4	52.6	1375.2	107.8	66.2	67.6	5.6	60.0	109.3	64.9	7.5	12.8	104.9	35.4	76.3	104.7	142.4	78.2	193.0	39.5	49.2	26.3	141.6	90.9	31.6	46.2	54.6	60.1	79.9	69.4	54.3	51.1	85.8
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355158-133358025	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 61.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Approved					NA	NA		2000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	12.9	8.8	4.2	11.3	4.4	6.6	13.0	4.0	7.2	7.3	8.2	12.0	52.0	5.5	3.2	8.7	7.9	9.6	17.4	4.2	4.6	46.7	228.3	14.1	16.8	5.3	4.7	7.3	18.3	8.0	6.0	5.2	5.7	7.0	5.4	0.3	28.8	3.6	3.0	7.4	46.8	3.6	4.9	23.7	8.5	5.6	5.1	6.1	6.6	2.6	8.0	7.9	7.7	4.8	23.3	7.2	13.6	28.4	3.8	9.2	24.8	18.3	20.7	6.5	8.1	46.4	12.4	0.0	20.7	13.8	0.0	1.2	4.9	6.3	0.5	8.4	4.9	22.3	10.3	50.7	20.1	25.2	14.8	9.6	0.2	2.6	1.4	3.0	9.2	22.9	22.2	29.7	13.9	23.0	3.9	33.6	9.5	13.5	3.2	21.8	0.4	13.0	7.5	0.0	1.4	11.0	6.7	20.6	25.3	6.8	0.2	38.3	18.7	0.1	18.4	0.0	0.1	15.5	2.7	16.7	5.5	10.2	7.1	0.1	68.9	6.5	16.0	73.2	14.7	36.0	14.0	13.4	57.2	34.5	14.9	13.1	3.3	17.1	15.7	79.0	10.4	28.6	4.2	4.4	4.0	7.2	4.2	4.6	5.3	4.7	5.7	4.9	5.1	4.8	20.4	6.4	10.0	0.0	32.7	12.1	9.2	8.5	6.2	0.1	12.2	25.7	10.9	22.8	11.4	9.2	0.0	10.3	25.1	79.2	31.3	13.6	3.7	3.8	9.7	14.1	3.0	24.4	0.6	12.7	9.0	25.6	8.6	7.7	27.3	15.5	25.0	564.7	172.0	0.0	1.2	49.7	6.1	103.0	55.4	10.3	10.2	68.7	26.6	1.9	85.6	3.5	13.4	0.0	1.0	12.5	119.5	3.8	29.6	17.8	690.7	368.1	4.0	1.1	13.1	11.6	14.9	20.2	23.7	10.0	9.9	6.6	21.5	4.1	61.1	12.1
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180138-31191605	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Supported	Nucleoplasm		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	88.6	47.6	43.6	102.9	48.6	98.9	65.1	50.6	59.2	85.3	27.2	72.5	59.5	102.0	40.9	58.5	99.2	38.8	70.4	46.9	48.6	83.6	54.3	64.8	97.9	44.3	43.0	134.2	57.3	85.0	47.2	58.3	46.9	59.1	62.8	59.4	60.0	70.4	98.6	53.8	62.6	98.1	45.7	69.3	59.4	69.1	44.8	174.1	58.6	86.0	113.2	87.5	63.2	52.1	386.6	337.2	492.6	292.9	128.3	101.7	429.3	504.1	253.1	319.6	238.3	440.7	254.9	579.6	359.3	310.7	349.4	173.0	563.6	421.0	284.3	341.5	304.7	486.6	224.6	445.3	222.7	529.7	348.5	222.4	99.8	437.5	258.9	120.1	295.7	419.6	537.6	204.7	357.0	483.0	446.2	475.5	649.0	307.7	402.0	677.0	535.9	350.1	344.0	265.6	279.1	478.9	344.5	255.7	267.8	314.9	291.8	597.5	276.3	371.5	365.5	242.1	520.5	181.4	350.4	779.0	204.4	364.2	460.9	12.3	38.2	52.8	53.6	67.3	49.9	29.1	36.5	45.9	41.7	35.2	40.3	43.9	35.0	37.3	59.3	50.3	31.0	27.4	43.6	48.6	50.6	59.2	46.9	48.6	44.3	43.0	46.9	45.7	44.8	52.1	414.6	102.5	121.2	58.1	470.7	144.8	345.7	201.0	507.6	272.6	209.8	223.8	102.1	112.9	156.3	104.8	131.3	299.3	488.8	266.8	68.4	183.6	130.8	201.0	366.1	278.4	212.1	188.2	75.4	154.8	398.5	309.0	222.8	309.7	229.7	445.0	174.2	59.1	208.5	201.9	85.9	229.5	132.2	148.4	270.7	51.2	307.3	282.7	165.4	94.6	185.4	230.8	341.9	117.6	122.2	175.7	219.4	215.5	266.6	245.4	205.4	69.7	115.4	266.3	164.3	584.4	344.2	221.0	237.1	443.6	154.3	295.1	518.2	327.9	232.6	281.2
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473146	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	1.9	2.2	4.3	1.0	4.7	0.8	3.4	4.2	4.2	4.0	2.0	2.5	2.5	3.1	1.2	1.9	3.3	1.8	1.7	3.0	3.3	3.1	2.0	2.4	1.8	4.3	5.5	5.2	2.6	5.1	1.3	3.5	3.3	2.2	2.7	5.2	2.7	2.1	0.6	3.2	2.6	2.9	2.7	1.5	2.3	1.5	4.8	2.9	2.8	1.2	2.2	2.2	2.2	2.5	2.4	4.5	6.8	8.3	10.8	10.8	3.4	4.3	7.1	4.2	5.4	6.3	3.6	2.7	5.1	5.8	3.5	5.9	10.4	4.1	4.1	5.8	3.8	8.6	3.6	7.0	4.9	1.9	2.9	8.0	7.0	1.1	5.4	8.8	8.6	4.4	8.0	3.2	3.9	1.4	6.6	2.8	9.1	6.4	3.0	4.8	5.1	1.4	6.1	5.4	2.4	2.3	2.5	3.7	5.1	7.0	3.8	1.9	6.6	3.2	1.4	8.1	3.6	1.3	2.2	1.8	2.0	5.4	3.4	0.4	0.6	0.7	1.3	0.2	1.4	1.0	0.7	1.2	1.3	0.3	0.8	0.8	0.4	1.6	0.2	0.7	1.7	0.6	4.3	4.7	4.2	4.2	3.0	3.3	4.3	5.5	3.3	2.7	4.8	2.5	4.5	3.2	2.0	140.0	2.5	2.7	2.7	3.4	4.0	2.9	3.7	3.8	2.5	2.8	3.2	3.7	10.4	12.0	3.0	1.5	1.9	4.5	248.8	2.8	5.7	3.8	3.6	3.8	16.3	4.0	7.0	5.8	6.1	3.0	5.7	10.1	5.3	3.6	3.4	3.3	20.2	3.2	4.1	2.2	1.8	334.2	6.8	2.2	1.8	29.0	3.0	29.9	5.2	44.2	16.4	4.0	1.0	4.9	5.0	1.4	5.3	3.0	2.0	11.0	0.0	5.7	4.6	7.0	2.7	5.5	1.7	6.0	2.6	6.5	3.6	1.3
FUT11	MGC33202	ENSG00000196968	"Fucosyltransferase 11"	Q495W5	10	73772276-73780251	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014033	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA014033: AB_1849192"	"prognostic unfavorable (6.78e-4)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	9.4	5.1	2.5	6.8	3.2	6.4	5.2	4.4	2.8	8.9	1.8	4.5	3.1	6.0	3.2	7.0	4.7	9.0	9.4	2.1	3.8	4.7	5.1	8.7	6.4	4.9	4.8	6.3	4.1	3.7	3.1	17.4	4.1	4.3	3.8	10.0	4.1	6.4	4.1	4.5	3.7	8.3	4.1	10.2	4.9	10.2	5.0	4.3	7.0	4.8	6.2	7.0	4.8	4.9	26.4	14.2	9.9	20.8	19.2	22.2	2.9	13.1	31.3	16.3	31.7	4.7	13.8	6.1	9.3	21.7	5.5	10.9	5.2	13.3	18.1	14.4	10.9	8.1	11.4	7.6	7.5	11.6	24.5	14.8	3.0	15.5	15.9	50.3	30.1	2.7	8.1	10.5	16.4	3.2	2.0	6.0	4.7	2.5	35.1	2.8	6.1	7.2	5.9	4.7	3.0	9.6	11.5	12.0	7.5	8.4	8.2	5.0	31.3	21.1	9.0	10.6	16.4	13.8	5.1	1.4	29.6	10.2	7.0	5.4	1.4	1.4	20.0	1.6	14.2	2.1	5.9	14.3	1.7	1.8	4.3	8.9	0.3	10.9	1.8	3.5	2.6	6.9	2.5	3.2	4.4	2.8	2.1	3.8	4.9	4.8	4.1	4.1	5.0	4.9	22.4	16.0	13.1	6.2	12.1	13.6	5.6	22.7	5.2	14.6	6.1	6.1	12.2	7.2	9.8	11.0	14.6	10.7	23.1	4.9	0.0	13.3	171.6	6.7	12.0	28.0	4.8	15.8	6.0	6.8	25.2	15.8	2.6	10.5	14.0	7.1	38.2	5.2	12.5	20.2	5.7	4.6	2.0	18.1	16.7	234.7	16.1	11.0	17.8	11.2	11.4	8.3	69.0	5.0	6.5	10.3	5.2	14.7	10.2	8.9	2.6	3.4	9.8	13.0	6.6	14.3	11.7	20.7	19.0	5.5	11.5	9.7	19.9	6.8	3.1	6.4
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705951	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;salivary gland: 66.2;stomach 1: 28.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 56.4;Club cells: 69.4;Distal enterocytes: 110.0;Gastric mucus-secreting cells: 83.6;Ionocytes: 57.0;Paneth cells: 75.5;Proximal enterocytes: 182.4;Undifferentiated cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 5.5"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 63.6;OE19: 76.1"	"Region enhanced"	"Detected in some"		"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.2	0.6	0.8	6.2	0.9	0.3	1.7	5.5	1.2	16.0	0.0	23.5	44.5	1.1	0.1	26.0	2.6	13.5	0.5	0.9	0.0	1.0	0.3	0.9	0.5	0.2	0.1	1.1	5.2	0.1	2.0	0.1	0.3	1.4	19.8	0.9	66.2	2.9	0.7	4.8	21.9	0.8	0.0	0.6	28.9	0.8	0.4	0.6	0.7	0.0	6.6	6.3	9.7	0.6	2.0	1.5	0.3	0.9	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.2	63.6	0.7	0.5	0.0	0.3	10.6	0.0	0.0	0.0	0.5	0.5	0.6	0.6	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.0	0.0	1.2	0.1	0.8	0.1	0.5	0.7	1.5	0.4	76.1	0.3	0.5	0.2	3.0	0.0	0.6	3.4	0.5	0.3	0.6	0.1	0.4	9.5	0.1	0.3	0.4	0.4	0.5	0.2	0.7	0.5	0.1	0.3	0.4	0.2	1.1	0.1	0.1	0.4	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.4	0.1	0.5	0.2	0.1	0.4	0.6	0.2	0.8	0.9	5.5	1.2	0.9	0.0	0.2	0.1	0.3	0.0	0.4	0.6	0.5	0.0	0.6	0.7	0.6	0.9	2.3	56.4	5.7	2.5	6.1	3.0	0.8	32.9	69.4	20.2	2.1	0.1	0.4	110.0	1.9	4.7	0.5	8.4	2.7	0.7	11.4	0.0	2.3	46.5	0.0	0.5	83.6	23.9	0.0	0.1	0.0	0.1	0.1	0.0	1.4	42.1	57.0	0.3	0.3	0.2	0.0	0.3	1.8	0.0	0.3	0.5	2.1	0.5	1.2	31.8	75.5	0.0	0.2	2.9	182.4	0.1	37.8	4.2	0.0	1.2	2.4	0.3	0.2	9.9	1.4	0.1	0.8	0.3	62.9	19.4
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.7;intestine: 72.3;retina: 79.3;salivary gland: 84.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.7;Intestinal goblet cells: 78.7;Pancreatic endocrine cells: 49.0;Paneth cells: 88.9;Proximal enterocytes: 85.2;Undifferentiated cells: 65.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 46.3;hTCEpi: 6.9;OE19: 20.6;RH-30: 14.8;SK-BR-3: 7.1"									HPA046966	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046966: AB_2679879"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.5	0.0	0.4	12.6	0.6	0.7	1.2	0.5	0.7	25.9	0.5	72.3	47.7	0.3	0.0	158.7	1.3	22.4	0.2	0.4	1.2	9.8	2.3	5.2	0.1	0.8	0.5	0.1	9.1	0.0	0.6	0.1	0.7	2.2	44.5	79.3	84.2	8.5	0.1	3.2	56.3	2.8	0.2	0.2	20.8	4.0	0.6	0.2	0.0	0.0	15.9	3.0	53.2	0.7	46.3	0.0	0.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.6	0.0	0.0	2.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	20.6	0.0	0.0	14.8	1.6	0.0	0.6	0.0	0.2	0.0	7.1	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.1	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.5	0.7	0.4	1.2	0.8	0.5	0.7	0.2	0.6	0.7	0.1	0.0	4.8	0.3	1.1	0.0	3.0	23.6	0.0	1.8	1.7	0.3	0.3	11.5	36.4	0.0	0.0	0.1	0.0	154.7	0.0	43.2	4.9	1.1	0.1	0.5	13.8	0.0	0.1	14.2	0.4	0.0	18.3	0.6	8.9	0.1	0.0	0.4	0.0	0.0	0.0	78.7	14.2	0.0	0.0	8.7	0.0	0.2	0.0	1.0	0.0	1.9	0.0	0.0	0.1	49.0	88.9	0.0	0.1	0.9	85.2	16.5	22.8	34.9	0.0	0.0	1.5	0.5	0.2	6.5	0.0	0.3	0.5	0.0	65.6	27.3
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9"	"Low region specificity"	"Detected in single"							"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	3.7	1.2	1.3	4.7	1.1	100.8	2.5	1.2	1.4	2.3	0.2	9.2	12.3	2.8	1.2	1.8	2.1	3.7	1.7	1.6	1.1	1.9	1.5	2.1	3.7	1.3	1.0	2.9	6.7	0.5	1.3	3.1	1.3	1.6	8.7	1.6	6.8	2.2	0.9	0.8	10.8	2.5	1.6	3.6	10.8	1.3	1.4	3.7	1.2	1.1	2.8	2.1	1.3	1.9	2.9	1.4	1.7	0.0	5.3	4.8	8.9	2.6	1.3	2.3	2.5	12.5	4.0	0.0	6.1	4.4	1.2	1.4	2.9	0.3	2.1	19.1	2.9	9.4	2.2	0.3	2.7	37.4	8.0	4.1	0.1	2.9	0.0	0.5	3.6	8.3	9.7	0.0	2.7	1.4	7.9	24.2	3.4	11.6	3.4	6.9	0.0	0.0	2.4	1.9	2.4	0.9	1.5	3.7	1.5	5.1	2.1	46.6	3.3	1.8	4.9	0.0	1.0	1.1	0.6	0.0	1.6	32.9	1.1	0.5	0.8	0.7	0.2	0.4	0.1	0.1	0.2	0.3	0.4	0.1	0.2	0.1	0.3	0.2	1.2	0.5	0.5	0.2	1.3	1.1	1.2	1.4	1.6	1.1	1.3	1.0	1.3	1.6	1.4	1.9	2.9	0.0	0.0	1.3	1.8	1.7	3.0	0.9	1.2	1.0	1.8	1.8	0.9	22.8	1.9	1.8	4.2	15.6	2.6	12.1	0.0	19.3	0.3	1.1	2.8	2.3	10.2	3.4	1.5	17.9	3.2	6.0	21.9	3.3	0.0	2.6	3.9	1.0	9.0	0.0	1.9	23.7	0.0	12.9	3.5	0.8	4.4	5.2	3.6	3.7	13.6	0.4	0.0	3.0	3.4	22.5	5.8	1.2	0.5	2.9	11.6	2.4	1.7	7.9	0.0	3.1	2.6	1.7	3.5	2.1	0.6	2.2	3.1	2.0	17.9	1.4
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.1"									HPA046966	Uncertain					NA	NA					"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046966: AB_2679879"				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1019.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.9	8.2	21.0	11.9	38.2	3.6	10.5	44.1	28.2	6.9	0.0	11.4	17.5	9.0	5.3	6.8	15.6	11.1	4.7	20.4	27.7	6.9	3.4	8.1	11.7	32.8	29.9	7.3	9.9	9.6	4.6	17.3	29.3	5.8	11.6	8.3	42.6	10.5	2.5	5.3	17.4	11.0	29.4	10.2	31.8	16.4	29.7	11.3	8.4	6.3	18.6	13.3	4.5	64.3	115.9	22.5	12.6	110.6	49.5	38.4	61.6	35.9	64.8	30.3	32.6	16.9	44.8	30.7	29.2	40.1	79.4	9.0	29.9	11.4	45.6	124.2	11.0	33.5	7.2	23.0	26.8	7.6	23.9	96.0	6.8	39.3	19.4	124.4	69.6	17.1	14.1	28.8	20.8	60.8	36.6	16.7	14.7	59.6	66.6	26.9	10.3	17.2	46.5	33.1	23.4	16.6	20.8	9.8	8.0	70.6	10.2	12.9	141.8	34.5	36.0	15.3	30.5	47.3	18.5	74.3	68.6	13.6	11.1	0.7	2.0	0.7	3.6	0.9	3.8	15.6	6.2	5.6	2.6	8.3	6.6	6.6	0.3	14.8	1.4	2.6	10.0	2.9	21.0	38.2	44.1	28.2	20.4	27.7	32.8	29.9	29.3	29.4	29.7	64.3	19.0	12.8	32.5	227.5	43.1	12.1	7.4	11.5	17.1	10.1	18.3	11.7	5.9	8.6	18.9	12.9	4.2	45.5	8.3	5.9	0.0	9.1	37.9	9.9	14.6	16.0	5.4	15.8	169.0	31.7	28.1	22.7	78.0	10.2	7.6	3.3	14.6	3.5	13.0	8.4	166.4	26.5	2.0	12.2	8.6	15.3	12.8	10.2	1.8	70.3	3.6	27.8	9.2	138.7	1019.1	54.7	10.3	13.5	124.3	8.8	24.5	8.4	15.3	9.1	0.0	14.3	13.2	34.6	26.8	7.4	9.8	14.1	18.9	10.6	21.7	7.2
FUZ	"CPLANE3, FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806866-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 78.7"	"Group enriched"	"Detected in many"	18	"Early spermatids: 1243.5;Late spermatids: 2329.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol		No	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	9.3	17.6	17.3	2.8	21.0	6.2	9.3	18.8	20.8	11.2	19.7	12.1	4.2	11.1	7.3	6.8	19.5	5.2	13.6	16.4	16.8	16.8	7.1	7.7	4.6	19.9	19.1	15.4	12.3	7.1	12.5	4.0	18.2	11.2	1.9	4.9	7.5	7.3	20.4	6.6	6.9	4.1	19.5	8.8	10.2	78.7	18.7	6.0	11.5	12.4	2.2	9.0	8.2	20.4	0.1	10.6	9.5	12.2	8.9	9.5	2.7	5.2	5.4	7.9	11.0	0.9	17.2	3.1	10.6	4.9	2.5	4.3	2.7	9.2	3.5	11.7	20.5	13.0	7.6	0.0	10.1	7.6	7.0	10.1	6.3	16.1	4.0	6.2	7.5	18.6	3.0	8.7	4.1	0.5	14.1	15.4	15.7	8.4	6.3	24.4	7.7	7.4	9.7	2.7	26.5	31.0	1.0	10.8	17.9	3.7	6.2	4.7	3.7	6.6	5.9	1.9	1.9	24.9	26.5	8.4	7.6	0.2	8.4	7.0	4.6	17.7	4.9	2.2	4.1	5.3	3.1	4.2	3.8	6.0	3.8	4.3	10.6	3.8	1.6	15.0	3.8	2.6	17.3	21.0	18.8	20.8	16.4	16.8	19.9	19.1	18.2	19.5	18.7	20.4	9.2	0.0	2.8	6.2	8.4	3.8	19.3	10.1	8.6	7.2	14.5	14.6	3.9	17.2	7.3	7.3	4.2	17.5	12.2	1.9	66.5	15.3	1243.5	61.6	8.0	6.5	2.4	19.3	2.7	5.1	12.1	11.1	6.1	8.1	10.2	11.5	13.6	5.8	13.2	10.1	3.0	3.5	12.2	7.1	7.6	2329.6	27.7	6.7	0.0	2.8	7.9	26.1	5.2	2.0	9.9	4.5	6.1	17.7	10.9	8.0	7.3	86.1	35.4	11.3	0.0	17.1	9.9	95.3	13.5	5.0	4.1	12.0	6.4	13.7	5.5	14.1
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 788.7;tongue: 451.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 986.2;Late spermatids: 1759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA		15000	"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	35.8	40.1	54.8	22.4	65.0	48.1	31.9	62.9	76.0	36.6	54.2	49.1	21.2	41.4	26.3	40.0	33.3	25.6	118.9	51.5	66.1	26.8	33.9	24.6	30.0	63.7	60.6	49.2	34.3	32.5	25.5	39.0	64.9	38.0	20.1	42.2	29.7	32.6	788.7	21.9	22.4	36.2	60.5	23.1	32.3	132.4	60.8	50.5	31.4	451.3	30.5	38.5	28.3	93.2	144.2	65.8	138.8	108.5	104.6	118.4	62.7	111.9	114.0	123.1	120.5	97.5	70.9	73.3	179.8	77.7	193.9	67.6	113.3	68.8	171.0	97.4	76.1	74.3	88.9	112.7	110.8	46.6	58.5	125.7	77.0	62.3	147.8	183.7	126.1	70.5	60.7	86.0	157.1	52.2	89.4	78.3	156.8	88.8	71.2	61.0	177.5	78.6	95.4	44.6	58.4	74.6	96.8	110.9	149.9	193.7	154.7	88.5	101.3	92.0	102.3	58.1	223.3	79.0	108.9	86.9	96.0	65.9	120.2	9.4	12.6	10.0	11.7	13.7	12.2	12.9	12.3	10.6	14.4	9.1	15.5	12.9	10.9	11.6	10.4	10.2	22.2	9.6	54.8	65.0	62.9	76.0	51.5	66.1	63.7	60.6	64.9	60.5	60.8	93.2	89.1	64.1	75.0	58.1	81.1	78.4	97.6	68.5	78.6	72.6	67.7	72.3	224.6	48.6	74.8	35.0	56.3	96.8	93.5	28.9	58.7	84.5	986.2	158.2	132.1	78.1	53.8	105.6	75.6	75.8	99.5	78.6	33.6	114.8	126.6	106.3	62.4	70.2	67.9	87.5	87.8	36.1	40.7	76.6	58.7	1759.0	84.2	73.2	49.8	48.7	138.5	97.5	52.5	86.5	137.5	73.3	39.2	76.0	74.3	68.8	62.1	106.8	104.1	86.5	32.9	116.3	89.1	318.6	113.5	57.9	70.6	61.2	87.3	97.4	42.8	67.1
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614897	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 63.9;Rod photoreceptor cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	19.7	27.9	31.5	11.4	34.3	9.8	17.4	36.5	37.9	21.2	26.9	26.7	13.9	21.7	11.6	20.9	20.1	10.9	66.0	33.2	40.0	22.2	20.6	19.2	14.1	41.1	40.9	20.4	16.2	30.7	33.0	15.5	43.4	21.6	11.5	37.7	19.9	18.2	120.9	22.5	17.4	17.1	33.4	16.8	19.9	27.4	37.2	20.8	17.1	84.4	15.1	23.3	19.4	34.9	36.6	48.3	43.8	45.7	36.7	25.0	33.7	54.2	45.1	77.2	53.2	27.2	11.9	33.8	34.8	37.2	34.1	40.1	58.2	24.8	51.4	39.1	62.4	19.6	42.2	15.9	35.7	0.2	39.8	23.5	35.8	58.8	56.4	43.3	27.1	26.9	35.4	11.6	38.8	18.6	26.9	19.3	26.2	18.9	25.8	37.9	26.6	21.3	28.2	13.0	26.1	47.2	37.3	24.3	37.8	41.3	25.3	14.5	24.3	36.0	22.5	24.0	64.8	19.0	18.6	15.5	41.3	15.8	48.0	2.6	0.8	2.5	0.9	1.0	1.3	0.5	1.5	1.9	1.3	0.9	1.2	1.3	2.1	1.0	0.6	0.9	1.8	0.8	31.5	34.3	36.5	37.9	33.2	40.0	41.1	40.9	43.4	33.4	37.2	34.9	10.3	32.1	17.9	10.7	7.7	11.5	15.4	7.9	2.8	46.9	10.4	8.3	41.7	8.6	9.5	16.5	31.3	15.9	15.1	12.0	1.9	11.6	1.8	11.1	9.2	10.5	9.6	15.6	10.3	9.3	11.5	10.8	10.7	11.0	2.5	12.9	15.0	11.7	9.1	63.9	12.0	10.1	10.2	7.3	9.7	2.7	9.6	7.1	0.0	3.7	7.4	23.3	16.5	8.5	12.4	17.6	12.5	15.4	6.3	15.4	15.5	8.9	7.6	55.8	6.6	14.2	17.7	22.9	28.2	8.7	14.3	17.1	7.6	14.6	7.4	10.3
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
FXYD4	CHIF	ENSG00000150201	"FXYD domain containing ion transport regulator 4"	P59646	10	43371636-43376335	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	43	"kidney: 297.7"	"Cell type enriched"	"Detected in some"	107	"Collecting duct cells: 5039.3"	"Group enriched"	"Detected in many"	5	"renal cancer: 10.7;urothelial cancer: 20.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"SuSa: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058421	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA058421: AB_2683714"	"unprognostic (2.92e-3)"	"unprognostic (5.25e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-1)"		"unprognostic (2.32e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	1.5	0.0	2.6	0.0	0.0	1.5	2.7	0.0	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.4	2.0	297.7	0.0	1.1	0.0	1.6	2.2	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	5.6	2.7	1.3	0.0	0.0	0.0	1.4	0.0	6.9	0.8	2.2	0.0	0.0	0.4	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	1.5	2.7	1.4	2.0	1.6	2.2	1.7	1.4	2.2	2.7	0.0	6.4	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	5039.3	0.0	0.5	0.0	0.5	46.9	0.0	2.6	6.4	2.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	9.2	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	11.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.1	0.1	8.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.4	0.3	0.1	1.0	1.4
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169881	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	203.1	39.2	30.8	130.8	31.0	275.2	171.1	31.9	47.2	226.2	36.9	59.0	28.6	75.5	20.1	116.1	103.6	68.8	82.3	29.9	36.6	42.0	40.2	148.5	187.4	43.4	34.7	28.6	28.0	17.2	39.8	91.7	37.9	68.8	43.3	3.5	70.3	46.5	28.6	85.8	106.6	59.8	35.4	238.3	67.9	9.2	40.0	85.0	59.2	32.6	187.8	104.8	183.8	39.9	932.2	216.7	0.2	0.9	310.5	390.2	213.6	521.7	686.4	362.8	269.3	61.9	263.6	212.9	139.3	632.2	130.3	212.3	132.5	321.3	231.4	265.7	87.9	397.7	111.8	0.5	244.3	228.6	378.0	233.6	141.6	265.3	452.2	213.2	348.5	58.0	380.0	989.0	229.5	1.5	27.4	95.1	66.4	853.4	126.0	127.6	45.0	272.7	134.0	5.2	38.8	0.3	287.1	148.6	316.6	115.0	78.0	180.4	494.8	443.6	170.0	487.7	40.2	1.5	16.2	54.4	675.9	524.8	694.4	644.0	596.4	111.1	451.5	628.4	422.0	602.8	756.5	467.4	718.7	545.6	489.2	405.6	140.1	840.8	636.9	325.0	894.6	934.1	30.8	31.0	31.9	47.2	29.9	36.6	43.4	34.7	37.9	35.4	40.0	39.9	291.0	3.2	13.4	0.0	330.7	107.1	73.4	106.3	54.1	0.6	80.2	51.2	5.2	32.9	27.8	99.3	0.0	18.9	349.7	2.9	0.0	156.1	1.7	3.4	63.5	276.5	10.7	111.2	2.2	197.3	462.9	93.1	71.9	2.2	361.5	0.3	323.8	6.1	430.3	0.0	0.4	8.2	4.1	385.9	492.1	4.6	6.5	403.9	209.9	10.3	243.7	0.4	260.6	1.0	0.1	585.0	7.8	0.7	302.5	72.2	0.2	4.4	5.5	0.4	65.7	5.7	107.6	1.6	8.1	24.0	69.2	50.9	459.5	0.7	10.0	100.3
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
FXYD6-FXYD2		ENSG00000255245	"FXYD6-FXYD2 readthrough"		11	117820163-117876667	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.5;salivary gland: 4.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MOLT-4: 6.5;RPTEC TERT1: 7.3"									"HPA068838, HPA075209"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane, Vesicles"		"HPA068838: AB_2686047, HPA075209: AB_2732285"																		0.3	0.2	0.4	0.0	0.4	0.0	0.2	0.5	0.5	0.4	0.2	0.9	0.1	1.0	0.8	0.1	0.6	0.9	0.6	0.4	0.4	7.5	0.2	0.4	0.0	0.3	0.3	1.3	1.9	0.0	0.3	0.2	0.3	0.3	0.0	0.0	4.5	0.1	0.2	0.1	0.3	0.3	0.3	0.9	0.3	0.3	0.3	0.4	0.3	0.2	0.1	0.4	0.2	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	11.0	0.0	0.0	0.0	0.0	97.8	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	2.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	15.8	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 273.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	2.1	0.4	119.1	1.7	140.3	0.6	1.1	45.1	273.1	5.8	37.8	2.7	0.6	1.9	0.0	0.4	0.9	0.4	0.7	153.8	75.1	0.4	1.1	1.1	2.8	124.3	83.1	1.0	0.2	0.0	2.1	0.1	129.5	1.0	0.2	1.6	0.5	0.3	2.7	1.3	2.0	0.2	70.1	2.8	1.0	1.3	101.6	0.2	0.5	0.1	1.5	0.8	3.1	185.5	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	119.1	140.3	45.1	273.1	153.8	75.1	124.3	83.1	129.5	70.1	101.6	185.5	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105252-39274528	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.0;lymphoid tissue: 112.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1670.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6200000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	10.2	5.8	5.7	82.5	5.5	53.0	5.1	6.3	9.3	6.6	7.4	10.0	9.1	3.8	10.5	5.7	3.6	16.8	2.4	5.4	7.9	5.0	13.6	17.6	85.8	16.7	19.1	2.7	1.8	2.1	1.5	17.9	15.8	4.2	11.0	0.5	7.4	3.0	1.2	2.0	15.0	11.6	9.3	73.0	12.2	3.3	13.3	112.8	2.6	2.7	63.0	17.1	1.8	13.9	0.2	4.2	0.0	0.0	0.5	0.0	21.1	0.1	1.2	0.3	0.4	0.4	0.3	0.3	0.0	0.0	8.0	16.4	0.0	0.3	0.1	0.3	0.0	61.5	0.0	0.1	0.0	23.3	18.6	0.3	0.4	0.0	0.4	0.1	0.0	211.9	0.0	0.0	0.0	0.0	212.9	13.5	0.2	0.1	0.1	61.3	0.0	0.3	1.0	3.5	0.1	0.0	0.1	0.5	6.5	1.4	0.0	5.2	0.0	0.0	0.2	0.2	0.2	0.4	0.0	4.5	0.0	81.4	0.2	151.3	359.0	354.6	76.3	406.5	52.9	1.8	216.7	134.5	127.6	1.3	271.7	169.8	1670.8	89.9	483.9	30.8	231.5	400.1	5.7	5.5	6.3	9.3	5.4	7.9	16.7	19.1	15.8	9.3	13.3	13.9	4.4	16.0	24.7	0.0	6.2	0.0	0.0	0.0	0.0	0.0	3.2	7.6	0.0	0.0	5.6	14.7	0.0	28.8	142.9	0.0	9.8	0.4	0.0	0.7	1.1	4.3	0.0	0.0	0.0	0.0	88.7	3.8	0.0	1.0	15.2	0.1	0.0	0.0	157.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	35.9	3.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	40.2	119.3	0.1	0.0	0.0
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain autophagy adaptor 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 263.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	16.7	13.0	10.5	9.7	12.0	6.5	13.4	9.6	9.4	23.1	11.3	42.0	8.0	25.6	10.3	21.3	15.4	18.7	66.8	8.6	10.3	10.7	10.8	14.7	8.6	15.5	10.8	23.1	12.7	20.3	7.6	8.2	14.8	19.3	10.7	33.0	14.9	22.9	263.3	19.3	14.4	28.2	15.1	10.2	20.4	3.3	11.9	10.5	16.5	104.6	8.2	39.6	16.9	15.1	10.8	10.3	3.0	13.0	27.9	21.8	4.9	10.2	23.7	13.1	14.6	5.6	9.3	7.9	5.6	14.2	12.7	7.9	8.5	17.0	15.7	3.3	9.0	11.4	8.7	6.3	19.0	8.8	7.9	24.3	16.7	21.1	20.5	20.3	26.7	13.4	7.4	11.3	9.5	6.7	9.0	5.5	4.5	8.8	9.8	3.1	8.3	4.4	15.9	37.2	2.2	3.4	6.4	20.0	17.6	4.4	9.7	5.7	20.8	5.0	5.9	17.0	5.7	6.4	4.4	2.7	17.2	11.1	9.6	0.7	0.5	0.3	2.0	0.5	2.7	0.2	1.2	2.1	0.2	0.2	0.5	0.7	0.4	1.5	0.3	1.3	1.2	0.7	10.5	12.0	9.6	9.4	8.6	10.3	15.5	10.8	14.8	15.1	11.9	15.1	9.5	28.9	13.7	12.4	4.8	4.1	4.8	5.6	3.4	11.2	8.5	4.8	89.3	8.6	13.0	16.5	35.5	4.3	8.7	6.8	3.9	8.8	0.1	6.4	8.9	9.3	9.6	6.9	0.8	8.3	2.2	14.0	12.8	11.2	2.5	14.9	11.4	9.2	4.1	0.0	0.8	7.6	2.0	5.8	4.6	1.6	12.8	5.1	10.6	10.3	4.0	20.0	6.2	8.0	21.2	11.0	2.5	17.7	3.0	17.3	8.7	6.2	18.6	37.1	6.6	20.8	12.8	2.3	0.8	8.4	4.1	2.9	12.7	6.1	6.2	7.9
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8"	"Cancer enhanced"	"Detected in all"		"glioma: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"NK-cells: 69.0;T-cells: 174.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 538.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		820000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	76.6	10.8	117.1	52.4	106.4	32.3	46.8	83.8	104.3	45.5	33.3	32.9	16.4	45.6	33.8	16.0	51.4	32.1	40.5	102.1	121.5	23.9	20.4	63.5	108.9	136.3	104.9	28.8	8.5	18.7	22.9	29.7	107.0	17.6	15.6	26.9	12.9	12.5	12.3	41.5	47.1	38.0	109.9	71.9	29.3	16.5	105.7	86.1	45.7	18.3	67.6	48.4	33.4	109.8	10.4	1.5	178.6	30.2	133.4	81.4	3.2	29.1	90.8	24.2	42.9	1.3	1.6	21.0	18.3	56.1	21.0	1.3	25.8	39.9	46.8	0.7	66.5	57.0	13.6	2.7	78.7	19.5	19.0	78.8	59.1	90.5	76.8	62.9	99.5	99.6	4.9	140.3	86.8	1.5	92.7	17.9	26.0	3.3	18.0	29.1	24.0	1.4	0.0	9.1	124.6	50.7	5.7	2.4	124.7	39.6	1.3	57.0	63.9	72.3	13.5	538.7	18.5	20.0	19.7	32.5	136.0	44.3	128.9	1.1	6.4	0.2	137.0	5.6	174.8	4.8	83.9	152.7	7.4	6.4	27.9	72.3	3.0	69.0	4.2	4.3	79.2	51.5	117.1	106.4	83.8	104.3	102.1	121.5	136.3	104.9	107.0	109.9	105.7	109.8	87.8	0.0	8.3	382.6	26.0	17.1	2.5	0.6	1.8	57.2	2.9	6.9	11.3	14.3	2.1	7.3	0.0	2.7	291.6	1.2	17.6	9.3	3.7	5.6	51.7	70.3	13.2	20.9	118.7	1.0	2.4	61.9	17.9	4.9	52.0	20.9	76.4	60.3	3.0	47.1	127.6	3.8	2.0	35.8	96.1	3.2	26.4	42.7	37.4	88.1	64.5	89.1	228.6	342.8	162.3	9.7	0.1	7.2	96.2	3.9	17.7	212.2	4.4	8.3	13.1	48.8	32.9	3.9	8.6	0.7	13.4	52.0	275.8	71.1	2.9	1.1
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264433-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.0;non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;HSkMC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.4	4.4	2.4	2.7	2.5	1.1	10.7	5.8	2.4	9.9	11.1	5.9	5.1	8.6	4.3	5.2	5.5	5.7	12.7	4.7	2.9	9.6	2.5	10.7	1.3	2.5	6.2	10.1	4.7	2.4	3.9	10.0	2.3	10.3	3.7	2.0	9.0	16.4	1.9	10.4	5.1	5.3	2.3	3.2	4.6	1.6	3.4	1.8	20.5	2.4	1.3	6.4	11.2	2.0	0.8	2.5	24.8	2.6	19.8	17.0	4.5	9.2	5.8	3.3	2.3	1.1	4.3	0.0	2.2	5.9	4.2	4.7	3.9	2.0	2.2	0.0	4.9	0.2	4.6	1.3	1.4	4.2	1.0	32.3	3.6	7.6	2.4	12.6	0.7	2.8	1.5	3.6	9.7	6.2	0.8	1.1	6.4	1.3	4.2	5.1	15.3	0.4	5.3	11.8	3.4	6.5	7.0	5.6	1.6	5.7	3.0	3.8	3.8	13.9	10.4	15.0	3.8	3.3	2.5	0.4	15.0	3.5	16.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	2.4	2.5	5.8	2.4	4.7	2.9	2.5	6.2	2.3	2.3	3.4	2.0	5.7	3.2	1.5	4.6	1.1	4.2	44.9	7.0	10.8	1.6	27.7	29.5	18.5	45.8	4.6	12.9	2.1	3.4	0.6	7.4	0.0	4.3	0.3	12.0	13.1	4.5	3.5	0.8	0.6	2.0	2.2	18.5	2.0	15.7	12.7	1.8	15.4	0.9	3.5	141.3	1.0	3.0	4.1	17.4	16.2	1.1	33.2	14.3	17.8	1.9	4.6	3.0	1.0	1.0	0.2	1.9	4.8	45.1	0.4	11.7	6.0	11.6	2.4	2.9	0.0	6.2	10.3	0.5	3.7	9.1	5.1	2.1	0.6	2.6	4.6	7.3
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
FZD3		ENSG00000104290	"Frizzled class receptor 3"	Q9NPG1	8	28494205-28574267	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 14.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 98.0;Excitatory neurons: 155.9;Inhibitory neurons: 82.3;Rod photoreceptor cells: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 9.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 53.2;Karpas-707: 27.9;SCLC-21H: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024995, HPA042320"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"CAB024995: , HPA042320: AB_2677948"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.69e-2)"	"unprognostic (4.26e-4)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.09e-3)"	1.0	2.9	5.2	1.5	6.7	1.5	2.3	5.7	9.9	2.4	13.8	2.2	1.3	3.4	6.9	1.9	3.5	1.3	1.1	6.8	4.0	2.6	0.6	1.0	2.1	1.8	5.4	7.0	3.5	4.2	3.8	1.3	4.2	4.3	1.2	14.7	3.3	5.5	1.2	1.5	1.0	2.4	0.9	0.6	2.5	5.0	3.2	1.8	3.4	1.3	1.4	1.9	1.6	2.6	14.8	3.1	53.2	10.2	0.0	0.8	7.9	0.5	1.1	3.0	1.3	3.1	3.1	6.9	2.6	0.3	6.6	5.2	8.0	8.8	2.1	9.1	5.8	4.8	1.0	2.0	0.0	2.7	7.9	0.6	4.1	0.2	2.3	0.6	0.6	7.3	3.5	27.9	0.1	3.7	0.2	5.8	13.3	6.4	4.6	3.3	8.0	6.8	4.0	4.4	39.6	10.7	2.9	7.5	8.7	7.0	7.4	4.0	0.0	0.0	14.3	2.0	3.7	5.1	6.1	6.7	4.2	0.0	2.7	0.7	0.2	0.0	1.6	0.2	2.1	1.1	1.2	2.3	0.9	0.6	1.6	1.6	0.1	0.9	0.0	9.3	0.0	0.7	5.2	6.7	5.7	9.9	6.8	4.0	1.8	5.4	4.2	0.9	3.2	2.6	1.7	9.6	12.0	65.6	5.6	6.6	7.9	17.0	10.8	28.1	21.6	11.7	6.0	4.3	17.7	9.2	98.0	10.5	15.7	1.4	1.9	12.1	25.7	24.2	18.7	4.3	28.7	5.0	155.9	14.9	9.7	8.8	8.2	27.7	5.7	29.3	8.6	3.0	4.2	21.9	82.3	6.3	8.2	1.0	7.4	11.9	48.1	2.1	33.8	14.0	0.7	17.0	2.1	52.8	14.3	11.8	3.4	51.1	17.2	14.1	0.8	11.4	17.5	87.1	26.3	8.6	15.0	58.4	45.6	5.6	4.7	4.8	5.0	15.0	5.4	7.7
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955395	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 120.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	120.1	9.5	6.7	5.8	6.2	0.3	55.6	5.1	7.3	12.5	7.8	14.9	2.8	12.2	7.6	6.5	16.3	11.5	27.4	5.6	5.9	27.1	14.6	32.9	6.2	6.5	6.3	12.9	9.5	6.4	8.7	11.7	7.0	12.5	6.3	1.1	12.2	30.2	31.5	5.9	8.8	13.4	5.6	14.1	14.1	5.1	8.5	3.9	18.1	40.6	4.6	10.5	9.5	5.9	1.3	1.1	2.7	5.2	63.6	16.5	3.7	8.4	7.6	3.2	3.3	7.1	0.9	0.0	1.8	2.6	4.4	2.8	3.1	1.3	2.5	0.2	2.1	2.8	2.3	85.2	18.9	0.0	0.1	46.0	0.5	2.8	0.5	7.5	93.6	0.1	3.9	0.4	2.2	2.2	0.0	0.0	3.9	7.5	18.8	0.1	4.8	0.2	9.0	13.7	0.6	0.8	3.5	1.0	1.4	5.6	12.0	0.0	46.3	7.8	5.1	9.2	1.7	0.4	1.3	0.0	1.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	5.1	7.3	5.6	5.9	6.5	6.3	7.0	5.6	8.5	5.9	83.0	0.0	1.3	9.8	0.5	1.5	0.5	1.3	2.2	0.7	5.5	3.2	8.3	7.2	2.0	36.8	10.4	0.2	0.5	1.0	3.9	0.5	0.7	0.4	2.7	51.2	0.0	2.7	8.1	1.6	0.2	17.7	4.1	0.5	0.0	9.1	99.6	14.1	0.2	0.0	3.4	1.3	0.0	6.7	1.8	2.2	9.3	0.6	0.0	10.3	0.0	0.2	2.1	3.0	0.7	1.0	0.1	6.8	0.3	1.4	0.7	9.4	2.1	0.2	32.9	14.4	26.6	0.3	3.2	1.3	0.6	0.3	0.4	16.6	1.1	0.2
FZD5	"C2orf31, DKFZP434E2135, HFZ5"	ENSG00000163251	"Frizzled class receptor 5"	Q13467	2	207762598-207769906	"G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 117.4;Hepatocytes: 59.8;Intestinal goblet cells: 50.1;Muller glia cells: 50.7;Undifferentiated cells: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 104.7;CACO-2: 26.2;Hep G2: 36.5;NTERA-2: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052361	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA052361: AB_2681799"	"unprognostic (4.97e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.15e-3)"	6.0	5.0	1.8	2.5	3.5	4.2	2.4	1.8	3.6	3.0	3.5	18.3	18.6	2.3	0.6	3.3	1.2	1.4	1.6	1.7	3.6	5.1	23.5	6.7	1.1	3.2	4.9	4.2	10.4	1.0	4.7	4.4	2.5	6.3	14.7	10.9	3.1	2.7	2.6	1.0	15.3	2.6	1.8	2.0	11.2	0.4	2.7	1.5	8.7	2.0	1.4	1.7	2.3	6.2	3.3	5.8	0.3	3.1	2.6	0.1	104.7	0.5	0.7	0.8	0.7	26.2	6.0	0.6	7.0	0.3	2.0	4.8	9.0	3.9	0.7	0.4	6.9	7.6	2.8	36.5	2.0	1.5	2.0	0.2	3.7	1.2	3.0	2.0	1.0	1.1	15.5	1.2	0.7	2.3	0.8	1.9	31.0	14.2	2.0	1.9	3.3	1.4	7.3	11.4	5.0	0.7	1.4	0.6	1.5	14.1	1.7	1.5	0.4	1.6	3.0	3.2	2.5	1.7	4.1	1.3	2.1	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.5	1.8	3.6	1.7	3.6	3.2	4.9	2.5	1.8	2.7	6.2	6.5	32.1	32.6	4.6	2.0	5.1	5.4	5.4	6.2	2.2	8.7	3.7	7.8	25.8	4.8	1.8	33.3	18.9	1.6	117.4	0.0	14.9	0.7	9.0	2.2	4.1	12.6	15.1	0.5	24.7	6.0	3.2	17.3	18.8	0.0	16.8	2.9	59.8	10.5	6.7	0.9	50.1	6.1	8.4	9.8	0.1	1.8	3.3	1.8	1.0	0.7	50.7	0.0	0.0	6.0	18.2	38.6	0.4	0.5	12.5	43.2	12.2	3.4	7.0	0.0	8.1	4.5	1.5	2.1	4.0	4.1	4.0	1.4	8.1	57.6	5.9
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 127.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	11.7	10.6	3.0	4.2	2.8	1.0	15.1	3.1	4.3	14.2	5.7	7.0	5.7	13.0	9.5	18.7	23.5	10.6	9.1	2.9	3.0	14.5	4.0	18.6	5.1	3.8	3.1	5.4	11.2	25.3	9.8	15.1	3.8	12.6	7.0	4.6	11.7	10.3	2.0	24.0	4.6	9.3	3.0	4.0	7.4	3.6	3.3	10.0	22.3	5.6	9.9	21.6	10.2	3.2	59.8	11.0	29.6	0.0	7.9	20.6	17.1	31.0	34.1	27.2	17.6	6.2	47.8	0.0	51.4	29.7	9.1	90.3	16.8	65.7	51.0	13.5	18.0	31.4	12.2	8.5	93.4	0.0	0.0	23.0	127.6	29.4	91.5	67.1	58.2	7.0	3.2	27.0	31.5	25.5	29.8	2.7	6.7	4.7	20.6	2.3	12.3	0.0	59.1	39.5	10.0	7.9	44.8	22.8	59.9	15.8	0.0	11.6	4.1	6.1	32.0	24.9	32.7	6.4	3.7	13.3	18.0	0.0	40.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.8	0.4	0.3	0.5	0.9	0.4	0.0	4.0	0.0	0.1	0.4	0.2	3.0	2.8	3.1	4.3	2.9	3.0	3.8	3.1	3.8	3.0	3.3	3.2	38.3	25.6	22.5	10.1	2.8	46.9	15.9	51.1	42.7	4.1	16.1	12.7	4.8	8.6	35.4	12.9	2.1	22.7	2.1	4.9	0.0	11.7	9.6	51.0	5.8	42.0	5.3	6.7	19.9	8.2	7.1	7.0	14.8	73.6	0.0	11.2	13.9	3.7	2.4	6.7	7.3	7.4	26.4	1.0	5.1	2.9	1.2	1.3	14.2	16.9	0.7	11.8	1.0	8.5	3.6	9.5	3.2	1.5	8.6	13.4	2.8	7.1	53.8	4.8	0.0	1.6	7.7	7.0	0.8	41.9	44.6	14.6	3.0	1.7	5.6	23.2
FZD7	FzE3	ENSG00000155760	"Frizzled class receptor 7"	O75084	2	202033855-202038441	"G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 30.9;Breast myoepithelial cells: 37.0;Cardiomyocytes: 21.1;Fibroblasts: 23.5;Proximal enterocytes: 21.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 30.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 42.8;BJ hTERT+: 48.4;CAPAN-2: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059979, HPA069165, HPA076183"	Approved		Supported	Vesicles		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA059979: , HPA069165: AB_2686096, HPA076183: "	"unprognostic (3.44e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.44e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.71e-5)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.05e-3)"	10.2	3.0	4.9	5.6	4.7	0.4	15.5	30.2	4.3	13.2	6.3	36.7	6.9	18.4	14.1	9.4	16.8	6.3	14.4	8.8	5.0	8.2	1.2	5.3	3.9	5.2	4.9	25.0	1.7	1.1	9.3	5.7	5.5	19.2	5.5	1.3	21.7	23.5	26.7	10.9	10.8	11.1	4.9	1.9	5.9	2.1	4.5	1.1	5.1	9.5	3.8	27.1	15.3	5.6	10.3	5.2	33.2	10.8	10.6	7.9	14.8	42.8	48.4	11.9	13.9	32.2	62.7	0.1	25.1	26.2	7.9	10.6	6.0	1.3	13.7	5.4	8.6	1.1	2.1	2.7	7.2	2.1	2.1	7.6	1.0	6.4	3.7	9.5	0.0	0.7	2.9	2.6	9.8	4.2	0.0	5.7	36.6	2.0	3.5	4.2	6.4	1.1	1.9	6.1	5.5	12.6	5.4	0.4	6.8	26.7	3.8	2.5	0.1	23.8	8.8	15.0	5.4	2.7	2.2	0.1	4.9	0.5	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	30.2	4.3	8.8	5.0	5.2	4.9	5.5	4.9	4.5	5.6	3.5	0.0	8.1	3.6	2.0	10.3	8.3	1.9	14.8	0.0	30.9	37.0	21.1	1.5	0.3	1.8	0.0	0.5	2.0	4.7	1.9	1.6	0.1	1.5	2.0	1.7	1.2	0.0	1.5	0.2	1.1	23.5	2.6	3.6	1.3	7.5	0.7	0.7	1.5	0.0	0.2	9.9	0.0	0.8	5.7	0.5	5.3	2.0	3.6	0.0	0.1	7.5	0.0	0.0	0.1	0.6	2.1	4.9	1.7	6.9	21.3	0.1	0.9	0.6	6.6	13.5	16.3	1.6	2.9	11.4	9.8	0.8	2.5	0.5	7.6	1.8
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638247-35642296	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Gastric mucus-secreting cells: 13.7;Muller glia cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.6;PC-3: 40.3;U-138 MG: 14.8;U-251 MG: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	5.6	1.4	5.2	1.2	5.8	0.1	3.7	1.8	6.1	2.3	39.4	8.7	0.6	2.5	0.5	0.9	5.4	1.3	9.7	5.9	2.1	6.9	3.1	4.4	1.3	1.8	3.3	1.8	4.7	2.4	2.7	0.4	2.0	1.3	2.0	3.9	3.3	1.4	3.1	3.7	2.0	1.6	1.5	11.7	7.2	2.5	4.3	1.4	6.7	2.5	0.6	1.8	1.6	5.0	0.0	4.4	0.7	0.0	1.7	0.1	2.6	4.8	0.2	0.2	0.2	0.5	0.7	0.0	0.7	2.1	4.8	1.5	0.5	1.5	0.0	0.0	12.4	0.0	0.5	0.2	0.8	0.0	0.3	1.5	6.0	9.7	3.8	15.6	3.4	0.0	0.3	0.0	1.3	1.9	0.0	0.0	4.0	0.3	40.3	4.1	2.5	0.0	7.7	0.3	12.0	0.4	0.9	0.2	0.0	5.5	0.1	0.7	8.1	14.8	2.2	7.3	13.4	0.0	0.0	0.0	8.5	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	1.8	6.1	5.9	2.1	1.8	3.3	2.0	1.5	4.3	5.0	12.2	19.2	3.3	12.4	0.0	0.3	1.0	4.2	2.2	0.6	4.1	10.8	10.2	1.5	3.1	0.0	2.1	0.1	0.5	11.2	0.0	3.4	0.0	4.2	2.7	7.2	1.2	0.0	0.4	3.1	0.3	6.1	13.7	9.3	0.0	1.6	10.4	4.5	0.6	0.0	0.5	2.7	0.0	0.8	1.3	0.1	1.2	1.2	0.0	1.9	0.2	27.2	0.0	1.0	0.3	3.5	1.5	2.2	0.1	0.8	0.5	4.2	2.1	1.3	6.6	2.7	5.8	0.2	1.4	1.2	1.1	0.1	0.4	0.7	4.8	0.2
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506311-3538334	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.2;Late spermatids: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	14.8	25.2	17.0	9.3	14.0	33.5	16.4	19.1	17.2	21.3	5.2	17.2	21.9	19.3	4.0	23.5	18.2	9.4	13.0	16.7	17.1	18.1	23.5	15.6	11.4	19.2	17.3	22.9	17.3	10.9	34.1	8.9	19.3	19.1	3.7	5.6	19.7	10.5	18.5	26.2	18.4	6.3	12.0	18.8	15.6	52.7	15.8	13.9	24.0	7.5	7.0	16.2	20.9	13.5	44.0	25.7	24.3	22.4	7.5	10.4	18.9	26.7	17.8	31.0	24.2	26.2	21.1	24.3	13.5	19.7	15.0	25.2	13.7	23.4	6.2	32.9	23.5	11.6	19.5	26.2	13.4	20.9	23.8	9.8	13.5	18.8	11.2	11.7	18.4	23.0	21.0	41.1	16.1	22.8	37.5	15.2	20.5	13.6	20.1	28.0	20.6	23.6	15.6	21.6	22.3	25.0	24.1	17.5	13.1	5.5	18.2	19.1	24.9	17.6	21.3	42.9	47.4	42.9	10.8	18.5	24.4	41.5	22.3	1.1	0.7	2.0	1.0	0.7	0.6	1.0	1.0	0.7	0.6	0.8	0.6	0.8	1.3	1.2	0.5	0.5	0.9	0.6	17.0	14.0	19.1	17.2	16.7	17.1	19.2	17.3	19.3	12.0	15.8	13.5	8.1	0.0	5.0	6.5	15.4	17.8	35.8	10.6	6.2	20.7	14.5	11.2	3.4	17.2	8.6	12.9	10.4	21.9	11.0	25.8	5.9	16.5	104.2	14.1	8.2	11.0	21.6	26.5	6.3	14.9	14.2	10.1	26.5	14.3	3.8	20.4	10.0	17.9	16.4	30.3	9.1	18.1	18.3	7.9	11.4	208.2	12.8	11.9	12.4	3.7	18.1	8.5	9.2	6.6	10.4	28.1	17.0	9.4	13.7	20.6	17.4	13.5	10.8	15.6	6.6	7.3	12.9	58.4	15.8	11.9	22.6	45.4	11.9	15.6	16.1	28.3
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559158-30620064	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 42.3"	"Group enriched"	"Detected in all"	6	"Early spermatids: 722.5;Late spermatids: 233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Uncertain		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	4.8	3.2	2.1	6.4	7.0	10.0	6.4	11.6	5.5	6.4	0.7	5.6	5.0	6.3	3.7	6.2	4.8	3.8	4.8	2.4	5.6	4.5	5.2	4.5	9.1	3.1	2.5	6.1	5.2	5.6	2.7	6.3	2.7	5.1	5.3	13.8	4.9	4.6	3.0	5.9	4.9	6.2	1.0	6.3	5.3	42.3	7.0	14.3	6.6	3.9	8.9	4.9	3.9	9.6	37.9	15.6	33.7	16.1	11.2	15.0	30.5	31.9	12.9	20.2	22.9	17.1	20.5	32.9	10.9	18.4	15.9	29.7	36.4	18.8	42.2	25.7	15.7	19.6	17.1	31.0	10.3	34.0	22.5	8.1	7.4	15.1	34.9	18.3	22.9	22.5	21.2	24.2	29.0	21.9	22.6	9.6	31.2	27.5	32.7	21.4	0.0	8.2	10.5	22.3	28.4	19.9	27.7	16.0	7.9	20.5	19.1	12.5	17.3	19.7	21.9	16.9	21.9	14.1	47.7	38.8	5.4	16.6	29.2	20.2	6.5	12.9	7.6	8.5	10.1	9.2	7.4	6.3	5.6	9.9	9.2	7.8	5.9	6.5	11.3	6.8	6.6	4.1	2.1	7.0	11.6	5.5	2.4	5.6	3.1	2.5	2.7	1.0	7.0	9.6	22.6	19.2	9.0	17.9	32.9	21.9	22.5	11.8	26.7	34.9	13.0	10.8	10.0	12.8	13.6	5.5	25.0	17.8	23.0	9.0	9.8	8.9	722.5	13.9	26.6	17.0	13.8	42.7	45.3	7.1	22.7	20.6	14.3	14.1	17.1	23.3	13.2	7.5	14.2	35.3	38.4	14.7	14.2	13.9	12.4	233.9	16.4	16.5	8.8	24.4	16.2	15.5	32.0	41.7	43.1	10.7	9.4	14.3	14.4	22.5	5.6	12.0	10.9	33.4	52.6	18.0	18.6	69.8	42.7	20.7	25.4	10.0	24.9	11.9	12.4	20.6
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812911	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		280000	"Cluster 13: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	52.3	46.8	32.9	60.2	36.1	27.5	54.1	42.8	44.6	42.0	41.0	47.8	34.8	42.5	33.1	54.8	51.0	38.8	51.0	30.7	36.1	57.1	69.0	36.1	78.3	34.5	35.7	62.5	30.4	41.5	16.5	58.2	35.8	41.3	50.6	18.3	31.8	37.3	112.2	43.4	33.9	47.8	35.0	46.7	40.3	65.5	38.6	66.0	42.6	92.1	85.7	66.3	31.9	43.3	204.9	267.0	177.0	96.3	253.2	119.2	232.4	204.1	190.6	290.6	348.6	413.7	310.3	384.7	307.0	188.0	231.6	210.9	319.7	395.6	333.7	122.5	173.8	232.9	201.1	334.8	128.8	281.6	163.9	123.4	186.7	243.7	232.2	98.7	209.7	140.9	191.3	173.3	254.5	179.7	273.9	142.4	231.4	146.0	209.6	254.3	235.1	187.2	163.1	290.5	195.2	132.0	200.8	307.0	319.3	169.2	246.3	174.7	238.2	202.0	239.7	187.3	364.0	104.9	171.3	305.0	132.2	229.6	337.8	132.2	102.3	84.7	189.2	135.4	255.3	168.8	215.6	186.7	141.0	160.0	201.8	193.2	37.8	203.7	134.1	134.7	249.2	287.2	32.9	36.1	42.8	44.6	30.7	36.1	34.5	35.7	35.8	35.0	38.6	43.3	88.9	19.2	41.4	32.7	112.0	239.5	101.3	82.4	148.0	37.1	74.8	60.7	62.3	44.3	66.2	64.4	16.7	94.0	91.7	47.3	78.2	69.6	49.6	80.6	104.4	112.1	50.2	96.1	25.7	53.0	94.6	98.0	70.3	87.2	73.6	73.8	76.8	169.4	78.2	57.2	30.6	59.4	50.8	81.2	195.0	30.1	65.0	73.3	87.2	37.5	83.7	54.3	45.3	29.7	45.3	59.2	42.9	57.2	89.3	160.0	33.5	80.0	74.2	36.6	39.5	111.6	90.7	58.0	89.3	155.6	256.4	67.3	99.6	72.2	78.5	98.0
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75641849-75724589	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA		47000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	37.6	41.5	32.6	50.9	35.6	69.2	50.3	24.2	48.5	47.2	12.9	61.7	52.4	45.1	32.1	49.5	55.2	49.7	47.8	33.7	51.7	67.5	65.3	46.0	60.2	26.0	28.8	32.0	42.2	56.0	28.2	38.4	32.4	77.8	58.0	46.8	37.0	49.2	115.1	25.5	62.6	55.0	24.0	48.0	47.5	60.5	40.0	66.5	74.6	119.5	61.2	65.8	25.8	30.0	96.8	96.6	160.5	131.1	134.8	136.6	54.1	141.6	144.6	96.2	101.5	128.5	137.1	197.1	125.5	120.1	87.0	68.8	170.1	176.0	136.6	111.4	66.2	185.7	95.7	141.7	119.8	188.4	146.2	109.9	144.4	114.6	122.8	129.1	172.1	114.9	140.9	139.2	150.7	63.0	218.4	63.1	154.1	140.3	36.3	159.8	199.2	96.3	112.3	125.8	124.1	141.1	105.7	151.0	201.9	165.7	75.1	90.9	178.5	95.3	76.5	107.7	81.7	136.2	133.9	195.2	135.5	122.9	122.7	83.1	36.2	62.4	50.0	47.8	76.4	35.1	48.1	55.8	41.1	28.2	46.9	51.5	30.8	59.6	64.1	18.5	44.1	64.1	32.6	35.6	24.2	48.5	33.7	51.7	26.0	28.8	32.4	24.0	40.0	30.0	72.8	54.5	100.7	26.1	126.3	89.0	81.7	53.2	114.4	61.4	71.8	55.2	79.1	20.0	81.0	53.3	50.1	36.4	133.0	92.2	41.1	59.0	213.8	84.7	57.8	69.8	135.4	43.9	70.6	68.9	49.3	56.7	65.2	80.0	105.7	76.7	51.0	77.7	45.7	70.7	74.9	107.9	50.8	75.9	131.3	228.8	26.4	86.1	60.5	30.9	85.3	29.3	53.5	36.7	59.1	94.8	66.6	39.9	117.7	84.5	88.3	104.1	85.8	69.1	19.7	57.2	91.9	63.2	74.8	79.8	77.7	41.3	186.2	99.5	75.6	88.3
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.1;liver: 286.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.7	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.1	75.1	286.7	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119881	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 156.2;Extravillous trophoblasts: 143.9;Kupffer cells: 122.7;Syncytiotrophoblasts: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 66.6;eosinophil: 22.8;intermediate monocyte: 50.3;myeloid DC: 39.7;neutrophil: 27.0;non-classical monocyte: 68.5"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.7;granulocytes: 27.0;monocytes: 68.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	31.7	29.9	16.9	22.6	20.8	16.7	30.1	19.2	26.5	25.8	17.1	29.2	24.7	31.2	35.2	15.8	29.1	29.9	35.1	18.3	24.7	37.6	47.3	44.4	22.5	28.2	21.6	18.8	37.2	33.3	38.8	48.5	26.6	33.2	8.7	6.6	37.7	23.6	47.0	25.5	26.9	14.6	21.0	54.3	26.9	56.0	26.0	20.4	32.6	25.1	7.0	31.5	22.0	31.4	35.6	67.8	13.2	43.2	40.4	40.2	85.1	21.8	39.6	16.2	13.2	20.3	56.3	12.7	56.5	17.3	13.8	14.8	4.1	25.2	3.8	16.5	49.9	0.2	12.8	73.3	69.7	1.7	40.4	86.7	35.4	30.6	10.5	32.8	28.9	33.5	12.9	51.5	12.4	81.3	6.0	8.4	27.3	8.7	46.8	30.9	44.8	22.2	13.1	36.5	15.1	43.4	28.5	31.3	39.0	8.1	89.5	50.1	18.8	59.7	31.5	43.6	8.1	121.4	36.5	3.8	19.1	32.8	38.4	0.6	66.6	22.8	3.7	50.3	4.4	3.1	2.8	3.8	39.7	3.0	3.2	2.3	27.0	3.0	68.5	9.5	2.1	32.9	16.9	20.8	19.2	26.5	18.3	24.7	28.2	21.6	26.6	21.0	26.0	31.4	21.9	19.2	41.3	31.6	9.3	11.2	19.6	38.7	8.0	16.1	24.1	28.2	19.9	24.3	24.7	14.7	8.4	156.2	11.8	11.5	5.9	25.2	55.7	14.3	16.7	21.6	6.1	4.8	16.2	15.8	143.9	33.0	20.4	27.8	8.8	28.5	23.6	26.4	99.8	11.8	18.9	10.9	12.2	122.7	29.6	29.3	23.9	83.9	24.9	20.6	39.1	32.1	8.2	11.6	12.5	9.4	13.5	19.2	12.9	20.2	31.4	21.5	9.3	18.5	6.6	15.0	13.9	66.0	29.4	10.3	8.4	166.2	8.2	30.2	14.4	14.8
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GAB2	KIAA0571	ENSG00000033327	"GRB2 associated binding protein 2"	Q9UQC2	11	78215293-78418348	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.0;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000271, HPA001368, CAB022159"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.32e-5)"	"unprognostic (6.95e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.67e-2)"	18.5	8.2	69.5	12.9	80.7	39.9	11.6	56.2	65.3	14.8	31.2	9.4	14.4	19.8	3.1	8.9	13.6	9.3	14.5	54.5	68.4	6.7	4.4	20.0	7.0	79.4	70.9	20.0	6.8	6.8	8.8	15.5	74.0	7.0	11.0	3.5	7.1	7.1	6.4	13.3	10.7	17.3	68.0	13.1	8.2	5.7	72.0	21.3	6.6	6.8	5.8	10.6	10.9	97.9	3.7	3.1	8.8	1.0	12.7	5.4	39.1	5.7	6.8	4.0	3.3	23.8	1.9	1.1	24.8	7.9	1.0	5.9	21.2	0.5	5.2	36.3	2.2	14.6	5.9	4.2	6.3	5.6	2.8	6.1	1.9	15.6	2.4	11.8	23.4	4.2	38.8	1.2	6.7	1.5	2.8	13.8	2.8	8.4	4.4	27.4	8.5	0.5	7.3	13.4	7.6	62.1	1.4	2.9	14.4	12.7	13.2	15.5	19.4	1.8	4.5	15.2	1.4	9.8	1.5	0.6	1.5	8.6	16.8	13.0	3.1	0.9	0.0	1.7	0.0	0.7	0.0	0.0	1.0	0.4	0.0	0.0	20.1	0.0	4.9	2.2	0.2	1.0	69.5	80.7	56.2	65.3	54.5	68.4	79.4	70.9	74.0	68.0	72.0	97.9	6.6	3.2	20.7	57.5	8.7	2.0	0.7	0.5	0.6	4.3	3.6	2.7	10.9	1.5	1.1	0.0	0.0	5.0	4.0	9.2	0.0	2.5	7.0	5.5	9.1	7.6	10.7	4.2	80.7	6.4	16.6	6.9	6.6	10.6	5.7	50.4	5.3	0.8	12.1	16.8	147.9	4.0	4.1	29.5	17.5	5.1	8.1	22.8	7.2	204.2	17.5	0.5	1.0	142.7	480.3	8.2	3.3	10.9	4.2	4.3	10.5	0.8	2.6	2.1	13.1	8.3	5.4	3.7	1.7	1.8	2.8	22.2	3.5	3.5	8.9	2.2
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010090	Approved		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	3.7	2.1	1.8	7.0	3.5	12.5	2.3	2.6	3.4	1.8	2.2	2.6	3.4	2.0	3.8	1.7	1.9	3.7	7.4	2.0	2.6	1.0	1.9	6.0	7.6	4.7	2.2	1.3	1.0	2.7	0.4	3.7	5.0	1.3	3.4	1.2	2.1	1.9	1.3	3.6	4.2	3.5	2.1	13.9	2.6	4.9	3.6	5.2	3.6	1.6	6.6	3.1	1.1	8.6	0.8	0.0	0.7	1.0	0.9	2.3	0.5	0.3	0.6	0.2	0.3	0.0	0.5	2.5	0.7	0.0	1.5	0.4	0.6	0.4	0.0	2.9	1.0	21.3	2.9	2.4	1.6	6.5	23.3	0.9	0.2	2.0	0.8	0.8	5.2	2.0	4.8	7.3	1.0	0.3	2.4	6.6	0.2	0.0	0.1	3.5	0.0	0.3	1.3	0.0	3.0	0.4	0.3	0.3	0.4	0.5	0.9	3.7	4.8	1.2	1.9	0.8	0.6	8.0	7.0	2.5	2.0	8.4	0.6	26.4	5.9	8.7	13.3	5.7	10.2	1.0	3.5	9.7	5.8	1.3	1.2	6.8	9.0	2.5	3.6	3.3	0.8	5.0	1.8	3.5	2.6	3.4	2.0	2.6	4.7	2.2	5.0	2.1	3.6	8.6	9.9	0.0	6.7	0.7	6.0	0.6	0.0	0.3	0.0	0.1	0.2	0.6	20.4	0.0	1.3	0.0	0.0	0.1	32.0	0.0	0.0	0.8	0.3	0.5	1.2	8.3	0.0	20.4	0.3	0.5	0.6	2.3	0.0	0.1	20.8	2.2	6.1	0.3	13.8	0.0	0.3	0.0	0.0	24.7	5.8	1.7	1.8	18.8	0.0	30.9	16.1	2.6	39.1	8.5	0.3	0.4	0.0	4.5	7.5	0.1	0.0	0.2	1.7	0.4	6.6	0.7	6.6	0.1	1.0	0.2	1.0	0.1	18.6	0.5	0.0	0.1
GAB4		ENSG00000215568	"GRB2 associated binding protein family member 4"	Q2WGN9	22	16961936-17008222	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.2;Late spermatids: 25.1;Spermatocytes: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044621	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA044621: AB_10967265"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABARAPL1	"APG8L, ATG8B, ATG8L, gec1"	ENSG00000139112	"GABA type A receptor associated protein like 1"	Q9H0R8	12	10212458-10223128	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 432.4;Syncytiotrophoblasts: 929.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 62.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 62.1;NK-cells: 22.6;T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 255.7;SiHa: 231.5;SuSa: 557.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051386, HPA065883"	Approved		Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA051386: AB_2681463, HPA065883: AB_2685574"	"unprognostic (9.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.85e-3)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.90e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (8.19e-8)"	"unprognostic (5.42e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.77e-1)"	185.4	97.7	115.0	33.6	131.3	164.3	150.7	102.6	215.8	75.2	105.2	101.9	40.8	77.7	125.3	44.1	91.1	75.5	334.3	141.9	155.8	314.9	207.4	146.0	15.2	145.7	105.6	157.9	138.2	126.0	218.2	190.1	135.9	92.9	35.0	327.0	118.1	69.8	381.8	71.5	67.1	64.7	90.9	42.3	133.6	37.4	123.2	21.8	93.4	163.3	14.2	107.5	82.8	138.4	8.7	18.3	36.2	34.2	200.8	57.3	30.2	200.0	91.8	33.6	43.9	79.5	30.1	2.0	16.4	215.4	84.8	54.6	32.0	24.2	24.5	6.1	29.9	11.8	115.4	22.0	255.7	14.8	13.3	101.0	52.0	25.9	20.4	96.7	82.5	23.7	14.9	0.5	14.4	0.7	12.4	15.2	88.3	1.9	18.2	0.9	66.1	0.9	139.7	21.6	3.5	7.6	231.5	36.8	71.5	557.0	16.9	8.8	113.1	10.9	36.6	17.4	9.6	35.3	60.4	55.8	36.5	6.7	16.2	53.6	4.8	43.0	26.7	2.7	8.9	0.2	3.6	16.3	2.9	0.1	3.4	14.2	62.1	22.6	6.7	1.1	5.8	6.5	115.0	131.3	102.6	215.8	141.9	155.8	145.7	105.6	135.9	90.9	123.2	138.4	216.8	60.9	35.7	15.0	23.5	62.8	196.6	57.1	101.3	118.3	45.0	26.0	197.8	72.9	33.6	58.8	154.3	310.8	171.8	38.5	432.4	62.5	295.1	57.8	75.0	88.0	71.0	61.7	45.5	57.2	31.1	128.9	61.7	143.9	17.7	15.4	63.9	112.1	72.0	89.2	41.4	37.6	75.3	73.1	56.4	70.3	25.7	111.6	74.7	18.7	24.6	114.2	25.7	13.0	26.6	45.4	31.5	24.5	57.2	130.7	55.0	250.3	16.1	237.6	19.7	96.8	85.2	10.0	8.8	32.6	42.3	929.0	125.6	25.8	11.5	169.0
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	20.4	18.0	10.2	2.4	10.9	2.8	20.7	6.4	9.6	45.3	0.0	33.6	0.2	42.8	0.0	14.5	39.0	0.9	28.4	3.9	0.0	16.9	4.7	20.6	2.0	0.3	2.0	40.7	10.4	1.1	30.8	1.3	0.0	34.3	0.5	0.5	16.3	4.2	6.1	19.2	20.2	1.4	0.0	39.0	18.5	7.9	6.1	0.2	22.8	0.0	1.2	25.3	31.6	0.0	2.4	0.0	1.5	6.3	0.7	1.6	1.6	1.6	0.7	1.4	0.4	1.9	0.1	1.1	1.5	0.0	0.3	2.0	0.7	0.0	0.0	5.9	2.6	6.4	3.7	0.0	0.9	0.2	3.1	0.0	0.0	1.2	0.0	1.8	0.8	3.3	5.5	0.0	0.2	1.5	0.6	0.1	0.4	0.0	0.9	2.9	0.6	0.1	0.2	0.0	0.4	1.0	0.4	0.0	2.6	0.4	1.2	0.9	3.6	2.5	6.2	0.2	3.1	5.4	0.6	0.0	1.4	2.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	10.2	10.9	6.4	9.6	3.9	0.0	0.3	2.0	0.0	0.0	6.1	0.0	16.8	12.8	20.2	150.5	10.6	11.9	6.2	4.7	10.2	30.6	13.4	17.7	13.9	1.5	10.7	3.7	0.0	0.3	5.7	0.8	0.0	1.4	4.7	1.3	30.6	17.0	7.2	5.7	58.7	0.9	0.2	16.0	1.5	1.9	7.6	14.6	22.5	0.3	1.1	23.5	68.1	4.7	2.0	5.9	18.3	3.1	15.2	14.4	0.0	19.7	11.0	9.8	0.0	72.4	16.3	1.7	1.6	25.6	0.7	7.6	0.1	1.0	1.1	17.3	13.1	12.5	18.8	1.2	2.7	5.3	11.1	0.5	5.9	6.7	1.5	2.8
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288109-98708935	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 90.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 386.5;Inhibitory neurons: 395.1"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.6;fHDF/TERT166: 7.3;HUVEC TERT2: 29.5;U-138 MG: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.0	3.6	26.0	0.2	40.8	0.0	0.0	10.6	90.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	39.9	18.0	0.0	0.0	0.3	0.0	12.7	19.6	0.0	0.1	0.2	0.6	0.1	12.5	0.0	0.0	8.5	0.0	0.1	2.8	0.2	0.0	0.1	8.3	0.0	0.2	0.6	39.5	0.0	1.4	0.5	0.2	0.5	0.0	36.3	0.0	0.0	0.0	0.0	0.1	0.1	1.2	14.6	2.9	3.0	5.5	0.1	0.1	0.0	0.9	7.3	0.6	0.0	0.1	0.2	1.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.9	0.2	0.0	29.5	0.0	0.3	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	1.2	11.5	0.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	26.0	40.8	10.6	90.4	39.9	18.0	12.7	19.6	12.5	8.3	39.5	36.3	0.1	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	86.4	0.5	0.1	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	90.3	0.1	0.0	0.6	0.0	0.0	386.5	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	395.1	0.0	0.0	0.0	0.0	34.5	0.3	0.1	1.8	11.2	0.0	1.8	0.0	26.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.3	1.3	0.7	0.9	0.0	0.1	0.4	0.0	0.3	0.1	0.0
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor subunit alpha"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	17.0	13.8	6.8	14.1	9.4	16.0	14.9	7.9	10.2	14.6	7.2	12.5	12.9	18.3	15.1	11.3	12.4	13.4	12.9	6.2	7.1	13.8	19.3	13.3	20.4	7.5	7.6	18.1	10.2	15.3	6.7	24.5	8.1	12.4	13.8	11.5	10.4	10.3	10.6	10.3	13.4	15.3	7.6	18.7	11.8	15.0	7.6	22.1	21.2	16.5	19.5	12.9	10.0	10.3	22.2	9.2	25.8	18.2	25.4	33.9	20.0	17.5	18.7	13.7	13.5	11.4	18.2	45.7	13.4	19.7	13.9	9.7	28.5	17.2	22.7	27.6	26.8	32.9	11.9	10.7	17.1	35.3	21.2	25.1	16.3	18.5	17.2	22.9	25.6	24.9	30.8	27.5	23.2	11.0	37.9	15.1	35.9	23.6	12.5	31.1	37.5	28.7	15.9	14.3	16.0	21.1	30.9	19.5	22.0	15.5	17.2	26.8	26.5	16.9	15.5	18.7	14.8	22.2	20.3	40.3	17.2	26.5	21.1	8.8	4.7	7.4	4.3	5.5	5.8	5.6	5.1	5.3	4.7	5.4	5.9	5.2	5.5	6.7	4.3	2.6	5.8	4.4	6.8	9.4	7.9	10.2	6.2	7.1	7.5	7.6	8.1	7.6	7.6	10.3	43.2	9.6	12.0	14.0	20.7	11.6	12.2	7.0	15.4	7.6	13.0	10.8	9.1	14.3	11.8	22.0	0.0	18.1	18.4	19.0	3.9	7.6	13.2	12.0	22.6	26.3	9.0	11.6	21.0	8.1	12.4	23.7	12.2	14.8	6.3	21.1	27.8	18.7	12.7	13.5	19.6	11.1	6.1	19.0	10.1	3.6	17.7	16.7	7.2	22.5	16.0	23.2	10.3	21.1	43.4	7.9	10.2	22.2	15.3	11.9	11.4	10.4	9.3	10.2	19.7	26.1	18.4	34.0	19.5	12.6	12.6	25.2	19.2	14.2	11.3	14.4
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor subunit beta 1"	Q06547	15	50275389-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: AB_2685842"	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	14.1	7.5	5.5	13.6	6.1	34.7	11.5	11.1	7.1	8.5	5.8	9.0	7.6	10.4	9.5	8.0	8.6	9.2	7.1	5.7	5.7	7.4	13.9	9.3	18.8	6.2	5.2	8.2	7.4	9.8	4.7	14.3	6.3	9.6	10.7	8.1	8.5	6.9	7.4	8.2	7.9	10.0	5.3	11.9	8.8	16.1	5.8	24.8	9.6	8.1	20.1	16.8	6.9	9.2	25.4	28.6	41.0	32.0	10.6	14.8	54.7	32.5	25.5	37.6	32.9	48.9	20.3	33.0	19.3	26.9	29.7	40.8	37.2	27.9	47.5	46.1	22.2	39.2	29.3	33.7	25.3	37.9	29.1	19.7	26.8	35.3	45.6	21.0	66.9	35.6	36.6	40.4	25.4	58.1	56.5	34.1	28.2	27.8	19.2	68.6	29.8	31.7	22.9	31.7	38.9	32.0	29.0	27.0	33.4	38.9	23.5	37.1	32.1	34.2	28.3	60.4	58.9	28.6	42.0	57.8	21.1	34.5	35.2	44.5	16.2	32.7	19.8	20.1	26.5	31.6	19.4	21.4	22.4	26.4	17.7	20.5	16.1	27.3	15.7	17.7	27.9	20.2	5.5	6.1	11.1	7.1	5.7	5.7	6.2	5.2	6.3	5.3	5.8	9.2	18.2	9.6	11.2	10.7	80.0	47.2	126.7	15.1	23.9	43.1	10.1	9.4	17.7	24.3	7.2	7.3	35.5	43.2	47.3	11.4	3.9	12.2	79.5	8.3	11.9	38.0	50.4	38.7	13.9	7.6	50.5	33.2	23.9	10.9	47.0	8.6	41.7	30.6	37.0	37.0	12.3	24.9	12.2	73.4	22.3	33.3	57.8	42.2	19.6	15.9	54.0	32.4	120.5	22.1	19.1	14.6	21.6	38.4	58.7	89.3	21.4	8.4	8.7	45.8	26.3	64.0	32.5	28.9	34.0	32.7	35.8	55.4	77.2	6.7	27.8	116.6
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor subunit beta 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	5.5	4.9	4.4	4.2	6.4	7.0	4.5	6.9	5.3	5.8	3.8	5.5	3.5	5.1	3.8	4.9	5.8	3.6	6.4	4.2	4.9	4.8	3.8	4.4	5.5	5.5	5.2	9.3	4.1	5.1	5.8	3.2	5.2	5.3	4.8	5.3	4.3	3.7	5.1	7.2	4.7	3.9	3.9	5.4	4.9	11.7	5.7	9.8	5.4	3.7	5.1	5.7	5.5	7.9	9.2	3.2	2.2	2.7	7.6	11.2	2.9	8.4	5.2	4.7	3.3	0.9	6.7	9.6	3.0	8.0	2.5	7.8	4.8	4.3	6.9	3.6	1.8	2.6	5.3	0.1	5.1	10.6	5.2	6.1	4.9	6.5	9.7	3.7	1.7	10.0	6.6	6.5	5.7	13.1	14.6	1.9	1.0	5.3	3.4	4.3	3.6	4.5	4.0	2.5	3.8	1.6	10.7	3.7	3.1	2.1	9.3	11.2	5.3	1.2	4.0	8.5	6.8	3.5	1.8	33.9	3.8	7.9	5.7	1.5	0.9	0.5	1.4	1.1	0.8	1.0	1.5	1.2	0.8	1.3	1.3	1.4	1.4	0.8	1.8	1.6	0.6	1.0	4.4	6.4	6.9	5.3	4.2	4.9	5.5	5.2	5.2	3.9	5.7	7.9	9.4	9.6	16.8	21.2	10.0	11.5	9.3	9.6	10.2	26.3	8.9	10.3	22.4	17.2	14.8	12.9	25.0	5.8	18.0	12.3	9.8	5.7	36.3	13.5	15.4	11.0	9.6	14.9	18.4	5.8	4.6	16.2	9.7	9.7	7.0	11.7	15.7	7.1	8.2	33.7	25.3	15.6	4.1	13.4	9.7	17.1	22.4	11.3	8.8	15.9	14.3	10.9	33.0	11.6	39.3	5.3	8.5	21.4	8.1	6.9	10.7	4.6	20.8	36.5	6.6	38.5	15.4	75.6	55.7	9.6	10.1	4.5	16.3	15.6	16.8	7.0
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 55.1;retina: 17.8"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		0.0	1.2	6.7	0.0	11.1	0.0	0.0	24.8	55.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	14.3	0.6	0.0	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.1	24.8	55.1	7.7	21.7	0.0	0.0	0.0	0.0	14.3	24.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	215.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.8	0.0	3.5	0.0	8.0	16.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor subunit alpha6"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	114	"brain: 71.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	14	"cerebellum: 71.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	40	"cerebellum: 1073.8"	"Region enriched"	"Detected in some"	37	"cerebellum: 262.3"	CAB022462	Approved					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.1	0.1	0.0	0.3	0.0	0.0	71.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	71.1	2.8	0.1	0.3	0.2	1.8	4.9	0.4	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor subunit beta2"	P47870	5	161288429-161549044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 71.7"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 570.3;Inhibitory neurons: 780.2"	"Cancer enriched"	"Detected in some"	20	"thyroid cancer: 10.2"	"Group enriched"	"Detected in many"	7	"cerebellum: 63.2;cerebral cortex: 71.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001964: , HPA067632: AB_2685874"	"unprognostic (5.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.26e-6)"	"unprognostic (2.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.04e-2)"	0.7	2.3	0.6	0.0	5.8	0.0	0.1	63.2	71.7	0.5	0.0	0.6	1.2	0.1	3.4	0.0	0.4	0.0	0.1	9.2	10.0	1.8	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.2	0.0	0.1	1.1	6.5	0.5	0.6	0.1	0.1	0.6	0.1	0.0	2.4	0.5	0.6	7.9	0.1	0.5	0.4	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.8	63.2	71.7	9.2	10.0	0.0	0.0	0.0	0.0	7.9	9.5	0.0	0.0	0.0	21.5	0.0	0.3	0.0	0.1	0.0	19.8	0.1	0.0	1.9	0.0	0.0	0.0	27.1	0.0	0.0	1.0	5.9	0.0	1.6	0.0	0.3	0.3	1.2	0.0	570.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	780.2	1.8	4.1	0.0	0.4	1.4	0.0	1.3	0.0	20.6	0.0	2.3	0.0	33.7	17.9	0.0	0.5	0.4	0.0	0.1	0.0	3.2	0.0	10.6	0.0	0.3	3.5	3.1	1.8	0.1	0.4	0.0	0.0	1.9	4.2	0.1
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor subunit delta"	O14764	1	2019329-2030758	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 49.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	0.3	1.5	12.8	0.0	16.9	0.0	0.5	49.6	40.5	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.4	0.7	14.7	5.4	0.7	0.2	0.9	0.2	14.3	18.1	0.2	0.1	0.7	2.7	0.1	20.2	0.2	0.0	1.4	0.3	0.0	0.3	0.4	0.2	0.3	1.0	0.3	0.1	3.6	29.7	0.1	0.9	0.4	0.0	0.2	0.2	14.7	0.0	0.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.7	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.8	16.9	49.6	40.5	14.7	5.4	14.3	18.1	20.2	1.0	29.7	14.7	1.0	3.2	3.6	4.9	0.1	0.5	0.0	0.0	0.0	14.7	0.3	0.0	0.9	0.0	6.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	3.4	0.0	0.0	30.0	0.0	0.3	0.5	0.0	0.2	2.5	0.3	0.0	0.0	0.1	13.5	37.4	0.0	0.0	0.0	0.3	0.2	0.0	0.9	0.0	8.4	0.0	1.4	0.0	3.0	4.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.4	1.6	0.0	0.0	4.8	0.1	11.3	0.1	0.0	0.3	0.4	0.2	0.1	0.1
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor subunit epsilon"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"brain: 52.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.7;Syncytiotrophoblasts: 61.4;Urothelial cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;EFO-21: 11.6;HeLa: 6.1;SiHa: 5.6"	"Region enriched"	"Detected in many"	4	"hypothalamus: 18.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 32.3"	HPA045918	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	9.7	0.4	6.3	0.3	4.5	0.0	4.4	0.0	9.7	1.7	0.9	0.4	0.7	0.6	1.8	1.0	0.7	0.5	9.5	0.8	52.3	1.1	0.1	0.6	0.2	5.1	38.0	0.8	0.8	0.9	2.2	3.3	33.0	1.8	0.3	0.1	0.8	3.4	0.3	3.2	0.4	0.3	0.2	0.2	0.3	0.1	14.0	0.1	1.0	0.0	0.2	0.6	2.3	0.2	0.2	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.0	0.8	0.4	1.9	0.6	0.0	11.6	2.5	0.0	1.9	0.0	0.6	0.5	0.0	0.4	1.3	6.1	0.7	0.2	0.0	0.1	0.8	0.5	0.9	0.2	1.1	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.7	0.0	0.8	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	0.0	9.7	0.8	52.3	5.1	38.0	33.0	0.2	14.0	0.2	7.7	16.0	9.3	0.7	0.7	17.2	22.9	18.6	30.7	0.0	6.8	4.6	7.3	11.5	25.2	1.8	0.0	25.0	0.5	10.0	0.0	4.1	2.0	7.6	12.8	9.0	1.8	0.0	0.0	0.4	3.5	9.2	0.0	29.2	0.0	0.1	4.2	0.9	3.0	0.0	0.0	2.3	4.1	0.6	4.6	3.5	1.5	0.3	1.8	2.8	0.7	0.6	1.0	0.0	0.0	6.1	7.4	2.2	0.0	19.2	21.6	0.2	5.6	0.3	0.0	19.6	5.7	1.2	2.1	22.5	10.9	61.4	1.3	0.1	3.6	42.2
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 44.7"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 135.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		0.1	0.1	21.6	0.0	20.6	0.0	0.0	19.0	27.3	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.4	31.7	0.0	0.0	0.0	0.0	24.8	38.0	1.2	0.0	0.0	0.6	0.0	23.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.2	44.7	0.0	0.1	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	19.0	27.3	19.4	31.7	24.8	38.0	23.9	21.1	44.7	23.1	0.3	0.0	0.0	135.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.2	0.0	15.4	0.0	2.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.6	0.0	1.8	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GABRG3		ENSG00000182256	"Gamma-aminobutyric acid type A receptor subunit gamma3"	Q99928	15	26971181-27541984	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 17.6;retina: 27.1;testis: 9.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 444.7;Inhibitory neurons: 615.5;Late spermatids: 351.0;Muller glia cells: 179.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 17.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 4.5;PC-3: 5.5;SK-MEL-30: 3.5;U-2 OS: 2.5;U-266/70: 3.2;U-87 MG: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054010	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054010: AB_2682342"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.43e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	0.0	0.4	3.5	0.2	3.0	0.0	0.4	0.0	4.2	0.8	0.0	0.0	0.0	0.1	1.9	0.0	0.4	0.0	0.0	0.9	17.6	0.7	0.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	3.0	0.0	0.0	6.6	0.0	27.1	0.8	0.2	0.0	0.3	0.0	0.0	0.6	1.0	0.0	9.3	10.2	1.0	1.5	0.0	0.8	0.0	0.2	2.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	5.5	0.0	0.0	1.0	0.0	0.0	0.1	1.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.2	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.0	4.2	0.9	17.6	0.5	0.2	0.0	0.6	10.2	2.9	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	4.6	2.5	1.4	0.9	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	86.2	3.2	0.1	0.3	0.0	0.0	444.7	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.0	615.5	0.0	0.0	0.0	0.0	351.0	0.9	0.2	0.0	7.5	0.0	179.9	0.0	16.1	7.9	0.0	0.0	0.7	0.0	3.1	0.0	0.3	0.0	4.6	0.0	0.1	0.1	1.6	7.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 152.3;esophagus: 171.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	4.5	3.6	10.4	7.3	10.5	9.9	152.3	15.8	16.2	13.1	5.4	4.2	15.4	48.6	19.0	171.5	12.9	27.3	5.4	7.6	23.0	6.1	7.1	14.7	5.7	12.5	6.1	3.9	23.8	2.0	2.0	9.1	10.6	12.7	4.9	42.1	35.8	16.6	13.7	19.0	16.2	2.6	2.7	7.4	27.4	8.3	10.4	4.7	6.1	2.7	42.2	5.4	29.4	17.9	215.1	9.9	10.1	7.0	0.7	4.3	23.8	3.8	1.5	0.5	0.6	38.1	23.6	3.3	236.8	1.1	2.3	75.7	6.4	0.5	0.6	3.5	7.6	14.1	166.8	5.7	0.8	5.1	11.2	1.6	3.0	2.8	1.8	8.0	1.4	13.4	57.6	26.5	0.4	6.7	9.5	4.7	84.5	3.7	331.3	13.7	6.6	8.2	13.8	11.6	8.2	4.0	76.5	3.9	2.2	418.8	4.2	2.4	8.8	19.1	69.3	15.7	15.7	10.0	6.7	6.3	2.6	13.9	2.9	11.8	1.9	6.1	0.4	1.5	1.1	0.3	0.4	0.3	0.6	0.7	0.5	0.5	4.5	0.2	5.7	0.9	0.6	2.3	10.4	10.5	15.8	16.2	7.6	23.0	12.5	6.1	10.6	2.7	10.4	17.9	1.1	3.2	0.6	0.0	0.9	0.0	14.9	44.4	0.0	0.0	169.0	113.2	0.7	51.5	83.1	1.8	0.0	5.2	2.3	0.0	0.0	10.4	0.0	146.0	48.8	3.8	0.0	0.0	0.3	13.8	0.6	2.4	2.0	464.0	0.0	0.0	0.0	0.1	2.3	0.0	0.2	0.3	12.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.1	0.0	0.0	24.2	0.1	0.1	34.0	0.0	0.0	0.2	5.9	0.0	0.0	4.5	0.0	5.7	2.7	0.0	0.6	146.6
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216665-26304558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 37.6;retina: 9.5"	"Cell type enriched"	"Detected in some"	13	"Inhibitory neurons: 293.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			0.0	0.0	13.1	0.0	37.3	0.0	0.0	6.9	16.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	37.6	0.0	0.0	0.0	0.0	6.6	14.8	0.0	3.6	0.0	0.4	0.0	7.7	0.0	0.0	9.5	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.1	0.4	11.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	37.3	6.9	16.2	6.0	37.6	6.6	14.8	7.7	3.1	11.9	3.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	293.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.6	0.0	0.3	0.0	2.0	6.1	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 16.3"	HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	343.5	75.9	45.3	41.4	52.8	321.4	217.4	51.4	63.8	104.8	55.0	205.1	17.2	83.4	3.3	53.9	190.0	91.4	372.7	45.1	57.8	245.6	408.9	343.2	33.1	56.3	55.5	159.2	92.6	49.2	174.1	45.1	54.9	90.8	9.9	57.1	72.6	28.5	84.1	144.8	67.9	27.3	55.0	75.9	187.3	17.1	59.7	65.9	209.2	30.8	12.7	103.9	100.0	49.5	62.1	12.2	1.4	8.1	44.1	33.6	3.8	61.7	17.7	47.6	24.4	17.1	23.3	29.1	40.7	30.7	17.1	33.8	3.2	20.5	11.5	22.5	11.0	3.2	13.9	6.6	74.3	6.7	19.7	54.8	13.1	14.3	70.2	51.3	19.0	3.1	1.6	76.9	49.5	19.9	7.7	33.0	7.3	6.2	25.7	28.5	22.0	46.6	21.7	11.0	0.6	0.6	68.7	50.6	20.9	26.2	26.9	49.5	78.8	47.2	43.2	34.0	77.9	34.3	27.9	12.5	11.5	20.0	15.7	32.1	33.5	131.2	58.1	40.8	52.3	21.0	40.7	45.2	32.9	30.2	35.5	47.9	92.5	43.3	33.5	36.9	54.6	35.3	45.3	52.8	51.4	63.8	45.1	57.8	56.3	55.5	54.9	55.0	59.7	49.5	1997.9	423.1	571.3	24.5	450.9	341.7	805.4	147.3	376.2	11.9	666.3	1851.8	952.6	173.0	226.3	51.5	6.2	93.0	988.3	213.7	191.7	374.3	1.6	614.2	539.7	800.0	85.3	8.6	3.0	209.8	54.0	1143.0	400.1	1122.9	786.6	53.9	138.8	126.1	430.9	13.5	1.5	164.4	282.8	174.8	1169.6	4.7	74.0	863.0	517.6	1.9	157.1	269.8	33.0	0.5	0.9	292.5	309.0	29.3	416.8	823.3	294.3	142.1	211.4	34.2	177.5	818.8	1753.4	1.4	7.8	399.0	308.9	144.2	514.7	128.4	98.8	301.3
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605012-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 317.8;liver: 366.0"	"Cell type enriched"	"Detected in many"	7	"Syncytiotrophoblasts: 1609.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 4.9"	"Group enriched"	"Detected in many"	4	"HDLM-2: 116.8;SCLC-21H: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023606	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	19.6	143.4	12.3	3.8	18.9	14.7	24.6	25.2	19.9	135.0	8.2	26.1	6.0	53.2	1.8	13.1	26.5	2.9	317.8	11.6	16.1	25.4	366.0	26.8	1.6	13.8	13.7	74.3	78.4	28.5	127.5	25.3	12.4	74.4	1.5	3.1	19.7	10.4	139.0	35.8	19.6	7.4	12.1	6.6	44.5	29.9	15.8	2.4	20.7	23.5	0.6	30.6	38.8	13.2	3.1	0.0	16.0	0.0	0.0	0.0	21.1	1.1	0.0	0.1	0.0	2.6	0.3	0.0	2.5	0.0	0.8	2.3	5.3	0.1	0.0	116.8	1.0	0.3	0.3	0.0	0.8	0.0	0.4	0.4	2.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	4.9	0.2	1.1	14.7	2.7	0.2	1.2	4.7	1.2	0.2	0.7	58.6	13.4	1.1	6.3	0.1	3.0	2.5	0.1	2.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	12.3	18.9	25.2	19.9	11.6	16.1	13.8	13.7	12.4	12.1	15.8	13.2	124.2	6.4	53.7	4.6	15.4	28.6	50.9	9.9	40.5	43.9	118.2	215.3	196.8	62.9	22.5	11.0	6.2	80.7	46.6	21.6	92.0	18.3	2.1	40.7	98.3	48.8	54.8	6.6	1.1	43.4	12.1	138.9	97.3	29.3	19.6	24.7	11.0	215.2	57.0	3.3	2.2	55.9	50.8	12.4	121.1	9.0	84.5	77.6	35.6	2.8	11.7	35.7	0.0	0.0	1.1	20.4	11.1	45.5	13.2	88.9	24.9	40.6	23.5	22.0	131.5	90.9	144.4	3.6	2.0	95.5	19.6	1609.4	57.5	165.8	20.0	12.4
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957223	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	32.0	46.3	28.9	14.0	28.8	20.6	29.9	28.7	41.3	32.0	27.2	39.0	12.4	34.4	7.7	41.8	30.7	7.5	75.7	28.4	31.0	42.0	52.2	25.2	13.5	31.1	33.1	28.7	39.0	11.6	34.6	11.0	30.6	37.1	4.8	7.4	28.9	9.5	80.1	31.4	25.4	6.8	28.5	32.5	33.1	22.7	30.4	8.8	30.9	23.1	6.5	36.3	28.4	29.9	68.7	56.9	23.5	33.2	16.1	20.8	32.7	49.4	24.5	48.2	39.5	79.1	27.1	49.1	79.8	29.8	34.7	47.0	28.9	48.2	12.4	32.1	140.5	34.9	78.6	90.2	39.2	58.2	51.3	24.7	38.4	33.6	27.5	25.7	28.3	46.1	53.6	18.8	30.3	100.6	93.2	122.8	65.0	44.0	176.7	68.1	23.7	79.2	38.1	39.9	71.9	65.7	36.8	49.3	60.4	11.6	38.4	54.7	46.4	93.0	32.9	81.7	92.3	73.4	55.1	52.0	64.5	72.7	54.8	13.4	35.6	12.6	33.3	34.6	33.1	102.5	51.3	53.1	43.6	84.1	55.1	40.0	2.1	39.9	29.9	41.4	46.9	29.5	28.9	28.8	28.7	41.3	28.4	31.0	31.1	33.1	30.6	28.5	30.4	29.9	111.9	41.7	51.6	6.5	132.4	145.4	189.2	198.9	83.6	59.9	127.0	141.1	157.0	114.4	123.4	138.0	22.9	321.9	101.5	232.1	401.1	265.8	41.8	166.8	139.9	151.8	139.1	159.3	6.1	381.7	355.8	138.3	88.2	130.6	73.6	158.1	146.7	288.8	245.5	37.0	8.1	205.7	101.7	132.9	228.9	56.0	191.3	106.0	179.7	8.4	253.1	103.9	95.8	7.1	14.7	311.5	138.3	170.4	142.4	247.0	215.9	616.7	160.6	88.8	190.7	141.0	164.4	85.4	129.4	153.3	160.8	204.3	105.6	235.8	258.9	171.0
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 25.8;tongue: 11.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;TIME: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.3	0.4	2.2	0.4	2.1	1.2	0.4	2.6	2.5	0.1	0.1	0.2	0.2	0.3	0.6	0.6	0.2	0.3	0.6	1.8	0.8	0.7	0.3	0.3	0.4	0.9	0.5	0.6	0.4	0.2	0.2	0.3	0.9	0.6	0.2	1.7	0.4	0.1	25.8	0.9	0.2	0.2	0.1	0.6	0.3	0.5	1.0	0.1	0.9	11.3	0.3	0.2	0.0	2.3	0.4	0.0	0.2	0.4	0.3	0.1	0.5	0.2	0.1	0.0	0.0	0.5	0.5	0.4	0.2	0.0	0.2	0.3	4.7	0.1	0.1	0.6	0.1	0.5	0.8	0.2	0.0	0.3	1.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	0.5	1.7	0.2	0.3	0.2	0.5	0.5	0.1	0.1	0.7	0.9	0.4	0.2	0.6	0.5	0.3	0.2	0.3	1.3	0.3	0.4	0.3	2.4	0.6	0.5	0.8	0.2	0.6	0.3	0.3	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.2	2.1	2.6	2.5	1.8	0.8	0.9	0.5	0.9	0.1	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	1.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	P0DTW1	X	49599025-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 113.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 739.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	739.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	24.4	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.0;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 2.1;Leydig cells: 1.2;Microglial cells: 1.0;Peritubular cells: 1.2;Spermatocytes: 3.2;Spermatogonia: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5;WM-115: 1.0"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	1.0	0.0	1.4	0.0	0.2	0.9	2.0	0.1	0.8	0.1	0.0	0.1	0.5	0.0	0.4	0.0	0.1	1.0	0.8	0.0	0.0	0.0	0.2	0.9	1.1	0.9	0.0	0.0	0.8	0.0	1.0	0.1	0.1	0.6	0.0	0.3	0.1	0.0	0.0	0.3	0.9	0.1	0.0	1.6	0.8	0.0	0.2	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.2	2.5	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.9	2.0	1.0	0.8	0.9	1.1	1.0	0.9	0.8	1.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	5.2	0.0	0.1	0.0	0.0	0.6	0.0	0.1
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 1.8"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.4;U-266/84: 2.1"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, O76087, P0CL82"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 178.7"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"AN3-CA: 1630.3;K-562: 1415.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	178.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.9	0.0	0.0	1630.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1415.3	30.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	360.9	0.0	5.1	56.9	7.5	0.3	1.0	0.6	72.0	0.0	0.2	0.0	171.2	1.3	11.5	4.6	4.8	12.1	3.4	8.4	12.6	8.7	0.0	7.8	9.7	8.6	1.4	14.7	10.5	12.4	20.2	11.5	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"retina: 1.6;stomach 1: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 439.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	439.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	54.7	0.0	0.0	8.4	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.0	20.8	0.2	1.5	0.9	0.5	1.6	0.8	0.8	2.0	0.2	0.0	1.5	0.3	1.7	0.0	0.3	1.4	0.9	4.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	230	"testis: 22.9"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 1.4;Spermatogonia: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"A-431: 53.9;U-266/84: 164.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	0.0	0.0	164.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"AN3-CA: 1145.9;K-562: 290.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1145.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	290.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	32.4	0.0	0.0	0.0	0.2	0.5	0.0	2.5	32.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"	Q4V321	X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 36.1"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 4.2;Spermatogonia: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 303.6;T-47d: 165.3;WM-115: 83.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	303.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	3.6	0.0	2.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	165.3	0.0	0.7	3.4	1.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	108	"testis: 92.5"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 108.0;Spermatogonia: 358.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 86.8;T-47d: 289.7;WM-115: 325.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	86.8	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	289.7	0.0	0.0	47.3	10.6	0.1	0.0	1.2	13.8	0.0	2.9	0.0	325.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	108.0	358.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"	Q4V326	X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"stomach 1: 12.8;testis: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 2587.1;K-562: 674.0"									HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.2	12.8	26.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2587.1	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	4.3	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	674.0	12.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.0	5.0	0.3	0.3	364.7	0.1	3.3	61.8	2.4	0.2	0.2	0.8	20.9	0.0	0.7	0.2	138.5	0.4	0.6	0.1	0.5	0.0	0.0	0.6	0.1	1.0	0.0	1.2	2.1	0.0	0.4	0.4	0.0	1.5	2.9	0.1	0.1	0.3	0.0	0.3	0.2	0.0	0.1	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	31.9	40.7	21.1	25.9	22.5	35.5	34.0	20.1	29.7	42.7	20.1	56.3	51.2	41.9	8.0	49.7	43.0	17.7	25.4	21.5	17.8	55.0	47.7	46.0	25.6	28.7	19.8	40.5	53.1	22.7	37.1	15.6	22.1	41.8	14.8	9.4	71.0	13.3	31.4	40.4	57.4	9.8	17.7	61.5	54.2	45.8	20.6	21.6	38.5	6.6	12.9	38.7	39.3	20.5	36.0	28.3	16.9	29.0	16.6	14.2	43.6	33.0	19.7	22.3	18.5	35.9	49.8	30.4	20.9	20.1	40.3	29.7	17.7	27.4	10.5	30.7	27.9	35.3	29.5	27.5	31.1	36.2	53.0	20.5	23.2	22.7	11.0	14.2	24.7	35.3	38.4	37.4	15.2	34.7	61.6	92.1	30.4	38.2	46.3	50.2	19.4	27.4	18.2	28.8	29.0	31.3	19.3	24.2	23.3	14.1	39.2	30.7	40.8	30.9	18.0	31.8	45.1	59.5	41.3	33.8	34.9	43.7	29.0	3.0	10.3	12.8	8.8	9.8	7.6	4.9	5.8	6.1	6.5	3.9	3.3	4.8	7.4	4.8	24.6	7.6	5.6	9.4	21.1	22.5	20.1	29.7	21.5	17.8	28.7	19.8	22.1	17.7	20.6	20.5	24.7	25.6	33.2	34.0	33.9	17.0	15.3	17.9	14.8	27.2	25.3	17.7	12.2	18.6	28.2	25.8	64.6	19.0	46.2	131.3	9.8	18.8	99.1	32.2	21.6	26.7	29.4	26.1	25.7	28.0	17.5	19.5	93.8	52.5	18.3	31.2	18.5	31.6	36.6	11.8	23.5	66.5	26.4	35.9	18.4	134.7	25.1	35.5	16.0	59.0	28.8	16.3	35.0	9.0	24.4	37.6	71.1	18.8	26.1	28.4	65.8	31.0	33.8	26.9	19.7	17.9	18.0	32.9	27.4	19.9	22.3	31.1	34.6	41.6	65.0	44.6
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"brain: 645.9;pituitary gland: 885.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	13	"hypothalamus: 645.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.2	0.9	2.8	14.9	2.1	0.7	4.4	1.1	5.2	1.0	0.8	17.6	1.8	0.2	0.0	0.8	1.0	0.2	1.0	2.2	645.9	1.5	0.3	0.5	0.1	48.5	5.1	0.2	2.1	0.1	885.8	0.3	13.8	4.4	4.0	0.0	0.9	0.2	0.4	33.3	4.1	9.9	0.6	0.3	9.7	1.0	19.5	0.7	0.4	0.0	0.0	0.7	2.9	2.6	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.1	1.1	5.2	2.2	645.9	48.5	5.1	13.8	0.6	19.5	2.6	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.6;intestine: 24.4;kidney: 18.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	1.3	0.2	14.8	0.4	33.3	0.8	1.1	27.7	25.8	2.7	0.3	5.2	23.0	2.4	1.7	0.5	3.1	5.2	1.1	14.6	18.3	18.4	4.0	1.9	0.7	32.9	29.0	2.3	6.9	0.7	1.5	0.9	31.0	3.1	2.4	2.3	0.5	1.4	3.1	1.6	24.4	0.3	23.2	0.3	8.2	5.0	29.1	0.1	0.2	0.3	0.0	1.6	1.8	51.6	0.0	27.6	0.5	0.2	0.0	0.0	2.0	0.0	0.2	0.0	0.0	7.7	3.8	0.4	14.6	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.7	0.4	0.4	5.7	0.6	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.4	6.6	0.6	0.0	0.2	0.3	1.1	3.9	10.6	0.4	0.2	0.0	0.7	1.1	0.1	0.3	1.8	0.0	0.4	0.2	0.7	0.2	0.2	0.8	0.2	0.2	0.3	0.0	2.4	1.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.6	0.0	0.0	14.8	33.3	27.7	25.8	14.6	18.3	32.9	29.0	31.0	23.2	29.1	51.6	0.5	0.0	0.0	2.3	0.3	0.4	0.1	0.0	0.0	0.8	0.6	3.3	0.6	30.0	0.0	3.7	0.0	0.1	0.0	14.0	15.6	7.0	1.1	1.1	0.3	0.3	10.9	2.7	2.0	11.1	0.1	0.3	5.1	2.4	0.0	0.9	0.0	1.6	0.1	0.0	1.9	5.7	0.0	0.3	0.3	0.8	1.5	0.2	0.0	0.0	0.0	35.3	0.0	26.7	53.6	5.0	8.8	2.2	0.1	0.4	48.1	24.6	0.1	1.3	0.0	2.1	0.3	12.4	14.3	0.0	0.3	0.3	0.2	0.0	7.6	0.1
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776822-241804287	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 9.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 3.7;HMC-1: 10.5"	"Not detected"	"Not detected"							HPA071809	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	0.5	0.3	0.4	0.8	0.3	0.2	0.0	0.0	0.6	0.5	0.0	9.4	0.0	0.1	0.0	0.0	0.5	0.4	0.1	0.2	0.3	0.3	0.5	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	3.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.6	0.2	0.3	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 126.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	18.6	12.5	5.9	7.8	6.7	5.6	17.1	6.4	8.4	17.5	5.9	12.5	20.6	16.5	1.0	24.4	14.9	4.3	19.7	6.0	6.6	32.0	126.4	18.7	7.4	7.9	6.3	13.7	31.2	10.6	5.7	5.8	7.5	13.3	2.0	0.7	20.0	5.7	8.6	20.6	18.3	3.9	7.0	24.5	17.6	16.0	6.8	6.1	11.6	3.6	3.4	13.0	17.8	8.2	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	5.9	6.7	6.4	8.4	6.0	6.6	7.9	6.3	7.5	7.0	6.8	8.2	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	10.3	16.8	8.5	8.5	9.3	6.6	11.2	10.1	9.3	12.5	14.8	15.2	20.2	8.5	8.7	8.1	12.2	8.9	12.8	8.7	8.5	30.4	21.1	10.5	8.3	8.6	9.0	9.3	12.2	17.5	9.6	9.9	9.0	9.7	16.2	7.7	9.9	10.9	10.5	9.0	16.6	10.7	8.5	8.9	13.2	7.0	8.3	12.6	14.8	16.9	10.0	9.3	8.5	11.4	14.7	17.1	7.5	10.1	19.1	29.7	21.9	14.7	20.2	14.7	17.2	21.6	15.0	4.8	11.6	15.9	18.0	20.5	30.2	21.6	20.6	26.2	9.1	26.8	15.7	18.4	20.9	19.2	8.2	15.4	38.4	15.7	37.4	16.8	30.2	11.0	27.4	25.5	16.1	15.9	13.9	15.3	3.3	44.0	15.9	16.7	9.5	71.0	27.3	13.8	9.1	6.0	16.6	33.3	29.6	15.0	16.9	18.3	16.6	14.1	9.6	58.4	14.3	20.9	76.2	8.9	22.2	70.1	19.8	45.4	15.3	28.4	18.1	16.7	18.9	14.0	18.0	17.3	15.2	11.1	14.2	14.3	7.6	19.6	17.2	13.3	35.3	13.1	8.5	9.3	10.1	9.3	8.7	8.5	8.6	9.0	9.0	8.5	8.3	11.4	13.6	3.2	14.9	48.6	12.7	5.6	13.6	16.8	9.1	13.3	12.1	10.3	3.1	27.1	14.5	5.5	37.5	14.8	10.6	14.5	29.4	20.0	12.0	19.2	15.7	12.0	9.0	12.0	92.2	13.1	29.0	12.7	18.3	12.0	2.5	9.8	22.9	25.7	20.4	15.2	90.1	25.1	20.3	16.8	5.7	4.8	11.5	12.6	14.2	63.7	16.5	11.6	20.6	41.7	109.5	10.7	16.2	11.3	27.9	8.3	30.5	56.5	34.1	25.8	0.0	13.4	11.6	22.3	5.9	9.0	6.3	25.7	13.9	13.8	19.0	9.7
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38666081-38741237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 86.5;kidney: 120.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 68.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 39.1;T-cells: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		620000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	9.0	86.5	5.2	12.2	5.1	3.8	10.4	6.0	6.1	9.3	8.3	34.7	71.4	8.1	23.0	5.8	35.8	16.5	13.0	4.9	4.8	120.2	72.5	14.3	16.0	5.4	6.1	15.5	15.0	21.3	3.0	7.7	5.4	10.2	33.3	4.4	8.7	20.8	13.1	3.8	52.8	10.4	5.7	6.6	14.9	4.4	7.0	11.0	15.1	12.3	10.2	10.8	6.4	6.0	0.2	27.1	8.1	0.0	27.3	15.4	14.9	3.2	10.3	7.5	12.2	32.4	14.4	10.9	18.9	15.3	14.5	4.3	11.7	0.7	14.5	49.5	19.3	5.9	7.1	62.7	10.0	2.4	0.4	11.1	0.4	17.5	0.0	10.5	8.2	0.0	17.2	71.1	13.9	0.9	23.4	41.0	12.4	59.2	8.6	15.2	0.6	21.3	9.3	45.1	1.5	11.2	0.1	18.9	14.7	10.2	9.0	5.4	3.4	2.5	0.5	18.6	1.0	76.4	54.3	0.3	17.9	7.0	0.3	39.1	4.8	4.2	21.5	3.3	31.8	6.8	33.1	31.2	10.3	4.7	11.7	10.2	11.3	5.5	0.7	0.8	68.3	11.9	5.2	5.1	6.0	6.1	4.9	4.8	5.4	6.1	5.4	5.7	7.0	6.0	9.7	28.9	11.0	13.4	10.0	6.6	6.7	3.4	10.8	3.6	7.8	4.2	23.4	24.3	6.5	69.9	0.0	23.6	19.0	83.2	25.4	12.1	1.4	28.5	11.6	10.0	13.2	8.2	2.3	15.1	31.4	16.1	17.9	10.1	7.0	16.8	14.6	48.1	94.8	3.3	1.4	40.5	4.1	18.6	43.6	1.3	20.2	34.7	17.8	4.7	9.9	38.2	18.6	0.5	1.3	6.8	64.5	97.8	14.7	5.7	161.1	222.1	14.8	6.8	6.6	16.6	10.4	1.0	2.3	3.2	6.0	6.3	44.0	43.3	80.4	5.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	9.2	12.8	9.4	9.3	10.0	22.2	6.3	10.0	11.5	9.1	22.1	10.0	10.6	7.4	14.5	8.8	11.4	9.7	11.0	10.6	12.0	8.6	8.1	10.4	7.4	12.6	16.4	6.7	5.0	8.6	11.9	8.6	12.0	7.7	6.1	3.3	8.3	4.7	6.4	8.4	10.6	7.1	10.8	9.1	8.1	26.3	11.3	4.8	9.1	3.6	5.6	9.0	9.1	12.0	5.7	42.7	6.2	43.4	47.1	22.4	41.9	17.9	27.3	19.1	14.7	22.7	36.8	7.1	37.1	29.2	28.8	33.0	9.0	14.2	11.4	4.7	13.8	4.5	17.0	13.2	31.5	3.6	28.5	31.4	26.9	21.4	6.0	27.0	16.4	7.8	9.9	4.1	11.3	33.3	9.2	15.0	14.2	14.3	19.6	19.6	5.4	12.1	11.9	13.2	15.8	12.2	42.4	4.0	21.9	14.4	27.3	32.5	31.3	41.8	31.5	43.2	10.0	4.3	4.5	12.6	45.2	29.7	25.4	1.4	17.4	31.3	4.5	12.5	3.9	3.0	2.5	4.0	11.3	1.3	2.5	3.1	21.7	4.0	9.6	4.7	4.6	8.5	9.4	10.0	10.0	11.5	10.6	12.0	12.6	16.4	12.0	10.8	11.3	12.0	4.8	16.0	4.8	9.4	5.9	6.5	7.3	27.7	9.1	5.0	6.8	5.0	8.4	4.3	11.0	3.7	6.2	9.9	8.5	16.8	3.9	5.7	21.0	27.2	9.6	7.2	12.0	1.3	7.6	3.7	14.0	13.8	6.1	8.9	1.3	11.9	7.5	6.4	18.7	25.2	10.4	6.8	8.2	13.2	6.3	37.3	7.2	11.3	7.2	2.8	18.2	8.8	14.4	4.0	9.8	5.6	13.6	6.8	9.9	6.7	17.3	5.9	35.1	10.0	6.6	9.4	9.0	51.3	42.8	6.3	5.7	15.9	7.9	16.5	10.1	6.8
GALNT1	GalNAc-T1	ENSG00000141429	"Polypeptide N-acetylgalactosaminyltransferase 1"	Q10472	18	35581117-35711834	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 331.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012628	Uncertain				"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA012628: AB_1849439"	"unprognostic (9.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.60e-2)"	28.9	20.6	11.9	27.4	12.1	26.0	37.2	12.3	14.2	26.5	15.1	42.8	42.9	19.4	19.7	57.6	15.9	28.9	23.8	10.9	14.4	17.4	45.9	23.3	33.5	13.1	13.2	16.9	24.6	12.2	13.5	52.0	13.5	25.4	41.1	17.1	46.8	18.0	29.0	52.4	49.3	22.7	13.1	25.4	27.1	16.9	13.1	18.6	30.0	37.3	40.8	70.5	27.0	13.9	32.5	34.9	40.5	37.6	78.5	74.0	53.4	33.2	35.4	30.3	27.4	21.0	61.9	38.3	34.9	36.0	28.7	24.4	20.2	63.8	48.1	45.0	18.5	48.7	62.8	48.8	39.2	106.6	62.1	50.7	59.7	47.6	52.1	90.1	331.4	30.8	14.8	49.3	118.9	26.1	31.6	40.5	41.6	33.5	16.4	38.9	53.0	18.5	124.8	148.9	21.8	42.9	59.4	43.0	36.2	77.1	32.9	82.8	116.3	55.7	22.5	37.0	37.1	70.1	35.7	72.5	39.1	72.1	29.5	7.2	3.4	7.6	3.2	4.5	3.6	4.1	2.2	2.9	4.0	2.4	2.0	3.0	4.3	4.6	6.6	4.4	2.5	1.4	11.9	12.1	12.3	14.2	10.9	14.4	13.1	13.2	13.5	13.1	13.1	13.9	85.6	80.1	44.1	35.9	33.4	29.8	28.4	28.8	22.2	31.3	77.2	43.8	43.3	48.6	39.9	16.5	12.5	31.0	44.8	109.1	7.9	42.6	1.4	77.6	44.7	41.7	38.9	30.9	57.5	39.9	92.7	49.8	26.0	73.0	20.3	51.7	35.7	71.3	77.9	85.8	56.3	59.0	16.2	58.8	37.1	2.9	19.0	56.7	19.6	57.1	41.3	105.9	28.8	54.3	56.8	58.5	51.4	18.0	36.7	54.4	76.8	22.0	33.5	28.5	13.1	55.2	28.7	6.5	12.2	26.3	82.1	33.2	33.7	50.3	85.3	52.8
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 65.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 284.9;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	12.1	15.6	10.7	14.4	14.5	19.3	13.5	12.1	10.0	24.1	33.0	16.1	14.4	6.3	6.0	4.9	14.6	16.7	9.0	9.5	12.5	9.7	4.4	15.5	9.9	16.1	13.9	65.8	9.8	13.6	11.5	4.7	12.3	9.1	14.7	7.8	13.5	3.7	5.4	6.0	12.6	11.6	9.9	15.8	22.0	4.5	13.9	7.8	16.6	8.2	9.4	11.1	5.2	12.6	25.6	85.3	20.3	17.8	42.2	37.3	15.6	71.7	39.9	27.9	26.7	12.1	56.7	16.6	49.3	121.4	49.9	4.4	9.4	56.0	25.4	43.2	6.7	45.4	16.0	16.5	32.4	9.9	42.3	46.7	12.9	22.7	33.2	284.9	54.4	12.5	10.5	50.9	48.4	26.4	1.1	6.8	8.0	71.1	17.3	5.1	10.7	16.6	38.6	17.1	2.7	6.6	31.8	117.0	9.4	29.6	45.6	7.4	161.2	67.5	15.9	16.8	77.7	14.5	15.0	8.7	44.2	19.3	21.1	2.0	1.2	2.4	3.1	1.6	2.8	1.9	1.8	2.0	1.4	2.1	0.8	2.1	2.5	1.9	1.8	1.1	1.6	1.0	10.7	14.5	12.1	10.0	9.5	12.5	16.1	13.9	12.3	9.9	13.9	12.6	17.4	9.6	46.4	32.7	17.4	4.8	3.9	5.6	1.8	4.6	12.4	8.6	5.0	5.7	8.7	14.7	4.2	0.7	27.7	23.0	9.8	9.1	10.3	12.4	7.4	14.1	3.0	21.4	14.3	30.1	1.5	13.7	30.5	22.3	10.2	10.5	23.9	5.3	8.5	0.0	15.9	20.4	6.1	19.5	7.8	22.5	38.2	12.4	0.0	74.0	11.9	17.4	44.3	156.9	66.9	36.8	13.6	50.0	15.4	8.2	15.3	2.7	0.7	10.5	6.6	5.6	7.8	2.0	4.0	1.2	3.7	0.8	21.7	27.3	12.2	4.2
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122340	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 408.0;kidney: 229.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.1;Inhibitory neurons: 130.7;Proximal tubular cells: 196.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	32.4	25.4	27.9	15.2	30.7	12.7	29.0	24.1	29.3	23.7	408.0	21.9	14.5	23.8	24.6	26.3	22.4	26.1	26.4	39.1	25.1	229.5	19.9	27.5	16.1	20.8	23.9	28.1	84.1	58.0	24.4	45.8	21.6	32.3	17.6	40.6	22.8	25.6	28.4	23.8	15.0	24.2	16.9	20.5	22.0	11.8	30.3	23.8	34.4	26.0	17.8	24.2	24.0	27.0	28.9	25.4	36.8	41.2	83.1	81.3	37.7	22.6	25.6	18.6	17.4	20.7	29.7	0.1	57.8	36.8	51.8	13.3	17.6	31.9	22.8	23.5	26.3	5.8	23.4	18.2	27.3	26.2	29.3	72.1	40.3	15.5	13.0	32.3	34.1	19.9	29.5	0.2	47.0	24.9	22.7	23.6	30.4	45.1	20.2	0.1	16.1	0.9	61.1	43.8	32.6	43.3	37.5	18.0	31.0	39.0	26.8	22.3	31.1	24.8	8.8	31.6	25.1	8.4	11.4	0.5	51.6	25.1	86.6	10.2	12.7	13.5	28.1	15.2	27.8	9.5	15.4	25.8	13.0	5.7	13.1	19.9	6.6	26.2	21.3	4.0	12.7	14.4	27.9	30.7	24.1	29.3	39.1	25.1	20.8	23.9	21.6	16.9	30.3	27.0	28.7	12.8	25.2	44.4	12.9	10.5	24.6	20.5	13.1	123.9	23.5	20.7	30.7	15.7	16.1	35.0	27.1	84.0	49.1	8.7	60.7	17.8	4.8	31.5	38.8	22.8	22.8	7.8	131.1	18.7	13.5	33.8	11.7	57.1	14.5	26.0	22.1	15.8	25.3	75.7	130.7	10.0	8.2	19.7	12.5	3.5	19.9	21.7	17.8	46.9	18.0	37.8	43.3	54.3	42.0	13.0	8.3	36.1	20.3	26.3	9.6	196.7	21.2	39.4	0.0	36.3	25.0	38.7	27.5	24.7	11.8	36.3	29.1	24.3	9.3	19.1
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GALNT13	"GalNAc-T13, KIAA1918"	ENSG00000144278	"Polypeptide N-acetylgalactosaminyltransferase 13"	Q8IUC8	2	153871922-154453979	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1;retina: 9.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 214.6;Inhibitory neurons: 333.1;Oligodendrocyte precursor cells: 986.7;Oligodendrocytes: 398.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 43.8;U-251 MG: 12.0;WM-115: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060775	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA060775: AB_2684358"	"unprognostic (1.97e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.21e-3)"	"unprognostic (7.73e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.05e-5)"	"unprognostic (8.61e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-1)"	2.1	5.0	8.4	0.2	9.9	0.1	1.2	30.1	7.7	1.7	1.0	0.4	0.2	1.8	1.2	0.1	0.4	0.5	0.2	7.6	17.9	0.1	0.0	2.1	0.0	9.3	12.3	0.5	0.3	0.0	1.7	0.4	11.4	2.0	0.3	9.9	4.1	1.4	1.0	0.6	0.3	1.0	9.5	0.0	0.4	0.6	10.8	0.0	0.0	0.0	0.0	0.7	0.2	11.4	0.0	5.2	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	5.5	0.0	0.0	0.1	2.8	0.0	5.0	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.6	0.0	0.1	0.1	0.5	1.0	0.0	0.0	0.2	7.3	0.2	6.9	0.0	0.3	1.0	0.0	0.0	7.5	43.8	0.1	0.1	0.0	0.7	0.0	0.1	0.0	0.1	1.9	0.1	12.0	0.6	0.1	0.0	7.2	0.0	33.5	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	9.9	30.1	7.7	7.6	17.9	9.3	12.3	11.4	9.5	10.8	11.4	0.2	25.6	1.1	13.1	0.0	0.1	0.0	0.0	0.0	14.4	0.2	0.3	1.0	0.0	1.3	0.0	52.1	0.1	0.0	0.1	0.0	0.0	1.9	0.4	21.5	0.7	3.5	0.0	214.6	0.2	0.0	2.8	0.0	0.3	0.0	0.1	0.0	0.0	0.1	72.3	333.1	1.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	2.8	0.0	0.9	0.0	986.7	398.2	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.6	0.0	0.2	0.5	0.8	0.6	0.0	0.1	0.0	0.2	4.2	0.9	0.0
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174680-16231992	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 157.4;brain: 141.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		40000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	157.4	4.9	45.1	1.7	55.8	2.7	87.2	62.5	49.3	12.3	14.4	21.7	3.0	11.4	11.9	12.4	24.9	5.6	18.1	47.9	90.8	11.8	4.0	9.4	4.1	137.6	60.4	22.3	3.6	2.4	3.5	32.3	130.8	6.0	3.9	13.4	25.5	4.7	36.3	41.7	21.2	7.0	102.4	12.3	15.3	9.1	62.8	4.0	18.3	35.3	1.3	33.0	22.8	141.7	0.4	1.3	0.9	1.0	133.0	128.8	0.3	3.4	2.5	0.4	1.3	0.0	0.5	0.5	1.9	7.8	2.3	0.8	0.5	1.4	2.0	0.6	1.4	1.1	1.9	0.0	7.4	1.5	0.4	102.8	0.0	1.2	1.8	2.4	2.8	0.7	0.2	3.0	1.1	1.9	0.0	2.1	0.5	0.8	1.1	0.3	1.1	24.1	0.5	0.5	0.4	0.3	0.4	1.0	0.6	0.6	0.7	1.8	3.9	0.6	4.3	26.8	0.6	1.4	5.1	1.4	2.5	0.4	0.4	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	45.1	55.8	62.5	49.3	47.9	90.8	137.6	60.4	130.8	102.4	62.8	141.7	103.9	0.0	1.7	34.6	0.1	0.5	0.4	0.0	0.0	3.8	1.1	0.9	2.8	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	26.6	0.5	3.3	26.9	0.0	0.0	4.9	0.0	0.1	24.7	0.0	1.0	1.3	0.1	41.7	1.8	0.1	0.0	3.9	0.0	0.0	0.8	2.1	16.7	1.8	0.5	0.0	22.5	0.1	47.4	0.0	5.0	69.3	0.2	0.0	0.7	1.8	2.1	0.0	0.1	0.0	3.2	0.0	7.3	2.1	25.5	0.5	0.1	0.9	0.0	0.2	0.3	0.0	0.3
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8;heart muscle: 45.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		370000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	14.4	11.6	25.7	2.0	24.4	0.1	12.0	14.7	28.4	7.6	6.5	6.5	2.2	7.3	2.8	3.6	5.6	3.4	45.0	27.0	35.5	7.7	2.0	3.4	3.2	19.6	22.5	2.1	4.3	2.5	4.7	0.4	19.9	4.0	2.2	1.3	23.5	4.6	4.4	7.5	3.7	8.6	16.4	12.1	3.2	3.5	40.8	2.2	4.9	5.8	1.3	3.1	5.0	21.3	0.0	0.8	8.5	0.3	11.7	5.3	0.0	1.3	0.1	1.5	2.3	0.4	0.0	0.0	0.2	1.4	0.8	0.0	3.0	0.0	0.3	0.1	6.0	0.0	0.2	0.5	0.1	0.0	0.5	0.5	0.0	17.0	0.0	17.2	0.9	0.0	0.0	0.0	2.8	0.5	0.0	0.0	1.7	0.0	0.1	0.0	4.8	0.0	0.5	0.0	8.7	3.0	1.8	0.4	0.0	0.3	0.3	0.0	0.1	1.7	19.9	2.2	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	24.4	14.7	28.4	27.0	35.5	19.6	22.5	19.9	16.4	40.8	21.3	4.0	0.0	0.0	16.6	0.0	4.1	0.4	0.0	0.0	2.8	3.1	3.0	46.7	0.0	0.0	0.0	2.1	0.1	0.2	0.0	3.9	0.1	9.7	0.2	0.4	1.7	0.0	0.0	27.6	0.0	0.0	24.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	23.8	0.1	0.0	0.0	6.1	11.2	0.9	0.3	3.6	5.6	0.0	0.1	0.0	8.0	1.6	0.0	0.0	3.8	0.0	0.5	0.1	0.1	0.0	0.8	6.6	10.1	14.8	0.6	2.1	0.3	3.3	0.0	0.3	11.2	0.6	0.4
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132144-71713600	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	3.2	8.7	30.5	1.9	37.9	0.0	2.0	35.9	51.2	4.0	46.0	16.6	0.3	16.6	3.1	9.3	8.7	2.5	43.5	55.0	3.2	5.7	0.4	9.3	0.0	2.1	3.8	31.6	10.1	1.2	13.3	0.2	3.0	14.7	1.0	3.3	3.3	8.2	4.7	2.2	3.9	8.3	0.0	3.4	2.4	5.0	11.2	2.6	10.1	2.9	1.5	21.2	3.3	24.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.7	0.0	0.0	45.7	0.0	14.1	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	37.9	35.9	51.2	55.0	3.2	2.1	3.8	3.0	0.0	11.2	24.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0
GALNT18	"GalNAc-T18, GALNT15, GALNTL4, MGC71806"	ENSG00000110328	"Polypeptide N-acetylgalactosaminyltransferase 18"	Q6P9A2	11	11270877-11622005	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 149.5;Excitatory neurons: 104.4;Inhibitory neurons: 156.3;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 42.1;HaCaT: 52.4;HBEC3-KT: 36.5;PC-3: 36.4;RPMI-8226: 39.3;SK-BR-3: 47.2;U-87 MG: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012955, HPA070681"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA012955: AB_1849460, HPA070681: "	"unprognostic (1.26e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-2)"	18.0	4.7	19.1	4.1	17.7	0.0	15.6	17.1	20.8	13.0	10.7	24.8	3.0	24.0	2.4	7.7	12.0	11.2	26.9	29.5	12.9	26.5	10.5	51.2	5.4	12.2	17.2	4.9	8.2	9.8	6.4	24.4	13.9	13.0	3.2	3.6	17.0	9.3	10.7	13.0	8.8	13.3	12.3	3.6	6.8	14.7	19.7	6.3	42.8	6.2	3.3	11.7	11.5	12.9	42.1	15.0	2.0	9.1	0.0	0.0	0.3	4.5	11.2	0.6	0.0	1.7	5.4	0.1	3.1	0.1	5.6	52.4	9.9	36.5	0.1	0.0	14.6	0.0	0.1	0.1	0.5	0.0	0.0	0.2	14.9	0.0	13.5	0.0	0.0	18.5	0.0	0.1	1.9	10.2	0.5	0.1	1.5	0.1	36.4	0.0	0.0	39.3	27.5	5.1	0.6	4.1	7.6	47.2	0.3	1.4	9.9	0.1	0.0	0.7	8.1	0.4	0.2	0.0	0.0	0.0	33.6	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	17.7	17.1	20.8	29.5	12.9	12.2	17.2	13.9	12.3	19.7	12.9	40.5	44.8	6.9	149.5	0.1	5.6	6.6	18.3	12.0	1.6	1.6	2.5	8.5	30.0	13.7	20.2	2.1	49.2	0.4	0.8	15.6	19.9	2.2	1.9	0.4	40.6	0.0	0.0	104.4	4.0	3.5	5.4	0.0	1.3	1.3	16.7	18.5	2.6	2.6	0.0	156.3	0.4	8.2	0.8	1.1	1.4	1.5	0.4	1.8	79.6	0.0	43.1	0.0	8.5	10.5	7.3	0.2	3.0	0.2	13.4	0.0	40.8	14.3	2.1	13.1	15.1	7.4	0.6	1.1	1.8	5.4	15.5	0.3	46.7	1.1	1.9
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282122	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 429.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	32.9	49.6	17.0	34.8	19.9	13.9	21.9	15.2	16.7	24.7	22.0	28.9	19.5	27.1	6.9	21.0	22.4	21.2	27.4	15.8	18.6	18.5	100.1	27.1	14.0	23.0	19.5	39.2	68.1	9.9	13.6	27.6	18.3	21.4	12.4	19.8	22.1	14.3	67.4	14.7	23.6	25.0	15.3	17.4	33.1	19.7	25.1	42.8	19.0	27.4	11.2	33.4	19.5	15.5	79.5	103.7	59.9	71.4	112.4	95.3	122.8	146.3	90.0	58.4	55.6	45.2	146.5	20.0	106.2	77.7	135.9	150.7	39.9	123.0	48.6	200.1	52.0	60.7	217.2	50.9	60.9	23.4	114.8	136.9	59.8	78.0	30.9	127.3	69.2	110.1	77.0	29.6	65.6	21.8	122.3	23.9	82.1	52.8	97.7	134.3	85.5	61.7	57.4	92.9	18.9	70.1	148.4	7.9	91.0	31.7	46.5	43.5	165.3	56.7	107.9	129.5	118.0	97.9	60.3	44.4	146.1	46.3	429.7	1.5	10.7	3.6	4.4	9.3	3.2	3.4	2.6	4.5	7.8	5.8	2.5	5.0	3.2	2.8	10.2	13.2	3.3	7.7	17.0	19.9	15.2	16.7	15.8	18.6	23.0	19.5	18.3	15.3	25.1	15.5	18.6	16.0	21.3	71.5	32.1	15.3	20.0	52.8	20.5	30.8	13.8	10.7	13.6	18.6	30.1	23.9	33.3	7.3	21.7	24.1	5.9	49.7	47.2	18.7	15.4	17.9	16.8	27.6	67.3	133.0	123.4	36.1	21.4	24.5	13.3	20.5	19.6	98.8	24.9	28.6	82.0	18.9	4.1	42.4	9.7	24.6	35.8	28.9	24.9	106.8	44.0	10.9	18.6	72.9	44.6	88.5	21.6	29.3	109.0	23.5	17.9	19.2	23.5	73.5	13.1	33.1	25.4	3.4	14.0	16.6	8.0	16.6	21.2	32.8	17.6	29.9
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747588-165794659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 50.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007613	Enhanced		Supported	"Golgi apparatus"		NA	NA		440000	"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.7	8.4	2.1	54.0	26.0	2.7	1.8	29.3	4.3	48.9	43.5	5.2	9.3	27.4	38.8	32.2	0.6	1.8	3.4	10.9	2.4	14.0	3.7	4.5	5.2	6.8	26.2	6.9	9.8	6.4	3.3	25.2	53.2	3.7	55.3	8.2	0.3	15.3	39.5	2.5	7.0	20.1	77.3	25.8	1.9	3.3	25.4	0.4	12.3	17.3	12.6	5.4	61.5	0.0	0.6	0.2	0.1	2.6	43.0	18.3	7.7	6.6	16.0	32.0	85.4	0.4	0.1	0.0	0.1	108.3	0.0	69.2	13.5	1.3	13.0	0.0	14.9	0.3	0.3	14.5	0.4	0.5	88.2	0.0	30.3	2.1	0.1	2.9	0.0	55.0	5.0	42.7	0.5	5.6	0.1	201.1	7.8	0.2	0.0	1.7	17.8	42.0	6.5	0.1	0.3	49.6	16.8	1.9	21.7	0.9	0.5	0.1	1.0	0.1	0.3	34.4	16.3	1.3	0.2	14.0	0.6	50.5	6.8	32.2	10.2	9.0	7.5	6.6	3.1	5.8	11.4	6.0	1.0	3.4	25.2	10.6	13.8	17.3	5.6	6.2	1.7	2.1	2.7	1.8	1.8	3.4	4.5	5.2	3.3	7.0	1.9	5.4	1.0	12.8	34.4	7.8	13.6	38.0	107.9	36.5	29.6	0.6	45.0	26.8	0.4	35.8	45.9	66.2	0.0	8.5	37.7	68.6	3.9	70.2	127.5	91.8	5.2	2.9	23.4	1.3	10.5	113.2	22.5	2.3	102.4	70.5	45.7	0.7	1.1	0.6	8.2	0.0	5.1	152.8	28.5	1.9	12.4	14.1	2.5	8.3	16.0	1.0	7.5	16.1	15.5	27.6	1.4	188.1	46.5	0.4	29.7	155.7	32.6	3.1	89.3	1.0	6.6	0.6	4.3	71.5	1.1	42.4	41.3	11.2	14.4	1.2	61.8	274.4
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257705-157318491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.5;lung: 10.2;stomach 1: 12.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.1	0.0	0.0	0.7	0.0	0.6	1.1	4.0	0.3	1.1	5.2	10.6	2.2	0.1	0.1	4.5	0.0	2.7	0.4	0.4	0.0	0.0	0.0	10.2	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.7	13.5	0.1	8.2	0.1	0.0	0.3	4.1	0.4	0.0	0.1	12.8	0.1	0.1	0.1	0.1	0.1	1.7	4.5	4.6	0.2	45.3	4.8	0.0	0.0	2.0	17.0	0.0	29.8	53.5	0.5	1.1	1.9	24.4	0.0	0.1	64.5	0.0	51.8	0.9	10.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.9	0.0	0.0	0.0	30.7	0.0	52.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.4	0.3	0.6	0.1	0.0	0.1	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.1	157.0	36.1	0.0	0.1	0.8	13.3	20.2	6.2	0.0	0.5	2.8	0.5	2.8	32.9	0.0	0.0	0.0	0.2	48.3	0.0	1.2	6.9	1.2	0.0	0.6	2.4	5.2	0.8	3.2	0.0	2.1	35.7	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	75.5	6.1	0.0	0.7	0.5	0.0	0.3	3.6	0.0	1.6	0.0	0.0	0.0	0.1	53.5	26.4	0.0	1.4	40.1	3.1	0.2	10.0	0.0	0.0	0.5	1.2	2.6	0.5	4.5	0.1	0.0	0.3	0.0	22.7	115.1
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 31.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	1.7	3.1	3.3	8.0	11.8	9.6	18.1	7.2	9.1	32.2	0.2	6.7	21.2	1.3	24.7	2.4	6.5	2.4	0.4	4.2	7.3	2.9	1.2	5.7	7.2	8.8	11.1	0.9	8.3	1.4	1.1	9.6	10.8	0.9	6.9	0.1	31.0	3.2	0.4	5.6	21.6	1.6	5.2	8.2	62.6	0.6	9.7	6.8	2.5	0.1	5.9	3.7	1.8	18.1	39.0	4.1	0.7	0.1	0.0	0.6	59.8	63.0	107.0	25.4	17.0	104.1	19.0	0.5	5.8	34.4	0.0	35.9	1.5	27.3	17.1	8.3	4.1	24.6	0.7	0.8	1.0	13.6	82.2	2.3	25.2	23.1	23.0	0.2	65.7	14.2	5.4	1.0	0.1	73.7	43.2	10.1	5.3	97.6	66.6	0.2	0.1	10.3	21.3	2.2	0.5	23.5	0.4	110.5	0.1	12.2	59.3	5.9	75.7	0.2	12.9	0.2	0.3	2.1	0.5	3.6	7.2	29.5	0.2	7.1	5.8	29.1	3.8	5.2	1.6	1.2	2.2	3.1	4.5	3.3	3.4	2.9	1.1	15.5	9.7	4.1	1.7	3.2	3.3	11.8	7.2	9.1	4.2	7.3	8.8	11.1	10.8	5.2	9.7	18.1	0.8	3.2	2.4	0.3	11.8	2.9	3.8	5.8	5.7	0.4	38.9	18.4	1.3	1.5	15.6	1.8	0.0	14.1	11.3	12.4	3.9	2.6	2.0	3.5	0.3	4.1	0.0	15.3	1.0	10.9	49.2	1.6	130.5	5.8	164.5	3.8	1.4	0.3	14.4	0.0	0.5	17.4	2.0	16.3	10.3	1.5	0.0	15.1	1.8	1.0	7.2	0.2	9.2	0.0	57.6	24.3	33.9	0.4	5.5	7.6	39.6	2.0	12.4	0.0	0.0	1.5	1.5	0.4	1.6	2.6	9.2	4.8	14.9	1.8	11.8	5.8
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	Q9NY28	12	4720400-4851927	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 31.3;testis: 13.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 23.4;U-266/84: 7.6"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Supported		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	0.4	0.6	3.2	1.8	3.3	0.0	0.6	2.7	5.1	0.5	2.0	14.0	5.7	0.3	0.1	0.1	0.6	0.0	2.5	3.2	2.8	0.4	0.2	0.3	0.2	3.4	3.2	0.7	0.2	0.0	2.8	0.1	3.3	0.4	31.3	0.2	0.4	0.3	0.1	0.2	12.6	0.8	2.9	0.5	0.5	13.5	3.3	0.0	0.2	0.0	0.0	0.4	0.3	4.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.1	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	3.2	3.3	2.7	5.1	3.2	2.8	3.4	3.2	3.3	2.9	3.3	4.1	0.1	6.4	0.5	1.3	0.5	0.0	0.0	0.1	0.6	2.1	0.1	2.3	4.5	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	95.2	0.5	0.1	0.5	6.6	0.0	1.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	47.0	0.0	0.0	0.0	150.2	1.5	0.1	0.0	3.7	0.2	0.5	0.0	15.1	7.4	0.2	0.6	2.6	0.0	0.1	1.0	1.0	0.0	0.6	6.6	0.7	0.1	12.3	8.3	0.0	0.0	0.0	0.8	0.3	2.2	0.0
GALNTL5	"GalNAc-T5L, GALNT15"	ENSG00000106648	"Polypeptide N-acetylgalactosaminyltransferase like 5"	Q7Z4T8	7	151956379-152019929	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.8"	"Group enriched"	"Detected in some"	77	"Early spermatids: 432.4;Late spermatids: 500.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011140	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA011140: AB_1078944"					"unprognostic (2.33e-2)"									"unprognostic (2.09e-1)"	"unprognostic (1.55e-1)"			0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	10.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	1.6	0.8	0.6	0.6	0.6	0.6	0.6	0.6	0.8	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	432.4	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	500.9	3.1	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;lymphoid tissue: 2.5"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 424.4;Inhibitory neurons: 1567.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.0	0.2	3.6	0.4	2.8	0.4	0.2	0.5	4.0	1.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.1	6.0	7.8	0.0	0.1	0.1	0.3	0.2	5.3	0.0	0.1	0.0	0.0	0.0	2.3	0.7	0.2	1.3	0.3	0.0	0.3	0.1	0.5	0.0	1.1	2.5	1.0	2.4	4.0	0.0	0.1	1.4	0.1	0.1	0.4	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.5	4.0	6.0	7.8	0.2	5.3	2.3	1.1	4.0	0.6	0.0	0.0	1.5	10.4	2.4	0.3	0.1	0.0	0.0	1.6	0.3	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	424.4	4.1	0.0	0.3	2.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1567.9	2.6	0.0	1.6	0.0	21.1	0.3	0.9	5.4	13.1	0.0	0.1	0.0	57.3	9.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	1.2	0.2	1.6	1.6	0.0	0.3	0.0	0.0	0.1	0.4	0.1
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176008-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 1.8;Glandular and luminal cells: 1.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053938	Uncertain				"Secreted in brain"	NA	NA						"Cluster 49: Ciliated cells - Cilium organization"			"HPA053938: AB_2682315"				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074781-76077537	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 7.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.7;Endometrial ciliated cells: 1.0;Macrophages: 1.5;Respiratory ciliated cells: 1.6;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;NTERA-2: 2.0;PC-3: 1.3;THP-1: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.1	0.1	0.2	0.3	0.0	0.9	0.0	0.1	0.2	0.3	0.0	7.7	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	5.8	1.7	0.3	0.2	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.9	0.2	0.2	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	1.1	0.0	0.7	1.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	2.0	0.0	1.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.3	0.2	0.0	0.3	3.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.4	0.4	0.2	0.4	0.3	0.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.4	1.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.3	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	0.2	1.6	0.0	0.0	0.0	0.1	0.7	1.1	0.0	0.1	0.3	0.3	0.0	0.2	0.4
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		260000	"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.7	14.0	5.3	6.7	5.9	8.1	6.3	5.5	6.5	6.9	4.6	8.5	18.3	6.9	5.3	5.3	7.8	6.8	10.4	5.2	6.3	10.0	50.0	6.6	12.0	5.5	5.7	8.2	7.5	13.0	6.1	9.2	5.3	6.4	6.7	6.3	12.3	7.5	10.2	15.2	16.5	4.0	4.5	9.7	8.1	2.4	6.1	7.8	8.2	7.6	7.7	5.3	6.1	4.7	5.5	7.5	6.8	2.4	9.0	9.2	7.8	4.2	12.1	4.3	5.1	9.5	4.8	6.1	4.2	5.2	1.6	2.9	1.3	11.8	0.8	9.7	4.8	2.5	14.7	9.8	8.7	1.4	2.9	12.6	7.4	2.7	3.6	9.3	10.6	8.3	2.3	6.4	7.3	5.1	5.4	10.3	2.3	6.7	1.3	8.4	5.9	3.3	12.5	7.8	1.6	5.7	5.0	9.8	5.4	5.0	9.2	8.2	1.6	1.7	3.4	3.4	0.0	3.9	2.4	1.3	4.1	4.4	10.8	16.5	23.7	11.7	15.4	21.5	21.3	24.8	25.2	21.1	21.5	13.2	15.3	14.8	4.6	29.0	20.4	18.2	30.0	17.6	5.3	5.9	5.5	6.5	5.2	6.3	5.5	5.7	5.3	4.5	6.1	4.7	12.6	6.4	21.2	10.7	19.0	21.7	13.4	19.3	19.4	44.0	10.5	12.1	25.7	14.3	15.4	16.5	47.9	72.5	13.9	17.3	29.4	18.3	7.6	7.8	11.8	14.6	16.3	13.7	9.1	7.3	36.3	18.3	9.2	8.0	20.3	24.7	23.6	69.9	24.1	47.1	12.5	17.0	26.4	15.5	8.7	36.8	18.3	12.4	21.4	5.6	15.9	18.7	34.0	6.0	3.7	6.9	37.5	13.9	10.7	4.7	67.1	46.3	11.1	38.5	6.6	11.2	12.2	4.8	6.6	8.6	20.2	59.1	25.5	27.4	20.4	9.2
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 615.1;skeletal muscle: 1234.9;tongue: 466.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	14.0	26.6	69.4	4.5	74.5	8.8	15.6	68.6	79.1	16.5	53.4	10.9	3.2	10.0	141.9	23.0	14.7	9.9	98.1	67.3	67.1	72.0	615.1	8.1	7.7	71.8	68.3	22.8	229.8	37.8	37.4	4.9	70.4	36.5	2.2	15.0	42.6	17.5	1234.9	32.8	6.4	4.6	68.8	10.7	31.8	55.0	76.1	24.8	22.2	466.4	4.3	12.9	15.3	94.5	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	69.4	74.5	68.6	79.1	67.3	67.1	71.8	68.3	70.4	68.8	76.1	94.5	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GAN	"GAN1, GIG, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314944-81390809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 24.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules		"CAB011825: AB_732515, HPA049473: AB_2680782"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	1.3	0.9	7.3	0.7	5.7	0.7	2.4	6.6	4.7	2.6	1.0	2.3	0.8	1.3	1.1	5.4	1.3	0.6	1.5	6.9	8.8	1.0	1.1	1.7	0.7	9.3	8.6	1.4	1.2	0.8	1.4	0.8	5.5	2.0	1.2	3.2	2.3	0.7	1.5	24.8	1.4	0.9	8.7	0.9	1.8	0.9	8.7	0.9	1.1	1.4	1.3	1.5	4.3	9.2	1.6	2.0	1.5	2.1	1.9	1.0	10.4	1.2	0.7	0.8	0.3	5.1	1.8	2.5	1.4	1.6	0.4	3.1	2.7	1.3	1.8	0.6	1.4	2.2	1.8	4.1	2.0	2.1	2.4	1.1	3.8	1.3	3.5	1.1	1.7	2.1	2.8	1.1	1.1	9.1	1.9	2.9	4.0	2.2	0.6	3.7	1.4	1.0	1.6	5.0	1.5	1.0	4.3	4.2	1.4	3.6	2.9	2.0	2.5	2.3	2.1	0.8	1.9	2.2	2.7	5.8	1.2	2.4	1.7	0.7	0.4	0.2	0.8	0.4	0.7	0.4	0.8	0.6	0.2	0.5	0.7	0.9	0.3	0.9	0.3	0.9	0.6	0.2	7.3	5.7	6.6	4.7	6.9	8.8	9.3	8.6	5.5	8.7	8.7	9.2	12.2	12.8	8.2	69.5	9.9	91.3	66.8	15.0	34.1	28.4	15.4	18.5	12.5	7.2	29.5	5.5	89.6	19.3	17.4	27.5	0.0	9.4	2.3	11.6	19.3	14.7	5.4	12.6	21.2	6.7	15.4	14.1	17.3	14.0	1.3	7.2	12.1	6.7	5.6	23.5	29.5	15.1	10.2	6.8	30.9	4.6	9.6	8.6	37.4	14.0	7.5	14.0	9.2	22.1	18.3	18.6	16.8	12.8	11.0	75.0	14.8	3.8	30.1	43.8	6.6	20.2	17.6	11.9	16.4	67.1	130.4	21.3	16.1	5.3	15.6	188.7
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		23000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	93.9	73.7	31.8	88.2	34.5	83.7	92.8	36.6	36.7	112.6	51.6	104.7	95.6	102.1	151.7	66.4	106.9	75.3	67.9	31.7	41.2	98.5	171.7	86.8	81.7	38.5	34.9	115.5	88.1	130.6	21.8	141.8	38.1	97.5	116.8	79.4	101.8	111.1	39.4	74.7	90.5	126.0	36.5	86.7	85.2	66.1	39.8	105.2	132.6	53.0	94.8	90.7	34.2	43.4	298.2	245.9	318.2	552.0	464.1	389.0	332.9	312.4	480.4	436.2	362.1	222.2	515.9	201.2	616.0	572.5	337.8	376.4	375.2	376.7	443.8	155.8	191.3	202.9	317.8	125.6	389.0	325.7	248.7	397.2	248.4	433.6	475.3	533.0	422.3	199.6	278.5	352.9	398.2	313.6	167.6	193.4	262.3	236.6	237.7	209.5	368.7	513.1	285.7	230.3	168.6	221.2	451.1	308.2	370.8	321.6	380.9	304.8	311.6	430.0	272.2	342.9	309.9	360.8	423.8	152.2	473.9	173.1	421.7	23.9	19.3	19.1	23.8	23.4	23.1	15.9	17.2	20.0	20.8	14.9	20.9	21.3	8.9	29.8	22.2	18.4	17.3	22.6	31.8	34.5	36.6	36.7	31.7	41.2	38.5	34.9	38.1	36.5	39.8	43.4	42.7	12.8	20.7	17.3	29.8	28.3	29.4	45.8	13.6	31.4	57.4	53.8	7.8	52.9	24.2	68.0	60.5	81.7	33.4	40.1	5.9	47.0	18.5	31.4	59.1	42.2	31.8	25.0	12.6	42.6	137.3	45.9	27.5	46.5	11.4	72.8	48.2	98.0	57.9	35.3	16.0	48.9	34.6	45.8	25.1	16.4	58.4	32.7	35.6	15.9	38.9	36.5	38.1	11.1	16.5	39.5	29.3	68.1	50.4	34.0	47.8	27.0	26.3	41.4	32.9	36.4	34.7	25.3	47.4	21.2	31.3	80.2	25.2	63.1	56.3	32.4
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	8.9	7.6	8.2	10.3	13.0	14.3	8.8	9.8	10.4	9.6	10.4	10.6	8.9	11.0	17.8	12.1	8.6	9.4	8.5	7.8	9.2	9.4	13.3	20.4	10.0	12.4	11.1	13.0	8.4	11.3	7.9	8.0	13.2	8.5	12.4	9.7	14.5	8.7	12.9	10.1	9.8	9.8	10.0	11.9	8.5	12.3	10.8	10.3	12.1	10.6	10.2	8.3	9.3	19.2	9.0	4.9	10.7	11.6	12.3	17.2	7.1	19.2	19.7	19.7	16.4	6.4	6.2	4.9	10.2	18.6	14.3	18.3	12.6	19.5	13.6	12.3	6.0	11.9	12.1	12.8	10.4	11.6	10.1	11.8	11.4	8.1	13.6	11.7	13.5	12.0	12.6	13.0	15.8	1.7	7.9	12.7	6.7	4.3	5.5	14.7	12.4	17.0	14.7	8.4	8.2	11.7	10.8	9.4	7.0	5.6	3.3	27.0	13.6	21.6	5.7	17.8	12.1	13.9	20.7	9.7	10.4	20.9	12.1	16.8	11.8	10.2	4.5	13.1	6.2	19.6	7.2	8.6	15.5	23.1	8.9	5.4	6.7	5.7	10.9	12.3	7.3	6.5	8.2	13.0	9.8	10.4	7.8	9.2	12.4	11.1	13.2	10.0	10.8	19.2	6.2	19.2	47.9	35.6	14.5	10.5	17.1	7.9	12.0	5.6	5.6	6.2	8.2	4.3	8.9	1.8	10.4	5.3	4.0	9.5	5.9	5.9	18.6	7.7	11.1	5.0	4.2	5.0	18.9	3.8	5.1	8.1	9.7	11.9	10.8	8.1	5.7	12.4	6.5	3.3	28.5	5.7	10.2	11.7	5.4	4.7	7.2	10.9	14.2	36.5	14.0	9.5	7.2	31.7	86.7	5.4	15.7	6.4	7.1	9.1	7.9	7.7	9.8	8.5	13.1	9.2	7.0	20.5	15.7	18.9	5.3	2.9	6.9	6.4	8.5	20.7
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 27580.7;tongue: 18892.5"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 10357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	1219.9	1815.8	2605.9	1191.3	2589.5	4608.5	1042.3	2869.0	3067.8	1163.8	2419.2	1720.0	1480.8	1080.9	769.9	2973.8	1042.8	1161.3	5572.8	2630.1	2880.0	2323.2	2557.9	1137.9	1388.3	2845.2	2861.3	1087.0	652.0	1616.0	1338.7	1190.6	2828.4	1241.0	1586.6	2386.8	1835.8	1238.7	27580.7	1775.5	1457.5	1424.4	2670.8	1208.5	1215.5	693.0	2985.1	1570.9	1022.1	18892.5	1861.0	1889.0	1672.9	2741.6	6063.0	10247.9	3109.5	4709.2	3026.2	5018.7	6516.0	4716.2	7218.1	7172.8	7491.2	7211.3	4091.6	7540.8	878.2	5947.4	4904.2	3359.8	3372.7	10829.1	5432.4	6263.1	3229.5	4224.9	5857.5	6279.2	3890.9	6710.2	3046.1	4089.0	3521.7	6553.0	7609.7	15565.8	7762.7	5052.4	2215.9	1484.1	8670.0	11849.8	7303.1	3247.3	10995.7	7254.7	3950.7	5849.8	5505.7	3512.8	7909.6	7115.9	2088.3	3331.0	4243.1	10206.4	5984.0	8874.7	1657.2	4311.2	4794.3	5049.0	5907.2	2717.1	7931.5	3178.4	2544.6	9374.4	10632.2	4050.5	8040.5	2575.4	4295.8	737.9	1325.8	2011.2	1171.4	1046.9	1364.8	1333.1	3253.6	652.5	757.6	886.9	1981.4	1227.8	1900.6	474.6	2126.1	6812.0	2605.9	2589.5	2869.0	3067.8	2630.1	2880.0	2845.2	2861.3	2828.4	2670.8	2985.1	2741.6	1036.7	237.2	259.5	228.2	1086.9	1818.8	2223.4	7367.5	4070.9	1157.6	1794.6	3689.2	40.4	1263.9	2213.7	1022.5	417.0	4237.7	1032.7	2579.6	3463.0	5198.9	759.8	770.1	702.4	1597.4	1324.3	1180.6	112.1	3794.5	10357.8	1127.1	1068.8	1021.8	562.3	2063.7	1242.9	1742.3	3895.3	2348.7	145.8	2351.2	2543.1	2586.7	2494.4	2257.7	889.4	2134.0	4220.8	86.2	3422.3	6177.9	1045.4	98.5	196.2	5681.8	3001.4	1026.9	2668.2	1714.0	5714.0	7286.7	864.3	1435.2	1150.4	1744.7	2827.8	429.9	476.2	3605.2	1600.7	4694.0	1514.9	1839.0	3140.9	2882.4
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533455-35545319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 269.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 8717.5"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		7500000	"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	1.2	2.7	0.4	4.1	1.3	2.4	0.2	1.2	1.3	0.0	0.1	0.6	3.3	2.7	0.0	3.0	1.9	3.6	4.0	0.2	0.5	0.9	0.3	1.9	6.5	0.3	0.4	3.4	5.2	0.0	0.1	1.1	0.4	2.0	0.0	3.5	5.1	0.0	1.6	13.9	3.2	0.0	0.1	5.2	2.4	269.8	0.8	0.0	11.4	0.0	0.0	1.5	0.1	1.5	6.5	22.4	6.4	9.6	0.0	0.0	5.4	1.9	0.0	0.0	0.0	13.8	10.4	10.7	2.9	0.0	2.6	7.6	0.0	0.0	0.0	10.5	11.2	7.1	16.7	7.1	0.1	6.4	8.3	0.0	0.0	0.0	0.0	3.9	0.0	10.3	17.6	6.0	0.0	19.6	2.5	3.0	8.6	4.1	3.1	7.6	4.3	8.3	0.0	6.1	11.3	5.1	2.4	5.7	7.0	4.3	4.8	2.7	2.1	7.2	7.9	1.8	2.7	16.9	4.8	6.2	3.9	11.4	2.6	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.3	1.2	1.3	0.2	0.5	0.3	0.4	0.4	0.1	0.8	1.5	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1915.7	0.0	0.0	1.6	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	8717.5	24.8	2.4	44.4	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	28.6	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.1	33.4	18.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 16.9;lymphoid tissue: 42.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 1000.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 1000.3"	"Cell line enhanced"	"Detected in some"		"HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.7	0.8	0.7	28.5	0.7	16.9	2.3	0.7	1.1	2.7	1.3	2.7	3.7	1.3	1.1	2.1	1.6	5.7	0.7	0.7	1.0	0.8	2.0	4.2	25.3	1.3	1.1	0.4	1.1	1.1	0.6	1.0	1.3	1.8	3.8	0.5	1.9	1.2	0.2	0.8	6.6	4.7	1.0	18.2	3.7	0.7	1.1	6.9	0.6	0.7	42.7	6.0	0.5	1.8	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	71.5	0.2	0.0	0.0	41.8	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	43.3	0.0	0.0	0.0	17.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	33.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	118.4	0.0	125.5	66.7	1000.3	0.4	46.5	0.5	97.0	0.4	0.4	76.8	97.4	0.3	0.3	82.0	1.4	59.3	205.4	0.3	32.0	0.7	0.7	0.7	1.1	0.7	1.0	1.3	1.1	1.3	1.0	1.1	1.8	0.4	3.2	1.9	0.0	84.8	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.2	0.0	0.6	0.0	0.0	0.0	160.1	0.0	0.0	0.0	1.6	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.1	0.4	0.5	0.0	55.0	0.0	0.4	0.0	14.3	0.0	0.0	0.0	0.0	19.4	6.0	0.5	0.0	43.0	0.0	1.9	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387, HPA074882"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		46000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Cytosol	"HPA029386: AB_10599604, HPA029387: AB_10600311, HPA074882: "	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	12.3	9.8	8.1	12.2	11.1	23.0	12.0	11.7	9.4	12.2	13.1	10.3	8.0	11.1	9.8	17.0	10.7	10.3	9.7	8.4	8.8	13.0	11.2	15.7	12.6	9.8	8.9	12.1	10.6	18.7	8.2	18.4	10.0	10.5	9.8	16.5	9.3	12.4	19.1	14.7	9.2	13.3	10.1	12.7	9.6	26.8	9.7	14.1	18.9	18.7	15.0	12.2	10.1	14.2	22.8	23.2	21.8	20.0	26.2	28.6	30.5	25.0	28.9	29.0	24.2	37.0	15.9	30.2	13.3	31.9	28.7	44.9	46.2	25.8	31.1	28.1	27.1	34.6	53.1	18.4	30.1	41.4	56.0	20.1	25.2	34.6	27.2	18.7	35.0	23.8	68.8	16.3	24.3	33.2	31.2	18.0	21.6	41.2	26.2	27.2	47.6	29.1	16.2	23.2	28.8	18.9	36.9	32.6	20.0	21.7	40.9	20.9	36.1	19.9	14.3	35.7	27.2	20.7	42.3	29.9	24.1	22.9	26.4	25.6	15.9	19.6	13.0	15.4	12.7	10.0	13.5	14.6	15.4	9.5	13.3	14.3	19.5	15.2	19.8	5.8	11.8	11.3	8.1	11.1	11.7	9.4	8.4	8.8	9.8	8.9	10.0	10.1	9.7	14.2	30.0	109.0	58.0	35.6	28.3	31.9	18.2	23.0	32.5	29.9	21.0	17.5	66.8	14.3	34.8	27.6	52.1	42.3	20.7	16.6	9.8	16.2	58.3	35.7	30.7	26.8	12.6	77.0	68.4	19.3	23.7	26.2	18.3	31.4	15.8	27.6	21.4	15.2	27.6	35.3	69.7	15.9	10.2	25.4	28.5	17.7	23.0	30.5	17.8	51.5	31.2	22.8	18.6	45.2	62.7	22.3	13.9	24.0	26.5	20.0	15.4	16.1	57.2	39.1	19.7	27.8	32.0	85.6	34.5	32.3	36.9	67.0	28.3	32.5	17.0	29.8
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470882	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 29.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 54.7;Urothelial cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.5;hTERT-HME1: 20.7;RT4: 19.6;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	5.0	6.0	5.1	1.8	7.0	7.2	4.5	7.5	7.2	4.2	0.3	4.8	4.4	2.3	2.1	8.2	2.7	2.9	5.1	9.5	7.1	11.2	6.7	3.2	0.6	9.8	6.5	2.7	29.9	0.6	3.3	2.8	8.5	3.0	3.7	6.2	7.9	2.9	5.9	11.0	4.2	2.2	7.6	2.0	8.5	3.4	6.7	0.4	2.0	2.8	1.7	7.2	7.4	11.7	1.2	1.8	1.8	0.4	4.9	4.0	4.5	0.5	0.0	0.0	0.0	0.4	2.7	3.4	2.6	0.1	2.0	4.0	2.7	5.0	0.0	1.0	1.9	0.0	3.8	1.3	3.0	0.3	0.3	4.4	15.5	0.2	20.7	0.2	0.2	2.0	0.2	0.9	2.2	2.8	1.0	0.2	2.0	9.9	1.0	1.2	7.4	5.6	8.0	19.6	6.3	18.0	4.1	6.5	0.1	2.3	0.9	3.4	0.2	1.3	1.3	0.0	0.6	2.3	0.4	0.9	2.3	0.0	1.5	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.6	0.3	0.5	1.0	1.1	0.0	1.9	0.0	0.0	5.1	7.0	7.5	7.2	9.5	7.1	9.8	6.5	8.5	7.6	6.7	11.7	11.9	9.6	42.6	0.0	0.2	0.0	37.6	0.0	3.4	34.2	6.9	5.1	0.0	11.5	8.6	25.8	4.2	20.4	0.0	10.7	1.9	11.8	14.8	19.8	8.7	2.0	3.6	0.0	0.0	13.3	2.6	14.3	27.0	41.7	3.8	0.9	0.4	8.8	1.7	42.1	0.0	8.4	0.0	4.0	0.0	3.4	1.8	1.9	0.0	0.0	0.6	34.9	0.0	0.0	0.0	9.3	5.7	5.3	0.5	54.7	19.8	23.4	4.4	7.4	0.0	29.8	6.5	3.9	7.5	13.7	0.0	33.5	0.9	1.7	7.6	114.2
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GARRE1	KIAA0355	ENSG00000166398	"Granule associated Rac and RHOG effector 1"	O15063	19	34254552-34355566	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 126.8;Cardiomyocytes: 15.7;Cytotrophoblasts: 23.8;Extravillous trophoblasts: 25.1;Syncytiotrophoblasts: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	18.8	5.6	5.0	7.2	6.7	3.4	16.8	7.3	4.5	10.8	6.7	7.8	5.4	11.0	3.0	8.0	10.1	9.5	12.0	3.6	5.6	8.2	7.3	12.4	9.1	7.0	7.0	9.4	10.4	10.8	7.7	23.3	6.6	8.3	5.6	8.1	7.4	6.4	15.4	10.3	8.2	8.6	5.2	16.1	6.6	7.1	7.1	8.5	10.9	17.0	7.5	8.0	9.9	10.3	3.4	10.2	8.9	4.6	6.0	5.7	11.6	7.6	6.2	5.7	8.4	8.1	3.9	7.7	16.4	7.1	7.1	2.4	6.6	3.6	6.2	11.0	5.8	4.7	3.9	6.2	7.6	2.1	3.7	6.7	6.2	7.5	11.0	22.6	23.7	4.3	14.4	3.8	6.2	1.8	1.4	1.9	6.8	4.6	3.7	3.4	6.2	4.1	4.8	3.8	10.3	8.5	8.7	33.9	10.9	12.9	2.7	3.8	19.7	19.5	7.2	5.0	8.1	6.4	9.5	2.4	3.7	0.8	9.7	0.0	0.7	0.0	0.8	1.4	1.3	2.3	1.8	0.8	0.8	2.8	1.6	1.0	2.2	1.5	2.1	1.1	3.0	0.8	5.0	6.7	7.3	4.5	3.6	5.6	7.0	7.0	6.6	5.2	7.1	10.3	126.8	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	23.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	25.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	34.1	2.3	0.0	0.0	0.0
GARS1	"CMT2D, DSMAV, GARS, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase 1"	P41250	7	30580533-30634033	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 34.1;Cytotrophoblasts: 47.0;Extravillous trophoblasts: 70.0;Hofbauer cells: 44.3;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		560000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	34.2	31.0	33.3	43.3	36.5	32.0	31.7	34.2	46.2	32.6	49.9	39.8	27.6	29.1	37.3	53.8	23.3	29.9	32.9	38.6	45.7	42.7	46.0	34.0	47.2	38.1	34.7	26.7	78.5	58.1	36.5	39.9	42.0	26.8	48.6	46.9	36.1	29.3	48.1	43.4	26.0	49.8	33.2	22.3	47.4	51.5	43.4	40.7	51.5	45.0	67.3	54.0	29.4	35.2	231.4	119.8	103.4	364.5	191.9	286.8	172.0	332.4	330.5	184.0	369.8	159.5	115.4	375.9	96.2	443.1	281.6	174.5	262.6	230.2	327.7	92.9	82.5	182.6	84.8	141.1	604.0	267.6	149.8	272.5	391.9	265.8	304.9	128.1	241.6	354.1	350.2	465.4	296.7	154.7	216.8	204.3	259.6	222.4	183.4	114.0	90.1	299.0	219.5	109.1	117.9	177.4	88.1	261.5	509.2	182.8	225.3	409.3	208.2	82.2	262.9	164.9	217.9	403.8	390.8	445.9	289.4	398.8	392.9	40.0	27.0	24.1	22.9	35.8	27.4	21.0	26.0	28.8	35.8	16.3	25.2	30.2	5.2	20.9	41.7	18.5	31.9	23.9	33.3	36.5	34.2	46.2	38.6	45.7	38.1	34.7	42.0	33.2	43.4	35.2	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	47.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	70.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	39.8	2.0	0.0	0.0	0.0
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.1	20.3	9.2	24.2	12.2	18.8	24.3	11.3	11.9	16.4	10.1	23.2	22.1	18.3	17.1	24.8	21.8	15.9	20.7	8.6	10.5	21.0	29.7	16.0	30.3	11.0	10.3	19.0	22.3	19.9	12.8	26.1	11.7	17.0	29.1	20.9	16.8	16.7	29.1	17.4	19.4	26.3	11.3	20.0	19.7	29.3	10.9	34.4	20.8	21.9	38.6	32.2	16.5	14.0	132.2	61.5	90.3	98.8	61.1	64.2	100.3	82.6	70.8	96.8	101.5	117.7	108.9	174.8	48.5	55.6	124.9	67.9	189.0	130.4	138.3	91.3	111.7	265.2	68.5	78.6	85.2	148.6	66.3	57.3	86.5	113.3	162.5	48.1	91.5	138.4	312.4	108.5	84.9	63.6	158.2	100.0	194.4	186.3	71.8	131.1	166.6	246.7	74.7	69.4	93.1	84.1	116.9	89.1	107.1	81.0	113.0	93.9	68.7	64.9	76.9	56.1	90.9	106.8	159.6	193.0	67.1	171.3	96.2	9.0	24.0	16.3	25.9	33.9	31.4	29.7	25.2	27.1	31.6	24.5	26.4	26.2	10.6	43.9	30.6	23.2	34.1	22.8	9.2	12.2	11.3	11.9	8.6	10.5	11.0	10.3	11.7	11.3	10.9	14.0	21.1	19.2	19.8	17.3	30.1	46.0	50.3	34.1	38.1	18.5	18.6	17.3	19.3	11.5	28.0	14.7	35.5	41.2	21.8	12.4	23.5	28.4	21.7	23.3	36.9	21.9	13.1	40.3	19.1	24.2	37.4	27.2	21.4	23.4	7.6	31.8	16.1	18.0	23.6	5.0	21.1	17.1	22.4	17.0	12.0	6.6	17.4	17.0	12.4	10.3	19.8	13.3	22.6	17.6	19.3	31.5	12.7	18.0	22.7	54.3	16.4	14.3	17.8	28.5	13.1	23.0	23.9	57.2	27.6	34.4	45.9	25.6	21.2	55.0	24.1	46.6
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944362-86947506	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 105.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 30.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1"	"Low region specificity"	"Detected in all"							"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA		27000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	81.5	6.4	3.6	16.6	4.4	0.2	38.3	3.5	4.4	27.1	16.1	27.6	2.2	105.4	15.2	5.8	60.7	10.5	27.1	3.2	2.7	12.5	2.2	7.8	6.8	3.8	3.8	45.1	11.2	1.9	8.4	22.1	3.6	22.6	2.3	3.3	13.1	9.6	12.2	22.2	9.3	43.4	3.4	3.6	16.3	1.8	3.8	7.1	15.9	9.3	3.1	22.5	27.1	6.8	0.0	0.0	7.5	44.2	29.3	10.9	0.8	8.8	59.8	2.9	2.6	0.0	0.1	0.0	0.5	15.8	0.3	0.6	0.0	0.3	1.2	5.2	17.8	0.0	25.0	0.0	14.9	0.1	0.7	41.1	6.3	1.0	5.3	0.0	0.0	0.9	0.0	0.0	12.6	0.0	0.0	0.4	9.5	0.3	0.1	9.6	91.1	0.0	0.4	0.0	1.0	4.0	12.9	0.0	14.1	4.8	0.1	0.2	0.1	13.0	3.6	0.9	3.0	0.0	0.0	0.0	0.4	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.4	3.5	4.4	3.2	2.7	3.8	3.8	3.6	3.4	3.8	6.8	15.8	0.0	0.6	2.0	0.4	25.9	7.5	10.9	10.2	8.3	3.9	28.3	5.5	0.0	3.1	14.7	10.4	21.5	7.8	0.1	9.8	0.5	0.1	2.4	36.6	5.6	0.0	0.4	1.2	0.4	3.7	127.1	1.1	2.0	0.0	2.1	22.9	0.3	5.8	5.0	2.6	0.3	0.0	1.0	15.4	0.9	32.3	2.2	17.8	1.9	0.2	90.3	7.2	8.5	4.4	0.2	0.0	12.4	2.1	4.5	0.0	2.6	0.7	3.2	39.5	213.7	15.4	0.3	1.3	1.0	12.5	4.5	2.1	0.8	0.2	0.4
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 84.6;Late spermatids: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 77.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	22.6	36.3	46.7	5.5	41.8	6.5	22.4	39.4	58.5	16.2	30.4	25.8	18.1	18.4	5.3	34.3	16.5	4.2	33.5	45.4	37.8	21.0	18.6	19.3	2.3	50.0	43.3	8.9	14.4	6.6	22.1	4.1	42.2	22.2	2.0	4.0	24.7	16.9	6.5	52.8	17.8	4.4	41.8	29.1	27.4	51.3	47.3	1.1	15.6	3.9	1.8	17.6	19.6	37.4	20.4	23.1	3.5	14.5	5.5	5.2	22.6	29.7	8.9	12.3	6.4	10.6	14.2	0.1	13.1	15.9	12.9	60.5	6.0	16.8	2.2	27.6	2.9	26.5	19.9	7.5	7.0	0.2	17.8	5.6	11.5	11.9	4.7	8.9	16.5	26.2	12.8	4.1	9.0	17.2	0.5	14.8	5.3	13.5	51.6	0.6	10.3	1.7	7.5	12.8	1.2	19.0	23.0	30.3	17.0	4.4	30.2	4.1	35.5	77.0	53.0	34.6	30.3	0.3	0.4	0.3	34.1	1.0	19.3	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	46.7	41.8	39.4	58.5	45.4	37.8	50.0	43.3	42.2	41.8	47.3	37.4	34.5	6.4	1.7	28.1	0.4	28.2	7.0	12.3	21.6	3.6	24.0	18.4	5.6	14.3	8.3	1.8	6.2	24.8	0.8	13.4	7.9	12.2	33.8	19.2	9.2	26.2	1.8	19.6	14.8	6.7	14.3	12.0	9.2	10.0	1.3	28.9	84.6	12.0	14.1	13.5	11.4	5.1	20.3	14.5	23.0	89.7	9.6	37.6	12.4	7.5	7.6	5.4	0.0	4.0	4.0	10.2	7.2	11.7	0.2	6.1	41.7	10.1	4.3	20.9	39.5	35.3	23.5	5.4	12.4	27.9	32.4	6.7	2.2	17.8	11.8	4.6
GAS2L2	GAR17	ENSG00000270765	"Growth arrest specific 2 like 2"	Q8NHY3	17	35744511-35753239	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 6.5;fallopian tube: 16.4"	"Group enriched"	"Detected in some"	6	"Endometrial ciliated cells: 23.0;Respiratory ciliated cells: 32.8"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HaCaT: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044370	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA044370: AB_2678915"	"unprognostic (3.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.54e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"		"unprognostic (4.42e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.92e-2)"	0.6	0.0	1.1	0.0	1.2	0.0	0.5	0.6	1.0	0.9	6.5	0.1	0.0	0.2	1.9	0.0	16.4	0.0	0.1	1.0	1.1	0.1	0.0	2.0	0.0	1.9	2.6	0.0	0.1	0.1	0.0	0.0	1.7	0.1	0.0	0.2	0.1	1.2	2.8	0.3	0.1	0.0	2.2	0.0	0.1	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	0.6	1.0	1.0	1.1	1.9	2.6	1.7	2.2	1.0	1.2	0.1	0.0	1.1	1.0	0.1	0.6	0.0	1.3	0.0	0.1	0.6	0.3	0.5	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.0	0.2	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.8	0.0	0.0	0.0	0.5	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0
GAS2L3		ENSG00000139354	"Growth arrest specific 2 like 3"	Q86XJ1	12	100573683-100628288	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"spinal cord: 13.8"	HPA048593	Approved					NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA048593: AB_2680455"	"unprognostic (1.03e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.04e-7)"	"unprognostic (2.79e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.58e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.67e-2)"	1.8	0.8	0.1	1.6	1.4	5.6	0.8	0.1	0.7	1.2	0.5	3.3	2.7	0.7	0.4	1.6	0.3	4.8	1.5	0.5	0.1	1.3	1.0	2.5	1.3	0.5	0.5	1.1	0.5	0.2	0.2	3.5	0.5	0.3	3.8	0.4	0.5	1.1	0.8	3.4	2.7	1.6	0.3	1.4	1.4	4.0	1.4	0.9	0.6	1.2	1.2	1.6	0.5	1.1	35.4	14.0	18.6	14.8	5.7	7.3	6.2	16.2	15.3	21.3	23.8	10.4	9.5	0.6	4.8	12.8	20.8	11.8	12.0	5.9	31.0	10.0	9.1	0.0	12.2	7.0	1.9	0.0	8.0	2.9	0.6	12.8	36.1	10.1	20.2	0.0	2.2	0.0	17.7	10.4	0.0	0.2	5.9	6.5	16.7	2.4	32.5	0.8	9.2	9.6	8.4	8.1	17.0	11.7	22.2	6.5	21.3	1.9	13.6	13.6	14.3	12.2	17.8	7.4	9.3	0.0	5.3	5.6	39.3	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.1	1.4	0.1	0.7	0.5	0.1	0.5	0.5	0.5	0.3	1.4	1.1	3.6	0.0	0.0	1.0	0.2	3.4	0.4	0.5	2.8	0.2	2.0	2.2	2.0	11.5	0.2	0.0	0.0	9.9	0.4	9.8	0.0	2.7	4.5	3.6	5.5	5.6	3.6	6.9	2.5	0.7	4.5	2.2	11.2	7.4	1.3	7.2	2.5	1.4	13.9	0.0	5.9	14.2	0.0	8.0	11.1	0.5	0.6	14.7	7.2	4.7	1.5	2.2	0.0	2.5	0.3	0.3	8.2	0.7	0.3	0.6	2.6	3.4	1.0	0.1	0.0	4.8	2.7	16.0	2.3	4.7	3.7	33.9	1.0	6.8	8.3	0.6
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864076	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 348.3;Sertoli cells: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 70.7"	"Lineage enriched"	"Detected in many"	50	"dendritic cells: 70.7"	"Cell line enhanced"	"Detected in many"		"BJ: 347.0;BJ hTERT+: 494.0;HSkMC: 281.3;RPMI-8226: 493.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	NA	NA	8900000	3600000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: AB_2683032"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (8.93e-6)"	124.2	32.5	26.7	18.8	28.7	3.6	77.4	33.9	32.0	244.4	59.3	67.8	48.7	171.7	13.8	63.2	161.3	58.9	169.1	24.1	34.6	72.7	37.1	97.3	22.5	37.4	36.1	118.0	49.9	58.5	58.4	51.6	38.5	100.9	25.2	6.3	84.4	63.8	99.2	101.4	47.8	57.9	30.8	29.4	70.0	60.1	34.1	39.6	101.2	67.5	10.6	127.0	172.0	25.2	151.3	6.6	4.4	3.8	169.5	94.0	18.4	347.0	494.0	141.3	168.4	9.6	71.0	1.4	11.4	157.2	24.9	139.1	2.4	77.7	35.6	0.2	20.1	1.1	11.1	1.0	120.8	1.0	2.1	281.3	44.9	39.1	39.0	243.2	5.3	2.3	2.6	79.9	231.9	7.4	0.8	1.5	9.5	24.0	9.9	4.5	0.1	493.5	51.9	1.9	23.5	21.3	38.3	1.3	0.4	23.8	45.9	119.4	81.7	36.9	45.0	4.4	100.5	0.1	8.0	1.5	41.9	3.6	5.8	0.0	1.4	0.0	0.0	1.1	0.0	0.1	0.2	0.0	11.3	0.1	0.0	0.0	0.0	0.1	0.3	70.7	0.0	1.4	26.7	28.7	33.9	32.0	24.1	34.6	37.4	36.1	38.5	30.8	34.1	25.2	133.2	198.7	25.9	23.2	20.8	84.4	94.7	18.5	70.0	38.0	17.9	114.3	86.8	50.1	23.4	31.3	0.0	1.8	59.1	92.4	27.4	45.7	5.1	35.2	33.1	71.9	10.3	5.3	26.2	6.7	1.9	152.7	19.9	32.3	8.2	154.7	159.9	21.6	101.6	348.3	31.9	69.5	8.2	22.3	100.4	8.9	92.2	48.6	122.7	41.2	9.8	32.7	0.0	3.0	7.5	24.1	58.6	59.5	147.4	30.5	84.1	0.6	15.5	12.5	322.1	22.9	121.1	5.3	17.6	27.6	71.9	2.9	4.7	214.8	151.4	31.1
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	5.2	10.3	9.5	2.8	9.7	1.4	6.3	10.0	14.3	7.8	12.3	7.7	2.6	6.5	10.1	8.4	18.9	6.1	15.4	9.5	9.9	13.8	5.5	7.1	2.8	10.3	10.0	8.9	10.5	16.3	14.1	2.1	10.1	7.3	3.0	5.0	11.4	8.6	15.1	4.5	3.9	4.4	10.3	3.4	8.2	16.8	10.9	2.5	12.5	10.0	2.0	6.3	5.8	10.2	17.9	14.5	1.8	8.5	7.8	6.2	14.3	3.6	8.8	13.9	4.1	14.1	13.0	1.0	9.1	7.1	8.4	17.8	5.9	9.9	3.3	0.0	10.7	3.7	9.0	16.2	8.7	2.2	2.8	7.9	6.0	10.4	4.7	6.3	8.3	5.8	14.3	2.1	6.1	41.9	2.5	9.9	11.6	11.3	7.4	0.7	15.7	1.0	17.4	8.5	14.6	10.7	18.4	9.7	21.0	1.6	19.6	8.4	6.2	8.6	10.3	4.7	8.3	3.4	5.4	0.0	21.3	2.7	15.1	1.7	1.2	1.4	0.7	2.0	0.7	0.4	1.0	1.4	1.7	0.8	0.8	0.7	1.5	0.0	1.3	1.9	1.6	0.8	9.5	9.7	10.0	14.3	9.5	9.9	10.3	10.0	10.1	10.3	10.9	10.2	5.9	22.4	11.3	20.5	3.1	1.1	4.7	7.0	5.7	11.9	14.1	10.8	7.9	25.8	13.4	22.0	20.9	3.0	0.7	5.9	13.7	17.1	198.3	45.5	7.1	5.8	6.0	3.0	27.5	10.9	3.6	5.5	12.2	10.0	2.5	16.1	7.1	4.8	4.1	26.9	24.6	6.3	8.2	0.8	1.4	277.8	14.0	2.3	5.4	1.9	1.3	12.4	0.0	13.0	6.0	10.0	4.6	7.5	1.1	5.8	5.3	30.9	82.3	28.0	6.6	6.7	9.5	28.7	11.9	7.2	2.6	1.6	1.6	25.2	5.3	5.8
GASK1A	"C3orf41, DKFZP434B172, FAM198A"	ENSG00000144649	"Golgi associated kinase 1A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		600000		"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	5.5	2.1	4.9	2.5	6.4	0.0	4.2	6.3	3.8	10.6	4.9	3.4	0.7	9.8	2.2	1.8	11.3	5.3	1.7	4.1	5.9	1.0	13.1	3.1	0.7	8.8	7.7	6.8	2.0	0.1	3.0	2.0	7.6	2.6	1.0	3.9	2.6	2.2	1.4	1.7	2.1	6.0	6.3	0.9	3.4	2.9	10.0	0.6	2.1	0.8	0.3	3.2	3.9	5.2	0.0	0.0	0.0	3.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.1	0.9	0.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.6	0.4	1.2	0.8	0.0	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.0	0.5	0.1	0.3	0.0	2.6	0.0	0.1	6.7	0.9	0.0	0.4	0.6	1.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	6.4	6.3	3.8	4.1	5.9	8.8	7.7	7.6	6.3	10.0	5.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0
GASK1B	"C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155"	ENSG00000164125	"Golgi associated kinase 1B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 206.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0"	"Group enriched"	"Detected in many"	41	"dendritic cells: 15.1;monocytes: 50.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA		13000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	73.9	206.2	29.0	39.8	29.2	2.8	47.3	21.8	23.3	47.0	11.9	23.4	13.3	77.7	21.8	17.2	19.4	37.1	77.9	28.7	29.6	9.5	8.6	14.1	11.2	51.7	33.0	140.3	14.2	11.5	2.8	29.0	26.9	23.6	23.3	0.8	23.6	30.0	12.4	7.3	18.5	70.2	34.1	20.8	11.8	10.4	35.5	5.7	17.7	16.7	6.8	43.2	9.2	33.0	12.5	9.9	6.1	1.1	77.0	143.3	11.4	3.1	2.4	0.6	3.7	13.3	4.9	0.1	0.3	5.0	5.1	0.2	70.7	18.9	1.8	0.1	0.2	1.0	0.0	37.0	51.4	0.6	0.3	166.4	4.6	24.2	2.6	8.0	193.3	0.0	13.0	0.0	35.7	0.8	0.0	0.2	0.4	43.4	0.2	0.1	0.5	0.2	0.0	27.5	0.4	0.1	0.0	27.8	8.2	33.4	5.4	0.3	9.3	16.0	17.1	9.6	6.1	0.0	0.1	44.8	2.5	0.3	74.3	0.1	50.6	0.0	0.1	28.8	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.7	0.1	14.0	0.6	0.0	17.8	29.0	29.2	21.8	23.3	28.7	29.6	51.7	33.0	26.9	34.1	35.5	33.0	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	1.2	14.5	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9556.1"	"Cell type enriched"	"Detected in some"	5	"Glandular and luminal cells: 103.7"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		87000		"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	0.9	0.0	0.6	0.0	0.7	0.4	0.9	0.2	0.4	0.0	57.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.3	0.0	3.7	0.0	0.8	1.0	0.0	0.0	0.0	0.1	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	9.3	9556.1	0.3	2.5	4.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.8	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.4	0.9	0.5	2.5	0.8	1.0	1.0	0.6	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.3	0.9	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	2.2	13.5	18.7	0.7	0.0	0.0	0.0	0.0	0.1	1.0	0.5	103.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.8	0.2	0.2	0.0	0.0	8.8	1.0	0.0	0.0	0.4
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786562-48794311	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 59.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 165.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 471.7"	"Lineage enriched"	"Detected in single"	1877	"granulocytes: 471.7"	"Group enriched"	"Detected in some"	9	"HEL: 221.5;HMC-1: 211.9;K-562: 238.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.2	0.1	0.0	0.1	0.2	59.9	0.1	0.2	0.1	0.2	0.0	0.2	0.5	0.3	0.0	0.2	0.1	0.6	0.1	0.0	0.2	0.2	0.3	2.0	0.1	0.3	0.2	0.0	0.0	0.0	0.2	1.0	0.2	0.3	0.3	0.4	0.1	0.1	0.0	0.3	0.5	0.3	0.2	2.0	0.5	1.4	0.2	0.1	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	221.5	0.0	0.0	0.0	0.2	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	238.9	0.4	0.0	0.0	0.1	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	83.6	0.2	471.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.0	0.0	4.4	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.0	0.0	1.3	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	165.6	0.1	0.0	0.5	0.3	0.0	0.0	37.9	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.4	31.5	0.0	9.2	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	1.2	0.2	0.0	0.0
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493201	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4"	"Group enriched"	"Detected in all"	5	"endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	330	"basophil: 513.2"	"Lineage enriched"	"Detected in single"	4344	"granulocytes: 513.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	16.9	9.8	7.1	2.7	5.3	5.1	12.8	3.6	4.6	32.9	2.1	6.6	4.3	42.7	7.1	4.9	49.7	10.7	19.5	3.9	3.4	20.7	1.3	34.8	2.8	8.2	12.2	4.3	13.7	6.9	9.7	22.5	7.9	54.4	2.9	0.1	4.8	52.2	6.4	9.2	8.5	10.8	4.0	11.4	6.6	2.7	8.8	0.8	7.3	5.2	1.2	33.8	23.9	4.1	24.4	5.9	1.3	15.9	2.0	0.6	281.0	53.8	45.2	18.0	6.5	10.0	10.7	0.5	14.8	31.9	1.5	25.5	14.7	0.0	7.6	0.0	8.3	360.7	42.9	16.0	4.0	36.8	187.4	0.3	0.3	0.7	0.3	2.9	28.6	0.2	96.7	0.5	0.4	9.0	0.1	74.2	1.0	0.2	1.8	0.1	7.0	0.4	0.5	21.5	21.8	325.9	13.6	70.1	2.4	14.4	13.5	15.0	52.0	1.2	0.7	12.7	7.4	0.1	0.0	0.2	0.6	2.5	3.7	513.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	7.1	5.3	3.6	4.6	3.9	3.4	8.2	12.2	7.9	4.0	8.8	4.1	69.0	6.4	27.7	0.0	0.9	4.8	25.5	0.0	1.2	0.2	1.5	1.5	5.7	0.0	1.8	75.4	0.0	63.4	2.3	0.5	1.9	0.2	10.1	74.2	43.2	75.4	3.0	62.4	0.0	14.2	261.6	8.8	0.5	116.5	638.7	0.9	57.5	0.2	10.8	0.0	0.0	0.3	0.0	0.3	4.6	6.4	0.6	7.9	8.8	15.9	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.4	5.4	29.5	0.0	0.2	0.7	0.2	0.0	2.2	11.0	0.6	4.7	0.9	2.4	321.4	14.0	0.2	0.3	10.5
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075198	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 109.9;skin 1: 172.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Group enriched"	"Detected in many"	5	"midbrain: 28.3;pons: 12.6"	"Group enriched"	"Detected in many"	41	"gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6"	"Group enriched"	"Detected in many"	57	"NK-cells: 36.1;T-cells: 43.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"Group enriched"	"Detected in some"	11	"medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	6.7	6.4	0.9	3.8	0.2	4.1	34.2	0.2	0.2	3.4	0.8	0.7	1.0	0.6	8.6	0.6	0.5	1.2	2.5	0.1	0.6	24.9	1.0	3.4	7.8	3.9	28.3	0.1	0.3	109.9	5.0	32.2	12.6	11.2	0.7	0.0	19.9	24.9	2.1	172.9	2.4	0.3	0.5	7.2	1.5	0.2	4.1	25.0	3.0	1.0	3.8	38.8	10.8	0.2	33.8	8.1	0.0	0.4	0.0	0.0	190.2	0.7	0.0	0.0	0.1	12.4	29.9	0.0	0.1	0.0	0.0	28.9	3.2	0.6	0.1	95.8	10.2	0.2	0.3	0.1	2.1	0.1	0.5	0.0	6.9	0.1	1.8	1.0	15.3	45.8	0.4	0.0	0.1	473.4	54.2	0.5	3.5	6.5	4.5	2.8	2.6	0.8	0.0	194.3	9.8	161.2	0.5	26.8	0.0	34.1	605.2	0.1	0.0	2.4	5.9	1.4	4.3	0.9	0.0	0.0	1.3	0.0	1.7	0.1	0.1	0.0	19.9	0.0	26.9	0.4	36.7	28.8	0.0	0.1	19.9	18.3	0.7	36.1	0.0	0.0	43.6	7.0	0.9	0.2	0.2	0.2	0.1	0.6	3.9	28.3	12.6	0.5	4.1	0.2	14.6	0.0	6.0	0.0	3.4	94.8	69.6	1.6	0.0	0.0	267.1	167.3	1.3	0.0	1.5	178.4	0.0	323.5	49.2	0.0	0.0	0.2	0.2	0.5	0.4	12.6	0.0	2.1	0.0	0.4	746.6	5.3	2.6	0.7	2.5	0.0	6.8	0.6	30.7	0.0	0.0	0.0	0.0	3.5	9.9	0.1	0.0	3.8	8.8	1.0	1.5	0.0	51.5	0.0	0.0	4.1	1.1	0.0	12.2	45.8	0.0	0.6	0.3	0.0	0.0	1.1	2.8	0.0	1.4	1.0	198.9	1134.9	93.4	0.5	0.0	106.1
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.6;ovary: 95.4;pancreas: 53.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.2	0.2	0.0	0.0	2.3	4.0	88.6	0.0	0.0	0.0	36.6	0.2	0.0	0.0	0.0	95.4	53.5	0.0	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.1	35.2	32.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	10.0	7.1	0.0	6.1	2.9	10.0	9.9	12.4	3.0	10.9	0.0	11.1	4.2	11.1	1.8	7.9	9.1	3.2	9.2	1.8	1.5	7.1	8.1	12.9	7.8	2.8	0.7	11.7	7.5	5.7	7.6	5.8	1.2	8.3	3.6	3.6	7.8	5.3	16.6	13.3	9.3	7.0	0.0	10.6	7.7	10.4	2.1	10.9	8.6	8.2	7.4	9.5	9.8	11.2	7.9	14.7	12.8	14.2	2.7	8.2	7.7	4.8	11.5	15.0	17.5	7.2	12.0	15.5	11.2	10.9	7.9	15.6	18.1	9.4	12.2	14.2	12.5	15.2	16.2	2.9	8.6	9.2	20.7	6.5	6.5	16.7	32.9	7.1	14.4	21.2	11.5	20.6	3.0	14.5	33.3	2.6	5.6	6.3	7.1	33.5	6.5	17.1	2.9	10.9	14.8	15.6	18.0	21.8	8.7	9.4	20.1	7.7	13.0	14.6	12.8	8.1	10.2	27.9	20.5	23.4	8.2	6.0	12.8	4.9	0.5	0.5	0.6	0.3	0.6	0.4	0.3	0.8	0.2	0.6	0.2	0.3	3.5	0.9	0.2	1.6	0.6	0.3	0.0	2.9	12.4	3.0	1.8	1.5	2.8	0.7	1.2	0.0	2.1	11.2	32.1	9.6	14.4	53.8	30.0	43.8	13.4	12.8	47.8	45.9	20.9	19.9	16.6	21.5	12.3	25.8	39.6	10.3	31.9	15.1	7.9	13.9	15.8	16.8	26.6	28.2	23.8	21.7	104.6	14.3	7.1	20.7	17.3	21.3	24.7	19.3	22.5	21.8	13.5	35.3	77.5	15.8	16.2	31.4	42.8	7.6	27.1	23.7	14.2	80.6	36.3	17.8	23.7	86.5	117.9	17.1	20.7	35.0	25.6	22.3	9.9	10.4	15.2	35.9	6.6	28.2	27.1	30.4	21.4	26.0	47.5	9.9	31.2	21.4	15.9	21.1
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.8	15.6	15.4	5.6	17.5	9.5	8.3	18.0	20.4	6.7	14.9	9.8	5.8	5.5	8.3	10.3	8.7	5.5	33.3	16.3	16.9	21.6	22.2	5.3	7.6	17.4	16.5	11.3	5.3	18.3	5.2	8.6	17.1	5.5	9.6	17.0	7.9	6.4	23.0	9.4	6.4	8.0	17.7	6.5	8.2	8.0	17.2	12.2	7.5	40.3	9.7	6.9	6.1	20.4	14.9	11.6	16.1	15.7	22.9	21.7	13.9	19.3	24.9	33.3	25.8	19.5	23.8	20.2	5.0	20.1	20.3	13.7	34.5	36.6	35.3	11.4	21.1	9.4	15.2	40.7	22.4	19.1	9.0	22.8	23.1	32.0	11.2	19.2	25.1	28.0	36.8	17.1	26.0	16.7	24.1	20.8	16.6	12.4	21.1	20.4	15.5	16.1	30.2	12.3	16.5	18.5	15.8	21.1	23.1	15.4	17.9	13.7	14.1	16.8	9.1	11.7	13.4	20.3	28.2	16.8	23.7	16.9	12.5	0.9	11.6	2.0	4.5	16.9	7.3	11.4	6.1	6.5	20.9	9.9	7.8	7.3	1.1	8.7	12.1	8.1	7.0	10.8	15.4	17.5	18.0	20.4	16.3	16.9	17.4	16.5	17.1	17.7	17.2	20.4	4.3	9.6	4.8	11.4	6.7	0.0	6.0	0.0	5.7	9.8	6.3	7.1	64.8	1.5	3.7	11.0	8.4	23.4	2.9	3.2	27.4	11.2	8.0	6.7	7.3	4.4	2.4	15.6	28.4	7.4	16.6	8.8	6.6	7.1	1.3	12.3	2.5	17.2	17.1	10.1	16.4	4.2	0.0	7.3	0.0	10.6	5.3	7.6	0.0	15.9	10.8	333.3	1.0	14.1	27.5	6.9	4.9	4.5	5.6	3.1	6.3	22.7	1.5	17.1	6.6	6.5	5.9	14.3	14.0	10.6	0.0	13.4	3.6	12.5	7.1	4.5
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	15.9	37.5	37.7	11.3	35.8	7.9	16.7	35.1	37.8	22.7	36.6	23.3	15.4	24.9	12.6	23.7	22.7	7.3	16.3	37.4	36.5	24.0	19.3	15.4	11.2	46.4	41.8	25.9	15.9	10.5	30.1	9.2	35.8	23.0	6.5	9.7	17.5	12.2	14.4	21.0	18.2	7.9	38.4	19.6	17.8	18.6	45.3	8.8	22.0	6.5	6.8	19.7	20.4	37.5	41.3	22.3	22.2	23.9	10.2	15.6	20.9	24.2	10.5	22.0	19.3	15.8	62.5	22.1	8.6	16.0	23.2	42.7	16.7	21.6	11.0	28.1	120.5	13.0	38.8	36.0	17.5	25.4	27.8	22.4	23.2	9.3	14.2	19.9	17.1	25.8	34.2	20.0	12.4	11.0	29.3	27.5	21.3	13.4	42.8	31.4	15.1	28.0	19.2	9.1	56.9	22.3	22.9	32.0	16.6	5.7	28.5	16.8	31.3	23.2	17.5	12.7	18.8	23.4	12.9	28.4	35.4	33.9	19.6	1.0	5.2	0.9	2.9	6.6	2.1	2.7	3.0	2.9	6.9	2.3	2.4	1.7	0.5	1.2	2.6	4.0	1.4	2.0	37.7	35.8	35.1	37.8	37.4	36.5	46.4	41.8	35.8	38.4	45.3	37.5	8.7	44.8	22.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	11.9	10.4	0.0	0.0	7.4	22.0	0.0	13.8	5.2	0.0	5.9	10.3	0.0	11.8	15.2	3.8	0.0	0.0	0.0	7.6	7.9	8.5	0.0	9.6	6.3	19.2	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	1.3	0.0	0.0	14.7	7.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	9.6	3.9	25.8	0.0	0.0
GATD3A	"C21orf33, D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Glutamine amidotransferase like class 1 domain containing 3A"	P0DPI2	21	44133610-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 178.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 7.0;Granulosa cells: 4.6;Hofbauer cells: 8.6;Proximal tubular cells: 4.8;Theca cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 156.3;U-266/70: 128.2;U-266/84: 117.9"									HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	21.3	25.3	10.4	7.7	11.8	1.3	18.6	12.2	50.3	18.9	8.2	19.0	2.0	12.1	25.7	19.8	27.4	1.3	68.4	10.3	11.9	51.0	78.2	12.3	8.0	15.0	13.5	18.8	18.2	18.3	16.0	5.8	12.8	16.6	1.0	6.1	18.2	7.8	60.2	17.1	15.7	1.0	12.3	16.3	19.2	11.3	13.4	8.2	15.2	178.6	20.7	18.3	15.1	12.7	1.8	3.7	2.6	0.7	34.4	34.0	52.0	64.2	39.7	49.2	38.9	82.4	0.6	156.3	0.9	0.2	1.6	0.8	0.4	35.3	25.1	35.0	77.7	8.0	11.3	49.0	38.3	3.1	1.1	0.4	2.8	15.7	1.9	29.5	2.2	40.0	31.7	56.5	19.7	6.5	1.6	3.9	1.4	4.9	9.0	1.6	0.8	28.4	2.6	1.2	55.8	0.6	1.3	1.6	52.7	1.0	2.8	4.4	33.8	22.7	1.4	38.1	0.8	128.2	117.9	2.5	1.7	10.2	29.5	10.8	16.4	9.6	16.9	24.9	15.6	27.4	21.5	21.3	3.7	28.1	17.6	15.1	7.6	21.0	40.4	17.6	18.5	23.1	10.4	11.8	12.2	50.3	10.3	11.9	15.0	13.5	12.8	12.3	13.4	12.7	4.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.0	2.5	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	3.9	1.6	0.0	2.6	1.1	2.1	0.0	0.0	0.0	2.5	3.6	1.9	0.0	1.9	0.0	4.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.8	11.9	0.0	0.0
GATD3B		ENSG00000280071	"Glutamine amidotransferase like class 1 domain containing 3B"	A0A0B4J2D5	21	5079294-5128413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 17.6;Ductal cells: 6.9;Hofbauer cells: 8.0;monocytes: 7.8;Proximal tubular cells: 31.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	53.8	77.8	82.0	34.9	87.3	31.7	48.6	88.9	90.2	40.9	76.0	55.1	71.8	36.9	27.5	59.4	44.4	41.2	195.5	78.2	87.4	141.7	239.9	34.5	53.8	89.0	86.3	66.6	52.7	61.9	54.8	40.2	90.2	43.9	57.5	32.2	60.1	33.4	208.0	40.6	51.3	32.4	83.9	48.2	50.1	33.0	89.9	35.9	55.1	225.6	28.1	40.0	41.1	85.5	55.8	52.7	57.1	98.7	42.8	38.3	23.7	0.0	4.5	1.9	2.9	7.0	54.8	2.6	61.9	62.9	51.7	38.8	77.2	34.7	1.1	36.8	32.8	217.2	60.1	47.6	41.7	94.8	39.7	80.4	69.6	28.3	57.1	39.5	64.4	66.1	86.6	51.2	34.9	118.5	94.4	103.6	110.9	150.0	80.5	190.1	43.1	223.3	72.4	49.8	48.5	96.4	76.7	138.9	52.0	28.4	146.2	131.4	19.7	27.7	39.0	2.5	33.7	80.7	79.2	37.6	64.9	192.0	20.7	87.3	110.4	60.4	102.2	123.5	101.4	153.3	129.7	107.0	147.7	167.1	124.6	95.2	21.7	136.1	167.7	96.3	145.3	190.3	82.0	87.3	88.9	90.2	78.2	87.4	89.0	86.3	90.2	83.9	89.9	85.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	2.9	1.4	0.0	17.6	6.9	0.0	1.1	1.9	0.7	0.0	0.0	0.0	5.0	3.2	0.3	0.0	2.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	7.8	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.7	0.0	0.0	31.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.4	0.7	1.9	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		470000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	23.9	37.9	22.5	24.8	24.4	41.7	25.1	25.9	24.3	26.7	27.4	35.1	23.9	22.9	50.2	27.6	20.5	28.3	19.1	26.1	27.7	33.6	33.7	28.3	19.9	27.3	28.0	16.9	33.4	103.1	43.8	39.2	36.2	23.3	39.8	12.4	26.8	33.6	9.1	33.4	22.5	29.7	25.0	29.0	22.7	8.8	29.2	19.7	37.7	13.6	28.0	27.1	21.9	29.5	38.0	72.2	25.1	34.2	254.8	55.8	29.3	65.4	230.4	95.3	119.0	43.2	135.7	26.3	70.4	153.7	152.0	76.2	35.9	46.4	50.3	55.5	25.1	21.8	45.1	23.2	73.6	25.8	87.0	73.4	38.2	199.7	30.2	100.2	85.6	22.2	23.4	42.9	113.5	82.6	32.5	11.9	16.3	61.9	51.2	26.8	41.9	108.1	63.9	29.0	23.9	33.5	57.4	136.4	145.3	45.6	102.6	63.3	65.7	71.7	31.7	91.9	53.7	86.2	78.6	20.4	126.6	23.4	56.4	21.4	36.0	15.3	20.8	35.8	13.2	11.1	15.7	13.8	22.4	7.8	11.0	11.7	28.9	11.6	37.2	12.5	23.4	23.3	22.5	24.4	25.9	24.3	26.1	27.7	27.3	28.0	36.2	25.0	29.2	29.5	6.8	3.2	5.1	3.3	8.8	6.0	5.8	9.5	4.6	4.0	12.7	6.5	8.8	17.2	8.1	12.9	2.1	30.7	6.2	36.1	3.9	30.5	1.4	12.3	9.7	12.2	14.6	7.4	3.4	32.4	27.9	18.6	20.9	17.9	7.0	7.9	17.2	23.2	65.2	5.0	2.7	11.6	4.1	33.3	9.9	2.8	9.9	26.8	26.6	1.0	22.8	11.7	12.3	0.5	3.3	29.5	15.8	9.1	19.8	6.7	28.6	20.6	8.5	6.0	0.0	9.4	21.6	22.5	12.5	8.6	4.4	59.4	8.5	6.0	10.4	6.5
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489703-81761645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 149.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 287.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		6500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	73.9	53.8	4.5	14.9	5.7	19.7	38.6	7.1	8.2	14.2	14.2	11.8	13.2	17.3	14.2	18.1	13.8	13.0	55.6	6.2	8.2	41.4	108.6	17.2	8.6	10.7	18.7	14.2	14.2	19.1	10.4	25.6	10.3	13.2	13.8	22.0	15.5	14.9	149.1	14.4	11.5	21.8	7.0	12.0	11.1	7.9	7.4	11.4	19.6	56.6	13.2	19.2	13.9	7.4	61.3	36.2	11.9	168.7	287.6	216.8	21.5	99.1	140.1	58.1	97.6	7.1	15.6	67.9	42.7	122.5	34.5	7.1	9.9	45.7	135.4	32.3	6.4	21.2	70.0	22.8	197.5	72.2	17.8	161.2	33.2	93.5	95.5	144.9	130.5	8.0	17.0	38.0	191.1	17.8	12.5	92.7	12.0	16.8	58.0	22.9	53.6	81.1	41.4	20.5	6.0	7.9	64.6	18.7	20.9	17.2	13.3	58.9	183.4	118.9	28.1	84.7	92.8	174.8	21.4	24.6	194.1	47.8	49.8	7.5	11.8	15.6	5.2	10.8	5.1	11.6	5.6	5.7	13.8	12.5	6.4	6.6	11.4	13.5	11.8	4.8	5.1	6.5	4.5	5.7	7.1	8.2	6.2	8.2	10.7	18.7	10.3	7.0	7.4	7.4	49.7	16.0	12.4	31.3	14.9	30.7	22.2	36.8	27.3	18.6	7.5	5.5	60.2	15.7	21.9	31.3	0.0	30.3	8.4	9.5	41.1	32.1	36.2	16.3	15.2	32.0	22.1	4.6	52.4	25.4	74.0	34.9	6.6	14.7	43.1	16.0	15.4	75.2	26.3	30.3	47.4	8.7	12.2	12.9	21.3	16.9	17.4	17.3	24.9	87.1	16.3	10.4	7.2	49.3	63.0	37.8	5.8	13.2	12.8	17.7	11.3	50.8	25.0	17.8	32.9	45.8	26.7	6.9	7.3	20.6	21.3	54.9	8.7	34.2	8.3	14.5
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245371-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: AB_2675651"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.4	21.1	31.5	16.0	31.7	25.0	19.3	28.7	47.2	21.7	34.9	24.6	20.6	23.5	12.7	21.9	19.7	9.8	30.0	32.2	27.7	21.7	23.2	20.5	14.6	28.5	37.3	21.6	25.6	24.4	31.5	11.5	30.6	24.2	13.9	19.2	24.5	15.2	48.1	24.9	25.8	16.4	27.1	21.7	21.2	20.5	29.8	11.8	25.4	30.1	13.8	21.7	20.5	29.1	19.4	49.7	23.3	25.1	62.9	40.7	28.1	37.7	56.0	45.3	48.1	52.7	35.1	21.7	29.7	59.6	33.8	38.6	45.9	52.8	33.8	35.4	36.9	33.3	38.1	44.6	26.4	35.2	46.8	37.3	28.0	60.7	57.5	77.2	45.2	22.5	20.7	53.7	41.8	36.9	24.2	38.9	15.4	29.5	35.6	33.6	72.1	18.8	39.3	30.9	15.0	16.3	30.2	22.3	26.5	33.1	50.4	30.8	60.5	29.1	29.6	37.7	55.6	32.4	36.3	26.5	30.0	36.3	22.1	28.6	4.5	4.3	4.9	5.0	5.9	6.5	3.6	6.5	5.0	3.9	5.7	5.3	4.6	4.6	4.1	4.2	7.4	3.9	31.5	31.7	28.7	47.2	32.2	27.7	28.5	37.3	30.6	27.1	29.8	29.1	12.5	12.8	10.1	56.5	15.5	9.8	5.5	10.6	17.6	24.7	15.7	12.8	17.0	15.7	10.9	12.9	56.3	12.2	15.1	31.4	3.9	12.5	4.9	14.3	18.1	12.3	12.0	13.9	72.1	16.7	16.3	14.6	31.1	15.6	7.6	10.3	8.2	17.6	12.2	52.2	73.0	21.9	12.2	11.0	5.0	4.7	10.2	13.4	12.4	66.5	9.5	11.1	9.2	80.9	71.1	18.6	20.7	11.3	46.0	7.7	27.1	9.0	12.3	41.0	6.6	21.7	12.3	36.0	25.4	20.7	13.1	17.6	16.0	19.1	19.4	6.7
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163933	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Hofbauer cells: 21.3;Kupffer cells: 31.9;Macrophages: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 64.1;HMC-1: 57.1;HUVEC TERT2: 24.0;NB-4: 29.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	9.9	10.5	6.3	11.0	5.9	9.9	6.5	11.8	7.0	5.4	11.8	5.3	3.3	6.7	2.7	3.6	7.4	7.5	6.7	5.9	8.2	5.6	1.3	9.7	9.7	13.5	11.2	12.5	3.4	4.8	4.2	12.8	13.8	6.1	3.2	1.0	4.8	4.2	2.2	3.5	6.7	6.7	7.7	8.9	22.2	1.3	11.5	2.7	6.7	2.9	8.1	6.0	6.3	8.5	0.1	1.6	1.5	0.0	1.0	1.1	0.5	4.7	3.8	2.6	0.1	0.0	0.9	1.2	15.5	4.7	1.7	17.3	10.5	1.0	0.1	0.0	0.5	64.1	1.1	0.0	12.4	2.4	57.1	5.3	1.7	0.6	0.1	10.5	24.0	0.8	18.7	0.2	1.0	0.3	0.2	29.0	4.9	0.5	0.4	4.5	0.4	1.7	1.6	0.2	0.4	1.8	0.0	2.6	0.1	2.0	0.1	14.0	14.8	0.0	2.0	1.9	0.1	0.0	0.0	0.1	0.3	10.2	0.8	6.2	10.7	5.2	0.2	7.2	0.4	1.8	0.3	0.0	3.0	2.7	0.1	0.1	1.7	0.2	6.4	2.2	0.2	2.5	6.3	5.9	11.8	7.0	5.9	8.2	13.5	11.2	13.8	7.7	11.5	8.5	1.6	0.0	1.7	4.9	4.9	0.8	2.2	0.6	2.8	0.3	4.1	2.7	2.6	1.5	0.7	1.8	0.0	2.4	0.0	0.6	0.0	3.2	0.0	0.5	1.8	1.8	0.0	16.4	2.4	0.6	1.1	7.3	2.6	0.3	11.4	3.6	0.7	0.0	21.3	0.0	1.9	0.3	0.0	31.9	3.1	0.0	7.5	22.0	0.0	5.6	11.1	2.4	0.0	1.5	0.0	0.8	12.1	1.9	0.7	1.5	0.1	1.6	0.0	0.2	0.0	3.9	6.2	0.1	0.1	1.4	1.1	3.6	2.0	0.5	1.2	1.7
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89051882-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 183.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 131.4;BJ hTERT+ SV40 Large T+ RasG12V: 175.2;GAMG: 129.1"									CAB015450	Approved				"Intracellular and membrane"	NA	NA		110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	23.9	7.9	4.1	71.6	4.1	5.2	18.2	4.0	5.6	23.8	3.7	23.0	16.8	26.4	5.5	10.4	18.2	44.4	10.5	3.3	5.4	12.1	88.0	44.4	55.1	19.2	5.0	13.2	6.0	6.5	5.5	20.4	11.9	19.2	13.5	1.2	12.2	14.3	5.1	9.3	17.8	37.0	6.7	51.6	16.5	3.4	5.8	21.3	17.9	5.4	21.6	43.0	15.4	5.8	13.9	0.2	0.0	0.0	11.6	22.4	35.6	34.3	72.4	131.4	175.2	3.5	7.5	12.4	22.1	44.5	129.1	2.4	0.0	18.8	61.7	41.1	0.1	2.9	9.4	0.3	70.7	0.0	1.8	54.6	6.3	61.0	10.3	29.8	34.5	18.4	0.0	9.9	44.7	0.0	31.9	0.2	0.2	0.0	1.4	43.6	40.7	0.8	7.2	21.0	0.5	0.0	39.2	8.3	3.8	0.0	0.8	0.1	40.2	33.4	1.6	10.8	29.7	0.4	0.2	0.1	13.2	0.2	3.3	0.7	38.8	5.6	94.1	126.1	90.7	17.3	93.3	99.0	46.7	12.4	69.1	79.4	106.2	62.4	134.1	0.3	172.2	92.0	4.1	4.1	4.0	5.6	3.3	5.4	19.2	5.0	11.9	6.7	5.8	5.8	70.7	73.7	24.1	1.0	13.5	39.6	183.9	31.7	19.9	0.2	10.3	18.4	3.3	15.7	28.9	9.2	0.0	59.8	16.6	27.3	0.0	36.0	0.1	75.0	85.5	56.4	9.0	1.7	0.2	74.5	73.6	36.2	18.3	33.3	14.5	17.8	22.5	75.3	32.6	0.0	0.1	4.1	4.1	36.5	19.2	1.0	9.9	58.6	5.4	6.5	78.1	9.9	43.3	0.0	0.1	42.5	9.9	25.6	8.8	19.1	13.3	14.0	78.4	0.3	13.1	45.5	39.4	0.1	0.4	11.5	21.5	34.9	44.9	36.6	11.0	28.3
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	66.6	89.2	3.1	31.8	3.2	8.0	64.6	2.8	4.7	80.4	2.5	100.4	15.0	63.4	11.7	41.2	64.4	22.7	21.4	2.5	4.6	27.3	27.7	89.7	26.2	8.8	5.1	60.5	7.5	27.9	13.8	8.1	5.7	54.6	18.4	0.5	34.6	20.6	53.8	55.4	62.0	31.8	3.7	51.1	46.0	9.0	6.4	9.3	21.1	16.5	15.9	83.8	65.4	4.0	5.4	0.1	0.0	0.0	19.1	12.5	1.9	2.1	17.0	2.1	6.8	0.0	5.0	0.0	20.3	14.0	14.8	0.7	0.0	0.1	1.3	25.9	0.0	0.1	3.1	1.3	2.6	0.5	0.9	14.1	0.0	5.1	0.0	9.3	18.1	0.0	0.3	0.4	7.4	0.0	0.0	4.3	0.0	4.6	0.1	0.0	7.5	0.0	3.7	21.6	0.0	0.2	7.4	1.5	0.1	0.5	0.1	1.0	13.9	2.7	0.1	3.1	1.5	14.0	0.0	0.0	6.9	0.1	0.1	19.1	31.4	10.9	34.4	42.8	43.3	4.7	32.4	32.9	11.6	3.4	24.3	25.4	139.4	26.7	77.8	0.6	79.1	32.5	3.1	3.2	2.8	4.7	2.5	4.6	8.8	5.1	5.7	3.7	6.4	4.0	35.4	25.6	34.3	0.7	21.5	46.5	123.5	24.9	18.2	0.2	56.1	30.4	4.1	27.1	27.1	18.4	0.0	40.2	47.7	41.9	0.0	113.9	35.7	59.6	39.7	60.5	10.2	8.2	0.6	73.2	51.2	41.2	18.3	152.4	47.4	2.5	28.2	30.5	33.2	0.0	1.1	15.7	8.2	84.5	29.4	33.3	4.7	81.1	8.8	14.0	60.6	0.5	110.2	1.5	0.1	73.2	25.9	8.6	17.3	80.3	128.3	12.2	27.5	0.2	19.7	81.9	45.2	1.8	4.6	24.9	61.8	57.7	81.8	33.3	15.3	87.0
GBP3	FLJ10961	ENSG00000117226	"Guanylate binding protein 3"	Q9H0R5	1	89006679-89022894	"Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.2;Pancreatic endocrine cells: 106.7;Proximal enterocytes: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 80.9;BJ hTERT+ SV40 Large T+ RasG12V: 56.3;LHCN-M2: 71.3"									HPA045657	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045657: AB_10961631"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.06e-3)"	8.4	9.2	3.5	10.9	3.8	1.6	12.8	3.3	6.3	7.2	2.9	39.1	78.3	8.9	10.0	6.1	15.3	10.8	5.1	3.3	4.7	13.9	14.9	22.8	14.5	5.4	4.2	8.2	5.9	4.1	4.2	13.8	4.4	10.3	27.4	0.6	11.8	20.2	1.8	7.2	59.8	9.3	4.1	16.1	31.7	2.3	4.1	10.0	9.7	4.2	8.6	27.4	7.7	5.0	26.4	1.6	0.0	0.0	24.5	28.6	4.3	44.4	80.9	41.5	56.3	0.0	2.0	1.9	8.5	40.4	24.0	10.9	0.0	29.5	40.2	0.6	0.0	2.5	4.0	0.5	20.8	9.0	0.1	22.3	5.7	31.1	11.0	28.3	13.9	4.2	0.0	5.8	71.3	0.0	6.5	1.1	0.2	14.3	20.0	2.0	4.8	3.1	41.6	49.1	0.0	0.2	14.0	7.9	0.0	0.8	0.1	2.6	17.2	44.6	3.1	0.4	4.8	7.6	2.6	0.1	0.4	0.2	11.4	0.1	6.0	0.3	11.8	7.0	10.5	3.6	10.5	9.8	6.5	2.8	6.5	9.7	3.1	6.9	13.3	0.4	8.6	5.6	3.5	3.8	3.3	6.3	3.3	4.7	5.4	4.2	4.4	4.1	4.1	5.0	20.7	6.4	18.1	2.9	7.3	6.9	25.7	19.4	6.8	0.1	11.5	7.4	1.4	35.8	24.8	22.0	0.0	7.6	12.4	127.2	13.7	59.4	0.1	46.7	15.0	21.2	9.1	5.7	0.3	61.6	8.2	12.5	27.0	35.0	4.5	5.6	22.5	10.6	5.0	0.0	0.2	34.8	14.2	12.0	5.8	1.5	9.9	18.0	0.0	2.8	21.1	0.7	28.8	0.5	0.1	106.7	71.4	15.4	13.6	17.5	133.3	32.8	69.3	0.2	19.7	3.9	8.0	0.5	0.2	5.9	4.8	2.2	21.8	10.9	28.8	37.2
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.7	3.3	0.4	73.9	0.5	34.9	4.6	0.4	1.7	3.1	1.5	6.9	5.8	2.3	1.4	2.6	3.1	11.5	2.0	0.4	0.5	2.0	11.1	19.1	54.4	2.9	0.7	2.7	1.1	0.7	1.0	2.8	1.2	2.3	8.0	0.2	4.8	1.2	0.7	1.0	9.0	6.1	0.5	42.7	9.2	4.0	0.8	12.4	2.3	0.9	23.3	12.7	1.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	1.2	1.2	0.0	0.1	0.1	6.5	5.3	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.6	3.0	0.3	0.0	0.0	10.0	1.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.6	1.3	0.1	0.0	0.0	4.0	0.1	0.5	0.5	0.0	2.2	20.7	0.5	0.1	0.2	31.5	0.0	0.9	15.3	1.1	97.5	38.0	150.4	4.8	63.1	89.3	6.7	6.0	23.2	35.8	97.9	53.4	44.9	0.7	243.8	38.4	0.4	0.5	0.4	1.7	0.4	0.5	2.9	0.7	1.2	0.5	0.8	0.7	2.1	6.4	5.1	0.0	12.4	0.0	0.2	0.5	0.6	0.0	0.4	0.4	0.7	1.5	4.2	0.0	4.2	0.1	39.2	0.1	0.0	0.0	0.4	3.7	0.4	2.8	0.0	0.8	0.0	1.1	0.0	1.5	2.0	3.9	10.8	0.2	4.6	0.6	4.0	0.0	0.7	0.0	0.0	18.9	1.4	0.2	0.0	17.1	0.0	2.8	10.4	2.9	75.2	0.0	0.0	1.3	0.0	0.0	22.9	0.4	0.0	0.3	8.0	0.4	0.0	0.9	0.9	0.1	2.9	0.9	0.0	0.1	72.9	11.0	0.1	0.1
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364059-89388160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 327.3"	"Cell type enriched"	"Detected in some"	25	"Squamous epithelial cells: 325.0"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 5.4;HaCaT: 11.3"					"Low region specificity"	"Detected in all"			HPA027744	Enhanced					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.3	0.2	0.3	0.2	0.2	0.3	0.4	25.9	0.1	0.0	0.0	0.1	0.1	327.3	0.3	0.2	0.1	0.3	0.2	0.0	0.1	0.3	0.1	0.5	0.2	0.4	0.1	0.0	0.8	0.0	0.5	0.1	0.0	0.1	62.8	0.1	0.2	0.9	0.0	0.0	0.3	0.2	0.3	0.0	0.3	1.1	0.2	0.2	55.0	0.1	32.0	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.3	0.3	0.7	0.2	0.1	0.1	0.6	0.1	0.3	0.3	0.3	0.4	0.3	0.2	0.5	0.2	0.5	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.2	12.5	0.1	0.0	0.0	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.5	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	12.8	0.0	0.0	0.0	1.2	0.0	0.1	325.0	0.0	0.0	0.2	1.2	0.0	1.2
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131742-89176009	"Predicted intracellular proteins"		Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	156	"liver: 100.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 4.7;Hepatic stellate cells: 5.7;Hepatocytes: 16.3;Theca cells: 4.1"	"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051245	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA051245: AB_2681404"	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	100.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	1.3	0.8	0.0	0.8	0.2	0.0	0.0	0.1	0.1	0.6	1.5	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	4.7	0.0	0.0	0.6	0.0	0.1	0.6	0.0	0.2	0.0	0.3	5.7	16.3	0.9	0.0	0.8	0.0	0.0	0.8	0.0	0.1	0.6	0.7	0.0	1.9	0.5	3.0	3.1	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.3	0.6	0.0	0.4	0.0	0.0	0.0	1.1	4.1	0.0	0.7
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 12.9;testis: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Low region specificity"	"Detected in single"			HPA055783	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.7	0.2	0.9	1.1	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC vitamin D binding protein"	P02774	4	71741696-71804041	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 8260.1"	"Group enriched"	"Detected in some"	27	"Cholangiocytes: 1552.8;Hepatocytes: 3017.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.0;RH-30: 3.0;SiHa: 1.8;U-698: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	73000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.6	0.1	0.0	495.5	0.1	0.0	0.0	46.1	8260.1	0.0	0.2	0.1	0.1	0.0	44.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	1.8	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1552.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	39.5	0.5	0.1	0.0	2.0	0.0	37.5	0.1	16.2	0.2	0.0	0.0	0.0	0.0	0.0	58.5	3017.1	0.1	0.0	0.1	0.7	0.0	83.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 325.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 327.4;neutrophil: 864.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 864.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	30.5	13.5	16.4	62.6	23.0	325.7	17.6	20.2	28.8	12.2	11.4	18.0	19.3	9.8	24.6	10.9	16.2	23.0	9.7	15.9	17.7	18.3	15.0	26.5	33.0	25.5	20.7	8.5	16.6	10.4	8.2	25.2	23.6	12.2	19.6	10.6	12.3	9.7	2.7	7.0	18.7	18.8	21.6	70.1	25.1	24.1	19.5	18.4	17.0	14.9	25.4	26.1	5.7	37.3	2.6	4.2	10.7	0.0	2.5	2.2	0.4	4.0	11.1	6.2	11.1	8.7	30.6	3.7	27.0	0.3	14.2	1.6	4.1	12.7	7.7	17.1	16.8	33.5	2.9	17.7	3.0	41.6	9.1	2.8	4.3	5.7	1.2	15.8	0.9	25.9	0.6	12.1	0.5	33.0	0.9	24.2	6.5	22.5	16.4	14.2	2.7	18.5	32.7	18.6	6.9	12.0	5.1	23.3	19.7	12.5	15.8	17.7	0.8	1.6	11.2	17.8	6.2	11.5	23.2	0.6	9.2	15.8	7.7	38.8	132.4	327.4	2.7	78.4	3.5	21.6	4.8	4.8	63.2	21.1	8.1	5.0	864.2	2.5	63.3	17.2	10.2	71.4	16.4	23.0	20.2	28.8	15.9	17.7	25.5	20.7	23.6	21.6	19.5	37.3	28.8	16.0	36.5	10.1	54.5	15.4	28.2	19.6	12.5	10.2	32.6	16.4	4.1	50.1	21.2	33.1	2.1	55.5	17.3	14.4	76.3	49.5	185.0	21.1	9.1	26.4	39.4	36.1	25.9	60.5	20.8	14.4	43.8	24.9	44.9	13.6	48.9	15.0	107.9	11.8	15.4	29.9	32.6	183.3	60.5	32.8	10.8	153.5	16.0	17.8	228.5	21.1	10.3	1.0	98.0	36.5	25.7	6.4	23.4	24.3	18.4	69.7	24.7	4.4	6.6	12.2	18.3	52.6	13.5	15.1	18.2	46.9	16.3	16.7	28.9	21.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580628-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 102.7;Late spermatids: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	6.6	6.6	5.4	7.8	6.3	13.5	9.2	6.4	5.7	7.0	6.2	6.9	6.5	6.1	6.5	7.0	5.9	6.3	4.8	5.2	5.9	6.2	10.6	6.9	8.6	6.3	6.3	8.0	6.9	9.4	4.5	7.5	6.1	7.3	6.2	3.6	8.2	6.7	6.6	7.8	6.5	5.1	6.2	8.3	7.7	11.0	6.1	8.3	7.7	6.7	9.9	7.1	4.7	7.2	15.7	20.8	9.0	19.5	19.7	13.5	12.4	13.4	15.5	13.2	16.5	17.5	10.5	14.4	8.0	12.6	29.7	17.0	13.1	14.7	14.1	20.3	11.9	10.6	11.4	9.2	29.2	18.5	16.9	12.7	39.7	14.1	27.8	12.4	12.6	14.2	17.6	16.1	15.0	15.6	18.0	16.0	18.8	17.2	16.1	12.7	9.8	16.5	11.4	12.0	14.2	20.6	14.4	67.9	27.5	16.1	11.6	13.2	16.4	19.5	6.3	17.0	15.6	43.6	20.6	9.1	19.3	18.6	20.2	5.3	7.1	13.2	7.1	6.9	9.1	6.6	6.4	7.0	6.6	6.3	5.1	5.2	13.1	8.7	8.2	3.8	6.5	8.1	5.4	6.3	6.4	5.7	5.2	5.9	6.3	6.3	6.1	6.2	6.1	7.2	4.8	12.8	7.7	0.0	9.6	10.6	5.0	2.7	12.0	4.1	11.5	6.1	3.6	4.3	3.7	3.7	4.2	7.2	7.3	10.0	5.9	5.1	102.7	4.3	5.5	6.7	7.2	8.2	0.0	6.4	4.6	5.0	8.6	6.8	1.3	5.9	5.0	7.4	5.2	11.8	0.0	8.2	2.0	10.1	8.3	131.7	5.3	7.6	12.4	0.0	6.9	4.9	5.2	0.0	0.0	5.9	6.6	3.8	6.3	5.4	6.0	4.5	2.4	5.9	6.6	5.9	6.5	7.8	4.6	6.3	10.4	10.4	8.8	5.8	5.8	5.4
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891160-12914207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.5;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	16.8	17.8	20.2	11.2	22.4	13.0	15.6	22.1	23.3	10.2	21.8	13.2	11.8	12.6	8.6	14.0	15.2	8.4	29.3	19.2	19.4	24.5	89.1	9.3	16.8	20.7	20.9	16.8	15.5	11.5	10.6	5.4	21.0	13.6	8.5	5.5	20.0	11.5	30.5	10.1	13.0	8.2	19.9	12.8	18.6	4.5	20.9	17.8	11.9	27.1	11.9	14.9	9.9	22.7	22.9	14.1	15.0	27.5	21.4	9.8	13.8	17.2	11.1	21.6	15.7	26.9	10.8	33.0	31.9	10.5	10.8	15.6	20.8	16.4	10.6	28.6	22.8	21.0	24.6	33.1	24.8	43.7	18.8	13.8	19.9	15.3	16.1	8.8	18.1	44.4	51.8	11.4	10.7	28.9	51.7	41.7	16.7	22.0	36.1	48.2	15.3	68.9	12.6	12.1	32.3	18.9	22.8	22.6	16.7	9.6	17.8	29.3	13.3	18.0	12.9	29.9	18.2	59.5	32.2	34.6	11.0	50.7	15.4	13.9	13.9	8.5	18.8	12.1	18.8	18.1	23.2	21.0	24.0	19.5	30.9	23.8	3.1	38.8	9.8	14.7	21.4	20.0	20.2	22.4	22.1	23.3	19.2	19.4	20.7	20.9	21.0	19.9	20.9	22.7	6.0	3.2	5.3	25.5	21.2	7.9	14.5	13.3	11.4	14.2	17.3	10.8	10.0	22.8	8.6	11.0	25.0	16.2	17.2	11.6	52.8	14.0	2.6	7.7	10.0	7.3	15.6	60.4	7.1	11.2	21.5	10.2	12.8	10.9	7.0	19.5	13.6	115.5	21.5	8.4	7.4	13.8	16.2	14.4	5.0	1.8	13.1	9.9	17.8	5.6	20.7	18.6	18.6	14.6	15.1	10.2	9.7	12.8	25.4	11.3	17.4	147.8	7.2	12.3	0.0	13.7	9.8	8.3	7.4	13.4	5.3	16.3	20.9	33.0	20.6	12.1
GCFC2	"C2orf3, DNABF, GCF, TCF9"	ENSG00000005436	"GC-rich sequence DNA-binding factor 2"	P16383	2	75652000-75710985	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077882	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA077882: AB_2686864"	"unprognostic (1.98e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (5.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.07e-2)"	10.7	10.5	13.8	4.2	16.3	7.4	12.1	14.4	17.3	19.2	9.7	9.7	3.7	11.1	11.4	9.6	13.7	4.7	11.3	12.2	14.4	19.0	28.5	7.8	8.8	13.7	14.5	14.3	14.1	7.5	11.2	6.9	13.9	14.0	3.8	11.7	7.8	5.5	29.1	15.8	8.1	6.3	15.1	12.3	9.4	12.0	14.4	7.6	12.1	9.1	6.5	9.0	10.4	17.3	14.4	13.9	9.8	11.6	5.3	6.7	12.7	9.5	7.7	9.7	9.2	16.7	10.3	14.2	13.4	6.5	11.9	5.5	11.9	6.5	13.0	20.9	25.5	10.9	13.6	44.9	8.3	18.8	10.2	7.2	8.2	4.8	14.5	11.0	11.6	17.6	16.5	8.2	9.3	11.3	19.6	31.8	15.5	10.5	15.3	22.8	20.1	34.6	16.3	15.7	18.0	22.6	12.8	14.5	16.2	6.9	10.8	10.6	12.6	9.3	12.2	13.4	19.3	9.5	17.7	10.8	9.2	11.7	20.7	0.6	8.1	3.8	10.4	5.7	11.9	18.2	9.7	12.1	9.4	12.6	14.3	13.2	0.4	5.4	9.6	13.3	11.5	8.9	13.8	16.3	14.4	17.3	12.2	14.4	13.7	14.5	13.9	15.1	14.4	17.3	11.6	16.0	11.2	49.6	15.7	27.8	20.5	14.0	21.6	11.2	14.4	13.5	22.4	17.2	20.2	12.9	0.0	36.7	14.8	7.3	21.5	16.0	31.5	11.4	18.0	15.0	16.2	12.0	60.8	19.0	23.5	21.9	8.2	8.7	13.9	15.6	13.2	24.9	12.5	16.8	51.7	7.5	8.2	13.9	12.0	75.4	16.8	8.8	14.2	20.6	7.1	10.6	16.5	75.9	75.9	13.8	7.8	9.8	11.3	18.0	6.2	19.3	15.1	9.1	13.1	20.2	13.5	15.5	22.7	16.5	24.7	23.7	13.3	17.4	10.6	16.8
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142882-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 1943.6"	"Cell type enriched"	"Detected in some"	23	"Enteroendocrine cells: 5457.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Region enriched"	"Detected in single"	55	"medulla oblongata: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.5"	"Region enriched"	"Detected in some"	5	"spinal cord: 13.7"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000	420000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				20.3	0.1	0.0	3.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	84.4	3.4	0.6	0.0	5.3	0.0	4.1	2.5	0.0	0.0	41.9	0.0	0.2	3.5	6.2	0.0	0.1	1943.6	0.0	0.0	0.1	0.1	0.8	151.9	0.0	0.3	0.0	0.0	37.2	130.2	0.8	0.0	0.2	41.2	0.0	0.0	0.4	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	186.8	0.2	12.1	0.0	5.6	44.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.2	0.0	0.0	0.3	0.1	5457.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	230.9	8.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.9	0.0
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 136.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.8	7.1	0.8	0.2	1.3	0.9	0.6	4.7	1.6	0.5	1.4	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.0	1.3	0.5	136.4	0.2	0.6	1.7	1.2	5.8	1.8	0.2	0.4	0.2	1.6	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.3	1.6	6.5	2.7	1.1	0.2	0.1	0.1	0.3	0.3	0.4	1.4	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.8	1.3	4.7	1.6	1.0	1.3	1.7	1.2	1.6	0.3	1.1	1.4	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing transcription factor 1"	Q9NP62	6	53126961-53148841	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 20.2"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 230.3;Syncytiotrophoblasts: 266.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"BEWO: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA011343: AB_2668489, HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.1	0.1	0.4	0.1	0.2	0.4	0.1	0.3	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.3	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	20.2	0.2	0.0	0.0	0.4	0.1	0.0	3.6	0.1	0.1	0.0	0.0	0.4	0.1	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.2	0.0	0.0	39.2	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.0	8.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.3	2.0	0.4	0.0	0.4	0.0	0.0	0.1	0.2	230.3	0.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	266.1	0.1	0.0	0.0	0.1
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1 activator of EIF2AK4"	Q92616	12	120127202-120194715	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	17.2	16.5	9.5	16.0	11.6	19.1	16.9	10.3	10.1	17.1	12.7	18.7	12.1	20.0	9.5	22.3	17.3	9.5	16.1	8.9	9.4	16.2	17.8	16.0	18.3	11.6	10.6	20.2	22.9	18.0	21.1	16.5	10.0	15.8	12.4	8.8	18.2	12.7	44.4	22.0	18.1	14.7	9.2	20.5	20.5	17.9	11.8	18.3	19.7	22.9	16.3	18.6	16.4	13.4	51.4	99.3	35.1	39.7	54.4	32.7	122.4	44.9	38.9	45.8	37.2	85.6	34.5	67.8	49.6	64.8	29.0	49.5	82.1	63.5	28.4	45.5	66.9	84.0	65.5	59.8	35.2	78.2	51.5	40.3	36.3	54.3	50.9	40.2	42.5	30.3	100.3	17.0	38.8	51.6	49.7	59.1	62.3	48.8	59.9	59.7	36.0	67.3	31.2	172.8	57.4	57.4	73.8	31.7	26.5	33.1	67.5	43.8	58.6	37.3	41.0	24.7	47.0	66.2	65.4	67.1	35.7	40.5	38.2	0.7	1.8	1.3	3.3	1.7	4.1	2.0	2.6	2.7	2.3	2.1	1.9	2.1	0.0	1.8	4.1	2.7	2.6	1.9	9.5	11.6	10.3	10.1	8.9	9.4	11.6	10.6	10.0	9.2	11.8	13.4	12.0	9.6	17.9	0.0	11.2	0.0	6.8	0.0	9.6	14.1	11.9	13.6	0.0	12.8	9.3	22.0	10.4	14.2	12.0	8.1	1.9	15.6	1.9	9.0	14.1	10.5	3.6	16.2	0.0	15.9	38.2	10.5	25.5	14.9	5.1	25.7	10.4	24.6	11.2	16.8	0.0	11.4	0.0	9.1	0.0	3.5	14.3	8.9	0.0	0.0	11.1	9.0	7.2	0.0	0.0	18.6	8.6	12.8	17.7	15.7	11.1	9.1	2.9	12.1	6.6	16.4	8.9	8.8	20.8	14.1	0.0	14.6	10.1	14.3	11.7	15.8
GCNA	"ACRC, NAAR1"	ENSG00000147174	"Germ cell nuclear acidic peptidase"	Q96QF7	X	71578411-71613583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 6.9;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 7.0;Plasma cells: 3.3;T-cells: 4.7;Theca cells: 4.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA023476, HPA030870"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA023476: AB_1844530, HPA030870: "	"unprognostic (6.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.07e-10)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.15e-5)"	1.9	4.6	4.1	1.3	4.5	1.3	1.4	5.1	8.1	2.0	3.7	1.5	0.8	1.3	0.9	1.3	1.5	0.7	1.9	4.5	4.7	2.2	2.6	2.4	1.9	4.8	3.8	1.8	2.5	0.2	2.0	0.4	4.4	1.8	0.7	2.2	1.3	0.4	4.2	1.4	2.4	0.7	3.4	4.9	1.8	11.0	4.1	1.1	2.2	1.2	1.0	1.5	1.7	4.8	0.3	0.5	1.1	1.0	2.2	2.0	0.6	1.8	1.0	0.6	1.0	1.0	0.7	2.9	1.4	1.0	0.6	1.4	2.2	0.1	0.9	0.5	1.5	0.6	2.8	0.3	0.6	0.5	2.6	0.8	3.5	0.5	0.5	2.3	0.4	2.2	0.8	1.8	1.3	0.3	0.2	2.1	1.1	1.3	1.3	0.5	0.0	2.1	1.4	0.8	0.6	0.1	0.6	0.3	1.6	1.1	0.2	1.8	0.7	0.7	1.3	0.9	0.5	0.5	1.4	1.1	1.2	1.1	1.1	0.2	0.1	0.0	0.1	0.1	0.3	0.3	0.4	0.8	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.1	0.8	0.1	4.1	4.5	5.1	8.1	4.5	4.7	4.8	3.8	4.4	3.4	4.1	4.8	1.8	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	3.7	0.0	0.0	6.9	0.0	0.0	0.8	0.0	2.9	1.5	0.5	0.0	0.0	0.0	1.0	0.1	0.9	0.0	7.0	2.5	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	4.7	4.0	0.0	0.0
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1"	Q02742	9	76419850-76651203	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 49.9;parathyroid gland: 84.1;stomach 1: 39.0;thyroid gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 93.8;Kupffer cells: 42.2;Proximal enterocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;HSkMC: 39.4;U-2197: 33.9"	"Group enriched"	"Detected in all"	6	"cerebellum: 7.6;olfactory bulb: 24.9"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	4.0	0.8	1.8	5.0	2.2	5.1	4.6	4.8	1.7	10.6	1.3	8.7	49.9	5.9	0.7	1.8	1.5	2.9	1.2	2.0	0.9	0.9	1.9	4.2	6.7	1.0	1.0	0.7	2.1	84.1	0.9	2.9	1.0	6.3	9.3	0.1	3.8	1.3	0.3	1.1	32.3	4.8	1.0	7.3	39.0	1.6	1.5	3.0	21.5	0.7	4.7	2.2	0.8	1.4	4.7	0.4	0.3	0.1	5.5	26.5	6.7	18.8	8.4	15.0	10.5	4.7	1.1	3.3	1.8	14.1	2.9	4.0	9.5	7.8	16.6	2.3	1.6	8.2	0.4	0.8	46.2	6.0	2.7	39.4	2.0	14.5	15.5	12.2	13.9	4.1	0.0	3.2	15.1	7.1	3.2	9.7	8.8	11.9	1.1	5.3	9.3	1.6	17.5	8.3	2.0	0.0	2.3	2.5	0.1	6.6	0.0	4.1	5.6	9.3	5.9	33.9	8.4	4.7	0.9	0.0	18.7	10.1	2.3	6.1	3.2	21.6	1.5	7.8	0.5	1.9	1.7	1.5	5.8	10.2	0.3	1.1	1.1	5.8	7.3	2.8	2.5	2.1	1.8	2.2	4.8	1.7	2.0	0.9	1.0	1.0	1.0	1.0	1.5	1.4	2.9	0.0	1.7	2.0	8.3	0.9	5.0	34.4	0.6	0.0	8.8	4.2	1.0	0.0	15.6	3.7	0.0	2.1	10.7	16.6	0.0	1.0	20.1	15.1	4.2	5.1	27.6	17.9	11.8	24.3	27.1	3.4	93.8	24.6	10.8	0.6	6.4	0.3	8.1	0.0	1.7	21.3	16.2	42.2	8.5	12.9	0.0	18.6	1.8	15.0	6.7	0.1	8.2	0.5	0.8	12.9	14.5	1.2	2.2	6.8	40.7	1.4	17.0	0.4	0.0	0.9	1.8	1.8	3.3	1.0	0.3	19.0	10.6	0.2	38.4	1.5
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.2	0.7	0.2	11.9	0.2	0.5	0.4	0.6	0.4	19.2	0.2	142.9	97.5	2.0	0.0	15.8	4.2	75.5	0.1	0.2	0.1	17.9	0.4	0.7	0.9	0.1	0.4	0.1	2.1	0.9	0.1	0.1	0.2	1.2	123.2	0.1	55.8	0.3	0.2	0.3	123.3	4.6	0.0	0.1	25.8	4.3	0.2	1.3	2.1	0.0	10.6	9.1	29.9	0.4	0.1	147.4	0.0	0.2	0.0	1.0	0.2	0.1	7.7	0.0	0.0	6.3	6.0	0.6	24.6	0.0	9.5	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.5	30.3	0.0	0.2	0.2	0.3	3.5	0.7	0.0	0.1	0.0	0.2	0.0	0.4	1.4	0.6	0.1	0.2	0.2	75.9	0.3	0.4	0.0	0.6	10.2	1.2	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.2	0.4	7.3	0.1	0.2	0.5	0.8	8.9	0.3	0.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.1	0.0	0.2	0.2	0.6	0.4	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.0	0.0	2.2	0.0	1.0	0.0	18.3	8.9	0.0	0.0	0.5	0.0	0.7	11.5	40.5	104.8	0.0	0.0	0.1	360.1	0.0	92.6	9.8	23.3	8.6	0.3	7.8	0.0	0.0	14.9	0.0	0.2	27.5	75.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	26.9	8.2	0.6	0.0	19.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.4	163.2	0.0	0.1	8.0	85.5	4.4	9.8	0.0	6.6	0.6	1.5	3.0	0.3	1.4	0.0	0.0	0.8	0.0	48.5	52.4
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 4.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.0	0.1	0.1	0.3	0.2	4.4	0.0	0.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.9	0.0	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 20.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 4.1;Granulosa cells: 5.7;Paneth cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.4;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 49.0;RT4: 19.1;TIME: 20.4"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	5.2	9.1	0.4	2.0	0.7	3.0	2.4	3.9	0.3	1.8	0.0	3.8	5.9	3.1	0.1	14.8	0.8	2.1	20.1	0.2	1.7	1.5	0.6	7.0	2.0	3.3	0.7	2.3	9.1	0.4	0.0	10.3	3.5	2.9	3.6	0.9	3.7	2.4	6.4	5.7	7.2	2.5	0.0	3.4	7.0	2.1	1.2	0.5	0.7	1.1	4.7	9.9	0.6	0.2	6.3	1.3	0.1	5.8	0.3	0.0	1.4	0.8	5.1	1.6	1.7	4.0	5.6	0.0	0.7	0.0	5.0	3.4	0.0	4.2	1.6	0.0	0.2	49.0	1.4	0.2	0.0	0.1	0.1	0.2	2.2	0.4	11.7	0.2	6.3	0.1	2.4	0.1	0.3	1.1	0.0	0.0	0.1	12.0	0.6	0.0	10.7	0.0	0.0	19.1	0.0	1.9	1.2	2.7	0.0	0.7	5.3	0.2	20.4	0.4	3.1	0.4	0.3	0.2	0.0	0.0	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.2	1.4	1.4	0.0	0.1	0.0	0.7	0.0	0.1	2.1	0.4	0.7	3.9	0.3	0.2	1.7	3.3	0.7	3.5	0.0	1.2	0.2	2.7	3.2	0.5	0.3	0.4	0.0	0.3	0.0	1.8	0.0	0.5	0.3	3.9	0.0	0.6	0.0	0.0	0.1	0.0	1.7	0.0	1.8	0.2	0.4	1.0	1.8	0.0	0.0	0.2	1.1	0.1	0.2	4.1	1.4	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.1	0.4	0.0	0.3	1.8	0.0	0.7	0.0	0.0	0.5	0.0	1.6	4.8	1.5	0.0	0.4	1.4	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.1	0.6	0.1	0.1	0.0	1.1	0.5	0.9
GCSAM	"GCET2, HGAL, MGC40441"	ENSG00000174500	"Germinal center associated signaling and motility"	Q8N6F7	3	112120839-112133270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 29.3;skin 1: 16.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.9;dendritic cells: 6.7;Langerhans cells: 5.3;monocytes: 23.3;T-cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Daudi: 132.8;U-698: 76.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA002473	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA002473: AB_1078960"	"unprognostic (8.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.17e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.38e-2)"	0.5	0.2	0.0	6.4	0.1	1.7	0.6	0.0	0.1	0.3	0.2	1.9	2.1	0.2	0.2	1.8	0.4	1.5	0.9	0.1	0.1	1.2	0.5	2.2	22.2	0.0	0.1	0.1	4.0	0.0	0.7	0.3	0.0	0.9	0.9	0.0	1.3	0.3	0.2	16.4	3.5	0.3	0.0	5.0	2.8	0.4	0.0	17.7	3.3	0.1	29.3	1.3	1.0	0.0	1.9	0.3	0.5	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	3.6	0.2	132.8	0.1	0.0	0.8	3.5	0.0	2.4	0.0	2.7	0.8	0.9	0.8	0.6	0.0	0.6	0.0	0.0	2.4	0.0	0.2	0.8	0.0	1.0	0.2	7.5	0.0	0.1	12.6	0.0	1.0	0.7	0.7	14.6	1.1	0.0	0.0	1.3	0.1	0.2	0.8	0.7	0.3	0.9	1.8	0.0	1.0	1.2	0.6	0.0	0.0	0.7	0.0	76.4	0.2	0.2	0.3	9.0	0.0	0.0	2.2	0.1	0.5	10.2	11.3	5.8	6.7	12.1	10.4	5.7	0.4	0.6	0.0	3.7	1.9	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	10.9	0.1	0.8	0.3	0.0	0.0	0.1	1.8	0.4	0.0	0.2	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.5	1.2	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	1.6	5.3	0.0	0.0	1.6	0.0	0.0	23.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	3.2	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.0	2.0	0.4	0.1	9.6	0.0	0.0	0.7
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.4"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.5	0.2	0.4	0.8	0.4	1.8	1.0	6.4	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.1	0.3	0.4	0.3	0.1	0.4	0.1	0.0	0.3	1.2	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	0.9	3.4	0.4	0.7	0.3	0.7	0.2	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	6.4	0.7	0.3	0.4	0.4	0.3	1.2	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081945-81096395	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 553.4;Extravillous trophoblasts: 1476.4;Proximal tubular cells: 655.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	28.7	20.1	58.9	6.9	66.5	6.3	24.2	62.9	113.8	18.2	50.8	16.0	7.2	17.5	68.9	15.5	19.8	11.7	38.1	55.8	60.9	78.2	118.9	10.8	6.7	60.1	66.0	18.4	19.7	31.0	14.3	26.0	61.1	18.7	13.0	15.6	15.6	16.7	59.3	10.1	9.5	11.8	61.7	6.3	17.5	7.4	63.7	10.4	96.4	63.6	9.3	18.3	15.2	67.8	63.6	28.3	82.4	37.0	40.4	30.9	175.5	35.9	26.4	43.3	20.6	37.0	57.2	17.2	32.3	15.9	31.9	33.3	64.5	36.5	71.6	4.7	86.7	21.8	34.9	114.6	45.7	70.3	24.1	32.0	47.8	26.8	53.7	13.0	22.3	45.1	86.3	3.4	42.9	67.7	45.9	138.8	113.0	49.6	57.5	72.7	44.1	25.5	98.4	56.4	43.7	45.3	53.3	32.9	70.8	63.9	48.3	33.2	19.8	27.6	49.3	44.0	37.8	14.7	31.8	102.1	18.2	41.3	22.6	3.6	1.3	1.3	2.8	2.1	4.6	3.5	2.6	4.0	3.9	2.5	4.4	5.9	1.7	7.0	1.7	10.8	2.2	2.4	58.9	66.5	62.9	113.8	55.8	60.9	60.1	66.0	61.1	61.7	63.7	67.8	31.1	3.2	5.9	16.3	24.8	29.1	94.6	73.6	52.3	43.7	97.9	115.6	12.9	44.3	31.4	80.9	37.5	553.4	13.8	15.3	295.4	70.0	32.4	34.8	128.3	31.9	26.4	71.1	12.6	42.5	1476.4	61.6	31.1	55.2	36.3	38.5	33.2	352.0	118.8	38.7	11.9	34.3	67.1	19.7	34.6	19.5	140.8	18.8	85.4	4.7	17.7	215.8	19.6	19.6	35.2	42.3	17.8	141.1	51.7	123.9	13.7	655.9	20.0	45.7	32.9	46.2	50.2	20.7	77.3	78.4	27.1	228.8	16.3	114.5	49.4	69.8
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74320613-74518007	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.7	9.6	19.0	3.3	22.5	1.2	4.0	15.2	26.0	2.9	4.9	2.5	2.4	3.9	1.9	4.0	2.8	2.5	2.1	25.3	19.7	4.2	1.5	2.4	3.3	14.5	17.0	6.0	7.4	12.4	20.6	1.2	18.1	4.1	2.4	19.0	2.4	4.1	2.7	1.7	2.3	2.8	12.2	1.9	2.0	4.7	16.7	4.5	6.6	3.1	2.8	3.9	2.6	20.5	3.5	16.8	17.7	4.8	1.2	1.6	1.5	1.8	8.2	8.3	9.5	7.8	5.0	14.8	2.5	1.2	10.6	6.6	12.4	7.0	16.2	19.7	3.6	7.4	8.9	14.0	0.7	7.6	15.8	4.7	2.3	5.3	8.2	0.9	1.1	7.3	3.4	0.3	4.8	5.7	12.6	0.4	20.1	24.5	17.9	8.7	9.2	3.2	2.9	15.3	18.2	38.9	13.1	3.4	9.7	4.9	14.9	2.6	0.0	11.7	6.2	2.9	5.5	9.3	15.7	6.8	7.3	0.3	13.8	0.5	0.9	1.0	0.8	3.1	1.0	1.4	0.8	1.3	0.8	1.3	0.6	0.6	1.8	0.7	5.5	0.2	4.0	0.8	19.0	22.5	15.2	26.0	25.3	19.7	14.5	17.0	18.1	12.2	16.7	20.5	6.4	6.4	5.1	27.1	5.9	1.8	7.4	4.2	6.2	46.9	6.2	6.1	5.9	5.7	3.6	3.7	47.9	0.4	3.9	2.1	9.8	5.2	5.4	15.4	7.0	6.7	20.4	2.1	75.7	5.8	0.3	4.8	3.1	2.8	17.2	2.1	6.4	1.8	4.7	47.1	67.3	1.7	12.2	6.3	2.5	1.3	4.1	4.6	1.8	15.0	2.9	23.5	4.1	67.8	41.9	3.7	1.4	5.7	2.6	2.6	3.6	6.6	4.9	47.7	0.0	8.0	5.5	14.7	13.1	3.7	1.3	0.0	3.1	6.5	1.7	3.8
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 30.7;pituitary gland: 17.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.4;Early spermatids: 9.8;Excitatory neurons: 20.9;Horizontal cells: 15.2;Inhibitory neurons: 23.4;Late spermatids: 30.4;Oligodendrocyte precursor cells: 10.1"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 12.5;SCLC-21H: 32.3;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA054182: , HPA063265: AB_2684972"	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	0.1	2.2	21.6	0.2	27.0	0.1	0.1	14.2	30.7	1.1	0.1	0.6	0.0	0.6	0.0	0.0	0.2	0.0	1.6	26.6	15.4	0.1	0.1	0.0	0.0	17.0	10.5	2.7	0.5	0.9	17.7	0.0	15.8	0.2	0.0	5.7	0.0	0.0	0.0	0.3	0.3	0.1	6.2	0.0	0.7	3.5	14.0	0.0	0.2	0.0	0.0	0.1	0.3	21.2	0.0	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	14.8	0.0	0.1	1.5	0.2	0.0	3.9	0.1	1.1	0.7	0.3	0.0	0.0	0.2	0.8	1.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	27.0	14.2	30.7	26.6	15.4	17.0	10.5	15.8	6.2	14.0	21.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.1	0.2	0.0	0.0	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	23.4	0.4	0.0	0.0	0.0	30.4	0.6	0.0	0.0	6.5	0.0	1.1	0.0	10.1	3.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929621	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	3.0	2.4	2.3	3.2	2.1	8.0	3.2	3.6	2.7	3.4	3.4	3.8	4.0	2.8	4.0	3.1	2.4	3.2	2.5	2.0	2.3	4.8	5.1	3.4	3.6	2.1	2.6	2.4	4.5	4.9	2.3	4.1	2.4	3.4	4.4	2.9	3.0	3.3	1.8	2.9	4.7	3.0	2.4	4.2	4.4	4.8	2.7	4.1	4.6	2.1	4.4	4.5	3.1	2.9	9.2	5.1	6.1	5.1	6.5	3.1	9.0	5.2	6.8	10.3	9.9	5.4	6.2	3.6	6.2	7.1	7.8	5.3	8.1	6.8	12.6	7.2	4.7	5.4	6.7	5.9	7.7	6.8	6.6	2.5	8.5	12.9	9.9	4.7	6.9	8.1	5.7	7.6	8.6	9.6	6.0	5.5	10.6	6.9	8.8	3.2	16.7	5.3	5.8	9.1	4.6	5.1	6.3	10.7	8.2	18.3	3.7	6.8	4.3	7.3	8.5	8.5	7.1	7.9	6.1	5.1	9.4	4.8	9.1	11.4	6.7	12.6	2.4	7.2	3.8	2.3	2.7	2.9	6.5	2.2	2.4	2.3	6.5	4.1	7.6	1.5	3.6	3.2	2.3	2.1	3.6	2.7	2.0	2.3	2.1	2.6	2.4	2.4	2.7	2.9	9.2	9.6	8.6	27.7	13.5	13.5	6.5	8.1	8.6	13.1	8.1	5.5	7.8	8.6	10.8	3.7	18.8	12.4	11.6	13.4	7.9	10.6	21.2	12.8	9.0	7.6	4.2	13.9	36.7	6.2	11.4	7.7	18.3	11.5	0.0	10.4	6.4	9.0	13.8	15.2	39.1	14.0	14.2	17.2	15.8	5.7	5.9	20.0	10.6	34.7	16.2	9.2	8.2	31.7	35.8	10.7	7.5	7.2	21.0	9.8	17.8	10.2	10.5	13.7	0.0	8.6	10.2	28.4	14.5	14.3	13.8	21.1	13.8	6.7	8.3	9.6
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300197-47313577	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.6;retina: 18.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	12.4	3.2	5.4	0.3	5.4	0.0	9.7	5.1	4.0	2.6	0.6	2.5	0.0	4.2	0.2	2.4	1.6	2.2	4.4	5.9	3.3	0.1	0.1	19.6	0.8	2.6	5.8	0.3	13.3	0.0	0.7	0.0	1.4	2.2	0.3	18.4	8.8	0.2	2.2	3.1	0.6	0.4	2.5	0.1	1.8	7.1	5.5	0.4	9.7	10.4	1.0	1.3	1.7	3.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.4	5.1	4.0	5.9	3.3	2.6	5.8	1.4	2.5	5.5	3.7	2.4	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.0	20.9	0.1	0.0	0.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.2	25.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	2.6	0.7	0.9	0.2	1.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.6	1.6	0.4	1.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0
GDF11	"BMP-11, BMP11"	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743122-55757264	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 76.6;Cone photoreceptor cells: 77.2;Horizontal cells: 57.2;Rod photoreceptor cells: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 127.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	340000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	3.6	4.0	22.5	3.7	17.5	1.8	2.3	16.4	17.8	6.8	15.9	5.4	1.6	7.6	2.0	2.4	5.0	4.6	7.5	18.1	18.5	3.0	1.3	3.6	2.8	22.0	26.6	5.7	2.9	2.9	4.7	2.0	20.9	6.0	1.6	21.6	4.8	9.4	1.8	1.5	3.7	4.6	18.3	5.6	2.7	1.1	22.3	4.6	3.6	2.0	1.8	5.9	3.4	17.7	4.9	7.6	32.8	18.6	24.4	17.8	8.2	10.1	9.5	12.5	10.7	26.0	2.1	9.5	13.0	10.5	5.9	4.6	25.0	18.0	4.3	18.2	22.7	11.7	12.3	4.1	4.9	9.8	127.7	17.2	1.0	18.3	5.2	14.0	16.4	12.7	13.2	30.1	16.0	9.2	16.0	8.5	26.4	0.3	18.9	25.1	8.9	5.9	7.7	6.6	22.2	13.6	6.2	2.8	2.6	13.3	10.7	10.7	10.1	15.0	22.9	11.9	7.4	8.1	2.6	4.9	8.0	9.7	10.8	0.2	0.2	0.5	1.2	0.1	1.0	0.7	0.7	0.7	0.2	0.7	0.6	0.8	0.3	0.2	0.4	0.7	0.5	0.1	22.5	17.5	16.4	17.8	18.1	18.5	22.0	26.6	20.9	18.3	22.3	17.7	8.4	0.0	1.1	19.2	10.9	0.5	9.8	0.6	4.0	76.6	6.3	6.6	25.6	1.5	0.9	0.0	77.2	3.6	16.6	1.5	0.0	5.0	0.6	9.9	35.2	8.0	10.7	11.1	4.3	1.4	5.3	13.3	3.1	18.0	5.7	7.6	6.4	0.2	1.6	57.2	10.8	1.9	0.0	1.9	0.7	0.8	9.0	4.4	3.6	1.9	4.1	30.6	22.6	17.1	3.2	3.3	4.1	5.7	4.1	9.8	3.4	0.5	0.1	53.1	13.1	31.1	18.1	2.9	4.1	3.0	0.9	4.7	18.9	7.2	2.2	6.2
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 371.8;urinary bladder: 175.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	960000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	34.8	11.7	1.3	1.5	1.4	0.4	24.9	1.0	2.3	18.9	40.9	29.2	4.5	13.6	2.2	4.8	5.5	19.9	4.5	4.3	1.3	371.8	88.6	46.9	0.6	2.0	1.7	4.7	112.3	25.9	12.3	86.9	1.5	105.3	24.4	1.2	12.5	4.6	5.5	6.4	12.3	1.9	1.2	11.4	75.5	1.6	2.5	0.3	11.2	0.5	1.7	175.4	19.2	1.6	1.8	95.6	9.4	3.5	22.3	18.5	416.5	33.1	17.9	1.2	18.8	4.2	29.6	0.4	58.8	3.0	97.0	0.7	0.0	12.2	4.7	0.2	2.2	0.9	9.2	225.5	564.9	0.1	35.7	48.8	140.1	90.7	58.6	0.7	99.5	0.0	152.4	0.7	22.9	23.5	0.1	0.8	5.4	34.4	52.5	0.2	3.7	0.2	69.9	94.6	0.9	1.0	0.4	5.5	127.9	35.1	2.6	0.4	213.1	0.0	7.4	1.8	1.5	1.5	4.0	0.4	51.9	0.1	27.8	0.0	0.7	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.1	1.3	1.4	1.0	2.3	4.3	1.3	2.0	1.7	1.5	1.2	2.5	1.6	6.6	35.3	62.4	0.0	1.8	1.3	350.6	366.1	0.0	0.1	54.2	15.5	0.7	47.1	1160.8	259.3	0.0	60.6	0.4	176.0	33.2	316.9	0.0	166.8	35.4	31.9	84.8	0.0	0.1	381.9	263.4	52.9	224.8	261.8	29.2	0.2	2.5	7.0	33.8	0.0	0.1	357.6	453.7	1.6	3.7	0.0	0.9	14.1	3.6	0.0	9.9	0.5	1.0	0.0	0.0	440.4	146.6	1.5	1.3	780.2	22.9	85.7	681.4	0.6	0.0	9.5	46.7	0.7	0.5	1.3	1.7	4304.7	5.5	3.4	291.0	3294.2
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322454-47327588	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Angiogenesis	"Cytokine, Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"liver: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	NA	NA	2210000	740000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB023357: AB_2111086"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689784-7695775	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 2.9"	"Cell type enriched"	"Detected in some"	25	"Granulosa cells: 30.2"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 452.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"			"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	2.9	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	452.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	77.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.2;Basal prostatic cells: 1.0;granulocytes: 1.3"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.6;BJ hTERT+: 5.4;GAMG: 9.4;HHSteC: 5.8;HSkMC: 14.4;U-87 MG: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA015648	Uncertain				"Secreted to blood"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	0.9	0.1	0.1	0.0	0.4	0.0	0.6	0.1	0.3	0.3	0.3	1.6	0.0	0.4	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.3	0.0	2.3	0.0	0.2	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.9	0.1	0.0	9.9	1.2	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.6	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.3	17.6	0.1	2.8	5.4	0.4	1.0	0.0	0.0	0.0	0.0	4.5	9.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	14.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.4	0.2	0.1	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	1.3	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.8	0.2	0.0	0.7	0.3	1.4	0.4	0.4	0.5	2.4	2.8	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.4	0.1	0.7	0.1	0.1	10.9	1.0	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.9	1.1	0.4	0.0	0.6	0.6	0.8	0.1	0.6	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.8	0.3	0.4	0.8	0.4	1.0	0.4	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.3	0.2	1.5	0.3	0.8	1.3	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.3	1.4	1.4	0.6	0.3	0.5	1.2	1.4	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.0	0.4	0.2	1.4	0.4	1.0	8.9	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.4	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.3	2.0	1.3	1.4	1.2	1.4	1.4	1.4	1.3	1.4	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Cytosol		NA	NA		31000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	77.3	85.9	351.5	54.9	381.7	41.2	67.4	309.6	438.5	99.7	214.0	91.8	36.7	92.2	46.2	57.5	94.6	47.3	99.1	391.8	349.9	74.4	53.9	90.1	53.9	344.5	312.7	120.0	54.7	63.4	176.0	60.4	349.5	74.9	41.7	130.9	49.7	69.5	62.9	61.6	67.5	78.9	311.4	89.4	68.5	54.1	330.6	58.7	63.0	70.8	51.1	89.2	81.2	366.2	100.2	88.9	195.9	164.6	77.7	91.4	64.5	149.6	91.1	140.4	146.0	52.6	51.1	79.5	149.3	139.4	213.2	79.7	172.7	83.9	96.5	147.5	93.8	25.0	142.6	35.5	113.5	24.6	90.5	94.7	101.3	163.4	99.6	154.6	92.4	95.7	31.1	120.5	169.4	99.2	77.9	62.1	53.0	106.1	168.8	77.6	51.6	45.0	98.8	46.5	272.5	210.3	67.6	86.1	109.0	150.3	50.9	42.5	110.4	131.9	116.8	138.4	212.0	182.1	202.0	128.3	140.7	54.5	162.5	23.7	8.4	26.9	12.1	12.6	18.0	9.9	13.0	12.0	7.0	10.1	10.0	10.1	30.0	8.7	21.3	12.1	16.2	7.3	351.5	381.7	309.6	438.5	391.8	349.9	344.5	312.7	349.5	311.4	330.6	366.2	39.3	16.0	27.4	30.3	35.9	27.1	24.8	48.3	33.6	71.3	24.1	25.7	62.6	24.3	29.0	27.6	25.0	22.7	27.0	31.4	31.3	39.4	2.9	33.1	41.1	35.3	90.8	9.2	48.8	31.3	39.3	37.5	37.8	34.3	33.7	29.7	30.4	17.7	36.3	60.6	43.2	24.8	65.1	35.9	40.9	6.0	37.6	35.5	17.8	22.5	59.0	37.7	19.6	33.2	46.4	50.2	25.9	39.9	35.7	27.4	24.3	25.5	46.8	37.1	52.6	29.5	49.8	33.9	66.6	20.7	30.3	49.5	43.2	22.0	15.0	26.2
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported		Approved	Cytosol		NA	NA		53000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA049290: AB_2680700, HPA057668: AB_2683498"	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	125.1	111.5	62.4	151.6	70.0	126.6	138.1	76.0	90.3	120.6	66.8	152.9	175.4	96.3	115.3	131.1	96.8	112.6	86.8	59.3	70.7	146.0	241.1	98.3	217.5	85.8	72.7	116.9	165.1	91.3	59.6	135.5	82.6	88.8	160.7	69.1	97.7	92.2	107.0	107.6	160.2	124.1	80.9	138.7	108.6	74.3	65.1	149.1	114.1	99.7	239.2	145.5	81.7	95.4	343.4	245.8	341.1	241.2	298.2	347.5	191.4	325.0	170.8	287.3	312.0	351.8	287.3	553.2	198.2	340.5	88.1	320.8	368.3	289.3	288.0	212.2	174.7	380.0	152.0	428.4	276.9	252.1	230.7	292.6	235.8	249.6	148.9	324.0	400.6	340.1	398.5	203.4	331.6	291.1	390.9	208.0	242.5	355.1	159.3	466.7	181.9	389.8	330.7	250.1	138.0	210.0	257.5	468.5	358.3	289.9	382.3	299.0	342.0	142.3	243.4	420.3	282.2	180.0	314.8	526.5	212.0	275.5	130.0	154.9	280.8	169.0	109.9	347.8	136.4	210.7	136.9	121.6	329.1	204.2	124.8	119.3	138.4	177.5	445.1	146.1	181.5	416.8	62.4	70.0	76.0	90.3	59.3	70.7	85.8	72.7	82.6	80.9	65.1	95.4	101.5	25.6	83.8	31.0	208.1	161.7	131.3	144.8	145.7	37.1	124.5	81.8	76.6	107.2	109.0	57.0	18.8	252.1	148.5	156.6	133.1	185.7	29.5	69.1	138.0	125.4	118.4	177.1	27.7	212.2	312.0	151.5	109.6	84.3	132.5	121.7	121.3	145.9	284.5	92.5	32.1	184.7	91.6	354.2	302.8	40.4	152.2	255.7	149.4	36.5	485.8	75.0	97.9	34.7	49.2	158.1	141.9	141.8	151.3	129.2	271.0	194.1	63.0	36.8	111.7	96.1	125.8	126.2	119.3	177.6	165.1	247.4	120.1	136.9	213.5	131.9
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37840041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.2;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.8"	"Low region specificity"	"Detected in some"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	0.1	0.4	2.3	1.6	1.5	0.1	0.3	5.8	1.4	0.8	0.0	8.2	1.4	1.3	2.5	0.9	0.9	0.9	0.8	0.6	1.6	0.9	0.7	0.0	0.1	0.7	3.1	3.6	0.0	0.0	0.1	5.0	1.0	1.3	2.4	0.3	0.2	4.5	10.1	1.3	2.0	2.1	0.2	0.4	1.6	0.4	6.1	0.1	0.1	4.3	0.0	0.7	0.8	2.9	0.0	0.0	0.1	0.1	1.8	1.0	0.0	5.5	3.4	1.1	1.6	0.0	0.1	0.1	0.0	7.4	0.1	0.2	0.0	0.1	2.2	0.0	0.2	0.0	0.4	0.5	0.2	0.1	0.1	1.8	0.1	41.4	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.4	0.1	0.0	0.1	9.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	2.7	12.6	0.1	0.0	0.0	5.5	0.0	1.4	6.2	4.0	0.0	0.0	12.6	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.5	5.8	1.4	0.6	1.6	0.7	3.1	1.0	0.2	6.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.6	0.6	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.1	3.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.1	0.0	0.0	11.5	1.8	0.9	3.4	0.0	0.3	0.1	0.0	2.6	0.0	0.5
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	7.1	2.4	6.1	6.0	6.1	1.8	5.4	6.8	11.4	18.7	5.9	25.9	8.4	5.3	9.3	45.6	5.7	2.5	5.2	6.0	6.1	17.9	2.1	6.4	4.2	7.5	6.1	6.8	2.2	0.4	4.8	11.4	8.0	5.7	17.2	6.5	9.0	2.2	2.1	11.0	10.2	5.2	6.3	9.0	18.8	1.8	6.1	4.1	4.7	0.9	20.9	5.4	19.1	6.8	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.1	6.1	6.8	11.4	6.0	6.1	7.5	6.1	8.0	6.3	6.1	6.8	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525941	"Enzymes, Predicted membrane proteins"	Neurogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 116.6;retina: 83.5"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	31.0	8.7	19.5	4.8	22.1	12.8	24.6	17.4	12.9	12.4	6.0	7.3	2.7	17.9	1.8	3.3	10.3	4.3	9.5	10.5	14.5	7.8	8.1	15.2	6.7	14.2	27.0	7.3	38.1	0.8	19.1	14.0	10.2	11.5	1.6	83.5	21.3	5.3	13.1	7.4	10.0	6.5	7.4	116.6	4.8	38.9	42.1	3.1	7.7	8.7	4.7	12.6	9.9	12.4	2.1	7.5	3.2	3.7	2.2	1.1	11.1	2.3	3.1	1.1	0.7	10.0	4.4	14.2	32.8	32.4	8.1	4.7	4.0	3.8	0.6	66.9	3.1	2.6	11.7	21.2	3.2	1.6	10.7	2.4	2.0	0.8	1.6	3.2	26.7	12.7	4.7	6.3	1.5	4.5	3.9	7.1	5.7	3.7	10.6	4.5	0.9	3.9	0.9	3.6	1.7	1.2	4.8	18.3	9.3	4.1	2.7	6.3	7.9	7.5	30.4	5.8	2.6	1.6	0.3	2.8	1.7	8.5	0.8	7.7	0.8	0.5	1.2	0.3	1.7	0.6	1.3	0.9	0.2	0.2	0.7	0.9	0.1	0.0	0.0	0.7	2.0	0.5	19.5	22.1	17.4	12.9	10.5	14.5	14.2	27.0	10.2	7.4	42.1	12.4	4.2	6.4	0.0	1.6	5.4	1.0	0.3	0.7	0.6	60.9	3.6	3.4	3.0	1.5	1.3	0.0	148.0	3.2	9.1	0.5	0.0	4.2	52.1	1.0	10.4	7.0	0.0	8.2	5.0	9.3	1.5	6.6	1.1	1.5	4.5	1.6	20.7	2.4	1.9	5.0	15.8	0.7	0.0	2.8	3.7	178.0	5.9	3.1	5.4	8.4	4.9	8.9	1.0	1.0	0.8	4.7	0.3	2.6	5.0	0.8	0.3	0.1	0.8	88.4	0.0	4.6	1.9	12.9	8.2	0.1	1.1	46.0	7.0	0.9	2.0	0.6
GDPGP1	C15orf58	ENSG00000183208	"GDP-D-glucose phosphorylase 1"	Q6ZNW5	15	90233808-90245811	"Enzymes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA048189, HPA059841"	Approved		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA048189: AB_2680307, HPA059841: AB_2684138"	"prognostic favorable (6.32e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-3)"	1.8	3.2	3.9	3.0	3.0	2.0	2.3	4.3	4.2	2.0	3.1	5.7	5.3	2.2	3.0	2.4	4.6	3.0	5.8	3.2	2.9	4.3	4.9	2.9	3.5	3.7	2.9	2.9	3.5	4.9	3.7	1.0	4.6	3.7	7.7	2.7	3.8	3.1	7.9	2.1	3.9	2.8	1.8	3.2	3.5	4.6	2.9	3.1	3.8	1.5	4.1	3.4	1.5	5.0	3.0	11.8	1.4	4.3	4.3	0.9	3.9	2.7	1.7	3.5	3.3	3.5	11.5	7.5	5.2	2.1	2.6	5.0	4.5	3.2	1.4	6.7	7.8	6.7	7.0	5.1	4.6	3.6	4.2	1.1	2.1	2.4	1.3	3.9	4.2	4.4	2.5	2.6	2.1	6.5	2.7	1.6	1.8	9.2	4.8	4.7	1.0	3.8	4.1	5.9	4.5	2.0	4.3	6.6	4.5	2.6	7.6	3.7	4.2	1.8	1.9	2.7	2.7	5.8	7.3	3.4	4.1	3.0	3.3	3.8	2.2	1.0	3.1	2.6	2.7	2.3	2.9	3.7	2.0	4.2	3.0	2.8	3.1	3.4	2.2	2.1	3.9	1.4	3.9	3.0	4.3	4.2	3.2	2.9	3.7	2.9	4.6	1.8	2.9	5.0	1.4	0.0	3.2	0.3	2.1	0.0	2.8	0.9	1.8	3.8	3.4	2.2	6.4	8.6	1.5	7.3	6.2	2.4	2.5	6.5	3.9	3.8	3.0	3.8	1.6	1.7	5.4	1.7	2.6	6.0	1.2	1.5	4.1	2.3	3.8	2.3	1.4	4.5	4.1	1.7	2.8	3.6	0.0	2.2	0.0	2.4	2.8	3.5	0.0	1.0	2.3	3.5	2.1	1.0	2.1	4.9	5.5	2.2	2.4	2.2	3.8	5.8	3.4	4.4	0.0	3.8	1.0	2.9	2.8	1.8	0.3	0.4	3.2	1.5	4.2	3.1
GEM	KIR	ENSG00000164949	"GTP binding protein overexpressed in skeletal muscle"	P55040	8	94249253-94262350	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 229.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 721.1;Fibroblasts: 395.9;Langerhans cells: 155.5;Smooth muscle cells: 359.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.0;U-266/70: 140.6;U-87 MG: 104.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 24.3"	HPA024798	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA024798: AB_10602137"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.76e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.93e-3)"	56.1	58.4	10.9	35.6	9.6	2.6	36.7	8.3	12.3	57.9	38.7	105.7	16.6	97.2	9.7	59.5	39.0	229.6	63.4	11.0	20.8	32.3	20.2	33.1	23.8	12.7	12.2	19.9	15.7	2.9	27.3	7.3	11.0	31.7	35.9	44.4	13.1	16.8	4.2	10.9	31.1	77.3	8.4	21.9	48.0	3.8	12.2	12.6	23.6	10.8	14.2	90.6	33.6	12.3	1.6	6.1	2.7	0.6	22.9	30.4	0.4	16.1	83.0	21.4	29.8	2.3	4.1	0.0	1.0	6.1	40.1	0.5	2.7	1.4	28.0	12.2	1.4	0.0	0.6	0.0	3.0	0.0	26.3	13.1	0.1	34.1	18.9	24.4	0.9	1.4	0.7	2.7	12.7	0.8	1.0	0.2	4.0	3.4	18.3	0.0	4.9	0.1	7.8	0.0	20.4	12.1	0.0	0.1	2.8	3.4	2.0	0.1	1.2	29.4	8.1	19.2	33.4	140.6	0.9	0.1	104.7	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	10.9	9.6	8.3	12.3	11.0	20.8	12.7	12.2	11.0	8.4	12.2	12.3	18.4	6.4	25.4	22.2	8.9	68.1	85.7	9.6	721.1	26.8	8.6	35.1	90.8	4.3	4.0	1.8	18.8	0.4	4.1	8.2	0.0	7.3	4.7	26.0	49.2	19.0	25.0	0.0	0.7	0.4	1.4	395.9	54.0	50.3	13.4	1.0	7.1	0.1	2.8	30.3	3.4	2.6	2.0	0.6	155.5	0.3	3.4	43.3	92.5	0.0	0.8	41.9	0.0	0.0	0.3	2.7	17.2	5.7	46.5	20.2	2.1	2.6	1.2	21.4	32.9	55.5	359.5	1.3	1.1	24.1	49.9	3.4	33.4	0.9	4.2	10.6
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 45.8;Late spermatids: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	6.1	4.3	6.1	4.5	6.3	10.3	7.9	10.2	7.9	5.9	4.6	6.0	6.7	5.4	7.2	5.7	5.9	4.2	7.7	5.7	3.9	6.1	5.6	4.8	8.8	3.6	2.6	5.9	4.7	3.7	4.6	5.6	3.6	4.8	6.1	4.7	4.3	4.5	12.1	6.3	4.7	7.7	1.1	5.2	5.1	8.3	3.4	9.1	5.5	7.9	7.8	6.2	5.5	6.2	23.6	34.5	33.3	23.7	11.3	12.6	17.0	11.5	9.0	30.3	30.0	30.7	27.9	36.0	23.4	9.8	11.0	17.5	45.6	18.7	31.5	17.6	26.7	21.5	18.1	76.8	23.9	32.6	12.8	7.3	17.6	18.8	27.5	8.7	26.6	31.4	25.2	25.6	17.3	48.9	36.3	31.2	23.6	29.7	38.3	32.8	36.4	22.6	17.5	15.6	32.2	6.2	24.5	17.7	12.4	18.4	41.5	14.0	11.2	12.7	20.0	13.3	18.6	26.8	44.2	54.1	6.6	34.0	19.6	10.8	12.0	9.9	13.5	13.1	9.8	15.3	12.3	13.5	16.2	15.8	13.5	14.4	3.1	11.9	11.5	16.1	11.8	9.2	6.1	6.3	10.2	7.9	5.7	3.9	3.6	2.6	3.6	1.1	3.4	6.2	11.6	6.4	3.7	4.9	10.3	8.5	8.1	20.9	8.0	5.9	7.3	12.1	6.0	5.7	11.4	5.5	10.4	12.9	7.0	2.2	11.7	10.8	45.8	11.2	11.3	10.6	3.6	17.2	7.4	6.4	18.9	12.5	2.6	7.5	5.7	11.7	9.7	6.6	11.4	5.0	6.2	7.1	14.2	10.6	7.3	41.1	9.0	6.3	7.2	4.7	9.4	8.1	9.2	4.0	7.4	6.9	2.5	9.8	9.4	8.0	3.1	14.7	15.5	6.9	6.6	8.3	8.1	25.9	15.4	11.3	8.0	3.8	9.1	11.6	9.3	4.8
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744421-753999	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA065699: AB_2685534, HPA067891: AB_2685918"	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	12.4	7.7	3.0	8.2	3.0	15.5	12.3	10.5	6.2	13.4	5.9	9.5	8.0	12.1	5.7	14.8	12.3	13.0	11.2	2.9	3.3	4.9	8.6	9.8	13.6	2.3	2.4	15.6	9.7	6.3	5.7	6.6	2.6	14.4	6.3	3.4	11.7	8.2	13.9	38.9	9.8	8.5	2.1	10.0	14.5	48.9	3.1	13.2	15.6	10.1	12.3	11.8	12.4	2.6	44.8	77.8	25.5	38.3	15.8	19.9	31.7	25.0	17.4	44.4	39.1	44.5	23.6	77.9	32.5	21.6	23.6	55.4	48.3	47.0	35.3	29.6	72.3	28.0	40.9	25.1	11.3	30.1	36.8	19.3	23.3	36.5	25.6	15.4	25.3	44.9	39.6	31.7	24.0	31.7	49.8	17.0	24.7	37.4	33.0	53.1	12.1	36.6	18.9	32.5	26.4	21.4	25.7	26.1	11.7	18.2	27.8	21.7	20.2	27.3	24.6	35.6	61.4	5.3	12.4	44.8	23.5	41.9	31.8	1.6	7.0	0.3	7.9	9.6	13.6	11.8	8.6	8.4	9.3	12.3	10.1	10.2	0.9	8.7	11.6	5.2	6.0	10.0	3.0	3.0	10.5	6.2	2.9	3.3	2.3	2.4	2.6	2.1	3.1	2.6	2.9	16.0	6.7	1.3	8.5	20.4	14.3	6.6	9.1	2.9	4.6	4.7	38.4	4.3	8.5	0.0	0.0	8.4	4.4	3.1	3.9	7.5	148.3	2.6	3.9	5.8	1.2	3.0	1.2	6.4	8.3	6.4	7.7	2.9	1.3	11.1	4.6	5.2	5.4	5.0	1.5	7.0	8.2	3.9	5.7	157.2	11.5	2.6	5.4	1.0	4.8	2.4	2.1	0.0	0.5	8.4	1.8	6.8	4.3	7.4	2.3	2.2	4.4	1.4	0.0	6.2	6.4	57.0	11.2	8.7	16.1	4.0	3.2	7.4	8.7	9.8
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785002	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.5;Spermatocytes: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: AB_2674753"	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	6.5	10.1	7.7	7.7	8.2	3.6	8.3	8.2	10.9	6.7	8.2	6.9	9.0	6.5	10.3	7.1	9.0	5.5	6.0	7.7	7.6	12.5	13.8	5.3	10.8	7.7	7.8	9.8	6.8	7.5	6.2	7.4	8.1	5.6	8.5	6.1	6.1	5.2	13.1	5.4	7.8	8.7	7.4	7.9	7.2	19.6	8.0	8.1	6.7	7.0	12.4	7.7	5.8	10.5	38.8	31.2	21.3	24.9	27.3	23.8	36.4	32.4	16.1	28.1	23.3	33.1	18.1	52.8	36.3	16.8	39.4	18.1	33.5	31.6	40.7	45.5	42.3	34.4	17.9	54.4	18.7	29.0	17.2	16.3	22.9	37.6	18.5	19.2	29.9	14.1	35.9	17.9	28.4	27.4	35.1	37.0	36.6	45.4	37.0	24.1	37.6	28.9	25.8	13.4	26.6	41.9	8.3	31.1	25.3	24.7	16.0	9.8	16.4	27.1	34.6	21.4	49.1	36.7	77.4	50.6	21.8	43.0	27.7	3.1	24.3	7.8	19.6	28.6	21.7	32.4	20.3	20.3	24.0	29.5	24.4	25.5	3.6	26.3	26.6	17.7	31.3	22.4	7.7	8.2	8.2	10.9	7.7	7.6	7.7	7.8	8.1	7.4	8.0	10.5	11.8	12.8	24.0	1.0	18.7	8.3	10.3	31.5	7.4	6.9	13.9	21.1	9.1	14.3	22.3	11.0	4.2	29.7	7.5	7.5	29.4	22.2	164.5	28.6	21.3	14.9	1.2	18.5	1.7	17.8	37.8	16.1	16.8	8.3	12.6	19.0	16.8	33.5	26.4	11.8	1.8	10.7	6.1	19.5	15.5	29.0	20.5	15.0	10.6	1.9	23.4	9.2	15.5	1.5	1.2	19.1	11.4	11.3	13.3	10.7	21.2	68.5	32.6	7.9	19.7	10.7	15.7	87.8	18.3	16.1	11.5	7.3	12.5	30.5	17.7	7.7
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14006726-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (7.73e-5)"	15.7	15.0	16.3	10.9	19.1	14.3	21.4	19.4	15.9	19.8	20.9	18.3	8.7	22.3	18.8	15.6	22.1	15.2	15.2	16.0	17.8	17.8	15.7	14.3	16.2	21.2	18.8	28.1	20.4	15.0	21.5	10.5	21.2	15.8	12.4	28.5	23.4	18.2	9.5	16.6	12.3	18.9	20.3	14.7	16.3	6.9	18.2	12.9	20.8	6.0	14.1	15.5	15.7	24.0	12.7	12.7	15.2	3.2	26.9	38.6	7.9	11.8	11.7	10.1	7.5	6.0	20.7	29.3	25.7	10.5	11.1	16.0	10.7	21.3	13.1	14.8	17.1	7.5	8.9	14.2	13.8	18.9	15.3	29.5	32.1	18.0	32.1	30.3	25.2	22.0	13.2	24.6	17.0	16.2	17.2	26.6	15.2	16.5	6.6	26.3	9.7	51.4	15.6	12.9	13.0	37.1	14.6	21.5	13.8	35.7	28.4	16.3	16.6	7.1	4.2	19.7	4.6	16.7	8.7	19.1	16.2	10.5	4.3	1.0	10.1	0.4	13.1	9.9	15.2	17.2	20.5	12.2	18.9	13.3	17.4	13.5	1.2	15.4	10.9	22.1	13.0	11.5	16.3	19.1	19.4	15.9	16.0	17.8	21.2	18.8	21.2	20.3	18.2	24.0	9.5	6.4	8.9	23.2	8.1	7.6	11.7	16.8	13.6	3.4	13.3	15.4	5.2	11.5	15.0	9.2	0.0	15.2	7.2	5.1	19.6	22.7	19.9	20.7	6.7	8.4	3.5	5.5	13.2	11.8	16.0	11.3	9.7	14.8	6.3	8.0	4.6	7.5	10.9	10.1	18.0	11.1	10.2	6.0	6.1	3.4	10.2	5.0	1.8	4.7	7.6	6.7	7.2	16.1	44.0	11.2	7.4	8.6	15.8	6.5	5.5	36.6	15.9	6.4	0.0	11.2	9.4	7.4	5.5	12.9	9.5	8.3	7.2	14.0	12.2	9.4
GEN1	"FLJ40869, Gen"	ENSG00000178295	"GEN1 Holliday junction 5' flap endonuclease"	Q17RS7	2	17753858-17788946	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020078, HPA021141"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA020078: AB_2670352, HPA021141: AB_2670599"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.90e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.89e-12)"	"unprognostic (3.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-3)"	1.6	1.8	1.1	4.8	1.0	15.1	3.2	0.7	1.2	2.3	15.4	5.2	3.2	1.8	9.3	5.6	1.4	4.4	2.3	1.5	1.7	1.7	8.6	2.0	10.8	2.1	2.4	0.9	2.2	1.1	3.0	3.9	1.8	2.7	6.9	2.5	5.6	2.7	1.7	7.5	4.5	1.4	1.7	5.1	3.0	8.5	1.6	5.4	1.9	1.5	11.8	1.5	3.7	1.8	29.4	15.0	14.0	9.9	3.2	4.1	23.9	21.3	6.7	9.9	9.6	19.6	13.0	27.4	8.2	7.3	10.4	18.4	16.4	12.8	13.7	21.4	9.1	15.7	16.3	9.5	1.9	20.2	17.0	3.1	4.7	16.8	7.7	3.0	8.0	13.7	21.0	19.6	16.4	14.1	15.2	16.4	9.5	9.4	6.8	17.7	36.3	10.9	5.6	19.6	15.3	20.8	11.5	14.3	7.5	9.5	9.8	10.6	10.7	22.4	9.8	12.2	21.8	13.1	26.0	45.1	9.6	18.3	16.0	0.1	0.4	0.3	0.3	0.3	0.2	1.7	0.3	0.6	0.6	0.7	0.4	0.4	0.1	0.4	0.4	0.6	0.5	0.3	1.1	1.0	0.7	1.2	1.5	1.7	2.1	2.4	1.8	1.7	1.6	1.8	3.6	6.4	3.6	12.1	16.9	2.8	2.7	5.2	5.7	5.7	4.5	3.0	4.4	1.5	8.1	3.7	12.5	4.4	6.9	9.3	0.0	2.1	4.6	4.9	8.5	4.0	1.8	15.3	14.1	2.3	4.8	4.2	17.3	6.6	1.3	14.5	2.2	5.4	3.8	3.3	13.0	7.3	0.0	3.1	1.0	3.7	1.8	4.0	1.8	6.5	2.9	3.8	1.0	12.5	11.0	2.9	4.0	0.7	11.2	3.2	5.3	2.5	5.0	3.6	6.6	15.0	5.3	14.2	11.4	8.1	1.8	3.3	3.7	8.0	7.2	2.9
GET1	"CHD5, WRB"	ENSG00000182093	"Guided entry of tail-anchored proteins factor 1"	O00258	21	39377698-39428528	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 12.0;Cardiomyocytes: 38.3;Cytotrophoblasts: 37.6;Extravillous trophoblasts: 35.3;Fibroblasts: 10.4;Hofbauer cells: 31.5;Syncytiotrophoblasts: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018527	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA018527: AB_1858860"	"unprognostic (4.34e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.02e-3)"	"unprognostic (9.48e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.78e-3)"	"unprognostic (8.13e-2)"	20.4	44.4	63.7	11.8	66.5	8.9	25.6	65.3	92.7	28.1	85.3	20.4	18.5	29.4	45.8	15.3	71.1	18.8	29.4	65.6	77.8	38.6	33.4	18.9	14.4	65.3	69.1	41.8	17.9	15.6	29.1	22.1	69.8	24.7	14.9	111.3	16.1	21.1	38.1	10.1	18.7	23.2	67.9	13.7	17.4	55.9	73.3	15.9	28.5	30.1	14.8	16.1	15.1	74.2	36.8	33.2	58.9	34.6	74.8	69.7	18.6	50.6	51.2	23.8	21.7	31.2	50.3	59.6	35.0	54.9	29.0	13.8	47.5	31.8	33.5	26.4	32.2	43.0	28.5	50.8	44.7	33.3	15.8	44.8	30.3	37.9	34.7	67.0	60.2	61.2	65.8	36.8	63.4	82.4	38.4	25.3	52.8	66.7	25.0	42.1	34.6	44.4	69.1	19.1	29.2	44.5	44.7	23.1	53.9	31.1	43.1	37.7	35.6	30.2	10.6	41.2	23.0	46.4	70.4	27.3	72.3	55.3	34.2	37.7	26.7	27.6	19.8	20.4	17.6	30.8	24.1	20.8	30.7	20.6	27.0	25.6	47.1	27.3	21.2	39.4	23.8	39.5	63.7	66.5	65.3	92.7	65.6	77.8	65.3	69.1	69.8	67.9	73.3	74.2	12.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	37.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	35.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	13.7	0.6	0.0	0.0	0.0
GET1-SH3BGR		ENSG00000285815	"GET1-SH3BGR readthrough"		21	39380332-39515506	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"retina: 6.1;skeletal muscle: 4.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.1;U-266/70: 6.7"									HPA018527	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA018527: AB_1858860"																		0.9	1.8	2.2	0.0	2.3	0.2	0.6	2.3	2.2	0.6	2.5	0.3	0.5	0.8	0.6	0.1	0.7	0.7	1.2	1.9	2.3	0.5	0.2	0.2	0.4	2.9	2.2	1.5	0.6	0.2		0.6	2.4	0.5	0.2	6.1	0.3	0.8	4.8	0.1	0.4	0.2	2.1	0.4	0.5	0.8	2.4	0.2	0.4	1.3	0.3	0.3		3.6	0.4	0.0	0.0	0.9	2.2	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.8	0.7	1.9	0.3	0.3	0.0	0.6	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.3	3.1	0.3	0.1	0.7	1.6	0.0	0.0	1.3	0.1	0.4	0.2	0.0	1.6	0.8	0.2	1.0	0.0	0.5	0.4	0.7	0.4	1.8	0.8	0.0	0.8	0.0	0.5	0.0	0.1	0.4	6.7	1.8	0.9	1.6	1.4	0.2	1.7	0.2	0.0	0.6	0.4	1.2	1.1	0.3	0.3	0.4	0.2	0.9	0.8	1.9	1.0	0.3	4.6	0.3	0.3	2.2	2.3	2.3	2.2	1.9	2.3	2.9	2.2	2.4	2.1	2.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GET3	"ARSA-I, ASNA1, TRC40"	ENSG00000198356	"Guided entry of tail-anchored proteins factor 3, ATPase"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	47.5	61.6	56.4	39.4	58.2	66.2	46.5	59.0	72.8	48.4	62.4	43.0	39.9	49.8	41.0	58.1	47.0	39.3	62.0	59.6	58.4	61.6	38.4	40.8	48.3	55.4	57.3	41.9	48.2	73.3	48.2	28.0	57.9	34.3	28.7	36.4	47.3	31.4	67.6	59.1	38.7	33.9	55.9	43.4	50.9	60.2	58.9	46.9	56.3	58.6	38.1	46.3	43.3	57.3	143.7	116.5	60.7	132.3	118.6	72.4	74.6	72.4	99.7	137.5	107.6	90.3	69.6	64.8	111.0	95.4	157.5	75.2	84.5	97.6	65.4	100.9	132.7	54.3	82.4	105.3	125.8	83.5	104.9	83.6	84.1	111.3	66.1	89.2	99.4	75.9	71.3	86.8	109.5	320.4	112.9	68.1	154.6	92.0	215.6	82.2	93.6	128.4	130.2	120.7	111.6	95.5	97.3	131.3	119.8	51.5	108.2	80.5	85.5	193.3	65.4	217.1	172.4	153.9	279.4	61.7	136.2	137.0	109.0	33.6	44.3	26.3	24.8	34.3	21.2	20.3	22.0	22.2	44.8	17.0	15.7	19.5	15.6	16.7	42.9	29.4	34.2	35.8	56.4	58.2	59.0	72.8	59.6	58.4	55.4	57.3	57.9	55.9	58.9	57.3	14.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	106.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	80.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	110.7	1.7	0.0	0.0	0.0
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 13076.3"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.9	1.8	5096.2	2.2	5407.4	14.1	3.5	5902.8	4887.4	1.9	2342.2	1.4	0.4	0.9	1.5	3.7	2.2	1.6	8.2	5059.3	9869.7	2.1	1.7	1.3	1.9	13076.3	9001.4	2.1	1.5	1.6	33.9	0.7	9204.1	1.3	1.0	117.7	1.9	1.0	2.1	2.6	0.7	0.9	10040.2	1.5	1.5	1.4	8068.5	0.4	1.7	0.3	1.1	1.4	0.9	10496.9	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	5096.2	5407.4	5902.8	4887.4	5059.3	9869.7	13076.3	9001.4	9204.1	10040.2	8068.5	10496.9	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984193-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	17.7	21.2	19.6	13.8	19.0	18.2	17.8	21.6	23.1	14.2	17.9	32.8	42.7	16.6	6.6	17.5	16.0	13.5	29.8	19.0	19.7	21.9	45.9	15.3	20.9	21.5	21.1	11.3	53.7	29.6	18.1	12.2	20.9	19.6	25.4	7.7	28.8	13.1	40.9	14.5	45.2	10.9	18.8	21.9	24.7	38.5	20.6	10.5	15.9	30.4	16.9	19.4	12.8	20.6	27.2	44.1	35.6	29.2	14.7	28.9	43.5	28.6	31.2	44.2	35.6	63.7	46.1	15.2	39.7	24.2	25.7	39.8	27.3	42.4	27.9	44.7	46.6	20.9	44.3	73.4	26.6	32.1	37.9	18.9	32.5	38.8	34.6	27.8	21.1	32.7	33.0	51.3	32.6	66.1	34.9	33.9	54.9	23.9	39.7	74.5	26.8	50.7	45.5	21.9	30.5	28.9	39.3	91.2	34.5	18.2	43.4	33.6	19.1	42.8	45.0	24.0	54.3	79.1	48.3	45.7	14.2	21.5	36.7	3.8	16.2	13.4	11.2	13.9	11.4	23.5	14.9	18.5	11.6	17.8	13.6	9.5	1.4	10.7	17.4	5.1	24.9	10.6	19.6	19.0	21.6	23.1	19.0	19.7	21.5	21.1	20.9	18.8	20.6	20.6	18.0	3.2	6.7	2.3	32.5	15.9	19.9	21.1	17.6	10.8	32.7	27.6	17.4	27.1	16.6	9.2	0.0	43.4	23.0	183.7	35.2	44.0	168.7	24.0	11.4	17.9	27.2	17.0	3.4	80.8	57.8	17.7	16.8	18.7	12.7	22.8	20.7	59.1	45.9	8.4	3.2	60.3	26.4	39.3	24.8	123.7	17.4	24.7	23.2	1.0	39.6	12.6	39.1	1.5	3.3	57.3	100.3	12.4	39.6	21.7	371.7	84.6	33.3	11.5	13.1	15.8	18.5	41.9	26.7	17.3	14.8	37.5	27.4	26.7	68.7	26.0
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.0	0.5	0.1	5.1	0.2	53.7	0.9	0.1	0.1	0.6	0.3	3.6	4.7	0.6	0.5	0.5	0.7	1.9	0.3	0.1	0.1	0.5	1.0	2.8	6.9	0.3	0.1	0.5	9.4	0.2	0.5	0.2	0.2	0.8	4.5	0.0	1.0	0.3	0.2	0.3	5.7	0.4	0.2	7.0	3.2	0.9	0.2	31.2	0.9	0.0	4.4	1.7	0.6	0.2	1.4	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.1	1.0	10.3	0.1	0.7	0.0	0.5	0.4	1.2	0.0	0.2	0.0	2.5	1.6	0.2	5.3	0.1	61.9	47.5	0.0	0.0	0.1	0.1	0.3	0.1	17.1	0.4	15.3	0.1	2.1	39.5	64.7	0.0	0.1	0.2	7.8	2.7	3.4	0.0	0.7	0.1	0.1	0.3	0.1	0.3	0.1	0.0	127.7	0.0	0.0	1.5	0.1	0.2	22.2	1.6	4.0	0.0	261.3	0.0	0.0	0.0	0.4	2.1	0.0	1.0	0.0	0.9	1.4	0.0	0.0	0.3	1.9	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.1	0.2	0.0	0.1	1.4	0.0	0.1	0.0	0.1	12.4	0.0	0.8	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	11.3	0.0	0.1	0.4	0.0	0.0	8.6	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.2	0.5	3.9	0.0	0.0	0.0	16.4	0.1	0.4	0.0
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.0"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.3	0.1	39.0	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.2	1.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.8	0.3	2.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GFM1	"EFGM, EGF1, GFM, mtEF-G1"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644527-158695581	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	26.7	25.0	12.3	21.7	13.2	24.1	27.8	18.1	21.3	14.1	16.8	30.1	24.9	17.2	20.8	24.1	13.4	17.5	39.0	13.0	15.5	43.7	49.6	18.8	20.7	14.5	13.2	12.7	26.4	40.1	12.0	25.7	15.3	19.6	31.5	46.4	21.0	21.9	63.0	15.2	19.8	20.9	13.7	16.4	23.9	23.5	14.1	16.6	32.1	60.2	20.7	23.5	12.9	15.7	92.2	55.9	25.5	32.0	41.8	30.6	34.2	42.6	49.8	75.9	57.4	73.2	58.7	73.9	54.7	39.2	32.0	55.9	62.5	47.8	84.3	40.6	33.7	56.1	34.6	34.3	48.6	76.7	35.9	37.3	55.7	43.8	41.0	17.6	50.2	43.0	71.7	50.3	67.9	56.9	49.6	30.6	55.7	97.0	29.8	49.8	28.0	132.6	51.0	38.3	48.9	42.8	63.8	96.1	79.1	19.9	132.1	60.0	28.0	46.4	21.0	69.4	74.1	82.7	61.4	138.9	41.8	65.0	52.4	18.9	19.3	13.8	22.2	27.2	28.6	17.0	19.3	23.0	23.3	16.4	22.1	23.9	3.0	25.4	22.0	11.2	17.4	18.4	12.3	13.2	18.1	21.3	13.0	15.5	14.5	13.2	15.3	13.7	14.1	15.7	31.4	19.2	19.0	17.0	26.1	21.5	26.0	20.9	20.5	57.3	23.0	11.9	54.8	22.8	18.9	12.9	31.3	31.6	20.1	22.2	11.7	19.9	15.4	12.4	20.2	36.6	19.3	29.0	39.8	25.0	17.6	20.9	22.4	14.8	19.0	17.7	22.5	61.6	29.0	15.2	43.9	24.5	30.5	20.4	21.5	7.6	22.7	21.7	17.8	18.7	33.8	27.3	16.5	22.6	43.3	20.3	10.5	17.0	19.2	21.7	22.1	37.9	25.1	51.6	13.1	21.5	23.4	34.4	31.6	20.1	21.0	30.8	22.3	41.4	28.9	22.0
GFM2	"EF-G2mt, EFG2, FLJ21661"	ENSG00000164347	"GTP dependent ribosome recycling factor mitochondrial 2"	Q969S9	5	74721206-74767147	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	"Nucleoplasm,Midbody ring,Mitochondria"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Midbody ring"	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.6	18.1	9.7	10.2	10.5	15.0	14.1	10.2	14.5	10.7	16.1	13.9	9.3	11.1	17.4	11.9	23.4	9.0	33.3	10.8	10.7	23.3	34.0	9.0	12.2	9.5	9.1	11.4	10.0	30.4	10.7	13.5	10.0	13.0	15.8	16.8	13.4	11.2	30.6	11.3	10.8	10.8	9.4	8.5	17.9	15.8	10.2	17.2	13.1	38.5	15.5	12.9	7.0	11.1	39.5	34.3	27.2	52.2	20.3	27.1	28.2	41.5	24.7	41.5	44.1	36.4	24.9	39.7	44.9	21.9	65.7	32.1	55.0	59.6	54.8	34.8	35.5	22.9	31.7	27.0	27.1	23.6	26.0	32.1	26.3	33.6	40.5	29.8	30.3	39.4	40.7	32.9	48.5	23.3	32.1	15.1	11.4	14.8	29.7	41.1	43.5	49.3	32.0	24.7	46.6	24.8	46.3	38.1	44.3	30.1	33.0	44.0	24.0	16.2	27.8	20.5	27.2	19.0	38.3	40.1	24.1	34.2	24.6	22.8	6.9	9.2	6.7	7.2	6.6	8.3	5.5	7.5	6.7	7.2	7.5	7.3	3.5	16.0	11.8	4.4	7.0	5.2	9.7	10.5	10.2	14.5	10.8	10.7	9.5	9.1	10.0	9.4	10.2	11.1	6.4	12.8	12.9	19.9	8.5	6.0	7.1	13.0	8.6	9.1	7.7	6.9	11.0	7.2	12.5	7.3	6.2	20.1	7.5	8.9	21.5	9.5	11.5	42.4	9.2	6.4	5.4	17.9	35.7	5.3	15.9	6.3	15.3	13.7	2.5	10.4	5.3	22.4	9.9	16.8	34.1	9.7	30.5	8.5	2.4	2.6	7.2	6.8	8.8	13.1	17.9	13.0	7.2	34.2	29.1	9.8	9.9	7.5	11.4	4.6	8.5	11.2	61.5	9.6	0.0	5.6	7.8	15.2	11.7	10.0	7.0	16.0	7.3	11.1	10.0	7.5
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719339	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	12.5	12.2	13.4	6.9	13.8	16.6	12.6	27.4	14.8	17.6	13.4	11.8	11.7	10.8	5.5	33.5	13.0	7.9	7.2	13.0	13.9	12.4	40.8	9.3	8.7	11.3	12.9	6.4	8.9	12.0	13.2	14.7	13.6	10.9	9.3	8.1	12.7	7.3	9.2	16.7	9.2	9.2	8.8	18.5	8.0	11.1	12.6	8.1	10.3	7.1	12.9	10.9	26.3	11.5	15.8	25.1	15.1	31.0	14.9	11.3	18.1	12.7	16.5	23.3	23.9	21.5	13.9	26.6	11.8	14.8	12.6	19.4	15.6	14.9	19.3	16.2	20.1	6.7	14.5	30.4	11.4	11.0	12.5	9.1	16.9	31.0	9.2	11.7	34.5	26.9	14.1	4.9	13.2	33.0	18.2	13.4	20.7	9.4	13.8	28.7	8.9	20.8	14.5	21.5	30.4	18.4	31.6	10.5	9.6	8.7	15.9	7.3	26.4	17.8	18.1	16.3	13.0	13.2	19.8	29.0	11.1	15.8	13.3	0.5	4.8	5.2	4.4	2.9	7.2	6.3	7.7	7.9	4.8	7.0	6.6	5.3	9.0	5.9	3.1	5.4	9.2	3.7	13.4	13.8	27.4	14.8	13.0	13.9	11.3	12.9	13.6	8.8	12.6	11.5	36.1	0.0	8.4	8.5	7.7	22.9	15.8	8.1	15.9	13.7	21.7	12.4	5.3	15.7	10.9	11.0	14.6	10.3	10.6	23.8	5.9	21.1	89.6	22.5	10.9	33.8	43.2	56.6	18.3	11.6	24.1	10.4	3.6	8.7	4.5	12.2	31.1	46.7	6.6	21.9	16.8	17.0	16.2	7.5	10.0	29.9	8.7	4.6	8.8	6.5	5.2	12.0	11.3	8.5	7.3	15.8	14.2	11.3	9.1	12.4	20.6	13.0	24.5	11.0	6.6	11.9	11.4	19.9	14.8	10.1	27.3	22.2	10.3	9.3	18.3	21.3
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300698-180353336	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 112.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 30.4;Fibroblasts: 77.9;Skeletal myocytes: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 119.1;ASC TERT1: 202.3;GAMG: 152.5;HSkMC: 130.7;hTEC/SVTERT24-B: 248.0;U-87 MG: 426.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA056892: AB_2683266, HPA059910: AB_2684157"	"unprognostic (3.48e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.52e-3)"	112.4	7.0	14.2	18.6	14.8	0.1	23.0	19.7	17.6	24.8	14.1	18.0	1.6	15.9	7.7	5.7	35.8	16.4	27.8	14.9	16.8	6.8	2.1	25.2	2.8	27.8	15.7	33.4	12.4	4.6	5.1	6.5	21.5	15.6	3.2	2.9	7.1	8.2	4.6	8.4	11.3	11.3	16.8	1.9	14.6	8.6	15.7	1.2	10.8	7.1	3.5	38.3	17.9	20.4	0.1	27.7	21.5	28.0	119.1	202.3	2.3	3.5	0.7	2.3	0.8	0.7	0.1	0.0	1.4	23.2	152.5	0.4	11.8	0.2	1.4	2.6	4.2	0.0	13.7	0.0	49.4	0.0	0.2	130.7	1.0	248.0	0.7	41.7	40.7	1.0	0.0	0.4	107.7	4.2	0.1	0.0	45.7	0.3	12.3	0.6	0.2	0.0	0.0	0.0	1.0	1.6	43.0	0.8	1.4	25.0	1.9	0.3	19.5	67.9	10.7	44.3	52.2	0.1	0.1	0.0	426.7	0.0	1.5	0.0	0.0	0.0	0.7	0.0	3.5	0.0	0.3	1.2	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	14.2	14.8	19.7	17.6	14.9	16.8	27.8	15.7	21.5	16.8	15.7	20.4	4.1	3.2	4.8	13.4	0.8	7.4	0.4	0.2	3.4	0.0	3.2	6.3	3.0	5.7	3.2	1.8	0.0	1.1	3.5	0.4	1.9	1.0	5.7	2.0	30.4	1.9	0.0	0.0	20.0	0.8	0.5	77.9	6.6	1.9	1.3	0.4	1.4	0.0	0.5	0.0	12.1	0.5	0.0	0.3	9.6	3.5	10.2	1.7	8.8	4.7	0.0	6.1	0.0	10.6	6.5	0.4	0.0	18.8	2.5	1.7	0.0	0.4	1.5	0.1	0.0	27.3	17.6	10.1	8.3	1.7	4.3	2.7	8.9	0.0	0.1	0.6
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GFRA2	"GDNFRB, NTNRA, RETL2, TRNR2"	ENSG00000168546	"GDNF family receptor alpha 2"	O00451	8	21690398-21812357	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.4;thyroid gland: 8.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 91.9;Horizontal cells: 220.4;Late spermatids: 238.1"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 6.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.0"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 9.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;monocytes: 9.2"	"Cell line enhanced"	"Detected in some"		"HEL: 9.1;HMC-1: 21.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024704, CAB032791"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA		9000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB032791: AB_2110428, HPA024704: AB_1849629"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.48e-4)"	"unprognostic (2.87e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.63e-3)"	2.4	1.8	1.2	2.0	1.0	0.6	0.6	0.0	5.0	2.6	0.0	2.1	1.9	0.5	0.2	1.5	1.3	0.6	1.0	1.5	2.2	0.2	0.9	1.2	1.6	0.0	0.8	0.3	0.3	0.1	0.4	7.1	0.0	0.4	1.1	2.6	0.9	1.5	0.1	0.5	1.8	2.0	0.0	7.5	1.0	9.4	1.8	1.1	8.7	0.6	0.8	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.9	0.8	0.0	9.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.9	1.2	1.0	0.0	5.0	1.5	2.2	0.0	0.8	0.0	0.0	1.8	0.0	0.3	0.0	1.8	1.3	0.1	1.8	0.2	0.0	0.0	4.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	91.9	0.0	1.2	0.3	0.0	0.0	39.5	0.0	0.1	1.8	0.0	0.1	1.3	0.0	0.7	0.2	0.6	220.4	6.5	0.0	0.0	30.6	25.2	238.1	0.6	11.8	0.0	3.7	0.5	1.9	0.0	2.5	1.1	0.0	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.1	6.6	0.7	1.8	1.2	7.0	0.0	0.9	0.3	0.2	0.1	0.0	0.1
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252380-138274621	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.9"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 32.0"	"Not detected"	"Not detected"							HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		150000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	1.8	1.6	0.0	2.1	0.2	0.0	1.6	2.5	0.3	7.4	0.0	13.0	2.7	0.5	2.5	2.3	1.2	1.9	5.7	0.1	0.2	0.5	0.5	2.0	0.1	0.1	0.1	1.3	3.7	0.0	2.0	0.0	0.2	4.1	3.8	0.0	3.2	5.9	0.2	3.1	3.3	2.0	0.1	0.0	6.3	4.2	0.1	0.5	0.8	0.4	0.1	5.1	7.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.1	0.0	0.0	2.0	1.2	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	32.0	0.5	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	8.7	0.0	0.0	0.0	53.1	0.0	0.2	0.2	0.2	0.5	0.0	0.0	26.7	0.3	0.0	0.0	0.1	0.0	0.1	0.2	6.1	0.0	0.2	20.9	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.8	8.4	0.1	0.0	0.3	0.0	0.1	0.0	0.1
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047372	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA						"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608725-37633564	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 179.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.2;Spermatocytes: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	25.0	49.3	35.9	23.3	39.7	37.2	27.3	39.0	42.3	38.0	41.0	35.0	24.3	32.1	21.5	41.1	37.4	20.4	29.5	35.3	35.0	42.4	42.1	33.7	29.1	41.1	37.6	46.3	34.5	33.2	52.7	19.1	38.4	40.0	17.8	22.8	34.9	19.6	43.1	35.7	40.7	16.9	36.1	55.6	34.9	179.3	41.2	26.9	44.7	24.6	21.1	31.6	33.5	45.0	37.4	28.3	32.9	31.1	28.0	23.0	35.4	30.8	25.0	27.0	29.6	23.3	21.8	59.9	20.6	22.9	17.0	35.0	29.4	35.6	24.8	51.0	53.6	24.0	52.3	27.3	28.1	56.1	42.6	28.4	31.3	38.9	24.2	45.1	26.5	30.3	48.0	36.8	27.8	37.7	24.8	64.2	26.2	39.2	28.7	28.5	25.8	25.2	28.8	31.0	30.4	54.0	18.7	39.0	48.9	31.3	42.4	42.0	31.0	36.8	35.2	32.1	24.4	81.1	35.3	62.5	39.9	33.6	30.8	8.1	10.7	6.1	18.0	10.2	22.1	8.3	7.2	23.3	6.7	5.0	5.1	16.5	4.5	11.6	7.9	5.8	8.0	11.5	35.9	39.7	39.0	42.3	35.3	35.0	41.1	37.6	38.4	36.1	41.2	45.0	17.9	25.6	38.5	26.8	50.9	24.2	31.1	36.5	21.1	57.6	26.5	20.8	19.2	20.0	34.5	44.1	83.4	38.8	34.7	67.3	5.9	34.9	148.2	27.6	19.8	32.6	32.4	38.3	18.4	20.1	37.4	18.8	44.4	26.5	49.4	33.3	40.7	20.4	77.1	25.2	19.3	40.4	32.6	66.9	40.3	221.2	26.4	50.5	16.0	20.6	47.9	37.0	73.2	16.6	28.7	36.6	51.6	22.6	24.4	24.7	55.4	13.2	46.7	74.1	26.3	26.9	22.1	193.4	50.4	19.7	28.6	56.8	59.6	44.4	42.8	33.6
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 159.9;U-698: 170.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067"	"unprognostic (1.27e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"	15.1	36.3	13.0	32.0	13.1	37.6	19.9	18.6	14.8	20.7	25.2	16.5	10.0	16.1	19.6	17.9	18.4	13.4	18.5	13.8	15.3	26.9	16.4	34.1	72.9	11.7	12.9	34.0	54.3	29.2	26.0	17.6	11.9	27.4	15.8	79.3	37.6	21.3	25.5	21.1	33.6	14.9	10.8	44.2	25.7	12.4	17.8	37.2	36.2	19.0	87.3	16.3	18.7	12.3	18.8	22.9	29.6	26.1	16.5	17.9	25.3	19.7	20.0	15.2	19.3	32.1	18.9	159.9	31.4	21.1	4.3	28.7	49.1	25.8	19.4	25.1	45.6	28.8	29.5	51.2	16.2	48.0	18.2	18.7	22.7	20.8	9.7	22.1	22.0	12.8	50.3	23.0	19.8	29.8	17.0	31.9	39.6	18.3	20.2	108.3	38.4	41.2	24.8	25.6	21.1	25.3	18.3	27.0	27.1	31.5	23.7	59.7	24.5	18.1	19.6	20.3	18.5	42.0	41.8	170.8	16.5	32.2	20.6	0.2	4.2	7.0	3.1	4.3	3.2	16.2	3.9	3.7	4.9	21.6	4.0	4.0	0.5	3.1	4.0	15.9	4.5	3.1	13.0	13.1	18.6	14.8	13.8	15.3	11.7	12.9	11.9	10.8	17.8	12.3	11.7	48.1	41.4	28.7	102.3	34.2	33.6	16.5	39.3	73.2	25.0	26.0	27.3	21.5	17.6	22.0	114.7	23.0	80.6	7.3	25.4	19.3	22.0	25.4	17.6	19.0	17.6	9.9	44.2	18.9	40.7	17.3	15.3	37.3	9.5	88.5	12.5	16.1	69.1	6.7	61.5	12.6	12.2	26.1	19.7	30.8	24.5	37.7	26.6	36.5	87.9	23.8	23.7	26.2	8.3	16.2	6.1	26.4	36.1	20.7	8.7	21.5	16.2	153.3	19.7	16.0	16.3	30.5	60.5	25.4	14.6	22.7	34.8	56.8	11.9	18.6
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: AB_2671629"	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	11.7	9.8	9.0	13.0	8.4	15.7	10.8	7.7	11.4	12.3	4.3	12.4	11.5	10.8	9.8	17.0	10.2	11.4	12.8	8.4	6.7	11.1	11.6	13.0	17.5	8.9	7.6	15.3	12.3	9.1	9.0	14.6	7.6	10.1	11.7	6.7	12.3	7.8	22.7	15.7	15.0	11.8	6.8	19.6	13.0	11.5	7.8	12.8	9.9	10.5	19.0	11.6	12.2	9.4	16.9	21.1	19.5	11.9	21.5	17.9	22.8	18.5	13.3	24.9	21.2	24.8	18.4	21.4	8.2	16.4	19.9	10.6	13.8	8.0	25.7	15.1	21.4	34.3	19.2	19.6	10.3	32.5	24.3	14.1	19.7	13.6	23.5	13.2	26.5	16.1	37.8	19.1	17.7	17.4	42.5	9.6	13.8	19.6	14.9	16.9	28.0	14.3	17.1	18.4	14.0	23.9	18.5	33.2	14.9	27.3	25.3	17.4	29.6	25.7	18.7	17.4	19.9	19.8	15.1	27.5	20.8	23.0	17.2	5.1	6.8	2.9	5.5	5.9	5.1	3.9	4.9	4.2	6.4	4.7	4.3	4.6	7.3	8.4	5.8	6.6	5.4	6.0	9.0	8.4	7.7	11.4	8.4	6.7	8.9	7.6	7.6	6.8	7.8	9.4	9.5	35.3	21.0	13.4	15.5	2.5	4.9	5.2	8.0	8.1	8.8	7.6	12.6	4.3	9.6	0.0	10.4	10.3	21.2	14.3	5.9	5.2	27.6	10.5	13.6	10.2	0.0	4.6	20.6	7.0	11.0	7.7	21.9	14.7	10.1	12.4	9.7	10.4	12.5	6.7	20.2	10.0	6.1	19.2	7.1	30.1	9.3	19.4	12.4	16.9	20.3	5.9	10.3	18.1	21.2	11.6	9.1	10.1	11.0	8.2	9.5	3.5	10.2	8.9	0.0	7.7	6.1	8.1	6.9	7.8	5.3	13.0	12.2	7.0	12.8	8.5
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"kidney: 75.5"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 133.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	5.8	6.0	3.4	3.8	4.1	1.6	5.0	3.9	4.7	2.6	3.5	7.6	8.7	3.2	2.1	2.7	3.0	2.9	1.6	3.1	4.0	75.5	16.7	3.0	3.4	4.4	4.1	2.8	15.2	3.0	1.5	3.0	3.9	3.4	4.9	6.8	8.9	3.1	2.3	4.8	6.1	2.4	4.3	4.1	7.1	6.6	3.8	3.6	3.5	4.2	5.8	3.4	2.5	4.7	14.2	1.7	11.3	12.2	9.4	14.3	4.9	8.8	2.3	1.5	3.8	0.2	12.6	1.4	4.9	6.4	0.2	0.7	1.8	2.6	0.5	20.1	7.6	6.0	1.1	0.7	13.4	8.6	19.1	17.3	9.8	0.2	0.8	0.1	5.7	6.6	3.1	0.3	2.3	0.9	1.4	1.1	0.6	27.4	3.8	0.9	2.8	1.8	14.1	2.4	133.3	5.0	2.8	6.2	6.6	10.5	5.9	28.0	5.5	0.0	0.1	3.0	2.4	7.3	4.4	0.5	0.7	6.4	6.2	0.0	4.1	0.8	5.8	5.9	5.5	3.9	4.8	6.4	3.3	4.3	2.9	4.3	0.0	7.0	6.2	2.4	5.4	3.4	3.4	4.1	3.9	4.7	3.1	4.0	4.4	4.1	3.9	4.3	3.8	4.7	3.2	0.0	1.5	7.5	7.2	2.7	3.0	1.1	5.2	1.7	4.4	3.2	0.9	1.5	2.1	7.3	14.6	13.4	2.6	4.6	7.9	8.7	4.7	2.6	2.1	3.4	7.8	1.7	2.7	10.0	11.8	3.6	3.1	4.2	5.7	4.1	4.2	14.0	12.1	1.7	3.2	4.7	2.0	9.8	1.4	10.3	2.8	6.2	0.0	4.7	10.0	6.8	19.6	3.5	8.0	9.1	4.5	3.8	2.1	2.3	10.5	152.0	0.1	3.3	6.6	4.3	1.8	22.5	10.9	3.9	2.0	4.4	6.1	12.4	7.7	2.5
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 414.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020735, HPA029914"	Approved					NA	Yes		2100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	58.6	25.6	18.1	28.4	20.5	22.4	44.8	16.9	24.4	19.2	19.5	38.6	31.3	17.3	105.2	51.7	24.4	25.9	13.0	20.0	18.3	31.9	35.6	16.6	27.8	18.0	18.1	15.5	23.3	43.5	15.9	34.8	17.3	24.9	39.4	10.7	33.4	15.9	16.9	56.5	26.6	21.2	17.3	16.0	22.7	12.1	19.7	21.9	19.3	20.8	32.2	33.1	31.2	17.8	194.0	50.0	79.4	107.7	32.6	58.8	92.5	64.6	25.1	60.5	72.4	66.6	66.1	123.7	42.0	24.3	68.9	238.8	84.1	67.8	78.6	24.0	93.1	87.7	104.6	88.6	42.6	150.1	65.4	57.6	53.4	63.4	81.0	20.9	62.1	58.7	126.8	69.4	48.6	108.6	91.4	202.1	115.6	198.3	79.5	90.1	91.9	123.8	59.5	174.0	100.3	101.2	58.0	355.9	73.5	102.8	228.7	140.7	37.7	39.6	75.6	75.6	128.6	50.8	129.2	96.7	30.9	201.4	75.9	10.4	19.9	7.0	14.1	20.4	19.9	22.7	18.8	18.4	34.2	17.2	17.8	17.4	1.1	25.0	12.2	30.0	26.1	17.2	18.1	20.5	16.9	24.4	20.0	18.3	18.0	18.1	17.3	17.3	19.7	17.8	37.9	16.0	39.4	10.1	25.1	77.0	50.1	96.0	60.3	23.4	107.0	109.5	51.6	24.3	67.0	44.1	4.2	414.7	21.8	56.9	123.3	99.8	29.2	129.6	40.4	46.3	28.3	53.0	26.0	80.1	167.7	41.4	44.9	103.8	27.3	53.5	33.5	51.4	129.8	33.7	10.1	90.1	67.1	44.5	57.4	10.0	24.8	42.8	62.2	12.2	36.2	32.2	24.7	8.5	8.9	60.1	50.6	39.1	33.4	68.8	60.6	188.4	69.4	15.1	26.3	25.2	45.1	63.3	46.7	147.0	74.7	135.6	26.7	67.7	138.0	69.6
GGCX	VKCFD1	ENSG00000115486	"Gamma-glutamyl carboxylase"	P38435	2	85544720-85561547	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 118.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018284	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA018284: AB_1849641"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (5.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.23e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.38e-2)"	13.8	11.0	6.0	8.3	7.4	3.2	10.8	8.3	7.7	10.7	11.7	7.8	7.4	10.5	13.8	9.2	10.5	11.3	9.5	6.9	6.2	16.3	118.8	13.8	6.3	7.4	6.9	12.4	15.8	18.0	7.8	23.4	7.5	10.0	9.9	7.7	14.7	12.1	7.9	9.2	7.3	13.4	7.3	6.2	9.1	4.7	7.0	4.8	12.6	8.6	7.2	12.2	8.8	11.2	17.1	27.2	19.0	21.3	93.8	26.6	42.2	29.9	35.1	21.6	30.4	47.3	20.6	6.1	29.7	49.3	27.1	27.2	13.7	37.7	23.7	10.9	18.7	11.1	17.4	45.2	34.8	7.0	10.1	33.1	22.0	43.8	29.7	35.6	31.0	10.8	13.5	8.7	63.5	22.4	3.5	5.3	8.9	47.7	23.4	6.6	44.6	15.3	30.0	32.5	7.2	12.1	26.8	52.2	28.2	32.1	25.6	6.8	28.6	27.5	23.9	27.1	20.9	6.8	20.1	5.1	26.5	7.1	39.4	3.7	4.2	2.2	1.7	4.4	1.6	0.4	0.7	0.7	2.9	0.4	1.7	1.6	1.7	1.4	2.6	2.4	1.2	2.0	6.0	7.4	8.3	7.7	6.9	6.2	7.4	6.9	7.5	7.3	7.0	11.2	27.1	28.9	40.3	10.1	25.1	18.7	20.6	27.8	13.6	21.6	22.9	19.8	27.9	32.9	24.1	29.5	16.7	60.8	28.4	16.1	7.9	29.9	4.2	16.9	19.4	20.8	14.4	5.7	10.9	39.5	50.2	29.4	11.7	26.8	15.8	17.8	23.9	163.0	31.3	8.4	8.9	17.6	22.4	26.9	29.0	2.2	20.2	24.5	21.4	5.6	29.6	19.5	17.5	9.5	12.6	25.0	12.6	20.3	38.4	16.4	16.2	27.1	16.9	33.6	6.6	42.3	22.8	23.5	11.2	20.0	15.2	53.8	20.8	15.1	16.4	23.6
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63014881-63039407	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.7;liver: 188.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 510.3;Early spermatids: 471.0;Extravillous trophoblasts: 273.4;Proximal tubular cells: 340.8;Syncytiotrophoblasts: 754.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 30.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 30.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	NA	NA		1200000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	9.8	5.4	11.1	14.2	11.1	43.7	16.5	10.7	14.3	5.9	13.1	54.3	11.3	6.3	4.4	20.7	3.5	4.3	3.1	11.1	12.3	125.7	188.6	8.0	10.9	13.3	11.1	3.1	9.9	13.1	1.9	54.9	13.7	4.4	74.4	2.1	13.0	3.7	2.1	27.2	9.9	11.6	10.1	5.5	8.2	33.9	14.4	17.8	2.4	3.2	22.5	8.5	10.8	11.1	110.5	97.6	97.4	15.7	94.1	39.6	69.6	64.3	105.1	94.2	137.7	144.5	183.8	69.8	18.0	77.1	166.8	87.2	97.2	101.9	138.9	139.0	71.6	112.3	50.3	105.1	17.6	53.5	65.9	29.1	29.2	93.9	50.7	59.4	116.1	66.9	62.4	255.2	177.3	64.3	28.8	71.1	51.0	231.6	86.0	77.6	95.2	98.1	75.8	40.3	38.6	69.9	91.8	103.6	98.5	91.6	116.6	65.8	65.5	104.2	115.6	99.4	111.3	112.6	127.2	88.3	158.0	0.1	185.0	0.0	2.1	2.3	1.1	1.7	0.8	6.5	1.5	1.7	0.9	2.7	1.8	1.9	3.0	4.4	2.0	30.6	2.7	1.9	11.1	11.1	10.7	14.3	11.1	12.3	13.3	11.1	13.7	10.1	14.4	11.1	13.1	16.0	7.3	11.1	26.1	30.2	23.2	66.6	9.1	2.0	14.9	21.0	3.2	17.2	31.1	22.0	0.0	510.3	11.7	49.2	37.2	19.7	471.0	5.4	11.5	13.1	13.2	62.5	11.5	7.4	273.4	27.2	11.7	7.6	10.8	21.4	13.6	219.5	72.4	0.0	8.7	70.7	44.7	21.0	15.5	154.2	5.9	12.0	24.9	1.0	32.1	23.1	2.1	3.5	2.9	4.3	23.7	8.2	106.9	10.5	4.3	340.8	18.3	1.3	26.3	12.8	20.4	80.3	133.0	35.9	43.0	754.5	8.5	9.3	102.0	23.1
GGNBP2	"DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403"	ENSG00000278311	"Gametogenetin binding protein 2"	Q9H3C7	17	36544912-36589848	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 467.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018914, HPA073392"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA018914: AB_2294667, HPA073392: AB_2686599"	"unprognostic (2.68e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	41.7	30.5	23.8	29.5	23.9	79.9	35.3	26.4	30.0	32.5	24.6	38.9	33.8	34.0	26.6	33.9	34.7	25.2	31.0	24.1	25.5	31.2	36.6	33.5	49.7	25.1	25.7	40.0	35.3	31.5	26.7	27.1	25.9	27.8	30.7	26.8	33.2	23.9	52.7	40.5	44.0	27.5	23.6	39.4	34.8	60.2	24.6	36.6	29.4	32.2	46.5	37.2	34.7	26.1	48.0	49.4	45.8	38.9	53.5	63.9	33.0	60.0	48.1	44.4	44.2	48.6	34.5	64.5	37.2	47.7	44.4	46.9	37.2	55.6	58.1	38.9	36.1	36.2	55.1	43.7	55.1	63.1	47.1	62.3	68.4	45.2	61.4	56.6	38.9	46.2	51.2	62.0	62.5	29.5	65.6	51.2	13.9	31.0	26.1	44.3	60.9	42.8	58.6	93.2	37.1	32.3	58.1	33.5	97.1	46.2	63.0	64.2	39.9	62.4	43.0	41.5	62.4	42.2	50.0	48.7	40.9	34.6	38.6	42.8	31.6	67.8	37.1	35.9	43.6	56.6	46.9	41.5	42.0	48.5	66.0	62.0	44.9	40.4	39.9	84.1	50.1	20.8	23.8	23.9	26.4	30.0	24.1	25.5	25.1	25.7	25.9	23.6	24.6	26.1	85.0	67.3	84.2	38.5	110.2	96.0	98.9	128.8	111.5	70.2	58.9	46.9	81.1	60.1	118.6	31.3	37.5	82.4	132.3	94.7	52.8	74.0	467.4	87.3	84.2	82.2	57.4	71.1	46.9	68.5	77.4	86.6	56.1	104.3	97.5	52.2	65.0	64.7	73.5	57.2	43.3	79.6	101.7	77.9	66.7	130.6	79.6	84.7	58.7	33.7	103.0	71.8	94.7	29.1	48.6	73.2	74.2	72.2	84.4	83.9	124.9	63.6	107.0	71.5	59.2	99.0	114.9	335.2	98.7	91.9	96.5	95.6	117.8	53.5	97.4	102.4
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 8.7;thyroid gland: 8.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	1.0	0.1	0.0	8.5	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.3	0.3	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	3.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3;eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	137.6	60.5	39.0	18.6	39.3	1.4	90.6	37.6	41.7	73.2	32.8	27.8	19.4	54.4	12.9	19.6	70.6	37.2	93.4	35.0	45.1	78.2	55.2	37.7	48.0	52.2	46.3	26.6	25.8	13.2	41.1	11.9	46.9	49.3	12.0	2.1	37.1	20.9	23.1	40.1	40.8	32.2	41.9	36.1	40.0	9.6	45.3	10.4	110.2	16.6	18.3	45.1	64.2	38.2	0.0	1.8	0.6	0.0	164.9	124.4	1.1	2.9	0.2	0.1	0.0	0.1	0.1	0.2	3.4	0.2	0.3	0.3	0.1	0.1	0.0	2.2	0.9	6.7	1.0	24.1	234.7	3.0	6.4	271.7	0.1	3.4	3.2	0.4	45.8	0.7	0.4	1.2	44.1	0.4	0.0	22.4	3.6	1.1	0.0	0.1	4.0	1.0	6.1	0.0	0.4	5.9	0.1	7.3	0.1	22.7	1.0	1.7	110.8	0.1	2.3	0.1	0.0	0.3	1.5	0.2	3.9	5.7	0.2	2.3	0.5	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.2	39.0	39.3	37.6	41.7	35.0	45.1	52.2	46.3	46.9	41.9	45.3	38.2	27.2	3.2	16.0	1.0	0.3	7.0	3.3	3.2	0.0	0.0	7.2	4.2	4.4	0.0	17.9	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.3	8.3	42.8	0.0	2.7	0.1	0.2	0.2	58.3	1.1	0.4	1.3	0.0	33.5	0.1	2.1	0.0	0.1	0.0	0.0	1.0	12.5	3.3	36.4	1.8	3.6	22.5	3.3	0.3	0.0	0.5	0.0	0.4	0.0	23.7	0.3	2.2	0.0	0.1	2.2	1.0	184.1	33.9	85.6	0.6	0.4	0.3	4.4	0.3	1.1	2.1	0.0	1.4
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.8;intestine: 53.4;salivary gland: 55.8;skin 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 208.5;Intestinal goblet cells: 69.4;Paneth cells: 135.8;Proximal enterocytes: 130.9;Undifferentiated cells: 86.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"RT4: 58.5;SK-BR-3: 19.4;T-47d: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		72000	"Cluster 6: Non-specific - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.6	0.4	5.0	0.5	0.2	9.0	0.7	0.7	7.9	0.4	53.4	44.5	0.4	41.1	53.8	8.5	5.3	0.0	0.5	0.3	39.2	0.4	3.5	0.0	0.5	0.4	0.5	46.8	0.0	0.5	0.0	0.5	6.5	34.0	0.1	55.8	6.4	0.4	56.2	38.4	0.8	0.2	0.1	23.7	0.7	0.4	0.7	0.2	0.0	9.0	18.4	18.8	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	6.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	58.5	0.2	0.2	0.0	19.4	0.0	0.0	60.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.7	0.7	0.5	0.3	0.5	0.4	0.5	0.2	0.4	0.9	0.1	35.3	6.9	0.0	1.1	4.1	14.7	12.5	5.2	0.0	17.9	11.0	0.2	20.0	38.0	23.9	2.1	0.0	0.3	208.5	21.5	23.8	0.1	7.4	0.3	0.5	6.0	0.0	0.0	38.2	0.0	0.9	24.5	2.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	69.4	12.2	0.0	1.8	0.2	0.6	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.0	10.6	135.8	0.0	0.0	5.5	130.9	39.5	45.9	0.3	0.0	0.4	2.3	0.0	0.1	30.6	20.9	0.0	1.0	0.0	86.1	26.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872856	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 60.9;Inhibitory neurons: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1900000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	13.2	13.8	37.0	11.8	35.8	5.5	15.4	43.4	43.8	25.6	53.2	19.1	16.0	19.3	29.1	10.1	21.1	18.2	22.3	38.6	33.3	24.9	16.8	14.4	18.2	34.3	28.9	24.1	27.1	22.9	40.5	13.7	33.6	24.8	14.9	22.7	30.8	22.6	67.5	17.9	20.1	14.9	22.5	15.4	22.1	10.1	32.0	15.8	28.8	13.8	13.6	19.7	18.0	35.4	5.2	7.7	38.5	39.5	29.7	26.4	34.2	21.7	21.9	17.5	26.0	40.6	25.5	0.0	25.1	17.1	17.8	3.6	16.8	9.5	11.5	1.8	29.9	15.9	16.0	21.3	26.5	0.8	24.9	38.5	10.6	19.7	9.1	52.2	1.5	20.3	12.0	2.8	12.2	9.1	4.2	8.1	8.9	9.1	3.8	0.1	26.3	25.9	25.3	7.7	22.4	26.1	11.2	17.6	28.2	14.4	13.5	14.2	0.6	59.8	23.6	5.7	12.6	29.6	4.2	1.9	70.4	1.5	22.4	1.4	2.8	1.5	6.9	2.0	2.0	6.1	5.8	2.6	2.5	5.4	11.5	8.2	0.3	3.0	0.7	1.4	5.1	1.8	37.0	35.8	43.4	43.8	38.6	33.3	34.3	28.9	33.6	22.5	32.0	35.4	2.0	3.2	2.7	23.2	6.4	7.4	18.1	14.8	9.1	40.2	9.6	5.8	1.9	32.9	11.1	18.4	12.5	24.2	2.2	14.2	0.0	16.1	3.2	3.3	7.6	2.1	10.8	1.7	60.9	5.6	12.3	14.0	23.4	4.5	2.5	9.0	1.4	12.1	4.5	40.4	58.0	15.2	38.7	3.2	4.4	1.8	12.5	3.2	10.6	17.8	2.8	9.7	4.1	31.2	25.5	6.3	17.8	7.9	1.9	9.3	11.9	6.1	7.2	19.3	6.6	16.0	9.4	13.9	15.5	5.7	4.3	16.8	7.2	17.0	17.9	13.9
GGTA1	"GGTA, GGTA1P, GLYT2"	ENSG00000204136	"Glycoprotein alpha-galactosyltransferase 1 (inactive)"	Q4G0N0	9	121444991-121499844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 133.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Endothelial cells: 2.2;granulocytes: 3.8;Macrophages: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.7;intermediate monocyte: 17.9;myeloid DC: 12.7;plasmacytoid DC: 27.5"	"Group enriched"	"Detected in many"	19	"dendritic cells: 27.5;monocytes: 22.7"	"Group enriched"	"Detected in some"	6	"AN3-CA: 4.3;HEL: 1.3;SH-SY5Y: 4.9"									HPA023262	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"			"HPA023262: AB_1849651"	"unprognostic (1.71e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.49e-2)"	"prognostic favorable (5.33e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.85e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.87e-2)"	33.4	18.5	15.4	10.1	18.9	68.2	40.4	12.7	19.9	17.2	14.4	14.9	12.0	10.7	7.4	24.2	10.1	23.1	18.7	16.4	15.3	5.7	15.0	21.9	25.7	13.9	15.2	7.6	5.0	4.8		41.7	13.7	6.5	15.4	0.5	133.2	15.3	5.0	13.6	16.1	12.5	14.1	40.4	8.7	4.1	16.0	9.9	5.1	13.4	10.4	21.4		14.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	17.9	0.0	0.7	0.0	0.0	12.7	0.0	0.0	0.0	1.2	0.1	0.4	27.5	0.0	7.2	15.4	18.9	12.7	19.9	16.4	15.3	13.9	15.2	13.7	14.1	16.0	14.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"lung: 32.3;testis: 18.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 137.8;Early spermatids: 45.2;Late spermatids: 130.2;Spermatocytes: 33.6"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"									"HPA045635, HPA047534"	Uncertain					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	32.3	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.5	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	137.8	15.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	33.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 18.0"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 22.4;Early spermatids: 24.6;Late spermatids: 28.4;Spermatocytes: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.6;U-2 OS: 3.3"									"HPA045635, HPA047534"	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	18.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	22.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"kidney: 10.5;thyroid gland: 8.2"	"Group enriched"	"Detected in some"	10	"Alveolar cells type 1: 3.2;Early spermatids: 5.3;Late spermatids: 12.1;Spermatocytes: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 1.5;U-2197: 1.0"									"HPA045635, HPA047534"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.5	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	10.5	0.1	2.2	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.2	2.3	0.1	0.0	8.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GH1	"GH, GH-N, GHN, hGH-N"	ENSG00000259384	"Growth hormone 1"	P01241	17	63917200-63918839	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	868	"pituitary gland: 59365.3"	"Cell type enhanced"	"Detected in single"		"Adipocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043715	Supported				"Secreted to blood"	NA	NA	2690000	6400000		"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 57: B-cells - Immune response"			"HPA043715: AB_2678632"	"unprognostic (1.91e-2)"							"unprognostic (3.51e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.45e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.03e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.33e-1)"		14.8	68.3	0.1	0.0	0.1	0.1	2.1	0.1	0.6	1.9	0.1	3.7	0.5	4.1	0.0	9.5	2.8	0.0	7.8	0.1	0.4	4.1	18.4	3.5	0.0	0.1	0.1	6.1	7.7	0.0	59365.3	0.8	0.1	5.5	0.0	0.0	4.8	0.0	3.5	36.2	3.9	0.0	0.1	7.7	11.8	7.2	0.1	0.3	5.4	0.1	0.0	1.5	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881944	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	79	"pituitary gland: 102.4;placenta: 127.5"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 8.6;Syncytiotrophoblasts: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 8.4"									HPA043715	Supported				"Secreted to blood"	NA	NA		4200000		"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA043715: AB_2678632"															"unprognostic (1.02e-1)"			0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	102.4	127.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	23.7	0.0	0.0	0.0	0.0
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	15.7	32.9	14.3	10.1	15.2	11.8	15.8	15.1	16.2	18.6	15.2	15.3	15.8	15.1	11.0	8.8	15.9	10.6	12.3	13.9	15.8	24.5	18.6	15.9	13.2	18.3	15.7	22.2	26.4	12.8	16.7	9.3	16.7	20.7	5.3	3.8	24.1	14.2	7.8	9.8	19.4	5.3	15.0	32.2	19.5	5.9	15.5	7.4	26.8	5.7	6.5	15.5	13.3	16.3	7.5	26.1	1.8	20.5	6.8	6.0	16.1	9.9	7.7	5.0	6.5	8.4	35.4	11.4	34.9	9.2	6.1	0.6	5.8	0.2	1.2	18.8	21.1	17.3	11.9	18.0	17.7	13.9	70.4	9.1	5.3	13.7	4.2	6.1	7.8	6.9	16.8	50.0	2.6	9.2	9.0	27.1	4.4	28.1	0.0	8.7	9.5	49.8	13.8	6.0	4.0	13.9	0.3	46.1	34.4	0.4	31.8	22.0	6.7	23.3	9.2	20.4	4.7	37.3	31.3	7.7	19.7	17.3	9.6	0.8	3.2	1.8	2.3	3.0	1.0	2.5	1.5	2.3	2.7	4.1	1.5	1.8	1.6	1.1	4.1	2.4	1.4	2.6	14.3	15.2	15.1	16.2	13.9	15.8	18.3	15.7	16.7	15.0	15.5	16.3	16.2	0.0	9.6	4.9	9.9	2.9	9.3	8.8	2.2	7.6	8.8	7.1	2.1	14.3	6.7	16.5	6.2	13.1	8.7	5.1	3.9	12.9	1.0	5.6	8.5	12.6	13.8	4.6	2.6	19.3	11.6	10.0	6.1	8.9	13.3	6.5	28.5	15.3	27.9	8.4	4.3	10.7	8.2	25.5	5.4	1.3	11.5	12.6	8.8	2.8	9.3	16.2	13.4	1.0	3.5	10.3	4.8	13.9	4.7	6.5	25.6	16.5	7.8	5.5	0.0	12.8	6.3	2.8	0.5	2.2	1.8	7.3	9.5	15.9	9.4	5.4
GHITM	"DERP2, HSPC282, My021, PTD010, TMBIM5"	ENSG00000165678	"Growth hormone inducible transmembrane protein"	Q9H3K2	10	84139509-84153568	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1114.2;Late spermatids: 2559.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016464, HPA061664"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA016464: AB_1849656, HPA061664: AB_2684579"	"unprognostic (6.26e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (5.71e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (2.32e-10)"	"unprognostic (2.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	113.9	179.5	124.3	87.0	133.3	110.6	93.8	138.6	147.7	73.1	150.6	171.2	163.5	76.8	86.1	114.4	71.4	68.9	365.3	136.1	146.1	300.7	271.1	74.1	87.3	136.6	128.1	72.7	77.7	197.3	88.8	70.3	138.5	80.6	166.4	144.3	94.4	84.2	369.3	79.7	137.1	85.7	125.4	73.8	123.1	115.7	137.5	86.5	105.9	456.6	103.3	92.3	76.5	123.1	228.2	230.8	97.1	223.5	162.6	143.3	171.6	153.3	267.4	193.7	180.2	283.1	183.8	178.9	167.7	203.2	170.9	199.9	208.4	200.0	185.9	179.8	157.4	127.7	227.3	281.0	306.5	402.0	200.0	162.7	384.1	200.4	577.8	201.8	169.9	150.5	299.9	324.3	180.4	197.4	143.6	318.9	98.3	184.8	203.2	128.3	89.4	270.5	271.4	179.2	79.4	92.4	154.7	134.1	325.1	111.2	273.7	254.2	145.3	94.0	126.5	138.5	251.1	227.9	265.7	199.9	246.8	364.4	67.1	293.7	284.9	276.5	173.9	304.7	194.2	211.0	178.9	186.0	279.9	177.9	166.6	178.8	223.7	206.7	281.3	145.3	235.3	578.0	124.3	133.3	138.6	147.7	136.1	146.1	136.6	128.1	138.5	125.4	137.5	123.1	94.1	96.1	87.6	23.2	138.0	170.3	185.1	440.9	87.0	135.9	102.2	71.8	689.3	140.2	235.8	158.2	70.9	260.4	134.0	376.0	579.2	295.3	1114.2	58.7	68.6	120.7	125.6	242.9	33.6	232.3	234.9	119.6	107.6	67.1	102.0	79.3	88.5	326.1	267.7	101.0	34.5	206.0	443.5	156.2	169.2	2559.1	110.3	153.0	163.7	16.9	228.3	269.0	114.4	14.6	24.3	223.3	276.3	136.9	167.3	180.1	343.7	802.9	173.4	159.9	144.7	114.5	219.8	263.1	153.2	150.4	170.3	386.0	141.6	158.4	281.4	212.9
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.7;liver: 213.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000		"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	84.7	5.6	1.8	1.7	2.1	0.2	30.1	1.7	1.7	5.2	2.3	5.8	1.1	4.5	4.6	3.9	5.4	5.2	8.9	1.8	5.6	11.8	213.3	4.0	1.3	1.0	2.0	7.5	2.1	5.5	1.2	4.8	1.4	11.1	5.7	0.4	3.7	4.7	45.7	5.6	4.3	4.0	1.1	4.0	6.1	1.7	3.4	2.3	4.6	11.6	0.9	5.0	5.8	1.4	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.7	1.7	1.8	5.6	1.0	2.0	1.4	1.1	3.4	1.4	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285666-10292947	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"stomach 1: 356.1"	"Cell type enriched"	"Detected in many"	52	"Gastric mucus-secreting cells: 1123.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	350000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	0.5	0.5	3.5	3.1	4.1	4.4	1.5	4.0	7.6	0.5	3.0	2.2	19.0	0.7	4.8	1.8	0.7	2.3	1.3	3.3	2.8	0.9	1.4	1.0	7.4	3.2	2.8	1.3	4.1	0.7	0.7	0.5	3.5	1.0	0.6	2.0	1.4	0.3	2.0	2.1	3.1	0.9	2.0	2.5	356.1	1.1	2.7	1.3	1.3	0.2	3.1	1.4	0.5	2.9	0.6	0.2	2.6	2.0	1.8	0.0	4.8	2.4	0.0	0.7	0.2	2.9	0.5	1.5	0.9	0.1	2.1	0.4	0.0	0.6	0.0	0.4	2.9	3.1	2.1	6.3	0.0	3.2	5.3	0.3	0.0	0.0	0.1	0.2	0.5	1.9	1.3	14.4	0.0	0.7	1.2	4.3	1.3	0.5	5.3	0.8	0.2	0.8	0.0	2.4	1.9	0.3	1.6	1.1	0.1	1.7	1.1	3.8	2.6	1.2	0.7	1.1	1.7	1.7	2.6	2.9	0.4	3.5	0.5	17.5	11.0	12.4	0.2	5.5	0.1	2.1	0.2	0.0	41.8	1.0	0.3	0.1	25.7	4.4	0.4	28.5	0.2	3.8	3.5	4.1	4.0	7.6	3.3	2.8	3.2	2.8	3.5	2.0	2.7	2.9	0.6	0.0	1.1	1.3	4.9	1.3	4.6	0.2	0.0	7.8	0.8	0.6	0.3	0.0	0.2	1.8	10.4	1.7	10.5	0.5	0.0	1.0	0.3	0.2	0.7	1.5	0.0	0.0	1.0	1.3	1.5	1.0	1123.8	0.8	0.0	0.6	1.8	0.1	1.8	3.3	0.6	0.1	0.0	3.8	8.8	1.0	0.3	5.7	1.8	2.8	7.4	2.2	21.6	0.0	0.7	0.9	0.1	0.4	0.7	4.9	1.5	0.2	0.2	9.1	6.6	4.0	0.9	1.7	1.3	0.0	0.6	0.3	4.0	0.7	0.8	2.2
GID4	"C17orf39, VID24"	ENSG00000141034	"GID complex subunit 4 homolog"	Q8IVV7	17	18039408-18068405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.1"	"Group enriched"	"Detected in many"	12	"Early spermatids: 665.5;Late spermatids: 1287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044348	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044348: AB_10959602"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	7.6	5.1	8.3	4.7	7.7	5.8	6.0	9.6	8.6	6.7	5.0	10.0	4.2	7.3	6.5	11.6	6.1	5.1	10.1	7.5	6.6	5.9	5.5	5.3	5.5	7.7	7.6	7.8	7.6	10.5	3.0	6.5	7.7	6.7	4.6	5.7	7.9	7.9	27.7	12.4	4.6	8.5	7.0	5.7	5.8	69.1	7.8	7.2	6.7	14.4	6.0	8.8	7.3	7.7	11.8	12.1	6.7	10.9	17.2	16.8	11.4	9.6	15.6	10.5	11.8	10.2	4.5	14.9	8.1	11.3	9.6	13.1	9.8	10.6	13.7	8.1	19.6	6.6	9.5	7.5	14.9	3.9	11.1	12.5	18.6	10.5	16.3	13.9	11.8	20.9	6.0	4.1	8.6	3.0	12.8	8.4	5.9	14.4	8.8	10.8	23.9	14.8	7.2	4.6	5.0	7.6	6.5	5.7	7.2	64.9	3.6	5.0	10.0	6.7	3.8	15.7	4.9	7.3	6.7	3.2	9.6	6.7	8.8	4.3	1.1	3.6	1.2	0.6	1.3	2.6	1.1	1.2	0.9	2.0	1.3	1.4	2.9	2.0	0.8	1.6	1.9	0.6	8.3	7.7	9.6	8.6	7.5	6.6	7.7	7.6	7.7	7.0	7.8	7.7	8.7	0.0	1.1	5.2	6.0	11.1	7.5	4.5	4.6	5.8	6.4	7.0	12.4	5.7	3.1	1.8	4.2	8.3	6.1	4.1	9.8	5.3	665.5	5.4	9.5	8.4	1.2	17.2	8.2	5.7	15.2	8.0	1.1	5.5	5.7	10.7	8.2	6.8	7.3	16.8	8.1	4.9	0.0	9.5	7.7	1287.8	12.8	7.4	7.2	11.2	9.7	5.4	10.3	9.5	9.8	9.1	1.6	15.8	5.0	16.3	6.9	11.4	3.5	3.9	13.1	8.6	9.0	78.1	26.3	7.2	18.2	15.5	5.9	7.0	4.4	8.0
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938147-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	12.5	13.3	18.8	13.5	18.3	39.2	17.1	18.7	18.3	19.1	16.7	16.6	13.8	16.3	16.8	41.8	20.1	11.1	14.2	19.2	18.6	17.2	24.7	12.7	20.7	17.8	18.4	26.3	20.4	19.0	15.9	13.0	17.4	16.2	14.3	13.0	17.1	14.8	14.8	30.5	15.5	12.5	18.8	16.9	18.1	13.7	19.2	25.3	18.4	13.2	23.1	15.6	22.5	18.3	39.9	25.0	36.6	33.2	29.5	23.1	35.8	21.8	18.2	61.1	27.5	121.4	37.9	49.9	36.5	28.4	25.1	45.2	33.9	45.3	36.9	13.4	16.6	46.5	32.8	58.6	23.2	54.5	37.7	25.6	49.4	26.4	30.4	22.2	30.1	32.5	36.3	21.0	21.3	56.0	65.3	48.4	37.0	66.1	37.0	51.1	68.8	29.9	22.5	55.4	38.0	31.0	51.5	49.9	32.8	27.0	69.5	51.9	30.6	36.4	45.4	28.8	29.9	21.9	27.0	51.2	24.6	26.2	23.5	5.3	9.5	15.4	9.8	8.3	11.6	7.4	10.4	11.1	8.9	8.2	11.2	12.7	13.5	12.3	7.7	6.7	9.9	8.1	18.8	18.3	18.7	18.3	19.2	18.6	17.8	18.4	17.4	18.8	19.2	18.3	33.5	19.2	27.4	11.4	42.7	51.6	46.9	76.6	50.1	23.1	56.4	53.0	30.9	52.9	46.5	40.5	6.2	101.7	48.6	57.3	41.1	44.7	19.1	46.4	27.4	37.7	45.0	71.1	17.7	40.4	105.1	35.1	27.0	40.1	26.6	24.4	46.4	77.7	51.8	16.8	15.0	50.1	50.8	47.9	46.4	19.4	32.9	42.9	24.9	11.2	62.1	28.3	51.5	11.6	14.4	40.8	39.2	42.2	44.0	68.2	55.7	42.5	38.8	16.5	13.1	34.1	30.7	49.1	57.9	82.1	79.8	156.9	45.8	21.6	52.1	71.7
GIGYF1	"GYF1, PERQ1"	ENSG00000146830	"GRB10 interacting GYF protein 1"	O75420	7	100679507-100694250	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 100.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020999, HPA023995"	Enhanced		Approved	Vesicles,Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Microtubules	"HPA020999: AB_2111744, HPA023995: AB_1855221"	"unprognostic (3.82e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.42e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.43e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.67e-3)"	25.7	25.9	21.1	15.6	21.1	30.5	26.9	27.7	24.1	36.1	21.3	26.5	15.8	34.9	11.0	19.1	30.2	10.4	22.4	19.5	17.3	27.3	23.1	22.6	18.9	20.9	18.8	43.4	36.1	13.5	41.9	11.4	18.7	28.5	8.0	8.8	29.6	13.7	26.5	33.5	30.7	11.2	16.2	39.1	25.1	32.2	21.4	17.2	32.8	16.7	11.3	23.5	23.6	24.0	16.5	16.8	26.1	38.2	12.3	9.6	46.6	15.3	12.4	9.4	10.8	9.8	27.6	22.9	19.2	11.1	19.0	19.4	12.9	15.3	5.8	24.4	26.4	15.9	48.5	14.3	12.2	18.1	26.1	15.1	12.2	12.0	17.0	15.3	9.5	26.4	44.8	21.9	8.7	37.5	32.1	100.1	32.0	6.5	20.1	51.2	13.9	23.1	6.9	14.8	23.3	36.7	19.8	31.2	18.2	17.6	14.2	30.2	14.7	26.8	32.9	44.7	14.2	17.8	8.4	12.3	15.6	35.9	16.2	2.2	1.3	1.2	2.4	1.2	1.8	1.3	1.6	1.5	0.5	1.9	1.4	1.5	4.5	1.3	1.3	2.0	0.9	0.5	21.1	21.1	27.7	24.1	19.5	17.3	20.9	18.8	18.7	16.2	21.4	24.0	26.5	3.2	7.8	19.9	18.1	31.7	11.0	5.8	8.0	25.5	25.5	20.6	8.3	32.9	5.8	18.4	18.8	12.0	31.2	19.5	15.6	11.5	1.0	12.2	24.3	17.5	18.6	9.9	18.1	9.4	10.7	17.8	18.8	17.5	5.7	26.5	22.5	19.0	11.4	52.2	17.7	22.8	6.1	25.5	19.8	3.8	24.5	15.6	17.8	29.0	12.5	15.3	20.6	14.6	22.6	11.8	18.0	18.0	10.5	16.7	20.4	9.9	5.0	28.0	32.9	33.2	19.6	16.4	36.0	6.8	22.4	16.3	20.5	12.9	16.1	10.2
GIGYF2	"GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15"	ENSG00000204120	"GRB10 interacting GYF protein 2"	Q6Y7W6	2	232697299-232860605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 333.8;Late spermatids: 563.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050899, HPA054612, HPA059918, HPA065064"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417"	"unprognostic (7.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.61e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.40e-3)"	"unprognostic (8.01e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (7.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.66e-1)"	19.1	19.4	13.5	19.1	17.2	21.6	23.1	23.5	14.6	19.0	11.4	17.8	17.6	21.3	13.8	20.4	18.1	15.7	25.6	13.5	18.5	25.2	15.8	16.7	20.4	14.6	13.6	27.4	25.5	40.5	9.6	22.0	15.9	22.0	19.5	22.9	28.4	17.0	37.5	21.2	20.0	18.5	11.4	21.3	21.5	37.9	15.5	24.6	25.9	32.1	21.4	18.6	12.4	21.6	34.3	30.8	37.2	38.1	51.2	44.7	44.1	37.9	36.5	31.3	33.0	30.6	29.6	20.1	9.3	33.5	59.8	36.6	44.2	34.7	41.2	49.4	32.1	71.6	30.5	46.9	36.7	61.3	44.9	31.1	34.6	38.1	59.2	33.6	34.9	33.5	72.8	24.2	33.1	36.5	40.7	24.3	37.5	29.8	25.7	38.7	74.5	27.8	28.6	51.8	33.4	27.5	41.8	30.5	37.7	32.9	29.8	40.1	53.1	33.6	28.6	34.1	29.6	47.6	26.1	40.3	31.6	35.0	31.3	39.2	10.7	13.1	8.0	7.8	10.5	6.1	7.1	7.9	11.2	10.6	8.5	7.9	13.7	13.4	18.9	8.3	10.7	6.4	13.5	17.2	23.5	14.6	13.5	18.5	14.6	13.6	15.9	11.4	15.5	21.6	31.3	57.7	68.4	98.2	26.7	15.7	36.9	25.8	23.9	50.6	29.6	26.0	85.5	25.8	50.8	36.8	60.5	32.2	28.0	28.8	25.4	31.1	333.8	41.2	54.5	36.8	19.2	41.0	105.0	27.3	22.0	36.7	25.0	45.0	17.7	35.4	20.0	28.8	28.5	48.8	131.2	27.9	24.4	29.3	12.1	563.9	37.6	31.8	26.6	98.4	32.9	38.8	42.2	116.6	171.7	29.2	15.0	36.9	39.0	40.6	29.5	18.5	43.3	38.7	26.3	55.0	36.0	128.4	93.4	27.3	19.2	73.2	28.8	46.3	30.3	37.4
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716606-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 189.8;Endothelial cells: 109.9;Hepatic stellate cells: 117.8;Kupffer cells: 109.1;monocytes: 74.9;NK-cells: 185.3;T-cells: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 14.7;MOLT-4: 9.2;TIME: 3.9"	"Low region specificity"	"Detected in many"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	9.8	2.5	3.0	11.0	3.0	1.0	7.9	2.9	3.5	3.8	3.0	3.7	3.5	4.6	1.1	2.1	4.4	3.2	9.3	2.8	2.9	3.5	2.4	8.9	19.6	3.5	3.2	1.5	1.4	1.5	1.1	7.1	3.4	2.3	2.2	0.1	2.5	2.0	5.4	2.5	6.9	3.8	3.5	24.7	3.3	0.8	3.6	6.6	5.3	7.1	8.4	3.5	3.0	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.7	1.9	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	32.2	0.1	43.8	29.6	51.1	0.3	47.5	54.2	13.5	0.6	68.2	56.2	2.7	42.6	30.6	0.8	34.0	35.0	3.0	3.0	2.9	3.5	2.8	2.9	3.5	3.2	3.4	3.5	3.6	3.2	189.8	3.2	1.5	0.0	5.1	5.5	0.6	0.0	1.2	0.6	1.9	3.6	5.9	2.8	0.6	0.0	0.0	0.3	51.5	0.1	0.0	0.3	0.3	0.4	0.6	109.9	0.0	10.5	0.0	0.4	0.3	3.7	1.5	0.2	8.2	0.2	117.8	2.0	37.9	0.0	0.0	0.0	0.0	109.1	7.6	1.3	1.5	48.0	8.8	0.0	74.9	0.3	185.3	0.0	0.0	0.1	0.1	0.0	7.6	0.7	0.2	0.5	0.0	1.0	0.0	2.5	3.5	0.3	0.5	0.7	3.1	0.4	97.3	1.0	0.0	0.7
GIMAP2	"DKFZp586D0824, HIMAP2, IAN12, IMAP2"	ENSG00000106560	"GTPase, IMAP family member 2"	Q9UG22	7	150685697-150693641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 45.0;Kupffer cells: 132.3;monocytes: 74.4;NK-cells: 96.8;T-cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 62.7;JURKAT: 34.9;MOLT-4: 79.5;REH: 34.0;U-937: 32.4"					"Not detected"	"Not detected"			"HPA013589, HPA014746"	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Lipid droplets"	Nucleoplasm	"HPA013589: AB_1849666, HPA014746: "	"prognostic favorable (3.50e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.91e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.08e-2)"	11.7	6.9	6.7	40.3	6.6	11.6	11.9	7.1	9.7	10.6	6.5	11.8	12.4	10.7	8.9	4.9	8.3	17.0	8.0	6.3	6.9	6.0	17.0	22.0	78.4	9.2	7.4	16.9	2.1	2.7	2.6	19.6	8.5	5.0	15.7	0.5	6.5	6.2	4.2	5.8	19.4	11.4	8.3	62.1	11.9	1.8	7.4	50.2	6.1	12.3	57.4	15.7	5.2	8.7	1.6	0.0	0.0	0.0	0.6	0.6	0.8	0.0	18.1	2.2	5.1	0.0	23.7	4.2	0.4	1.4	9.8	1.0	0.0	1.0	0.2	19.8	0.0	12.8	0.0	0.5	2.8	9.9	12.6	6.8	1.8	1.7	0.1	5.3	62.7	34.9	0.4	4.9	1.0	0.0	79.5	24.9	0.0	0.0	0.0	34.0	0.6	9.7	0.1	5.9	0.0	0.0	0.1	0.1	6.3	0.0	0.9	25.2	14.2	0.9	0.3	0.2	0.1	5.6	5.5	0.0	2.3	32.4	3.4	15.1	83.8	7.3	93.9	118.3	118.3	15.8	122.0	114.8	47.6	15.8	166.7	124.8	40.7	136.2	121.4	5.7	107.6	130.2	6.7	6.6	7.1	9.7	6.3	6.9	9.2	7.4	8.5	8.3	7.4	8.7	15.5	12.8	2.2	1.0	11.8	3.3	1.9	0.6	1.2	0.1	1.7	1.3	1.1	1.5	1.1	0.0	0.0	0.4	22.8	1.5	0.0	1.6	0.0	3.8	3.8	27.8	0.0	13.5	0.1	0.7	0.7	3.4	1.1	1.1	19.7	1.4	45.0	4.2	38.1	0.0	0.2	4.2	6.1	132.3	11.1	0.1	4.1	38.5	1.8	7.5	74.4	0.9	96.8	2.0	0.3	1.0	2.9	0.7	4.0	2.2	8.4	1.2	4.6	0.1	6.6	1.7	1.1	0.1	0.3	0.5	3.1	0.4	57.7	4.8	3.7	2.5
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567369-150573953	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 326.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019135, HPA019137, HPA027198"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	46.1	18.3	15.0	75.1	15.6	4.2	31.8	16.2	21.2	19.7	16.3	21.2	16.5	23.0	9.6	12.0	18.7	24.6	31.3	14.3	16.0	17.3	29.9	50.8	127.7	19.2	18.0	7.7	6.7	9.6	6.0	48.7	18.0	10.2	22.4	1.5	11.2	13.3	17.5	8.4	25.0	38.3	18.8	115.6	18.0	4.2	16.4	30.5	21.1	48.1	85.1	31.1	11.6	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	326.4	3.4	0.1	0.3	0.0	0.0	0.4	0.2	0.4	0.0	0.0	12.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	370.2	5.2	325.8	390.9	404.2	3.0	408.0	402.8	122.1	1.3	424.3	361.9	339.7	263.4	320.4	5.3	312.1	776.9	15.0	15.6	16.2	21.2	14.3	16.0	19.2	18.0	18.0	18.8	16.4	18.7	182.3	3.2	12.4	0.3	7.3	6.8	0.2	0.0	3.4	0.1	2.2	4.7	9.9	5.7	1.8	11.0	0.0	0.6	82.6	0.0	0.0	0.2	0.6	0.3	0.4	195.2	0.0	9.7	0.5	0.2	0.8	9.0	2.0	0.3	6.3	0.0	222.0	3.7	96.4	0.0	0.1	0.0	0.0	197.2	20.9	1.7	5.0	110.0	10.6	18.7	176.0	0.2	344.0	0.0	0.1	0.1	0.0	0.0	14.7	0.4	0.0	1.9	0.7	0.4	13.1	3.9	7.9	0.0	0.8	1.1	6.1	0.8	186.2	0.8	0.0	0.3
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.3;Endothelial cells: 83.5;Hepatic stellate cells: 92.1;Kupffer cells: 75.2;monocytes: 37.4;NK-cells: 91.6;T-cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 75.1;NK-cells: 217.3;T-cells: 127.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.4;HUVEC TERT2: 124.9;MOLT-4: 43.3;TIME: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026715, HPA050740"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA026715: AB_1849675, HPA050740: AB_2797239"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.91e-4)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	42.0	9.4	9.7	33.9	9.7	2.5	21.8	9.7	10.6	14.9	8.0	12.0	13.6	19.3	7.3	8.4	16.9	14.7	29.1	8.0	9.5	12.4	12.7	38.8	50.2	11.4	10.5	5.7	5.2	8.0	3.3	32.3	11.3	6.4	12.2	0.6	7.8	10.0	24.7	6.4	18.7	25.8	10.9	64.0	11.6	3.2	11.6	29.3	14.2	34.7	33.9	16.5	6.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	6.3	0.0	0.0	0.0	0.4	18.4	0.1	0.0	0.0	0.0	0.0	124.9	0.5	0.0	4.6	0.0	0.0	43.3	5.4	0.0	0.0	0.0	4.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.8	35.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	13.0	0.0	11.6	58.1	2.1	112.9	75.1	127.2	0.4	104.3	120.2	22.1	0.3	108.3	103.0	8.0	217.3	60.2	0.7	105.7	163.5	9.7	9.7	9.7	10.6	8.0	9.5	11.4	10.5	11.3	10.9	11.6	10.1	95.3	0.0	1.1	0.0	3.1	3.8	0.1	0.0	0.6	0.0	1.1	1.0	7.4	0.0	0.0	0.0	0.0	0.2	24.5	0.1	0.0	0.0	0.4	0.1	0.2	83.5	0.0	19.4	0.0	0.2	0.3	3.4	0.0	0.2	2.5	0.3	92.1	1.7	30.6	0.0	0.0	0.1	0.0	75.2	6.5	2.2	1.2	20.0	1.8	13.1	37.4	0.1	91.6	0.0	0.1	0.1	0.0	0.0	2.9	0.1	0.0	0.2	0.7	0.4	0.0	2.6	2.2	0.3	0.1	0.4	3.1	0.4	41.2	1.2	0.0	0.3
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514872-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 170.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 92.9;MOLT-4: 78.6"	"Not detected"	"Not detected"							"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	49.8	15.0	16.3	73.6	17.4	6.6	37.4	17.1	21.3	19.2	16.0	20.3	21.1	27.8	19.8	12.6	21.5	22.1	40.1	15.5	17.2	20.9	20.4	61.0	170.1	19.0	17.8	7.4	7.6	10.5	5.6	31.5	19.1	10.9	23.3	1.2	13.7	12.0	27.8	9.3	40.1	33.6	17.6	124.3	22.0	4.5	18.0	52.5	28.2	56.1	99.2	29.6	13.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	92.9	9.4	0.0	0.0	0.0	0.0	78.6	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.7	656.5	9.6	1184.0	595.9	1164.2	6.5	1762.9	1440.6	286.3	6.5	2269.3	1597.2	52.5	1121.0	666.6	16.3	1076.9	2581.7	16.3	17.4	17.1	21.3	15.5	17.2	19.0	17.8	19.1	17.6	18.0	17.6	265.8	0.0	13.2	0.3	13.1	2.4	0.4	0.0	2.8	0.0	2.8	5.6	14.6	5.7	0.6	1.8	0.0	0.2	125.1	0.2	0.0	0.5	1.3	0.9	0.6	263.3	0.0	17.0	0.0	0.7	0.0	8.0	3.1	0.7	13.9	0.0	267.4	5.3	15.5	0.0	0.0	0.1	0.0	156.8	10.6	2.0	2.5	54.9	1.8	22.5	140.8	0.4	632.4	0.5	0.1	0.4	1.2	0.4	19.3	0.2	0.0	1.7	0.7	0.4	0.0	6.0	9.4	0.2	0.9	1.1	3.3	0.4	255.9	0.9	0.2	0.0
GIMAP8	"DKFZp667I133, hIAN6, IAN9"	ENSG00000171115	"GTPase, IMAP family member 8"	Q8ND71	7	150450630-150479393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.4;Endothelial cells: 66.0;Hepatic stellate cells: 86.0;Kupffer cells: 75.1;Microglial cells: 32.8;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 59.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014474, HPA017765"	Supported					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014474: AB_1849685, HPA017765: AB_1849683"	"unprognostic (7.86e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.31e-1)"	20.3	5.7	4.4	21.3	5.0	0.7	16.0	4.7	5.5	9.8	5.5	6.7	6.8	10.4	3.1	4.3	9.0	7.5	17.4	4.1	4.5	8.3	9.4	27.0	23.2	5.4	4.9	3.5	2.8	4.6	2.6	15.4	5.4	4.9	7.2	0.3	4.3	5.3	9.8	4.7	10.5	12.7	5.4	40.6	5.0	2.0	5.1	7.3	11.9	15.1	13.5	8.4	5.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.7	0.0	9.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.5	45.2	0.0	15.3	59.0	17.4	0.5	14.8	13.9	13.0	0.0	16.7	13.6	4.8	15.5	57.4	0.7	7.7	26.8	4.4	5.0	4.7	5.5	4.1	4.5	5.4	4.9	5.4	5.4	5.1	5.8	67.4	3.2	5.3	0.3	0.8	3.1	0.5	0.0	1.8	0.0	0.4	0.8	5.5	5.7	0.0	1.8	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.2	0.1	66.0	0.0	1.3	0.1	0.0	0.0	2.3	0.5	0.2	3.8	0.0	86.0	1.6	6.8	0.0	0.1	0.0	0.0	75.1	2.8	0.9	0.3	21.9	0.0	32.8	44.2	0.0	19.6	0.0	0.1	0.0	0.0	0.0	2.2	0.9	0.0	0.2	1.5	0.0	0.0	1.5	1.2	0.2	0.4	0.5	1.7	0.1	11.1	0.2	0.0	0.4
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: AB_2684491"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	2.2	4.0	1.8	2.9	2.0	0.6	4.3	3.0	3.5	3.4	1.3	2.5	2.5	3.2	3.6	2.2	3.2	1.7	6.7	1.7	2.3	4.3	4.3	2.3	3.6	2.2	2.1	5.4	2.9	5.2	1.1	2.4	2.1	3.5	3.2	7.2	3.0	3.6	7.8	2.4	2.5	2.8	2.2	3.0	3.2	4.7	2.2	4.2	4.1	6.9	3.5	2.7	1.7	3.2	4.0	4.7	5.8	4.0	2.8	7.1	4.4	5.6	3.8	4.0	3.6	2.6	5.3	2.5	5.0	2.2	3.5	4.7	5.4	7.9	5.3	3.3	4.4	3.5	4.2	3.1	5.5	3.5	2.3	2.6	8.7	3.6	7.3	4.8	3.0	4.1	3.3	3.6	6.4	2.9	4.6	2.3	4.6	3.3	7.0	4.0	6.4	6.0	5.3	3.4	5.1	3.2	4.3	2.8	5.6	4.1	8.7	5.9	2.4	4.0	2.5	4.4	4.2	4.4	3.5	3.6	5.3	5.6	3.5	0.4	1.4	2.8	1.7	1.8	2.0	2.6	2.4	2.6	1.7	2.6	2.8	3.0	2.1	2.3	4.0	1.7	4.4	1.4	1.8	2.0	3.0	3.5	1.7	2.3	2.2	2.1	2.1	2.2	2.2	3.2	5.4	9.6	5.3	11.4	6.1	0.9	4.7	12.5	4.0	9.4	3.5	4.4	18.7	2.8	6.5	5.5	0.0	7.7	3.6	2.9	23.5	8.0	1.6	4.3	6.5	3.9	4.2	1.7	9.1	4.3	4.9	4.7	4.1	3.1	16.5	6.1	3.3	4.5	5.5	0.0	12.2	4.0	10.2	3.5	2.0	0.7	5.0	4.8	0.0	4.7	4.8	9.3	5.2	23.1	23.7	4.0	4.7	6.8	2.6	3.6	4.5	8.8	7.6	13.4	6.6	4.0	6.5	23.8	12.2	2.7	2.0	8.2	6.1	5.7	3.6	3.0
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		35000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	56.0	44.0	25.7	24.0	31.4	41.2	45.0	33.9	36.1	47.8	38.5	43.0	25.9	46.4	44.6	32.2	39.2	38.2	58.6	25.0	28.9	92.7	45.7	36.0	26.1	30.6	29.0	50.5	36.8	55.3	24.7	62.6	30.6	40.3	34.8	21.9	32.2	47.4	47.1	36.4	28.1	50.5	29.3	35.1	34.1	48.0	26.9	21.7	73.9	42.3	24.7	42.2	34.0	38.9	27.2	19.5	30.5	41.4	162.6	96.1	48.3	89.0	107.5	68.1	85.1	25.4	35.7	19.4	46.9	87.6	62.9	53.8	20.1	46.0	89.0	33.6	39.6	18.9	17.5	30.5	62.0	37.2	17.2	107.8	39.1	58.0	39.6	74.7	74.7	27.0	24.6	31.8	65.1	35.3	22.9	27.9	10.1	40.2	20.1	25.2	54.0	15.1	97.7	23.9	19.2	18.1	90.1	53.2	18.9	33.5	32.9	38.4	51.3	35.9	37.0	92.9	60.9	30.6	38.6	24.5	67.4	33.1	34.3	21.0	18.5	25.1	8.8	17.8	10.5	22.8	10.2	9.7	13.9	17.0	9.8	8.0	32.1	11.4	23.4	16.9	10.7	10.6	25.7	31.4	33.9	36.1	25.0	28.9	30.6	29.0	30.6	29.3	26.9	38.9	120.5	80.1	53.7	10.1	44.6	46.8	58.6	75.1	46.7	21.3	50.1	50.3	54.1	38.6	53.4	66.2	29.2	81.1	31.4	64.5	39.2	92.7	191.0	42.2	77.3	78.9	26.8	32.2	11.9	80.7	77.1	103.4	18.3	60.7	29.1	48.2	104.6	41.9	45.6	16.8	13.9	23.1	46.8	56.0	47.7	369.6	129.5	46.6	42.7	5.6	75.7	86.5	18.6	17.1	25.0	67.8	33.5	112.8	45.3	65.0	49.8	132.1	33.8	22.6	98.6	85.9	71.1	166.5	82.8	48.7	47.0	122.7	32.0	65.7	22.4	64.0
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407673-25452628	"Disease related genes, Predicted intracellular proteins"	"DNA replication"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 9.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Erythroid cells: 14.7;Extravillous trophoblasts: 17.9;Late spermatids: 21.9;Spermatocytes: 14.2;Spermatogonia: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051185	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	0.7	0.6	0.9	3.2	0.8	3.4	1.6	1.8	1.0	1.0	0.4	3.2	3.0	1.4	0.7	4.3	0.8	0.8	0.5	0.8	0.5	1.1	1.2	0.5	5.3	0.4	0.5	0.9	0.5	0.6	0.2	2.9	0.6	0.8	3.9	0.8	0.8	0.4	0.5	3.7	2.9	2.0	0.3	1.5	2.0	9.0	0.6	7.3	0.6	0.0	5.9	1.3	1.5	0.9	43.6	38.8	46.5	30.4	2.6	3.5	46.7	18.9	9.1	35.5	37.2	33.7	42.1	53.3	21.0	7.9	26.4	49.0	40.9	34.4	40.7	14.3	14.2	36.7	13.8	41.3	0.9	48.5	16.2	1.7	2.0	33.8	6.9	4.7	19.1	30.1	36.1	33.9	21.2	47.0	75.1	36.0	31.8	30.0	20.0	53.1	53.6	35.7	13.6	28.8	19.4	20.3	19.3	45.3	16.7	26.0	42.9	24.2	8.7	27.7	29.9	18.2	35.1	13.6	41.1	42.0	7.4	46.8	32.0	0.2	0.2	0.1	0.3	0.2	0.1	0.5	0.2	0.1	0.5	0.3	0.1	0.3	0.2	0.4	0.2	0.5	0.8	0.2	0.9	0.8	1.8	1.0	0.8	0.5	0.4	0.5	0.6	0.3	0.6	0.9	0.2	0.0	0.6	1.3	1.5	3.2	1.0	1.5	1.8	1.8	1.1	1.3	0.4	0.0	1.6	1.8	0.0	8.2	0.2	1.9	0.0	1.1	60.2	0.5	1.3	1.1	1.2	14.7	6.4	0.7	17.9	2.0	3.6	1.3	1.3	6.8	0.7	0.7	5.9	0.0	3.7	2.5	0.0	1.6	0.8	21.9	0.6	1.2	0.0	1.0	0.0	1.3	0.0	4.0	1.6	0.4	0.6	1.2	8.9	0.6	0.4	2.1	1.7	0.2	0.0	0.5	1.4	14.2	19.7	5.4	1.4	2.5	0.8	2.0	5.5	0.8
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 163.5;Spermatogonia: 148.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 271.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	1.0	0.9	3.0	5.4	2.8	14.7	3.7	3.0	3.7	1.7	2.2	6.4	4.6	1.6	1.3	4.7	1.1	0.4	0.6	4.5	2.2	0.7	3.0	0.8	9.0	2.3	2.4	1.4	0.9	2.6	0.8	3.0	2.3	1.5	7.0	11.1	1.3	0.8	2.7	3.2	5.3	1.6	2.3	3.0	2.2	9.6	2.3	10.2	1.8	1.0	11.0	1.4	2.1	2.6	50.7	36.2	69.0	28.9	2.0	6.7	18.3	33.8	13.7	49.8	30.5	48.2	32.9	60.0	18.1	12.0	26.0	38.0	73.7	28.1	47.9	20.8	63.9	29.2	25.7	54.6	0.3	20.6	15.6	1.8	3.4	30.0	11.5	6.1	21.6	47.5	82.4	13.8	28.9	107.1	72.7	77.8	38.8	45.0	27.3	100.7	41.5	33.1	16.4	20.9	94.2	30.0	49.4	10.0	10.0	27.3	100.0	28.2	12.8	32.1	42.5	30.6	39.5	25.6	48.3	271.9	18.7	43.4	37.2	0.7	0.2	1.1	1.0	1.0	0.1	1.0	3.3	2.3	1.3	0.7	1.6	1.1	0.9	3.2	2.8	0.8	8.5	1.7	3.0	2.8	3.0	3.7	4.5	2.2	2.3	2.4	2.3	2.3	2.3	2.6	0.6	3.2	0.0	0.7	8.5	9.2	7.4	9.5	4.0	20.3	13.1	18.5	1.0	0.0	3.8	3.7	2.1	35.3	3.1	11.9	3.9	8.2	9.8	1.5	3.3	2.4	3.0	43.3	0.5	1.5	31.8	7.2	5.6	2.7	1.3	21.6	0.0	2.1	23.8	8.4	0.4	14.9	4.1	1.3	6.6	29.4	1.2	3.3	0.0	0.0	1.1	5.6	0.0	1.0	0.6	2.0	4.5	1.9	43.1	2.6	2.4	0.7	1.7	7.5	19.7	4.2	7.9	163.5	148.4	13.8	3.8	12.7	4.2	2.2	33.6	7.4
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406147	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 146.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	4.3	7.4	2.0	4.2	4.2	8.4	3.7	3.7	2.6	3.7	2.2	5.8	3.2	2.8	3.7	9.1	2.4	1.5	6.2	2.4	2.5	2.5	2.6	2.1	7.8	3.0	3.5	1.3	1.7	3.7	2.0	3.7	2.7	2.2	4.2	1.8	3.4	4.6	1.8	4.5	2.8	3.8	2.8	5.4	2.6	6.8	3.2	8.8	1.9	4.9	8.0	3.0	6.7	2.7	20.2	22.4	26.5	14.3	2.9	3.7	13.3	22.4	9.8	35.4	26.8	16.9	20.2	35.0	17.5	7.6	26.3	18.7	24.5	18.8	39.6	19.5	30.4	20.4	12.0	20.5	1.6	26.1	33.7	4.2	3.5	18.4	6.3	7.9	24.4	28.9	33.5	14.4	15.0	20.9	48.1	24.2	24.5	17.2	45.3	82.6	29.4	44.4	12.8	12.6	30.3	20.1	37.3	24.3	12.8	10.6	12.9	21.4	10.4	23.5	27.8	14.2	28.4	14.3	20.2	146.3	16.2	26.1	29.3	0.1	1.8	0.1	1.9	1.6	1.5	2.5	1.6	2.9	4.1	4.4	1.5	2.5	0.4	4.1	1.0	8.2	2.4	1.5	2.0	4.2	3.7	2.6	2.4	2.5	3.0	3.5	2.7	2.8	3.2	2.7	3.9	0.0	2.6	9.1	3.2	1.8	4.9	2.7	4.0	1.5	2.0	1.7	4.1	0.0	1.4	0.0	2.1	9.1	4.5	1.6	0.0	3.7	20.7	1.8	2.1	4.3	0.0	12.4	0.6	2.0	7.6	2.5	1.5	7.9	1.3	6.9	3.6	0.8	2.8	5.0	0.2	0.9	0.0	1.6	1.1	9.2	1.5	1.9	1.8	2.8	2.6	1.8	2.1	5.0	1.2	1.9	0.3	1.2	6.2	1.7	0.2	0.5	1.1	1.8	6.6	1.6	3.0	4.6	8.7	13.0	2.4	3.1	2.4	3.2	2.8	4.9
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529218-41545030	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	0.8	0.8	0.9	4.0	1.2	5.9	1.8	1.5	1.1	0.9	0.9	2.1	1.6	1.4	0.7	1.7	0.8	1.5	0.7	0.9	0.9	0.6	1.4	0.7	5.1	1.4	1.0	1.1	0.9	0.6	0.2	2.6	1.2	0.7	3.0	0.8	0.8	0.5	0.5	2.1	1.7	1.5	0.5	1.7	1.3	2.9	1.0	6.2	1.3	0.1	6.0	1.2	0.8	2.3	20.3	28.3	39.4	17.9	2.4	3.1	16.4	28.1	16.9	28.8	33.6	26.4	17.3	28.1	11.2	14.3	21.6	15.0	32.1	23.4	41.9	10.4	17.8	40.8	20.6	17.9	0.6	8.9	20.2	1.7	1.1	47.2	10.4	6.6	14.4	33.0	20.3	9.0	20.4	13.8	37.6	10.1	22.0	21.5	15.4	34.4	36.8	11.8	10.3	19.1	12.2	9.5	20.3	8.8	8.1	19.9	22.8	9.9	10.0	19.3	28.9	36.1	28.8	10.6	16.4	33.0	13.8	20.9	48.3	1.5	0.7	0.3	1.5	0.7	0.9	1.2	2.5	1.0	0.3	2.8	1.5	1.0	1.9	1.4	0.3	2.9	3.7	1.0	0.9	1.2	1.5	1.1	0.9	0.9	1.4	1.0	1.2	0.5	1.0	2.3	1.3	0.0	1.1	0.7	6.4	2.8	2.8	2.3	1.2	4.0	2.1	4.3	0.8	0.0	1.3	9.2	2.1	9.1	5.6	3.7	0.0	1.8	0.9	2.0	2.3	1.9	3.5	9.9	0.2	1.8	12.4	3.5	4.1	3.7	1.3	17.5	1.1	0.5	4.8	0.0	0.7	4.0	4.1	1.8	9.4	0.6	1.2	5.7	0.0	0.0	9.6	1.7	3.1	0.0	2.5	2.1	0.3	2.2	9.2	1.2	0.5	0.9	0.3	2.5	0.0	3.6	5.9	9.6	11.8	2.5	1.1	5.9	6.9	9.0	6.0	1.6
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	209	"intestine: 259.5"	"Cell type enriched"	"Detected in single"	4	"Intestinal goblet cells: 1.9"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 6.6;BEWO: 5.9;Hep G2: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900	540000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	259.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.7	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.5	5.9	0.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	9.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Human disease related genes, Predicted intracellular proteins"			"Congenital muscular dystrophy, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 345.8"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		11000	"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	51.0	54.8	80.0	22.4	91.5	3.3	54.3	88.7	94.4	99.8	64.7	120.2	24.7	53.7	17.6	345.8	48.9	23.4	66.1	74.5	82.1	104.1	58.4	76.3	15.9	89.4	91.4	34.4	43.5	20.8	56.0	28.7	88.1	63.6	41.1	17.9	100.9	31.0	65.1	150.2	45.5	17.5	82.0	37.7	78.7	24.9	91.1	18.6	55.8	23.3	21.0	74.1	140.1	92.3	328.1	148.6	44.7	70.6	40.6	40.7	35.2	119.7	59.8	96.7	87.3	80.3	120.6	4.7	220.3	85.2	64.6	183.8	38.7	100.6	32.6	33.8	69.0	63.9	100.7	79.7	123.7	6.9	75.3	46.7	98.5	58.8	51.3	57.4	66.0	47.2	30.1	54.4	49.9	243.8	21.3	13.3	48.6	182.1	147.8	21.7	37.4	43.7	121.6	281.6	41.8	46.2	67.1	163.2	157.0	23.1	102.5	35.1	115.4	135.7	74.6	191.7	130.1	50.5	70.5	17.3	113.9	51.9	146.2	3.0	0.7	0.1	5.1	1.1	4.7	1.9	5.1	5.1	1.1	0.8	4.2	3.3	0.3	1.5	0.5	3.6	12.0	1.7	80.0	91.5	88.7	94.4	74.5	82.1	89.4	91.4	88.1	82.0	91.1	92.3	30.6	28.9	15.2	22.9	8.3	113.9	77.4	52.1	35.9	69.8	73.6	31.6	14.8	37.1	62.8	82.8	35.5	36.3	19.3	501.1	52.8	167.9	1.1	92.2	30.5	32.4	43.1	1.7	28.8	164.3	77.1	32.6	69.3	76.8	10.2	37.3	23.2	18.0	55.9	75.7	32.2	87.8	42.7	10.8	29.8	2.4	20.5	16.1	58.7	10.3	23.4	73.3	18.6	17.1	71.6	296.7	285.4	25.2	6.8	120.4	36.0	52.7	38.0	46.0	19.7	18.1	44.5	6.4	20.4	107.0	169.8	25.7	22.9	47.7	138.1	199.7
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GIPR		ENSG00000010310	"Gastric inhibitory polypeptide receptor"	P48546	19	45668221-45683722	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 22.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 4.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB022710, HPA068054"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"CAB022710: , HPA068054: "	"unprognostic (2.40e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-4)"	"unprognostic (1.82e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.59e-2)"	10.0	0.3	1.8	3.1	2.6	2.0	9.0	2.3	3.3	2.5	2.7	6.9	3.7	0.3	0.7	2.5	10.2	1.4	15.2	1.8	2.7	3.8	0.7	5.6	2.7	4.1	4.7	0.1	10.8	5.6	0.4	0.2	4.5	7.1	4.9	13.1	7.8	0.4	0.3	4.2	4.2	0.3	1.7	4.0	22.7	0.2	4.4	0.6	2.5	0.0	2.4	2.6	3.4	4.4	0.7	0.4	1.3	0.7	0.6	0.0	0.1	1.0	0.8	0.0	0.7	0.4	3.9	1.9	0.6	0.8	0.7	2.0	0.3	0.2	0.1	9.8	0.3	1.6	1.0	0.3	0.1	0.6	20.6	0.0	0.3	0.1	0.0	1.8	0.0	2.1	4.5	2.2	0.0	0.2	0.1	1.1	0.0	2.9	0.7	0.5	0.4	4.4	0.5	0.9	13.9	1.2	0.0	0.8	0.2	0.5	2.0	3.1	0.4	0.0	0.5	0.3	0.2	16.7	0.2	0.4	0.6	1.5	0.3	1.1	0.1	0.5	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.9	0.0	0.2	0.4	0.2	1.8	2.6	2.3	3.3	1.8	2.7	4.1	4.7	4.5	1.7	4.4	4.4	1.4	3.2	6.3	0.0	1.0	0.9	3.4	2.9	0.0	0.3	2.0	0.5	4.0	5.7	9.8	5.5	0.0	0.0	3.7	13.2	0.0	2.2	0.4	7.1	0.1	0.5	29.9	0.0	0.2	3.6	0.1	0.5	28.1	0.7	1.3	0.1	0.0	0.0	0.1	0.0	0.4	6.8	4.1	0.0	7.8	0.2	0.0	1.4	0.0	0.0	0.5	0.2	1.0	0.0	5.0	5.6	11.3	0.0	4.0	1.5	0.3	0.1	44.5	17.4	13.1	0.3	3.5	0.2	0.3	1.5	0.4	0.1	2.1	0.1	1.9	2.8
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.8;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	30.2	13.5	79.4	18.0	89.3	14.4	29.9	29.1	122.3	22.0	14.9	20.5	17.9	20.9	7.6	28.6	22.5	15.5	28.9	101.2	38.0	18.4	7.6	34.8	21.3	42.5	45.3	21.3	21.9	18.0	23.7	21.1	39.7	21.3	10.1	12.1	19.0	14.4	31.9	34.2	20.5	12.9	31.7	22.3	19.1	88.8	51.8	23.1	23.2	18.5	15.2	21.6	23.6	62.1	49.7	80.9	39.1	69.9	30.4	19.1	45.3	23.9	23.4	28.2	25.1	33.1	18.0	37.3	37.3	31.5	50.5	79.5	41.6	61.4	14.4	48.3	49.7	26.9	39.8	29.8	37.0	34.4	21.3	23.4	69.2	32.4	50.5	40.0	53.0	48.6	22.3	31.2	20.5	50.9	109.0	45.7	29.2	49.9	19.2	81.7	52.3	55.6	25.8	26.7	82.0	70.0	33.8	77.2	117.7	27.9	38.0	45.0	66.2	26.7	38.2	59.3	49.0	25.8	39.3	41.5	43.9	29.0	45.9	0.1	1.6	1.4	1.9	2.5	0.9	0.7	1.9	2.1	2.2	0.6	1.6	1.1	0.5	2.4	1.8	1.8	1.3	1.8	79.4	89.3	29.1	122.3	101.2	38.0	42.5	45.3	39.7	31.7	51.8	62.1	54.6	3.2	1.5	21.9	9.5	27.1	6.7	9.2	10.2	15.5	12.6	16.3	8.7	4.3	4.9	5.5	10.4	5.1	17.3	19.2	1.9	7.5	97.8	9.4	16.8	30.8	14.9	1.7	16.8	9.4	8.0	9.7	11.2	10.5	1.3	17.9	22.5	4.0	8.3	11.8	14.1	13.8	8.2	9.5	18.9	99.2	14.3	10.6	8.8	15.9	7.4	13.3	9.2	12.5	16.9	9.5	11.5	10.5	8.7	13.4	17.2	6.1	9.8	10.2	13.1	17.3	9.5	30.5	11.5	14.4	28.1	3.6	12.4	8.6	14.6	8.3
GIT2	"KIAA0148, PKL"	ENSG00000139436	"GIT ArfGAP 2"	Q14161	12	109929802-109996389	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004681	Approved		Approved	Microtubules		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Microtubules		"CAB004681: AB_425820"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.41e-2)"	16.6	18.0	12.1	25.5	18.1	60.2	13.0	20.3	17.0	14.0	9.8	15.0	11.2	14.1	10.8	11.5	12.1	15.4	17.4	16.4	12.1	11.7	11.8	16.9	33.1	16.2	13.9	17.8	17.2	14.1	13.8	22.9	16.5	12.8	13.8	9.1	13.5	12.8	14.7	13.1	19.0	19.8	12.1	36.0	10.7	13.9	15.3	37.0	16.4	15.6	32.1	16.3	12.8	16.2	20.6	24.6	16.6	18.4	28.6	26.3	11.9	42.1	41.3	37.0	23.2	12.5	10.8	49.8	16.3	51.7	14.6	14.9	14.5	18.8	38.1	42.1	14.3	32.7	15.0	14.6	18.1	47.7	49.6	22.0	17.4	34.9	18.7	34.0	39.5	28.5	17.2	12.4	46.0	13.1	42.0	66.4	11.7	11.7	17.7	34.5	41.7	27.9	18.2	17.1	10.1	14.9	27.1	12.5	16.6	17.0	17.9	39.3	37.3	25.0	12.6	20.0	22.0	25.0	22.8	49.3	21.5	34.9	21.2	85.6	76.4	172.9	42.7	72.0	41.6	42.4	42.3	43.9	74.7	49.4	36.0	32.2	165.1	49.3	71.3	30.6	46.5	63.7	12.1	18.1	20.3	17.0	16.4	12.1	16.2	13.9	16.5	12.1	15.3	16.2	26.3	19.2	15.3	24.8	44.8	9.6	6.4	11.3	11.4	24.7	10.8	10.0	7.8	14.3	12.2	27.6	8.4	13.1	37.7	9.9	3.9	16.0	6.5	7.6	16.9	24.0	7.8	19.4	73.2	14.0	11.3	15.3	14.8	11.1	14.5	36.1	24.7	13.7	35.1	33.7	82.2	6.7	8.2	65.5	32.0	5.2	18.6	45.1	14.2	66.5	64.5	9.3	61.8	28.6	39.8	18.4	8.6	19.9	26.1	4.3	22.8	7.2	12.4	18.7	13.1	29.4	14.5	36.1	20.1	11.8	11.4	6.2	36.5	19.1	9.9	7.4
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435595-121449727	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	121.2	287.6	313.5	24.7	310.2	0.9	60.6	260.1	409.0	261.7	193.1	17.5	18.2	98.7	10.6	74.9	32.7	99.9	168.9	273.6	362.6	21.2	10.6	67.9	21.1	340.3	380.9	43.5	19.4	236.2	31.3	290.2	307.4	83.3	19.7	3.3	35.6	148.0	10.3	388.2	24.7	112.5	335.9	4.2	30.7	36.9	373.3	24.3	169.1	22.1	34.9	116.0	184.9	341.0	0.1	43.5	186.8	0.4	99.7	61.5	0.4	142.5	286.9	46.9	113.7	0.7	0.4	0.0	15.8	55.8	40.2	18.3	5.1	87.4	151.3	0.1	51.6	2.3	15.7	0.0	124.1	0.0	0.4	164.6	92.1	172.5	61.7	462.7	362.3	0.0	0.1	4.3	9.4	8.4	0.1	80.6	365.8	0.1	47.2	0.1	0.0	3.7	188.6	21.0	0.4	2.9	0.0	0.3	0.1	453.4	14.9	0.3	269.5	143.8	39.4	122.8	93.5	0.1	0.1	0.1	350.4	0.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.5	310.2	260.1	409.0	273.6	362.6	340.3	380.9	307.4	335.9	373.3	341.0	152.2	250.0	80.0	276.2	0.1	234.9	133.6	71.1	77.4	0.3	9.5	20.1	199.7	0.0	17.5	1.8	2.1	53.4	0.4	0.0	0.0	76.9	0.5	21.5	215.5	166.6	0.0	0.0	0.3	4.2	7.9	124.4	0.5	51.7	8.8	494.3	33.9	0.1	8.6	0.0	0.6	0.0	4.1	0.9	55.3	1.7	2.5	3.6	44.4	15.0	0.6	0.3	0.0	4.0	1.0	10.8	0.0	4.1	0.1	29.7	0.0	0.1	6.2	0.3	0.0	5.9	80.2	0.9	1.8	68.3	378.2	20.0	4.9	127.1	0.4	52.7
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	92	"Horizontal cells: 18.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021145	Uncertain					NA	NA						"Cluster 62: Horizontal cells - Visual perception"			"HPA021145: AB_2670600"															"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.0	1.0	0.0	0.2	0.0	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792999-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	79.4	20.4	10.1	9.3	11.0	0.3	61.5	9.8	15.1	26.6	9.0	14.7	2.8	33.8	5.5	7.5	40.0	17.3	83.6	10.5	9.6	35.8	17.3	40.7	11.3	10.3	10.2	18.0	7.0	10.6	6.4	61.6	10.6	18.8	3.8	0.8	10.1	10.7	34.7	14.8	13.9	15.2	10.2	9.9	12.9	5.4	10.2	2.7	39.8	35.2	5.4	28.1	22.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	11.0	9.8	15.1	10.5	9.6	10.3	10.2	10.6	10.2	10.2	9.9	90.4	0.0	0.0	0.3	0.6	9.7	1.9	0.2	1.2	0.2	1.1	1.5	9.0	1.5	0.6	3.7	0.0	0.2	0.7	0.0	0.0	11.0	0.1	3.1	0.5	81.4	15.6	2.7	0.0	0.0	0.1	7.7	2.6	4.9	0.0	0.5	234.2	1.8	0.3	0.0	0.0	0.0	0.0	6.3	10.7	1.1	0.9	2.2	19.6	1.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	12.8	0.2	3.0	0.0	0.1	1.2	0.7	664.0	4.4	306.3	0.2	1.2	0.7	8.7	0.0	1.3	1.6	0.1	5.2
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 36.7;placenta: 85.4"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 133.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	18.6	2.2	2.5	6.0	3.4	0.0	10.5	2.4	4.1	5.5	2.6	4.7	3.4	10.8	2.3	4.8	8.2	6.3	36.7	2.4	2.2	17.1	1.2	26.4	1.7	2.8	2.6	4.0	2.6	3.4	0.5	85.4	2.5	4.0	4.1	0.2	1.6	9.4	2.1	1.4	5.9	8.2	2.6	3.9	3.0	2.9	2.7	0.6	5.3	8.9	2.3	7.4	3.8	2.7	1.8	0.0	0.3	0.0	0.0	0.0	5.7	4.4	2.2	2.2	0.5	0.1	0.2	0.0	1.4	0.7	0.0	0.3	0.0	9.3	3.5	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.1	0.1	0.2	133.8	0.0	12.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	2.4	4.1	2.4	2.2	2.8	2.6	2.5	2.6	2.7	2.7	14.3	3.2	4.2	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.2	1.5	17.7	0.0	0.0	3.7	0.0	135.3	0.1	0.0	0.0	0.0	7.6	0.1	0.3	14.7	0.0	0.0	0.0	0.0	345.3	3.7	0.0	0.1	0.0	19.9	37.9	0.0	15.8	0.0	0.0	0.0	0.0	0.6	0.0	9.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	39.5	0.5	11.1	4.3	0.4	0.2	0.3	31.1	0.5	0.1	0.0	0.1
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147902795-147909269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 5.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.6;Spermatocytes: 39.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014715, HPA062940"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA9	"CX58, CX59, GJA10"	ENSG00000131233	"Gap junction protein alpha 9"	P57773	1	38874069-38881587	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"GAMG: 1.0"					"Low region specificity"	"Detected in all"			HPA067850	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"				"HPA067850: AB_2685910"	"unprognostic (2.00e-1)"	"unprognostic (8.78e-2)"			"unprognostic (4.55e-2)"	"unprognostic (2.66e-1)"		"unprognostic (4.79e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"		"unprognostic (4.11e-3)"	"unprognostic (2.32e-2)"	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.2	0.5	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.1	1.4	1.7	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.2	0.4	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.8	0.5	0.0	0.2	0.0	0.0	0.2	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.2	0.5	0.1	0.1	1.4	1.7	0.7	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759740-34762327	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 43.1"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	2.6	0.0	0.2	0.7	0.0	0.2	0.0	0.0	5.5	2.3	0.2	4.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.5	1.0	0.2	43.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.1	0.0	2.3	7.9	1.4	0.0	9.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.1	12.2	0.0	8.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	31.1	13.9	1.2	0.0	0.3	0.1	0.1	0.0	5.7	0.0	0.0	0.1	0.1	0.3	0.0	3.7	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	37.0	1.3	0.0	0.0	12.9	0.1	0.0	6.8	0.0	0.0	0.0	0.7	0.0	0.0	3.5	6.0	0.3	0.1	0.0	0.4	102.6
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"esophagus: 101.0;skin 1: 95.1;vagina: 35.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 48.6;Basal prostatic cells: 38.0;Basal respiratory cells: 49.6;Squamous epithelial cells: 63.8;Suprabasal keratinocytes: 83.5;Urothelial cells: 66.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 36.7;head and neck cancer: 57.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;HaCaT: 90.8;HBEC3-KT: 40.7;hTCEpi: 147.4;RT4: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.2	0.1	1.0	0.0	1.0	0.0	3.9	0.6	1.3	12.8	0.0	0.1	0.0	0.1	3.4	101.0	0.6	3.4	0.1	1.4	0.3	0.1	0.4	0.3	0.0	0.4	0.4	0.1	1.1	0.0	0.8	0.6	0.5	5.2	0.1	0.0	13.9	3.1	0.3	95.1	0.2	0.0	0.6	0.1	0.1	2.3	0.7	1.4	0.9	0.1	12.6	7.1	35.0	0.9	29.1	0.3	0.1	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.3	90.8	0.0	40.7	0.0	0.1	0.0	7.0	0.9	0.0	0.0	0.0	0.0	0.1	147.4	0.0	23.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	50.9	0.1	0.0	3.6	1.5	0.0	0.4	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.3	1.4	0.3	0.4	0.4	0.5	0.6	0.7	0.9	0.0	0.0	1.1	0.3	0.0	48.6	38.0	49.6	12.5	0.0	2.8	1.9	0.5	0.0	17.2	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	4.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.5	0.0	0.0	12.4	0.0	0.0	0.0	1.4	0.0	0.0	63.8	83.5	0.4	0.2	0.0	0.3	66.2
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923266-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 8.7;pancreas: 11.1;salivary gland: 11.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 36.3;Breast myoepithelial cells: 26.9;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 12.8;Prostatic glandular cells: 13.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.3;SK-MEL-30: 2.3;U-2197: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"			"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.6	0.5	0.8	0.1	0.9	0.1	8.7	0.1	1.2	0.3	0.0	0.5	0.4	0.2	0.0	0.2	0.3	0.3	0.4	0.9	0.3	1.0	2.7	0.2	0.2	0.2	0.4	0.4	11.1	0.0	0.4	1.0	0.2	4.6	0.0	1.0	11.7	0.1	0.2	2.6	0.3	0.2	0.0	0.3	1.4	1.7	0.6	0.1	0.3	0.2	0.0	0.3	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.5	0.6	0.1	0.5	0.2	0.4	1.1	1.3	0.0	0.0	0.4	0.3	0.0	0.4	0.1	0.2	0.1	0.3	2.3	0.5	0.7	0.0	0.3	0.1	0.4	1.8	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.9	0.1	1.2	0.9	0.3	0.2	0.4	0.2	0.0	0.6	0.5	1.1	3.2	3.7	0.0	0.4	0.3	4.9	1.4	0.0	0.0	36.3	26.9	0.0	4.3	2.1	1.8	0.0	0.0	0.6	0.0	1.9	0.4	0.4	0.0	0.0	1.5	1.2	0.0	0.7	24.0	0.0	0.2	0.0	0.0	4.5	0.2	1.1	5.0	0.1	0.0	0.4	0.1	8.2	0.0	0.3	1.1	0.3	0.1	0.0	0.0	0.6	4.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	13.0	0.0	9.7	0.3	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	9.4
GJD4	"CX40.1, FLJ90023"	ENSG00000177291	"Gap junction protein delta 4"	Q96KN9	10	35605341-35608935	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038266	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"		"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA038266: AB_10672741"	"unprognostic (2.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-6)"	"unprognostic (2.00e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"		"unprognostic (8.49e-2)"		"unprognostic (7.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.19e-10)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-1)"	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.5	0.0	0.3	0.2	0.2	0.2	0.1	0.5	0.2	1.4	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	1.7	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GJE1	CX23	ENSG00000203733	"Gap junction protein epsilon 1"	A6NN92	6	142133090-142135151	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014916	Uncertain					NA	NA									"HPA014916: AB_1847134"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406361-79408228	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	306	"testis: 89.5"	"Group enriched"	"Detected in some"	92	"Early spermatids: 589.0;Late spermatids: 163.3;Spermatocytes: 194.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"SCLC-21H: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060687	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	89.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	589.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK3P	"GKP3, GKTB"	ENSG00000229894	"Glycerol kinase 3 pseudogene"	Q14409	4	165277812-165279679	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Distal tubular cells: 1.9;Excitatory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060687	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 11: Alveolar cells - Smell perception"			"HPA060687: AB_2684343"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.19e-2)"			"unprognostic (6.99e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.56e-1)"	"unprognostic (3.34e-4)"	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	1.2	1.8	0.0	0.2	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5"	Q6ZS86	3	142157527-142225592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	4.6	7.0	2.3	3.8	2.4	7.8	6.8	4.8	2.7	5.0	7.0	6.8	9.4	5.4	9.0	4.3	6.0	3.2	2.4	2.3	2.4	3.6	2.1	3.8	2.2	4.4	3.1	8.6	4.0	3.1	5.8	1.7	4.0	8.4	7.3	4.7	11.0	4.0	2.5	5.9	8.0	3.3	2.9	2.2	5.2	3.2	3.0	2.1	4.6	1.5	2.4	4.2	4.4	4.6	11.2	2.7	3.9	2.6	8.0	15.2	6.7	3.6	2.5	3.9	2.5	4.2	6.0	7.9	3.2	3.5	4.3	4.6	4.5	3.5	5.2	2.9	4.3	5.2	7.1	3.1	4.3	6.1	6.7	6.2	3.0	2.6	3.4	2.5	2.3	9.1	4.6	4.7	7.2	7.2	5.3	5.0	2.5	7.5	3.1	4.9	4.2	2.9	4.1	6.8	3.8	2.8	10.1	10.5	3.3	2.3	14.8	4.0	2.5	3.1	2.6	6.9	4.1	4.9	5.1	8.1	5.6	3.8	5.3	2.0	0.4	0.3	1.5	0.3	0.7	0.2	0.5	0.5	0.3	0.4	0.3	0.6	1.1	1.5	2.6	0.4	0.2	0.2	2.3	2.4	4.8	2.7	2.3	2.4	4.4	3.1	4.0	2.9	3.0	4.6	13.7	38.5	30.7	31.6	6.8	4.0	12.3	3.7	15.9	30.6	26.6	13.6	10.5	17.2	17.3	27.6	29.2	13.1	80.5	37.4	7.9	14.9	2.8	32.7	22.5	9.7	27.9	8.8	37.6	20.4	7.3	15.2	25.0	39.2	8.8	23.2	5.0	11.8	5.6	15.2	44.1	42.0	0.0	10.0	3.9	5.2	33.8	20.2	3.6	15.9	9.3	10.2	127.7	27.6	75.6	19.3	31.6	46.6	34.6	21.5	69.5	6.1	14.1	33.0	26.3	16.0	9.0	4.0	5.9	19.4	4.0	6.8	21.0	21.1	34.5	17.3
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739425-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 50.1;testis: 199.5"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1339.6;Late spermatids: 481.5;Spermatocytes: 642.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	7.9	6.4	18.5	2.7	20.3	3.9	6.2	26.9	23.5	8.2	25.7	12.1	4.3	8.8	6.7	3.7	8.2	5.0	14.9	17.0	19.9	7.4	9.4	4.2	3.9	19.2	19.3	12.9	8.4	10.3	12.5	2.4	19.6	8.8	3.5	22.5	5.2	9.0	50.1	2.0	5.3	6.1	19.4	4.1	7.6	199.5	20.7	9.1	9.9	26.4	3.8	7.8	4.6	23.2	7.2	8.4	6.0	8.0	0.8	0.0	9.0	2.6	2.1	4.1	4.2	1.1	3.7	10.8	2.7	1.2	13.7	1.4	6.0	0.7	7.0	13.2	5.6	6.4	4.1	6.2	8.7	2.9	0.6	0.2	4.8	2.1	2.2	11.9	3.8	10.2	5.3	8.6	1.2	6.6	16.1	9.8	5.1	3.3	4.9	10.9	13.7	3.7	4.3	1.1	20.3	11.9	6.0	2.7	4.8	9.2	1.2	5.8	1.3	1.4	10.0	0.9	4.7	14.6	34.5	4.3	3.0	2.0	1.6	1.2	0.2	0.2	0.5	0.0	0.5	0.7	0.5	0.5	0.2	0.6	0.3	0.7	1.1	2.0	0.1	0.1	0.6	0.0	18.5	20.3	26.9	23.5	17.0	19.9	19.2	19.3	19.6	19.4	20.7	23.2	14.2	6.4	11.2	32.0	17.9	7.0	14.7	2.7	2.8	54.1	21.1	17.3	51.7	20.0	2.6	14.7	45.9	8.8	13.1	5.4	13.7	13.4	1339.6	18.4	5.4	12.6	13.1	14.3	19.7	6.6	2.9	8.6	5.1	13.6	2.5	28.9	10.0	21.3	4.1	121.1	32.6	10.8	4.1	4.4	6.2	481.5	26.4	7.7	10.6	27.2	2.3	51.1	8.2	36.2	42.0	4.9	7.4	21.4	15.0	17.5	9.0	14.3	5.4	85.2	26.3	32.0	11.0	642.9	79.4	4.2	4.5	2.9	13.7	15.4	12.2	8.9
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980980	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1840	"stomach 1: 37425.0"	"Cell type enriched"	"Detected in some"	28	"Gastric mucus-secreting cells: 9780.9"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		18000000		"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	3.0	1.8	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	0.0	1.4	0.0	0.3	0.0	3.6	0.4	0.0	1.0	0.0	0.0	1.8	0.8	3.5	0.0	0.0	0.0	0.4	4.8	0.0	0.3	20.3	0.0	0.7	0.3	0.0	0.4	0.1	1.0	0.5	0.4	0.0	0.0	10.4	37425.0	0.4	0.0	1.1	0.2	0.2	0.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.4	0.0	16.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	10.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	3.3	9780.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.5	0.0	0.0
GKN2	"blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465"	ENSG00000183607	"Gastrokine 2"	Q86XP6	2	68945232-68952893	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"stomach 1: 4612.5"	"Cell type enriched"	"Detected in some"	22	"Gastric mucus-secreting cells: 2770.2"	"Cancer enriched"	"Detected in some"	8	"stomach cancer: 43.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;HaCaT: 1.1;HMC-1: 2.0;MOLT-4: 1.6;NTERA-2: 2.3;PC-3: 4.5;U-2 OS: 1.6;U-266/70: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057765	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA057765: AB_2683520"								"unprognostic (1.81e-1)"			"unprognostic (1.44e-4)"			"unprognostic (2.22e-1)"				0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.2	0.1	80.8	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.4	4612.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.3	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.4	109.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.9	2770.2	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	121.2	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236598-219245478	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 52.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.5;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	4.6	4.8	3.1	4.0	3.4	4.5	5.3	3.3	3.0	5.3	14.7	3.1	3.1	5.9	11.4	2.5	23.1	9.0	2.2	3.0	3.7	13.6	3.1	5.3	3.0	5.5	7.0	7.1	3.1	14.4	6.8	8.5	4.5	5.6	3.7	8.0	4.5	4.8	0.9	4.6	4.1	5.8	4.4	4.9	2.8	52.3	3.7	3.4	8.4	1.0	3.4	5.9	2.1	5.6	2.8	4.8	7.4	5.9	8.0	9.8	3.7	4.6	9.7	5.7	5.3	1.9	7.7	0.9	4.1	4.1	4.3	1.5	1.9	4.6	4.5	2.6	3.6	2.9	6.9	4.5	19.7	1.1	4.4	11.4	2.9	5.4	3.3	13.5	5.3	4.3	1.8	5.3	5.4	4.0	2.5	2.7	1.3	1.0	1.3	2.5	4.1	4.0	11.5	1.6	4.7	4.2	3.9	5.3	4.3	4.9	8.4	2.6	4.1	4.7	5.8	2.8	2.6	5.0	1.7	1.5	8.8	1.2	12.3	1.9	5.1	0.3	0.7	6.4	0.4	0.4	0.5	0.7	2.1	1.0	1.1	0.7	2.1	1.0	5.4	0.9	0.2	1.7	3.1	3.4	3.3	3.0	3.0	3.7	5.5	7.0	4.5	4.4	3.7	5.6	3.2	3.2	5.1	3.3	1.3	1.8	2.6	3.6	0.6	4.7	4.9	5.6	1.9	1.5	6.3	3.7	12.5	3.4	1.9	1.1	3.9	3.8	41.5	15.7	3.9	4.2	4.9	1.3	0.9	1.8	2.2	8.4	1.1	2.2	0.0	2.7	8.6	1.3	14.5	3.3	1.1	3.2	2.0	5.6	2.4	25.6	10.8	4.4	8.8	1.9	2.7	5.0	3.1	1.0	0.5	2.1	3.3	6.4	1.8	2.7	6.5	16.5	23.9	10.2	6.6	3.8	2.2	117.4	9.7	1.8	1.7	1.4	2.0	7.0	2.4	1.7
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 160.6"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 182.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 21.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;NK-cell: 3.1"	"Group enriched"	"Detected in many"	24	"NK-cells: 3.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	1.5	2.1	3.0	2.6	2.1	0.3	7.0	0.1	7.7	5.9	14.7	27.6	5.7	33.9	2.1	3.5	25.6	2.8	1.2	8.5	0.3	20.7	0.6	3.6	0.6	1.0	0.8	13.7	10.6	25.0	14.1	1.5	1.0	34.5	11.7	160.6	9.1	25.2	1.0	9.4	4.0	4.4	0.1	0.6	9.0	8.3	0.7	0.5	22.7	0.2	0.6	6.7	5.0	1.3	16.0	1.6	8.2	4.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	13.3	49.9	0.0	16.3	0.0	6.8	52.6	25.2	0.4	0.0	0.0	23.9	0.0	6.7	0.6	2.2	0.0	28.4	0.3	0.7	0.0	0.0	0.0	0.1	7.6	26.3	0.0	0.0	15.3	4.4	3.0	4.7	123.6	18.2	0.0	0.0	1.5	14.1	11.0	34.9	13.1	11.4	14.2	0.0	1.2	18.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	1.2	0.0	0.6	1.2	0.0	0.1	0.9	1.4	0.0	3.1	0.0	0.0	0.0	0.5	3.0	2.1	0.1	7.7	8.5	0.3	1.0	0.8	1.0	0.1	0.7	1.3	0.2	0.0	1.8	0.3	0.4	2.2	5.2	1.0	1.8	6.2	7.2	7.9	1.6	1.5	2.5	0.0	41.7	0.2	3.4	19.5	0.0	2.5	2.1	7.9	22.1	1.2	9.0	0.0	1.6	2.4	1.0	3.6	4.1	2.2	0.0	41.9	0.0	0.2	0.2	5.0	1.2	5.9	0.0	0.0	0.3	6.8	1.2	0.3	5.4	1.0	0.0	10.8	1.0	1.0	0.3	2.2	6.3	0.7	2.2	8.1	3.0	8.4	10.1	182.0	0.0	3.7	2.3	2.6	4.6	1.9	0.9	0.1	2.5	3.4	11.5	2.7
GLB1L3	FLJ90231	ENSG00000166105	"Galactosidase beta 1 like 3"	Q8NCI6	11	134274245-134319564	"Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0;prostate: 7.9;seminal vesicle: 4.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.8;Excitatory neurons: 39.5;Inhibitory neurons: 20.9;Oligodendrocyte precursor cells: 11.6;Spermatogonia: 7.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"Group enriched"	"Detected in many"	11	"gdT-cell: 1.2;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.9;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.9;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.5;JURKAT: 11.4;NTERA-2: 3.4;PC-3: 4.5;SCLC-21H: 6.8"	"Not detected"	"Not detected"							HPA039916	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039916: AB_2676746"	"unprognostic (1.64e-3)"	"unprognostic (7.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.69e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.58e-3)"	"unprognostic (3.81e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.52e-5)"	"unprognostic (1.39e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.07e-1)"	0.0	1.0	0.9	0.4	1.0	0.1	0.3	2.3	4.0	0.4	0.0	0.9	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.9	0.0	1.6	2.7	4.3	0.0	3.3	0.1	0.0	0.0	0.1	0.0	1.3	0.2	0.1	1.3	0.0	0.1	0.1	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.0	2.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	2.2	0.0	3.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	6.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	3.1	1.9	0.0	0.0	2.4	1.9	0.0	0.0	0.0	0.0	1.5	0.6	0.9	1.0	2.3	4.0	0.4	0.1	0.5	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	1.3	0.1	0.5	0.1	1.3	0.0	0.5	0.4	1.3	0.7	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.0	0.0	9.8	0.1	0.3	0.3	0.0	0.0	39.5	0.0	3.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	20.9	0.0	0.0	0.0	0.0	1.2	0.6	0.1	0.0	1.9	0.0	0.3	0.0	11.6	0.9	0.1	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.7	0.0	0.0	0.1	4.3	7.5	0.0	0.1	1.2	0.3	0.0	0.0	0.1
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968796-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 193.3;Inhibitory neurons: 149.3;Oligodendrocyte precursor cells: 276.5;Plasma cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.7;U-266/70: 86.8;U-698: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.4	3.5	0.7	7.1	4.4	7.4	3.2	6.0	7.4	4.3	0.0	4.5	5.2	2.5	1.0	2.0	2.0	3.4	1.2	0.7	3.1	3.1	3.4	8.9	12.2	0.9	0.8	4.2	1.1	4.9	2.1	3.8	0.8	2.7	4.0	7.4	3.8	1.6	2.1	4.0	3.8	2.2	0.0	7.1	5.3	10.9	2.4	33.7	16.7	1.6	14.8	4.4	1.4	5.7	5.3	0.8	8.4	2.1	2.5	3.6	1.7	4.4	6.1	2.5	2.4	2.7	1.7	14.3	1.0	3.6	4.3	0.8	7.7	2.3	3.3	7.2	6.0	4.3	10.1	1.9	4.1	6.8	6.0	1.7	2.8	1.7	5.6	4.2	2.3	5.3	15.7	37.7	4.5	3.0	3.1	6.7	20.9	2.3	5.2	15.3	6.3	7.7	2.5	6.0	13.8	26.9	6.7	8.2	0.5	22.3	9.8	17.5	1.9	4.6	2.0	4.1	2.3	86.8	29.8	40.4	4.8	7.0	3.5	2.0	0.0	0.7	1.1	0.1	1.0	0.7	1.1	0.8	0.0	1.4	0.6	0.7	0.5	2.1	0.0	1.0	2.0	0.2	0.7	4.4	6.0	7.4	0.7	3.1	0.9	0.8	0.8	0.0	2.4	5.7	7.2	83.3	49.5	98.9	28.5	10.3	8.2	4.3	5.7	63.4	13.3	11.2	6.9	1.5	21.6	7.3	43.8	11.6	50.2	3.6	1.9	1.2	87.6	9.5	12.8	4.0	19.3	6.9	193.3	1.6	11.4	8.0	4.6	10.2	5.7	41.5	6.4	9.2	13.5	8.4	149.3	7.6	8.2	2.7	4.6	20.5	8.1	9.4	8.8	112.4	3.1	19.4	71.1	276.5	73.2	3.4	2.6	11.3	132.0	19.6	2.4	2.0	15.4	21.5	6.6	6.6	9.8	76.0	36.0	8.1	13.1	28.7	36.1	8.5	4.3	13.6
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.0;Microglial cells: 76.8;Oligodendrocytes: 154.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 2.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		240000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	9.1	12.2	6.7	5.6	7.8	0.9	8.9	35.8	6.2	8.2	8.4	12.8	14.2	6.4	6.9	10.0	5.5	7.5	6.3	6.0	6.7	13.3	16.8	8.4	3.5	5.7	8.5	12.7	4.7	8.7	6.4	13.4	7.2	5.8	14.2	13.2	10.9	5.8	4.1	10.4	11.5	7.0	7.5	4.4	9.1	3.9	8.8	4.9	4.1	4.9	5.1	6.6	4.6	8.0	9.6	8.5	5.6	9.7	18.6	17.6	2.0	17.6	23.2	13.3	25.2	7.1	23.6	5.8	8.5	14.4	16.8	14.0	12.1	11.4	27.1	2.2	13.4	9.7	15.0	7.2	17.9	4.2	19.0	12.1	7.8	16.6	18.6	9.7	119.4	4.3	3.9	6.0	25.4	5.9	2.6	7.4	2.7	9.7	5.9	5.8	22.6	7.3	12.3	10.1	17.9	3.7	18.0	11.0	38.1	3.8	7.9	5.8	41.8	12.7	15.7	14.3	15.8	2.5	3.7	1.3	12.9	7.0	18.8	0.0	2.1	0.0	0.3	1.6	0.5	0.2	0.8	0.4	1.8	0.2	0.5	0.7	0.0	0.2	2.3	1.9	2.0	0.9	6.7	7.8	35.8	6.2	6.0	6.7	5.7	8.5	7.2	7.5	8.8	8.0	16.9	0.0	15.4	4.9	6.2	4.8	10.1	8.3	26.2	10.3	18.8	19.4	8.1	7.2	8.8	11.0	10.4	22.7	12.1	21.3	5.9	13.0	3.9	4.0	5.4	22.6	20.4	9.4	79.0	13.8	12.7	14.0	28.1	4.9	2.5	11.8	16.4	27.2	16.4	8.4	41.5	27.1	10.2	13.3	4.4	5.1	6.2	10.7	8.8	76.8	13.7	13.1	4.1	35.7	154.9	16.9	28.2	17.7	7.1	5.3	32.4	18.3	18.2	16.6	13.1	6.6	9.4	29.8	25.9	27.9	6.5	33.0	5.9	17.1	26.4	13.3
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLDN	"CLOM, COLM, colmedin, CRG-L2, UNC-122"	ENSG00000186417	Gliomedin	Q6ZMI3	15	51341655-51408005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 84.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 510.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050873, HPA059441"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		410000		"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA050873: , HPA059441: AB_2684018"	"unprognostic (5.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.15e-5)"	"unprognostic (3.21e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.07e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.37e-1)"	18.5	2.3	18.1	1.6	51.1	0.7	9.7	35.0	28.6	1.8	0.0	3.5	0.2	0.5	0.5	0.5	1.2	3.4	5.0	15.5	31.2	0.4	0.1	8.7	0.2	47.6	48.9	0.5	0.5	0.4	0.6	3.9	56.4	2.4	6.4	1.3	1.4	0.7	1.0	5.0	0.6	0.6	26.0	2.9	2.1	0.2	41.7	0.1	0.8	0.9	0.2	1.5	1.5	84.8	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	1.0	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.3	2.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	18.1	51.1	35.0	28.6	15.5	31.2	47.6	48.9	56.4	26.0	41.7	84.8	40.1	0.0	2.6	2.0	0.0	6.2	0.0	0.3	0.0	9.2	0.2	0.3	8.4	0.0	0.1	0.0	0.0	5.2	0.0	47.0	0.0	0.0	0.0	0.0	0.1	3.7	1.2	0.0	7.4	0.0	0.6	7.9	4.6	0.2	0.0	4.5	0.0	0.2	4.9	0.0	17.2	1.7	0.0	14.9	9.5	0.0	0.3	16.1	3.6	42.2	0.0	0.3	0.0	2.0	510.8	0.1	28.6	0.0	0.0	0.1	0.0	0.1	0.9	0.8	0.0	4.7	9.8	0.1	0.1	0.0	4.0	100.4	0.6	0.4	5.1	1.6
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLG1	"CFR-1, ESL-1, MG-160"	ENSG00000090863	"Golgi glycoprotein 1"	Q92896	16	74447427-74607144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010815	Supported		Supported	"Golgi apparatus"		NA	NA		2100000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA010815: AB_2232486"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.85e-2)"	"prognostic favorable (1.56e-7)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-4)"	42.7	36.8	25.0	17.4	26.3	9.0	40.3	24.0	25.7	53.3	17.3	44.5	17.3	57.8	22.4	30.9	46.7	20.4	50.5	24.7	27.5	42.6	25.6	38.2	16.3	27.0	29.0	69.0	58.1	34.3	38.9	24.9	25.2	37.5	18.7	20.3	36.1	24.9	53.8	35.2	36.4	29.9	25.0	35.1	36.3	40.6	29.5	20.0	43.1	16.4	18.9	42.3	40.8	30.0	38.4	52.2	44.7	43.3	113.7	113.2	42.8	45.0	64.2	48.6	68.3	34.4	116.0	22.8	59.8	102.9	35.8	71.1	30.1	62.1	80.1	10.3	26.1	17.9	37.8	54.3	70.5	29.3	12.6	68.0	32.8	63.6	66.3	91.3	100.8	54.8	19.0	24.9	44.2	70.0	14.1	26.0	34.7	81.2	20.6	33.9	32.6	59.5	31.6	17.1	15.8	23.3	87.3	24.9	25.0	47.7	28.2	36.5	79.1	46.1	40.9	48.2	30.3	47.4	51.2	41.1	86.3	22.5	46.6	3.2	16.7	13.3	19.1	15.7	19.2	11.6	23.8	20.9	18.5	10.1	28.2	22.6	7.3	15.4	19.9	18.4	21.0	19.0	25.0	26.3	24.0	25.7	24.7	27.5	27.0	29.0	25.2	25.0	29.5	30.0	52.8	64.1	50.7	114.3	46.4	27.1	27.2	33.0	55.8	68.5	35.6	35.6	79.5	77.2	39.7	51.5	146.0	78.0	75.6	33.5	7.9	39.9	39.7	49.2	79.3	62.0	38.6	25.0	133.4	42.5	43.6	101.4	38.7	58.0	3.8	91.0	75.3	40.7	50.1	70.7	155.3	31.9	24.4	68.8	42.1	28.1	96.9	44.4	42.7	62.8	64.8	59.6	111.2	97.5	137.3	40.8	28.8	114.3	100.2	33.6	47.8	44.2	44.3	57.9	92.1	84.6	59.9	89.2	87.9	30.5	21.6	75.2	72.4	72.4	32.9	26.4
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	2.4	1.2	1.3	1.7	1.6	0.5	1.5	3.5	1.9	11.1	0.4	3.0	2.5	9.5	6.6	0.6	3.7	5.5	2.1	1.0	2.1	1.4	0.8	1.6	0.7	1.9	2.4	1.5	0.8	0.0	1.0	0.5	1.7	4.2	4.1	0.0	1.5	2.8	0.6	1.7	3.3	2.4	1.7	0.9	1.9	4.7	4.2	0.3	2.3	1.8	1.0	4.4	3.1	1.1	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.3	1.6	3.5	1.9	1.0	2.1	1.9	2.4	1.7	1.7	4.2	1.1	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.1	1.9	9.2	3.6	8.8	0.1	8.9	1.0	5.4	7.2	0.0	11.6	1.2	11.8	2.7	3.7	8.2	3.8	1.6	6.3	5.5	1.7	0.3	3.4	0.9	1.7	10.4	13.2	0.7	0.5	1.1	11.9	3.0	5.5	2.9	1.8	2.8	8.2	1.1	8.3	3.4	10.7	0.5	1.1	2.6	1.7	14.4	3.0	4.6	2.3	1.7	4.8	7.3	2.3	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.8	1.0	5.4	6.3	5.5	1.7	10.4	3.0	0.5	14.4	2.3	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	11.6	6.6	8.8	4.7	8.2	5.8	10.7	8.3	15.4	12.3	3.3	10.8	6.4	10.3	2.1	12.8	10.2	2.7	13.0	9.6	7.1	13.7	12.0	6.9	5.6	7.4	6.8	13.4	12.6	4.6	9.3	2.0	7.5	13.4	3.7	2.5	9.2	3.9	9.2	12.9	10.4	1.8	5.1	11.6	11.5	10.4	7.5	5.5	10.1	2.0	4.8	11.3	11.1	7.2	6.7	13.5	6.2	9.9	9.9	4.1	7.0	3.9	2.3	2.9	3.5	3.9	19.1	8.7	7.2	6.5	4.2	8.7	3.4	4.3	1.9	15.3	10.3	13.4	7.1	4.6	7.1	4.2	4.3	12.9	2.3	4.0	8.5	6.7	6.4	13.2	7.2	14.1	8.0	18.5	19.7	3.5	5.8	12.8	19.0	11.9	2.9	8.8	7.0	15.0	6.0	7.0	11.7	5.0	8.2	5.7	22.1	1.9	3.6	4.3	12.1	6.2	4.1	18.6	9.7	7.0	7.0	8.0	7.3	0.0	0.3	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.3	0.6	0.2	0.3	1.1	0.0	1.1	0.6	0.2	8.8	8.2	8.3	15.4	9.6	7.1	7.4	6.8	7.5	5.1	7.5	7.2	9.5	0.0	0.0	13.1	11.2	7.4	12.7	1.3	13.6	14.6	10.9	12.2	2.0	12.8	1.1	12.9	20.9	5.0	20.6	15.4	25.4	2.6	6.3	8.2	10.6	6.8	11.5	5.9	7.2	4.0	4.5	9.5	11.7	7.3	4.5	15.8	8.9	7.7	7.2	6.7	8.4	7.6	2.0	10.1	5.7	4.3	16.1	9.9	8.8	12.2	6.9	11.9	13.4	4.5	15.5	3.6	17.9	16.6	8.8	9.4	16.4	20.1	2.3	11.9	6.6	11.2	10.6	13.4	14.7	15.8	10.7	2.9	11.9	14.6	13.7	9.9
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480753-75503863	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 216.3;Extravillous trophoblasts: 384.2;Hofbauer cells: 242.4;Kupffer cells: 273.9;Langerhans cells: 393.2;Macrophages: 259.6;monocytes: 220.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 189.3;U-138 MG: 363.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	17.2	16.9	2.0	47.0	1.7	18.3	11.5	1.5	5.6	15.6	3.8	11.4	6.6	32.6	6.0	7.9	17.9	33.5	9.2	2.3	2.8	5.6	12.5	22.1	32.7	4.0	3.3	13.7	3.7	2.3	3.9	25.8	3.9	9.2	12.6	1.7	9.7	17.1	3.1	3.4	14.1	39.9	3.4	36.4	10.8	4.8	4.2	19.8	5.4	7.3	32.3	35.0	6.7	8.4	7.2	7.0	5.9	0.6	22.0	46.2	0.9	93.0	97.5	76.8	55.7	3.8	2.7	23.9	19.1	101.7	67.6	1.2	0.2	38.6	124.7	38.0	1.6	1.2	8.4	6.1	25.1	8.4	1.3	43.0	14.1	189.3	41.4	123.1	62.0	1.7	1.7	29.0	144.7	0.1	4.0	20.2	0.6	0.2	2.8	1.0	4.5	0.8	8.1	1.6	0.2	0.2	38.5	0.3	0.2	12.5	0.9	6.7	102.6	363.8	35.4	39.2	144.1	5.1	0.8	2.1	144.4	9.9	5.6	25.3	352.7	40.9	115.0	232.6	77.2	73.9	80.5	90.7	240.2	90.2	24.3	50.4	462.1	20.4	265.6	202.1	91.2	265.0	2.0	1.7	1.5	5.6	2.3	2.8	4.0	3.3	3.9	3.4	4.2	8.4	6.5	12.8	16.0	2.0	121.6	13.6	189.2	23.0	4.0	2.9	15.5	19.9	0.9	5.7	10.0	3.7	4.2	4.8	216.3	0.3	0.0	102.8	14.3	11.3	119.4	7.0	3.5	11.8	13.3	83.9	384.2	46.1	2.0	16.4	10.1	0.8	10.4	4.4	242.4	6.7	14.6	0.4	4.1	273.9	393.2	5.9	14.3	259.6	16.0	28.1	220.9	1.4	123.6	2.5	1.5	90.9	2.5	53.8	66.8	106.5	0.1	1.5	10.6	3.2	13.1	8.1	50.2	7.9	1.0	4.6	9.8	16.8	161.9	26.7	0.6	42.8
GLIPR1L1	MGC26856	ENSG00000173401	"GLIPR1 like 1"	Q6UWM5	12	75334670-75370560	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 33.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 226.7;Spermatocytes: 179.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 109.1"					"Low region specificity"	"Detected in many"			HPA042095	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042095: AB_10796898"	"unprognostic (2.45e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.11e-2)"	0.2	0.8	0.6	0.1	2.0	0.3	0.1	3.9	1.0	0.2	0.5	0.1	0.2	0.5	0.0	0.8	0.2	0.8	1.3	0.5	1.9	0.6	0.1	0.4	0.4	1.8	1.6	0.6	0.2	0.0	0.5	0.0	1.7	0.3	0.0	1.1	0.6	0.0	0.5	1.1	0.3	0.0	0.9	0.4	0.3	33.6	2.2	0.0	0.3	0.0	0.0	0.2	0.1	2.0	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	109.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.2	14.5	0.1	0.2	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.6	2.0	3.9	1.0	0.5	1.9	1.8	1.6	1.7	0.9	2.2	2.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	226.7	0.1	0.3	0.5	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	28.3	5.3	0.3	0.0	1.9	0.0	0.3	0.0	5.0	5.1	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.3	6.6	0.2	0.2	179.3	2.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391089-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 254.0;Spermatocytes: 306.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.0	2.7	5.1	0.8	5.2	0.3	2.4	6.5	5.9	2.1	2.5	0.9	0.6	2.3	3.7	1.0	3.1	1.0	2.3	5.5	5.0	2.0	1.5	1.2	0.7	4.0	4.3	7.1	2.6	4.1	2.6	0.9	4.4	1.5	0.4	3.0	1.0	3.0	2.3	1.9	0.8	1.1	4.0	1.6	0.7	46.8	4.7	1.3	2.4	1.6	0.4	0.9	0.9	6.3	0.2	0.4	0.2	0.4	2.9	1.6	0.5	0.4	0.3	0.1	0.2	0.1	0.3	0.2	1.0	0.3	0.7	0.1	0.0	0.1	0.3	0.6	0.2	0.1	0.6	4.2	2.1	0.4	0.0	0.5	0.9	0.4	1.5	2.5	0.1	0.1	0.2	0.5	0.8	0.1	0.4	0.3	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	0.7	0.3	0.5	5.6	1.7	0.2	1.7	0.1	0.8	0.6	7.6	0.9	0.3	0.7	0.7	0.2	0.2	0.2	0.5	0.7	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.5	0.1	0.3	0.5	0.9	0.6	0.3	0.1	0.7	1.0	0.2	5.1	5.2	6.5	5.9	5.5	5.0	4.0	4.3	4.4	4.0	4.7	6.3	1.5	0.0	3.1	15.0	0.3	0.9	4.6	1.7	3.4	5.6	2.9	3.0	4.0	1.5	1.8	0.0	0.0	1.7	1.5	0.1	9.8	0.6	254.0	4.9	1.4	1.5	0.0	0.4	7.4	0.0	0.2	3.0	1.1	0.5	1.3	1.4	0.0	0.2	0.6	1.7	13.3	0.1	0.0	0.3	0.3	39.0	7.5	0.7	0.0	10.3	0.0	6.7	0.0	27.2	28.1	0.1	0.0	5.7	0.1	1.2	0.1	1.4	14.1	2.0	6.6	5.6	1.9	306.8	19.4	0.3	0.4	0.4	0.6	2.1	0.3	2.1
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.1;seminal vesicle: 7.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.6;Excitatory neurons: 28.0;Inhibitory neurons: 13.3;Proximal tubular cells: 4.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2;hippocampal formation: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;GAMG: 5.9;hTERT-RPE1: 4.7;PC-3: 7.3;U-138 MG: 5.1"	"Not detected"	"Not detected"							HPA001409	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.0	0.1	0.5	0.4	0.5	0.0	1.2	0.2	2.2	5.1	0.0	0.3	0.3	0.9	0.5	0.8	0.8	0.6	1.0	2.2	0.0	4.3	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	8.1	0.0	0.0	0.8	7.6	0.1	2.0	0.6	0.2	0.1	0.2	0.8	2.3	0.0	0.2	0.4	0.0	0.0	2.6	4.6	0.3	0.0	0.0	0.0	0.4	2.8	3.7	0.0	2.0	4.5	1.7	1.3	0.0	0.0	0.0	0.1	2.1	5.9	0.0	0.0	0.0	0.5	0.0	1.3	0.0	1.4	0.1	1.0	0.0	0.0	2.5	0.2	2.1	2.0	4.7	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.9	0.1	1.3	0.0	0.0	3.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.2	2.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	1.3	0.1	6.6	0.0	0.0	4.0	1.3	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.2	0.1	0.0	0.0	28.0	0.0	0.0	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	1.0	2.9	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.2	0.1	0.1	0.0	4.8	0.0	0.0	0.0	0.4	0.8	1.8	2.8	0.3	1.7	0.1	0.1	0.1	0.0	0.1
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 39.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 102.2;Excitatory neurons: 97.8;Inhibitory neurons: 91.5;Oligodendrocyte precursor cells: 72.9;Rod photoreceptor cells: 148.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	3.4	4.6	3.6	6.1	4.7	7.5	7.0	6.8	5.8	4.8	4.1	4.7	3.6	6.0	5.7	6.5	3.8	4.0	5.3	4.6	3.3	4.5	3.9	3.8	8.3	2.5	2.9	5.0	3.0	5.3	3.7	5.6	2.7	5.1	4.9	39.1	2.7	3.8	5.2	9.4	4.5	4.7	2.9	4.4	3.8	8.2	2.8	8.6	6.2	4.4	8.8	5.4	4.2	4.1	21.5	8.8	26.7	14.6	9.1	14.2	25.0	15.0	12.5	18.6	16.2	16.2	8.3	22.1	23.4	8.9	27.1	16.2	14.3	13.5	25.4	16.8	20.7	29.1	16.5	16.5	9.0	38.7	14.7	11.2	7.5	21.1	9.3	7.3	19.7	19.6	24.9	12.9	23.7	4.8	23.7	27.8	40.2	10.9	17.4	19.1	36.7	14.9	20.6	20.9	24.3	12.7	25.3	24.1	15.6	15.4	11.5	34.9	13.9	12.8	12.5	22.3	22.4	11.7	18.1	28.6	4.8	36.8	7.7	0.0	0.6	1.2	3.0	1.4	5.5	2.6	3.0	3.6	2.1	1.8	2.8	3.2	0.1	7.4	0.7	1.6	2.6	1.5	3.6	4.7	6.8	5.8	4.6	3.3	2.5	2.9	2.7	2.9	2.8	4.1	6.8	9.6	8.3	29.7	16.7	8.9	13.7	16.2	12.0	28.3	7.6	6.7	10.0	7.2	8.5	12.9	102.2	15.1	31.6	2.9	1.9	5.9	1.7	4.9	13.6	7.9	10.7	12.8	97.8	5.2	12.1	10.5	9.2	5.4	8.2	10.7	5.7	2.1	8.3	26.9	91.5	4.4	10.2	3.9	7.7	1.1	12.5	7.1	8.8	28.1	6.8	14.2	37.0	72.9	46.0	5.3	3.3	7.9	12.2	9.6	2.3	9.7	4.0	148.1	6.6	10.5	18.9	19.8	30.1	9.4	8.9	15.7	28.3	15.0	5.5	7.7
GLMP	"C1orf85, MGC31963, NCU-G1"	ENSG00000198715	"Glycosylated lysosomal membrane protein"	Q8WWB7	1	156290089-156295689	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029121	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA029121: AB_10600794"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.68e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	33.9	68.3	11.8	17.1	12.8	19.4	25.6	12.9	15.4	38.1	21.1	24.6	30.3	24.4	23.2	29.8	21.1	44.7	18.1	11.7	13.9	52.2	59.8	28.9	22.6	13.6	13.6	22.0	27.0	29.4	19.7	48.0	15.0	57.3	21.1	2.7	35.2	20.4	7.4	29.2	26.9	24.5	12.4	32.3	28.8	6.4	16.0	12.2	23.6	9.6	15.4	36.0	26.8	14.4	22.7	40.8	3.9	27.0	224.8	121.7	27.5	40.8	172.0	58.1	79.0	50.9	68.7	0.0	83.2	59.0	1.9	14.6	0.6	30.0	18.4	4.6	41.8	7.0	22.9	60.6	101.4	19.7	58.1	119.9	36.0	55.9	17.9	85.1	89.0	17.6	32.8	3.1	34.6	28.5	10.1	0.1	46.5	56.9	20.9	17.4	0.0	74.3	53.7	24.5	12.9	42.2	27.1	76.4	120.6	45.6	38.3	54.2	45.7	25.7	5.0	46.2	26.9	24.9	45.9	11.3	44.0	15.7	36.3	35.0	71.3	12.2	23.4	74.5	21.7	13.1	23.0	20.5	31.8	7.7	22.7	21.7	19.4	18.0	55.6	21.3	43.4	36.9	11.8	12.8	12.9	15.4	11.7	13.9	13.6	13.6	15.0	12.4	16.0	14.4	11.7	3.2	19.1	3.3	7.3	0.0	16.4	0.0	10.8	2.0	12.3	11.6	5.8	31.5	5.0	31.3	0.0	70.3	7.6	13.8	27.4	51.3	0.6	8.5	19.1	17.5	10.9	18.5	1.6	38.3	68.5	33.4	18.8	14.2	8.8	14.9	42.8	69.8	197.7	1.7	1.9	19.4	0.0	66.8	0.0	1.4	16.4	41.1	0.0	1.0	29.8	21.0	13.4	2.0	3.9	29.8	22.2	13.9	23.0	28.9	44.9	67.3	5.8	1.5	13.1	11.9	17.1	0.9	1.9	17.8	0.0	69.6	9.3	17.6	11.8	18.7
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	42.5	46.8	27.4	33.5	31.0	22.5	34.5	25.4	33.3	28.4	33.4	71.3	80.5	31.6	33.6	42.9	44.9	32.6	37.3	30.6	36.4	75.7	67.7	31.5	46.9	27.8	27.9	39.9	40.5	37.6	23.2	36.7	28.8	37.8	48.3	25.6	39.5	27.3	39.8	44.3	72.7	31.9	28.3	36.8	85.3	19.4	35.3	35.2	47.4	23.0	40.0	41.5	22.4	27.5	121.1	106.8	120.9	67.1	52.0	51.5	73.8	94.4	57.6	75.0	56.7	87.4	84.0	142.9	100.2	42.8	69.7	85.5	106.6	60.1	78.0	105.4	91.2	69.0	55.7	115.5	51.6	72.1	87.5	36.2	81.9	75.5	66.0	47.7	70.4	116.9	115.1	90.4	80.2	73.9	124.1	55.3	88.7	118.8	36.3	122.7	49.0	65.9	74.5	81.2	54.8	91.8	74.8	53.6	124.6	75.3	66.6	75.2	92.2	71.0	56.8	99.9	120.4	50.3	100.0	89.1	83.6	79.5	75.9	26.1	51.8	48.7	68.1	64.1	73.2	70.0	81.0	82.2	45.9	75.4	68.9	75.7	7.1	64.0	70.4	47.2	99.1	75.9	27.4	31.0	25.4	33.3	30.6	36.4	27.8	27.9	28.8	28.3	35.3	27.5	52.2	57.7	35.2	11.4	48.5	47.9	40.4	91.1	40.5	39.6	39.2	36.3	30.9	54.3	70.4	101.2	29.2	104.5	43.2	39.3	178.1	77.3	34.0	44.0	34.3	43.8	28.9	54.7	12.7	57.4	85.9	41.5	71.4	40.8	40.4	42.1	31.1	58.8	82.3	13.5	13.6	52.0	97.6	30.1	26.5	63.3	38.8	40.8	67.6	7.5	61.7	39.8	44.3	10.1	13.2	58.7	52.0	46.6	27.5	39.4	110.5	186.1	66.8	38.7	46.0	30.3	45.8	23.5	32.9	53.6	54.8	69.1	53.3	57.2	63.7	39.3
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761747-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 5.8;intestine: 10.6;kidney: 11.2;liver: 8.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 45.2;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA010667	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.3	0.0	4.7	10.6	0.0	5.8	0.1	1.9	0.8	0.0	0.0	0.0	11.2	8.2	1.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.1	0.2	6.1	1.9	0.3	0.3	0.0	0.0	10.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	3.2	2.6	1.3	0.5	0.0	0.3	0.2	0.0	0.6	8.3	1.0	0.0	4.3	0.3	7.3	0.0	0.1	0.0	14.4	13.7	0.6	0.2	3.0	0.1	0.0	1.2	2.7	0.2	0.9	0.1	0.0	0.0	1.1	0.0	0.1	0.0	8.0	0.0	0.0	0.3	7.3	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.5	0.0	0.5	0.5	0.8	13.9	0.0	0.1	0.3	45.2	70.5	2.7	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	8.9	0.7
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892099	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 12.2;intestine: 13.5;urinary bladder: 11.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 6.4;Leydig cells: 3.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.0;cerebral cortex: 3.6;hippocampal formation: 3.2;white matter: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 78.1"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.1;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	8.1	0.3	0.4	0.7	3.0	0.0	0.8	0.0	3.6	6.0	0.0	13.5	9.9	1.2	0.0	0.7	1.6	12.2	0.6	3.2	0.0	0.3	2.7	1.0	0.6	0.0	0.2	0.4	1.6	0.0	0.0	1.1	0.0	0.1	6.0	3.4	0.0	0.1	0.1	0.1	8.2	1.9	0.0	0.1	3.7	0.4	0.0	0.1	0.2	0.2	0.2	11.8	1.5	1.7	0.0	16.6	0.0	0.0	0.8	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	78.1	0.6	1.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	3.6	3.2	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	6.4	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	23.3	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 28.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 74.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	34	"AN3-CA: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.0	0.0	5.4	0.1	3.4	0.1	0.0	8.3	4.6	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	4.6	23.4	0.0	0.0	0.0	0.0	4.9	28.4	0.1	0.0	0.0	0.3	0.1	13.7	0.0	3.8	4.9	0.1	0.0	0.0	0.1	0.1	0.1	5.9	0.0	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.4	8.3	4.6	4.6	23.4	4.9	28.4	13.7	5.9	12.6	1.5	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.6	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	7.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.7	74.3	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.0	0.3	0.0	2.0	12.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076125-157172090	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;parathyroid gland: 33.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.6;hTERT-RPE1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.7	7.0	16.5	1.1	17.7	0.2	10.6	7.4	35.5	9.0	4.5	3.3	0.6	2.9	5.2	1.0	7.3	3.2	11.1	18.0	12.9	3.8	1.2	3.1	0.3	9.4	6.9	1.2	15.2	33.0	7.5	2.6	10.8	6.2	0.9	8.5	19.5	4.7	3.3	1.8	1.4	3.7	5.7	0.0	2.9	1.6	9.8	1.1	1.0	4.9	0.2	1.4	1.5	13.5	8.0	3.4	9.5	28.6	18.0	7.2	0.0	16.0	10.1	7.6	14.4	0.0	24.0	0.0	3.7	16.2	9.4	0.0	7.2	2.5	14.3	0.0	9.7	5.0	3.8	0.3	8.1	6.2	0.0	6.4	2.2	13.4	1.9	37.8	6.9	5.1	0.0	0.0	14.1	0.0	0.8	0.0	0.6	0.0	2.3	0.0	13.0	0.0	20.6	1.5	10.3	6.1	0.0	7.3	1.2	1.4	6.8	1.6	10.5	4.5	13.2	7.6	15.3	0.0	0.0	0.0	10.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.5	17.7	7.4	35.5	18.0	12.9	9.4	6.9	10.8	5.7	9.8	13.5	0.5	0.0	1.1	26.1	0.0	1.1	0.9	3.1	1.2	10.8	7.8	4.8	13.9	4.3	3.5	0.0	2.1	0.4	0.4	0.1	0.0	8.8	0.3	6.9	3.4	2.1	0.0	1.7	168.6	1.8	0.0	3.9	0.0	2.0	1.3	7.0	3.3	0.0	0.1	1.7	110.7	0.0	4.1	0.3	1.9	0.3	0.3	0.1	3.6	15.9	0.6	13.2	0.0	110.1	31.5	1.5	0.0	3.4	0.0	0.6	0.0	0.5	10.4	2.2	0.0	8.5	2.2	1.3	3.3	0.4	0.3	0.1	0.1	1.3	0.1	0.2
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	17	"Early spermatids: 796.4;Late spermatids: 1841.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 240.2"					"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	16.1	22.3	16.0	7.9	16.5	9.5	12.4	17.0	28.7	10.2	15.4	14.4	11.7	8.2	10.7	16.7	7.2	6.9	37.0	16.5	18.2	16.2	25.9	9.8	5.2	17.3	15.8	6.2	9.6	5.5	8.4	7.5	17.9	17.9	9.0	2.5	11.1	8.4	37.6	12.9	10.6	8.7	15.9	9.8	12.9	30.2	16.8	3.8	7.2	24.8	7.3	13.9	11.7	17.2	47.2	57.8	14.6	32.8	52.2	33.9	24.0	67.2	29.8	55.6	45.9	36.3	44.2	20.0	36.1	28.6	67.1	44.4	17.5	39.4	56.7	45.6	30.4	40.4	39.0	42.6	55.9	32.8	39.0	23.1	33.8	76.5	38.4	21.6	35.7	13.7	60.8	21.9	68.4	66.3	26.9	60.6	16.8	75.6	38.2	23.7	22.9	48.3	53.7	31.4	13.8	12.4	26.9	81.2	240.2	21.6	35.2	37.5	21.6	42.8	11.2	93.7	70.5	42.6	48.7	41.4	40.8	38.1	61.2	13.6	18.8	26.6	12.7	23.1	14.2	13.2	13.4	11.7	22.5	10.8	11.7	13.4	9.6	16.1	30.0	9.2	18.6	14.5	16.0	16.5	17.0	28.7	16.5	18.2	17.3	15.8	17.9	15.9	16.8	17.2	24.2	9.6	10.1	5.5	14.8	18.2	21.1	39.1	14.2	7.2	21.7	23.6	62.8	12.8	21.5	16.5	6.2	39.2	19.5	25.8	29.4	41.1	796.4	16.1	24.2	18.7	13.8	15.6	11.3	41.4	41.6	25.2	14.8	17.7	46.9	16.4	11.0	30.3	44.2	1.7	10.1	26.5	32.6	15.0	26.9	1841.1	17.4	26.8	26.6	5.6	25.9	9.9	28.8	5.0	10.1	38.3	31.5	18.0	20.5	39.2	40.3	74.3	13.9	11.5	6.6	15.5	36.2	12.3	25.4	21.3	19.9	24.8	14.0	33.1	24.1	20.5
GLRX3	"bA500G10.4, GLRX4, GRX3, GRX4, PICOT, TXNL2"	ENSG00000108010	"Glutaredoxin 3"	O76003	10	130136391-130184521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 280.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028941	Approved					NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA028941: AB_10601015"	"unprognostic (7.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (9.03e-6)"	"unprognostic (9.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	36.0	44.6	24.3	40.5	25.7	38.0	35.2	25.9	30.9	29.8	26.9	32.9	35.9	29.4	28.4	58.4	25.3	28.6	54.3	25.5	28.4	37.7	42.9	28.4	54.5	27.6	26.9	24.0	35.4	36.1	21.2	40.9	28.4	27.1	38.7	27.8	32.3	29.5	53.5	41.4	31.3	40.8	25.8	27.1	33.4	64.4	26.5	39.6	32.6	55.1	63.0	49.8	38.0	26.9	209.9	134.2	126.8	195.3	84.0	130.8	136.5	149.9	148.3	182.5	153.5	234.4	164.5	157.8	94.2	118.3	160.4	133.7	170.8	179.5	198.0	123.6	145.7	84.0	87.2	201.9	108.8	163.9	80.8	85.4	205.0	167.2	227.3	164.2	147.3	116.8	190.1	72.4	201.1	103.0	119.4	239.8	146.7	121.5	142.8	161.3	131.8	59.8	179.5	114.1	62.4	84.7	85.8	93.2	194.2	139.2	69.2	103.0	111.6	96.2	96.4	130.7	219.2	52.7	87.4	316.0	201.6	88.9	59.5	25.7	45.2	21.5	40.6	58.8	48.2	52.1	45.1	45.4	70.3	37.8	34.4	41.7	7.3	59.1	51.8	44.8	76.7	49.5	24.3	25.7	25.9	30.9	25.5	28.4	27.6	26.9	28.4	25.8	26.5	26.9	47.6	41.7	28.1	20.9	38.4	82.8	90.1	167.1	32.5	24.1	42.1	40.5	61.5	40.0	74.4	27.6	14.6	122.9	47.3	38.3	62.6	160.1	252.7	39.6	43.4	57.0	34.0	44.6	24.7	147.7	162.2	48.3	28.5	38.7	42.5	47.7	43.2	36.2	113.2	42.1	24.6	50.7	77.3	44.6	54.2	138.9	40.7	46.1	49.8	15.0	72.9	37.9	47.4	22.1	22.5	150.2	32.3	50.4	41.0	115.2	58.7	100.7	58.3	25.1	19.7	41.2	95.1	280.9	188.1	62.7	99.0	163.1	41.8	49.7	64.7	100.5
GLRX5	"C14orf87, GRX5, PR01238"	ENSG00000182512	"Glutaredoxin 5"	Q86SX6	14	95533503-95544724	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 518.5;Erythroid cells: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042465, HPA063716"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA042465: AB_10794048, HPA063716: AB_2685102"	"unprognostic (2.57e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.83e-10)"	"unprognostic (1.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	37.2	52.1	44.1	17.6	44.9	178.8	27.2	43.8	50.2	22.3	46.7	44.8	46.2	19.2	39.0	24.5	23.6	17.5	76.9	46.6	45.8	74.5	105.5	18.3	23.1	43.3	44.5	32.8	31.5	46.3	18.9	37.8	44.3	26.8	37.3	10.1	29.3	29.6	195.0	18.3	33.2	24.4	42.9	20.8	34.2	35.7	46.2	40.3	26.7	168.9	27.0	24.5	15.0	42.9	77.1	92.7	61.4	68.0	74.2	57.5	202.0	54.9	56.1	69.4	69.1	124.8	87.5	111.7	77.4	42.8	39.2	75.5	116.5	79.6	71.5	68.5	94.4	100.3	63.4	202.2	73.5	160.9	96.5	55.4	74.1	49.9	81.1	28.1	76.1	94.4	115.7	88.3	61.2	205.5	133.6	165.9	81.5	89.7	107.8	220.8	184.3	67.8	93.3	89.3	127.9	75.2	54.8	81.3	87.7	59.9	107.7	72.6	55.6	30.5	65.0	77.6	85.7	41.7	57.9	92.0	67.2	99.8	72.2	0.4	2.9	4.8	3.4	4.3	4.9	4.6	4.6	6.0	4.7	5.4	3.7	3.9	1.3	3.9	2.7	9.0	6.2	1.8	44.1	44.9	43.8	50.2	46.6	45.8	43.3	44.5	44.3	42.9	46.2	42.9	78.7	28.9	30.0	7.8	41.1	108.5	58.7	7.5	61.5	38.5	112.8	135.9	150.0	64.3	10.4	95.6	33.3	97.8	66.5	76.3	518.5	15.2	312.0	49.7	61.5	58.9	54.0	1134.9	15.0	15.6	164.9	66.2	46.4	48.3	14.7	110.3	47.2	147.2	58.7	50.5	16.4	72.1	4.1	41.7	58.7	90.2	54.3	50.7	87.2	7.5	21.3	128.1	52.5	12.5	15.2	15.2	39.5	73.7	75.2	108.2	51.8	281.4	9.1	43.0	59.2	61.1	92.7	115.4	79.0	102.2	124.9	53.8	48.8	169.0	88.0	76.6
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 204.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 41.3;Hepatocytes: 54.9;Inhibitory neurons: 31.6"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 7.6;Daudi: 42.8;Hep G2: 7.4;SCLC-21H: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.2	1.6	4.0	0.2	3.2	0.1	1.3	4.4	11.4	0.5	0.0	0.6	0.3	0.9	2.3	1.5	4.1	0.2	0.2	3.4	5.0	1.9	204.9	1.4	0.9	4.7	1.6	0.8	21.2	5.6	5.8	0.0	4.8	1.4	1.6	11.2	1.5	2.3	0.0	2.8	0.5	0.5	0.5	0.5	1.4	0.5	1.9	1.3	1.4	0.0	1.5	0.6	0.7	8.2	7.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	4.3	1.2	42.8	0.5	0.0	0.0	0.8	0.0	6.5	0.0	0.0	6.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	3.2	1.2	0.5	0.0	0.1	6.6	3.9	3.4	12.6	0.5	1.3	0.3	0.0	1.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.8	1.7	0.4	0.0	0.3	1.8	2.2	0.0	0.0	0.0	0.0	0.5	0.7	4.0	3.2	4.4	11.4	3.4	5.0	4.7	1.6	4.8	0.5	1.9	8.2	0.2	0.0	2.7	5.5	2.3	1.7	4.8	4.6	10.8	10.7	0.9	1.7	0.0	0.0	4.5	0.0	6.2	0.2	0.1	0.1	7.9	0.5	0.0	0.3	0.2	0.5	1.2	8.0	41.3	2.0	0.0	0.5	1.1	0.2	1.3	0.3	2.5	54.9	0.1	3.3	31.6	0.1	0.0	1.6	0.7	0.0	0.9	0.1	1.8	3.7	0.2	3.1	0.0	8.0	3.3	0.7	0.1	0.0	0.9	1.3	0.0	0.6	1.7	10.2	0.0	0.3	0.2	0.6	1.5	5.5	1.1	0.3	1.1	0.0	0.3	1.3
GLT6D1	GLTDC1	ENSG00000204007	"Glycosyltransferase 6 domain containing 1"	Q7Z4J2	9	135623648-135639540	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 4.7"	"Group enriched"	"Detected in some"	39	"Early spermatids: 26.8;Late spermatids: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023424	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA023424: AB_1849729"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694486-52706032	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	33.1	39.8	25.4	22.5	26.6	9.3	35.6	25.2	29.3	47.5	35.6	27.7	25.9	35.0	41.3	18.3	54.4	29.8	32.6	26.2	26.7	40.4	69.5	29.6	25.3	24.0	26.9	53.8	35.7	46.0	64.8	48.2	25.5	30.5	32.3	32.2	29.9	32.7	20.8	22.6	23.4	32.2	25.9	24.6	28.9	64.5	26.4	29.2	64.0	24.6	26.8	31.6	28.6	28.6	28.7	33.2	65.7	52.0	142.6	179.8	36.8	70.3	107.8	60.6	69.1	15.5	52.6	24.0	19.7	122.7	73.3	31.9	42.1	72.0	79.5	43.5	30.6	22.8	61.4	71.7	68.3	34.0	68.5	104.1	62.9	52.1	66.8	139.8	91.3	40.6	29.4	53.6	80.6	29.2	23.4	51.8	33.8	49.8	61.5	17.4	37.3	81.9	71.3	30.8	26.9	46.5	58.6	27.9	48.9	61.2	47.7	44.2	67.1	43.7	33.9	63.9	39.6	60.2	73.7	26.4	76.0	53.2	56.2	38.4	13.0	21.8	19.1	8.5	18.3	14.1	22.2	20.0	11.8	9.8	22.3	15.6	6.9	30.3	9.3	23.1	16.8	10.9	25.4	26.6	25.2	29.3	26.2	26.7	24.0	26.9	25.5	25.9	26.4	28.6	25.8	0.0	9.6	16.0	16.0	12.1	16.1	40.3	13.6	41.5	18.1	19.7	15.3	17.2	23.8	18.4	12.5	58.4	26.5	9.4	23.5	34.4	71.4	38.5	38.4	22.7	18.6	8.6	17.9	27.1	63.5	59.2	14.8	15.2	5.7	35.6	34.2	38.2	26.9	21.9	16.8	21.1	30.5	13.6	12.0	23.0	53.7	12.3	24.9	8.4	26.5	37.0	34.0	15.6	14.6	23.3	16.9	48.5	39.1	14.7	22.8	21.5	44.4	21.3	26.3	31.6	25.2	149.5	50.0	10.3	8.0	26.1	21.4	74.2	17.3	10.0
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850945-109880541	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 334.1;skin 1: 276.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 266.5;Suprabasal keratinocytes: 479.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056461, HPA065503"	Approved		Supported	Cytosol		NA	NA		25000	"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA056461: AB_2683138, HPA065503: "	"unprognostic (1.18e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (4.17e-6)"	"unprognostic (3.28e-2)"	19.0	21.7	59.1	17.5	98.8	19.3	27.1	93.6	75.1	94.4	43.1	38.4	14.6	15.9	34.8	334.1	13.6	14.2	21.0	62.3	69.9	53.2	15.1	24.4	19.3	110.3	89.5	18.2	23.8	31.4	12.5	17.8	102.5	29.4	31.8	7.0	84.7	19.1	18.6	276.6	32.1	18.8	84.0	21.5	21.6	16.3	87.3	18.0	23.5	18.1	108.2	33.6	178.0	138.5	39.3	27.9	15.5	16.7	36.2	41.4	11.0	47.4	58.2	36.0	29.7	11.3	14.9	34.5	25.3	57.8	17.5	47.3	24.2	54.9	50.7	35.0	21.5	22.6	15.9	16.5	31.6	24.6	25.5	30.1	68.8	64.6	45.3	53.9	61.3	34.8	10.1	22.5	53.2	52.9	33.6	19.8	28.1	32.0	36.8	29.3	36.4	36.3	20.5	116.1	20.0	19.8	30.1	77.1	26.0	14.1	36.1	8.6	83.2	41.4	21.9	61.5	36.5	30.1	27.7	23.8	83.0	25.1	25.9	42.6	65.7	37.3	51.5	66.0	32.4	23.9	31.0	46.5	48.8	21.5	20.1	35.8	32.9	42.4	57.0	8.0	37.6	40.6	59.1	98.8	93.6	75.1	62.3	69.9	110.3	89.5	102.5	84.0	87.3	138.5	48.1	25.6	60.9	10.4	37.5	145.4	109.1	72.1	88.2	11.4	55.6	44.4	14.6	18.6	62.7	44.1	14.6	86.5	48.3	95.6	199.6	39.0	20.5	30.1	33.3	47.9	32.4	10.1	9.9	56.5	20.0	35.0	28.5	59.1	20.8	19.0	34.2	15.3	34.5	13.5	11.4	39.2	50.8	61.6	84.6	11.7	23.0	55.3	60.5	13.1	61.8	23.4	64.9	21.6	140.1	53.5	40.0	18.0	26.2	80.6	102.3	38.2	25.2	12.3	39.5	23.5	37.3	22.9	20.8	266.5	479.2	210.6	46.3	31.4	59.1	129.0
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788964-4790589	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 73.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 83.7;Proximal tubular cells: 135.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 3.4;CACO-2: 9.2;Hep G2: 13.7;MCF7: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		150000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.5	0.5	1.3	0.5	1.1	1.5	0.3	2.3	2.7	0.4	0.0	0.5	10.1	0.5	0.0	0.8	0.4	0.3	0.2	1.0	2.1	12.0	73.8	0.4	0.1	3.1	2.8	0.3	0.7	0.2	0.8	0.1	2.0	0.4	0.0	0.3	1.0	0.0	1.3	1.7	6.2	0.0	0.4	1.1	1.1	0.1	1.5	0.0	0.2	0.0	0.0	0.5	0.5	1.4	0.5	1.8	0.1	1.5	0.0	0.0	3.4	0.4	0.0	0.0	0.0	9.2	0.6	0.8	0.9	0.0	0.3	1.7	0.0	0.0	0.0	1.7	1.2	0.1	0.7	13.7	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.4	0.0	4.1	0.1	0.1	0.2	0.6	0.7	0.7	0.5	0.2	0.0	0.7	1.1	0.7	1.6	0.3	0.4	0.0	1.0	0.1	1.7	0.5	0.7	0.4	0.3	0.1	0.5	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.3	1.1	2.3	2.7	1.0	2.1	3.1	2.8	2.0	0.4	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.2	1.5	0.5	0.0	0.0	0.0	0.1	0.4	17.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.0	0.0	2.2	83.7	0.1	0.0	0.2	0.6	0.0	1.3	0.4	0.2	0.6	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.6	0.3	21.1	135.8	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.1	0.3	0.3	0.1	0.3	0.4
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047610-121050094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 3.9;testis: 15.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Cytotrophoblasts: 4.6;Early spermatids: 2.6;Hepatocytes: 4.6;Proximal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;K-562: 4.3;OE19: 2.1;SK-MEL-30: 5.5;THP-1: 2.7;WM-115: 6.0"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	1.7	1.7	0.0	0.1	0.3	0.0	1.2	0.0	0.8	0.4	0.5	0.5	0.0	0.4	1.7	0.5	0.4	0.4	0.9	0.4	0.0	1.6	3.9	0.5	0.1	0.0	0.0	0.4	1.0	0.5	0.4	0.8	0.0	0.4	0.0	0.1	0.6	0.2	0.5	0.6	0.4	0.1	0.0	0.1	0.6	15.4	0.1	0.0	0.4	0.1	0.1	0.4	0.4	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.8	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.1	1.2	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.8	0.0	0.0	2.3	0.1	0.0	0.5	0.0	0.6	0.0	0.4	0.1	2.6	0.0	0.0	0.0	2.1	4.6	0.1	0.1	1.9	0.2	2.6	0.6	0.8	0.9	0.0	0.0	1.2	0.4	0.5	0.8	0.0	0.5	0.0	0.1	0.0	4.6	0.5	0.0	0.4	0.1	0.0	1.2	0.3	2.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.2	3.3	0.0	0.1	0.0	0.9	0.4	1.2	1.0	0.1	0.1	2.5	0.3	0.7	0.2	0.3
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"kidney: 571.8;liver: 698.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 346.7;Proximal tubular cells: 1261.0"	"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.4"	"Not detected"	"Not detected"							"HPA040251, HPA044094"	Enhanced					NA	NA		21000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favorable (1.31e-6)"	"unprognostic (2.69e-1)"				47.0	0.1	0.0	0.1	0.1	0.1	8.5	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	571.8	698.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	11.5	0.0	31.3	0.0	0.1	0.0	0.0	123.3	0.0	6.0	0.0	0.0	0.6	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	346.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	8.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1261.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 576.3"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 234.3;Proximal tubular cells: 797.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.3	0.4	0.1	0.4	0.3	1.6	0.1	0.7	0.1	1.3	0.9	0.0	0.1	0.3	141.4	576.3	0.0	0.1	0.9	0.2	0.0	1.7	2.6	0.0	0.0	1.1	11.1	0.3	0.2	1.9	0.0	0.0	0.6	0.2	0.0	0.3	0.1	2.7	0.1	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.1	0.5	0.4	2.0	0.0	4.9	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.9	0.2	1.1	0.3	0.3	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.3	12.8	0.0	14.7	0.0	0.0	0.0	0.1	107.6	0.1	0.0	2.5	0.1	0.5	0.0	8.0	0.7	0.6	0.0	0.1	0.0	0.1	0.0	0.1	5.0	234.3	0.0	0.0	0.8	0.1	0.0	8.1	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	1.3	0.0	797.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.9	0.1	0.9	0.2
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"	A0A0U1RQE8	11	59086307-59094786	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 7.3;lymphoid tissue: 2.8"	"Cell type enriched"	"Detected in single"	57	"Proximal tubular cells: 5.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0	0.0	0.8	0.0	0.0	7.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.9	0.0	1.8	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 12.0;cervix: 19.9;salivary gland: 33.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 16.7;endometrial cancer: 15.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6"					"Low region specificity"	"Detected in many"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.2	0.1	0.2	0.1	0.3	0.1	12.0	0.2	0.5	19.9	0.0	0.1	0.3	0.4	0.3	0.9	0.1	7.5	0.3	0.2	0.4	0.9	0.1	0.0	0.3	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.9	0.2	0.3	33.4	0.1	0.0	1.4	0.1	0.3	0.7	0.3	0.1	0.0	0.2	0.1	0.1	0.5	0.4	0.1	0.3	1.1	0.0	0.0	0.4	0.0	0.7	2.6	0.0	1.7	5.3	2.3	3.7	0.0	0.0	0.1	0.0	1.4	1.0	0.4	6.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	14.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	6.6	2.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.5	0.2	0.4	0.7	0.2	0.6	0.7	0.2	1.1	0.2	0.0	0.0	0.0	0.0	1.0	2.3	1.4	0.0	0.5	14.8	2.2	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	1.1	0.0	0.0	1.5	1.4	0.0	0.5	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	3.0	0.4	0.1	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.1	6.6	0.2	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.9
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499923-49528078	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"				"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4"	"Cell line enhanced"	"Detected in all"		"BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	17.4	20.5	29.3	30.0	39.7	20.6	28.0	38.9	31.1	30.8	17.9	19.7	15.8	15.1	30.8	56.2	15.4	23.4	26.2	27.1	34.3	11.4	24.8	39.0	61.4	42.6	37.9	21.3	14.9	28.3	6.6	57.9	44.3	21.1	26.3	11.7	17.0	17.9	7.2	81.8	16.3	20.0	39.0	36.0	15.8	11.6	36.2	72.3	13.0	10.5	77.9	40.3	49.5	46.7	22.3	14.8	15.1	71.7	98.0	48.2	207.1	35.0	75.1	19.0	25.6	30.3	26.1	71.9	35.1	26.9	51.1	60.0	16.7	291.8	27.2	41.4	10.5	11.7	16.8	37.9	23.7	19.1	117.1	65.4	287.0	24.4	16.4	26.0	27.6	85.1	11.4	30.7	30.1	9.6	38.4	18.0	10.2	11.4	32.3	17.7	7.1	46.3	18.4	43.3	3.9	13.4	29.1	133.0	58.3	52.0	30.7	22.5	24.6	46.0	17.6	38.3	10.6	75.2	96.8	187.0	53.1	30.1	19.4	7.6	40.4	2.4	3.7	13.6	2.7	30.9	4.3	3.9	39.6	29.8	6.1	4.8	8.7	4.4	3.4	28.0	5.4	18.6	29.3	39.7	38.9	31.1	27.1	34.3	42.6	37.9	44.3	39.0	36.2	46.7	5.8	16.0	23.0	5.5	25.0	14.9	18.5	63.2	26.7	5.8	5.4	15.5	30.9	0.0	29.7	18.4	2.1	53.6	8.3	4.4	1.9	7.2	0.5	5.7	6.8	7.3	3.6	5.0	2.2	8.1	224.7	10.2	10.7	7.7	69.6	16.3	8.6	24.2	100.8	6.7	2.7	5.4	10.2	55.7	32.5	1.6	8.1	67.8	8.8	2.8	52.5	8.0	7.2	3.5	9.5	6.0	4.7	13.9	28.8	6.7	6.2	5.4	19.9	3.7	0.0	7.9	6.9	1.8	4.2	45.6	23.9	52.5	5.6	6.4	6.7	36.5
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less 1, spermatogenesis associated"	Q96IK5	2	69829660-69881384	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 93.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039579	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	9.4	6.5	4.4	8.1	4.8	13.6	10.6	5.3	6.7	8.6	11.6	10.7	15.9	7.7	8.8	8.2	7.9	8.5	4.8	5.2	4.4	11.5	10.7	7.7	12.0	4.4	4.7	8.5	9.1	19.1	6.5	9.3	4.3	11.1	12.2	6.1	9.4	8.7	4.1	8.8	13.1	6.4	4.6	9.1	8.6	16.3	4.5	18.5	9.2	5.4	12.2	8.3	6.3	5.3	14.7	10.3	17.2	18.4	15.0	13.1	18.4	12.1	8.0	8.1	13.7	9.9	13.5	30.7	9.7	8.0	9.5	14.2	20.3	10.5	14.1	14.2	21.2	48.0	11.3	22.8	9.9	36.1	32.4	7.2	11.3	6.4	14.9	10.5	14.5	23.2	19.5	21.8	12.9	12.6	37.1	33.7	18.4	24.9	9.6	26.1	22.6	23.6	11.9	22.2	27.0	22.5	13.2	19.1	14.8	13.4	12.6	22.2	9.0	12.4	15.5	19.4	14.7	22.1	28.6	18.9	12.8	29.5	13.0	93.5	8.0	40.1	11.1	6.3	19.1	8.8	10.9	13.7	7.5	8.3	15.6	15.5	26.8	26.8	10.3	7.9	15.5	9.4	4.4	4.8	5.3	6.7	5.2	4.4	4.4	4.7	4.3	4.6	4.5	5.3	17.9	28.9	27.4	22.9	25.9	26.8	21.4	19.5	27.3	22.5	28.3	20.4	7.6	74.4	22.0	18.4	27.1	38.3	42.5	40.0	41.1	36.1	264.8	26.7	21.8	19.5	23.4	29.0	68.1	17.5	51.9	19.4	16.3	18.4	22.2	24.2	26.4	25.4	15.9	21.9	63.8	37.0	44.7	23.8	13.1	50.8	15.8	15.0	16.0	11.2	22.8	44.2	50.4	42.7	45.6	15.2	21.7	22.6	28.2	33.0	42.1	23.2	38.4	37.0	13.1	26.0	21.1	44.2	45.1	38.4	27.7	81.5	36.7	17.5	30.6	25.7
GMCL2	"GCL, GMCL1L, GMCL1P1"	ENSG00000244234	"Germ cell-less 2, spermatogenesis associated"	Q8NEA9	5	178184505-178187371	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	80	"testis: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039579	Uncertain					NA	NA									"HPA039579: AB_10805480"				"unprognostic (3.25e-1)"	"unprognostic (3.69e-1)"					"unprognostic (2.58e-4)"				"unprognostic (2.82e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245605	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 106.0;salivary gland: 105.4;stomach 1: 97.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 208.5;Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 367.6;Proximal enterocytes: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		72000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	10.7	7.6	8.6	30.1	7.1	9.1	14.6	5.8	7.1	29.4	9.7	87.7	106.0	7.8	10.4	65.8	11.5	20.5	9.5	7.6	7.0	19.6	31.1	9.0	14.2	6.6	6.9	6.7	43.8	20.5	12.9	7.1	6.7	18.3	82.4	1.5	105.4	8.0	5.1	10.6	87.3	10.3	6.1	11.4	97.1	9.2	7.3	13.9	11.9	4.9	20.8	13.7	14.2	6.2	45.9	10.6	7.4	52.6	11.8	32.0	17.9	12.5	25.7	22.7	21.2	23.1	26.1	21.7	37.3	13.6	22.4	18.3	22.9	43.8	26.2	30.0	28.8	21.0	11.2	110.3	13.2	34.2	22.5	35.6	14.9	18.0	37.2	21.9	26.9	73.0	13.9	9.8	14.7	26.3	49.0	40.1	11.4	246.4	36.0	24.8	16.8	112.4	55.4	59.5	41.4	9.9	11.5	17.7	28.8	33.6	16.4	21.4	11.7	17.4	13.1	17.7	22.5	22.1	33.6	23.1	11.4	23.6	23.4	7.0	12.9	1.5	7.8	8.3	10.3	10.5	9.4	7.5	14.5	5.0	7.6	10.8	3.8	13.1	6.8	6.1	13.2	8.3	8.6	7.1	5.8	7.1	7.6	7.0	6.6	6.9	6.7	6.1	7.3	6.2	19.7	0.0	4.5	40.8	19.8	4.2	20.1	38.3	27.3	3.7	33.1	19.3	2.9	12.8	40.5	38.6	0.0	18.7	6.5	104.1	119.3	36.5	5.7	7.8	7.3	23.0	111.7	9.7	208.5	69.7	30.8	12.4	276.8	11.9	4.5	13.2	18.2	19.6	13.5	8.4	167.5	367.6	50.8	10.9	7.6	4.6	12.2	11.0	23.2	143.4	14.7	3.3	9.2	83.9	50.2	47.0	85.5	16.6	53.1	40.7	190.7	38.1	38.3	0.7	13.1	5.8	16.6	6.5	33.1	20.1	6.1	16.7	18.6	13.4	165.1	43.5
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668778-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	4.7	3.0	2.3	5.7	2.2	13.6	4.3	5.9	3.1	5.1	3.1	4.4	2.9	4.9	3.0	5.2	4.4	4.2	3.1	2.5	1.9	3.6	3.4	4.3	6.7	2.5	2.2	5.6	4.1	3.3	3.7	5.7	2.5	3.5	4.4	5.6	3.4	3.1	5.3	5.0	4.4	4.8	1.9	5.5	4.1	6.0	2.6	10.6	3.5	4.4	8.0	4.3	4.4	3.1	12.1	8.5	14.1	12.9	4.6	8.5	10.0	12.5	9.0	7.9	11.7	2.7	9.4	22.1	6.5	11.7	4.7	4.6	12.7	9.7	10.2	25.4	7.9	20.4	8.9	5.2	6.9	17.1	10.2	6.8	6.8	19.2	12.3	6.9	11.1	10.8	12.6	17.1	9.6	10.5	10.7	5.7	18.9	8.0	5.7	7.2	9.7	10.3	6.0	9.6	10.4	8.6	12.1	8.0	8.1	9.4	6.1	8.7	11.2	5.4	13.1	9.3	17.0	7.6	13.8	12.1	6.6	15.8	8.7	8.1	5.4	9.9	6.7	7.0	5.1	4.0	6.5	7.9	6.3	6.0	5.3	5.5	7.6	7.5	9.0	4.6	6.0	4.6	2.3	2.2	5.9	3.1	2.5	1.9	2.5	2.2	2.5	1.9	2.6	3.1	12.9	6.4	20.0	3.9	20.5	17.0	19.9	8.6	8.6	23.6	9.0	10.2	4.0	10.0	11.0	14.7	12.5	14.1	17.7	12.7	5.9	10.9	13.3	10.1	12.5	13.2	7.8	26.7	7.0	11.1	16.6	10.0	9.2	16.3	28.5	12.8	16.8	6.1	10.7	25.2	5.9	13.1	10.2	13.4	7.9	2.8	9.6	12.2	1.8	4.7	14.8	17.5	29.9	5.0	9.2	11.5	14.1	7.9	11.5	12.4	8.5	5.7	7.1	24.7	19.7	18.3	13.0	34.8	28.6	8.3	16.8	32.3	19.5	13.2	11.0	19.6
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	7.5	8.0	6.2	5.0	5.9	19.3	7.4	6.3	6.7	8.7	5.5	8.5	5.0	9.0	2.5	9.3	10.3	3.1	7.9	6.1	5.3	8.5	9.0	8.2	6.7	6.2	5.8	9.5	9.8	5.6	8.3	3.6	5.6	9.0	2.4	2.1	8.8	3.5	9.2	9.3	9.3	3.3	5.2	10.7	8.2	13.4	6.2	8.1	15.5	3.4	4.4	8.0	7.1	5.6	13.8	8.3	9.9	8.6	4.7	4.3	13.2	9.3	5.9	14.7	7.7	25.9	10.1	10.9	9.5	8.1	10.6	19.2	7.8	13.7	6.5	5.8	8.8	8.5	12.7	12.6	6.4	8.1	13.6	6.2	12.9	9.5	11.8	6.2	6.5	13.6	12.6	7.7	5.1	14.9	19.8	17.8	7.1	16.3	13.1	21.3	10.1	10.1	6.1	12.1	14.8	12.2	17.0	14.8	10.0	4.5	18.1	13.3	8.3	16.0	8.7	9.7	10.4	14.7	12.8	17.2	9.7	7.5	10.7	0.0	0.8	1.4	1.7	1.0	1.5	0.7	1.5	1.5	0.8	1.0	1.6	1.4	1.7	0.8	2.5	1.0	1.1	1.0	6.2	5.9	6.3	6.7	6.1	5.3	6.2	5.8	5.6	5.2	6.2	5.6	5.6	3.2	5.6	9.1	7.3	6.0	11.2	3.8	5.2	5.2	6.4	5.6	3.2	4.3	5.0	3.7	0.0	4.1	6.3	9.3	1.9	4.3	29.3	6.9	5.2	6.8	9.6	2.5	5.3	5.4	6.9	4.2	5.6	10.3	2.5	6.0	4.6	6.6	4.5	8.4	4.2	7.6	2.0	3.5	3.8	6.9	4.1	4.5	1.8	4.7	3.2	2.4	4.1	2.5	4.8	6.1	8.2	5.7	7.8	12.0	5.5	3.5	4.2	5.9	6.6	5.0	4.6	22.2	9.5	5.1	5.4	11.5	8.9	3.5	6.1	12.1
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489026	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	25.2	21.8	62.8	23.5	68.8	28.8	26.0	61.6	90.4	18.6	39.8	35.0	33.5	19.3	14.0	15.8	14.2	16.5	17.2	61.4	75.6	33.6	25.8	24.2	25.3	73.0	64.5	16.1	12.8	20.1	12.3	26.5	71.4	14.8	35.2	18.4	10.7	12.9	7.0	13.7	29.5	18.2	84.0	18.4	19.0	11.1	71.9	16.2	21.9	10.2	24.4	22.3	11.4	85.3	92.7	36.9	71.8	53.2	75.8	94.5	53.9	93.2	67.9	66.2	82.1	42.6	79.4	85.2	42.4	92.0	39.5	33.4	73.7	64.0	104.4	30.9	25.4	42.5	37.4	39.9	64.7	59.9	35.5	72.0	58.8	57.1	56.0	67.9	60.8	38.4	31.4	28.8	106.1	45.7	36.8	22.9	46.4	52.1	38.9	36.9	84.7	24.4	84.4	86.3	42.4	65.5	64.6	54.4	71.4	59.0	59.8	46.4	48.1	94.9	71.9	48.7	58.4	10.4	19.4	52.0	80.0	36.3	61.5	6.8	10.2	9.1	5.0	13.3	7.0	6.6	5.9	5.1	12.6	7.8	6.2	6.6	16.1	8.0	14.0	4.4	8.5	6.2	62.8	68.8	61.6	90.4	61.4	75.6	73.0	64.5	71.4	84.0	71.9	85.3	23.3	25.6	16.2	8.1	39.3	59.9	50.2	33.6	48.9	18.4	28.0	18.0	17.3	20.0	22.6	25.8	4.2	39.3	33.7	61.8	21.5	38.7	27.3	21.5	29.5	22.2	29.9	14.5	16.8	23.3	84.5	35.1	23.9	36.1	21.6	25.4	16.8	24.5	45.4	21.9	13.6	33.6	26.4	34.6	36.4	7.5	20.2	43.0	46.2	8.4	37.8	25.7	25.7	14.1	16.5	37.3	32.1	15.8	16.9	56.0	26.0	60.5	16.4	15.4	13.1	77.0	54.5	16.0	11.4	33.5	43.8	58.3	26.2	18.8	36.2	56.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643657	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	7.5	3.3	2.9	32.0	2.4	50.9	5.4	2.5	6.1	3.7	2.5	9.6	10.4	3.3	1.4	8.6	5.4	6.0	2.9	3.8	4.0	4.3	4.7	16.9	29.4	6.5	4.4	2.6	6.0	8.9	3.6	4.6	5.7	5.4	6.5	0.4	6.9	2.8	1.1	6.9	22.6	4.3	4.5	54.3	16.7	2.9	6.6	19.1	8.5	1.9	22.9	8.3	5.3	7.4	9.9	4.5	5.9	6.5	6.4	3.3	23.5	6.1	5.2	3.6	3.4	3.6	13.0	24.1	12.1	4.3	4.7	11.5	3.9	6.7	2.3	8.3	6.1	7.6	7.1	4.0	1.9	21.7	92.0	4.2	4.5	3.9	2.0	4.2	8.2	21.1	5.3	8.5	3.9	14.6	13.7	35.8	3.5	12.7	8.1	23.3	2.6	14.0	6.9	23.3	5.1	15.2	8.4	8.7	3.7	4.5	8.0	30.7	15.0	6.6	3.8	7.6	4.6	4.3	1.9	19.8	4.2	28.0	4.6	7.0	19.5	51.9	13.2	23.7	12.3	12.6	8.4	11.9	15.1	12.8	8.9	9.7	71.8	9.7	33.1	13.5	10.0	12.5	2.9	2.4	2.5	6.1	3.8	4.0	6.5	4.4	5.7	4.5	6.6	7.4	1.7	0.0	10.2	0.3	26.6	1.1	1.7	2.5	1.2	0.0	1.9	1.3	0.9	2.8	3.1	0.0	0.0	0.6	14.9	21.2	0.0	4.1	0.1	1.4	0.9	1.8	0.0	1.3	2.1	4.7	5.3	0.9	24.5	4.0	7.0	3.5	2.5	1.6	22.7	0.0	2.1	6.6	0.0	33.3	6.6	0.4	0.6	26.7	1.8	6.5	27.6	0.4	20.6	0.5	0.2	12.9	20.2	0.7	13.9	2.0	9.3	0.7	1.5	0.1	0.0	0.4	1.6	0.6	1.3	3.5	1.1	0.8	25.8	0.9	6.0	4.1
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852737-190892429	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.8;fallopian tube: 8.1;liver: 4.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4"	"Cancer enriched"	"Detected in some"	5	"ovarian cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"SCLC-21H: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA043663	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.1	0.2	2.8	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.1	0.3	1.7	1.9	4.1	0.0	0.0	0.6	0.7	0.1	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.3	1.7	0.6	0.7	0.5	0.7	0.7	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.6	5.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.5	4.4	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GMPPA		ENSG00000144591	"GDP-mannose pyrophosphorylase A"	Q96IJ6	2	219498884-219506989	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035512, HPA035513"	Approved		Approved	Nucleoplasm		NA	NA		51000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA035512: AB_2674660, HPA035513: AB_10671934"	"unprognostic (3.43e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.40e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.90e-10)"	"prognostic favorable (5.24e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	22.6	25.8	19.3	23.9	20.1	19.0	21.6	20.1	22.6	32.1	22.4	29.7	28.8	26.4	68.7	25.5	24.6	19.7	27.1	20.1	20.5	25.7	68.5	20.9	20.7	20.5	19.8	20.1	60.3	24.7	48.5	21.2	20.0	37.3	32.3	8.0	40.1	23.4	22.8	17.8	30.0	26.2	19.6	35.2	32.5	9.6	21.3	13.2	28.6	12.6	23.8	25.2	23.1	19.8	43.4	36.0	21.2	37.8	79.5	70.6	56.4	73.8	98.6	85.2	105.2	66.8	40.5	23.4	51.1	107.7	54.3	40.1	39.7	63.9	73.3	45.3	35.0	45.5	35.7	119.3	72.0	24.1	51.7	54.3	50.7	79.9	89.9	43.9	52.8	29.7	82.3	66.3	66.8	55.5	23.8	45.3	21.7	52.8	38.5	18.6	22.9	42.4	48.6	30.1	27.4	24.0	31.0	46.3	52.1	44.4	31.5	38.8	30.9	49.2	33.6	89.4	40.9	45.4	19.4	28.9	100.4	26.7	55.8	76.0	52.6	37.3	30.1	56.0	35.0	32.1	23.4	31.9	43.5	24.1	17.3	15.7	11.8	36.4	59.3	43.9	34.8	35.2	19.3	20.1	20.1	22.6	20.1	20.5	20.5	19.8	20.0	19.6	21.3	19.8	12.5	16.0	14.4	5.5	18.8	5.6	12.8	25.2	6.2	6.1	20.9	13.5	13.2	10.0	20.1	16.5	6.2	37.6	16.6	37.7	35.2	24.3	1.3	8.5	15.8	9.5	10.8	19.1	3.1	30.0	79.8	19.2	38.7	14.4	19.0	13.3	11.0	36.3	33.7	1.7	3.6	61.6	10.2	17.6	10.0	3.4	18.3	16.5	12.4	1.9	15.9	11.1	12.3	1.0	4.9	19.0	37.6	13.5	50.3	15.1	45.9	36.8	11.6	4.7	13.1	7.9	27.1	4.4	6.5	9.9	8.5	47.2	13.5	10.7	29.1	15.1
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723973	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 130.2;Syncytiotrophoblasts: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain					NA	NA		38000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	14.5	30.1	6.1	16.1	6.0	11.8	15.3	5.7	6.6	20.8	9.2	23.1	14.5	18.6	14.5	26.3	19.5	9.5	18.2	6.0	6.3	17.5	44.2	21.4	13.0	6.7	6.5	14.0	57.4	10.1	39.4	7.5	6.1	27.9	12.2	4.1	35.4	14.7	13.4	14.9	21.8	9.4	6.1	27.9	26.2	9.6	6.8	9.3	26.3	5.7	13.0	15.9	16.8	5.9	31.8	27.0	21.0	12.3	15.6	10.8	21.7	36.1	17.1	29.0	26.1	18.7	21.5	17.6	15.8	18.1	22.2	16.7	18.6	29.0	10.6	17.2	14.5	13.5	27.2	21.5	31.1	19.0	19.6	8.2	15.1	40.0	34.8	11.3	24.8	20.2	10.4	32.0	16.3	20.3	27.3	11.7	12.2	22.5	34.3	9.2	12.5	30.4	16.3	24.0	13.8	16.0	15.7	36.5	12.5	10.6	20.6	13.9	21.9	25.7	25.0	33.4	38.8	33.7	11.1	13.6	25.4	14.7	28.6	22.1	15.6	6.7	18.3	21.3	18.6	22.7	15.9	19.3	14.7	22.5	11.8	14.6	4.0	11.3	21.8	61.8	12.0	14.8	6.1	6.0	5.7	6.6	6.0	6.3	6.7	6.5	6.1	6.1	6.8	5.9	7.3	9.6	17.2	1.6	35.4	0.8	22.8	0.7	2.8	3.7	34.1	14.1	4.5	15.7	3.8	18.4	2.1	28.5	28.5	43.6	29.4	39.8	10.0	18.3	14.3	10.7	16.7	9.9	0.8	50.6	67.2	15.5	34.7	17.8	0.0	11.2	9.3	28.4	39.0	6.7	0.8	55.9	0.0	10.7	1.7	10.0	15.5	13.7	1.8	1.0	40.9	5.8	19.6	1.0	0.4	31.9	27.1	7.5	130.2	40.9	29.2	25.7	14.4	6.2	0.0	5.3	12.2	22.9	12.6	14.7	1.7	79.5	14.7	13.1	32.8	37.1
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Approved		Approved	Nucleoplasm,Nucleoli		No	No		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	45.0	92.1	24.5	19.7	25.7	19.3	44.3	25.8	30.2	44.7	28.2	44.2	30.9	38.2	29.9	38.7	44.9	32.0	39.6	24.8	25.7	70.1	56.0	38.8	26.9	26.2	25.6	51.2	49.0	67.7	48.1	22.7	26.8	41.7	25.5	18.8	41.8	26.3	40.6	35.2	45.8	21.2	26.0	55.9	50.7	21.9	26.1	28.4	58.4	19.8	27.3	43.1	40.3	26.2	27.1	34.2	29.0	26.7	50.9	74.7	40.0	32.1	59.2	47.3	55.7	38.8	24.6	34.7	22.5	49.8	25.5	43.6	42.4	69.2	69.5	19.0	25.5	24.3	25.0	159.1	46.8	53.7	51.4	72.2	54.9	23.6	47.7	61.1	69.7	52.3	12.5	33.3	46.6	51.8	50.1	57.1	34.3	39.5	37.3	33.5	24.2	22.6	69.1	52.7	22.0	36.2	16.9	45.8	52.6	39.5	38.6	41.1	36.2	23.0	15.8	32.0	20.6	59.4	63.1	21.8	16.6	38.9	20.2	24.3	34.2	15.0	19.7	27.5	21.6	13.7	21.5	23.7	35.9	15.9	19.3	20.2	56.0	14.9	27.9	15.8	31.5	26.5	24.5	25.7	25.8	30.2	24.8	25.7	26.2	25.6	26.8	26.0	26.1	26.2	25.2	25.6	18.7	10.7	23.2	11.0	44.5	49.9	27.3	19.6	24.8	32.9	12.5	38.6	35.7	53.3	4.2	67.2	22.6	35.6	101.8	43.6	18.3	29.6	16.6	26.3	10.3	20.6	7.8	33.0	48.5	18.8	17.9	20.0	31.7	29.7	16.8	24.8	50.0	18.5	8.0	19.8	30.5	46.6	14.6	10.5	28.9	32.5	21.4	9.4	32.1	43.3	25.7	7.5	11.7	33.7	32.1	25.2	21.2	19.0	50.2	123.1	43.2	19.7	26.3	16.0	24.5	19.8	10.3	20.7	10.7	49.3	24.6	51.3	28.4	30.5
GNA11	"FBH, FBH2, FHH2, HHC2"	ENSG00000088256	"G protein subunit alpha 11"	P29992	19	3094362-3123999	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 330.6;Proximal enterocytes: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"HPA048886: AB_2680544"	"unprognostic (4.64e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.26e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.48e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	33.5	32.5	36.4	16.2	31.2	8.3	32.6	53.8	35.3	31.7	18.9	66.7	117.5	42.4	12.7	28.7	44.5	20.0	51.7	33.5	27.3	40.4	26.2	34.7	7.5	30.3	29.6	32.5	33.9	26.3	29.8	22.3	28.6	40.4	38.7	11.0	33.3	47.1	54.2	34.4	139.3	28.7	26.6	21.4	34.9	50.6	31.3	8.5	32.9	39.2	7.0	38.8	27.0	31.1	56.1	31.2	27.9	48.5	41.7	28.4	30.9	53.8	53.7	71.8	57.8	41.7	27.3	12.0	29.2	76.4	43.6	39.0	37.8	42.7	44.3	30.1	21.9	3.3	35.7	23.6	42.2	3.8	11.8	36.9	36.8	48.4	29.2	36.9	57.8	3.4	27.8	1.9	49.1	25.8	3.0	14.4	20.5	38.4	29.4	23.2	26.4	11.9	33.8	40.8	66.0	40.7	38.3	45.2	27.2	18.9	33.3	7.9	50.0	45.7	33.3	85.4	73.5	1.3	3.9	7.9	33.0	2.9	52.3	2.5	1.4	0.3	0.7	0.7	0.8	0.9	0.5	0.6	0.2	1.1	1.2	0.9	5.1	0.5	1.5	2.3	0.1	0.3	36.4	31.2	53.8	35.3	33.5	27.3	30.3	29.6	28.6	26.6	31.3	31.1	62.3	32.1	24.1	5.2	3.5	32.6	9.5	15.4	13.6	22.7	43.2	47.9	17.8	35.8	12.6	27.6	37.5	13.2	2.4	330.6	7.9	21.4	45.2	26.9	23.0	33.9	54.6	5.2	8.8	25.4	13.5	25.3	29.6	26.1	4.5	24.1	58.2	28.5	9.0	45.4	11.3	84.1	26.4	9.1	16.4	20.0	50.1	5.1	23.2	11.2	1.1	29.0	0.0	7.1	14.1	36.1	96.0	80.5	1.2	16.0	323.0	18.9	35.4	15.8	19.7	28.5	30.5	23.7	8.9	20.6	41.2	20.4	2.0	22.1	94.9	13.4
GNA12	gep	ENSG00000146535	"G protein subunit alpha 12"	Q03113	7	2728105-2844308	"Human disease related genes, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 68.3;Syncytiotrophoblasts: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010046	Approved		Supported	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB010046: AB_2263416"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.45e-3)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.27e-4)"	17.8	14.9	42.5	11.2	47.1	11.0	12.2	38.4	35.8	12.9	18.3	16.6	5.1	17.0	4.7	7.7	12.9	9.4	17.9	36.1	39.6	8.6	9.3	12.8	12.8	53.2	43.9	18.2	11.9	8.0	12.3	24.4	42.5	9.5	6.1	3.0	8.0	11.4	6.7	5.0	11.3	13.6	46.2	10.6	11.6	10.1	52.6	5.6	6.7	7.3	10.1	16.6	9.2	42.3	35.5	19.1	19.4	29.2	30.4	24.1	53.5	29.1	33.7	30.9	35.3	18.4	24.5	7.5	19.4	34.6	64.7	15.6	13.5	30.1	20.9	89.9	13.5	15.3	9.9	19.6	35.4	2.5	13.1	23.5	16.1	36.3	24.4	31.8	33.3	10.6	17.3	23.0	28.1	16.8	4.1	14.1	27.3	9.1	32.9	26.8	22.4	15.2	11.4	23.8	15.4	22.3	16.4	24.4	12.2	27.6	13.6	20.9	39.5	33.6	39.9	33.2	48.6	16.1	20.3	6.8	36.1	22.5	33.7	1.4	0.5	0.1	0.2	1.3	0.3	1.0	0.5	0.3	0.4	1.7	0.5	0.0	0.1	0.0	0.3	1.8	0.7	0.4	42.5	47.1	38.4	35.8	36.1	39.6	53.2	43.9	42.5	46.2	52.6	42.3	21.8	6.4	11.7	41.8	22.0	7.0	3.8	5.4	0.6	6.0	14.5	10.4	16.3	10.0	6.1	1.8	12.5	63.7	16.6	8.0	3.9	7.9	13.3	9.3	21.8	16.7	7.8	9.5	31.9	10.2	17.0	19.6	10.2	10.8	0.0	13.9	19.2	13.5	25.4	8.4	36.0	5.5	6.1	21.6	63.5	13.6	17.1	25.8	21.4	22.5	21.7	16.1	7.2	68.3	29.9	13.2	4.0	18.8	7.3	8.4	4.7	7.1	5.8	10.7	0.0	16.8	17.3	8.6	9.4	1.2	3.7	173.2	6.2	23.7	5.3	3.2
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 144.5"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.7	22.5	21.3	41.5	23.9	144.5	15.8	25.0	22.5	17.6	21.3	27.7	21.0	17.9	10.5	18.2	15.9	26.5	12.6	20.2	26.6	17.6	27.0	27.1	46.8	26.9	21.7	22.6	15.3	15.8	8.3	39.3	30.1	15.1	26.2	17.2	10.4	16.1	36.8	12.1	23.3	22.9	25.4	33.5	18.0	15.4	23.7	49.9	17.9	38.6	44.6	30.5	12.3	35.2	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	23.9	25.0	22.5	20.2	26.6	26.9	21.7	30.1	25.4	23.7	35.2	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GNA14		ENSG00000156049	"G protein subunit alpha 14"	O95837	9	77423079-77648322	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 219.1;Early spermatids: 50.2;Hepatic stellate cells: 61.4;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	95	"basophil: 27.3"	"Lineage enriched"	"Detected in single"	95	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HUVEC TERT2: 1.6;PC-3: 3.2;THP-1: 1.6;U-2197: 2.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048886: AB_2680544"	"unprognostic (7.80e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-4)"	"unprognostic (2.48e-6)"	"unprognostic (6.35e-3)"	"unprognostic (3.34e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-1)"	3.4	2.2	7.3	4.0	6.5	0.0	2.4	2.7	8.4	3.6	11.8	5.8	1.7	15.6	5.2	4.8	3.6	4.9	4.1	9.2	4.5	11.7	6.0	8.8	3.3	9.7	5.0	6.0	1.4	1.4	3.1	7.0	7.0	6.8	6.1	0.1	8.0	13.7	0.6	0.9	3.0	13.8	8.1	7.3	3.3	2.1	5.6	0.7	17.6	0.6	2.1	7.6	4.8	13.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.3	1.0	0.3	0.0	0.6	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.4	3.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.8	0.4	0.0	1.2	0.3	1.6	0.4	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.3	6.5	2.7	8.4	9.2	4.5	9.7	5.0	7.0	8.1	5.6	13.9	2.3	0.0	1.1	219.1	0.2	0.6	2.0	0.2	0.0	0.0	1.0	0.4	0.8	0.0	6.5	0.0	0.0	0.1	0.0	2.6	0.0	0.7	50.2	1.7	4.9	12.8	3.0	2.7	15.8	1.0	0.1	4.2	0.0	1.8	4.5	0.1	61.4	1.2	0.3	0.0	4.4	13.7	2.0	2.5	1.1	38.8	3.7	0.2	1.8	15.9	0.0	0.0	0.0	7.1	12.4	0.1	2.7	1.9	0.0	1.0	0.5	7.1	20.8	0.0	0.0	19.4	0.9	0.4	0.7	0.3	0.6	0.1	0.2	0.5	2.9	4.9
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136033-3163749	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.6;esophagus: 108.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8"	"Group enriched"	"Detected in all"	4	"cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 67.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043113	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA043113: AB_10967343"	"prognostic favorable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	6.8	3.1	4.0	12.4	3.8	75.6	4.6	4.0	7.3	13.3	4.7	2.5	1.7	1.3	0.4	108.8	2.4	4.6	1.9	4.1	4.1	2.0	1.4	13.1	4.2	5.4	4.5	0.8	1.2	0.4	1.4	7.6	5.1	11.6	1.8	0.1	19.5	2.5	0.6	50.8	2.5	3.1	4.9	8.8	4.3	1.4	6.6	32.0	1.2	0.9	12.1	28.1	41.6	6.4	44.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	18.7	0.1	0.1	0.0	0.1	36.2	0.0	65.4	0.0	0.1	0.0	19.1	0.1	0.0	0.0	27.2	152.1	0.0	40.0	0.2	26.2	0.0	0.0	16.6	0.1	0.3	0.0	0.0	162.4	59.8	0.1	2.9	0.0	119.3	0.0	0.2	0.0	23.6	0.2	0.0	4.6	0.2	0.2	0.0	0.0	62.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.3	29.8	0.1	19.4	29.1	14.3	0.0	21.8	1.1	0.0	2.0	0.3	28.8	0.0	0.0	0.0	6.9	4.4	15.5	67.1	8.7	13.3	4.0	3.8	4.0	7.3	4.1	4.1	5.4	4.5	5.1	4.9	6.6	6.4	1.0	9.6	8.8	0.0	2.2	67.2	141.5	65.5	9.1	0.2	7.4	3.7	0.5	0.0	39.0	3.7	0.0	0.5	27.6	0.5	0.0	0.7	0.5	1.4	0.5	3.1	6.6	21.0	1.3	0.0	0.8	2.5	3.6	3.9	34.3	0.0	0.7	0.0	66.5	0.0	0.4	2.2	57.0	36.2	190.6	0.8	0.0	78.3	21.4	7.5	32.0	0.0	0.0	0.0	0.2	13.2	0.3	0.0	3.6	69.3	0.0	0.1	21.7	0.1	19.7	0.3	3.3	4.0	2.0	38.0	95.8	0.4	19.6	0.1	1.4	173.8
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	79768028-80226181	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1600000	"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	47.5	26.2	8.9	2.6	18.8	0.4	34.9	14.9	17.7	18.5	4.4	25.4	4.7	14.8	0.7	19.7	10.9	3.2	9.4	10.8	13.3	36.6	15.2	15.2	2.0	18.8	15.0	17.1	4.5	1.3	10.9	13.6	18.4	8.8	2.6	1.5	10.4	3.0	6.2	47.9	9.9	4.1	15.5	5.9	17.7	13.0	14.2	1.3	14.2	2.9	1.5	24.7	19.9	36.6	2.2	18.6	10.5	0.0	14.5	7.9	9.1	14.3	7.2	5.5	8.7	0.0	3.4	0.0	4.5	9.3	5.1	2.6	7.0	9.5	5.4	0.0	11.9	10.4	12.9	1.2	14.8	1.8	0.0	12.0	19.9	4.1	9.5	4.4	3.5	0.0	0.0	0.1	7.7	0.6	0.0	0.1	6.1	0.2	11.0	8.6	5.2	7.8	15.7	7.0	12.5	9.2	13.5	0.0	10.3	5.4	2.0	0.3	13.0	21.8	15.6	5.1	4.4	0.0	0.0	0.2	6.1	1.2	10.2	1.3	0.4	0.4	0.1	0.4	0.0	0.0	0.1	0.1	1.9	0.1	1.1	0.5	0.3	12.8	1.0	0.2	0.1	0.4	8.9	18.8	14.9	17.7	10.8	13.3	18.8	15.0	18.4	15.5	14.2	36.6	121.1	19.2	13.8	11.4	0.9	220.0	20.6	81.6	35.3	3.9	7.0	7.7	6.7	21.5	42.3	29.5	0.0	83.6	1.3	11.1	88.0	7.2	1.7	23.2	58.5	31.5	19.9	4.2	71.4	3.8	84.6	35.9	4.6	40.3	30.3	43.9	17.5	20.0	10.0	26.9	77.4	7.8	36.7	1.0	28.6	7.0	33.5	3.9	103.2	4.7	2.9	49.1	0.0	53.3	410.7	9.4	6.3	74.4	1.2	17.4	0.9	18.4	36.8	5.0	111.7	10.6	70.8	9.7	45.7	31.9	214.2	183.5	2.9	2.9	10.7	19.2
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548615-109600195	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	12.7	8.2	5.8	14.2	6.1	27.7	11.9	7.3	7.5	10.9	8.6	11.8	10.4	12.1	8.0	21.8	8.0	11.3	4.2	6.0	6.5	11.2	15.3	9.7	14.1	6.7	5.9	8.8	9.3	8.9	1.8	14.8	6.8	10.3	11.8	17.8	7.7	9.0	3.8	18.4	10.6	13.6	6.3	11.4	9.0	8.7	6.2	14.2	8.0	5.5	15.9	15.5	4.0	7.3	48.3	16.4	31.0	17.3	28.4	35.0	25.7	35.3	28.6	36.0	35.5	24.4	16.1	25.3	22.4	37.6	21.6	24.5	30.0	35.3	49.4	29.2	18.0	22.1	26.3	21.9	25.1	34.9	18.8	25.2	30.4	41.3	27.8	24.2	42.8	19.1	29.8	24.2	35.5	32.9	27.3	28.4	31.3	23.0	19.1	19.2	73.6	16.6	37.4	35.4	19.5	34.9	24.7	27.6	39.4	22.8	21.1	30.5	36.7	29.4	40.7	44.9	39.2	25.6	30.2	29.2	47.6	34.4	47.1	32.4	29.7	57.8	21.1	44.3	22.4	20.1	20.4	20.6	31.9	17.1	16.8	19.4	53.8	19.9	44.6	14.2	23.8	36.3	5.8	6.1	7.3	7.5	6.0	6.5	6.7	5.9	6.8	6.3	6.2	7.3	104.0	44.8	31.5	17.0	76.6	151.2	104.3	92.2	63.2	29.9	67.7	45.3	14.3	37.1	61.0	58.8	350.3	80.3	98.8	63.9	64.6	97.9	14.7	65.5	71.5	82.6	84.3	43.8	37.5	101.7	153.7	69.2	55.5	110.9	46.3	50.1	56.7	57.2	107.9	25.2	36.4	72.3	59.0	115.0	106.9	9.4	48.7	127.4	74.7	31.9	102.4	47.9	45.3	35.7	31.3	101.6	58.9	47.4	66.3	72.5	48.9	53.5	51.7	26.2	52.6	59.0	77.6	68.6	54.7	82.1	188.4	106.9	94.3	51.7	63.5	143.0
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11689264-11885685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.9;Inhibitory neurons: 119.5;Oligodendrocyte precursor cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 99.0"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.4;HeLa: 27.4;U-2 OS: 13.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"basal ganglia: 164.1"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.7	1.5	29.2	2.9	99.0	0.8	4.1	3.5	36.7	7.3	0.0	7.1	1.5	6.6	2.2	8.0	3.9	4.6	3.5	39.6	16.7	4.0	2.0	2.7	4.9	8.3	8.9	2.9	1.8	4.8	16.3	2.8	6.8	9.3	3.6	4.1	4.7	17.0	21.7	7.2	3.2	7.5	1.9	2.9	3.1	6.5	14.4	4.3	7.8	13.1	5.5	13.2	7.0	4.8	0.7	8.7	10.3	0.7	0.8	0.2	1.2	0.1	0.4	0.7	0.0	9.2	1.6	26.4	1.6	0.1	5.7	0.4	9.7	8.1	0.0	5.6	9.0	0.2	27.4	5.2	0.1	0.3	0.6	1.2	11.9	0.0	0.2	0.4	0.0	0.3	2.4	0.3	0.3	0.3	0.3	0.8	8.4	7.2	0.2	0.2	1.4	0.2	0.6	0.3	9.4	0.2	12.3	0.6	3.0	2.3	0.2	0.3	1.5	1.1	13.2	0.5	2.6	0.5	0.3	0.1	0.5	0.3	0.3	0.6	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.5	29.2	99.0	3.5	36.7	39.6	16.7	8.3	8.9	6.8	1.9	14.4	4.8	4.3	3.2	5.9	17.0	1.1	10.6	11.6	6.6	10.2	7.2	2.4	8.9	3.6	0.0	8.0	3.7	16.7	0.5	13.8	3.2	1.9	0.4	4.2	1.7	3.6	5.7	0.0	0.0	76.9	3.0	3.5	7.2	1.5	3.8	5.7	3.2	1.8	1.9	0.9	3.3	119.5	0.6	30.5	0.8	5.2	2.7	0.9	2.3	14.2	8.4	0.0	1.1	21.6	58.8	3.7	1.2	1.9	3.0	1.7	6.8	1.5	5.0	10.4	3.9	6.6	14.5	10.9	4.3	10.5	11.5	7.5	0.5	2.9	0.3	1.4	15.0
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191390-56357444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 171.2;retina: 52.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.8;Bipolar cells: 189.2;Excitatory neurons: 138.7;Inhibitory neurons: 132.2;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 368.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.7;BJ hTERT+ SV40 Large T+: 20.0;SCLC-21H: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced					NA	NA		510000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB008387: AB_591430, HPA040878: AB_2677184"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	3.0	7.9	100.8	3.4	171.2	0.1	1.1	55.1	121.9	2.1	0.0	34.0	3.1	7.7	3.0	2.9	2.9	2.5	34.1	101.9	87.6	1.1	10.2	0.9	1.1	74.6	89.6	1.7	3.9	1.5	28.5	0.5	77.9	5.1	5.1	52.4	2.3	16.5	2.0	1.4	7.3	10.2	44.6	1.3	11.0	13.8	107.3	1.1	1.9	0.6	1.1	7.9	2.5	110.3	7.3	0.0	0.6	0.1	0.0	0.1	0.9	7.6	30.7	20.0	9.5	0.4	0.0	0.0	0.2	0.0	7.3	0.6	4.9	0.0	13.7	0.2	0.9	0.0	2.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0	0.0	6.1	0.0	0.2	0.0	0.8	0.0	0.1	11.1	0.3	0.1	0.1	7.1	0.1	0.0	0.0	61.2	12.2	12.5	0.2	0.7	3.1	0.2	0.0	0.0	0.2	6.8	0.0	3.6	0.8	0.0	0.1	0.3	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	100.8	171.2	55.1	121.9	101.9	87.6	74.6	89.6	77.9	44.6	107.3	110.3	0.6	0.0	0.5	135.8	0.8	0.8	0.3	0.2	0.0	189.2	1.4	0.6	43.3	1.5	0.1	0.0	6.2	0.4	4.9	0.1	0.0	0.0	26.8	0.7	4.4	1.5	23.3	0.8	138.7	0.0	0.2	6.8	1.5	1.2	0.0	0.2	0.7	10.4	0.1	79.1	132.2	1.0	0.0	0.8	2.1	53.6	34.8	1.7	3.6	13.1	0.0	20.5	1.0	87.9	368.3	0.3	0.0	44.4	2.1	0.4	0.1	0.3	0.1	13.1	0.0	8.2	5.6	15.4	8.8	0.3	0.4	0.1	7.2	0.1	0.3	0.2
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716097-78031811	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 27.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		800000	"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	23.5	21.3	37.2	18.8	42.2	43.8	20.1	35.8	51.3	21.1	19.3	30.3	14.5	23.7	18.7	23.2	16.9	20.1	8.6	51.0	38.5	20.9	22.0	31.1	9.9	40.5	42.7	22.4	14.6	16.3	12.5	21.7	39.9	21.2	27.2	10.4	16.8	25.7	10.5	8.9	16.8	27.4	42.4	11.3	27.9	11.5	45.5	19.7	23.1	11.8	9.1	23.5	13.8	48.5	30.6	34.1	29.8	32.0	34.9	35.5	42.8	40.7	29.7	16.6	20.6	10.5	24.1	0.1	32.0	35.5	24.5	48.5	22.5	23.4	20.6	1.1	12.5	83.0	29.0	21.4	31.4	51.8	30.0	24.3	28.0	33.9	32.5	34.3	42.7	70.3	14.8	0.2	29.5	38.5	58.8	31.0	24.0	46.5	4.7	22.0	36.5	0.3	37.8	64.5	33.1	49.6	29.3	23.3	30.5	27.5	22.2	18.3	55.0	29.2	1.9	41.9	24.0	0.2	0.1	0.3	20.3	28.9	32.0	27.0	2.5	5.7	0.8	2.2	1.7	0.9	2.0	1.1	2.8	0.9	2.1	1.7	8.9	3.6	4.5	3.2	2.2	1.5	37.2	42.2	35.8	51.3	51.0	38.5	40.5	42.7	39.9	42.4	45.5	48.5	117.7	176.3	97.5	556.6	4.8	47.3	38.4	42.7	39.3	34.0	75.6	54.5	6.0	58.6	48.3	77.3	16.7	47.4	33.4	137.0	7.9	36.2	18.9	57.5	64.2	107.3	92.3	58.0	405.6	39.7	53.2	51.7	70.8	76.0	50.7	40.2	98.6	64.0	53.7	82.4	242.0	92.5	30.5	139.5	173.9	11.1	39.4	128.8	48.0	394.4	114.6	40.5	8.2	338.3	495.2	54.2	60.7	52.3	6.2	70.5	52.9	45.4	67.0	5.0	26.3	62.3	40.8	5.6	13.2	46.3	21.6	29.0	25.0	45.2	75.4	70.1
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNAT1	CSNBAD3	ENSG00000114349	"G protein subunit alpha transducin 1"	P11488	3	50191610-50197696	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	904	"retina: 1120.2"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 2275.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hippocampal formation: 6.5"	"Not detected"	"Not detected"			HPA045393	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA045393: AB_2679310"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"		"unprognostic (8.56e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.82e-3)"		"unprognostic (6.10e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.48e-3)"	0.1	0.1	0.3	0.1	0.2	0.7	0.2	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	1120.2	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.4	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	222.9	0.1	0.1	0.4	0.0	0.0	0.0	241.8	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.1	13.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.0	0.0	38.2	0.6	0.0	0.0	0.0	0.0	397.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2275.4	0.0	0.0	0.0	4.7	2.1	0.7	0.0	0.1	0.0	0.1	0.1	0.1
GNAT3	"GDCA, gustducin"	ENSG00000214415	"G protein subunit alpha transducin 3"	A8MTJ3	7	80458635-80512064	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"intestine: 1.8"	"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071345	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA071345: "											"unprognostic (2.01e-1)"							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GNAZ		ENSG00000128266	"G protein subunit alpha z"	P19086	22	23070519-23125032	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Horizontal cells: 124.5;Rod photoreceptor cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.3;SCLC-21H: 39.0;SH-SY5Y: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003011	Enhanced		Approved	Vesicles		NA	NA		180000	"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA003011: AB_1078918"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.30e-1)"	9.2	6.6	30.7	2.8	35.9	1.6	8.4	27.4	36.2	5.4	27.8	14.8	1.7	10.1	2.8	5.0	10.2	11.2	2.4	33.6	24.5	2.0	0.5	1.4	1.8	29.6	30.7	8.9	1.6	7.5	24.1	0.3	32.0	8.5	1.6	33.0	1.8	17.2	1.4	1.4	3.2	11.9	27.0	4.7	11.5	4.3	29.0	0.5	1.5	2.1	1.2	8.0	3.6	35.7	0.1	2.0	6.8	14.3	0.0	0.0	0.4	9.2	18.3	8.9	6.0	0.1	0.1	17.7	0.6	0.8	12.2	0.3	8.4	0.3	6.4	2.2	7.0	1.1	10.2	13.1	0.6	0.0	1.4	0.0	0.3	0.2	0.5	2.2	0.2	1.0	0.2	5.4	0.2	6.4	0.1	0.1	4.1	0.5	5.5	0.1	6.8	2.7	0.1	0.1	39.0	24.0	2.0	4.4	1.9	0.8	1.9	0.2	0.0	7.2	8.2	2.0	0.2	6.6	12.0	9.2	3.7	0.6	2.8	0.9	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.0	2.0	30.7	35.9	27.4	36.2	33.6	24.5	29.6	30.7	32.0	27.0	29.0	35.7	32.1	3.2	0.0	4.9	0.7	0.3	0.3	0.4	0.0	12.6	0.8	1.7	1.6	7.2	0.7	3.7	8.4	0.0	0.7	0.3	0.0	2.0	1.5	1.6	0.5	5.0	4.8	2.7	11.0	1.6	0.0	1.1	1.5	0.4	0.0	2.1	2.2	0.4	0.1	124.5	11.0	0.3	2.0	0.0	1.7	2.1	4.1	18.6	1.8	1.0	1.2	19.3	1.0	2.0	16.5	0.7	0.0	4.1	0.1	0.3	0.1	0.9	1.3	37.7	0.0	9.0	2.1	2.0	4.2	0.0	0.4	0.0	0.6	0.9	0.2	0.1
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB1L	"GY2, WDR14"	ENSG00000185838	"G protein subunit beta 1 like"	Q9BYB4	22	19783223-19854939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034627, HPA034628"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA034627: AB_10600662, HPA034628: AB_10600440"	"unprognostic (2.14e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.68e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.64e-5)"	"unprognostic (9.80e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.86e-2)"	3.5	2.2	1.4	2.8	1.8	1.7	3.5	1.0	3.7	3.8	0.6	4.0	4.1	4.1	0.4	4.9	3.9	1.0	2.7	1.8	0.8	2.6	2.8	3.1	2.3	1.3	0.7	3.5	3.9	0.4	2.2	1.4	0.9	3.4	0.3	0.3	3.3	1.3	3.7	5.9	3.7	0.6	0.6	5.3	2.7	2.4	0.9	4.0	3.0	0.6	1.3	4.2	4.2	1.3	13.5	10.2	2.9	8.9	0.9	1.7	8.0	9.1	2.5	4.4	4.1	18.3	5.2	18.1	5.8	2.1	2.1	25.5	2.0	4.3	0.6	11.7	34.0	10.9	13.6	9.1	2.7	12.6	2.9	1.4	2.0	3.9	1.5	1.0	1.7	8.1	66.6	6.8	0.8	19.3	28.1	18.1	5.0	3.9	17.1	14.6	8.1	4.1	0.4	5.4	5.9	6.4	3.5	8.8	15.5	0.5	2.3	3.2	4.2	9.8	11.8	16.1	9.3	8.8	7.8	9.6	10.6	11.1	3.4	7.3	6.0	15.9	13.2	7.9	12.7	9.4	12.6	10.0	9.8	11.9	12.1	11.0	6.1	12.0	5.9	13.3	17.0	7.5	1.4	1.8	1.0	3.7	1.8	0.8	1.3	0.7	0.9	0.6	0.9	1.3	2.4	3.2	4.4	3.6	6.9	22.0	6.3	11.8	5.2	8.5	4.7	5.5	1.6	2.8	5.7	0.0	12.5	15.2	5.2	4.6	3.9	5.6	28.3	2.9	3.3	4.6	0.0	4.0	6.7	3.3	13.8	4.3	2.0	4.1	12.7	7.8	2.2	2.8	10.3	0.0	4.1	4.6	8.2	7.3	15.5	6.5	3.4	4.6	14.2	1.9	4.9	3.0	6.2	4.5	4.3	5.9	2.6	4.9	5.4	8.8	6.3	4.9	1.9	4.7	6.6	2.8	4.4	13.8	10.2	5.1	16.2	4.7	7.9	2.7	5.2	5.3
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673567-100679174	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		940000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	198.4	211.0	131.4	128.3	137.3	207.5	188.0	112.3	179.6	209.4	103.8	168.0	103.2	182.4	63.7	328.4	179.8	105.5	175.9	130.2	138.1	186.1	185.8	210.1	107.9	140.3	130.1	175.3	184.8	98.9	203.3	107.4	123.6	183.0	83.6	20.1	190.8	113.6	175.9	295.5	143.5	113.5	126.3	225.9	172.4	92.9	137.6	90.2	144.8	90.2	105.7	165.2	217.7	120.7	358.6	268.6	222.7	272.5	169.8	199.9	194.3	208.4	288.4	294.3	241.7	205.3	333.7	157.7	216.0	311.3	332.2	243.0	177.7	312.6	103.0	216.9	152.1	120.8	198.7	171.3	282.4	157.7	254.5	259.5	291.1	304.2	244.6	237.6	343.6	132.5	228.6	303.3	270.4	980.0	249.5	450.3	173.5	225.1	290.1	234.3	136.3	253.8	235.4	291.3	241.0	380.1	278.0	449.2	201.3	125.3	192.4	192.1	325.8	313.8	346.8	619.2	266.6	88.8	111.9	240.9	237.1	349.7	443.6	27.6	28.6	70.9	17.5	42.7	16.2	13.6	17.9	15.4	28.1	18.1	11.8	12.4	117.2	15.4	35.9	23.8	23.5	12.5	131.4	137.3	112.3	179.6	130.2	138.1	140.3	130.1	123.6	126.3	137.6	120.7	138.1	57.7	97.0	16.0	104.1	151.8	159.3	72.9	148.0	10.4	105.4	106.0	35.0	100.1	55.5	84.6	4.2	172.4	89.4	285.4	162.4	163.7	32.6	133.5	106.8	136.5	180.4	127.7	12.7	218.7	312.1	117.6	135.1	127.2	44.4	97.6	126.0	69.9	264.4	72.3	10.8	211.2	75.3	198.6	198.8	20.1	144.8	193.5	140.5	15.9	160.8	128.2	96.8	5.0	6.9	257.1	285.6	130.1	122.5	226.5	162.3	107.0	68.3	8.5	65.7	62.0	162.2	34.3	69.6	240.7	194.8	293.9	117.8	88.1	192.2	259.5
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"retina: 426.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.9	1.4	6.3	1.6	6.0	1.0	0.6	6.7	9.5	2.3	6.7	1.4	1.7	2.2	0.7	0.4	1.6	1.1	4.4	5.9	6.6	2.0	0.2	0.7	1.6	5.7	5.3	2.8	0.7	1.5	36.2	0.4	5.6	2.1	0.6	426.5	2.1	1.4	1.3	0.7	1.5	3.2	5.2	0.9	1.0	0.6	5.7	0.3	1.6	0.3	1.6	1.6	1.1	6.4	0.4	1.2	9.4	3.1	1.3	2.0	0.9	4.8	0.8	2.5	2.1	1.9	0.5	14.1	0.1	5.1	0.1	0.5	9.2	0.3	2.3	1.2	2.1	3.4	6.8	1.5	0.9	1.1	2.3	2.4	0.5	2.4	2.7	9.6	2.5	1.8	1.5	1.3	1.2	0.7	0.7	0.8	17.0	0.1	0.5	0.7	2.8	0.9	0.5	0.4	1.1	2.2	0.4	0.1	1.0	2.5	0.1	0.6	4.0	3.2	3.8	4.8	6.7	1.4	1.0	40.9	1.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	6.7	9.5	5.9	6.6	5.7	5.3	5.6	5.2	5.7	6.4	0.3	0.0	0.0	5.2	1.3	0.4	0.4	0.2	1.2	471.3	0.8	1.3	6.1	0.0	0.1	0.0	932.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	3.3	0.0	1.3	12.3	0.0	0.0	2.3	2.0	0.1	0.0	0.1	1.1	0.0	0.1	74.0	12.4	0.0	4.1	0.3	0.4	0.0	3.7	0.1	1.8	3.7	0.1	86.7	0.0	6.0	1.2	0.1	0.0	3.4	3.2	0.8	0.0	0.1	0.6	462.8	0.0	0.3	1.4	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.2
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396088-179451476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 81.1;Kupffer cells: 98.1;Macrophages: 66.8;Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106"	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	14.9	6.3	8.7	21.9	19.2	33.7	12.4	7.3	11.2	11.5	2.9	9.5	5.9	9.2	3.7	21.9	7.0	15.2	13.9	9.6	8.7	5.9	7.8	16.0	17.7	15.5	8.5	5.8	2.8	2.7	3.0	21.8	14.5	4.5	8.6	2.0	4.7	4.0	3.1	34.1	6.4	23.5	14.5	18.1	7.4	4.3	10.9	7.9	6.3	5.7	11.5	13.2	6.8	19.7	33.4	15.4	37.7	0.8	23.8	41.5	44.1	46.7	33.1	54.1	61.3	0.8	3.7	61.6	9.9	54.3	49.7	0.6	36.4	43.1	56.7	143.6	29.2	71.3	54.9	0.7	23.4	62.3	16.2	32.9	6.6	42.4	21.6	12.0	59.3	13.7	18.7	0.8	42.8	1.3	32.8	24.3	18.9	0.2	19.3	61.4	49.2	25.3	34.9	1.9	7.0	20.5	37.5	33.0	61.1	23.0	67.5	26.1	45.3	45.1	27.4	13.6	61.6	0.3	0.9	0.8	24.7	52.8	35.4	5.6	21.3	11.0	0.2	27.8	0.1	6.7	0.4	0.3	24.9	13.6	0.4	0.3	14.5	3.4	23.5	12.8	0.6	8.8	8.7	19.2	7.3	11.2	9.6	8.7	15.5	8.5	14.5	14.5	10.9	19.7	40.0	25.6	12.8	17.9	20.1	18.7	1.8	2.5	13.6	1.7	14.3	12.3	15.6	0.0	12.3	3.7	6.2	13.8	11.5	0.1	3.9	1.1	1.2	15.6	22.9	42.9	0.0	22.9	18.6	1.6	18.7	26.6	3.6	10.8	10.8	16.2	53.2	0.9	81.1	1.7	18.4	0.0	2.0	98.1	17.4	1.4	10.2	66.8	14.2	91.8	59.9	0.8	2.1	11.6	7.7	2.8	0.0	15.8	8.1	2.6	0.2	0.2	11.3	4.0	26.3	9.9	41.8	2.3	16.8	23.4	25.4	4.1	2.9	14.7	0.0	1.3
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115100-52191392	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 120.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 267.5;Cone photoreceptor cells: 279.4;Muller glia cells: 206.9;Rod photoreceptor cells: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853"	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	11.2	14.5	20.7	11.8	22.5	5.4	12.7	26.7	28.3	27.1	8.7	18.8	5.9	28.3	17.2	11.8	26.8	20.8	22.8	21.9	25.6	36.3	18.8	8.9	21.9	22.5	13.6	49.4	18.9	40.6	25.9	5.7	23.4	16.6	5.5	120.0	11.2	25.5	2.5	8.7	13.1	17.4	9.4	13.5	11.1	15.7	23.6	14.9	21.7	4.7	19.9	20.8	18.1	15.1	18.9	47.6	12.9	23.1	21.5	26.9	12.5	36.1	34.8	31.4	34.0	13.3	13.9	32.6	11.0	29.7	52.9	27.0	23.1	34.3	23.6	25.5	17.5	21.8	60.7	15.6	25.7	11.0	75.8	25.0	28.3	25.2	9.3	33.3	19.9	28.2	1.7	29.9	34.8	33.6	17.6	31.4	12.1	6.3	20.9	23.4	44.9	40.0	22.4	56.7	20.8	18.0	34.6	3.2	28.7	15.8	11.1	33.9	49.5	28.1	30.7	32.2	36.8	18.9	39.0	35.7	58.9	26.6	46.2	10.1	3.8	0.4	21.4	3.8	17.6	41.5	27.2	25.5	10.1	43.8	25.2	21.9	2.2	23.6	3.2	20.6	42.5	18.7	20.7	22.5	26.7	28.3	21.9	25.6	22.5	13.6	23.4	9.4	23.6	15.1	15.9	22.4	23.8	17.0	79.5	19.2	22.8	15.5	21.1	267.5	20.7	27.9	18.3	34.3	21.8	18.4	279.4	4.8	27.1	2.7	19.6	28.9	1.8	28.3	28.7	17.7	19.7	6.1	72.8	18.5	24.8	23.5	8.6	59.9	29.8	20.1	13.6	10.0	3.8	111.0	67.7	1.7	14.2	6.2	15.2	4.6	39.7	20.5	19.6	8.4	4.0	206.9	15.5	22.1	7.8	19.1	5.1	116.9	18.7	10.9	0.8	36.3	24.6	296.5	46.0	16.6	23.9	2.1	6.2	10.8	16.3	2.9	31.9	20.1	2.8	17.8
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GNG11	GNGT11	ENSG00000127920	"G protein subunit gamma 11"	P61952	7	93921735-93928610	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Adipocytes: 1903.6;Endothelial cells: 1236.2;Hepatic stellate cells: 994.2;Macrophages: 481.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 20.5;neutrophil: 9.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 219.9;HUVEC TERT2: 349.6;SK-MEL-30: 221.8;TIME: 201.1;U-87 MG: 187.1"	"Low region specificity"	"Detected in all"							HPA045255	Uncertain					NA	NA		3400000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045255: AB_10794781"	"unprognostic (1.30e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.71e-3)"	75.5	16.8	14.4	8.1	14.6	2.5	64.4	14.7	22.0	24.9	13.7	23.5	6.7	26.8	10.9	10.9	33.5	15.5	48.3	14.1	14.7	34.9	12.1	39.8	7.8	14.9	14.6	56.7	8.8	4.4	9.3	85.9	15.3	15.8	6.4	1.5	9.1	17.9	15.4	11.4	16.1	16.7	15.1	39.0	16.0	3.3	16.1	19.0	29.1	18.6	3.5	27.9	18.4	14.9	0.2	34.2	67.2	31.0	51.2	40.0	0.0	34.8	67.7	19.0	26.7	0.1	2.9	0.0	219.9	17.5	79.9	0.5	0.5	3.2	23.8	0.2	2.0	11.0	35.9	0.0	81.8	0.0	0.1	13.4	0.1	61.0	6.0	78.7	349.6	0.0	0.1	0.2	85.9	0.0	0.1	0.1	5.8	0.0	10.4	32.5	7.6	0.1	41.3	0.0	0.1	67.2	0.0	0.2	221.8	8.6	144.4	2.4	201.1	93.4	10.4	68.3	3.9	0.0	0.2	0.7	187.1	0.0	81.8	20.5	0.7	0.3	0.1	0.1	0.2	2.3	0.0	0.0	1.0	2.0	0.2	0.0	9.8	0.0	0.1	3.7	0.1	50.2	14.4	14.6	14.7	22.0	14.1	14.7	14.9	14.6	15.3	15.1	16.1	14.9	1903.6	12.8	27.3	1.3	20.6	83.6	11.8	3.1	5.7	0.7	15.2	26.8	94.8	11.5	3.1	187.6	0.0	2.3	15.4	0.1	74.3	135.7	5.9	124.1	94.6	1236.2	0.0	40.6	0.0	5.7	12.9	207.3	0.5	236.4	2.5	12.7	994.2	11.1	17.0	0.0	0.0	0.3	18.3	55.9	89.5	17.0	82.3	481.1	188.5	26.2	49.6	9.2	41.2	0.5	0.2	4.3	0.0	86.9	8.0	11.0	0.0	12.9	1.7	4.7	151.2	115.5	165.0	1.9	7.6	2.7	65.8	23.8	15.9	109.9	0.0	4.5
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701475-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA		550000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"	63.4	57.0	14.4	28.5	12.3	0.3	50.1	10.4	14.0	59.3	13.5	68.4	122.0	59.7	27.7	82.0	43.4	59.3	34.5	13.7	19.5	79.2	44.8	34.3	12.0	21.9	29.1	47.9	25.2	54.7	13.1	60.2	16.9	38.3	65.7	6.6	26.6	47.6	12.9	80.4	110.8	73.9	18.6	56.2	42.7	17.7	16.4	15.9	59.8	19.7	22.7	56.5	46.5	18.7	60.5	55.5	58.0	31.5	241.2	207.9	59.5	182.9	237.2	157.9	141.0	26.5	58.2	0.1	75.9	258.0	98.8	44.2	36.6	150.0	275.7	0.5	28.1	1.0	46.0	0.1	96.0	0.1	3.0	125.7	87.8	168.7	221.8	221.1	251.9	0.0	3.6	0.3	175.6	10.2	0.1	0.5	44.1	65.7	68.3	0.3	119.6	0.9	151.8	53.5	13.2	26.8	126.8	52.1	248.4	48.8	26.9	1.1	326.7	182.5	118.8	332.0	114.5	3.0	0.3	0.5	115.3	7.1	252.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	12.3	10.4	14.0	13.7	19.5	21.9	29.1	16.9	18.6	16.4	18.7	49.7	54.5	32.2	54.5	2.1	201.3	78.8	53.3	78.6	2.1	52.4	37.1	26.7	35.8	42.8	58.8	6.2	61.8	0.9	243.1	74.3	96.2	14.6	51.8	20.6	67.0	34.7	5.3	0.5	138.5	105.6	82.6	45.3	49.3	3.8	21.3	76.1	45.6	27.9	3.3	15.3	56.3	30.5	18.2	32.4	16.6	71.4	6.2	78.2	21.5	3.6	3.0	0.0	63.3	1.3	143.7	99.9	75.6	0.2	119.9	227.3	177.9	79.2	18.9	52.6	54.8	71.7	1.8	18.8	83.1	216.8	175.9	4.5	107.1	61.8	109.1
GNG13	"G(gamma)13, h2-35"	ENSG00000127588	"G protein subunit gamma 13"	Q9P2W3	16	798041-800734	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	37	"brain: 47.4;retina: 55.8"	"Cell type enriched"	"Detected in some"	16	"Bipolar cells: 311.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"cerebellum: 47.4;thalamus: 23.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.4;HEK 293: 9.0;HeLa: 6.5;MCF7: 12.9"	"Region enhanced"	"Detected in all"		"cerebellum: 940.0"	"Group enriched"	"Detected in many"	6	"cerebellum: 37.7;olfactory bulb: 14.0"	HPA046272	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"			"HPA046272: AB_10960062"	"unprognostic (1.84e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.41e-2)"		"unprognostic (8.47e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.77e-2)"		"unprognostic (7.12e-2)"	"unprognostic (1.55e-1)"		"unprognostic (3.38e-1)"	0.0	0.0	3.8	0.1	1.2	0.2	0.0	47.4	4.6	0.0	0.0	0.9	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.1	55.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	23.2	0.6	0.0	0.0	0.1	0.0	0.0	4.8	0.2	3.6	0.5	1.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	10.4	0.3	1.1	0.3	0.0	0.1	1.6	0.0	0.0	0.0	1.2	9.0	1.3	6.5	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.8	0.0	12.9	1.3	0.7	1.2	0.1	1.0	2.8	2.8	0.6	0.0	1.5	0.9	0.8	0.9	0.3	0.2	0.3	0.7	0.1	0.0	1.3	1.2	1.7	0.3	0.4	2.5	4.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.2	47.4	4.6	0.2	2.4	0.0	4.5	1.9	0.0	23.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	311.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GNG5		ENSG00000174021	"G protein subunit gamma 5"	P63218	1	84498325-84506581	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032623, HPA043651"	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB032623: AB_2109919, HPA043651: AB_2678600"	"unprognostic (1.82e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.75e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.22e-2)"	132.0	93.4	51.8	77.3	56.2	176.7	114.2	54.3	76.1	106.5	58.6	143.2	110.4	99.9	69.2	148.9	97.0	56.4	278.2	51.3	56.7	189.5	165.4	159.8	77.5	57.5	55.1	78.1	118.5	62.6	71.9	75.5	58.0	96.5	100.2	19.0	108.5	56.3	266.5	104.8	112.7	67.3	54.9	148.9	142.2	96.4	54.9	102.8	106.8	164.1	94.0	100.5	102.6	55.7	205.2	82.4	218.6	189.3	143.5	161.9	263.4	194.6	130.3	230.2	241.5	107.4	123.8	127.8	179.9	184.6	346.3	105.2	127.3	183.3	195.1	165.2	200.7	264.4	83.9	213.9	245.7	184.7	96.9	148.0	223.5	228.0	139.9	132.3	247.1	146.8	249.0	194.2	222.9	55.5	268.7	405.3	287.7	139.7	255.2	171.0	271.4	151.2	301.7	100.2	66.2	212.6	141.0	186.6	395.0	169.1	133.6	240.4	193.7	179.0	213.3	264.5	250.4	213.0	157.3	192.4	104.8	240.5	169.2	512.9	447.6	425.3	192.8	568.4	154.7	286.4	204.1	190.5	428.5	226.8	163.6	177.5	879.6	218.7	655.9	461.8	269.9	426.7	51.8	56.2	54.3	76.1	51.3	56.7	57.5	55.1	58.0	54.9	54.9	55.7	327.9	266.0	231.9	15.7	150.2	278.6	316.7	478.4	224.8	3.4	286.2	398.1	1037.7	303.1	364.7	277.7	6.2	405.2	248.3	668.3	716.1	413.6	777.6	344.8	218.5	296.1	210.0	277.0	2.0	486.0	486.6	213.9	209.5	342.8	174.8	216.1	280.6	382.0	599.6	18.5	1.2	405.6	319.4	371.5	463.1	122.3	181.1	417.2	249.1	15.9	564.4	430.9	241.0	3.0	4.0	631.1	639.7	195.6	322.0	496.2	571.6	724.9	312.3	16.7	131.5	195.4	271.3	206.8	133.7	367.5	261.0	311.7	171.1	134.1	421.0	541.2
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702694	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"brain: 360.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 145.4;Distal tubular cells: 123.3;Horizontal cells: 169.9;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 206.1;Plasma cells: 169.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9;melanoma: 20.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0"	"Group enriched"	"Detected in many"	4	"B-cells: 57.2;dendritic cells: 48.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 22.3;REH: 66.5;SK-MEL-30: 31.2;U-266/70: 61.0;U-266/84: 30.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 1277.2"					HPA057790	Supported	Supported				NA	NA		72000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.5	5.7	70.8	5.3	360.9	6.6	4.4	83.9	127.9	5.5	14.0	6.7	5.2	7.2	5.1	12.0	8.2	3.5	26.4	70.1	66.0	10.5	4.2	4.0	9.9	97.2	87.9	12.2	8.0	6.2	17.4	1.4	76.8	9.5	3.1	15.1	26.0	5.7	3.4	2.6	14.2	3.5	76.0	19.4	6.8	8.9	154.1	2.7	5.8	8.1	9.4	7.9	3.3	81.4	0.2	0.0	3.2	7.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.7	22.3	1.0	0.3	0.3	0.2	3.5	0.0	0.1	0.0	3.1	0.6	0.1	2.7	1.6	0.0	12.9	0.4	0.5	0.0	0.2	0.2	0.0	2.7	0.3	14.2	0.0	2.2	0.6	1.4	2.6	0.4	1.4	66.5	0.0	6.2	0.3	0.0	0.1	9.2	0.1	0.1	31.2	2.1	0.4	5.6	0.1	0.1	3.0	0.2	0.2	61.0	30.0	4.7	0.2	7.0	16.5	3.5	1.5	8.0	0.4	0.5	1.1	57.2	0.5	0.4	6.0	50.1	1.2	0.7	11.8	0.2	0.1	48.0	0.0	3.0	70.8	360.9	83.9	127.9	70.1	66.0	97.2	87.9	76.8	76.0	154.1	81.4	14.5	6.4	4.2	40.8	145.4	2.5	13.0	0.3	5.2	10.5	22.9	30.1	55.1	15.7	3.3	9.2	8.4	0.6	56.1	0.9	123.3	17.0	5.4	2.1	2.3	11.7	6.1	8.6	26.5	4.8	1.1	6.6	5.6	3.5	12.7	8.6	19.2	11.4	63.2	169.9	38.8	2.0	0.0	8.5	15.0	11.4	2.5	12.3	51.6	45.9	11.2	84.7	3.1	102.5	206.1	2.7	1.8	2.6	169.7	7.5	0.7	22.6	2.9	11.1	6.6	7.1	5.4	2.7	2.6	1.5	2.0	3.4	6.9	2.1	2.2	7.2
GNGT1	GNG1	ENSG00000127928	"G protein subunit gamma transducin 1"	P63211	7	93591573-93911265	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	644	"retina: 1902.1"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 3097.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.4;HeLa: 3.4;SK-BR-3: 3.0;SuSa: 4.3;T-47d: 5.3;U-266/84: 4.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042721	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA042721: AB_10806370"		"unprognostic (1.30e-1)"	"unprognostic (2.55e-4)"	"unprognostic (3.32e-4)"		"unprognostic (5.01e-2)"		"unprognostic (2.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.55e-1)"		"unprognostic (2.23e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.9	0.2	0.0	0.0	1902.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.5	1.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.1	1.4	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.4	0.2	1.3	2.6	1.0	0.1	3.0	0.0	4.3	5.3	0.1	0.1	0.0	2.7	0.1	0.0	2.8	4.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.6	0.1	0.0	0.2	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	371.1	0.0	0.0	0.1	0.0	0.7	0.0	385.7	0.5	0.0	0.1	1.9	0.4	0.1	0.2	0.0	21.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	198.5	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	619.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.8	3097.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.1	0.0	0.1	0.0	0.0
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 157.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 73.0;Kupffer cells: 26.5;NK-cells: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 66.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 64.8;HDLM-2: 54.5;HUVEC TERT2: 19.4;RH-30: 21.6;TIME: 19.9;U-698: 18.2"	"Low region specificity"	"Detected in all"							HPA043381	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	3.1	2.6	2.7	7.7	3.0	2.5	1.8	3.4	4.0	2.3	3.0	2.9	3.5	2.4	0.6	2.7	2.0	4.5	3.0	2.7	3.7	4.4	3.4	7.2	14.1	3.9	3.2	1.5	1.6	1.0	1.2	2.7	3.7	2.1	3.8	157.0	1.1	1.3	0.9	0.9	5.2	3.7	3.4	19.9	2.4	0.8	3.3	5.5	2.4	2.7	18.4	3.3	1.6	4.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.5	1.0	0.9	0.3	0.0	64.8	0.7	0.1	0.0	0.0	0.0	0.1	4.6	54.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	19.4	8.8	0.0	0.4	1.5	0.0	4.6	3.6	0.6	0.0	0.0	12.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	19.9	0.0	12.6	0.0	0.1	0.2	2.9	18.2	0.3	0.2	0.0	0.1	8.8	1.1	30.4	47.3	27.3	3.7	4.6	21.1	20.3	4.5	2.9	11.7	1.9	26.7	66.7	1.9	3.4	12.7	2.7	3.0	3.4	4.0	2.7	3.7	3.9	3.2	3.7	3.4	3.3	4.6	4.5	0.0	1.1	0.0	4.6	0.4	0.0	0.0	0.0	2.7	0.2	0.3	0.8	0.0	0.6	0.0	73.0	0.0	15.5	0.0	3.9	0.0	1.1	0.1	0.1	5.2	0.0	8.0	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.1	2.5	0.1	11.1	0.0	0.4	0.0	0.0	26.5	2.0	8.2	0.6	13.6	0.0	1.0	9.5	5.9	52.5	0.0	0.1	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	14.8	6.6	0.1	0.3	0.1	0.1	0.0	0.1	0.3	11.4	0.4	0.0	0.0
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA		11000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	22.6	19.6	3.3	3.5	3.5	2.0	21.7	2.0	4.0	30.5	1.7	19.3	0.6	27.3	3.9	17.0	26.2	2.4	15.2	2.3	4.8	21.2	13.1	27.8	2.3	3.3	3.0	37.5	24.3	7.8	23.8	2.8	3.5	19.9	3.4	4.1	16.6	3.9	15.0	23.3	17.4	4.5	2.7	18.7	20.0	38.0	4.7	5.0	23.3	1.6	4.6	21.1	22.9	5.4	10.5	2.2	5.9	16.9	10.9	12.8	0.4	3.2	6.4	2.6	4.0	15.1	6.5	4.8	6.2	10.4	25.8	6.9	15.4	12.7	4.4	1.8	9.0	7.8	7.9	1.4	0.0	1.3	5.0	11.0	9.9	20.4	6.7	0.0	1.1	18.6	14.2	0.3	6.5	2.4	3.8	0.2	3.4	8.4	1.6	7.3	3.6	5.3	8.7	4.5	5.2	4.9	4.2	3.1	1.6	2.0	3.0	4.9	6.2	10.5	3.0	2.0	3.7	7.9	9.3	9.9	0.1	6.6	13.1	0.2	0.2	0.2	0.7	0.2	1.0	0.4	0.8	0.9	0.0	0.3	0.1	0.3	0.2	0.4	0.2	0.1	0.5	0.5	3.3	3.5	2.0	4.0	2.3	4.8	3.3	3.0	3.5	2.7	4.7	5.4	48.2	44.8	41.8	17.3	45.0	59.3	104.0	44.1	56.3	40.6	35.4	40.6	14.3	34.3	28.8	25.8	41.7	72.6	36.3	22.6	23.5	38.4	113.1	30.0	40.2	50.8	46.0	13.3	26.2	35.3	65.5	46.4	27.5	47.5	31.7	40.9	50.7	16.9	28.5	16.8	27.0	25.8	26.4	19.8	32.5	193.5	36.4	24.6	28.4	9.4	14.8	30.9	18.6	11.1	10.8	29.9	22.1	32.0	42.6	56.2	32.4	30.3	20.7	34.6	39.5	47.9	58.1	108.4	51.8	36.1	40.6	160.1	46.0	40.9	27.0	66.7
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595937	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	27.8	22.4	11.1	24.8	12.1	49.9	30.4	12.5	13.5	21.7	13.1	22.8	17.8	22.8	24.4	26.4	20.1	19.4	21.6	10.9	12.1	19.2	31.6	22.7	26.5	13.0	12.0	20.4	20.8	20.9	19.3	23.5	12.7	18.2	25.5	11.7	23.2	14.2	50.6	29.5	18.7	24.4	12.1	19.6	21.9	30.2	13.5	26.1	16.0	29.0	32.7	35.2	21.2	14.1	66.5	33.5	63.9	66.4	49.8	57.1	102.9	98.6	68.5	89.3	90.4	92.6	75.2	107.8	62.7	73.5	50.8	60.6	105.1	80.5	121.1	62.6	83.5	108.4	66.4	74.5	66.5	143.3	73.7	36.2	72.6	122.4	144.3	42.7	65.2	47.1	146.8	74.6	87.3	58.2	77.7	85.9	165.8	48.2	65.9	81.8	114.7	121.8	75.0	70.7	76.9	71.1	74.2	73.4	73.1	93.8	52.7	82.5	53.0	59.1	83.9	127.2	138.6	69.9	67.8	185.8	68.3	113.2	77.3	23.2	28.1	24.4	22.5	36.3	26.0	28.1	21.0	24.6	39.8	21.1	21.9	21.2	2.8	33.5	35.3	29.0	28.2	21.7	11.1	12.1	12.5	13.5	10.9	12.1	13.0	12.0	12.7	12.1	13.5	14.1	18.5	16.0	48.1	6.5	29.7	63.3	84.3	37.2	27.3	8.8	17.5	14.5	21.9	12.8	63.3	7.3	10.4	37.2	27.8	18.2	27.4	52.9	54.0	27.2	31.0	28.1	17.3	17.7	6.4	62.3	49.4	40.8	23.9	29.7	48.1	29.5	11.0	18.3	32.0	6.7	5.3	27.3	24.4	17.9	29.6	13.5	23.9	27.7	8.8	8.4	31.7	21.1	25.7	3.5	5.7	51.5	21.9	19.2	32.4	68.3	15.7	18.8	54.4	9.6	0.0	44.8	34.8	46.7	45.6	29.5	52.8	46.1	28.3	20.6	27.5	56.5
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530183-54621521	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	4.6	3.6	2.0	7.0	3.6	8.9	4.8	2.6	2.7	4.8	3.1	4.7	3.9	4.7	3.7	5.7	4.7	4.7	7.2	2.7	2.6	4.4	3.9	5.0	7.6	3.1	3.6	3.8	5.0	5.7	2.3	5.6	3.2	3.7	6.1	3.8	4.0	4.4	7.1	5.7	4.7	7.3	2.7	6.9	5.3	2.3	3.4	8.3	8.5	7.8	8.5	6.7	3.5	5.4	20.7	49.1	9.5	20.9	10.2	8.3	15.2	9.8	8.7	13.4	9.9	43.4	16.6	26.9	21.3	18.2	15.1	18.7	34.6	14.9	19.0	15.9	16.4	30.0	34.0	17.2	7.9	42.6	26.0	10.0	7.1	31.0	17.4	5.7	13.4	16.4	19.2	27.0	14.0	36.5	25.5	11.8	29.6	13.0	26.7	27.7	23.9	27.8	10.3	28.8	17.1	8.4	39.7	24.3	11.7	20.9	30.9	11.4	20.0	22.6	22.1	21.8	18.4	19.9	25.7	35.9	12.8	34.6	27.8	23.6	14.4	15.0	16.5	12.8	15.0	15.1	14.8	13.8	11.1	16.0	10.6	11.7	19.2	21.5	15.0	10.2	9.3	12.5	2.0	3.6	2.6	2.7	2.7	2.6	3.1	3.6	3.2	2.7	3.4	5.4	9.2	12.8	18.5	14.4	15.3	1.3	3.6	3.9	9.6	10.2	6.1	3.9	8.5	8.6	11.8	3.7	12.5	7.1	14.1	7.4	3.9	9.4	0.4	8.2	17.2	9.4	3.5	12.0	14.8	8.7	6.4	7.4	10.7	9.6	10.8	10.9	7.1	4.6	4.9	8.4	14.8	4.7	8.2	9.4	4.2	0.0	5.6	9.4	0.0	14.0	12.0	3.4	25.7	16.1	23.2	9.8	3.9	3.0	10.0	4.2	6.8	5.3	7.8	9.3	6.6	8.5	7.1	1.1	7.7	6.6	2.0	5.5	11.9	9.5	7.6	3.6
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698852	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 288.7;endometrium 1: 71.9;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5070.6;NK-cells: 8318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 17623.2"	"Group enriched"	"Detected in all"	63	"NK-cells: 17623.2;T-cells: 7874.6"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000	17000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	6.9	2.7	8.1	11.6	7.8	288.7	5.2	8.1	18.7	4.3	7.1	5.7	4.0	71.9	3.9	2.6	6.1	6.5	4.3	7.8	9.8	2.9	10.4	36.8	21.9	12.7	11.6	1.5	1.2	0.8	1.8	17.0	10.6	2.0	6.1	0.5	2.0	5.3	9.2	1.5	10.3	4.3	8.8	86.3	5.0	0.9	9.8	3.5	3.6	3.5	17.6	6.4	2.5	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	177.1	26.2	17.7	7874.6	26.3	2145.8	34.2	837.4	3344.7	22.4	23.0	231.3	2928.7	202.5	17623.2	32.3	58.2	40.3	8118.6	8.1	7.8	8.1	18.7	7.8	9.8	12.7	11.6	10.6	8.8	9.8	9.8	26.8	12.8	78.9	0.0	23.3	7.0	0.2	0.0	0.0	0.1	7.2	3.7	3.0	10.0	6.2	0.0	2.1	2.3	5070.6	1.3	1.9	1.9	0.0	7.5	12.0	13.0	1.8	47.2	0.2	0.0	3.4	29.3	0.5	10.6	52.4	0.1	23.2	5.3	6.0	0.0	0.1	3.3	0.0	22.4	7.2	0.2	0.3	28.4	80.0	9.4	48.6	0.1	8318.3	0.0	0.1	0.0	1.2	0.0	247.4	0.1	2.4	9.5	3.6	0.2	0.0	7.0	5.4	0.2	0.6	0.6	7.7	1.1	1230.0	1.0	1.6	0.6
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 127.2;Proximal tubular cells: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 382.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		930000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	18.8	38.4	26.9	17.3	28.8	8.1	20.9	26.2	35.2	26.7	27.7	19.7	29.5	28.7	51.9	13.6	18.4	22.3	17.3	28.1	30.8	76.4	16.6	17.6	22.7	27.0	27.7	31.8	11.3	27.9	20.5	22.2	29.3	22.2	21.9	17.7	14.6	28.3	26.4	14.8	22.5	29.2	27.0	30.9	14.5	18.8	29.7	24.9	27.8	25.7	19.8	33.3	17.1	30.7	42.6	61.0	23.2	115.8	77.1	51.9	54.6	32.6	78.7	84.7	95.8	91.3	49.2	0.2	72.9	23.6	382.3	44.0	109.9	98.0	74.8	32.9	46.5	31.3	33.1	65.5	137.2	86.4	39.2	63.5	56.9	54.5	144.8	63.2	91.6	80.6	37.3	110.1	93.0	27.2	66.8	9.8	88.0	62.8	121.4	25.5	76.3	94.3	81.8	114.8	20.6	54.0	65.0	67.8	127.9	67.5	54.6	26.5	43.3	50.9	33.3	76.9	47.5	61.2	126.9	47.1	74.2	29.3	45.0	0.3	48.6	7.1	37.2	59.1	77.9	19.4	30.0	34.2	51.7	11.1	35.3	38.8	12.7	15.8	56.3	29.6	27.6	40.2	26.9	28.8	26.2	35.2	28.1	30.8	27.0	27.7	29.3	27.0	29.7	30.7	10.5	9.6	14.9	10.7	8.2	6.0	40.8	20.9	21.1	11.6	12.6	17.8	12.6	12.8	20.1	18.4	8.4	26.7	11.1	6.9	35.2	29.3	1.1	5.8	19.8	14.6	15.0	9.9	11.5	14.2	48.6	22.8	7.7	9.6	12.0	30.8	15.4	7.4	127.2	6.7	12.7	6.2	12.2	60.2	10.7	3.6	19.9	48.5	14.2	12.2	23.5	40.5	15.5	7.1	11.5	21.6	7.1	26.7	7.8	32.9	19.4	102.3	8.0	7.9	0.0	10.4	11.7	10.4	17.0	17.6	7.4	29.7	16.6	64.8	9.1	34.7
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		820000	"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	13.1	12.6	9.6	9.8	10.8	8.4	14.5	21.9	13.3	13.9	7.5	12.3	7.9	16.6	14.0	10.1	12.6	10.5	17.5	10.8	9.9	13.8	4.0	10.0	12.6	9.5	9.8	22.6	8.2	13.0	12.8	6.7	9.9	14.7	8.2	18.5	9.2	15.2	11.3	9.7	8.5	16.5	10.4	11.8	9.1	11.6	9.8	13.2	18.1	10.1	10.5	12.0	10.0	12.5	15.7	10.9	11.4	9.7	17.8	24.7	3.9	27.1	30.3	17.9	16.7	5.6	19.1	13.6	15.5	23.4	29.8	5.3	10.6	26.3	19.7	18.4	11.9	19.3	16.6	9.2	18.8	20.8	17.7	28.5	18.1	17.9	13.1	22.6	26.5	18.1	12.2	17.9	33.6	0.7	25.2	11.6	5.5	10.4	19.5	16.3	24.3	8.0	17.3	9.5	19.5	15.8	12.1	7.0	27.2	5.4	14.9	12.1	25.9	23.7	22.6	38.5	31.6	23.0	38.7	19.7	38.6	14.3	21.3	9.3	2.4	5.0	9.7	3.6	11.2	12.2	9.0	9.3	3.7	10.5	11.2	10.8	1.1	9.8	4.9	2.8	10.7	4.7	9.6	10.8	21.9	13.3	10.8	9.9	9.5	9.8	9.9	10.4	9.8	12.5	18.4	9.6	4.6	17.0	19.8	12.5	8.9	18.6	8.0	15.6	9.2	8.1	14.1	2.8	9.4	14.7	8.4	1.2	15.7	3.0	15.6	13.3	30.3	7.9	21.9	14.4	6.7	6.5	29.1	15.1	1.1	22.0	7.1	8.5	15.8	8.5	11.4	1.6	4.8	13.5	29.2	4.4	18.3	3.7	8.7	5.0	16.1	4.2	8.8	8.4	4.3	19.8	13.4	31.2	20.4	14.2	2.9	23.7	6.3	5.2	2.9	13.2	8.0	18.2	13.1	14.3	20.0	34.4	29.9	5.7	10.7	0.5	13.7	20.0	4.4	5.2
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775193-52791668	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044647	Approved					NA	NA		72000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	21.5	7.3	4.8	11.1	5.5	3.9	16.8	6.9	6.1	14.6	5.0	18.4	15.0	9.2	9.5	8.5	8.4	11.4	5.4	5.9	5.8	13.6	77.1	6.0	7.3	4.9	4.7	9.3	25.4	8.0	5.8	10.5	5.4	15.5	22.0	5.6	19.3	7.0	11.2	6.7	14.1	10.7	4.9	5.5	19.7	15.3	5.1	5.8	8.5	7.3	8.5	13.8	6.1	6.2	99.8	37.6	30.5	34.7	32.0	73.8	49.9	63.6	41.4	53.5	54.8	43.4	59.1	56.3	34.6	64.2	26.2	40.0	59.2	64.0	92.9	32.4	31.1	38.1	36.2	55.1	46.2	42.7	19.5	29.9	53.1	92.9	99.5	27.7	62.1	35.3	36.7	13.4	70.8	85.6	52.0	21.9	31.8	129.1	67.6	34.7	14.4	33.9	51.2	51.3	30.6	42.8	54.1	70.5	46.6	20.8	83.4	14.6	70.1	55.2	56.9	97.6	50.0	14.0	28.4	24.4	26.1	27.4	32.8	6.4	1.7	0.1	5.0	2.1	6.0	4.6	5.2	4.6	4.0	5.1	5.9	4.7	0.6	5.5	5.0	2.4	6.8	3.1	4.8	5.5	6.9	6.1	5.9	5.8	4.9	4.7	5.4	4.9	5.1	6.2	14.1	16.0	12.1	5.2	10.7	19.2	33.7	19.1	10.2	9.6	23.6	16.3	3.6	18.6	18.5	12.9	4.2	23.3	10.6	13.4	33.2	40.3	43.8	16.0	25.5	17.7	5.4	13.3	16.5	37.6	74.8	25.8	32.6	39.5	7.0	16.5	12.1	89.4	15.5	3.3	10.8	61.0	10.2	6.0	9.3	11.8	19.6	8.6	7.2	8.4	5.4	5.3	18.6	9.0	9.0	45.9	14.0	18.0	13.8	42.0	8.0	16.1	13.0	6.4	19.7	18.3	24.7	71.2	7.2	22.3	21.3	12.2	10.6	13.7	30.1	38.1
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase subunits alpha and beta"	Q3T906	12	101745499-101830959	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		160000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	11.9	7.9	18.8	16.2	22.2	23.9	16.4	14.4	20.0	17.4	2.7	29.6	14.2	11.8	6.2	15.6	8.8	14.8	21.5	22.7	10.8	14.5	9.4	27.0	20.6	8.5	11.1	7.2	11.3	23.0	8.4	14.8	9.7	20.1	30.3	13.0	54.3	13.0	16.4	25.1	16.2	15.9	8.9	19.0	21.3	10.4	12.4	34.1	13.9	25.9	17.8	19.3	12.0	13.3	18.2	17.5	6.4	10.9	52.3	24.8	19.6	25.4	52.3	24.7	32.2	13.5	12.4	38.1	17.9	35.1	20.1	23.2	29.8	32.8	38.4	18.1	15.6	16.3	15.4	19.3	9.7	15.0	31.7	19.3	17.7	23.5	13.8	61.4	44.0	30.0	25.9	11.0	23.4	27.8	45.6	21.0	22.0	22.6	12.5	10.6	32.6	51.2	39.5	46.8	13.6	11.2	42.3	29.7	60.7	23.5	30.6	9.8	43.6	23.1	12.5	19.6	14.4	30.0	32.9	21.5	26.4	21.8	14.6	8.6	3.8	4.4	18.8	3.6	6.2	3.0	4.0	10.3	7.1	4.9	5.1	7.9	1.4	17.0	4.6	6.9	3.3	3.7	18.8	22.2	14.4	20.0	22.7	10.8	8.5	11.1	9.7	8.9	12.4	13.3	25.3	60.9	65.0	35.9	42.1	16.8	32.9	16.2	17.1	23.6	25.2	18.9	43.5	18.6	27.8	22.0	25.0	25.7	107.3	68.3	7.9	10.3	0.6	25.3	23.7	21.1	18.0	19.5	84.5	15.1	15.0	18.9	33.1	61.6	122.8	24.6	10.4	9.7	46.7	8.4	83.8	29.6	24.4	46.7	17.6	3.8	17.1	41.2	42.7	30.0	43.5	26.9	192.6	135.2	19.8	15.7	129.3	12.8	63.9	28.1	17.7	13.8	10.0	37.0	0.0	18.6	14.9	12.4	33.0	26.7	14.3	8.8	63.4	30.6	49.7	46.5
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase subunit gamma"	Q9UJJ9	16	1351931-1364113	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 135.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		560000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	34.8	94.0	33.5	19.3	41.3	25.0	34.5	37.8	43.3	31.4	43.2	27.9	17.7	29.7	28.9	23.6	28.5	23.7	28.7	32.6	34.8	37.1	40.9	28.4	27.9	38.8	35.5	35.7	39.6	40.2	32.9	20.9	39.3	29.9	16.2	15.6	42.9	20.7	34.6	37.2	30.9	14.9	35.1	38.3	34.8	21.4	35.7	13.3	33.9	16.9	14.4	28.8	26.5	44.5	13.3	21.2	15.3	26.9	135.2	50.3	20.1	38.3	49.6	14.9	28.4	19.1	37.0	8.4	43.0	51.8	22.5	24.0	9.2	22.4	7.6	27.0	20.2	11.3	73.9	33.0	57.6	18.2	43.2	67.3	38.4	14.2	20.3	41.6	27.5	15.2	13.7	48.4	24.6	30.7	8.7	18.7	14.4	33.9	11.8	30.5	12.9	38.6	37.3	17.1	12.0	15.5	38.5	39.2	28.7	8.5	36.9	27.3	27.0	29.8	25.5	24.6	19.1	50.6	40.4	17.7	24.4	15.6	20.3	70.5	77.0	49.5	43.3	74.4	39.6	32.1	36.7	40.8	61.5	31.1	33.4	30.8	32.0	32.6	73.9	52.2	46.9	49.7	33.5	41.3	37.8	43.3	32.6	34.8	38.8	35.5	39.3	35.1	35.7	44.5	39.7	41.7	41.7	17.3	31.9	20.9	26.5	25.4	46.7	15.1	34.0	42.9	9.4	37.1	43.2	20.2	25.0	25.0	34.9	25.8	9.8	27.4	2.6	17.7	29.8	25.6	9.1	9.9	22.7	14.5	20.3	49.7	47.4	23.7	24.6	21.1	30.7	35.2	50.2	8.4	20.5	18.0	14.2	43.4	41.7	4.6	30.1	47.8	33.8	9.4	25.7	31.0	30.9	15.1	32.4	14.8	32.9	17.7	76.1	22.1	32.1	41.7	28.5	24.5	19.7	24.4	22.9	25.4	24.2	48.1	20.3	31.1	30.6	20.5	21.7	24.5
GNRH1	"GNRH, GRH, LHRH"	ENSG00000147437	"Gonadotropin releasing hormone 1"	P01148	8	25419258-25424654	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 9.9;Peritubular cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.7;hypothalamus: 12.1;olfactory bulb: 6.7"	"Group enriched"	"Detected in some"	23	"basal ganglia: 14.1;hypothalamus: 32.3"	HPA027532	Supported				"Secreted to blood"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA027532: AB_10612111"	"unprognostic (6.49e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.53e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.08e-9)"	"unprognostic (7.98e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.68e-2)"	5.1	2.3	5.4	1.4	8.8	3.0	4.9	7.7	7.2	9.0	6.4	6.7	1.9	4.2	4.7	5.7	6.2	1.8	7.7	5.4	15.8	6.0	3.2	6.8	2.2	6.5	6.2	8.6	4.0	0.6	4.7	1.4	6.8	8.3	1.7	9.2	5.4	1.7	3.1	8.6	5.9	1.0	5.2	7.0	4.3	4.6	6.7	1.9	4.4	1.0	1.7	5.7	8.5	8.1	1.0	1.5	4.0	2.2	1.4	4.7	1.7	3.7	1.4	1.1	1.7	1.5	1.1	1.3	0.8	2.1	2.6	3.8	1.2	0.3	2.7	1.7	3.3	1.4	5.9	1.5	1.1	0.2	1.4	2.6	2.1	0.8	0.7	3.6	0.9	1.3	1.5	1.1	1.8	0.6	1.4	3.2	1.4	1.2	0.5	0.9	0.6	0.6	1.0	0.7	21.1	0.7	1.1	0.7	1.4	1.5	0.7	1.8	3.4	3.1	1.5	3.8	1.5	0.3	0.2	1.8	1.5	1.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	5.4	8.8	7.7	7.2	5.4	15.8	6.5	6.2	6.8	5.2	6.7	8.1	2.4	0.0	0.5	3.3	1.1	5.0	1.9	1.7	5.2	3.6	2.5	1.3	1.8	1.5	1.4	3.7	4.2	0.1	1.0	2.3	0.0	0.2	0.3	0.7	0.6	2.1	1.8	0.0	3.0	0.6	0.4	3.1	0.0	1.0	0.0	1.0	1.4	0.3	0.5	0.0	2.8	0.5	0.0	0.8	2.2	0.5	9.9	0.4	3.6	2.8	0.8	0.6	4.1	1.5	1.7	0.6	0.6	9.8	1.8	3.7	1.8	0.2	0.9	3.9	0.0	2.4	1.9	1.8	1.2	3.4	2.4	0.1	1.4	0.5	1.4	1.8
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Early spermatids: 1.2;Excitatory neurons: 2.0;Inhibitory neurons: 2.0;Late spermatids: 1.8;Oligodendrocytes: 1.3;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/84: 3.8"					"Low region specificity"	"Detected in many"			HPA004338	Uncertain				"Secreted to blood"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.5	0.5	1.7	0.6	1.3	0.3	0.3	3.8	2.0	0.4	0.6	0.2	0.2	0.5	0.6	0.3	0.9	0.5	0.5	2.0	1.3	0.7	2.0	0.3	0.4	1.0	0.6	2.2	0.1	0.2	0.9	0.2	0.7	1.9	0.1	0.3	0.8	0.8	0.1	0.1	0.2	0.0	0.1	0.3	1.0	1.4	1.2	0.1	1.1	0.0	0.0	0.3	0.3	0.8	0.5	0.5	1.4	1.8	0.8	0.2	0.2	0.3	0.0	0.2	0.3	0.9	0.3	0.7	0.0	0.1	0.5	1.5	0.5	0.5	0.4	0.5	1.6	0.6	0.6	1.1	0.0	0.0	0.9	1.1	1.1	1.1	0.0	0.2	0.4	1.2	0.7	0.2	0.6	0.5	0.3	1.2	0.6	0.0	0.0	0.4	0.2	0.4	0.2	1.3	2.1	0.9	0.1	1.2	0.7	0.6	1.3	0.6	0.0	0.8	0.3	0.7	0.8	0.5	3.8	0.4	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.3	3.8	2.0	2.0	1.3	1.0	0.6	0.7	0.1	1.2	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67737118-67754388	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Inhibitory neurons: 1.3;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.0	0.7	0.4	0.1	0.7	0.0	0.0	0.2	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.0	0.3	0.8	0.5	0.1	0.1	0.0	5.4	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.3	0.9	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	1.0	0.3	0.8	0.8	0.5	1.2	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759431	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 228.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		510000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	106.1	174.7	18.0	56.4	19.9	25.4	51.9	20.4	21.3	58.9	80.7	35.3	34.6	49.5	38.5	26.2	43.8	63.7	52.9	17.2	26.4	132.0	56.2	71.5	41.0	30.0	23.3	64.3	24.1	76.8	23.0	80.2	25.5	38.5	36.9	25.1	32.9	47.7	30.1	26.3	41.4	69.2	22.5	51.2	34.6	31.8	27.3	20.5	72.8	29.0	26.9	63.7	27.6	31.2	41.0	61.3	50.7	81.4	240.0	145.2	108.8	92.0	213.5	108.4	117.1	55.9	53.3	17.4	117.0	117.8	133.3	33.1	49.1	52.6	119.5	51.4	36.6	41.4	45.4	36.4	109.3	30.6	346.2	139.6	62.9	111.5	49.3	342.0	200.1	24.7	28.8	117.2	156.8	32.6	8.1	17.9	19.4	102.8	53.2	23.8	77.3	53.7	91.5	116.2	33.7	37.3	119.6	56.6	82.4	65.8	102.2	40.4	185.1	104.5	54.8	101.8	54.4	112.1	143.4	14.9	151.1	58.4	72.1	51.7	136.9	27.5	29.3	158.4	21.9	13.0	15.9	22.6	78.2	10.0	16.4	16.4	56.6	18.4	228.5	19.3	13.0	101.9	18.0	19.9	20.4	21.3	17.2	26.4	30.0	23.3	25.5	22.5	27.3	31.2	52.6	48.1	31.7	19.2	11.0	16.6	8.4	14.8	11.4	10.5	28.4	17.0	59.9	22.8	24.2	103.0	18.8	24.3	18.8	24.2	1.9	36.2	24.4	26.5	25.5	50.6	41.9	15.4	25.0	15.1	19.7	40.2	12.2	32.9	48.1	36.3	58.5	57.9	81.0	16.8	31.3	16.6	18.3	198.8	46.5	24.5	34.8	107.8	16.0	27.2	79.0	20.1	13.4	15.1	19.9	20.0	15.7	37.2	16.0	17.2	60.9	64.3	42.8	7.5	6.6	23.1	24.9	11.3	7.8	10.5	12.9	29.1	13.2	30.0	18.2	19.2
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GOLGA2	"GM130, golgin-95"	ENSG00000167110	"Golgin A2"	Q08379	9	128255829-128275995	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015421, HPA021178, HPA021230, HPA021799"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841"	"unprognostic (2.88e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (3.70e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (9.77e-5)"	"unprognostic (3.92e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.27e-2)"	51.8	44.2	31.5	31.3	31.8	33.4	49.6	30.4	31.5	73.5	44.1	48.2	28.9	57.0	59.7	75.0	49.9	42.2	63.9	30.9	36.2	42.3	50.3	47.3	24.5	34.0	36.3	57.4	65.3	77.4	122.4	56.9	36.7	54.4	44.5	31.4	65.1	54.9	57.2	73.4	38.0	58.1	28.7	33.4	51.7	35.8	33.0	23.3	53.3	51.1	32.1	48.6	66.3	31.8	49.1	48.1	52.8	54.9	130.4	148.3	46.3	93.6	129.2	79.4	71.1	60.7	44.7	23.1	34.4	154.3	84.4	94.4	30.3	47.4	74.2	34.1	28.9	25.5	114.0	48.3	85.2	38.2	71.4	95.4	74.0	79.1	81.9	124.9	64.3	55.1	83.8	58.6	77.6	99.8	33.0	33.9	16.2	92.0	86.2	32.9	58.1	40.0	63.4	42.5	29.3	34.9	62.5	52.1	43.2	53.3	117.0	32.2	86.3	102.9	51.8	66.9	50.8	40.7	51.1	29.7	89.8	20.0	65.6	32.4	6.6	12.2	6.2	5.3	3.8	6.0	4.1	3.4	2.7	7.3	4.4	6.1	30.2	7.4	8.2	13.2	3.6	2.9	31.5	31.8	30.4	31.5	30.9	36.2	34.0	36.3	36.7	28.7	33.0	31.8	33.9	44.8	66.8	20.9	27.0	31.7	27.7	45.1	41.5	68.0	53.8	34.8	88.1	45.8	57.8	42.3	41.7	37.9	32.6	69.6	43.0	47.6	41.5	62.9	82.2	35.5	46.1	18.7	15.1	60.8	35.6	67.1	59.7	94.3	65.9	33.6	44.6	72.3	28.3	25.2	20.4	90.9	40.7	24.9	23.1	7.7	68.3	34.2	24.9	10.3	19.5	33.4	28.8	15.6	15.5	57.7	45.1	64.7	55.6	43.7	42.6	35.4	73.2	51.7	13.1	59.6	43.3	99.5	51.1	71.4	45.5	102.3	28.1	29.5	42.6	44.2
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768914-132829078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	12.4	12.3	19.2	12.5	18.8	13.7	11.6	14.8	20.2	15.9	20.6	15.8	7.9	14.7	9.2	16.2	12.8	8.7	13.7	19.1	18.6	9.7	14.0	13.5	12.8	18.6	19.1	17.0	19.6	7.8	26.9	10.5	20.1	14.7	11.7	26.3	17.3	10.8	14.7	15.4	13.6	12.3	13.3	15.1	15.1	11.6	20.5	17.7	12.5	8.6	11.1	14.5	14.3	17.4	19.7	39.1	13.4	23.2	42.2	28.7	25.9	34.1	23.3	23.8	20.9	40.7	8.7	25.6	16.8	45.4	17.1	19.7	16.3	19.6	14.1	6.4	17.3	27.6	44.6	26.0	25.9	29.5	36.2	23.4	22.8	26.8	26.6	23.4	22.7	19.1	27.1	9.8	21.0	30.2	27.0	26.7	14.0	15.1	24.8	21.8	14.1	10.9	13.4	47.1	16.1	10.5	27.0	22.9	14.6	15.2	31.1	22.2	38.7	23.5	17.6	26.8	21.9	31.0	32.0	40.4	28.8	16.3	28.7	3.2	2.0	2.6	3.4	2.9	3.1	2.5	2.6	3.3	2.3	3.4	2.7	2.9	1.5	3.9	2.3	3.9	3.6	2.0	19.2	18.8	14.8	20.2	19.1	18.6	18.6	19.1	20.1	13.3	20.5	17.4	22.9	44.8	40.6	25.8	22.0	21.7	12.7	17.0	13.1	26.0	21.2	16.1	35.4	8.6	26.8	14.7	100.1	13.4	20.6	63.0	7.9	15.2	23.8	21.8	46.9	24.8	22.2	16.4	40.2	27.8	24.2	29.0	48.9	47.5	12.0	33.3	14.6	24.1	16.0	18.5	41.1	50.2	10.2	15.1	16.4	34.6	25.7	18.2	17.8	21.5	18.4	20.1	23.7	22.6	33.3	31.5	27.1	22.6	54.2	32.3	17.9	8.6	26.4	110.6	6.6	32.1	27.7	25.1	24.8	19.0	33.1	23.1	21.7	24.6	32.5	29.4
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794305-92839947	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	26.0	23.3	21.4	18.2	23.7	10.4	33.1	22.4	26.4	32.2	23.9	26.4	23.3	21.9	54.2	25.0	19.2	24.0	21.5	20.8	22.3	25.5	54.3	22.4	18.8	22.6	22.4	20.6	32.2	33.6	23.5	28.2	23.1	31.2	32.5	15.8	32.4	25.8	26.9	23.3	22.9	26.0	22.6	19.1	32.9	34.3	22.1	16.9	33.2	20.0	23.3	24.1	19.6	25.9	32.4	29.4	25.9	23.7	53.1	71.4	44.3	43.9	80.4	41.9	49.2	21.8	43.4	21.0	35.1	70.2	29.2	33.4	23.1	35.9	56.6	25.8	11.2	19.9	14.0	29.3	61.5	23.3	31.8	55.1	63.7	29.5	60.6	46.2	42.0	21.8	17.7	27.3	46.5	60.1	18.1	19.6	16.1	70.2	31.0	13.9	37.9	21.1	42.8	38.9	18.4	26.0	40.0	29.6	45.7	35.7	51.0	25.6	35.0	23.9	15.6	31.3	22.2	33.3	27.6	18.2	54.9	18.2	40.8	10.4	10.0	23.6	10.3	13.0	11.8	9.5	10.4	10.6	9.9	9.5	9.2	8.1	8.8	8.7	11.9	9.1	12.9	6.7	21.4	23.7	22.4	26.4	20.8	22.3	22.6	22.4	23.1	22.6	22.1	25.9	18.7	28.9	26.3	8.8	15.7	7.8	11.2	17.9	16.5	7.5	16.2	11.9	26.8	8.6	19.6	14.7	12.5	23.7	17.2	23.8	29.4	25.3	31.6	17.6	24.6	16.7	22.3	15.8	17.6	32.7	32.0	21.7	33.1	25.7	9.5	29.7	13.9	33.5	15.4	25.2	15.6	31.6	4.1	14.7	10.3	18.5	23.0	14.6	12.4	15.0	18.2	15.6	16.5	14.6	21.9	28.9	12.0	25.2	29.2	19.4	19.9	24.2	18.7	10.7	26.3	18.0	19.3	34.1	37.0	16.5	11.4	50.3	15.9	15.6	16.5	16.5
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"liver: 4.1;testis: 15.1"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	15.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6B		ENSG00000215186	"Golgin A6 family member B"	A6NDN3	15	72654738-72666394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"liver: 3.5;testis: 7.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 3.9;Early spermatids: 8.6;Excitatory neurons: 2.7;Inhibitory neurons: 2.7;Oligodendrocytes: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (5.47e-3)"		"unprognostic (1.88e-2)"			"unprognostic (2.07e-1)"				"unprognostic (2.01e-1)"	"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6C		ENSG00000167195	"Golgin A6 family member C"	A6NDK9	15	75258599-75270199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 9.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (6.53e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GOLGA6D		ENSG00000140478	"Golgin A6 family member D"	P0CG33	15	75282835-75295807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (7.95e-3)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0
GOLGA6L1		ENSG00000273976	"Golgin A6 family like 1"	Q8N7Z2	15	23127066-23136822	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	106	"testis: 28.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA047733: "																		0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6L22		ENSG00000277865	"Golgin A6 family like 22"	H0YM25	15	22458903-22469230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 9.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 58.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA047733: "						"unprognostic (2.71e-2)"								"unprognostic (1.08e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6L6	FLJ36131	ENSG00000277322	"Golgin A6 family like 6"	A8MZA4	15	20531856-20541800	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	52	"testis: 5.2"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA047733: "						"unprognostic (1.10e-1)"								"unprognostic (1.67e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA7	"GCP16, GOLGA3AP1, GOLGA7A, HSPC041"	ENSG00000147533	"Golgin A7"	Q7Z5G4	8	41490396-41510980	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046878: AB_2679854"	"unprognostic (2.93e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.88e-1)"	41.3	31.5	73.8	28.7	91.2	42.6	34.1	78.5	112.3	30.5	56.6	29.9	31.6	33.6	27.9	34.5	23.2	33.3	28.1	73.6	78.2	42.8	46.9	30.3	36.9	84.1	83.6	31.2	32.4	33.7	15.8	48.6	82.3	30.6	26.0	31.7	38.8	26.5	25.5	47.8	32.1	32.0	75.4	36.3	28.5	40.8	76.6	36.5	28.5	29.8	32.0	33.1	24.8	110.0	58.2	64.9	48.2	56.1	59.8	51.7	36.8	49.6	48.5	57.2	63.0	115.8	53.3	27.9	64.4	46.7	54.6	39.6	48.0	38.6	63.5	39.3	42.7	56.5	36.7	48.0	65.3	26.2	45.3	45.6	71.1	36.6	54.1	46.3	56.5	49.4	68.1	53.9	46.7	42.6	83.6	70.7	54.1	53.1	31.2	50.4	86.8	30.6	66.9	53.3	86.1	55.5	44.6	34.4	90.7	40.3	70.5	49.9	58.9	48.2	46.4	61.7	44.0	40.7	67.7	40.7	51.3	44.5	68.3	204.9	78.1	78.8	83.9	68.5	82.2	34.8	79.4	76.9	59.2	32.9	65.8	65.9	136.7	78.0	68.1	40.5	94.9	139.7	73.8	91.2	78.5	112.3	73.6	78.2	84.1	83.6	82.3	75.4	76.6	110.0	74.6	6.4	22.9	11.8	31.4	110.4	53.9	63.1	44.3	28.3	48.3	42.9	25.5	28.6	38.4	29.5	4.2	61.2	69.6	29.5	95.9	62.7	22.2	28.1	43.1	57.4	42.5	33.9	15.8	48.0	68.4	55.0	29.6	36.5	17.7	35.4	52.5	46.6	64.3	18.5	17.8	30.3	59.0	69.7	95.2	21.7	45.1	53.7	60.5	13.1	65.5	77.9	87.6	14.6	90.5	55.1	21.0	62.1	31.2	77.0	53.2	120.5	28.4	30.7	59.2	49.2	60.4	152.3	135.0	43.5	108.5	85.9	69.5	38.1	30.5	55.4
GOLGA7B	"bA451M19.3, bA459F3.4, C10orf132, C10orf133"	ENSG00000155265	"Golgin A7 family member B"	Q2TAP0	10	97849843-97871580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.0;choroid plexus: 26.2;epididymis: 23.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 25.5;Excitatory neurons: 33.6;Inhibitory neurons: 21.2;Late spermatids: 16.6;Rod photoreceptor cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.3;GAMG: 14.5;HDLM-2: 5.7;SK-MEL-30: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046878: AB_2679854"	"unprognostic (7.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.90e-3)"	1.2	2.3	28.7	0.8	30.7	0.2	1.1	33.9	36.0	1.0	26.2	1.1	1.5	0.2	23.4	2.6	0.4	0.4	5.6	32.9	28.0	0.2	0.6	0.7	1.4	29.2	29.2	0.1	8.0	0.0	9.3	0.2	27.5	0.5	0.5	16.9	0.7	0.5	4.6	14.5	2.0	0.1	25.1	0.5	1.0	1.3	29.8	0.3	0.9	3.2	1.1	0.6	2.0	30.0	5.3	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	14.5	1.9	0.0	0.4	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	1.0	0.3	0.0	1.8	0.1	0.1	0.3	0.8	1.4	0.0	1.0	22.6	0.0	2.1	0.1	0.1	0.1	0.0	0.0	0.2	1.7	0.8	0.0	3.9	2.3	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	28.7	30.7	33.9	36.0	32.9	28.0	29.2	29.2	27.5	25.1	29.8	30.0	0.2	0.0	0.5	25.5	0.0	12.5	0.1	0.7	0.0	6.4	0.6	4.4	2.3	12.8	0.2	1.8	2.1	0.0	3.2	0.3	0.0	6.4	5.4	0.3	0.4	0.5	12.0	0.0	33.6	4.3	0.0	0.6	0.0	0.4	0.0	0.0	0.4	0.0	5.1	3.3	21.2	1.1	0.0	0.0	1.2	16.6	0.3	0.2	7.2	5.6	0.6	3.2	3.1	2.5	1.9	7.4	0.1	0.4	0.0	0.3	1.2	0.0	0.0	18.7	0.0	1.5	0.3	3.9	2.3	0.0	5.1	0.0	2.9	0.0	0.4	0.3
GOLGA8A	"CFAP286, FAP286, GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.0;HeLa: 80.1"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.68e-6)"	24.5	18.6	16.1	10.4	11.7	7.9	32.4	18.5	21.4	56.3	11.0	32.7	10.5	31.6	31.8	31.2	37.6	7.3	23.6	13.1	10.0	33.2	6.8	22.4	14.0	17.8	8.8	62.5	22.9	6.3	22.8	2.2	11.9	37.8	2.2	26.4	26.8	10.2	7.6	36.8	38.2	3.2	7.0	48.1	30.3	40.0	12.8	1.2	56.8	1.0	2.1	33.0	40.2	12.2	2.4	13.4	3.7	12.5	0.1	0.0	2.8	20.3	0.1	3.4	1.5	23.3	0.0	0.1	3.6	2.4	6.9	21.7	9.5	6.8	5.3	20.1	7.6	48.0	80.1	15.0	1.3	18.4	12.6	0.0	19.5	2.3	0.5	2.3	0.3	7.0	46.0	40.0	9.2	4.3	4.7	34.6	6.9	6.4	7.2	19.6	11.2	16.2	7.7	13.8	17.1	8.2	13.6	9.2	2.2	0.1	3.6	11.4	10.5	15.7	3.5	0.0	3.6	37.5	13.4	5.5	4.7	38.9	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.1	11.7	18.5	21.4	13.1	10.0	17.8	8.8	11.9	7.0	12.8	12.2	37.3	211.5	71.6	82.9	16.1	26.1	10.9	13.4	7.4	95.3	36.1	41.9	35.0	5.7	127.6	1.8	100.1	2.9	21.1	6.5	0.0	4.2	37.5	17.6	83.9	18.4	16.1	2.5	114.4	2.6	5.0	17.4	13.7	52.3	13.9	39.3	14.6	1.5	2.4	84.1	91.8	11.9	14.2	6.8	20.1	8.4	31.4	8.5	23.2	38.4	1.7	14.8	6.2	146.8	62.5	4.7	6.9	21.1	19.3	8.5	6.6	0.9	52.0	117.6	0.0	26.7	22.4	33.0	23.5	7.8	21.6	3.3	32.9	39.9	11.7	9.4
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 228.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 14.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	16.5	28.8	10.9	7.2	11.0	18.4	20.8	13.8	15.0	28.7	10.8	18.6	0.9	16.8	11.9	10.0	27.9	6.9	15.5	11.0	11.1	41.1	41.8	23.8	19.6	11.2	10.9	55.6	228.4	0.7	60.6	3.0	10.9	37.8	1.4	8.0	18.1	10.6	10.1	13.4	25.2	2.0	10.9	38.5	28.7	43.2	11.1	2.8	113.8	1.3	7.4	19.7	13.4	11.2	2.6	2.8	0.3	5.3	2.8	5.4	7.3	2.3	0.7	2.5	4.0	2.8	3.5	0.0	4.7	2.5	0.3	2.1	0.9	2.4	1.9	3.6	8.4	0.4	20.4	16.2	3.9	2.3	2.5	7.8	3.3	1.5	4.5	2.7	2.6	4.0	0.9	0.2	2.3	1.2	1.2	24.5	3.2	5.0	4.6	0.1	0.0	0.4	2.2	4.9	3.8	5.8	1.3	0.4	3.2	3.9	2.2	4.8	0.0	3.7	8.8	1.1	4.0	1.8	1.7	3.9	1.2	1.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.0	13.8	15.0	11.0	11.1	11.2	10.9	10.9	10.9	11.1	11.2	19.0	192.3	66.5	95.0	34.8	21.9	8.8	10.9	33.0	53.6	30.9	34.3	37.4	20.0	74.7	31.3	73.0	7.6	30.6	2.8	1.9	9.2	53.8	17.3	27.1	11.0	7.2	13.0	133.4	13.0	5.4	12.7	20.4	24.5	9.5	36.4	11.0	28.7	1.5	45.4	126.1	10.1	12.2	6.6	9.9	10.8	39.4	5.0	21.4	12.2	6.4	9.3	32.0	112.1	24.2	16.8	4.9	37.6	45.1	7.6	7.1	5.8	39.9	67.8	13.1	13.5	13.8	48.9	28.4	10.0	14.8	2.9	49.8	22.0	9.4	6.6
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	19.9	25.2	11.0	7.1	12.7	14.1	24.1	15.0	12.9	21.9	26.5	18.8	12.2	17.4	32.1	15.1	15.8	13.3	18.5	13.2	10.5	18.6	17.9	15.3	8.4	8.5	9.9	21.9	27.1	20.7	25.0	13.4	9.0	25.8	17.1	31.0	25.2	19.9	14.2	20.2	19.0	10.0	9.6	16.6	19.7	14.6	9.3	11.3	21.0	11.1	9.8	16.3	15.7	11.5	19.9	15.7	15.3	9.9	28.8	31.0	9.6	12.6	27.5	11.9	13.4	13.8	7.1	4.3	10.4	23.6	11.9	9.0	9.2	13.7	14.1	6.3	17.5	12.2	20.1	19.2	17.2	13.7	16.0	25.4	31.9	7.5	18.7	25.8	15.3	7.3	5.8	9.6	12.7	14.3	4.1	9.9	9.9	19.1	16.4	5.4	12.0	10.3	17.7	20.2	10.8	12.0	15.5	11.0	16.7	17.3	13.6	15.2	21.5	11.4	6.9	4.9	9.2	17.8	11.4	7.2	15.3	6.6	4.3	1.6	4.1	4.3	4.3	2.2	3.5	3.4	3.5	3.3	2.6	2.8	3.3	3.6	15.4	3.9	1.7	5.5	3.9	1.6	11.0	12.7	15.0	12.9	13.2	10.5	8.5	9.9	9.0	9.6	9.3	11.5	118.9	291.7	233.9	101.2	97.3	51.6	89.1	62.1	96.8	101.4	110.2	130.3	274.8	74.4	179.2	53.3	123.0	78.7	134.7	148.6	11.7	104.3	56.0	247.9	186.4	102.7	91.9	36.8	72.9	111.0	53.0	135.5	144.8	284.0	115.6	220.7	74.3	68.9	34.5	69.0	80.2	176.8	65.1	47.2	48.3	23.8	198.5	82.1	33.8	68.4	76.8	82.1	54.6	50.3	72.8	100.2	95.7	199.0	176.0	74.9	79.9	29.3	165.7	193.6	85.5	165.9	120.5	155.0	66.8	70.2	45.7	150.8	102.6	197.7	101.7	88.3
GOLIM4	"GIMPC, GOLPH4, GPP130, P138"	ENSG00000173905	"Golgi integral membrane protein 4"	O00461	3	168008689-168095924	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 370.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001677, HPA002315"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA001677: AB_1079017, HPA002315: AB_1079018"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-3)"	24.8	12.6	25.4	21.4	23.0	9.0	12.9	24.7	32.1	16.8	13.9	53.4	65.8	21.9	8.9	15.7	15.7	28.5	54.6	27.7	34.8	31.3	59.2	29.1	11.3	39.5	29.5	19.9	11.9	12.8	9.6	22.4	40.1	15.2	51.1	53.0	17.3	13.6	32.4	9.3	85.2	26.6	35.1	23.0	24.3	9.0	27.5	6.5	19.0	30.7	9.5	16.8	10.7	33.6	23.7	34.5	47.8	30.4	79.7	58.6	14.5	135.8	72.4	36.3	33.2	38.7	28.4	51.6	159.1	82.4	58.4	42.5	44.4	39.9	54.9	81.3	57.0	83.8	100.2	48.1	32.1	80.5	45.8	61.5	20.9	33.4	32.8	32.2	42.1	0.0	43.7	146.2	41.9	39.2	0.1	21.8	46.9	44.2	36.6	0.1	48.1	72.2	20.6	8.5	42.9	55.5	83.5	25.1	28.4	31.7	30.9	36.1	79.0	114.9	44.2	81.3	110.1	56.4	43.4	109.4	57.1	47.4	52.4	3.2	2.5	10.8	0.6	2.8	0.2	1.2	0.1	0.5	3.3	2.0	0.0	0.2	0.0	5.5	2.3	4.0	0.0	0.7	25.4	23.0	24.7	32.1	27.7	34.8	39.5	29.5	40.1	35.1	27.5	33.6	74.9	48.1	124.8	141.0	11.1	41.4	24.4	18.3	41.5	16.2	21.3	20.6	157.3	67.2	23.3	36.8	37.5	11.4	33.5	184.5	17.6	21.8	1.7	20.6	51.5	70.9	63.3	33.9	18.1	29.6	17.2	119.2	34.1	30.9	58.3	23.3	45.3	178.8	39.1	16.8	84.2	136.5	12.2	50.7	57.5	3.3	39.7	42.2	37.4	38.4	22.0	370.3	14.4	145.8	44.7	23.6	181.2	51.1	28.9	26.0	195.2	31.6	9.2	62.8	46.0	108.2	82.5	5.5	37.6	20.1	35.9	5.5	16.5	20.4	167.6	8.4
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 396.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 372.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		81000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	22.2	159.8	72.5	33.8	78.8	6.6	39.5	69.2	84.5	70.0	99.0	195.7	235.1	40.1	15.7	13.6	38.1	131.0	12.7	72.1	93.8	74.7	19.0	14.7	9.7	73.4	76.1	36.9	41.6	37.6	36.4	17.2	69.9	143.2	163.9	25.5	173.4	10.5	9.4	14.9	61.3	28.4	80.1	41.7	396.2	17.4	108.0	45.4	68.1	4.8	5.6	38.3	14.9	79.2	146.0	139.5	102.4	116.7	129.3	74.3	108.0	64.8	46.6	99.9	80.5	69.4	282.9	2.7	62.6	126.2	96.6	109.4	63.7	64.1	71.9	5.0	101.2	45.3	89.1	3.4	76.8	67.3	34.9	113.4	34.2	94.1	34.0	124.9	172.9	21.2	28.7	4.2	57.3	68.4	8.3	49.6	161.9	188.9	99.6	42.9	116.9	21.8	166.0	61.2	115.1	72.0	88.2	189.0	73.8	66.1	106.7	68.1	110.5	25.9	72.6	79.3	78.3	372.3	37.4	0.9	112.2	29.8	57.8	1.9	3.6	0.4	3.5	2.6	0.4	0.6	0.2	0.5	0.4	0.6	0.4	0.7	4.2	0.7	4.2	1.5	0.1	1.8	72.5	78.8	69.2	84.5	72.1	93.8	73.4	76.1	69.9	80.1	108.0	79.2	13.8	9.6	15.3	30.3	1.7	2.3	10.8	11.3	4.6	20.1	41.4	21.1	4.9	80.1	80.9	35.0	8.4	8.4	10.7	362.8	25.4	168.4	339.0	78.0	49.8	20.5	73.1	11.2	47.0	222.2	35.0	30.4	245.6	56.8	1.3	65.9	8.6	11.1	11.8	67.3	43.2	95.5	325.5	5.0	2.6	391.6	18.3	6.6	23.2	6.5	6.9	16.9	12.3	82.0	19.3	282.9	265.2	13.2	3.2	72.6	71.8	16.0	78.6	6.7	0.0	13.5	19.5	10.3	38.7	2.9	1.0	6.4	5.2	60.7	245.6	29.1
GOLM2	"CASC4, DKFZp459F1927, H63"	ENSG00000166734	"Golgi membrane protein 2"	Q6P4E1	15	44288719-44415758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043015, HPA049488"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1200000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA043015: AB_2678271, HPA049488: AB_2680790"	"unprognostic (2.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.45e-5)"	"unprognostic (2.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.12e-1)"	39.5	84.5	48.5	32.4	47.0	16.5	43.2	43.1	59.2	57.9	62.4	45.7	28.8	50.4	53.5	23.7	53.8	50.5	33.1	42.8	52.6	54.0	60.9	40.9	30.8	49.6	51.5	55.3	37.4	82.0	38.7	34.4	46.9	67.5	43.8	33.7	47.8	56.1	22.3	13.2	29.8	44.4	46.7	35.4	49.4	34.6	52.9	28.9	84.6	26.3	29.5	39.2	24.3	52.7	45.0	38.7	51.9	92.6	141.4	121.8	32.0	78.6	125.2	44.9	57.1	19.3	80.0	13.5	106.4	119.3	47.8	53.8	34.4	25.5	48.2	64.6	19.5	21.4	41.8	35.9	65.1	42.5	68.1	72.1	28.3	49.8	38.4	126.8	53.4	34.2	33.0	103.4	56.2	23.2	36.7	33.2	14.8	60.8	27.5	30.5	29.3	43.3	58.8	54.4	23.3	53.2	60.7	57.0	26.6	28.1	64.1	49.2	76.4	78.1	39.8	112.5	69.5	79.0	145.1	27.9	92.6	58.5	51.7	20.9	14.7	20.8	15.2	9.8	16.3	11.9	12.4	15.2	12.0	10.7	9.5	9.9	37.8	10.5	18.2	10.6	13.2	13.6	48.5	47.0	43.1	59.2	42.8	52.6	49.6	51.5	46.9	46.7	52.9	52.7	19.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	16.3	16.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	19.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	12.7	2.9	0.0	0.0	0.0
GOLPH3	"GOPP1, GPP34, MIDAS, Vps74"	ENSG00000113384	"Golgi phosphoprotein 3"	Q9H4A6	5	32124716-32174319	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044564, HPA055841"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Vesicles"		"HPA044564: AB_10795169, HPA055841: AB_2682940"	"unprognostic (1.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	50.1	38.3	28.5	41.9	29.2	20.8	50.0	29.8	34.5	56.2	32.9	76.6	46.3	41.6	58.7	43.1	41.0	77.7	38.4	26.5	29.6	61.5	110.1	50.7	49.2	30.2	29.5	51.5	62.6	54.9	29.8	68.4	29.9	75.3	60.2	19.8	64.8	50.4	37.3	32.8	49.3	52.3	29.1	39.5	52.9	27.0	29.7	43.9	48.0	57.0	52.4	60.5	41.3	32.3	57.7	37.9	59.9	65.5	111.3	106.1	171.6	77.8	103.3	71.5	67.7	51.9	101.3	51.7	75.0	105.7	69.3	52.8	75.1	54.9	89.7	67.7	44.9	56.9	119.9	99.4	89.4	88.8	64.0	81.3	77.1	70.3	80.1	65.8	57.9	33.6	60.5	121.8	80.4	58.0	57.1	115.3	51.8	78.0	38.5	52.8	86.4	53.8	89.9	72.1	45.6	51.0	180.8	186.9	79.4	75.6	76.4	97.1	56.5	62.7	58.5	49.7	55.6	136.1	179.3	62.5	56.3	125.8	76.4	6.8	8.0	19.2	7.8	10.6	6.8	11.5	8.4	10.1	8.9	16.0	9.9	7.2	7.9	8.5	10.5	6.9	13.2	4.2	28.5	29.2	29.8	34.5	26.5	29.6	30.2	29.5	29.9	29.1	29.7	32.3	33.9	60.9	49.2	26.8	53.3	70.0	44.5	30.0	51.2	13.5	59.6	30.7	31.7	88.6	42.8	44.1	10.4	67.3	52.0	72.6	52.8	58.0	5.2	46.3	35.8	46.2	52.0	50.5	47.9	44.1	111.6	51.7	57.6	71.3	14.5	16.8	59.3	153.6	54.4	13.5	45.8	86.3	40.7	63.7	56.2	16.1	50.7	49.1	44.4	43.1	48.7	20.2	36.0	53.8	60.1	49.7	35.1	57.2	120.0	83.9	59.8	59.8	49.1	10.0	39.5	30.8	52.1	15.4	25.1	68.2	73.6	110.0	45.6	50.4	50.2	80.7
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	17.5	22.1	12.7	16.9	14.1	25.8	18.5	13.4	18.9	18.0	12.7	13.4	10.6	14.6	15.6	13.6	12.5	13.9	14.8	13.9	15.1	15.5	18.8	17.6	15.0	13.2	14.6	10.9	21.6	11.9	19.0	29.0	13.8	16.1	14.8	14.1	16.1	13.2	15.5	12.9	11.3	17.7	13.9	12.4	14.2	10.6	14.7	11.2	15.9	11.8	14.1	17.8	12.2	16.3	31.2	30.0	28.5	36.5	56.5	83.2	46.1	126.5	48.2	40.4	63.3	45.4	48.1	19.4	29.8	66.6	71.0	30.1	23.4	27.2	69.5	29.4	22.8	29.7	19.6	32.8	61.0	37.0	36.8	44.2	50.1	44.9	85.6	67.7	35.8	24.4	18.6	21.1	59.2	30.7	17.3	62.1	75.7	27.8	23.5	14.0	65.0	39.4	32.2	18.7	7.2	23.1	49.0	20.6	70.4	90.2	28.2	39.4	40.6	46.5	49.5	57.1	67.2	20.3	45.9	51.8	63.6	35.5	64.2	48.0	26.6	20.8	22.1	31.4	26.6	22.7	25.8	24.4	27.0	25.9	23.3	23.8	7.2	21.6	29.4	29.4	28.0	27.6	12.7	14.1	13.4	18.9	13.9	15.1	13.2	14.6	13.8	13.9	14.7	16.3	23.4	9.6	15.6	15.0	38.9	46.7	23.4	42.7	27.3	27.6	20.4	11.2	18.9	22.8	36.8	16.5	10.4	29.0	34.9	13.8	27.4	31.6	3.4	10.9	26.3	28.7	13.1	22.9	70.4	33.4	72.4	45.7	15.3	21.7	21.5	10.3	16.8	23.2	41.0	18.5	49.3	31.7	38.7	23.6	65.1	5.2	17.4	35.4	53.4	14.0	26.0	17.5	18.6	25.1	25.4	38.6	15.4	19.9	75.8	49.0	8.7	21.7	18.2	7.7	13.1	24.6	39.3	23.7	32.4	22.8	63.9	64.0	39.1	9.6	14.6	44.9
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749659-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	11.3	7.6	4.7	10.7	4.9	9.5	11.4	7.6	5.9	10.1	6.3	10.9	7.4	10.7	10.4	8.3	9.7	7.4	8.4	4.4	4.5	8.9	7.9	10.5	12.3	4.4	6.1	10.1	10.1	10.8	9.5	10.0	4.3	9.9	9.2	14.0	9.5	9.1	12.4	11.4	11.2	10.5	3.5	12.6	9.4	9.0	5.2	14.3	11.3	8.1	12.1	10.0	9.4	5.9	13.7	11.1	21.2	13.0	13.0	16.2	13.2	12.0	14.7	15.4	14.9	13.2	12.2	15.7	13.0	15.8	7.7	15.3	15.9	14.1	17.6	14.7	11.1	15.3	14.0	7.3	12.2	18.6	14.0	14.4	12.2	17.0	15.9	15.7	18.5	17.0	20.3	5.8	13.2	13.5	16.2	11.1	23.4	16.7	12.6	14.8	13.2	17.7	11.2	16.1	11.8	19.8	14.3	14.4	11.6	21.0	16.2	22.2	20.5	12.4	10.1	12.7	15.4	23.9	16.9	25.6	10.8	11.0	14.0	3.5	2.6	2.4	3.6	2.0	2.4	2.1	2.4	2.5	2.7	4.0	2.4	2.2	5.7	4.5	1.8	2.9	2.5	1.8	4.7	4.9	7.6	5.9	4.4	4.5	4.4	6.1	4.3	3.5	5.2	5.9	52.3	16.0	36.1	52.5	41.8	12.1	20.6	18.6	17.6	67.2	25.0	26.2	22.1	17.2	27.7	20.2	131.3	27.1	41.6	25.5	9.8	23.5	18.8	29.5	40.0	42.2	32.4	36.4	45.0	18.1	23.8	28.8	37.8	37.5	38.1	40.8	29.3	13.8	19.7	77.4	40.3	23.5	16.2	23.8	19.1	11.7	35.1	27.0	16.0	28.1	40.2	39.2	80.3	26.2	27.6	24.0	20.6	27.4	38.5	26.9	23.2	14.0	19.8	160.7	39.5	38.8	30.6	54.7	40.5	18.3	17.5	45.0	47.9	50.1	22.6	24.0
GON7	C14orf142	ENSG00000170270	"GON7 subunit of KEOPS complex"	Q9BXV9	14	93202894-93207065	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051832	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		41000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli rim"		"HPA051832: AB_2681628"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favorable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	6.9	13.2	9.0	5.8	8.8	0.4	8.3	8.6	11.5	12.1	15.8	13.9	13.2	5.4	23.3	6.8	35.4	7.2	14.7	9.0	10.1	17.8	12.9	8.8	1.9	9.8	9.4	5.6	10.4	12.6	12.8	5.6	10.2	7.9	12.0	13.4	7.9	5.7	13.4	4.9	10.2	5.2	8.6	8.8	9.1	8.7	9.6	3.7	8.7	12.9	9.9	6.9	5.7	9.1	11.6	9.2	13.3	8.9	9.2	21.4	9.3	11.0	6.2	21.6	17.5	9.1	18.1	4.7	7.2	7.0	12.6	18.2	18.3	9.2	25.1	0.1	0.0	4.6	22.5	22.6	4.7	9.7	19.6	4.1	11.9	15.1	9.7	6.0	13.3	5.5	16.7	1.5	9.3	26.8	11.3	23.4	3.4	49.6	4.3	20.0	12.9	21.4	23.4	12.9	15.8	19.8	8.2	20.4	24.8	11.8	16.8	19.9	13.6	7.6	15.1	16.5	6.2	10.0	29.6	3.1	23.2	10.8	13.2	6.2	0.9	0.4	0.8	1.7	0.1	0.0	0.5	0.6	1.5	0.7	0.2	0.4	0.9	0.3	0.8	0.2	0.8	0.5	9.0	8.8	8.6	11.5	9.0	10.1	9.8	9.4	10.2	8.6	9.6	9.1	17.2	6.4	13.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	19.7	23.9	0.0	0.0	9.9	14.7	0.0	19.6	12.7	0.0	68.4	27.7	0.0	187.5	15.8	7.3	0.0	0.0	0.0	21.7	18.1	5.8	0.0	27.4	10.1	9.4	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	17.5	0.0	0.0	1.4	0.0	0.0	51.8	94.7	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	7.7	7.0	21.3	0.0	0.0
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532131-170553834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027250, HPA027746"	Approved		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	3.1	5.2	1.6	1.9	1.6	0.6	2.8	1.6	3.1	3.8	1.9	3.6	1.4	3.2	3.5	2.3	2.1	2.1	3.1	1.5	2.3	2.5	4.3	2.5	3.6	1.6	1.8	4.3	3.7	1.9	3.0	3.1	1.7	2.8	3.3	1.3	3.3	2.6	1.1	1.9	2.7	2.0	1.7	3.1	2.1	2.0	2.0	2.8	3.0	2.1	3.0	3.1	3.3	1.8	3.4	3.8	4.5	2.0	9.0	5.8	2.9	4.8	7.5	3.6	4.6	1.9	4.9	5.1	6.1	4.3	2.4	4.0	6.4	2.8	6.0	4.8	1.6	2.5	4.0	2.8	4.9	4.4	3.1	4.4	2.5	4.2	3.9	5.5	3.5	2.3	4.4	2.3	5.3	0.6	5.8	4.0	4.7	6.2	4.0	3.9	3.8	6.0	4.2	1.9	1.4	3.0	3.6	4.8	11.5	3.1	2.7	8.4	4.4	6.8	3.1	2.9	7.2	3.5	4.4	3.8	5.2	4.0	5.4	0.7	3.9	0.0	2.3	4.2	3.9	2.8	4.1	3.5	4.3	2.8	3.6	3.0	0.5	3.8	3.1	2.7	5.3	2.6	1.6	1.6	1.6	3.1	1.5	2.3	1.6	1.8	1.7	1.7	2.0	1.8	8.1	0.0	11.4	8.8	8.9	2.8	4.0	6.5	8.6	4.7	5.2	7.1	9.4	10.0	7.1	5.5	2.1	6.0	6.2	12.8	3.9	12.3	2.3	5.5	10.4	8.3	0.0	3.4	9.3	6.0	7.3	10.5	9.2	6.7	13.9	5.2	5.3	6.6	7.1	5.0	7.7	9.4	8.2	6.9	4.6	3.2	14.0	5.6	3.6	3.7	10.1	4.3	3.1	9.0	7.3	5.7	9.8	6.4	10.3	4.9	4.3	6.0	2.4	7.1	6.6	8.2	9.3	13.1	8.1	5.4	1.6	5.6	6.3	5.1	6.4	3.0
GORASP1	"FLJ23443, GOLPH5, GRASP65, P65"	ENSG00000114745	"Golgi reassembly stacking protein 1"	Q9BQQ3	3	39096599-39107863	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.9;Late spermatids: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056283	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA056283: AB_2683085"	"unprognostic (1.06e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.92e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.13e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.24e-3)"	16.9	13.5	35.4	12.8	36.4	11.5	18.6	38.7	35.7	25.2	30.3	23.6	13.6	18.8	16.6	20.0	22.2	15.6	21.3	34.1	35.9	26.9	26.3	19.6	13.4	41.7	36.9	13.3	24.5	22.5	15.4	21.0	38.0	22.1	26.0	20.6	26.2	30.7	16.3	16.4	18.5	24.0	42.0	21.5	19.1	10.5	38.8	11.8	18.4	19.0	17.4	17.9	14.8	46.6	15.6	19.0	18.0	17.8	42.8	28.1	16.6	27.1	31.1	27.5	24.6	11.3	18.4	16.8	15.7	41.4	17.2	24.7	20.7	32.2	19.3	22.4	14.3	23.8	18.7	16.0	19.3	20.0	25.8	22.0	43.8	28.5	28.0	30.6	38.2	6.0	19.8	20.3	26.3	22.6	5.6	18.9	13.1	35.7	23.1	6.0	10.7	23.8	27.4	28.1	7.1	14.0	25.7	51.4	16.1	24.4	33.2	20.7	29.0	15.4	14.3	37.0	15.0	14.1	14.8	4.1	18.3	16.7	23.0	6.5	12.0	7.0	3.3	12.7	4.5	11.7	4.1	3.1	12.8	9.3	4.7	3.4	6.9	2.8	17.2	7.2	6.7	8.0	35.4	36.4	38.7	35.7	34.1	35.9	41.7	36.9	38.0	42.0	38.8	46.6	21.1	3.2	9.8	23.2	8.7	4.1	10.6	6.5	8.0	8.5	12.9	9.7	8.7	12.8	7.2	12.9	0.0	14.0	3.4	21.4	11.7	10.7	98.9	15.5	11.4	13.4	11.4	5.5	7.7	8.7	11.1	8.9	24.5	16.3	1.3	8.8	8.9	11.4	9.5	8.4	9.2	15.3	8.2	7.2	9.8	56.1	7.2	9.5	12.4	9.4	7.0	7.3	0.0	9.0	9.6	11.0	8.0	6.4	5.7	11.4	14.2	6.0	10.7	11.1	0.0	8.8	10.0	10.1	6.8	8.0	5.8	19.8	4.4	6.5	15.1	12.6
GORASP2	"GOLPH6, GRASP55, GRS2"	ENSG00000115806	"Golgi reassembly stacking protein 2"	Q9H8Y8	2	170928464-170967130	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 380.7;Syncytiotrophoblasts: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035274, HPA035275, CAB075758"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		830000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.38e-8)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-1)"	32.1	43.1	32.6	32.0	34.6	33.7	40.5	35.8	36.7	62.6	34.1	43.5	38.3	43.2	60.4	46.8	34.3	37.2	57.6	32.5	35.9	33.6	45.6	34.3	39.9	34.2	34.5	37.3	67.1	47.3	40.0	55.5	34.8	40.7	43.6	37.0	68.4	52.6	39.7	38.6	36.7	46.1	34.6	31.1	42.0	32.0	34.4	41.8	50.8	38.1	44.2	53.3	24.0	37.0	66.1	51.7	72.2	54.9	137.5	103.2	83.0	101.5	113.9	89.6	113.8	132.8	84.2	97.0	59.7	143.2	61.0	75.9	82.3	96.0	102.2	57.8	81.2	107.5	41.2	198.8	138.4	90.2	62.9	79.2	102.9	90.0	148.3	95.7	98.9	64.5	92.4	72.4	80.3	103.2	85.5	87.0	74.3	109.9	49.3	68.4	64.5	115.0	112.9	91.8	59.3	54.3	58.4	91.6	95.9	59.0	60.8	73.6	93.5	82.8	56.2	79.5	55.7	81.1	56.2	112.4	86.6	58.3	95.6	48.3	38.3	27.0	53.0	40.6	81.7	44.8	59.1	63.4	48.3	40.7	58.0	48.5	9.6	64.5	46.8	63.9	57.0	62.8	32.6	34.6	35.8	36.7	32.5	35.9	34.2	34.5	34.8	34.6	34.4	37.0	28.7	41.7	36.6	15.0	46.7	37.2	39.6	83.4	38.1	30.6	33.0	22.5	40.9	27.1	64.2	20.2	31.3	114.4	49.3	39.2	56.7	69.1	196.6	16.2	34.4	32.1	31.3	35.1	20.1	78.1	112.1	48.4	48.4	32.7	20.3	25.7	38.9	45.0	46.4	42.1	23.0	63.9	48.8	22.7	29.7	380.7	58.7	23.9	48.0	22.5	46.3	39.3	35.0	27.2	31.7	69.7	41.9	49.7	171.9	62.1	31.7	43.7	23.1	34.8	59.2	27.5	40.3	39.6	39.6	47.1	36.1	229.7	43.4	44.9	48.2	67.7
GOSR1	"GOLIM2, GOS-28, GOS28, GS28, P28"	ENSG00000108587	"Golgi SNAP receptor complex member 1"	O95249	17	30477362-30527592	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020590	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA020590: AB_1850374"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.14e-2)"	18.3	15.2	9.5	16.0	9.6	12.6	22.3	11.5	11.1	19.0	10.0	19.8	15.9	21.0	15.4	18.0	23.5	16.0	17.9	9.9	10.0	25.0	30.8	16.6	17.6	9.7	10.2	20.8	22.0	28.2	13.1	19.5	9.5	21.0	23.4	19.5	18.5	17.8	17.2	14.8	18.0	20.8	8.5	14.6	19.4	22.8	9.9	24.1	24.2	19.4	24.6	19.8	12.4	10.4	33.7	54.9	35.5	26.1	27.6	27.1	25.2	35.2	35.2	50.1	45.0	48.8	22.8	34.0	33.6	38.9	44.8	29.8	43.1	36.2	57.0	20.3	34.6	35.0	41.4	32.3	37.5	55.5	39.6	27.6	28.8	48.8	54.3	27.2	32.8	36.0	55.4	30.9	33.9	23.1	43.8	28.9	36.3	55.5	21.9	41.0	47.6	27.2	25.7	47.0	31.7	30.3	36.6	76.2	44.8	38.5	58.9	40.6	37.0	33.6	29.9	31.4	46.2	41.0	56.3	60.6	32.4	26.7	45.1	26.0	21.6	29.5	29.8	27.8	34.8	33.8	28.5	28.2	30.0	35.8	33.7	32.8	26.2	36.1	27.4	30.6	33.6	19.3	9.5	9.6	11.5	11.1	9.9	10.0	9.7	10.2	9.5	8.5	9.9	10.4	45.9	28.9	52.9	35.3	40.6	27.0	34.9	51.3	30.1	62.4	36.0	38.7	45.9	38.6	61.2	42.3	62.6	48.0	28.2	26.7	50.9	39.8	124.3	41.5	44.2	38.4	41.9	21.7	42.8	40.1	39.6	42.5	26.0	33.5	61.4	38.0	35.3	47.7	27.8	104.3	40.8	31.4	40.7	29.4	21.6	46.7	29.5	27.6	16.0	35.6	31.6	70.2	26.8	37.7	49.5	36.9	23.8	28.2	26.2	37.8	26.2	41.9	75.3	67.5	19.7	52.9	45.3	80.2	44.3	27.4	27.1	73.1	33.0	33.4	29.9	31.0
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 303.0;Late spermatids: 796.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499"	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	23.2	25.6	28.5	21.7	28.7	16.4	24.8	31.6	37.6	24.8	32.9	22.8	49.8	23.8	31.6	21.5	21.3	18.3	32.5	29.3	29.3	42.2	33.9	23.6	26.4	28.7	29.7	26.1	31.3	35.5	37.1	28.7	29.2	23.1	27.4	25.0	32.5	30.5	43.1	21.9	43.2	29.8	28.1	30.1	23.1	48.3	29.5	27.1	26.6	34.3	31.8	25.2	18.6	30.9	44.6	47.2	33.5	40.3	54.9	39.3	37.8	59.7	58.5	63.5	56.7	60.1	25.7	37.7	33.1	75.4	66.5	30.1	43.4	48.5	77.8	83.0	33.3	56.8	37.4	60.1	60.3	44.9	44.1	40.8	47.1	52.2	73.2	49.0	52.6	43.7	56.5	50.9	46.2	46.8	50.0	24.2	31.1	60.1	65.8	43.5	64.0	44.5	40.7	37.7	28.8	61.5	33.3	19.2	47.9	57.1	55.1	31.3	62.1	60.0	38.8	47.4	58.9	64.6	39.4	60.1	56.1	28.6	67.1	39.5	33.1	29.2	33.9	63.2	31.3	29.8	29.7	27.8	32.7	38.6	29.1	25.4	3.6	31.2	86.0	29.7	38.8	35.2	28.5	28.7	31.6	37.6	29.3	29.3	28.7	29.7	29.2	28.1	29.5	30.9	23.7	25.6	18.7	17.9	22.0	16.6	17.3	16.7	4.6	18.5	21.1	18.0	16.2	15.7	14.5	33.1	6.2	30.2	23.8	15.9	23.5	34.5	303.0	9.1	18.0	25.2	7.2	20.6	24.2	42.7	33.1	18.4	15.3	11.0	14.5	22.7	21.8	22.4	45.1	23.5	26.3	16.8	16.2	22.0	14.7	796.1	16.8	15.0	10.6	21.5	22.0	16.4	14.4	17.1	28.4	58.1	24.2	14.3	23.5	22.1	96.5	90.0	13.7	20.4	0.0	9.3	26.8	33.1	26.7	7.4	16.9	52.7	14.9	18.4	12.6	20.5
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 511.1;liver: 369.5;skeletal muscle: 489.9;tongue: 1011.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 449.0;Distal tubular cells: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	14.7	54.9	67.8	14.7	71.1	8.0	22.7	70.3	119.1	53.1	82.6	50.9	62.0	13.1	25.9	42.7	17.9	49.0	511.1	70.0	77.6	143.1	369.5	15.5	14.1	83.5	55.0	18.1	34.0	142.4	22.5	14.4	83.7	22.7	59.2	106.2	48.6	27.4	489.9	23.9	45.8	21.4	48.4	16.9	58.9	33.6	69.1	17.7	47.7	1011.6	30.3	22.3	21.0	70.1	73.7	40.3	46.0	114.4	35.1	30.7	127.1	58.9	108.7	101.8	109.8	89.9	56.4	71.9	20.4	50.2	89.2	88.6	107.1	78.9	105.8	25.7	46.7	28.1	46.7	114.3	184.9	77.9	44.0	47.3	82.5	86.9	228.4	69.5	49.5	48.6	71.1	106.2	65.4	64.9	42.5	56.5	29.2	118.7	56.1	45.5	44.4	72.8	173.7	37.5	19.6	28.7	44.8	59.3	222.6	66.8	115.7	27.1	23.3	25.4	56.3	28.0	68.7	76.8	99.7	74.3	65.4	40.8	34.1	4.0	8.7	6.8	19.7	25.8	18.4	17.6	21.5	20.7	21.9	21.2	15.6	22.7	0.8	20.5	31.5	36.4	27.6	15.6	67.8	71.1	70.3	119.1	70.0	77.6	83.5	55.0	83.7	48.4	69.1	70.1	10.3	16.0	16.2	26.1	38.8	11.9	41.8	82.7	24.5	95.6	18.8	21.2	449.0	72.9	34.4	73.5	62.6	35.9	10.7	62.1	240.7	51.9	166.7	17.8	9.3	16.7	19.7	39.5	47.4	30.8	18.1	23.5	76.9	21.5	31.8	20.2	17.2	191.8	31.6	75.7	63.3	45.3	54.9	12.4	6.9	24.1	11.1	13.0	49.8	13.1	10.5	36.6	6.2	21.1	37.2	27.6	34.4	14.3	22.4	13.1	97.0	163.3	27.9	76.5	13.1	15.2	20.5	116.7	10.4	40.9	10.4	55.1	14.6	47.0	66.4	42.3
GOT1L1	MGC33309	ENSG00000169154	"Glutamic-oxaloacetic transaminase 1 like 1"	Q8NHS2	8	37934281-37940124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	25	"testis: 14.1"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 137.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028778	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA028778: AB_10602138"														"unprognostic (6.93e-3)"	"unprognostic (5.46e-1)"			0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734342	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 698.4;tongue: 726.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 341.9;Hepatocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018139, HPA058537"	Enhanced				"Intracellular and membrane"	NA	NA		2800000	"Cluster 13: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA018139: AB_1849903, HPA058537: "	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	19.6	73.9	52.4	27.4	55.9	21.1	36.3	62.5	66.9	34.1	129.4	57.6	37.4	36.5	66.3	66.9	46.7	24.1	313.2	57.9	59.3	88.0	321.4	25.2	35.6	60.6	51.0	29.4	33.2	98.6	46.7	24.7	62.5	59.0	65.0	91.4	47.7	65.7	698.4	41.1	35.7	46.7	50.1	28.5	54.9	28.9	58.7	35.9	42.6	726.8	57.0	57.0	45.1	61.0	137.2	182.4	93.8	114.8	66.6	59.8	122.0	101.4	108.8	197.6	107.7	158.9	120.1	302.3	117.3	114.6	86.5	195.5	203.2	199.2	250.1	83.1	182.0	81.4	92.1	179.3	84.2	132.3	71.9	58.4	110.9	125.2	108.2	112.4	201.8	141.9	167.0	30.6	102.2	122.5	164.0	128.0	127.7	90.8	338.0	177.8	142.7	291.1	187.9	197.7	148.2	107.6	195.2	208.5	74.8	84.2	105.5	42.7	82.3	71.4	129.3	56.2	132.4	69.9	68.6	247.4	76.7	130.9	73.8	4.6	20.6	7.4	28.3	16.9	43.7	26.5	33.1	34.1	34.7	22.3	30.1	28.4	1.8	30.2	18.4	30.0	48.7	31.2	52.4	55.9	62.5	66.9	57.9	59.3	60.6	51.0	62.5	50.1	58.7	61.0	15.1	9.6	15.8	11.8	19.8	32.0	37.0	39.4	34.1	34.5	27.5	16.3	341.9	22.8	22.5	36.8	77.2	42.6	11.8	42.6	56.7	50.8	4.0	30.4	20.0	23.8	20.5	39.3	24.7	42.5	38.8	21.1	30.1	25.4	14.5	37.5	23.2	176.1	39.1	20.2	27.1	33.5	26.4	17.0	15.1	8.1	18.0	13.5	24.9	5.6	12.7	16.1	8.2	11.6	17.6	40.3	13.3	22.6	39.2	38.2	27.6	63.2	17.5	48.9	0.0	15.2	24.0	11.9	15.0	68.9	30.0	23.7	17.4	36.4	54.4	69.6
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet subunit alpha"	P07359	17	4932277-4935023	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Macrophages: 14.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.1"	"Immune cell enriched"	"Detected in single"	13	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	24	"HEL: 71.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					NA	NA		1600000000	"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.5	0.1	0.1	3.8	0.4	4.9	0.4	2.1	0.2	0.4	0.1	0.7	1.2	0.3	0.0	0.5	0.4	0.3	0.5	0.1	0.0	0.5	0.8	1.5	14.7	0.1	0.0	0.4	0.3	0.0	0.2	0.3	0.1	0.4	0.5	2.3	0.9	0.0	2.7	2.4	1.8	0.0	0.0	3.6	0.8	0.4	0.1	0.6	0.4	0.0	7.7	0.4	0.5	0.0	0.1	2.3	0.5	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.2	0.3	2.3	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.8	1.8	71.6	1.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.7	0.7	0.0	0.8	0.6	0.3	0.3	0.2	0.4	1.2	0.5	0.3	0.0	1.4	0.1	0.3	0.9	0.0	0.3	0.6	2.9	1.3	0.3	0.4	0.4	1.5	0.2	1.2	0.5	1.7	1.0	1.1	0.7	7.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.2	0.1	0.4	2.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.3	1.5	0.6	0.4	0.0	1.8	0.2	0.5	1.1	0.0	0.2	0.0	2.1	0.3	0.4	0.1	3.9	0.2	0.3	0.8	1.8	0.5	0.0	1.7	0.2	0.0	0.2	0.7	0.0	2.4	0.0	0.1	2.5	0.9	0.1	0.0	0.2	0.0	0.0	0.9	3.3	0.6	0.3	14.2	0.0	0.0	2.6	0.3	1.0	0.0	0.1	0.0	0.0	1.9	0.3	0.4	0.3	0.9	0.0	2.7	0.0	1.4	0.5	1.0	0.6	0.0	1.8	0.3	1.0	0.1	0.1	0.3
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309574-20327808	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	966	"pancreas: 35381.6"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 504.1"	"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015739, HPA016668"	Enhanced				"Secreted to digestive system"	NA	NA		41000	"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			7.1	1.9	0.2	0.9	0.2	0.7	3.8	0.6	0.4	2.5	0.4	3.9	36.6	2.1	0.2	3.9	1.4	18.7	6.5	0.3	0.2	33.4	5.0	1.5	2.1	0.2	0.6	15.4	35381.6	0.0	2.9	2.4	0.3	33.4	6.2	0.1	7.5	0.0	1.6	1.8	10.1	0.1	0.1	2.5	27.4	1.9	0.2	0.1	1.3	0.0	0.2	1.0	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	1.1	0.1	0.1	87.2	0.0	0.0	0.0	0.0	0.0	1.7	9.8	1.3	7.5	0.3	0.5	0.2	0.0	0.0	0.0	504.1	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.3	15.6	0.3	0.4	0.0	0.0	4.2	0.2	0.0	0.0	0.0	20.7	13.9	0.4	0.0	69.7	2.0	0.0	0.0	0.3	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	19.9	2.1
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Early spermatids: 14.3;Excitatory neurons: 9.9;Inhibitory neurons: 10.2;Late spermatids: 8.7;Macrophages: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 9.4;K-562: 4.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047611, HPA066482"	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA047611: , HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.1	0.0	0.1	0.0	0.1	0.9	0.2	0.7	0.5	0.5	0.0	0.2	0.0	0.2	0.0	1.4	0.4	0.0	0.7	0.1	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.4	0.1	0.1	1.2	0.1	0.0	0.0	0.9	0.2	2.7	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	9.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.7	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.3	0.3	0.0	2.0	0.3	0.4	0.7	1.5	0.3	0.0	6.2	0.1	0.4	0.7	0.0	0.1	14.3	1.4	0.4	1.2	0.0	0.0	9.9	0.4	0.3	0.6	0.0	2.2	1.3	0.8	3.3	0.2	0.1	3.3	10.2	0.0	0.0	0.8	0.2	8.7	0.3	10.3	0.0	1.0	0.3	0.4	2.1	1.5	1.5	0.2	0.1	0.0	0.0	0.4	0.1	0.0	1.9	2.6	0.0	0.4	0.2	1.4	1.2	0.0	0.1	0.5	0.4	0.0	0.3	0.7
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 215.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 775.5;Intestinal goblet cells: 211.6;Paneth cells: 420.3;Proximal enterocytes: 266.1;Undifferentiated cells: 147.2"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 24.2;T-reg: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 24.2"	"Cell line enriched"	"Detected in some"	8	"OE19: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.4	0.0	0.0	18.5	0.0	0.7	0.2	0.0	0.2	0.0	0.4	215.9	150.0	0.3	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	7.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	196.2	0.0	0.0	0.4	0.3	0.0	136.9	7.2	0.0	0.9	1.5	0.2	0.2	2.3	0.0	0.1	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.3	1.8	14.4	0.0	0.0	0.8	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	3.8	1.6	0.2	10.9	5.7	2.7	2.2	24.2	3.5	0.2	0.2	2.6	0.0	19.5	6.8	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	775.5	0.0	0.0	3.9	0.0	0.0	0.1	26.1	0.8	0.4	0.0	0.0	0.0	0.5	0.0	4.5	0.0	0.0	0.0	0.5	0.0	0.3	211.6	0.0	1.9	1.3	2.3	0.3	1.8	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.1	420.3	0.0	0.0	0.0	266.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	3.1	0.0	147.2	0.2
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 275.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	47.0	75.5	35.7	21.2	37.5	48.2	46.7	39.9	43.6	52.2	62.3	46.1	35.8	56.9	18.8	51.7	45.9	25.0	72.1	35.9	35.6	61.9	69.9	42.6	23.4	41.9	37.4	49.9	66.2	47.5	37.2	20.0	40.7	50.9	13.1	11.4	60.5	40.5	71.7	47.1	46.8	18.8	40.1	48.4	55.8	40.9	38.1	18.6	60.1	28.4	12.9	43.0	42.8	47.6	67.3	117.2	26.9	84.7	60.8	51.5	92.8	68.5	66.5	55.8	57.4	49.0	108.9	36.6	94.1	73.9	26.4	82.5	17.9	67.2	8.1	60.4	59.0	58.0	53.1	36.3	58.6	28.5	83.2	56.8	61.6	56.9	39.4	45.0	46.4	61.5	42.1	125.7	54.1	237.6	55.9	26.5	27.2	79.3	275.8	38.1	34.2	176.9	48.4	46.8	45.7	63.2	88.8	112.4	51.1	14.7	73.2	79.3	31.6	51.8	88.6	29.5	77.2	70.0	57.5	24.9	91.2	34.8	72.0	35.7	64.4	59.0	84.2	78.1	57.2	37.4	41.7	66.7	59.6	40.1	40.6	57.7	14.8	69.1	91.9	107.1	40.1	76.7	35.7	37.5	39.9	43.6	35.9	35.6	41.9	37.4	40.7	40.1	38.1	47.6	41.0	38.5	40.0	13.7	46.7	28.8	54.9	84.6	37.0	60.8	74.9	59.9	42.7	55.8	58.0	44.1	64.6	123.4	72.5	100.2	25.4	125.8	5.7	30.8	30.7	37.3	56.9	48.0	12.8	89.9	152.9	57.1	56.6	37.3	64.8	45.1	42.5	74.9	86.6	55.5	14.6	52.6	79.3	53.6	25.6	10.9	40.4	41.2	72.9	6.5	57.4	98.0	98.9	15.6	20.4	76.0	91.0	37.6	85.5	58.0	155.1	90.3	46.8	73.2	59.2	50.8	50.5	194.8	109.9	55.9	22.3	109.3	38.9	66.5	85.3	48.1
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038966, HPA058739"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: AB_2683804"	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	6.2	6.6	2.4	3.2	2.2	6.5	5.3	4.8	3.2	6.9	0.7	6.1	3.0	6.7	3.0	5.8	6.1	2.1	5.5	2.3	2.2	6.9	5.0	5.2	4.3	1.0	1.6	8.0	4.9	1.8	6.0	3.6	1.2	5.7	2.9	5.6	5.3	2.5	4.3	4.5	5.2	2.6	0.3	5.6	5.6	5.3	1.6	3.2	6.1	1.8	3.6	6.5	6.4	3.3	4.7	3.8	6.2	4.6	2.6	5.3	6.3	6.1	3.8	6.1	5.8	7.8	9.1	10.9	4.3	4.1	5.8	9.6	6.6	5.1	5.7	9.2	9.2	8.1	6.3	5.4	3.9	10.9	4.5	3.3	2.9	4.8	3.2	3.7	4.9	8.5	7.2	2.4	4.0	5.5	11.0	9.3	5.7	11.9	4.4	11.0	5.3	4.5	3.5	4.6	3.2	5.1	5.8	4.0	3.5	4.5	4.0	11.0	7.9	4.0	3.3	4.6	5.1	4.0	4.0	11.5	4.1	6.7	5.2	2.4	3.9	6.7	4.0	3.1	3.2	4.8	4.1	2.7	4.4	6.2	4.7	4.2	2.9	4.0	3.3	5.7	3.1	2.5	2.4	2.2	4.8	3.2	2.3	2.2	1.0	1.6	1.2	0.3	1.6	3.3	18.5	32.1	34.2	26.1	19.1	7.1	15.6	11.6	15.4	24.4	13.7	13.6	16.2	15.7	22.3	23.9	18.8	27.9	19.6	6.8	23.5	13.0	7.0	15.2	26.1	17.3	18.0	14.7	65.0	13.3	13.1	19.0	9.2	17.2	21.5	27.7	16.8	17.3	15.5	23.5	57.3	11.3	12.2	14.2	7.6	5.1	26.8	12.9	12.4	24.4	15.6	18.5	29.9	53.3	42.6	11.4	11.1	26.7	10.5	10.0	10.7	21.0	22.3	26.1	26.3	20.1	23.1	48.7	26.7	16.7	9.2	18.2	16.2	22.9	12.6	11.8
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149865-112215377	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 305.7;liver: 144.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Hepatocytes: 184.5;Horizontal cells: 45.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.3;Hep G2: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	305.7	33.9	14.9	4.8	17.1	3.4	67.7	12.2	14.0	3.0	6.9	6.4	4.0	4.2	75.1	2.9	3.1	6.0	12.3	12.4	13.0	4.4	144.1	4.1	4.6	12.9	16.0	5.3	5.0	4.3	2.1	3.0	12.1	3.9	4.7	5.1	17.2	5.3	8.3	3.2	6.1	4.9	11.5	2.9	4.9	5.6	15.7	3.6	12.4	8.8	4.3	4.8	2.6	10.5	9.9	7.4	9.7	12.9	250.3	9.1	12.7	9.2	10.5	6.6	5.1	17.3	5.7	6.9	5.0	6.5	6.1	12.3	15.5	7.9	12.3	5.0	8.4	6.4	7.9	71.8	7.7	11.2	3.4	43.8	13.1	11.7	23.6	49.7	5.8	9.7	8.5	6.1	7.7	5.6	9.6	8.8	8.1	5.6	10.1	9.7	25.4	5.1	4.3	6.8	4.1	12.1	12.8	6.1	14.5	8.9	6.3	4.0	4.4	7.5	4.6	9.4	14.8	6.1	7.3	14.3	8.8	9.8	5.8	0.0	0.3	0.1	0.7	0.4	0.9	0.5	0.5	0.5	0.4	1.1	0.5	0.9	0.0	0.3	0.3	0.6	0.6	0.3	14.9	17.1	12.2	14.0	12.4	13.0	12.9	16.0	12.1	11.5	15.7	10.5	9.1	9.6	27.1	90.8	5.2	0.4	0.8	1.6	4.6	5.3	8.1	8.4	18.9	20.0	4.3	5.5	10.4	5.2	4.3	1.7	1.9	2.7	0.5	5.1	10.0	5.0	1.2	12.2	8.2	3.3	2.9	5.1	3.6	4.2	2.5	12.7	6.4	184.5	3.1	45.4	9.4	3.0	0.0	9.3	1.0	0.9	5.3	1.9	1.8	10.3	1.4	6.1	3.1	10.1	10.1	3.4	2.7	12.0	6.4	1.1	3.7	3.3	4.7	9.1	6.6	4.3	6.6	4.0	3.2	5.4	0.1	1.9	3.3	8.6	5.0	0.6
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661228-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	14.5	11.8	1.5	2.7	1.9	3.9	14.7	3.6	2.8	14.9	1.4	15.9	1.6	15.9	2.5	11.4	14.9	2.1	21.5	1.5	1.8	14.7	16.0	13.2	3.8	2.0	1.7	17.3	15.1	3.3	13.5	1.8	2.2	14.0	2.4	2.3	13.8	2.0	28.4	15.8	15.6	1.1	1.4	16.7	15.4	36.4	1.8	6.7	12.8	2.8	2.3	15.0	13.3	2.6	3.3	3.3	1.7	5.6	8.3	6.6	4.4	3.2	5.2	3.1	4.2	0.2	4.8	10.8	5.2	3.4	4.2	3.9	0.0	8.1	2.3	6.4	5.6	11.3	0.0	3.7	5.7	3.7	4.3	3.2	4.3	10.4	6.9	6.1	3.8	10.9	3.0	8.8	4.2	2.6	13.1	4.4	0.0	5.1	1.2	5.4	7.5	7.9	5.1	2.6	12.6	8.4	4.3	1.9	5.4	4.6	5.1	9.2	4.8	7.3	7.0	0.5	0.0	6.5	10.8	4.1	8.6	7.9	4.2	11.8	3.1	9.9	4.1	2.5	4.1	2.0	3.2	2.5	3.1	2.9	3.7	3.3	9.5	4.5	2.6	3.8	4.6	2.7	1.5	1.9	3.6	2.8	1.5	1.8	2.0	1.7	2.2	1.4	1.8	2.6	22.6	38.5	21.7	5.9	30.5	25.0	24.2	27.6	23.3	29.1	25.0	23.4	35.9	30.0	21.6	18.4	35.5	30.1	28.3	26.4	45.0	31.6	55.4	21.9	21.4	29.1	27.1	33.0	3.2	23.6	39.7	23.8	13.3	22.9	35.4	21.9	27.8	30.3	27.7	11.8	3.5	29.9	22.4	27.0	18.5	51.5	34.5	21.0	19.6	3.7	43.5	37.8	47.4	5.0	7.3	21.9	43.3	24.8	29.2	32.3	90.5	74.5	20.1	47.3	19.7	21.6	29.7	180.8	87.2	16.2	34.2	47.1	26.9	17.3	26.9	19.9
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Breast glandular cells: 84.5;Sertoli cells: 98.6;Smooth muscle cells: 30.3;Spermatocytes: 64.4;Spermatogonia: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 8.2;BJ hTERT+ SV40 Large T+: 19.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.6;OE19: 13.9;U-2 OS: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036841	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	5.8	0.8	1.5	1.4	1.7	1.2	4.5	1.4	1.7	2.4	3.3	1.8	0.2	1.5	3.1	0.8	1.6	1.6	7.4	1.2	1.3	1.6	1.0	1.3	2.4	1.7	1.6	1.2	1.6	0.1	0.6	1.4	2.0	1.1	1.0	0.2	2.2	2.8	2.1	1.1	2.2	1.6	1.3	4.6	2.1	7.6	2.4	0.8	1.7	3.0	1.9	2.0	1.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	19.6	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.7	1.0	1.6	0.5	0.7	0.4	2.4	0.3	1.1	0.0	0.1	1.0	0.0	0.5	0.6	1.5	1.7	1.4	1.7	1.2	1.3	1.7	1.6	2.0	1.3	2.4	2.1	12.9	0.0	1.1	0.3	3.5	1.0	1.1	0.7	0.6	0.7	84.5	3.4	1.3	1.5	0.5	1.8	0.0	0.1	1.7	3.1	1.9	2.2	1.9	0.1	0.5	6.5	0.0	0.8	1.0	2.0	0.6	3.3	1.5	0.5	1.3	0.2	10.8	0.0	2.4	8.4	0.4	0.6	0.0	0.8	2.1	5.3	0.6	1.5	1.8	1.9	0.7	1.0	1.0	0.0	1.4	0.8	1.3	0.0	3.6	0.4	0.0	0.2	0.2	0.4	98.6	3.2	30.3	64.4	45.3	0.4	0.1	0.1	2.2	0.3	2.1	1.8
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 60.0;Early spermatids: 82.3;Macrophages: 60.5;Proximal enterocytes: 56.2;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 157.6;GAMG: 116.4;HMC-1: 57.4;U-87 MG: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029414	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	14.0	1.0	0.9	5.7	1.1	11.9	6.5	3.9	2.7	5.5	8.9	13.7	39.9	3.7	1.2	8.3	3.6	8.6	25.3	1.0	2.8	88.4	18.1	4.2	2.0	5.5	3.4	16.1	1.2	23.2	5.0	1.5	5.5	1.6	11.1	1.2	3.5	3.6	37.6	2.6	35.6	3.5	2.0	4.7	15.2	7.4	2.7	1.7	19.8	12.5	2.1	6.0	6.3	1.8	30.6	29.6	0.0	0.4	1.5	3.7	0.6	2.4	4.3	0.6	0.6	2.2	157.6	0.0	3.2	5.9	116.4	6.8	14.3	2.8	0.5	2.1	6.7	0.0	9.2	29.7	4.2	8.9	57.4	2.0	0.2	1.1	3.5	11.5	15.0	8.5	25.1	23.7	0.6	3.1	2.3	2.2	0.7	45.6	12.5	0.3	6.7	11.6	29.8	2.0	0.7	0.0	5.8	6.1	17.3	1.6	1.2	1.6	0.7	6.9	12.3	6.9	28.9	1.1	2.2	0.0	66.4	17.6	52.2	182.5	33.2	4.0	0.6	27.8	6.0	0.1	3.5	2.0	81.4	0.1	2.5	1.2	91.1	1.6	23.6	0.3	2.3	10.4	0.9	1.1	3.9	2.7	1.0	2.8	5.5	3.4	5.5	2.0	2.7	1.8	4.8	6.4	6.8	0.0	1.3	0.0	60.0	0.0	8.0	0.8	10.2	4.1	0.0	4.3	5.0	11.0	0.0	0.4	0.8	18.6	15.6	4.8	82.3	1.0	1.1	5.4	1.2	6.1	0.0	6.8	1.3	5.5	34.7	2.4	7.6	0.8	7.5	13.2	14.8	5.0	0.0	9.9	0.0	11.3	0.0	21.7	1.2	60.5	0.0	0.0	28.7	0.1	1.0	0.0	0.0	10.4	6.7	0.7	1.2	32.4	56.2	67.4	1.5	0.3	6.6	5.8	1.7	10.6	1.9	5.2	0.0	1.0	7.3	4.9	3.6	28.9
GPAT4	"AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7"	ENSG00000158669	"Glycerol-3-phosphate acyltransferase 4"	Q86UL3	8	41577187-41625001	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016471	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA016471: AB_1844649"	"unprognostic (3.05e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.08e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.98e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (1.73e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (5.65e-4)"	23.6	33.6	13.5	28.0	15.3	28.4	42.4	29.7	17.6	24.7	25.0	21.3	19.7	28.6	12.8	16.3	21.0	23.1	20.4	13.4	15.0	30.1	32.7	23.9	22.3	16.2	16.5	23.0	23.1	40.5	16.2	27.2	15.6	18.3	21.7	15.4	25.4	20.3	57.6	18.4	19.0	33.2	15.4	21.2	26.8	24.2	15.7	22.1	20.0	39.9	27.4	24.6	18.8	16.8	39.0	42.4	49.7	38.9	53.1	64.1	43.7	82.7	70.8	61.4	63.6	28.7	76.1	53.8	56.6	68.7	75.4	22.0	58.7	37.3	78.8	58.0	32.4	63.0	49.0	26.5	31.0	6.8	87.1	40.6	26.9	64.0	23.0	52.5	64.1	52.7	47.9	61.5	63.4	16.5	60.0	17.3	53.1	71.3	22.5	34.7	49.8	29.2	36.4	57.5	32.4	44.7	32.2	43.9	89.1	56.5	60.9	42.4	47.0	63.0	43.8	73.0	62.6	33.0	47.9	58.7	51.9	36.9	63.1	16.0	17.0	7.8	12.5	15.9	11.6	8.6	9.6	12.6	21.0	9.9	8.5	8.5	3.8	5.8	14.3	8.0	9.7	13.8	13.5	15.3	29.7	17.6	13.4	15.0	16.2	16.5	15.6	15.4	15.7	16.8	20.0	3.2	31.2	0.0	14.5	0.0	13.2	0.0	11.4	16.9	50.2	19.6	0.0	27.1	13.6	11.0	10.4	33.9	18.4	10.8	3.9	41.3	40.6	14.1	19.4	21.7	17.0	21.5	0.0	39.8	42.5	13.1	27.0	29.2	2.5	21.2	18.2	62.4	27.1	15.2	0.0	14.2	0.0	28.1	0.0	58.7	12.8	31.7	0.0	0.0	31.2	11.8	9.2	0.0	0.0	44.9	11.3	10.5	23.9	27.7	13.3	28.2	5.8	15.1	6.6	20.3	11.6	4.3	14.8	10.1	0.0	40.4	16.7	23.0	11.1	18.2
GPATCH1	"ECGP, FLJ10206, FLJ38686, GPATC1"	ENSG00000076650	"G-patch domain containing 1"	Q9BRR8	19	33080899-33130542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043430, HPA043604, HPA074327"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cell Junctions"	"HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: "	"unprognostic (2.38e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.95e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-3)"	3.5	3.1	3.0	3.5	3.2	3.7	4.4	5.1	4.0	4.0	2.0	4.8	5.4	4.5	4.4	4.3	3.9	2.8	3.8	3.1	2.9	4.4	3.4	3.4	4.9	2.8	3.0	7.2	3.8	6.3	2.6	4.2	3.0	4.2	4.5	3.9	4.6	3.4	4.2	5.6	4.6	4.4	2.7	4.3	4.9	4.4	3.3	5.9	4.7	3.2	5.0	3.6	3.6	3.4	8.8	18.2	8.4	9.1	5.5	6.2	7.1	7.8	5.4	11.6	9.7	12.9	7.9	12.3	9.7	6.2	5.5	7.7	10.6	6.4	10.1	21.4	6.6	11.7	6.8	9.8	7.2	20.3	7.6	5.3	7.4	7.9	7.2	5.6	6.6	9.6	12.5	7.7	5.8	11.2	11.8	7.1	5.9	11.5	7.5	11.9	10.6	5.5	5.4	5.4	9.3	6.2	12.3	7.6	4.6	7.2	6.4	14.5	7.5	10.2	7.6	5.6	11.3	6.4	11.1	10.6	6.3	10.3	9.5	23.1	6.4	7.4	6.0	6.6	4.1	6.2	5.6	7.7	6.0	7.0	9.6	6.0	4.7	3.5	3.7	5.3	9.2	5.0	3.0	3.2	5.1	4.0	3.1	2.9	2.8	3.0	3.0	2.7	3.3	3.4	6.5	9.6	7.9	5.9	9.1	6.1	5.0	6.0	10.8	9.7	5.2	4.6	11.8	1.5	9.8	7.3	14.6	10.5	10.7	12.0	15.6	6.8	3.2	5.2	9.4	6.4	4.2	4.2	7.2	4.5	5.2	7.5	10.2	6.8	16.5	10.1	7.9	4.6	4.1	3.3	7.0	7.7	8.2	6.0	5.2	2.1	10.2	5.8	8.8	2.8	5.8	7.1	16.5	5.5	7.0	9.0	8.7	8.2	5.5	3.3	6.8	6.6	10.3	11.9	0.0	8.0	7.3	19.5	14.8	6.5	3.7	5.5	9.1	7.0	6.5	3.4
GPATCH11	"CCDC75, CENP-Y, CENPY, FLJ38348"	ENSG00000152133	"G-patch domain containing 11"	Q8N954	2	37084451-37099244	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038231, HPA038232"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038231: AB_2675904, HPA038232: AB_10675788"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.16e-2)"	23.0	6.3	7.5	7.8	8.5	10.0	6.9	8.8	9.9	7.0	6.0	4.5	4.8	4.8	3.7	5.1	3.7	4.4	5.4	7.7	8.8	5.5	5.7	6.3	12.7	8.3	8.0	5.9	3.0	5.5	3.5	5.7	8.5	4.0	4.9	21.0	3.7	4.1	2.4	5.9	5.0	4.3	8.5	8.0	4.8	11.6	8.0	10.3	6.4	5.4	11.7	5.2	3.1	10.4	12.5	7.4	12.4	9.7	25.7	11.9	13.2	22.1	8.9	13.1	10.7	9.4	5.2	14.4	12.1	8.3	11.4	8.8	14.8	5.3	19.5	24.7	16.1	26.3	9.8	9.6	8.3	31.7	27.5	7.8	9.4	18.0	10.1	8.6	11.6	9.0	25.0	65.8	15.4	6.3	20.6	17.4	5.3	20.5	10.3	16.9	26.4	40.7	5.7	5.3	14.9	13.9	11.6	7.4	11.2	9.9	7.6	14.6	12.9	23.7	13.1	17.4	24.7	25.6	28.2	21.6	16.9	26.2	21.3	5.9	2.4	2.2	4.4	2.0	4.4	8.7	3.2	3.7	3.6	6.8	3.4	3.5	0.8	6.7	0.7	12.2	2.6	1.5	7.5	8.5	8.8	9.9	7.7	8.8	8.3	8.0	8.5	8.5	8.0	10.4	14.7	12.8	8.1	3.9	23.3	4.2	2.7	5.7	7.4	24.3	6.2	7.0	14.1	8.6	5.0	11.0	25.0	8.8	48.7	12.1	11.7	9.3	32.9	12.6	20.0	12.8	3.0	22.1	14.3	14.1	30.5	12.2	8.6	13.9	12.0	8.7	17.9	15.0	13.4	13.5	12.1	9.1	6.1	18.8	15.0	10.5	16.1	21.1	3.6	5.6	12.7	28.9	22.6	10.6	12.5	14.8	4.9	22.2	23.2	1.6	9.7	13.2	11.5	52.7	13.1	13.4	21.7	75.5	43.6	7.8	5.4	3.8	16.8	13.7	6.0	2.0
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	4.1	4.2	3.5	4.1	4.0	3.2	7.1	3.0	4.8	5.9	6.3	4.3	4.9	6.5	5.9	5.5	5.0	6.1	3.5	4.3	5.1	5.2	4.9	4.2	5.1	2.9	3.2	4.8	3.9	6.9	4.4	6.3	3.1	6.9	4.6	5.7	3.7	5.3	6.6	4.4	4.8	5.1	3.2	4.8	4.8	6.2	4.5	6.3	6.6	2.9	5.6	6.1	4.1	3.8	8.4	9.4	9.9	7.8	8.6	8.7	8.2	7.7	9.4	10.5	9.9	8.3	10.6	8.9	7.6	6.7	6.5	9.7	11.2	9.1	12.2	6.6	6.4	5.9	7.9	5.3	10.6	9.0	6.7	7.7	13.0	12.3	20.0	9.1	7.3	9.8	14.7	0.1	7.7	7.9	12.2	6.4	18.0	6.7	10.2	5.9	22.7	10.7	7.4	17.9	11.6	16.5	13.7	12.5	10.7	15.5	11.7	8.7	7.5	9.8	6.8	13.9	7.2	9.0	6.8	8.4	7.4	5.9	7.1	4.1	3.1	1.1	2.6	1.9	1.8	2.6	3.0	1.8	3.4	2.8	2.7	2.4	0.4	2.7	2.9	5.0	2.9	1.5	3.5	4.0	3.0	4.8	4.3	5.1	2.9	3.2	3.1	3.2	4.5	3.8	17.5	12.8	15.9	43.8	19.4	15.6	16.1	13.4	14.8	55.4	27.2	27.9	14.4	21.5	15.3	18.4	171.0	20.8	24.5	22.4	13.7	20.4	62.6	41.3	36.4	20.5	20.8	12.0	113.1	18.0	22.2	23.0	19.4	24.0	9.5	32.9	20.7	12.4	15.7	50.5	60.5	21.5	18.3	9.2	9.2	22.8	19.9	16.6	5.4	39.4	17.2	27.7	28.8	46.3	47.1	15.0	17.2	23.0	24.5	17.5	17.9	18.1	22.3	144.2	19.7	36.8	20.2	53.3	23.8	12.9	19.5	21.6	20.0	41.4	23.1	19.0
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	9.9	8.9	7.5	12.1	10.1	37.5	9.7	10.7	9.7	8.9	11.4	9.9	8.5	10.5	9.5	11.3	8.0	12.2	13.3	7.8	10.2	8.9	6.8	10.7	12.1	9.9	8.9	10.4	8.7	9.2	6.9	11.3	9.4	9.8	10.8	15.5	8.2	9.8	12.1	9.0	9.2	11.9	9.9	10.8	9.3	13.8	8.8	11.6	9.7	14.0	12.1	10.5	9.3	12.8	18.7	24.0	19.2	15.3	11.0	17.0	15.7	21.7	15.0	20.7	20.1	16.0	30.8	22.2	12.6	16.8	16.8	22.0	23.4	14.2	36.6	24.7	12.9	19.5	26.1	10.1	14.2	13.7	27.6	17.6	12.6	17.8	23.0	16.2	21.9	18.1	20.6	30.6	18.6	30.6	18.3	17.7	24.2	11.1	17.5	20.3	23.2	11.5	14.7	37.0	15.5	19.2	24.5	21.6	12.0	19.7	25.2	21.2	24.0	26.7	15.3	14.9	16.5	30.7	31.3	29.2	21.4	18.4	28.0	5.3	7.3	7.9	3.5	6.6	3.0	6.3	1.9	5.2	7.2	5.3	4.2	3.0	5.6	5.6	4.8	5.6	4.5	3.7	7.5	10.1	10.7	9.7	7.8	10.2	9.9	8.9	9.4	9.9	8.8	12.8	35.3	16.0	18.2	48.0	30.2	23.3	37.4	26.0	22.2	100.0	19.9	21.2	46.3	18.6	25.2	18.4	104.3	16.2	36.8	18.8	3.9	20.0	151.4	28.9	46.2	38.2	47.8	17.1	76.0	13.3	12.7	36.6	21.9	54.5	43.7	48.2	29.3	11.6	25.2	158.2	67.0	19.3	24.4	43.0	48.9	138.9	24.8	43.5	23.2	59.0	47.7	42.3	43.3	82.0	75.0	30.4	29.4	37.6	24.6	56.9	40.2	13.5	24.4	122.7	26.3	55.0	41.7	56.6	27.2	18.7	27.3	17.4	31.2	34.9	20.6	42.6
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900467	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	8.3	11.5	10.9	6.3	12.1	23.2	8.2	11.2	13.0	8.0	9.5	8.6	8.5	8.6	8.9	9.4	6.8	5.7	9.9	10.2	9.9	9.1	12.5	6.7	9.0	10.7	11.0	7.1	8.9	7.9	7.6	8.0	10.2	8.2	6.2	5.4	7.9	6.1	18.1	13.0	9.3	6.4	10.4	11.8	9.9	10.8	11.2	9.3	7.5	12.4	7.5	8.5	7.6	12.9	12.5	9.9	9.4	14.5	8.9	8.5	12.7	9.4	10.9	18.6	16.2	12.1	14.6	11.4	10.3	9.6	9.7	12.6	15.8	17.8	9.9	13.0	18.1	22.5	22.3	25.2	11.9	15.2	14.6	12.5	15.7	18.3	10.1	8.2	12.1	14.9	26.7	15.0	7.8	9.2	13.5	28.2	21.5	14.4	12.2	16.6	13.5	18.0	9.2	6.5	12.2	14.6	18.8	16.0	27.9	10.1	14.3	14.5	12.9	11.8	13.9	16.2	10.7	19.0	27.4	15.2	10.6	21.6	10.6	30.3	17.9	22.3	16.2	14.6	13.1	12.5	13.3	14.2	18.7	11.9	13.6	13.0	7.8	9.8	19.0	14.2	12.6	14.4	10.9	12.1	11.2	13.0	10.2	9.9	10.7	11.0	10.2	10.4	11.2	12.9	5.4	3.2	3.9	1.6	11.7	9.7	4.8	5.6	8.0	6.4	7.0	4.7	4.0	1.5	3.7	0.0	12.5	15.5	10.3	11.6	5.9	10.9	2.2	4.5	4.1	8.1	11.3	6.9	3.5	12.5	10.0	5.3	11.2	6.1	5.7	7.8	8.2	6.2	11.2	5.0	3.0	4.7	6.1	9.4	7.5	1.4	5.3	10.0	8.8	1.9	15.3	6.6	12.3	3.5	3.5	10.6	7.5	7.2	8.3	4.3	10.4	7.4	3.1	5.5	6.6	6.6	5.9	12.5	25.3	8.3	9.8	30.1	11.2	6.6	6.2	4.9
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594301-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	24.5	19.5	12.1	16.7	12.4	10.6	18.9	8.7	17.3	14.9	8.0	19.8	8.9	19.9	9.1	21.7	16.6	6.8	23.0	11.5	12.4	26.5	21.4	14.9	16.8	12.5	13.0	15.0	19.6	15.6	10.1	9.6	12.8	19.2	13.0	2.9	16.3	10.6	79.0	17.3	16.2	14.3	9.9	18.6	19.3	13.1	11.7	11.8	14.4	31.9	19.0	22.8	16.1	14.7	54.6	67.6	31.2	46.3	28.1	20.4	44.0	66.0	27.8	53.3	30.7	74.9	44.8	131.6	55.0	47.8	34.3	38.7	68.9	59.4	54.5	38.2	65.2	82.1	65.2	57.3	26.2	174.9	48.3	25.0	51.1	96.9	79.3	13.1	36.6	44.0	135.5	31.8	40.7	96.2	82.0	39.8	138.9	92.5	71.4	72.9	52.1	96.3	35.0	58.4	50.4	75.8	59.6	146.7	41.6	31.9	46.2	89.3	52.8	50.7	66.0	53.4	121.1	57.8	69.5	169.9	45.7	89.7	79.7	0.1	9.4	0.1	20.9	17.9	20.4	29.1	21.2	24.0	17.5	30.7	24.1	25.1	0.4	19.0	22.0	11.1	15.7	12.6	12.1	12.4	8.7	17.3	11.5	12.4	12.5	13.0	12.8	9.9	11.7	14.7	17.0	32.1	38.3	5.2	36.0	73.7	65.9	32.5	26.2	7.7	23.8	25.4	27.2	25.8	33.4	16.5	8.4	35.6	19.5	26.5	25.4	51.9	12.9	19.1	53.7	32.5	37.0	42.9	6.4	57.1	53.0	29.0	23.0	20.1	57.7	24.3	18.5	46.9	37.4	8.4	4.6	26.1	10.2	13.6	21.3	11.4	26.8	19.0	23.2	2.8	18.8	6.9	23.7	1.5	3.3	53.0	17.5	26.7	23.8	92.5	7.8	34.3	14.9	6.4	32.9	66.0	45.4	47.4	44.3	33.5	62.7	15.5	26.3	38.6	43.6	51.5
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395281-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 312.1;Inhibitory neurons: 287.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	10.5	9.2	12.0	11.3	13.3	18.3	11.0	15.0	14.0	10.6	9.3	8.9	11.1	14.5	11.8	9.4	11.1	8.8	8.9	11.8	12.5	9.0	7.0	10.7	15.7	12.9	12.9	17.3	8.0	14.4	0.4	13.1	12.7	9.5	10.4	30.1	9.3	10.2	33.4	15.5	11.0	12.5	12.1	13.1	8.8	10.8	13.0	20.8	11.0	13.8	15.4	9.8	0.8	13.5	22.0	12.8	22.8	18.9	17.5	20.2	23.1	16.7	21.1	18.3	19.2	19.0	13.9	31.1	10.9	23.7	15.8	16.7	23.3	19.3	27.2	25.7	20.8	26.5	15.5	22.5	20.9	25.7	20.3	22.9	20.5	20.9	27.2	18.4	20.2	19.4	20.1	18.7	16.8	10.0	33.7	9.9	16.0	12.5	16.2	27.1	25.8	21.7	16.0	10.6	15.9	19.3	16.6	10.6	20.9	27.0	13.9	17.3	22.5	18.0	12.6	19.3	23.4	20.1	17.9	29.2	16.8	14.1	19.3	8.2	6.1	4.9	9.4	6.0	8.7	8.6	8.2	7.8	6.5	7.1	7.5	7.3	4.6	10.3	13.6	8.0	4.1	5.2	12.0	13.3	15.0	14.0	11.8	12.5	12.9	12.9	12.7	12.1	13.0	13.5	38.8	22.4	32.5	148.5	64.6	48.7	53.1	52.0	47.8	72.7	28.8	22.7	40.5	30.0	46.0	25.8	123.0	42.4	76.6	25.2	9.8	32.8	19.6	38.7	63.3	38.8	38.8	50.1	312.1	24.5	39.3	48.4	23.9	56.5	42.4	44.6	44.3	19.4	23.0	146.4	287.3	20.3	36.7	36.2	42.3	7.6	63.0	38.6	23.2	108.7	42.5	43.5	161.7	172.9	204.1	34.7	24.7	43.2	58.1	45.3	30.2	14.6	29.8	125.3	52.6	68.6	51.2	93.1	74.2	33.7	46.9	53.4	69.8	43.1	25.4	56.8
GPBAR1	"BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5"	ENSG00000179921	"G protein-coupled bile acid receptor 1"	Q8TDU6	2	218259496-218263861	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.9;breast: 17.8;gallbladder: 17.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.3;Enteroendocrine cells: 46.0;Hofbauer cells: 16.3;Kupffer cells: 50.6;Macrophages: 19.9;monocytes: 45.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"classical monocyte: 288.1;intermediate monocyte: 712.0;non-classical monocyte: 695.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 712.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HHSteC: 1.7;U-937: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA062890	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA062890: AB_2684896"	"unprognostic (8.47e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.76e-3)"	"unprognostic (4.32e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.40e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.29e-1)"	31.9	1.6	0.1	2.7	0.2	2.2	17.8	0.4	0.7	0.6	0.2	3.8	1.0	0.9	0.0	0.5	1.2	17.3	5.1	0.2	0.1	5.3	1.9	2.2	0.8	0.1	0.1	1.8	1.7	0.0	0.8	3.9	0.1	1.1	0.5	0.0	0.8	0.3	0.5	1.4	4.9	10.1	0.1	7.5	6.4	2.4	0.3	0.4	1.7	0.7	0.2	4.8	0.8	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	1.7	0.1	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.9	0.8	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	1.9	0.1	0.6	288.1	0.4	0.7	712.0	0.7	0.2	0.5	0.7	140.2	0.7	0.6	0.4	6.5	0.5	695.6	6.0	0.9	156.5	0.1	0.2	0.4	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	6.2	0.0	3.4	0.0	1.1	0.3	0.2	0.2	0.0	0.0	0.1	0.3	0.5	1.5	0.1	3.7	0.0	0.5	1.8	0.2	11.7	0.2	8.2	1.0	20.3	1.5	46.0	0.0	0.0	0.5	4.5	2.8	6.6	0.8	1.3	6.2	1.8	0.0	16.3	0.0	0.0	2.7	0.0	50.6	1.2	1.9	3.4	19.9	0.0	1.9	45.3	0.0	0.0	0.0	0.0	0.5	1.5	2.6	0.3	0.3	0.4	0.2	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.4	1.6	0.8	0.1	0.2	0.4
GPBP1	DKFZp761C169	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 622.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (4.15e-5)"	39.2	48.6	67.6	37.8	72.0	66.0	55.7	87.7	87.8	46.5	63.6	38.9	31.2	42.6	48.0	36.9	47.0	36.6	39.8	66.0	67.8	48.0	44.0	43.5	57.8	66.2	68.0	65.1	35.7	50.1	41.7	43.3	66.8	42.1	36.9	83.7	42.6	36.5	59.0	38.2	40.3	32.7	68.5	48.1	37.6	75.2	67.3	69.0	51.5	56.5	53.0	43.9	38.0	85.4	56.4	45.3	83.7	70.1	53.8	51.6	75.9	42.9	72.4	68.6	88.4	73.0	63.2	74.2	48.0	44.0	84.9	37.5	71.9	48.6	86.8	41.7	48.1	61.9	49.6	61.5	62.9	45.2	60.8	43.6	74.8	56.1	78.1	65.8	56.7	59.5	62.3	117.6	56.4	72.3	70.3	78.6	51.2	28.2	31.3	75.4	68.5	72.7	53.7	58.7	72.7	56.0	62.1	53.4	69.6	54.3	104.9	75.8	37.3	25.0	50.2	35.1	62.0	90.0	79.6	81.6	40.7	66.7	46.9	93.8	38.2	76.4	59.6	41.0	76.3	71.5	72.1	72.6	43.7	61.9	78.5	73.8	73.2	79.5	45.5	29.8	84.9	68.8	67.6	72.0	87.7	87.8	66.0	67.8	66.2	68.0	66.8	68.5	67.3	85.4	132.9	60.9	88.3	129.3	272.2	227.5	241.1	102.6	206.1	139.8	146.1	87.9	89.0	65.8	121.9	84.6	148.0	99.0	246.9	149.6	99.7	76.5	249.9	246.6	134.0	123.1	107.7	82.7	106.4	55.9	74.3	143.2	115.2	267.8	142.8	119.0	68.2	47.0	56.2	134.6	96.4	103.3	118.0	70.3	622.0	102.4	133.9	162.8	188.5	112.4	160.7	95.7	178.2	168.9	221.6	70.5	176.3	91.4	261.6	246.5	87.9	72.6	154.6	199.0	52.6	129.7	139.9	379.3	279.6	195.6	237.7	161.7	285.2	107.0	102.0	304.1
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	28.7	26.7	25.2	31.0	29.4	49.3	40.9	27.3	28.0	35.0	26.1	57.3	54.0	35.6	37.6	45.0	36.2	30.3	41.7	23.6	27.1	47.0	66.3	39.2	39.9	27.7	28.3	30.6	39.3	41.7	25.5	34.1	28.2	35.8	61.2	27.4	42.4	36.1	46.2	47.2	56.7	36.3	26.8	36.9	42.6	57.9	27.4	54.7	48.7	54.9	49.5	35.6	36.7	32.8	41.1	24.7	42.1	44.9	48.4	47.1	57.5	31.9	52.2	44.8	56.1	25.2	44.8	56.3	40.5	43.7	46.9	42.0	46.6	47.8	56.3	64.4	33.4	73.7	28.9	39.2	66.7	74.2	65.1	34.6	102.0	35.3	99.4	60.2	57.7	71.0	63.7	48.7	51.6	22.0	66.2	65.8	60.4	54.8	27.7	43.0	55.1	41.9	51.5	40.2	51.9	34.7	52.6	76.6	83.5	81.6	35.1	86.2	49.8	32.0	33.6	35.2	48.9	47.2	46.9	41.3	34.0	60.6	34.5	24.0	21.6	40.3	21.6	27.3	22.9	16.5	20.9	21.1	23.0	14.1	22.6	22.4	22.6	26.6	30.6	13.1	26.4	21.1	25.2	29.4	27.3	28.0	23.6	27.1	27.7	28.3	28.2	26.8	27.4	32.8	43.3	60.9	24.4	54.5	45.1	64.9	41.2	28.3	59.2	23.5	51.3	33.5	46.9	41.5	34.3	60.7	35.5	26.2	47.5	96.8	50.9	33.0	23.4	38.1	32.2	38.6	38.3	62.1	48.5	38.9	33.7	25.4	44.9	47.5	59.6	24.3	37.5	81.3	25.0	37.0	49.0	67.2	32.6	49.9	51.6	17.6	20.5	46.1	23.2	70.3	41.3	18.2	45.3	50.8	93.8	51.2	57.0	21.4	36.6	62.8	75.5	58.7	33.0	32.9	19.7	22.4	42.0	78.9	75.3	71.7	67.8	45.4	47.1	27.7	68.6	78.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435663-240468076	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 226.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		9500000		"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	36.8	78.5	42.8	9.0	37.0	0.4	30.7	25.3	64.4	44.5	3.1	36.7	5.8	37.1	9.3	88.4	30.8	8.5	145.2	41.7	28.5	47.6	35.7	21.9	1.4	29.2	30.4	45.1	25.8	9.8	55.7	29.0	26.3	67.8	3.5	5.0	35.2	22.5	134.2	226.0	17.4	16.4	11.3	15.6	23.0	48.7	46.0	9.1	15.7	35.3	6.6	35.1	62.3	24.8	69.0	92.9	21.6	56.7	64.3	61.5	87.3	161.5	78.8	18.3	21.2	33.3	74.9	1.8	21.8	172.0	100.1	186.0	11.7	114.7	3.8	33.3	9.8	0.1	80.7	41.7	92.2	1.6	6.2	54.3	73.4	41.2	21.3	38.1	9.7	3.4	0.4	3.3	47.5	36.0	1.3	0.6	33.7	7.7	20.5	12.3	98.2	16.1	15.0	109.6	21.5	14.4	105.7	91.9	10.1	19.3	29.1	7.0	45.6	97.3	162.3	46.9	67.8	0.7	0.4	0.8	69.4	1.7	111.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	37.0	25.3	64.4	41.7	28.5	29.2	30.4	26.3	11.3	46.0	24.8	1.2	16.0	6.1	45.7	0.7	45.9	69.6	62.2	56.3	22.4	8.3	18.2	53.2	21.5	34.0	25.8	2.1	73.7	0.3	3.7	7.9	27.8	0.9	6.2	24.7	2.8	0.0	0.0	53.0	10.8	199.8	21.0	1.5	8.9	4.5	49.4	11.0	26.3	9.1	25.2	45.0	7.0	16.2	0.6	7.7	3.8	19.0	1.2	35.6	5.6	1.6	24.9	1.0	18.6	8.9	17.6	0.9	7.5	0.9	67.0	0.5	2.3	30.2	6.4	26.3	33.9	38.2	2.2	9.9	44.8	46.2	102.7	1.9	14.5	3.6	110.5
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"lymphoid tissue: 5.2;skin 1: 5.7;testis: 11.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.7;Enteroendocrine cells: 10.7;Spermatocytes: 13.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.8;AN3-CA: 15.8;BEWO: 14.2;SH-SY5Y: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.94e-4)"	0.5	0.3	1.1	1.0	0.9	1.1	0.7	1.1	1.4	1.3	0.6	0.8	0.3	1.8	0.1	0.5	0.9	0.2	0.5	1.1	0.9	0.5	0.1	0.4	1.2	1.2	1.0	1.6	0.2	0.7	0.8	0.1	1.1	0.7	0.4	0.5	0.8	0.2	0.4	5.7	0.9	0.4	1.2	1.1	0.3	11.9	1.0	5.2	0.2	0.0	0.5	0.6	1.0	1.5	0.1	0.2	39.8	15.8	0.0	0.0	14.2	1.3	0.0	0.2	0.3	0.0	0.5	3.5	0.9	0.4	2.3	1.4	1.4	0.5	0.0	0.0	1.2	0.3	0.6	0.1	0.7	0.8	6.1	1.3	0.8	0.9	0.0	0.7	2.0	9.2	1.6	0.0	1.0	0.6	9.7	1.2	7.0	0.7	2.3	10.7	2.9	0.1	0.2	0.7	10.5	43.5	0.8	1.0	1.6	5.6	0.7	0.8	1.5	0.4	6.2	0.9	0.3	1.4	0.5	4.9	0.4	2.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	1.1	1.4	1.1	0.9	1.2	1.0	1.1	1.2	1.0	1.5	0.6	0.0	0.0	1.0	2.2	1.8	1.0	0.6	1.8	0.2	1.1	1.7	2.3	0.0	0.1	1.8	4.2	0.4	0.2	0.4	0.0	1.4	37.7	0.9	2.1	0.8	10.7	2.1	0.2	1.0	0.8	1.6	2.6	0.8	0.0	7.9	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.6	0.4	6.4	0.9	1.0	0.0	1.0	0.6	1.2	2.1	8.0	1.1	1.3	0.4	1.2	0.1	0.8	0.0	0.1	0.4	2.3	0.0	1.8	2.8	13.6	5.7	0.3	3.8	0.4	0.9	1.6	1.1	0.7
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398621-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.1;kidney: 7.3;testis: 6.1"	"Cell type enriched"	"Detected in some"	20	"Astrocytes: 3868.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 49.9;HeLa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.1	1.6	10.3	0.3	18.1	0.1	0.0	6.7	9.6	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.5	1.1	8.4	12.1	7.3	1.3	3.2	0.2	18.2	13.4	0.4	0.1	0.0	1.7	0.4	20.5	0.1	0.5	0.5	0.1	0.4	0.0	0.1	0.1	0.1	5.7	0.0	0.1	6.1	23.1	0.1	1.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.6	0.0	1.7	0.0	0.8	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.4	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	10.3	18.1	6.7	9.6	8.4	12.1	18.2	13.4	20.5	5.7	23.1	4.9	0.0	0.0	2.7	3868.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	64.6	0.0	1.6	0.0	0.0	0.1	0.0	0.0	116.6	0.0	0.0	0.4	0.0	0.1	0.0	7.9	0.0	0.0	0.1	0.0	190.6	0.1	0.0	0.0	0.4	1.0	0.3	0.1	0.0	118.0	0.6	0.0	0.0	127.2	20.9	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226807-94408020	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	9.1	2.2	0.8	8.9	1.9	0.1	2.2	1.7	1.5	3.6	1.1	6.3	2.3	2.4	2.4	5.2	4.1	17.0	6.2	1.3	3.1	7.7	17.7	3.5	0.4	1.7	2.4	7.3	1.6	1.8	2.9	1.3	2.3	6.2	6.5	5.6	3.1	15.1	0.6	1.1	4.3	7.8	2.0	2.2	5.4	2.0	1.9	1.7	1.7	1.9	0.9	11.6	2.4	2.1	0.0	4.7	10.2	4.5	62.5	19.5	0.0	7.2	0.0	4.9	6.4	0.0	0.0	0.2	0.0	16.0	0.0	0.0	5.7	1.2	9.1	0.0	4.1	0.0	0.1	20.2	37.8	0.1	0.1	70.8	0.5	11.7	8.1	64.3	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.1	6.4	0.0	3.4	0.0	1.6	0.1	5.5	0.0	4.1	16.8	0.0	1.9	0.0	39.5	14.0	0.0	0.0	26.9	22.6	25.4	12.3	15.9	0.1	0.0	52.8	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.9	1.7	1.5	1.3	3.1	1.7	2.4	2.3	2.0	1.9	2.1	0.6	0.0	0.5	163.2	0.0	0.6	0.5	0.5	0.6	50.3	0.6	1.9	1.7	4.3	0.7	7.3	10.4	0.2	0.0	0.1	0.0	0.3	6.7	1.6	25.9	1.1	0.0	0.0	333.6	0.0	0.1	31.2	0.0	3.1	0.0	36.0	5.7	41.2	0.5	0.0	496.1	0.1	2.0	1.3	1.0	5.0	4.7	0.5	1.8	31.9	0.0	2.7	0.0	691.6	13.2	0.1	0.0	1.9	0.1	1.6	0.0	14.5	0.0	115.0	0.0	34.4	20.9	4.2	2.7	0.5	0.4	0.1	0.7	11.9	0.1	0.2
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 609.9;skeletal muscle: 577.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	609.9	4.7	9.1	1.6	16.8	0.2	229.2	22.7	12.8	0.3	5.5	6.4	76.4	0.2	5.3	4.9	0.5	16.6	9.2	10.1	14.2	149.3	147.6	18.4	1.0	32.6	18.3	0.3	7.2	13.0	1.3	0.0	26.5	1.3	3.3	1.0	33.0	1.3	577.1	10.2	76.9	1.3	32.7	0.4	3.3	0.8	18.4	1.5	2.7	215.7	0.4	4.1	1.0	49.4	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.8	22.7	12.8	10.1	14.2	32.6	18.3	26.5	32.7	18.4	49.4	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.1;Late spermatids: 95.5;Oligodendrocyte precursor cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.3;eosinophil: 1.7;intermediate monocyte: 1.6;myeloid DC: 2.7;neutrophil: 1.1;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 1.7;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		620000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	8.2	5.7	13.3	8.1	17.7	13.4	16.2	15.2	18.6	10.3	6.5	18.6	14.4	6.8	5.2	20.3	18.2	8.9	6.2	19.8	16.3	8.0	3.4	11.4	7.0	13.5	16.2	8.6	6.8	20.5	5.5	6.7	13.1	10.9	18.0	9.6	14.9	7.1	24.7	12.5	15.7	6.1	14.5	8.5	17.4	5.5	18.5	6.1	12.2	14.3	8.6	14.3	9.5	13.6	39.0	27.2	15.3	24.5	32.6	39.6	0.1	48.0	31.2	32.1	38.6	53.9	35.7	8.4	31.9	27.4	13.2	44.5	28.9	44.5	41.4	23.9	9.5	6.0	46.9	0.0	12.0	11.2	12.6	19.5	15.4	55.6	27.1	20.6	24.1	3.7	12.0	1.9	41.7	24.4	0.3	1.0	28.7	15.2	31.0	12.3	9.8	9.2	41.8	50.7	27.3	9.9	45.0	34.4	30.4	25.9	10.9	30.8	22.8	5.7	26.9	26.5	36.5	1.3	0.3	0.4	32.9	3.0	47.1	0.3	3.3	1.7	0.3	1.6	0.5	0.1	0.1	0.4	2.7	0.2	0.3	0.2	1.1	0.4	2.3	0.3	0.5	1.5	13.3	17.7	15.2	18.6	19.8	16.3	13.5	16.2	13.1	14.5	18.5	13.6	12.1	19.2	12.3	151.1	7.8	20.0	23.3	24.9	21.1	5.5	23.4	12.8	13.1	7.2	19.8	22.0	6.2	9.6	6.2	52.1	1.9	9.5	84.8	12.3	6.1	11.3	17.4	6.9	27.9	13.4	15.2	9.2	30.5	23.3	12.7	13.0	10.4	3.4	21.3	5.0	46.9	17.1	10.2	18.6	18.7	95.5	12.2	21.0	24.9	61.8	10.8	4.2	4.1	148.3	48.7	16.2	17.4	7.2	5.6	66.7	16.0	3.9	18.2	11.1	0.0	8.3	12.3	2.6	3.2	41.7	21.5	11.1	7.6	7.0	19.4	77.8
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		6900	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (4.61e-5)"	13.8	11.1	35.5	3.5	36.0	2.6	13.4	48.4	54.1	9.7	20.9	11.8	7.4	9.9	11.6	12.2	11.1	6.2	17.1	36.1	37.6	25.3	62.4	9.3	3.8	32.7	35.3	8.9	23.9	11.7	13.6	3.6	32.3	11.3	10.1	23.1	9.4	6.6	24.5	15.2	9.0	6.2	32.4	6.7	14.7	6.2	34.6	5.8	11.9	13.8	4.3	11.4	10.7	39.5	39.9	8.8	13.7	15.9	14.2	17.5	9.5	11.1	5.7	12.7	12.2	2.8	17.9	0.0	1.8	7.7	5.5	13.1	17.0	19.9	18.9	15.0	14.9	15.8	9.4	22.3	7.8	9.1	15.8	13.3	13.8	2.9	16.0	4.8	11.8	13.8	9.3	14.2	7.1	19.2	11.9	22.2	5.0	28.3	17.0	0.0	32.5	13.2	16.7	7.5	25.8	10.3	10.2	31.6	12.4	3.3	18.5	11.5	6.7	14.1	24.8	11.3	13.0	22.8	9.1	0.3	10.5	0.8	11.2	0.0	0.7	0.3	2.0	1.2	3.2	1.2	2.5	1.7	1.1	1.9	1.7	1.6	0.0	1.3	1.0	1.5	3.0	0.7	35.5	36.0	48.4	54.1	36.1	37.6	32.7	35.3	32.3	32.4	34.6	39.5	11.5	6.4	13.1	493.0	11.8	4.7	9.2	5.8	27.9	34.3	12.4	6.7	12.7	8.6	10.8	1.8	52.1	3.9	3.5	8.6	13.7	4.0	3.8	7.2	13.5	10.7	6.0	7.6	686.5	5.3	2.3	8.7	19.9	13.6	0.0	3.9	15.7	47.6	3.7	43.7	866.7	15.0	8.2	5.8	1.7	5.0	11.1	4.5	1.8	148.0	1.3	8.9	1.0	576.1	597.5	3.1	7.8	5.7	15.1	11.5	7.1	20.1	2.4	34.9	0.0	12.5	11.8	11.8	8.9	26.7	5.8	2.1	7.9	9.0	10.4	6.5
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPIHBP1	"GPI-HBP1, LOC338328"	ENSG00000277494	"Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1"	Q8IV16	8	143213218-143217170	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;breast: 54.5"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 356.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Karpas-707: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066302	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA066302: AB_2685654"	"unprognostic (2.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-3)"	90.7	4.9	12.9	0.4	23.7	0.1	54.5	22.7	27.2	8.7	7.5	5.3	0.6	11.4	0.2	3.5	11.7	6.5	38.6	13.3	17.9	11.0	1.6	27.4	2.4	35.8	20.8	6.6	1.8	1.1	3.4	6.5	32.9	3.9	0.5	0.1	4.1	1.6	30.2	7.4	3.7	2.4	18.0	19.3	4.1	2.0	22.8	1.9	5.5	29.7	1.0	10.5	7.9	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	23.7	22.7	27.2	13.3	17.9	35.8	20.8	32.9	18.0	22.8	53.5	356.5	0.0	3.2	0.0	0.5	1.5	0.1	0.0	1.2	0.0	1.0	0.6	4.3	0.0	0.6	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	77.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	1.3	0.0	35.7	0.4	0.0	0.0	0.1	0.0	0.0	0.8	2.1	0.6	1.5	0.4	0.0	8.4	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.4	3.0	0.0	0.7	0.2	1.1	0.0	0.4	1.1	0.0	0.2
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.2	0.9	2.0	0.6	1.7	0.9	1.3	7.6	4.7	1.1	0.1	1.0	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.3	2.4	0.6	46.1	0.9	0.9	1.8	1.9	1.2	0.6	2.5	1.7	0.2	1.9	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.4	1.4	0.6	0.6	0.7	1.4	1.4	5.1	2.4	0.6	1.3	1.1	1.5	2.1	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	2.0	1.7	7.6	4.7	1.3	2.4	1.8	1.9	1.9	0.6	1.4	2.1	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 577.8;choroid plexus: 249.3;retina: 147.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 34.8;naive B-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 34.8"	"Group enriched"	"Detected in some"	10	"AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	3.8	4.2	366.9	1.4	455.6	0.5	2.5	422.6	577.8	6.8	249.3	25.4	1.9	7.7	2.9	1.9	7.5	4.4	2.8	469.8	268.7	7.1	13.4	20.1	2.6	225.0	265.4	12.3	1.8	0.7	7.7	0.3	222.4	5.7	6.0	147.3	0.9	6.9	0.6	0.8	3.4	11.1	257.9	15.8	1.1	1.5	281.9	0.3	11.9	0.6	1.3	2.6	2.9	336.4	0.3	0.7	49.9	0.5	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.1	0.7	43.0	0.2	0.2	1.8	0.9	17.4	1.5	0.1	0.2	4.0	0.5	3.7	1.4	0.1	0.4	0.7	0.1	0.0	0.1	0.2	2.0	0.0	0.1	0.4	1.7	0.0	1.2	1.6	0.6	1.2	0.0	0.6	0.2	0.2	0.3	0.1	2.1	0.5	0.4	0.2	0.9	0.2	0.3	0.6	0.1	0.2	0.9	0.6	0.6	50.8	1.6	0.1	2.6	1.8	0.4	1.1	0.8	0.1	0.1	0.1	0.1	0.1	34.8	0.1	0.0	0.2	16.6	0.1	0.1	0.4	0.1	0.2	2.9	0.1	0.8	366.9	455.6	422.6	577.8	469.8	268.7	225.0	265.4	222.4	257.9	281.9	336.4	0.6	96.1	8.7	3712.4	9.6	1.8	5.3	0.0	0.0	220.3	0.2	0.1	0.7	1.5	0.6	0.0	14.6	0.0	0.0	0.1	1.9	0.0	11.7	0.4	0.1	29.0	0.0	5.3	833.0	0.2	0.2	2.4	0.0	0.2	0.0	0.2	116.0	2.1	0.3	124.5	581.3	0.0	0.0	4.4	0.4	3.6	3.4	1.6	0.0	208.0	0.0	459.6	0.0	1341.6	37.3	0.0	0.0	1.5	0.1	9.0	0.0	3.4	0.0	30.5	0.0	15.3	3.3	0.5	0.4	0.2	0.9	0.1	1.2	3.0	0.0	6.5
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13770939-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 743.2;choroid plexus: 180.7;retina: 207.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 633.3;Excitatory neurons: 361.3;Melanocytes: 357.5;Muller glia cells: 1722.4;Oligodendrocyte precursor cells: 408.1;Oligodendrocytes: 1476.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 192.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	220	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in single"	268	"dendritic cells: 77.7"	"Cell line enhanced"	"Detected in many"		"AF22: 154.8;AN3-CA: 150.1;ASC TERT1: 74.2;HSkMC: 110.0;SK-MEL-30: 154.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002913	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	7.5	9.3	418.4	6.0	518.8	1.1	26.4	540.4	521.1	27.1	180.7	33.8	5.0	6.3	12.1	11.5	6.5	5.9	15.8	447.8	463.6	7.7	1.1	16.8	2.8	596.3	459.3	4.4	3.2	0.6	17.2	1.3	580.5	21.8	7.8	207.7	14.8	35.2	2.5	13.9	9.2	5.4	533.4	14.5	11.7	3.5	419.9	0.8	5.0	7.5	1.9	9.1	19.7	743.2	0.4	0.4	154.8	150.1	41.6	74.2	0.4	0.9	6.9	0.1	0.0	0.4	0.5	0.7	0.3	0.0	0.6	1.3	7.6	0.8	0.0	0.6	25.2	0.4	10.0	0.4	1.5	0.5	0.9	110.0	0.9	0.0	1.9	0.6	0.0	3.0	0.4	6.8	1.5	0.6	3.4	0.7	48.5	0.1	2.5	2.0	13.7	23.9	0.0	0.5	7.8	4.4	0.8	4.4	154.4	41.9	0.7	3.6	0.3	1.0	1.3	0.3	2.0	0.5	0.3	0.3	1.4	0.3	12.4	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	77.7	0.1	0.7	418.4	518.8	540.4	521.1	447.8	463.6	596.3	459.3	580.5	533.4	419.9	743.2	13.8	0.0	5.1	633.3	15.8	33.0	22.7	5.9	6.8	74.4	37.1	47.1	1.3	1.5	7.8	22.0	87.6	5.0	50.7	3.0	0.0	5.4	1.5	45.8	32.7	12.5	1.2	5.3	361.3	3.7	3.7	54.2	0.0	30.4	4.5	19.7	10.8	0.4	1.2	26.9	144.0	5.0	8.2	1.9	33.5	3.2	24.2	3.7	357.5	40.3	4.6	1722.4	50.4	408.1	1476.6	2.3	6.0	32.0	7.3	26.5	6.1	1.1	11.0	151.4	46.0	137.7	43.6	9.6	13.3	7.0	17.0	13.7	20.5	8.6	3.2	14.8
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651511	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	22.8	22.8	19.3	20.3	19.8	34.1	26.4	19.9	26.1	18.1	19.5	22.7	19.9	19.1	19.9	25.5	21.0	18.6	21.3	19.4	21.6	26.3	24.6	18.6	28.7	22.5	22.6	18.4	22.8	25.9	16.6	26.5	21.8	17.7	25.6	24.9	21.5	16.9	32.4	24.8	19.6	22.4	19.6	22.2	20.6	25.5	21.9	30.1	22.8	27.2	30.3	24.0	19.5	21.2	94.6	53.3	48.8	35.4	44.3	44.8	48.7	52.0	50.5	70.7	52.1	58.0	47.4	58.8	49.2	56.4	65.4	39.5	67.6	63.4	71.5	55.4	47.6	66.8	38.3	70.7	57.3	100.0	33.7	46.7	54.8	72.6	67.1	49.4	75.2	51.5	84.7	53.5	84.1	54.2	60.3	75.1	83.4	70.9	50.7	60.2	144.4	61.0	57.9	53.5	42.9	67.6	57.2	61.5	58.4	44.7	37.1	56.0	62.9	61.5	91.1	30.9	122.7	60.8	71.8	156.9	88.0	85.0	51.8	92.4	61.3	55.1	79.1	71.6	86.0	74.6	72.2	92.0	89.7	68.7	63.8	78.2	9.3	106.1	72.1	46.8	79.2	82.3	19.3	19.8	19.9	26.1	19.4	21.6	22.5	22.6	21.8	19.6	21.9	21.2	17.6	12.8	10.4	2.3	18.7	21.7	21.7	28.2	10.8	9.2	14.8	11.8	11.8	14.3	19.7	14.7	4.2	43.5	28.8	9.5	23.5	46.4	86.3	20.5	14.1	17.3	17.4	18.7	6.6	36.3	46.2	14.3	9.7	21.7	24.7	17.7	17.5	10.2	33.4	11.8	6.6	13.0	20.3	20.1	26.8	76.0	14.9	17.6	23.2	2.8	28.9	15.0	27.8	5.0	5.0	46.3	13.5	10.9	11.2	20.1	16.2	20.8	14.3	10.9	13.1	13.2	19.0	36.6	23.4	13.6	18.6	33.1	31.0	20.2	20.0	18.9
GPN2	"ATPBD1B, FLJ10349"	ENSG00000142751	"GPN-loop GTPase 2"	Q9H9Y4	1	26876132-26890283	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028059	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA028059: AB_10612113"	"unprognostic (2.14e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (3.56e-8)"	"unprognostic (1.17e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.18e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-2)"	15.2	22.2	10.9	11.9	10.3	21.6	14.5	11.9	12.1	13.6	9.3	16.3	15.4	14.4	16.0	21.1	12.0	12.0	19.3	10.1	10.7	15.9	19.7	13.1	15.7	11.3	9.9	12.4	14.9	17.4	13.8	13.1	10.4	16.6	17.2	11.9	14.0	12.3	23.2	19.1	15.5	15.4	9.7	17.2	15.4	13.0	11.0	15.3	12.7	13.3	19.9	16.7	14.9	11.6	35.6	16.7	20.2	19.4	21.2	20.3	15.7	26.1	35.0	40.3	41.9	27.4	38.4	17.0	33.7	37.5	32.0	34.3	43.7	60.9	51.9	20.1	28.7	29.6	30.7	29.8	36.3	39.6	30.8	25.4	23.3	65.3	46.1	23.1	40.1	20.7	30.1	19.3	34.9	29.6	19.8	35.0	36.8	38.2	35.2	26.6	29.9	28.6	30.3	19.8	27.2	18.5	34.9	23.0	43.0	21.5	27.5	16.1	24.3	29.8	31.0	25.6	27.3	39.6	21.9	25.6	23.1	36.1	26.9	7.5	29.1	31.3	23.6	33.5	26.5	30.0	22.9	22.7	27.2	31.0	17.2	16.6	9.2	21.4	35.0	28.0	29.8	16.5	10.9	10.3	11.9	12.1	10.1	10.7	11.3	9.9	10.4	9.7	11.0	11.6	9.4	16.0	11.8	1.6	12.6	18.7	15.7	20.1	9.1	9.6	9.3	6.5	4.1	24.3	16.4	16.5	8.4	35.4	9.8	26.5	13.7	22.1	13.8	12.1	10.0	12.2	18.5	11.1	3.8	19.1	26.3	12.6	14.8	14.6	17.7	13.2	12.1	14.6	22.3	13.5	3.3	17.2	4.1	13.9	9.5	6.1	9.6	11.6	8.8	2.8	23.2	7.5	5.2	3.5	4.0	19.0	20.4	11.7	9.1	20.4	25.9	17.2	8.5	9.6	6.6	10.9	11.1	19.8	12.6	11.7	22.4	43.2	11.4	12.2	17.8	27.4
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452486-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	25.6	18.9	10.4	16.3	11.7	15.4	24.4	12.9	12.9	15.7	11.6	15.6	8.1	17.8	15.2	16.3	18.5	13.8	34.2	10.0	11.0	31.4	32.1	16.9	22.9	12.2	11.2	23.3	19.9	29.2	11.1	21.3	12.8	22.2	13.1	23.4	24.2	18.0	47.9	11.1	10.6	19.5	13.0	16.2	15.6	41.3	10.9	18.1	21.2	51.1	18.1	17.6	13.8	14.9	42.3	65.8	43.2	42.8	47.5	30.1	57.6	57.1	34.1	62.2	50.3	59.7	24.6	81.5	38.5	31.0	46.0	37.9	54.2	50.5	83.9	46.9	50.6	47.7	33.8	50.5	33.2	75.2	42.2	32.2	31.4	61.1	39.5	34.9	45.6	67.0	82.1	17.9	44.3	28.2	69.8	142.8	53.4	58.6	64.8	23.5	59.9	62.2	39.3	37.8	34.7	34.8	57.7	39.0	49.9	55.0	66.7	87.7	25.4	51.6	38.0	51.3	66.6	24.7	68.0	85.1	38.2	68.5	60.3	41.0	54.4	79.4	30.0	71.9	32.8	46.5	32.0	34.2	51.1	47.9	40.5	26.9	27.4	28.4	75.3	62.5	30.1	41.6	10.4	11.7	12.9	12.9	10.0	11.0	12.2	11.2	12.8	13.0	10.9	14.9	23.8	25.6	34.5	3.3	24.5	29.8	49.3	57.9	15.9	18.8	28.8	32.5	43.8	20.0	36.0	33.1	14.6	62.4	26.6	3.8	107.6	30.4	111.1	24.9	24.6	20.8	8.3	26.9	4.3	21.3	74.0	25.4	8.2	21.5	31.0	18.6	18.2	38.1	94.7	21.9	5.6	9.1	40.7	19.1	17.7	22.6	19.9	33.2	16.0	14.0	39.6	25.7	19.6	3.5	6.4	22.4	11.0	23.7	20.9	55.5	5.3	72.1	34.2	33.0	26.3	31.0	35.3	187.2	77.6	20.8	25.4	46.7	19.2	22.1	13.7	40.2
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.2"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 12.3;Granulosa cells: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	1.5	2.7	0.1	0.2	0.9	0.0	0.7	0.5	0.3	2.6	12.2	0.3	0.1	0.5	0.2	4.5	0.5	1.2	1.6	0.6	0.3	0.4	0.0	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.2	3.9	0.0	0.2	0.3	0.7	0.9	0.1	0.7	4.8	0.3	1.0	0.0	0.0	0.1	0.9	0.2	0.0	0.3	2.4	0.3	1.0	5.6	0.0	2.2	0.2	1.8	0.0	0.4	7.5	0.6	14.4	24.7	8.8	7.4	0.0	0.0	0.0	0.8	7.3	0.6	0.2	0.7	0.0	2.9	0.0	0.3	0.0	4.2	0.0	133.9	0.0	0.0	5.5	61.8	12.5	20.0	10.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	6.9	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	6.1	2.9	0.0	0.0	1.6	0.1	0.0	0.3	10.5	4.8	12.5	1.1	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	12.3	4.5	0.0	0.0	0.0	42.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.2	0.0	0.0	0.8	1.0	0.7	0.5	0.0	0.0	0.4
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137023929-137033995	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"brain: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 12.4;cerebral cortex: 4.4;hypothalamus: 14.3;thalamus: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 38.3"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA001084: AB_1078920"																		0.0	0.0	2.1	0.0	12.4	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	12.4	0.3	4.4	0.1	14.3	1.3	0.6	1.5	1.2	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	18.9	17.3	21.0	15.1	22.1	12.2	20.3	21.9	21.3	20.1	24.4	21.3	11.6	18.8	15.3	18.7	22.0	16.1	18.3	19.5	23.9	20.5	13.0	20.3	11.0	23.4	25.3	17.9	18.8	28.7	16.6	23.3	25.6	23.6	22.6	26.3	18.3	19.9	17.8	22.7	12.9	23.2	21.8	13.4	16.7	17.3	23.5	14.3	34.9	17.0	14.2	15.8	14.2	23.8	29.7	42.0	39.6	31.7	42.4	44.6	39.9	45.9	52.5	37.9	37.5	40.6	39.5	16.4	33.4	52.1	44.5	73.0	30.7	28.6	32.3	24.7	20.3	17.0	49.1	23.8	40.9	36.2	24.4	37.5	44.3	38.1	38.7	44.1	35.9	19.0	25.0	15.8	33.6	36.6	19.4	14.7	26.8	60.0	31.7	18.3	58.7	25.9	32.1	40.2	13.6	30.7	59.8	42.8	33.1	34.9	75.0	19.3	42.9	48.1	25.1	40.3	35.3	9.8	35.6	15.2	43.5	17.0	46.9	1.5	2.8	1.9	0.7	3.4	1.0	1.0	0.7	0.8	1.8	1.0	0.5	1.2	3.3	0.9	3.6	1.1	0.7	1.3	21.0	22.1	21.9	21.3	19.5	23.9	23.4	25.3	25.6	21.8	23.5	23.8	14.8	25.6	19.3	47.7	8.0	6.4	5.1	14.8	5.2	16.9	17.8	12.2	23.0	14.3	16.4	16.5	39.6	15.4	11.4	20.7	0.0	13.4	6.5	23.7	19.3	14.3	9.6	4.6	32.7	17.6	19.2	16.2	16.8	26.4	6.3	17.9	24.3	11.6	15.1	18.5	39.7	19.4	6.1	17.0	17.6	5.7	19.0	13.8	14.2	22.5	15.6	11.0	9.2	38.2	48.6	21.9	15.9	19.2	11.2	13.2	9.3	6.5	24.5	15.5	0.0	16.3	15.3	16.2	11.5	12.2	10.9	26.7	10.4	13.5	18.4	10.9
GPR108	LUSTR2	ENSG00000125734	"G protein-coupled receptor 108"	Q9NPR9	19	6729914-6737603	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041924, HPA041951, HPA063863"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Vesicles	"HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.04e-7)"	"unprognostic (1.58e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (8.68e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.13e-3)"	29.9	45.2	26.9	18.8	29.3	26.2	32.7	29.7	27.2	36.8	29.9	39.9	32.9	31.6	31.6	39.6	40.1	32.2	22.5	24.2	29.4	42.1	34.4	32.4	23.2	28.9	28.1	34.5	46.7	49.0	23.2	22.2	27.5	34.4	28.1	27.8	57.5	40.2	18.4	31.2	36.6	26.3	27.7	33.3	35.8	25.5	29.1	23.5	41.3	20.5	27.8	31.0	32.9	27.8	33.5	35.9	21.7	42.6	83.0	44.8	24.4	25.6	77.0	34.7	36.7	22.2	37.5	15.8	46.4	52.4	41.6	28.1	24.7	53.3	17.8	64.1	28.4	25.7	37.7	29.6	81.3	16.7	33.7	48.7	100.2	33.5	67.2	45.9	41.3	37.9	26.4	102.7	35.6	23.3	29.5	24.0	15.6	60.2	31.5	23.7	24.7	61.0	72.7	32.6	0.2	23.4	25.9	41.8	38.7	18.4	39.9	40.0	34.4	19.7	12.5	63.2	27.6	66.2	39.3	11.4	68.0	52.9	21.7	79.3	116.1	123.0	82.6	109.7	75.2	48.2	65.2	70.4	84.6	49.9	45.9	52.8	178.4	80.9	130.5	30.0	81.2	132.7	26.9	29.3	29.7	27.2	24.2	29.4	28.9	28.1	27.5	27.7	29.1	27.8	40.8	9.6	14.5	12.7	26.3	26.5	43.7	107.4	21.1	28.3	42.7	33.0	8.0	45.8	59.7	36.8	22.9	58.7	31.1	76.4	37.2	87.7	38.0	30.8	23.6	32.7	21.7	6.9	5.4	110.1	37.2	27.4	39.3	44.1	26.0	15.0	40.7	26.7	57.1	21.9	6.0	57.6	81.4	30.3	46.7	94.9	23.6	42.4	30.2	5.6	50.3	46.0	42.2	7.5	9.6	83.3	83.7	18.4	27.8	29.1	121.2	55.0	39.8	43.0	39.5	22.2	26.4	34.3	19.9	27.2	31.8	58.6	38.9	28.3	47.1	36.1
GPR12	"GPCR21, PPP1R84"	ENSG00000132975	"G protein-coupled receptor 12"	P47775	13	26755200-26760786	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;retina: 8.4;skin 1: 5.4"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 9.7;Excitatory neurons: 9.5;Hofbauer cells: 17.6;Horizontal cells: 33.7;Inhibitory neurons: 15.7;Skeletal myocytes: 8.1"	"Group enriched"	"Detected in some"	7	"breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050972	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA050972: AB_2681295"	"unprognostic (2.37e-2)"				"unprognostic (9.64e-3)"			"unprognostic (3.75e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.40e-1)"	0.2	0.0	3.7	0.0	14.3	0.1	1.4	7.6	10.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.2	8.1	1.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.4	0.2	0.0	0.0	8.4	2.9	0.0	0.1	5.4	0.1	0.1	0.1	0.1	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	14.3	7.6	10.7	8.1	1.0	0.0	3.3	0.2	0.1	4.3	2.9	0.4	0.0	0.0	1.6	0.0	0.1	0.2	0.0	0.0	2.8	2.7	2.8	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	9.7	0.0	9.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	17.6	33.7	15.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2	3.6	0.0	0.0	1.9	0.0	5.0	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	8.1	0.2	0.1	0.3	0.0	0.1	0.3	0.2	0.0	0.0	0.2
GPR132	G2A	ENSG00000183484	"G protein-coupled receptor 132"	Q9UNW8	14	105049395-105065445	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.0;lymphoid tissue: 7.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;Langerhans cells: 45.5;Macrophages: 30.2;monocytes: 19.1;NK-cells: 15.5;T-cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"HDLM-2: 26.9;Karpas-707: 26.6;THP-1: 8.2"									"HPA029694, HPA029695"	Supported					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029694: AB_10600213, HPA029695: AB_10601984"	"unprognostic (2.71e-3)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.44e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.72e-1)"	2.1	0.7	0.9	7.0	0.7	8.0	0.9	0.7	0.9	0.9	1.0	1.3	1.0	0.6	0.4	0.8	1.6	1.4	0.8	0.8	1.0	5.4	0.5	2.7	7.7	1.6	1.1	0.3	0.7	0.3	0.5	1.5	1.2	0.8	0.9	0.3	0.9	0.3	0.5	2.6	4.3	0.8	1.0	7.8	1.7	0.3	1.2	1.9	4.6	0.6	4.5	2.4	1.1	1.3	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.6	0.0	0.0	0.7	0.0	0.0	0.0	26.9	0.3	0.6	0.1	0.0	0.1	2.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	26.6	0.0	0.8	0.0	2.7	0.1	0.0	0.0	2.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	8.2	0.4	0.1	0.1	0.0	0.3	0.7	2.6	0.3	0.0	2.4	0.0	9.6	6.0	5.5	6.1	7.7	5.9	4.2	4.8	5.5	5.7	4.5	4.8	5.3	4.7	5.8	9.1	3.1	3.6	5.0	0.9	0.7	0.7	0.9	0.8	1.0	1.6	1.1	1.2	1.0	1.2	1.3	0.6	0.0	1.9	0.7	23.6	1.7	0.1	1.0	0.0	0.0	0.3	0.3	0.8	0.0	0.7	1.8	0.0	0.1	12.2	0.0	1.9	0.4	0.0	2.2	0.8	0.9	0.0	4.0	0.7	0.6	0.3	0.4	1.1	5.2	12.7	0.0	0.0	0.0	3.9	0.0	0.6	0.0	0.0	7.1	45.5	0.2	0.0	30.2	5.4	7.5	19.1	0.0	15.5	0.0	0.1	1.2	0.0	0.0	11.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.0	20.7	0.0	0.0	0.9
GPR135	"HUMNPIIY20, PAFR"	ENSG00000181619	"G protein-coupled receptor 135"	Q8IZ08	14	59429022-59465342	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 150.0;Late spermatids: 215.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045337	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA045337: AB_10960528"	"unprognostic (1.55e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.68e-3)"	1.2	1.7	1.3	0.6	1.1	0.2	0.9	3.3	1.5	2.2	3.5	1.5	0.2	2.0	1.1	0.6	3.1	0.8	2.1	0.9	1.7	0.9	0.6	0.9	0.3	1.5	1.5	2.5	0.9	2.5	3.4	0.6	0.8	1.9	0.5	0.8	0.6	2.7	0.8	0.6	0.9	1.2	0.8	0.5	1.0	6.0	1.3	0.2	1.4	0.3	0.3	2.1	1.5	1.2	0.4	0.5	0.8	1.0	0.7	1.0	0.7	0.9	0.5	0.6	0.6	0.2	0.9	0.4	0.6	1.1	0.2	0.5	0.4	0.3	0.8	0.9	0.3	0.3	2.8	0.3	0.6	0.5	0.4	0.6	0.6	0.9	0.4	1.3	0.4	0.4	0.5	0.6	0.8	0.3	0.1	1.2	0.6	0.0	1.8	0.6	0.6	0.4	0.6	0.4	1.1	1.3	2.1	0.3	0.1	0.4	0.4	0.2	1.5	1.5	1.2	0.4	1.0	0.1	0.0	0.3	0.5	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	1.1	3.3	1.5	0.9	1.7	1.5	1.5	0.8	0.8	1.3	1.2	1.0	0.0	0.5	9.1	1.1	0.3	0.8	0.4	0.0	5.0	0.5	0.4	2.6	1.5	2.7	3.7	2.1	0.4	0.3	0.0	0.0	0.6	150.0	9.7	4.5	0.7	3.0	0.8	21.3	0.7	0.3	2.4	0.5	0.5	0.0	7.0	1.1	0.2	0.1	1.7	20.6	0.2	0.0	0.0	0.5	215.5	3.1	0.6	0.0	3.7	0.4	4.3	1.0	7.5	13.3	0.5	0.0	3.8	0.4	1.1	0.4	1.1	7.6	2.4	0.0	3.6	2.8	22.7	1.8	0.2	0.1	0.1	0.5	5.4	0.7	0.2
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 203.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: AB_2684889"	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favorable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	20.6	32.6	54.4	16.4	50.9	13.7	19.6	49.4	63.8	24.5	42.5	22.6	12.2	23.6	12.6	28.9	22.3	15.0	29.1	52.8	44.3	34.0	33.9	19.4	14.9	55.3	50.5	18.7	16.2	23.2	26.5	15.6	56.2	29.1	7.5	11.8	23.7	14.8	16.8	22.5	19.5	10.4	45.9	24.5	27.4	203.8	56.2	10.6	30.8	15.9	12.8	26.7	21.4	48.2	22.0	50.2	18.6	49.5	34.9	19.9	69.6	25.5	24.3	31.0	18.4	38.0	31.6	22.7	42.4	24.1	51.9	44.3	28.8	17.1	9.7	73.0	27.9	22.7	53.7	22.5	21.6	15.0	40.9	24.8	25.0	27.5	19.0	20.8	16.3	28.4	20.6	56.2	19.1	56.9	16.8	40.5	22.5	20.4	49.9	31.0	18.0	37.5	20.0	30.3	27.2	32.6	30.0	44.6	30.6	21.4	46.0	6.3	23.1	69.1	46.8	53.3	18.7	41.9	84.9	20.5	50.0	12.3	44.9	1.9	2.8	5.1	2.3	2.5	2.9	2.7	2.0	1.7	3.0	3.8	2.1	1.8	14.0	1.9	2.1	3.0	1.6	1.4	54.4	50.9	49.4	63.8	52.8	44.3	55.3	50.5	56.2	45.9	56.2	48.2	13.0	3.2	11.2	12.7	15.0	14.4	18.5	21.8	19.4	14.1	16.2	13.3	5.3	20.0	13.7	12.9	12.5	49.6	9.5	26.2	15.6	39.0	193.1	14.4	14.8	15.8	16.2	14.7	9.3	26.6	69.7	13.4	15.3	10.0	2.5	10.3	11.4	10.8	23.2	20.2	9.0	16.8	14.2	15.4	14.5	573.0	19.3	11.5	14.2	6.5	16.4	38.9	11.3	4.5	11.2	30.8	14.6	16.1	13.4	26.7	31.5	19.6	18.6	9.1	26.3	8.7	14.1	175.0	55.9	16.9	15.2	119.6	10.8	16.6	15.1	23.3
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 135.6"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.0;Muller glia cells: 226.0;Proximal tubular cells: 115.1;Rod photoreceptor cells: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 17.6;monocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.8;SK-MEL-30: 220.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	15.8	6.9	33.4	15.4	39.4	6.4	13.7	35.6	39.8	25.2	18.8	11.4	9.7	19.1	39.9	9.1	6.1	20.3	22.2	32.8	35.4	68.1	22.1	16.7	18.4	36.9	38.3	12.2	3.7	13.1	3.3	30.0	37.3	10.4	10.8	135.6	6.2	14.7	1.4	18.8	8.7	15.9	34.2	16.4	11.0	3.5	37.3	6.3	15.1	5.0	16.9	28.7	13.2	38.1	5.6	7.8	6.4	5.7	82.8	46.6	2.0	12.3	27.5	7.4	10.3	1.8	6.7	0.9	19.1	13.0	16.7	4.3	8.4	7.6	7.2	5.4	15.8	3.2	1.0	1.4	11.7	4.3	29.7	30.5	25.4	5.7	2.8	23.3	12.0	7.6	0.5	0.1	12.6	6.7	3.6	1.7	3.1	2.4	2.9	6.1	10.0	2.4	10.8	20.1	4.6	9.3	4.2	16.9	220.5	4.9	22.1	7.5	10.7	11.2	7.8	26.2	12.1	1.0	7.2	0.8	6.7	3.1	17.3	17.6	0.9	9.6	0.9	4.1	0.4	0.5	0.6	2.7	1.1	0.3	0.3	0.8	0.1	0.1	7.3	0.3	1.7	0.4	33.4	39.4	35.6	39.8	32.8	35.4	36.9	38.3	37.3	34.2	37.3	38.1	7.3	0.0	1.7	17.6	10.3	25.7	22.2	8.0	14.2	31.9	8.2	4.8	23.0	7.2	5.1	12.9	35.5	46.7	9.7	1.1	17.6	14.4	0.1	1.9	10.2	7.1	8.5	4.0	14.8	10.4	9.9	19.3	6.6	2.1	20.3	2.8	11.7	4.1	88.0	52.2	15.4	2.7	0.0	81.4	139.0	0.9	9.0	55.0	69.4	8.4	83.8	226.0	4.1	30.2	14.9	11.1	2.7	6.0	8.4	21.4	2.2	115.1	6.1	171.2	0.0	7.1	10.5	0.1	1.1	9.4	19.9	40.8	19.9	3.5	2.7	29.8
GPR137C	"DKFZp762F0713, TM7SF1L2"	ENSG00000180998	"G protein-coupled receptor 137C"	Q8N3F9	14	52552836-52637713	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;epididymis: 8.1;retina: 17.3"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 85.5;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003640, HPA030763"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA003640: AB_2667025, HPA030763: AB_10602352"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.84e-2)"	"unprognostic (8.50e-3)"	"unprognostic (7.34e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.42e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.88e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.60e-1)"	0.5	0.7	5.3	0.2	3.8	0.9	0.5	14.6	7.2	0.6	0.0	0.4	0.7	0.8	8.1	0.4	0.3	1.1	1.0	4.0	5.5	0.4	0.6	0.8	0.4	5.9	5.9	0.7	0.2	0.4	1.5	0.4	5.0	0.7	0.4	17.3	0.2	0.4	0.5	0.2	0.3	0.4	2.4	1.0	0.4	2.9	8.4	0.3	0.6	0.6	0.1	0.4	0.3	7.7	0.8	0.3	6.6	6.4	1.7	0.6	2.7	3.3	2.2	3.2	7.8	0.9	1.4	0.2	1.9	2.2	6.5	1.5	2.5	0.5	4.5	0.4	1.7	0.3	1.5	0.4	0.1	0.1	1.1	0.4	0.0	2.8	0.2	0.6	1.5	1.1	0.9	2.3	4.4	3.8	0.1	0.6	1.1	0.4	4.1	1.2	4.3	0.3	1.0	4.8	7.4	9.1	1.3	0.2	0.1	2.7	4.4	0.0	0.0	6.8	7.6	5.5	2.3	0.4	1.6	0.8	1.5	0.1	1.9	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.5	1.4	0.0	0.0	0.3	0.5	0.1	1.5	0.1	0.0	0.5	0.2	5.3	3.8	14.6	7.2	4.0	5.5	5.9	5.9	5.0	2.4	8.4	7.7	2.8	0.0	1.3	20.2	0.7	0.6	0.7	0.1	2.2	22.4	1.4	1.4	2.5	1.5	0.1	0.0	2.1	0.3	0.4	0.4	0.0	0.3	2.3	3.4	1.6	3.8	1.2	0.0	85.5	0.2	0.3	1.9	1.1	6.2	0.0	5.6	2.2	0.5	0.5	6.7	125.4	0.7	0.0	2.2	0.8	1.5	0.6	0.9	1.8	21.5	0.2	5.4	1.0	101.6	137.4	0.0	0.0	0.7	1.0	1.8	0.1	0.2	0.1	20.2	0.0	1.1	1.7	6.9	5.1	1.3	0.9	0.1	1.2	1.2	0.1	0.5
GPR139	PGR3	ENSG00000180269	"G protein-coupled receptor 139"	Q6DWJ6	16	20028239-20073890	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	10	"brain: 4.9"	"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046596	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA046596: AB_2679713"					"unprognostic (2.94e-1)"													0.0	0.0	0.3	0.0	3.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.3	0.4	0.0	1.5	4.0	3.3	2.6	0.6	4.9	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"pancreatic cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2;choroid plexus: 14.4"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 40.6;Melanocytes: 126.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003648	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.6	1.1	10.6	0.1	13.0	0.0	1.7	11.8	11.5	2.0	14.4	1.4	0.5	3.2	5.3	2.4	2.8	0.9	0.1	10.8	13.1	4.6	1.7	1.0	0.5	12.6	14.2	3.3	1.2	2.9	2.7	6.1	12.3	2.6	1.4	0.9	3.3	4.4	0.0	8.9	0.5	1.0	11.4	0.0	0.7	0.8	13.1	1.8	3.2	0.0	1.6	1.1	1.1	12.2	1.9	0.4	4.6	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	1.1	0.1	0.1	0.3	0.0	0.2	0.6	2.3	0.0	3.4	0.1	1.6	0.0	0.0	24.2	6.7	0.0	0.0	0.0	0.0	12.1	0.0	0.1	11.1	0.0	0.1	0.0	0.1	0.1	22.2	3.2	0.9	0.0	0.3	0.0	159.6	10.8	1.9	0.0	4.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	3.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	10.6	13.0	11.8	11.5	10.8	13.1	12.6	14.2	12.3	11.4	13.1	12.2	0.1	0.0	0.0	9.8	0.2	5.5	1.3	1.8	2.2	0.5	2.1	1.7	0.9	0.0	4.9	7.3	0.0	40.6	0.0	0.8	1.9	4.9	0.2	1.7	1.6	1.5	0.0	0.0	0.6	0.6	2.1	1.0	0.0	1.3	0.0	1.8	2.9	0.3	4.8	0.0	0.3	0.8	2.0	0.0	1.6	1.8	1.8	0.1	126.3	1.0	0.0	1.2	0.0	0.5	0.6	1.2	0.2	6.4	0.0	1.8	0.2	5.0	3.2	0.2	0.0	0.0	0.7	0.2	1.3	4.2	0.6	10.1	0.7	1.0	2.0	1.8
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046655, HPA060527"	Uncertain		Supported	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA046655: , HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154334943-154430190	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 6.9"	"Cell type enriched"	"Detected in some"	22	"Inhibitory neurons: 48.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in many"			HPA018020	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018020: AB_1849334"																		0.0	0.0	0.5	0.0	6.9	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	0.0	0.9	0.0	4.4	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	1.2	2.6	0.1	3.0	1.9	2.9	4.4	0.6	6.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531978-98534681	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 31.3"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 31.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 5.1;T-reg: 12.1"	"Group enriched"	"Detected in many"	26	"B-cells: 3.6;T-cells: 12.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 4.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013775	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.6	0.0	0.0	4.5	0.2	0.2	3.8	0.1	0.2	0.5	0.0	20.0	2.7	0.2	0.0	2.5	0.1	2.3	0.1	0.0	0.1	0.2	0.3	1.9	2.4	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.4	31.3	0.0	4.9	0.2	0.0	0.3	10.2	0.8	0.1	5.3	1.6	0.0	0.1	1.9	0.4	0.0	5.3	7.2	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	3.6	10.8	5.1	0.0	0.6	0.5	0.8	0.3	0.0	0.0	0.2	12.1	2.1	0.0	0.2	0.1	0.2	0.0	0.1	0.5	0.3	0.4	0.1	0.1	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
GPR150	PGR11	ENSG00000178015	"G protein-coupled receptor 150"	Q8NGU9	5	95620087-95622142	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;pancreas: 6.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Extravillous trophoblasts: 5.3;granulocytes: 5.7;Hofbauer cells: 3.5;NK-cells: 2.1;Spermatocytes: 2.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;SiHa: 1.2;TIME: 2.7"					"Low region specificity"	"Detected in some"			HPA026635	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026635: AB_1849266"	"unprognostic (3.03e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.95e-2)"	"unprognostic (5.34e-4)"	"unprognostic (1.98e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	0.9	0.1	1.9	0.0	2.7	0.0	0.7	0.0	2.6	0.3	0.0	0.3	0.1	0.2	0.1	0.1	0.3	0.1	0.1	2.5	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.0	6.9	1.2	0.6	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.6	0.3	0.0	0.0	0.4	1.6	0.2	2.2	0.1	0.1	0.0	0.1	0.3	0.2	1.8	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.8	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.2	0.0	0.3	0.0	0.0	0.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	2.7	0.0	2.6	2.5	0.8	0.0	0.0	0.0	0.0	2.2	1.8	0.5	0.0	0.6	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.2	0.0	0.4	0.0	0.2	5.3	0.9	0.0	0.0	5.7	0.0	0.4	0.5	3.5	0.0	0.0	0.3	0.0	0.3	0.3	1.1	0.0	0.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.2	0.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.5	0.5	0.1	0.3	0.0	1.4	0.0	0.8	0.1
GPR152	PGR5	ENSG00000175514	"G protein-coupled receptor 152"	Q8TDT2	11	67451301-67452729	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035078	Uncertain					NA	NA									"HPA035078: AB_10670286"								"unprognostic (3.81e-2)"		"unprognostic (1.69e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.76e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR153	PGR1	ENSG00000158292	"G protein-coupled receptor 153"	Q6NV75	1	6247353-6261098	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatocytes: 33.2;Horizontal cells: 63.9;Intestinal goblet cells: 52.5;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.1;PC-3: 68.6;RH-30: 32.2;SCLC-21H: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA007159	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA007159: AB_1849268"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (5.74e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	13.2	2.0	17.8	2.9	8.4	0.3	10.4	0.7	11.3	12.2	0.2	9.9	4.0	9.3	11.3	7.8	8.7	3.8	9.4	7.9	9.7	2.9	7.1	10.5	1.8	4.7	11.8	8.9	1.5	5.5	12.0	6.9	2.9	6.4	5.2	3.2	3.1	3.3	1.8	9.2	21.9	4.8	3.6	6.9	3.5	2.2	28.3	1.4	1.9	1.4	1.4	6.9	7.9	3.2	6.1	1.0	14.4	17.4	26.1	10.3	1.2	4.0	3.6	1.5	1.7	2.5	2.4	0.0	6.0	4.2	3.3	7.8	0.8	17.2	0.6	4.0	3.5	0.1	2.4	0.5	5.1	0.6	2.3	6.3	4.5	1.1	0.9	2.7	1.2	5.3	0.9	0.0	5.0	6.7	2.0	4.7	1.1	3.5	68.6	7.5	32.2	0.4	0.6	3.4	32.7	11.8	2.7	10.0	8.4	3.9	3.9	3.2	3.5	3.5	3.3	0.5	1.8	0.3	0.3	1.4	1.6	8.0	1.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	17.8	8.4	0.7	11.3	7.9	9.7	4.7	11.8	2.9	3.6	28.3	3.2	0.7	0.0	0.0	0.3	0.1	3.4	1.8	8.9	1.2	6.2	1.3	2.2	6.2	4.3	5.5	0.0	0.0	0.2	5.9	3.3	0.0	0.2	1.2	0.6	8.5	1.6	3.5	2.7	1.7	0.0	0.3	9.9	1.1	0.4	1.3	0.7	0.7	33.2	1.1	63.9	3.0	52.5	6.1	1.0	3.7	2.5	4.7	1.5	5.4	1.0	2.2	2.7	3.1	6.6	0.1	0.6	9.2	7.5	1.3	1.6	9.6	2.0	1.7	1.6	0.0	9.6	4.7	0.1	1.7	1.1	7.4	0.4	1.2	1.3	2.0	17.2
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 83.4;stomach 1: 52.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.3	9.7	8.7	5.9	16.3	2.3	2.4	6.5	12.1	2.4	83.4	10.2	3.8	1.9	12.3	5.9	1.6	5.7	7.0	12.2	5.3	20.1	7.3	3.0	6.3	5.5	5.3	2.5	18.2	8.9	2.3	4.4	5.2	7.5	3.7	10.0	3.6	8.4	4.7	13.2	4.0	6.1	3.5	5.4	52.6	2.2	7.1	3.0	8.3	4.4	3.6	4.1	2.7	6.1	0.7	0.3	0.8	2.0	4.9	2.7	0.5	3.8	1.3	0.6	2.1	0.3	0.2	2.2	1.2	2.8	1.3	0.2	1.3	1.1	2.1	0.8	1.5	2.3	1.1	0.2	0.9	0.7	1.1	3.9	3.1	1.9	0.6	4.0	1.0	3.0	0.3	5.5	4.2	0.6	1.6	0.8	0.4	2.3	1.5	1.9	5.6	1.0	2.0	1.3	5.9	5.0	1.2	0.8	2.0	2.5	0.3	0.3	2.6	2.7	1.0	3.9	0.5	14.6	2.2	0.3	3.0	0.6	9.9	1.3	2.2	0.1	1.8	4.0	1.6	1.1	3.1	2.9	0.6	1.0	2.5	3.9	7.3	3.6	5.7	0.3	5.5	1.4	8.7	16.3	6.5	12.1	12.2	5.3	5.5	5.3	5.2	3.5	7.1	6.1	18.5	12.8	3.6	31.3	9.8	42.7	4.0	4.0	29.0	34.9	5.8	6.1	26.0	2.8	6.8	11.0	125.1	1.5	12.2	0.6	1.9	1.9	0.7	1.4	24.1	9.8	12.7	15.2	99.4	6.0	1.2	9.7	9.7	0.6	1.3	4.0	16.1	16.1	6.1	50.5	131.1	0.8	2.0	50.4	23.0	1.8	14.9	27.0	152.9	8.4	34.3	16.7	11.3	130.2	21.2	3.5	0.1	32.0	14.3	3.1	0.4	41.7	0.5	25.8	0.0	16.9	9.5	3.3	3.2	7.5	28.6	0.8	25.7	52.4	1.0	1.8
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285222	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 8.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.3;PC-3: 1.3;SiHa: 3.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.4	0.0	0.2	1.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.7	0.4	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.7	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.5	0.0	0.2	0.0	0.3	1.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	3.5	0.0	0.4	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.2	0.1	0.3	0.3	0.1	0.3	0.1	0.3	0.0	0.0	0.0	15.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.3	0.2	0.0	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	1.0	0.0	1.3	0.0	13.0	2.9	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.1	0.6	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129102	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 268.1;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8;SK-BR-3: 62.7;U-266/70: 30.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.3	4.8	0.7	4.4	0.8	1.3	3.3	1.1	1.2	7.9	10.7	3.1	4.0	2.9	1.3	30.2	2.9	2.0	12.9	1.4	0.6	2.3	9.0	6.7	3.1	1.7	0.9	4.3	4.1	15.1	1.4	8.7	1.2	3.5	2.2	0.9	8.9	2.3	59.6	22.6	2.8	1.7	0.7	3.9	3.7	2.0	1.1	2.5	3.3	23.9	7.5	6.7	13.7	1.0	9.0	5.0	1.5	4.1	1.4	1.3	8.0	2.8	1.8	2.3	3.1	4.1	3.4	1.1	3.4	3.0	2.9	18.9	4.6	1.8	3.4	25.2	7.6	0.1	16.0	6.2	4.9	0.1	2.0	1.2	3.9	3.9	2.4	2.3	1.8	3.7	1.4	31.8	0.9	6.5	3.8	1.9	1.7	4.4	6.3	0.6	1.3	4.3	1.4	6.0	2.3	6.1	10.8	62.7	5.2	3.0	8.9	1.1	13.3	7.8	2.0	20.5	1.3	30.6	5.2	0.1	5.8	12.6	3.3	0.7	0.4	0.1	0.6	0.3	0.5	0.4	0.4	0.6	0.2	0.6	0.4	0.5	1.2	0.2	0.1	0.2	0.2	0.2	0.7	0.8	1.1	1.2	1.4	0.6	1.7	0.9	1.2	0.7	1.1	1.0	3.1	6.4	8.9	0.0	5.3	13.6	10.2	17.8	12.5	0.7	14.7	8.4	13.4	2.8	12.3	5.5	2.1	34.8	2.9	6.8	0.0	3.5	0.1	13.7	6.9	4.0	0.0	0.0	1.4	3.9	10.0	4.8	5.1	26.5	0.0	3.2	2.5	14.8	4.0	1.7	1.2	4.8	10.2	0.8	268.1	0.2	1.8	13.1	7.2	0.0	107.4	1.0	0.0	0.0	0.2	13.9	4.3	5.3	4.7	6.8	7.5	1.6	7.4	1.4	0.0	5.5	4.2	0.6	2.3	43.6	24.3	48.2	3.5	5.0	5.5	16.1
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25174802-25602229	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 21.3;T-47d: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.0	0.7	2.6	0.1	12.7	0.0	0.0	24.9	8.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	2.4	0.0	0.0	0.0	0.0	8.5	4.7	0.0	0.0	0.2	1.4	0.3	8.8	0.1	0.1	4.5	0.0	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.5	7.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	0.0	5.6	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	12.7	24.9	8.6	3.5	2.4	8.5	4.7	8.8	2.3	7.0	4.3	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	19.9	0.0	0.1	0.1	0.0	0.0	367.4	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.7	301.9	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	10.3	0.0	26.2	0.0	419.7	101.6	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.8	0.0	0.1	0.1	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821624-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 180.3;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 86.3;Excitatory neurons: 36.8;Horizontal cells: 40.4;Inhibitory neurons: 32.9;Muller glia cells: 55.9;Respiratory ciliated cells: 56.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.9;intermediate monocyte: 4.3;neutrophil: 17.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 17.4;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;AN3-CA: 21.1;hTERT-RPE1: 18.1;NTERA-2: 19.8;SH-SY5Y: 13.5;U-2 OS: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA055135: AB_2682710"	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	5.1	6.8	116.5	4.4	122.2	1.3	2.7	111.7	180.3	5.8	108.2	15.2	3.1	7.6	2.5	2.3	18.3	5.9	10.9	138.2	106.4	5.6	6.2	17.6	1.5	100.8	100.5	5.8	2.5	10.6	31.7	4.4	101.0	5.8	2.7	20.6	1.4	1.7	1.5	1.4	8.0	5.9	93.3	6.6	5.0	1.5	106.2	1.4	2.8	1.1	0.7	7.2	2.8	117.4	0.0	3.9	17.7	21.1	1.9	1.3	0.1	1.3	4.6	3.9	2.3	0.4	0.0	0.0	0.1	2.6	0.1	0.1	2.8	0.0	1.9	0.0	1.3	2.1	0.2	0.0	3.0	0.4	0.0	3.2	0.0	6.0	0.3	18.1	10.9	1.6	1.0	0.1	1.5	0.0	0.5	1.5	19.8	0.0	0.1	0.0	2.2	3.9	1.3	0.0	1.5	13.5	0.0	0.0	0.6	12.0	0.1	5.3	7.4	2.7	16.1	1.4	2.5	0.0	1.3	0.1	2.9	3.8	0.3	0.0	6.9	0.0	0.0	4.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	17.4	0.0	1.5	1.7	0.0	1.9	116.5	122.2	111.7	180.3	138.2	106.4	100.8	100.5	101.0	93.3	106.2	117.4	0.5	0.0	0.0	11.8	0.3	0.8	0.2	2.3	0.0	86.3	3.6	1.3	3.8	1.5	2.6	1.8	4.2	0.1	0.0	0.0	1.9	0.0	0.1	9.3	5.6	3.5	0.0	0.4	36.8	0.0	0.1	2.9	0.0	0.3	0.0	0.6	6.1	1.5	2.6	40.4	32.9	0.0	2.0	3.7	3.4	0.6	7.5	5.2	0.0	6.5	4.2	55.9	0.0	23.1	3.7	0.1	0.0	14.7	0.1	0.5	0.0	1.9	56.2	9.0	0.0	0.5	8.1	0.0	0.2	0.2	0.1	0.3	0.2	1.3	0.1	0.1
GPR17		ENSG00000144230	"G protein-coupled receptor 17"	Q13304	2	127645864-127652639	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.8;intestine: 23.8"	"Cell type enriched"	"Detected in some"	58	"Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in some"	32	"glioma: 16.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;REH: 4.4;TIME: 4.3;U-2 OS: 1.7;U-2197: 2.0;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029766	Enhanced	Supported	Approved	Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA029766: AB_10612114"	"unprognostic (8.10e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.77e-5)"	"unprognostic (8.40e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	9.8	1.1	9.1	3.4	6.3	0.1	7.9	4.7	9.7	3.6	3.5	23.8	1.5	14.8	1.4	2.4	5.3	2.1	19.8	6.4	5.5	3.0	2.6	9.3	1.1	7.2	7.5	1.8	2.2	0.0	0.7	1.2	7.2	5.5	0.1	0.1	2.0	0.0	7.5	3.4	6.0	0.0	6.4	7.5	5.8	0.9	7.7	0.1	3.8	0.2	0.0	8.8	5.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	1.2	0.1	0.0	4.3	0.0	1.7	2.0	2.6	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	6.3	4.7	9.7	6.4	5.5	7.2	7.5	7.2	6.4	7.7	8.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	58.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203216	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 110.3"	"Lineage enriched"	"Detected in many"	15	"T-cells: 110.3"	"Cell line enriched"	"Detected in some"	25	"U-266/70: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067323	Supported					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA067323: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	3.7	1.6	0.5	21.3	1.5	1.2	1.9	1.7	3.8	4.3	12.3	4.3	4.5	1.5	0.5	2.5	3.0	6.2	0.9	1.1	0.4	1.3	4.3	6.4	17.4	2.5	0.7	0.8	0.7	0.2	0.5	0.5	0.7	1.9	4.6	0.0	1.7	0.8	0.2	0.9	12.9	1.1	0.1	13.0	5.9	0.3	1.1	13.0	1.8	0.1	11.3	9.3	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.2	0.0	0.2	0.3	3.5	27.9	0.2	110.3	0.0	40.2	53.5	2.3	0.5	24.1	21.1	0.8	7.3	0.5	2.2	21.4	9.4	0.5	1.5	1.7	3.8	1.1	0.4	2.5	0.7	0.7	0.1	1.1	1.2	0.4	0.0	2.2	0.3	2.3	1.1	0.4	0.0	0.6	4.8	0.3	0.3	1.0	0.0	1.3	0.0	2.1	0.4	25.8	0.1	0.0	0.0	0.2	0.1	0.6	0.5	0.0	2.7	0.8	0.0	0.0	2.3	4.6	0.1	2.5	0.0	1.8	1.6	0.1	21.9	0.3	0.5	0.0	2.2	8.1	0.1	0.0	4.8	0.0	0.0	14.0	5.7	6.2	0.5	0.0	0.0	0.0	0.0	14.9	0.2	0.0	0.5	0.0	0.1	0.0	0.5	1.2	0.8	0.7	0.1	0.6	0.7	107.6	0.1	0.0	0.3
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GPR176	Gm1012	ENSG00000166073	"G protein-coupled receptor 176"	Q14439	15	39799008-39920266	"G-protein coupled receptors, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 32.0;Inhibitory neurons: 56.8;Oligodendrocyte precursor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 276.1;fHDF/TERT166: 186.5;U-138 MG: 119.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039943, HPA039979"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039943: AB_10697711, HPA039979: AB_2676782"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-3)"	"unprognostic (9.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (9.38e-7)"	"prognostic unfavorable (6.84e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.26e-2)"	13.2	6.1	10.0	4.1	10.6	0.3	6.6	11.2	10.5	6.8	1.1	3.9	2.0	5.6	2.0	1.7	4.4	7.0	4.2	10.1	10.4	3.9	1.9	7.5	6.3	9.7	8.8	1.8	1.6	1.9	5.0	2.4	12.3	7.1	2.3	6.3	2.9	3.6	1.7	3.5	3.4	4.6	6.0	4.1	2.2	7.2	8.8	2.1	5.0	1.1	5.8	6.4	5.3	5.9	52.3	2.6	3.2	0.6	36.9	64.6	0.0	108.3	276.1	64.3	99.5	3.7	8.3	0.7	8.7	186.5	37.1	1.6	7.7	8.4	100.7	1.7	11.2	7.7	7.7	0.1	41.1	0.0	0.4	50.7	1.0	56.7	47.6	65.7	24.6	2.4	1.0	1.1	91.8	2.1	0.1	0.0	3.2	0.4	9.3	2.7	32.3	0.3	1.6	0.6	12.0	47.8	27.9	0.0	4.4	0.7	9.0	0.5	31.8	119.5	33.9	7.2	40.7	1.1	3.6	0.1	24.9	0.0	47.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	10.6	11.2	10.5	10.1	10.4	9.7	8.8	12.3	6.0	8.8	5.9	3.0	0.0	0.0	8.5	0.9	1.8	0.2	0.8	0.0	1.1	0.4	0.6	0.9	1.5	0.1	0.0	0.0	0.0	0.3	0.1	0.0	9.3	22.3	0.1	3.1	1.8	0.0	0.0	32.0	3.9	0.0	3.4	0.0	0.2	0.0	0.1	0.7	0.1	0.1	1.7	56.8	0.0	0.0	0.0	1.8	13.5	1.2	0.7	1.8	3.7	0.0	14.9	0.0	40.7	1.4	12.0	0.0	1.2	3.1	3.0	0.0	1.2	0.0	1.1	13.1	3.8	15.2	2.9	3.8	0.5	1.0	0.0	0.4	0.8	0.0	0.1
GPR179	"CSNB1E, GPR158L1"	ENSG00000277399	"G protein-coupled receptor 179"		17	38324571-38343956	"Human disease related genes, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	8	"retina: 13.9"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA017885	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"			"HPA017885: AB_2279357"	"unprognostic (1.65e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-4)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.57e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.09e-10)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.41e-4)"	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	1.7	0.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	13.9	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.4	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.2	0.8	1.1	1.7	0.3	1.1	0.5	1.4	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR18		ENSG00000125245	"G protein-coupled receptor 18"	Q14330	13	99254732-99261744	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.7;lymphoid tissue: 38.9;testis: 13.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 172.6;Late spermatids: 190.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 65.3;NK-cells: 52.9;T-cells: 41.9"	"Group enriched"	"Detected in some"	4	"Daudi: 8.1;THP-1: 20.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013873	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA013873: AB_1849285"	"unprognostic (3.87e-6)"	"unprognostic (1.31e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.31e-6)"	"unprognostic (2.89e-1)"	"unprognostic (7.55e-4)"	"unprognostic (4.27e-5)"	"unprognostic (3.45e-3)"	"unprognostic (2.31e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.20e-6)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.92e-3)"	0.4	0.1	0.2	12.2	0.3	9.7	0.2	0.7	0.4	0.3	0.9	0.9	1.0	0.4	0.2	0.5	0.2	1.2	0.3	0.2	0.1	0.3	0.9	0.7	38.9	0.7	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.4	1.0	0.0	0.9	0.1	0.1	0.3	4.1	0.2	0.1	10.5	1.5	13.0	0.3	7.9	0.4	0.1	32.5	2.1	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.9	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	3.5	0.0	0.2	1.9	0.5	24.4	5.5	41.3	65.3	22.1	34.0	12.6	53.3	41.9	38.9	2.2	52.9	5.3	12.5	6.4	13.1	0.2	0.3	0.7	0.4	0.2	0.1	0.7	0.2	0.4	0.1	0.3	0.4	0.2	0.0	1.3	0.3	44.7	0.3	0.0	0.0	0.0	1.0	0.1	0.3	1.0	0.0	0.6	0.0	0.0	0.0	14.4	0.1	0.0	0.0	172.6	1.3	0.2	0.2	1.2	6.1	0.4	0.0	0.0	0.2	1.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	1.2	190.5	0.9	3.9	0.0	0.0	0.6	0.0	18.6	0.5	0.1	0.0	0.1	1.2	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.2	1.8	0.4	0.0	0.3	0.0	20.5	0.1	0.1	0.1
GPR180	ITR	ENSG00000152749	"G protein-coupled receptor 180"	Q86V85	13	94601857-94634661	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047250	Approved		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA047250: AB_2679998"	"unprognostic (3.91e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.16e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.80e-2)"	5.8	2.3	3.0	2.4	3.6	0.9	2.6	4.5	4.5	2.7	4.1	2.1	2.0	2.4	1.8	1.7	2.5	1.8	1.8	3.4	3.2	2.5	6.9	2.4	2.4	2.8	3.0	2.4	3.1	2.5	3.5	3.6	3.1	2.5	2.5	7.0	2.8	2.3	1.8	1.9	1.6	2.8	3.6	2.2	2.7	1.1	3.2	2.6	3.6	1.8	2.6	2.3	1.5	3.6	14.6	3.6	5.1	5.4	10.5	11.4	2.1	9.7	7.7	9.3	12.3	4.4	9.8	4.8	4.1	8.4	6.4	9.0	7.3	6.9	12.7	12.7	4.6	9.4	4.9	0.0	8.3	13.6	7.3	6.5	5.8	5.7	7.7	8.3	9.6	6.8	2.7	2.3	9.3	2.1	6.9	3.0	3.3	10.4	4.0	7.8	6.8	2.0	10.4	4.3	7.4	5.3	4.5	9.9	12.2	6.4	7.0	5.5	8.7	5.7	4.6	6.8	8.2	3.8	4.2	2.2	9.5	10.9	7.9	0.1	0.5	0.1	0.8	0.3	1.4	0.5	0.9	0.6	0.9	0.5	1.1	0.9	0.0	0.5	0.4	0.6	1.2	0.4	3.0	3.6	4.5	4.5	3.4	3.2	2.8	3.0	3.1	3.6	3.2	3.6	9.0	3.2	4.1	20.2	6.1	6.0	5.4	11.2	7.4	12.5	7.4	5.5	6.8	7.2	7.8	12.9	31.3	8.7	9.3	3.8	5.9	8.3	1.0	11.1	8.9	8.3	10.3	3.6	47.6	10.2	27.8	11.8	9.7	9.0	5.1	9.2	9.7	30.8	10.5	18.5	30.5	9.8	6.1	4.4	4.9	0.7	9.6	5.3	7.2	18.7	4.1	15.4	9.2	40.7	26.3	9.6	3.7	5.7	16.0	10.6	3.0	7.5	16.8	22.0	6.6	6.3	10.6	3.5	10.6	6.4	4.7	4.1	6.6	3.6	5.5	5.0
GPR182	"ADMR, AM-R, G10D, hrhAMR"	ENSG00000166856	"G protein-coupled receptor 182"	O15218	12	56994492-56998447	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 17.0;testis: 6.1"	"Group enriched"	"Detected in some"	38	"Early spermatids: 74.4;Hepatic stellate cells: 75.7;Late spermatids: 184.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027037	Enhanced					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"			"HPA027037: AB_1844622"	"unprognostic (6.13e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.10e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.94e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.34e-3)"	0.4	3.1	0.2	0.5	0.1	0.0	0.5	0.3	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.2	0.0	1.5	3.9	0.8	1.5	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	17.0	0.2	6.1	0.0	0.0	1.2	0.1	0.1	0.3	0.3	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.4	0.0	0.0	2.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	184.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294539-99307399	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.7;lymphoid tissue: 84.5"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 2572.5;Macrophages: 809.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1050.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"HDLM-2: 157.7;HL-60: 108.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033690, HPA075590"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB033690: AB_2114269, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	26.2	12.8	1.9	84.5	2.1	112.7	11.2	2.2	3.5	12.6	7.1	14.8	8.0	6.6	2.4	15.2	6.5	40.5	13.1	1.8	5.5	3.8	17.1	20.1	67.7	8.1	3.0	3.5	4.6	3.8	5.1	27.8	5.2	9.4	21.3	2.0	5.2	3.9	2.0	5.9	23.6	21.9	3.9	35.1	15.7	1.5	3.5	31.8	15.2	4.1	75.6	52.3	5.3	7.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.8	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.4	157.7	0.0	1.4	0.4	0.0	0.0	108.6	0.3	0.0	0.0	1.5	0.0	0.0	0.0	5.7	2.6	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.8	0.3	0.7	0.0	1050.9	10.4	391.6	43.7	3.8	264.5	364.1	463.0	240.9	77.9	172.1	286.1	39.8	9.9	487.0	3.9	255.2	401.6	255.9	1.9	2.1	2.2	3.5	1.8	5.5	8.1	3.0	5.2	3.9	3.5	7.3	6.0	16.0	26.3	0.0	413.9	61.6	0.8	0.5	2.2	0.3	2.5	3.9	4.6	1.5	6.3	0.0	6.2	1.0	168.8	0.5	1.9	0.2	0.7	0.6	1.3	17.1	0.0	4.4	0.2	2.9	1.5	12.8	11.2	0.9	60.9	0.1	0.7	1.2	113.4	0.0	0.2	0.0	18.3	119.1	2572.5	2.8	0.3	809.4	145.9	46.9	248.7	0.1	1.0	0.5	0.3	1.0	0.0	0.0	85.5	0.4	0.0	0.8	3.8	0.9	6.6	2.1	9.1	0.4	0.2	1.3	53.4	1.8	245.2	0.0	0.3	0.6
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660890-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.8;Excitatory neurons: 15.2;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.9;NTERA-2: 39.7;SuSa: 28.5;WM-115: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	0.3	0.8	7.2	2.0	7.3	0.9	0.3	9.1	10.3	0.1	3.6	0.5	0.3	0.1	0.1	0.5	0.2	0.3	0.1	7.0	9.1	0.1	0.2	0.2	1.8	6.3	6.8	0.0	0.3	0.1	7.8	0.3	6.9	0.1	0.6	2.0	0.1	0.1	0.0	0.8	0.5	0.3	7.0	0.7	0.4	4.3	7.6	2.8	0.1	0.0	2.4	0.3	0.1	6.9	1.6	0.6	16.6	0.4	0.0	0.0	7.0	1.6	1.7	2.9	2.5	6.6	10.1	6.8	2.5	1.2	2.3	1.3	2.7	0.3	4.8	39.9	0.3	1.6	0.7	1.1	0.0	1.7	0.6	0.1	0.0	3.1	1.9	1.2	0.5	0.7	0.3	13.8	0.6	2.4	0.6	1.0	39.7	1.7	3.0	4.4	2.5	0.2	0.2	1.4	5.4	5.0	0.7	1.4	13.4	28.5	0.9	1.7	0.0	0.8	7.2	1.3	3.9	7.6	7.2	13.3	3.1	4.7	20.4	0.0	0.0	0.0	1.2	0.0	0.8	0.2	2.4	1.4	0.0	0.1	0.4	0.9	2.9	0.3	0.0	0.0	6.5	0.3	7.2	7.3	9.1	10.3	7.0	9.1	6.3	6.8	6.9	7.0	7.6	6.9	0.2	0.0	0.0	7.8	0.4	0.1	0.1	0.0	0.0	1.8	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.7	0.1	0.2	0.1	0.0	2.7	15.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	15.6	0.1	0.0	0.3	0.3	1.6	0.3	0.2	0.0	2.8	0.0	1.7	0.0	15.6	5.9	0.2	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	3.6	0.6	0.0	0.0	0.1	1.2	0.0	0.3	0.1
GPR21		ENSG00000188394	"G protein-coupled receptor 21"	Q99679	9	123033667-123035665	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA041651	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA041651: AB_10794673"													"unprognostic (9.22e-3)"			"unprognostic (1.46e-1)"		0.9	0.0	0.2	0.5	1.0	0.1	0.3	0.0	2.1	0.6	0.0	0.2	0.1	0.9	0.2	0.5	0.4	0.5	0.3	0.8	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.5	0.4	0.1	0.2	0.1	0.2	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123697399	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"brain: 7.7"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 11.4"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 62.7"	HPA062736	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA062736: AB_2684855"	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.2	0.0	1.5	0.0	0.0	0.0	3.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	2.0	0.0	0.0	0.0	0.0	2.6	7.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	3.5	6.4	2.0	2.6	7.7	1.6	1.7	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71753855-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.8;neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.4	4.0	21.3	1.5	22.9	15.7	3.9	13.0	19.7	3.5	7.4	1.6	0.3	5.0	2.8	3.7	6.8	1.0	3.4	19.9	20.6	3.2	0.1	1.4	0.2	18.0	18.3	4.4	3.1	17.3	9.2	1.2	16.2	5.1	0.5	1.8	1.4	4.3	0.7	2.1	0.7	2.9	19.7	3.3	2.0	4.7	22.9	0.5	6.2	1.9	0.2	2.0	2.3	18.9	0.0	1.1	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	17.9	0.0	0.8	0.1	4.3	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	17.5	0.9	0.0	2.9	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	14.6	1.2	0.2	28.9	0.0	0.0	0.0	0.0	0.0	13.6	7.8	3.0	10.9	3.8	0.0	0.0	3.6	9.9	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	7.2	0.0	0.1	0.0	0.0	0.1	21.3	22.9	13.0	19.7	19.9	20.6	18.0	18.3	16.2	19.7	22.9	18.9	0.2	0.0	1.1	0.0	0.1	1.9	4.2	0.0	4.0	10.3	6.5	7.5	3.5	2.8	1.3	12.9	4.2	1.4	0.4	0.2	1.9	0.7	0.2	2.1	4.9	0.4	1.2	1.7	0.0	0.0	1.3	1.2	1.1	8.1	0.0	2.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.9	3.2	0.0	0.0	8.6	0.5	1.0	0.0	0.0	0.3	0.1	1.2	0.0	5.6	0.0	0.1	1.5	0.4	0.0	2.3	1.7	0.2	4.8	4.7	1.7	0.3	0.7	0.5	0.3	2.0
GPR3	ACCA	ENSG00000181773	"G protein-coupled receptor 3"	P46089	1	27392622-27395814	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;heart muscle: 5.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Basal squamous epithelial cells: 2.8;Cardiomyocytes: 2.8;Enteroendocrine cells: 4.8;Horizontal cells: 5.0;Inhibitory neurons: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB006254	Uncertain					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"			"CAB006254: AB_425462"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.30e-3)"	"unprognostic (6.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-2)"	1.9	0.6	1.5	0.7	1.7	1.0	1.3	4.2	7.8	0.6	0.4	0.7	0.2	0.5	0.0	0.5	0.8	0.7	5.4	2.2	3.1	1.5	0.4	2.2	0.2	4.0	3.1	0.4	0.6	0.5	4.4	0.4	3.9	0.9	0.2	1.5	0.5	0.1	0.5	0.6	0.5	0.6	2.5	0.2	0.8	0.2	2.2	0.2	1.8	1.5	0.1	0.8	0.4	2.5	1.9	1.0	5.3	5.9	0.2	0.6	0.7	3.4	4.0	5.2	3.8	1.6	1.1	0.3	0.8	1.6	5.3	1.3	1.4	4.2	4.0	0.1	0.2	1.5	0.3	3.4	0.6	3.4	4.5	0.7	0.0	7.3	1.6	0.5	1.6	2.3	4.3	5.8	6.4	2.7	0.7	4.8	7.8	2.7	8.4	9.2	4.2	2.5	2.2	0.4	1.0	2.5	1.7	0.7	6.6	2.2	0.1	0.7	1.0	3.9	7.1	23.0	4.2	0.7	4.3	0.5	5.9	1.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	4.2	7.8	2.2	3.1	4.0	3.1	3.9	2.5	2.2	2.5	5.5	0.0	0.0	0.7	0.1	0.1	2.3	1.0	2.8	1.6	0.7	0.5	2.8	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.6	0.3	1.4	4.8	0.0	2.6	0.0	0.3	1.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	5.0	4.6	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	1.7	1.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.5	0.4
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167155247-167157980	"G-protein coupled receptors, Predicted membrane proteins"	"Lipid metabolism"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.5;retina: 39.0"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.3	0.1	65.3	0.0	0.5	53.8	43.4	0.3	5.2	0.6	0.0	1.6	0.2	3.7	0.6	0.2	0.1	31.2	40.4	0.3	10.0	0.2	0.1	62.8	56.3	0.0	1.5	0.1	0.2	5.1	62.5	0.5	0.3	39.0	0.9	0.5	0.6	2.3	0.6	1.2	45.2	2.1	1.3	10.6	47.8	0.0	0.0	0.1	0.0	1.4	0.6	109.5	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	65.3	53.8	43.4	31.2	40.4	62.8	56.3	62.5	45.2	47.8	109.5	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122917-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 76.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.7;Muller glia cells: 59.6;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 20.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.2;MCF7: 1.5;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061629, HPA064454"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cell Junctions"	"Vesicles, Plasma membrane"	"HPA061629: , HPA064454: AB_2685268"	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	0.1	0.2	55.2	0.0	71.1	0.2	0.0	60.7	52.2	0.2	10.6	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	48.0	50.7	0.0	0.2	0.0	0.0	66.7	67.0	0.0	0.0	0.0	0.6	0.0	53.7	0.2	0.2	2.8	0.1	0.3	0.1	0.1	0.3	0.1	59.4	0.0	0.2	0.3	76.4	0.0	0.1	0.1	0.0	0.0	0.1	53.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	55.2	71.1	60.7	52.2	48.0	50.7	66.7	67.0	53.7	59.4	76.4	53.1	0.0	0.0	0.0	91.7	0.1	0.4	0.5	0.7	0.0	1.2	0.3	0.3	1.1	1.5	1.7	0.0	4.2	0.1	0.0	4.9	0.0	3.2	4.5	0.9	0.2	0.1	0.0	0.0	0.4	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.8	0.9	0.1	0.0	2.8	0.0	59.6	0.0	89.0	20.4	2.1	2.7	1.9	0.0	0.8	1.3	0.1	1.1	4.9	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.7	0.1	0.2	0.7	1.0
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416805-132646582	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 12.1;Early spermatids: 20.6;Late spermatids: 19.4;Oligodendrocyte precursor cells: 18.6;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CAPAN-2: 26.9;hTEC/SVTERT24-B: 30.8;RT4: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA022111	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.2	0.0	0.7	0.9	0.7	0.0	2.1	0.5	0.7	4.4	1.3	6.8	4.6	0.4	0.8	0.8	3.6	2.2	0.0	0.4	0.7	2.6	3.3	3.9	0.0	1.6	2.2	0.0	3.9	5.1	0.1	0.1	2.0	0.5	5.7	0.0	0.5	1.0	0.0	1.0	3.7	0.3	1.2	0.0	6.1	0.2	0.7	0.0	1.3	0.0	0.2	2.6	0.6	0.2	32.0	18.1	0.3	0.0	0.5	3.6	0.0	2.8	11.1	5.8	3.3	17.7	26.9	0.0	9.7	1.9	13.1	18.6	0.0	12.9	5.7	0.1	0.0	0.0	1.9	0.7	0.6	0.0	0.0	1.1	9.7	30.8	3.1	7.0	0.1	0.0	0.0	0.0	4.2	3.0	0.0	0.0	0.3	7.3	10.5	0.0	0.5	0.0	21.2	27.9	0.0	0.1	2.0	10.3	0.1	1.1	5.8	0.0	5.6	12.4	12.2	4.2	16.8	0.0	0.0	0.1	18.9	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.5	0.7	0.4	0.7	1.6	2.2	2.0	1.2	0.7	0.2	0.0	16.0	8.7	12.1	0.0	0.1	0.7	2.4	0.0	0.2	1.5	0.9	0.2	2.8	6.7	0.0	0.0	0.0	2.7	10.3	0.0	5.6	20.6	2.6	0.2	0.1	2.4	0.0	3.9	3.1	0.0	0.2	4.1	1.8	0.0	0.0	0.0	3.6	0.0	0.0	4.9	1.6	0.0	0.6	0.3	19.4	0.3	0.3	0.0	1.0	0.6	1.4	0.0	18.6	1.8	5.9	3.0	0.4	0.1	0.3	1.9	0.7	6.1	0.0	0.0	0.1	0.3	32.4	1.2	0.5	0.0	0.0	0.0	0.0	4.9	1.2
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602212	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.7;Endothelial cells: 26.4;Hepatic stellate cells: 24.7;Sertoli cells: 6.6;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 18.7;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	40.6	6.9	7.0	3.3	6.2	0.5	22.1	6.0	8.8	4.9	6.2	4.2	0.9	7.4	0.7	2.6	6.0	3.3	23.8	5.6	5.9	24.6	3.6	28.6	0.9	8.0	7.5	3.5	3.7	1.4	5.9	4.0	8.6	5.8	0.7	0.9	2.9	0.9	5.7	2.9	5.1	2.5	6.5	4.1	5.6	1.7	10.7	0.5	18.2	2.5	0.6	7.0	4.9	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.1	0.0	0.1	0.0	2.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.0	0.3	0.3	0.0	18.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.3	0.1	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	6.2	6.0	8.8	5.6	5.9	8.0	7.5	8.6	6.5	10.7	6.3	26.7	0.0	0.5	0.7	0.1	2.4	0.2	0.0	1.2	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.3	26.4	0.0	0.0	0.1	0.0	0.0	1.5	2.0	0.2	0.0	0.0	24.7	0.1	0.3	0.0	0.2	0.0	0.0	1.2	1.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	6.6	0.6	16.8	0.0	0.2	0.1	1.3	0.0	0.1	0.3	0.0	0.3
GPR42	"FFAR3L, GPR41L, GPR42P"	ENSG00000126251	"G protein-coupled receptor 42"	O15529	19	35370929-35372962	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.9;Kupffer cells: 1.9;Macrophages: 1.2;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044681	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"			"Cluster 41: Macrophages - Immune response"			"HPA044681: AB_2679043"											"unprognostic (1.73e-3)"			"unprognostic (1.31e-4)"				0.6	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0
GPR45	"PSP24, PSP24A"	ENSG00000135973	"G protein-coupled receptor 45"	Q9Y5Y3	2	105241743-105243467	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Group enriched"	"Detected in some"	51	"Early spermatids: 4.2;Late spermatids: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 1.3;U-2 OS: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055940	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA055940: AB_2682977"	"unprognostic (3.80e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.99e-2)"	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.1	0.1	0.0	0.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.7	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.8	0.6	1.5	0.6	0.9	0.9	0.5	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR61	BALGR	ENSG00000156097	"G protein-coupled receptor 61"	Q9BZJ8	1	109539872-109548406	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.2;pituitary gland: 3.5;retina: 3.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 18.9;Cone photoreceptor cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007326, HPA026088"	Supported					NA	NA				"Cluster 58: Brain - Synaptic function"		"Cluster 56: Bipolar cells - Visual perception"			"HPA007326: AB_1849308, HPA026088: AB_10602323"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.46e-4)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.85e-2)"	0.0	0.7	1.2	0.0	1.7	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.7	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.2	3.2	1.3	0.3	0.1	0.4	0.0	0.0	1.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	18.9	0.2	0.0	0.6	0.0	0.0	0.0	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	1.7	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794125-96837477	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	0.5	0.9	1.4	0.7	3.5	0.1	0.4	0.7	2.7	1.5	2.7	1.2	1.5	0.5	0.3	0.5	0.7	0.7	0.5	1.5	0.1	0.3	0.0	0.3	0.1	1.6	0.6	1.0	1.4	1.0	0.9	0.7	2.0	0.9	1.8	0.2	0.4	0.5	0.2	0.4	1.1	0.6	0.0	0.3	1.1	2.4	0.9	0.6	0.6	0.1	0.2	0.8	1.4	1.8	0.0	0.1	1.6	0.4	2.3	0.8	0.4	1.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.1	1.3	1.2	5.4	2.5	0.0	8.8	4.1	5.2	0.4	0.0	13.5	3.3	0.6	2.5	0.4	0.0	3.7	0.3	0.0	7.6	3.8	20.8	0.5	0.4	2.5	0.0	5.4	0.0	0.7	0.0	1.9	4.3	0.3	0.2	2.4	1.5	0.3	3.3	0.6	1.7	1.3	0.7	0.0	1.4	2.1	0.2	2.0	1.6	0.9	0.1	0.8	2.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	1.4	3.5	0.7	2.7	1.5	0.1	1.6	0.6	2.0	0.0	0.9	1.8	0.6	0.0	0.0	2.3	0.2	1.9	0.7	0.3	4.0	1.5	0.6	0.9	0.7	2.8	0.1	1.8	0.0	0.2	0.3	0.1	0.0	0.4	31.4	0.1	0.5	0.7	3.0	0.4	46.2	0.9	0.7	2.5	1.1	0.1	0.0	31.2	1.1	0.0	0.2	0.0	20.3	0.5	0.0	0.0	8.9	35.2	3.4	0.4	1.8	9.4	0.1	0.2	0.0	11.6	4.8	0.4	0.1	4.9	1.0	1.1	0.1	0.2	0.0	0.2	0.0	0.4	2.2	24.6	10.5	1.9	0.3	0.1	0.4	2.1	0.5	0.3
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005135-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.6;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5"	"Not detected"	"Not detected"							"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	2.0	1.1	0.5	9.1	0.6	12.6	0.9	0.5	0.8	1.1	0.6	1.2	1.6	0.7	0.4	0.9	0.7	2.8	0.6	0.4	1.0	0.8	2.7	4.3	8.8	1.9	1.0	0.3	0.4	0.4	0.4	1.7	1.6	0.8	1.5	0.1	0.7	0.5	0.2	0.3	2.4	2.3	1.0	9.6	1.6	0.6	1.2	4.2	0.4	0.5	6.6	3.4	0.5	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.2	7.5	9.0	0.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	39.0	19.8	43.6	33.8	28.4	62.4	9.3	16.9	26.2	13.0	8.1	8.6	19.4	15.2	49.1	32.1	5.9	9.0	24.5	0.5	0.6	0.5	0.8	0.4	1.0	1.9	1.0	1.6	1.0	1.2	2.3	2.9	3.2	21.6	0.3	77.8	4.2	0.5	0.0	0.0	0.2	1.9	3.2	0.4	7.2	1.3	0.0	0.0	0.2	256.1	0.5	0.0	0.0	9.1	0.2	0.4	2.1	0.0	6.6	0.0	0.0	0.3	2.3	6.6	0.5	317.8	0.0	3.9	1.4	62.8	0.0	0.0	0.6	0.0	112.5	73.1	1.4	0.6	88.6	3.6	4.7	90.9	0.0	319.3	0.0	0.1	0.0	0.0	0.0	25.6	0.2	0.1	0.3	0.7	0.2	0.0	0.9	2.0	0.1	0.1	0.7	5.3	0.4	192.8	0.9	0.4	0.2
GPR78		ENSG00000155269	"G protein-coupled receptor 78"	Q96P69	4	8558725-8619761	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.4;placenta: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 25.8"									HPA013209	Uncertain					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA013209: AB_10601657"	"unprognostic (6.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.70e-2)"		"unprognostic (3.82e-4)"	"unprognostic (6.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.88e-15)"	"unprognostic (5.55e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.90e-3)"	"unprognostic (8.15e-2)"	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	4.9	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724181-41730130	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.7;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 16.5;Cone photoreceptor cells: 20.9;Kupffer cells: 37.0;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"eosinophil: 40.2;NK-cell: 10.9"	"Group enriched"	"Detected in many"	10	"granulocytes: 40.2;NK-cells: 10.9"	"Cell line enriched"	"Detected in single"	30	"HMC-1: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035914	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	0.1	0.9	0.7	2.3	0.5	0.1	0.6	0.8	0.7	0.3	0.4	1.1	1.7	0.3	0.1	0.4	0.3	0.6	0.1	0.5	1.0	0.3	0.7	0.2	3.2	1.4	0.7	0.2	0.1	0.2	0.1	0.0	0.7	0.2	1.1	0.0	0.4	0.4	0.0	0.4	2.7	0.3	0.6	1.1	0.9	0.0	1.3	0.5	0.3	0.0	6.9	0.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	40.2	0.0	2.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.3	10.9	2.4	0.0	0.0	0.2	0.7	0.5	0.8	0.7	0.5	1.0	1.4	0.7	0.7	0.6	1.3	0.8	0.7	0.0	7.2	2.0	5.5	4.7	5.2	2.8	0.6	16.5	1.2	0.3	0.4	4.3	5.9	1.8	20.9	0.9	3.7	3.1	0.0	2.0	0.2	1.0	3.4	3.1	1.2	0.8	1.7	1.1	0.2	2.9	1.5	1.4	0.0	1.4	3.3	1.3	1.3	13.5	2.2	2.0	2.0	37.0	7.7	0.2	4.1	13.9	3.6	0.0	3.4	1.7	12.3	10.6	1.1	2.8	5.1	3.0	1.3	3.6	6.9	0.3	1.1	17.2	0.0	3.4	2.3	1.6	1.1	0.3	2.7	0.7	12.6	3.9	3.4	3.8
GPR84	EX33	ENSG00000139572	"G protein-coupled receptor 84"	Q9NQS5	12	54362445-54364487	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.8;urinary bladder: 15.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 21.9;Langerhans cells: 17.7;Macrophages: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"basophil: 9.0;classical monocyte: 9.9;myeloid DC: 14.8;neutrophil: 6.0"	"Group enriched"	"Detected in many"	62	"dendritic cells: 14.8;granulocytes: 9.0;monocytes: 9.9"	"Group enriched"	"Detected in some"	5	"HL-60: 13.0;NB-4: 40.0"									HPA027603	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA027603: AB_10612115"	"unprognostic (5.40e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.16e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.36e-9)"	"unprognostic (1.27e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.44e-2)"	4.5	1.1	1.0	8.3	1.1	22.8	0.3	1.0	1.8	0.4	1.4	0.4	0.3	0.3	0.3	0.5	0.7	1.0	0.6	1.0	1.7	0.9	0.4	2.4	0.3	2.6	1.6	0.3	0.4	0.1	0.8	3.1	1.7	0.6	0.6	2.7	0.6	0.2	0.0	0.7	0.4	1.9	1.7	3.6	0.6	0.3	1.8	0.5	0.6	0.2	0.8	15.8	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.0	2.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.1	0.0	9.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	14.8	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	2.1	1.0	1.1	1.0	1.8	1.0	1.7	2.6	1.6	1.7	1.7	1.8	3.1	0.2	0.0	0.5	2.0	0.3	0.9	0.1	4.6	0.0	2.6	0.2	0.3	0.1	0.0	1.2	0.0	4.2	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	1.6	0.0	0.0	0.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	1.1	0.0	0.0	2.8	17.7	0.2	0.0	31.8	0.0	0.0	1.2	0.1	0.0	1.5	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.1
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651092-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.6;Cardiomyocytes: 28.6;Cone photoreceptor cells: 37.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;REH: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA000161: AB_2247872, HPA031061: AB_2673718"	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.23e-2)"	8.6	22.6	25.1	5.4	23.9	3.8	9.9	19.8	31.2	32.4	2.7	23.3	2.4	25.5	10.7	4.4	26.7	7.6	17.7	22.8	33.2	10.3	2.9	7.2	9.4	16.6	17.8	53.4	5.6	17.3	43.5	2.9	18.6	20.4	4.5	29.9	8.7	17.7	6.1	5.2	12.4	15.3	12.8	11.3	9.6	5.3	23.6	6.8	26.1	4.2	7.6	18.6	16.9	20.2	0.2	0.5	1.7	1.1	1.7	1.7	1.0	1.8	0.1	2.7	4.5	0.2	0.3	0.0	0.4	3.8	0.3	0.5	0.5	0.1	3.9	0.0	0.2	0.1	0.6	0.5	1.4	0.2	0.2	2.2	0.7	3.3	0.3	0.4	0.2	1.8	0.3	0.1	4.3	0.4	3.7	0.1	1.2	0.3	0.6	5.6	1.7	0.0	0.2	0.4	1.7	2.7	0.6	0.2	0.5	1.4	0.2	0.9	0.5	0.8	1.0	0.5	0.3	0.3	0.5	0.0	0.4	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.2	1.1	0.4	0.0	0.7	2.3	2.3	0.0	0.1	0.0	0.3	0.8	0.5	25.1	23.9	19.8	31.2	22.8	33.2	16.6	17.8	18.6	12.8	23.6	20.2	5.1	0.0	3.6	0.0	4.4	3.6	4.1	0.8	1.8	42.6	1.8	3.0	28.6	1.5	3.5	5.5	37.5	0.4	3.5	0.1	0.0	0.2	0.3	0.6	6.5	7.3	6.0	0.4	0.0	0.2	0.2	9.9	1.1	0.7	2.5	13.9	7.1	0.7	0.3	6.7	0.0	0.7	0.0	0.3	2.0	1.7	15.2	1.3	1.8	0.0	0.5	12.9	3.1	0.0	0.0	0.6	0.1	15.4	2.2	3.8	0.4	1.7	1.2	18.8	6.6	16.9	8.5	7.0	2.4	0.4	0.9	0.1	7.3	6.5	0.8	1.6
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.6;Cardiomyocytes: 16.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	5.1	15.0	19.1	2.1	18.9	0.4	7.8	10.6	22.3	13.6	6.7	7.5	1.7	17.7	9.0	4.2	10.7	5.1	14.5	18.6	31.4	10.2	6.8	5.0	1.8	13.8	15.0	30.1	9.3	14.9	20.0	3.7	15.8	12.5	3.1	12.7	9.2	11.8	7.5	5.8	3.2	10.3	12.8	4.2	4.0	4.7	24.8	4.5	15.2	6.5	1.7	6.4	6.5	13.4	0.6	6.8	17.8	13.8	5.5	6.5	1.3	10.3	9.3	8.7	16.9	2.3	3.1	0.0	3.5	10.8	4.3	2.4	21.5	5.6	11.0	0.0	8.3	0.9	2.0	0.5	4.0	1.7	1.2	6.9	5.8	9.7	0.4	10.1	6.2	1.7	2.7	0.7	10.6	3.2	4.9	0.7	8.9	2.2	9.3	6.4	2.9	0.0	5.4	2.5	3.9	12.2	10.4	2.0	1.5	5.4	5.7	3.6	5.6	6.1	12.9	12.5	9.9	0.3	0.4	0.0	8.2	1.1	3.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.4	0.2	0.1	1.4	0.6	0.0	0.8	0.0	0.5	0.5	0.4	19.1	18.9	10.6	22.3	18.6	31.4	13.8	15.0	15.8	12.8	24.8	13.4	4.3	0.0	1.5	0.0	0.5	2.3	5.1	2.1	4.0	19.6	3.5	4.1	16.4	7.2	3.6	5.5	2.1	6.2	0.3	0.6	9.8	1.6	0.5	0.7	4.1	4.3	3.0	0.0	0.0	0.9	0.5	6.6	0.0	0.6	0.0	13.2	8.2	7.3	0.9	16.8	0.0	1.4	2.0	0.6	0.8	1.1	12.2	0.6	0.0	0.0	0.5	12.2	0.0	0.0	0.0	1.1	1.8	12.4	0.0	3.2	0.3	10.8	0.8	6.8	6.6	8.9	4.9	13.4	9.1	2.4	3.0	2.2	0.7	8.0	1.1	1.5
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12891559-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 201.9;urinary bladder: 130.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 939.1;Club cells: 357.8;Distal enterocytes: 477.9;Pancreatic endocrine cells: 600.7;Paneth cells: 359.8;Urothelial cells: 1252.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 355.6;A549: 285.7;CAPAN-2: 1347.4;HaCaT: 351.2;SiHa: 492.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	31.5	3.7	1.2	11.5	0.9	1.8	9.6	1.0	1.4	35.4	3.4	56.4	18.7	8.9	0.4	23.0	9.8	24.9	18.9	1.8	0.8	9.0	1.8	201.9	0.2	2.7	4.5	21.4	2.7	0.9	2.5	13.5	1.0	10.2	48.4	1.6	23.5	1.3	0.7	5.8	20.9	5.1	0.5	0.4	33.6	1.5	2.1	0.3	55.5	0.6	4.4	130.8	30.6	1.8	355.6	285.7	0.1	1.3	3.4	1.5	18.4	105.2	39.5	66.2	49.4	49.1	1347.4	0.1	8.6	83.3	67.2	351.2	1.0	50.1	101.7	0.4	4.3	0.2	105.4	2.2	23.8	0.1	0.3	1.8	66.5	27.5	6.7	82.3	40.9	0.0	0.5	0.3	2.9	251.7	0.2	0.3	1.6	130.0	43.5	0.2	6.7	0.3	133.6	69.6	0.5	0.6	492.0	36.8	15.9	52.3	10.9	1.0	4.0	2.6	83.9	156.1	4.3	0.2	0.3	0.3	34.6	0.3	2.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.2	0.9	1.0	1.4	1.8	0.8	2.7	4.5	1.0	0.5	2.1	1.8	10.0	939.1	200.2	0.0	1.0	12.5	329.6	202.8	4.6	0.1	80.6	41.7	1.9	11.5	357.8	46.0	0.0	3.8	1.5	477.9	0.0	46.9	0.1	91.8	54.1	15.8	8.3	0.0	0.2	72.1	11.7	108.5	176.9	288.1	10.1	0.2	8.6	0.2	1.6	0.0	0.4	43.5	61.1	0.3	18.0	0.4	13.4	9.6	51.6	0.0	0.6	3.5	0.0	0.0	0.1	600.7	359.8	10.1	0.5	320.1	114.0	0.2	86.3	0.4	0.0	23.0	38.8	1.5	0.3	22.7	9.1	1.1	4.9	0.7	110.4	1252.7
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 490.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0"	"Cancer enhanced"	"Detected in all"		"glioma: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 92.5;HHSteC: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	25.3	7.0	249.1	4.4	428.3	0.1	19.6	365.2	263.4	12.8	13.1	8.1	5.7	13.1	14.8	8.1	20.1	15.3	40.7	245.8	278.4	22.4	3.2	5.8	7.8	379.4	327.1	22.6	21.7	45.9	14.1	15.7	333.0	9.6	2.4	17.4	40.1	17.7	72.7	7.5	11.1	7.5	262.7	2.5	41.3	34.0	315.0	3.2	13.8	73.8	3.4	12.8	8.6	490.3	1.2	29.9	29.0	5.2	29.3	2.0	5.3	0.3	7.4	2.9	1.8	28.0	1.0	0.0	92.5	1.0	18.9	1.6	21.6	0.2	1.7	0.2	8.6	0.0	0.1	0.0	60.3	0.0	0.0	2.5	0.0	4.9	0.0	7.9	14.3	0.7	6.6	0.6	6.7	1.5	0.1	0.1	31.8	0.0	15.6	8.9	0.0	0.2	1.1	13.8	22.9	1.9	3.6	1.9	27.2	9.1	0.1	0.6	2.9	0.0	3.5	14.4	0.8	0.4	0.1	0.3	1.4	0.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	249.1	428.3	365.2	263.4	245.8	278.4	379.4	327.1	333.0	262.7	315.0	490.3	71.4	0.0	3.0	75.4	1.2	1.3	5.3	2.6	9.1	30.7	22.5	16.3	15.7	40.0	7.2	31.3	0.0	5.0	0.3	0.2	1.9	65.3	197.7	4.1	20.7	44.8	0.0	0.0	2.4	64.5	1.4	14.8	31.6	13.7	0.0	0.4	9.3	0.2	4.1	0.0	13.5	0.0	38.7	1.6	2.6	269.9	23.9	2.2	16.0	7.5	1.0	24.8	0.0	51.8	171.0	72.8	0.0	26.7	1.3	12.3	0.0	0.3	3.3	6.0	13.1	3.3	13.0	4.9	1.6	2.4	1.7	2.5	0.8	7.0	0.2	1.6
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 192.7;stomach 1: 230.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	Yes		15000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	16.1	19.3	17.4	3.1	18.4	0.4	20.1	48.9	18.1	42.0	28.0	38.7	25.0	17.1	10.2	12.2	30.0	21.3	33.7	14.8	16.9	135.7	192.7	23.0	2.1	18.1	18.7	38.2	136.1	28.2	14.8	11.9	18.6	45.6	14.6	1.5	37.4	24.3	110.1	43.9	30.3	4.0	16.6	22.3	230.3	4.0	17.0	4.4	74.8	33.9	3.0	30.8	20.9	15.7	17.3	61.6	3.8	5.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	66.4	73.0	0.0	45.0	0.3	18.5	52.9	7.7	1.0	0.1	0.2	10.7	0.0	4.0	82.4	15.8	0.0	146.7	1.3	26.7	0.0	0.0	69.2	0.0	0.1	4.8	1.2	0.0	18.0	0.7	17.2	9.2	79.5	80.8	0.2	0.1	2.8	172.1	89.9	27.5	2.5	3.7	5.9	0.1	33.1	108.0	4.6	0.0	0.0	5.5	0.1	0.1	0.1	0.4	0.2	6.5	2.5	0.4	0.0	1.1	0.1	0.0	2.5	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.7	7.9	0.0	0.3	17.4	18.4	48.9	18.1	14.8	16.9	18.1	18.7	18.6	16.6	17.0	15.7	11.2	3.2	57.7	13.4	1.4	13.6	39.2	79.6	26.7	0.8	27.3	19.4	211.3	67.2	76.2	136.1	0.0	0.8	11.8	74.9	29.4	65.5	0.1	62.5	6.6	20.9	45.5	5.3	0.1	68.1	20.3	11.3	143.2	74.9	10.2	0.1	48.2	183.6	12.3	5.0	0.5	50.8	69.2	16.3	4.6	1.7	18.0	6.3	3.6	2.8	4.1	15.9	0.0	5.0	0.2	41.2	153.8	22.2	1.2	44.6	61.0	73.5	45.4	1.5	144.7	4.7	64.0	0.5	5.0	14.8	11.2	25.3	2.4	1.5	48.5	63.1
GPRC5D		ENSG00000111291	"G protein-coupled receptor class C group 5 member D"	Q9NZD1	12	12940775-12952147	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skin 1: 47.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Gastric mucus-secreting cells: 5.6;Late spermatids: 6.2;Melanocytes: 5.4;Plasma cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"memory B-cell: 21.9;naive B-cell: 7.5"	"Lineage enriched"	"Detected in many"	14	"B-cells: 21.9"	"Group enriched"	"Detected in many"	9	"Karpas-707: 84.5;RPMI-8226: 85.9;U-266/84: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071909	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA071909: AB_2686470"	"unprognostic (4.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.00e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.63e-2)"	0.9	0.6	0.2	0.4	0.4	0.6	3.0	0.1	0.2	1.2	2.0	2.7	1.8	0.2	0.0	2.5	0.3	0.8	0.8	0.2	0.4	0.6	1.0	7.2	0.7	1.1	1.2	0.5	2.1	0.0	1.5	0.3	0.5	1.2	2.3	0.3	4.5	0.0	0.2	47.8	2.7	0.0	0.3	1.6	2.3	2.7	0.6	0.1	1.2	0.0	1.1	0.7	1.0	0.3	1.3	1.4	0.0	1.5	0.0	0.0	3.3	0.4	0.0	0.0	0.3	1.3	3.2	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	7.6	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	84.5	0.2	3.1	0.0	0.0	0.8	3.9	0.1	0.1	0.0	85.9	0.0	3.4	2.6	0.5	1.9	1.4	0.0	3.5	0.0	0.0	2.3	0.0	3.9	0.1	0.0	4.4	25.2	1.1	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	21.9	0.2	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.2	0.4	0.1	0.2	0.2	0.4	1.1	1.2	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	5.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.3	0.0	6.2	0.0	0.1	5.4	1.9	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.1;pituitary gland: 8.1;retina: 6.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 12.8;Excitatory neurons: 7.5;Horizontal cells: 21.9;Inhibitory neurons: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 56.5;SCLC-21H: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Vesicles	"HPA036478: AB_2675145, HPA070892: AB_2686321"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	0.5	1.6	16.9	0.8	15.9	0.2	0.3	6.8	19.5	0.3	0.0	1.1	3.8	0.4	0.0	0.8	0.1	0.3	0.4	22.1	15.7	0.6	0.4	0.4	0.8	4.3	3.5	0.0	0.6	0.1	8.1	0.3	5.1	0.2	0.4	6.9	0.3	0.0	0.3	1.0	3.2	0.7	3.3	0.4	0.8	1.5	14.8	0.9	0.2	0.2	1.1	0.3	0.2	6.6	7.5	7.9	9.8	14.1	2.1	4.6	8.3	9.8	5.1	7.5	9.7	9.6	4.8	17.0	19.6	5.3	22.0	6.5	6.3	6.8	6.5	56.5	4.3	0.3	4.1	3.4	0.9	0.4	4.2	2.3	5.1	8.1	1.2	1.5	5.5	3.8	9.1	24.0	6.3	19.7	1.8	0.0	9.9	5.0	15.4	31.7	10.9	10.1	8.4	7.7	59.5	34.1	11.4	3.2	17.7	1.2	7.4	6.5	6.8	13.8	16.0	5.3	14.5	0.4	2.3	4.8	11.9	0.8	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	15.9	6.8	19.5	22.1	15.7	4.3	3.5	5.1	3.3	14.8	6.6	0.4	0.0	0.0	0.3	0.5	2.4	0.1	0.3	0.6	12.8	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.3	1.9	0.4	0.0	0.5	0.6	1.0	1.8	0.0	7.5	1.8	0.9	0.4	0.0	1.2	0.0	0.3	0.0	0.0	0.9	21.9	8.0	0.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	1.9	0.1	1.1	1.0	2.5	0.3	1.6	0.1	0.0	0.8	0.2	0.0	0.3	0.4	3.1	0.0	1.5	0.3	0.7	2.7	0.4	1.4	0.1	0.3	0.4	0.2	0.1
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.5;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.1	0.0	1.7	0.6	1.6	0.0	0.9	5.9	2.1	0.9	0.4	6.2	3.6	0.0	0.0	4.4	0.3	0.2	0.0	0.6	6.7	5.7	0.3	10.5	0.0	5.5	4.9	0.1	5.7	2.1	4.2	0.0	5.7	1.9	3.4	0.1	2.8	1.1	0.1	17.4	8.0	0.1	1.8	0.0	5.1	3.0	9.7	0.0	3.4	0.0	0.5	0.6	2.0	1.0	10.2	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.0	1.7	0.3	0.3	0.1	3.7	12.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.9	2.1	0.6	6.7	5.5	4.9	5.7	1.8	9.7	1.0	0.0	19.2	3.7	0.0	0.0	1.7	2.8	1.9	2.8	0.3	1.4	1.0	0.2	7.2	2.1	3.7	0.0	0.0	0.0	30.4	0.0	11.3	9.3	0.0	0.0	0.1	6.6	0.0	0.7	20.2	0.0	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	30.8	0.0	0.0	0.3	20.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	13.1	0.4	0.0	2.1	21.7	4.0	1.8	0.1	0.0	0.0	0.2	2.9	0.8	2.4	6.1	0.0	0.1	0.0	7.3	1.3
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236383-89307800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"					"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	2.7	1.2	4.1	9.0	9.5	7.8	1.4	17.8	3.1	2.2	0.9	5.3	6.2	1.4	0.7	0.9	0.9	3.5	4.0	2.2	7.3	3.9	2.0	6.9	10.2	4.3	6.5	3.2	5.1	0.6	2.9	1.0	4.5	0.8	7.1	3.5	1.5	0.6	1.0	0.6	5.3	1.4	4.1	7.1	3.6	0.4	5.0	2.8	1.3	3.2	7.9	2.7	1.0	5.9	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.8	0.1	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	102.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	27.7	0.3	0.1	27.2	0.6	0.0	0.1	1.1	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	15.9	13.2	0.1	0.5	0.0	0.0	0.0	0.3	0.0	2.8	1.0	3.8	0.2	2.7	2.2	0.9	0.0	1.1	1.1	0.0	1.9	1.5	0.0	3.4	1.0	4.1	9.5	17.8	3.1	2.2	7.3	4.3	6.5	4.5	4.1	5.0	5.9	11.1	0.0	22.6	10.1	6.7	1.1	0.9	0.1	0.0	12.2	1.6	1.7	20.3	8.6	5.0	3.7	0.0	0.2	51.2	17.4	1.9	2.0	0.2	5.8	3.4	11.7	78.7	6.5	21.7	9.4	0.1	3.0	15.8	15.0	7.6	12.2	1.8	0.4	18.7	26.9	32.7	38.0	0.0	28.2	29.0	0.0	0.3	53.9	1.8	41.2	7.4	1.0	23.7	26.2	0.5	1.3	11.0	1.2	48.6	0.3	16.3	1.9	0.7	10.8	78.9	3.3	32.7	0.1	0.8	0.3	1.0	0.3	76.9	0.7	26.2	0.5
GPS2		ENSG00000132522	"G protein pathway suppressor 2"	Q13227	17	7311324-7315564	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 279.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067540	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067540: AB_2685860"	"unprognostic (1.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.50e-5)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.28e-3)"	45.4	47.7	30.3	15.5	30.9	26.8	39.7	30.7	37.8	42.1	28.4	47.5	14.6	39.5	14.2	38.0	36.8	13.2	65.8	30.3	30.9	49.8	33.3	34.0	17.2	31.8	30.7	39.5	39.0	24.4	33.8	13.9	31.1	35.3	17.1	12.0	39.4	16.9	154.9	52.0	34.5	15.6	29.5	34.6	40.0	102.7	31.2	21.6	34.6	52.9	20.1	43.9	37.2	31.7	28.1	60.6	24.9	26.4	36.5	20.2	21.2	20.1	26.7	45.2	39.0	39.2	16.1	32.0	15.5	31.1	32.3	42.1	25.4	42.4	31.5	37.9	34.8	30.1	62.2	53.0	26.4	19.1	37.1	19.3	31.2	59.0	17.1	19.5	26.0	29.7	18.8	8.6	43.2	25.8	38.2	21.2	24.6	29.3	22.8	29.5	30.8	34.1	36.4	32.1	23.5	39.5	35.6	23.6	28.9	21.4	23.6	18.6	15.9	23.0	20.5	28.2	48.9	25.0	37.0	21.0	30.3	23.2	38.1	78.3	47.2	82.7	53.5	59.8	49.5	81.6	56.6	58.5	39.5	63.8	51.9	47.8	79.1	41.5	67.7	66.0	81.2	58.1	30.3	30.9	30.7	37.8	30.3	30.9	31.8	30.7	31.1	29.5	31.2	31.7	29.1	12.8	10.8	19.9	36.9	15.8	11.5	11.4	29.0	29.9	19.2	17.8	1.2	17.2	16.6	20.2	66.7	13.5	55.7	52.4	25.4	21.7	100.3	15.0	22.6	18.9	16.8	29.9	15.0	26.8	11.1	14.9	25.5	17.5	19.0	23.4	11.4	10.6	10.3	38.7	12.5	23.2	6.1	14.1	25.0	279.3	21.1	21.1	19.6	13.1	21.6	15.5	41.2	10.6	17.1	19.5	35.9	15.4	42.2	8.4	42.2	25.7	14.6	44.8	19.7	17.4	18.8	37.4	42.9	18.1	16.9	19.6	39.0	17.1	21.8	9.1
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	13.0	21.7	32.6	4.2	30.6	4.5	12.4	50.9	44.4	38.7	12.7	18.5	3.3	23.3	7.2	6.0	20.3	4.7	74.9	30.5	26.7	19.6	4.7	35.4	2.1	34.9	29.8	38.1	42.3	3.8	19.7	6.6	28.7	30.6	1.2	18.7	8.6	5.9	2.7	17.0	9.3	4.0	25.1	19.9	17.2	29.4	28.6	2.0	12.4	0.7	1.1	15.1	24.4	28.6	3.9	6.2	14.5	25.4	8.1	14.1	12.1	43.0	17.6	11.8	6.4	12.5	4.1	0.0	17.8	26.0	9.9	2.9	2.3	8.8	2.6	35.1	25.5	5.0	23.4	2.3	34.7	0.3	6.1	23.0	5.8	10.8	6.2	14.5	12.0	5.9	13.5	0.2	7.9	14.2	2.4	4.9	15.5	1.4	22.5	82.3	26.2	12.7	3.2	2.8	35.6	44.4	8.0	1.0	13.7	5.6	17.7	8.6	20.0	21.7	17.5	25.7	8.9	7.6	0.3	0.1	13.0	0.0	21.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	32.6	30.6	50.9	44.4	30.5	26.7	34.9	29.8	28.7	25.1	28.6	28.6	4.7	3.2	3.3	26.1	0.6	4.2	2.3	0.8	0.0	37.2	2.5	5.8	12.4	0.0	0.8	0.0	22.9	0.6	1.6	0.0	11.7	3.3	0.6	2.7	18.1	3.9	1.8	2.5	9.0	1.9	0.8	9.1	0.5	5.5	5.7	14.2	3.6	0.0	1.1	10.1	11.6	0.0	0.0	0.3	2.8	1.3	10.5	1.5	8.8	6.5	0.5	36.0	0.0	9.5	10.4	7.3	0.0	9.4	0.3	10.6	0.0	0.1	0.6	43.0	0.0	5.8	6.0	0.4	3.7	0.1	3.3	0.3	1.1	3.3	0.0	4.0
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.9;tongue: 54.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 133.5;Oligodendrocyte precursor cells: 134.7;Oligodendrocytes: 127.4;Syncytiotrophoblasts: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;T-reg: 1.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	5.3	3.5	27.3	4.4	39.5	14.4	7.5	33.8	25.2	12.6	10.8	15.3	9.1	6.8	2.6	34.1	4.2	2.6	4.3	23.3	29.5	2.3	2.9	9.0	6.4	33.9	36.3	3.3	3.6	9.7	3.1	7.7	33.9	5.9	15.2	8.6	10.1	4.7	10.7	37.7	11.5	10.5	32.1	2.7	5.1	11.5	34.1	18.4	3.2	54.4	13.2	6.0	17.7	46.9	135.6	16.2	36.8	27.7	36.4	20.2	30.0	24.2	61.4	29.9	45.4	16.0	31.7	30.5	6.7	33.4	21.0	28.3	25.3	59.1	39.6	30.7	15.8	19.8	34.7	16.5	4.8	28.6	18.5	4.1	113.9	29.4	129.8	9.4	26.9	19.5	14.9	42.3	58.4	37.8	26.1	12.2	8.7	52.1	29.4	20.1	66.7	6.6	24.3	18.6	30.4	26.9	37.0	69.2	26.9	10.3	27.6	24.3	18.0	21.7	36.7	64.8	48.5	18.4	20.9	28.6	34.3	47.4	108.9	0.1	0.3	3.2	0.2	0.3	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.3	0.3	0.1	0.1	0.1	1.8	0.1	27.3	39.5	33.8	25.2	23.3	29.5	33.9	36.3	33.9	32.1	34.1	46.9	4.6	16.0	3.3	63.0	5.7	62.7	18.8	12.9	47.3	47.7	3.0	3.7	2.5	2.8	12.5	7.3	133.5	46.3	6.7	10.8	11.7	2.5	54.0	5.2	20.6	5.1	9.1	33.9	11.7	1.9	47.7	19.5	8.6	9.2	2.5	14.4	2.9	1.6	9.0	43.7	24.0	14.1	10.2	5.3	11.3	21.3	18.6	4.9	26.6	3.7	5.3	8.0	2.1	134.7	127.4	4.8	7.8	5.3	5.3	5.6	8.4	0.9	9.0	48.1	0.0	43.6	6.9	20.6	28.9	24.0	40.6	89.2	7.1	10.0	18.7	15.5
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 179.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	22.6	2.4	2.2	4.6	1.9	2.3	12.5	3.3	4.7	0.7	3.5	36.0	18.3	0.5	0.4	2.4	1.3	2.4	40.3	2.1	0.4	13.9	179.6	0.4	0.3	0.8	0.5	1.1	10.3	1.4	2.9	0.1	0.6	1.8	5.8	0.6	14.6	1.2	50.1	17.1	18.0	0.4	0.2	0.6	15.0	2.6	0.9	0.0	0.9	24.3	0.2	0.6	1.3	0.9	0.2	0.8	0.2	0.5	0.4	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.9	0.4	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.7	1.3	0.3	1.5	2.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	2.8	0.0	1.3	0.4	0.4	0.3	0.6	0.5	0.5	0.1	1.5	0.0	0.9	0.5	0.8	0.2	0.7	0.1	0.1	1.9	0.1	0.2	0.1	0.6	0.7	0.1	2.9	0.2	0.2	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	1.9	3.3	4.7	2.1	0.4	0.8	0.5	0.6	0.2	0.9	0.9	0.2	0.0	0.0	14.4	5.3	1.7	1.3	1.2	0.6	0.9	14.1	4.6	8.5	34.3	1.8	7.3	0.0	0.0	0.4	176.9	21.5	1.1	16.5	0.5	0.4	1.1	2.4	43.2	0.8	2.4	3.3	0.3	51.0	0.7	8.9	0.3	14.3	237.3	0.1	3.3	0.5	30.4	0.0	14.4	2.1	48.1	0.6	1.2	1.8	1.0	0.1	15.6	0.0	2.0	0.0	1.3	88.4	0.4	0.1	1.2	139.7	164.9	0.5	2.0	0.0	2.0	0.4	1.0	0.6	2.4	4.5	0.0	1.8	0.4	62.1	1.6
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GPX1		ENSG00000233276	"Glutathione peroxidase 1"	P07203	3	49357176-49358353	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3273.8;Kupffer cells: 3971.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1534.3;granulocytes: 1010.7;monocytes: 1337.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011582, HPA044758"	Approved		Supported	Cytosol		NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB011582: AB_2112120, HPA044758: AB_2679076"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (7.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.73e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.64e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.64e-3)"	321.4	200.0	178.3	151.9	186.6	246.7	151.5	190.2	298.9	90.9	247.3	86.9	122.2	82.2	17.8	134.3	86.5	91.1	95.5	173.1	198.9	152.9	281.6	168.3	174.3	234.0	213.0	61.9	74.4	35.2	85.7	121.2	208.3	107.0	42.7	8.3	113.1	53.9	157.1	70.4	113.6	70.4	218.0	195.9	92.9	31.5	217.6	75.3	82.1	61.7	86.6	116.8	94.9	256.3	322.8	189.2	72.6	95.4	113.5	205.9	225.9	217.7	114.7	151.5	80.1	157.8	229.7	0.6	301.6	139.8	181.7	93.2	98.8	660.3	31.6	200.2	271.6	224.8	190.2	397.4	575.6	161.0	594.4	455.9	267.6	292.4	221.5	190.0	341.5	78.6	0.5	179.3	125.9	0.8	51.2	407.0	441.3	147.4	510.5	190.8	93.8	120.3	258.2	385.6	87.7	178.5	249.5	1.5	287.3	75.7	1.5	559.5	546.5	209.7	236.0	385.8	453.6	1.1	127.9	116.3	390.5	436.3	507.8	1010.7	1337.0	707.6	69.8	483.7	100.9	314.2	127.7	83.7	1093.1	276.8	118.4	116.2	136.4	107.4	275.8	1534.3	233.3	1401.2	178.3	186.6	190.2	298.9	173.1	198.9	234.0	213.0	208.3	218.0	217.6	256.3	0.0	109.0	323.5	6.2	148.1	249.7	432.8	985.0	92.2	32.1	0.0	0.0	0.0	220.2	616.7	0.0	10.4	499.9	491.5	229.5	0.0	0.0	300.7	0.0	0.0	227.8	251.3	364.1	12.8	0.0	830.3	131.0	73.4	0.0	480.6	0.0	585.7	888.1	3273.8	1.7	17.9	285.0	386.6	3971.6	965.7	1102.9	134.5	1305.5	273.9	41.2	828.6	63.4	138.0	8.0	7.6	0.0	179.0	67.0	82.4	481.0	349.9	0.0	490.0	14.6	210.4	150.6	151.8	12.7	169.4	112.1	154.1	278.8	112.2	0.0	367.3	517.0
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11673.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4524.7	443.8	57.8	75.4	68.3	7.9	3188.6	62.7	73.8	917.6	578.2	741.2	88.3	416.0	90.7	568.6	1038.4	136.4	2362.4	68.2	117.5	11673.5	986.3	2471.8	133.2	317.7	104.5	517.8	257.0	112.4	793.7	592.2	136.6	557.5	93.4	4204.9	481.4	140.0	847.9	669.7	720.6	61.0	67.5	555.7	641.1	80.4	135.8	26.8	3627.5	458.9	44.9	1196.7	891.7	70.3	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	57.8	68.3	62.7	73.8	68.2	117.5	317.7	104.5	136.6	67.5	135.8	70.3	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 18580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	927.8	535.3	415.1	127.4	428.7	178.0	733.3	440.7	519.1	280.8	478.7	249.0	259.0	188.4	318.9	220.4	199.2	196.6	426.0	419.2	450.3	536.5	687.8	307.9	216.4	430.9	448.3	260.3	157.9	285.5	398.4	147.2	454.1	322.1	110.9	167.5	304.9	193.8	672.3	290.4	236.2	87.9	418.2	213.2	219.0	1403.5	444.0	158.7	291.5	399.7	182.5	319.0	245.2	429.1	258.1	286.8	405.8	863.0	1202.1	706.0	449.3	199.3	713.5	371.1	375.9	590.5	339.8	92.8	211.8	405.8	313.5	283.1	239.7	289.3	180.5	522.3	436.5	175.0	246.9	849.2	697.4	207.6	269.4	707.3	432.1	188.3	314.7	665.9	527.1	317.5	249.4	225.7	311.1	660.4	353.8	354.9	386.2	569.7	458.9	482.8	55.3	271.3	408.9	629.9	348.3	220.6	390.5	366.1	422.1	246.7	358.1	498.0	450.9	392.3	257.4	680.6	254.6	786.5	582.0	224.3	369.4	412.2	230.9	578.9	539.6	564.4	219.8	405.4	256.9	352.7	319.7	230.7	404.0	309.9	339.4	245.0	265.1	196.6	462.2	278.8	310.3	841.7	415.1	428.7	440.7	519.1	419.2	450.3	430.9	448.3	454.1	418.2	444.0	429.1	415.9	179.5	189.7	21.2	281.7	510.0	525.8	1188.1	512.2	332.2	845.1	868.2	264.6	316.0	600.6	472.6	98.0	562.5	231.3	479.1	1592.6	515.8	4209.7	546.8	326.3	268.7	397.1	215.0	24.5	368.7	1327.3	536.1	99.9	442.3	346.1	242.6	322.0	826.2	1184.1	208.6	33.1	328.7	671.4	583.1	1304.8	18580.2	384.9	735.2	677.7	21.5	1786.8	502.6	192.6	13.6	35.4	484.0	507.9	312.9	189.2	694.7	1861.9	3024.7	800.9	246.0	243.3	244.6	587.1	1310.8	202.4	357.7	467.0	978.1	281.0	186.7	336.4	662.6
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160167-55167297	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 254.4;fHDF/TERT166: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	13.3	6.1	1.2	12.5	1.2	0.1	12.6	1.2	1.6	37.1	6.9	7.3	2.9	21.1	21.9	6.2	14.3	17.0	11.2	1.0	1.7	6.5	2.2	6.9	3.8	1.5	1.1	27.3	4.6	9.3	2.4	39.7	1.4	10.2	8.4	1.3	7.2	15.8	1.5	5.0	4.1	27.2	1.5	4.0	5.6	5.6	1.2	1.3	22.3	6.3	3.0	17.8	9.8	3.6	37.2	39.0	75.3	77.0	180.7	223.9	36.6	179.8	254.4	97.0	192.7	3.2	82.1	0.0	199.0	246.4	86.5	28.2	46.0	51.5	131.5	0.5	17.3	2.1	49.1	6.9	64.4	0.0	0.0	157.5	60.8	68.3	35.5	126.5	122.7	0.0	1.1	0.1	137.4	14.4	0.0	0.0	32.6	1.0	42.8	0.1	40.2	0.0	65.9	1.3	0.1	1.4	56.6	4.6	68.0	80.8	56.6	3.4	102.7	63.6	65.6	84.5	102.3	0.1	0.5	0.5	103.0	0.1	118.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	1.6	1.0	1.7	1.5	1.1	1.4	1.5	1.2	3.6	10.9	0.0	1.1	0.3	0.3	7.1	6.0	38.3	9.1	0.2	8.9	6.1	4.3	0.0	33.3	25.8	0.0	49.5	0.2	0.5	5.9	13.7	0.4	6.5	62.7	18.6	0.0	0.0	0.1	38.8	218.9	76.6	2.6	4.9	4.5	30.9	19.2	0.2	10.2	0.0	0.1	4.7	4.1	0.0	6.9	0.6	51.3	1.1	24.9	5.6	1.1	7.9	0.0	0.0	0.1	15.8	0.3	39.9	1.4	2.6	0.1	0.5	36.5	0.3	13.1	20.1	38.2	0.1	0.4	3.1	6.1	13.3	1.8	29.9	0.9	2.4
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	37.9	36.9	17.8	28.0	15.9	23.9	31.1	16.4	24.5	33.2	17.5	30.1	15.1	32.5	5.3	11.6	36.2	16.5	30.3	17.4	18.5	27.4	21.2	58.1	28.8	21.8	20.7	38.4	80.8	17.8	29.2	16.8	21.5	32.6	8.4	5.1	55.6	17.0	47.8	14.5	23.3	18.9	18.2	42.1	35.8	16.6	21.5	18.7	25.4	18.9	12.8	35.7	20.1	17.1	17.3	106.0	21.3	41.5	23.9	27.5	19.6	21.6	27.5	21.8	21.6	39.8	11.9	10.8	41.2	25.2	19.3	9.5	22.2	31.9	8.2	48.9	47.3	24.6	25.5	36.8	48.3	21.7	41.1	46.5	19.9	16.1	26.7	36.6	71.5	54.1	31.8	5.7	16.0	13.2	46.5	23.6	38.6	28.4	12.7	47.1	6.9	10.7	24.8	2.5	30.8	64.4	20.0	12.7	33.7	18.4	19.4	20.6	38.9	34.9	22.3	8.0	29.6	8.8	26.3	22.4	23.5	19.6	27.0	23.1	5.7	5.4	3.5	9.6	7.3	0.6	4.6	2.7	5.1	1.2	3.5	5.4	12.7	5.7	19.9	1.7	4.1	3.8	17.8	15.9	16.4	24.5	17.4	18.5	21.8	20.7	21.5	18.2	21.5	17.1	51.0	22.4	37.3	28.1	23.6	20.8	64.4	15.1	18.2	15.8	22.0	18.7	12.3	0.0	16.1	16.5	16.7	13.1	32.3	3.5	3.9	36.8	1.4	15.3	19.9	63.2	39.4	20.4	8.9	57.8	35.8	25.6	10.7	16.5	9.5	39.5	66.4	5.6	53.8	8.4	12.1	15.0	14.2	39.4	81.6	3.0	25.7	37.7	33.8	15.0	146.0	23.1	19.6	12.5	15.1	41.2	9.6	25.2	40.4	68.6	1.4	15.1	11.5	14.9	13.1	15.4	26.0	1.2	5.7	3.4	15.3	33.1	48.1	50.6	19.7	51.9
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 7.0"	"Group enriched"	"Detected in many"	4	"A549: 62.4;HDLM-2: 168.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.8	258.8	22.5	4.3	27.4	18.6	1.1	80.1	52.3	0.9	91.8	1.6	34.6	1.1	9.4	0.6	3.6	12.1	15.0	55.6	19.4	15.5	1.5	2.6	5.4	25.7	20.1	15.2	2.4	0.7	16.6	5.0	24.2	1.1	1.1	96.7	1.9	2.0	3.4	0.5	25.2	1.2	9.4	3.6	11.4	16.8	33.5	6.6	4.9	2.2	3.5	1.2	0.8	26.1	0.1	62.4	3.5	0.1	0.3	0.7	9.5	20.5	14.6	4.1	1.8	2.6	0.4	3.8	10.4	10.1	6.8	0.0	6.2	0.0	4.3	168.5	5.0	0.0	28.3	0.7	0.0	22.1	0.0	1.0	0.1	7.1	0.0	5.2	1.8	1.6	0.0	0.2	3.7	0.5	3.8	7.2	7.6	28.3	23.0	10.8	9.8	6.8	0.2	0.0	20.0	16.3	4.9	0.5	0.1	8.1	0.5	12.0	12.3	23.8	3.2	4.2	1.0	0.0	0.0	0.0	4.6	20.5	1.1	0.0	1.2	0.4	0.4	0.7	0.2	0.0	1.5	1.2	1.7	0.0	0.2	0.2	0.1	1.6	0.7	7.0	0.7	0.5	22.5	27.4	80.1	52.3	55.6	19.4	25.7	20.1	24.2	9.4	33.5	26.1	1.4	0.0	0.5	94.7	0.6	0.0	0.0	0.1	1.2	44.3	1.1	1.0	5.7	21.5	0.2	5.5	114.7	6.9	17.9	0.1	3.9	0.7	9.6	1.6	0.6	1.0	0.0	0.0	120.7	0.4	3.7	1.6	16.3	0.9	0.0	41.9	0.7	0.0	2.6	45.4	102.8	1.8	0.0	3.8	2.6	2.7	0.6	7.5	0.0	37.5	2.5	23.4	0.0	95.0	5.5	3.9	1.3	0.7	2.4	0.1	17.3	8.9	0.4	92.3	0.0	3.0	4.2	3.9	1.9	0.1	0.4	2.5	7.2	109.3	1.5	0.0
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1"	"Group enriched"	"Detected in many"	13	"B-cells: 2.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.5;HUVEC TERT2: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.4	1.9	13.0	1.7	12.0	0.1	8.8	11.9	15.3	3.1	9.0	5.0	7.6	2.2	2.0	5.5	10.7	2.6	0.7	11.6	12.1	24.0	27.7	4.9	2.0	13.9	15.4	0.8	12.7	10.6	8.1	6.1	11.8	2.6	3.9	14.3	12.0	2.1	0.8	12.1	16.7	0.7	12.3	1.3	9.0	16.8	14.5	1.1	3.9	3.2	3.9	2.0	3.7	10.0	1.6	0.0	4.0	3.0	0.7	1.8	5.2	3.5	3.1	0.7	2.1	0.0	13.5	0.4	1.0	2.0	1.4	1.3	0.7	1.5	1.8	1.9	0.6	0.3	0.1	0.0	1.4	0.2	0.0	3.0	1.0	0.6	0.1	7.1	10.2	4.5	0.0	0.1	1.1	0.4	1.6	0.2	0.3	1.4	0.5	0.0	0.8	2.4	4.2	1.9	0.8	1.1	1.0	5.2	3.4	1.6	3.6	0.0	2.2	1.5	2.8	0.0	0.3	2.2	1.3	1.9	2.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.2	0.0	2.9	0.1	0.1	2.1	0.1	0.0	0.0	0.0	0.0	13.0	12.0	11.9	15.3	11.6	12.1	13.9	15.4	11.8	12.3	14.5	10.0	4.5	12.8	10.5	181.8	15.6	1.0	6.9	3.0	5.2	0.2	9.9	7.0	0.9	15.7	7.1	14.7	37.5	17.5	0.3	10.1	31.3	4.4	97.1	33.3	8.5	4.7	4.9	2.7	29.7	2.7	3.7	1.5	6.6	51.9	0.0	1.4	5.7	17.0	1.5	11.8	4.3	5.5	4.1	0.3	0.8	80.5	2.8	0.9	1.8	9.4	0.1	13.4	0.0	82.4	1.7	2.3	9.3	1.5	6.3	2.8	34.3	14.0	27.9	19.7	0.0	1.2	1.7	28.2	6.7	6.8	4.7	42.4	1.9	5.0	5.3	7.0
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159806-72197787	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.9;placenta: 48.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 165.5;SK-BR-3: 75.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (7.29e-2)"	0.0	0.0	2.1	0.5	1.7	0.0	10.2	2.0	1.3	1.9	2.1	1.2	1.0	0.4	35.9	1.1	5.8	0.3	0.1	2.2	3.9	3.2	0.0	15.0	0.4	6.5	13.1	0.1	0.5	0.1	0.7	48.7	10.1	1.3	0.8	0.9	2.1	5.2	0.0	2.5	3.3	0.2	2.6	0.2	0.8	0.4	3.0	0.2	8.9	0.0	0.4	0.3	0.7	2.0	2.1	0.0	0.1	0.0	0.0	0.0	165.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.6	0.0	0.0	1.2	0.0	10.0	0.2	0.0	0.2	0.3	0.1	0.0	1.2	0.0	0.0	0.1	2.1	0.0	7.5	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.1	1.7	0.1	0.3	75.8	0.1	5.5	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	2.0	1.3	2.2	3.9	6.5	13.1	10.1	2.6	3.0	2.0	0.1	70.5	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.3	0.0	0.0	7.4	3.7	0.0	106.2	0.1	0.0	0.0	0.1	0.0	14.0	0.2	0.2	0.0	0.0	0.0	0.0	29.5	0.8	0.0	0.7	1.3	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	10.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	147.1	0.3	0.1	0.0	0.0
GRAMD2B	"FLJ21313, GRAMD3, NS3TP2"	ENSG00000155324	"GRAM domain containing 2B"	Q96HH9	5	126360132-126496494	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009678, HPA010095"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA009678: AB_2112580, HPA010095: AB_1849952"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.90e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.12e-2)"	12.8	16.0	56.5	6.9	57.1	1.6	38.7	54.1	55.1	32.2	47.7	28.6	29.6	29.4	15.5	8.9	34.3	10.9	11.7	49.4	54.6	32.9	24.4	11.3	7.4	61.3	64.7	30.3	8.9	8.7	10.0	24.7	55.2	16.9	29.8	6.6	23.1	23.7	3.8	27.3	36.0	22.1	64.9	6.1	16.4	4.1	54.0	13.2	40.4	5.6	11.2	13.8	16.3	60.5	66.1	3.7	3.0	14.6	62.4	21.5	19.4	71.2	114.1	28.7	37.2	2.6	73.6	0.0	26.4	75.4	0.7	17.5	0.9	27.6	30.9	6.1	4.8	3.1	8.2	3.9	14.2	0.0	2.3	34.6	10.4	29.2	9.4	36.4	0.2	0.0	0.0	0.0	50.7	6.7	0.0	0.9	3.1	13.7	4.6	1.3	17.6	14.3	38.8	69.1	1.1	0.1	11.9	6.0	21.2	12.8	22.9	4.2	6.6	6.6	2.1	11.6	12.7	3.9	3.5	0.1	1.4	0.0	19.2	0.2	0.4	0.0	2.9	0.4	2.8	0.5	1.6	2.3	1.7	0.2	3.0	1.8	0.3	1.1	0.3	4.3	2.4	1.2	56.5	57.1	54.1	55.1	49.4	54.6	61.3	64.7	55.2	64.9	54.0	60.5	10.2	16.0	17.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	25.5	73.2	0.0	0.0	45.8	40.5	0.0	32.3	10.0	0.0	23.5	14.1	0.0	51.8	49.0	3.2	0.0	0.0	0.0	8.7	46.5	8.7	0.0	153.2	3.8	4.9	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	2.8	0.0	0.0	18.3	48.8	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	58.6	4.7	2.8	0.0	0.0
GRAP		ENSG00000154016	"GRB2 related adaptor protein"	Q13588	17	19020656-19047011	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;B-cells: 21.2;Endothelial cells: 19.8;Hepatic stellate cells: 30.7;Microglial cells: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 99.7;T-cells: 133.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 87.1;HUVEC TERT2: 38.9;JURKAT: 30.1;REH: 47.8;TIME: 70.4;U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046595, HPA066654"	Uncertain		Approved	Centrosome		NA	NA		1400000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	6.3	3.5	6.7	13.9	6.2	6.5	5.9	6.1	6.9	3.9	5.0	2.6	1.9	3.3	0.5	1.8	4.6	5.3	3.7	5.8	6.1	4.9	6.0	7.1	36.9	6.8	6.5	1.8	0.9	0.6	1.9	6.1	6.8	2.7	1.8	0.4	1.6	3.7	1.7	2.4	15.7	3.3	6.5	37.5	2.2	6.3	7.0	31.9	5.5	1.4	30.7	3.6	2.2	6.0	0.0	0.2	4.5	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.0	87.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	5.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	38.9	30.1	0.2	0.0	0.0	0.2	19.9	1.9	0.9	0.0	0.0	47.8	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	6.8	70.4	0.0	0.2	9.8	0.1	0.1	0.0	60.2	0.1	0.1	0.3	21.5	9.4	1.3	21.5	4.8	21.5	99.7	67.4	28.4	10.5	82.7	133.6	66.5	2.9	21.4	0.4	7.9	62.3	48.9	6.7	6.2	6.1	6.9	5.8	6.1	6.8	6.5	6.8	6.5	7.0	6.0	11.2	6.4	1.8	0.0	21.2	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.6	0.0	0.0	0.1	3.1	0.0	0.0	0.3	2.3	1.1	0.2	19.8	0.0	4.0	0.0	0.0	0.7	0.4	0.0	1.2	2.5	0.1	30.7	0.8	8.2	0.0	0.0	0.4	0.0	4.4	0.7	0.8	0.0	1.9	0.0	9.4	2.9	0.2	2.1	0.0	0.1	0.2	0.0	0.4	3.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.7	0.3	0.0	1.0	0.3	6.9	0.5	0.3	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127535-19159187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 1.6;B-cells: 3.0;Endothelial cells: 2.0;Hepatic stellate cells: 2.5;Microglial cells: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 9.1"	"Lineage enriched"	"Detected in many"	6	"B-cells: 9.1"	"Group enriched"	"Detected in some"	6	"Daudi: 40.5;HUVEC TERT2: 15.6;TIME: 41.5;U-698: 34.6"									"HPA051796, HPA066654"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA051796: AB_2681613, HPA066654: AB_2685699"	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	2.5	1.7	3.9	14.8	3.3	2.1	1.7	2.4	3.5	1.7	1.7	1.2	1.3	3.6	0.2	0.9	2.6	3.6	1.6	2.3	2.9	2.9	1.7	4.9	25.0	3.9	3.4	1.0	0.3	0.1	0.8	2.9	3.7	1.2	2.0	0.2	0.6	2.3	1.6	0.9	10.2	2.0	2.9	25.6	1.5	1.2	3.9	8.9	2.6	0.4	25.7	1.7	1.0	2.5	0.0	2.1	2.8	0.0	0.3	0.1	0.7	0.4	0.0	0.0	0.0	1.0	0.5	40.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	5.2	0.0	0.0	0.0	0.0	1.7	0.2	0.4	1.3	0.0	5.2	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	0.2	41.5	0.0	0.3	1.9	0.0	0.0	0.0	34.6	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	1.1	0.2	0.1	3.8	1.6	0.5	0.0	0.0	0.0	0.0	0.8	0.7	3.9	3.3	2.4	3.5	2.3	2.9	3.9	3.4	3.7	2.9	3.9	2.5	0.9	3.2	0.0	1.6	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	2.5	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	11.2	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.7	0.0	0.0	0.0
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 143.0;Late spermatids: 212.6;Oligodendrocytes: 124.7;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 10.0;eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 10.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB019423, HPA027502, HPA031818"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	27.6	26.0	29.5	6.5	33.6	10.0	25.0	25.2	32.5	18.2	28.5	27.2	17.2	19.8	10.3	9.5	18.8	21.6	34.8	26.5	40.2	29.3	32.1	20.6	6.0	31.5	41.8	14.2	94.3	10.5	24.3	14.7	40.2	20.1	6.4	83.5	16.5	15.0	57.4	9.1	13.3	16.1	21.6	36.8	17.6	18.1	48.2	2.8	27.8	76.0	4.0	31.0	15.9	33.5	0.3	32.5	51.6	21.1	23.5	17.8	27.6	13.1	11.3	24.9	29.7	19.8	0.4	0.7	22.6	16.7	71.0	3.1	53.5	13.9	12.2	0.4	21.6	56.7	32.6	14.4	49.8	36.0	84.1	46.4	21.0	38.6	37.4	23.9	62.7	3.9	109.5	0.6	18.7	4.0	6.4	48.0	56.9	27.2	55.4	16.8	0.0	0.3	16.0	13.1	22.7	0.2	1.6	8.1	68.7	33.0	27.7	71.6	78.7	21.8	29.6	45.4	50.4	2.1	0.7	0.4	68.9	32.2	75.2	10.0	0.1	3.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	29.5	33.6	25.2	32.5	26.5	40.2	31.5	41.8	40.2	21.6	48.2	33.5	46.3	6.4	8.3	3.9	1.2	7.5	5.3	9.4	7.4	12.1	14.8	9.0	13.5	47.1	5.2	5.5	87.6	4.5	0.3	6.9	1.9	18.3	143.0	5.3	12.4	45.2	0.0	19.0	64.8	24.4	16.5	15.4	5.6	9.7	0.0	0.8	53.2	26.8	1.6	5.0	55.0	2.8	6.1	9.7	5.5	212.6	1.8	4.0	7.2	40.3	0.8	21.8	0.0	41.7	124.7	36.4	3.0	0.4	0.6	22.2	11.2	22.2	2.3	81.9	0.0	9.2	10.9	1.9	16.2	1.2	4.3	2.6	1.5	0.9	3.8	7.0
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492417-164621482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.6;tongue: 20.3"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 92.0;Granulosa cells: 272.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.5"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	0.7	3.0	0.0	0.3	0.4	0.0	0.3	0.0	0.6	0.1	0.1	0.9	0.9	0.2	5.4	1.2	0.1	0.1	2.7	1.3	0.1	6.6	12.6	0.4	0.0	0.3	0.2	2.0	4.7	0.0	0.3	1.7	0.0	0.3	0.3	0.4	0.3	0.3	2.4	0.2	0.2	0.4	0.0	0.2	0.2	2.6	0.3	0.0	0.9	20.3	0.0	0.0	0.1	0.0	0.8	5.5	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.5	0.0	2.9	0.0	0.9	0.3	0.8	1.2	0.3	0.0	4.1	0.0	0.3	1.3	0.1	0.0	0.0	0.3	0.8	1.8	0.0	1.6	9.6	0.0	0.0	0.0	1.5	2.1	0.0	0.0	1.9	0.2	1.2	0.0	0.0	0.1	9.1	0.4	3.1	0.3	0.0	0.3	0.0	1.1	0.7	0.0	11.8	0.1	1.2	0.0	0.1	0.4	0.1	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.6	1.3	0.1	0.3	0.2	0.0	0.0	0.3	0.0	4.5	0.0	5.4	0.7	0.1	0.1	0.3	0.0	0.0	1.3	1.6	1.4	17.7	22.8	0.0	16.5	0.0	0.2	1.3	0.3	92.0	13.5	1.5	0.6	0.2	3.0	0.0	0.0	24.5	3.3	0.2	2.4	0.0	1.9	0.0	272.4	1.1	40.4	0.0	0.0	6.2	2.6	0.0	1.0	0.3	4.4	9.3	3.2	19.6	1.9	1.0	0.3	0.0	3.5	2.3	4.0	0.0	17.3	0.0	0.8	0.3	14.7	0.0	0.8	13.1	0.8	10.9	0.7	6.4	0.1	0.0	0.1	0.2	30.4	1.6	0.2
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GREB1	KIAA0575	ENSG00000196208	"Growth regulating estrogen receptor binding 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"ovary: 278.3"	"Cell type enriched"	"Detected in many"	9	"Granulosa cells: 545.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.8	3.4	8.5	0.7	9.6	0.4	13.7	2.1	9.9	60.2	0.8	1.0	0.7	61.3	7.0	0.6	53.4	2.8	4.6	7.8	20.4	1.8	3.1	1.4	0.6	8.7	8.5	278.3	7.6	0.7	8.9	3.0	4.4	63.4	0.2	1.5	1.1	3.8	4.0	2.7	0.9	12.8	3.2	0.2	3.0	14.9	10.7	0.3	0.6	4.8	0.3	1.7	21.5	6.5	0.1	1.0	40.3	0.5	0.2	0.2	1.8	0.0	0.1	0.1	0.3	0.3	0.2	2.5	0.3	0.0	6.9	0.2	3.1	0.2	0.1	5.1	3.6	0.4	0.3	39.6	0.5	0.3	2.1	0.5	2.2	0.6	0.4	0.4	0.0	3.9	0.5	1.0	0.3	61.8	1.2	2.0	13.0	0.1	0.1	29.1	0.0	1.9	0.1	0.0	11.8	40.5	0.9	1.1	30.4	5.2	138.0	0.7	0.0	4.1	2.0	0.4	0.1	6.0	4.4	24.7	6.8	11.9	1.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.0	8.5	9.6	2.1	9.9	7.8	20.4	8.7	8.5	4.4	3.2	10.7	6.5	0.4	0.0	0.5	20.2	0.7	0.8	1.9	0.0	0.6	4.8	24.7	13.7	8.3	5.7	0.6	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.8	35.7	36.0	1.3	0.0	0.0	15.0	0.2	3.6	16.9	0.0	23.4	3.8	545.2	0.7	8.9	3.2	3.3	46.9	0.0	0.0	0.0	1.2	2.5	20.2	1.4	5.4	1.0	0.0	0.2	0.0	11.6	20.9	0.4	0.0	55.3	5.0	14.3	0.0	2.5	2.9	0.5	0.0	7.2	14.8	1.1	2.9	0.3	0.3	0.3	1.1	33.1	0.0	2.5
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"GREB1 like retinoic acid receptor coactivator"	Q9C091	18	21242242-21525417	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 9.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 95.2;Inhibitory neurons: 39.2;Leydig cells: 46.0;Oligodendrocytes: 252.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 50.7;BEWO: 100.9;CACO-2: 45.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041647, HPA044218"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	2.6	1.4	5.5	0.1	4.3	0.2	3.3	3.5	3.6	1.2	0.0	0.6	0.1	2.6	2.8	0.2	4.4	0.1	5.3	2.6	8.1	0.4	1.8	0.2	0.1	4.0	4.7	3.7	0.1	0.3	1.2	2.1	4.1	1.6	0.1	3.1	0.5	2.9	9.2	1.3	0.5	0.8	1.7	0.0	0.6	6.2	6.4	0.0	3.8	6.8	0.0	0.1	0.7	4.4	0.0	0.9	50.7	0.0	11.4	0.0	100.9	2.4	2.4	4.3	3.8	45.7	3.7	0.1	5.1	7.6	0.1	9.7	19.4	2.4	7.5	0.7	9.3	0.0	13.4	0.4	0.3	0.0	0.0	0.0	0.7	0.1	9.3	0.5	0.0	1.4	0.0	0.3	10.5	3.5	0.2	0.2	4.9	0.4	6.0	0.2	0.0	2.0	4.8	8.7	3.2	0.0	0.1	1.6	0.2	13.2	2.7	0.2	20.9	0.5	2.9	4.9	0.0	0.1	0.7	0.0	2.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	4.3	3.5	3.6	2.6	8.1	4.0	4.7	4.1	1.7	6.4	4.4	0.4	0.0	0.5	0.7	0.4	0.1	0.1	1.0	0.0	32.3	3.1	1.1	13.4	0.0	1.1	3.7	2.1	3.2	1.8	0.1	0.0	0.2	8.3	2.2	3.4	0.5	0.0	0.0	23.1	0.4	13.2	6.2	0.0	7.0	0.0	95.2	0.0	3.1	0.5	0.0	39.2	0.2	0.0	0.0	1.1	17.9	46.0	0.3	1.8	2.8	0.1	0.8	2.1	8.0	252.5	2.8	0.0	35.7	0.0	0.6	0.3	0.0	2.3	1.6	6.6	2.8	2.3	4.3	5.6	0.0	0.9	1.5	0.3	10.5	1.5	0.2
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32718004-32745106	"Disease related genes, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 113.0;smooth muscle: 68.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8"	"Group enriched"	"Detected in many"	5	"hippocampal formation: 3.2;olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			HPA007526	Uncertain				"Secreted to blood"	NA	NA	242000000			"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	32.7	0.5	1.4	6.5	3.6	0.2	5.5	1.1	2.4	44.7	0.0	36.1	2.6	9.6	0.0	13.6	1.1	113.0	1.3	1.5	1.3	1.2	1.1	2.2	1.1	3.1	3.0	0.3	2.2	0.0	0.2	0.3	1.8	8.2	26.7	0.1	0.6	3.8	0.6	7.6	52.3	68.2	1.1	0.8	36.8	0.5	3.8	0.0	2.3	0.0	1.7	21.7	50.4	6.1	0.0	3.5	0.0	0.0	11.1	12.5	0.0	294.7	468.5	112.5	286.8	0.3	0.0	0.0	0.0	957.0	0.0	0.0	0.0	0.0	109.7	0.0	0.1	0.0	0.1	0.0	3.3	0.0	0.0	3.1	0.0	227.8	0.1	70.6	0.0	0.0	0.0	0.0	143.4	0.1	0.0	0.0	1.2	0.0	0.9	0.0	20.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	57.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	3.6	1.1	2.4	1.5	1.3	3.1	3.0	1.8	1.1	3.8	6.1	0.7	0.0	0.0	0.3	0.4	6.6	6.5	0.0	0.6	2.1	1.7	0.9	3.4	0.0	0.0	66.2	2.1	0.2	0.7	0.4	0.0	0.4	0.2	0.6	2.3	1.9	0.0	0.0	2.5	0.0	0.1	17.7	0.0	0.7	0.0	121.1	0.7	1.2	1.0	1.7	0.5	0.6	0.0	0.3	12.8	0.0	0.0	2.3	3.6	0.0	2.7	0.3	0.0	1.5	40.5	0.3	0.0	0.4	0.2	9.9	0.1	0.3	0.0	1.3	0.0	181.4	16.1	0.1	1.4	0.3	4.5	0.3	2.1	0.1	0.1	6.5
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612155	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 31.4;liver: 26.3"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 298.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 32.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"	NA	NA		12000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.8	1.7	2.1	9.7	2.9	0.1	3.4	0.1	6.1	0.9	0.0	17.1	10.8	9.6	2.2	17.1	1.4	31.4	0.0	1.3	1.8	2.3	26.3	1.2	0.2	2.1	1.7	6.6	0.2	22.9	2.1	4.0	1.9	2.6	20.1	5.8	4.2	1.8	7.3	3.6	14.9	6.4	1.3	3.2	9.3	0.3	2.8	0.3	0.5	0.7	0.2	3.8	0.5	2.0	0.0	0.0	0.1	0.0	1.9	2.4	0.0	6.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	2.8	1.3	0.0	0.0	3.9	0.5	0.8	0.4	1.0	0.0	0.0	3.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	2.9	0.1	6.1	1.3	1.8	2.1	1.7	1.9	1.3	2.8	2.0	0.2	0.0	0.0	0.3	0.2	4.7	0.0	0.0	0.6	20.8	14.0	0.1	0.6	0.0	0.0	0.0	12.5	7.4	0.6	0.6	0.0	0.0	0.0	2.3	1.2	0.6	1.2	0.0	28.6	0.0	1.7	17.4	0.0	13.7	0.0	0.1	0.7	20.4	1.5	0.0	30.5	0.1	0.0	0.3	6.2	0.2	0.0	0.2	1.8	3.7	0.0	0.4	1.0	1.5	1.2	0.1	0.1	4.5	0.1	0.6	0.0	0.0	0.7	6.7	0.0	0.2	1.4	2.4	2.7	0.6	3.7	298.0	1.6	2.3	0.6	0.1
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.6;skin 1: 87.7;vagina: 66.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	4.5	1.3	2.2	1.2	2.3	8.7	39.8	0.8	2.8	31.0	1.0	1.5	1.2	1.0	7.3	119.6	2.2	3.0	2.5	2.7	2.5	4.0	12.2	5.0	1.0	0.8	1.5	0.4	4.2	29.0	3.6	26.7	0.9	11.4	1.0	11.4	44.7	7.3	1.1	87.7	0.7	0.7	0.6	0.8	3.7	3.2	4.3	0.9	2.9	0.4	26.1	13.9	66.9	1.7	10.9	0.2	1.2	3.0	0.4	0.5	212.3	1.0	1.5	0.7	1.2	0.9	7.5	1.4	0.4	0.1	1.5	6.5	13.0	1.4	3.1	3.2	5.9	0.3	2.3	4.3	0.3	0.7	1.2	0.4	5.5	6.0	0.0	0.0	1.1	2.3	2.2	4.1	0.0	14.3	2.2	1.7	0.8	3.5	2.5	0.9	1.0	1.9	1.4	41.4	2.4	1.6	2.0	112.3	2.7	17.4	13.7	0.4	1.2	0.6	2.6	3.3	1.3	2.7	1.7	1.5	0.6	1.7	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	1.7	2.2	2.3	0.8	2.8	2.7	2.5	0.8	1.5	0.9	0.6	4.3	1.7	2.2	3.2	8.1	3.9	1.2	40.0	23.1	10.7	2.8	25.5	37.1	19.9	2.1	1.5	31.1	20.2	62.6	61.9	1.3	1.2	0.0	2.9	6.4	4.5	1.3	4.2	3.5	0.0	14.6	9.1	80.5	5.4	3.1	9.6	10.2	0.4	2.5	7.7	7.7	11.8	6.0	0.8	4.1	1.0	15.7	3.0	0.0	10.6	21.4	1.9	1.0	1.1	0.0	4.0	1.0	5.7	0.1	0.4	1.0	31.5	0.1	2.4	18.6	11.5	0.0	3.0	3.7	9.6	5.1	35.2	132.7	184.6	2.1	0.1	1.2	104.6
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319357-24364482	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 120.8;skin 1: 53.5;vagina: 47.7"	"Group enriched"	"Detected in some"	5	"Squamous epithelial cells: 113.5;Suprabasal keratinocytes: 99.3;Urothelial cells: 78.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 13.3;head and neck cancer: 16.1;urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 46.1;HaCaT: 36.6;MCF7: 58.5;OE19: 21.2;RT4: 64.8;SuSa: 33.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.2	0.1	0.4	0.3	0.4	0.1	1.9	1.4	0.6	23.3	0.1	0.1	0.6	0.1	1.6	120.8	0.6	0.7	0.0	0.3	1.3	0.2	0.3	0.1	0.0	3.8	4.6	0.0	0.2	0.9	0.2	1.4	3.4	1.5	0.2	0.1	16.7	1.6	0.1	53.5	0.3	0.0	2.3	0.0	0.5	2.3	0.8	1.0	0.0	0.0	25.1	34.7	47.7	1.9	1.2	2.7	1.0	0.0	0.0	0.0	46.1	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	36.6	0.1	3.3	0.0	1.2	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	14.2	0.2	2.7	0.0	0.0	0.0	0.2	0.1	0.0	58.5	0.0	0.2	2.4	21.2	0.0	0.0	0.0	0.2	4.6	64.8	0.3	0.0	0.2	6.3	0.0	33.3	4.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.4	0.6	0.3	1.3	3.8	4.6	3.4	2.3	0.8	1.9	0.0	0.0	0.6	0.0	0.0	14.4	13.2	5.2	8.6	0.0	1.1	0.3	0.5	0.0	6.4	1.8	0.0	4.1	0.0	0.9	0.0	0.4	0.5	3.8	0.1	0.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	2.0	0.3	2.1	0.3	0.0	0.3	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.1	0.2	0.0	3.3	0.0	0.0	0.0	0.3	2.6	0.0	113.5	99.3	18.5	0.0	0.0	0.1	78.4
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 652.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 864.6;Proximal tubular cells: 817.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	58.9	143.1	72.6	35.5	83.9	40.5	55.7	84.1	74.3	53.0	76.1	60.5	63.5	58.5	62.6	62.5	51.0	36.6	107.6	69.7	76.4	156.5	652.5	42.9	55.8	76.3	76.2	63.4	64.2	49.1	35.7	35.2	77.6	50.7	35.4	20.8	74.8	46.4	168.5	64.2	51.4	42.8	75.9	41.7	60.7	37.9	78.4	34.7	43.4	146.4	51.5	52.9	51.8	89.4	111.7	157.7	87.5	81.0	80.1	86.4	87.7	86.2	114.3	115.8	125.2	60.3	47.2	106.5	50.0	105.3	85.8	49.3	51.7	113.5	69.3	140.3	62.8	61.6	144.1	107.5	124.3	58.7	61.6	104.2	97.2	67.6	87.4	98.0	102.2	67.5	116.1	42.9	104.2	85.3	58.9	60.8	53.5	101.1	67.5	55.4	62.1	59.1	155.9	63.0	36.3	64.3	74.4	143.8	84.1	79.1	80.1	75.7	109.7	63.5	100.4	44.0	76.9	33.1	27.4	70.8	90.8	33.5	95.7	45.0	64.7	33.9	39.3	66.9	32.7	61.6	40.8	44.6	70.3	65.6	39.6	33.9	14.5	64.5	56.7	63.4	57.8	52.0	72.6	83.9	84.1	74.3	69.7	76.4	76.3	76.2	77.6	75.9	78.4	89.4	50.7	57.7	30.2	24.2	37.5	43.3	52.5	87.3	41.5	39.0	53.7	65.7	103.7	177.3	53.8	51.5	20.9	152.6	33.9	65.3	248.4	78.0	14.9	38.4	65.4	47.9	62.2	54.7	10.3	89.0	93.0	67.7	52.0	44.8	50.1	93.3	67.5	864.6	110.8	23.5	11.0	79.7	71.2	82.9	45.8	16.0	74.6	49.2	80.0	14.0	71.1	102.8	33.0	16.1	44.9	73.8	56.9	98.6	30.1	46.4	135.6	817.7	36.0	29.1	78.9	54.3	71.8	22.3	19.0	74.6	56.3	88.9	32.5	233.3	80.9	48.1
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 83.7;retina: 32.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 322.4;Inhibitory neurons: 608.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;ASC diff: 3.5;BJ: 5.5;BJ hTERT+: 2.9;LHCN-M2: 8.1;U-266/70: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035202	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035202: AB_2674516"	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.2	0.4	38.7	0.1	42.8	0.0	0.4	43.5	79.8	0.2	0.0	0.6	0.2	0.1	0.7	0.1	0.1	0.0	0.8	83.7	23.2	0.1	0.0	9.3	0.0	3.4	3.6	0.2	0.3	0.2	1.2	0.0	2.7	0.1	0.1	32.6	0.1	0.5	0.2	0.3	0.3	1.0	5.3	0.0	0.6	0.9	27.9	0.1	0.3	0.4	0.0	0.1	0.3	18.1	0.0	0.0	11.6	0.0	3.5	2.3	0.0	5.5	2.9	0.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	42.8	43.5	79.8	83.7	23.2	3.4	3.6	2.7	5.3	27.9	18.1	0.2	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	36.3	0.3	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	5.1	0.1	5.6	0.4	0.0	0.0	322.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	608.8	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	7.5	0.0	49.0	0.0	94.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;retina: 17.8"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 468.4;Horizontal cells: 198.5;Inhibitory neurons: 396.3;Oligodendrocyte precursor cells: 385.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 23.8;BJ hTERT+: 34.5;fHDF/TERT166: 45.9;U-2197: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058659: AB_2683791, HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	0.8	10.3	20.0	0.3	25.3	0.1	1.4	1.3	31.6	6.7	0.0	0.7	0.3	2.1	3.6	0.4	1.5	1.2	2.0	29.0	4.0	2.5	7.7	0.3	0.5	1.9	3.4	4.1	1.7	0.0	1.0	0.4	1.4	1.7	0.8	17.8	0.2	1.9	0.2	0.5	0.5	1.9	4.5	0.1	2.0	0.7	6.4	0.2	0.2	0.1	0.8	0.6	2.8	20.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	23.8	34.5	0.4	0.9	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.6	0.0	15.1	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	25.3	1.3	31.6	29.0	4.0	1.9	3.4	1.4	4.5	6.4	20.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.8	0.6	13.6	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.1	0.3	8.7	0.3	0.0	0.0	468.4	0.2	0.1	6.4	1.1	0.2	0.0	0.1	0.4	6.1	0.1	198.5	396.3	0.0	0.0	0.0	1.5	0.3	9.3	0.2	1.8	14.0	0.0	1.9	0.0	385.0	67.6	0.3	0.0	4.1	0.0	0.4	0.0	6.2	0.1	3.8	0.0	0.2	4.5	0.0	0.1	0.0	1.0	0.1	0.1	0.7	0.0	0.0
GRID2	"GluD2, GluR-delta-2"	ENSG00000152208	"Glutamate ionotropic receptor delta type subunit 2"	O43424	4	92303966-93810157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 40.2;testis: 34.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 380.6;Excitatory neurons: 787.2;Inhibitory neurons: 982.0;Late spermatids: 674.2;Microglial cells: 382.2;Oligodendrocyte precursor cells: 2319.7;Oligodendrocytes: 453.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.8"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 7.7;U-266/70: 3.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 68.3"	"HPA056253, HPA058538"	Enhanced					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA056253: AB_2683079, HPA058538: AB_2683747"	"unprognostic (2.78e-1)"			"unprognostic (1.29e-4)"	"unprognostic (7.23e-3)"			"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.38e-3)"		0.0	2.2	5.6	0.0	6.2	0.0	0.0	40.2	4.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	3.1	10.7	0.1	0.0	0.0	0.0	4.6	5.3	2.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	4.9	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.1	34.0	14.2	0.0	0.0	0.2	0.0	0.1	0.1	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	3.5	0.0	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.2	40.2	4.0	3.1	10.7	4.6	5.3	4.8	3.4	14.2	3.8	0.0	0.0	0.0	86.8	0.0	0.0	0.0	0.0	2.2	108.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	380.6	0.0	0.1	1.5	0.0	0.0	787.2	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.1	28.6	982.0	0.0	0.0	0.0	0.0	674.2	5.0	0.2	0.0	382.2	0.0	115.3	0.0	2319.7	453.5	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	7.7	6.6	0.0	1.2	3.7	2.9	0.2	0.0	0.0	0.0	6.4	0.0	0.0
GRIK1	"GluK1, GLUR5"	ENSG00000171189	"Glutamate ionotropic receptor kainate type subunit 1"	P39086	21	29536933-29940033	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 12.5;brain: 32.6;retina: 38.2"	"Group enriched"	"Detected in some"	10	"Inhibitory neurons: 2260.1;Oligodendrocyte precursor cells: 862.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014623, HPA073879"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA014623: AB_1850305, HPA073879: "	"unprognostic (1.39e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.47e-8)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-3)"	0.2	12.5	7.5	0.2	6.6	0.1	1.8	2.4	6.0	0.8	0.0	0.3	0.0	0.1	2.0	0.3	0.0	0.1	0.0	8.4	12.3	0.0	0.1	0.1	0.1	30.0	11.2	0.3	0.0	0.0	0.2	0.4	32.6	2.4	0.5	38.2	0.0	0.1	0.1	0.8	0.4	0.1	2.6	0.1	0.2	0.5	9.7	0.0	0.0	0.0	0.0	0.4	0.4	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	6.6	2.4	6.0	8.4	12.3	30.0	11.2	32.6	2.6	9.7	2.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.0	0.0	149.8	2.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.1	1.2	0.4	0.0	0.0	29.8	0.0	0.0	0.7	0.0	0.2	0.0	148.8	0.0	0.0	0.1	1.7	2260.1	0.0	0.0	0.0	0.4	13.2	0.3	0.2	3.6	10.3	0.0	2.5	0.0	862.5	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.1	33.8	0.1	0.0
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	101181257-102070083	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"brain: 93.3"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 724.6;Inhibitory neurons: 2376.0;Oligodendrocyte precursor cells: 1234.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.9"	"Region enhanced"	"Detected in all"		"cerebellum: 93.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.4;BJ hTERT+: 26.6;fHDF/TERT166: 20.8;HAP1: 10.2;SiHa: 11.1;WM-115: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"	"unprognostic (1.43e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-4)"	0.2	1.8	18.7	0.4	20.3	0.3	0.2	93.3	25.2	1.4	0.0	0.5	0.6	0.4	1.1	0.4	0.3	0.5	4.5	20.7	28.4	0.8	0.1	0.1	0.1	1.0	6.8	0.4	2.6	0.0	1.6	2.4	7.9	0.9	0.4	4.2	0.7	1.2	0.9	1.6	0.6	0.3	1.6	0.4	0.3	0.7	19.8	0.0	3.4	0.1	0.0	0.5	0.4	7.6	0.1	0.1	3.1	0.2	3.6	0.1	0.0	16.4	26.6	0.8	0.5	0.0	0.3	0.1	0.0	20.8	0.0	5.1	10.2	0.0	0.3	0.0	0.0	1.7	8.5	0.0	0.9	0.0	0.2	0.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.2	2.7	0.0	0.2	0.1	0.4	0.1	0.7	0.0	3.3	7.0	11.1	0.0	0.5	0.5	0.0	0.8	0.0	2.1	0.5	0.1	1.3	0.1	0.0	0.1	1.5	0.0	24.6	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	18.7	20.3	93.3	25.2	20.7	28.4	1.0	6.8	7.9	1.6	19.8	7.6	0.2	0.0	0.5	54.9	0.0	0.6	1.0	0.1	0.6	11.4	0.1	0.0	5.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.8	3.4	1.9	0.4	1.8	0.0	724.6	0.6	0.0	1.8	0.0	0.5	0.0	13.0	0.0	0.0	0.1	0.0	2376.0	0.0	0.0	0.0	0.0	7.7	0.3	0.1	1.8	38.4	0.0	0.5	0.0	1234.0	40.5	0.1	1.1	0.4	0.0	0.8	0.1	0.0	2.2	1.1	0.0	0.7	4.6	0.0	0.5	0.1	0.6	0.0	0.0	4.3	0.1	0.9
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	0.0	1.7	6.8	0.0	6.5	0.0	0.4	5.6	6.4	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.3	10.3	6.0	0.2	0.0	1.5	0.1	7.2	6.2	2.8	0.0	0.0	1.6	0.2	7.3	0.3	0.1	1.0	0.1	0.0	0.0	0.2	0.1	0.1	4.9	0.4	0.0	0.8	9.6	0.1	2.0	0.1	0.1	0.1	0.2	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.6	18.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	4.7	0.0	0.2	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.5	5.6	6.4	10.3	6.0	7.2	6.2	7.3	4.9	9.6	5.5	0.0	0.0	0.6	82.9	0.1	0.0	0.1	0.0	1.2	0.8	0.5	0.5	1.6	0.0	0.0	0.0	35.5	0.0	0.7	0.0	0.0	0.0	4.4	0.3	0.0	0.2	0.0	0.0	115.6	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	43.7	0.0	0.0	0.8	0.0	7.5	0.3	1.0	0.0	4.7	0.2	0.0	8.2	196.1	108.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	7.8	0.2	0.8	3.3	0.1	0.0	0.1	0.4	0.1	0.0	0.5
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 132.6;Inhibitory neurons: 134.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	0.0	0.1	15.7	0.2	46.4	0.0	0.2	0.0	186.7	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	35.9	0.0	0.0	0.0	0.1	0.1	1.3	19.5	0.0	0.1	0.2	0.7	0.0	3.8	0.7	0.0	3.7	1.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.4	0.0	1.9	0.0	2.5	0.0	0.0	5.2	3.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	46.4	0.0	186.7	35.9	0.0	1.3	19.5	3.8	0.0	0.0	35.6	0.0	0.0	0.0	8.5	0.0	0.0	0.3	0.1	0.0	28.0	1.2	0.9	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.9	0.2	0.1	0.2	1.8	0.0	132.6	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.7	134.4	1.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	9.4	2.0	1.7	0.0	10.1	7.6	0.2	0.1	0.0	0.0	0.7	0.5	0.1	0.3	7.8	0.0	0.0	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.7	0.0	8.4	0.0	0.1	0.0	31.7	0.3	0.0	0.2	0.3	0.3	2.5	1.1	2.1	0.1	3.0	20.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.1	0.1	0.6	0.2	0.2	0.2	0.1	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.4	0.0	31.7	20.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
GRIN2B	"GluN2B, NMDAR2B"	ENSG00000273079	"Glutamate ionotropic receptor NMDA type subunit 2B"	Q13224	12	13437942-13982002	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"brain: 36.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 625.2;Inhibitory neurons: 882.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	34	"amygdala: 11.5;basal ganglia: 15.6;cerebral cortex: 36.1;hippocampal formation: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;NTERA-2: 1.6;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069762	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA069762: AB_2686192"	"unprognostic (2.01e-2)"	"unprognostic (4.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.39e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.48e-5)"	"unprognostic (2.43e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-1)"	0.2	0.0	11.5	0.0	15.6	0.0	0.0	0.0	36.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	15.6	0.0	36.1	29.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	8.8	0.7	0.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	0.0	35.0	0.3	0.1	0.4	0.0	0.0	625.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	882.5	0.5	0.0	0.0	0.0	35.8	0.0	0.0	0.0	14.0	0.0	0.1	0.0	173.4	9.9	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.0	1.8	0.0	0.1	0.2	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1
GRIN2D	"EB11, GluN2D, NMDAR2D, NR2D"	ENSG00000105464	"Glutamate ionotropic receptor NMDA type subunit 2D"	O15399	19	48393668-48444931	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 8.4"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 36.5;Oligodendrocyte precursor cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.3;EFO-21: 11.5;HMC-1: 28.4;NB-4: 17.6;SK-BR-3: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB009006	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB009006: AB_2279191"	"unprognostic (9.96e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.43e-4)"	"unprognostic (7.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.66e-13)"	"unprognostic (2.15e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.14e-1)"	0.6	0.3	3.0	0.3	1.4	0.1	0.3	3.0	2.8	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.4	0.3	0.3	1.2	4.8	0.1	0.1	0.2	0.1	4.7	5.8	0.2	0.1	0.9	0.2	0.9	4.8	0.3	0.0	0.8	0.2	0.0	0.1	0.6	0.7	0.1	2.4	0.2	0.2	1.1	8.4	0.0	0.7	0.0	0.0	0.1	0.3	0.6	1.5	17.3	0.4	0.0	1.2	3.5	9.8	2.1	0.0	0.5	0.1	1.3	10.0	0.5	11.5	1.1	0.1	0.1	0.1	0.2	0.3	2.3	0.4	5.4	0.6	2.2	1.8	0.4	28.4	1.3	0.0	1.0	0.0	0.1	0.4	0.1	9.9	0.5	0.1	3.2	0.0	17.6	0.5	8.6	0.3	0.1	0.0	0.3	0.3	0.0	1.8	1.7	0.8	15.0	0.1	0.2	0.0	6.6	5.8	0.0	0.1	0.0	0.0	5.8	3.5	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	3.0	2.8	1.2	4.8	4.7	5.8	4.8	2.4	8.4	0.6	0.3	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.9	0.2	0.3	0.4	0.0	0.0	2.3	0.2	4.6	0.9	0.0	0.1	0.0	0.1	1.8	0.2	1.3	0.0	36.5	0.0	0.0	0.3	0.2	1.5	0.6	0.6	0.0	1.0	0.2	0.7	0.0	15.6	1.3	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.4	0.0	0.0	1.8	0.2	0.2	0.1	0.0
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990056-143993415	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 432.6;monocytes: 355.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	273.1	218.3	154.1	109.0	147.4	215.1	236.4	143.9	226.4	178.9	99.4	144.9	72.1	137.8	79.7	134.2	149.0	74.5	154.8	158.9	149.8	200.8	447.1	233.9	77.7	151.6	155.6	152.7	97.2	144.4	127.7	86.2	160.5	176.0	33.2	180.7	116.7	181.7	145.4	167.1	138.1	75.1	152.1	311.3	104.6	269.4	163.1	58.5	187.4	57.4	55.2	162.1	139.3	140.2	79.3	155.9	76.4	129.5	392.6	196.9	114.5	112.5	258.9	184.4	168.7	95.5	64.3	57.9	120.2	249.7	128.6	69.8	136.8	162.3	75.5	83.1	95.9	60.2	85.9	114.5	412.0	12.7	90.7	254.2	441.0	132.7	193.3	194.5	90.1	23.9	56.1	76.8	160.7	489.5	34.7	32.6	53.4	75.8	231.2	45.4	39.9	111.4	93.2	229.1	52.3	84.8	163.5	177.9	225.8	104.1	342.2	77.6	91.8	115.4	127.1	158.0	82.1	124.3	78.3	44.6	147.4	79.0	67.6	1.8	32.0	9.7	2.5	36.4	3.5	8.3	2.5	2.9	13.3	7.1	4.5	4.1	18.6	3.3	36.1	22.9	2.3	16.0	154.1	147.4	143.9	226.4	158.9	149.8	151.6	155.6	160.5	152.1	163.1	140.2	54.5	19.2	52.7	35.3	45.4	37.2	32.5	58.7	121.3	91.1	62.7	79.4	23.2	45.8	27.9	53.3	79.2	137.2	22.6	29.1	23.5	75.0	273.8	36.8	56.1	47.7	42.1	60.0	21.3	69.1	55.8	67.7	16.8	36.1	16.4	76.2	51.4	194.5	178.4	33.7	26.6	24.3	42.7	225.1	86.7	432.6	61.5	184.3	37.4	22.5	355.1	89.9	6.2	12.5	9.3	66.0	54.5	67.7	44.4	46.7	72.9	73.6	29.4	95.8	46.0	32.4	45.6	96.0	16.9	83.2	36.9	264.2	20.8	38.7	31.4	25.5
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.4"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.5	4.3	8.5	2.7	6.6	0.5	3.0	0.0	14.2	1.2	0.0	3.1	1.1	3.5	4.7	7.3	4.2	1.6	2.7	3.9	12.4	3.3	0.3	0.8	0.7	0.7	7.6	1.2	2.0	16.4	3.3	8.2	2.2	4.6	1.7	4.8	6.0	9.3	1.0	9.8	1.9	2.8	0.0	2.6	0.8	6.2	3.0	0.7	5.0	0.6	1.3	2.6	2.0	3.7	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	8.5	6.6	0.0	14.2	3.9	12.4	0.7	7.6	2.2	0.0	3.0	3.7	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GRIPAP1	"DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3"	ENSG00000068400	"GRIP1 associated protein 1"	Q4V328	X	48973720-49002264	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 212.7;Rod photoreceptor cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000282, HPA000615"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Cytosol"		"HPA000282: AB_1079022, HPA000615: AB_1079023"	"unprognostic (3.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.93e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-7)"	"unprognostic (4.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.63e-7)"	17.2	23.8	30.6	23.6	31.7	35.3	16.6	28.0	35.5	19.6	19.6	19.3	19.0	17.5	24.7	19.3	19.3	13.3	15.3	31.4	30.4	20.6	22.0	21.3	25.4	29.2	29.6	19.9	15.4	22.9	33.6	15.6	29.9	19.0	15.4	48.1	16.7	15.5	18.4	24.4	21.9	14.7	23.1	28.1	19.4	19.7	30.1	26.1	20.9	12.9	24.1	18.0	17.5	32.2	27.9	43.6	30.7	64.3	18.1	13.8	27.7	22.4	27.6	28.3	26.7	23.7	24.0	42.1	12.6	22.3	30.4	39.0	38.5	24.5	22.6	49.3	19.7	34.0	59.8	25.2	31.1	36.7	58.3	14.4	34.5	37.7	27.8	26.2	26.1	35.6	25.2	54.3	26.3	51.5	32.2	49.3	36.3	19.8	23.5	35.3	46.1	33.8	28.0	34.1	27.0	30.0	47.6	18.8	28.4	44.4	42.6	72.5	31.3	14.9	23.2	30.7	18.5	33.0	27.6	29.6	25.9	54.9	25.9	32.5	14.6	21.3	10.1	13.3	8.6	11.3	10.4	9.7	12.0	13.6	8.9	9.5	25.9	15.7	13.0	12.4	9.0	9.5	30.6	31.7	28.0	35.5	31.4	30.4	29.2	29.6	29.9	23.1	30.1	32.2	22.6	9.6	25.1	13.7	28.6	8.2	15.5	25.2	10.8	67.6	11.6	9.1	13.9	22.8	26.7	18.4	212.7	21.2	30.1	25.8	29.4	15.5	9.3	23.8	19.3	21.2	21.7	17.2	32.1	18.4	9.9	14.4	26.0	26.3	43.1	31.2	18.5	18.5	17.2	69.0	32.9	22.4	34.6	27.0	18.7	14.4	17.1	28.5	7.2	10.3	32.7	25.3	33.0	18.1	17.7	18.4	30.6	19.2	22.2	16.9	23.9	19.1	25.5	169.4	19.7	16.9	17.8	11.5	10.1	16.6	14.2	26.1	25.1	35.8	16.5	19.5
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667219-113737736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"retina: 42.6"	"Group enriched"	"Detected in some"	16	"Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 84.9"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266473-67286556	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 197.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 318.0;REH: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA060707"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: "	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	41.2	35.6	42.4	73.0	42.7	197.1	38.0	31.6	63.8	41.3	16.9	54.3	38.2	34.7	10.4	68.1	41.6	28.8	49.1	44.4	32.5	38.6	47.4	64.1	102.4	36.4	31.6	30.1	33.1	16.2	37.5	25.5	36.5	59.1	33.3	7.9	47.1	22.8	55.6	68.3	88.7	25.1	29.1	186.8	45.4	24.1	36.9	74.7	32.2	40.9	77.8	41.3	47.4	41.8	43.1	29.8	28.1	48.0	22.2	19.9	28.7	24.7	23.4	33.0	27.4	67.1	69.0	215.3	39.5	23.0	44.0	56.7	41.3	33.5	17.2	264.4	26.3	122.5	35.4	30.8	27.9	259.5	238.3	18.0	38.2	26.5	34.8	24.4	42.8	87.7	45.3	107.7	29.0	80.7	147.5	318.0	35.3	125.8	44.4	417.0	55.3	65.2	34.0	54.6	57.0	30.8	36.9	52.9	90.5	16.9	49.7	283.0	24.5	26.7	34.8	33.6	28.4	69.2	67.5	195.3	34.0	153.6	24.6	12.6	17.8	19.2	8.4	27.6	6.3	6.1	6.3	7.0	10.2	6.4	5.0	4.9	35.7	6.9	33.7	9.0	4.4	15.9	42.4	42.7	31.6	63.8	44.4	32.5	36.4	31.6	36.5	29.1	36.9	41.8	33.4	3.2	17.9	0.0	16.7	0.0	0.0	0.0	0.0	0.0	24.5	19.7	0.0	0.0	4.3	5.5	0.0	8.9	80.2	0.0	1.9	10.3	0.0	16.6	14.7	9.0	0.0	0.0	0.0	12.6	5.9	6.1	0.0	18.9	21.5	22.3	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	32.4	0.0	0.0	17.7	0.0	0.0	5.6	0.7	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	9.6	31.0	36.3	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963571-3040760	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3;testis: 42.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 357.7;Late spermatids: 500.3;Spermatocytes: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057023	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	2.8	3.3	6.2	1.1	6.2	1.3	2.4	19.3	8.4	3.0	0.3	2.8	1.0	2.7	2.3	1.8	2.1	2.4	4.9	6.5	5.7	2.2	2.0	2.0	1.2	6.0	5.5	3.5	5.4	4.4	6.2	1.6	5.7	2.0	1.4	10.1	2.9	2.1	4.8	2.3	1.4	2.1	3.6	1.4	3.0	42.3	6.4	1.6	3.3	4.4	1.2	2.3	2.2	7.2	2.3	0.8	2.7	7.9	6.3	6.1	1.6	4.3	1.9	2.4	2.1	2.3	0.7	5.1	1.9	7.1	4.8	0.7	3.6	3.6	2.1	3.4	3.4	5.6	3.2	2.6	3.8	2.3	1.9	4.1	5.7	4.3	2.0	2.7	4.7	5.5	5.4	6.6	5.8	2.6	4.8	4.8	2.1	3.3	6.0	6.1	3.4	2.1	2.3	2.9	15.2	4.8	2.7	1.2	4.1	1.9	6.0	3.5	5.5	6.6	1.7	4.5	4.0	6.5	4.0	3.8	3.3	5.0	2.2	2.1	0.3	0.6	0.3	0.7	0.4	0.3	0.2	0.2	0.1	0.3	0.5	0.4	1.1	0.5	0.2	0.7	0.1	0.4	6.2	6.2	19.3	8.4	6.5	5.7	6.0	5.5	5.7	3.6	6.4	7.2	3.9	3.2	7.4	34.6	2.1	11.2	3.2	5.0	7.4	57.1	5.0	5.5	11.4	4.3	5.6	3.7	123.0	2.1	4.7	0.8	13.7	2.7	357.7	4.2	7.2	4.2	10.3	8.6	53.9	3.8	5.3	8.7	5.1	3.8	5.7	75.0	6.1	3.0	3.4	18.5	71.1	2.4	4.1	2.9	4.6	500.3	13.1	3.1	7.2	9.4	3.0	11.4	2.1	48.2	29.3	2.1	0.4	8.2	5.3	1.8	2.0	5.0	1.2	58.2	6.6	8.4	5.7	180.4	22.3	6.5	11.4	3.0	4.0	34.6	1.3	2.4
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207571-119459745	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	38.4	18.0	4.2	5.9	5.0	2.7	24.6	5.0	4.6	18.8	3.5	26.3	10.0	21.1	3.5	12.6	19.6	5.7	48.8	4.0	5.1	14.2	12.9	65.6	7.8	3.9	3.6	35.0	4.7	21.3	13.3	8.3	3.9	14.1	4.9	1.0	7.8	4.0	11.9	11.5	25.8	7.3	3.3	37.0	27.5	4.1	4.9	6.2	19.6	9.7	6.8	19.4	18.1	3.5	3.7	2.3	5.4	5.7	11.8	11.0	1.6	7.1	32.1	4.1	2.3	1.7	5.4	3.9	1.6	11.1	7.5	0.9	2.3	7.7	2.7	15.4	2.0	0.7	4.6	7.0	8.2	0.2	2.0	1.5	1.1	8.5	1.2	5.2	24.9	2.4	0.4	3.7	1.5	0.7	3.8	3.5	0.8	25.8	5.2	1.3	0.8	0.9	0.6	1.5	1.8	4.9	2.4	1.1	7.0	3.0	0.1	0.9	7.8	2.3	1.6	14.6	2.8	0.9	4.4	2.4	4.9	4.4	2.4	0.4	1.5	2.9	2.0	1.4	0.1	3.8	3.0	1.6	0.9	4.0	4.5	2.0	2.1	0.1	0.5	0.0	4.0	1.7	4.2	5.0	5.0	4.6	4.0	5.1	3.9	3.6	3.9	3.3	4.9	3.5	32.6	57.7	3.7	3.6	19.7	1.7	0.7	0.5	1.2	3.9	2.3	2.0	19.4	0.0	1.3	3.7	0.0	3.7	13.3	0.4	0.0	1.1	18.7	0.4	5.1	28.4	4.8	0.0	17.7	3.1	15.8	35.7	18.8	1.0	4.5	7.8	24.7	2.2	4.4	1.7	36.5	0.8	6.1	15.5	6.3	4.9	4.4	14.2	7.2	56.2	3.6	0.0	19.6	14.1	5.7	2.4	1.2	4.5	10.2	0.7	4.9	0.6	0.8	0.9	59.2	18.2	46.5	1.3	2.1	0.7	2.4	13.1	14.1	4.6	0.5	0.9
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 134.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.6;NK-cells: 123.6;Plasma cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	14.0	10.8	12.6	36.7	12.3	134.1	12.7	8.1	16.0	11.3	9.2	19.7	18.5	14.8	2.4	21.5	13.3	12.4	13.3	12.7	9.6	11.0	13.6	21.8	61.6	13.3	10.5	11.1	13.3	5.5	10.5	6.8	11.1	15.8	8.8	2.2	17.9	7.4	15.7	15.5	29.1	9.2	8.9	63.3	15.9	22.3	10.7	35.9	10.2	6.2	30.2	16.6	13.2	13.9	41.1	44.2	15.7	67.8	4.6	7.4	66.4	29.4	15.1	36.2	35.5	103.0	34.1	48.7	44.0	15.6	53.5	29.1	24.3	67.0	14.3	133.9	77.3	43.5	36.2	36.0	24.1	58.6	52.8	11.7	16.1	36.2	21.4	8.8	20.5	87.8	45.6	170.9	11.2	117.4	61.3	61.4	26.7	20.4	48.1	57.1	25.5	71.2	10.7	32.9	36.0	48.6	24.3	42.5	56.8	7.1	32.6	63.4	26.3	29.6	43.8	31.2	75.1	48.8	64.2	40.7	20.0	95.0	29.2	12.7	20.9	74.5	23.6	36.5	17.0	19.3	19.6	21.9	11.9	19.5	20.3	18.0	50.6	40.3	51.9	12.5	26.4	22.6	12.6	12.3	8.1	16.0	12.7	9.6	13.3	10.5	11.1	8.9	10.7	13.9	9.2	0.0	2.2	2.6	71.7	23.7	60.3	4.9	5.7	10.5	14.7	17.3	3.0	10.0	4.6	3.7	6.2	13.9	70.8	18.2	15.6	6.0	37.2	7.4	8.2	6.6	11.4	41.7	3.7	8.3	12.6	9.7	16.8	6.4	14.7	13.9	10.0	6.5	20.4	16.8	3.5	14.3	4.1	29.8	18.8	90.6	6.2	41.2	14.2	2.8	26.4	9.0	123.6	2.0	3.3	10.3	14.0	5.3	112.2	61.1	11.8	8.5	2.0	8.6	13.1	8.4	10.7	3.9	4.2	11.9	20.3	12.7	66.5	12.1	17.1	56.6
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"retina: 11.3"	"Cell type enriched"	"Detected in some"	73	"Cone photoreceptor cells: 329.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.1	0.4	0.2	0.0	0.6	1.0	0.1	0.1	0.2	0.0	0.0	0.0	329.4	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	2.4	0.0	0.1	0.0	1.9	0.1	1.1	0.0	4.5	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.3	0.1	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM2	"GPRC1B, mGlu2, MGLUR2"	ENSG00000164082	"Glutamate metabotropic receptor 2"	Q14416	3	51707068-51718613	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"brain: 6.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027868, HPA065166"	Approved	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027868: , HPA065166: AB_2685425"	"unprognostic (1.01e-1)"	"unprognostic (8.61e-4)"	"unprognostic (7.66e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-2)"	0.3	0.0	1.6	0.0	2.2	0.4	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.7	0.0	0.0	0.1	0.0	4.9	0.1	0.0	0.1	0.0	0.1	0.0	6.0	0.1	0.0	0.4	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	2.3	1.7	0.7	4.9	0.1	6.0	0.0	0.4	0.3	0.4	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.1	0.0	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.4	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.0	0.0	0.2	0.1	3.5	1.1	0.2	0.3	0.0	0.1	0.2	0.0	0.1
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018643-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"brain: 80.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in all"	7	"cerebellum: 80.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 7.6;SCLC-21H: 18.2"	"Region enhanced"	"Detected in all"		"cerebellum: 79.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 138.8"	CAB022096	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.0	0.2	3.1	0.0	10.7	0.0	0.0	80.3	5.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	2.6	3.5	0.1	0.7	0.0	0.5	0.0	5.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.0	0.8	6.5	0.0	0.0	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	10.7	80.3	5.2	2.2	1.7	2.6	3.5	5.0	1.1	6.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.4	0.1	0.2	3.0	0.0	9.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.8	1.1	0.0	0.3	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.9	5.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1
GRM6	"CSNB1B, GPRC1F, mGlu6, MGLUR6"	ENSG00000113262	"Glutamate metabotropic receptor 6"	O15303	5	178977587-178996206	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Receptor, Transducer"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"retina: 42.6"	"Cell type enriched"	"Detected in some"	31	"Bipolar cells: 440.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014511	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 56: Bipolar cells - Visual perception"			"HPA014511: AB_2669025"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.36e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.3	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.3	0.1	0.0	440.5	0.1	0.0	1.9	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	3.3	0.4	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.0	0.0	0.6	4.2	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	14.2	0.0	0.3	0.2	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1
GRM8	"GLUR8, GPRC1H, mGlu8, MGLUR8"	ENSG00000179603	"Glutamate metabotropic receptor 8"	O00222	7	126438598-127253093	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 44.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 59.5;Excitatory neurons: 104.9;Inhibitory neurons: 134.0;Late spermatids: 69.1;Oligodendrocyte precursor cells: 32.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;HEK 293: 1.4;NTERA-2: 3.5;RH-30: 2.4;SCLC-21H: 3.3;SH-SY5Y: 1.7;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051481	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051481: AB_2681499"	"unprognostic (4.57e-3)"	"unprognostic (5.10e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.12e-2)"	0.0	0.6	3.0	0.3	3.3	0.0	0.0	0.7	3.7	0.1	44.3	1.7	0.1	0.0	0.0	0.0	0.1	0.5	2.4	4.5	4.7	0.6	3.6	0.2	0.0	8.1	8.4	0.8	0.5	0.0	0.3	0.0	9.0	0.1	2.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	2.7	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.0	2.4	0.0	0.1	0.0	3.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.3	0.7	3.7	4.5	4.7	8.1	8.4	9.0	0.0	2.7	1.8	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	59.5	0.0	0.0	0.6	1.2	0.0	104.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.2	0.0	0.0	134.0	0.7	0.0	0.0	0.0	69.1	0.6	0.0	0.0	13.1	0.0	0.3	0.0	32.6	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	1.2	1.6	0.0	0.0	0.0	0.0	0.1	0.9	0.0
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345246-44353106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1420.7;Kupffer cells: 892.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	138000000	110000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	158.9	123.2	61.5	160.4	67.2	478.5	120.7	67.7	97.3	156.7	73.9	189.8	130.9	108.3	134.0	534.0	87.1	157.3	153.0	61.0	69.7	167.4	118.9	309.5	183.2	81.0	71.5	73.8	108.9	87.8	84.4	183.2	87.6	111.7	110.3	12.5	262.9	100.6	60.6	189.7	179.0	91.9	71.8	349.8	127.9	59.4	94.3	67.8	127.7	45.9	107.8	150.0	198.3	97.3	119.3	197.5	52.7	159.5	443.2	231.8	181.2	147.3	447.5	231.6	309.8	86.3	294.0	364.0	299.4	217.6	312.9	185.3	68.6	334.5	75.8	55.8	186.8	38.4	93.8	175.2	245.5	61.6	493.6	332.4	450.5	188.1	106.0	391.2	269.8	64.3	75.1	51.3	148.8	183.1	32.8	172.8	44.3	110.5	334.0	97.7	180.8	433.0	248.2	145.9	54.7	74.7	201.0	92.7	360.9	138.0	209.4	229.0	340.7	437.6	104.6	300.5	97.8	116.3	313.9	122.3	268.1	149.6	124.2	215.1	2057.5	176.5	35.1	1122.4	27.8	174.0	37.1	31.1	1534.2	112.2	27.8	26.5	851.2	30.6	548.1	1331.9	55.4	1613.4	61.5	67.2	67.7	97.3	61.0	69.7	81.0	71.5	87.6	71.8	94.3	97.3	113.0	86.6	83.3	12.7	82.8	112.7	151.1	574.2	97.9	23.6	85.7	69.7	90.7	133.0	332.7	218.8	18.8	429.1	195.7	494.8	9.8	447.7	2.1	103.8	83.8	170.9	124.3	38.7	6.8	307.3	324.1	149.4	83.6	372.5	75.5	90.0	207.8	84.7	1420.7	47.1	6.6	214.6	146.5	892.0	360.8	6.8	60.9	699.2	208.1	20.6	501.6	58.9	20.6	11.1	11.8	285.3	581.7	57.2	65.8	70.7	312.1	120.5	70.0	11.8	85.5	45.4	83.3	25.1	72.2	255.5	96.5	640.0	30.8	89.6	274.5	175.6
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058895-7068064	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036647	Supported		Supported	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	15.4	35.9	12.7	7.7	13.2	24.9	11.2	14.2	16.4	7.2	14.2	10.1	9.0	7.0	8.4	10.9	8.4	7.5	23.1	13.1	13.6	20.7	32.4	7.7	10.2	14.0	13.5	10.4	10.1	13.1	6.9	7.8	14.4	7.9	9.7	12.4	8.6	7.9	26.8	10.7	7.8	8.3	13.8	10.4	11.1	12.8	13.7	7.6	8.9	29.7	11.3	15.2	7.6	14.1	21.7	20.0	11.3	22.3	21.3	17.9	13.9	27.9	22.2	30.8	22.6	35.5	27.5	46.4	18.3	21.4	47.7	21.5	45.0	32.0	35.9	11.2	28.2	49.8	17.6	38.7	24.9	50.7	24.2	17.8	41.4	27.3	32.8	15.7	27.4	30.8	29.7	18.9	36.7	21.9	40.3	62.5	16.9	38.8	65.7	26.6	42.1	19.5	31.0	22.4	31.6	15.3	21.9	21.5	24.3	11.4	19.3	29.2	23.8	20.5	12.7	29.5	49.3	20.3	31.1	31.0	27.9	32.6	16.5	12.0	25.2	41.1	22.8	27.6	31.9	27.3	24.4	25.9	36.3	21.6	30.8	23.9	8.4	26.2	22.7	22.0	26.6	27.2	12.7	13.2	14.2	16.4	13.1	13.6	14.0	13.5	14.4	13.8	13.7	14.1	52.5	25.6	32.1	1.6	40.7	133.4	134.8	68.5	60.9	27.8	44.0	43.6	96.1	34.3	43.1	38.6	10.4	69.3	52.9	35.3	133.1	75.0	60.3	35.0	41.7	51.5	18.5	34.5	4.5	47.7	80.3	46.5	26.0	38.0	58.2	23.2	25.0	109.4	60.3	28.6	5.1	34.1	52.9	29.0	74.7	84.9	28.0	41.7	64.0	2.8	54.0	26.4	17.5	3.0	6.5	91.4	27.6	29.0	27.0	116.5	49.2	203.1	36.2	28.0	0.0	38.1	56.3	51.7	55.0	58.1	125.2	86.1	61.6	92.0	47.0	120.3
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 44.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	6.8	4.2	4.6	5.9	5.0	5.0	5.1	8.8	6.2	13.4	2.8	4.1	4.8	4.3	4.1	44.9	3.8	3.5	8.2	4.8	6.1	6.2	4.7	9.3	7.2	6.3	5.5	5.4	3.7	6.5	3.0	7.5	6.6	3.9	3.9	5.6	7.2	4.0	8.8	4.5	5.0	3.6	5.3	4.8	5.5	4.6	6.0	5.3	6.5	5.1	11.0	4.9	11.0	5.9	16.3	9.5	12.5	44.2	7.9	8.1	25.2	14.8	11.9	13.5	19.1	22.7	10.6	17.5	15.0	7.6	18.0	12.4	20.3	20.8	18.8	9.0	18.0	21.1	16.0	11.9	22.1	21.2	11.1	12.4	24.5	16.3	26.8	5.9	9.7	22.1	18.5	39.4	9.9	11.2	13.4	17.1	16.0	9.9	34.5	17.3	17.0	22.0	8.8	15.7	25.3	20.7	14.7	25.9	44.5	9.3	23.0	24.5	11.2	14.6	16.3	10.4	21.3	14.7	21.6	16.6	14.3	28.9	14.5	9.9	2.5	3.6	5.1	2.4	6.1	3.9	7.6	5.6	3.9	1.8	9.9	7.5	2.0	3.8	2.8	1.1	15.1	4.8	4.6	5.0	8.8	6.2	4.8	6.1	6.3	5.5	6.6	5.3	6.0	5.9	20.9	9.6	6.4	2.3	3.3	17.8	5.3	9.9	9.6	6.1	7.0	6.0	8.8	4.3	9.3	9.2	8.4	9.2	3.5	5.1	1.9	5.3	11.6	2.3	4.9	36.0	6.0	11.4	4.3	6.0	18.2	6.0	3.6	5.6	2.5	6.6	20.3	7.1	6.0	3.3	5.1	4.5	10.2	9.7	7.4	5.4	4.1	2.7	7.2	5.6	4.5	5.4	2.1	3.0	4.9	7.5	3.1	5.3	4.4	7.1	6.5	6.2	5.0	6.7	0.0	6.1	6.0	22.6	12.0	10.0	19.6	5.6	9.2	5.2	7.2	8.2
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
GRTP1	"FLJ22474, TBC1D6"	ENSG00000139835	"Growth hormone regulated TBC protein 1"	Q5TC63	13	113324163-113364148	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Proximal enterocytes: 70.2;Rod photoreceptor cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 60.4;T-47d: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046201	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA046201: AB_2679584"	"unprognostic (5.31e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.07e-3)"	"prognostic favorable (1.50e-5)"	"unprognostic (4.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.50e-3)"	4.4	14.2	2.6	3.2	2.6	2.9	7.9	3.5	5.3	14.3	5.8	24.8	46.0	8.6	3.5	21.6	10.5	6.1	2.6	2.7	2.0	19.3	83.9	4.5	1.6	2.8	2.8	12.8	9.8	8.3	2.8	2.9	2.5	18.3	13.3	20.9	14.5	4.9	10.0	25.9	38.8	3.0	2.8	7.8	13.2	9.5	2.7	1.6	4.0	1.3	2.5	10.6	17.0	3.2	10.1	3.8	7.5	12.9	1.2	1.9	23.6	1.9	0.0	0.5	0.2	21.9	23.2	0.6	1.5	0.6	4.7	15.5	6.6	1.9	0.0	0.5	8.7	13.5	11.2	21.9	2.1	1.1	4.8	0.6	2.9	1.6	0.2	1.0	0.0	1.3	8.2	0.7	0.0	20.5	0.2	1.9	21.2	60.4	2.9	1.1	0.3	0.4	1.7	12.3	0.6	6.6	0.4	11.3	2.7	8.9	54.6	1.3	1.0	0.4	2.8	1.8	0.7	3.8	4.3	1.5	8.1	3.0	4.4	0.6	0.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.3	0.5	0.2	2.2	0.3	0.5	0.3	0.1	0.7	2.6	2.6	3.5	5.3	2.7	2.0	2.8	2.8	2.5	2.8	2.7	3.2	1.1	0.0	6.0	11.1	0.8	21.7	24.0	23.4	14.2	5.8	12.7	8.6	1.2	30.0	15.9	3.7	81.3	28.8	0.7	51.8	23.5	10.0	0.4	6.2	4.8	3.0	3.6	3.8	0.5	9.2	9.2	4.0	14.3	8.8	0.0	18.3	5.7	30.1	1.7	3.3	0.5	28.2	16.2	0.8	1.9	0.8	8.1	2.3	1.8	1.0	2.6	13.7	0.0	1.0	1.0	9.6	43.3	8.6	0.1	11.0	70.2	45.8	9.6	69.6	0.0	5.9	5.3	0.2	8.8	18.2	23.7	25.3	1.2	2.7	40.1	23.8
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445841-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.0	13.7	6.3	14.0	5.8	14.0	14.4	7.0	6.9	13.7	7.2	11.5	13.1	16.1	4.2	18.2	13.0	8.6	13.6	6.2	6.7	13.0	16.3	10.9	16.0	6.9	7.4	13.7	18.6	13.0	8.6	11.4	7.4	12.2	6.5	3.7	12.7	8.9	28.4	17.5	10.9	8.6	5.6	14.1	13.8	7.4	8.7	11.5	11.8	14.5	10.6	14.6	13.5	7.3	58.3	148.9	25.0	47.3	20.2	19.8	21.6	44.9	20.8	62.2	51.8	84.0	42.4	83.4	37.8	28.7	35.0	48.8	62.7	67.9	24.9	63.8	86.5	78.2	48.6	60.4	23.0	71.9	47.8	23.8	37.0	58.9	29.4	14.3	31.5	43.8	107.3	50.1	27.0	59.1	75.1	180.1	68.1	63.8	43.2	92.9	28.3	58.5	26.4	70.4	56.2	32.1	51.3	71.0	22.4	15.4	34.6	36.5	35.2	57.9	49.1	25.9	107.1	50.6	126.8	78.3	19.7	64.8	69.0	0.3	24.8	3.3	41.5	40.7	46.4	44.4	37.1	41.0	40.9	44.8	42.6	40.3	2.0	41.6	32.4	29.7	36.3	37.4	6.3	5.8	7.0	6.9	6.2	6.7	6.9	7.4	7.4	5.6	8.7	7.3	17.3	3.2	17.5	1.0	26.8	46.3	31.7	18.6	23.3	13.4	16.0	13.7	7.1	14.3	14.3	12.9	0.0	41.4	15.1	14.4	23.5	29.0	3.8	13.1	20.5	19.1	19.2	28.8	1.6	18.2	39.7	18.1	13.3	14.3	19.7	16.8	13.6	18.5	24.4	21.9	3.9	14.5	14.2	11.1	14.3	19.4	17.1	11.4	28.4	2.8	25.3	6.1	19.6	3.0	2.6	22.4	6.5	12.4	28.5	24.2	6.8	18.8	16.8	15.7	19.7	22.7	20.4	9.4	34.3	20.5	40.6	35.0	17.9	26.3	17.1	24.0
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42892713-43030658	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"seminal vesicle: 2.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 3.2;Spermatocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040824	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRXCR2	DFNB101	ENSG00000204928	"Glutaredoxin and cysteine rich domain containing 2"	A6NFK2	5	145858521-145937126	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Early spermatids: 15.1;Late spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.2;hippocampal formation: 4.1"	HPA059421	Uncertain					NA	NA						"Cluster 34: Spermatids - Unknown function"			"HPA059421: AB_2684010"						"unprognostic (4.71e-2)"						"unprognostic (2.91e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSC2	GSCL	ENSG00000063515	"Goosecoid homeobox 2"	O15499	22	19146993-19150292	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 1.2;retina: 1.1;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043011	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"				"HPA043011: AB_10959883"						"unprognostic (3.29e-1)"									"unprognostic (1.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977768	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 58.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		44000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	3.4	0.7	0.2	0.9	0.2	0.4	3.5	0.4	0.4	0.8	0.2	0.7	0.6	0.4	6.6	3.2	0.3	0.8	0.3	0.3	0.2	0.3	0.3	0.4	0.7	0.4	0.0	0.1	0.3	1.3	0.1	1.6	0.4	0.1	1.2	0.0	0.8	0.0	0.4	58.9	0.5	0.6	0.0	0.2	0.3	0.3	0.4	0.5	0.1	0.1	3.4	1.1	1.5	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.5	0.4	0.2	0.0	0.1	0.8	0.0	2.7	0.5	5.4	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.9	0.1	0.1	2.2	0.0	2.6	0.0	1.3	0.8	0.1	0.1	0.6	0.9	0.7	0.1	0.1	0.2	0.5	0.5	0.2	0.2	0.4	0.4	0.3	0.2	0.4	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	5.0	0.0	0.1	0.7	0.0	5.6	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	2.8	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	"Cytolysis, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2;liver: 52.8;stomach 1: 47.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"SK-BR-3: 458.1"					"Not detected"	"Not detected"			"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	13.5	1.4	12.2	13.1	12.4	5.1	9.3	12.9	22.6	6.0	11.6	45.0	66.9	3.4	5.1	4.8	6.2	12.5	4.8	12.5	11.3	6.0	52.8	7.9	11.0	11.5	11.4	6.3	8.2	0.3	4.0	2.9	11.6	10.9	57.0	5.3	4.6	4.4	1.5	8.3	76.2	5.0	11.2	15.0	47.4	4.3	11.9	10.8	8.9	0.4	8.4	20.1	5.6	13.2	2.0	1.5	2.9	0.8	6.7	4.3	2.6	1.8	1.1	0.6	1.8	1.7	55.2	2.8	2.5	1.7	0.9	7.6	1.6	1.6	4.0	11.7	1.8	1.1	0.8	0.8	2.0	0.3	0.7	2.9	9.2	2.4	3.3	4.6	1.2	9.0	1.3	3.5	0.7	0.6	3.3	6.2	0.8	18.2	2.0	3.1	1.1	4.5	0.2	1.8	1.1	1.4	0.6	458.1	1.9	13.2	2.4	1.9	1.7	2.0	3.0	5.1	1.0	9.9	9.2	2.8	0.7	1.9	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	12.2	12.4	12.9	22.6	12.5	11.3	11.5	11.4	11.6	11.2	11.9	13.2	1.5	3.2	12.0	9.1	3.9	1.9	1.4	4.9	4.0	2.8	3.3	2.9	2.5	8.6	8.1	5.5	4.2	1.6	3.5	45.7	0.0	1.7	5.5	1.5	1.8	1.8	6.1	0.0	20.1	7.8	0.6	1.2	62.2	1.8	1.3	3.0	0.4	8.1	0.3	1.7	9.2	30.7	0.0	1.3	2.0	5.4	1.2	1.1	3.6	3.7	1.5	1.3	2.1	7.1	5.1	8.9	54.2	1.9	5.6	1.4	108.2	0.3	14.1	2.3	0.0	1.4	2.2	0.4	1.4	1.8	3.4	0.3	4.8	3.0	23.7	6.7
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786624	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 33.1;lymphoid tissue: 12.8;skin 1: 25.5;vagina: 11.4"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 46.5;Basal squamous epithelial cells: 37.5;Squamous epithelial cells: 29.5;Suprabasal keratinocytes: 53.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.8;head and neck cancer: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 3.7;hTCEpi: 1.8;HUVEC TERT2: 2.0;TIME: 5.8"					"Low region specificity"	"Detected in many"			"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.1	33.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	5.4	0.0	0.0	25.5	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.4	11.4	0.1	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.0	1.0	0.0	46.5	0.9	7.4	37.5	0.0	1.5	0.9	3.6	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.1	0.0	3.9	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.1	29.5	53.1	0.0	0.1	0.0	0.0	2.8
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 226.7;Proximal enterocytes: 297.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004656: AB_426076, HPA044487: AB_2678957"	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	43.1	36.0	6.5	34.1	6.7	39.4	41.5	6.5	9.0	42.9	11.1	48.4	51.3	36.7	9.1	22.5	41.5	15.7	24.6	6.2	6.4	50.6	88.8	54.8	42.3	7.7	7.2	39.5	35.1	19.2	18.3	16.5	7.2	39.0	13.6	1.0	32.5	15.1	11.0	16.8	60.3	12.4	7.1	120.1	37.9	7.3	7.0	24.4	46.4	6.1	16.1	35.8	31.7	7.1	40.8	18.4	0.3	0.1	13.4	14.7	23.8	13.8	36.4	44.0	47.4	3.1	54.6	14.5	21.9	21.1	19.6	12.5	0.7	31.1	11.1	43.8	2.8	23.2	5.4	22.6	17.8	4.2	1.0	35.5	2.6	16.1	9.4	14.5	34.1	34.2	1.4	49.1	2.3	0.8	87.5	7.1	0.3	27.3	67.6	30.2	1.5	48.7	22.5	39.9	0.5	0.6	44.2	39.8	43.4	5.6	69.7	24.8	13.3	0.2	44.6	3.2	22.1	16.5	22.4	0.4	26.5	19.6	21.8	65.4	44.7	45.9	55.0	73.2	44.8	39.9	48.6	53.7	40.7	31.1	33.8	40.4	46.2	41.1	69.1	29.1	71.1	46.8	6.5	6.7	6.5	9.0	6.2	6.4	7.7	7.2	7.2	7.1	7.0	7.1	91.1	12.8	29.1	6.8	39.8	10.8	47.1	55.7	23.9	0.2	31.6	30.5	12.2	47.1	37.5	31.3	0.0	62.0	54.6	226.7	60.7	68.3	2.2	33.8	20.0	57.0	39.6	14.9	0.1	92.7	98.1	34.0	68.8	27.2	27.3	171.1	75.3	72.3	63.1	0.0	0.1	114.8	30.5	50.1	18.4	7.0	23.6	52.5	17.8	7.5	74.4	28.9	81.4	0.5	0.1	50.2	181.1	22.6	41.1	34.6	297.7	121.8	43.1	1.7	59.2	24.0	34.4	1.4	12.3	13.8	8.9	41.7	61.5	24.2	131.8	45.9
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Syncytiotrophoblasts: 182.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 24.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 174.6;K-562: 205.4;T-47d: 200.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	27.2	15.2	1.4	14.2	0.7	31.9	22.0	24.4	7.9	16.9	0.0	17.9	15.9	15.1	5.0	12.7	15.9	10.6	23.2	3.9	3.0	12.3	14.2	17.7	11.3	4.5	5.8	23.7	23.4	38.6	28.0	31.7	2.1	12.7	11.5	14.4	30.3	13.6	37.9	18.8	14.8	14.2	0.0	18.4	20.8	14.7	2.0	40.7	19.3	9.3	8.7	13.0	14.1	0.7	19.3	33.6	22.0	55.5	13.9	12.7	174.6	25.3	17.4	13.9	5.2	29.0	25.6	11.2	29.9	28.9	12.5	17.9	35.1	9.7	7.0	21.2	29.7	82.4	33.6	36.5	17.9	38.5	44.8	23.7	22.7	14.9	7.1	14.5	3.7	65.7	205.4	2.0	4.6	129.9	138.1	33.9	38.4	20.7	9.9	89.7	7.4	29.1	12.6	7.2	142.7	99.3	49.8	91.8	4.7	19.9	200.7	94.6	6.4	28.3	35.5	7.9	6.9	30.0	19.5	65.3	16.2	23.8	25.4	2.8	0.7	2.2	1.4	1.3	1.4	1.6	0.5	0.9	1.2	1.5	0.2	1.0	0.6	0.9	3.3	0.0	0.0	0.6	1.4	0.7	24.4	7.9	3.9	3.0	4.5	5.8	2.1	0.0	2.0	0.7	52.9	67.3	68.1	30.3	16.6	14.0	7.3	11.6	21.1	65.0	39.6	16.8	37.0	25.8	24.1	38.6	146.0	52.9	25.5	33.6	1.9	14.9	4.3	48.8	34.7	27.0	59.7	65.6	53.2	12.4	75.9	21.7	39.3	61.6	43.6	80.9	17.2	34.7	12.3	35.3	45.4	67.5	20.3	15.1	24.0	5.5	47.2	17.5	10.6	19.7	12.2	7.1	35.0	14.1	13.7	17.9	20.9	61.3	18.6	14.3	12.6	6.2	30.5	62.3	6.6	15.5	10.1	2.3	18.3	33.5	30.0	182.2	21.5	55.8	25.7	12.3
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787528-28063714	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.5;heart muscle: 23.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 8.3;THP-1: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.2	0.2	15.6	0.1	19.4	0.2	0.1	9.4	19.5	0.2	4.4	0.4	0.3	0.3	0.3	0.1	1.5	0.0	23.0	17.9	11.0	0.3	0.4	0.4	0.1	21.8	20.0	0.1	0.1	0.0	0.5	0.9	19.0	0.2	0.1	2.4	0.2	0.1	0.3	0.8	0.4	0.0	12.5	0.3	1.1	1.6	22.5	0.0	0.3	0.0	0.0	0.4	0.1	11.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	3.2	0.7	0.0	0.5	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	19.4	9.4	19.5	17.9	11.0	21.8	20.0	19.0	12.5	22.5	11.8	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.1	8.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	7.4	0.1	0.0	0.0	26.0	0.0	0.0	1.8	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	7.4	0.4	0.0	0.0	0.0	3.6	0.0	0.1	0.0	4.7	0.0	0.2	0.0	89.5	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.7	0.3	0.5	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42226225-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	30.6	43.3	37.5	22.1	44.0	30.7	29.4	33.6	90.2	34.5	13.7	39.4	40.9	38.1	21.7	40.2	31.8	18.7	45.8	47.0	30.9	39.2	30.4	30.4	23.7	39.1	30.9	34.5	29.6	34.4	32.1	19.9	37.6	33.3	21.1	32.6	31.7	25.9	79.2	42.9	37.1	23.0	20.5	31.2	35.4	30.6	38.2	32.9	29.6	42.0	22.7	37.7	33.0	49.5	57.0	102.1	54.3	53.2	30.3	29.5	25.9	42.7	36.1	49.6	46.0	39.0	39.6	41.0	39.6	33.9	44.8	25.6	49.5	51.3	38.5	33.8	74.5	41.5	41.3	42.7	42.7	51.7	54.0	27.2	45.8	41.9	47.7	44.8	46.5	34.7	73.9	63.0	41.1	80.0	87.7	39.0	42.8	84.5	40.0	58.4	33.8	30.4	43.4	76.1	63.7	67.5	52.8	71.6	36.6	42.8	39.5	69.5	40.6	52.0	40.9	31.0	71.9	65.8	82.8	38.7	66.4	49.8	58.2	0.9	0.5	1.4	0.5	0.8	0.9	0.3	0.3	0.7	0.2	0.2	0.2	0.8	1.7	0.3	0.4	0.6	0.5	0.7	37.5	44.0	33.6	90.2	47.0	30.9	39.1	30.9	37.6	20.5	38.2	49.5	45.6	6.4	16.2	5.2	16.4	24.6	17.7	7.3	14.8	40.8	35.0	39.2	12.9	17.2	7.9	16.5	62.6	23.4	31.4	42.3	3.9	15.2	8.6	19.6	21.5	26.6	23.4	28.6	15.1	17.2	25.3	21.3	16.8	25.0	2.5	27.2	18.2	13.9	20.3	60.6	14.9	29.7	6.1	21.3	15.4	14.6	17.7	25.2	16.0	8.4	14.4	41.8	21.6	11.1	12.2	24.2	24.3	16.6	12.6	29.0	45.0	16.0	5.9	47.0	6.6	50.4	27.4	16.4	19.4	20.2	28.1	44.1	20.6	42.6	28.8	30.1
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821321-120094994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	11.0	13.6	9.2	11.7	9.5	15.1	11.2	16.6	16.9	10.0	0.0	11.7	12.3	10.3	11.1	13.8	10.1	11.1	18.2	8.2	13.8	12.0	14.8	13.9	10.4	15.2	15.3	9.3	10.7	17.3	7.1	16.3	16.5	10.0	12.4	23.6	13.2	9.3	17.5	16.3	15.3	13.3	4.9	12.9	12.6	23.1	9.6	20.0	15.1	18.0	11.7	12.0	9.5	12.5	59.3	22.7	46.8	25.5	31.9	29.5	50.3	36.6	57.6	28.3	29.3	25.9	23.8	24.1	19.1	43.0	33.8	46.0	22.2	59.1	45.8	15.5	6.6	42.2	18.4	16.6	35.6	31.6	49.9	34.3	39.5	27.0	56.8	27.3	31.5	29.3	13.6	34.6	40.5	25.1	44.0	10.7	25.2	23.3	28.3	16.9	41.0	22.2	25.1	45.3	37.1	22.6	38.5	29.0	44.1	41.1	30.9	27.0	40.0	45.5	55.1	12.7	20.6	31.9	35.2	44.8	29.4	22.0	33.9	1.0	1.8	6.3	0.7	1.6	1.2	0.5	1.0	1.7	1.4	0.7	0.9	0.8	6.6	0.5	2.1	1.1	1.2	0.8	9.2	9.5	16.6	16.9	8.2	13.8	15.2	15.3	16.5	4.9	9.6	12.5	39.3	32.1	26.7	113.6	28.3	50.9	37.8	22.2	46.1	63.2	21.9	17.0	39.7	20.0	21.4	18.4	60.5	27.0	29.0	37.3	11.7	26.9	138.2	25.2	31.6	31.5	26.9	15.4	218.7	32.0	49.3	25.1	46.4	32.5	17.2	18.1	25.0	22.9	21.5	143.0	246.3	22.3	20.3	27.3	29.2	48.1	13.1	33.4	35.6	197.7	35.5	31.6	22.6	241.8	202.5	49.0	23.4	19.9	29.0	28.7	35.8	17.3	16.3	42.4	13.1	24.4	38.2	38.8	29.3	50.8	41.1	43.0	36.4	32.7	25.9	41.6
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoli	"HPA043054: AB_2678293, HPA046782: AB_2679803"	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	11.4	13.1	13.6	17.5	16.7	16.2	13.2	14.7	16.7	10.4	10.9	60.4	48.3	10.6	11.3	41.0	10.9	14.2	11.0	15.7	14.8	16.4	23.3	9.7	19.6	12.9	12.0	6.7	9.9	9.5	8.1	13.8	13.3	13.9	54.6	67.8	12.1	9.9	12.7	14.5	56.6	15.9	13.9	11.8	23.3	48.7	13.7	11.1	10.3	10.6	22.4	21.1	16.2	14.9	21.9	30.5	33.6	23.1	25.2	29.1	56.6	39.7	30.7	26.2	28.8	22.7	36.6	20.9	23.6	30.4	15.9	23.8	22.1	24.2	37.9	49.9	21.1	8.8	16.1	17.5	23.4	23.1	14.5	23.2	37.7	33.1	32.7	20.1	34.6	23.5	19.2	18.7	33.6	53.5	17.0	18.6	37.3	33.9	38.3	16.7	31.4	19.3	61.5	79.9	11.8	38.4	44.8	41.6	34.9	33.7	31.9	14.3	37.8	12.0	15.1	25.6	12.8	21.7	67.0	17.8	30.6	16.4	19.6	64.4	20.9	47.0	27.7	24.3	42.8	38.3	37.6	32.4	21.2	33.1	37.0	34.5	40.9	37.5	33.6	17.9	66.6	28.6	13.6	16.7	14.7	16.7	15.7	14.8	12.9	12.0	13.3	13.9	13.7	14.9	12.6	12.8	7.4	5.9	24.8	45.2	24.2	27.6	19.9	26.8	18.4	14.5	18.9	14.3	21.7	20.2	41.7	42.7	17.9	166.1	72.4	34.1	384.9	32.3	11.1	17.4	28.1	24.0	14.3	39.4	43.3	12.1	41.8	32.2	19.7	6.6	17.9	17.3	23.6	23.5	10.8	73.0	52.9	19.8	19.6	321.7	8.1	16.8	19.6	5.6	25.2	22.3	16.5	10.6	17.9	39.9	102.9	7.9	22.6	37.4	81.8	47.4	28.6	104.0	19.7	6.5	16.5	40.0	34.1	35.7	65.9	119.6	24.4	7.9	69.1	43.7
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 2486.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1649.5;Fibroblasts: 4145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1135.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1313.9;HaCaT: 533.6"	"Region enriched"	"Detected in all"	4	"white matter: 869.2"	"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	240000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	1892.9	162.5	169.7	109.7	317.4	175.0	1244.6	291.2	213.0	577.4	155.6	867.4	152.0	767.7	108.2	435.1	663.2	226.1	2486.9	163.4	219.8	153.1	40.6	308.7	93.2	380.9	284.6	303.8	140.7	70.9	260.6	79.0	354.7	344.0	204.6	57.8	508.7	400.9	420.4	612.9	384.1	350.0	270.6	136.5	469.7	78.1	279.0	99.7	702.6	687.8	87.3	897.2	655.5	376.1	38.4	60.9	39.0	129.8	1313.9	351.8	26.4	130.9	264.7	30.1	56.5	64.2	130.1	3.0	36.6	182.8	48.5	533.6	3.2	84.3	16.9	6.5	7.6	31.2	57.1	167.5	32.0	7.0	146.0	140.0	84.9	51.7	34.4	83.1	120.4	6.1	10.4	5.3	137.0	81.1	0.4	304.4	12.7	76.2	45.1	8.4	13.1	4.3	156.4	63.4	7.7	10.4	60.9	62.5	197.2	84.6	245.3	158.8	217.4	100.0	33.2	10.4	12.8	1.8	2.0	3.2	105.3	18.2	278.1	302.9	122.0	1135.9	1.9	84.9	0.8	17.6	0.8	1.4	345.3	6.7	0.8	0.7	307.1	217.8	23.7	243.2	4.2	105.4	169.7	317.4	291.2	213.0	163.4	219.8	380.9	284.6	354.7	270.6	279.0	376.1	1649.5	147.4	55.7	82.3	22.7	341.2	278.1	252.7	103.0	7.5	120.8	212.0	272.0	85.8	354.3	121.4	77.2	55.8	74.9	557.7	105.7	258.5	9.9	141.9	163.1	724.8	63.1	17.2	17.1	202.3	94.3	4145.2	322.7	220.6	104.0	31.8	273.5	16.5	492.6	1.7	9.0	762.9	512.7	139.0	798.7	20.2	588.7	273.7	537.2	155.5	487.5	220.6	55.6	33.2	443.1	315.8	590.5	671.8	24.1	91.4	77.4	39.8	583.7	86.5	611.4	362.4	740.4	8.7	13.7	175.9	299.1	84.0	58.7	34.3	52.2	144.7
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	60.8	57.5	22.3	49.5	24.7	76.3	46.0	24.4	33.3	42.0	27.4	56.0	33.8	34.5	46.6	67.9	30.1	35.2	53.4	23.9	24.5	53.6	76.3	47.7	55.4	25.0	23.1	33.3	62.2	62.7	27.5	50.0	26.2	47.8	59.6	35.3	41.0	41.8	127.0	43.5	34.3	46.9	25.0	40.2	49.8	68.7	23.1	56.3	57.7	97.8	82.0	85.7	39.6	29.3	220.1	212.9	116.1	161.0	164.2	169.3	167.5	238.0	245.9	187.1	185.4	153.1	197.8	295.7	303.9	207.5	130.1	164.3	297.8	220.3	312.9	142.4	153.6	202.0	163.1	325.5	137.9	258.7	103.5	133.5	170.0	212.0	288.3	122.4	210.4	146.2	331.7	148.7	220.0	211.2	219.8	134.0	232.9	163.0	120.1	256.4	200.5	345.6	184.7	189.3	186.4	99.6	342.0	256.3	144.2	164.3	222.4	122.6	163.3	206.8	129.5	151.5	190.3	146.6	233.2	253.8	145.4	258.1	128.5	1.4	5.8	7.7	6.3	11.1	8.8	7.9	8.1	7.7	7.0	6.5	8.2	8.1	1.9	7.2	9.9	3.8	10.5	4.3	22.3	24.7	24.4	33.3	23.9	24.5	25.0	23.1	26.2	25.0	23.1	29.3	69.4	76.9	160.2	39.5	92.3	242.2	232.0	47.1	170.8	47.7	95.0	61.6	123.4	57.2	69.1	86.5	50.1	76.1	94.5	88.1	103.7	58.9	94.9	109.0	95.6	74.4	66.6	328.5	61.6	63.4	118.3	77.2	81.1	153.9	24.7	93.2	43.5	77.9	75.2	52.2	47.0	107.2	32.6	60.8	116.3	51.6	47.8	80.9	64.0	35.6	50.1	43.6	25.7	38.7	42.9	73.0	66.9	47.4	166.2	271.0	38.3	120.3	52.7	41.5	59.2	94.6	123.0	138.3	83.5	198.5	257.7	102.1	132.1	128.1	114.1	270.4
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743442-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 95.5;Late spermatids: 189.0;Muller glia cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 47.6;PC-3: 53.8;SuSa: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol		NA	NA		130000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	6.2	6.5	6.8	5.8	7.1	2.8	6.2	5.6	7.5	4.4	5.3	5.0	3.2	5.4	7.5	2.7	5.6	5.1	6.8	6.9	10.7	6.3	11.2	5.5	9.2	5.1	7.1	9.9	4.8	6.1	6.5	2.4	6.1	6.8	3.5	7.7	6.3	6.1	5.9	2.7	5.0	5.3	5.3	5.8	3.9	13.3	9.5	10.4	6.0	5.3	8.6	4.8	2.3	4.7	0.0	9.9	19.7	0.0	13.6	11.8	0.0	11.3	1.9	8.0	10.0	6.3	10.0	29.3	0.0	9.7	24.6	3.2	0.0	5.3	9.1	0.0	12.7	0.4	0.0	0.0	10.1	0.0	12.3	15.7	2.5	7.0	7.1	13.6	11.7	13.4	7.9	2.2	14.2	0.0	2.6	1.8	47.6	0.0	53.8	14.0	18.6	0.0	14.5	10.6	0.0	16.6	0.0	0.0	10.5	38.9	0.0	9.5	7.5	7.9	16.0	7.4	7.5	0.0	17.3	0.0	10.5	1.9	8.9	2.9	2.5	1.6	4.5	3.6	4.5	7.9	3.9	4.3	8.2	8.1	6.3	5.5	0.3	6.5	2.7	6.9	5.6	3.6	6.8	7.1	5.6	7.5	6.9	10.7	5.1	7.1	6.1	5.3	9.5	4.7	6.4	12.8	11.8	3.6	10.1	1.8	5.3	8.9	3.4	17.0	4.2	7.0	17.9	14.3	8.0	14.7	8.4	9.6	11.5	2.0	5.9	14.2	95.5	1.4	10.7	8.3	3.0	4.2	3.9	8.7	4.3	11.2	3.1	1.3	10.8	6.3	6.1	20.3	6.2	11.8	4.3	3.5	2.0	7.6	2.1	189.0	12.8	4.9	3.6	1.9	9.8	61.4	14.4	3.5	2.6	5.6	5.5	18.8	7.6	6.5	0.8	11.5	10.0	10.4	26.3	8.2	7.6	11.6	10.4	2.5	1.4	3.4	7.5	15.7	3.2	3.9
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	18.8	46.9	24.2	17.7	25.6	27.1	23.8	21.4	26.2	21.1	24.6	41.1	30.4	17.4	67.7	43.4	26.9	17.9	24.8	25.4	25.3	42.7	44.8	21.7	15.9	23.7	25.1	14.3	15.7	27.7	26.4	19.8	25.5	34.2	40.6	15.7	28.9	18.6	20.4	34.6	28.4	19.1	22.9	23.7	28.5	23.7	25.9	21.5	23.2	16.9	18.5	22.9	26.1	25.4	63.7	75.7	36.2	51.2	41.4	42.8	51.5	52.9	48.7	81.6	67.1	139.9	75.5	44.8	68.6	54.9	78.7	58.7	53.6	134.8	68.5	20.9	30.4	176.1	46.8	140.1	58.1	44.8	59.5	45.3	141.8	77.0	128.8	36.3	58.4	59.5	87.1	35.7	100.6	70.1	72.5	63.5	21.4	83.2	96.0	64.8	72.7	106.9	117.7	63.9	71.0	41.3	93.6	86.5	70.9	19.7	106.5	40.5	46.7	93.1	52.5	61.7	46.5	35.7	35.9	49.1	79.4	48.6	56.7	17.5	36.2	8.7	30.4	39.2	27.6	12.8	24.0	31.4	43.6	8.7	27.7	23.7	8.4	29.3	36.6	23.9	32.6	29.0	24.2	25.6	21.4	26.2	25.4	25.3	23.7	25.1	25.5	22.9	25.9	25.4	10.6	19.2	10.5	13.4	9.9	26.3	32.5	72.4	38.7	23.0	32.8	20.8	17.1	27.1	38.1	25.8	10.4	79.4	19.1	58.1	25.4	51.6	55.6	14.8	18.2	16.1	23.4	26.9	12.2	47.2	52.5	19.3	37.2	16.4	17.7	80.1	10.0	27.3	59.9	35.3	13.8	50.6	48.8	17.2	17.3	164.1	10.2	26.8	16.0	5.6	31.0	29.6	19.6	10.1	9.9	39.8	40.1	18.4	19.6	21.4	33.8	121.5	18.1	16.9	26.3	12.0	21.0	14.7	18.9	38.1	24.2	49.0	20.6	52.1	77.7	33.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 696.0;liver: 2058.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	149.5	0.0	0.7	0.1	2.5	109.4	0.0	0.0	0.0	696.0	2058.5	4.8	0.1	0.0	0.0	0.2	299.2	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	115.5	0.0	0.0	0.0	11.7	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.3;fallopian tube: 65.4;placenta: 22.7;skin 1: 26.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.3	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.1	0.5	0.0	0.3	0.8	0.8	0.0	65.4	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.5	0.9	0.1	2.9	0.0	22.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	26.0	0.4	0.1	0.0	0.0	2.4	11.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
GSTA4		ENSG00000170899	"Glutathione S-transferase alpha 4"	O15217	6	52977948-52995304	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 295.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 280.0;Granulosa cells: 335.6;Syncytiotrophoblasts: 450.3;Theca cells: 415.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 20.0"	"Lineage enriched"	"Detected in many"	6	"monocytes: 20.0"	"Cell line enhanced"	"Detected in many"		"AF22: 95.4;ASC TERT1: 93.1"					"Low region specificity"	"Detected in all"			HPA048934	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA048934: AB_2680563"	"unprognostic (5.13e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	19.2	295.7	51.2	6.9	52.6	1.7	36.0	55.6	61.0	37.0	37.7	19.2	20.4	27.5	61.2	53.4	24.7	22.9	20.4	53.8	55.5	32.1	34.8	38.7	7.3	44.1	43.5	51.9	31.3	74.4	43.1	48.0	45.2	40.7	24.5	31.2	32.8	28.5	35.9	136.0	19.0	26.2	43.0	13.6	37.2	37.3	48.7	9.9	25.0	36.7	21.4	15.6	40.3	53.8	1.3	10.3	95.4	80.3	56.1	93.1	8.9	13.6	33.7	9.4	16.0	15.6	0.3	1.0	9.1	25.8	10.1	3.9	69.7	13.5	11.8	2.3	29.2	3.3	8.2	54.4	39.8	0.0	2.3	80.1	20.6	12.0	10.1	28.5	59.1	14.1	12.9	15.0	31.9	0.0	1.2	0.3	36.4	58.5	17.3	2.4	41.2	18.6	34.3	1.7	42.2	62.1	0.4	9.9	24.9	48.9	2.5	2.8	28.5	10.0	22.6	9.3	11.6	18.4	2.5	0.5	15.2	1.5	11.0	0.0	0.0	0.0	2.6	0.9	2.0	0.8	0.7	1.2	0.9	2.9	0.5	0.7	0.0	3.2	20.0	1.7	0.8	0.9	51.2	52.6	55.6	61.0	53.8	55.5	44.1	43.5	45.2	43.0	48.7	53.8	15.4	51.3	84.3	22.9	2.2	44.9	22.0	79.0	35.3	39.7	26.1	31.2	10.0	15.7	44.4	27.6	0.0	280.0	3.6	5.6	54.8	14.0	1.4	3.5	24.1	20.0	23.9	9.5	63.4	9.0	108.8	40.5	23.0	4.1	5.7	335.6	31.4	21.1	69.8	37.0	88.2	41.8	57.0	2.5	14.6	9.6	41.7	3.5	96.0	13.1	2.8	70.1	4.1	75.9	62.7	10.8	9.6	39.1	0.8	25.8	12.7	47.7	15.6	11.3	19.7	28.5	36.3	4.7	10.5	96.3	135.5	450.3	3.9	415.9	18.0	21.1
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	2.6	2.4	1.7	3.8	2.1	5.3	5.5	3.8	2.1	3.6	5.7	3.7	2.6	3.6	2.7	5.0	4.3	3.6	2.3	1.6	2.0	4.4	2.5	2.6	4.6	2.0	2.3	2.9	3.2	3.5	2.3	3.7	2.0	3.9	4.0	7.3	2.2	3.5	2.1	3.3	3.0	4.1	1.7	2.8	3.3	10.8	1.9	4.7	5.3	2.7	5.2	2.4	2.2	3.2	11.2	10.0	22.2	19.5	5.8	7.4	16.6	15.5	7.9	18.6	16.6	9.2	21.0	13.2	7.7	6.5	10.8	8.9	25.8	16.0	26.3	19.9	7.2	10.7	9.5	12.6	2.5	20.7	7.4	4.0	8.0	17.2	13.1	7.0	11.6	13.2	22.0	11.7	16.0	9.1	21.9	7.7	12.2	16.4	11.5	14.9	13.1	7.4	20.4	8.0	18.0	8.1	11.9	17.2	6.6	19.5	15.3	8.3	8.8	13.8	14.4	8.6	12.2	4.4	10.1	7.4	8.6	10.4	19.4	0.7	0.8	0.4	0.9	1.1	1.0	1.0	0.8	0.3	1.0	1.1	0.9	1.5	5.5	1.4	1.4	1.3	0.1	0.7	1.7	2.1	3.8	2.1	1.6	2.0	2.0	2.3	2.0	1.7	1.9	3.2	5.8	6.4	3.9	32.7	5.2	2.5	3.6	2.4	2.2	22.3	10.4	4.8	3.3	8.6	1.9	9.2	27.1	6.1	2.6	5.6	3.9	5.8	120.2	7.7	8.1	4.6	4.2	12.8	32.0	5.0	8.1	5.0	6.6	9.9	2.5	9.3	3.6	8.0	7.7	21.9	32.2	4.4	2.0	5.1	3.1	52.4	8.4	4.2	5.4	9.4	4.2	7.3	3.1	53.8	35.4	6.8	1.3	4.5	7.1	3.8	1.7	5.0	2.4	21.4	0.0	5.4	4.9	11.2	7.5	6.4	4.3	3.3	2.9	6.3	6.1	2.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	150.9	180.9	77.5	135.9	82.5	187.0	159.1	82.7	89.2	154.5	141.0	217.9	317.2	95.2	110.7	154.0	144.7	140.6	271.7	75.7	82.7	257.2	449.3	125.1	185.0	85.2	84.0	71.1	138.0	308.2	79.7	104.2	85.3	111.4	230.8	26.9	213.0	96.4	238.6	132.6	277.1	106.6	79.8	236.5	163.4	85.1	83.3	96.2	160.1	324.1	183.7	129.5	112.4	88.6	150.7	106.1	14.7	130.1	224.2	319.7	68.8	87.0	148.4	76.3	150.8	64.5	375.2	85.4	120.8	126.7	114.5	222.4	57.5	136.2	66.0	165.0	62.3	69.6	80.9	102.9	154.1	84.7	108.4	290.4	164.3	88.0	62.0	113.1	205.3	109.5	99.3	100.9	207.2	116.2	87.3	152.9	34.7	291.3	158.6	73.9	2.4	169.6	266.1	81.6	59.7	81.4	159.4	256.3	137.4	88.3	123.6	117.0	122.2	41.0	37.7	108.5	75.2	171.0	86.5	20.0	148.5	336.0	86.6	351.1	537.1	210.7	298.5	597.9	289.7	254.5	554.6	386.4	445.2	183.2	281.3	274.6	165.0	188.3	641.7	187.0	800.5	917.1	77.5	82.5	82.7	89.2	75.7	82.7	85.2	84.0	85.3	79.8	83.3	88.6	181.9	70.5	95.6	17.0	134.1	114.2	174.9	244.0	118.4	11.6	181.9	198.2	172.9	211.6	219.5	121.4	12.5	295.3	151.4	301.6	291.6	160.5	561.3	102.7	95.8	117.0	153.6	63.3	25.8	120.3	132.0	96.4	185.5	92.9	145.1	47.4	155.3	322.1	304.2	8.4	28.8	252.8	154.6	288.3	174.1	1160.2	72.7	195.8	151.2	16.9	228.5	85.9	194.7	16.6	14.3	104.5	505.2	50.8	130.0	82.9	670.0	620.2	154.0	15.4	85.5	65.9	121.7	6.9	10.3	166.3	116.4	183.7	250.7	150.7	366.5	218.9
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 479.1;liver: 609.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Region enriched"	"Detected in all"	18	"cerebral cortex: 479.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4"	"Low region specificity"	"Detected in all"							"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	55.5	155.7	26.1	17.4	26.4	9.7	56.9	24.9	479.1	61.5	26.9	39.1	27.9	38.1	69.6	152.3	45.8	29.4	30.5	25.9	25.8	37.3	609.6	28.2	1.8	25.5	26.3	178.4	66.8	48.7	33.5	8.7	26.1	47.0	22.4	10.2	43.8	128.6	69.3	73.5	47.3	64.3	25.0	63.6	59.5	57.0	26.6	33.5	27.7	0.0	17.9	127.0	135.2	25.3	0.3	0.6	0.3	1.3	0.0	0.0	0.5	0.0	0.3	0.2	0.4	1.0	7.0	26.9	0.1	41.6	0.0	1.3	0.1	0.6	0.7	0.1	0.4	87.0	96.1	1.7	78.6	0.0	0.7	0.1	0.1	73.0	0.3	48.1	62.4	50.1	0.0	56.8	2.5	0.0	115.4	0.7	54.6	0.1	0.0	0.4	0.6	11.1	9.0	0.1	5.3	0.7	0.0	0.3	0.5	2.6	1.1	44.5	0.2	35.5	2.0	0.9	0.1	45.1	64.4	3.7	30.7	1.1	2.0	2.2	26.1	32.2	28.8	39.1	31.0	30.8	31.4	28.5	77.8	32.5	33.1	32.6	2.0	30.1	17.4	41.1	38.9	28.5	26.1	26.4	24.9	479.1	25.9	25.8	25.5	26.3	26.1	25.0	26.6	25.3	0.3	9.6	6.8	0.0	0.2	1.8	0.6	2.0	0.0	0.1	2.7	1.9	6.0	2.8	6.7	0.0	0.0	0.0	0.8	0.4	0.0	1.2	0.0	0.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	2.5	0.0	5.0	5.5	0.1	0.0	0.0	0.3	0.0	7.1	2.2	0.4	3.7	0.5	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.6	0.1	2.2	0.0	0.1	1.9	0.0	5.1	0.0	0.0	0.3	1.4	0.5	0.4	0.0	1.6	0.0	0.8	0.0	0.2	1.8
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.0;HSkMC: 115.6"	"Low region specificity"	"Detected in all"							"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		1200000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	73.7	84.4	92.3	11.9	109.9	10.7	81.2	86.7	104.6	165.9	111.5	115.2	26.3	70.6	43.7	61.6	102.7	22.0	99.7	93.5	104.7	86.8	35.6	45.2	14.3	94.3	97.1	240.9	54.5	53.6	113.7	9.3	91.9	159.0	17.7	25.1	55.2	80.7	218.4	88.2	65.5	34.2	93.9	52.6	88.3	41.9	105.2	15.9	97.9	108.4	12.6	108.3	144.5	90.6	0.0	3.5	37.8	38.9	44.0	116.0	7.2	24.5	42.6	22.1	28.0	6.7	0.0	0.7	25.5	61.1	18.0	0.2	3.1	0.2	28.6	1.5	0.8	14.0	0.4	9.3	29.6	1.1	25.2	115.6	1.0	32.7	0.0	58.5	16.1	11.6	4.2	0.7	48.5	0.3	19.5	24.6	6.7	0.7	32.4	23.8	0.1	0.2	6.6	0.5	8.1	18.7	0.0	1.0	13.0	21.7	38.6	7.0	0.2	24.3	1.2	35.3	1.9	11.9	19.0	1.3	36.7	0.5	0.3	1.8	3.8	29.6	3.1	6.3	3.1	8.8	8.8	3.4	23.0	6.2	34.4	15.1	2.2	18.0	4.1	29.8	9.4	10.8	92.3	109.9	86.7	104.6	93.5	104.7	94.3	97.1	91.9	93.9	105.2	90.6	2.0	0.0	4.8	16.0	4.5	4.8	2.4	0.9	20.5	1.5	4.5	4.3	61.0	2.8	11.5	3.7	0.0	0.5	6.1	0.4	0.0	0.2	1.9	2.8	10.3	5.8	0.0	10.9	1.5	0.0	0.2	19.2	14.8	2.7	2.5	4.4	1.8	0.8	1.5	3.3	2.6	1.3	2.0	0.8	2.3	10.4	15.5	3.4	5.4	11.2	0.7	7.2	8.2	12.5	0.7	0.1	0.0	10.5	28.4	0.8	0.4	1.2	9.9	0.3	6.6	5.6	13.6	0.3	0.8	27.0	2.8	0.5	5.1	4.0	0.7	1.6
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 377.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 802.2;Early spermatids: 2092.4;Late spermatids: 3843.4;Spermatocytes: 1177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.4;gdT-cell: 3.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive CD4 T-cell: 7.8;naive CD8 T-cell: 4.3;T-reg: 1.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;T-cells: 7.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 228.4;T-47d: 479.6;WM-115: 186.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		790000	"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	38.7	39.0	56.9	11.0	61.1	3.3	83.5	50.3	69.1	52.7	109.7	45.0	46.8	32.1	243.2	53.6	35.1	47.0	74.8	56.9	63.6	188.1	20.0	23.6	6.2	54.4	54.8	120.4	101.0	41.1	33.7	21.6	55.5	47.5	19.9	21.1	22.6	165.9	65.8	57.2	27.8	58.3	57.5	14.1	76.2	377.9	61.6	13.2	57.9	51.2	7.9	57.1	53.2	58.3	0.2	6.9	49.3	0.1	64.5	39.9	8.5	54.3	9.4	58.2	56.2	21.8	1.9	0.1	30.8	27.8	40.1	2.6	10.0	22.3	80.5	0.3	14.9	50.8	152.1	33.9	69.5	0.0	115.2	40.3	27.0	87.8	0.1	63.5	73.1	61.9	4.7	0.6	26.6	30.0	14.5	1.2	5.3	0.2	93.1	0.4	31.9	2.3	16.3	117.1	86.1	46.0	112.5	228.4	10.5	14.1	479.6	75.3	57.9	0.8	20.9	59.6	36.3	7.7	13.1	0.2	0.6	0.1	186.9	0.3	0.1	3.4	3.1	0.1	0.8	0.3	3.9	2.2	0.1	0.2	7.8	4.3	0.9	0.7	0.1	0.5	1.9	1.5	56.9	61.1	50.3	69.1	56.9	63.6	54.4	54.8	55.5	57.5	61.6	58.3	22.2	6.4	11.5	18.3	7.0	143.5	97.2	104.4	50.1	17.5	196.1	176.8	88.0	50.1	35.9	222.5	6.2	16.3	8.7	17.3	802.2	88.0	2092.4	51.4	40.6	32.9	50.4	33.0	7.5	149.5	9.0	131.6	43.8	93.6	9.5	22.7	58.2	14.2	10.6	15.2	8.0	24.9	28.5	13.9	54.1	3843.4	385.5	15.1	60.5	2.8	3.5	247.5	2.1	14.6	1.7	126.4	32.5	276.1	3.4	53.7	116.9	38.9	5.4	19.2	190.7	23.8	94.4	1177.6	54.4	71.9	107.4	10.3	24.4	121.4	44.1	80.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656099-109674836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 149.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 382.8;Proximal tubular cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"eosinophil: 351.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 351.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	22.3	31.1	19.7	15.3	23.7	5.9	22.5	19.1	23.8	24.5	40.0	45.4	149.5	22.6	24.3	31.3	22.2	17.8	33.5	19.2	19.9	45.9	41.2	14.6	11.8	20.7	20.9	42.9	21.2	57.8	18.6	7.6	20.2	25.8	38.5	12.5	21.2	41.0	92.4	20.6	99.4	25.7	21.1	30.2	28.8	15.1	20.1	9.9	27.7	45.5	15.6	36.8	28.8	20.2	13.5	6.0	10.5	78.9	23.0	35.1	13.4	4.3	34.1	9.8	12.8	43.3	1.5	12.5	16.1	19.1	19.3	13.6	27.1	14.4	6.2	18.9	0.0	27.4	23.5	38.8	37.1	9.5	31.8	22.3	14.0	12.6	0.0	27.5	8.1	31.7	12.8	18.4	6.9	12.7	8.1	41.9	8.2	56.3	31.9	16.9	5.8	18.5	38.8	9.6	7.4	17.6	0.2	68.2	54.9	7.8	18.6	20.1	3.6	11.4	44.0	12.5	6.3	27.0	51.4	1.1	37.1	13.9	32.5	11.9	14.5	351.7	12.2	14.5	7.4	17.0	9.3	14.1	37.8	14.9	8.9	10.7	1.8	12.8	3.6	12.6	14.1	12.6	19.7	23.7	19.1	23.8	19.2	19.9	20.7	20.9	20.2	21.1	20.1	20.2	6.9	9.6	2.7	11.4	9.9	18.1	27.3	17.9	18.8	6.2	14.7	19.0	30.2	21.5	9.5	31.3	0.0	21.0	13.9	53.0	101.8	45.9	3.0	4.5	10.8	8.6	7.2	4.2	3.3	57.7	18.6	22.9	13.3	5.4	21.0	13.3	14.3	35.7	35.6	5.0	3.3	45.9	6.1	17.2	26.0	6.4	30.1	14.9	40.9	2.8	14.8	23.9	17.5	5.0	3.4	35.4	38.6	24.8	13.3	6.7	382.8	109.8	7.5	5.4	32.9	15.3	23.2	7.0	7.3	23.0	15.3	8.8	11.2	12.6	96.7	26.9
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 657.7"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 676.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 1106.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037603, HPA037604"	Enhanced					NA	NA		120000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	95.0	145.4	119.1	102.8	123.1	191.6	89.9	121.3	166.7	90.1	118.0	92.7	167.6	72.0	96.2	79.3	75.4	84.8	277.4	117.3	124.8	154.4	657.7	154.7	93.1	121.3	127.1	83.1	80.5	129.7	102.9	113.6	122.7	80.3	94.8	38.2	75.6	89.6	148.4	63.8	165.2	86.9	122.2	107.1	93.3	14.9	128.8	124.8	82.9	122.5	77.4	109.6	82.6	136.4	287.7	194.5	142.9	249.3	201.4	385.1	62.8	358.3	640.7	237.9	257.2	247.2	292.8	254.2	152.8	245.6	296.8	158.8	97.0	329.2	244.5	128.4	233.7	186.6	122.1	542.7	359.7	241.5	294.5	291.5	136.7	346.3	414.5	331.3	464.1	231.2	394.4	153.4	511.4	159.3	188.3	330.0	130.4	308.1	134.8	136.0	94.9	108.1	358.4	185.1	72.1	88.6	117.6	81.0	1106.0	238.2	92.0	192.7	426.6	276.9	143.6	427.3	328.4	2.7	3.3	2.0	517.7	416.2	112.0	842.8	532.4	157.9	133.0	457.0	164.5	148.8	164.6	172.9	429.3	111.9	143.0	144.3	151.8	185.0	369.1	203.0	204.8	632.1	119.1	123.1	121.3	166.7	117.3	124.8	121.3	127.1	122.7	122.2	128.8	136.4	107.4	76.9	72.6	8.8	64.8	93.7	328.2	297.6	51.2	36.9	63.5	105.5	328.2	218.8	113.3	101.2	20.9	394.2	82.0	101.6	332.6	341.0	22.4	68.1	79.6	164.5	103.5	192.8	12.1	248.4	176.6	173.0	49.5	81.7	146.3	107.6	388.0	628.2	676.5	23.5	11.7	163.8	124.1	321.8	223.6	17.3	114.6	484.5	126.3	8.4	277.7	81.2	95.8	8.5	21.8	347.6	150.7	112.8	39.9	169.4	483.2	538.0	114.3	29.8	151.2	85.3	176.1	5.7	5.1	55.8	78.7	111.0	81.4	224.8	196.6	204.9
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304950	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048141	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.5	3.5	5.0	0.3	5.7	2.0	5.2	3.4	5.3	4.3	0.4	4.4	2.8	2.2	4.9	11.8	4.3	1.2	0.6	4.4	4.1	14.0	2.8	2.4	0.3	2.2	2.5	5.4	16.7	5.0	14.6	1.0	2.6	8.3	3.1	6.0	7.5	3.2	1.4	14.8	3.5	1.2	1.1	0.5	10.9	35.9	4.3	2.2	7.0	1.3	0.7	3.8	7.5	5.3	10.2	1.4	0.5	0.6	0.6	1.3	1.4	9.6	16.9	4.7	4.9	0.6	17.1	1.6	4.0	0.8	0.5	10.7	0.5	5.3	1.2	1.1	3.2	0.5	3.1	2.4	2.1	0.7	0.7	1.7	16.2	0.3	18.3	1.3	0.8	1.7	1.5	2.9	1.3	12.3	0.1	0.5	1.7	22.1	1.1	0.5	0.7	0.3	4.6	6.5	0.6	1.1	3.3	2.4	2.9	0.8	12.6	0.3	2.4	1.5	5.1	0.6	0.5	2.8	6.4	0.4	1.5	0.8	0.5	0.2	0.1	0.7	0.5	0.2	0.3	0.3	0.5	0.3	0.0	0.5	0.7	0.4	1.7	1.0	0.1	0.3	1.2	0.2	5.0	5.7	3.4	5.3	4.4	4.1	2.2	2.5	2.6	1.1	4.3	5.3	3.6	3.2	21.0	13.1	1.3	34.2	62.1	94.5	50.1	19.0	61.7	78.2	3.0	21.5	46.4	40.5	16.7	14.4	3.8	12.8	133.1	30.6	314.6	26.9	7.6	5.4	54.2	3.6	33.9	63.3	9.9	4.7	31.6	37.6	2.5	3.3	15.7	3.6	1.8	0.0	28.7	34.0	50.8	1.6	3.7	442.8	2.8	2.7	17.8	1.9	2.1	11.1	1.0	24.1	20.1	31.6	29.1	9.8	0.9	25.6	27.1	43.8	31.2	23.0	6.6	3.1	7.4	22.0	8.9	46.0	47.3	6.7	4.3	11.6	40.7	58.0
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583742-67586656	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2087.9"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 4033.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4998.3;OE19: 7810.3"	"Low region specificity"	"Detected in all"							"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	290.5	276.2	346.8	232.1	370.3	601.3	288.7	358.9	425.7	641.9	695.8	329.6	394.6	331.9	280.3	2087.9	647.5	435.8	367.2	341.4	381.9	567.7	45.1	468.3	321.8	375.7	379.2	306.9	340.9	737.4	320.2	326.9	378.5	291.7	197.1	137.9	541.2	780.4	355.0	731.4	321.7	214.2	367.0	257.2	535.5	45.8	378.1	296.9	579.0	312.5	380.8	526.5	946.2	377.7	1202.5	1599.4	763.7	1198.9	577.8	645.2	705.3	511.3	678.1	761.2	589.3	2956.3	1225.0	3.3	1144.7	813.5	683.7	1707.8	2073.9	2248.5	214.4	848.0	765.3	59.9	1107.6	0.5	852.2	400.3	667.6	807.2	4998.3	609.9	583.3	560.9	1160.2	847.2	1318.2	321.8	605.7	4.3	918.2	1100.6	1475.2	7810.3	681.3	844.8	129.6	3.8	1236.8	3.6	260.6	754.3	719.1	230.9	2394.0	598.2	3.6	656.3	634.5	351.6	883.8	740.6	378.6	200.0	1353.9	447.1	400.0	652.4	747.8	56.0	3145.4	246.6	720.0	2470.8	271.9	509.2	322.4	597.7	3582.7	476.3	267.8	466.5	130.5	1443.8	1608.5	1435.1	363.3	3948.4	346.8	370.3	358.9	425.7	341.4	381.9	375.7	379.2	378.5	367.0	378.1	377.7	466.7	1153.8	872.3	25.5	296.8	865.6	1914.8	3813.8	767.2	170.0	628.7	838.3	297.3	987.9	2763.5	1230.4	33.3	2116.8	372.4	655.0	1805.9	1811.9	4.9	1381.0	589.0	431.4	368.2	166.3	6.8	1444.4	1703.9	710.5	781.9	1020.9	269.9	795.0	382.3	10.5	861.2	70.7	10.1	992.4	1930.7	597.9	1090.3	25.5	572.3	703.5	1531.5	27.2	2166.5	558.5	459.3	17.6	38.4	1412.1	948.9	400.2	591.6	2266.2	844.4	3495.5	3715.4	274.4	361.6	401.3	941.7	4.8	54.9	4033.7	1061.7	1645.5	342.5	527.8	1118.5	3418.6
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B"	P0CG30	22	23957414-23961195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 81.8;breast: 307.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 27.6;Muller glia cells: 20.9;Peritubular cells: 28.6;Skeletal myocytes: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 57.0;HHSteC: 81.9;SK-MEL-30: 60.3;T-47d: 64.8"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	12.3	81.8	21.6	4.3	21.5	0.0	307.9	21.4	27.0	16.6	19.5	17.2	1.4	15.5	12.0	24.7	16.1	5.5	23.9	20.8	22.7	15.2	39.5	18.5	1.8	22.2	22.2	22.6	26.1	6.4	26.0	4.4	22.2	40.6	1.9	3.8	12.5	10.4	16.4	47.8	8.3	11.8	21.0	10.2	23.8	5.5	24.3	1.8	18.6	41.0	1.6	12.1	14.0	21.1	17.0	0.8	0.0	57.0	1.0	1.1	2.4	8.0	4.7	11.5	11.9	24.8	0.2	0.0	12.9	20.2	29.7	24.5	0.0	25.5	5.2	0.0	2.2	0.9	33.6	4.0	81.9	0.1	9.1	33.4	4.0	33.2	6.7	32.6	9.6	0.0	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.9	12.5	0.0	42.4	0.1	26.0	0.0	1.1	23.8	8.2	0.2	60.3	0.2	64.8	0.9	32.0	9.9	6.5	1.3	6.4	0.0	0.0	0.1	6.1	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	21.5	21.4	27.0	20.8	22.7	22.2	22.2	22.2	21.0	24.3	21.1	8.1	3.2	3.6	1.3	0.9	0.0	8.6	0.0	2.8	3.9	9.4	17.9	0.2	7.2	1.3	0.0	0.0	1.6	0.1	0.0	29.4	7.9	0.6	1.3	11.8	7.1	1.2	5.3	2.4	9.1	3.5	7.6	1.1	2.9	1.3	2.2	18.5	27.6	10.5	0.0	2.1	0.4	0.0	3.8	0.0	1.5	9.9	1.5	0.0	0.0	3.2	20.9	0.0	2.0	0.7	4.2	0.0	28.6	0.7	7.9	0.0	5.7	0.0	2.8	6.6	26.7	9.6	0.4	0.7	0.9	0.0	1.8	0.2	0.4	0.1	3.8
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	10.4	10.1	3.0	12.9	4.3	7.4	13.0	12.3	11.1	11.0	0.1	10.1	9.6	12.0	14.7	13.2	8.7	9.9	10.2	4.6	4.3	11.4	14.5	9.0	16.2	2.3	2.8	13.0	9.8	14.5	5.7	13.2	2.7	10.8	11.0	13.5	8.3	9.0	10.7	11.3	9.1	10.4	2.4	12.6	10.6	19.6	3.3	21.1	23.2	15.5	14.7	10.7	7.4	5.3	20.5	20.0	41.0	27.8	22.8	19.0	15.7	25.9	24.7	21.6	19.4	30.0	20.1	33.9	20.5	20.1	15.9	15.5	28.7	18.2	38.0	31.1	9.0	31.4	21.5	17.9	22.5	21.6	30.6	17.9	13.6	29.8	38.4	22.5	22.4	27.1	19.5	44.0	27.9	34.0	54.9	12.5	22.9	15.5	19.8	30.0	36.6	20.8	14.4	41.2	40.2	23.7	59.8	22.8	25.6	19.6	34.6	17.8	29.4	21.9	17.0	30.7	25.9	35.9	42.2	34.5	17.5	24.6	35.8	7.3	0.7	1.3	1.3	0.5	1.0	0.7	1.2	0.7	0.4	0.6	1.0	1.2	1.2	1.0	2.6	1.9	0.7	0.5	3.0	4.3	12.3	11.1	4.6	4.3	2.3	2.8	2.7	2.4	3.3	5.3	27.0	19.2	13.6	25.5	22.3	18.0	8.6	11.9	10.8	24.9	18.4	19.7	26.5	5.7	14.0	23.9	35.5	15.1	21.4	21.2	1.9	12.0	59.4	14.5	26.5	20.7	18.6	32.0	32.9	13.0	14.4	20.0	17.9	18.9	30.4	37.2	16.8	25.9	17.0	40.4	33.4	17.5	10.2	25.2	22.1	8.0	12.8	25.0	10.6	29.0	30.9	22.0	18.6	26.7	26.4	12.4	15.8	13.5	56.2	16.6	13.0	15.0	11.4	15.8	26.3	22.0	23.7	28.6	26.5	23.9	24.4	26.0	21.7	16.2	11.6	12.0
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	5.2	7.7	4.2	6.6	4.9	4.4	5.1	4.6	5.5	4.9	7.9	5.0	4.6	4.6	4.5	4.2	4.2	3.7	5.1	4.4	4.8	4.3	5.0	4.9	9.1	5.0	4.7	5.7	4.5	4.6	2.9	6.6	4.9	4.6	5.8	5.6	4.2	5.6	7.0	3.6	4.2	5.7	4.5	7.7	4.7	9.9	4.9	8.3	5.5	9.3	9.0	5.5	4.2	5.4	13.7	18.7	23.0	14.1	16.9	7.8	20.0	9.0	8.2	13.8	14.7	22.5	9.6	22.3	15.3	6.8	10.7	16.1	21.4	11.8	19.2	15.6	5.0	28.7	12.8	19.0	13.1	26.1	16.8	10.4	12.6	10.3	14.5	9.4	21.4	18.9	20.4	11.3	14.8	15.6	21.6	13.2	22.0	13.1	17.2	17.7	27.0	16.6	13.8	8.6	4.9	15.1	13.5	11.6	12.6	20.6	14.7	19.8	18.9	12.9	14.0	4.1	10.2	9.9	11.8	31.5	13.5	26.0	12.5	18.0	7.2	11.6	6.6	11.2	8.3	9.3	8.1	9.5	8.7	7.3	8.6	8.4	5.0	10.8	10.5	4.1	10.2	7.6	4.2	4.9	4.6	5.5	4.4	4.8	5.0	4.7	4.9	4.5	4.9	5.4	4.1	3.2	4.4	3.3	6.8	1.9	3.0	4.1	3.4	5.3	4.6	1.8	4.9	8.6	6.3	7.3	0.0	9.0	4.7	3.8	5.9	5.1	7.7	8.1	6.0	5.4	1.2	5.5	3.8	4.4	8.4	3.8	3.1	6.1	12.7	9.1	7.5	5.3	9.2	16.8	4.0	3.2	6.1	8.3	2.2	2.9	2.1	7.0	3.6	8.4	12.5	5.5	14.4	4.5	7.2	4.9	2.5	4.9	5.3	3.3	3.4	5.9	5.1	4.4	0.0	3.5	3.9	14.3	22.8	2.8	2.6	8.8	5.7	9.7	3.9	3.1
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	24.5	29.1	14.9	17.8	16.1	9.4	19.9	19.9	19.3	25.1	16.9	20.9	19.5	19.4	17.2	26.4	16.4	13.2	16.2	15.9	17.3	21.4	28.1	17.8	25.9	14.8	15.1	30.3	51.8	15.4	20.1	16.8	15.0	18.7	16.0	11.6	15.9	14.6	13.4	20.6	17.5	18.5	14.7	20.4	24.4	32.7	16.5	22.4	17.4	11.0	26.6	24.1	24.1	15.8	53.7	43.7	29.2	31.2	77.4	68.2	22.0	57.7	52.4	46.5	58.6	26.2	38.2	70.0	48.0	51.9	67.0	37.8	49.1	53.8	61.5	31.8	28.2	34.9	28.9	63.0	75.4	17.1	29.5	50.6	70.7	49.7	50.7	46.3	65.3	51.2	68.7	42.1	74.5	37.3	83.7	42.9	33.1	66.0	51.9	43.2	31.6	35.4	50.9	36.7	22.4	29.1	32.1	21.5	46.5	38.3	20.8	20.9	49.9	30.6	31.4	25.9	39.8	42.6	62.7	77.0	48.2	28.8	41.3	4.3	4.2	6.4	3.6	3.5	4.1	18.8	5.7	7.6	7.3	11.7	5.6	5.5	2.2	9.7	3.7	8.2	7.0	2.8	14.9	16.1	19.9	19.3	15.9	17.3	14.8	15.1	15.0	14.7	16.5	15.8	20.2	0.0	8.4	16.6	48.7	47.9	48.1	44.3	48.3	9.2	19.1	17.5	9.9	17.2	28.2	14.7	10.4	43.0	32.3	26.5	19.6	31.5	96.7	42.2	33.8	22.9	13.2	14.1	30.2	33.1	51.4	30.0	31.1	29.0	11.4	17.7	26.4	27.0	34.1	5.0	30.1	24.2	22.4	21.6	39.3	58.9	39.4	28.4	21.4	13.1	58.8	9.0	46.4	17.1	21.8	43.3	23.4	70.7	35.9	72.7	46.5	48.2	40.0	14.9	26.3	17.5	28.0	74.3	87.9	38.3	46.5	62.1	36.9	26.1	24.5	91.8
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367045	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB004637: AB_425470, HPA046660: AB_2679743"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	19.0	18.2	6.0	7.6	6.4	4.7	18.2	7.6	7.2	16.5	10.0	17.9	7.5	15.6	8.2	19.4	14.6	9.4	14.9	6.7	6.0	16.2	17.2	13.9	10.9	5.5	5.8	19.2	17.9	8.2	13.8	10.0	5.6	15.8	8.2	13.1	18.7	10.0	16.6	20.0	14.7	8.4	5.8	17.2	15.2	26.5	6.1	8.8	16.0	8.3	11.1	17.7	16.9	7.6	14.7	13.3	11.0	15.5	25.1	20.1	13.7	21.8	23.6	19.0	21.9	13.9	5.6	24.9	8.4	22.4	27.2	19.8	19.1	20.1	24.1	11.0	18.5	15.9	13.4	14.1	35.8	30.7	16.5	22.4	23.8	11.7	37.3	15.7	17.3	12.8	25.2	12.6	27.7	13.6	15.6	23.3	9.8	24.7	19.8	16.1	23.4	11.3	15.3	19.6	12.5	13.5	17.8	17.1	27.0	9.4	8.8	17.5	12.6	24.9	12.2	45.3	17.8	6.3	16.0	17.7	21.5	24.0	24.4	11.0	5.0	5.4	3.8	5.0	4.2	5.4	4.8	4.3	5.4	5.7	5.8	4.7	3.5	7.5	6.0	2.9	5.2	4.2	6.0	6.4	7.6	7.2	6.7	6.0	5.5	5.8	5.6	5.8	6.1	7.6	27.8	16.0	18.2	19.2	26.1	48.3	22.7	22.2	39.9	17.3	23.4	20.6	28.3	22.8	21.9	11.0	20.9	26.1	26.8	14.7	7.9	25.2	50.2	19.0	17.7	21.6	7.7	26.1	32.1	30.5	27.5	27.1	21.4	20.2	18.3	20.0	22.1	13.9	25.2	21.9	29.9	12.9	14.2	20.8	27.2	46.1	17.1	28.8	23.2	20.6	25.9	23.4	25.7	24.1	29.4	28.8	10.5	16.1	25.7	23.4	18.6	25.1	23.6	21.2	6.6	23.4	23.2	84.8	30.1	37.6	51.7	28.2	20.4	29.2	16.8	26.8
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662604	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004844: AB_2667265, HPA053562: AB_2682191"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	10.4	9.0	6.1	12.9	6.0	11.2	15.6	5.8	6.9	11.7	5.0	14.0	10.5	12.9	8.9	15.4	15.0	9.7	10.7	5.8	5.2	11.2	14.1	9.7	16.6	5.9	6.3	11.2	5.6	11.7	5.9	12.9	6.4	13.0	16.2	10.1	7.3	11.3	13.8	12.8	10.6	14.2	5.8	10.4	11.7	12.2	6.2	16.0	13.4	11.1	16.1	11.4	8.2	7.1	42.0	21.7	27.6	35.5	33.3	37.1	38.9	31.2	38.2	47.1	31.6	23.2	21.1	48.4	37.4	43.0	18.8	27.8	46.2	56.4	56.2	41.4	32.5	39.7	19.3	33.3	46.8	80.9	25.3	39.7	42.2	38.2	85.9	35.3	34.2	59.4	60.4	15.7	42.9	27.4	40.5	27.2	35.6	29.6	39.9	41.3	42.1	27.4	24.1	40.1	24.8	21.8	41.1	19.8	32.1	30.1	55.4	48.1	22.9	29.3	22.3	45.9	50.7	28.8	42.3	47.6	33.7	40.5	34.3	11.4	4.6	6.0	7.6	6.9	7.6	5.9	6.1	8.1	7.0	5.7	8.7	8.0	0.6	10.7	7.0	5.9	6.7	4.1	6.1	6.0	5.8	6.9	5.8	5.2	5.9	6.3	6.4	5.8	6.2	7.1	20.8	22.4	24.3	23.5	19.2	11.7	12.3	20.9	27.9	16.2	12.6	15.2	7.4	12.8	22.3	12.9	10.4	26.3	13.8	8.4	3.9	12.9	8.6	18.3	24.7	11.1	6.7	21.6	26.6	11.0	23.4	17.1	16.8	16.7	24.1	19.9	12.1	16.9	17.2	16.8	27.8	12.3	6.1	12.3	7.9	4.3	11.8	15.3	1.8	10.3	16.1	21.9	7.2	15.6	23.1	10.8	10.8	11.3	17.1	10.5	6.1	15.8	20.7	13.7	13.1	18.8	15.2	32.6	27.1	25.7	13.2	23.7	14.5	36.2	15.7	10.4
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74650231-74760692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA		55000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	61.2	75.3	32.5	48.2	36.4	32.7	52.2	36.7	35.7	57.5	64.7	41.9	52.8	57.5	41.3	54.9	66.9	47.0	51.2	32.3	31.5	70.9	57.6	52.3	56.7	31.2	33.7	64.4	49.8	106.0	42.9	56.1	31.6	64.2	39.9	82.8	69.4	54.1	84.2	62.9	48.0	61.5	31.0	47.6	67.6	25.4	35.1	70.6	118.0	56.8	68.8	49.4	38.8	46.4	136.4	110.4	222.6	219.9	120.6	106.7	46.3	83.7	76.9	90.5	89.6	76.9	161.6	165.4	33.7	104.1	121.6	116.3	221.1	101.3	116.2	126.4	115.9	85.6	128.0	107.7	72.3	159.5	126.9	98.8	84.7	68.8	70.0	132.6	123.3	55.2	165.3	80.0	110.9	126.8	133.7	147.5	243.6	286.9	67.1	146.0	77.5	133.1	118.7	232.2	185.5	236.3	153.0	226.5	78.7	185.8	116.4	105.2	111.7	123.6	66.8	62.8	108.8	90.2	83.3	256.2	70.9	95.8	126.6	20.4	10.0	17.4	11.3	7.3	16.6	22.1	14.6	16.7	14.6	24.1	17.8	17.4	4.1	21.3	6.6	23.0	8.7	9.7	32.5	36.4	36.7	35.7	32.3	31.5	31.2	33.7	31.6	31.0	35.1	46.4	118.5	80.1	60.6	55.8	80.3	60.2	83.3	136.3	125.7	276.4	140.7	113.7	30.3	210.1	106.3	119.5	283.5	112.6	101.5	46.0	56.7	155.4	37.1	368.7	201.3	98.2	112.5	91.7	68.6	83.0	64.4	78.8	117.8	321.8	13.3	246.1	115.3	101.0	80.3	250.7	74.1	71.0	73.2	106.7	53.7	39.8	152.8	76.0	55.2	46.9	122.3	200.9	101.0	102.5	98.1	132.5	70.6	193.0	81.4	117.6	150.6	110.2	233.3	184.3	85.5	96.8	87.8	34.1	51.9	145.8	91.9	72.2	60.5	172.7	63.9	124.3
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GTF3A	"AP2, TFIIIA"	ENSG00000122034	"General transcription factor IIIA"	Q92664	13	27424619-27435823	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007990	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007990: AB_1857960"	"unprognostic (9.88e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.41e-1)"	63.5	40.3	51.0	50.3	53.0	85.3	59.3	53.1	63.0	31.9	50.4	41.8	30.3	26.6	57.4	38.3	32.8	33.4	126.7	52.8	51.9	52.5	129.8	33.2	81.2	53.2	53.3	16.0	116.4	34.5	26.9	28.4	52.7	30.7	40.4	10.4	70.4	34.8	89.3	25.0	32.3	38.0	53.0	54.6	46.9	17.4	52.9	111.6	31.2	132.6	89.8	46.0	23.7	56.2	91.2	78.8	65.4	136.8	90.4	98.8	93.3	95.1	86.0	118.3	75.4	118.5	139.4	275.3	65.9	112.6	73.9	64.9	136.6	131.0	165.8	289.2	93.1	229.9	71.6	135.4	102.5	432.3	150.9	81.5	137.9	109.2	142.4	81.8	107.2	246.9	184.2	88.6	140.5	178.3	311.3	467.9	115.8	299.6	210.7	154.8	169.3	254.0	142.5	39.2	158.9	81.5	67.6	101.6	141.7	83.7	73.7	223.6	66.0	62.5	67.1	49.3	99.1	57.0	104.9	275.1	67.1	264.9	117.4	116.8	173.8	162.5	250.2	180.1	335.2	290.5	251.6	271.7	218.4	250.3	192.5	219.6	38.3	243.7	169.5	298.3	345.1	484.4	51.0	53.0	53.1	63.0	52.8	51.9	53.2	53.3	52.7	53.0	52.9	56.2	96.9	44.8	33.0	15.0	183.3	63.2	62.4	109.1	56.3	41.7	107.2	117.6	207.8	91.5	58.3	27.6	29.2	76.3	207.1	20.0	150.6	195.7	33.9	60.1	68.1	76.3	34.8	126.4	28.7	190.6	187.4	75.0	63.2	49.1	75.5	93.0	40.0	146.7	215.5	35.3	25.8	60.6	77.3	156.1	119.3	85.6	63.6	133.9	97.8	15.9	185.3	73.1	236.9	7.1	24.3	153.3	28.9	58.3	248.4	122.7	35.6	207.7	37.9	35.7	85.5	58.3	76.1	34.8	145.1	83.4	64.4	42.1	187.1	89.0	69.8	70.3
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;dendritic cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	18.1	28.8	24.2	9.9	24.4	16.6	16.7	21.5	32.6	31.2	40.5	21.2	8.8	26.7	7.8	65.2	24.6	11.5	38.5	24.6	21.8	25.4	21.7	20.3	12.2	20.4	20.8	24.4	35.3	18.6	47.8	11.0	19.6	40.4	9.7	18.3	24.9	12.6	50.2	51.0	18.5	15.5	17.0	21.3	24.7	26.6	22.2	18.6	34.6	20.8	11.2	19.7	35.1	21.7	27.8	60.1	43.3	50.7	37.8	30.4	24.6	29.5	33.0	40.2	34.0	45.0	25.6	30.5	42.3	36.4	30.6	30.3	55.4	37.6	32.9	13.7	53.1	25.2	49.8	63.8	21.3	29.1	32.2	37.5	28.0	49.5	21.8	26.9	40.2	34.6	31.7	24.2	32.0	67.6	32.5	34.8	58.4	15.1	28.3	59.7	53.4	31.4	25.2	28.7	54.4	36.5	29.8	24.9	18.6	34.4	44.8	21.8	43.2	40.2	24.0	25.6	30.7	25.6	24.8	30.2	16.6	31.7	30.2	2.6	3.4	3.5	31.9	3.2	23.0	3.1	3.6	15.8	4.3	2.2	3.7	10.0	2.5	12.2	3.3	6.6	4.0	6.9	24.2	24.4	21.5	32.6	24.6	21.8	20.4	20.8	19.6	17.0	22.2	21.7	16.9	19.2	23.9	29.7	10.8	18.4	7.3	14.3	23.3	45.5	10.6	11.9	27.4	10.0	17.2	12.9	93.8	7.8	86.2	18.4	5.9	11.8	2.8	40.4	37.3	18.0	30.0	7.2	30.2	11.5	4.3	22.5	19.9	22.3	19.0	26.1	13.9	13.7	10.9	26.9	33.9	17.6	18.3	10.3	7.7	4.5	19.3	12.9	3.6	14.0	10.0	15.0	52.5	17.1	23.4	15.8	9.3	15.8	29.6	13.9	10.2	9.0	30.8	35.1	13.1	16.4	15.1	17.2	18.2	34.8	20.6	4.2	32.7	25.7	12.2	6.7
GTF3C2	"KIAA0011, TFIIIC110"	ENSG00000115207	"General transcription factor IIIC subunit 2"	Q8WUA4	2	27325849-27357034	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008274, HPA035836"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008274: , HPA035836: AB_10601813"	"unprognostic (1.76e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (1.33e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.00e-1)"	18.7	25.6	19.5	23.2	20.8	23.5	21.1	26.2	27.6	19.0	23.5	25.3	22.4	19.8	23.7	34.5	24.4	15.3	23.2	19.9	20.8	23.3	21.1	19.7	26.6	21.2	18.7	20.7	30.7	33.1	20.0	19.6	20.0	20.1	27.7	25.2	25.2	18.5	28.7	32.2	24.2	23.3	17.2	26.8	24.3	26.0	22.0	30.4	29.4	18.5	33.5	23.2	21.4	28.1	86.2	75.7	62.5	60.6	36.2	35.2	91.2	30.8	41.8	39.8	33.7	56.3	53.7	75.1	54.1	43.0	40.8	50.6	93.2	59.2	38.0	59.5	81.0	63.3	48.5	76.0	33.0	69.7	60.6	44.4	52.3	45.4	58.4	38.0	51.8	50.4	90.1	54.9	38.8	70.4	64.9	50.7	118.2	69.0	47.6	79.1	69.2	83.9	56.8	63.9	58.0	101.5	33.1	78.6	57.7	52.8	42.2	39.3	39.6	48.2	52.4	36.9	58.1	60.2	71.9	169.4	48.1	55.4	53.8	29.6	18.2	14.5	14.3	15.0	15.1	13.3	12.6	15.2	15.6	11.4	12.4	12.2	8.4	13.3	19.2	9.8	8.5	19.7	19.5	20.8	26.2	27.6	19.9	20.8	21.2	18.7	20.0	17.2	22.0	28.1	7.9	19.2	22.1	11.8	17.5	9.8	9.8	11.9	18.2	11.3	13.9	11.6	11.7	14.3	14.9	5.5	22.9	19.3	12.9	22.2	9.8	16.6	54.9	13.6	10.9	10.3	3.5	24.8	17.3	22.8	23.6	10.0	17.3	14.6	18.3	16.2	10.0	11.1	16.1	10.1	16.2	17.6	12.2	18.4	7.6	61.9	9.3	12.1	5.4	16.9	18.3	8.9	12.3	14.1	18.9	21.5	9.0	7.9	18.6	13.0	16.0	11.8	14.8	18.0	6.6	9.7	11.8	9.1	16.4	19.4	12.6	20.0	13.7	11.8	15.1	14.4
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	26.5	33.6	26.3	20.6	30.4	42.4	29.1	35.1	35.8	36.2	23.9	28.8	26.4	31.7	22.3	39.0	32.0	17.5	39.1	26.9	27.5	27.5	32.9	23.7	27.7	28.1	28.6	44.6	33.6	24.5	36.0	24.6	29.0	34.3	19.2	13.7	29.1	20.7	47.9	38.6	30.3	21.6	26.2	32.1	28.5	29.4	28.5	44.5	28.6	32.3	25.3	29.2	33.2	36.6	44.1	77.5	67.3	63.3	35.9	32.5	93.2	42.0	45.4	78.6	55.4	83.5	71.8	72.7	38.7	47.1	63.2	103.9	79.8	76.3	40.2	74.9	69.1	86.8	90.3	78.7	55.9	66.2	176.0	45.0	49.9	83.5	57.7	38.0	69.1	235.1	112.5	66.0	42.1	142.1	107.9	92.4	87.5	100.6	79.7	113.9	69.5	89.2	52.4	50.2	80.4	59.7	71.2	73.4	43.8	38.1	96.5	95.6	46.0	92.0	71.3	59.1	71.8	25.8	57.3	78.0	44.8	49.8	62.4	54.2	16.0	22.5	15.8	18.9	23.0	14.6	16.3	20.7	17.2	13.6	18.1	16.4	9.5	20.7	16.3	16.6	19.4	17.8	26.3	30.4	35.1	35.8	26.9	27.5	28.1	28.6	29.0	26.2	28.5	36.6	16.0	9.6	19.0	17.3	21.0	12.4	16.5	21.7	30.7	14.2	25.2	21.6	29.3	14.3	17.2	16.5	8.4	42.1	20.0	30.4	29.4	25.5	3.4	16.2	15.4	16.4	14.4	22.3	9.0	30.3	38.4	19.7	18.3	19.9	16.5	50.1	18.5	17.2	22.5	15.2	7.9	15.9	34.6	15.7	9.9	4.3	17.4	15.8	16.0	8.4	14.8	18.8	15.5	6.0	16.6	27.2	25.4	21.4	17.4	13.9	27.3	11.7	14.6	20.8	46.0	17.2	19.4	20.5	31.9	26.1	16.6	41.6	17.6	34.0	25.7	19.4
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
GTPBP1	"GP-1, HSPC018"	ENSG00000100226	"GTP binding protein 1"	O00178	22	38705742-38738299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003166, HPA064702"	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA003166: AB_10601476, HPA064702: AB_2685329"	"unprognostic (1.42e-3)"	"unprognostic (5.82e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (3.17e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.98e-3)"	18.4	19.0	16.5	23.4	19.1	105.4	18.4	20.0	44.3	20.3	20.8	20.5	20.5	20.0	12.1	22.4	22.1	17.7	20.0	18.4	19.3	18.4	17.1	28.9	23.0	19.3	17.0	27.4	22.0	19.2	25.5	16.0	17.0	23.8	17.6	34.7	21.2	15.5	31.7	27.5	22.9	16.6	15.5	28.0	20.4	20.3	16.7	20.0	24.9	19.9	23.0	18.7	19.4	23.9	29.2	10.5	37.4	30.2	12.6	19.7	18.3	27.4	28.7	39.0	33.9	22.0	16.3	27.9	9.8	26.9	17.5	26.6	45.5	28.8	21.6	49.2	32.8	48.7	36.9	16.3	23.9	57.7	24.3	20.3	22.0	31.2	48.7	21.3	24.3	20.2	29.4	56.5	21.8	12.1	32.1	26.1	27.0	16.7	20.8	61.8	38.2	36.7	13.8	23.3	51.0	17.7	33.3	21.0	19.6	16.2	19.0	24.2	26.1	22.3	22.0	16.4	21.2	51.8	18.7	38.5	20.1	29.0	16.9	3.5	3.1	3.9	4.7	4.6	4.2	4.6	3.5	4.9	3.4	3.8	2.5	3.7	7.8	2.3	5.1	1.7	3.3	3.4	16.5	19.1	20.0	44.3	18.4	19.3	19.3	17.0	17.0	15.5	16.7	23.9	17.8	9.6	8.4	7.8	31.8	27.8	36.0	12.7	15.4	32.6	17.5	15.5	11.2	5.7	12.4	12.9	22.9	7.2	35.9	40.3	5.9	13.2	4.5	22.2	14.3	13.1	16.2	35.3	5.5	19.3	7.9	14.5	23.4	26.4	14.0	17.5	13.6	12.4	8.6	20.2	7.9	24.3	16.2	18.4	43.9	5.4	16.1	19.3	10.6	4.7	26.6	13.2	20.6	5.5	15.2	19.9	21.1	19.2	52.8	47.4	29.8	6.1	16.6	41.0	26.3	19.9	14.5	17.2	7.7	19.2	34.2	19.0	31.9	15.5	13.0	51.0
GTPBP10	"DKFZP686A10121, FLJ38242, OBGH2"	ENSG00000105793	"GTP binding protein 10"	A4D1E9	7	90335223-90391453	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021076	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA021076: AB_1850411"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.76e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.72e-3)"	8.5	7.2	3.2	8.9	3.2	6.5	10.6	5.3	5.7	7.0	1.9	8.8	8.8	7.6	6.4	8.2	6.3	5.6	10.1	3.0	4.3	12.5	18.7	5.7	11.0	3.3	2.8	8.6	7.6	8.1	4.5	6.1	4.0	6.9	9.6	7.2	6.1	5.3	12.3	6.8	7.1	7.1	3.9	7.3	10.7	11.3	3.5	12.7	9.8	10.0	9.7	9.5	5.6	4.3	33.9	21.1	14.1	21.3	17.1	15.3	23.2	21.2	13.9	19.5	15.4	31.1	25.0	42.2	34.6	14.5	41.6	21.3	32.4	28.3	25.3	26.5	16.6	17.4	12.8	16.4	16.3	51.0	14.9	18.3	12.1	32.4	64.3	15.5	11.5	35.0	64.8	30.1	17.6	34.6	35.8	14.5	17.4	30.8	25.5	22.7	41.3	35.2	14.3	18.4	17.4	16.3	27.2	41.3	41.2	20.1	20.0	21.9	21.1	27.3	31.9	48.9	41.2	22.6	30.7	59.3	20.5	35.4	29.5	23.6	5.3	9.4	6.3	7.4	10.9	11.7	10.2	7.7	6.4	9.2	10.8	10.2	5.1	7.8	4.5	5.7	13.3	5.6	3.2	3.2	5.3	5.7	3.0	4.3	3.3	2.8	4.0	3.9	3.5	4.3	11.0	12.8	21.1	21.5	17.6	5.9	8.5	13.5	9.6	12.6	9.8	11.0	14.3	7.2	17.0	16.5	14.6	7.6	9.7	6.2	13.7	8.7	21.8	8.8	12.1	9.4	9.6	12.8	29.7	15.8	7.2	10.8	10.2	8.9	12.0	12.7	8.6	14.3	6.4	5.0	35.5	7.4	14.2	7.5	6.0	4.4	9.3	7.4	7.2	42.2	7.4	11.2	9.2	36.7	50.8	10.2	4.9	9.4	7.4	8.4	7.8	21.8	15.3	12.4	6.6	18.9	10.5	26.2	18.9	12.0	6.1	6.7	15.5	15.6	9.1	8.4
GTPBP2		ENSG00000172432	"GTP binding protein 2"	Q9BX10	6	43605316-43629264	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031418, HPA031419"	Approved		Approved	Vesicles		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA031418: AB_2673872, HPA031419: AB_10600709"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (1.44e-15)"	"unprognostic (1.13e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	38.5	29.8	14.5	15.3	15.3	28.7	37.4	16.5	17.9	39.5	16.0	34.0	19.9	26.8	15.5	61.3	25.1	12.5	35.4	14.4	15.0	36.1	33.3	46.7	16.9	17.5	16.7	29.0	40.0	24.1	40.0	18.0	15.6	31.5	17.0	18.9	42.6	11.6	31.6	26.5	34.7	15.4	14.3	44.5	35.9	27.2	17.0	16.8	44.2	10.4	17.0	33.9	40.4	16.2	59.2	10.9	37.7	24.0	28.3	30.6	45.6	56.3	55.2	52.6	70.1	12.0	19.9	18.8	23.5	26.9	53.8	31.6	9.8	14.5	45.6	60.9	31.6	44.1	33.0	13.9	126.0	35.6	50.1	35.1	160.5	72.5	181.4	35.1	20.5	25.7	77.1	107.8	26.2	13.9	23.4	45.1	10.6	41.2	14.8	19.4	29.5	17.5	24.0	25.8	33.1	32.4	19.5	14.0	72.5	19.0	30.3	37.3	34.8	27.2	33.2	20.5	38.3	70.8	38.2	26.7	45.4	26.0	27.5	5.4	0.8	2.1	1.2	0.7	0.9	0.6	0.2	1.1	0.4	1.0	0.7	1.0	1.3	0.6	0.9	1.1	0.6	1.2	14.5	15.3	16.5	17.9	14.4	15.0	17.5	16.7	15.6	14.3	17.0	16.2	19.6	3.2	5.5	6.8	5.1	5.2	2.3	4.3	1.2	5.9	7.5	5.0	11.4	5.7	5.7	1.8	8.4	2.8	5.3	24.0	0.0	10.1	17.0	8.5	8.2	9.7	1.2	14.3	7.2	10.1	9.8	6.8	11.7	13.3	1.3	5.7	6.8	5.5	8.2	1.7	6.3	8.8	2.0	12.6	6.5	47.6	5.3	16.0	7.2	5.6	10.1	3.4	1.0	5.5	9.1	20.7	13.4	4.1	2.4	5.8	6.8	1.8	4.1	9.2	13.1	5.3	7.8	7.1	8.1	4.4	5.3	2.5	3.8	4.7	6.0	12.6
GTPBP3	"FLJ14700, GTPBG3, MSS1, MTGP1, THDF1"	ENSG00000130299	"GTP binding protein 3, mitochondrial"	Q969Y2	19	17334920-17342731	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042158	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA042158: AB_10964400"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (2.81e-4)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.79e-1)"	8.0	13.5	6.8	5.1	5.9	4.9	9.1	6.1	7.0	10.6	6.0	8.8	5.5	8.5	1.8	13.1	9.6	2.1	8.7	6.3	7.5	11.3	14.1	7.6	6.5	9.0	7.1	10.2	12.2	5.3	8.8	3.3	9.0	10.5	2.9	4.1	10.2	3.9	9.2	15.1	9.4	2.8	6.2	12.7	9.3	3.0	7.0	3.5	8.8	3.1	4.3	8.9	10.4	6.5	19.7	11.6	10.6	13.8	3.5	3.3	51.2	9.1	3.8	8.2	8.0	16.2	15.6	29.8	22.8	3.4	5.8	17.2	13.5	7.8	6.7	24.9	62.6	17.8	18.4	21.4	4.6	19.3	11.2	3.4	11.2	7.6	9.7	5.7	6.6	20.9	34.6	13.0	4.2	15.7	23.2	17.2	22.4	12.2	51.5	27.4	8.2	28.3	7.6	8.8	24.7	22.0	9.8	14.9	12.9	7.0	13.2	7.9	7.2	12.6	11.3	28.0	16.3	21.9	36.7	35.4	10.0	25.0	9.8	0.4	2.3	0.4	4.8	3.2	4.0	3.0	4.5	4.3	3.6	4.1	4.9	4.6	0.7	5.2	1.7	6.7	3.3	2.8	6.8	5.9	6.1	7.0	6.3	7.5	9.0	7.1	9.0	6.2	7.0	6.5	10.5	3.2	5.3	11.8	10.8	17.1	9.3	11.4	13.6	20.3	14.9	14.9	7.2	4.3	6.1	5.5	31.3	21.4	10.2	5.9	7.9	12.5	0.3	5.2	7.7	9.7	3.0	12.0	6.2	10.9	25.3	9.0	9.2	7.9	2.5	15.7	8.6	9.8	10.1	11.8	9.4	9.7	12.2	5.6	7.7	0.2	11.8	6.2	10.6	2.8	8.6	8.3	12.3	8.0	8.3	10.8	7.5	13.5	18.0	9.7	9.1	7.1	5.9	20.7	6.6	7.2	10.8	2.9	4.6	11.5	17.5	8.3	12.6	15.9	13.2	6.4
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988434-1019932	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	15.6	19.6	8.0	12.6	8.5	26.9	12.8	8.6	8.7	8.4	9.4	9.5	8.6	11.0	8.8	11.4	9.2	7.9	11.1	8.8	9.5	9.4	10.9	8.5	13.9	9.1	9.4	9.8	11.9	10.3	7.8	10.2	9.1	9.0	10.8	8.9	7.8	8.4	26.6	9.5	8.2	12.2	9.5	9.4	9.2	21.0	9.4	12.0	9.8	14.8	15.6	18.3	8.7	10.1	57.0	49.4	37.1	34.9	27.9	31.1	27.3	52.3	18.8	62.6	53.3	73.2	43.3	87.0	15.2	45.5	21.3	43.6	77.4	52.0	71.2	41.8	50.9	94.7	35.3	45.4	44.5	41.3	47.1	43.1	42.7	72.7	51.6	25.5	34.7	62.9	98.3	33.5	60.1	57.0	62.0	40.3	56.2	77.9	33.8	59.3	35.5	57.6	37.9	37.4	19.3	57.3	37.3	44.7	66.3	36.7	61.8	42.3	32.4	30.3	16.4	71.5	65.2	45.0	86.9	103.5	33.9	43.5	24.9	18.2	9.6	3.6	12.4	16.2	14.3	12.0	11.7	12.6	12.9	11.2	12.7	12.5	1.5	18.4	13.3	8.6	16.6	8.9	8.0	8.5	8.6	8.7	8.8	9.5	9.1	9.4	9.1	9.5	9.4	10.1	36.2	57.7	74.3	5.9	41.8	62.7	100.0	52.8	35.3	26.1	28.1	27.4	32.6	21.5	83.5	29.5	18.8	50.3	37.4	18.4	33.2	57.7	70.9	46.8	51.9	49.2	22.1	37.4	9.3	44.1	54.9	48.9	33.6	78.8	66.9	40.1	20.0	27.5	34.7	23.5	8.9	29.9	40.7	26.0	24.4	20.9	24.8	33.1	23.2	8.4	39.5	26.5	22.6	6.0	10.2	72.2	17.3	29.3	37.0	84.7	10.6	25.6	55.8	32.7	19.7	58.5	51.4	88.7	84.9	47.0	67.2	95.4	37.5	57.7	32.6	102.6
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"	O43824	X	304529-318819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	31.4	24.2	22.5	17.2	24.3	26.2	29.9	22.2	33.2	25.8	17.3	29.6	19.7	28.1	3.2	26.7	29.6	9.9	46.5	20.9	19.7	33.1	38.7	25.9	19.3	26.9	23.4	30.5	42.6	12.0	17.0	9.6	23.7	26.1	5.8	4.1	30.1	12.3	69.4	30.8	26.3	6.8	21.3	26.8	35.8	13.4	22.2	13.2	27.5	27.1	6.9	29.6	22.6	30.7	40.4	65.4	14.2	29.9	16.1	17.5	52.6	24.5	18.0	30.4	27.7	100.8	32.9	50.1	34.0	13.8	41.3	24.6	15.0	23.9	4.9	42.1	44.1	41.5	32.2	70.0	43.2	28.2	38.9	21.7	31.0	20.3	14.8	11.2	24.7	32.8	31.1	23.0	12.7	79.5	50.4	37.1	34.8	8.1	46.0	22.3	25.0	80.7	17.9	46.3	39.8	33.9	26.8	30.0	46.2	7.6	26.9	24.3	33.0	44.2	30.4	66.0	38.3	30.9	30.1	78.0	23.0	36.8	20.9	5.3	4.1	4.8	4.8	4.3	4.8	4.9	4.2	5.5	4.0	3.4	5.1	4.6	0.5	3.7	4.0	7.3	6.3	2.6	22.5	24.3	22.2	33.2	20.9	19.7	26.9	23.4	23.7	21.3	22.2	30.7	35.3	19.2	19.2	17.0	33.8	28.2	48.2	7.9	34.7	28.1	38.1	34.0	20.3	32.9	9.2	27.6	27.1	22.0	45.1	32.1	52.8	13.1	1.4	20.1	27.3	26.2	17.9	16.6	10.9	15.0	46.0	32.9	37.8	23.6	11.4	44.9	21.0	38.1	29.3	13.5	9.6	24.7	16.2	25.7	28.0	1.6	19.6	32.6	26.6	6.5	16.7	22.0	33.0	12.1	18.7	10.4	17.4	18.8	32.5	98.1	23.2	89.5	6.7	27.2	6.6	33.2	31.2	4.5	13.5	36.9	26.6	29.4	38.9	54.3	38.1	51.2
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990984-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.8;Spermatocytes: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	5.3	5.7	3.6	6.1	4.3	8.4	5.6	4.6	4.9	4.6	4.6	6.0	6.6	5.6	3.7	7.4	4.4	5.2	11.9	3.9	3.9	7.3	5.9	4.3	11.2	4.3	3.8	6.7	6.8	8.9	4.5	6.1	4.2	5.7	7.1	4.2	6.5	3.7	20.0	4.8	6.0	5.5	4.4	4.9	7.5	14.4	3.9	9.7	10.1	18.3	8.1	5.9	4.7	6.4	25.5	10.8	15.7	16.5	9.2	15.6	11.5	17.9	14.7	17.0	20.5	18.6	10.4	16.8	9.7	10.0	14.2	17.1	21.0	17.1	23.5	7.0	13.4	46.5	11.4	11.6	8.4	28.9	10.5	11.9	11.9	9.6	7.0	19.2	16.1	19.9	16.4	19.5	18.0	8.8	18.5	14.4	32.8	13.2	20.8	16.1	14.7	10.4	14.4	16.3	17.5	18.2	14.2	11.3	25.7	13.7	12.3	19.6	9.8	12.7	19.4	4.5	16.0	13.1	17.4	24.0	12.7	23.6	14.0	7.9	4.3	2.9	6.4	3.0	5.7	4.2	7.8	6.3	8.1	3.6	9.9	6.5	0.7	8.7	2.7	3.7	5.4	4.5	3.6	4.3	4.6	4.9	3.9	3.9	4.3	3.8	4.2	4.4	3.9	6.4	13.1	16.0	15.4	2.9	16.9	13.5	15.9	28.8	8.0	11.5	12.9	12.4	25.8	10.0	19.5	5.5	6.2	28.3	27.1	10.4	23.5	16.3	79.8	17.7	12.9	11.6	10.2	22.7	5.5	18.3	25.1	13.3	12.8	18.3	19.7	20.0	17.9	7.7	22.7	10.1	6.3	10.3	28.5	16.7	14.8	35.5	11.8	13.6	10.6	4.7	18.3	10.4	13.4	7.1	6.9	16.5	12.2	5.7	17.1	12.8	17.7	29.6	16.0	14.0	0.0	17.4	15.8	79.7	28.1	16.1	12.1	15.2	22.5	34.9	12.0	18.9
GTSF1	"Cue110, FAM112B, FLJ32942"	ENSG00000170627	"Gametocyte specific factor 1"	Q8WW33	12	54455950-54473602	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 186.1"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1181.4;Late spermatids: 1810.3;Spermatocytes: 531.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 23.2"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 294.6;HMC-1: 207.5;K-562: 290.1;NB-4: 442.3;THP-1: 405.8;U-266/84: 337.6;U-937: 216.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038876, HPA038877"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038876: AB_10670911, HPA038877: AB_2676251"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.97e-5)"	"unprognostic (4.16e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.18e-2)"	0.5	0.5	0.3	2.4	0.5	6.3	0.4	0.5	0.5	0.1	0.0	0.8	1.4	0.3	0.5	0.2	0.1	1.1	0.9	0.3	0.3	0.6	1.3	1.9	5.6	0.5	0.3	0.3	0.2	0.1	0.2	14.1	0.6	0.4	1.9	0.3	0.3	0.1	0.4	0.5	1.4	0.3	0.2	3.6	0.7	186.1	0.4	6.1	0.4	0.1	10.9	1.0	0.2	0.9	1.1	0.0	0.3	0.0	0.0	0.0	146.3	0.2	0.0	0.0	0.0	0.3	0.1	114.1	52.2	0.0	0.1	0.4	151.3	0.0	0.0	59.7	0.1	0.1	0.0	0.1	0.0	294.6	207.5	0.0	0.0	0.0	0.1	0.1	0.0	85.3	290.1	113.6	0.0	0.0	0.2	442.3	0.1	0.0	0.0	0.2	0.0	158.8	0.0	0.2	0.2	0.9	0.0	5.7	0.3	2.5	0.1	405.8	1.4	0.1	10.3	0.1	0.7	113.1	337.6	0.7	0.0	216.5	0.1	28.3	9.4	18.9	23.5	9.8	28.3	33.4	26.3	33.1	16.9	33.7	24.3	25.4	4.5	32.2	11.2	33.6	31.0	16.7	0.3	0.5	0.5	0.5	0.3	0.3	0.5	0.3	0.6	0.2	0.4	0.9	0.1	0.0	0.6	0.3	4.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	48.1	6.3	0.4	0.0	0.0	1181.4	0.0	0.0	1.7	0.0	2.1	0.2	0.0	106.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	12.0	0.0	0.2	0.2	0.0	2.2	3.0	1810.3	15.8	4.0	3.6	0.0	10.3	0.0	6.2	0.0	0.1	0.0	0.0	10.1	6.5	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	531.1	105.5	0.0	0.3	27.0	5.0	0.2	0.5	0.0
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43727002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"testis: 223.7"	"Group enriched"	"Detected in some"	115	"Early spermatids: 2791.6;Late spermatids: 4158.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"REH: 1.1;U-698: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA054694	Enhanced		Uncertain	Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli		"HPA054694: AB_2682576"	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	223.7	0.0	0.4	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2791.6	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4158.1	19.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	30.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42181338	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	91	"retina: 804.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 667.2;Late spermatids: 432.4;Muller glia cells: 219.9;Rod photoreceptor cells: 1191.6"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Group enriched"	"Detected in some"	8	"NTERA-2: 3.8;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.0	0.0	1.5	0.1	3.5	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.4	0.0	0.0	0.0	0.1	1.5	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	804.8	0.0	0.0	0.1	0.1	0.1	0.1	0.8	0.0	0.0	8.8	6.2	0.0	0.0	0.0	0.2	0.0	0.1	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.0	0.0	4.9	0.0	0.0	1.5	3.5	0.9	1.8	1.3	5.4	1.5	1.4	1.4	0.8	6.2	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	140.7	0.0	0.0	0.3	0.0	0.0	0.0	667.2	0.6	1.3	0.0	0.0	0.0	106.5	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	65.6	1.0	0.0	4.1	0.0	0.0	432.4	1.8	0.1	0.0	0.0	5.2	219.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1191.6	0.0	0.0	1.2	3.2	3.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42183284-42194956	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 466.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.3;U-698: 3.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.5	0.9	3.5	0.8	3.6	1.3	1.4	3.8	4.1	2.3	2.2	1.3	0.3	1.9	1.0	0.8	2.3	0.2	1.6	3.2	3.2	1.0	1.9	1.1	0.7	3.3	3.2	2.7	0.9	0.2	1.0	0.4	3.6	1.5	0.5	466.0	1.1	0.5	2.6	2.8	1.4	1.0	3.0	2.1	0.8	2.6	3.5	1.0	1.0	0.9	0.9	1.1	1.4	4.6	0.1	0.6	1.3	0.5	1.0	0.9	0.3	0.5	0.8	0.8	0.7	1.1	0.4	1.6	0.8	0.1	0.2	0.4	1.4	0.2	1.4	1.3	0.6	0.4	0.1	0.2	0.4	1.5	0.5	0.3	4.3	0.8	1.1	0.4	0.1	1.2	1.0	1.5	0.2	1.3	0.6	1.0	0.0	0.3	0.3	0.2	0.8	0.1	0.8	0.5	0.6	0.9	0.0	0.2	0.1	0.2	0.1	0.9	0.0	0.2	1.7	0.6	0.7	2.7	1.3	3.9	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.5	3.6	3.8	4.1	3.2	3.2	3.3	3.2	3.6	3.0	3.5	4.6	0.2	0.0	0.0	23.2	0.0	0.3	0.1	0.0	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	83.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.0	8.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	6.7	11.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	2.8	0.1	8.1	0.0	11.6	28.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	53.0	0.0	0.5	0.4	0.5	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"retina: 296.7"	"Cell type enriched"	"Detected in some"	4	"Cone photoreceptor cells: 125.1"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	85	"RPTEC TERT1: 14.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	1.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	41.5	0.0	0.4	0.0	0.1	0.0	0.0	296.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.3	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	14.5	0.0	0.0	0.0	125.1	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.6	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	17.5	0.0	0.0
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162690-42164745	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"intestine: 927.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 3728.7;Paneth cells: 17085.1;Proximal enterocytes: 12113.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 52.1"	"Not detected"	"Not detected"							HPA018215	Enhanced				"Secreted to blood"	NA	NA		18000000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.8	0.1	0.0	3.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	716.9	56.5	0.9	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.4	0.2	1.2	0.7	0.0	0.0	0.1	1.2	0.0	0.2	7.3	0.0	0.1	725.9	0.0	0.0	2.0	0.1	0.0	927.5	17.2	0.0	0.2	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3728.7	0.0	2.6	0.1	0.0	0.0	0.0	47.7	0.0	0.0	1.1	4.4	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17085.1	0.0	0.0	0.0	12113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	3.8	0.0	206.6	0.2
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674019-107018476	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;placenta: 17.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 353.8;Inhibitory neurons: 141.8;Oligodendrocyte precursor cells: 208.6;Sertoli cells: 105.2;Smooth muscle cells: 107.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.8;BJ hTERT+ SV40 Large T+ RasG12V: 13.4;HBF TERT88: 7.1;TIME: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB009534: AB_2279509"	"unprognostic (7.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.70e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.48e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	3.4	2.0	5.3	0.6	18.4	0.0	1.9	1.6	13.8	12.7	0.0	0.7	0.2	12.3	3.1	0.4	5.9	1.5	2.7	7.1	3.9	1.8	1.7	4.6	0.7	4.7	2.6	1.2	4.3	0.6	0.5	17.9	4.9	1.8	0.5	3.5	0.6	6.8	1.8	0.6	0.4	13.1	0.4	6.0	0.3	1.7	8.6	0.2	1.4	3.6	0.3	0.9	2.8	7.4	0.0	0.2	4.0	0.0	0.2	2.4	2.2	0.3	11.8	1.5	13.4	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	7.1	0.0	1.1	0.0	0.1	0.0	0.2	0.0	1.6	0.6	0.0	1.8	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	3.6	0.0	0.7	0.5	0.8	0.2	4.6	3.7	3.0	0.8	1.2	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	18.4	1.6	13.8	7.1	3.9	4.7	2.6	4.9	0.4	8.6	7.4	29.5	0.0	0.5	20.2	0.5	1.7	2.2	0.0	1.2	24.0	0.4	0.9	5.1	0.0	0.0	3.7	12.5	0.1	0.0	0.1	0.0	5.8	2.5	0.9	24.2	12.5	0.0	2.7	353.8	0.2	0.0	8.2	0.0	1.1	0.0	42.7	2.2	0.2	0.4	18.5	141.8	0.0	0.0	0.8	1.5	6.5	24.5	1.1	3.6	18.7	0.0	29.3	0.0	208.6	10.7	0.3	0.0	25.2	1.2	2.4	0.0	0.1	0.0	4.8	105.2	20.7	107.0	1.6	1.5	0.7	1.1	0.3	0.5	19.6	0.0	1.5
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	226.7	198.9	291.7	93.9	277.9	251.9	213.3	255.3	465.2	187.1	274.1	196.5	113.8	169.2	48.6	333.8	161.8	116.3	240.0	302.8	257.9	230.6	318.1	222.8	124.5	263.1	263.0	146.9	208.9	72.0	165.7	78.9	261.8	161.3	31.5	110.8	191.0	71.6	149.0	285.7	155.0	53.6	266.3	179.4	202.0	107.3	281.3	97.1	151.3	61.8	39.2	188.6	202.4	289.4	356.1	122.4	53.0	164.5	155.6	186.6	264.3	230.8	116.5	130.8	102.8	70.6	239.1	133.4	266.5	151.4	110.0	230.3	45.7	252.0	14.0	203.7	357.1	79.3	292.9	156.3	282.8	90.5	133.0	260.0	150.6	91.9	73.3	94.2	179.2	279.9	219.5	205.1	109.5	295.2	411.4	194.3	166.8	172.6	522.9	155.3	99.9	354.9	125.2	164.1	173.7	311.3	148.7	250.2	309.7	13.5	185.2	191.7	318.5	237.7	157.4	353.4	387.5	186.8	221.9	151.6	300.3	146.2	246.0	379.0	323.8	663.9	420.6	363.0	406.5	265.0	346.8	454.1	279.7	230.8	256.5	323.4	420.1	339.5	390.9	567.3	394.6	571.4	291.7	277.9	255.3	465.2	302.8	257.9	263.1	263.0	261.8	266.3	281.3	289.4	503.7	60.9	87.2	35.3	199.9	660.0	271.5	643.5	215.7	195.5	425.9	448.7	130.8	195.9	312.2	237.3	717.2	241.6	351.2	655.8	694.6	510.9	134.0	212.5	272.0	451.4	269.6	866.9	50.2	685.5	417.9	276.9	189.1	304.2	182.6	162.5	365.5	353.4	407.5	109.4	33.5	426.5	384.5	291.7	557.0	609.3	233.6	265.6	519.4	22.5	355.5	411.0	398.6	16.1	58.6	975.0	718.8	243.8	365.6	571.5	857.7	801.1	231.6	570.9	249.8	158.2	378.6	89.8	100.3	448.6	719.7	262.4	326.7	226.3	331.5	612.2
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP PTB domain containing engulfment adaptor 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 83.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 136.5;Inhibitory neurons: 115.5;Muller glia cells: 129.4;Syncytiotrophoblasts: 204.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.9;SH-SY5Y: 83.4;WM-115: 228.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020587	Enhanced		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favorable (4.25e-6)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	9.4	24.5	2.0	5.8	6.4	0.2	13.1	0.0	4.3	27.7	33.0	13.3	13.5	35.3	83.0	19.2	18.2	17.5	5.2	3.6	7.3	21.3	0.8	13.3	1.7	22.7	4.1	31.8	22.2	26.1	3.4	19.7	23.2	27.7	7.8	17.7	16.1	28.1	9.6	6.2	15.8	21.7	0.3	5.9	22.6	28.0	4.0	1.7	7.8	16.7	3.3	11.9	14.3	0.1	12.5	26.9	106.9	23.8	17.1	15.5	18.6	16.5	27.0	25.1	19.9	18.9	62.6	0.0	13.2	13.2	28.2	8.3	20.0	1.5	18.9	0.0	13.9	27.0	20.5	0.2	15.1	0.0	0.2	10.1	4.2	13.0	14.2	42.9	12.7	0.0	22.5	0.5	19.3	1.8	0.0	0.4	27.4	18.1	46.0	0.1	25.1	14.0	60.0	4.7	0.5	83.4	0.0	14.6	40.2	47.9	4.7	0.1	5.9	7.8	3.8	26.3	9.6	0.0	0.1	0.0	4.6	0.0	228.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	6.4	0.0	4.3	3.6	7.3	22.7	4.1	23.2	0.3	4.0	0.1	22.8	16.0	13.4	43.4	1.6	15.7	23.9	3.6	10.2	1.5	10.6	12.2	1.6	45.8	28.2	23.9	0.0	41.1	0.6	3.7	45.0	33.0	5.0	23.9	35.4	32.1	136.5	0.0	82.7	38.2	5.9	55.3	39.8	52.1	0.0	2.2	10.0	1.5	3.2	1.7	115.5	4.6	14.2	1.0	10.5	7.9	20.5	2.0	35.6	53.4	1.1	129.4	0.0	3.0	3.1	51.3	9.8	61.3	1.4	79.8	30.8	43.2	43.5	3.7	6.6	42.2	27.9	79.6	23.9	38.9	27.6	204.4	2.7	27.0	4.7	34.5
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381303-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.9;Distal tubular cells: 9.8;granulocytes: 3.8;Granulosa cells: 7.0;Proximal tubular cells: 6.7;Theca cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: AB_2683429"	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	1.1	1.5	1.5	1.4	1.6	1.1	1.9	3.2	2.1	1.7	4.4	1.3	1.4	1.8	1.9	0.4	2.0	0.7	1.0	1.4	0.8	1.4	0.7	0.9	1.9	0.5	0.1	2.2	6.5	1.0	2.4	0.8	0.6	1.2	1.5	14.2	1.9	0.8	1.1	1.4	1.3	0.9	0.0	1.7	1.4	3.4	1.2	2.4	1.9	0.6	1.6	0.9	1.3	1.5	1.1	1.2	4.4	3.2	1.2	1.6	1.5	0.6	0.5	1.1	1.1	3.0	2.0	3.6	1.2	0.5	1.3	2.6	1.9	0.8	1.9	2.0	1.2	1.9	5.0	1.3	0.7	2.5	1.2	0.7	1.2	1.4	0.8	1.0	0.9	4.9	1.2	2.3	0.4	1.3	2.4	3.8	0.9	0.9	1.4	3.7	2.9	1.9	0.7	0.8	6.5	2.9	1.2	0.7	0.7	1.7	2.1	0.8	0.6	2.1	2.2	3.2	0.7	2.1	1.6	4.6	0.8	1.7	1.1	1.5	0.3	0.4	0.4	0.2	0.3	0.5	0.6	0.5	0.2	0.6	0.6	0.6	1.0	0.8	0.2	0.3	0.8	0.2	1.5	1.6	3.2	2.1	1.4	0.8	0.5	0.1	0.6	0.0	1.2	1.5	2.1	0.0	3.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.0	0.0	2.5	1.8	0.0	1.1	1.7	0.0	9.8	1.2	0.0	2.4	2.5	0.8	0.0	0.0	0.0	0.6	0.6	1.4	0.0	0.6	3.8	7.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.7	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.9	5.5	0.0	0.0
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991408-149031775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 560.0;tongue: 357.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA		30000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	40.3	31.1	30.1	31.3	32.2	219.8	33.8	33.1	39.4	36.5	28.7	152.2	16.7	64.1	38.7	53.6	52.6	23.9	117.8	29.9	44.0	29.0	18.6	41.1	24.8	37.0	39.7	43.8	42.7	25.2	31.5	23.0	39.0	47.3	25.6	34.3	39.7	64.4	560.0	21.2	37.7	68.1	35.9	59.2	50.7	115.1	33.6	18.0	21.1	357.6	23.0	86.1	30.8	38.3	62.7	39.8	29.0	32.6	78.5	81.7	39.5	90.2	74.4	128.3	119.2	52.3	62.2	0.1	43.5	105.1	68.4	18.8	76.7	39.8	128.6	21.1	33.3	47.6	16.7	59.9	70.7	49.1	68.8	45.1	63.8	42.7	53.3	66.8	74.7	30.7	29.8	109.8	74.7	110.3	9.6	38.9	34.9	48.3	32.2	26.7	43.8	89.3	35.7	57.6	23.7	11.3	47.6	64.6	54.4	27.3	64.4	51.4	62.9	65.4	19.4	47.4	66.9	98.7	59.1	44.4	55.1	74.3	21.7	22.7	58.1	42.4	39.4	59.6	73.1	15.9	25.7	41.3	64.0	14.0	13.8	23.5	27.0	44.3	67.9	25.3	39.4	50.1	30.1	32.2	33.1	39.4	29.9	44.0	37.0	39.7	39.0	35.9	33.6	38.3	27.7	12.8	11.1	16.3	28.3	12.1	22.4	27.7	12.5	9.4	22.5	17.1	229.8	15.7	21.9	33.1	18.8	36.5	50.4	9.9	27.4	43.4	251.2	7.9	15.2	32.6	14.4	12.2	9.8	77.6	47.2	45.0	17.3	9.5	18.3	19.7	45.3	13.5	95.3	6.7	11.3	19.0	26.4	87.1	26.3	368.8	53.1	56.2	40.9	6.5	56.2	132.1	36.0	11.6	5.4	31.6	14.3	76.8	104.1	45.9	15.0	17.3	16.1	7.0	65.7	35.8	50.3	296.7	52.2	23.1	14.9	29.3	61.2	33.8	15.2	19.6
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828822-2882820	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 156.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	156.3	2.2	10.3	1.9	10.8	0.2	38.9	18.4	8.8	3.0	8.5	3.9	1.5	6.6	1.0	0.9	5.1	2.2	1.4	11.2	18.9	2.0	18.5	0.5	0.6	29.4	24.5	2.5	5.4	1.0	0.8	2.1	27.3	4.0	2.8	1.4	4.7	6.6	0.3	1.9	2.1	3.7	36.0	0.3	4.5	0.9	13.7	0.4	1.7	0.5	0.3	3.7	2.0	35.4	0.1	11.5	39.1	0.2	20.5	0.0	28.5	2.0	6.3	6.1	8.2	30.4	0.6	0.0	3.1	5.2	6.6	0.0	22.5	0.5	6.8	0.2	6.3	0.1	0.7	32.6	6.7	0.0	8.9	8.1	0.4	1.0	0.0	0.2	0.0	0.0	0.3	0.1	6.6	1.9	0.0	1.0	38.4	0.4	0.2	6.1	13.0	0.0	0.0	0.1	0.0	0.7	0.1	0.3	87.6	59.0	4.1	25.4	0.0	0.0	6.7	3.8	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.3	10.8	18.4	8.8	11.2	18.9	29.4	24.5	27.3	36.0	13.7	35.4	0.3	0.0	0.0	10.7	0.2	0.4	1.1	0.5	0.0	1.2	2.1	0.8	1.2	4.3	0.2	0.0	4.2	6.0	0.0	1.2	5.9	1.0	0.4	3.8	1.0	0.3	20.4	0.0	5.9	4.0	7.9	1.6	4.6	0.7	0.0	10.2	0.0	20.2	1.1	0.0	4.9	1.7	0.0	1.0	0.0	0.5	0.6	0.1	3.6	0.0	0.0	1.6	0.0	0.5	0.1	2.1	0.6	3.0	0.0	1.0	0.4	2.4	1.1	0.1	0.0	0.3	1.2	0.3	1.5	0.0	0.3	2.3	0.0	3.2	3.5	0.7
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GYPC	"CD236, CD236R, Ge, GPC, GYPD"	ENSG00000136732	"Glycophorin C (Gerbich blood group)"	P04921	2	126656133-126696667	"Blood group antigen proteins, CD markers, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1728.6;Hofbauer cells: 488.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 66.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 433.1;K-562: 362.1;SK-MEL-30: 668.4;U-266/70: 363.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008965, CAB009445"	Enhanced		Supported	"Plasma membrane"		NA	NA		970000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"CAB009445: AB_2116251, HPA008965: AB_1078455"	"unprognostic (1.63e-2)"	"unprognostic (7.14e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.00e-3)"	172.3	73.0	17.3	51.5	17.6	441.0	109.2	17.5	30.8	75.7	20.2	89.1	18.2	62.3	20.2	42.3	68.4	56.3	161.9	16.5	20.2	58.4	18.5	101.4	110.5	22.2	18.4	91.5	34.8	9.6	16.9	50.3	22.0	46.5	19.3	10.3	26.4	56.1	212.7	37.0	52.9	55.9	20.6	98.5	41.0	7.3	23.6	59.6	33.3	204.1	75.9	73.0	54.4	24.9	1.3	0.0	152.0	0.2	116.1	100.5	0.2	24.0	186.4	28.9	84.9	0.0	0.2	0.6	0.4	69.6	107.6	0.3	85.7	0.1	9.5	79.7	0.0	279.0	0.0	0.0	433.1	99.0	0.7	237.4	0.0	23.1	0.1	2.3	1.0	190.4	362.1	214.6	70.5	0.0	0.1	148.9	46.7	0.0	0.4	18.1	12.1	0.4	11.8	0.0	0.2	0.0	0.3	0.0	668.4	20.7	0.0	258.5	65.7	107.3	1.0	7.3	1.2	363.9	257.4	0.5	51.4	135.8	99.3	0.8	28.6	2.2	153.1	40.3	172.2	95.8	136.7	186.5	50.0	102.6	190.5	188.3	21.9	81.1	24.7	27.1	179.4	119.0	17.3	17.6	17.5	30.8	16.5	20.2	22.2	18.4	22.0	20.6	23.6	24.9	260.7	6.4	7.7	0.7	152.7	38.0	3.4	17.0	43.3	0.6	14.6	110.5	34.9	84.4	6.0	14.7	2.1	4.9	194.0	0.0	135.0	202.9	1.6	3.6	99.8	157.2	0.0	1728.6	0.4	4.9	6.9	170.5	10.2	2.5	22.9	23.3	229.2	6.2	488.7	0.0	0.5	1.1	0.0	118.0	108.5	4.9	87.3	134.9	305.9	15.0	98.0	5.1	204.9	6.0	0.1	6.0	0.4	69.2	250.9	9.4	0.0	8.1	1.7	2.6	59.2	65.8	88.6	0.2	0.7	41.9	26.6	9.0	228.0	31.8	1.6	2.9
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968130-48993310	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	32.4	26.3	17.9	16.2	18.8	46.0	23.7	26.4	23.3	17.1	22.2	21.7	15.3	18.8	8.9	38.2	18.7	10.1	118.5	19.7	17.6	21.8	14.9	16.0	15.5	22.2	20.9	19.7	13.6	15.7	15.5	11.3	19.6	27.4	14.7	19.2	22.2	15.5	319.4	20.7	19.9	16.7	16.4	18.5	23.2	6.1	20.2	14.7	15.9	201.6	14.4	24.3	23.2	18.3	67.3	26.3	19.0	26.3	43.2	16.9	37.6	45.5	31.7	46.8	54.3	25.8	21.3	28.0	27.0	44.7	12.4	46.6	32.0	57.7	40.6	17.4	46.5	23.1	33.3	23.1	24.3	25.4	15.9	41.8	27.2	30.2	25.4	40.5	39.8	28.8	16.4	36.1	59.4	25.4	31.8	21.9	10.2	29.0	29.8	26.6	33.2	27.5	46.7	70.6	11.8	16.4	40.5	52.1	10.4	25.2	27.7	26.1	31.0	57.1	22.0	26.1	50.5	29.8	33.1	13.5	58.3	22.2	13.1	7.7	9.4	6.6	7.0	5.3	8.6	5.2	6.0	6.5	13.4	3.9	4.7	4.4	3.7	10.6	8.0	7.2	8.6	7.1	17.9	18.8	26.4	23.3	19.7	17.6	22.2	20.9	19.6	16.4	20.2	18.3	3.5	0.0	14.2	21.9	5.9	5.1	3.7	11.7	11.4	4.2	7.3	5.5	67.9	2.8	5.8	0.0	16.7	7.6	6.8	13.2	0.0	8.1	0.3	6.9	8.9	7.1	7.2	4.8	14.7	6.9	31.7	5.0	12.8	11.9	4.5	6.7	9.7	5.2	8.3	0.0	16.6	9.2	4.1	7.0	5.7	0.7	5.3	7.2	7.2	4.7	9.8	3.3	10.3	8.5	6.9	11.8	8.2	5.7	9.7	5.4	9.2	6.0	6.2	11.7	0.0	5.0	7.3	1.3	2.9	15.3	4.1	4.0	5.2	3.8	11.7	3.3
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 173.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 63.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	3.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.1	2.4	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.2	173.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	63.6	0.0	0.0	7.7	0.0	6.1	1.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373062	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	5.9	18.7	9.6	5.5	10.4	31.5	5.0	11.1	10.9	6.0	9.2	6.5	3.9	6.5	5.3	4.4	6.5	5.5	12.4	9.4	9.8	7.7	6.4	6.0	5.2	10.0	12.8	9.2	5.2	6.7	7.9	6.4	9.9	5.9	4.1	10.5	5.0	6.8	9.4	4.7	4.8	5.7	10.6	5.3	5.4	13.3	11.7	5.5	7.0	8.1	4.4	5.8	4.6	10.4	8.2	14.2	8.9	9.0	10.3	10.0	7.1	9.8	9.0	9.9	9.2	10.9	6.4	16.6	8.5	8.5	19.3	14.3	10.3	13.2	11.2	2.8	6.7	15.4	6.0	14.7	13.4	9.3	9.0	10.1	9.6	10.7	16.3	13.8	6.7	11.4	10.6	25.2	14.3	10.9	14.5	11.6	6.6	11.5	19.3	9.5	21.3	11.6	7.4	8.2	13.7	7.8	8.7	15.4	20.9	7.3	10.2	13.4	8.7	16.0	9.2	12.1	10.6	20.5	9.0	14.4	4.7	41.8	8.8	0.0	1.6	0.8	0.7	0.9	0.5	1.0	1.0	1.0	1.6	0.6	0.9	1.0	1.2	0.5	1.2	1.3	0.3	0.9	9.6	10.4	11.1	10.9	9.4	9.8	10.0	12.8	9.9	10.6	11.7	10.4	9.8	6.4	9.6	5.5	12.6	10.8	3.1	3.8	8.6	12.6	6.0	6.9	19.7	1.5	4.7	3.7	18.8	4.9	8.7	3.9	7.9	3.6	18.9	10.4	9.7	8.4	5.4	4.0	6.6	3.3	3.2	8.3	7.1	17.8	13.9	8.2	2.2	5.2	8.7	6.7	7.6	4.2	4.1	13.2	28.8	27.5	9.3	23.9	1.8	1.0	2.5	10.3	5.2	4.5	5.6	4.0	4.6	8.2	11.6	3.2	2.8	3.8	7.7	13.4	0.0	8.8	11.5	20.7	8.9	7.6	8.4	5.6	7.9	14.0	3.7	1.8
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.0;JURKAT: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	5.6	6.0	0.9	16.7	0.9	35.3	7.2	0.9	2.5	7.6	1.2	14.7	29.2	14.7	8.8	4.8	4.6	14.0	4.0	0.8	1.0	3.2	15.2	21.9	68.1	1.6	0.9	4.5	1.0	1.3	1.0	3.1	1.1	3.1	17.8	0.0	7.1	3.0	1.7	1.6	27.6	7.2	1.1	51.1	11.7	2.0	1.1	12.4	2.9	1.3	19.2	13.5	2.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	3.8	941.4	2.3	926.2	3.4	250.0	922.7	3.1	1.3	48.5	494.1	19.9	718.8	4.0	3.2	33.1	712.7	0.9	0.9	0.9	2.5	0.8	1.0	1.6	0.9	1.1	1.1	1.1	1.1	5.1	3.2	18.1	0.0	12.3	0.4	0.1	0.0	2.8	0.0	2.7	2.4	1.6	5.7	3.1	0.0	0.0	0.4	739.3	1.4	0.0	1.6	0.0	1.7	2.7	2.8	0.0	36.2	0.0	0.0	0.2	7.8	20.4	2.1	7.6	0.0	17.9	2.8	0.3	0.0	0.1	1.5	0.0	25.8	2.6	0.0	0.0	12.3	3.6	0.0	12.6	0.0	1543.8	0.0	0.1	0.0	3.9	0.0	40.8	0.1	2.8	3.3	2.9	0.0	0.0	2.6	2.6	0.0	0.1	1.1	1.4	0.7	709.4	0.0	1.8	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.9;lymphoid tissue: 25.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 1678.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.0"					"Low region specificity"	"Detected in many"			HPA029200	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.4	5.2	1.2	3.1	1.3	33.9	4.6	1.3	2.4	2.6	1.6	2.7	2.4	2.0	5.0	3.6	3.5	7.0	2.5	1.1	1.3	1.2	6.7	15.9	25.2	2.0	1.2	2.8	0.8	0.7	2.4	1.6	1.5	1.4	2.5	0.0	7.9	2.1	1.9	0.6	2.8	3.4	1.3	24.4	4.7	0.8	1.4	3.8	1.5	0.6	4.5	7.5	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	31.6	3.4	1.7	1678.5	3.6	30.2	7.6	490.7	1389.6	3.3	4.6	155.1	1214.0	18.6	250.8	5.4	44.6	4.5	1436.5	1.2	1.3	1.3	2.4	1.1	1.3	2.0	1.2	1.5	1.3	1.4	1.3	2.9	0.0	4.6	0.0	3.3	1.1	0.1	0.0	0.0	0.0	1.7	1.5	1.4	8.6	0.0	0.0	0.0	0.1	575.2	0.0	0.0	0.1	0.1	0.3	0.3	1.5	0.0	8.6	0.0	0.0	0.0	1.2	1.1	0.4	1.3	0.0	7.5	1.2	0.1	0.0	0.0	0.0	0.0	9.3	3.4	0.2	0.0	4.5	3.6	1.9	3.1	0.0	492.3	0.0	0.1	0.0	0.0	0.0	43.7	0.2	0.0	2.6	0.7	0.0	0.0	1.9	1.3	0.1	0.0	0.4	1.8	0.0	302.2	0.0	0.1	0.1
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024256-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 99.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.3;T-cells: 301.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 741.6;NK-cell: 505.5"	"Group enriched"	"Detected in many"	199	"NK-cells: 505.5;T-cells: 741.6"	"Cell line enriched"	"Detected in single"	10	"JURKAT: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.0	3.9	0.1	19.4	0.1	10.5	4.9	0.1	0.4	4.3	0.3	3.4	1.6	4.0	4.5	3.0	2.0	11.6	2.0	0.1	0.2	1.7	10.7	5.9	99.6	0.5	0.2	2.7	1.0	0.8	0.5	0.5	0.3	3.2	4.6	0.0	4.6	1.0	0.2	0.6	7.3	2.2	0.2	30.4	6.5	1.2	0.3	11.9	2.3	0.3	27.8	8.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	1.1	164.3	1.0	741.6	0.5	100.2	457.3	0.5	0.5	4.9	77.4	3.1	505.5	0.9	0.9	7.0	95.5	0.1	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.3	0.2	0.3	0.3	3.8	3.2	7.0	0.0	10.7	1.5	0.1	0.0	1.8	0.0	1.5	1.7	0.1	2.8	0.6	0.0	0.0	0.0	136.3	0.1	0.0	0.0	1.3	0.8	0.4	0.8	0.0	4.4	0.0	0.0	0.0	1.2	4.1	0.8	2.5	0.0	8.6	1.5	0.2	0.0	0.0	0.0	0.0	10.3	2.5	1.2	0.0	6.4	1.8	0.0	5.1	0.0	29.9	0.0	0.1	0.0	0.0	0.0	45.1	0.1	0.2	0.8	0.0	0.0	0.0	1.8	1.7	0.0	0.3	0.2	0.6	0.3	301.9	0.0	0.0	0.1
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 22.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 385.8;NK-cells: 810.5;T-cells: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 583.9"	"Group enriched"	"Detected in all"	33	"NK-cells: 194.9;T-cells: 583.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.7;HMC-1: 2.1;JURKAT: 3.5;MOLT-4: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015624	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	2.2	1.1	0.9	10.0	0.9	21.6	1.1	3.6	2.0	1.4	0.3	1.5	2.1	0.8	0.2	0.8	1.3	1.8	0.8	0.9	0.9	1.0	3.3	5.3	19.2	1.0	0.8	0.7	0.4	0.0	0.9	0.4	1.0	1.3	0.3	0.2	2.8	0.4	0.7	0.8	6.2	0.2	0.7	22.7	3.7	1.8	0.9	8.7	1.6	0.1	3.8	1.5	1.4	1.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.1	0.0	0.4	1.3	0.6	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.1	0.5	0.1	0.3	0.1	9.1	1.4	1.3	583.9	1.7	366.5	0.9	189.2	471.3	1.5	4.0	182.8	379.2	11.9	194.9	2.3	3.6	99.1	227.5	0.9	0.9	3.6	2.0	0.9	0.9	1.0	0.8	1.0	0.7	0.9	1.0	3.4	0.0	0.0	0.3	5.7	3.1	0.1	0.0	0.6	0.5	2.4	2.2	0.1	1.5	0.0	0.0	0.0	0.2	385.8	0.1	0.0	0.4	0.9	0.6	1.5	1.4	0.0	12.0	0.3	0.4	0.4	2.2	13.3	1.1	0.0	0.1	3.6	1.4	0.2	0.0	0.2	0.4	0.0	3.7	4.7	1.6	0.0	5.9	1.8	1.0	8.6	1.6	810.5	0.5	0.3	0.3	0.0	0.0	35.8	0.1	0.0	1.2	0.0	1.4	0.0	1.5	1.2	0.5	1.1	0.9	1.4	0.5	243.6	0.2	0.1	0.1
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
H1-10	"H1FX, H1X, MGC15959, MGC8350"	ENSG00000184897	"H1.10 linker histone"	Q92522	3	129314771-129316286	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1004.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 937.8"	"Low region specificity"	"Detected in all"							"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	121.4	54.7	39.9	42.6	43.9	1004.3	145.0	60.6	68.6	162.4	25.2	125.0	44.6	143.1	9.2	107.8	142.2	13.9	82.0	43.1	48.4	162.7	100.1	115.8	44.3	29.5	26.0	168.9	100.0	30.1	112.6	25.4	25.1	124.5	11.9	13.9	98.7	20.8	110.7	258.4	106.7	13.2	27.8	127.7	115.7	40.9	38.2	131.5	94.4	12.3	18.3	130.9	140.7	46.4	141.8	73.4	135.8	59.3	13.6	16.1	129.1	60.5	43.5	70.4	74.3	44.5	75.5	17.8	65.5	21.6	47.2	139.1	57.3	39.0	10.8	129.4	111.7	53.8	55.5	61.1	57.3	62.6	14.1	32.4	51.9	28.7	64.7	32.0	40.7	241.7	83.7	308.5	10.0	147.9	290.9	124.1	127.2	25.8	81.6	207.4	58.1	170.9	22.1	29.1	216.0	250.1	64.1	31.7	196.3	26.1	124.1	125.1	40.9	54.4	283.5	53.5	51.2	937.8	385.2	156.9	44.5	58.6	61.1	0.5	5.5	17.8	4.4	4.2	4.0	5.7	6.7	5.2	7.9	5.3	8.4	4.3	1.2	5.2	3.9	11.4	6.1	2.4	39.9	43.9	60.6	68.6	43.1	48.4	29.5	26.0	25.1	27.8	38.2	46.4	188.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	66.8	73.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	114.2	46.9	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	68.4	17.6	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
H1-3	"H1.3, H1d, H1F3, H1s-2, HIST1H1D"	ENSG00000124575	"H1.3 linker histone, cluster member"	P16402	6	26234212-26234987	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.1;brain: 24.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.4;dendritic cells: 23.3;Extravillous trophoblasts: 18.3;Hofbauer cells: 7.5;Plasma cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 24.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.8;MOLT-4: 9.9;NB-4: 4.3;REH: 4.0;SiHa: 3.8;U-266/70: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported					NA	NA		4000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	1.2	0.1	1.3	0.2	0.5	21.1	1.1	24.1	4.6	1.7	3.4	1.5	0.0	0.1	0.1	0.7	0.4	0.0	0.4	0.5	1.4	0.6	0.3	1.3	1.9	2.5	1.8	0.3	0.0	0.0	0.1	0.5	4.5	1.4	0.7	0.0	0.5	0.0	0.0	2.4	2.5	0.1	3.8	1.3	0.6	0.3	2.6	5.5	0.5	0.0	0.4	0.2	3.8	7.0	0.7	0.5	0.1	0.0	0.2	0.0	5.8	0.3	0.2	0.7	0.5	0.1	0.6	0.0	0.1	0.1	0.3	0.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.2	0.8	1.7	1.7	0.1	0.0	9.9	4.3	0.5	0.0	1.7	4.0	0.1	2.2	0.0	0.0	1.9	0.3	3.8	1.6	0.0	0.5	0.7	0.9	0.0	0.2	0.0	0.1	0.6	4.8	2.5	0.3	0.6	1.2	0.5	22.3	7.5	6.5	31.4	4.4	21.9	32.1	28.7	21.7	18.2	46.7	37.1	30.6	2.6	25.8	6.9	32.8	23.4	14.1	1.3	0.5	24.1	4.6	0.5	1.4	2.5	1.8	4.5	3.8	2.6	7.0	3.5	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	18.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.6	3.6	0.0	0.0	0.0
H1-4	"H1.4, H1e, H1F4, H1s-4, HIST1H1E"	ENSG00000168298	"H1.4 linker histone, cluster member"	P10412	6	26156329-26157115	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 52.3;brain: 53.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.2;Cytotrophoblasts: 8.0;dendritic cells: 18.6;Extravillous trophoblasts: 11.3;Hofbauer cells: 7.7;Plasma cells: 6.7;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 53.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.5;U-266/70: 12.5;U-266/84: 15.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes		8300000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	1.7	0.3	0.4	0.3	2.4	52.3	2.7	53.8	26.5	3.2	7.3	1.7	0.3	0.5	0.3	1.2	0.7	0.4	0.6	2.8	11.7	2.1	1.1	1.2	2.5	11.8	0.0	1.8	1.8	0.3	1.9	0.9	3.2	2.5	0.4	0.0	3.0	0.2	0.4	4.1	2.7	0.1	5.0	1.4	1.4	1.4	5.5	2.7	0.9	0.1	0.5	0.9	2.8	11.4	2.6	0.3	0.5	5.5	0.1	0.0	6.6	0.0	0.4	1.2	0.9	0.1	1.6	1.3	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.8	1.6	0.9	0.5	0.4	0.1	0.8	1.1	0.1	0.3	0.3	0.6	0.1	0.5	1.4	4.4	7.0	0.2	0.5	8.6	7.8	2.0	0.8	0.8	4.0	1.3	10.5	0.3	0.0	4.0	0.9	3.3	0.8	1.2	0.6	1.1	2.8	0.5	2.5	3.8	1.5	2.6	12.5	15.1	6.1	12.6	2.3	1.2	257.4	43.0	106.3	66.4	42.1	76.6	73.6	52.1	61.6	49.0	119.6	39.4	37.1	60.4	70.7	39.5	48.6	56.9	31.4	0.4	2.4	53.8	26.5	2.8	11.7	11.8	0.0	3.2	5.0	5.5	11.4	3.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	8.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	11.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.3	1.8	0.0	0.0	0.0
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H1-6	"H1FT, H1t, HIST1H1T"	ENSG00000187475	"H1.6 linker histone, cluster member"	P22492	6	26107412-26108135	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 2.2;choroid plexus: 1.6;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	13	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA065718, HPA068266"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"					"HPA065718: AB_2685543, HPA068266: AB_2685967"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-2)"		"unprognostic (9.52e-2)"		"unprognostic (9.94e-2)"		"unprognostic (5.12e-1)"		"unprognostic (1.57e-1)"	"unprognostic (7.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"		"unprognostic (6.28e-3)"	0.0	0.0	0.3	0.1	1.0	0.0	0.1	0.3	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.3	0.8	0.5	0.4	1.1	0.5	0.6	0.3	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H1-7	"H1FNT, H1T2, HANP1"	ENSG00000187166	"H1.7 linker histone"	Q75WM6	12	48328980-48330279	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 217.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046204	Approved					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"				"HPA046204: AB_2679586"	"unprognostic (2.94e-1)"	"unprognostic (2.50e-1)"			"unprognostic (1.95e-1)"	"unprognostic (1.50e-3)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-5)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.79e-3)"	"unprognostic (9.84e-2)"	0.2	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.5	0.2	0.3	0.0	0.0	0.3	0.1	217.1	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1-8	H1FOO	ENSG00000178804	"H1.8 linker histone"	Q8IZA3	3	129543214-129551467	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"testis: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037992	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"HPA037992: AB_10671517"															"unprognostic (5.43e-2)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.3	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC11	"H2A.1b, H2A/p, H2AFP, HIST1H2AG, pH2A/f"	ENSG00000196787	"H2A clustered histone 11"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.8;testis: 3.1"	"Group enriched"	"Detected in some"	10	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.0;dendritic cells: 1.5;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;granulocytes: 9.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"K-562: 15.5;SiHa: 17.3;U-266/84: 48.8"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	0.3	0.3	0.7	0.3	0.9	2.4	2.8	0.5	0.7	0.5	0.7	0.9	1.3	0.1	0.6	0.6	0.2	0.3	0.2	0.6	1.0	0.2	0.5	0.3	1.0	1.5	1.4	0.1	0.2	0.0	0.1	0.4	1.4	0.7	0.7	0.1	0.1	0.4	0.2	0.2	1.1	0.2	1.2	0.9	0.5	3.1	1.7	1.9	0.3	0.3	0.4	0.4	0.4	1.7	2.1	2.8	2.3	2.0	7.1	1.5	1.5	0.7	1.1	2.4	0.3	1.2	2.1	0.7	3.0	0.9	2.3	4.2	2.8	1.2	1.6	3.7	1.6	1.1	5.2	0.0	1.5	1.1	2.2	2.7	0.5	0.7	0.8	1.2	0.8	2.0	15.5	6.9	0.1	2.7	2.9	1.8	1.3	3.1	1.9	1.9	2.3	8.0	0.4	0.5	9.0	2.1	17.3	2.7	1.0	1.1	0.0	0.7	0.9	2.6	5.8	2.1	1.1	12.4	48.8	4.9	0.5	1.7	1.6	9.5	0.3	0.6	0.4	0.2	0.9	2.3	1.7	1.1	0.5	2.8	1.4	1.3	2.3	0.9	0.6	1.0	2.9	5.3	0.7	0.9	0.5	0.7	0.6	1.0	1.5	1.4	1.4	1.2	1.7	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0
H2AC12	"dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH"	ENSG00000274997	"H2A clustered histone 12"	Q96KK5	6	27147106-27147562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.8;brain: 2.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.2	0.1	0.5	0.0	0.9	8.8	0.3	0.7	0.5	0.2	0.8	0.7	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.0	0.1	0.2	1.1	1.6	1.3	0.1	0.1	0.1	0.0	0.3	1.8	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.1	0.1	1.8	0.6	0.2	1.6	2.0	1.5	0.1	0.0	0.2	0.2	0.2	2.8	1.7	2.0	0.7	3.0	0.0	0.0	0.4	0.2	0.3	0.3	0.0	2.0	0.6	2.7	0.6	0.0	0.3	0.2	0.6	0.0	0.0	1.4	5.4	3.0	2.5	0.0	0.0	2.1	1.1	0.0	0.0	0.7	0.0	0.0	0.5	1.1	3.1	1.7	0.5	0.3	6.2	6.9	2.1	0.6	0.7	2.2	1.9	3.2	0.0	0.2	1.5	0.4	0.9	0.3	0.2	0.0	0.6	1.0	0.0	0.6	1.7	0.1	1.8	1.8	2.0	4.0	0.8	2.8	0.6	0.0	0.8	0.0	2.2	2.3	1.0	3.3	4.1	3.8	2.0	11.9	2.1	1.5	0.0	5.1	1.4	1.4	0.7	2.0	0.5	0.9	0.7	0.5	0.3	0.9	1.6	1.3	1.8	1.8	2.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
H2AC13	"H2A/c, H2AFC, HIST1H2AI"	ENSG00000196747	"H2A clustered histone 13"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 4.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 42.1;U-266/84: 118.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	0.3	0.1	1.0	0.2	0.5	5.2	0.1	0.6	0.6	0.3	2.8	2.5	0.9	0.0	0.1	0.7	0.4	0.3	0.1	0.4	1.2	0.1	0.2	0.5	1.5	1.7	1.8	0.4	0.0	0.7	0.0	0.7	1.6	0.2	2.2	0.0	0.1	0.0	0.0	0.2	1.1	0.1	1.6	1.1	0.9	0.5	2.5	2.5	0.1	0.0	0.6	0.4	0.5	4.2	2.4	8.5	2.0	1.4	0.9	0.5	0.8	1.6	0.3	2.7	2.0	2.8	1.5	2.4	5.1	0.7	1.5	1.8	0.0	1.5	1.2	8.6	11.0	3.7	12.6	8.0	0.9	0.9	1.9	3.7	0.6	0.8	0.2	2.3	0.6	3.0	42.1	9.9	0.0	11.8	6.5	7.0	2.2	7.2	3.2	3.4	0.0	16.6	3.0	1.6	11.7	2.3	23.6	3.4	0.8	0.7	14.2	1.1	0.4	1.2	4.6	1.0	1.0	9.1	118.9	5.0	1.1	9.8	0.7	0.0	0.2	1.5	0.3	0.3	0.3	0.8	1.4	0.3	1.1	1.1	0.3	0.2	2.1	1.0	0.3	1.0	1.8	1.0	1.0	0.5	0.6	0.6	0.4	1.2	1.7	1.8	1.6	1.6	2.5	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC14	"H2A/E, H2AFE, HIST1H2AJ"	ENSG00000276368	"H2A clustered histone 14"	Q99878	6	27814302-27814777	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 7.2"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.1	0.0	0.2	0.3	0.4	7.2	0.0	0.5	0.7	0.5	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.1	0.1	1.0	1.7	0.0	0.0	0.1	0.2	0.1	0.8	3.5	0.0	0.9	0.0	0.0	0.0	0.7	1.0	0.8	0.7	1.8	1.4	0.1	3.1	0.3	0.5	0.1	1.0	0.0	0.8	0.4	1.4	0.3	4.6	0.7	6.9	0.2	0.0	1.7	0.0	0.2	0.5	0.2	0.0	1.0	1.6	0.0	9.8	0.2	11.5	5.0	4.6	1.4	1.5	2.4	4.6	0.0	1.4	0.1	1.9	0.3	0.8	0.8	1.0	0.3	0.2	0.3	3.4	0.0	0.0	1.6	0.3	0.1	4.8	3.1	2.9	0.8	3.2	2.2	0.0	0.0	0.0	0.2	0.2	0.4	0.3	1.3	1.3	1.1	1.3	0.4	0.1	1.1	0.1	0.1	0.1	2.8	1.7	0.2	0.4	0.5	0.7	0.2	0.4	0.7	0.5	1.3	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0
H2AC15	"H2A/d, H2AFD, HIST1H2AK"	ENSG00000275221	"H2A clustered histone 15"	P0C0S8	6	27837880-27838375	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"dendritic cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.3;SCLC-21H: 3.5;U-266/84: 3.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"																		0.4	1.0	0.9	0.4	0.9	1.0	0.4	2.7	1.3	0.9	2.5	0.4	0.1	0.5	1.7	0.3	1.2	1.0	1.7	0.9	1.8	0.9	0.6	0.8	1.2	1.9	1.5	2.0	0.6	0.4	1.3	0.3	2.0	1.2	0.4	0.2	0.4	0.3	0.8	0.2	0.6	0.0	2.2	0.8	0.4	2.6	2.2	1.2	1.3	0.4	0.2	0.4	0.7	3.9	0.0	1.3	0.1	1.7	0.3	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.6	0.1	0.2	0.1	1.4	0.5	0.0	0.3	0.4	0.1	0.4	3.3	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	0.4	0.0	0.2	0.0	1.1	0.6	0.2	0.1	0.3	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.4	0.1	0.0	1.2	3.9	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.0	1.3	4.1	1.7	1.5	0.0	3.2	2.5	1.8	0.0	0.9	0.4	0.7	1.3	2.6	0.9	0.9	2.7	1.3	0.9	1.8	1.9	1.5	2.0	2.2	2.2	3.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0
H2AC16	"dJ193B12.9, H2A/i, H2AFI, HIST1H2AL"	ENSG00000276903	"H2A clustered histone 16"	P0C0S8	6	27865317-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;brain: 2.5"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.8;MOLT-4: 5.2"					"Low region specificity"	"Detected in single"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	0.1	0.1	0.5	0.1	0.3	7.6	0.2	0.6	0.4	0.0	1.0	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.3	1.0	0.1	0.1	0.4	0.4	1.5	1.3	0.0	0.0	0.3	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.2	0.7	0.2	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.2	2.5	2.8	1.2	0.8	0.0	0.0	0.0	0.5	0.9	0.5	1.5	1.4	0.0	0.7	2.0	0.8	0.2	0.8	0.8	0.0	0.2	1.0	1.9	4.8	0.6	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	4.5	3.3	0.2	3.0	5.2	3.9	1.6	1.5	0.6	2.6	0.0	0.2	0.3	2.0	1.6	1.4	1.0	0.1	0.4	0.1	0.7	1.1	0.0	0.1	0.0	1.0	1.7	3.7	0.0	4.0	0.8	3.1	0.7	2.0	1.4	1.1	0.1	1.3	0.0	2.4	1.2	1.3	3.6	5.9	0.4	0.7	6.1	0.0	2.9	2.6	1.1	0.7	0.5	0.3	0.6	0.4	0.3	1.0	1.5	1.3	1.5	1.2	1.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC17	"H2A.1, H2A/n, H2AFN, HIST1H2AM"	ENSG00000278677	"H2A clustered histone 17"	P0C0S8	6	27892699-27893185	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;brain: 5.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.2;Syncytiotrophoblasts: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 63.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	0.4	0.4	1.3	0.2	0.9	3.2	0.3	1.2	1.1	0.5	2.5	0.8	0.7	0.3	0.2	0.9	0.0	0.0	0.2	0.5	1.5	0.2	0.5	0.6	1.5	3.3	3.2	0.0	0.3	0.3	0.0	0.9	3.2	0.6	0.6	0.0	0.3	0.0	0.2	0.4	0.8	0.0	2.7	1.2	0.4	0.9	2.4	2.1	0.7	0.0	0.4	0.3	0.7	5.8	3.7	2.6	2.3	5.4	0.3	0.2	4.8	1.2	0.6	2.4	3.1	0.9	1.6	5.8	4.3	0.7	2.9	2.2	2.3	1.6	1.9	4.6	1.3	2.9	3.5	3.9	0.0	2.1	2.4	1.8	0.0	1.7	0.0	0.2	2.3	4.2	12.5	8.0	0.4	6.8	12.6	8.9	4.2	2.1	1.2	7.7	3.6	11.9	1.2	0.9	8.9	1.6	6.5	0.6	0.9	1.2	5.4	1.7	0.0	1.1	0.2	1.2	2.0	9.0	28.9	14.2	1.5	9.7	1.0	63.8	5.0	21.1	10.0	6.0	5.9	13.5	8.8	8.6	18.3	15.3	3.5	4.2	16.7	8.5	10.5	22.5	13.4	9.7	1.3	0.9	1.2	1.1	0.5	1.5	3.3	3.2	3.2	2.7	2.4	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0
H2AC18	"H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3"	ENSG00000203812	"H2A clustered histone 18"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				73.9	37.8	7.8	16.5	7.1	175.8	47.2	8.4	18.6	121.9	51.9	46.1	11.4	13.9	7.7	79.5	50.5	14.6	59.9	8.5	19.9	88.7	74.7	152.6	12.7	21.6	12.9	54.6	24.0	0.1	31.4	21.8	14.1	200.5	3.4	0.0	46.9	6.5	42.7	116.2	31.7	5.5	14.0	127.6	59.8	117.5	13.7	15.1	31.1	3.8	2.3	42.7	135.9	11.4	14.7	0.0	1.1	0.0	11.1	7.8	0.0	29.8	12.3	17.3	14.5	0.3	7.3	7.5	20.5	11.7	0.7	4.6	1.6	5.5	2.0	15.3	0.0	3.7	31.7	8.8	11.4	0.0	7.9	55.0	9.9	4.2	4.8	0.0	4.5	0.0	43.6	116.8	6.0	21.6	0.0	28.9	0.0	30.1	31.4	6.1	0.0	47.8	7.4	11.8	2.7	1.2	50.4	10.1	1.6	0.0	41.2	12.8	10.1	7.8	58.3	1.5	2.6	472.4	300.7	11.5	26.3	59.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.1	8.4	18.6	8.5	19.9	21.6	12.9	14.1	14.0	13.7	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0
H2AC19	"H2A/r, HIST2H2AA4"	ENSG00000272196	"H2A clustered histone 19"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 1820.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 1820.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				63.3	27.8	32.4	10.1	36.7	20.9	40.2	57.3	31.8	111.3	43.3	39.5	10.8	10.0	0.0	66.7	45.2	6.9	34.4	31.6	38.9	52.0	58.3	140.4	3.8	43.5	36.7	53.3	13.7	3.0	27.2	4.7	42.4	156.3	1.0	6.1	41.1	0.0	30.3	102.5	31.9	0.0	45.7	124.6	64.4	109.9	32.3	9.6	29.1	2.6	1.4	47.4	124.3	50.6	14.9	41.0	4.2	9.4	0.0	0.0	12.9	31.6	0.0	0.0	0.0	26.4	13.9	0.0	36.4	0.0	10.0	23.0	0.0	0.0	0.0	20.4	53.9	5.4	35.5	15.5	0.0	5.2	27.4	0.0	0.0	0.0	0.0	9.7	0.0	18.7	32.9	61.2	0.0	85.0	18.5	5.6	15.7	75.7	31.8	14.3	6.4	20.1	0.0	5.9	37.8	16.1	98.8	21.2	9.1	5.3	38.5	8.9	0.0	6.9	71.4	14.1	4.5	270.8	249.5	20.8	0.0	26.9	11.6	314.7	206.9	388.5	34.8	121.2	35.8	72.9	30.4	32.6	135.6	93.1	22.8	21.6	1820.8	41.6	151.6	193.3	48.3	215.9	32.4	36.7	57.3	31.8	31.6	38.9	43.5	36.7	42.4	45.7	32.3	50.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
H2AC20	"H2A, H2A/q, H2AFQ, HIST2H2AC"	ENSG00000184260	"H2A clustered histone 20"	Q16777	1	149886918-149887411	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.3;brain: 27.2;choroid plexus: 20.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.86e-5)"	3.8	3.6	15.5	0.8	20.6	25.3	3.5	24.0	14.0	5.4	20.0	3.1	0.2	2.0	0.0	2.2	2.7	0.4	2.6	10.0	27.2	2.3	2.6	4.7	0.5	19.8	13.1	4.3	2.4	0.1	3.0	0.5	16.7	3.2	0.1	0.5	1.4	0.1	0.7	4.5	3.3	0.4	19.9	5.2	2.5	1.2	18.2	1.6	1.8	0.0	0.1	2.5	4.1	18.2	3.9	4.2	5.0	15.7	0.0	0.7	7.8	1.2	0.9	2.4	3.3	2.5	1.1	8.0	0.2	0.2	0.5	2.0	0.3	1.6	0.0	0.7	5.7	1.9	1.6	12.2	0.0	4.7	4.6	0.9	0.2	0.2	0.5	0.1	1.6	2.0	1.7	10.0	0.5	60.6	5.7	5.4	6.7	4.5	10.0	1.8	2.2	1.4	1.0	2.4	1.8	7.5	3.2	1.2	3.8	0.4	0.6	4.4	1.5	1.1	10.9	1.9	2.9	5.5	4.0	4.2	2.9	6.3	2.3	47.2	33.8	19.0	22.9	22.6	20.2	13.1	20.1	18.5	17.7	33.1	14.0	14.8	98.4	19.1	25.6	24.9	16.3	22.6	15.5	20.6	24.0	14.0	10.0	27.2	19.8	13.1	16.7	19.9	18.2	18.2	2.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.7	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	18.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.8	1.5	0.0	0.0	0.0
H2AC21	HIST2H2AB	ENSG00000184270	"H2A clustered histone 21"	Q8IUE6	1	149887469-149887965	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	0.2	0.1	3.3	0.0	4.6	3.4	0.3	15.3	3.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	3.0	0.1	0.1	0.2	0.0	0.5	1.3	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.5	0.0	1.5	0.3	0.1	0.1	2.3	0.3	0.1	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.2	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.2	0.0	3.3	1.9	0.4	0.3	0.5	0.7	0.2	0.7	0.0	0.1	0.6	0.4	0.8	0.0	0.1	0.0	0.2	1.4	0.0	0.3	1.2	0.0	0.3	1.6	1.9	0.5	0.6	0.1	0.2	1.5	1.9	0.8	2.2	1.7	2.0	3.7	3.7	3.3	2.1	6.6	2.3	2.5	9.8	3.6	2.0	4.0	2.0	0.5	3.3	4.6	15.3	3.0	1.7	3.0	0.5	1.3	1.0	1.5	2.3	3.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H2AC4	"H2A/m, H2AFM, HIST1H2AB"	ENSG00000278463	"H2A clustered histone 4"	P04908	6	26033092-26033618	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.5;brain: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.2	0.0	0.5	0.0	0.4	1.5	0.0	2.0	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.7	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.9	0.5	0.2	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.4	0.7	0.7	1.2	0.0	1.0	0.4	0.2	0.5	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	1.4	0.1	0.1	0.6	0.9	0.0	0.2	1.2	0.1	0.0	0.0	1.0	0.1	0.4	0.0	1.5	0.4	0.6	0.5	0.7	0.1	0.2	0.2	0.5	0.0	0.0	0.2	0.0	0.5	0.4	2.0	0.5	0.6	0.6	0.8	1.2	0.7	0.3	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
H2AC6	"H2AFL, HIST1H2AC"	ENSG00000180573	"H2A clustered histone 6"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.9;Cardiomyocytes: 23.3;Cytotrophoblasts: 14.3;Extravillous trophoblasts: 28.5;Hofbauer cells: 16.2;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1552.9"	"Lineage enriched"	"Detected in all"	14	"granulocytes: 1552.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 61.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	14.0	12.7	26.8	5.0	39.2	12.9	10.7	38.1	38.5	21.6	24.1	13.1	11.5	4.7	11.3	28.1	10.8	10.3	11.2	34.5	41.7	21.5	30.2	22.9	5.5	37.9	34.4	12.7	7.2	0.9	10.5	5.2	33.9	26.0	5.3	3.9	10.8	2.1	20.2	16.7	13.2	2.1	52.1	21.2	13.8	4.7	30.6	18.1	12.7	4.7	2.0	12.0	28.6	65.4	13.2	30.7	0.1	0.0	14.4	8.8	1.5	8.4	2.4	4.0	4.1	10.3	3.7	0.0	36.8	4.2	1.8	4.0	0.0	0.8	2.7	18.4	3.5	1.8	21.5	3.8	10.8	0.7	8.8	26.5	4.5	1.4	4.5	10.9	1.4	0.7	23.1	11.9	3.9	20.0	2.9	3.4	1.3	10.4	13.9	2.3	0.2	25.6	13.2	8.7	3.2	3.2	29.5	4.0	13.4	7.1	33.3	2.4	3.2	6.9	20.5	3.6	1.7	32.7	61.0	4.7	2.0	28.4	1.1	440.2	31.9	324.6	28.0	24.6	25.7	61.7	29.7	19.4	28.3	109.5	34.9	19.6	1552.9	33.7	65.6	79.9	33.8	662.0	26.8	39.2	38.1	38.5	34.5	41.7	37.9	34.4	33.9	52.1	30.6	65.4	10.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	14.3	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	28.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	75.9	1.1	0.0	0.0	0.0
H2AC7	"H2A.3, H2A/g, H2AFG, HIST1H2AD"	ENSG00000196866	"H2A clustered histone 7"	P20671	6	26198784-26199293	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5;U-266/84: 6.3"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	0.7	0.2	0.4	0.3	1.7	2.9	0.6	4.1	2.1	3.3	3.6	0.5	0.0	0.1	0.0	2.5	0.6	0.3	0.4	1.0	1.9	0.6	1.2	2.1	0.5	3.1	1.7	0.7	0.1	0.0	0.3	0.2	2.1	2.1	0.1	0.0	0.5	0.0	0.0	1.1	0.5	0.0	3.9	1.2	0.6	0.3	3.0	1.8	0.3	0.0	0.3	0.3	2.8	6.8	1.1	0.0	0.2	0.2	0.0	0.0	0.2	0.7	0.1	1.1	0.0	1.3	0.4	0.7	1.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	1.0	0.3	1.4	1.3	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.7	2.5	1.3	0.0	0.0	3.7	1.5	1.1	0.0	1.1	1.0	0.4	0.9	0.4	0.1	1.4	0.2	0.6	0.8	0.1	0.0	1.4	0.3	0.0	1.1	3.1	0.0	1.0	17.5	6.3	2.2	1.0	1.3	0.4	2.3	0.3	3.8	1.3	1.9	1.3	2.7	2.0	4.0	1.1	7.6	1.9	1.9	17.9	1.8	2.2	6.2	2.7	0.8	0.4	1.7	4.1	2.1	1.0	1.9	3.1	1.7	2.1	3.9	3.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC8	"H2A.1, H2A/a, H2AFA, HIST1H2AE"	ENSG00000277075	"H2A clustered histone 8"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.2;breast: 40.7"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 41.2;white matter: 17.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.0"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	4.3	2.4	2.1	1.6	5.6	19.3	40.7	41.2	6.0	14.7	4.6	7.9	3.6	1.6	16.7	8.6	7.8	1.8	4.2	5.1	3.7	11.6	5.7	7.9	2.9	2.3	1.1	6.8	1.0	0.4	3.4	1.6	3.7	32.9	2.1	1.5	4.7	1.2	0.2	16.5	4.6	0.6	1.7	9.5	5.2	4.3	3.3	9.4	5.8	0.1	0.8	2.2	17.4	17.5	4.1	0.0	3.0	0.0	4.9	0.9	0.8	1.3	2.0	4.3	2.9	2.0	3.3	0.2	10.8	0.4	3.9	3.4	1.5	2.0	1.7	4.5	3.7	2.7	5.9	2.6	0.9	0.3	4.1	8.4	0.9	1.8	0.2	1.2	2.1	0.8	11.4	2.9	0.4	7.5	9.3	7.9	3.5	14.1	3.7	7.3	2.4	14.7	1.8	2.3	11.9	5.0	10.9	3.7	2.4	2.0	14.9	4.1	0.0	0.2	0.8	1.8	1.8	37.0	0.0	0.0	1.5	5.5	2.7	18.2	2.2	8.2	2.8	2.6	4.1	4.7	3.3	4.6	5.9	6.0	1.7	2.3	10.1	4.5	1.6	17.6	4.4	10.4	2.1	5.6	41.2	6.0	5.1	3.7	2.3	1.1	3.7	1.7	3.3	17.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0
H2AJ	"FLJ10903, H2AFJ, MGC921"	ENSG00000246705	"H2A.J histone"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 565.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 256.2;MCF7: 338.4;RT4: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	236.7	186.0	29.1	33.8	34.1	60.4	223.6	33.7	40.9	123.7	37.9	126.6	55.4	105.6	20.9	155.7	106.6	36.0	125.5	27.7	31.3	115.7	82.7	129.6	29.6	37.1	32.5	63.6	182.3	21.1	34.2	57.7	35.7	275.8	29.3	5.3	166.8	35.0	91.4	198.4	85.2	25.1	33.4	94.8	111.1	565.0	33.1	34.2	85.0	24.8	18.2	122.8	124.9	38.7	107.9	256.2	10.0	0.0	112.2	73.8	163.2	78.9	43.4	31.3	30.4	50.9	172.4	0.1	48.7	38.6	0.2	100.7	6.2	60.1	8.5	5.7	4.6	4.3	92.6	43.8	160.5	0.1	39.0	97.0	64.5	43.3	40.0	12.7	63.0	0.0	0.1	0.1	15.9	338.4	0.7	28.7	16.0	77.8	58.0	42.4	0.0	21.0	51.0	239.0	3.0	1.0	99.8	122.3	0.4	34.6	187.0	32.6	63.1	0.3	29.6	46.2	15.6	25.0	39.4	0.4	8.6	0.3	25.4	84.0	127.6	29.3	51.3	76.4	46.3	16.8	49.6	38.0	117.2	21.7	34.9	38.2	46.6	61.2	69.4	58.2	78.1	72.1	29.1	34.1	33.7	40.9	27.7	31.3	37.1	32.5	35.7	33.4	33.1	38.7	58.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	130.2	56.4	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	124.3	59.5	0.0	0.0	0.0	0.0	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	160.3	6.5	0.0	0.0	0.0
H2AP	"CXorf27, HIP17, HYPM"	ENSG00000187516	"H2A.P histone"	O75409	X	37990779-37991314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 44.2"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SuSa: 1.2"	"Not detected"	"Not detected"							HPA003356	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA003356: AB_1078593"															"unprognostic (2.99e-2)"			0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	44.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.4	0.8	0.6	0.2	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0
H2AW	"HIST3H2A, MGC3165"	ENSG00000181218	"H2A.W histone"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 29.7;U-266/70: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	6.0	35.9	6.3	0.8	6.1	5.9	6.8	13.4	6.9	27.9	9.9	5.9	3.2	5.4	1.6	19.2	7.2	1.2	17.8	5.8	6.7	4.4	1.1	4.4	1.2	5.0	4.9	14.1	3.9	3.7	12.9	1.0	5.3	11.1	0.9	4.9	10.3	0.4	1.0	18.0	5.5	0.3	5.0	13.0	6.3	5.8	6.9	1.8	2.1	0.7	0.9	5.4	24.2	5.5	5.9	3.1	4.0	5.6	3.3	3.3	4.8	2.9	2.8	8.2	5.7	3.1	4.8	2.7	3.4	0.6	0.0	14.3	2.9	1.4	1.9	4.2	29.7	4.2	4.0	0.0	7.6	3.0	8.1	7.3	8.4	1.5	3.5	3.3	3.5	5.4	15.0	0.0	0.0	8.4	3.9	0.0	6.2	3.5	7.5	0.0	0.0	22.9	1.4	3.5	24.7	17.4	10.2	8.9	20.7	0.6	15.7	2.2	1.3	0.0	0.1	11.0	2.6	29.4	22.4	0.0	2.9	3.0	2.1	4.4	1.4	0.0	5.8	2.8	4.3	2.7	5.5	4.3	3.0	2.1	4.2	4.1	0.6	6.5	7.0	0.5	10.4	3.4	6.3	6.1	13.4	6.9	5.8	6.7	5.0	4.9	5.3	5.0	6.9	5.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	14.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	53.8	2.4	0.0	0.0	0.0
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
H2AZ2	"H2AFV, H2AV, MGC10170, MGC10831, MGC1947"	ENSG00000105968	"H2A.Z variant histone 2"	Q71UI9	7	44826791-44848087	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 238.5;Cytotrophoblasts: 174.1;dendritic cells: 85.4;Extravillous trophoblasts: 435.9;Hofbauer cells: 242.8;Syncytiotrophoblasts: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057236	Supported					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA057236: AB_2683377"	"unprognostic (2.16e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (4.86e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	67.9	82.0	98.4	95.7	106.3	316.8	68.2	115.2	106.2	65.9	75.2	106.5	78.2	71.8	69.7	85.5	64.3	57.3	142.7	91.1	100.5	92.8	90.1	77.1	145.2	94.0	104.7	61.7	72.3	83.3	59.0	65.4	97.6	70.3	103.9	141.7	65.9	66.4	139.3	60.2	96.1	78.0	104.0	90.5	87.3	92.8	110.0	288.1	79.4	134.9	170.7	69.2	64.3	103.9	278.2	280.7	368.9	313.8	147.1	115.0	154.2	184.0	202.9	202.4	245.3	234.7	356.1	349.7	195.1	234.4	393.3	308.2	286.9	237.9	319.6	335.1	175.4	221.8	461.0	298.4	103.6	566.6	296.1	92.3	103.0	236.6	209.2	165.6	248.5	379.1	402.8	383.2	306.3	575.2	536.8	919.1	282.0	342.3	266.2	433.4	411.5	331.0	219.7	244.9	233.7	318.9	330.8	369.3	142.3	363.1	328.6	558.4	220.1	181.9	533.3	168.3	459.5	354.6	401.1	619.7	188.6	448.7	589.5	104.7	62.0	229.9	62.2	54.1	80.5	77.7	86.7	83.4	96.4	76.1	63.2	61.2	74.6	77.0	50.3	147.0	169.1	48.2	98.4	106.3	115.2	106.2	91.1	100.5	94.0	104.7	97.6	104.0	110.0	103.9	34.6	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	238.5	0.0	0.0	0.0	0.0	174.1	85.4	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	435.9	37.0	0.0	0.0	0.0	0.0	0.0	0.0	242.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	106.9	17.1	0.0	0.0	0.0
H2BC1	"bA317E16.3, H2BFU, HIST1H2BA, STBP, TSH2B"	ENSG00000146047	"H2B clustered histone 1"	Q96A08	6	25726777-25727345	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 6.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011603, HPA042205, HPA043013"	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269"															"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H2BC11	"H2B/r, H2BFR, HIST1H2BJ"	ENSG00000124635	"H2B clustered histone 11"	P06899	6	27125897-27132795	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 3.0;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 6.0;Hofbauer cells: 4.1;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"K-562: 150.1;Karpas-707: 86.7;SiHa: 134.1;U-2 OS: 137.1;U-266/70: 129.2;U-266/84: 151.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.3	1.4	3.4	2.3	3.9	9.1	1.9	3.8	5.9	15.0	3.8	5.0	1.4	1.5	3.0	9.5	3.7	1.9	4.1	3.0	4.3	2.4	4.2	9.1	3.1	5.3	4.4	1.3	0.6	0.3	1.0	1.7	6.1	6.9	2.4	0.3	3.2	2.3	6.2	2.9	2.5	2.0	5.3	12.7	4.0	31.9	5.9	7.2	2.7	3.7	2.6	2.5	10.8	8.4	13.4	17.1	5.3	4.6	26.3	1.4	7.0	7.1	3.9	29.7	12.6	14.1	7.7	2.4	22.7	7.8	12.9	9.3	6.5	6.3	15.5	16.2	14.3	4.3	18.2	0.8	2.5	1.7	10.2	11.0	0.7	6.6	2.2	4.2	1.3	6.8	150.1	86.7	8.5	6.9	5.9	8.1	5.8	15.1	15.5	3.1	3.5	16.5	2.8	4.7	35.3	3.5	134.1	8.7	4.2	6.9	0.3	6.4	4.1	7.2	137.1	5.6	3.3	129.2	151.8	35.6	1.9	42.3	3.7	2.3	0.7	1.1	0.5	0.8	0.9	1.9	0.9	0.4	0.5	2.4	0.5	0.6	16.2	1.3	0.3	1.2	3.0	15.9	3.4	3.9	3.8	5.9	3.0	4.3	5.3	4.4	6.1	5.3	5.9	8.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0
H2BC12	"H2BFAiii, H2BFT, HIST1H2BK"	ENSG00000197903	"H2B clustered histone 12"	O60814	6	27146361-27146855	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.4;Hofbauer cells: 1.1;Syncytiotrophoblasts: 3.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 1269.7;SiHa: 771.0;U-2 OS: 949.9;U-266/84: 1355.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	45.2	28.9	10.3	35.9	13.4	46.4	31.2	8.1	13.1	46.1	15.1	45.7	41.6	35.2	27.7	64.2	59.9	37.7	32.1	12.2	11.1	31.3	94.0	47.1	59.6	13.3	12.3	28.9	60.0	14.8	16.2	44.7	12.9	75.1	26.4	0.4	43.1	21.7	8.5	30.3	44.8	22.1	15.7	66.9	56.0	44.6	13.6	65.7	49.2	6.7	24.2	35.0	42.8	21.6	64.6	153.7	25.7	41.2	116.0	37.0	84.7	118.1	70.5	157.9	99.1	133.1	68.9	28.1	338.6	64.2	94.1	78.3	29.8	35.8	19.7	95.1	201.2	42.0	91.0	4.4	46.2	29.9	183.4	205.0	26.8	29.5	28.1	38.8	27.6	14.1	1269.7	194.4	66.5	166.3	49.1	52.6	20.2	204.6	98.8	27.9	24.2	265.9	55.2	23.4	124.1	74.2	771.0	178.6	56.9	18.9	473.7	29.8	41.6	57.6	949.9	54.0	18.8	293.6	1355.8	207.7	34.7	314.1	34.5	244.6	49.0	329.3	21.6	45.3	19.6	112.1	21.3	21.9	53.1	141.9	25.7	20.4	308.2	28.5	96.3	120.8	65.7	68.3	10.3	13.4	8.1	13.1	12.2	11.1	13.3	12.3	12.9	15.7	13.6	21.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0
H2BC13	"dJ97D16.4, H2B/c, H2BFC, HIST1H2BL"	ENSG00000185130	"H2B clustered histone 13"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.7;cerebral cortex: 1.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.3;U-266/84: 12.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	0.1	0.2	0.3	0.0	0.3	6.1	0.1	2.7	1.6	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.4	0.2	0.2	0.3	1.2	0.3	0.0	0.4	0.1	0.2	0.3	2.2	2.0	0.6	2.1	0.0	0.0	0.1	1.3	0.3	1.1	2.8	0.9	1.5	0.8	0.5	0.2	0.6	1.4	0.0	0.2	0.4	1.0	2.9	1.6	2.7	3.5	0.0	2.6	2.1	0.9	0.0	0.0	0.0	0.2	0.6	1.8	2.1	5.2	0.0	5.6	12.3	4.5	1.9	1.5	3.0	2.8	0.0	1.3	0.0	2.0	2.7	1.0	3.5	1.4	0.2	0.2	1.2	0.9	0.5	0.1	1.4	1.1	0.9	2.9	12.5	3.9	0.3	4.7	0.5	0.5	0.3	2.3	0.5	0.1	0.7	1.0	0.3	0.6	0.7	0.6	0.2	0.3	4.1	0.2	0.3	0.4	1.1	0.5	0.3	0.3	2.7	1.6	0.5	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC14	"dJ160A22.3, H2B/e, H2BFE, HIST1H2BM"	ENSG00000273703	"H2B clustered histone 14"	Q99879	6	27815022-27815489	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;lymphoid tissue: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9"	"Not detected"	"Not detected"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.5	0.0	0.1	0.3	0.5	3.5	0.0	1.2	0.6	1.1	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.4	0.4	0.3	0.2	0.5	1.5	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.7	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.4	0.8	3.1	0.2	0.0	1.1	0.0	1.0	1.1	1.5	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.2	0.3	1.5	0.3	0.2	1.9	0.0	0.0	0.4	0.9	0.0	0.0	0.0	1.1	0.0	0.7	0.2	0.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	14.8	0.0	0.4	4.0	9.9	2.8	0.9	0.6	6.2	0.0	0.3	0.0	0.0	0.2	1.7	0.6	0.9	0.0	0.1	0.8	3.0	0.0	0.0	1.6	1.0	0.1	12.3	0.5	5.9	0.9	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	1.2	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC15	"H2B/d, H2BFD, HIST1H2BN"	ENSG00000233822	"H2B clustered histone 15"	Q99877	6	27837760-27855709	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	0.2	1.5	0.3	0.5	0.5	1.0	0.6	2.1	0.5	0.7	0.6	0.4	0.4	0.6	0.8	0.3	0.7	0.3	1.5	0.4	0.3	0.6	0.9	0.5	0.6	0.3	0.2	1.0	1.4	0.6	1.0	0.3	0.4	0.8	0.3	1.7	0.5	0.1	0.9	0.3	0.5	0.2	0.5	0.6	0.4	1.5	0.2	0.6	1.2	0.1	0.2	0.3	0.4	1.7	0.7	0.1	1.1	0.8	0.9	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.6	0.5	1.8	0.2	0.5	1.1	1.0	0.3	0.2	0.9	2.1	0.6	2.4	0.6	1.0	0.7	1.8	0.9	0.2	0.1	0.4	0.8	0.1	1.0	5.5	3.8	0.6	0.5	1.6	1.9	0.6	0.5	0.5	0.9	0.7	4.1	0.3	0.2	6.4	1.0	2.2	1.0	0.8	0.5	1.7	0.6	1.2	1.3	1.4	0.7	0.3	3.4	7.1	1.5	0.5	0.4	0.5	0.5	1.4	1.0	1.9	1.2	1.1	4.8	1.3	1.3	2.9	3.3	0.9	0.8	8.8	0.8	0.8	4.0	1.8	0.7	0.3	0.5	2.1	0.5	0.4	0.3	0.3	0.2	0.4	0.5	0.2	1.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	11.7	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0
H2BC17	"H2B.2, H2B/n, H2BFN, HIST1H2BO"	ENSG00000274641	"H2B clustered histone 17"	P23527	6	27893425-27893891	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;brain: 2.3;lymphoid tissue: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 36.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	0.3	0.1	0.7	0.2	0.3	2.4	0.1	1.1	0.8	0.6	1.3	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.2	0.2	0.7	0.2	0.4	1.0	0.7	1.2	2.3	0.0	0.0	0.0	0.0	0.6	1.9	0.5	0.3	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.8	1.3	0.2	0.2	1.8	2.6	0.2	0.0	0.6	0.3	0.8	2.0	2.8	3.0	1.6	5.1	0.7	0.0	3.0	0.9	0.1	5.3	5.1	1.1	1.5	3.2	2.3	0.2	1.3	2.6	2.9	0.5	1.4	2.4	2.0	1.9	4.7	2.1	0.0	0.3	1.4	0.3	0.0	0.4	0.5	0.1	1.4	2.3	7.6	9.1	0.2	1.3	12.9	10.9	1.8	1.8	2.2	7.4	1.7	5.5	1.1	0.4	7.3	1.4	5.8	1.3	0.8	0.6	2.3	0.2	0.0	1.7	0.3	1.8	2.4	9.1	36.0	8.8	1.0	10.2	0.8	0.6	0.1	1.7	0.3	0.2	0.4	0.5	0.3	0.6	1.0	0.9	0.1	0.2	2.6	0.5	0.3	0.7	0.6	2.0	0.7	0.3	1.1	0.8	0.2	0.7	1.2	2.3	1.9	0.8	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC18	HIST2H2BF	ENSG00000203814	"H2B clustered histone 18"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 30.8"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 30.8"	"Cell line enriched"	"Detected in many"	7	"U-266/70: 49.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	10.2	6.7	4.2	1.3	5.0	3.0	5.3	10.0	3.7	36.5	13.1	6.5	0.6	1.1	2.5	9.6	9.7	1.0	7.4	3.4	7.0	8.9	7.2	28.0	0.9	6.0	7.4	35.3	4.7	0.3	5.6	2.2	6.7	30.2	0.9	2.9	6.9	0.9	0.7	17.8	3.3	0.6	5.4	15.8	12.9	3.7	5.5	2.8	6.1	0.5	0.7	6.1	34.7	7.9	0.7	1.0	0.5	1.0	0.6	0.1	0.5	1.0	0.2	0.8	1.0	0.5	1.3	0.7	0.4	0.2	0.8	2.1	0.2	0.0	0.1	2.1	0.7	0.7	3.0	0.1	0.4	0.4	2.7	1.2	0.0	0.4	0.5	0.4	0.1	0.5	1.8	3.8	0.0	1.5	5.2	3.1	0.7	3.6	1.5	0.5	1.7	1.2	0.2	0.2	2.7	0.9	6.6	0.3	0.5	1.0	2.0	0.4	0.0	0.7	0.0	1.1	0.6	49.7	1.7	2.0	1.0	0.5	0.2	0.0	1.4	0.3	0.8	0.5	0.8	0.7	1.1	0.4	0.9	2.1	0.5	0.4	30.8	0.7	0.6	0.8	0.2	0.2	4.2	5.0	10.0	3.7	3.4	7.0	6.0	7.4	6.7	5.4	5.5	7.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0
H2BC21	"H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE"	ENSG00000184678	"H2B clustered histone 21"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 87.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	17.8	15.3	35.1	7.2	40.2	21.2	17.7	38.7	38.7	60.8	38.7	22.0	5.2	7.4	22.8	41.7	27.5	5.5	77.3	33.5	37.2	46.3	18.0	37.2	6.2	41.6	38.0	61.7	13.4	9.5	32.5	14.8	39.0	95.2	6.1	69.1	23.5	6.6	62.8	84.0	14.8	6.2	41.0	27.3	32.0	13.7	38.9	20.1	15.2	29.2	3.4	25.1	79.5	55.8	2.8	2.8	4.5	0.9	23.5	6.3	2.2	9.7	6.5	4.0	1.3	1.1	4.4	0.5	2.6	8.6	5.7	10.9	3.6	1.7	2.2	3.4	2.8	0.8	11.5	2.1	7.4	0.8	12.6	21.4	7.9	1.7	6.6	4.8	1.3	4.0	12.0	56.8	5.0	16.8	3.1	5.1	2.8	22.6	5.8	3.6	1.7	13.7	3.8	2.3	30.3	4.9	33.4	4.5	2.7	10.7	23.4	2.4	1.7	3.0	33.6	2.2	0.9	93.7	53.8	2.6	4.0	3.6	1.9	21.3	4.8	8.2	1.3	6.2	2.3	1.5	1.8	2.1	3.3	3.8	2.2	2.2	58.6	1.3	12.3	8.9	2.2	10.1	35.1	40.2	38.7	38.7	33.5	37.2	41.6	38.0	39.0	41.0	38.9	55.8	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	25.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	160.2	0.3	0.0	0.0	0.0
H2BC3	"H2B/f, H2BFF, HIST1H2BB"	ENSG00000276410	"H2B clustered histone 3"	P33778	6	26043227-26043713	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;brain: 2.6;lymphoid tissue: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.0	0.0	0.5	0.0	0.5	1.1	0.0	2.1	0.6	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	1.3	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.2	1.3	1.3	0.0	0.0	1.6	1.7	0.7	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.1	0.1	0.1	0.3	0.3	2.2	0.0	0.2	0.5	0.4	2.6	0.5	0.5	0.8	0.1	2.2	1.4	2.4	0.9	1.9	0.9	1.2	0.5	2.0	0.1	0.2	6.4	1.9	0.3	0.5	0.5	2.1	0.6	0.2	1.3	0.9	1.2	0.9	0.6	2.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	4.3	3.4	9.5	6.0	17.4	25.0	6.7	11.4	8.8	9.1	9.9	3.1	3.2	1.2	3.6	14.7	7.1	4.6	3.6	10.5	15.0	5.3	13.1	8.0	2.9	20.3	10.9	2.6	2.6	0.9	5.8	7.2	16.3	21.8	2.3	1.5	7.5	0.9	14.5	6.7	3.0	1.2	21.5	5.1	7.0	6.4	9.4	14.9	3.6	8.0	2.3	3.5	10.2	27.6	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	9.5	17.4	11.4	8.8	10.5	15.0	20.3	10.9	16.3	21.5	9.4	27.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2BC5	"H2B/b, H2BFB, HIST1H2BD"	ENSG00000158373	"H2B clustered histone 5"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 151.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 117.9;U-266/84: 134.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	25.4	13.4	17.8	7.6	21.9	53.8	18.5	48.7	19.2	151.7	41.8	34.6	11.0	6.3	27.7	37.6	53.5	15.3	31.4	17.9	29.7	67.2	62.9	36.8	9.2	22.2	23.7	101.8	15.7	2.1	30.5	9.3	28.0	144.0	17.1	9.7	28.9	3.6	18.5	44.1	23.3	4.3	27.5	35.4	26.1	11.3	23.8	35.2	25.2	7.3	4.1	17.9	95.5	33.9	17.9	39.7	12.0	6.8	91.2	8.3	3.6	15.5	8.9	19.6	12.3	13.3	14.5	8.1	95.2	18.5	21.8	27.9	6.8	6.6	9.2	36.6	16.9	5.4	33.7	14.5	9.8	7.2	14.7	59.7	10.3	5.5	7.7	7.6	4.9	7.5	57.1	43.3	3.6	64.2	16.4	18.1	12.6	76.1	18.2	6.5	7.6	54.4	18.7	12.8	38.1	16.1	96.8	25.1	15.9	23.1	63.4	2.6	3.0	24.4	63.4	9.9	3.3	117.9	134.9	20.5	3.1	33.2	5.0	35.3	2.3	16.9	8.1	5.1	10.4	13.4	12.3	13.5	5.6	20.0	11.4	8.7	24.8	10.5	6.9	19.3	8.9	2.4	17.8	21.9	48.7	19.2	17.9	29.7	22.2	23.7	28.0	27.5	23.8	33.9	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	7.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	39.4	0.3	0.0	0.0	0.0
H2BC6	"H2B.h, H2B/h, H2BFH, HIST1H2BE"	ENSG00000274290	"H2B clustered histone 6"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;REH: 5.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.8	0.4	1.6	0.5	2.0	2.7	0.6	3.0	1.5	3.6	3.6	0.7	0.4	0.4	0.4	0.7	0.6	0.4	0.6	1.6	0.3	1.0	0.6	1.3	0.9	1.9	0.8	0.9	0.2	0.1	0.7	0.3	0.4	2.6	0.5	1.1	1.3	0.2	0.8	1.7	0.3	0.2	1.8	0.9	0.8	0.5	0.6	2.9	0.5	0.6	0.6	0.4	2.1	1.5	0.3	2.1	1.9	0.5	1.6	0.2	0.2	1.9	0.6	0.3	0.1	0.5	1.3	0.4	0.8	0.3	0.9	2.7	0.3	0.7	0.3	0.9	0.5	0.2	1.0	0.1	0.1	0.1	1.6	0.4	0.1	0.4	0.1	0.6	0.2	0.5	1.4	1.0	0.0	1.0	3.0	5.3	1.5	1.0	0.5	5.1	0.1	1.5	0.8	1.1	1.5	2.2	2.3	0.8	0.5	0.8	1.6	1.0	0.5	0.8	1.5	0.6	1.2	1.3	2.7	0.3	0.4	0.8	0.3	2.9	0.6	1.0	0.7	0.5	0.5	1.0	0.7	0.9	0.2	1.2	0.6	0.6	2.1	0.6	0.6	1.2	1.1	0.3	1.6	2.0	3.0	1.5	1.6	0.3	1.9	0.8	0.4	1.8	0.6	1.5	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in single"		"Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 24.8;U-266/84: 18.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.9	0.2	0.6	0.2	1.1	1.2	1.6	4.0	0.9	3.3	1.5	1.4	0.0	0.1	0.0	3.2	1.8	0.2	0.4	0.8	0.6	1.4	0.6	1.7	0.3	1.9	1.7	0.8	0.2	0.0	0.6	0.2	2.4	7.4	0.2	0.6	1.1	0.0	0.0	0.9	0.7	0.0	2.1	2.3	0.7	0.6	1.2	1.7	0.6	0.1	0.4	0.4	4.5	2.4	0.5	0.3	0.2	0.5	0.3	0.0	0.2	0.2	0.1	0.7	0.1	0.7	0.1	0.6	1.0	0.0	0.3	1.0	0.5	0.1	0.3	0.8	0.2	0.4	1.8	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.0	0.1	0.5	2.0	4.5	0.0	0.1	4.0	1.6	0.6	0.8	0.6	1.5	0.7	3.0	0.1	0.1	2.4	0.4	4.9	0.9	0.1	0.3	4.4	0.2	0.1	0.3	2.2	0.0	0.6	24.8	18.8	1.3	0.1	1.2	0.5	0.0	0.0	0.6	0.2	0.1	0.6	0.2	0.2	0.3	0.1	1.0	0.2	0.5	2.4	0.2	0.3	0.3	0.2	0.5	0.6	1.1	4.0	0.9	0.8	0.6	1.9	1.7	2.4	2.1	1.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0
H2BC8	"H2B.1A, H2B/a, H2BFA, HIST1H2BG"	ENSG00000273802	"H2B clustered histone 8"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	3.1	0.9	1.5	1.2	1.4	6.7	13.2	8.0	1.8	23.9	4.8	5.9	1.1	0.9	2.0	9.1	4.3	0.9	3.3	1.5	1.9	4.3	3.1	7.5	1.6	1.4	2.2	5.7	1.1	0.1	2.9	1.1	3.6	19.7	2.0	1.6	6.9	0.5	0.1	13.2	3.2	0.4	2.8	7.1	3.7	1.8	1.9	4.1	2.6	0.0	1.4	1.6	18.4	4.6	3.0	0.1	1.4	0.0	4.4	0.2	0.4	3.7	0.3	2.3	0.9	0.4	2.6	0.0	3.7	0.3	1.0	3.2	1.3	1.2	1.3	2.6	1.6	0.8	1.5	1.4	0.7	0.3	2.4	1.7	0.6	0.7	0.1	0.1	0.5	0.1	9.6	0.2	0.0	2.2	2.8	2.1	1.5	7.1	1.9	1.8	0.8	5.4	1.3	0.7	8.5	1.3	10.5	3.8	1.2	3.7	21.2	0.9	0.3	0.0	1.2	0.3	0.5	19.6	0.1	0.0	0.3	1.3	0.7	18.1	1.3	3.2	2.0	0.9	6.4	4.4	3.2	4.0	5.1	5.3	1.5	1.3	5.8	1.4	1.8	16.0	3.0	2.2	1.5	1.4	8.0	1.8	1.5	1.9	1.4	2.2	3.6	2.8	1.9	4.6	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.2	0.0	0.0	0.0
H2BC9	"H2B/j, H2BFJ, HIST1H2BH"	ENSG00000275713	"H2B clustered histone 9"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;vagina: 4.3"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.5	0.2	0.4	0.6	0.4	1.4	0.6	0.3	0.5	1.9	0.8	2.0	3.0	0.4	0.8	4.2	0.8	0.3	0.2	0.3	0.4	0.9	0.2	1.6	0.8	0.8	0.7	0.1	0.0	0.1	0.1	0.2	0.7	3.5	0.8	0.0	1.3	0.0	0.0	0.6	1.7	0.1	0.6	3.7	0.7	0.6	0.7	2.9	1.0	0.1	0.5	0.4	4.3	1.1	1.8	0.1	7.0	0.0	0.0	0.1	1.1	0.9	0.3	1.2	0.6	2.4	1.1	0.0	1.7	0.1	1.8	3.4	0.0	0.6	1.7	0.9	0.1	1.3	6.1	0.4	0.0	0.0	4.0	0.3	0.3	0.4	0.5	0.0	0.3	1.0	2.7	6.2	0.1	2.0	3.8	2.7	1.6	0.0	1.8	4.0	0.0	0.9	0.0	2.7	3.2	2.9	4.2	1.4	0.6	0.3	2.0	3.3	0.0	0.6	0.0	0.7	3.1	16.9	4.5	0.0	0.5	1.5	3.8	3.7	0.2	0.6	0.3	0.0	0.1	0.6	0.2	0.4	0.6	0.3	0.0	0.1	3.0	0.8	0.1	0.2	0.4	5.2	0.4	0.4	0.3	0.5	0.3	0.4	0.8	0.7	0.7	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	29.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0
H2BE1		ENSG00000285480	"H2B.E variant histone 1"	A0A2R8Y619	7	151207837-151210378	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 4.5;U-266/84: 3.3"					"Low region specificity"	"Detected in some"			HPA043013	Uncertain					NA	NA					"Cluster 29: U-266 - Adaptive immune response"				"HPA043013: AB_2678269"																		0.8	0.3	0.9	0.4	1.2	0.6	0.8	1.2	1.3	0.3	0.6	0.1	0.2	1.1	0.2	0.6	0.2	0.9	0.2	0.9	1.6	0.0	0.2	0.8	1.2	1.2	1.1	0.7	0.0	0.0		0.2	1.3	0.1	0.1	0.0	0.0	0.3	0.9	4.7	0.3	0.5	1.0	1.0	0.2	0.3	1.2	0.5	0.1	0.3	0.4	0.0		1.3	0.0	0.4	0.0	0.3	1.0	1.2	0.0	0.3	0.1	0.1	0.0	1.0	0.6	0.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.6	1.8	0.2	0.2	0.0	0.5	0.3	0.8	1.3	0.2	0.0	1.8	0.3	0.4	0.4	0.2	1.5	0.0	0.3	0.1	0.1	0.1	0.0	0.6	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	1.2	0.5	0.0	0.2	0.6	0.1	4.5	3.3	0.1	0.4	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	1.2	1.3	0.9	1.6	1.2	1.1	1.3	1.0	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BS1	H2BFS	ENSG00000234289	"H2B.S histone 1"	P57053	21	43565182-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;K-562: 1.0;U-2 OS: 1.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				0.9	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.1	0.7	0.0	0.9	0.0	1.3	0.7	0.0	0.6	0.1	0.0	0.2	2.0	1.0	0.1	0.1	0.1	0.5	1.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.7	0.0	0.1	0.6	0.8	0.0	0.0	1.6	0.6	1.1	0.1	0.0	0.7	0.0	0.0	0.4	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
H2BU1	HIST3H2BB	ENSG00000196890	"H2B.U histone 1"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5;cervix: 4.7;vagina: 3.5"	"Cell type enhanced"	"Detected in single"		"Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.0;U-266/70: 15.1;U-266/84: 3.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	0.7	0.7	0.8	0.0	0.5	0.2	0.2	3.5	0.7	4.7	0.1	0.2	0.1	0.1	0.1	1.4	1.0	0.0	0.8	0.4	1.6	0.6	0.1	0.9	0.1	0.9	0.8	0.6	0.1	0.0	0.9	0.0	1.1	0.8	0.0	0.5	0.3	0.0	0.1	1.2	0.3	0.0	0.4	0.8	0.3	0.2	1.9	0.0	0.4	0.0	0.1	0.4	3.5	0.5	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.8	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.1	1.2	0.4	0.8	0.3	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	15.1	3.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.1	0.8	0.5	3.5	0.7	0.4	1.6	0.9	0.8	1.1	0.4	1.9	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
H2BW1	H2BFWT	ENSG00000123569	"H2B.W histone 1"	Q7Z2G1	X	104011147-104013687	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA056289, HPA060383"	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA056289: AB_2683087, HPA060383: "						"unprognostic (5.07e-2)"				"unprognostic (1.55e-1)"					"unprognostic (1.15e-1)"		"unprognostic (1.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3-2	"HIST2H3PS2, p06"	ENSG00000273213	"H3.2 histone (putative)"		1	143894544-143905966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 13.4;ovary: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 11.8;SH-SY5Y: 11.9;THP-1: 16.3;U-2197: 16.3"	"Low region specificity"	"Detected in all"							HPA042570	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 18: U-2197 - ECM organization"				"HPA042570: AB_2678056"	"unprognostic (2.29e-2)"				"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"		"unprognostic (1.10e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.57e-2)"	"unprognostic (8.78e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.44e-2)"	2.0	13.4	4.4	2.2	4.3	0.3	1.3	9.2	5.3	1.3	1.5	0.8	0.4	3.3	1.8	2.3	3.2	1.9	1.2	3.4	6.8	0.8	0.4	1.7	2.3	6.1	6.1	16.7	1.5	0.9		1.3	7.7	5.5	0.8	1.4	1.7	2.3	0.4	2.6	0.7	4.3	7.6	9.1	4.0	3.0	6.7	0.4	3.5	0.3	1.5	1.4		6.7	0.1	0.0	0.3	0.1	5.9	4.3	0.2	11.8	6.2	7.4	7.0	0.0	2.6	0.0	0.9	5.5	6.9	0.1	0.0	0.5	5.4	0.0	0.6	0.0	0.1	0.0	9.2	0.0	0.0	7.0	0.1	10.9	1.9	1.9	5.7	0.0	0.7	0.1	0.9	0.0	0.0	6.8	0.0	3.0	0.1	0.0	0.0	0.0	4.8	0.2	1.2	11.9	0.0	5.7	0.0	0.0	0.1	16.3	1.9	2.0	0.1	16.3	2.0	0.1	0.0	0.0	7.8	0.0	4.4	0.6	0.3	0.0	0.0	1.0	0.2	0.2	0.1	0.1	0.6	0.5	0.0	0.1	0.3	0.7	1.4	0.6	0.0	0.1	4.4	4.3	9.2	5.3	3.4	6.8	6.1	6.1	7.7	7.6	6.7	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3-3A	"H3.3A, H3F3, H3F3A"	ENSG00000163041	"H3.3 histone A"	P84243	1	226061851-226072019	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 600.6;Cytotrophoblasts: 1411.0;Extravillous trophoblasts: 2181.9;Hofbauer cells: 1487.3;Syncytiotrophoblasts: 1616.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4487.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 4487.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	409.6	440.4	240.3	662.2	255.8	2033.8	594.8	262.4	343.4	544.2	244.8	708.3	655.2	492.2	721.3	595.8	565.3	487.7	500.1	229.1	252.3	457.9	537.9	438.9	793.5	273.8	247.1	453.0	435.4	499.7	270.0	490.0	274.4	474.8	790.0	271.6	586.9	382.0	337.1	617.2	672.5	468.6	272.4	539.1	547.2	255.9	246.8	1239.6	480.5	435.5	894.6	597.6	409.0	295.7	751.2	417.0	1589.6	910.2	432.9	498.9	1186.2	337.3	416.2	547.8	429.0	446.2	1214.5	715.3	731.0	427.9	273.5	684.4	802.4	631.9	535.0	445.9	1371.0	889.5	569.9	595.2	427.8	901.4	1026.6	465.6	715.8	385.3	502.1	743.0	826.8	915.7	1271.3	1125.2	626.2	433.8	1791.8	1504.6	2163.0	1881.1	815.7	1286.9	1110.4	1871.4	1159.6	784.3	1542.1	2279.8	991.0	1227.4	842.4	882.3	1399.1	2103.7	471.4	397.1	527.2	532.6	1024.0	523.6	643.4	1178.4	380.2	853.2	874.1	869.5	1043.6	1486.1	378.9	830.2	385.9	722.1	405.2	415.8	791.8	661.7	375.0	423.1	4487.2	442.5	945.8	635.2	636.8	1364.8	240.3	255.8	262.4	343.4	229.1	252.3	273.8	247.1	274.4	272.4	246.8	295.7	600.6	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	1411.0	449.2	0.0	0.0	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	2181.9	188.0	0.0	0.0	0.0	0.0	0.0	0.0	1487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	1616.9	75.3	0.0	0.0	0.0
H3-3B	"H3.3B, H3F3B"	ENSG00000132475	"H3.3 histone B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 4220.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21089.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 21089.7"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	607.2	369.9	223.8	532.5	262.6	4220.9	628.9	264.4	288.8	741.2	186.6	415.4	329.9	507.4	180.3	798.6	585.7	467.9	312.8	210.7	226.0	438.3	380.2	553.2	509.1	268.7	241.9	1166.0	578.0	341.1	357.5	427.1	242.8	348.2	223.1	299.8	519.2	237.1	332.5	1153.2	407.5	322.9	253.7	449.9	393.0	654.3	246.0	464.0	500.7	155.6	296.2	545.3	675.2	316.1	1386.5	1194.2	490.0	486.1	273.3	424.9	675.1	636.7	557.1	764.8	609.3	1290.7	952.6	683.6	593.1	373.2	539.5	530.0	390.5	881.0	432.0	375.9	883.0	612.8	668.2	1112.0	615.7	1029.2	755.0	467.3	534.2	785.6	1004.7	339.3	582.5	437.8	885.6	1193.0	399.4	2015.3	1492.3	859.5	394.8	442.8	1322.8	1091.7	894.2	746.6	607.3	803.5	988.1	1096.0	645.8	933.7	1402.2	259.3	734.2	1091.3	549.1	1359.7	1205.2	595.2	1721.1	1431.3	932.2	843.5	720.5	967.6	761.1	7991.0	3667.6	10060.5	2613.4	3365.8	2482.2	3199.5	2474.2	2478.9	3218.1	2813.7	2635.4	2173.4	21089.7	3240.7	3199.0	3294.6	2999.0	9615.0	223.8	262.6	264.4	288.8	210.7	226.0	268.7	241.9	242.8	253.7	246.0	316.1	1321.3	0.0	0.0	0.0	294.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	398.6	0.0	0.0	0.0	0.0	1625.3	844.9	0.0	0.0	0.0	0.0	0.0	0.0	172.3	0.0	0.0	0.0	0.0	1626.9	485.1	0.0	0.0	0.0	0.0	0.0	0.0	1908.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	257.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	314.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	377.9	0.0	0.0	0.0	0.0	3503.3	211.7	0.0	0.0	0.0
H3-4	"H3.4, H3/g, H3FT, H3t, HIST3H3"	ENSG00000168148	"H3.4 histone"	Q16695	1	228424845-228425360	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 1.6;choroid plexus: 1.1;testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001386, CAB003812, HPA042570"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoplasm		"CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056"	"unprognostic (4.45e-1)"				"unprognostic (4.66e-2)"			"unprognostic (1.36e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.75e-2)"		"unprognostic (4.04e-2)"	"unprognostic (1.39e-2)"			"unprognostic (2.26e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.7	0.2	1.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.7	0.1	0.1	0.8	0.2	0.8	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3-5	"H3.5, H3F3C"	ENSG00000188375	"H3.5 histone"	Q6NXT2	12	31791185-31792298	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 21.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 83.8;Endothelial cells: 16.8;Fibroblasts: 23.8;Smooth muscle cells: 31.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 73.0"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.3"									HPA042570	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.73e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.86e-2)"	0.5	0.3	0.1	1.0	0.1	3.1	0.5	0.1	0.5	0.6	0.1	0.3	0.5	0.5	0.2	0.6	0.6	0.1	0.3	0.1	0.1	0.3	0.3	0.5	0.4	0.2	0.1	1.0	0.5	0.1	0.3	0.4	0.2	0.3	0.0	0.7	0.5	0.0	0.4	1.0	0.9	0.0	0.1	1.4	0.6	21.8	0.1	0.0	0.4	0.0	0.7	0.4	0.5	0.2	1.6	0.3	0.7	0.3	0.1	0.0	0.5	0.2	0.1	0.4	0.1	0.5	0.6	0.2	0.6	0.0	0.3	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	1.2	1.6	0.3	0.1	0.0	0.8	0.3	1.0	0.1	0.2	1.2	2.3	0.0	0.9	2.0	0.2	0.5	1.5	0.1	0.8	1.5	0.5	2.0	1.1	0.4	0.6	0.7	0.7	0.7	36.7	14.5	41.6	10.2	15.5	9.1	16.0	10.3	10.1	13.2	13.2	10.9	10.4	73.0	15.0	14.0	12.7	14.0	40.9	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.8	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	2.7	23.8	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0
H3C1	"H3/A, H3FA, HIST1H3A"	ENSG00000275714	"H3 clustered histone 1"	P68431	6	26020451-26020958	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.8;brain: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.7;Plasma cells: 1.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 18.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.0"									HPA042570	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (3.07e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.85e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.21e-2)"	0.2	0.4	2.5	0.1	0.8	7.8	0.1	18.9	3.9	0.3	0.0	0.2	0.0	0.1	0.9	0.3	0.2	0.1	0.3	1.0	4.2	0.1	0.2	0.3	0.4	2.6	5.8	0.1	0.0	0.0	0.2	0.1	2.7	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.9	0.2	0.2	2.9	1.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.7	0.0	0.5	0.2	0.0	1.0	0.0	0.7	1.7	0.0	0.3	0.6	0.4	0.0	0.3	0.0	1.0	0.2	1.4	0.3	1.2	1.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.2	0.1	0.0	2.2	2.0	1.2	0.9	0.4	0.9	1.1	0.5	0.0	0.7	0.5	0.7	1.0	0.7	1.6	0.2	0.0	0.1	0.9	0.0	0.0	4.0	0.3	0.4	0.3	0.1	0.0	0.4	1.4	1.3	13.6	1.5	4.3	3.5	1.5	3.0	2.2	2.6	2.0	3.1	3.1	1.8	1.7	13.5	8.0	0.9	4.9	3.5	1.3	2.5	0.8	18.9	3.9	1.0	4.2	2.6	5.8	2.7	0.9	1.4	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
H3C10	"H3/k, H3F1K, H3FK, HIST1H3H"	ENSG00000278828	"H3 clustered histone 10"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.4"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 4.4;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.3;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"basophil: 101.9;neutrophil: 37.8"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 101.9"	"Cell line enhanced"	"Detected in many"		"K-562: 33.7;SiHa: 28.3;U-266/70: 23.5;U-266/84: 61.3"									HPA042570	Approved					NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.6	1.3	0.9	0.4	0.8	4.4	0.8	0.8	1.1	2.1	1.9	2.8	1.3	0.3	0.5	3.3	0.8	0.4	1.0	1.0	0.7	1.1	2.4	4.0	1.0	1.2	1.1	1.9	0.2	0.8	0.4	0.9	1.0	2.6	2.6	0.1	0.6	0.2	0.6	1.3	1.3	0.2	1.0	6.4	1.5	1.4	1.0	3.1	1.2	1.1	0.4	0.6	2.9	1.8	1.9	7.2	3.0	2.5	4.2	0.5	0.4	1.0	0.7	3.4	1.3	2.2	2.1	1.3	6.5	0.8	2.0	3.9	1.1	1.7	2.2	9.2	4.4	1.8	6.9	9.3	1.1	1.6	2.7	5.6	0.5	0.7	0.8	1.5	1.4	1.7	33.7	15.5	0.7	14.5	3.0	3.6	1.5	13.3	2.7	1.6	0.0	17.0	3.6	0.8	9.3	1.8	28.3	5.7	1.2	1.6	13.4	0.5	1.6	1.5	4.5	0.9	0.4	23.5	61.3	5.0	0.1	7.9	0.3	101.9	4.2	9.2	1.4	1.3	1.7	1.4	2.2	2.0	3.3	5.3	1.4	1.1	37.8	1.7	1.5	7.1	8.1	203.1	0.9	0.8	0.8	1.1	1.0	0.7	1.2	1.1	1.0	1.0	1.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0
H3C11	"H3.f, H3/f, H3FF, HIST1H3I"	ENSG00000275379	"H3 clustered histone 11"	P68431	6	27871845-27872346	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 2.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.1;MOLT-4: 4.0;NB-4: 2.8;REH: 4.2"									HPA042570	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	0.1	0.1	0.9	0.3	0.8	1.2	0.0	1.2	0.7	0.1	2.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.1	0.0	0.3	4.0	2.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.1	5.5	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.2	0.0	0.2	0.4	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.4	1.3	0.3	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	2.8	0.6	0.1	0.0	4.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.4	1.5	0.3	1.2	0.5	1.3	1.0	2.3	2.3	1.1	1.5	0.6	8.2	0.3	3.4	1.2	1.5	0.9	0.8	1.2	0.7	0.3	1.5	4.0	2.6	2.9	2.2	3.4	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H3C12	"H3/j, H3FJ, HIST1H3J"	ENSG00000197153	"H3 clustered histone 12"	P68431	6	27890315-27893106	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;brain: 2.1;choroid plexus: 1.3;lymphoid tissue: 1.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.4;U-266/84: 11.7"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.0	0.0	0.2	0.0	0.4	1.2	0.1	0.6	0.6	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	1.0	0.9	2.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.0	0.3	0.9	1.1	0.0	0.0	0.2	0.1	0.1	1.3	0.9	0.3	1.3	0.6	0.5	0.2	0.6	0.3	0.0	0.7	0.1	0.0	0.2	4.4	0.7	0.2	0.5	0.1	0.9	0.5	0.0	0.2	0.4	0.8	1.8	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	1.9	1.0	0.0	0.5	2.0	2.5	1.7	0.8	0.2	1.0	0.3	0.4	0.0	0.0	2.3	1.0	1.5	1.4	0.0	0.2	0.4	0.5	0.0	0.5	0.0	0.1	0.2	3.1	11.7	1.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.9	0.7	0.5	0.1	0.2	0.0	0.3	0.2	0.1	0.7	0.1	0.2	0.4	0.6	0.6	0.3	0.4	0.9	2.1	1.5	0.6	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H3C13	HIST2H3D	ENSG00000183598	"H3 clustered histone 13"	Q71DI3	1	149813225-149813693	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 7.7;U-266/70: 19.2"									HPA042570	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (3.35e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.27e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-4)"	"unprognostic (6.95e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.48e-3)"	0.8	0.8	3.5	0.8	2.0	3.2	0.5	13.3	2.3	0.9	4.0	0.8	0.2	0.4	0.0	1.1	0.6	0.8	0.8	2.1	6.6	0.7	0.7	1.1	0.7	3.3	3.3	1.5	0.7	0.0	0.4	0.2	3.4	1.0	0.0	0.1	0.2	0.0	0.1	0.7	1.2	0.0	4.0	1.3	1.1	0.8	11.1	0.5	0.6	0.0	0.1	0.4	0.8	3.6	0.6	0.0	0.1	2.3	0.3	0.0	0.2	1.3	0.0	0.0	0.0	0.3	0.4	0.5	0.3	0.0	0.2	0.8	0.0	0.0	0.0	1.2	0.4	0.2	3.5	0.0	0.2	0.0	1.7	0.6	0.0	0.4	0.2	0.3	0.0	0.6	1.7	1.5	0.0	1.2	2.0	7.7	1.7	0.4	3.1	1.0	0.0	1.3	0.0	0.8	0.4	0.3	1.1	0.0	0.1	0.1	0.4	0.4	0.4	1.1	0.0	0.7	0.0	19.2	2.1	1.3	0.3	0.4	0.6	0.0	1.2	0.5	0.9	1.5	1.8	0.9	1.2	1.4	1.0	4.7	0.4	0.3	9.8	0.4	0.5	2.2	0.1	0.3	3.5	2.0	13.3	2.3	2.1	6.6	3.3	3.3	3.4	4.0	11.1	3.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H3C14	"H3, H3.2, H3/m, H3F2, H3FM, HIST2H3C, MGC9629"	ENSG00000203811	"H3 clustered histone 14"	Q71DI3	1	149839538-149841193	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 5.6;U-266/70: 4.8;U-266/84: 5.1"									"HPA042570, CAB069990"	Supported					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"				"CAB069990: AB_10804539, HPA042570: AB_2678056"					"unprognostic (1.78e-1)"			"unprognostic (2.25e-1)"		"unprognostic (2.42e-1)"				"unprognostic (1.36e-2)"				0.1	0.1	2.2	0.1	3.5	0.8	0.1	12.2	2.7	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.5	0.0	0.4	1.5	0.5	0.1	0.4	0.2	0.1	2.6	1.8	0.1	0.4	0.0	0.2	0.0	4.3	1.3	0.0	1.0	0.2	0.0	0.2	0.3	0.1	0.0	1.0	0.2	0.2	0.9	1.4	0.1	0.1	0.0	0.0	0.2	0.4	4.1	0.4	2.2	0.4	0.3	0.1	0.0	0.7	0.3	0.0	0.4	0.1	0.3	0.4	0.2	0.3	0.0	0.2	1.7	0.0	0.1	0.1	0.5	3.7	0.3	2.0	0.1	0.0	0.3	1.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	1.8	2.0	0.1	1.5	1.1	1.4	1.2	2.7	0.8	0.9	0.2	1.0	0.0	0.2	3.2	0.7	5.6	1.5	0.2	0.6	0.9	1.2	0.0	0.4	3.1	0.2	0.2	4.8	5.1	1.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.5	12.2	2.7	1.5	0.5	2.6	1.8	4.3	1.0	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C15	"H3/n, H3/o, HIST2H3A"	ENSG00000203852	"H3 clustered histone 15"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 5.6;U-266/70: 4.8;U-266/84: 5.1"									HPA042570	Approved					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				0.1	0.1	2.2	0.1	3.5	0.8	0.1	12.2	2.7	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.3	1.5	0.5	0.2	0.3	0.2	0.1	2.6	1.8	0.1	0.4	0.0	0.2	0.0	4.3	1.2	0.0	1.0	0.2	0.0	0.2	0.3	0.1	0.0	1.0	0.2	0.2	0.7	1.4	0.1	0.1	0.0	0.0	0.1	0.2	4.1	0.4	2.2	0.4	0.3	0.1	0.0	0.7	0.3	0.0	0.4	0.1	0.3	0.4	0.2	0.3	0.0	0.2	1.7	0.0	0.1	0.1	0.5	3.7	0.3	2.0	0.1	0.0	0.3	1.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	1.8	2.0	0.1	1.5	1.1	1.4	1.2	2.7	0.8	0.9	0.2	1.0	0.0	0.2	3.2	0.7	5.6	1.5	0.2	0.6	0.9	1.2	0.0	0.4	3.1	0.2	0.2	4.8	5.1	1.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.5	12.2	2.7	1.5	0.5	2.6	1.8	4.3	1.0	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C2	"H3/l, H3FL, HIST1H3B"	ENSG00000286522	"H3 clustered histone 2"	P68431	6	26031589-26032099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 4.1;choroid plexus: 1.6;lymphoid tissue: 1.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 8.4"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"																		0.0	0.1	1.3	0.1	0.8	6.4	0.1	0.3	1.0	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.5	1.0	2.2	0.0	0.0	0.0		0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	4.1	1.7	0.1	0.2	0.0	0.0		3.2	1.2	2.7	1.1	2.5	0.0	0.2	0.0	0.1	0.4	0.4	0.4	0.6	0.9	2.0	1.4	0.2	0.7	0.4	0.9	0.7	0.9	1.4	2.7	2.1	4.0	0.8	0.0	1.6	1.4	1.6	0.0	0.3	0.0	0.0	0.5	0.6	4.3	3.8	0.6	0.6	5.0	5.0	2.0	0.5	1.9	2.9	1.8	5.6	0.3	0.0	1.3	1.1	3.9	1.0	0.3	0.0	1.8	1.0	0.9	0.8	3.1	0.4	1.2	6.3	8.4	2.6	2.1	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.3	0.8	0.3	1.0	0.6	0.7	1.0	2.2	2.2	0.6	4.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C3	"H3.1, H3/c, H3FC, HIST1H3C"	ENSG00000287080	"H3 clustered histone 3"	P68431	6	26045384-26045869	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.2;brain: 1.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 6.5"									HPA042570	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 32: U-937 - Innate immune response"				"HPA042570: AB_2678056"																		0.1	0.0	0.6	0.0	0.4	4.2	0.0	0.3	0.5	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.0	0.1	0.1	0.6	0.7	1.8	0.0	0.0	0.0		0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.7	1.8	1.1	0.0	0.0	0.1	0.2		1.1	1.7	0.3	0.8	0.0	0.3	0.0	0.0	1.2	0.5	3.3	2.8	0.0	0.2	0.0	0.0	0.5	1.8	0.7	0.0	0.2	2.4	2.3	0.2	2.5	0.2	2.0	0.2	1.6	1.0	0.3	0.2	1.0	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	2.7	3.3	1.4	1.8	2.7	2.8	0.0	0.2	0.7	3.6	0.0	1.0	3.1	1.8	0.3	0.1	0.8	1.0	0.0	0.0	0.0	1.2	2.1	1.5	0.1	0.0	0.8	6.5	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.3	0.3	0.5	0.1	0.6	0.1	1.1	0.0	0.2	1.1	0.5	0.6	0.4	0.3	0.5	0.4	0.7	0.7	1.8	1.6	0.4	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C4	"H3/b, H3FB, HIST1H3D"	ENSG00000197409	"H3 clustered histone 4"	P68431	6	26196784-26197286	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.2;brain: 15.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.7;MOLT-4: 5.4;U-266/70: 11.7;U-266/84: 6.9"									HPA042570	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	0.6	0.8	4.3	0.1	4.1	12.2	0.6	15.9	3.2	2.3	5.7	1.0	0.6	0.2	0.0	2.0	0.9	0.5	0.5	1.1	2.6	0.9	1.5	1.4	0.4	4.8	5.2	0.8	0.2	0.0	0.6	0.2	4.8	2.8	0.0	0.1	1.0	0.1	0.0	0.7	0.7	0.1	6.7	1.7	0.6	0.8	4.5	1.8	0.6	0.0	0.3	0.7	2.8	10.9	1.5	0.0	0.2	1.2	0.8	0.3	0.7	0.0	0.3	1.6	1.1	2.9	0.6	2.7	1.3	0.4	0.0	0.4	0.7	0.1	0.0	1.5	0.2	0.1	1.3	2.0	0.1	0.9	1.8	0.1	0.1	1.2	0.3	0.0	0.5	1.1	1.2	5.7	0.0	0.6	5.4	4.6	0.2	0.1	0.9	2.7	0.3	3.1	0.0	0.0	0.8	0.1	0.0	1.0	0.8	0.0	0.6	1.6	1.4	0.3	2.9	0.0	1.5	11.7	6.9	0.6	1.5	0.3	0.4	14.8	1.6	4.2	3.4	1.6	8.6	8.3	2.5	3.5	3.9	13.0	2.6	4.6	22.2	3.2	3.5	5.1	3.3	0.9	4.3	4.1	15.9	3.2	1.1	2.6	4.8	5.2	4.8	6.7	4.5	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C6	"H3.1, H3/d, H3FD, HIST1H3E"	ENSG00000274750	"H3 clustered histone 6"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;hTERT-RPE1: 7.5;SCLC-21H: 11.9;T-47d: 7.3"					"Low region specificity"	"Detected in all"			HPA042570	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	3.5	1.0	1.0	1.5	0.4	1.8	3.9	3.2	1.2	2.7	2.9	4.7	0.8	4.9	2.8	1.5	1.0	6.0	1.1	1.5	1.6	2.9	0.5	1.3	2.0	1.7	1.0	0.7	1.5	0.6	0.9	2.4	3.4	1.9	0.2	1.9	0.7	5.1	1.2	4.7	0.4	1.9	2.2	2.6	1.4	1.4	1.2	2.6	3.7	0.9	1.2	1.2	3.4	1.9	2.0	2.8	1.3	3.3	1.6	0.2	1.3	1.5	0.7	0.5	0.6	1.1	0.0	10.5	0.5	1.0	2.3	0.0	0.3	0.6	2.9	2.5	0.4	1.0	0.6	1.0	0.1	1.7	2.3	2.4	0.3	0.7	7.5	1.1	0.2	0.3	2.2	1.9	1.8	0.4	0.1	0.2	1.4	1.9	1.4	0.6	0.3	5.7	1.1	11.9	1.4	1.9	3.0	3.4	0.4	7.3	1.2	0.6	1.3	0.4	0.4	0.3	0.8	0.3	0.2	0.6	0.1	0.7	0.2	0.7	0.0	0.5	0.6	0.7	0.5	0.7	0.7	0.5	0.9	0.6	0.7	2.7	0.2	0.6	1.7	1.3	0.5	1.0	1.5	3.9	3.2	1.1	1.5	2.0	1.7	2.4	1.9	1.4	3.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0
H3C7	"H3/i, H3FI, HIST1H3F"	ENSG00000277775	"H3 clustered histone 7"	P68431	6	26250142-26250635	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;brain: 3.7;choroid plexus: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 2.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.3;U-266/84: 6.2"									"HPA042570, CAB070190"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	0.0	0.1	0.6	0.2	0.6	1.6	0.0	1.2	0.7	0.0	2.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.6	0.0	1.1	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.4	0.0	0.5	0.0	0.9	0.2	0.8	2.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.6	0.8	1.2	1.2	0.0	0.9	1.9	4.3	0.1	0.0	1.1	2.1	0.0	0.6	0.0	0.3	2.2	0.5	0.8	0.4	0.0	0.1	1.6	1.6	0.0	0.2	0.0	0.1	1.1	1.2	6.2	0.0	1.2	1.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.6	0.6	1.2	0.7	0.5	0.4	1.9	0.9	1.4	1.0	1.8	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
H3C8	"H3/h, H3FH, HIST1H3G"	ENSG00000273983	"H3 clustered histone 8"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.8;Hofbauer cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;SiHa: 6.8;U-266/70: 6.3"									HPA042570	Approved					NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.3	0.4	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.1	0.1	0.2	0.4	0.1	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.7	0.0	0.0	0.1	0.3	0.3	0.1	0.7	0.3	2.7	0.0	0.0	0.3	0.0	0.7	2.2	0.9	0.4	0.5	0.6	0.0	0.1	1.9	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.2	0.5	0.0	1.5	0.0	1.6	0.8	0.3	1.3	2.4	0.0	0.6	0.0	1.0	0.5	0.5	0.2	0.3	6.8	2.1	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.0	0.1	6.3	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0
H3Y1	"H3.Y, H3.Y.1"	ENSG00000269466	"H3.Y histone 1"	P0DPK2	5	17654868-17655849	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"U-2 OS: 1.7"									HPA042570	Uncertain					NA	NA					"Cluster 9: U-2 OS - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042570: AB_2678056"															"unprognostic (1.50e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3Y2	"H3.X, H3.Y.2"	ENSG00000268799	"H3.Y histone 2"	P0DPK5	5	17490967-17492076	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042570	Approved					NA	NA									"HPA042570: AB_2678056"															"unprognostic (2.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4-16	"HIST4H4, MGC24116"	ENSG00000197837	"H4 histone 16"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Cytotrophoblasts: 1.0;dendritic cells: 2.6;Hofbauer cells: 1.6;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 24.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 4.7;HeLa: 3.7"	"Low region specificity"	"Detected in all"							"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm		NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	0.4	1.0	4.5	1.2	12.0	0.6	0.9	3.8	6.0	2.0	2.9	0.7	1.2	0.8	1.8	2.2	1.5	1.4	0.8	1.9	12.1	0.7	0.4	0.8	1.5	6.4	5.9	1.2	1.2	0.2	0.5	1.7	4.2	4.3	1.2	1.2	1.4	0.9	0.5	1.7	1.0	0.6	5.4	1.9	2.7	1.7	15.9	1.4	1.7	0.0	1.2	0.8	1.1	4.9	1.3	0.5	0.0	1.5	1.6	0.0	0.9	0.8	0.0	0.6	0.5	0.8	4.7	1.2	0.3	0.4	0.0	0.8	0.0	0.6	0.3	1.5	0.6	0.0	3.7	1.2	0.4	0.3	1.1	1.1	0.3	0.1	0.6	0.0	0.0	0.4	0.0	1.5	0.0	0.6	0.3	0.4	1.6	0.4	0.2	1.3	0.0	2.3	0.0	3.4	0.5	0.8	3.1	0.8	0.2	0.3	0.5	0.6	1.0	0.2	2.4	0.6	1.0	1.6	1.1	3.6	1.1	0.0	0.8	0.0	2.5	0.3	2.3	2.4	4.1	5.3	2.7	2.6	2.7	5.7	2.4	2.8	24.1	3.0	1.0	4.6	4.0	1.6	4.5	12.0	3.8	6.0	1.9	12.1	6.4	5.9	4.2	5.4	15.9	4.9	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
H4C1	"H4FA, HIST1H4A"	ENSG00000278637	"H4 clustered histone 1"	P62805	6	26021649-26022050	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 22.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	8	"cerebellum: 22.1"	"Group enriched"	"Detected in some"	6	"eosinophil: 2.9;neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1;NB-4: 8.4;REH: 9.1"	"Not detected"	"Not detected"							"CAB021887, HPA042201"	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.1	0.0	0.9	1.0	0.3	1.7	0.1	22.1	2.8	0.2	0.0	0.1	1.1	0.1	0.3	0.5	0.0	0.3	0.1	0.5	0.3	0.1	0.1	0.3	0.7	0.1	2.0	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.1	0.9	3.4	0.5	0.0	0.9	0.2	0.0	0.6	2.9	1.1	2.2	0.0	0.4	0.0	0.0	0.2	0.7	0.9	1.4	0.0	4.0	2.0	0.7	0.0	0.1	3.4	1.5	0.0	0.3	0.3	1.1	1.8	1.0	0.0	0.0	0.4	4.1	0.0	0.0	0.3	0.0	0.0	0.9	2.3	0.9	3.0	0.0	0.9	10.1	8.4	1.7	0.6	0.0	9.1	1.5	1.6	0.0	0.2	3.0	1.3	1.1	4.3	0.1	0.0	2.3	2.1	0.0	2.2	5.6	2.1	2.4	1.2	2.0	0.0	1.0	3.3	4.3	0.0	0.8	2.9	0.9	0.7	0.2	0.3	0.9	0.3	0.7	0.5	0.3	0.2	10.5	1.1	0.1	0.4	1.1	0.1	0.9	0.3	22.1	2.8	0.5	0.3	0.1	2.0	2.2	0.4	0.9	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
H4C11	"H4/e, H4F2iv, H4FE, HIST1H4J"	ENSG00000197238	"H4 clustered histone 11"	P62805	6	27824092-27824480	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 2.5;Extravillous trophoblasts: 8.0;Hofbauer cells: 4.4;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"basophil: 80.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.0;U-266/70: 2.4;U-266/84: 1.1;U-937: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042201	Supported					NA	NA		25000000	"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.4	10.0	0.0	0.0	0.4	0.0	4.1	0.0	0.4	4.7	0.2	6.7	0.0	4.1	0.0	4.9	4.9	1.2	3.9	0.1	0.2	4.3	20.6	4.4	0.0	0.2	0.1	4.8	1.2	0.0	4.2	0.0	0.2	8.6	0.0	0.0	1.9	0.0	0.4	2.9	5.4	1.4	0.0	11.5	3.2	2.7	0.2	0.0	8.7	0.0	0.0	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.1	0.0	0.0	6.3	0.0	80.9	2.3	13.5	8.6	9.9	3.0	6.1	8.1	9.9	0.0	6.0	3.6	4.4	0.2	13.6	14.3	6.7	9.0	8.6	0.0	0.4	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
H4C12	"dJ160A22.1, H4/d, H4F2iii, H4FD, HIST1H4K"	ENSG00000273542	"H4 clustered histone 12"	P62805	6	27831174-27831560	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.2;brain: 20.7"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 160.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 160.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 63.7;MCF7: 63.3"									HPA042201	Supported					NA	NA		25000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	4.1	5.5	12.2	2.8	14.6	22.2	2.1	4.5	18.9	3.8	0.0	7.6	6.1	3.1	1.0	1.4	3.3	3.7	0.5	17.4	7.1	1.1	8.0	1.2	4.6	0.5	5.5	0.9	1.0	7.1	0.4	1.5	2.0	5.1	3.4	0.4	1.1	2.0	0.4	0.7	5.8	1.2	6.7	5.7	5.9	1.4	4.1	8.8	2.7	2.0	2.2	2.9	0.4	20.7	8.0	9.9	21.0	35.4	13.3	5.0	12.4	8.9	4.4	8.7	5.6	17.2	2.6	12.6	16.4	3.7	2.1	19.4	0.5	13.1	2.7	18.5	3.7	8.4	19.0	63.7	7.5	12.4	10.8	15.9	3.5	5.4	2.9	1.2	7.8	7.1	16.5	26.6	0.3	63.3	22.8	13.0	13.3	13.3	20.3	9.2	1.5	9.1	1.5	3.6	11.7	15.8	16.3	9.0	12.1	2.9	12.4	6.1	7.9	4.4	21.0	2.3	0.1	14.3	16.7	23.0	5.6	9.2	8.7	160.3	9.4	40.4	29.8	21.3	25.8	33.8	29.0	31.6	18.2	37.1	17.4	22.1	22.9	28.0	26.3	20.0	38.9	24.6	12.2	14.6	4.5	18.9	17.4	7.1	0.5	5.5	2.0	6.7	4.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C13	"H4.k, H4/k, H4FK, HIST1H4L"	ENSG00000275126	"H4 clustered histone 13"	P62805	6	27873148-27873534	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.1;NB-4: 2.3;REH: 1.0"	"Low region specificity"	"Detected in many"							HPA042201	Approved					NA	NA		25000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"				"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.3	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	1.7	1.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.1	2.3	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.5	0.3	0.1	0.8	0.4	0.7	1.1	2.7	0.2	0.6	0.0	0.8	0.7	1.7	0.5	0.1	0.5	0.3	0.3	0.4	0.3	0.4	1.7	1.1	1.4	1.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C14	"H4/n, H4F2, H4FN, HIST2H4, HIST2H4A"	ENSG00000270882	"H4 clustered histone 14"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.1"	"Cell type enriched"	"Detected in single"	21	"Cardiomyocytes: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 61.9;U-2 OS: 52.8;U-266/70: 50.6"									HPA042201	Approved					NA	NA		25000000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	4.1	5.2	12.6	2.7	15.0	7.3	4.0	48.1	9.5	5.7	9.9	6.4	3.2	4.0	0.0	5.0	7.9	6.5	5.3	7.5	36.1	5.0	5.9	4.7	7.8	8.2	14.1	4.3	6.8	1.3	7.2	2.9	9.2	12.0	0.2	0.5	4.6	4.5	2.5	5.9	5.4	0.6	11.7	7.2	5.2	1.6	33.2	10.2	6.8	2.5	0.5	5.2	6.7	10.6	7.1	41.9	2.2	7.4	8.4	2.7	3.2	3.4	2.8	11.0	5.2	8.3	11.1	2.7	11.9	1.1	3.5	19.8	0.0	7.4	0.4	16.0	23.4	3.0	33.6	3.3	7.7	2.8	2.5	12.5	9.5	3.7	5.7	0.3	1.9	3.2	13.3	27.8	0.6	38.4	10.5	6.9	9.9	12.8	15.9	9.0	5.7	24.1	1.2	2.8	39.5	11.5	61.9	5.9	9.0	1.3	25.7	5.4	0.0	5.1	52.8	7.1	5.7	50.6	46.6	15.7	5.1	8.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	15.0	48.1	9.5	7.5	36.1	8.2	14.1	9.2	11.7	33.2	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
H4C15	"H4/o, HIST2H4B"	ENSG00000270276	"H4 clustered histone 15"	P62805	1	149854045-149861210	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 4.8;SiHa: 7.5;U-266/70: 8.6;U-266/84: 7.6"					"Low region specificity"	"Detected in all"			HPA042201	Supported					NA	Yes		25000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"					"unprognostic (8.20e-2)"					"unprognostic (2.69e-1)"				"unprognostic (1.77e-1)"				2.0	3.2	2.5	0.1	2.5	2.1	1.7	2.4	3.5	2.6	1.3	4.0	1.7	2.2	2.5	1.0	2.8	0.7	2.2	2.5	1.8	2.4	1.7	1.7	1.3	1.6	1.8	1.8	1.6	2.0	4.9	0.9	1.6	3.5	1.0	3.1	1.4	1.1	2.4	2.3	1.7	2.2	2.7	2.3	2.2	0.8	1.6	4.6	2.0	1.1	0.6	2.8	1.5	2.0	0.0	0.0	0.8	0.2	0.8	0.8	0.1	1.4	2.6	0.2	0.0	0.0	0.5	0.8	1.3	0.7	0.2	0.0	0.4	0.0	0.1	1.5	0.5	0.0	3.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	1.1	1.0	1.9	0.0	4.5	0.1	3.1	0.2	0.5	0.1	0.8	0.0	1.1	0.3	0.1	0.3	0.6	4.8	2.9	7.5	0.8	0.3	0.0	1.6	0.1	1.8	0.3	1.8	0.5	0.2	8.6	7.6	1.2	0.7	0.2	1.1	1.8	1.3	1.6	1.4	2.1	2.5	1.8	1.6	1.2	1.9	4.3	1.3	2.3	5.8	1.3	1.2	2.4	2.5	3.4	2.5	2.5	2.4	3.5	2.5	1.8	1.6	1.8	1.6	2.7	1.6	2.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H4C2	"H4/I, H4FI, HIST1H4B"	ENSG00000278705	"H4 clustered histone 2"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 87.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	6	"cerebellum: 87.0"	"Immune cell enriched"	"Detected in many"	6	"neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.0"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA042201	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	0.3	0.0	5.5	0.0	4.2	1.9	0.2	87.0	12.2	0.5	9.6	0.2	0.1	0.1	0.0	0.1	0.4	0.0	0.1	2.5	8.2	0.2	0.4	0.2	0.6	5.2	9.1	0.2	0.1	0.0	0.1	0.1	13.8	0.2	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.0	7.0	0.2	0.2	0.2	15.2	2.0	0.4	0.0	0.1	0.1	0.2	6.2	0.9	0.0	0.1	1.8	0.0	0.0	0.0	1.4	0.1	0.8	0.5	0.3	0.2	0.7	0.2	0.3	0.5	0.2	0.4	0.0	0.5	0.3	1.9	2.4	1.2	1.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.6	0.2	1.4	2.4	1.9	0.4	0.4	0.3	1.7	0.8	1.5	0.0	0.6	0.5	0.3	0.2	1.0	0.0	0.0	0.2	1.2	0.0	0.5	1.2	1.0	1.8	1.4	1.5	1.2	0.7	0.7	0.9	0.0	0.9	1.3	1.7	1.2	1.5	2.7	1.8	1.3	0.7	6.7	1.4	0.8	43.0	0.3	2.4	2.3	1.3	0.5	5.5	4.2	87.0	12.2	2.5	8.2	5.2	9.1	13.8	7.0	15.2	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H4C3	"dJ221C16.1, H4/g, H4FG, HIST1H4C"	ENSG00000197061	"H4 clustered histone 3"	P62805	6	26103933-26104337	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"brain: 238.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 200.9;Cytotrophoblasts: 584.5;Extravillous trophoblasts: 700.1;Hofbauer cells: 264.1;Syncytiotrophoblasts: 220.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 238.7"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5;PC-3: 21.4"									HPA042201	Supported					NA	Yes		25000000	"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	0.2	0.2	28.3	0.9	52.6	5.0	0.2	238.7	33.5	0.4	0.6	1.0	0.3	0.6	0.0	0.7	0.5	0.1	0.1	21.1	37.6	0.6	0.6	0.2	2.1	8.1	28.8	0.4	0.4	0.1	0.2	0.4	19.4	0.2	1.1	0.4	1.8	0.3	0.1	0.3	0.5	0.0	25.9	1.0	0.4	0.6	39.9	3.7	1.2	0.0	1.7	0.8	0.1	39.1	2.3	2.1	0.8	3.3	0.0	0.4	0.0	1.3	1.0	0.7	1.6	3.3	0.6	0.8	1.0	0.4	0.9	1.2	2.5	0.7	0.6	1.9	39.5	1.5	4.5	5.0	1.0	1.8	1.3	1.7	0.0	0.5	0.0	0.0	0.9	0.6	2.3	1.6	0.6	1.1	8.9	4.4	2.1	1.5	21.4	2.5	1.2	3.7	1.4	0.2	2.2	1.4	1.1	1.5	0.9	0.9	1.0	5.4	0.6	2.3	2.4	1.1	1.9	3.1	3.2	4.4	1.4	3.3	1.2	605.5	279.8	218.0	343.5	117.8	331.0	645.7	432.0	285.4	218.9	559.1	496.9	378.6	509.7	325.0	128.7	317.6	322.8	2335.9	28.3	52.6	238.7	33.5	21.1	37.6	8.1	28.8	19.4	25.9	39.9	39.1	25.3	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.9	0.0	0.0	0.0	0.0	584.5	76.4	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	700.1	54.9	0.0	0.0	0.0	0.0	0.0	0.0	264.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	220.3	13.0	0.0	0.0	0.0
H4C4	"H4/b, H4FB, HIST1H4D"	ENSG00000277157	"H4 clustered histone 4"	P62805	6	26188710-26189112	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 33.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.2;HeLa: 5.0;RT4: 8.9"									HPA042201	Supported					NA	NA		25000000	"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	0.1	0.5	10.8	0.0	19.0	0.8	0.8	33.9	11.4	0.3	5.0	0.2	0.0	0.2	0.3	0.6	0.7	0.1	0.2	7.9	3.4	0.2	0.4	0.4	0.2	4.0	3.3	0.1	0.1	0.1	0.3	0.2	6.7	1.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.1	15.4	0.6	0.2	0.4	9.7	2.0	0.5	0.0	0.1	0.0	0.3	5.6	1.0	1.1	0.8	0.0	1.3	0.0	0.5	0.7	0.4	1.9	0.9	1.8	0.4	4.0	0.3	0.0	1.5	0.5	2.3	0.4	0.6	0.3	5.2	0.6	5.0	1.7	0.0	0.4	0.1	0.4	0.0	0.2	0.7	0.0	1.6	0.5	1.3	1.1	0.0	1.9	1.5	2.7	1.4	0.9	0.3	0.4	0.0	0.5	0.5	8.9	0.5	0.3	0.8	0.5	0.5	0.6	0.9	0.3	0.0	0.4	2.9	0.3	1.1	1.2	1.2	0.0	0.8	1.1	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.2	0.2	3.4	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.3	10.8	19.0	33.9	11.4	7.9	3.4	4.0	3.3	6.7	15.4	9.7	5.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H4C5	"H4/j, H4FJ, HIST1H4E"	ENSG00000276966	"H4 clustered histone 5"	P62805	6	26204552-26206038	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 69.4"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.7;dendritic cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 4.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 69.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 6.1;U-266/70: 11.3"									HPA042201	Supported					NA	NA		25000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	0.8	0.5	12.1	0.4	14.5	2.1	0.8	69.4	14.4	3.8	0.5	1.9	0.9	0.5	0.8	2.6	2.7	0.2	1.1	10.8	8.1	3.1	1.0	1.0	0.5	3.9	3.2	2.8	0.5	0.2	2.2	0.5	6.9	7.5	0.5	1.5	1.3	0.3	0.0	1.9	0.9	0.2	15.2	1.5	1.6	2.0	7.2	1.9	1.5	0.0	0.4	0.6	3.6	16.8	1.1	0.7	1.3	3.1	0.5	0.0	0.7	1.1	0.3	0.5	0.4	0.4	1.1	0.4	1.5	0.3	0.7	1.9	0.7	0.1	0.7	0.9	0.8	0.3	1.5	0.7	0.0	0.5	1.2	0.3	0.0	0.4	0.3	0.3	0.4	1.0	2.3	2.6	0.1	0.4	6.1	2.8	1.3	0.5	1.0	2.7	1.4	2.7	0.5	0.4	3.7	0.9	0.8	1.3	0.4	0.4	1.2	0.5	0.5	1.5	2.1	0.4	0.9	11.3	4.7	1.7	0.3	1.1	1.1	2.7	2.1	1.8	2.0	1.8	2.9	2.5	3.0	2.0	3.1	5.4	3.2	2.6	2.6	2.3	5.5	2.7	2.0	1.2	12.1	14.5	69.4	14.4	10.8	8.1	3.9	3.2	6.9	15.2	7.2	16.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0
H4C6	"H4, H4/c, H4FC, HIST1H4F"	ENSG00000274618	"H4 clustered histone 6"	P62805	6	26240393-26240793	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 7.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 5.1;white matter: 7.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.5;REH: 1.9"									HPA042201	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			0.0	0.0	0.4	0.0	0.5	0.9	0.0	0.5	5.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	4.5	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.5	3.0	2.4	2.3	5.5	3.9	4.0	3.8	6.9	3.2	2.3	10.7	2.1	2.0	6.4	1.1	1.5	0.4	0.5	0.5	5.1	0.9	0.7	1.3	0.7	0.7	1.5	0.6	7.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H4C7	"H4/l, H4FL, HIST1H4G"	ENSG00000275663	"H4 clustered histone 7"	Q99525	6	26246611-26246996	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported					NA	NA									"HPA042201: AB_2677898"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C8	"H4/h, H4FH, HIST1H4H"	ENSG00000158406	"H4 clustered histone 8"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 51.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.8;dendritic cells: 3.4;Extravillous trophoblasts: 1.5;Hofbauer cells: 1.8;Plasma cells: 1.3;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 51.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 4.2;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 17.5;U-266/84: 29.8"	"Low region specificity"	"Detected in single"							HPA042201	Supported					NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	0.5	0.2	5.7	0.1	5.2	0.9	0.3	51.4	8.6	1.3	1.9	0.9	0.6	0.2	0.0	1.2	0.2	0.7	0.6	4.5	7.3	0.2	0.6	0.5	0.0	5.3	4.9	0.4	0.3	0.0	0.1	0.2	4.6	0.4	0.0	0.0	0.3	0.0	2.5	0.8	0.2	0.0	9.5	0.1	0.2	0.4	5.5	1.1	0.3	0.0	0.7	0.2	0.6	18.4	3.1	3.6	0.4	0.4	1.0	0.0	2.4	4.7	0.0	0.0	0.0	3.5	0.9	2.1	5.8	0.3	0.1	1.9	0.0	0.7	0.3	3.6	1.5	3.8	8.3	4.2	2.2	1.4	2.7	2.7	0.0	1.7	1.5	0.0	3.5	0.9	4.2	0.0	1.9	3.5	17.5	10.9	1.6	0.2	3.6	11.5	2.3	1.4	0.0	3.1	2.8	1.2	4.9	4.9	2.4	0.0	6.0	5.7	0.8	2.5	6.3	1.7	7.7	2.9	29.8	3.1	1.1	7.4	2.6	0.0	0.2	4.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	8.9	0.0	0.0	0.5	0.0	1.1	5.7	5.2	51.4	8.6	4.5	7.3	5.3	4.9	4.6	9.5	5.5	18.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0
H4C9	"H4/m, H4FM, HIST1H4I"	ENSG00000276180	"H4 clustered histone 9"	P62805	6	27138588-27139881	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 75.5;SiHa: 43.8;U-2 OS: 73.3;U-266/84: 78.9"									HPA042201	Approved					NA	NA		25000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"	"unprognostic (2.49e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (6.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-2)"	1.2	3.3	0.3	3.7	0.5	3.2	0.6	0.2	1.5	0.6	0.0	1.9	3.8	2.0	0.0	2.6	0.5	2.3	1.5	0.6	0.6	0.5	2.7	1.7	4.2	0.8	0.8	1.6	3.7	0.0	0.3	2.5	0.7	3.0	0.2	0.2	2.4	0.0	0.4	1.3	4.0	0.0	0.9	3.5	4.0	2.7	0.6	1.0	3.6	0.0	0.1	1.4	1.1	0.7	4.2	8.5	4.6	3.0	3.2	0.4	5.1	8.1	0.3	0.4	0.3	8.3	6.0	1.3	22.7	0.1	12.5	6.5	0.8	0.2	0.2	5.8	12.5	3.0	13.4	0.4	0.5	2.5	14.8	1.1	0.3	0.0	0.4	7.7	0.4	2.9	75.5	22.2	0.0	12.9	3.8	5.6	1.9	30.2	5.3	3.4	2.7	21.3	0.2	2.2	15.4	5.6	43.8	19.8	5.1	5.2	37.9	1.8	2.7	5.6	73.3	6.8	0.8	22.2	78.9	14.5	3.3	16.8	5.9	14.4	3.0	17.4	1.7	2.4	1.4	5.3	1.5	1.7	3.0	6.6	1.8	1.9	16.5	3.0	5.9	6.4	4.1	3.5	0.3	0.5	0.2	1.5	0.6	0.6	0.8	0.8	0.7	0.9	0.6	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
H6PD	"GDH, H6PDH"	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234774-9271337	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		140000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	29.0	30.5	7.5	12.6	11.6	9.7	23.0	8.2	9.0	22.6	18.8	15.1	11.2	25.7	14.4	13.5	28.3	12.6	18.9	6.4	7.8	11.5	94.5	20.3	12.4	14.4	10.8	44.9	18.9	10.6	12.7	14.1	11.4	19.5	9.1	4.2	56.2	13.1	48.3	35.7	16.8	16.6	9.6	14.5	18.7	8.1	11.4	13.1	14.7	21.0	11.4	16.7	16.5	10.9	9.9	8.0	6.8	25.5	68.9	78.9	6.4	9.8	24.0	7.1	10.9	1.5	20.1	10.9	11.2	15.3	9.1	10.3	1.8	4.8	10.3	32.8	2.2	0.0	2.8	6.7	38.6	3.5	4.1	77.7	9.1	17.2	11.1	15.6	32.9	5.9	2.9	18.2	14.0	5.7	3.9	8.2	3.7	7.5	4.6	1.2	0.9	9.3	9.1	4.0	2.3	12.0	12.9	10.0	12.0	4.7	7.5	17.4	32.9	24.3	3.9	6.2	2.8	24.1	7.6	2.5	40.8	15.6	15.7	1.6	2.3	0.3	1.6	2.4	1.3	1.3	1.2	1.5	1.0	1.6	1.2	1.1	1.5	1.2	2.3	1.4	1.1	1.5	7.5	11.6	8.2	9.0	6.4	7.8	14.4	10.8	11.4	9.6	11.4	10.9	24.1	25.6	29.5	17.9	10.1	14.3	13.2	16.9	18.8	19.6	10.3	8.3	17.5	58.6	18.8	20.2	27.1	11.2	9.1	16.6	0.0	22.9	0.8	11.2	36.0	19.8	7.8	9.0	8.4	21.3	8.5	33.6	5.6	15.5	3.8	29.9	19.6	164.0	12.1	16.8	9.1	15.1	8.2	25.4	11.4	2.9	48.1	14.2	12.4	13.1	51.6	10.4	19.6	16.6	18.6	20.0	17.0	36.9	4.5	17.2	23.1	7.4	19.1	10.9	0.0	50.5	11.7	4.6	5.5	10.5	12.8	5.9	11.6	26.1	23.6	14.2
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 437.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 124.4;Hepatocytes: 221.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 64.7;RPTEC TERT1: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000		"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.9	0.0	0.0	3.1	2.9	1.7	0.0	2.2	36.0	3.8	0.1	0.0	14.2	437.3	0.8	0.0	0.0	0.0	0.0	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.1	12.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	64.7	0.0	0.0	0.1	0.0	50.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	124.4	0.0	1.8	0.0	0.0	0.0	0.0	3.9	31.4	0.5	10.8	0.8	0.4	0.0	5.3	1.0	3.9	0.0	0.0	17.9	6.5	0.0	0.0	5.3	221.4	1.0	0.0	0.0	0.2	0.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	12.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450169-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3"	"Group enriched"	"Detected in many"	10	"Early spermatids: 224.6;Late spermatids: 808.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	21.9	12.8	62.7	7.0	70.1	1.8	16.8	55.1	73.3	16.1	40.8	19.2	3.0	13.5	7.0	7.6	13.5	8.8	28.1	62.3	63.9	27.0	7.6	10.8	8.3	66.2	65.4	15.6	6.6	12.9	22.6	3.5	66.1	12.5	4.2	16.0	6.2	11.1	16.8	9.5	10.4	9.7	59.5	7.5	12.5	43.9	61.3	4.6	13.7	13.4	5.3	18.4	13.0	68.9	14.8	16.6	20.6	22.3	44.7	37.9	14.6	19.5	21.8	14.5	15.7	24.9	24.0	7.5	9.4	29.4	45.9	10.6	17.4	3.7	11.6	9.0	10.3	2.9	7.8	42.0	22.7	0.7	3.0	15.5	6.7	16.5	13.0	21.9	10.4	8.4	3.4	21.6	26.4	15.2	0.3	4.6	9.6	20.5	15.8	7.6	17.9	0.3	24.8	6.4	13.0	8.8	10.6	6.2	32.5	15.2	4.5	3.2	17.8	19.8	4.6	36.6	16.8	13.2	14.0	3.3	15.9	5.9	29.8	0.0	0.0	0.0	0.5	0.1	0.5	1.9	1.6	1.3	0.0	1.1	1.1	1.1	0.1	0.4	0.3	0.0	1.3	0.2	62.7	70.1	55.1	73.3	62.3	63.9	66.2	65.4	66.1	59.5	61.3	68.9	22.2	0.0	7.4	27.1	5.9	11.5	10.8	0.9	4.0	22.6	3.8	6.9	11.0	14.3	5.5	18.4	0.0	2.5	5.5	0.9	17.6	4.7	224.6	7.3	9.0	14.6	13.1	0.8	47.4	5.8	7.4	13.3	1.5	8.1	1.3	13.0	15.0	6.3	6.6	23.5	33.2	0.9	4.1	1.3	9.3	808.8	13.7	6.0	17.8	10.3	2.7	22.2	3.1	18.6	37.5	6.3	0.0	23.7	5.1	10.0	1.1	43.7	1.8	15.6	6.6	5.8	26.4	26.8	15.4	0.9	8.0	1.4	13.3	3.0	1.3	6.0
HACD2	PTPLB	ENSG00000206527	"3-hydroxyacyl-CoA dehydratase 2"	Q6Y1H2	3	123490820-123585053	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 249.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019282	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"			"CAB019282: "	"unprognostic (3.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.36e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (6.90e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.59e-2)"	68.3	11.2	16.2	16.5	23.5	8.7	22.8	19.3	20.5	14.6	8.4	26.7	29.9	16.6	17.7	18.9	13.1	16.7	10.7	16.0	19.7	24.1	48.4	19.4	21.3	19.4	17.1	12.5	17.4	21.3	7.7	15.5	21.0	29.5	27.7	13.8	16.4	12.9	5.3	32.5	25.8	16.7	17.8	12.3	21.2	19.0	16.6	14.9	19.4	8.4	28.6	14.7	17.1	33.9	76.9	42.7	28.8	21.1	88.3	19.5	106.5	53.7	22.2	54.6	39.4	87.9	66.1	44.1	37.8	51.7	63.3	162.8	52.3	67.4	57.3	28.3	17.5	30.8	37.3	68.9	28.7	41.2	29.4	27.2	169.7	26.5	73.6	85.2	29.0	30.0	6.3	42.7	33.4	59.8	19.7	12.3	37.2	92.7	37.4	29.6	31.6	46.9	66.5	48.6	50.5	15.8	249.9	52.7	34.6	41.5	54.9	21.1	22.7	56.8	42.2	57.5	53.1	25.2	34.7	35.9	25.5	28.5	31.1	0.7	1.6	1.1	1.5	1.2	2.2	1.5	1.9	1.9	2.8	2.0	1.8	1.7	0.5	1.3	1.0	1.6	2.5	1.2	16.2	23.5	19.3	20.5	16.0	19.7	19.4	17.1	21.0	17.8	16.6	33.9	19.8	6.4	43.1	8.8	17.5	0.0	28.7	0.0	23.9	9.5	27.8	21.5	13.5	22.8	15.5	46.0	6.2	21.5	18.9	29.4	7.9	15.4	19.8	22.3	14.9	17.0	15.8	15.4	34.3	18.7	16.5	17.3	25.0	35.7	3.8	17.1	16.8	47.5	22.9	1.7	29.7	16.4	0.0	24.2	0.0	10.4	11.5	25.1	0.0	12.2	19.6	14.5	19.6	25.1	32.6	19.6	16.6	17.7	15.0	40.6	33.8	17.8	2.9	13.9	6.6	14.8	11.3	10.5	24.8	35.1	0.0	6.7	14.2	11.8	19.9	33.2
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578349	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	23.1	84.1	56.1	18.5	57.1	17.3	74.4	64.6	67.5	40.2	73.2	30.0	28.9	29.9	43.0	19.2	32.4	34.1	11.8	54.3	87.8	79.6	119.1	30.3	18.8	68.3	79.6	47.8	29.8	61.5	44.2	37.2	87.2	41.6	34.3	54.0	28.6	34.3	6.9	27.7	29.2	28.1	70.0	21.2	68.7	34.6	88.3	29.0	70.8	7.8	20.3	43.0	17.8	75.8	88.9	194.4	211.3	106.2	130.3	78.0	99.8	95.9	82.4	106.6	119.6	149.9	129.1	110.8	81.8	104.7	132.6	237.9	344.4	80.1	94.8	61.9	191.8	88.1	88.7	165.3	65.9	110.6	64.9	80.3	58.7	73.3	52.5	102.7	105.5	65.1	117.5	40.8	174.3	105.6	82.5	86.0	180.6	235.3	65.4	91.8	178.9	125.0	152.1	151.2	126.8	111.9	103.6	114.9	110.5	197.5	117.1	57.9	84.2	134.4	117.6	66.9	134.9	79.1	251.2	154.5	89.7	105.8	82.6	8.5	7.5	2.5	31.7	11.2	36.1	23.7	28.6	30.2	13.2	22.2	33.0	32.9	1.0	23.2	12.7	17.4	24.6	22.7	56.1	57.1	64.6	67.5	54.3	87.8	68.3	79.6	87.2	70.0	88.3	75.8	63.6	64.1	64.8	84.5	18.7	0.0	60.5	0.0	76.2	121.3	94.8	64.5	9.9	62.9	27.9	176.6	100.1	189.1	23.8	6.1	25.4	71.3	107.2	62.8	76.2	51.8	43.7	67.3	57.5	46.3	124.4	62.7	73.4	39.8	16.4	127.0	42.1	165.2	51.2	139.7	97.1	26.3	0.0	23.1	0.0	32.5	87.3	22.2	0.0	29.0	5.2	89.8	16.5	57.8	66.7	32.1	18.2	88.4	28.9	71.5	28.3	56.2	36.5	83.7	78.9	40.9	41.9	156.9	110.3	54.3	0.0	113.1	22.3	136.2	45.1	78.7
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999509-21031640	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 60.7;Kupffer cells: 78.8;Macrophages: 99.3;monocytes: 87.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.2;HDLM-2: 10.8;TIME: 8.6;U-937: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	1.9	2.8	1.3	3.5	1.2	12.0	2.4	2.0	2.5	5.3	2.7	4.2	2.0	3.5	1.1	2.6	3.9	3.0	0.8	1.2	1.1	2.0	1.1	8.3	4.4	1.1	0.7	3.9	0.5	1.1	0.6	6.4	0.9	2.7	3.1	1.3	1.4	2.2	0.4	2.5	2.9	4.2	0.5	3.9	2.0	1.0	1.0	5.2	2.1	1.5	4.0	2.7	1.8	1.5	4.2	1.2	0.4	0.1	0.0	0.1	0.1	3.8	17.2	3.0	3.4	0.0	0.0	3.7	2.1	7.4	0.0	1.1	0.2	1.6	3.8	10.8	0.1	0.0	1.3	0.0	2.3	3.1	3.2	6.6	6.7	2.7	0.0	0.0	1.0	4.3	0.0	2.1	0.6	0.1	0.0	4.3	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.7	0.0	0.9	0.3	0.0	2.4	3.0	5.9	8.6	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	13.4	0.1	21.4	8.8	14.4	2.5	10.9	2.4	1.4	2.7	2.8	10.2	1.3	1.9	2.7	12.4	3.7	11.3	1.1	3.7	5.0	1.3	1.2	2.0	2.5	1.2	1.1	1.1	0.7	0.9	0.5	1.0	1.5	6.3	48.1	6.1	2.3	15.8	0.0	10.7	0.0	16.5	1.6	5.4	5.8	2.1	2.8	11.2	12.9	0.0	12.2	26.1	0.1	5.9	0.6	0.5	33.0	8.4	5.6	0.0	27.1	4.3	0.5	37.9	23.1	4.1	5.6	3.8	17.7	11.7	1.0	60.7	0.0	2.4	0.1	0.0	78.8	0.0	0.4	3.7	99.3	0.0	11.2	87.7	11.0	36.0	0.0	0.4	0.1	0.1	1.2	20.1	3.7	0.0	9.3	48.8	1.6	13.1	4.6	13.4	0.3	7.8	11.7	0.0	5.1	33.1	11.9	0.3	4.5
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560699-15601852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 117.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 117.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	14.4	12.0	7.5	8.2	7.8	11.6	14.6	10.4	10.5	9.1	7.9	10.0	56.6	8.3	16.6	7.5	10.8	8.8	11.0	7.6	7.0	26.0	51.8	9.7	14.1	7.4	7.2	7.5	15.2	20.0	7.8	7.8	7.0	10.8	12.0	12.2	9.1	9.1	17.6	10.6	27.7	9.5	7.4	11.4	13.2	26.7	6.8	13.9	20.4	10.6	14.5	10.3	6.4	10.0	15.1	28.6	8.2	30.7	13.4	12.4	82.3	14.2	22.0	26.6	26.3	27.3	14.3	14.6	9.7	18.7	10.5	10.4	18.7	25.3	23.8	13.6	36.4	25.4	17.7	24.7	20.3	30.5	23.1	13.7	16.2	37.9	16.6	8.3	31.4	18.3	24.0	21.2	22.9	28.7	14.0	12.6	19.7	19.7	29.7	14.4	21.5	19.6	26.4	20.2	9.6	12.3	22.4	19.0	25.2	12.8	8.5	25.4	22.5	14.1	14.6	17.4	24.7	27.2	50.9	28.5	27.1	26.4	17.2	117.3	16.0	18.3	14.4	20.1	21.2	15.4	15.5	18.0	16.0	21.2	14.8	16.1	3.4	24.1	24.2	10.2	19.8	13.0	7.5	7.8	10.4	10.5	7.6	7.0	7.4	7.2	7.0	7.4	6.8	10.0	12.4	9.6	17.3	34.9	22.1	10.3	12.0	13.5	20.5	19.3	9.1	10.2	6.4	14.3	15.6	11.0	29.2	27.2	15.7	6.1	13.7	16.0	66.6	12.6	6.0	12.3	9.1	8.2	67.4	25.2	18.0	12.0	11.2	5.4	13.3	12.7	8.9	24.3	13.2	13.5	55.8	7.5	10.2	9.3	8.1	56.8	23.3	8.8	12.4	25.3	19.3	24.8	8.2	40.7	38.8	14.5	11.2	15.4	21.4	9.0	41.9	39.7	29.8	38.3	6.6	9.0	11.2	51.1	24.4	8.6	7.1	18.9	19.4	15.1	10.6	7.9
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035174	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 280.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria		No	Yes		1000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	143.0	54.1	23.2	20.9	23.8	27.4	74.9	24.6	26.3	37.9	33.5	101.2	84.4	49.8	24.9	34.2	56.2	24.0	175.6	22.9	27.2	140.2	225.5	22.8	22.2	24.7	26.3	54.3	42.1	40.2	18.0	13.7	26.0	35.4	90.8	10.4	55.9	42.4	249.7	28.0	89.1	72.7	26.0	18.0	60.7	27.9	24.9	76.0	37.7	280.3	28.5	34.1	28.7	28.0	32.2	27.9	64.3	46.2	149.2	48.2	27.0	43.1	68.5	49.6	48.9	21.2	60.9	185.0	23.5	38.8	34.6	42.0	85.5	64.5	55.5	49.6	37.2	39.9	50.5	48.9	24.3	88.2	17.0	50.4	34.1	35.1	32.3	41.4	34.4	127.1	53.1	98.7	57.3	58.9	163.6	36.7	29.0	147.8	30.1	113.5	84.3	89.2	54.5	129.4	73.2	43.1	41.1	161.9	45.6	37.0	77.4	70.8	20.6	35.5	18.9	48.5	26.7	52.1	63.3	80.6	47.0	60.2	27.0	0.0	11.1	11.4	17.2	14.2	22.1	31.4	19.5	20.7	36.8	27.1	22.4	22.2	1.2	36.7	20.1	41.7	17.7	16.3	23.2	23.8	24.6	26.3	22.9	27.2	24.7	26.3	26.0	26.0	24.9	28.0	17.3	28.9	33.8	11.1	25.7	15.6	54.2	65.8	41.5	6.9	46.5	56.1	225.6	52.9	48.1	35.0	4.2	41.0	18.3	164.7	160.4	43.3	196.8	41.4	22.6	17.5	32.4	65.6	15.1	32.2	44.7	28.2	52.5	26.1	10.8	63.9	21.0	272.4	116.5	6.7	18.9	93.3	36.7	37.8	11.8	108.5	46.3	25.3	21.4	12.2	15.3	26.8	8.2	9.5	9.9	23.0	100.8	35.3	32.0	33.9	383.0	318.8	70.8	6.8	39.5	21.7	38.2	22.4	20.3	64.0	18.2	17.0	19.6	66.3	194.2	49.1
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 502.5"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		470000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	105.0	125.3	57.7	31.1	60.7	46.3	94.9	65.0	69.6	72.6	59.1	108.4	115.0	61.8	30.7	90.1	60.1	32.4	330.2	52.8	61.9	99.0	156.7	66.9	35.3	64.4	62.2	77.8	101.4	95.0	57.4	39.2	64.2	60.2	76.1	14.9	77.9	33.4	502.5	95.7	106.2	57.4	61.8	68.4	93.8	49.0	62.4	46.7	59.5	300.7	58.5	79.1	73.6	67.2	105.7	88.1	58.4	90.8	221.1	139.9	51.5	80.6	84.7	78.5	67.7	114.7	104.1	71.7	50.2	138.4	78.6	66.8	103.4	152.6	72.5	139.1	103.6	103.3	86.2	197.9	73.3	132.2	69.2	142.7	101.6	112.4	109.3	82.8	127.7	70.4	140.2	133.2	101.1	128.2	63.4	137.7	50.1	77.5	134.1	52.9	128.5	143.7	90.3	125.3	41.9	85.1	94.6	104.6	102.4	44.5	52.2	125.8	127.1	48.8	70.7	69.9	58.0	44.8	86.5	113.4	77.6	150.2	56.2	22.5	84.0	33.5	31.8	92.3	39.1	40.5	36.8	38.7	80.8	31.2	42.6	40.1	20.9	38.8	86.1	31.3	50.9	89.9	57.7	60.7	65.0	69.6	52.8	61.9	64.4	62.2	64.2	61.8	62.4	67.2	122.4	89.8	99.0	47.0	101.2	89.0	137.5	139.9	97.3	35.6	89.7	96.4	349.9	82.9	128.0	77.3	52.1	182.0	95.1	242.1	131.0	120.8	39.2	73.3	121.1	99.1	91.4	155.9	22.8	108.5	94.7	96.1	100.4	85.5	139.9	140.3	84.3	185.1	163.0	20.2	28.2	156.5	89.5	136.8	106.0	74.3	92.6	145.0	81.8	12.2	170.7	65.4	93.7	30.7	37.4	90.0	195.6	84.2	90.4	76.2	527.4	182.5	84.8	62.3	52.6	129.9	109.6	147.9	54.9	136.5	103.3	129.2	100.5	154.7	216.7	104.4
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290465	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 793.3;skeletal muscle: 950.6;tongue: 1097.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1167.5;Distal tubular cells: 520.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		61000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	127.0	224.7	120.6	51.1	135.4	58.8	91.3	146.4	138.1	65.2	128.0	110.7	224.2	55.9	73.7	101.3	68.8	64.3	793.3	109.0	138.1	231.4	324.8	64.7	54.9	135.9	141.6	78.4	83.7	209.5	48.1	65.6	139.6	77.1	113.2	63.0	104.8	75.0	950.6	74.4	184.4	79.0	141.4	75.8	109.0	67.1	143.3	53.1	90.8	1097.1	62.5	89.2	64.1	152.8	108.2	83.2	56.6	102.2	342.1	190.1	57.9	89.0	134.6	89.0	86.8	100.5	101.7	53.9	60.8	145.3	100.1	82.8	95.2	124.8	109.2	121.1	83.1	123.6	44.9	194.2	145.9	100.6	90.0	183.7	201.6	92.7	149.0	151.0	168.2	81.0	105.2	83.9	189.5	78.0	57.1	190.7	39.8	160.2	89.0	61.7	188.3	103.2	183.3	148.9	27.2	93.7	151.7	169.8	239.5	68.5	105.4	177.9	118.0	83.5	86.9	79.3	65.1	62.6	101.1	94.7	95.5	158.4	84.4	95.7	168.1	66.4	45.2	150.3	57.6	65.5	61.3	56.6	154.2	49.7	55.8	51.3	72.7	88.2	123.3	51.8	94.7	135.6	120.6	135.4	146.4	138.1	109.0	138.1	135.9	141.6	139.6	141.4	143.3	152.8	106.5	48.1	36.5	63.0	48.3	62.1	136.5	183.3	49.5	29.3	49.5	52.3	1167.5	104.4	107.7	97.5	56.3	227.9	42.4	129.5	520.4	124.0	93.4	59.5	49.0	75.2	74.9	85.2	32.7	57.2	75.2	79.5	53.0	60.2	62.8	94.2	69.9	277.6	139.6	13.5	33.0	93.4	114.0	98.1	67.4	99.7	56.5	78.1	88.9	27.2	110.2	65.0	32.0	35.2	47.5	58.4	134.8	62.8	37.1	60.5	376.0	321.1	73.5	80.0	72.3	72.9	80.7	120.4	49.4	53.8	54.7	186.6	45.2	194.0	113.5	110.3
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827157	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 378.7;Proximal tubular cells: 501.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	41.2	109.0	81.5	20.2	84.2	82.1	35.1	82.7	103.9	22.8	78.9	53.7	45.3	24.6	31.1	29.0	28.5	21.9	138.6	89.9	83.8	100.1	236.2	39.2	24.6	82.8	80.2	22.0	63.5	54.0	72.7	23.1	83.7	33.5	23.3	32.2	32.5	37.7	198.8	31.2	44.8	24.7	80.1	35.2	52.9	91.7	84.0	35.8	35.1	156.2	18.4	34.8	24.6	87.6	31.1	46.1	40.9	46.5	35.1	13.8	37.0	38.1	35.2	57.7	46.1	23.7	26.5	6.4	76.5	32.9	39.6	33.2	39.1	38.2	17.2	64.5	63.4	12.0	47.9	69.3	50.2	15.7	62.6	16.9	80.6	28.8	19.6	50.6	50.1	79.8	16.1	56.3	18.3	51.2	41.1	34.0	15.7	32.0	42.3	34.2	25.8	73.6	74.5	13.8	54.7	47.4	41.8	52.9	84.9	30.8	38.7	52.0	38.7	17.5	21.5	36.9	44.6	63.3	64.7	19.8	29.8	14.5	28.5	37.3	33.3	64.9	26.0	59.1	19.0	31.3	34.0	27.3	30.7	30.4	32.0	27.4	29.7	25.5	88.2	64.8	42.8	30.3	81.5	84.2	82.7	103.9	89.9	83.8	82.8	80.2	83.7	80.1	84.0	87.6	46.2	9.6	39.0	11.8	33.7	23.8	45.1	59.7	12.0	117.1	39.5	31.1	84.2	65.8	39.7	46.0	64.6	52.4	43.2	60.9	158.5	45.6	193.1	75.0	12.1	35.3	39.6	378.7	24.6	38.3	38.5	25.6	23.9	35.5	30.4	36.0	41.0	186.9	76.2	138.0	22.2	41.2	93.6	49.0	41.6	60.1	46.9	47.6	55.2	12.2	50.1	95.2	64.9	7.1	19.7	49.7	68.8	54.9	50.4	48.3	168.9	501.7	70.2	117.0	72.3	33.3	61.1	245.2	68.3	29.1	45.6	68.7	44.1	45.3	39.9	49.9
HAGHL	MGC2605	ENSG00000103253	"Hydroxyacylglutathione hydrolase like"	Q6PII5	16	726936-735525	"Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.8;Bipolar cells: 53.5;Endometrial ciliated cells: 40.5;Hofbauer cells: 41.0;Respiratory ciliated cells: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.3;U-266/70: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074402	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA074402: AB_2732254"	"unprognostic (6.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.92e-2)"	"unprognostic (5.36e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.41e-1)"	3.3	2.7	7.6	2.1	12.8	1.4	3.0	13.3	11.5	6.6	20.1	5.2	0.8	4.7	0.0	2.6	17.9	0.7	13.0	5.9	9.5	10.2	1.9	7.6	3.1	12.4	10.7	4.0	2.1	1.7	21.9	0.4	10.6	5.7	0.0	0.5	3.7	0.9	0.5	3.4	13.6	0.1	12.2	15.2	3.5	8.5	10.5	2.0	3.5	0.1	1.1	4.1	3.8	12.5	4.4	4.4	0.8	4.9	0.9	2.0	3.9	4.1	1.7	0.7	0.6	2.0	5.3	9.6	5.5	0.3	1.2	5.9	0.9	1.3	0.1	26.3	3.7	3.1	11.4	3.6	4.6	12.1	8.5	3.4	1.2	0.0	1.2	1.4	0.5	7.8	5.5	7.5	1.0	26.5	0.3	16.5	5.6	4.3	8.8	6.3	2.7	49.3	1.5	1.2	19.5	11.6	1.9	15.1	17.8	0.1	9.0	19.5	4.3	4.2	6.5	1.5	2.2	60.3	8.6	14.2	6.0	11.4	8.1	0.0	0.7	1.0	3.6	0.3	4.1	8.8	2.9	4.2	0.9	2.1	0.8	2.7	0.0	4.3	0.1	3.5	3.4	2.2	7.6	12.8	13.3	11.5	5.9	9.5	12.4	10.7	10.6	12.2	10.5	12.5	1.1	3.2	0.6	43.8	19.7	1.1	2.0	16.2	0.6	53.5	6.3	10.9	10.6	0.0	7.1	3.7	0.0	0.5	10.4	1.6	35.2	2.4	6.6	40.5	7.9	1.4	3.6	10.9	24.6	0.0	1.4	2.8	3.6	1.9	8.2	0.6	1.1	0.5	41.0	11.8	15.4	2.6	4.1	6.9	3.2	18.4	6.8	10.4	19.6	6.5	5.9	10.6	13.4	6.6	30.9	3.2	1.2	6.0	5.7	10.0	0.0	9.0	65.8	9.9	0.0	0.5	3.3	8.5	6.8	0.8	0.3	0.4	12.8	0.9	1.7	0.9
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	2.9	0.1	11.5	2.2	0.1	0.4	0.8	0.1	0.5	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	198.2	2.3	0.5	0.1	0.1	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.1	0.8	0.5	0.0	7.6	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.2	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 24.3;intestine: 66.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.8"	"Region enriched"	"Detected in single"	4	"thalamus: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SH-SY5Y: 119.5;SuSa: 212.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: AB_10796563, HPA075313: "			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	4.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	3.7	0.0	0.0	0.0	0.0	0.5	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.3	12.3	0.0	0.0	0.0	0.3	1.5	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	119.5	0.0	0.0	0.0	212.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	15.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.5"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5;stomach cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"SH-SY5Y: 410.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.9	28.0	0.0	5.4	0.0	0.0	2.1	0.5	0.0	22.2	0.0	60.5	2.5	33.4	0.3	1.0	16.0	16.2	36.8	0.0	0.0	0.1	5.5	0.0	0.2	0.0	0.0	15.3	4.1	0.0	0.1	20.9	0.2	1.3	4.4	0.0	0.8	1.0	0.2	1.5	11.0	27.3	0.0	1.1	22.1	0.4	0.0	0.4	1.5	1.1	0.8	12.4	5.3	0.0	0.0	0.1	0.0	0.0	16.6	7.7	0.3	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.3	0.0	0.1	1.7	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	410.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	4.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.2	0.0	0.1	0.1	100.3	2.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.2	9.0	317.1	2.7	0.0	0.0	0.0	0.4	1.4	30.4	0.0	5.3	0.0	0.0	6.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	2.3	0.9	39.4	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.9	0.1	0.3	0.2	0.3	2.3	1.3	0.6	0.0	0.0
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	583	"liver: 607.8"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 301.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049552, HPA072442"	Enhanced					NA	NA		240000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	607.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	301.4	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.4"	"Cell type enriched"	"Detected in many"	4	"Glandular and luminal cells: 66.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"REH: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023394, HPA076992"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoli	"HPA023394: AB_1850492, HPA076992: AB_2686822"	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.6	1.5	24.8	0.3	18.9	0.1	1.0	14.8	21.6	14.5	10.2	2.1	2.7	3.4	1.6	1.1	2.6	1.5	0.1	18.3	58.8	3.3	0.4	0.9	0.2	26.7	26.4	1.2	1.0	0.0	11.6	1.5	24.5	1.9	0.5	0.8	1.5	1.3	0.2	1.6	1.5	0.6	20.3	3.5	11.0	2.1	68.4	2.8	5.0	0.1	0.2	0.5	1.9	16.8	0.2	3.1	1.4	3.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.9	0.2	0.2	1.1	0.2	0.5	13.1	6.7	0.5	0.0	0.0	3.4	0.0	1.8	0.1	0.3	0.0	0.6	0.0	1.6	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	1.6	18.7	0.8	96.0	0.0	3.7	0.6	1.0	0.4	0.1	0.7	0.4	0.1	1.5	2.4	0.0	0.0	0.0	1.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	24.8	18.9	14.8	21.6	18.3	58.8	26.7	26.4	24.5	20.3	68.4	16.8	1.1	0.0	1.7	3.3	0.3	3.1	7.3	1.0	6.8	1.6	1.6	6.7	3.6	0.0	1.9	0.0	2.1	1.5	0.5	1.1	0.0	0.3	0.5	11.5	7.6	3.2	0.0	0.0	1.0	0.9	0.7	3.4	7.7	66.5	0.0	0.2	1.4	0.8	0.5	0.0	5.4	0.6	4.1	0.6	2.2	0.6	0.3	1.2	0.0	0.0	0.4	0.6	2.1	14.6	0.3	1.5	0.2	0.7	0.3	5.3	0.2	0.2	1.7	1.8	0.0	10.6	2.3	0.1	4.7	8.4	3.1	15.7	0.9	0.1	1.1	3.5
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83720855	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 75.0"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 146.7;Granulosa cells: 43.2;Inhibitory neurons: 35.6;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"PC-3: 152.4;SuSa: 70.1;TIME: 91.8;U-2 OS: 139.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	0.3	0.8	0.7	0.0	0.1	1.1	0.9	0.1	0.0	9.0	7.2	0.6	0.3	2.1	0.0	0.8	3.9	0.6	2.7	0.1	0.0	0.5	0.0	0.9	1.0	0.5	0.5	0.2	0.0	75.0	0.6	0.9	11.1	0.1	0.5	0.0	0.0	0.3	10.8	0.5	0.3	0.2	4.8	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.0	3.4	0.0	152.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	70.1	0.1	0.0	91.8	0.0	139.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.9	0.6	2.7	0.9	1.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.1	0.5	6.9	0.0	0.0	0.5	0.0	10.6	146.7	0.0	0.1	0.0	43.2	0.0	0.0	10.6	0.0	35.6	2.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	23.7	0.1	3.8	0.4	0.0
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619331-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 270.8"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocytes: 202.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	0.7	0.3	52.0	0.0	147.5	0.0	0.5	179.7	74.3	0.8	16.4	0.5	0.8	2.7	0.0	0.1	2.6	0.0	1.7	51.3	84.9	0.5	0.1	0.3	0.0	270.8	149.6	0.6	0.1	0.2	0.4	0.0	215.0	2.5	0.0	0.1	0.2	0.1	0.7	0.3	0.7	0.0	141.7	0.1	0.3	1.3	132.9	0.0	0.3	0.1	0.0	1.3	1.0	255.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	147.5	179.7	74.3	51.3	84.9	270.8	149.6	215.0	141.7	132.9	255.2	1.5	0.0	0.0	5.2	0.0	0.1	0.1	0.0	0.0	1.7	0.9	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	2.3	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	12.5	202.1	0.0	5.0	0.0	0.0	0.2	2.8	0.0	0.0	0.5	32.9	0.9	14.4	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877294-88895597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 966.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 50.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.7;U-2 OS: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	10.3	1.9	2.1	11.5	2.0	3.1	8.6	1.9	2.7	5.1	2.1	3.2	0.6	4.3	0.1	6.1	6.2	2.7	4.6	2.1	2.0	6.1	0.9	9.7	11.7	2.4	2.1	2.7	1.4	0.5	2.2	1.4	2.5	5.7	0.4	4.2	6.0	0.7	3.6	6.2	4.6	2.7	2.3	5.7	3.5	1.0	2.4	2.9	4.6	0.6	3.2	6.9	5.6	2.1	2.0	7.0	1.3	15.4	4.4	4.2	4.7	4.4	1.0	1.6	2.0	4.4	6.4	0.0	11.9	5.4	2.5	1.7	14.7	1.9	0.0	34.7	12.9	4.9	0.3	0.0	0.6	0.0	0.1	1.6	0.8	3.0	0.2	0.2	7.1	0.6	0.1	9.3	0.8	0.2	0.1	0.0	11.2	0.0	0.2	0.0	0.6	11.5	2.9	0.1	0.1	4.2	0.9	0.7	6.1	1.9	0.0	0.6	1.3	10.8	31.2	8.1	0.7	1.1	0.1	0.1	3.8	0.0	9.3	1.4	1.1	0.0	1.2	0.8	5.4	0.2	18.3	7.4	2.2	1.5	18.3	8.6	0.3	10.1	0.2	0.8	50.9	5.9	2.1	2.0	1.9	2.7	2.1	2.0	2.4	2.1	2.5	2.3	2.4	2.1	16.0	0.0	3.4	1.3	4.0	32.0	10.8	13.5	4.6	2.5	47.1	42.4	9.3	1.5	10.4	1.8	10.4	5.8	3.2	0.5	0.0	5.3	0.0	6.3	3.7	29.4	0.0	0.0	1.3	2.0	966.2	8.5	1.5	12.1	1.3	2.5	3.3	0.1	19.3	0.0	0.1	0.9	6.1	0.3	22.0	0.2	0.9	3.0	17.8	2.8	9.7	3.8	3.1	0.5	0.1	9.9	0.1	0.7	0.5	10.4	0.0	0.2	2.7	103.8	13.1	7.2	24.5	0.3	2.1	6.3	24.2	20.4	9.4	0.2	0.5	7.8
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19254756-19262804	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 107.1"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 16.0;Hepatocytes: 6.7;Inhibitory neurons: 19.9;Proximal enterocytes: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;NTERA-2: 8.3;SCLC-21H: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.1	1.0	5.8	0.1	3.7	0.2	0.2	18.3	107.1	2.0	0.0	0.2	12.4	0.8	0.1	0.0	0.2	0.2	0.1	10.7	20.0	0.5	14.1	0.1	0.1	46.6	9.7	0.6	0.9	0.0	0.7	0.2	43.2	0.6	0.1	2.3	0.1	0.3	0.0	0.2	15.4	0.2	10.9	0.1	0.3	0.1	33.6	0.0	0.0	0.0	0.0	0.1	0.5	35.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	3.5	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.0	0.4	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.7	18.3	107.1	10.7	20.0	46.6	9.7	43.2	10.9	33.6	35.6	0.1	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	16.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.4	6.7	0.1	0.0	19.9	0.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	15.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: AB_2679332"	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	2.0	2.6	2.6	2.4	4.5	5.6	2.4	3.3	4.2	2.3	2.3	3.0	2.6	1.7	3.4	2.3	2.1	2.0	2.5	2.7	3.1	2.9	3.3	2.2	3.4	3.5	3.5	1.4	2.4	2.2	2.5	2.8	3.6	2.2	3.4	2.7	2.8	1.9	2.6	3.2	2.8	3.0	2.8	2.4	4.0	12.1	4.0	4.2	2.7	2.0	3.4	2.6	1.5	7.3	3.3	5.3	4.3	4.1	8.4	5.1	5.1	4.7	4.5	6.3	8.0	3.7	3.7	5.8	2.9	3.9	7.1	6.3	4.6	4.1	5.9	6.7	5.5	5.9	3.9	4.2	9.8	5.5	7.6	6.5	10.7	4.2	8.2	2.4	4.0	6.2	9.4	7.0	5.3	7.1	6.8	2.3	11.8	10.8	6.4	4.5	6.1	10.3	4.8	3.9	4.1	3.4	5.6	5.9	6.8	5.7	9.9	4.7	3.8	6.3	4.9	8.4	4.3	6.6	7.7	6.3	4.8	3.2	6.6	21.9	7.6	10.9	9.6	10.3	6.7	4.7	7.6	7.0	6.4	6.6	7.2	8.0	11.2	6.9	9.8	8.3	10.2	4.4	2.6	4.5	3.3	4.2	2.7	3.1	3.5	3.5	3.6	2.8	4.0	7.3	1.0	0.0	1.3	1.3	2.2	1.0	2.7	4.0	1.8	3.5	2.5	1.8	2.3	1.5	4.4	0.0	2.1	4.9	1.5	2.1	5.9	4.1	70.9	4.7	2.2	1.4	1.2	13.5	1.5	2.2	3.4	1.7	2.0	4.7	0.0	1.6	1.8	2.8	3.3	3.3	1.5	2.2	8.2	3.3	0.8	73.0	3.1	1.7	1.8	0.0	4.2	2.9	1.0	0.5	4.6	3.0	0.8	1.9	3.4	1.6	3.4	3.5	6.1	3.7	0.0	2.1	2.0	25.2	13.5	1.7	2.7	9.3	2.2	2.2	1.7	2.3
HARS1	"HARS, HisRS, USH3B"	ENSG00000170445	"Histidyl-tRNA synthetase 1"	P12081	5	140673035-140691537	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	31.6	39.9	64.8	27.1	67.0	24.3	29.3	64.9	88.7	32.9	57.9	39.2	21.8	34.5	27.1	42.9	30.8	21.0	38.3	67.8	72.2	30.7	47.3	27.2	29.6	71.2	69.9	31.3	40.8	37.1	60.0	18.5	72.8	33.0	29.6	18.5	29.2	32.0	56.7	53.9	28.6	35.2	62.1	32.2	36.0	25.6	77.4	32.2	27.1	33.4	36.8	34.3	32.0	71.9	66.8	94.3	55.5	120.5	68.9	74.9	57.9	104.8	75.0	118.6	109.4	174.8	54.1	88.4	90.3	118.3	94.3	66.6	85.9	169.2	111.6	74.5	105.0	63.7	115.4	111.8	86.3	101.1	49.8	80.4	51.5	129.0	72.6	69.5	122.1	52.2	56.5	68.6	125.6	111.0	71.8	100.6	43.3	52.3	60.9	65.4	82.0	70.9	97.0	82.2	86.5	83.7	86.1	121.5	84.2	54.9	89.5	55.5	100.3	107.8	41.6	61.5	144.7	68.5	90.5	89.4	82.8	83.1	76.1	16.2	31.2	24.0	61.0	46.3	54.2	34.9	54.1	57.6	48.5	34.6	58.1	55.4	8.1	59.3	54.9	34.3	51.3	56.7	64.8	67.0	64.9	88.7	67.8	72.2	71.2	69.9	72.8	62.1	77.4	71.9	9.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	41.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	48.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	36.0	1.7	0.0	0.0	0.0
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691430-140699305	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035941, HPA075303"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA035941: AB_10671237, HPA075303: "	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	19.6	24.6	14.0	13.8	14.2	14.4	18.9	13.7	14.2	22.0	16.8	23.5	16.6	19.5	15.0	20.0	18.4	9.8	27.9	14.0	14.2	23.3	19.3	16.0	15.1	14.1	14.0	21.1	15.6	20.8	20.8	14.2	14.4	20.2	22.3	11.5	17.5	13.4	35.0	21.1	20.9	14.0	13.8	26.9	20.4	14.8	14.3	15.2	19.0	28.4	16.1	21.1	20.6	15.7	20.9	46.2	19.6	50.6	21.9	28.6	32.3	26.3	29.8	36.1	31.4	42.7	25.5	26.3	41.3	29.3	35.5	25.9	27.3	49.4	33.2	26.6	22.4	19.1	45.3	28.6	20.9	26.1	27.1	27.0	32.9	35.3	39.7	29.4	26.5	27.4	18.0	24.1	35.6	26.6	25.7	32.1	22.6	15.7	28.9	25.8	19.9	26.8	33.9	48.1	27.0	38.9	38.1	61.0	54.2	28.5	54.0	25.5	32.5	32.4	17.8	18.2	35.2	23.6	37.0	25.2	25.4	29.5	32.9	37.7	13.1	28.6	19.1	18.9	21.1	16.9	18.4	19.2	14.9	14.8	19.0	20.6	15.1	29.3	15.0	12.1	20.1	13.3	14.0	14.2	13.7	14.2	14.0	14.2	14.1	14.0	14.4	13.8	14.3	15.7	8.6	3.2	5.8	2.6	12.3	3.4	3.7	7.8	9.6	5.5	5.9	5.5	20.4	7.2	7.8	5.5	0.0	20.3	6.6	8.5	13.7	14.9	1.1	5.3	8.0	9.7	7.7	9.9	5.5	16.1	18.7	6.3	13.3	6.4	2.5	11.8	9.7	7.2	10.0	0.0	4.8	8.7	18.3	8.2	6.2	2.3	9.3	7.4	3.6	2.8	12.8	8.3	3.1	6.0	6.2	18.3	12.1	10.5	9.6	4.1	7.2	9.0	8.6	5.6	0.0	4.4	7.0	8.9	14.4	9.5	4.0	14.4	8.0	11.2	11.7	4.4
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723991	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.6;ovary: 20.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 26.6;Bipolar cells: 20.3;Cholangiocytes: 38.6;Fibroblasts: 64.2;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 112.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	49.6	0.5	1.4	6.3	1.1	3.6	1.3	1.1	1.1	0.1	0.0	2.8	0.1	1.0	0.0	0.8	9.0	5.5	9.2	0.9	2.0	0.5	0.6	3.7	0.0	1.8	0.8	20.8	2.1	0.3	0.9	0.3	0.7	0.2	0.5	0.2	0.2	0.0	0.2	5.4	1.3	0.7	0.3	0.3	1.7	0.3	2.2	0.1	0.7	0.0	0.0	6.3	0.6	1.3	0.0	0.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	3.2	0.0	27.0	0.0	0.1	0.0	0.0	0.0	0.2	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.8	0.0	0.0	0.0	0.0	112.6	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	1.1	1.1	1.1	0.9	2.0	1.8	0.8	0.7	0.3	2.2	1.3	1.5	0.0	1.8	0.0	0.2	26.6	0.1	0.8	0.6	20.3	0.0	0.0	1.3	38.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.5	0.0	0.0	1.7	0.0	0.2	64.2	2.6	0.0	2.5	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.8	9.0	0.2	0.3	8.3	8.8	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.5	0.0	3.1	10.6	0.1	0.5	0.4	17.8	0.1	0.3	0.0	0.0	0.2
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105653-69118719	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.5;urinary bladder: 92.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.3;Basal prostatic cells: 51.6;Basal respiratory cells: 107.1;Suprabasal keratinocytes: 158.6;Urothelial cells: 115.5"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 52.5;PC-3: 270.5;RT4: 111.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.8	0.5	0.9	0.7	1.2	0.9	7.5	1.3	1.3	4.6	0.9	5.3	2.9	0.9	1.1	33.5	1.2	4.8	0.7	0.6	1.1	1.1	1.3	20.1	0.4	1.0	1.3	1.4	1.3	0.4	1.7	3.4	1.1	3.7	3.1	0.8	5.4	1.5	1.2	9.7	2.2	0.6	0.4	0.8	12.8	3.5	1.0	0.5	5.9	0.9	2.8	92.8	10.3	1.0	3.5	17.1	1.0	0.9	0.3	0.4	6.6	1.1	0.4	1.0	0.4	3.4	9.0	0.7	2.0	0.4	4.0	52.5	2.9	31.5	1.0	0.2	1.3	0.0	0.2	0.6	0.1	0.3	0.9	0.5	8.6	1.0	3.0	4.0	0.7	0.6	0.1	0.4	0.3	1.8	1.2	0.7	15.5	18.7	270.5	2.0	0.1	0.2	28.3	111.6	19.2	0.8	1.8	0.1	0.3	3.1	0.6	0.8	0.3	0.9	0.9	29.9	1.8	1.0	0.9	0.2	1.0	0.0	0.6	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.9	1.2	1.3	1.3	0.6	1.1	1.0	1.3	1.1	0.4	1.0	1.0	4.2	0.0	30.8	0.7	0.2	162.3	51.6	107.1	8.6	1.1	1.6	6.1	1.4	0.0	12.2	0.0	2.1	1.0	0.1	16.4	0.0	4.5	10.2	0.7	0.3	2.4	0.0	0.4	1.0	3.6	0.9	1.1	5.1	2.7	0.0	0.4	1.1	0.2	0.3	0.0	2.1	0.7	2.0	0.0	6.5	22.7	1.2	0.5	3.6	0.0	0.0	0.1	0.0	0.5	0.8	2.4	0.2	0.4	0.6	18.4	0.1	0.7	3.0	1.0	0.0	0.9	1.9	0.5	0.7	25.6	158.6	0.3	1.1	0.1	2.2	115.5
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983686	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	27.7	27.0	14.3	33.5	15.5	59.8	41.4	15.9	19.2	26.8	15.3	27.7	19.9	24.6	16.7	26.6	24.4	24.6	31.4	13.1	16.2	32.2	30.2	25.7	48.7	15.0	14.6	23.2	30.0	37.9	16.9	30.6	15.5	29.0	30.7	28.8	32.8	24.0	67.7	23.8	21.7	29.3	16.1	27.7	23.6	20.1	15.5	50.7	32.8	50.8	47.5	39.0	19.6	17.3	132.4	61.5	106.6	98.8	55.2	56.8	75.2	133.9	88.9	144.4	149.9	144.3	88.2	147.0	85.0	81.5	122.7	101.3	116.7	109.5	220.5	83.5	115.8	131.1	91.5	131.0	26.7	165.5	77.9	34.2	62.2	191.0	63.6	45.5	92.6	100.4	136.5	93.1	166.5	91.8	131.1	148.3	89.0	158.9	63.9	102.8	134.4	99.4	85.3	130.2	67.8	55.4	112.4	62.4	118.1	81.5	86.4	164.5	47.5	129.8	99.2	109.5	137.1	40.9	100.5	173.8	87.6	117.8	113.8	47.6	35.3	53.7	32.8	42.0	40.6	35.5	34.9	34.0	27.4	30.7	33.9	37.6	40.3	44.6	59.2	14.3	49.2	34.0	14.3	15.5	15.9	19.2	13.1	16.2	15.0	14.6	15.5	16.1	15.5	17.3	55.6	35.3	28.9	13.7	49.7	74.2	117.7	129.7	46.1	24.2	36.4	42.3	49.5	25.8	66.2	27.6	33.3	77.5	43.5	19.0	82.2	45.2	70.3	33.1	32.3	43.2	14.3	103.1	28.6	46.5	83.1	43.7	15.8	28.9	40.6	30.7	28.9	20.1	51.8	28.6	45.3	20.9	111.9	29.5	36.3	14.7	30.7	34.5	32.0	16.9	28.8	53.4	43.3	21.6	28.0	27.8	21.0	36.9	50.8	52.0	18.2	46.0	65.4	42.0	39.5	43.8	51.3	65.7	67.5	28.8	52.7	58.3	49.0	43.9	29.4	64.1
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104378-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favorable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	14.3	11.0	7.2	18.4	7.2	37.8	18.9	7.3	10.2	13.7	9.0	18.5	14.3	17.0	38.7	14.5	13.4	16.9	11.8	7.0	7.8	13.0	13.7	12.2	35.6	7.5	7.6	26.4	11.4	14.3	10.7	17.8	7.8	10.4	22.1	9.5	10.5	12.9	7.2	10.1	14.3	16.8	8.0	14.6	13.0	16.2	7.3	41.4	13.3	13.2	39.5	16.2	11.9	8.1	72.8	43.6	157.3	86.9	38.8	59.4	42.5	68.4	65.7	105.5	104.4	43.2	39.5	136.4	40.5	48.3	49.8	74.6	94.0	56.4	115.1	77.7	64.2	99.2	40.7	82.0	32.5	184.2	59.7	28.6	21.6	64.6	33.3	45.6	115.1	91.5	72.4	39.8	94.2	41.9	150.0	87.7	101.1	33.0	24.9	144.6	112.4	98.4	85.4	49.9	74.3	77.2	64.3	22.3	52.9	60.7	33.3	89.0	67.9	62.8	42.1	27.9	73.4	43.5	73.2	130.6	39.9	157.0	74.0	11.1	46.5	36.7	40.3	45.4	45.0	79.4	53.0	48.9	58.3	64.8	38.1	45.0	4.9	55.9	35.8	62.5	99.9	55.4	7.2	7.2	7.3	10.2	7.0	7.8	7.5	7.6	7.8	8.0	7.3	8.1	20.6	12.8	12.2	3.3	26.5	17.5	15.8	47.8	16.5	6.1	16.4	18.7	10.1	15.7	33.0	14.7	4.2	58.7	22.0	11.1	17.6	38.2	7.5	15.9	18.3	29.4	12.1	53.9	4.2	42.3	111.7	25.1	7.1	14.5	29.8	31.3	23.2	6.9	50.9	11.8	4.8	24.1	28.5	33.6	24.7	12.4	22.7	25.8	21.4	4.7	45.8	21.5	37.0	8.0	5.2	31.8	12.4	25.9	21.9	8.1	14.3	24.7	29.3	8.7	19.7	15.9	20.2	50.8	55.8	15.3	15.5	23.7	23.9	20.7	26.8	12.9
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548828-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	7.9	5.7	5.5	5.8	5.8	36.5	7.5	5.8	9.5	4.7	4.2	5.8	4.8	6.0	5.5	6.4	4.7	4.6	5.8	6.2	5.8	5.3	5.4	7.0	8.1	6.1	5.6	5.4	6.6	4.5	4.2	6.4	6.2	4.2	5.9	5.4	5.0	3.8	7.2	6.2	5.4	6.7	5.8	5.4	4.9	5.0	5.8	8.9	5.1	5.8	7.9	7.0	4.7	7.6	23.6	12.0	21.5	13.7	10.9	12.3	20.3	22.9	13.9	21.8	17.1	24.5	11.8	13.8	11.1	13.4	18.6	34.6	23.7	15.2	21.5	19.4	13.3	20.0	19.7	19.0	15.6	34.2	14.5	10.6	11.1	16.2	17.7	9.2	22.0	19.2	36.2	17.5	21.3	14.1	21.4	28.5	16.8	31.9	15.3	27.9	26.4	15.0	12.6	16.4	17.8	14.8	23.2	20.6	13.2	15.6	18.7	22.4	17.1	28.7	21.4	39.0	43.8	18.7	61.1	40.0	18.5	38.0	21.6	4.0	4.3	3.9	4.4	5.3	4.5	6.0	4.4	3.7	3.9	5.1	3.3	4.5	1.9	2.9	7.5	4.5	5.2	2.8	5.5	5.8	5.8	9.5	6.2	5.8	6.1	5.6	6.2	5.8	5.8	7.6	17.5	12.8	14.4	5.5	19.4	13.6	20.9	10.9	18.2	7.8	8.6	8.0	4.2	14.3	11.6	3.7	16.7	14.5	17.7	7.1	3.9	14.2	35.2	10.9	12.3	14.6	17.3	31.1	11.6	16.5	27.6	12.9	12.2	10.4	24.6	9.0	7.9	9.7	21.7	16.8	9.3	10.6	8.2	18.5	23.6	7.3	11.1	19.0	1.8	9.4	19.6	9.7	10.3	11.6	10.4	18.8	11.2	11.3	20.1	20.2	8.7	13.3	15.8	16.3	19.7	16.5	12.4	34.0	9.6	23.2	15.3	13.4	21.1	14.0	10.8	17.1
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA029803: AB_10601428"	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.24e-4)"	29.3	24.8	12.8	29.2	13.8	63.5	39.7	12.9	15.6	33.7	14.4	32.3	28.1	26.2	22.2	30.5	31.0	26.4	26.5	11.8	13.6	26.0	32.2	31.7	40.7	15.2	14.2	52.8	45.2	27.6	14.5	22.4	15.0	26.1	30.2	10.4	33.2	26.4	19.1	39.3	30.6	24.3	13.9	37.7	32.0	12.9	13.8	30.8	27.7	22.9	36.7	29.0	31.7	15.6	77.0	51.2	55.5	56.9	42.0	50.4	86.6	36.5	48.2	39.3	56.1	37.0	88.5	146.2	17.2	22.3	29.2	75.5	31.2	44.9	34.5	39.8	23.0	48.1	35.8	90.2	37.7	63.3	77.8	35.7	84.7	17.5	50.9	48.2	71.1	82.0	35.8	71.2	41.6	58.1	69.8	56.7	29.9	59.3	50.9	66.3	68.8	57.0	35.2	40.7	22.5	37.1	52.7	54.0	34.0	24.1	47.8	50.2	39.3	36.2	46.3	26.3	33.6	74.6	67.9	67.1	16.7	70.6	20.9	8.7	79.5	17.7	15.7	54.1	20.8	38.2	29.1	22.2	101.3	33.0	40.2	32.0	100.8	23.7	34.7	28.5	43.2	46.0	12.8	13.8	12.9	15.6	11.8	13.6	15.2	14.2	15.0	13.9	13.8	15.6	4.9	22.4	6.8	16.0	13.4	12.4	5.9	8.7	29.6	1.0	13.7	11.0	1.3	11.5	7.5	1.8	0.0	12.4	3.4	9.6	5.9	17.6	0.6	2.3	3.9	7.5	7.8	42.2	3.7	27.3	13.8	8.3	16.3	3.7	3.8	4.9	8.9	4.4	17.3	0.0	6.1	20.9	2.0	29.1	13.0	0.5	5.6	17.3	5.4	15.9	33.4	6.2	3.1	7.5	8.9	18.4	18.7	4.1	21.5	3.4	26.3	8.0	9.6	0.5	0.0	3.3	6.2	3.1	6.1	32.0	11.1	8.2	10.9	1.2	35.2	5.9
HAUS5	"dgt5, KIAA0841"	ENSG00000249115	"HAUS augmin like complex subunit 5"	O94927	19	35612735-35625355	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 55.4;Spermatogonia: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067250	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA067250: AB_2685812"	"unprognostic (9.24e-3)"	"prognostic favorable (7.68e-4)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (4.15e-8)"	"unprognostic (2.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	4.0	5.1	6.2	3.9	6.3	5.6	4.8	7.2	10.7	7.7	6.0	3.6	1.6	5.2	2.2	6.5	6.1	1.6	4.0	6.1	6.1	5.7	5.1	3.8	6.0	6.4	6.2	10.4	6.2	1.8	5.0	1.8	6.5	4.7	2.2	4.0	4.4	1.2	7.5	5.3	5.3	2.5	6.2	7.7	4.2	10.9	6.2	4.1	4.7	1.2	4.9	4.2	5.5	7.0	6.7	5.1	14.0	5.2	1.9	2.9	1.6	7.0	2.1	4.4	6.0	3.4	5.1	14.1	6.1	2.5	2.8	4.1	9.1	4.2	9.8	10.3	7.8	16.2	7.7	3.2	1.9	12.5	3.4	2.9	2.4	3.2	5.0	4.1	3.9	14.2	9.0	12.1	5.3	6.0	16.9	5.2	3.7	8.1	5.9	12.3	12.6	6.5	3.6	4.2	4.3	3.4	6.6	5.7	4.2	8.7	7.3	10.3	3.7	3.2	9.1	5.0	5.4	6.5	5.3	13.5	4.8	10.5	4.1	0.8	0.8	0.2	3.1	1.8	3.0	3.4	2.9	2.2	1.9	2.3	3.0	2.5	0.4	4.2	1.0	1.5	2.3	1.1	6.2	6.3	7.2	10.7	6.1	6.1	6.4	6.2	6.5	6.2	6.2	7.0	5.8	0.0	5.6	8.5	10.3	6.0	5.7	5.0	9.6	5.4	6.2	6.6	4.1	7.2	2.8	14.7	8.4	10.9	6.5	3.5	3.9	4.2	15.1	6.2	5.9	5.8	2.4	10.1	3.3	3.5	10.8	6.2	6.1	4.5	7.0	12.2	5.7	3.9	4.7	3.3	6.3	2.9	2.0	0.6	7.0	7.9	5.3	3.9	5.4	1.9	2.5	3.7	6.2	5.0	9.5	4.2	2.1	6.8	11.2	2.2	0.6	1.3	13.1	4.3	0.0	5.1	5.8	55.4	30.3	7.2	5.7	7.3	7.8	4.3	4.8	3.7
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053141-19102904	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 215.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Approved	"Nuclear speckles,Centriolar satellite,Cytosol"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	5.3	6.5	5.2	7.9	7.3	17.0	9.2	8.9	7.4	5.4	4.2	5.8	4.0	7.1	6.2	5.2	4.7	5.1	5.2	5.1	6.2	4.1	6.9	4.7	11.4	6.4	6.2	8.2	3.9	6.1	3.0	6.9	6.6	5.6	6.2	9.1	4.5	5.6	4.4	8.1	5.2	7.2	6.1	6.9	4.3	24.0	6.1	15.1	5.3	7.2	10.7	6.2	4.2	9.3	34.7	23.7	46.4	36.3	17.4	20.9	25.1	36.5	25.5	32.7	49.9	12.2	15.4	40.5	13.1	21.1	25.0	14.2	43.3	21.3	50.4	36.8	20.9	215.8	42.1	27.8	11.6	29.0	46.7	13.0	21.5	30.9	66.9	16.9	24.0	40.4	29.8	25.7	37.8	11.3	56.6	49.1	49.9	19.4	23.2	43.3	31.8	16.4	18.0	19.8	27.1	37.3	16.4	15.0	23.6	29.5	11.6	36.1	24.1	29.3	17.7	25.5	42.2	10.2	24.0	39.7	27.3	24.0	13.0	9.8	1.5	1.6	2.8	1.5	3.9	2.3	2.8	3.6	1.5	2.3	3.3	2.9	2.3	5.0	1.4	1.8	3.7	1.7	5.2	7.3	8.9	7.4	5.1	6.2	6.4	6.2	6.6	6.1	6.1	9.3	15.9	19.2	12.5	7.8	14.3	9.7	12.6	8.7	9.1	11.8	9.4	9.3	8.4	5.7	7.2	9.2	10.4	10.5	21.9	5.6	0.0	9.8	124.9	11.8	14.4	11.6	2.4	34.1	10.3	6.1	15.3	9.5	5.6	15.3	11.4	23.8	3.9	6.8	8.2	11.8	10.2	4.6	2.0	5.8	7.7	28.2	11.8	14.5	8.8	10.3	8.2	13.5	12.3	7.1	16.8	9.0	3.4	8.2	17.3	14.6	4.5	3.2	3.6	9.7	6.6	16.2	10.1	68.9	56.0	9.1	8.1	4.9	18.2	11.0	9.4	9.4
HAUS8	"HICE1, MGC20533, NY-SAR-48"	ENSG00000131351	"HAUS augmin like complex subunit 8"	Q9BT25	19	17049729-17075625	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.4;Spermatogonia: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039406	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039406: AB_10794090"	"unprognostic (1.14e-1)"	"prognostic favorable (9.54e-4)"	"unprognostic (8.73e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.35e-13)"	"unprognostic (7.46e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-3)"	3.5	4.6	1.1	7.5	1.1	11.5	3.3	1.6	1.4	2.0	0.9	5.6	5.1	2.8	2.5	3.0	2.2	2.7	2.9	1.1	1.3	2.1	4.6	3.1	14.6	1.3	1.2	2.5	1.9	2.5	1.8	5.4	1.2	2.3	5.0	1.0	2.7	2.7	3.4	3.8	4.6	2.8	1.0	6.9	3.6	10.7	1.3	9.5	2.4	2.6	14.3	3.5	1.9	1.3	29.8	19.2	28.5	29.5	5.2	5.0	58.1	29.5	14.7	44.4	44.0	29.9	19.0	59.8	29.7	12.9	12.7	28.3	29.2	14.7	33.4	34.6	32.6	37.3	20.1	20.7	2.9	24.9	34.2	1.5	3.9	27.8	9.2	4.7	17.8	27.4	31.8	27.5	24.9	37.6	42.2	28.5	29.5	34.0	36.7	38.5	29.8	24.7	10.5	21.2	26.7	16.1	27.8	17.0	15.5	18.2	19.5	21.5	11.2	27.8	18.7	48.6	40.4	14.9	21.3	40.6	15.2	47.5	25.2	0.2	5.1	5.6	5.4	15.0	5.9	12.0	6.4	7.0	3.6	11.0	8.6	5.7	3.3	7.7	14.2	4.4	11.1	5.1	1.1	1.1	1.6	1.4	1.1	1.3	1.3	1.2	1.2	1.0	1.3	1.3	3.2	3.2	2.8	1.0	12.0	6.6	13.5	10.2	6.2	2.9	4.4	5.2	4.5	7.2	5.1	1.8	2.1	25.1	6.2	8.5	5.9	7.2	12.6	3.7	5.9	3.8	0.0	18.1	2.0	7.8	25.4	7.8	1.5	4.6	4.5	7.8	4.6	4.2	12.1	1.7	2.3	7.9	14.2	8.5	12.1	3.2	5.9	12.2	10.6	2.8	6.4	2.6	5.2	2.0	3.2	7.0	3.0	3.8	4.4	5.5	5.3	3.0	3.5	6.3	6.6	4.2	6.1	40.4	47.0	4.7	4.5	9.9	7.5	5.6	6.5	5.1
HAVCR1	"CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1"	ENSG00000113249	"Hepatitis A virus cellular receptor 1"	Q96D42	5	157029413-157059119	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 4.6;kidney: 7.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;Inhibitory neurons: 1.3;Microglial cells: 5.6;Oligodendrocytes: 1.8;Proximal tubular cells: 2.3"	"Cancer enriched"	"Detected in many"	12	"renal cancer: 26.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 93.0;CACO-2: 113.9;RPTEC TERT1: 43.5"					"Low region specificity"	"Detected in many"			"HPA007173, CAB075697"	Uncertain		Approved	Vesicles		NA	NA	155000		"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB075697: , HPA007173: AB_1080282"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.46e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.20e-2)"		"unprognostic (3.21e-1)"	"unprognostic (8.70e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.10e-3)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.32e-4)"	0.3	0.0	0.3	0.4	0.3	0.9	0.1	0.6	0.4	0.1	0.5	4.6	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.4	0.3	7.5	0.3	0.3	0.6	0.7	0.4	0.1	0.0	0.1	0.0	0.1	0.5	0.0	3.5	0.3	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.3	0.9	0.5	0.1	0.1	0.0	0.3	0.1	0.0	0.8	0.0	93.0	0.2	0.0	0.3	0.0	13.8	0.0	0.0	0.0	0.0	113.9	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	43.5	3.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.2	0.2	0.3	0.1	0.1	0.2	0.6	0.5	0.2	0.4	0.1	0.1	0.6	0.4	0.3	0.3	0.6	0.4	0.4	0.3	0.7	0.4	0.5	0.3	0.5	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	5.6	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.0
HAVCR2	"CD366, FLJ14428, Tim-3, TIM3, TIMD3"	ENSG00000135077	"Hepatitis A virus cellular receptor 2"	Q8TDQ0	5	157085832-157142869	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.6;granulocytes: 80.6;Hofbauer cells: 148.3;Kupffer cells: 89.1;Langerhans cells: 67.8;Macrophages: 83.2;monocytes: 49.5;NK-cells: 70.0;Proximal tubular cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 53.8;intermediate monocyte: 57.9;myeloid DC: 137.9;NK-cell: 97.1;non-classical monocyte: 36.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 137.9;monocytes: 57.9;NK-cells: 97.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.8;Daudi: 6.4;HDLM-2: 26.3;HMC-1: 6.0;RPMI-8226: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB026003	Enhanced					NA	NA		9900000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB026003: "	"unprognostic (2.50e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.34e-1)"	14.2	8.2	9.5	19.7	11.1	13.9	5.3	11.1	13.3	4.9	10.4	5.4	4.0	3.2	6.0	3.7	3.3	12.8	2.5	9.1	11.8	26.8	9.8	22.6	32.1	18.0	13.7	1.7	3.0	2.8	1.8	16.9	16.9	2.1	6.8	1.2	2.9	2.9	1.7	2.2	4.9	7.9	16.1	24.1	4.7	2.0	17.5	9.1	1.6	2.1	14.0	13.1	1.2	27.2	0.0	0.2	0.1	0.2	7.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	6.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	26.3	0.0	1.1	0.1	0.0	0.0	0.0	6.0	0.4	0.4	0.0	0.2	0.0	0.0	0.7	0.1	2.3	0.0	0.1	0.1	3.9	0.2	0.0	0.0	0.1	3.0	21.5	0.3	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.2	0.3	0.0	0.9	0.3	0.3	0.0	0.3	1.8	0.2	0.1	0.7	0.1	16.7	53.8	0.1	14.6	57.9	3.0	1.2	5.9	7.9	137.9	0.5	7.0	9.5	2.5	97.1	36.1	16.4	11.5	43.1	9.5	11.1	11.1	13.3	9.1	11.8	18.0	13.7	16.9	16.1	17.5	27.2	1.2	6.4	6.5	2.0	5.9	1.0	0.2	0.1	0.0	0.9	0.7	1.5	1.1	0.0	1.9	0.0	0.0	0.6	87.6	0.3	7.9	0.1	11.1	0.1	0.1	3.7	0.0	1.3	2.1	0.0	0.8	0.9	0.5	0.1	80.6	0.1	1.1	0.5	148.3	0.0	1.7	0.3	0.0	89.1	67.8	7.8	0.3	83.2	3.6	31.9	49.5	0.1	70.0	1.0	4.8	0.1	0.1	0.0	16.3	0.5	0.1	57.7	0.0	0.2	6.6	0.7	0.5	0.3	0.4	0.1	1.3	1.1	26.3	1.5	0.2	0.3
HAX1	"HAX-1, HCLSBP1, HS1BP1"	ENSG00000143575	"HCLS1 associated protein X-1"	O00165	1	154272589-154275875	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055141, HPA075289"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055141: AB_2682714, HPA075289: AB_2686742"	"unprognostic (1.32e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.96e-1)"	58.6	63.0	100.0	43.6	105.5	36.8	74.4	105.2	124.1	60.0	100.6	62.0	48.0	46.2	100.1	53.7	61.7	40.4	168.6	100.5	107.9	76.1	104.0	45.2	58.3	102.1	99.9	72.9	85.5	84.9	88.6	40.5	102.9	55.5	63.3	54.1	85.8	63.8	256.7	48.8	43.2	64.1	105.1	47.1	66.3	69.5	105.0	67.4	69.2	242.7	77.3	58.5	48.9	103.3	115.3	100.7	84.2	178.0	100.3	111.8	132.1	109.8	178.7	227.0	207.5	126.6	125.7	170.9	150.7	188.0	105.9	100.0	190.7	151.3	172.3	171.0	140.8	81.8	76.5	104.4	221.5	172.5	167.0	104.4	274.2	172.8	206.3	82.2	129.7	246.1	166.1	244.8	145.6	260.9	169.9	136.1	88.7	277.4	213.2	121.3	59.7	326.7	115.4	60.8	123.2	121.7	96.4	228.2	326.7	137.5	190.0	454.8	64.5	92.7	122.7	97.7	148.8	284.8	315.9	315.3	139.0	158.4	153.4	266.5	97.6	215.4	113.7	121.9	129.3	136.1	139.2	128.3	118.6	142.2	166.5	132.6	61.1	116.7	150.1	122.8	183.3	163.9	100.0	105.5	105.2	124.1	100.5	107.9	102.1	99.9	102.9	105.1	105.0	103.3	69.9	28.9	37.6	7.2	125.2	74.6	112.2	118.8	60.9	57.0	92.8	123.1	106.9	62.9	71.6	46.0	47.9	84.8	76.1	54.1	181.9	93.3	147.6	41.3	36.6	65.6	57.6	66.0	12.0	106.4	132.1	62.2	36.7	34.0	99.6	80.6	61.4	90.3	98.7	40.4	12.9	67.1	91.6	63.9	79.3	104.6	61.2	66.8	87.2	9.4	128.5	91.1	91.6	7.5	17.1	84.6	63.6	62.1	192.9	92.5	128.7	141.8	59.3	97.5	59.2	58.2	76.0	223.8	112.0	71.0	76.4	88.8	97.7	74.3	71.7	101.7
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24344.4"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	893.7	183.0	112.1	82.0	216.3	24344.4	316.6	159.4	246.9	237.7	340.5	141.4	10.6	41.4	2.4	244.9	350.9	60.1	1766.9	56.9	92.1	1405.5	1100.4	2201.7	5.0	141.5	169.4	159.7	100.5	5.1	465.7	1992.7	183.4	170.1	11.5	3.1	138.1	43.7	234.0	194.6	85.0	7.0	211.1	5527.7	135.9	104.8	125.3	20.7	609.2	1123.2	3.6	167.2	351.2	113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	112.1	216.3	159.4	246.9	56.9	92.1	141.5	169.4	183.4	211.1	125.3	113.5	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 38218.6"	"Cell type enriched"	"Detected in many"	22	"Erythroid cells: 198314.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 486.7;granulocytes: 955.3"	"Group enriched"	"Detected in some"	18	"HEL: 1196.2;K-562: 328.3"									"CAB038417, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	1592.0	322.5	162.6	186.3	292.4	38218.6	545.3	268.0	377.0	573.3	570.7	254.0	21.6	85.9	5.9	432.5	570.5	147.6	2590.3	86.6	156.5	2302.8	1853.6	4204.3	9.7	210.6	249.2	288.5	141.3	11.4	807.8	3618.9	260.6	302.7	26.7	4.0	305.4	131.9	568.3	188.5	154.3	12.9	316.4	8125.4	264.0	185.0	185.4	34.6	1192.5	1744.6	10.1	325.2	632.8	179.9	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.1	0.0	0.0	3.2	0.0	1.9	4.9	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.6	1196.2	0.5	0.0	0.0	0.2	1.7	0.4	0.1	0.4	0.0	0.0	0.0	0.1	328.3	0.0	0.1	0.6	0.0	0.3	0.1	0.5	0.0	0.0	0.0	43.4	0.0	0.9	11.9	9.7	1.1	0.0	0.0	0.1	1.4	0.2	5.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.2	119.6	28.1	315.1	99.6	1.7	3.7	39.2	8.5	7.1	42.5	19.1	22.8	73.9	955.3	49.5	3.3	486.7	1.0	15003.3	162.6	292.4	268.0	377.0	86.6	156.5	210.6	249.2	260.6	316.4	185.4	179.9	184.7	3.2	1.5	0.0	97.6	44.4	0.4	0.1	0.6	1.7	20.2	22.2	6.8	70.1	0.7	0.0	0.0	0.0	162.2	6.9	54.8	0.0	3.4	0.6	0.8	50.9	3.0	198314.0	0.0	0.0	0.0	241.0	4.1	0.9	1.3	0.3	142.8	131.2	0.0	0.0	0.0	7.5	4.1	770.6	149.6	16.9	0.0	402.9	8790.3	0.0	37.5	2.3	954.7	0.0	0.0	0.0	3.6	0.0	0.3	0.2	0.1	29.6	2.5	58.6	0.0	25.2	171.5	1.0	9.9	1.1	44.6	0.0	306.3	0.1	5.0	0.1
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 133301.6"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 672352.3"	"Group enriched"	"Detected in all"	4	"cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1"	"Region enriched"	"Detected in all"	11	"cerebral cortex: 3368.5"	"Group enriched"	"Detected in all"	5	"neutrophil: 658.1;plasmacytoid DC: 379.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 379.7;granulocytes: 658.1"	"Cell line enhanced"	"Detected in some"		"HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2"									"CAB009526, HPA043234"	Enhanced					NA	NA		10000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	1641.5	481.4	155.7	217.3	219.2	133301.6	637.4	235.7	3368.5	546.2	384.6	278.2	28.8	78.8	45.6	505.7	829.6	792.7	2658.8	108.9	154.4	2333.1	1907.3	4039.6	26.8	209.6	243.5	289.0	158.5	50.5	808.2	6345.0	303.0	312.0	148.9	31.0	548.1	290.6	578.8	135.3	169.8	66.3	316.2	9225.9	269.1	170.6	171.4	196.8	1152.0	12902.5	40.3	320.1	633.5	180.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.1	4.2	0.0	0.0	0.0	0.0	99.5	25.3	73.7	37.8	1.3	4.0	21.5	6.8	1.1	35.2	13.8	13.7	39.9	658.1	47.9	5.0	379.7	1.4	22388.9	155.7	219.2	235.7	3368.5	108.9	154.4	209.6	243.5	303.0	316.2	171.4	180.7	441.7	3.2	8.4	0.0	280.5	157.0	2.3	5.1	0.0	4.0	54.7	72.0	3.4	217.3	4.5	7.3	4.2	2.2	369.9	5.2	50.9	0.0	0.0	6.8	6.6	151.7	3.6	672352.3	0.0	0.0	11.3	276.1	0.0	5.1	0.0	4.6	443.4	420.5	7.3	3.3	0.0	7.2	6.1	1452.1	702.6	0.0	0.0	1091.0	27383.1	0.0	72.7	9.7	38.1	0.0	0.0	0.1	3.5	0.0	1.9	0.0	0.1	272.4	84.9	117.8	0.0	126.0	396.8	0.0	0.0	0.0	252.5	2.2	769.8	0.3	3.0	0.1
HBD		ENSG00000223609	"Hemoglobin subunit delta"	P02042	11	5232678-5243657	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"bone marrow: 2797.6"	"Cell type enriched"	"Detected in some"	318	"Erythroid cells: 22112.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5"									"CAB037087, HPA043234"	Supported					NA	NA		6600000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB037087: AB_260051, HPA043234: AB_2678378"	"unprognostic (1.32e-2)"		"unprognostic (4.87e-2)"		"unprognostic (4.14e-2)"	"unprognostic (2.26e-3)"		"unprognostic (1.52e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.04e-1)"		"unprognostic (8.67e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.17e-1)"	2.2	0.3	0.5	0.6	0.6	2797.6	0.7	0.8	2.7	0.1	0.7	0.5	0.0	0.1	0.0	0.3	2.8	0.1	2.5	0.5	0.4	3.2	7.5	6.2	0.5	0.6	0.5	0.3	0.2	4.5	2.2	19.5	0.7	0.2	0.3	0.1	2.2	0.3	0.5	0.6	0.2	0.0	0.6	49.1	0.3	0.1	0.5	4.3	1.0	11.5	0.2	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	74.5	0.0	0.0	0.0	0.3	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.4	25.5	0.0	0.0	0.1	0.0	0.4	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.2	0.0	1.6	0.0	105.0	0.5	0.6	0.8	2.7	0.5	0.4	0.6	0.5	0.7	0.6	0.5	1.0	0.0	0.0	0.0	0.0	11.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	22112.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	13.6	13.4	0.1	0.0	0.0	0.0	0.0	16.9	1.9	0.1	0.0	6.2	69.4	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0
HBE1	HBE	ENSG00000213931	"Hemoglobin subunit epsilon 1"	P02100	11	5268345-5505652	"Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 174.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"K-562: 10059.8"	"Not detected"	"Not detected"							HPA043234	Approved					NA	NA		510000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"			"HPA043234: AB_2678378"	"unprognostic (7.59e-2)"			"unprognostic (6.70e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.25e-1)"		"unprognostic (1.64e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.02e-3)"		"unprognostic (2.14e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.34e-2)"	0.5	0.3	0.4	0.0	0.7	0.3	0.2	0.0	1.1	0.5	0.0	0.2	0.0	0.3	0.4	0.1	0.4	0.0	0.3	0.5	0.8	0.3	1.3	0.3	0.0	0.7	0.2	0.6	0.2	0.0	0.3	0.8	0.5	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.2	0.0	0.4	0.2	0.5	0.4	0.2	0.3	0.0	0.0	0.2	0.3	1.1	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	649.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10059.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.7	0.0	0.0	31.9	0.1	0.9	19.4	0.1	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	1.1	0.5	0.8	0.7	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.9	0.0	0.3	4.3	0.0	16.0	0.5	0.0	31.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	174.7	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	14.8	0.1	0.0	0.9	0.1
HBEGF	"DTR, DTS, HEGFL"	ENSG00000113070	"Heparin binding EGF like growth factor"	Q99075	5	140332843-140346603	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 128.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 818.1;Squamous epithelial cells: 281.8;Urothelial cells: 548.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 1.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 61.2;JURKAT: 81.5;TIME: 68.9;U-698: 93.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053243	Uncertain				"Secreted to blood"	NA	NA	118000		"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA053243: AB_2682086"	"unprognostic (3.64e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.44e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	69.5	11.6	11.6	32.3	13.9	36.4	28.7	13.5	14.4	13.1	11.6	19.7	4.6	12.1	2.3	42.3	14.3	56.6	36.3	11.5	12.9	12.8	9.6	44.9	3.2	14.9	13.7	5.2	6.6	5.6	13.1	16.0	14.1	12.8	15.5	12.1	12.0	4.8	28.0	20.1	14.3	36.6	14.7	6.3	31.4	5.4	13.6	4.8	15.9	20.1	4.6	128.6	18.9	16.7	23.2	1.6	3.4	8.1	1.6	0.6	2.7	21.8	8.5	40.5	33.2	13.0	24.4	0.3	16.9	5.4	14.1	7.1	4.2	37.0	61.2	1.3	3.8	0.5	4.9	1.8	1.2	1.5	1.0	0.9	45.7	44.4	17.8	12.0	20.5	81.5	0.2	3.6	8.7	1.6	2.0	10.8	2.9	9.2	6.0	4.0	13.1	0.7	25.0	3.0	1.2	1.3	6.4	0.8	7.8	22.8	1.4	5.9	68.9	23.1	19.5	7.4	49.5	0.5	1.8	93.6	29.1	11.0	30.3	0.0	0.3	0.0	0.0	2.2	0.0	0.3	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.2	11.6	13.9	13.5	14.4	11.5	12.9	14.9	13.7	14.1	14.7	13.6	16.7	186.2	221.2	69.3	1.3	5.7	214.6	818.1	161.9	95.6	2.8	37.9	77.8	80.8	24.3	58.0	11.0	0.0	2.5	5.4	199.2	0.0	37.6	0.5	23.6	22.9	94.7	88.3	0.0	2.1	10.7	1.8	35.2	62.7	74.0	21.5	0.6	22.5	3.4	73.2	5.0	2.9	105.1	18.3	39.7	36.2	0.7	0.3	210.2	32.0	4.7	2.1	7.4	0.0	1.0	8.8	89.5	130.6	0.7	3.1	153.2	181.9	1.0	16.4	1.0	0.0	50.5	33.1	2.0	7.4	281.8	125.2	2.6	12.7	1.0	97.7	548.7
HBG1	HBG-T2	ENSG00000213934	"Hemoglobin subunit gamma 1"	P69891	11	5248269-5249857	"Human disease related genes, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"placenta: 367.3"	"Cell type enriched"	"Detected in single"	76	"Macrophages: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	48	"K-562: 3611.8"									HPA043234	Approved					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA043234: AB_2678378"					"unprognostic (3.17e-2)"													1.5	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.7	1.0	0.1	0.4	0.2	0.4	0.0	0.4	0.3	0.0	2.1	0.1	0.2	1.3	1.3	3.0	0.0	0.3	0.2	0.4	0.4	0.0	0.6	367.3	0.3	0.4	0.0	0.0	0.2	0.0	0.9	0.3	0.3	0.0	0.1	5.5	0.4	0.2	0.1	0.9	1.0	2.3	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3611.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.1	0.2	0.1	0.7	0.1	0.2	0.3	0.2	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HBG2	HBG-T1	ENSG00000196565	"Hemoglobin subunit gamma 2"	P69892	11	5253188-5505605	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	132	"placenta: 10310.3"	"Group enriched"	"Detected in some"	17	"Erythroid cells: 66.1;Macrophages: 74.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	192	"HEL: 8197.4;K-562: 8088.4"									"CAB016143, HPA043234"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB016143: AB_2295004, HPA043234: AB_2678378"	"unprognostic (4.48e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	6.8	1.6	1.6	0.5	2.0	78.2	2.5	1.5	4.7	4.2	2.0	2.8	1.4	1.1	0.5	2.0	2.0	5.3	8.2	1.8	1.1	5.9	6.1	16.4	0.3	1.1	1.2	2.2	9.3	0.8	3.1	10310.3	1.1	1.5	0.1	0.4	3.7	0.2	4.2	1.2	0.9	4.4	0.7	27.3	3.3	0.8	1.2	2.4	4.8	0.6	0.4	0.4	3.1	2.0	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.2	23.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8197.4	0.5	0.4	0.0	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8088.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.0	8.9	1.9	0.1	0.3	0.2	0.0	0.0	42.3	0.1	0.6	3.0	0.1	0.6	1.9	1.9	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	6.5	1.6	2.0	1.5	4.7	1.8	1.1	1.1	1.2	1.1	0.7	1.2	2.0	2.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	66.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.6	0.3	74.6	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.3	0.2	1.5	0.9	0.0	0.0	0.0	0.6	0.3	0.0	0.1
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202522	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	58.4	49.8	13.2	15.0	18.3	49.0	52.4	17.1	14.8	50.1	15.2	45.9	16.3	53.1	20.0	54.4	40.0	19.9	39.8	13.0	14.7	26.7	37.8	40.1	17.3	19.2	16.1	51.1	34.9	29.0	24.2	24.6	19.2	35.4	17.8	16.5	46.6	22.5	86.4	70.9	34.9	22.1	15.0	34.0	38.0	57.1	14.9	23.6	36.8	39.6	19.9	43.4	51.5	25.7	9.0	10.1	18.8	12.2	38.7	36.1	8.8	15.6	35.1	11.2	19.6	3.6	23.5	8.7	20.4	21.8	23.3	11.4	7.7	9.7	13.9	6.5	7.0	6.0	16.7	6.9	22.1	4.3	17.3	42.3	28.3	10.9	13.3	37.7	37.0	8.8	11.3	21.2	14.5	14.8	7.3	13.6	11.8	12.8	11.5	6.9	13.8	22.4	19.9	11.1	7.3	22.0	18.4	26.7	25.9	25.9	8.3	13.2	35.8	14.7	11.4	22.7	4.7	24.6	31.9	9.0	14.4	9.2	15.3	142.1	59.5	80.0	37.5	61.7	35.8	35.6	39.5	36.5	40.3	34.6	45.2	38.5	146.2	53.8	64.1	20.5	55.6	91.8	13.2	18.3	17.1	14.8	13.0	14.7	19.2	16.1	19.2	15.0	14.9	25.7	67.9	22.4	39.7	37.2	72.9	108.2	77.6	56.2	91.6	29.7	83.1	54.7	22.1	31.5	51.6	33.1	8.4	46.1	95.5	56.1	45.0	50.5	175.9	56.8	45.8	51.8	54.2	59.5	32.6	32.3	26.1	76.8	50.4	93.3	50.7	25.7	35.3	36.8	28.9	42.1	35.2	41.3	85.5	49.8	81.8	332.7	54.0	67.8	74.7	49.6	46.3	33.4	37.0	40.2	91.4	33.7	46.6	57.9	70.2	82.8	55.1	45.3	37.6	29.2	46.0	91.4	70.0	53.0	38.0	55.3	133.0	210.4	94.8	42.6	28.1	89.9
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180459-181179	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 25.6"	"Cell type enriched"	"Detected in some"	9	"Erythroid cells: 399.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.3;T-cells: 1.3"	"Group enriched"	"Detected in some"	8	"HEL: 22.4;Hep G2: 15.8;K-562: 56.5"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"		NA	NA		160000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Lipid droplets"		"HPA062473: AB_2684774"		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.3	0.1	3.1	0.0	3.2	25.6	0.1	0.8	4.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	2.8	1.7	0.5	0.4	0.9	0.0	0.8	1.2	0.1	0.0	0.0	0.7	0.8	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	3.6	0.1	1.9	3.1	0.0	0.2	0.0	0.0	0.0	0.2	2.2	0.0	1.3	0.4	4.1	0.0	0.0	0.7	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.5	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	22.4	1.0	15.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.3	56.5	0.0	0.0	0.2	2.5	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.8	0.0	0.5	2.9	0.0	0.0	0.7	0.0	0.1	0.9	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	0.2	0.4	0.9	0.0	0.0	0.2	0.6	1.3	0.0	0.0	0.1	0.0	4.3	3.1	3.2	0.8	4.7	2.8	1.7	0.8	1.2	1.3	0.6	3.1	2.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.0	399.8	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.7	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	4.1	0.3	7.6	3.6	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	6.0	36.1	0.0	0.1	0.3	0.6	1.2	0.3	0.0
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis, Translation regulation"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		9200	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	35.3	32.5	29.7	31.2	51.8	82.5	39.7	37.9	48.1	31.8	23.6	29.9	23.0	31.8	23.0	43.9	29.9	26.6	50.9	28.3	44.6	36.9	63.1	24.5	40.3	41.2	34.7	32.6	39.5	47.1	17.1	35.4	43.0	28.7	29.5	44.8	42.3	29.4	167.2	26.9	26.9	38.5	33.2	23.5	29.6	32.8	39.4	65.5	38.6	123.4	43.4	34.0	20.0	87.1	63.9	41.9	85.7	124.8	76.7	67.9	65.4	125.5	107.7	116.7	143.6	70.7	46.8	109.5	55.3	111.9	84.3	46.6	121.1	92.4	181.2	111.8	82.9	335.3	113.6	95.5	91.9	209.5	87.9	67.8	68.7	111.0	135.0	87.2	98.5	128.2	182.7	89.4	125.1	60.0	129.6	53.0	55.4	75.6	45.3	120.0	95.3	74.9	72.3	59.7	84.2	57.4	85.6	88.7	88.4	67.4	74.1	124.6	93.6	82.4	85.5	103.3	134.8	202.5	158.3	184.8	125.5	106.8	104.9	108.7	47.8	52.0	44.0	44.9	48.9	49.3	51.2	44.2	55.9	42.7	68.9	57.0	22.0	66.4	44.9	44.6	67.5	57.7	29.7	51.8	37.9	48.1	28.3	44.6	41.2	34.7	43.0	33.2	39.4	87.1	25.9	25.6	25.7	27.1	32.0	27.3	26.9	23.2	31.3	42.7	22.1	17.8	56.0	17.2	30.4	11.0	14.6	32.2	36.8	11.1	25.4	25.2	36.3	27.1	28.9	24.4	16.3	58.0	61.4	20.4	33.7	26.2	20.4	27.1	60.0	23.9	18.2	39.3	13.5	21.9	56.2	11.1	16.2	18.0	18.9	12.6	18.6	17.6	30.2	29.0	28.0	26.5	19.6	47.3	198.7	18.7	12.3	22.2	53.7	21.6	13.9	23.5	24.0	26.6	39.5	36.6	25.9	28.3	25.8	24.9	18.6	40.5	34.5	27.5	14.6	25.7
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	142728-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.9;testis: 7.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	80	"K-562: 2189.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		80000000		"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.6	0.0	0.5	0.0	0.4	3.9	0.6	0.2	0.8	0.5	0.8	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.5	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.1	7.3	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	27.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2189.0	0.2	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	40.0	0.0	0.1	3.7	0.0	82.9	0.5	0.0	42.4	1.8	0.0	0.0	0.0	0.1	0.4	0.0	192.0	0.0	0.3	0.0	0.0	0.3	0.3	275.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	6.6	1.9	4.8	1.3	1.8	0.0	0.1	10.4	0.1	0.0	0.1	0.0
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.2	0.3	0.1	9.8	0.2	22.1	7.6	0.1	5.9	8.9	0.2	0.7	0.9	0.2	0.3	40.8	0.7	0.8	0.9	0.3	0.1	3.9	2.9	11.9	0.6	0.1	0.1	0.1	0.2	5.5	0.3	4.5	1.2	3.4	0.3	0.2	14.2	14.7	0.2	30.2	1.0	0.3	0.1	25.9	1.5	2.7	0.2	10.5	0.5	1.9	10.2	6.9	14.0	0.1	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.2	0.1	5.9	0.3	0.1	0.1	0.1	1.2	0.1	0.2	0.1	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;esophagus: 16.8;lymphoid tissue: 19.6;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.7"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Cell line enriched"	"Detected in some"	4	"RT4: 37.1"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	5.6	0.1	0.0	9.2	0.1	27.4	2.3	0.0	4.7	2.5	0.2	0.5	0.2	0.0	0.5	16.8	0.7	0.6	0.7	0.1	0.0	0.9	1.8	8.2	0.4	0.0	0.0	0.1	0.0	3.4	0.2	1.9	0.9	1.5	0.1	0.1	3.4	2.7	0.1	17.4	0.2	0.2	0.0	19.6	0.4	0.1	0.1	4.0	0.4	1.1	7.8	7.1	4.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	58.6	2.2	0.8	0.0	16.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	177.2	0.0	84.4	0.0	0.0	2.9	0.0	0.1	0.0	4.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	3.2	6.7	0.0	0.7	94.4	81.1	57.3	159.4	0.2	0.7	0.3	0.0	0.0	24.6	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.5	1.4	0.0	0.1	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	12.2	10.6	57.4	0.2	0.0	20.1	8.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.7	0.0	0.1	2.2	0.2	0.0	0.0	1.4	0.1	0.0	66.9	106.3	13.8	1.0	0.0	0.0	66.1
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123086	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	13.9	16.1	6.2	13.7	6.7	20.5	12.6	7.0	8.4	8.4	8.4	21.6	23.1	9.6	7.6	19.3	8.5	10.8	39.0	7.4	6.8	17.6	22.9	11.5	15.6	6.7	6.2	8.3	9.9	25.1	8.3	13.1	6.4	9.5	21.6	13.5	15.2	10.0	64.4	17.6	20.2	12.5	6.2	14.5	15.3	10.2	6.7	13.0	10.8	57.0	17.1	22.3	11.6	6.1	54.3	60.5	31.8	28.5	25.6	25.2	29.2	52.0	43.0	67.8	57.5	70.7	38.5	34.3	26.3	46.1	80.8	49.8	63.2	51.8	70.5	30.8	48.0	34.1	80.8	38.6	47.3	40.9	39.4	24.2	37.4	67.9	46.5	37.9	49.1	26.1	63.1	41.1	46.3	72.5	28.0	31.4	51.5	36.6	70.1	27.3	59.9	65.4	44.0	44.8	20.9	24.2	54.8	58.7	38.2	66.7	45.6	27.1	48.7	42.4	23.6	110.4	47.0	26.9	29.0	47.8	35.5	28.8	42.7	25.6	47.8	30.1	20.2	66.4	19.0	39.0	19.6	18.2	62.2	34.7	17.1	22.1	13.1	19.1	57.4	56.2	23.5	19.0	6.2	6.7	7.0	8.4	7.4	6.8	6.7	6.2	6.4	6.2	6.7	6.1	15.5	6.4	4.8	2.3	20.8	54.8	53.2	57.0	22.8	5.3	16.1	13.7	49.3	17.2	33.3	16.5	0.0	32.9	12.4	44.6	50.9	34.9	13.7	19.0	10.4	21.0	10.8	32.8	3.8	29.3	37.9	17.1	12.8	16.7	13.3	10.4	15.7	18.5	41.8	8.4	4.5	19.2	67.1	21.0	44.1	2.3	13.4	23.5	24.9	1.9	27.9	13.0	7.2	2.0	2.7	68.4	31.9	10.5	18.4	63.5	46.4	36.0	28.9	7.1	6.6	12.5	20.1	24.4	28.4	21.8	46.0	40.9	12.0	15.6	30.2	88.6
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947557-153971818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078588	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	18.8	25.5	18.4	15.5	16.9	40.2	17.1	14.9	22.5	21.9	10.3	29.7	11.4	33.6	8.5	25.1	24.3	7.6	23.1	19.7	14.1	22.1	23.8	21.6	19.0	16.6	16.8	25.5	21.1	11.4	33.9	8.7	15.2	23.5	7.0	7.2	19.2	12.8	28.4	18.6	25.3	11.1	13.6	32.8	24.8	17.9	16.8	26.1	21.1	10.5	12.1	23.6	19.8	17.1	45.3	57.7	38.4	48.9	15.8	11.2	56.3	18.2	14.0	21.1	19.1	61.5	29.8	81.6	45.3	23.6	34.6	36.4	41.8	29.7	11.0	43.6	49.2	49.0	47.7	48.8	10.8	60.9	77.8	17.6	19.1	36.8	15.9	12.7	22.7	58.2	69.4	50.2	15.0	63.0	84.6	78.2	50.0	29.4	35.1	97.5	31.6	49.3	16.0	41.4	42.5	46.2	33.7	34.4	19.4	18.4	31.7	54.4	30.2	39.9	49.0	35.0	59.4	79.1	117.0	100.2	32.5	58.6	38.6	0.9	2.1	0.9	3.0	3.1	2.1	2.4	2.4	2.3	2.4	2.4	2.4	3.4	0.4	1.5	2.2	4.2	1.7	2.3	18.4	16.9	14.9	22.5	19.7	14.1	16.6	16.8	15.2	13.6	16.8	17.1	19.1	19.2	17.8	7.5	21.9	16.6	13.4	15.5	20.5	21.0	24.6	18.7	35.9	20.0	13.6	12.9	14.6	16.5	26.8	20.1	3.9	17.4	0.6	16.7	18.4	21.2	19.2	39.9	8.4	16.5	21.3	17.7	19.9	21.6	3.8	25.0	15.7	29.5	21.3	20.2	8.3	23.2	8.2	35.2	13.8	1.8	17.4	26.0	5.4	9.4	28.6	13.6	17.5	8.0	7.2	19.5	13.3	21.8	32.0	25.7	12.6	8.8	13.4	12.4	6.6	21.8	21.2	11.3	25.0	28.9	13.9	15.9	22.8	14.3	23.9	20.5
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022625-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 511.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 396.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 376.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	82.6	98.5	174.5	20.9	178.9	17.9	74.8	164.1	248.1	124.9	129.3	131.5	30.4	140.6	29.2	59.0	81.7	43.1	138.7	172.0	182.0	180.5	48.2	72.0	24.2	181.5	182.7	86.7	44.0	40.9	97.7	32.1	185.2	102.8	18.8	21.6	50.6	87.4	511.6	76.3	53.1	47.5	154.0	45.9	65.6	36.6	181.0	17.0	68.0	196.2	18.3	85.2	103.0	174.1	59.6	175.6	32.5	38.1	123.0	160.9	33.4	26.0	115.0	57.8	161.2	37.9	75.8	49.2	66.1	108.3	52.8	81.0	32.7	121.5	26.3	62.7	88.4	21.3	132.2	65.5	105.2	37.3	39.5	205.7	73.9	62.1	63.4	376.5	81.5	33.0	30.4	81.6	63.3	63.0	20.1	53.0	70.5	34.7	36.5	70.1	31.3	124.6	209.4	13.7	57.3	48.4	54.7	70.7	78.5	77.5	48.6	28.1	35.5	98.4	256.8	85.8	50.7	53.0	59.1	40.7	42.9	22.1	23.8	5.3	36.3	16.3	20.1	28.2	19.3	23.2	25.5	21.7	44.9	21.7	18.5	22.9	8.0	25.8	26.5	22.1	36.7	17.9	174.5	178.9	164.1	248.1	172.0	182.0	181.5	182.7	185.2	154.0	181.0	174.1	51.3	57.7	15.0	17.9	30.7	85.4	58.0	123.7	92.2	29.3	45.2	80.0	45.8	47.1	37.4	198.6	6.2	116.2	23.7	53.7	240.7	49.7	5.2	38.0	56.0	38.3	43.7	37.0	19.3	26.5	120.7	98.4	34.1	45.3	40.0	26.1	60.3	45.9	117.9	20.2	19.8	40.9	40.7	57.5	57.0	15.8	96.3	42.2	64.0	13.1	51.0	52.6	39.1	6.6	19.0	26.7	55.4	178.3	35.0	37.8	114.2	396.2	28.4	28.1	124.9	39.7	149.2	15.2	44.3	69.5	65.8	53.9	35.0	26.7	45.9	41.3
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	6.3	6.7	3.8	3.6	5.2	2.7	5.1	4.4	5.4	7.4	2.0	9.2	5.2	7.9	5.0	6.2	5.3	5.7	5.1	3.7	4.2	5.7	7.3	4.7	4.6	4.9	5.0	7.8	6.0	6.7	4.1	6.4	4.8	7.2	4.3	8.0	4.5	9.4	9.7	4.4	5.0	7.2	4.7	5.1	5.2	9.5	4.6	5.2	6.9	11.2	3.7	5.9	6.0	6.6	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	3.8	5.2	4.4	5.4	3.7	4.2	4.9	5.0	4.8	4.7	4.6	6.6	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 17.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		0.0	0.4	1.8	0.0	2.5	0.1	0.0	2.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.4	7.2	2.5	1.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	24.5	0.0	0.1	0.1	0.0	0.0	29.4	0.0	0.0	7.4	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	671.7	0.7	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	6.7	766.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.5	0.0	14.8	0.0	21.1	14.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	199.4	0.0	0.3	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277463-155289848	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 9.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.5	3.1	0.7	0.5	0.4	0.1	1.7	2.6	0.9	4.7	0.0	5.0	2.6	2.6	0.0	4.6	1.5	0.0	1.2	0.1	2.3	6.0	14.7	1.4	0.3	1.5	1.3	3.6	2.5	0.1	7.3	0.2	2.3	2.9	0.5	0.2	3.4	0.2	0.7	5.8	5.1	0.0	0.1	1.5	2.3	1.2	1.0	0.0	2.9	0.0	0.1	2.4	4.2	0.0	2.0	0.7	2.4	0.7	0.6	0.0	1.3	1.6	0.7	0.0	0.3	0.0	2.7	1.8	1.2	0.0	1.2	5.1	0.3	0.0	0.0	2.5	3.1	0.7	2.6	0.5	0.0	0.8	1.3	0.0	0.0	0.0	0.1	0.7	0.2	2.7	4.3	3.1	0.4	0.0	1.4	0.7	1.9	0.3	2.3	3.0	2.0	2.7	0.0	0.3	4.3	5.2	1.3	1.7	0.0	0.0	1.4	0.3	0.2	1.3	1.3	4.0	1.5	1.6	0.7	1.1	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	2.6	0.9	0.1	2.3	1.5	1.3	2.3	0.1	1.0	0.0	1.1	0.0	0.6	2.3	0.2	1.3	0.9	1.3	1.8	3.1	2.0	1.8	1.8	1.5	1.4	1.8	4.2	0.4	0.2	5.8	0.0	1.1	0.6	0.5	0.9	0.6	4.2	0.4	5.0	0.4	0.4	1.1	2.0	1.4	1.3	1.3	2.5	2.1	0.8	0.0	9.3	2.0	4.1	0.3	1.0	0.8	0.9	0.8	0.0	2.8	0.6	1.4	0.0	4.5	1.5	1.3	2.6	1.2	0.7	0.8	6.1	1.2	0.2	1.9	0.0	0.6	0.6	3.6	3.6	2.2	2.7	0.0	0.6	1.5	4.0	0.9
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 8.5;heart muscle: 8.4;testis: 7.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 29.4;Late spermatids: 49.5"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.0	0.4	3.6	0.0	0.7	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.4	1.0	2.8	0.0	0.0	0.0	0.0	5.0	4.2	0.0	0.1	0.0	0.5	0.0	4.6	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.5	0.0	0.1	7.2	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	2.2	1.8	1.0	2.8	5.0	4.2	4.6	2.5	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.4	0.6	0.0	0.2	1.8	0.0	1.5	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.3	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1067	"brain: 384.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Enteroendocrine cells: 3.0;Kupffer cells: 1.6;Oligodendrocyte precursor cells: 2.0;Proximal enterocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	7	"hypothalamus: 384.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"hypothalamus: 93.5"	"Region enriched"	"Detected in some"	21	"hypothalamus: 25.3"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 58: T-cells - T-cell receptor"			"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.1	0.0	1.8	0.1	1.9	0.1	0.0	0.6	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	384.8	0.0	0.0	0.0	0.0	0.6	3.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.6	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.8	1.9	0.6	1.2	0.5	384.8	0.6	3.1	1.7	0.3	52.6	0.6	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.5	0.1	0.1	3.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.2	0.6	0.0	0.4	0.8	0.0	1.6	1.0	0.2	0.0	0.3	0.0	1.0	0.8	0.1	0.0	2.0	0.3	0.4	0.1	0.0	0.4	0.0	1.6	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.9	0.1	0.9	0.1
HCRTR1	OX1R	ENSG00000121764	"Hypocretin receptor 1"	O43613	1	31617686-31632518	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.1;Inhibitory neurons: 1.0;Late spermatids: 4.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"hypothalamus: 1.5;medulla oblongata: 1.0;midbrain: 3.6;pons: 3.7;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014018	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014018: AB_1854810"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.54e-5)"	"unprognostic (3.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	0.3	0.9	0.3	0.0	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	1.5	0.4	0.0	0.0	0.1	1.0	3.6	0.0	0.0	0.0	0.3	0.5	3.7	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.0	0.1	1.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	1.5	1.0	3.6	3.7	0.1	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0
HCRTR2	OX2R	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282617	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"brain: 7.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.7;Inhibitory neurons: 18.3;Peritubular cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"AF22: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054516	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054516: AB_2682513"						"unprognostic (4.86e-1)"		"unprognostic (2.69e-2)"		"unprognostic (1.86e-2)"	"unprognostic (2.32e-1)"			"unprognostic (7.45e-2)"	"unprognostic (7.39e-2)"			0.0	0.0	1.5	0.0	0.9	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.6	0.6	0.0	0.0	0.0	2.4	7.0	0.3	0.0	0.0	0.0	0.4	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	1.2	0.7	1.5	1.6	2.4	7.0	4.5	0.7	1.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902529-35904377	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 253.7;lymphoid tissue: 115.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	27.2	9.5	14.0	53.6	13.8	253.7	14.1	13.7	18.5	9.6	16.6	12.7	11.3	8.3	4.7	5.5	9.9	11.5	8.3	13.5	17.0	10.6	14.5	40.3	68.0	18.3	14.7	5.7	6.7	2.5	9.6	24.7	17.6	9.4	8.6	2.2	10.7	8.2	4.2	6.6	28.2	11.2	17.1	115.6	15.4	3.4	18.2	59.6	7.9	3.0	37.8	16.4	8.0	22.2	0.9	0.0	0.3	0.5	1.1	0.0	0.3	1.9	1.1	0.0	0.6	0.8	1.2	26.9	1.7	2.0	0.4	0.9	0.0	0.2	0.0	0.6	0.0	239.9	0.5	0.7	0.9	139.6	154.3	1.6	0.3	0.0	0.0	0.7	0.0	14.8	2.1	33.4	0.4	0.4	16.9	54.7	0.3	0.3	0.7	0.8	0.5	2.0	0.4	0.1	0.9	0.4	1.3	0.7	0.9	0.2	0.5	177.8	0.5	1.4	1.8	0.2	0.2	1.6	1.1	39.5	1.4	272.2	0.3	124.7	725.8	105.8	1583.4	546.1	1172.3	78.6	664.6	1293.3	409.8	51.0	550.6	1108.0	196.1	1290.7	314.4	823.7	629.9	1421.2	14.0	13.8	13.7	18.5	13.5	17.0	18.3	14.7	17.6	17.1	18.2	22.2	12.3	6.4	43.3	0.0	85.3	28.6	1.3	1.7	2.8	0.4	11.4	12.8	1.2	15.7	7.1	9.2	0.0	3.8	993.2	1.8	0.0	2.8	1.3	4.0	2.5	18.3	0.0	84.2	0.1	1.2	4.7	9.5	14.8	5.5	240.4	0.3	21.0	14.3	571.1	1.7	0.1	0.9	2.0	396.6	584.5	3.0	2.1	392.7	44.4	5.6	309.9	0.7	1687.0	0.0	0.1	1.0	1.4	0.0	97.7	0.6	2.0	6.1	5.1	2.2	19.7	4.2	6.2	2.2	4.9	2.7	21.0	6.0	769.9	1.0	2.7	1.2
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	31.4	42.8	20.8	76.7	22.1	59.3	56.0	21.9	28.0	56.6	20.3	119.5	74.5	48.1	51.4	81.3	56.8	55.4	29.0	20.4	21.9	47.9	41.7	41.2	119.7	23.3	21.8	65.7	40.0	62.3	31.6	53.0	23.1	57.6	108.3	18.9	52.1	57.2	15.3	38.0	80.8	46.8	21.8	61.7	84.1	36.2	22.0	103.9	78.4	17.5	123.9	63.7	51.7	23.4	152.5	90.6	57.4	114.7	32.9	39.0	118.7	105.1	117.1	138.0	126.6	168.0	266.3	233.4	190.3	116.9	140.2	173.1	178.1	143.1	151.5	219.3	176.8	161.3	105.7	130.1	77.4	288.1	223.4	70.7	77.0	107.1	70.3	107.7	106.1	298.5	215.2	90.1	61.6	115.7	331.6	161.4	133.2	180.2	229.6	225.0	136.0	104.0	149.5	216.1	44.7	56.6	176.0	117.0	227.9	224.0	137.9	220.6	123.8	91.3	106.2	28.5	261.1	54.4	124.9	319.2	75.3	235.8	121.4	147.5	87.7	200.1	130.0	115.9	107.5	151.6	126.2	140.6	103.0	142.0	143.7	133.6	63.7	144.2	156.4	64.9	142.0	204.6	20.8	22.1	21.9	28.0	20.4	21.9	23.3	21.8	23.1	21.8	22.0	23.4	45.3	25.6	45.4	25.5	82.7	24.9	57.4	99.1	38.7	15.1	35.1	29.1	22.1	61.5	73.4	68.0	16.7	93.1	64.0	142.4	95.9	75.7	20.2	33.7	39.8	56.2	86.3	60.8	1.9	73.6	110.9	25.8	65.2	39.5	30.4	23.6	63.5	28.1	43.6	11.8	8.8	122.8	52.9	38.2	19.0	8.7	41.0	35.0	28.4	16.9	52.7	34.2	69.0	14.6	19.4	92.5	141.5	44.4	38.4	28.5	57.0	30.0	67.3	14.6	59.2	22.8	38.1	72.5	69.8	60.2	25.4	93.4	73.6	102.6	136.0	55.8
HDAC10	DKFZP761B039	ENSG00000100429	"Histone deacetylase 10"	Q969S8	22	50245183-50251405	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, DNA damage, DNA recombination, DNA repair"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB045977	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB045977: AB_11124034"	"unprognostic (1.53e-1)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.43e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (4.74e-11)"	"unprognostic (2.21e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.38e-3)"	8.9	9.8	4.9	6.0	4.8	9.6	7.1	3.6	10.3	9.3	5.4	9.9	6.6	6.8	1.2	10.7	8.0	3.9	4.9	5.1	4.5	11.5	16.8	8.5	6.7	5.1	4.5	7.6	11.2	2.2	13.2	3.3	4.5	10.8	1.5	0.2	8.7	2.8	5.1	9.2	12.6	1.9	3.9	17.2	11.4	2.2	5.1	4.2	9.5	0.5	2.8	7.2	8.1	4.1	6.1	3.3	0.9	5.0	4.2	3.3	11.4	4.2	3.4	2.3	1.4	6.4	6.6	4.0	5.7	3.1	2.2	10.2	2.1	5.9	0.5	5.4	5.7	8.5	10.1	10.4	7.5	10.9	27.0	7.0	4.4	2.3	1.3	4.8	4.2	7.8	6.3	6.1	2.0	18.7	5.8	25.9	2.0	6.5	7.4	13.4	3.3	24.6	3.8	10.5	2.7	6.5	4.2	1.4	7.2	1.2	10.8	15.8	7.4	3.9	5.7	6.7	2.5	7.8	2.6	3.6	6.4	6.7	2.8	0.4	1.6	2.5	0.7	1.8	0.6	0.4	0.3	0.5	1.3	0.4	0.3	0.3	0.8	0.5	1.0	1.2	0.6	1.1	4.9	4.8	3.6	10.3	5.1	4.5	5.1	4.5	4.5	3.9	5.1	4.1	13.9	0.0	3.4	12.1	17.7	8.7	4.8	10.3	9.1	5.7	14.3	13.6	0.6	12.8	6.8	14.7	16.7	11.6	28.6	25.4	7.9	6.3	3.3	9.3	6.9	8.5	20.9	8.4	8.9	3.8	16.2	8.1	32.6	9.0	5.1	16.6	10.0	7.9	21.1	0.0	10.6	17.3	6.1	20.0	13.3	8.3	11.1	19.9	8.8	4.7	18.1	2.9	20.6	3.5	2.4	6.1	17.8	7.9	12.3	3.4	29.2	16.3	14.3	6.5	0.0	3.0	6.3	1.0	2.3	13.1	9.5	10.3	26.0	13.5	18.3	4.4
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	24.3	39.8	7.8	22.7	8.4	37.3	25.3	7.8	9.5	25.7	9.9	23.3	18.7	23.5	26.4	34.1	26.5	20.3	24.4	8.7	8.4	24.2	39.6	21.4	32.7	8.2	8.0	26.0	28.4	44.9	18.4	22.4	7.9	20.6	24.5	16.4	25.5	21.9	40.2	40.8	23.5	26.1	8.5	27.8	23.3	15.8	8.5	38.3	24.1	34.1	42.7	26.2	25.8	8.2	59.8	40.2	74.0	109.5	68.5	54.3	47.0	42.6	93.5	94.8	134.8	86.5	49.7	86.4	54.0	56.2	67.3	51.2	72.9	98.8	117.0	74.6	79.0	68.8	33.3	50.4	48.1	83.5	60.1	47.0	63.2	55.3	71.3	49.6	61.9	76.8	67.6	44.7	61.5	55.8	92.1	72.9	63.9	36.8	31.0	65.8	76.2	62.3	49.9	59.7	60.2	49.4	57.0	57.1	71.7	46.2	61.8	52.3	32.1	58.3	36.1	45.8	71.8	36.6	47.8	82.1	48.8	78.6	50.8	41.3	51.7	39.6	34.1	53.8	45.5	47.8	42.5	41.9	107.5	47.5	45.9	38.5	21.5	35.1	46.8	55.1	55.6	43.8	7.8	8.4	7.8	9.5	8.7	8.4	8.2	8.0	7.9	8.5	8.5	8.2	19.1	9.6	13.2	16.6	36.0	44.2	26.8	38.1	37.0	33.2	29.0	25.5	15.9	18.6	19.6	12.9	60.5	55.3	43.8	18.5	21.5	33.4	10.4	10.0	21.0	21.3	18.0	50.7	40.6	35.4	51.6	28.8	19.9	10.2	18.4	33.9	21.4	18.7	38.8	50.5	38.2	19.7	28.5	19.5	44.9	4.2	22.4	31.7	32.0	10.3	51.1	33.3	38.1	22.1	21.9	33.4	16.3	22.2	36.3	28.7	19.5	20.5	10.8	36.5	26.3	18.1	24.7	25.4	27.5	38.1	51.4	61.2	30.3	42.6	25.9	30.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	30.8	24.7	39.3	10.9	33.5	20.7	28.8	48.8	48.5	40.6	3.3	36.3	11.6	33.2	15.5	45.1	34.1	15.9	53.5	40.4	31.6	24.8	17.4	33.6	14.0	37.6	41.1	45.0	22.5	31.5	48.1	22.6	35.1	29.2	7.3	24.3	22.9	15.1	77.5	71.3	22.9	14.8	22.4	26.4	24.0	19.7	40.0	10.4	30.8	28.6	11.6	29.2	37.0	50.3	8.7	5.5	14.9	3.5	28.2	21.7	53.6	22.8	56.1	11.3	18.1	12.3	9.1	13.5	9.0	54.4	16.5	6.9	17.6	9.8	4.7	21.2	28.7	26.3	18.6	28.6	12.2	8.7	35.7	31.2	16.5	12.8	15.8	19.0	9.3	10.6	20.0	26.5	65.5	6.7	14.3	26.2	16.4	6.7	13.0	54.7	41.6	35.4	1.2	3.8	38.6	20.3	6.7	27.6	31.2	21.8	39.3	49.6	5.1	27.8	17.5	6.6	11.7	43.6	39.7	16.2	16.0	10.7	13.4	11.6	9.2	9.7	5.4	13.5	3.8	7.2	4.3	5.4	11.1	7.5	4.5	4.0	20.9	4.5	16.8	9.7	4.1	7.3	39.3	33.5	48.8	48.5	40.4	31.6	37.6	41.1	35.1	22.4	40.0	50.3	24.0	12.8	13.7	11.1	20.4	29.2	32.3	9.0	26.2	87.8	23.8	21.3	27.1	30.0	11.9	20.2	118.9	21.9	19.6	22.4	21.5	17.2	20.2	17.1	10.7	22.1	46.0	9.3	18.9	8.7	53.1	24.1	10.2	25.1	12.6	47.0	24.3	9.3	22.7	82.4	31.0	14.9	6.1	18.5	17.8	10.0	48.4	29.8	14.2	12.2	16.5	18.9	11.3	14.1	26.2	11.5	16.5	43.6	14.2	41.2	21.5	7.3	12.4	60.4	65.7	31.8	40.1	4.2	32.7	28.1	32.8	218.1	17.0	29.9	11.3	25.3
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	21.9	26.0	26.6	14.2	30.7	22.9	23.6	31.1	54.2	29.6	29.8	27.8	17.8	26.8	10.6	24.4	28.2	11.1	26.0	26.7	33.0	57.9	97.3	25.2	15.6	32.6	32.7	32.5	26.3	22.3	45.6	13.8	33.9	24.4	16.1	27.9	21.6	12.2	26.1	21.4	28.0	15.3	28.9	29.4	26.6	53.8	30.6	18.8	27.1	16.1	15.1	23.7	22.8	31.0	31.0	25.7	49.6	19.1	20.2	16.6	33.4	14.4	12.4	27.2	26.2	24.9	25.7	29.9	13.8	17.1	34.6	21.3	30.6	15.5	23.2	27.7	19.1	40.7	32.2	26.0	18.3	19.2	60.4	25.7	25.1	21.5	25.3	24.8	23.5	37.4	45.9	31.9	17.7	10.9	27.0	29.3	18.5	14.2	24.5	23.1	53.5	31.3	15.8	13.3	25.9	25.3	29.5	8.7	17.4	63.4	36.1	17.5	19.1	21.5	26.7	29.3	14.2	29.6	31.3	21.3	21.3	24.0	21.5	0.0	5.1	5.8	4.7	8.3	3.4	3.7	3.3	3.4	7.6	5.3	3.1	2.9	2.5	3.6	11.7	8.3	4.0	4.9	26.6	30.7	31.1	54.2	26.7	33.0	32.6	32.7	33.9	28.9	30.6	31.0	11.4	19.2	25.1	20.9	12.5	7.5	10.2	8.8	6.2	37.6	10.7	10.4	10.6	8.6	17.5	18.4	50.1	11.5	12.6	21.4	19.6	7.9	48.1	10.0	13.0	10.3	14.4	11.4	15.2	7.4	12.3	10.7	21.9	13.2	6.3	22.5	13.6	51.9	11.1	40.4	18.4	15.5	10.2	12.3	9.8	18.4	14.0	13.2	5.4	10.3	12.7	21.9	18.6	17.1	19.0	7.2	13.2	11.3	12.8	7.1	17.8	47.6	12.4	34.0	13.1	15.5	11.1	88.4	41.7	8.6	5.8	9.7	9.7	21.8	16.2	7.2
HDAC8	"HDACL1, KDAC8, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573101	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease variant, FDA approved drug targets, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.8;Excitatory neurons: 186.8;Inhibitory neurons: 191.3;Microglial cells: 134.9;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 141.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048560	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048560: AB_2680442"	"unprognostic (1.42e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.10e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.12e-3)"	9.2	21.2	16.1	9.8	16.2	17.5	10.3	23.2	19.1	10.3	14.4	9.8	8.5	9.5	22.8	10.2	8.8	9.7	11.9	15.8	19.4	15.1	16.3	9.0	10.9	14.4	13.2	11.2	11.0	11.5	13.4	9.5	15.1	11.2	11.8	16.5	11.4	8.1	10.7	11.5	8.1	10.6	9.7	8.4	10.2	4.2	16.2	8.6	13.0	10.4	10.9	9.7	9.6	20.8	21.0	27.2	20.5	29.9	26.9	24.4	13.5	14.0	21.3	15.9	19.1	20.8	23.3	15.2	38.6	17.2	27.5	14.5	37.0	23.1	21.7	25.9	25.5	21.5	32.7	22.4	14.2	29.9	30.4	22.3	15.4	20.2	15.1	27.6	27.1	20.3	22.4	38.4	24.4	24.8	15.9	53.8	25.9	31.2	38.1	19.7	24.0	26.7	32.8	21.0	16.5	33.0	26.7	19.7	26.9	25.9	12.0	26.9	21.8	15.0	21.3	19.4	13.5	13.5	28.1	18.1	18.5	34.7	20.3	13.8	16.5	28.1	10.5	13.8	8.7	11.9	11.2	9.6	17.2	12.2	8.4	7.5	1.7	10.9	14.5	6.0	15.6	9.8	16.1	16.2	23.2	19.1	15.8	19.4	14.4	13.2	15.1	9.7	16.2	20.8	13.0	3.2	25.7	120.8	14.5	6.1	12.7	15.3	17.1	15.4	9.5	9.7	11.3	12.8	15.7	7.3	43.8	16.4	8.0	7.2	9.8	13.9	0.9	8.8	11.3	12.5	9.1	17.1	186.8	12.4	13.2	14.0	10.7	8.4	12.0	19.2	12.5	10.3	15.8	23.5	191.3	9.3	16.2	8.2	9.0	1.2	11.8	13.3	7.2	134.9	10.9	10.3	8.2	146.8	141.1	11.2	4.7	10.5	19.9	10.6	9.3	22.6	17.4	17.3	26.3	10.1	16.0	4.7	0.8	12.6	6.3	13.5	11.8	15.1	9.7	12.6
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 102.9;epididymis: 46.1"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Region enriched"	"Detected in many"	6	"hypothalamus: 102.9"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.3	0.4	0.0	3.5	5.6	4.7	1.4	0.0	0.2	2.3	0.7	3.8	4.1	2.5	46.1	4.8	0.8	11.2	0.7	0.2	102.9	0.4	0.5	6.9	0.9	0.0	13.7	0.1	1.2	0.5	0.4	0.4	0.0	1.7	3.6	0.8	1.3	0.9	0.3	2.3	4.6	2.5	0.0	0.5	12.9	1.3	17.8	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	5.6	0.0	0.2	0.2	102.9	0.0	13.7	0.0	0.0	17.8	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		44000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	47.4	84.4	58.0	20.1	65.9	19.7	42.1	59.5	98.5	47.2	78.4	38.8	20.3	36.2	29.6	49.7	37.0	15.1	82.3	60.8	64.5	75.6	22.9	31.9	27.1	65.1	66.8	41.1	44.5	49.4	50.0	15.7	63.0	38.5	22.1	31.5	45.8	23.8	118.1	39.0	30.6	13.6	60.8	27.6	43.7	58.7	61.6	22.2	40.3	60.7	24.8	39.2	39.5	60.7	29.7	81.2	46.2	191.3	23.0	30.8	59.7	36.4	41.4	30.9	33.1	122.7	30.4	119.9	80.8	57.4	89.0	26.5	53.1	41.1	36.5	46.7	166.8	55.2	43.6	125.1	65.0	76.6	45.3	56.0	61.8	49.6	104.6	44.6	20.2	67.8	205.1	51.4	59.5	162.7	61.2	73.8	57.7	79.9	58.8	92.8	37.2	25.2	68.7	34.1	84.0	44.5	43.9	84.8	88.8	35.4	50.2	126.6	18.2	37.7	44.5	58.8	75.8	72.1	48.2	110.1	56.0	122.6	80.4	13.8	33.4	6.7	53.3	30.6	43.8	71.2	57.7	72.6	36.1	59.4	71.3	78.2	7.3	62.1	29.0	38.3	55.7	44.0	58.0	65.9	59.5	98.5	60.8	64.5	65.1	66.8	63.0	60.8	61.6	60.7	23.0	25.6	41.2	22.5	39.3	44.6	64.3	114.9	70.6	62.6	73.5	114.4	119.9	37.1	55.3	62.5	14.6	86.6	56.0	35.0	338.5	86.0	61.3	50.9	60.7	24.2	64.5	33.4	17.1	98.0	156.4	67.5	33.6	37.5	38.0	84.8	9.3	21.3	112.2	69.0	17.9	76.4	77.3	54.2	20.4	42.1	91.0	34.6	80.0	15.0	31.7	90.5	155.5	19.1	10.6	58.5	45.3	114.7	47.4	101.9	72.3	254.8	38.9	25.0	39.5	83.9	72.6	124.5	74.6	88.6	43.0	45.7	47.6	145.8	84.1	57.9
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742109-156766925	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm	"Secreted to blood"	NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	96.3	89.7	95.9	72.8	98.8	305.3	90.6	98.4	113.4	91.4	98.0	109.2	130.2	77.6	70.0	186.3	112.8	62.5	119.0	92.8	95.1	135.4	222.3	113.5	64.6	106.3	99.7	86.8	93.2	92.8	67.8	71.8	98.8	81.7	118.1	68.9	96.6	56.8	234.9	155.3	128.4	70.5	100.8	77.2	99.1	42.6	99.6	157.2	90.7	132.5	114.9	106.7	102.7	105.7	491.5	249.1	258.2	125.6	150.0	203.0	296.8	158.4	406.3	366.8	234.4	279.4	500.9	335.5	310.6	325.0	158.6	338.8	408.9	365.0	356.0	276.1	299.9	278.1	339.4	241.2	202.0	411.9	227.4	152.4	335.7	292.8	560.4	278.6	272.4	249.6	387.0	260.4	293.7	369.3	345.5	459.2	472.1	755.4	347.7	384.8	156.9	435.1	401.0	162.6	396.9	432.0	380.4	480.3	199.3	319.8	387.6	621.9	242.4	181.1	286.5	230.3	408.9	364.0	486.0	555.6	238.9	318.4	235.2	6.2	9.9	9.2	6.6	8.8	4.9	5.6	5.6	5.9	11.6	6.6	5.0	4.7	5.6	5.2	10.0	11.9	8.2	6.8	95.9	98.8	98.4	113.4	92.8	95.1	106.3	99.7	98.8	100.8	99.6	105.7	51.9	70.5	99.2	12.1	35.3	147.3	185.1	90.5	76.2	66.7	89.9	66.0	91.0	98.7	75.3	71.7	27.1	44.1	72.4	121.4	80.3	112.2	48.4	144.0	79.2	66.1	124.6	217.8	12.0	132.0	107.3	66.7	62.7	91.8	30.4	67.4	35.0	164.5	52.7	53.8	12.4	104.3	48.8	45.6	89.1	47.0	40.7	71.0	39.2	14.0	57.3	71.4	25.7	5.5	16.1	165.7	59.5	45.9	59.0	281.3	138.2	118.1	126.8	34.9	19.7	70.9	57.8	27.7	28.3	108.6	159.4	54.9	50.5	83.2	114.9	228.6
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569566-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 91.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045679, HPA063707"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	165.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472297-4502208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	27.2	29.0	24.8	16.5	25.5	14.4	28.1	24.2	32.3	42.9	17.8	40.4	15.7	39.3	9.6	29.4	35.6	10.0	32.0	27.4	20.5	31.2	31.3	25.4	17.7	22.9	22.2	49.5	26.9	12.5	38.3	15.0	22.0	36.4	7.6	10.8	26.0	18.6	67.8	29.3	27.0	12.6	19.7	33.4	28.1	74.6	22.2	18.6	29.3	19.1	11.8	34.2	34.8	24.6	71.6	41.2	70.1	65.5	29.9	30.3	49.0	56.2	30.1	60.4	53.3	47.5	30.4	62.6	32.1	41.6	31.8	40.2	46.9	51.1	35.2	70.4	74.7	38.6	32.4	63.5	38.5	38.3	52.8	43.5	27.4	41.6	20.2	42.8	55.9	57.8	45.1	76.3	29.6	50.6	86.9	76.4	80.2	28.5	73.3	85.4	57.6	40.6	38.0	35.8	77.0	76.1	54.7	31.0	47.2	38.1	30.6	60.2	74.8	38.0	51.7	72.3	54.1	94.1	52.9	43.6	53.2	60.8	41.1	0.0	0.9	1.7	0.6	0.6	0.1	0.5	0.7	0.5	0.7	5.6	1.1	0.4	0.2	1.3	0.3	1.0	1.0	0.5	24.8	25.5	24.2	32.3	27.4	20.5	22.9	22.2	22.0	19.7	22.2	24.6	25.5	6.4	5.4	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.3	15.2	0.0	0.0	5.0	12.9	0.0	37.0	14.3	0.0	19.6	26.4	0.0	26.9	31.0	9.8	0.0	0.0	0.0	19.8	30.1	13.9	0.0	19.8	1.3	44.7	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	23.6	9.5	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	15.2	7.1	42.7	0.0	0.0
HDGFL3	"Hdgfrp3, HRP-3"	ENSG00000166503	"HDGF like 3"	Q9Y3E1	15	83112738-83207823	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040719	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA040719: AB_2677097"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	6.3	5.9	11.1	2.9	12.0	2.4	5.6	11.6	14.9	5.0	7.2	7.0	1.2	6.0	8.3	3.6	4.7	4.0	5.7	11.8	11.5	4.8	0.8	5.1	2.9	10.5	10.5	5.0	1.7	17.7	6.8	3.0	10.5	4.9	2.6	8.5	2.4	4.6	2.5	2.0	2.9	5.3	11.1	3.4	2.9	9.7	11.8	4.3	6.5	2.5	2.2	5.6	3.8	10.7	7.2	6.2	17.9	9.3	7.4	10.1	5.9	6.7	11.9	7.0	7.3	0.5	13.2	0.1	8.0	1.8	7.5	2.9	19.9	10.3	10.1	33.5	10.2	11.6	3.0	0.1	10.3	0.4	1.8	6.0	8.4	8.0	13.9	10.8	17.0	12.4	9.0	0.3	13.2	7.4	7.1	0.7	13.3	0.0	3.5	0.1	17.4	0.1	10.5	14.6	22.5	17.1	10.1	2.4	8.9	12.9	2.8	1.3	14.7	14.5	10.8	3.0	20.9	2.1	0.8	8.6	6.7	5.5	10.0	0.7	0.3	1.0	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.8	1.8	0.1	0.2	0.0	0.1	11.1	12.0	11.6	14.9	11.8	11.5	10.5	10.5	10.5	11.1	11.8	10.7	96.9	12.8	17.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	34.3	27.3	0.0	0.0	10.5	20.2	0.0	0.3	14.1	0.0	15.6	21.1	0.0	34.2	48.4	25.8	0.0	0.0	0.0	22.9	0.6	15.4	0.0	25.6	5.1	41.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	23.6	0.0	0.0	3.1	0.0	0.0	0.3	9.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.3	3.5	48.1	0.0	0.0
HDHD2	DKFZP564D1378	ENSG00000167220	"Haloacid dehalogenase like hydrolase domain containing 2"	Q9H0R4	18	47107408-47150500	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040697, CAB045978, HPA059818"	Approved		Approved	Vesicles		NA	NA		240000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB045978: AB_11124418, HPA040697: AB_2677084, HPA059818: AB_2684132"	"unprognostic (3.22e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.17e-1)"	13.7	26.3	29.1	10.5	31.0	10.5	17.0	37.2	33.4	10.9	27.3	17.2	13.4	11.8	16.0	14.3	16.2	11.9	27.2	28.3	31.5	23.9	30.2	13.5	19.6	34.2	31.8	14.2	17.9	27.0	15.6	11.6	35.2	17.6	16.5	22.1	14.0	17.1	15.5	11.7	13.7	13.5	31.2	13.5	15.8	11.4	31.9	28.1	26.4	24.1	21.2	13.1	10.0	37.5	14.1	9.1	34.5	16.9	20.6	28.4	9.6	15.8	15.3	24.9	25.0	4.7	11.1	23.0	13.4	17.7	11.3	12.2	19.0	21.2	35.3	19.2	17.6	22.1	15.0	23.5	28.2	31.1	19.6	23.4	25.5	14.0	31.3	27.1	21.0	37.2	22.8	26.3	32.6	19.0	29.2	19.6	33.9	11.9	9.3	28.1	22.0	31.2	31.4	21.5	31.2	26.0	15.0	10.6	19.5	23.7	16.0	42.7	15.2	18.9	15.2	5.4	11.5	33.1	16.9	19.9	23.3	32.1	18.8	21.4	24.7	19.7	20.7	22.9	21.8	27.3	21.5	20.5	23.9	26.7	27.1	21.6	2.3	30.5	23.3	15.8	24.2	21.4	29.1	31.0	37.2	33.4	28.3	31.5	34.2	31.8	35.2	31.2	31.9	37.5	8.8	16.0	18.2	21.5	16.9	7.1	11.1	10.7	13.6	22.5	17.7	10.5	13.1	15.7	14.0	11.0	14.6	25.0	9.7	15.6	72.4	18.9	1.9	11.0	8.5	11.5	13.8	13.9	28.9	17.9	15.0	11.0	12.8	6.4	7.6	15.6	13.9	28.1	21.7	45.4	29.2	16.2	14.2	20.3	15.0	2.7	17.7	15.0	16.0	20.6	22.7	53.1	14.4	36.7	45.4	16.4	19.3	23.7	9.7	17.5	16.0	57.7	16.4	27.0	19.7	15.1	19.7	20.2	35.1	13.1	6.0	19.7	12.2	29.8	21.6	13.0
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	12.2	156.4	16.8	11.1	18.0	8.4	19.5	16.2	19.3	19.9	14.5	59.7	82.9	13.4	14.9	42.1	16.5	17.8	22.4	15.8	17.7	56.3	122.8	10.2	10.2	15.7	17.0	19.9	53.0	68.4	23.1	5.0	16.2	30.4	35.9	8.0	52.2	16.1	8.8	28.3	68.5	7.7	15.7	17.6	50.1	7.0	18.5	6.7	38.7	5.7	7.6	17.6	21.1	15.5	7.4	20.8	4.4	12.3	10.7	4.7	37.0	5.4	10.1	8.6	9.3	38.3	36.1	16.2	6.6	3.0	17.0	28.3	7.0	8.3	2.9	22.9	16.1	22.4	12.5	24.1	12.5	1.4	16.6	7.4	17.4	7.0	19.7	9.9	4.5	14.9	18.0	4.0	4.1	48.3	10.4	6.5	9.9	73.7	16.1	8.5	0.0	13.2	11.0	15.4	11.1	7.0	9.3	39.4	14.0	9.5	24.8	4.7	4.5	1.7	0.1	1.4	1.9	9.7	20.2	6.8	2.1	0.1	1.3	0.2	3.7	8.2	12.4	2.1	14.0	14.8	14.2	11.5	6.1	16.6	14.5	11.1	2.4	8.2	0.2	14.1	17.1	8.5	16.8	18.0	16.2	19.3	15.8	17.7	15.7	17.0	16.2	15.7	18.5	15.5	4.1	9.6	10.1	24.5	19.7	9.9	20.6	26.6	10.8	10.3	38.6	31.2	15.8	80.1	32.6	23.9	10.4	29.4	11.7	214.0	86.1	84.8	0.2	20.9	6.4	9.4	40.3	15.4	9.2	156.4	16.5	8.6	112.7	22.3	7.6	122.4	9.7	85.4	20.6	1.7	10.4	80.4	28.5	6.5	3.7	2.0	14.3	6.9	10.6	6.5	13.7	12.1	15.5	5.5	4.9	104.8	208.6	9.1	9.3	23.7	254.0	275.1	33.3	13.8	6.6	5.5	11.1	0.3	6.0	42.9	14.6	31.6	14.0	26.0	94.6	51.4
HDHD5	CECR5	ENSG00000069998	"Haloacid dehalogenase like hydrolase domain containing 5"	Q9BXW7	22	17137511-17165287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Ductal cells: 35.2;Extravillous trophoblasts: 42.2;Granulosa cells: 37.0;Hofbauer cells: 42.3;Proximal tubular cells: 41.1;Theca cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005548	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA005548: AB_1078497"	"unprognostic (4.04e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.54e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.21e-3)"	17.4	29.7	15.0	13.2	15.3	16.5	17.3	15.4	15.7	12.9	16.7	21.5	26.5	14.6	6.8	21.7	13.6	9.8	45.0	15.4	14.8	19.8	40.5	12.6	14.5	15.4	14.9	12.2	20.9	17.5	11.6	8.1	14.6	15.5	14.1	5.7	18.6	10.0	46.9	23.0	17.2	11.4	14.8	19.3	19.9	15.9	15.9	13.6	10.1	55.7	12.0	16.5	14.1	15.0	64.0	41.5	30.5	41.5	17.7	10.8	38.8	17.9	19.6	47.1	50.2	61.1	23.3	103.9	29.3	21.6	23.0	44.0	38.7	42.0	21.8	31.6	56.7	0.0	30.7	0.0	29.4	47.6	23.5	26.1	51.1	21.0	23.1	26.4	33.3	67.4	31.0	26.2	24.9	62.1	84.2	97.2	46.6	97.9	36.7	47.4	45.8	26.3	32.2	34.7	61.4	46.5	34.9	49.9	54.3	23.9	50.1	58.5	29.1	39.7	29.4	28.2	31.3	41.3	48.5	77.8	32.0	0.1	34.2	12.3	86.2	4.7	28.4	56.7	35.6	24.6	26.4	25.8	74.5	23.6	34.3	29.3	4.5	30.7	31.4	30.9	29.7	48.0	15.0	15.3	15.4	15.7	15.4	14.8	15.4	14.9	14.6	14.8	15.9	15.0	21.5	6.4	2.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	23.9	22.4	0.0	0.0	5.0	5.5	0.0	26.5	9.3	0.0	43.0	35.2	0.0	8.4	14.9	9.2	0.0	0.0	0.0	28.2	42.2	7.7	0.0	11.5	5.1	37.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	5.2	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.5	0.0	0.0	41.1	1.5	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	15.7	3.4	55.8	0.0	0.0
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004189, CAB026457"	Enhanced		Supported	Cytosol		NA	NA		95000	"Cluster 14: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.39e-5)"	"prognostic unfavorable (4.12e-4)"	159.7	135.7	54.9	114.0	62.4	105.4	150.9	54.7	55.0	204.1	169.6	181.9	136.2	138.5	180.0	194.2	212.9	156.1	160.3	59.3	55.3	135.1	247.7	112.8	81.2	67.6	65.4	151.4	603.8	164.1	141.6	176.1	62.1	182.0	171.1	66.8	446.8	143.0	367.6	118.6	136.0	171.8	60.2	79.2	231.6	226.5	78.0	74.7	191.3	365.8	111.1	158.6	98.6	76.0	310.0	239.5	237.4	383.7	587.9	715.3	362.6	736.7	719.9	319.7	451.3	233.1	299.2	93.2	88.1	1039.3	334.0	235.2	356.9	465.8	528.2	150.4	236.0	323.0	305.1	535.7	566.7	233.0	251.4	528.8	369.1	466.0	515.9	500.4	448.1	140.9	310.1	120.0	511.9	309.5	120.4	106.1	237.9	290.4	161.2	111.7	511.9	175.5	255.1	380.1	208.4	223.5	332.3	334.5	278.4	304.2	262.6	201.8	585.4	402.1	255.1	551.5	325.3	136.2	130.8	166.5	488.1	161.1	371.8	26.0	39.3	17.4	15.6	41.0	20.3	19.6	17.7	18.8	41.3	12.7	15.5	15.1	22.0	19.2	58.1	26.4	18.1	27.5	54.9	62.4	54.7	55.0	59.3	55.3	67.6	65.4	62.1	60.2	78.0	76.0	53.9	76.9	102.7	38.5	60.6	70.2	117.4	80.4	150.2	41.0	125.3	98.8	220.5	71.4	124.9	75.4	43.8	133.9	34.7	176.2	135.0	106.7	111.0	152.8	178.3	80.8	96.5	72.6	44.5	122.1	166.5	156.3	203.4	168.2	68.4	199.3	86.7	199.3	94.6	69.0	45.9	291.1	30.5	70.3	66.4	398.0	148.8	75.1	56.9	46.9	77.8	53.5	20.6	46.3	58.1	116.5	118.4	174.9	354.7	203.9	136.3	117.9	163.3	40.0	65.7	126.5	117.0	132.1	120.7	192.4	77.6	215.5	50.7	134.0	163.2	156.1
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.1;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 45.8;Oligodendrocytes: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	1.3	1.6	0.6	0.7	0.9	0.0	1.6	2.9	1.6	1.8	0.0	1.3	0.3	1.8	1.5	1.1	1.6	1.3	1.1	0.8	1.3	1.1	1.0	1.0	0.5	1.1	0.6	2.1	0.5	1.2	1.2	0.3	1.0	1.4	1.1	1.8	1.3	1.5	0.4	0.4	0.7	1.7	0.8	1.0	0.7	1.0	0.6	0.4	1.4	0.4	0.6	1.3	1.0	1.3	0.0	1.5	7.5	0.0	4.4	3.9	0.0	2.3	3.2	5.0	4.9	0.3	0.8	0.0	0.4	1.8	6.2	0.3	0.1	0.5	4.3	0.0	0.3	0.0	1.4	0.0	3.6	0.0	0.0	2.2	0.0	3.1	2.2	3.2	5.4	0.0	0.0	0.0	4.9	0.1	0.0	0.0	4.7	0.0	2.2	0.0	5.7	0.0	2.4	1.0	0.2	3.9	0.0	0.1	0.0	2.7	0.4	0.0	6.4	2.5	1.9	0.8	2.2	0.1	0.0	0.0	1.5	0.0	0.9	0.0	2.3	0.0	0.7	3.5	0.1	1.8	0.2	0.2	3.2	0.5	0.6	0.4	0.0	0.9	3.5	0.3	0.1	0.6	0.6	0.9	2.9	1.6	0.8	1.3	1.1	0.6	1.0	0.8	0.6	1.3	7.8	0.0	2.7	19.2	2.8	2.5	23.1	2.8	5.7	9.4	4.8	5.2	1.9	1.5	3.5	5.5	12.5	0.0	2.7	1.7	0.0	7.0	8.7	2.9	7.1	6.7	7.1	0.4	51.1	1.8	0.0	7.7	2.0	6.6	1.3	4.1	1.8	0.7	1.0	6.7	56.7	1.5	0.0	1.9	3.6	2.1	4.1	4.1	0.0	20.6	3.8	4.1	1.0	45.8	26.5	2.9	1.9	3.4	1.2	12.4	0.5	2.9	1.3	5.3	0.0	8.8	7.5	2.4	0.3	3.0	1.7	0.1	1.5	4.7	1.3	19.6
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604516	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		470000	"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	8.5	5.6	3.3	11.1	4.1	12.7	9.8	4.6	4.0	6.8	3.3	6.2	5.6	8.7	6.5	7.3	7.0	5.5	4.4	3.5	3.7	5.4	5.5	5.2	12.9	3.7	3.3	9.4	8.7	7.9	3.4	7.7	3.8	6.2	7.5	4.8	6.2	6.4	6.6	10.4	6.2	8.0	3.7	8.5	6.2	14.4	4.2	10.1	7.9	5.7	13.5	10.8	6.7	6.5	35.2	41.4	21.2	32.3	29.1	32.5	47.4	27.7	17.8	31.2	27.7	41.8	29.0	57.3	30.4	25.8	19.3	41.5	48.7	29.7	42.0	29.0	56.0	40.7	28.3	36.1	26.1	73.5	25.2	26.7	26.2	47.2	40.5	14.9	36.3	25.9	93.8	18.8	31.5	18.8	35.1	20.1	84.9	44.8	16.9	38.6	30.6	53.8	19.9	34.9	19.9	44.1	33.5	23.7	28.3	14.1	28.2	27.2	34.7	31.2	29.5	40.6	69.4	35.4	47.2	65.5	27.8	40.2	47.4	1.6	3.3	1.0	6.0	4.2	5.6	9.1	5.9	6.6	4.0	6.5	8.1	7.8	0.4	5.7	4.2	5.2	5.3	2.3	3.3	4.1	4.6	4.0	3.5	3.7	3.7	3.3	3.8	3.7	4.2	6.5	13.3	3.2	12.8	19.6	21.8	19.8	16.3	8.3	26.2	12.4	9.8	7.6	4.2	7.2	11.7	5.5	18.8	8.1	15.0	3.6	3.9	8.9	10.5	8.4	26.3	12.4	4.2	12.6	35.1	8.5	10.8	15.2	8.6	11.3	32.9	23.4	10.4	9.7	7.5	6.7	30.4	6.2	4.1	11.3	7.5	2.7	14.0	11.7	1.8	26.2	9.6	3.0	9.2	36.2	34.1	12.0	4.3	10.1	19.0	15.7	3.3	5.6	11.5	9.6	0.0	19.4	11.8	29.3	30.1	19.3	16.9	4.9	18.1	15.6	11.1	12.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HEATR4	MGC48595	ENSG00000187105	"HEAT repeat containing 4"	Q86WZ0	14	73478484-73558947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;testis: 11.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Early spermatids: 85.5;Excitatory neurons: 19.8;Inhibitory neurons: 16.9;Late spermatids: 29.3;Oligodendrocyte precursor cells: 13.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.2;SCLC-21H: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003642, HPA079348"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"HPA003642: AB_1079376, HPA079348: "	"unprognostic (5.25e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	0.5	0.5	0.2	0.8	0.2	0.9	0.4	6.4	1.0	0.7	0.0	0.4	1.9	1.0	0.3	0.6	0.6	0.8	0.6	0.8	0.0	0.4	0.8	0.5	1.6	0.0	0.0	1.0	0.9	0.2	0.5	0.3	0.1	0.4	0.1	2.9	0.8	0.1	1.9	3.6	0.8	0.1	0.0	1.0	0.7	11.5	0.1	0.0	1.0	0.0	0.0	0.3	0.5	0.8	0.7	0.8	0.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.2	0.0	2.2	0.2	0.9	0.3	0.2	0.7	0.4	0.4	0.3	0.0	1.1	2.4	0.3	0.8	1.1	1.2	0.5	1.3	0.1	0.4	0.1	0.9	0.7	0.1	0.6	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	0.4	0.1	0.2	0.5	0.5	0.3	0.0	0.6	0.5	0.5	0.3	0.3	0.0	0.2	0.2	0.1	0.2	0.2	6.4	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.2	0.0	1.5	27.4	0.2	0.3	0.5	0.1	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	85.5	0.3	0.3	0.4	0.0	0.0	19.8	0.0	0.2	0.5	0.0	0.9	0.0	0.4	0.0	0.6	0.1	0.0	16.9	0.2	0.0	0.0	1.0	29.3	0.6	0.3	0.0	3.7	0.0	0.6	0.0	13.0	6.8	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.9	0.7	11.1	1.6	0.0	0.9	0.1	0.4	0.1	0.0	0.1
HEATR5A	"C14orf125, DKFZP434I1735"	ENSG00000129493	"HEAT repeat containing 5A"	Q86XA9	14	31291788-31420550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 120.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 120.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049539	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA049539: AB_2680809"	"unprognostic (2.63e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.47e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.11e-6)"	"unprognostic (1.00e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.00e-2)"	8.6	11.1	8.9	8.9	12.5	7.0	8.0	11.0	8.8	9.6	9.7	14.1	10.3	7.3	5.8	10.0	8.9	7.4	16.3	8.2	12.9	10.2	8.7	8.9	5.7	13.8	11.6	6.2	4.8	9.1	7.5	12.1	15.5	5.8	11.4	7.4	8.0	5.7	12.1	4.2	12.0	10.3	10.1	8.0	7.5	8.2	10.5	3.5	7.6	20.3	6.7	10.9	6.6	18.5	28.3	43.3	12.2	15.7	29.0	27.3	25.3	33.6	28.3	18.0	18.3	17.4	21.1	15.1	31.4	50.7	10.8	18.6	23.2	10.3	25.5	11.5	21.4	11.4	56.5	73.8	16.9	21.9	15.8	12.8	5.5	15.4	14.6	14.1	22.8	6.9	23.4	15.2	21.0	25.2	8.2	9.4	9.3	17.8	25.2	4.7	24.1	8.6	11.9	17.5	5.1	15.3	77.2	35.3	78.4	17.0	20.0	6.2	35.4	13.1	19.6	22.5	13.6	14.9	42.3	23.8	3.9	12.0	19.5	120.4	11.8	47.3	2.7	11.7	1.6	4.7	1.9	2.4	8.2	3.6	1.6	2.9	38.4	3.7	18.1	3.7	2.0	4.6	8.9	12.5	11.0	8.8	8.2	12.9	13.8	11.6	15.5	10.1	10.5	18.5	7.8	28.9	20.2	58.4	7.5	5.9	2.4	6.3	5.2	12.1	9.9	5.5	17.0	5.7	15.5	18.4	14.6	13.1	2.7	33.5	1.9	11.7	3.5	16.3	9.0	8.7	6.7	2.5	27.1	11.7	10.8	13.1	9.7	7.4	11.4	6.9	10.4	14.8	10.6	1.7	38.8	13.5	10.2	14.8	10.8	1.3	12.2	13.6	10.6	42.2	15.1	19.2	1.0	67.8	96.6	17.6	22.4	11.7	10.1	6.3	17.3	8.9	21.8	9.3	0.0	18.1	9.6	21.7	13.2	10.0	7.2	18.1	5.9	11.4	13.1	4.9
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084372	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		6800	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Vesicles, Cytosol"		"HPA042025: AB_10959880, HPA055639: AB_2682870"	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	9.7	8.8	7.1	15.0	7.1	24.3	14.5	11.7	9.8	9.9	4.9	9.9	10.8	9.5	16.9	11.7	8.1	10.7	9.7	7.4	6.4	9.3	9.3	10.8	31.9	5.8	5.2	9.8	18.2	13.4	6.3	10.2	6.4	11.4	13.5	24.3	14.3	7.7	4.9	18.2	11.5	8.3	3.9	19.0	12.3	9.6	7.0	24.7	11.8	9.4	31.2	10.1	8.5	8.1	16.2	8.1	11.7	17.8	11.9	11.7	14.9	10.1	7.4	9.0	9.1	9.6	10.9	34.6	7.1	8.6	11.9	13.4	11.6	8.2	11.7	17.0	12.6	22.6	11.3	13.1	7.4	24.5	28.5	10.8	11.2	13.0	12.3	9.9	15.5	18.3	21.6	29.8	10.9	9.6	21.5	17.4	7.7	16.7	5.6	20.5	11.9	26.3	10.5	13.8	14.3	12.6	10.6	16.7	7.8	11.7	12.0	7.9	17.2	13.5	7.7	9.9	7.9	18.5	16.2	39.0	11.0	14.3	9.0	18.3	5.0	12.3	7.7	2.8	7.1	9.7	8.5	8.7	9.0	14.0	8.7	7.6	5.2	7.5	4.4	11.2	9.7	5.9	7.1	7.1	11.7	9.8	7.4	6.4	5.8	5.2	6.4	3.9	7.0	8.1	12.9	22.4	10.3	35.9	20.8	9.8	4.2	4.7	6.8	13.0	11.9	8.3	20.8	8.6	7.1	5.5	10.4	7.0	24.4	11.3	1.9	4.6	6.3	14.8	10.0	9.5	5.4	18.7	62.3	6.2	6.2	9.4	25.5	11.1	7.0	9.8	11.7	7.8	6.3	16.8	58.9	8.9	6.1	17.0	15.7	2.6	9.0	13.2	7.2	56.2	9.2	6.5	16.5	57.3	69.7	8.8	6.3	6.4	17.6	5.5	12.7	5.4	12.8	16.2	19.7	6.5	10.6	3.6	11.2	11.7	11.6	5.6	14.5	7.7	8.7	4.9
HEATR6	"ABC1, FLJ22087"	ENSG00000068097	"HEAT repeat containing 6"	Q6AI08	17	60041008-60078922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 64.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030789, HPA062157"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA030789: AB_10601660, HPA062157: AB_2684700"	"unprognostic (1.98e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.22e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.02e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	4.5	7.2	5.3	2.1	6.0	3.1	4.3	6.8	5.9	6.7	4.4	7.4	1.8	7.1	3.2	4.6	6.6	1.9	5.1	5.1	5.3	4.1	3.6	5.0	3.0	6.2	5.4	7.7	5.1	3.4	7.3	2.7	6.2	5.7	2.3	5.2	5.2	3.5	6.0	5.5	6.1	2.7	5.4	7.2	4.9	4.9	5.8	3.0	4.6	2.4	2.2	6.5	5.2	7.8	4.8	13.0	9.5	7.5	5.1	9.1	6.9	4.5	8.9	8.8	9.7	5.2	3.6	1.8	7.8	8.0	7.1	4.9	5.6	6.0	11.9	4.1	7.2	9.3	8.8	9.7	5.6	7.0	10.1	7.1	8.8	6.4	7.6	9.5	4.7	6.0	5.9	5.1	6.6	64.6	8.9	3.6	5.9	3.9	8.7	3.2	16.9	5.8	5.7	7.1	5.4	13.7	4.6	1.6	6.6	8.2	7.9	5.6	4.5	8.9	15.0	8.2	8.4	6.5	7.1	0.1	7.6	5.1	6.9	2.4	3.4	3.4	3.4	5.4	3.2	8.2	2.5	2.5	6.0	4.3	3.3	2.6	0.5	3.0	5.6	2.9	2.9	2.7	5.3	6.0	6.8	5.9	5.1	5.3	6.2	5.4	6.2	5.4	5.8	7.8	4.6	12.8	6.3	9.4	8.0	0.9	2.8	6.2	6.2	11.1	3.1	5.0	9.2	2.8	8.1	7.3	10.4	5.7	5.0	1.1	3.9	4.8	1.0	4.8	9.1	5.1	6.7	3.0	13.1	3.3	3.4	7.4	6.6	4.3	11.4	8.8	4.2	2.8	4.6	6.7	13.7	1.5	4.1	5.6	2.6	0.7	3.4	8.5	1.8	15.9	15.3	8.8	7.2	16.6	25.3	2.9	1.0	11.3	3.3	1.7	1.5	3.3	10.5	6.6	6.6	6.5	15.4	5.1	7.7	3.6	2.3	2.1	7.6	10.1	3.1	1.2
HEATR9	"C17orf66, FLJ32830"	ENSG00000270379	"HEAT repeat containing 9"	A2RTY3	17	35854946-35868891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 10.1"	"Group enriched"	"Detected in some"	17	"Early spermatids: 88.4;Late spermatids: 36.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA023129	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA023129: AB_1845599"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.44e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.61e-10)"	"unprognostic (6.78e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.61e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	88.4	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	36.4	0.6	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0
HEBP1	"HBP, HEBP"	ENSG00000013583	"Heme binding protein 1"	Q9NRV9	12	12974870-13000265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 242.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 837.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056417, HPA075277"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		290000	"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA056417: AB_2683122, HPA075277: AB_2686741"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.45e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.43e-2)"	72.5	108.1	43.1	21.0	49.6	57.9	66.6	48.0	46.0	54.8	47.3	44.5	242.9	43.8	17.4	42.6	49.9	41.4	58.5	40.9	46.0	69.1	145.8	54.6	28.2	52.5	46.5	80.0	75.9	50.2	27.8	34.6	49.9	42.4	21.7	15.2	43.7	36.8	39.3	59.6	165.7	38.7	49.9	58.5	45.1	29.8	46.8	19.5	122.6	37.7	21.4	51.2	50.3	53.5	74.2	46.2	29.3	54.8	229.6	167.6	20.5	65.0	91.0	60.2	79.7	29.8	26.6	21.2	25.2	128.8	51.9	64.7	37.6	54.2	69.1	3.0	30.0	12.0	51.0	74.2	159.1	22.3	11.3	134.7	47.9	80.7	101.9	187.0	124.3	25.1	13.6	19.4	103.9	48.1	18.3	34.9	42.5	71.5	30.0	40.2	85.3	22.1	50.8	74.1	16.6	14.8	85.6	41.1	86.5	84.2	21.3	33.6	140.2	45.7	53.1	72.6	36.2	16.4	14.4	7.9	73.2	38.5	18.8	15.6	65.7	17.2	9.6	49.4	13.5	11.5	16.5	10.4	51.2	11.8	20.6	12.1	21.0	18.7	69.8	25.3	9.7	25.9	43.1	49.6	48.0	46.0	40.9	46.0	52.5	46.5	49.9	49.9	46.8	53.5	120.1	54.5	21.3	2.0	14.9	37.5	56.2	38.3	39.9	43.0	73.3	95.8	26.7	115.8	19.8	57.0	4.2	36.2	14.5	56.5	99.7	89.5	33.8	8.6	27.4	80.4	20.4	174.4	1.5	100.3	27.1	68.6	28.5	14.6	1.3	31.6	162.4	121.7	82.0	6.7	1.7	45.3	18.3	85.4	43.1	13.0	89.2	53.7	62.2	0.0	78.1	44.2	10.3	4.5	3.5	71.1	90.5	94.0	8.0	79.8	837.6	93.0	7.0	6.7	52.6	35.7	40.8	13.8	7.5	44.5	36.1	26.3	14.5	84.3	93.6	54.3
HEBP2	"C6orf34, SOUL"	ENSG00000051620	"Heme binding protein 2"	Q9Y5Z4	6	138403531-138422197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 678.8;Urothelial cells: 1174.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 219.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016928	Approved					NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA016928: AB_1850572"	"unprognostic (8.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.76e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.07e-4)"	168.1	34.4	13.9	15.0	11.2	31.8	147.3	13.8	13.8	50.6	14.8	51.7	21.9	35.2	28.0	131.1	30.4	12.8	78.5	11.2	15.8	42.4	72.3	26.4	7.0	14.1	17.4	27.8	37.2	14.6	27.2	13.3	14.8	52.7	19.2	10.1	72.2	10.5	132.8	80.4	32.7	13.3	13.4	17.6	54.3	7.5	22.9	8.6	27.0	33.5	12.3	51.5	81.5	12.5	42.8	8.6	13.6	45.4	42.5	17.1	88.2	45.7	12.8	6.0	9.9	23.2	28.3	1.3	74.0	24.0	29.0	40.0	13.2	22.7	3.4	31.0	60.8	17.4	8.7	42.9	24.8	27.4	0.1	20.8	25.8	6.5	22.6	32.2	23.7	31.5	40.7	23.4	10.5	34.9	9.0	83.7	17.7	22.2	33.1	29.1	20.5	26.1	26.5	31.8	31.0	5.7	47.5	85.5	29.4	21.0	27.6	219.5	28.9	14.5	40.8	18.7	46.1	36.5	31.5	17.2	25.2	41.6	9.4	5.6	7.9	5.6	1.5	8.2	2.0	5.0	4.3	2.5	7.4	2.9	2.0	1.7	14.6	1.9	5.0	4.6	6.4	2.3	13.9	11.2	13.8	13.8	11.2	15.8	14.1	17.4	14.8	13.4	22.9	12.5	106.3	19.2	31.6	5.9	48.7	117.5	387.1	73.4	71.7	28.6	274.7	262.4	160.8	190.1	98.1	121.4	14.6	273.3	49.2	231.9	295.4	304.3	4.5	167.0	104.2	91.7	102.2	38.3	1.1	578.1	408.5	70.7	72.9	229.9	45.1	38.4	74.6	547.6	93.6	18.5	1.0	169.4	79.3	84.7	58.5	10.9	67.7	70.9	58.7	8.4	98.3	90.5	51.5	3.5	1.8	678.8	224.6	66.5	68.2	510.0	115.2	353.0	72.7	38.9	59.2	78.4	89.0	11.7	58.2	201.2	204.9	291.3	59.9	29.2	141.8	1174.8
HECA	"dJ225E12.1, HDC, HDCL, hHDC"	ENSG00000112406	"Hdc homolog, cell cycle regulator"	Q9UBI9	6	139135080-139180802	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 125.8;Langerhans cells: 153.3;Suprabasal keratinocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012581, HPA042313"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA012581: , HPA042313: AB_10796903"	"unprognostic (2.98e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-3)"	"unprognostic (5.77e-2)"	17.2	8.7	10.5	21.5	10.4	39.2	14.2	10.1	13.8	13.8	7.8	12.7	16.5	13.4	6.4	19.3	12.6	13.1	17.4	12.1	11.3	6.4	10.8	19.2	28.8	10.7	11.1	16.7	9.9	9.7	7.0	10.9	12.6	9.5	12.4	3.9	17.9	8.1	20.3	26.1	17.6	13.8	11.9	27.5	12.0	9.5	12.4	31.6	9.6	15.8	25.8	14.2	15.9	14.1	4.8	1.0	9.2	10.5	20.8	19.0	6.8	8.6	14.4	3.8	8.8	1.9	5.3	20.9	12.2	17.9	9.1	7.9	5.6	7.8	7.0	32.9	11.9	10.5	4.6	0.3	6.5	18.6	9.2	21.7	18.8	8.3	10.1	10.4	12.9	13.8	4.5	27.5	7.1	4.9	9.0	15.1	1.7	4.2	1.7	14.0	9.3	10.6	3.3	15.2	8.8	2.6	7.1	19.1	5.5	10.2	4.4	24.4	16.4	6.7	6.3	15.2	7.5	16.4	13.1	18.8	2.4	10.7	3.8	7.0	1.3	2.0	2.8	1.8	3.5	1.5	4.3	3.8	1.0	1.9	4.1	4.1	5.0	1.5	5.5	1.1	3.9	1.4	10.5	10.4	10.1	13.8	12.1	11.3	10.7	11.1	12.6	11.9	12.4	14.1	35.6	6.4	13.9	10.1	38.2	125.8	22.4	15.9	38.7	1.8	29.1	14.4	41.9	8.6	11.6	11.0	2.1	7.3	70.2	53.4	0.0	7.0	12.0	37.8	18.5	34.9	13.1	22.5	20.4	9.8	6.2	22.3	11.7	53.4	13.3	11.7	36.8	13.0	19.1	1.7	23.2	25.5	16.2	84.3	153.3	12.4	15.5	65.7	44.4	38.4	25.7	6.6	29.9	13.0	10.9	14.7	28.4	19.5	48.8	42.4	34.8	4.7	12.3	2.7	52.6	26.4	23.7	12.6	6.7	33.7	142.2	17.4	76.7	10.8	17.2	59.1
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 127.5;Inhibitory neurons: 99.4;Microglial cells: 60.0;Oligodendrocyte precursor cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA037767	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	6.6	5.8	6.9	3.7	7.7	1.6	7.3	8.1	8.7	9.0	2.2	8.3	3.0	12.0	11.3	5.3	9.4	7.9	6.0	7.2	5.2	7.1	3.2	6.9	3.4	3.5	3.6	11.8	5.3	7.5	6.9	7.3	1.9	16.8	5.0	11.7	5.7	16.4	5.8	4.6	4.6	12.6	3.3	3.8	5.5	7.0	5.3	3.8	6.7	7.2	2.3	8.2	7.4	6.8	5.8	2.9	29.0	12.0	6.2	6.8	5.2	4.7	6.2	9.2	8.5	0.3	5.4	0.0	3.9	4.8	5.4	0.4	7.9	3.3	11.3	6.3	9.8	3.4	23.1	1.8	3.1	0.7	2.1	7.0	2.9	6.7	5.7	13.0	7.0	7.1	4.5	14.6	14.5	2.7	3.6	1.8	12.1	0.5	2.9	9.0	19.1	3.5	6.5	1.6	6.8	7.2	9.1	2.0	9.4	8.8	13.2	2.0	7.3	9.2	6.3	0.6	8.9	1.0	2.0	8.2	8.1	0.1	5.4	0.0	0.0	0.0	0.4	0.4	0.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.0	2.8	0.1	0.0	0.0	0.2	6.9	7.7	8.1	8.7	7.2	5.2	3.5	3.6	1.9	3.3	5.3	6.8	9.4	0.0	5.1	45.4	3.5	6.1	8.8	3.6	8.6	20.6	6.3	8.4	7.9	4.3	6.0	5.5	27.1	0.4	1.2	1.1	21.5	2.7	2.8	6.8	14.2	8.9	9.0	1.3	127.5	3.7	0.4	12.8	7.1	7.3	3.8	7.8	8.2	1.2	6.5	28.6	99.4	2.7	4.1	7.0	6.5	2.0	12.2	7.0	7.2	60.0	2.3	13.1	0.0	87.0	21.2	2.5	1.4	14.3	4.5	4.9	0.5	1.4	7.2	9.1	13.1	15.8	10.5	9.5	9.5	8.4	4.4	0.4	3.0	4.5	1.2	4.3
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011324	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.7;Proximal enterocytes: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (3.19e-1)"	22.8	24.5	19.7	12.3	21.2	15.0	20.0	20.9	20.6	17.1	18.7	33.2	47.2	18.1	16.0	26.4	13.8	12.3	17.0	20.4	20.7	19.6	30.5	14.0	16.5	22.2	20.5	19.5	37.0	26.7	11.9	14.2	22.3	14.8	26.2	7.4	34.1	15.6	39.9	27.9	40.4	14.8	19.8	20.1	22.6	13.6	20.9	12.7	17.0	24.0	14.4	20.4	18.9	22.6	22.1	19.8	12.4	20.1	42.5	26.5	24.3	20.6	31.2	22.3	25.2	28.7	6.8	10.3	17.1	34.1	50.0	20.2	29.7	21.5	20.0	19.3	22.8	16.6	28.4	24.9	37.2	13.0	26.8	28.6	36.5	38.4	14.8	23.2	50.4	17.8	38.0	11.3	28.9	18.8	16.6	10.6	17.1	24.9	29.6	19.5	22.7	15.0	33.2	25.7	29.7	12.4	27.9	47.8	25.5	31.1	15.5	12.0	38.0	25.7	20.4	32.2	23.9	14.4	18.3	5.8	41.3	14.0	12.9	10.7	8.0	8.0	7.3	10.9	6.3	6.0	6.1	6.5	7.3	3.3	5.0	6.1	2.8	4.0	6.3	5.5	6.7	6.5	19.7	21.2	20.9	20.6	20.4	20.7	22.2	20.5	22.3	19.8	20.9	22.6	6.9	3.2	8.2	7.2	5.6	3.8	2.2	3.1	8.6	5.2	8.5	6.2	6.0	8.6	5.8	5.5	6.2	7.1	9.2	33.7	1.9	10.3	1.2	4.0	7.5	7.0	2.4	20.6	5.4	15.5	14.2	7.0	21.4	8.1	6.3	6.4	6.4	14.1	13.6	6.7	5.0	15.1	0.0	15.3	2.9	2.3	14.6	7.8	3.6	4.7	10.2	3.1	5.2	2.0	4.7	13.2	28.1	9.8	9.1	2.8	44.8	6.9	1.4	6.2	6.6	4.5	6.7	4.5	7.4	9.7	6.1	6.0	7.1	13.5	14.9	2.3
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.7	6.5	6.3	3.1	6.1	14.2	6.8	15.6	6.9	10.0	3.4	11.3	2.0	9.5	4.0	11.0	8.4	3.1	6.8	5.9	2.0	7.5	7.6	7.8	3.8	1.0	0.8	8.5	8.8	6.1	11.7	4.1	1.3	10.5	3.6	10.8	7.9	4.0	8.0	10.7	7.6	4.2	0.4	7.6	10.0	6.8	1.2	6.5	13.5	5.6	4.1	8.8	9.7	6.7	5.1	9.2	7.7	6.1	8.7	7.4	3.2	3.2	3.6	4.8	4.0	8.6	1.3	5.2	3.2	6.7	5.4	4.6	10.8	4.3	3.9	7.0	9.4	8.6	10.7	3.8	2.6	6.1	6.3	4.7	4.8	7.3	5.1	8.7	7.7	9.6	10.2	3.9	4.5	4.4	6.7	7.7	3.3	5.7	7.1	8.3	4.2	3.3	2.4	8.8	12.8	8.0	9.2	7.5	2.8	7.2	5.3	6.7	11.0	5.2	4.0	5.7	4.6	11.8	5.7	6.5	4.1	3.3	2.9	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.0	6.3	6.1	15.6	6.9	5.9	2.0	1.0	0.8	1.3	0.4	1.2	6.7	14.7	19.2	20.8	96.9	15.7	11.5	8.4	8.3	18.8	54.3	15.1	11.7	20.1	12.8	9.4	12.9	141.8	10.9	15.2	14.6	0.0	8.0	7.0	23.9	25.9	14.2	27.6	47.4	190.4	8.7	5.2	11.2	23.9	32.2	8.2	17.9	15.7	15.2	6.6	80.8	180.0	14.2	8.2	11.1	6.7	6.3	11.5	12.6	7.2	66.5	11.1	17.7	14.4	109.1	138.8	10.3	9.0	15.8	15.8	12.8	9.2	5.6	16.0	53.8	0.0	19.3	14.6	25.0	7.8	22.1	14.9	8.9	12.9	12.4	14.0	9.0
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112629-43566001	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.4;kidney: 7.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 135.6;Excitatory neurons: 533.3;Inhibitory neurons: 157.3;Late spermatids: 72.0;Oligodendrocyte precursor cells: 277.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebral cortex: 16.4"	"Group enriched"	"Detected in some"	4	"basophil: 4.9;neutrophil: 3.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.8;GAMG: 3.7;U-266/70: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.1	0.0	1.5	0.2	1.7	0.5	0.2	0.0	16.4	0.1	0.0	0.2	0.0	0.2	0.6	1.0	0.1	1.9	0.0	0.7	0.0	7.8	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.3	0.1	2.2	0.4	0.2	0.9	0.6	0.1	0.1	0.0	0.1	0.3	1.8	0.2	0.0	0.5	2.6	0.2	0.3	0.1	3.8	0.0	3.8	0.3	0.5	0.0	0.0	0.0	1.2	2.2	0.1	0.5	0.0	0.0	0.2	2.3	2.2	3.7	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.3	0.2	0.2	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.8	0.9	0.3	12.0	0.4	0.0	2.7	0.3	0.0	4.9	0.8	0.7	0.3	0.5	0.2	0.6	0.3	0.1	0.1	1.0	0.3	0.3	3.3	0.6	0.6	0.9	0.1	0.0	1.5	1.7	0.0	16.4	0.7	0.0	0.2	0.0	0.1	0.0	0.2	3.8	0.0	0.0	0.0	7.8	0.1	0.4	0.3	0.0	0.0	15.4	0.1	0.3	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	135.6	1.1	3.6	0.2	0.0	0.0	533.3	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.4	0.1	0.0	45.4	157.3	0.1	0.0	0.0	1.4	72.0	0.3	0.2	0.0	24.4	0.1	0.6	0.0	277.9	4.8	0.0	1.4	0.4	0.0	0.4	4.3	15.8	0.0	1.9	0.0	0.6	0.4	3.2	3.3	0.3	0.3	0.0	0.6	0.2	0.5	0.3
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 331.5;Hepatic stellate cells: 99.2;Inhibitory neurons: 375.4;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 460.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.7;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.7;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.1;hTEC/SVTERT24-B: 16.3;HUVEC TERT2: 20.9;SCLC-21H: 31.6;TIME: 26.3;U-138 MG: 21.7"	"Low region specificity"	"Detected in all"							HPA034609	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	4.1	1.5	2.4	1.2	3.5	0.1	1.7	4.4	6.1	2.2	0.0	0.4	0.4	0.8	0.3	3.1	3.5	2.1	8.1	3.3	0.0	1.6	2.7	5.3	2.0	1.1	0.8	0.2	0.6	4.3	1.2	7.4	2.1	0.4	0.4	2.7	0.9	0.5	1.4	0.8	0.5	1.3	0.0	6.0	0.9	3.5	1.7	0.8	3.8	3.5	2.4	1.0	0.6	8.2	0.1	1.4	2.3	0.0	1.4	4.2	1.6	2.7	7.3	2.1	2.6	0.3	0.1	1.4	0.5	13.4	3.3	3.2	0.9	0.1	4.5	30.1	1.6	0.0	2.3	0.2	0.2	0.5	0.3	1.0	1.3	16.3	5.7	4.1	20.9	0.0	0.2	0.1	6.7	1.8	0.0	0.7	2.5	0.2	1.0	0.0	0.5	0.0	0.1	0.0	31.6	2.5	2.0	0.5	0.0	0.4	0.1	0.2	26.3	21.7	1.4	4.6	0.7	0.2	0.0	1.3	5.4	0.1	0.2	0.1	0.3	0.8	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.5	0.0	0.0	4.7	0.0	3.7	0.0	0.0	0.1	2.4	3.5	4.4	6.1	3.3	0.0	1.1	0.8	2.1	0.0	1.7	8.2	61.2	0.0	12.1	12.7	3.6	2.2	0.3	0.1	3.4	9.5	1.1	0.8	18.7	0.0	0.1	0.0	0.0	0.2	0.7	0.6	0.0	0.1	11.1	0.4	1.6	34.2	2.4	0.0	331.5	0.0	0.3	4.2	0.5	0.3	1.3	4.9	99.2	1.5	0.1	0.0	375.4	0.6	0.0	7.2	3.0	5.3	0.0	1.4	3.6	14.0	1.2	12.0	0.0	143.2	460.7	0.1	0.0	2.6	3.4	0.4	0.0	0.1	1.0	1.1	0.0	1.2	2.2	0.5	6.1	9.2	1.6	0.1	1.4	0.7	0.1	0.6
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055997	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		510000000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	30.1	9.9	19.3	19.2	23.2	1.9	14.8	27.0	15.0	20.8	28.3	11.9	8.0	19.2	6.2	16.1	13.2	38.9	67.3	14.3	22.7	15.2	7.5	55.1	16.5	32.0	28.1	12.4	31.6	16.1	3.6	33.4	28.6	13.9	12.2	46.8	7.7	14.6	14.3	5.2	9.4	25.4	27.3	17.9	9.8	13.5	30.3	8.6	52.2	24.2	15.7	30.0	10.1	30.6	7.0	7.1	54.7	4.2	73.2	58.7	21.1	64.9	90.1	72.6	83.5	58.5	1.0	2.8	43.8	174.1	52.3	15.3	7.4	31.6	97.9	6.5	3.7	1.3	42.3	8.4	241.5	1.8	80.6	77.8	10.1	87.4	21.5	351.3	69.3	5.0	0.1	1.0	25.7	1.3	2.8	0.1	10.1	0.1	5.5	4.8	41.0	0.2	14.6	1.2	1.0	5.6	134.8	10.6	6.4	55.1	24.2	4.3	93.9	37.7	41.3	150.5	29.1	6.9	19.7	0.4	76.8	6.5	82.4	1.1	0.1	0.0	1.9	1.7	1.1	0.5	0.6	1.7	0.4	0.3	1.2	0.8	0.0	3.9	1.9	0.4	0.2	0.5	19.3	23.2	27.0	15.0	14.3	22.7	32.0	28.1	28.6	27.3	30.3	30.6	90.1	86.6	5.8	28.7	4.9	5.0	8.0	25.4	6.8	6.1	2.4	5.7	90.5	7.2	6.5	27.6	264.8	1.8	19.2	0.5	0.0	32.0	7.0	4.0	20.1	121.5	0.0	6.1	0.9	6.4	65.3	44.8	1.1	2.2	26.6	24.9	130.3	3.5	6.8	1.7	14.9	0.5	4.1	18.4	7.3	9.4	5.0	7.1	7.2	92.8	4.0	6.0	35.0	13.0	57.6	6.4	0.1	13.9	8.6	5.2	0.8	1.3	1.0	66.8	0.0	24.0	28.7	1.0	1.1	2.7	4.4	3.3	14.2	3.1	0.1	1.3
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 182.0;Spermatogonia: 173.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 5.5"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 36.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.1	1.2	0.8	6.4	0.3	16.3	3.0	5.5	1.2	3.2	1.3	4.3	2.9	2.9	1.4	5.9	1.7	2.0	0.7	0.4	1.3	2.5	1.8	1.7	12.4	0.8	0.8	2.6	1.2	1.4	3.0	4.1	1.0	2.1	5.1	1.1	1.9	1.0	0.3	5.3	3.9	2.2	0.9	4.3	3.7	12.8	0.9	15.9	1.1	0.2	12.6	3.6	3.2	1.5	57.7	55.4	70.6	90.1	2.9	6.4	37.4	42.9	27.8	34.4	54.6	70.3	45.5	70.0	16.7	15.5	29.1	56.3	40.9	34.9	50.7	68.5	45.5	37.3	56.3	58.0	1.7	71.2	31.6	3.6	2.0	42.1	20.0	9.4	24.0	46.0	20.7	43.5	43.1	54.9	75.2	35.6	73.4	42.3	24.1	70.3	62.1	16.3	24.2	72.2	28.4	22.8	50.3	14.5	7.8	59.0	60.9	23.1	17.2	38.4	19.4	35.4	52.4	22.3	47.6	74.5	19.0	42.8	17.9	0.3	0.7	0.0	7.0	1.5	2.4	18.8	11.4	9.4	2.3	23.2	5.2	7.7	1.0	10.2	1.0	36.8	19.7	2.3	0.8	0.3	5.5	1.2	0.4	1.3	0.8	0.8	1.0	0.9	0.9	1.5	4.7	9.6	3.9	0.0	19.7	21.5	11.5	12.6	13.1	16.4	10.0	15.0	1.0	12.8	12.6	22.0	0.0	46.3	13.2	26.2	3.9	9.0	2.0	9.3	16.4	8.1	10.8	50.5	3.3	6.2	43.4	13.0	17.9	16.3	5.7	60.6	5.7	3.6	15.1	6.7	5.4	17.8	8.2	2.2	10.3	5.3	9.0	7.3	1.8	9.4	5.7	4.3	1.0	4.5	6.6	4.7	1.8	5.7	37.5	3.7	1.7	1.6	6.3	11.4	19.7	10.5	16.4	182.0	173.9	22.9	9.9	11.1	15.7	16.5	30.9	11.7
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.5"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070444-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Nucleoli rim"	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	6.3	6.6	3.8	8.5	4.9	12.5	6.6	12.0	5.7	7.6	8.4	5.8	4.8	7.4	6.1	4.7	6.1	7.1	6.1	3.6	6.9	6.9	10.9	6.8	9.8	4.1	5.2	12.3	7.8	12.0	6.1	11.2	4.0	6.1	6.6	14.3	6.2	6.2	9.1	4.4	5.9	7.5	3.3	9.1	6.5	10.8	5.5	15.4	8.7	14.0	8.9	6.6	5.0	3.3	10.3	10.0	12.3	12.3	14.8	8.4	18.7	9.0	8.8	11.8	12.4	14.7	7.9	21.2	7.2	12.0	7.4	10.5	23.3	11.3	18.4	8.2	7.3	27.2	10.7	12.5	7.1	22.3	15.6	9.8	10.5	11.4	14.1	8.8	18.1	15.6	19.1	12.9	9.8	13.0	29.0	7.6	7.4	9.2	9.7	19.3	21.6	9.2	9.1	14.3	12.0	11.0	14.3	11.5	15.2	16.9	13.7	13.7	16.1	14.5	16.6	8.0	8.1	10.7	13.4	15.5	7.2	13.7	15.5	2.3	3.3	2.8	5.1	2.8	6.3	1.7	3.1	3.2	2.8	2.8	1.9	2.6	2.3	2.6	1.9	2.2	3.0	2.3	3.8	4.9	12.0	5.7	3.6	6.9	4.1	5.2	4.0	3.3	5.5	3.3	42.9	19.2	37.1	89.1	44.3	32.1	24.6	30.2	29.6	50.8	32.8	23.6	31.1	24.3	30.2	27.6	93.8	32.9	95.8	29.4	7.9	19.1	5.2	49.4	55.8	32.3	38.3	48.8	93.1	14.2	42.8	30.9	38.7	118.5	33.7	51.9	61.8	52.1	31.9	67.3	112.1	30.2	16.2	79.4	28.8	10.5	38.8	55.4	14.2	107.7	62.0	24.0	104.0	134.2	72.6	19.2	23.1	42.9	67.1	29.3	27.7	14.6	26.1	54.9	13.1	45.9	34.0	36.0	26.0	33.6	20.2	18.3	71.0	32.6	26.3	45.8
HELZ2	"KIAA1769, PDIP1, PRIC285"	ENSG00000130589	"Helicase with zinc finger 2"	Q9BYK8	20	63558086-63574239	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 46.1;Urothelial cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 59.4;GAMG: 34.5;SK-MEL-30: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051267	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA051267: "	"unprognostic (1.86e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.16e-1)"	6.6	4.2	4.0	5.6	2.9	15.6	5.6	2.3	2.1	5.7	1.6	5.5	3.8	4.2	0.6	7.4	5.0	3.0	7.0	1.9	2.6	6.6	7.7	9.9	4.8	6.2	3.1	3.9	5.8	0.8	5.1	2.3	4.1	4.6	0.9	0.1	12.2	1.1	1.8	4.8	6.3	1.0	6.4	12.3	7.6	1.2	4.7	3.0	5.9	0.9	1.8	3.9	3.9	2.7	10.0	3.7	1.2	3.7	2.2	2.8	7.1	3.5	5.2	59.4	23.0	10.1	12.4	0.2	7.5	1.3	34.5	15.3	0.7	3.6	2.3	3.7	1.7	0.2	4.6	3.5	4.8	0.3	23.4	3.5	2.5	4.3	0.7	1.3	2.8	0.2	1.8	4.1	0.7	9.9	1.1	10.2	1.9	2.6	11.4	2.2	2.0	3.9	1.7	11.4	0.9	3.3	10.9	0.7	25.4	0.7	3.4	3.0	4.5	5.7	8.4	4.7	3.6	5.2	0.7	0.2	6.2	1.6	5.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	4.0	2.9	2.3	2.1	1.9	2.6	6.2	3.1	4.1	6.4	4.7	2.7	24.7	9.6	6.0	0.3	10.5	8.7	22.7	8.8	4.6	1.0	8.8	5.5	4.5	8.6	12.1	9.2	0.0	2.1	15.9	26.0	0.0	8.8	0.1	11.6	9.6	24.9	30.9	3.2	0.1	7.7	13.4	11.6	26.0	17.5	0.0	46.1	10.4	6.0	3.5	0.0	0.3	19.5	4.1	4.3	17.1	0.0	7.2	10.8	3.6	4.7	7.0	1.7	24.7	1.0	0.4	20.4	20.7	2.2	6.4	28.9	17.9	0.8	9.6	2.7	6.6	12.2	9.9	0.7	0.3	5.1	8.4	1.9	14.7	17.7	14.5	47.4
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 246.7"	"Group enriched"	"Detected in some"	27	"Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	28	"granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1"	"Cell line enriched"	"Detected in some"	5	"K-562: 290.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.1	0.0	0.1	0.8	0.1	246.7	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.9	1.5	0.4	0.0	0.0	0.2	0.0	0.1	5.9	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.0	3.2	0.2	50.5	0.1	12.6	0.2	0.1	1.5	0.1	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	64.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	290.9	0.3	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.2	0.0	1.5	0.5	1.8	0.0	0.0	0.1	2.2	0.1	0.0	0.2	0.0	0.5	0.0	1.5	0.7	0.1	0.0	5.1	2.1	0.6	2.0	0.0	0.0	0.9	2.7	0.1	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.2	0.4	0.1	0.0	0.0	1329.5	0.2	0.0	0.5	0.0	1206.7	0.4	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.7	0.7	1.0	0.0	0.2	0.0	0.0	1.6	0.0	1439.7	5.9	47.4	1.8	0.0	2.1	0.0	4.1	0.0	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.1	10.0	4.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0
HEMK1	MTQ1	ENSG00000114735	"HemK methyltransferase family member 1"	Q9Y5R4	3	50569152-50596168	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 149.9;Late spermatids: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034701, HPA034702"	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA034701: AB_10601429, HPA034702: AB_10673101"	"unprognostic (1.27e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.95e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.44e-3)"	12.2	18.6	12.9	11.3	13.6	9.1	13.1	13.4	17.1	19.1	18.5	16.4	11.6	14.4	10.8	14.7	17.4	8.6	17.6	12.6	13.3	23.0	29.7	13.9	15.0	13.9	13.9	21.7	22.3	15.4	19.4	10.5	13.8	22.8	10.7	5.7	21.2	11.7	9.8	10.1	15.0	11.0	13.6	19.3	18.9	27.0	13.3	15.3	25.2	12.5	11.5	17.4	15.2	14.7	11.8	7.0	10.5	10.2	23.6	18.3	14.8	13.6	11.1	13.0	16.1	6.0	18.7	11.7	10.6	18.9	13.8	13.3	8.0	31.2	5.6	58.4	6.5	13.4	11.7	8.1	19.9	14.1	9.2	13.9	24.1	13.8	15.8	22.9	15.9	22.3	11.9	11.9	12.4	10.4	24.1	14.9	4.6	13.5	18.6	7.9	5.2	23.2	15.5	13.9	3.8	11.9	5.1	15.1	15.6	13.8	12.1	21.2	7.2	13.8	11.9	11.0	17.2	10.6	5.7	6.6	20.6	18.0	8.1	24.5	12.4	12.3	18.7	9.0	16.8	19.8	14.8	15.6	17.1	17.5	16.1	17.2	2.0	16.1	5.7	22.0	10.8	13.3	12.9	13.6	13.4	17.1	12.6	13.3	13.9	13.9	13.8	13.6	13.3	14.7	5.9	12.8	13.4	9.4	14.0	4.5	13.2	11.1	6.2	11.2	12.5	10.0	14.8	8.6	14.8	7.3	0.0	25.7	14.9	11.3	11.7	13.5	149.9	10.3	7.6	6.4	0.0	8.6	2.1	8.2	18.9	12.3	11.2	8.0	17.1	16.0	16.1	15.2	19.9	6.7	2.6	19.7	12.2	8.1	4.6	151.1	11.5	9.1	8.8	4.7	17.4	12.7	16.5	2.0	4.1	9.7	10.3	8.2	12.5	8.2	19.2	20.0	22.0	20.0	19.7	10.8	8.3	27.3	8.7	9.1	3.4	13.7	13.8	7.8	16.0	10.0
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 72.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"cerebellum: 9.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	5.4	2.9	8.6	8.0	8.9	13.3	8.0	6.8	9.2	8.5	4.9	6.5	5.0	3.9	4.7	2.7	2.3	6.5	1.8	8.9	9.6	3.4	2.0	4.7	13.5	8.0	8.1	5.2	2.1	0.9	5.3	5.6	8.9	3.7	9.5	3.0	3.0	3.4	3.2	3.8	7.6	3.6	7.8	11.1	4.7	72.0	10.6	18.7	2.2	6.2	11.3	6.2	2.0	8.6	16.9	8.5	0.7	0.0	0.7	0.5	0.1	4.0	1.5	9.4	1.5	24.7	26.0	0.0	8.9	7.5	0.0	0.1	0.0	0.2	5.9	5.5	0.0	42.4	31.7	0.0	8.1	25.4	36.4	7.8	0.5	2.1	0.0	0.0	1.9	71.4	0.0	18.5	0.4	42.8	68.2	75.3	24.0	13.5	3.7	29.3	0.0	1.5	0.0	18.0	40.1	0.0	35.3	9.8	0.1	2.4	0.0	55.7	0.5	0.0	31.4	17.5	0.1	11.2	15.0	0.1	0.0	98.6	0.3	43.3	19.7	43.2	61.8	24.0	55.6	12.6	30.0	56.4	24.6	7.1	24.7	45.1	19.6	55.6	29.8	19.5	31.2	39.9	8.6	8.9	6.8	9.2	8.9	9.6	8.0	8.1	8.9	7.8	10.6	8.6	2.4	0.0	1.1	2.3	5.4	1.7	1.4	6.6	1.2	5.2	8.1	7.1	1.8	14.3	4.0	5.5	0.0	12.8	28.0	4.0	3.9	3.0	12.2	2.2	3.6	3.0	4.9	13.9	5.2	1.3	21.5	5.2	2.6	2.4	7.0	2.9	6.1	0.5	15.8	0.0	3.7	4.0	4.1	11.7	3.3	20.1	5.0	7.5	1.8	3.7	11.2	3.6	58.7	4.0	2.7	2.8	7.4	3.0	8.0	1.2	5.5	0.8	2.8	2.4	6.6	3.0	3.5	178.5	107.7	2.9	1.6	5.2	23.0	8.5	6.1	3.3
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.9;smooth muscle: 82.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		3700000		"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	8.2	19.1	18.2	14.7	25.0	0.0	8.3	20.8	19.2	23.8	8.7	81.9	79.0	34.7	14.4	11.9	14.2	38.7	36.0	16.7	21.2	8.1	3.5	12.3	3.6	22.3	24.4	22.1	2.3	1.4	3.7	1.3	20.4	24.3	77.6	15.0	7.6	31.8	0.8	4.8	81.6	82.7	18.8	11.1	12.4	3.5	21.7	1.3	5.1	3.2	2.6	19.5	10.1	21.0	0.0	0.0	28.5	2.3	0.0	0.1	0.8	7.3	0.4	0.0	0.0	17.4	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	25.4	0.0	0.0	0.3	0.2	0.1	36.0	0.0	0.0	0.0	9.9	0.0	0.0	72.5	0.6	28.5	0.0	0.0	0.6	14.1	4.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	68.6	0.0	0.0	0.7	16.2	1.2	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	25.0	20.8	19.2	16.7	21.2	22.3	24.4	20.4	18.8	21.7	21.0	2.5	0.0	0.0	78.0	0.5	0.9	0.0	0.0	0.0	1.0	0.9	6.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	211.0	0.0	0.3	0.6	1.3	15.1	4.1	40.8	0.0	0.3	1.1	0.0	12.6	0.0	1.2	0.0	1.1	6.4	0.0	0.2	0.0	2.9	95.6	0.0	0.0	1.9	1.5	11.5	0.3	0.0	6.5	0.0	26.1	0.0	3.5	36.2	5.0	96.9	29.7	0.0	0.3	156.2	0.0	0.7	1.3	6.6	4.4	9.8	0.0	0.3	0.3	0.6	0.0	0.5	6.9	72.4	0.2
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021354-94114208	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 4.5;lymphoid tissue: 9.5;skin 1: 3.8;vagina: 4.5"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 10.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.4;HBEC3-KT: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		260000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	9.5	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 11.4;brain: 37.3;liver: 20.9"	"Group enriched"	"Detected in some"	23	"Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	287	"Hep G2: 55.5"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		11.4	0.2	6.1	0.1	23.1	0.0	8.3	0.3	9.4	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	5.0	6.1	0.2	20.9	0.1	0.1	37.3	10.3	0.1	0.2	0.0	2.4	0.0	13.5	0.8	0.0	2.2	0.4	0.0	0.2	0.3	0.7	0.0	5.1	0.1	0.5	0.5	19.0	0.0	0.2	0.0	0.0	0.2	0.5	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	23.1	0.3	9.4	5.0	6.1	37.3	10.3	13.5	5.1	19.0	17.9	0.2	0.0	0.0	94.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	3.1	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.5	0.6	0.0	0.0	1.9	0.0	29.1	0.0	49.3	114.6	0.0	0.0	1.2	0.0	0.1	0.0	2.2	0.0	1.9	0.0	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833948	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	10.5	7.4	8.6	10.3	10.1	27.4	12.7	14.1	20.3	13.0	5.2	11.8	5.3	10.8	6.5	8.1	7.6	9.6	15.2	9.3	0.0	9.1	9.1	10.6	13.7	1.7	0.3	18.5	8.4	22.7	8.8	10.3	1.8	8.6	9.2	18.3	8.8	10.3	30.4	12.1	9.9	12.4	0.0	15.2	10.2	11.5	0.0	25.6	14.0	29.3	12.8	9.2	7.9	22.7	13.5	17.1	19.1	6.6	33.3	21.1	6.4	10.3	13.4	10.7	12.3	10.9	5.3	19.8	9.3	19.8	9.7	14.5	31.2	9.0	14.6	15.4	9.6	42.5	26.4	7.8	5.3	31.6	25.1	15.3	8.5	15.1	14.5	9.3	22.7	13.3	44.0	8.6	9.4	21.7	11.3	6.5	9.3	10.4	8.7	12.2	20.6	11.6	4.4	32.9	17.0	8.4	18.2	12.5	10.5	23.0	6.1	12.7	23.6	13.6	12.6	11.9	13.6	9.4	17.4	13.3	7.8	23.3	4.9	24.4	3.8	8.7	4.9	3.4	3.7	5.9	5.5	4.6	3.4	9.5	5.5	5.4	13.5	2.9	6.7	7.5	7.8	1.8	8.6	10.1	14.1	20.3	9.3	0.0	1.7	0.3	1.8	0.0	0.0	22.7	66.0	6.4	39.5	113.0	44.2	14.9	10.6	16.1	17.1	65.3	19.7	17.1	64.8	17.2	19.9	22.0	66.7	8.8	66.1	11.4	1.9	11.0	28.7	13.5	24.0	44.5	10.2	47.5	458.8	14.1	15.1	28.5	34.7	17.8	50.6	36.5	47.2	21.0	16.2	85.8	338.0	13.1	10.2	43.2	27.4	14.3	27.7	39.2	19.6	137.7	36.0	29.9	35.0	160.4	201.5	11.7	14.7	39.9	44.9	12.7	12.5	15.7	16.6	55.0	6.6	34.4	36.0	43.5	31.3	17.1	15.3	8.9	61.1	31.9	14.4	12.1
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	5.3	5.7	2.5	2.3	2.9	4.0	4.9	1.5	3.1	5.5	3.0	9.3	2.6	7.6	1.7	5.2	6.1	2.2	7.4	2.3	1.1	3.7	3.7	5.1	2.3	2.0	1.8	8.3	6.1	5.4	6.3	2.7	2.7	4.4	2.8	5.3	4.8	2.9	14.2	5.3	6.1	3.7	0.4	4.3	6.3	4.8	2.7	4.4	5.8	9.3	2.4	5.6	5.0	6.2	8.5	16.5	11.2	4.7	9.2	6.9	3.2	6.0	7.1	7.6	7.3	8.6	1.1	8.5	7.2	10.4	11.5	8.5	12.0	5.9	5.6	5.2	7.8	54.0	20.2	2.9	3.5	12.8	4.1	5.7	4.5	9.0	11.2	4.9	10.2	7.0	21.2	3.4	7.3	3.9	2.9	4.3	3.4	6.4	7.1	10.2	16.0	0.7	2.6	18.2	12.3	7.1	14.6	4.1	4.5	5.8	4.8	14.8	15.3	14.0	9.2	5.5	9.1	2.2	3.3	7.7	6.5	5.9	7.6	0.1	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.6	0.2	0.1	2.5	2.9	1.5	3.1	2.3	1.1	2.0	1.8	2.7	0.4	2.7	6.2	56.2	22.4	23.5	68.9	34.3	16.4	15.3	18.1	27.9	107.9	39.1	31.2	66.6	21.5	23.6	64.4	148.0	25.9	28.5	31.8	1.9	28.7	13.0	35.0	55.8	73.3	28.1	67.9	88.9	30.4	15.5	34.3	43.3	29.6	3.8	135.0	38.9	36.7	19.0	122.8	82.9	32.1	16.2	22.3	20.7	15.8	56.2	22.1	69.4	84.3	26.9	41.0	45.3	65.9	89.7	36.6	30.8	52.3	56.6	20.5	31.1	19.8	19.6	142.9	65.7	46.0	43.2	72.5	66.4	38.3	21.0	17.8	30.0	62.7	35.5	11.5
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592434-88708541	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 114.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 23.8;Cytotrophoblasts: 7.0;Extravillous trophoblasts: 17.3;Hofbauer cells: 9.3;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 48.2;hTERT-HME1: 68.6"									HPA039170	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	11.6	10.2	10.6	13.3	13.4	24.3	14.0	24.5	12.5	13.3	9.4	11.4	11.6	9.9	9.6	16.5	10.2	12.0	21.9	9.6	9.5	14.9	12.1	13.6	17.1	13.6	9.4	12.0	9.3	21.1	9.4	10.1	14.0	19.5	12.1	114.1	12.1	10.9	19.3	18.2	12.1	13.6	7.8	16.1	12.8	3.2	10.0	16.8	14.5	24.4	15.0	11.0	15.3	16.8	12.2	2.4	2.4	3.8	15.3	23.9	9.0	14.5	24.2	13.0	8.5	2.8	14.8	12.0	7.9	48.2	6.1	5.2	4.4	14.1	13.0	7.2	3.4	8.9	6.3	1.9	7.9	22.6	15.7	13.2	15.4	12.7	68.6	8.9	14.2	7.5	7.8	6.2	29.5	3.8	17.8	6.7	0.4	9.6	3.9	19.7	16.5	4.5	8.3	2.6	3.4	3.2	20.4	10.7	4.6	3.9	1.9	12.2	25.7	16.7	9.6	19.9	10.4	11.5	3.1	7.5	11.5	10.2	6.1	7.8	4.9	7.3	3.8	5.6	4.4	4.3	4.7	4.0	5.4	4.2	7.0	4.4	16.2	2.4	9.2	2.4	8.1	2.9	10.6	13.4	24.5	12.5	9.6	9.5	13.6	9.4	14.0	7.8	10.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	17.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0
HERC3	KIAA0032	ENSG00000287542	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"		4	88523810-88708450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 8.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Excitatory neurons: 73.2;Inhibitory neurons: 101.6;Oligodendrocytes: 113.9"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA039170	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA039170: AB_10673414"																		1.0	0.9	1.4	1.4	1.2	2.1	1.3	1.9	1.6	2.1	2.1	1.2	0.8	0.9	0.9	1.5	0.8	0.8	2.4	0.9	1.5	1.5	1.3	1.2	1.4	1.8	1.3	1.1	0.6	5.0		1.1	1.8	2.5	1.6	8.5	1.7	1.8	0.9	1.5	0.7	0.9	1.0	1.7	1.2	0.4	1.3	2.1	1.5	1.9	2.1	1.2		1.4	1.9	0.0	0.3	0.5	0.6	4.5	0.5	1.4	4.1	1.8	1.5	0.4	1.4	2.3	0.3	4.6	1.0	0.3	0.0	1.3	1.9	0.4	0.5	1.6	0.1	0.5	0.6	3.4	2.2	1.8	1.9	1.7	5.1	0.9	3.0	0.6	0.7	0.9	3.6	0.0	1.7	0.3	0.0	0.4	0.3	1.8	1.6	0.9	2.3	0.0	0.4	0.7	0.5	0.6	0.8	0.6	0.3	0.5	3.3	1.8	0.7	0.3	2.1	1.4	0.0	0.7	1.5	1.4	0.9	0.0	0.5	0.3	0.3	0.4	0.4	0.3	0.5	0.3	0.6	0.1	0.7	0.8	0.9	0.4	0.7	0.0	0.8	0.4	1.4	1.2	1.9	1.6	0.9	1.5	1.8	1.3	1.8	1.0	1.3	1.4	8.6	6.4	6.9	35.9	15.5	35.9	10.6	7.6	9.6	23.9	11.3	3.8	0.0	5.7	5.5	9.2	110.5	0.0	11.0	14.6	1.9	4.1	3.6	5.2	7.0	7.3	27.6	8.2	73.2	9.1	0.0	8.1	9.2	9.5	15.8	3.4	7.9	13.5	0.0	32.0	101.6	8.9	8.2	22.3	22.0	3.0	8.4	17.9	14.2	68.4	14.1	14.0	8.2	57.3	113.9	10.9	8.2	13.2	12.3	11.6	10.5	9.2	7.2	70.0	6.6	11.1	8.5	3.5	6.7	16.3	50.7	0.0	16.7	4.9	6.1	11.2
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 201.4;fHDF/TERT166: 226.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	13.9	19.6	18.2	14.4	18.9	10.9	14.3	19.5	23.5	15.2	15.3	14.1	13.8	14.9	14.0	14.5	13.4	13.3	13.6	20.6	22.4	13.7	16.6	13.9	21.0	19.4	19.7	15.3	11.1	12.0	14.1	16.5	19.4	12.2	15.9	13.9	11.5	11.4	13.5	13.4	14.6	15.6	18.1	18.2	11.6	14.2	21.1	15.2	13.1	12.3	19.4	16.2	14.3	26.7	75.4	30.4	16.7	28.5	47.5	63.9	15.5	201.4	125.5	75.5	47.6	17.5	35.3	29.7	14.3	226.7	40.6	40.9	21.1	28.9	102.0	17.6	9.2	13.7	51.3	12.2	22.6	17.3	21.3	30.2	33.8	39.3	34.4	89.1	47.5	15.0	14.9	14.3	117.4	35.2	11.3	19.9	9.9	15.8	49.0	15.3	7.6	8.2	32.3	23.7	8.7	9.4	66.1	26.4	26.5	37.6	15.4	20.1	65.0	38.2	17.5	94.7	31.9	8.7	11.2	17.8	67.7	32.3	13.6	10.8	5.0	6.6	3.9	4.1	5.0	3.4	4.1	4.5	5.7	3.4	4.1	4.2	6.7	5.2	4.1	1.6	5.6	3.7	18.2	18.9	19.5	23.5	20.6	22.4	19.4	19.7	19.4	18.1	21.1	26.7	29.8	48.1	29.3	127.0	41.0	50.3	33.7	27.2	26.2	50.1	29.1	16.6	23.0	14.3	24.1	18.4	43.8	29.3	38.7	78.7	7.9	19.5	66.4	44.3	45.4	30.9	22.1	32.4	170.2	12.2	40.8	30.3	34.1	70.9	30.4	31.3	28.5	24.5	23.6	53.8	148.8	29.9	26.4	42.9	23.3	47.4	26.8	30.9	17.8	149.9	36.0	18.9	40.2	174.9	209.2	38.6	52.3	19.2	17.4	42.6	37.8	24.9	25.5	45.8	6.6	33.2	28.1	25.2	12.4	23.4	60.9	15.6	40.9	38.5	21.9	48.5
HERC5	CEB1	ENSG00000138646	"HECT and RLD domain containing E3 ubiquitin protein ligase 5"	Q9UII4	4	88457119-88506163	"Predicted membrane proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.5;Spermatocytes: 272.1;Spermatogonia: 431.3"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 89.9;BJ hTERT+ SV40 Large T+ RasG12V: 123.5;SK-MEL-30: 58.1"					"Low region specificity"	"Detected in all"			HPA043929	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA043929: AB_10962492"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-1)"	5.5	6.0	3.1	6.0	3.8	18.8	4.9	2.7	5.1	7.8	4.8	3.9	4.0	15.4	3.3	2.6	5.9	5.8	4.0	2.8	3.0	6.4	9.7	6.5	7.2	4.5	4.0	14.0	7.7	9.6	4.1	10.2	4.1	5.5	2.6	3.7	11.9	5.8	1.5	2.5	4.6	13.4	5.6	12.1	4.8	57.9	3.1	13.9	5.3	3.4	4.3	4.5	4.4	4.6	7.5	3.5	2.0	0.4	0.4	0.8	27.9	0.6	10.7	89.9	123.5	1.1	19.9	0.3	4.9	0.0	40.8	1.4	13.7	2.1	7.6	46.4	8.4	12.1	13.2	0.3	0.8	14.8	5.5	0.8	0.6	22.7	0.0	4.9	0.6	24.4	0.5	28.2	1.7	0.8	45.9	18.2	7.5	0.4	2.4	45.3	35.9	1.9	1.6	1.7	0.5	11.7	15.0	0.3	58.1	23.3	1.2	8.2	0.3	1.1	0.2	0.5	5.9	38.7	36.3	0.3	8.6	10.9	1.1	14.8	7.2	11.6	7.6	8.4	8.6	7.1	8.7	6.3	2.7	4.4	5.4	4.7	25.1	8.0	7.9	8.0	27.7	5.0	3.1	3.8	2.7	5.1	2.8	3.0	4.5	4.0	4.1	5.6	3.1	4.6	26.9	0.0	0.5	5.5	14.8	4.0	5.9	0.8	8.0	7.9	6.4	7.1	2.3	2.8	1.0	1.8	18.8	25.8	19.9	1.1	23.5	2.6	90.5	5.4	2.0	20.6	0.0	3.8	0.4	5.1	12.1	10.9	3.6	3.9	2.5	57.1	14.3	7.8	15.0	0.0	1.1	0.7	0.0	8.1	2.5	19.4	9.9	16.6	7.2	7.5	8.3	9.6	16.5	18.1	1.8	2.8	2.3	9.1	34.5	7.3	2.6	9.8	1.7	2.8	19.7	10.8	7.9	272.1	431.3	2.5	1.8	11.9	19.2	20.2	0.4	1.7
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443097	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	4.1	5.5	6.5	5.4	7.2	7.9	6.2	5.2	8.8	14.2	4.3	6.1	5.3	8.5	4.2	20.9	9.7	10.7	9.6	7.0	7.6	6.0	4.8	8.1	5.0	8.2	6.6	8.3	5.4	7.1	4.4	5.5	7.3	8.4	6.1	4.4	30.5	5.1	3.0	4.1	5.3	8.0	11.7	8.2	7.2	3.9	6.9	12.3	4.3	4.7	5.3	6.0	11.2	6.8	6.7	4.5	0.3	0.9	0.3	3.8	1.2	0.8	22.1	116.1	85.8	0.4	8.3	0.0	1.5	2.1	18.8	2.5	10.9	5.7	7.6	13.9	2.2	6.3	3.8	0.6	3.7	11.3	4.2	5.2	1.3	9.1	0.3	7.0	3.4	5.2	0.0	1.5	2.6	4.1	5.3	3.6	1.5	6.0	2.2	3.6	0.1	0.5	7.8	8.2	0.3	2.7	8.2	2.7	13.5	5.6	4.8	2.0	1.2	1.6	2.1	0.2	2.1	0.3	0.1	0.0	5.2	2.5	5.4	4.4	3.2	4.7	6.4	3.4	12.8	3.5	8.9	6.3	2.8	3.0	6.9	4.7	1.9	6.0	7.4	0.3	12.5	4.2	6.5	7.2	5.2	8.8	7.0	7.6	8.2	6.6	7.3	11.7	6.9	6.8	11.4	12.8	10.6	14.4	5.8	2.8	5.2	3.3	4.6	18.1	4.9	4.6	13.9	7.2	9.8	5.5	16.7	5.8	5.0	8.3	0.0	7.8	1.3	6.4	3.9	11.5	1.8	4.8	21.5	17.4	1.8	6.6	5.6	5.0	5.7	25.9	5.3	2.2	5.0	1.7	25.8	2.9	4.1	2.2	0.8	1.6	4.4	4.7	5.4	28.1	5.7	3.7	4.1	24.1	2.8	13.3	2.4	5.7	3.8	8.3	6.2	4.1	14.6	1.0	6.6	2.0	3.6	0.8	2.1	18.4	1.1	2.5	8.2	13.3	2.5	8.0
HERPUD1	"HERP, KIAA0025, Mif1, SUP"	ENSG00000051108	"Homocysteine inducible ER protein with ubiquitin like domain 1"	Q15011	16	56932142-56944864	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 2680.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 497.6;U-266/70: 533.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037041, CAB037104, HPA040754, HPA041219"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"		"CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.39e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.41e-9)"	"unprognostic (1.06e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.27e-3)"	75.3	108.4	68.4	102.0	70.6	113.6	128.9	73.7	92.6	127.1	99.0	149.5	98.2	65.7	220.2	53.2	86.5	77.8	92.0	67.9	77.9	193.1	193.0	92.0	114.1	77.3	72.8	188.8	377.0	206.9	78.8	97.1	75.2	213.0	141.8	39.7	170.0	102.0	102.9	58.7	84.9	77.8	78.4	114.8	144.1	25.0	74.6	58.0	213.6	120.9	246.6	94.5	45.0	82.8	28.6	30.9	29.8	61.8	66.9	86.9	105.2	65.9	104.6	83.5	64.9	43.1	63.5	115.0	82.7	64.6	84.6	47.9	51.0	23.3	82.4	67.1	30.8	9.9	48.3	156.3	364.6	21.1	49.5	106.0	219.2	38.0	119.6	100.4	64.4	125.9	15.9	159.6	236.3	24.1	39.8	42.7	19.1	164.8	68.9	27.0	74.9	497.6	179.8	31.8	32.7	37.5	57.5	278.8	308.2	41.9	31.3	77.4	40.0	34.8	34.4	30.8	26.8	533.9	191.0	182.6	49.3	28.7	46.4	224.0	291.2	139.5	113.2	238.1	124.0	383.2	120.1	149.7	230.6	340.4	77.2	117.8	215.9	179.6	175.0	915.5	263.8	417.7	68.4	70.6	73.7	92.6	67.9	77.9	77.3	72.8	75.2	78.4	74.6	82.8	316.4	70.5	105.9	16.6	964.5	364.0	561.8	316.3	203.7	134.6	191.3	185.2	221.5	91.5	193.4	71.7	281.5	131.9	577.3	369.1	170.2	192.7	73.3	162.5	121.3	199.8	434.4	40.8	29.9	197.7	182.4	223.8	251.8	260.5	151.8	108.8	134.2	164.0	194.7	47.1	32.2	569.7	290.9	241.6	395.9	251.6	104.1	507.7	948.0	88.1	197.0	94.3	81.4	21.1	30.7	144.8	336.5	95.5	2680.7	447.4	156.1	209.0	95.6	117.1	98.6	178.8	215.6	54.7	10.6	146.6	255.3	693.8	342.6	137.4	311.4	456.8
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35697459	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 329.7;Late spermatids: 660.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	"Nucleoli,Nucleoli rim"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"HPA015630: AB_1850609, HPA076087: AB_2686774"	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	17.4	13.6	17.1	19.7	19.8	33.6	14.7	18.6	19.1	17.3	19.4	16.2	15.9	21.0	15.0	21.2	16.6	19.3	16.6	16.4	16.2	16.1	23.5	21.1	21.5	17.9	17.3	32.6	28.9	14.3	10.3	17.7	17.2	15.1	16.8	23.0	14.8	12.8	16.4	23.1	16.8	17.9	16.5	24.3	17.1	26.0	18.2	18.0	23.3	14.4	19.8	18.3	16.0	21.2	36.4	13.1	25.5	28.2	34.0	26.7	18.0	25.4	31.3	14.6	16.9	15.3	39.3	28.2	35.0	28.9	58.4	41.7	12.7	16.8	22.4	17.0	16.3	18.5	17.1	12.6	29.3	17.2	20.9	31.5	31.4	18.1	29.6	32.9	24.8	32.9	28.2	34.8	27.3	19.3	21.1	31.3	19.5	23.8	15.9	22.6	34.0	20.0	20.4	16.4	23.8	37.9	35.3	30.5	23.0	42.2	31.5	25.0	28.9	26.1	29.4	24.5	19.9	45.0	57.4	28.0	24.9	27.9	48.0	8.8	7.4	23.2	11.0	8.4	12.6	4.8	9.7	12.0	6.3	7.0	6.1	8.6	12.4	13.7	11.3	3.8	10.1	5.7	17.1	19.8	18.6	19.1	16.4	16.2	17.9	17.3	17.2	16.5	18.2	21.2	30.8	25.6	17.1	66.6	48.1	16.8	17.0	9.0	20.5	14.1	12.0	12.7	12.8	20.0	11.8	5.5	8.4	17.6	57.4	19.8	17.6	25.0	329.7	20.5	19.3	21.5	14.3	27.4	25.8	28.9	25.0	23.2	24.5	25.5	36.8	24.4	24.3	21.8	17.5	11.8	44.2	11.8	12.2	25.1	20.0	660.5	27.4	27.3	23.2	31.9	28.5	24.0	40.2	37.2	34.7	34.7	16.0	25.2	42.8	17.9	24.3	12.7	11.1	13.9	13.1	26.5	26.6	45.0	18.7	19.9	15.8	31.1	83.2	16.6	14.2	20.3
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.7;skin 1: 16.9;vagina: 18.8"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 48.9;Late spermatids: 45.3;Paneth cells: 33.0;Squamous epithelial cells: 58.5;Syncytiotrophoblasts: 99.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 17.0;head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 19.7;HaCaT: 37.6;HBEC3-KT: 32.3;hTCEpi: 18.3;PC-3: 13.4;TIME: 55.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039462	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.1	0.0	0.2	0.8	0.2	0.4	0.8	0.4	0.4	9.8	0.2	6.1	0.3	0.3	0.6	33.7	2.6	0.1	0.1	0.3	0.2	1.1	0.1	1.1	0.1	0.3	0.2	0.1	0.0	0.3	0.2	6.7	0.4	1.6	4.6	1.2	3.7	0.1	0.1	16.9	1.3	0.3	0.1	0.1	0.1	2.9	0.2	0.3	0.0	0.1	1.7	0.3	18.8	0.7	1.8	0.6	0.0	0.2	0.3	0.1	19.7	0.0	0.0	0.1	0.0	0.5	0.3	0.1	3.5	0.2	0.2	37.6	1.0	32.3	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.2	0.1	18.3	0.1	0.7	0.0	9.8	0.0	0.3	0.3	0.1	2.9	0.1	1.6	0.0	2.0	13.4	0.1	0.0	0.2	0.3	0.5	0.2	0.0	1.9	10.3	0.3	1.9	1.4	0.7	55.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.1	0.2	0.7	0.4	9.6	3.9	0.0	0.4	6.5	8.7	10.5	8.0	1.8	2.0	1.5	9.1	0.0	12.7	1.8	4.2	3.6	0.4	17.3	0.0	1.1	19.4	10.3	1.2	1.5	3.0	0.0	0.0	0.0	4.6	1.1	0.0	9.9	1.3	0.2	1.4	0.2	0.9	0.0	0.0	48.9	6.1	0.6	4.8	45.3	0.3	1.2	1.8	0.0	0.1	1.0	1.0	0.0	0.0	0.5	33.0	0.7	0.3	10.9	9.2	6.6	16.8	6.1	0.0	1.4	0.9	5.8	4.8	58.5	19.6	99.3	0.8	0.1	13.1	23.2
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244179-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 11.0"	"Region enriched"	"Detected in some"	30	"cerebellum: 34.8"	"Low region specificity"	"Detected in some"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA					"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.2	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530263	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 18.7;skin 1: 4.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.8"	"Group enriched"	"Detected in many"	4	"amygdala: 10.3;basal ganglia: 14.2;cerebral cortex: 5.1;hypothalamus: 12.4;thalamus: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	0.5	0.0	10.3	0.0	14.2	0.0	0.3	0.7	5.1	0.4	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	2.5	2.8	12.4	0.1	0.3	0.3	0.0	1.1	0.9	0.1	0.0	0.0	2.5	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.4	0.2	0.1	0.9	18.7	0.0	0.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	14.2	0.7	5.1	2.8	12.4	1.1	0.9	1.0	0.4	18.7	0.0	24.8	0.0	0.0	53.5	0.2	0.1	0.3	0.2	1.8	2.9	1.1	2.8	1.4	0.0	0.3	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	5.4	0.8	5.1	0.0	0.0	0.7	0.0	0.0	0.3	0.0	8.9	0.0	0.1	0.0	0.0	0.0	3.3	0.8	4.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	1.9	0.0	113.4	0.0	15.6	0.3	0.0	2.9	0.0	0.0	0.5	0.1	0.0	0.0	7.7	0.0	1.0	6.2	0.0	0.4	6.2	1.4	0.0	0.5	0.0	3.0	0.2
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120592-8124106	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.1"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Smooth muscle cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.3	0.1	0.2	0.0	0.2	0.0	0.3	1.7	1.6	0.7	0.0	0.3	0.0	0.7	0.0	0.3	0.5	0.1	0.9	0.5	0.2	2.1	0.0	0.9	0.1	0.2	0.0	0.9	0.1	0.4	0.4	0.6	0.2	0.4	0.0	0.5	0.6	0.0	0.2	0.5	0.2	0.0	0.3	0.4	0.2	1.1	0.2	0.0	0.5	0.0	0.1	0.2	0.7	0.4	6.0	0.4	0.5	1.8	0.1	0.2	0.2	0.3	0.5	0.5	2.2	0.1	0.3	6.0	0.1	0.0	1.0	0.7	8.3	0.7	0.0	6.5	3.9	0.2	13.9	0.1	0.7	0.7	0.8	0.1	1.1	1.8	4.4	1.0	0.1	1.0	0.2	2.9	0.2	0.1	0.1	0.3	0.2	0.5	1.5	0.6	0.3	1.2	0.2	0.0	0.3	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	1.3	1.4	2.1	3.9	0.9	0.4	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.7	1.6	0.5	0.2	0.2	0.0	0.2	0.3	0.2	0.4	0.9	0.0	0.0	1.0	0.2	2.2	1.0	0.3	1.2	2.3	2.3	1.7	1.3	0.0	0.1	1.8	0.0	0.0	0.8	0.2	0.0	0.1	1.7	0.2	0.1	1.7	0.0	0.0	1.1	0.0	0.0	1.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.3	1.8	0.0	0.0	0.5	3.6	0.0	0.6	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.1	1.6	0.0	0.1	0.2	0.7	0.0	1.5	5.9	0.1	0.6	1.0	1.6	0.3	0.3	0.0	0.2	0.2
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197838-57227606	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 36.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.5;U-266/84: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.3	1.8	1.7	1.0	1.7	5.9	2.6	2.2	2.2	1.2	1.4	1.0	1.1	0.9	3.4	1.0	1.1	1.6	1.1	1.7	1.7	2.1	3.8	1.4	1.8	1.9	1.7	1.4	1.8	1.6	1.8	1.1	1.9	1.5	0.8	2.0	1.1	2.0	0.8	4.2	1.0	0.6	1.8	2.2	1.9	6.3	1.8	1.3	2.5	0.6	1.3	0.9	1.0	1.9	1.3	1.2	2.6	4.3	0.4	1.6	0.8	0.1	0.5	0.8	1.4	0.6	3.9	3.4	0.6	0.1	1.0	0.2	1.2	1.4	1.0	2.0	2.9	5.0	1.8	0.4	2.9	1.6	0.5	4.1	1.2	0.4	2.8	2.1	0.7	7.2	0.8	4.3	0.3	0.3	2.2	9.1	73.5	1.1	0.8	0.8	1.6	1.7	3.6	0.7	1.1	3.5	1.0	1.4	2.7	1.2	1.0	7.0	0.5	3.3	1.3	1.0	1.4	12.2	23.7	10.1	1.2	3.1	1.6	0.5	0.8	0.4	0.2	1.6	0.0	0.6	0.2	0.1	0.5	0.5	0.2	0.1	1.4	0.7	0.2	1.8	0.0	0.2	1.7	1.7	2.2	2.2	1.7	1.7	1.9	1.7	1.9	1.8	1.8	1.9	1.0	0.0	0.5	6.5	0.9	0.4	0.6	1.4	0.0	0.3	1.3	1.8	0.8	1.5	0.4	1.8	0.0	1.5	1.7	0.9	0.0	0.4	0.5	1.7	0.7	1.2	0.0	0.0	1.7	0.2	1.1	0.6	0.5	0.4	0.0	1.0	1.4	1.0	2.1	1.7	1.5	0.1	2.0	1.6	0.6	0.4	0.9	2.0	0.0	6.5	1.1	1.6	0.0	3.0	5.1	0.5	0.2	0.4	0.2	0.7	0.7	1.2	0.9	2.6	0.0	0.8	0.5	36.3	7.6	0.3	1.1	0.5	0.7	2.7	0.7	0.4
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HEXD	"FLJ23825, HEXDC"	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.8;Cardiomyocytes: 6.1;Cytotrophoblasts: 5.9;dendritic cells: 10.1;Extravillous trophoblasts: 6.4;Hofbauer cells: 16.2;Plasma cells: 4.1;Syncytiotrophoblasts: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 62.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	31.5	20.5	6.9	4.4	7.4	9.0	21.0	10.1	7.8	32.5	9.3	17.0	4.1	22.4	3.9	15.4	25.3	3.1	15.0	6.6	6.3	27.0	29.8	14.8	7.0	7.6	7.0	29.9	55.2	4.1	31.9	1.8	8.0	34.6	2.1	3.6	19.8	4.2	28.4	14.4	24.2	2.1	6.2	36.1	21.3	12.5	7.8	5.0	25.4	7.6	3.4	17.6	21.1	9.6	3.4	8.0	3.5	5.9	11.3	9.9	10.7	4.5	5.4	4.4	4.7	3.1	11.1	9.5	4.8	1.7	3.0	4.9	2.0	2.5	1.7	6.4	15.5	4.1	8.4	3.9	9.9	2.9	10.2	7.3	1.9	1.3	4.6	4.7	5.7	5.9	5.5	3.2	1.3	7.5	10.0	8.6	3.7	6.5	5.1	11.5	3.2	17.9	3.5	4.5	4.9	11.1	9.4	5.5	9.1	1.3	8.4	10.7	5.2	2.8	5.3	2.2	3.1	14.6	2.1	7.0	2.3	6.9	3.2	9.5	3.0	5.6	18.4	24.3	12.4	8.3	3.9	6.5	3.8	11.0	5.8	9.3	5.5	25.4	10.8	62.3	3.2	11.2	6.9	7.4	10.1	7.8	6.6	6.3	7.6	7.0	8.0	6.2	7.8	9.6	7.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	5.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.0	1.4	0.0	0.0	0.0
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"HEXIM P-TEFb complex subunit 1"	O94992	17	45148475-45152099	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	16.8	32.6	16.3	13.2	15.4	36.3	17.0	16.2	16.5	17.2	16.5	22.5	17.7	19.6	15.9	24.2	21.3	14.3	15.0	14.8	16.8	21.1	26.8	17.3	12.8	17.0	19.1	14.4	19.7	14.1	19.2	25.2	16.0	24.2	10.2	9.0	19.2	19.8	33.2	22.6	24.9	13.0	17.7	25.6	23.1	21.6	19.7	15.4	20.1	21.6	12.4	19.7	17.6	14.2	35.7	111.1	22.8	33.0	36.7	19.6	55.3	30.9	27.8	25.0	27.8	52.6	49.3	15.5	93.1	32.7	12.1	28.2	13.8	30.4	20.0	32.2	32.9	48.2	65.8	65.0	32.0	30.3	61.4	23.0	25.5	18.6	8.1	62.6	12.7	26.8	21.5	36.6	19.0	47.8	31.9	34.9	20.9	32.9	33.4	13.1	19.9	19.2	66.5	62.1	12.2	9.2	46.6	52.0	52.2	23.0	54.2	23.5	24.3	25.1	34.6	14.6	58.5	33.1	11.4	10.0	23.0	28.1	29.1	16.2	4.0	6.8	4.2	6.1	2.4	3.0	4.2	3.7	3.3	3.2	3.7	3.9	10.0	3.7	7.3	3.4	3.8	2.2	16.3	15.4	16.2	16.5	14.8	16.8	17.0	19.1	16.0	17.7	19.7	14.2	210.3	73.7	111.8	7.2	76.1	84.5	75.0	57.7	157.1	25.1	127.0	215.9	59.7	87.2	60.5	25.8	22.9	134.8	114.3	250.4	7.9	35.0	2.2	88.8	66.1	91.3	52.8	82.1	10.7	23.6	70.1	99.2	94.3	137.9	125.9	16.5	42.5	40.5	42.1	15.2	12.9	122.0	54.9	33.9	83.2	3.0	35.1	83.0	53.4	9.4	38.4	27.7	28.8	7.1	8.2	25.3	127.1	43.6	44.1	52.1	184.9	53.8	45.7	24.8	26.3	249.2	128.2	2.6	7.9	126.7	71.5	467.5	111.1	16.9	92.2	34.4
HEXIM2	FLJ32384	ENSG00000168517	"HEXIM P-TEFb complex subunit 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9;testis: 44.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 150.9;Late spermatids: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.8	10.1	8.5	5.2	9.0	4.6	4.6	12.2	9.8	4.9	13.4	7.1	10.2	4.7	4.5	4.7	5.6	7.8	6.9	7.2	7.3	10.5	15.1	4.2	7.3	9.1	8.4	6.2	10.8	7.5	7.9	3.4	8.2	6.0	2.7	4.8	11.5	5.7	56.9	6.6	7.6	2.8	8.6	6.4	8.1	44.6	9.0	5.0	8.7	15.1	3.3	5.8	3.9	9.1	9.0	31.7	6.9	15.3	7.5	12.3	13.1	4.9	5.9	7.8	8.6	12.1	23.4	5.6	25.0	3.5	4.0	14.6	6.8	6.0	2.4	12.9	10.9	4.2	33.4	55.1	5.4	3.6	8.9	10.7	5.6	6.8	2.4	15.1	3.9	11.3	4.6	13.4	3.6	15.6	5.7	7.6	7.5	12.5	13.8	7.7	10.4	17.1	9.8	8.8	8.2	7.2	4.4	8.8	20.7	4.8	23.3	6.1	3.8	14.0	7.5	9.4	11.7	20.7	23.9	5.2	11.0	6.6	10.7	8.2	11.7	10.6	4.8	9.4	8.0	10.1	3.5	5.8	10.2	5.5	2.7	5.0	8.2	8.1	3.1	12.9	4.7	12.0	8.5	9.0	12.2	9.8	7.2	7.3	9.1	8.4	8.2	8.6	9.0	9.1	3.1	0.0	1.5	1.6	4.8	2.0	4.0	3.1	5.7	13.1	6.8	7.2	0.3	5.7	2.5	1.8	4.2	11.7	4.1	2.7	19.6	5.5	150.9	4.9	3.0	4.3	4.8	0.8	2.2	1.6	5.4	3.9	3.6	3.4	7.0	8.8	5.3	7.7	7.0	3.3	3.0	6.2	4.1	9.3	3.3	274.9	5.9	16.4	3.6	1.0	4.9	11.6	5.2	1.5	3.1	1.6	3.1	7.2	7.2	2.0	18.3	36.2	1.8	9.9	0.0	5.4	4.6	41.4	13.7	3.3	3.0	6.2	2.1	7.2	6.1	2.5
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79762371-79767857	"Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	21.1	2.2	17.4	2.1	23.0	0.6	19.0	19.4	19.1	7.2	9.6	6.7	1.7	3.5	0.9	2.8	3.9	4.2	23.9	18.4	20.3	2.8	2.8	15.2	2.2	18.1	21.0	2.0	3.4	3.3	18.4	17.8	19.3	6.0	2.6	5.3	10.1	1.7	19.5	4.2	5.8	3.2	19.1	2.4	4.8	3.1	22.8	3.4	6.5	16.2	2.5	9.3	5.2	15.4	1.7	0.1	1.1	9.1	0.8	0.7	22.0	2.1	2.1	0.3	0.3	0.1	0.1	3.3	2.3	1.0	1.0	4.6	4.9	0.1	0.2	0.5	125.7	0.0	4.1	2.1	1.4	0.0	0.7	1.3	3.7	0.1	16.2	0.4	3.4	0.0	9.0	3.6	1.3	0.1	0.0	0.5	0.1	0.3	28.8	0.0	4.6	3.3	0.4	3.9	5.2	14.6	0.1	2.4	93.3	19.6	0.1	0.1	2.0	0.7	2.4	0.0	1.8	3.3	0.7	0.2	3.4	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	1.3	0.0	0.0	0.0	17.4	23.0	19.4	19.1	18.4	20.3	18.1	21.0	19.3	19.1	22.8	15.4	105.2	0.0	1.8	15.0	0.8	3.2	3.4	27.6	2.8	6.8	8.6	12.2	4.3	0.0	19.5	0.0	0.0	6.8	1.8	5.3	15.6	2.6	4.6	12.6	4.1	47.6	36.8	0.0	7.7	1.2	112.6	5.3	1.5	33.5	10.8	1.9	41.0	0.9	1.8	21.9	8.0	2.0	26.4	0.6	5.7	3.2	0.0	2.3	33.8	20.6	0.0	10.9	0.0	18.6	1.0	0.7	7.5	0.4	0.8	1.7	0.2	0.4	7.7	12.2	0.0	74.5	12.1	0.6	15.4	3.4	3.0	23.4	1.1	1.5	2.5	2.6
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.5	0.9	8.8	1.0	12.0	0.1	5.7	9.4	7.6	8.0	3.0	2.5	1.3	7.5	16.4	1.8	13.5	1.7	30.7	7.2	10.4	3.1	5.3	3.2	0.5	12.7	10.0	7.1	3.3	2.6	5.5	3.7	10.6	2.1	1.3	5.7	2.0	2.7	16.2	2.4	2.1	1.7	14.1	1.9	2.0	6.6	11.8	0.7	3.1	4.9	0.6	2.7	4.7	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.5	7.1	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.6	0.0	0.4	0.0	0.0	3.2	0.0	0.3	0.5	0.6	0.9	0.0	0.1	2.3	0.0	0.0	0.0	6.6	3.2	1.9	0.0	14.8	0.3	0.0	0.1	0.8	17.6	0.3	0.1	0.6	0.0	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	12.0	9.4	7.6	7.2	10.4	12.7	10.0	10.6	14.1	11.8	12.2	2.8	3.2	1.1	12.4	0.7	3.8	0.5	8.7	3.4	0.4	9.8	5.7	21.5	0.0	2.7	0.0	8.4	0.0	1.4	0.1	9.8	0.1	49.9	46.1	4.2	6.0	0.0	2.7	0.1	1.8	0.1	3.3	1.1	36.8	0.0	73.9	1.8	8.0	0.1	1.7	0.4	0.0	2.0	0.8	3.0	80.6	6.5	0.6	3.6	5.6	0.0	34.8	3.1	2.5	23.4	1.1	0.1	23.3	3.1	0.3	0.0	6.4	5.4	5.2	52.6	17.5	41.8	16.2	15.1	7.7	2.0	0.0	2.0	2.8	0.1	0.3
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif like"	Q9NQ87	1	39623435-39639643	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 69.5"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 17.5;Leydig cells: 26.1;Peritubular cells: 56.8;Sertoli cells: 52.6;Skeletal myocytes: 33.4;Smooth muscle cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 8.0;LHCN-M2: 20.8;RH-30: 26.5;THP-1: 6.2;U-266/84: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	17.9	12.4	9.5	5.6	12.0	0.1	9.3	10.5	6.9	18.5	4.1	7.2	1.9	27.9	5.7	4.8	17.4	8.0	57.0	5.4	15.0	9.5	4.2	23.5	1.7	11.3	15.6	13.4	69.5	2.4	15.3	29.5	12.9	17.0	3.4	6.7	2.7	14.4	6.0	2.9	4.9	25.0	7.3	6.3	6.0	16.0	17.1	1.3	20.4	5.4	2.0	8.7	11.3	8.3	0.0	2.8	4.8	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	2.0	0.3	0.0	1.6	0.5	0.0	0.0	2.8	0.0	0.3	0.0	3.2	5.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.0	0.5	0.7	20.8	1.9	0.0	0.1	0.0	0.2	0.1	1.4	26.5	0.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	1.1	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.7	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	12.0	10.5	6.9	5.4	15.0	11.3	15.6	12.9	7.3	17.1	8.3	1.3	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.9	0.1	0.0	3.6	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	1.0	5.4	1.3	4.0	1.9	0.0	0.0	0.1	3.5	0.3	13.3	2.0	2.4	0.0	0.7	1.4	0.0	0.3	1.7	0.2	0.2	0.0	0.0	2.3	17.5	26.1	0.4	5.4	4.7	0.1	0.4	0.0	0.0	2.4	2.8	0.3	56.8	0.0	0.2	0.0	0.1	0.0	3.9	52.6	33.4	29.5	0.4	2.0	0.1	0.1	0.3	0.3	1.9	0.4	0.2
HFE	"HFE1, HLA-H"	ENSG00000010704	"Homeostatic iron regulator"	Q30201	6	26087281-26098343	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.2;T-47d: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	9.6	7.9	1.3	5.3	2.1	0.6	7.8	1.4	1.9	6.7	9.3	5.8	5.9	4.9	12.4	4.8	4.5	8.1	3.7	1.5	1.5	6.7	15.4	7.5	3.6	2.4	1.7	7.3	6.3	15.4	1.2	6.1	2.2	6.8	6.9	1.3	6.9	9.6	2.3	2.8	5.0	6.0	1.7	8.6	8.3	1.7	1.9	1.7	9.9	3.0	3.1	7.4	3.2	2.8	17.2	39.2	0.7	18.6	27.3	21.1	0.1	12.2	28.5	15.1	23.6	3.3	34.3	1.8	32.4	20.2	22.9	10.7	0.0	14.2	19.1	4.6	0.2	0.5	8.1	2.6	5.6	0.0	0.7	21.6	4.0	16.7	1.4	13.2	10.4	0.0	0.7	0.4	13.0	7.2	0.1	0.2	0.9	8.1	0.0	2.3	0.0	0.3	12.5	11.5	0.1	0.1	7.3	0.0	10.2	0.3	54.0	1.9	8.2	10.6	1.1	10.7	10.6	0.2	0.4	0.2	15.9	0.2	23.5	1.3	10.7	0.0	1.5	10.4	1.2	3.3	1.6	2.1	4.7	1.3	0.4	1.0	1.9	0.2	9.2	0.3	0.3	3.8	1.3	2.1	1.4	1.9	1.5	1.5	2.4	1.7	2.2	1.7	1.9	2.8	3.9	3.2	5.1	1.0	1.7	1.7	2.6	3.7	6.2	1.0	3.7	2.2	3.2	2.8	6.7	5.5	2.1	1.7	0.5	3.8	0.0	4.1	0.1	1.8	2.3	3.4	1.8	2.7	0.1	3.4	0.8	4.6	8.2	1.5	2.5	3.0	6.8	12.2	11.1	0.0	0.1	4.0	4.1	25.4	7.6	0.2	3.7	7.4	0.0	2.8	3.8	2.9	2.1	0.0	3.3	2.4	0.9	6.0	0.3	2.6	2.9	2.7	5.9	1.7	0.0	5.7	2.4	0.2	1.1	3.4	3.4	1.8	1.0	2.8	3.3	1.9
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699010-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 311.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 94.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000	14000	"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	7.9	19.8	1.6	6.3	3.3	12.3	5.2	1.5	7.8	7.2	1.8	4.4	2.6	8.1	3.6	2.9	5.4	16.6	4.7	2.9	3.6	11.8	30.3	19.5	2.2	3.6	2.3	1.8	2.1	2.1	2.4	311.9	4.3	7.2	3.4	14.2	2.4	6.4	0.8	0.9	2.3	7.1	1.8	6.5	3.9	2.4	2.9	1.5	5.6	3.9	1.5	10.4	6.3	3.3	0.0	0.0	0.1	0.0	21.6	171.6	0.1	0.7	33.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	135.8	82.4	0.4	41.4	0.0	87.4	0.3	0.0	2.2	0.0	0.1	240.7	0.6	0.0	0.0	56.4	0.0	0.0	0.2	0.8	0.0	7.5	0.0	0.0	0.2	9.3	0.0	0.1	0.0	0.2	0.0	3.5	0.4	2.0	0.0	0.1	0.0	0.1	0.0	0.0	62.6	16.9	0.1	94.0	15.2	3.9	0.0	18.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	3.2	0.0	17.3	1.0	0.0	4.3	1.6	3.3	1.5	7.8	2.9	3.6	3.6	2.3	4.3	1.8	2.9	3.3	6.2	0.0	4.1	16.3	0.0	1.0	0.2	0.0	1.8	0.2	0.3	0.5	1.3	1.5	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	15.2	1.0	23.8	6.2	0.0	2.1	0.3	0.0	4.9	95.8	0.5	0.9	1.3	0.0	25.0	0.5	18.4	0.0	22.4	0.0	0.0	12.5	1.9	2.3	18.3	14.0	1.8	7.5	10.5	36.2	1.0	0.0	0.1	0.0	0.0	10.9	0.3	0.4	0.0	0.0	0.0	0.7	13.1	0.9	26.2	0.2	0.3	0.3	0.1	12.0	0.6	1.3	0.0	0.4
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441968-3449486	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"liver: 217.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	9300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	1.5	0.0	2.3	0.0	0.1	2.2	2.6	0.5	0.7	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.1	1.3	0.6	0.6	217.1	0.1	0.0	0.9	0.6	0.1	0.1	0.0	0.7	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	3.8	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	2.2	2.6	1.3	0.6	0.9	0.6	0.9	0.5	0.8	0.6	0.1	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.6	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	4.4	2.2	72.0	0.0	3.3	3.9	0.0	0.0	3.2	0.0	165.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	21.5	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137774-144140851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 26.4;PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: AB_2678013"	"unprognostic (2.13e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	2.3	3.2	1.8	1.0	1.3	0.6	1.5	1.4	1.8	2.0	1.2	1.9	0.6	2.3	0.1	3.1	1.7	0.5	2.1	1.7	1.1	1.9	3.2	1.3	0.6	2.1	1.2	1.7	3.1	0.8	1.4	0.4	1.4	1.9	0.5	0.1	1.8	0.8	2.7	2.2	1.6	0.7	1.3	2.2	2.9	2.4	1.5	0.6	2.0	1.2	0.6	2.6	1.9	1.6	8.3	2.7	1.9	3.5	2.7	1.7	4.9	13.8	1.1	2.9	1.9	3.6	2.1	23.9	18.7	2.6	1.1	8.6	3.8	1.9	0.9	11.7	14.5	9.1	2.4	1.8	2.6	5.1	5.9	1.2	5.9	3.2	2.0	1.0	1.3	4.9	26.4	0.9	1.8	6.9	17.5	4.7	5.4	3.1	46.6	21.8	1.6	3.7	1.7	1.9	4.1	4.4	6.4	3.4	5.1	0.6	2.9	1.8	4.9	1.7	14.2	5.1	16.5	13.9	9.7	6.1	1.7	8.5	2.8	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.8	0.4	0.3	0.0	0.6	0.2	0.1	0.1	0.1	1.8	1.3	1.4	1.8	1.7	1.1	2.1	1.2	1.4	1.3	1.5	1.6	5.2	0.0	2.4	2.6	5.8	0.0	2.6	0.0	5.2	4.2	6.7	5.7	2.2	2.8	0.6	5.5	0.0	11.1	7.2	1.3	11.7	3.5	11.2	2.8	7.0	3.1	4.9	5.9	1.2	1.8	13.4	4.3	7.1	4.0	0.0	7.9	1.4	9.9	12.2	6.7	1.2	4.0	0.0	4.8	0.0	22.1	7.5	5.6	0.0	1.0	3.5	8.3	14.4	0.0	1.0	2.9	5.6	3.4	4.9	3.2	5.4	10.2	1.5	3.7	6.6	2.6	3.8	15.1	14.8	6.9	0.0	3.1	5.9	11.0	6.5	1.6
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	73.3	95.6	101.5	24.8	102.2	54.5	69.7	98.9	127.1	81.4	98.2	75.7	29.3	66.7	32.7	118.8	70.2	27.0	82.1	103.3	99.3	100.8	85.7	80.1	30.6	105.9	103.2	74.4	85.1	28.1	81.7	24.8	104.3	86.3	25.3	15.7	72.4	29.6	93.7	95.2	81.2	28.5	98.1	100.6	84.6	105.9	102.7	35.3	68.5	18.5	24.8	81.1	83.9	104.1	104.2	93.1	47.8	66.6	56.0	59.8	57.3	65.5	86.6	99.6	76.8	72.6	65.0	23.4	47.2	106.4	88.6	63.2	43.7	100.6	45.8	19.7	76.0	58.8	98.8	117.5	92.8	47.1	55.4	78.1	100.9	93.9	121.9	82.7	120.9	44.5	54.8	30.4	92.1	77.9	58.1	71.4	43.8	75.9	88.9	51.3	48.6	41.0	94.5	87.7	54.9	86.1	54.6	114.9	78.3	48.3	82.3	98.6	87.3	119.5	82.4	69.6	123.3	41.6	17.6	21.8	96.9	53.3	89.4	48.8	28.7	38.9	24.5	32.3	16.6	16.4	18.5	19.4	23.5	15.8	14.1	16.0	44.7	27.1	33.6	19.3	22.3	35.9	101.5	102.2	98.9	127.1	103.3	99.3	105.9	103.2	104.3	98.1	102.7	104.1	20.8	25.6	28.7	17.6	22.0	27.9	23.8	27.7	29.6	30.6	27.0	25.9	3.1	17.2	27.6	22.0	35.5	34.0	27.4	60.9	1.9	43.3	72.3	45.6	28.7	26.3	11.4	23.4	14.2	42.6	36.5	21.8	68.8	66.1	23.4	26.3	16.1	20.7	29.5	23.5	12.6	32.4	22.4	22.9	26.6	137.8	28.9	30.3	23.2	15.9	28.1	20.6	25.7	6.6	16.1	68.2	42.7	23.0	27.6	53.9	41.1	14.6	32.3	35.5	13.1	17.8	24.0	36.9	32.5	37.0	30.3	50.2	23.5	22.1	36.2	50.8
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140464-43202855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029578	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	32.3	20.0	13.1	17.5	13.0	21.7	27.8	10.6	13.5	35.0	13.8	25.4	18.4	30.1	30.6	24.0	29.0	25.9	23.3	13.3	17.6	20.0	26.6	24.5	11.7	13.3	12.0	35.9	29.9	22.7	30.7	28.4	13.2	26.9	17.2	12.5	25.9	23.3	14.4	35.4	20.9	25.1	11.4	17.6	23.2	7.6	15.8	11.3	26.9	17.6	15.7	25.2	28.7	13.0	27.4	36.0	8.9	18.0	71.7	53.8	13.3	30.5	36.2	21.8	19.3	5.1	39.2	14.8	20.5	42.9	15.2	15.5	4.0	18.5	12.7	6.4	6.9	16.3	22.2	8.1	23.0	3.7	2.5	36.2	25.9	11.7	24.9	34.5	39.2	7.0	7.5	22.1	40.4	10.0	14.8	7.2	8.0	16.3	5.4	1.6	16.1	7.7	36.1	22.8	4.7	14.0	39.0	12.6	17.4	19.0	43.7	20.9	46.3	33.2	5.4	20.9	12.7	17.9	18.2	6.1	26.8	6.3	20.8	0.2	8.8	9.4	2.7	5.4	3.0	1.9	2.3	2.8	15.8	2.1	1.7	1.9	3.2	8.8	8.6	2.0	1.7	5.0	13.1	13.0	10.6	13.5	13.3	17.6	13.3	12.0	13.2	11.4	15.8	13.0	39.1	16.0	31.9	48.0	26.7	18.0	19.5	22.6	8.6	50.6	23.9	21.7	10.5	28.6	17.8	51.5	50.1	39.2	30.1	27.2	3.9	26.7	0.5	23.5	42.1	37.8	24.1	15.3	61.8	28.1	39.4	34.3	32.6	36.5	8.2	51.2	49.6	23.5	29.2	25.2	76.3	28.0	18.3	34.3	58.8	3.2	35.1	43.3	19.6	44.0	33.5	13.5	34.0	50.8	43.8	29.9	17.0	31.6	19.8	20.7	31.4	9.9	23.5	39.6	26.3	30.2	28.2	1.1	3.0	22.3	21.2	30.1	25.0	37.4	21.7	17.7
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	2.1	6.5	1.1	0.6	1.1	0.4	3.3	0.3	1.6	3.4	3.6	2.3	1.1	2.5	3.1	2.8	2.8	2.2	2.4	1.0	0.4	4.0	2.7	2.1	0.8	0.7	0.8	2.1	2.3	1.7	3.2	1.3	0.6	4.0	1.3	1.7	4.4	2.0	0.3	3.4	2.5	1.1	0.9	2.2	1.8	2.5	0.6	2.0	4.6	0.2	0.8	3.1	2.9	0.9	0.8	0.9	2.3	1.3	1.0	1.3	4.8	1.2	1.1	1.9	3.1	0.2	0.9	0.0	1.2	0.9	3.1	0.6	0.5	0.5	2.2	1.7	1.2	0.0	0.1	1.1	0.2	0.3	13.6	1.2	2.7	1.6	1.2	3.2	0.3	1.2	0.0	0.0	11.6	1.2	0.6	0.0	0.6	0.7	0.1	1.3	12.4	0.0	7.5	2.6	1.9	7.8	2.1	0.0	6.0	5.9	4.0	0.7	1.7	2.8	8.5	1.6	4.7	3.8	0.2	0.0	1.1	0.8	2.3	0.0	0.3	0.0	0.7	0.4	1.3	1.5	0.9	0.8	0.4	1.8	0.0	0.2	0.0	0.1	0.1	3.7	0.2	0.4	1.1	1.1	0.3	1.6	1.0	0.4	0.7	0.8	0.6	0.9	0.6	0.9	2.0	0.0	2.4	25.8	5.3	2.2	5.7	2.8	6.8	0.5	5.8	2.4	2.4	4.3	1.2	9.2	0.0	4.6	13.9	1.9	3.9	2.6	1.2	8.8	2.6	2.0	0.0	0.4	47.7	0.7	3.6	3.0	2.6	5.8	0.0	4.6	3.6	2.5	1.9	0.0	11.8	2.7	4.1	2.9	0.5	0.5	1.2	1.5	0.0	20.6	1.0	15.6	0.0	17.1	26.0	1.2	2.1	0.4	2.2	3.7	2.3	0.6	12.9	0.5	0.0	1.7	1.7	0.3	1.3	3.1	2.6	2.2	2.8	0.4	2.0	5.2
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 241.1;heart muscle: 521.2;skeletal muscle: 282.3;tongue: 154.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.2;thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018174	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	0.5	0.7	77.5	0.0	163.6	0.0	1.3	124.7	110.1	0.5	34.3	0.3	0.0	0.9	0.4	4.0	1.8	0.4	521.2	76.0	109.5	0.3	0.3	0.7	0.3	152.8	152.1	0.1	1.3	2.9	3.8	0.1	149.3	1.7	0.1	37.8	10.7	0.2	282.3	1.3	0.2	0.2	101.0	0.2	0.2	1.1	127.8	2.2	21.4	154.2	0.1	0.1	0.3	241.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.5	163.6	124.7	110.1	76.0	109.5	152.8	152.1	149.3	101.0	127.8	241.1	0.0	0.0	0.0	59.1	0.0	0.4	0.0	0.0	0.0	119.6	0.0	0.0	65.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.1	1.2	0.0	0.0	4.8	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	11.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	5.4	2.8	0.0	49.9	0.0	1.5	168.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.2	0.0	5.5	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;lung: 16.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 322.6;TIME: 376.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	2.3	2.3	10.4	0.4	25.4	0.8	0.3	10.7	19.6	1.3	0.0	3.2	2.6	1.6	3.8	0.0	0.1	1.1	0.2	17.1	11.0	0.8	6.8	16.2	0.0	20.0	20.2	0.6	2.6	0.0	0.3	0.0	13.6	4.7	3.2	0.9	0.3	2.6	0.4	0.2	3.7	0.1	9.4	0.0	5.9	1.5	18.1	2.7	0.6	1.3	0.0	5.0	0.3	37.3	0.0	0.1	4.9	0.1	0.3	1.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.0	0.2	0.3	0.0	2.2	0.0	2.0	0.1	0.0	0.1	0.1	0.0	0.0	10.4	7.8	17.2	322.6	29.1	0.1	0.0	4.8	0.0	47.7	0.0	4.4	0.0	2.8	0.4	65.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	376.7	0.4	3.9	0.3	2.5	2.2	0.0	10.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	25.4	10.7	19.6	17.1	11.0	20.0	20.2	13.6	9.4	18.1	37.3	0.3	12.8	175.6	3.9	0.4	0.0	0.0	0.5	0.0	42.7	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.5	6.0	0.6	0.0	0.0	17.6	0.4	0.0	38.9	0.0	0.4	16.5	0.1	9.3	0.1	0.1	0.0	13.9	0.0	2.0	0.0	0.4	4.5	136.1	1.3	1.8	1.0	0.0	0.3	0.0	8.5	413.3	0.1	0.0	44.0	0.0	0.0	0.0	0.0	4.4	3.3	0.0	1.7	0.9	0.3	0.5	0.0	0.6	0.0	1.0	162.7	0.0	0.0
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548104	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.8;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	9	"Early spermatids: 16.7;Late spermatids: 25.5;Spermatocytes: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 18.7;Hep G2: 5.7;RH-30: 21.3;SuSa: 7.8;U-87 MG: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	18.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.3	0.0	21.3	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	7.8	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	25.5	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	13.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HHLA2	"B7-H5, B7-H7, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 129.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8"					"Low region specificity"	"Detected in all"			HPA055478	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.4	0.2	0.5	5.6	0.4	1.1	0.2	0.7	1.3	0.0	0.0	87.9	86.8	0.3	0.8	0.5	3.7	29.2	0.2	0.6	0.7	7.6	0.1	5.7	0.6	0.7	0.3	0.1	2.9	0.1	0.2	0.1	0.6	0.2	83.0	1.2	0.2	0.3	0.5	0.3	129.9	2.0	0.2	0.3	9.4	3.3	0.6	0.4	0.2	0.0	0.3	0.0	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.7	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	0.0	4.0	0.1	0.1	1.4	0.2	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.8	0.0	0.2	0.4	1.5	0.5	0.2	0.3	0.3	0.1	0.8	0.0	0.1	0.7	0.7	0.7	0.0	0.1	0.5	0.1	0.2	0.1	0.1	0.7	0.2	0.2	1.3	0.7	0.3	0.0	0.4	0.1	0.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.5	0.4	0.7	1.3	0.6	0.7	0.7	0.3	0.6	0.2	0.6	0.8	0.0	0.0	2.0	0.7	0.4	0.0	0.1	0.7	0.0	0.0	0.7	0.3	0.2	27.1	1.6	0.0	0.0	0.0	0.0	274.7	0.0	8.5	3.3	3.2	0.0	0.3	1.8	0.0	1.3	37.6	0.1	0.3	2.6	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	12.5	2.0	0.0	0.7	4.2	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.5	0.9	35.7	64.2	0.0	0.0	0.1	186.8	20.4	19.4	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.1	0.5	0.0	17.7	0.1
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662883	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 543.9;Proximal tubular cells: 355.1;Syncytiotrophoblasts: 272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced					NA	NA		820000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	62.1	79.0	15.0	11.9	18.0	7.6	56.5	18.8	18.4	37.2	27.6	33.8	35.0	35.3	11.6	20.4	41.6	28.4	66.7	13.2	18.2	160.5	197.9	20.4	15.1	16.1	17.0	33.4	34.2	97.4	14.1	47.4	16.9	44.7	34.5	31.5	45.4	42.4	117.4	13.1	32.0	37.2	15.6	18.0	34.0	26.4	17.4	21.2	54.5	203.2	14.8	33.5	18.0	17.5	74.0	46.8	31.0	50.1	89.1	109.8	29.3	44.8	83.8	46.3	52.8	27.6	85.2	29.9	38.4	81.4	79.4	67.1	34.5	66.5	67.3	20.9	34.6	14.6	73.0	114.3	73.8	22.4	16.1	101.2	54.1	34.8	120.6	112.1	61.7	35.3	59.7	29.2	117.2	31.2	21.4	34.7	30.0	110.4	56.0	21.2	31.2	33.1	106.5	43.6	28.6	31.7	93.8	173.5	77.9	76.4	75.0	48.6	40.3	28.6	49.5	47.1	31.2	51.8	39.7	17.8	41.2	67.8	85.1	5.3	17.3	8.2	16.7	22.8	22.5	18.2	18.4	19.3	19.3	16.4	24.0	19.8	3.0	22.9	22.0	9.1	13.2	17.4	15.0	18.0	18.8	18.4	13.2	18.2	16.1	17.0	16.9	15.6	17.4	17.5	17.3	9.6	6.4	56.2	14.1	21.3	43.6	51.9	17.1	15.8	58.8	28.2	105.8	58.6	37.7	47.8	4.2	181.1	8.1	23.3	543.9	35.8	58.5	22.8	28.5	21.5	15.6	33.2	64.4	29.1	138.9	44.6	43.3	27.3	2.5	12.0	25.4	149.8	53.7	23.5	85.9	28.9	40.7	28.3	10.0	62.3	44.7	18.5	65.8	51.5	11.0	34.1	8.2	147.2	131.6	28.0	24.1	36.9	20.1	46.1	58.4	355.1	50.8	11.9	46.0	31.6	35.4	35.0	44.3	22.4	15.5	272.4	15.2	77.3	38.8	47.3
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HIC1	"ZBTB29, ZNF901"	ENSG00000177374	"HIC ZBTB transcriptional repressor 1"	Q14526	17	2054154-2063241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Fibroblasts: 44.3;Leydig cells: 57.5;Peritubular cells: 48.2;Sertoli cells: 46.0;Smooth muscle cells: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.9;BJ: 11.9;HSkMC: 7.1;TIME: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043372	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043372: AB_10795614"	"unprognostic (1.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-2)"	24.5	8.6	5.0	5.7	4.0	1.3	16.5	3.4	3.8	23.9	2.8	16.1	6.5	27.0	1.5	5.7	21.5	4.4	23.4	3.0	3.1	12.4	5.9	15.2	2.1	5.7	4.5	30.0	3.8	0.9	19.7	1.4	4.1	20.1	1.7	0.5	5.2	4.5	8.5	5.3	11.7	3.2	3.9	8.9	9.8	4.9	5.6	2.3	12.6	1.2	0.5	17.9	13.9	2.4	0.6	0.7	0.8	0.6	4.7	6.9	1.4	11.9	6.4	1.6	2.3	0.6	0.3	0.1	0.2	6.2	0.6	1.1	0.7	0.2	0.5	0.4	1.5	0.3	0.8	0.3	4.0	0.2	0.5	7.1	0.8	2.4	0.1	3.3	6.2	0.6	1.8	2.8	0.4	0.0	0.1	0.4	0.2	0.0	0.4	0.7	0.3	0.3	0.2	0.4	0.4	0.7	0.2	0.1	0.0	0.2	0.0	0.1	12.4	4.3	0.1	4.2	6.2	0.4	0.4	0.2	0.4	0.4	1.1	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	4.0	3.4	3.8	3.0	3.1	5.7	4.5	4.1	3.9	5.6	2.4	25.6	0.0	1.8	1.0	3.9	4.0	2.1	1.5	1.2	2.1	1.9	1.8	5.8	0.0	1.0	1.8	0.0	0.1	19.2	0.1	0.0	0.5	0.5	2.0	38.6	26.9	1.8	0.4	0.2	1.1	0.7	44.3	1.1	1.6	2.5	0.2	23.9	0.3	0.5	0.0	0.3	0.1	2.0	8.5	6.0	1.6	57.5	15.5	3.6	6.5	0.2	0.3	12.3	0.0	0.0	0.2	0.1	48.2	2.3	1.1	0.2	0.1	1.0	1.6	46.0	12.5	30.1	0.8	2.9	1.1	4.1	0.1	13.0	13.3	0.0	2.6
HIC2	"HRG22, KIAA1020, ZBTB30, ZNF907"	ENSG00000169635	"HIC ZBTB transcriptional repressor 2"	Q96JB3	22	21417371-21451463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.6;Extravillous trophoblasts: 41.4;Syncytiotrophoblasts: 39.5"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 69.2;K-562: 126.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031884, HPA059399"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031884: AB_10602234, HPA059399: AB_2684003"	"unprognostic (2.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.33e-1)"	"unprognostic (3.86e-2)"	"unprognostic (5.64e-2)"	2.2	1.2	2.5	1.4	2.6	3.7	1.5	0.8	2.8	1.7	0.0	2.1	1.3	2.0	0.5	2.6	2.2	0.8	1.5	2.7	0.9	1.7	1.8	1.8	1.5	1.0	0.6	3.4	2.1	1.1	2.6	5.8	0.9	1.2	0.8	1.5	1.4	0.7	1.1	1.5	2.1	0.7	0.2	2.4	2.4	7.4	1.0	1.7	2.4	1.1	0.9	1.1	1.5	1.4	2.2	2.7	14.4	4.3	1.1	0.9	69.2	1.4	0.5	1.4	1.2	27.2	0.8	5.1	1.4	0.9	0.9	5.9	10.2	0.9	0.8	3.4	15.0	6.8	4.0	15.0	1.2	6.0	3.1	1.1	0.5	2.1	0.9	0.7	1.1	2.1	126.9	2.1	0.7	2.1	2.7	6.2	15.3	4.8	2.0	6.7	6.4	0.8	0.7	3.6	4.0	7.0	1.8	2.1	2.6	14.9	1.2	9.0	1.9	2.2	5.4	2.1	1.6	4.2	3.6	5.4	1.8	2.5	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	2.5	2.6	0.8	2.8	2.7	0.9	1.0	0.6	0.9	0.2	1.0	1.4	10.3	3.2	1.1	3.6	7.7	5.5	5.4	2.6	23.9	14.8	4.7	4.2	3.9	7.2	1.7	1.8	14.6	39.6	4.4	10.0	0.0	2.6	14.2	8.3	7.6	6.5	6.1	5.7	11.8	2.6	41.4	6.6	11.2	7.6	1.3	6.4	2.9	3.0	10.3	8.4	7.5	7.4	6.1	3.8	4.3	29.9	5.6	5.6	5.4	1.9	4.5	3.0	2.1	5.0	2.3	2.8	4.6	10.1	10.4	8.1	7.0	1.6	1.5	7.3	6.6	10.7	6.0	12.2	24.5	27.1	4.5	39.5	5.8	2.6	9.3	7.5
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950742-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 111.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"		"HPA031406: AB_2673866"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.34e-4)"	13.2	5.8	21.7	6.6	26.9	2.0	23.2	41.5	33.3	19.9	2.8	17.9	39.1	11.9	29.1	5.5	19.0	21.6	12.4	22.0	24.3	12.3	4.4	20.4	5.3	27.4	22.7	3.0	111.2	14.4	44.0	20.1	30.3	36.2	17.9	8.7	86.2	20.2	4.6	7.6	27.3	6.3	10.4	16.7	68.7	6.8	25.4	2.8	16.8	5.7	6.3	12.3	7.6	39.1	5.2	11.4	1.3	15.8	0.0	0.0	2.7	0.0	0.6	1.1	1.0	10.6	5.8	0.0	1.0	0.0	1.4	4.9	14.5	1.0	0.8	0.0	11.4	0.1	0.3	10.1	2.7	0.0	1.1	0.2	6.0	0.1	2.4	0.3	26.0	3.8	0.7	4.0	0.0	115.9	0.7	0.2	0.4	99.2	7.1	0.2	0.0	21.8	14.5	44.8	21.1	56.7	0.0	172.6	0.0	3.6	101.2	0.0	0.5	0.1	1.4	0.4	0.0	2.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.9	0.7	0.0	0.1	1.0	1.1	0.0	0.0	0.0	2.6	0.0	0.4	21.7	26.9	41.5	33.3	22.0	24.3	27.4	22.7	30.3	10.4	25.4	39.1	21.4	0.0	5.5	4.9	4.6	1.5	2.6	3.1	0.6	14.3	20.4	12.3	3.8	4.3	8.6	0.0	0.0	26.3	1.1	16.0	3.9	19.0	0.4	10.2	3.0	19.1	35.3	0.0	16.1	26.9	1.7	1.0	71.4	20.3	0.0	1.1	20.7	0.4	2.5	20.2	15.5	89.5	16.2	0.8	0.4	1.0	0.9	0.7	7.2	6.5	0.6	2.8	0.0	8.0	50.9	22.9	87.8	0.0	22.7	17.8	107.4	0.5	6.5	4.4	0.0	1.5	1.8	0.4	2.1	0.5	0.4	35.0	1.8	0.1	15.6	13.9
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 subunit alpha"	Q16665	14	61695513-61748259	"Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 448.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 155.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 155.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 941.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	64.9	133.7	22.1	146.6	24.0	448.3	36.2	28.2	26.1	132.9	24.7	42.8	33.6	52.4	74.8	62.1	41.1	145.4	36.5	21.1	28.4	104.2	51.6	75.7	71.4	29.7	29.7	35.3	36.0	91.7	30.7	77.6	33.3	46.9	41.7	35.5	45.3	67.2	12.1	34.2	37.3	59.1	27.2	72.4	37.6	32.4	38.5	55.8	49.5	17.6	88.2	169.9	43.1	26.5	313.6	123.6	112.7	344.7	185.2	297.1	161.5	253.8	270.1	288.7	258.9	54.1	100.3	75.8	186.2	293.0	73.6	71.8	71.0	416.1	352.5	33.7	41.0	46.5	105.3	93.1	414.8	20.1	49.3	523.4	129.2	216.5	225.6	408.6	198.1	44.4	32.3	0.4	941.4	65.6	59.2	24.3	108.9	49.6	159.7	4.3	269.1	22.8	400.2	204.3	100.3	111.9	472.5	67.0	170.7	148.9	70.6	36.3	119.2	700.2	157.3	235.9	215.2	39.1	61.2	84.1	369.9	38.5	194.7	43.8	22.3	155.0	11.5	18.0	14.4	19.5	15.0	13.3	19.6	19.0	22.6	15.6	56.3	19.7	19.4	9.2	11.0	18.4	22.1	24.0	28.2	26.1	21.1	28.4	29.7	29.7	33.3	27.2	38.5	26.5	93.3	70.5	116.0	69.2	157.3	106.4	101.8	102.6	97.9	54.1	38.5	30.1	43.5	87.2	69.0	261.1	50.1	24.8	65.1	44.1	103.7	278.5	3.6	95.6	131.3	152.3	66.4	35.3	45.6	251.6	67.1	81.4	49.5	272.3	223.6	339.7	176.0	30.7	136.4	156.5	39.3	39.0	57.0	145.9	111.7	6.2	24.2	240.2	103.2	53.4	87.1	134.0	26.8	78.9	35.8	236.9	21.9	48.5	60.0	59.3	20.2	192.1	37.7	54.8	52.6	75.8	136.9	80.5	44.2	128.7	87.9	25.4	91.6	92.2	51.8	116.0
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 subunit alpha"	Q9Y2N7	19	46297042-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.5;Astrocytes: 257.9;Endothelial cells: 60.4;Leydig cells: 136.4;Muller glia cells: 79.9;Oligodendrocyte precursor cells: 69.9;Peritubular cells: 103.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.3;HHSteC: 19.1;HSkMC: 16.8;TIME: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	34.2	8.8	24.1	1.1	24.7	0.7	24.2	17.5	25.9	32.5	9.4	55.4	1.1	31.1	4.1	10.8	35.8	2.6	55.9	19.5	17.4	7.3	2.7	32.8	1.2	22.2	22.3	34.2	6.5	0.5	22.6	27.4	18.6	22.3	2.0	10.0	7.5	7.1	10.7	10.8	24.8	3.0	16.8	31.8	37.3	5.4	22.5	0.5	13.0	9.7	0.4	55.0	25.1	17.3	0.0	0.0	1.5	0.2	4.3	9.3	0.4	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	19.1	0.1	0.5	16.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	2.3	0.0	0.1	16.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.7	0.1	0.4	0.7	0.1	0.0	24.1	24.7	17.5	25.9	19.5	17.4	22.2	22.3	18.6	16.8	22.5	17.3	83.5	3.2	1.8	257.9	0.5	1.1	2.2	0.3	0.6	1.5	1.4	0.9	45.7	17.2	0.7	0.0	0.0	0.2	0.3	0.2	1.9	0.0	1.9	2.4	7.0	60.4	1.2	8.0	0.7	0.0	0.4	13.6	1.1	2.3	0.0	3.1	51.0	0.9	0.6	0.0	3.5	1.2	0.0	1.3	2.1	7.4	136.4	0.7	3.6	33.7	0.0	79.9	0.0	69.9	1.2	0.1	8.0	103.4	0.0	1.6	0.5	0.1	0.0	2.5	6.6	5.5	8.4	1.6	3.6	0.2	2.3	0.5	0.4	0.1	2.1	0.7
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42782908-42804490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 509.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	121.3	130.0	134.6	75.3	140.6	53.8	81.4	151.4	198.8	90.2	135.4	295.2	162.2	65.9	95.2	162.8	62.6	79.3	323.1	139.4	155.1	198.9	343.5	66.5	50.9	148.1	148.8	39.4	60.8	111.4	90.5	64.6	153.5	101.5	300.1	152.7	75.1	96.3	174.2	68.8	134.8	96.2	156.1	48.9	145.9	63.7	145.6	52.8	115.5	316.7	80.0	99.5	120.1	174.0	159.9	67.0	182.9	165.2	420.3	244.3	195.2	205.1	151.0	168.4	165.8	132.8	166.7	95.8	120.5	161.8	114.0	92.9	143.0	203.0	225.6	135.5	145.9	301.0	127.6	257.4	191.8	180.4	131.4	274.0	233.7	129.0	181.4	94.7	159.8	135.1	299.7	110.3	247.3	51.1	96.1	61.1	162.7	133.7	176.5	80.9	138.0	72.1	454.1	361.1	82.7	108.2	187.6	142.0	207.0	182.9	145.0	130.0	166.1	127.4	105.2	341.1	219.1	89.7	184.1	207.2	165.2	185.7	100.6	115.7	66.2	130.5	72.9	115.4	65.8	56.6	71.5	73.6	77.2	43.6	60.3	70.5	70.0	65.6	143.2	509.4	99.4	171.5	134.6	140.6	151.4	198.8	139.4	155.1	148.1	148.8	153.5	156.1	145.6	174.0	50.1	54.5	82.4	32.3	39.7	131.2	153.1	244.8	59.2	35.7	86.4	62.0	351.5	80.1	133.0	138.0	10.4	114.1	99.5	638.8	632.0	113.3	8.4	87.3	41.2	50.8	82.0	126.8	32.8	145.0	202.7	98.1	100.9	63.6	93.3	49.7	59.6	197.9	77.1	28.6	27.3	193.5	343.8	46.9	113.3	13.0	30.7	63.4	176.1	21.5	82.7	232.5	43.3	14.1	32.9	279.4	610.7	52.3	65.5	193.5	122.4	296.4	106.0	41.2	78.9	28.8	119.8	186.1	78.7	94.2	204.6	299.9	50.7	101.5	168.0	254.2
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388751-176389761	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	146.1	175.6	143.3	87.0	146.2	133.1	113.5	147.2	175.0	104.7	168.0	199.4	118.9	111.7	51.3	130.0	105.0	80.5	318.7	139.8	146.0	182.7	163.3	95.7	132.9	143.9	142.2	118.7	108.7	204.9	125.1	54.6	141.6	127.9	96.3	45.5	163.2	92.7	422.5	140.8	136.6	68.1	145.3	129.3	148.6	66.0	149.0	110.7	114.0	297.9	92.7	152.3	105.2	145.7	104.9	166.6	99.0	172.6	98.5	186.4	262.2	66.6	109.7	164.7	206.4	176.0	202.2	183.3	149.9	107.1	214.2	127.3	146.2	260.6	65.9	424.0	234.0	92.6	161.7	244.7	137.4	149.7	230.1	238.2	213.2	93.7	113.3	126.3	141.7	146.5	104.0	341.5	124.0	315.9	165.3	178.1	124.8	195.5	181.7	157.1	75.6	324.7	265.5	158.7	107.9	141.5	71.4	295.2	310.5	100.7	173.3	233.7	96.8	118.5	124.7	110.2	142.5	165.2	216.6	158.4	150.5	254.1	77.5	284.2	743.6	219.8	391.2	975.8	389.5	618.1	540.1	452.6	930.0	496.0	488.1	464.2	124.6	308.0	1024.9	616.8	621.8	971.3	143.3	146.2	147.2	175.0	139.8	146.0	143.9	142.2	141.6	145.3	149.0	145.7	100.4	73.7	78.6	0.0	212.5	232.2	332.8	358.0	272.0	60.5	225.5	288.5	145.3	174.5	191.0	182.1	12.5	223.0	184.2	415.6	534.1	204.5	83.9	140.0	120.6	110.9	266.6	90.8	0.0	237.3	185.4	129.1	142.2	124.2	130.0	157.0	120.3	217.0	378.7	65.6	0.0	450.7	219.7	458.8	345.2	56.8	140.1	292.1	257.9	0.0	449.7	138.1	230.7	0.0	0.0	110.0	493.0	85.0	184.2	292.6	313.8	542.8	142.3	47.7	118.3	145.9	138.8	96.7	79.4	301.8	225.0	280.2	223.7	182.1	385.3	532.4
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675798-72686182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	10	"testis: 3.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.3	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.1	0.0	20.1	1.5	0.0	0.1	0.1	0.1	0.0	0.1	0.2
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Heat shock protein nuclear import factor hikeshi"	Q53FT3	11	86302211-86345943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	34.7	27.0	46.1	17.8	46.7	19.0	31.4	47.8	71.5	33.9	44.5	40.8	10.4	32.3	24.7	33.4	31.0	15.0	57.1	46.1	47.2	17.0	24.7	23.9	26.0	46.6	46.0	37.5	22.8	22.9	31.5	28.3	47.1	24.5	19.1	32.5	19.8	28.6	59.9	29.5	20.8	31.1	49.1	28.5	23.5	19.0	47.1	32.9	17.7	57.8	30.8	32.8	31.8	50.9	28.6	30.5	72.7	40.5	59.9	74.2	38.2	43.2	52.0	44.2	52.6	90.8	77.8	29.0	96.9	57.4	83.9	59.9	54.2	95.1	47.0	62.0	47.6	47.0	47.5	68.2	80.8	58.0	36.8	52.7	94.9	52.8	62.5	56.9	85.9	54.7	51.1	64.6	91.5	78.0	69.6	136.7	59.5	186.3	20.1	53.0	35.7	65.4	77.2	53.2	44.8	38.7	53.8	39.8	31.1	72.7	64.1	38.5	44.2	52.1	36.4	105.8	32.7	27.7	68.3	57.6	26.6	54.4	52.6	47.8	53.4	44.4	48.6	52.5	54.3	61.8	59.1	53.6	68.9	52.9	51.1	52.3	11.2	57.9	53.9	53.7	84.5	43.2	46.1	46.7	47.8	71.5	46.1	47.2	46.6	46.0	47.1	49.1	47.1	50.9	59.9	38.5	32.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	53.4	81.3	0.0	0.0	14.9	27.6	0.0	129.6	28.7	0.0	41.1	76.1	0.0	41.4	60.4	28.7	0.0	0.0	0.0	66.3	146.2	30.2	0.0	36.8	22.7	52.1	0.0	0.0	94.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	50.1	0.0	0.0	0.0	0.0	49.8	0.0	0.0	4.1	0.0	0.0	43.2	27.7	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	77.6	18.1	59.3	0.0	0.0
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 164.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 72.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 67.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 116.1"	"Low region specificity"	"Detected in all"							HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	101.1	8.1	14.9	6.9	19.8	20.2	59.9	22.6	18.7	59.1	12.8	23.5	5.7	11.1	7.5	164.3	10.9	8.8	56.9	15.9	18.9	40.2	38.8	50.3	5.9	26.5	26.8	45.5	12.4	4.4	13.8	36.2	22.3	14.8	7.3	43.3	23.6	7.0	6.0	50.6	8.0	8.2	21.1	8.8	19.0	17.1	25.4	7.6	14.5	5.5	7.4	38.3	86.1	21.0	30.0	61.3	34.1	37.6	45.5	16.9	62.5	11.0	13.4	22.6	24.6	15.0	26.5	21.2	8.3	16.5	22.9	19.6	19.4	23.3	28.6	11.3	17.3	12.2	13.9	14.1	10.2	19.8	16.7	28.0	19.7	17.8	11.8	23.0	18.8	32.5	18.2	8.1	22.6	37.2	60.9	36.8	41.2	22.3	26.7	45.5	15.5	31.0	12.5	44.8	32.3	29.1	17.0	116.1	21.8	30.5	95.6	18.4	13.3	28.6	13.9	21.4	13.5	8.2	6.3	25.7	51.7	30.1	25.0	23.4	6.6	67.8	4.5	7.5	6.3	17.6	5.5	5.3	6.8	17.6	5.4	5.3	2.6	13.9	5.9	11.9	4.0	4.1	14.9	19.8	22.6	18.7	15.9	18.9	26.5	26.8	22.3	21.1	25.4	21.0	22.6	9.6	5.5	0.0	9.3	64.2	14.8	170.8	9.1	6.5	11.1	13.8	4.1	2.8	140.2	1.8	18.8	114.3	5.0	10.0	0.0	27.5	0.5	23.6	49.1	30.9	13.1	12.6	0.0	8.9	246.8	44.0	6.6	38.6	18.9	85.6	11.0	3.3	27.6	26.9	0.0	11.2	311.3	4.4	89.2	2.4	30.4	14.8	37.4	0.0	13.7	15.8	3.1	0.0	0.0	35.5	4.5	24.5	6.4	27.1	2.4	9.6	98.9	23.2	6.6	7.0	43.4	7.8	17.3	10.0	52.0	241.1	9.7	16.2	14.9	122.4
HINFP	"DKFZP434F162, HiNF-P, MIZF, ZNF743"	ENSG00000172273	"Histone H4 transcription factor"	Q9BQA5	11	119121580-119136059	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA061008	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA061008: AB_2684414"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (4.44e-8)"	"unprognostic (4.17e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.95e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.25e-2)"	5.1	4.8	8.4	4.6	9.8	4.6	5.2	12.4	9.9	6.2	7.8	7.5	6.9	5.7	4.4	5.5	7.1	3.8	5.5	8.5	7.7	6.7	4.3	5.1	6.8	8.6	7.8	6.8	7.1	6.0	5.2	4.3	8.6	5.7	7.1	11.0	6.6	5.1	9.2	8.6	7.1	5.8	6.7	7.1	6.7	6.6	9.4	11.5	6.2	8.1	7.0	6.5	5.5	11.9	5.9	9.4	10.3	9.6	8.4	5.7	9.3	4.5	7.1	10.1	11.1	17.0	12.9	7.6	15.7	6.3	11.2	13.7	18.0	4.5	6.7	16.9	8.9	39.1	6.8	5.8	9.9	11.7	9.0	8.0	16.0	10.6	9.2	11.7	8.1	14.1	15.7	12.9	5.7	11.5	14.7	10.5	9.1	10.7	8.6	14.5	11.4	8.7	6.8	5.5	14.6	7.1	7.7	11.3	6.3	10.0	15.4	13.3	6.1	8.9	3.5	6.0	5.5	6.1	6.8	8.3	3.3	10.0	6.8	12.8	12.9	9.3	10.0	10.2	11.2	10.0	12.3	11.9	16.5	12.5	16.3	10.0	8.0	17.2	6.9	7.9	16.6	10.4	8.4	9.8	12.4	9.9	8.5	7.7	8.6	7.8	8.6	6.7	9.4	11.9	7.9	0.0	8.8	12.4	11.0	14.4	7.4	10.3	10.8	19.1	12.6	8.6	5.5	8.6	9.2	9.2	35.5	7.4	13.8	17.6	5.9	9.4	9.4	8.3	8.7	10.3	8.4	7.8	16.6	11.0	8.0	7.5	7.1	8.2	5.1	11.3	12.1	4.5	5.4	15.2	16.2	9.7	4.1	7.2	9.5	3.4	8.4	7.2	8.8	4.7	18.1	9.6	12.3	7.5	9.1	9.3	10.3	6.4	12.4	8.6	15.5	5.6	9.5	29.5	0.0	7.4	9.2	38.6	31.8	7.7	16.3	8.3	11.6	12.4	10.7	6.5
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131155383-131224468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 3537.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	132.6	175.0	235.7	139.8	245.1	259.3	172.7	241.6	326.2	117.6	243.8	227.6	176.1	119.6	187.5	181.3	165.6	108.0	167.2	245.9	247.8	256.7	474.2	119.0	206.5	241.6	237.2	121.5	165.5	285.6	152.5	87.5	249.1	155.1	226.5	110.8	172.8	116.4	334.1	170.0	196.3	124.2	242.6	126.9	136.5	80.1	240.8	166.5	177.2	278.4	192.3	152.9	129.7	245.3	437.1	522.7	448.2	877.2	273.1	297.1	441.3	300.3	230.9	235.4	272.1	547.1	516.8	563.3	625.7	329.6	569.1	253.4	315.4	635.3	244.1	500.0	514.6	199.1	814.0	771.9	532.6	349.4	65.4	400.1	618.6	295.8	528.2	533.7	314.1	727.8	313.4	1132.1	338.8	419.9	548.0	945.6	415.6	425.6	362.0	407.9	436.1	988.1	500.6	567.0	563.3	351.9	380.5	243.5	612.0	574.4	291.2	520.8	396.0	351.7	244.0	323.0	684.2	342.3	561.4	578.8	497.8	586.8	346.3	179.8	187.9	85.0	196.3	109.9	298.0	384.9	462.0	294.2	396.9	332.6	416.0	325.5	35.6	269.0	128.0	521.4	362.5	608.6	235.7	245.1	241.6	326.2	245.9	247.8	241.6	237.2	249.1	242.6	240.8	245.3	582.7	282.0	279.1	34.3	718.2	1301.2	1472.2	1928.1	889.5	191.2	1134.3	1831.1	517.0	1028.0	882.2	715.4	45.9	780.9	641.6	1245.1	1663.0	1024.5	783.0	718.9	443.7	501.2	698.1	669.7	53.8	774.3	1632.8	400.2	355.2	753.7	108.2	666.5	436.2	2380.1	887.1	148.0	48.0	947.2	915.5	472.4	906.9	206.3	392.4	447.0	965.8	34.7	1269.4	405.1	488.1	26.7	55.4	894.3	1094.2	418.6	679.7	1998.9	1690.3	3537.5	708.3	194.0	243.3	287.0	730.3	625.5	197.9	1109.1	1146.1	456.8	671.1	464.3	1280.4	1713.2
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	50.8	79.5	41.7	15.5	43.9	27.0	48.5	44.9	46.8	23.2	40.3	42.6	34.9	25.9	48.6	27.5	29.9	14.9	87.4	39.8	43.1	91.1	169.2	30.2	21.0	43.8	42.5	19.2	65.9	72.6	41.2	17.6	42.0	33.9	34.2	20.4	39.7	26.1	80.1	33.4	34.2	20.1	43.9	33.8	56.9	29.8	47.3	38.8	38.4	85.5	23.8	30.6	24.2	44.0	30.3	76.1	47.1	45.6	29.0	24.3	33.2	27.8	39.2	42.3	46.1	49.9	31.1	39.9	31.7	25.3	59.8	29.3	21.2	40.9	44.1	87.8	40.7	42.2	64.1	45.8	68.1	25.1	40.0	27.3	36.8	40.2	64.8	16.7	33.2	91.4	25.5	117.4	34.0	60.3	61.3	31.3	21.4	70.0	138.7	60.8	33.1	53.6	61.5	21.5	38.4	46.4	36.0	42.7	49.6	27.5	45.9	44.6	16.5	22.0	37.7	30.4	35.7	107.0	127.3	57.4	49.8	32.2	36.2	41.0	77.5	4.7	68.9	58.5	62.4	98.9	73.7	69.8	113.4	96.7	56.4	58.6	7.6	66.8	56.9	246.1	107.3	81.2	41.7	43.9	44.9	46.8	39.8	43.1	43.8	42.5	42.0	43.9	47.3	44.0	49.3	22.4	17.5	5.2	57.9	45.4	63.4	137.6	49.5	39.8	99.1	105.8	115.1	130.1	68.3	80.9	20.9	154.9	69.3	148.2	633.9	115.5	67.3	83.9	28.6	47.8	96.0	100.8	1.7	172.1	71.7	53.2	52.5	44.6	18.4	43.5	63.1	457.4	113.9	20.2	2.5	127.4	126.1	61.1	51.4	128.0	40.4	47.7	120.9	1.9	74.1	123.7	87.6	1.5	4.5	85.6	157.5	44.8	77.7	40.7	181.4	578.1	105.1	45.5	46.0	54.2	72.6	38.4	77.4	64.7	45.9	56.8	51.0	85.1	126.7	84.8
HINT3	"FLJ33126, HINT4"	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956770-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 352.2;Spermatocytes: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	18.1	23.4	31.2	12.6	33.9	12.3	23.0	31.0	43.3	18.3	22.8	19.6	15.7	16.6	17.8	22.3	16.4	16.2	28.4	29.4	31.4	22.2	28.3	21.0	11.3	33.9	32.1	14.7	19.3	30.6	14.4	14.5	33.8	29.7	17.6	15.3	25.5	22.4	112.8	17.5	16.0	17.3	36.6	10.5	24.8	12.3	32.5	13.6	23.5	84.6	11.4	18.4	10.8	38.0	13.2	10.3	14.1	29.5	5.5	14.8	17.5	14.1	20.2	10.6	11.0	25.6	7.2	28.4	25.5	9.4	23.7	19.5	18.2	11.9	12.3	27.4	23.5	12.0	15.1	21.6	25.4	19.2	19.6	11.8	25.9	10.7	27.0	27.3	16.1	21.0	38.3	18.7	10.6	20.1	15.5	13.7	4.8	27.1	9.9	12.8	9.7	9.7	21.8	24.0	28.2	17.4	12.9	18.0	67.8	10.2	18.4	28.9	11.4	7.2	10.1	34.8	20.3	27.1	33.3	18.2	20.4	18.1	9.5	12.5	9.3	8.9	4.4	5.9	4.6	7.0	5.9	4.8	7.7	6.3	6.0	5.3	11.2	5.9	8.6	4.3	6.3	5.3	31.2	33.9	31.0	43.3	29.4	31.4	33.9	32.1	33.8	36.6	32.5	38.0	11.7	80.1	61.2	11.8	16.7	18.1	10.2	22.1	24.5	21.8	26.5	18.4	38.7	10.0	29.8	16.5	8.4	19.2	13.4	17.2	33.2	29.3	352.2	23.6	11.5	12.3	16.3	6.9	27.0	20.2	6.4	13.7	19.4	25.8	9.5	15.2	10.4	17.5	27.2	6.7	29.8	25.1	20.3	15.3	14.6	78.3	9.9	19.3	21.4	5.6	17.3	43.4	11.3	21.6	40.0	21.4	28.7	17.3	8.1	20.9	15.3	28.0	25.7	25.4	6.6	18.3	15.1	110.7	40.2	21.5	17.3	26.4	11.3	14.6	18.5	19.9
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533298-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 9.5;eosinophil: 6.8;neutrophil: 6.8;NK-cell: 3.0;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.7	7.9	23.6	7.3	38.7	5.4	13.2	29.8	29.0	11.7	14.4	6.1	2.7	9.8	9.2	5.3	12.9	8.3	9.0	22.4	24.9	14.8	9.3	18.5	4.7	34.6	35.4	8.0	3.8	4.2	3.4	19.7	32.0	6.8	4.1	4.6	4.0	11.2	4.2	10.6	5.0	12.2	24.5	11.2	4.8	30.4	34.8	3.1	15.3	8.4	4.5	9.0	7.9	50.9	5.2	55.9	37.1	35.2	15.3	20.8	11.1	9.7	6.3	6.2	4.6	3.2	5.0	3.8	11.2	24.2	21.6	6.3	38.1	8.0	8.3	3.1	7.1	3.0	6.6	5.3	15.2	0.8	14.8	16.0	4.8	20.4	4.2	11.4	26.3	4.2	4.0	3.6	10.1	21.6	2.5	22.2	40.5	0.5	6.6	4.4	15.5	0.3	4.7	20.0	1.8	16.2	9.0	5.6	12.5	32.8	34.6	13.9	9.4	18.0	13.7	6.2	13.6	4.0	0.4	8.9	18.1	8.0	12.4	9.5	0.9	6.8	0.9	0.9	0.7	0.3	0.1	0.7	1.4	0.4	0.1	0.5	6.8	3.0	0.7	3.3	1.4	0.3	23.6	38.7	29.8	29.0	22.4	24.9	34.6	35.4	32.0	24.5	34.8	50.9	54.0	60.9	37.5	43.8	7.8	17.6	6.2	7.1	20.5	12.0	14.8	10.7	14.3	11.5	12.2	27.6	12.5	2.1	27.2	2.2	13.7	14.4	256.9	15.5	24.2	54.3	4.8	7.8	16.3	6.0	10.0	17.1	6.1	25.5	14.0	25.9	36.8	22.5	14.9	23.5	19.0	3.0	6.1	18.5	49.1	1373.3	22.4	24.1	10.6	45.9	9.4	14.3	21.6	336.3	313.7	3.1	7.7	24.8	18.4	4.2	0.3	2.6	1.3	9.4	85.5	25.9	44.8	12.1	5.6	5.6	9.1	0.8	13.5	7.7	3.3	3.5
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862961	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 103.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 10.6"	"Group enriched"	"Detected in many"	8	"B-cells: 10.6;granulocytes: 2.9;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	18.5	24.0	68.6	10.4	95.5	13.3	22.6	78.8	80.3	16.0	33.5	16.3	31.8	9.0	3.8	18.0	9.0	7.7	18.9	68.0	67.8	50.2	25.6	15.4	17.5	87.3	83.8	5.6	50.2	8.9	42.0	4.7	75.6	21.0	4.9	5.5	58.7	10.5	7.2	51.7	36.0	2.2	65.3	20.9	66.7	8.5	85.7	12.6	21.5	4.4	11.7	11.4	19.7	103.4	38.1	10.8	8.0	33.1	2.3	6.1	39.2	5.9	9.5	5.9	4.6	16.8	11.1	36.0	19.0	4.3	8.9	32.4	9.7	21.4	0.5	5.8	14.0	0.8	13.8	17.8	7.1	2.8	24.5	3.8	14.9	8.0	13.4	8.1	40.5	16.5	9.6	2.0	3.4	54.4	17.4	8.8	7.4	32.8	12.8	9.0	10.2	12.5	19.6	45.4	8.1	17.9	7.1	18.0	9.5	4.3	36.6	1.5	32.8	3.7	27.5	11.7	5.7	24.8	14.2	21.8	6.0	6.0	3.1	0.0	0.0	2.9	2.7	0.0	1.5	9.3	1.7	2.1	0.0	10.6	3.0	1.9	0.2	0.7	0.0	0.0	0.4	2.0	68.6	95.5	78.8	80.3	68.0	67.8	87.3	83.8	75.6	65.3	85.7	103.4	57.0	0.0	13.4	134.5	38.0	13.3	16.8	8.4	6.8	16.4	21.2	18.2	4.2	60.1	11.1	60.7	29.2	3.7	18.2	28.4	0.0	40.1	3.1	21.9	4.7	18.2	7.8	1.3	11.2	28.7	13.1	2.3	80.5	37.5	5.7	25.3	19.2	24.4	0.6	18.5	9.7	29.9	22.4	1.2	4.2	2.9	1.5	2.2	10.6	9.4	0.1	12.5	7.2	168.9	117.8	22.7	25.3	1.2	17.2	20.2	47.5	17.9	14.2	16.6	0.0	2.5	4.1	6.5	13.3	11.5	21.0	1.9	15.0	1.3	23.9	28.4
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929324-113977869	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	19.8	20.0	24.7	20.2	23.5	142.0	16.8	44.5	20.9	24.4	42.4	19.0	12.7	18.1	17.2	23.1	35.0	22.2	18.0	20.6	32.5	18.2	17.8	23.4	20.9	37.2	39.4	22.8	21.8	21.3	20.5	17.7	29.8	15.4	18.9	56.5	15.2	17.7	25.7	23.4	16.8	18.2	36.9	20.7	17.8	47.1	27.5	57.4	29.8	27.1	20.6	19.7	18.8	25.6	23.4	18.8	25.4	19.5	29.2	15.2	17.1	15.8	19.0	22.2	20.9	21.8	8.8	31.4	21.2	25.3	8.2	15.5	33.1	18.6	31.7	23.0	16.7	45.8	23.7	23.0	24.3	36.7	54.2	16.5	26.5	28.3	28.7	20.8	33.2	54.2	31.8	32.8	32.1	176.4	48.8	21.0	26.2	17.1	15.8	29.1	74.4	10.9	19.8	19.9	11.2	15.0	28.9	30.6	20.5	27.9	17.7	52.3	32.6	21.5	29.0	35.3	24.3	20.1	17.2	26.7	23.7	29.3	50.3	2.1	2.5	5.0	3.0	2.1	3.0	0.9	2.7	2.8	1.7	1.1	2.6	3.3	5.8	2.7	1.6	3.7	2.0	1.5	24.7	23.5	44.5	20.9	20.6	32.5	37.2	39.4	29.8	36.9	27.5	25.6	30.1	54.5	37.2	14.4	26.0	61.4	16.2	16.7	15.4	57.7	29.8	20.2	34.6	22.8	24.5	27.6	70.9	10.7	125.8	38.9	5.9	14.6	95.2	147.9	33.4	28.9	37.2	64.4	27.4	21.0	10.3	24.3	20.9	47.0	46.9	26.3	21.8	37.4	22.2	74.0	33.9	25.4	12.2	49.5	77.7	101.4	22.1	50.2	21.4	31.9	43.1	30.6	36.0	21.1	26.5	18.8	22.4	37.2	43.5	33.7	17.8	16.4	116.4	64.8	26.3	36.5	44.3	49.7	31.5	25.6	80.6	14.2	69.7	21.9	28.3	32.7
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	57.8	21.5	29.5	25.3	31.5	23.3	35.1	32.9	23.4	27.6	75.9	30.7	16.7	33.1	24.2	30.9	31.7	30.6	53.7	19.9	42.1	38.2	29.8	26.9	22.8	35.5	36.2	27.2	25.8	46.7	12.8	34.7	27.8	23.3	20.6	22.4	22.9	26.1	69.0	22.3	20.2	39.3	34.2	30.6	22.1	18.9	43.1	25.5	33.7	85.3	24.7	32.3	22.4	33.0	19.3	18.0	13.4	15.1	60.5	37.9	12.9	20.0	23.1	15.9	13.3	19.9	13.8	20.7	16.3	24.4	8.0	24.3	10.2	22.2	22.1	30.8	15.8	21.0	20.3	15.2	25.0	22.9	12.8	35.8	42.8	6.1	17.7	16.5	19.4	14.8	6.4	40.4	26.0	10.1	19.2	15.8	3.4	17.3	11.1	25.4	47.3	19.9	26.4	29.4	2.0	11.3	27.1	30.7	18.7	14.2	34.6	41.2	25.8	24.8	16.9	28.9	14.6	21.7	37.2	21.4	11.9	23.5	23.7	10.6	12.7	6.1	4.0	9.4	5.0	2.8	3.6	4.3	14.0	3.3	3.2	4.0	21.1	4.4	11.1	1.7	4.0	5.0	29.5	31.5	32.9	23.4	19.9	42.1	35.5	36.2	27.8	34.2	43.1	33.0	122.2	12.8	44.7	46.0	29.6	66.5	42.8	21.3	39.3	16.2	35.8	25.8	159.9	37.1	32.9	33.1	18.8	18.6	31.2	32.7	5.9	13.0	21.8	76.5	80.5	96.5	37.1	20.6	44.9	24.9	13.4	59.2	23.0	49.0	14.5	24.3	57.5	53.2	30.7	32.0	48.0	28.4	12.2	102.0	76.0	26.1	42.9	68.1	58.7	73.1	69.1	16.2	25.7	45.8	69.1	21.5	21.1	37.6	24.9	52.6	40.7	35.0	65.4	24.9	52.6	83.4	56.4	10.7	8.1	33.4	75.0	15.5	29.8	12.5	25.2	51.2
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.7;Inhibitory neurons: 51.1;Oligodendrocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	11.2	12.9	16.1	10.6	15.1	26.1	10.2	14.6	15.9	9.4	13.3	14.0	13.9	12.3	6.0	12.4	12.2	7.3	12.9	15.9	14.1	13.8	21.7	10.6	14.2	14.2	15.3	11.2	12.6	22.1	13.2	8.4	13.8	9.3	10.1	7.3	9.9	8.8	23.4	12.5	13.7	9.4	14.0	13.1	14.2	10.1	17.9	20.6	56.1	11.0	11.4	12.2	8.6	14.6	27.0	23.5	32.4	33.7	31.0	20.5	22.5	22.4	25.7	36.1	35.6	53.8	15.4	52.1	10.6	29.0	21.5	30.8	46.4	28.2	23.1	32.1	53.9	48.4	25.5	49.5	33.6	113.1	33.6	24.7	27.1	28.3	27.6	19.4	26.5	51.6	253.1	27.0	20.9	33.7	56.0	40.4	29.6	63.8	23.5	43.7	46.0	15.6	20.9	29.8	47.0	31.2	25.0	25.4	31.7	16.4	16.0	39.0	30.7	24.5	36.0	25.4	26.5	28.4	30.3	53.7	28.7	36.2	20.7	4.8	0.7	3.3	1.3	0.7	1.3	2.4	0.7	1.3	0.9	4.5	0.3	1.0	1.3	2.1	0.4	1.7	0.4	0.8	16.1	15.1	14.6	15.9	15.9	14.1	14.2	15.3	13.8	14.0	17.9	14.6	7.7	6.4	0.5	29.4	7.4	9.2	2.2	4.4	0.6	7.7	6.4	7.4	2.3	2.8	2.3	5.5	2.1	3.8	12.6	11.7	5.9	5.4	6.2	6.8	8.4	5.6	2.4	19.4	49.7	8.9	3.6	4.7	3.1	7.1	0.0	8.7	7.1	21.1	6.6	16.8	51.1	10.5	4.1	9.1	3.8	2.4	5.0	4.9	10.6	38.4	7.9	5.5	14.4	37.7	45.5	7.9	8.4	6.8	4.5	5.0	8.2	9.9	4.2	4.6	6.6	7.7	6.1	12.9	10.3	4.5	10.5	3.0	6.6	9.2	14.2	2.2
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992330-29996074	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 129.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	12.3	11.6	24.4	9.0	25.5	15.8	11.8	23.9	24.7	13.3	19.0	16.0	8.3	13.5	10.6	9.6	12.2	7.1	19.2	22.9	23.8	12.6	14.9	11.6	13.1	25.5	24.6	16.8	11.0	15.6	14.5	6.8	25.4	11.9	7.3	20.1	11.1	12.8	33.5	14.6	10.9	8.6	24.1	12.9	10.6	38.7	24.4	25.6	11.7	21.7	12.3	14.2	11.5	25.7	27.4	27.7	44.2	28.5	13.9	14.8	13.4	20.9	16.1	21.2	18.2	24.8	26.8	52.7	42.5	13.7	15.3	19.0	28.8	26.6	15.8	47.8	28.1	56.7	36.2	26.9	11.5	50.3	42.4	7.4	19.4	20.9	32.3	12.4	13.4	50.6	27.2	57.0	12.9	20.0	66.1	26.3	13.0	17.8	15.5	65.9	52.6	52.5	14.9	12.2	28.6	34.7	21.7	16.3	14.5	11.3	24.2	30.6	15.4	28.4	21.8	20.3	20.5	37.1	31.0	31.4	26.8	43.2	38.1	4.6	7.5	15.0	16.7	12.0	11.4	19.1	18.6	15.3	6.3	14.6	19.3	17.9	3.4	14.3	20.8	19.1	22.9	10.8	24.4	25.5	23.9	24.7	22.9	23.8	25.5	24.6	25.4	24.1	24.4	25.7	19.1	67.3	26.3	2.0	14.9	12.7	17.1	11.2	14.8	36.4	14.6	19.6	30.4	10.0	15.8	9.2	14.6	30.6	18.7	12.5	29.4	10.5	27.6	12.6	10.9	15.4	9.6	27.0	2.1	12.1	28.9	14.6	4.6	10.9	31.0	12.1	10.8	16.7	18.7	15.2	2.7	10.8	14.2	8.2	11.9	12.0	20.5	9.8	5.4	1.0	8.8	37.3	32.0	3.5	4.7	6.3	11.4	22.6	22.0	6.7	25.6	19.9	19.9	49.4	13.1	14.7	18.6	129.5	46.2	10.2	11.4	11.5	20.9	12.1	14.0	8.3
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"HIVEP zinc finger 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.6"	"Group enriched"	"Detected in many"	5	"Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	1.6	0.6	0.8	2.1	2.1	1.6	1.4	1.4	1.6	0.4	0.0	0.5	0.4	0.4	0.3	1.9	0.5	0.7	0.8	2.0	0.0	1.0	0.3	1.9	1.7	0.7	0.4	0.5	0.8	0.4	2.1	0.6	1.0	1.4	0.5	0.6	1.6	0.3	0.6	4.6	0.6	0.8	0.1	1.1	0.7	0.3	0.5	6.6	1.5	0.4	2.1	1.8	0.5	0.3	1.9	0.6	0.2	1.8	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	4.0	0.6	1.0	1.5	2.7	0.4	0.4	3.1	18.8	0.5	0.2	0.9	0.0	0.4	0.3	0.3	5.6	0.4	9.5	1.1	0.6	0.5	1.3	0.0	11.0	1.8	1.2	3.0	0.8	0.6	0.6	2.3	2.0	2.9	2.2	1.5	0.4	2.0	0.6	2.6	0.7	0.5	1.1	0.9	3.4	3.4	2.0	2.2	0.6	4.6	3.3	1.4	2.6	8.1	0.2	7.5	0.0	0.5	0.0	0.6	1.1	0.1	0.1	0.2	0.3	0.4	0.4	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.4	0.8	2.1	1.4	1.6	2.0	0.0	0.7	0.4	1.0	0.1	0.5	0.3	5.9	6.4	10.5	83.9	9.6	23.7	26.5	4.3	17.6	16.4	15.1	11.0	6.9	5.7	8.2	1.8	2.1	0.4	17.6	3.5	1.9	3.1	9.9	1.2	7.7	7.5	3.6	4.4	219.6	2.7	4.4	11.1	1.5	2.8	1.3	0.2	11.4	2.5	6.2	25.2	271.9	1.2	2.0	6.5	17.3	31.9	8.7	15.0	5.4	163.9	9.1	16.0	27.8	83.9	196.0	3.1	0.1	4.1	3.3	15.5	1.9	3.2	1.1	3.5	6.6	23.9	7.4	11.3	8.6	23.7	8.7	0.8	14.5	10.0	0.9	11.1
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		560000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	47.0	24.4	61.0	45.0	65.7	60.3	40.6	58.0	76.6	54.7	64.2	60.1	13.1	41.3	11.2	129.9	37.0	25.7	150.8	69.1	62.7	49.2	8.5	48.1	34.1	56.7	59.8	19.9	12.3	25.0	44.9	49.3	71.1	52.9	31.9	147.6	67.1	53.1	193.5	102.6	29.2	49.8	40.0	40.3	61.6	77.2	53.5	44.9	71.0	146.7	47.6	74.3	80.9	54.1	101.6	56.6	74.2	71.1	81.0	60.4	47.1	98.3	256.5	128.5	138.0	16.3	11.0	7.3	75.8	165.9	92.9	86.2	69.9	220.0	122.0	67.5	54.5	250.0	58.3	1.1	91.7	5.1	181.2	91.5	125.8	184.5	407.6	160.8	135.4	36.8	424.5	51.3	178.7	167.7	29.7	13.1	113.8	51.7	247.0	44.8	45.0	0.6	88.7	117.4	75.7	88.7	112.6	215.4	65.2	104.3	117.7	16.5	140.4	190.5	86.4	106.5	139.6	61.1	42.8	17.4	247.3	130.4	56.1	68.7	88.8	44.6	41.5	125.2	69.0	33.5	47.9	47.6	81.0	19.9	41.7	33.9	20.9	31.2	135.4	9.1	58.1	110.4	61.0	65.7	58.0	76.6	69.1	62.7	56.7	59.8	71.1	40.0	53.5	54.1	26.1	25.6	32.4	38.2	26.5	48.3	50.5	37.8	43.9	83.9	33.1	21.7	130.6	4.3	34.2	27.6	54.2	70.6	14.6	30.3	13.7	28.6	374.0	32.6	28.0	37.9	18.7	104.8	53.8	30.6	93.3	30.3	41.3	34.5	23.4	72.6	26.7	1.1	49.4	304.5	49.8	28.7	44.7	41.7	21.9	1034.1	15.2	51.3	37.4	29.0	35.3	32.9	20.6	14.1	3.5	54.6	11.1	18.4	19.1	29.1	0.7	1.1	30.7	95.5	19.7	22.2	43.1	5.3	6.2	86.0	51.7	118.9	30.5	28.3	19.3	43.5
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74834127-74893359	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 144.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 216.4;Early spermatids: 89.5;Paneth cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA		100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	58.2	2.7	2.7	14.6	3.9	45.7	16.0	4.8	5.6	7.8	2.7	46.6	2.8	5.1	66.1	19.9	9.7	9.5	7.9	3.5	3.6	1.9	2.7	15.2	5.8	11.1	6.3	14.9	2.9	2.5	1.9	13.1	8.5	4.9	37.3	144.0	14.7	1.1	45.6	14.6	13.0	3.3	5.9	6.9	18.7	32.8	6.0	3.7	14.1	83.7	7.8	27.1	15.9	8.6	55.9	0.4	12.5	45.4	103.3	10.8	46.5	21.3	30.6	23.4	33.4	44.0	9.8	40.7	20.1	9.9	30.2	19.0	57.0	44.7	67.0	11.6	12.5	55.1	12.4	61.0	32.5	80.8	86.3	18.2	47.3	44.5	77.1	26.3	11.3	23.0	49.2	0.2	6.9	39.6	19.8	82.0	45.3	52.4	38.2	31.8	26.2	31.7	14.2	77.2	9.2	44.6	13.5	67.4	27.4	17.8	3.6	12.8	9.4	74.0	13.4	31.2	39.2	27.1	8.2	20.2	172.5	57.9	19.9	16.8	14.0	51.7	0.2	11.0	0.6	1.2	0.8	0.1	11.8	1.3	1.2	1.2	11.2	0.0	7.7	0.3	1.5	4.7	2.7	3.9	4.8	5.6	3.5	3.6	11.1	6.3	8.5	5.9	6.0	8.6	1.6	16.0	45.3	4.9	5.7	51.6	9.5	26.7	5.7	14.8	16.0	5.6	7.2	4.3	24.2	5.5	83.4	2.3	0.6	216.4	0.0	4.6	89.5	5.8	4.1	4.4	39.0	4.2	0.2	4.5	33.5	6.4	14.8	15.0	22.2	27.2	1.4	0.3	15.8	21.9	0.1	37.7	6.1	20.8	35.1	46.0	14.6	22.8	23.2	25.3	18.9	6.3	2.1	0.5	0.7	25.6	108.3	7.9	4.7	34.3	5.4	0.2	15.2	42.1	13.1	19.9	3.3	3.9	4.2	10.7	57.0	8.2	3.6	5.8	51.7	70.0
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899346	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 129.3;lymphoid tissue: 76.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 1.4;cerebral cortex: 1.6;thalamus: 2.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 569.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 569.7;monocytes: 200.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		2000000	"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	8.4	4.5	0.0	19.0	0.2	129.3	2.6	1.4	1.6	0.8	0.2	2.5	2.0	1.0	0.1	0.9	5.1	2.1	4.0	0.2	0.0	1.8	5.2	25.1	4.2	0.0	0.0	1.0	1.5	0.1	0.7	2.8	0.0	1.1	1.4	0.1	1.5	0.3	0.9	0.5	3.1	7.9	0.0	76.6	2.1	1.3	2.4	1.4	1.3	0.5	0.7	4.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	0.1	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.6	0.0	569.7	92.5	204.8	0.3	179.4	0.2	0.4	0.2	0.1	30.2	0.2	0.1	0.1	32.2	0.2	200.9	1.4	0.2	43.6	0.0	0.2	1.4	1.6	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.4	1.3	0.0	0.4	0.2	34.5	0.0	0.4	0.0	0.0	43.9	0.9	1.8	0.0	38.8	0.0	1.0	14.6	0.0	2.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.0
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220332-69267552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.5;retina: 46.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	23	"T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 11.9"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	1.1	2.7	1.3	0.0	0.0	1.4	1.0	1.1	1.4	6.8	53.5	0.9	0.0	0.1	4.6	6.8	0.0	1.0	1.1	13.3	4.6	1.5	1.0	1.3	2.1	0.0	6.2	0.0	0.3	0.0	1.7	0.0	4.2	46.8	0.1	0.0	0.0	0.1	48.0	0.5	1.4	0.3	1.1	1.0	1.0	5.2	9.3	0.0	0.2	0.0	0.1	1.2	1.2	40.1	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.1	57.5	111.4	0.0	33.9	0.3	45.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	33.6	2.7	0.0	0.0	0.0	0.3	0.4	3.2	0.6	0.0	11.3	0.0	0.0	0.7	0.1	0.2	0.1	0.0	11.9	1.3	0.0	1.2	0.1	81.9	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.4	1.6	0.2	0.8	0.0	0.1	0.0	8.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.5	0.0	3.1	1.0	0.0	0.0	5.8	2.3	0.0	0.2	0.0	0.0	5.4	1.0	1.1	1.3	1.4	1.0	1.0	1.1	1.3	2.1	1.7	1.4	1.0	1.2	0.0	3.2	4.8	11.8	0.7	0.0	0.0	0.3	0.0	1.9	0.0	0.0	1.0	31.5	1.0	16.5	0.0	0.0	0.2	29.0	1.9	32.6	0.6	50.0	4.5	0.5	0.0	0.0	0.4	7.3	0.0	0.2	1.5	55.2	0.0	0.0	0.0	0.4	0.1	3.3	0.5	5.6	0.0	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	126.9	0.0	0.0	0.5	25.5	12.7	0.0	0.3	0.0	56.3	15.7	0.3	5.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.1	5.6	0.3
HLA-B	AS	ENSG00000234745	"Major histocompatibility complex, class I, B"	P01889	6	31353872-31357188	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 2493.7"	"Cell type enhanced"	"Detected in all"		"monocytes: 5683.6;NK-cells: 7881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 638.3;EFO-21: 547.1;U-266/70: 1285.6;U-698: 377.2"									CAB015418	Enhanced					NA	NA		190000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB015418: AB_831547"	"unprognostic (2.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.16e-3)"	"unprognostic (8.51e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.69e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-2)"	944.9	581.6	5.5	429.4	8.1	53.5	850.0	5.5	14.4	552.0	6.0	912.0	4.7	567.1	222.1	434.4	488.6	461.2	563.1	4.6	6.7	731.7	488.9	1646.3	1061.9	9.6	10.4	296.9	268.7	24.2	288.3	106.6	7.5	439.2	238.5	8.1	485.9	3.8	237.9	936.4	1295.6	75.4	7.7	2493.7	540.1	132.6	6.7	4.4	593.2	3.8	414.9	476.2	582.0	7.9	638.3	0.0	0.0	0.1	13.5	98.9	3.8	0.5	1.2	0.5	1.1	0.0	1.9	22.7	547.1	111.0	203.2	231.9	116.4	112.4	0.0	2.3	29.9	8.3	0.8	0.0	79.8	0.2	2.4	200.2	0.5	0.0	13.9	183.3	0.4	39.8	1.3	30.2	0.0	0.3	1.5	161.4	0.6	0.0	0.1	19.7	3.4	4.7	163.5	0.6	0.9	3.7	5.5	1.4	1.4	0.2	32.6	6.2	134.7	21.4	4.8	4.9	2.3	1285.6	291.0	377.2	1.1	6.5	0.6	141.1	196.5	232.6	233.0	163.6	215.7	162.4	194.8	198.8	150.8	113.0	150.9	212.0	420.5	179.3	123.6	127.3	213.1	400.2	5.5	8.1	5.5	14.4	4.6	6.7	9.6	10.4	7.5	7.7	6.7	7.9	2836.3	913.5	1007.9	14.0	2936.9	1165.9	761.2	1139.6	396.1	27.7	533.2	550.2	168.5	1382.6	948.3	388.1	6.2	31.4	3876.2	3264.3	68.4	4206.8	63.9	311.6	349.2	2480.7	836.0	550.3	1.4	1771.3	182.3	777.7	1044.4	773.2	620.5	212.5	2189.2	701.5	2602.0	60.6	3.4	2121.8	1129.1	4229.7	2158.6	65.7	644.9	2674.7	891.2	126.5	5683.6	209.2	7881.6	25.1	3.9	2085.3	2327.5	306.9	2983.6	993.4	4541.4	183.9	829.4	27.3	1314.8	356.3	729.7	652.9	91.6	360.3	1004.3	50.9	3661.2	1219.5	1527.4	1161.2
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 120.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 400.4;Hofbauer cells: 354.3;Kupffer cells: 411.6;Langerhans cells: 1350.5;Macrophages: 591.4;monocytes: 332.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.8;intermediate monocyte: 3.8;memory B-cell: 6.3;myeloid DC: 7.2;naive B-cell: 6.4;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	12	"B-cells: 6.4;dendritic cells: 7.2;monocytes: 3.8"	"Group enriched"	"Detected in some"	5	"U-266/70: 30.5;U-698: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	79.9	63.6	0.1	1.0	0.1	23.4	63.4	0.1	0.6	33.1	0.5	26.7	1.6	19.8	22.8	16.0	31.4	0.9	23.5	0.1	0.2	48.0	15.1	98.3	2.4	0.3	0.2	13.5	19.4	0.1	15.6	0.9	0.2	23.1	13.6	0.4	25.9	0.3	11.8	25.1	69.6	0.5	0.3	120.4	32.7	4.0	0.2	0.6	33.1	0.2	36.9	21.3	20.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.1	0.1	0.1	0.0	0.1	0.0	0.5	1.9	0.0	0.0	0.5	0.3	0.3	2.5	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.7	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	30.5	13.7	94.3	0.6	0.0	0.0	0.0	3.8	0.3	0.2	3.8	0.0	6.3	0.1	0.2	7.2	6.4	0.0	0.1	0.4	0.3	1.2	5.2	0.4	3.6	0.1	0.1	0.1	0.6	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.5	240.5	73.7	171.3	0.7	400.4	48.3	15.5	77.3	17.6	1.8	38.2	32.0	5.2	45.8	95.9	53.3	2.1	4.9	175.6	19.3	17.6	101.0	3.4	12.5	3.1	123.6	3.0	30.5	0.8	51.1	4.2	16.4	43.8	24.5	41.2	8.2	37.1	4.4	354.3	0.0	1.2	25.0	22.4	411.6	1350.5	5.3	16.1	591.4	80.0	14.0	332.4	4.3	33.0	1.5	1.3	26.6	46.2	18.8	68.9	19.1	267.0	47.1	77.6	1.3	19.7	5.4	15.6	4.1	4.8	7.0	41.9	4.0	44.7	4.3	42.6	60.9
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Group enriched"	"Detected in many"	4	"B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	38.3	35.9	0.1	13.2	0.2	6.9	25.7	0.3	1.0	21.6	0.1	19.9	0.0	14.6	7.4	9.3	14.6	0.1	11.1	0.0	0.6	41.9	7.8	59.9	17.6	0.3	0.4	9.5	9.1	0.0	9.2	0.8	0.2	13.1	14.9	0.5	14.7	0.0	5.3	14.3	78.8	0.0	0.9	101.5	17.6	2.2	0.1	9.9	45.9	0.0	18.8	14.4	10.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	27.6	12.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	7.8	0.4	31.9	0.0	0.1	0.0	0.5	73.2	16.7	1.2	73.8	2.6	94.0	1.0	2.9	85.0	128.8	0.7	2.4	4.7	16.2	28.1	85.3	6.7	71.4	0.1	0.2	0.3	1.0	0.0	0.6	0.3	0.4	0.2	0.9	0.1	1.1	36.8	9.6	57.0	0.7	228.5	12.0	1.0	5.4	2.2	0.2	2.5	4.7	2.6	5.7	12.7	16.5	0.0	1.7	129.4	3.3	11.7	28.8	0.5	7.5	5.4	37.2	4.2	10.3	0.8	4.4	1.6	3.8	3.1	38.5	15.2	22.7	5.7	0.5	274.8	0.0	0.6	8.5	2.0	201.9	472.8	1.5	3.4	272.4	16.0	27.2	187.1	0.5	21.6	1.0	0.1	2.5	17.8	1.9	3.8	1.3	284.8	7.4	16.8	1.1	6.6	1.6	3.1	0.6	0.7	1.1	10.9	2.7	17.6	0.9	10.3	8.7
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004182-33009591	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.3;B-cells: 61.5;dendritic cells: 20.3;Kupffer cells: 29.4;Langerhans cells: 59.0;Macrophages: 37.7;monocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 17.8;naive B-cell: 21.0"	"Group enriched"	"Detected in many"	11	"B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HDLM-2: 9.1;REH: 40.5;U-698: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045038, HPA076922"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA045038: AB_10959457, HPA076922: "	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	7.1	6.1	0.2	7.8	0.4	1.5	6.5	0.4	0.4	4.9	0.3	3.2	5.0	3.0	1.2	2.3	5.0	2.1	2.2	0.3	1.0	8.0	2.8	12.7	15.1	1.8	0.8	2.8	2.4	0.9	3.5	0.0	1.5	5.0	4.2	0.4	3.2	2.1	0.8	2.8	15.2	1.1	0.8	28.7	4.0	0.4	0.7	7.0	4.5	1.0	19.8	3.0	3.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	40.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	8.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.0	0.0	14.6	0.1	0.3	17.8	21.0	0.3	1.3	0.7	0.2	4.7	5.0	1.0	2.4	0.2	0.4	0.4	0.4	0.3	1.0	1.8	0.8	1.5	0.8	0.7	1.2	7.5	3.2	30.3	0.0	61.5	1.9	0.6	0.1	0.6	0.0	0.5	2.4	1.6	1.5	2.0	3.7	0.0	0.1	20.3	0.3	0.0	6.6	0.1	0.3	0.2	8.5	0.0	2.5	0.0	0.2	0.1	1.2	0.5	0.3	5.1	3.5	1.1	0.0	13.4	0.0	0.0	0.1	2.0	29.4	59.0	0.2	0.3	37.7	0.0	6.5	41.9	0.6	4.1	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	2.9	1.4	0.2	0.0	0.7	0.6	0.0	0.2	0.5	1.1	0.1	4.1	1.0	0.3	1.2
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32820466	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 19.5;lymphoid tissue: 41.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 84.4;Langerhans cells: 35.6;monocytes: 44.7;Plasma cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 213.8;naive B-cell: 258.1"	"Lineage enriched"	"Detected in many"	20	"B-cells: 258.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.1;U-698: 14.9;U-937: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013846	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA013846: AB_1853928"	"prognostic favorable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	1.0	0.6	0.1	0.8	0.2	3.3	1.5	0.1	0.5	0.9	0.0	2.7	1.9	0.7	0.0	2.0	0.7	1.2	0.5	0.1	0.2	2.1	0.9	2.9	21.6	0.3	0.1	0.6	0.3	0.0	2.7	0.0	0.2	1.1	1.9	1.1	4.2	0.8	0.2	1.7	19.5	0.4	0.2	41.0	2.0	1.2	0.2	8.3	1.9	1.3	28.2	3.7	1.3	0.2	0.2	0.0	0.0	0.1	0.4	1.3	0.1	0.1	0.0	0.0	0.8	0.4	2.2	38.1	0.3	0.5	0.0	0.5	2.6	2.3	0.0	1.0	0.6	0.1	1.1	0.0	0.0	0.1	0.3	0.6	0.7	0.0	1.0	0.0	0.0	0.4	2.0	1.4	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.7	0.2	2.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.3	0.9	0.5	14.9	0.0	7.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	213.8	0.3	0.1	13.2	258.1	0.0	0.2	0.5	0.2	0.3	0.6	0.8	6.8	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.2	0.2	1.7	0.0	4.8	5.9	84.4	1.0	0.3	2.2	1.2	0.9	1.2	0.9	0.0	0.0	1.0	0.0	0.0	0.0	4.7	0.1	0.0	0.9	1.3	4.3	2.4	0.9	0.0	2.7	1.0	0.2	0.4	0.3	0.0	14.8	1.3	0.2	0.0	0.0	0.6	0.0	1.8	0.1	0.0	1.0	35.6	0.9	0.0	4.6	14.2	1.9	44.7	0.7	2.1	2.0	1.3	0.4	0.0	0.0	35.0	0.3	0.4	0.3	0.4	0.6	6.6	0.4	1.2	0.1	0.3	0.7	1.6	0.0	2.3	0.1	0.3	0.4
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 319.9;lymphoid tissue: 359.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6"	"Group enriched"	"Detected in all"	7	"B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		240000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	180.8	108.0	2.2	33.4	2.0	12.8	138.4	2.7	3.3	76.7	2.5	72.1	20.2	55.3	8.3	43.1	63.0	13.0	62.0	2.0	3.4	99.0	36.8	319.9	51.3	4.9	2.8	24.9	28.6	5.9	58.0	3.4	4.3	64.0	16.1	2.0	59.5	16.2	29.5	66.3	174.4	14.6	4.3	359.6	52.1	13.4	3.1	30.2	76.6	7.3	51.5	58.6	60.0	4.4	0.1	0.0	0.0	0.0	0.8	1.3	1.1	0.4	0.4	0.5	0.0	0.0	4.9	37.2	5.0	0.9	7.1	0.0	0.0	0.0	0.1	115.9	2.5	6.2	0.0	0.0	0.1	0.0	11.6	1.7	0.0	2.2	0.0	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	30.3	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	1.3	2.6	7.8	0.1	0.1	0.0	5.6	0.9	26.1	12.2	0.2	4.4	2.2	81.8	6.6	21.6	187.4	5.7	150.4	9.6	23.9	296.0	136.5	3.4	15.7	3.0	20.9	124.1	82.6	29.2	136.0	2.2	2.0	2.7	3.3	2.0	3.4	4.9	2.8	4.3	4.3	3.1	4.4	621.8	83.3	404.3	0.3	1387.3	206.7	7.2	12.4	9.1	2.8	41.2	110.4	12.1	64.3	107.3	23.9	0.0	4.2	574.9	10.6	9.8	36.4	2.8	1.2	4.1	337.8	10.2	80.3	0.5	18.8	9.3	53.7	48.4	2.8	64.6	14.3	62.2	7.5	1153.8	5.0	0.9	18.2	12.2	1794.6	8122.8	11.7	18.0	2736.9	302.4	32.8	2940.3	5.1	94.7	0.0	0.1	4.7	5.4	27.4	100.2	10.6	114.0	42.7	129.2	5.0	52.6	14.7	29.8	1.3	4.8	6.0	175.2	6.8	157.8	11.5	28.6	34.4
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763532	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 52.4"	"Cell type enriched"	"Detected in some"	33	"Langerhans cells: 1010.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073187	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 31: Skin - Epidermis development"		"Cluster 41: Macrophages - Immune response"			"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	4.6	1.9	0.0	0.0	0.0	0.1	3.8	0.0	0.0	3.3	0.2	1.8	0.3	0.9	0.1	7.3	1.4	0.5	1.4	0.0	0.0	2.3	0.6	14.6	0.7	0.1	0.0	0.4	0.6	0.0	1.9	0.0	0.0	1.5	1.0	0.0	2.5	0.0	0.8	52.4	6.5	0.0	0.0	12.8	1.3	0.6	0.0	0.2	2.4	0.0	0.4	1.4	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	3.2	13.0	0.0	5.9	28.4	0.0	0.1	0.0	0.0	0.4	1.7	0.4	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	6.2	1010.0	0.5	0.9	30.5	26.6	1.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.6	0.1	27.6	0.1	2.7	0.0	0.0	0.4
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439878-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 940.2;lymphoid tissue: 1277.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 4744.7;Kupffer cells: 4311.3;Langerhans cells: 24286.4;Macrophages: 6377.4;monocytes: 6924.4;Proximal enterocytes: 3639.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 36.2"	"Group enriched"	"Detected in all"	4	"classical monocyte: 209.3;intermediate monocyte: 408.8;memory B-cell: 379.6;naive B-cell: 418.5;non-classical monocyte: 255.2;plasmacytoid DC: 229.8"	"Group enriched"	"Detected in all"	5	"B-cells: 418.5;dendritic cells: 229.8;monocytes: 408.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 715.7;HDLM-2: 1623.6;REH: 277.1;U-266/70: 242.2;U-698: 730.2;U-87 MG: 258.0"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		950000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	510.2	294.8	3.3	304.4	3.6	1.0	370.7	3.6	36.2	176.5	3.6	175.6	117.9	124.0	260.4	129.1	145.1	61.5	128.4	3.6	3.6	290.3	95.8	940.2	1277.8	7.8	7.5	58.5	73.9	0.1	125.6	23.5	5.9	141.5	151.1	8.3	156.0	8.5	79.4	195.5	713.3	1.4	3.5	1091.9	388.0	25.6	4.0	198.8	175.5	0.0	805.5	172.8	143.3	6.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	715.7	6.3	0.0	0.0	1.5	0.0	0.0	0.0	1623.6	0.0	17.7	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.1	0.1	0.0	0.0	277.1	0.4	0.9	0.0	0.1	0.6	0.7	1.3	0.3	22.8	0.0	0.0	0.8	0.0	8.9	1.4	2.7	1.6	242.2	6.1	730.2	258.0	0.5	0.5	5.9	209.3	74.1	2.1	408.8	1.1	379.6	2.4	10.8	4.6	418.5	1.2	2.2	17.9	15.0	255.2	229.8	19.8	137.8	3.3	3.6	3.6	36.2	3.6	3.6	7.8	7.5	5.9	3.5	4.0	6.0	935.5	291.7	1070.1	0.3	4744.7	748.4	18.1	160.7	84.2	4.1	101.2	172.6	22.5	115.8	458.0	150.8	0.0	12.7	983.5	79.5	29.4	329.2	8.7	26.9	5.2	803.1	64.9	228.5	0.2	59.8	18.3	128.0	159.6	27.1	174.8	80.9	167.4	19.8	2809.0	1.7	0.2	175.0	146.5	4311.3	24286.4	25.8	30.1	6377.4	773.7	59.0	6924.4	8.4	81.4	0.0	0.1	46.3	182.5	4.5	107.5	32.9	3639.5	303.5	487.1	19.7	72.3	27.8	78.0	3.5	5.2	35.3	576.1	25.9	218.8	0.8	245.4	273.3
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517353-32530287	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 356.2;lymphoid tissue: 423.3"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4068.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 61.9"	"Group enriched"	"Detected in all"	10	"B-cells: 26.1;dendritic cells: 61.9;monocytes: 35.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 641.1;HMC-1: 154.2;U-698: 189.9;U-87 MG: 238.6"									HPA043151	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	110.0	63.0	1.0	138.9	1.4	23.0	82.6	0.9	4.2	53.8	2.9	70.1	13.1	39.7	109.8	48.6	61.0	2.5	48.0	0.9	1.9	66.6	42.6	356.2	423.3	1.2	1.3	25.4	27.9	0.0	27.2	6.6	0.9	32.6	52.9	3.0	27.6	0.0	22.3	47.9	184.7	0.2	2.3	228.4	214.2	11.8	3.2	165.8	46.1	0.0	162.8	56.2	28.9	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.7	0.0	0.0	0.0	641.1	6.2	0.0	0.0	0.0	0.0	0.6	154.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.2	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	6.6	0.0	0.0	56.0	0.1	3.3	0.8	1.9	0.4	41.4	0.8	189.9	238.6	1.8	0.1	0.2	28.6	3.8	0.9	35.2	0.1	23.0	0.8	2.4	61.9	26.1	0.1	1.1	0.7	2.1	20.3	13.3	4.1	51.9	1.0	1.4	0.9	4.2	0.9	1.9	1.2	1.3	0.9	2.3	3.2	2.0	467.2	16.0	84.9	0.0	632.7	104.3	3.1	9.3	23.9	0.6	9.9	15.2	9.5	88.6	35.6	14.7	4.2	1.4	140.9	17.5	1.9	2.8	2.7	1.5	1.1	285.3	1.8	72.3	0.1	8.1	2.9	30.3	75.4	2.0	60.1	1.5	88.5	3.4	475.2	0.0	0.1	35.4	12.2	516.2	4068.5	7.4	15.8	978.8	120.9	8.4	246.9	0.5	9.2	0.0	0.1	31.5	52.3	34.3	46.2	6.7	661.5	37.0	71.6	1.8	19.7	8.9	17.3	0.8	1.3	11.2	90.6	3.1	68.0	0.3	50.8	65.7
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"	P13747	6	30489509-30494194	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 109.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.3;U-266/70: 284.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	724.7	217.2	9.6	173.7	10.0	410.3	578.9	10.9	109.5	360.1	7.3	329.4	0.6	313.5	119.3	330.9	336.5	186.1	356.0	7.7	13.1	375.2	332.8	1144.6	336.3	16.6	22.7	213.2	156.6	95.8	121.8	117.3	16.1	251.2	116.8	12.4	252.5	93.0	179.2	518.3	428.9	89.0	10.0	1007.2	259.5	41.1	11.7	86.0	381.9	0.0	137.5	295.0	366.3	14.2	100.7	16.7	6.8	57.0	212.3	166.4	0.9	0.0	0.0	0.1	0.3	40.0	189.1	65.6	98.7	92.7	148.3	121.6	12.8	53.1	0.0	67.6	32.7	78.6	18.7	0.0	0.0	0.2	38.3	135.4	94.4	67.7	0.0	0.0	0.2	34.6	9.8	0.9	54.5	0.2	0.3	0.8	0.5	32.0	0.0	20.6	0.2	97.4	82.7	58.4	0.3	4.8	63.3	56.9	0.3	1.2	0.0	132.7	102.0	60.7	0.1	0.5	14.7	284.8	171.6	29.4	0.3	62.1	149.2	1140.0	335.4	1153.0	723.3	550.2	602.2	449.1	539.9	709.2	158.5	450.3	531.5	547.8	1916.1	512.9	648.0	138.3	611.7	1441.6	9.6	10.0	10.9	109.5	7.7	13.1	16.6	22.7	16.1	10.0	11.7	14.2	2347.3	310.9	411.0	8.1	950.6	484.6	386.6	284.2	183.8	2.7	238.7	204.0	108.3	231.6	270.0	123.2	6.2	88.2	1304.6	603.0	17.6	484.9	5.0	157.7	157.9	1554.7	216.2	172.3	0.1	677.2	277.0	402.8	233.4	325.6	531.6	59.2	1647.8	120.1	700.6	5.0	0.1	545.3	248.2	1220.4	512.2	11.0	132.0	821.6	466.0	105.9	740.5	100.2	1874.4	2.0	0.5	682.2	559.1	76.3	716.6	436.9	473.9	79.9	214.7	9.5	177.5	535.1	350.1	10.6	7.0	170.0	426.5	359.0	1162.1	196.5	285.0	544.4
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 13.8;placenta: 11.1"	"Cell type enriched"	"Detected in many"	45	"Extravillous trophoblasts: 1850.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000	67000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"		"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.4	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.0	0.3	0.3	0.1	0.4	0.0	0.0	0.7	0.4	2.7	0.0	0.0	0.0	0.2	1.2	0.0	13.8	11.1	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.4	0.7	0.0	0.0	1.3	0.7	2.7	0.0	0.4	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.4	0.8	0.6	1.0	0.7	0.6	0.9	0.4	0.5	0.5	1.3	2.1	0.8	0.6	0.1	1.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	1.2	22.8	7.3	7.1	1.2	0.0	0.2	0.0	0.8	4.3	1.8	0.0	0.0	10.7	2.7	28.1	0.0	4.5	20.1	0.9	1.3	8.8	17.5	2.7	0.0	5.6	1850.2	5.5	1.5	2.6	0.0	0.7	6.4	1.2	25.5	0.0	0.0	34.3	2.0	8.1	27.3	13.0	2.5	4.8	12.4	0.0	1.4	0.0	3.1	0.0	0.0	24.9	19.9	2.6	0.9	14.3	0.2	0.3	0.6	0.0	0.0	4.8	3.8	5.9	2.8	0.1	35.2	40.5	6.8	1.9	18.2	15.0
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36748626-36990236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 86.2;Inhibitory neurons: 99.7;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA017379: AB_1850768"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	5.0	5.1	4.9	4.2	5.5	3.3	7.4	9.1	5.8	5.1	9.4	4.7	4.2	4.0	7.0	6.1	5.3	4.2	3.7	6.3	5.4	6.4	10.6	4.9	3.7	5.9	4.6	3.8	7.6	10.6	8.8	4.1	6.3	8.9	4.4	6.1	8.5	6.6	13.3	2.8	4.9	4.5	4.1	3.1	5.7	5.7	5.4	3.3	10.7	6.2	4.3	5.4	2.8	5.5	23.8	10.4	13.0	9.6	14.8	13.7	13.3	13.0	12.7	7.1	7.0	10.8	11.0	10.6	6.4	21.4	13.0	8.2	5.9	11.6	5.5	21.0	9.2	16.4	9.6	6.7	14.9	8.6	11.0	10.2	17.0	10.6	23.6	15.5	9.0	12.0	19.7	31.9	17.4	14.2	4.6	5.4	21.8	16.7	11.3	7.1	7.5	11.2	10.8	24.8	8.3	9.9	16.7	8.8	14.8	10.0	16.2	9.1	10.5	9.1	2.7	8.9	7.8	25.6	19.8	7.1	14.6	11.1	10.7	1.9	0.8	0.8	3.6	2.0	2.9	1.2	1.9	2.3	0.8	1.3	2.4	2.2	1.2	4.8	5.1	1.9	1.6	1.8	4.9	5.5	9.1	5.8	6.3	5.4	5.9	4.6	6.3	4.1	5.4	5.5	3.0	9.6	12.5	46.4	4.1	3.3	9.2	5.3	6.8	12.8	9.4	7.4	4.5	8.6	8.4	12.9	22.9	8.9	5.1	3.5	7.9	7.8	5.6	8.0	8.0	3.8	6.0	7.4	86.2	8.1	5.4	5.1	9.7	8.0	5.7	7.9	4.2	18.5	4.6	18.5	99.7	5.2	4.1	5.1	2.1	4.3	4.4	4.0	0.0	45.9	3.2	5.6	8.2	79.9	80.1	9.0	2.9	7.2	4.2	7.8	8.0	6.1	9.2	14.2	0.0	9.0	6.8	5.2	11.5	8.7	4.0	5.1	5.5	11.1	5.4	6.9
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4;Spermatogonia: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	12.2	23.6	10.3	7.4	11.9	11.5	13.8	20.7	12.0	11.1	17.6	9.9	5.3	13.6	10.2	7.5	11.5	9.3	19.0	10.3	13.4	16.9	18.5	7.8	11.9	13.1	12.6	18.8	13.6	17.2	12.4	8.2	13.9	15.7	7.5	27.6	11.1	11.6	11.6	5.6	6.8	12.1	15.1	8.7	9.9	44.7	12.2	15.8	21.0	11.4	11.2	8.3	6.0	17.5	66.7	31.8	44.3	34.6	29.0	37.3	4.3	44.1	26.2	32.0	37.0	25.8	45.1	42.7	52.3	20.6	62.3	1.9	60.1	17.5	52.9	23.7	29.1	102.6	23.6	10.5	18.1	27.2	40.7	23.7	9.3	23.9	13.9	48.4	18.7	68.1	36.5	26.9	44.2	33.5	56.4	40.9	33.5	33.3	39.3	64.2	49.8	6.6	26.2	21.1	43.5	25.6	66.9	30.4	60.8	23.3	91.5	25.9	13.2	37.1	22.4	53.1	48.5	39.3	23.5	55.4	36.2	36.3	14.6	8.2	1.0	3.5	4.3	1.7	8.0	6.9	3.8	5.8	3.4	4.9	5.6	5.7	0.0	4.7	1.9	7.8	3.9	2.8	10.3	11.9	20.7	12.0	10.3	13.4	13.1	12.6	13.9	15.1	12.2	17.5	19.5	25.6	20.4	56.8	15.6	5.6	8.5	12.9	10.8	99.3	20.1	16.5	46.4	18.6	18.5	31.3	41.7	10.2	29.9	1.9	35.2	10.1	9.9	36.7	31.1	14.3	4.9	71.5	67.5	8.4	10.1	27.6	12.8	11.7	55.7	55.8	13.2	17.2	8.7	47.1	88.7	6.9	18.3	4.6	3.1	12.3	33.8	11.9	5.4	28.1	5.2	35.4	12.3	66.4	68.7	7.4	3.6	32.4	19.3	8.2	2.0	19.2	26.2	76.2	13.1	37.5	23.8	143.4	113.2	11.5	4.3	1.6	22.1	100.6	7.5	6.6
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879431-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.7;Endothelial cells: 32.5;Hepatic stellate cells: 47.5;Hofbauer cells: 34.1;Kupffer cells: 24.8;Langerhans cells: 23.5;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 65.1;neutrophil: 55.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 65.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 32.4;THP-1: 100.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	35.2	4.7	1.4	10.3	1.3	86.5	18.6	1.4	2.0	7.5	1.5	44.4	4.8	5.5	0.5	3.9	9.3	9.6	18.9	2.0	1.6	6.8	21.8	23.1	8.5	1.9	1.7	4.2	4.3	1.3	3.0	13.8	2.0	6.3	2.0	0.0	3.5	0.4	9.2	8.7	18.9	5.6	1.9	15.7	5.2	1.8	2.6	2.1	9.5	4.2	2.3	11.0	8.8	1.9	0.0	2.1	0.0	3.2	9.2	14.7	3.0	11.4	18.9	12.8	10.6	0.2	0.3	0.0	0.1	6.8	2.5	0.0	0.5	0.0	5.3	3.0	5.9	0.0	1.1	0.3	15.1	3.9	0.8	15.4	0.2	14.7	0.8	1.1	5.7	0.0	4.0	0.0	1.6	0.0	0.0	10.3	0.3	0.0	5.2	0.3	9.0	0.1	0.8	0.1	0.0	2.4	0.7	0.0	32.4	0.1	0.0	100.4	1.8	8.7	0.0	1.3	9.3	0.0	0.0	0.0	14.1	12.3	3.6	65.1	10.4	22.3	0.0	3.4	0.0	5.7	0.0	0.0	13.0	2.7	0.0	0.0	55.9	0.7	0.7	8.7	0.4	3.3	1.4	1.3	1.4	2.0	2.0	1.6	1.9	1.7	2.0	1.9	2.6	1.9	35.7	9.6	5.3	1.0	4.3	2.8	0.1	0.0	0.6	0.1	0.5	1.3	5.7	0.0	0.0	0.0	0.0	0.6	3.0	0.4	0.0	0.5	0.5	0.2	2.6	32.5	0.0	8.4	0.3	0.4	0.7	8.4	0.5	0.3	3.8	0.1	47.5	10.8	34.1	0.0	0.2	0.3	0.0	24.8	23.5	0.4	2.5	17.8	0.0	4.7	44.2	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.2	0.0	0.1	0.0	0.0	6.6	7.5	10.6	0.1	2.2	0.3	3.1	0.4	1.1	0.4	0.3	0.4
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514410-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 324.9;Plasma cells: 400.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	78.6	102.9	10.5	60.9	13.5	61.7	63.4	13.6	15.7	100.0	42.4	54.5	52.6	72.9	111.4	128.6	70.4	46.7	55.9	12.5	17.1	61.4	136.1	83.7	40.7	17.8	17.9	59.2	241.1	68.8	90.0	64.6	17.4	66.0	44.4	20.8	217.7	80.3	44.6	51.6	52.1	49.1	14.2	70.2	92.5	21.9	23.9	30.5	74.7	14.1	54.2	64.9	72.2	20.9	143.8	147.6	56.6	87.7	260.2	163.5	197.6	239.0	221.3	159.7	162.8	287.3	166.8	90.4	312.8	262.7	209.7	253.8	74.9	162.0	97.7	46.2	112.0	201.3	99.7	179.3	287.0	118.1	78.1	152.5	103.5	133.7	182.7	159.0	124.5	56.0	90.2	364.0	148.8	170.3	100.0	84.0	67.8	234.9	248.5	63.6	272.6	436.5	154.4	75.6	76.3	90.4	243.5	234.9	199.2	56.4	182.0	109.5	153.3	243.1	129.8	246.3	136.2	225.5	145.5	71.7	328.7	413.0	219.4	117.7	380.9	190.8	116.7	372.6	159.7	91.9	108.0	112.9	260.8	74.4	70.6	84.1	282.8	117.5	363.7	271.9	104.1	374.1	10.5	13.5	13.6	15.7	12.5	17.1	17.8	17.9	17.4	14.2	23.9	20.9	67.4	51.3	55.4	23.8	78.2	33.4	59.0	127.8	31.3	45.4	65.6	49.1	13.6	71.4	102.2	53.3	123.0	154.0	70.7	115.2	13.7	145.6	15.5	55.0	111.5	60.9	61.5	38.9	40.5	169.7	139.0	93.2	80.0	128.4	42.4	55.5	53.2	86.4	324.9	43.7	39.2	134.5	63.1	81.2	83.1	15.9	60.6	106.1	65.8	28.1	77.4	52.2	53.5	33.7	23.8	144.3	81.2	43.6	400.6	92.4	54.8	51.0	49.3	44.8	32.9	49.2	79.2	26.1	26.4	60.0	35.4	213.6	60.1	97.2	70.8	69.3
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 170.8"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 935.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	10.3	15.9	9.3	9.3	10.4	170.8	9.4	11.5	10.4	7.9	10.1	13.7	12.5	10.2	11.9	14.4	7.7	4.0	17.3	9.1	10.0	12.3	22.8	8.8	9.2	10.7	10.2	3.8	16.2	9.2	8.5	10.6	10.6	8.6	14.9	5.9	9.9	8.6	30.4	10.5	10.1	10.5	10.4	15.2	11.7	5.7	10.7	7.6	8.9	23.9	11.9	9.6	8.0	12.6	40.0	59.9	27.7	47.5	21.6	27.2	41.7	31.1	34.8	45.0	38.2	74.4	60.2	59.4	68.3	40.1	42.0	53.7	41.6	60.1	28.2	42.0	42.4	97.2	22.5	55.0	40.8	37.6	31.2	29.8	38.0	71.5	53.1	18.7	21.5	55.9	154.6	25.7	35.9	158.4	36.3	72.6	32.1	72.8	36.5	41.9	27.8	59.5	45.3	36.2	31.1	41.4	24.6	38.4	29.3	19.3	64.7	52.3	20.0	33.0	25.5	32.9	36.0	14.2	16.7	36.6	22.7	47.4	40.0	48.5	38.5	4.4	13.6	35.2	17.8	21.4	12.5	15.1	52.8	24.4	19.7	14.7	1.3	11.5	22.2	35.1	14.2	26.6	9.3	10.4	11.5	10.4	9.1	10.0	10.7	10.2	10.6	10.4	10.7	12.6	5.2	9.6	9.0	4.2	12.1	7.9	11.0	26.7	13.6	5.6	14.5	16.8	13.7	18.6	12.8	11.0	27.1	57.8	12.1	12.4	19.6	25.6	1.7	5.8	10.4	6.2	13.2	935.9	3.8	31.2	61.1	9.0	5.6	5.8	2.5	6.3	4.6	23.7	29.1	10.1	5.7	19.1	14.2	13.0	10.4	3.0	5.9	9.5	14.2	1.9	15.3	7.5	8.2	4.5	8.6	23.3	13.0	8.6	25.0	14.5	9.2	24.5	13.6	25.9	0.0	8.6	11.7	1.7	32.0	18.8	8.1	23.3	6.1	16.7	31.0	10.5
HMCES	"C3orf37, DC12, SRAPD1"	ENSG00000183624	"5-hydroxymethylcytosine binding, ES cell specific"	Q96FZ2	3	129278828-129306186	"Predicted intracellular proteins"	"DNA damage"	"DNA-binding, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 124.9;Spermatocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044968	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA044968: AB_2679160"	"unprognostic (9.18e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.08e-3)"	35.8	22.0	27.6	37.3	32.5	37.8	32.9	26.6	32.4	25.8	22.4	36.1	29.4	24.0	23.0	41.7	27.0	21.1	40.3	29.8	30.1	27.4	53.7	27.1	99.7	27.3	27.6	28.3	15.3	68.9	22.2	20.9	27.6	24.6	30.9	27.7	26.8	26.2	57.7	35.5	28.8	23.2	26.4	29.8	26.4	39.9	32.5	57.1	22.4	48.5	131.0	28.5	28.8	27.1	149.4	66.2	74.4	85.9	90.6	37.8	66.8	51.2	41.5	73.1	56.6	105.0	67.9	286.0	53.9	46.9	57.2	106.3	94.8	110.8	83.7	58.0	51.2	59.7	52.7	76.0	38.8	52.1	41.9	36.7	56.6	61.1	60.2	35.6	45.5	63.5	61.2	244.2	40.9	197.3	74.8	45.1	48.4	108.5	42.8	66.6	63.8	50.5	77.0	88.8	74.0	45.6	114.4	70.8	70.6	45.6	121.0	52.1	36.8	36.3	63.7	87.3	66.5	135.8	87.2	289.3	43.4	41.9	41.1	35.5	25.5	65.0	30.4	27.4	31.6	37.5	36.7	36.3	26.3	62.1	36.1	40.0	52.5	27.2	40.9	28.1	48.0	31.2	27.6	32.5	26.6	32.4	29.8	30.1	27.3	27.6	27.6	26.4	32.5	27.1	26.1	32.1	25.6	11.4	23.5	58.2	71.2	72.4	54.7	21.5	18.8	16.1	35.6	30.0	30.4	22.0	10.4	49.2	32.0	30.8	37.2	39.6	8.6	16.0	10.2	27.8	21.0	28.2	13.6	47.0	37.6	23.3	17.9	15.7	22.2	11.0	20.7	26.1	19.7	26.9	14.7	17.3	32.6	8.1	39.4	8.6	24.5	15.7	58.7	10.3	16.4	38.6	25.7	7.1	10.6	33.8	16.9	31.2	124.9	37.3	19.9	21.1	25.2	12.5	13.1	21.0	27.1	127.8	83.6	30.7	43.9	35.0	47.3	23.9	30.7	61.0
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734391-186190949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 9.9"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	9.7	1.4	1.3	0.6	1.2	0.0	8.4	0.9	1.1	3.7	1.3	9.0	0.9	1.9	2.5	5.4	1.8	6.5	8.4	0.8	1.1	2.5	7.8	20.3	0.4	1.5	1.9	3.9	0.9	0.9	3.2	4.8	1.5	7.5	2.8	0.6	7.7	1.4	4.8	4.1	3.1	4.3	1.4	8.4	1.7	2.6	1.7	0.8	3.2	7.0	2.4	1.8	3.8	0.9	0.2	0.1	1.6	0.0	4.7	4.7	0.0	0.5	0.9	0.3	0.5	0.0	0.1	1.9	0.2	22.3	1.6	5.0	0.1	0.2	0.1	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.7	0.0	5.6	0.4	20.1	2.8	0.0	0.2	0.0	0.0	76.5	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	50.2	4.5	0.1	0.0	0.0	13.7	1.3	0.0	5.1	0.2	0.0	0.3	2.7	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	1.2	0.9	1.1	0.8	1.1	1.5	1.9	1.5	1.4	1.7	0.9	33.8	3.2	7.0	0.3	0.0	3.2	0.2	4.9	2.2	1.7	1.2	1.8	2.8	0.0	0.8	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.3	0.6	1.5	21.4	0.0	0.0	1.1	0.0	0.8	22.2	0.0	0.9	0.0	5.2	7.9	1.9	0.1	26.9	3.8	0.0	0.0	0.3	2.8	2.7	3.7	0.4	5.4	45.0	0.0	0.1	0.0	3.0	1.5	0.0	0.0	2.2	1.2	0.1	0.0	0.2	1.0	0.0	0.0	2.5	7.7	0.5	0.1	0.4	1.7	0.0	0.4	0.1	0.0	0.2
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.9;intestine: 51.1"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 283.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.8;RH-30: 18.0;SCLC-21H: 2.6;SH-SY5Y: 4.1;U-138 MG: 2.9;U-87 MG: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA053903: AB_2682301, HPA070647: AB_2686290"	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	14.4	1.3	0.3	1.5	0.2	0.0	3.9	0.1	0.7	21.4	0.0	51.1	5.2	33.9	0.1	4.8	10.1	0.7	12.4	0.1	0.9	4.0	1.2	3.8	1.2	2.0	0.7	2.6	0.9	0.1	0.3	0.2	4.0	9.2	1.9	0.0	2.2	2.3	25.0	4.1	21.6	4.2	1.2	0.4	4.9	5.7	1.0	1.2	4.8	6.3	0.2	9.2	12.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	18.0	0.1	0.0	0.1	2.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.7	0.1	0.9	2.0	0.7	4.0	1.2	1.0	0.4	1.2	3.2	7.5	2.3	0.5	0.9	0.4	0.0	0.0	1.1	0.2	0.3	4.8	0.0	3.7	0.0	0.0	0.1	0.1	22.9	1.9	0.0	17.0	0.0	0.2	5.0	0.0	0.0	1.3	0.0	0.1	24.8	0.0	0.1	7.6	0.1	0.7	2.3	0.4	1.7	5.8	3.6	2.0	0.8	0.8	10.6	0.0	2.3	1.8	1.0	0.0	0.0	0.0	0.5	0.7	0.1	8.3	0.0	0.1	0.8	34.1	1.2	4.0	0.7	0.0	283.7	4.5	0.9	1.1	0.0	0.6	0.3	1.6	2.9	5.5	4.7
HMG20A	"FLJ10739, HMGX1, HMGXB1"	ENSG00000140382	"High mobility group 20A"	Q9NP66	15	77420412-77485607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008126	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA008126: AB_1079072"	"unprognostic (2.04e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	12.2	18.2	14.5	15.9	14.2	10.2	14.2	15.1	17.6	15.2	7.8	15.4	12.4	20.3	13.6	13.4	13.2	15.5	25.1	14.4	14.8	14.0	24.9	15.7	25.2	11.5	12.9	22.2	13.0	18.1	9.7	21.8	11.3	11.6	17.0	26.0	13.5	13.9	27.2	13.4	14.2	15.7	12.0	35.8	13.6	21.3	15.0	31.6	15.0	26.4	22.1	14.4	10.8	16.6	17.8	29.8	53.8	38.4	22.4	28.4	21.6	23.2	34.6	27.2	29.5	18.6	26.7	30.2	26.4	27.0	21.0	23.8	76.6	29.3	27.6	27.1	38.4	62.3	26.6	24.5	33.4	46.1	35.7	31.9	20.9	24.2	26.8	36.3	54.9	38.9	47.8	24.6	25.1	14.1	36.8	32.1	39.0	15.8	14.2	48.0	52.1	34.2	31.1	30.7	21.1	45.3	37.5	22.6	70.6	51.2	22.3	48.3	33.8	32.3	28.4	15.2	28.4	33.2	75.7	59.9	24.1	66.3	38.4	9.2	20.8	16.9	29.1	21.2	34.4	31.3	22.9	27.3	27.8	27.3	30.8	27.3	3.4	49.2	26.1	21.1	23.7	24.9	14.5	14.2	15.1	17.6	14.4	14.8	11.5	12.9	11.3	12.0	15.0	16.6	14.6	12.8	11.5	39.2	18.1	8.8	5.3	10.0	13.6	20.6	13.0	12.3	47.2	14.3	10.7	11.0	25.0	13.7	12.9	12.2	5.9	9.9	25.9	10.4	21.1	16.8	18.0	15.4	60.1	8.0	9.5	17.2	13.7	10.0	12.7	16.5	22.9	32.4	16.6	38.7	56.9	15.6	6.1	28.6	11.9	79.5	12.8	13.0	14.2	29.0	22.1	14.3	19.6	64.3	71.1	9.0	10.8	13.9	13.3	6.0	8.4	10.6	4.9	20.6	19.7	13.4	13.2	28.2	17.0	11.3	7.4	13.8	16.4	25.5	13.8	5.5
HMG20B	"BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL"	ENSG00000064961	"High mobility group 20B"	Q9P0W2	19	3572777-3579088	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 265.7;Melanocytes: 229.5;Syncytiotrophoblasts: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 411.1;WM-115: 405.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050220, HPA053157, HPA069832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210"	"unprognostic (2.97e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.72e-7)"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.89e-5)"	50.4	41.4	27.3	18.2	29.3	30.1	49.9	29.1	33.7	50.9	29.4	59.0	28.1	54.5	15.6	48.1	44.7	16.8	36.8	26.0	27.5	56.0	54.4	38.3	20.1	32.6	28.4	38.0	38.1	30.3	18.1	22.7	31.8	68.9	17.2	8.8	49.9	25.6	25.9	58.3	47.6	19.9	29.6	39.2	54.2	36.0	30.3	48.2	39.3	12.0	15.9	49.0	43.8	34.1	93.1	39.0	34.6	83.0	42.2	38.1	64.1	58.7	42.4	52.6	40.0	14.1	33.5	50.5	53.7	42.6	47.5	44.4	20.3	40.0	31.3	45.1	46.6	24.8	132.2	37.7	27.2	33.9	117.5	32.5	47.0	30.2	20.0	53.4	53.4	44.8	42.0	81.9	35.0	126.3	64.7	62.0	39.7	78.5	78.4	42.3	60.4	69.5	39.0	58.4	21.7	66.0	81.7	141.3	411.1	32.4	106.8	90.5	77.4	27.7	62.1	99.3	50.8	76.4	43.0	36.2	72.0	85.6	405.1	44.9	68.1	66.2	40.1	70.1	35.8	35.2	34.1	43.6	66.1	30.2	36.3	35.3	37.9	59.5	77.0	59.5	41.4	51.8	27.3	29.3	29.1	33.7	26.0	27.5	32.6	28.4	31.8	29.6	30.3	34.1	50.1	28.9	19.3	9.8	27.9	70.5	52.1	67.4	47.8	3.4	75.0	70.9	8.7	28.6	40.0	18.4	10.4	122.9	34.1	50.0	92.0	65.0	26.7	39.7	41.4	42.5	66.8	24.4	0.7	45.5	265.7	35.4	32.6	44.4	37.5	58.1	38.6	20.9	81.9	8.4	0.7	170.8	57.0	29.6	93.4	49.6	37.3	47.1	229.5	3.7	86.2	41.2	42.2	0.5	11.7	58.6	68.5	44.8	34.9	62.8	74.7	76.2	29.5	18.7	32.9	22.4	53.4	39.9	17.4	53.0	79.8	303.7	30.8	49.6	68.7	62.9
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003506, CAB005873, HPA073663"	Supported		Supported	Nucleoplasm	"Secreted to blood"	NA	NA		2800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: "	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	312.0	224.3	266.2	355.1	282.2	1021.3	318.2	267.6	362.4	319.0	227.0	327.8	281.9	363.6	270.1	297.0	265.5	227.0	242.2	250.1	282.9	243.7	360.8	242.2	664.8	281.5	273.3	254.9	189.3	226.1	163.3	252.1	286.2	265.9	381.2	174.8	224.5	280.1	388.5	244.2	309.2	319.5	277.7	284.9	269.0	153.9	269.9	900.3	267.4	364.7	738.9	282.7	274.1	308.2	816.7	617.4	1402.5	1054.0	384.5	380.1	551.4	1012.6	547.9	957.3	643.5	983.6	1328.6	1639.3	515.5	924.0	880.6	886.5	1484.7	817.4	1639.6	869.6	622.4	1727.4	455.4	913.5	210.3	2513.6	1009.8	253.4	426.0	713.3	656.6	497.8	1302.2	1350.8	1167.9	571.7	855.6	1508.3	3224.3	2682.1	1184.3	1424.3	683.7	2673.3	1927.8	965.8	908.1	792.8	1264.0	1139.8	928.6	682.0	541.0	672.3	668.5	1857.9	814.7	637.2	921.8	689.7	1197.1	513.9	714.8	3508.3	261.1	1634.0	1369.3	1036.6	503.7	926.1	467.3	410.9	522.1	582.6	532.3	530.7	520.1	590.7	477.4	459.7	631.7	615.4	411.0	512.5	702.6	1072.0	266.2	282.2	267.6	362.4	250.1	282.9	281.5	273.3	286.2	277.7	269.9	308.2	948.9	458.3	496.6	188.4	920.7	791.1	986.7	942.7	752.4	414.3	471.9	630.0	172.5	561.9	561.3	603.2	131.3	998.9	759.9	408.1	766.9	941.3	113.4	611.2	1040.2	766.0	423.0	1808.9	58.5	967.2	1441.4	676.5	486.3	728.3	546.8	772.2	589.0	749.5	728.8	196.9	47.2	675.6	710.1	549.9	884.4	107.2	720.1	694.2	674.1	81.5	578.7	609.9	879.5	99.5	149.3	1212.3	554.8	666.9	1252.9	811.2	506.7	827.5	418.7	252.8	650.8	588.9	1005.9	549.1	1211.0	1045.8	691.9	465.7	797.9	515.7	839.1	867.9
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990771	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 136.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 11.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 738.7;U-698: 675.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062583, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Nucleoli	"HPA062583: AB_2684800, HPA073663: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	8.9	13.7	10.5	19.7	10.5	85.6	15.6	10.4	20.3	34.0	6.5	43.9	27.1	16.4	44.8	26.1	16.9	9.7	11.3	14.5	13.9	19.6	101.4	15.9	25.2	13.0	11.2	5.9	17.2	85.4	4.2	136.6	11.3	13.9	32.4	3.1	23.8	15.9	53.5	19.2	28.1	13.8	10.2	21.2	16.1	40.1	13.4	65.2	14.3	8.9	35.8	18.7	10.5	9.5	263.5	115.5	351.9	184.2	14.5	42.9	437.4	112.9	73.6	127.9	66.1	91.6	106.0	183.0	354.8	87.5	72.3	123.3	324.4	738.7	143.3	125.6	94.7	159.4	110.2	145.6	21.5	243.9	78.0	33.9	171.6	52.5	131.5	32.7	168.3	110.5	84.5	105.4	154.2	201.9	269.3	186.2	209.2	171.0	138.1	325.4	286.3	103.6	95.2	125.3	252.7	164.4	167.4	177.7	56.0	199.3	157.8	158.5	128.0	53.0	123.9	169.9	253.1	94.9	128.7	675.7	63.1	121.3	109.9	0.0	4.3	11.3	0.4	3.0	0.1	2.7	2.0	2.9	6.1	0.5	0.0	0.2	0.7	0.8	5.0	3.1	5.8	2.5	10.5	10.5	10.4	20.3	14.5	13.9	13.0	11.2	11.3	10.2	13.4	9.5	10.4	38.5	31.2	0.7	15.1	23.7	18.9	158.6	12.5	0.5	24.2	16.0	16.0	8.6	123.5	31.3	2.1	419.1	4.5	32.1	37.2	82.4	232.3	61.9	18.9	19.6	65.7	136.1	1.3	86.5	820.7	17.6	22.4	55.9	8.2	44.2	13.6	84.4	101.0	0.0	3.7	37.0	219.7	20.8	43.7	75.9	3.7	22.1	21.4	2.8	23.6	4.1	1.0	1.5	0.5	91.5	35.7	3.4	47.1	27.5	31.8	66.5	113.3	1.8	0.0	39.8	29.0	22.7	50.2	41.1	20.3	1400.2	10.1	10.4	60.7	18.5
HMGB4	FLJ40388	ENSG00000176256	"High mobility group box 4"	Q8WW32	1	33860475-33864791	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1077	"testis: 372.2"	"Group enriched"	"Detected in some"	117	"Early spermatids: 11656.4;Late spermatids: 21015.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA035699	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA035699: AB_10960531"															"unprognostic (1.33e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	372.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11656.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21015.5	100.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	138.7	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGCL	HL	ENSG00000117305	"3-hydroxy-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 322.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.4;Proximal tubular cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	27.5	63.0	26.3	16.8	27.5	7.5	25.8	27.5	28.3	27.5	33.0	53.3	45.7	20.2	47.2	32.8	35.6	26.3	42.5	24.6	26.9	115.5	322.5	23.6	21.7	28.0	26.2	21.6	33.4	60.2	26.3	19.9	27.7	31.7	52.9	16.1	30.3	27.9	63.7	25.5	40.0	23.3	27.4	26.8	40.9	17.9	30.1	23.4	40.5	70.2	25.1	28.6	24.2	29.6	28.5	16.0	17.7	13.4	70.6	53.5	6.8	22.0	38.3	23.3	28.2	10.2	53.7	14.8	44.3	34.6	19.0	22.4	21.3	35.7	25.2	30.4	16.1	19.8	13.8	23.5	90.9	7.8	12.7	62.4	52.0	30.8	58.5	62.5	32.2	27.4	20.6	20.3	43.3	29.3	12.2	15.3	4.6	77.4	22.1	17.2	14.5	27.9	55.4	14.5	14.8	13.2	28.6	10.8	49.3	23.3	33.9	19.3	24.3	19.3	11.6	35.5	9.7	28.7	15.2	13.3	47.7	28.7	23.0	103.5	67.0	66.0	36.3	66.0	39.8	45.9	39.1	42.1	58.0	51.2	39.6	37.7	25.5	54.4	77.5	43.9	45.5	61.7	26.3	27.5	27.5	28.3	24.6	26.9	28.0	26.2	27.7	27.4	30.1	29.6	19.9	12.8	25.7	14.0	16.3	5.9	29.9	54.3	9.6	24.6	19.9	17.1	33.7	41.5	30.6	49.7	18.8	43.0	10.0	48.1	119.3	57.7	2.3	25.0	17.5	22.5	9.0	18.7	4.3	24.0	27.3	20.8	30.5	23.1	17.7	29.7	30.4	172.4	61.6	35.3	5.3	49.5	28.5	23.5	7.7	3.6	21.8	23.5	21.4	8.4	41.4	37.1	24.7	6.0	12.5	31.2	53.8	24.5	8.3	29.4	70.9	216.8	31.5	25.5	6.6	17.1	21.6	6.6	5.4	13.8	6.5	41.3	15.2	65.6	48.9	24.3
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75364001	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 105.7"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 239.5;Theca cells: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797, CAB078688"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"CAB016797: , CAB078688: AB_2665607, HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	10.8	39.5	19.8	18.1	20.7	24.6	30.8	15.7	23.0	20.1	16.2	45.2	38.1	16.8	25.3	49.1	12.2	15.2	7.4	21.5	25.0	21.1	105.7	24.2	14.7	26.6	21.3	9.7	16.5	24.8	8.2	17.7	25.2	23.3	37.3	18.7	15.5	8.1	6.4	55.2	26.5	12.9	14.2	14.8	27.6	23.3	20.5	17.8	23.4	7.1	18.6	14.1	26.7	17.5	68.5	25.6	260.7	89.2	54.9	103.4	65.5	19.3	53.6	38.6	85.0	95.8	163.7	60.3	68.7	31.7	245.2	84.5	136.4	225.9	39.4	20.8	50.8	47.0	36.7	78.6	80.8	39.8	32.9	66.8	130.7	133.6	65.6	19.2	31.5	84.8	50.4	86.4	61.0	45.2	72.7	39.9	112.5	17.7	19.7	50.7	78.7	86.5	155.2	154.5	91.0	41.3	41.4	43.7	38.3	89.6	43.1	102.4	37.2	20.5	30.0	22.4	32.8	28.1	38.1	83.2	29.7	75.2	43.7	10.0	14.8	8.8	7.7	8.9	6.2	5.1	5.2	7.8	16.9	5.2	5.3	7.2	28.8	12.5	10.5	4.9	9.0	7.5	19.8	20.7	15.7	23.0	21.5	25.0	26.6	21.3	25.2	14.2	20.5	17.5	11.6	19.2	43.3	23.2	14.9	41.4	10.1	37.6	43.3	23.5	19.0	12.1	7.0	12.8	33.3	27.6	18.8	19.7	25.7	80.4	3.9	13.5	46.6	124.4	34.3	13.4	43.0	11.6	49.9	22.0	24.0	13.7	28.5	239.5	24.1	71.3	7.9	97.5	13.1	40.4	35.8	56.0	28.5	14.8	11.8	22.2	9.3	19.5	16.0	15.0	12.1	9.7	7.2	28.1	24.7	15.0	40.0	6.0	14.4	18.4	15.5	6.9	31.6	15.2	13.1	7.0	20.2	23.4	12.0	69.8	91.6	46.7	19.2	148.7	30.4	18.8
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	19.2	55.2	25.2	27.2	32.9	15.8	40.1	23.0	38.6	56.4	16.8	50.2	93.6	19.8	36.1	137.5	12.4	23.3	16.1	36.1	44.6	32.8	390.2	51.4	21.5	46.5	34.7	21.6	26.6	31.7	15.0	22.5	47.2	40.5	45.4	34.2	53.2	15.7	17.8	85.9	47.2	19.9	24.7	14.8	43.4	33.2	35.3	19.1	23.6	16.7	31.5	18.3	69.5	30.4	103.4	48.8	797.7	93.0	45.8	178.4	54.1	16.2	63.8	22.8	45.2	86.6	146.6	108.4	35.6	23.3	523.5	80.2	199.7	467.2	24.1	23.5	240.7	40.1	45.3	119.3	71.3	88.0	28.0	98.5	56.2	119.5	47.9	14.0	23.7	98.4	73.1	291.7	19.4	48.9	81.3	111.9	143.1	41.7	25.9	57.5	111.9	121.8	357.7	158.2	68.2	33.0	83.6	41.4	25.9	114.5	63.6	116.7	28.3	17.1	85.7	18.0	15.5	38.8	64.0	148.3	15.0	106.2	15.5	3.3	1.8	1.9	2.4	3.3	2.4	3.8	2.6	3.4	3.5	2.9	2.2	3.1	3.0	3.2	3.6	2.9	2.6	1.6	25.2	32.9	23.0	38.6	36.1	44.6	46.5	34.7	47.2	24.7	35.3	30.4	27.8	67.3	172.6	70.5	44.8	108.3	42.3	93.8	68.3	43.6	46.3	30.0	8.9	47.1	79.2	47.8	52.1	22.3	43.3	211.2	13.7	43.0	9.0	47.1	20.2	31.3	92.1	22.3	44.9	59.8	41.1	32.3	100.4	98.6	58.5	56.6	22.1	511.7	25.5	48.8	42.6	101.9	75.3	21.9	38.2	3.2	12.8	27.5	26.6	15.0	49.1	26.4	14.4	53.3	41.8	50.4	132.3	14.3	38.1	149.2	56.8	21.4	51.1	50.1	0.0	40.1	32.8	20.0	8.7	197.9	236.4	44.5	36.4	129.4	62.9	74.5
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB012260: AB_304786, HPA048694: AB_2680496"	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	56.1	73.7	54.1	120.5	52.3	202.4	121.4	52.0	63.7	115.8	54.6	126.0	121.3	78.8	187.6	124.8	100.2	72.9	39.1	53.3	58.7	114.4	100.8	72.5	219.1	57.1	57.5	72.9	92.2	132.1	73.8	111.6	55.7	93.2	136.2	245.5	97.1	75.2	16.2	82.5	133.6	65.3	57.2	100.9	113.2	64.8	56.4	238.7	117.2	26.3	294.9	114.2	73.8	58.5	517.7	135.9	450.3	316.3	74.5	131.1	299.7	266.6	191.8	261.0	233.0	262.6	420.6	1161.6	246.8	223.7	309.8	106.5	317.4	377.9	336.1	459.5	317.7	883.6	225.7	355.8	187.0	768.2	291.3	167.4	349.9	260.2	350.6	222.4	363.6	513.6	680.2	191.6	436.7	686.7	780.2	691.0	798.0	682.3	237.8	853.2	224.7	466.0	469.5	308.3	386.3	362.2	582.8	364.1	356.0	183.1	479.5	807.5	239.6	127.2	128.7	94.0	279.7	235.6	394.8	690.7	179.4	882.9	341.4	103.7	76.4	282.5	138.0	68.9	153.5	228.9	175.2	143.7	216.5	205.8	195.2	172.2	53.8	174.5	67.7	294.9	221.5	231.4	54.1	52.3	52.0	63.7	53.3	58.7	57.1	57.5	55.7	57.2	56.4	58.5	169.9	93.0	139.7	55.2	420.4	278.5	532.0	674.9	233.9	265.1	650.7	412.6	56.1	307.4	349.0	285.1	331.5	599.2	405.1	306.8	737.6	479.9	642.8	304.4	287.3	223.3	345.2	275.6	34.9	350.5	970.7	196.6	221.7	309.2	219.9	277.8	135.7	176.2	533.9	240.6	55.1	442.1	514.7	176.1	389.6	180.6	175.8	279.6	243.7	45.0	415.1	427.8	358.4	96.5	68.8	381.0	307.4	200.1	335.9	684.7	327.8	625.4	226.8	1301.8	32.9	122.0	179.5	81.9	149.1	399.7	313.7	602.1	326.1	289.2	537.1	699.9
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472440-26476642	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		640000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	216.3	225.6	180.2	254.5	187.3	1137.3	234.8	179.6	251.3	328.1	162.5	280.3	176.3	283.8	359.3	291.1	293.4	142.9	192.5	170.6	183.1	259.7	212.9	259.2	436.5	185.1	178.8	394.6	252.5	160.4	328.7	214.9	188.4	281.6	301.1	285.0	217.1	162.8	251.8	242.8	270.0	235.8	188.7	324.3	224.7	160.4	175.8	916.1	306.1	133.5	534.0	245.1	250.7	211.6	1074.5	304.8	1192.5	496.5	112.0	251.6	390.8	517.2	331.2	1089.4	835.7	305.8	1073.1	1107.2	443.1	482.3	338.4	627.8	1564.6	565.6	1001.7	684.2	906.7	1222.2	401.5	360.2	197.7	2793.6	738.7	254.9	303.4	602.1	369.1	245.1	541.7	866.8	964.3	643.0	623.0	690.8	1906.1	1363.3	922.7	1463.0	619.6	1384.3	1598.6	776.5	380.3	278.6	1064.5	641.1	1384.3	498.7	651.4	304.9	759.0	1508.9	322.3	536.9	920.4	977.1	943.6	641.2	899.2	1266.9	338.9	2989.0	1056.9	331.8	530.8	1430.5	279.2	622.3	267.3	532.2	379.7	343.3	531.5	505.6	412.4	337.7	462.4	355.5	690.4	704.7	746.7	1084.6	180.2	187.3	179.6	251.3	170.6	183.1	185.1	178.8	188.4	188.7	175.8	211.6	128.7	342.9	394.4	28.1	459.3	288.6	323.8	383.2	211.1	180.2	353.0	241.3	93.4	221.6	314.8	261.1	141.8	898.7	325.2	227.2	371.7	218.4	204.3	328.9	291.1	190.3	576.9	980.4	14.4	268.7	606.4	435.4	263.5	278.1	383.0	375.0	185.6	147.5	763.0	94.2	22.2	564.5	193.3	434.3	467.9	53.5	185.8	477.5	227.7	15.0	655.6	376.0	399.6	15.1	36.9	93.7	304.4	151.9	669.5	250.4	238.0	320.4	495.6	370.2	124.9	249.0	325.7	306.4	412.0	585.8	213.4	923.4	369.5	351.9	613.2	314.0
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	92.4	174.4	132.9	69.5	136.2	72.8	116.1	141.8	190.4	82.2	153.6	100.6	90.4	93.6	168.6	95.1	209.3	82.8	227.2	132.9	135.8	168.4	147.5	111.5	127.1	139.5	135.2	105.5	90.3	116.7	152.0	114.6	140.8	84.7	73.4	164.6	154.3	68.0	151.4	81.1	74.1	76.1	136.6	91.5	106.9	83.2	133.7	112.7	113.2	130.1	109.9	77.1	81.9	145.6	101.7	90.3	309.7	135.0	121.9	99.6	70.1	69.0	73.7	75.6	110.3	508.3	83.9	1.2	124.2	56.5	101.0	63.4	203.6	78.3	74.2	298.7	170.9	355.9	292.3	268.9	78.0	294.9	52.3	121.5	85.4	50.3	27.7	72.9	170.9	74.3	212.3	275.0	123.8	92.9	136.3	564.7	227.8	87.7	224.5	229.7	472.6	103.8	525.3	145.3	126.0	168.5	131.3	149.4	102.4	271.1	85.1	488.6	75.0	20.9	91.7	73.5	155.3	235.3	375.2	1.9	11.8	1.1	103.0	38.3	147.3	13.6	107.8	148.0	95.9	112.9	75.7	92.8	179.2	99.8	88.7	106.8	7.2	142.3	143.9	208.6	90.4	169.3	132.9	136.2	141.8	190.4	132.9	135.8	139.5	135.2	140.8	136.6	133.7	145.6	140.6	96.1	167.9	129.9	110.1	171.1	193.7	516.8	234.5	261.8	301.4	376.3	424.5	231.6	373.7	242.8	75.0	940.6	169.9	35.3	602.6	229.3	72.5	775.8	108.1	166.0	272.9	95.4	115.8	198.6	823.7	165.3	116.2	199.2	109.6	80.9	261.3	256.3	309.7	195.2	105.3	131.1	435.4	186.0	206.5	60.9	187.0	148.4	257.9	58.1	403.3	320.2	198.8	66.9	159.7	107.2	52.4	167.0	211.3	85.3	36.5	852.5	900.3	134.3	144.7	102.4	233.9	26.8	52.0	260.0	149.9	555.3	109.9	232.4	121.5	173.2
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113699-81201913	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 107.4"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.6;Karpas-707: 298.5"	"Low region specificity"	"Detected in all"							"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		41000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	13.2	24.6	31.6	6.1	31.8	34.0	14.5	28.8	60.6	12.7	27.7	16.6	23.0	17.2	65.2	14.8	17.5	11.0	10.2	29.3	32.3	27.6	23.0	8.7	5.3	35.3	32.5	20.4	12.7	20.3	29.7	4.8	32.6	15.4	16.3	7.3	13.0	19.4	9.4	12.0	21.5	10.8	32.1	12.9	13.8	107.4	32.7	30.7	17.9	8.7	6.6	12.1	11.6	33.1	1.1	9.6	26.4	130.0	22.2	6.8	5.5	7.4	11.5	2.2	3.2	3.1	49.6	209.6	22.7	3.1	2.1	8.9	158.6	19.2	4.8	123.5	62.9	87.6	97.0	1.6	2.6	147.9	83.1	5.6	4.9	8.1	7.9	7.3	10.4	132.2	118.2	298.5	13.3	4.4	135.2	51.8	117.9	29.5	34.5	5.1	110.1	98.3	32.0	3.5	1.1	3.1	0.9	2.9	9.1	22.6	16.3	34.6	12.2	4.2	33.5	20.4	28.5	20.7	9.4	33.8	12.4	57.5	7.4	1.3	3.1	1.2	7.5	1.6	6.6	3.8	4.4	4.0	5.2	6.0	8.7	7.6	1.4	3.4	2.2	10.0	1.7	2.9	31.6	31.8	28.8	60.6	29.3	32.3	35.3	32.5	32.6	32.1	32.7	33.1	18.1	9.6	16.4	19.9	9.0	15.9	27.6	12.8	17.6	3.5	18.9	17.5	11.1	27.1	16.2	46.0	0.0	0.6	6.4	22.7	68.4	12.8	24.5	44.0	11.0	18.1	17.4	64.8	11.6	18.7	0.4	15.4	16.8	31.1	13.3	39.4	22.1	87.2	15.7	1.7	16.5	34.2	28.5	11.3	10.8	79.7	29.5	10.2	8.8	13.1	2.9	25.8	7.2	25.6	8.5	7.1	19.6	41.0	9.6	15.0	27.4	113.6	55.9	1.7	46.0	13.3	19.6	18.9	8.7	32.8	14.9	0.4	8.3	31.0	45.0	24.4
HMGXB4	"HMG2L1, THC211630"	ENSG00000100281	"HMG-box containing 4"	Q9UGU5	22	35257452-35295807	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000725, HPA076681"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA000725: AB_1079073, HPA076681: "	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.24e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.85e-2)"	"unprognostic (8.25e-3)"	"unprognostic (6.67e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.54e-2)"	7.9	4.7	5.1	7.8	6.5	23.4	8.1	6.5	7.2	6.7	3.7	6.6	6.4	11.6	3.7	8.6	7.6	7.0	6.5	5.3	5.8	4.1	5.1	5.6	7.5	5.9	5.3	14.0	7.0	8.2	2.2	9.0	5.8	7.4	7.4	8.5	6.7	6.2	7.2	6.7	6.7	9.5	4.9	6.3	5.0	7.9	6.1	11.3	6.7	7.2	7.7	8.6	5.3	8.2	22.6	4.9	37.6	17.6	9.3	16.4	9.9	22.3	31.6	22.1	20.1	4.3	8.9	27.5	10.2	23.3	13.4	13.0	14.9	18.3	26.2	23.3	18.6	24.6	6.5	5.3	11.2	56.8	25.1	15.8	14.0	18.5	14.2	13.3	16.8	21.0	19.7	21.6	17.1	11.0	35.1	15.1	15.7	15.6	14.2	25.3	32.5	10.7	13.8	17.5	22.1	23.0	19.6	15.6	16.5	10.6	9.6	16.1	13.3	20.1	41.9	24.1	19.5	26.1	25.5	34.8	17.1	15.9	31.7	34.5	12.5	16.9	13.4	14.8	11.7	10.4	13.1	14.3	9.8	13.3	8.4	9.6	19.0	9.6	13.8	10.8	12.1	5.9	5.1	6.5	6.5	7.2	5.3	5.8	5.9	5.3	5.8	4.9	6.1	8.2	30.6	12.8	18.5	18.3	30.9	20.9	52.3	33.3	16.5	60.6	26.0	25.1	14.4	34.3	29.7	27.6	35.5	48.0	30.1	31.5	29.4	40.4	14.7	22.2	35.5	32.4	16.9	56.6	17.7	29.3	54.5	34.8	27.5	31.9	52.1	51.9	36.8	24.1	31.8	67.3	20.5	31.9	28.5	26.4	17.6	12.7	53.7	29.1	8.8	7.5	32.1	21.0	34.0	17.1	31.5	35.3	27.4	56.8	21.2	58.1	26.4	21.0	15.6	73.5	39.5	46.4	32.9	67.0	82.9	28.0	22.6	64.7	30.4	33.1	32.3	57.8
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 515.3;Late spermatids: 2001.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	63.0	51.3	43.7	23.2	51.9	18.3	55.7	56.9	55.2	47.1	36.2	41.0	34.8	35.8	22.5	84.5	35.9	26.9	149.9	47.7	50.0	71.2	109.5	46.6	33.2	55.8	49.2	25.6	39.7	38.6	43.8	17.9	57.1	34.5	25.1	22.5	44.1	14.1	37.9	44.4	42.6	22.7	44.7	67.8	100.2	152.2	54.3	24.3	41.9	32.3	36.3	33.2	49.0	53.5	82.9	38.2	20.5	45.6	65.8	31.5	33.8	53.9	26.5	48.3	43.7	48.3	55.5	36.9	64.0	55.7	34.6	51.5	75.4	126.9	48.4	51.5	48.4	27.5	35.2	63.3	43.7	56.8	44.4	48.7	41.7	55.7	37.6	37.9	83.7	46.9	44.7	18.1	44.5	114.3	48.7	58.4	34.2	81.1	35.7	54.3	33.7	84.4	72.3	51.8	34.4	19.4	43.1	95.1	66.4	33.9	58.2	36.3	91.7	25.7	39.9	120.3	30.1	24.3	30.0	78.0	16.5	52.5	35.2	87.6	37.1	252.6	166.3	46.5	142.1	69.8	153.8	168.5	73.6	66.8	145.5	151.6	125.1	99.0	35.7	39.2	155.4	142.3	43.7	51.9	56.9	55.2	47.7	50.0	55.8	49.2	57.1	44.7	54.3	53.5	33.8	35.3	41.5	7.8	37.2	54.8	35.7	73.5	19.4	29.3	26.4	29.1	70.6	32.9	54.5	36.8	20.9	75.3	59.8	70.7	129.1	79.7	515.3	38.6	30.9	53.4	31.8	14.3	23.0	90.7	69.6	39.4	89.7	53.3	19.7	38.8	75.0	93.0	67.2	28.6	21.6	37.6	85.5	23.9	52.9	2001.6	45.4	30.6	62.2	5.6	29.3	53.9	141.1	9.5	32.9	114.9	70.7	56.1	47.1	37.7	110.8	239.3	39.9	27.8	72.3	14.6	58.0	199.7	149.8	28.2	51.6	38.4	88.3	47.4	48.9	28.7
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148136-123150672	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 2.2;kidney: 1.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Region enhanced"	"Detected in some"		"midbrain: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"REH: 38.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.3"	"CAB013268, CAB022752"	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	2.2	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.0	5.5	15.4	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.7	34.7	0.0	0.0	0.1	0.1	0.0	9.5	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	14.3	0.1	0.0	0.0	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPA1P48		ENSG00000224578	"Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48"		16	51553436-51647132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 88.9;Enteroendocrine cells: 67.5;Exocrine glandular cells: 138.9;granulocytes: 109.6;monocytes: 57.4;Pancreatic endocrine cells: 77.9;Undifferentiated cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001666, HPA005812"	Uncertain		Uncertain	Nucleoplasm		NA	NA						"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.11e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.2	32.8	0.0	32.7	0.0	0.0	0.0	0.0	0.0	25.1	16.4	12.2	0.0	22.3	1.8	0.0	0.0	14.9	19.1	11.7	88.9	0.0	7.0	12.6	13.1	67.5	0.0	0.0	138.9	0.0	13.7	0.0	8.1	109.6	13.0	0.0	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	57.4	0.0	0.0	0.0	0.0	77.9	14.3	0.0	1.6	0.0	0.0	21.1	14.6	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	20.9	8.7	66.2	0.0
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26171151-26201529	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	367.0	421.3	101.3	151.4	105.4	77.6	314.1	110.9	140.3	403.5	106.4	381.8	124.8	404.3	116.1	417.6	376.3	62.4	463.6	99.7	106.4	530.8	388.5	364.9	184.1	106.4	105.0	527.8	350.2	80.8	337.6	118.9	108.2	300.8	127.5	131.1	325.1	79.2	764.9	280.5	419.0	84.2	102.3	447.5	353.4	370.5	105.4	174.8	367.2	92.0	172.5	339.9	360.8	111.7	202.5	101.8	491.6	312.7	110.7	117.5	249.6	255.8	110.7	149.6	183.6	159.8	338.5	210.2	104.2	180.1	218.8	300.0	196.3	268.7	288.5	74.9	191.2	232.6	309.9	212.1	72.9	374.6	359.4	123.6	192.4	156.3	253.3	194.6	161.1	273.9	210.9	250.4	280.4	229.1	216.5	817.2	320.7	81.7	117.7	239.5	122.1	159.3	287.0	335.8	190.7	245.6	203.5	291.8	127.7	393.6	326.3	359.7	222.0	193.2	265.6	184.6	253.7	367.0	296.0	308.7	149.9	453.8	316.5	0.0	1.7	1.3	4.8	1.0	4.0	2.7	3.0	0.8	0.8	0.8	2.7	2.6	0.6	3.3	0.8	1.6	1.0	0.5	101.3	105.4	110.9	140.3	99.7	106.4	106.4	105.0	108.2	102.3	105.4	111.7	717.8	487.2	591.0	194.6	667.5	738.5	797.7	793.2	560.5	469.4	361.0	361.3	702.1	316.0	665.8	343.9	298.2	971.6	707.7	435.1	461.8	568.0	128.2	465.8	640.8	600.5	491.4	683.2	123.3	452.2	939.9	602.7	449.6	591.1	644.7	680.5	333.4	382.8	613.1	312.9	147.2	533.1	496.4	388.5	681.9	150.0	411.0	640.3	393.1	157.4	572.0	545.4	484.1	198.0	320.6	438.2	438.7	390.0	751.0	520.4	428.4	506.8	608.0	547.0	440.4	599.4	726.5	596.9	490.6	573.8	600.5	1082.8	701.7	652.2	541.4	632.1
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1800000	"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	162.9	119.0	101.6	210.8	104.5	235.2	144.2	107.5	114.6	183.8	98.8	185.3	129.2	180.1	178.1	244.6	164.3	75.4	118.4	93.7	124.1	193.6	144.3	175.2	232.9	111.8	103.1	208.2	141.4	130.5	137.5	158.5	106.9	141.0	194.7	181.7	138.8	118.1	136.3	179.9	152.3	164.2	103.8	174.7	143.1	175.8	108.6	308.3	176.0	93.0	304.8	153.3	189.2	108.1	657.6	432.9	934.3	469.8	248.2	221.2	717.8	489.3	235.7	382.8	358.5	885.1	337.4	1315.9	366.5	388.4	518.3	370.6	944.2	616.7	712.9	609.6	556.2	996.1	620.3	1727.6	264.8	1064.7	584.0	249.8	288.3	569.9	422.1	217.9	537.3	587.4	723.1	414.3	492.1	891.1	746.9	444.4	507.3	762.5	405.0	947.2	790.1	414.2	547.9	1227.6	545.1	484.7	729.6	228.1	316.4	700.8	325.6	652.5	582.2	476.3	540.4	338.0	719.0	387.6	759.5	1117.2	305.4	699.5	320.0	8.9	21.2	10.8	25.0	22.6	20.2	21.2	20.0	22.0	23.4	20.4	17.5	18.1	8.2	23.5	23.0	37.8	25.9	14.5	101.6	104.5	107.5	114.6	93.7	124.1	111.8	103.1	106.9	103.8	108.6	108.1	274.8	166.7	255.1	84.5	277.4	351.8	429.6	442.1	224.8	192.8	155.2	135.1	64.2	114.4	302.7	160.0	98.0	512.7	368.9	200.7	121.3	257.2	47.2	296.5	387.2	289.7	275.0	288.6	56.9	273.8	563.0	231.4	184.0	343.0	278.1	222.6	196.7	165.0	342.7	148.0	70.5	315.0	193.3	221.0	372.5	44.0	204.7	258.3	192.1	73.1	311.1	187.1	232.8	65.9	88.6	276.1	184.0	209.5	336.6	288.9	136.8	156.7	257.8	164.4	151.2	319.3	461.9	362.8	208.3	331.1	330.5	496.0	307.9	214.1	310.7	382.6
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204533-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	86.7	103.2	33.2	92.5	34.9	139.7	63.9	35.6	37.0	66.0	37.3	144.7	98.2	75.5	43.8	122.0	64.4	51.1	83.1	32.4	39.1	91.9	88.3	69.1	95.7	36.9	35.4	56.7	55.4	76.2	46.2	64.0	36.9	59.8	119.0	27.1	68.1	54.0	119.0	115.4	88.9	74.4	35.5	79.9	85.5	38.2	36.9	117.0	52.0	58.7	102.7	122.3	72.7	38.5	347.4	282.5	424.1	414.7	153.8	134.6	613.2	378.5	174.3	296.9	317.2	525.4	251.8	555.2	340.3	204.7	361.1	223.2	373.1	516.7	363.8	865.9	439.5	349.8	223.7	325.1	153.7	446.1	285.6	134.0	239.2	267.3	266.8	122.3	270.3	218.4	290.1	245.7	302.0	934.2	542.6	429.7	389.5	354.0	401.7	436.3	255.6	329.8	254.2	364.8	389.5	302.4	295.2	407.9	278.8	264.0	244.7	270.7	244.0	359.7	305.2	256.2	527.8	285.4	360.2	649.3	145.2	488.2	298.8	3.2	4.4	15.7	5.1	7.0	5.7	5.9	4.1	6.0	4.4	5.2	3.9	4.7	0.8	5.8	7.5	10.9	4.8	2.2	33.2	34.9	35.6	37.0	32.4	39.1	36.9	35.4	36.9	35.5	36.9	38.5	124.7	32.1	41.0	4.6	115.4	281.6	212.1	42.7	243.0	26.5	129.6	141.3	45.9	41.5	42.7	49.7	18.8	106.3	148.5	251.2	50.9	118.9	9.3	112.4	225.6	107.1	119.2	273.2	3.5	151.7	208.9	110.1	167.7	124.7	44.5	102.0	53.6	101.2	101.0	16.8	4.3	219.0	48.8	67.0	129.9	11.1	74.0	109.9	67.6	8.4	56.2	34.7	76.2	3.5	6.1	204.2	138.2	88.0	179.6	275.0	90.5	116.8	25.8	28.3	78.9	149.7	173.6	81.6	122.4	362.5	339.8	114.4	129.7	238.1	247.9	235.5
HNRNPC	HNRPC	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	286.9	309.2	274.1	319.5	290.1	540.3	328.5	283.9	332.6	307.8	248.8	266.7	232.3	318.9	311.9	318.3	328.5	246.4	269.5	275.3	289.2	372.9	334.4	251.8	497.7	287.2	275.4	427.3	237.7	257.8	237.7	342.0	299.0	249.6	290.9	407.3	225.9	247.9	288.2	260.1	255.2	265.9	295.2	306.5	232.3	193.7	276.6	557.8	259.2	244.0	496.0	374.6	278.6	327.1	1076.2	832.7	1277.7	748.5	754.8	704.7	910.2	673.2	764.3	1034.3	900.6	799.4	787.6	1935.6	414.1	772.1	656.8	775.6	1611.4	1035.4	1389.0	1236.1	918.1	992.8	614.2	1241.4	920.6	1495.2	762.6	731.8	854.2	756.5	1781.1	897.8	1078.4	957.7	1483.6	787.1	829.5	1020.0	1713.7	1435.2	1351.4	990.3	770.1	1375.0	1073.9	925.3	1159.7	956.9	699.0	665.5	838.5	760.9	786.4	1057.3	725.2	1332.6	783.1	388.9	698.2	473.8	972.8	708.8	1144.4	1873.6	370.6	1215.3	794.1	480.2	515.1	516.9	419.0	450.9	544.5	531.4	494.0	451.2	716.3	467.0	552.1	478.2	810.8	471.0	439.4	460.5	575.7	1220.5	274.1	290.1	283.9	332.6	275.3	289.2	287.2	275.4	299.0	295.2	276.6	327.1	172.7	153.8	233.9	69.5	307.2	536.2	583.9	512.2	331.8	169.8	259.9	191.5	137.9	173.0	393.2	275.8	198.1	612.6	309.4	134.0	283.7	315.0	169.0	365.1	352.2	257.5	224.0	389.9	74.3	216.6	746.8	287.1	197.2	555.6	415.9	281.3	174.2	233.9	388.5	116.1	79.2	276.0	260.4	293.8	500.1	76.5	270.0	325.7	208.1	99.3	341.9	157.9	227.6	97.5	112.2	210.7	151.1	230.9	293.6	531.5	135.0	370.8	381.9	296.1	151.2	285.1	282.6	391.5	249.0	315.5	539.9	874.9	339.1	311.8	318.0	590.3
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPDL	"HNRPDL, JKTBP, laAUF1, LGMD1G"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422565-82430462	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	267.9	192.7	133.9	221.1	162.3	404.9	259.1	143.9	214.8	288.6	126.4	296.5	151.4	283.6	157.2	209.6	275.4	147.3	229.0	137.8	162.8	220.1	181.2	292.4	247.8	161.6	155.2	368.8	248.8	111.9	231.2	161.5	163.9	218.2	153.2	210.6	200.3	155.8	395.5	232.4	246.1	205.0	140.4	243.2	233.4	119.5	153.1	199.1	245.4	168.8	188.5	233.3	266.4	197.4	405.2	208.8	762.2	151.9	282.0	152.2	249.8	426.5	460.4	371.3	351.5	289.2	324.8	745.8	263.5	467.3	191.2	306.5	582.9	395.3	433.5	165.3	421.1	432.9	354.2	524.9	133.0	745.8	309.1	271.1	112.3	417.2	370.3	294.6	299.6	467.5	572.4	300.4	365.7	169.3	701.6	519.6	526.6	363.9	244.4	624.1	615.1	342.2	437.2	259.4	322.5	556.0	265.6	339.6	262.3	344.7	354.3	418.2	253.4	371.2	462.1	246.3	519.7	351.6	363.7	828.3	325.4	428.8	320.2	44.5	36.8	32.3	60.4	59.6	49.9	63.3	54.0	56.7	29.1	61.4	74.6	66.0	15.3	42.9	77.8	46.8	46.0	51.3	133.9	162.3	143.9	214.8	137.8	162.8	161.6	155.2	163.9	140.4	153.1	197.4	314.7	272.4	281.3	104.8	486.6	659.0	612.1	364.2	429.6	223.4	287.0	304.9	201.0	150.2	359.4	152.6	106.3	520.8	472.3	128.1	297.4	338.3	57.7	294.3	410.9	296.7	236.0	260.7	163.9	255.8	629.2	361.5	271.7	432.2	387.7	319.8	127.1	132.7	326.5	176.7	152.9	225.5	240.1	218.2	452.0	50.7	212.5	344.3	311.3	80.6	339.0	303.9	272.9	143.7	298.8	231.5	131.1	202.8	480.6	556.8	173.0	300.2	288.2	188.3	164.3	602.9	397.0	161.8	391.4	433.0	554.2	521.0	488.0	238.7	241.1	478.6
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm		NA	Yes		2500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: AB_2686166"	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	114.6	77.7	43.3	133.9	48.6	161.3	102.9	49.8	47.9	86.8	65.2	124.5	134.2	78.3	58.9	114.9	119.4	88.9	63.7	40.2	45.9	94.4	173.2	97.6	181.4	52.4	51.4	87.3	87.5	73.1	50.5	113.6	51.5	90.8	118.9	80.4	85.2	74.8	93.6	104.5	130.7	89.1	49.2	123.5	118.0	84.0	49.4	193.3	72.7	79.6	182.8	160.0	81.8	58.3	292.1	302.9	184.2	280.7	220.5	239.5	269.1	222.5	371.0	305.6	358.2	285.5	394.7	581.8	139.2	242.0	179.3	401.7	496.8	363.6	249.5	245.6	297.2	371.2	178.6	370.9	271.4	550.5	360.9	293.2	282.4	237.6	434.6	177.1	266.4	281.3	382.0	256.2	234.2	453.4	542.5	300.5	139.5	439.1	252.4	449.0	172.7	276.8	314.9	442.7	226.1	226.8	226.6	410.4	344.3	199.2	457.4	265.3	200.4	140.1	264.4	231.8	356.8	228.5	415.8	352.6	227.1	520.0	139.7	205.5	234.9	227.2	247.0	269.2	301.0	238.9	256.6	273.3	251.8	200.7	213.8	204.0	152.2	287.9	253.6	140.6	315.8	460.5	43.3	48.6	49.8	47.9	40.2	45.9	52.4	51.4	51.5	49.2	49.4	58.3	223.8	134.6	102.8	13.4	206.9	336.0	336.5	204.9	189.5	51.4	156.8	126.4	66.3	157.3	147.9	112.2	47.9	292.9	201.7	164.7	176.1	218.6	360.1	203.8	153.3	176.6	126.8	199.6	10.8	142.2	414.8	157.0	154.9	147.0	116.1	106.9	127.5	222.3	226.0	48.8	12.0	230.1	164.8	193.3	181.7	92.7	146.0	178.5	99.6	24.4	213.0	116.9	219.4	16.6	32.7	161.4	152.1	117.8	163.3	280.8	189.7	233.1	242.0	163.6	98.6	179.7	278.1	184.5	167.3	210.2	330.5	210.4	229.9	126.3	238.8	314.0
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		7100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	283.6	308.1	186.1	326.2	197.1	637.3	265.3	202.4	236.6	264.5	227.4	270.2	287.0	297.0	227.3	276.8	269.7	243.8	275.8	188.8	220.3	279.2	346.8	240.4	401.9	203.1	187.8	317.5	247.4	350.8	198.2	325.8	203.0	251.3	277.5	342.2	242.2	251.4	315.3	256.1	282.9	287.6	205.7	298.3	250.1	183.4	194.4	548.5	297.2	312.9	423.7	351.2	230.7	241.0	926.1	624.2	1048.4	625.7	492.2	540.7	840.0	634.1	785.0	778.2	726.4	527.0	641.2	1087.2	425.8	671.1	673.8	689.5	1061.5	772.9	941.8	753.7	624.2	765.1	511.9	754.6	648.7	958.6	726.5	554.6	577.4	665.6	876.1	583.7	806.1	605.5	792.8	541.4	776.4	809.0	1198.4	652.1	934.7	929.3	599.3	1030.2	835.0	727.6	760.3	747.6	677.1	802.6	669.6	703.8	645.5	721.8	698.6	801.6	665.8	537.9	631.7	552.7	844.2	564.7	795.5	784.6	514.3	762.6	779.5	582.0	438.9	559.2	302.2	419.8	378.9	347.8	346.6	348.7	457.5	324.4	354.8	327.2	546.1	477.9	429.1	270.8	457.4	1012.5	186.1	197.1	202.4	236.6	188.8	220.3	203.1	187.8	203.0	205.7	194.4	241.0	354.7	205.1	270.0	58.4	398.4	506.0	540.7	421.5	313.0	180.9	281.6	203.3	195.0	230.2	322.4	263.0	89.6	585.3	379.9	288.1	395.2	448.2	43.4	326.2	329.0	331.7	387.0	447.9	45.9	368.3	738.5	323.4	233.9	384.2	336.8	300.0	260.9	356.6	388.4	156.5	51.2	379.2	307.2	352.9	412.9	45.4	334.6	333.4	327.3	58.1	448.9	362.5	338.8	71.9	116.2	397.0	282.7	321.2	281.0	353.3	260.0	416.7	308.1	182.6	276.1	340.9	479.7	345.9	241.7	309.5	448.7	728.5	368.6	334.9	406.9	453.2
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561969-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.0	16.4	16.3	12.5	20.7	51.7	14.7	19.3	21.3	16.2	12.9	16.1	15.5	18.2	13.9	10.2	16.7	14.1	12.8	28.6	8.3	11.1	10.8	16.4	12.5	5.9	8.1	16.9	15.9	16.8	9.2	13.1	7.2	13.9	11.8	26.6	12.8	15.0	13.8	11.4	12.7	12.8	7.8	12.0	15.7	22.6	9.3	31.0	17.7	11.9	9.6	15.2	12.8	15.8	36.7	16.9	48.2	28.4	22.9	21.6	30.1	33.8	27.5	28.8	24.1	19.0	20.7	0.5	29.5	30.4	30.9	23.0	30.7	25.4	29.6	54.6	26.8	26.7	32.3	48.6	21.6	49.9	26.4	16.9	19.6	24.0	26.5	28.5	30.6	23.9	45.9	79.7	34.3	17.2	54.9	27.2	48.4	35.2	30.6	10.6	33.9	18.1	25.0	47.2	32.9	36.9	29.8	25.8	26.0	26.7	21.8	21.6	32.0	21.5	32.1	23.8	28.1	43.4	46.9	0.3	18.5	12.2	26.8	10.6	6.3	9.7	10.3	3.2	17.9	0.4	24.2	18.9	12.0	1.9	7.2	4.6	4.2	6.8	1.2	0.2	38.5	5.8	16.3	20.7	19.3	21.3	28.6	8.3	5.9	8.1	7.2	7.8	9.3	15.8	17.0	19.2	23.4	26.8	5.5	28.7	35.2	16.5	33.0	13.3	18.0	15.2	18.8	8.6	18.8	27.6	8.4	26.2	6.4	13.9	19.6	22.4	155.6	18.1	18.8	20.1	14.4	22.5	68.6	24.3	28.9	26.0	32.1	11.6	9.5	26.3	22.5	7.4	24.4	6.7	40.1	15.4	6.1	15.0	90.2	48.7	27.7	23.1	39.2	37.5	24.5	22.3	2.1	48.7	28.4	21.2	14.2	52.3	23.0	23.6	16.6	18.6	14.5	11.7	39.5	22.6	28.4	91.1	28.8	19.4	21.3	22.2	48.0	22.3	18.8	21.4
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		470000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	51.1	47.9	18.4	48.7	21.6	56.6	49.0	26.0	22.9	55.0	22.3	44.7	33.6	66.1	25.8	54.9	52.6	29.0	40.4	18.1	22.2	43.8	27.2	47.6	58.0	20.2	19.6	61.6	34.0	42.3	33.9	50.0	21.6	35.0	43.2	40.2	46.7	31.8	55.9	51.2	46.7	44.7	20.1	41.9	38.9	31.0	19.2	71.9	43.5	27.7	60.0	48.3	50.1	26.8	161.7	103.9	200.9	123.5	70.0	73.6	103.6	102.7	118.0	178.3	123.0	73.2	113.4	202.3	52.1	141.4	88.9	89.5	211.0	143.9	208.5	142.3	161.4	192.5	131.0	121.9	68.4	224.2	125.1	74.8	86.7	141.5	113.4	73.3	112.9	153.0	185.4	139.9	119.2	98.3	268.3	71.6	111.6	105.3	103.4	196.9	186.5	144.1	96.5	88.7	137.3	132.6	141.8	116.0	88.7	109.5	98.6	102.6	121.0	102.6	133.4	123.8	129.5	81.3	149.0	276.8	71.9	200.7	117.7	21.7	35.9	44.9	49.0	47.2	51.7	41.4	45.0	47.7	45.8	41.6	48.0	45.5	12.8	53.9	48.1	30.0	58.4	46.6	18.4	21.6	26.0	22.9	18.1	22.2	20.2	19.6	21.6	20.1	19.2	26.8	112.0	118.6	109.1	29.0	132.7	127.6	207.1	139.0	95.6	127.8	89.1	78.0	72.3	84.4	138.0	88.3	43.8	253.0	125.8	60.2	92.0	126.6	22.9	110.5	183.8	129.3	116.4	150.4	28.6	126.5	274.4	135.3	92.2	146.2	172.0	171.4	61.8	73.1	106.6	126.2	32.6	107.8	138.4	77.7	92.4	17.2	120.9	98.8	83.6	36.5	147.7	159.9	112.3	63.3	60.6	125.2	64.1	116.6	144.3	208.5	59.6	76.9	114.5	111.1	85.5	159.1	170.2	170.4	148.3	136.4	129.9	206.7	136.5	157.3	116.8	182.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	110.3	111.9	123.7	76.1	132.5	177.5	100.9	131.8	139.8	101.6	122.3	93.3	65.5	103.0	121.3	99.9	106.6	62.7	92.7	122.5	123.5	129.9	105.6	80.7	98.3	125.7	127.9	134.5	99.4	109.6	88.2	96.0	127.3	92.2	84.2	126.3	86.8	79.5	116.5	91.9	94.5	76.7	129.8	103.0	95.0	90.2	127.6	141.2	103.6	61.6	115.5	97.0	86.8	144.6	308.9	242.9	311.8	249.4	160.5	136.4	307.9	215.2	138.2	193.3	171.1	234.0	198.6	481.9	195.6	183.0	185.4	235.3	424.4	244.0	304.5	204.8	280.2	417.4	203.4	360.7	168.8	482.7	242.9	156.2	143.9	211.6	220.1	169.8	200.4	296.9	553.0	174.0	264.3	221.2	517.8	497.8	545.5	227.4	217.2	510.6	392.7	261.9	314.3	222.9	260.6	257.5	339.2	220.4	280.9	226.8	305.2	531.7	244.5	192.6	283.7	207.0	384.3	283.4	332.9	458.6	156.8	403.1	282.2	23.0	14.4	20.6	18.0	12.9	19.2	22.6	22.0	22.1	15.8	21.8	25.5	21.5	20.6	19.8	15.0	31.3	21.3	10.1	123.7	132.5	131.8	139.8	122.5	123.5	125.7	127.9	127.3	129.8	127.6	144.6	269.6	326.9	375.8	67.9	271.9	271.2	416.4	137.1	277.2	149.5	254.3	166.5	186.8	118.7	281.4	193.1	183.5	202.2	323.4	163.7	97.8	215.5	389.9	283.4	530.1	248.6	198.1	269.4	61.8	180.9	259.5	267.1	202.9	429.8	363.6	375.3	133.2	121.9	184.5	141.3	65.2	208.0	109.9	223.7	268.6	481.9	153.7	402.7	122.7	45.9	251.4	151.4	228.6	67.8	107.7	188.9	141.8	142.6	331.6	215.8	141.4	133.2	240.1	213.7	144.7	317.0	364.3	194.9	162.7	292.7	239.2	252.7	310.6	379.9	234.6	288.1
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307787	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	85.7	65.9	53.2	89.1	62.4	176.2	75.0	64.3	63.8	78.0	58.9	85.7	81.3	85.0	49.1	81.4	82.8	58.0	75.7	52.9	58.9	48.3	52.5	75.0	102.4	63.9	56.3	116.3	71.7	64.7	58.3	48.8	60.6	59.6	73.1	91.2	84.7	66.7	92.7	93.2	78.7	79.0	53.1	86.4	73.5	79.8	56.1	140.0	69.9	75.6	109.6	75.2	72.1	66.0	284.3	371.2	216.5	200.4	104.3	124.0	82.2	163.1	194.1	207.1	187.8	218.7	213.2	250.1	112.3	206.4	116.8	91.2	208.1	191.3	234.6	248.5	172.9	272.9	168.8	170.4	121.0	259.5	244.3	132.9	116.8	185.8	171.6	186.5	195.7	187.1	203.1	233.8	185.9	217.0	341.0	151.8	165.0	270.8	126.7	219.0	171.6	142.3	149.0	298.8	171.2	154.2	363.3	212.6	95.4	147.7	163.7	290.2	188.4	231.6	218.6	105.4	318.3	264.3	184.5	238.4	147.5	210.8	311.6	13.2	6.2	11.0	11.9	6.7	18.1	8.8	14.4	12.4	7.3	9.0	9.9	7.9	13.5	12.6	7.9	13.7	10.9	5.7	53.2	62.4	64.3	63.8	52.9	58.9	63.9	56.3	60.6	53.1	56.1	66.0	57.0	80.1	69.6	14.7	105.4	56.2	42.9	35.9	71.7	63.2	69.0	58.5	64.1	52.9	36.1	31.3	73.0	50.1	151.9	51.4	45.0	65.1	51.6	52.7	76.8	57.7	76.7	129.4	13.9	62.2	58.8	67.7	55.5	54.2	58.9	78.8	60.3	43.0	63.6	48.8	16.2	66.4	30.5	102.4	76.5	73.9	86.3	92.3	35.6	16.9	81.1	70.8	93.7	21.6	22.2	68.6	39.4	71.5	152.2	48.6	49.5	29.5	49.9	97.3	78.9	74.7	70.3	113.6	108.9	99.1	60.2	53.4	134.2	60.3	73.6	43.6
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm		NA	NA		88000	"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891"	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	30.4	20.9	44.3	28.6	45.4	27.3	26.2	47.3	52.3	28.7	37.2	40.5	29.0	32.5	36.3	37.2	29.1	17.1	33.1	45.0	43.1	26.8	21.1	25.8	35.1	42.3	43.8	26.5	32.5	24.7	20.9	25.1	43.0	26.6	28.0	37.5	30.6	30.2	48.6	39.8	35.2	28.3	42.4	34.1	31.3	16.7	45.5	47.4	24.3	35.9	37.6	34.2	28.2	44.2	110.9	49.8	83.5	50.3	45.1	55.3	14.4	70.2	41.5	52.1	40.2	34.4	37.5	129.1	36.5	57.9	45.0	62.2	51.2	66.3	69.1	59.1	27.8	123.0	64.9	39.1	41.2	127.8	78.1	43.8	50.7	50.2	61.4	41.0	64.8	33.5	46.6	47.8	61.0	63.5	128.1	114.1	39.8	41.4	42.9	88.6	77.0	62.3	65.4	65.2	48.4	56.3	71.7	57.8	75.3	39.3	43.5	55.6	72.8	61.0	28.2	77.4	74.4	60.8	54.3	124.6	55.3	62.1	57.5	1.1	0.8	1.3	1.4	0.6	1.0	1.0	1.0	1.2	0.5	1.3	0.8	0.9	1.0	0.8	1.4	1.4	1.0	0.5	44.3	45.4	47.3	52.3	45.0	43.1	42.3	43.8	43.0	42.4	45.5	44.2	21.1	28.9	12.1	0.0	19.0	29.4	15.0	20.2	13.6	31.3	25.0	18.7	43.8	30.0	17.5	53.3	10.4	27.9	32.4	68.8	5.9	27.4	9.9	20.8	26.3	30.6	38.4	23.5	0.0	36.0	26.9	23.0	19.4	29.7	15.2	28.0	37.5	40.7	37.9	42.1	0.0	48.3	22.4	54.1	29.4	6.9	42.0	27.6	14.2	0.0	38.0	18.2	24.7	0.0	0.0	35.0	42.7	45.9	12.5	24.1	59.6	25.6	16.1	19.7	32.9	22.8	27.5	15.6	20.1	19.6	32.1	25.2	19.8	20.6	58.6	17.4
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.8;liver: 54.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039466	Approved					NA	NA		16000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	4.1	8.3	5.8	0.2	7.4	0.4	1.9	9.3	5.0	0.7	11.4	0.2	0.3	1.1	3.7	1.0	2.0	2.5	21.1	4.4	6.5	51.8	54.8	1.4	0.3	8.2	9.2	0.2	15.3	5.7	3.6	0.1	8.3	1.1	0.1	0.8	1.7	2.1	3.4	1.5	0.3	0.5	7.3	0.4	0.2	0.9	7.9	0.3	1.8	12.1	0.2	0.4	0.9	10.3	0.3	3.7	0.1	7.8	1.5	0.3	0.1	0.1	0.2	0.0	0.0	3.0	0.2	0.3	9.7	0.2	0.5	2.6	0.0	0.2	0.1	0.1	4.0	0.1	1.4	26.1	1.1	0.2	0.1	0.3	0.7	0.1	0.1	1.9	0.4	0.1	0.0	0.4	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.1	0.6	0.4	31.5	0.6	0.6	1.0	0.1	1.3	0.5	0.2	2.8	0.0	0.2	0.8	0.2	0.3	0.2	0.5	0.9	0.1	2.0	0.1	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.2	0.2	1.0	0.2	0.2	0.3	0.2	0.1	5.8	7.4	9.3	5.0	4.4	6.5	8.2	9.2	8.3	7.3	7.9	10.3	0.0	0.0	0.0	7.2	1.5	0.1	0.7	0.5	1.8	0.4	0.1	0.4	6.0	35.8	0.2	9.2	0.0	0.1	0.0	0.1	29.4	5.9	3.8	1.8	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.5	0.0	0.1	0.4	43.3	0.1	1.7	1.2	0.0	0.0	1.3	0.0	18.4	0.0	0.8	1.8	1.0	0.0	2.0	0.0	1.5	12.3	0.5	0.1	0.0	0.0	0.1	0.0	98.0	3.2	0.3	0.0	4.5	0.9	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.2
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffold protein 1"	Q86YM7	5	79372636-79514134	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;skeletal muscle: 34.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 440.0;Inhibitory neurons: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	2.8	1.3	2.1	2.3	14.0	0.3	2.5	10.6	27.6	3.9	0.0	1.2	0.7	6.7	4.1	4.6	1.7	6.8	20.5	17.9	5.6	5.8	1.7	5.1	1.1	0.0	3.3	3.8	2.2	4.1	2.3	5.4	2.2	1.7	1.0	5.8	1.2	1.7	34.0	2.4	0.8	4.7	0.6	0.8	2.0	5.3	7.4	1.3	15.0	12.9	1.4	8.0	1.7	15.1	14.6	9.8	14.5	23.1	5.4	3.6	33.5	9.0	7.2	9.0	9.6	15.5	9.9	0.2	26.9	7.8	16.2	7.7	18.2	24.5	15.4	2.2	14.3	17.3	3.9	15.7	8.8	8.3	5.4	5.8	15.4	8.1	22.4	3.6	4.3	26.4	21.7	9.3	11.7	20.4	34.8	5.7	24.5	5.2	8.4	22.4	23.8	22.2	9.6	22.3	14.7	8.8	17.2	12.0	9.3	16.0	16.5	7.2	0.7	6.6	16.7	8.0	16.1	4.5	10.8	8.5	18.8	3.3	13.0	0.0	0.0	0.0	0.4	0.0	0.2	0.4	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.1	14.0	10.6	27.6	17.9	5.6	0.0	3.3	2.2	0.6	7.4	15.1	4.3	51.3	9.6	21.9	12.1	64.2	28.0	8.5	20.5	24.4	25.6	18.2	95.2	7.2	12.1	16.5	27.1	58.4	20.3	4.3	11.7	4.8	4.7	30.6	24.9	9.5	11.4	0.4	440.0	4.3	44.8	19.3	5.6	39.9	5.7	16.9	4.6	6.9	11.9	52.2	112.1	7.5	10.2	9.6	29.7	5.5	5.6	13.9	21.4	31.9	3.0	4.4	8.2	86.0	19.3	5.5	2.7	8.6	8.9	23.3	3.1	7.0	10.8	8.1	13.1	29.7	19.3	6.9	10.3	23.9	54.8	84.4	9.8	10.2	3.0	25.2
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffold protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 226.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	1.5	6.3	6.5	1.1	7.6	4.6	26.9	8.2	12.8	23.1	69.8	3.2	8.5	8.4	33.7	21.2	25.9	12.8	21.9	16.2	7.8	7.2	46.4	5.3	1.3	5.7	4.6	2.6	226.2	5.1	7.7	0.6	5.7	57.7	1.0	6.4	71.2	4.6	108.7	45.0	1.3	1.4	4.1	4.8	55.4	6.1	6.0	3.0	28.9	55.9	3.6	1.3	11.7	8.0	16.6	6.9	7.2	18.9	0.2	0.1	1.1	1.1	0.0	1.7	0.6	1.2	11.5	0.1	8.8	8.4	8.3	9.1	52.7	24.9	1.2	45.1	33.5	10.6	0.4	8.3	0.7	0.4	32.6	1.8	37.4	0.6	2.1	1.9	0.0	20.6	0.4	92.6	7.0	48.4	3.2	1.1	11.4	1.4	5.1	2.2	11.5	5.5	25.3	20.1	50.8	13.1	18.6	14.1	17.6	5.2	17.1	3.5	0.2	17.2	31.7	1.3	15.3	11.8	5.9	1.8	29.0	0.4	6.4	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.3	0.1	0.0	0.4	0.0	0.0	0.5	0.2	0.3	6.5	7.6	8.2	12.8	16.2	7.8	5.7	4.6	5.7	4.1	6.0	8.0	1.9	16.0	10.1	24.8	3.8	4.6	56.1	7.2	10.2	15.0	39.7	20.4	23.0	215.9	14.6	11.0	18.8	1.1	4.4	0.3	7.9	29.6	1.9	184.4	15.4	12.4	3.0	8.2	24.8	76.5	0.4	3.6	14.3	151.9	0.0	11.9	1.4	59.6	13.3	20.2	35.1	0.4	0.0	3.2	73.9	4.0	1.8	9.2	37.4	7.5	7.9	18.5	1.0	6.6	11.8	25.9	0.1	0.7	4.1	81.5	0.7	12.1	4.0	5.1	0.0	7.8	4.8	5.5	16.6	19.4	6.0	0.7	3.1	4.1	0.4	30.5
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffold protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 125.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 76.4;Muller glia cells: 72.6;Proximal tubular cells: 84.2;Theca cells: 322.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 353.6;THP-1: 420.0;U-266/84: 375.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 189.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	33.1	29.6	33.3	9.9	41.9	22.3	26.2	76.9	44.6	31.7	41.1	27.0	7.0	24.6	6.4	15.3	16.7	16.5	25.0	40.4	35.1	52.2	6.1	25.6	7.9	42.3	40.9	20.1	12.4	37.5	8.6	14.7	42.8	21.9	6.0	5.9	27.6	9.4	114.5	35.4	14.4	10.6	39.4	125.1	17.0	9.2	41.6	7.4	49.3	18.6	3.8	29.7	26.0	45.5	112.1	28.5	53.1	44.4	48.3	48.6	26.2	108.1	94.9	106.4	53.4	14.6	41.8	0.9	49.9	122.1	76.1	68.6	18.4	140.4	58.9	4.0	11.0	0.1	9.7	27.5	44.9	21.5	1.7	39.3	89.4	59.0	79.1	113.0	130.3	7.9	3.2	28.6	78.1	30.3	1.9	353.6	27.3	6.1	115.5	55.2	16.2	53.4	38.2	28.3	0.2	44.8	26.6	31.2	78.5	10.2	14.0	420.0	105.3	94.0	42.0	114.5	132.2	274.2	375.4	93.6	148.0	270.6	69.8	0.1	15.0	2.9	0.1	5.3	0.0	2.3	0.8	0.3	1.3	2.7	0.1	0.0	5.8	0.0	1.6	0.2	0.8	4.2	33.3	41.9	76.9	44.6	40.4	35.1	42.3	40.9	42.8	39.4	41.6	45.5	21.7	3.2	0.0	9.4	9.3	11.9	22.4	24.4	6.8	2.2	14.3	22.5	4.1	2.8	8.0	12.9	0.0	1.0	0.6	0.1	11.7	22.9	2.0	4.3	18.7	38.0	1.8	0.4	0.3	13.6	2.4	20.5	0.0	6.3	10.2	34.8	21.8	0.7	76.4	1.7	3.9	0.9	22.4	16.2	7.6	1.7	13.7	32.2	12.4	1.9	8.3	72.6	0.0	1.0	13.4	42.0	0.0	10.9	13.8	25.2	0.0	84.2	3.6	4.1	0.0	14.4	27.8	4.7	6.7	4.2	14.5	1.1	2.5	322.4	0.3	21.4
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HOOK1	HK1	ENSG00000134709	"Hook microtubule tethering protein 1"	Q9UJC3	1	59814786-59876322	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 611.0;Late spermatids: 942.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 35.4;OE19: 24.4;RPTEC TERT1: 32.9;SK-BR-3: 32.1"	"Low region specificity"	"Detected in all"							"HPA018537, HPA018820"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA018537: AB_1850907, HPA018820: AB_1850910"	"unprognostic (9.82e-3)"	"unprognostic (4.29e-1)"	"prognostic favorable (4.53e-6)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.79e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-1)"	0.9	5.4	3.6	3.3	4.3	3.6	11.3	6.8	5.2	4.7	6.1	15.4	12.0	2.0	5.7	13.4	6.9	3.8	2.2	4.3	2.0	16.0	30.9	3.7	2.8	0.6	1.3	0.5	18.4	28.0	8.6	2.3	0.7	6.2	13.5	52.8	17.8	4.9	0.2	11.0	15.9	0.5	0.3	1.4	10.5	16.5	2.7	2.3	13.7	0.0	4.7	3.3	5.5	2.7	17.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	14.4	0.1	35.4	0.0	0.1	9.5	3.6	7.3	0.0	0.5	16.0	0.3	4.8	17.7	0.0	0.1	3.7	0.0	15.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	7.1	0.0	0.0	13.6	24.4	6.5	0.0	0.0	18.5	32.9	17.3	13.6	5.6	0.2	32.1	0.4	13.8	19.1	0.3	0.0	0.0	0.1	0.0	0.0	21.9	17.4	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	1.7	1.1	1.8	0.4	0.0	2.2	6.6	2.0	0.0	1.8	0.0	0.0	0.3	0.7	3.6	4.3	6.8	5.2	4.3	2.0	0.6	1.3	0.7	0.3	2.7	2.7	0.2	16.0	29.9	3.9	10.4	39.6	18.1	17.0	51.8	134.4	30.9	16.8	19.0	32.9	51.3	20.2	79.2	21.9	4.6	42.5	31.3	28.2	611.0	46.9	6.7	1.7	36.5	5.9	51.5	34.4	3.0	5.4	25.5	93.6	0.0	10.0	1.1	56.1	1.6	79.1	46.2	36.0	22.4	0.6	1.8	942.1	5.0	1.9	16.0	4.7	0.7	154.4	1.0	2.0	2.6	18.7	41.0	3.4	14.0	24.7	52.7	59.9	50.4	100.3	0.0	2.5	2.2	33.2	9.3	45.4	49.7	35.8	6.8	0.0	51.0	19.7
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 291.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.7;RT4: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Vesicles, Cytosol"		"HPA043519: AB_2678525, HPA050351: AB_2681102"	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (7.59e-5)"	"prognostic favorable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	40.0	20.6	15.8	10.3	15.1	4.1	45.8	15.5	21.0	31.4	14.3	35.8	52.0	15.1	46.8	55.5	27.0	20.9	63.3	14.8	15.2	54.9	46.8	24.0	7.1	15.3	14.3	24.9	98.1	38.4	113.8	14.2	15.5	53.1	25.0	13.4	59.3	26.8	70.7	56.2	43.1	10.7	12.7	18.0	41.8	24.7	14.8	7.5	96.2	34.0	13.3	25.1	39.3	15.5	38.5	9.7	11.3	8.0	12.5	11.5	40.5	11.9	5.6	6.5	8.3	33.3	44.2	7.5	20.8	11.5	5.7	48.6	12.0	34.3	6.8	19.7	8.8	7.5	21.1	11.0	5.9	4.2	10.2	14.0	32.4	8.3	13.4	15.0	3.9	14.6	12.6	5.7	13.6	83.7	4.3	7.8	4.8	24.9	10.2	12.1	7.1	18.6	13.4	100.5	28.1	14.5	8.7	25.7	7.3	11.5	35.3	9.1	7.2	12.6	8.5	19.7	4.2	20.6	23.9	4.5	13.4	14.2	9.3	0.2	0.8	0.0	1.4	1.3	0.9	1.7	1.8	0.6	1.3	1.2	3.0	1.9	1.0	1.3	0.8	0.6	0.4	1.1	15.8	15.1	15.5	21.0	14.8	15.2	15.3	14.3	15.5	12.7	14.8	15.5	14.8	19.2	38.0	25.1	34.4	50.5	99.8	135.0	158.8	117.7	84.4	62.9	29.6	75.8	84.5	82.8	100.1	85.0	11.9	137.2	43.0	77.5	9.2	26.2	21.0	18.6	63.0	11.1	28.9	45.4	40.2	24.2	140.2	39.3	12.6	30.7	22.1	24.4	16.6	63.9	43.3	93.9	118.0	11.1	21.6	9.1	27.1	20.4	28.4	6.5	19.7	26.6	10.3	17.1	10.6	46.7	98.0	26.7	30.1	131.6	291.7	45.4	49.3	84.5	13.1	24.5	25.4	73.9	26.1	82.1	65.5	128.1	27.9	42.1	95.6	87.1
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896946-43030535	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	9.8	6.2	3.1	7.4	8.7	11.1	8.9	11.9	8.9	8.2	1.5	7.5	7.5	8.3	8.2	10.6	7.0	14.4	4.6	4.0	11.1	6.6	7.3	8.0	6.6	7.6	4.9	6.1	7.6	7.2	4.1	8.6	7.3	12.4	7.7	8.8	9.6	7.1	10.6	8.1	8.9	6.7	4.4	6.6	9.5	11.4	4.9	6.4	21.7	8.2	7.4	9.3	6.0	15.5	11.2	10.9	26.2	14.2	19.0	16.7	10.1	14.0	11.6	11.5	10.7	14.5	12.8	13.9	13.9	18.8	10.9	6.4	22.1	9.5	18.5	9.5	6.4	26.3	9.2	10.2	10.6	2.8	14.9	13.7	6.6	15.4	13.2	15.9	16.7	9.7	14.7	15.9	14.0	2.7	21.7	5.2	9.5	8.8	3.3	12.6	27.3	3.5	8.6	16.5	6.7	10.6	15.9	6.7	7.4	11.4	12.2	9.4	30.2	17.1	13.2	20.9	9.0	15.6	18.6	18.1	14.5	9.9	25.8	9.4	2.0	2.0	1.2	2.0	0.4	0.9	1.1	0.9	2.4	0.9	0.6	0.8	2.2	1.2	1.9	1.4	0.8	1.1	3.1	8.7	11.9	8.9	4.0	11.1	7.6	4.9	7.3	4.4	4.9	15.5	75.3	93.0	60.6	90.1	43.2	68.3	36.2	28.7	43.3	40.1	29.4	22.4	48.2	44.3	43.6	25.8	33.3	43.6	40.6	26.1	27.4	47.1	120.3	60.0	84.0	65.2	65.4	34.5	102.1	32.8	25.9	65.8	33.1	93.8	53.8	37.9	60.3	36.4	38.0	75.7	107.6	26.9	20.3	79.4	96.4	36.3	44.7	82.8	55.2	78.7	118.6	36.3	37.0	119.1	157.8	59.7	27.6	53.8	43.6	43.5	37.3	21.4	35.2	32.2	65.7	63.4	74.6	28.0	21.5	39.8	74.7	113.7	40.9	42.6	16.2	71.1
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 117.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.2	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.0	0.9	0.1	117.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HORMAD2	"CT46.2, MGC26710"	ENSG00000176635	"HORMA domain containing 2"	Q8N7B1	22	30080464-30177075	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 52.8;Spermatocytes: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003074, HPA043880"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA003074: AB_1850916, HPA043880: "					"unprognostic (1.43e-1)"		"unprognostic (6.77e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.36e-2)"			"unprognostic (8.19e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"		0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.9	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.2	0.0	133.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 27.9;Endometrial stromal cells: 17.9;Intestinal goblet cells: 15.8;Proximal tubular cells: 13.2;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 10.5;pons: 7.8;spinal cord: 9.4;white matter: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.2;CACO-2: 25.2;CAPAN-2: 66.5;HEK 293: 29.7;WM-115: 35.5"	"Region enriched"	"Detected in single"	30	"pons and medulla: 3.0"	"Region enhanced"	"Detected in some"		"medulla oblongata: 3.9;spinal cord: 3.1"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	7.1	3.2	0.0	2.3	0.0	0.3	7.3	0.0	0.0	5.3	0.0	12.2	3.9	8.5	6.4	8.2	18.4	2.9	0.6	0.0	0.0	12.9	0.7	6.0	1.4	10.5	0.6	3.0	0.7	3.8	0.0	0.1	7.8	6.5	4.6	0.0	0.2	2.3	7.6	4.9	9.5	3.4	9.4	2.3	6.6	2.8	0.1	1.6	2.2	3.1	0.2	8.9	3.7	7.1	11.9	13.7	0.0	38.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	25.2	66.5	1.8	18.7	1.0	5.2	15.9	0.7	1.7	0.0	0.5	29.7	0.5	0.4	20.6	1.3	0.7	0.7	2.4	0.1	3.1	3.6	0.0	3.6	1.7	1.3	0.2	1.5	0.6	0.0	1.0	0.0	3.3	8.6	14.1	4.4	0.0	11.4	5.4	5.6	0.0	2.1	0.0	5.8	0.5	1.1	0.8	16.5	0.0	2.0	3.9	3.1	0.0	0.0	0.6	1.2	2.6	35.5	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.6	7.8	9.4	0.1	7.1	6.2	0.0	0.0	0.0	0.2	1.1	3.8	0.0	27.9	0.0	5.7	6.1	1.0	0.0	0.0	3.7	0.0	0.0	0.7	6.2	5.9	0.1	8.1	2.0	17.9	5.8	4.2	1.7	0.0	0.0	0.0	6.8	0.0	0.5	1.3	0.2	9.3	0.3	0.1	0.0	0.0	15.8	0.0	0.3	0.7	9.1	0.6	1.3	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.3	0.0	0.0	2.4	5.5	13.2	0.0	0.0	0.0	2.9	9.2	2.2	1.4	11.8	1.3	0.0	1.2	0.1	16.6	4.5
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 5.2;Distal enterocytes: 7.5;Distal tubular cells: 5.9;Endometrial stromal cells: 14.8;Enteroendocrine cells: 9.0;Smooth muscle cells: 6.2;Undifferentiated cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	"Immune cell enhanced"	"Detected in single"		"basophil: 3.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.1"	"Group enriched"	"Detected in many"	9	"AN3-CA: 61.7;HEK 293: 84.4"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.3"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.0	2.7	0.1	1.4	0.1	0.2	2.4	0.0	0.2	2.5	0.0	6.6	0.2	5.4	3.7	0.3	10.0	0.2	0.0	0.1	0.0	4.5	0.0	2.1	1.1	7.1	0.0	0.2	0.0	0.3	0.0	0.1	1.8	2.5	1.5	0.0	0.1	1.9	1.2	2.9	4.2	1.4	7.7	0.2	1.3	0.0	0.0	0.1	0.2	0.0	0.0	3.0	1.4	5.4	1.2	2.1	0.1	61.7	0.1	0.0	0.2	0.5	0.6	0.4	0.6	1.5	7.2	1.5	2.3	0.5	0.2	2.8	1.5	0.0	0.0	1.9	84.4	1.0	1.2	0.8	0.0	1.3	2.1	4.9	0.1	0.0	0.8	0.1	2.9	2.0	0.4	0.0	0.7	0.8	0.1	0.3	0.1	0.4	2.1	8.4	0.0	0.0	5.9	3.9	6.4	0.0	2.9	0.3	1.3	0.0	0.8	0.8	0.0	0.1	0.9	3.3	2.3	0.0	0.0	1.4	0.0	6.2	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	7.1	0.0	1.8	7.7	0.0	5.4	2.1	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0	0.0	4.0	5.2	0.0	0.0	0.0	1.8	0.0	0.0	0.5	7.5	5.9	0.0	0.0	0.6	14.8	1.9	9.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	1.0	3.4	1.3	0.1	0.0	0.0	3.7	6.2	0.0	0.0	0.3	0.4	0.0	0.4	0.1	8.0	1.4
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531011	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044576	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48728750	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 41.1;prostate: 82.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 144.7;Enteroendocrine cells: 195.2;Intestinal goblet cells: 77.0;Paneth cells: 71.3;Prostatic glandular cells: 61.9;Undifferentiated cells: 81.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"PC-3: 173.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	82.3	41.1	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	4.6	0.0	1.9	6.0	0.0	13.2	0.0	0.0	0.5	0.6	0.0	0.2	0.0	2.5	3.0	0.0	3.0	0.0	1.4	0.0	8.7	0.0	0.1	1.0	4.2	2.5	1.5	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.7	0.0	0.0	0.3	0.0	2.2	173.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	2.7	0.0	4.4	0.5	0.0	0.5	0.0	0.5	4.7	4.7	1.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	144.7	0.0	0.0	0.6	0.0	0.0	0.2	195.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	77.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.1	0.2	0.1	81.6	14.6
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 70.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"medulla oblongata: 28.3;pons: 13.0;spinal cord: 24.5;white matter: 13.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2"	"Region enriched"	"Detected in single"	39	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	22	"medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	22.7	11.3	0.2	7.8	0.1	1.8	19.3	0.2	0.2	23.3	0.3	43.6	6.5	13.6	70.5	13.5	38.5	7.6	5.2	0.3	0.1	38.7	4.1	12.6	4.8	28.3	1.0	1.6	4.8	20.0	0.2	4.2	13.0	9.3	11.8	0.0	0.6	25.4	10.6	7.7	27.5	9.4	24.5	15.7	17.7	10.3	0.4	1.3	4.8	8.2	1.2	11.3	10.2	13.6	6.6	13.9	10.1	4.6	8.7	12.1	2.5	0.2	0.0	0.2	0.2	6.2	43.9	3.5	34.0	30.1	4.4	0.3	2.0	0.7	0.1	10.6	47.4	10.9	7.0	0.0	13.4	0.0	27.3	12.3	0.0	13.3	0.7	6.5	13.8	13.2	14.8	0.4	8.4	0.2	0.7	0.3	0.2	14.3	1.3	0.0	7.0	1.4	35.0	6.7	0.0	0.1	1.5	0.0	7.8	7.5	13.9	3.0	15.1	4.5	13.6	2.5	38.2	3.5	4.5	0.4	9.5	0.0	8.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.6	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.1	28.3	1.0	13.0	24.5	0.4	13.6	26.6	0.0	1.9	0.0	0.5	2.5	3.0	0.0	11.4	0.0	5.9	2.7	1.8	1.5	0.7	99.3	0.0	3.2	2.0	11.4	7.9	0.2	37.9	25.6	4.3	13.6	2.4	0.8	0.0	0.0	0.8	8.1	0.0	35.0	8.8	0.0	25.0	0.4	0.7	0.0	0.0	7.5	0.0	1.6	4.2	12.9	0.3	0.8	5.4	0.0	0.3	0.0	6.2	0.0	0.0	0.4	7.7	0.4	0.4	3.2	7.6	0.9	0.0	0.0	0.0	4.8	6.2	6.1	11.7	13.9	1.4	0.4	2.0	0.0	9.5	7.0
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575507-48578350	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Collecting duct cells: 64.4;Glandular and luminal cells: 25.1;Hepatic stellate cells: 24.3;NK-cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"medulla oblongata: 11.3;pons: 4.6;spinal cord: 9.1;white matter: 5.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 63.7;HMC-1: 37.5;K-562: 33.7"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	13	"medulla oblongata: 3.7;spinal cord: 4.7"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	6.9	3.1	0.1	3.7	0.0	0.7	3.5	0.0	0.1	6.8	0.1	9.8	2.6	3.4	19.6	3.4	12.8	3.3	1.0	0.0	0.0	8.7	1.1	4.6	2.3	11.3	0.2	0.3	1.2	4.4	0.0	2.6	4.6	1.0	2.4	0.0	0.3	7.6	2.6	2.5	5.1	4.3	9.1	4.4	4.3	1.2	0.2	1.9	1.0	3.9	1.4	2.9	2.2	5.8	0.3	0.5	0.0	0.2	12.2	9.2	5.2	0.0	0.0	0.8	0.4	6.2	3.1	9.2	63.7	3.3	0.7	0.3	11.8	0.0	0.2	23.3	21.5	21.9	1.6	0.0	12.5	0.0	37.5	10.0	0.0	14.9	0.0	1.2	18.4	14.6	33.7	0.6	15.1	0.0	5.5	0.2	0.0	5.8	0.0	0.0	12.3	4.5	12.5	5.4	0.0	0.0	1.7	0.0	8.7	4.2	0.5	4.3	6.0	0.4	0.5	2.2	0.4	5.0	11.9	2.1	4.3	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.3	0.2	4.6	9.1	0.2	5.8	19.9	0.0	0.0	0.0	3.0	3.8	1.3	0.0	28.5	0.0	2.7	1.7	0.9	0.0	0.0	64.4	0.0	23.5	18.4	1.0	11.7	0.2	0.2	18.5	2.7	19.0	0.0	5.0	0.0	0.0	13.1	8.2	0.5	25.1	3.8	0.0	24.3	0.2	4.0	0.0	0.0	2.3	0.0	2.8	4.4	0.2	0.3	2.1	5.4	0.0	1.3	0.0	38.1	0.0	0.0	0.0	1.9	0.0	6.6	0.5	1.0	2.0	0.7	0.0	0.0	5.9	6.4	6.0	23.2	15.5	1.8	6.0	9.9	0.1	1.8	3.1
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 113.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 20.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	319	"spinal cord: 31.8"	HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	13.1	1.1	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.2	0.0	1.5	0.0	0.1	8.8	0.0	0.0	0.0	0.0	22.5	0.0	0.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.5	113.5	16.4	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.1	0.7	3.3	0.0	291.5	82.5	75.6	0.5	10.1	24.4	13.6	12.6	0.6	0.9	0.5	2.7	67.6	1.9	31.4	4.1	0.0	6.5	15.2	5.6	3.0	36.2	0.0	0.4	0.0	3.7	36.0	0.5	1.0	0.0	0.0	0.1	8.5	2.3	0.0	9.4	1.8	0.1	7.5	0.1	36.4	1.1	0.0	0.4	0.0	30.6	0.0	0.0	3.9	6.9	10.0	15.7	0.4	99.4	2.2	0.0	8.0	10.2	0.2	13.3	1.3	0.2	0.1	0.1	1.7	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	21.2	0.0	0.0	0.0	0.0	4.8	7.9	0.3	0.0	0.0	16.5	0.0	0.0	0.1	0.0	62.6	0.0	0.2	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.6	0.9	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	100.4	0.0	0.0	0.0	22.4	5.2	3.6	4.4	0.0	19.2	0.1	0.4	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954903-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 1.2;brain: 1.1;skin 1: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8;stomach cancer: 2.0"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 23.4;OE19: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXC13	"HOX3, HOX3G"	ENSG00000123364	"Homeobox C13"	P31276	12	53938831-53946544	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"skin 1: 9.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.7;Breast myoepithelial cells: 3.0;Spermatogonia: 1.2;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 31.2;HaCaT: 66.1;SK-BR-3: 36.0;T-47d: 28.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051634	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA051634: AB_2616459"	"unprognostic (5.16e-3)"	"unprognostic (1.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.78e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.74e-9)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.68e-1)"	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.7	10.5	0.0	31.2	0.5	0.0	18.4	1.9	4.4	2.8	1.5	2.7	0.5	0.0	0.4	0.0	2.0	66.1	8.0	2.1	1.6	0.0	6.4	0.0	8.4	0.0	0.0	0.0	6.6	0.0	15.4	0.0	6.0	0.0	0.0	0.1	11.8	0.0	11.5	20.1	0.0	0.0	0.3	6.6	2.7	0.0	0.4	0.0	0.0	6.0	0.0	0.0	10.4	36.0	4.9	7.4	28.1	0.1	0.0	0.1	13.1	0.2	4.2	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.7	3.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54033050-54035361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;fallopian tube: 4.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Group enriched"	"Detected in many"	15	"medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.6"	"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.5;spinal cord: 2.1"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.0	0.9	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	2.7	0.9	4.1	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.2	3.4	0.1	2.6	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.2	1.2	1.1	0.7	1.5	1.9	0.0	2.1	1.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.8	1.9	0.0	7.1	4.0	4.8	0.0	0.4	0.3	0.8	0.6	3.0	0.4	0.0	0.5	2.1	0.0	1.1	0.1	0.0	0.3	2.4	2.4	0.0	1.0	0.1	0.1	0.0	0.1	4.5	0.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	7.6	0.5	0.2	3.9	0.9	1.4	0.0	0.0	1.2	0.7	2.6	0.2	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	3.6	1.9	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.2	0.0	0.3	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.8	0.0	1.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	2.5	3.2	1.0	2.2	0.9	0.3	0.1	1.0	0.1	0.0
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54008985-54012769	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;skeletal muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"spinal cord: 10.5"	"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.2	0.0	0.7	0.0	0.0	5.6	0.0	0.0	0.4	0.0	0.4	0.0	0.4	15.4	0.2	7.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.1	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.3	0.0	0.1	16.8	3.1	5.7	7.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	1.0	2.7	0.0	15.0	41.6	27.6	0.2	2.8	0.1	4.9	3.1	4.4	2.4	0.0	0.3	49.8	0.8	2.0	3.9	1.2	5.4	5.3	5.3	0.9	2.1	0.0	4.9	0.0	5.8	33.2	3.9	15.7	9.0	0.5	0.4	0.8	0.6	0.0	38.7	1.2	0.0	0.4	0.0	0.3	0.7	0.0	0.0	0.0	6.1	0.0	0.0	2.0	5.4	1.0	13.8	3.6	1.6	0.0	0.0	1.0	8.0	6.8	1.7	0.1	0.0	0.0	0.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.6	0.1	0.0	1.2	0.0	1.5	2.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	12.2	0.0	0.0	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.2	6.2	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.3	7.4	0.0	1.3	6.6	17.9	7.6	5.6	3.1	0.2	4.3	0.3	0.3	3.2	0.1	0.1
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099795-176102489	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.5;seminal vesicle: 1.5"	"Cell type enriched"	"Detected in single"	12	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;REH: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151550-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.4;epididymis: 28.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Group enriched"	"Detected in many"	21	"medulla oblongata: 10.6;pons: 5.6;spinal cord: 8.1;white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.5"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 6.0;spinal cord: 7.8"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	6.9	8.3	0.0	1.6	0.0	0.0	7.4	0.0	0.1	7.1	0.0	7.3	1.0	24.4	28.0	1.1	14.3	1.5	0.6	0.0	0.0	18.5	0.0	0.4	1.7	10.6	0.3	15.1	0.6	0.1	0.0	0.4	5.6	2.9	2.0	0.0	0.7	11.1	2.8	2.4	6.2	9.7	8.1	7.2	1.0	3.0	0.0	0.2	1.2	0.5	0.4	2.7	4.0	7.3	0.5	0.3	0.0	0.0	2.0	3.0	0.0	0.2	0.9	0.1	1.1	0.9	0.0	0.0	16.6	3.4	0.7	0.2	2.6	0.0	0.4	0.0	39.7	0.5	0.0	0.0	0.5	0.0	0.1	9.3	2.6	0.0	0.5	0.2	6.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	29.6	4.1	2.5	4.2	0.6	0.0	11.0	0.6	0.0	0.0	5.0	0.5	0.2	2.9	2.1	0.0	0.1	0.0	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.3	5.6	8.1	0.0	7.3	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	3.7	0.1	1.1	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	2.6	4.7	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	0.0	0.1	0.3	6.5	0.0	0.0	6.6	0.6	0.9	0.3	0.4	0.0	0.6	0.0	0.1	3.0	1.3	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"liver: 61113.6"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 29.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	673.1	11.4	1.3	26.9	1.7	231.5	34.2	1.4	2.9	71.9	3.6	3.6	1.5	3.5	2.9	5.3	74.6	1.3	146.7	1.4	1.4	19.8	61113.6	91.3	1.7	29.7	2.0	9.9	7.6	0.2	49.9	2.5	3.7	7.3	0.6	0.7	6.1	0.2	5.0	3.4	4.4	4.5	2.3	72.0	6.2	2.1	8.3	2.7	6.3	0.4	3.0	3.8	3.3	5.9	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	1.3	1.7	1.4	2.9	1.4	1.4	29.7	2.0	3.7	2.3	8.3	5.9	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20740266-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"		NA	Yes		30000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: AB_2682440"	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	87.9	78.9	62.2	76.2	75.1	141.7	80.1	69.6	76.5	143.6	62.1	107.9	71.3	116.5	63.0	94.8	96.7	75.3	75.7	64.5	66.6	83.5	66.5	84.1	91.4	68.1	64.4	135.6	74.4	98.1	60.9	85.9	67.5	81.3	88.2	96.4	83.0	74.3	113.9	86.9	93.8	100.3	61.3	89.2	83.1	54.5	68.7	134.5	106.3	78.7	90.3	93.9	114.2	107.6	207.3	106.1	261.6	157.5	152.3	172.8	157.3	230.2	182.4	156.7	163.1	97.6	232.0	208.2	113.4	176.6	108.4	171.9	136.7	125.5	199.8	306.5	124.7	296.2	230.5	85.4	98.1	209.7	181.7	135.1	90.6	159.0	208.5	193.0	160.5	245.1	169.9	251.8	180.1	64.2	323.5	93.0	69.3	152.6	126.3	250.4	255.0	219.2	113.6	66.6	175.0	180.0	279.8	112.9	181.2	132.9	117.3	138.7	196.4	176.2	164.2	180.7	139.2	144.0	194.2	246.7	150.2	213.0	204.0	102.4	55.3	202.6	57.1	45.0	59.7	70.8	61.9	62.1	52.2	58.4	80.4	54.5	66.1	63.3	54.9	59.5	71.6	49.0	62.2	75.1	69.6	76.5	64.5	66.6	68.1	64.4	67.5	61.3	68.7	107.6	129.4	150.6	156.2	96.9	112.1	130.4	137.4	81.6	159.9	117.8	116.6	108.7	161.4	94.4	94.5	104.8	54.2	87.6	144.7	105.6	154.6	87.0	40.8	85.3	184.6	136.8	103.7	214.6	98.3	93.4	70.7	161.9	98.8	128.2	137.8	131.8	129.2	101.0	72.6	80.8	93.7	113.4	83.4	100.7	104.1	22.3	172.7	116.9	113.8	130.2	111.2	119.5	127.7	142.7	189.9	113.0	90.1	162.5	162.0	124.6	91.7	110.7	54.6	97.6	157.8	145.2	148.3	141.3	110.1	201.8	134.5	92.9	151.9	116.2	115.3	118.4
HPCA	DYT2	ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 517.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basal ganglia: 1309.6;hippocampal formation: 990.7"	"CAB012340, HPA043245"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	0.2	0.4	99.4	0.0	517.5	0.0	0.1	50.3	322.2	0.7	37.5	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.3	326.8	52.2	0.3	0.2	0.1	0.0	43.0	54.8	0.6	0.5	0.3	1.8	0.0	41.6	0.5	0.4	18.4	0.1	0.1	0.2	0.1	0.4	0.2	54.8	0.1	0.2	3.6	105.8	0.0	0.4	0.0	0.0	0.2	0.4	82.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	517.5	50.3	322.2	326.8	52.2	43.0	54.8	41.6	54.8	105.8	82.6	0.1	0.0	0.0	3.6	0.0	0.0	1.4	0.5	0.0	198.3	0.4	0.9	0.4	0.0	0.1	0.0	6.2	0.1	0.1	1.7	0.0	0.3	155.4	0.0	0.4	0.3	18.0	0.0	21.9	0.5	0.3	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.1	13.5	7.8	2.8	0.0	0.0	0.0	119.7	1.2	0.1	0.0	2.8	0.0	9.1	0.0	4.5	3.7	0.3	5.9	0.4	0.0	1.3	2.0	2.0	0.2	19.3	0.0	0.1	0.5	4.2	8.5	0.1	0.3	0.1	0.0	0.0	2.2	1.4
HPCAL1	"BDR1, HLP2, VILIP-3"	ENSG00000115756	"Hippocalcin like 1"	P37235	2	10302889-10427617	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 182.4"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 228.8;Intestinal goblet cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 310.6;HDLM-2: 324.5;PC-3: 354.2;U-87 MG: 334.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Supported					NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA043245: AB_2678385"	"unprognostic (3.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (2.73e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (4.06e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	47.1	62.1	123.2	24.1	140.0	14.4	31.4	182.4	146.9	42.8	54.3	43.2	35.2	90.4	9.3	16.9	40.3	15.1	49.6	114.1	132.2	71.4	62.5	102.3	27.7	129.9	114.8	15.5	52.6	8.5	65.0	22.1	138.2	21.9	21.3	21.2	20.4	9.0	27.3	18.8	63.7	28.1	84.0	47.3	73.3	46.8	123.8	16.6	33.1	15.1	17.3	20.9	23.0	81.1	51.8	88.6	6.2	25.5	13.8	35.4	59.8	41.0	110.5	58.3	63.6	31.4	128.5	20.1	47.3	30.6	310.6	18.9	16.7	56.8	26.1	324.5	30.1	44.8	94.8	69.2	61.4	27.8	86.5	19.3	25.9	139.1	43.1	207.3	77.7	30.5	41.8	129.1	105.5	70.5	23.2	168.4	32.5	43.2	354.2	29.5	24.3	88.8	85.0	14.8	22.8	152.5	43.0	51.6	102.7	21.6	16.2	72.5	94.2	72.8	22.4	77.7	69.8	38.5	44.7	10.5	334.9	67.4	174.0	24.5	50.9	61.9	21.6	39.9	23.6	26.7	38.9	27.4	43.5	21.3	46.3	30.7	70.0	24.5	36.3	15.7	36.0	29.5	123.2	140.0	182.4	146.9	114.1	132.2	129.9	114.8	138.2	84.0	123.8	81.1	88.6	83.3	86.8	9.4	48.2	33.8	23.4	4.3	11.4	76.9	19.9	12.4	15.9	30.0	16.9	18.4	16.7	4.9	30.1	39.7	93.9	48.6	25.7	10.3	15.1	72.2	62.6	18.7	23.5	37.1	145.6	22.9	53.0	10.8	55.2	26.3	81.8	32.7	67.6	228.8	23.3	308.8	4.1	79.2	77.9	19.2	17.1	65.1	56.9	31.9	43.9	51.7	46.4	12.5	10.3	46.1	64.5	10.9	45.5	14.8	111.7	100.3	6.8	33.6	6.6	18.2	14.5	20.8	14.9	15.6	30.1	41.3	45.0	6.2	44.8	19.2
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2530.4"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 7.8"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.3	5.3	0.6	0.7	0.4	0.9	4.6	3.2	0.6	2.0	119.0	1.2	0.1	4.1	0.7	0.7	6.4	1.1	3.5	7.8	0.5	531.0	2530.4	2.0	0.3	1.5	1.0	4.7	3.9	0.1	1.1	0.3	0.8	2.3	0.5	0.3	0.2	7.3	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.2	3.5	0.1	0.7	0.1	0.1	3.7	1.9	1.0	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.6	0.4	3.2	0.6	7.8	0.5	1.5	1.0	0.8	0.6	3.5	1.0	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.8	0.9	5.6	0.2	8.8	0.0	11.6	7.0	7.2	1.6	4.2	1.1	1.4	4.0	3.9	0.3	7.4	4.0	5.1	5.7	6.5	200.5	866.2	11.8	0.4	7.5	8.1	1.3	272.1	24.2	14.8	0.5	7.5	20.1	0.3	0.3	15.6	4.7	22.1	0.9	1.1	0.2	6.5	2.6	58.2	1.3	7.6	0.2	19.9	5.4	0.1	0.6	0.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.8	7.0	7.2	5.7	6.5	7.5	8.1	7.5	6.5	7.6	11.7	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063148-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 811.9"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 503.0;Smooth muscle cells: 128.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 50.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	55000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		5.5	0.5	14.1	0.2	15.3	0.1	2.0	13.9	16.7	1.2	11.3	1.2	0.6	0.3	0.4	0.3	1.3	0.7	137.2	13.7	14.3	4.0	811.9	1.5	0.7	14.4	14.3	2.0	0.6	0.0	0.3	0.0	13.6	1.6	0.1	0.8	0.3	0.3	1.7	0.6	1.1	0.1	12.8	0.3	1.7	1.9	15.2	0.2	1.1	0.2	0.1	0.4	1.9	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	2.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.6	0.6	0.0	14.1	15.3	13.9	16.7	13.7	14.3	14.4	14.3	13.6	12.8	15.2	13.1	0.0	0.0	7.5	2.3	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.0	22.4	12.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	5.3	0.2	0.2	0.0	2.6	0.0	0.0	0.0	1.1	10.8	503.0	0.0	0.0	0.2	0.0	2.0	12.8	0.0	2.8	9.9	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	13.0	0.2	0.1	0.0	6.1	128.8	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460165-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 226.9;Spermatocytes: 213.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006360, CAB012200"	Enhanced		Supported	Cytosol		NA	NA		9400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	15.6	26.2	37.3	24.3	39.4	54.7	20.4	26.0	63.7	13.6	22.9	25.5	20.4	14.0	62.7	20.3	16.9	14.6	24.5	40.3	47.1	45.5	45.8	14.5	32.1	31.2	32.1	16.8	37.1	21.9	31.5	16.3	34.7	15.4	23.5	74.1	13.5	16.0	22.6	14.8	26.5	17.3	24.6	16.9	32.2	76.1	31.4	31.3	22.1	17.8	30.6	25.4	13.9	31.3	138.0	64.9	18.0	37.2	39.4	56.1	54.1	71.6	68.7	89.5	116.8	58.7	85.5	154.4	158.7	46.7	106.8	82.0	117.4	98.2	153.4	129.2	219.3	84.0	85.0	60.2	38.9	182.9	74.0	41.6	36.1	80.1	126.4	49.5	104.9	90.3	65.5	3.8	71.0	141.0	141.9	157.0	37.0	160.7	171.8	83.8	91.1	158.6	109.6	65.7	113.0	61.6	51.7	41.5	50.1	48.8	35.5	75.2	52.4	60.5	45.6	175.0	181.5	56.5	105.1	0.9	74.6	199.5	33.8	5.8	21.9	20.4	20.8	36.5	30.0	24.0	30.4	27.6	37.9	24.8	24.8	26.9	5.6	39.4	35.5	15.7	57.4	25.3	37.3	39.4	26.0	63.7	40.3	47.1	31.2	32.1	34.7	24.6	31.4	31.3	32.1	19.2	8.2	11.1	39.6	39.6	55.7	75.6	18.8	38.3	26.4	22.0	23.8	30.0	29.9	57.0	4.2	17.9	28.1	16.8	226.9	50.1	11.9	30.1	28.3	39.2	27.5	101.8	55.3	32.3	30.5	29.5	30.1	41.8	34.9	29.0	20.7	22.2	71.2	25.2	43.1	30.4	63.1	60.7	81.7	32.2	40.7	56.2	55.2	10.3	122.5	37.2	26.8	22.1	30.7	36.6	28.2	26.7	30.9	78.1	24.1	30.2	28.9	78.0	52.6	31.6	39.4	213.5	172.6	40.4	38.8	6.0	53.8	30.2	51.3	46.8
HPS1	"BLOC3S1, HPS"	ENSG00000107521	"HPS1 biogenesis of lysosomal organelles complex 3 subunit 1"	Q92902	10	98416198-98446935	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061260	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA061260: AB_2684459"	"unprognostic (1.31e-1)"	"prognostic favorable (3.37e-5)"	"unprognostic (8.95e-2)"	"prognostic favorable (2.93e-5)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.19e-1)"	"unprognostic (9.38e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.30e-3)"	16.8	22.2	12.9	13.4	12.7	37.2	15.3	12.0	15.2	15.6	14.5	18.7	18.4	14.1	6.2	14.1	13.9	13.9	13.2	13.4	12.7	16.3	19.9	16.4	21.3	13.5	12.9	12.3	21.8	6.2	13.4	8.9	13.3	16.1	9.1	2.1	20.4	10.4	7.3	16.2	24.4	7.9	12.6	25.2	18.4	12.8	14.2	10.7	12.7	3.3	12.1	16.3	14.1	12.4	16.9	15.3	1.2	20.6	16.6	19.6	9.4	13.4	43.4	14.3	22.0	10.5	14.7	17.4	16.6	16.3	19.8	20.1	7.7	7.6	6.5	31.4	17.4	27.1	10.0	20.5	37.7	22.0	50.6	21.9	21.1	15.3	19.5	16.7	18.1	11.3	12.0	29.5	15.1	24.0	8.0	18.4	4.2	11.8	9.4	12.8	0.0	12.7	16.6	19.0	3.2	12.3	9.7	7.2	27.6	7.9	16.9	23.5	28.9	10.8	13.8	23.8	14.5	17.3	12.3	12.9	33.0	35.4	12.6	20.2	19.3	36.5	11.3	27.5	11.4	12.4	8.9	10.3	22.6	12.4	6.1	7.4	13.5	16.9	27.4	16.0	14.6	13.6	12.9	12.7	12.0	15.2	13.4	12.7	13.5	12.9	13.3	12.6	14.2	12.4	16.8	19.2	23.8	17.6	49.9	22.3	48.2	40.8	46.1	3.7	40.5	43.9	24.2	28.6	30.2	23.9	2.1	28.3	33.7	72.0	19.6	50.7	33.5	12.4	18.3	18.5	27.1	83.9	11.4	50.3	29.7	27.9	43.8	14.1	29.8	11.6	28.9	26.6	80.6	0.0	14.1	37.5	22.4	62.6	48.7	56.8	27.7	57.4	35.6	12.2	78.6	17.8	60.8	5.5	18.1	60.5	83.0	26.7	43.7	47.7	80.7	59.3	14.7	3.1	13.1	22.3	22.4	28.6	9.5	33.3	18.0	24.6	39.7	41.3	33.1	69.2
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3 biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129638-149173732	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	7.6	9.2	4.2	11.4	4.7	5.6	7.9	4.8	4.2	7.5	8.3	7.5	11.0	9.9	4.9	5.6	8.6	9.0	5.0	3.7	6.0	12.0	8.0	9.7	17.6	6.7	5.6	14.0	6.7	5.7	3.7	10.6	6.8	9.3	9.1	9.6	6.6	8.5	2.8	4.7	10.8	10.3	5.6	16.0	9.2	6.9	5.2	16.8	8.8	3.9	16.4	8.4	5.2	8.5	49.1	26.5	15.7	16.3	21.4	27.4	11.7	19.7	38.4	25.3	32.4	9.1	31.8	12.4	23.8	23.7	115.3	16.5	17.4	13.4	32.4	30.6	13.9	5.8	11.8	9.9	19.1	15.7	9.1	18.0	13.5	24.4	10.0	51.6	26.2	20.2	6.5	29.4	32.5	30.3	11.3	22.1	37.7	26.3	21.1	13.4	10.3	33.7	13.9	24.1	4.7	12.4	16.8	17.7	35.9	33.4	19.2	20.5	13.2	25.2	4.5	26.0	29.0	24.0	10.0	30.6	37.7	30.1	6.3	20.7	12.5	12.1	12.0	15.2	14.5	15.4	10.9	12.9	19.5	12.2	8.4	10.9	5.7	9.8	10.3	11.0	10.7	10.9	4.2	4.7	4.8	4.2	3.7	6.0	6.7	5.6	6.8	5.6	5.2	8.5	9.9	12.8	19.5	17.6	28.6	3.7	3.9	11.5	6.8	6.7	9.1	7.4	2.5	5.7	22.9	7.3	2.1	21.0	24.3	8.0	5.9	10.7	3.0	10.6	11.6	9.9	9.0	7.4	13.3	18.1	14.6	10.8	16.8	10.4	15.2	18.0	17.5	6.9	19.8	3.3	16.5	8.8	14.2	29.3	23.8	4.8	11.5	33.1	14.2	38.4	14.4	25.1	19.6	19.1	27.3	12.9	4.9	30.1	15.4	6.8	13.6	22.8	20.7	5.2	0.0	7.4	8.4	4.4	8.4	8.7	5.3	14.1	18.9	5.4	7.5	5.1
HPS4	"BLOC3S2, KIAA1667, LE"	ENSG00000100099	"HPS4 biogenesis of lysosomal organelles complex 3 subunit 2"	Q9NQG7	22	26443423-26483837	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 86.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033106, HPA050189"	Approved		Approved	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	Centrosome		"CAB033106: AB_2264349, HPA050189: AB_2681046"	"unprognostic (1.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.46e-2)"	6.6	8.9	10.4	6.5	11.4	10.3	6.7	11.1	10.5	9.0	12.2	6.7	5.4	6.9	7.7	9.9	9.2	6.1	4.5	10.3	11.5	8.6	8.5	6.5	8.5	10.9	10.8	12.1	12.7	12.1	11.0	5.6	11.2	8.3	5.5	7.6	6.6	7.7	4.6	14.0	7.3	7.1	10.7	9.0	8.1	13.1	11.4	13.0	9.8	5.0	9.6	6.9	8.4	10.5	16.3	7.5	15.5	15.9	11.5	13.6	8.2	9.7	18.8	21.4	19.1	7.9	7.8	15.4	7.5	11.8	12.1	13.2	14.9	21.0	19.3	11.4	15.4	15.6	6.3	13.3	20.5	18.4	17.0	13.3	17.1	19.5	34.5	18.1	14.2	25.5	17.4	19.0	15.7	6.9	31.2	6.2	9.3	15.0	8.0	86.3	18.3	20.4	9.9	10.1	17.6	13.0	9.4	10.6	46.7	11.6	11.5	13.9	8.8	24.8	46.2	12.4	12.2	28.1	23.4	50.5	16.2	11.8	16.3	10.8	3.2	3.1	4.8	2.3	4.5	5.5	3.9	4.1	4.3	4.7	4.5	5.0	1.1	7.2	2.1	5.7	2.8	4.7	10.4	11.4	11.1	10.5	10.3	11.5	10.9	10.8	11.2	10.7	11.4	10.5	16.6	12.8	32.4	28.7	38.7	12.5	28.3	28.9	17.1	52.6	14.4	12.4	6.3	17.2	25.5	42.3	114.7	21.7	31.7	11.6	17.6	20.4	24.3	16.3	17.2	18.6	26.5	48.1	18.4	27.1	19.4	14.1	28.1	14.1	42.4	40.6	22.5	14.2	24.8	43.7	31.1	20.1	44.7	18.3	12.2	24.3	32.6	19.1	48.0	19.7	14.9	23.7	21.6	32.6	36.4	45.0	13.6	19.9	25.1	29.4	18.0	15.7	28.1	119.3	0.0	16.0	12.2	32.3	46.6	11.1	14.9	20.0	20.6	23.6	21.4	26.9
HPS5	"AIBP63, BLOC2S2, RU2"	ENSG00000110756	"HPS5 biogenesis of lysosomal organelles complex 2 subunit 2"	Q9UPZ3	11	18278668-18322198	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077851	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA077851: "	"unprognostic (2.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.89e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.72e-1)"	7.4	8.4	4.4	5.8	5.5	3.7	10.5	4.7	4.5	5.1	5.9	4.8	6.1	5.0	2.8	7.3	5.1	3.9	5.9	4.0	4.6	5.4	35.7	8.6	9.2	5.6	5.0	7.1	6.8	3.6	8.5	7.1	5.9	4.8	3.3	8.9	16.3	3.5	5.5	6.3	8.1	3.9	5.2	9.0	4.6	14.8	5.4	5.9	6.0	3.1	8.3	4.9	5.5	7.4	5.9	8.5	9.0	9.1	11.9	6.6	9.8	15.3	12.6	9.9	10.4	5.3	1.8	14.1	5.8	13.3	12.4	8.3	10.6	10.1	12.1	11.8	7.7	6.9	7.1	6.7	11.2	15.2	12.4	10.6	9.9	6.1	12.9	10.0	8.0	9.0	9.1	8.0	16.1	4.8	8.1	11.0	4.5	6.8	9.3	11.8	12.9	6.0	9.6	5.3	3.0	5.9	19.2	6.8	22.8	8.9	5.1	8.8	5.9	11.3	6.1	14.8	7.1	3.4	12.0	16.1	6.2	7.8	32.4	12.3	3.6	2.9	2.1	5.4	2.6	5.3	2.6	2.2	8.3	4.4	2.5	2.6	1.0	2.8	6.0	3.2	2.6	2.5	4.4	5.5	4.7	4.5	4.0	4.6	5.6	5.0	5.9	5.2	5.4	7.4	17.2	96.1	14.6	13.1	30.8	15.6	14.2	16.2	12.5	17.5	17.4	23.0	18.2	17.2	14.7	7.3	31.3	22.2	16.0	4.7	5.9	5.2	50.9	20.7	11.2	13.4	10.7	11.6	16.7	8.4	10.6	11.8	18.3	30.0	14.5	17.8	7.9	45.1	18.1	10.1	21.0	5.0	12.2	22.7	45.0	18.6	8.4	35.8	28.4	11.2	32.3	16.1	0.0	21.1	24.0	6.2	8.5	13.2	17.4	15.2	27.1	6.5	21.1	26.1	6.6	17.1	13.1	16.2	12.6	19.6	15.3	17.4	17.8	10.5	6.0	21.8
HPS6	"BLOC2S3, FLJ22501"	ENSG00000166189	"HPS6 biogenesis of lysosomal organelles complex 2 subunit 3"	Q86YV9	10	102065349-102068036	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040687	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040687: AB_2677078"	"unprognostic (4.15e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.50e-2)"	6.2	8.0	4.3	6.5	4.4	7.5	6.0	4.0	5.3	6.1	3.3	8.1	7.8	9.0	3.5	10.3	7.2	4.1	7.1	4.6	4.4	5.6	6.6	6.5	7.7	5.4	4.2	5.5	9.2	6.7	4.4	5.6	4.4	5.0	4.7	1.9	7.6	5.6	8.1	9.0	8.3	5.1	4.1	9.2	8.5	3.6	5.1	5.6	4.9	5.9	6.5	7.0	5.8	4.1	26.0	21.5	6.3	17.3	19.4	14.0	13.5	16.8	25.0	20.0	16.3	11.5	17.4	13.6	16.7	18.8	11.4	25.9	11.9	27.4	5.3	19.8	16.4	14.1	10.1	8.4	12.2	16.5	17.0	15.6	28.0	12.7	16.1	20.2	14.6	11.8	9.6	7.4	15.9	17.5	12.2	21.8	6.2	12.1	17.5	16.7	2.2	11.8	17.3	11.8	4.6	13.0	9.8	11.9	13.1	8.1	23.4	20.9	19.0	7.6	9.3	7.6	17.3	12.7	10.5	9.8	15.4	19.3	6.1	0.0	1.9	2.5	3.1	2.9	2.7	2.3	2.6	2.6	1.8	1.6	1.2	1.5	2.1	3.9	1.4	3.0	2.0	1.2	4.3	4.4	4.0	5.3	4.6	4.4	5.4	4.2	4.4	4.1	5.1	4.1	4.2	9.6	2.6	1.3	6.9	1.9	7.7	4.5	3.4	8.1	2.8	2.8	6.2	4.3	4.3	5.5	12.5	12.4	4.7	9.2	7.9	12.4	0.1	3.0	3.7	4.8	2.4	6.1	1.2	14.9	9.5	4.5	4.6	3.2	0.0	4.6	6.1	6.7	10.6	10.1	1.2	5.8	0.0	6.3	2.7	0.9	7.5	4.8	5.4	1.0	10.5	10.1	10.3	1.5	0.6	12.6	5.8	5.3	4.2	6.3	8.7	6.2	3.7	5.1	0.0	4.3	5.6	2.4	4.2	6.0	2.4	10.1	5.9	5.3	9.0	6.3
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;cervix: 36.7;vagina: 27.6"	"Cell type enriched"	"Detected in some"	9	"Astrocytes: 900.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BJ hTERT+: 10.2;HEL: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	2.0	0.0	9.9	2.0	20.9	0.0	5.2	15.4	7.6	36.7	3.6	2.9	2.7	4.5	0.0	14.3	1.8	1.4	0.1	5.8	21.1	3.5	0.0	2.2	0.0	23.2	29.6	0.2	0.0	0.0	0.3	1.5	21.5	11.1	3.0	0.0	2.4	4.2	0.3	3.2	5.2	1.7	16.5	0.0	4.6	2.7	28.5	0.1	0.1	3.0	0.4	18.3	27.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	20.9	15.4	7.6	5.8	21.1	23.2	29.6	21.5	16.5	28.5	11.9	0.3	0.0	0.0	900.7	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.4	24.8	0.3	0.0	0.0	6.4	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	97.3	0.2	0.0	0.0	0.0	48.6	0.3	0.0	0.0	40.3	0.0	0.0	0.0	16.6	4.6	0.0	0.0	0.4	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.9	11.5	2.1	0.0	0.1	0.0	0.2	0.8	0.0	0.7
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5440.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 6095.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	1.1	0.8	0.8	0.1	0.7	0.1	5.9	1.0	1.0	1.6	0.6	1.2	0.4	1.0	0.2	0.5	1.6	0.3	0.9	0.7	0.7	1.4	5440.6	1.2	0.3	0.7	0.7	1.6	5.5	0.1	1.2	0.3	0.7	2.4	0.6	1.7	1.1	0.6	0.3	1.6	1.1	0.3	0.6	3.8	0.9	1.1	0.8	0.1	0.9	0.0	0.1	1.1	1.2	0.7	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.3	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.2	21.3	0.0	3.0	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	0.2	1.1	0.0	0.5	0.3	0.2	1.0	0.1	0.4	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.0	1.0	0.7	0.7	0.7	0.7	0.7	0.6	0.8	0.7	0.5	3.2	0.5	0.3	15.1	0.6	0.2	0.2	0.0	1.5	19.1	7.7	0.7	80.1	0.2	0.0	2.1	0.1	0.1	0.6	0.0	0.1	2.3	0.2	0.3	6.2	0.0	157.7	0.7	0.6	0.1	0.4	0.0	1.2	0.0	1.1	132.8	6095.8	0.2	0.0	0.8	0.7	0.0	155.3	0.2	2.9	0.3	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.7	0.2	0.0	1.0	2.1	0.0	0.4	0.5	0.6	0.5	0.0	0.3	0.0	11.3	0.2	0.5	0.3
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	50	"heart muscle: 718.3;skeletal muscle: 453.0;tongue: 244.7"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 1182.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 5.8;HSkMC: 5.6;K-562: 8.0;THP-1: 13.9;U-266/84: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004833	Enhanced				"Intracellular and membrane"	NA	NA		100000		"Cluster 38: Heart - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	9.3	3.6	2.5	0.6	2.7	0.0	5.7	3.1	4.0	6.4	2.0	2.4	0.9	6.3	5.4	4.5	9.2	2.2	718.3	2.5	2.3	3.5	1.9	2.8	0.8	2.4	2.6	4.6	1.3	1.5	1.5	2.1	2.6	4.3	0.9	0.8	8.1	2.5	453.0	2.9	2.3	2.1	2.2	0.5	1.8	1.4	2.8	0.6	4.7	244.7	0.4	3.1	3.9	2.4	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	5.8	0.0	0.0	1.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	13.9	0.2	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	3.1	4.0	2.5	2.3	2.4	2.6	2.6	2.2	2.8	2.4	3.7	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	1.0	0.8	1.0	1182.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.3	1.7	11.0	1.2	0.0	0.0	0.2	0.0	20.9	0.0	0.5	0.0	0.0	0.7	0.6	0.1	3.3	0.1	2.8	0.0	0.0	1.1	0.4	8.4	0.3	3.6	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.4	8.2	0.1	0.2	0.5	0.0	0.0	0.2	65.7	8.7	44.2	0.0	0.2	0.1	0.1	0.1	0.2	2.8	1.5	0.2
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5433.2"	"Cell type enriched"	"Detected in some"	29	"Hepatocytes: 479.7"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;RH-30: 3.0;SiHa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.4	5433.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.6	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	479.7	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	5.7	3.0	5.5	3.1	6.2	0.1	3.4	1.7	6.5	5.0	2.1	8.8	2.7	4.3	4.8	3.3	7.4	7.1	1.5	6.1	5.3	4.2	0.7	4.1	1.2	4.6	2.9	5.9	0.6	0.9	0.5	3.9	3.6	2.4	5.1	0.2	1.8	3.5	0.9	5.1	4.3	5.4	3.2	1.0	1.7	0.8	5.8	1.2	1.2	2.2	1.4	14.3	5.0	4.1	2.6	6.1	0.0	0.0	2.7	28.5	4.2	4.6	15.3	13.3	8.8	1.1	21.8	0.0	13.4	10.6	13.5	17.3	0.0	6.3	17.7	10.1	0.0	1.4	9.7	0.0	8.4	4.5	2.4	10.0	3.7	30.4	10.5	18.4	19.1	0.2	0.0	0.1	5.8	0.0	0.0	1.9	0.0	2.6	5.4	0.4	1.6	0.6	23.2	3.6	0.2	0.0	6.6	4.6	0.0	0.2	0.0	3.5	28.8	14.8	9.4	15.3	23.4	0.0	1.7	0.1	22.5	3.9	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	5.5	6.2	1.7	6.5	6.1	5.3	4.6	2.9	3.6	3.2	5.8	4.1	11.5	6.4	1.1	33.3	0.1	46.1	8.9	7.4	6.8	0.0	0.5	0.5	0.5	0.0	19.3	1.8	0.0	0.2	0.0	44.9	0.0	0.6	0.3	20.5	6.9	20.2	3.5	0.0	34.6	0.7	1.0	16.7	8.6	41.6	2.5	28.8	2.5	0.0	27.2	0.0	19.1	15.1	4.1	12.5	12.3	0.2	3.7	9.8	0.0	2.8	0.1	0.0	0.0	2.0	1.1	14.0	21.0	0.0	0.0	6.2	29.1	0.7	5.0	0.2	0.0	6.8	2.8	1.8	3.3	2.2	41.5	0.5	1.0	0.2	15.8	19.3
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0;heart muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 26.2;Excitatory neurons: 62.2;Inhibitory neurons: 19.1;Kupffer cells: 29.4;Macrophages: 36.2;monocytes: 24.3;Smooth muscle cells: 33.6"	"Group enriched"	"Detected in many"	5	"melanoma: 2.9;renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 134.4;neutrophil: 161.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 161.7;monocytes: 51.6"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 65.6;SK-MEL-30: 19.2;THP-1: 18.0;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.6	1.5	4.5	12.0	14.4	37.0	3.0	1.1	9.6	5.1	0.5	1.4	6.2	2.2	0.9	1.4	2.9	2.5	26.3	5.3	1.4	2.3	1.0	7.2	3.8	1.2	1.6	1.1	1.5	1.3	0.8	10.2	1.1	4.7	1.1	0.3	1.4	4.6	0.8	2.2	6.4	3.6	1.7	18.0	19.5	0.5	3.9	8.5	1.5	1.5	3.1	4.1	2.0	5.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	5.0	2.9	0.0	0.0	7.1	0.0	65.6	0.0	0.3	0.5	0.0	0.0	0.0	19.2	1.7	0.1	18.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.6	4.3	134.4	45.8	52.8	0.2	44.9	0.3	0.0	3.8	1.0	23.5	0.1	7.9	4.8	161.7	2.1	51.6	18.3	3.3	15.3	4.5	14.4	1.1	9.6	5.3	1.4	1.2	1.6	1.1	1.7	3.9	5.1	1.1	0.0	2.5	1.0	1.0	0.8	0.1	0.0	0.6	9.3	3.7	0.9	26.2	0.0	2.5	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.6	0.1	0.8	1.9	0.0	3.0	62.2	2.4	0.2	3.3	7.1	0.1	2.5	3.0	0.0	0.2	11.8	1.7	19.1	0.6	0.0	29.4	8.5	1.0	0.0	36.2	0.0	10.3	24.3	0.1	0.0	1.5	1.7	0.3	0.0	0.4	0.3	0.2	0.6	0.3	0.7	0.2	0.0	0.1	33.6	0.2	0.9	0.1	0.3	0.0	4.7	0.1	0.5	0.0
HRH4	"AXOR35, GPCR105, GPRv53, H4R, HH4R"	ENSG00000134489	"Histamine receptor H4"	Q9H3N8	18	24460637-24479961	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;Early spermatids: 1.2;granulocytes: 1.3;Late spermatids: 1.3;Melanocytes: 1.8;Spermatocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"basophil: 212.9;eosinophil: 61.1"	"Lineage enriched"	"Detected in many"	191	"granulocytes: 212.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035009	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"		"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035009: AB_10671507"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.83e-6)"	"unprognostic (1.31e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.65e-7)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-4)"	"unprognostic (7.70e-2)"	0.1	0.1	0.2	0.4	0.1	0.8	0.0	0.3	0.3	0.1	0.3	0.1	0.5	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.3	0.6	0.5	0.1	0.0	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	1.3	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	212.9	0.1	61.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.5	0.5	0.2	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.3	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	1.8	1.0	0.0	0.3	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.8	0.3	1.3	0.3	0.0	0.6	0.0	0.5	0.2	0.0	0.4
HRK	DP5	ENSG00000135116	"Harakiri, BCL2 interacting protein"	O00198	12	116856144-116881441	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;choroid plexus: 4.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.3;Endometrial ciliated cells: 10.3;Enteroendocrine cells: 11.3;Excitatory neurons: 9.5;Paneth cells: 10.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	30	"eosinophil: 1.3;memory B-cell: 3.6;naive B-cell: 3.9"	"Group enriched"	"Detected in many"	27	"B-cells: 3.9;granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.1;SCLC-21H: 9.1;SH-SY5Y: 7.8;SK-MEL-30: 22.0;U-698: 37.0"	"Low region specificity"	"Detected in all"							CAB025973	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025973: "	"unprognostic (9.38e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.42e-2)"	0.2	0.7	4.5	0.4	6.1	0.7	0.1	0.6	7.4	0.0	4.5	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	14.4	3.4	0.1	0.0	0.1	0.8	1.5	2.1	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.1	0.3	0.2	0.0	0.5	0.2	0.1	0.0	1.3	0.2	0.0	0.5	3.9	3.5	3.8	0.0	0.7	0.0	0.0	2.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.4	0.0	0.2	4.5	2.4	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.0	2.1	0.1	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.1	1.0	0.0	1.5	0.1	0.0	9.1	7.8	0.5	0.0	22.0	0.4	0.6	0.2	0.0	0.0	1.8	0.2	0.0	1.0	0.5	37.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	6.1	0.6	7.4	14.4	3.4	1.5	2.1	1.1	1.3	3.9	2.8	1.1	0.0	0.0	0.0	7.0	0.1	0.1	0.1	0.0	4.5	3.2	3.0	2.4	0.0	0.8	0.0	14.6	0.1	0.1	2.2	0.0	0.1	11.3	10.3	0.1	1.4	11.3	0.0	9.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.4	4.5	0.0	0.2	3.6	5.6	0.6	0.2	0.0	6.6	0.3	0.0	10.1	0.0	1.1	0.3	0.0	0.2	6.6	0.6	0.0	0.1	0.7	0.4	3.0	0.7	0.0	0.1	0.3	0.0	1.0	0.1
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212076-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 1.0;Horizontal cells: 1.7;Rod photoreceptor cells: 3.5"	"Cancer enriched"	"Detected in single"	4	"melanoma: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.9"	"Not detected"	"Not detected"							HPA031469	Uncertain		Approved	Mitochondria		No	No		180000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.1	0.2	0.9	0.0	0.4	0.0	0.1	0.0	0.6	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.0	0.2	0.4	1.9	0.3	0.1	0.1	0.0	1.8	0.7	0.4	0.4	0.0	0.2	0.0	1.1	0.2	0.0	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.4	0.7	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.0	0.6	0.4	1.9	1.8	0.7	1.1	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
HROB	"C17orf53, MCM8IP, MGC3130"	ENSG00000125319	"Homologous recombination factor with OB-fold"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.3;testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	1.5	0.4	0.1	1.1	0.1	9.3	1.4	0.4	0.3	0.9	0.0	0.9	0.9	0.8	0.1	2.7	0.5	0.2	0.7	0.1	0.2	0.4	0.6	0.6	1.6	0.3	0.2	0.8	0.3	0.4	0.4	0.9	0.3	0.7	1.0	0.3	0.7	0.3	0.9	1.7	0.9	0.7	0.1	1.3	0.6	11.4	0.2	2.3	0.3	0.2	1.9	0.6	1.2	0.3	8.9	11.1	8.3	7.6	0.6	2.3	9.8	6.7	5.9	12.8	13.9	11.3	5.4	9.4	5.8	5.8	13.3	7.5	10.9	10.5	11.1	10.6	14.0	6.0	10.1	7.7	0.3	6.6	7.3	1.9	1.6	15.7	7.7	1.5	5.3	10.2	13.8	11.6	6.2	6.7	15.7	10.2	5.6	4.0	10.8	10.0	13.2	11.6	3.0	7.0	5.1	2.9	4.1	4.0	3.4	9.4	8.1	7.7	2.4	12.1	9.5	8.3	9.9	6.7	12.2	8.0	5.7	5.1	7.1	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.9	0.4	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0
HS1BP3	HS1-BP3,FLJ14249	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol		No	No		54000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	18.5	31.0	16.4	10.0	20.6	13.7	15.9	17.9	19.6	21.5	19.4	33.6	13.1	22.2	13.3	18.6	19.4	16.4	23.3	16.9	17.5	24.8	57.4	18.5	9.2	20.4	19.3	17.5	14.5	13.1	16.3	15.5	19.4	26.7	12.6	3.7	16.7	17.5	13.0	23.3	17.7	21.1	15.8	18.4	22.0	13.8	21.3	7.4	17.8	10.1	7.6	29.2	17.8	23.3	20.3	23.1	11.5	14.1	58.8	39.2	22.7	7.6	34.9	17.7	23.0	18.2	24.0	13.5	5.9	11.1	80.1	12.5	23.1	24.0	8.6	17.4	19.1	7.2	11.3	61.2	54.8	5.5	30.5	42.1	53.8	20.0	36.5	20.7	34.1	11.9	4.7	28.3	20.5	17.4	2.5	9.3	9.6	29.9	16.4	13.3	23.3	13.4	39.0	24.4	10.9	16.7	5.4	23.4	45.0	23.2	14.6	11.2	21.7	17.3	18.5	27.0	11.7	19.9	24.5	12.9	37.3	25.8	18.7	17.9	14.7	14.5	6.0	13.9	4.2	6.8	3.6	4.7	9.9	4.3	3.0	3.3	17.7	3.8	18.3	3.6	3.4	8.6	16.4	20.6	17.9	19.6	16.9	17.5	20.4	19.3	19.4	15.8	21.3	23.3	17.6	6.4	17.9	3.3	8.2	4.5	7.4	5.6	2.2	4.0	6.2	8.0	6.2	8.6	10.9	7.3	0.0	9.8	6.5	12.5	17.6	21.4	20.8	9.3	9.4	8.4	6.7	7.0	2.6	14.9	17.8	9.7	8.2	12.5	2.5	8.5	11.0	9.2	30.7	15.2	2.5	7.3	12.2	20.1	5.5	42.7	8.4	13.9	14.2	4.7	13.1	8.9	15.5	3.0	5.4	9.7	11.9	10.5	4.9	5.2	21.6	28.2	10.4	5.3	0.0	7.1	17.1	16.7	10.5	5.8	5.3	17.5	6.3	7.8	7.7	4.5
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914635-87109982	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.0	25.7	11.5	9.4	13.8	3.8	8.1	8.0	12.2	10.5	13.2	9.3	9.7	9.1	9.9	7.0	6.7	10.6	7.0	11.9	11.4	13.8	17.2	8.2	11.8	10.1	11.0	12.7	10.1	13.4	6.6	8.3	8.1	9.5	9.0	19.3	6.7	9.9	4.4	8.2	9.3	7.8	8.8	12.7	8.3	9.3	12.2	10.6	12.9	4.7	11.6	9.4	5.9	8.4	24.4	20.4	59.0	38.5	31.9	92.3	20.4	23.3	30.5	19.2	21.2	78.1	30.6	53.3	22.1	16.4	33.2	14.5	27.2	19.5	30.8	42.1	22.2	64.0	21.0	63.0	13.4	33.6	31.0	38.2	17.0	31.0	25.6	30.4	28.8	29.7	44.6	27.4	28.1	8.6	33.8	20.2	19.8	26.5	12.9	41.2	55.7	11.6	23.5	50.3	12.6	19.0	30.6	26.2	27.2	15.2	17.2	15.2	25.7	24.0	29.8	42.2	29.7	25.1	19.9	49.7	14.8	23.6	25.0	6.2	1.1	1.0	1.3	0.6	1.6	1.1	1.5	1.5	0.7	2.8	1.4	0.9	1.2	1.1	2.8	0.7	0.9	1.0	11.5	13.8	8.0	12.2	11.9	11.4	10.1	11.0	8.1	8.8	12.2	8.4	13.0	16.0	12.4	160.9	14.2	16.6	8.6	9.3	19.9	10.9	11.9	7.6	12.8	14.3	15.2	20.2	4.2	8.2	5.7	13.5	13.7	18.2	5.5	7.1	23.6	13.8	23.4	12.2	126.1	11.5	9.3	16.9	11.2	8.0	19.0	74.2	18.2	28.9	37.7	8.4	130.1	12.5	18.3	12.8	13.5	3.8	6.8	15.3	12.4	53.4	8.2	28.8	5.2	95.0	54.5	11.3	7.7	20.3	24.0	7.3	17.6	18.3	11.2	17.7	0.0	21.1	16.8	10.1	15.0	12.8	15.8	4.4	12.9	77.4	13.5	7.1
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429564	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ovary: 31.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 112.0;granulocytes: 96.3;Granulosa cells: 285.0;Peritubular cells: 90.3;Urothelial cells: 92.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.4"	"Group enriched"	"Detected in some"	36	"memory B-cell: 14.9;naive B-cell: 26.6;plasmacytoid DC: 42.3"	"Group enriched"	"Detected in many"	108	"B-cells: 26.6;dendritic cells: 42.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 20.6;HaCaT: 6.0;RPTEC TERT1: 13.2;RT4: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.6	2.5	2.3	2.7	1.9	2.0	1.9	25.4	6.9	2.4	0.0	2.1	3.7	3.4	1.3	11.6	4.4	12.7	1.9	1.6	4.7	5.9	0.4	1.8	2.3	4.7	3.3	31.9	1.0	0.1	4.7	0.7	3.8	2.0	1.1	1.0	5.6	1.5	0.4	0.5	2.9	0.9	4.4	3.3	6.5	1.3	5.8	1.3	1.6	0.2	1.2	14.5	2.6	6.1	5.8	1.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.6	0.0	0.4	0.0	0.0	6.0	0.0	2.8	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.1	1.6	2.2	1.2	0.0	0.0	13.2	14.5	4.6	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	14.9	0.0	0.0	0.7	26.6	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.1	2.3	1.9	25.4	6.9	1.6	4.7	4.7	3.3	3.8	4.4	5.8	6.1	3.5	3.2	5.8	0.0	13.1	9.1	13.5	70.1	5.2	3.7	2.4	9.3	3.2	32.9	112.0	20.2	4.2	0.5	21.6	5.2	0.0	25.0	1.7	3.6	1.0	28.9	2.4	0.0	13.4	2.1	42.1	13.2	23.9	14.9	96.3	285.0	25.0	0.4	37.6	1.7	35.0	7.2	71.2	3.5	3.7	2.0	8.7	12.5	1.8	6.5	4.9	32.9	8.2	24.1	0.7	51.9	6.5	90.3	0.0	5.6	2.7	19.1	61.2	2.6	0.0	0.5	17.5	5.4	5.6	36.6	8.1	1.4	1.4	68.5	4.3	92.9
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814162-22916338	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 29.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 99.8;Hofbauer cells: 16.9;Inhibitory neurons: 25.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 9.7;SH-SY5Y: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017736	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA017736: AB_1851095"	"unprognostic (4.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (5.97e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.00e-2)"	3.0	1.2	11.5	0.0	16.8	0.0	2.1	0.8	29.9	1.8	0.5	0.7	0.0	0.7	0.0	0.2	0.6	0.0	1.0	11.7	6.2	0.4	0.6	5.4	0.0	3.9	6.6	0.3	0.2	0.0	0.3	0.1	5.2	1.9	0.2	0.4	3.1	0.0	0.4	2.0	0.5	0.1	2.4	0.3	0.7	0.3	2.6	0.0	1.8	0.1	0.0	1.1	1.1	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	16.8	0.8	29.9	11.7	6.2	3.9	6.6	5.2	2.4	2.6	16.3	0.8	0.0	0.0	1.6	0.0	3.6	0.2	0.0	0.0	10.3	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.6	0.1	0.0	0.0	2.3	0.0	0.0	99.8	0.0	0.2	1.9	0.0	0.2	0.0	0.0	0.4	0.2	16.9	0.0	25.7	0.0	0.0	1.0	2.7	1.5	1.2	7.3	0.0	0.0	0.0	0.0	0.0	3.5	1.8	0.9	0.0	5.7	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.3	5.8	0.1	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.8
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13494032-13601929	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"medulla oblongata: 5.9"	"Immune cell enhanced"	"Detected in some"		"T-reg: 2.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 2.2"	"Group enriched"	"Detected in many"	4	"PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.3"	"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	0.4	2.0	0.1	1.9	1.0	1.0	0.4	0.0	0.6	4.5	3.2	1.2	1.4	0.7	0.1	4.6	1.3	0.3	2.5	0.2	0.0	1.4	1.9	1.2	2.6	5.9	1.4	8.1	0.3	0.0	0.7	2.7	1.1	3.1	0.3	1.3	2.0	4.9	0.1	0.7	1.2	0.2	3.5	6.4	0.6	2.3	0.1	0.3	0.3	0.0	1.6	0.5	3.4	0.5	0.1	0.3	3.3	0.0	2.7	6.8	5.1	18.2	4.4	3.2	2.0	0.0	0.6	0.0	2.6	11.2	0.0	0.0	0.1	0.0	3.1	1.1	18.3	4.9	1.5	2.0	1.6	0.0	1.2	4.9	0.1	8.5	2.2	5.5	0.0	0.2	19.2	0.0	3.8	2.5	0.1	3.3	3.5	0.0	40.9	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	2.0	0.1	0.6	0.2	3.1	0.4	0.1	123.0	0.0	0.0	0.0	73.2	0.0	9.1	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.5	0.0	0.0	0.5	0.5	0.2	0.3	0.0	1.7	2.2	0.3	0.1	1.0	0.0	0.6	0.2	0.0	5.9	1.4	1.1	3.5	0.1	0.5	0.2	0.0	0.0	9.8	0.0	0.6	0.0	0.0	5.7	0.3	0.0	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.4	0.3	1.1	0.0	0.0	1.8	0.2	0.0	4.7	0.0	0.2	0.0	11.6	7.1	0.0	1.6	26.9	4.1	0.0	0.0	0.8	0.3	0.1	13.7	0.0	0.0	1.9	0.0	2.4	0.0	0.5	0.2	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	4.0	0.3	0.4	9.3	0.6	0.1	0.1	0.0	0.0	0.0
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;skeletal muscle: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 102.5;Excitatory neurons: 154.8;Inhibitory neurons: 130.9;Oligodendrocytes: 606.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 4.6;RT4: 6.8;SCLC-21H: 14.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.0	0.3	3.5	0.1	9.7	0.2	0.0	3.6	4.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.0	7.2	7.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.1	1.1	0.0	1.3	3.2	0.2	0.1	0.1	6.5	0.0	0.2	0.1	7.6	0.0	0.0	1.4	0.0	2.2	0.0	6.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.9	4.6	0.0	0.8	0.0	0.0	6.8	14.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	4.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.7	3.6	4.4	2.8	4.5	7.2	7.0	7.3	6.5	7.6	6.0	0.0	0.0	0.0	102.5	0.0	1.3	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	11.0	18.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	154.8	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	130.9	0.4	0.0	0.0	0.0	0.8	3.7	0.0	0.0	9.4	0.0	0.0	0.0	11.6	606.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	7.9	0.1	1.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;kidney: 13.9;ovary: 14.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034625	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034625: AB_10612119"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.2	2.4	12.4	0.6	10.0	0.0	2.0	1.2	7.4	1.0	0.0	0.6	0.1	3.5	2.4	3.9	1.8	0.3	0.2	9.6	10.7	13.9	0.0	0.7	0.1	6.3	22.5	14.1	5.3	0.3	1.1	8.4	7.3	2.8	0.8	1.5	0.9	0.8	6.2	0.2	0.1	1.5	4.9	0.0	0.9	2.9	20.3	0.6	0.4	0.9	0.5	2.5	0.7	2.6	10.7	0.1	14.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	0.0	0.0	15.2	0.0	0.0	0.5	21.7	0.1	0.0	0.0	46.2	0.1	28.1	0.0	0.0	0.0	0.0	0.7	20.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.8	0.3	0.1	11.8	7.2	0.6	0.0	66.1	0.0	13.3	33.7	1.8	82.0	14.8	0.0	0.1	23.7	0.0	0.1	0.0	0.0	2.6	9.6	23.8	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	10.0	1.2	7.4	9.6	10.7	6.3	22.5	7.3	4.9	20.3	2.6	0.0	0.0	0.0	1.6	0.0	0.3	0.2	1.8	6.8	0.2	4.3	2.4	0.8	0.0	5.5	3.7	0.0	35.7	0.2	0.3	5.9	0.0	0.5	0.3	0.6	0.5	0.0	0.0	37.5	2.0	2.6	2.6	0.0	0.1	0.0	0.1	0.0	0.0	3.4	0.0	44.2	0.2	2.0	0.0	0.0	1.1	62.7	0.2	0.0	10.3	0.0	5.3	0.0	54.3	1.4	0.8	0.2	35.3	0.0	1.3	0.0	0.1	9.8	0.4	0.0	17.9	0.3	0.3	1.1	11.1	0.3	17.4	0.1	0.3	0.2	1.8
HSBP1L1	"FLJ10967, MGC189743"	ENSG00000226742	"Heat shock factor binding protein 1 like 1"	C9JCN9	18	79964582-79970822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 31.9;T-cells: 26.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 162.8;SK-MEL-30: 100.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048273	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA048273: AB_2680337"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.15e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.76e-2)"	9.6	17.4	18.4	2.9	17.8	2.9	9.6	19.9	26.4	10.0	23.4	16.0	6.7	7.6	11.1	17.4	8.7	5.7	6.7	17.2	18.1	18.6	29.7	10.7	4.2	19.1	18.5	6.6	20.4	19.7	6.7	9.9	19.6	10.2	13.1	14.8	12.8	7.6	12.5	16.0	6.5	5.7	18.1	5.2	10.1	0.8	20.3	4.3	8.9	10.6	4.9	6.2	10.6	17.2	32.2	8.6	0.3	0.5	4.6	15.4	12.7	14.3	32.2	14.8	13.0	16.5	21.7	0.0	3.6	18.8	0.2	18.3	28.5	18.9	7.0	30.6	6.7	0.0	8.8	9.6	162.8	0.0	0.0	18.0	49.6	1.7	10.8	31.5	0.3	4.8	0.0	0.0	0.7	26.8	0.1	0.0	0.0	17.6	30.1	0.3	0.0	0.0	53.7	7.6	0.5	1.8	15.2	20.9	100.2	1.4	11.9	7.6	0.0	0.1	0.0	0.4	0.1	0.0	16.7	0.0	0.2	8.9	0.6	31.9	6.8	8.6	5.8	4.4	6.9	2.2	10.1	6.2	2.8	2.5	26.0	14.0	0.4	5.2	1.6	3.3	4.9	6.2	18.4	17.8	19.9	26.4	17.2	18.1	19.1	18.5	19.6	18.1	20.3	17.2	36.4	54.5	34.5	12.1	5.0	39.8	66.0	135.5	67.2	12.0	89.8	93.6	12.4	48.6	109.2	49.7	22.9	126.6	9.6	119.8	68.4	63.8	1.3	47.2	13.2	23.0	11.5	11.4	5.7	62.1	67.1	16.0	31.6	59.4	19.0	37.2	30.0	122.5	44.7	20.2	11.0	81.3	71.2	20.5	18.0	1.3	19.9	16.0	39.2	6.5	4.0	33.2	6.2	1.0	3.1	137.3	99.6	24.5	2.3	80.2	70.6	80.6	80.3	33.0	0.0	6.3	15.9	1.3	1.3	46.8	57.8	117.4	12.2	34.5	99.6	104.4
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742039-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: AB_2673919"	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.38e-4)"	8.6	15.3	5.1	6.0	4.9	3.2	9.8	5.3	6.9	12.3	4.7	11.1	8.6	8.0	5.1	7.9	9.3	7.1	8.4	4.8	5.1	11.0	22.0	6.2	11.0	5.6	4.8	12.0	12.5	5.3	7.3	4.5	5.7	10.7	4.5	1.0	18.8	6.2	11.6	7.9	7.3	4.6	5.0	9.0	11.5	4.1	5.4	4.3	8.0	8.1	4.9	10.7	9.0	5.8	13.8	8.5	3.4	5.5	6.3	16.0	6.5	9.9	13.8	14.2	8.8	3.8	4.8	15.1	4.6	5.6	3.4	9.5	6.9	6.3	6.9	14.6	27.2	5.3	5.8	10.7	13.4	9.7	7.7	10.9	13.8	8.0	12.6	7.5	11.0	4.2	8.2	13.1	5.7	20.1	4.3	8.9	8.4	15.0	20.9	8.6	10.8	17.2	15.9	3.9	11.8	10.8	5.4	20.5	25.9	2.9	8.6	5.9	6.0	19.3	10.2	18.6	9.2	18.2	15.9	13.5	13.5	7.1	13.2	10.1	7.8	4.1	6.1	15.2	7.3	13.0	6.2	7.2	11.5	9.6	6.6	8.3	0.4	11.1	12.0	6.0	4.9	5.9	5.1	4.9	5.3	6.9	4.8	5.1	5.6	4.8	5.7	5.0	5.4	5.8	21.4	22.4	19.6	14.4	22.8	11.6	22.2	23.3	40.5	5.5	29.4	37.7	7.8	18.6	23.9	20.2	6.2	16.0	16.7	9.0	29.4	25.0	5.5	12.7	23.3	18.4	19.8	12.6	10.0	28.0	13.5	21.4	11.7	21.6	23.4	17.2	20.3	36.3	27.9	5.0	11.2	14.6	16.2	19.0	14.9	4.3	18.6	19.2	14.2	9.4	22.6	17.4	41.2	16.1	14.2	21.2	11.3	11.7	34.1	20.5	20.2	58.1	24.1	8.1	6.6	19.1	21.9	15.1	16.7	19.8	15.6	13.3	15.9	27.1	21.2	17.2
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 968.3"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000	"Cluster 35: T-regs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	22.4	7.7	9.8	14.6	15.4	0.3	12.0	23.0	22.0	2.8	8.1	4.2	1.2	4.2	15.7	2.1	5.1	8.0	7.5	11.0	16.0	24.3	968.3	39.9	4.3	14.3	21.4	59.9	3.2	0.2	8.8	72.5	16.3	27.8	3.3	0.6	2.5	13.0	5.5	33.8	5.0	12.9	9.4	7.3	7.1	7.2	12.8	0.6	5.2	10.6	1.9	27.9	6.3	17.5	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	9.8	15.4	23.0	22.0	11.0	16.0	14.3	21.4	16.3	9.4	12.8	17.5	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42552922-42555214	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"placenta: 82.3"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 1574.2;Syncytiotrophoblasts: 1495.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"BEWO: 399.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021032, HPA065296"	Enhanced		Supported	Cytosol		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	4.4	1.9	3.8	1.7	4.2	0.8	3.0	3.9	4.6	3.0	2.7	2.2	2.1	2.1	0.7	6.0	3.2	0.5	2.1	3.8	3.5	2.4	2.0	1.5	1.0	4.8	3.5	6.8	3.0	0.6	2.4	82.3	4.4	2.6	0.1	0.6	3.7	0.5	4.4	6.3	2.1	0.2	3.2	2.0	2.2	3.8	3.9	0.4	2.8	0.0	0.4	1.7	3.1	6.1	7.0	6.0	1.8	20.2	1.0	0.3	399.0	4.3	0.0	0.0	0.0	2.9	2.8	0.1	4.0	0.2	1.8	9.7	0.7	3.9	0.0	7.6	10.7	3.7	3.8	4.3	0.9	2.7	3.9	0.9	13.2	0.5	2.7	1.5	0.1	2.6	5.7	1.2	0.0	4.8	3.2	2.3	0.4	1.4	2.8	3.9	3.0	2.5	0.5	3.4	4.3	5.6	2.4	41.4	4.2	0.9	48.5	1.1	4.3	2.7	5.4	2.4	2.7	7.7	4.6	1.5	1.9	1.9	2.8	1.0	2.2	2.5	1.1	2.4	1.3	1.2	1.4	1.1	1.3	1.4	1.0	1.0	2.2	1.6	1.5	0.9	0.8	2.0	3.8	4.2	3.9	4.6	3.8	3.5	4.8	3.5	4.4	3.2	3.9	6.1	2.3	0.0	2.2	6.5	2.2	3.1	8.0	14.9	6.2	8.3	11.6	10.7	3.0	4.3	5.3	5.5	12.5	333.0	3.3	4.7	23.5	1.7	1.4	3.3	9.3	4.2	4.2	0.8	1.4	5.6	30.4	11.6	1.5	3.8	2.5	1574.2	3.6	6.4	29.7	10.1	1.6	2.7	8.2	0.6	1.2	1.9	1.8	3.6	1.8	1.9	1.0	11.2	2.1	2.0	3.3	2.0	2.0	3.4	1.4	11.6	2.5	20.5	4.2	8.9	0.0	6.7	29.2	0.8	2.7	14.6	7.4	1495.8	2.6	30.0	2.6	10.4
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434370	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, tRNA processing"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 444.0;Proximal tubular cells: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	71.1	110.7	63.5	52.5	67.5	64.8	62.7	70.0	64.7	58.1	64.6	62.8	58.0	62.0	56.2	111.6	55.4	33.4	103.8	62.0	68.4	99.1	261.3	48.4	59.4	70.4	68.2	67.1	74.8	73.4	66.1	37.2	67.8	50.7	62.9	12.7	55.0	46.0	90.5	90.0	50.3	62.0	66.6	52.0	66.4	21.5	69.1	60.1	66.4	81.6	76.3	56.3	59.8	69.2	121.9	203.1	97.2	181.3	93.4	41.0	146.5	73.7	72.9	192.0	125.3	210.3	101.8	205.8	65.6	84.9	124.2	124.5	316.1	148.7	104.3	164.1	177.7	97.1	283.6	177.0	156.3	185.1	145.5	87.6	138.9	148.7	82.8	41.6	142.2	181.2	141.6	158.1	90.3	426.7	165.3	277.0	269.9	163.0	259.5	166.2	179.2	364.9	149.3	132.2	171.1	225.1	211.7	250.2	138.6	123.0	263.3	169.8	64.2	81.7	129.7	171.9	113.4	128.3	194.1	256.5	113.4	384.9	123.2	54.2	127.8	40.4	84.8	125.1	87.2	98.8	78.0	84.1	176.7	111.4	64.4	67.9	10.5	98.7	94.5	96.5	114.8	126.6	63.5	67.5	70.0	64.7	62.0	68.4	70.4	68.2	67.8	66.6	69.1	69.2	42.8	48.1	37.3	4.9	61.8	86.4	90.2	150.8	44.9	11.8	72.5	74.9	62.0	107.2	70.2	101.2	4.2	173.2	55.0	73.8	283.7	131.5	1.6	26.1	64.7	58.3	104.6	71.3	2.5	135.4	228.1	72.0	28.1	51.9	56.5	75.3	56.4	444.0	136.8	13.5	3.3	78.2	99.7	73.9	98.6	5.7	78.3	65.4	96.0	3.7	118.7	61.3	89.6	6.6	6.2	101.9	54.1	94.8	83.3	74.6	78.5	427.8	31.5	13.2	78.9	63.1	117.9	23.6	56.3	91.3	116.2	151.6	62.4	104.1	103.0	83.7
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336515-87391188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 288.6;liver: 241.6"	"Cell type enhanced"	"Detected in all"		"Paneth cells: 498.6;Proximal enterocytes: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 768.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 768.7;monocytes: 202.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 295.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	56.0	64.1	15.0	33.0	15.7	109.9	45.5	19.7	18.6	44.0	18.8	139.6	216.7	57.5	28.2	21.5	44.2	107.7	21.0	15.6	18.4	75.9	241.6	104.4	41.5	20.1	17.5	60.6	54.5	10.9	13.1	47.2	18.9	25.5	145.8	8.2	14.8	34.2	12.1	14.5	288.6	49.4	19.3	42.7	36.6	10.1	16.7	36.3	19.3	26.3	34.9	41.8	33.5	22.8	1.0	45.4	22.2	56.1	66.5	92.4	31.2	23.4	39.3	16.1	29.9	38.2	295.2	0.0	45.8	26.2	14.8	0.9	65.6	5.2	18.0	72.1	13.8	63.3	22.9	131.0	37.6	114.8	114.0	65.3	1.7	22.5	7.4	51.3	31.5	27.4	67.9	32.7	30.1	1.8	24.0	144.8	37.8	146.7	7.6	63.2	20.4	77.7	45.5	70.0	7.2	69.3	47.5	1.6	87.0	28.2	0.1	112.7	24.9	11.0	47.9	43.1	13.0	15.0	6.6	7.1	20.1	80.6	77.0	591.1	202.0	442.9	62.5	142.7	74.8	57.1	62.6	64.6	108.2	47.6	55.8	64.2	768.7	82.3	125.8	36.8	77.4	171.6	15.0	15.7	19.7	18.6	15.6	18.4	20.1	17.5	18.9	19.3	16.7	22.8	169.0	314.1	179.5	13.4	89.0	28.0	77.0	16.0	10.8	1.8	5.0	6.2	5.3	368.9	83.7	44.1	2.1	30.6	63.1	356.8	25.4	53.9	1.2	9.0	28.1	101.8	93.7	68.8	16.8	58.6	59.7	77.3	28.1	18.8	100.1	34.1	112.5	337.3	129.1	18.5	14.7	180.8	18.3	220.4	176.2	5.1	104.1	139.1	67.6	43.1	197.3	36.3	113.3	16.6	19.0	65.9	498.6	59.5	60.8	39.5	1134.9	173.6	62.2	3.9	72.3	77.9	43.0	2.7	15.4	10.4	21.5	14.9	93.8	65.4	281.0	93.9
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680680-43856617	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	60.9	65.4	42.0	31.4	50.4	25.1	48.8	58.1	63.0	51.3	71.5	65.8	67.3	37.4	50.6	36.3	41.3	35.6	69.5	42.0	54.3	91.3	122.9	51.4	28.5	58.8	52.1	45.3	43.5	134.3	28.5	41.6	58.9	52.8	59.5	47.0	46.9	41.5	27.8	30.0	41.7	48.6	52.8	34.8	56.1	33.5	48.9	22.3	66.8	51.6	32.3	31.4	26.8	61.9	40.2	64.3	68.4	69.6	226.8	211.5	45.0	96.7	97.8	67.3	73.0	75.7	80.7	97.4	69.4	91.5	111.7	151.6	48.7	125.5	82.6	19.0	89.2	46.4	28.3	66.2	114.6	132.3	125.4	131.1	93.6	68.1	193.6	85.9	96.1	60.4	43.9	157.9	59.4	22.9	38.6	63.1	126.0	49.9	45.3	63.9	102.3	110.8	129.5	95.9	24.5	56.5	132.0	110.7	100.2	64.6	80.2	112.5	92.4	73.9	28.3	189.3	117.6	81.6	110.3	58.3	78.5	25.0	55.4	8.8	13.4	7.0	12.1	14.8	13.5	12.7	9.6	10.5	21.3	15.2	15.6	13.9	11.2	16.4	8.2	18.4	6.2	11.6	42.0	50.4	58.1	63.0	42.0	54.3	58.8	52.1	58.9	52.8	48.9	61.9	73.6	64.1	111.1	96.6	45.4	31.7	47.1	92.8	57.5	77.1	46.1	36.4	80.7	74.4	81.4	51.5	77.2	60.4	30.6	82.2	27.4	100.2	61.8	36.9	47.5	70.9	138.2	40.8	126.9	82.3	42.1	59.7	60.6	37.0	155.9	37.3	76.1	214.0	63.5	121.1	155.6	75.5	87.5	50.9	43.7	24.1	34.2	45.3	39.2	59.0	37.2	128.2	30.9	128.7	97.5	71.4	62.5	56.8	61.4	61.3	54.2	50.1	75.8	67.8	78.9	45.4	60.2	17.5	14.5	66.0	45.7	74.8	29.4	95.5	115.5	48.6
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322886	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 573.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"							HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	9.4	0.3	0.6	0.2	0.6	1.4	6.4	2.4	1.0	2.7	0.1	0.7	0.4	2.7	0.2	0.2	1.0	0.2	0.4	0.6	0.5	0.4	573.7	3.6	0.2	0.8	0.5	0.5	1.8	0.1	0.2	0.8	0.9	4.5	0.4	0.8	0.2	0.2	0.3	6.5	0.7	4.2	0.4	0.7	0.3	0.4	0.5	0.3	0.2	0.1	0.1	1.2	7.8	0.9	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.1	1.4	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.2	1.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.6	0.6	2.4	1.0	0.6	0.5	0.8	0.5	0.9	0.4	0.5	0.9	100.0	3.2	6.4	1.6	0.0	2.5	22.6	0.3	0.0	0.2	0.2	0.3	0.3	4.3	42.9	1.8	0.0	0.1	0.4	1.0	0.0	0.1	2.7	0.4	0.5	2.4	1.8	5.3	3.7	0.4	0.3	0.8	0.0	0.1	0.0	0.2	1.8	131.3	0.2	0.0	3.0	0.5	0.0	2.4	0.4	2.7	0.0	0.7	0.0	0.0	0.3	0.3	0.0	1.5	2.8	0.1	1.4	0.4	0.1	4.7	0.2	0.5	34.0	0.1	0.0	0.7	0.4	0.0	0.9	0.2	0.4	0.0	0.7	0.2	0.7	57.0
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813018-48836510	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2;Hofbauer cells: 149.9;Proximal tubular cells: 434.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.7;NK-cells: 4.7;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"GAMG: 53.9;HHSteC: 49.5;hTERT-RPE1: 37.9;Karpas-707: 50.7;RT4: 40.5"	"Not detected"	"Not detected"							HPA021467	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	9.2	39.5	38.1	3.2	36.3	1.2	11.2	42.8	47.7	34.1	72.5	10.5	3.3	31.6	5.6	4.2	22.7	11.6	8.1	37.2	38.2	58.2	78.8	13.1	8.0	35.6	41.2	56.2	6.2	46.7	24.1	7.3	35.3	15.0	1.9	10.0	6.4	9.2	1.3	7.7	8.2	8.5	35.8	8.7	8.6	4.8	43.6	9.6	25.3	2.2	3.8	15.8	14.6	37.0	0.1	14.0	14.1	2.4	15.8	2.6	0.3	2.6	19.9	1.1	1.2	13.4	0.2	8.0	14.2	0.6	53.9	0.1	1.3	0.1	1.3	0.5	1.0	4.1	0.3	1.8	49.5	0.0	20.9	19.0	0.5	1.2	0.5	37.9	18.1	4.8	0.1	50.7	0.1	0.5	1.1	0.4	1.2	8.2	9.3	7.9	0.1	1.5	0.0	40.5	3.5	9.0	0.0	1.8	10.9	6.0	0.4	0.5	0.0	0.3	5.2	0.5	0.1	8.9	18.9	0.6	11.9	1.2	0.1	0.0	0.0	0.0	0.9	0.0	1.5	3.7	1.5	0.7	0.0	2.5	3.1	2.3	0.0	4.7	0.0	0.5	0.5	0.8	38.1	36.3	42.8	47.7	37.2	38.2	35.6	41.2	35.3	35.8	43.6	37.0	3.3	3.2	11.5	21.5	6.0	2.5	3.6	1.7	0.0	5.5	1.3	5.0	2.0	1.5	4.4	7.3	0.0	1.4	0.3	0.0	78.2	1.9	0.4	0.3	3.5	8.2	13.2	5.3	5.0	1.1	3.0	14.1	2.0	0.7	7.0	7.4	28.5	32.0	149.9	11.8	5.0	0.3	8.2	13.4	9.5	1.4	4.1	17.3	21.4	6.5	8.0	53.5	1.0	4.5	0.8	2.6	0.0	7.2	0.1	3.8	2.2	434.5	0.7	1.6	0.0	2.4	2.9	5.6	15.7	0.3	1.8	2.2	2.8	7.5	0.2	2.9
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 429.0;liver: 217.9;placenta: 381.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	1.6	0.0	0.4	4.2	0.2	0.7	26.4	0.9	0.4	4.3	0.2	74.8	429.0	1.2	0.1	9.6	0.1	21.1	0.2	0.3	0.2	9.6	217.9	2.3	0.3	0.1	0.0	0.3	23.2	0.0	1.2	381.8	0.1	2.0	56.9	17.4	22.1	0.2	0.1	4.2	188.6	2.4	0.0	0.2	20.1	0.3	0.1	0.4	0.1	0.0	3.4	78.6	1.4	0.3	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.9	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.3	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.1;testis: 36.7"	"Group enriched"	"Detected in some"	6	"Leydig cells: 108.1;Oligodendrocytes: 93.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;HEL: 1.0;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	1.6	0.8	3.1	0.2	4.3	0.0	1.7	3.4	5.9	3.1	2.4	2.7	0.5	1.5	0.9	0.7	3.5	0.2	2.1	3.1	3.6	4.7	15.1	1.8	0.0	4.3	3.9	1.4	4.2	0.0	1.7	0.1	4.2	3.2	0.1	0.7	1.0	0.1	0.5	0.9	3.7	0.0	3.3	0.9	1.4	36.7	4.2	0.1	10.0	0.1	0.0	1.6	1.8	5.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	4.3	3.4	5.9	3.1	3.6	4.3	3.9	4.2	3.3	4.2	5.4	0.0	0.0	0.0	15.3	0.2	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	4.0	0.2	0.0	0.4	1.8	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.5	0.0	0.0	0.4	14.4	108.1	1.1	0.0	4.7	0.1	0.6	0.0	1.0	93.2	0.2	0.1	12.8	0.0	0.1	0.6	0.0	0.5	0.2	0.0	0.1	0.5	1.9	1.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1804.3"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	8.5	2.5	13.1	6.9	16.2	0.5	0.7	13.4	18.9	28.0	9.4	24.7	3.2	20.9	1.6	9.9	6.5	9.1	0.8	12.3	12.6	2.5	1804.3	63.2	0.8	12.0	14.6	6.0	0.6	0.5	0.6	5.4	11.5	51.2	7.6	0.8	0.4	69.2	0.4	1.2	4.8	13.1	12.4	47.5	5.7	23.3	13.7	0.9	31.4	0.5	0.9	36.7	14.6	12.8	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	13.1	16.2	13.4	18.9	12.3	12.6	12.0	14.6	11.5	12.4	13.7	12.8	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"	4.3	16.1	3.3	5.1	3.1	2.8	8.2	3.0	6.0	5.6	3.8	6.4	6.7	4.0	7.2	8.9	5.1	4.2	3.5	2.9	4.0	5.2	30.2	7.6	8.3	3.8	3.7	6.8	5.3	5.1	7.7	4.6	3.9	5.9	8.0	4.0	6.2	3.5	6.0	7.6	6.6	4.4	3.3	5.6	5.9	2.6	3.7	8.1	6.1	2.8	8.1	5.5	5.6	3.7	12.6	12.2	32.4	13.8	18.4	18.3	20.2	4.6	15.9	9.4	19.0	17.0	35.7	29.6	10.6	4.4	58.3	19.1	30.6	43.4	9.9	12.4	15.5	7.7	8.2	26.8	15.2	13.9	12.7	11.6	23.5	36.8	11.6	7.4	15.7	19.4	14.5	19.0	8.3	8.9	17.7	13.7	20.5	24.4	15.3	9.5	19.3	18.5	33.3	19.5	27.6	14.6	8.0	7.7	7.9	27.5	12.3	17.1	9.8	4.4	10.2	6.7	10.0	11.2	12.7	29.4	6.6	1.2	11.1	21.7	6.7	12.1	13.6	6.8	14.8	12.6	10.1	13.7	6.9	11.9	12.9	12.4	5.5	8.2	8.5	10.0	17.9	12.2	3.3	3.1	3.0	6.0	2.9	4.0	3.8	3.7	3.9	3.3	3.7	3.7	8.8	0.0	25.5	22.5	22.6	11.0	19.5	48.3	35.9	23.6	24.9	11.9	2.4	12.8	26.1	11.0	62.6	17.2	19.9	14.9	3.9	16.9	2.0	9.4	7.9	12.0	6.0	4.2	8.4	27.1	15.1	13.1	8.6	9.3	5.1	32.8	8.9	62.0	13.4	11.8	9.1	14.5	18.3	5.0	16.9	1.9	6.8	12.2	17.8	5.6	10.6	14.3	16.5	12.5	22.6	15.0	17.9	7.2	18.1	19.0	12.1	10.2	19.9	44.1	0.0	5.9	10.5	4.9	6.6	15.6	12.6	19.2	23.5	34.1	11.6	12.6
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204655-33206831	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Proximal tubular cells: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		97000	"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	9.6	24.6	10.1	6.5	10.5	9.7	17.0	9.9	11.3	13.7	10.9	18.0	19.7	7.2	29.4	25.5	23.6	7.9	20.3	9.6	10.8	30.7	67.4	11.2	10.5	11.3	11.9	8.6	55.3	42.2	14.1	5.6	12.3	11.3	16.2	11.8	25.1	16.5	20.8	25.9	18.8	7.3	11.4	12.1	15.1	5.9	10.8	13.3	32.9	25.0	15.1	9.8	12.8	11.3	7.0	15.0	6.8	9.3	2.3	4.4	1.3	0.8	4.7	0.1	0.1	5.8	17.5	45.4	11.2	1.2	2.2	29.1	7.2	11.7	1.0	8.6	0.0	2.6	14.0	27.1	20.0	0.0	3.8	5.0	28.9	0.2	49.4	0.4	2.1	13.6	0.3	46.2	4.1	9.4	31.2	1.3	2.1	23.3	2.9	11.0	1.2	79.5	27.8	1.3	12.1	7.6	2.9	34.3	7.6	4.6	62.0	1.8	1.3	0.7	7.3	0.6	0.4	65.5	42.4	16.6	3.1	1.0	1.7	0.1	5.8	2.0	18.7	13.4	30.0	16.6	24.0	29.2	11.6	13.1	26.4	28.5	0.7	16.8	14.6	20.8	21.8	26.7	10.1	10.5	9.9	11.3	9.6	10.8	11.3	11.9	12.3	11.4	10.8	11.3	12.5	19.2	21.6	3.3	18.6	29.7	28.3	55.0	21.6	12.4	31.3	34.8	31.8	48.6	25.9	22.0	6.2	29.9	9.7	21.2	125.2	27.9	6.3	20.0	6.0	10.1	18.0	12.8	0.3	32.4	12.9	9.1	16.3	13.7	7.0	9.8	10.0	83.2	17.4	1.7	0.5	26.6	20.3	10.3	16.4	18.1	7.5	7.9	49.8	1.0	8.1	32.6	6.2	1.0	0.7	21.9	21.1	6.0	47.6	15.4	74.8	137.2	33.3	14.8	0.0	11.3	9.8	8.1	8.5	40.0	37.2	17.4	18.0	29.8	44.4	31.5
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 77.7"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 140.8;Syncytiotrophoblasts: 502.0"	"Cancer enriched"	"Detected in single"	4	"urothelial cancer: 1.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.0;cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 64.1;SuSa: 26.5"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	1.2	0.2	0.0	1.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	77.7	0.0	0.1	0.5	0.0	0.1	0.0	0.1	4.5	8.7	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	7.0	0.7	0.8	26.5	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	140.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	502.0	0.0	0.1	1.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 2174.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.4"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.2	2174.8	0.3	2.1	0.8	0.0	0.1	0.0	0.7	0.2	0.0	7.7	0.0	0.2	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.9	0.5	0.0	0.1	3.6	0.1	0.4	1.0	0.0	1.0	0.0	0.1	0.2	38.7	0.1	0.0	0.2	0.3	2.9	0.2	0.5	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	3.5	0.0	0.0	0.0	40.6	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	38.8	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	68.9	1.7	0.0
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989147	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 61.8;eosinophil: 27.3"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 61.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Approved		Enhanced	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	27.3	25.7	5.7	10.9	6.2	4.4	17.1	14.7	9.1	8.5	3.5	15.9	19.5	9.5	2.1	12.3	9.4	11.5	11.7	5.9	5.9	27.7	136.5	11.2	8.4	6.3	5.4	8.6	25.6	8.0	5.4	4.5	6.6	8.2	5.8	1.6	10.0	4.5	7.0	18.5	18.4	9.8	5.6	16.3	11.1	6.0	7.1	2.8	6.3	4.5	5.5	13.9	8.7	6.9	20.3	23.2	2.4	11.5	7.9	28.5	1.4	24.8	38.7	4.8	10.0	1.7	34.4	1.2	8.1	30.3	0.8	6.1	2.2	3.6	2.4	91.0	5.4	1.6	18.6	66.2	7.4	0.5	98.1	13.7	6.0	23.1	4.6	11.2	2.2	1.2	4.9	1.0	18.3	43.6	0.6	14.4	1.9	8.5	3.2	2.5	7.8	22.3	15.1	1.3	8.4	4.1	3.2	15.9	2.2	1.1	31.1	1.6	11.5	10.0	2.8	96.1	2.7	1.6	15.4	1.1	39.1	2.5	0.8	61.8	1.4	27.3	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.2	0.0	0.1	1.2	0.5	0.0	0.6	0.0	0.7	5.7	6.2	14.7	9.1	5.9	5.9	6.3	5.4	6.6	5.6	7.1	6.9	7.6	3.2	4.2	3.3	1.2	7.9	2.6	4.1	4.0	0.7	13.6	9.8	1.7	27.1	2.2	14.7	0.0	2.0	0.5	10.8	15.6	42.5	37.5	1.9	7.1	11.1	7.8	4.8	0.2	30.3	3.5	26.0	8.2	4.2	9.5	9.0	6.8	68.9	53.9	1.7	0.4	11.4	6.1	7.3	15.9	2.2	6.5	11.4	14.2	0.0	12.8	2.1	0.0	0.5	1.2	20.7	14.0	5.3	1.9	1.8	45.3	46.7	1.3	0.5	13.1	9.4	6.3	0.8	1.2	4.9	12.6	1.4	1.7	6.5	23.5	2.8
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112380080-112472405	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 181.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	76.3	63.6	28.1	13.3	30.1	11.6	22.8	25.1	29.5	23.3	27.6	31.7	38.9	22.8	11.5	29.8	21.2	19.0	89.9	24.8	33.1	69.0	149.0	28.7	13.9	25.4	33.2	50.8	20.0	21.8	8.8	16.8	27.1	20.3	26.9	12.6	18.8	15.9	151.7	31.1	32.2	20.5	26.6	18.6	24.6	14.0	32.0	19.6	30.4	181.3	15.8	29.2	15.0	28.5	45.0	39.4	29.0	14.8	49.0	48.4	33.4	30.1	18.6	21.1	17.7	77.0	49.4	28.5	16.2	44.4	26.9	50.6	31.9	42.2	25.8	120.9	21.0	30.0	58.5	76.1	30.7	17.1	18.5	52.0	29.9	31.3	22.8	30.5	24.8	34.7	42.3	18.9	58.2	29.6	42.5	15.3	17.2	106.9	50.3	27.1	87.4	42.7	44.5	40.4	20.7	14.5	75.8	49.5	26.0	23.7	70.0	20.0	28.3	30.2	27.9	85.2	29.6	21.5	57.3	13.5	37.0	24.8	18.2	54.3	8.4	32.8	4.6	8.1	6.8	6.9	4.8	5.0	9.5	8.4	5.6	5.9	48.0	5.9	11.5	9.4	8.7	4.9	28.1	30.1	25.1	29.5	24.8	33.1	25.4	33.2	27.1	26.6	32.0	28.5	32.0	99.3	84.3	48.6	14.1	13.3	17.5	21.6	29.6	9.3	12.0	13.3	214.8	14.3	32.2	14.7	6.2	26.5	18.3	23.7	64.6	15.5	153.9	38.6	38.3	19.1	14.9	32.8	10.8	18.7	30.9	31.1	29.0	27.8	30.4	187.2	17.2	124.2	35.7	6.7	12.2	32.2	8.2	23.6	12.5	163.0	27.4	27.5	8.8	15.9	47.3	24.1	6.2	16.1	19.3	13.2	23.5	47.0	20.9	16.0	52.4	111.1	37.7	14.5	46.0	18.1	46.9	12.9	16.4	34.2	16.2	31.7	16.2	108.9	36.2	29.5
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314720	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	51.7	55.7	20.0	14.7	19.2	18.0	47.9	18.2	24.0	48.6	17.0	70.6	14.1	51.7	7.4	48.1	52.1	12.4	133.5	18.6	19.1	50.2	46.0	49.5	14.5	22.3	21.4	57.3	68.7	18.7	48.1	17.0	20.2	53.2	10.8	7.6	39.8	17.1	125.1	49.2	39.7	15.3	18.6	42.8	57.8	107.8	21.7	14.7	45.7	32.2	12.6	58.7	46.2	18.0	40.8	53.8	22.9	19.6	37.6	35.0	37.9	29.7	26.6	28.8	25.0	36.3	34.6	46.7	42.5	41.5	28.2	28.9	35.2	42.7	18.3	29.9	40.7	58.4	51.8	50.1	59.1	17.1	43.4	34.2	39.3	40.6	74.2	30.6	39.4	41.9	39.6	27.1	29.4	82.0	58.0	26.2	29.4	52.6	154.2	37.2	19.9	59.2	20.6	40.5	34.3	27.9	45.4	35.9	52.8	23.8	40.5	34.5	40.2	29.5	66.3	46.8	49.5	18.8	15.4	39.9	41.8	31.4	28.8	14.2	23.2	26.3	16.7	24.9	17.2	19.2	17.8	21.1	24.6	17.3	17.1	15.9	9.7	16.3	32.2	12.6	22.9	19.2	20.0	19.2	18.2	24.0	18.6	19.1	22.3	21.4	20.2	18.6	21.7	18.0	46.5	6.4	11.2	8.5	40.4	51.4	73.8	53.8	39.9	67.8	37.0	30.5	46.4	22.8	34.7	29.5	62.6	69.9	38.2	43.3	150.6	39.2	248.7	35.1	20.5	44.4	40.9	120.8	12.1	41.1	80.6	34.7	44.9	34.6	37.5	51.1	40.7	63.8	49.5	69.0	14.7	36.8	42.7	25.7	45.6	106.7	37.3	32.7	33.8	12.2	59.7	24.9	34.0	6.0	12.9	45.3	49.3	42.9	40.4	76.6	63.8	34.9	25.9	33.1	59.2	41.3	39.2	84.4	47.7	36.3	45.5	111.0	39.0	105.9	45.8	76.4
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
HSF2BP	MEILB2	ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529186-43659488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 24.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 125.5;Late spermatids: 49.0;Spermatocytes: 132.4;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.3	0.3	0.4	0.1	0.5	0.1	0.5	0.3	0.9	0.5	0.3	0.3	0.2	0.6	0.5	0.3	0.6	0.2	0.4	1.3	0.7	0.5	0.2	0.2	0.3	0.5	0.5	0.7	0.2	0.8	0.8	0.9	0.6	0.4	0.2	0.9	0.4	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.2	24.1	0.7	0.1	0.5	0.1	0.2	0.3	0.4	0.7	4.6	0.9	1.2	0.5	0.2	1.1	1.1	1.6	0.9	1.6	1.4	6.1	4.5	3.5	2.4	0.9	5.7	1.8	0.6	12.8	0.5	0.9	1.1	0.6	1.9	0.3	1.4	1.5	0.4	0.7	8.2	0.7	3.8	7.5	0.4	2.0	1.3	1.1	3.9	0.8	2.0	1.4	3.9	1.1	1.9	2.9	1.2	0.5	2.0	0.8	1.3	1.0	3.3	1.6	1.7	0.5	1.7	1.7	2.6	0.9	3.0	0.2	2.4	1.2	0.9	2.8	0.8	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.0	0.3	0.7	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.9	1.3	0.7	0.5	0.5	0.6	0.3	0.7	0.7	0.2	0.0	0.0	2.6	0.1	0.9	1.5	4.7	2.8	1.0	1.3	1.7	0.7	0.0	2.0	0.0	0.0	1.8	0.2	0.2	0.0	1.1	125.5	0.5	1.4	0.5	0.0	0.0	3.0	0.2	2.8	2.1	0.0	0.4	0.0	2.4	0.4	0.3	0.7	0.0	1.7	0.1	0.0	0.0	0.7	49.0	1.8	0.5	0.0	0.0	0.0	2.1	0.0	3.0	4.4	2.7	0.3	1.5	0.0	0.8	0.0	1.1	2.8	2.5	13.1	0.5	0.9	132.4	63.1	0.6	0.4	0.8	0.2	3.8	0.3	1.0
HSF5	FLJ40311	ENSG00000176160	"Heat shock transcription factor 5"	Q4G112	17	58420167-58488408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"testis: 48.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 53.8;Spermatocytes: 68.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.3;T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016440, HPA063613"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA016440: AB_1851142, HPA063613: AB_2685060"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (7.48e-3)"	"unprognostic (7.40e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (6.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.64e-2)"	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	48.7	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.6	0.5	0.0	1.3	1.1	0.8	0.0	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	14.6	3.1	0.1	0.0	0.0	0.0	0.2	2.1	0.5	2.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	68.8	3.3	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HSFX1	LW-1	ENSG00000171116	"Heat shock transcription factor family, X-linked 1"	Q9UBD0	X	149774068-149776867	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											"HPA051700, HPA063040"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"		Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"			"unprognostic (2.30e-2)"	"unprognostic (6.32e-2)"		"unprognostic (3.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-1)"	0.8	0.8	1.5	0.3	1.8	0.0	1.1	1.9	2.6	1.7	2.8	1.8	0.5	1.3	3.3	1.2	1.5	0.8	1.9	2.0	1.4	1.0	1.0	0.9	0.4	1.5	1.5	3.1	1.0	0.8	1.2	1.2	2.2	2.0	0.1	0.7	1.3	0.6	1.3	1.2	1.0	0.4	1.0	2.5	1.0	3.4	1.8	0.1	1.5	0.0	0.4	1.4	1.5	1.8	0.0	1.1	0.0	0.4	1.4	0.9	0.2	0.2	0.0	0.2	0.0	0.8	0.7	0.7	1.2	0.1	0.7	0.0	0.6	0.2	0.1	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.6	1.1	0.3	0.0	0.0	0.2	0.1	1.3	0.1	0.5	0.3	0.1	0.6	0.3	0.8	0.0	1.0	0.5	0.5	0.2	0.1	0.0	0.2	0.8	0.1	0.2	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.8	1.9	2.6	2.0	1.4	1.5	1.5	2.2	1.0	1.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFX2		ENSG00000268738	"Heat shock transcription factor family, X-linked 2"	Q9UBD0	X	149592512-149595314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 12.3"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HEK 293: 1.1;hTCEpi: 1.5;MCF7: 1.4;U-138 MG: 1.5"									"HPA051700, HPA063040"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"					"unprognostic (7.64e-2)"					"unprognostic (6.92e-3)"				"unprognostic (2.00e-1)"				0.3	0.4	0.8	0.2	1.0	0.0	0.6	0.9	2.2	0.5	1.0	0.6	0.5	0.6	0.2	0.4	1.0	0.0	1.2	0.7	0.1	0.5	0.5	0.6	0.1	0.5	0.3	1.0	0.4	1.3	0.4	0.4	0.4	0.9	0.5	1.0	1.0	1.4	0.7	1.2	0.3	0.7	0.0	1.1	0.4	12.3	0.1	0.6	0.5	2.1	0.2	0.3	0.5	0.8	0.5	0.0	1.1	0.6	0.0	0.2	0.0	0.2	0.5	0.2	0.6	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.3	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.1	0.3	0.5	1.5	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.9	2.2	0.7	0.1	0.5	0.3	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953931	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Plasma cells: 4874.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		330000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 12: NES - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	330.4	340.6	166.0	423.5	183.7	438.9	341.8	185.3	234.2	363.2	225.6	340.5	261.4	302.2	1032.5	157.5	305.5	218.9	309.5	164.4	206.2	317.1	736.4	271.1	245.9	205.0	191.3	302.6	397.1	336.0	247.2	521.1	201.6	360.2	387.5	185.6	254.9	382.8	87.5	120.0	269.5	385.7	188.8	322.4	297.6	180.7	196.5	228.2	1411.8	91.2	328.0	356.6	164.6	237.3	856.5	459.9	926.2	940.0	960.1	897.5	1229.9	1449.4	1133.4	776.0	1038.1	839.1	805.3	243.8	1102.2	1579.2	995.1	583.2	934.6	1578.9	1063.2	607.3	307.4	684.5	447.6	861.0	1457.4	702.1	514.6	519.6	690.9	920.0	1342.8	2643.7	1513.9	293.8	560.0	914.8	1039.9	314.7	409.2	768.3	756.9	925.5	544.5	372.2	597.1	1079.2	1064.3	527.1	271.5	645.7	889.2	912.0	932.7	1468.4	743.9	1016.2	854.4	566.1	476.0	462.8	607.9	945.5	949.0	455.6	1106.9	494.7	904.5	113.8	81.3	30.3	199.7	88.6	244.9	108.5	118.5	187.8	111.8	71.1	75.9	133.8	18.7	199.3	83.3	322.7	81.1	188.5	166.0	183.7	185.3	234.2	164.4	206.2	205.0	191.3	201.6	188.8	196.5	237.3	507.5	237.2	373.8	28.7	646.0	309.3	905.1	743.6	196.9	50.3	261.4	334.0	687.8	235.9	475.3	257.5	156.4	568.4	480.6	424.0	56.7	471.2	89.6	570.8	751.1	439.6	406.6	213.5	34.0	250.4	1081.0	714.0	390.9	690.9	405.3	500.6	446.9	891.9	553.1	77.4	41.9	631.5	238.0	300.1	309.8	47.0	563.2	378.4	421.6	52.5	240.5	141.0	199.8	30.2	61.3	321.8	419.1	337.7	4874.6	760.6	246.1	271.4	404.2	111.6	216.9	325.7	569.3	489.0	154.4	196.3	260.7	921.0	316.0	542.6	494.6	620.0
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0"	"Group enriched"	"Detected in many"	14	"B-cells: 1.7;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	15.8	21.9	10.9	1.5	13.5	0.0	8.8	11.2	28.2	13.7	7.9	12.4	0.7	9.2	12.5	3.9	10.3	2.3	9.6	16.6	11.1	17.4	1.6	3.0	2.7	17.3	12.2	20.5	2.7	20.0	7.9	0.8	16.4	5.6	1.9	11.0	2.6	5.5	4.9	5.7	4.1	4.6	2.7	3.8	4.7	6.2	27.3	2.1	9.4	3.4	2.8	7.9	10.0	14.7	8.0	10.0	0.1	7.1	6.6	4.4	0.1	5.5	10.1	1.9	1.0	10.0	2.8	0.0	4.1	7.6	5.2	6.1	8.4	0.7	4.9	0.0	3.2	0.0	0.8	5.5	1.9	0.0	1.0	1.7	6.6	7.3	0.9	13.9	0.0	3.3	0.0	0.0	2.1	4.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	1.2	22.1	1.8	5.3	12.7	4.0	2.9	3.0	2.4	3.2	0.0	0.0	1.4	5.5	12.3	10.2	0.1	3.2	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.9	13.5	11.2	28.2	16.6	11.1	17.3	12.2	16.4	2.7	27.3	14.7	2.1	6.4	3.6	27.7	1.0	11.1	1.6	0.5	2.8	35.8	5.2	6.9	7.8	2.8	2.0	12.9	22.9	0.1	0.1	1.6	15.6	4.2	4.4	12.5	16.1	3.1	0.0	0.0	205.0	3.5	0.1	17.8	0.0	4.4	0.0	2.4	2.9	0.4	0.1	30.3	186.4	0.3	0.0	0.0	5.2	9.7	63.3	0.5	26.6	9.4	0.0	35.8	0.0	27.6	54.8	2.4	0.0	68.4	0.1	2.1	0.0	25.4	11.3	10.2	13.1	14.7	14.9	1.0	5.2	0.5	5.1	0.3	0.8	82.0	0.3	0.7
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732685-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 65.0;Endothelial cells: 50.1;Hepatic stellate cells: 16.1;Late spermatids: 16.8;Microglial cells: 15.0;Peritubular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.9;EFO-21: 4.9;HUVEC TERT2: 9.5;TIME: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013659: AB_1234541, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	23.1	4.1	9.3	3.0	8.9	1.3	23.0	6.6	7.8	15.0	4.2	6.6	1.8	12.5	1.2	4.2	10.3	4.7	29.3	6.6	7.0	11.8	1.7	20.6	1.7	8.2	7.9	8.2	2.6	1.5	2.9	11.3	8.4	4.9	1.2	0.4	5.4	1.9	12.3	7.7	6.1	4.0	6.8	25.3	5.1	5.2	10.4	0.7	9.2	10.2	0.9	10.2	10.2	6.0	0.5	1.7	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.2	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.4	9.5	0.4	0.3	0.2	0.0	1.0	0.4	0.9	1.0	0.0	0.8	1.8	0.2	0.5	0.0	0.0	0.9	0.7	0.3	0.2	0.1	0.1	0.2	0.5	5.3	0.1	2.2	0.7	0.4	0.4	0.3	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.3	8.9	6.6	7.8	6.6	7.0	8.2	7.9	8.4	6.8	10.4	6.0	65.0	0.0	0.0	0.3	0.4	1.9	0.1	0.0	0.0	0.5	0.7	0.3	5.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.8	0.2	3.2	50.1	0.0	0.0	0.5	0.0	0.2	10.5	0.0	0.1	0.0	0.1	16.1	0.3	0.5	0.0	0.4	0.0	0.0	1.4	2.5	16.8	7.5	0.2	0.0	15.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	2.0	3.5	1.7	0.3	1.1	0.4	0.3	0.7	0.0	0.2
HSPA13	STCH	ENSG00000155304	"Heat shock protein family A (Hsp70) member 13"	P48723	21	14371115-14383484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 231.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014797	Approved				"Intracellular and membrane"	NA	NA		3300000	"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014797: AB_1857567"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	13.5	24.0	12.3	17.7	14.3	23.5	15.7	11.1	16.0	19.1	8.4	12.4	10.0	21.9	26.4	9.1	8.5	12.3	13.8	13.9	21.1	16.3	13.3	12.9	15.8	12.6	14.0	16.4	9.3	24.0	17.3	22.8	17.0	15.4	12.6	23.3	9.4	16.9	3.4	3.8	10.0	19.2	13.8	15.1	12.7	22.7	16.7	16.9	27.7	8.0	17.4	18.4	5.0	13.4	21.2	17.0	65.7	38.2	46.6	37.4	41.8	58.6	68.9	47.8	54.5	16.1	22.8	36.7	40.3	42.4	71.1	9.1	30.8	20.1	79.6	38.5	24.0	35.8	16.4	30.4	119.5	58.8	44.0	33.4	64.4	68.4	117.0	60.5	40.6	32.6	30.5	231.9	52.7	21.2	39.6	17.9	49.0	9.9	23.2	36.6	57.8	81.2	25.1	8.1	15.0	36.7	43.6	22.6	84.6	33.4	31.1	38.7	40.7	62.1	51.7	49.3	43.4	87.5	70.5	29.2	69.9	37.2	79.5	23.1	4.8	4.9	6.6	5.4	11.4	7.1	7.0	7.1	5.5	3.7	7.7	7.4	1.9	12.1	4.9	8.3	6.0	6.1	12.3	14.3	11.1	16.0	13.9	21.1	12.6	14.0	17.0	13.8	16.7	13.4	14.0	9.6	14.1	11.4	29.7	12.7	14.7	16.9	20.5	41.0	15.6	8.6	14.6	4.3	10.8	3.7	14.6	22.1	25.1	5.1	0.0	8.6	6.8	6.6	31.4	14.6	14.9	26.7	21.0	10.4	31.1	26.4	5.6	15.1	19.0	21.2	12.5	11.8	14.5	60.6	28.2	8.1	4.1	15.8	28.9	2.8	9.9	16.7	23.2	12.2	8.6	34.8	8.2	31.7	15.5	9.3	3.7	19.2	131.4	15.2	2.9	7.5	7.8	21.9	13.1	23.6	25.0	40.2	12.7	12.9	10.2	64.2	24.6	11.9	4.1	13.6
HSPA14	"HSP70-4, HSP70L1"	ENSG00000187522	"Heat shock protein family A (Hsp70) member 14"	Q0VDF9	10	14838306-14871741	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046180	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA046180: AB_2679571"	"unprognostic (5.84e-3)"	"unprognostic (5.85e-3)"	"unprognostic (5.73e-2)"	"unprognostic (6.40e-3)"	"unprognostic (7.98e-3)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (3.70e-8)"	"unprognostic (2.20e-1)"	"unprognostic (9.60e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.90e-1)"	8.9	9.2	9.2	14.7	9.5	42.8	13.3	13.5	12.4	8.5	7.8	14.7	13.1	9.2	11.1	11.0	7.1	8.9	11.4	10.0	9.5	10.2	11.8	8.8	19.4	8.3	8.2	7.9	11.5	8.2	8.8	10.1	8.6	8.8	17.8	10.3	10.1	8.9	21.4	13.3	12.5	9.7	8.6	12.0	9.4	30.9	9.1	18.6	10.3	16.6	19.1	13.0	8.0	10.2	54.0	38.9	33.7	30.7	15.7	21.7	43.6	27.8	14.6	47.5	37.9	52.1	38.9	66.8	21.6	25.7	23.5	43.1	55.3	32.8	49.7	28.2	56.0	62.1	33.0	30.4	13.4	43.6	39.9	15.9	15.0	38.9	11.4	11.8	24.3	53.8	54.3	53.6	35.4	37.3	65.7	30.4	34.9	55.2	20.7	50.3	43.8	53.9	24.7	27.2	19.1	23.5	31.3	43.1	35.8	32.0	49.0	57.6	13.6	19.8	27.7	77.8	45.1	36.6	85.4	67.8	39.6	56.3	11.4	15.8	12.3	13.3	13.7	18.0	14.9	15.1	14.0	17.2	13.4	14.5	11.7	14.6	6.1	17.8	15.8	14.7	20.3	10.7	9.2	9.5	13.5	12.4	10.0	9.5	8.3	8.2	8.6	8.6	9.1	10.2	8.2	6.4	3.3	7.2	18.7	26.3	20.5	37.9	30.7	16.6	7.8	5.8	19.3	14.3	21.2	3.7	6.2	36.2	17.5	16.2	1.9	4.2	53.9	6.7	8.7	12.1	6.0	20.4	21.8	3.9	65.6	16.2	18.3	8.9	10.2	7.4	11.7	12.6	22.8	6.7	19.5	17.0	26.4	11.6	20.3	14.6	14.0	12.1	14.2	10.3	9.0	17.6	23.7	14.6	15.9	4.7	19.9	12.4	33.3	24.4	15.2	2.0	12.5	13.7	13.1	23.3	33.1	223.8	71.4	25.7	26.1	48.7	21.5	8.0	21.2	22.2
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815543-31817946	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	64	"cerebral cortex: 403.6"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 4450.4"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	Yes		47000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	640.5	350.5	3.5	12.7	3.8	0.0	167.2	6.3	403.6	414.1	3.4	497.7	0.0	209.7	15.9	452.9	194.6	5.9	927.7	4.3	3.7	745.9	1116.2	1055.0	9.1	5.4	5.1	369.7	308.2	1.1	474.3	12.0	4.0	427.7	4.2	6.5	111.5	0.5	294.4	257.3	174.4	2.2	3.8	451.9	483.2	98.0	3.7	2.5	340.2	0.3	2.3	569.2	553.7	6.1	0.2	524.1	0.0	0.1	20.1	14.4	0.0	0.3	0.0	0.0	0.0	1.6	0.7	0.0	122.9	28.7	0.0	0.4	0.0	34.1	0.0	6.9	4450.4	0.0	1.7	3.1	0.0	1.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.4	0.0	0.5	0.7	0.0	0.0	16.6	5.3	0.0	0.1	4.1	0.0	49.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	2.3	3.2	1.1	3.6	0.7	0.6	1.6	1.4	0.3	0.2	0.7	0.6	6.8	0.8	2.0	0.3	3.0	0.4	3.5	3.8	6.3	403.6	4.3	3.7	5.4	5.1	4.0	3.8	3.7	6.1	1537.0	147.4	97.0	427.4	312.4	362.4	7514.5	125.5	968.7	305.3	782.0	844.3	1010.7	81.5	109.3	126.9	379.5	43.2	148.1	634.6	41.1	86.8	81.0	534.7	488.1	1049.0	469.2	64.0	9.7	21.6	154.1	1208.6	592.8	753.4	445.4	18.1	123.5	95.2	270.4	205.3	11.4	560.1	114.0	319.0	2690.4	49.5	603.0	1715.2	839.6	398.2	126.6	768.2	15.5	17.1	207.0	39.5	668.8	160.6	1173.3	1404.1	68.4	72.9	177.2	690.2	151.2	443.4	1802.0	65.4	148.8	1105.8	336.3	104.3	1382.2	285.6	454.9	3444.4
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827738-31830254	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 3007.4;Urothelial cells: 1619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 204.3"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	526.3	340.1	0.7	0.4	1.3	0.0	126.0	1.6	5.6	475.3	0.6	361.2	0.0	154.0	9.1	375.2	231.5	2.3	718.3	1.1	1.9	555.5	685.4	845.3	0.0	0.8	1.0	682.2	336.5	3.3	438.2	0.0	1.2	303.6	0.5	2.6	94.8	0.3	159.9	299.0	139.1	0.0	0.4	274.7	372.0	93.8	1.5	0.0	289.9	0.0	0.0	415.3	503.3	1.2	0.4	24.1	0.4	0.2	1.1	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	15.4	0.0	0.5	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	204.3	0.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	1.6	0.0	0.0	0.3	3.2	0.0	0.4	41.5	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.6	5.6	1.1	1.9	0.8	1.0	1.2	0.4	1.5	1.2	563.2	112.2	75.0	140.7	242.7	239.2	3007.4	63.2	630.0	44.6	509.4	403.9	512.3	40.0	73.7	69.9	131.3	82.7	82.8	542.8	19.6	45.5	1.9	434.9	380.2	446.2	318.6	57.9	2.7	15.6	140.8	585.8	595.8	710.4	346.8	14.1	25.7	17.7	142.0	47.1	2.8	426.3	61.1	84.4	1140.4	9.8	220.6	627.1	642.1	126.5	17.7	192.4	1.0	5.5	61.8	21.4	524.1	54.9	967.0	584.2	159.1	38.3	75.0	144.2	105.2	226.4	846.5	15.2	46.4	904.0	221.9	259.7	604.6	116.7	400.5	1619.4
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815283	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 63.2"	"Group enriched"	"Detected in many"	22	"Early spermatids: 212.5;Late spermatids: 560.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;EFO-21: 1.5;HEK 293: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		53000000		"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	1.2	1.4	0.0	0.0	0.2	0.1	0.9	1.4	0.3	1.5	0.0	1.8	0.1	1.8	0.0	0.6	2.4	0.0	1.4	0.1	0.2	1.5	1.2	1.3	0.0	0.2	0.2	2.2	0.9	0.0	1.7	0.0	0.3	1.1	0.0	0.1	1.0	0.0	3.9	1.0	1.5	0.0	0.2	2.4	1.3	63.2	0.4	0.0	1.5	0.1	0.0	1.6	1.1	0.6	0.1	1.1	0.1	0.4	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.4	0.4	0.1	0.0	0.1	0.3	4.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.4	0.6	4.2	0.0	1.1	2.9	3.5	0.9	1.3	0.4	2.2	2.6	1.9	2.0	4.5	0.0	0.9	0.0	8.4	0.6	1.4	1.4	0.0	0.7	212.5	2.0	0.7	2.2	1.8	3.2	0.6	0.2	0.6	1.3	0.0	1.3	0.0	0.9	1.8	1.1	1.3	3.3	0.8	1.4	0.0	4.4	2.5	560.9	5.0	2.1	5.4	2.8	4.1	3.6	1.0	0.5	2.0	0.4	1.4	2.2	1.9	0.9	0.9	0.6	2.2	2.8	0.0	0.8	2.9	17.0	8.7	1.7	0.1	0.4	3.8	0.9	1.5	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 320.2;skeletal muscle: 170.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4"	"Low region specificity"	"Detected in all"							"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		63000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	9.8	6.5	83.9	7.5	161.2	0.7	6.4	148.0	116.3	12.5	84.2	94.1	5.5	51.6	18.6	42.3	17.0	5.3	39.7	88.5	96.0	73.0	4.2	14.2	3.8	170.1	122.9	5.6	8.8	7.8	15.2	61.5	174.9	10.8	9.5	1.2	16.4	4.5	170.4	31.7	29.6	28.7	128.5	20.2	18.5	121.0	125.3	3.0	2.7	60.6	5.0	42.9	16.0	320.2	30.4	75.4	11.4	0.2	8.1	0.7	114.4	42.3	99.0	16.6	27.3	2.9	52.9	7.4	16.8	46.4	3.6	33.6	0.0	2.2	10.1	4.3	5.8	0.1	4.0	0.2	7.9	0.2	10.0	3.7	1.7	2.4	0.1	4.1	1.1	0.5	0.0	6.0	8.4	13.5	0.5	0.4	8.4	11.7	9.1	6.0	0.0	0.1	26.1	4.6	101.4	5.8	1.8	3.7	0.1	3.9	2.9	3.1	1.6	0.3	0.2	3.7	0.2	7.6	0.2	0.2	9.2	0.1	11.4	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.0	1.0	0.1	83.9	161.2	148.0	116.3	88.5	96.0	170.1	122.9	174.9	128.5	125.3	320.2	74.7	0.0	5.2	18.6	21.1	54.0	31.2	35.1	342.0	1.9	37.5	57.1	39.1	5.7	8.8	132.4	0.0	42.5	30.8	29.2	238.7	8.3	35.7	56.4	63.8	59.6	28.1	0.0	0.5	5.6	509.9	40.7	83.6	54.5	13.3	1.4	32.2	0.8	15.7	0.0	1.1	63.4	24.4	3.1	25.7	27.3	8.7	24.0	30.2	6.5	0.0	14.2	0.0	2.5	157.4	5.5	15.6	7.5	7.1	7.5	8.5	1.5	4.6	2.4	26.3	48.6	66.2	578.6	77.1	175.8	42.3	75.9	29.8	4.5	12.9	11.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 242.2;lung: 94.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebral cortex: 242.2"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 317.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 317.9"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 50.7"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	26.2	15.7	11.3	9.9	16.3	3.6	3.6	22.1	242.2	2.9	24.7	9.3	1.7	1.7	0.7	7.3	3.8	8.7	31.7	12.9	12.4	27.2	33.0	94.4	2.3	15.1	12.4	46.8	5.9	1.1	23.8	20.5	28.7	3.3	1.7	1.8	3.3	5.0	3.8	8.4	5.1	2.3	13.8	63.5	34.5	2.4	15.5	1.3	12.8	3.6	1.7	18.5	10.9	20.1	0.8	1.5	0.0	0.3	0.0	1.1	1.0	0.6	0.5	0.2	0.4	0.5	0.7	0.2	2.2	0.2	0.8	0.4	0.5	0.4	0.3	0.5	0.1	0.3	1.4	0.0	0.0	0.1	3.3	0.2	1.0	0.5	0.0	0.0	0.0	0.2	0.6	50.7	0.0	0.0	0.3	1.3	0.1	0.3	5.4	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.2	0.9	3.1	0.1	0.4	0.7	0.2	0.1	0.5	0.4	3.6	6.9	0.4	0.0	1.3	1.3	2.3	6.5	35.1	13.4	6.4	44.1	1.0	0.2	0.7	3.4	12.2	0.0	0.0	1.6	317.9	8.3	37.7	0.2	0.0	11.8	11.3	16.3	22.1	242.2	12.9	12.4	15.1	12.4	28.7	13.8	15.5	20.1	14.0	9.6	9.3	0.3	23.8	29.3	335.3	4.4	5.2	42.5	8.7	36.2	11.1	0.0	12.2	5.5	127.2	1.8	12.8	25.3	0.0	0.4	3.2	16.2	16.4	36.7	71.0	24.0	0.0	0.0	11.2	98.8	30.1	26.2	2.5	0.0	3.9	0.3	76.0	10.1	0.0	71.0	4.1	47.8	478.8	1.1	5.6	213.7	103.2	1.0	15.8	36.1	5.2	0.0	0.1	0.3	16.5	0.0	104.1	180.1	0.0	1.5	17.1	36.9	0.0	11.1	235.6	2.9	0.6	16.5	21.7	18.3	391.3	3.6	67.3	92.7
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138553756-138575675	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	88.6	226.3	10.3	51.5	15.1	98.8	72.4	25.4	26.0	60.3	28.8	80.3	61.2	67.0	33.9	87.8	56.5	38.3	179.5	10.9	19.6	112.1	194.2	62.5	43.6	19.6	20.7	80.0	79.8	169.4	71.4	46.5	23.8	56.4	56.5	48.8	78.9	46.7	288.9	77.5	64.3	44.2	21.6	54.7	91.8	50.1	17.8	44.6	91.3	193.6	55.7	73.8	65.6	29.1	196.0	276.6	111.4	231.0	138.1	94.3	274.7	198.3	196.7	255.4	268.6	579.4	194.4	419.3	263.7	150.8	382.0	158.6	334.0	314.1	298.2	219.7	177.9	230.5	209.0	270.4	360.4	229.0	201.3	142.6	317.7	299.5	494.8	78.7	128.0	167.8	280.4	297.5	134.7	220.6	206.7	82.9	182.5	191.6	173.3	252.1	188.8	302.4	192.8	267.4	150.1	112.4	242.5	338.5	630.7	269.0	230.5	200.5	117.7	204.1	126.5	174.9	313.5	324.6	300.5	378.6	249.6	301.4	202.6	11.8	31.3	10.7	39.8	34.9	46.2	31.7	30.6	36.8	42.0	22.4	34.1	33.9	4.3	28.3	38.8	17.9	31.3	53.6	10.3	15.1	25.4	26.0	10.9	19.6	19.6	20.7	23.8	21.6	17.8	29.1	63.0	99.3	123.8	43.1	101.7	87.8	228.6	157.2	84.8	88.2	83.4	63.8	337.3	70.1	153.8	99.3	83.4	194.7	114.7	80.8	223.0	151.4	12.1	90.1	98.4	83.1	73.0	75.1	41.1	106.1	132.9	109.6	73.9	126.6	167.8	86.1	43.5	175.9	133.9	99.3	48.4	95.4	148.5	54.1	76.4	12.6	67.4	100.1	83.6	25.3	92.3	92.5	43.3	27.6	43.3	93.8	66.0	72.6	102.3	131.1	85.8	231.3	119.7	89.3	46.0	134.3	136.2	52.5	91.4	93.2	73.9	175.5	130.7	157.9	150.7	141.2
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302673-76304295	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 5909.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 2482.8;MCF7: 3979.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	964.4	856.4	810.6	329.6	835.1	52.3	560.5	821.6	1798.8	2123.4	864.3	2043.6	208.7	2824.2	131.7	5909.6	993.8	217.2	2981.9	776.6	944.5	986.4	554.9	790.9	99.0	894.1	838.7	731.6	751.7	221.1	303.3	324.3	870.8	979.0	73.8	10.2	1075.3	522.5	3669.8	2258.3	523.8	1066.9	808.2	224.5	770.3	99.8	840.0	218.7	627.1	628.1	279.3	1579.4	3398.4	869.5	1251.1	902.4	79.5	576.8	487.3	447.5	5.1	514.9	249.8	260.9	325.8	84.8	660.7	8.5	389.1	599.1	514.1	1094.2	359.0	279.6	76.5	690.9	106.4	41.5	611.4	345.5	267.9	69.9	466.5	542.8	2482.8	370.0	50.5	436.6	831.3	169.5	459.4	1079.7	276.5	3979.7	117.1	508.9	407.4	212.7	800.6	417.3	195.8	974.5	342.8	423.2	7.6	529.1	363.8	1323.3	456.0	224.5	1674.9	551.6	504.2	778.8	1200.3	221.7	1310.1	85.7	145.9	10.7	575.9	247.2	579.5	19.7	13.6	10.9	58.8	78.2	28.1	115.0	92.4	62.1	31.5	105.5	102.1	88.2	5.8	79.7	112.8	56.5	64.5	46.7	810.6	835.1	821.6	1798.8	776.6	944.5	894.1	838.7	870.8	808.2	840.0	869.5	708.2	272.4	186.4	78.4	145.4	1849.8	16589.4	3603.0	1728.4	243.4	312.5	174.4	822.3	264.5	1899.4	1144.0	323.2	161.7	62.0	824.2	1500.7	2021.4	11.9	1181.8	1060.9	1038.7	422.0	136.1	4.3	6539.7	399.4	998.5	219.2	1227.1	216.7	136.3	725.7	234.7	1199.8	70.7	2.2	433.0	1245.1	147.7	2828.9	30.8	299.5	1024.8	2056.2	35.6	188.0	171.4	50.4	8.0	2.7	2719.4	1417.1	534.5	296.9	3854.8	95.3	2324.4	1253.9	29.2	611.4	551.2	2129.1	20.3	105.5	6300.1	2241.7	2432.7	758.2	68.2	390.5	13091.2
HSPB11	"C1orf41, FAP232, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945699	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	25.9	36.4	36.2	34.1	37.1	61.2	46.5	35.5	49.9	33.9	46.4	31.9	25.0	42.6	70.5	30.1	79.6	26.8	26.6	38.4	36.9	35.3	55.1	29.7	62.5	35.5	35.5	41.8	26.4	30.8	23.1	41.6	35.6	34.9	34.5	29.8	24.0	36.6	11.4	37.3	26.0	36.8	36.3	34.8	36.8	30.7	35.3	55.8	96.8	19.6	62.3	39.5	19.2	38.6	115.4	50.3	141.8	31.2	51.1	67.7	59.4	95.8	91.4	142.5	163.8	122.2	60.5	134.7	77.1	69.6	251.8	88.9	62.2	99.5	168.7	114.6	91.6	166.6	108.1	163.7	58.2	83.7	108.0	70.0	76.7	135.5	37.0	88.4	77.4	82.5	102.3	30.6	184.4	24.9	184.8	132.4	59.5	96.1	111.5	125.5	184.3	72.5	118.3	128.7	74.2	59.8	140.7	64.8	95.4	142.7	396.4	118.5	52.7	92.4	115.1	104.9	107.8	54.6	97.3	141.7	148.5	78.1	81.5	171.2	47.4	130.6	87.0	65.9	78.8	95.6	85.6	104.7	56.8	76.9	67.1	84.9	33.5	109.4	71.8	121.8	122.0	58.3	36.2	37.1	35.5	49.9	38.4	36.9	35.5	35.5	35.6	36.3	35.3	38.6	37.8	32.1	31.4	14.7	54.3	106.4	79.6	244.6	68.9	22.4	67.5	73.2	42.7	42.9	134.6	51.5	8.4	181.9	72.0	42.4	117.4	60.4	55.7	249.2	60.0	40.7	77.3	48.6	18.2	65.7	101.3	59.0	27.5	60.3	61.5	59.3	31.8	64.9	115.0	13.5	16.9	42.2	217.7	46.5	74.8	15.7	61.5	57.2	78.2	11.2	80.5	87.8	70.0	13.0	22.9	79.6	52.0	63.6	80.8	70.5	54.7	119.2	412.1	19.8	39.5	32.6	93.0	130.0	97.9	66.4	82.8	116.8	73.7	120.3	39.7	118.0
HSPB2	"Hs.78846, MKBP"	ENSG00000170276	"Heat shock protein family B (small) member 2"	Q16082	11	111912734-111914093	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 153.2;skeletal muscle: 251.3;tongue: 316.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.7;Fibroblasts: 39.1;Leydig cells: 43.5;Melanocytes: 37.4;Smooth muscle cells: 39.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.1;renal cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 48.4;ASC TERT1: 23.4;fHDF/TERT166: 59.7;HSkMC: 23.3;LHCN-M2: 35.2;U-138 MG: 31.5"									HPA079414	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA079414: "	"unprognostic (5.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.69e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	39.8	5.3	26.7	4.3	28.9	0.0	21.5	37.4	32.5	30.2	24.4	21.1	3.4	25.0	5.7	15.4	22.2	18.5	153.2	25.8	26.7	13.3	2.3	17.3	5.4	29.0	27.3	14.0	1.4	1.4	3.8	12.2	27.2	13.1	4.0	1.8	7.1	13.0	251.3	14.7	9.1	19.1	27.2	7.3	9.6	2.3	28.9	1.4	9.6	316.8	2.0	16.1	19.0	26.2	0.0	0.0	0.0	7.0	48.4	23.4	0.2	5.6	0.0	0.0	0.3	0.0	0.0	0.0	0.5	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	23.3	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	35.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.2	31.5	3.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	28.9	37.4	32.5	25.8	26.7	29.0	27.3	27.2	27.2	28.9	26.2	8.5	0.0	0.0	0.0	0.0	7.0	0.3	0.0	1.2	0.4	5.1	16.4	115.7	1.5	0.6	1.8	0.0	0.8	0.1	0.0	1.9	0.4	0.1	0.1	7.9	3.5	0.0	0.0	0.0	0.0	0.7	39.1	0.0	0.2	0.0	0.4	4.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	10.3	1.1	43.5	0.6	37.4	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.3	0.0	23.5	0.0	0.5	13.1	22.8	39.8	0.8	0.6	0.6	5.8	1.5	1.0	0.4	0.0	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 4135.3;skeletal muscle: 2417.8;tongue: 1229.5"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 2389.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 315.1"	"Not detected"	"Not detected"							HPA027639	Approved		Approved	Nucleoplasm		NA	NA		130000		"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	306.8	123.4	3.9	32.1	4.4	0.2	119.7	8.8	5.1	49.6	8.6	138.3	5.1	179.5	7.5	44.2	64.8	18.7	4135.3	4.1	5.6	38.5	3.2	22.1	1.7	13.1	7.9	25.4	9.2	38.8	5.3	7.1	12.0	43.0	8.0	3.1	35.1	24.4	2417.8	19.3	34.0	189.2	5.3	4.5	71.4	20.2	4.7	0.6	14.1	1229.5	0.7	99.2	30.5	6.7	0.0	0.0	0.0	1.5	70.7	3.2	1.8	18.4	1.1	0.0	0.2	0.0	0.1	0.0	0.0	315.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	3.4	0.0	0.0	2.1	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.1	0.1	0.0	0.1	5.3	3.3	0.0	0.0	0.0	1.3	0.0	11.8	0.0	1.3	0.1	1.1	0.0	14.1	0.6	1.9	0.0	10.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.4	8.8	5.1	4.1	5.6	13.1	7.9	12.0	5.3	4.7	6.7	0.5	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.8	0.2	0.4	2389.7	0.0	0.0	3.7	0.0	2.8	0.0	0.0	13.7	1.4	55.5	0.1	0.7	26.6	0.0	0.0	0.0	0.2	1.4	46.3	0.0	0.1	0.0	0.4	0.0	0.0	1.6	1.7	0.1	0.0	0.0	0.0	4.6	74.2	14.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.5	0.0	0.2	0.0	0.6	0.0	20.2	42.6	1.9	0.9	0.1	2.6	3.3	0.5	3.0	0.0	0.1
HSPB8	"CMT2L, E2IG1, H11, HSP22"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119171555-119224855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 897.3"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoplasm	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	57.0	13.9	172.2	34.4	172.6	0.0	33.4	179.5	141.8	58.1	147.0	381.0	8.9	114.4	10.1	163.2	58.7	43.1	469.3	147.8	231.0	63.3	4.8	95.7	11.4	188.3	206.1	23.4	30.8	183.1	17.5	92.1	193.0	143.5	35.8	28.2	50.8	289.0	897.3	70.5	50.5	114.1	211.5	56.2	110.4	12.0	193.6	40.3	29.2	448.5	98.7	239.2	100.1	235.5	21.1	16.1	0.3	0.0	14.4	11.5	60.2	32.5	28.7	5.9	0.3	40.0	0.6	0.1	89.6	42.4	48.0	2.4	0.3	0.0	0.6	0.1	1.2	0.0	66.0	3.2	11.2	0.0	0.1	14.1	4.1	22.3	1.3	21.6	12.3	0.0	0.2	0.0	13.0	130.5	0.0	0.2	5.7	0.0	23.0	0.0	22.9	2.9	38.3	6.2	0.4	1.0	13.5	1.6	6.8	50.5	29.0	0.2	20.4	15.8	39.8	21.7	1.7	0.0	0.2	0.2	67.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	172.6	179.5	141.8	147.8	231.0	188.3	206.1	193.0	211.5	193.6	235.5	2.7	44.8	48.2	42.1	0.7	102.3	108.5	4.5	126.3	0.7	95.2	17.5	599.1	7.2	5.4	5.5	8.4	149.1	1.0	0.0	0.0	59.7	12.2	98.1	20.2	27.4	0.0	0.0	6.2	11.4	17.5	82.2	5.6	142.7	1.3	0.0	25.4	0.0	19.4	1.7	6.6	0.0	2.0	1.0	9.4	11.0	1.5	1.6	12.4	2.8	1.0	51.7	0.0	0.0	0.9	12.9	0.0	0.4	0.3	24.6	0.0	52.0	3.1	2.1	6.6	39.8	76.9	0.9	0.2	38.0	28.7	1340.0	3.5	0.1	0.2	72.7
HSPBAP1	"FLJ22623, PASS1"	ENSG00000169087	"HSPB1 associated protein 1"	Q96EW2	3	122739999-122793831	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Microglial cells: 52.5;Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044930	Approved		Approved	Mitochondria		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA044930: AB_10961122"	"unprognostic (3.40e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.70e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.24e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.12e-3)"	4.2	5.4	2.9	4.3	3.3	3.1	3.8	3.4	4.2	3.8	4.1	3.7	2.5	3.8	1.9	2.8	3.1	3.5	3.2	3.3	3.5	4.3	3.5	4.6	6.2	4.0	3.4	3.0	3.8	3.7	2.7	6.0	4.0	3.3	3.4	4.6	3.2	3.2	15.9	4.3	3.8	3.8	3.4	7.3	3.0	10.7	3.4	6.4	6.2	8.7	5.5	4.3	3.2	3.9	5.4	4.1	5.8	5.2	6.8	5.1	11.3	2.6	6.7	6.1	8.6	5.6	4.1	6.9	4.2	1.8	15.4	6.4	9.0	5.0	7.1	4.3	2.5	4.6	4.8	3.3	15.4	4.2	6.1	7.7	18.0	5.1	16.3	5.8	5.8	6.9	3.1	5.8	5.6	3.5	6.1	5.3	6.6	4.2	8.2	6.2	7.8	6.8	6.4	2.1	6.4	6.5	6.2	2.4	23.3	5.5	2.9	8.8	5.8	7.1	4.2	2.3	3.7	5.7	6.1	8.1	4.4	6.2	7.1	23.0	16.5	12.0	6.1	12.2	7.6	11.0	8.0	6.1	13.0	8.3	8.6	8.4	30.6	6.3	24.1	4.5	10.3	8.2	2.9	3.3	3.4	4.2	3.3	3.5	4.0	3.4	4.0	3.4	3.4	3.9	10.2	6.4	5.3	10.7	20.8	10.7	3.9	5.0	6.8	6.6	3.9	5.7	5.7	4.3	3.9	5.5	60.5	16.8	11.4	4.9	3.9	5.5	35.7	7.3	5.1	6.4	0.0	7.2	15.2	6.0	11.0	6.5	5.6	4.4	6.3	6.4	11.0	3.6	12.9	8.4	24.7	3.1	4.1	24.1	14.1	8.0	9.6	20.1	5.4	52.5	29.4	3.7	14.4	8.0	22.9	4.3	3.5	4.9	6.4	3.2	6.3	4.5	5.9	12.8	6.6	7.1	4.9	36.8	8.4	5.0	7.5	48.6	10.3	7.4	3.5	1.7
HSPBP1	FES1	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262223-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 270.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA		19000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396"	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	24.6	29.0	41.4	14.5	50.8	16.6	25.4	41.4	60.5	29.8	34.1	34.9	15.7	39.3	5.2	42.1	38.4	6.2	46.9	41.9	40.3	38.8	37.9	23.9	12.3	40.3	41.8	34.3	27.4	18.9	26.8	8.3	38.6	29.3	6.7	7.3	25.2	10.4	46.9	33.7	24.0	8.0	39.2	21.0	28.9	32.5	39.6	9.6	27.1	16.9	8.1	33.3	29.7	39.5	86.9	150.0	27.1	38.6	15.3	14.3	78.8	44.3	17.8	45.0	38.3	85.5	57.7	56.1	42.1	24.3	27.0	59.0	33.1	43.9	11.6	48.4	270.8	74.9	48.2	79.7	34.1	72.3	38.1	18.5	39.4	44.6	20.9	19.4	22.5	46.5	61.6	31.1	15.8	80.3	65.4	64.2	95.6	75.2	125.8	63.7	41.7	121.0	30.4	54.8	71.0	108.0	54.2	54.2	46.9	14.4	41.7	56.4	29.8	50.3	55.0	29.4	83.1	48.4	126.9	60.0	57.6	62.6	56.6	2.0	25.7	7.2	39.1	45.4	40.9	53.9	42.2	44.7	52.9	64.3	42.1	41.1	1.7	44.2	39.6	29.3	43.3	25.1	41.4	50.8	41.4	60.5	41.9	40.3	40.3	41.8	38.6	39.2	39.6	39.5	11.8	9.6	11.5	5.5	15.6	26.8	39.7	55.5	29.6	15.9	20.1	20.8	13.2	34.3	35.1	35.0	6.2	48.0	11.6	46.4	72.4	62.5	13.4	69.4	15.2	18.5	22.6	18.1	8.6	46.1	57.0	22.0	25.5	13.4	10.8	20.0	10.4	23.9	39.1	13.5	11.6	31.7	44.7	11.3	13.7	16.0	19.6	11.9	17.8	3.7	28.2	14.9	21.6	6.0	7.3	42.6	44.4	17.7	27.3	29.5	25.5	62.5	119.8	14.8	26.3	24.2	31.9	39.0	28.8	27.9	29.5	37.5	17.1	16.6	58.9	35.2
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486584-197516737	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 790.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1737.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		18000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	179.4	790.6	188.6	128.3	191.6	110.6	168.8	204.9	401.9	96.9	217.8	170.0	158.1	90.8	89.3	124.5	132.6	69.1	145.0	184.3	198.6	374.9	462.6	136.6	149.2	199.6	198.5	167.6	219.0	159.2	116.0	148.6	205.3	104.5	195.1	71.8	93.9	93.6	162.7	83.3	148.7	104.5	195.1	94.6	155.4	57.6	198.6	99.3	138.7	176.7	172.7	144.6	92.3	201.4	559.7	650.1	541.3	496.9	373.6	389.2	786.5	573.2	304.7	686.1	495.6	2219.1	326.2	1724.4	730.0	304.1	834.2	538.4	2232.9	633.2	943.0	417.0	888.2	1209.8	984.8	2562.8	353.2	1331.4	349.1	445.5	717.1	599.5	1053.2	471.4	542.6	919.1	1535.3	606.8	501.7	690.4	853.6	1304.2	1086.4	735.2	1424.9	1000.1	679.7	1235.5	709.5	539.7	716.5	400.8	582.0	608.5	771.0	1116.3	425.0	789.4	242.2	405.8	570.4	532.8	910.0	331.1	861.4	1399.5	485.7	795.3	456.7	12.1	52.3	11.4	36.4	81.8	71.7	63.8	59.6	54.3	84.6	54.0	81.0	70.3	11.0	62.6	72.1	49.4	51.8	70.6	188.6	191.6	204.9	401.9	184.3	198.6	199.6	198.5	205.3	195.1	198.6	201.4	216.4	166.7	172.5	38.8	220.4	246.6	1737.2	247.5	264.0	75.8	216.0	263.1	239.2	195.9	287.9	79.1	256.5	825.7	197.7	213.7	375.6	235.0	6.2	322.2	304.5	233.9	274.6	241.6	31.9	145.9	419.8	356.0	215.6	445.2	299.5	407.1	63.1	312.5	328.0	95.9	47.2	302.2	166.8	88.6	479.3	12.8	130.5	381.9	163.7	30.0	138.5	125.7	68.0	20.6	35.6	171.4	163.2	113.6	322.9	705.9	160.1	797.1	328.6	117.1	85.5	199.0	471.7	88.5	106.0	262.4	207.1	1001.2	467.2	1017.4	512.1	861.5
HSPE1	"CPN10, EPF, GroES, HSP10"	ENSG00000115541	"Heat shock protein family E (Hsp10) member 1"	P61604	2	197500140-197503449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1077.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1907.6;Proximal tubular cells: 1978.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 4135.5"	"Low region specificity"	"Detected in all"							"CAB017366, HPA038755, HPA048272"	Supported					NA	Yes		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336"	"unprognostic (2.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.83e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.08e-3)"	152.1	709.5	383.2	143.9	387.5	116.8	212.7	410.3	1077.6	122.3	402.1	257.2	164.9	84.3	213.0	132.9	131.4	97.4	208.0	383.7	400.8	410.7	662.7	111.0	154.5	400.9	394.7	130.1	112.6	173.0	125.5	164.0	399.9	137.9	246.3	85.8	121.9	114.8	181.4	80.5	168.2	116.8	403.6	86.5	130.5	58.7	391.2	144.8	104.5	213.1	207.9	216.6	85.5	440.8	593.1	926.1	675.1	521.5	560.5	314.0	905.5	586.2	307.9	620.8	577.3	2796.6	504.6	1079.2	782.2	333.8	1542.1	510.4	1895.0	681.2	782.0	512.3	874.7	1099.8	1789.0	4135.5	239.0	1503.6	497.2	382.4	532.1	577.8	297.6	392.7	631.0	720.9	1588.2	338.0	481.1	1027.2	1107.2	1706.9	1077.5	985.2	1513.4	747.6	568.2	1388.5	967.4	1028.3	581.5	375.1	546.4	713.9	545.5	1588.2	287.1	881.7	355.7	466.1	643.3	501.0	1019.4	427.8	1016.0	1758.3	515.6	726.7	640.6	33.2	95.5	24.4	166.3	174.5	216.3	287.1	223.6	210.1	156.6	221.8	251.7	264.1	12.6	200.3	143.1	263.4	198.7	176.0	383.2	387.5	410.3	1077.6	383.7	400.8	400.9	394.7	399.9	403.6	391.2	440.8	341.6	195.5	160.2	0.0	380.6	435.1	1907.6	690.4	301.7	90.7	393.6	511.2	355.6	381.8	363.3	195.0	250.2	839.3	334.4	553.8	911.7	354.0	22.3	520.7	291.3	296.3	440.3	233.1	0.0	231.2	634.0	370.0	274.2	493.3	324.6	215.7	94.6	1092.0	517.2	63.9	0.0	605.0	427.2	150.6	616.4	36.1	216.6	534.4	409.1	0.0	214.2	204.2	133.9	0.0	0.0	285.3	466.2	141.8	323.4	830.7	562.1	1978.2	475.8	160.2	131.5	283.6	642.5	140.0	241.9	381.2	371.8	976.7	685.9	791.7	775.5	1111.7
HSPE1-MOB4		ENSG00000270757	"HSPE1-MOB4 readthrough"		2	197500413-197550726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.6;Astrocytes: 1.6;Excitatory neurons: 1.5;Inhibitory neurons: 1.7;Oligodendrocytes: 1.6;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038755, HPA044125, HPA048272"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038755: AB_2676190, HPA044125: AB_2678822, HPA048272: AB_2680336"	"unprognostic (7.69e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-2)"		"unprognostic (9.15e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.26e-2)"	6.0	19.1	2.9	11.2	3.3	2.0	5.1	3.6	5.4	4.6	3.7	5.1	7.8	5.5	0.0	10.6	4.4	1.7	7.5	3.3	3.5	4.8	4.2	4.6	5.5	3.2	3.2	3.6	4.3	3.7	3.7	7.5	3.5	2.9	3.1	6.4	7.1	2.2	11.6	4.8	4.8	2.4	3.9	5.6	4.4	3.3	3.1	6.8	4.3	3.6	6.8	5.1	6.0	4.0	16.1	8.0	33.1	8.3	12.5	7.5	16.3	28.6	7.0	12.6	9.0	13.5	16.7	14.1	22.2	10.4	24.0	16.7	20.9	4.6	17.0	23.3	4.3	19.4	11.7	8.0	12.2	18.4	24.3	8.0	8.3	15.6	8.8	13.6	7.1	13.0	12.5	8.7	12.2	16.4	21.3	13.2	18.8	16.5	12.4	15.6	12.4	16.5	15.1	28.4	14.4	10.7	13.0	18.9	24.4	27.1	14.5	29.2	14.3	15.9	18.0	19.7	24.4	12.1	24.8	24.3	22.4	8.9	23.7	34.1	13.6	15.6	14.2	16.3	13.9	15.8	16.3	15.8	16.7	12.7	15.6	17.3	17.7	19.6	15.4	11.8	21.9	16.2	2.9	3.3	3.6	5.4	3.3	3.5	3.2	3.2	3.5	3.9	3.1	4.0	0.0	9.6	2.6	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134973-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1251.1"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1316.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 1251.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	52.2	42.1	175.9	23.5	193.6	20.7	27.9	175.2	1251.1	25.0	182.5	29.3	11.3	25.9	37.6	35.8	54.8	32.3	57.3	184.9	189.3	73.5	47.6	66.6	34.9	172.7	180.7	56.3	28.6	30.3	63.8	37.8	180.9	28.4	25.3	26.7	20.1	29.3	36.6	21.7	20.4	28.0	177.2	32.3	53.1	67.8	190.2	37.4	32.2	32.6	45.1	58.8	35.4	227.4	69.9	130.7	105.1	10.2	99.1	56.0	70.0	117.8	104.6	179.0	82.8	154.9	105.4	179.6	71.9	82.4	253.7	131.2	411.7	104.8	229.2	141.6	51.7	155.7	69.3	137.2	32.3	109.1	118.8	35.5	236.5	119.6	68.3	93.0	105.4	62.0	132.7	27.8	127.4	94.7	158.1	124.2	150.3	338.6	96.6	122.5	85.8	58.9	135.0	83.5	108.5	90.1	107.4	104.0	56.6	160.6	35.0	104.7	64.4	61.3	77.4	89.2	132.4	21.8	76.0	150.6	51.0	129.8	104.7	1.4	5.0	2.7	7.6	12.2	9.4	11.1	9.7	11.8	8.4	10.6	14.7	13.8	0.5	16.7	19.6	6.6	7.0	7.7	175.9	193.6	175.2	1251.1	184.9	189.3	172.7	180.7	180.9	177.2	190.2	227.4	171.1	131.4	87.7	36.6	130.8	214.6	1316.2	44.7	175.2	38.7	152.2	143.3	163.6	40.0	123.3	46.0	417.0	23.2	78.9	153.2	29.4	49.8	100.0	346.1	140.1	132.3	227.7	58.9	121.0	35.9	64.2	249.6	94.3	250.6	248.6	61.7	26.4	25.7	90.6	30.3	77.7	159.0	65.1	38.6	452.1	36.5	33.8	281.3	163.7	55.3	42.6	28.2	26.8	30.7	53.2	45.5	154.0	39.1	142.0	426.3	18.2	31.6	290.5	79.0	39.5	98.1	153.1	161.3	164.6	151.1	143.3	42.5	363.8	58.5	166.1	511.8
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383782	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 283.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	30.0	57.5	29.6	32.3	35.9	18.6	29.6	33.2	46.1	24.2	34.7	88.4	135.9	13.8	31.4	50.0	13.5	44.8	21.2	29.2	31.3	32.6	97.8	39.1	28.5	34.1	31.7	16.2	26.7	27.8	39.9	28.5	34.6	22.4	80.7	1.9	35.0	20.6	46.2	36.0	121.4	14.4	32.3	38.6	75.4	21.4	32.3	20.2	51.3	21.3	27.4	37.7	35.4	45.8	109.6	177.5	3.9	0.2	52.5	39.4	38.7	46.4	45.8	35.3	41.8	103.2	93.8	24.8	93.1	58.3	136.6	149.7	0.0	28.2	33.9	283.9	21.4	30.8	170.1	0.2	125.3	11.3	139.6	57.3	196.0	28.7	44.5	0.0	102.2	0.0	76.8	31.6	66.3	102.0	0.4	7.0	56.5	193.2	87.1	23.2	0.3	89.8	48.1	60.1	47.2	0.5	150.9	59.1	73.6	18.0	123.7	57.0	125.4	25.1	54.8	51.0	1.2	33.5	44.7	0.6	0.4	76.9	111.4	233.4	133.3	171.1	64.3	126.4	73.4	65.9	74.1	69.2	76.9	76.4	63.9	62.7	304.1	64.5	135.2	23.2	140.9	116.7	29.6	35.9	33.2	46.1	29.2	31.3	34.1	31.7	34.6	32.3	32.3	45.8	49.2	25.6	9.6	3.9	28.0	36.3	60.0	74.2	67.2	1.0	32.9	26.7	11.6	102.9	43.7	47.8	0.0	53.7	16.7	175.6	31.3	91.4	51.1	19.3	6.1	29.5	24.1	28.8	12.9	72.3	118.0	23.8	49.5	34.5	22.9	22.7	33.2	77.5	82.8	3.3	9.1	100.3	105.8	54.0	27.6	59.5	19.9	61.3	44.4	8.4	114.6	9.5	39.1	3.5	40.2	94.7	157.3	9.4	21.4	65.2	269.7	69.0	37.4	1.7	13.1	19.2	28.5	45.5	21.5	87.2	42.1	61.6	33.4	13.2	87.8	62.7
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58320193	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.7	7.2	4.3	6.5	5.0	7.2	8.7	7.3	5.5	6.8	4.7	8.9	12.1	8.4	5.9	8.7	7.8	6.8	12.5	4.8	5.6	11.1	15.2	5.7	6.8	3.6	4.6	12.1	7.4	12.0	5.7	6.7	4.6	7.1	9.1	9.2	7.4	8.6	44.1	7.9	8.7	7.6	4.3	7.2	7.0	7.4	4.5	6.6	10.4	37.8	8.0	6.9	4.9	5.5	10.4	7.1	10.9	8.7	11.6	11.2	15.1	13.8	10.2	17.0	14.4	15.9	7.7	19.9	4.0	10.1	12.8	8.7	18.5	12.6	16.8	11.0	13.1	13.7	16.1	13.9	11.3	16.7	11.4	15.1	15.1	17.3	11.4	11.0	14.6	14.3	12.2	19.9	11.1	6.4	11.2	8.9	17.2	10.2	17.3	7.2	7.2	14.7	12.5	13.8	7.0	10.5	8.4	9.4	17.2	12.1	10.9	15.9	8.1	14.5	10.8	14.3	17.2	15.4	27.6	15.7	12.7	11.9	9.8	17.9	19.2	29.2	19.7	23.7	21.5	28.1	20.0	25.2	20.2	27.6	27.5	21.3	13.6	24.9	20.4	24.5	15.6	15.7	4.3	5.0	7.3	5.5	4.8	5.6	3.6	4.6	4.6	4.3	4.5	5.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050438-70058848	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2602	"salivary gland: 48372.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077315	Approved				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 11: Alveolar cells - Smell perception"			"HPA077315: "									"unprognostic (2.22e-1)"									0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	18.5	0.0	0.0	5.5	0.0	0.0	0.0	0.0	48372.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028455-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1102	"salivary gland: 136053.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HL-60: 1.7"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB073541: "																		0.0	0.1	0.7	0.3	1.3	18.9	0.1	2.8	2.3	0.0	0.0	2.4	0.3	0.2	0.4	0.2	0.1	0.1	26.2	0.9	0.0	0.1	0.1	0.2	0.3	0.1	0.0	26.0	123.4	0.1	1.8	13.1	0.2	0.2	3.0	0.7	136053.4	0.1	0.1	10.0	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.5	0.4	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.0	1.6	0.2	0.1	0.3	0.1	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.7	0.2	0.2	0.4	0.9	0.4	0.1	0.4	1.0	0.2	0.1	0.1	0.1	0.6	0.4	0.4	0.2	0.3	0.3	0.7	0.4	0.0	0.3	0.6	0.4	0.3	0.5	0.9	0.2	0.3	0.5	0.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.7	1.3	2.8	2.3	0.9	0.0	0.1	0.0	0.2	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63957874-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 24.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NTERA-2: 1.2;SCLC-21H: 1.1"	"Low region specificity"	"Detected in many"							HPA018073	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018073: AB_1856704"					"unprognostic (1.81e-1)"													0.0	0.0	0.7	0.0	6.2	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.0	3.4	24.3	3.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.2	0.0	9.1	11.4	0.0	3.4	24.3	7.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.6;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"		"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	2.1	0.4	6.0	0.0	0.2	0.0	3.8	0.8	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	2.1	0.5	0.0	0.4	0.0	0.6	4.3	0.3	0.1	0.0	0.2	6.7	1.2	0.2	0.1	0.3	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.0	5.0	0.5	9.6	0.0	0.2	0.3	0.0	1.3	0.5	1.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	6.0	0.0	3.8	1.2	2.1	0.6	4.3	1.2	0.1	9.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937528-87016679	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;ovary: 4.2"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 125.4;Inhibitory neurons: 104.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"PC-3: 1.7;SH-SY5Y: 6.6"					"Low region specificity"	"Detected in many"			HPA004931	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.0	0.0	1.7	0.0	3.0	0.0	0.0	0.0	4.2	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.2	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.0	0.0	4.2	2.6	1.3	0.2	0.3	0.1	0.0	1.2	2.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	1.1	0.0	0.0	0.0	125.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	104.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87792706-87993839	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.8;retina: 3.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 232.6;Inhibitory neurons: 79.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;LHCN-M2: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005555	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA005555: AB_1856708"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.67e-6)"	"unprognostic (1.25e-4)"	"unprognostic (1.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.31e-2)"	0.7	0.2	0.0	0.0	0.1	0.6	0.4	0.0	1.5	0.4	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.3	0.1	0.3	1.8	0.0	0.1	0.0	3.6	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	0.5	0.1	0.2	0.2	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.5	2.2	0.0	0.0	4.6	0.0	0.4	0.0	0.0	0.0	0.1	0.8	0.3	0.2	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	2.2	0.0	3.0	232.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.1	0.0	0.6	0.5	0.2	0.0	0.4	1.8	13.1	0.2	20.4	0.0	2.5	3.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	19.7	0.1	12.7	0.3	1.9	0.0	0.0	0.0	0.2	0.2	0.1	0.1
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831546-46897076	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;choroid plexus: 5.6"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;ASC TERT1: 4.6;BEWO: 1.4;HEL: 1.5;U-138 MG: 2.3;U-2 OS: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014011: AB_1856709"	"unprognostic (8.01e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.94e-5)"	"unprognostic (4.78e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.28e-2)"	0.9	0.3	6.7	0.8	9.7	0.1	0.5	0.0	15.2	0.6	5.6	0.5	0.4	0.5	0.0	0.5	0.3	1.6	0.7	11.8	8.7	0.1	0.1	0.3	0.0	0.5	1.4	0.3	0.0	0.0	0.2	0.0	2.9	0.2	0.6	0.8	0.0	0.6	0.3	0.1	0.4	2.6	0.1	0.0	0.2	0.6	1.6	0.7	0.1	0.6	0.2	0.8	0.5	5.8	0.0	0.0	0.0	0.0	1.8	4.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	6.7	9.7	0.0	15.2	11.8	8.7	0.5	1.4	2.9	0.1	1.6	5.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	8.6	0.1	0.0	0.0	81.7	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	10.1	0.0	0.0	0.3	0.0	2.2	0.9	1.9	0.0	3.7	0.0	4.6	0.0	2.5	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 17.4;cervix: 21.5;endometrium 1: 18.8;smooth muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 1.8;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.8;T-cells: 1.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	0.9	17.4	0.4	1.5	0.4	1.2	0.8	0.9	0.6	21.5	1.2	9.0	1.5	18.8	11.8	0.7	2.4	1.2	4.7	0.4	0.6	3.4	3.6	0.9	1.0	0.5	0.4	0.8	0.2	0.6	0.3	4.1	0.5	0.3	2.1	0.2	0.5	1.4	0.1	0.1	4.8	16.8	0.2	0.4	4.5	0.4	0.4	1.2	3.2	0.3	0.8	2.2	0.8	0.6	0.2	0.3	0.0	0.1	0.5	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.7	0.1	0.3	16.5	0.0	0.0	0.0	0.0	3.2	1.4	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	32.7	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.4	0.5	0.2	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.2	1.5	17.7	4.1	0.0	0.0	0.7	0.7	0.1	0.8	0.0	3.4	0.0	0.1	5.7	1.5	3.4	1.7	0.9	0.0	0.0	0.8	0.0	0.2	0.6	2.2	0.0	4.7	6.2	0.0	1.0	0.5	0.6	0.2	0.0	5.3	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.2
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.0;salivary gland: 5.0"	"Group enriched"	"Detected in some"	11	"Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	15	"memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	127	"B-cells: 13.8;dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5"	HPA069442	Supported					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"			"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.0	0.4	0.7	2.1	1.2	0.0	0.0	0.4	1.0	0.0	0.4	2.1	0.6	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.5	0.1	0.0	0.0	6.5	0.4	0.5	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	5.0	0.0	0.0	0.7	1.7	0.7	0.4	0.5	0.8	0.1	0.5	0.4	0.0	0.0	8.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.7	1.2	0.4	1.0	1.1	0.5	0.4	0.5	0.4	0.4	0.5	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	3.0	0.1	0.0	23.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HTR3B	5-HT3B	ENSG00000149305	"5-hydroxytryptamine receptor 3B"	O95264	11	113904677-113949078	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.4;Oligodendrocytes: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.5"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039559	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039559: AB_10672779"					"unprognostic (1.60e-2)"	"unprognostic (8.37e-2)"			"unprognostic (2.84e-1)"	"unprognostic (3.28e-1)"				"unprognostic (1.71e-1)"	"unprognostic (2.46e-1)"			0.0	0.1	0.0	0.2	0.5	0.5	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.4	0.1	0.3	0.2	0.1	0.0	0.5	0.0	2.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR3E		ENSG00000186038	"5-hydroxytryptamine receptor 3E"	A5X5Y0	3	184097064-184106995	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Inhibitory neurons: 1.1;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.5;Paneth cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RH-30: 1.3"									HPA049764	Enhanced					NA	NA					"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA049764: AB_2680869"		"unprognostic (4.12e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.15e-1)"		"unprognostic (4.57e-4)"		"unprognostic (3.61e-3)"		"unprognostic (1.15e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.47e-1)"		"unprognostic (3.32e-1)"	"unprognostic (2.67e-1)"		"unprognostic (4.16e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.9	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148451032-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 12.1;heart muscle: 4.5;intestine: 9.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 42.0;Inhibitory neurons: 44.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040591	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA040591: AB_2677028"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.74e-2)"		"unprognostic (2.37e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.68e-2)"			"unprognostic (1.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.83e-5)"	0.2	0.7	1.8	0.4	12.1	0.0	0.0	0.0	4.5	0.2	0.0	2.6	4.8	0.1	0.0	0.1	0.2	0.8	4.5	7.6	2.4	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	2.8	1.0	0.0	0.0	0.0	0.0	9.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	12.1	0.0	4.5	7.6	2.4	0.1	0.9	0.2	0.0	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	42.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.0	6.1	0.0	1.5	0.0	0.0	0.0	10.8	0.0	0.0	0.8	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155087392	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 8.7;Excitatory neurons: 7.6;Inhibitory neurons: 10.0;Late spermatids: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							CAB017467	Approved					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.0	0.0	1.7	0.0	1.6	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	3.6	2.8	1.3	1.6	0.6	2.7	1.8	0.2	1.2	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19664875-19680966	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 9.7"	"Cell type enhanced"	"Detected in single"		"Excitatory neurons: 1.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.7;cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"							HPA068165	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA068165: "	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-5)"	"unprognostic (1.38e-4)"	"unprognostic (2.69e-2)"		"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.33e-3)"	"unprognostic (8.63e-2)"	"unprognostic (5.47e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.02e-1)"	0.0	0.0	1.2	0.2	9.7	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	9.7	0.0	2.4	0.7	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.6;parathyroid gland: 13.1;testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	0.5	0.2	2.4	0.9	1.4	0.3	0.3	0.0	2.5	0.4	0.4	0.6	0.5	0.2	0.1	0.7	0.2	0.9	0.1	2.7	7.1	0.1	0.4	0.2	0.6	1.5	3.2	0.1	0.2	13.1	0.1	0.3	1.9	0.2	0.9	0.1	0.3	0.1	0.9	0.5	1.4	0.3	0.5	1.1	0.7	8.7	7.6	0.2	0.1	0.5	0.3	2.3	0.6	0.8	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.7	0.3	0.7	1.0	0.0	1.2	0.0	0.0	0.1	2.0	4.7	1.3	11.3	2.8	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	7.8	10.1	3.3	33.4	6.3	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.2	1.2	0.0	1.6	1.0	0.1	0.0	0.0	1.2	0.4	0.0	0.5	0.0	5.4	0.6	0.0	0.2	0.3	6.1	0.0	0.1	9.6	0.0	0.0	0.0	10.2	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.4	0.0	2.5	2.7	7.1	1.5	3.2	1.9	0.5	7.6	0.8	0.1	0.0	0.0	0.7	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.0	1.7	0.0	24.2	0.0	2.0	2.2	0.0	2.7	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	13.1	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529725-74533332	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA		260000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	11.4	8.6	8.1	8.1	8.7	11.1	6.8	9.1	9.7	7.1	7.7	6.4	6.9	6.9	1.0	6.0	7.1	4.7	9.4	8.1	8.3	8.1	6.5	6.6	7.8	8.6	8.5	10.9	7.4	9.4	4.7	6.3	8.3	4.8	3.3	2.5	8.5	5.3	14.5	5.4	7.9	5.3	8.2	9.9	6.4	6.2	9.6	9.1	6.8	9.0	4.8	6.5	5.8	9.2	19.1	14.7	14.7	12.6	21.3	9.0	30.1	17.0	10.3	10.3	7.0	21.1	8.5	16.6	12.9	10.7	26.0	19.7	12.0	19.6	2.4	34.0	31.4	33.3	10.8	19.0	19.8	15.3	22.4	9.9	13.7	18.4	19.5	18.4	14.2	23.5	43.9	24.9	9.7	14.1	22.0	31.1	10.0	22.8	37.7	15.8	37.0	17.1	9.6	8.2	15.1	17.7	8.9	18.6	32.5	7.3	9.3	13.2	10.6	19.2	19.7	33.4	35.3	29.5	10.2	9.8	13.6	23.4	13.0	5.8	7.0	4.0	4.8	5.7	5.8	11.0	4.8	4.1	8.6	9.9	4.3	4.1	2.6	5.0	4.5	4.5	5.7	5.5	8.1	8.7	9.1	9.7	8.1	8.3	8.6	8.5	8.3	8.2	9.6	9.2	30.7	0.0	4.8	6.2	27.3	20.6	19.7	33.8	13.6	12.0	17.4	21.7	0.9	21.5	15.7	11.0	0.0	24.7	25.8	12.5	35.2	32.4	30.8	11.9	18.1	29.6	9.0	118.5	6.3	17.7	37.8	23.3	11.2	12.9	27.3	20.9	22.9	12.7	31.5	10.1	6.3	12.3	20.3	10.7	19.4	48.9	24.8	14.6	30.2	2.8	26.3	20.2	30.9	5.5	7.5	26.1	16.8	20.7	36.0	21.3	24.8	36.8	13.5	16.3	26.3	18.7	56.5	64.3	43.3	16.7	22.0	20.2	20.6	27.1	20.0	15.7
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269754-8307098	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 194.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 158.8;Leydig cells: 43.5;Peritubular cells: 42.9;Skeletal myocytes: 99.0;Theca cells: 25.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 67.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 182.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	68.0	6.0	0.9	8.7	1.3	13.4	50.4	0.9	1.3	35.4	5.0	33.9	8.7	42.4	10.6	15.1	26.2	35.5	194.9	0.9	1.0	6.2	3.2	38.0	1.2	1.0	1.0	93.0	6.8	0.4	15.7	20.4	1.0	26.3	4.8	0.1	22.8	6.7	32.1	28.1	16.9	11.8	1.0	2.9	21.9	4.3	1.7	2.2	26.0	12.9	0.7	62.4	32.6	0.7	0.0	1.0	1.4	0.0	5.8	10.8	0.3	2.4	0.2	2.8	0.6	0.1	0.1	0.0	13.6	6.4	1.4	0.1	1.2	0.0	0.9	0.0	2.3	1.3	13.9	0.0	6.1	0.0	0.6	1.2	0.0	4.2	0.0	1.7	9.8	0.0	0.3	0.0	10.2	0.0	0.2	36.5	6.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	15.8	0.3	26.4	0.5	0.2	28.8	0.1	1.1	8.1	1.4	4.7	182.1	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.9	1.3	0.9	1.0	1.0	1.0	1.0	1.0	1.7	0.7	12.6	0.0	0.0	0.0	0.0	5.2	0.5	0.0	0.6	0.0	0.5	0.9	16.5	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	1.2	0.3	8.1	5.3	0.0	0.0	0.0	0.0	4.2	158.8	0.5	0.3	0.0	6.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	8.6	1.4	43.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.4	0.4	0.0	0.1	0.0	0.0	0.0	99.0	10.6	0.4	0.7	0.6	5.3	1.4	0.9	25.2	0.0	0.2
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974228-38988663	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 67.0"	"Cell type enriched"	"Detected in some"	10	"Extravillous trophoblasts: 444.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"BEWO: 233.6"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"	NA	NA		23000	"Cluster 17: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA045402: AB_2679316"	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	0.8	0.5	0.8	0.8	1.2	7.2	1.2	3.5	5.0	0.9	0.0	0.5	0.3	0.9	0.9	0.1	0.3	0.5	0.3	1.3	0.9	0.4	0.5	2.0	2.5	0.6	0.5	0.6	0.8	0.5	0.1	67.0	0.6	0.6	0.7	1.8	0.3	1.1	1.0	0.8	0.4	0.7	0.1	1.2	0.4	0.9	1.4	0.5	0.5	0.1	1.7	0.4	0.1	2.0	0.4	0.3	0.2	0.4	0.8	0.4	233.6	0.6	0.4	0.3	0.4	0.4	0.5	0.5	0.2	0.2	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.4	0.7	0.3	0.2	0.6	0.6	0.7	0.2	0.2	0.5	0.3	0.2	0.2	0.4	1.3	0.2	0.5	0.4	0.3	0.3	0.1	0.2	0.2	0.2	0.4	0.2	0.7	0.4	0.6	0.5	0.3	0.1	9.6	0.5	0.7	0.0	0.7	0.5	0.3	0.3	0.5	0.2	0.2	0.2	0.7	0.2	0.3	0.1	0.4	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.5	0.2	0.2	0.5	0.2	0.2	0.5	0.3	0.0	0.8	1.2	3.5	5.0	1.3	0.9	0.6	0.5	0.6	0.1	1.4	2.0	0.1	0.0	0.0	0.0	1.0	0.1	1.7	0.1	1.2	0.5	0.1	0.3	0.7	0.0	0.0	0.0	2.1	2.8	1.1	0.1	0.0	0.0	0.1	0.2	0.7	0.3	0.0	0.0	0.4	0.0	444.0	1.2	0.0	0.5	0.0	0.7	1.4	0.0	11.6	1.7	0.2	0.0	0.0	0.6	0.3	0.0	0.0	3.8	1.8	1.0	0.0	0.4	1.0	1.5	0.2	0.3	0.0	0.0	0.5	1.5	0.0	0.2	0.1	0.2	0.0	3.5	0.2	0.0	0.1	0.0	0.1	40.4	0.7	0.2	0.2	1.1
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873020-32044633	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.8"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 109.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	0.7	1.0	0.8	1.3	1.3	0.2	1.2	0.4	4.7	0.4	0.0	3.6	1.4	4.1	1.9	0.4	1.9	0.5	0.4	4.2	2.6	3.7	0.5	0.9	0.4	0.4	0.1	0.6	9.8	0.1	1.1	4.6	0.1	0.9	3.7	3.0	0.6	2.1	0.3	3.0	2.7	2.4	0.0	0.1	1.3	0.9	0.2	0.7	0.6	0.2	0.6	1.5	0.7	1.6	0.0	3.9	13.2	0.1	0.0	0.0	16.3	1.3	0.0	0.2	0.0	5.3	0.1	0.0	0.5	6.2	0.2	0.0	7.7	0.0	0.1	0.1	3.9	0.0	3.7	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	1.1	0.2	1.1	10.2	0.1	0.1	0.1	18.1	0.1	1.3	0.0	14.8	9.8	13.2	1.0	0.5	9.3	5.5	1.4	0.0	0.1	9.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	4.7	4.2	2.6	0.4	0.1	0.1	0.0	0.2	1.6	0.2	6.4	9.1	7.5	0.0	5.1	2.6	0.2	0.6	8.1	0.5	2.8	3.5	14.3	3.0	7.3	2.1	9.2	0.0	4.6	0.0	5.3	0.2	1.2	1.3	0.8	4.9	0.0	19.0	3.3	13.9	7.9	0.5	3.4	0.0	4.3	0.4	1.0	2.7	3.3	109.6	5.1	0.0	0.0	4.2	0.1	0.3	0.4	3.6	1.0	0.1	8.1	0.0	10.1	1.5	1.6	4.4	0.0	0.0	2.1	1.8	1.9	0.8	1.2	0.0	6.3	2.2	0.7	1.1	0.7	5.8	6.2	0.5	0.0	10.6	0.9
HUS1		ENSG00000136273	"HUS1 checkpoint clamp component"	O60921	7	47963288-47979615	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026787	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA026787: AB_10601431"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-3)"	"unprognostic (6.93e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.89e-2)"	6.3	8.4	4.4	5.7	4.7	8.3	5.2	5.4	7.4	5.4	6.2	7.4	6.8	5.8	5.6	8.5	4.2	4.1	7.0	4.5	4.7	7.1	11.2	6.3	7.5	5.0	5.7	5.5	6.3	9.7	6.3	7.6	4.9	5.3	8.6	3.5	6.1	4.2	11.1	4.4	5.3	7.8	4.4	5.3	4.3	3.6	5.5	6.9	6.3	6.9	7.6	6.9	6.1	5.4	8.8	16.7	10.7	18.2	9.8	10.0	9.0	20.2	8.4	11.1	10.2	11.8	10.8	9.3	10.2	15.5	57.4	13.6	11.9	15.8	24.3	10.5	8.2	5.2	16.5	9.5	10.3	9.5	12.4	7.0	20.2	12.8	7.0	9.1	18.8	8.4	10.1	10.5	31.8	11.7	13.0	24.8	13.2	15.7	15.2	8.1	7.9	14.7	15.8	24.1	14.6	18.8	13.4	19.8	9.9	20.3	15.3	22.6	9.4	22.1	15.0	31.9	23.0	8.3	19.6	17.2	17.6	17.6	35.4	18.6	14.2	8.2	12.6	13.4	12.7	9.1	11.9	13.7	12.6	10.0	12.5	12.9	3.3	14.9	9.0	14.9	14.1	9.5	4.4	4.7	5.4	7.4	4.5	4.7	5.0	5.7	4.9	4.4	5.5	5.4	20.0	3.2	6.2	4.2	22.8	9.7	16.2	12.7	11.4	11.3	9.0	7.1	16.8	4.3	13.2	11.0	10.4	17.9	18.6	26.1	21.5	17.1	29.6	11.0	17.5	16.5	6.7	8.6	5.9	14.7	31.1	11.2	7.1	16.1	23.5	14.3	10.0	16.7	23.7	13.5	6.2	10.8	14.2	12.8	17.7	48.2	9.3	23.3	17.8	8.4	20.0	8.1	15.5	6.6	8.2	18.6	37.9	11.7	15.8	10.7	16.5	15.8	7.4	14.9	0.0	12.6	10.7	12.8	6.7	11.7	7.2	31.9	20.8	11.0	9.4	15.0
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 162.1;lymphoid tissue: 72.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 178.4;Early spermatids: 87.3;Hofbauer cells: 57.0;Late spermatids: 76.4;Spermatocytes: 117.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NB-4: 286.4;U-698: 90.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039329	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	8.2	5.1	23.4	32.0	34.7	6.9	5.2	24.3	21.1	9.3	162.1	6.5	4.8	10.1	11.5	4.6	9.2	8.3	17.5	26.2	29.5	3.3	4.4	13.7	65.0	25.7	32.8	13.5	1.7	2.2	3.0	8.1	27.8	6.4	6.7	2.7	3.9	8.7	7.9	3.0	17.8	10.3	20.2	42.7	7.6	44.7	27.6	16.2	3.9	9.8	72.9	9.7	5.2	25.0	0.1	0.5	2.8	0.2	4.5	4.7	1.4	0.9	1.1	2.6	1.4	0.5	0.0	2.9	2.4	5.1	0.0	0.4	3.3	0.2	3.7	0.2	0.6	0.1	0.3	0.7	4.0	44.1	3.1	6.2	0.4	2.4	0.0	0.4	6.4	13.4	1.9	2.4	4.7	0.2	6.4	286.4	3.2	0.0	2.7	5.4	0.2	0.3	0.0	0.1	0.3	0.4	0.1	0.0	0.2	2.9	0.0	42.8	1.9	0.0	0.2	0.4	0.1	27.4	3.7	90.5	0.3	2.2	0.2	378.0	208.3	675.7	14.0	197.8	7.7	550.4	13.2	22.7	88.7	799.8	25.2	17.2	327.4	182.6	185.0	131.7	31.0	193.2	23.4	34.7	24.3	21.1	26.2	29.5	25.7	32.8	27.8	20.2	27.6	25.0	18.4	3.2	5.3	9.4	178.4	0.8	1.9	2.0	1.2	0.5	1.2	2.8	6.6	0.0	3.6	1.8	0.0	0.4	25.8	0.0	0.0	0.5	87.3	0.5	5.8	13.1	0.0	0.8	0.6	0.2	1.4	5.4	1.5	0.3	8.2	3.9	12.1	0.3	57.0	0.0	0.5	0.2	0.0	41.7	17.2	76.4	13.4	42.2	12.4	15.0	31.6	15.2	23.7	2.0	0.1	0.5	0.1	13.9	9.9	0.6	0.0	0.5	1.7	1.8	13.1	4.7	15.1	117.5	2.8	0.7	0.4	1.2	7.6	0.5	0.2	1.2
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronidase 2"	Q12891	3	50317790-50322782	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 282.8"	"Group enriched"	"Detected in many"	5	"Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 363.3;TIME: 502.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	97.4	62.6	24.7	29.1	23.0	3.1	93.9	24.9	28.3	51.6	24.3	34.0	17.9	66.1	10.3	39.7	55.6	47.5	92.2	22.3	24.8	85.1	32.2	186.8	40.0	26.0	24.9	29.1	27.9	25.7	41.6	87.4	27.5	37.2	11.5	3.3	37.5	22.0	30.9	37.1	38.7	37.4	27.1	282.8	38.6	22.0	28.1	9.5	80.9	35.7	14.6	47.0	45.8	24.9	26.8	38.5	63.0	64.1	38.2	32.9	39.6	29.8	41.2	42.0	32.6	44.6	77.3	7.0	102.4	43.6	82.5	27.4	24.6	58.7	12.0	14.2	19.6	9.7	34.9	69.2	33.0	8.1	24.4	51.9	48.8	42.1	13.8	38.1	363.3	18.2	17.6	8.0	35.4	37.0	17.7	16.6	72.0	23.2	55.7	15.5	12.4	26.1	52.4	24.2	16.6	53.3	30.4	31.2	31.8	21.2	34.4	20.3	502.9	50.0	49.7	33.5	47.5	13.9	24.1	21.6	29.4	25.5	73.0	0.0	9.5	10.7	1.4	14.1	3.0	1.1	1.3	3.8	5.3	1.5	0.4	0.7	9.2	2.8	13.6	4.0	1.9	3.3	24.7	23.0	24.9	28.3	22.3	24.8	26.0	24.9	27.5	27.1	28.1	24.9	497.6	19.2	9.9	5.2	3.6	13.0	28.6	45.2	11.4	7.8	17.6	16.6	7.3	32.9	30.9	33.1	6.2	33.6	4.1	13.5	11.7	53.0	4.7	8.5	19.8	216.3	7.3	10.1	1.6	38.7	38.4	26.6	16.8	13.8	0.0	31.5	253.1	9.1	46.2	8.4	1.9	13.0	42.7	12.6	9.3	5.0	24.5	9.4	17.8	15.9	7.6	19.7	5.2	4.0	3.4	45.6	13.5	22.2	4.2	45.3	16.1	11.8	11.0	6.1	39.5	11.2	26.0	11.2	56.0	24.9	12.6	32.7	4.1	50.0	16.6	33.3
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronidase 3"	O43820	3	50292831-50299405	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.4"	"Group enriched"	"Detected in many"	17	"Early spermatids: 79.7;Late spermatids: 268.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 33.2;eosinophil: 54.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in all"		"HEL: 58.8;HMC-1: 101.1;THP-1: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA049402	Uncertain				"Secreted to blood"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	2.1	2.8	5.1	1.3	5.4	36.4	1.8	6.7	8.3	2.0	2.9	1.9	1.7	1.6	1.1	3.9	1.6	1.8	1.8	5.1	4.0	2.6	5.1	2.1	1.2	7.4	4.0	1.5	1.9	0.9	1.9	1.5	7.3	3.2	1.0	1.1	3.5	2.4	1.0	2.1	1.8	2.2	3.9	1.7	4.5	13.9	5.4	1.6	1.7	0.9	1.6	1.8	2.7	5.8	6.0	6.9	3.8	4.3	7.6	3.9	2.3	6.5	5.8	8.0	6.1	9.3	6.2	5.2	3.1	7.5	12.4	6.5	7.0	15.2	3.0	12.3	3.6	58.8	18.8	7.6	5.5	6.4	101.1	8.1	11.5	8.1	5.2	5.8	8.4	5.8	4.6	6.3	3.8	3.6	2.4	37.4	2.9	7.0	17.2	2.6	5.1	9.5	9.5	2.6	4.7	5.4	9.6	7.5	5.1	4.4	4.9	107.2	11.1	6.8	4.9	22.2	3.8	3.0	7.0	4.4	6.0	22.5	5.8	33.2	4.1	54.6	1.3	2.3	2.2	1.6	4.1	1.9	8.2	2.9	1.1	1.5	1.4	2.1	1.4	2.0	2.6	2.4	5.1	5.4	6.7	8.3	5.1	4.0	7.4	4.0	7.3	3.9	5.4	5.8	2.5	3.2	1.1	0.3	0.8	3.1	2.8	8.1	2.8	1.5	2.2	2.8	0.4	1.5	5.0	3.7	4.2	2.8	0.2	0.8	9.8	5.6	79.7	2.0	1.6	3.5	4.2	9.2	2.4	0.7	5.3	1.2	4.1	2.1	7.0	1.1	7.1	2.1	2.1	5.0	1.6	1.9	6.1	1.9	4.4	268.2	1.8	2.0	3.6	1.0	5.9	1.5	0.0	0.5	0.3	3.6	0.4	2.6	1.9	2.2	0.5	2.7	1.8	0.8	6.6	1.2	1.8	4.3	4.6	3.7	3.7	3.0	2.2	1.6	1.8	3.5
HYAL4		ENSG00000106302	"Hyaluronidase 4"	Q2M3T9	7	123828983-123877481	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 4.0;skeletal muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.8;Cytotrophoblasts: 4.3;Extravillous trophoblasts: 8.1;Spermatogonia: 4.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CAPAN-2: 5.9;RT4: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.1	0.6	0.0	0.7	0.5	0.1	1.0	1.0	0.1	0.5	0.2	0.0	0.1	0.4	0.4	0.0	0.1	0.2	0.7	0.4	0.4	0.1	0.4	0.2	0.5	0.3	0.2	0.5	0.0	0.0	4.0	0.7	0.2	0.1	1.0	0.5	0.2	3.9	0.9	0.2	0.0	0.1	0.8	0.2	2.1	0.5	0.0	0.4	0.0	1.0	0.2	0.0	1.3	0.2	0.4	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.0	13.9	0.2	0.0	0.0	0.8	0.0	1.1	0.2	0.0	2.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.0	0.6	0.7	1.0	1.0	0.7	0.4	0.5	0.3	0.7	0.1	0.5	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	8.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	4.4	0.0	0.0	2.2	0.0	0.0	0.0	0.2
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN axonemal central pair apparatus protein"	Q4G0P3	16	70802084-71230722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;choroid plexus: 23.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.3	0.3	2.2	0.3	3.2	0.5	0.5	1.2	1.4	1.2	23.9	0.6	0.2	0.9	2.0	0.1	5.3	0.5	0.5	3.4	3.5	1.3	0.5	1.4	0.3	8.9	9.9	1.1	0.7	2.5	4.4	0.1	5.8	0.8	0.1	6.4	0.3	0.3	0.1	0.5	0.2	0.1	8.0	0.4	0.2	4.7	4.3	0.0	1.9	0.0	0.0	0.5	0.4	4.4	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.1	1.8	0.3	0.1	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.1	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.4	0.1	0.1	0.4	2.8	0.4	1.1	0.2	5.3	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.4	0.0	0.1	0.9	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.7	0.1	0.3	0.2	0.1	0.0	2.2	3.2	1.2	1.4	3.4	3.5	8.9	9.9	5.8	8.0	4.3	4.4	0.1	3.2	2.6	35.3	0.0	0.0	0.2	2.6	0.0	17.0	1.5	1.1	2.5	0.0	18.3	9.2	52.1	0.0	0.4	0.0	1.9	2.5	35.4	150.6	6.5	0.7	3.5	0.0	49.2	0.6	0.0	1.4	0.0	4.0	0.0	5.0	0.0	0.0	0.1	0.0	25.9	0.1	4.1	0.0	0.0	31.5	2.5	0.3	3.6	3.7	0.0	9.3	0.0	26.2	21.8	0.3	0.1	4.5	0.1	0.6	0.0	1.8	153.2	30.5	0.0	2.0	1.7	17.7	7.5	0.0	0.0	0.0	0.5	1.6	0.1	0.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43450989-43453989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	31.7	22.8	28.1	9.3	29.2	12.1	19.3	29.6	36.3	23.4	27.9	21.3	44.1	23.3	15.4	15.0	24.2	18.7	20.8	27.0	31.2	29.5	44.6	23.0	11.3	30.9	28.9	42.1	53.7	25.2	14.6	10.5	30.9	19.8	12.3	4.1	35.3	47.0	20.8	16.2	34.4	13.2	30.0	12.2	23.9	3.9	28.4	8.8	19.1	10.2	9.2	17.4	15.3	32.4	58.7	7.3	2.2	3.5	9.8	15.1	0.2	48.4	35.7	52.6	34.3	24.2	97.7	0.0	4.1	29.7	25.1	10.9	0.0	45.8	21.6	15.2	20.5	10.2	25.0	0.0	58.8	0.0	0.0	9.4	12.4	64.0	0.0	56.3	106.7	0.5	1.2	0.0	34.5	1.2	9.6	8.8	11.1	5.6	15.5	46.0	0.0	0.3	37.5	2.2	27.2	20.3	56.0	30.4	13.2	8.7	9.2	72.0	59.5	3.7	0.0	12.4	99.2	0.0	0.0	0.0	4.1	13.4	105.5	10.6	1.7	3.7	4.2	1.3	5.5	4.3	7.1	3.3	5.8	5.3	6.6	2.0	0.1	7.5	1.8	29.9	0.7	4.0	28.1	29.2	29.6	36.3	27.0	31.2	30.9	28.9	30.9	30.0	28.4	32.4	29.8	19.2	64.4	5.9	16.1	28.0	45.2	22.8	51.8	16.9	41.0	65.3	0.4	65.8	23.0	57.0	10.4	18.6	19.2	56.6	45.0	106.7	1.2	9.9	23.6	23.2	69.5	21.5	1.4	86.1	115.9	45.7	25.5	18.7	43.2	33.5	25.0	59.0	29.8	8.4	1.9	89.1	16.2	8.5	31.0	4.5	31.7	23.5	40.9	1.9	15.8	45.0	8.2	4.5	4.8	109.6	97.0	30.5	41.7	33.7	232.5	146.9	12.4	16.7	26.3	31.3	58.2	1.4	3.0	27.3	22.0	12.0	12.3	49.8	47.6	38.4
HYKK	"AGPHD1, LOC123688"	ENSG00000188266	"Hydroxylysine kinase"	A2RU49	15	78507564-78537372	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Late spermatids: 33.7;Proximal enterocytes: 37.0;Proximal tubular cells: 39.4;Skeletal myocytes: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.2;U-266/84: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040706	Approved		Approved	Vesicles,Aggresome		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Aggresome	"HPA040706: AB_10795528"	"unprognostic (9.26e-2)"	"unprognostic (1.98e-4)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.90e-2)"	4.5	4.8	2.8	1.0	3.1	1.3	4.5	2.2	3.2	5.6	1.6	4.6	7.3	3.8	5.9	2.8	4.3	2.4	5.3	2.7	2.2	12.3	5.7	2.1	2.0	2.0	2.0	6.1	6.8	4.8	3.5	0.7	1.8	4.1	3.4	2.6	3.5	4.1	6.2	2.8	7.2	3.6	1.6	1.3	5.1	5.3	2.3	1.9	4.5	5.4	1.7	3.9	3.8	2.9	4.3	6.3	1.0	11.3	2.3	5.3	2.7	1.5	2.7	3.7	4.2	2.2	4.9	3.1	1.4	2.5	6.3	5.2	10.0	3.3	3.5	1.5	22.2	1.7	3.8	5.6	6.0	0.5	1.9	4.8	6.4	1.4	2.7	1.8	2.7	13.8	4.0	8.4	2.2	5.0	4.2	1.0	0.7	9.8	8.3	2.4	12.4	2.7	7.1	5.1	1.3	1.6	2.9	8.6	10.9	1.9	9.5	0.4	1.9	2.4	1.8	4.3	4.4	12.9	24.2	0.2	3.2	0.2	3.4	0.4	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	3.0	0.6	0.3	0.1	0.0	0.3	0.5	0.4	2.8	3.1	2.2	3.2	2.7	2.2	2.0	2.0	1.8	1.6	2.3	2.9	4.1	12.8	4.1	4.6	1.4	3.6	7.7	4.5	6.2	2.0	4.5	9.8	6.7	0.0	2.9	7.3	2.1	7.3	1.5	2.8	29.4	2.5	14.0	2.7	3.3	4.1	4.2	1.3	2.8	7.9	4.4	5.4	5.1	1.5	0.0	2.4	6.8	7.1	0.8	0.0	2.7	3.9	2.0	1.0	0.9	33.7	5.3	1.0	7.2	2.8	0.3	7.5	0.0	0.5	1.1	2.9	3.6	3.8	1.7	3.7	37.0	39.4	3.5	1.9	0.0	28.1	4.0	5.4	8.0	4.9	1.6	3.4	1.6	3.9	5.7	4.7
HYLS1	FLJ32915	ENSG00000198331	"HYLS1 centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900646	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 80.8;Late spermatids: 54.9;Spermatocytes: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	2.9	2.4	5.7	3.0	5.3	2.4	4.3	8.0	8.5	4.2	4.9	4.7	6.0	3.8	6.7	3.7	4.2	2.6	5.0	5.4	5.3	5.5	5.8	2.5	6.2	5.0	4.7	3.9	2.2	2.7	2.3	4.4	5.0	5.0	5.0	4.3	3.1	6.1	2.7	4.8	3.3	6.4	4.5	3.6	5.4	26.5	6.0	5.2	2.5	4.3	9.0	3.8	2.3	5.2	11.2	23.9	8.4	5.9	16.5	11.6	14.8	27.3	10.9	24.8	16.9	0.3	17.2	5.0	11.3	25.4	8.4	15.8	12.2	10.0	28.7	27.1	9.2	3.5	2.3	4.9	12.9	12.4	16.9	7.2	11.0	25.2	28.3	5.1	18.4	11.0	6.1	27.3	33.6	18.6	9.1	36.2	18.4	46.2	40.8	19.0	0.1	16.5	27.3	17.9	11.6	7.2	29.6	22.2	11.0	10.5	53.6	26.9	16.7	1.8	20.9	19.4	4.6	10.1	11.4	11.4	5.1	26.7	22.2	5.7	7.6	1.5	10.6	8.7	10.2	16.1	13.8	12.6	10.0	16.1	13.2	9.7	1.1	6.8	6.3	20.4	15.5	7.1	5.7	5.3	8.0	8.5	5.4	5.3	5.0	4.7	5.0	4.5	6.0	5.2	3.9	0.0	0.5	2.6	9.3	4.2	2.8	8.0	4.6	7.1	4.1	5.3	5.5	1.5	2.2	1.8	4.2	18.6	11.5	4.0	11.7	5.5	80.8	5.8	3.4	3.7	4.9	9.1	14.3	4.2	13.0	5.9	8.6	2.1	0.0	7.1	6.8	5.4	7.6	0.0	13.8	3.2	8.2	3.2	4.0	54.9	8.4	2.5	7.2	6.5	11.9	5.8	12.3	6.0	5.8	3.6	5.8	6.0	4.2	3.3	5.2	12.1	4.8	6.5	6.6	2.3	5.7	92.1	32.3	6.2	4.3	4.4	4.9	7.5	5.5	1.5
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044188-119057227	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 201.9"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 118.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 35.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 418.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"	NA	NA		130000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049296: AB_2680702"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favorable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.38e-2)"	38.2	48.5	30.7	27.1	32.2	18.6	31.0	28.3	34.1	37.2	25.5	40.9	18.1	44.6	51.2	47.4	40.8	14.0	56.5	32.9	41.0	63.0	201.9	47.7	17.4	32.6	34.5	36.1	165.9	18.8	100.1	19.9	34.2	47.9	21.3	11.9	46.3	20.7	19.1	25.0	39.0	19.0	28.5	47.6	60.3	85.7	35.2	21.7	87.2	8.4	20.9	39.9	31.7	32.9	40.5	34.5	77.2	224.4	41.2	19.7	107.7	56.1	38.0	63.1	47.2	105.0	103.0	85.3	418.9	40.7	122.1	59.5	71.5	69.3	53.8	92.8	26.1	151.8	32.6	76.7	187.7	88.6	73.5	23.9	91.1	55.2	185.3	57.9	100.2	57.2	53.5	136.8	33.9	97.8	59.4	49.6	55.5	83.2	33.6	63.1	55.9	144.3	48.6	67.8	45.7	70.0	80.4	103.8	53.3	65.5	78.8	82.9	75.0	59.9	46.4	27.2	77.5	88.1	64.0	61.2	53.8	76.2	135.6	4.4	4.5	2.2	11.7	6.1	12.6	5.4	6.4	8.7	5.0	4.0	4.0	6.1	1.3	7.6	4.4	35.9	5.5	4.7	30.7	32.2	28.3	34.1	32.9	41.0	32.6	34.5	34.2	28.5	35.2	32.9	16.4	9.6	14.1	6.2	22.7	17.8	18.5	17.5	14.2	11.5	28.5	21.1	12.4	15.7	16.8	25.8	43.8	11.2	36.6	35.3	9.8	20.7	74.0	20.4	29.1	20.0	35.8	17.0	12.0	18.8	26.6	21.0	39.8	38.1	15.8	43.1	13.9	49.9	22.2	25.2	13.7	52.1	18.3	8.2	21.6	38.8	13.1	17.8	23.2	5.6	15.5	8.7	17.5	4.5	9.3	31.4	24.2	13.5	118.7	44.4	14.9	17.6	16.7	14.5	13.1	16.4	15.6	27.8	29.1	16.2	19.9	19.3	20.8	14.8	27.3	24.7
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43804427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	8.9	9.8	13.8	5.9	13.8	4.9	6.5	16.6	22.0	5.0	13.8	5.0	3.7	4.3	5.1	4.2	6.0	2.9	8.5	13.8	15.0	6.5	14.2	7.6	6.5	14.7	15.2	6.2	9.4	6.2	5.6	3.6	14.7	6.8	3.8	8.6	5.5	4.3	19.2	6.1	5.1	4.9	13.4	5.5	5.8	7.9	14.2	6.1	5.2	14.7	7.7	8.3	4.3	15.4	13.5	36.8	17.3	19.5	11.6	11.5	6.5	21.8	13.1	18.9	12.6	23.7	7.4	19.8	25.9	16.7	17.8	23.1	30.3	24.9	14.3	17.3	37.3	26.4	64.6	34.0	17.8	30.4	16.3	10.1	24.2	21.3	18.1	9.3	14.7	20.9	40.5	16.9	17.2	33.5	19.2	33.9	19.5	48.6	40.9	15.4	12.6	22.4	17.7	26.5	33.9	24.7	20.7	31.1	13.3	10.6	23.7	19.5	13.3	22.6	11.8	24.2	55.8	20.5	40.6	46.2	15.1	33.1	26.8	16.8	25.7	22.1	25.0	37.7	26.4	30.0	26.8	26.7	23.5	31.4	29.9	27.9	9.4	26.7	47.7	39.8	27.5	23.5	13.8	13.8	16.6	22.0	13.8	15.0	14.7	15.2	14.7	13.4	14.2	15.4	11.3	6.4	14.5	0.0	11.1	30.0	15.0	8.1	13.6	11.2	14.4	11.9	0.7	8.6	12.1	7.3	54.2	6.6	8.2	6.4	9.8	6.5	2.4	7.2	9.6	10.7	10.7	9.5	0.0	8.4	4.4	12.5	26.0	7.7	8.8	4.5	6.4	6.5	3.9	13.5	0.0	11.6	8.2	4.4	26.2	1.1	5.0	9.1	23.2	0.0	4.7	4.9	6.2	0.0	0.0	6.8	4.7	2.2	11.3	14.8	7.2	10.4	15.4	28.5	0.0	23.2	11.8	3.9	4.7	19.4	37.4	4.9	10.4	9.1	9.4	11.1
IAH1		ENSG00000134330	"Isoamyl acetate hydrolyzing esterase 1 (putative)"	Q2TAA2	2	9473658-9496543	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 433.4;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040523, HPA076040"	Approved		Approved	Nucleoplasm		NA	NA		240000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA040523: AB_2677021, HPA076040: "	"unprognostic (1.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.41e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.91e-2)"	40.7	47.5	27.5	16.9	28.2	27.3	34.1	32.6	37.3	33.3	32.6	41.2	20.0	30.4	31.4	26.6	28.2	23.0	56.9	27.4	29.6	39.4	46.0	31.3	27.0	27.6	27.8	35.6	23.3	45.6	31.1	24.2	28.6	26.6	29.1	22.3	22.4	29.3	43.0	22.6	26.2	27.4	27.5	25.9	29.9	65.8	29.0	28.5	28.8	72.6	31.0	30.6	29.9	31.8	41.0	40.8	4.7	0.5	73.4	140.7	0.9	33.4	76.8	48.7	46.4	0.5	44.2	21.1	17.6	106.7	35.2	27.8	15.4	32.2	48.5	81.2	26.8	26.7	16.1	27.5	139.6	0.1	21.2	85.1	92.9	36.6	42.6	93.6	49.2	37.8	0.4	13.3	100.1	39.4	106.6	4.2	6.4	53.6	20.6	26.0	0.1	6.1	79.4	21.1	29.0	56.2	26.0	37.2	52.6	2.4	37.9	46.4	38.6	38.7	17.0	17.5	52.6	10.6	0.7	8.2	53.4	16.6	44.3	33.3	38.0	31.9	30.2	35.3	33.8	38.5	35.2	34.6	49.6	32.7	27.2	30.9	23.0	37.6	42.8	52.4	46.0	25.6	27.5	28.2	32.6	37.3	27.4	29.6	27.6	27.8	28.6	27.5	29.0	31.8	44.4	32.1	26.2	25.1	53.7	89.9	100.5	92.4	21.6	33.6	41.3	51.2	45.4	52.9	40.1	49.7	12.5	74.2	65.0	36.2	92.0	68.9	433.4	49.9	56.9	30.1	25.7	41.4	43.2	76.9	109.8	73.5	16.8	50.1	36.8	74.0	36.4	53.1	87.4	42.1	35.1	28.6	42.7	78.2	95.2	503.0	93.8	66.3	92.5	19.7	116.8	44.0	80.3	23.1	44.4	90.5	37.3	73.0	38.5	75.6	68.0	138.8	42.7	57.4	98.6	82.8	75.2	243.2	48.8	41.4	95.8	44.5	64.9	87.0	47.5	89.5
IAPP	"AMYLIN, DAP, IAP"	ENSG00000121351	"Islet amyloid polypeptide"	P10997	12	21354959-21379980	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"pancreas: 166.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 44.5;Pancreatic endocrine cells: 15.2"	"Cancer enriched"	"Detected in single"	76	"pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000352, HPA053194"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	11900		"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"CAB000352: AB_2121635, HPA053194: AB_2682076"							"unprognostic (5.52e-3)"				"unprognostic (1.00e-1)"	"unprognostic (4.16e-1)"		"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"			0.5	0.0	0.1	0.0	0.2	1.0	0.0	0.5	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	2.3	0.0	0.2	0.1	0.5	0.0	166.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.3	0.1	0.2	0.1	0.5	0.2	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	44.5	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.5	0.3	0.3	0.2	0.0	0.4	0.3	0.3	0.1	0.0	0.8
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094132-220148041	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		35000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	55.8	49.8	19.9	33.3	21.1	18.3	41.8	23.5	25.4	35.3	37.8	54.2	43.4	31.8	31.4	47.9	41.4	30.5	60.0	20.0	21.8	65.5	83.8	31.0	38.8	22.7	22.2	39.0	33.6	80.5	16.0	40.7	25.0	36.1	54.8	34.8	40.0	37.5	92.9	40.5	40.4	39.4	21.6	28.4	39.1	30.1	22.3	31.8	39.7	85.7	43.1	35.6	30.0	22.9	137.2	125.6	70.7	69.9	104.2	104.4	169.6	81.4	86.9	87.9	70.7	121.7	138.8	125.6	107.1	101.4	68.0	129.3	99.0	101.5	100.9	87.5	119.3	62.6	94.6	137.8	64.6	100.4	64.9	76.0	101.3	95.4	97.6	84.7	86.9	79.9	156.9	70.7	116.7	75.9	79.8	72.0	92.1	106.2	82.1	69.5	140.7	202.2	126.2	90.4	38.0	106.6	123.2	188.2	130.3	80.6	218.5	111.9	89.8	86.1	71.6	117.0	138.4	60.0	98.9	90.8	91.3	77.3	97.6	33.8	24.6	22.8	23.0	27.7	30.8	23.6	24.9	30.3	29.2	18.3	27.8	25.6	4.7	28.3	22.3	10.6	29.9	26.7	19.9	21.1	23.5	25.4	20.0	21.8	22.7	22.2	25.0	21.6	22.3	22.9	66.4	35.3	38.0	15.7	30.7	20.1	28.6	44.1	34.7	28.6	40.1	39.4	144.3	22.8	42.9	29.5	25.0	79.0	31.5	54.2	11.7	47.7	20.0	63.8	48.3	43.7	36.2	29.6	17.3	65.4	55.5	37.0	32.1	44.3	19.6	41.3	37.5	99.6	45.9	20.2	22.7	55.4	28.5	51.0	11.2	6.8	37.3	35.9	19.6	15.0	46.1	34.6	27.8	16.6	31.5	67.4	44.9	42.5	33.1	34.1	38.4	36.1	62.0	35.5	46.0	46.3	39.0	44.6	44.1	63.5	26.6	71.7	31.0	54.4	69.9	27.6
IBA57	"C1orf69, FLJ12734"	ENSG00000181873	"Iron-sulfur cluster assembly factor IBA57"	Q5T440	1	228165804-228182257	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Heme biosynthesis"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030555, HPA030556, HPA030557"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433"	"unprognostic (3.00e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.01e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.71e-9)"	"unprognostic (4.94e-2)"	"unprognostic (5.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (7.14e-2)"	2.0	2.7	2.6	1.4	2.3	4.1	1.4	2.9	2.5	1.3	2.2	1.8	1.6	1.8	0.5	1.6	1.3	1.0	3.3	2.1	2.0	2.0	2.8	1.9	1.6	2.7	2.2	1.9	2.9	2.1	0.9	1.4	2.3	1.2	1.4	0.5	1.7	1.0	6.1	3.0	1.7	1.7	2.1	1.7	2.0	1.1	2.8	1.3	1.3	4.0	1.7	1.3	1.2	3.5	2.5	2.5	2.7	1.2	1.3	1.4	3.3	1.5	0.7	1.1	0.6	5.3	2.1	5.3	3.1	1.6	0.6	4.4	2.0	3.2	1.0	1.1	4.5	3.1	3.5	2.6	1.1	3.7	3.5	2.2	1.8	1.3	1.5	1.0	1.6	3.2	5.4	2.4	1.1	2.0	3.6	2.2	2.0	3.4	2.8	4.4	3.1	2.4	1.6	5.1	4.1	2.8	2.4	7.5	1.9	0.5	6.0	4.9	3.8	3.0	2.8	2.1	3.7	1.8	0.9	2.6	1.4	1.6	2.3	1.6	0.4	0.2	0.6	0.4	1.0	0.4	0.5	0.5	0.3	0.7	0.7	0.7	0.5	0.8	0.4	1.0	0.5	0.2	2.6	2.3	2.9	2.5	2.1	2.0	2.7	2.2	2.3	2.1	2.8	3.5	5.7	9.6	11.0	4.2	10.2	8.2	8.8	3.9	2.8	5.8	5.6	5.6	15.3	8.6	9.2	0.0	12.5	10.7	5.0	14.5	7.9	5.4	22.2	5.2	6.0	8.8	7.2	49.3	3.8	6.9	8.6	5.2	5.1	10.3	15.2	6.7	5.3	7.9	5.5	3.3	4.1	8.0	4.1	4.4	6.4	30.7	3.7	6.0	7.2	6.5	4.2	4.4	4.1	3.0	5.8	8.8	6.3	7.2	5.8	6.3	9.4	6.7	3.2	19.5	6.6	9.7	4.7	14.9	11.2	4.4	6.0	16.3	7.2	8.3	11.9	8.3
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169986-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA023826: AB_1851378, HPA048438: AB_2680392"	"unprognostic (3.13e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	7.3	14.3	2.5	8.1	3.3	3.7	7.9	3.2	2.6	8.9	3.1	8.6	8.4	8.0	4.8	8.3	7.6	6.0	10.0	2.0	2.7	10.3	22.2	7.0	6.7	2.8	3.4	8.8	11.0	12.3	4.8	6.3	3.0	7.7	10.4	8.5	8.9	7.4	21.4	4.1	8.4	7.4	3.5	6.5	11.5	4.0	3.1	7.2	10.3	20.9	7.2	8.6	5.9	3.5	8.3	17.0	12.2	10.3	14.4	19.8	5.5	19.3	21.1	15.5	16.6	9.0	9.6	16.4	11.9	22.8	20.5	8.8	9.8	10.8	18.5	22.5	7.3	17.6	8.8	14.1	20.2	20.7	10.3	17.1	17.6	14.8	36.8	14.5	15.7	11.4	16.4	10.0	16.7	12.7	7.2	6.7	5.5	13.0	9.1	10.2	25.7	6.5	23.2	18.9	8.2	9.0	13.0	16.1	10.3	10.8	15.1	12.5	12.6	9.0	6.7	11.3	15.6	10.3	17.1	7.5	9.9	13.4	11.9	1.3	1.2	1.0	1.8	1.1	2.4	1.6	1.8	1.6	1.9	1.0	1.7	1.6	0.0	1.0	2.3	1.4	2.7	0.8	2.5	3.3	3.2	2.6	2.0	2.7	2.8	3.4	3.0	3.5	3.1	3.5	26.1	41.7	47.6	46.4	33.5	13.6	42.8	19.4	15.4	55.6	27.4	19.0	64.9	40.0	41.2	38.6	54.2	23.9	25.9	62.2	15.6	37.5	4.2	37.4	28.1	27.3	38.9	37.4	102.6	51.6	16.4	34.1	117.8	57.0	36.8	38.1	21.8	77.0	26.7	52.2	97.9	49.3	6.1	33.4	26.1	4.1	25.7	36.1	23.2	44.0	43.6	32.7	25.7	80.9	190.0	52.1	55.5	21.1	68.2	53.4	31.1	28.3	42.1	39.2	26.3	42.0	29.1	21.2	22.9	41.1	11.6	9.4	29.8	67.0	41.9	64.4
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 594.7;Late spermatids: 867.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	9	"T-cells: 29.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	15.8	10.4	11.3	5.7	16.2	23.8	21.1	21.5	21.8	16.4	1.2	22.8	13.6	6.8	13.6	9.5	13.7	11.1	44.3	13.4	9.3	16.0	8.8	11.2	13.5	8.0	9.5	1.7	62.7	20.9	19.8	8.2	9.3	22.1	23.5	2.9	37.1	4.9	2.8	12.8	17.8	5.6	5.1	12.4	30.5	24.2	13.3	5.0	14.1	3.3	9.6	13.8	7.4	15.3	0.0	1.5	1.7	0.2	0.2	0.0	4.2	0.0	0.0	0.6	0.2	1.0	47.1	0.3	5.2	0.1	0.9	0.0	0.8	1.9	0.0	0.0	6.8	9.1	0.9	0.0	0.4	9.1	1.8	0.0	3.0	0.0	0.0	0.5	31.5	8.2	26.4	0.0	0.0	42.5	0.4	0.0	9.9	48.4	0.4	0.0	0.0	19.5	19.0	49.4	66.1	105.8	0.0	52.1	0.7	11.6	43.4	14.3	19.8	0.0	0.9	0.2	1.0	14.1	7.5	0.0	0.0	6.9	10.3	1.0	2.4	0.2	0.3	0.8	0.6	0.4	5.4	0.4	2.4	0.7	0.3	0.2	3.4	0.9	0.4	0.6	29.9	1.3	11.3	16.2	21.5	21.8	13.4	9.3	8.0	9.5	9.3	5.1	13.3	15.3	73.4	28.9	24.4	6.5	1.6	20.5	16.2	7.1	9.1	10.4	42.8	28.7	43.2	22.8	20.1	22.0	6.2	2.7	2.1	28.2	43.0	38.4	594.7	34.2	5.8	44.1	77.2	16.4	132.1	74.8	0.8	4.5	56.1	65.4	8.2	11.2	42.1	1.3	23.9	0.0	138.0	80.5	44.7	8.1	9.3	867.0	7.5	9.6	14.2	60.0	6.3	0.8	3.1	49.3	3.9	59.8	53.1	3.0	1.7	53.8	23.8	8.3	17.8	1.7	6.6	1.2	5.6	13.9	9.6	18.4	8.9	2.2	9.5	4.7	41.8	42.7
ICA1L	"ALS2CR14, ALS2CR15"	ENSG00000163596	"Islet cell autoantigen 1 like"	Q8NDH6	2	202773150-202871766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.7;Inhibitory neurons: 114.3;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042507	Approved		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA042507: AB_10797016"	"unprognostic (4.14e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.05e-4)"	"unprognostic (1.66e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.50e-4)"	"unprognostic (4.15e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.58e-3)"	3.8	4.8	9.8	1.3	12.0	3.9	3.5	23.2	20.6	7.1	7.4	6.8	1.5	7.5	5.7	2.6	9.5	3.6	4.9	13.4	13.7	3.2	0.5	2.2	1.5	3.7	5.5	8.1	2.7	7.1	15.7	5.2	1.6	5.5	1.6	17.5	1.9	6.1	5.1	1.9	2.0	4.6	3.3	1.4	3.7	8.3	9.9	2.7	5.1	6.7	1.2	5.4	3.4	8.7	1.5	1.2	2.9	8.4	2.7	5.0	21.8	2.9	3.8	1.6	2.3	1.4	0.6	1.7	0.8	3.5	4.6	0.8	4.0	1.4	2.1	1.5	3.1	3.6	1.8	1.8	1.5	4.4	2.1	1.9	2.4	1.7	1.4	4.9	2.4	5.6	2.8	1.6	2.5	0.7	3.6	6.0	8.4	0.5	3.1	4.3	4.4	0.7	1.6	3.9	7.8	7.5	4.5	0.2	1.9	2.4	1.0	3.4	1.6	7.0	1.8	1.5	4.4	5.5	8.9	4.5	4.0	1.4	1.3	1.2	1.1	0.6	0.9	1.2	0.7	1.3	0.8	0.7	1.6	2.3	1.1	1.6	1.5	2.3	2.1	1.1	0.7	0.7	9.8	12.0	23.2	20.6	13.4	13.7	3.7	5.5	1.6	3.3	9.9	8.7	13.0	9.6	10.0	62.0	10.5	2.0	4.4	2.9	1.2	58.7	4.1	2.8	15.2	1.5	8.7	18.4	60.5	16.3	5.7	1.0	0.0	5.3	28.7	40.9	17.0	5.8	19.2	2.5	171.7	4.9	37.7	12.0	3.6	9.9	6.3	17.4	5.7	1.1	3.6	16.8	114.3	2.1	4.1	5.3	9.7	40.2	31.7	5.2	7.2	15.9	3.8	22.1	17.5	93.5	42.7	3.4	0.6	46.3	2.1	5.2	1.9	3.7	36.7	84.1	0.0	10.0	6.3	34.1	8.8	1.9	2.3	7.5	7.3	6.0	1.7	2.7
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289952-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 40.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	239	"amygdala: 13.6;basal ganglia: 15.4;cerebral cortex: 26.2;hippocampal formation: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	14	"amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4"	"HPA008943, HPA009083, CAB025178"	Enhanced					NA	NA		3300000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.3	0.0	13.6	0.0	15.4	0.6	0.2	0.0	26.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.2	40.2	0.0	1.0	0.0	6.2	0.2	0.0	0.0	2.1	0.0	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	3.5	0.0	0.0	7.4	0.0	0.0	0.3	5.0	0.8	0.2	0.5	0.0	0.1	5.6	2.3	0.0	0.0	6.5	0.2	0.0	0.0	0.2	1.0	16.3	6.1	0.5	0.1	0.0	3.1	0.0	0.6	0.1	0.0	0.0	0.0	2.0	13.2	0.1	0.0	0.8	0.0	2.3	0.0	0.3	4.9	0.1	0.0	14.7	0.2	0.0	0.9	0.1	2.3	0.2	0.5	0.0	2.7	0.0	0.0	1.5	0.0	0.9	0.0	17.5	3.1	3.5	9.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	15.4	0.0	26.2	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.4	2.8	1.6	0.4	0.3	0.2	0.3	1.8	0.7	1.6	5.2	33.9	0.0	1.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.5	0.6	0.5	2.8	0.0	8.2	17.7	0.0	0.1	1.1	1.1	1.3	2.5	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.3	1.7	0.0	0.0	2.1	0.0	2.8	0.3	0.0	0.0	1.5	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.4	0.5	0.0	0.0	0.7	1.7	1.7	1.3	0.4	0.1	0.1	0.7	0.1	0.2	0.2
ICE1	KIAA0947	ENSG00000164151	"Interactor of little elongation complex ELL subunit 1"	Q9Y2F5	5	5420664-5490220	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054452, HPA061934"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA054452: AB_2682492, HPA061934: AB_2684641"	"unprognostic (1.45e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.39e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.33e-1)"	8.7	6.9	8.1	9.1	8.8	13.7	10.2	11.3	8.4	8.7	4.4	9.0	7.2	11.6	9.0	7.6	8.2	7.1	8.1	10.2	7.0	10.0	7.1	8.1	11.5	6.2	5.7	13.9	9.2	14.1	7.5	12.7	6.4	7.8	7.8	12.8	7.5	8.8	16.5	8.7	7.5	10.3	4.5	10.0	7.7	7.5	7.1	14.5	10.2	15.5	11.3	9.5	6.6	8.1	17.9	22.1	24.8	23.9	23.6	23.1	32.0	15.1	18.0	17.8	19.5	17.1	12.9	24.1	20.6	21.8	35.1	16.5	34.4	17.7	29.8	33.4	17.5	19.5	68.9	12.5	14.3	44.5	15.4	18.5	18.6	21.3	32.8	17.7	22.3	18.0	28.1	19.5	18.8	15.6	32.6	15.9	21.0	11.4	18.6	37.7	22.6	16.3	15.0	19.9	16.0	16.6	52.5	16.9	20.2	23.8	14.7	13.9	25.4	23.0	29.4	29.9	23.9	21.1	26.9	39.6	19.3	32.9	19.9	0.4	0.5	1.1	0.9	0.7	1.1	0.9	0.8	0.9	0.5	0.8	0.7	0.9	0.1	1.1	0.4	1.1	1.1	0.3	8.1	8.8	11.3	8.4	10.2	7.0	6.2	5.7	6.4	4.5	7.1	8.1	29.8	22.4	29.5	42.1	30.3	0.0	17.7	0.0	26.2	40.2	20.1	26.3	33.0	14.3	14.2	16.5	31.3	35.6	35.1	10.8	25.4	22.6	5.8	19.5	37.4	27.5	9.0	23.5	68.2	22.7	22.4	25.0	19.9	25.7	11.4	28.6	15.4	13.8	15.7	45.4	57.3	11.6	0.0	13.8	0.0	5.2	22.4	19.9	0.0	36.5	26.1	24.6	17.5	39.7	62.1	23.0	6.4	22.2	37.5	24.1	11.1	14.8	6.6	34.7	6.6	50.5	27.8	51.6	47.0	25.9	0.0	10.9	33.9	36.4	11.4	16.9
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 112.8"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	22.6	23.0	12.4	13.6	18.1	4.0	15.8	18.2	13.1	20.3	17.7	20.9	19.6	20.1	20.9	21.6	16.2	13.1	27.1	12.5	12.9	25.9	13.6	14.9	10.2	12.6	14.9	9.1	17.4	26.8	22.0	21.0	12.7	17.3	17.4	28.7	17.1	18.9	53.0	19.2	18.3	21.9	12.3	9.1	15.7	5.2	14.5	14.9	18.1	82.6	11.0	17.4	16.0	12.0	35.8	32.6	43.7	43.0	131.2	51.8	18.7	84.9	56.1	48.7	36.9	35.0	28.2	39.0	31.7	66.7	42.0	47.4	50.5	35.6	51.5	78.8	51.3	26.8	46.0	26.8	25.5	42.5	36.4	33.3	23.5	51.2	19.2	32.4	38.5	31.6	26.5	29.8	55.7	22.3	43.2	29.6	29.7	64.1	46.0	35.8	61.5	22.6	59.3	25.8	59.2	28.8	41.3	96.3	37.2	48.4	25.2	35.4	48.1	55.3	21.7	65.4	61.6	27.7	57.8	30.5	27.1	96.5	29.3	2.6	1.9	1.6	3.1	2.2	2.7	1.1	2.5	3.1	1.7	1.8	2.1	1.8	0.6	1.8	1.9	2.7	1.4	1.9	12.4	18.1	18.2	13.1	12.5	12.9	12.6	14.9	12.7	12.3	14.5	12.0	18.0	22.4	12.1	5.9	7.7	6.2	9.6	12.2	7.4	18.0	16.3	9.8	39.3	15.7	19.6	29.5	31.3	57.6	12.3	40.7	13.7	21.9	3.5	19.5	18.8	18.1	22.8	14.9	10.2	22.2	85.7	19.6	12.8	16.9	5.1	13.9	21.8	23.9	29.1	48.8	9.4	21.4	12.2	12.0	7.0	5.1	20.8	9.8	7.2	7.5	12.1	18.9	10.3	2.0	5.4	26.8	12.2	26.4	18.3	14.1	45.5	36.9	41.7	58.8	13.1	9.9	22.1	15.4	26.8	28.2	10.4	32.0	10.4	13.9	23.1	14.7
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.7	0.0	16.5	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.4	0.2	0.0	0.0	0.2	0.4	2.6	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.2	0.4	0.0	16.2	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
ICOSLG	"B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;brain: 33.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 28.5;Glandular and luminal cells: 22.7;Langerhans cells: 39.0;monocytes: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"									"CAB026037, HPA029179, CAB079997"	Approved		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA		130000000	"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , CAB079997: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	3.1	3.6	12.1	4.9	21.8	18.2	2.6	10.7	17.9	3.9	0.2	2.1	2.5	1.9	1.4	5.4	3.4	4.1	5.2	11.7	12.4	8.3	3.3	3.1	8.0	18.7	17.9	0.8	2.1	0.7	1.4	3.1	17.1	3.3	1.8	1.4	3.0	1.4	1.5	6.6	3.8	1.3	11.0	4.3	4.9	1.4	18.2	2.6	2.3	1.8	5.5	3.2	3.5	33.3	0.5	4.6	0.2	3.9	1.0	1.5	10.4	1.0	0.9	0.5	0.3	7.9	0.6	19.9	2.9	0.5	1.8	5.8	2.7	1.6	0.3	2.0	2.0	0.6	4.0	2.3	0.9	8.7	14.1	1.4	2.6	1.2	1.3	0.3	1.1	0.7	3.3	1.7	0.3	5.2	0.4	11.4	2.7	13.2	4.8	17.1	1.3	11.6	0.8	10.3	2.0	0.1	12.9	18.2	0.4	1.4	5.1	12.2	1.1	0.6	4.4	0.4	0.4	16.4	12.2	16.2	5.8	8.0	2.5	0.3	0.3	0.2	0.1	0.3	0.1	1.8	0.3	0.1	0.2	2.4	0.3	0.4	0.3	0.2	0.2	0.7	0.1	0.2	12.1	21.8	10.7	17.9	11.7	12.4	18.7	17.9	17.1	11.0	18.2	33.3	1.2	0.0	1.5	0.3	28.5	7.5	5.8	8.4	3.4	1.7	8.7	5.8	0.6	1.5	2.4	9.2	0.0	0.4	2.0	7.9	0.0	2.0	1.9	9.8	2.1	4.6	5.3	0.8	0.0	0.7	1.1	5.6	4.6	22.7	0.0	0.2	1.4	2.8	3.7	0.0	0.0	4.5	8.2	8.8	39.0	4.0	3.1	15.6	8.8	0.0	21.0	1.2	2.1	0.0	0.5	0.8	3.8	10.9	4.7	16.0	3.6	3.5	0.6	1.2	0.0	4.5	6.1	0.1	0.2	4.7	6.5	0.5	2.9	0.3	4.5	7.9
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557926-23559501	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Myogenesis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1710.3;Basal respiratory cells: 1091.1;Hepatic stellate cells: 1508.2;Ionocytes: 1210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 318.8;naive B-cell: 306.1"	"Group enriched"	"Detected in many"	39	"B-cells: 318.8;T-cells: 177.0"	"Cell line enhanced"	"Detected in many"		"U-698: 598.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB021353: , HPA024677: AB_2671647"	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	163.4	49.5	42.5	22.7	37.4	6.9	114.1	38.6	51.6	81.6	39.6	89.2	29.8	84.2	15.5	42.9	134.1	39.1	177.1	39.2	70.3	93.2	31.6	99.6	26.3	59.3	52.2	106.1	41.0	8.3	120.4	51.0	49.5	110.3	22.3	10.1	39.8	108.1	41.3	62.9	76.3	20.9	48.2	41.9	89.0	6.9	53.7	34.8	195.9	52.1	13.3	131.6	90.3	42.9	24.1	152.6	57.2	199.1	27.2	2.8	53.0	154.2	16.8	105.0	14.5	8.9	1.2	150.2	168.2	80.3	21.7	216.1	77.7	25.1	12.3	1.2	68.8	2.4	227.5	89.6	77.9	0.2	0.4	80.1	141.9	2.8	1.5	104.0	91.7	67.1	0.9	2.0	107.8	59.9	21.0	0.6	41.9	140.0	37.6	189.5	82.1	5.6	1.3	66.3	78.3	55.0	148.4	155.8	12.7	49.9	38.1	5.2	162.3	151.5	72.4	69.4	92.2	47.4	45.9	598.1	34.4	1.8	79.0	0.6	1.3	0.3	3.8	1.8	1.3	318.8	69.8	13.9	5.0	306.1	113.3	45.6	3.6	0.7	2.1	6.2	177.0	36.9	42.5	37.4	38.6	51.6	39.2	70.3	59.3	52.2	49.5	48.2	53.7	42.9	1710.3	115.4	62.6	77.7	211.6	205.2	340.3	1091.1	583.4	4.1	128.3	187.3	35.8	20.0	337.1	209.7	10.4	193.4	27.8	384.8	23.5	216.6	1.9	555.2	270.3	988.8	432.3	41.0	0.1	441.5	931.4	496.5	384.3	562.4	15.2	394.7	1508.2	7.0	70.6	5.0	0.2	560.1	1210.5	71.7	254.9	3.7	41.0	91.1	249.1	62.8	21.0	378.5	1.0	0.5	3.1	88.4	388.8	0.7	67.1	168.4	223.1	7.9	110.6	17.7	519.4	266.4	780.2	0.9	2.8	577.6	189.5	279.2	86.7	19.5	323.3	116.5
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	NA	NA		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	6.7	10.1	3.4	2.8	3.6	3.5	6.1	3.7	4.2	8.1	5.9	8.6	3.3	7.4	9.7	9.8	6.5	2.9	11.7	3.4	3.7	5.9	11.4	5.9	3.4	3.8	3.7	5.4	12.3	9.5	4.7	2.7	3.9	9.1	3.8	10.3	7.8	4.2	28.8	36.4	6.8	3.7	3.6	6.3	8.2	25.8	3.6	2.4	6.7	9.7	4.1	8.9	7.9	3.8	12.1	22.9	6.2	15.1	10.5	5.8	8.5	10.4	13.3	6.1	5.2	19.4	9.5	12.5	16.4	14.3	7.2	16.3	14.6	10.0	3.9	14.7	8.8	5.1	13.7	25.9	11.5	14.9	6.5	5.4	6.6	9.1	14.0	7.8	8.6	3.3	10.0	8.1	5.4	18.0	6.6	8.8	10.2	10.4	5.2	10.2	10.8	9.0	10.9	19.3	2.2	5.6	14.3	6.4	6.7	6.8	12.6	6.3	15.3	4.4	8.2	5.0	10.4	11.2	12.2	14.5	6.9	10.9	4.4	0.3	3.5	1.4	2.0	4.2	2.2	2.9	2.6	2.9	4.6	2.1	1.9	2.0	0.0	3.7	5.9	1.3	3.9	2.3	3.4	3.6	3.7	4.2	3.4	3.7	3.8	3.7	3.9	3.6	3.6	3.8	12.9	9.6	14.1	20.9	11.1	5.2	6.1	10.5	5.2	15.0	8.7	4.3	45.7	7.2	10.6	7.3	47.9	11.2	10.0	14.0	1.9	14.0	46.4	14.9	19.3	10.8	10.8	19.6	43.3	20.2	5.7	9.1	22.4	16.5	1.3	9.9	11.7	24.1	11.9	6.7	42.6	12.7	18.3	16.6	5.4	12.0	6.5	12.5	8.8	23.4	7.8	7.8	4.1	20.6	24.0	16.5	5.7	10.1	24.2	12.2	9.0	10.7	23.3	26.9	6.6	7.6	13.2	51.5	11.0	19.6	16.3	3.8	8.5	9.8	9.8	9.6
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA		8300	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	55.6	61.3	51.8	33.4	53.0	57.9	54.7	60.8	57.9	56.6	49.4	70.8	73.9	57.3	35.9	62.4	49.8	29.6	185.8	53.8	56.3	71.0	60.5	43.9	41.9	58.0	54.0	57.7	46.0	75.3	36.8	41.1	60.0	45.7	59.7	46.1	49.1	43.1	204.0	61.9	59.9	44.7	50.6	53.1	63.7	36.6	56.6	59.5	49.4	236.6	56.5	55.5	53.4	56.0	111.6	147.4	66.0	57.9	71.3	55.9	76.0	58.2	74.0	134.5	106.7	191.4	113.4	124.5	52.2	80.4	123.7	152.7	122.9	189.0	122.6	34.7	96.7	151.2	58.4	200.6	69.7	166.5	31.8	74.4	71.5	125.9	65.7	59.2	80.4	105.6	194.9	67.7	83.0	61.1	146.1	190.4	128.3	113.4	137.9	117.7	120.2	140.2	77.7	102.5	118.5	85.5	71.9	235.0	127.3	50.8	118.1	73.0	72.4	104.2	65.4	35.8	136.3	91.2	225.3	129.8	49.1	169.9	101.2	76.0	111.7	72.2	84.9	120.8	64.5	96.3	72.8	77.7	131.9	84.6	84.6	73.1	31.4	84.8	110.9	61.2	108.1	102.1	51.8	53.0	60.8	57.9	53.8	56.3	58.0	54.0	60.0	50.6	56.6	56.0	50.7	38.5	28.2	10.4	52.1	56.7	60.2	103.8	48.9	37.9	38.5	38.2	186.0	52.9	49.5	23.9	33.3	133.9	71.3	81.7	156.5	88.5	59.3	28.2	36.0	53.7	50.7	41.6	7.0	102.1	86.3	49.2	37.2	35.9	48.2	54.1	41.7	55.4	97.6	13.5	7.6	68.4	71.2	57.7	60.9	115.1	45.1	51.7	69.4	10.3	78.7	49.3	56.7	6.6	8.9	70.8	72.5	47.4	38.1	37.5	121.7	174.9	33.4	33.4	78.9	50.0	64.1	52.8	55.3	48.4	60.0	108.5	49.1	63.4	113.7	54.3
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
IDI1		ENSG00000067064	"Isopentenyl-diphosphate delta isomerase 1"	Q13907	10	1039152-1049119	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039169	Approved					NA	NA		28000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA039169: AB_10674280"	"unprognostic (1.61e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.72e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.61e-2)"	32.2	93.7	36.9	36.6	38.9	133.9	152.1	44.6	44.2	24.5	36.9	37.3	66.7	17.0	28.5	50.5	16.7	21.9	24.6	39.9	46.8	41.3	160.2	39.9	39.0	49.4	46.9	26.7	31.3	25.9	43.9	23.4	51.1	50.2	34.3	37.5	26.3	13.4	105.9	37.9	34.8	17.7	42.4	44.0	37.2	25.3	44.0	26.3	21.8	44.7	39.8	20.0	30.8	47.0	89.5	33.4	173.4	42.0	71.1	154.1	25.2	36.7	41.5	42.4	88.7	89.6	136.8	80.9	23.6	40.8	101.7	75.8	97.8	177.8	38.3	27.9	93.8	78.2	50.1	103.2	83.9	30.4	37.5	99.3	73.2	119.3	15.6	18.1	33.4	75.0	54.5	111.1	72.2	72.4	59.1	51.9	69.0	74.6	19.5	67.2	82.0	89.5	185.7	79.7	26.6	31.6	46.4	96.5	100.7	53.5	99.3	103.8	33.4	22.7	12.9	66.8	27.2	64.3	64.7	151.3	28.2	89.4	20.4	76.0	15.1	37.6	27.6	28.3	27.5	25.8	21.0	22.7	13.9	26.0	15.3	22.6	41.4	24.2	33.5	14.4	24.8	26.6	36.9	38.9	44.6	44.2	39.9	46.8	49.4	46.9	51.1	42.4	44.0	47.0	119.2	73.7	144.3	53.8	176.2	89.6	80.4	175.7	58.1	77.4	110.0	70.0	79.0	51.5	109.6	40.5	37.5	63.3	233.5	167.5	150.6	62.9	277.8	61.5	28.6	64.6	106.0	31.1	36.2	102.6	53.6	62.8	79.5	108.2	100.7	60.5	67.1	322.8	86.9	63.9	41.0	107.6	156.6	59.1	63.2	101.5	26.4	88.8	133.4	20.6	55.8	130.9	118.4	47.3	65.1	81.9	130.9	29.7	60.2	116.6	70.5	63.5	65.6	70.3	26.3	62.3	73.4	82.5	37.0	79.2	144.6	187.2	154.9	171.1	65.0	121.2
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	8.9	12.0	18.8	6.1	24.5	5.8	8.7	20.6	26.8	4.3	22.7	9.5	26.3	5.3	13.3	8.3	12.9	6.4	5.8	19.1	22.6	50.9	70.5	7.3	11.0	20.3	20.8	5.5	13.8	14.8	9.0	3.0	20.6	8.4	9.2	10.9	8.8	9.5	2.3	7.1	26.9	4.4	20.5	7.9	8.9	3.7	20.8	38.9	13.2	2.6	9.5	5.2	3.9	21.1	4.3	10.4	1.7	1.8	4.6	6.9	7.8	3.4	8.6	3.5	2.8	2.9	5.3	5.8	5.2	5.8	3.5	8.4	1.3	2.0	3.6	11.9	1.6	2.1	4.6	12.7	19.4	1.5	2.8	4.3	3.3	7.2	7.2	6.2	7.9	16.0	1.9	7.1	4.8	26.8	3.7	1.4	1.6	18.1	6.0	4.6	4.2	3.3	9.6	5.5	6.9	8.6	7.5	6.5	7.6	2.5	6.0	8.1	7.4	1.6	1.3	14.3	6.1	9.0	10.4	1.0	7.3	2.4	2.8	100.7	13.0	19.1	30.5	24.1	25.4	39.3	26.0	24.7	18.1	26.7	20.2	27.2	2.8	33.1	47.6	20.9	52.2	24.8	18.8	24.5	20.6	26.8	19.1	22.6	20.3	20.8	20.6	20.5	20.8	21.1	6.2	12.8	8.7	14.7	9.3	6.8	3.2	7.3	4.0	8.9	10.0	8.4	9.9	10.0	8.8	5.5	0.0	8.0	11.3	8.4	80.3	11.3	0.4	34.6	2.0	5.6	7.3	2.5	4.7	16.1	4.6	8.0	4.6	7.0	20.8	10.2	3.3	44.3	11.1	10.1	5.6	12.8	12.2	11.6	7.5	2.0	4.4	8.2	12.4	11.2	19.8	38.0	24.7	8.0	11.4	5.4	21.7	4.1	12.1	4.6	84.2	224.4	28.3	3.5	0.0	8.8	5.9	1.4	1.5	5.4	5.8	3.0	13.7	9.9	11.2	4.2
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.7;placenta: 110.9"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	9.8	0.7	0.6	40.5	0.4	0.7	2.0	0.4	0.8	7.2	1.0	5.3	10.3	10.2	1.2	1.3	2.6	6.2	1.8	0.4	0.6	1.7	2.4	25.9	58.7	0.7	0.3	1.2	1.2	0.2	0.1	110.9	0.5	2.0	8.2	1.3	1.9	3.0	8.1	1.3	8.4	2.4	0.4	23.0	5.8	1.1	0.8	31.2	4.0	0.6	31.5	9.1	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.6	0.4	0.4	0.8	0.4	0.6	0.7	0.3	0.5	0.4	0.8	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IDS	"ID2S, SIDS"	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476988-149521096	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 323.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 194.3;basal ganglia: 212.9;cerebral cortex: 323.4;hippocampal formation: 320.5;white matter: 109.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA078003	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	32.7	43.3	194.3	29.5	212.9	47.6	27.9	0.0	323.4	37.5	0.0	35.7	21.1	35.1	43.5	26.1	35.7	26.3	42.2	320.5	25.7	22.7	15.8	40.5	31.0	9.7	9.4	45.4	23.3	57.0	67.8	16.3	3.1	29.4	20.8	48.6	24.7	41.0	25.1	37.1	27.9	30.5	0.2	34.1	23.0	6.1	32.3	17.2	27.2	38.9	36.0	32.8	31.5	109.4	46.4	50.7	19.6	12.7	22.1	40.9	9.2	26.6	67.8	23.3	43.9	10.2	32.7	110.0	69.6	38.3	49.1	22.6	21.3	40.5	30.1	40.8	17.7	11.5	14.7	5.7	17.8	18.8	101.3	21.4	19.6	50.9	33.1	95.5	37.8	20.2	5.7	76.6	34.7	57.9	19.6	9.3	17.5	28.8	34.3	12.4	19.4	20.7	27.8	10.5	28.9	67.6	9.8	22.1	32.0	33.2	6.9	7.9	44.3	29.9	31.3	50.1	70.8	54.5	47.3	79.3	138.0	44.3	22.1	117.5	56.9	171.7	70.9	63.0	53.2	35.2	43.1	54.0	48.7	27.0	28.4	42.9	261.1	37.2	73.9	36.8	74.0	63.0	194.3	212.9	0.0	323.4	320.5	25.7	9.7	9.4	3.1	0.2	32.3	109.4	53.7	99.3	64.4	55.8	150.9	33.1	60.6	44.0	20.5	178.3	43.2	43.8	44.1	27.1	58.9	82.8	45.9	34.2	158.5	66.9	21.5	50.2	1.3	59.8	36.8	44.7	168.4	19.6	232.3	74.0	25.7	78.3	31.1	49.5	226.2	25.5	60.3	33.0	44.0	222.1	243.7	29.0	73.2	94.8	109.8	3.7	72.7	98.4	51.6	63.7	120.9	55.0	146.2	39.2	95.8	85.0	50.3	89.5	98.8	71.3	74.6	22.3	112.4	59.5	59.2	68.1	65.2	3.5	6.6	22.2	43.8	143.0	183.9	16.4	17.1	96.9
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IER3	"DIF-2, IEX-1, IEX-1L, PRG1"	ENSG00000137331	"Immediate early response 3"	P46695	6	30743199-30744548	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 2626.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A-431: 155.9;EFO-21: 55.6;HBEC3-KT: 189.9;RPTEC TERT1: 203.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043847	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA043847: AB_2678699"	"unprognostic (2.83e-3)"	"unprognostic (9.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (5.57e-4)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.77e-2)"	153.6	102.5	0.0	14.4	0.0	0.0	48.2	0.0	0.4	176.4	0.0	81.3	0.0	40.5	3.4	257.9	56.5	0.0	167.9	0.0	0.0	257.1	101.1	158.3	0.0	0.0	0.0	32.5	98.5	0.0	32.3	0.0	0.0	59.4	0.0	1.1	90.2	0.0	12.9	88.8	40.8	0.0	0.0	67.4	157.7	6.3	0.0	0.0	32.3	0.0	1.0	50.9	199.7	0.0	155.9	0.0	0.0	18.0	4.4	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	55.6	9.9	16.2	0.0	0.0	189.9	0.0	0.6	7.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	203.4	24.3	0.0	0.5	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	1.3	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.4	208.3	142.4	2.6	47.9	457.7	865.5	557.8	905.5	1.8	735.2	929.2	8.5	175.8	321.4	101.2	0.0	40.3	179.1	634.3	82.2	1141.6	1.4	889.8	539.8	400.7	147.9	3.6	2.9	710.7	58.1	824.8	431.2	2626.8	124.9	5.8	69.7	19.6	329.5	3.3	2.0	656.2	105.8	110.1	711.5	3.6	9.9	914.8	236.5	35.6	295.3	16.0	10.3	1.0	0.6	802.4	671.0	6.8	52.7	658.9	85.3	18.4	85.0	3.3	26.3	331.4	552.5	0.3	2.2	1251.9	329.2	83.0	92.2	35.5	434.9	644.5
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176364	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Diabetes mellitus, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 357.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	13.7	17.2	8.1	11.8	8.2	14.5	14.2	11.1	10.0	10.5	11.2	14.1	16.9	11.2	10.9	12.0	9.0	10.2	17.0	8.2	9.1	31.4	19.5	12.3	11.4	8.8	8.9	11.6	13.7	19.2	15.5	10.9	9.0	13.9	13.0	14.1	15.0	7.9	31.1	13.8	15.7	9.5	8.0	11.1	15.9	9.3	8.9	11.1	15.9	21.7	10.6	13.9	11.0	8.9	27.1	15.3	22.9	20.5	30.5	33.8	15.9	62.7	30.5	30.6	32.2	12.5	22.7	26.5	19.3	28.1	25.0	32.3	21.8	22.1	33.2	43.5	19.5	23.3	23.0	38.2	32.5	70.5	33.2	26.8	27.7	27.6	20.6	28.9	26.7	23.7	19.4	39.7	33.0	15.0	25.1	33.7	11.6	11.5	18.4	24.7	35.9	37.9	31.2	26.0	26.4	29.4	21.5	18.1	38.8	16.4	18.0	40.1	38.7	45.2	23.3	22.0	34.7	56.9	66.4	27.9	35.3	44.4	37.2	15.9	17.2	16.1	25.0	16.6	22.2	18.9	21.1	21.5	16.6	20.9	19.6	20.8	1.9	17.3	17.5	34.5	23.6	19.3	8.1	8.2	11.1	10.0	8.2	9.1	8.8	8.9	9.0	8.0	8.9	8.9	80.8	86.6	51.8	7.8	58.9	0.0	64.6	0.0	73.4	48.0	96.0	51.4	63.1	97.2	19.2	51.5	8.4	104.9	61.3	35.6	140.8	124.3	18.4	49.5	47.7	70.8	37.6	51.3	15.7	138.9	126.3	76.2	57.6	55.6	13.9	40.0	83.6	138.8	108.9	40.4	17.4	69.1	0.0	63.6	0.0	13.3	84.8	54.8	0.0	12.2	79.4	69.6	86.5	16.1	19.1	139.3	50.1	48.5	158.8	117.3	125.0	357.0	26.2	48.0	52.6	40.4	61.6	163.3	158.9	88.1	0.0	177.2	54.4	36.7	62.2	109.4
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088700-181092900	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 282.8;Macrophages: 276.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	12.8	6.3	9.5	11.2	10.2	49.5	8.4	10.1	19.3	10.2	11.2	10.6	5.6	14.8	2.5	26.5	15.2	6.1	27.8	10.7	9.7	5.8	6.7	23.2	9.4	10.0	9.2	3.3	5.2	1.8	5.2	11.0	9.1	5.6	5.6	1.1	6.8	3.7	33.4	22.1	13.3	8.3	9.8	32.7	9.0	5.4	10.3	8.7	5.0	16.5	10.8	10.9	13.3	12.8	25.3	21.8	11.7	10.3	15.9	21.9	31.3	43.6	45.9	24.1	21.4	6.1	13.8	8.3	18.9	16.9	16.9	45.5	3.8	29.7	15.6	47.6	18.7	7.4	11.5	4.1	24.9	8.6	23.1	15.7	29.5	28.0	18.7	18.3	16.6	6.9	31.0	36.5	43.3	11.5	8.6	13.8	12.2	9.5	10.8	9.8	20.4	31.6	8.8	13.7	16.9	18.2	22.1	21.3	51.7	14.2	17.0	7.5	25.3	17.3	30.5	19.9	26.8	23.9	9.1	6.5	13.5	9.0	4.9	3.6	1.4	2.7	1.0	5.5	1.2	4.0	0.8	1.4	1.1	3.0	0.1	0.5	1.2	1.1	5.3	0.2	1.3	0.7	9.5	10.2	10.1	19.3	10.7	9.7	10.0	9.2	9.1	9.8	10.3	12.8	156.4	22.4	66.7	3.6	124.8	69.8	163.7	24.2	53.5	24.2	198.1	197.7	110.9	21.5	25.9	9.2	37.5	10.9	131.1	94.2	0.0	10.6	5.1	66.7	83.0	87.2	56.4	32.0	8.7	6.9	56.4	74.7	50.0	67.3	36.1	35.0	41.4	5.6	50.9	8.4	2.8	110.6	6.1	149.5	282.8	11.9	12.2	276.4	46.2	11.2	56.1	17.8	17.5	0.5	1.3	21.9	54.8	9.4	61.5	94.9	35.0	1.5	27.4	21.3	0.0	177.9	102.8	3.6	5.4	115.9	59.7	34.2	151.3	15.5	62.0	146.8
IFFO1	"HOM-TES-103, IFFO"	ENSG00000010295	"Intermediate filament family orphan 1"	Q0D2I5	12	6538961-6556073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069344	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA069344: AB_2686126"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.43e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (6.53e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.47e-7)"	"unprognostic (5.71e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.58e-2)"	9.4	7.7	5.4	5.7	5.8	6.3	6.0	6.1	11.5	10.8	3.0	9.1	3.0	10.3	1.5	2.5	8.2	4.4	8.2	6.1	6.3	4.7	5.6	8.0	7.3	6.9	5.1	7.9	3.2	0.6	7.4	4.9	7.2	5.6	2.5	3.6	3.0	5.0	10.6	3.4	6.2	5.3	4.7	11.5	3.7	7.2	6.5	5.0	4.0	4.6	4.8	8.8	6.8	7.6	0.1	0.0	6.1	0.0	9.1	15.0	0.0	9.2	8.3	7.3	6.4	1.2	0.1	1.7	0.0	8.9	2.3	0.0	4.6	1.3	2.4	13.8	15.2	7.2	0.2	10.2	6.3	7.3	11.5	9.2	0.0	5.5	0.0	8.6	7.2	7.7	0.0	2.0	18.2	0.0	6.5	5.8	14.1	0.0	0.0	9.7	10.6	3.3	2.4	0.0	0.0	5.5	0.0	0.0	4.6	6.2	0.0	7.1	11.1	7.0	0.0	5.7	5.2	3.0	0.8	5.6	5.2	3.1	18.7	0.1	4.8	2.8	1.6	3.3	1.5	0.8	1.4	1.7	3.1	0.9	0.5	0.9	1.3	2.7	6.6	1.6	1.1	2.4	5.4	5.8	6.1	11.5	6.1	6.3	6.9	5.1	7.2	4.7	6.5	7.6	14.9	0.0	2.4	16.0	8.9	2.5	0.3	0.7	0.0	15.0	1.3	2.7	10.9	1.5	0.7	0.0	4.2	4.4	17.7	0.6	1.9	0.7	13.2	0.5	9.2	12.6	0.0	3.8	28.9	1.4	3.1	14.1	1.5	0.6	1.3	11.6	11.7	6.5	21.6	21.9	20.5	1.4	0.0	23.1	9.1	11.2	19.0	17.4	19.6	15.9	12.7	11.1	16.5	13.0	10.5	0.4	1.4	13.5	12.0	0.3	1.2	2.8	0.2	12.7	32.9	15.8	13.2	5.6	5.0	0.6	2.0	1.2	12.9	10.1	1.1	0.2
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904280-18956676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 43.0;skin 1: 169.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.0;Basal prostatic cells: 83.0;Suprabasal keratinocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"basophil: 12.6"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	5.3	9.2	7.4	8.2	6.6	10.4	12.6	19.6	10.6	12.3	0.6	9.0	2.0	7.4	2.4	43.0	5.2	7.0	4.2	6.4	7.9	6.8	5.8	7.5	8.6	11.2	9.3	3.3	19.1	10.7	6.5	7.2	9.7	9.4	2.8	4.3	14.4	9.1	7.9	169.9	3.9	7.1	6.8	6.3	4.4	1.8	9.6	6.2	6.4	4.2	14.0	8.5	21.6	8.8	23.3	37.2	9.9	27.4	6.2	4.9	16.0	17.2	11.4	9.2	6.4	51.5	26.6	0.3	21.6	13.1	10.6	57.6	7.6	36.6	7.4	139.3	6.7	0.4	7.1	20.4	4.5	4.0	21.3	3.2	36.3	12.4	15.7	15.2	19.9	1.2	1.4	4.6	6.1	4.9	3.9	3.7	4.2	23.9	8.8	13.1	6.1	9.8	5.4	14.9	31.6	1.7	13.1	18.2	12.6	10.1	4.9	2.1	54.6	12.4	17.2	7.3	50.5	9.7	11.3	0.8	8.3	5.7	14.8	12.6	0.2	0.0	0.4	0.3	0.5	0.5	0.3	0.4	0.1	0.2	0.3	0.6	0.0	0.2	0.0	0.4	0.3	0.1	7.4	6.6	19.6	10.6	6.4	7.9	11.2	9.3	9.7	6.8	9.6	8.8	4.1	3.2	5.4	5.5	6.0	121.0	83.0	24.1	40.5	6.8	11.5	13.5	6.8	12.8	9.7	1.8	0.0	5.1	20.9	4.9	1.9	17.3	1.3	23.3	5.9	7.7	2.4	3.2	8.5	17.6	5.4	4.7	3.1	10.2	3.8	0.8	4.6	3.4	2.4	25.2	9.6	1.3	2.0	1.6	17.1	4.5	1.2	6.8	14.2	1.0	3.5	4.4	8.2	11.6	8.8	14.6	3.3	3.0	15.5	15.0	0.8	9.3	23.1	1.8	0.0	3.5	7.5	0.8	0.4	32.4	100.3	4.0	13.9	0.4	1.3	44.2
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI27	"FAM14D, ISG12, P27"	ENSG00000165949	"Interferon alpha inducible protein 27"	P40305	14	94104836-94116698	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 3792.9;Distal enterocytes: 2150.5;Endothelial cells: 1972.1;Exocrine glandular cells: 1603.8;Intestinal goblet cells: 1638.8;Pancreatic endocrine cells: 1678.1;Paneth cells: 2179.2;Proximal enterocytes: 3048.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.0"	"Group enriched"	"Detected in many"	6	"monocytes: 7.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 2026.8;BJ hTERT+ SV40 Large T+ RasG12V: 1782.5;EFO-21: 547.7;Karpas-707: 501.5;SK-MEL-30: 607.2"									HPA028875	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA028875: AB_10601434"	"unprognostic (1.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.78e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.65e-1)"	470.3	323.3	178.3	115.7	177.4	162.8	410.3	180.9	232.6	351.4	162.7	374.4	129.2	137.8	39.9	310.4	163.2	344.1	471.5	174.5	182.4	217.9	150.4	608.2	48.3	203.8	187.7	75.6	39.3	30.3	65.3	183.8	215.0	85.0	221.4	6.1	156.9	47.0	113.1	129.8	256.2	117.4	194.9	797.8	697.0	140.2	194.1	202.8	149.8	152.4	54.2	116.9	213.7	190.8	181.3	0.4	1.3	0.4	0.5	21.7	1.7	2.8	8.8	2026.8	1782.5	3.8	146.8	1.5	547.7	115.3	33.8	5.7	1.1	0.2	79.7	2.1	3.7	1.0	1.4	0.9	13.7	0.6	1.1	2.0	2.0	353.8	0.1	1.1	284.0	1.3	1.1	501.5	0.1	0.5	1.7	1.1	0.5	0.5	24.7	1.8	0.5	0.6	1.2	0.6	0.4	1.1	0.0	0.1	607.2	1.4	0.9	3.0	0.3	0.2	2.7	325.8	1.0	9.4	14.6	3.9	0.9	0.5	1.4	0.0	1.3	0.5	0.3	7.0	0.3	0.0	2.6	0.7	0.8	0.1	0.0	0.4	0.0	0.4	2.1	0.1	2.5	2.1	178.3	177.4	180.9	232.6	174.5	182.4	203.8	187.7	215.0	194.9	194.1	190.8	3792.9	391.0	82.7	1.3	26.8	171.2	6.5	126.9	91.6	4.9	23.4	38.2	45.9	151.5	237.4	12.9	8.4	7.3	14.9	2150.5	1.9	50.6	13.6	1035.5	188.3	1972.1	267.8	42.3	0.6	1603.8	221.2	330.8	892.5	838.5	45.1	1174.4	742.5	5.8	158.3	5.0	0.4	1638.8	107.8	106.9	163.5	36.7	172.1	59.6	350.4	84.3	26.1	8.3	0.0	0.0	0.7	1678.1	2179.2	417.5	6.3	11.1	3048.1	23.7	548.1	20.5	276.1	45.2	295.8	20.3	12.1	151.9	140.4	5.2	34.1	302.4	523.4	80.4
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30 lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 572.7;lymphoid tissue: 708.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	132.4	121.0	18.4	708.3	20.8	283.8	58.6	20.3	104.5	40.8	48.7	129.0	197.3	22.2	26.9	38.7	57.3	109.6	31.2	18.0	23.3	80.3	148.2	572.7	370.7	32.0	24.9	14.8	61.3	75.0	27.9	128.8	40.5	31.6	148.0	2.6	66.3	22.0	12.6	55.0	153.6	165.0	26.8	385.3	112.2	16.0	69.4	91.9	54.2	9.0	221.0	215.7	19.6	49.8	115.5	59.2	0.4	37.9	11.2	19.9	102.6	11.8	17.2	34.6	91.8	132.3	193.1	655.7	96.6	39.7	175.2	85.1	69.9	30.1	3.7	182.5	55.2	8.1	98.1	188.9	111.8	20.1	46.9	70.4	60.4	59.8	19.7	4.4	2.0	23.8	96.8	394.8	16.6	217.3	9.9	2.5	21.2	380.6	68.7	65.8	4.5	717.7	101.1	3.7	5.3	8.0	200.5	457.4	11.3	7.4	31.6	8.8	4.2	55.2	34.2	120.7	12.0	14.6	794.7	368.5	154.1	133.5	8.5	106.9	9509.8	3890.4	40.8	14243.6	38.8	952.6	28.5	31.1	5699.9	708.1	19.7	24.3	2102.8	70.2	9865.9	173.2	41.5	11082.7	18.4	20.8	20.3	104.5	18.0	23.3	32.0	24.9	40.5	26.8	69.4	49.8	6.4	9.6	38.8	0.0	54.2	3.6	2.5	2.1	2.2	0.4	8.6	13.2	1.1	4.3	18.3	12.9	0.0	5.6	4.0	8.3	1.9	1.8	0.3	2.5	1.7	8.4	0.0	4.6	0.1	1.1	14.8	8.1	6.6	4.1	13.9	0.2	3.6	1.3	155.9	0.0	0.1	14.9	2.0	205.4	139.3	0.2	0.3	426.2	5.4	1.0	144.1	0.7	5.2	0.0	0.1	1.2	3.4	0.0	47.7	4.6	5.9	5.4	8.9	0.7	0.0	2.6	1.8	0.2	0.7	3.7	3.3	12.0	9.6	1.5	9.6	1.2
IFI35	IFP35	ENSG00000068079	"Interferon induced protein 35"	P80217	17	43006740-43014456	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045946, HPA075580"	Approved		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA045946: AB_2679509, HPA075580: "	"prognostic favorable (1.41e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.49e-1)"	27.5	41.3	15.4	27.2	16.4	24.9	24.2	15.6	18.2	18.4	16.2	27.4	24.6	17.4	11.7	10.2	20.8	20.1	20.9	14.9	16.7	29.7	30.6	25.6	26.4	20.2	16.6	23.8	13.6	10.5	14.2	15.0	17.3	27.8	20.4	1.5	29.4	15.2	6.3	11.3	30.2	21.3	20.3	39.9	22.7	5.0	17.0	23.4	20.8	9.3	19.0	21.1	15.4	17.0	12.7	28.8	0.2	1.5	24.2	29.1	6.1	8.2	84.6	204.5	299.2	10.7	46.2	3.9	16.1	24.7	108.0	7.0	1.6	12.9	16.3	33.5	6.1	9.3	10.5	39.5	59.6	10.5	19.3	40.3	4.9	29.0	3.6	18.6	18.8	8.0	5.4	61.2	8.2	12.5	22.7	8.5	0.1	11.6	13.0	18.4	0.1	23.7	25.7	10.9	5.4	0.2	16.4	6.3	88.2	0.6	26.5	20.3	9.3	15.1	0.3	4.8	13.3	54.1	21.8	1.1	27.1	8.2	14.8	60.7	102.7	61.6	44.3	127.8	40.4	37.8	34.0	41.7	62.0	40.0	26.8	33.6	62.1	56.9	122.0	67.0	51.8	80.5	15.4	16.4	15.6	18.2	14.9	16.7	20.2	16.6	17.3	20.3	17.0	17.0	65.2	16.0	9.7	2.6	28.6	10.5	29.6	31.8	12.5	0.8	16.5	11.3	5.5	11.5	22.7	18.4	2.1	22.7	36.7	83.1	41.1	47.8	9.4	12.3	27.4	32.1	31.7	12.8	0.7	64.0	32.5	32.8	26.5	16.2	7.6	122.4	37.1	31.3	84.8	1.7	0.6	39.4	12.2	36.8	19.2	39.5	28.9	47.8	24.9	5.6	75.5	10.4	64.9	1.0	1.0	41.8	116.7	23.7	54.0	19.1	128.0	93.7	18.0	0.8	6.6	13.2	36.3	0.5	0.4	5.1	9.2	10.4	32.3	25.0	34.6	29.6
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.6;Endothelial cells: 54.5;Microglial cells: 53.4;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 176.5;BJ hTERT+ SV40 Large T+ RasG12V: 216.2;GAMG: 177.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	18.8	16.8	19.0	25.3	20.0	100.8	16.6	17.7	33.0	19.3	17.6	9.7	20.0	15.4	34.9	10.8	12.1	45.4	21.8	17.6	19.0	21.6	21.0	30.9	20.0	27.0	19.6	13.9	8.8	3.8	14.2	21.4	21.2	9.7	9.3	1.3	71.7	11.4	5.8	10.3	14.5	18.5	24.4	65.0	21.0	7.5	20.3	31.0	16.5	10.9	11.6	21.1	9.6	21.0	7.7	0.3	1.3	0.3	5.3	35.9	0.2	5.0	65.5	176.5	216.2	0.0	22.0	10.3	49.9	4.7	177.9	4.1	0.0	2.9	28.6	22.5	0.0	26.8	20.6	0.0	7.3	0.0	0.0	22.7	0.3	76.8	1.0	13.8	33.5	6.7	0.0	35.1	42.5	0.2	22.7	1.9	0.0	0.1	14.4	17.4	53.6	1.2	5.2	5.0	0.6	1.4	1.8	0.5	82.9	0.0	0.0	1.1	41.6	32.3	13.4	3.6	33.9	3.0	3.8	0.3	50.1	30.4	9.2	0.4	15.4	0.1	6.9	15.4	13.8	2.4	10.0	6.6	7.1	1.7	4.2	5.6	4.5	7.8	8.4	2.0	5.1	6.0	19.0	20.0	17.7	33.0	17.6	19.0	27.0	19.6	21.2	24.4	20.3	21.0	54.6	28.9	16.2	10.7	4.7	3.6	10.2	16.3	5.7	0.0	4.6	5.2	5.4	2.8	21.0	9.2	0.0	0.2	9.9	1.1	0.0	13.1	0.6	6.7	4.4	54.5	6.7	4.6	0.0	12.3	0.3	15.8	11.7	7.0	18.3	25.1	43.5	3.6	29.5	0.0	2.1	1.7	6.1	34.2	7.6	1.1	13.4	38.1	5.4	53.4	27.8	0.6	5.2	51.8	0.5	11.8	0.1	17.3	3.2	5.1	3.8	2.7	20.7	0.3	19.7	12.3	12.4	0.3	0.5	4.4	4.5	0.0	22.4	24.8	2.5	14.0
IFI44L	"C1orf29, GS3686"	ENSG00000137959	"Interferon induced protein 44 like"	Q53G44	1	78619902-78646145	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 80.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.7;Endothelial cells: 78.2;Macrophages: 55.4;Microglial cells: 97.4;Peritubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.0;BJ hTERT+ SV40 Large T+ RasG12V: 108.8;GAMG: 74.4;HSkMC: 58.9;SK-MEL-30: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA053247, HPA060372"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA053247: AB_2682088, HPA060372: AB_2684267"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (2.95e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.03e-2)"	14.3	6.4	11.3	6.3	13.7	41.8	7.0	10.5	16.2	5.7	7.9	5.3	4.6	7.5	5.3	3.2	9.1	32.4	10.7	10.0	15.3	6.7	8.3	12.7	10.5	34.5	16.4	10.6	3.7	2.5	3.4	16.3	21.8	3.0	4.1	0.9	80.5	5.3	3.7	2.1	3.9	12.0	35.3	43.9	5.9	7.1	13.9	31.9	7.3	14.2	4.6	12.5	2.0	17.5	0.2	0.0	3.5	0.0	1.9	29.0	0.0	0.4	24.1	95.0	108.8	0.0	1.5	14.4	11.8	0.5	74.4	0.0	0.0	0.1	1.8	0.5	0.0	0.1	9.0	0.1	3.5	0.3	0.3	58.9	0.2	9.1	2.2	25.8	0.9	0.2	0.0	2.3	3.2	0.0	1.0	0.3	0.0	0.0	6.9	0.3	0.2	0.0	5.4	0.6	0.0	0.0	20.5	0.0	53.7	0.1	0.0	0.4	0.4	1.1	1.5	2.5	2.5	3.3	0.8	0.1	17.5	0.2	0.2	0.1	9.3	0.2	1.4	11.1	4.5	6.6	4.8	3.5	2.5	2.7	2.5	1.8	3.7	10.3	6.6	5.0	1.4	3.6	11.3	13.7	10.5	16.2	10.0	15.3	34.5	16.4	21.8	35.3	13.9	17.5	105.7	0.0	7.4	9.1	14.6	4.0	3.1	4.0	1.2	0.0	3.4	5.2	4.4	2.8	7.9	7.3	0.0	0.1	8.0	1.1	0.0	4.0	0.7	5.4	3.1	78.2	0.0	1.3	0.0	8.3	0.2	14.9	2.0	5.8	2.5	39.5	31.1	0.3	23.9	0.0	0.1	0.0	0.0	20.1	7.0	3.7	23.6	55.4	3.6	97.4	23.0	1.2	6.2	0.5	0.4	2.1	0.0	48.2	1.9	2.0	0.4	1.1	12.4	0.3	6.6	7.4	11.1	1.1	0.5	0.6	2.0	0.3	12.6	24.6	0.1	7.2
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666064-27672212	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 4084.0;Extravillous trophoblasts: 1291.2;Syncytiotrophoblasts: 4273.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 1349.9;BJ hTERT+ SV40 Large T+ RasG12V: 1570.7;EFO-21: 544.1;SK-MEL-30: 1075.0"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	84.0	161.4	117.5	37.5	142.0	113.2	73.1	106.8	159.3	99.7	164.7	76.3	44.0	55.6	39.1	30.5	49.6	56.8	114.2	126.4	168.7	154.1	135.6	143.5	14.9	200.8	145.5	81.4	57.2	116.0	316.7	298.2	155.6	60.6	24.5	17.2	334.3	23.0	23.8	35.3	52.1	43.6	299.5	91.0	96.1	61.9	153.1	62.2	166.9	20.1	14.5	43.8	47.4	139.2	15.6	4.4	22.7	14.1	72.4	38.8	90.6	48.5	220.1	1349.9	1570.7	8.0	58.5	6.1	544.1	22.1	352.4	5.2	5.5	10.8	43.7	117.3	18.4	36.4	11.2	4.8	19.4	12.4	45.1	43.3	1.8	82.1	1.1	20.9	12.6	31.6	2.5	95.2	15.3	4.4	44.1	153.4	4.4	28.7	46.4	29.6	12.1	14.9	12.2	0.9	32.2	28.8	59.9	13.6	1075.0	6.7	6.9	46.5	21.7	12.6	19.3	9.4	8.4	113.5	68.1	4.4	24.6	105.3	35.8	193.3	265.8	252.0	128.7	374.6	127.9	57.3	128.2	118.0	117.6	47.0	132.7	130.9	506.8	102.0	259.4	12.8	172.9	113.2	117.5	142.0	106.8	159.3	126.4	168.7	200.8	145.5	155.6	299.5	153.1	139.2	158.0	141.1	74.4	5.2	26.1	23.5	19.8	39.3	29.0	15.2	17.5	14.4	12.9	54.3	42.2	64.4	10.4	4084.0	44.7	13.2	19.6	244.0	3.4	61.4	76.4	194.8	58.4	27.6	3.6	340.0	1291.2	149.3	21.4	91.8	63.3	186.3	82.8	40.4	685.3	3.3	7.4	60.5	67.1	71.8	49.1	11.5	110.6	169.4	71.2	24.4	93.8	95.1	46.4	16.1	3.9	214.2	11.7	204.7	96.0	48.2	16.9	32.7	89.3	5.6	111.7	60.9	63.1	7.9	1.6	5.8	22.4	4273.1	59.6	138.6	13.0	49.0
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267074-162318684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.6;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002656	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	6.2	6.4	3.1	12.7	4.3	38.1	5.9	3.2	3.0	6.5	4.4	7.4	13.1	6.4	4.3	7.5	7.2	9.5	5.1	2.3	3.3	5.6	8.5	10.9	11.7	7.2	3.4	7.0	7.1	8.1	5.9	8.3	5.0	5.5	6.8	1.1	17.5	4.7	1.7	5.0	10.0	5.7	8.1	16.4	9.6	2.4	4.2	10.9	6.0	3.2	9.7	6.4	5.2	4.4	6.7	0.3	0.2	0.0	7.4	6.0	2.8	1.2	17.7	62.3	71.5	1.2	16.7	13.3	10.5	1.0	31.9	8.5	1.1	9.8	6.3	35.4	4.5	7.1	0.8	2.8	5.0	8.2	6.4	5.3	4.8	8.9	1.7	6.5	4.9	6.9	0.3	38.9	1.0	12.5	9.3	6.4	0.0	5.4	3.8	7.5	0.0	18.8	5.9	7.3	0.4	0.1	3.7	20.7	34.0	0.3	5.7	7.1	4.1	1.9	1.7	1.1	2.7	15.2	26.8	1.9	3.5	6.5	5.6	4.4	11.5	4.4	6.6	12.5	9.2	12.4	8.2	7.2	11.1	12.8	6.7	6.9	15.2	4.0	12.7	1.6	10.3	7.8	3.1	4.3	3.2	3.0	2.3	3.3	7.2	3.4	5.0	8.1	4.2	4.4	24.7	32.1	12.0	4.6	20.1	6.8	11.2	7.7	6.2	0.0	4.8	5.2	5.0	12.8	11.1	7.3	0.0	6.4	10.2	10.9	5.9	18.7	55.6	17.3	7.9	22.3	15.7	8.2	2.8	18.7	17.5	8.8	10.7	20.2	13.3	10.4	13.6	6.5	14.4	0.0	0.7	11.5	8.2	12.8	8.7	53.3	13.7	20.0	5.4	28.1	23.9	7.3	10.3	0.5	4.0	13.4	10.1	13.2	16.0	9.1	11.8	4.8	17.5	0.1	0.0	10.9	4.9	1.6	1.3	10.2	5.8	3.4	13.1	6.9	6.7	11.1
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406487	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 66.7"	"Group enriched"	"Detected in all"	8	"granulocytes: 66.7;monocytes: 21.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1"									"CAB045980, HPA053890, HPA055380"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.5	38.0	12.6	4.5	12.4	9.9	14.3	15.2	17.8	17.2	13.0	14.6	3.9	6.9	6.6	5.0	9.5	13.8	22.7	12.4	12.7	23.7	24.9	14.1	3.4	15.1	14.2	9.1	6.1	11.9	20.3	9.9	13.5	6.7	5.0	8.0	42.0	6.2	17.4	4.9	7.5	7.9	29.4	18.7	6.9	5.4	13.9	13.3	9.1	20.6	2.4	7.6	9.4	14.4	10.0	1.2	2.6	17.2	8.1	16.5	0.2	11.7	68.9	325.3	318.1	1.0	10.4	0.7	3.8	14.6	63.4	8.2	1.0	1.0	15.6	0.6	1.1	1.7	8.4	0.9	9.2	1.4	1.7	13.5	0.3	6.2	0.1	6.4	0.4	1.7	0.2	7.7	3.5	0.3	2.3	6.8	0.3	0.1	6.3	3.1	0.8	2.0	7.9	1.2	0.1	0.6	3.1	2.4	69.6	2.4	1.3	1.5	0.5	1.7	1.9	2.5	1.4	1.0	1.3	0.6	2.2	2.3	0.9	9.9	12.6	15.4	1.6	15.6	2.9	3.0	4.1	2.9	3.7	3.2	5.7	3.5	66.7	1.9	21.7	0.2	4.9	6.6	12.6	12.4	15.2	17.8	12.4	12.7	15.1	14.2	13.5	29.4	13.9	14.4	63.3	35.3	5.8	7.2	2.5	2.9	3.3	12.9	3.4	26.4	2.4	5.2	19.1	4.3	7.6	9.2	18.8	4.8	4.7	6.3	64.6	12.6	0.4	21.1	3.2	41.4	0.0	4.0	13.8	5.1	20.8	22.8	0.5	7.2	2.5	11.0	9.3	12.1	36.9	32.0	13.3	1.4	4.1	14.5	3.3	3.0	19.3	13.3	1.8	16.9	13.5	77.9	1.0	12.1	14.4	3.6	4.7	43.6	0.7	1.1	9.8	26.7	17.8	13.4	39.5	18.1	11.4	0.5	3.0	1.0	1.7	1.4	3.1	15.4	0.2	1.2
IFIT1B	"bA149I23.6, IFIT1L"	ENSG00000204010	"Interferon induced protein with tetratricopeptide repeats 1B"	Q5T764	10	89378056-89385205	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 25.7"	"Cell type enriched"	"Detected in single"	320	"Erythroid cells: 96.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062924	Approved					NA	NA				"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 6: Erythroid cells - Oxygen transport"			"HPA062924: AB_2684906"	"unprognostic (2.59e-1)"	"unprognostic (3.13e-1)"			"unprognostic (6.62e-3)"	"unprognostic (4.55e-2)"			"unprognostic (4.11e-2)"	"unprognostic (9.34e-2)"			"unprognostic (1.76e-1)"	"unprognostic (6.86e-2)"				0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFIT2	"cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K"	ENSG00000119922	"Interferon induced protein with tetratricopeptide repeats 2"	P09913	10	89283694-89309271	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 53.5;Glandular and luminal cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 420.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 420.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 141.0;BJ hTERT+ SV40 Large T+ RasG12V: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003408	Approved		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA003408: AB_1079100"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.46e-2)"	7.7	6.7	12.6	13.1	17.3	48.4	5.4	14.7	16.2	6.1	8.2	5.4	6.7	5.0	6.2	2.8	9.3	13.6	7.5	11.7	14.1	10.2	21.8	21.0	7.9	19.5	16.6	9.2	3.1	10.0	2.5	16.4	18.9	4.1	4.5	1.7	8.8	6.5	2.3	3.7	5.7	6.5	30.1	27.5	3.6	2.2	15.9	12.6	3.4	6.8	5.7	6.3	2.9	20.8	29.3	1.1	0.3	14.5	13.0	14.4	5.2	10.7	32.4	141.0	113.0	0.1	20.0	3.2	5.9	7.8	20.6	28.9	0.6	1.5	15.4	11.6	0.1	5.3	14.3	0.0	22.2	0.7	2.3	8.2	0.7	10.7	1.6	8.6	0.7	2.8	0.1	0.5	2.2	0.1	3.4	6.6	3.5	0.0	6.1	2.1	3.7	0.8	4.8	5.6	0.1	0.2	3.8	0.6	24.7	1.8	0.7	1.6	0.9	1.5	0.3	3.9	1.1	1.4	5.1	0.5	2.3	2.4	2.9	97.6	32.6	107.8	9.5	75.9	5.1	19.2	8.0	6.5	10.6	17.7	7.6	6.8	420.2	8.9	92.3	12.7	3.9	17.6	12.6	17.3	14.7	16.2	11.7	14.1	19.5	16.6	18.9	30.1	15.9	20.8	53.5	41.7	6.7	1.6	12.3	1.5	5.3	6.6	1.2	1.3	5.6	9.5	7.4	11.5	9.4	12.9	0.0	2.9	27.6	23.5	9.8	35.0	0.2	34.9	9.1	34.9	3.5	0.8	1.0	4.2	1.6	10.9	2.0	67.0	5.1	3.8	16.4	6.1	26.0	25.2	2.1	5.9	4.1	25.5	3.3	0.2	8.1	29.5	7.2	4.7	20.9	13.3	12.3	2.0	20.3	6.3	11.5	11.7	2.4	19.1	18.9	30.8	4.7	0.9	0.0	8.3	14.3	0.2	0.2	3.2	0.6	1.4	13.1	6.2	2.1	5.8
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327307-89377473	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.5;Ductal cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 488.1"	"Group enriched"	"Detected in all"	19	"granulocytes: 488.1;monocytes: 125.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	21.3	20.1	10.5	20.4	22.7	42.9	14.3	15.9	14.8	11.5	1.5	11.2	25.4	12.9	11.7	6.8	17.7	24.6	15.5	11.8	15.9	19.3	28.6	44.2	9.0	24.7	17.0	18.1	7.4	5.4	6.1	31.1	25.0	6.0	9.0	3.8	34.6	12.5	7.1	6.4	18.7	18.1	37.2	47.6	12.6	6.8	15.7	33.1	7.4	14.8	5.3	13.5	7.8	35.0	38.7	2.7	0.9	10.3	41.7	43.9	0.5	25.4	198.8	468.4	540.2	2.0	54.3	3.3	11.2	39.0	112.0	33.6	0.6	4.9	34.0	5.6	0.7	15.9	10.1	1.2	23.8	4.5	13.8	27.8	0.6	40.6	3.4	17.9	2.8	1.5	1.1	8.3	12.7	0.3	10.7	11.7	0.7	0.1	12.1	10.2	3.3	2.4	13.3	19.1	0.4	0.2	5.9	0.7	96.8	1.4	1.4	5.7	4.0	8.2	1.9	14.7	7.4	13.8	11.3	0.9	12.0	19.9	7.9	105.7	45.8	172.5	4.6	101.9	1.0	9.7	6.6	3.0	15.6	10.9	3.7	4.5	488.1	2.1	125.0	3.5	16.3	19.4	10.5	22.7	15.9	14.8	11.8	15.9	24.7	17.0	25.0	37.2	15.7	35.0	89.5	51.3	10.1	5.9	8.0	3.2	6.7	13.0	4.0	10.7	3.1	5.5	32.5	10.0	12.5	9.2	4.2	5.2	8.3	6.8	21.5	70.6	0.9	26.0	16.6	66.4	0.0	10.3	9.1	36.3	12.8	20.1	4.6	39.3	13.9	19.8	20.0	13.6	34.6	60.6	8.4	4.0	4.1	21.7	4.4	0.5	30.4	26.8	3.6	17.8	22.0	20.8	8.2	6.0	50.2	23.3	9.4	28.2	2.5	10.0	34.6	14.5	12.3	2.1	46.0	16.0	22.2	1.2	1.6	2.9	1.8	1.9	6.3	14.4	3.7	6.2
IFIT5	RI58	ENSG00000152778	"Interferon induced protein with tetratricopeptide repeats 5"	Q13325	10	89414568-89421605	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 109.1;BJ hTERT+ SV40 Large T+ RasG12V: 128.0"					"Low region specificity"	"Detected in all"			"HPA037957, HPA062180"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA037957: AB_10672499, HPA062180: AB_2684705"	"unprognostic (2.17e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-1)"	13.3	11.6	11.9	11.1	14.3	16.1	9.7	18.7	13.5	11.4	25.0	9.4	9.4	10.2	9.1	7.4	11.2	12.6	14.6	10.8	14.5	14.2	14.1	17.1	13.2	14.7	13.0	14.1	9.2	22.8	3.7	14.6	14.4	9.7	8.9	9.0	12.2	10.5	3.7	5.5	11.1	14.2	19.2	18.6	9.1	6.3	12.5	10.5	10.8	6.4	11.3	12.3	4.6	16.8	41.8	12.5	17.3	56.9	46.7	43.4	3.7	33.2	59.5	109.1	128.0	1.0	19.0	1.8	12.1	38.7	42.8	34.8	20.9	19.3	26.0	17.8	13.1	5.0	8.9	7.8	52.4	0.4	3.1	34.9	7.4	32.0	23.7	30.8	6.2	10.8	0.0	29.4	30.8	7.7	12.6	3.8	2.2	0.0	21.9	11.0	20.0	4.6	23.7	5.1	1.9	11.1	18.2	6.6	51.6	4.7	6.2	3.5	15.5	14.0	10.3	23.2	20.0	3.8	0.6	0.2	24.2	3.3	11.6	24.7	15.7	19.3	13.9	25.6	16.4	21.4	14.7	13.0	14.2	18.1	16.8	14.1	45.2	8.3	32.1	1.3	14.1	12.3	11.9	14.3	18.7	13.5	10.8	14.5	14.7	13.0	14.4	19.2	12.5	16.8	24.8	6.4	14.8	3.6	12.8	8.5	35.7	15.2	13.6	8.3	4.4	4.3	8.9	11.5	12.4	9.2	0.0	6.3	7.5	7.2	11.7	13.7	0.1	11.2	17.1	23.1	4.9	2.1	3.6	9.1	11.5	17.9	6.1	13.3	15.2	6.2	12.1	16.5	11.0	35.3	7.2	5.5	6.1	8.9	6.0	1.0	21.1	10.8	7.2	4.7	12.3	14.6	7.2	4.5	10.2	10.5	5.9	17.3	6.8	21.0	7.5	17.0	9.6	5.3	19.7	15.4	14.2	17.2	14.4	7.7	3.8	4.5	9.3	4.7	2.5	29.1
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFITM2	"1-8D, DSPA2c"	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	303655-309397	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 920.0;NK-cells: 1350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 23410.9"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 23410.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2"									"HPA004337, HPA044731"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		450000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA004337: AB_1851427, HPA044731: "	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	1086.2	307.0	90.3	258.0	90.2	177.0	681.0	89.6	116.6	785.6	101.4	358.6	40.9	702.8	52.1	237.2	903.8	97.4	619.6	92.0	97.9	703.1	1288.5	1069.9	99.9	94.4	89.4	650.1	211.1	112.0	200.6	145.3	94.9	406.1	41.8	27.0	228.9	102.5	195.9	236.7	305.6	200.4	92.8	1402.1	304.3	123.0	95.4	29.8	437.7	132.8	105.8	493.1	496.6	95.1	32.2	65.4	313.1	2.9	137.2	358.3	0.9	106.8	65.1	27.0	63.3	1.7	206.9	2.7	126.6	424.6	0.4	68.5	1.1	9.3	9.0	1.8	41.1	75.1	102.6	117.6	547.7	124.1	494.9	710.9	2.3	5.2	3.3	64.4	51.2	22.5	5.2	210.5	11.6	129.9	2.5	603.3	36.4	5.3	229.4	101.0	29.9	1.1	181.6	0.4	0.8	7.0	65.4	74.9	34.5	5.3	86.7	69.8	338.3	5.7	26.8	36.1	1.4	4.5	5.0	3.3	14.5	485.2	18.1	2706.4	537.4	3789.5	666.6	1421.9	480.8	846.9	590.1	639.5	612.5	799.2	511.7	510.3	23410.9	1225.0	2199.0	279.0	411.7	1376.6	90.3	90.2	89.6	116.6	92.0	97.9	94.4	89.4	94.9	92.8	95.4	95.1	920.0	307.7	540.0	5.9	301.1	104.4	251.1	161.4	215.1	0.3	59.7	66.5	51.8	154.4	209.2	248.3	0.0	8.3	814.7	22.5	487.2	433.0	7.8	67.1	468.6	828.4	9.6	100.7	0.0	256.7	16.9	515.8	30.5	78.5	530.5	68.8	752.1	684.1	223.4	0.0	0.0	39.4	24.4	372.8	255.9	31.5	507.6	645.9	209.9	12.2	177.3	80.5	1350.1	0.0	0.1	161.9	149.2	223.8	123.0	126.3	4.7	45.3	104.8	1.5	315.5	442.5	568.4	8.4	10.4	22.8	83.0	23.4	667.2	61.8	44.3	102.4
IFITM3	"1-8U, DSPA2b"	ENSG00000142089	"Interferon induced transmembrane protein 3"	Q01628	11	319676-329475	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 2128.0;Endothelial cells: 2064.8;Hepatocytes: 2268.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2907.6;non-classical monocyte: 3344.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 2907.6;monocytes: 3344.3;NK-cells: 926.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 3222.7;BJ hTERT+ SV40 Large T+ RasG12V: 4076.3;HHSteC: 3609.8;HSkMC: 3476.2"									HPA004337	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA004337: AB_1851427"	"unprognostic (4.17e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (5.78e-7)"	"unprognostic (7.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.19e-1)"	1850.7	745.9	639.0	597.4	667.4	237.0	1281.1	644.9	909.9	1683.7	730.9	1212.1	235.2	1545.6	840.1	484.5	1933.7	702.4	1199.6	643.2	732.4	1299.5	2506.4	1573.4	272.7	745.4	671.4	1262.3	576.3	637.2	493.2	829.2	697.9	885.6	238.9	92.6	555.3	631.7	364.5	511.2	599.9	1121.8	666.2	1241.8	736.0	266.7	728.7	229.3	935.7	426.0	154.9	1203.7	1038.2	649.0	554.1	49.6	1930.0	508.9	952.4	1538.6	44.2	842.4	1638.0	3222.7	4076.3	65.4	1818.6	1.3	873.1	1276.4	826.0	872.0	1.1	619.9	176.8	19.2	57.1	8.1	578.4	570.2	3609.8	5.7	5.2	3476.2	136.1	257.3	561.7	418.1	610.5	5.2	3.1	5.0	290.3	1095.0	2.7	26.3	243.0	2.2	425.3	74.2	185.3	4.8	1741.5	50.1	1.5	3.5	1007.5	170.0	891.9	259.0	41.3	39.7	1130.9	192.1	131.9	180.6	34.8	2.5	3.4	10.3	89.6	7.6	315.3	520.4	740.1	563.7	115.7	2745.9	69.0	82.2	82.6	118.9	396.9	55.6	77.8	109.0	2907.6	926.2	3344.3	31.1	52.9	921.0	639.0	667.4	644.9	909.9	643.2	732.4	745.4	671.4	697.9	666.2	728.7	649.0	1971.3	532.0	709.5	32.0	35.5	317.2	684.3	856.2	1237.9	1.2	207.9	253.1	157.4	539.1	562.1	527.8	2.1	122.2	68.6	94.4	559.6	2128.0	27.3	164.2	1197.8	2064.8	54.1	92.0	0.0	1898.5	635.5	1572.4	103.5	207.0	242.7	223.5	2002.5	2268.4	539.7	0.0	0.1	228.2	132.2	491.4	463.2	102.3	1861.8	713.0	361.1	39.4	130.7	162.4	62.8	0.0	0.5	1135.8	198.3	1060.7	18.7	416.9	54.1	563.8	260.3	7.8	959.8	953.3	1483.2	26.9	12.5	222.4	209.1	125.7	96.6	303.3	263.4	270.6
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440439-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;hTERT-RPE1: 2.2"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"Cluster 20: HeLa - Mitochondria"				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.1	0.1	0.4	0.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA10	IFN-alphaC	ENSG00000186803	"Interferon alpha 10"	P01566	9	21206181-21207143	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Cell type enriched"	"Detected in single"	17	"Granulosa cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 40: Granulosa cells - Unknown function"			"HPA047557: AB_2680087"																		0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.2	1.0	0.6	0.5	0.6	0.7	0.5	0.1	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21240005	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA						"Cluster 41: Macrophages - Immune response"			"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA16	IFN-alphaO	ENSG00000147885	"Interferon alpha 16"	P05015	9	21216373-21217311	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA17	"IFN-alphaI, LEIF2C1"	ENSG00000234829	"Interferon alpha 17"	P01571	9	21227243-21228222	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384255-21385398	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"brain: 1.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 2.5;Granulosa cells: 1.7;Oligodendrocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA	253000		"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA047557: AB_2680087"																		0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.2	0.8	0.5	0.8	0.7	0.7	0.6	0.2	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA21	IFN-alphaI	ENSG00000137080	"Interferon alpha 21"	P01568	9	21165637-21166660	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA4	"IFN-alpha4a, MGC142200"	ENSG00000236637	"Interferon alpha 4"	P05014	9	21186694-21187671	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA5	IFN-alphaG	ENSG00000147873	"Interferon alpha 5"	P01569	9	21304326-21305312	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA6	IFN-alphaK	ENSG00000120235	"Interferon alpha 6"	P05013	9	21349835-21351378	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA						"Cluster 57: B-cells - Immune response"			"HPA047557: AB_2680087"																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA7	"IFN-alphaJ, IFNA-J"	ENSG00000214042	"Interferon alpha 7"	P01567	9	21201469-21202205	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA8	IFN-alphaB	ENSG00000120242	"Interferon alpha 8"	P32881	9	21409117-21410185	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA									"HPA047557: AB_2680087"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324429-33359864	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	40.8	22.3	14.3	36.4	14.6	30.8	32.3	15.7	15.2	26.3	9.6	28.9	26.7	22.4	23.2	25.2	23.8	30.2	21.2	15.0	16.2	32.0	76.6	29.7	28.8	17.4	15.6	23.5	29.2	40.5	7.7	49.5	16.9	27.2	30.5	23.6	30.2	24.1	32.7	20.5	27.4	24.0	15.7	33.5	31.6	20.9	17.5	33.1	41.2	24.8	29.7	39.8	9.0	18.6	47.3	24.4	27.4	24.2	55.8	80.8	23.7	44.6	74.2	32.9	36.1	31.7	57.2	42.4	35.4	49.4	36.3	28.4	23.3	37.0	43.8	33.8	26.0	62.8	29.0	20.2	33.9	50.8	43.3	58.2	38.4	43.6	37.7	39.4	63.1	40.3	67.6	198.2	56.5	22.8	38.7	22.2	24.9	46.6	25.6	29.5	75.0	62.4	33.7	44.0	22.5	24.1	50.5	42.4	39.3	20.8	58.2	36.8	61.3	39.3	24.7	58.2	28.2	102.3	132.7	43.2	66.3	64.4	50.5	77.3	45.4	27.7	23.6	64.0	23.1	56.2	31.5	28.6	37.4	57.0	37.0	29.0	166.7	28.0	80.3	54.3	41.2	35.2	14.3	14.6	15.7	15.2	15.0	16.2	17.4	15.6	16.9	15.7	17.5	18.6	101.2	109.0	45.8	17.6	69.3	45.8	57.0	72.3	18.8	51.9	42.5	29.7	33.5	34.3	78.8	44.1	29.2	28.1	43.8	25.3	21.5	73.0	17.7	37.9	58.4	75.5	26.9	27.1	26.3	90.5	92.4	61.1	35.7	44.5	39.2	30.3	53.9	81.3	69.2	58.9	29.4	28.9	46.8	82.1	47.5	10.7	32.6	77.6	37.4	30.9	86.8	34.3	42.2	34.2	27.2	64.7	25.5	30.9	137.3	63.9	37.6	28.7	59.6	30.0	19.7	54.9	44.9	38.5	17.5	21.5	44.9	20.1	38.3	25.1	27.5	72.2
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077104-21077942	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"Hofbauer cells: 2.2;Macrophages: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073843	Supported				"Secreted to blood"	NA	NA	3750		"Cluster 36: GdT-cells - Adaptive immune response"		"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"			"HPA073843: "	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 283.2;T-cells: 200.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 7: Non-specific - Mitochondria"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	0.7	0.7	0.1	3.5	0.2	11.5	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.0	0.0	0.3	1.5	1.8	7.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.9	0.2	0.0	0.0	0.3	0.2	0.0	1.3	0.4	0.1	0.1	0.5	0.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.4	6.6	0.0	0.4	0.5	3.7	0.1	0.9	0.0	0.0	0.1	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.0	0.0	0.0	3.1	3.2	1.3	0.0	0.0	0.0	4.8	5.5	0.2	1.5	0.0	0.0	0.0	0.0	283.2	0.1	0.0	0.0	0.2	1.0	1.1	1.3	0.0	0.4	0.0	0.0	0.0	1.5	6.1	1.1	0.0	0.0	1.4	1.2	0.1	0.0	0.0	0.5	0.0	4.4	5.5	0.0	0.0	10.4	7.2	0.0	0.0	0.0	19.6	0.0	0.1	0.0	1.1	0.0	10.9	0.2	0.0	0.3	0.0	0.0	0.0	1.0	2.9	0.0	0.0	0.8	4.0	0.0	200.1	0.0	0.2	0.2
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197485-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 867.1;Club cells: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	155.5	59.3	54.6	131.5	57.8	146.2	121.4	64.5	72.1	74.1	56.8	74.7	97.9	58.1	67.4	65.0	55.7	88.4	103.7	53.1	59.9	44.4	104.0	153.8	140.2	71.9	60.3	43.3	44.5	47.4	26.3	86.1	75.9	53.2	74.4	40.4	57.7	57.4	58.3	66.2	101.2	75.9	69.2	165.9	51.3	27.9	59.9	69.2	58.3	75.5	135.2	112.6	58.0	85.0	23.2	23.4	25.1	33.4	166.8	86.7	23.0	67.0	90.0	38.0	53.3	148.7	39.8	24.5	99.2	36.1	55.1	130.0	24.1	62.6	51.5	49.4	37.4	36.1	23.3	192.9	97.3	112.9	46.6	195.9	232.6	33.3	51.4	36.1	48.7	29.1	32.0	34.9	29.2	27.7	17.7	47.0	22.0	191.9	18.6	51.3	28.4	32.1	65.5	104.4	27.4	39.5	77.3	41.9	57.5	47.8	15.5	68.7	71.1	36.2	27.7	48.5	31.8	25.3	25.5	23.8	19.4	69.2	36.5	158.6	518.4	356.3	106.9	502.6	224.7	91.3	60.0	90.0	309.4	98.3	39.2	43.1	736.0	48.4	375.6	85.1	48.0	519.3	54.6	57.8	64.5	72.1	53.1	59.9	71.9	60.3	75.9	69.2	59.9	85.0	298.7	80.1	59.9	21.5	76.4	127.6	177.6	867.1	84.2	15.4	49.8	37.3	49.6	37.1	405.7	27.6	12.5	78.5	240.8	111.0	7.9	74.2	11.6	91.4	52.7	110.7	13.1	25.7	21.4	101.4	67.1	94.7	33.6	112.8	63.3	10.3	62.8	56.5	149.8	10.1	24.2	25.5	270.6	326.2	220.0	6.1	44.1	261.7	49.8	147.1	138.4	23.5	52.5	25.1	44.9	76.0	57.6	49.2	74.5	129.6	82.0	17.2	150.6	28.1	13.1	45.7	75.7	14.6	22.4	47.3	113.2	209.9	121.5	48.3	33.9	140.2
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33403413-33479348	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 433.1;Urothelial cells: 602.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 661.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (9.58e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.13e-10)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.15e-3)"	72.9	41.1	5.9	8.6	7.0	46.6	65.6	2.4	8.2	48.3	7.9	46.8	14.2	31.2	3.4	67.4	37.8	11.6	46.4	7.0	11.2	53.1	43.1	61.8	10.6	8.8	6.4	38.8	32.0	5.6	37.8	18.6	7.6	48.2	7.9	1.0	64.5	6.3	30.0	53.3	51.6	8.6	10.0	80.8	35.8	29.5	12.2	8.1	52.3	10.3	11.9	46.4	56.8	14.0	10.1	10.2	5.9	9.7	16.6	28.2	13.1	30.4	30.0	8.9	13.8	11.3	7.7	15.6	19.8	23.8	24.2	8.6	10.9	25.6	3.1	76.3	44.9	6.0	5.0	12.2	11.0	19.5	17.7	21.4	17.0	14.7	16.6	15.9	20.1	9.9	33.4	11.9	10.2	4.4	5.0	23.2	18.1	15.8	48.0	20.2	14.1	19.6	8.5	10.8	7.9	15.5	19.3	1.9	38.4	1.5	7.1	17.7	30.8	10.1	22.0	8.9	8.8	24.6	28.2	25.4	8.5	23.3	44.7	221.7	283.8	181.7	0.9	281.2	1.2	145.6	16.4	1.7	104.0	158.2	37.7	16.3	661.8	3.5	314.8	31.9	19.2	198.5	5.9	7.0	2.4	8.2	7.0	11.2	8.8	6.4	7.6	10.0	12.2	14.0	72.2	41.7	20.5	9.1	101.4	72.0	225.1	164.8	147.4	9.0	69.3	39.2	18.4	38.6	58.2	27.6	8.4	33.6	11.2	185.3	27.4	117.8	44.6	32.1	51.0	55.1	51.6	17.7	18.7	55.7	86.1	66.8	62.7	50.4	60.3	52.1	40.0	29.6	167.6	15.2	18.9	56.2	57.0	154.5	146.7	60.8	42.0	190.8	56.9	45.0	246.6	8.7	6.2	15.6	5.0	138.6	150.3	32.7	67.9	433.1	151.9	50.1	25.4	8.4	13.1	61.3	33.7	13.4	2.8	90.5	70.0	17.4	16.9	3.4	41.3	602.7
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268396-39270188	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Breast myoepithelial cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"HDLM-2: 10.9"									CAB025489	Uncertain				"Secreted to blood"	NA	NA					"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154168-24187959	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 17.4;Proximal enterocytes: 18.2;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 4.9;naive B-cell: 5.9;plasmacytoid DC: 11.3"	"Group enriched"	"Detected in many"	5	"B-cells: 5.9;dendritic cells: 11.3"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4;U-266/84: 19.4;U-698: 40.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA017319: AB_1851708"	"prognostic favorable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	0.4	2.2	1.1	2.8	1.2	0.6	2.6	6.2	1.1	1.7	2.2	3.8	5.8	0.9	1.9	3.6	1.8	2.1	3.1	0.8	2.6	3.0	8.4	2.9	7.8	2.5	2.2	1.3	5.0	5.2	5.9	0.3	2.5	3.4	4.0	1.8	4.5	2.1	3.6	7.3	9.2	0.4	1.9	2.8	2.9	1.0	2.7	1.4	4.4	1.3	9.7	2.1	2.3	2.7	6.7	1.3	0.0	0.0	0.0	0.0	1.6	0.0	0.6	1.2	1.0	11.3	1.9	14.3	15.1	0.0	5.4	5.0	6.6	11.6	0.9	3.0	3.5	0.0	2.3	3.4	0.0	0.0	0.0	0.0	3.8	0.3	3.5	2.5	0.0	2.9	0.3	0.0	0.0	1.6	0.2	0.4	14.0	0.5	4.1	0.1	0.0	1.2	2.6	2.8	2.0	1.3	3.5	2.0	1.4	2.4	2.7	0.1	0.0	0.0	2.7	0.0	0.1	51.4	19.4	40.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	4.9	0.3	1.4	0.0	5.9	0.5	1.4	0.0	0.0	0.0	11.3	0.3	0.5	1.1	1.2	6.2	1.1	0.8	2.6	2.5	2.2	2.5	1.9	2.7	2.7	0.5	0.0	4.8	2.3	5.9	11.1	10.0	4.1	12.5	3.4	1.4	3.2	3.5	2.8	2.3	1.8	0.0	0.6	5.3	17.4	3.9	2.9	2.2	3.4	0.2	0.5	0.0	0.0	2.2	2.3	1.0	0.8	3.1	2.7	0.0	1.5	0.0	8.4	2.3	0.0	2.8	4.1	0.0	0.8	1.9	4.3	0.3	3.0	0.0	2.8	5.5	2.9	0.0	0.5	0.1	2.4	6.1	0.0	12.5	4.3	18.2	2.3	5.1	2.3	0.0	0.0	0.6	0.0	0.7	8.3	12.6	0.3	2.2	0.1	3.3	17.2
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422887-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 64.2;neutrophil: 112.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 112.3"	"Low cell line specificity"	"Detected in all"											"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	35.2	24.6	11.2	6.5	14.4	57.7	32.3	13.2	16.2	23.0	31.7	30.3	8.1	20.8	4.8	24.0	25.4	4.6	30.9	13.9	19.0	21.3	27.3	40.1	3.9	11.0	13.2	31.3	102.9	9.8	31.2	7.9	13.0	28.1	5.5	13.4	25.7	6.4	58.9	21.9	22.2	10.2	11.7	19.9	38.3	24.5	13.1	4.5	25.6	3.1	3.9	24.1	25.8	19.6	22.1	26.8	25.9	21.7	44.4	28.2	25.0	23.8	26.6	36.0	29.6	42.7	21.1	12.2	52.9	18.8	64.6	15.0	21.5	29.2	46.9	17.1	31.7	13.8	46.1	37.9	61.5	19.9	9.5	24.7	43.4	39.7	47.1	18.9	18.3	22.2	46.5	17.4	14.2	35.7	24.1	20.1	51.8	26.9	30.1	24.6	9.2	22.9	6.0	6.1	37.9	18.9	28.0	15.5	61.2	57.7	9.8	15.2	12.6	45.8	10.4	35.0	68.5	27.2	34.8	37.1	12.9	43.6	63.8	19.8	7.6	64.2	7.2	6.5	6.2	8.7	7.7	7.9	6.6	7.2	6.8	7.0	112.3	8.0	6.4	4.6	8.6	5.2	11.2	14.4	13.2	16.2	13.9	19.0	11.0	13.2	13.0	11.7	13.1	19.6	179.3	32.1	31.4	39.2	110.6	197.3	159.3	55.6	259.6	50.3	141.7	142.6	60.6	37.1	55.0	18.4	89.6	66.5	130.9	276.0	17.6	49.6	43.9	123.2	159.7	96.8	138.2	24.6	36.1	56.5	84.2	135.5	162.6	190.1	74.4	51.3	52.8	21.7	126.1	21.9	24.4	183.5	54.9	96.9	153.4	10.1	36.7	141.8	103.2	44.0	55.8	32.4	20.6	24.1	42.6	55.1	287.8	41.0	104.6	143.9	226.9	13.3	34.1	86.8	39.5	138.9	172.7	25.5	14.5	135.1	126.0	151.7	129.8	53.4	180.0	154.4
IFRD2	"IFNRP, SKMc15, SM15"	ENSG00000214706	"Interferon related developmental regulator 2"	Q12894	3	50287732-50292918	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 139.9;Prostatic glandular cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068560	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA068560: AB_2686005"	"prognostic favorable (7.22e-4)"	"unprognostic (5.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.78e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	39.4	44.9	16.7	13.9	17.8	15.6	33.9	17.4	20.9	24.4	19.2	33.2	20.1	26.8	11.8	44.3	28.2	10.9	69.4	16.2	16.6	39.3	97.0	30.7	14.1	18.0	17.7	23.1	87.3	17.8	22.1	9.3	17.2	45.1	15.0	3.6	33.7	16.7	109.6	25.4	28.1	14.9	17.9	28.3	67.9	17.4	18.0	8.4	31.9	44.6	12.5	36.1	23.6	18.0	70.1	70.5	19.1	60.3	19.2	22.0	44.0	52.4	28.2	62.8	44.3	58.3	69.5	47.3	37.7	36.3	53.9	40.0	40.2	83.8	32.3	45.4	80.7	68.4	93.5	69.5	37.9	70.1	41.4	20.4	70.6	65.7	81.9	20.7	54.0	41.8	44.2	37.9	37.6	65.1	46.5	82.0	48.1	86.1	135.4	29.8	27.7	108.1	38.0	41.3	33.7	32.5	33.2	90.4	34.4	18.3	43.1	66.4	39.5	52.2	65.6	91.3	107.9	26.5	48.9	41.8	41.4	91.1	77.9	11.7	24.1	3.6	33.1	34.4	47.5	32.4	35.0	32.3	35.2	34.0	36.7	33.3	2.3	39.0	19.7	35.0	30.9	30.5	16.7	17.8	17.4	20.9	16.2	16.6	18.0	17.7	17.2	17.9	18.0	18.0	36.9	19.2	24.6	5.9	26.8	67.3	71.7	51.7	31.9	17.3	48.5	37.1	1.7	32.9	36.4	20.2	20.9	35.3	23.8	22.1	29.4	68.8	67.2	11.3	27.8	30.3	15.6	93.6	7.1	89.6	49.5	24.8	62.7	13.1	7.6	28.6	13.9	50.7	31.2	18.5	6.7	29.6	34.6	13.7	28.4	139.9	13.7	15.2	35.6	2.8	16.5	13.3	25.7	4.5	7.3	68.2	26.8	14.3	31.9	153.3	31.3	58.6	10.4	12.0	0.0	30.8	34.9	21.9	19.1	43.1	68.6	30.4	19.2	40.3	56.3	76.8
IFT122	"FAP80, SPG, WDR10, WDR10p, WDR140"	ENSG00000163913	"Intraflagellar transport 122"	Q9HBG6	3	129440036-129520507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 72.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.7;Late spermatids: 70.3;Spermatocytes: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041815	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA041815: AB_10804118"	"unprognostic (7.16e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.67e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.20e-3)"	9.6	7.4	5.7	5.2	7.6	10.1	12.4	6.5	9.2	13.1	15.3	7.6	4.7	12.6	12.7	7.2	24.7	6.7	12.0	6.8	6.8	11.7	9.2	8.8	6.7	4.5	6.2	25.4	13.3	13.9	14.4	10.8	3.0	7.4	6.9	11.2	7.9	8.5	3.9	13.8	5.3	8.9	3.7	4.5	9.0	72.8	7.0	8.9	13.1	2.9	5.7	6.6	8.4	6.3	16.5	24.6	21.0	13.5	29.7	21.0	10.5	8.5	12.9	14.8	14.1	11.9	10.7	10.6	10.0	11.3	14.5	10.4	8.2	7.7	13.3	5.8	8.8	8.2	21.8	10.3	8.1	22.2	7.2	24.7	5.7	11.4	8.8	12.9	20.3	21.8	8.4	22.1	12.1	18.2	18.2	11.6	14.1	12.3	7.0	16.3	8.0	7.7	15.7	3.0	25.9	10.6	24.8	8.2	7.5	7.9	22.6	17.9	9.0	10.1	8.7	13.6	10.2	15.0	11.4	9.3	9.2	11.3	8.1	4.5	3.1	3.7	0.9	2.2	1.6	1.9	1.6	2.3	3.2	2.1	1.8	2.2	1.4	1.5	0.9	0.8	3.0	2.1	5.7	7.6	6.5	9.2	6.8	6.8	4.5	6.2	3.0	3.7	7.0	6.3	7.5	9.6	8.2	28.1	4.3	2.7	5.8	4.5	2.8	9.7	18.0	13.3	6.4	15.7	5.6	25.8	37.5	6.7	4.5	6.2	7.9	5.2	81.7	43.4	11.0	9.7	3.0	7.4	35.1	8.9	5.2	9.8	19.9	10.2	5.1	8.7	20.7	6.0	9.3	5.0	23.1	10.2	4.1	7.2	2.2	70.3	18.6	4.1	3.6	15.0	3.8	11.8	3.1	12.1	15.9	3.4	4.2	13.9	3.4	3.6	6.2	8.2	37.3	21.4	0.0	12.8	7.7	120.4	38.0	5.4	2.8	2.6	4.1	10.6	8.7	3.4
IFT140	"gs114, KIAA0590, WDTC2"	ENSG00000187535	"Intraflagellar transport 140"	Q96RY7	16	1510427-1612072	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.8;Late spermatids: 25.6;Respiratory ciliated cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042197	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA042197: AB_2677895"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.91e-3)"	"unprognostic (6.22e-3)"	5.5	8.9	10.1	2.2	10.3	1.8	7.0	10.5	13.2	11.3	20.8	7.4	3.4	9.6	4.9	4.1	15.3	5.3	4.9	9.8	11.8	10.4	3.8	8.7	2.4	10.2	14.8	12.6	7.7	8.4	15.7	3.1	9.8	9.5	1.3	6.4	6.0	5.3	2.7	5.6	4.8	2.5	10.2	4.1	6.8	15.3	11.6	3.2	22.9	1.0	1.1	12.0	7.2	8.3	2.0	12.4	9.5	9.6	8.0	5.9	5.4	2.6	9.5	2.7	3.3	3.4	9.9	3.8	7.3	3.9	3.6	7.5	1.7	1.5	1.9	3.3	7.6	2.3	9.3	8.3	6.9	1.3	4.7	8.4	5.9	3.2	4.2	10.5	2.0	7.6	2.6	2.2	2.1	12.0	6.9	3.9	10.4	2.5	2.9	6.3	3.4	5.7	8.3	6.2	18.0	10.0	2.9	5.0	3.9	5.1	17.4	5.1	3.9	2.2	7.0	4.0	1.1	6.8	2.6	2.4	3.7	0.8	2.9	0.0	0.4	0.2	0.4	0.2	3.7	0.6	0.6	1.4	0.6	0.2	1.9	3.0	0.0	1.1	0.3	0.5	0.1	0.8	10.1	10.3	10.5	13.2	9.8	11.8	10.2	14.8	9.8	10.2	11.6	8.3	2.9	12.8	11.5	19.9	1.2	1.7	2.9	4.0	4.6	3.7	6.8	6.0	4.0	5.7	6.1	11.0	25.0	7.8	2.2	2.1	1.9	3.2	21.7	27.8	5.9	2.1	5.4	2.5	12.7	1.0	1.3	4.5	7.1	6.2	1.3	11.5	2.2	0.9	2.3	8.4	12.4	6.1	8.2	0.6	0.7	25.6	4.7	1.4	0.0	13.1	0.4	5.6	0.0	6.6	4.9	2.1	1.5	4.1	0.7	1.4	1.0	3.5	31.2	17.2	0.0	3.1	3.0	20.9	7.5	2.0	1.1	2.2	1.6	6.2	3.5	1.5
IFT172	"BBS20, NPHP17, osm-1, SLB, wim"	ENSG00000138002	"Intraflagellar transport 172"	Q9UG01	2	27444377-27489805	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 439.9;Late spermatids: 703.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044893	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"			"HPA044893: AB_10795009"	"unprognostic (1.05e-3)"	"unprognostic (6.52e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.05e-6)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.47e-2)"	3.1	3.3	2.2	2.5	2.6	1.8	4.0	2.5	2.4	5.2	11.8	4.6	1.8	4.5	1.6	2.4	17.0	3.2	4.3	2.3	2.8	4.5	1.5	4.9	2.0	3.6	3.6	8.9	4.8	13.0	9.9	2.4	3.5	3.6	2.1	5.7	4.2	4.2	3.6	2.9	2.7	3.8	2.4	3.9	3.5	12.5	2.4	2.7	5.9	3.9	2.1	3.6	3.4	3.7	5.8	5.3	7.1	10.0	12.6	10.6	4.5	5.5	4.0	6.5	5.5	4.8	4.6	6.3	8.3	7.3	3.9	6.4	13.4	6.7	6.2	3.1	9.4	16.1	9.4	5.6	7.3	7.8	3.4	8.6	3.0	10.3	3.8	9.0	10.8	7.3	5.3	2.2	2.4	4.5	4.4	3.8	5.0	4.6	5.5	0.0	3.7	3.5	5.0	3.7	5.5	8.8	2.8	4.8	9.7	6.0	4.8	4.6	11.6	2.9	1.7	3.7	8.3	2.8	1.7	6.7	11.9	2.3	5.7	0.0	0.4	0.3	0.4	0.6	0.3	0.7	0.2	0.4	0.9	0.5	0.3	0.3	0.0	0.9	0.1	0.4	0.2	0.4	2.2	2.6	2.5	2.4	2.3	2.8	3.6	3.6	3.5	2.4	2.4	3.7	5.2	3.2	9.4	53.5	3.1	2.0	16.6	35.3	8.6	15.4	17.2	12.1	6.3	38.6	32.7	23.9	52.1	1.0	1.7	82.4	0.0	34.4	439.9	59.0	7.1	4.5	34.7	7.6	63.2	98.7	0.6	5.9	23.9	14.2	0.0	11.0	5.7	1.2	1.7	5.0	64.3	96.4	57.0	3.2	1.6	703.6	12.8	2.8	5.4	11.2	1.9	7.1	5.2	24.6	44.9	104.9	106.3	10.9	2.4	7.5	142.0	2.3	154.6	41.7	0.0	11.7	8.5	22.6	6.6	10.1	1.4	0.4	2.8	10.1	75.1	39.8
IFT20		ENSG00000109083	"Intraflagellar transport 20"	Q8IY31	17	28328325-28335489	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021376	Approved		Approved	Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"HPA021376: AB_1851460"	"unprognostic (1.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.71e-3)"	24.9	32.9	26.6	14.7	26.9	77.0	26.8	27.0	46.1	23.4	29.1	37.0	28.8	20.9	39.2	18.8	22.6	22.2	19.7	26.9	28.3	33.5	41.4	22.3	20.7	27.7	27.6	21.6	116.1	25.5	45.2	24.1	27.0	29.9	20.0	26.7	41.2	20.5	9.5	17.6	28.0	20.0	27.5	24.9	42.4	50.1	27.0	22.8	29.2	7.5	19.9	27.9	19.6	27.9	27.3	39.0	25.2	20.7	74.2	75.2	24.2	47.2	58.0	28.9	45.5	59.6	12.7	13.4	24.8	59.8	17.5	29.1	16.9	35.1	41.8	55.0	72.5	8.0	39.7	26.7	72.7	34.1	16.0	57.6	46.4	24.8	39.9	48.2	46.1	26.6	24.2	32.8	23.0	38.2	30.7	26.8	16.9	82.4	21.8	14.4	32.6	35.4	46.2	26.7	31.7	46.2	31.3	64.3	74.8	43.6	41.0	38.2	51.3	16.9	25.8	25.3	25.9	49.6	44.8	17.1	61.6	24.6	25.1	53.7	67.7	52.6	38.6	50.6	44.8	43.2	39.2	38.6	78.1	51.6	39.8	34.7	71.1	36.8	49.0	56.1	45.8	53.7	26.6	26.9	27.0	46.1	26.9	28.3	27.7	27.6	27.0	27.5	27.0	27.9	42.1	38.5	55.8	17.9	36.7	37.0	38.0	63.0	34.7	63.3	74.6	68.3	6.1	47.1	51.5	51.5	60.5	73.0	47.4	30.7	140.8	60.8	245.4	79.8	40.3	47.3	62.6	25.7	31.3	113.2	82.6	47.4	32.1	39.5	23.5	34.2	38.2	48.6	54.2	57.2	36.5	69.5	40.7	47.8	69.4	53.4	60.3	49.6	32.0	7.5	72.8	37.4	42.2	24.6	30.7	68.0	29.9	57.6	57.8	45.9	127.8	98.0	102.6	78.3	78.9	33.5	67.0	164.8	53.0	25.7	42.8	81.4	35.9	59.6	43.1	49.5
IFT22	"DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5"	ENSG00000128581	"Intraflagellar transport 22"	Q9H7X7	7	101310914-101321823	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 92.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042930	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Microtubules, Cytosol"		"HPA042930: AB_10794537"	"unprognostic (1.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	12.4	22.1	20.2	3.7	21.4	2.8	14.3	19.1	25.7	18.6	27.2	22.1	2.8	21.1	22.9	8.5	27.8	12.1	24.0	21.4	21.7	35.5	7.8	13.1	4.0	20.0	21.1	19.5	18.4	29.9	31.1	2.8	20.2	18.0	3.4	41.4	14.7	6.4	26.3	10.1	7.5	5.8	20.7	4.7	14.9	76.4	21.2	10.1	24.4	19.6	3.6	17.2	11.5	19.9	26.1	38.6	20.7	47.9	17.1	14.5	4.6	8.6	4.8	10.6	7.9	15.4	19.3	3.1	22.1	17.8	41.1	16.6	12.2	12.7	8.2	6.2	16.4	0.6	16.4	15.8	12.6	8.7	4.9	14.9	10.9	25.2	5.9	36.5	10.4	18.2	11.2	3.4	12.6	92.5	15.6	16.3	21.6	19.5	17.4	14.4	13.1	5.3	20.1	15.8	22.3	37.0	25.3	21.0	13.7	33.5	16.3	6.6	10.6	33.1	24.6	64.0	18.0	3.1	10.3	7.5	21.7	2.5	17.3	1.4	0.8	0.9	4.0	1.7	3.8	7.5	4.8	3.6	1.6	5.9	4.3	4.4	1.1	5.8	3.3	4.7	2.0	2.3	20.2	21.4	19.1	25.7	21.4	21.7	20.0	21.1	20.2	20.7	21.2	19.9	12.0	25.6	14.3	6.5	11.9	0.0	25.1	0.0	22.2	26.6	35.5	54.4	42.9	55.8	19.2	49.7	54.2	19.7	2.3	4.0	138.9	73.9	577.5	176.0	32.1	17.0	18.5	17.4	7.2	36.9	17.3	28.3	12.8	28.0	9.5	37.9	21.8	10.7	17.7	32.0	5.3	13.1	0.0	2.7	0.0	1478.7	37.9	6.9	0.0	2.8	2.9	76.2	3.1	3.0	2.4	29.9	13.5	41.3	4.8	17.1	2.9	170.2	102.7	103.9	13.1	21.8	22.6	357.7	71.5	15.0	0.0	6.6	7.3	36.0	8.0	20.4
IFT27	"BBS19, FAP156, RABL4, RAYL"	ENSG00000100360	"Intraflagellar transport 27"	Q9BW83	22	36758202-36776256	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 257.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"U-138 MG: 159.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048791	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA048791: "	"unprognostic (3.04e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.06e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (9.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.62e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (5.55e-4)"	11.6	21.7	24.5	8.5	25.5	8.8	11.5	25.7	27.0	13.5	32.3	19.3	12.3	13.8	19.4	9.7	36.6	9.5	23.9	23.9	24.6	22.3	18.4	11.2	9.8	24.9	28.9	15.1	16.2	23.2	39.6	8.0	26.4	15.2	9.7	15.6	14.6	16.5	15.0	11.6	12.5	8.8	25.8	11.8	16.1	23.2	25.5	9.7	18.1	11.9	9.1	14.9	11.1	25.9	17.8	21.9	25.3	28.8	19.9	19.1	15.1	14.1	18.2	18.3	16.1	0.9	15.9	19.3	24.2	13.2	26.3	16.1	13.9	16.0	14.1	37.1	37.4	5.1	4.3	0.0	36.6	6.2	23.3	15.5	25.6	19.4	8.9	14.8	19.6	15.7	9.1	15.5	12.5	32.6	7.7	5.5	13.5	34.4	28.5	36.4	0.0	10.8	18.3	11.4	24.3	26.4	15.0	11.4	37.8	21.3	25.8	11.0	11.6	159.2	9.3	21.3	2.7	36.2	23.6	7.0	25.1	15.5	35.3	14.5	31.8	36.1	24.6	25.0	24.6	22.8	20.4	23.0	39.2	26.0	19.9	19.0	11.7	23.1	30.0	30.5	29.9	21.1	24.5	25.5	25.7	27.0	23.9	24.6	24.9	28.9	26.4	25.8	25.5	25.9	23.6	6.4	18.4	34.3	18.8	23.3	29.0	50.1	12.5	35.2	29.9	32.1	19.9	20.0	51.6	40.5	29.2	27.2	15.2	19.9	105.7	26.1	66.0	110.5	20.2	23.2	53.3	7.8	8.9	23.0	20.9	27.8	14.3	18.7	33.0	27.6	26.0	18.7	40.7	30.3	12.3	46.9	65.1	13.8	25.0	24.3	27.4	17.8	35.6	5.6	13.2	60.5	21.6	11.6	10.4	19.8	18.3	31.6	29.5	24.7	39.4	57.0	257.2	41.9	13.1	24.2	26.9	78.5	17.9	14.1	33.2	17.5	19.0	21.0	31.6	27.9
IFT43	"C14orf179, FLJ32173, MGC16028"	ENSG00000119650	"Intraflagellar transport 43"	Q96FT9	14	75902136-76084585	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003438	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Centriolar satellite"	"HPA003438: AB_1078327"	"unprognostic (1.64e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.07e-2)"	21.5	24.0	29.2	12.2	29.5	5.4	25.1	28.9	31.4	24.6	38.7	27.5	23.0	24.6	49.6	18.0	64.5	18.2	43.2	28.7	29.7	38.9	41.5	20.6	11.6	29.5	31.2	16.2	22.6	27.1	32.8	21.5	30.9	26.9	19.4	25.1	16.1	30.5	13.9	15.4	19.3	27.7	29.8	15.5	21.6	40.5	29.4	15.9	33.0	8.8	17.0	25.5	18.4	29.8	34.8	38.2	27.5	42.7	33.9	54.3	19.5	22.3	42.7	33.6	33.5	14.6	34.9	3.9	23.8	39.5	30.4	36.2	26.7	41.3	37.6	18.3	25.6	1.8	22.3	0.1	94.9	3.8	8.0	48.6	44.4	37.1	48.3	48.6	52.1	38.5	9.6	15.2	40.8	69.7	14.3	6.0	14.2	42.7	48.9	9.1	22.2	10.9	77.0	30.0	26.7	31.9	43.9	29.8	31.5	36.9	77.4	10.2	24.3	19.7	24.7	28.9	19.6	20.1	18.8	4.4	76.9	1.6	20.6	34.5	11.6	19.7	13.8	16.4	17.6	33.8	14.9	14.4	15.7	23.1	24.3	23.4	5.8	15.4	16.4	20.2	19.6	13.4	29.2	29.5	28.9	31.4	28.7	29.7	29.5	31.2	30.9	29.8	29.4	29.8	40.9	12.8	27.4	50.3	14.8	18.6	44.1	103.7	38.1	27.8	36.0	45.6	43.8	42.9	66.1	64.4	66.7	41.9	8.7	24.7	64.6	53.8	147.5	171.0	54.5	35.3	15.7	5.9	46.4	38.7	14.7	39.4	38.2	33.2	26.6	28.7	38.6	32.9	22.4	10.1	55.0	30.2	61.1	7.6	20.0	33.2	33.8	11.5	26.6	14.0	32.0	49.8	14.4	38.2	38.5	33.5	18.7	35.0	13.7	25.8	45.1	160.2	305.8	87.7	32.9	31.2	63.5	124.4	37.2	24.6	21.6	41.9	16.2	32.8	26.1	34.5
IFT46	"C11orf2, C11orf60, CFAP32, FLJ21827"	ENSG00000118096	"Intraflagellar transport 46"	Q9NQC8	11	118544528-118572970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 64.9;Respiratory ciliated cells: 84.3;Spermatocytes: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037909, HPA057550"	Approved		Approved	"Actin filaments"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"		"HPA037909: AB_10672731, HPA057550: AB_2683464"	"unprognostic (8.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-1)"	14.7	19.4	29.0	8.8	29.7	5.6	26.8	33.9	35.8	23.1	37.3	18.6	7.7	19.4	24.8	13.7	66.8	16.4	21.3	28.5	32.5	26.9	17.0	15.1	11.0	32.1	37.2	27.2	16.7	18.4	28.9	8.7	31.8	20.9	11.1	35.7	15.9	20.2	17.9	13.5	10.3	20.7	31.5	11.8	15.0	28.1	31.4	16.0	27.5	17.6	12.8	16.0	16.7	32.1	15.6	18.4	26.1	16.9	42.8	35.7	3.2	31.9	46.2	29.3	27.6	22.5	28.8	23.8	46.1	38.6	7.2	22.1	26.7	31.8	34.4	9.1	21.8	49.2	9.0	8.6	32.0	11.8	13.8	32.4	37.0	49.0	46.2	26.6	28.9	32.1	27.4	16.0	37.3	71.7	31.3	15.6	7.7	27.3	38.0	25.6	20.0	19.0	23.5	21.4	16.7	18.3	23.2	29.9	20.1	15.0	46.2	16.7	24.6	31.6	20.2	18.4	12.0	9.9	14.3	26.7	16.0	21.2	23.2	2.8	5.2	5.9	8.6	4.3	9.9	11.1	7.6	7.9	6.9	8.3	9.2	5.5	1.6	11.0	4.2	7.0	9.9	4.8	29.0	29.7	33.9	35.8	28.5	32.5	32.1	37.2	31.8	31.5	31.4	32.1	5.5	9.6	10.3	10.4	4.9	4.0	8.3	14.4	8.0	12.5	11.6	8.4	14.5	10.0	15.4	11.0	18.8	5.3	3.8	1.6	5.9	17.1	20.5	64.9	11.7	9.3	4.2	6.6	8.7	11.6	7.1	9.5	4.1	9.6	12.0	10.2	8.6	5.9	8.8	1.7	8.9	4.3	14.2	2.4	3.5	15.7	10.2	3.1	1.8	5.6	5.5	14.8	2.1	4.0	6.4	10.2	4.2	18.4	6.1	6.1	3.4	14.3	84.3	16.5	0.0	11.3	11.5	44.9	38.4	6.5	7.0	1.9	4.2	9.8	5.3	3.9
IFT52	"C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5"	ENSG00000101052	"Intraflagellar transport 52"	Q9Y366	20	43590937-43647299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063367, HPA067423"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA063367: , HPA067423: AB_2685837"	"unprognostic (2.88e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.30e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	23.5	15.1	12.2	11.7	12.6	29.1	26.1	12.4	15.2	29.3	14.3	16.3	9.2	27.4	29.0	14.8	38.0	19.0	11.8	12.5	13.5	20.5	7.8	16.9	18.3	12.3	12.8	39.2	15.7	22.5	16.5	17.5	12.8	17.5	17.8	15.1	13.6	23.8	4.7	15.5	11.2	24.3	13.3	15.7	12.2	31.8	14.1	22.8	31.3	9.0	18.9	19.5	18.0	14.2	33.9	25.4	50.3	35.8	41.9	46.4	23.9	20.8	46.1	53.6	51.6	70.5	33.7	18.8	32.8	42.6	43.4	27.7	21.3	37.3	58.6	15.6	20.0	24.8	16.2	65.9	51.4	33.4	16.4	37.8	40.2	34.9	27.0	39.0	42.7	41.4	21.3	26.1	39.9	34.0	46.4	51.5	28.4	22.2	24.9	48.6	57.5	27.8	41.8	32.9	38.8	45.3	63.6	46.7	52.2	25.3	21.8	45.1	26.9	47.3	35.1	26.3	31.1	25.3	26.9	32.8	56.8	24.0	34.8	8.0	22.0	16.8	18.4	20.9	15.0	17.5	14.7	17.5	28.4	15.3	15.4	16.0	6.3	17.4	26.2	21.5	18.6	17.3	12.2	12.6	12.4	15.2	12.5	13.5	12.3	12.8	12.8	13.3	14.1	14.2	21.1	6.4	13.1	11.4	13.7	13.0	12.8	22.4	12.0	11.5	14.1	19.2	2.9	11.5	13.2	7.3	0.0	19.9	16.0	14.8	19.6	26.1	78.4	32.1	19.4	18.1	9.5	23.4	20.5	22.2	19.7	25.3	8.2	10.5	14.5	26.7	23.2	2.6	19.4	8.4	22.5	11.0	14.2	18.2	13.9	20.9	28.6	13.3	17.8	12.2	21.3	22.6	18.6	14.6	25.7	14.8	10.1	38.4	13.5	5.9	5.5	18.3	49.0	12.8	13.1	23.9	24.8	57.3	18.5	12.2	14.9	9.6	12.1	30.4	10.3	10.5
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222435	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1675.3;Late spermatids: 2795.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 41.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.9	15.3	11.6	8.6	11.7	13.2	13.1	10.2	15.5	11.7	14.8	13.3	6.0	13.3	45.1	8.5	32.0	13.4	10.4	11.4	11.5	21.3	4.5	40.7	17.3	12.0	12.2	14.0	13.8	23.0	16.3	7.8	11.6	27.5	14.6	24.0	9.1	17.5	4.2	8.6	9.0	10.6	11.9	12.1	9.8	42.8	12.0	8.2	26.1	4.4	16.4	13.9	8.3	11.8	35.5	17.2	12.8	23.1	26.1	26.9	7.1	10.6	25.8	15.3	13.6	12.4	6.1	39.5	13.3	17.8	22.0	13.9	11.5	17.8	25.8	6.2	12.2	13.6	8.0	3.3	19.4	28.5	30.2	16.3	16.1	19.9	34.2	24.4	17.5	6.6	6.4	6.9	17.8	18.9	9.5	25.8	13.6	2.7	21.0	6.1	11.5	6.3	31.6	12.3	21.1	14.7	15.9	5.2	9.9	7.1	11.0	8.3	7.5	19.6	10.2	10.5	12.6	8.1	6.2	20.7	28.4	2.7	7.3	0.2	3.5	3.1	3.6	6.5	5.8	41.9	7.4	4.5	10.2	34.9	6.2	3.7	1.8	6.8	12.8	2.0	5.1	4.9	11.6	11.7	10.2	15.5	11.4	11.5	12.0	12.2	11.6	11.9	12.0	11.8	36.6	471.1	291.2	18.6	98.4	41.0	114.1	72.9	34.7	25.6	42.2	50.9	33.8	58.6	201.9	51.5	68.8	22.3	16.9	51.1	117.4	158.8	1675.3	266.3	57.8	38.2	57.2	13.7	52.6	134.1	19.3	78.9	25.5	37.0	44.3	57.1	25.7	5.9	14.5	28.6	20.3	35.7	42.7	8.1	27.7	2795.4	65.3	19.3	46.2	4.7	13.1	56.8	8.2	13.0	13.5	79.4	36.6	64.3	40.2	151.4	24.3	124.5	528.7	72.7	52.6	61.7	61.3	242.2	43.6	25.4	37.2	14.9	30.2	104.9	52.3	93.0
IFT74	"CCDC2, CMG-1, CMG1, FLJ22621"	ENSG00000096872	"Intraflagellar transport 74"	Q96LB3	9	26947039-27066134	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 93.2;Respiratory ciliated cells: 97.4;Spermatocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020247, HPA026684"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA020247: AB_1846140, HPA026684: AB_1846141"	"unprognostic (3.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.43e-1)"	7.4	12.8	5.0	6.4	4.9	6.7	14.9	5.8	5.7	13.4	14.8	9.1	4.5	12.4	22.4	8.3	21.8	6.6	8.3	4.8	5.5	13.0	11.8	7.8	6.1	6.3	5.8	12.5	8.3	16.6	12.5	9.7	5.6	11.7	8.9	14.6	7.6	13.3	9.1	7.1	5.9	10.4	5.0	8.1	6.7	49.0	6.1	10.0	20.3	8.9	7.5	8.3	7.7	5.5	15.3	26.2	24.3	18.8	17.5	29.4	6.1	16.8	26.8	20.7	17.8	2.9	10.3	6.7	13.9	17.9	21.8	12.8	18.6	23.6	22.8	17.3	8.6	17.0	10.5	12.0	27.8	10.6	16.3	22.9	32.9	24.8	42.6	25.6	13.4	1.4	12.0	22.8	31.4	6.3	12.4	25.9	15.4	11.7	10.7	7.5	9.8	17.0	31.1	9.3	21.0	21.2	11.0	15.2	9.1	14.8	23.2	14.6	9.1	0.0	20.0	5.1	15.6	7.5	24.5	5.4	9.8	12.6	9.5	2.3	6.2	2.0	5.8	7.3	4.7	12.4	6.1	5.8	9.2	12.6	10.3	7.7	0.4	12.1	7.0	7.8	6.1	3.9	5.0	4.9	5.8	5.7	4.8	5.5	6.3	5.8	5.6	5.0	6.1	5.5	10.1	32.1	27.4	27.4	8.2	7.8	15.8	24.4	10.2	23.9	12.1	16.0	29.1	7.2	28.4	16.5	22.9	23.1	3.4	17.2	21.5	26.5	84.5	93.2	27.6	12.1	13.2	10.7	15.5	22.7	10.6	14.8	7.1	23.1	16.5	19.2	8.9	8.6	15.8	28.6	17.8	13.5	8.2	49.6	4.5	36.1	20.2	9.3	5.4	19.7	8.3	25.2	1.0	23.1	24.2	11.7	10.5	18.0	7.7	6.0	10.2	33.1	97.4	43.5	19.7	18.1	25.4	208.2	29.9	9.7	8.4	10.9	8.3	35.9	17.2	7.3
IFT80	"FAP167, KIAA1374, WDR56"	ENSG00000068885	"Intraflagellar transport 80"	Q9P2H3	3	160256986-160399880	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 254.5;Respiratory ciliated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035868	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA035868: AB_10959463"	"unprognostic (2.71e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.70e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.60e-3)"	7.5	10.0	17.2	8.3	25.6	6.2	11.5	17.0	26.2	13.3	20.6	7.7	6.1	14.6	16.9	8.9	17.3	11.6	10.0	17.6	20.0	17.9	7.6	14.5	12.1	18.7	21.0	16.5	10.2	27.5	25.7	7.6	18.7	9.8	9.9	25.1	7.3	10.8	4.7	12.3	8.3	10.8	15.4	9.4	11.2	24.1	19.7	18.2	18.2	6.8	11.6	8.9	8.9	40.1	23.9	16.3	36.9	16.9	34.0	59.8	9.1	20.0	29.3	15.1	19.8	13.3	33.9	15.5	25.7	18.9	22.9	20.3	13.1	19.3	33.7	23.1	14.5	20.7	23.4	9.5	33.8	9.9	17.4	33.2	13.0	17.2	18.4	68.1	17.1	19.7	8.9	28.8	23.8	11.5	18.4	11.7	11.6	15.0	9.5	16.3	19.3	26.3	31.5	6.9	22.0	23.2	21.9	20.6	26.1	23.9	34.5	11.3	15.3	15.5	10.5	21.2	19.9	41.7	28.9	28.5	26.7	17.8	15.6	0.9	0.5	0.5	0.6	0.2	0.6	0.8	0.7	0.7	0.7	0.7	1.0	0.7	0.4	0.9	0.5	1.4	1.0	0.6	17.2	25.6	17.0	26.2	17.6	20.0	18.7	21.0	18.7	15.4	19.7	40.1	6.5	41.7	33.0	42.7	7.0	3.3	5.9	7.5	15.4	16.7	6.4	3.8	7.2	18.6	14.4	23.9	16.7	3.1	7.3	3.8	7.9	5.6	30.5	39.0	19.0	7.0	11.4	11.6	61.7	1.8	2.9	13.8	5.6	9.6	2.5	13.3	6.8	4.0	2.9	1.7	44.9	5.2	2.0	4.1	2.7	9.5	16.4	4.4	1.8	27.2	2.5	8.0	7.2	46.3	254.5	2.6	2.6	21.8	10.9	2.4	1.9	6.7	71.7	18.1	6.6	8.3	8.3	43.2	10.4	8.5	3.8	0.7	8.8	11.6	5.1	3.6
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218793	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 79.1;Respiratory ciliated cells: 148.2;Spermatocytes: 179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Centrosome	"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.9	9.0	5.0	4.6	5.0	1.5	8.8	7.5	6.0	15.6	10.8	13.6	2.7	14.5	18.5	5.9	18.3	8.5	7.6	5.2	6.0	9.4	4.1	8.3	3.0	7.2	7.0	14.5	5.2	16.5	15.2	5.0	4.4	12.3	5.7	23.0	9.3	14.3	6.8	5.7	5.2	8.5	5.1	4.0	7.4	31.8	5.3	5.8	13.8	6.7	2.9	11.5	9.7	4.1	14.1	26.2	53.0	22.7	9.6	19.6	4.0	8.8	13.5	18.7	16.0	5.1	7.8	4.6	4.8	17.0	13.2	12.2	19.7	10.4	24.1	5.9	10.8	9.7	15.4	8.4	8.3	6.0	4.5	14.1	11.6	17.7	4.5	45.2	11.8	9.0	12.0	2.5	17.3	3.0	12.3	10.1	26.2	8.1	8.6	14.4	13.9	6.2	23.2	9.4	32.8	36.2	24.1	5.0	36.8	14.7	26.9	9.1	8.0	10.5	5.4	8.8	8.4	7.9	8.0	6.3	25.3	7.6	12.2	0.0	0.3	0.1	0.2	0.2	0.5	0.4	0.5	0.2	1.0	0.4	0.4	0.1	0.8	0.7	0.3	1.0	0.2	0.3	5.0	5.0	7.5	6.0	5.2	6.0	7.2	7.0	4.4	5.1	5.3	4.1	5.2	12.8	20.1	26.4	2.4	6.1	12.9	20.3	11.4	16.4	8.6	11.6	22.1	8.6	26.0	14.7	41.7	2.5	0.6	2.3	15.6	10.9	51.8	79.1	36.1	6.0	21.6	2.5	30.1	4.0	1.6	14.9	8.2	11.9	3.8	16.8	4.6	4.8	2.6	25.2	31.8	4.3	18.3	1.3	1.4	18.1	14.0	2.5	35.6	11.2	2.1	19.1	1.0	41.2	14.5	5.7	1.9	27.8	1.9	3.6	0.9	10.5	148.2	37.7	6.6	14.4	25.6	179.0	46.0	7.4	6.5	1.0	1.5	36.3	3.5	4.8
IFTAP	"C11orf74, FLJ38678, HEPIS, NWC"	ENSG00000166352	"Intraflagellar transport associated protein"	Q86VG3	11	36594369-36675695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.0;Cardiomyocytes: 60.7;Cytotrophoblasts: 19.3;Extravillous trophoblasts: 19.0;Fibroblasts: 8.5;Hofbauer cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044880	Uncertain		Approved	Aggresome,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Aggresome, Cytosol"		"HPA044880: AB_10796908"	"unprognostic (9.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.24e-1)"	17.1	20.0	19.5	5.3	20.0	13.3	15.3	19.7	31.0	17.0	33.0	30.7	7.5	16.2	23.7	9.5	31.7	12.7	45.3	19.7	19.1	25.3	18.7	11.8	5.4	19.3	20.0	21.8	18.0	16.5	25.9	10.3	19.4	12.8	10.4	19.5	12.2	10.3	41.0	7.2	10.1	16.5	18.9	8.3	17.5	52.4	19.8	10.5	82.2	42.3	5.0	17.5	12.9	20.1	11.4	19.7	41.4	31.3	39.0	56.2	16.4	24.5	26.8	23.6	43.3	0.7	18.8	0.2	18.1	25.0	32.4	4.5	28.3	33.9	48.8	0.2	47.8	19.9	9.2	20.0	30.0	27.4	4.5	36.4	24.4	15.7	22.4	40.5	40.4	15.2	25.4	0.3	25.6	18.8	4.9	22.7	24.8	7.0	31.0	19.5	51.4	11.3	34.1	3.6	0.6	46.6	28.0	5.4	42.6	37.4	38.3	14.7	24.7	32.3	22.3	43.4	21.8	6.2	12.3	0.0	29.4	33.2	17.0	10.5	18.3	1.2	1.6	15.4	5.1	0.0	4.8	3.9	20.9	0.3	11.6	2.9	1.0	14.1	15.3	28.5	0.7	8.3	19.5	20.0	19.7	31.0	19.7	19.1	19.3	20.0	19.4	18.9	19.8	20.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	19.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	19.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0
IGBP1	"α4, IBP1"	ENSG00000089289	"Immunoglobulin binding protein 1"	P78318	X	70133447-70166324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"	Chaperone	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000634, HPA001004, CAB034139"	Approved		Approved	Cytosol		NA	NA		48000	"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB034139: AB_2295670, HPA000634: AB_1079102, HPA001004: AB_1079104"	"unprognostic (3.59e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.10e-3)"	56.3	43.2	38.5	29.7	40.3	57.5	55.1	40.3	45.8	68.6	36.9	60.2	57.8	53.3	62.0	46.6	73.5	48.3	53.4	38.6	40.4	57.9	29.4	36.6	59.4	40.4	39.9	119.1	118.6	38.7	35.6	37.6	40.6	42.2	56.2	30.1	64.4	32.1	118.0	63.4	58.3	42.4	41.7	40.7	70.1	18.7	39.7	68.2	57.3	99.9	69.5	52.4	54.5	42.7	42.7	48.9	30.9	35.9	122.2	163.3	44.5	35.6	99.6	47.9	57.1	45.5	55.7	79.1	58.7	62.0	62.6	57.1	73.8	59.1	60.8	31.4	53.2	25.1	52.7	82.9	83.6	59.4	43.9	158.1	143.1	44.3	63.2	166.6	81.8	57.9	51.4	69.5	52.6	42.7	48.7	100.4	37.5	98.0	73.6	42.3	65.0	79.5	77.8	67.2	35.4	43.4	46.3	40.0	87.0	56.4	21.3	61.1	65.8	25.8	40.2	46.0	27.2	65.0	53.7	40.1	36.4	50.5	31.1	51.4	46.1	41.8	34.1	46.0	40.9	50.9	47.4	45.2	51.1	41.8	53.7	48.9	31.4	39.8	39.0	25.6	75.2	48.0	38.5	40.3	40.3	45.8	38.6	40.4	40.4	39.9	40.6	41.7	39.7	42.7	50.1	32.1	54.7	12.1	79.3	100.1	114.2	163.9	82.0	21.5	81.4	82.2	75.8	70.1	85.6	27.6	8.4	123.8	45.3	91.3	103.7	80.3	126.3	58.0	61.1	64.1	69.9	38.9	19.3	143.2	129.0	62.2	46.9	57.9	34.8	90.8	85.3	20.9	82.7	6.7	19.5	128.0	69.2	123.1	89.6	121.5	81.4	75.6	49.8	15.0	119.8	48.9	90.6	13.6	27.6	86.4	153.1	61.7	52.9	70.8	342.0	182.0	57.8	23.6	26.3	62.3	63.0	12.2	25.0	76.2	120.3	124.9	81.9	96.1	128.4	130.4
IGBP1P2		ENSG00000266826	"Immunoglobulin (CD79A) binding protein 1 pseudogene 2"		17	58660424-58692018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	31	"testis: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000634, HPA001004"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Cytosol		"HPA000634: AB_1079102, HPA001004: AB_1079104"					"unprognostic (3.14e-2)"					"unprognostic (1.59e-1)"		"unprognostic (2.37e-1)"		"unprognostic (8.67e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.94e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IGF1	"IGF, IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 86.7;cervix: 89.0"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 1279.3;Leydig cells: 1103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.9;HDLM-2: 49.6;K-562: 22.4;Karpas-707: 11.3;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048946	Approved				"Secreted to blood"	NA	NA	103000000	330000000	"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA048946: AB_2680566"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	86.7	5.1	1.2	27.1	1.8	0.9	38.7	0.3	2.3	89.0	1.3	6.9	5.4	46.9	10.6	6.6	13.0	21.5	15.1	2.2	1.0	3.1	83.5	11.6	6.5	2.5	1.1	9.0	3.9	1.4	1.2	24.2	2.0	38.5	6.7	5.4	7.6	33.4	8.5	4.9	5.7	74.3	1.2	9.8	7.7	7.6	2.0	3.1	25.4	5.9	3.7	21.3	22.7	0.9	0.3	0.0	0.0	0.0	37.9	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	22.4	11.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.2	1.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.4	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.8	0.3	2.3	2.2	1.0	2.5	1.1	2.0	1.2	2.0	0.9	11.8	3.2	2.2	1.0	8.5	2.5	0.7	0.0	1.8	168.1	4.0	6.2	0.4	2.8	0.7	0.0	0.0	1.1	0.6	0.2	0.0	0.0	17.5	35.8	1279.3	38.9	0.0	5.3	1.2	0.6	1.5	259.7	2.6	34.5	0.0	0.3	6.4	243.0	122.0	0.0	123.9	0.0	16.2	25.8	12.5	58.0	1103.2	42.0	14.2	27.2	3.6	4.4	0.0	0.5	0.9	0.1	0.0	193.4	66.9	1.2	0.0	1.4	0.1	9.0	0.0	139.3	19.6	1.9	1.2	1.6	2.7	1.2	9.1	69.4	0.2	0.4
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648539-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 239.4;Inhibitory neurons: 194.6;Microglial cells: 245.4;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 261.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.3;T-cells: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010268, HPA045563"	Approved					NA	NA		46000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"			"CAB010268: AB_671792, HPA045563: AB_2679368"	"unprognostic (1.30e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	7.3	11.3	10.1	3.6	11.2	11.0	12.2	12.0	12.0	10.1	35.5	12.5	2.5	11.0	11.1	7.5	13.0	4.5	9.6	9.5	8.2	11.6	0.9	9.5	2.7	12.4	13.4	15.8	15.4	2.1	8.8	12.1	11.2	14.7	4.5	16.0	10.0	9.6	7.0	11.1	6.5	6.1	10.3	5.8	9.6	8.4	13.2	6.1	12.9	11.6	3.4	9.9	10.0	11.1	6.1	34.0	22.6	0.2	11.9	8.3	16.3	8.0	14.5	2.5	2.2	15.6	17.5	1.6	22.1	13.8	14.7	31.6	10.9	25.0	1.9	0.1	11.1	27.5	32.3	31.2	10.4	11.1	2.5	12.1	14.9	4.5	18.6	9.3	8.4	2.8	1.4	5.4	9.9	48.1	5.4	9.8	23.0	11.8	1.3	7.7	19.3	6.7	7.4	37.8	8.1	35.9	56.0	3.3	30.1	50.2	16.7	3.8	24.5	1.5	26.5	6.5	12.0	1.9	9.8	5.9	4.6	10.0	5.9	1.9	0.3	0.9	0.4	0.2	0.2	0.1	0.3	0.1	0.1	0.4	1.4	0.4	4.3	0.5	0.3	0.1	0.0	0.3	10.1	11.2	12.0	12.0	9.5	8.2	12.4	13.4	11.2	10.3	13.2	11.1	30.8	28.9	13.4	157.7	3.5	32.8	28.8	31.1	35.3	51.5	58.3	33.4	30.8	5.7	30.2	22.0	91.8	33.7	8.0	10.7	1.9	16.6	27.6	79.7	39.6	26.1	35.0	7.8	239.4	11.2	20.3	25.2	11.2	91.3	0.0	106.5	52.5	1.5	6.5	75.7	194.6	21.1	20.3	6.6	8.3	53.4	18.0	8.3	21.4	245.4	8.5	45.6	14.4	237.7	261.0	29.1	12.9	13.5	4.3	70.9	5.3	21.8	55.4	36.1	0.0	20.4	27.6	4.0	17.2	17.9	32.0	27.5	6.4	20.9	24.5	51.5
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2141238	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 2749.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 86.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1200000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	99.7	58.4	5.5	9.2	32.6	0.9	41.8	12.6	86.0	75.5	236.8	22.3	4.7	75.2	52.7	18.8	128.4	34.8	91.7	6.5	7.1	31.8	305.9	9.8	3.4	20.2	6.6	117.8	37.5	5.2	25.4	2749.2	10.1	14.5	4.8	0.5	11.6	15.2	82.1	8.4	10.9	14.7	13.0	14.4	11.9	23.7	10.9	3.4	12.4	114.0	4.7	24.2	23.6	9.0	0.0	2.8	0.3	0.6	0.2	0.3	1.8	112.8	1.3	3.6	0.4	862.0	0.4	0.1	8.4	0.0	2.1	0.1	0.9	7.0	7.9	0.1	0.5	0.2	0.2	600.5	143.4	0.7	0.0	174.7	0.5	0.7	0.2	0.1	1.4	0.0	0.3	0.0	333.7	2.2	0.1	0.8	1.2	0.2	1.5	0.1	408.5	0.9	0.0	0.9	32.7	495.6	0.7	0.1	0.0	83.0	4.2	0.0	0.4	0.2	20.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	32.6	12.6	86.0	6.5	7.1	20.2	6.6	10.1	13.0	10.9	9.0	40.6	3.2	3.1	0.0	2.6	5.4	0.5	0.5	0.6	0.4	0.0	0.0	6.5	8.6	0.9	3.7	0.0	1104.3	0.0	0.0	0.0	0.0	13.1	0.0	0.0	498.4	0.0	16.0	0.0	0.0	3196.3	334.2	0.0	0.0	0.0	0.0	171.4	494.9	218.2	0.0	0.0	0.0	0.0	11.6	5.5	91.1	3007.5	3.4	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	643.9	0.0	1.1	0.0	0.0	0.9	0.5	65.7	33.5	37.5	3.8	6.3	1.5	4.1	1612.9	1.8	0.0	0.0	0.4
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997385-49056145	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 5.5;testis: 4.8"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 37.3;Spermatocytes: 30.4;Spermatogonia: 21.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 146.7;CACO-2: 238.7;Hep G2: 112.0;K-562: 124.4;NTERA-2: 117.6;REH: 140.0;SuSa: 111.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021367, HPA062273"	Enhanced		Supported	Cytosol		NA	NA		13000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	59.5	146.7	0.1	5.2	7.6	105.0	8.5	0.2	12.1	20.1	238.7	4.0	12.4	0.9	1.0	3.6	0.0	91.4	0.0	21.1	0.0	52.9	91.3	33.6	112.0	6.9	48.8	23.6	10.4	0.0	2.9	0.2	4.1	24.9	16.6	124.4	0.0	16.6	0.9	0.1	42.9	117.6	0.2	0.2	140.0	48.3	0.0	0.0	0.1	0.0	0.0	5.1	0.1	3.6	111.4	0.2	13.5	0.5	0.0	1.4	12.5	0.0	0.1	0.1	80.7	0.1	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	1.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.6	0.0	0.0	3.5	0.2	0.0	0.0	0.0	5.3	0.1	0.1	3.9	0.0	2.7	0.2	0.0	37.3	3.7	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.0	0.8	4.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	5.3	0.7	0.0	0.0	1.1	1.1	30.4	21.7	0.0	0.1	2.9	0.3	0.1	0.0	0.3
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643130-185825042	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 263.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	8.0	9.0	0.9	4.1	1.1	11.9	5.3	6.4	2.0	7.2	1.3	12.6	15.0	5.0	0.7	3.3	11.2	7.5	9.0	1.0	2.1	8.2	1.6	11.7	1.3	2.2	2.1	6.6	4.9	6.4	1.4	15.1	1.3	1.9	14.9	22.3	9.3	1.1	2.0	4.4	16.0	4.6	1.5	4.4	13.2	6.1	1.9	2.2	7.3	3.4	1.8	3.8	5.5	1.2	129.4	11.0	124.2	22.5	64.8	102.5	73.2	68.5	94.2	102.2	121.6	94.1	36.2	0.0	98.2	56.9	130.1	57.7	58.4	97.3	163.9	0.2	58.2	37.7	0.6	64.1	140.2	1.2	0.2	75.0	50.4	67.6	263.9	53.2	95.3	10.1	37.6	0.1	75.2	1.1	0.3	27.8	87.3	22.1	45.7	13.5	48.1	38.8	63.7	0.4	7.7	1.2	5.0	0.2	113.5	120.5	10.1	82.1	144.8	34.8	74.8	44.6	78.2	0.4	0.2	0.3	34.7	0.1	50.3	0.4	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.7	1.7	0.4	0.0	0.6	0.9	1.1	6.4	2.0	1.0	2.1	2.2	2.1	1.3	1.5	1.9	1.2	6.2	12.8	11.6	2.3	0.6	19.8	20.1	48.1	1.2	5.2	18.4	6.2	15.7	44.3	49.2	25.8	16.7	2.8	0.9	82.0	3.9	38.9	126.6	86.4	13.8	18.9	35.6	46.9	0.7	25.4	18.0	25.3	20.9	117.7	2.5	64.5	39.7	0.5	16.4	1.7	1.1	44.7	46.8	8.8	16.9	81.7	5.3	10.5	14.2	13.1	11.3	21.2	6.2	4.5	0.2	61.1	80.1	0.4	1.5	63.0	68.8	11.4	74.8	176.7	0.0	2.0	18.8	4.7	14.4	1.2	14.6	6.3	1.1	0.8	45.9	77.8
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470491	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.3;placenta: 28.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 84.8;Early spermatids: 40.8;Extravillous trophoblasts: 93.4;Hofbauer cells: 38.5;Late spermatids: 24.1;Syncytiotrophoblasts: 78.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 170.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol		NA	NA		27000	"Cluster 24: B-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.3	0.0	0.6	0.8	0.3	0.6	0.1	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.8	2.1	0.9	0.2	0.0	0.3	0.0	0.0	0.5	0.5	4.2	0.0	0.0	0.0	0.6	0.3	0.0	28.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	5.1	0.3	1.6	0.8	0.1	7.3	0.2	0.2	0.1	48.7	14.0	104.5	31.0	16.2	42.8	63.7	8.1	35.7	19.6	24.2	45.0	37.4	36.4	42.1	21.3	86.4	31.2	45.8	35.2	34.2	5.9	18.3	19.3	38.1	37.9	50.3	35.5	13.1	44.1	24.2	15.0	6.3	114.7	170.0	20.0	89.5	0.2	47.8	0.0	21.6	23.5	83.0	36.6	43.3	33.2	34.8	47.1	38.4	4.2	27.4	59.6	4.8	0.3	38.9	118.3	0.0	6.6	68.9	18.6	1.2	40.6	21.0	0.0	15.8	56.7	73.8	38.6	72.8	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	1.0	2.8	0.3	0.7	0.3	0.0	0.5	0.0	0.0	0.5	0.0	0.3	0.0	0.0	84.8	1.4	0.1	0.0	1.2	40.8	5.4	0.2	1.7	0.0	0.0	2.0	0.2	93.4	3.5	0.0	1.5	3.8	0.1	1.1	0.2	38.5	1.7	12.9	0.0	0.0	0.8	0.6	24.1	2.1	11.3	3.6	5.6	2.9	0.2	2.1	1.5	1.8	1.0	0.0	0.0	2.1	0.2	0.0	0.1	2.6	1.6	0.0	0.4	7.7	6.8	3.5	0.7	0.4	78.5	0.3	0.0	0.0	0.6
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 116.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.3	0.2	0.5	0.3	0.9	0.4	0.4	1.4	0.8	0.5	0.9	0.6	0.3	0.2	0.1	0.1	0.7	1.6	0.2	0.3	0.1	1.0	116.7	0.8	0.0	0.7	0.4	0.7	2.5	0.0	0.7	0.0	0.8	0.5	0.1	0.2	0.8	0.1	0.5	0.9	0.6	0.0	0.4	0.3	11.0	1.9	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.4	0.8	0.3	0.1	0.7	0.4	0.8	0.4	0.4	1.8	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1198.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000		"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	2.6	0.1	0.2	0.0	0.2	0.0	2.4	0.2	0.3	0.3	0.1	0.0	0.3	79.6	0.1	0.0	4.1	0.3	0.5	0.2	0.3	1.6	1198.4	0.1	0.1	0.8	0.3	46.3	0.5	0.0	0.5	204.5	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.3	1.1	0.3	0.0	0.0	0.0	0.2	0.2	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.8	0.3	0.9	0.2	0.3	0.2	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443450-40457725	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.7;Endometrial stromal cells: 542.2;Endothelial cells: 502.3;Fibroblasts: 585.4;Hepatic stellate cells: 566.5;Hepatocytes: 501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 19.5;NK-cell: 37.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 37.0;T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"A549: 1334.8;ASC diff: 961.5;ASC TERT1: 933.8;BJ: 1066.4;BJ hTERT+: 1088.2;HSkMC: 2001.2;U-2197: 882.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	NA	NA	227000000	410000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA066240: AB_2685643"	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	884.7	248.1	26.0	307.7	26.9	2.4	754.6	25.3	46.5	1020.7	65.0	618.0	82.8	795.8	141.9	246.7	791.1	391.4	502.9	25.6	28.2	464.4	1475.9	390.1	60.0	29.5	34.1	1270.4	164.4	44.6	203.7	231.8	28.9	470.0	133.5	13.1	264.4	279.0	107.3	241.7	289.5	645.1	28.3	295.5	369.6	67.7	35.3	38.9	501.4	97.4	44.2	552.1	576.2	25.8	0.2	1334.8	66.8	0.5	961.5	933.8	2.2	1066.4	1088.2	199.7	154.4	59.7	17.3	0.3	563.7	511.0	27.2	11.9	22.6	6.8	90.2	4.8	1.3	4.3	91.3	89.9	601.2	2.9	0.5	2001.2	4.6	267.7	37.7	23.8	350.6	0.1	21.7	0.2	290.5	41.2	0.8	252.5	37.2	58.9	178.2	67.2	1.3	2.1	8.4	42.1	18.3	53.0	482.3	2.0	17.0	63.5	486.6	24.7	534.7	276.0	14.4	882.1	1.1	0.9	0.6	1.7	163.8	9.9	72.4	0.0	0.0	0.0	2.7	0.0	19.5	0.8	5.0	6.7	0.0	5.2	0.3	0.6	0.0	37.0	0.0	0.2	0.0	1.4	26.0	26.9	25.3	46.5	25.6	28.2	29.5	34.1	28.9	28.3	35.3	25.8	672.7	9.6	37.4	1.3	17.6	56.3	97.1	36.7	79.1	3.2	118.9	163.2	16.9	90.1	16.2	7.3	0.0	6.1	10.6	93.3	17.6	4.1	6.7	69.8	542.2	502.3	8.4	37.9	3.8	2.4	7.2	585.4	13.7	59.1	2.5	230.9	566.5	501.2	273.6	1.7	3.4	74.7	4.1	42.8	94.0	16.5	246.4	21.3	72.9	18.7	3.4	3.8	1.0	1.0	0.3	39.1	72.1	118.5	7.4	63.8	71.6	204.7	18.5	1.1	190.7	13.8	299.9	1.9	8.2	26.8	47.7	7.5	20.3	25.9	109.0	73.6
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38406528-38424454	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 16.5"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	0.8	1.5	2.4	0.5	4.2	0.5	0.1	3.4	2.8	0.2	1.4	0.5	0.9	0.7	0.1	0.3	0.3	0.6	1.3	2.6	2.0	0.2	0.3	0.8	0.2	1.5	2.3	0.1	0.9	0.0	1.1	0.6	1.7	0.4	0.3	0.3	0.1	1.6	0.2	0.2	0.6	1.1	1.0	0.1	1.6	2.1	2.8	2.9	16.5	0.0	0.1	0.5	0.1	1.8	0.0	8.6	360.4	0.4	0.0	0.0	0.2	2.4	0.0	0.5	0.3	0.1	0.2	0.1	1.3	0.3	0.0	0.1	44.0	0.0	0.5	0.0	2.7	0.1	1.2	0.2	0.0	1.7	1.2	0.4	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.2	2.5	0.1	0.3	0.2	104.2	0.5	0.7	0.1	97.5	0.9	0.0	0.2	334.3	332.6	6.4	0.5	0.0	241.3	2.3	2.3	0.4	0.1	7.7	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.0	2.4	4.2	3.4	2.8	2.6	2.0	1.5	2.3	1.7	1.0	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.3	0.6	0.1	0.0	1.8	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229742-46231243	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"esophagus: 113.0;salivary gland: 34.5;vagina: 31.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.7;Basal respiratory cells: 12.5;Prostatic glandular cells: 4.4;Squamous epithelial cells: 2.1;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 6.9;RT4: 25.6;SK-BR-3: 8.6"									HPA014001	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	34.5	0.0	0.0	3.5	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.8	0.0	0.0	4.8	0.4	31.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	6.9	0.0	1.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	12.5	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.3	2.1	3.4	0.0	0.0	0.0	0.0	0.2
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 41.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Excitatory neurons: 27.1;Inhibitory neurons: 29.3;Oligodendrocytes: 38.5;Spermatocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 82.4;OE19: 166.9"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	2.4	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.8	0.1	0.0	0.5	0.0	0.2	0.5	1.5	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	0.7	0.3	0.0	0.0	1.5	0.3	0.9	0.8	0.0	0.8	0.4	1.0	0.0	0.0	41.6	0.1	0.2	0.2	0.0	0.0	4.1	0.3	1.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	1.7	0.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.0	1.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	166.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.4	0.7	0.3	0.8	0.2	0.3	2.1	0.0	0.0	0.0	17.9	0.0	2.2	0.0	1.1	0.0	1.7	2.0	1.5	0.6	0.0	0.7	0.0	0.0	4.3	0.0	0.7	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.0	27.1	0.2	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	29.3	0.4	0.0	0.0	0.3	5.4	0.0	0.0	1.8	0.0	0.0	0.2	0.0	6.0	38.5	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.9	0.0	0.0	0.7	9.8	8.7	0.0	4.7	2.6	0.2	0.0	1.4	0.0
IGFL3	UNQ483	ENSG00000188624	"IGF like family member 3"	Q6UXB1	19	46120067-46124688	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 27.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 3.1;Basal respiratory cells: 1.7;Exocrine glandular cells: 6.5;Melanocytes: 1.8;Suprabasal keratinocytes: 8.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.7;CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 1.3;U-87 MG: 2.4"									HPA062776	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA062776: AB_2684866"	"unprognostic (8.61e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.69e-1)"		"unprognostic (4.78e-2)"	"unprognostic (7.45e-3)"		"unprognostic (2.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-4)"			"unprognostic (2.86e-2)"	"unprognostic (1.90e-1)"		"unprognostic (3.69e-2)"	0.0	0.0	0.6	0.0	1.2	0.1	1.5	0.0	1.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	1.1	0.2	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.1	0.5	0.1	0.0	0.3	27.7	0.0	0.1	0.2	0.0	0.0	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.2	1.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.2	1.2	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	1.2	0.5	0.3	1.1	0.2	1.1	0.2	0.4	2.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"retina: 19.5;skin 1: 6.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 9.5;Inhibitory neurons: 10.1;Rod photoreceptor cells: 42.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.9;HaCaT: 3.5;OE19: 6.1"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.0	0.3	1.3	0.1	1.1	0.1	0.1	1.0	2.2	0.0	0.0	0.1	0.4	0.3	1.3	1.0	0.2	0.5	1.0	1.2	0.4	0.1	0.1	0.3	0.4	0.0	0.1	0.9	0.0	0.5	1.6	0.1	0.4	0.4	0.2	19.5	0.5	0.0	0.2	6.9	0.3	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.8	0.0	0.0	0.3	0.0	1.8	0.0	3.9	0.1	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.1	0.5	3.5	0.0	0.0	0.0	0.4	0.6	0.0	0.6	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.4	0.0	0.3	0.2	6.1	0.2	0.0	1.7	0.9	0.0	0.2	0.2	0.3	0.0	0.1	0.9	0.4	0.2	0.7	0.4	0.3	0.7	0.2	0.2	0.4	0.3	0.1	0.1	0.6	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.1	1.0	2.2	1.2	0.4	0.0	0.1	0.4	0.0	0.3	1.8	0.0	0.0	0.0	2.6	0.0	1.0	0.0	0.8	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	10.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	3.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.1	0.8	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 29.9;granulocytes: 38.7;Langerhans cells: 33.7;Macrophages: 28.8;monocytes: 115.6;Plasma cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 899.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 899.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.9;Karpas-707: 26.0;U-266/70: 34.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA012369, HPA070778"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Plasma membrane"		"HPA012369: AB_1858095, HPA070778: "	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	7.6	10.9	6.1	19.5	6.8	14.4	6.2	6.0	9.3	4.9	6.0	6.5	6.1	3.4	5.5	4.0	6.4	6.1	4.5	5.9	11.1	14.0	49.9	11.3	33.0	9.1	6.8	4.4	9.3	1.4	5.5	4.5	7.4	6.2	6.4	4.6	7.8	1.5	4.5	4.4	13.2	4.4	5.6	28.6	7.9	6.7	7.1	12.6	7.2	2.1	23.2	7.3	3.5	7.5	2.2	10.0	3.5	8.3	1.1	1.7	2.0	1.5	1.1	1.8	4.7	3.0	2.4	4.0	3.2	0.7	0.6	1.6	2.0	2.1	0.9	3.3	5.0	15.0	3.4	9.1	2.8	1.7	32.9	2.7	1.3	3.5	0.8	0.6	1.9	7.7	4.9	26.0	0.5	7.4	5.1	16.7	1.6	9.4	2.7	6.0	3.3	8.3	1.7	3.2	2.4	4.5	3.4	2.4	1.8	1.3	3.4	7.8	0.5	4.2	2.0	2.6	4.0	34.0	7.5	2.8	4.9	5.8	3.0	147.9	190.9	184.1	94.2	167.7	106.6	169.3	107.3	88.8	253.2	172.1	95.8	77.0	208.6	144.9	125.3	899.7	136.3	139.5	6.1	6.8	6.0	9.3	5.9	11.1	9.1	6.8	7.4	5.6	7.1	7.5	0.3	0.0	13.5	2.6	24.5	0.6	0.3	0.0	0.0	0.4	1.3	1.3	1.2	1.5	5.0	0.0	0.0	0.6	29.9	1.2	1.9	1.9	0.0	0.8	0.6	0.8	3.0	6.1	0.3	4.2	1.8	0.9	1.1	0.7	38.7	0.6	2.2	20.3	14.6	0.0	0.4	1.8	0.0	15.7	33.7	0.6	0.0	28.8	5.4	1.9	115.6	2.7	12.3	2.5	1.0	1.4	0.3	0.0	42.1	0.2	0.9	10.8	3.6	0.4	0.0	1.0	0.9	0.4	0.5	1.9	0.9	0.3	20.8	0.4	2.4	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin like and fibronectin type III domain containing 1"	Q86VF2	1	201190824-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 186.3"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 103.8"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HeLa: 76.6"	"Group enriched"	"Detected in many"	7	"amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9"	"Low region specificity"	"Detected in some"			HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.9	0.6	0.1	0.0	10.4	15.1	0.0	0.9	0.2	0.3	1.2	0.6	0.1	0.1	0.5	0.1	0.1	0.2	0.2	7.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.3	186.3	0.3	0.0	0.8	0.0	0.0	0.1	2.5	0.4	0.0	14.6	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	76.6	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.2	0.6	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	22.1	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	103.8	0.7	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
IGHA1		ENSG00000211895	"Immunoglobulin heavy constant alpha 1"	P01876	14	105703995-105708665	"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9"	"Group enriched"	"Detected in many"	10	"B-cells: 17763.5;Plasma cells: 34095.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	203	"memory B-cell: 2571.8;naive B-cell: 1114.6"	"Lineage enriched"	"Detected in many"	284	"B-cells: 2571.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		130000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (8.87e-5)"	"unprognostic (5.36e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (3.81e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.83e-7)"	"unprognostic (8.10e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	200.6	41.7	1.4	1121.1	1.0	918.5	953.5	0.7	6.5	214.3	4.2	5973.6	7411.2	79.9	3.5	641.9	203.5	662.9	73.8	0.6	1.3	278.5	327.7	1305.3	1420.6	3.5	1.1	40.6	115.1	3.5	38.3	6.7	1.1	202.5	1338.5	0.0	8904.9	69.0	10.8	56.7	3788.8	69.5	1.4	6397.6	6664.9	23.2	1.0	131.0	447.3	0.4	1949.0	1616.2	302.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.8	0.0	0.0	3.6	0.0	0.0	0.0	17.4	0.0	3.7	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	4.1	14.4	5.5	0.0	0.0	3.8	4.3	34.7	0.0	0.0	9.7	22.3	2.6	0.0	0.0	0.0	0.0	1.6	5.1	0.0	3.9	4.2	3.2	78.2	24.0	2.2	0.0	2.4	0.0	3.8	3.0	0.6	1.3	0.3	1.0	2571.8	0.7	1.1	1.5	1114.6	0.4	1.0	9.0	0.9	0.9	1.7	1.0	508.3	1.4	1.0	0.7	6.5	0.6	1.3	3.5	1.1	1.1	1.4	1.0	1.9	11.8	131.4	783.5	0.0	17763.5	0.0	26.0	0.0	1.2	0.0	22.4	4.6	4.7	22.8	46.4	0.0	0.0	0.7	55.5	20.8	0.0	0.0	0.0	0.1	0.1	26.5	28.4	167.0	0.0	0.0	0.5	56.5	99.4	0.1	584.8	0.0	353.8	225.1	1.6	0.0	0.0	13.6	0.0	57.8	0.0	0.0	0.0	34.6	0.0	0.0	6.7	0.0	11.3	0.0	0.0	0.0	12.8	0.0	34095.8	33.2	0.0	1.4	16.0	0.0	0.0	2.0	13.6	0.0	0.0	0.8	0.0	6.0	2514.2	0.0	27.9	1.2
IGHA2		ENSG00000211890	"Immunoglobulin heavy constant alpha 2 (A2m marker)"	P01877	14	105583731-105588395	"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 5017.7;salivary gland: 3728.4"	"Group enriched"	"Detected in many"	22	"B-cells: 3713.4;Plasma cells: 10918.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	876	"memory B-cell: 279.6;naive B-cell: 123.8"	"Lineage enriched"	"Detected in single"	1214	"B-cells: 279.6"	"Group enriched"	"Detected in some"	42	"U-266/70: 181.9;U-266/84: 63.9"	"Not detected"	"Not detected"							"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		67000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (1.98e-9)"	"unprognostic (3.20e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.40e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.50e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.47e-1)"	24.3	3.7	0.0	14.2	0.0	12.4	329.7	0.0	0.0	47.6	0.0	5017.7	15.3	8.9	0.0	219.7	35.0	0.9	4.8	0.0	0.0	49.7	35.1	134.2	6.8	0.0	0.0	5.3	30.3	0.0	4.9	0.3	0.0	37.7	8.8	0.0	3728.4	0.1	2.1	17.8	2261.3	1.0	0.0	700.9	670.1	1.1	0.0	22.4	59.8	0.0	13.0	93.4	67.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.9	181.9	63.9	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	279.6	0.0	0.1	0.1	123.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	12.4	0.0	3713.4	0.0	2.4	0.0	2.8	0.0	1.4	0.3	1.2	5.7	0.6	0.0	0.0	0.1	3.2	3.7	0.0	0.0	0.0	0.0	0.0	15.6	8.5	56.2	0.0	0.0	0.0	8.0	10.7	0.0	15.2	0.0	78.9	6.0	0.3	0.0	0.0	2.9	0.0	10.8	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	10918.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	12.3	0.0	0.4	325.4	0.0	4.8	0.2
IGHD	"FLJ00382, FLJ46727, MGC29633"	ENSG00000211898	"Immunoglobulin heavy constant delta"	P01880	14	105836765-105845678	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 330.9"	"Group enriched"	"Detected in some"	47	"B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 58.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	63	"memory B-cell: 279.1;naive B-cell: 815.9"	"Lineage enriched"	"Detected in many"	93	"B-cells: 815.9"	"Group enriched"	"Detected in some"	7	"Daudi: 82.3;U-698: 95.8"									CAB012703	Approved				"Immunoglobulin genes"	NA	NA		14000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB012703: AB_10554307"	"prognostic favorable (1.49e-6)"	"unprognostic (1.84e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.30e-2)"	2.8	0.4	0.0	35.4	0.0	39.2	9.3	0.0	0.4	0.9	0.0	2.2	3.4	5.0	0.2	2.8	0.6	19.0	5.7	0.0	0.0	2.1	3.5	34.1	111.6	0.2	0.0	0.3	0.4	0.2	0.0	0.3	0.0	6.4	1.9	0.0	67.1	1.2	0.4	1.5	17.6	0.9	0.0	146.7	43.3	0.3	0.1	8.3	1.3	0.0	330.9	20.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	12.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	2.7	0.5	0.3	0.4	0.3	0.2	279.1	0.3	0.8	0.7	815.9	1.0	0.3	3.3	0.3	0.5	8.7	0.4	39.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	261.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	0.0	9.2	0.0	0.0	0.0	0.0	0.0	588.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	474.2	0.0	0.0	0.0
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11451.9;urinary bladder: 3998.0"	"Group enriched"	"Detected in many"	16	"B-cells: 3900.5;Plasma cells: 9883.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.7"	"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 766.8"	"Lineage enriched"	"Detected in many"	123	"B-cells: 766.8"	"Group enriched"	"Detected in many"	9	"Karpas-707: 157.8;U-698: 392.7"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	NA	NA		230000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.49e-9)"	"unprognostic (3.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.61e-2)"	526.0	696.8	0.7	1661.1	0.6	681.1	203.2	0.5	4.5	518.2	2.8	302.1	103.7	210.6	18.4	334.4	661.5	312.9	143.2	0.4	2.2	491.7	356.1	962.4	3281.1	4.7	3.2	407.0	38.5	7.9	35.8	2.3	2.3	209.8	85.1	0.3	391.6	250.8	13.1	28.5	1008.8	27.6	12.7	11451.9	608.9	172.8	1.2	1773.7	1277.9	0.1	5826.8	3998.0	267.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	8.4	0.0	5.3	0.0	0.0	0.0	22.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	157.8	0.0	0.0	1.7	2.1	2.6	0.0	0.0	2.9	15.1	3.7	0.0	0.0	18.2	17.0	3.1	0.0	0.0	0.0	0.0	0.2	10.8	0.0	3.2	3.3	4.5	4.9	0.3	392.7	0.1	3.7	0.0	0.2	0.3	0.1	0.3	0.0	0.2	766.8	0.6	0.3	0.4	134.9	0.0	0.1	6.2	0.1	0.1	0.1	0.2	96.2	0.7	0.6	0.5	4.5	0.4	2.2	4.7	3.2	2.3	12.7	1.2	1.8	2.9	73.7	378.5	0.0	3900.5	0.0	8.1	0.0	0.0	0.0	0.5	0.0	2.8	22.8	9.3	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.5	0.0	0.1	8.5	13.9	83.4	0.0	0.0	0.0	13.6	8.2	0.0	209.4	0.0	46.1	52.9	0.1	0.0	0.0	5.0	0.0	62.8	0.0	0.9	0.0	9.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	5.4	0.0	9883.3	9.1	0.0	10.9	1.5	0.1	0.0	0.0	1.5	1.9	1.0	0.0	0.0	0.0	415.6	0.0	13.6	0.1
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4319.4"	"Group enriched"	"Detected in some"	8	"B-cells: 2050.1;Plasma cells: 2918.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	447	"memory B-cell: 339.0;naive B-cell: 119.3"	"Lineage enriched"	"Detected in single"	661	"B-cells: 339.0"	"Group enriched"	"Detected in some"	4	"RH-30: 9.6;RPMI-8226: 25.1"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		250000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"prognostic favorable (3.53e-4)"	"unprognostic (6.88e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (3.30e-6)"	"unprognostic (1.06e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (4.72e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.40e-2)"	109.5	11.0	1.3	170.0	1.4	34.8	56.0	0.2	4.1	59.9	0.8	202.8	7.5	55.8	0.8	90.2	51.5	20.7	15.2	0.2	1.1	157.5	98.2	171.0	65.4	0.9	0.2	16.3	8.0	0.1	8.2	0.0	0.5	64.2	9.4	0.0	201.2	1.2	3.5	13.3	330.7	1.0	1.5	4319.4	87.2	2.3	0.3	16.7	134.4	0.0	226.0	100.4	104.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	25.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	339.0	0.5	0.0	0.3	119.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.5	1.3	1.4	0.2	4.1	0.2	1.1	0.9	0.2	0.5	1.5	0.3	1.8	0.2	54.5	305.3	0.0	2050.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	2.8	13.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	4.1	0.0	32.5	0.0	0.0	0.0	3.1	0.0	0.0	126.1	0.0	8.2	5.1	0.1	0.0	0.0	0.9	0.0	12.4	0.0	0.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2918.6	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.1	305.5	0.0	0.7	0.0
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2478.2"	"Group enriched"	"Detected in some"	10	"B-cells: 964.5;Plasma cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 122.7;naive B-cell: 73.7"	"Lineage enriched"	"Detected in single"	571	"B-cells: 122.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 339.7"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		170000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"unprognostic (7.29e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (4.58e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (9.09e-8)"	"unprognostic (2.84e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.72e-2)"	80.0	2.1	0.4	2478.2	0.6	42.2	5.8	0.5	1.0	33.9	0.3	40.6	85.5	10.8	0.2	401.2	28.5	101.3	19.2	0.3	0.4	44.0	43.7	49.4	136.5	0.6	0.4	3.9	4.2	0.5	1.9	0.2	1.3	31.2	44.3	0.1	16.4	4.1	0.8	4.7	186.2	1.8	1.1	831.6	57.4	2.2	0.4	49.9	108.3	0.0	872.5	588.7	29.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	43.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.6	339.7	0.0	0.0	3.5	3.7	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.3	1.5	0.6	0.1	57.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.7	0.0	0.0	0.1	73.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.6	0.4	0.6	0.5	1.0	0.3	0.4	0.6	0.4	1.3	1.1	0.4	0.3	1.3	6.4	118.8	0.0	964.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.0	8.6	3.7	0.0	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.0	0.4	2.5	27.8	26.7	0.0	0.0	0.0	4.3	0.0	0.0	50.4	0.0	16.4	36.7	0.0	0.0	0.0	10.5	0.0	51.9	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2099.3	0.2	0.0	10.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	152.3	0.0	12.8	0.1
IGHM		ENSG00000211899	"Immunoglobulin heavy constant mu"	P01871	14	105851705-105856218	"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 1315.0;lymphoid tissue: 4112.3"	"Group enriched"	"Detected in many"	14	"B-cells: 3757.1;Plasma cells: 9906.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	16	"memory B-cell: 4278.4;naive B-cell: 6731.2"	"Lineage enriched"	"Detected in all"	19	"B-cells: 6731.2"	"Group enriched"	"Detected in many"	9	"Daudi: 4983.6;U-698: 4905.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB008643	Uncertain				"Immunoglobulin genes"	NA	NA		110000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008643: AB_1617732"	"unprognostic (2.91e-3)"	"prognostic favorable (6.49e-4)"	"unprognostic (9.30e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.70e-6)"	"unprognostic (9.61e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.28e-3)"	52.0	9.0	0.4	373.7	0.4	395.3	56.6	0.2	1.7	67.9	1.8	446.8	1204.9	11.1	10.2	66.8	38.5	141.7	50.5	0.2	0.4	48.4	84.7	180.6	3192.1	1.9	0.3	9.7	44.5	0.6	8.7	3.6	0.7	15.1	201.4	0.0	325.1	6.1	2.7	1.7	1315.0	7.9	1.0	4112.3	528.9	70.9	0.7	117.3	37.0	0.7	497.1	128.0	10.5	0.5	4.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4983.6	2.9	0.0	0.0	0.8	0.0	0.0	0.0	21.6	0.0	3.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	1.7	28.7	1.2	0.0	0.0	580.2	2.2	6.9	0.0	0.0	4.0	5.8	3.0	0.5	1.2	0.0	0.2	3.8	6.5	0.0	13.8	1.2	2.5	1.5	1.5	4905.9	0.0	2.4	0.0	10.8	5.4	5.6	3.1	1.2	2.3	4278.4	5.5	6.8	5.4	6731.2	4.5	3.8	25.4	11.4	4.5	346.1	11.4	815.2	0.4	0.4	0.2	1.7	0.2	0.4	1.9	0.3	0.7	1.0	0.7	0.5	1.0	38.5	254.5	0.0	3757.1	0.0	0.2	0.0	1.2	0.0	2.2	0.8	0.3	31.5	14.2	0.0	0.0	0.0	63.8	1.8	0.0	0.0	0.0	0.0	0.1	4.2	6.7	474.1	0.0	0.0	0.0	10.8	27.5	0.0	152.6	0.0	56.7	147.9	0.1	0.0	0.0	2.2	0.0	158.1	0.0	0.0	0.0	12.4	0.0	0.0	5.2	0.0	11.3	0.0	0.0	0.0	1.2	0.0	9906.5	0.3	0.0	2.2	1.5	0.0	0.0	0.4	16.8	0.0	0.0	0.2	0.0	0.0	415.0	0.3	4.1	0.1
IGHV5-10-1	IGHV5-A	ENSG00000282651	"Immunoglobulin heavy variable 5-10-1"	A0A0J9YXX1	14	106107972-106108464	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 316.6;lymphoid tissue: 568.1"	"Cell type enriched"	"Detected in single"	36	"B-cells: 3.6"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"memory B-cell: 74.8;naive B-cell: 66.7"	"Lineage enriched"	"Detected in many"	16	"B-cells: 74.8"	"Group enriched"	"Detected in some"	6	"Daudi: 9.4;U-698: 4.8"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA006014: "																		4.5	28.4	0.0	229.8	0.0	38.7	102.0	0.0	0.9	68.9	0.1	274.0	0.9	10.8	0.0	111.5	20.0	92.5	6.2	0.0	0.0	5.5	7.3	128.3	121.2	0.1	0.0	54.0	5.7	0.4	0.3	0.2	0.2	6.9	316.6	0.0	75.5	19.0	0.1	1.6	51.6	10.9	0.0	203.8	148.3	0.1	0.0	39.3	7.3	0.0	568.1	196.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	4.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	66.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV5-51		ENSG00000211966	"Immunoglobulin heavy variable 5-51"	A0A0C4DH38	14	106578744-106579236	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3"	"Cell type enriched"	"Detected in some"	87	"Plasma cells: 5993.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		2700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA006014: "	"unprognostic (2.03e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.80e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.17e-1)"	20.0	4.8	0.3	0.0	0.0	0.0	25.9	0.1	1.7	17.8	0.7	245.7	0.0	8.6	6.3	19.1	15.2	27.1	2.1	0.1	0.7	15.4	15.0	56.2	0.0	0.9	0.0	8.8	17.1	1.0	2.2	0.6	0.2	11.2	0.0	0.0	224.5	0.0	0.7	3.2	144.8	1.7	0.6	547.1	99.9	4.8	0.1	0.0	25.6	0.0	0.0	353.3	14.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	1.3	1.2	0.8	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.7	0.1	0.7	0.9	0.0	0.2	0.6	0.1	1.3	0.0	0.0	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	44.9	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5993.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0
IGIP	"C5orf53, LOC492311"	ENSG00000182700	"IgA inducing protein"	A6NJ69	5	140125937-140129392	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 55.4"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.7;ASC TERT1: 13.1"	"Low region specificity"	"Detected in all"							"HPA041877, HPA048615"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA041877: AB_2677721, HPA048615: AB_2680462"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.94e-1)"	"prognostic favorable (6.25e-6)"	"unprognostic (2.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.98e-2)"	"unprognostic (7.77e-2)"	8.3	8.9	43.6	2.9	41.0	0.1	7.7	38.9	55.4	12.7	29.7	14.1	3.7	9.2	9.0	6.3	8.9	3.7	11.8	38.3	40.9	9.3	10.0	9.4	4.5	41.5	43.8	9.9	8.4	13.7	18.6	4.2	43.9	12.0	3.8	19.5	8.0	8.1	10.4	9.0	8.3	4.6	45.7	7.8	9.2	4.0	45.1	4.2	11.9	9.2	3.9	10.7	11.6	40.8	2.0	0.6	0.9	2.8	13.7	13.1	1.3	5.1	5.0	1.1	1.5	2.0	1.6	3.8	5.3	6.9	0.6	2.1	1.1	3.1	2.3	3.4	1.9	0.8	3.0	1.5	3.2	1.0	1.3	4.5	7.7	2.2	4.2	8.6	1.4	2.8	0.6	1.5	4.4	1.8	1.2	2.6	0.2	1.6	1.5	1.2	2.4	1.7	6.6	1.8	1.0	1.5	2.8	1.8	3.1	1.0	1.4	3.0	8.8	3.5	0.3	1.2	2.8	3.6	2.5	1.3	3.7	2.6	2.6	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.2	0.0	43.6	41.0	38.9	55.4	38.3	40.9	41.5	43.8	43.9	45.7	45.1	40.8	6.5	12.8	5.1	14.0	2.3	2.0	2.1	3.2	0.0	21.3	4.5	3.7	14.4	8.6	5.4	3.7	14.6	2.5	1.4	5.5	0.0	3.3	1.9	2.4	3.5	5.4	9.0	0.0	22.2	1.8	1.5	4.4	3.6	2.2	8.2	3.0	7.9	5.9	1.0	28.6	19.8	4.2	0.0	2.2	1.3	1.3	6.5	2.2	7.2	14.0	3.9	5.9	3.1	9.5	17.6	2.8	4.4	17.0	1.3	3.7	7.8	4.2	6.1	8.8	0.0	11.2	5.5	2.4	1.3	1.7	4.0	1.8	1.9	2.8	4.0	2.2
IGKC	HCAK1	ENSG00000211592	"Immunoglobulin kappa constant"		2	88857161-88857683	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"intestine: 35196.7;lymphoid tissue: 63075.6"	"Group enriched"	"Detected in many"	12	"B-cells: 72318.1;Plasma cells: 96515.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	21	"memory B-cell: 39143.0;naive B-cell: 35081.5"	"Lineage enriched"	"Detected in all"	23	"B-cells: 39143.0"	"Group enriched"	"Detected in many"	6	"Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB015377	Uncertain				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB015377: AB_2251264"	"prognostic favorable (6.59e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.82e-3)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (2.17e-9)"	"unprognostic (1.85e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.59e-1)"	1025.4	2379.8	13.1	20500.0	13.3	6315.2	11287.7	11.3	33.6	3649.2	26.7	35196.7	24515.5	877.3	474.1	5708.4	1137.6	5995.3	810.4	11.4	16.7	1176.6	1580.5	5824.2	21356.1	25.1	18.2	2214.9	462.9	72.6	101.8	22.2	15.3	843.6	30618.3	4.0	19606.1	2123.2	32.9	250.8	17061.1	1259.7	43.5	26904.1	22740.5	1083.9	13.4	8576.0	2151.1	8.1	63075.6	24817.5	705.0	20.2	17.1	0.0	0.0	0.0	0.0	0.0	103.7	0.0	0.0	0.1	0.0	0.0	0.0	9909.1	15.3	0.0	1.0	22.2	0.0	0.0	0.0	510.2	0.0	30.9	0.0	0.0	0.0	67.8	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.4	0.0	0.0	18.3	83.2	28.8	0.0	0.0	16.7	56.4	1509.5	0.6	0.0	79.6	146.1	19.6	1.5	6.0	0.5	0.5	17.2	66.7	0.0	56.9	24.3	44.0	10337.6	3927.9	12154.4	0.0	28.9	0.0	47.5	55.6	31.6	24.6	11.2	21.7	39143.0	28.3	18.3	46.6	35081.5	15.2	16.8	65.2	24.1	29.1	1735.4	23.7	8567.0	13.1	13.3	11.3	33.6	11.4	16.7	25.1	18.2	15.3	43.5	13.4	20.2	58.6	336.5	1863.8	0.0	72318.1	0.0	189.2	0.0	2.2	0.0	8.8	7.0	5.7	163.0	88.5	0.0	0.0	48.0	452.1	39.8	3.9	0.0	2.8	0.7	0.3	72.8	77.8	1658.9	0.0	0.2	37.3	186.5	64.7	0.4	849.0	15.5	340.2	334.8	8.9	0.0	0.0	35.1	0.0	496.3	0.0	11.0	0.0	64.4	0.0	0.0	26.4	0.0	59.8	0.0	0.0	0.0	25.9	0.4	96515.7	193.2	0.3	45.2	12.4	0.0	0.0	3.7	38.4	0.3	0.2	5.9	0.0	49.4	6505.3	0.1	50.2	1.9
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 395.8;lymphoid tissue: 788.8"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	13.6	144.8	0.0	201.7	0.2	73.1	116.8	0.0	0.4	50.8	0.2	395.8	240.6	7.3	0.0	57.1	16.2	69.6	9.9	0.1	0.1	13.7	17.8	65.3	238.6	0.6	0.0	18.1	7.2	0.2	1.4	0.0	1.1	7.2	278.6	0.0	219.0	5.4	0.4	2.8	231.2	11.2	1.2	360.5	254.9	6.7	0.0	69.5	32.7	0.0	788.8	243.3	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.0	0.2	0.0	0.4	0.1	0.1	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	11.8	4.7	0.1	159.1	0.1	40.0	75.9	0.0	0.8	76.0	0.6	279.7	199.4	6.3	0.5	34.3	6.6	99.0	11.4	0.0	0.1	9.2	14.9	40.5	155.0	0.2	0.0	17.7	2.0	0.1	3.6	0.1	0.1	5.6	235.6	0.0	126.9	30.9	0.8	0.7	143.6	11.8	0.1	315.4	158.9	2.0	0.1	45.7	18.4	0.0	597.8	260.3	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 375.0;lymphoid tissue: 454.4"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	12.8	26.5	0.1	183.7	0.2	27.7	87.1	0.0	0.7	11.9	0.4	358.5	294.8	6.6	4.1	54.7	12.4	55.7	10.9	0.0	0.1	10.3	14.2	36.5	95.7	0.6	0.0	12.4	3.3	1.1	1.0	0.1	0.2	5.5	375.0	0.0	134.3	31.0	1.3	1.2	152.7	4.7	0.1	306.1	159.7	2.4	0.3	45.6	25.8	0.0	454.4	182.6	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.6	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-27	"A20, IGKV127"	ENSG00000244575	"Immunoglobulin kappa variable 1-27"	A0A075B6S5	2	89213423-89213928	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0;lymphoid tissue: 347.1;salivary gland: 177.6"	"Cell type enriched"	"Detected in some"	126	"Plasma cells: 4951.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	683	"memory B-cell: 152.7;naive B-cell: 185.3"	"Lineage enriched"	"Detected in single"	748	"B-cells: 185.3"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.8"					"Not detected"	"Not detected"			HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.56e-5)"	"unprognostic (6.50e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (8.84e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.67e-2)"	17.2	9.2	0.0	133.5	0.0	28.5	70.0	0.0	0.4	16.8	0.1	268.0	183.3	6.2	7.7	30.4	6.9	37.5	10.7	0.1	0.1	11.8	9.7	55.2	124.7	0.7	0.3	8.8	4.9	0.2	1.0	0.0	0.1	6.4	212.3	0.0	177.6	8.8	0.6	0.9	200.2	5.1	0.2	276.9	91.9	1.0	0.0	46.9	19.4	0.0	347.1	87.7	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	152.7	0.1	0.1	0.1	185.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	15.8	0.0	0.0	0.0	0.4	0.1	0.1	0.7	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	12.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4951.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Region enriched"	"Detected in many"	7	"spinal cord: 12.0"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	50.5	21.9	0.1	266.2	0.5	139.5	320.5	0.6	1.0	129.8	0.4	471.5	296.2	20.7	2.8	106.2	33.4	187.2	23.2	0.2	1.6	36.7	37.9	130.4	529.5	0.4	1.0	37.0	8.3	1.9	2.7	0.4	0.7	18.7	511.9	0.2	476.4	127.7	0.7	2.5	175.9	14.5	12.0	820.8	627.3	13.5	0.2	381.9	53.9	0.2	1727.5	623.3	26.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.1	0.5	0.6	1.0	0.2	1.6	0.4	1.0	0.7	12.0	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-37	"IGKV137, O14"	ENSG00000239862	"Immunoglobulin kappa variable 1-37 (non-functional)"	A0A075B6S9	2	89297264-89297785	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.2;lymphoid tissue: 17.2;urinary bladder: 5.6"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 73.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	247	"memory B-cell: 21.2;naive B-cell: 28.2"	"Lineage enriched"	"Detected in single"	283	"B-cells: 28.2"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "								"unprognostic (3.47e-1)"						"unprognostic (1.17e-1)"				0.1	0.2	0.0	2.9	0.0	0.8	2.4	0.0	0.0	0.5	0.0	4.5	3.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.4	1.2	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	2.6	0.6	0.0	0.0	2.0	0.2	0.0	3.7	1.5	0.0	0.0	0.9	0.1	0.0	17.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	10.9	9.1	0.0	54.7	0.1	14.2	17.7	0.0	0.1	21.8	0.0	108.5	70.5	5.7	0.0	11.6	12.5	14.3	1.5	0.2	0.0	10.9	6.8	27.2	36.5	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.2	4.2	13.3	0.0	151.2	0.9	0.2	1.3	74.4	1.2	0.0	254.9	83.2	0.3	0.0	5.9	31.0	0.0	42.5	17.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-5		ENSG00000243466	"Immunoglobulin kappa variable 1-5"	P01602	2	88947301-88947957	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2"	"Cell type enriched"	"Detected in some"	240	"Plasma cells: 39194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	364	"memory B-cell: 859.0;naive B-cell: 860.5"	"Lineage enriched"	"Detected in many"	364	"B-cells: 860.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.19e-4)"	"unprognostic (1.26e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (7.60e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (4.36e-8)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-2)"	35.8	82.0	0.2	639.7	0.2	115.4	233.9	0.1	1.6	115.8	0.6	777.1	528.7	17.1	2.0	146.2	86.9	124.8	18.7	0.1	0.5	36.2	32.0	125.3	387.2	1.0	0.2	60.8	10.8	0.5	3.0	0.4	0.3	16.7	745.0	0.0	392.2	34.8	0.9	3.2	429.7	24.4	1.3	915.4	456.3	11.5	0.2	155.3	58.4	0.0	1459.2	945.2	28.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	1.6	0.5	0.0	0.0	0.3	1.0	5.0	0.0	0.0	2.9	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.7	0.4	0.6	0.1	0.4	0.0	0.6	0.0	0.7	1.2	1.3	0.5	0.2	0.4	859.0	2.3	0.3	1.0	860.5	0.2	0.3	1.4	0.4	0.6	0.7	0.6	113.5	0.2	0.2	0.1	1.6	0.1	0.5	1.0	0.2	0.3	1.3	0.2	0.5	0.0	0.0	0.6	0.0	163.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	7.0	89.7	0.0	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39194.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	11.8	0.0	0.2	0.0
IGKV1-6		ENSG00000239855	"Immunoglobulin kappa variable 1-6"	A0A0C4DH72	2	88966262-88966767	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 155.5;lymphoid tissue: 606.3"	"Cell type enriched"	"Detected in some"	33	"Plasma cells: 877.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	801	"memory B-cell: 123.6;naive B-cell: 85.7"	"Lineage enriched"	"Detected in single"	946	"B-cells: 123.6"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.44e-5)"	"unprognostic (5.25e-3)"	"unprognostic (3.78e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.86e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (5.23e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.54e-1)"	8.2	1.7	0.1	84.1	0.1	37.0	50.3	0.0	0.4	16.5	0.1	155.5	110.5	4.0	4.1	23.5	5.0	18.1	5.3	0.0	0.0	7.7	6.3	20.0	82.3	0.1	0.1	4.0	1.8	0.0	1.1	0.0	0.0	4.3	145.9	0.0	95.0	2.2	0.2	0.6	59.1	5.1	0.2	209.5	130.3	0.7	0.0	22.7	16.4	0.0	606.3	144.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	123.6	0.0	0.0	0.1	85.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.1	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	877.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
IGKV1-8	"IGKV18, L9"	ENSG00000240671	"Immunoglobulin kappa variable 1-8"	A0A0C4DH67	2	88992409-88992931	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 29.7;lymphoid tissue: 55.0;salivary gland: 21.2;stomach 1: 18.6;urinary bladder: 41.7"	"Cell type enriched"	"Detected in some"	40	"Plasma cells: 622.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	311	"memory B-cell: 131.0;naive B-cell: 136.4"	"Lineage enriched"	"Detected in single"	317	"B-cells: 136.4"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6100000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.64e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.41e-3)"		"prognostic favorable (5.13e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (4.14e-7)"	"unprognostic (6.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.98e-1)"	2.1	2.5	0.0	13.5	0.0	7.1	6.7	0.0	0.1	2.0	0.0	29.7	12.0	1.3	0.0	2.9	1.4	5.4	1.5	0.0	0.0	3.3	2.1	4.8	13.7	0.0	0.0	0.5	0.9	0.0	0.1	0.0	0.0	1.4	19.3	0.0	21.2	0.7	0.0	0.1	13.9	0.6	0.0	51.3	18.6	0.3	0.0	7.0	3.3	0.0	55.0	41.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	131.0	0.0	0.4	0.1	136.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0
IGKV1-9	"IGKV19, L8"	ENSG00000241755	"Immunoglobulin kappa variable 1-9"	A0A0C4DH69	2	89009982-89010515	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 7178.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	705	"memory B-cell: 300.5;naive B-cell: 296.8"	"Lineage enriched"	"Detected in single"	709	"B-cells: 300.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.10e-7)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.70e-2)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.04e-8)"	"unprognostic (4.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.40e-1)"	12.6	12.6	0.2	184.3	0.4	53.6	202.8	0.0	1.3	15.8	0.4	428.1	267.0	8.3	0.8	52.9	78.3	30.0	13.9	0.1	0.1	15.4	17.9	40.1	201.8	0.3	0.1	20.7	2.5	0.5	1.3	0.1	0.2	12.8	348.6	0.0	221.3	13.3	0.5	1.6	182.8	13.3	0.4	313.1	283.7	35.1	0.1	85.1	34.2	0.0	671.3	187.5	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	300.5	0.1	0.0	0.3	296.8	0.0	0.1	0.3	0.2	0.2	0.1	0.3	34.5	0.2	0.4	0.0	1.3	0.1	0.1	0.3	0.1	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7178.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0
IGKV1D-12		ENSG00000278857	"Immunoglobulin kappa variable 1D-12"	P01611	2	90159840-90160335	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.6;lymphoid tissue: 47.5;salivary gland: 34.6"	"Cell type enriched"	"Detected in some"	178	"Plasma cells: 232.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"memory B-cell: 13.0;naive B-cell: 12.2"	"Lineage enriched"	"Detected in single"	35	"B-cells: 13.0"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (1.94e-4)"	"unprognostic (9.04e-4)"	"unprognostic (3.42e-2)"			"prognostic favorable (3.23e-4)"		"unprognostic (3.09e-2)"		"unprognostic (4.66e-2)"	"unprognostic (1.34e-1)"		"unprognostic (1.33e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	1.7	0.3	0.0	9.6	0.0	0.9	7.6	0.0	0.2	3.0	0.0	26.6	1.6	1.3	0.0	2.2	1.8	0.0	0.3	0.0	0.0	1.7	1.0	11.6	12.5	0.1	0.0	0.2	0.4	0.0	0.2	0.1	0.1	1.1	9.1	0.0	34.6	0.3	0.1	0.2	22.7	5.5	0.0	47.5	9.5	0.2	0.0	1.3	4.0	0.0	9.4	2.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.1	12.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-13		ENSG00000276566	"Immunoglobulin kappa variable 1D-13"	"A0A0B4J2D9, P0DP09"	2	90154073-90154574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 103.7;lymphoid tissue: 317.6"	"Cell type enriched"	"Detected in some"	141	"Plasma cells: 6195.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	733	"memory B-cell: 480.8;naive B-cell: 331.6"	"Lineage enriched"	"Detected in single"	868	"B-cells: 480.8"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		370000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (4.68e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.71e-3)"		"unprognostic (3.01e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.60e-2)"	4.8	0.4	0.0	101.2	0.0	34.8	34.3	0.0	0.0	46.6	0.0	85.6	21.7	5.4	0.0	17.9	10.2	2.5	3.5	0.0	0.0	8.1	6.4	39.4	317.6	0.0	0.0	1.0	1.9	0.0	0.4	0.0	0.1	3.1	78.3	0.0	54.2	1.4	0.0	1.1	103.7	6.8	0.0	102.8	20.3	2.7	0.0	29.0	7.2	0.0	223.2	45.9	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.1	0.2	480.8	0.2	0.1	0.5	331.6	0.0	0.0	0.4	0.1	0.1	0.2	0.1	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6195.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-16		ENSG00000241244	"Immunoglobulin kappa variable 1D-16"	P01601	2	90100236-90100738	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 79.1;intestine: 92.0;lymphoid tissue: 165.5"	"Cell type enriched"	"Detected in some"	249	"Plasma cells: 1994.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 17.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	327	"memory B-cell: 57.6;naive B-cell: 120.1"	"Lineage enriched"	"Detected in single"	442	"B-cells: 120.1"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		9000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.41e-4)"	"unprognostic (4.41e-3)"	"unprognostic (3.96e-3)"	"unprognostic (5.39e-2)"		"unprognostic (1.35e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (4.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.84e-1)"	2.4	0.4	0.0	30.2	0.0	15.0	18.9	0.0	0.4	11.0	0.1	92.0	39.0	1.6	0.0	13.8	2.5	79.1	1.3	0.0	0.0	1.7	3.9	10.0	27.5	0.0	0.0	2.5	0.9	0.6	0.1	0.0	0.1	3.6	50.3	0.0	30.3	0.9	0.0	0.2	34.4	1.0	0.3	56.6	26.7	0.4	0.0	9.9	2.7	0.0	165.5	23.5	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.1	120.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1994.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGKV1D-17		ENSG00000242766	"Immunoglobulin kappa variable 1D-17"	A0A075B6S4	2	90082635-90083291	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 6.8;lymphoid tissue: 12.5;salivary gland: 5.7"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 7.7;naive B-cell: 4.1"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.47e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.44e-1)"		"prognostic favorable (5.68e-4)"		"unprognostic (1.19e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.04e-3)"	1.3	0.1	0.1	5.1	0.1	0.9	0.8	0.1	0.2	0.3	0.8	6.8	1.5	0.2	0.0	0.5	0.8	0.6	0.0	0.1	0.1	0.3	0.4	1.5	0.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	2.2	0.0	5.7	0.3	0.0	0.4	4.7	0.4	0.1	12.5	2.0	0.0	0.1	0.3	0.5	0.0	4.5	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-33		ENSG00000239975	"Immunoglobulin kappa variable 1D-33"	P01593	2	89913982-89916052	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;lymphoid tissue: 63.0;salivary gland: 73.3"	"Cell type enriched"	"Detected in some"	410	"Plasma cells: 5131.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	116	"memory B-cell: 6.3;naive B-cell: 16.8"	"Lineage enriched"	"Detected in single"	169	"B-cells: 16.8"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4900000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (5.10e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.11e-2)"			"unprognostic (2.03e-4)"		"unprognostic (7.90e-2)"		"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"			"unprognostic (4.54e-2)"	"unprognostic (4.23e-2)"			2.8	0.5	0.0	3.8	0.1	2.3	8.3	0.0	0.1	3.6	0.1	32.7	1.3	1.4	0.0	4.6	2.7	2.6	0.2	0.2	0.2	4.0	2.2	17.9	6.8	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	1.6	2.0	0.0	73.3	8.6	0.0	0.5	19.1	0.0	0.5	63.0	21.2	0.1	0.0	4.7	3.3	0.2	9.1	16.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5131.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
IGKV1D-37	"IGKV1D37, O4"	ENSG00000250036	"Immunoglobulin kappa variable 1D-37 (non-functional)"	P0DSN7	2	89884740-89885216	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.7;stomach 1: 15.0;urinary bladder: 20.1"	"Cell type enriched"	"Detected in single"	11	"Plasma cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	209	"memory B-cell: 13.6;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	284	"B-cells: 29.1"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 2.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "														"unprognostic (2.68e-1)"				0.1	0.0	0.0	4.2	0.0	3.3	2.4	0.0	0.0	0.8	0.0	8.6	12.7	0.1	0.4	2.1	0.2	0.5	0.2	0.4	0.0	0.1	0.4	0.8	4.1	0.0	0.1	0.4	1.2	0.0	0.0	0.1	0.0	0.7	1.0	0.0	7.1	0.0	0.2	0.0	6.0	0.2	0.0	6.5	15.0	0.2	0.0	1.1	0.1	0.0	2.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-39		ENSG00000251546	"Immunoglobulin kappa variable 1D-39"	P04432	2	89862482-89862981	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2922.1;lymphoid tissue: 6491.8;stomach 1: 2259.8"	"Cell type enriched"	"Detected in some"	298	"Plasma cells: 7890.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	226	"memory B-cell: 470.5;naive B-cell: 733.0"	"Lineage enriched"	"Detected in many"	275	"B-cells: 733.0"	"Group enriched"	"Detected in some"	36	"Daudi: 731.4;U-698: 516.7"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.88e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.14e-3)"			"prognostic favorable (5.99e-5)"		"unprognostic (3.84e-1)"		"unprognostic (4.34e-2)"	"unprognostic (1.28e-1)"			"unprognostic (9.06e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-1)"	147.3	181.1	0.6	1609.8	0.8	466.1	990.4	0.5	4.2	369.0	2.1	2922.1	2055.2	80.0	52.5	611.3	132.1	629.8	87.5	0.4	2.0	82.3	171.8	685.1	1968.9	2.6	0.8	214.9	26.5	3.5	5.5	1.3	3.6	80.9	2261.1	0.4	1229.7	148.4	2.3	33.2	1255.9	88.7	4.2	1712.0	2259.8	27.6	1.3	770.5	209.3	0.0	6491.8	1816.1	46.9	2.5	0.3	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	731.4	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	5.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.3	6.6	2.4	0.0	0.0	1.0	2.9	10.3	0.0	0.0	11.1	17.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	2.5	0.0	0.1	516.7	0.0	1.6	0.0	0.5	0.4	0.8	0.6	0.2	0.4	470.5	0.3	0.3	0.4	733.0	0.5	0.2	2.6	0.8	0.4	0.4	0.3	47.6	0.6	0.8	0.5	4.2	0.4	2.0	2.6	0.8	3.6	4.2	1.3	2.5	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7890.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	14.0	0.0	0.0	0.0
IGKV1D-42		ENSG00000211633	"Immunoglobulin kappa variable 1D-42 (non-functional)"	A0A075B6H8	2	90190193-90190681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.7;lymphoid tissue: 25.3"	"Cell type enriched"	"Detected in single"	93	"Plasma cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 5.6;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	57	"B-cells: 5.6"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.6"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		41000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (8.08e-6)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-2)"			"unprognostic (2.51e-3)"		"unprognostic (1.84e-1)"			"unprognostic (2.10e-2)"		"unprognostic (1.66e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.0	7.6	0.0	6.6	10.8	0.0	0.0	0.8	0.0	18.8	7.5	0.2	0.3	1.4	0.2	1.7	0.1	0.0	0.0	0.0	0.3	2.8	2.6	0.1	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.1	47.7	0.0	8.5	0.0	0.0	0.1	7.9	0.0	0.0	4.2	13.9	0.0	0.0	0.6	0.3	0.0	25.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-43		ENSG00000242580	"Immunoglobulin kappa variable 1D-43"	A0A0B4J1Z2	2	90209873-90210529	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.9;lymphoid tissue: 4.8;stomach 1: 3.6"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 695.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	152	"memory B-cell: 13.3;naive B-cell: 17.0"	"Lineage enriched"	"Detected in single"	171	"B-cells: 17.0"	"Cell line enriched"	"Detected in single"	310	"RPMI-8226: 79.1"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		380000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.32e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-2)"		"unprognostic (4.57e-3)"		"unprognostic (1.37e-3)"		"unprognostic (3.15e-1)"	"unprognostic (2.67e-2)"		"unprognostic (3.82e-5)"	"unprognostic (3.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.06e-1)"	0.2	0.0	0.0	2.8	0.0	1.3	1.4	0.0	0.0	0.0	0.0	2.7	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	2.0	0.2	0.0	0.0	2.9	0.0	0.0	1.8	3.6	0.0	0.0	0.5	0.1	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	695.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV1D-8		ENSG00000239819	"Immunoglobulin kappa variable 1D-8"	A0A087WSZ0	2	90220727-90221384	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 4.2;lymphoid tissue: 14.2;salivary gland: 5.6"	"Cell type enriched"	"Detected in some"	29	"Plasma cells: 338.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	323	"memory B-cell: 32.7;naive B-cell: 31.8"	"Lineage enriched"	"Detected in single"	328	"B-cells: 32.7"	"Cell line enriched"	"Detected in some"	26	"RPMI-8226: 38.3"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1900000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.93e-4)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.76e-3)"		"prognostic favorable (8.80e-5)"	"unprognostic (6.07e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.32e-1)"	0.5	0.0	0.0	5.3	0.0	0.7	1.2	0.0	0.0	0.6	0.0	4.2	1.6	0.1	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.3	0.3	1.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	2.6	0.0	5.6	0.0	0.0	0.0	2.8	0.0	0.0	8.3	1.9	0.0	0.0	1.2	0.6	0.0	14.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	338.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV1OR2-108	"IGKV1/OR2-108, IGKV1OR2108, IGO1"	ENSG00000231292	"Immunoglobulin kappa variable 1/OR2-108 (non-functional)"		2	113406396-113406872	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 38.2;lymphoid tissue: 56.7"	"Cell type enriched"	"Detected in single"	652	"Plasma cells: 65.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"memory B-cell: 13.5;naive B-cell: 12.2"	"Lineage enriched"	"Detected in single"	58	"B-cells: 13.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.6;HBEC3-KT: 7.2;hTEC/SVTERT24-B: 4.1;REH: 4.1"	"Not detected"	"Not detected"							HPA048721	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.53e-6)"	"unprognostic (2.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.37e-1)"		"unprognostic (3.64e-3)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.96e-6)"	"unprognostic (6.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.95e-1)"	0.5	1.4	0.1	23.3	0.4	11.2	16.7	0.0	0.3	4.8	5.6	38.2	21.8	0.3	0.0	6.8	0.4	5.5	0.2	0.8	0.0	0.1	1.4	6.9	14.0	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.9	22.1	0.1	15.2	0.5	0.1	4.8	13.9	0.8	0.0	12.7	16.9	0.0	0.1	3.8	1.3	0.0	56.7	21.7	0.1	0.0	2.1	0.7	0.3	0.0	0.0	0.0	0.4	0.0	2.2	0.3	1.5	3.0	1.2	6.6	0.0	0.9	1.1	0.3	0.0	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.1	2.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.6	0.4	0.0	1.6	4.1	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	1.3	0.2	0.2	0.1	1.2	0.1	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.1	0.4	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3-11		ENSG00000241351	"Immunoglobulin kappa variable 3-11"	P04433	2	89027171-89027731	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6"	"Cell type enriched"	"Detected in some"	129	"Plasma cells: 27475.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"spinal cord: 19.8"	"Group enriched"	"Detected in many"	292	"memory B-cell: 1729.8;naive B-cell: 1401.2"	"Lineage enriched"	"Detected in many"	323	"B-cells: 1729.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"unprognostic (3.97e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	45.8	60.5	0.4	733.2	0.3	189.1	385.3	0.2	2.1	136.2	0.6	1373.3	701.6	32.1	11.5	143.5	34.0	253.5	18.9	0.2	0.6	44.4	55.2	227.4	575.7	0.6	0.7	120.8	13.7	1.9	3.2	0.9	0.9	30.1	1090.9	0.1	496.0	60.9	1.2	14.2	536.0	59.5	19.8	1100.0	788.6	22.2	0.3	261.9	88.8	0.9	2812.9	1822.6	33.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.4	1.8	1.5	0.0	0.0	3.7	4.6	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.7	0.7	0.6	1.8	0.3	0.1	0.0	1.4	0.0	1.9	1.3	1.2	2.0	0.2	0.7	1729.8	0.8	0.6	1.6	1401.2	0.8	0.8	5.3	0.9	1.1	1.2	1.3	186.7	0.4	0.3	0.2	2.1	0.2	0.6	0.6	0.7	0.9	19.8	0.3	1.0	0.0	0.0	0.5	0.0	211.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	82.6	0.0	0.0	0.0	2.5	1.9	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27475.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	62.0	0.0	0.3	0.0
IGKV3-15		ENSG00000244437	"Immunoglobulin kappa variable 3-15"	P01624	2	89085177-89085787	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 22923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	561	"memory B-cell: 2243.8;naive B-cell: 1651.4"	"Lineage enriched"	"Detected in all"	646	"B-cells: 2243.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.57e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.02e-3)"	"unprognostic (3.89e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.06e-3)"	"unprognostic (5.36e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.17e-1)"	47.9	114.5	0.0	603.8	0.1	131.0	174.3	0.0	1.5	141.8	0.3	785.8	431.4	19.4	34.7	120.0	30.0	144.4	14.8	0.1	0.3	35.2	36.7	184.8	500.9	0.7	0.3	55.4	9.3	2.5	3.0	0.5	0.3	18.3	649.4	0.0	399.3	114.2	1.0	2.7	335.8	29.5	1.5	1020.7	629.8	64.8	0.2	250.2	77.7	0.0	1996.3	784.8	28.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	1.2	2.2	0.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.7	0.5	0.0	0.0	0.0	1.0	0.0	1.8	3.4	0.8	1.0	0.4	0.8	2243.8	1.0	1.1	1.8	1651.4	1.0	1.1	1.9	1.0	1.3	1.7	1.5	193.1	0.0	0.1	0.0	1.5	0.1	0.3	0.7	0.3	0.3	1.5	0.2	1.0	0.0	0.0	0.0	0.0	269.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.6	73.4	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22923.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.5	0.0	0.0	0.2	0.0	0.0	28.2	0.0	0.0	0.0
IGKV3-20		ENSG00000239951	"Immunoglobulin kappa variable 3-20"	P01619	2	89142574-89143160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3080.6;lymphoid tissue: 5246.5"	"Cell type enriched"	"Detected in some"	138	"Plasma cells: 52154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	329	"memory B-cell: 1602.7;naive B-cell: 1222.4"	"Lineage enriched"	"Detected in many"	373	"B-cells: 1602.7"	"Group enriched"	"Detected in many"	215	"U-266/70: 3769.9;U-266/84: 1732.3"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.86e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (7.35e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-2)"	104.8	56.4	0.9	1791.2	0.9	380.3	736.4	0.5	4.2	326.9	2.6	3080.6	1714.2	59.0	7.8	302.1	105.2	637.2	55.7	0.5	1.6	106.2	113.5	454.0	2815.6	2.1	8.4	153.5	32.8	5.8	9.6	1.8	1.4	56.1	2731.8	0.2	1270.5	224.5	3.3	13.4	1355.8	82.8	10.4	2699.1	1412.9	24.7	1.2	671.5	224.3	1.8	5246.5	1644.0	70.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	6.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.0	5.9	2.8	0.0	0.0	3.0	6.0	10.4	0.0	0.0	7.7	12.8	1.4	0.0	0.1	0.0	0.0	0.8	4.4	0.0	2.0	1.5	4.3	3769.9	1732.3	1.8	0.0	2.3	0.0	4.0	1.2	0.7	0.7	0.4	0.8	1602.7	0.8	0.6	3.5	1222.4	0.4	0.7	4.2	0.8	1.0	0.9	0.8	196.9	0.9	0.9	0.5	4.2	0.5	1.6	2.1	8.4	1.4	10.4	1.2	1.5	0.1	3.2	1.3	0.0	376.9	0.0	0.0	0.0	5.2	0.0	0.1	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.4	0.0	0.0	0.0	55.3	124.4	0.0	1.3	0.0	3.6	5.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	52154.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	26.7	0.0	0.2	0.0
IGKV3-7		ENSG00000243063	"Immunoglobulin kappa variable 3-7 (non-functional)"	A0A075B6H7	2	88978468-88979081	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.6;lymphoid tissue: 22.2;salivary gland: 15.9;stomach 1: 10.2"	"Group enriched"	"Detected in some"	37	"B-cells: 1.5;Plasma cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 27.8;naive B-cell: 24.3"	"Lineage enriched"	"Detected in single"	65	"B-cells: 27.8"	"Not detected"	"Not detected"											HPA047702	Approved				"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.17e-4)"	"unprognostic (3.07e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-2)"		"unprognostic (1.20e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	0.3	0.4	0.0	15.0	0.0	4.2	3.9	0.0	0.0	2.1	0.0	18.6	15.1	0.3	0.1	1.5	0.1	1.3	0.0	0.0	0.0	0.2	0.5	1.8	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	13.6	0.0	15.9	0.1	0.0	0.0	11.2	0.7	0.0	4.9	10.2	0.0	0.0	1.4	0.1	0.0	22.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	24.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3D-11		ENSG00000211632	"Immunoglobulin kappa variable 3D-11"	A0A0A0MRZ8	2	90172802-90173414	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7"	"Cell type enriched"	"Detected in some"	34	"Plasma cells: 196.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	468	"memory B-cell: 152.5;naive B-cell: 146.1"	"Lineage enriched"	"Detected in single"	478	"B-cells: 152.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.1"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.40e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.24e-3)"		"prognostic favorable (5.58e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.24e-2)"	1.3	0.7	0.3	35.9	0.2	8.9	6.4	0.0	0.1	1.7	0.0	38.6	32.2	0.8	0.0	2.4	2.1	2.7	0.5	0.0	0.1	2.1	1.3	12.4	13.0	0.1	0.3	1.5	0.5	0.0	0.1	0.0	0.1	0.7	26.6	0.0	18.8	0.3	0.0	0.1	23.6	0.7	0.2	29.9	27.7	0.2	0.0	4.2	2.3	0.0	58.5	17.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	152.5	0.0	0.0	0.1	146.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	30.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
IGKV3D-15		ENSG00000224041	"Immunoglobulin kappa variable 3D-15"	A0A087WSY6	2	90114838-90115402	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 126.7;lymphoid tissue: 203.0;salivary gland: 54.1;stomach 1: 87.4;urinary bladder: 58.0"	"Cell type enriched"	"Detected in some"	622	"Plasma cells: 3673.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	191	"memory B-cell: 181.1;naive B-cell: 155.6"	"Lineage enriched"	"Detected in single"	206	"B-cells: 181.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		4800000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.11e-4)"	"prognostic favorable (7.46e-4)"	"unprognostic (9.16e-3)"	"unprognostic (1.74e-1)"		"unprognostic (1.90e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.93e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (8.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	3.1	4.4	0.1	93.5	0.4	11.1	17.1	0.1	0.5	5.9	0.3	111.6	63.0	1.0	0.0	16.4	5.2	10.1	2.3	0.1	0.2	3.6	2.0	18.0	43.6	0.4	0.2	17.9	4.0	0.3	0.1	0.0	0.2	1.7	126.7	0.0	54.1	1.1	0.1	0.6	46.7	4.3	0.3	56.3	87.4	0.2	0.1	13.0	4.5	0.0	203.0	58.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	181.1	0.0	0.0	0.1	155.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	27.5	0.1	0.4	0.1	0.5	0.1	0.2	0.4	0.2	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3673.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKV3D-20		ENSG00000211625	"Immunoglobulin kappa variable 3D-20"	A0A0C4DH25	2	90038848-90039479	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 131.8;lymphoid tissue: 275.4"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 289.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	1042	"memory B-cell: 197.3;naive B-cell: 99.0"	"Lineage enriched"	"Detected in single"	1388	"B-cells: 197.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 19.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		11000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.82e-4)"	"unprognostic (4.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (7.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	4.0	6.3	0.0	81.2	0.0	16.0	32.4	0.0	0.6	12.2	0.1	131.8	55.9	2.7	0.0	15.3	4.2	16.2	6.4	0.0	0.1	3.0	6.4	20.6	73.5	0.2	0.1	7.1	3.3	0.0	0.3	0.1	0.1	3.7	88.1	0.0	64.0	3.3	0.1	2.6	77.7	6.0	0.3	88.4	82.5	1.2	0.0	16.2	5.2	0.0	275.4	38.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.5	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	197.3	0.0	0.1	0.1	99.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
IGKV3D-7		ENSG00000228325	"Immunoglobulin kappa variable 3D-7"	A0A0C4DH55	2	90234812-90235370	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.6;lymphoid tissue: 5.5;stomach 1: 4.4;urinary bladder: 5.5"	"Cell type enriched"	"Detected in single"	415	"Plasma cells: 207.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 2.8;naive B-cell: 4.3"	"Lineage enriched"	"Detected in single"	44	"B-cells: 4.3"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 48.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		3700000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "		"unprognostic (2.74e-1)"				"unprognostic (8.62e-3)"		"unprognostic (6.59e-2)"			"unprognostic (2.14e-1)"			"unprognostic (3.05e-1)"	"unprognostic (4.02e-1)"			0.1	0.0	0.0	5.5	0.2	1.3	0.1	0.0	0.1	0.2	0.0	4.0	4.6	0.0	0.0	1.9	0.1	1.5	0.0	0.1	0.1	0.0	0.2	0.5	1.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.1	0.0	0.0	4.4	0.0	0.0	3.8	4.4	0.0	0.1	0.2	0.6	0.0	4.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3OR2-268	"IGKV268, IGKV3/OR2-268, IGKV3/OR2-268A, IGKV3OR2-268A"	ENSG00000233999	"Immunoglobulin kappa variable 3/OR2-268 (non-functional)"		2	87338511-87339035	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 100.4;lymphoid tissue: 85.7"	"Cell type enriched"	"Detected in some"	302	"Plasma cells: 2604.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 220.0;naive B-cell: 78.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 220.0"	"Group enriched"	"Detected in some"	71	"U-266/70: 183.9;U-266/84: 593.2"									HPA047702	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (8.06e-4)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"			"prognostic favorable (1.41e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (2.80e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-1)"	0.4	1.3	0.3	45.8	0.4	11.8	28.5	0.1	0.6	3.4	0.2	100.4	33.9	0.9	0.0	1.3	0.7	24.7	1.3	0.3	0.4	0.6	2.6	7.5	23.8	0.3	0.2	3.3	1.2	0.0	0.0	0.1	0.2	1.6	59.5	0.0	29.4	1.6	0.0	0.6	27.7	4.1	0.1	19.3	34.0	0.4	0.2	10.3	1.2	0.0	85.7	24.4	0.8	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.5	0.2	183.9	593.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	220.0	2.8	0.1	0.1	78.9	0.0	0.1	0.1	0.1	0.0	0.2	30.0	32.7	0.3	0.4	0.1	0.6	0.3	0.4	0.3	0.2	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2604.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
IGLC3	IGLC	ENSG00000211679	"Immunoglobulin lambda constant 3 (Kern-Oz+ marker)"	P0DOY3	22	22906342-22906803	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4115.7;lymphoid tissue: 8175.8;stomach 1: 4130.0;urinary bladder: 3726.3"	"Group enriched"	"Detected in many"	35	"B-cells: 12202.8;Plasma cells: 5357.3;T-cells: 3582.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	34	"memory B-cell: 7254.6;naive B-cell: 6119.2"	"Lineage enriched"	"Detected in all"	37	"B-cells: 7254.6"	"Cell line enriched"	"Detected in many"	15	"RPMI-8226: 10741.3"									"CAB000050, CAB016533"	Supported				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB000050: , CAB016533: AB_629719"	"prognostic favorable (2.32e-4)"	"unprognostic (1.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.54e-2)"	"unprognostic (8.41e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.45e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.77e-2)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.04e-9)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.97e-2)"	156.2	550.9	2.6	2377.2	2.7	840.6	1388.6	1.4	9.1	220.4	7.1	4115.7	4046.3	115.2	33.2	508.5	88.0	707.7	63.7	1.3	2.8	178.6	171.7	1081.6	2745.8	7.2	1.4	247.8	47.6	7.0	19.0	3.2	2.0	134.0	2268.4	0.3	2264.0	177.1	5.8	20.7	2373.2	113.9	3.4	4261.5	4130.0	55.4	2.1	426.9	232.0	0.9	8175.8	3726.3	111.5	6.4	0.6	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	60.1	0.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	18.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	338.0	0.0	0.0	10.8	15.0	2.8	0.0	0.0	700.2	9.3	10741.3	0.0	0.0	16.6	25.1	4.4	20.8	0.0	0.0	4.9	0.8	11.1	0.0	6.3	7.2	5.0	88.0	103.4	36.1	1.2	5.3	0.5	6.4	9.1	3.9	6.0	2.0	27.3	7254.6	5.1	3.6	6.9	6119.2	2.6	3.3	60.7	4.3	4.6	195.3	4.7	1415.5	2.6	2.7	1.4	9.1	1.3	2.8	7.2	1.4	2.0	3.4	2.1	6.4	2.0	22.4	97.3	0.0	12202.8	0.0	0.7	0.0	0.0	0.0	5.4	0.5	15.3	8.6	3.7	0.0	0.0	0.2	8.8	5.0	0.0	0.0	0.0	0.0	0.1	7.4	12.2	54.8	0.0	0.0	0.0	22.1	5.6	0.1	47.9	0.0	195.9	127.7	0.2	0.0	0.0	3.5	0.0	23.1	0.0	0.0	0.0	5.6	0.0	0.0	2.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	5357.3	0.2	0.0	1.1	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.8	0.0	0.1	3582.0	0.0	6.3	0.9
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 70.0;testis: 25.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.8"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.8"	"Cell line enriched"	"Detected in some"	32	"REH: 787.7"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		48000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.3	0.3	0.3	70.0	0.0	0.3	0.4	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.1	1.4	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.2	25.2	0.2	10.1	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	14.3	2.6	0.0	0.0	0.0	787.7	0.3	17.3	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.1	6.2	0.0	0.0	0.3	0.3	0.0	0.6	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.3	0.3	0.3	0.4	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.9	0.0	78.0	0.2	0.3	0.3	0.0	10.5	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	140.7	1.2	0.4	119.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	6.2	0.0	0.0	0.0	1.5	0.3	17.1	0.6	0.0	0.3	0.0	17.9	0.1	0.0	0.2
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;retina: 13.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7"	"Group enriched"	"Detected in many"	5	"glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041994	Approved				"Secreted in brain"	NA	NA		15000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	1.7	1.7	11.5	0.2	9.0	0.7	0.9	23.4	21.6	0.5	1.1	0.6	0.1	0.1	0.7	4.2	0.1	0.2	0.3	11.7	17.1	0.4	1.9	0.2	0.0	47.2	19.1	1.2	0.2	1.8	1.2	0.4	44.9	0.2	0.0	13.9	0.7	0.7	0.0	0.6	0.3	0.1	16.5	0.1	0.2	8.0	22.2	0.0	0.2	0.0	0.0	0.4	1.2	10.8	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	16.0	0.2	0.0	0.0	0.0	3.5	0.0	0.1	0.1	23.0	0.0	0.0	0.0	9.9	0.2	2.2	0.0	0.0	6.4	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	9.0	23.4	21.6	11.7	17.1	47.2	19.1	44.9	16.5	22.2	10.8	2.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.8	0.1	0.3	79.1	17.6	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.7	0.0	2.5	0.0	5.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.9	0.9	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.5	70.9	0.3	485.2	0.2	332.4	317.1	0.2	2.0	192.0	0.9	1234.9	643.4	39.2	0.0	217.7	19.2	310.4	28.1	0.1	0.4	26.3	70.1	176.2	1117.0	1.0	0.3	34.1	7.6	2.7	2.0	0.7	1.5	21.9	684.4	0.2	627.3	19.6	1.2	4.1	481.7	37.2	0.4	654.2	1460.4	56.0	0.3	335.5	35.9	0.0	3325.7	679.7	30.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.3	0.2	0.2	2.0	0.1	0.4	1.0	0.3	1.5	0.4	0.3	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-10		ENSG00000211669	"Immunoglobulin lambda variable 3-10"	A0A075B6K4	22	22811747-22812281	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 317.0;lymphoid tissue: 707.7;stomach 1: 288.7"	"Cell type enriched"	"Detected in some"	52	"Plasma cells: 1090.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.3;medulla oblongata: 1.8"	"Group enriched"	"Detected in some"	786	"memory B-cell: 548.7;naive B-cell: 315.0"	"Lineage enriched"	"Detected in single"	998	"B-cells: 548.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HL-60: 1.0;RH-30: 1.6"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		2000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"unprognostic (6.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (7.40e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (9.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	33.3	112.9	0.5	144.0	0.4	65.5	111.1	0.1	3.3	41.3	0.6	308.0	176.3	7.6	4.5	56.3	7.9	43.5	20.5	0.1	0.2	12.2	20.8	48.0	230.5	1.8	0.2	14.6	10.8	0.9	0.8	0.4	0.6	11.0	317.0	0.0	139.7	10.8	0.2	8.1	94.9	5.8	0.1	217.1	288.7	97.4	0.2	25.9	8.6	0.0	707.7	140.2	7.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.2	0.0	0.2	548.7	0.1	0.2	0.2	315.0	0.0	0.2	0.3	0.1	0.1	0.3	0.1	43.2	0.5	0.4	0.1	3.3	0.1	0.2	1.8	0.2	0.6	0.1	0.2	0.2	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1090.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0
IGLV3-25		ENSG00000211659	"Immunoglobulin lambda variable 3-25"	P01717	22	22686726-22687271	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2440.7;stomach 1: 1015.7"	"Cell type enriched"	"Detected in some"	41	"Plasma cells: 17441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	45	"memory B-cell: 545.0;naive B-cell: 794.2"	"Lineage enriched"	"Detected in many"	53	"B-cells: 794.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		3200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (5.55e-4)"	"unprognostic (8.28e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.78e-7)"	"unprognostic (1.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	56.8	163.2	0.2	293.2	0.2	243.2	430.9	0.1	1.7	151.9	1.3	847.4	338.9	20.8	2.1	161.5	49.8	177.1	29.8	0.2	0.3	17.1	45.7	870.5	1024.7	1.8	0.2	21.8	14.5	1.7	1.7	0.5	0.6	18.9	467.5	0.0	532.3	116.5	0.7	2.4	228.9	34.1	0.4	543.5	1015.7	59.8	0.5	155.9	23.1	0.0	2440.7	779.6	20.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.7	0.4	1.7	0.0	0.0	1.6	1.5	2.7	0.0	0.0	4.6	5.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.1	0.8	1.8	0.2	0.7	0.0	1.3	0.0	0.8	0.4	0.3	0.7	0.1	0.2	545.0	0.4	0.1	0.5	794.2	0.2	0.1	14.9	0.3	0.6	0.3	0.3	76.5	0.2	0.2	0.1	1.7	0.2	0.3	1.8	0.2	0.6	0.4	0.5	0.6	0.0	0.0	0.0	0.0	84.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	1.9	40.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17441.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	417.4	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
IGLV3-9		ENSG00000211670	"Immunoglobulin lambda variable 3-9"	A0A075B6K5	22	22819010-22819756	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 313.9;stomach 1: 117.3"	"Cell type enriched"	"Detected in some"	9	"Plasma cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	51	"memory B-cell: 64.7;naive B-cell: 168.7"	"Lineage enriched"	"Detected in many"	74	"B-cells: 168.7"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 41.3"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (2.59e-4)"	"unprognostic (6.52e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.40e-2)"		"prognostic favorable (9.80e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.47e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-1)"	1.8	23.5	0.1	84.6	0.0	27.8	14.9	0.0	0.1	7.3	0.1	87.1	58.7	2.0	0.0	20.8	1.8	18.6	7.6	0.0	0.0	3.2	6.2	17.1	139.8	0.7	0.0	3.9	2.4	0.2	0.1	0.0	0.1	1.4	64.0	0.0	46.2	3.1	0.1	1.5	60.3	5.2	0.0	64.6	117.3	1.6	0.1	35.0	3.8	0.0	313.9	72.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.3	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	0.3	0.0	41.3	5.8	0.7	0.0	3.9	0.0	0.0	0.1	0.0	1.2	0.0	2.2	64.7	1.3	1.4	0.0	168.7	0.4	1.8	0.1	0.5	0.1	0.0	0.1	6.5	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
IGLV7-43		ENSG00000211652	"Immunoglobulin lambda variable 7-43"	P04211	22	22395018-22395489	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 161.9;lymphoid tissue: 238.7;stomach 1: 115.9"	"Cell type enriched"	"Detected in some"	57	"Plasma cells: 1304.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"memory B-cell: 132.0;naive B-cell: 54.2"	"Lineage enriched"	"Detected in single"	461	"B-cells: 132.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		130000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (6.49e-6)"	"unprognostic (7.85e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.62e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (7.63e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	8.0	0.8	0.0	31.2	0.1	15.8	45.7	0.0	0.5	4.9	0.0	161.9	132.8	3.6	0.5	7.9	3.3	22.1	3.5	0.0	0.1	3.1	4.2	13.0	59.0	0.0	0.0	4.1	2.2	0.0	1.0	0.2	0.1	2.3	129.3	0.0	72.5	4.7	0.1	0.5	57.1	17.7	0.0	168.6	115.9	0.5	0.0	31.3	6.4	0.7	238.7	31.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	132.0	0.0	0.0	0.0	54.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1304.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.2	0.0
IGLV7-46		ENSG00000211649	"Immunoglobulin lambda variable 7-46"	A0A075B6I9	22	22369614-22370087	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 400.6;lymphoid tissue: 459.1;stomach 1: 250.7;urinary bladder: 444.0"	"Cell type enriched"	"Detected in some"	180	"Plasma cells: 6758.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.6"	"Group enriched"	"Detected in some"	377	"memory B-cell: 183.6;naive B-cell: 82.3"	"Lineage enriched"	"Detected in single"	521	"B-cells: 183.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		270000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (3.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.25e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	15.1	3.8	0.0	59.8	0.3	44.2	171.7	0.1	0.9	4.1	0.1	400.6	162.4	4.4	0.0	43.7	3.0	56.0	5.2	0.0	1.6	5.7	7.7	44.9	82.2	0.4	0.0	9.0	6.2	0.1	0.8	0.1	0.2	2.5	298.6	0.0	107.2	5.2	0.5	0.8	133.1	12.1	0.1	248.1	250.7	0.7	0.2	57.3	8.7	0.0	459.1	444.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.3	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	183.6	0.1	0.0	0.1	82.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	15.2	0.0	0.3	0.1	0.9	0.0	1.6	0.4	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6758.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 73.4;pituitary gland: 167.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 3.9;Bipolar cells: 14.0;Breast glandular cells: 5.0;Horizontal cells: 3.3;Melanocytes: 3.6;Skeletal myocytes: 7.2"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 47.6;SH-SY5Y: 31.2"	"Region enhanced"	"Detected in all"		"hypothalamus: 144.0"	"Low region specificity"	"Detected in all"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		100000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	1.9	12.5	9.7	0.8	10.0	0.1	2.8	9.7	9.7	3.3	4.8	0.9	0.4	1.2	2.4	1.6	2.5	1.2	12.1	7.5	73.4	0.7	1.5	0.3	0.4	10.0	21.6	1.1	2.6	0.8	167.8	0.7	24.0	4.0	0.4	6.4	2.4	5.7	2.0	1.4	0.6	3.1	7.4	0.3	1.0	12.2	32.4	0.6	4.5	5.1	0.9	0.4	0.9	8.4	0.4	0.6	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.1	1.8	0.0	0.0	6.0	0.4	0.0	3.0	47.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	4.1	2.8	0.0	0.0	0.0	0.1	0.1	0.2	3.4	31.2	0.0	0.2	0.0	4.1	0.6	0.0	0.0	0.5	0.8	0.0	4.1	1.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.0	9.7	9.7	7.5	73.4	10.0	21.6	24.0	7.4	32.4	8.4	0.2	3.2	0.6	3.9	0.2	0.0	0.5	0.0	1.2	14.0	5.0	1.7	2.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.5	0.0	0.1	0.0	0.7	0.7	0.3	0.0	3.3	0.4	0.0	0.0	0.0	0.8	1.1	0.0	0.2	3.6	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.7	0.0	7.2	0.3	0.1	0.4	0.0	0.4	0.3	0.1	0.0	0.0	0.3
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		540000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	3.9	4.0	1.4	0.9	0.7	0.6	6.1	0.3	1.0	0.5	3.2	1.3	0.5	1.4	1.6	2.9	4.3	9.7	4.3	2.8	1.1	0.2	0.3	8.6	1.4	0.1	1.0	17.7	0.7	1.3	1.7	0.7	0.3	0.1	1.3	0.2	5.2	0.2	0.1	1.9	1.2	1.5	0.0	0.9	0.7	0.9	3.6	1.3	1.5	0.5	2.5	2.2	0.3	0.3	0.0	0.1	0.3	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.3	0.3	7.5	44.1	0.0	1.6	23.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.1	55.1	0.1	0.1	1.0	0.0	5.9	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.1	0.0	0.0	2.4	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.3	1.0	2.8	1.1	0.1	1.0	0.3	0.0	3.6	0.3	2.0	0.0	0.5	1.0	0.6	2.4	1.2	0.5	2.8	15.8	0.6	0.9	1.6	2.8	6.3	1.8	4.2	21.7	2.7	0.2	0.0	0.1	170.5	11.4	4.0	0.9	6.0	3.4	2.4	1.3	2.9	20.4	0.5	0.5	0.0	0.0	0.0	0.1	1.3	60.6	2.8	0.7	4.1	0.8	3.2	34.1	6.8	2.9	3.6	61.8	1.1	25.6	0.0	0.5	0.7	0.4	0.1	1.2	0.3	0.7	0.0	0.3	12.5	2.4	0.0	0.5	2.2	10.7	7.9	0.8	2.4	30.9	0.6	2.5	0.1	0.2
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704312-18726230	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"skin 1: 1.0"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Distal tubular cells: 21.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB026459, HPA037851"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB026459: , HPA037851: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.3	0.2	0.6	0.0	0.5	0.3	2.9	2.4	4.7	1.4	0.6	1.3	7.5	5.3	1.7	0.0	3.1	23.9	0.0	0.0	1.0	1.5	21.5	3.3	1.4	5.3	1.2	0.9	3.6	0.0	3.2	4.3	0.0	0.7	2.0	5.8	2.5	0.7	0.4	0.4	1.5	1.7	1.7	5.8	8.2	0.3	1.0	4.6	1.5	0.6	0.0	0.0	0.7	0.5	2.1	1.5	0.3	9.5	2.6	0.7	0.3	4.0	0.3	2.2	6.1	0.9	0.0	0.5	1.0	0.0	0.4	0.7	1.7	0.0	2.9	3.1	2.8	8.4
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 256.5;WM-115: 239.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.5	1.8	0.9	1.3	1.8	0.3	8.5	1.8	3.9	6.1	1.4	6.5	7.7	2.9	5.7	23.2	2.0	3.2	9.1	1.1	3.0	11.4	0.5	8.4	0.5	2.0	3.5	0.4	2.6	2.1	2.4	11.1	2.3	5.6	5.8	7.5	9.1	5.7	1.6	18.2	8.8	2.9	4.7	0.4	8.7	4.1	4.9	10.9	8.3	1.5	5.3	5.0	10.9	2.9	22.3	36.9	28.2	7.2	6.4	13.4	75.5	0.1	1.0	2.9	1.0	21.5	12.4	0.0	11.4	0.3	15.8	60.7	12.6	30.4	1.3	256.5	9.3	12.1	13.7	0.6	0.0	1.2	22.2	1.7	23.1	0.2	5.2	5.3	0.2	4.1	3.7	0.2	0.6	78.0	0.9	0.8	17.8	13.4	0.9	9.1	34.6	0.1	21.6	27.5	16.4	50.0	8.9	84.7	55.1	53.9	28.7	1.5	0.1	4.9	16.4	0.2	23.0	0.3	1.3	0.1	2.2	0.7	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	1.8	3.9	1.1	3.0	2.0	3.5	2.3	4.7	4.9	2.9	3.5	16.0	36.0	1.0	0.0	19.6	8.6	23.2	23.9	29.3	17.1	10.8	16.1	7.2	9.1	14.7	0.0	13.7	0.1	29.3	3.9	14.0	2.1	8.3	2.1	3.3	3.0	0.0	11.8	1.9	27.3	7.8	16.8	14.4	1.3	7.3	1.8	0.6	2.1	6.7	18.8	5.0	2.0	1.3	11.1	2.2	1.2	0.5	8.8	0.0	3.1	11.3	0.0	1.5	0.4	16.4	7.3	0.0	0.0	10.2	15.4	11.4	11.3	0.8	0.0	26.4	2.8	0.5	3.8	30.6	27.7	13.3	0.4	3.5	9.3	11.4
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 114.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 5.8"									HPA057282	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Focal adhesion sites"		"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.3	1.2	2.0	0.2	2.8	0.4	0.9	0.6	1.9	0.7	2.4	0.4	0.3	0.7	1.9	0.2	0.7	0.4	3.3	1.5	2.6	0.4	0.4	0.3	0.4	1.5	1.6	1.0	1.5	0.2	0.6	2.5	1.3	1.4	0.7	1.2	0.5	0.4	0.2	0.5	0.3	0.4	0.7	0.4	0.5	1.1	3.6	0.6	0.6	0.1	0.4	0.4	0.1	1.4	0.7	0.4	2.4	0.6	2.3	1.8	0.6	0.4	0.6	0.6	1.0	0.4	0.7	0.8	0.6	0.9	0.9	0.6	0.8	1.6	1.3	1.3	1.1	0.7	1.9	0.3	1.4	1.0	0.3	1.7	2.9	1.5	1.7	1.2	0.3	0.3	1.4	0.5	0.9	0.9	0.2	0.3	1.3	0.6	0.4	0.4	1.1	0.4	1.0	1.0	1.1	0.3	0.6	1.6	1.0	1.0	5.8	0.6	0.2	1.0	1.2	0.5	1.0	0.5	0.4	0.5	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	2.8	0.6	1.9	1.5	2.6	1.5	1.6	1.3	0.7	3.6	1.4	0.0	0.0	0.0	8.5	0.0	0.0	0.2	0.0	0.0	1.2	1.0	0.8	9.7	0.0	0.1	1.8	0.0	1.6	0.0	0.6	5.9	0.6	12.8	0.0	0.4	0.2	0.0	0.0	2.9	0.2	1.7	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.1	0.4	0.0	0.0	0.0	4.8	0.3	0.1	0.0	0.0	0.0	1.0	0.0	5.0	1.0	0.2	0.2	0.4	0.0	1.4	0.0	6.8	0.1	0.2	0.0	0.0	0.2	0.5	0.2	0.0	0.0	114.1	0.1	1.1	0.4	2.0
IGSF6	DORA	ENSG00000140749	"Immunoglobulin superfamily member 6"	O95976	16	21639550-21652608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in many"	13	"Hofbauer cells: 216.2;Kupffer cells: 246.9;Langerhans cells: 132.6;Macrophages: 327.1;monocytes: 179.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1213.7"	"Lineage enhanced"	"Detected in all"		"granulocytes: 1213.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041023, HPA041072"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA041023: AB_10794434, HPA041072: AB_10794262"	"unprognostic (7.94e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.18e-2)"	"prognostic favorable (1.54e-5)"	"unprognostic (3.27e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.02e-1)"	2.6	2.3	0.5	13.4	0.6	1.7	1.2	0.8	1.0	1.0	0.7	5.1	1.7	0.4	0.2	0.6	1.1	0.3	0.7	0.6	0.5	0.8	5.5	7.4	3.9	1.0	0.7	0.4	0.9	0.7	0.5	3.3	0.9	0.9	1.5	0.2	2.0	1.6	0.2	0.5	2.7	0.5	0.5	29.8	1.3	0.2	0.6	2.2	0.6	0.9	1.2	2.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.5	303.9	46.2	0.7	357.2	0.8	3.8	0.5	0.9	233.9	0.5	0.9	1.2	1213.7	2.7	263.5	55.5	1.0	210.7	0.5	0.6	0.8	1.0	0.6	0.5	1.0	0.7	0.9	0.5	0.6	1.4	1.7	3.2	12.2	0.7	7.1	3.2	0.7	0.0	0.0	1.3	1.4	3.7	4.0	2.8	5.0	1.8	10.4	0.7	15.2	0.0	0.0	0.2	0.4	1.0	1.2	4.0	0.0	6.5	1.1	0.0	1.4	3.2	0.0	2.5	10.1	0.4	2.9	1.8	216.2	0.0	0.8	0.3	0.0	246.9	132.6	0.1	0.9	327.1	8.8	16.9	179.9	0.7	3.1	1.0	0.4	0.0	1.2	0.0	1.3	0.6	0.1	0.4	4.4	2.1	0.0	0.9	1.1	0.1	0.2	0.6	2.0	1.4	5.4	0.2	0.0	0.5
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 155.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles		NA	NA		280000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (4.08e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.75e-3)"	21.9	19.1	97.9	14.0	119.0	3.7	26.7	91.7	130.7	25.7	39.9	31.7	26.5	19.8	22.7	22.3	28.2	12.3	29.0	106.0	82.4	35.5	53.9	23.6	16.8	109.3	97.8	37.5	31.8	15.8	30.7	11.2	99.9	26.4	10.4	14.3	30.1	18.2	12.4	50.3	28.5	7.0	98.6	24.2	27.5	33.4	94.7	13.6	28.6	7.1	8.9	20.3	25.0	155.3	26.8	15.7	20.1	51.3	11.6	7.3	42.9	12.9	16.8	26.9	25.0	17.9	17.9	39.0	47.1	18.8	23.4	50.3	8.2	18.9	3.8	47.3	15.0	5.1	17.3	31.2	19.2	13.5	41.7	9.0	37.7	17.5	5.6	19.0	5.6	42.0	7.0	21.8	6.3	25.4	33.8	31.3	42.4	55.6	24.8	19.1	10.3	28.7	24.7	27.4	8.5	36.6	14.8	47.4	177.6	17.5	33.7	17.3	5.8	11.8	25.4	21.5	10.6	59.6	71.2	17.7	41.6	5.3	31.6	0.1	5.2	2.4	22.0	7.2	19.5	19.6	18.0	25.6	5.8	22.7	23.4	25.7	1.4	9.2	4.7	9.9	26.9	11.3	97.9	119.0	91.7	130.7	106.0	82.4	109.3	97.8	99.9	98.6	94.7	155.3	12.2	9.6	3.3	18.3	21.1	43.7	30.2	43.1	26.2	55.6	28.0	29.2	3.3	17.2	16.7	38.6	10.4	32.8	15.1	36.1	5.9	34.2	3.8	12.0	7.2	7.8	19.9	7.4	65.3	12.4	219.7	22.4	6.6	26.4	10.2	12.2	13.2	28.8	14.9	65.6	43.8	24.7	44.7	4.3	16.2	1.1	16.8	8.5	42.7	9.4	51.5	75.7	10.3	9.0	107.2	20.6	39.5	15.8	20.0	22.0	47.6	15.8	6.0	11.8	6.6	39.8	15.3	4.0	6.6	21.0	62.4	69.4	19.5	13.6	32.6	26.0
IGSF9	"IGSF9A, KIAA1355, Nrt1"	ENSG00000085552	"Immunoglobulin superfamily member 9"	Q9P2J2	1	159927039-159945613	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.8;retina: 34.8;skin 1: 23.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Distal enterocytes: 83.5;Gastric mucus-secreting cells: 37.8;Rod photoreceptor cells: 145.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 24.9;HaCaT: 37.0;NTERA-2: 18.9;SCLC-21H: 32.9;SH-SY5Y: 16.8;T-47d: 18.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.9;cerebellum: 5.5"	HPA037753	Uncertain				"Intracellular and membrane"	NA	NA		140000		"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA037753: AB_10672915"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.30e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	4.4	0.0	0.1	0.6	0.4	0.2	2.1	0.1	0.3	2.6	0.0	9.8	7.4	0.8	2.0	10.0	4.6	0.4	0.9	0.1	0.5	1.4	32.8	0.5	0.0	0.2	0.2	0.7	1.7	1.6	0.6	0.2	0.2	6.0	4.3	34.8	5.7	3.5	0.0	23.3	9.6	0.3	0.0	0.2	12.8	5.0	0.5	1.8	1.4	0.0	0.7	1.8	6.3	0.2	8.6	0.0	3.3	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	12.1	4.2	0.0	0.3	0.1	0.0	37.0	1.8	5.1	0.0	0.0	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.5	0.0	0.0	1.5	0.4	0.0	0.0	15.9	0.3	0.0	18.9	14.4	4.0	0.0	0.0	1.5	0.0	11.6	32.9	16.8	1.1	14.3	0.0	3.3	18.6	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.1	0.5	0.2	0.2	0.2	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.1	13.4	3.7	8.2	6.8	11.6	5.6	6.2	1.8	10.0	3.4	0.0	93.8	1.3	0.0	83.5	0.0	4.5	19.8	7.8	0.9	1.3	8.3	0.0	0.0	33.8	3.2	1.2	37.8	13.7	0.0	1.9	0.4	19.6	0.2	1.7	0.0	7.9	4.1	0.3	2.8	3.4	0.3	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.1	29.0	12.5	0.0	0.1	2.1	24.1	0.1	3.4	145.8	0.0	0.2	0.4	0.6	1.8	6.4	12.5	0.7	0.2	0.7	7.4	1.7
IGSF9B	"KIAA1030, LINC00947, LOC283174, MIR4697HG"	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133896438-133956968	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8;choroid plexus: 20.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 38.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010802	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cell Junctions"		"HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	1.0	1.4	9.4	1.4	3.8	0.2	0.8	38.8	30.7	2.2	20.2	4.7	0.5	4.8	3.0	2.8	4.6	1.2	6.7	8.3	0.0	0.4	0.0	0.8	0.7	0.0	0.9	1.0	0.9	0.7	2.6	0.6	1.1	2.6	1.3	9.3	0.8	4.1	4.7	2.3	1.3	4.5	0.0	0.9	1.9	3.3	0.0	0.5	2.5	3.5	0.7	2.6	1.6	0.0	0.0	0.6	1.2	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.1	2.6	1.6	0.7	0.6	0.3	3.7	3.9	0.0	0.1	2.8	3.1	0.0	0.0	0.0	0.1	1.0	5.1	0.1	0.0	0.0	0.5	0.5	0.0	4.7	0.0	0.0	0.0	1.9	0.5	0.4	2.5	10.0	0.0	0.0	0.0	0.0	0.9	0.0	17.7	11.1	0.1	0.2	0.0	3.7	1.8	0.0	0.0	1.2	1.3	1.0	0.9	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	3.8	38.8	30.7	8.3	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	3.4	0.1	0.2	0.0	2.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.4	0.0	0.0	0.9	0.0	0.0	25.2	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.5	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	30.7	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.2	0.6	0.0	0.3	0.1	4.8	0.0	0.6	0.1	0.2	0.1
IHO1	"CCDC36, CT74, FLJ25320, LELA1"	ENSG00000173421	"Interactor of HORMAD1 1"	Q8IYA8	3	49198428-49258106	"Predicted intracellular proteins"	"Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 7.5;testis: 26.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 1.4;Fibroblasts: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;hTEC/SVTERT24-B: 9.2;LHCN-M2: 4.0;NTERA-2: 2.5;U-2197: 5.1;WM-115: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045690, HPA069534"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA045690: AB_10964634, HPA069534: AB_2686146"	"unprognostic (1.54e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.51e-4)"	"unprognostic (3.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.33e-2)"	3.2	1.4	0.2	0.3	0.2	0.2	1.8	0.9	0.5	1.3	7.5	1.1	0.2	1.2	0.4	0.4	1.3	0.7	1.1	0.4	0.0	0.3	0.1	0.5	0.3	0.1	0.3	3.8	0.2	0.1	0.2	0.9	0.1	0.4	0.1	0.7	0.3	0.5	0.9	0.6	0.4	1.0	0.1	0.5	0.3	26.5	0.5	0.1	1.0	0.8	0.1	0.8	0.6	0.1	0.0	0.1	0.0	0.0	1.9	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.1	1.7	0.0	9.2	0.0	0.0	1.2	0.0	0.0	0.1	4.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.5	0.4	0.0	0.1	0.3	0.1	0.1	0.5	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662480	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.7;Endometrial ciliated cells: 510.8;Respiratory ciliated cells: 732.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA048798: AB_2680525"	"unprognostic (9.90e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	73.9	64.0	53.4	68.7	56.6	135.4	66.9	64.4	70.8	70.0	62.3	76.1	55.4	73.9	74.4	77.0	143.5	53.4	74.2	54.2	68.6	67.0	68.6	69.5	89.9	60.6	60.6	78.8	48.3	74.3	55.8	64.9	59.9	60.3	70.3	90.4	65.2	66.2	136.5	73.4	67.9	64.6	57.0	71.6	60.5	107.7	57.6	114.0	72.6	83.0	96.0	69.6	68.1	62.3	119.1	132.5	114.4	163.2	125.7	106.4	133.4	139.0	146.7	151.6	153.2	184.1	133.4	138.9	167.4	145.4	172.3	120.9	168.2	190.1	175.4	198.1	136.6	130.4	213.2	117.8	129.6	214.6	136.9	117.2	124.4	151.5	136.8	112.0	132.7	114.9	144.3	121.1	137.3	110.0	184.1	216.8	74.5	100.3	134.2	145.5	160.7	141.4	117.7	109.2	103.6	112.3	171.5	155.6	172.9	97.9	181.3	171.8	141.2	126.2	87.9	106.2	167.8	181.8	294.1	188.4	141.8	162.4	94.5	353.1	136.5	240.3	188.3	157.1	168.9	197.4	202.7	194.3	139.0	191.5	212.7	199.1	229.4	198.8	193.0	131.2	284.4	247.0	53.4	56.6	64.4	70.8	54.2	68.6	60.6	60.6	59.9	57.0	57.6	62.3	110.7	163.5	134.9	10.1	102.8	46.1	86.4	127.5	61.5	75.3	40.0	57.7	126.7	80.1	177.1	86.5	29.2	115.2	139.9	69.2	121.3	106.4	438.7	510.8	124.9	91.4	34.1	137.6	7.6	99.6	99.6	82.6	50.0	107.2	132.2	68.0	54.3	74.7	70.6	53.8	8.2	66.4	97.6	56.8	58.8	55.0	98.2	80.2	56.9	8.4	107.4	116.1	151.4	8.5	7.4	110.1	67.3	83.8	76.9	50.5	80.4	120.8	732.0	97.3	72.3	96.0	115.7	311.3	145.0	65.3	45.5	132.8	128.5	93.0	65.5	66.9
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in all"		"BJ: 206.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	14.0	7.1	2.3	15.3	2.8	5.1	10.1	2.3	3.1	12.6	5.0	6.6	4.1	10.3	5.8	4.8	6.7	12.9	9.3	2.3	2.9	8.3	10.3	11.0	12.6	3.2	2.7	5.9	5.8	4.2	7.7	26.8	3.2	6.8	7.0	1.2	6.1	7.4	2.6	3.1	5.7	16.0	2.9	11.8	5.6	4.6	3.1	11.6	9.3	4.8	9.6	17.1	7.4	3.7	13.0	39.8	43.5	28.4	102.8	105.8	39.4	206.0	124.7	53.3	67.2	8.8	12.4	42.4	35.5	128.7	37.1	26.7	17.5	80.5	90.1	12.4	26.7	16.2	23.9	59.8	39.3	30.2	31.1	81.1	16.6	62.4	54.5	95.3	75.3	7.8	25.5	16.0	133.3	11.8	14.0	68.7	16.9	10.2	33.5	11.9	64.0	21.7	88.9	14.6	6.6	20.8	58.9	4.1	34.1	73.6	13.1	37.0	71.6	115.7	41.3	50.5	53.9	17.2	20.1	31.8	33.3	27.2	85.1	11.4	6.4	19.3	2.8	4.9	3.3	5.9	1.8	2.9	5.4	3.8	2.0	2.0	28.1	5.0	5.7	3.7	2.6	1.8	2.3	2.8	2.3	3.1	2.3	2.9	3.2	2.7	3.2	2.9	3.1	3.7	44.9	12.8	15.7	1.6	34.4	7.6	15.5	55.6	21.6	2.8	7.9	22.4	3.0	0.0	18.7	3.7	4.2	35.5	32.5	2.3	11.7	10.5	2.8	7.9	47.4	47.7	0.0	19.8	5.9	5.8	65.3	47.0	2.6	4.4	20.8	32.7	44.3	8.4	45.7	3.3	3.3	4.8	12.2	31.2	34.1	3.6	30.7	35.4	14.2	14.0	40.4	2.0	37.0	11.6	2.2	5.1	3.1	17.0	74.8	7.6	1.0	10.1	6.3	2.6	39.5	27.8	46.8	32.1	16.0	9.0	7.2	10.1	23.6	25.3	2.9	6.5
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332460	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.4	8.2	9.1	4.7	9.8	4.8	8.3	9.2	10.9	7.2	11.7	6.8	4.8	8.1	7.3	10.2	11.6	8.6	5.6	9.2	9.5	6.8	6.6	11.3	12.2	10.5	9.9	6.1	6.2	13.5	4.0	8.2	10.0	7.9	6.8	12.3	8.9	9.3	13.7	11.4	4.9	12.7	9.7	10.5	5.5	3.2	10.1	10.8	9.4	24.3	11.6	11.1	6.8	10.2	6.2	15.7	8.0	13.6	17.3	18.9	5.8	9.2	18.2	15.2	17.2	3.1	13.9	14.1	10.0	16.5	12.5	5.6	8.4	18.3	17.8	9.8	10.8	17.8	7.8	5.9	20.9	6.1	24.0	12.3	13.7	15.0	19.1	36.1	20.7	11.6	12.8	6.9	34.6	5.1	13.9	11.3	6.1	18.9	6.0	11.1	15.3	10.0	19.6	5.7	1.3	4.7	6.4	6.4	11.7	10.0	8.7	23.6	13.6	7.2	3.9	13.9	6.1	2.8	4.0	10.3	13.8	7.6	16.7	7.4	5.0	5.6	4.6	4.1	4.3	4.4	5.1	5.5	3.7	4.8	4.8	4.7	5.2	5.1	5.5	8.5	5.9	2.9	9.1	9.8	9.2	10.9	9.2	9.5	10.5	9.9	10.0	9.7	10.1	10.2	31.3	12.8	26.9	19.2	28.4	24.3	34.1	13.9	25.6	12.7	20.6	15.5	8.8	14.3	15.4	16.5	135.5	10.4	34.1	15.9	1.9	13.4	2.3	13.9	15.6	27.4	11.4	10.1	19.7	13.6	5.3	12.4	21.9	16.5	38.0	24.0	19.6	12.0	18.6	18.5	20.6	16.4	8.2	32.3	24.0	3.4	16.4	23.4	19.6	58.1	33.7	8.7	47.4	17.1	30.2	16.6	15.0	12.8	18.2	31.9	13.2	5.5	20.2	47.9	6.6	13.1	11.4	4.8	7.0	17.8	29.1	15.2	24.3	6.2	14.1	30.8
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 47.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.4	3.7	2.6	16.7	4.6	8.7	3.1	2.0	3.2	4.1	1.9	7.8	7.4	1.7	3.9	14.6	2.8	5.1	1.4	2.7	3.3	3.4	1.6	4.1	24.3	4.1	3.6	1.2	3.4	1.0	1.9	2.6	3.9	3.6	7.7	0.1	6.9	2.1	0.5	15.0	8.0	2.5	2.7	14.2	7.2	0.7	4.4	16.5	4.5	0.3	20.4	8.4	6.8	4.6	17.8	13.9	3.7	0.4	6.7	9.2	3.9	7.1	22.3	9.4	10.4	11.5	26.9	35.3	18.6	14.5	11.5	23.0	0.1	18.1	2.2	5.5	3.5	4.7	8.8	7.6	8.4	29.5	14.8	12.2	3.2	7.7	1.7	10.9	14.2	9.4	2.3	10.0	10.5	3.6	19.2	47.7	5.2	4.3	10.9	9.7	4.3	27.7	10.7	29.4	0.0	0.0	2.9	22.9	4.2	4.5	13.8	20.3	26.5	9.0	5.5	6.9	8.5	3.5	1.8	23.3	17.1	24.2	3.7	12.2	32.8	0.6	21.2	23.3	14.8	26.4	32.4	30.1	9.5	14.0	25.7	27.3	2.2	23.9	13.4	3.2	52.8	28.6	2.6	4.6	2.0	3.2	2.7	3.3	4.1	3.6	3.9	2.7	4.4	4.6	0.4	0.0	4.5	0.7	13.7	1.9	3.6	37.8	1.8	0.0	4.3	3.7	0.9	4.3	16.3	0.0	0.0	4.2	7.9	11.7	0.0	12.1	3.3	1.5	0.9	0.7	3.6	4.4	1.5	12.6	5.2	3.4	17.3	2.4	5.1	3.7	2.2	0.8	13.8	0.0	1.5	6.4	8.2	12.9	0.7	7.0	0.9	16.0	7.2	1.9	9.0	0.0	14.4	1.0	0.2	15.9	21.5	0.7	6.4	3.2	10.7	3.5	14.5	0.0	0.0	0.7	3.1	0.3	0.9	11.1	4.8	1.5	15.8	3.9	10.2	11.6
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase regulatory subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease variant, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	24.4	32.1	18.0	27.6	19.2	42.5	21.7	18.1	23.8	18.9	16.6	22.1	21.2	24.3	6.2	25.5	19.4	16.0	21.5	17.9	17.3	20.7	62.5	29.7	29.0	22.7	19.3	18.3	18.7	10.8	20.2	11.9	21.6	19.9	10.7	6.3	19.8	13.3	20.0	28.4	26.6	14.1	17.9	41.8	22.6	18.8	20.6	19.7	22.9	9.8	18.7	24.8	21.1	23.6	45.8	46.6	11.2	37.1	22.2	18.2	29.7	28.2	35.1	29.4	43.9	32.2	26.5	35.6	73.5	32.6	79.6	39.8	15.0	27.3	12.0	39.6	25.2	27.5	65.4	54.9	37.4	29.3	92.7	23.4	25.6	39.9	15.8	19.4	33.2	34.6	16.6	34.3	23.5	43.1	29.7	52.9	10.4	32.5	69.2	35.4	16.7	38.4	27.6	27.4	19.5	19.9	32.7	32.9	23.0	8.7	19.4	33.4	36.4	29.8	33.9	70.6	69.9	67.5	49.0	69.2	41.4	50.6	41.3	24.9	34.2	61.3	35.3	42.2	24.1	21.3	21.4	26.5	29.8	20.9	17.1	21.3	50.4	30.7	51.1	25.4	26.8	31.0	18.0	19.2	18.1	23.8	17.9	17.3	22.7	19.3	21.6	17.9	20.6	23.6	16.0	3.2	14.3	8.5	22.3	12.4	12.1	20.6	6.2	6.1	8.0	9.8	6.9	10.0	13.6	12.9	10.4	23.3	27.3	14.0	1.9	18.7	0.9	8.0	10.8	15.3	4.9	9.9	5.5	16.9	16.8	12.6	12.8	9.5	29.2	12.0	10.8	36.4	28.3	25.2	4.8	7.7	14.2	17.2	15.9	2.0	14.3	29.4	12.4	4.7	44.5	11.1	48.4	3.0	11.4	23.4	12.8	13.9	13.7	12.5	10.9	7.6	8.3	10.2	6.6	9.6	13.7	4.6	12.8	10.6	10.5	38.0	24.6	10.2	8.5	14.2
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	2.1	2.0	2.6	3.8	5.5	5.5	2.3	3.2	3.2	3.4	0.7	1.8	0.8	1.9	3.2	19.4	2.8	3.1	1.9	2.9	3.8	1.5	1.4	2.9	7.0	5.2	3.5	2.0	2.0	5.2	1.9	2.0	5.3	3.3	1.7	5.5	8.4	4.3	4.1	9.1	1.2	0.8	3.2	5.5	4.4	2.5	3.9	40.3	7.8	1.6	6.8	9.6	8.3	7.4	2.8	1.0	5.3	0.3	17.1	17.2	3.3	3.4	3.9	0.8	1.7	1.4	4.6	3.7	4.4	2.0	0.4	6.5	0.1	1.8	2.7	0.0	0.9	1.9	3.6	0.5	0.1	8.9	0.6	16.9	1.6	0.1	0.5	4.3	0.0	70.5	1.2	3.1	1.6	5.2	31.1	8.9	1.1	2.2	0.8	18.1	3.5	0.0	1.5	28.6	1.6	1.0	0.0	3.6	0.0	4.4	4.8	0.9	9.2	4.9	3.8	2.3	0.7	6.0	2.0	20.6	2.4	0.0	1.1	3.9	0.0	4.8	1.8	0.0	4.9	0.2	0.6	1.4	0.0	1.0	0.3	1.5	0.0	5.5	0.0	0.5	5.8	0.3	2.6	5.5	3.2	3.2	2.9	3.8	5.2	3.5	5.3	3.2	3.9	7.4	2.1	9.6	12.6	77.4	5.2	5.9	23.2	7.9	11.4	4.8	5.1	2.2	7.6	1.5	19.5	7.3	4.2	4.3	27.4	2.8	0.0	2.3	1.3	16.1	1.8	2.4	3.0	9.0	17.7	3.1	1.2	2.7	8.6	18.1	3.8	2.5	2.5	2.2	2.1	0.0	19.9	2.3	4.1	2.4	2.1	0.7	1.8	2.8	1.8	31.9	1.3	3.0	39.1	100.5	78.3	3.6	1.0	2.2	13.9	15.9	1.1	1.0	31.7	7.3	0.0	10.2	4.5	0.8	0.7	47.8	8.7	4.0	22.1	2.0	1.4	51.8
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	4	"B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.0	0.8	0.3	18.8	0.2	5.9	1.8	0.7	0.6	1.5	0.6	3.3	3.5	1.0	0.7	1.5	0.7	3.0	0.5	0.7	0.1	0.6	2.0	3.1	36.5	0.5	0.1	0.7	0.4	0.1	0.2	0.3	0.4	1.0	3.1	0.3	2.2	0.3	0.5	0.9	12.1	0.8	0.1	22.3	6.2	1.6	0.4	23.0	0.9	0.3	41.0	4.5	0.7	1.0	0.2	0.2	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	69.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	15.6	0.3	4.2	0.4	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.1	1.8	35.6	0.0	0.2	6.2	2.4	0.2	3.9	0.1	0.3	0.2	12.7	0.0	4.2	0.4	0.2	1.2	0.5	0.1	0.1	0.2	0.8	0.3	0.3	0.5	0.2	0.1	41.7	50.0	108.1	0.1	0.2	0.1	1.0	0.2	0.8	26.3	0.1	28.8	13.2	11.0	20.3	0.1	11.9	4.5	12.2	1.1	4.5	0.3	0.6	18.9	8.7	0.3	0.2	0.7	0.6	0.7	0.1	0.5	0.1	0.4	0.1	0.4	1.0	1.1	9.6	21.8	0.3	108.1	0.1	2.2	0.0	0.0	1.7	1.2	0.9	4.0	1.5	5.6	1.8	0.0	0.1	76.5	0.2	0.0	0.1	12.8	1.9	0.9	2.4	0.0	4.0	0.6	0.0	0.4	2.3	3.1	3.9	47.9	0.4	4.2	1.2	0.1	0.0	0.4	0.1	0.0	6.3	0.0	11.8	0.0	4.4	0.0	2.8	3.3	0.2	121.5	0.0	0.1	1.2	0.1	0.0	80.2	1.8	0.0	0.3	0.7	1.7	0.0	4.0	1.2	6.3	2.3	0.6	0.1	0.3	99.9	0.1	0.0	1.6
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA046270: AB_2679607, HPA049016: AB_2680600"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	4.9	9.2	5.6	2.1	5.7	3.8	3.7	7.1	6.5	4.8	5.7	5.5	1.6	4.5	4.0	2.6	5.8	2.7	4.1	5.3	5.8	3.7	3.2	3.7	2.1	6.4	6.2	7.6	2.9	8.1	7.5	3.0	5.8	3.9	2.0	8.5	2.7	4.2	9.9	2.5	3.5	2.9	5.5	2.9	4.1	5.0	6.2	4.0	5.1	5.4	2.3	4.3	3.2	6.0	1.7	1.6	11.6	3.9	2.3	2.4	2.7	1.8	3.1	2.1	3.0	6.5	2.5	1.1	2.0	2.9	2.3	1.3	1.5	1.8	4.6	36.2	1.7	7.3	1.7	3.0	2.6	3.3	2.6	4.0	2.1	2.2	1.7	3.9	2.2	0.2	10.7	5.5	3.4	2.0	4.1	1.6	5.1	1.8	1.4	3.6	3.1	1.3	3.1	1.4	4.4	3.8	2.6	0.8	4.3	2.9	3.0	3.3	1.3	1.8	3.1	1.8	1.5	3.5	2.2	1.5	3.7	3.2	2.4	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.9	0.1	5.6	5.7	7.1	6.5	5.3	5.8	6.4	6.2	5.8	5.5	6.2	6.0	5.5	3.2	9.4	10.7	2.5	3.6	1.9	3.4	10.2	20.3	16.6	15.4	7.5	10.0	4.2	3.7	8.4	3.0	0.8	3.9	1.9	2.9	13.8	7.7	10.4	5.3	6.0	4.2	13.3	4.2	2.8	8.8	2.0	8.0	1.3	4.0	8.2	6.7	2.7	8.4	17.7	3.0	4.1	9.8	3.1	2.7	8.7	4.1	5.4	7.5	6.0	18.3	0.0	14.6	15.5	4.3	2.1	10.9	1.6	2.4	1.7	4.9	4.3	12.3	0.0	10.3	9.9	21.2	5.9	10.4	3.3	4.0	3.8	16.0	2.3	2.1
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206774541	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.7;lymphoid tissue: 7.7"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 28.3;Kupffer cells: 44.4;Langerhans cells: 35.5;Macrophages: 99.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"thalamus: 3.5"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1;intermediate monocyte: 1.8"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 14.6;U-266/70: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670		"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	6.7	2.1	0.1	7.7	0.1	3.2	0.7	0.2	0.7	0.8	0.9	1.0	0.8	0.3	0.1	1.5	1.4	3.5	1.1	0.2	0.5	0.2	1.6	1.5	5.7	0.7	0.4	0.4	0.1	0.2	0.4	1.9	0.6	0.4	1.3	0.0	0.2	0.7	0.0	0.1	1.1	3.1	0.5	4.9	0.8	0.8	3.5	2.9	0.2	1.2	2.0	2.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.1	0.2	0.7	0.2	0.5	0.7	0.4	0.6	0.5	3.5	1.2	0.5	0.0	1.9	0.0	5.6	1.0	0.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.1	0.2	1.9	0.0	0.4	0.0	0.0	0.1	0.8	1.1	0.2	1.3	0.0	0.7	0.5	28.3	0.0	0.0	0.0	0.0	44.4	35.5	2.9	0.0	99.5	1.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.8	0.0	0.2	0.7	1.1	0.1	12.9	0.0	0.0	0.4
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266367-33310187	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 198.4;Extravillous trophoblasts: 164.9;Syncytiotrophoblasts: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB020670, HPA047550"	Approved		Approved	Cytosol		NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	24.6	14.5	8.2	30.3	8.2	19.8	18.1	8.1	11.3	20.2	8.6	40.6	36.5	14.7	9.9	27.6	23.9	23.9	13.8	8.1	7.8	16.8	27.5	25.8	27.6	9.0	8.1	20.4	25.4	10.7	11.3	62.5	8.9	18.6	38.0	4.8	23.6	12.3	12.4	20.2	45.7	19.8	8.6	43.1	33.8	5.0	9.5	30.5	14.0	9.8	26.0	29.3	19.3	9.8	28.8	21.6	4.9	19.1	82.7	61.3	30.0	22.9	62.3	23.5	33.6	20.6	36.1	10.9	25.0	37.8	48.3	34.5	13.2	14.8	17.3	28.5	15.5	30.8	15.1	15.2	58.3	29.5	54.6	62.5	26.8	41.2	23.5	36.8	34.6	25.6	20.6	79.7	32.5	29.1	22.6	27.4	4.2	59.1	11.4	18.5	14.4	33.9	22.6	16.6	7.5	8.0	45.4	35.3	37.5	9.7	21.3	104.5	31.0	24.1	22.7	40.0	12.4	49.9	48.3	6.8	40.5	44.5	19.4	103.8	115.0	98.9	32.0	134.9	35.2	51.6	39.3	38.1	67.9	54.1	36.8	36.3	219.4	56.9	141.6	73.6	77.6	87.5	8.2	8.2	8.1	11.3	8.1	7.8	9.0	8.1	8.9	8.6	9.5	9.8	3.1	35.3	20.5	11.8	26.5	14.5	38.0	54.0	19.4	5.8	3.3	2.8	12.3	32.9	32.3	3.7	14.6	198.4	33.6	102.1	0.0	20.1	1.1	2.3	3.5	23.5	10.2	17.7	14.5	30.1	164.9	24.2	29.6	2.4	35.5	2.1	31.8	23.2	116.6	8.4	12.7	64.4	30.5	111.3	25.3	1.6	31.7	54.3	14.2	23.4	80.6	6.7	49.4	14.6	18.5	23.4	86.8	23.7	39.9	44.3	103.1	1.1	15.8	6.4	19.7	16.9	9.1	2.9	5.0	21.7	14.6	315.6	21.0	0.2	41.4	67.6
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34650702-34661902	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Craniosynostosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 57.8;Late spermatids: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.8;HSkMC: 38.2"					"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652"	Supported				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229"	"unprognostic (7.76e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.71e-2)"	26.6	14.8	20.0	15.5	22.9	13.7	30.2	23.9	23.8	44.6	17.2	58.0	21.7	32.9	12.2	16.3	36.8	19.5	66.4	20.6	20.4	21.9	50.7	22.6	32.0	21.4	21.5	38.0	12.9	29.2	21.8	10.3	20.4	30.3	11.4	18.7	26.1	15.7	30.0	61.3	37.9	19.6	20.8	33.3	26.0	18.3	21.6	16.9	48.0	28.5	21.1	32.2	34.1	22.9	2.5	5.5	11.7	11.7	16.5	28.9	5.5	13.8	19.1	8.8	11.9	2.0	4.6	2.6	3.7	36.8	3.3	5.0	3.4	5.0	3.5	23.8	9.2	7.9	23.4	1.0	8.4	2.7	4.3	38.2	6.1	4.9	1.7	11.9	5.6	16.4	3.3	5.4	11.3	1.6	3.6	18.6	2.5	2.0	3.7	5.6	2.3	2.7	2.9	2.5	3.4	12.3	1.7	3.7	5.3	6.1	10.1	10.2	5.2	4.1	10.0	3.2	0.0	3.7	2.6	1.0	10.9	3.1	20.1	2.1	1.0	0.0	1.4	1.4	2.1	0.8	2.7	2.2	1.3	1.0	2.5	1.8	0.3	1.0	0.3	0.5	1.7	1.7	20.0	22.9	23.9	23.8	20.6	20.4	21.4	21.5	20.4	20.8	21.6	22.9	15.8	3.2	14.3	26.8	2.6	17.5	5.8	3.6	6.2	19.6	6.4	25.1	37.9	1.5	3.6	3.7	14.6	11.3	5.1	3.7	0.0	1.9	18.3	0.7	4.4	15.2	9.1	0.8	4.3	0.7	4.1	42.7	3.1	1.3	0.0	57.8	17.5	32.1	4.6	23.5	9.0	5.0	0.0	3.5	19.6	97.2	11.1	3.6	32.0	4.7	2.6	15.2	6.2	5.0	7.3	0.3	4.3	5.7	2.4	2.9	7.0	2.4	1.4	9.0	0.0	32.9	8.9	4.6	21.6	1.4	14.1	12.4	6.0	12.2	5.2	1.7
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988835-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.8"	"Not detected"	"Not detected"			HPA001886	Uncertain				"Secreted to blood"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.3	0.4	0.9	0.6	0.9	1.5	0.7	0.9	2.0	0.2	0.3	0.8	0.5	0.3	0.1	4.1	2.1	0.2	0.8	0.8	0.8	0.4	0.1	2.1	0.8	0.9	1.1	0.5	0.5	0.0	0.5	0.1	1.0	0.3	0.4	0.1	0.3	0.1	0.2	0.1	0.8	0.2	0.7	1.2	0.5	0.3	0.9	0.4	0.2	0.7	0.5	0.7	0.6	1.1	3.1	0.3	0.4	2.6	0.0	0.2	0.2	3.3	2.1	3.9	8.1	1.2	0.1	0.0	0.2	0.5	4.5	0.3	0.8	0.5	3.6	13.2	4.1	0.1	0.2	0.9	2.5	0.7	6.1	0.6	1.0	6.9	2.7	2.7	1.2	0.3	0.0	2.1	2.4	0.1	0.1	0.0	0.4	0.1	1.8	2.4	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.6	0.5	0.6	0.9	1.4	0.9	0.8	0.8	2.3	6.3	1.4	0.0	0.0	1.5	5.9	0.8	0.0	0.0	0.5	0.3	0.1	0.5	0.5	0.1	0.6	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.9	0.9	2.0	0.8	0.8	0.9	1.1	1.0	0.7	0.9	1.1	1.0	0.0	0.6	1.0	3.4	0.1	2.1	1.0	1.2	0.0	1.6	2.2	0.4	0.0	1.1	0.0	0.0	0.1	0.7	0.3	0.0	1.5	0.0	3.9	0.2	1.4	2.4	0.8	0.1	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.9	4.1	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	4.0	1.3	0.4	0.2	0.0	2.1	2.9	0.1	0.0	6.1	0.0	6.6	1.5	0.3	0.4	2.9	2.6	0.1	0.0	0.7	0.1	0.5	1.3
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330487	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 6.7"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	NA	NA	140000		"Cluster 11: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 3: Monocytes - Immune response regulation"			"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67398724	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;placenta: 7.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.4;Excitatory neurons: 22.5;Inhibitory neurons: 16.6;T-cells: 12.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 2.5;melanoma: 5.6;renal cancer: 1.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 4.5"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 21.3"	"Group enriched"	"Detected in many"	35	"NK-cells: 21.3;T-cells: 6.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 4.6;SCLC-21H: 6.8;SK-MEL-30: 18.4;THP-1: 13.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	1.9	0.3	1.2	1.2	1.6	0.8	0.4	0.0	2.3	0.6	0.0	0.4	0.3	0.2	0.3	0.8	0.1	0.5	0.2	4.5	0.0	0.3	0.8	0.4	1.8	0.0	0.7	0.2	2.6	0.8	0.0	7.0	0.0	0.1	0.4	0.1	1.3	0.7	3.5	1.4	0.4	0.4	0.0	1.4	0.3	1.0	0.3	1.0	0.1	0.7	0.9	0.7	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.1	18.4	0.0	0.0	13.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.0	0.0	3.2	0.0	1.6	1.0	0.0	0.0	0.0	0.1	0.3	21.3	0.0	0.0	3.9	1.2	1.2	1.6	0.0	2.3	4.5	0.0	0.0	0.7	0.0	0.0	0.3	0.7	0.2	0.0	2.3	1.0	0.6	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.5	0.3	0.3	0.1	0.0	0.8	22.5	0.0	0.0	0.9	2.6	0.7	0.0	1.5	0.0	0.0	3.8	0.0	16.6	0.0	0.0	0.8	0.9	0.9	0.0	0.5	1.8	2.8	0.0	0.0	4.1	1.0	1.6	0.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.0	0.6	0.0	12.8	0.0	0.0	0.1
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636583-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.0;monocytes: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;Karpas-707: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.4	1.3	7.1	1.4	4.0	6.0	2.1	1.8	5.3	1.4	7.7	6.1	4.5	2.5	4.4	4.5	4.9	5.1	1.2	1.3	7.9	3.6	7.8	9.7	2.3	1.3	1.5	2.7	0.7	3.6	3.1	1.8	4.1	5.3	4.3	3.6	2.7	8.6	3.4	10.0	4.6	1.5	15.4	4.8	2.5	1.8	6.8	15.6	3.4	6.6	4.5	6.4	1.9	2.8	6.3	0.3	0.6	0.9	5.4	1.6	6.7	6.1	6.8	5.5	3.4	8.1	2.5	8.5	6.2	6.0	4.4	0.1	3.4	3.6	17.6	1.7	0.5	16.7	0.5	4.5	1.9	1.3	2.1	1.5	4.4	0.5	13.7	4.3	2.3	4.0	18.8	4.2	0.9	4.2	0.3	3.3	2.3	1.7	1.0	16.0	0.5	9.2	0.8	0.6	1.6	3.1	4.7	3.2	0.8	0.9	0.3	6.6	6.9	4.3	2.0	4.2	13.0	1.8	1.0	7.2	0.8	2.5	10.4	16.1	0.6	2.7	15.1	5.0	4.1	3.3	2.5	5.5	4.0	1.4	1.4	1.2	3.2	16.5	0.2	2.0	6.1	1.3	1.4	2.1	1.8	1.2	1.3	2.3	1.3	1.8	1.5	1.8	1.9	14.8	0.0	2.8	0.3	9.9	6.1	2.5	2.1	2.2	0.6	2.1	1.3	2.9	2.8	5.3	5.5	0.0	1.2	5.0	4.7	0.0	9.4	6.6	6.9	78.0	14.8	0.0	1.3	2.0	14.0	1.6	5.5	4.1	5.9	0.0	0.9	11.4	2.5	4.7	0.0	4.8	5.4	0.0	17.0	22.1	2.5	2.8	16.7	8.8	4.7	72.0	21.1	8.2	3.0	0.2	19.8	8.2	1.2	9.3	6.2	9.9	12.0	3.9	0.9	6.6	7.6	4.0	1.2	0.8	5.6	3.4	0.3	6.0	0.1	2.6	3.0
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	8	"cerebellum: 7.1"	CAB026215	Approved				"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	19.3	7.5	3.3	20.4	3.7	11.7	18.3	3.0	4.6	21.5	3.6	12.3	16.2	15.0	4.6	11.5	18.8	23.2	17.8	2.8	4.4	14.1	19.5	44.5	21.3	5.7	3.9	3.7	11.5	2.2	4.6	16.1	4.6	10.4	10.9	0.3	8.0	5.3	7.1	11.2	15.7	12.1	4.8	15.1	16.3	3.2	4.6	5.7	12.1	10.2	11.6	25.7	12.7	3.5	16.8	2.4	0.0	0.7	21.5	4.9	4.3	8.6	18.4	10.7	11.4	0.3	70.8	1.9	41.3	16.0	6.0	15.6	2.0	12.1	2.4	78.5	3.5	2.0	4.9	1.2	42.7	0.9	0.6	4.1	4.2	6.0	0.2	4.4	29.1	1.3	20.5	23.5	0.3	9.3	3.6	8.9	0.4	6.7	6.8	10.0	0.0	13.4	2.8	1.3	0.1	0.1	12.9	1.4	0.6	0.2	6.1	8.0	10.8	0.5	1.3	30.1	11.2	20.5	6.2	0.4	4.9	12.4	0.7	10.2	26.0	6.6	18.9	32.8	29.1	10.8	14.7	19.7	7.1	6.4	6.1	11.0	7.5	11.5	21.0	0.1	17.7	12.8	3.3	3.7	3.0	4.6	2.8	4.4	5.7	3.9	4.6	4.8	4.6	3.5	25.2	6.4	5.0	1.3	6.0	5.7	5.7	9.9	4.6	0.0	4.4	3.0	5.8	22.8	3.3	0.0	0.0	0.6	4.2	5.8	0.0	39.1	1.7	5.1	23.0	21.0	5.4	19.8	3.3	55.2	1.6	37.6	9.7	6.7	3.8	0.1	36.0	8.7	6.6	0.0	0.9	6.8	2.0	14.7	5.5	2.1	5.0	7.3	3.6	12.2	55.0	0.0	4.1	1.0	0.3	35.5	13.3	0.7	22.2	20.1	9.3	0.1	3.4	0.0	0.0	7.1	6.4	0.2	0.4	4.6	6.5	0.1	7.8	0.0	9.3	6.8
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in single"	14	"T-cells: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Karpas-707: 2.7;U-266/84: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920			"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;Karpas-707: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000		"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	1.4	2.2	0.0	1.0	0.0	0.2	2.9	0.5	0.1	3.2	0.0	3.1	0.3	4.3	0.0	1.5	1.1	0.4	1.1	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.4	2.8	2.1	0.3	0.9	1.3	2.2	0.0	0.6	0.8	3.7	0.0	0.0	0.1	0.2	0.0	1.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.8	44.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.6	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	1.0	1.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.6	7.6	0.1	0.1	0.0	0.3	0.0	0.0	9.9	0.0	0.1
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638572-88640468	"Predicted secreted proteins"	"Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.1;urinary bladder: 1.7"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 210.7;Club cells: 191.2;Ionocytes: 52.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065051	Supported				"Secreted to blood"	NA	NA	30500			"Cluster 71: Testis - DNA repair"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA065051: AB_2685413"	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.7	0.0	0.0	0.1	0.0	0.1	4.3	191.2	0.0	0.0	0.0	1.6	0.7	0.0	0.9	0.0	0.9	0.2	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	52.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.3	0.1	21.8	0.0	0.0	0.0	1.3	0.4	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 59.9;NB-4: 52.5;THP-1: 74.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		62000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	9.1	5.6	5.5	9.6	11.3	31.8	6.9	5.7	7.5	5.4	6.8	4.7	3.8	5.4	5.0	5.2	6.0	3.6	4.6	6.3	5.5	3.7	5.7	10.0	6.9	9.8	7.3	4.5	5.2	3.9	3.8	3.5	8.9	5.0	3.4	1.5	5.2	2.8	1.8	6.9	6.2	5.3	7.7	16.6	5.6	2.0	7.7	15.4	4.2	2.6	5.6	4.6	4.7	9.6	7.9	4.5	4.1	5.1	8.0	4.6	5.1	11.5	7.4	5.3	6.8	4.4	5.1	7.1	4.6	11.6	6.9	12.4	5.6	5.4	3.7	11.6	6.6	0.0	2.6	2.8	9.2	59.9	17.8	6.8	7.9	4.7	3.7	5.2	5.7	5.6	3.0	7.3	5.5	6.7	7.2	52.5	2.2	10.1	4.3	1.6	0.8	1.3	5.1	5.8	2.8	0.1	8.0	6.7	5.7	4.6	5.3	74.7	15.9	4.1	5.8	6.1	4.3	5.8	3.4	3.3	6.0	28.3	4.5	8.5	7.4	7.2	1.1	3.4	0.9	0.5	1.5	1.2	3.9	0.4	2.4	1.8	16.5	1.5	3.5	1.8	1.0	2.6	5.5	11.3	5.7	7.5	6.3	5.5	9.8	7.3	8.9	7.7	7.7	9.6	14.0	12.8	14.1	2.9	13.8	8.8	6.6	10.2	10.8	3.9	7.2	5.8	6.1	10.0	8.6	5.5	8.4	6.1	18.7	23.6	0.0	8.7	4.0	7.2	8.1	13.7	13.2	9.2	8.3	12.6	11.9	13.6	29.0	9.7	7.6	58.9	17.5	11.1	34.0	3.3	6.4	13.9	6.1	81.4	16.2	2.1	9.0	61.4	8.8	41.2	114.2	4.3	28.8	12.5	11.4	12.2	12.4	4.5	10.3	9.1	14.7	3.4	8.0	2.9	13.1	10.4	10.0	3.0	13.4	9.0	6.8	6.4	25.4	8.1	12.4	9.6
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
IL17RC	IL17-RL	ENSG00000163702	"Interleukin 17 receptor C"	Q8NAC3	3	9917074-9933630	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.7;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.1;monocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 71.2;ASC TERT1: 43.6;HSkMC: 40.7;T-47d: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019885, CAB026255"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB026255: , HPA019885: AB_1851664"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (8.60e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-1)"	17.5	32.2	5.5	4.2	5.5	3.8	18.8	5.0	7.1	16.6	6.0	21.4	15.0	15.0	4.9	23.6	14.8	7.4	19.9	5.7	6.6	15.7	63.7	9.2	1.8	6.2	5.9	12.9	15.3	17.0	27.9	2.9	4.9	31.3	4.7	1.1	23.7	12.6	16.9	32.2	15.5	6.9	6.6	5.9	16.8	1.7	7.0	1.9	13.9	15.7	2.4	17.9	19.4	5.0	7.3	4.6	1.5	4.5	71.2	43.6	10.8	10.0	23.4	12.3	19.5	1.6	19.9	0.0	11.8	15.8	8.7	5.1	2.0	10.7	4.1	4.7	6.0	1.9	13.6	6.6	22.0	0.1	0.0	40.7	8.7	14.9	3.3	5.7	10.6	0.0	0.8	9.1	9.8	11.3	0.2	0.4	0.9	2.6	31.4	4.5	5.1	2.6	9.1	4.1	4.0	6.4	6.1	13.7	10.8	0.4	41.2	0.8	8.9	13.4	6.4	5.9	6.7	0.1	0.3	0.0	21.0	0.9	9.8	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	5.5	5.5	5.0	7.1	5.7	6.6	6.2	5.9	4.9	6.6	7.0	5.0	10.1	0.0	0.5	18.9	2.0	10.8	18.6	11.2	12.5	2.1	30.2	24.1	3.4	18.6	11.7	1.8	0.0	5.8	2.6	22.4	3.9	15.1	0.5	8.0	8.7	7.8	14.4	6.5	3.8	21.1	4.7	15.7	15.8	10.0	0.0	14.0	11.4	43.9	11.0	1.7	4.8	25.3	16.2	6.0	7.8	1.4	19.0	6.0	14.2	4.7	3.4	25.5	1.0	7.1	0.9	13.2	29.8	17.0	1.7	25.7	53.2	17.7	6.9	1.6	19.7	12.8	12.4	0.8	0.5	13.3	19.9	2.9	2.1	11.9	20.0	16.6
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
IL17RE	FLJ23658	ENSG00000163701	"Interleukin 17 receptor E"	Q8NFR9	3	9902612-9916402	"Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.8;skin 1: 31.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 92.6;Gastric mucus-secreting cells: 58.1;Intestinal goblet cells: 52.1;Paneth cells: 37.7;Proximal enterocytes: 74.4;Undifferentiated cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;ASC TERT1: 38.5;hTCEpi: 16.5;T-47d: 19.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"					HPA019011	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA019011: AB_1851667"	"unprognostic (1.08e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.43e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-2)"	6.1	0.4	0.5	1.4	1.6	0.0	5.9	2.2	1.0	4.5	0.3	16.6	20.8	1.8	2.7	7.5	2.5	6.8	1.2	0.4	0.9	2.8	0.8	8.1	0.4	1.5	0.4	0.6	9.7	4.2	1.6	1.1	2.3	4.8	13.8	0.1	6.3	3.3	0.4	31.0	20.4	1.4	0.4	1.0	16.7	0.2	0.3	2.8	3.2	0.2	1.7	1.7	6.6	0.4	2.6	0.3	0.0	0.1	15.5	38.5	11.3	1.0	1.4	0.3	0.9	2.9	2.3	0.0	0.6	2.7	0.0	7.1	0.0	6.2	0.1	0.1	0.1	0.8	0.2	6.8	0.4	0.0	3.2	2.4	16.5	0.0	0.1	0.0	0.1	2.5	0.1	0.0	0.7	3.1	0.4	11.3	0.1	8.1	0.8	0.0	0.0	0.1	2.8	3.2	0.6	0.2	0.0	6.5	0.0	0.3	19.4	0.3	1.5	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.4	6.5	0.2	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	2.2	1.0	0.4	0.9	1.5	0.4	2.3	0.4	0.3	0.4	3.4	6.4	1.1	3.3	1.0	14.5	11.9	2.3	14.2	3.0	8.4	8.3	0.9	15.7	2.0	16.5	0.0	4.3	0.8	92.6	7.9	2.7	0.2	1.4	2.0	1.3	33.6	9.0	2.4	4.8	1.8	4.9	58.1	1.3	0.0	1.2	1.8	15.4	2.6	1.7	1.9	52.1	2.0	2.2	3.5	0.4	2.1	1.6	5.4	0.0	1.0	4.7	2.1	2.0	0.6	2.5	37.7	3.4	0.8	6.1	74.4	8.0	1.0	1.0	19.7	1.8	7.2	1.6	2.3	11.8	14.8	0.8	2.8	1.0	40.8	4.6
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.3;stomach 1: 2.3"	"Cell type enriched"	"Detected in single"	21	"Gastric mucus-secreting cells: 12.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045546	Supported					NA	NA				"Cluster 3: T-cells - Adaptive immune response"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	1.0	2.3	0.1	1.0	3.9	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.6	0.1	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143253-112164096	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.5;skin 1: 149.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000	16000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	19.9	6.1	5.3	18.2	5.4	31.6	12.6	5.9	8.6	38.0	7.0	34.1	22.0	2.4	3.3	124.5	8.0	23.0	3.0	5.3	6.0	23.8	9.1	23.0	67.8	7.5	6.2	1.9	17.9	1.3	2.9	6.7	7.4	6.1	29.1	6.9	15.0	3.0	6.0	149.6	22.0	3.6	6.7	29.3	13.4	1.9	5.7	8.0	3.7	2.1	25.7	25.3	77.0	11.3	117.9	40.0	0.0	0.4	0.0	0.0	0.7	2.0	0.0	0.0	0.1	22.4	182.3	0.1	25.7	0.3	3.2	167.0	0.0	125.8	0.0	0.3	1.2	17.5	35.6	9.9	3.9	9.3	32.6	0.2	188.5	0.3	43.5	0.2	0.1	0.1	0.5	0.3	1.6	0.2	0.2	0.9	0.2	31.9	110.2	0.1	0.1	0.4	79.9	24.8	0.1	0.0	78.4	52.1	0.5	1.0	31.0	25.4	0.3	0.4	208.9	1.2	35.9	0.4	0.3	0.6	0.2	67.1	0.2	6.8	8.7	16.0	0.1	10.9	0.0	0.7	0.1	0.0	25.8	0.7	0.0	0.5	9.5	19.6	6.3	5.6	0.0	2.5	5.3	5.4	5.9	8.6	5.3	6.0	7.5	6.2	7.4	6.7	5.7	11.3	1.0	173.1	38.4	0.7	6.0	122.9	33.5	186.4	215.1	2.6	4.6	7.7	1.0	41.5	66.1	9.2	0.0	2.3	10.8	109.9	80.3	24.7	2.4	94.9	1.4	4.6	14.5	26.3	3.8	143.0	3.7	18.8	20.9	32.5	101.2	2.8	8.2	1.9	68.4	0.0	4.6	30.1	57.0	241.0	37.3	1.9	0.0	123.8	3.6	61.8	38.8	2.7	6.2	2.0	1.1	161.4	104.6	4.5	4.6	23.6	67.5	22.3	69.6	39.1	6.6	0.6	3.9	1.5	1.3	152.6	111.2	1.8	9.6	0.3	47.8	90.5
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998613-72005715	"Disease related genes, Metabolic proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 14.0;Exocrine glandular cells: 13.6;Kupffer cells: 14.2;Langerhans cells: 12.9;Macrophages: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	16000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	14.4	18.4	6.0	25.0	6.3	7.9	13.6	7.1	9.1	12.5	4.9	12.7	8.3	10.4	3.5	6.4	10.1	8.1	10.9	5.8	8.3	24.9	15.0	31.1	26.2	8.7	7.8	11.1	8.4	2.5	10.7	17.1	9.0	16.5	11.0	3.8	8.9	4.2	5.0	7.4	17.2	13.5	6.1	49.2	10.2	6.1	8.5	6.5	12.6	2.4	11.9	12.2	8.5	7.3	1.7	2.3	5.1	2.9	1.0	1.6	5.9	3.3	1.8	3.0	4.0	11.7	2.4	1.2	2.2	1.3	3.4	4.0	2.5	2.4	2.0	2.5	3.8	4.5	7.6	3.7	1.3	2.4	12.3	2.4	2.3	2.4	1.2	3.5	6.3	7.9	7.4	2.0	1.8	3.2	3.8	5.7	3.6	1.9	2.2	6.1	5.4	1.9	2.1	4.4	2.8	5.3	3.0	4.2	3.7	4.8	3.6	2.7	13.6	4.2	3.5	5.1	1.9	3.3	1.8	2.1	1.7	11.5	2.3	7.0	20.2	56.1	52.5	72.9	23.9	31.9	27.5	31.6	36.9	20.2	22.5	32.5	8.6	5.2	60.9	53.7	15.1	39.8	6.0	6.3	7.1	9.1	5.8	8.3	8.7	7.8	9.0	6.1	8.5	7.3	14.0	6.4	3.3	0.7	8.0	2.0	0.4	0.7	0.0	3.3	2.1	1.9	1.8	1.5	1.0	0.0	10.4	1.0	7.2	0.5	0.0	3.0	0.0	1.1	1.9	11.1	0.0	0.8	0.7	13.6	1.4	3.4	1.1	1.8	7.6	2.2	10.4	0.5	11.2	3.3	0.5	0.8	0.0	14.2	12.9	0.0	0.9	15.4	0.0	1.0	4.6	1.1	7.2	0.5	0.0	5.4	0.2	0.7	2.3	1.0	1.1	1.9	1.8	3.7	0.0	1.8	1.6	0.7	0.5	0.6	2.0	0.8	6.4	1.6	0.8	0.2
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991960-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 6.4;pons: 1.9"	"Immune cell enriched"	"Detected in some"	26	"neutrophil: 377.5"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 377.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 469.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	27000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	19.7	5.9	0.2	35.5	0.7	52.8	3.7	0.3	6.4	10.3	1.9	29.7	0.8	2.5	3.5	41.2	17.7	5.3	4.0	0.2	0.5	16.0	11.6	30.8	3.3	0.5	0.4	1.2	3.7	0.3	0.8	20.1	1.9	2.3	43.7	0.1	7.9	2.2	1.2	30.7	4.6	3.4	0.3	90.1	33.0	0.5	0.7	7.4	1.9	2.9	38.5	6.2	20.5	0.3	7.3	0.9	0.0	0.0	0.9	1.2	0.8	0.0	0.2	0.0	0.1	7.7	0.2	0.1	14.7	0.0	0.3	2.9	0.0	0.5	0.0	469.8	0.4	0.1	0.1	4.0	2.5	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	60.4	0.0	0.0	0.0	0.0	24.0	1.7	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	0.4	7.2	0.2	0.0	0.3	0.0	0.5	0.2	0.0	0.1	4.3	0.0	0.0	2.3	0.0	0.0	0.9	0.0	14.5	0.0	0.0	0.0	377.5	0.2	0.1	0.2	5.9	1.5	0.2	0.7	0.3	6.4	0.2	0.5	0.5	0.4	1.9	0.3	0.7	0.3	1.2	6.4	1.1	0.0	1.7	147.9	13.5	2.0	495.7	0.0	0.5	0.4	0.6	10.0	0.3	1.8	0.0	1.2	1.2	23.8	5.9	15.0	2.8	14.5	1.5	4.4	6.7	2.7	0.0	8.3	36.3	6.1	18.3	8.0	2.5	0.0	3.6	16.2	5.8	0.0	0.0	117.4	0.0	207.9	1083.3	4.0	0.3	210.8	32.0	0.0	3.5	0.0	0.0	0.0	0.0	211.0	26.8	0.0	1.6	20.4	0.0	0.7	2.2	0.0	6.6	0.7	3.8	0.7	2.2	38.1	84.0	27.8	2.7	0.4	26.8	14.4
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 225.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 23.8;neutrophil: 95.0"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 95.0"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		350000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	6.2	2.9	4.0	11.4	1.1	20.3	4.3	0.0	8.7	4.4	0.5	2.2	1.8	4.0	2.6	13.1	5.4	12.1	3.9	4.6	3.1	3.3	225.8	8.2	2.7	2.4	3.7	3.0	3.9	1.5	1.2	37.0	3.3	3.9	2.2	2.4	5.2	3.4	1.3	11.9	2.2	6.4	1.5	5.4	4.5	1.3	5.5	4.6	4.0	2.1	4.8	9.4	5.5	3.3	13.3	3.0	5.5	0.8	9.5	7.7	10.0	5.8	11.9	13.4	13.2	5.8	29.3	2.2	59.2	16.4	31.1	34.1	3.0	57.6	18.7	2.5	3.6	2.9	5.3	14.5	19.6	20.2	9.5	10.3	23.1	19.7	59.2	27.8	6.0	5.9	0.4	0.2	6.4	6.5	1.7	9.4	8.5	6.0	6.0	9.5	8.2	4.8	5.3	14.8	1.0	0.0	26.3	15.0	247.1	5.2	9.6	14.6	7.9	10.3	10.4	32.1	26.6	5.0	0.2	0.5	17.2	18.0	60.9	11.7	3.8	23.8	1.8	4.3	3.3	2.1	2.1	2.3	3.8	2.1	2.0	1.3	95.0	0.3	6.3	0.6	2.1	1.4	4.0	1.1	0.0	8.7	4.6	3.1	2.4	3.7	3.3	1.5	5.5	3.3	3.5	0.0	14.7	6.5	6.8	44.7	16.5	45.8	68.9	6.5	2.5	4.7	5.5	40.0	22.8	3.7	8.4	8.5	3.6	1.8	0.0	7.7	4.4	8.6	3.8	8.0	5.4	4.4	44.3	7.5	109.2	7.3	7.1	12.3	7.6	0.7	7.5	295.8	7.8	0.0	63.3	1.4	4.1	33.7	17.7	0.6	4.4	28.8	8.8	53.4	5.0	1.0	6.2	298.6	1.5	19.7	0.8	2.6	5.3	11.5	0.7	1.1	8.7	0.6	0.0	18.0	5.1	0.1	0.6	30.9	37.2	24.2	5.2	1.4	1.1	14.3
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 1969.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2"	"Group enriched"	"Detected in many"	694	"dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000	45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	13.0	2.1	0.2	46.7	0.4	233.3	9.0	0.4	1.3	278.1	1.1	4.4	10.7	2.5	2.9	1969.7	2.1	17.0	2.5	0.3	0.3	1.6	248.5	20.1	1.4	0.4	0.5	0.9	1.8	2.0	2.3	21.1	0.8	2.4	4.0	0.0	287.1	7.5	0.8	128.6	8.8	3.9	0.8	14.7	45.5	6.4	1.3	5.2	6.4	3.0	311.7	185.7	465.0	0.6	59.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.2	0.0	0.6	0.2	0.2	0.0	1.1	112.3	0.0	3.3	0.0	0.1	0.0	0.3	0.0	17.3	0.0	0.3	20.3	0.0	14.3	0.7	0.0	2.0	0.0	0.0	0.3	0.3	0.0	0.5	0.1	14.7	0.0	13.2	0.0	0.0	0.1	0.1	0.0	106.6	0.0	0.0	0.1	0.8	0.1	0.0	0.0	27.3	0.3	1.4	0.0	0.7	0.1	0.6	0.1	0.2	10.3	10.5	0.3	0.0	63.8	1.9	0.0	27.7	0.0	0.1	0.0	0.0	61.7	0.1	0.1	0.1	240.2	0.0	13.7	0.8	0.1	19.8	0.2	0.4	0.4	1.3	0.3	0.3	0.4	0.5	0.8	0.8	1.3	0.6	1.7	6.4	7.7	0.0	4.1	184.4	81.3	151.8	56.9	0.0	4.9	3.4	0.4	11.5	60.6	3.7	0.0	1.8	0.2	6.5	0.0	27.5	34.8	7.8	1.4	4.8	0.0	3.2	0.3	28.0	2.9	11.0	44.4	23.6	10.1	0.0	3.3	53.0	306.0	0.0	0.2	1.1	6.1	39.8	292.6	93.3	0.6	111.1	24.9	0.0	22.6	0.0	2.1	0.5	0.2	149.9	0.1	0.4	2.8	58.4	9.3	0.2	20.2	0.0	0.0	0.3	3.8	0.8	0.2	469.7	336.6	4.5	3.3	0.0	3.2	464.9
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Melanocytes: 3.6;T-cells: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300					"Cluster 7: Non-specific - Mitochondria"			"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.4	0.0	0.0	0.0
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865623-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.8;skin 1: 1.1"	"Cell type enriched"	"Detected in some"	4	"Basal keratinocytes: 69.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000			"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	6.6	15.1	0.0	0.0	9.4	3.7	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.3	0.0	9.9	0.0	0.1	0.0	0.1	7.3
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.4;skin 1: 37.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 58.6;Endometrial ciliated cells: 110.4;Glandular and luminal cells: 69.8;Muller glia cells: 54.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;HaCaT: 6.9;OE19: 10.1;RT4: 11.5;SH-SY5Y: 10.8;T-47d: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favorable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.9	8.8	3.0	0.7	3.5	0.1	26.4	3.9	2.7	17.1	4.9	4.6	3.1	5.9	4.4	7.0	17.3	4.9	2.4	2.4	3.9	0.4	0.4	5.9	0.0	3.7	4.7	4.9	7.9	2.8	1.6	0.2	4.0	8.6	4.6	4.9	9.7	5.5	0.7	37.7	1.3	3.0	4.3	0.0	6.2	2.0	4.2	1.6	1.1	2.4	2.6	6.0	11.9	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	9.5	0.0	0.1	1.5	0.1	6.9	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	10.1	1.4	0.0	0.4	0.0	0.0	11.5	0.7	10.8	0.5	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.5	3.9	2.7	2.4	3.9	3.7	4.7	4.0	4.3	4.2	3.5	1.4	3.2	26.1	6.2	0.0	21.9	12.0	12.7	6.2	3.5	58.6	39.5	4.6	37.1	22.3	3.7	0.0	2.7	0.5	12.1	0.0	15.3	0.8	110.4	8.0	1.1	7.3	0.0	0.1	0.7	10.6	5.0	19.9	69.8	2.5	0.1	0.4	0.0	0.5	0.0	1.3	23.1	28.5	0.0	1.6	0.9	8.7	0.8	14.2	0.0	0.0	54.6	0.0	3.0	0.3	13.1	11.7	15.1	0.0	18.7	1.7	1.2	36.0	1.3	0.0	2.3	1.7	0.3	3.8	25.3	18.0	8.2	1.3	6.4	12.3	21.1
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402174-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.5	0.4	1.4	11.9	1.0	7.6	0.2	1.1	2.6	0.2	0.9	0.8	0.6	0.3	0.2	0.3	0.2	1.1	0.7	0.9	2.3	0.9	0.4	2.9	24.7	2.1	2.3	0.2	0.3	0.0	0.5	0.8	3.3	0.4	0.9	1.1	0.6	0.1	0.3	0.8	2.1	0.7	1.2	5.5	1.5	1.1	1.2	14.4	0.6	0.0	18.8	2.2	0.2	1.6	0.1	0.2	0.3	0.2	0.0	1.3	0.8	0.8	0.1	0.1	2.2	0.2	0.2	25.9	0.2	2.1	1.4	0.1	0.0	0.1	0.1	110.8	0.1	5.4	0.2	0.7	3.4	0.2	1.5	3.8	0.0	6.8	0.1	0.7	0.0	0.6	0.3	49.3	3.8	0.2	0.1	0.5	0.9	0.1	0.0	0.4	37.2	63.0	0.0	0.1	0.2	0.2	0.1	0.1	2.7	0.2	0.1	1.3	2.8	1.9	0.7	0.6	0.2	24.7	9.4	5.9	5.2	1.4	0.2	0.5	0.4	0.1	13.4	8.3	4.9	1.8	8.6	14.2	2.3	14.2	9.2	9.3	0.9	9.5	27.0	1.1	10.8	7.3	1.4	1.0	1.1	2.6	0.9	2.3	2.1	2.3	3.3	1.2	1.2	1.6	0.2	0.0	1.3	0.0	15.5	0.4	0.1	0.0	0.0	2.0	0.2	0.1	1.9	0.0	0.0	0.0	4.2	0.1	21.8	0.1	0.0	0.0	6.5	0.1	0.2	0.9	0.0	0.0	0.4	0.0	0.1	0.3	1.5	0.2	0.0	0.0	1.1	0.2	8.2	0.0	0.5	0.0	0.0	5.0	11.4	5.7	0.0	3.6	1.8	2.8	1.8	0.2	23.7	0.5	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.5	0.0	0.8	0.8	0.2	0.0	0.0	0.9	0.1	25.1	0.1	0.1	0.1
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 3.6;lymphoid tissue: 3.2"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 8.9;Breast myoepithelial cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	NA	NA	40500000			"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.3	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.1	0.0	0.0	0.0	8.9	9.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"urinary bladder: 44.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 43.4;Ionocytes: 73.2;Langerhans cells: 151.8;Pancreatic endocrine cells: 70.5;Spermatocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 14.1;memory B-cell: 18.9;memory CD4 T-cell: 25.7;memory CD8 T-cell: 12.5;naive B-cell: 21.5;naive CD4 T-cell: 28.1;naive CD8 T-cell: 17.6;T-reg: 15.6"	"Group enriched"	"Detected in many"	12	"B-cells: 21.5;T-cells: 28.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.3;CAPAN-2: 25.6;U-266/70: 42.1;U-266/84: 20.5"	"Region enhanced"	"Detected in some"		"white matter: 3.9"	"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	11000		"Cluster 30: Non-specific - Translation"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.6	0.3	0.3	2.1	0.2	3.2	0.3	0.1	0.2	0.4	0.1	0.4	0.2	1.0	0.5	4.5	0.4	0.9	0.3	0.4	0.2	0.6	1.1	1.2	4.2	0.3	0.2	0.3	0.7	0.0	0.6	0.6	0.2	0.5	0.3	0.1	1.3	0.2	0.2	0.7	1.9	0.0	0.2	2.2	0.7	4.4	0.3	7.2	0.4	0.0	8.8	44.5	0.5	0.3	15.3	0.3	0.5	0.5	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.5	25.6	0.9	7.5	0.0	0.8	1.3	0.0	2.5	0.1	1.1	0.5	0.4	0.3	1.2	0.0	0.3	0.9	0.1	0.0	0.0	0.7	3.1	0.0	3.5	0.6	6.2	0.1	0.6	0.6	0.8	2.2	0.3	0.4	0.4	0.2	0.6	8.9	7.4	0.5	0.6	0.3	0.4	1.4	2.1	0.2	7.0	0.5	0.5	0.5	0.4	1.8	42.1	20.5	2.1	0.5	3.7	0.4	0.0	0.4	0.0	2.8	0.0	14.1	18.9	25.7	12.5	0.9	21.5	28.1	17.6	0.2	2.0	0.1	0.1	15.6	10.0	0.3	0.2	0.1	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.5	3.2	2.2	0.0	13.6	3.6	12.1	16.2	0.6	0.0	1.2	1.4	0.4	0.0	23.7	1.8	0.0	0.4	1.5	1.1	1.9	43.4	6.9	11.1	1.0	1.4	0.0	0.0	0.3	7.4	0.5	2.3	1.5	16.6	0.0	0.3	0.0	0.5	2.5	0.0	0.2	1.0	73.2	0.8	151.8	4.2	0.3	14.7	8.8	0.0	34.7	0.5	0.0	0.0	0.3	70.5	0.1	0.7	7.4	6.1	0.4	0.6	15.3	0.5	0.0	0.4	1.4	41.9	6.9	0.6	4.0	0.0	14.4	0.2	2.0	16.3
IL23R	IL-23R	ENSG00000162594	"Interleukin 23 receptor"	Q5VWK5	1	67138907-67259979	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.6;testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.1;Enteroendocrine cells: 3.0;Late spermatids: 6.0;T-cells: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"MAIT T-cell: 21.7"	"Lineage enriched"	"Detected in single"	29	"T-cells: 21.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.4;HMC-1: 9.1;K-562: 3.6;U-2197: 13.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056427	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA056427: AB_2683129"	"unprognostic (4.01e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.41e-3)"	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.9	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.4	1.5	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	2.4	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	13.8	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	21.7	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.6	1.6	0.0	0.0	11.1	0.2	0.1	0.1	3.0	0.0	0.3	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.2	6.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.0	4.2	0.0	0.4	0.2
IL24	"C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16"	ENSG00000162892	"Interleukin 24"	Q13007	1	206897443-206904139	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.2;lymphoid tissue: 25.5;urinary bladder: 14.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.8;Basal prostatic cells: 2.9;Fibroblasts: 11.6;Smooth muscle cells: 7.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 9.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 5.4;T-cells: 3.6"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 172.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025972	Uncertain				"Secreted to blood"	NA	NA	140000		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB025972: "	"prognostic favorable (5.09e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.43e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.33e-2)"	3.5	0.1	0.1	3.6	0.1	1.5	0.7	0.1	0.2	0.4	0.2	1.3	0.0	1.0	0.0	0.9	1.0	1.3	0.8	0.1	0.3	0.8	1.2	1.8	5.8	0.2	0.4	0.2	0.2	0.0	0.5	0.9	0.3	1.0	0.0	0.0	1.1	0.0	3.8	0.2	15.2	0.1	0.1	25.5	0.6	0.1	0.3	0.0	1.0	0.0	0.2	14.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.7	0.0	0.4	0.0	0.5	0.2	0.1	0.0	3.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	2.5	18.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	16.7	0.7	0.0	0.0	0.0	2.3	1.2	7.4	0.5	2.5	0.8	0.3	1.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	5.4	1.7	2.7	0.0	5.0	3.6	2.9	0.4	0.4	0.0	0.0	1.9	0.8	0.1	0.1	0.1	0.2	0.1	0.3	0.2	0.4	0.3	0.1	0.3	0.1	0.2	0.0	1.3	0.0	1.8	6.8	2.9	0.5	0.0	0.0	0.4	0.3	1.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	0.7
IL25	"IL-17E, IL-25, IL17E"	ENSG00000166090	"Interleukin 25"	Q9H293	14	23372809-23376403	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	22	"Cardiomyocytes: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB024864	Uncertain				"Secreted to blood"	NA	NA	4230000					"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB024864: "	"unprognostic (1.49e-1)"				"unprognostic (6.82e-2)"													0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
IL27	"IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28"	ENSG00000197272	"Interleukin 27"	Q8NEV9	16	28499362-28512051	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antiviral protein, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 26.7"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 18.1;Syncytiotrophoblasts: 23.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 4.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.6;intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"BEWO: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB024722	Approved				"Secreted to blood"	NA	NA	521000		"Cluster 7: Monocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB024722: "	"unprognostic (4.79e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (1.30e-4)"	"unprognostic (3.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (6.07e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.41e-7)"	"unprognostic (6.44e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	0.2	0.2	0.2	1.2	0.1	0.9	0.1	0.3	0.4	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.1	26.7	0.5	0.4	0.4	0.4	0.0	0.1	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	1.7	0.1	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	3.6	0.8	0.0	3.8	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.5	0.1	0.0	0.2	1.0	0.2	0.1	0.3	0.4	0.3	0.2	0.4	0.4	0.2	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	18.1	0.9	0.0	0.4	0.0	0.0	3.5	1.2	0.1	0.0	2.3	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.1	0.0	0.0	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;lymphoid tissue: 17.4;urinary bladder: 11.2"	"Group enriched"	"Detected in some"	6	"granulocytes: 80.8;monocytes: 177.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 175.9;T-reg: 248.0"	"Group enriched"	"Detected in many"	14	"granulocytes: 175.9;T-cells: 248.0"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 1113.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced					NA	NA		410000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	18.9	1.9	0.0	14.2	0.0	0.4	1.4	0.1	0.2	0.5	1.1	3.3	1.9	0.5	0.2	2.6	0.3	2.9	0.8	0.1	0.1	0.7	0.5	2.4	17.4	0.5	0.1	0.1	0.5	0.3	0.9	2.5	0.4	0.4	2.1	0.0	0.5	0.8	0.1	0.4	6.5	4.7	0.1	7.5	1.2	0.2	0.2	5.2	1.3	0.6	12.9	11.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1113.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	0.4	18.9	0.0	0.3	0.0	175.9	0.1	20.1	0.6	0.0	2.2	14.7	27.3	3.1	0.2	7.3	2.0	0.2	0.9	13.4	0.3	0.2	248.0	3.2	0.0	0.0	0.1	0.2	0.1	0.1	0.5	0.1	0.4	0.1	0.2	0.2	0.4	0.0	1.8	1.0	13.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.2	0.2	0.6	0.4	0.0	0.8	0.2	0.6	0.0	0.7	1.1	0.1	80.8	0.0	0.4	0.2	0.3	0.0	0.2	0.0	0.0	7.7	4.8	0.1	0.0	19.3	3.6	1.9	177.6	0.0	2.1	0.0	0.3	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.1	0.6	0.0	19.6	0.0	0.1	0.2
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 118.0;lymphoid tissue: 346.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 186.1;dendritic cells: 199.0;Distal enterocytes: 202.0;NK-cells: 310.0;Paneth cells: 133.2;Plasma cells: 221.2;T-cells: 289.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"Karpas-707: 2316.2"									"HPA046641, HPA049691"	Enhanced		Approved	Vesicles		NA	NA		13000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA046641: AB_2679733, HPA049691: AB_2680851"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	12.8	6.2	2.7	132.2	2.4	87.3	14.1	2.5	6.3	10.2	4.0	98.9	50.4	7.5	7.5	15.1	6.8	28.2	4.6	2.3	2.8	7.1	20.6	51.7	235.6	3.6	2.7	4.9	4.1	1.9	1.5	16.9	4.2	7.8	118.0	0.5	19.0	5.9	2.6	15.4	82.8	12.3	3.1	119.4	41.4	2.2	3.0	346.4	5.8	6.3	306.9	46.4	5.5	3.8	1.2	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	4.7	9.1	187.3	13.5	0.0	0.7	1.7	0.4	0.0	0.0	160.3	0.2	23.6	0.3	0.3	0.2	99.3	4.0	0.0	0.0	0.0	0.1	0.1	0.0	220.5	43.3	2316.2	0.0	0.0	356.4	193.7	0.4	0.9	0.1	79.5	0.8	20.0	0.0	0.7	0.2	0.3	2.3	0.1	0.5	0.0	0.0	3.5	0.4	0.0	1.0	0.0	0.5	132.1	242.2	119.6	2.1	397.4	0.9	540.5	102.2	169.7	1204.7	239.5	1179.9	604.7	1086.3	1250.7	243.5	603.0	742.0	943.1	773.0	1190.3	177.0	368.9	1422.2	1494.0	2.7	2.4	2.5	6.3	2.3	2.8	3.6	2.7	4.2	3.1	3.0	3.8	3.3	3.2	11.2	0.0	186.1	8.2	8.1	13.1	1.2	0.0	1.5	1.7	0.9	4.3	4.2	0.0	0.0	0.5	199.0	202.0	0.0	1.2	0.1	0.8	0.7	5.8	77.7	27.1	0.0	2.3	0.3	4.2	13.7	0.7	39.3	0.4	6.1	2.1	31.1	0.0	0.0	24.5	4.1	25.2	116.7	0.0	0.0	45.4	42.7	1.0	91.1	0.1	310.0	0.0	0.1	28.0	133.2	0.4	221.2	4.3	88.8	1.1	2.3	0.4	0.0	1.3	2.6	0.0	0.1	1.8	6.8	0.3	289.5	0.0	18.6	8.9
IL31	IL-31	ENSG00000204671	"Interleukin 31"	Q6EBC2	12	122172029-122174221	"Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Early spermatids: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025657	Uncertain				"Secreted to blood"	NA	NA	37800					"Cluster 34: Spermatids - Unknown function"			"CAB025657: "														"unprognostic (1.70e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851357-55922854	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;lymphoid tissue: 2.1;testis: 1.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Late spermatids: 1.2;Spermatocytes: 2.5;Syncytiotrophoblasts: 1.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 26.3;HBEC3-KT: 10.3;HHSteC: 9.5;hTERT-HME1: 11.5;U-2 OS: 16.8;U-87 MG: 20.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.1	1.8	0.0	2.1	0.0	0.6	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.4	0.5	0.2	0.5	0.3	0.1	0.0	0.2	0.0	0.0	0.4	26.3	0.0	0.0	10.3	2.2	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	7.3	2.9	4.8	11.5	0.6	4.1	0.1	0.0	0.4	1.4	0.0	0.0	1.2	0.0	0.0	6.8	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	2.0	0.5	16.8	0.0	0.8	0.0	0.0	0.0	20.8	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.3	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	2.5	0.6	0.0	0.1	1.1	0.0	0.7	0.0	0.0
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 829.3;pancreas: 674.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1696.0;Exocrine glandular cells: 1490.0;Pancreatic endocrine cells: 2546.1;Proximal enterocytes: 4916.6;Proximal tubular cells: 4315.8;T-cells: 1711.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 4625.7"	"Lineage enriched"	"Detected in all"	8	"T-cells: 4625.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 514.7;CAPAN-2: 328.6;HDLM-2: 707.9;Hep G2: 504.3;Karpas-707: 404.6;MOLT-4: 319.9;RH-30: 348.0;U-937: 314.5"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"	NA	NA	46100		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	91.1	36.7	21.3	206.7	21.0	49.1	58.7	20.3	27.6	19.2	19.0	206.5	339.8	30.4	13.5	45.5	20.6	117.4	180.6	19.1	20.0	418.8	829.3	271.5	402.7	24.0	20.4	22.3	674.4	10.2	17.7	62.8	23.0	54.2	142.7	1.0	87.1	42.2	543.7	26.9	558.9	88.4	21.2	440.7	87.4	19.2	24.8	198.0	84.3	328.6	200.2	118.8	23.1	21.3	254.1	10.7	1.2	0.3	0.5	28.4	19.5	12.4	31.3	14.9	24.8	514.7	328.6	0.6	59.8	7.0	92.1	10.7	1.0	29.6	18.0	707.9	2.7	1.2	49.8	504.3	55.7	1.4	20.5	34.2	3.4	12.9	54.9	12.1	60.0	7.9	0.7	404.6	19.5	1.7	319.9	8.2	7.2	3.2	7.6	0.7	348.0	34.4	239.3	16.7	0.7	3.9	109.9	7.4	1.9	50.9	7.2	4.0	161.6	56.9	67.2	3.1	36.5	4.7	10.7	1.6	1.1	314.5	29.7	30.8	10.9	12.7	2570.7	9.1	2584.2	9.3	2337.1	2483.4	9.2	7.8	884.8	1712.5	46.9	553.7	11.3	13.4	4625.7	2238.1	21.3	21.0	20.3	27.6	19.1	20.0	24.0	20.4	23.0	21.2	24.8	21.3	334.4	198.7	64.9	0.0	81.7	59.5	68.0	462.2	12.0	0.4	50.3	44.3	5.6	221.6	119.6	119.5	0.0	9.0	550.3	1038.3	252.4	1696.0	0.2	46.5	36.7	286.4	135.1	64.6	0.1	1490.0	14.1	136.7	118.3	53.7	52.6	1.5	68.6	124.1	4.2	0.0	0.1	273.1	244.1	40.5	116.1	1.9	35.1	60.7	65.8	5.6	225.8	0.0	518.0	0.0	0.1	2546.1	1004.5	45.9	81.7	101.2	4916.6	4315.8	55.1	0.6	19.7	278.5	117.4	5.8	1.3	7.1	51.6	6.6	1711.8	27.8	182.2	105.7
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 120.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 53.6;U-2197: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	38.7	16.7	9.2	44.6	9.3	0.2	27.2	7.0	12.1	56.2	6.4	24.8	8.8	50.0	15.9	24.5	25.9	33.4	40.9	8.5	10.8	5.0	36.7	53.0	47.1	7.8	8.3	5.0	3.4	3.7	5.7	61.1	7.1	30.0	19.4	2.0	18.9	31.5	6.1	44.0	15.6	50.8	8.3	20.5	33.6	5.8	10.8	13.1	12.6	13.8	43.0	120.7	21.2	8.6	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.1	16.9	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.7	0.3	0.4	53.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	162.9	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	9.3	7.0	12.1	8.5	10.8	7.8	8.3	7.1	8.3	10.8	8.6	63.5	6.4	7.2	39.5	1.0	24.2	17.0	73.9	27.3	0.0	9.4	4.1	5.8	4.3	77.8	0.0	0.0	0.0	0.1	2.2	0.0	3.0	0.5	12.4	7.1	141.8	10.7	8.0	0.2	7.9	0.0	87.5	48.4	20.6	1.3	0.0	499.4	5.0	0.1	0.0	0.1	0.2	2.0	20.8	10.2	1.6	20.5	1.7	1.8	1.0	0.0	9.5	0.0	0.5	0.1	12.1	0.2	12.4	0.2	5.2	0.0	0.0	62.1	0.1	0.0	65.5	11.5	0.0	0.4	3.3	48.4	0.1	1.2	0.1	1.1	4.9
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022089-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 2.2;lymphoid tissue: 3.8;skin 1: 8.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"GAMG: 71.8;U-87 MG: 73.3"	"Not detected"	"Not detected"							HPA035664	Uncertain				"Secreted to blood"	NA	NA	15300			"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"				"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	1.4	0.0	0.0	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 136.8"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.7	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	136.8	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"T-cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	861	"basophil: 474.9"	"Lineage enriched"	"Detected in single"	861	"granulocytes: 474.9"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	NA	NA	13600		"Cluster 38: Basophils - Unknown function"		"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB078477: AB_417057, HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.1	0.3	0.1	0.4	0.1	0.3	0.1	0.5	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.5	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	474.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.3;testis: 26.8"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 295.1;monocytes: 682.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	1.6	0.6	0.4	18.3	0.6	4.2	0.9	0.8	0.6	1.1	0.7	1.7	4.1	1.6	0.2	0.6	3.9	2.0	0.5	0.6	0.5	4.8	1.2	2.4	9.3	1.7	0.9	0.4	0.7	0.2	0.6	1.9	1.8	0.8	1.4	0.1	0.9	0.5	0.3	1.3	2.7	1.5	1.0	4.1	3.1	26.8	1.2	3.4	0.5	0.2	6.7	4.5	0.5	2.3	1.0	1.2	0.8	0.7	0.0	0.8	0.3	0.5	2.0	1.4	2.1	0.7	1.9	3.5	34.3	0.4	2.9	0.5	0.4	0.0	0.2	62.4	0.2	1.6	0.1	0.5	0.1	1.2	12.3	1.0	0.4	0.6	0.1	0.4	2.6	0.4	0.4	47.3	0.1	0.4	0.7	2.1	0.4	0.9	0.1	1.0	0.9	3.6	2.5	3.2	0.7	0.8	0.5	0.9	0.5	0.2	0.4	2.8	2.9	7.1	1.0	0.1	1.0	4.1	9.7	2.0	1.0	0.5	0.7	0.3	22.0	0.3	6.4	36.8	103.4	0.4	13.2	11.5	11.6	0.2	0.3	0.1	0.5	1.3	5.3	1.3	0.7	8.8	0.4	0.6	0.8	0.6	0.6	0.5	1.7	0.9	1.8	1.0	1.2	2.3	0.8	0.0	0.0	0.0	3.6	9.7	0.6	9.8	0.0	0.1	1.2	1.3	0.5	0.0	5.5	3.7	0.0	0.4	1.0	0.2	0.0	3.5	75.4	2.9	0.6	6.7	0.0	0.0	0.4	4.0	0.7	1.3	0.5	2.1	1.3	0.1	1.1	0.2	97.4	0.0	0.4	0.3	6.1	3.0	295.1	18.4	0.3	38.8	3.6	1.9	682.5	0.1	1.0	0.0	0.4	0.5	0.1	0.4	0.7	1.4	0.3	2.7	1.6	0.2	0.0	0.2	2.5	45.2	3.6	0.4	8.2	0.8	6.3	0.0	0.2	2.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;testis: 5.1"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.8;TIME: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB010304	Approved				"Secreted to blood"	NA	NA	4130		"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB010304: AB_2296159"	"unprognostic (1.66e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.30e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-2)"		"unprognostic (7.98e-2)"	"unprognostic (2.03e-2)"		"unprognostic (3.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	0.1	0.0	0.8	0.1	0.3	0.0	0.0	1.7	1.2	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.2	1.5	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.2	5.1	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	1.7	1.2	1.5	0.3	0.3	0.1	0.8	0.8	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.7	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	19.5	1.2	0.0	0.1	0.0	1.6	0.0	0.0	0.0
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 217.6;urinary bladder: 281.3"	"Group enriched"	"Detected in many"	4	"Adipocytes: 188.5;Endometrial ciliated cells: 163.9;Endothelial cells: 287.4;Fibroblasts: 593.3;Glandular and luminal cells: 322.2;Smooth muscle cells: 449.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	44	"memory B-cell: 3.9;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	48	"B-cells: 4.8"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 2214.7;GAMG: 1447.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	217.6	13.9	3.6	30.8	3.8	46.8	31.3	3.7	6.0	4.7	9.2	22.1	1.9	5.7	0.0	34.9	18.9	41.6	55.1	3.8	3.8	17.7	13.0	114.9	9.1	4.0	4.3	6.2	19.5	10.0	38.3	11.3	4.9	16.5	17.3	1.4	12.0	2.0	7.8	7.6	8.3	19.5	3.9	7.0	18.0	1.2	4.7	6.3	14.2	4.1	3.7	281.3	5.7	4.1	0.1	0.0	0.0	0.0	0.7	2.2	7.5	8.9	2214.7	43.2	151.0	0.0	0.6	0.2	71.6	15.2	1447.6	1.7	0.0	0.3	59.9	94.2	0.2	0.0	3.7	0.0	47.3	0.0	0.6	5.6	0.0	413.8	63.1	44.2	18.2	0.0	10.6	0.5	1.9	0.1	0.0	0.3	1.6	0.7	0.5	0.0	0.0	0.0	124.2	0.0	0.0	0.0	144.5	0.1	0.6	7.9	0.1	0.1	14.5	15.2	1.4	28.2	4.7	0.0	27.8	0.4	98.5	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	3.8	3.7	6.0	3.8	3.8	4.0	4.3	4.9	3.9	4.7	4.1	188.5	6.4	22.7	0.0	27.0	44.6	3.4	28.5	1.8	0.1	1.4	1.1	1.4	0.0	17.7	3.7	0.0	1.1	0.4	0.1	0.0	9.8	0.4	163.9	44.6	287.4	0.0	0.0	0.0	2.8	4.0	593.3	0.0	322.2	6.3	0.0	3.6	0.1	4.1	0.0	0.0	0.0	0.0	9.3	76.5	0.2	0.0	27.4	40.9	2.8	4.2	0.0	0.0	0.0	0.1	4.3	0.1	0.0	0.9	16.4	0.0	0.0	8.1	0.0	0.0	28.9	449.0	0.0	0.1	0.4	33.4	1.4	8.6	0.2	0.0	20.6
IL6ST	"CD130, GP130, sGP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55995022	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 16.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		160000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	67.1	46.0	26.8	14.1	31.0	9.6	51.3	30.9	36.7	43.0	21.3	33.9	4.2	35.2	18.5	18.4	34.2	23.6	35.1	23.5	31.4	30.0	77.6	53.3	15.9	32.1	27.0	36.9	21.9	39.6	22.5	101.7	35.9	32.6	14.3	28.6	31.9	29.9	41.0	17.8	31.1	28.7	35.1	34.7	27.8	8.9	25.3	23.6	40.4	34.7	16.2	37.7	35.1	42.9	14.4	35.6	9.4	18.8	75.5	151.3	22.3	54.5	175.2	44.1	62.4	40.5	16.3	1.1	33.7	52.5	71.6	7.8	9.8	19.2	84.1	1.6	8.5	4.6	20.1	14.2	155.1	0.4	6.2	135.1	11.1	103.1	42.7	43.6	101.8	1.9	3.7	51.0	47.0	2.9	0.7	0.8	1.5	1.8	10.1	1.1	22.5	14.4	22.5	12.1	3.8	5.9	26.6	5.7	19.7	13.7	29.5	3.1	147.8	12.4	10.1	44.5	24.6	14.6	8.2	0.5	28.9	1.1	31.1	0.0	3.9	0.1	0.7	3.4	0.3	0.8	3.7	0.8	2.1	0.4	16.7	4.8	0.6	0.8	0.5	1.9	4.1	4.0	26.8	31.0	30.9	36.7	23.5	31.4	32.1	27.0	35.9	35.1	25.3	42.9	221.6	134.6	149.8	59.4	30.0	103.9	98.0	60.6	71.2	56.5	202.4	81.3	81.5	124.4	105.4	68.0	35.5	77.9	33.1	34.5	7.9	85.3	12.3	76.4	227.6	256.2	19.8	41.1	25.7	62.0	75.5	285.5	59.1	580.3	32.9	58.6	808.5	219.8	56.0	16.8	70.0	34.1	46.8	93.7	99.1	16.7	105.9	60.3	80.0	188.3	45.8	190.8	7.2	75.4	64.2	80.8	35.6	130.5	100.6	163.9	33.6	52.2	80.3	39.3	98.6	158.7	150.3	54.4	38.6	44.9	83.5	101.8	75.5	228.7	17.1	106.1
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 108.8;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.7;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;HDLM-2: 15.4;HEL: 18.2;HMC-1: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019590	Approved				"Secreted to blood"	NA	NA	60700		"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	2.3	1.2	0.2	4.1	0.3	2.1	1.5	0.4	0.2	2.3	0.3	5.1	6.7	1.1	0.3	3.5	4.8	3.1	0.6	0.3	0.5	1.4	4.2	3.3	8.7	0.6	0.4	0.9	1.0	0.0	0.5	0.3	0.5	1.8	4.4	0.7	1.1	0.9	0.1	8.8	8.7	1.1	0.4	3.5	3.8	1.7	1.2	0.8	1.3	0.1	4.2	2.8	1.5	0.2	0.3	0.0	0.1	0.0	0.4	0.4	0.0	1.4	1.4	1.3	1.9	0.0	7.6	0.1	0.0	4.4	4.5	4.2	0.1	0.0	0.0	15.4	0.0	18.2	0.6	2.1	0.1	0.1	25.4	1.3	0.0	0.2	0.6	4.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	5.4	3.2	0.0	2.4	2.6	0.3	0.2	0.0	0.1	0.0	0.2	0.8	0.9	0.0	2.0	0.3	0.0	0.0	3.4	0.0	1.9	5.2	0.3	0.0	0.4	0.2	0.0	9.7	1.0	1.0	2.2	8.7	0.2	0.3	0.0	0.5	0.8	0.3	7.3	0.6	0.2	0.3	0.4	0.2	0.3	0.5	0.6	0.4	0.5	0.4	1.2	0.2	0.6	0.0	3.6	5.9	12.2	6.0	3.2	1.2	10.8	0.1	1.3	0.9	0.7	5.7	2.4	1.8	0.0	0.0	1.3	7.8	9.8	1.2	108.8	22.9	0.8	4.9	3.0	10.5	16.0	5.1	0.0	2.5	11.2	0.6	0.0	0.1	1.8	2.4	0.9	0.0	11.0	6.2	2.0	1.0	3.3	145.5	0.6	1.9	0.0	1.0	3.4	2.0	0.0	20.1	6.0	2.6	11.5	1.2	1.0	1.2	12.4	9.5	24.2	0.4	0.0	2.2	0.5	2.3	0.9	5.2	6.5	0.0	1.6	0.1	4.6	1.7
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	5	"granulocytes: 4.5;T-cells: 2.7"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.7;urothelial cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.8;granulocytes: 3.4;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 247.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.90e-7)"	0.1	0.0	0.2	1.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.5	0.6	0.2	0.1	0.5	0.3	0.8	0.0	0.1	0.1	0.1	0.2	1.0	2.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.9	0.1	0.4	0.1	0.1	0.4	1.7	0.1	0.1	1.7	0.7	0.0	0.1	3.4	0.3	0.0	2.2	4.4	0.2	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.3	23.8	0.0	0.0	0.0	0.5	247.8	0.0	0.2	0.0	0.0	0.0	0.0	5.6	3.7	0.8	0.0	1.1	9.5	4.9	0.0	0.1	0.0	0.6	0.1	0.0	0.0	19.2	0.2	0.1	0.0	0.4	0.2	0.0	0.3	0.4	0.0	0.1	0.6	0.1	0.1	1.2	0.6	0.9	0.2	0.3	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.8	0.3	0.6	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022247	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Club cells: 14.7;Collecting duct cells: 20.2;Cytotrophoblasts: 16.6;Distal enterocytes: 17.5;Glandular and luminal cells: 13.5;Respiratory ciliated cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;HDLM-2: 8.2;MCF7: 5.1;RT4: 7.5;T-47d: 5.3;U-266/70: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favorable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.0	0.7	0.2	1.3	0.1	0.3	2.9	0.2	0.3	11.7	0.1	8.2	3.3	1.0	12.8	3.8	5.1	3.3	0.0	0.1	0.0	6.5	0.2	2.9	1.1	0.1	0.1	0.0	6.7	15.7	2.4	1.8	0.1	6.9	7.2	0.2	8.0	10.6	0.1	1.2	2.4	0.3	0.0	0.6	0.8	0.6	0.1	0.8	7.3	0.0	2.2	2.2	1.1	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	6.3	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.4	2.8	7.5	0.2	0.0	0.0	0.7	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	1.4	1.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	12.8	7.4	0.3	1.3	0.0	0.8	7.5	0.0	0.0	4.2	2.4	0.7	4.3	14.7	20.2	0.0	16.6	0.1	17.5	1.9	7.5	0.2	6.3	1.6	0.1	3.5	0.0	0.5	3.7	0.5	0.1	1.1	13.5	0.0	0.2	0.0	0.1	1.2	0.0	0.5	7.9	8.2	0.6	0.0	0.0	0.0	0.3	1.8	1.9	0.0	0.0	0.0	0.0	0.2	2.6	8.9	0.0	2.1	2.2	2.5	2.1	13.7	0.0	0.0	0.0	0.6	0.0	0.1	5.9	0.6	5.1	0.1	0.0	7.8	3.5
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975540	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;retina: 10.6;testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.9;Excitatory neurons: 45.0;Muller glia cells: 89.1;Oligodendrocyte precursor cells: 96.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;JURKAT: 5.7;MOLT-4: 4.3;U-2 OS: 9.6;U-251 MG: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.3	0.3	7.0	0.2	6.7	0.5	0.0	0.0	8.0	0.1	0.0	1.6	0.1	0.1	0.4	0.1	0.2	0.3	1.4	8.7	4.4	2.8	0.4	0.4	0.2	0.0	4.8	0.1	0.1	0.0	1.4	0.1	0.2	0.8	0.3	10.6	0.1	1.1	0.1	0.0	0.2	0.7	0.0	0.1	0.1	8.8	12.8	1.1	0.1	0.2	0.2	0.3	0.1	1.5	0.0	0.0	7.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.8	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	4.3	0.0	2.7	0.1	0.0	0.0	0.2	0.5	0.5	0.1	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	9.6	0.0	5.4	1.8	0.0	0.4	1.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	6.7	0.0	8.0	8.7	4.4	0.0	4.8	0.2	0.0	12.8	1.5	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	4.3	0.0	0.6	0.0	6.2	0.0	2.0	0.2	0.0	0.1	12.7	0.0	0.1	0.2	1.2	0.0	45.0	0.2	0.3	0.6	0.0	0.1	0.0	1.7	0.4	1.6	0.1	1.7	17.6	0.0	0.0	0.0	0.0	18.8	0.6	0.2	0.0	5.6	0.6	89.1	0.0	96.0	16.5	0.1	0.2	0.0	0.9	0.0	0.0	4.9	0.0	8.8	0.0	8.8	0.5	4.8	2.0	0.0	0.0	0.3	0.5	0.1	0.3	0.0
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
ILRUN	"C6orf106, dJ391O22.4, FLJ22195"	ENSG00000196821	"Inflammation and lipid regulator with UBA-like and NBR1-like domains"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 211.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.9;Cardiomyocytes: 73.7;Cytotrophoblasts: 13.7;dendritic cells: 11.8;Hofbauer cells: 15.6;Syncytiotrophoblasts: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Supported	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Centrosome, Cytosol"	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	57.0	35.3	38.4	31.4	39.3	28.6	35.2	48.8	51.6	26.6	36.2	43.4	30.1	29.5	29.0	42.1	27.2	29.3	76.8	39.8	39.8	43.1	77.1	42.5	34.0	41.6	49.9	25.8	30.3	47.3	24.5	30.4	41.5	30.7	29.8	46.7	33.9	32.4	211.7	37.0	35.7	39.4	39.6	31.6	35.0	67.8	43.7	32.9	37.4	187.4	44.8	40.2	28.1	41.4	94.0	41.8	40.3	59.8	95.7	51.9	48.5	63.5	72.3	72.1	89.4	83.0	42.1	107.0	46.1	62.3	99.5	90.7	120.0	52.6	90.3	151.4	47.0	89.2	47.3	80.0	93.4	76.0	96.2	35.4	108.0	73.3	66.4	49.5	58.6	43.9	103.0	43.6	41.7	56.3	52.7	52.7	37.7	152.0	37.3	40.6	52.2	57.0	57.0	91.2	48.6	38.0	93.3	44.9	91.8	82.1	56.5	63.3	60.1	59.1	45.6	63.0	62.7	63.2	154.3	81.8	21.3	66.7	70.1	23.9	3.7	8.1	8.9	6.6	4.7	6.7	6.4	7.1	4.4	8.1	3.5	5.5	4.6	6.2	8.3	2.2	10.0	5.7	38.4	39.3	48.8	51.6	39.8	39.8	41.6	49.9	41.5	39.6	43.7	41.4	9.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.0	0.0	0.0	13.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	8.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	21.6	1.6	0.0	0.0	0.0
ILVBL	"209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535"	ENSG00000105135	"IlvB acetolactate synthase like"	A1L0T0	19	15114984-15125786	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067682	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus, Vesicles"		"HPA067682: AB_2685885"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.91e-8)"	"unprognostic (4.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.40e-1)"	29.7	45.5	22.7	13.9	27.5	15.5	27.5	30.9	25.1	29.7	32.8	46.2	50.1	24.3	14.4	40.9	22.6	25.5	73.7	21.4	25.5	41.6	56.8	19.2	15.5	29.2	25.3	28.3	42.5	65.8	34.4	19.2	26.3	24.2	18.6	13.8	27.7	23.2	18.7	43.4	43.7	13.7	24.8	17.6	41.1	25.5	25.2	10.5	48.0	25.0	10.6	28.5	30.6	32.3	68.8	41.0	34.4	40.7	43.8	29.7	39.6	31.6	42.2	37.2	47.5	65.5	162.1	29.7	61.1	34.2	22.3	50.6	20.9	38.5	10.8	27.5	41.1	43.7	41.3	72.4	70.1	37.2	37.0	44.6	43.9	21.7	28.3	30.4	35.0	29.6	17.9	37.6	29.3	159.0	24.9	29.6	31.9	54.9	58.8	36.0	31.1	46.5	32.3	33.6	28.4	38.3	18.8	81.2	62.1	13.2	37.2	31.2	37.7	55.9	30.7	71.0	45.1	26.1	29.2	15.1	35.9	35.8	43.1	22.7	22.2	5.5	21.1	31.8	24.0	11.9	17.7	22.0	26.3	12.9	22.9	23.6	2.5	23.7	30.3	19.1	20.2	23.3	22.7	27.5	30.9	25.1	21.4	25.5	29.2	25.3	26.3	24.8	25.2	32.3	28.0	25.6	11.7	18.3	12.7	12.7	26.8	53.8	22.2	95.3	18.0	14.9	36.1	62.9	43.0	25.8	27.1	84.2	15.8	67.8	19.6	48.4	6.2	9.9	13.4	23.2	44.4	12.6	4.9	50.6	148.2	21.4	40.2	13.0	11.4	29.0	26.7	59.3	43.2	18.5	8.3	60.6	28.5	12.1	9.5	6.5	25.7	15.8	83.6	5.6	6.8	48.0	7.2	9.0	15.7	32.3	68.4	19.9	17.2	18.6	123.0	50.4	26.1	36.8	19.7	14.7	21.2	20.3	20.8	25.0	16.2	253.4	11.8	48.2	73.2	23.4
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	11.7	15.6	42.8	6.4	43.7	11.1	19.3	45.5	66.4	13.5	41.8	12.7	8.6	11.5	29.8	11.7	10.4	5.1	26.2	42.8	42.3	27.2	18.6	8.9	9.5	42.4	42.0	17.5	16.4	17.9	23.3	6.9	42.3	14.3	10.0	37.7	11.8	14.1	50.0	12.5	9.5	10.7	42.9	10.8	15.1	16.7	43.0	24.8	13.2	42.1	13.1	10.9	12.6	43.5	22.9	26.9	95.6	21.0	14.9	9.9	15.3	19.9	8.7	16.2	11.7	21.0	17.5	20.7	18.7	15.9	32.5	25.8	37.6	28.8	23.8	24.9	52.6	29.4	45.5	32.3	15.8	29.6	19.9	8.0	27.1	8.7	19.2	29.5	17.5	48.8	38.0	23.2	15.9	28.2	48.5	48.9	15.8	114.6	26.3	41.1	72.2	20.6	54.6	26.2	22.5	27.0	32.5	11.6	32.5	61.9	37.1	35.1	2.6	15.3	27.2	16.2	42.2	17.2	58.2	47.5	24.9	24.9	18.5	21.9	3.0	32.2	28.9	3.4	26.3	34.1	25.3	29.5	8.1	32.1	32.0	39.8	0.8	37.3	3.0	40.2	35.4	13.6	42.8	43.7	45.5	66.4	42.8	42.3	42.4	42.0	42.3	42.9	43.0	43.5	29.2	35.3	14.6	30.7	22.4	18.2	26.8	60.5	12.0	30.6	44.6	55.1	56.8	18.6	26.8	60.7	33.3	36.3	17.6	21.7	119.3	17.0	39.8	30.2	16.9	19.4	56.5	47.4	40.6	24.5	32.5	19.7	20.9	33.8	22.7	22.7	18.2	45.0	21.3	43.7	48.0	30.6	52.9	7.7	11.4	10.5	13.4	9.4	8.8	24.4	10.3	85.3	30.9	51.3	60.7	15.8	26.7	20.7	22.0	26.0	18.6	98.4	28.9	38.5	32.9	19.1	51.0	61.6	23.0	19.6	27.3	23.7	24.2	16.2	34.7	26.2
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110662644-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 247.8;Distal tubular cells: 160.4;Excitatory neurons: 365.4;Inhibitory neurons: 373.9;Microglial cells: 455.3;Oligodendrocyte precursor cells: 273.9;Oligodendrocytes: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026711	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	19.2	14.2	10.4	5.1	12.5	5.2	15.7	9.6	11.7	12.4	14.2	14.6	7.6	15.3	11.9	8.0	16.0	8.5	13.1	11.9	12.2	34.0	25.7	8.1	7.5	11.3	11.3	19.5	12.1	20.1	8.0	9.0	11.3	19.0	8.2	9.2	11.1	21.1	27.3	10.2	12.9	14.2	10.9	8.4	11.8	9.9	11.4	8.9	23.5	25.1	7.5	12.5	10.5	13.1	17.5	10.3	6.1	25.1	15.8	16.0	10.7	11.8	11.9	7.7	8.1	5.1	19.8	28.4	31.4	10.2	14.3	9.6	6.6	23.6	12.7	17.9	6.7	9.7	44.2	14.0	24.2	18.2	1.1	27.9	30.7	3.3	21.4	35.0	10.2	26.2	32.0	21.4	5.9	12.3	24.4	20.3	6.0	33.2	15.8	5.1	50.0	15.0	28.0	7.3	7.0	22.1	5.1	23.8	67.3	17.2	9.6	10.4	6.5	11.8	12.3	11.9	14.4	12.2	3.5	17.4	12.9	8.4	63.1	15.9	9.1	2.9	10.5	11.9	19.4	28.5	18.3	12.3	17.0	38.7	25.0	17.6	0.5	47.0	17.3	21.3	12.4	8.1	10.4	12.5	9.6	11.7	11.9	12.2	11.3	11.3	11.3	10.9	11.4	13.1	22.3	19.2	13.2	247.8	20.4	32.9	34.4	41.4	39.9	11.3	35.3	39.4	19.5	15.7	23.9	47.8	8.4	22.4	11.9	3.1	160.4	30.1	8.4	10.4	12.6	15.3	19.3	21.9	365.4	8.1	27.1	19.5	12.8	12.0	3.8	11.3	11.7	23.8	11.7	8.4	373.9	7.0	28.5	4.9	14.1	5.6	49.4	6.1	21.4	455.3	10.1	16.3	1.0	273.9	233.7	10.8	6.8	35.0	9.2	36.2	25.5	66.8	13.3	15.6	13.1	19.5	46.7	24.2	12.8	28.0	26.6	16.3	12.6	18.7	11.7	22.1
IMMT	"HMP, Mic60, MICOS60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195472	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 288.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	41.3	82.4	30.3	34.9	31.8	40.3	36.5	33.1	39.0	30.2	41.9	57.4	57.4	35.0	27.6	43.4	30.9	27.1	174.8	31.9	34.5	80.9	65.0	32.5	44.3	35.3	34.2	28.1	48.5	90.2	36.0	36.7	35.1	29.4	58.1	42.4	37.9	35.1	200.9	38.0	46.6	38.9	29.8	44.8	56.0	49.2	32.6	52.3	35.5	288.9	47.1	41.5	33.8	32.8	115.6	111.2	99.2	45.6	93.7	88.3	101.5	80.5	85.6	108.0	98.7	160.7	89.1	175.7	78.9	87.7	87.7	83.4	128.9	118.4	131.8	71.4	105.9	139.0	65.6	192.0	95.7	135.9	91.1	100.6	84.0	101.7	119.5	67.2	124.7	99.7	138.4	96.7	105.1	99.0	135.6	140.8	117.8	175.1	88.2	89.9	211.2	158.7	122.5	128.3	119.3	89.0	82.9	124.0	126.3	77.4	70.7	94.6	93.6	76.0	83.6	112.0	101.8	76.6	104.1	119.9	86.9	158.8	94.4	12.1	29.2	12.2	23.5	34.0	20.7	15.9	20.6	19.3	32.9	13.7	18.3	22.3	3.8	20.8	33.2	17.2	23.2	25.4	30.3	31.8	33.1	39.0	31.9	34.5	35.3	34.2	35.1	29.8	32.6	32.8	29.3	54.5	49.2	31.3	42.1	23.3	34.9	51.6	30.1	40.9	21.6	19.7	223.0	24.3	57.3	40.5	33.3	94.9	49.6	57.9	133.1	59.9	152.4	26.5	34.0	38.3	56.0	76.1	41.6	52.8	73.9	36.3	39.8	26.8	48.0	55.6	35.7	64.2	70.9	23.5	46.5	46.2	38.7	49.4	28.3	158.9	27.7	48.9	17.8	26.2	80.6	30.2	52.5	29.1	44.1	43.3	36.3	36.9	56.4	28.6	59.8	92.6	41.8	42.5	6.6	39.7	58.2	100.7	54.6	41.1	24.9	98.5	45.6	118.6	68.0	33.6
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81656914-81686331	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved					NA	No		310000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	12.8	11.3	12.7	12.7	13.3	27.0	10.2	11.8	15.8	8.9	14.8	26.9	23.5	10.4	11.7	20.7	11.8	11.8	25.8	14.6	12.6	16.4	31.3	10.2	17.6	10.9	13.4	13.5	8.6	15.5	10.1	8.2	13.0	11.0	28.4	18.2	8.3	8.1	14.1	5.1	23.2	18.0	12.4	11.2	14.7	38.2	12.1	19.6	21.8	29.0	16.3	14.0	10.5	15.1	12.5	34.6	23.3	17.2	14.0	21.9	9.8	35.7	26.5	31.3	36.7	16.3	20.1	47.2	27.5	26.2	45.6	9.4	27.1	12.0	41.3	50.7	26.5	35.7	19.2	20.8	23.8	36.7	35.0	20.3	17.6	24.9	48.2	30.2	35.2	35.6	32.8	38.7	30.6	8.7	46.1	18.4	10.1	32.2	37.2	21.2	16.9	19.2	31.7	43.5	9.3	38.7	23.9	6.2	41.3	39.6	20.4	27.4	26.4	24.9	32.8	19.8	44.1	45.2	58.5	67.4	29.4	20.7	35.9	50.5	6.6	29.4	13.6	10.3	16.8	20.3	13.5	14.9	7.5	13.7	14.0	16.8	11.2	20.5	11.8	12.0	19.6	9.5	12.7	13.3	11.8	15.8	14.6	12.6	10.9	13.4	13.0	12.4	12.1	15.1	22.2	16.0	12.7	15.3	25.7	13.8	16.9	16.8	28.5	15.8	8.5	6.9	38.3	21.5	17.3	9.2	14.6	9.7	29.4	54.4	31.3	16.2	4.0	23.2	19.7	16.5	21.5	11.6	19.4	20.3	11.0	16.1	12.2	17.3	33.0	11.5	13.9	32.9	14.3	25.2	12.5	19.8	18.3	16.2	13.1	8.2	15.5	16.4	12.4	12.2	21.9	23.4	13.4	14.1	14.0	19.0	62.3	15.1	18.1	14.4	30.4	30.7	25.1	15.9	13.1	15.5	17.0	78.4	19.2	26.9	8.7	3.0	26.2	18.7	22.3	21.3
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
IMPACT	RWDD5	ENSG00000154059	"Impact RWD domain protein"	Q9P2X3	18	24426634-24453531	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Stress response, Translation regulation"	"Actin-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 65.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 65.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041045, HPA041968"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA041045: AB_10793866, HPA041968: AB_10795603"	"unprognostic (1.13e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (7.90e-4)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.60e-3)"	19.3	21.0	10.1	12.0	11.5	15.8	25.1	11.2	10.4	15.5	9.6	18.0	16.1	16.4	18.9	21.7	14.2	12.7	19.3	8.6	18.1	24.4	22.3	15.7	11.5	12.2	14.7	17.1	20.5	27.8	10.0	15.0	12.2	18.0	14.9	10.1	25.0	16.0	20.3	11.4	16.5	13.0	12.2	15.2	15.9	34.5	21.9	11.2	32.5	13.1	12.0	12.7	8.0	12.5	27.8	15.6	26.4	33.0	25.2	37.8	43.1	36.4	43.1	20.1	19.9	5.4	23.8	16.7	35.8	38.9	12.4	31.9	9.1	40.3	29.7	0.1	8.2	24.9	14.9	8.8	38.0	99.0	23.1	33.0	30.6	13.4	82.1	24.2	38.7	0.0	21.2	0.2	33.6	25.6	0.2	17.5	44.0	48.8	17.1	0.1	51.6	8.4	22.0	43.2	21.8	26.9	51.6	22.6	37.7	20.8	31.9	33.2	48.0	80.5	10.4	15.3	15.6	31.0	43.0	0.3	32.4	12.3	35.5	65.8	9.6	18.4	4.2	12.2	5.6	4.0	5.5	4.1	12.3	5.3	5.6	4.7	1.5	9.0	9.0	8.5	8.0	6.0	10.1	11.5	11.2	10.4	8.6	18.1	12.2	14.7	12.2	12.2	21.9	12.5	20.8	19.2	14.9	11.1	10.9	11.3	11.5	23.5	18.2	11.3	34.6	26.0	30.4	17.2	22.9	14.7	2.1	30.7	11.0	10.8	37.2	19.5	17.2	21.2	24.2	18.8	15.6	23.3	7.6	22.4	20.2	20.1	16.8	13.7	20.3	43.3	15.0	33.5	26.4	5.0	13.7	25.6	26.4	19.8	10.4	21.0	16.1	21.6	19.6	5.6	25.3	41.7	7.2	10.1	9.9	20.2	7.1	27.1	11.1	15.1	17.3	47.8	25.4	11.0	13.1	15.3	21.0	83.9	75.6	27.0	14.5	16.4	10.3	52.5	21.9	10.2
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 106.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 165.8;Cone photoreceptor cells: 141.8;Horizontal cells: 121.1;Rod photoreceptor cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 89.1;eosinophil: 89.1;intermediate monocyte: 104.5;myeloid DC: 59.9;neutrophil: 197.5;non-classical monocyte: 135.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 59.9;granulocytes: 197.5;monocytes: 135.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 374.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		17000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.72e-5)"	54.8	15.9	19.2	33.8	18.5	44.1	38.7	15.7	23.7	18.5	12.7	24.8	8.3	15.1	2.5	30.0	17.7	11.9	23.7	18.1	17.8	15.8	5.7	31.7	25.5	26.3	18.7	20.5	30.1	5.3	26.7	11.4	25.6	27.8	9.8	106.2	29.5	13.1	4.7	23.2	19.1	19.6	17.1	55.9	48.9	16.5	20.0	8.4	11.5	6.2	15.9	29.4	20.4	17.1	111.5	93.2	13.8	102.8	56.5	40.7	38.8	74.1	46.4	61.9	40.1	68.3	35.0	70.8	24.7	111.1	64.4	83.3	78.6	104.1	30.9	25.8	87.1	46.4	66.8	49.1	51.4	62.1	21.1	49.4	49.5	63.2	62.5	29.2	74.5	42.0	46.9	51.8	21.0	76.1	44.1	164.9	77.4	87.7	108.0	51.9	25.2	150.8	27.5	35.1	58.3	55.6	48.0	374.6	68.3	8.6	42.7	119.7	68.5	103.6	37.7	55.0	53.6	38.5	38.3	90.6	53.0	134.0	64.6	11.2	89.1	89.1	22.7	104.5	24.4	15.5	17.9	20.2	59.9	8.9	10.3	12.7	197.5	11.7	135.9	6.0	21.5	58.3	19.2	18.5	15.7	23.7	18.1	17.8	26.3	18.7	25.6	17.1	20.0	17.1	66.8	0.0	11.2	4.6	13.5	8.8	9.3	13.6	9.6	165.8	12.8	9.9	5.1	2.8	8.6	5.5	141.8	3.3	11.1	6.3	5.9	8.1	0.5	4.0	10.9	20.3	9.6	9.7	8.2	17.8	21.3	15.1	44.9	6.5	21.0	46.0	13.6	1.0	46.1	121.1	11.2	10.1	28.5	58.5	21.7	2.0	4.7	38.2	16.0	3.7	65.3	27.3	24.7	2.0	1.5	10.9	3.1	6.8	29.6	21.5	0.8	1.1	7.4	205.5	0.0	9.0	17.3	2.9	16.9	15.8	7.4	2.3	20.4	18.6	11.9	10.3
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029447	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	109.1	89.3	42.1	68.0	43.0	105.3	188.6	44.2	41.6	169.6	37.3	100.8	75.3	113.5	48.2	169.0	199.3	64.9	70.0	39.5	45.2	67.5	63.5	83.3	78.7	46.9	43.2	331.0	313.9	55.7	65.0	81.0	46.6	97.6	121.2	22.0	87.9	66.4	272.8	180.0	74.1	100.9	45.1	68.6	93.4	36.1	43.8	95.9	75.1	124.4	122.0	119.7	137.5	48.9	271.8	150.6	201.6	211.3	309.2	558.4	200.6	180.8	298.2	425.5	361.0	265.8	235.2	485.7	128.2	220.7	119.5	183.1	433.6	369.8	371.1	119.9	135.3	362.2	205.0	257.8	264.4	388.4	139.0	497.7	403.1	414.6	756.5	331.8	313.5	337.7	221.7	266.2	354.1	213.4	327.0	258.9	269.0	255.4	300.2	143.5	218.4	487.9	251.7	166.2	130.2	128.9	198.1	216.5	341.3	170.2	277.3	166.1	151.4	181.0	347.7	449.5	468.8	253.3	193.3	227.3	214.1	421.9	188.1	21.8	27.8	10.7	43.6	46.8	81.9	79.7	58.4	47.7	51.1	79.6	84.9	71.6	10.9	60.5	41.6	38.0	40.2	45.2	42.1	43.0	44.2	41.6	39.5	45.2	46.9	43.2	46.6	45.1	43.8	48.9	40.5	64.1	60.9	3.9	92.2	202.7	255.0	253.8	229.9	16.1	202.7	231.8	32.3	74.4	122.4	36.8	14.6	327.3	34.5	51.1	80.3	133.6	2.7	49.0	120.5	60.9	60.7	112.5	2.9	187.1	280.6	104.4	70.3	51.2	66.1	98.0	52.8	24.9	95.3	15.2	4.1	124.4	114.0	55.9	105.4	6.7	123.3	50.0	88.9	1.0	67.3	26.5	24.7	4.0	5.2	108.8	70.8	71.1	64.6	160.1	47.4	92.0	53.7	15.8	39.5	149.4	215.1	22.6	62.5	195.7	195.6	314.0	52.3	166.8	266.5	157.2
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921114-76072678	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	267	"retina: 670.7"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 673.5;Rod photoreceptor cells: 694.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"	"Region enriched"	"Detected in single"	4	"basal ganglia: 3.3"	"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.3	0.1	0.5	0.0	2.5	0.0	0.5	1.0	1.4	0.3	0.8	0.3	1.0	0.2	0.0	0.2	0.1	0.4	0.2	0.5	0.4	0.6	0.2	0.6	0.1	0.6	0.6	0.1	1.8	0.0	0.3	0.2	0.6	0.2	0.0	670.7	0.5	0.0	0.2	1.4	0.8	0.0	0.1	0.2	0.3	0.3	0.6	0.1	0.4	0.0	0.0	0.2	0.3	1.6	0.6	0.0	0.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	1.0	1.4	0.5	0.4	0.6	0.6	0.6	0.1	0.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	0.2	0.0	0.0	0.0	673.5	0.2	0.0	0.0	3.9	0.0	1.9	0.2	0.0	3.0	0.0	0.0	1.6	0.0	9.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	30.3	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	85.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	694.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0
IMPG2	"IPM200, RP56, SPACRCAN"	ENSG00000081148	"Interphotoreceptor matrix proteoglycan 2"	Q9BZV3	3	101222546-101320575	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"retina: 305.4"	"Group enriched"	"Detected in some"	18	"Cone photoreceptor cells: 517.1;Rod photoreceptor cells: 329.1"	"Cancer enriched"	"Detected in single"	12	"ovarian cancer: 2.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008779, HPA015907"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA008779: AB_2668138, HPA015907: AB_2669323"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.80e-5)"	"unprognostic (6.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-9)"	"unprognostic (7.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.08e-2)"	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.1	1.7	0.1	0.0	0.1	0.1	0.0	9.6	0.1	0.1	0.2	1.1	0.3	0.0	0.0	0.2	0.9	0.3	0.1	0.1	0.0	0.1	0.0	1.1	0.1	0.1	305.4	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	1.1	0.9	0.3	1.1	0.2	0.3	0.2	0.3	0.0	0.0	5.9	0.4	0.1	0.0	0.1	0.0	22.8	0.1	0.5	0.6	0.0	0.1	0.0	517.1	0.0	0.3	0.0	1.9	0.1	0.3	0.7	0.5	2.4	0.0	0.0	7.5	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.1	13.5	14.0	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.0	4.7	1.2	23.4	0.0	8.5	2.6	0.1	0.0	0.7	0.6	0.1	0.0	0.0	0.5	329.1	0.0	0.6	0.3	0.1	0.3	0.0	0.3	0.0	0.2	1.2	0.0	0.0
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277138-103290346	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 160.7;pituitary gland: 41.4;retina: 97.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	0.2	12.1	34.2	1.2	35.5	0.0	0.0	63.3	160.7	0.0	0.0	3.3	0.6	0.0	0.0	0.6	0.0	0.1	0.0	31.8	109.5	0.0	0.0	0.2	0.1	107.9	37.5	0.0	2.0	0.4	41.4	0.1	98.1	0.2	1.2	97.3	0.1	0.0	0.0	0.8	1.1	0.8	25.3	0.0	1.1	2.7	72.8	1.7	0.1	0.0	0.2	1.1	0.5	51.9	0.0	25.4	11.8	0.0	0.1	0.0	19.3	13.3	3.3	3.1	0.3	0.0	0.0	0.0	5.4	0.9	1.5	1.9	11.0	0.0	0.7	24.6	4.9	0.0	6.8	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	13.6	0.0	53.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	103.3	58.7	71.6	0.1	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	3.4	3.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	35.5	63.3	160.7	31.8	109.5	107.9	37.5	98.1	25.3	72.8	51.9	0.1	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	62.4	0.0	0.4	0.5	0.0	0.0	0.0	22.9	0.2	0.0	0.1	0.0	0.1	41.4	0.4	0.2	0.9	7.8	0.0	28.7	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.5	45.4	39.8	0.0	0.0	0.0	0.0	26.5	0.3	0.1	0.0	2.8	0.0	8.7	0.0	1.0	5.4	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	48.2	0.0	0.0	0.6	20.3	4.1	1.0	0.4	0.1	0.1	0.1	0.0	0.6
INAFM1	PRR24	ENSG00000257704	"InaF motif containing 1"	C9JVW0	19	47274885-47275723	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 100.3;Smooth muscle cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064015	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA064015: AB_2685177"	"unprognostic (3.88e-2)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-1)"	"unprognostic (4.36e-3)"	24.1	65.4	26.3	9.0	25.3	9.0	22.8	23.5	30.3	39.6	29.2	34.5	6.4	32.3	4.8	14.7	31.4	9.8	23.8	27.2	34.7	22.6	18.1	26.0	5.5	31.8	31.6	33.9	27.7	4.6	21.0	6.6	27.8	32.4	3.4	16.1	15.2	9.0	17.0	25.3	15.9	9.3	23.8	18.5	23.0	12.9	31.6	4.9	21.6	4.9	3.3	31.2	26.9	22.1	11.1	10.1	8.8	14.4	2.6	7.7	5.2	12.6	4.2	5.7	7.4	4.9	4.9	5.8	3.9	7.8	4.5	8.0	2.2	5.0	1.4	11.6	13.6	9.3	6.3	7.7	13.1	6.7	13.6	10.9	8.9	5.4	4.8	4.2	2.3	6.4	15.1	12.4	2.3	22.5	5.1	43.1	2.6	11.2	10.1	9.0	3.5	4.8	4.5	6.5	6.6	8.4	13.8	4.3	6.2	2.3	6.1	6.5	5.4	6.5	9.6	3.7	6.7	5.9	5.0	5.5	13.4	4.7	5.8	11.0	15.4	36.3	3.1	11.0	2.5	11.3	3.6	4.3	13.6	8.6	6.6	4.7	58.6	2.9	14.4	16.0	5.0	7.1	26.3	25.3	23.5	30.3	27.2	34.7	31.8	31.6	27.8	23.8	31.6	22.1	23.8	9.6	7.0	7.5	6.3	0.0	43.5	0.0	15.9	16.5	20.7	20.8	9.4	8.6	3.7	11.0	10.4	20.1	3.1	12.6	19.6	11.4	13.5	16.4	100.3	18.3	7.3	18.9	5.0	12.4	15.3	30.5	11.7	16.5	1.3	10.2	11.4	14.8	10.0	3.3	11.6	13.0	0.0	15.9	0.0	22.9	61.8	12.3	0.0	4.7	8.0	5.9	8.2	3.5	2.7	9.6	17.7	25.9	9.0	31.3	28.4	15.4	0.7	48.6	46.0	12.9	73.4	10.3	13.0	10.6	0.0	27.6	6.5	16.2	13.2	49.0
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.2;intestine: 55.4;skin 1: 47.0"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511, HPA079622"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: "	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.1	0.0	1.4	4.0	1.4	4.5	1.7	0.8	1.3	8.8	1.8	33.8	47.3	1.1	0.5	44.2	4.2	16.3	0.2	1.4	1.4	15.3	0.4	3.5	0.4	1.1	1.4	0.1	13.2	0.1	0.3	1.9	1.0	7.0	30.1	0.4	12.3	2.6	0.2	47.0	55.4	1.1	1.0	0.3	27.3	1.1	1.5	0.9	0.1	0.0	5.7	17.1	20.3	1.0	27.5	40.8	23.3	0.0	0.0	0.0	60.3	0.0	0.0	0.7	0.5	43.4	49.6	0.0	13.3	0.0	1.1	66.0	0.0	17.4	0.5	0.0	5.0	3.8	1.8	17.2	0.1	8.5	0.8	0.0	26.1	0.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.1	1.4	45.2	57.8	9.2	0.2	9.7	54.0	24.4	34.9	0.1	2.8	2.6	41.5	0.0	27.3	17.1	7.9	0.0	0.1	10.1	0.1	2.9	46.2	20.6	0.0	0.1	8.6	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.4	1.4	0.8	1.3	1.4	1.4	1.1	1.4	1.0	1.0	1.5	1.0	0.6	12.8	7.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	0.0	5.0	14.7	0.0	7.6	0.1	0.0	5.9	33.3	0.0	26.8	2.2	0.7	0.0	0.0	0.0	45.5	13.2	0.4	0.0	25.1	1.3	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	0.0	26.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.5	0.3	0.0	0.0
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 47.8"	"Group enriched"	"Detected in many"	19	"Early spermatids: 130.0;Late spermatids: 306.6;Spermatocytes: 211.3;Spermatogonia: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	2.9	3.7	3.2	6.3	3.4	1.6	2.1	4.3	4.2	3.6	2.0	3.3	10.8	5.2	0.8	5.1	3.2	7.1	6.6	3.0	3.8	4.0	3.8	4.6	8.5	4.3	3.4	8.1	3.9	1.6	2.2	3.0	4.5	4.5	1.2	4.4	5.7	1.7	10.6	8.0	7.9	2.2	3.6	7.3	5.0	47.8	4.3	0.4	8.0	4.8	0.4	2.7	2.4	3.9	5.0	5.6	3.9	3.7	2.6	1.0	4.7	5.3	0.5	1.4	1.5	4.0	5.9	23.9	3.5	1.4	4.6	14.0	0.7	0.3	0.8	10.0	5.9	5.2	7.6	2.7	1.8	0.8	12.2	1.5	0.0	0.8	0.4	8.5	0.5	8.4	6.6	10.9	1.0	2.6	7.4	1.7	1.7	2.3	1.5	9.0	2.0	2.2	0.9	1.6	11.7	3.5	2.6	3.4	3.1	4.1	7.0	1.1	10.8	4.9	1.8	4.7	4.1	1.8	1.0	1.1	4.8	12.6	2.5	0.2	0.8	0.0	0.2	1.5	0.6	0.4	0.4	0.5	0.3	0.2	0.7	0.6	0.2	0.0	1.2	0.4	0.2	0.2	3.2	3.4	4.3	4.2	3.0	3.8	4.3	3.4	4.5	3.6	4.3	3.9	1.0	0.0	1.1	1.0	0.6	1.1	1.5	1.2	0.6	0.5	0.9	0.8	1.0	1.5	1.2	3.7	2.1	0.6	0.1	9.3	0.0	0.7	130.0	0.6	0.8	1.3	0.0	2.7	0.8	1.6	0.7	1.3	1.5	0.6	4.5	2.5	0.7	1.4	1.2	0.0	0.9	2.0	2.0	0.0	1.5	306.6	7.2	1.1	1.8	1.0	0.7	6.1	0.0	1.0	1.1	1.2	9.3	1.2	0.1	0.4	5.2	2.2	1.5	0.8	6.6	2.0	1.9	211.3	87.1	0.3	0.9	0.8	0.2	0.7	2.9	0.8
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
INF2	"C14orf151, C14orf173, MGC13251"	ENSG00000203485	"Inverted formin 2"	Q27J81	14	104681146-104722535	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 229.3;Gastric mucus-secreting cells: 183.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 100.8"	"Region enhanced"	"Detected in all"		"basal ganglia: 224.1"	"Low region specificity"	"Detected in all"			HPA000724	Approved		Approved	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		3000000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA000724: AB_1078325"	"unprognostic (1.42e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.24e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.70e-2)"	42.8	21.4	14.0	8.4	29.6	7.5	35.2	18.3	29.5	28.7	1.4	40.4	21.2	24.3	2.3	20.4	20.9	8.9	24.1	14.7	14.7	27.3	30.2	34.3	6.9	30.7	25.5	13.6	15.7	2.0	8.3	11.7	27.5	23.2	4.7	3.3	17.9	7.5	13.7	26.9	31.7	4.4	12.2	31.4	34.7	32.2	26.3	2.1	20.8	1.5	3.4	30.2	28.5	71.2	26.3	92.1	9.9	16.0	7.6	12.2	84.2	49.0	14.5	21.9	14.0	35.5	40.2	3.7	46.6	17.9	17.0	43.3	9.4	22.7	9.5	18.5	26.6	22.0	59.9	23.9	16.5	6.8	21.0	11.4	14.5	15.8	6.8	15.0	24.1	9.1	10.7	10.5	18.0	30.0	10.2	17.9	17.1	18.3	100.8	29.8	19.2	9.4	12.6	38.0	20.5	12.8	26.4	36.7	11.7	8.0	8.0	4.9	49.9	29.4	22.1	45.7	22.5	6.9	3.7	3.7	41.2	12.1	25.1	0.5	2.1	0.1	0.9	0.7	0.7	1.6	3.2	0.6	2.4	1.5	2.5	1.6	1.6	1.2	0.1	5.1	4.0	3.2	14.0	29.6	18.3	29.5	14.7	14.7	30.7	25.5	27.5	12.2	26.3	71.2	48.8	64.1	13.4	10.1	22.5	22.7	17.5	19.0	17.1	0.3	16.5	14.6	14.3	28.6	15.0	3.7	0.0	54.8	5.2	229.3	5.9	24.1	1.2	7.8	8.6	29.8	17.4	17.2	16.7	25.5	87.8	17.9	183.0	18.2	14.7	8.4	25.4	29.8	32.6	0.0	1.9	86.2	12.2	21.8	35.6	2.1	5.6	25.5	8.8	20.6	14.0	55.3	1.0	11.1	89.6	58.1	110.7	4.5	7.8	26.6	90.4	7.3	9.4	2.0	32.9	5.7	36.1	1.1	4.5	8.5	18.8	31.6	9.3	12.9	66.9	38.2
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876"	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	13.7	7.3	5.9	8.6	6.2	20.2	10.2	6.5	10.2	10.6	5.9	13.4	9.7	12.6	5.3	8.3	14.4	6.7	9.1	6.6	6.7	9.5	18.6	12.8	9.7	7.2	6.2	22.4	8.2	3.1	9.4	7.7	6.4	11.2	4.3	6.7	9.9	4.9	11.7	9.4	12.2	4.8	6.0	14.4	10.0	31.5	6.4	13.0	7.6	9.5	6.3	10.1	9.4	8.0	28.8	11.1	19.8	19.0	9.1	6.1	19.7	14.5	12.1	9.2	11.1	21.5	19.9	18.4	22.9	5.7	14.3	17.8	8.0	7.2	7.7	34.8	15.3	16.3	16.2	16.2	5.2	21.7	15.2	5.6	7.4	8.0	4.8	7.2	6.5	19.6	15.3	15.0	6.0	16.5	37.7	24.9	19.4	17.9	9.3	27.0	10.0	10.4	8.1	14.5	19.4	20.9	14.2	28.3	20.7	6.8	9.5	25.3	9.8	11.3	13.9	11.9	16.5	18.0	19.5	24.0	18.9	17.6	18.8	38.5	4.5	18.0	15.9	5.6	16.7	23.4	13.2	14.2	4.3	27.5	13.5	11.2	6.2	20.4	6.5	4.7	18.8	9.4	5.9	6.2	6.5	10.2	6.6	6.7	7.2	6.2	6.4	6.0	6.4	8.0	87.2	9.6	18.8	5.9	34.5	36.3	15.4	17.0	54.7	16.7	49.8	88.9	27.0	12.8	11.1	7.3	14.6	14.3	32.0	31.5	7.9	11.7	212.5	51.6	58.5	28.6	12.5	12.6	4.4	6.9	78.8	36.1	27.5	55.7	2.5	20.1	11.0	27.4	17.3	3.3	3.8	31.6	12.2	18.2	23.8	45.8	9.3	29.3	17.8	1.9	14.2	17.8	21.6	2.0	4.3	8.0	18.6	14.7	19.7	22.9	34.2	11.5	21.4	21.1	13.1	70.5	57.7	25.5	17.9	48.8	43.8	15.3	29.6	18.0	24.2	22.4
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183505058-183512429	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favorable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	9.5	42.3	5.2	5.2	5.8	21.7	8.7	6.8	6.8	7.2	5.5	9.4	10.6	5.2	10.2	14.6	8.8	8.9	7.5	5.0	9.6	12.2	10.5	8.6	5.9	6.4	6.4	37.4	15.8	6.1	23.3	6.1	6.0	8.7	6.7	8.6	10.7	4.5	26.1	12.1	14.3	4.6	4.6	9.1	11.5	33.3	8.0	12.5	9.3	14.8	6.7	11.4	9.9	5.3	19.1	11.4	15.5	12.3	28.1	16.4	12.7	20.1	17.4	15.6	13.3	10.4	20.2	13.5	5.2	14.7	12.7	8.3	10.4	15.6	19.8	10.4	7.6	23.4	11.4	13.5	8.5	19.3	25.1	12.7	14.3	17.0	7.1	12.8	7.5	13.0	13.2	49.8	11.5	18.8	24.7	19.6	12.5	5.5	11.1	10.3	8.6	22.5	18.8	8.7	15.3	11.5	13.3	17.6	5.3	10.0	8.3	13.9	6.4	10.5	16.5	7.2	13.0	10.7	8.6	9.1	19.3	14.3	7.6	15.2	6.3	19.7	3.2	6.6	5.0	11.9	6.3	5.7	7.8	8.4	8.8	7.6	6.4	3.8	8.5	7.6	5.4	3.7	5.2	5.8	6.8	6.8	5.0	9.6	6.4	6.4	6.0	4.6	8.0	5.3	18.7	6.4	21.0	6.2	20.1	49.3	20.5	20.7	105.9	25.7	36.3	41.8	12.1	25.8	18.2	16.5	12.5	26.1	18.8	32.7	74.3	20.9	68.4	93.0	26.3	21.7	18.6	26.7	7.1	34.9	94.9	29.1	11.7	82.9	40.0	85.4	15.4	24.1	30.0	25.2	5.3	24.2	16.2	24.2	43.3	35.2	82.6	27.3	26.6	1.0	13.9	40.5	6.2	3.5	5.1	33.3	28.3	53.8	19.5	34.2	112.9	47.8	39.8	23.6	19.7	23.7	28.0	95.3	74.9	71.6	46.2	21.2	25.6	50.4	23.0	39.3
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950763-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 80.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.3	7.7	3.8	9.9	4.5	80.5	10.1	11.3	5.5	8.3	3.3	9.1	8.2	10.8	10.5	7.4	9.7	8.5	8.5	3.5	4.5	9.7	9.2	10.9	14.9	4.2	4.7	8.9	8.5	7.7	6.0	15.1	4.7	8.0	11.8	7.6	8.6	7.7	4.7	4.6	7.6	13.0	4.8	15.5	9.7	8.1	4.2	18.6	11.5	8.4	13.5	8.5	5.0	5.7	19.3	5.6	24.8	14.0	9.2	7.3	8.3	12.9	10.1	18.1	21.1	7.3	21.6	31.3	5.7	11.3	19.0	9.2	24.1	9.9	20.7	22.1	42.2	22.5	21.2	4.3	12.6	43.8	25.5	5.4	5.0	16.0	11.3	8.7	28.7	19.1	51.0	48.4	17.5	6.7	36.0	26.0	29.9	10.9	10.4	17.6	17.7	25.7	18.4	19.4	22.4	24.1	13.3	26.9	14.0	15.3	6.1	17.0	10.4	18.5	6.8	40.0	23.7	22.2	15.1	46.0	9.3	28.9	15.6	44.0	28.0	26.4	20.1	30.8	19.9	21.7	20.3	18.7	23.4	24.3	20.4	18.6	50.7	30.6	32.3	17.7	27.1	14.8	3.8	4.5	11.3	5.5	3.5	4.5	4.2	4.7	4.7	4.8	4.2	5.7	27.1	19.2	18.4	24.5	37.7	7.6	20.4	17.6	9.1	23.3	16.3	14.4	14.2	11.5	14.0	7.3	4.2	38.8	31.7	19.6	21.5	12.6	7.2	21.5	20.1	24.7	12.0	27.0	14.5	18.0	22.0	19.5	16.8	28.3	33.7	21.8	21.4	14.3	17.9	26.9	21.5	18.7	22.4	35.8	16.6	4.3	13.7	23.4	16.0	18.7	24.3	17.6	27.8	22.6	24.3	15.5	17.7	9.8	26.8	14.0	17.7	12.8	13.5	19.8	19.7	26.9	25.9	16.6	15.3	12.0	11.2	45.7	28.6	25.7	15.4	18.7
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650301-6663142	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA031817: AB_2674056, HPA057338: AB_2683412"	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	22.9	26.4	43.8	15.5	44.5	11.6	27.9	45.8	51.7	34.9	40.7	33.7	17.9	27.4	30.7	22.8	27.4	18.1	23.9	44.0	43.9	29.7	25.7	18.6	27.6	44.9	44.0	31.3	19.7	32.0	27.7	21.6	44.8	33.0	21.8	22.3	25.9	23.1	19.3	31.0	26.7	22.5	44.8	37.7	26.9	20.4	44.7	38.5	34.9	23.8	24.5	29.5	27.2	49.3	9.2	12.3	35.8	17.0	27.3	26.9	22.9	12.0	19.4	19.6	23.4	5.6	41.1	15.9	7.8	16.8	15.6	14.3	17.8	14.1	21.7	31.1	26.4	22.9	22.5	11.5	16.0	9.1	10.4	27.3	32.3	10.4	13.3	63.4	29.8	30.6	10.9	8.9	19.0	6.6	33.2	13.9	52.8	20.3	11.7	30.9	18.8	17.0	24.7	10.4	14.7	38.3	18.6	6.2	23.2	51.5	8.2	25.0	22.7	8.1	16.1	9.1	7.9	10.7	15.6	21.6	21.6	14.0	8.3	32.2	31.1	26.8	33.5	43.5	31.2	30.9	27.8	28.7	34.3	48.2	37.9	32.9	20.1	38.0	51.0	26.5	30.9	37.9	43.8	44.5	45.8	51.7	44.0	43.9	44.9	44.0	44.8	44.8	44.7	49.3	20.5	22.4	19.0	15.0	26.8	8.2	11.1	19.1	13.6	31.2	22.2	27.6	10.9	17.2	17.9	18.4	18.8	43.3	37.0	14.4	29.4	25.0	2.0	17.1	21.6	22.4	25.2	18.1	23.1	8.1	11.7	21.8	10.2	14.8	27.9	40.7	20.0	8.9	24.6	35.3	23.0	18.6	30.5	16.6	12.4	6.7	34.5	27.0	10.6	13.1	32.6	34.6	52.5	18.6	20.7	11.9	16.9	37.6	11.7	11.8	21.3	24.4	12.5	26.4	32.9	13.6	21.2	20.7	19.1	9.9	10.1	30.6	22.3	31.8	14.6	9.7
ING5	"FLJ23842, p28ING5"	ENSG00000168395	"Inhibitor of growth family member 5"	Q8WYH8	2	241687085-241729478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042685	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA042685: AB_10797507"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (8.25e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.87e-2)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.74e-3)"	12.4	11.3	16.7	8.9	17.1	12.1	12.6	20.5	18.2	19.4	15.3	13.8	9.6	15.0	15.8	13.8	18.8	7.3	12.6	16.4	16.6	14.8	17.1	12.2	12.9	14.7	13.9	25.2	24.0	10.7	24.6	7.9	15.5	21.9	9.1	10.1	19.8	9.8	14.3	18.7	15.4	8.1	11.7	15.7	16.8	9.7	15.5	12.0	23.2	9.5	10.8	14.4	16.2	18.0	12.0	10.9	24.4	14.9	18.5	21.1	30.4	13.2	10.5	13.0	10.4	11.5	11.6	12.0	4.6	12.4	14.0	17.7	22.9	11.8	15.8	12.9	21.6	28.7	17.2	35.0	15.7	30.6	18.2	18.1	18.7	12.8	20.8	15.2	14.4	19.9	28.1	8.0	12.4	20.2	24.6	42.5	28.6	20.5	8.0	42.9	30.1	11.0	12.2	19.2	31.4	19.0	7.0	13.7	18.8	16.0	9.4	20.3	10.2	17.3	18.7	11.2	14.5	17.7	6.7	33.8	12.4	18.4	13.0	21.5	4.0	8.8	2.5	3.2	3.0	3.3	4.2	3.4	2.3	3.7	4.6	3.1	3.9	2.5	3.5	3.7	5.8	2.8	16.7	17.1	20.5	18.2	16.4	16.6	14.7	13.9	15.5	11.7	15.5	18.0	13.4	44.8	33.7	25.1	25.4	9.4	34.6	10.0	21.1	14.7	24.6	26.4	13.9	14.3	19.5	18.4	14.6	20.4	21.3	15.1	31.3	9.3	26.7	23.4	31.6	12.4	8.4	11.3	24.2	10.1	15.3	17.6	13.3	25.1	15.8	22.9	13.6	12.3	7.2	15.2	22.6	16.7	16.2	7.7	7.0	10.4	17.1	11.6	8.8	4.7	8.8	16.3	6.2	18.6	26.9	8.9	9.4	11.3	20.1	26.4	11.6	17.7	11.5	18.8	19.7	22.5	17.4	7.5	11.9	18.1	14.2	17.4	19.9	17.3	15.6	17.7
INHA		ENSG00000123999	"Inhibin subunit alpha"	P05111	2	219569162-219575711	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 75.6;ovary: 104.4;testis: 95.3"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	1.2	75.6	3.4	0.2	3.7	0.1	1.4	2.7	4.8	2.0	2.2	0.9	0.2	2.0	2.2	0.8	3.0	0.4	16.3	3.5	3.2	3.1	0.7	0.8	0.1	3.4	2.9	104.4	12.3	0.7	6.6	11.3	3.5	3.1	0.0	1.9	1.5	1.1	0.8	2.1	0.4	0.4	2.5	0.4	0.7	95.3	3.4	0.0	3.3	0.0	0.0	1.0	1.8	3.0	0.4	0.2	0.0	1.9	0.6	0.1	3.5	0.3	0.2	0.5	0.2	0.3	3.2	0.0	0.2	0.7	0.5	2.0	0.2	0.5	0.0	0.0	0.6	4.5	1.8	2.4	0.3	0.0	0.0	0.6	0.8	0.0	0.5	1.4	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.1	1.2	0.1	0.9	0.1	0.2	0.0	0.5	0.2	0.3	0.8	1.1	9.9	0.3	4.9	0.5	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	2.7	4.8	3.5	3.2	3.4	2.9	3.5	2.5	3.4	3.0	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.8	0.0	2.7	0.3	0.3	2.2	0.0	0.1	7.3	2.1	11.8	0.0	0.0	0.0	2.8	0.8	0.5	0.5	0.2	0.0	0.0	5.9	8.9	35.5	1.2	0.0	0.5	0.0	254.3	0.7	0.1	2.6	6.7	6.9	0.0	0.0	0.3	0.0	5.0	4.1	0.2	0.0	0.0	0.0	3.7	0.0	1.0	0.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	1.5	3.4	0.6	0.0	0.0	331.0	0.0	75.6	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"liver: 148.4"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Region enhanced"	"Detected in some"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	148.4	0.1	0.1	0.9	0.0	0.0	0.9	0.1	1.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.1	0.9	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
INIP	"C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C"	ENSG00000148153	"INTS3 and NABP interacting protein"	Q9NRY2	9	112683926-112718149	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020382	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA020382: AB_1845840"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.67e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.47e-3)"	"prognostic favorable (2.00e-8)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.26e-1)"	7.4	8.7	8.0	8.4	10.9	10.4	11.4	9.7	11.9	8.0	5.4	10.1	10.3	7.2	8.6	9.8	8.4	8.6	7.5	8.1	9.6	10.8	11.0	8.4	14.5	9.2	8.8	8.2	5.0	10.7	6.5	6.1	9.6	6.9	11.5	10.3	8.1	6.5	6.5	9.2	10.9	7.6	8.4	9.7	7.4	5.4	9.6	14.5	10.6	10.0	14.1	9.3	6.2	15.5	16.5	15.6	21.4	31.0	18.2	19.2	21.9	22.7	12.4	19.4	19.3	19.7	13.2	43.8	13.9	15.7	14.6	22.9	21.0	10.9	25.8	53.0	12.3	18.2	17.6	18.0	11.8	37.1	13.3	10.4	14.7	20.6	16.6	9.5	18.2	22.1	31.7	27.5	21.4	27.8	33.3	19.0	11.1	29.8	28.8	36.5	45.1	18.9	22.2	21.9	27.9	20.9	28.7	18.1	15.7	14.2	27.1	23.1	15.4	16.1	24.7	30.9	22.4	13.7	62.4	37.3	20.4	21.3	27.7	30.4	24.8	32.5	15.7	29.3	20.7	15.5	20.1	23.4	27.1	20.0	21.8	18.9	19.8	18.4	27.0	9.7	20.8	20.3	8.0	10.9	9.7	11.9	8.1	9.6	9.2	8.8	9.6	8.4	9.6	15.5	15.6	22.4	15.6	9.1	19.1	36.7	18.1	31.4	13.1	17.1	19.2	16.5	15.5	15.7	22.4	14.7	16.7	21.4	20.6	19.4	56.7	23.4	3.9	21.0	18.8	18.1	22.3	19.4	18.3	16.1	32.0	14.9	12.8	18.7	26.6	11.2	15.7	17.7	26.1	43.7	15.4	17.1	32.6	24.5	33.5	3.2	14.0	26.2	19.6	3.7	42.3	24.7	34.0	16.6	25.2	24.2	12.3	12.0	11.8	17.9	21.7	31.7	13.0	16.9	0.0	17.3	13.1	17.4	15.8	19.4	41.8	14.8	23.0	12.4	19.8	25.2
INKA1	"C3orf54, FAM212A"	ENSG00000185614	"Inka box actin regulator 1"		3	49803261-49805030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4"	"Group enriched"	"Detected in many"	7	"B-cells: 65.9;granulocytes: 59.6"	"Cell line enhanced"	"Detected in many"		"HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9"	"Low region specificity"	"Detected in all"							HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	5.1	2.3	4.8	2.0	5.0	3.5	4.1	5.2	7.6	6.2	2.8	3.2	0.8	4.7	1.4	19.7	2.8	1.5	5.2	5.3	5.5	5.8	1.1	5.4	4.1	6.2	5.3	2.2	1.3	0.5	2.1	3.1	5.7	6.4	0.5	0.2	4.9	2.1	11.7	24.1	4.3	1.8	5.8	6.7	2.4	2.9	6.5	1.6	2.1	2.3	3.9	5.5	10.3	7.0	1.3	1.1	1.5	1.1	1.8	4.1	0.0	3.0	1.9	1.4	1.7	0.1	0.0	14.9	0.4	2.2	1.5	8.7	0.5	10.4	0.1	2.6	0.0	68.5	0.7	0.2	2.6	10.4	45.1	5.4	14.5	2.9	2.6	0.9	6.1	1.0	4.7	1.2	1.2	0.6	0.9	38.5	1.1	0.0	5.8	13.9	0.8	3.3	0.1	16.9	0.8	5.3	2.7	0.5	1.5	0.4	0.3	42.1	3.8	7.3	0.9	3.4	1.3	1.7	1.7	1.2	3.2	34.9	1.8	59.6	2.4	11.6	1.3	5.9	0.3	65.9	1.5	1.8	0.7	64.4	2.2	3.6	1.3	0.0	8.5	9.3	1.6	6.4	4.8	5.0	5.2	7.6	5.3	5.5	6.2	5.3	5.7	5.8	6.5	7.0	19.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.7	0.0	0.5	1.6	8.4	0.0	0.0	0.0	1.2	0.7	3.0	0.0	0.1	0.0	0.1	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0
INKA2	"C1orf183, FAM212B, FLJ31105"	ENSG00000197852	"Inka box actin regulator 2"	Q9NTI7	1	111680630-111755824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.6;U-87 MG: 73.0;WM-115: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	7.4	1.0	8.8	3.0	13.0	2.9	4.0	5.0	16.7	2.3	2.0	3.5	1.2	3.9	1.7	6.6	5.1	2.9	13.8	14.6	4.0	2.7	0.9	4.8	1.0	4.3	3.8	2.1	1.2	2.3	0.7	6.1	3.9	3.0	2.4	1.4	2.3	4.0	7.8	5.5	2.4	5.8	3.5	5.3	3.8	2.6	4.0	2.1	2.5	8.9	1.7	2.8	3.4	9.8	2.5	2.3	5.1	3.2	20.5	7.3	1.7	1.8	4.0	3.3	7.8	4.1	0.1	2.0	0.9	1.8	1.6	2.2	2.2	4.9	3.2	4.6	1.9	15.0	1.8	4.0	8.1	1.1	2.3	6.0	20.9	35.6	1.6	0.9	8.9	2.6	0.1	3.3	5.3	2.8	1.1	1.2	1.2	2.4	2.0	2.2	19.4	0.7	0.9	3.5	10.2	3.4	1.1	0.1	9.8	5.6	2.8	3.3	3.5	7.1	11.4	3.9	1.5	20.7	3.8	2.1	73.0	4.5	28.0	0.2	1.8	1.4	0.0	1.4	0.0	0.2	0.1	0.1	1.0	0.4	0.0	0.0	25.2	0.6	2.0	0.5	0.0	0.6	8.8	13.0	5.0	16.7	14.6	4.0	4.3	3.8	3.9	3.5	4.0	9.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
INO80C	"C18orf37, FLJ38183, hIes6, IES6"	ENSG00000153391	"INO80 complex subunit C"	Q6PI98	18	35452230-35497979	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.7;Pancreatic endocrine cells: 165.1;Spermatocytes: 209.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049060	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA049060: AB_2680617"	"unprognostic (3.40e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (5.56e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.14e-3)"	"unprognostic (5.38e-2)"	18.0	17.4	23.2	14.5	24.4	46.2	16.0	24.9	23.7	18.4	30.9	21.1	18.4	12.0	13.6	45.7	13.7	13.0	25.6	23.2	31.1	21.8	19.2	17.5	26.2	22.2	23.1	9.8	13.3	8.0	29.2	20.7	24.2	13.9	21.8	33.6	20.7	9.2	42.4	40.5	18.6	11.0	21.0	31.2	30.4	92.2	31.5	21.9	15.2	30.7	29.2	21.4	20.8	23.6	46.5	30.1	27.1	14.9	9.5	23.6	29.7	17.5	13.2	27.3	36.5	37.5	38.7	77.4	36.6	11.9	41.6	31.3	52.4	112.7	24.8	22.9	28.3	97.8	36.0	40.7	21.0	57.4	60.1	10.7	31.9	70.7	37.9	33.7	80.0	32.3	30.4	27.8	44.7	49.3	36.4	48.5	34.6	32.2	18.0	28.5	19.2	26.5	58.4	58.9	37.3	25.8	27.9	31.6	23.4	41.8	31.5	46.1	51.5	30.9	13.5	24.0	32.3	24.1	28.4	137.8	25.2	52.7	19.2	21.3	14.8	35.6	12.3	20.6	12.2	24.9	17.0	16.3	22.2	17.8	17.2	14.2	23.0	12.4	18.3	33.5	21.7	11.8	23.2	24.4	24.9	23.7	23.2	31.1	22.2	23.1	24.2	21.0	31.5	23.6	40.2	6.4	10.1	5.9	19.5	24.0	22.1	72.3	18.8	4.4	16.3	15.2	17.8	18.6	31.6	12.9	4.2	59.8	14.0	81.4	31.3	43.9	184.7	16.7	6.6	30.5	15.0	29.0	15.6	40.0	105.1	14.1	41.8	14.4	20.3	9.0	22.1	16.6	52.2	5.0	11.3	20.4	36.7	17.9	15.0	49.6	6.2	16.4	23.2	6.5	14.1	22.8	14.4	9.0	10.9	165.1	76.0	7.2	26.4	20.7	48.8	80.9	31.5	14.1	0.0	18.5	15.6	209.0	40.3	35.3	39.9	73.2	16.4	11.9	35.9	34.7
INO80D	FLJ20309	ENSG00000114933	"INO80 complex subunit D"	Q53TQ3	2	205993721-206086303	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 158.7;Excitatory neurons: 127.7;Inhibitory neurons: 129.0;Oligodendrocytes: 188.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043976	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA043976: AB_10960835"	"unprognostic (6.79e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (4.83e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.03e-2)"	4.6	3.0	0.7	2.3	1.1	17.9	4.3	5.3	1.4	4.3	1.0	3.9	3.4	4.0	1.4	4.4	3.9	3.0	3.6	0.5	0.6	3.0	3.7	4.1	4.4	1.4	0.5	5.1	4.1	1.4	4.0	2.5	0.8	3.4	1.4	5.1	4.2	0.9	5.7	6.1	4.7	1.0	0.0	3.9	3.8	5.6	1.1	1.7	5.2	1.7	1.7	3.6	4.5	3.0	2.4	1.8	4.5	3.6	1.3	1.6	3.3	1.8	0.9	1.3	1.0	3.6	4.7	2.4	2.9	1.1	4.5	3.2	1.7	1.2	1.5	2.1	3.3	5.2	4.2	4.4	0.8	4.5	3.3	1.0	1.6	1.6	2.1	3.5	1.7	2.9	5.1	5.6	1.4	3.2	2.5	14.8	6.0	1.4	2.6	3.1	2.8	2.6	1.3	4.1	4.1	3.9	3.3	2.1	3.5	3.6	2.9	4.4	4.7	3.7	3.6	1.6	2.2	7.0	5.7	6.1	2.9	3.9	2.8	4.1	2.2	2.0	3.0	1.2	2.5	4.1	2.2	1.4	1.6	5.2	2.5	1.9	5.1	2.0	3.4	4.5	2.6	0.9	0.7	1.1	5.3	1.4	0.5	0.6	1.4	0.5	0.8	0.0	1.1	3.0	31.5	22.4	34.7	158.7	35.5	30.8	18.2	9.8	25.6	39.5	19.9	13.8	17.5	31.5	18.6	18.4	39.6	8.4	43.0	27.3	5.9	13.5	3.7	25.3	31.4	27.8	25.2	29.9	127.7	13.1	5.9	29.4	26.5	41.2	32.4	24.1	17.2	16.3	11.7	11.8	129.0	20.3	4.1	21.7	28.9	5.4	20.2	23.1	17.8	117.1	25.9	16.8	26.8	126.2	188.3	17.8	19.9	15.4	33.2	26.1	24.3	12.8	16.2	39.9	13.1	55.6	29.3	11.3	5.7	31.2	29.1	15.5	33.6	16.4	17.8	25.7
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995715-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	25.9	22.7	36.6	22.1	39.0	33.1	26.4	38.8	43.1	31.6	29.1	35.3	19.9	30.8	29.2	29.7	40.8	24.8	25.3	35.7	36.3	21.9	26.4	28.7	32.9	40.3	38.9	38.0	25.5	39.9	23.2	24.8	38.0	24.1	36.5	13.4	32.4	34.7	30.9	27.6	24.0	40.3	37.1	26.5	24.8	27.8	38.3	42.5	33.3	29.7	46.8	30.8	25.5	42.5	79.1	95.1	59.6	88.0	54.0	45.6	55.0	66.9	75.2	95.4	93.8	54.7	85.7	101.6	100.4	75.3	63.0	52.9	73.8	109.8	80.0	106.7	88.8	50.2	57.7	79.0	63.5	66.4	59.5	53.5	89.1	112.1	87.6	54.9	115.4	137.5	64.4	55.6	89.9	114.7	142.0	87.2	120.3	55.4	55.1	176.9	72.6	104.7	73.2	39.5	90.8	111.3	36.8	65.1	83.7	48.9	80.8	53.0	62.5	68.0	48.3	58.7	84.6	58.9	120.2	92.9	77.3	96.2	97.9	1.5	6.1	5.1	4.3	4.1	3.6	4.5	3.4	5.0	4.9	3.3	3.2	3.3	3.0	3.5	6.8	5.1	5.2	21.4	36.6	39.0	38.8	43.1	35.7	36.3	40.3	38.9	38.0	37.1	38.3	42.5	32.8	38.5	19.6	15.0	27.6	14.8	19.1	34.0	37.0	15.1	23.5	22.6	0.8	22.8	24.1	20.2	20.9	36.9	27.6	32.9	33.2	29.3	1.9	17.1	13.3	25.4	35.2	14.9	6.6	39.3	40.1	20.2	45.9	19.2	15.8	16.4	23.9	18.9	27.8	8.4	6.9	28.4	32.6	22.4	15.0	5.2	26.1	24.0	19.6	14.0	25.2	20.4	29.9	9.0	14.4	38.0	39.7	27.8	35.2	12.4	48.2	29.8	19.7	20.9	26.3	17.3	23.1	44.4	23.3	33.6	17.2	18.1	30.9	13.9	31.6	12.4
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343570-190371665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 96.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 96.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		31000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	24.0	35.0	35.6	11.4	41.2	14.8	20.7	36.5	47.5	27.4	24.5	22.3	36.7	18.1	12.5	71.9	18.9	23.5	30.9	36.2	42.0	19.6	33.1	27.9	9.3	37.5	37.0	11.8	26.6	41.6	29.6	13.4	37.6	18.2	21.0	17.0	17.0	13.4	21.2	37.4	25.3	19.6	34.7	25.8	18.2	52.9	38.1	23.7	19.0	35.7	20.9	42.1	35.8	54.0	26.7	7.4	13.9	0.0	15.0	31.8	0.3	30.9	41.5	28.8	37.5	28.8	16.5	0.2	36.3	30.5	9.3	35.8	5.4	19.9	35.0	32.8	11.7	19.5	22.1	17.5	31.5	15.2	6.0	21.6	30.6	32.9	18.6	20.7	54.7	0.3	48.6	16.3	51.3	0.1	1.1	14.3	4.2	42.3	40.4	0.7	11.2	0.3	22.6	62.2	20.6	7.8	21.7	1.4	31.7	14.4	0.1	21.0	51.0	18.4	13.2	33.3	18.5	3.1	3.5	0.3	5.7	6.0	14.9	26.2	8.3	96.0	6.9	8.1	6.3	3.3	4.3	4.7	8.7	4.4	2.4	3.6	3.9	16.2	4.7	0.2	20.3	5.1	35.6	41.2	36.5	47.5	36.2	42.0	37.5	37.0	37.6	34.7	38.1	54.0	63.0	3.2	5.5	44.1	8.0	86.4	155.4	33.2	50.7	15.0	9.9	14.6	20.9	38.6	27.5	11.0	6.2	6.9	9.7	50.4	7.9	33.4	727.4	18.8	16.0	59.6	31.1	1.7	30.3	85.4	2.6	30.7	29.6	26.9	8.8	3.8	88.5	21.9	8.8	16.8	36.7	23.7	20.3	10.7	27.3	836.0	26.8	14.0	26.6	17.8	12.2	73.2	14.4	29.7	125.6	53.1	40.8	23.7	12.9	90.7	50.6	20.8	13.0	11.9	26.3	26.0	19.4	18.1	11.4	170.2	97.3	4.0	10.4	37.8	35.4	229.0
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594392	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	8.7	8.2	15.9	13.2	19.5	12.7	6.1	18.8	22.0	7.0	1.0	11.3	7.3	7.5	5.2	7.7	6.6	9.9	10.5	15.9	9.9	5.2	4.1	9.6	17.2	9.2	3.5	7.0	6.6	8.9	7.7	8.1	9.2	6.0	7.9	10.7	5.6	6.3	8.4	4.1	8.8	9.8	4.7	16.7	7.3	5.9	5.9	20.3	5.9	11.6	12.5	10.8	5.5	10.1	12.7	11.0	18.2	14.8	10.4	11.1	19.2	10.0	9.4	10.9	11.3	14.6	11.5	7.8	13.3	15.4	14.0	12.6	12.6	11.1	8.5	27.7	10.9	9.5	9.7	6.5	8.8	17.3	34.3	9.9	9.9	10.6	9.0	9.5	15.1	44.9	8.5	67.4	8.3	16.2	26.3	16.8	17.6	7.4	11.3	12.0	12.5	51.9	5.6	41.6	12.8	15.7	12.1	10.1	9.5	18.7	4.8	13.8	14.3	12.7	17.9	10.1	7.5	50.2	31.1	5.8	10.5	16.2	11.5	1.1	1.0	2.3	2.8	2.2	3.3	0.4	1.6	1.8	1.1	0.1	2.2	2.5	1.1	3.2	3.4	3.3	0.9	1.0	15.9	19.5	18.8	22.0	15.9	9.9	9.2	3.5	9.2	4.7	5.9	10.1	14.6	6.4	13.1	50.9	11.2	8.0	6.4	2.8	9.1	49.7	5.3	4.2	12.6	2.8	7.8	5.5	8.4	10.2	64.6	4.1	3.9	4.0	13.5	6.2	9.1	14.2	5.4	7.2	150.5	1.5	8.7	9.9	6.6	6.3	0.0	22.4	14.3	3.4	10.5	33.7	124.4	5.6	4.1	36.4	18.4	10.9	9.3	25.3	10.6	73.1	26.8	8.4	71.1	55.8	26.1	3.8	2.5	12.0	48.6	5.9	1.2	3.3	5.1	14.1	6.6	9.9	12.4	8.6	14.0	5.2	6.1	9.4	48.3	9.4	3.6	6.8
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 158.7;Early spermatids: 178.1;Excitatory neurons: 196.8;Inhibitory neurons: 614.4;Late spermatids: 291.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 30.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 150.4;SK-MEL-30: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	9.9	4.0	5.2	6.7	6.7	2.1	18.3	3.2	6.4	13.1	0.3	5.8	4.6	5.4	3.9	7.5	7.3	7.9	17.4	5.5	3.4	5.4	1.8	6.5	10.8	1.3	2.7	5.7	2.5	2.0	1.3	5.7	1.9	4.7	5.1	1.7	2.7	4.7	7.9	3.6	5.5	7.3	0.0	6.8	5.8	18.6	7.3	5.9	4.3	5.2	6.9	14.0	8.7	6.0	27.7	11.4	7.3	3.6	5.5	3.4	1.4	32.5	37.9	8.2	15.3	3.1	150.4	0.8	8.9	29.4	12.6	41.1	0.0	37.9	19.1	0.1	1.1	6.6	4.0	0.1	1.8	1.4	5.0	5.9	5.2	5.8	19.4	24.7	4.8	0.0	0.0	1.5	17.9	49.1	1.1	0.0	0.3	16.8	8.1	0.3	24.7	1.4	11.3	50.3	0.6	0.7	3.7	11.2	66.6	4.3	34.2	4.9	3.1	18.8	22.6	28.0	0.3	0.4	0.1	0.1	4.4	29.7	49.5	6.1	0.2	0.0	5.2	0.0	10.1	0.0	30.4	13.6	0.1	0.1	20.6	8.9	0.5	17.0	0.0	0.1	17.4	5.9	5.2	6.7	3.2	6.4	5.5	3.4	1.3	2.7	1.9	0.0	7.3	6.0	13.4	0.0	0.6	158.7	2.6	6.6	9.5	7.0	4.0	7.5	49.0	15.5	42.2	7.2	20.2	9.2	0.0	1.7	8.7	8.7	5.9	12.2	178.1	19.8	58.2	13.2	8.9	6.1	196.8	30.6	5.1	5.1	19.4	5.4	6.3	0.6	6.4	0.3	8.1	6.7	614.4	3.5	4.1	2.8	4.9	291.9	13.7	3.9	72.9	47.8	1.3	0.9	2.1	79.4	57.6	76.3	0.2	6.4	4.5	20.5	10.1	0.9	35.7	0.8	85.5	5.2	84.7	2.5	1.9	1.9	2.6	1.9	60.4	1.8	4.3	42.9
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	13.3	9.3	9.5	10.3	10.7	20.7	11.9	14.7	11.8	16.1	11.5	18.7	6.9	13.9	9.9	7.2	15.7	8.4	12.8	9.2	9.3	10.8	16.2	14.7	18.5	11.5	10.2	23.9	10.5	8.9	11.9	10.4	11.4	10.9	10.0	12.5	8.4	11.1	9.1	10.8	13.4	11.9	9.0	17.3	13.7	7.0	10.5	13.4	12.2	6.0	18.7	16.8	11.7	15.3	6.8	4.6	10.7	15.7	12.3	15.8	18.5	7.5	12.5	9.6	13.2	7.2	9.4	23.2	3.6	12.9	5.0	9.1	14.3	6.0	12.8	16.2	6.3	35.8	15.4	4.9	17.7	19.0	47.4	17.8	3.7	10.2	6.6	9.4	11.0	16.4	11.7	25.6	12.4	5.3	16.7	21.4	15.5	9.5	3.9	18.7	21.3	10.9	5.5	6.2	4.3	6.8	8.8	4.2	18.9	15.7	5.2	15.8	10.6	8.8	7.9	8.5	7.1	20.8	11.8	18.3	10.1	15.8	8.1	27.3	2.9	16.5	7.0	2.3	9.9	7.1	4.8	6.7	6.1	7.6	6.1	5.8	3.7	6.2	6.0	5.4	6.8	4.9	9.5	10.7	14.7	11.8	9.2	9.3	11.5	10.2	11.4	9.0	10.5	15.3	5.7	28.9	26.3	35.3	11.8	2.2	5.8	2.1	4.0	14.7	2.2	2.3	3.2	1.5	6.4	1.8	25.0	4.1	7.9	3.9	0.0	2.4	10.7	2.3	8.4	5.9	3.5	6.5	47.5	4.4	15.4	6.3	16.8	3.3	8.2	6.9	5.3	7.8	5.2	23.5	48.5	5.0	6.1	8.1	5.4	15.9	8.4	8.3	7.2	35.6	11.3	4.6	28.8	20.1	39.4	3.0	4.7	9.1	8.5	4.5	3.5	2.6	5.8	18.9	6.6	7.7	7.1	4.6	8.1	3.4	3.3	4.7	11.2	7.7	4.7	4.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439845	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Focal adhesion sites"		"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	12.1	10.8	15.0	6.9	15.0	6.4	11.7	15.3	19.9	15.1	11.3	13.1	5.7	15.2	2.3	10.6	17.6	5.3	13.7	14.0	14.3	13.3	12.2	11.9	8.2	15.1	13.3	16.2	10.8	6.6	14.3	5.7	15.5	12.3	3.3	7.4	9.5	5.3	8.5	11.2	11.7	5.6	11.4	20.8	8.9	20.1	14.8	6.4	15.1	3.8	4.7	12.2	12.0	13.9	8.9	10.3	12.6	13.2	6.5	7.1	14.9	10.7	5.7	7.4	5.1	12.5	6.0	10.8	10.5	11.1	11.9	25.2	6.2	8.6	2.8	36.8	25.4	8.5	27.1	8.4	10.3	9.5	11.9	10.9	8.8	9.8	7.2	10.3	8.9	14.8	14.5	14.0	7.0	22.3	11.4	19.9	8.1	5.3	16.0	21.1	8.7	8.3	7.4	9.8	14.1	12.2	10.4	8.5	7.6	7.6	15.1	15.6	11.8	24.1	9.4	10.1	18.2	11.6	10.6	4.5	12.0	7.8	9.7	0.0	0.1	0.5	0.5	0.0	0.3	0.7	0.6	0.4	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.1	15.0	15.0	15.3	19.9	14.0	14.3	15.1	13.3	15.5	11.4	14.8	13.9	14.7	3.2	6.9	17.0	5.0	5.5	1.8	2.6	5.7	7.4	6.5	6.9	5.0	7.2	3.4	3.7	2.1	2.3	7.6	4.0	1.9	4.8	0.9	11.8	8.1	7.4	6.1	0.8	12.2	5.6	2.8	5.7	3.6	6.8	8.9	8.3	6.1	3.8	3.2	15.2	12.9	2.6	6.1	3.5	3.5	1.3	7.5	3.7	5.4	6.5	3.5	8.9	1.0	8.5	8.5	6.7	1.6	5.7	2.5	3.3	3.4	2.4	10.0	10.8	0.0	5.5	7.5	15.3	9.1	5.4	4.8	0.8	5.3	5.6	3.9	1.6
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 12983.6"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000			"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.2	4.0	0.1	0.2	0.1	49.8	0.6	0.0	0.0	0.7	0.0	12.8	1.5	1.4	0.0	1.8	0.3	3.7	5.6	0.1	0.1	40.7	1.4	1.7	5.4	0.2	0.4	2.6	12983.6	0.0	0.3	1.4	0.8	0.5	0.0	0.0	3.1	0.0	0.3	96.4	0.7	0.0	0.0	1.4	42.2	0.3	0.0	0.0	1.3	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"pancreas: 9.1"	"Cell type enriched"	"Detected in single"	11	"Hepatocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 2: Hepatocytes - Metabolism"			"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSC		ENSG00000188487	"INSC spindle orientation adaptor protein"	Q1MX18	11	15112424-15247208	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039769	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039769: AB_10697556"	"unprognostic (1.64e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.00e-2)"	0.2	0.8	0.2	1.0	0.1	0.6	0.2	0.1	0.2	1.1	0.1	4.7	2.1	0.1	0.1	0.5	0.3	0.6	1.2	0.1	0.2	0.3	0.2	0.9	0.0	0.3	0.2	0.1	0.9	25.3	0.2	0.0	0.2	1.0	1.8	0.0	0.5	1.0	0.0	0.1	3.0	0.5	0.2	0.1	2.4	0.7	0.1	0.2	0.3	0.1	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.6	6.0	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.0	0.2	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	1.0	0.0	0.0	1.5	0.2	0.0	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.1	4.6	0.2	0.0	0.1	1.8	0.0	0.5	3.1	0.0	0.9	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	10.9	0.0	0.0	0.1	0.2	0.0	8.9	0.0	0.0	0.0	0.0	1.1	1.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6
INSIG2		ENSG00000125629	"Insulin induced gene 2"	Q9Y5U4	2	118088452-118110997	"Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033861	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033861: AB_2249149"	"unprognostic (3.84e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.75e-2)"	10.4	6.2	5.0	5.7	5.4	3.8	8.5	7.3	6.3	8.7	7.2	8.8	9.6	9.4	8.9	6.6	7.0	8.2	8.5	7.1	5.1	12.3	28.0	10.3	7.3	5.4	5.8	10.3	11.7	12.4	7.0	9.0	5.7	8.0	7.3	8.9	8.5	6.3	7.8	10.2	9.7	8.8	5.3	11.3	12.6	6.3	6.4	9.6	10.6	6.8	9.1	7.3	8.1	5.5	33.0	7.7	9.2	4.8	26.1	13.2	11.7	9.0	10.2	7.5	13.7	6.7	32.8	6.3	31.6	12.8	14.6	13.5	8.0	17.9	14.6	13.2	11.1	6.6	8.8	38.2	6.0	8.8	9.9	17.5	14.2	8.3	14.6	22.7	18.3	9.7	3.8	11.3	11.4	4.2	9.4	6.0	4.4	10.5	10.0	6.3	7.6	7.2	12.1	12.0	7.5	8.8	5.5	9.0	5.2	10.2	4.4	6.0	21.1	10.9	7.9	8.5	4.5	16.3	12.3	6.5	17.4	6.4	6.6	6.6	6.8	12.3	7.2	10.4	8.2	7.7	7.2	6.8	7.4	6.4	8.0	9.1	7.0	9.3	11.6	7.1	7.1	6.0	5.0	5.4	7.3	6.3	7.1	5.1	5.4	5.8	5.7	5.3	6.4	5.5	9.6	35.3	28.9	17.3	30.9	40.9	13.4	98.8	13.6	14.9	26.1	10.7	19.5	62.9	36.9	44.1	12.5	20.0	26.7	13.5	19.6	89.7	4.1	11.8	10.2	18.1	20.9	12.6	27.7	62.1	37.7	18.6	15.8	18.5	21.0	10.9	42.8	48.7	29.7	25.2	25.1	13.1	34.6	23.6	46.3	4.3	12.8	19.0	32.0	20.6	23.4	22.8	16.5	27.2	20.5	92.5	14.4	14.3	50.8	25.3	34.4	29.6	23.9	12.4	0.0	21.3	30.1	38.1	16.1	11.6	40.1	19.8	21.5	8.4	13.2	32.1
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"		Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 409.3"	"Cell type enriched"	"Detected in some"	19	"Theca cells: 24080.8"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.5	1.6	1.2	4.8	1.3	1.8	0.5	2.3	1.5	0.1	1.3	0.5	1.5	0.3	0.8	0.6	0.8	0.4	0.2	1.4	1.5	0.5	0.4	0.9	2.9	1.2	1.3	29.6	0.2	0.0	0.2	0.3	1.4	0.6	0.0	0.1	0.6	0.0	0.2	0.3	1.7	0.0	1.2	5.2	0.8	409.3	1.5	0.5	0.3	0.4	1.2	0.4	0.3	1.3	0.2	0.6	0.1	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.5	0.0	0.2	0.0	0.0	1.2	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	1.0	0.2	1.1	0.0	1.1	2.6	0.9	0.0	0.1	0.1	0.3	5.2	4.7	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	2.1	0.1	0.1	1.3	0.0	0.4	0.2	0.0	0.7	0.4	0.7	0.0	0.9	0.9	0.1	1.1	0.7	1.0	2.2	0.5	0.1	0.1	0.8	0.5	1.2	1.3	2.3	1.5	1.4	1.5	1.2	1.3	1.4	1.2	1.5	1.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.1	6.8	0.0	0.1	3.4	0.0	0.0	0.3	0.0	0.4	42.3	0.0	0.0	0.0	0.9	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	257.1	1240.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	998.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.9	5.7	0.0	0.0	0.5	0.8	24080.8	0.0	0.0
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	106	"intestine: 128.9"	"Cell type enriched"	"Detected in some"	365	"Enteroendocrine cells: 8836.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA030100, CAB033849"	Enhanced				"Secreted to blood"	NA	NA	38500000			"Cluster 37: Intestine - Unknown function"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.8	1.1	0.0	1.2	75.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.8	0.5	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.2	0.0	0.9	0.1	128.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	1.1	0.8	0.8	1.1	1.0	0.9	0.9	0.8	0.9	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.3	0.0	0.0	8836.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.0
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5123880-5185647	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"retina: 6.8;testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 134.0;Excitatory neurons: 22.0;Inhibitory neurons: 26.2;Late spermatids: 17.9;Microglial cells: 21.5;Spermatocytes: 35.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;Karpas-707: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021364	Enhanced				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.1	0.3	0.5	0.6	0.7	1.5	0.0	1.1	1.2	0.0	0.1	0.2	0.3	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.9	0.1	0.1	0.2	1.0	0.6	0.2	0.4	0.0	0.0	0.0	0.8	0.6	0.2	0.0	6.8	0.2	0.0	0.3	1.0	0.2	0.0	0.1	1.1	0.6	14.9	0.5	0.1	0.2	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	1.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	1.2	0.4	0.9	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	134.0	0.1	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	26.2	0.0	0.0	0.0	0.0	17.9	1.2	0.0	0.0	21.5	0.0	0.0	0.0	9.5	8.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	35.7	10.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0
INSM2	"IA-6, Mlt1"	ENSG00000168348	"INSM transcriptional repressor 2"	Q96T92	14	35534164-35537054	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.6;retina: 2.7"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	134	"SH-SY5Y: 114.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in some"			"HPA044885, HPA051925"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA044885: AB_10794779, HPA051925: AB_2681664"	"unprognostic (9.88e-2)"	"unprognostic (8.74e-2)"			"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"		"unprognostic (3.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-3)"		"unprognostic (7.51e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.36e-3)"	"unprognostic (5.00e-1)"	0.0	0.3	0.9	0.0	1.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	114.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	2.2	0.9	3.6	1.9	0.8	2.1	0.3	1.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.4	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.1	4.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 54.9;U-266/70: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	Yes		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.0	22.6	12.5	2.8	16.8	5.6	13.0	17.3	12.8	14.6	18.8	15.0	10.0	18.4	6.3	4.1	16.9	8.2	26.3	10.0	12.2	21.8	33.0	7.2	2.3	18.3	16.3	39.9	64.2	13.0	16.3	7.4	18.7	15.2	10.4	6.5	16.9	9.9	23.5	11.5	12.2	11.5	14.1	48.2	12.5	5.4	16.6	2.7	14.5	13.3	3.5	12.3	9.2	22.5	6.2	3.2	3.6	5.7	18.8	6.1	11.1	3.5	2.9	1.6	1.6	8.4	7.0	9.0	8.2	6.8	4.0	1.6	8.9	1.4	1.2	0.0	6.4	0.0	2.3	22.6	8.2	4.3	6.7	10.0	4.5	0.2	4.9	4.2	3.8	4.8	9.5	54.9	1.8	3.2	3.1	7.8	3.3	3.8	5.2	29.0	2.1	7.6	0.1	27.8	6.6	5.2	6.5	3.8	3.3	6.4	1.4	21.6	3.6	3.4	2.1	8.2	5.1	40.4	23.9	20.2	4.3	7.3	0.0	2.7	8.6	5.9	0.2	8.8	0.3	0.8	0.3	0.1	9.8	1.1	0.7	0.1	1.9	1.0	12.5	8.2	0.0	1.6	12.5	16.8	17.3	12.8	10.0	12.2	18.3	16.3	18.7	14.1	16.6	22.5	75.6	48.1	34.7	64.9	10.6	64.9	63.6	34.7	8.0	40.4	134.0	76.2	92.1	137.2	83.3	62.5	79.2	17.8	6.7	124.1	15.6	55.1	4.7	26.8	106.8	123.9	163.6	25.0	68.3	78.7	53.7	43.7	20.4	42.1	3.8	168.4	255.2	246.0	9.2	38.7	100.8	97.3	32.6	49.0	31.1	9.0	96.3	35.0	51.6	62.8	24.2	31.6	0.0	62.8	183.5	50.7	68.8	245.3	21.8	107.9	122.9	114.1	65.3	23.6	59.2	37.6	44.2	5.2	3.6	3.2	68.8	38.3	4.7	81.4	65.2	130.0
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859117	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.5;kidney: 3.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.9;Cardiomyocytes: 2.3;Early spermatids: 2.8;Spermatocytes: 4.1;Spermatogonia: 5.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 14.5;pons: 13.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.6;SH-SY5Y: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025285	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.5	1.4	0.0	0.0	0.5	0.0	0.2	1.2	1.9	1.3	0.2	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.5	3.8	0.0	0.0	0.0	14.5	0.6	0.0	0.2	0.0	0.6	0.0	13.4	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	1.9	0.0	0.5	14.5	0.6	13.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.6;heart muscle: 48.5"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.5	2.6	32.6	0.9	30.1	0.1	1.9	27.2	42.8	7.9	1.6	6.6	0.8	4.2	3.4	12.0	7.8	1.9	48.5	38.9	28.8	15.5	0.4	2.7	0.2	26.9	56.6	13.5	1.4	2.9	5.2	0.5	27.7	10.6	0.6	3.9	3.3	11.0	4.6	13.3	2.4	3.2	22.8	0.7	3.7	4.5	46.3	0.2	2.1	2.6	0.9	6.4	16.9	34.7	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.6	30.1	27.2	42.8	38.9	28.8	26.9	56.6	27.7	22.8	46.3	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSYN2A	"C10orf141, FAM196A, FLJ45557, INSYN2"	ENSG00000188916	"Inhibitory synaptic factor 2A"	Q6ZSG2	10	127135426-127196591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.0"	"Cell type enhanced"	"Detected in single"		"Endothelial cells: 1.4"	"Group enriched"	"Detected in some"	13	"breast cancer: 3.4;glioma: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 2.7;U-87 MG: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035898, HPA035899"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035898: AB_10964352, HPA035899: AB_10961723"	"unprognostic (4.00e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-1)"	0.1	0.0	4.5	0.1	6.2	0.0	0.6	2.8	5.8	0.1	1.2	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.1	3.4	5.3	0.3	0.0	0.2	0.0	4.4	5.4	0.7	0.1	0.0	0.2	0.0	4.2	0.7	0.1	1.6	0.2	0.1	0.0	0.1	0.3	0.1	2.6	0.3	0.2	0.6	8.0	1.1	0.1	0.1	0.1	0.2	0.1	2.3	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	6.2	2.8	5.8	3.4	5.3	4.4	5.4	4.2	2.6	8.0	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSYN2B	"C5orf57, FAM196B"	ENSG00000204767	"Inhibitory synaptic factor family member 2B"	A6NMK8	5	169861303-169980495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.5;breast: 6.9;salivary gland: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.0;HUVEC TERT2: 23.2;U-138 MG: 66.3;U-251 MG: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047227	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA047227: AB_2679992"	"unprognostic (5.30e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (1.26e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.73e-3)"	0.3	0.5	3.4	0.4	6.5	0.2	6.9	3.5	4.6	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	3.5	4.1	0.4	0.1	0.1	0.0	5.3	5.7	1.8	0.0	0.0	0.1	0.0	4.8	0.6	0.0	0.4	5.2	0.0	0.0	0.3	0.0	0.2	4.7	1.4	0.0	0.1	5.4	0.2	0.8	0.0	0.0	0.0	0.0	5.8	0.2	0.3	1.7	0.1	11.4	3.5	0.0	7.8	3.3	5.1	4.3	0.0	0.0	0.0	15.6	38.0	11.7	0.0	0.1	12.3	10.9	0.0	0.0	0.0	2.7	0.0	2.2	0.0	0.0	1.1	0.0	7.0	6.8	12.4	23.2	0.0	0.0	0.1	16.3	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	14.2	66.3	0.8	1.9	25.3	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	6.5	3.5	4.6	3.5	4.1	5.3	5.7	4.8	4.7	5.4	5.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INTS1	"DKFZp586J0619, INT1, KIAA1440, NET28"	ENSG00000164880	"Integrator complex subunit 1"	Q8N201	7	1470277-1504389	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021658, HPA053009"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA021658: AB_1852402, HPA053009: AB_2682016"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (7.72e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (4.30e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	19.4	20.3	11.1	13.2	9.2	25.7	20.2	3.2	16.8	23.8	2.2	24.5	14.9	23.4	2.0	21.6	23.9	8.0	23.6	10.5	2.9	23.0	23.5	19.9	15.6	11.2	6.5	28.0	31.2	9.0	25.1	9.5	6.2	24.9	4.1	4.7	21.3	10.0	56.0	23.8	24.0	5.4	2.9	26.6	22.8	47.9	8.2	22.4	25.8	11.6	6.3	22.3	19.5	8.8	63.9	54.4	20.8	54.2	15.0	11.5	72.3	26.5	14.6	20.1	17.6	60.3	48.3	34.1	27.2	19.1	40.4	64.6	11.8	31.5	5.6	16.7	64.8	24.3	80.3	40.5	17.4	42.6	35.0	15.5	14.6	20.7	14.5	12.0	22.1	47.5	68.8	26.5	12.4	77.1	24.2	115.9	114.0	23.3	48.2	60.4	23.6	34.9	9.6	47.7	39.2	96.4	38.1	68.8	24.1	11.9	54.7	42.2	41.3	32.8	92.8	27.6	44.1	55.0	31.6	33.6	36.8	36.2	68.7	2.0	0.9	1.0	1.4	0.6	0.9	0.8	1.1	1.2	1.2	2.7	0.6	0.9	0.7	1.0	0.6	0.6	1.5	0.8	11.1	9.2	3.2	16.8	10.5	2.9	11.2	6.5	6.2	2.9	8.2	8.8	16.5	12.8	25.8	19.9	14.0	5.9	4.9	11.1	9.6	34.7	20.7	17.4	52.0	14.3	11.5	11.0	25.0	12.9	14.6	44.6	0.0	16.3	23.2	21.4	15.2	18.3	18.0	5.9	22.4	23.6	13.3	15.8	30.1	27.4	1.3	43.6	15.4	26.3	15.0	48.8	14.5	23.4	12.2	19.8	8.1	41.4	13.4	12.8	5.4	12.2	12.6	14.9	7.2	12.5	11.0	19.9	21.7	15.4	17.9	9.1	28.8	12.9	13.7	36.1	26.3	16.6	15.7	20.8	11.6	13.3	8.0	15.2	12.2	23.5	29.3	6.1
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817391-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	27.7	24.0	42.2	24.6	44.1	34.3	29.1	44.2	57.6	27.5	40.3	28.5	26.6	22.5	20.3	26.6	38.7	21.5	21.7	44.4	43.2	29.9	47.6	24.2	30.5	43.0	42.3	25.3	42.6	28.3	18.7	23.0	42.9	29.2	27.3	37.2	30.4	20.0	25.6	31.8	24.1	26.1	42.1	22.7	25.0	15.2	43.7	29.2	43.7	18.6	33.2	24.6	18.0	45.1	40.0	57.3	32.5	42.1	48.7	53.3	41.5	29.5	50.6	40.3	38.4	33.6	19.7	113.9	47.9	33.1	43.9	42.3	39.5	38.5	44.8	22.4	40.0	51.7	62.6	63.2	35.0	45.2	34.2	42.3	58.9	29.8	46.5	24.8	40.2	65.4	66.3	88.2	28.4	33.9	86.7	53.4	42.6	92.9	32.2	43.7	35.9	73.1	52.8	60.7	32.2	26.1	41.1	51.0	37.1	29.1	26.2	43.6	29.2	25.5	35.0	59.1	39.5	24.7	30.5	81.5	51.4	64.4	41.1	10.0	23.7	14.5	19.6	21.4	30.8	26.5	25.6	25.2	30.9	21.7	28.1	25.1	7.7	27.7	18.6	27.1	31.8	20.2	42.2	44.1	44.2	57.6	44.4	43.2	43.0	42.3	42.9	42.1	43.7	45.1	25.5	16.0	51.1	74.4	40.3	37.6	40.9	29.3	43.3	60.2	28.3	20.3	22.5	37.1	39.1	20.2	52.1	33.7	41.5	22.9	35.2	43.6	53.9	78.8	23.1	33.0	20.4	27.3	88.8	40.0	49.2	34.1	25.5	33.4	35.5	63.6	35.3	61.0	42.4	70.7	61.0	34.3	22.4	34.0	25.5	31.9	34.8	35.6	17.8	37.5	37.8	33.9	45.3	80.9	74.9	33.1	27.4	35.0	48.6	53.4	33.9	37.5	70.0	99.0	13.1	29.1	32.5	8.3	32.3	50.8	45.0	22.3	40.6	41.2	42.0	32.7
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324687	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	39.7	40.8	26.0	24.0	28.6	29.0	39.0	37.2	40.1	64.7	27.7	70.6	32.8	66.6	26.4	43.9	61.1	24.1	54.9	27.2	28.4	40.4	45.7	35.6	31.8	30.3	27.2	63.6	53.6	28.9	40.0	28.2	30.6	52.9	20.8	13.0	38.3	27.6	90.3	47.2	44.9	26.7	24.5	45.4	52.4	76.0	28.0	29.6	40.7	44.2	25.1	67.5	50.6	33.6	58.4	56.2	31.5	62.1	52.4	41.7	34.1	31.2	49.9	67.6	50.1	53.2	71.0	63.2	43.6	60.7	40.6	41.4	46.3	67.7	29.9	60.3	60.5	49.8	79.7	70.2	80.2	39.1	52.5	72.1	35.9	61.7	91.7	38.2	71.7	59.7	59.5	56.3	34.2	50.8	77.6	52.1	39.1	53.6	60.1	61.0	30.8	93.1	47.6	31.3	45.0	42.1	31.9	83.8	91.7	23.4	45.5	57.0	54.5	43.6	39.6	50.8	40.0	87.3	101.8	85.1	60.4	68.7	22.0	66.5	69.6	48.0	65.2	82.1	68.9	50.3	56.4	59.8	81.2	44.0	52.2	50.2	33.2	64.8	101.7	52.9	78.7	81.0	26.0	28.6	37.2	40.1	27.2	28.4	30.3	27.2	30.6	24.5	28.0	33.6	36.4	38.5	33.7	0.0	9.5	0.0	0.0	0.0	0.0	0.0	32.6	33.9	0.0	0.0	13.0	18.4	0.0	77.3	24.1	0.0	31.3	56.4	0.0	27.1	27.2	14.0	0.0	0.0	0.0	53.9	63.9	18.7	0.0	23.2	10.1	40.4	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	36.2	0.0	0.0	0.0	0.0	54.8	0.0	0.0	6.8	0.0	0.0	34.4	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	77.0	12.7	49.8	0.0	0.0
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	15.2	11.1	12.8	10.9	13.3	30.4	20.2	14.9	18.0	14.1	12.0	14.7	18.1	14.6	17.8	13.5	13.2	12.7	18.9	12.4	14.9	18.7	22.6	16.4	14.0	12.3	14.0	11.6	12.6	17.2	10.3	11.9	12.5	18.1	15.6	17.2	14.4	13.4	26.5	14.0	15.5	17.1	12.7	12.6	15.0	13.9	14.3	19.9	19.9	26.0	17.0	15.6	11.2	13.7	24.4	12.8	28.5	29.8	27.5	32.6	20.8	28.2	29.1	34.7	35.9	18.1	26.9	34.9	15.4	31.9	26.9	13.8	31.7	40.7	42.8	36.9	19.0	26.3	19.6	25.7	44.3	46.7	23.0	31.0	51.7	34.5	51.4	22.5	32.3	29.1	39.8	26.7	37.8	25.6	55.3	28.9	12.4	35.3	19.5	28.0	31.0	26.8	32.5	16.3	30.7	24.6	19.8	32.6	31.0	22.4	26.4	27.2	21.3	22.7	23.3	24.8	30.5	40.8	40.9	52.2	25.3	31.5	46.0	64.0	23.7	38.5	25.7	26.6	28.9	33.0	29.4	29.4	27.7	32.1	30.6	28.3	17.9	42.9	28.3	42.6	34.8	21.9	12.8	13.3	14.9	18.0	12.4	14.9	12.3	14.0	12.5	12.7	14.3	13.7	19.0	12.8	11.8	14.0	15.1	11.0	11.8	25.8	15.4	10.5	12.1	11.7	18.7	11.5	12.9	3.7	10.4	16.1	13.6	8.3	43.0	25.2	35.8	8.1	11.2	16.8	6.0	15.6	13.8	20.3	18.6	10.8	8.6	8.7	24.7	9.9	11.7	9.3	17.8	10.1	15.7	5.2	30.5	9.0	9.5	28.4	12.2	9.8	7.2	9.4	15.5	14.0	21.6	27.2	19.1	20.5	6.8	8.2	18.9	14.2	16.5	17.1	6.2	9.3	0.0	12.9	20.1	13.4	16.2	14.1	10.4	18.3	13.0	14.9	10.2	11.0
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	9.9	21.4	9.3	11.3	13.4	17.2	11.7	13.2	14.3	10.4	8.1	9.7	9.9	10.0	10.3	14.6	8.5	8.2	12.2	9.5	11.6	13.2	15.1	7.9	16.7	15.4	12.0	8.0	11.5	8.0	8.1	10.0	14.8	8.5	10.7	21.8	9.0	7.0	19.0	11.8	8.5	11.9	13.9	12.9	15.4	12.1	12.2	18.6	9.9	18.1	16.8	12.8	10.6	20.0	33.4	38.1	21.5	46.4	30.5	48.9	30.9	44.9	27.4	43.3	48.1	58.4	43.1	82.7	45.0	25.1	40.6	46.2	56.1	43.6	72.8	39.5	37.4	66.7	44.5	44.9	53.9	110.6	38.4	26.3	32.2	69.5	147.0	53.5	56.8	35.6	71.5	31.9	46.7	40.9	57.9	197.8	94.6	45.6	68.9	40.8	62.3	114.0	36.4	31.0	17.8	16.7	39.1	30.6	47.4	72.8	42.6	23.4	36.5	50.1	36.2	85.6	55.1	15.6	19.6	119.4	33.1	75.8	36.2	7.8	8.1	7.8	14.6	5.7	22.1	9.7	18.2	18.2	9.9	11.3	12.7	15.7	2.5	25.9	5.2	6.7	28.1	10.5	9.3	13.4	13.2	14.3	9.5	11.6	15.4	12.0	14.8	13.9	12.2	20.0	7.2	22.4	7.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	7.9	8.3	0.0	0.0	2.5	5.5	0.0	11.8	8.8	0.0	3.9	13.7	0.0	8.7	16.7	3.9	0.0	0.0	0.0	11.9	16.1	8.3	0.0	8.2	7.6	13.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.6	0.0	0.0	11.6	2.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	13.1	6.5	18.5	0.0	0.0
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	12.5	15.8	13.2	14.2	15.8	18.0	22.3	14.7	16.6	20.9	18.2	21.8	14.1	18.1	27.4	16.1	24.2	19.6	13.4	13.5	14.8	21.3	21.1	15.6	22.7	14.5	14.9	18.4	17.7	22.9	16.3	19.2	14.6	19.1	23.6	13.1	16.2	19.8	9.9	18.0	17.2	18.8	14.8	18.9	18.1	18.9	15.8	25.4	23.2	13.6	24.3	23.6	13.6	17.7	26.4	46.7	46.1	36.8	25.2	31.4	29.5	28.4	36.5	46.4	42.5	42.2	61.2	42.9	38.9	35.6	38.5	52.0	99.4	47.6	40.5	37.8	60.2	37.5	32.2	46.4	50.0	38.7	46.2	30.6	46.9	35.1	53.7	34.1	50.8	64.8	52.2	24.3	33.4	41.7	44.3	41.2	33.8	66.2	25.6	37.5	38.8	49.0	36.7	48.6	33.1	26.3	34.2	34.5	49.5	39.2	32.3	44.0	25.2	31.8	33.2	28.8	45.6	23.9	48.4	58.1	32.1	70.0	38.1	25.7	11.0	6.2	19.8	12.7	22.3	19.3	20.3	22.6	19.8	14.8	21.1	19.2	1.2	23.8	9.5	17.9	30.8	16.6	13.2	15.8	14.7	16.6	13.5	14.8	14.5	14.9	14.6	14.8	15.8	17.7	12.2	22.4	10.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	13.0	11.0	0.0	0.0	5.6	12.9	0.0	40.5	7.7	0.0	21.5	18.2	0.0	12.8	11.8	6.8	0.0	0.0	0.0	15.4	30.5	6.7	0.0	12.6	7.6	22.5	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.5	0.0	0.0	15.1	10.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	49.8	4.8	24.0	0.0	0.0
INTS2	"INT2, KIAA1287"	ENSG00000108506	"Integrator complex subunit 2"	Q9H0H0	17	61865367-61928016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049524	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"			"HPA049524: AB_2680804"	"unprognostic (4.57e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.52e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.42e-1)"	3.2	3.0	0.3	3.6	1.0	2.5	3.0	2.5	1.4	3.2	0.2	2.8	2.7	3.3	1.0	3.6	2.8	1.5	3.1	0.3	0.4	2.1	2.7	2.6	5.4	0.8	0.5	3.1	2.2	4.0	3.1	2.5	0.5	2.4	3.3	4.3	2.9	0.8	3.1	3.6	3.1	1.9	0.0	3.4	2.8	4.6	1.1	4.9	2.7	1.7	5.4	2.8	3.3	1.9	8.9	15.4	14.8	8.2	4.5	5.2	6.8	6.2	3.6	9.1	6.9	9.1	4.9	17.7	5.0	3.2	11.4	12.7	14.3	4.1	15.2	8.2	10.5	20.7	6.1	15.8	2.8	26.0	14.3	4.0	6.0	6.9	14.2	5.0	6.6	11.5	19.0	10.6	6.4	17.2	31.0	10.5	5.5	12.7	10.4	23.3	39.6	13.9	3.5	7.9	11.3	12.6	7.7	4.2	5.9	10.3	18.1	8.7	6.6	19.8	12.9	6.8	8.9	8.4	16.2	24.3	6.0	9.6	6.2	2.1	0.3	0.2	0.9	0.6	1.4	1.5	1.0	1.3	0.8	0.4	1.1	1.4	0.4	0.4	0.9	0.7	1.2	0.4	0.3	1.0	2.5	1.4	0.3	0.4	0.8	0.5	0.5	0.0	1.1	1.9	7.3	6.4	3.1	17.3	8.3	4.6	3.3	4.7	6.8	12.9	5.9	4.6	9.1	8.6	6.1	1.8	14.6	5.5	6.7	3.3	0.0	3.3	4.5	8.4	8.4	5.8	2.4	9.4	19.8	2.6	3.9	5.9	5.1	9.3	5.1	11.1	6.1	6.4	5.3	15.2	26.4	5.7	6.1	7.9	2.2	9.6	4.4	6.0	0.0	9.4	7.4	6.0	3.1	24.1	37.3	4.7	1.7	3.4	5.4	4.9	3.1	1.7	8.4	10.9	0.0	8.0	7.3	12.4	10.9	9.1	5.4	2.2	8.7	7.1	5.8	3.8
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728050-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	14.3	18.7	1.7	10.8	2.0	2.9	14.7	0.5	3.2	16.8	0.9	16.1	4.2	18.3	13.4	12.1	20.7	9.7	13.0	2.2	2.1	15.9	11.8	14.9	8.6	2.7	0.9	23.3	13.0	8.2	17.8	9.6	1.3	11.9	6.5	3.6	12.1	11.3	14.9	12.2	12.9	9.4	0.0	13.2	16.7	12.8	4.4	6.7	15.3	8.3	7.7	13.6	14.4	1.5	26.2	15.8	14.0	19.2	21.3	17.4	19.1	18.2	8.7	21.7	17.4	8.5	24.5	21.3	37.8	24.2	11.8	27.0	28.0	18.7	10.2	24.6	23.0	15.4	37.7	3.8	13.8	18.8	20.5	12.3	7.5	9.5	11.7	17.5	14.4	13.8	19.2	14.6	9.0	8.5	18.6	10.0	23.6	25.5	26.8	24.5	6.4	13.1	8.1	24.7	11.8	15.5	18.9	39.7	11.4	18.4	13.3	25.3	6.1	22.7	6.7	18.1	18.1	17.1	13.7	19.5	24.9	8.9	11.3	0.0	0.8	0.9	0.9	0.5	0.8	0.3	0.3	0.5	1.2	0.3	0.2	0.5	0.8	0.7	2.9	0.3	0.5	0.2	1.7	2.0	0.5	3.2	2.2	2.1	2.7	0.9	1.3	0.0	4.4	1.5	29.1	22.4	22.8	59.7	11.9	10.5	9.5	10.4	15.9	23.7	20.2	22.4	4.6	10.0	11.7	31.3	20.9	13.9	11.6	9.2	0.0	11.9	13.1	39.3	29.4	21.5	12.1	10.9	30.8	8.4	13.4	16.3	23.9	38.8	5.7	32.9	26.7	13.9	12.2	21.9	26.1	16.5	8.2	9.1	22.0	7.6	9.6	14.6	7.2	30.0	17.6	15.4	14.4	27.2	29.7	9.9	14.9	12.0	11.6	10.6	9.8	13.3	25.9	22.4	26.3	11.2	16.5	10.2	12.2	13.9	10.2	10.3	10.0	20.2	14.0	12.2
INTS4	"INT4, MGC16733, MST093"	ENSG00000149262	"Integrator complex subunit 4"	Q96HW7	11	77878720-77994671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042378	Uncertain		Supported	"Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"		"HPA042378: AB_10797388"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.20e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.20e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (9.39e-2)"	12.8	16.8	13.6	12.8	15.7	18.5	13.4	19.1	14.8	16.7	13.6	13.7	9.5	12.9	11.9	13.7	13.6	9.2	12.8	13.5	15.0	14.3	18.0	12.7	16.7	15.9	14.9	17.0	17.7	11.5	13.1	11.4	16.6	15.7	11.9	14.5	13.2	9.6	11.5	14.2	15.6	10.8	15.8	21.0	13.9	9.9	15.2	17.8	13.8	7.8	16.9	14.4	14.8	21.9	11.1	18.2	23.2	27.3	18.7	16.8	19.1	13.0	14.5	16.6	14.6	37.8	30.0	19.2	27.0	23.3	25.5	27.2	25.6	25.8	26.5	28.0	16.2	29.8	24.2	22.2	17.1	30.5	17.2	17.1	13.9	33.9	29.4	18.1	26.6	20.6	28.9	28.3	25.6	23.2	28.5	49.7	22.1	40.4	19.8	27.2	21.5	36.5	20.8	22.0	16.6	24.0	23.1	15.2	9.9	26.8	28.2	16.3	17.7	22.7	30.4	60.0	16.9	30.7	32.2	40.7	8.1	20.5	22.7	12.6	14.0	7.7	12.3	15.3	17.7	12.2	12.8	14.5	15.1	13.1	17.1	13.3	3.5	17.0	14.0	6.0	17.2	11.3	13.6	15.7	19.1	14.8	13.5	15.0	15.9	14.9	16.6	15.8	15.2	21.9	5.6	9.6	3.1	18.3	15.1	4.8	7.1	8.2	8.6	13.4	5.4	6.3	5.6	10.0	6.0	5.5	16.7	13.4	18.7	5.5	5.9	7.5	5.0	6.8	5.4	7.0	1.8	9.1	20.0	4.0	11.5	7.3	8.2	5.5	12.7	12.8	5.0	3.1	10.2	5.0	19.4	6.4	6.1	8.1	4.5	4.2	6.5	7.9	7.2	20.6	14.8	7.8	13.4	26.2	30.8	6.0	7.8	4.9	7.3	4.4	11.0	6.6	8.6	16.9	6.6	10.0	11.1	12.1	17.7	7.1	2.4	11.5	13.5	8.1	6.4	5.3
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	8.3	9.3	5.5	8.0	5.7	5.4	8.5	5.7	6.0	10.1	5.5	9.1	7.8	11.4	5.3	12.1	12.9	5.8	8.1	5.7	5.4	8.6	12.6	7.7	10.6	6.0	5.6	10.2	10.3	8.8	6.6	6.0	5.8	9.2	5.8	2.8	11.7	6.9	13.9	12.4	8.8	8.3	5.5	10.5	9.5	6.1	5.8	8.3	7.8	8.3	9.2	9.1	8.7	5.8	17.5	21.1	12.2	11.4	23.5	17.1	11.4	14.2	14.4	18.7	13.4	15.1	19.0	33.1	25.0	18.0	15.5	26.7	24.6	32.9	9.0	20.8	17.1	17.2	15.8	10.2	21.2	19.0	15.7	19.9	25.3	20.1	17.1	14.2	18.8	14.5	26.6	18.9	16.3	35.8	22.0	22.1	18.7	20.7	26.4	22.2	16.5	39.9	14.3	11.3	16.4	13.8	15.9	22.0	22.2	8.6	31.3	12.9	15.7	17.8	13.6	27.6	12.9	26.5	21.9	23.8	20.5	14.3	17.2	4.3	5.3	3.9	6.4	3.5	10.1	4.1	5.9	5.7	5.5	5.0	6.9	6.4	1.9	7.7	4.1	5.5	4.6	6.3	5.5	5.7	5.7	6.0	5.7	5.4	6.0	5.6	5.8	5.5	5.8	5.8	5.0	3.2	7.8	2.3	8.8	2.2	7.1	8.2	4.6	7.5	6.6	6.3	3.1	7.2	9.3	3.7	0.0	14.0	10.7	4.8	11.7	12.0	6.4	5.7	5.0	6.9	6.7	2.5	2.0	10.6	9.3	5.2	4.1	4.4	8.9	6.7	9.7	11.5	8.7	10.1	2.1	7.9	8.2	7.0	3.1	8.9	6.5	4.3	0.0	1.9	12.6	10.4	8.2	2.0	1.0	9.7	2.2	7.9	7.3	8.5	8.7	10.2	13.2	3.8	13.1	5.1	8.6	10.8	11.3	5.4	4.1	19.8	6.8	9.1	7.6	5.9
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	14.0	14.8	7.7	16.6	9.1	15.0	11.8	17.8	10.0	12.8	11.1	12.1	11.2	14.8	11.6	19.7	10.5	14.0	14.0	9.5	9.0	12.9	28.2	10.0	20.9	9.1	8.2	13.7	37.9	15.9	9.4	14.8	10.1	10.7	10.9	18.9	11.5	9.7	8.4	15.2	13.1	13.4	8.2	15.2	15.4	62.1	8.3	20.7	15.7	16.7	17.3	16.0	11.7	18.2	17.6	13.8	32.8	17.2	17.2	40.6	17.8	36.3	33.5	35.9	25.1	16.2	46.9	20.3	8.5	26.3	22.7	31.0	45.2	20.0	50.6	39.3	12.6	38.7	21.9	19.1	41.6	43.4	33.6	25.3	36.5	33.7	50.7	46.1	31.3	25.5	24.1	30.2	35.9	13.3	26.9	26.8	23.5	51.6	12.4	20.2	23.4	20.3	26.8	11.6	18.2	18.0	36.5	30.2	24.3	24.2	15.4	41.5	17.7	22.1	15.2	23.6	20.8	26.5	21.7	33.0	18.2	22.7	39.2	8.0	2.0	3.2	5.9	1.3	6.7	3.9	4.0	5.0	2.1	4.0	5.6	6.5	5.5	5.0	1.5	4.6	5.0	2.4	7.7	9.1	17.8	10.0	9.5	9.0	9.1	8.2	10.1	8.2	8.3	18.2	241.6	25.6	49.5	75.4	121.4	76.3	68.7	12.0	162.8	58.3	157.5	215.6	78.4	47.1	18.3	22.0	118.9	81.4	164.8	107.2	15.6	23.4	94.3	48.4	67.4	94.5	76.0	29.5	82.2	26.3	47.5	127.4	61.7	64.5	48.2	71.4	57.8	37.3	34.8	45.4	66.7	94.8	12.2	44.2	60.1	81.3	44.1	97.5	23.2	78.7	33.3	55.9	53.5	94.0	118.9	25.9	59.7	31.6	90.9	53.7	77.1	11.9	12.9	74.9	26.3	374.7	119.4	122.4	40.5	161.3	72.5	73.7	137.8	66.5	90.3	68.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520659-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.7;U-937: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	3.4	7.5	3.3	6.3	2.9	13.1	3.8	8.7	3.7	6.7	2.6	7.7	2.6	4.6	2.8	4.7	6.5	3.8	4.4	3.0	3.0	3.8	1.1	4.4	12.6	3.5	3.6	8.2	2.1	1.8	6.7	3.3	3.4	5.0	7.1	5.1	12.0	3.6	1.1	6.1	7.3	3.7	3.3	10.2	3.4	6.3	3.4	8.4	3.3	0.8	11.3	5.7	5.1	3.7	0.1	0.0	7.5	8.9	2.2	2.5	0.0	1.9	4.0	2.2	6.6	0.7	3.2	7.5	6.3	1.6	5.4	5.6	8.4	2.5	1.5	5.8	3.0	6.5	0.7	0.0	1.9	6.8	0.5	3.3	2.4	2.5	2.5	3.8	2.8	4.9	4.3	11.8	1.6	5.5	6.5	20.7	3.5	8.0	3.1	5.3	2.4	6.4	1.8	3.0	1.2	2.7	2.6	2.6	0.2	3.2	2.8	12.5	1.6	5.6	3.2	0.0	2.2	13.5	11.2	11.3	1.9	19.0	1.1	0.0	1.6	1.4	2.9	1.4	3.8	3.3	3.4	3.5	2.3	3.5	5.2	3.4	0.8	1.9	1.8	2.2	2.0	2.5	3.3	2.9	8.7	3.7	3.0	3.0	3.5	3.6	3.4	3.3	3.4	3.7	6.8	12.8	5.8	0.0	7.3	0.0	0.0	0.0	0.0	0.0	7.2	14.0	0.0	0.0	3.7	3.7	0.0	2.1	15.9	0.0	0.0	1.3	0.0	16.0	5.3	3.3	0.0	0.0	0.0	1.6	0.3	3.3	0.0	11.1	25.2	7.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.3	0.0	0.0	1.0	6.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	6.9	11.1	0.0	0.0
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	8.8	7.5	4.4	13.9	4.8	15.5	8.1	8.3	6.4	14.5	6.9	12.8	7.8	13.2	4.2	10.5	9.5	7.3	10.2	4.8	6.4	6.4	8.9	7.5	17.4	5.7	4.4	11.4	13.5	10.1	8.3	9.4	4.6	10.4	14.8	10.3	11.0	8.7	12.6	10.3	10.6	13.6	4.0	9.9	10.6	30.6	6.3	20.6	8.8	12.0	13.6	10.4	10.4	6.1	52.4	31.9	49.2	43.4	17.7	41.7	25.5	27.5	26.0	35.7	33.0	22.5	38.0	52.3	25.2	20.7	44.3	31.5	61.3	29.2	47.6	58.1	28.8	45.7	19.3	22.1	21.1	24.6	31.7	17.1	13.5	34.7	29.6	40.8	40.1	35.1	44.4	38.9	22.0	34.5	53.7	20.4	28.1	114.9	55.8	42.7	19.7	29.0	30.0	26.6	34.6	18.4	26.8	7.7	24.1	40.3	37.3	31.6	28.1	16.1	18.9	31.1	25.1	22.0	43.0	45.2	21.6	49.4	32.2	2.1	9.6	15.1	4.6	6.8	7.5	13.4	10.8	11.8	9.3	10.4	11.0	6.5	9.3	9.6	6.6	5.5	10.0	4.5	4.4	4.8	8.3	6.4	4.8	6.4	5.7	4.4	4.6	4.0	6.3	6.1	11.0	16.0	8.6	16.6	19.4	5.9	11.6	9.1	9.6	13.7	6.1	4.6	8.3	5.7	11.6	7.3	33.3	10.0	9.7	10.3	3.9	8.3	36.0	15.0	12.1	11.8	18.0	17.7	44.8	13.4	12.9	10.8	8.6	6.1	12.7	15.2	8.9	5.5	9.5	28.6	40.9	11.8	8.2	11.6	6.6	6.4	16.1	14.0	7.2	25.3	21.6	8.0	16.5	33.2	31.2	10.9	14.6	16.1	18.0	8.8	9.5	5.1	19.7	18.9	6.6	10.6	13.1	54.7	32.5	9.0	7.0	8.5	14.2	11.0	11.1	8.1
INTU	"CPLANE4, KIAA1284, PDZD6, PDZK6"	ENSG00000164066	"Inturned planar cell polarity protein"	Q9ULD6	4	127623271-127726737	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 13.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Cone photoreceptor cells: 137.6;Endometrial ciliated cells: 81.4;Oligodendrocytes: 78.0;Respiratory ciliated cells: 84.0;Rod photoreceptor cells: 181.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036714, HPA036715, HPA061467"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: "	"unprognostic (1.09e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.33e-2)"	1.5	1.6	6.0	1.2	5.9	2.6	2.9	4.0	7.0	1.4	4.9	1.2	2.1	2.6	5.1	1.3	2.4	1.5	0.9	4.6	3.2	1.9	0.7	1.6	1.1	1.0	3.1	3.3	1.2	1.1	2.8	1.0	1.3	1.8	1.6	13.2	1.8	1.2	1.1	3.8	1.0	1.3	0.3	1.3	2.1	2.3	6.3	0.6	2.7	2.5	0.7	1.2	1.6	5.9	2.5	1.7	8.7	3.1	1.1	2.7	0.7	1.4	0.7	1.0	1.9	1.2	2.2	1.8	2.1	1.2	2.8	1.5	7.0	1.3	2.9	0.8	2.1	2.6	3.3	3.0	1.1	2.3	1.2	1.2	1.5	2.9	0.7	2.6	2.7	0.9	3.4	2.0	1.4	1.2	0.8	1.2	4.0	0.9	1.6	0.8	2.0	0.5	1.8	1.8	4.1	2.9	2.9	1.6	1.0	4.3	1.8	1.3	2.1	2.5	1.9	2.2	2.0	1.2	1.9	0.6	2.1	1.0	1.5	1.1	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.4	0.3	0.2	0.4	0.1	0.0	6.0	5.9	4.0	7.0	4.6	3.2	1.0	3.1	1.3	0.3	6.3	5.9	8.9	22.4	15.4	133.5	0.6	6.0	10.4	7.2	12.0	56.3	13.7	24.8	15.6	10.0	18.8	3.7	137.6	8.3	0.4	2.7	7.9	7.6	10.2	81.4	30.5	8.2	11.5	3.8	36.0	5.1	6.2	18.7	10.2	15.8	5.1	22.9	6.4	2.5	3.0	37.0	36.6	5.9	10.2	1.6	9.6	11.9	14.0	3.0	7.2	23.4	0.5	16.5	0.0	19.6	78.0	3.4	1.5	11.7	0.0	6.9	1.1	11.2	84.0	181.8	0.0	17.8	10.9	8.7	20.4	7.9	6.1	1.9	1.7	12.9	7.0	6.4
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	17.9	20.2	32.4	12.1	33.6	12.5	17.2	27.6	34.9	21.5	17.2	24.1	12.1	25.6	12.2	20.0	19.4	12.9	15.8	35.9	27.7	21.3	14.6	17.5	13.3	26.4	28.2	25.5	19.8	22.8	21.5	16.4	27.4	18.1	11.3	18.3	17.4	17.2	12.6	23.1	17.8	16.9	24.5	21.9	18.5	32.2	30.7	17.2	16.2	11.4	13.2	19.1	16.0	29.0	20.6	24.5	27.9	33.1	28.6	21.8	22.5	26.6	27.8	42.7	37.3	31.9	20.9	17.3	16.8	29.7	28.8	14.9	39.8	24.2	24.0	35.6	30.6	40.5	36.1	21.8	31.4	25.0	26.7	25.6	29.4	46.4	27.8	24.0	36.1	20.3	26.7	20.3	21.4	18.2	30.6	25.6	30.2	16.1	37.6	19.1	19.8	35.7	27.7	30.8	15.0	29.8	33.4	21.8	30.6	16.0	17.6	36.2	32.8	23.9	23.6	33.1	31.0	24.3	35.6	18.8	21.9	28.4	24.9	4.7	7.3	12.1	11.7	5.4	11.4	6.0	10.4	12.8	5.6	8.4	12.6	12.7	33.3	10.3	7.0	4.1	11.8	9.5	32.4	33.6	27.6	34.9	35.9	27.7	26.4	28.2	27.4	24.5	30.7	29.0	17.1	25.6	12.3	24.5	25.0	15.6	14.7	7.4	11.4	38.4	19.7	15.0	8.8	18.6	10.1	12.9	89.6	19.2	27.6	22.0	5.9	14.5	88.2	24.9	19.9	19.0	27.6	24.2	42.3	13.0	16.1	14.7	14.8	17.3	19.7	19.6	19.6	12.2	12.8	30.3	46.6	14.1	10.2	15.0	14.2	23.7	21.1	17.8	19.6	31.9	15.9	19.6	35.0	43.7	39.8	19.2	8.8	16.6	28.9	19.6	14.6	12.5	21.8	78.3	19.7	16.2	18.3	24.6	21.9	13.7	18.8	27.5	27.6	30.5	12.8	20.4
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	57.6	96.3	53.1	39.5	57.2	130.1	80.1	84.6	57.8	117.2	52.8	106.0	79.8	101.8	108.4	95.4	78.3	47.9	62.3	53.7	58.4	106.9	83.5	55.4	53.7	56.2	53.3	99.1	91.2	48.0	121.8	44.8	55.1	111.6	88.0	63.7	88.7	42.2	45.8	145.4	89.1	43.1	49.7	78.9	79.5	55.5	55.2	72.2	108.8	31.5	43.5	66.7	113.4	64.2	25.9	49.5	100.6	71.2	55.5	69.3	72.6	48.0	54.0	54.0	62.2	41.1	67.0	45.5	38.7	45.5	67.8	65.3	50.6	72.1	50.0	54.1	44.9	52.2	172.7	89.5	45.0	50.3	48.9	65.7	103.0	73.3	59.7	71.8	76.2	143.8	39.5	55.4	63.9	57.3	107.4	68.3	77.4	50.0	90.4	44.4	33.3	50.0	73.7	121.7	62.4	94.6	103.9	69.5	53.0	79.6	67.7	83.3	54.8	58.3	57.4	37.0	48.7	50.6	65.4	64.2	53.3	57.7	52.4	158.1	50.5	92.7	63.4	50.8	57.6	60.8	55.1	60.4	50.1	60.2	51.1	52.7	80.3	67.5	65.3	52.0	84.2	46.8	53.1	57.2	84.6	57.8	53.7	58.4	56.2	53.3	55.1	49.7	55.2	64.2	63.3	70.5	52.9	38.5	41.3	83.1	87.2	182.5	174.2	66.5	69.9	77.5	12.9	38.6	109.1	99.3	39.6	114.3	39.4	157.4	76.3	58.7	43.8	50.8	64.8	46.1	110.2	40.1	31.1	47.4	73.9	73.7	64.2	56.9	54.5	60.3	32.5	25.1	41.4	20.2	40.6	108.6	150.5	16.6	33.5	16.4	81.1	24.5	26.6	22.5	30.3	32.4	44.3	50.8	52.6	60.5	105.7	68.4	34.0	59.0	84.7	65.5	68.4	56.0	52.6	31.5	50.6	71.6	57.9	90.3	83.0	124.0	43.3	87.9	89.8	89.3
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 17.7;brain: 13.6;lymphoid tissue: 13.5;thyroid gland: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 71.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 19.8;THP-1: 10.5;U-937: 11.0"	"Low region specificity"	"Detected in all"							"HPA028708, HPA028710"	Supported		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	0.7	0.2	8.4	7.9	5.4	17.7	1.5	4.1	13.6	2.7	0.0	1.3	0.7	1.1	1.4	1.4	2.1	2.9	0.6	5.4	3.2	2.8	2.0	1.5	13.5	0.0	7.4	0.6	0.7	0.1	0.6	1.6	0.0	0.8	1.2	0.2	1.2	0.4	0.2	0.5	2.3	0.9	0.0	6.8	2.4	0.9	12.2	10.6	39.1	0.2	12.8	2.1	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	19.8	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.1	1.2	0.8	0.0	0.5	0.1	0.1	0.3	0.7	2.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	3.2	14.5	71.6	13.0	6.5	27.6	0.0	16.3	12.5	16.2	0.1	27.9	16.8	42.7	14.3	8.5	0.4	22.6	12.6	8.4	5.4	4.1	13.6	5.4	3.2	0.0	7.4	0.0	0.0	12.2	5.4	1.1	0.0	1.7	7.8	3.5	0.6	0.5	0.4	12.0	0.6	1.8	1.0	1.1	1.5	1.7	1.8	0.0	1.7	46.1	0.0	7.9	2.1	1.3	2.0	1.2	2.3	0.0	3.2	120.0	0.0	0.1	1.0	3.1	2.5	0.0	0.1	3.3	1.1	2.8	3.3	9.8	0.5	2.0	23.4	15.2	0.3	0.3	15.2	0.0	252.9	17.9	0.2	27.8	9.0	14.6	0.0	0.1	0.4	20.7	0.6	0.1	2.0	1.3	0.2	0.0	3.4	0.4	0.2	1.1	4.0	0.6	2.7	65.5	2.0	0.3	1.3
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267894	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.0;monocytes: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	4.9	3.1	3.1	5.8	3.1	2.4	4.7	4.1	4.5	4.4	2.3	7.1	7.9	2.3	3.4	5.2	2.9	6.9	1.8	2.9	3.2	4.1	18.1	3.3	4.6	3.6	3.6	1.8	3.8	12.1	1.9	8.7	3.2	3.4	6.0	4.7	2.7	1.7	2.7	5.1	10.4	1.9	3.2	6.4	3.5	2.2	3.5	4.5	4.1	3.2	4.4	5.2	2.5	3.2	16.3	4.1	5.9	5.8	5.7	6.6	5.1	4.2	9.0	3.5	7.1	8.3	10.1	13.0	8.3	5.0	3.4	4.9	5.0	5.6	11.2	5.9	3.8	3.2	3.9	7.9	3.4	5.1	7.1	7.3	4.9	6.0	12.0	4.0	7.7	3.7	2.1	6.5	6.3	4.1	7.0	9.8	3.8	6.6	3.8	0.5	12.8	6.0	6.6	4.1	4.1	7.1	5.5	14.4	4.3	9.6	12.0	6.1	6.7	3.8	7.4	8.1	5.4	13.8	8.7	10.1	7.2	5.3	1.5	1.7	0.7	1.6	0.1	0.7	0.1	0.3	0.1	0.1	0.4	0.2	0.4	0.1	3.0	0.2	1.0	0.2	0.0	0.1	3.1	3.1	4.1	4.5	2.9	3.2	3.6	3.6	3.2	3.2	3.5	3.2	8.9	6.4	4.2	16.6	16.9	54.0	10.0	8.4	26.2	10.0	11.6	8.3	2.8	4.3	13.3	1.8	6.2	10.5	8.1	29.3	3.9	4.2	3.0	24.3	9.7	9.9	8.4	3.0	21.8	4.9	22.5	15.7	8.2	22.8	7.0	2.5	8.2	13.2	10.0	13.5	27.8	10.6	10.2	22.8	40.7	1.4	2.8	29.1	26.6	24.4	16.6	5.4	2.1	30.7	23.6	6.2	21.7	1.9	8.5	9.6	28.6	9.1	29.1	5.8	6.6	10.2	8.5	10.0	5.1	20.1	58.1	9.4	10.1	4.1	11.1	17.5
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 22.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	16.0	9.1	13.4	9.7	13.7	6.6	14.4	13.6	14.6	10.6	16.3	9.2	6.9	9.4	8.5	12.0	10.2	10.7	14.7	14.7	13.7	11.9	11.4	7.7	10.4	14.1	13.7	9.4	8.6	13.4	6.0	16.5	13.6	9.0	8.6	6.3	8.5	8.4	12.6	8.8	7.9	11.0	14.4	13.4	8.5	21.4	13.9	10.0	14.0	14.4	10.1	13.4	9.9	15.7	27.1	25.4	22.3	34.6	17.0	23.4	30.9	28.4	20.5	29.1	31.9	27.5	20.2	45.3	22.2	28.9	35.5	21.4	47.3	32.0	45.6	17.5	24.6	21.6	24.5	24.4	12.8	23.7	11.6	16.7	17.7	34.3	35.7	13.7	113.8	22.4	41.5	14.5	27.9	26.0	26.1	32.2	28.0	15.4	14.5	31.6	33.7	41.6	17.7	26.4	24.1	13.9	24.8	19.3	21.0	21.9	24.9	17.0	51.8	17.4	19.3	19.8	26.4	11.3	20.0	31.3	21.2	33.4	21.3	16.5	2.4	2.2	3.8	3.8	4.5	3.3	3.9	3.9	4.0	4.8	5.5	4.0	2.5	22.7	7.0	2.4	2.8	3.6	13.4	13.7	13.6	14.6	14.7	13.7	14.1	13.7	13.6	14.4	13.9	15.7	39.6	9.6	3.7	35.9	11.8	8.5	4.2	3.3	13.6	4.2	6.2	4.8	13.2	5.7	4.5	7.3	2.1	7.6	7.9	2.7	3.9	4.2	42.2	8.4	7.0	40.0	3.0	21.7	68.4	5.5	6.7	7.6	6.1	5.6	13.3	9.6	65.0	6.2	5.2	5.0	55.0	4.4	2.0	6.5	6.4	25.3	5.6	7.4	3.6	20.6	2.6	3.9	10.3	28.1	48.3	3.3	1.7	4.1	10.7	5.2	2.6	3.6	25.6	4.9	6.6	9.7	8.7	14.6	16.2	10.9	8.8	5.1	8.8	4.6	5.7	4.8
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946950-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.1;skeletal muscle: 128.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 91.1;Oligodendrocytes: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	11.9	22.6	67.6	9.8	94.1	9.6	11.7	80.4	82.5	15.8	49.3	20.8	9.2	18.9	13.8	20.0	14.1	9.3	44.7	66.5	69.4	26.8	18.9	12.2	9.8	84.6	85.8	13.4	13.7	27.5	26.4	10.2	79.2	18.9	10.1	23.9	15.8	16.1	128.3	14.9	14.0	15.7	70.2	15.4	16.8	48.5	95.9	14.2	21.2	74.1	10.4	18.0	15.2	122.1	22.2	17.7	17.5	27.8	46.5	24.0	14.6	20.8	19.3	30.5	23.2	13.6	11.0	23.1	21.0	27.3	19.3	24.3	31.7	36.7	20.1	23.6	27.1	24.1	34.0	18.9	32.7	16.2	21.6	24.6	36.7	39.6	24.6	22.8	20.5	17.7	24.6	20.7	24.6	15.4	16.5	21.3	16.1	18.9	29.4	22.6	22.0	24.2	22.4	21.2	27.8	12.9	19.5	32.5	27.5	22.7	20.4	22.3	16.8	30.3	18.1	26.7	23.9	23.0	30.4	11.0	19.3	34.6	26.9	0.0	1.4	1.2	2.0	1.6	1.7	1.1	1.3	2.0	2.3	0.8	1.1	1.5	0.5	1.9	1.6	2.3	1.7	1.0	67.6	94.1	80.4	82.5	66.5	69.4	84.6	85.8	79.2	70.2	95.9	122.1	4.2	0.0	2.0	13.1	7.4	3.3	3.2	9.1	2.8	18.9	5.6	4.1	23.4	12.8	6.3	11.0	8.4	6.4	5.1	8.6	1.9	7.3	53.5	8.0	5.6	5.8	3.0	4.8	9.8	4.2	3.7	5.2	6.1	6.0	0.0	12.6	3.6	11.5	16.3	28.6	8.8	5.3	12.2	8.3	3.3	91.1	8.4	5.8	8.8	1.9	7.1	11.6	4.1	5.5	79.2	5.9	1.1	15.8	6.2	4.3	9.1	18.2	8.6	8.7	0.0	6.4	10.4	32.4	12.3	7.1	4.3	4.1	3.6	8.4	7.3	3.8
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	8.9	13.2	1.6	4.7	1.4	4.2	8.0	1.5	1.6	6.9	4.4	7.2	3.2	7.7	2.0	14.0	8.0	1.1	7.8	1.3	2.1	14.1	14.7	6.7	2.8	1.6	1.4	6.9	27.7	2.6	9.4	2.5	1.8	6.8	1.4	0.3	8.7	3.6	21.0	10.7	5.9	1.9	1.4	7.3	8.6	40.4	1.6	2.1	7.0	1.0	1.8	8.7	7.0	2.0	21.9	49.2	6.0	36.0	4.1	8.6	28.4	14.8	6.3	23.5	12.5	39.2	22.4	31.3	16.1	10.6	12.2	25.6	20.4	28.8	2.6	12.1	29.8	20.4	18.6	77.0	8.7	45.4	18.1	7.5	12.3	24.3	6.0	5.3	11.8	15.8	37.5	8.5	15.0	76.6	21.8	21.2	29.1	28.5	41.7	24.4	17.3	23.2	12.6	25.7	29.3	21.1	19.7	31.8	13.9	2.9	27.1	14.7	12.4	22.9	30.8	21.0	32.4	19.8	27.1	34.2	10.8	19.3	31.8	0.0	1.1	0.4	3.3	1.9	3.8	1.8	2.8	2.7	2.4	2.6	2.3	2.9	0.0	2.7	2.4	3.2	1.7	1.9	1.6	1.4	1.5	1.6	1.3	2.1	1.6	1.4	1.8	1.4	1.6	2.0	3.5	0.0	7.9	0.7	4.9	5.9	3.8	5.0	4.6	0.8	11.1	9.7	1.6	8.6	8.7	5.5	4.2	12.1	5.5	3.1	0.0	13.3	80.5	8.3	3.9	5.6	4.2	3.4	1.3	11.0	11.1	4.5	1.1	5.0	0.0	3.1	2.9	5.8	7.9	1.7	1.1	5.9	2.0	2.2	2.6	118.0	5.0	1.3	0.0	0.0	1.7	1.6	2.1	1.0	0.8	6.8	2.5	5.7	2.9	6.1	0.7	11.7	15.1	2.7	6.6	7.0	4.7	52.1	18.8	3.9	6.3	5.9	3.1	6.1	10.4	2.7
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	20.1	21.6	17.8	23.0	21.8	16.5	22.2	25.3	19.9	22.1	26.1	29.4	26.6	23.9	17.1	24.2	17.2	21.4	16.7	19.1	21.4	32.2	34.6	23.1	28.1	22.0	19.8	26.6	27.8	51.9	15.5	22.5	20.9	21.8	32.2	22.8	19.8	25.4	18.5	24.3	23.7	26.8	18.1	25.2	24.1	24.5	20.9	29.3	31.7	21.7	27.5	23.9	15.5	22.8	41.2	46.8	44.3	32.9	40.9	46.8	62.3	44.4	42.5	34.9	40.6	32.9	41.8	52.9	38.1	54.8	37.0	25.8	49.7	48.4	50.5	62.0	35.1	43.1	56.0	29.8	26.8	63.3	32.8	37.8	29.8	55.5	47.1	62.5	58.5	36.4	39.2	38.7	49.9	21.0	47.6	39.3	86.7	56.5	18.1	38.5	93.1	42.7	43.6	55.5	27.3	33.7	46.6	33.7	25.0	78.6	53.8	22.7	52.4	33.2	29.0	72.3	39.3	38.0	54.9	78.4	40.6	37.4	58.7	3.4	1.9	2.4	1.9	2.5	2.8	2.4	2.1	2.0	1.4	3.2	2.2	3.0	2.5	2.6	2.6	1.4	2.8	1.3	17.8	21.8	25.3	19.9	19.1	21.4	22.0	19.8	20.9	18.1	20.9	22.8	18.4	9.6	21.0	22.2	17.3	9.6	6.7	6.3	12.5	13.4	12.2	7.4	20.3	8.6	16.6	11.0	12.5	11.8	13.5	17.2	3.9	10.1	51.5	14.3	17.5	17.5	6.7	14.5	38.8	14.0	6.8	13.4	16.8	14.2	12.0	25.0	21.0	25.1	16.1	8.4	35.0	13.8	8.2	24.8	10.8	11.9	8.7	17.4	8.8	30.9	16.7	12.7	18.6	59.8	35.7	14.1	8.1	13.2	17.5	7.6	15.0	15.7	9.9	14.3	13.1	17.0	14.8	17.4	5.2	23.4	9.2	17.9	13.6	11.1	14.8	9.0
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750653	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	5.5	4.4	3.2	3.8	4.7	3.4	6.1	3.9	2.9	4.8	3.7	5.6	4.9	6.5	5.3	6.3	6.5	5.0	7.0	2.6	4.1	7.1	6.8	4.3	4.4	3.5	3.9	7.5	6.6	9.5	2.2	4.0	3.7	7.1	5.7	7.4	5.7	6.4	14.3	5.0	5.3	5.6	3.7	3.8	5.0	10.2	3.6	6.6	9.7	9.0	4.9	3.8	2.8	4.9	9.6	9.1	8.0	11.8	9.8	18.2	6.2	9.9	7.1	6.9	7.0	5.6	6.8	5.2	10.1	12.3	7.9	6.7	8.8	7.3	9.9	12.2	5.2	7.3	7.7	6.9	9.8	2.1	6.2	15.5	8.3	15.0	8.1	8.0	6.8	9.4	9.0	10.3	12.2	6.4	7.3	0.4	4.8	7.0	4.9	3.1	14.7	4.3	5.7	10.4	11.5	7.5	19.1	10.3	9.5	9.1	10.0	1.8	7.9	7.5	9.2	5.3	7.9	8.3	10.4	9.2	12.0	3.1	11.9	4.1	0.6	3.5	4.6	0.4	3.4	3.1	2.7	3.7	0.7	2.6	3.4	4.0	2.6	3.7	0.8	0.6	4.7	2.5	3.2	4.7	3.9	2.9	2.6	4.1	3.5	3.9	3.7	3.7	3.6	4.9	7.6	12.8	10.0	11.1	7.9	2.5	5.6	7.6	6.8	12.4	6.5	4.8	18.8	5.7	8.1	5.5	12.5	7.8	4.7	10.1	3.9	6.5	26.0	10.7	10.1	5.2	5.4	3.0	5.4	7.3	6.9	9.6	9.7	6.7	12.7	15.9	3.3	5.9	1.4	18.5	7.1	6.8	6.1	1.3	1.1	7.6	7.2	2.8	1.8	4.7	3.4	19.0	18.6	6.0	11.9	5.8	4.6	6.4	7.4	3.9	9.5	8.4	10.1	16.8	0.0	14.0	9.3	40.8	14.7	6.7	4.7	7.7	8.4	23.5	5.8	4.9
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613183-92670131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 31.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.4	6.9	5.2	4.5	5.7	8.5	6.4	7.5	6.4	9.1	3.9	4.1	3.2	5.2	4.8	31.6	5.4	4.6	7.8	6.9	4.7	4.4	5.3	4.7	5.7	5.5	5.1	5.4	3.6	8.5	8.1	5.5	5.7	4.2	4.4	5.7	8.8	2.8	7.6	29.8	4.2	5.4	5.0	5.4	4.6	11.6	5.6	5.9	4.6	6.1	8.7	5.7	15.5	5.6	19.3	10.1	9.2	8.0	11.1	8.2	30.4	13.5	8.5	13.6	7.8	6.3	7.4	11.9	6.6	18.9	12.0	27.1	16.4	18.9	11.3	14.9	10.4	9.8	21.9	9.9	7.8	16.7	11.2	8.1	18.4	16.3	12.7	12.4	10.3	9.8	13.5	14.1	13.6	26.3	9.6	7.7	15.8	21.2	14.9	8.5	9.8	4.9	8.0	11.5	19.1	11.2	10.9	44.9	7.8	8.9	10.6	4.2	19.7	10.0	11.3	28.2	14.4	13.0	16.2	6.5	13.0	7.5	9.9	0.0	1.4	3.4	3.6	1.8	4.1	2.4	3.0	3.1	2.1	2.2	2.3	2.6	2.1	0.8	1.9	2.3	4.6	1.9	5.2	5.7	7.5	6.4	6.9	4.7	5.5	5.1	5.7	5.0	5.6	5.6	6.8	3.2	3.4	10.1	4.8	25.4	6.4	7.6	16.5	7.5	6.0	4.7	0.4	1.5	5.1	1.8	6.2	10.8	4.6	5.0	5.9	6.2	11.0	8.3	5.3	6.8	6.7	6.1	23.8	8.0	13.8	4.1	7.1	10.2	0.0	3.6	10.0	3.1	5.1	15.2	23.7	3.5	6.1	7.5	4.6	33.7	3.1	5.3	3.6	7.5	2.8	4.9	8.2	20.6	23.3	9.1	1.4	3.0	6.0	6.4	2.6	3.6	2.6	4.6	6.6	3.9	3.5	20.0	19.4	25.5	29.5	22.8	6.0	4.4	3.7	10.5
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769761-121835079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 155.3;Spermatogonia: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 131.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.6	11.2	9.6	14.7	10.0	20.4	23.1	11.0	10.5	15.7	10.8	13.0	12.0	15.5	19.7	12.5	16.6	12.1	9.7	10.1	10.1	12.2	8.9	12.3	24.3	9.7	9.5	17.9	18.3	13.9	15.3	11.5	9.5	15.9	16.2	18.9	15.6	15.5	11.4	15.5	14.1	11.8	9.7	18.3	12.3	28.9	10.4	22.1	10.5	5.7	25.7	14.2	13.7	11.0	38.3	10.1	48.9	55.5	7.5	11.6	57.2	17.4	10.8	19.7	23.8	33.6	18.1	76.8	23.9	10.1	30.2	28.7	30.5	14.5	29.3	15.1	23.8	51.2	22.2	28.7	20.0	64.1	14.8	7.4	27.2	13.7	30.3	10.2	15.2	32.4	31.0	27.9	22.3	19.3	41.7	44.5	40.1	22.6	18.1	40.4	23.4	24.9	11.4	16.9	26.0	20.9	17.3	12.2	31.3	16.0	10.8	49.4	12.9	18.5	22.4	9.1	23.4	66.4	44.9	131.2	17.9	29.0	17.1	3.2	6.6	11.7	7.2	12.3	10.5	22.8	9.8	9.0	9.6	21.6	11.5	7.2	2.8	12.2	14.1	8.7	11.7	6.4	9.6	10.0	11.0	10.5	10.1	10.1	9.7	9.5	9.5	9.7	10.4	11.0	15.8	6.4	15.0	48.3	28.4	18.9	19.2	20.0	19.9	15.2	19.6	17.3	8.4	11.5	26.5	11.0	27.1	26.6	21.9	7.7	3.9	11.1	3.7	31.1	12.7	11.2	7.2	21.5	60.1	12.9	8.2	15.4	11.7	12.6	8.8	21.9	6.8	6.2	10.5	13.5	66.8	8.6	20.3	9.8	14.1	7.4	15.5	11.3	14.2	51.5	15.8	12.8	17.5	49.3	59.5	13.9	8.2	13.5	45.2	15.7	7.9	7.5	69.2	27.7	13.1	17.8	15.9	155.3	96.5	16.2	20.6	14.1	19.9	8.4	11.9	16.3
IQCC	FLJ10547	ENSG00000160051	"IQ motif containing C"	Q4KMZ1	1	32205671-32208682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 22.2;Spermatogonia: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028602, HPA028686"	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA028602: AB_10600298, HPA028686: AB_10601985"	"unprognostic (1.45e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (7.81e-6)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.97e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.12e-3)"	"prognostic favorable (3.79e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.66e-1)"	1.0	1.8	2.3	1.0	2.7	2.1	2.1	3.6	3.1	1.5	5.3	1.5	0.9	1.5	4.4	1.2	3.5	1.4	1.2	2.6	2.2	1.7	0.8	1.1	1.6	2.1	2.2	2.1	2.4	2.9	3.6	1.1	1.9	1.6	1.5	2.8	1.8	1.7	1.6	2.3	1.2	1.2	2.0	1.3	1.9	8.8	2.4	2.1	3.4	1.3	1.7	1.2	1.3	2.4	6.6	2.3	5.1	4.8	0.9	1.9	3.3	3.7	4.2	7.8	7.2	5.3	5.7	2.3	3.9	1.1	1.3	5.5	5.4	3.3	6.5	3.2	5.6	4.2	5.2	2.3	1.2	4.5	2.7	1.3	3.5	6.9	3.1	2.9	1.6	8.9	7.6	0.5	3.5	4.6	7.7	4.7	3.3	3.6	4.9	10.4	3.1	5.5	2.9	2.3	7.3	2.9	7.4	4.2	4.1	4.7	5.1	4.5	2.2	2.8	5.1	4.1	6.2	2.9	2.1	2.1	3.9	4.2	5.9	0.8	0.3	0.1	1.1	0.4	1.0	2.3	1.2	0.9	0.7	0.8	1.3	0.7	1.1	1.6	0.4	1.0	1.6	0.5	2.3	2.7	3.6	3.1	2.6	2.2	2.1	2.2	1.9	2.0	2.4	2.4	1.7	0.0	2.3	2.0	0.7	0.3	1.0	0.9	1.2	5.4	2.9	1.9	1.6	7.2	0.4	3.7	6.2	1.9	2.1	2.3	3.9	1.8	1.7	8.5	2.0	1.6	3.0	7.0	2.0	1.4	1.6	2.0	1.5	2.1	1.3	2.1	0.0	0.4	0.9	6.7	1.9	4.8	0.0	0.0	1.1	1.8	1.2	0.7	0.0	0.0	1.2	2.6	1.0	0.5	1.3	1.1	1.8	2.6	0.6	0.6	0.9	0.6	3.6	8.6	0.0	2.4	1.7	22.2	11.6	1.1	0.9	1.0	1.3	1.8	2.0	0.3
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.0;testis: 44.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 155.2;Endometrial ciliated cells: 76.6;Late spermatids: 104.6;Respiratory ciliated cells: 125.8;Spermatocytes: 92.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.4;granulocytes: 1.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 28.2;RPTEC TERT1: 13.8;U-698: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA046810: AB_2679818, HPA048782: AB_2680519"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	0.8	0.9	2.5	1.0	2.6	0.3	1.3	2.7	2.5	2.2	8.4	0.7	0.2	1.9	2.0	1.8	22.0	1.0	1.4	2.4	2.8	2.9	0.2	2.6	1.0	4.4	5.7	1.5	1.0	5.1	3.9	0.6	3.6	0.7	0.8	3.7	1.1	1.2	0.4	0.7	0.4	1.0	3.8	0.2	0.5	44.3	2.7	0.7	1.8	0.1	2.6	1.9	0.8	4.1	3.6	4.1	1.3	1.1	1.5	1.6	0.9	0.5	28.2	1.4	1.9	0.7	10.9	3.9	3.0	0.8	11.0	0.7	0.6	1.2	2.3	0.3	1.2	1.3	1.5	0.7	0.8	0.4	0.9	0.6	0.8	4.3	1.4	7.6	0.9	1.5	0.2	0.3	0.3	4.1	0.2	7.6	0.3	1.9	1.0	0.2	0.6	1.0	13.8	4.3	3.1	1.3	1.0	1.4	4.5	1.0	5.0	2.2	0.3	0.6	2.0	1.3	0.8	1.1	0.9	15.6	2.0	0.2	2.4	1.9	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	2.5	2.6	2.7	2.5	2.4	2.8	4.4	5.7	3.6	3.8	2.7	4.1	0.7	3.2	1.7	4.2	0.6	2.4	3.2	10.1	1.2	0.5	2.4	2.8	4.3	4.3	16.2	5.5	14.6	1.4	0.3	3.7	13.7	3.7	155.2	76.6	3.4	0.5	6.6	0.0	1.2	0.8	0.3	2.7	1.1	11.6	0.0	1.0	1.1	0.4	2.1	0.0	1.0	0.7	6.1	0.3	0.6	104.6	2.1	2.3	3.6	1.9	2.5	7.2	1.0	0.0	2.9	0.7	3.4	5.3	0.3	1.8	0.2	16.6	125.8	5.2	0.0	1.2	4.1	92.9	4.8	0.7	1.7	1.9	0.9	1.5	0.3	4.8
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614733	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 410.0;Late spermatids: 419.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	4.5	6.6	19.3	6.5	16.7	5.6	6.2	9.6	19.3	7.5	22.5	9.4	12.0	8.3	10.3	5.3	14.6	7.2	6.6	17.3	16.3	6.6	3.3	7.5	4.3	16.5	18.6	7.7	7.6	11.0	14.4	3.5	11.3	7.8	8.7	9.8	9.1	9.3	4.9	7.3	10.1	6.6	13.3	4.6	9.6	31.7	18.6	4.3	10.5	5.5	3.5	5.7	4.3	15.1	35.5	18.2	7.0	23.0	9.2	13.4	13.2	7.2	11.7	8.8	9.4	9.5	19.6	2.5	8.0	16.7	19.7	17.9	5.1	7.4	8.9	6.3	10.9	4.9	21.9	2.6	6.8	12.8	6.4	5.8	13.5	8.3	9.9	10.4	10.3	8.9	15.4	4.5	11.8	35.8	5.2	8.6	6.6	15.7	12.4	4.9	8.4	8.8	10.1	15.9	15.7	18.7	8.2	33.9	7.1	4.9	41.5	17.1	10.3	7.6	15.7	30.2	12.2	4.9	8.0	0.5	15.3	8.5	22.1	0.8	0.8	2.3	0.6	1.2	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.6	4.6	0.2	0.4	2.6	0.2	0.2	19.3	16.7	9.6	19.3	17.3	16.3	16.5	18.6	11.3	13.3	18.6	15.1	4.8	12.8	14.3	14.4	2.1	5.5	5.7	5.3	6.2	8.9	12.3	7.9	9.1	14.3	11.4	12.9	60.5	4.1	13.8	27.4	17.6	20.6	410.0	44.8	15.3	5.7	8.4	1.7	16.6	19.7	10.0	7.0	24.5	9.4	1.3	7.6	6.4	2.8	10.1	20.2	17.4	12.3	12.2	8.1	5.3	419.3	14.0	9.3	0.0	3.7	12.0	14.9	12.3	4.5	4.2	24.1	18.9	15.4	8.0	5.4	12.1	9.5	58.7	36.7	19.7	7.8	6.6	40.9	43.8	3.5	4.3	1.9	4.9	11.2	12.4	4.0
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889077-197960142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 52.8;testis: 43.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.0;Endometrial ciliated cells: 176.3;Late spermatids: 489.4;Respiratory ciliated cells: 322.2;Spermatocytes: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"	Cytosol	"HPA042787: AB_10797021, HPA051981: AB_2732572"	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.0	5.2	8.9	3.3	9.7	3.2	5.8	8.4	9.5	5.9	25.2	3.2	2.6	4.6	10.0	4.0	52.8	4.6	4.4	8.7	10.6	6.4	3.7	9.1	3.8	15.0	19.8	3.6	2.0	4.4	6.1	3.5	14.1	3.9	3.7	18.1	2.5	4.5	2.0	2.7	2.7	4.3	14.3	3.4	3.7	43.9	10.9	2.9	8.1	2.1	4.2	3.6	2.2	14.6	5.3	5.8	7.3	7.1	15.6	15.7	2.9	6.4	7.1	7.5	7.6	1.2	5.0	1.9	7.0	5.2	9.6	4.9	5.4	5.0	12.0	4.4	3.8	3.2	3.3	2.9	3.6	4.4	5.0	8.1	6.1	8.1	2.6	6.1	3.6	8.8	3.5	7.2	5.8	12.2	2.4	2.1	4.6	7.8	7.6	6.8	4.8	2.6	7.2	2.2	6.4	7.7	10.6	4.3	4.4	6.4	32.2	3.0	3.7	4.8	3.3	14.5	6.7	6.2	18.4	3.1	18.1	6.1	7.8	2.0	3.8	4.3	3.4	2.7	2.2	4.3	2.9	2.3	3.3	1.6	2.7	3.7	2.3	3.3	2.6	2.9	3.1	2.3	8.9	9.7	8.4	9.5	8.7	10.6	15.0	19.8	14.1	14.3	10.9	14.6	7.4	6.4	7.7	16.6	8.5	9.3	3.3	14.8	2.2	13.1	27.9	15.2	11.0	5.7	31.8	5.5	75.0	6.4	10.1	3.1	15.6	7.1	255.0	176.3	15.0	8.2	4.2	4.8	10.1	4.2	5.8	13.1	5.6	16.3	8.8	30.9	5.3	4.2	6.6	10.1	8.8	2.9	26.4	6.0	24.9	489.4	22.7	10.3	14.2	14.0	2.9	13.5	11.3	10.6	13.2	11.9	1.9	23.7	5.7	2.2	1.4	10.4	322.2	43.8	6.6	6.8	18.7	122.7	31.6	5.9	8.9	5.2	10.8	46.5	2.9	2.5
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254786-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040845	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.3	1.1	0.7	0.3	0.8	0.1	1.6	0.7	1.4	0.9	4.2	0.5	0.2	0.8	2.6	0.5	6.8	0.6	0.9	0.7	1.8	2.2	1.0	0.9	0.4	2.5	2.2	0.3	0.7	3.7	2.0	0.4	1.6	0.6	0.7	5.0	0.6	0.8	0.5	0.6	0.1	0.3	2.0	0.4	1.1	11.5	1.9	1.0	4.1	0.0	0.2	0.7	0.3	1.4	1.7	1.6	0.8	1.3	1.1	2.6	0.6	0.9	0.7	1.3	0.9	0.1	1.9	1.2	0.8	1.5	1.5	2.8	2.6	1.0	2.3	0.2	1.2	0.3	1.6	0.2	1.7	0.5	0.3	1.7	1.1	2.9	2.8	1.3	0.5	3.1	2.6	1.1	1.0	1.8	0.4	0.4	0.9	1.0	1.1	0.3	1.2	1.3	1.6	0.7	2.6	0.7	1.2	1.6	4.8	1.6	4.3	0.3	1.2	1.5	0.7	2.4	1.0	2.5	3.2	0.3	3.1	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.8	0.7	1.4	0.7	1.8	2.5	2.2	1.6	2.0	1.9	1.4	0.7	3.2	1.1	27.4	0.3	1.3	1.0	1.6	1.8	1.5	2.7	2.2	1.1	0.0	2.8	1.8	8.4	0.2	0.3	0.4	0.0	1.0	59.4	15.9	1.1	0.9	0.0	0.4	26.5	0.8	0.5	0.7	8.2	2.0	0.0	0.7	0.0	0.0	0.3	1.7	18.2	0.5	4.1	0.0	0.7	37.3	0.9	0.3	0.0	8.4	1.0	1.1	0.0	9.0	9.5	0.7	0.0	0.7	0.5	0.3	0.2	2.2	30.3	5.4	0.0	1.5	0.6	48.8	18.2	1.2	0.4	0.3	0.4	4.2	0.4	1.0
IQCJ		ENSG00000214216	"IQ motif containing J"	Q1A5X6	3	158962928-159266307	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 5.8"	"Group enriched"	"Detected in some"	97	"Early spermatids: 27.3;Late spermatids: 50.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 5.8;basal ganglia: 3.9;cerebral cortex: 4.8;hippocampal formation: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Daudi: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052835	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA052835: AB_2681970"	"unprognostic (1.99e-2)"																	0.0	0.0	5.8	0.0	3.9	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	3.9	0.0	4.8	5.3	0.1	0.3	1.1	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 165.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		22.0	5.1	82.3	9.7	90.6	2.2	15.4	84.9	165.9	9.2	56.6	49.8	4.5	19.6	6.3	15.4	18.2	12.5	57.2	83.9	73.9	17.8	14.3	19.6	2.2	93.5	88.0	4.4	2.7	1.1	7.3	23.6	92.0	17.7	6.8	14.2	6.5	20.4	27.6	5.7	12.8	25.9	81.5	4.3	18.3	4.7	87.2	2.5	5.7	3.2	1.8	35.8	10.8	110.5	87.9	14.8	28.9	34.4	6.6	6.3	25.1	73.6	17.3	59.4	40.5	55.6	20.9	4.4	46.4	24.6	22.6	34.8	11.3	24.9	48.5	72.7	27.6	0.1	31.2	2.8	7.7	4.2	0.5	6.5	20.8	26.5	31.1	49.3	44.5	4.9	0.0	0.3	27.7	3.9	0.3	0.0	24.2	7.0	31.9	10.2	58.4	0.0	57.6	4.7	5.8	26.8	39.8	16.7	21.8	32.9	9.8	0.8	37.6	34.0	47.5	22.9	101.5	0.3	0.5	0.4	19.1	12.4	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.3	90.6	84.9	165.9	83.9	73.9	93.5	88.0	92.0	81.5	87.2	110.5	4.7	6.4	0.0	1.0	0.1	1.5	7.3	0.8	12.5	11.5	0.3	0.9	0.6	0.0	1.4	1.8	6.2	0.0	0.1	0.3	0.0	0.9	2.0	2.1	0.8	5.7	0.0	0.0	11.3	0.6	0.0	3.1	0.0	2.3	2.5	0.0	1.8	0.6	0.0	0.0	4.7	0.2	0.0	0.3	1.2	0.6	0.3	1.2	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.2	0.0	1.2	0.0	1.3	0.0	4.2	2.4	0.6	0.0	2.5	5.4	0.1	0.4	3.5	0.9	0.0	0.5	0.0	0.2	1.6
IQCK	"FLJ36575, MGC35048"	ENSG00000174628	"IQ motif containing K"	Q8N0W5	16	19716456-19858467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026792, HPA048786"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	Cytosol	"HPA026792: AB_1853889, HPA048786: AB_2680520"	"unprognostic (4.21e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	3.8	2.7	5.3	1.3	5.7	0.5	5.9	5.2	6.8	7.5	8.7	2.6	3.8	4.6	15.4	1.6	20.2	5.7	3.5	5.1	8.7	8.7	2.1	4.0	1.5	6.2	7.2	6.5	3.6	19.4	6.3	3.2	5.7	3.4	2.9	11.0	6.4	7.6	3.0	2.1	1.6	3.8	6.8	1.8	3.9	18.2	5.6	1.6	16.8	2.9	1.1	4.1	2.0	8.0	2.6	6.8	8.7	5.7	2.6	8.1	0.5	0.0	4.4	4.0	3.1	0.4	4.8	0.3	4.7	2.4	2.5	3.0	1.9	3.3	2.8	1.1	1.8	0.1	1.9	3.4	8.2	1.6	0.0	4.7	2.7	5.4	1.2	4.5	4.4	4.2	2.8	0.8	2.5	8.5	1.6	0.9	2.6	2.8	6.4	5.3	0.8	0.4	10.0	1.8	8.1	3.4	3.9	1.2	5.3	1.6	3.6	0.9	3.1	1.1	0.9	4.6	0.9	0.1	0.6	0.0	5.4	0.2	1.9	0.0	0.3	0.0	0.5	1.3	0.9	0.5	0.5	0.8	0.1	0.2	1.0	0.5	0.0	0.0	1.3	0.3	0.5	0.3	5.3	5.7	5.2	6.8	5.1	8.7	6.2	7.2	5.7	6.8	5.6	8.0	42.4	16.0	5.1	128.3	1.7	6.1	9.7	16.4	9.6	54.1	18.3	16.5	0.7	24.3	17.8	46.0	114.7	4.9	1.3	8.6	46.9	47.2	57.2	76.9	19.0	22.1	5.4	0.8	31.9	29.6	2.8	11.8	12.8	14.9	0.0	6.2	11.7	2.1	6.0	3.3	45.9	4.3	32.6	2.4	3.9	34.8	18.0	3.7	17.8	15.0	1.5	26.3	0.0	37.2	53.4	29.8	2.2	18.0	2.3	7.3	2.0	32.5	98.7	107.4	6.6	7.5	15.6	101.7	35.8	3.9	5.1	4.1	3.0	18.1	6.7	5.1
IQCN	KIAA1683	ENSG00000130518	"IQ motif containing N"	Q9H0B3	19	18257097-18274509	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.8;testis: 33.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.6;Alveolar cells type 2: 43.7;Breast glandular cells: 13.8;Breast myoepithelial cells: 17.5;dendritic cells: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042409	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"			"HPA042409: AB_10794421"	"unprognostic (1.36e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.15e-4)"	"unprognostic (9.79e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.64e-4)"	"unprognostic (4.17e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.92e-3)"	1.4	0.7	8.5	0.7	7.4	3.1	1.8	16.8	16.4	3.7	5.9	1.0	0.4	3.2	1.9	0.9	3.2	0.9	0.4	7.7	8.6	1.3	1.0	1.9	1.2	8.7	7.9	3.9	1.4	0.7	2.6	0.3	9.3	1.5	0.8	2.0	1.1	0.8	1.5	2.3	1.4	1.5	5.5	2.0	1.2	33.7	8.8	0.9	3.0	0.1	0.5	0.7	1.5	11.0	0.0	2.2	0.3	1.3	0.5	1.0	0.3	0.3	0.2	0.0	0.1	0.3	0.7	0.5	0.2	0.7	0.3	0.0	0.0	0.2	0.0	0.6	0.1	0.8	1.0	0.4	0.1	0.1	0.2	0.5	0.0	0.2	0.4	1.2	0.2	0.1	0.0	0.6	0.0	0.9	0.2	0.3	0.2	0.6	0.0	0.2	0.0	0.2	0.3	0.3	1.0	0.2	0.1	0.1	0.5	0.7	0.7	0.2	0.0	0.1	0.1	0.7	0.0	0.3	0.2	0.2	0.4	0.0	0.0	0.5	0.3	0.2	0.3	0.1	0.1	0.4	0.3	0.1	0.1	0.6	0.3	0.2	1.7	0.4	0.1	0.6	0.2	0.1	8.5	7.4	16.8	16.4	7.7	8.6	8.7	7.9	9.3	5.5	8.8	11.0	23.6	3.2	43.7	0.0	5.8	0.0	0.0	0.0	0.0	0.0	13.8	17.5	0.0	0.0	1.3	1.8	0.0	1.5	22.3	0.0	0.0	2.7	0.0	6.7	4.5	1.4	0.0	0.0	0.0	0.9	0.5	2.8	0.0	10.2	5.1	4.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.3	2.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.8	8.5	4.2	0.0	0.0
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388242-90502239	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	57.3	31.1	14.4	69.3	30.0	69.7	51.6	19.8	20.5	62.0	26.9	67.1	32.3	72.2	21.3	75.6	45.1	55.0	22.9	17.0	21.5	35.6	18.8	74.2	58.9	29.0	24.6	39.6	30.1	49.7	12.1	79.8	28.1	36.2	66.9	7.1	72.2	38.0	15.0	64.9	37.9	81.3	16.5	57.7	52.6	13.0	27.9	65.4	64.3	25.4	63.4	63.5	31.4	63.4	148.9	81.5	39.8	46.6	99.3	128.4	229.6	139.7	127.0	124.7	132.4	93.6	150.5	82.7	66.2	231.5	111.4	259.2	80.6	153.5	149.5	106.4	56.6	55.5	145.8	34.3	120.2	102.9	113.6	76.2	139.5	147.2	206.5	152.7	172.8	53.0	49.0	112.8	192.3	76.5	55.4	30.8	51.6	235.8	45.6	67.5	106.5	72.1	126.9	233.8	49.5	37.3	195.1	96.9	100.7	162.8	85.1	86.5	224.2	141.1	73.4	120.4	145.6	43.3	67.0	82.4	128.3	98.5	77.5	30.6	27.5	20.0	21.8	25.2	19.3	12.6	13.5	18.9	23.3	12.5	7.9	14.0	89.9	27.6	31.0	13.8	16.1	16.9	14.4	30.0	19.8	20.5	17.0	21.5	29.0	24.6	28.1	16.5	27.9	63.4	180.9	266.0	286.3	36.2	129.2	103.0	124.9	87.7	72.8	4.6	115.1	88.4	18.0	54.3	167.2	77.3	16.7	89.7	215.3	204.5	7.9	95.9	8.8	133.8	127.9	135.7	60.7	46.7	39.7	98.7	159.4	116.5	91.7	242.0	209.3	130.2	95.3	11.6	149.0	1.7	24.4	121.1	63.1	407.5	175.1	13.2	47.8	261.6	71.2	60.9	272.2	13.5	200.8	9.5	316.0	128.1	112.1	48.2	137.3	98.6	72.7	19.6	134.2	30.2	78.9	108.8	131.0	18.9	32.6	99.3	113.4	95.6	176.8	56.0	152.0	151.5
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain ArfGEF 1"	Q6DN90	3	12897043-13283281	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 183.0;Cone photoreceptor cells: 193.9;Excitatory neurons: 191.3;Horizontal cells: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 66.5;U-266/84: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	26.8	38.7	37.0	19.3	49.4	54.9	19.7	13.9	85.6	20.5	0.0	19.6	7.0	19.6	7.4	9.2	19.5	11.0	35.3	42.7	19.9	16.8	30.9	28.4	24.6	48.1	14.2	21.1	19.3	30.9	18.5	19.0	50.6	22.4	7.1	56.3	15.3	13.7	34.4	12.8	22.3	12.3	4.3	46.6	17.7	10.8	17.6	14.0	16.1	27.0	16.4	19.6	15.3	55.1	10.2	13.3	11.4	12.5	9.6	12.8	66.5	10.8	9.1	7.2	5.5	9.1	8.1	21.2	12.0	20.1	7.9	5.8	9.0	5.7	5.3	14.1	19.0	12.6	8.0	38.0	10.3	0.2	5.1	13.0	10.6	14.7	8.3	9.6	6.7	8.6	36.0	20.6	5.1	31.6	8.2	13.1	12.3	7.6	26.4	11.3	3.9	29.6	4.4	12.8	9.5	18.2	7.4	27.5	6.5	10.4	11.6	8.6	17.5	7.5	19.2	6.4	1.5	43.6	64.7	8.1	14.2	6.0	6.1	4.5	2.7	3.9	2.5	2.9	1.9	5.0	1.7	1.9	1.4	4.3	1.7	2.0	8.3	1.3	2.8	4.9	1.3	2.1	37.0	49.4	13.9	85.6	42.7	19.9	48.1	14.2	50.6	4.3	17.6	55.1	29.1	3.2	17.9	59.7	45.6	11.5	7.9	7.8	12.0	110.1	16.1	15.9	183.0	21.5	10.7	3.7	193.9	9.9	48.5	3.4	7.9	6.8	2.9	7.3	13.2	29.8	10.2	46.3	191.3	12.9	42.2	22.8	8.2	5.0	15.2	21.6	24.7	42.7	22.0	235.6	128.4	13.3	4.1	60.4	42.4	4.8	16.8	34.2	7.2	78.7	36.3	16.6	45.3	67.3	78.8	7.8	3.8	22.6	23.3	19.0	3.0	5.8	29.1	123.1	26.3	24.9	30.6	2.2	1.7	3.5	7.7	21.8	24.8	45.2	8.5	13.2
IRAG1	"IRAG, JAW1L, MRVI1"	ENSG00000072952	"Inositol 1,4,5-triphosphate receptor associated 1"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 24.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8"	"Region enriched"	"Detected in many"	5	"thalamus: 7.6"	"Low region specificity"	"Detected in all"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		220000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	29.7	8.0	64.6	18.2	85.8	1.5	16.1	50.4	53.4	55.4	17.7	67.6	8.5	60.8	16.1	37.5	45.6	33.2	10.1	54.5	54.3	9.3	2.1	13.3	3.7	65.8	71.4	20.2	2.9	2.7	3.8	11.8	54.4	37.9	17.3	1.7	4.1	39.5	6.7	9.3	22.0	69.1	55.2	7.1	33.7	8.2	89.8	2.3	10.2	8.1	1.8	43.8	21.9	48.8	0.1	0.0	4.2	0.0	20.8	4.1	0.2	15.3	17.6	0.0	0.0	0.4	1.7	0.0	0.1	6.9	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.0	0.2	4.8	0.4	0.0	0.1	0.0	1.2	0.0	0.6	0.1	0.3	0.0	0.1	0.3	0.5	0.0	0.1	6.8	0.0	0.3	0.0	0.0	0.0	3.1	0.0	2.6	0.0	4.4	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	6.0	0.0	0.7	2.2	1.7	0.0	3.9	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	24.0	0.0	5.7	0.1	0.0	0.7	64.6	85.8	50.4	53.4	54.5	54.3	65.8	71.4	54.4	55.2	89.8	48.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
IRAG2	"JAW1, LRMP"	ENSG00000118308	"Inositol 1,4,5-triphosphate receptor associated 2"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 60.3;lymphoid tissue: 202.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 210.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 634.3;REH: 221.9;U-698: 722.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA002967, HPA007356, HPA018505"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA		6700	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum, Plasma membrane"		"HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	9.6	1.9	8.5	47.2	5.4	60.3	6.5	2.3	5.6	2.4	3.2	10.1	8.7	2.5	2.8	5.2	5.1	7.8	2.4	6.6	2.6	9.4	6.2	7.7	171.7	6.0	4.4	5.7	30.7	1.5	2.4	4.4	6.1	3.4	9.2	1.1	3.6	4.4	1.1	5.8	19.1	4.5	3.6	37.5	10.1	1.0	2.8	95.1	4.9	1.6	202.8	14.5	8.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	634.3	0.3	0.0	0.0	0.2	0.0	2.4	0.0	22.1	0.0	37.8	0.0	0.1	0.0	49.7	54.2	0.0	0.0	0.7	0.0	0.1	0.0	31.5	7.8	40.6	0.0	0.0	54.5	91.2	0.1	0.0	0.0	221.9	0.3	63.8	0.7	29.7	0.2	0.1	0.2	0.3	0.2	0.1	0.0	36.7	0.5	0.0	1.5	0.0	0.1	40.4	7.8	722.4	0.2	21.8	0.0	80.2	21.0	210.1	23.6	40.8	20.2	66.1	14.9	24.2	22.4	51.0	25.5	25.4	151.3	49.0	51.5	20.8	2.7	20.2	8.5	5.4	2.3	5.6	6.6	2.6	6.0	4.4	6.1	3.6	2.8	4.6	13.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010506-154019902	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	48.6	61.2	24.4	37.6	25.3	82.4	40.7	23.6	34.9	29.0	20.0	41.4	43.3	31.8	7.7	69.1	28.8	20.2	34.4	22.3	26.5	44.2	64.7	48.9	33.7	38.1	30.0	28.9	84.9	12.4	37.5	17.8	30.8	46.1	15.0	4.5	41.6	21.0	92.5	44.3	51.1	16.4	29.6	69.9	41.9	20.8	34.3	19.4	24.5	16.8	24.0	47.7	36.5	29.4	467.2	178.9	24.5	201.2	48.4	38.5	108.3	68.8	64.5	104.0	96.0	142.3	199.4	200.8	371.4	73.6	157.6	124.3	57.6	112.4	39.8	156.7	173.4	73.3	158.6	85.7	110.8	174.2	118.7	53.2	96.1	99.0	107.8	53.2	62.8	39.6	130.9	220.3	73.3	171.4	70.8	152.1	60.9	148.4	353.5	181.6	126.4	334.7	68.5	86.3	137.4	98.7	82.2	88.6	135.2	9.5	34.3	179.2	86.4	123.8	194.6	284.6	424.2	274.8	190.6	358.2	179.6	205.1	130.8	1.3	7.2	6.2	5.3	9.2	4.7	6.5	4.3	4.4	4.8	7.9	2.5	4.7	5.2	5.4	7.5	10.9	2.3	3.3	24.4	25.3	23.6	34.9	22.3	26.5	38.1	30.0	30.8	29.6	34.3	29.4	20.2	0.0	13.3	5.9	29.7	13.4	14.5	10.9	5.2	9.1	23.9	19.0	9.3	18.6	16.0	11.0	6.2	11.4	33.0	41.4	7.9	40.5	0.9	9.8	13.5	18.1	20.4	18.1	9.7	113.6	20.9	15.2	18.3	17.3	12.7	25.5	13.2	35.9	57.2	16.8	8.9	27.2	0.0	51.4	24.7	3.8	18.0	43.0	14.2	11.2	24.2	21.8	13.4	4.5	6.6	75.0	28.6	21.4	33.5	30.0	39.4	19.6	10.0	5.3	0.0	14.5	14.9	1.6	8.1	15.1	13.1	12.3	19.6	18.4	39.4	25.3
IRAK1BP1	"AIP70, SIMPL"	ENSG00000146243	"Interleukin 1 receptor associated kinase 1 binding protein 1"	Q5VVH5	6	78867551-78946440	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Excitatory neurons: 73.1;Inhibitory neurons: 57.2;Late spermatids: 52.0;Oligodendrocyte precursor cells: 56.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035742, HPA035743"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA035742: AB_10670119, HPA035743: AB_2674764"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.58e-1)"	1.5	1.8	0.4	1.0	1.0	5.3	2.4	5.3	2.8	1.8	1.7	1.7	1.1	2.8	4.4	1.2	3.2	1.4	1.7	1.0	0.5	2.9	0.9	2.2	1.8	0.3	0.1	3.1	3.2	3.6	3.4	1.1	0.6	1.8	1.4	5.6	2.6	2.4	1.2	2.3	1.4	2.1	0.0	2.0	3.5	3.9	0.5	3.0	3.3	1.1	1.0	1.5	1.5	1.4	1.1	2.0	3.7	3.5	1.6	3.5	2.1	0.8	2.1	0.8	1.4	1.8	0.9	1.6	0.9	1.9	2.0	2.3	7.1	3.4	1.4	3.7	2.8	1.3	2.4	0.9	2.1	7.6	1.3	2.9	3.3	1.5	1.8	2.7	2.7	4.9	4.0	2.1	1.3	0.6	2.2	3.8	1.8	0.5	2.0	0.4	2.2	1.2	3.6	1.9	5.1	6.0	1.1	1.2	0.9	2.4	2.8	5.1	1.9	1.8	1.3	0.6	2.4	2.5	3.3	2.2	0.6	0.3	2.3	0.9	0.0	0.0	0.3	0.0	0.2	0.3	0.3	0.1	0.1	0.2	0.4	0.4	0.4	0.2	0.1	0.4	0.4	0.1	0.4	1.0	5.3	2.8	1.0	0.5	0.3	0.1	0.6	0.0	0.5	1.4	6.1	19.2	7.8	39.2	3.3	2.5	5.3	3.9	10.8	10.3	5.2	8.5	13.6	8.6	9.3	3.7	33.3	3.6	3.5	1.0	9.8	5.5	65.4	20.5	11.5	5.5	6.6	7.8	73.1	6.0	0.8	5.8	5.1	3.6	0.0	11.6	5.0	2.4	1.6	5.0	57.2	2.7	0.0	1.3	0.9	52.0	10.5	1.6	0.0	22.5	0.8	12.9	2.1	56.3	33.6	3.3	1.0	8.2	3.1	1.2	0.6	11.8	21.5	17.9	13.1	8.2	8.1	42.3	15.2	6.3	2.6	0.8	2.5	11.1	3.2	2.8
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164919-10243745	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.7;Oligodendrocytes: 34.3;Prostatic glandular cells: 23.4;Urothelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.2;BJ hTERT+: 35.2;CAPAN-2: 35.6;GAMG: 62.6;RT4: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	6.4	3.6	4.0	6.0	3.9	23.3	4.6	3.9	8.0	2.9	1.7	2.1	2.0	2.0	0.7	7.2	1.8	4.4	1.9	3.2	5.1	3.4	10.8	10.4	3.8	5.1	4.1	1.0	1.9	1.0	1.2	2.2	5.6	3.3	1.7	1.5	3.6	1.8	17.0	5.2	5.4	1.4	3.4	4.5	3.4	1.3	4.2	3.9	3.1	4.3	11.5	16.1	4.5	8.0	2.7	7.6	0.3	1.0	8.1	6.7	33.2	2.9	35.2	4.7	4.5	3.6	35.6	0.1	0.9	4.3	62.6	0.8	0.8	9.0	6.3	2.3	2.5	0.8	1.7	9.9	3.9	0.0	1.1	4.1	1.5	17.3	22.4	12.4	9.7	0.3	1.8	10.7	5.7	0.1	0.0	1.8	0.3	4.2	7.5	1.7	0.0	0.6	10.3	49.2	0.5	0.3	3.3	0.1	0.3	0.8	0.8	1.7	10.1	10.7	0.9	6.5	7.0	3.6	11.3	2.1	22.9	4.7	1.9	0.2	1.0	0.1	5.8	0.7	6.0	4.2	1.7	3.3	1.0	3.2	1.2	3.0	2.1	7.4	0.2	0.0	0.7	2.2	4.0	3.9	3.9	8.0	3.2	5.1	5.1	4.1	5.6	3.4	4.2	8.0	3.9	0.0	4.1	1.6	8.3	8.0	20.8	9.9	5.2	0.9	1.6	1.3	2.0	0.0	6.1	0.0	0.0	0.2	3.8	1.3	0.0	9.8	4.1	4.3	2.4	12.3	0.0	0.0	6.3	4.2	0.7	4.3	7.7	16.7	0.0	0.1	0.7	4.8	3.4	0.0	7.0	0.7	4.1	2.9	43.7	1.5	0.9	20.9	5.4	13.1	1.9	2.1	7.2	7.1	34.3	15.7	0.3	0.0	7.4	23.4	2.6	1.1	1.3	0.0	0.0	4.2	2.0	0.7	0.9	4.7	7.4	1.0	3.9	0.2	0.5	30.4
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	8.6	6.5	4.0	13.6	4.6	10.0	8.9	4.5	5.1	7.9	5.1	7.9	9.1	6.8	7.0	10.5	7.0	8.8	5.4	3.9	4.6	8.0	9.2	8.5	17.5	5.5	4.7	5.6	15.1	6.9	6.2	8.3	5.4	7.5	8.4	12.3	8.4	7.0	3.0	13.3	11.9	7.2	4.8	18.6	10.5	5.8	4.9	18.5	10.9	3.2	16.3	7.8	7.9	5.3	9.3	6.8	4.7	6.2	16.5	27.6	6.7	12.9	9.1	10.0	9.1	5.8	8.7	15.8	12.4	10.7	6.6	7.5	5.3	8.3	14.2	22.8	4.9	15.2	5.2	3.7	9.4	21.2	17.7	14.7	12.7	12.7	7.4	17.4	15.0	15.1	14.4	11.6	27.8	5.1	18.6	11.7	1.7	0.0	7.9	12.2	5.8	8.4	7.8	8.8	3.4	3.3	6.3	7.9	6.2	6.4	9.9	18.5	13.4	12.2	2.3	15.1	9.0	14.0	19.4	13.7	12.7	56.2	6.9	20.8	4.0	8.7	6.1	4.6	6.3	3.3	4.9	5.3	3.7	4.4	4.4	4.8	7.9	7.9	5.9	5.1	6.7	4.6	4.0	4.6	4.5	5.1	3.9	4.6	5.5	4.7	5.4	4.8	4.9	5.3	24.1	19.2	15.6	5.2	36.5	10.8	11.3	10.7	17.1	5.8	15.2	11.2	4.5	17.2	11.3	33.1	20.9	14.9	52.1	15.7	21.5	12.7	18.4	14.1	12.4	17.3	3.6	12.0	2.9	17.8	8.4	13.7	33.6	15.2	22.1	10.7	16.1	8.7	16.9	8.4	3.4	11.9	14.2	24.7	20.2	23.2	12.5	25.1	10.6	20.6	28.2	9.9	60.8	2.5	14.7	13.3	7.2	11.3	33.2	8.9	18.6	13.8	9.5	27.2	6.6	9.5	11.0	28.2	12.5	17.2	11.8	27.9	41.1	15.0	9.2	13.5
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501453	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	17.1	25.2	7.5	18.2	7.7	27.7	18.8	16.3	9.3	15.2	8.4	17.4	17.9	17.9	11.8	15.2	14.6	14.9	12.5	7.4	10.5	18.3	23.1	14.9	22.8	7.0	7.2	22.0	11.4	17.8	8.2	21.8	7.1	16.5	20.3	19.4	10.6	15.4	18.8	14.4	18.4	16.1	7.0	24.8	16.4	15.1	9.5	29.7	28.7	23.5	20.9	13.4	11.7	8.8	19.9	34.9	52.8	33.2	45.5	29.7	35.5	33.3	26.0	29.7	26.9	34.6	33.8	73.1	22.1	28.0	20.3	37.8	124.7	33.2	26.1	23.4	43.0	63.6	35.0	24.4	23.8	69.4	65.7	31.5	22.4	22.9	27.7	30.2	35.4	42.6	67.9	25.4	25.5	29.7	42.8	35.2	69.1	24.1	12.4	49.6	53.0	20.8	32.4	54.2	31.7	47.3	45.1	31.4	35.7	59.2	29.5	59.7	28.9	30.3	20.8	16.8	29.2	31.5	74.8	41.7	21.8	63.1	22.2	3.8	2.5	2.0	2.4	3.3	3.1	2.7	2.6	2.4	3.5	2.6	2.5	3.5	2.8	3.0	2.6	4.0	2.3	1.4	7.5	7.7	16.3	9.3	7.4	10.5	7.0	7.2	7.1	7.0	9.5	8.8	24.3	22.4	40.7	33.0	37.5	14.1	16.6	19.3	14.8	55.6	23.1	18.4	24.9	25.8	26.1	23.9	66.7	35.0	56.2	45.3	0.0	19.9	18.1	19.3	38.2	26.6	31.9	42.3	52.3	19.6	23.7	27.7	32.1	21.2	17.7	66.2	38.9	41.8	26.1	79.1	55.6	31.0	18.3	61.3	18.4	10.8	32.9	37.7	14.2	28.1	52.9	22.4	54.6	50.3	49.0	26.3	49.8	30.5	28.5	33.7	49.1	19.6	25.7	51.1	6.6	29.5	23.2	33.9	29.6	24.5	18.6	30.6	33.9	56.3	36.0	29.6
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132440440-132508719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.1"	"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 138.1;REH: 114.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: AB_2684945"	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	53.7	19.1	8.2	88.0	7.6	142.1	29.5	8.1	9.4	21.3	7.7	46.3	84.8	21.3	11.7	24.3	24.4	32.6	25.8	7.3	7.5	32.9	54.4	119.0	86.3	17.2	8.1	18.4	15.6	7.4	17.3	22.2	15.8	36.4	38.1	2.8	28.7	16.2	16.7	19.7	68.8	33.1	8.8	117.4	47.4	13.5	10.5	66.4	25.8	13.3	45.3	63.9	24.1	8.0	26.7	22.8	2.3	8.1	22.1	18.9	42.5	14.7	58.8	41.6	52.2	11.3	79.4	26.7	15.8	18.4	64.8	35.7	7.4	33.7	14.3	54.2	7.1	33.2	8.1	6.9	138.1	14.6	34.3	36.9	9.4	31.7	32.2	26.5	22.4	19.1	6.9	97.5	13.1	15.9	87.6	32.7	3.4	9.3	14.6	114.5	23.2	31.7	22.5	27.8	6.4	3.6	14.6	30.8	13.4	10.1	4.7	24.2	13.0	20.5	8.1	12.8	19.8	74.8	27.0	19.3	24.9	27.2	15.5	175.3	167.1	257.0	157.2	244.1	106.9	68.4	104.2	129.9	95.7	62.5	63.5	91.7	621.0	136.9	272.4	52.4	122.1	160.0	8.2	7.6	8.1	9.4	7.3	7.5	17.2	8.1	15.8	8.8	10.5	8.0	369.9	102.5	114.3	1.0	216.5	88.1	129.4	66.3	306.7	14.7	216.5	186.6	17.0	47.1	58.0	22.0	33.3	24.0	396.3	183.6	19.6	112.1	92.5	242.3	170.8	223.1	87.1	36.6	1.1	114.3	42.6	224.4	212.0	288.1	105.2	32.0	58.2	14.6	49.7	1.7	1.2	137.4	57.0	73.9	228.7	9.1	27.4	134.1	72.9	7.5	257.2	16.7	399.6	2.5	1.1	88.6	140.6	7.9	248.6	270.9	155.5	22.4	110.9	46.5	13.1	516.2	225.0	1.3	6.8	118.8	82.7	11.2	301.4	20.5	94.6	95.0
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883608-45886141	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NB-4: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	11.1	15.8	12.2	4.6	11.9	3.6	12.3	13.8	15.8	17.8	3.8	17.6	7.3	20.0	3.6	11.8	16.9	3.2	16.6	12.7	10.8	14.2	21.0	8.3	5.2	15.2	11.9	21.7	15.7	7.1	20.6	3.1	11.8	15.3	2.0	4.3	13.7	6.9	22.0	14.4	13.8	3.0	10.3	13.6	16.4	9.3	11.8	6.1	12.3	7.9	2.8	15.9	12.0	14.8	18.1	27.1	6.5	14.6	5.5	3.4	10.8	13.0	7.4	10.2	8.9	10.1	8.4	14.5	9.6	6.7	6.1	16.7	4.7	4.9	3.0	18.4	46.4	14.6	7.6	13.1	11.1	15.2	13.1	4.8	6.6	5.3	3.8	6.4	6.3	17.8	23.4	11.2	4.0	14.1	31.0	82.8	12.3	6.7	23.8	35.2	7.7	12.6	7.4	9.9	19.4	33.3	13.8	17.8	17.3	2.5	14.8	27.8	9.2	8.8	17.7	6.8	18.6	30.4	36.2	8.6	11.9	14.3	13.0	0.0	0.3	0.1	0.7	0.4	0.7	0.7	0.6	0.6	0.3	0.6	0.9	0.5	0.4	0.7	0.2	0.5	0.6	0.4	12.2	11.9	13.8	15.8	12.7	10.8	15.2	11.9	11.8	10.3	11.8	14.8	6.0	0.0	1.1	2.6	8.4	10.7	5.8	4.1	14.2	15.2	13.5	11.4	1.3	11.5	2.4	11.0	0.0	10.9	8.4	8.9	13.7	7.8	2.0	6.0	6.7	6.3	9.6	10.1	2.2	9.5	6.6	8.2	7.1	6.9	0.0	8.3	7.9	9.3	5.0	10.1	3.2	11.2	0.0	2.2	8.6	1.5	18.6	5.1	8.8	3.7	4.5	10.2	5.2	2.0	3.7	7.5	11.9	10.9	2.5	7.4	9.3	13.5	3.0	7.0	19.7	10.7	11.7	3.8	2.2	8.9	11.2	8.8	7.3	9.9	8.7	3.0
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234610178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 277.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	35.6	39.6	43.3	25.6	50.2	157.2	45.0	48.5	49.1	50.0	43.3	42.5	39.6	55.8	26.5	47.0	45.1	40.7	45.0	40.5	45.4	34.2	53.6	43.7	36.3	55.2	49.0	54.8	49.5	45.5	24.1	29.6	51.1	39.2	49.3	26.9	55.0	33.5	47.4	64.2	42.2	31.7	48.9	28.4	44.4	18.0	44.7	29.6	57.3	40.5	30.3	38.7	43.7	61.1	28.0	41.5	29.8	45.7	61.2	48.1	35.1	21.8	18.4	12.7	14.2	24.5	33.5	0.0	49.4	21.2	43.3	37.4	16.2	28.3	20.2	45.2	36.8	26.7	32.9	72.3	49.4	101.0	91.0	57.0	65.8	28.3	53.4	74.4	33.0	24.5	23.0	55.6	33.2	8.4	25.5	107.2	27.1	65.1	15.7	49.6	13.8	66.8	25.1	22.9	58.8	41.8	35.2	46.7	72.7	29.8	45.1	277.5	36.8	45.5	19.0	34.7	41.6	122.9	33.8	9.1	23.1	89.6	63.4	10.1	4.5	8.5	3.9	3.6	4.0	4.3	4.8	4.6	4.7	4.0	4.9	4.1	2.3	3.0	1.9	17.8	4.0	2.5	43.3	50.2	48.5	49.1	40.5	45.4	55.2	49.0	51.1	48.9	44.7	61.1	96.0	134.6	191.3	28.1	75.6	325.9	440.4	142.3	139.5	34.6	126.6	109.7	63.6	133.0	143.8	51.5	10.4	44.6	168.3	84.2	13.7	65.8	24.9	180.8	126.2	101.9	145.5	76.6	14.3	50.0	58.0	97.3	47.4	285.2	107.5	39.6	117.4	185.7	88.9	58.9	22.9	117.1	71.2	131.8	271.2	27.1	69.6	159.7	110.3	30.9	83.2	87.7	38.1	20.6	64.2	68.9	92.0	81.3	39.2	138.2	81.7	40.2	95.1	19.5	78.9	117.1	102.9	29.5	24.1	182.1	396.2	79.4	91.3	15.5	162.7	370.6
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028708	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	26.1	25.3	12.2	9.2	13.9	5.6	28.5	13.4	12.0	20.1	12.8	32.4	6.9	25.8	5.1	13.3	33.7	6.5	22.6	14.1	21.1	28.7	19.1	20.9	6.2	15.2	14.8	32.4	17.5	19.8	22.6	7.9	10.9	18.4	3.3	7.3	19.2	10.1	16.8	25.2	15.1	8.0	12.6	19.0	18.8	13.5	19.0	9.7	18.7	4.2	3.3	26.4	18.2	9.4	15.4	13.2	32.2	36.3	9.6	8.8	45.8	15.9	13.0	4.4	5.9	6.2	24.8	5.4	11.3	13.6	12.4	23.6	5.6	11.8	3.7	25.8	19.1	6.9	13.0	8.5	12.5	1.9	29.7	11.8	9.1	7.8	6.8	34.8	6.0	10.9	10.4	59.4	5.7	42.2	21.0	14.5	14.5	6.6	68.2	4.4	9.1	13.0	15.6	22.4	24.9	36.0	22.5	23.2	42.5	8.6	16.1	3.4	10.4	20.2	19.5	6.8	10.3	22.9	26.3	9.0	31.3	4.7	25.8	1.7	1.4	1.3	2.8	1.9	2.7	1.4	2.5	2.6	1.3	1.6	2.0	2.3	9.0	5.9	2.3	10.7	2.6	0.8	12.2	13.9	13.4	12.0	14.1	21.1	15.2	14.8	10.9	12.6	19.0	9.4	71.4	22.4	14.3	5.9	40.2	73.7	32.5	22.5	115.5	57.1	54.6	41.5	19.5	32.9	11.6	64.4	29.2	22.8	58.9	10.8	37.2	19.6	1.3	25.3	26.0	44.0	47.6	10.8	8.2	19.0	49.7	47.8	12.2	25.6	26.6	15.2	55.6	60.5	33.3	10.1	8.6	14.7	16.2	54.7	78.9	4.0	30.1	26.6	35.6	9.4	10.0	57.8	38.1	8.5	4.8	17.8	7.0	34.3	21.1	30.0	6.7	23.1	13.8	10.4	39.5	56.4	83.2	1.6	50.5	54.2	50.6	46.0	39.0	27.5	12.8	20.6
IRF3		ENSG00000126456	"Interferon regulatory factor 3"	Q14653	19	49659569-49665875	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004895, CAB013018"	Approved		Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB013018: AB_2533904, HPA004895: AB_1851887"	"unprognostic (5.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.17e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.91e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.52e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (1.56e-7)"	"unprognostic (1.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (3.47e-2)"	"prognostic favorable (3.61e-4)"	32.9	33.7	27.9	20.8	27.4	24.9	33.8	27.4	36.0	46.5	27.8	39.0	18.8	37.0	10.2	37.3	39.7	19.5	31.8	26.4	27.4	46.3	42.4	39.7	42.6	28.3	27.2	44.1	36.6	12.1	37.0	21.1	28.7	46.7	11.4	5.8	34.7	22.8	18.0	43.5	53.0	14.4	27.9	73.9	38.3	16.0	29.7	29.9	43.0	9.4	24.2	40.2	41.1	28.2	82.2	88.3	30.1	44.7	22.6	35.3	68.1	35.1	52.8	59.8	77.7	62.6	93.8	47.7	39.4	32.9	49.8	66.2	32.5	91.0	26.1	66.0	57.6	44.7	33.8	58.2	25.5	33.1	43.9	33.9	63.6	79.2	23.8	30.5	47.9	60.9	50.4	50.7	32.3	79.9	53.4	94.2	36.0	82.3	80.7	60.8	29.4	83.8	43.7	69.2	16.7	21.7	64.5	69.6	35.9	29.5	30.6	64.4	33.6	35.0	32.7	26.7	46.0	69.4	76.9	47.9	40.1	77.2	35.7	25.4	27.6	50.3	58.6	29.3	52.8	37.8	57.1	55.0	22.0	37.9	49.5	45.2	35.1	46.3	36.0	30.2	81.0	39.5	27.9	27.4	27.4	36.0	26.4	27.4	28.3	27.2	28.7	27.9	29.7	28.2	42.5	25.6	33.9	16.0	51.3	54.2	35.6	58.4	29.0	33.0	40.1	39.2	7.9	35.8	51.9	40.5	29.2	78.2	57.6	83.6	19.6	39.4	3.7	30.4	29.5	33.1	44.9	40.0	3.9	46.5	92.0	30.4	76.0	37.0	77.3	33.8	38.6	25.7	39.0	16.8	5.6	70.5	46.8	32.2	29.9	8.9	41.0	33.9	30.2	10.3	71.1	37.9	122.6	7.1	10.8	46.8	60.0	35.7	70.4	26.7	74.8	25.8	45.4	47.7	32.9	23.1	28.2	13.7	15.9	23.2	45.6	49.3	69.2	30.9	63.8	30.1
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391752-411443	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	3.1	0.4	0.1	15.9	0.1	29.2	3.2	0.1	0.2	19.0	0.2	6.9	7.6	1.5	0.3	0.9	0.7	2.5	1.0	0.1	0.1	0.4	2.4	2.2	23.2	0.3	0.1	0.6	0.1	0.0	0.3	0.1	0.2	0.5	6.8	0.0	4.5	0.4	0.2	6.8	10.2	0.7	0.2	17.4	7.2	1.1	0.1	7.0	1.1	0.1	26.1	6.3	2.4	0.2	0.4	0.0	0.0	0.0	22.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	221.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.8	0.0	0.0	0.1	0.1	1.2	0.0	0.0	26.1	0.0	200.0	0.0	0.0	0.4	0.0	0.0	0.2	32.0	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.3	177.2	141.3	58.4	0.2	0.0	109.0	0.1	1.8	0.0	0.6	1.5	0.0	10.4	1.0	1.0	10.6	10.8	1.7	0.7	0.0	0.3	1.5	12.1	5.8	1.5	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.8	0.0	5.3	0.0	57.2	8.3	0.1	0.0	0.0	0.0	0.6	1.5	1.2	1.5	0.0	0.0	0.0	0.0	66.8	0.2	0.0	0.1	0.0	0.3	0.9	0.6	0.0	0.0	0.1	0.7	0.0	1.8	1.5	0.4	0.0	0.0	1.1	0.5	0.3	0.0	0.1	0.1	0.0	0.6	109.7	0.2	3.4	21.7	44.4	0.0	56.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	235.6	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	1.0	0.4	4.3	0.1	29.8	0.0	0.1	0.1
IRF5		ENSG00000128604	"Interferon regulatory factor 5"	Q13568	7	128937457-128950038	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Hofbauer cells: 38.4;Kupffer cells: 34.5;Macrophages: 27.8;monocytes: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 17.6;dendritic cells: 43.6;monocytes: 53.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.3;RPMI-8226: 91.9;THP-1: 50.0;U-937: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046700, HPA076024"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA046700: AB_2679761, HPA076024: "	"unprognostic (4.01e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.20e-3)"	5.5	3.5	4.8	13.1	3.9	20.6	3.2	4.9	5.2	3.2	3.9	4.4	9.5	1.6	3.0	12.6	4.5	6.3	1.8	4.3	6.4	13.5	5.1	10.6	16.2	8.7	6.3	1.0	5.9	6.4	5.2	3.9	7.4	3.3	3.6	0.5	6.8	12.7	0.8	8.6	11.2	3.1	7.6	24.0	4.6	1.2	7.9	4.2	2.2	1.2	11.8	6.5	5.8	11.3	13.9	4.6	0.0	1.4	0.0	0.0	0.0	0.2	0.1	1.2	0.9	0.3	5.7	10.8	5.2	0.2	12.1	12.9	3.4	2.6	0.3	124.3	2.9	18.3	0.3	1.9	0.0	2.7	25.4	0.0	15.1	0.3	1.8	1.0	0.0	0.1	0.0	31.5	0.0	5.0	0.0	4.8	0.3	1.7	2.6	0.8	0.1	91.9	3.8	8.1	0.4	2.0	2.7	3.0	1.4	0.0	4.8	50.0	0.0	0.0	0.3	0.5	1.2	19.4	13.5	4.5	0.5	62.6	0.3	1.8	42.7	4.2	1.0	53.1	4.0	17.6	2.3	0.8	43.6	15.0	0.1	0.1	2.9	4.9	38.0	10.4	6.2	22.7	4.8	3.9	4.9	5.2	4.3	6.4	8.7	6.3	7.4	7.6	7.9	11.3	0.1	0.0	3.6	0.0	12.7	0.8	0.8	2.2	0.0	0.3	0.8	0.9	0.8	2.8	2.4	20.2	0.0	0.3	7.2	0.8	3.9	3.1	0.2	2.8	0.3	0.9	0.0	6.1	0.4	2.4	0.3	0.3	2.0	2.6	8.8	0.5	0.0	1.2	38.4	0.0	0.3	1.5	0.0	34.5	16.5	0.2	0.0	27.8	0.0	8.4	76.1	0.0	3.1	0.0	0.1	2.3	1.7	0.0	9.3	0.7	4.9	6.2	10.1	0.3	0.0	0.2	0.7	0.1	0.5	2.8	2.0	1.5	3.0	0.0	1.5	2.1
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2;lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 576.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	10.4	2.6	1.3	1.6	1.6	1.6	7.5	1.5	2.1	11.2	2.2	8.8	0.0	3.4	0.0	12.7	4.7	2.2	7.9	1.2	1.6	15.6	38.2	14.4	0.9	2.7	1.6	4.7	5.9	0.2	6.2	0.7	2.4	9.2	0.3	0.3	8.8	0.8	11.3	7.8	15.3	0.9	1.3	33.2	8.6	1.9	1.6	1.4	10.7	1.3	2.2	5.1	7.3	1.6	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.4	3.9	15.5	9.6	2.2	0.1	0.0	3.7	0.6	3.7	0.5	0.2	0.1	1.0	0.2	0.0	0.1	0.0	0.2	0.8	0.0	0.0	1.6	0.6	0.0	0.6	0.7	0.1	1.9	0.0	6.5	0.1	0.0	0.7	0.0	0.0	3.1	1.3	0.1	0.2	0.0	0.2	0.1	3.1	0.0	0.6	1.8	0.4	0.3	0.0	1.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.7	20.4	30.6	8.1	46.1	7.8	16.5	6.7	7.0	24.3	20.8	7.5	8.5	12.9	18.7	49.5	596.9	13.5	19.7	1.3	1.6	1.5	2.1	1.2	1.6	2.7	1.6	2.4	1.3	1.6	1.6	65.0	16.0	19.0	2.9	59.2	34.4	32.3	19.6	18.8	0.4	27.7	20.2	4.3	18.6	18.2	20.2	0.0	6.1	576.1	70.1	9.8	29.9	5.9	20.1	6.3	33.0	26.3	4.8	0.0	16.9	39.0	19.3	40.8	21.2	31.7	20.1	17.9	31.7	37.3	0.0	0.1	42.5	22.4	23.2	65.4	28.9	12.2	67.4	37.4	3.7	65.2	2.7	40.2	1.0	1.3	29.9	73.8	4.9	65.1	24.8	37.6	6.3	25.5	4.6	13.1	8.8	19.8	0.4	5.9	8.0	28.4	24.1	42.7	4.6	18.9	34.6
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
IRF9	ISGF3G	ENSG00000213928	"Interferon regulatory factor 9"	Q00978	14	24161265-24166565	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 76.6;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;GAMG: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001862	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001862: AB_1079153"	"unprognostic (4.96e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.84e-3)"	"unprognostic (8.17e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (7.58e-8)"	"unprognostic (1.56e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.92e-4)"	25.2	27.1	16.0	25.0	17.4	25.4	22.5	16.3	15.9	31.6	13.3	29.3	17.6	27.7	13.1	21.8	25.0	24.2	19.1	14.7	17.9	29.1	25.9	28.2	25.2	22.0	17.9	25.0	14.1	11.6	22.1	12.8	17.5	22.1	9.9	3.6	36.4	12.7	9.0	20.7	26.8	17.6	22.2	48.5	25.3	8.3	18.0	22.7	22.8	8.8	20.4	27.0	22.5	21.2	3.9	2.4	2.5	0.9	15.9	17.6	1.6	7.3	37.5	76.6	58.9	5.2	22.5	5.0	7.7	20.3	48.5	6.0	1.6	1.5	19.3	24.3	0.0	11.6	2.1	6.1	25.3	1.1	14.2	17.2	5.3	9.1	1.9	15.1	8.3	1.0	1.7	32.6	10.0	4.5	2.0	4.8	0.4	2.8	7.4	0.8	2.5	3.0	17.2	2.6	0.4	2.6	6.6	3.5	38.9	5.1	1.1	9.7	16.1	8.1	5.7	4.8	1.7	32.4	24.9	4.7	9.4	1.8	7.3	197.2	80.5	112.3	73.4	103.1	58.1	93.3	72.4	62.0	61.7	88.7	64.0	58.4	202.8	74.8	103.9	75.1	103.0	103.4	16.0	17.4	16.3	15.9	14.7	17.9	22.0	17.9	17.5	22.2	18.0	21.2	37.9	25.6	15.1	21.2	22.8	2.3	8.6	6.1	6.2	6.6	8.0	10.3	0.2	10.0	9.7	5.5	8.4	1.5	32.0	6.1	0.0	4.9	0.2	9.0	19.4	21.0	1.8	7.4	5.0	5.5	21.9	14.8	20.9	9.4	24.6	42.0	11.0	1.7	7.0	8.4	4.9	5.3	10.2	8.2	8.0	1.0	12.8	13.4	5.4	26.2	13.4	11.2	73.2	32.2	9.5	6.2	10.9	6.8	13.2	8.4	21.8	2.6	32.3	4.3	13.1	33.7	15.1	1.3	1.7	3.7	2.7	1.6	26.1	24.9	4.9	12.4
IRGC	"CINEMA, Iigp5, IRGC1"	ENSG00000124449	"Immunity related GTPase cinema"	Q6NXR0	19	43716076-43720021	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	638	"testis: 149.7"	"Group enriched"	"Detected in some"	139	"Early spermatids: 1460.2;Late spermatids: 2465.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046769, HPA060064"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA046769: AB_2679797, HPA060064: AB_2684195"		"unprognostic (3.38e-2)"		"unprognostic (3.83e-2)"	"unprognostic (8.52e-2)"					"unprognostic (1.26e-1)"				"unprognostic (2.55e-1)"	"unprognostic (2.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1460.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2465.6	10.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	14.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRGQ	"FKSG27, IRGQ1"	ENSG00000167378	"Immunity related GTPase Q"	Q8WZA9	19	43584369-43596135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043254, HPA050338"	Approved		Approved	Vesicles		NA	NA		45000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA043254: AB_10794178, HPA050338: AB_2681094"	"unprognostic (1.98e-1)"	"prognostic favorable (5.17e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.48e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.24e-2)"	"prognostic favorable (3.92e-4)"	"unprognostic (2.82e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.65e-2)"	2.3	3.0	6.7	1.5	6.6	7.0	2.4	2.3	8.3	3.6	0.0	2.9	1.5	3.4	1.5	2.8	3.3	1.2	4.5	8.0	4.5	2.5	2.4	3.7	1.0	12.7	5.6	4.3	2.7	2.2	4.2	1.4	5.2	2.8	1.3	3.2	3.1	1.6	6.0	2.9	2.0	1.6	1.5	2.3	2.7	2.2	7.4	1.0	2.6	3.9	1.5	2.7	2.9	3.6	2.6	4.3	3.5	7.1	3.7	2.6	3.5	2.3	1.4	2.6	2.6	3.3	1.5	1.6	3.6	2.8	2.5	3.7	3.3	1.8	1.6	3.1	2.4	2.3	6.0	2.7	2.3	3.1	3.2	2.6	3.6	3.3	1.8	2.8	3.3	2.7	3.4	3.3	2.5	2.2	3.9	2.2	1.8	0.8	2.3	7.2	3.2	1.3	2.1	5.4	6.7	6.0	6.3	6.4	1.8	3.7	4.2	2.8	5.2	8.7	6.3	2.2	3.2	3.4	3.1	2.8	5.2	1.4	7.0	2.3	0.5	0.3	0.2	0.4	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.2	1.0	0.3	0.5	0.5	0.2	0.3	6.7	6.6	2.3	8.3	8.0	4.5	12.7	5.6	5.2	1.5	7.4	3.6	5.3	12.8	18.1	9.8	5.4	6.5	10.9	8.8	8.6	17.1	16.5	11.0	28.8	17.2	10.5	3.7	27.1	5.8	5.0	15.7	1.9	12.6	7.4	12.6	14.5	10.9	36.0	4.4	11.7	13.0	3.8	8.0	9.7	18.6	12.7	18.3	8.2	14.3	8.6	20.2	12.3	14.4	2.0	11.1	9.9	5.7	3.1	12.0	5.4	4.7	7.2	11.9	0.0	9.0	9.1	17.8	8.6	10.5	5.9	18.5	10.5	10.9	7.0	20.8	0.0	13.8	9.3	2.8	2.6	12.5	6.7	7.7	5.3	9.6	11.8	16.4
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731312-226799820	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.4;Theca cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.6	9.7	1.7	2.9	1.6	0.5	11.7	5.2	3.1	14.7	1.8	10.3	3.9	17.4	1.9	3.6	15.0	5.6	5.0	1.6	1.0	3.4	10.5	5.0	1.7	1.8	1.6	20.9	3.5	3.3	1.5	9.5	1.2	7.8	2.7	1.5	3.0	7.0	28.0	5.2	5.1	10.3	2.0	2.0	5.3	0.8	1.6	8.1	20.0	2.9	1.3	11.6	6.6	1.5	5.7	26.0	18.6	0.7	25.0	14.8	0.0	15.6	12.2	20.4	13.0	15.0	14.4	2.3	2.5	10.6	14.0	10.0	1.2	15.0	11.5	5.9	1.0	0.1	1.7	7.1	12.5	0.5	0.1	20.7	8.1	16.1	14.5	12.3	0.0	2.3	3.0	22.7	14.0	22.6	4.9	6.6	7.5	3.6	14.3	1.1	24.1	0.1	9.3	18.9	3.2	0.5	5.0	3.6	8.4	14.9	13.7	0.3	1.3	26.8	24.2	20.9	15.1	10.6	4.6	3.4	26.5	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.2	3.1	1.6	1.0	1.8	1.6	1.2	2.0	1.6	1.5	1.7	19.2	4.6	5.9	2.7	35.4	31.9	29.7	19.4	19.3	36.9	28.1	13.4	14.3	12.8	0.0	0.0	6.4	0.0	13.2	17.6	15.4	1.6	22.1	28.4	2.1	2.4	0.0	17.3	11.4	0.6	28.3	2.0	24.3	0.0	75.4	1.8	57.4	1.7	20.2	31.3	6.5	24.4	1.3	4.6	1.8	22.7	3.6	16.0	15.0	0.8	8.4	0.0	26.7	1.7	11.1	8.2	14.7	9.5	14.5	23.4	3.0	8.1	1.7	13.1	9.5	22.8	1.0	1.2	4.2	23.7	18.3	1.2	110.3	7.7	22.8
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
IRS4	"IRS-4, PY160"	ENSG00000133124	"Insulin receptor substrate 4"	O14654	X	108719946-108736563	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.7;choroid plexus: 8.0;pituitary gland: 5.3"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 2.9;Oligodendrocytes: 1.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 14.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.4;NTERA-2: 1.3;RT4: 3.1;WM-115: 2.2"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.7;hypothalamus: 45.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.5;hypothalamus: 36.7"	HPA017372	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017372: AB_2669600"	"unprognostic (3.74e-3)"				"unprognostic (3.27e-2)"			"unprognostic (1.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.28e-4)"	"unprognostic (8.71e-2)"	0.0	0.0	4.1	0.0	1.3	0.0	0.0	0.0	0.5	1.0	8.0	0.0	0.0	1.4	0.5	0.0	0.2	0.0	0.0	1.3	14.7	0.0	0.0	0.0	0.0	2.0	2.6	4.6	0.0	0.0	5.3	0.0	3.3	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.9	0.0	0.2	0.0	10.6	3.8	1.8	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.5	1.3	14.7	2.0	2.6	3.3	0.9	10.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.5;breast: 16.2;kidney: 28.9;salivary gland: 17.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		7.3	0.0	3.6	0.0	4.2	0.6	16.2	6.8	1.6	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.8	5.4	28.9	0.0	3.1	0.1	16.9	10.2	0.0	0.2	0.2	1.0	0.0	17.5	0.1	0.0	0.1	17.8	0.5	0.1	8.9	0.0	0.0	7.5	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	6.4	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.2	6.8	1.6	1.8	5.4	16.9	10.2	17.5	7.5	6.8	6.4	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751677	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 24.0;salivary gland: 30.6;skin 1: 28.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1"	"Group enriched"	"Detected in many"	5	"midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2"	"Region enhanced"	"Detected in some"		"pons: 5.1"	"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	3.8	0.1	2.0	0.0	2.7	0.0	24.0	4.9	1.0	0.6	0.4	0.7	0.0	0.0	3.1	4.5	0.2	0.0	1.5	0.8	2.8	21.5	0.0	18.1	0.2	20.7	8.2	0.0	2.0	2.9	1.6	5.6	22.3	3.6	0.3	1.1	30.6	0.9	0.3	28.2	0.0	0.0	4.2	0.0	15.7	2.1	4.7	0.5	1.8	0.6	0.2	0.2	2.0	4.2	10.7	0.0	93.2	0.0	5.4	3.9	56.4	5.4	3.4	5.0	4.0	11.8	0.0	0.0	0.0	11.5	0.0	32.0	0.1	24.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	68.9	2.4	20.1	0.0	0.0	0.0	0.0	0.0	3.6	19.1	0.0	0.1	10.2	25.7	0.0	0.0	5.7	0.0	22.7	0.0	3.5	0.0	18.6	39.1	0.0	14.3	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	4.9	1.0	0.8	2.8	20.7	8.2	22.3	4.2	4.7	4.2	5.5	109.0	74.2	0.0	0.2	202.1	17.6	33.1	31.9	1.4	147.4	159.8	2.7	0.0	23.9	7.3	0.0	27.8	1.2	3.0	27.4	0.1	5.0	0.1	0.4	2.9	0.0	0.0	0.0	0.0	18.6	15.0	15.3	0.0	1.3	0.1	0.0	0.0	3.3	0.0	0.0	2.5	14.2	0.0	15.4	10.4	0.0	0.7	19.6	0.0	0.0	0.3	0.0	1.5	0.0	0.3	2.9	0.0	0.1	23.5	0.2	0.6	13.0	2.5	0.0	3.6	14.6	9.4	9.4	20.1	131.3	15.2	0.9	0.0	2.8	8.3
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55324203-55330756	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.8;heart muscle: 9.8;skin 1: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.5;Collecting duct cells: 5.5;Hofbauer cells: 4.7;Late spermatids: 5.1;Melanocytes: 3.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HEK 293: 1.9;RPTEC TERT1: 7.1;SK-MEL-30: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	9.8	0.1	0.2	0.0	0.6	0.0	4.8	1.1	0.3	2.3	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.1	9.8	0.0	1.1	2.7	0.0	1.8	0.1	0.5	0.8	0.2	0.1	1.7	0.2	0.1	0.6	0.2	0.0	1.6	1.9	0.0	2.8	8.9	0.3	0.1	0.2	1.3	0.0	0.4	0.6	2.2	0.6	1.3	1.1	0.0	0.5	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.1	0.0	1.1	4.8	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.3	0.0	1.1	0.5	0.8	0.6	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.5	0.0	7.5	0.4	0.6	1.3	0.0	1.2	5.5	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.8	0.0	0.6	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.7	5.1	0.0	0.1	3.6	0.0	0.6	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.3	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0
ISCA1	"HBLD2, hIscA, ISA1, MGC4276"	ENSG00000135070	"Iron-sulfur cluster assembly 1"	Q9BUE6	9	86264546-86283102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 994.9;Erythroid cells: 315.5;Late spermatids: 804.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA042789	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA042789: AB_10797022"	"unprognostic (1.14e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (4.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.31e-1)"	38.3	48.0	45.6	16.6	47.4	75.6	33.6	50.6	52.1	25.1	45.1	29.8	28.6	29.3	23.4	19.9	29.1	25.8	62.3	47.2	49.5	60.1	45.9	22.4	17.3	46.9	48.4	34.7	27.8	54.8	32.8	35.5	49.4	26.5	26.1	43.3	21.3	31.5	91.7	20.6	24.7	28.5	44.5	19.5	24.9	46.0	47.6	22.1	39.3	105.7	15.7	27.1	19.1	45.7	43.2	30.5	43.6	59.5	83.7	36.9	53.8	45.3	31.9	44.9	26.0	23.7	23.5	28.9	30.5	37.1	33.7	38.2	42.7	35.0	32.5	66.3	29.5	48.2	34.0	44.1	39.4	42.9	25.0	41.7	54.9	30.1	28.8	38.3	36.0	42.4	25.3	54.2	38.9	43.7	48.6	23.5	85.4	62.5	64.4	32.3	57.9	39.6	63.8	41.4	62.7	46.0	39.1	63.0	54.4	41.4	21.5	24.6	29.3	25.7	31.0	45.1	59.7	41.8	87.3	20.5	51.4	29.5	32.1	45.8	14.8	29.5	19.5	12.7	23.1	18.0	23.1	20.2	10.6	14.8	25.1	24.3	24.3	19.7	13.9	17.5	28.8	21.7	45.6	47.4	50.6	52.1	47.2	49.5	46.9	48.4	49.4	44.5	47.6	45.7	61.3	28.9	15.0	14.7	71.2	60.9	78.0	41.2	38.7	52.9	51.7	57.1	44.0	55.8	19.0	29.5	20.9	75.4	107.0	41.7	140.8	67.0	994.9	93.0	40.1	43.6	53.8	315.5	29.0	43.8	90.0	48.8	31.1	54.2	16.5	45.5	44.3	88.3	45.7	67.3	28.1	36.4	46.8	34.7	42.0	804.2	56.5	56.6	55.2	10.3	37.0	58.6	34.0	18.6	22.7	62.2	38.0	48.9	62.7	81.7	64.1	121.4	44.4	49.4	32.9	47.2	56.9	84.3	65.6	41.1	52.6	114.0	85.0	75.9	41.2	56.9
ISCA2	"HBLD1, ISA2"	ENSG00000165898	"Iron-sulfur cluster assembly 2"	Q86U28	14	74493756-74497106	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030492	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030492: AB_10603772"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.89e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.98e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.68e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (5.23e-2)"	15.1	33.9	20.3	9.7	20.6	15.5	16.9	22.4	23.9	13.7	27.4	16.9	14.2	11.0	46.4	15.4	19.5	7.6	34.3	19.5	21.2	30.6	22.0	12.9	17.0	21.2	21.1	18.1	18.1	12.9	23.4	12.8	21.3	18.5	17.5	19.1	17.8	12.1	38.3	13.3	16.0	8.4	21.1	20.0	18.1	20.6	22.6	18.5	26.0	29.2	17.4	13.7	13.4	21.5	43.4	30.7	28.4	18.1	25.5	37.2	35.9	19.7	26.3	30.2	36.3	36.3	39.3	21.8	25.3	16.6	38.2	30.7	27.8	25.9	40.7	30.7	20.2	13.7	13.1	39.6	38.3	17.7	30.2	31.2	29.0	18.2	20.6	28.0	30.8	44.4	18.2	25.5	32.7	51.0	42.9	34.5	21.0	60.2	28.3	29.8	31.9	21.8	42.6	34.1	19.1	19.6	20.8	24.4	31.8	30.5	60.2	20.9	16.9	17.1	39.5	25.3	17.7	43.3	60.3	40.2	28.0	20.6	25.4	130.8	109.1	159.0	91.8	108.0	93.5	172.3	127.6	111.6	111.0	165.4	148.5	122.1	87.5	101.5	106.6	218.1	157.4	161.3	20.3	20.6	22.4	23.9	19.5	21.2	21.2	21.1	21.3	21.1	22.6	21.5	25.2	19.2	20.4	7.2	36.2	15.4	27.2	74.9	13.6	22.1	36.2	38.2	113.3	22.8	42.7	33.1	12.5	70.8	28.8	45.5	146.8	62.0	41.0	38.3	17.6	27.2	29.3	73.2	4.4	55.0	70.1	28.8	24.5	18.1	12.6	31.8	28.9	42.4	81.5	28.6	5.5	36.3	63.1	33.2	18.3	19.3	33.5	30.4	8.8	2.8	49.0	69.8	41.2	3.0	7.2	59.5	50.8	18.0	25.0	40.2	51.4	133.5	78.6	31.6	13.1	15.1	25.1	107.2	63.7	25.4	13.2	25.4	30.7	43.1	42.3	27.6
ISCU	"hnifU, ISU2, NIFUN"	ENSG00000136003	"Iron-sulfur cluster assembly enzyme"	Q9H1K1	12	108562582-108569368	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1430.2;Late spermatids: 969.5;Proximal tubular cells: 1315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB006329, HPA038602, HPA057592"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478"	"unprognostic (1.72e-1)"	"prognostic favorable (4.90e-7)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.73e-7)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-3)"	"prognostic favorable (6.12e-4)"	174.8	387.6	186.3	89.8	187.5	98.2	166.8	209.9	216.8	174.4	222.2	222.9	88.8	170.2	148.8	91.2	142.5	106.5	507.1	186.2	223.0	341.3	119.9	138.3	138.9	223.4	192.5	169.2	106.2	286.0	228.9	111.1	214.4	150.5	112.0	58.9	123.7	196.1	422.3	111.6	142.7	122.2	187.0	163.9	169.2	123.2	188.0	151.6	184.4	381.5	138.3	179.0	133.4	177.0	47.5	113.8	78.9	47.3	277.4	211.6	191.7	92.8	152.2	69.7	65.7	84.9	66.0	47.4	77.9	128.5	74.6	67.5	76.2	106.8	62.5	147.2	82.0	51.8	60.7	190.6	161.5	124.4	59.0	206.6	234.3	75.4	149.3	176.8	107.7	100.7	98.3	148.8	147.8	102.9	98.1	225.4	76.4	70.9	165.7	64.0	52.5	205.3	204.5	134.6	67.4	62.4	67.5	39.7	108.7	98.3	102.2	99.4	92.3	70.3	59.0	56.8	47.8	175.9	207.8	146.3	109.5	91.8	72.4	478.2	182.1	567.9	224.5	200.5	269.2	564.4	292.6	292.7	128.4	516.7	366.2	305.0	554.2	207.5	239.3	225.2	334.2	400.8	186.3	187.5	209.9	216.8	186.2	223.0	223.4	192.5	214.4	187.0	188.0	177.0	129.8	76.9	158.9	19.9	206.3	98.1	148.6	227.0	98.4	46.2	137.5	212.3	674.1	145.8	148.6	233.6	10.4	453.7	142.2	120.1	1430.2	154.3	433.2	78.1	76.5	140.8	75.0	165.5	52.6	149.8	164.0	165.5	64.2	37.1	116.5	89.1	126.0	112.3	263.0	45.4	53.7	117.6	193.3	140.1	110.2	969.5	202.0	129.9	249.1	23.4	502.4	167.9	163.7	14.6	26.0	141.3	96.3	308.4	299.4	171.8	235.9	1315.1	160.4	45.8	223.5	97.4	158.1	294.5	242.1	92.6	93.1	475.2	153.6	154.2	139.8	177.7
ISG15	"G1P2, IFI15, UCRP"	ENSG00000187608	"ISG15 ubiquitin like modifier"	P05161	1	1001138-1014540	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 320.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 497.1;Paneth cells: 403.1;Proximal enterocytes: 461.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 1460.2;BJ hTERT+ SV40 Large T+ RasG12V: 1466.7;HeLa: 501.4;SK-MEL-30: 487.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004627	Approved				"Secreted to blood"	NA	NA	5000000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004627: AB_1079152"	"unprognostic (3.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.11e-10)"	"unprognostic (4.55e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.46e-2)"	46.8	24.3	42.9	36.9	39.8	136.1	39.0	42.0	49.9	79.0	32.6	47.0	42.5	29.6	3.9	24.0	19.9	31.3	55.4	38.3	36.8	73.2	113.5	59.9	29.7	63.2	42.7	17.6	18.9	8.8	40.3	44.8	63.8	28.1	6.9	1.1	320.4	14.1	15.9	13.4	34.8	18.2	134.8	75.3	31.3	10.5	48.7	48.5	34.7	8.1	11.6	29.2	25.7	38.3	58.1	8.5	4.4	38.2	6.0	11.8	33.2	39.5	95.7	1460.2	1466.7	95.6	91.7	51.4	282.0	33.4	248.2	36.1	4.5	17.3	22.7	58.2	23.7	24.3	501.4	65.2	53.8	15.4	94.5	24.6	5.6	92.7	1.8	4.8	46.1	67.7	14.1	27.4	12.0	282.3	50.0	253.5	4.7	36.3	315.3	85.7	11.0	26.1	19.2	18.0	2.0	1.8	77.1	12.6	487.0	1.9	2.9	29.8	25.8	28.5	27.4	13.2	8.7	35.5	19.6	39.6	27.9	60.2	2.7	508.7	278.6	871.3	228.3	425.4	295.5	259.1	258.6	251.7	174.8	215.7	165.2	191.1	663.3	276.7	381.1	59.4	509.7	217.6	42.9	39.8	42.0	49.9	38.3	36.8	63.2	42.7	63.8	134.8	48.7	38.3	240.1	38.5	17.5	1.6	71.8	44.6	47.9	83.7	9.1	2.0	29.3	21.5	24.3	25.8	61.8	46.0	0.0	24.2	213.7	289.1	5.9	134.1	3.5	65.5	66.1	200.5	35.2	8.0	0.6	280.4	497.1	84.5	25.0	95.4	60.9	113.8	70.6	58.2	273.6	0.0	2.2	104.9	63.1	62.0	273.8	14.0	32.9	170.4	88.9	13.1	132.5	21.2	134.9	2.5	0.3	192.0	403.1	41.3	48.7	39.3	461.3	32.1	50.7	3.2	98.6	15.4	179.1	6.2	7.3	7.9	36.9	32.3	169.4	63.0	39.5	55.4
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728766	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.7"	"Group enriched"	"Detected in all"	30	"Early spermatids: 816.3;Late spermatids: 2897.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	12.0	10.5	6.2	11.4	6.1	16.7	10.7	8.3	8.1	10.7	4.9	12.5	9.2	12.9	7.5	18.5	11.5	9.0	10.2	6.9	6.2	11.8	13.5	10.0	14.9	6.1	6.0	13.8	11.7	9.3	9.1	11.9	5.8	11.3	12.3	6.6	11.3	8.0	9.8	14.6	12.0	12.4	5.6	13.3	12.2	95.7	6.0	12.2	9.7	6.6	17.0	15.3	12.4	6.3	29.8	22.6	19.1	20.5	19.4	14.2	29.5	20.4	17.9	26.3	18.2	30.2	21.3	56.7	24.3	15.3	11.9	39.2	47.0	32.2	19.9	28.4	30.6	30.9	16.4	17.8	18.9	73.7	32.3	14.3	32.4	24.6	24.7	17.1	24.2	23.9	49.5	25.4	17.0	40.4	31.8	21.3	62.9	60.3	38.0	37.5	22.3	35.9	19.6	23.8	40.4	48.5	24.8	69.8	21.3	27.8	44.5	45.8	16.2	15.2	22.4	18.8	41.9	33.9	56.3	70.3	13.8	37.1	20.2	28.2	8.7	17.2	8.5	11.0	9.8	7.2	6.5	8.7	8.2	8.6	6.6	7.7	15.1	12.1	12.4	5.5	6.7	6.1	6.2	6.1	8.3	8.1	6.9	6.2	6.1	6.0	5.8	5.6	6.0	6.3	16.4	28.9	43.4	4.9	43.6	52.9	40.4	18.9	46.7	22.4	30.5	23.6	10.1	18.6	29.1	7.3	25.0	34.9	57.7	32.0	17.6	21.2	816.3	21.7	22.8	24.9	31.8	29.8	13.5	17.3	37.5	24.2	26.0	38.5	27.8	22.7	21.4	18.6	21.3	23.5	9.8	32.3	10.2	28.4	38.0	2897.0	29.2	33.2	23.2	2.8	21.6	19.8	36.0	6.0	6.3	23.6	16.7	25.9	38.4	38.0	33.8	13.9	19.5	20.5	26.3	30.2	24.5	48.0	27.3	41.7	60.7	37.5	51.5	23.4	31.5	45.8
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383448-51394730	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9;seminal vesicle: 19.2;vagina: 15.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4"	"Group enriched"	"Detected in many"	5	"hypothalamus: 11.5;thalamus: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 297.1"	"Group enriched"	"Detected in many"	8	"basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 5.8;hypothalamus: 5.4"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.9	1.3	0.4	0.0	1.4	0.0	0.1	0.0	1.8	7.8	0.0	1.1	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.0	0.5	0.0	4.8	0.0	2.2	7.8	1.2	12.0	2.4	22.9	1.1	19.2	0.0	1.1	0.7	0.1	0.0	0.0	10.0	1.6	6.0	4.3	0.3	0.0	0.4	0.7	15.9	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.0	3.8	0.0	0.0	0.3	2.7	0.0	2.5	0.0	0.0	2.2	4.6	3.4	0.0	0.0	7.1	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	3.2	0.0	3.0	0.0	0.0	0.0	19.1	297.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	1.8	0.0	11.5	1.0	0.5	1.2	0.0	6.0	0.2	0.0	0.0	0.0	0.0	0.1	1.5	5.1	11.8	0.0	207.5	0.0	0.0	0.2	0.0	2.8	0.0	4.2	34.4	0.0	0.5	0.0	0.1	17.3	0.0	0.0	1.7	91.6	0.0	0.0	0.0	10.9	6.1	11.7	0.0	0.0	0.0	0.0	0.0	2.7	43.7	0.0	1.9	8.2	0.0	0.4	3.2	0.3	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.8	11.8	0.0	0.0	4.0	2.5	7.3	0.0	1.0	34.2	0.0	0.0	0.2	5.6
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ISLR2	KIAA1465	ENSG00000167178	"Immunoglobulin superfamily containing leucine rich repeat 2"	Q6UXK2	15	74100311-74138540	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 32.1;testis: 13.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.1;Late spermatids: 64.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 32.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SCLC-21H: 57.9;SH-SY5Y: 86.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012930, HPA067333"	Uncertain					NA	NA		110000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA012930: AB_2668772, HPA067333: AB_2685824"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.53e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.44e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	1.7	1.3	9.9	0.6	32.1	0.1	1.6	0.0	16.0	2.7	0.0	1.0	0.6	2.7	0.2	0.7	1.2	1.0	4.6	11.0	3.9	0.3	0.1	0.7	2.1	0.0	0.0	0.2	0.8	0.6	0.6	0.2	0.0	0.4	0.4	1.2	0.7	0.5	2.2	0.6	1.2	1.1	0.0	0.9	0.6	13.6	6.6	0.2	0.4	3.1	0.2	0.4	0.3	8.5	0.0	0.3	5.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	57.9	86.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.2	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	9.9	32.1	0.0	16.0	11.0	3.9	0.0	0.0	0.0	0.0	6.6	8.5	9.8	0.0	0.6	0.7	0.0	0.1	0.0	0.1	0.6	1.9	0.2	0.3	6.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	52.1	0.3	3.8	3.3	0.0	0.0	5.4	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	64.1	0.3	0.2	0.0	6.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.3	0.4	1.9	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498816	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"placenta: 213.4"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 386.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA		1100000		"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.6	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.8	0.8	0.2	0.1	1.2	3.7	0.2	0.4	0.1	0.1	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.4	0.5	213.4	0.2	1.8	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.8	0.0	0.2	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.7	0.2	0.6	0.1	0.3	0.2	0.1	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.0	617.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.7	0.0	0.0	177.5	0.0	0.0	0.0	0.0
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 284.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.2;Proximal tubular cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 270.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	50.4	55.6	39.7	20.0	41.2	21.4	38.3	42.7	52.4	25.4	48.1	62.1	36.2	28.4	8.1	52.2	25.8	17.2	69.5	39.5	43.9	101.4	284.3	26.4	19.2	46.6	44.4	23.3	44.4	39.9	46.3	9.3	43.7	40.9	16.3	3.3	41.8	28.7	95.7	37.6	37.2	16.8	42.6	50.8	41.4	65.6	42.1	9.9	39.1	49.0	14.0	41.6	30.3	44.4	52.8	78.1	20.1	55.6	13.6	28.4	67.7	37.9	36.7	45.7	46.4	40.0	88.2	98.6	66.2	42.2	44.0	51.1	39.7	46.6	14.6	38.9	270.2	57.6	17.8	128.0	55.6	63.2	163.5	42.5	44.2	29.4	22.0	20.4	42.4	39.3	93.6	61.1	28.9	101.9	0.3	73.6	32.4	113.2	217.9	72.1	44.4	126.0	75.0	47.7	24.7	70.5	35.5	75.3	41.4	11.9	63.8	109.4	32.4	34.0	48.5	38.8	44.7	78.7	73.0	78.7	52.2	79.4	58.3	0.7	16.0	0.9	12.7	33.8	12.6	18.7	11.6	16.2	29.5	12.6	11.5	11.8	0.7	24.3	27.8	24.1	15.2	15.0	39.7	41.2	42.7	52.4	39.5	43.9	46.6	44.4	43.7	42.6	42.1	44.4	25.4	6.4	6.3	5.5	38.0	59.5	65.3	148.8	32.5	12.5	51.7	56.5	20.8	48.6	50.3	62.5	2.1	32.5	19.1	200.1	162.4	65.1	44.5	37.8	39.0	36.9	71.3	46.9	3.5	68.1	105.5	44.2	63.7	25.1	45.2	43.2	28.5	272.2	96.0	13.5	5.4	225.4	87.5	44.5	50.6	43.6	38.8	39.0	62.2	2.8	28.0	53.1	21.6	6.6	12.8	56.4	125.8	30.9	80.5	128.7	253.7	479.9	26.1	10.0	26.3	32.0	39.0	183.8	16.4	69.6	68.6	21.6	19.4	123.4	190.7	74.8
IST1	"CHMP8, KIAA0174"	ENSG00000182149	"IST1 factor associated with ESCRT-III"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041802, HPA054532"	Approved		Supported	Vesicles		NA	NA		270000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041802: AB_10794491, HPA054532: AB_2682517"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favorable (8.88e-4)"	47.7	44.1	43.2	38.8	49.7	81.0	50.5	46.2	50.6	49.0	43.9	68.3	52.4	55.9	42.4	50.5	61.4	46.8	50.4	42.9	45.3	68.7	37.9	50.0	64.3	47.2	47.6	60.0	46.9	90.4	57.2	60.1	47.1	45.7	62.9	32.4	52.0	45.8	64.1	52.5	52.0	60.8	45.5	50.6	52.5	47.4	46.1	62.2	59.4	80.8	81.6	53.0	44.3	53.8	57.0	81.9	113.3	73.2	110.7	77.9	95.7	70.0	87.1	95.2	98.9	90.1	77.1	80.5	84.2	81.2	67.7	83.8	112.0	74.2	120.4	53.7	54.1	68.1	46.8	146.9	83.8	66.9	91.9	92.7	100.8	85.5	81.6	94.8	120.6	74.8	94.5	28.7	99.5	94.9	87.4	55.6	129.7	92.7	50.6	135.7	62.0	99.1	78.5	81.8	85.0	63.3	77.2	40.3	63.9	138.2	73.7	82.2	60.7	71.8	70.9	44.5	55.9	75.0	145.5	226.7	60.7	59.2	88.6	234.9	195.1	243.5	158.7	185.4	172.6	179.1	150.6	166.9	180.1	178.5	159.6	150.1	300.0	193.7	185.1	124.9	244.9	293.9	43.2	49.7	46.2	50.6	42.9	45.3	47.2	47.6	47.1	45.5	46.1	53.8	59.7	48.1	51.8	39.8	57.1	70.1	41.2	49.8	39.9	29.2	69.1	50.0	43.9	60.1	48.1	46.0	25.0	56.7	68.4	130.6	35.2	47.1	18.4	50.0	52.8	55.4	75.4	30.7	35.5	41.7	44.3	48.1	42.3	70.1	61.4	55.1	61.1	40.8	53.4	21.9	41.6	76.3	46.8	81.1	73.8	22.5	41.0	57.2	42.7	38.4	75.9	22.2	51.5	34.2	59.7	58.1	88.4	47.8	45.2	51.5	82.2	52.4	56.2	30.3	59.2	45.3	44.4	52.4	57.3	34.4	70.0	65.7	51.8	31.3	57.6	66.4
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161063	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	18.7	13.7	9.1	19.0	9.0	51.6	17.0	9.8	9.6	20.2	7.5	21.6	15.4	19.5	15.1	22.2	15.5	17.4	21.4	8.8	9.1	15.0	10.8	14.1	32.0	9.2	9.3	19.7	15.8	11.2	8.8	22.1	8.9	13.3	16.9	10.4	15.0	12.3	34.9	20.3	16.2	20.3	8.2	18.2	14.9	12.4	8.8	22.7	14.9	21.3	30.1	18.3	19.4	8.9	53.7	20.5	29.6	41.6	35.1	36.4	34.5	39.3	35.0	46.1	44.2	40.6	39.3	67.3	41.3	32.6	40.0	44.8	56.3	31.8	64.9	65.0	26.5	78.0	35.2	32.8	32.7	121.2	53.4	22.9	21.7	40.6	62.3	28.7	37.7	43.2	57.1	33.5	25.2	54.2	73.8	67.1	32.3	55.9	31.3	64.9	67.3	47.5	17.3	33.5	46.8	35.3	72.7	15.7	41.9	16.0	30.3	99.1	45.2	33.5	33.4	49.8	41.6	40.1	26.1	131.9	30.8	69.4	39.0	79.8	57.6	94.2	54.8	56.4	61.4	56.1	55.8	58.7	62.8	50.7	61.0	55.0	90.7	84.8	51.2	54.5	73.5	56.5	9.1	9.0	9.8	9.6	8.8	9.1	9.2	9.3	8.9	8.2	8.8	8.9	26.5	25.6	23.4	0.0	27.4	27.4	16.5	21.3	20.5	19.7	17.0	15.6	19.7	21.5	21.8	9.2	22.9	44.1	38.5	15.8	23.5	26.7	2.8	11.9	23.0	25.3	9.0	29.0	0.0	28.0	41.2	21.8	12.8	21.0	45.6	25.8	26.0	12.3	34.8	20.2	0.0	16.7	16.2	21.1	25.6	1.8	16.1	23.9	10.6	0.0	43.7	20.7	46.4	0.0	0.0	24.4	15.3	16.1	24.1	17.4	18.8	23.2	14.8	19.0	19.7	18.8	20.9	57.4	42.6	20.0	35.8	45.8	32.9	18.7	20.5	16.9
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	7.6	7.2	2.4	10.1	2.8	7.1	7.5	2.4	5.7	7.3	2.5	7.6	3.9	8.1	4.4	5.2	6.9	4.2	5.7	2.3	2.9	7.8	9.6	9.4	8.1	2.5	2.6	9.4	7.2	8.8	5.6	6.5	3.2	7.6	7.4	2.7	6.6	8.3	3.9	5.5	6.7	7.7	2.1	9.2	6.8	5.1	2.7	16.7	7.6	3.7	9.0	7.6	4.6	3.5	26.1	5.7	12.9	11.9	15.8	9.3	5.6	12.2	28.5	19.4	23.6	3.0	13.1	0.9	17.7	22.0	22.2	9.8	5.1	20.4	11.9	9.9	1.0	2.4	2.5	10.2	27.1	10.8	12.9	21.5	10.7	12.1	7.7	19.2	25.4	23.7	4.2	9.9	16.9	10.8	16.3	7.7	9.1	27.7	6.7	13.7	5.6	9.1	20.8	9.9	0.9	5.8	5.8	13.1	18.9	10.7	6.5	10.3	21.0	9.4	7.9	13.5	5.6	14.3	7.0	4.4	10.7	1.1	13.3	0.1	0.5	0.1	0.6	0.2	0.6	0.0	0.6	0.8	0.2	0.1	0.8	0.7	0.6	0.6	0.4	0.2	0.4	0.6	2.4	2.8	2.4	5.7	2.3	2.9	2.5	2.6	3.2	2.1	2.7	3.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363241-34540748	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 139.7;Oligodendrocytes: 260.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	19.5	16.2	13.7	18.1	27.1	27.3	20.0	19.6	17.7	24.5	17.7	21.6	20.2	19.4	16.6	42.8	15.7	17.0	20.2	14.7	15.9	23.3	55.6	18.7	21.4	19.8	20.0	18.8	16.5	23.1	7.8	25.6	21.0	19.6	23.5	25.6	18.7	19.9	17.2	14.0	20.9	21.5	15.9	20.4	20.9	38.5	20.2	23.2	26.3	21.7	25.7	30.6	14.8	45.7	55.5	34.6	35.2	25.9	38.3	57.4	42.7	43.5	52.0	56.2	54.0	101.5	83.8	26.7	42.1	55.6	73.9	66.2	54.9	92.3	66.2	20.8	17.9	78.3	28.2	59.3	43.9	32.6	34.4	31.7	46.2	44.4	72.2	49.8	41.7	40.6	45.5	45.7	46.2	26.5	49.2	18.8	16.9	35.6	44.2	40.9	76.3	63.6	34.7	91.2	21.4	16.4	82.0	32.7	51.0	33.9	38.3	31.1	39.5	61.5	36.0	42.8	33.3	36.2	40.5	40.0	41.0	21.6	38.0	4.6	6.7	7.0	12.0	7.0	12.5	9.2	4.2	6.1	4.9	7.8	3.7	5.7	20.2	7.6	4.9	14.3	5.8	4.3	13.7	27.1	19.6	17.7	14.7	15.9	19.8	20.0	21.0	15.9	20.2	45.7	26.1	12.8	21.8	56.5	33.1	15.0	23.9	11.7	25.6	19.5	15.1	8.5	25.0	12.8	25.6	31.3	25.0	17.5	46.1	28.8	5.9	12.8	59.0	26.5	34.6	20.7	12.0	26.5	85.0	16.3	21.2	24.2	33.1	36.1	19.0	17.9	18.2	53.0	15.8	15.2	72.3	16.9	10.2	24.3	26.7	139.7	22.4	31.4	26.6	68.4	30.0	38.2	43.3	79.4	260.0	22.6	23.7	15.4	50.3	25.8	21.1	26.8	23.5	26.0	13.1	21.4	22.0	40.6	25.5	30.4	16.2	46.9	30.8	12.3	11.9	40.6
ITFG1	"CDA08, LNKN-1, TIP"	ENSG00000129636	"Integrin alpha FG-GAP repeat containing 1"	Q8TB96	16	47154387-47464149	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 285.9;Oligodendrocytes: 263.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015590, HPA019728"	Approved		Approved	"Intermediate filaments,Aggresome"	"Intracellular and membrane"	NA	NA		28000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Intermediate filaments"	Aggresome	"HPA015590: AB_1846347, HPA019728: AB_1846348"	"unprognostic (6.53e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-3)"	25.3	42.2	18.5	16.4	23.8	12.5	25.2	17.1	22.0	28.8	26.0	35.1	30.5	27.8	31.2	19.1	26.3	28.8	44.7	23.7	22.9	47.8	45.4	27.4	13.5	13.6	14.0	28.0	27.3	56.0	15.7	40.7	15.9	29.4	33.1	33.3	21.8	28.9	23.8	12.9	26.7	29.1	16.6	19.3	28.3	36.7	18.5	17.2	43.2	24.6	16.7	24.4	13.8	19.5	22.2	24.8	44.0	31.1	84.1	65.0	54.1	50.7	72.9	45.6	24.3	14.2	51.8	25.9	70.4	63.5	30.9	31.9	21.6	33.0	44.9	11.8	17.0	14.0	22.0	33.2	39.4	32.7	59.6	48.3	55.6	23.3	30.1	96.3	44.4	24.2	40.3	33.5	58.3	21.1	20.2	16.3	14.5	27.4	24.5	31.0	43.4	66.5	60.2	15.9	21.9	30.8	46.0	53.6	24.0	43.7	23.7	29.9	43.0	48.9	23.7	26.3	20.7	47.6	66.7	48.4	48.9	20.6	39.2	17.9	33.9	33.4	16.0	33.0	15.2	16.6	19.0	17.7	25.8	17.2	20.7	17.4	21.2	23.8	33.1	17.5	26.1	29.2	18.5	23.8	17.1	22.0	23.7	22.9	13.6	14.0	15.9	16.6	18.5	19.5	38.9	51.3	28.1	165.9	37.2	38.4	43.4	81.3	27.9	50.8	32.6	23.2	56.8	50.1	62.2	82.8	47.9	100.6	32.3	79.3	9.8	60.5	129.0	33.0	28.7	37.8	61.9	27.8	250.7	52.4	86.4	48.5	41.8	35.0	8.2	54.5	39.3	68.7	50.9	40.4	285.9	43.2	73.2	53.8	30.0	32.0	35.1	41.9	28.4	146.1	45.4	39.4	38.1	214.6	263.5	45.3	37.0	61.3	60.1	35.3	65.2	49.6	54.5	47.4	78.9	30.1	49.8	93.7	98.3	25.5	30.3	114.0	29.9	66.0	38.1	37.4
ITFG2	"FGGAP1, MDS028"	ENSG00000111203	"Integrin alpha FG-GAP repeat containing 2"	Q969R8	12	2812622-2859791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038664, HPA038665"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038664: AB_10672722, HPA038665: AB_2676138"	"unprognostic (5.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.24e-1)"	"unprognostic (5.89e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.43e-2)"	12.8	15.6	6.0	11.4	8.1	14.4	14.0	10.2	8.1	17.7	10.7	14.2	12.4	18.7	14.5	13.1	17.1	8.9	12.1	5.9	9.2	16.4	12.2	15.0	15.9	7.7	7.9	28.9	22.1	28.1	14.1	14.5	8.1	13.9	15.0	8.1	17.9	15.6	8.3	11.7	14.5	13.4	6.2	19.6	16.1	5.1	8.0	18.1	26.7	9.7	15.8	14.7	14.9	11.8	7.3	10.6	11.9	9.7	10.2	11.6	11.0	15.9	9.0	18.9	13.8	22.7	17.6	16.5	4.4	15.0	9.4	9.1	18.5	15.9	14.1	14.7	10.6	23.1	12.7	9.1	18.8	21.7	12.0	15.7	18.4	17.3	26.4	15.5	13.1	15.6	12.8	17.3	10.9	21.9	31.3	12.6	24.6	16.5	8.0	15.6	13.3	9.5	11.3	12.3	5.7	18.3	19.5	17.1	7.2	16.2	10.6	9.9	13.4	12.4	7.4	12.0	30.8	2.2	1.4	25.0	8.0	12.4	12.8	4.0	16.6	8.4	19.2	22.2	18.0	25.8	14.7	19.0	19.6	24.2	19.8	18.6	1.9	23.4	35.6	14.6	13.2	16.5	6.0	8.1	10.2	8.1	5.9	9.2	7.7	7.9	8.1	6.2	8.0	11.8	11.1	12.8	17.9	12.7	35.9	3.3	9.8	9.3	10.2	39.8	16.5	15.6	17.1	18.6	12.1	12.9	64.6	28.1	27.6	13.0	11.7	9.2	46.3	13.0	19.1	10.5	9.5	17.9	13.6	7.2	8.9	15.0	23.0	13.2	6.3	18.7	12.1	11.3	13.4	32.0	15.2	15.2	8.2	12.0	5.1	12.1	16.8	11.0	1.8	8.4	16.8	10.0	42.2	10.1	25.8	7.2	14.4	13.2	19.6	9.1	20.5	6.1	8.7	56.0	6.6	11.7	16.9	13.2	20.0	14.3	4.0	17.4	24.3	22.2	19.5	5.9
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain					NA	NA		6300000		"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	13.9	22.4	0.6	1.0	0.8	0.0	10.2	0.7	0.9	5.1	0.4	36.6	1.1	16.3	2.5	5.7	9.9	2.2	10.6	0.5	0.8	11.0	17.1	22.1	0.8	0.8	0.8	3.6	3.1	2.1	2.3	5.8	0.8	12.6	2.7	0.1	2.3	7.2	4.6	2.3	12.5	5.8	0.8	27.9	16.6	0.8	0.8	0.2	9.7	2.5	0.4	17.9	5.1	0.9	0.0	0.0	0.3	0.0	1.4	0.4	0.1	0.3	1.3	0.3	0.7	0.7	0.0	0.0	0.1	4.5	0.5	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.3	0.3	4.5	0.0	0.0	0.7	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.5	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.7	0.9	0.5	0.8	0.8	0.8	0.8	0.8	0.8	0.9	264.1	54.5	26.8	2.9	1.7	3.2	4.7	1.5	2.8	1.8	3.6	13.8	12.6	5.7	8.7	5.5	2.1	1.5	2.9	5.5	1.9	3.0	21.3	7.7	41.8	120.5	16.4	5.3	3.6	5.4	16.8	40.2	6.1	22.1	10.1	1.0	77.1	110.5	2.2	0.0	19.5	14.0	0.0	7.2	8.2	6.1	9.3	5.6	7.2	63.7	9.1	0.4	0.0	1.5	4.2	19.6	7.7	8.2	2.9	3.2	6.5	15.1	6.3	2.0	98.6	18.6	143.9	0.9	1.1	0.5	3.1	3.4	46.0	13.6	14.0	2.3
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296532-68432163	"Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.3;endometrium 1: 53.1;smooth muscle: 25.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.8;Excitatory neurons: 13.4;Fibroblasts: 30.1;Microglial cells: 18.7;Peritubular cells: 13.5;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 119.5;hTERT-RPE1: 174.5;U-138 MG: 80.6;WM-115: 45.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.3;spinal cord: 2.1"	HPA051813	Uncertain					NA	NA		260000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	6.5	3.4	0.2	1.1	1.5	0.2	3.2	0.7	1.1	26.3	0.4	2.1	0.8	53.1	13.5	1.5	12.0	2.4	12.7	0.2	0.3	6.5	0.7	1.7	0.5	0.2	0.2	4.6	0.8	0.4	1.8	1.5	0.1	5.2	1.3	0.4	1.2	7.4	2.1	2.7	1.6	25.0	0.1	3.2	1.6	0.9	0.1	0.2	2.0	2.4	0.1	3.9	8.2	0.5	0.0	0.2	0.4	0.9	3.7	0.1	0.1	7.9	15.1	1.6	0.5	0.1	0.2	0.1	0.6	119.5	2.1	0.2	0.0	0.0	0.4	0.0	0.2	0.5	6.8	0.0	10.8	0.2	7.0	1.5	0.0	3.1	0.3	174.5	0.0	0.1	0.2	0.3	20.9	0.1	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	5.5	0.1	0.1	18.5	0.1	0.5	5.0	80.6	0.7	2.1	0.1	0.2	0.0	0.1	13.5	0.2	45.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	1.5	0.7	1.1	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.5	2.9	0.0	0.0	0.3	0.3	0.8	0.5	0.0	0.6	3.9	1.0	7.0	13.8	0.0	0.0	1.8	0.0	0.0	0.3	0.1	1.9	0.3	0.3	0.2	0.8	1.1	0.0	0.0	13.4	0.0	0.1	30.1	1.5	0.3	0.0	0.2	2.2	0.5	0.3	0.0	0.7	0.0	0.0	0.6	1.2	0.5	6.8	0.6	0.0	18.7	0.0	0.3	0.0	0.0	0.5	0.2	0.0	13.5	0.2	0.3	0.1	0.3	0.0	1.6	19.7	2.7	5.4	0.0	0.2	0.2	0.4	0.1	0.6	0.2	0.0	0.3
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;epididymis: 10.7;lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 64.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 64.5"	"Group enriched"	"Detected in some"	14	"HEL: 404.6;HMC-1: 631.7"	"Not detected"	"Not detected"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		90000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.8	0.2	3.7	0.2	3.6	16.6	0.4	4.0	4.8	1.5	3.8	0.3	0.0	0.9	10.7	0.3	1.5	0.8	1.4	3.5	3.6	1.0	0.5	5.1	0.2	3.6	3.5	1.5	0.1	1.3	1.9	1.1	3.6	0.6	0.1	1.6	0.1	0.8	0.6	0.1	0.3	0.2	3.3	11.2	0.3	2.9	3.5	0.1	3.1	1.1	0.1	0.2	0.7	3.7	0.5	0.7	2.2	0.3	0.1	0.3	18.4	0.3	0.1	0.8	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.6	1.8	0.0	0.4	0.4	1.1	404.6	0.3	1.3	0.0	0.2	631.7	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.7	1.1	0.0	0.7	0.5	36.4	0.8	0.0	0.7	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.5	0.5	0.1	1.5	4.5	0.9	0.3	0.2	0.7	0.0	0.0	0.4	0.2	0.3	0.4	0.3	0.8	64.5	0.3	4.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.5	0.0	0.0	0.8	0.0	19.3	3.7	3.6	4.0	4.8	3.5	3.6	3.6	3.5	3.6	3.3	3.5	3.7	0.3	0.0	1.5	1.0	0.4	0.3	0.4	0.1	1.8	5.1	0.2	1.1	1.5	1.5	1.3	5.5	8.4	1.3	0.1	0.6	0.0	0.0	16.1	1.0	0.7	2.1	0.0	43.5	4.1	0.0	1.4	1.1	0.0	3.2	17.8	0.1	3.6	0.0	0.2	3.3	2.8	0.0	0.0	3.1	0.7	24.8	1.8	23.0	0.0	1.0	2.9	1.3	0.0	9.5	4.6	0.1	0.0	1.9	0.1	0.3	0.0	0.0	0.0	3.0	0.0	1.8	0.7	3.4	7.4	0.5	0.0	0.7	0.6	0.1	0.3	0.3
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	17.5	29.8	5.3	9.9	5.4	0.4	17.3	6.0	6.1	14.8	5.2	25.4	30.4	21.3	11.7	24.1	24.5	17.9	13.2	5.0	10.9	68.9	2.2	65.8	3.0	7.5	6.6	12.8	15.9	17.7	21.1	26.7	11.9	19.5	15.5	4.4	19.4	15.7	9.0	30.8	26.7	15.6	4.2	11.1	24.5	2.1	7.8	5.9	43.5	4.1	6.2	46.7	17.1	4.0	181.8	234.9	1.4	7.5	4.3	17.5	37.3	83.4	177.9	123.1	93.2	5.3	276.2	0.4	507.9	59.5	400.4	126.8	2.2	647.2	73.9	22.9	3.5	0.1	56.8	1.6	105.1	0.3	5.0	21.6	313.5	123.2	540.7	572.8	91.6	9.1	0.1	2.6	236.0	52.9	0.7	0.5	5.5	81.2	141.0	0.4	12.1	13.7	562.0	311.1	9.7	3.9	89.8	12.2	205.0	56.2	21.1	2.4	200.8	541.8	169.4	5.6	329.5	8.1	14.2	5.9	920.8	1.9	570.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	5.4	6.0	6.1	5.0	10.9	7.5	6.6	11.9	4.2	7.8	4.0	8.5	54.5	30.1	3.6	3.4	57.4	63.5	63.5	48.3	18.0	17.1	32.0	5.3	27.1	26.2	77.3	25.0	2.8	1.3	91.2	0.0	111.9	0.5	26.4	3.1	14.7	14.5	0.0	24.3	105.1	3.2	5.3	47.4	20.7	3.8	3.4	8.9	0.3	1.1	3.3	20.0	25.1	16.2	1.2	8.2	0.6	1.8	2.0	17.8	8.4	4.3	3.1	2.1	3.0	0.8	245.6	26.7	4.1	4.5	72.6	69.6	4.4	21.7	16.2	13.1	5.6	23.4	0.5	1.6	17.0	23.2	1.8	3.8	0.9	44.7	104.2
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419266	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 398.8;smooth muscle: 361.9;urinary bladder: 386.5"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 101.5;Extravillous trophoblasts: 391.9;Hepatic stellate cells: 88.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 615.4;HUVEC TERT2: 1360.8;TIME: 1277.7;U-87 MG: 623.6"	"Region enriched"	"Detected in many"	5	"basal ganglia: 10.4"	"Low region specificity"	"Detected in many"			"HPA002642, CAB009008"	Enhanced					NA	NA		26000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavorable (4.07e-6)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavorable (2.91e-4)"	"prognostic unfavorable (2.23e-5)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (2.18e-3)"	114.4	47.1	8.7	136.2	9.2	46.4	69.1	9.2	13.8	64.0	9.7	398.8	15.3	106.1	5.0	72.3	71.1	50.8	113.9	8.5	9.0	26.6	48.6	121.7	17.5	11.3	9.9	39.3	20.9	14.9	10.5	91.6	11.3	141.9	40.6	1.3	24.5	114.9	29.1	50.5	87.6	361.9	10.6	16.3	90.8	4.0	17.1	13.2	40.5	25.7	12.5	386.5	76.9	9.8	65.4	23.9	43.6	0.6	130.8	278.7	113.5	286.0	308.2	300.9	220.6	17.1	15.3	0.5	206.9	308.5	149.1	10.1	12.5	81.4	197.4	0.4	12.2	28.1	31.3	1.1	179.5	88.7	44.4	206.8	39.2	351.9	258.3	615.4	1360.8	15.6	25.6	0.8	165.4	6.4	13.7	99.2	18.1	4.2	19.1	13.7	29.2	6.2	46.9	1.1	0.1	0.6	57.7	4.3	2.2	93.8	7.1	79.9	1277.7	353.0	62.3	85.9	121.5	0.3	3.6	0.7	623.6	83.0	118.5	16.4	64.9	0.5	14.2	27.3	11.2	0.1	10.9	10.9	62.6	0.3	7.7	6.6	89.1	26.4	24.0	3.4	4.9	42.9	8.7	9.2	9.2	13.8	8.5	9.0	11.3	9.9	11.3	10.6	17.1	9.8	58.3	3.2	4.4	1.6	2.7	14.3	3.4	11.3	4.0	1.1	6.1	2.8	16.3	14.3	4.9	0.0	0.0	5.4	19.6	0.0	0.0	34.0	0.3	1.7	32.1	101.5	0.0	3.4	1.4	3.4	391.9	45.0	0.5	3.0	19.7	5.1	88.9	27.1	28.4	0.0	1.2	0.0	2.0	22.8	58.5	0.5	6.5	38.5	10.6	14.0	24.6	0.0	21.6	0.0	0.2	8.8	0.0	4.5	8.7	3.6	0.0	0.2	1.8	1.1	13.1	11.1	30.7	0.2	0.7	1.3	10.7	34.6	14.3	2.4	0.0	2.0
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 144.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.9"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		3300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	45.9	8.3	20.1	27.8	16.7	5.8	55.6	16.6	20.3	64.3	42.8	65.4	74.2	43.1	9.5	25.1	25.3	37.2	29.2	17.2	20.9	42.7	8.8	29.3	18.7	20.8	18.8	5.6	42.0	14.0	6.2	76.8	19.3	24.4	62.4	7.3	81.0	30.8	27.7	46.6	67.4	39.0	20.5	41.2	66.1	26.1	25.0	33.9	21.1	42.6	21.4	55.0	26.8	16.5	77.5	64.8	26.7	49.1	1.4	0.9	146.3	326.2	34.6	32.1	20.0	36.2	141.3	0.7	90.9	86.8	73.8	356.8	17.7	705.8	58.1	0.7	16.6	1.9	64.8	58.7	4.8	21.4	2.4	6.2	298.9	2.0	301.4	32.9	209.6	40.8	0.3	5.5	41.6	3.7	5.9	17.8	48.2	214.2	54.5	1.1	82.3	1.6	48.0	106.6	0.8	3.4	61.2	0.1	69.7	28.0	13.1	1.4	97.9	44.9	41.1	84.2	56.8	4.8	3.6	1.9	1.7	7.2	185.0	4.4	0.2	22.9	5.3	0.0	10.7	0.2	6.7	6.4	0.1	0.5	12.8	5.9	0.7	7.1	0.0	0.0	8.1	4.3	20.1	16.7	16.6	20.3	17.2	20.9	20.8	18.8	19.3	20.5	25.0	16.5	327.2	9.6	19.5	88.5	8.8	244.7	236.4	43.4	88.8	1.4	55.0	72.8	32.5	22.8	10.5	27.6	56.3	103.8	14.4	139.6	5.9	34.4	31.2	82.5	34.8	196.0	57.4	1.7	4.0	62.1	26.5	20.8	219.7	149.3	8.2	103.4	11.7	21.5	25.5	1.7	6.1	128.8	20.3	3.2	20.8	46.8	4.1	10.0	51.6	119.9	1.7	1.3	29.9	1.5	8.8	127.9	104.2	2.6	109.0	184.8	54.5	52.2	9.2	13.9	0.0	11.8	18.4	7.7	20.2	141.5	84.0	22.3	30.1	44.0	146.3	247.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513954-15719922	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 14.1"	HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		200000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	8.6	10.5	1.6	2.1	2.1	0.1	2.7	1.9	5.0	23.8	8.0	6.1	6.7	9.7	5.5	9.8	8.8	6.7	7.7	7.0	0.9	10.0	0.7	20.8	3.2	1.5	2.8	5.7	0.8	4.7	3.2	0.2	1.1	37.4	6.1	1.6	1.8	30.8	2.9	3.3	6.8	9.1	1.5	19.9	19.3	0.6	1.5	1.0	5.6	6.9	4.4	15.7	9.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	8.4	2.5	0.0	0.0	0.0	0.0	19.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.7	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.9	5.0	7.0	0.9	1.5	2.8	1.1	1.5	1.5	2.2	1.2	0.0	1.3	0.7	2.4	1.0	1.9	0.0	0.6	6.3	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.0	11.4	0.0	0.0	82.8	0.0	0.0	10.1	0.0	0.2	0.0	0.0	4.2	0.0	0.1	0.0	56.1	0.0	0.0	0.0	1.8	0.1	0.9	0.5	1.8	34.7	0.0	13.6	0.0	64.8	4.0	0.0	0.0	0.0	25.5	1.5	0.0	0.0	0.0	0.3	52.6	11.3	57.6	0.0	0.2	0.4	1.1	0.0	1.2	0.1	0.1	1.4
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823507	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 23.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		500000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.8	15.5	1.9	4.5	1.8	8.5	5.9	0.0	6.2	21.8	3.6	9.6	6.3	10.6	4.0	15.5	5.4	9.4	20.1	7.8	0.7	4.0	14.8	8.9	4.1	0.9	1.3	5.0	1.8	2.6	1.7	9.8	0.4	12.5	6.8	0.7	4.2	10.8	2.8	3.0	9.1	15.8	0.7	22.6	7.5	6.9	5.0	1.8	20.7	9.8	2.4	6.5	4.5	1.2	0.2	0.0	4.3	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	10.1	0.0	3.2	1.4	0.0	0.1	0.2	3.8	0.0	0.0	0.1	0.6	8.1	0.1	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.4	0.3	0.0	0.2	0.5	11.8	0.1	0.5	0.7	16.9	0.0	3.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.0	6.2	7.8	0.7	0.9	1.3	0.4	0.7	5.0	1.2	20.8	0.0	14.7	16.0	0.1	2.5	1.1	0.1	1.2	1.2	1.1	2.9	12.9	2.8	3.1	1.8	0.0	0.2	0.0	0.0	0.0	0.1	1.5	1.4	4.9	21.6	0.0	3.0	82.0	0.0	0.5	7.5	0.0	0.9	6.3	36.2	54.3	1.3	2.8	0.0	61.0	0.1	0.0	31.9	2.2	4.2	41.3	5.7	3.6	53.4	0.1	0.6	0.0	93.5	6.2	0.0	0.0	74.9	0.4	0.2	0.0	0.1	0.0	0.0	0.0	3.2	3.3	0.6	0.9	0.0	1.7	0.3	1.8	25.9	0.4	0.3
ITGAD	"ADB2, CD11d"	ENSG00000156886	"Integrin subunit alpha D"	Q13349	16	31393335-31426505	"CD markers, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 20.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.1;Kupffer cells: 4.2;Late spermatids: 1.0;Macrophages: 1.6;T-cells: 2.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA026786	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA026786: AB_10603773"	"unprognostic (2.79e-2)"	"unprognostic (2.39e-4)"	"unprognostic (2.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.44e-4)"	"unprognostic (6.99e-3)"	"unprognostic (6.89e-3)"	"unprognostic (5.02e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.51e-2)"	0.2	0.0	0.0	0.8	0.0	3.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	1.3	0.3	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	20.5	0.1	0.2	0.1	1.2	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.4	0.0	0.8	0.0	0.2	0.0	0.0	4.2	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801188	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;intestine: 5.9;lung: 6.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.7"	"Cell line enriched"	"Detected in single"	22	"MOLT-4: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036313, HPA052147"	Enhanced					NA	NA		38000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA036313: AB_10795355, HPA052147: "	"unprognostic (9.81e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (8.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (3.56e-4)"	0.2	0.0	0.2	1.1	0.6	6.5	0.7	0.0	0.5	0.3	0.1	1.7	3.6	0.2	0.2	0.8	0.5	1.7	0.0	0.1	0.1	0.0	0.1	6.6	0.5	0.1	0.2	0.4	0.1	0.1	0.0	0.1	0.1	0.3	1.5	0.0	1.2	0.4	0.0	0.4	5.9	0.2	0.1	0.8	2.8	0.7	0.2	4.2	0.3	0.0	1.5	0.9	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	12.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.6	1.6	0.1	0.5	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.5	0.2	0.6	0.0	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	32.7	6.4	25.7	10.4	65.4	30.0	38.9	74.2	33.0	15.8	45.0	58.5	59.6	38.6	33.9	14.7	8.4	27.6	62.5	25.1	92.0	35.6	54.5	39.8	35.3	34.0	28.2	36.2	8.9	65.6	58.5	42.4	18.8	47.0	67.4	22.8	42.8	53.2	53.0	6.7	7.8	25.1	67.1	42.3	44.9	40.3	26.8	50.8	58.7	1.9	54.1	61.1	53.5	9.0	15.7	56.8	21.3	29.7	61.1	48.8	40.3	81.5	31.3	19.6	26.3	21.3	43.7	107.3	33.3	53.8	41.3	13.1	68.0	35.0	39.3	38.5
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 182.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 50.0;NB-4: 19.9;U-937: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		1000000	"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	13.4	4.7	3.4	24.7	3.5	182.8	3.0	4.5	4.2	3.3	4.8	3.0	2.2	2.0	0.7	2.6	2.3	5.9	2.9	3.6	5.1	1.0	3.5	16.4	7.4	6.7	5.7	1.6	2.3	1.3	0.1	7.7	7.3	1.5	3.4	0.3	2.4	2.2	1.4	1.7	3.5	11.2	6.5	13.1	3.1	1.4	8.6	5.2	1.0	3.1	10.4	8.0	0.2	10.8	0.8	1.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.5	0.8	1.3	0.9	0.0	0.4	0.1	0.0	0.4	0.0	7.6	0.0	1.0	0.0	0.0	0.0	1.8	50.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.3	0.1	1.0	0.0	2.2	0.0	0.0	0.0	0.5	0.4	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	22.6	0.1	93.3	55.7	70.2	31.1	20.9	1.9	4.8	3.3	9.5	9.5	1.0	0.9	7.7	58.4	54.4	3.2	0.6	1.2	27.0	3.4	3.5	4.5	4.2	3.6	5.1	6.7	5.7	7.3	6.5	8.6	10.8	1.4	3.2	9.8	0.7	9.3	1.1	0.3	1.5	0.0	0.0	1.8	3.8	2.3	4.3	1.8	0.0	0.0	0.3	45.4	0.0	0.0	1.2	0.5	0.3	0.4	1.6	3.6	9.4	1.0	0.0	0.7	1.1	1.1	0.5	35.5	0.5	2.2	1.2	47.2	0.0	1.0	0.1	0.0	117.7	45.5	1.8	0.3	83.2	0.0	41.2	87.4	0.0	75.2	3.0	0.3	0.9	0.0	0.0	4.5	0.5	0.0	0.2	0.9	0.0	13.1	1.2	0.5	0.7	0.9	0.5	1.0	0.8	14.9	0.0	0.3	0.2
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590056-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RT4: 369.7;SuSa: 297.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	39.9	38.7	20.1	36.5	30.8	6.4	27.7	39.7	23.5	39.7	40.3	20.1	15.9	36.8	10.5	24.5	26.3	47.3	80.0	18.2	32.7	52.1	18.0	25.7	15.8	42.5	33.0	64.7	25.7	82.7	11.9	47.4	46.4	29.8	21.6	80.4	32.1	28.1	16.3	41.4	16.3	56.7	45.3	21.4	34.2	14.7	30.2	18.0	62.6	30.5	21.6	43.1	16.0	54.6	49.1	57.5	37.4	119.9	134.1	90.0	141.7	93.8	75.5	32.5	32.5	50.7	164.0	0.4	179.7	106.3	113.4	60.2	19.3	88.5	46.7	9.7	17.2	11.7	69.1	69.6	52.8	8.3	7.0	65.8	41.3	72.7	61.1	194.1	78.7	5.9	11.6	23.9	87.4	19.4	5.0	6.8	28.3	29.1	28.5	0.1	76.2	6.8	83.5	369.7	7.7	23.0	108.6	33.2	40.1	297.0	26.2	22.4	240.5	199.4	61.9	41.4	80.3	5.9	10.4	5.5	80.3	3.3	100.6	6.2	0.6	0.9	0.4	1.1	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	20.1	30.8	39.7	23.5	18.2	32.7	42.5	33.0	46.4	45.3	30.2	54.6	39.8	28.9	22.9	134.8	4.9	128.4	64.0	127.7	42.7	118.4	50.4	23.4	145.5	80.1	35.3	77.3	77.2	55.1	9.4	32.4	1.9	78.7	0.6	61.7	61.1	47.2	7.3	2.1	36.3	101.8	26.9	65.4	57.6	100.2	49.5	21.2	27.8	18.2	27.6	15.2	35.9	19.9	14.2	44.3	56.7	3.1	19.3	29.3	46.2	75.9	17.4	70.9	2.1	184.5	156.1	165.9	23.8	25.9	9.2	103.4	11.2	32.4	27.0	60.2	32.9	29.0	63.3	1.7	2.4	27.7	103.7	39.7	10.9	18.1	15.5	77.7
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 51.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 5.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		38000000	"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	8.0	0.6	0.3	9.5	0.7	6.2	5.3	0.7	1.0	3.8	1.0	16.9	3.5	13.2	2.6	4.2	7.6	3.5	5.5	0.5	0.8	15.0	3.4	5.6	0.9	2.3	1.0	1.5	0.7	1.2	1.2	4.5	2.0	4.8	7.0	0.9	2.6	16.1	1.5	2.7	5.8	22.9	1.2	2.9	3.8	2.5	1.2	0.3	51.4	2.4	1.2	9.6	2.6	1.1	0.1	1.5	0.7	0.1	8.6	3.8	0.1	4.7	23.1	9.6	8.6	0.3	0.1	0.6	167.8	1.2	13.4	0.0	0.1	0.0	12.6	3.4	0.0	163.4	0.5	0.0	7.8	0.0	0.2	3.4	0.0	54.6	1.4	6.7	43.6	2.5	0.5	0.3	2.1	0.0	1.0	0.1	0.1	0.0	0.8	0.0	4.2	0.0	109.8	0.2	0.0	0.5	5.6	0.0	33.2	8.8	0.1	0.2	47.1	2.1	2.4	1.3	11.7	0.2	0.1	1.1	78.3	0.0	255.9	5.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.0	6.8	0.3	0.7	0.7	1.0	0.5	0.8	2.3	1.0	2.0	1.2	1.2	1.1	1.3	0.0	0.0	0.0	0.5	0.1	0.2	0.9	0.0	0.0	0.1	0.3	0.8	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	3.9	0.8	0.9	3.1	0.0	0.0	0.4	0.4	0.0	2.1	0.0	0.9	0.0	0.6	1.8	0.7	0.8	0.0	0.6	0.0	0.0	0.3	0.7	8.8	0.3	15.8	0.0	1.0	0.4	0.0	0.0	0.0	0.4	1.5	0.0	1.2	0.0	0.3	0.0	4.6	0.2	0.0	6.6	0.3	2.1	0.0	2.0	0.1	0.4	1.2	0.3	0.4	0.0	0.2
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028463	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favorable (4.32e-4)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavorable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	6.8	11.5	2.3	7.9	2.3	11.9	15.0	2.5	4.6	7.8	3.7	10.7	8.0	8.8	15.9	9.0	9.3	10.8	4.4	2.2	2.5	12.6	6.4	7.2	18.0	2.5	2.4	14.1	10.1	18.2	5.3	10.1	2.5	8.7	10.1	2.8	7.8	6.2	2.5	9.1	6.0	5.6	2.4	8.9	8.0	20.6	2.3	20.2	13.5	4.4	16.4	10.1	8.3	2.6	63.6	32.9	35.9	28.6	8.6	25.2	32.3	30.3	18.7	51.6	63.4	18.2	29.0	57.4	22.6	7.3	26.2	44.3	28.2	30.8	63.7	43.4	74.2	43.9	41.3	35.1	9.2	60.4	27.6	6.5	22.4	29.9	23.5	24.3	26.6	34.5	51.5	74.6	7.3	27.8	66.4	57.0	45.5	24.1	38.2	42.5	61.4	84.7	34.8	19.4	46.1	28.8	34.7	20.0	50.4	53.0	19.9	20.0	16.1	17.9	26.1	36.6	46.2	37.1	64.1	54.4	30.0	75.4	27.7	14.2	4.0	1.4	6.5	3.2	11.3	15.9	10.2	10.6	5.1	15.4	11.3	10.2	1.1	15.6	3.9	8.8	12.2	6.7	2.3	2.3	2.5	4.6	2.2	2.5	2.5	2.4	2.5	2.4	2.3	2.6	22.0	9.6	13.9	24.2	40.9	33.9	56.3	49.8	34.7	10.7	35.9	43.7	11.5	28.6	38.2	25.8	10.4	45.9	19.3	10.1	29.4	42.2	100.8	45.2	22.1	21.6	17.4	40.0	23.6	34.3	56.3	28.6	20.4	21.1	23.5	40.7	23.9	9.7	30.0	6.7	23.6	18.1	42.7	21.0	26.1	121.4	21.5	18.9	21.4	15.0	23.7	21.2	30.9	18.6	31.0	24.8	4.1	25.9	30.7	13.7	6.0	39.1	54.3	15.8	32.9	18.2	21.9	200.5	54.4	30.8	32.7	19.2	26.6	13.6	31.9	35.8
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 200.6;skin 1: 205.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 173.6;Distal enterocytes: 133.3;Gastric mucus-secreting cells: 165.1;Pancreatic endocrine cells: 284.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 897.3;HaCaT: 345.1;HBEC3-KT: 768.6;hTCEpi: 256.9;RT4: 254.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 37.4"	"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		980000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	39.2	5.3	82.8	12.4	87.8	1.6	66.6	74.9	91.8	58.4	76.4	87.5	56.9	24.0	3.6	101.2	43.8	20.0	22.7	80.5	86.9	18.2	5.6	18.4	4.5	104.6	104.8	8.5	24.5	2.8	21.1	35.4	82.6	85.3	15.7	8.7	200.6	18.5	6.8	205.9	75.5	6.4	102.4	76.9	79.9	4.9	82.0	4.1	17.6	6.0	7.2	58.4	98.8	99.6	172.7	148.5	0.3	2.1	0.4	1.3	199.2	0.7	0.6	0.5	0.9	16.1	897.3	0.1	31.5	0.3	1.3	345.1	1.0	768.6	0.5	0.7	0.6	0.9	39.6	17.0	1.2	0.2	1.8	1.1	256.9	0.6	159.2	18.0	5.5	0.6	0.5	15.7	0.1	95.8	2.0	2.0	1.0	92.8	127.8	2.7	4.4	2.2	204.8	254.9	0.2	1.9	4.9	15.2	2.2	5.3	63.9	1.5	16.9	4.6	7.8	0.7	1.9	5.6	2.1	0.7	2.0	0.8	2.7	0.0	0.2	0.0	0.4	0.4	1.1	0.7	0.1	0.5	0.0	2.0	0.4	0.3	0.7	0.0	0.0	4.6	0.8	0.4	82.8	87.8	74.9	91.8	80.5	86.9	104.6	104.8	82.6	102.4	82.0	99.6	26.9	12.8	2.2	50.3	1.4	49.5	45.1	173.6	67.2	0.3	21.2	36.6	7.5	25.8	38.9	23.9	2.1	89.8	1.8	133.3	1.9	33.3	0.4	61.3	5.7	26.8	9.6	0.8	0.7	28.8	20.2	5.2	165.1	60.2	2.5	1.1	17.9	0.4	9.4	0.0	0.7	59.2	18.3	0.3	5.4	0.4	3.7	1.9	12.4	1.9	0.1	34.4	0.0	1.5	0.7	284.4	68.4	1.5	2.6	17.1	94.0	2.6	53.3	1.0	0.0	1.2	5.0	1.1	8.2	28.1	13.1	111.1	1.8	0.5	60.1	42.0
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		64000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	102.7	32.5	24.4	26.0	33.4	3.3	71.3	32.6	20.3	84.7	71.0	48.1	33.1	75.9	16.4	54.9	33.2	71.7	68.8	24.6	28.7	48.6	51.4	53.9	6.0	38.2	32.9	28.0	23.1	21.8	20.5	82.3	35.4	37.3	24.9	14.3	49.6	46.9	30.0	88.9	32.5	60.1	32.3	41.0	29.7	13.5	32.5	12.2	34.3	33.7	9.9	40.3	70.0	35.8	189.1	459.9	32.4	82.7	296.6	84.2	166.3	197.5	120.0	35.9	57.6	92.6	240.3	0.8	93.5	336.3	177.0	148.0	29.5	102.7	31.2	2.0	20.1	66.3	69.5	98.0	51.0	0.4	116.8	51.2	23.2	91.1	46.9	508.7	121.2	0.2	60.7	98.1	122.7	190.0	0.8	1.1	145.8	105.1	50.4	0.4	52.2	71.8	98.8	41.2	0.9	67.5	146.6	214.5	165.7	56.4	121.9	4.2	318.2	134.9	200.7	118.5	103.7	16.6	18.4	1.3	141.3	0.8	477.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	2.5	24.4	33.4	32.6	20.3	24.6	28.7	38.2	32.9	35.4	32.3	32.5	35.8	50.4	6.4	6.7	55.5	1.0	17.2	23.1	18.8	6.2	8.1	20.6	27.2	28.9	42.9	10.0	29.5	4.2	68.5	0.6	34.9	11.7	38.3	10.7	22.0	21.4	27.5	3.5	2.7	0.9	18.8	7.4	52.1	11.2	13.4	0.0	135.9	31.1	39.1	72.3	35.3	18.1	12.9	2.0	36.8	17.5	4.1	20.2	28.5	10.6	60.9	0.4	50.2	0.0	16.6	12.5	70.4	27.0	16.6	0.6	24.9	21.0	10.7	6.2	14.9	39.5	31.3	52.1	2.6	7.0	15.6	22.3	55.1	1.7	1.0	16.3	14.8
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9;choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	133	"basophil: 16.5"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	3.8	2.6	25.7	4.2	41.8	0.3	9.6	53.9	19.2	15.4	39.4	3.7	3.2	7.7	14.0	6.4	7.5	8.7	2.9	19.5	37.5	21.6	0.8	2.4	0.5	38.9	48.4	4.7	13.3	5.1	5.4	5.2	42.7	6.7	2.8	4.6	13.6	9.0	0.2	6.3	4.2	3.0	39.7	0.0	4.2	6.5	35.6	0.8	2.1	0.9	6.9	7.2	9.0	48.6	28.2	1.1	44.3	5.6	3.7	15.2	0.0	0.1	0.5	0.2	1.5	0.3	6.9	0.0	54.6	2.0	1.7	30.1	1.9	4.5	0.5	0.0	0.7	0.0	23.1	0.0	1.8	0.0	0.1	1.8	12.6	0.5	2.4	27.1	2.4	0.0	0.0	8.3	0.8	0.1	0.0	0.0	3.3	0.4	4.8	0.0	3.7	0.0	88.1	2.5	0.7	1.9	8.6	0.2	23.5	0.8	0.7	0.1	3.0	11.2	7.1	3.2	5.8	10.2	0.1	0.0	2.7	0.0	127.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	25.7	41.8	53.9	19.2	19.5	37.5	38.9	48.4	42.7	39.7	35.6	48.6	0.7	12.8	4.8	106.4	2.5	33.1	117.2	39.4	34.7	13.3	26.3	18.7	3.0	38.6	57.9	38.6	0.0	20.0	0.4	5.0	7.9	26.3	3.0	376.2	150.6	5.2	34.0	0.0	28.1	17.4	1.2	15.5	7.7	551.9	1.3	0.9	1.4	0.2	3.3	1.7	8.2	7.4	34.6	1.0	4.7	6.5	44.1	9.8	3.6	4.7	31.6	24.3	0.0	192.0	119.2	35.8	6.1	44.8	2.0	149.7	14.5	76.7	100.1	1.4	0.0	4.8	7.0	1.4	1.1	34.6	12.4	4.9	5.5	1.9	9.6	150.7
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777595-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	782	"liver: 1504.9"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1087.0"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	59000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.2	1504.9	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	1.9	0.4	0.4	0.0	0.4	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.1	0.0	29.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	1087.0	0.1	0.0	0.0	0.0	0.0	20.2	0.0	1.7	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.1
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	668	"liver: 2156.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.3	0.1	1.1	0.1	3.0	1.6	3.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.6	1.0	0.8	2156.1	0.6	0.1	0.6	0.5	0.0	0.2	0.0	1.7	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.9	0.3	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	1.6	3.2	0.6	1.0	0.6	0.5	0.6	0.9	0.9	0.7	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 792.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1183.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 17.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	5.0	0.7	0.5	0.9	0.7	0.0	2.1	0.5	0.8	5.3	0.4	1.1	0.3	3.5	1.7	1.3	3.4	1.2	0.7	0.5	0.4	0.7	792.7	3.0	2.5	0.4	0.4	2.8	0.3	0.1	0.3	1.7	0.5	1.1	1.0	0.1	0.4	2.4	0.6	1.3	1.2	1.2	0.4	8.1	1.2	3.5	0.4	0.2	1.2	0.4	1.7	1.4	2.3	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.5	0.8	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.1	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.5	0.1	1.4	0.8	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.1	0.1	3.5	0.0	90.9	0.0	0.0	0.1	2.1	0.0	0.0	0.0	12.3	66.4	1183.8	0.0	0.0	0.0	0.0	0.0	85.1	0.3	132.0	1.2	0.1	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	9.1	0.4	0.3	0.0	0.1	0.3	3.6	19.2	0.0	0.1
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain 4"	Q14624	3	52812962-52830688	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"liver: 1863.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	58000000000	"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	4.2	18.5	4.1	1.2	4.2	10.0	3.0	3.7	5.0	4.2	3.5	3.6	1.0	2.9	1.7	1.4	3.8	1.1	3.2	3.9	3.6	5.4	1863.4	4.9	1.7	3.9	3.8	2.4	48.9	0.1	4.3	0.7	3.9	4.0	1.0	3.3	2.1	1.8	40.3	2.5	3.4	1.5	3.6	7.4	3.9	1.8	3.8	2.2	5.2	2.8	1.2	5.3	3.3	3.9	0.0	0.1	0.4	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.0	0.0	0.2	2.4	0.1	1.0	0.0	1.2	0.4	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.0	0.3	0.8	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.3	0.1	0.0	0.4	0.4	0.0	3.0	1.4	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	4.1	4.2	3.7	5.0	3.9	3.6	3.9	3.8	3.9	3.6	3.8	3.9	0.7	0.0	1.1	22.5	0.9	0.8	0.3	0.3	0.0	10.0	0.6	1.3	1.1	2.8	0.8	0.0	12.5	0.0	0.4	0.1	0.0	0.3	119.2	0.7	0.7	0.8	0.0	8.4	11.6	2.6	0.0	0.6	1.1	0.4	0.0	2.7	2.5	134.6	0.5	5.0	8.6	0.2	0.0	2.2	1.0	126.5	1.2	1.3	0.0	5.6	1.9	2.3	2.1	3.0	3.1	2.3	0.5	1.9	0.7	0.2	0.0	0.3	0.3	6.0	6.6	6.2	2.4	1.3	1.5	0.0	0.3	0.3	1.2	3.2	0.1	0.1
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 112.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	112.7	3.7	17.9	19.4	18.6	0.2	53.3	19.7	23.2	17.4	28.6	62.7	13.9	24.3	6.3	21.4	10.5	27.7	16.8	14.7	18.0	16.4	1.6	22.4	12.5	18.9	18.1	21.2	15.0	6.3	5.4	86.9	19.7	24.0	16.8	3.5	9.5	46.6	17.8	12.0	21.6	28.8	15.7	3.4	24.0	6.2	22.5	3.8	24.5	22.5	13.4	51.4	15.3	15.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	18.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	14.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	102.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.6	19.7	23.2	14.7	18.0	18.9	18.1	19.7	15.7	22.5	15.2	74.9	3.2	2.7	1.3	0.2	11.3	3.0	0.1	6.8	2.7	1.6	17.3	8.7	8.6	3.7	0.0	2.1	282.7	0.8	0.1	0.0	25.7	2.0	18.7	1.5	58.8	0.0	0.0	0.5	0.4	70.2	111.3	0.0	34.1	2.5	0.5	1.8	0.1	20.7	0.0	0.7	0.0	8.2	1.2	19.6	2.2	5.3	3.6	14.2	160.2	1.1	21.9	0.0	1.5	1.0	0.3	0.0	15.4	0.9	1.8	0.2	2.1	0.7	3.2	78.9	32.3	110.1	1.7	7.7	0.7	8.8	221.9	3.0	0.3	0.0	1.6
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748918-54798255	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"WM-115: 50.7"									HPA000506	Uncertain				"Secreted to blood"	NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"			"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876540-160885180	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 757.3;intestine: 1247.8"	"Cell type enriched"	"Detected in many"	14	"Intestinal goblet cells: 1818.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 9.2;non-classical monocyte: 24.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 24.1"	"Group enriched"	"Detected in some"	4	"HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	6400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	757.3	0.3	0.0	26.4	0.0	2.6	0.5	0.0	0.0	0.3	0.0	444.2	272.7	0.5	2.1	0.4	6.2	0.8	233.8	0.0	0.0	35.5	3.1	40.3	0.3	0.0	0.0	9.7	3.3	0.0	0.4	1.3	0.0	0.6	1247.8	0.0	24.9	3.3	0.7	0.2	415.7	7.7	0.0	2.5	15.9	2.0	0.0	0.7	0.6	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	71.4	2.1	3.7	0.0	0.1	0.1	46.4	0.0	37.7	0.8	0.0	0.0	4.3	18.0	4.0	0.0	3.6	1.4	87.8	8.6	0.0	1.3	1.4	60.7	1.9	0.8	0.0	0.0	1818.6	0.0	124.7	0.0	0.7	14.6	1.8	0.0	0.0	0.3	0.0	1.0	0.0	0.0	7.3	17.7	3.0	0.0	0.3	15.4	0.1	0.8	0.0	0.0	0.0	10.8	0.1	0.9	0.0	0.0	0.3	2.1	15.3	59.4	0.1
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954809	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"intestine: 408.3"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 76.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 2.8;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8"					"Low region specificity"	"Detected in all"			"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 11: Alveolar cells - Smell perception"			"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	6.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	238.7	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.4	11.7	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	408.3	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	1.9	0.0	3.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	5.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.2	0.0	0.4	11.0	0.3	0.1	0.0	0.0	5.0	0.0	0.3	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.6	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	6.3	17.5	0.4
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	60.0	27.2	88.3	15.5	105.9	17.3	45.3	84.7	92.7	57.0	57.2	60.1	44.4	66.8	11.6	24.8	30.3	19.4	59.2	92.5	80.7	35.6	48.3	31.6	9.0	90.2	95.8	27.1	30.7	14.8	20.6	6.8	83.0	38.8	16.4	9.3	21.0	21.7	40.9	22.2	58.5	23.4	83.2	38.1	34.2	29.5	100.4	6.9	25.4	16.1	6.6	62.5	35.0	100.7	28.1	56.6	10.3	26.3	22.5	12.6	27.8	11.8	17.5	22.9	13.8	32.8	48.9	17.7	57.4	18.6	8.7	32.5	29.6	50.3	7.2	65.9	13.1	39.2	14.6	28.5	16.8	17.9	41.5	8.2	29.5	11.6	26.3	9.9	22.8	18.0	21.9	19.8	11.3	74.6	15.5	25.5	22.0	36.4	25.5	29.1	15.1	26.3	15.5	46.3	28.0	35.5	29.6	59.0	49.5	7.8	79.5	21.7	18.0	15.9	17.3	27.0	18.9	19.3	19.1	11.4	14.6	13.8	110.8	5.3	9.8	18.2	3.2	15.4	1.9	3.3	2.0	2.1	7.0	1.0	1.2	2.2	42.9	2.4	25.9	3.5	3.0	5.1	88.3	105.9	84.7	92.7	92.5	80.7	90.2	95.8	83.0	83.2	100.4	100.7	11.8	12.8	11.1	32.0	10.8	7.4	7.5	8.3	2.8	10.2	11.8	7.6	24.3	17.2	5.1	29.5	18.8	9.7	12.9	73.5	13.7	19.2	12.7	18.1	12.5	12.4	28.8	5.9	45.1	27.3	10.0	8.9	13.3	21.2	16.5	9.2	13.9	31.3	19.4	6.7	21.6	24.8	4.1	44.7	11.8	30.3	14.9	30.5	26.6	16.9	23.2	17.2	18.6	31.7	46.5	44.6	38.7	48.2	13.2	15.2	106.6	23.0	3.3	13.7	19.7	7.4	17.8	4.3	14.3	7.0	4.4	6.8	12.7	10.3	34.5	11.0
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;intestine: 18.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.6;OE19: 18.2"	"Low region specificity"	"Detected in all"							HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.2	7.3	21.4	0.7	26.7	0.4	0.2	13.8	36.5	1.3	10.9	10.7	17.6	0.3	0.1	0.3	0.5	0.2	2.6	28.7	12.4	0.2	1.7	0.5	0.1	10.9	12.0	0.3	1.9	2.0	0.4	0.3	11.6	0.8	2.7	0.3	1.4	0.3	4.4	0.4	18.1	0.3	11.3	0.2	10.9	10.4	12.1	0.0	0.2	0.0	0.0	0.6	0.9	20.4	7.1	1.9	0.3	7.9	0.0	2.5	14.3	4.3	3.4	2.8	2.9	16.3	0.3	0.0	3.5	0.4	6.3	0.8	3.4	0.3	0.2	6.6	4.3	9.9	4.7	33.6	12.6	3.4	0.5	0.2	0.2	2.7	0.8	1.6	0.2	1.3	12.9	1.9	1.0	4.7	0.3	6.5	0.9	18.2	5.6	1.7	1.4	0.6	0.3	0.4	0.7	1.5	3.2	0.0	0.3	0.0	0.9	5.0	0.3	6.9	7.1	7.7	11.8	1.0	10.8	0.0	12.6	13.2	2.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.4	26.7	13.8	36.5	28.7	12.4	10.9	12.0	11.6	11.3	12.1	20.4	0.1	0.0	0.0	3.3	0.5	0.1	0.3	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.1	51.4	0.0	0.1	45.4	0.3	2.4	0.5	0.0	0.8	23.7	0.7	0.5	0.3	34.1	0.3	0.0	1.0	0.4	0.3	0.2	0.0	0.8	12.0	0.0	0.0	0.0	166.4	2.5	0.4	0.0	1.9	0.0	7.9	0.0	1.5	2.9	0.8	16.1	1.5	0.1	0.1	35.8	0.1	0.1	0.2	6.6	0.3	0.5	14.4	4.9	0.0	0.0	0.1	0.4	0.1	18.7	0.2
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 211.8;choroid plexus: 123.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.5;Astrocytes: 225.3;Microglial cells: 58.1;Oligodendrocytes: 110.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA		39000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	29.6	4.5	148.6	15.6	205.6	19.0	19.6	152.0	104.8	28.0	123.3	45.3	6.6	48.8	17.0	14.0	27.0	10.0	16.2	109.0	149.5	15.1	3.2	22.5	29.0	211.8	188.0	9.5	5.8	7.1	6.8	15.9	169.1	14.5	6.7	0.6	30.2	22.7	12.4	19.4	24.9	31.7	154.6	23.5	21.2	3.7	207.6	33.2	8.3	12.3	20.3	38.6	15.6	133.7	4.7	5.0	7.9	9.1	6.1	3.9	2.1	1.2	5.5	2.5	5.7	0.7	5.8	21.6	7.4	1.2	0.5	6.8	10.1	4.1	1.2	3.0	6.9	9.6	5.5	0.0	2.3	8.8	16.4	4.4	5.9	2.8	2.5	6.9	17.2	10.8	0.1	2.9	0.3	4.5	16.7	12.1	17.3	3.5	8.0	6.4	14.2	4.8	18.2	7.5	4.6	6.0	3.8	2.8	47.2	7.7	11.7	10.1	12.0	3.2	2.4	2.9	7.6	0.2	8.0	25.8	0.8	8.0	12.1	0.9	0.9	5.4	2.6	1.3	2.3	1.2	3.2	2.7	0.6	1.8	4.7	3.5	3.4	2.1	2.5	0.5	1.9	2.0	148.6	205.6	152.0	104.8	109.0	149.5	211.8	188.0	169.1	154.6	207.6	133.7	70.5	0.0	7.4	225.3	16.0	12.2	4.8	3.1	7.4	0.3	7.0	5.3	8.5	1.5	4.5	7.3	0.0	0.6	28.9	1.2	3.9	2.2	2.8	4.7	6.8	42.2	4.2	5.2	2.4	2.4	2.3	8.9	3.6	4.5	10.1	21.8	27.8	1.0	19.8	0.0	6.9	2.8	2.0	16.0	38.0	22.9	7.2	14.4	19.6	58.1	10.2	1.2	28.8	10.6	110.6	2.7	3.7	9.4	11.8	5.1	2.0	0.6	2.6	0.1	0.0	5.9	16.3	0.9	4.7	5.3	10.1	0.4	35.2	3.7	3.1	2.7
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26335352-26833194	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 551.4;Excitatory neurons: 287.2;Microglial cells: 802.9;Oligodendrocyte precursor cells: 441.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.3	10.4	10.5	8.1	7.3	6.0	17.3	6.3	9.7	4.8	3.4	6.2	5.3	5.2	5.7	7.4	5.5	5.5	3.7	7.7	8.7	12.6	44.3	5.6	7.9	19.1	13.2	5.9	7.7	11.4	2.2	10.9	14.9	5.5	6.6	8.8	16.9	2.9	1.8	10.2	4.9	4.5	13.1	6.7	5.2	2.5	16.1	20.1	4.3	4.1	6.8	4.9	4.7	15.6	4.9	2.0	2.9	4.6	8.5	8.6	3.0	4.4	6.1	3.0	3.1	0.2	2.4	16.5	2.7	5.9	3.3	5.2	15.1	9.3	4.0	3.9	5.1	13.5	4.4	27.1	7.9	12.0	5.8	8.1	1.2	6.3	11.6	6.2	28.5	6.5	6.4	5.1	3.9	4.0	8.6	17.8	12.2	4.4	1.5	2.9	7.0	10.7	7.3	7.4	0.9	4.5	19.8	3.5	11.4	11.3	7.7	6.0	62.6	6.0	2.3	5.9	5.7	4.9	4.2	31.2	5.7	5.6	3.9	32.4	6.4	9.9	2.9	2.7	2.5	5.4	2.6	2.4	1.4	5.0	3.0	2.7	17.3	4.8	4.3	11.9	4.4	1.0	10.5	7.3	6.3	9.7	7.7	8.7	19.1	13.2	14.9	13.1	16.1	15.6	27.1	48.1	52.9	551.4	45.7	20.9	17.8	3.3	31.3	3.2	87.0	57.1	24.5	34.3	8.6	23.9	146.0	21.0	39.1	7.7	7.9	20.8	3.1	13.3	64.9	38.5	78.5	33.4	287.2	23.4	9.5	20.3	16.8	22.7	44.4	60.0	25.0	123.7	39.5	0.0	99.1	46.1	32.6	46.3	8.2	6.7	18.0	68.7	33.8	802.9	28.2	13.0	41.2	441.8	22.3	17.6	37.0	17.7	83.6	25.9	14.5	14.6	5.0	64.7	0.0	22.7	17.6	3.6	6.3	54.3	26.7	27.9	29.2	43.4	11.7	15.8
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
ITPRID1	"CCDC129, FLJ38344"	ENSG00000180347	"ITPR interacting domain containing 1"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 15.9;salivary gland: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024103	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	2.7	0.1	3.9	0.1	1.6	11.0	0.4	1.7	0.0	0.5	1.1	0.6	0.1	0.0	0.0	0.1	0.0	0.7	9.7	0.1	0.0	0.0	0.0	4.8	15.9	0.0	0.1	0.0	0.1	0.0	9.2	0.1	0.1	0.1	5.3	0.0	0.0	2.3	0.5	0.6	1.4	0.0	0.4	1.3	13.2	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.9	11.0	0.4	0.7	9.7	4.8	15.9	9.2	1.4	13.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.4;Inhibitory neurons: 151.9;Rod photoreceptor cells: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.5;non-classical monocyte: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	55.5	15.5	18.0	9.9	18.4	6.8	27.9	16.4	26.2	19.8	22.8	14.7	8.9	20.3	12.0	11.4	16.7	19.8	20.9	18.3	14.0	10.9	26.4	11.5	6.8	14.5	13.6	19.6	5.0	7.0	6.7	24.4	14.9	14.5	11.0	28.5	7.9	22.3	22.0	11.9	9.7	18.4	8.8	15.4	11.1	12.3	17.0	5.0	10.3	22.0	3.9	15.4	13.4	14.1	36.3	14.9	70.4	23.4	32.3	30.8	115.3	35.8	34.4	20.6	19.8	56.7	27.0	8.5	28.3	43.1	42.7	13.7	42.2	24.9	22.0	3.5	18.6	10.3	30.9	26.7	24.4	7.4	9.9	30.5	22.0	38.6	21.2	23.5	55.3	9.8	13.7	5.8	33.4	8.2	10.3	9.8	104.5	12.6	11.3	13.2	33.7	17.6	30.9	14.7	13.2	14.4	51.4	10.6	12.6	44.6	13.0	7.2	50.2	22.9	30.9	18.1	12.5	7.0	20.8	7.9	20.8	22.9	26.0	0.0	4.2	5.5	0.3	3.2	0.3	0.0	0.5	0.1	1.3	0.0	0.2	0.1	0.2	0.1	5.1	0.3	0.0	0.8	18.0	18.4	16.4	26.2	18.3	14.0	14.5	13.6	14.9	8.8	17.0	14.1	19.8	25.6	18.6	217.4	1.8	18.1	22.6	10.8	36.5	73.1	12.2	8.1	81.8	18.6	14.5	11.0	91.8	20.8	1.1	22.4	0.0	19.9	10.2	13.3	67.7	21.3	9.1	47.4	110.9	12.5	28.0	31.9	19.4	21.0	2.5	30.7	28.2	54.2	55.6	65.6	151.9	7.2	20.3	30.0	10.9	8.6	24.8	27.3	10.6	74.0	10.8	46.9	0.0	80.4	46.4	37.1	10.3	71.5	3.1	18.3	16.8	16.6	18.8	146.2	13.1	20.1	39.7	32.4	47.7	8.9	11.8	15.6	2.7	21.4	10.5	27.2
ITSN2	"KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP"	ENSG00000198399	"Intersectin 2"	Q9NZM3	2	24202864-24360536	"Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036475	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Plasma membrane"		"HPA036475: AB_10670718"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.64e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.12e-2)"	23.1	21.4	11.0	35.8	11.1	73.6	15.3	6.6	12.3	22.1	17.5	19.5	17.6	19.5	12.9	36.7	15.4	19.0	20.0	10.3	10.3	21.2	27.4	27.0	53.3	12.1	12.5	16.4	67.0	18.7	16.2	24.7	11.8	17.8	20.1	16.0	18.4	15.0	23.3	26.5	22.4	18.0	9.4	43.3	24.7	15.2	15.3	30.0	50.7	18.9	50.9	22.2	24.5	15.7	41.2	19.7	4.8	14.2	13.6	18.1	43.5	24.5	22.8	11.1	13.2	19.2	21.4	63.6	21.2	20.4	32.7	18.2	21.9	15.5	18.3	50.8	21.0	86.1	12.6	21.4	22.9	44.7	47.6	14.2	17.7	19.4	33.7	21.1	35.3	23.7	25.0	46.7	17.6	16.9	18.4	21.7	8.9	24.9	19.1	22.8	55.7	19.0	19.6	76.0	3.3	9.9	19.4	20.6	29.5	19.2	14.1	23.7	49.1	23.6	20.6	19.6	22.9	50.6	60.4	65.0	18.8	40.4	21.0	69.6	30.4	56.2	31.1	37.0	32.8	68.7	26.8	27.7	28.7	73.1	27.4	24.6	112.8	26.5	59.3	18.9	31.2	20.3	11.0	11.1	6.6	12.3	10.3	10.3	12.1	12.5	11.8	9.4	15.3	15.7	62.6	96.1	103.3	64.6	143.2	51.7	82.0	21.7	41.5	23.7	21.9	20.2	70.5	22.8	48.5	29.5	20.9	26.1	88.6	42.5	17.6	53.0	4.3	42.8	21.5	62.8	24.5	33.2	114.7	75.5	35.3	40.7	53.0	62.1	103.9	30.4	39.3	27.8	42.4	13.5	98.2	28.6	26.4	93.1	111.1	7.6	30.1	102.2	24.9	132.1	107.1	16.0	105.0	104.0	140.5	88.3	48.4	18.0	85.2	74.9	40.1	27.0	35.3	33.2	13.1	54.2	40.3	95.6	58.8	36.4	58.1	24.2	94.9	28.3	24.6	116.6
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405485-40435947	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Theca cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	25.8	80.5	35.1	14.5	40.8	15.9	45.3	35.6	40.8	29.4	39.5	31.6	24.3	26.4	29.0	16.0	35.0	21.5	61.7	34.0	41.5	59.1	145.4	24.3	19.6	40.2	38.8	43.3	27.4	39.2	58.3	15.3	37.5	42.1	27.2	13.0	31.8	36.8	55.7	8.6	26.8	23.8	37.9	27.9	46.7	25.0	44.5	16.8	119.2	55.4	19.5	31.1	20.8	45.3	20.9	11.9	22.9	38.9	35.9	32.9	1.0	27.6	32.7	39.4	24.0	36.5	16.0	0.8	57.7	43.4	32.6	20.8	45.9	46.6	30.1	36.4	34.0	52.1	36.2	38.9	64.6	22.0	48.5	45.3	18.5	23.5	55.3	46.3	38.8	60.4	2.5	2.4	42.1	27.1	27.3	38.9	17.8	1.3	33.0	41.2	32.6	27.9	45.2	51.6	37.3	21.5	38.2	83.4	18.7	21.5	69.0	117.6	27.6	29.9	20.2	23.6	24.9	54.5	38.5	1.0	30.9	22.8	28.4	17.0	24.8	36.7	33.3	36.1	31.0	27.5	18.5	26.6	58.8	27.6	18.5	26.7	2.3	39.4	73.1	89.2	26.9	24.3	35.1	40.8	35.6	40.8	34.0	41.5	40.2	38.8	37.5	37.9	44.5	45.3	13.1	28.9	54.5	27.4	19.0	2.3	21.0	17.3	13.1	26.0	27.5	22.2	88.0	45.8	29.9	44.1	14.6	20.3	34.0	17.9	95.9	19.7	5.4	21.4	31.0	18.6	19.7	21.3	15.3	14.9	7.3	20.2	29.6	19.9	34.7	46.5	21.4	135.0	28.1	16.8	16.6	24.4	14.2	18.3	6.2	7.4	20.5	18.6	5.4	21.5	28.8	26.0	26.8	25.1	21.4	14.8	9.4	24.8	10.0	16.6	22.0	97.3	29.3	19.9	19.7	25.0	18.2	16.1	3.7	17.4	0.6	9.9	18.0	105.7	35.4	11.9
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
IVNS1ABP	"ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317273	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 452.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 309.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 250.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	43.9	17.8	16.7	46.6	26.5	452.5	50.5	21.1	20.8	24.9	26.9	40.2	38.4	22.4	18.1	27.0	19.6	36.4	28.9	15.2	19.7	94.1	23.0	27.7	26.4	20.9	18.3	28.4	25.5	32.4	17.3	26.0	22.3	22.2	51.1	15.0	55.2	26.4	23.1	33.5	34.8	16.9	18.3	27.3	42.2	15.9	20.0	24.9	34.3	21.6	24.1	37.7	29.8	35.0	24.6	22.1	79.2	31.6	27.1	9.0	68.4	46.6	15.3	30.1	27.5	26.2	39.7	36.8	36.8	24.0	13.4	32.9	29.0	31.8	32.1	24.9	21.6	36.8	39.1	22.6	10.9	26.2	13.9	6.7	35.7	23.1	73.2	67.6	39.6	38.6	23.6	21.2	54.6	18.0	44.6	18.1	48.7	61.8	5.6	24.7	20.2	21.0	250.7	31.4	52.5	44.5	40.6	35.4	31.4	103.4	16.2	13.3	27.2	41.9	24.5	10.4	34.9	28.0	23.8	22.8	32.1	26.0	19.4	7.9	10.9	10.5	10.5	7.1	9.6	6.1	8.0	7.7	12.6	3.7	8.5	8.3	33.0	10.4	10.3	3.4	8.9	12.1	16.7	26.5	21.1	20.8	15.2	19.7	20.9	18.3	22.3	18.3	20.0	35.0	159.1	44.8	59.0	13.7	61.3	188.9	90.4	40.9	163.4	14.5	74.0	51.3	56.0	22.8	57.4	128.8	52.1	17.3	102.0	288.3	164.4	41.6	34.4	93.2	36.7	85.8	60.4	52.8	18.2	41.5	67.5	50.3	90.7	159.7	41.1	309.2	26.4	23.3	34.8	21.9	26.2	109.6	36.7	107.2	242.3	34.9	5.9	141.5	101.4	33.7	41.3	11.3	63.8	37.7	72.9	24.0	56.4	2.6	62.7	60.9	103.2	86.3	45.8	32.7	6.6	51.4	52.6	33.2	19.8	108.9	181.6	18.3	120.0	54.2	102.7	91.7
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"Interacts with SUPT6H, CTD assembly factor 1"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035719: AB_10669527, HPA061866: AB_2684628"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	24.2	18.5	26.7	23.2	32.3	31.5	22.2	30.3	37.8	23.1	30.1	24.8	23.4	22.9	23.8	22.9	21.3	18.9	48.4	26.8	32.2	30.1	40.2	22.5	28.8	30.7	32.1	18.0	21.6	23.8	24.8	26.5	32.0	23.3	23.8	26.5	22.7	19.3	76.0	21.6	24.4	21.9	27.7	27.6	23.1	23.2	31.5	31.2	20.7	62.0	28.4	25.8	23.4	40.4	52.0	34.5	68.4	45.0	51.0	42.4	71.4	73.9	50.0	67.2	55.9	81.6	38.8	48.7	38.2	59.3	51.4	41.9	66.7	58.2	79.4	50.7	45.4	68.1	50.6	92.9	60.2	78.2	54.5	42.0	43.6	71.5	64.0	35.7	58.0	60.3	72.8	37.0	64.3	48.3	77.7	63.4	92.2	43.0	46.8	68.9	53.5	44.9	67.6	62.0	53.4	34.7	52.9	65.9	60.3	73.4	29.6	53.5	66.4	66.3	50.4	40.4	43.8	28.6	33.6	64.5	36.6	54.2	45.0	3.6	13.2	18.5	9.7	14.8	11.8	11.4	11.1	11.8	13.0	15.1	10.5	11.0	13.9	15.0	17.3	11.8	11.0	9.5	26.7	32.3	30.3	37.8	26.8	32.2	30.7	32.1	32.0	27.7	31.5	40.4	23.1	112.2	74.3	35.3	36.6	15.7	55.3	22.8	23.9	27.9	16.9	15.7	77.4	21.5	53.5	16.5	27.1	40.0	33.5	35.1	19.6	38.6	13.2	38.5	39.8	28.9	28.1	30.7	21.9	25.5	56.3	41.9	32.1	36.8	42.3	42.3	20.7	25.7	27.1	21.9	27.8	25.7	30.5	16.4	25.4	8.5	39.1	29.2	10.6	25.3	40.1	26.4	46.4	25.6	105.0	41.9	28.0	31.6	37.5	53.8	25.1	19.1	44.6	44.7	32.9	29.3	35.6	69.8	52.0	24.1	17.0	92.8	37.4	34.6	26.9	77.2
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
IZUMO1	"IZUMO, MGC34799, OBF"	ENSG00000182264	"Izumo sperm-egg fusion 1"	Q8IYV9	19	48740852-48746909	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 18.9"	"Group enriched"	"Detected in some"	44	"Early spermatids: 156.4;Late spermatids: 112.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038104	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA038104: AB_10670655"	"unprognostic (2.03e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.31e-3)"	"unprognostic (6.92e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.0	0.6	0.1	0.4	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	18.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.4	0.3	0.2	2.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	2.9	0.0	0.4	0.0	0.3	0.5	2.0	0.0	1.3	112.7	1.2	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	3.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.2
IZUMO2	"C19orf41, MGC33947, SCRL"	ENSG00000161652	"IZUMO family member 2"	Q6UXV1	19	50152548-50163195	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	283	"testis: 64.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 730.7;Late spermatids: 355.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042143	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA042143: AB_10794078"			"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.31e-2)"			"unprognostic (1.81e-1)"		"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.75e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.2	0.3	0.8	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	730.7	0.1	0.1	0.4	3.6	0.0	1.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.4	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.3	355.2	4.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	3.4	0.0	0.8	0.0	0.1	0.1	0.3	13.1	1.3	0.3	7.0	5.5	0.0	0.4	0.0	0.2	0.0	0.4	1.4
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 443.1"	"Group enriched"	"Detected in many"	51	"Early spermatids: 1750.8;Late spermatids: 2537.9;Spermatocytes: 824.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.5;RPMI-8226: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	2.9	1.9	15.2	1.2	15.3	0.5	3.3	15.1	20.9	2.7	15.1	3.0	0.5	2.6	2.5	2.6	5.1	1.9	3.0	14.6	14.4	4.3	5.4	2.1	1.8	15.1	15.7	6.5	8.6	0.8	10.1	0.4	15.2	7.5	0.8	2.9	2.4	2.4	2.6	2.5	2.0	0.7	14.9	1.6	3.9	443.1	15.6	1.7	4.6	1.2	2.2	2.5	2.3	15.7	0.6	0.5	0.3	2.7	1.1	1.2	0.3	0.4	0.6	0.4	0.0	0.2	0.5	0.4	0.6	0.6	0.0	0.5	0.0	2.9	0.1	1.2	0.2	0.0	1.1	0.8	3.2	0.0	0.4	0.5	1.1	0.7	0.8	0.9	0.0	1.5	0.0	8.5	1.1	0.1	0.8	0.2	0.3	1.1	0.7	0.7	0.0	10.9	1.2	0.3	0.4	0.7	0.4	0.9	0.4	0.2	0.5	1.0	0.0	0.3	0.1	0.1	0.2	0.9	1.1	0.8	1.4	0.9	0.2	0.0	0.7	0.6	0.6	1.1	1.5	2.7	2.1	1.6	0.9	0.7	1.7	0.7	1.6	0.5	1.6	1.2	2.2	0.9	15.2	15.3	15.1	20.9	14.6	14.4	15.1	15.7	15.2	14.9	15.6	15.7	1.0	0.0	0.0	31.0	10.3	2.4	4.1	32.8	4.0	3.4	2.5	2.3	1.5	5.7	19.7	9.2	8.4	0.5	2.6	2.0	5.9	2.5	1750.8	4.6	1.9	1.7	7.7	0.4	1.2	5.8	4.5	3.7	1.1	2.3	0.0	2.2	0.7	9.5	1.0	0.0	1.6	1.9	14.2	3.2	8.2	2537.9	28.6	4.3	12.4	0.0	11.3	6.6	1.0	1.5	28.0	1.8	0.7	19.9	8.2	6.8	1.9	11.1	12.1	8.6	6.6	2.6	2.1	824.6	14.3	6.3	1.7	1.6	5.6	2.4	4.4	7.0
JADE1	"JADE-1, PHF17"	ENSG00000077684	"Jade family PHD finger 1"	Q6IE81	4	128809700-128875224	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020016	Approved		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA020016: AB_1855292"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.93e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (8.22e-6)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.68e-1)"	25.3	21.6	11.7	10.3	12.8	46.2	20.1	21.6	12.4	16.4	10.0	16.3	8.6	12.3	8.7	12.2	18.5	12.6	17.7	10.2	15.9	24.7	11.7	15.9	15.2	13.6	14.1	27.9	70.8	16.5	15.0	11.2	14.8	18.0	6.2	20.4	18.9	17.2	14.9	13.4	12.3	12.7	12.0	15.4	19.1	9.7	15.8	17.8	31.4	11.5	12.3	19.5	12.9	12.1	13.5	25.8	25.2	18.6	33.7	23.7	32.9	21.0	12.5	22.4	20.4	22.8	22.9	40.8	24.3	12.1	9.8	4.5	29.8	7.4	24.9	31.9	13.5	22.8	35.9	20.9	57.9	37.5	17.6	26.5	11.5	27.3	20.2	18.5	24.5	26.1	36.7	54.3	17.5	16.2	47.8	28.0	67.8	13.5	13.1	35.0	17.3	22.0	35.7	6.5	32.7	23.7	20.1	16.2	16.5	35.0	13.1	20.9	17.1	21.9	36.3	16.9	24.8	35.9	32.0	46.0	23.7	36.8	18.3	31.4	10.7	35.9	17.2	17.2	21.1	13.4	18.3	19.2	10.4	18.6	25.5	19.9	13.8	31.1	23.6	4.9	14.6	16.3	11.7	12.8	21.6	12.4	10.2	15.9	13.6	14.1	14.8	12.0	15.8	12.1	24.5	38.5	25.4	17.6	35.4	14.9	16.1	4.3	32.5	40.3	25.8	32.3	33.9	42.9	13.7	49.7	50.1	25.2	42.0	3.1	19.6	30.1	3.6	45.5	21.7	21.7	10.2	48.8	24.5	48.7	16.5	36.7	25.5	37.0	17.7	34.3	18.2	37.3	10.1	28.6	31.8	8.3	46.8	28.5	14.3	4.2	36.1	16.3	21.4	12.2	27.5	26.7	107.1	17.1	19.2	44.0	7.8	48.2	41.2	12.6	12.6	34.7	29.7	28.4	85.5	33.0	59.0	6.6	21.9	20.9	13.4	4.0	40.9	8.9	10.8	5.9
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	16.1	20.1	11.8	15.2	16.5	9.8	13.7	10.3	14.0	16.3	1.1	14.5	10.2	12.9	6.4	9.7	16.1	10.7	12.1	11.2	16.0	11.9	5.5	13.8	26.8	14.4	12.8	23.9	13.3	20.4	13.1	7.1	13.9	13.0	6.2	8.9	14.5	14.1	12.7	12.0	18.4	9.8	9.8	21.8	12.7	6.8	13.9	15.8	16.2	8.5	16.2	17.9	11.6	15.7	66.6	46.2	1.3	2.0	13.8	18.5	19.6	10.7	28.9	21.0	26.4	35.2	50.4	75.2	24.7	13.4	21.3	13.0	6.4	60.8	8.2	44.2	2.3	18.0	30.0	7.7	17.5	19.2	2.5	11.8	27.3	26.3	29.5	14.5	15.1	21.4	10.5	24.4	13.1	26.4	35.6	18.5	14.7	19.5	23.9	29.9	1.2	29.8	19.9	18.1	9.0	5.6	30.2	0.8	42.2	11.4	12.1	25.3	22.5	13.9	12.7	43.2	30.1	10.6	49.7	68.3	24.1	34.1	22.6	0.9	0.6	2.0	3.2	0.6	3.4	3.8	3.1	3.1	1.1	2.3	3.0	3.1	0.7	1.9	1.6	0.5	3.1	1.3	11.8	16.5	10.3	14.0	11.2	16.0	14.4	12.8	13.9	9.8	13.9	15.7	13.6	9.6	11.2	4.2	35.1	4.2	7.0	6.5	21.6	24.4	10.3	7.1	13.3	12.8	6.0	7.3	35.5	7.3	41.0	7.7	7.9	5.5	0.6	4.6	5.4	12.5	11.5	4.6	15.3	16.9	9.7	10.2	5.6	3.6	2.5	16.0	18.2	3.5	4.2	10.1	16.0	8.8	6.1	30.5	15.7	0.8	20.5	12.1	1.8	5.6	19.4	7.4	42.2	9.0	16.5	8.8	4.9	19.2	22.4	4.6	13.8	10.4	9.5	22.9	0.0	6.7	11.6	0.3	3.3	6.0	3.7	7.3	35.0	4.2	10.7	4.3
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 37.2;Oligodendrocytes: 36.8;Spermatocytes: 42.7;Spermatogonia: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.8;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: AB_2685326"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	3.5	10.7	3.5	3.1	4.9	2.0	6.3	5.1	5.1	5.6	2.7	3.6	2.2	6.0	15.9	3.5	3.9	3.2	3.1	3.2	4.1	3.7	7.6	3.6	4.9	6.6	4.4	7.1	8.3	3.3	1.1	15.4	6.2	4.2	3.4	2.5	3.5	7.2	1.7	3.3	4.6	5.0	5.0	5.0	4.1	12.1	5.2	7.2	4.1	2.6	6.1	4.7	2.6	8.8	12.1	10.6	17.2	11.9	6.2	4.6	65.7	7.1	5.9	7.8	8.7	12.3	10.3	0.1	4.9	5.2	11.6	4.7	21.1	5.7	11.2	32.6	13.8	9.6	11.9	12.0	10.2	7.3	5.0	3.5	7.8	5.5	17.7	4.8	14.9	18.1	6.7	5.6	6.1	12.5	26.5	8.9	13.6	7.8	9.0	27.0	19.4	16.9	6.6	11.0	14.8	13.1	20.4	18.7	11.3	28.3	12.4	7.6	9.3	8.2	14.2	11.7	4.7	4.3	4.0	22.7	2.3	6.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	3.5	4.9	5.1	5.1	3.2	4.1	6.6	4.4	6.2	5.0	5.2	8.8	4.1	0.0	7.8	1.0	14.4	4.2	2.3	1.8	2.2	1.5	9.9	4.2	5.4	1.5	1.6	5.5	0.0	9.6	0.1	2.0	0.0	2.4	1.1	3.9	3.9	5.1	8.4	6.5	5.5	3.6	10.3	2.0	2.6	4.4	0.0	9.7	6.1	13.3	1.8	0.0	12.7	2.6	6.1	1.0	5.7	3.7	4.7	1.4	3.6	14.0	2.8	1.2	1.0	37.2	36.8	3.1	1.1	3.8	1.9	4.1	0.5	2.9	1.2	2.3	6.6	1.9	2.8	42.7	35.3	5.8	8.1	14.2	0.7	3.5	2.4	3.7
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	44.2	10.1	10.3	13.0	9.5	21.8	30.3	8.4	12.0	44.0	8.9	23.7	13.8	27.3	19.5	52.4	27.0	21.6	20.7	12.8	9.8	21.7	6.2	23.9	8.4	12.4	14.2	20.3	22.0	20.9	8.2	67.9	10.0	25.9	23.0	22.1	15.8	26.7	9.8	57.2	13.6	23.6	9.7	23.3	25.1	4.5	12.1	9.3	19.9	22.8	15.6	28.5	50.0	8.5	4.1	20.6	63.1	78.1	11.8	11.3	2.3	2.4	11.9	3.3	1.8	18.5	11.2	0.7	59.0	2.4	17.7	85.8	9.4	219.2	2.7	0.2	4.5	7.0	2.2	87.9	5.8	28.4	0.5	4.6	63.7	10.6	131.1	12.5	21.1	0.3	0.1	8.8	6.0	0.2	0.0	20.2	18.2	68.7	20.3	5.3	3.9	13.1	29.9	25.6	2.8	2.1	6.3	4.4	26.2	49.8	0.3	3.3	80.5	14.2	9.9	11.8	187.9	3.6	0.6	0.9	9.1	10.3	11.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	10.3	9.5	8.4	12.0	12.8	9.8	12.4	14.2	10.0	9.7	12.1	8.5	73.0	41.7	15.4	5.9	1.1	104.6	54.9	76.3	211.1	9.7	13.2	29.1	20.6	30.0	34.4	16.5	43.8	16.9	6.8	64.3	1.9	31.6	5.0	197.4	22.2	102.5	5.3	0.0	6.9	30.4	1.0	41.9	76.0	96.4	7.0	2.7	60.0	1.8	4.2	21.9	9.2	12.8	20.3	5.9	33.9	9.6	21.5	9.1	14.2	22.5	2.8	11.9	2.1	24.6	1.3	97.3	18.3	33.8	4.3	24.5	7.8	2.3	30.2	69.1	85.5	46.7	190.1	0.9	3.2	343.9	106.8	2.2	4.3	107.2	39.1	33.7
JAG2		ENSG00000184916	"Jagged canonical Notch ligand 2"	Q9Y219	14	105140982-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol		NA	NA		370000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178"	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	7.2	1.0	4.0	1.3	3.6	0.1	9.6	0.9	5.0	4.6	0.5	3.1	1.1	5.3	0.4	8.8	5.3	1.8	12.8	3.5	7.4	4.3	0.9	5.1	0.7	4.6	4.4	1.5	6.8	1.5	17.4	3.0	6.8	8.1	0.2	0.8	7.8	2.8	9.7	19.5	4.0	1.1	2.5	2.0	3.0	3.2	6.5	1.6	4.7	2.8	0.6	5.2	6.8	1.6	16.8	6.7	0.4	1.7	0.0	0.0	20.0	0.2	0.1	0.0	0.0	5.6	20.1	0.0	13.8	0.0	0.1	62.6	4.0	21.0	0.0	2.3	9.7	0.0	20.0	0.0	0.2	0.1	3.9	0.2	9.9	0.0	2.3	0.2	5.1	0.9	4.1	0.0	0.0	7.6	0.0	0.0	2.0	2.1	2.3	5.3	3.9	7.2	0.1	4.4	31.4	1.0	5.6	1.3	0.2	0.3	15.8	2.5	17.2	0.1	1.7	0.0	0.2	0.9	0.1	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.6	0.9	5.0	3.5	7.4	4.6	4.4	6.8	2.5	6.5	1.6	56.1	6.4	3.2	1.0	0.2	23.3	7.6	30.9	27.3	2.7	3.8	26.4	6.7	2.8	7.6	0.0	25.0	2.2	2.2	2.7	0.0	3.9	0.1	16.5	0.9	34.2	0.0	0.0	12.1	2.7	1.0	1.8	2.0	7.4	0.0	1.1	7.9	0.6	0.7	26.9	9.9	3.6	4.1	0.8	2.9	1.0	1.5	1.1	7.2	15.0	1.3	0.6	1.0	0.5	1.1	3.3	2.1	0.7	0.9	4.4	8.2	0.3	11.5	4.8	0.0	3.7	3.7	0.8	13.5	6.0	6.8	1.4	3.4	0.3	2.7	1.5
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-65067754	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 700.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	99.6	38.2	44.8	73.9	42.6	51.4	60.7	46.7	45.4	58.2	61.7	50.5	33.9	56.7	60.8	38.7	40.7	64.2	49.5	46.0	53.9	55.4	86.6	62.1	110.1	56.0	47.0	77.1	46.7	55.0	35.6	57.0	49.1	42.2	54.5	41.7	34.2	55.2	83.4	79.2	50.8	64.2	44.0	88.3	49.5	46.8	59.8	103.8	45.0	118.6	101.7	81.2	39.3	45.5	50.4	66.2	27.7	3.0	336.8	177.2	35.1	76.3	116.1	64.6	75.7	21.4	27.7	76.5	59.1	142.8	118.7	27.8	19.4	63.6	93.8	102.7	29.5	104.0	32.1	56.2	126.6	40.2	68.4	159.9	92.6	97.2	103.0	78.4	208.7	37.0	37.9	78.9	80.1	31.2	22.3	39.6	18.6	65.3	37.4	30.5	77.8	28.5	213.8	84.9	19.8	57.9	107.4	51.6	52.9	56.6	104.3	28.6	180.8	74.7	34.1	174.2	42.0	47.7	23.6	60.4	70.5	57.9	34.1	162.4	52.1	146.8	94.0	66.3	105.7	89.1	90.2	100.7	69.4	73.1	97.0	80.6	177.9	305.4	76.2	55.0	117.1	130.8	44.8	42.6	46.7	45.4	46.0	53.9	56.0	47.0	49.1	44.0	59.8	45.5	211.2	51.3	94.9	62.3	219.8	116.6	150.7	91.3	78.0	37.0	66.2	71.6	112.8	87.2	84.2	112.2	22.9	9.0	345.0	89.2	43.0	171.3	125.2	90.1	167.0	183.0	66.4	52.8	59.6	213.8	105.2	131.9	91.3	151.2	57.0	48.7	174.2	91.4	58.5	21.9	85.3	62.0	69.2	160.2	148.9	101.7	96.0	177.9	49.8	80.6	234.8	53.5	700.3	61.3	42.7	217.5	58.6	84.7	175.2	183.8	53.7	79.0	61.9	38.6	164.3	70.6	191.8	40.8	53.1	71.2	166.1	12.2	256.0	95.7	47.6	200.1
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;dendritic cells: 20.1;Macrophages: 17.9;NK-cells: 18.6;Plasma cells: 18.4;T-cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.7;HEL: 15.9;HMC-1: 15.5;Karpas-707: 40.2;U-266/70: 15.4;U-266/84: 24.7;U-937: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.7	2.5	4.0	36.3	4.4	18.6	4.0	3.9	5.6	3.3	3.7	4.0	3.0	2.2	2.4	2.8	5.3	4.8	3.2	4.1	6.7	6.2	2.9	13.1	40.5	7.3	6.1	15.5	1.8	1.9	3.1	5.7	6.4	4.4	3.1	0.6	3.5	1.9	0.7	1.7	15.4	3.5	5.5	55.1	4.6	2.6	6.6	11.3	4.9	0.9	29.7	7.4	3.1	6.1	0.2	0.6	0.5	1.8	0.6	2.4	0.4	0.8	0.0	0.1	0.1	0.0	1.6	0.7	3.3	0.7	0.4	0.2	0.0	0.4	0.0	35.7	0.0	15.9	0.1	1.5	1.2	0.0	15.5	8.4	0.5	0.1	0.0	0.1	0.3	3.6	0.1	40.2	0.0	0.7	6.5	0.0	0.3	0.9	1.3	8.2	0.0	0.7	0.8	0.0	0.0	0.6	0.2	0.4	0.1	0.2	3.5	2.4	0.7	0.0	0.7	0.0	0.0	15.4	24.7	4.3	0.1	24.2	0.3	2.0	7.5	0.3	17.8	14.6	20.2	9.4	21.1	18.6	6.8	10.3	20.2	18.5	25.1	13.4	14.2	5.5	18.0	12.4	4.0	4.4	3.9	5.6	4.1	6.7	7.3	6.1	6.4	5.5	6.6	6.1	5.5	0.0	4.6	2.3	27.8	0.8	0.6	0.5	0.6	0.6	0.5	0.8	1.9	0.0	1.0	1.8	0.0	1.1	20.1	0.0	0.0	0.5	1.0	0.3	2.1	8.0	0.0	6.1	4.3	0.4	0.8	4.6	2.0	0.4	5.1	0.8	9.7	0.4	14.5	0.0	2.6	0.0	0.0	9.2	1.9	2.0	12.5	17.9	3.6	4.7	16.6	0.9	18.6	0.0	0.4	0.5	0.0	14.7	18.4	0.5	0.0	0.3	0.9	0.7	6.6	0.3	2.9	0.3	0.7	0.3	1.0	1.4	37.7	14.8	0.1	0.6
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;pituitary gland: 10.2;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.6;dendritic cells: 17.6;Excitatory neurons: 82.9;Inhibitory neurons: 53.6;Muller glia cells: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7"	"Lineage enriched"	"Detected in many"	33	"T-cells: 36.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;JURKAT: 14.3;MOLT-4: 45.2;SCLC-21H: 18.6;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"	0.3	4.8	21.4	1.0	31.1	1.3	0.1	5.0	30.4	0.2	0.1	1.0	0.2	0.1	0.1	0.3	0.2	0.5	0.1	21.6	22.0	0.2	0.3	0.9	3.0	9.0	13.5	0.5	0.6	0.0	10.2	0.0	12.8	4.2	0.2	17.0	0.7	0.1	0.1	0.1	1.1	0.2	7.1	2.6	0.6	5.2	16.2	0.3	0.7	0.0	0.6	0.7	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.4	45.2	0.0	3.4	0.0	2.6	2.3	0.0	0.7	0.0	0.0	18.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.3	0.0	11.2	0.3	11.2	22.6	0.0	0.2	0.8	10.1	0.1	1.1	0.0	0.1	36.7	5.4	21.4	31.1	5.0	30.4	21.6	22.0	9.0	13.5	12.8	7.1	16.2	20.3	0.2	0.0	0.0	35.6	0.8	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.8	0.0	0.0	0.0	2.1	0.0	17.6	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.4	82.9	0.0	0.0	0.5	2.6	0.8	0.0	0.2	0.0	0.0	0.1	3.3	53.6	0.0	0.0	1.3	0.5	2.4	0.0	0.5	0.0	7.5	0.3	61.2	12.3	7.1	3.1	0.1	0.0	0.0	2.3	1.3	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.9	4.6	0.0	0.1	0.0	16.2	0.4	0.0	0.0
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585438-147782775	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.0;T-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA046929: AB_2679867, HPA065023: AB_2685407"	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	0.2	3.3	11.4	1.0	12.5	0.5	0.1	24.8	14.3	0.5	0.1	2.2	0.4	1.0	0.2	1.3	0.1	1.4	0.4	11.4	12.1	0.3	2.6	2.0	0.9	11.7	11.8	0.1	0.8	1.0	8.3	0.1	12.4	0.6	0.5	5.3	0.2	0.4	0.0	0.3	0.6	1.5	10.4	0.8	1.8	2.9	13.0	7.0	0.1	1.6	0.9	0.7	0.2	16.6	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	3.1	6.9	2.0	0.0	0.0	0.3	0.0	5.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	47.5	0.0	0.1	5.1	0.0	11.4	0.1	0.1	2.0	47.8	16.0	0.0	0.1	22.4	15.4	0.0	0.3	0.1	2.5	0.0	0.0	0.0	3.5	4.0	0.0	1.1	3.3	2.0	4.6	8.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	5.3	0.7	2.8	5.5	0.1	0.3	0.7	4.6	0.5	7.0	0.2	1.1	1.3	1.5	11.4	12.5	24.8	14.3	11.4	12.1	11.7	11.8	12.4	10.4	13.0	16.6	0.2	0.0	1.5	195.5	1.5	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.7	0.0	1.3	0.0	2.1	0.0	13.3	0.0	0.0	0.8	11.3	0.2	0.5	0.3	1.2	3.0	250.7	0.0	0.0	1.2	0.5	0.1	29.1	10.3	0.7	3.1	1.3	85.8	229.4	0.8	0.0	0.9	0.0	8.4	0.0	4.2	0.0	11.2	0.4	24.4	23.7	159.3	198.5	0.2	0.0	0.0	3.1	0.0	0.1	0.1	1.5	7.9	0.0	0.4	0.7	7.8	2.0	0.1	0.1	0.3	13.8	18.9	0.0	0.3
JAKMIP3	"bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2"	ENSG00000188385	"Janus kinase and microtubule interacting protein 3"	Q5VZ66	10	132036336-132184858	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 20.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.4;Excitatory neurons: 39.4;Inhibitory neurons: 32.3;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 92.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;RPMI-8226: 2.0;U-266/84: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022872	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA022872: AB_2249331"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.71e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.19e-4)"	"unprognostic (1.59e-2)"	0.1	1.0	1.9	0.1	5.1	0.1	0.2	2.8	5.1	0.3	0.0	0.6	0.1	0.6	0.2	0.2	0.5	0.4	0.6	1.5	5.1	0.0	0.0	0.1	0.0	9.2	5.2	1.7	0.4	0.1	3.1	0.0	10.4	1.5	0.1	0.7	0.3	0.5	1.4	0.2	0.2	0.4	2.1	0.1	0.2	0.7	6.8	0.1	0.3	0.1	0.0	0.5	0.3	20.7	0.0	3.0	0.1	1.4	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	1.1	0.1	1.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.9	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	8.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.1	2.8	5.1	1.5	5.1	9.2	5.2	10.4	2.1	6.8	20.7	0.2	0.0	0.0	14.4	0.0	0.0	0.2	0.0	0.0	3.7	0.4	0.4	6.2	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.3	0.6	0.0	0.0	39.4	0.2	0.0	1.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	3.3	32.3	0.1	0.0	0.3	0.0	0.8	2.1	0.1	0.0	3.7	0.1	1.4	1.0	27.2	92.8	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.5	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134069071-134152001	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 342.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	7	"B-cells: 5.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 99.5;RH-30: 122.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		44000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	23.6	18.7	53.4	10.1	86.3	1.3	19.2	68.7	73.4	33.4	52.9	54.6	6.6	40.8	17.5	21.5	28.7	24.5	31.0	56.5	61.3	11.4	3.2	29.6	7.8	73.5	76.8	48.7	5.1	17.7	33.3	102.7	71.0	32.5	12.9	47.3	13.3	44.5	7.0	13.0	22.5	42.8	59.7	13.5	22.4	35.7	73.3	17.6	15.8	14.6	7.5	41.7	23.4	115.2	0.0	1.0	87.9	42.5	85.3	62.7	75.4	37.0	49.1	15.1	14.8	0.3	0.6	0.0	38.7	53.3	56.2	0.5	70.0	0.7	28.2	0.2	29.6	0.3	0.0	6.9	24.9	0.4	36.2	43.2	0.0	10.7	9.6	35.8	99.5	40.8	0.3	0.2	64.5	1.0	27.5	0.2	18.9	0.6	2.9	0.5	122.8	0.0	0.9	0.2	57.5	32.2	0.0	0.2	1.0	35.3	0.2	0.2	0.6	25.1	18.4	40.3	24.7	0.1	0.1	0.4	27.6	1.2	48.0	0.0	0.0	0.1	1.3	0.0	1.6	5.3	1.6	0.9	0.0	3.1	2.3	1.7	0.5	0.0	0.0	0.0	0.0	1.8	53.4	86.3	68.7	73.4	56.5	61.3	73.5	76.8	71.0	59.7	73.3	115.2	22.2	0.0	6.0	12.7	10.9	5.1	5.6	0.9	0.0	21.7	0.3	9.3	15.7	0.0	0.7	5.5	8.4	6.0	1.2	0.1	1.9	0.4	2.1	0.8	23.3	35.5	0.0	0.4	84.3	0.2	71.2	29.6	1.5	0.5	1.3	11.7	12.5	0.0	8.6	8.4	44.2	0.0	12.2	0.6	4.2	4.9	42.9	10.9	17.8	24.4	0.2	20.2	1.0	76.4	342.8	0.3	0.0	64.3	0.9	2.2	0.0	0.2	1.5	75.6	26.3	19.0	24.3	15.5	19.2	0.2	3.8	6.2	3.5	9.7	0.0	1.0
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180795	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 25.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.7;granulocytes: 25.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	15.4	83.8	11.1	10.9	12.4	24.4	11.7	11.5	16.5	62.4	12.4	32.8	3.4	41.8	21.3	10.1	16.4	12.4	22.4	13.2	15.3	5.1	15.7	10.1	14.6	7.3	8.3	13.9	6.6	6.3	13.4	16.1	9.1	29.5	8.3	7.8	4.6	35.2	6.9	7.1	8.3	38.6	8.1	14.6	8.3	18.8	17.4	11.5	14.9	6.9	15.9	19.2	27.3	10.0	1.4	0.8	4.8	1.0	35.6	42.9	0.0	11.1	28.6	18.4	22.8	0.1	7.6	33.7	22.6	23.5	12.5	0.7	6.3	8.5	15.0	5.1	10.2	12.2	7.7	0.0	24.2	4.8	3.1	19.4	10.2	13.8	8.9	14.1	11.8	2.2	0.3	53.2	10.3	1.4	1.3	17.5	10.0	0.2	7.7	3.6	2.2	10.1	6.7	0.3	3.0	4.7	9.2	0.3	12.0	14.0	3.5	6.1	11.7	29.0	11.0	8.0	12.9	9.2	2.9	12.5	9.2	12.5	16.2	25.6	3.9	6.9	4.8	3.3	1.3	2.8	1.3	3.2	3.7	3.7	0.5	3.0	1.5	4.1	3.5	13.7	3.2	3.1	11.1	12.4	11.5	16.5	13.2	15.3	7.3	8.3	9.1	8.1	17.4	10.0	10.2	3.2	7.0	57.8	33.4	14.7	3.0	3.8	3.4	6.7	3.5	4.8	25.3	10.0	3.0	1.8	6.2	0.5	37.9	1.3	7.9	14.8	122.1	28.3	160.1	14.5	5.4	115.6	316.6	2.3	1.4	24.6	9.2	18.6	24.1	12.6	3.6	5.5	9.4	16.8	306.3	0.6	2.0	25.7	45.6	89.8	55.0	28.0	23.2	168.6	35.5	4.4	40.2	241.3	262.5	5.3	0.4	34.6	8.7	2.7	0.0	2.4	12.7	4.7	13.1	9.9	15.3	8.7	16.5	3.4	11.2	1.4	25.3	1.6	0.3	1.5
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012803-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (2.54e-4)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	31.2	7.5	13.5	5.2	21.2	0.1	13.0	5.1	13.0	6.5	3.1	36.0	1.4	17.3	7.5	5.9	12.5	10.4	18.3	10.8	7.2	6.7	1.8	24.2	3.5	12.5	8.4	10.9	16.9	4.9	4.5	33.6	10.1	7.8	3.9	13.1	2.4	9.5	9.9	3.7	3.7	17.3	7.3	0.9	4.5	14.0	13.3	6.1	13.6	14.8	1.8	18.3	4.4	8.1	15.3	6.7	5.9	0.0	3.7	0.9	8.6	8.1	8.5	1.2	2.0	2.6	0.1	0.0	0.6	29.3	1.7	0.3	1.6	0.5	3.3	1.7	3.6	0.0	0.0	0.1	16.0	0.0	1.0	9.1	0.2	19.9	1.5	0.5	29.9	0.4	0.0	0.0	24.9	0.5	0.0	0.7	1.2	0.9	10.2	0.0	3.3	0.0	1.2	0.3	0.8	0.1	0.3	0.1	0.0	8.4	0.0	1.4	67.8	14.9	3.6	4.7	0.7	6.2	0.8	0.0	3.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	21.2	5.1	13.0	10.8	7.2	12.5	8.4	10.1	7.3	13.3	8.1	106.8	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	16.4	0.0	1.3	8.5	30.3	0.0	0.0	0.0	0.4	0.9	2.2	0.0	0.8	1.3	72.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	0.2	7.1	0.0	0.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Kupffer cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	53.5	20.0	23.2	29.3	22.0	78.6	40.2	22.8	28.2	31.6	22.0	31.6	22.5	22.7	3.7	25.4	28.5	27.7	39.1	23.5	24.2	18.9	20.5	47.2	13.1	24.6	22.9	21.6	23.1	8.1	17.3	17.5	22.6	21.8	11.3	16.4	24.2	15.0	21.9	29.1	30.1	20.9	22.6	66.8	23.3	4.7	25.4	4.8	25.1	16.7	10.6	25.3	31.6	21.8	15.5	13.5	2.5	26.8	81.5	60.2	90.5	47.5	51.0	30.4	38.1	33.0	13.5	12.4	23.5	90.7	5.6	59.5	16.7	16.2	13.1	16.7	1.9	17.0	26.0	11.9	167.1	24.1	1.3	106.5	95.2	12.4	30.6	11.9	1.5	13.8	2.2	23.0	27.7	76.4	1.4	39.8	9.1	30.4	8.7	8.2	0.3	34.0	14.8	8.6	2.1	10.4	48.9	69.4	55.1	29.7	66.4	52.1	6.2	38.1	57.5	2.4	7.0	18.7	6.0	28.8	11.5	90.0	19.1	0.1	4.5	4.4	0.0	8.1	0.0	11.8	0.2	0.0	2.4	5.1	0.0	0.0	7.7	0.1	13.2	2.1	0.2	1.4	23.2	22.0	22.8	28.2	23.5	24.2	24.6	22.9	22.6	22.6	25.4	21.8	70.7	12.8	33.5	26.8	9.9	16.4	6.0	5.8	19.9	21.8	26.2	18.2	17.7	12.8	8.1	9.2	10.4	1.4	1.2	20.0	0.0	2.4	0.3	21.6	18.4	21.2	5.4	0.8	18.9	6.6	5.6	49.5	10.2	23.9	2.5	10.1	10.4	8.5	9.7	8.4	20.8	14.9	4.1	87.7	25.7	1.5	18.0	47.3	12.4	14.0	13.8	38.6	2.1	18.1	3.0	8.5	8.2	16.6	9.8	2.6	17.7	3.0	7.4	31.1	6.6	47.2	19.5	0.1	0.9	19.7	8.9	0.3	2.2	5.3	8.7	11.5
JHY	"C11orf63, FLJ23554"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882683-122963862	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	6.0	1.8	1.7	2.2	2.7	1.1	3.6	3.4	2.4	3.1	17.3	3.5	1.5	2.1	2.7	1.8	7.4	2.6	2.2	1.8	3.8	7.8	0.4	4.5	2.2	4.1	5.4	3.2	2.8	5.6	4.8	1.3	3.8	3.5	1.7	1.6	1.4	2.5	0.2	1.9	1.9	2.0	3.8	2.5	2.0	35.7	3.2	3.2	5.1	0.8	2.0	2.6	1.8	3.6	2.8	3.9	2.2	0.1	0.6	0.4	0.7	5.9	6.8	2.5	1.1	0.3	10.3	0.1	1.5	9.1	13.6	2.4	2.7	1.4	1.1	9.5	2.8	0.1	1.8	0.1	0.9	1.7	4.7	2.8	7.4	0.4	0.6	6.3	3.8	4.1	0.0	0.1	2.0	1.8	0.1	0.6	0.3	8.2	3.5	1.0	0.0	1.3	7.0	3.2	5.8	4.2	7.1	3.9	2.6	2.8	4.7	0.6	1.2	7.9	1.0	0.2	4.8	0.1	0.0	0.1	2.1	2.1	5.3	0.5	0.3	0.1	1.3	0.1	1.8	1.1	1.3	1.7	2.4	0.6	0.9	1.0	0.4	2.4	0.1	0.6	0.3	0.5	1.7	2.7	3.4	2.4	1.8	3.8	4.1	5.4	3.8	3.8	3.2	3.6	4.4	12.8	4.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.2	0.0	0.0	7.4	5.5	0.0	0.2	2.2	0.0	3.9	5.5	0.0	41.5	3.1	1.1	0.0	0.0	0.0	1.4	0.9	2.2	0.0	8.7	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	12.0	19.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.8	1.3	0.0	0.0
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: AB_2686429"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	25.9	34.9	23.6	17.7	26.5	22.9	32.5	29.5	30.3	23.0	34.2	29.6	17.3	30.5	26.4	17.8	31.2	30.8	25.9	22.9	30.2	44.5	34.0	30.7	25.2	30.1	29.8	25.8	20.7	56.6	28.6	33.8	31.3	29.9	29.5	34.7	25.4	27.0	17.1	17.9	24.0	27.7	28.7	23.0	24.4	30.4	26.1	22.1	34.6	21.1	20.7	26.4	16.2	32.0	54.8	68.0	57.3	46.8	40.9	59.0	42.8	85.9	76.6	52.6	62.9	21.8	108.1	27.7	75.6	85.5	55.3	40.0	41.2	52.8	72.1	82.8	24.0	30.3	38.5	42.3	56.0	45.6	53.6	60.9	56.6	45.9	32.6	82.1	55.7	35.8	25.4	54.9	100.7	54.1	25.6	37.8	31.2	45.9	60.4	31.4	73.6	27.9	92.1	59.3	23.7	40.9	82.8	68.4	45.1	40.0	66.4	32.3	72.4	54.9	65.6	53.0	58.0	21.7	45.5	32.7	80.7	33.2	68.0	86.3	59.3	82.3	34.4	74.8	34.3	36.1	37.0	37.0	51.9	34.1	38.9	36.5	89.4	50.2	83.0	70.5	47.0	57.8	23.6	26.5	29.5	30.3	22.9	30.2	30.1	29.8	31.3	28.7	26.1	32.0	25.5	22.4	31.2	29.7	23.6	30.0	32.8	132.9	54.1	30.3	31.6	27.1	10.2	41.5	66.3	46.0	18.8	64.2	42.0	27.4	7.9	45.4	174.5	43.3	31.7	26.9	31.2	40.8	30.3	54.8	64.8	37.4	27.5	20.9	34.9	28.0	26.4	41.9	57.8	28.6	26.8	26.7	89.5	60.3	31.4	61.2	35.4	40.4	48.0	19.7	34.2	40.1	29.9	28.1	34.5	51.4	21.3	31.6	50.2	26.3	22.4	53.0	110.6	30.3	13.1	27.5	58.8	85.1	41.1	30.7	29.1	29.8	27.6	30.3	24.6	20.9
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 590.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	16.3	12.5	3.7	18.9	5.4	40.2	22.3	49.7	6.6	19.9	6.4	11.3	16.9	24.0	11.3	12.8	12.5	24.6	12.1	4.0	4.5	15.6	22.3	16.0	22.1	5.0	5.0	24.7	13.1	21.9	6.8	14.4	6.2	14.1	12.3	41.4	13.1	11.5	11.0	11.1	18.9	15.6	3.1	20.9	14.5	15.7	4.8	20.4	20.8	13.8	21.3	16.0	9.4	7.7	23.2	11.5	26.5	20.4	13.8	25.2	9.3	15.8	32.5	13.9	19.0	19.8	24.2	31.3	9.4	14.9	12.6	18.6	7.6	15.2	24.7	8.5	9.6	11.9	11.9	14.4	16.8	25.8	4.3	25.3	15.3	24.7	71.3	31.5	25.4	22.0	21.4	23.0	33.1	6.2	19.8	13.8	28.3	5.2	40.0	34.0	57.5	15.0	14.1	16.5	14.4	23.5	23.8	14.7	22.8	19.3	14.6	46.0	30.6	12.9	18.1	11.3	20.0	20.4	17.4	29.1	15.7	15.1	11.7	0.6	2.7	3.2	1.8	1.8	2.7	4.4	1.9	1.9	2.3	4.2	2.7	2.3	14.1	1.7	1.6	4.0	1.8	1.1	3.7	5.4	49.7	6.6	4.0	4.5	5.0	5.0	6.2	3.1	4.8	7.7	256.1	112.2	93.3	214.5	184.4	151.9	369.2	46.6	93.9	88.7	106.7	92.7	69.4	55.8	96.9	55.2	152.2	34.7	117.4	80.7	13.7	63.3	38.3	155.8	179.7	176.7	86.0	75.3	590.1	47.0	27.7	141.1	119.8	210.1	93.1	79.1	118.2	37.2	57.9	117.8	416.5	66.8	38.7	89.8	185.0	42.3	103.8	206.8	76.5	355.1	96.6	61.2	58.7	419.2	378.8	76.7	88.4	89.5	124.8	161.0	90.6	32.4	104.1	170.9	72.3	214.4	112.6	158.6	146.5	56.4	134.0	33.2	145.6	76.0	52.3	286.7
JMJD4	FLJ12517	ENSG00000081692	"Jumonji domain containing 4"	Q9H9V9	1	227730425-227735411	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.0;Late spermatids: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027260, HPA052861"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Vesicles	"HPA027260: AB_10602608, HPA052861: AB_2681975"	"unprognostic (1.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.68e-3)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.68e-1)"	6.8	12.8	8.5	4.8	7.9	3.6	7.1	7.7	9.4	6.2	8.1	6.2	4.3	8.1	4.8	6.8	7.0	4.1	7.4	8.6	8.4	7.4	11.9	5.2	6.9	9.0	9.2	7.9	9.6	5.8	10.0	4.0	9.3	9.7	2.4	1.6	8.7	5.6	10.2	6.0	6.2	4.2	8.3	9.0	5.9	14.8	8.6	6.5	6.4	4.7	4.4	6.8	4.6	8.9	18.4	26.4	8.4	9.3	9.0	5.1	31.0	11.3	11.6	17.0	10.4	22.6	15.2	24.3	16.8	10.7	9.1	18.1	5.8	17.9	2.0	13.2	29.4	14.9	13.3	17.8	15.8	15.7	7.1	9.0	11.1	16.2	11.8	6.7	8.8	17.5	19.7	7.8	8.3	15.4	19.5	8.3	14.6	13.9	42.2	17.8	10.3	21.9	10.1	16.7	16.4	11.1	10.8	37.4	14.5	4.3	30.2	16.9	7.7	8.6	8.8	10.6	21.0	14.5	5.0	9.3	8.6	7.6	24.1	3.2	7.2	2.8	11.1	7.4	12.2	8.7	8.4	7.7	6.6	8.6	13.1	11.4	0.7	14.3	4.1	13.2	10.2	8.0	8.5	7.9	7.7	9.4	8.6	8.4	9.0	9.2	9.3	8.3	8.6	8.9	7.0	6.4	7.2	4.6	7.9	4.1	8.0	8.6	1.8	14.0	16.6	13.2	3.7	4.3	7.4	7.3	0.0	13.1	7.2	8.8	5.9	21.7	74.0	5.2	11.0	6.9	9.0	13.9	4.4	28.9	14.0	9.7	10.7	4.9	7.0	12.7	6.8	14.5	16.9	11.8	3.3	6.9	2.0	7.6	2.1	204.9	11.5	6.1	12.4	2.8	11.0	12.2	13.4	3.0	2.1	23.7	5.6	4.1	14.7	11.0	12.9	12.5	7.7	14.7	6.6	6.7	8.2	36.1	7.5	7.4	4.7	9.6	7.3	13.3	7.3	7.5
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 121.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	30.3	27.0	14.2	17.0	16.3	121.7	19.6	19.2	29.5	20.2	15.3	32.3	15.4	19.4	7.4	18.8	22.4	18.7	41.2	14.3	16.5	18.3	18.5	26.8	15.7	16.2	16.2	27.6	18.0	11.0	22.4	16.2	16.2	19.9	10.3	29.5	15.2	10.7	38.2	15.6	18.4	16.0	14.6	21.1	24.4	17.8	16.9	13.4	16.6	28.1	12.8	23.9	20.4	20.8	39.0	53.3	18.0	23.5	22.6	19.4	17.6	34.7	26.8	49.6	47.6	53.6	18.7	25.3	14.9	37.6	72.6	28.8	57.3	17.3	47.2	18.6	45.9	37.3	37.5	54.4	36.8	19.7	55.0	23.9	26.8	54.2	18.2	31.6	41.6	13.8	57.1	45.2	37.0	24.4	34.7	28.4	15.9	37.3	62.4	27.1	33.6	39.2	16.6	12.1	31.1	31.1	30.2	43.7	43.7	30.4	39.5	28.6	27.7	56.7	33.3	29.9	65.8	50.6	28.8	23.4	55.7	17.4	32.5	50.8	28.6	40.2	24.7	37.8	24.0	20.5	28.4	28.2	25.9	13.0	23.3	22.2	23.3	14.6	39.4	22.4	31.0	20.1	14.2	16.3	19.2	29.5	14.3	16.5	16.2	16.2	16.2	14.6	16.9	20.8	44.1	25.6	22.9	9.1	29.3	83.2	79.9	46.1	67.2	16.5	30.8	42.8	30.5	14.3	29.2	9.2	50.1	29.0	96.5	33.1	17.6	28.1	30.3	39.1	29.6	36.0	39.4	13.0	6.6	27.4	52.9	37.9	33.1	58.6	65.2	18.6	28.2	10.2	32.7	6.7	7.4	32.0	24.4	19.5	79.2	12.5	16.1	52.4	58.7	3.7	26.9	11.8	21.6	7.1	7.9	29.6	32.1	17.7	50.0	38.5	40.8	7.9	20.5	35.4	13.1	32.7	69.2	59.6	27.2	48.8	73.6	30.5	80.4	29.9	31.3	60.2
JMJD7		ENSG00000243789	"Jumonji domain containing 7"	P0C870	15	41828092-41837581	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 31.2;RT4: 43.5"	"Low region specificity"	"Detected in all"							HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (2.92e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	6.7	8.4	6.3	4.2	6.2	8.2	9.0	19.9	9.5	13.6	8.0	7.3	4.8	6.5	3.1	35.4	8.6	6.5	11.2	5.8	6.3	10.1	10.3	10.8	7.3	5.8	5.2	11.6	15.9	9.0	9.8	3.0	7.0	14.5	3.0	1.9	21.9	6.8	7.7	33.3	8.0	2.9	5.1	7.9	11.5	6.7	5.9	5.6	15.6	6.6	6.6	11.4	21.0	7.0	7.9	7.5	9.3	2.6	2.5	1.7	5.8	3.1	6.6	5.1	4.1	10.5	5.9	1.0	6.4	2.0	5.3	19.6	4.3	15.6	1.6	7.7	4.6	10.5	10.4	6.5	4.1	5.1	11.0	1.1	13.6	3.4	7.2	4.7	5.8	9.9	7.0	6.2	3.7	10.8	6.6	4.9	4.0	31.2	4.8	2.9	6.3	7.6	11.5	43.5	9.9	3.5	2.6	13.5	4.3	2.7	26.2	5.4	5.4	3.7	8.3	8.0	6.1	10.2	3.7	3.2	4.9	12.4	5.7	6.1	14.8	10.8	14.1	15.8	14.8	7.2	15.7	18.6	10.6	11.1	19.7	15.6	3.9	13.0	15.8	6.7	16.7	12.6	6.3	6.2	19.9	9.5	5.8	6.3	5.8	5.2	7.0	5.1	5.9	7.0	0.1	3.2	5.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	2.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	3.4	0.1	0.0	0.6	0.0	0.0	0.0
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Club cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RT4: 2.6"									HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	1.1	0.3	0.1	0.8	0.0	1.0	0.9	0.3	0.4	1.4	0.5	0.9	0.2	1.1	0.4	1.9	1.1	0.4	0.6	0.1	0.1	0.4	0.3	0.9	0.2	0.1	0.1	1.2	0.5	0.9	0.4	0.1	0.3	0.7	0.2	0.2	1.5	0.4	0.8	2.8	0.8	0.6	0.1	0.6	0.8	0.3	0.3	0.4	0.8	0.5	0.3	1.0	1.4	0.2	0.2	0.0	0.6	2.0	0.5	1.3	0.7	0.4	1.1	0.5	0.8	0.8	0.0	0.2	0.8	0.5	0.0	1.8	0.2	1.2	0.1	0.0	0.2	0.3	0.4	0.2	1.9	0.0	0.9	0.7	0.9	0.2	0.4	0.0	0.2	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.8	0.5	2.6	0.6	0.8	1.8	0.0	0.2	0.0	0.4	2.1	0.3	0.3	0.2	2.0	0.7	0.5	0.2	0.0	1.0	0.2	0.2	0.0	0.3	0.0	1.1	0.4	0.5	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.1	0.3	0.2	0.2	9.6	4.8	0.0	0.9	0.1	0.2	0.1	2.2	0.6	0.4	0.1	0.6	1.5	2.7	0.0	0.0	0.2	0.1	1.1	0.0	0.6	0.0	0.1	0.3	0.4	2.4	0.0	0.0	0.5	0.1	0.2	1.5	0.4	1.3	0.1	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	1.0	0.0	0.1	1.1	0.5	0.0	2.3	0.1	1.2	0.0	0.9	0.6	0.0	0.1	0.2	0.0	0.1	2.0	1.0	0.1	1.0	0.1	1.2	0.1
JMY	"FLJ37870, WHAMM2"	ENSG00000152409	"Junction mediating and regulatory protein, p53 cofactor"	Q8N9B5	5	79236131-79327211	"Predicted intracellular proteins"	"DNA damage, DNA repair"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 25.2;Karpas-707: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037508, HPA043308"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA037508: , HPA043308: AB_10806502"	"unprognostic (1.87e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (7.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.15e-1)"	4.5	5.0	5.7	3.4	6.7	10.3	5.8	8.3	7.8	7.3	4.5	10.9	3.2	11.8	7.1	4.9	5.3	4.7	5.0	5.8	5.3	6.4	5.2	4.0	4.2	5.8	5.7	13.3	9.4	11.4	4.8	3.2	6.3	6.4	4.3	11.8	7.4	5.8	8.9	6.7	4.4	7.2	4.9	4.9	5.1	7.3	6.6	5.5	10.2	7.7	4.1	6.0	5.6	7.3	3.8	3.6	2.7	7.1	7.4	6.7	9.5	3.5	9.1	3.2	5.1	1.7	4.1	2.6	25.2	4.0	3.7	4.1	9.6	4.7	5.1	11.5	8.8	5.2	5.9	3.6	11.3	2.3	3.3	6.4	12.3	1.5	13.9	6.6	4.0	6.9	3.2	43.7	2.7	5.0	5.0	4.9	4.5	0.8	2.4	4.9	8.7	11.2	6.9	3.9	10.7	5.8	4.5	4.9	8.3	4.5	4.0	4.8	4.2	1.4	2.4	0.8	2.3	12.3	11.5	2.6	2.8	2.3	2.3	0.0	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.3	0.0	0.1	0.4	0.3	0.1	0.9	0.0	0.2	0.3	0.0	5.7	6.7	8.3	7.8	5.8	5.3	5.8	5.7	6.3	4.9	6.6	7.3	18.9	9.6	14.9	35.6	36.7	29.8	11.3	11.0	24.5	35.7	14.9	13.7	40.7	15.7	17.4	16.5	43.8	6.4	49.8	6.1	1.9	8.1	35.6	36.3	35.2	16.7	23.9	18.7	55.5	9.8	5.4	24.6	15.8	53.9	8.2	28.8	8.6	15.4	4.4	40.4	53.6	8.3	10.2	9.3	21.0	21.5	24.2	35.8	23.2	15.9	5.2	20.5	9.2	47.7	42.5	10.7	7.6	35.7	85.2	21.4	6.8	7.8	24.9	40.8	13.1	29.6	27.7	37.1	39.2	19.8	39.8	20.2	56.5	34.6	7.6	17.6
JOSD1	KIAA0063	ENSG00000100221	"Josephin domain containing 1"	Q15040	22	38685543-38701556	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001168	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA001168: AB_1079162"	"unprognostic (6.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.41e-1)"	33.6	22.1	30.7	25.0	32.6	89.6	25.0	30.9	34.2	24.0	23.2	40.9	27.5	25.6	14.8	23.0	28.0	34.1	24.6	33.0	27.7	20.0	23.8	30.9	21.8	29.9	28.7	48.9	25.9	16.8	27.8	22.7	30.6	23.1	38.4	21.5	21.3	18.2	24.4	27.4	35.8	27.8	29.2	22.7	24.8	19.2	29.2	27.9	22.3	22.0	24.3	33.1	22.9	32.6	69.6	24.5	35.1	45.7	44.1	53.5	26.6	52.2	62.1	66.5	69.3	40.5	34.4	66.3	26.4	52.6	44.3	43.8	49.2	46.4	53.4	71.4	32.6	35.2	57.3	34.9	74.9	63.8	33.1	46.7	67.8	62.9	107.1	58.3	79.8	41.0	32.0	68.2	49.4	29.4	27.9	25.9	13.3	41.8	27.5	49.5	51.5	27.9	36.1	35.3	32.3	17.4	59.9	29.3	54.7	29.2	29.4	18.2	70.0	39.4	48.1	51.4	32.1	74.9	71.1	54.2	52.4	33.5	37.5	1.0	1.8	1.9	2.6	2.8	1.8	1.6	2.2	3.4	1.3	1.6	2.3	3.7	3.6	2.3	1.6	1.0	3.2	1.4	30.7	32.6	30.9	34.2	33.0	27.7	29.9	28.7	30.6	29.2	29.2	32.6	45.0	25.6	17.1	12.7	53.1	46.4	75.0	20.2	34.7	28.2	41.0	45.1	17.0	44.3	18.5	36.8	22.9	10.5	94.1	133.1	13.7	34.6	4.9	51.6	38.6	35.3	23.4	21.0	25.2	39.3	15.0	24.2	53.5	114.5	16.5	26.9	23.9	24.8	22.7	18.5	21.7	61.8	12.2	32.6	106.3	4.8	12.8	74.2	16.0	6.5	27.3	27.5	12.3	7.1	24.6	68.0	88.1	13.9	61.5	62.4	64.6	18.1	17.4	23.6	13.1	27.9	27.3	16.2	24.2	35.5	51.6	12.9	75.2	17.8	35.0	102.7
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 99.3;Ductal cells: 90.1;Endometrial ciliated cells: 107.3;Extravillous trophoblasts: 205.9;Glandular and luminal cells: 77.5;Pancreatic endocrine cells: 78.9;Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041888, HPA041908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 22: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favorable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	21.2	17.0	12.7	18.6	21.1	11.3	36.4	33.2	19.8	39.5	14.1	32.7	21.9	21.1	17.9	47.7	63.4	13.6	20.3	12.0	16.3	48.8	41.1	20.0	19.9	58.0	27.8	19.8	29.6	20.9	15.1	48.1	46.9	47.9	30.5	4.6	26.6	18.2	17.5	31.3	24.2	19.5	28.4	12.8	28.2	18.1	25.6	35.5	27.7	14.0	31.3	31.2	25.9	51.7	148.1	147.5	168.4	93.9	23.9	39.3	151.9	143.6	44.8	117.7	99.8	194.5	188.3	94.6	107.8	71.1	116.4	141.9	223.5	194.2	135.7	77.2	135.2	78.4	80.2	111.4	36.7	93.5	44.8	28.1	121.6	116.4	149.6	64.9	75.7	85.4	187.5	37.0	68.6	169.5	117.1	46.6	185.3	164.4	112.0	212.7	159.3	136.2	186.2	82.5	156.1	85.6	214.9	205.3	66.5	161.1	250.3	59.6	87.9	113.9	201.1	54.8	141.1	31.5	136.3	198.8	35.8	71.5	170.5	2.1	3.7	4.1	5.2	3.3	7.2	4.8	5.8	4.2	2.8	7.6	6.3	5.4	0.3	6.8	1.7	6.6	5.8	4.4	12.7	21.1	33.2	19.8	12.0	16.3	58.0	27.8	46.9	28.4	25.6	51.7	11.9	25.6	10.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	33.3	23.4	0.0	0.0	12.4	9.2	0.0	99.3	4.5	0.0	43.0	90.1	0.0	107.3	19.2	8.5	0.0	0.0	0.0	25.6	205.9	7.4	0.0	77.5	2.5	23.4	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	28.4	0.0	0.0	0.0	0.0	78.9	0.0	0.0	1.2	0.0	0.0	26.0	27.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	168.7	3.6	18.9	0.0	0.0
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.1;Late spermatids: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	7.4	6.2	4.2	7.6	4.4	1.7	8.8	4.5	4.9	9.8	4.3	7.1	7.2	8.4	7.4	5.9	10.1	6.6	6.1	4.0	5.3	6.7	4.2	6.2	9.3	4.7	4.7	13.2	5.1	6.9	4.1	8.4	4.8	8.4	9.0	11.1	8.8	6.9	4.1	7.8	8.4	6.9	4.4	7.5	8.6	11.7	4.7	9.6	9.6	4.4	9.2	6.8	6.0	5.3	9.4	5.8	11.8	8.9	23.1	25.7	8.6	15.6	10.5	10.9	14.2	9.8	22.2	12.8	22.3	14.4	13.9	14.5	5.9	10.6	12.6	13.9	5.5	11.9	17.0	7.5	18.7	6.8	7.4	12.2	16.3	15.8	19.6	20.3	10.0	14.5	6.4	5.5	17.9	1.9	8.8	19.8	1.8	16.7	7.9	8.9	11.5	10.5	13.5	9.7	4.7	8.6	9.1	6.2	7.1	11.0	7.6	9.1	12.4	21.1	9.4	18.6	6.4	4.7	10.9	7.5	9.8	10.9	9.2	3.3	2.6	2.6	1.6	2.1	2.3	2.2	2.6	2.0	2.6	1.6	3.2	2.9	0.9	1.8	2.5	4.1	1.3	1.6	4.2	4.4	4.5	4.9	4.0	5.3	4.7	4.7	4.8	4.4	4.7	5.3	6.2	9.6	5.8	4.2	5.0	4.7	10.3	6.6	2.8	7.4	7.6	8.9	6.8	15.7	12.0	0.0	4.2	6.0	11.7	9.0	1.9	11.5	171.1	9.9	13.6	5.8	6.0	4.8	3.4	5.1	5.0	9.9	7.1	6.8	3.8	5.0	6.4	2.2	5.0	8.4	3.0	10.5	4.1	7.2	5.2	49.3	8.4	6.0	1.8	1.0	6.9	5.2	6.2	3.5	8.2	8.2	4.5	9.4	2.4	8.4	7.6	6.1	25.3	12.3	0.0	6.0	9.6	9.9	4.9	5.3	6.0	4.0	4.8	7.5	9.7	8.4
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"skeletal muscle: 335.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8"	"Group enriched"	"Detected in many"	6	"amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1"	"Not detected"	"Not detected"			HPA044741	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		13000	"Cluster 24: B-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	0.2	0.1	0.4	0.9	0.4	0.4	0.4	0.4	0.4	0.3	0.2	1.5	2.9	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.4	0.6	0.3	0.7	0.5	0.3	0.3	0.1	0.5	0.0	0.3	0.0	0.3	1.9	0.1	0.0	8.9	0.0	335.4	0.3	1.4	0.0	0.3	5.4	1.7	1.9	0.5	0.1	0.6	18.6	0.6	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	26.8	0.0	0.0	0.2	0.0	0.0	0.0	46.6	0.1	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	7.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	26.7	109.8	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	444.1	57.8	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.5	0.3	0.1	0.0	5.3	0.0	31.7	0.5	0.3	0.2	0.6	0.8	0.6	0.4	0.6	1.5	0.1	0.0	2.1	0.2	0.7	1.7	0.0	1.8	19.0	0.7	0.3	0.3	5.4	1.3	0.2	1.0	0.6	1.1	1.5	1.1	6.3	2.9	0.7	0.6	0.5	0.0	0.1	2.3	2.0	1.3	2.2	18.2	0.6	1.1	46.2	0.0	0.0	0.5	1.0	0.0	0.1	1.0	0.3	0.0	139.4	0.3	0.6	0.4	1.7	0.5	0.0	132.6	0.6	7.6	1.9	0.2	1.0	0.3	5.0	0.5	0.7	0.2
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977674	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006514	Approved		Uncertain	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	105.6	119.8	121.1	60.4	125.1	127.0	103.0	122.3	153.9	99.8	149.0	117.8	89.5	89.8	96.3	110.8	91.8	53.7	121.0	120.8	122.2	135.4	207.1	110.2	80.4	125.4	122.2	98.4	232.2	93.9	185.9	68.0	121.5	131.0	86.7	49.8	162.0	68.0	166.5	99.8	115.3	50.1	123.3	136.9	164.8	46.6	126.6	77.7	120.5	82.7	80.2	96.3	89.4	123.4	206.3	139.4	57.9	108.0	189.0	116.2	163.5	144.6	142.3	95.9	96.0	135.3	166.7	193.7	198.7	171.8	59.1	181.0	151.0	113.2	78.1	180.5	296.0	112.5	158.4	139.0	198.1	221.4	165.7	110.4	210.4	101.1	119.1	131.0	115.4	223.7	169.3	139.2	68.4	359.6	161.5	280.5	125.8	402.1	239.1	163.9	79.3	393.1	123.7	110.9	158.4	158.8	115.3	332.7	208.4	107.4	209.1	316.4	89.6	46.5	80.4	144.4	189.0	201.8	244.7	211.3	114.5	209.6	103.7	98.7	119.5	173.2	74.7	86.4	90.9	143.5	104.0	118.7	88.9	139.9	107.0	85.6	104.9	85.3	96.5	147.4	98.5	97.7	121.1	125.1	122.3	153.9	120.8	122.2	125.4	122.2	121.5	123.3	126.6	123.4	127.7	80.1	101.1	15.7	184.3	156.8	177.4	227.5	104.7	56.6	253.4	207.3	96.5	213.1	171.4	99.3	22.9	308.8	237.3	273.4	258.2	251.9	7.1	145.0	95.3	120.4	212.0	178.8	26.3	411.8	405.0	155.6	149.9	125.9	82.5	113.2	125.7	341.3	289.1	57.2	24.0	423.4	213.6	235.8	185.8	20.1	151.6	176.3	170.7	19.7	207.9	140.4	257.5	19.6	29.1	274.1	302.2	123.4	344.8	346.0	368.2	274.1	138.2	60.2	105.2	105.3	114.0	58.9	71.5	173.4	190.2	289.5	173.6	136.6	315.2	304.0
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791486-12793315	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 679.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 679.4;monocytes: 182.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	722.8	259.5	22.9	110.3	28.0	455.2	248.5	90.1	65.2	283.3	30.4	287.0	52.8	130.1	2.2	449.1	874.8	92.6	383.5	28.3	68.8	184.2	279.0	399.2	65.0	83.5	29.8	649.5	150.0	20.8	351.9	39.4	33.6	195.0	22.0	32.0	131.6	56.1	144.6	605.9	145.0	58.1	51.5	153.3	309.8	30.0	31.3	78.8	198.7	73.3	12.9	333.0	330.6	34.8	52.9	10.4	2.8	6.4	11.3	27.4	10.2	22.8	19.2	11.0	10.0	6.8	30.4	18.2	77.4	8.4	33.5	98.5	2.5	34.3	1.2	629.0	9.9	18.0	42.2	9.0	15.1	24.3	80.5	34.9	97.6	10.0	7.5	22.0	5.3	12.9	48.1	32.6	3.6	158.8	16.8	147.5	1.7	36.1	40.0	22.4	7.7	38.8	7.5	65.5	23.7	36.0	98.4	59.5	30.5	1.7	10.5	27.0	17.6	32.2	18.7	64.3	28.9	256.4	411.4	17.1	37.7	62.7	8.9	29.1	132.2	132.2	33.4	182.7	33.4	30.6	36.8	42.0	87.1	25.4	25.5	28.5	679.4	18.6	177.2	7.9	38.7	124.1	22.9	28.0	90.1	65.2	28.3	68.8	83.5	29.8	33.6	51.5	31.3	34.8	3158.0	115.4	423.2	130.2	1751.7	1463.9	1778.3	2367.7	1985.1	81.0	1296.9	1693.1	374.0	474.7	707.4	154.5	39.6	129.7	1766.9	819.7	49.0	833.3	9.5	468.5	1091.4	1469.5	1502.1	244.8	8.7	546.7	224.7	2182.3	1060.1	627.8	510.5	310.0	852.4	84.6	1178.4	21.9	4.4	1029.3	740.6	674.1	2747.6	27.9	815.2	1583.3	894.6	20.6	379.3	634.6	115.4	4.5	2.4	1026.7	875.3	263.3	842.5	1036.7	701.0	84.2	337.3	168.8	1163.6	2566.6	2624.1	9.4	10.5	1164.3	1804.1	440.3	2362.6	417.0	687.7	472.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279694-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 2129.8;dendritic cells: 1844.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favorable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	296.3	189.3	190.3	38.9	201.6	429.1	257.3	172.1	208.5	159.7	153.1	185.2	62.9	186.6	37.5	118.3	291.4	30.0	210.6	187.5	192.5	148.8	211.8	227.3	28.8	261.3	213.2	424.2	178.4	40.4	256.4	45.1	180.9	159.1	33.0	25.7	112.7	33.8	81.0	287.7	161.3	57.5	182.5	100.5	201.4	97.4	180.4	58.2	154.8	37.1	15.9	129.5	147.7	263.8	84.2	35.3	33.3	37.9	25.9	28.8	150.5	35.0	40.8	19.2	25.4	38.3	72.9	42.1	39.4	34.8	31.1	46.1	8.2	8.3	9.5	84.6	75.9	62.7	30.3	84.9	58.6	29.5	81.4	27.8	33.7	20.0	25.9	44.5	15.3	18.8	86.5	119.8	5.2	113.6	89.9	92.5	69.7	22.7	50.6	32.7	20.9	94.0	27.8	13.1	184.2	75.1	41.7	45.4	122.0	37.5	38.6	43.9	54.7	11.8	54.8	74.4	20.9	171.3	73.8	36.3	41.5	44.7	27.9	10.5	6.5	6.8	4.9	8.2	3.8	8.4	6.4	4.5	4.9	8.7	4.5	5.0	19.7	4.8	8.3	11.3	5.7	2.4	190.3	201.6	172.1	208.5	187.5	192.5	261.3	213.2	180.9	182.5	180.4	263.8	2129.8	179.5	386.7	104.5	1176.8	317.1	400.4	76.0	188.4	129.8	1147.5	1419.1	158.8	291.7	84.4	257.5	79.2	78.5	1844.7	810.5	31.3	96.5	80.8	1026.0	1289.3	468.1	568.8	78.3	51.6	140.8	112.9	950.9	336.4	1561.4	257.7	514.1	338.4	436.1	100.1	139.7	41.0	569.6	67.1	332.7	506.0	59.2	123.3	847.7	249.1	65.6	91.7	625.2	27.8	44.7	132.0	154.4	464.2	88.8	734.5	253.6	538.1	65.4	90.4	174.3	131.5	1064.7	798.4	11.8	22.7	172.0	394.1	164.3	1158.2	448.7	297.4	232.7
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358285	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.6;pancreas: 1.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.7;Glandular and luminal cells: 2.7;Proximal tubular cells: 1.1;Spermatocytes: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;EFO-21: 4.1;Hep G2: 5.3"									HPA036021	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	4.6	0.9	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	3.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1434.2;Inhibitory neurons: 480.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	9.4	6.3	15.0	2.2	23.4	0.3	6.7	0.0	31.3	9.1	4.9	2.0	2.5	7.7	1.9	9.5	4.6	2.9	12.8	21.3	3.4	3.8	5.8	4.4	0.9	0.0	6.6	3.1	8.8	3.5	4.1	4.2	0.0	2.8	1.8	4.5	2.8	4.9	27.2	2.0	2.0	6.2	0.0	8.5	12.1	2.6	10.7	0.5	5.1	19.3	1.6	2.6	6.0	20.9	0.7	1.1	6.2	1.3	0.9	0.2	8.1	2.5	1.5	2.4	1.1	57.4	4.5	0.2	0.8	6.4	3.9	0.4	1.4	0.0	2.0	0.0	0.7	35.3	0.4	8.9	0.1	0.0	0.0	0.4	0.0	0.5	0.1	2.6	2.9	0.1	8.3	0.2	0.7	4.2	0.0	0.0	3.5	20.1	5.4	1.8	2.8	0.0	0.2	0.5	2.1	15.9	0.7	0.5	0.5	6.0	1.2	0.1	14.4	7.0	2.8	1.0	1.1	0.0	0.6	0.0	0.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	1.6	0.4	15.0	23.4	0.0	31.3	21.3	3.4	0.0	6.6	0.0	0.0	10.7	20.9	56.2	3.2	3.9	191.3	0.6	1.7	1.5	0.3	0.6	61.2	6.1	7.1	32.1	18.6	0.5	16.5	6.2	8.0	2.5	40.5	1.9	5.0	57.0	15.0	18.8	23.2	9.6	5.3	1434.2	8.4	1.7	5.9	29.0	7.4	3.8	4.4	45.3	21.7	1.0	0.0	480.8	16.4	0.0	1.6	1.1	64.0	3.7	5.3	3.6	48.7	0.0	4.7	8.2	162.3	63.1	4.4	21.0	33.1	0.3	2.6	34.8	3.6	8.4	2.7	19.7	8.8	21.8	5.2	2.6	4.9	1.1	14.2	1.0	17.5	12.3	1.6
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 355.5;Late spermatids: 228.7;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.1;dendritic cells: 4.0;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	42.6	9.6	49.0	9.5	52.7	1.5	31.2	42.3	47.5	40.9	61.8	49.2	12.1	62.2	13.0	64.6	31.7	15.2	88.2	45.1	44.9	31.6	101.9	13.6	7.6	51.6	44.9	22.1	28.3	9.4	27.9	25.8	48.3	42.5	14.9	11.0	29.9	31.8	66.4	51.8	23.6	37.4	47.6	6.9	25.9	15.4	48.4	9.4	30.8	39.9	11.8	70.1	52.3	48.9	5.9	12.2	4.0	72.0	57.8	21.9	19.9	37.1	25.8	3.1	3.7	30.2	2.5	46.2	8.9	46.0	7.0	12.3	15.7	30.4	5.3	22.7	8.3	0.1	17.0	96.0	8.1	11.2	0.0	12.6	41.6	3.2	35.6	13.2	31.2	1.6	2.4	56.4	23.1	14.4	4.5	46.9	5.3	8.9	9.0	1.7	7.9	8.6	24.5	36.1	1.8	0.0	3.6	10.9	50.9	33.3	7.1	8.7	46.1	8.4	3.2	10.8	17.1	9.8	61.9	0.2	5.6	21.1	15.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	1.3	0.4	0.4	1.1	2.4	0.8	0.0	0.1	0.0	4.0	1.7	0.5	49.0	52.7	42.3	47.5	45.1	44.9	51.6	44.9	48.3	47.6	48.4	48.9	18.3	12.8	34.2	355.5	4.9	23.1	102.1	11.4	37.0	22.2	16.8	18.0	94.1	24.3	8.1	18.4	41.7	89.2	15.7	8.3	7.9	11.6	102.3	14.2	15.4	21.9	18.0	9.1	12.1	7.9	6.8	21.8	7.7	13.1	1.3	38.5	23.6	70.0	13.3	0.0	29.0	12.8	4.1	6.9	6.5	228.7	32.3	3.3	23.2	60.9	1.2	6.5	0.0	322.7	191.4	9.6	7.5	20.7	10.7	50.5	17.6	13.6	7.0	20.2	26.3	129.9	24.0	28.4	25.6	36.2	25.7	66.2	4.7	6.9	26.0	63.6
KANK2	"ANKRD25, KIAA1518, MXRA3"	ENSG00000197256	"KN motif and ankyrin repeat domains 2"	Q63ZY3	19	11164270-11197791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 402.5;Endometrial stromal cells: 149.6;Leydig cells: 126.2;Peritubular cells: 225.7;Smooth muscle cells: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 327.8;ASC TERT1: 365.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015643	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA015643: AB_1844839"	"unprognostic (2.37e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.63e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	150.2	55.5	25.7	50.5	27.2	17.9	97.7	22.8	25.6	275.3	24.5	413.2	36.8	376.9	64.6	139.1	222.1	125.0	200.5	20.0	27.9	54.1	51.3	134.5	20.7	29.5	26.5	213.9	35.4	14.3	29.8	62.3	29.0	140.5	58.7	19.0	39.3	173.6	56.9	49.7	108.0	277.7	23.8	57.8	123.7	25.0	29.5	15.7	71.7	51.1	12.4	255.2	148.5	22.6	42.4	91.1	28.3	30.3	327.8	365.1	20.2	188.9	161.0	92.1	76.2	36.3	27.0	177.2	88.1	234.3	59.6	40.0	25.6	13.7	61.3	9.3	18.4	77.2	105.6	37.5	123.9	11.8	21.4	158.7	20.1	67.3	9.0	237.2	37.8	5.5	51.5	14.3	143.6	75.7	2.3	9.9	31.4	27.5	95.1	59.7	234.8	42.2	65.4	22.7	16.6	51.7	188.2	16.4	22.4	32.7	25.1	41.2	139.1	131.5	52.6	170.1	75.2	13.7	32.9	61.3	111.0	66.3	136.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	25.7	27.2	22.8	25.6	20.0	27.9	29.5	26.5	29.0	23.8	29.5	22.6	34.1	57.7	28.3	7.8	1.3	6.2	5.5	5.2	2.2	2.0	5.2	7.1	402.5	27.1	12.0	20.2	20.9	6.9	0.6	2.5	3.9	8.1	2.4	12.7	149.6	41.2	0.0	76.2	0.9	4.4	4.9	69.2	13.3	11.9	7.6	7.7	32.5	28.2	22.5	0.0	4.1	2.6	4.1	10.6	15.1	3.8	126.2	6.3	8.8	42.2	0.5	34.9	4.1	1.0	1.4	11.9	1.2	225.7	0.8	6.7	1.6	3.7	8.0	23.4	92.1	79.2	131.0	1.8	7.2	2.8	7.7	2.3	2.3	7.7	5.2	8.4
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236165-62319434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6;pancreas: 15.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.7	0.5	1.0	0.5	5.8	0.0	2.6	10.1	3.2	0.3	0.1	1.0	0.3	0.2	0.7	0.2	0.3	0.5	0.3	0.8	4.6	1.4	3.0	2.5	0.0	19.2	13.8	0.3	15.2	5.6	0.1	10.8	22.6	1.5	1.0	1.0	8.4	0.6	0.2	0.5	0.3	0.2	5.3	0.8	2.0	0.9	7.6	0.8	0.3	0.8	0.0	0.2	0.5	8.9	0.0	0.0	1.1	0.0	0.0	0.0	31.8	0.1	0.0	0.1	0.0	4.8	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.4	13.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.0	1.0	0.6	0.0	27.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	5.8	10.1	3.2	0.8	4.6	19.2	13.8	22.6	5.3	7.6	8.9	0.1	0.0	0.0	1.3	0.0	0.0	2.4	0.4	0.6	0.3	0.5	7.0	0.9	0.0	0.0	0.0	0.0	31.8	0.0	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	2.3	8.0	19.0	0.9	0.0	0.1	0.0	0.1	0.4	1.5	2.3	0.0	2.3	1.4	0.0	0.0	0.0	0.3	0.0	0.4	1.8	1.0	0.0	0.1	0.0	0.5	34.3	0.4	0.2	3.8	0.0	0.0	0.0	0.8	0.0	0.5	0.0	1.2	4.2	0.0	1.0	0.2	0.0	5.5	0.1	0.0	1.0	0.1
KANSL1	"CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1"	ENSG00000120071	"KAT8 regulatory NSL complex subunit 1"	Q7Z3B3	17	46029916-46225389	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006874, HPA007208"	Approved		Supported	Nucleoplasm		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006874: AB_1852393, HPA007208: AB_1852395"	"unprognostic (2.46e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (1.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.79e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-2)"	12.3	9.2	3.7	7.6	4.4	12.9	11.3	13.8	6.7	14.2	2.1	11.7	4.2	15.3	9.1	12.9	11.7	4.1	7.3	4.1	4.0	8.4	5.8	9.4	7.6	4.2	4.7	15.2	12.4	11.9	9.0	7.2	5.4	9.1	8.4	9.4	11.1	4.5	16.4	17.2	12.0	9.8	3.6	9.2	10.0	17.5	4.8	16.9	12.0	9.0	9.7	12.7	13.1	5.8	3.1	2.4	11.2	5.1	2.5	4.0	7.0	3.0	5.8	5.4	6.4	11.6	0.9	11.8	4.9	12.5	16.2	6.7	22.6	8.1	10.7	14.9	11.3	1.6	5.8	14.3	17.3	1.3	4.3	4.1	17.2	12.2	19.6	7.6	13.4	18.6	5.1	12.3	12.1	4.5	42.5	2.9	3.4	2.8	14.1	24.3	21.9	20.2	8.3	7.4	5.7	13.8	15.3	0.5	9.8	29.8	17.4	21.5	11.8	23.2	13.5	9.0	3.2	20.6	15.2	17.6	6.4	6.4	16.2	0.0	0.1	0.3	0.2	0.1	0.2	0.4	0.3	0.5	0.0	0.1	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	3.7	4.4	13.8	6.7	4.1	4.0	4.2	4.7	5.4	3.6	4.8	5.8	53.4	32.1	36.7	226.9	47.7	27.1	19.7	22.4	42.7	68.1	57.4	39.5	13.2	20.0	18.2	47.8	102.2	15.0	95.5	35.0	1.9	37.1	162.9	58.2	80.2	40.9	31.8	22.1	334.6	25.4	20.4	33.3	33.1	85.9	24.1	111.4	30.4	25.3	21.1	69.0	326.7	29.2	28.5	41.7	25.3	136.6	34.8	38.1	21.4	327.9	52.3	23.6	60.8	313.6	346.4	40.8	27.2	30.1	60.1	33.7	28.9	12.7	18.9	78.5	26.3	42.0	43.7	29.4	50.9	48.9	30.1	14.6	70.6	71.6	27.2	32.7
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021421-210171409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 198.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.6;Inhibitory neurons: 117.9;Microglial cells: 103.0;Oligodendrocyte precursor cells: 190.5;Oligodendrocytes: 158.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA043102: AB_2678316, HPA046790: AB_2679808"	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	11.6	8.3	10.7	6.2	13.5	5.5	10.3	14.3	9.2	14.4	8.9	9.9	6.5	18.7	17.4	6.9	13.2	15.7	9.7	9.7	11.7	22.7	9.4	11.9	6.7	11.3	12.6	28.5	15.2	198.9	10.0	8.3	12.0	16.9	6.8	12.5	10.0	17.0	12.1	13.3	6.7	13.3	10.6	6.3	12.4	25.3	10.8	26.7	19.7	18.4	5.2	13.6	11.3	17.7	2.7	1.4	14.5	6.1	11.7	8.7	4.0	4.1	5.4	2.7	7.4	2.7	10.9	7.9	5.5	2.8	6.5	3.8	3.4	1.5	4.3	3.4	2.7	6.3	6.1	4.6	7.3	7.4	4.3	5.5	6.5	2.7	1.9	11.5	6.1	7.2	4.5	7.1	4.1	2.7	8.5	19.7	8.4	4.8	1.9	6.1	3.9	6.1	16.0	4.0	9.0	8.5	3.7	2.3	2.9	14.4	2.5	16.1	4.9	5.3	4.3	1.9	3.1	4.9	2.2	7.7	7.0	3.5	7.1	0.2	0.3	0.5	0.2	0.4	0.2	0.1	0.2	0.2	0.4	0.3	0.3	0.3	0.4	0.6	0.1	0.3	0.1	0.1	10.7	13.5	14.3	9.2	9.7	11.7	11.3	12.6	12.0	10.6	10.8	17.7	12.8	28.9	20.1	113.6	4.6	7.4	6.7	3.9	11.4	8.6	5.4	6.7	9.2	20.0	6.6	31.3	14.6	1.7	1.5	2.3	3.9	13.2	30.3	22.3	17.0	8.8	6.0	4.6	79.0	5.5	0.9	14.2	9.2	14.7	10.8	23.6	6.4	7.4	2.7	5.0	117.9	3.2	8.2	2.8	6.7	22.2	14.6	8.5	7.2	103.0	5.5	9.6	4.1	190.5	158.9	6.7	4.7	30.1	3.0	7.0	2.0	15.8	36.0	8.7	13.1	31.1	15.6	44.9	7.8	5.5	11.1	1.9	2.7	6.6	2.8	4.1
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653211-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: AB_2676046"	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.32e-4)"	11.9	11.4	6.0	8.2	7.0	41.8	12.2	8.6	8.0	13.9	7.3	11.8	8.1	14.1	11.5	13.3	12.6	7.7	13.4	6.5	6.9	12.2	9.8	10.9	13.9	7.0	6.5	16.3	9.7	12.2	9.3	12.2	6.7	11.1	9.3	11.8	13.0	8.3	40.7	13.4	11.9	9.8	6.7	13.2	10.8	14.6	6.8	14.2	11.5	23.1	13.8	12.4	12.8	8.8	19.5	26.5	21.8	12.8	25.6	22.0	48.1	20.8	17.6	35.9	19.5	45.2	25.1	31.9	39.0	25.5	14.0	18.3	37.1	23.5	29.5	30.4	22.5	37.1	20.2	12.9	29.2	40.0	13.9	20.8	31.2	25.5	46.2	18.0	17.2	24.8	43.7	20.9	25.0	18.7	39.2	29.2	28.6	28.1	26.0	33.4	21.3	35.9	17.2	27.1	25.1	17.6	43.2	30.0	25.7	21.8	40.2	43.4	12.8	25.5	18.9	10.9	19.7	29.8	50.7	46.2	12.4	89.5	13.6	35.3	19.7	23.5	25.1	21.2	23.7	27.3	23.9	25.9	25.8	23.8	27.9	26.9	9.0	24.3	23.0	20.2	32.2	24.0	6.0	7.0	8.6	8.0	6.5	6.9	7.0	6.5	6.7	6.7	6.8	8.8	18.0	3.2	14.3	9.8	24.7	11.9	14.7	17.9	32.5	15.6	15.7	15.5	10.9	8.6	15.0	14.7	29.2	22.5	36.5	10.2	9.8	13.3	24.4	8.2	13.9	13.7	9.0	14.1	11.5	9.8	12.5	15.1	12.2	12.4	11.4	19.8	14.6	9.6	11.9	15.2	13.8	9.1	10.2	11.9	13.2	13.8	12.5	13.7	16.0	7.5	14.8	8.2	11.3	15.1	18.8	12.2	4.7	10.1	16.9	12.1	10.8	15.6	10.2	22.8	26.3	15.7	16.6	38.5	34.8	19.9	11.2	25.3	30.6	15.9	12.4	9.8
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KASH5	"CCDC155, FLJ32658"	ENSG00000161609	"KASH domain containing 5"	Q8N6L0	19	49388219-49417990	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 54.5"	"Cell type enriched"	"Detected in single"	18	"Cardiomyocytes: 1.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-266/70: 3.6;U-698: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA019937, HPA019940"	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA019937: AB_1848877, HPA019940: AB_1848879"	"unprognostic (1.31e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.31e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.11e-9)"	"unprognostic (6.50e-2)"	"unprognostic (4.18e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.6	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KAT14	"ATAC2, CRP2BP, CSRP2BP, dJ717M23.1, PRO1194"	ENSG00000149474	"Lysine acetyltransferase 14"	Q9H8E8	20	18137228-18188387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.5;Extravillous trophoblasts: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068443	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA068443: AB_2685990"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.60e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (4.51e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	6.4	8.4	8.9	4.5	9.5	2.0	7.9	8.9	9.9	7.6	7.6	9.8	8.8	7.8	10.5	7.1	9.4	5.2	7.3	9.8	9.0	9.0	8.3	4.7	7.4	8.0	8.3	10.8	8.0	10.3	7.9	8.3	7.9	7.5	8.8	7.2	7.9	8.0	20.8	9.9	8.5	7.7	8.3	7.7	11.2	8.6	10.3	11.3	8.3	16.6	7.8	8.8	7.4	9.3	8.9	12.9	10.1	9.7	13.4	11.2	87.5	8.4	12.1	11.2	11.1	46.7	11.8	20.7	5.1	7.0	15.9	10.8	10.3	8.9	8.9	8.0	4.1	13.0	3.6	7.4	11.0	12.4	8.5	9.2	16.1	6.7	12.7	10.0	9.1	16.9	7.4	10.6	11.1	10.7	22.1	7.0	14.9	20.4	12.2	11.1	25.1	8.2	10.7	5.3	13.8	8.7	10.8	24.8	13.8	9.2	10.4	11.1	7.7	10.5	4.1	7.4	6.3	9.2	19.0	11.1	3.4	6.0	11.3	0.6	5.7	1.8	9.1	5.7	10.8	7.9	9.2	10.8	8.5	9.8	12.9	10.0	0.5	10.7	11.1	5.9	5.9	8.4	8.9	9.5	8.9	9.9	9.8	9.0	8.0	8.3	7.9	8.3	10.3	9.3	3.1	9.6	6.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	3.9	0.0	0.0	4.3	1.8	0.0	17.5	1.6	0.0	1.9	4.5	0.0	6.9	5.8	2.1	0.0	0.0	0.0	6.4	38.2	2.3	0.0	5.8	3.8	8.3	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.0	6.9	4.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.1	1.6	7.9	0.0	0.0
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113111-42121367	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	14.1	20.8	11.3	6.5	11.9	4.2	13.2	7.7	18.9	20.3	3.1	15.4	6.7	17.2	1.7	14.7	21.0	3.1	10.1	10.8	12.7	13.1	15.7	9.7	5.3	10.8	10.4	28.4	16.9	5.8	14.4	4.6	10.0	16.9	4.0	1.0	10.0	4.3	11.8	15.9	13.5	3.4	5.3	17.4	13.0	10.8	14.0	4.7	14.6	2.1	4.6	15.5	16.4	12.4	24.7	46.6	6.8	25.3	9.3	7.6	29.7	15.7	8.3	34.0	16.7	31.9	19.5	48.1	38.6	12.1	25.6	36.0	27.9	25.0	12.1	27.0	58.0	12.0	29.8	28.8	9.7	32.3	30.8	9.0	20.8	19.1	11.9	9.2	13.8	11.9	30.7	8.9	9.1	26.4	77.7	23.5	14.5	60.9	0.0	18.3	13.3	31.9	9.2	24.4	32.4	14.2	16.8	36.2	13.2	5.1	26.9	15.3	10.7	17.1	17.4	25.1	28.2	23.8	24.5	26.9	12.5	27.5	9.7	0.0	0.1	0.0	0.2	0.0	0.4	0.5	0.5	0.6	0.4	0.3	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.2	11.3	11.9	7.7	18.9	10.8	12.7	10.8	10.4	10.0	5.3	14.0	12.4	21.5	12.8	11.5	84.5	19.0	12.2	12.6	6.8	26.2	16.5	18.9	22.7	7.1	18.6	6.6	18.4	10.4	25.1	10.7	7.9	3.9	9.2	1.3	5.9	11.3	18.4	15.7	6.7	39.6	8.0	20.5	12.1	17.3	8.2	11.4	25.8	22.5	20.2	12.1	10.1	41.0	10.1	6.1	10.9	6.8	3.7	32.6	9.8	7.2	32.8	5.2	3.7	5.2	41.7	28.3	6.7	7.3	29.0	7.2	10.9	4.0	4.1	5.4	7.8	13.1	15.1	10.8	5.2	18.2	18.7	13.9	11.2	7.8	26.4	20.2	9.1
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040446-20154404	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	17.9	9.9	38.7	15.4	46.5	48.0	10.3	39.1	40.3	14.9	33.8	13.8	17.7	12.3	8.1	27.4	11.7	12.6	35.9	34.4	42.2	16.6	39.3	16.2	22.4	41.7	44.9	27.7	18.7	51.0	10.2	13.7	43.0	14.5	12.5	33.9	37.6	13.0	60.2	14.3	21.5	13.6	37.1	19.8	13.9	2.7	42.2	23.6	14.4	56.1	20.1	11.9	15.1	45.1	2.7	6.9	3.8	6.2	15.1	14.2	8.8	8.8	13.0	9.1	13.3	2.1	4.5	24.0	3.6	16.7	11.5	2.0	9.4	2.8	7.6	21.8	9.0	21.0	10.7	0.7	7.1	3.2	26.2	6.1	5.0	7.9	5.1	16.0	8.8	5.8	13.7	32.9	13.0	3.3	7.0	6.4	1.6	6.7	6.8	9.1	7.1	5.1	12.4	14.2	1.9	4.1	4.9	7.9	30.5	5.9	8.2	14.2	8.5	15.3	6.1	5.8	10.1	12.3	27.6	5.7	13.9	13.8	33.0	0.6	0.4	1.3	1.5	0.7	1.5	0.4	1.3	1.1	0.4	0.8	0.4	0.8	2.4	0.5	0.5	1.2	2.2	0.3	38.7	46.5	39.1	40.3	34.4	42.2	41.7	44.9	43.0	37.1	42.2	45.1	15.5	32.1	20.8	165.2	11.9	8.5	11.3	2.2	3.4	14.6	5.5	5.0	64.1	4.3	10.4	5.5	4.2	7.3	19.5	16.6	11.7	3.8	3.8	6.4	5.7	14.6	11.5	52.2	22.4	4.4	1.1	11.7	3.6	13.1	10.8	12.3	20.7	33.6	7.7	15.2	32.1	7.3	4.1	22.8	23.3	1.8	6.5	16.0	17.8	52.5	11.1	14.8	14.4	418.2	175.4	3.3	2.4	5.3	19.9	7.1	24.7	6.2	12.7	11.9	6.6	25.2	9.0	0.8	1.4	10.0	12.9	9.9	23.5	2.9	3.8	8.0
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051994	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Supported	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	14.4	7.1	8.6	15.4	12.7	38.2	12.3	20.1	10.5	13.7	9.7	10.2	9.6	15.6	8.6	13.4	12.0	11.2	9.1	9.1	12.8	9.1	10.0	16.7	16.8	12.7	12.4	21.5	11.7	18.0	6.7	14.9	12.9	11.0	10.6	18.1	9.6	9.7	13.1	16.6	12.1	13.5	8.2	15.7	11.3	11.4	10.1	27.0	14.2	16.0	17.2	12.0	10.7	16.7	19.6	23.2	34.8	21.8	17.8	20.3	9.8	15.4	20.6	17.9	14.2	16.3	11.5	33.4	13.4	19.0	19.5	17.3	27.3	18.6	23.2	16.1	14.4	60.4	14.2	10.3	14.8	27.3	23.6	17.1	19.1	20.4	24.8	14.5	18.8	29.7	36.6	24.2	16.0	10.4	59.9	9.4	12.8	20.4	8.1	37.7	39.1	9.9	11.0	27.1	17.6	16.7	15.8	12.4	13.8	15.8	26.3	12.9	25.5	21.6	15.3	21.1	15.5	16.8	22.1	33.8	12.6	14.1	17.3	2.5	0.8	1.8	1.6	0.9	1.6	1.4	1.6	2.1	0.6	1.6	1.9	1.8	5.1	1.9	0.9	1.1	1.9	1.2	8.6	12.7	20.1	10.5	9.1	12.8	12.7	12.4	12.9	8.2	10.1	16.7	87.5	35.3	34.9	64.0	54.0	50.3	24.2	15.5	18.2	54.8	31.7	25.5	23.7	18.6	25.3	12.9	54.2	14.4	61.5	23.2	3.9	14.2	2.6	30.3	47.5	56.7	24.7	31.2	62.8	11.8	17.0	32.4	21.4	44.8	35.4	31.9	43.5	25.3	17.0	58.9	76.6	24.9	10.2	44.2	34.5	4.8	28.3	43.7	23.2	120.9	30.3	27.9	61.8	93.5	129.2	15.7	20.2	23.0	38.7	30.7	22.9	10.6	22.8	44.9	19.7	49.3	34.6	37.8	37.0	23.0	61.2	21.1	61.4	19.7	19.3	27.2
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74824927-75032624	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	7.6	6.3	5.0	3.1	5.6	8.8	7.3	5.6	5.3	10.5	2.0	9.6	3.2	9.2	5.2	6.9	8.3	3.8	7.5	5.7	4.0	4.3	4.6	6.5	4.4	3.1	3.5	12.2	8.6	10.5	7.4	4.4	3.0	6.5	4.1	6.4	7.3	4.3	11.8	8.0	8.1	6.0	3.0	5.4	9.3	7.8	5.6	9.8	7.3	6.0	4.1	9.1	8.9	4.9	4.7	4.4	8.0	6.9	6.2	9.2	4.1	4.1	7.5	3.4	3.6	3.4	5.3	9.8	2.1	7.1	3.5	3.8	4.2	3.3	5.6	4.2	6.8	3.6	3.9	4.5	4.5	8.6	2.4	5.9	5.3	4.5	6.9	10.5	3.8	7.7	3.9	9.0	4.2	4.7	8.2	4.3	5.0	4.9	25.7	12.7	4.3	2.4	2.3	2.3	4.2	6.9	4.1	7.4	3.7	2.8	4.5	3.2	4.7	4.6	5.5	3.1	3.8	6.4	8.1	6.4	5.0	8.9	1.3	1.7	1.3	1.6	2.3	1.0	2.6	2.2	1.9	2.1	1.1	2.8	2.9	2.6	1.8	4.4	1.1	1.7	1.7	1.0	5.0	5.6	5.6	5.3	5.7	4.0	3.1	3.5	3.0	3.0	5.6	4.9	34.5	44.8	53.7	90.1	48.1	19.9	20.8	16.3	74.6	52.8	36.7	27.3	53.9	12.8	29.3	9.2	68.8	10.4	51.8	22.5	9.8	12.7	6.2	41.1	72.7	24.9	23.8	32.0	130.2	18.0	10.6	44.4	57.6	50.8	41.7	68.0	18.9	16.0	11.0	43.7	131.2	21.7	12.2	12.3	15.0	8.3	42.3	24.1	14.2	41.2	13.6	45.5	42.2	101.0	92.1	10.5	19.4	40.3	62.5	21.0	17.8	10.2	28.6	52.5	26.3	55.3	44.1	33.1	32.2	46.6	17.5	22.7	59.7	27.1	17.5	23.5
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	17.6	14.2	16.1	8.1	16.9	40.9	16.6	24.2	21.5	20.1	15.1	20.9	7.2	22.6	12.2	20.4	20.3	6.6	22.8	16.5	14.8	17.7	11.7	14.5	10.4	13.6	12.3	20.9	12.4	23.5	17.1	10.0	15.5	17.5	10.0	19.2	17.8	14.0	37.7	25.5	16.0	12.4	10.3	15.9	16.0	38.6	14.9	17.4	21.1	20.1	13.5	22.5	19.0	18.7	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	16.1	16.9	24.2	21.5	16.5	14.8	13.6	12.3	15.5	10.3	14.9	18.7	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;Daudi: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.3	3.4	9.6	1.8	11.1	2.7	4.0	14.4	14.7	3.4	23.1	2.6	1.4	2.3	5.5	2.6	7.1	4.4	4.4	9.1	9.2	10.4	6.9	3.3	3.2	10.6	11.5	3.3	2.9	18.0	8.0	1.7	11.2	4.3	2.5	10.8	4.4	2.7	6.1	7.4	2.2	1.8	8.6	3.7	2.2	15.5	10.3	1.9	17.5	2.9	2.1	2.3	3.1	12.9	2.7	5.7	3.5	21.5	7.1	7.9	1.6	2.4	2.1	1.9	2.5	0.2	7.5	28.2	2.2	4.2	2.6	0.9	6.9	0.7	1.6	2.6	3.7	1.3	2.0	0.4	2.8	1.7	2.4	16.5	2.6	3.5	0.9	4.9	0.7	12.8	1.0	2.3	11.5	2.7	1.9	3.7	7.6	4.0	3.9	7.8	1.5	0.1	6.4	0.4	7.6	8.8	2.7	0.5	1.0	11.9	15.5	16.7	1.5	7.1	0.7	2.7	1.7	1.8	1.5	19.7	3.7	18.0	13.4	0.1	0.1	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.0	0.6	0.3	0.3	0.2	0.1	0.2	0.1	0.0	0.0	9.6	11.1	14.4	14.7	9.1	9.2	10.6	11.5	11.2	8.6	10.3	12.9	3.7	0.0	1.1	84.2	1.0	1.5	3.0	2.9	8.0	9.9	1.6	1.3	2.9	1.5	5.2	3.7	6.2	0.0	0.2	2.5	13.7	0.9	91.8	22.6	6.2	2.5	0.0	1.7	28.2	0.2	0.0	3.1	3.6	1.6	0.0	3.9	2.2	4.2	3.6	11.8	41.8	0.7	2.0	1.9	0.9	71.4	1.5	1.5	3.6	18.7	0.9	2.6	0.0	26.7	38.7	0.2	0.3	2.2	0.4	1.0	0.2	12.1	35.2	2.3	0.0	7.5	1.9	58.7	4.6	2.8	1.1	0.1	0.6	2.6	2.3	1.9
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735739-57757244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	9.9	13.3	16.0	10.8	18.4	23.0	10.6	5.5	24.7	10.1	11.8	9.9	10.6	11.2	4.1	15.9	19.2	6.2	11.7	18.2	11.7	10.3	9.5	11.9	10.5	10.4	9.1	9.6	14.0	10.7	13.7	7.2	10.1	10.2	5.5	5.9	13.1	7.7	10.4	29.0	10.1	6.5	6.6	12.9	10.3	37.1	13.2	12.8	11.0	7.9	8.2	8.7	11.9	16.3	20.8	35.7	19.2	25.0	10.4	9.2	35.2	13.9	18.5	35.2	19.6	30.2	18.3	16.1	28.0	8.8	13.2	27.0	25.8	27.9	16.2	11.1	74.8	21.0	20.4	42.5	11.5	47.6	77.6	9.5	17.3	28.7	16.1	14.8	21.2	58.8	42.8	8.2	15.0	21.6	67.6	60.1	34.0	14.7	61.4	53.7	23.8	59.6	10.6	9.9	97.0	29.2	23.8	27.1	16.8	7.6	10.2	23.9	16.0	24.5	21.9	22.9	31.0	18.5	16.1	19.9	35.2	36.6	15.7	50.8	18.9	46.1	21.0	20.8	20.4	9.3	17.5	16.3	17.8	9.3	16.0	15.5	27.9	16.1	22.7	11.9	20.1	21.7	16.0	18.4	5.5	24.7	18.2	11.7	10.4	9.1	10.1	6.6	13.2	16.3	5.5	3.2	5.5	3.3	5.2	9.1	8.0	11.5	9.6	10.2	8.4	7.1	2.6	4.3	7.7	5.5	6.2	17.3	8.5	13.2	11.7	13.7	115.4	18.8	4.4	6.0	4.8	8.8	14.8	13.6	11.7	6.6	12.8	4.7	5.1	7.6	6.8	4.7	9.9	18.5	11.2	9.2	6.1	5.1	2.5	36.6	7.8	7.6	7.2	3.7	6.1	10.0	11.3	2.5	4.9	10.1	5.1	4.9	13.3	7.3	10.5	8.0	26.2	10.9	6.6	4.9	6.3	41.8	8.3	11.9	13.8	7.7	10.9	8.2	11.8	7.8
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KATNIP	"JBTS26, KIAA0556"	ENSG00000047578	"Katanin interacting protein"	O60303	16	27550133-27780369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.7;Cardiomyocytes: 4.5;Cytotrophoblasts: 3.0;dendritic cells: 1.4;Extravillous trophoblasts: 2.6;Hofbauer cells: 2.6;Syncytiotrophoblasts: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 14.3;eosinophil: 3.6;neutrophil: 9.9;NK-cell: 5.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 14.3;NK-cells: 5.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035089, HPA035090"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Plasma membrane"	"HPA035089: AB_10671509, HPA035090: AB_10601129"	"unprognostic (1.81e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.76e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.72e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.45e-1)"	4.4	4.8	5.2	4.7	5.9	6.7	5.4	3.9	6.9	6.3	22.7	6.5	4.8	6.3	6.2	9.7	29.7	5.1	5.4	5.4	4.1	7.8	4.0	6.3	4.4	6.7	7.8	5.1	9.0	7.7	11.5	4.4	4.9	8.8	7.2	31.3	7.9	5.7	3.3	8.9	6.0	5.5	4.9	6.2	9.3	9.9	6.3	5.6	15.9	1.7	4.0	5.3	5.8	6.6	6.7	13.5	7.5	7.0	11.1	10.1	12.4	8.9	9.6	7.7	10.4	12.0	10.9	5.7	12.4	12.8	15.0	11.0	9.7	11.5	15.4	26.5	6.7	4.5	14.9	7.0	6.6	6.1	11.0	10.8	9.9	17.1	18.2	10.0	15.5	6.3	7.3	4.7	11.1	15.3	6.7	7.5	4.6	8.6	5.5	9.6	9.1	6.2	14.5	9.2	9.5	6.1	8.9	7.9	5.0	10.3	17.8	5.3	13.5	9.8	6.2	7.7	7.9	6.3	5.7	6.4	11.3	5.9	8.9	14.3	1.8	3.6	0.7	1.2	0.7	0.8	0.4	1.2	1.2	1.1	1.6	0.3	9.9	5.0	0.4	1.4	1.6	0.3	5.2	5.9	3.9	6.9	5.4	4.1	6.7	7.8	4.9	4.9	6.3	6.6	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061989-101068131	"Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.0;Gastric mucus-secreting cells: 44.4;Intestinal goblet cells: 53.5;Proximal enterocytes: 78.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 30.8;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA011800	Uncertain				"Secreted to extracellular matrix"	NA	NA		65000		"Cluster 64: Macrophages - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.11e-1)"	2.9	0.6	0.3	0.6	0.2	0.3	2.8	0.3	0.4	7.1	0.1	1.9	2.8	2.0	1.3	0.6	2.1	0.6	8.1	0.5	0.2	2.0	0.5	1.2	0.7	0.4	0.3	0.5	0.9	0.8	3.6	0.8	0.4	5.2	1.6	0.4	6.9	2.2	4.1	1.7	3.2	1.5	0.2	18.0	6.6	1.9	0.4	1.0	2.5	3.1	0.3	3.6	2.9	0.2	3.3	1.6	1.8	30.8	1.8	7.4	2.0	5.2	5.6	1.0	1.0	6.2	2.0	0.2	2.8	4.6	0.5	0.7	1.9	0.1	0.3	3.1	0.8	0.4	6.5	6.7	0.5	0.4	2.3	1.1	0.4	0.1	0.9	0.4	0.0	0.9	0.7	3.2	0.9	5.3	0.1	1.9	0.5	7.2	11.7	12.4	9.1	0.4	0.6	1.6	0.3	1.2	0.5	0.8	1.7	0.7	36.7	0.5	0.1	0.7	2.1	0.5	1.2	0.9	2.6	2.5	1.3	3.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.4	0.5	0.2	0.4	0.3	0.4	0.2	0.4	0.2	8.3	0.0	1.5	0.7	0.3	2.0	0.9	1.6	0.6	1.5	2.5	3.0	3.4	1.5	1.6	0.0	2.1	0.3	0.3	23.0	1.9	0.5	0.1	4.1	1.3	5.1	2.4	2.7	0.1	2.1	0.6	16.9	44.4	7.2	0.0	0.2	3.6	0.3	0.8	0.0	0.1	53.5	4.1	4.8	1.9	0.1	9.9	0.9	1.8	0.0	0.0	0.8	0.0	0.0	0.1	1.5	12.8	0.4	0.2	5.0	78.1	0.4	0.7	2.2	0.0	10.4	6.1	3.9	1.4	0.7	2.8	0.5	0.6	0.2	8.1	0.4
KAZN	"C1orf196, FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 91.5"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 1065.9;Inhibitory neurons: 2872.7;Oligodendrocyte precursor cells: 1360.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 85.6;SK-BR-3: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: AB_2674146, HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	12.6	17.7	27.3	3.0	31.5	0.6	11.4	43.6	33.6	17.0	23.9	5.5	5.1	4.2	12.2	34.9	12.6	7.7	6.9	25.0	24.1	24.9	5.8	16.5	1.0	37.1	32.9	16.7	9.2	29.5	5.1	6.3	32.7	7.5	3.9	12.9	21.4	7.4	1.4	23.5	5.3	3.6	29.2	91.5	5.1	4.5	34.1	1.9	10.3	1.6	5.5	8.9	21.3	47.1	17.7	3.0	18.5	85.6	7.9	8.2	6.3	8.3	6.9	15.0	10.8	4.0	9.3	0.0	21.1	17.8	2.7	6.3	4.3	13.5	7.5	0.5	8.4	10.1	10.2	26.6	5.8	0.0	5.0	11.6	17.7	3.5	2.3	6.8	0.1	2.5	4.2	19.8	12.2	12.8	0.1	1.1	5.1	7.9	2.6	6.0	0.4	10.6	25.5	5.4	9.8	7.1	1.5	46.3	33.0	10.5	2.8	6.7	0.0	12.4	11.6	19.8	10.1	3.3	3.0	0.0	11.6	17.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	27.3	31.5	43.6	33.6	25.0	24.1	37.1	32.9	32.7	29.2	34.1	47.1	17.6	3.2	1.8	124.1	0.9	50.3	16.6	9.7	31.3	12.4	23.0	27.9	3.4	4.3	9.1	49.7	8.4	1.5	0.9	12.3	17.6	2.0	6.8	51.4	15.8	19.4	7.1	0.0	1065.9	1.6	8.1	27.0	3.6	16.8	3.8	9.7	31.1	0.1	0.8	0.0	2872.7	5.2	18.3	0.9	11.4	9.1	19.0	1.1	46.2	93.7	0.0	74.2	4.1	1360.7	143.5	1.5	1.6	17.3	0.3	19.4	2.0	12.9	30.3	3.2	6.6	33.5	23.6	0.3	3.2	26.2	90.4	46.4	1.4	41.6	3.5	24.8
KBTBD11	"KIAA0711, KLHDC7C"	ENSG00000176595	"Kelch repeat and BTB domain containing 11"	O94819	8	1973677-2006936	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Proximal enterocytes: 58.0;Proximal tubular cells: 32.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;HEK 293: 2.0;MOLT-4: 1.4;REH: 1.8;SCLC-21H: 2.0;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051159	Uncertain		Approved	"Intermediate filaments"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Intermediate filaments"		"HPA051159: AB_2681367"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.76e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-2)"	3.0	6.6	3.6	0.2	5.0	0.0	2.8	2.3	10.8	1.5	0.0	7.0	0.1	0.9	0.0	1.2	2.6	0.0	2.6	7.6	0.7	9.2	7.8	2.7	0.0	6.2	1.9	1.3	3.6	0.1	3.7	0.0	3.4	2.8	0.0	0.0	1.2	0.1	1.1	1.6	9.8	0.0	3.3	7.5	2.0	1.2	2.9	0.0	3.9	0.0	0.0	1.9	1.1	9.3	0.5	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.0	2.3	10.8	7.6	0.7	6.2	1.9	3.4	3.3	2.9	9.3	6.1	0.0	8.1	17.6	0.6	1.0	0.4	0.0	0.0	24.3	1.0	0.6	5.2	8.6	0.1	12.9	35.5	0.0	0.6	25.6	25.4	2.0	0.8	0.6	0.4	7.9	6.0	3.6	29.2	3.8	0.2	2.0	1.1	0.7	0.0	1.3	4.2	18.2	3.6	20.2	12.6	13.0	0.0	13.5	1.9	0.3	5.0	8.0	1.8	9.4	15.7	9.6	2.1	9.5	16.3	11.9	10.7	10.5	1.5	3.1	58.0	32.2	1.7	31.3	0.0	15.1	1.3	0.3	3.7	0.0	0.9	0.3	1.0	0.1	19.7	1.4
KBTBD13	"hCG_1645727, NEM6"	ENSG00000234438	"Kelch repeat and BTB domain containing 13"	C9JR72	15	65076746-65079948	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062737	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA062737: AB_2684856"										"unprognostic (1.18e-1)"		"unprognostic (7.88e-2)"			"unprognostic (6.07e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.2	0.5	0.1	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	26.4	16.4	23.0	21.7	25.2	54.6	20.9	27.3	24.9	17.2	21.4	16.9	15.9	20.8	10.7	16.1	15.6	25.2	20.3	21.0	24.8	15.3	21.5	22.5	25.6	27.2	25.8	16.4	11.8	17.1	15.0	25.8	27.2	16.3	19.6	25.9	14.4	15.0	57.6	16.3	17.6	23.6	26.3	27.0	14.8	18.1	26.5	30.5	18.6	40.3	24.0	22.0	17.3	28.8	38.3	18.8	47.5	23.5	28.1	28.0	17.1	33.4	33.9	31.2	37.6	18.7	28.6	31.9	22.6	34.7	52.3	27.5	24.5	26.2	39.2	12.6	17.6	27.1	30.6	24.4	28.9	29.3	34.2	30.1	26.9	34.0	32.9	28.9	34.9	28.6	50.3	46.2	46.4	31.4	24.3	47.9	38.6	26.5	17.7	23.4	41.6	26.7	27.6	22.3	24.9	46.4	21.5	29.1	38.6	39.6	20.7	49.5	30.5	29.6	38.7	28.3	46.5	37.5	39.3	57.6	28.8	34.9	77.0	14.5	6.4	21.4	10.9	12.2	9.2	7.1	5.4	9.7	5.6	9.8	4.2	6.9	39.2	10.7	14.6	2.9	7.6	4.1	23.0	25.2	27.3	24.9	21.0	24.8	27.2	25.8	27.2	26.3	26.5	28.8	67.2	28.9	23.9	24.5	27.0	40.4	15.7	13.4	44.3	14.6	20.4	15.6	18.4	20.0	22.1	1.8	10.4	6.9	41.4	18.1	0.0	11.8	7.7	21.6	23.1	48.7	14.9	25.2	21.0	12.2	8.7	22.2	17.9	33.8	43.7	20.4	36.8	14.6	13.3	8.4	20.5	14.0	4.1	24.6	23.1	6.2	13.1	32.5	24.9	34.7	13.0	8.7	15.5	29.7	36.8	16.8	10.3	6.0	25.2	17.1	10.5	5.1	7.3	8.9	19.7	26.4	21.1	19.1	8.8	25.9	36.1	7.5	28.4	10.8	11.4	18.5
KBTBD3	BKLHD3	ENSG00000182359	"Kelch repeat and BTB domain containing 3"	Q8NAB2	11	106051098-106077459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047385	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA047385: AB_2680023"	"unprognostic (9.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.42e-7)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-2)"	2.4	2.5	4.3	1.7	5.4	1.2	2.9	9.7	6.9	2.7	2.3	2.6	1.9	2.5	4.4	1.9	2.4	1.1	3.4	4.3	5.5	4.2	2.8	2.3	1.7	5.9	4.7	3.6	3.8	2.8	3.9	1.0	6.7	2.4	1.7	10.3	3.9	2.9	3.5	2.2	2.3	1.9	5.8	2.0	2.4	3.7	5.9	2.1	3.9	3.1	1.9	2.4	2.4	9.3	1.9	1.3	2.6	3.1	3.3	3.4	0.6	1.6	2.0	1.4	0.9	1.1	3.6	1.0	4.2	0.5	1.9	1.2	1.3	1.3	1.0	2.0	0.5	2.7	0.8	1.0	1.5	1.1	2.4	1.3	3.9	1.2	1.2	2.9	1.9	1.8	1.0	2.6	1.3	0.3	2.6	2.7	1.1	2.2	1.7	1.2	1.6	4.7	4.9	0.4	2.1	2.6	2.4	2.4	2.0	1.9	3.0	1.5	1.6	0.7	1.1	0.6	0.6	0.9	0.6	2.4	1.4	2.4	1.2	30.8	5.6	18.5	12.1	3.2	11.0	13.2	13.7	12.6	7.5	10.9	12.9	11.6	3.6	15.0	3.4	4.5	15.5	7.2	4.3	5.4	9.7	6.9	4.3	5.5	5.9	4.7	6.7	5.8	5.9	9.3	13.0	9.6	12.8	11.1	10.8	6.2	16.5	38.6	12.5	17.6	13.3	16.0	28.5	18.6	18.9	12.9	20.9	10.8	9.3	8.8	37.2	14.4	103.5	11.5	5.3	12.7	6.0	5.7	23.5	29.5	8.8	14.3	6.1	14.3	16.5	6.9	15.7	19.2	9.7	16.8	22.6	15.0	40.7	6.3	10.4	22.8	11.8	6.4	19.6	10.3	14.5	21.4	18.6	23.1	44.3	13.4	14.1	17.0	5.6	6.2	19.0	34.3	17.8	19.3	13.1	10.9	10.2	21.5	4.6	5.2	9.8	2.6	15.4	10.3	13.5	10.1
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47578976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: AB_2675671"	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	10.2	13.9	5.8	4.6	6.2	8.7	10.0	7.2	6.2	10.0	6.4	12.8	4.2	13.2	8.8	9.2	10.6	4.6	10.6	5.9	5.8	9.9	8.3	8.3	6.4	5.5	5.7	10.9	8.4	12.4	13.0	4.3	5.6	8.5	6.2	7.4	10.3	6.7	24.3	13.1	10.5	6.7	5.7	10.9	10.4	14.5	5.7	7.9	9.3	11.0	8.4	11.3	8.3	6.0	5.0	11.8	13.0	10.2	7.8	10.6	3.7	9.0	11.8	12.8	11.2	4.0	9.8	9.6	4.8	11.6	9.2	8.5	7.5	13.3	10.9	12.6	10.7	7.2	15.9	5.7	5.8	15.3	14.5	9.6	9.1	5.4	6.9	8.8	13.4	6.7	5.4	7.6	10.2	13.1	11.2	4.6	6.4	14.0	7.6	10.2	17.0	5.4	13.8	11.9	17.2	11.0	7.7	10.4	6.5	4.3	17.4	4.8	10.7	7.9	8.4	12.1	9.0	10.3	20.3	14.2	11.5	4.2	8.8	11.6	4.6	11.7	12.5	3.8	13.8	11.6	9.8	11.4	5.9	10.9	10.6	11.4	8.3	13.5	4.1	2.5	12.8	10.4	5.8	6.2	7.2	6.2	5.9	5.8	5.5	5.7	5.6	5.7	5.7	6.0	6.2	6.4	3.6	3.3	9.6	4.8	6.2	16.4	7.4	14.0	6.9	4.4	0.1	8.6	11.3	11.0	8.4	12.3	9.7	6.9	23.5	13.9	14.5	10.2	5.2	9.0	7.2	9.5	5.7	13.7	7.3	5.8	1.5	4.6	10.8	6.8	7.5	8.8	8.1	13.5	6.6	4.0	20.3	4.1	2.9	18.3	5.0	4.3	1.8	3.7	11.4	24.9	10.3	2.5	4.6	9.0	2.9	9.4	5.8	4.1	6.3	10.9	18.8	12.1	13.1	6.9	6.0	23.7	20.1	4.0	4.5	14.1	10.2	7.6	5.4	4.6
KBTBD6	DKFZp547E1912	ENSG00000165572	"Kelch repeat and BTB domain containing 6"	Q86V97	13	41127569-41132802	"Predicted intracellular proteins"	"Unfolded protein response"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046861, HPA048914"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA046861: AB_2679843, HPA048914: AB_2680554"	"unprognostic (6.21e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.25e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.85e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.41e-1)"	2.8	6.1	11.2	3.1	11.4	5.5	5.9	9.8	11.8	5.3	5.9	2.9	2.6	5.6	3.2	2.8	8.3	2.0	6.5	10.5	15.2	5.1	3.7	2.4	4.1	8.8	10.1	5.9	3.5	4.8	6.5	3.6	10.1	4.8	2.1	4.3	3.3	4.2	2.8	3.2	2.3	2.9	8.3	3.2	2.7	5.4	14.9	5.1	5.2	4.2	4.6	2.6	2.6	9.3	3.6	6.9	12.8	16.2	15.0	11.4	4.0	7.5	7.4	8.7	7.4	9.6	4.1	4.8	4.5	6.4	5.6	10.7	20.8	9.4	13.7	4.5	22.0	9.9	9.2	11.2	7.9	7.3	3.7	9.8	9.6	6.2	13.3	7.6	6.3	7.6	8.3	2.7	11.4	5.2	8.9	7.3	9.6	7.9	8.1	6.9	12.2	3.1	8.9	7.8	5.1	11.4	10.4	10.5	7.6	4.4	7.2	9.9	7.0	4.5	5.3	4.5	6.3	2.0	1.9	6.8	6.8	7.8	8.7	3.6	1.6	0.4	1.8	1.2	2.0	1.1	2.8	2.3	1.6	1.3	3.3	3.5	0.8	1.4	2.9	1.1	1.7	1.4	11.2	11.4	9.8	11.8	10.5	15.2	8.8	10.1	10.1	8.3	14.9	9.3	3.8	9.6	4.2	4.6	3.7	3.2	3.3	4.7	3.4	20.6	7.6	6.9	14.6	5.7	2.4	7.3	10.4	4.2	4.3	1.2	7.9	2.6	5.0	3.9	9.5	5.2	3.0	2.5	9.9	1.8	7.6	6.8	2.0	3.5	0.0	8.2	13.6	8.2	1.7	18.5	18.0	2.1	0.0	2.2	3.7	2.9	8.7	2.0	8.8	2.8	2.2	8.0	3.1	12.1	10.6	1.5	0.5	11.7	2.6	3.4	1.1	8.6	2.2	11.1	6.6	11.1	5.9	7.8	9.7	3.2	3.4	2.9	5.1	10.7	3.2	2.4
KBTBD7	DKFZP434E2318	ENSG00000120696	"Kelch repeat and BTB domain containing 7"	Q8WVZ9	13	41189834-41194569	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043709, HPA046861, HPA048914"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA043709: AB_10961260, HPA046861: AB_2679843, HPA048914: AB_2680554"	"unprognostic (8.68e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (4.36e-2)"	"unprognostic (7.59e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (4.98e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	2.9	4.1	4.5	2.9	4.9	4.4	5.4	6.5	5.8	4.5	4.8	3.1	3.9	3.4	5.2	2.4	5.0	2.2	4.6	4.4	4.4	5.4	6.9	3.1	4.3	4.3	4.5	5.8	4.2	6.2	3.1	4.4	4.7	5.9	2.7	6.0	5.9	5.0	4.2	3.5	3.1	2.7	4.8	4.5	4.9	3.5	4.4	4.7	6.3	4.0	4.6	2.8	1.5	6.1	2.2	4.5	9.0	10.5	9.5	4.1	3.3	2.2	3.1	2.9	2.0	5.9	4.2	3.9	3.3	2.8	3.8	7.3	6.9	4.7	2.9	5.4	8.8	10.5	6.0	5.3	4.4	1.8	8.3	2.3	8.2	1.0	2.7	5.4	3.2	7.1	5.1	0.4	5.6	6.5	9.5	4.1	8.9	9.4	2.3	10.4	5.7	2.0	6.3	5.0	5.2	7.1	3.3	9.9	3.1	7.9	6.0	9.6	3.2	1.7	2.2	1.6	1.9	2.6	3.3	0.0	4.1	4.7	4.1	2.1	5.0	11.5	2.9	5.1	3.4	2.3	3.4	3.4	3.6	2.1	5.0	4.5	13.7	3.2	3.9	1.8	2.6	2.9	4.5	4.9	6.5	5.8	4.4	4.4	4.3	4.5	4.7	4.8	4.4	6.1	10.4	9.6	6.7	4.2	8.3	4.1	14.3	10.3	13.1	27.8	17.2	15.1	9.2	17.2	9.2	12.9	14.6	16.8	7.1	17.1	19.6	6.6	53.2	5.6	9.6	9.7	12.7	16.0	5.4	5.8	14.7	16.6	16.3	8.6	8.9	10.7	15.7	27.6	8.5	5.0	7.2	12.5	16.2	14.2	3.5	5.1	15.8	7.5	5.4	4.7	10.0	17.2	13.4	9.0	9.7	3.7	13.7	21.8	6.1	6.9	12.4	17.4	6.2	19.2	19.7	15.6	12.5	17.7	15.0	10.6	6.8	9.9	6.7	12.2	11.3	11.5
KBTBD8	"KIAA1842, TA-KRP"	ENSG00000163376	"Kelch repeat and BTB domain containing 8"	Q8NFY9	3	66998307-67011210	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 20.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.9;Langerhans cells: 35.2;Macrophages: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.6;Karpas-707: 28.4;U-698: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041285, HPA069190"	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA041285: AB_10796341, HPA069190: AB_2686101"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-4)"	"unprognostic (1.99e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.54e-1)"	1.4	1.1	1.4	6.9	2.0	13.9	1.0	1.7	3.2	0.7	3.8	2.4	1.8	0.4	0.2	1.3	0.4	1.8	3.8	1.7	1.1	0.6	1.3	2.2	20.4	0.7	0.7	0.4	0.9	0.3	0.5	3.2	0.7	1.0	1.9	1.3	0.9	0.4	1.6	0.5	2.8	1.2	0.8	5.7	2.2	7.8	0.9	3.6	0.8	2.2	20.7	1.9	0.3	1.4	1.2	1.4	2.5	2.9	1.7	1.1	5.3	3.1	1.1	2.3	1.6	5.7	0.6	62.6	0.8	0.9	1.3	1.7	14.5	3.4	3.6	10.7	4.7	23.0	0.7	2.9	2.2	14.8	23.9	1.9	1.5	4.6	4.0	0.7	1.7	12.4	5.7	28.4	1.6	2.4	11.9	2.5	10.5	2.3	1.1	6.8	2.5	8.5	0.7	1.9	8.6	3.1	1.2	1.0	2.1	3.1	0.6	4.2	4.8	7.7	1.8	16.8	6.0	16.4	27.6	43.3	2.1	11.7	2.6	0.0	1.1	0.4	1.1	3.0	0.6	6.2	1.3	1.2	2.4	6.7	1.2	0.8	0.0	1.1	2.6	0.3	2.4	1.2	1.4	2.0	1.7	3.2	1.7	1.1	0.7	0.7	0.7	0.8	0.9	1.4	2.3	0.0	1.8	0.3	31.9	5.2	0.4	0.1	5.7	1.3	1.9	2.5	11.6	1.5	0.7	0.0	2.1	4.0	7.5	2.1	0.0	0.5	1.4	0.3	0.3	1.6	1.2	3.0	4.5	0.9	1.4	1.3	1.1	0.4	4.5	0.1	2.2	0.5	3.8	3.3	2.7	1.2	2.0	1.9	35.2	1.3	0.0	20.9	0.0	1.9	1.3	1.7	0.0	2.0	1.8	1.2	1.5	0.4	11.0	0.3	0.9	0.5	0.2	0.7	0.0	3.5	2.5	9.9	5.3	5.1	5.5	2.5	9.1	0.8	1.4	0.5
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	39.7	24.0	23.4	34.0	22.2	60.8	33.8	21.3	30.2	28.1	20.4	46.7	34.8	29.2	39.7	58.3	27.6	29.5	44.1	25.6	24.1	33.1	45.0	31.9	36.1	25.2	26.5	24.7	80.0	39.2	20.8	33.0	24.8	27.9	46.4	32.4	36.8	31.8	140.0	35.2	36.2	40.5	24.8	28.3	33.5	69.0	27.3	37.0	40.4	71.7	52.3	37.7	36.1	22.1	102.3	76.4	66.7	51.8	69.0	66.2	114.5	106.0	96.0	97.4	64.6	93.8	104.5	110.9	107.2	141.6	97.0	65.1	52.7	100.6	127.8	87.6	37.9	69.8	55.9	97.3	134.7	77.9	63.9	69.0	155.7	95.7	262.5	86.4	74.7	57.2	71.3	83.1	98.4	91.5	76.9	42.6	74.9	125.5	64.1	55.4	94.7	68.5	88.3	85.8	64.8	48.9	61.0	76.0	101.8	76.4	35.3	48.1	66.2	98.9	99.2	93.5	111.8	99.1	130.9	110.4	74.5	55.7	75.8	3.1	1.6	5.4	2.7	1.4	2.1	2.3	1.9	2.0	1.4	3.1	1.6	1.8	4.5	1.9	2.2	2.6	6.0	1.0	23.4	22.2	21.3	30.2	25.6	24.1	25.2	26.5	24.8	24.8	27.3	22.1	45.5	32.1	26.6	25.5	29.6	70.9	92.9	32.7	24.5	31.8	42.8	34.3	51.4	21.5	33.2	12.9	14.6	23.6	42.0	56.2	25.4	34.8	85.2	55.3	33.8	33.1	19.2	29.0	47.9	53.4	32.0	31.9	18.8	80.5	17.7	30.9	24.3	32.9	20.1	72.3	47.4	29.0	20.3	33.3	61.1	127.7	25.7	34.7	26.6	51.5	36.8	37.5	21.6	45.8	36.6	61.2	40.8	29.0	27.6	107.6	44.8	30.7	22.5	27.5	26.3	48.2	47.2	44.9	24.6	34.4	79.0	40.8	32.1	27.1	33.7	135.5
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.1;Excitatory neurons: 39.6;Inhibitory neurons: 18.6;Oligodendrocyte precursor cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.2	0.0	10.6	0.0	22.5	0.0	0.3	27.6	50.1	0.6	3.9	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	7.9	0.0	0.0	0.0	0.0	24.9	10.7	0.0	0.0	0.8	0.9	0.0	25.2	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.2	0.1	9.5	0.0	1.2	0.0	24.3	1.2	0.6	0.0	0.0	0.3	0.3	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	22.5	27.6	50.1	21.0	7.9	24.9	10.7	25.2	9.5	24.3	28.2	0.1	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	15.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	16.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 81.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2;testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 81.3"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	1.3	0.3	5.0	0.7	7.4	0.0	0.6	11.1	81.3	0.2	0.0	1.6	0.4	0.1	0.3	0.4	0.1	0.3	0.7	4.5	12.5	0.1	0.0	0.1	0.6	28.0	7.5	0.1	0.8	0.0	2.1	0.0	32.0	0.5	0.5	9.6	0.5	0.8	1.0	0.5	0.6	0.4	0.1	0.3	0.7	0.9	27.1	3.0	2.3	2.1	1.5	0.3	0.3	20.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	3.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	5.0	7.4	11.1	81.3	4.5	12.5	28.0	7.5	32.0	0.1	27.1	20.7	0.1	0.0	0.0	49.9	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	36.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	37.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	8.4	0.0	19.8	0.0	36.2	6.8	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	4.2	0.0	0.4	1.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 4.9;T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	0.5	0.9	3.4	6.4	2.0	4.6	0.9	1.1	4.9	1.1	0.0	2.4	2.5	0.5	0.0	0.5	0.3	1.3	0.4	5.0	7.2	0.2	0.8	5.9	9.4	1.1	3.3	0.7	0.4	0.4	0.4	0.7	5.0	0.5	1.9	0.6	1.4	0.2	0.1	0.2	2.6	0.6	0.2	6.0	4.3	0.5	3.3	25.4	0.7	0.1	7.6	2.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	45.6	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.0	9.6	0.0	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	32.6	31.9	11.6	0.0	2.7	0.0	0.0	1.1	0.0	8.9	0.0	10.0	2.8	13.4	14.3	1.4	4.9	10.4	7.9	0.0	1.3	0.1	0.6	13.4	4.4	3.4	2.0	1.1	4.9	5.0	7.2	1.1	3.3	5.0	0.2	3.3	0.0	0.2	0.0	1.9	1.3	11.5	0.4	0.0	0.0	0.0	2.5	0.1	0.0	0.6	0.0	0.0	1.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.3	13.1	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.8	0.0	0.4	0.0	60.2	0.0	0.0	1.6	2.4	0.0	0.0	3.1	3.6	2.8	2.4	0.3	3.1	7.5	1.3	0.0	0.0	0.0	61.6	0.0	0.0	0.1	0.0	0.2	6.6	0.0	0.1	4.3	0.9	0.1	0.6	0.0	20.3	0.0	0.0	0.1
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 6.1;brain: 20.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 62: Horizontal cells - Visual perception"			"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			1.5	6.1	4.7	0.0	20.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	4.7	4.4	0.2	0.0	0.7	0.0	1.6	1.7	0.0	0.0	0.0	1.3	0.2	1.3	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	20.0	0.0	6.5	4.7	4.4	1.6	1.7	1.3	0.1	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.4	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 52.7;heart muscle: 39.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 143.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in single"	13	"NTERA-2: 4.2"	"Low region specificity"	"Detected in many"							"HPA021516, CAB022562"	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"			"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	2.2	0.5	3.1	0.2	4.6	0.1	1.4	2.2	3.8	0.8	52.7	3.6	0.3	1.5	0.3	4.9	1.8	0.8	39.8	6.0	7.5	1.1	0.2	2.8	0.2	3.7	6.2	2.4	1.3	0.0	7.1	1.9	2.7	0.6	0.5	7.5	0.3	0.9	3.8	0.5	1.2	0.5	4.3	0.5	3.6	0.2	5.4	0.1	1.3	4.8	0.4	3.6	1.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	3.1	4.6	2.2	3.8	6.0	7.5	3.7	6.2	2.7	4.3	5.4	4.7	0.7	0.0	0.0	0.3	1.6	0.9	0.0	0.0	0.0	143.1	0.0	0.0	20.9	0.0	0.0	0.0	2.1	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	3.7	0.1	1.9	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	13.1	3.5	29.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 113.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 115.6;Cone photoreceptor cells: 212.7;Excitatory neurons: 150.6;Inhibitory neurons: 89.9;Rod photoreceptor cells: 386.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;CACO-2: 2.2;HL-60: 1.1;hTCEpi: 1.2;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB001979: , HPA042434: AB_2677996"	"unprognostic (4.51e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.25e-4)"	10.7	1.5	4.3	0.3	6.6	0.0	2.8	0.0	17.8	1.2	0.0	6.2	0.2	7.3	0.8	1.7	6.0	0.6	1.2	6.6	0.0	0.3	2.4	0.3	0.0	0.0	0.0	0.4	0.3	0.2	2.7	0.1	0.0	2.2	0.6	113.3	1.6	3.1	7.3	0.5	2.0	5.0	0.0	0.3	3.4	0.4	0.0	0.1	0.1	4.4	0.0	3.8	0.9	7.9	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.9	0.7	0.6	0.9	0.0	0.0	0.7	0.0	0.0	0.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	6.6	0.0	17.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	7.9	20.2	0.0	2.2	7.8	0.5	0.8	0.2	0.0	0.0	115.6	0.9	0.5	3.4	1.5	0.7	0.0	212.7	0.0	0.4	0.0	0.0	0.0	0.7	19.8	2.9	8.0	0.0	0.0	150.6	0.0	0.0	1.4	0.0	4.2	3.8	1.5	0.0	5.7	0.1	18.5	89.9	0.0	0.0	0.0	0.3	0.8	4.4	0.4	0.0	12.2	0.0	38.2	0.0	43.2	3.3	0.1	0.0	34.6	0.1	0.1	0.0	0.2	4.0	386.9	0.0	0.9	7.0	0.2	0.5	0.2	0.3	0.1	0.4	0.2	0.0	0.1
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 47.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	1.1	0.1	3.3	0.9	0.2	41.0	47.3	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.5	8.0	0.1	0.2	0.1	0.2	8.8	3.0	0.2	0.4	0.0	2.2	0.0	9.3	0.2	0.0	7.0	0.3	0.0	0.5	0.5	0.3	0.0	1.0	0.2	0.3	1.4	12.3	0.1	0.3	1.2	0.0	0.3	0.5	18.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	1.1	3.3	41.0	47.3	4.5	8.0	8.8	3.0	9.3	1.0	12.3	18.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 46.9"	"Group enriched"	"Detected in some"	51	"Excitatory neurons: 389.6;Inhibitory neurons: 1425.5"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.0	0.0	9.2	0.0	18.4	0.0	1.7	0.0	46.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.5	17.2	0.0	0.2	0.0	0.0	22.3	15.9	0.0	0.0	0.0	7.0	0.0	24.5	2.6	0.0	8.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	18.4	0.0	46.9	6.5	17.2	22.3	15.9	24.5	0.0	45.5	9.4	0.0	0.0	0.0	17.6	0.0	0.0	2.9	0.0	0.0	15.9	16.7	7.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	0.0	389.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1425.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	2.6	0.0	14.1	14.8	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.8;thyroid gland: 52.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Endometrial ciliated cells: 23.9;Excitatory neurons: 15.6;Glandular and luminal cells: 16.3;Inhibitory neurons: 18.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 75.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;CAPAN-2: 7.2;HDLM-2: 7.0;HMC-1: 20.3;K-562: 7.0;SK-BR-3: 14.0;T-47d: 12.0;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	0.8	1.3	3.1	2.8	1.9	0.7	3.5	17.3	75.8	6.2	0.0	0.8	0.6	2.8	2.6	1.6	23.2	0.5	2.4	12.5	0.0	17.8	4.4	4.6	2.6	20.0	3.4	0.4	5.7	14.1	21.1	1.2	11.4	4.4	0.5	8.0	3.0	8.1	1.3	2.9	3.3	0.7	3.1	5.7	1.2	3.6	15.0	2.5	52.1	0.1	1.9	2.0	1.5	20.2	0.0	0.5	0.0	1.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	7.7	7.2	0.7	0.9	0.0	0.5	1.1	0.2	0.0	0.0	7.0	1.7	0.0	0.0	2.0	0.0	0.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.0	0.0	2.7	0.1	0.0	0.9	1.1	3.3	0.0	0.1	0.0	0.5	0.3	0.0	1.2	1.7	14.0	0.0	0.1	12.0	2.4	0.2	0.0	8.2	0.0	0.0	0.0	0.1	0.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	1.9	17.3	75.8	12.5	0.0	20.0	3.4	11.4	3.1	15.0	20.2	0.3	0.0	0.5	3.3	2.4	0.8	1.0	0.2	0.0	8.8	4.4	2.5	2.7	1.5	2.4	20.2	8.4	2.3	0.2	0.2	0.0	1.6	0.3	23.9	1.2	0.7	4.2	0.0	15.6	1.4	0.9	0.2	0.5	16.3	0.0	0.1	1.1	2.4	2.8	1.7	18.3	0.1	4.1	7.3	1.9	0.6	0.6	6.3	0.0	3.7	3.2	0.8	0.0	2.0	1.9	0.3	0.1	0.0	0.3	1.3	0.0	3.3	1.1	6.2	0.0	0.1	1.1	1.3	1.2	0.4	0.6	2.3	0.4	0.0	0.1	0.9
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.6;NB-4: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	3.8	0.9	2.8	1.5	2.8	2.7	1.8	5.5	2.7	2.7	0.1	2.0	0.8	3.6	1.4	1.1	5.4	2.4	2.3	2.9	3.0	1.7	1.4	2.6	1.3	3.6	2.9	2.7	1.1	0.4	2.3	1.0	3.9	2.3	0.8	6.1	0.9	2.1	0.5	1.3	2.2	2.5	3.3	3.3	1.8	1.5	3.2	0.7	1.8	0.4	1.4	2.3	2.3	3.8	0.3	1.6	0.7	3.9	5.1	4.1	1.3	0.8	3.3	2.3	1.5	1.1	0.5	1.3	2.8	2.6	0.6	0.5	0.6	0.3	2.2	2.3	2.7	1.2	1.8	0.1	1.9	0.3	2.5	10.6	1.4	4.2	0.4	3.7	0.8	1.9	0.9	3.0	1.7	3.1	0.4	9.2	2.1	0.2	0.6	1.1	0.7	1.3	2.6	1.3	0.4	1.8	0.7	0.0	1.8	7.9	1.7	1.3	2.0	0.5	2.1	0.5	0.2	2.5	3.5	3.2	1.4	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	2.8	5.5	2.7	2.9	3.0	3.6	2.9	3.9	3.3	3.2	3.8	0.9	0.0	1.1	1.0	0.4	0.8	0.0	0.4	0.0	0.2	0.3	0.3	0.8	0.0	0.2	1.8	0.0	0.1	0.4	0.3	1.9	0.2	0.1	0.2	1.0	0.6	3.5	0.0	0.7	0.0	0.1	1.2	0.5	0.5	0.0	1.7	1.1	0.0	0.1	0.0	1.1	0.3	0.0	0.6	0.0	0.2	1.8	0.4	0.0	1.0	0.1	0.4	0.0	2.0	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.3	3.0	0.0	0.1	0.6	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 47.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 690.0;Inhibitory neurons: 1068.2;Oligodendrocyte precursor cells: 1952.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;HSkMC: 2.9;NTERA-2: 2.4;RT4: 2.7;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	1.7	0.5	8.1	0.5	10.5	0.0	1.0	47.3	8.6	1.1	0.0	0.3	0.3	3.2	0.1	0.1	1.2	4.2	0.2	5.5	10.1	0.0	0.1	0.2	0.1	29.3	15.4	3.3	0.2	0.7	1.9	0.4	26.8	0.2	0.2	1.0	0.3	0.9	0.2	0.1	0.1	2.0	4.9	0.0	0.2	1.7	19.2	0.3	0.4	2.8	0.0	1.1	0.5	2.5	0.0	0.0	0.2	0.0	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	2.7	13.2	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	47.3	8.6	5.5	10.1	29.3	15.4	26.8	4.9	19.2	2.5	0.6	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	2.7	1.0	1.9	0.3	0.0	2.7	690.0	0.2	0.0	6.0	0.0	0.8	0.0	6.6	0.7	0.0	0.0	0.0	1068.2	0.0	2.0	0.0	0.0	1.7	3.7	0.1	0.0	40.3	0.0	0.0	0.0	1952.8	9.7	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.5	0.0	10.9	3.0	5.0	3.4	0.0	0.1	0.0	0.0	4.3	0.0	0.1
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989668	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.8;Cardiomyocytes: 38.1;Excitatory neurons: 105.7;Hepatocytes: 37.8;Inhibitory neurons: 88.4;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.8;SCLC-21H: 10.1;U-2 OS: 1.6;WM-115: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	4.5	1.5	17.0	4.7	13.8	0.2	3.0	18.1	17.9	2.3	0.0	5.9	0.9	5.3	12.6	4.1	5.1	5.5	8.4	16.2	6.4	1.3	15.4	1.7	0.5	1.0	35.6	0.5	4.5	3.9	3.4	0.5	3.4	11.3	2.4	12.7	1.6	12.0	2.6	7.1	2.2	9.8	0.9	3.2	3.3	2.0	9.2	0.3	1.1	1.7	0.5	5.9	3.2	10.8	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.0	13.8	18.1	17.9	16.2	6.4	1.0	35.6	3.4	0.9	9.2	10.8	1.1	0.0	9.3	18.3	0.3	7.5	11.9	2.9	0.0	46.8	7.8	1.5	38.1	0.0	1.5	0.0	4.2	0.1	0.4	1.5	0.0	0.8	35.7	0.5	14.5	1.6	0.0	2.7	105.7	23.8	0.2	3.7	0.0	0.7	0.0	0.0	1.8	37.8	0.2	30.3	88.4	0.4	4.1	0.8	1.9	32.3	18.0	0.5	3.6	1.0	0.0	6.2	0.0	45.8	8.7	4.8	1.2	1.9	0.0	21.9	0.1	0.3	0.1	4.8	0.0	0.8	1.7	1.5	1.0	2.0	6.7	0.0	0.5	0.1	2.4	13.4
KCNE2	"LQT6, MiRP1"	ENSG00000159197	"Potassium voltage-gated channel subfamily E regulatory subunit 2"	Q9Y6J6	21	34364006-34371381	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"stomach 1: 316.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 35.0;Gastric mucus-secreting cells: 109.1;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	6	"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;SCLC-21H: 1.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 29.0"					"HPA029706, HPA051553"	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA029706: AB_2673159, HPA051553: AB_2681532"	"unprognostic (5.29e-4)"	"unprognostic (3.13e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.65e-5)"	"unprognostic (7.45e-2)"	"unprognostic (7.33e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.81e-2)"	0.5	0.4	1.1	0.3	1.2	0.1	0.4	0.9	1.3	0.6	1.3	1.1	7.1	0.3	0.8	0.4	0.4	0.5	0.4	1.1	1.4	1.6	1.3	0.5	0.1	1.1	1.2	0.5	0.7	0.0	0.5	0.2	1.3	0.5	0.3	0.4	0.3	0.3	0.8	0.3	0.2	0.0	1.1	0.2	316.3	4.1	1.4	0.0	1.0	0.3	0.0	0.6	0.3	1.2	0.3	0.1	0.8	1.5	0.0	0.0	1.0	0.3	0.2	0.0	0.0	0.3	0.4	0.3	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.1	1.6	0.1	0.6	0.0	0.3	1.1	1.1	0.6	0.2	0.2	0.4	0.1	0.1	1.9	0.1	0.5	0.2	0.5	0.9	0.5	0.4	0.0	0.4	0.2	0.2	0.1	1.6	0.9	0.3	0.1	0.8	0.4	0.0	0.3	0.5	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	1.1	1.2	0.9	1.3	1.1	1.4	1.1	1.2	1.3	1.1	1.4	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	35.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.3	109.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.0
KCNE3	"HOKPP, MiRP2"	ENSG00000175538	"Potassium voltage-gated channel subfamily E regulatory subunit 3"	Q9Y6H6	11	74454841-74467729	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 70.5;stomach 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	48	"basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6"	"Group enriched"	"Detected in many"	115	"dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014849	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014849: AB_1852112"	"unprognostic (1.61e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (4.67e-3)"	"unprognostic (4.89e-4)"	"unprognostic (4.12e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	7.3	2.8	2.8	20.7	2.9	8.2	5.2	2.5	3.6	9.9	7.0	34.9	70.5	8.8	1.9	4.6	9.4	24.6	5.0	3.0	3.0	20.1	5.0	13.8	5.0	3.8	3.6	14.0	10.8	3.6	3.1	12.7	3.6	8.0	47.3	8.1	15.4	3.4	1.3	1.3	40.0	11.1	3.3	12.6	56.2	1.8	4.1	1.9	33.5	3.0	3.2	6.2	4.5	4.9	0.1	0.1	0.1	0.2	8.1	2.1	7.1	0.1	0.0	1.0	0.8	23.0	2.0	0.3	21.3	0.1	0.1	0.3	1.8	0.0	0.7	0.0	0.2	70.3	0.4	4.7	2.9	0.6	12.0	7.1	0.0	0.6	0.0	0.3	0.3	0.1	1.9	0.3	0.8	0.1	0.1	44.7	0.9	155.3	0.1	7.6	0.3	0.5	1.7	0.0	0.0	0.4	0.1	0.0	0.0	5.4	0.1	32.7	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.1	12.9	0.1	51.4	38.5	23.4	0.1	41.8	0.2	0.2	0.1	0.1	18.3	0.3	0.1	0.1	53.1	0.2	36.6	0.7	0.0	13.2	2.8	2.9	2.5	3.6	3.0	3.0	3.8	3.6	3.6	3.3	4.1	4.9	4.4	0.0	6.8	0.3	0.7	0.3	0.6	1.1	3.4	0.2	0.2	0.3	0.7	8.6	5.6	1.8	0.0	0.4	0.0	8.6	3.9	0.5	0.1	3.1	3.4	8.9	2.4	2.1	0.2	7.3	7.4	4.5	41.8	5.0	33.7	0.2	5.7	2.0	40.6	0.0	0.3	27.9	4.1	104.0	2.9	0.3	3.7	37.8	0.0	8.4	59.0	22.7	1.0	0.0	0.0	3.3	8.9	2.6	0.2	0.4	8.6	23.4	4.6	1.2	0.0	4.7	0.7	0.0	0.4	2.7	0.1	2.1	1.0	8.8	44.3	0.6
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 37.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 164.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Microtubules	"Nuclear bodies"	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	13.3	3.4	7.7	11.0	6.9	0.5	6.9	6.0	11.2	5.0	5.8	8.0	1.3	30.7	2.3	5.1	7.9	20.3	13.5	8.0	6.9	7.5	5.1	3.1	5.7	9.5	8.1	12.3	10.3	1.8	10.3	6.7	9.3	4.4	2.0	3.3	2.7	5.5	5.4	3.2	3.6	37.5	6.9	4.5	12.5	1.1	7.5	0.7	9.4	3.2	1.1	10.7	3.8	8.0	0.0	0.8	0.0	164.3	36.6	3.7	0.2	4.0	3.8	0.8	1.8	0.0	0.2	0.0	0.0	2.5	5.8	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	4.5	0.0	0.1	6.3	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.2	6.7	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.1	0.1	0.4	6.4	0.1	12.1	0.7	0.1	0.0	0.0	3.8	0.1	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	6.9	6.0	11.2	8.0	6.9	9.5	8.1	9.3	6.9	7.5	8.0	8.2	0.0	2.2	4.2	0.0	3.8	0.4	0.2	0.0	0.1	1.8	0.4	4.9	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.8	16.3	19.8	4.8	0.0	0.0	0.0	0.2	32.3	9.2	0.6	3.8	0.4	3.9	0.2	0.1	3.3	0.3	0.0	2.0	0.0	5.8	0.3	21.1	1.0	32.0	5.6	0.0	6.1	0.0	1.0	0.0	0.4	0.1	17.0	0.4	1.4	0.0	0.0	3.7	0.7	118.3	1.7	128.3	0.1	0.2	0.4	3.1	0.3	0.6	0.1	0.2	1.8
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023107	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 87.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 53.7;Granulosa cells: 34.0;Syncytiotrophoblasts: 97.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	71	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.5;U-138 MG: 40.4;WM-115: 34.6"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 19.1;cerebral cortex: 14.9;hippocampal formation: 18.1;white matter: 9.1"	"Group enriched"	"Detected in all"	5	"amygdala: 12.6;basal ganglia: 11.1;cerebral cortex: 22.4;hippocampal formation: 16.8"	"HPA039530, HPA040024"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.4	3.0	17.3	2.2	26.7	0.0	0.4	0.0	21.7	17.9	0.1	5.0	0.2	87.4	0.8	6.7	19.2	0.9	1.3	14.9	0.6	0.5	0.2	0.3	2.2	28.9	46.8	0.7	2.7	4.1	0.8	7.1	3.2	5.6	0.8	0.1	2.2	12.8	0.0	0.5	5.3	4.1	1.0	2.7	0.7	9.5	1.2	0.2	0.2	0.0	0.9	3.4	6.2	1.1	0.9	3.6	2.7	13.3	1.5	3.4	0.2	11.6	0.1	6.7	5.3	0.2	0.2	0.0	7.1	3.5	18.8	3.4	1.7	3.5	6.9	0.4	4.7	0.0	13.6	0.0	23.2	0.0	0.4	6.8	53.5	25.7	26.1	1.3	1.8	0.1	0.2	0.0	0.6	13.4	0.0	0.4	13.7	0.0	25.0	0.0	0.0	0.0	0.0	4.1	3.9	15.0	25.5	29.3	19.9	4.3	2.1	1.9	0.7	40.4	23.9	0.3	3.4	0.1	0.0	0.0	11.8	1.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.3	26.7	0.0	21.7	14.9	0.6	28.9	46.8	3.2	1.0	1.2	1.1	0.2	3.2	1.1	0.3	10.5	1.1	11.0	0.6	13.6	0.3	1.1	2.3	1.1	7.2	0.9	0.0	0.0	53.7	0.0	7.5	0.0	2.6	18.2	9.3	2.0	1.2	0.0	0.0	2.0	0.0	2.7	1.5	0.5	15.9	0.0	34.0	0.4	0.3	3.3	1.7	2.2	0.6	0.0	0.0	0.3	20.3	1.5	0.3	0.0	1.0	0.0	0.2	1.0	0.0	0.6	0.2	3.4	4.1	0.0	18.1	12.8	0.1	0.9	0.2	0.0	1.1	7.1	12.7	0.7	5.4	0.3	97.0	0.4	0.3	0.4	9.9
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.2;Horizontal cells: 114.4;Inhibitory neurons: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 10.3"	HPA048628	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 62: Horizontal cells - Visual perception"			"HPA048628: AB_2680466"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.1	0.0	0.9	0.0	1.2	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.7	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.0	2.7	3.2	1.7	0.1	1.5	0.1	0.8	0.6	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	6.9	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.2	0.0	8.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	114.4	31.3	0.1	0.0	1.5	0.0	0.0	0.3	0.8	0.0	6.5	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.9	0.0	0.0	0.0	1.2	2.1	0.0	0.0	6.3	0.0	0.1	0.2	0.0
KCNH1	"eag, eag1, h-eag, hEAG, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134165	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9"	"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.2	0.9	6.8	0.4	9.2	0.0	0.2	9.5	17.9	0.7	2.7	0.5	0.3	0.4	0.2	0.1	0.6	0.2	0.0	11.2	5.3	0.1	0.1	0.0	0.0	4.8	4.4	0.1	0.2	0.0	0.7	0.3	4.0	0.5	0.3	0.3	0.1	0.1	0.2	0.1	0.8	0.2	4.0	0.0	0.5	1.5	4.9	0.2	0.1	0.6	0.0	0.2	0.4	8.3	0.0	2.1	0.4	0.1	0.0	0.1	0.1	1.0	0.2	2.1	2.4	0.0	0.0	0.0	0.0	1.4	2.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	6.0	0.0	0.4	12.9	2.4	0.2	12.9	1.7	9.2	0.0	0.0	1.6	0.2	2.0	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	9.2	9.5	17.9	11.2	5.3	4.8	4.4	4.0	4.0	4.9	8.3	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.2	2.8	0.1	0.0	0.0	533.5	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	261.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	7.5	0.0	0.0	0.0	19.1	116.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.8;kidney: 7.0;pituitary gland: 5.3;prostate: 3.9;retina: 4.4"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 44.8;Cardiomyocytes: 25.6;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 34.6;Proximal enterocytes: 40.3;Proximal tubular cells: 14.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.3;SH-SY5Y: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.1;olfactory bulb: 2.4;spinal cord: 2.5"	HPA061704	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.1	0.9	0.0	1.1	0.2	0.0	0.9	1.1	0.0	0.3	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.6	7.0	0.0	0.3	0.0	1.6	1.5	0.0	1.3	0.0	5.3	0.1	1.7	3.9	0.2	4.4	0.0	0.0	0.1	0.1	4.8	0.0	1.1	0.1	0.8	1.2	1.5	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.9	1.1	0.6	1.6	1.6	1.5	1.7	1.1	1.5	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	44.8	0.0	0.3	25.6	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	3.0	0.6	0.1	1.3	34.6	0.0	1.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.8	0.0	0.0	0.0	3.4	0.0	0.1	1.8	0.0	0.0	1.1	0.0	0.5	0.1	0.1	1.2	0.0	0.0	1.4	40.3	14.1	0.0	3.1	0.0	0.2	1.0	0.0	0.7	0.0	0.1	0.1	0.1	0.0	0.8	0.1
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838767	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.9;retina: 1.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 685.6;Inhibitory neurons: 352.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SCLC-21H: 6.0;SK-BR-3: 5.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebral cortex: 53.0"	HPA018039	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018039: AB_1852125"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.12e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.68e-2)"	0.0	0.1	0.7	0.1	0.8	0.1	0.0	1.2	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.2	5.9	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.1	0.0	0.0	685.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.1	21.9	352.4	0.0	0.0	0.6	0.0	68.3	0.0	0.1	0.0	4.7	0.0	0.2	0.0	20.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.0;pituitary gland: 10.7"	"Group enriched"	"Detected in some"	63	"Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.0	1.8	7.3	0.3	11.9	0.2	0.5	6.5	16.0	0.3	2.8	0.6	0.4	0.1	0.1	0.1	0.2	0.4	0.2	6.4	8.8	0.1	0.1	0.0	0.8	8.4	8.8	0.0	1.5	0.1	10.7	0.0	8.2	0.7	0.5	3.4	1.1	0.2	0.0	0.4	1.1	0.1	5.8	1.1	1.4	1.7	9.7	0.4	0.2	0.0	0.7	0.1	0.3	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.3	11.9	6.5	16.0	6.4	8.8	8.4	8.8	8.2	5.8	9.7	15.4	0.0	0.0	0.0	2.0	9.7	0.5	1.6	0.0	0.0	4.2	1.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	3.2	0.1	0.1	0.1	3.6	0.0	9.3	0.6	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	10.4	1.5	0.0	0.0	0.0	1.9	0.0	0.1	3.6	1.0	0.0	3.4	0.0	331.7	989.4	0.5	0.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.2	0.5	1.2	3.4	0.0	0.0	0.1	0.3	0.1	0.6	0.4
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;choroid plexus: 15.1;epididymis: 21.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"RPTEC TERT1: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	0.5	4.2	23.5	0.5	26.5	0.0	1.0	19.4	28.3	2.7	15.1	0.7	0.2	1.6	21.6	0.3	1.7	1.8	0.4	21.8	32.6	3.8	0.1	1.0	0.5	24.3	26.6	0.3	1.4	1.3	1.0	1.2	24.7	1.5	0.5	5.8	0.4	5.6	0.1	0.4	0.3	1.1	28.7	1.5	0.4	2.7	32.7	0.1	0.7	0.2	0.4	0.5	0.6	19.6	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.5	19.4	28.3	21.8	32.6	24.3	26.6	24.7	28.7	32.7	19.6	0.0	0.0	0.0	57.8	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	2.0	1.2	0.0	0.0	18.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	50.5	221.4	0.0	0.0	0.0	0.6	0.7	5.0	0.1	0.0	167.7	0.0	0.2	0.0	196.1	2.8	0.0	0.0	11.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297327-95386077	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.0;Leydig cells: 25.4;Oligodendrocyte precursor cells: 54.8;Peritubular cells: 42.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.8;BJ hTERT+: 18.0;hTERT-RPE1: 23.2;RPTEC TERT1: 35.2;U-138 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	6.7	1.5	21.8	0.8	20.0	0.0	5.4	15.2	31.2	10.7	12.2	9.8	1.2	10.6	3.6	2.4	10.1	1.5	6.0	22.1	16.8	8.4	2.0	2.4	0.4	15.4	17.2	10.1	2.4	27.0	6.4	5.3	15.2	9.3	0.9	0.5	5.6	14.7	1.5	6.0	3.7	5.1	15.3	2.6	5.5	12.2	18.0	24.4	19.7	1.8	0.5	9.0	10.6	19.3	13.8	0.0	0.8	6.1	5.3	4.2	0.0	6.3	18.0	10.1	9.3	0.0	0.0	0.0	0.6	8.3	5.5	0.2	4.0	1.1	4.3	0.0	1.4	0.0	1.8	0.0	2.2	0.0	0.0	2.9	3.6	2.2	10.0	23.2	0.0	1.0	0.0	0.0	0.8	8.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	35.2	0.0	0.7	0.2	0.3	0.3	6.8	0.0	0.3	0.1	0.3	16.3	3.8	0.0	4.9	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	20.0	15.2	31.2	22.1	16.8	15.4	17.2	15.2	15.3	18.0	19.3	0.4	0.0	1.1	13.4	0.5	0.4	0.8	0.0	1.2	8.1	1.0	1.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.2	7.9	0.2	0.6	0.3	3.7	1.0	4.2	0.0	39.0	0.0	0.1	3.5	0.0	0.3	0.0	7.5	0.0	0.5	0.1	0.0	5.1	0.1	0.0	0.0	0.4	1.3	25.4	0.1	7.2	1.9	0.6	0.5	0.0	54.8	3.0	0.2	0.0	42.9	0.0	0.5	1.0	1.5	0.0	0.0	0.0	8.3	3.7	0.1	0.9	0.2	0.9	0.0	0.0	1.5	0.3	0.1
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	117	"kidney: 198.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.6	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.5	0.1	198.0	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.1	0.3	0.5	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17385248-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 134.7;tongue: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.7	0.6	5.1	0.4	8.3	0.2	3.0	12.4	11.9	0.6	0.0	1.1	1.0	0.9	1.6	1.5	0.7	0.5	13.8	5.3	4.2	4.7	1.5	2.5	0.8	8.0	3.4	0.3	11.3	5.0	7.4	0.1	8.2	2.2	0.4	1.3	2.2	2.4	134.7	1.5	1.3	0.1	2.6	1.6	13.1	0.6	6.4	0.3	5.1	40.7	0.5	0.9	0.4	5.9	1.5	2.1	0.2	4.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	2.0	0.2	6.6	0.2	0.0	0.3	0.3	4.1	0.1	0.2	1.6	12.3	3.4	0.9	0.5	0.1	0.5	0.3	0.1	0.2	0.0	0.1	0.1	0.0	5.6	3.5	3.6	0.0	10.0	0.7	0.1	1.1	4.0	0.3	1.3	1.6	2.0	0.3	0.9	8.5	0.7	0.0	3.4	0.0	0.0	4.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	6.5	0.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	8.3	12.4	11.9	5.3	4.2	8.0	3.4	8.2	2.6	6.4	5.9	1.5	0.0	2.7	3.3	0.1	0.0	0.1	0.0	0.0	2.1	2.6	0.9	14.1	0.0	0.6	5.5	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.3	0.3	4.2	0.0	5.5	0.4	0.0	0.9	0.0	0.6	0.0	0.2	0.4	1.3	0.1	0.0	5.9	0.9	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.0	0.8	0.1	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.7	0.0	1.3	0.2	0.2	0.3	1.0	0.0	0.0	0.0	0.1	0.4	0.2
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 25.5;skeletal muscle: 69.1;tongue: 25.7"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.3	1.1	2.9	0.6	2.2	0.4	0.8	25.5	3.3	1.2	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.4	1.5	2.9	1.3	0.1	1.9	0.1	4.0	6.0	0.4	0.2	5.5	0.8	0.4	3.1	0.6	0.3	1.3	0.7	0.6	69.1	3.6	0.4	0.6	1.1	1.2	1.1	0.8	10.8	0.1	1.1	25.7	1.0	0.7	0.5	1.4	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.2	25.5	3.3	1.5	2.9	4.0	6.0	3.1	1.1	10.8	1.4	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium inwardly rectifying channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 7.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8;head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.9;parathyroid gland: 36.0"	"Group enriched"	"Detected in many"	4	"Horizontal cells: 240.6;Oligodendrocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"			"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	1.9	0.8	7.2	5.1	19.5	1.9	4.9	13.4	13.1	0.9	0.0	3.9	0.9	0.9	0.6	2.9	6.6	1.4	9.8	5.9	11.8	1.0	1.3	2.1	1.3	18.6	16.2	0.7	0.4	36.0	0.6	6.3	18.2	1.8	3.2	7.6	1.3	1.8	9.7	4.7	1.4	1.0	10.5	7.3	0.8	0.3	14.5	1.8	1.2	8.4	1.5	1.9	1.8	42.9	0.0	0.9	1.8	0.0	1.9	0.5	0.0	0.6	4.5	0.1	0.1	0.0	0.0	0.0	0.4	0.5	1.2	0.5	0.1	0.3	0.1	0.0	0.2	0.0	0.6	0.0	5.4	0.0	0.0	2.0	0.1	2.8	0.3	8.9	6.3	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.2	0.8	0.2	7.5	29.2	0.0	0.7	0.0	0.4	0.8	0.5	0.1	0.0	3.5	0.3	0.5	0.1	10.6	0.1	0.1	2.4	0.0	0.0	0.1	2.3	0.0	1.5	4.2	3.5	5.6	0.0	6.9	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	30.4	0.0	7.3	0.2	0.0	0.8	7.2	19.5	13.4	13.1	5.9	11.8	18.6	16.2	18.2	10.5	14.5	42.9	12.0	0.0	3.2	0.0	0.6	8.2	4.1	4.9	16.5	43.5	5.8	9.3	19.3	0.0	1.9	1.8	0.0	0.5	0.1	13.5	0.0	0.1	0.3	2.3	0.2	16.0	10.7	0.4	3.8	0.0	0.4	1.7	4.1	1.6	0.0	0.1	3.3	0.1	6.8	240.6	16.2	2.7	0.0	36.9	7.4	0.0	1.5	7.8	3.6	2.8	8.2	5.8	0.0	1.5	164.7	0.0	12.3	1.2	0.0	2.2	0.9	0.1	4.9	5.2	0.0	3.9	2.6	0.1	0.9	6.9	3.3	1.4	0.8	0.2	8.5	0.3
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.3;pancreas: 20.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.3	1.2	0.6	0.9	0.4	0.9	0.6	2.0	1.3	0.2	0.8	0.8	0.3	0.9	1.0	0.9	2.2	8.5	0.7	3.2	5.4	0.4	5.9	1.6	3.7	1.7	0.9	20.4	1.3	11.9	7.3	2.7	1.3	0.7	1.0	0.9	9.6	0.4	0.4	0.5	0.6	1.7	13.6	2.3	1.1	7.9	5.8	0.5	0.4	0.5	1.5	0.4	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.2	0.9	0.6	2.0	0.7	3.2	3.7	1.7	2.7	1.7	7.9	3.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 71.3"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 197.2;Smooth muscle cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031066	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	28.6	17.3	4.9	3.2	5.4	0.0	22.1	4.8	5.7	17.0	11.6	15.6	1.2	18.8	0.7	3.6	14.8	1.8	71.3	4.7	5.0	13.9	41.9	13.8	2.5	5.2	5.3	16.8	42.4	1.8	7.8	3.0	5.1	13.0	0.3	0.8	6.4	8.4	17.1	5.8	5.9	5.5	5.2	8.0	12.7	1.0	7.2	0.6	16.1	4.5	0.4	15.1	11.5	4.7	0.0	0.1	0.9	0.0	1.4	3.2	0.0	11.1	4.4	6.5	1.9	58.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	4.3	2.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	2.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	4.8	5.7	4.7	5.0	5.2	5.3	5.1	5.2	7.2	4.7	18.7	3.2	29.5	2.9	0.0	1.3	0.4	0.0	0.6	0.0	9.2	3.0	28.3	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	10.8	12.8	1.2	0.0	3.6	1.3	0.0	9.8	0.0	0.9	0.0	1.0	2.9	23.0	0.3	0.0	0.2	0.0	0.0	0.8	1.5	0.1	0.3	0.3	1.8	0.0	0.0	13.2	0.0	0.5	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.0	197.2	3.3	61.6	0.0	1.0	0.1	0.9	0.3	0.3	0.5	0.2	0.6
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium inwardly rectifying channel subfamily J member 9"	Q92806	1	160081538-160090563	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 65.8;choroid plexus: 20.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.9;Excitatory neurons: 23.5;Horizontal cells: 8.4;Inhibitory neurons: 12.6;Oligodendrocytes: 8.3"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	0.0	0.3	55.2	0.0	57.0	0.0	0.0	64.9	65.8	0.0	20.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	38.6	0.2	0.0	0.0	0.0	38.1	49.8	0.0	0.0	0.0	2.0	0.0	41.5	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.0	0.0	37.2	0.0	0.1	0.4	58.5	0.0	0.0	0.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	57.0	64.9	65.8	56.8	38.6	38.1	49.8	41.5	37.2	58.5	61.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.9	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.0	8.4	12.6	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.7	0.0	1.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614106-233672514	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;Horizontal cells: 200.2;Prostatic glandular cells: 222.9;Urothelial cells: 371.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	69	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 64.7;SCLC-21H: 62.5;U-266/70: 137.3;U-266/84: 134.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 117.0"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	3.9	4.1	17.7	2.9	19.8	0.3	5.7	58.0	28.4	7.8	50.4	15.7	16.9	6.1	30.9	20.9	10.9	12.1	41.0	24.3	13.7	9.2	12.1	4.4	1.0	23.5	17.8	7.3	5.5	16.2	22.2	6.8	24.1	6.4	13.9	18.5	15.1	11.3	0.4	13.3	12.6	3.8	15.4	0.9	38.1	0.9	16.3	0.5	7.2	0.9	4.4	11.5	14.4	21.3	33.2	18.3	0.1	0.0	0.0	0.0	50.2	8.8	0.0	0.0	0.0	0.0	52.9	0.0	20.7	6.8	7.3	47.1	8.9	15.2	0.0	0.1	15.8	0.0	64.7	0.0	0.5	0.0	1.8	3.9	17.0	0.0	12.4	1.1	0.2	17.7	7.9	15.0	0.0	12.6	12.2	0.1	10.9	38.5	41.0	0.0	2.7	3.7	16.0	28.4	62.5	11.8	33.5	14.3	0.0	1.0	4.1	0.1	0.0	0.1	25.8	0.0	1.0	137.3	134.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	17.7	19.8	58.0	28.4	24.3	13.7	23.5	17.8	24.1	15.4	16.3	21.3	0.4	9.6	22.9	5.9	0.6	63.3	136.7	32.6	3.4	2.9	23.0	6.0	54.7	12.8	44.6	18.4	4.2	0.5	3.0	91.0	1.9	29.2	1.1	52.7	26.4	3.5	29.3	0.0	157.8	48.3	14.0	31.2	50.4	89.3	0.0	15.0	0.0	8.9	0.6	200.2	61.0	56.3	24.4	0.3	4.4	0.2	1.5	1.0	10.6	12.2	0.0	72.6	0.0	36.2	73.2	96.3	82.4	0.0	0.2	222.9	10.6	8.8	42.9	5.1	0.0	2.3	6.9	0.6	3.2	19.1	47.6	0.8	1.4	0.5	31.2	371.6
KCNK10	"K2p10.1, PPP1R97, TREK-2, TREK2"	ENSG00000100433	"Potassium two pore domain channel subfamily K member 10"	P57789	14	88180103-88326907	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;intestine: 5.1;stomach 1: 2.6"	"Group enriched"	"Detected in some"	4	"dendritic cells: 12.5;Excitatory neurons: 43.8;Inhibitory neurons: 17.0;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 11.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	62	"plasmacytoid DC: 10.0"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 10.0"	"Cell line enhanced"	"Detected in some"		"OE19: 1.5;REH: 1.7;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030462	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA030462: AB_10601919"	"unprognostic (9.52e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.26e-3)"	0.0	0.3	4.0	0.4	3.6	0.2	0.0	5.1	4.1	0.2	0.0	1.3	5.1	0.0	0.0	1.1	0.0	0.0	0.0	4.4	2.9	2.4	0.0	0.1	0.1	4.2	2.9	0.0	1.4	0.0	0.5	0.0	3.5	0.0	0.7	0.1	0.2	0.0	0.0	0.0	2.6	0.1	2.3	0.1	2.6	0.5	2.4	0.0	0.0	0.0	0.4	0.0	0.2	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.1	1.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.1	4.0	3.6	5.1	4.1	4.4	2.9	4.2	2.9	3.5	2.3	2.4	4.6	0.0	0.0	0.0	0.7	0.1	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.5	2.1	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	43.8	0.6	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.0	1.6	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	37.7	11.9	0.1	0.3	0.0	0.0	0.0	1.5	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.2	0.0	0.0	0.1	0.0	1.6	0.1
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.6;parathyroid gland: 6.0;testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 41.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;RT4: 1.9;SuSa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.3	0.8	1.7	1.7	1.5	0.0	0.2	0.9	1.9	0.1	5.6	0.4	0.5	0.2	1.0	0.2	0.3	0.4	1.6	1.6	1.4	3.9	0.5	0.4	0.6	1.6	2.3	0.1	0.3	6.0	0.3	0.2	1.8	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.5	0.3	1.8	0.6	0.4	9.2	2.2	1.1	1.9	0.0	0.5	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.9	0.7	0.2	0.0	0.7	0.5	2.9	0.0	0.7	0.0	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.5	0.9	1.9	1.6	1.4	1.6	2.3	1.8	1.8	2.2	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	6.3	0.0	0.4	0.0	0.0	6.0	0.0	4.4	0.0	0.0	4.0	8.1	0.6	0.0	3.2	0.0	41.2	9.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.3	0.1	0.1	0.4	0.0	0.1
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745865-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 48.9"	"Region enriched"	"Detected in single"	18	"olfactory bulb: 6.8"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 3.9"	HPA064861	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	4.0	2.1	0.3	0.2	0.5	0.0	3.0	0.1	0.4	3.2	0.2	0.5	0.2	2.3	0.2	0.7	5.2	1.0	1.7	0.1	0.9	2.0	0.3	2.0	0.0	0.2	0.3	2.2	1.6	0.1	3.5	0.1	0.1	1.6	0.0	0.2	1.7	1.3	0.4	1.4	0.6	1.1	0.1	0.1	2.8	3.3	0.2	0.0	2.7	0.2	0.0	1.0	1.5	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.3	0.1	0.1	0.3	0.0	0.0	0.8	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.4	0.0	1.4	0.6	4.6	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.1	0.9	0.2	0.3	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.5	1.9	0.0	0.6	0.1	1.6	1.0	0.7	15.7	0.4	9.2	0.0	0.0	0.0	0.3	0.0	3.9	0.2	1.7	2.3	2.5	1.2	0.0	1.0	7.0	0.0	3.9	1.1	1.6	0.0	6.3	1.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.3	0.3	6.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	1.5	0.3	0.4	0.0	5.6	0.0	0.2	0.1	0.1	0.0	0.5	0.6	0.2	0.4	1.4	0.9	0.0	0.1	0.3	1.0	7.4
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNK18	"K2p18.1, TRESK, TRESK-2, TRESK2, TRIK"	ENSG00000186795	"Potassium two pore domain channel subfamily K member 18"	Q7Z418	10	117197489-117210299	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044739	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"					"HPA044739: AB_10795008"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 138.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 471.1;Bipolar cells: 409.8;Excitatory neurons: 1023.7;Inhibitory neurons: 635.9;Oligodendrocyte precursor cells: 708.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ: 100.8;hTERT-HME1: 115.3;PC-3: 159.6;U-138 MG: 112.6;U-87 MG: 109.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054648: AB_2682556"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-3)"	10.9	12.6	36.2	8.9	38.0	1.0	15.8	1.0	45.0	54.4	4.2	118.2	7.3	138.7	31.4	33.7	47.8	22.4	3.7	36.4	10.1	11.4	19.2	9.6	7.8	4.8	15.2	13.9	8.0	0.2	26.9	4.8	5.7	48.3	21.1	40.2	42.8	76.1	96.6	5.0	23.3	92.8	1.0	24.1	33.6	5.8	15.6	2.1	3.0	18.7	3.5	44.3	24.6	28.4	0.3	30.3	0.1	0.3	4.6	24.8	0.3	100.8	89.2	23.9	11.8	6.7	0.6	0.0	0.7	75.9	56.8	0.2	0.0	59.0	14.6	60.9	0.6	0.0	0.0	0.0	45.0	0.0	0.4	17.4	10.7	38.3	115.3	84.0	9.8	0.5	0.0	0.0	42.6	1.2	1.9	0.2	1.8	0.2	159.6	0.1	3.6	0.1	15.3	0.2	9.1	1.1	0.0	2.5	0.1	11.9	12.2	0.1	65.4	112.6	12.7	20.6	90.0	0.0	0.2	0.0	109.8	0.1	45.1	0.0	0.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.1	36.2	38.0	1.0	45.0	36.4	10.1	4.8	15.2	5.7	1.0	15.6	28.4	0.9	0.0	4.3	471.1	2.8	2.0	71.7	5.7	17.6	409.8	30.4	43.9	3.5	5.7	4.8	1.8	60.5	0.3	0.5	2.8	29.4	3.3	74.4	20.9	17.9	3.4	4.9	0.0	1023.7	10.7	0.2	16.2	0.5	29.7	0.0	1.9	2.5	27.3	10.8	6.7	635.9	59.6	46.8	106.0	3.9	63.1	3.7	36.7	48.0	133.0	4.0	52.3	0.0	708.2	33.9	8.7	1.4	1.2	8.7	64.0	1.4	0.9	0.1	17.2	6.6	20.6	19.2	3.4	2.5	7.7	0.3	0.3	0.7	177.2	1.7	2.4
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.4;SCLC-21H: 3.3"									CAB022649	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.3	5.1	2.5	0.0	3.0	0.0	0.7	1.5	4.0	1.4	0.9	1.2	0.5	2.9	35.4	0.4	13.9	0.5	5.8	4.0	2.3	3.4	0.2	1.1	0.0	3.0	2.7	12.7	4.0	0.2	1.7	0.1	2.3	0.5	0.3	0.2	0.2	1.1	0.2	0.3	0.5	1.9	2.2	1.3	3.0	0.2	2.1	0.0	0.3	0.2	0.0	0.2	0.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.5	3.3	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	1.5	4.0	4.0	2.3	3.0	2.7	2.3	2.2	2.1	2.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.1	8.7	0.2	0.0	13.8	0.0	311.8	0.0	0.0	2.7	0.0	1.9	0.0	12.7	1.8	0.0	0.0	0.0	791.1	0.0	4.1	0.0	0.0	0.1	2.8	0.1	0.0	12.2	0.0	0.0	0.0	1982.5	6.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	10.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.1
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.8;HEL: 8.1;NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	4.9	3.6	1.5	2.2	1.8	1.1	4.6	1.7	1.9	3.5	1.6	4.0	1.5	3.2	1.5	2.0	2.9	1.7	3.5	1.5	1.7	4.8	5.5	3.0	2.2	1.9	1.7	3.2	5.3	1.2	3.3	4.2	1.8	4.2	1.5	2.3	3.1	1.1	1.3	2.4	3.5	1.4	1.3	7.5	3.7	3.9	1.7	0.9	3.2	0.5	1.9	3.7	2.7	1.7	2.2	0.5	0.8	0.0	0.9	0.8	1.3	0.6	0.3	0.9	0.4	4.8	1.9	0.1	2.1	0.4	1.8	0.8	0.0	0.1	1.0	2.7	0.3	8.1	2.6	1.8	0.8	0.1	2.5	1.3	0.4	0.6	0.0	0.7	0.8	0.0	0.3	0.0	1.1	1.5	0.1	5.7	0.0	0.9	1.6	2.4	0.0	0.1	0.7	1.5	1.1	0.2	0.7	0.8	0.5	0.7	2.1	4.4	0.5	0.4	0.7	0.2	0.6	0.7	0.3	2.6	0.4	3.1	0.6	0.8	0.1	0.1	0.3	0.1	0.2	1.2	0.2	0.3	0.0	0.6	0.2	0.2	0.6	1.1	0.0	0.1	0.4	0.0	1.5	1.8	1.7	1.9	1.5	1.7	1.9	1.7	1.8	1.3	1.7	1.7	4.2	0.0	3.6	3.9	2.9	0.3	1.4	0.3	0.0	2.5	2.1	1.3	1.1	2.8	1.5	0.0	14.6	1.2	0.6	3.8	0.0	5.0	11.2	1.5	2.3	5.3	4.9	0.8	3.4	3.6	1.3	1.5	0.5	2.0	2.5	3.4	2.9	1.4	1.1	0.0	4.6	1.4	0.0	2.1	1.9	13.3	2.8	1.4	0.0	5.6	1.4	1.8	1.0	4.0	6.4	3.3	0.8	3.0	0.9	1.7	1.9	0.3	1.1	7.8	6.6	1.6	1.6	2.0	2.6	0.3	0.1	1.2	1.0	2.3	1.4	1.0
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366290-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;choroid plexus: 18.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.7;Hepatic stellate cells: 37.1;Inhibitory neurons: 45.0;Oligodendrocytes: 86.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.7;RH-30: 8.2;RT4: 9.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072287	Enhanced	Approved	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA072287: AB_2686507"	"unprognostic (3.90e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.05e-2)"	2.3	14.9	35.3	1.1	39.5	0.2	2.0	29.7	43.5	3.1	18.9	8.6	1.0	1.8	1.1	1.0	1.7	1.4	4.7	36.4	29.7	3.7	0.5	6.1	1.3	38.5	32.2	2.6	0.5	0.2	1.9	2.5	32.1	3.2	1.2	1.9	1.7	2.1	2.4	2.6	3.0	1.2	28.9	1.2	2.1	2.1	38.4	1.3	2.1	1.5	1.0	2.5	2.6	54.2	0.0	0.3	4.9	2.7	0.3	0.2	0.5	0.6	0.9	0.2	0.7	0.2	1.8	2.4	0.3	0.0	1.0	0.0	5.3	0.8	0.2	1.1	3.1	1.3	1.1	2.9	0.0	0.1	0.1	1.4	0.1	0.0	0.0	0.5	0.2	3.5	0.0	0.0	0.9	0.7	1.8	0.4	7.7	0.1	5.6	2.6	8.2	0.2	0.2	9.3	2.4	2.9	0.7	0.9	0.0	7.3	2.7	0.1	0.1	0.3	1.3	0.1	0.3	1.7	0.0	2.5	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.1	35.3	39.5	29.7	43.5	36.4	29.7	38.5	32.2	32.1	28.9	38.4	54.2	8.5	0.0	0.6	2.6	1.1	3.2	0.2	0.4	0.6	23.1	2.8	1.9	4.3	0.0	0.2	23.9	0.0	0.2	2.1	0.1	0.0	0.1	0.9	4.7	1.1	8.7	0.0	3.2	95.7	0.0	0.4	9.6	0.0	3.4	0.0	7.2	37.1	0.7	1.2	0.0	45.0	0.4	0.0	10.8	2.6	2.2	6.5	2.9	1.8	20.6	0.7	1.5	0.0	13.6	86.9	0.0	0.0	18.0	0.2	0.8	0.0	9.7	0.0	3.0	0.0	12.8	5.1	2.2	7.8	0.2	5.5	0.3	1.4	14.0	0.5	0.0
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 27.8;brain: 20.8;liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.4	27.8	7.8	0.2	10.8	0.0	0.5	11.3	14.0	2.0	2.2	1.4	0.3	2.9	0.3	0.2	0.4	0.4	6.8	20.8	7.5	3.9	31.3	2.3	0.4	11.1	4.7	0.7	4.5	0.4	7.6	0.0	6.7	9.6	0.7	2.5	0.5	4.3	9.5	1.3	0.3	2.0	9.0	0.5	0.7	3.0	8.2	0.2	0.3	6.7	0.2	2.3	1.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	17.5	2.7	0.3	0.0	0.0	0.2	0.0	0.5	0.0	2.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.2	0.0	0.3	0.0	1.4	6.4	0.0	0.0	0.0	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.2	12.9	0.4	0.3	21.8	0.3	0.0	0.5	1.8	0.0	0.1	0.0	0.1	2.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.8	11.3	14.0	20.8	7.5	11.1	4.7	6.7	9.0	8.2	11.1	1.4	0.0	1.1	36.2	0.0	0.3	0.3	0.0	0.0	7.9	0.6	1.3	15.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.6	0.5	0.0	8.2	0.0	0.0	149.9	0.9	0.0	0.8	0.0	1.3	0.0	0.8	5.0	18.3	0.0	0.0	97.0	1.0	0.0	1.0	0.3	0.5	0.0	0.1	21.4	6.5	0.0	0.4	0.0	63.3	9.2	1.0	0.1	0.0	1.2	4.7	0.0	0.7	0.0	7.8	0.0	0.1	0.3	0.3	6.5	0.3	0.3	0.0	0.0	0.2	0.5	0.6
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 168.8;Skeletal myocytes: 121.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	0.9	1.1	24.9	3.9	24.2	0.3	0.7	15.1	12.8	2.7	0.0	7.4	3.0	4.9	0.6	1.7	5.7	1.5	2.1	16.9	18.5	2.1	0.2	1.5	3.5	14.4	33.1	0.8	0.3	1.1	1.2	0.0	16.5	1.6	2.4	0.3	1.3	1.2	6.1	0.3	2.2	6.0	12.9	3.5	2.4	0.5	25.7	1.0	1.9	5.3	5.5	3.1	1.6	11.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.3	3.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	26.1	0.5	0.0	0.3	0.0	0.1	0.8	0.1	0.0	65.5	0.6	0.1	0.2	0.0	0.8	0.0	2.5	0.0	16.2	18.7	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	62.3	8.8	21.4	0.6	0.0	6.2	4.7	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	24.9	24.2	15.1	12.8	16.9	18.5	14.4	33.1	16.5	12.9	25.7	11.0	8.7	12.8	2.7	168.8	3.9	1.3	0.6	0.7	0.6	0.5	0.1	0.0	3.4	0.0	2.1	0.0	2.1	0.1	0.0	0.0	3.9	0.2	3.4	26.6	0.6	25.9	4.2	0.0	18.2	0.2	0.0	16.3	0.0	5.8	0.0	2.0	13.9	0.3	0.4	0.0	13.6	0.0	4.1	0.0	3.0	7.7	0.3	0.9	0.0	11.2	0.0	2.2	0.0	12.1	5.0	0.0	2.2	0.0	30.9	0.5	0.0	0.3	18.3	0.4	0.0	121.5	1.3	0.7	0.2	0.8	1.7	0.0	0.5	22.5	0.0	0.7
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 130.8"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.7;WM-115: 258.6"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.6	0.7	1.7	11.8	1.9	18.3	12.4	1.3	1.8	11.8	1.4	18.5	6.4	1.6	1.8	6.5	5.8	3.5	1.1	1.5	1.6	1.4	0.8	7.3	12.5	1.6	1.6	0.6	1.0	0.0	0.7	14.3	1.7	28.6	6.2	0.2	130.8	7.5	0.4	29.1	26.0	0.7	1.9	20.5	35.1	2.7	2.0	5.0	2.1	0.2	9.2	18.2	6.5	2.3	22.4	35.2	0.1	0.2	0.0	2.2	55.0	0.8	1.7	0.7	0.1	0.5	85.7	6.7	9.8	0.9	9.1	13.6	0.0	28.8	1.7	40.9	0.0	29.8	48.6	0.5	0.0	0.3	0.3	0.0	2.9	1.3	6.6	52.7	0.0	0.3	2.6	2.3	0.3	18.7	4.8	17.9	0.2	43.1	42.4	16.8	0.7	21.0	13.0	55.3	0.2	0.1	62.2	70.1	32.6	1.7	0.3	15.1	1.5	12.6	75.9	0.4	45.3	0.1	1.4	2.6	45.9	5.1	258.6	5.8	21.1	0.0	0.5	35.3	0.7	37.3	10.4	5.0	30.7	21.6	6.6	6.3	1.1	0.0	20.1	0.9	15.2	11.2	1.7	1.9	1.3	1.8	1.5	1.6	1.6	1.6	1.7	1.9	2.0	2.3	1.6	0.0	1.9	1.3	24.7	2.8	45.7	79.5	3.4	0.2	69.7	56.6	0.4	7.2	18.4	1.8	4.2	231.1	4.1	22.0	0.0	5.9	1.2	1.7	0.2	4.0	0.0	32.4	1.5	3.9	14.1	2.3	57.1	4.2	0.0	0.0	0.4	0.0	43.7	0.0	1.1	8.9	2.0	7.2	78.2	0.3	0.0	23.3	21.4	1.0	2.5	0.1	1.0	0.5	0.8	63.8	22.3	0.0	22.4	63.5	1.0	0.1	2.2	0.5	0.0	0.3	1.4	0.4	1.4	2.1	2.3	763.3	9.5	0.0	51.1	65.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 91.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	0.0	6.2	55.7	0.1	37.2	0.0	0.0	27.8	91.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.2	68.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	1.1	0.0	19.1	0.0	0.1	1.6	0.0	2.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	10.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	21.2	35.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.6	0.0	8.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.5	0.2	0.0	0.0	0.1	0.0	0.0	67.8	119.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	55.7	37.2	27.8	91.9	68.1	0.0	2.6	0.0	0.1	0.0	1.0	12.9	0.6	0.0	0.0	7.2	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	16.5	0.0	0.1	1.0	0.0	0.0	61.7	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.5	37.5	0.2	0.0	0.0	0.0	8.1	0.6	0.1	0.0	1.0	0.0	0.9	0.0	50.8	2.1	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.1	0.1	7.4	28.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198853	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.3;skeletal muscle: 21.1;tongue: 12.2"	"Group enriched"	"Detected in some"	30	"Excitatory neurons: 2136.7;Inhibitory neurons: 862.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 28.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.9;HEL: 23.2;HL-60: 31.5;U-251 MG: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.1	1.6	1.2	1.3	7.5	5.1	0.4	0.0	28.3	0.4	0.0	0.4	0.2	0.1	0.0	0.9	0.3	0.3	0.2	4.3	0.0	0.1	0.2	0.3	2.2	17.4	1.0	0.1	0.1	0.0	0.2	0.4	19.4	1.3	0.3	0.2	1.2	0.9	21.1	0.1	0.7	0.3	0.0	1.1	0.3	1.2	0.0	1.7	4.7	12.2	2.0	0.9	0.6	4.6	4.4	1.1	0.0	0.2	0.0	1.5	0.0	34.9	5.2	5.1	4.3	0.0	0.0	21.2	0.0	11.9	0.4	0.7	0.1	2.1	6.1	0.3	7.2	23.2	0.1	0.0	0.9	31.5	0.0	0.3	0.8	14.5	14.9	3.3	0.0	0.0	1.4	14.2	10.2	0.1	0.0	13.5	1.3	0.0	7.1	0.0	1.1	14.4	1.9	0.0	5.8	2.7	0.0	0.1	13.7	0.2	4.3	2.3	0.0	21.0	9.2	0.1	23.4	14.8	0.4	9.3	0.2	14.9	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.1	0.3	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.2	7.5	0.0	28.3	4.3	0.0	17.4	1.0	19.4	0.0	0.0	4.6	0.0	0.0	0.0	38.8	7.6	0.3	3.6	0.7	5.2	0.3	0.4	0.5	3.6	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	5.5	2136.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	862.4	0.0	0.0	0.0	1.5	1.6	0.0	0.2	1.8	49.6	0.0	0.1	1.0	30.2	26.7	0.0	0.0	0.0	7.6	5.7	0.0	0.0	0.0	0.2	0.0	6.0	0.8	0.5	0.5	0.8	0.3	0.3	2.8	0.0	0.0	0.7
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98426958-98432853	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.7;Endometrial stromal cells: 3.0;Excitatory neurons: 4.5;Inhibitory neurons: 1.7;Leydig cells: 1.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.7;white matter: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 2.1;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051417: AB_2681478"	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	0.6	0.4	0.0	0.1	0.5	0.0	0.2	0.0	4.7	0.6	0.0	0.3	0.0	0.3	0.5	0.2	0.3	0.4	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.4	1.5	0.0	0.2	0.2	0.7	0.0	1.0	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.7	0.6	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lung: 23.5;skeletal muscle: 86.0;tongue: 45.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.9	1.1	2.6	3.8	2.9	0.0	6.2	3.9	4.0	7.8	9.5	12.5	3.7	3.2	2.6	6.0	3.9	5.4	6.6	2.9	4.2	5.0	3.8	23.5	0.6	10.5	7.9	1.0	9.8	2.9	1.2	11.0	12.5	6.5	5.0	0.4	11.2	3.1	86.0	5.6	5.4	3.3	5.3	1.0	9.5	3.9	4.3	1.4	2.3	45.5	2.0	6.8	6.3	4.4	8.5	1.4	0.7	0.0	1.6	0.8	3.8	2.8	8.5	1.7	2.0	0.1	17.1	0.0	0.9	3.0	1.9	2.7	20.7	0.1	1.8	0.0	5.7	0.0	0.2	0.1	8.1	0.2	0.7	0.7	12.9	0.1	1.2	15.5	0.4	3.9	0.4	0.0	1.0	2.2	0.0	0.0	10.2	11.5	0.2	2.4	69.2	28.9	1.8	48.2	20.3	0.7	0.0	5.3	6.1	4.8	2.8	0.0	0.2	2.7	0.0	0.2	21.6	0.1	34.9	0.1	15.2	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	3.9	4.0	2.9	4.2	10.5	7.9	12.5	5.3	4.3	4.4	3.8	28.9	8.2	0.0	0.0	13.9	16.8	6.9	21.1	0.2	11.5	7.0	0.5	18.6	6.8	11.0	0.0	0.6	0.0	10.9	0.0	21.5	0.3	0.9	0.6	5.9	32.5	0.0	0.3	0.4	3.5	12.1	8.2	0.9	1.3	4.3	2.5	5.4	0.5	0.0	16.9	5.6	14.2	0.0	4.5	1.2	1.5	0.4	21.4	1.9	0.7	0.1	0.0	7.1	2.5	2.4	4.9	3.8	1.2	13.6	4.1	5.5	1.7	0.2	6.6	13.5	10.6	0.3	3.4	8.0	5.8	0.8	0.6	30.6	10.3	7.1
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.1;lymphoid tissue: 15.8;skeletal muscle: 13.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.8"	HPA059880	Uncertain					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	0.4	0.1	3.9	0.1	7.9	0.1	0.3	1.9	37.1	0.3	0.0	0.3	0.1	0.1	0.1	0.2	0.6	0.2	1.2	4.2	0.0	0.0	0.1	0.3	0.0	4.5	0.0	5.0	0.1	0.0	8.7	0.3	2.8	0.1	0.0	0.4	0.2	0.0	13.4	0.1	0.2	0.0	0.0	15.8	0.5	0.9	0.0	0.0	0.1	8.2	0.0	0.2	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	1.8	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.9	1.9	37.1	4.2	0.0	4.5	0.0	2.8	0.0	0.0	12.5	0.0	0.0	0.0	3.6	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	60.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.3	0.0	3.5	2.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.1	1.1	0.3	1.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.2;Inhibitory neurons: 240.5;Oligodendrocyte precursor cells: 310.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;hTERT-RPE1: 9.0;SCLC-21H: 7.5;SH-SY5Y: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	1.0	0.6	0.9	0.1	2.0	0.0	0.4	0.0	2.0	0.4	0.3	0.5	0.2	0.3	0.4	1.0	0.5	1.4	1.8	2.5	3.3	0.3	2.8	1.8	0.1	0.0	0.2	3.8	0.1	0.0	0.9	0.2	0.0	1.0	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.5	0.6	0.2	0.5	1.1	1.0	0.1	1.1	0.8	0.1	0.8	0.4	0.5	0.0	0.1	1.8	0.0	0.2	0.2	0.0	0.0	1.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	3.2	0.0	0.0	1.2	0.0	0.4	0.1	9.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.5	7.5	5.6	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	2.0	2.5	3.3	0.0	0.2	0.0	0.6	1.0	0.5	0.8	41.7	1.1	6.8	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.1	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.2	0.8	0.0	0.0	220.2	0.0	0.0	9.3	0.0	0.0	0.0	6.1	2.5	6.2	0.0	0.0	240.5	0.0	0.0	0.0	0.7	3.3	6.5	0.0	1.8	58.1	0.0	0.0	0.0	310.7	6.1	0.0	0.0	4.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.4	4.0	0.6	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.2
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717510-2730037	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"retina: 289.1"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 515.0;Rod photoreceptor cells: 530.1"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	289.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.3	0.9	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.2	0.0	0.0	0.0	515.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	2.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	1.3	0.0	0.0	0.0	0.0	25.3	0.6	0.0	0.0	0.0	0.0	69.1	0.0	0.5	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	530.1	13.1	0.0	0.0	7.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448655-109477359	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	40.3	23.4	20.5	26.2	19.7	15.4	32.9	17.2	20.3	34.2	32.1	42.5	14.7	43.8	14.0	36.6	27.4	33.0	24.1	19.7	31.0	23.0	11.4	31.9	21.9	21.1	23.1	18.1	12.4	22.2	17.0	25.4	26.6	29.2	33.2	14.3	20.7	44.3	11.5	30.3	22.3	57.0	19.2	23.2	25.8	16.3	30.1	14.9	47.1	11.7	22.8	39.0	29.4	18.9	28.4	27.9	84.6	27.5	67.8	91.2	18.5	59.0	80.2	38.8	38.2	28.1	23.1	27.5	34.0	136.4	19.2	22.0	30.7	51.6	35.9	26.0	22.0	32.3	19.2	19.3	44.5	24.9	26.7	92.2	30.7	50.0	29.3	54.7	89.5	26.4	21.5	11.5	68.0	15.1	29.8	32.9	48.1	12.7	36.0	29.2	37.7	22.6	38.5	48.9	29.5	44.3	35.6	38.8	41.8	47.5	45.2	18.8	70.0	42.3	15.5	24.0	32.8	26.0	52.8	37.1	48.8	20.2	60.5	10.9	9.5	6.4	13.5	14.4	10.1	6.6	8.0	10.0	11.9	6.2	8.8	11.1	6.5	25.1	17.2	9.0	10.0	14.9	20.5	19.7	17.2	20.3	19.7	31.0	21.1	23.1	26.6	19.2	30.1	18.9	21.1	16.0	29.9	6.2	9.0	14.7	20.1	17.4	11.4	5.4	12.1	13.5	11.5	10.0	13.7	5.5	16.7	9.1	19.4	31.5	5.9	15.3	12.2	9.9	17.8	26.8	11.5	6.5	9.8	13.1	12.8	15.5	10.7	12.8	14.0	11.3	24.7	5.3	11.5	8.4	8.1	13.4	10.2	13.6	13.3	11.3	11.5	14.6	16.0	8.4	15.7	2.8	81.4	8.0	9.4	25.9	11.8	18.8	7.5	12.2	6.4	10.5	12.2	4.4	26.3	13.4	32.6	13.5	6.3	10.2	16.6	13.5	10.6	10.4	15.0	18.1
KCTD11	"C17orf36, KCASH1, REN"	ENSG00000213859	"Potassium channel tetramerization domain containing 11"	Q693B1	17	7351889-7354944	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Ubl conjugation pathway"	"Developmental protein, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 9.6;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.6;hTCEpi: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052035	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA052035: AB_2681704"	"unprognostic (1.98e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (6.78e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	10.5	7.3	5.6	6.1	6.2	1.0	8.2	6.3	6.0	31.6	6.4	8.5	5.8	11.4	7.9	40.1	9.2	7.5	6.4	5.6	5.9	8.0	6.2	8.1	6.0	7.1	6.0	7.8	7.8	9.1	6.5	7.4	6.2	8.8	5.6	3.4	15.6	9.8	5.3	35.1	8.5	7.8	6.1	8.7	8.5	3.4	7.4	3.0	9.9	3.9	10.3	28.6	35.5	6.5	18.2	7.7	5.6	4.0	23.5	13.6	5.1	10.9	19.3	12.5	10.6	6.6	8.1	2.3	6.1	20.2	11.8	32.3	0.7	53.6	10.9	10.4	2.1	0.2	4.0	0.8	11.7	0.3	10.2	10.7	38.1	13.8	7.6	25.7	3.8	1.9	2.4	3.0	9.7	8.1	1.5	2.5	1.5	8.5	3.3	1.9	5.1	2.3	13.3	7.1	0.3	2.4	8.1	8.4	1.2	6.9	11.5	1.0	7.6	10.3	8.2	7.0	6.2	2.1	0.9	0.8	12.1	5.1	7.4	9.6	2.6	1.6	1.4	3.5	0.4	1.0	0.7	0.6	1.5	0.7	0.3	1.0	0.4	1.0	2.9	0.1	0.1	1.9	5.6	6.2	6.3	6.0	5.6	5.9	7.1	6.0	6.2	6.1	7.4	6.5	3.1	9.6	1.1	3.3	3.4	1.8	17.6	32.2	4.0	3.9	5.8	4.1	0.8	7.2	13.8	5.5	2.1	6.1	1.6	11.1	3.9	13.3	25.3	9.4	12.1	3.8	7.2	0.0	0.0	9.4	6.5	9.3	15.8	6.1	4.5	4.0	4.2	2.5	4.8	1.7	0.4	6.5	10.2	3.5	5.0	8.7	17.7	3.5	1.8	1.9	10.5	3.7	11.3	0.0	1.4	32.8	5.0	21.8	3.8	13.1	8.0	3.4	24.5	1.9	19.7	5.9	11.6	1.2	1.2	6.6	4.4	9.9	3.6	4.1	4.0	18.4
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	3.4	23.1	2.0	1.6	2.0	0.1	20.4	5.1	2.9	10.4	3.2	8.1	4.9	3.4	14.3	1.5	11.7	6.7	0.6	2.1	2.1	11.5	10.3	8.2	0.3	1.9	2.3	0.8	27.2	8.3	2.5	1.3	2.2	7.0	11.9	1.6	28.7	19.1	0.2	1.9	5.2	2.1	1.6	0.6	20.8	0.6	2.5	1.3	15.9	0.6	0.5	2.3	1.4	1.7	0.0	3.5	0.6	0.5	1.3	0.8	3.5	1.8	1.6	3.4	8.4	13.5	8.8	0.1	9.3	1.1	0.4	1.0	0.6	26.1	8.9	0.5	13.2	0.0	3.0	29.0	4.9	0.2	0.1	4.0	0.7	13.9	11.0	2.5	1.0	0.2	0.3	0.1	1.4	0.2	0.3	0.8	6.5	0.5	0.5	0.4	0.0	0.0	45.9	3.5	2.3	0.2	0.0	0.2	4.5	0.8	1.4	1.1	0.8	0.2	20.2	0.7	0.4	0.3	0.2	0.2	0.2	0.2	3.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	2.0	2.0	5.1	2.9	2.1	2.1	1.9	2.3	2.2	1.6	2.5	1.7	0.6	3.2	10.8	0.0	0.2	0.4	12.2	2.0	2.8	0.4	13.7	12.8	0.0	1.5	4.1	5.5	0.0	0.6	0.3	5.2	3.9	2.6	0.3	2.7	2.0	0.9	4.8	0.0	0.0	17.1	1.3	1.1	14.3	3.7	1.3	0.5	0.0	4.8	0.2	0.0	0.0	20.8	0.0	0.0	0.0	0.0	3.4	0.4	1.8	0.0	0.1	2.1	0.0	0.0	0.0	10.5	6.6	5.3	0.0	14.3	2.2	15.1	0.1	0.0	0.0	0.0	1.8	0.2	0.3	0.7	0.1	0.7	0.3	0.7	8.5	7.4
KCTD16	KIAA1317	ENSG00000183775	"Potassium channel tetramerization domain containing 16"	Q68DU8	5	144170873-144485686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 11.0"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 801.9;Inhibitory neurons: 788.9;Oligodendrocyte precursor cells: 362.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.9;TIME: 6.2;U-87 MG: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044590, HPA050154"	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044590: AB_2679008, HPA050154: AB_2681034"	"unprognostic (7.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.81e-5)"	"unprognostic (9.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (2.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.80e-3)"	"unprognostic (1.22e-2)"	0.0	0.5	1.1	0.0	11.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	11.0	0.0	6.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	40.8	0.0	0.0	0.0	0.3	0.0	14.3	0.0	0.1	0.7	1.5	0.0	0.0	2.1	0.1	0.0	0.1	0.0	4.3	9.7	0.3	0.1	0.6	0.0	0.0	801.9	5.5	0.0	0.9	0.0	0.0	0.0	0.1	0.4	0.0	0.1	20.2	788.9	0.4	0.0	0.0	0.5	5.3	0.0	0.0	0.0	16.9	0.1	0.8	0.0	362.4	34.9	1.8	0.0	0.0	0.0	0.0	0.1	0.8	0.9	2.9	0.0	0.1	0.4	4.8	2.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0
KCTD17	FLJ12242	ENSG00000100379	"Potassium channel tetramerization domain containing 17"	Q8N5Z5	22	37051736-37063390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Ubl conjugation pathway"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 90.8"	HPA018459	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA018459: AB_1852169"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.22e-5)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.94e-2)"	8.2	15.6	64.8	9.8	113.7	2.4	6.7	46.0	71.6	14.2	44.4	15.9	3.4	14.9	1.8	7.2	10.7	8.5	26.6	68.0	54.1	5.8	3.5	9.3	10.6	44.8	70.4	13.7	3.7	7.8	43.0	6.5	52.4	11.2	5.2	3.6	3.4	9.0	1.7	21.1	10.4	9.4	43.8	11.1	7.9	46.0	83.8	7.0	7.6	3.0	6.9	16.9	13.0	55.5	15.9	20.5	31.7	23.7	14.9	14.8	1.2	16.2	15.6	25.9	22.3	4.4	4.6	12.2	10.9	20.8	20.3	4.2	10.0	19.0	10.9	23.8	26.8	5.2	5.6	4.9	22.1	0.0	6.1	17.3	9.2	26.6	5.8	17.5	33.6	15.9	1.2	13.2	16.5	12.8	11.0	0.3	20.3	9.4	17.4	19.8	8.4	3.6	6.7	4.1	26.4	32.9	15.0	14.1	7.5	6.6	3.8	4.2	19.6	33.5	31.2	16.0	12.0	17.7	5.5	2.0	29.6	7.3	18.6	0.0	0.8	0.0	0.9	1.0	0.9	1.2	0.6	0.9	0.9	0.4	0.8	0.6	0.0	1.6	0.4	0.2	1.0	0.4	64.8	113.7	46.0	71.6	68.0	54.1	44.8	70.4	52.4	43.8	83.8	55.5	8.8	0.0	0.5	11.1	5.8	1.5	4.6	2.8	1.2	17.3	1.3	1.5	5.0	4.3	0.8	5.5	2.1	0.4	5.0	17.7	0.0	11.9	24.9	0.7	12.7	9.7	13.1	0.8	22.4	6.1	2.8	9.9	4.1	0.9	4.5	12.0	12.8	0.5	9.2	13.5	11.6	5.3	0.0	9.6	17.0	28.1	10.5	9.8	3.6	1.9	13.0	16.4	8.2	4.5	7.1	3.2	16.0	9.1	4.6	1.2	0.5	2.5	1.5	7.8	0.0	7.8	11.7	19.7	7.1	1.3	4.8	7.5	8.5	10.2	7.0	2.4
KCTD18	"6530404F10Rik, FLJ31322, FLJ37818"	ENSG00000155729	"Potassium channel tetramerization domain containing 18"	Q6PI47	2	200488958-200519784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045498, HPA058028"	Approved		Approved	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA045498: AB_10959387, HPA058028: AB_2683583"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	9.9	8.9	8.2	7.6	9.6	9.8	10.2	8.9	9.9	8.4	9.0	10.1	8.7	8.5	8.2	9.0	8.8	7.2	8.4	7.8	8.5	9.9	10.0	8.5	11.0	9.1	9.1	10.4	11.9	10.4	6.3	6.2	9.3	11.1	8.4	5.6	10.6	9.4	10.6	9.2	7.9	7.7	9.0	10.2	9.3	7.2	8.7	10.6	13.8	8.9	11.0	9.8	8.0	9.4	10.2	9.3	4.5	16.9	21.2	26.2	11.6	12.3	15.4	7.7	10.1	7.5	11.4	7.1	9.1	12.4	12.6	9.6	4.5	14.8	9.8	17.3	4.9	10.2	6.7	5.3	14.4	8.4	11.6	17.6	27.4	8.9	16.9	17.9	6.7	10.5	7.1	9.5	13.9	10.5	18.2	8.2	2.5	8.7	8.3	12.5	10.2	8.4	10.1	10.0	5.1	7.1	9.7	8.2	15.1	9.7	10.9	13.4	11.4	15.7	3.6	8.0	5.9	18.1	14.0	8.0	18.0	8.8	11.3	7.8	3.2	6.4	3.2	4.7	4.9	4.0	4.1	4.8	3.4	4.0	5.1	5.1	2.5	4.6	3.2	4.1	5.0	3.2	8.2	9.6	8.9	9.9	7.8	8.5	9.1	9.1	9.3	9.0	8.7	9.4	7.8	6.4	9.4	7.2	11.3	4.5	5.9	5.7	10.8	7.2	9.1	6.9	6.2	8.6	6.5	3.7	0.0	8.0	10.8	5.6	1.9	7.2	22.7	8.8	7.3	5.7	1.2	3.4	10.1	8.4	7.8	8.6	8.2	5.3	2.5	11.8	8.6	9.4	7.2	10.1	9.5	8.4	6.1	11.4	6.6	4.2	11.8	11.2	7.2	6.5	16.7	11.1	18.6	6.6	18.3	6.5	7.4	12.4	7.5	5.8	8.5	13.5	9.8	10.5	19.7	12.2	7.9	19.0	16.5	12.8	4.0	5.1	10.1	11.0	7.3	4.0
KCTD19	FLJ40162	ENSG00000168676	"Potassium channel tetramerization domain containing 19"	Q17RG1	16	67289428-67326760	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 32.9"	"Group enriched"	"Detected in some"	8	"Early spermatids: 49.2;Spermatocytes: 72.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.6;neutrophil: 2.9;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049310, HPA053321"	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA049310: AB_2680706, HPA053321: AB_2682110"	"unprognostic (2.44e-1)"	"unprognostic (2.14e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.88e-4)"	"unprognostic (4.44e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.44e-2)"	0.1	0.0	2.9	0.8	3.0	3.2	0.1	4.5	3.7	0.2	1.2	0.1	0.3	0.4	1.3	0.5	0.4	0.8	0.0	2.6	2.5	0.2	0.1	0.2	0.1	4.4	3.1	0.0	0.1	0.1	0.2	0.3	4.7	0.1	0.2	0.3	0.3	0.1	0.6	1.5	0.3	0.2	1.8	0.3	0.4	32.9	5.6	0.5	0.4	0.1	0.1	0.4	0.0	7.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.6	0.4	0.6	0.3	0.6	0.3	0.5	0.3	0.0	0.0	0.0	0.6	0.0	2.0	0.4	1.5	0.6	0.4	0.0	0.3	0.2	0.2	0.4	0.5	0.6	0.3	0.0	0.1	6.4	0.4	0.1	0.0	0.0	0.5	0.5	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.8	0.1	0.3	0.1	0.6	0.1	0.3	0.6	0.0	0.4	1.7	0.0	5.6	1.1	0.3	0.6	0.0	0.5	1.6	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.2	2.9	0.4	0.2	2.7	0.2	0.4	2.9	3.0	4.5	3.7	2.6	2.5	4.4	3.1	4.7	1.8	5.6	7.3	0.1	0.0	2.3	0.7	0.1	0.4	1.5	0.0	0.0	1.1	0.3	0.1	1.3	0.0	1.3	0.0	6.2	0.2	4.2	0.0	0.0	0.1	49.2	0.1	0.1	0.3	0.0	0.0	0.6	0.0	0.2	0.6	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.3	7.5	0.9	0.5	3.6	0.0	0.6	0.2	0.0	1.0	0.4	0.0	0.0	0.7	0.1	1.0	0.1	0.1	0.0	2.5	0.0	1.2	0.6	72.7	6.1	0.0	0.3	0.1	0.4	0.2	0.2	1.4
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	41.6	25.9	15.3	28.1	16.7	27.7	21.3	16.0	16.4	23.7	14.8	21.5	14.3	25.7	15.4	28.1	19.5	28.9	18.0	15.6	19.5	16.0	31.2	22.0	27.6	18.6	19.4	22.8	12.8	14.6	11.9	26.0	18.6	19.3	18.1	10.9	14.6	21.0	20.7	29.6	15.7	31.5	16.3	25.3	14.7	10.3	17.0	34.8	14.3	18.9	29.5	28.6	17.6	17.5	36.7	16.9	47.0	90.4	62.8	41.3	23.4	43.7	60.4	46.9	52.2	43.6	20.8	124.3	38.2	72.4	26.8	33.3	62.3	31.4	77.3	90.3	34.9	70.3	26.0	46.5	29.9	68.9	46.8	41.1	32.5	36.1	23.0	31.2	48.7	64.1	112.8	68.2	44.9	33.1	78.5	26.6	17.5	29.1	15.3	78.0	53.4	68.8	25.5	40.6	11.4	65.9	38.4	38.6	116.6	46.6	53.5	68.1	56.4	126.2	43.4	37.5	55.0	53.0	132.9	87.8	21.7	93.7	131.4	29.7	17.4	11.4	8.1	15.1	9.4	6.8	6.5	6.8	16.3	5.6	6.5	6.6	12.5	7.8	8.9	9.0	8.6	13.9	15.3	16.7	16.0	16.4	15.6	19.5	18.6	19.4	18.6	16.3	17.0	17.5	38.3	38.5	23.7	21.9	28.6	50.1	19.6	15.2	24.5	22.4	23.7	23.9	15.9	28.6	22.2	16.5	10.4	26.3	45.4	14.0	1.9	18.2	0.7	20.0	33.8	38.3	15.1	64.6	23.3	14.2	18.9	38.9	23.9	24.6	53.8	40.8	44.6	45.6	26.7	15.2	23.3	15.5	12.2	51.3	126.3	2.3	31.7	61.4	33.8	27.2	58.4	18.1	30.9	22.6	26.5	19.5	16.3	53.4	48.7	18.9	18.8	19.0	22.5	10.5	19.7	35.8	42.7	8.1	27.2	27.6	63.4	23.0	39.6	23.8	16.1	32.2
KCTD21	KCASH2	ENSG00000188997	"Potassium channel tetramerization domain containing 21"	Q4G0X4	11	78171249-78188626	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041964	Uncertain		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA041964: AB_10795647"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.40e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.70e-1)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	7.3	13.4	14.4	6.2	13.6	3.5	4.4	13.1	14.3	5.8	8.7	6.5	5.0	5.0	9.2	9.6	6.2	7.9	6.3	13.7	14.3	5.5	15.9	6.7	5.4	14.7	16.3	13.7	3.5	5.7	5.9	7.7	15.0	4.2	4.8	4.3	5.8	5.2	8.5	4.9	4.5	7.1	12.4	4.6	4.5	4.0	14.6	5.9	11.2	7.0	6.2	7.1	5.9	14.7	5.2	11.8	6.7	5.0	23.8	16.9	4.1	10.1	9.6	7.1	7.1	11.1	7.8	5.0	9.9	11.4	9.5	10.1	6.5	8.4	7.3	6.9	3.9	3.8	15.4	9.8	13.2	2.4	4.7	16.4	15.4	15.5	8.8	14.8	11.0	6.1	8.1	4.5	9.7	7.3	3.8	7.3	3.0	19.0	8.9	5.0	5.1	3.1	8.3	9.3	4.6	7.1	6.4	4.6	4.9	12.1	10.6	2.6	12.9	11.3	11.0	30.0	3.9	8.6	9.2	4.8	5.9	3.9	6.4	2.0	5.4	7.5	0.9	6.0	1.4	0.6	1.4	1.7	3.7	1.4	1.3	1.0	8.3	1.4	5.1	0.8	1.1	2.2	14.4	13.6	13.1	14.3	13.7	14.3	14.7	16.3	15.0	12.4	14.6	14.7	1.9	0.0	2.7	4.6	0.7	1.8	1.2	1.5	0.6	1.7	2.4	2.2	3.5	5.7	2.0	0.0	0.0	1.2	0.6	2.8	1.9	1.5	0.3	1.4	2.5	2.3	0.0	0.0	4.1	2.2	1.1	2.8	1.1	1.9	5.7	7.0	3.6	7.4	2.3	6.7	3.4	1.3	0.0	3.1	1.1	0.5	4.4	1.3	1.8	4.7	2.8	1.0	0.0	4.0	4.2	2.5	1.7	9.1	1.0	1.9	2.3	2.7	1.1	0.9	0.0	1.2	2.9	1.5	2.7	3.6	1.4	1.9	1.8	3.8	1.7	2.1
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567304-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"T-47d: 227.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015142	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	35.1	77.2	19.6	11.8	26.9	15.9	67.2	34.8	21.8	23.8	19.3	35.1	45.5	23.6	27.4	38.7	19.3	27.7	13.0	19.4	23.2	27.7	71.8	17.0	8.6	29.1	25.4	23.4	32.8	36.7	12.0	29.7	29.9	38.5	28.4	39.8	27.7	29.6	15.2	18.8	49.5	28.9	25.1	11.6	26.7	20.1	25.5	11.3	27.6	23.8	10.9	23.9	30.7	33.8	52.8	37.2	41.6	24.1	34.3	57.5	57.1	42.8	40.0	37.1	38.5	33.0	85.6	14.6	23.4	45.0	11.1	50.3	44.1	43.4	42.5	8.2	45.8	26.3	71.0	46.3	28.3	26.9	5.1	53.5	30.0	47.0	35.5	46.7	34.6	19.8	51.8	13.9	41.1	45.6	11.7	13.8	69.9	76.2	47.0	17.7	58.8	56.9	42.8	35.2	48.7	54.0	65.9	95.0	36.6	52.1	227.5	34.3	31.1	36.8	36.4	46.1	49.4	12.5	18.2	5.3	29.0	14.1	28.5	0.5	0.4	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.4	0.5	0.2	0.2	0.7	0.5	0.2	0.6	0.1	0.2	19.6	26.9	34.8	21.8	19.4	23.2	29.1	25.4	29.9	25.1	25.5	33.8	26.5	9.6	11.6	41.4	2.4	18.0	25.2	9.4	19.4	31.7	60.0	31.9	13.3	40.0	17.6	11.0	18.8	27.2	4.6	15.5	23.5	26.6	1.3	14.0	29.8	20.6	39.6	19.3	53.5	20.7	15.7	30.3	21.4	19.6	5.1	30.7	16.1	60.5	8.0	18.5	62.9	40.6	14.2	9.3	8.4	3.2	27.7	7.9	16.0	33.7	5.5	24.0	0.0	53.3	106.7	16.5	19.1	22.6	4.6	21.9	50.1	28.3	14.4	24.2	26.3	41.8	20.4	6.3	14.6	45.2	17.6	17.5	2.5	32.0	33.0	38.3
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 24.6;choroid plexus: 9.4"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 2.6;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 9.5"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 20.7;hTERT-RPE1: 12.5;RPTEC TERT1: 11.8;U-138 MG: 13.9;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.1	0.0	20.2	0.0	24.6	0.1	0.5	8.3	17.6	0.1	9.4	1.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	16.6	11.3	0.2	0.0	0.0	0.0	10.9	10.7	0.0	0.2	0.0	1.8	0.2	9.7	0.0	0.2	0.0	0.5	0.1	0.0	3.1	0.5	0.7	12.4	0.0	0.0	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.2	0.0	0.0	0.0	0.5	0.6	20.7	0.0	0.0	2.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.7	12.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.0	3.1	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	24.6	8.3	17.6	16.6	11.3	10.9	10.7	9.7	12.4	13.2	13.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	10.1	9.5	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492096-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	9.7	9.3	32.4	5.2	34.1	17.1	12.8	41.4	40.7	13.6	35.5	12.5	6.6	13.8	30.9	14.1	13.7	9.9	10.2	37.5	30.2	20.9	17.1	7.7	8.6	32.7	33.9	14.7	8.2	11.2	20.5	12.8	32.2	11.1	9.0	45.8	7.7	10.2	8.7	8.6	8.0	12.6	31.4	11.1	8.3	6.8	31.1	8.5	14.0	12.5	8.8	9.7	14.5	43.0	10.2	9.5	27.8	12.0	23.9	16.9	10.4	12.0	10.7	17.4	20.3	9.2	5.5	20.0	3.9	8.6	20.3	5.4	22.8	7.0	15.4	20.7	10.4	9.3	24.4	11.2	11.3	7.1	7.2	10.4	10.8	13.8	8.7	41.0	11.6	6.9	5.2	9.2	15.2	9.6	11.0	11.3	20.4	9.1	17.8	10.9	7.7	14.3	16.7	4.7	15.5	13.6	6.6	15.5	8.7	21.2	62.9	5.3	6.3	15.6	14.4	20.1	18.4	10.1	16.9	23.6	13.7	14.8	12.2	27.2	16.3	11.4	14.5	17.0	16.9	14.3	10.6	13.8	23.1	11.3	11.9	10.1	5.3	9.6	12.5	8.9	11.4	8.2	32.4	34.1	41.4	40.7	37.5	30.2	32.7	33.9	32.2	31.4	31.1	43.0	5.7	3.2	2.7	30.3	6.9	8.9	10.5	4.1	8.6	20.8	6.7	4.6	8.8	10.0	8.0	9.2	25.0	10.1	10.7	4.2	19.6	8.5	5.0	3.8	6.8	8.7	9.1	8.6	14.8	4.0	6.8	11.9	2.0	3.9	0.0	52.2	8.9	6.9	6.7	25.2	19.7	4.4	10.2	9.1	14.3	2.2	10.8	6.5	12.4	5.6	11.7	23.2	10.3	14.1	19.6	3.7	5.8	12.0	3.7	9.3	4.5	28.4	3.7	19.2	0.0	9.3	8.2	13.8	22.9	11.5	10.1	8.8	5.0	12.9	6.4	4.0
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173903-44448809	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;retina: 6.8"	"Group enriched"	"Detected in some"	4	"Astrocytes: 169.4;Excitatory neurons: 223.7;Inhibitory neurons: 445.3;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 610.8"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.2;NTERA-2: 1.5;SCLC-21H: 5.7;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031562	Enhanced		Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	1.5	0.2	5.4	0.0	9.6	0.0	0.0	26.0	7.0	1.0	3.6	0.9	0.0	1.4	0.2	0.1	0.2	0.3	0.2	6.4	11.5	0.8	0.0	0.1	0.0	9.2	12.7	1.5	0.6	1.0	0.0	0.0	10.2	0.4	0.1	6.8	0.4	0.9	1.5	0.1	0.1	0.5	14.6	0.0	1.5	1.3	8.2	0.0	3.0	1.1	0.0	0.1	0.3	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.6	26.0	7.0	6.4	11.5	9.2	12.7	10.2	14.6	8.2	16.3	0.1	0.0	0.0	169.4	0.0	0.0	0.6	0.0	1.8	2.6	1.3	0.3	0.3	4.3	0.0	3.7	4.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.5	1.0	0.0	0.0	223.7	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.4	0.0	0.1	0.0	445.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.2	0.0	4.4	0.0	322.7	610.8	0.2	0.0	0.0	0.0	1.2	0.0	1.9	0.0	17.1	0.0	1.7	0.2	0.1	1.6	1.0	0.0	0.1	0.0	10.0	0.0	0.1
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382575-48391551	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 856.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	109.3	124.4	58.0	61.7	56.5	45.8	106.6	54.5	59.7	132.5	78.1	120.3	132.5	110.0	117.3	107.3	112.2	100.9	96.6	56.1	62.5	119.5	127.2	101.4	53.3	61.1	59.1	165.8	138.9	191.7	116.2	128.7	59.0	102.5	128.5	39.0	137.7	105.0	76.8	103.8	114.5	100.6	56.2	79.5	120.1	93.7	62.9	51.6	121.8	58.4	73.2	102.5	102.4	58.0	216.2	305.3	173.1	184.7	379.7	440.6	126.5	207.4	363.9	247.0	281.0	202.3	238.7	89.1	132.6	456.4	154.4	187.6	211.1	222.2	234.0	72.7	224.5	74.4	99.4	382.2	329.6	84.1	133.4	419.6	268.0	168.5	178.5	387.4	233.0	75.3	131.7	160.9	333.1	173.6	79.4	856.7	126.3	426.8	122.5	112.1	103.4	141.0	316.2	176.3	172.9	134.5	182.1	160.6	113.1	196.7	126.6	102.1	182.6	173.4	142.6	145.3	179.3	451.1	382.0	60.2	110.1	112.4	181.1	10.8	41.0	12.6	18.1	34.7	20.8	17.0	17.6	19.7	30.6	14.3	14.3	16.1	9.9	20.2	30.2	45.4	20.4	18.2	58.0	56.5	54.5	59.7	56.1	62.5	61.1	59.1	59.0	56.2	62.9	58.0	150.8	35.3	54.2	8.5	82.2	75.3	130.6	147.1	124.7	39.4	141.0	154.4	28.8	98.7	110.9	93.8	6.2	231.7	59.5	153.0	56.7	224.1	6.2	72.0	188.8	111.4	145.0	56.8	8.7	169.0	605.5	161.0	120.3	166.3	62.7	149.2	102.8	79.6	180.0	40.4	12.7	379.6	93.6	107.6	73.5	14.2	163.5	103.1	92.5	8.4	102.3	89.8	35.0	10.6	10.6	190.3	199.8	132.0	365.9	161.2	213.8	149.6	49.2	28.1	85.5	87.9	131.6	41.8	69.1	127.7	70.2	387.7	55.4	191.3	202.9	157.6
KDELR2	"ELP-1, ERD2.2"	ENSG00000136240	"KDEL endoplasmic reticulum protein retention receptor 2"	P33947	7	6445953-6484190	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 786.7;Extravillous trophoblasts: 944.9;Syncytiotrophoblasts: 759.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016459	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA016459: AB_1852180"	"unprognostic (2.16e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.40e-5)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.42e-1)"	"prognostic unfavorable (6.79e-8)"	"unprognostic (7.72e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.71e-2)"	83.9	70.6	31.2	67.1	32.7	25.5	84.6	33.8	35.5	132.5	53.0	132.8	117.6	82.9	119.2	63.4	68.3	85.0	74.2	30.5	33.8	81.4	229.6	73.2	36.3	34.2	32.0	64.9	99.6	68.2	70.7	148.4	34.1	107.0	144.2	23.6	103.8	84.2	40.4	52.4	119.1	106.3	33.6	44.2	155.6	64.0	34.7	24.9	98.3	44.4	52.1	91.7	58.6	35.5	280.7	121.6	116.4	223.0	558.2	512.4	116.0	415.2	374.8	236.5	353.8	197.0	180.6	44.7	113.0	591.3	352.8	245.8	169.9	173.1	365.1	24.6	97.6	55.0	120.0	271.6	338.4	84.0	72.4	327.8	171.8	230.7	272.3	263.8	217.5	42.2	123.4	128.2	325.4	234.7	25.8	80.9	112.8	358.0	181.5	61.5	180.6	117.6	190.6	116.2	108.5	130.2	172.7	304.6	135.2	177.8	252.3	144.7	189.0	180.0	262.4	439.6	223.4	93.9	84.4	76.8	299.5	162.8	525.7	77.8	72.0	77.0	47.6	74.8	61.0	44.0	49.0	52.5	72.0	43.6	39.4	43.3	47.2	43.5	77.8	127.3	49.1	56.9	31.2	32.7	33.8	35.5	30.5	33.8	34.2	32.0	34.1	33.6	34.7	35.5	110.2	25.6	71.0	17.9	109.7	192.2	175.5	239.0	67.7	26.7	141.6	82.4	60.6	117.2	159.5	62.5	12.5	417.9	86.9	261.0	35.2	217.2	786.7	59.2	152.5	136.4	114.3	100.1	22.5	323.5	944.9	262.9	170.2	121.4	68.6	75.7	119.6	377.8	300.9	32.0	29.5	492.7	89.5	91.7	210.8	115.9	151.3	112.4	177.9	37.5	99.2	31.2	58.7	29.7	24.5	224.8	232.9	121.9	486.7	427.2	244.1	113.5	87.7	31.2	72.3	89.4	177.1	527.9	149.8	122.4	198.9	759.9	73.2	136.1	279.6	319.1
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468078-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 73.2;Fibroblasts: 54.7;Intestinal goblet cells: 70.6;Proximal enterocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 267.0;BJ: 180.5;BJ hTERT+: 182.0;fHDF/TERT166: 289.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	13.4	4.4	0.9	7.6	1.3	2.0	12.2	2.9	2.1	31.1	8.7	18.1	15.4	7.5	29.5	4.8	7.4	19.6	15.7	1.3	0.9	8.5	12.6	10.3	3.2	1.5	1.7	3.5	15.9	12.1	14.2	16.0	1.1	19.7	22.5	3.1	34.4	10.9	2.1	4.1	18.5	15.5	1.3	2.5	35.0	3.9	1.1	1.7	6.3	3.7	7.2	12.5	4.4	1.5	35.8	11.1	8.7	37.2	142.7	267.0	6.4	180.5	182.0	42.7	105.3	22.1	45.1	0.3	38.2	289.3	15.2	5.1	8.9	10.7	51.0	0.4	21.8	2.5	8.7	55.2	62.9	0.4	24.1	99.9	8.0	53.9	5.7	60.1	52.4	0.3	9.0	0.1	70.7	56.8	0.1	1.3	2.1	150.2	33.2	0.2	2.4	11.8	51.5	4.8	0.7	4.6	46.7	2.7	22.9	3.6	13.3	2.4	41.5	45.8	29.0	160.3	18.0	1.7	0.6	0.2	73.5	0.1	65.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.0	1.6	0.2	0.1	0.9	1.3	2.9	2.1	1.3	0.9	1.5	1.7	1.1	1.3	1.1	1.5	14.5	0.0	4.8	0.3	4.5	7.6	5.7	7.5	1.2	1.3	10.0	4.2	2.5	8.6	10.0	14.7	2.1	5.1	0.3	9.1	7.9	19.0	0.2	8.0	19.4	10.2	4.9	0.8	0.7	31.6	73.2	54.7	24.5	11.0	1.3	6.9	14.6	5.3	4.7	0.0	0.5	70.6	0.0	0.9	14.5	0.6	32.6	1.1	16.0	1.9	1.0	6.3	0.0	0.0	0.4	31.5	4.9	16.1	12.8	16.3	40.1	0.8	9.2	1.4	0.0	1.7	20.5	0.5	2.4	1.6	7.1	8.2	2.3	4.2	11.1	7.8
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	36	"B-cells: 3.4;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA028634, HPA028639"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Cytosol	"HPA028634: , HPA028639: AB_10599191"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.1	1.1	0.4	1.3	0.3	0.1	10.3	1.6	1.3	4.0	0.3	8.9	12.4	0.9	19.7	20.2	7.4	2.9	0.4	0.4	0.2	11.0	4.7	4.4	0.8	0.3	0.3	0.1	16.2	12.5	10.4	3.9	0.4	7.2	7.1	1.3	12.8	4.6	0.0	17.7	10.5	0.3	0.2	0.6	10.6	2.6	0.3	2.3	10.0	0.0	3.4	4.8	8.3	0.7	24.9	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	12.1	22.7	0.0	0.9	0.0	0.0	21.4	0.0	30.3	0.0	0.1	0.4	0.0	0.0	4.4	0.3	0.0	0.0	0.1	38.5	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.0	14.7	0.0	0.1	1.7	39.3	0.1	0.0	0.0	3.7	5.5	11.7	14.9	0.0	0.2	25.2	0.1	2.7	16.1	0.4	0.2	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	2.5	4.3	3.0	0.1	3.4	6.2	3.8	0.0	0.0	0.0	0.0	0.2	1.7	0.4	0.3	1.6	1.3	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.7	0.2	12.8	8.8	0.0	0.8	0.0	14.3	0.0	10.8	0.6	15.1	16.3	0.3	12.8	2.5	14.7	0.0	32.6	1.5	17.2	25.4	29.4	0.4	7.3	0.8	0.7	7.8	0.0	0.2	23.2	26.5	0.6	13.7	8.0	0.0	0.1	0.0	4.4	2.7	0.0	0.1	13.1	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.2	1.1	0.0	0.0	0.1	21.8	25.2	0.0	0.4	16.8	26.2	10.1	5.1	2.5	0.0	0.0	0.3	6.3	7.5	14.4	0.0	29.7	1.2	0.0	16.9	19.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7700	"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	25.7	30.8	24.7	23.5	25.8	48.1	30.6	26.5	27.0	33.1	20.4	31.6	26.4	36.0	46.9	35.0	34.2	25.3	26.1	25.3	28.2	24.7	22.3	24.5	34.7	19.8	22.0	41.4	36.2	51.2	41.5	31.5	21.0	32.2	33.8	30.9	36.6	29.4	47.3	38.2	29.2	30.1	21.2	25.2	29.3	86.9	27.4	55.8	28.5	34.0	37.2	34.6	31.5	21.8	128.1	64.7	180.8	160.7	47.0	59.5	128.4	53.1	66.4	106.0	93.7	61.2	120.5	94.5	74.1	87.6	53.7	139.5	169.5	101.0	133.3	86.3	102.7	133.0	105.7	150.6	59.6	103.7	56.0	55.6	71.4	112.8	78.9	93.0	134.1	171.7	148.0	43.4	76.3	75.9	227.3	79.2	118.3	70.8	93.0	214.7	119.1	64.1	89.0	81.0	225.0	169.9	239.4	62.4	80.2	126.1	62.7	76.2	109.5	47.0	78.4	88.1	73.6	55.6	47.1	109.3	49.2	120.4	68.3	2.0	2.5	4.3	4.1	4.3	3.4	7.4	3.5	3.8	3.1	2.1	4.5	4.9	0.2	3.0	5.5	6.8	4.4	1.4	24.7	25.8	26.5	27.0	25.3	28.2	19.8	22.0	21.0	21.2	27.4	21.8	18.7	19.2	29.1	33.6	15.9	18.6	27.1	19.9	33.0	27.5	20.4	22.1	24.4	11.5	19.0	23.9	27.1	31.6	18.1	15.7	17.6	35.4	43.5	45.9	49.3	20.4	22.8	29.7	51.1	24.7	57.2	24.8	23.4	44.4	12.0	49.5	16.8	17.2	15.0	15.2	51.2	24.9	22.4	15.1	19.7	20.3	21.5	20.2	12.4	30.0	28.1	19.3	12.3	50.3	30.4	28.1	13.5	23.0	28.9	26.3	17.2	15.7	29.5	19.8	0.0	22.2	25.0	131.8	67.1	36.1	12.8	16.6	15.4	34.3	27.6	20.5
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119263-67258082	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.5	13.2	10.7	27.2	10.6	47.1	19.7	18.0	12.1	24.3	14.1	23.3	14.7	29.1	17.4	31.9	19.3	19.0	17.4	10.6	11.2	14.3	19.9	24.0	27.5	12.6	10.7	24.5	13.0	16.1	13.1	18.0	10.9	21.6	17.1	18.5	21.3	19.2	33.8	29.4	23.9	24.0	9.7	27.0	18.9	29.0	11.9	27.8	19.0	24.5	28.7	23.9	25.9	10.9	49.9	31.8	17.6	27.7	17.1	27.0	13.5	21.5	26.6	41.0	27.9	48.7	25.4	38.8	37.5	33.3	23.8	48.2	31.3	22.5	33.1	66.4	13.4	28.9	39.2	11.7	16.9	24.5	38.1	21.7	23.9	39.4	25.7	20.7	29.9	22.7	27.4	54.4	18.6	35.4	32.5	18.1	36.1	29.8	25.6	39.9	29.4	21.4	14.7	33.7	24.2	18.9	71.0	38.6	39.0	21.6	59.9	23.9	38.7	25.0	16.7	34.5	18.8	29.3	35.4	25.4	22.0	17.2	17.8	0.4	1.1	0.3	2.5	0.8	2.7	3.6	1.9	2.3	0.6	3.6	1.9	1.9	2.7	2.7	0.5	0.9	2.6	1.9	10.7	10.6	18.0	12.1	10.6	11.2	12.6	10.7	10.9	9.7	11.9	10.9	41.4	38.5	35.8	75.1	56.6	41.2	23.3	23.4	75.7	75.3	40.3	30.9	31.1	34.3	31.0	16.5	137.6	23.9	77.5	43.2	0.0	17.3	20.6	84.8	63.0	38.4	31.8	22.1	89.4	14.5	13.4	32.4	42.8	112.3	27.3	42.1	29.3	35.5	21.5	95.9	89.8	27.5	24.4	46.5	59.6	11.2	21.5	49.1	19.6	104.0	43.3	19.8	33.0	96.0	99.5	25.9	25.5	23.0	72.5	37.2	21.2	10.3	40.0	111.7	19.7	40.2	32.3	52.0	38.1	78.7	47.7	32.3	66.9	33.8	29.5	48.7
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352685-138437028	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	21.7	19.4	22.6	16.9	23.0	25.4	25.3	22.2	22.8	22.7	21.1	23.9	18.6	23.0	28.3	21.2	24.2	14.2	20.0	21.3	20.7	21.4	14.5	19.3	23.0	23.4	22.7	30.8	20.3	34.2	16.5	20.5	21.5	21.8	24.0	36.3	22.2	25.9	41.5	28.1	23.4	20.8	21.9	26.0	21.6	19.4	23.9	35.9	23.2	27.1	29.4	24.8	19.9	21.8	24.3	32.4	65.0	58.7	27.2	23.3	47.0	15.6	27.1	30.0	33.5	35.7	27.2	46.3	27.9	30.3	41.0	24.3	53.2	37.8	32.6	30.3	29.3	39.2	28.6	27.1	25.4	32.2	43.3	26.9	39.0	22.1	26.7	23.2	34.6	29.3	31.8	26.1	34.3	30.3	46.4	41.0	31.0	34.1	13.7	53.1	48.5	30.9	40.4	31.6	32.7	35.9	27.0	28.0	25.7	93.2	27.3	43.5	31.9	17.9	17.4	19.3	28.8	32.8	16.7	40.2	12.5	45.6	25.6	0.2	2.9	4.2	2.3	2.2	3.2	2.3	2.7	3.0	2.5	2.0	2.5	2.3	5.5	4.2	2.3	3.0	1.7	1.3	22.6	23.0	22.2	22.8	21.3	20.7	23.4	22.7	21.5	21.9	23.9	21.8	22.8	16.0	15.7	43.1	22.1	15.9	13.7	15.1	20.5	21.3	29.1	29.5	33.2	17.2	17.0	22.0	29.2	13.4	24.0	26.8	0.0	16.0	6.1	22.8	19.9	18.9	21.0	25.4	40.9	16.8	10.7	18.5	17.9	24.2	13.3	26.3	18.2	23.0	17.6	23.5	39.1	26.4	18.3	39.2	18.3	2.8	21.1	27.9	16.0	50.6	27.0	17.3	16.5	41.7	56.9	19.9	28.0	23.0	16.2	21.2	20.9	16.1	25.6	31.9	26.3	21.8	18.7	13.0	15.5	26.2	21.6	10.9	19.1	17.1	24.6	21.0
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650149-43705518	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	10.6	20.6	10.7	12.2	11.3	12.1	12.8	12.7	12.4	15.1	11.8	18.0	28.0	14.2	13.0	14.4	18.0	11.8	10.0	10.7	9.3	12.7	14.8	14.7	15.6	10.7	10.4	19.7	12.7	19.1	10.9	11.2	10.9	13.7	18.5	19.6	13.3	11.4	11.1	21.8	22.6	14.9	10.0	13.9	14.4	5.7	10.7	21.6	17.3	15.7	18.0	13.7	11.8	11.2	25.1	22.6	36.6	63.6	34.5	32.6	25.3	23.4	26.4	34.7	34.6	26.0	21.7	32.5	23.5	23.4	26.3	25.3	45.1	27.6	35.4	23.2	37.8	46.5	33.7	21.2	32.7	33.4	35.9	35.4	43.2	33.7	42.3	26.6	37.0	27.9	23.5	45.1	25.5	19.6	26.4	28.2	59.9	21.5	23.0	35.0	42.2	23.9	24.3	48.8	32.1	29.1	50.5	34.2	63.3	52.8	20.0	111.5	28.1	20.6	32.8	18.7	31.9	20.7	26.7	29.2	21.3	27.8	39.3	10.2	4.9	9.0	4.4	3.7	4.9	4.3	4.3	3.6	4.1	3.1	2.9	2.6	3.0	4.1	5.2	3.6	4.9	3.5	10.7	11.3	12.7	12.4	10.7	9.3	10.7	10.4	10.9	10.0	10.7	11.2	5.3	9.6	22.3	12.7	14.0	9.2	5.3	8.3	25.6	20.1	8.9	7.5	7.4	8.6	8.2	1.8	37.5	8.5	10.4	19.3	5.9	8.6	9.7	11.2	9.8	9.2	12.0	16.4	21.3	6.7	6.1	9.8	23.4	6.9	13.3	12.0	7.9	13.1	8.9	32.0	17.8	16.6	10.2	9.7	5.5	6.1	12.5	7.9	1.8	5.6	11.6	10.9	13.4	17.6	23.8	10.7	13.5	14.7	14.3	5.4	17.3	6.9	25.4	23.5	6.6	11.1	7.7	0.6	2.9	21.0	4.7	8.1	9.5	13.6	15.4	6.0
KDM4D	"FLJ10251, JMJD2D"	ENSG00000186280	"Lysine demethylase 4D"	Q6B0I6	11	94973709-94999519	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 33.3"	"Group enriched"	"Detected in many"	7	"Early spermatids: 115.7;Late spermatids: 43.7;Spermatocytes: 102.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055854, HPA064037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA055854: AB_2682944, HPA064037: AB_2685180"	"unprognostic (1.98e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	0.5	0.6	0.5	0.3	0.5	0.0	0.8	0.5	0.6	0.5	0.4	0.2	0.1	0.5	0.8	0.3	1.0	0.4	1.0	0.5	0.5	0.5	0.3	0.4	0.7	0.5	0.5	0.9	0.3	0.9	0.5	0.4	0.4	0.5	0.3	2.1	0.6	0.6	0.6	0.7	0.3	0.5	0.6	0.6	0.3	33.3	0.5	0.6	0.7	0.7	0.6	0.4	0.3	0.6	0.5	0.8	3.3	2.4	0.7	0.8	1.5	1.1	1.2	3.0	2.6	0.9	1.0	1.2	3.5	0.9	2.9	1.0	2.1	2.3	2.3	1.4	2.2	1.1	0.4	1.3	0.6	0.5	0.3	1.5	1.2	3.0	2.7	0.4	1.1	4.4	1.2	0.5	1.2	1.0	1.9	1.2	1.4	0.8	4.0	2.6	1.4	0.9	0.7	0.3	1.9	2.3	1.3	1.1	0.9	1.7	1.2	0.4	0.9	2.0	1.2	3.2	1.7	0.7	2.5	0.2	0.7	0.6	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.6	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.4	0.6	0.5	0.6	0.8	0.0	0.0	2.6	0.2	0.0	0.2	0.8	0.6	7.0	0.8	0.9	1.1	1.5	0.4	0.0	2.1	0.9	1.6	0.0	3.9	0.8	115.7	1.3	1.4	1.1	0.0	0.4	1.8	0.6	0.9	0.9	0.5	0.4	0.0	2.6	2.2	1.3	0.7	3.3	2.6	0.1	0.0	0.6	0.3	43.7	2.1	0.8	0.0	4.7	0.7	3.9	1.0	3.5	4.3	0.2	0.1	1.2	0.5	0.2	0.0	1.3	1.0	3.3	0.0	0.8	0.7	102.5	11.4	0.7	0.0	0.3	0.3	2.5	0.3	0.2
KDM4E	"JMJD2E, KDM4DL, KDM5E"	ENSG00000235268	"Lysine demethylase 4E"	B2RXH2	11	95025258-95027596	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051740, HPA054225"	Uncertain					NA	NA									"HPA051740: AB_2681586, HPA054225: AB_2682421"	"unprognostic (1.32e-1)"										"unprognostic (6.31e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.10e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724495-202808487	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.6;Spermatocytes: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	9.1	7.7	1.5	2.6	2.2	14.1	9.9	5.8	4.8	14.7	7.9	10.6	2.1	12.6	3.3	21.0	9.9	2.9	6.0	4.6	1.5	6.2	4.6	10.8	2.2	0.8	0.4	12.8	8.3	2.6	6.9	4.7	0.2	10.6	2.2	17.8	12.5	2.4	4.7	24.3	8.6	3.1	1.0	7.4	8.7	62.3	1.2	4.1	8.4	0.8	2.1	10.9	15.7	2.3	9.9	2.4	14.0	9.8	7.2	6.6	23.7	6.2	9.4	6.2	6.4	2.2	8.8	0.1	5.7	7.9	2.3	11.8	9.0	8.3	5.4	0.5	12.8	7.7	2.4	1.9	5.5	17.7	8.9	9.4	12.1	7.0	7.2	10.1	11.7	7.3	20.9	0.3	4.9	6.3	5.8	16.4	21.9	4.3	28.0	18.7	0.1	0.4	6.5	10.7	10.7	23.4	14.7	7.9	8.7	15.7	16.6	10.5	12.8	8.2	5.8	1.4	5.2	2.3	1.1	8.2	6.0	5.5	4.1	44.6	6.4	19.6	7.7	4.8	4.6	10.9	8.9	4.3	4.2	17.4	9.6	6.0	34.4	12.9	10.4	6.6	7.2	3.9	1.5	2.2	5.8	4.8	4.6	1.5	0.8	0.4	0.2	1.0	1.2	2.3	24.5	89.8	38.5	46.7	22.2	64.4	34.8	53.0	84.2	35.5	57.1	50.0	9.5	11.5	53.6	16.5	62.6	41.8	12.4	23.7	5.9	47.6	191.6	65.2	71.8	31.9	43.6	50.2	75.8	22.3	34.3	42.7	47.9	69.5	27.1	28.6	17.2	10.9	7.7	15.2	53.5	38.1	44.7	15.1	21.9	243.6	36.4	15.5	26.6	40.3	11.3	69.8	10.3	39.7	42.5	45.4	21.8	32.7	25.8	43.1	15.2	8.2	61.9	138.6	32.9	22.8	40.2	390.9	71.0	95.9	116.2	82.4	21.2	61.5	30.2	55.6
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873188-45112779	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	9.6	8.0	6.7	4.5	7.6	19.4	10.6	7.2	10.6	15.7	6.5	9.1	6.2	14.0	5.1	11.1	14.0	3.4	6.6	6.8	6.9	6.8	10.4	10.8	8.0	7.3	6.8	17.2	10.8	6.4	8.6	3.9	7.3	7.7	4.1	3.8	10.5	3.1	10.4	18.4	13.0	4.1	7.1	14.1	12.5	12.2	7.0	12.9	9.4	6.1	5.3	9.8	15.2	9.9	7.3	5.8	7.0	9.3	5.0	6.8	15.7	4.9	4.2	4.0	4.1	10.4	5.2	4.6	3.2	3.5	10.1	13.9	6.5	5.4	3.9	7.6	10.8	2.4	4.5	5.2	3.7	2.6	13.2	2.6	6.4	8.2	6.6	5.1	4.2	5.3	6.4	10.1	2.4	6.0	6.9	13.6	6.8	4.2	7.4	6.4	7.1	1.4	3.8	9.2	6.2	4.4	18.2	6.8	10.7	14.1	8.5	0.0	3.0	5.4	5.2	5.2	3.6	5.5	8.8	5.6	4.0	3.3	3.3	7.3	1.7	1.5	1.9	3.5	2.1	1.9	2.5	2.8	3.1	1.2	2.5	2.4	2.8	2.8	3.0	1.7	2.2	2.0	6.7	7.6	7.2	10.6	6.8	6.9	7.3	6.8	7.3	7.1	7.0	9.9	23.2	6.4	10.6	92.1	26.0	26.1	14.3	9.4	38.1	7.7	16.8	12.1	12.8	12.8	10.9	7.3	14.6	4.5	26.1	24.6	0.0	8.4	1.5	26.4	25.5	13.1	13.1	16.8	88.3	7.5	7.9	14.2	23.0	39.7	2.5	27.3	6.4	17.6	7.0	25.2	74.0	14.0	6.1	9.1	13.8	2.0	6.5	19.9	10.6	116.2	12.6	6.8	6.2	118.1	264.6	9.1	17.4	7.2	31.4	14.2	22.6	3.7	8.9	9.7	6.6	20.9	17.0	14.1	12.5	29.3	26.3	10.9	27.4	10.6	13.1	17.1
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7834217-7854796	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.6;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	33.6	13.3	3.1	20.0	2.4	35.5	12.6	12.5	22.9	12.2	3.4	15.4	14.3	14.0	3.4	13.6	17.1	15.6	17.7	3.2	4.5	14.6	15.2	27.4	8.0	4.8	3.2	29.7	17.1	7.9	21.8	6.8	3.3	14.5	4.1	6.2	12.0	6.2	12.4	16.4	17.5	5.5	1.4	20.7	17.7	16.1	5.0	16.4	15.9	8.2	4.6	19.8	12.4	6.2	4.9	7.0	12.5	19.0	4.6	3.4	16.2	3.8	5.4	2.7	2.8	9.3	3.6	11.4	4.5	3.0	3.9	12.2	5.8	5.1	1.6	4.7	4.5	5.3	6.7	6.2	13.0	7.2	15.6	5.3	8.0	6.1	5.1	7.2	4.8	11.8	8.8	4.8	1.2	7.7	10.6	6.5	6.4	4.9	3.9	11.9	2.9	3.2	5.1	7.7	6.6	21.4	4.8	11.5	10.3	7.3	6.4	8.9	2.3	4.0	7.1	7.0	5.5	5.6	1.2	3.9	5.3	4.2	8.1	3.6	0.6	1.1	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.5	0.3	0.4	8.9	0.1	0.2	0.7	0.1	0.4	3.1	2.4	12.5	22.9	3.2	4.5	4.8	3.2	3.3	1.4	5.0	6.2	135.5	25.6	33.6	6.2	158.8	214.4	122.2	30.8	156.0	45.2	113.7	70.9	10.8	42.9	32.4	7.3	31.3	15.1	127.6	47.8	1.9	28.0	29.2	88.2	67.1	80.5	79.9	8.4	9.0	25.1	15.9	85.4	73.4	181.6	178.6	44.8	34.2	22.7	23.4	38.7	10.9	62.5	18.3	50.4	393.1	10.7	16.4	219.2	56.9	4.7	25.6	13.2	9.2	5.5	1.9	58.4	49.1	13.9	70.7	99.6	53.9	9.8	20.5	17.1	19.7	181.2	83.0	20.1	19.3	138.1	188.0	52.0	104.1	22.0	46.2	86.6
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140176983	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	6.6	2.1	2.1	6.9	1.6	16.4	4.7	3.8	3.9	9.5	1.5	8.4	8.2	6.6	1.4	7.0	2.9	4.5	4.1	2.7	1.6	3.6	6.7	4.8	7.0	2.5	2.5	2.1	4.5	4.1	1.3	9.1	2.8	3.3	9.3	5.8	5.1	2.1	12.6	7.5	8.3	4.4	2.4	5.6	9.3	7.7	3.7	6.7	2.8	13.2	8.0	5.7	3.7	3.0	0.8	0.4	2.7	2.8	2.4	2.3	5.4	1.2	1.7	0.4	0.5	0.2	0.4	1.9	1.9	1.3	1.4	1.0	3.7	2.3	0.8	10.8	2.3	0.1	0.4	5.1	2.5	1.8	1.9	2.4	5.1	1.4	8.0	1.3	2.6	5.0	6.1	8.2	0.5	0.8	3.6	3.1	4.3	6.3	1.5	3.8	0.2	4.0	0.9	1.2	4.7	5.8	2.8	6.5	2.7	4.3	8.8	0.7	4.6	0.5	1.0	1.7	0.8	2.9	0.4	6.2	1.5	5.0	1.0	0.6	0.8	0.3	0.3	0.4	0.3	0.5	0.5	0.5	1.1	1.1	0.5	0.3	2.2	0.6	0.2	0.4	0.4	0.3	2.1	1.6	3.8	3.9	2.7	1.6	2.5	2.5	2.8	2.4	3.7	3.0	34.4	16.0	25.5	25.5	30.6	49.8	44.8	17.7	8.0	11.8	11.1	7.4	14.6	8.6	30.1	16.5	27.1	12.3	17.8	36.7	1.9	7.2	5.2	17.0	18.2	23.8	52.7	32.4	35.3	9.4	2.8	20.0	30.5	28.7	8.2	12.2	18.5	18.5	10.7	6.7	34.8	38.0	12.2	31.4	86.7	4.9	7.8	35.4	3.6	96.5	34.7	4.3	10.3	35.7	36.0	12.2	28.7	4.1	11.8	35.3	26.9	3.3	33.3	9.2	6.6	14.9	17.8	31.2	14.3	12.3	46.5	37.9	18.5	3.4	27.2	50.0
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203508-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 80.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 56.4;Proximal enterocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	2.1	3.5	4.0	3.1	4.0	1.3	2.2	5.3	4.2	2.6	3.2	2.7	13.3	3.0	1.8	2.0	2.5	2.2	2.4	4.1	4.0	3.0	80.3	2.2	3.4	3.7	3.5	3.0	5.1	2.4	4.0	1.5	3.9	3.6	1.7	2.3	2.3	2.1	4.6	1.7	12.5	1.6	3.6	4.6	2.6	2.7	3.8	3.5	3.1	3.0	2.6	2.7	2.3	4.1	1.4	3.0	5.0	2.7	1.1	1.5	2.7	1.7	1.9	3.8	3.3	2.6	2.4	7.6	2.9	2.5	1.9	1.6	3.0	2.7	2.2	9.2	4.4	4.9	3.3	6.2	2.7	3.6	5.5	1.9	2.1	2.4	1.7	2.2	3.1	3.5	6.1	4.8	2.4	2.3	3.4	6.4	8.5	1.1	1.8	5.2	3.1	6.9	1.4	1.6	4.8	2.9	0.7	2.5	1.9	1.7	2.7	4.8	3.4	4.5	2.2	1.7	1.8	2.9	3.1	6.3	1.9	3.3	0.4	0.2	2.1	0.8	2.5	1.9	2.1	1.9	3.6	3.5	1.9	4.3	3.4	4.9	0.1	1.3	1.9	4.0	2.3	2.3	4.0	4.0	5.3	4.2	4.1	4.0	3.7	3.5	3.9	3.6	3.8	4.1	0.7	0.0	1.7	3.3	2.4	0.3	0.2	0.7	3.4	1.9	0.7	0.6	1.5	1.5	1.6	0.0	2.1	2.0	2.4	1.0	3.9	1.3	0.6	0.5	1.2	1.6	5.4	0.8	2.4	0.7	0.7	1.0	3.1	0.4	0.0	1.5	1.1	56.4	2.0	0.0	2.5	1.6	2.0	1.9	1.2	0.9	0.3	1.3	0.0	1.9	1.4	1.4	1.0	1.5	3.2	0.7	0.5	1.2	3.0	0.5	25.4	1.4	5.9	2.5	0.0	0.9	1.4	1.1	2.5	0.6	0.0	1.4	2.0	1.6	1.2	0.2
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367228	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003673: AB_425440, HPA044884: AB_2679131"	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favorable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	32.3	22.4	12.8	8.1	19.9	4.8	25.4	19.5	16.7	26.9	12.3	24.6	7.0	22.7	20.8	22.4	18.9	12.6	20.7	12.7	16.4	20.1	36.7	21.5	7.0	20.6	17.7	21.3	15.7	13.1	12.1	8.5	20.0	16.3	7.4	7.0	22.8	11.6	16.7	44.5	15.1	13.3	17.6	8.4	16.4	6.1	16.6	7.1	17.2	8.9	6.8	23.9	23.4	22.4	14.9	6.5	6.7	7.5	52.6	39.0	13.0	48.8	29.7	10.5	13.9	2.7	10.0	15.1	20.3	19.1	17.4	64.6	8.7	27.3	12.8	28.6	14.5	11.6	8.7	3.4	40.1	22.0	7.8	37.4	50.7	16.8	47.9	19.3	10.5	9.9	9.5	21.0	28.1	6.2	23.6	9.7	8.0	3.7	23.5	15.5	19.7	21.9	29.0	9.6	8.5	16.4	23.4	11.3	21.9	8.8	6.1	12.1	24.9	44.0	10.6	14.8	21.3	90.4	44.9	8.7	33.2	13.0	13.4	0.1	5.2	0.5	6.5	8.1	26.6	5.7	13.6	10.2	8.0	4.7	9.3	6.1	1.3	14.2	3.9	3.8	19.1	5.3	12.8	19.9	19.5	16.7	12.7	16.4	20.6	17.7	20.0	17.6	16.6	22.4	53.1	35.3	49.1	21.9	30.1	158.6	131.7	47.0	122.3	37.4	63.4	63.6	27.7	62.9	43.5	38.6	27.1	58.8	15.6	34.6	15.6	50.7	1.0	43.9	53.0	48.1	20.4	17.4	19.1	36.7	70.4	82.0	26.5	64.9	26.0	52.3	51.8	88.3	36.4	40.4	24.2	31.8	42.7	32.2	47.7	6.5	71.1	39.9	56.9	14.0	31.5	56.5	13.4	21.6	57.0	47.4	44.6	70.7	24.5	104.3	43.4	39.6	41.2	41.1	32.9	73.7	48.4	1.3	5.2	89.7	143.1	91.4	37.7	51.1	40.3	94.7
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486125-10503558	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	31.3	41.2	54.8	20.5	61.6	20.4	30.3	61.8	60.9	32.7	49.7	37.6	26.5	31.3	22.2	55.4	28.9	24.3	60.7	53.2	59.4	32.5	60.9	25.3	23.2	61.4	60.5	25.3	32.8	24.3	30.0	17.0	60.3	36.8	16.5	16.4	34.7	24.9	178.2	38.7	27.5	18.7	58.8	32.2	33.2	20.5	59.6	23.0	35.6	75.7	18.5	41.4	36.3	68.4	58.0	102.8	27.2	35.1	55.8	45.4	30.3	48.1	35.9	46.6	41.6	73.7	54.2	82.9	122.9	53.3	34.8	49.7	55.6	36.9	23.7	78.3	61.7	126.3	29.9	87.9	54.5	65.4	63.9	50.0	51.0	53.5	25.1	39.1	46.3	23.7	79.1	135.4	41.6	79.9	46.1	177.8	80.8	54.2	88.6	84.6	34.8	95.1	30.4	67.4	75.3	40.4	66.8	42.4	42.1	23.9	37.8	82.3	56.5	72.9	41.0	86.0	57.0	86.8	113.0	81.1	58.0	78.5	56.0	36.4	37.9	41.4	55.3	33.8	53.1	26.3	38.5	52.0	45.4	11.7	23.6	33.7	20.9	42.5	34.6	31.4	50.2	41.8	54.8	61.6	61.8	60.9	53.2	59.4	61.4	60.5	60.3	58.8	59.6	68.4	18.3	28.9	20.8	5.5	13.8	21.9	24.4	40.3	27.9	21.5	15.7	11.4	24.0	21.5	25.4	11.0	8.4	27.3	11.6	33.2	13.7	32.8	27.5	13.4	17.1	27.8	26.9	45.2	5.3	36.3	25.2	23.5	18.8	13.3	12.0	22.8	35.3	34.4	29.0	26.9	5.9	21.4	40.7	15.1	13.4	43.9	29.2	16.1	10.6	3.7	41.8	43.0	7.2	11.6	18.3	29.8	27.1	25.9	26.6	33.3	36.8	24.9	17.2	13.9	13.1	17.7	22.4	21.2	16.6	34.7	22.0	26.8	20.1	29.6	31.5	24.8
KERA	"CNA2, SLRR2B"	ENSG00000139330	Keratocan	O60938	12	91050491-91058024	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Fibroblasts: 2.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"amygdala: 4.1;basal ganglia: 5.6;cerebral cortex: 6.2;hippocampal formation: 5.6"	HPA039321	Uncertain				"Secreted to extracellular matrix"	NA	NA						"Cluster 50: Fibroblasts - ECM organization"			"HPA039321: AB_10795248"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.65e-1)"		"unprognostic (6.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.96e-2)"		"unprognostic (4.93e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.53e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362658-73364171	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	3156	"testis cancer: 254.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA043699	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 33: Fibroblasts - ECM organization"			"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KHDC4	"BLOM7, KIAA0907, SNORA80EHG"	ENSG00000132680	"KH domain containing 4, pre-mRNA splicing factor"	Q7Z7F0	1	155913045-155934413	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 57.0;Endometrial ciliated cells: 54.7;Glandular and luminal cells: 88.2;Granulosa cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008796	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA008796: AB_1079369"	"unprognostic (6.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.22e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.79e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (2.78e-10)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (4.36e-5)"	27.9	29.5	21.0	22.3	22.0	11.9	30.8	27.4	25.1	42.5	21.6	34.4	23.0	32.1	45.2	28.8	33.5	15.0	27.7	20.9	21.3	42.6	30.2	34.1	28.9	21.5	21.5	47.7	32.7	18.5	44.6	23.2	21.7	39.2	27.3	55.5	38.3	20.7	39.8	32.5	36.5	15.5	21.5	37.6	37.6	24.7	21.3	27.1	33.6	21.3	29.7	37.0	36.2	25.3	27.6	20.7	43.2	26.2	22.6	31.6	26.6	23.2	18.4	34.6	35.5	21.6	59.6	34.0	25.2	13.3	24.7	49.5	40.0	16.4	34.0	27.2	83.5	30.7	70.8	26.0	15.9	36.3	25.4	20.7	42.4	24.3	18.8	40.8	25.2	38.2	37.4	37.9	31.8	13.3	35.1	35.6	47.7	26.0	29.4	41.0	23.3	30.1	30.7	14.7	29.9	29.7	17.2	17.9	25.1	35.2	37.6	60.5	21.2	33.3	23.2	10.9	31.7	61.3	28.4	30.1	24.0	33.5	25.7	4.1	1.5	3.0	2.1	2.0	2.8	2.7	2.3	2.8	1.5	2.6	2.9	2.7	1.9	2.4	3.0	1.6	2.0	1.0	21.0	22.0	27.4	25.1	20.9	21.3	21.5	21.5	21.7	21.5	21.3	25.3	19.4	12.8	19.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	35.2	23.5	0.0	0.0	12.4	57.0	0.0	26.5	25.7	0.0	3.9	11.2	0.0	54.7	20.0	9.5	0.0	0.0	0.0	7.2	20.0	11.0	0.0	88.2	6.3	48.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	13.5	0.0	0.0	0.0	0.0	18.7	0.0	0.0	8.3	0.0	0.0	7.9	12.4	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	30.8	10.5	34.4	0.0	0.0
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679961-62286225	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;retina: 4.0;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1423.1;Inhibitory neurons: 720.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.8"	"Group enriched"	"Detected in some"	13	"memory B-cell: 5.9;naive B-cell: 6.9;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.9;dendritic cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 4.7;NTERA-2: 1.6;THP-1: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000500, HPA029392"	Supported					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	0.1	0.9	1.0	0.3	2.0	0.1	0.0	0.0	5.8	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	2.3	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.0	0.1	0.1	4.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	1.0	0.1	0.1	0.5	0.6	4.1	0.0	0.5	0.2	0.0	2.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.3	1.9	0.0	0.3	1.0	2.0	0.0	5.8	0.9	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	38.5	3.3	17.6	24.3	0.0	0.0	0.0	0.6	41.4	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.7	1423.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.4	0.0	0.1	35.3	720.1	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	117.1	0.3	30.5	0.0	238.8	99.4	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.0	3.1	0.0	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457456-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 157.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1"	"Cancer enhanced"	"Detected in all"		"glioma: 9.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 27.9;cerebral cortex: 50.9;hippocampal formation: 29.8;white matter: 41.1"	"Immune cell enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	16.8	16.4	21.4	5.6	27.9	2.6	11.5	0.0	50.9	17.0	0.0	12.5	4.1	6.8	22.8	6.2	6.5	11.5	10.3	29.8	0.6	19.3	12.3	8.8	3.0	7.5	1.4	9.3	9.2	7.6	6.8	2.0	0.4	8.4	8.9	21.1	11.0	12.3	32.6	6.4	5.9	8.7	0.0	2.8	6.9	157.7	5.7	9.2	5.6	31.2	4.2	10.6	9.0	41.1	0.5	1.8	30.9	1.7	6.5	12.0	12.4	20.7	28.6	19.2	9.8	11.1	4.4	0.1	10.9	19.8	0.3	2.7	19.5	20.9	26.0	4.4	33.6	0.1	11.2	22.9	5.0	5.8	69.8	2.6	2.8	10.5	16.1	23.2	15.9	36.7	2.6	51.0	34.5	7.5	2.2	1.2	6.3	16.9	34.0	87.8	42.0	22.6	76.0	0.6	39.5	33.4	1.5	4.4	22.6	19.4	1.4	1.8	1.3	23.6	40.7	0.4	45.2	17.9	0.0	0.1	14.3	0.0	85.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	27.9	0.0	50.9	29.8	0.6	7.5	1.4	0.4	0.0	5.7	41.1	15.4	28.9	5.3	20.2	3.1	15.0	14.7	2.3	2.8	160.9	23.8	10.8	12.3	2.8	4.8	7.3	0.0	0.6	0.6	7.0	25.4	14.6	364.5	24.2	21.1	13.7	23.4	0.8	828.6	22.9	1.2	37.2	2.0	40.7	4.5	4.0	5.0	21.8	0.8	6.7	190.8	8.7	10.2	3.5	10.9	142.4	16.1	5.2	14.2	227.7	1.6	7.0	0.0	578.6	34.9	19.8	2.5	8.6	1.1	19.3	2.1	29.0	2.9	16.1	0.0	57.9	34.5	276.1	33.1	3.4	9.2	1.4	2.1	12.7	6.6	12.6
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	24.5	24.1	13.9	28.8	17.1	39.1	23.6	20.7	15.0	27.2	15.0	28.9	27.7	25.1	17.3	27.8	28.1	18.2	18.0	12.3	13.9	16.6	19.0	25.2	27.9	19.7	15.5	41.4	28.3	19.9	18.1	33.0	17.5	25.0	25.6	8.4	24.4	21.2	22.5	26.6	33.4	20.0	14.5	32.4	38.8	9.5	15.4	24.2	22.5	17.7	31.2	27.1	25.2	19.6	28.2	35.1	29.2	23.4	31.2	30.5	29.7	27.3	33.2	30.9	24.2	22.1	48.6	39.3	15.6	25.9	25.3	26.9	25.8	44.4	22.9	63.4	12.0	17.8	33.1	41.1	32.0	26.3	37.1	31.3	100.2	32.0	42.4	42.3	36.4	29.1	24.0	35.7	17.6	36.6	9.6	16.5	7.6	53.7	28.6	15.0	0.3	20.2	19.9	42.1	20.9	21.8	22.4	14.6	36.9	29.0	17.5	30.4	36.2	28.1	24.4	33.9	16.0	66.5	39.9	27.4	15.3	14.4	26.0	0.9	1.3	1.9	1.7	1.6	1.0	1.3	1.4	1.4	0.9	2.3	1.0	1.0	1.7	1.6	1.3	1.5	1.4	1.2	13.9	17.1	20.7	15.0	12.3	13.9	19.7	15.5	17.5	14.5	15.4	19.6	15.3	12.8	16.3	10.7	15.6	8.9	25.3	15.1	11.4	2.9	13.8	11.9	3.4	17.2	13.0	7.3	2.1	24.7	14.3	32.2	1.9	18.1	0.4	8.6	10.3	15.0	10.8	22.1	2.9	41.8	13.6	11.6	36.7	13.4	14.0	13.5	9.7	9.5	13.6	0.0	1.5	26.1	18.3	12.6	9.3	3.1	14.0	13.3	12.4	6.5	16.6	8.3	16.5	3.5	6.7	41.1	17.3	11.3	8.6	33.7	35.0	3.9	12.9	9.2	13.1	13.6	14.3	1.1	1.6	9.4	12.8	26.8	12.7	14.6	17.6	34.3
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413102-6424811	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		710000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	78.3	90.9	39.2	44.8	37.0	63.9	73.6	35.0	44.6	109.8	14.0	90.2	53.8	121.7	17.0	111.3	105.3	27.5	62.5	39.3	32.0	66.8	89.9	73.5	52.1	35.8	34.4	120.7	89.5	24.7	77.5	44.0	32.6	75.7	34.2	41.0	75.1	33.1	100.5	93.7	88.4	36.3	31.1	79.6	81.8	106.5	35.5	53.8	83.4	26.0	45.7	94.5	91.5	44.1	302.1	128.6	148.0	139.2	62.0	67.0	216.8	103.7	84.0	147.2	148.3	259.2	77.2	286.8	187.3	76.7	82.8	162.6	203.5	104.5	162.2	2.6	240.3	209.2	94.9	158.2	86.0	204.9	186.2	74.9	47.6	108.3	117.0	65.8	124.0	138.6	328.7	142.5	95.7	146.9	290.7	182.3	264.3	78.9	187.9	284.3	124.5	206.5	73.0	143.9	152.5	160.7	133.8	119.7	144.3	121.7	118.5	222.4	111.4	108.0	160.9	230.4	230.9	257.1	306.8	279.8	107.3	298.1	130.9	1.6	2.7	2.1	2.2	3.1	2.5	2.4	2.6	2.9	2.9	3.2	1.5	1.6	1.9	1.3	2.8	4.8	1.9	1.7	39.2	37.0	35.0	44.6	39.3	32.0	35.8	34.4	32.6	31.1	35.5	44.1	39.8	9.6	17.5	9.1	27.9	58.8	23.6	18.7	33.6	44.6	50.9	49.7	12.8	41.5	23.5	31.3	50.1	41.8	35.7	46.5	5.9	28.0	84.2	38.5	52.4	32.7	57.6	41.8	12.3	30.9	47.5	33.8	21.9	51.9	18.4	41.8	41.4	44.0	38.9	50.5	12.9	50.5	10.2	42.9	44.2	24.4	50.7	32.0	26.6	12.2	26.7	37.9	15.5	11.1	19.1	32.9	34.9	46.3	33.8	36.9	36.0	23.0	17.4	57.4	26.3	39.7	29.9	92.1	57.3	48.8	72.5	40.0	22.9	34.6	60.4	32.1
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156986-175192999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 100.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 105.8;Skeletal myocytes: 107.0;Syncytiotrophoblasts: 377.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 91.3;RPMI-8226: 65.5;U-698: 115.6"									"HPA016895, HPA068812"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA016895: AB_2669476, HPA068812: AB_2686041"	"unprognostic (5.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-1)"	44.8	8.9	4.6	23.2	4.8	13.1	24.8	5.3	6.5	16.0	7.1	11.2	11.9	11.7	5.4	9.7	18.8	21.6	18.7	4.4	5.3	34.6	22.7	39.8	30.4	8.9	6.2	6.1	25.7	12.3	7.7	100.5	7.5	11.7	12.2	1.0	23.5	6.0	17.2	8.0	14.7	10.9	5.8	26.8	15.0	2.7	5.8	21.4	10.8	16.0	32.0	17.1	10.5	5.3	8.8	0.3	0.4	0.0	0.0	0.0	0.0	3.9	10.5	0.1	0.0	4.5	12.5	91.3	20.9	0.0	0.5	35.9	6.3	42.2	0.0	31.2	5.1	9.8	19.0	0.6	1.0	0.7	1.2	0.0	11.4	0.0	15.6	0.0	13.9	13.0	8.2	14.9	0.0	2.1	11.7	0.1	2.9	7.5	7.7	9.8	4.5	65.5	13.3	21.8	0.5	3.3	6.5	34.9	0.8	21.5	22.3	2.0	5.6	0.0	4.0	0.1	0.8	36.4	47.4	115.6	1.6	0.0	9.6	32.3	12.4	2.0	11.0	6.5	9.8	29.3	11.8	9.1	10.7	28.1	12.2	10.7	51.2	6.3	2.5	2.4	18.7	11.8	4.6	4.8	5.3	6.5	4.4	5.3	8.9	6.2	7.5	5.8	5.8	5.3	57.2	38.5	5.5	0.7	59.4	26.6	105.8	22.4	29.0	0.0	41.3	39.4	4.0	10.0	11.4	12.9	0.0	71.8	14.1	22.6	13.7	13.6	0.5	41.1	18.9	29.7	4.2	10.3	0.1	23.6	7.9	45.7	20.9	41.7	11.4	8.9	16.4	7.4	11.4	0.0	0.2	7.4	10.2	10.4	18.9	1.6	16.8	13.5	7.2	1.0	18.7	4.9	18.6	0.0	0.1	23.6	26.4	10.5	36.9	55.7	8.1	5.1	12.5	0.1	26.3	107.0	89.3	0.4	3.6	10.3	11.1	377.1	31.8	1.2	18.4	43.5
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614446-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted to blood"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	36.1	30.7	22.4	28.5	20.7	31.5	30.6	18.2	23.5	22.7	31.7	30.8	19.7	23.1	25.7	31.3	29.2	20.5	24.2	24.4	21.3	43.0	18.6	30.7	28.4	29.9	24.4	23.9	24.4	51.8	25.2	29.6	29.3	27.1	34.8	27.5	28.9	27.1	51.9	31.8	26.7	35.3	20.2	28.8	23.3	24.9	26.5	32.3	35.4	42.5	34.9	30.3	16.0	20.6	66.5	123.8	61.4	58.8	109.3	64.8	44.8	60.9	80.1	72.3	67.6	85.9	29.4	92.0	71.2	111.2	75.3	86.2	91.4	89.6	87.1	102.8	88.7	73.2	95.9	47.2	47.0	129.1	121.3	66.5	68.2	98.0	74.1	56.1	104.9	64.1	70.6	29.0	66.8	94.4	94.5	61.1	26.9	119.0	46.6	71.7	69.0	60.0	43.4	116.9	60.2	46.5	76.8	205.5	50.7	76.0	123.2	88.6	98.1	55.0	60.4	74.5	116.2	27.2	33.8	58.0	62.8	81.7	65.4	0.3	1.1	1.5	1.2	1.0	1.2	1.1	0.5	1.0	1.3	0.6	0.6	0.7	0.7	0.8	1.2	2.9	0.7	0.7	22.4	20.7	18.2	23.5	24.4	21.3	29.9	24.4	29.3	20.2	26.5	20.6	21.5	16.0	17.8	15.0	16.5	10.3	8.9	8.7	15.4	31.7	19.3	14.7	30.2	14.3	13.0	12.9	29.2	15.3	34.4	30.5	5.9	9.9	19.4	20.4	16.1	16.4	12.1	14.1	19.1	11.0	9.4	14.1	21.4	16.4	8.2	20.4	18.5	30.5	10.6	28.6	18.3	16.4	8.2	31.5	18.6	23.2	9.3	19.9	10.6	14.0	25.3	14.3	21.6	11.6	12.7	9.8	12.1	6.4	17.1	15.8	17.9	15.1	15.1	22.5	0.0	20.3	20.1	30.5	28.1	22.9	11.1	45.6	17.0	24.2	22.6	11.7
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	13.0	12.0	18.6	8.5	19.9	16.2	13.3	20.2	20.9	12.0	17.8	14.0	8.5	15.4	12.6	20.6	15.3	12.4	33.2	18.0	22.3	18.8	15.0	12.0	7.5	18.2	22.5	13.1	10.6	23.9	10.3	10.4	19.8	14.7	12.3	24.7	8.9	14.6	32.5	7.6	11.5	13.1	20.1	12.9	10.9	12.0	23.4	11.7	15.1	51.1	8.6	10.4	9.8	21.0	13.7	13.0	26.7	16.7	18.8	20.2	14.0	17.4	18.1	12.0	10.1	8.2	11.3	9.0	5.8	19.7	18.5	7.0	13.7	7.7	15.5	5.1	5.6	26.7	11.1	11.0	9.9	11.6	33.6	13.6	17.7	13.4	7.4	15.4	12.6	8.9	20.3	7.6	15.4	6.7	22.3	11.7	14.1	10.2	14.3	15.7	27.3	4.2	20.3	12.8	20.2	13.1	12.9	11.4	12.1	18.3	14.5	21.1	16.0	11.0	12.8	9.8	15.2	13.1	14.1	7.0	13.5	12.2	30.3	2.0	2.0	5.7	2.1	1.4	2.9	1.3	1.6	2.5	1.3	1.3	1.5	1.6	10.6	1.8	2.1	2.0	1.6	0.9	18.6	19.9	20.2	20.9	18.0	22.3	18.2	22.5	19.8	20.1	23.4	21.0	27.6	32.1	39.2	62.3	19.1	12.7	27.4	12.9	24.5	77.2	29.0	20.6	132.1	10.0	29.0	12.9	37.5	14.7	23.6	47.9	41.1	23.4	45.0	74.4	28.0	20.6	25.1	49.9	123.8	11.7	7.7	27.7	44.9	38.7	12.6	16.3	15.0	42.9	11.2	99.3	120.7	20.9	30.5	23.9	11.8	64.2	24.8	28.4	7.2	73.1	34.8	49.7	27.8	90.0	138.0	21.8	24.8	33.1	24.2	28.0	29.6	24.6	58.0	44.6	26.3	39.4	31.6	31.6	22.4	19.2	11.1	22.4	27.4	27.0	17.5	35.7
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646191	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.3;pituitary gland: 4.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.0	0.4	10.0	0.2	10.3	0.0	0.1	4.3	10.4	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	9.2	5.8	0.0	0.0	0.6	0.0	7.2	7.4	0.0	1.4	0.1	4.1	0.0	7.6	0.4	0.4	1.2	0.2	0.0	0.0	0.7	0.2	0.1	2.7	0.2	0.8	1.1	12.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.0	2.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	0.0	2.1	0.8	0.3	0.0	0.0	2.4	1.0	0.0	1.9	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	3.8	0.2	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.3	3.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	10.0	10.3	4.3	10.4	9.2	5.8	7.2	7.4	7.6	2.7	12.3	4.8	0.1	3.2	0.5	119.5	0.6	0.0	0.0	0.5	0.0	3.6	0.1	0.1	1.4	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	65.6	2.6	0.1	0.0	10.2	0.0	129.2	0.0	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	72.7	0.8	0.0	0.0	0.0	96.8	0.6	0.2	0.0	5.6	0.6	0.3	0.0	5.0	3.1	0.3	0.1	0.7	0.0	0.2	0.0	0.1	10.9	0.9	0.0	0.1	0.0	1.2	1.5	0.0	0.0	0.7	0.1	0.1	0.3	0.3
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433492-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	14.3	26.6	28.3	13.0	28.0	15.9	27.8	23.4	28.0	25.6	28.9	25.6	26.3	14.4	26.2	18.3	35.1	21.3	44.5	28.0	27.6	38.2	34.2	30.9	17.7	26.9	29.2	14.9	42.1	45.6	26.9	30.6	25.5	34.9	30.0	34.1	33.5	18.5	37.7	20.1	24.8	14.4	24.8	20.1	34.4	17.1	32.4	17.8	41.4	40.1	16.8	15.8	15.1	24.9	13.5	19.6	39.8	31.5	52.7	36.9	37.8	17.9	37.8	25.5	37.5	21.2	52.9	15.0	48.0	19.6	38.1	26.1	29.7	28.8	28.9	23.8	21.7	20.3	23.4	23.6	41.3	16.9	26.8	52.3	36.2	29.5	38.0	84.3	42.2	18.1	27.2	21.0	35.2	13.6	10.1	14.3	45.3	37.4	11.7	11.3	33.8	18.7	41.8	32.4	8.7	24.6	25.8	30.6	53.3	86.9	32.3	23.1	43.6	17.4	18.7	14.9	28.0	31.1	26.7	9.8	44.3	21.8	17.7	8.8	19.4	9.4	5.0	6.1	4.8	3.4	4.1	4.7	5.6	4.1	5.5	4.0	47.2	9.8	4.0	3.7	4.0	8.7	28.3	28.0	23.4	28.0	28.0	27.6	26.9	29.2	25.5	24.8	32.4	24.9	24.2	73.7	74.1	85.2	18.3	7.9	14.4	16.5	15.4	74.8	33.9	26.0	55.0	47.1	42.4	35.0	108.4	33.3	16.6	35.4	3.9	19.2	9.6	21.0	17.7	24.6	21.6	14.7	93.2	32.5	22.5	19.4	28.5	30.8	21.5	42.7	28.9	47.4	19.1	63.9	95.2	59.5	16.2	31.4	7.6	7.5	17.4	19.2	14.2	62.8	31.4	30.5	29.9	115.1	99.3	30.3	27.6	17.3	17.2	26.0	36.8	17.5	45.4	61.9	6.6	24.5	15.7	22.5	21.2	17.8	9.2	31.2	21.9	30.1	31.2	14.8
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.2;Excitatory neurons: 53.5;Inhibitory neurons: 53.3;Late spermatids: 199.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 25.8;monocytes: 23.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		67000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.4	11.3	23.5	9.9	35.8	17.1	2.5	35.8	63.3	7.7	0.0	11.0	4.6	5.2	2.7	7.7	3.3	4.7	4.6	41.2	3.3	3.6	2.5	7.5	5.9	12.1	2.6	2.7	15.2	4.1	32.6	3.9	2.6	9.2	6.1	9.2	6.9	4.8	10.2	10.6	6.8	5.6	0.8	8.2	10.8	5.8	2.8	2.8	2.4	3.7	6.6	14.9	6.4	27.4	6.7	7.1	4.7	6.8	8.6	6.4	1.2	6.6	10.4	9.2	5.3	3.2	3.1	2.2	2.8	8.0	5.6	5.8	4.4	10.5	5.7	4.9	3.6	4.3	1.9	1.7	4.1	0.5	5.9	11.9	5.5	10.6	1.4	3.9	5.0	4.6	19.1	5.4	8.3	10.5	0.8	1.8	4.6	7.8	5.6	0.8	6.0	1.4	8.7	4.8	13.7	2.1	7.7	12.7	3.1	4.7	10.3	1.3	10.0	5.7	4.3	8.7	2.3	8.4	1.6	4.8	7.5	3.3	6.2	24.6	11.1	17.9	1.4	13.4	0.4	0.0	0.9	0.9	4.1	0.1	0.8	0.9	25.8	1.3	23.9	5.9	0.3	5.3	23.5	35.8	35.8	63.3	41.2	3.3	12.1	2.6	2.6	0.8	2.8	27.4	0.9	6.4	5.8	7.5	2.6	4.0	7.8	12.4	2.2	17.9	2.7	1.1	8.3	2.8	15.3	1.8	6.2	0.6	8.0	16.0	0.0	2.8	50.2	2.8	7.5	3.3	11.4	0.4	53.5	4.7	0.8	6.9	10.7	4.9	2.5	1.7	3.3	2.9	6.9	48.8	53.3	8.6	10.2	21.5	4.6	199.5	16.1	30.9	3.6	11.2	24.5	3.1	3.1	8.5	7.0	9.1	7.2	26.7	16.5	15.0	4.8	1.8	23.9	5.4	0.0	5.4	3.4	4.1	4.1	1.2	4.4	3.4	4.6	4.8	5.2	29.8
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551297	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	5.0	5.1	4.6	4.8	4.9	5.4	5.7	6.0	7.1	5.1	4.5	4.9	3.3	4.3	6.2	5.0	4.3	4.9	4.7	4.3	4.9	4.0	6.5	4.2	7.4	4.9	5.1	6.0	4.0	6.1	7.1	3.7	5.0	5.1	6.0	7.9	4.2	4.6	5.8	5.2	4.4	6.3	4.7	5.4	3.9	16.4	4.7	12.4	4.9	6.1	7.1	5.6	4.8	6.5	21.1	14.0	20.2	9.7	16.4	15.6	8.7	17.3	16.3	15.1	15.7	6.0	11.3	23.4	11.4	14.8	6.2	12.3	19.1	10.9	24.8	16.8	6.9	17.9	11.1	18.2	11.2	27.6	15.3	10.5	4.6	11.2	17.7	7.2	19.9	22.3	18.0	12.4	28.4	13.5	16.9	11.4	8.7	10.7	22.8	20.5	23.5	14.6	10.9	8.8	11.1	8.4	18.4	12.3	8.9	10.8	14.7	14.4	18.8	23.4	18.4	12.9	14.5	7.4	9.5	19.0	16.2	21.8	13.7	13.2	2.0	5.0	7.0	2.1	5.6	6.3	6.6	5.3	2.6	6.8	8.5	6.1	2.0	9.7	3.2	3.3	7.1	2.6	4.6	4.9	6.0	7.1	4.3	4.9	4.9	5.1	5.0	4.7	4.7	6.5	17.9	12.8	14.5	29.4	20.9	3.2	6.1	6.2	12.5	30.5	10.1	9.8	14.1	7.2	9.3	9.2	81.3	7.5	20.1	5.9	5.9	6.5	142.0	18.5	19.6	13.9	10.7	22.1	52.0	5.2	8.4	14.5	16.8	11.0	21.5	15.2	9.3	4.7	9.5	32.0	56.7	8.5	10.2	7.9	2.8	108.1	10.2	10.8	8.8	27.2	10.6	17.0	14.4	47.3	73.9	5.9	3.0	12.0	20.6	4.3	4.3	7.7	20.0	51.0	0.0	19.7	12.3	61.6	23.9	12.4	4.5	4.8	24.4	15.7	7.3	3.3
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578147-6640711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9;Excitatory neurons: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA023057, HPA023494"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	4.9	5.7	6.8	4.6	6.8	3.5	7.3	3.8	7.3	8.4	10.5	7.1	3.5	8.5	11.0	7.1	10.1	5.2	4.1	7.2	6.6	8.7	3.7	5.3	5.0	4.3	4.9	10.1	5.6	14.0	8.8	5.3	3.6	7.7	6.9	10.8	5.7	8.3	2.1	5.7	5.4	8.4	3.4	7.6	6.5	16.6	6.0	8.5	9.0	2.7	5.1	6.4	6.4	5.5	19.9	16.1	19.4	13.2	7.2	11.9	7.7	10.5	10.0	15.1	14.0	11.1	4.8	7.9	7.1	10.4	9.9	18.4	17.8	10.1	23.9	8.1	15.1	4.3	14.8	8.7	12.0	6.9	9.3	7.1	12.9	13.7	13.0	15.5	11.8	9.1	9.9	1.0	12.3	5.9	7.7	6.2	11.8	9.7	8.1	11.1	6.8	2.5	13.9	12.9	7.3	12.7	13.2	3.9	8.9	12.5	6.5	4.5	11.1	13.1	6.7	7.6	16.8	1.8	2.6	2.8	9.8	4.5	10.6	0.0	0.7	0.6	0.5	0.7	0.6	0.8	0.5	0.5	0.4	0.4	0.3	0.3	1.9	0.4	0.4	0.6	0.4	0.2	6.8	6.8	3.8	7.3	7.2	6.6	4.3	4.9	3.6	3.4	6.0	5.5	5.4	6.4	12.3	25.8	3.4	3.2	2.9	2.6	4.6	3.8	5.9	5.2	3.6	7.2	8.3	0.0	16.7	2.4	2.9	5.2	0.0	4.1	90.9	13.2	9.5	5.7	7.2	3.0	46.6	3.8	1.1	6.3	9.7	5.8	1.3	12.9	3.9	2.1	2.5	10.1	29.2	3.9	4.1	3.1	0.6	15.4	4.4	3.2	0.0	25.3	2.8	2.1	2.1	27.2	14.7	3.9	4.9	3.4	5.6	3.6	2.2	2.9	29.3	12.1	0.0	5.9	5.4	15.1	7.8	5.0	2.4	1.2	3.1	9.3	4.4	2.7
KIAA0825	"C5orf36, DKFZp686F0372, MGC34713"	ENSG00000185261	KIAA0825	Q8IV33	5	94152966-94618597	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 53.2;Cone photoreceptor cells: 50.1;Excitatory neurons: 171.0;Inhibitory neurons: 168.5;Microglial cells: 56.2;Oligodendrocyte precursor cells: 63.3;Oligodendrocytes: 62.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"neutrophil: 12.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038030, HPA038031"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038030: AB_10672735, HPA038031: AB_2675794"	"unprognostic (1.26e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.93e-4)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.02e-5)"	"unprognostic (3.00e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.09e-2)"	0.9	1.0	1.8	0.6	1.9	1.0	1.1	1.9	1.8	1.0	1.0	0.6	0.4	1.4	1.3	1.1	2.6	1.2	0.9	1.6	1.6	1.5	0.9	1.0	0.7	2.3	2.4	1.6	0.9	1.4	1.0	0.9	1.7	1.0	0.7	3.4	0.6	0.8	0.4	0.6	0.6	0.9	1.2	0.8	0.6	3.0	1.8	0.7	1.9	0.6	0.5	1.0	0.5	1.3	0.5	0.2	0.6	1.6	2.1	2.7	0.2	1.6	1.4	1.0	1.5	0.0	1.1	0.2	1.7	0.6	1.1	0.8	0.3	1.1	1.3	0.0	0.3	0.2	9.9	0.2	1.5	0.3	0.1	1.6	1.1	1.3	0.3	1.3	1.0	0.9	0.2	0.0	1.9	1.1	0.7	0.7	0.9	0.3	0.2	0.8	0.1	0.1	2.0	0.5	1.0	1.3	1.6	0.1	0.3	1.0	0.8	1.2	1.0	0.9	0.2	1.3	0.6	0.4	0.4	0.0	2.0	0.5	0.8	0.0	0.6	0.0	0.4	0.2	0.2	0.8	0.4	0.6	0.6	0.4	0.2	0.3	12.4	0.6	0.4	0.6	0.2	0.2	1.8	1.9	1.9	1.8	1.6	1.6	2.3	2.4	1.7	1.2	1.8	1.3	3.0	6.4	4.1	53.2	1.5	1.3	1.4	1.4	1.2	9.8	2.8	1.7	2.3	2.8	2.1	1.8	50.1	1.0	2.7	0.8	0.0	1.1	10.4	20.3	6.5	1.6	0.0	1.3	171.0	0.6	0.6	4.6	1.5	2.3	1.3	3.7	1.4	1.8	1.0	15.2	168.5	0.6	2.0	1.0	1.6	6.0	1.2	1.7	0.0	56.2	0.7	4.6	0.0	63.3	62.7	0.8	0.2	1.5	1.7	0.6	1.0	3.3	13.1	20.5	0.0	4.4	3.0	8.7	3.9	1.2	1.1	0.3	4.3	5.8	0.6	0.7
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324152-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.1	8.1	5.3	0.7	5.8	2.4	3.7	14.2	5.2	2.3	10.5	2.5	1.8	3.0	6.2	2.3	5.8	3.1	1.7	5.3	8.7	9.2	5.5	3.0	0.2	4.1	5.0	8.6	9.1	11.6	6.3	1.2	3.9	2.9	1.3	15.0	2.8	2.6	1.5	5.8	1.1	2.9	3.7	0.6	11.1	22.3	6.0	3.2	3.6	1.4	0.4	1.3	1.1	5.0	10.7	6.3	13.2	12.4	0.4	0.3	2.9	2.8	3.3	6.5	7.5	2.8	5.5	0.1	3.0	0.7	11.0	6.1	18.1	5.6	5.4	0.9	10.1	0.2	9.7	2.5	2.3	1.9	0.4	1.5	9.5	6.0	7.0	7.7	0.2	5.8	4.4	0.2	0.6	3.8	6.0	4.0	0.6	2.6	1.5	2.2	0.5	0.0	13.8	1.3	38.1	13.6	4.8	12.5	4.0	9.0	11.8	1.5	0.0	0.8	3.2	1.8	4.2	6.2	14.6	0.1	2.4	0.5	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	5.8	14.2	5.2	5.3	8.7	4.1	5.0	3.9	3.7	6.0	5.0	1.5	6.4	2.7	7.5	1.4	9.7	5.1	3.5	17.6	17.8	13.3	8.1	3.7	5.7	3.7	3.7	27.1	2.3	0.9	0.9	5.9	5.0	87.9	41.8	2.2	1.6	8.4	0.8	22.4	2.9	1.2	2.1	11.2	13.3	1.3	8.3	0.4	5.6	0.5	11.8	25.9	1.5	0.0	0.0	0.4	65.4	2.8	0.4	3.6	1.0	0.1	5.7	0.0	12.1	13.1	3.9	1.7	0.4	3.2	3.0	0.2	10.0	25.9	16.3	6.6	5.7	2.1	28.8	11.9	4.7	8.7	0.7	1.2	7.6	1.6	2.0
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175599-67184040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 74.3;Early spermatids: 84.9;Horizontal cells: 107.7;Late spermatids: 198.4;Rod photoreceptor cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA065996: AB_2685593"	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	14.6	25.1	19.9	4.9	20.1	3.4	11.5	25.6	26.6	21.5	12.4	11.8	6.5	21.1	7.5	12.4	30.8	6.0	11.7	21.0	18.8	19.2	9.3	14.5	2.1	21.2	17.3	39.7	11.7	6.6	46.1	5.7	21.3	17.1	5.2	29.2	10.8	4.1	5.1	9.3	11.2	7.1	15.9	16.2	14.4	23.5	17.7	4.1	25.3	2.2	1.7	15.5	13.3	20.4	3.1	5.0	19.0	11.9	3.6	8.2	12.3	7.9	1.6	3.6	3.4	5.1	3.1	5.7	5.0	3.3	3.0	11.6	5.4	4.5	2.3	5.2	7.1	8.3	15.6	4.7	2.8	3.8	16.2	4.7	2.0	4.5	1.7	13.4	6.0	12.2	8.6	5.3	4.6	5.1	8.6	6.4	4.1	3.1	8.2	23.0	9.1	11.1	6.3	7.3	21.6	18.0	9.4	4.7	2.6	9.0	10.2	6.4	7.0	11.8	8.4	5.8	3.4	6.6	5.9	6.0	15.3	5.7	6.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	19.9	20.1	25.6	26.6	21.0	18.8	21.2	17.3	21.3	15.9	17.7	20.4	5.3	3.2	7.9	29.4	1.3	2.9	3.8	7.0	7.4	74.3	6.3	6.9	3.3	8.6	8.8	7.3	43.8	3.9	2.3	6.6	3.9	5.6	84.9	6.7	14.9	5.8	13.1	1.7	23.6	2.5	6.7	5.4	10.7	10.8	4.5	18.6	7.1	4.3	4.2	107.7	28.9	4.6	10.2	0.6	2.1	198.4	6.8	2.3	5.4	5.6	1.7	13.8	0.0	20.1	14.9	3.4	5.4	10.9	1.2	4.5	2.1	1.9	5.1	68.0	19.7	2.8	8.8	6.9	10.9	5.9	2.4	3.0	2.0	16.3	6.6	4.8
KIAA0930	"bK268H5.C22.1, C22orf9"	ENSG00000100364	KIAA0930	Q6ICG6	22	45192244-45240894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 211.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 132.2;Excitatory neurons: 139.6;Oligodendrocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 11.0;eosinophil: 8.6;intermediate monocyte: 13.9;myeloid DC: 12.1;non-classical monocyte: 17.3;plasmacytoid DC: 10.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 12.1;granulocytes: 8.6;monocytes: 17.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038091	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	Nucleoplasm	"HPA038091: AB_10675627"	"unprognostic (4.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (6.90e-8)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (8.95e-7)"	"unprognostic (6.89e-3)"	"unprognostic (5.32e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.15e-1)"	33.9	58.3	195.7	27.7	209.3	24.7	25.9	163.3	211.9	46.0	130.3	29.4	14.6	24.0	40.4	34.5	18.2	16.0	18.1	184.1	189.1	23.8	48.4	24.8	29.0	182.8	192.6	13.6	20.1	18.5	19.2	12.0	179.8	29.1	11.2	3.5	26.7	24.7	33.8	64.0	21.4	15.2	170.4	38.7	18.6	26.2	193.6	20.4	18.4	13.1	22.3	44.0	35.6	210.3	49.6	31.5	19.1	38.3	64.1	30.2	19.2	26.9	26.8	28.2	24.1	29.5	26.5	33.2	39.2	42.8	22.5	54.5	29.5	118.6	10.7	35.6	46.4	0.1	42.0	34.3	25.7	89.4	19.7	17.1	59.2	27.3	45.3	21.5	26.8	23.9	11.7	53.1	17.4	56.9	40.0	82.8	18.9	35.8	26.5	48.1	12.9	110.7	42.6	29.7	15.9	28.4	42.5	57.6	75.5	36.8	28.1	327.8	36.5	29.0	50.6	39.7	15.7	44.9	32.9	32.1	34.0	133.7	30.3	0.8	11.0	8.6	2.3	13.9	1.6	2.3	0.9	2.6	12.1	1.8	0.9	1.6	2.5	1.9	17.3	10.0	2.0	3.7	195.7	209.3	163.3	211.9	184.1	189.1	182.8	192.6	179.8	170.4	193.6	210.3	11.4	6.4	8.8	132.2	9.9	52.8	18.6	22.7	6.8	7.3	13.9	13.5	11.5	12.8	11.8	18.4	6.2	2.0	24.9	16.2	0.0	18.6	2.9	11.6	9.3	9.7	10.7	23.1	139.6	20.7	6.5	32.7	4.6	19.5	2.5	3.8	17.5	23.3	67.5	5.0	56.7	10.0	14.2	71.1	50.0	10.8	10.8	59.8	44.4	24.4	68.5	6.5	13.4	16.1	152.9	18.0	13.7	14.7	11.2	25.6	15.7	13.8	9.3	5.9	0.0	10.2	10.9	7.5	4.4	15.2	57.3	2.7	9.3	5.3	12.8	23.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152331-122362758	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 245.2;Inhibitory neurons: 246.5;Oligodendrocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	29.3	24.9	39.5	13.7	48.4	60.3	31.7	41.7	42.8	29.8	62.3	29.6	18.8	27.6	29.8	17.5	27.2	19.8	22.9	36.0	38.5	27.8	21.3	28.2	19.8	48.4	39.1	41.6	24.8	56.3	47.1	17.5	44.6	21.9	22.1	82.4	22.4	21.7	55.5	28.7	28.3	22.1	35.4	26.4	23.3	26.6	44.0	23.1	31.5	42.2	16.8	24.5	25.6	60.5	30.5	9.5	22.3	14.8	36.3	46.7	11.6	13.5	25.3	13.6	14.9	7.2	15.7	15.9	7.6	32.2	18.4	11.2	13.7	16.7	22.0	12.1	8.8	17.7	18.4	13.7	18.9	16.7	9.4	27.2	19.6	16.4	22.3	37.2	29.3	17.0	11.6	18.8	28.5	10.3	14.5	13.0	7.4	14.6	10.7	8.2	30.8	4.1	24.1	22.6	13.0	11.6	8.4	9.7	18.8	35.8	10.6	13.5	39.8	16.8	16.7	14.0	14.0	18.1	12.5	11.5	17.8	14.4	12.6	1.8	0.7	4.3	1.6	1.8	1.7	1.2	1.1	1.1	0.7	1.8	0.9	1.1	3.3	1.0	0.9	1.1	1.6	0.4	39.5	48.4	41.7	42.8	36.0	38.5	48.4	39.1	44.6	35.4	44.0	60.5	94.6	86.6	42.8	245.2	36.0	20.9	22.0	19.8	26.2	126.0	36.2	27.6	69.2	22.8	35.9	42.3	125.1	12.0	59.6	42.4	1.9	13.8	35.1	34.3	52.8	47.2	21.6	27.1	194.0	17.5	7.0	41.2	59.7	47.2	21.5	64.4	35.0	24.1	12.7	92.5	246.5	27.3	20.3	30.1	17.5	27.7	51.3	41.0	16.0	153.6	32.5	60.9	26.8	161.9	239.9	20.7	34.9	50.8	47.9	19.3	50.0	10.3	33.1	145.0	32.9	63.1	54.9	63.2	33.9	28.9	24.4	13.0	52.0	34.0	32.0	23.0
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIAA1191	"FLJ21022, p33MONOX, p60MONOX"	ENSG00000122203	KIAA1191	Q96A73	5	176346062-176361807	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044701, HPA048145"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA044701: AB_2679053, HPA048145: AB_2680283"	"unprognostic (7.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.39e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (5.02e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.73e-2)"	41.7	44.3	40.6	26.7	43.8	30.8	46.0	33.4	43.2	50.9	44.3	46.3	49.6	49.4	52.5	61.2	66.8	42.9	86.7	45.1	47.4	199.3	70.4	47.9	29.2	39.1	39.6	90.0	57.3	87.0	33.1	38.2	45.1	55.2	44.5	58.6	72.3	64.8	70.9	44.2	51.0	55.1	32.7	34.0	62.0	12.8	46.3	36.6	60.8	63.2	37.5	49.7	34.3	33.9	61.5	63.4	105.1	142.7	95.6	72.8	82.6	86.8	86.2	96.6	106.1	118.2	60.2	24.0	111.9	105.5	145.2	53.8	67.6	157.6	113.1	125.0	81.4	27.9	41.4	63.1	111.0	24.0	47.2	73.9	115.2	83.2	70.8	109.6	120.7	39.1	43.1	51.2	108.6	81.7	34.7	14.5	47.1	65.6	81.2	25.2	66.1	21.1	92.6	60.0	82.8	91.6	92.3	45.7	103.6	94.6	66.9	27.1	106.5	88.4	40.2	65.7	107.5	33.7	49.7	27.7	69.0	46.5	71.3	33.8	23.8	32.9	28.7	28.6	32.1	25.1	27.3	27.6	23.1	18.3	28.4	29.7	10.4	27.4	29.0	18.2	40.2	28.6	40.6	43.8	33.4	43.2	45.1	47.4	39.1	39.6	45.1	32.7	46.3	33.9	26.8	54.5	41.0	16.6	31.3	34.0	40.6	29.1	39.3	31.3	40.8	35.6	61.2	34.3	35.9	33.1	25.0	25.0	35.8	38.7	93.9	37.2	2.5	27.5	24.5	30.2	43.2	17.4	19.6	27.4	13.7	29.6	28.1	35.6	17.7	20.6	26.0	45.8	15.8	48.8	22.7	28.3	30.5	21.4	27.1	7.9	31.1	19.8	21.4	12.2	29.5	33.5	13.4	12.5	16.0	37.9	37.5	38.4	28.6	45.0	50.1	304.3	35.1	30.8	13.1	23.8	26.0	7.2	6.0	38.7	31.7	33.4	30.3	20.0	30.6	47.5
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.0"	"Not detected"	"Not detected"							"HPA000551, HPA048322"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA000551: AB_1079165, HPA048322: AB_2680358"	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	39.4	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	19.8	0.3	0.0	0.0	0.2	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.0	1.9	25.2	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.6	0.0	11.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	11.5	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.4	1.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.6;Karpas-707: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	28.4	16.5	9.8	3.5	12.1	0.2	30.5	2.2	9.6	15.7	42.2	13.1	12.9	6.0	13.3	30.9	16.9	14.7	17.8	27.5	2.0	18.0	17.5	14.4	2.6	6.0	11.2	13.1	13.6	42.8	6.5	20.9	5.7	20.5	14.7	23.7	39.2	22.5	108.4	17.6	11.3	3.3	0.5	7.5	17.4	15.7	4.2	12.6	33.6	52.7	9.3	12.1	19.1	17.2	19.5	9.7	3.8	0.1	2.4	6.8	82.6	3.7	6.0	8.6	18.2	16.6	30.3	1.0	18.6	7.6	17.6	31.5	4.7	36.2	9.5	7.2	3.4	0.4	23.1	19.4	4.2	0.0	0.3	25.3	22.8	19.0	5.2	3.9	0.0	1.7	0.0	75.7	4.4	6.8	10.8	0.6	8.5	18.9	8.7	0.8	22.0	16.2	20.1	25.3	2.4	1.3	9.4	31.4	0.0	38.3	15.2	0.0	20.3	13.1	14.1	52.9	4.9	33.4	30.4	0.1	43.4	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	12.1	2.2	9.6	27.5	2.0	6.0	11.2	5.7	0.5	4.2	17.2	149.7	38.5	34.4	27.4	1.0	121.3	74.1	58.0	145.1	13.6	38.8	39.0	39.1	24.3	73.7	33.1	8.4	50.2	0.4	52.5	3.9	32.3	33.7	64.5	19.6	34.4	23.9	0.0	609.1	26.2	21.2	23.3	50.0	85.9	1.3	6.6	25.0	24.8	5.3	0.0	1251.8	22.8	26.4	14.6	7.8	11.3	17.7	1.3	1.8	30.0	0.0	93.6	0.0	255.9	10.3	24.1	22.7	33.1	3.1	36.8	15.4	6.3	36.9	3.1	13.1	19.6	20.4	0.8	1.1	96.4	51.0	65.1	2.2	14.2	19.4	43.7
KIAA1328		ENSG00000150477	KIAA1328	Q86T90	18	36829106-37232172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 230.8;Alveolar cells type 2: 228.3;Inhibitory neurons: 113.9;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 178.0;Respiratory ciliated cells: 122.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040946	Approved		Approved	"Nuclear speckles,Vesicles,Lipid droplets"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	"Vesicles, Lipid droplets"	"HPA040946: AB_10794998"	"unprognostic (3.66e-2)"	"unprognostic (5.37e-4)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.64e-3)"	6.9	7.1	24.6	7.7	33.8	22.0	5.7	54.3	62.5	5.0	10.1	6.2	9.0	9.5	9.0	6.6	6.1	7.2	6.6	27.2	13.9	7.2	7.0	7.3	7.5	5.5	1.5	13.7	5.3	5.1	2.8	8.3	12.5	7.6	5.5	37.9	9.4	3.9	11.0	13.6	9.4	5.5	0.6	8.3	9.0	16.8	12.6	4.0	7.0	4.1	4.6	4.6	3.6	75.8	26.2	7.4	11.2	13.5	3.8	5.8	10.5	10.7	4.0	5.1	3.4	12.9	16.4	18.1	32.8	4.1	8.6	11.7	4.2	4.7	6.4	15.3	5.0	22.9	24.6	9.3	3.6	16.0	11.9	5.4	5.8	5.6	5.0	5.5	4.4	10.9	18.1	40.7	5.0	23.0	10.6	10.6	25.0	9.6	11.4	14.0	11.9	12.8	4.2	22.2	11.7	13.5	12.8	15.9	6.7	20.4	23.3	8.3	13.8	22.4	29.5	13.3	11.2	32.2	43.8	14.4	11.0	11.3	15.4	23.8	6.7	9.9	8.2	5.0	9.8	7.4	7.2	7.0	3.2	11.4	9.3	7.5	13.2	7.4	8.0	5.5	9.4	4.0	24.6	33.8	54.3	62.5	27.2	13.9	5.5	1.5	12.5	0.6	12.6	75.8	10.9	230.8	228.3	85.5	13.3	5.7	7.9	7.0	6.8	36.1	6.5	7.1	6.0	7.2	106.8	5.5	20.9	8.8	6.5	1.7	5.9	7.6	51.9	6.8	10.5	18.2	3.0	5.5	83.8	5.8	7.8	23.9	5.1	6.9	107.9	13.5	9.7	3.0	6.6	16.8	113.9	3.2	2.0	4.4	4.6	13.0	9.3	18.3	7.2	94.6	5.0	10.1	19.6	117.6	178.0	6.3	3.7	7.9	8.0	3.6	4.4	4.4	122.7	30.9	0.0	14.3	11.0	45.3	19.6	6.6	7.0	3.8	20.6	11.5	4.5	5.0
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741830-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.7;hTCEpi: 103.0;RT4: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	7.9	93.0	14.6	7.0	10.7	1.2	24.3	1.8	15.6	14.5	27.1	42.5	51.7	10.1	12.2	76.7	23.5	16.0	5.1	12.4	6.5	43.9	12.0	18.2	1.2	5.2	5.5	22.3	70.7	37.8	9.1	8.4	4.3	40.9	30.9	1.2	68.3	20.2	3.1	74.1	45.9	6.7	4.2	1.4	61.8	5.1	7.7	8.2	39.4	3.2	12.1	22.2	28.1	8.8	65.7	33.6	5.4	9.3	2.4	4.6	24.6	7.9	15.3	8.9	8.7	37.0	125.7	0.2	32.3	11.6	26.5	95.1	10.3	67.8	4.6	0.2	13.4	13.6	49.4	30.4	4.0	0.2	33.3	1.7	103.0	23.6	28.2	40.1	18.6	2.7	20.1	0.4	4.3	54.3	0.3	0.6	11.0	56.3	20.9	8.7	6.7	16.7	85.8	117.5	4.6	4.7	49.5	70.1	9.7	33.7	74.7	4.3	17.6	14.9	39.3	13.7	17.3	0.8	0.3	0.3	15.2	2.3	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	10.7	1.8	15.6	12.4	6.5	5.2	5.5	4.3	4.2	7.7	8.8	5.7	12.8	56.9	5.5	0.6	73.9	37.0	52.7	59.2	0.6	69.8	42.3	3.8	72.9	52.0	27.6	2.1	15.6	1.5	154.4	9.8	47.3	4.2	54.7	5.6	8.7	28.9	1.3	10.2	66.7	5.2	6.7	51.0	50.2	27.8	10.2	4.6	10.6	2.9	0.0	5.2	54.0	48.8	0.8	6.5	5.1	8.7	2.2	7.2	3.7	2.4	0.8	0.0	2.0	0.4	60.7	64.6	4.9	0.3	80.9	84.7	14.8	60.7	0.1	6.6	3.1	7.5	3.8	2.7	59.7	83.1	7.9	2.1	59.9	65.4	99.6
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981389	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.6;SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"		NA	NA		14000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane"	"Intermediate filaments"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	0.6	1.7	2.7	0.3	3.0	0.3	1.5	0.0	4.4	1.4	0.0	0.8	0.7	1.7	1.8	0.5	2.2	1.0	1.2	4.3	0.8	3.9	0.4	1.8	0.2	1.6	2.5	1.2	6.3	2.4	1.8	1.3	0.0	1.5	0.7	5.7	2.4	5.5	0.5	0.8	0.7	1.3	1.4	0.3	1.3	1.2	2.5	2.4	0.7	0.8	0.2	1.1	0.6	2.4	4.9	9.2	9.1	14.9	0.1	0.0	4.2	5.2	4.6	2.6	3.4	8.4	2.6	0.0	2.9	8.2	8.6	1.0	5.7	1.4	3.6	2.5	3.8	2.6	11.5	2.2	1.3	3.8	3.2	1.2	2.8	0.9	1.4	3.5	4.8	3.4	1.7	0.1	3.6	4.5	2.9	4.7	7.8	4.1	20.6	6.8	4.5	0.0	1.7	3.3	11.8	21.5	2.6	5.2	2.2	5.1	3.7	2.4	3.3	2.9	2.8	0.1	5.1	0.9	0.0	0.1	4.0	1.4	7.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.0	0.0	4.4	4.3	0.8	1.6	2.5	0.0	1.4	2.5	2.4	2.0	0.0	2.2	11.8	0.1	0.5	2.1	1.6	0.6	18.5	6.3	4.6	2.5	0.0	2.9	7.3	56.3	2.5	0.2	0.3	0.0	2.3	0.5	8.5	8.1	4.8	10.8	1.3	92.2	3.2	2.2	3.0	3.6	8.0	16.5	13.8	2.2	0.8	0.5	3.3	54.6	2.5	6.1	0.8	1.2	0.2	1.5	0.5	1.8	26.2	0.0	7.2	0.0	69.9	2.2	5.0	1.4	2.6	1.0	3.1	0.5	8.1	12.2	29.2	6.6	2.2	2.9	0.3	7.2	0.1	0.9	1.5	1.1	2.4	2.9	1.6
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.0;Erythroid cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	4.1	4.8	2.0	3.6	2.4	8.6	5.4	9.4	3.7	4.6	0.0	2.9	2.1	6.1	3.7	3.3	2.8	4.6	3.5	2.3	3.0	3.6	4.9	2.7	4.6	2.9	2.4	7.6	2.8	5.2	3.7	9.4	2.8	5.2	2.6	4.0	2.7	3.6	1.6	2.5	2.4	4.4	1.4	4.5	2.1	8.0	2.8	5.9	5.7	3.4	3.9	4.8	2.6	2.6	8.6	3.5	21.9	25.1	8.5	13.7	12.0	14.1	11.6	12.0	14.4	5.9	2.7	3.4	11.4	10.4	10.6	4.2	16.7	8.3	16.4	10.7	12.7	35.9	8.0	13.3	11.1	29.0	12.7	10.1	5.9	10.6	11.7	8.5	11.5	9.1	49.9	2.7	14.4	6.8	14.0	17.5	14.2	3.0	5.0	12.8	16.0	8.4	8.0	17.6	18.5	16.8	9.3	3.0	10.6	15.1	7.2	26.0	9.4	18.6	7.7	17.9	10.2	10.9	15.4	16.8	11.5	21.0	7.7	0.2	2.5	2.0	2.3	2.0	2.7	3.7	3.4	3.0	3.9	3.1	4.2	3.6	0.1	5.3	2.0	4.0	4.4	1.9	2.0	2.4	9.4	3.7	2.3	3.0	2.9	2.4	2.8	1.4	2.8	2.6	15.4	9.6	6.3	10.4	8.8	10.5	4.5	13.0	13.1	15.4	7.4	11.7	23.1	1.5	7.8	7.3	2.1	43.3	11.7	1.0	11.7	7.0	87.0	4.6	29.6	12.5	5.4	74.9	32.4	5.4	33.2	21.4	3.1	3.2	13.3	30.5	8.2	4.0	12.5	10.1	32.7	2.4	6.1	6.6	7.1	21.9	12.8	8.9	3.6	12.2	9.7	9.6	15.5	23.6	24.4	2.8	0.9	14.7	13.0	2.3	0.7	14.6	8.4	8.2	19.7	19.5	17.6	23.4	17.9	8.7	4.4	10.7	10.6	29.5	3.2	1.6
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180912897-180951614	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.3"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 95.3;Cone photoreceptor cells: 131.3;Rod photoreceptor cells: 176.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SH-SY5Y: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear membrane, Vesicles"		"HPA028227: AB_10601765, HPA061684: AB_2684585"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	5.7	1.2	3.8	1.3	3.9	0.4	4.0	15.4	6.1	7.2	4.3	8.4	2.4	8.1	1.3	3.5	6.1	2.5	7.7	4.9	2.4	6.2	0.5	3.6	1.2	3.6	3.2	5.8	1.7	0.3	1.8	2.8	2.9	4.8	0.6	25.3	3.2	2.1	2.0	2.5	2.9	3.1	2.8	2.5	3.2	1.7	4.0	0.3	6.1	0.4	0.4	7.4	4.2	5.3	1.7	0.8	1.4	3.0	4.3	10.5	4.8	3.3	3.8	1.6	0.9	1.6	1.7	0.7	3.0	4.1	0.8	3.2	0.3	0.1	0.5	0.9	1.3	2.4	0.6	2.2	5.9	1.5	1.7	5.0	0.1	0.2	0.1	2.7	2.2	2.5	2.1	1.1	1.4	1.4	2.1	0.6	3.3	0.5	0.4	1.1	17.8	2.5	2.6	1.6	12.2	44.7	1.0	1.1	7.3	1.4	1.3	2.1	5.2	3.4	2.5	4.0	1.3	2.3	3.2	1.6	0.4	1.2	2.3	1.3	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	3.8	3.9	15.4	6.1	4.9	2.4	3.6	3.2	2.9	2.8	4.0	5.3	1.0	0.0	1.8	9.8	0.5	0.4	0.8	0.8	0.6	95.3	0.5	0.6	3.5	1.5	1.3	1.8	131.3	0.3	0.5	0.0	1.9	0.4	4.6	0.8	3.6	2.1	0.0	0.0	5.0	0.2	0.4	3.3	0.0	2.2	1.3	1.6	1.8	0.1	1.8	3.3	1.5	0.0	0.0	0.3	0.4	1.8	7.8	0.5	3.6	1.0	1.0	10.0	0.0	4.5	1.4	0.7	0.0	5.7	0.1	0.4	0.2	1.8	0.1	176.0	6.6	8.4	2.4	0.6	0.6	0.2	0.3	0.3	0.4	0.6	0.1	0.0
KIAA1671		ENSG00000197077	KIAA1671	Q9BY89	22	24952730-25197448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4;Excitatory neurons: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"OE19: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018135	Approved		Approved	Microtubules		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA018135: AB_1859551"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.68e-2)"	"prognostic favorable (3.19e-6)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.87e-2)"	10.7	13.7	12.4	5.1	13.2	0.8	22.5	2.8	17.9	10.3	8.6	16.0	14.4	6.6	5.2	25.9	20.0	14.8	11.3	20.0	7.7	11.0	34.1	12.2	5.5	6.7	8.3	8.5	10.1	10.3	11.2	4.1	3.9	13.2	14.2	15.5	25.9	15.5	25.1	28.0	16.8	6.8	6.5	3.8	12.4	4.9	13.5	15.6	26.6	22.1	8.9	8.9	18.7	5.6	25.2	15.7	3.3	5.9	0.1	0.1	2.6	0.1	0.1	1.4	0.1	12.6	9.0	0.1	11.7	1.1	6.9	29.8	25.5	25.2	1.0	0.2	10.6	0.1	16.7	16.9	3.3	0.1	1.3	0.6	22.4	7.9	24.3	16.6	28.9	0.5	0.3	0.1	3.4	11.6	0.1	0.1	5.2	39.9	8.3	1.1	26.6	4.9	16.3	10.8	8.0	6.7	20.3	14.0	1.3	10.8	7.6	0.2	19.5	1.4	27.0	16.6	4.5	0.1	0.4	0.1	10.0	0.0	4.3	0.2	0.0	0.0	1.8	0.0	0.2	0.0	0.5	1.3	0.0	0.1	0.2	0.8	0.2	0.4	0.0	0.1	0.1	0.3	12.4	13.2	2.8	17.9	20.0	7.7	6.7	8.3	3.9	6.5	13.5	5.6	27.7	12.8	21.9	74.4	1.1	10.8	21.1	16.2	18.2	4.2	25.4	16.5	11.9	25.8	19.2	5.5	22.9	0.2	3.0	62.9	0.0	18.9	2.6	31.2	3.5	28.5	7.2	5.3	67.8	18.9	0.1	4.9	22.4	30.2	1.3	4.2	29.6	47.8	2.4	16.8	22.9	12.3	6.1	1.9	5.9	3.5	7.2	1.6	10.6	43.1	0.6	21.6	0.0	12.5	3.4	21.4	34.1	9.1	0.6	18.2	34.1	8.8	32.0	17.6	0.0	11.0	9.3	6.8	8.8	27.3	14.5	1.0	6.6	6.6	20.1	29.2
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210503-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 105.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: AB_2681331"	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	5.6	2.1	18.4	6.0	87.7	0.5	3.4	39.2	42.2	13.1	0.0	9.0	2.4	14.6	6.4	5.1	8.7	16.2	11.4	29.0	64.1	4.1	1.2	2.5	5.0	59.2	62.3	13.6	0.9	0.1	2.2	0.1	54.7	6.6	4.2	0.5	5.8	7.3	0.6	1.4	4.2	14.7	18.3	2.7	3.6	2.6	75.3	8.3	2.0	1.7	4.7	5.2	4.8	105.0	3.0	0.3	75.6	0.1	11.3	16.9	0.0	7.6	4.3	0.0	0.0	0.3	2.2	0.0	0.3	2.4	2.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.3	0.0	2.2	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.0	1.1	0.4	1.4	0.0	0.0	0.0	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	87.7	39.2	42.2	29.0	64.1	59.2	62.3	54.7	18.3	75.3	105.0	0.1	0.0	0.0	63.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	2.5	0.2	0.0	0.0	0.8	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.4	1.1	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.9	3.7	0.2	1.8	67.5	0.0	0.0	0.0	19.6	135.6	0.6	0.0	7.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.1	1.2	0.3	0.3	0.2	0.3	0.0	0.0	0.4	0.0	0.0
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	2.4	1.6	3.2	1.8	3.7	1.1	1.8	4.1	6.2	4.2	1.2	3.2	2.6	1.8	2.2	1.6	3.4	1.3	2.5	3.4	3.3	1.2	1.0	3.6	1.5	5.2	3.2	1.0	1.6	1.3	3.3	1.6	5.7	4.2	3.7	11.2	1.4	1.3	1.8	3.9	2.8	2.4	2.2	1.4	2.5	3.7	5.2	2.5	1.8	2.2	1.6	1.5	1.8	6.1	5.1	10.9	12.5	5.3	6.5	7.7	4.3	10.1	2.2	4.8	4.4	3.4	3.2	2.1	2.6	7.5	9.8	6.3	8.2	3.3	6.7	10.0	3.0	2.2	6.9	8.8	3.5	2.5	2.0	3.7	4.9	8.8	3.1	5.3	7.1	3.0	2.1	1.7	13.5	0.4	2.1	1.7	3.9	5.9	2.5	6.7	10.5	0.5	5.4	10.6	7.5	4.7	11.8	2.6	3.4	9.1	1.8	2.7	9.4	7.8	3.1	6.5	6.8	1.0	3.1	3.0	5.6	1.8	5.5	0.4	0.5	1.8	0.4	0.7	0.4	0.5	0.4	0.2	0.5	0.1	0.0	0.3	1.3	0.5	1.0	0.3	1.5	0.2	3.2	3.7	4.1	6.2	3.4	3.3	5.2	3.2	5.7	2.2	5.2	6.1	12.9	6.4	5.8	26.1	1.5	2.5	3.2	4.4	1.8	14.5	3.5	2.8	7.0	2.8	11.6	3.7	56.3	1.1	4.5	7.5	0.0	3.8	4.0	22.4	8.3	8.0	7.7	5.5	91.2	6.2	2.7	8.0	14.8	4.5	1.3	18.6	7.1	0.9	5.8	8.4	78.5	5.3	4.1	5.9	5.3	2.6	3.7	5.2	3.6	22.5	9.1	5.1	7.2	19.1	63.8	9.2	8.4	1.9	2.0	4.0	4.7	0.8	58.0	45.4	0.0	4.4	7.5	10.5	20.7	4.8	3.3	0.4	4.0	0.9	4.7	2.7
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486827-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.8;Excitatory neurons: 64.2;Inhibitory neurons: 55.1;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 166.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	1.1	6.6	5.5	1.1	10.5	4.9	2.2	9.3	6.9	5.1	4.4	1.4	1.7	3.4	0.9	1.5	3.0	1.3	1.3	3.9	6.6	5.8	3.4	2.1	1.3	8.2	8.9	9.9	2.6	1.4	1.8	0.7	7.0	1.5	1.5	10.0	3.0	2.4	0.9	1.6	1.9	3.1	7.5	1.5	4.8	5.8	10.7	3.9	2.4	0.8	1.3	1.4	1.9	14.5	3.7	5.2	20.7	6.0	1.4	0.3	9.9	2.7	0.9	3.2	3.6	9.5	2.4	11.8	3.1	8.9	2.2	3.2	15.3	1.5	4.5	3.6	6.2	4.6	7.3	6.7	0.8	7.0	5.6	0.6	1.2	4.2	2.0	2.9	2.6	11.0	11.0	2.9	1.0	4.2	11.0	4.0	11.4	8.6	2.4	8.8	11.8	3.3	4.3	5.1	10.6	11.2	4.5	4.7	2.7	11.4	4.3	7.1	0.5	1.1	6.1	0.7	3.3	5.3	10.4	6.9	1.4	4.8	0.8	0.4	0.7	0.0	0.5	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	0.4	5.5	10.5	9.3	6.9	3.9	6.6	8.2	8.9	7.0	7.5	10.7	14.5	0.5	3.2	19.3	169.8	3.7	4.7	3.4	1.5	6.8	20.6	7.9	4.2	4.3	4.3	6.2	1.8	14.6	1.2	3.0	4.6	7.9	3.2	4.1	12.1	8.1	1.4	4.8	3.8	64.2	6.7	1.0	3.3	8.2	8.0	0.0	20.3	0.4	8.0	1.0	6.7	55.1	4.4	12.2	7.5	4.6	2.5	6.5	4.2	1.8	15.9	2.5	8.3	3.1	127.6	166.4	3.3	6.2	5.3	5.0	6.5	5.0	11.0	5.9	12.1	6.6	2.5	4.1	1.5	8.0	5.3	4.7	0.8	1.6	29.9	5.2	5.7
KIAA2012		ENSG00000182329	KIAA2012		2	202073255-202205188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	7	"brain: 6.9;choroid plexus: 3.1;fallopian tube: 9.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 38.9;Endometrial ciliated cells: 12.3;Excitatory neurons: 24.8;Late spermatids: 28.6;Respiratory ciliated cells: 43.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077834	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA077834: "	"unprognostic (1.91e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.94e-5)"	"unprognostic (1.60e-1)"	"unprognostic (9.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.95e-3)"	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.1	1.3	0.3	3.1	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	1.9	1.1	0.0	0.9	0.8	0.0	5.6	6.9	0.0	0.0	0.0	0.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.1	1.3	1.9	1.1	5.6	6.9	3.1	4.9	1.9	0.9	0.2	3.2	0.0	1.0	0.1	0.0	0.3	0.0	0.0	2.9	0.4	0.1	1.0	0.0	1.8	0.0	2.1	0.1	0.2	0.0	0.0	0.0	38.9	12.3	0.6	0.4	0.0	0.0	24.8	0.2	0.1	0.6	0.0	0.6	0.0	0.2	1.1	4.8	0.1	3.3	2.8	0.0	0.0	0.0	0.0	28.6	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	43.0	2.4	0.0	0.8	0.2	1.5	3.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.7;Proximal enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	27.9	25.6	23.6	17.3	28.7	19.3	25.5	28.0	24.1	25.4	24.9	43.7	65.5	35.5	35.7	30.1	27.1	20.6	39.1	23.9	24.3	30.2	59.4	23.8	21.8	32.3	28.8	19.7	42.4	20.0	31.8	20.9	27.7	27.8	20.1	6.1	40.4	25.7	51.9	37.8	61.8	17.2	27.6	35.1	31.4	37.2	27.3	16.8	26.8	23.2	13.1	32.2	25.5	31.6	61.2	44.5	20.5	40.6	34.0	23.2	33.8	38.1	39.8	45.0	46.4	55.1	61.7	39.8	56.9	36.2	35.2	69.3	27.8	37.6	23.8	46.3	71.4	27.4	39.7	95.7	38.4	57.2	54.3	29.7	41.0	44.1	19.4	48.7	43.6	31.2	42.6	51.5	27.2	46.2	36.6	80.1	27.0	27.0	60.6	46.3	37.4	97.6	29.0	16.5	76.1	43.0	30.9	34.1	74.8	20.4	28.6	52.6	42.1	37.9	49.2	56.3	52.6	61.8	47.1	46.0	45.1	91.8	41.1	3.3	4.9	5.1	4.7	4.2	3.7	5.2	2.5	3.6	3.5	6.8	2.5	3.3	11.1	4.1	3.5	8.5	5.5	2.6	23.6	28.7	28.0	24.1	23.9	24.3	32.3	28.8	27.7	27.6	27.3	31.6	26.1	22.4	13.4	12.4	18.7	22.2	9.2	13.6	6.8	20.7	30.5	27.1	18.7	18.6	13.0	25.8	12.5	18.1	32.6	116.7	3.9	15.5	24.4	23.7	18.4	22.9	40.9	11.8	9.9	19.3	30.8	18.7	17.3	27.7	13.3	23.1	27.1	75.2	26.5	32.0	8.8	50.1	22.4	40.3	23.0	41.5	22.7	27.1	19.6	6.5	26.5	18.7	28.8	8.5	22.1	24.7	72.2	23.0	18.4	17.3	139.9	22.3	17.8	22.1	19.7	27.5	15.7	17.6	8.6	15.0	28.1	13.3	16.0	31.1	59.4	17.3
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6008482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	6.8	5.1	13.5	5.6	17.2	6.4	6.2	24.1	11.7	7.8	25.1	6.4	4.8	7.9	5.8	6.1	6.4	5.7	5.7	9.9	12.1	6.1	4.9	5.9	6.7	11.6	13.3	10.2	5.2	8.6	6.2	6.9	11.9	6.2	5.0	10.4	6.1	5.4	9.5	8.2	5.6	6.3	10.3	8.1	6.5	11.5	12.6	8.3	8.4	9.5	5.9	6.2	7.1	17.0	7.1	3.5	7.2	4.6	5.4	8.5	3.2	4.6	6.8	4.4	4.0	2.3	4.0	8.8	1.7	5.8	5.5	3.5	4.2	3.9	6.5	19.2	3.0	26.5	8.4	3.7	4.2	9.4	11.6	5.3	5.0	3.9	6.4	8.3	6.9	5.7	2.8	16.2	5.5	2.2	5.1	17.2	4.0	4.1	2.8	5.3	4.6	4.5	4.8	4.9	9.3	5.3	4.3	4.0	3.7	4.9	4.1	12.6	7.8	8.4	4.7	4.2	5.3	11.1	9.5	8.8	4.3	4.3	2.3	5.0	2.3	7.0	4.2	1.9	4.8	5.9	4.1	3.8	0.9	3.8	4.5	4.8	6.0	4.8	4.5	2.9	2.6	0.8	13.5	17.2	24.1	11.7	9.9	12.1	11.6	13.3	11.9	10.3	12.6	17.0	47.8	44.8	34.0	99.9	40.3	44.6	29.9	21.4	37.5	89.0	33.5	25.5	53.7	42.9	22.1	38.6	79.2	17.1	51.9	31.0	7.9	18.2	33.0	28.3	40.9	39.7	38.5	18.7	97.8	13.4	10.6	33.2	31.1	46.7	20.2	43.5	29.3	18.7	16.9	45.4	119.1	34.7	16.2	25.5	28.8	17.2	70.5	31.9	23.2	113.4	55.1	47.7	95.8	116.1	170.1	18.4	29.1	76.3	35.4	34.4	30.1	11.9	18.2	81.5	46.0	45.8	40.1	127.7	121.2	38.3	52.4	30.0	45.1	38.7	28.5	42.0
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Neurogenesis		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	21.2	21.6	20.9	14.5	40.6	24.4	19.6	34.9	27.5	22.3	21.6	19.6	11.4	29.3	15.3	15.1	16.6	17.7	21.9	22.1	28.9	22.1	15.7	23.6	13.1	43.9	31.5	37.7	18.8	42.8	16.9	21.4	43.4	20.0	16.5	38.0	14.5	18.0	14.5	16.7	13.8	23.6	35.7	17.1	16.5	10.6	32.0	21.6	20.0	16.7	12.3	16.7	17.9	73.9	13.5	21.3	41.8	26.8	51.4	33.9	21.9	26.2	21.6	16.4	15.0	21.5	13.5	25.2	26.1	39.4	31.5	22.5	37.9	16.1	24.0	36.4	25.7	22.7	15.9	22.6	36.3	23.6	29.9	35.3	24.9	26.1	33.7	25.1	25.9	21.6	44.7	30.8	29.2	14.8	24.2	12.7	22.7	22.3	18.8	22.7	30.7	12.7	21.7	25.4	35.4	59.3	20.8	20.7	23.6	21.7	13.3	26.6	34.4	36.1	19.0	36.6	28.5	22.4	21.1	33.5	21.1	31.2	28.1	4.1	3.4	4.2	3.6	3.9	2.6	1.9	2.6	3.0	2.7	1.8	2.7	3.1	5.3	3.2	4.6	1.8	2.4	2.2	20.9	40.6	34.9	27.5	22.1	28.9	43.9	31.5	43.4	35.7	32.0	73.9	57.1	99.3	115.7	129.6	25.2	32.8	27.6	25.1	19.9	86.2	31.3	25.0	40.2	25.8	48.6	29.5	139.7	21.5	35.0	33.9	0.0	33.3	1.3	32.3	77.8	51.8	43.3	36.4	108.3	23.6	10.0	55.0	39.8	53.1	35.4	144.0	47.8	30.9	28.8	154.8	149.2	23.4	44.7	52.7	46.0	5.9	69.6	45.9	24.9	60.9	44.2	60.5	34.0	162.3	322.2	29.0	29.8	65.5	27.3	25.7	24.5	10.5	34.4	58.0	6.6	65.4	54.2	28.1	23.4	26.4	29.5	10.9	40.2	52.1	23.9	36.0
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 162.3;pancreas: 85.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020192, HPA024127"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Plasma membrane"		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	2.2	1.1	2.1	0.0	25.3	0.4	3.6	11.4	2.8	7.8	25.5	4.2	1.0	0.2	8.0	24.7	0.2	2.0	0.9	162.3	27.7	1.6	0.5	0.6	1.1	0.7	85.4	0.8	0.6	1.1	1.0	7.0	4.2	0.1	3.6	4.8	0.0	1.4	16.1	0.4	0.4	0.2	11.0	2.4	1.3	1.3	31.8	0.0	0.1	0.2	0.3	0.8	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.6	0.2	0.0	5.2	0.0	0.6	0.0	0.2	0.1	0.2	0.0	0.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.0	0.4	0.1	17.2	0.6	0.0	0.0	0.1	44.8	0.2	6.6	0.1	0.0	0.9	0.0	0.2	4.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	0.4	3.6	2.0	0.9	0.6	1.1	1.0	0.4	1.3	0.8	0.1	0.0	4.4	0.0	1.3	0.0	0.9	0.6	0.0	0.0	20.3	10.8	0.4	105.8	0.0	90.1	0.0	0.1	0.0	7.9	80.3	43.3	7.0	8.3	1.5	0.3	64.1	0.0	0.7	11.8	9.3	0.4	14.8	15.6	0.0	0.0	0.0	10.2	0.3	0.0	0.3	22.0	0.0	0.3	0.0	14.7	0.6	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.7	21.3	0.0	0.0	2.2	60.3	79.1	0.0	0.0	0.0	0.0	0.3	3.2	7.9	0.0	0.0	0.5	0.9	0.3	28.9	0.5
KIF13A	bA500C11.2	ENSG00000137177	"Kinesin family member 13A"	Q9H1H9	6	17759183-17987635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.5"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 831.4;Oligodendrocytes: 453.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029253, HPA029254"	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA029253: AB_10611115, HPA029254: AB_10602094"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (2.96e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.44e-2)"	24.1	20.0	23.9	10.3	29.7	19.4	21.3	25.9	24.4	23.6	31.2	29.4	27.4	25.4	13.1	20.1	18.9	17.7	47.8	21.2	22.9	14.1	16.0	25.3	5.3	24.6	25.8	20.2	14.7	21.2	11.9	11.9	25.3	23.7	25.4	21.6	17.2	18.6	104.5	28.6	23.5	22.4	21.5	8.1	14.5	8.6	27.1	8.3	27.9	72.5	7.4	29.9	24.3	33.9	24.8	18.0	21.3	13.1	28.4	27.0	25.3	33.6	57.0	28.9	29.5	6.5	5.9	0.2	26.3	58.4	36.5	24.3	16.3	42.6	36.2	2.5	9.8	10.6	44.9	32.1	18.9	0.4	10.3	21.5	34.9	31.3	47.1	37.2	23.8	0.1	39.5	0.3	31.8	10.0	0.1	1.5	16.9	5.7	11.0	12.6	29.1	0.2	18.1	62.1	5.8	11.5	27.7	20.6	38.4	36.7	29.9	1.5	16.8	52.6	15.2	17.4	31.8	0.2	0.1	0.2	18.9	0.8	39.2	2.1	1.3	1.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	5.9	0.1	0.5	0.1	0.0	0.2	23.9	29.7	25.9	24.4	21.2	22.9	24.6	25.8	25.3	21.5	27.1	33.9	29.9	35.3	44.4	149.5	4.3	57.2	39.6	9.2	21.1	32.9	20.5	23.1	67.7	17.2	12.8	20.2	18.8	4.1	2.8	20.3	11.7	5.9	20.9	14.5	27.9	28.6	12.5	20.4	134.4	8.7	4.0	24.0	13.7	16.5	5.1	9.7	15.4	25.5	11.9	5.0	42.2	27.2	6.1	22.3	14.7	10.5	15.5	18.9	17.8	105.9	21.1	37.6	5.2	831.4	453.8	9.2	27.4	24.8	0.6	38.4	18.2	10.9	23.5	26.8	26.3	32.7	35.3	6.8	14.9	8.1	45.6	9.0	2.2	2.9	32.7	38.0
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067278-29263124	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 64.5;parathyroid gland: 161.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 140.2;Oligodendrocytes: 371.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favorable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	11.7	25.9	6.8	47.6	5.1	9.2	34.9	30.6	8.7	16.6	18.3	16.1	6.7	9.4	8.4	7.1	8.4	5.3	20.0	29.4	18.5	10.2	8.5	4.3	47.3	43.7	7.2	10.9	161.5	10.0	3.8	42.1	10.9	13.8	7.9	15.6	8.5	4.7	20.0	15.7	5.5	29.3	8.9	19.2	6.6	40.1	5.1	9.0	3.0	4.6	9.5	6.1	64.5	12.4	13.2	4.6	3.8	7.5	4.3	6.7	0.7	2.9	3.9	6.2	8.3	6.9	2.6	6.9	0.8	7.1	8.2	3.7	2.1	5.1	3.9	3.6	6.6	1.8	8.4	7.2	1.8	19.2	5.0	3.9	8.9	3.6	8.3	17.1	4.9	8.6	9.5	12.9	3.8	9.7	3.1	2.3	17.4	2.2	5.5	10.6	4.9	17.0	13.2	1.3	9.1	2.4	8.0	11.7	4.8	5.9	3.7	22.8	2.8	7.6	0.8	5.6	6.9	11.1	4.4	16.4	3.4	13.2	0.1	1.5	1.7	1.5	1.1	0.7	1.4	0.6	0.9	0.5	0.8	0.5	0.6	0.7	0.9	0.6	2.2	0.6	0.5	25.9	47.6	34.9	30.6	20.0	29.4	47.3	43.7	42.1	29.3	40.1	64.5	22.2	44.8	24.8	30.0	16.5	4.5	13.8	17.2	5.2	13.3	23.5	11.2	5.3	20.0	36.8	35.0	60.5	6.4	35.8	95.8	11.7	25.7	8.0	55.3	12.7	14.2	25.2	7.4	26.7	25.0	0.9	10.0	55.0	140.2	41.0	10.6	13.9	18.6	8.9	16.8	35.3	44.1	36.7	25.7	6.3	3.5	8.1	24.4	7.2	41.2	12.1	9.5	12.3	47.3	371.1	39.7	58.0	20.3	42.5	28.1	34.7	17.8	34.9	26.2	6.6	36.4	7.4	6.3	7.7	9.8	6.8	5.1	31.8	5.9	36.0	32.5
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761721-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.5;Late spermatids: 78.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035516, HPA035517, HPA061469"	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: "	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.2	0.1	0.1	1.2	0.1	5.0	0.4	0.2	0.2	0.3	0.0	1.4	1.4	0.3	0.0	1.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	1.6	0.1	0.2	0.1	0.0	0.8	1.4	0.4	0.1	0.4	0.8	7.3	0.1	9.2	0.0	0.0	2.2	0.3	0.4	0.1	7.5	3.9	17.6	12.8	1.2	1.4	3.9	8.6	5.3	10.8	9.0	6.6	7.2	13.8	2.8	3.1	4.0	6.3	10.1	4.7	13.1	11.6	2.3	14.9	7.7	8.4	0.1	15.6	6.6	0.3	0.2	7.3	7.1	1.6	8.6	18.4	9.3	17.2	8.2	3.9	30.0	5.7	18.2	9.7	7.0	11.9	19.0	7.9	2.4	4.9	8.2	7.8	14.2	4.6	2.9	4.6	7.7	11.7	4.8	10.4	8.5	8.8	11.5	7.2	12.7	17.3	5.5	16.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.6	1.6	1.9	0.4	0.9	0.0	0.1	0.5	0.8	1.8	0.0	0.7	0.0	2.1	3.3	0.8	2.5	0.0	0.8	177.5	1.3	1.7	1.2	0.0	28.0	3.2	0.0	5.9	1.9	5.1	1.4	0.0	12.3	0.0	0.2	3.5	0.0	3.8	2.6	0.0	1.6	1.4	78.0	0.0	1.8	0.0	0.0	0.3	0.7	1.0	3.0	4.7	0.5	0.1	0.4	9.7	0.5	0.5	0.1	0.2	0.0	0.0	0.4	1.9	20.2	14.7	6.0	1.0	0.7	3.1	1.1	5.3	0.5
KIF16B	"C20orf23, dJ971B4.1, FLJ20135, SNX23"	ENSG00000089177	"Kinesin family member 16B"	Q96L93	20	16272104-16573448	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 38.1"	"Low region specificity"	"Detected in all"							HPA051198	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA051198: AB_2681385"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.52e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (4.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.61e-2)"	10.1	27.4	5.4	6.4	6.1	5.9	15.8	4.9	8.6	6.3	3.6	24.5	16.7	6.1	12.5	9.4	5.1	8.3	11.5	4.3	6.4	18.1	11.7	8.8	5.3	6.4	5.4	12.8	6.5	31.5	5.2	4.8	6.0	7.3	19.1	9.7	7.3	10.8	17.1	11.9	20.8	7.4	3.9	8.2	12.8	5.1	6.3	5.9	11.1	13.1	4.7	7.9	6.2	7.9	7.7	19.3	9.1	8.3	6.8	5.0	8.8	7.4	4.5	4.6	5.0	9.5	18.5	10.7	4.7	8.0	12.7	6.9	10.8	11.0	6.8	5.7	6.2	4.8	4.7	17.6	4.2	0.0	10.5	8.0	21.4	5.5	10.6	7.0	1.8	8.1	8.7	0.0	7.5	12.2	0.1	2.0	2.6	24.9	8.7	8.1	7.2	18.9	7.2	12.2	4.0	7.9	8.0	38.1	23.9	10.7	11.3	6.3	3.7	7.0	5.9	11.4	3.4	0.0	4.9	3.2	6.6	3.2	14.3	0.0	2.1	0.5	2.0	1.7	2.7	2.7	2.2	1.5	3.4	2.6	2.3	1.7	0.2	4.5	1.8	1.6	1.6	1.7	5.4	6.1	4.9	8.6	4.3	6.4	6.4	5.4	6.0	3.9	6.3	7.9	13.1	19.2	31.7	54.9	9.8	19.1	16.1	11.0	37.5	8.7	30.5	16.0	29.2	4.3	14.8	5.5	18.8	15.7	7.7	60.6	3.9	6.5	12.6	13.2	14.2	13.6	23.4	5.0	67.6	12.3	5.5	15.1	18.3	20.8	9.5	13.6	12.5	15.9	19.1	37.0	84.2	38.9	4.1	12.2	35.7	9.8	11.5	19.8	10.6	59.0	4.9	8.6	10.3	60.3	94.1	13.3	40.9	14.7	6.9	11.1	36.8	21.1	11.6	11.5	6.6	22.7	13.4	12.9	15.0	26.3	22.4	37.5	9.4	12.9	24.8	19.3
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.0	0.2	2.3	0.0	2.2	0.0	0.0	0.0	3.3	0.3	1.8	0.2	0.1	0.4	0.0	0.0	1.8	0.0	0.0	2.3	4.9	0.4	0.1	0.2	0.0	0.6	1.4	0.2	0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.3	0.0	0.0	23.2	3.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.8	0.7	0.4	0.0	0.0	0.0	0.1	1.2	1.6	0.6	0.4	0.2	0.4	0.0	0.5	0.9	0.3	0.0	0.6	0.4	0.4	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.3	0.5	3.7	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	3.3	2.3	4.9	0.6	1.4	0.4	0.3	3.1	0.0	18.9	0.0	0.0	0.7	0.2	1.7	0.0	0.1	0.6	0.0	0.2	0.3	2.8	0.0	0.2	1.8	4.2	0.1	2.8	0.1	0.0	0.0	44.0	2.8	0.3	15.2	0.0	0.0	11.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	15.4	0.5	5.1	0.0	2.8	0.0	0.0	1.6	9.8	88.7	1.2	3.2	1.8	1.9	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.1	0.1	0.1	0.3	3.5	0.3	19.7	0.5	2.7	3.2	4.3	0.1	1.3	1.6	0.2	5.2	0.1	0.2
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020619-28108156	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.2	0.1	0.0	1.9	0.1	8.2	0.7	0.0	0.1	0.7	0.1	1.6	1.5	0.5	0.3	1.4	0.3	0.5	0.0	0.1	0.1	0.3	0.3	1.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.1	0.3	2.0	0.6	0.3	0.4	0.2	1.2	1.4	0.8	0.1	0.7	0.6	13.7	0.2	9.6	1.1	0.1	4.6	0.7	0.5	0.1	27.9	27.4	27.2	19.0	0.9	3.7	9.1	28.3	13.2	44.2	46.0	9.2	11.0	23.3	10.0	14.7	24.1	27.2	23.4	11.1	61.4	23.4	14.2	15.2	17.8	11.8	2.1	22.6	13.4	6.8	1.4	15.5	18.1	7.8	17.2	19.0	24.6	20.0	25.2	14.8	23.1	16.7	13.4	18.0	11.1	17.8	65.0	11.6	12.5	8.0	16.3	12.6	23.7	11.1	7.8	16.5	23.8	6.9	10.1	35.0	27.2	33.2	37.4	7.9	19.8	23.4	21.0	16.5	25.2	4.1	0.0	0.3	0.1	0.2	0.3	1.0	0.4	0.2	0.3	0.4	0.3	0.1	0.0	1.4	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	3.2	0.0	0.0	4.7	2.3	1.3	1.4	1.2	0.3	1.3	2.9	0.5	0.0	2.2	0.0	6.2	4.6	2.8	1.9	0.0	0.6	43.1	3.4	2.5	1.1	1.8	15.4	0.2	0.9	7.1	5.4	1.5	3.4	4.5	9.7	1.4	0.0	2.2	0.0	0.1	1.9	0.0	1.6	1.4	8.7	0.6	1.4	0.0	1.0	1.1	0.7	1.0	0.5	0.9	0.5	0.1	0.4	5.1	0.2	0.2	0.6	1.7	1.9	0.0	2.5	1.9	78.7	28.3	4.3	1.0	1.6	3.9	2.7	3.6	0.5
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.7;fallopian tube: 12.0;lymphoid tissue: 13.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 44.4;Enteroendocrine cells: 23.8;Hepatic stellate cells: 15.4;Intestinal goblet cells: 14.1;Plasma cells: 15.6;Respiratory ciliated cells: 57.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: AB_2686593"	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.4	0.1	7.5	0.4	10.3	0.2	1.2	4.0	11.4	2.2	3.5	1.7	3.0	0.3	0.0	0.5	12.0	0.4	0.3	7.2	7.4	0.2	0.9	1.9	0.1	7.5	8.0	0.2	1.1	0.0	0.3	0.0	5.9	0.9	0.6	0.1	1.0	0.2	0.4	0.6	2.3	0.4	6.2	13.5	0.7	0.6	7.7	1.0	1.9	0.6	0.1	1.6	1.5	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.4	7.5	10.3	4.0	11.4	7.2	7.4	7.5	8.0	5.9	6.2	7.7	16.7	1.3	0.0	0.0	2.0	1.3	0.0	0.4	2.5	0.0	1.1	0.1	0.0	1.6	0.0	6.3	0.0	0.0	0.0	3.5	0.8	0.0	0.0	0.5	44.4	0.2	4.2	23.8	0.4	0.0	0.0	3.1	1.0	1.1	0.7	0.0	0.0	15.4	0.1	0.1	0.0	0.1	14.1	4.1	0.6	1.6	0.3	0.0	0.3	3.6	0.0	0.1	5.7	3.1	4.0	3.7	0.0	0.1	0.0	15.6	0.3	0.2	0.0	57.6	0.3	0.0	1.8	1.3	0.2	1.6	0.0	0.1	0.0	2.5	0.2	1.9	0.2
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210570-10381603	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 103.6;retina: 127.4;skeletal muscle: 202.3;tongue: 150.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 413.9;Cone photoreceptor cells: 579.6;Excitatory neurons: 297.4;Inhibitory neurons: 281.6;Oligodendrocytes: 521.3;Rod photoreceptor cells: 389.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Nucleoli fibrillar center"	"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	11.1	14.8	64.1	8.2	73.5	16.0	12.4	68.4	67.0	11.0	0.0	16.7	9.5	15.5	6.8	18.3	10.5	10.3	29.7	65.9	58.2	14.6	12.1	11.0	4.2	74.7	61.6	15.7	13.2	20.5	12.6	10.2	78.1	11.9	9.2	127.4	12.8	9.3	202.3	14.2	10.6	15.2	44.0	7.3	9.4	19.7	60.4	4.8	10.9	150.9	5.0	11.6	12.5	103.6	25.0	17.7	81.3	31.8	22.0	24.6	7.0	24.0	16.6	24.8	25.0	19.5	12.2	3.6	23.4	38.9	13.2	17.7	58.9	18.8	34.2	35.1	19.3	14.7	25.8	23.0	17.6	5.2	4.5	19.0	18.8	42.3	26.7	18.0	31.1	15.4	16.6	14.4	27.7	7.5	5.9	5.2	17.9	10.9	13.0	24.6	47.2	6.6	10.3	12.2	55.3	27.0	33.8	16.1	32.9	33.5	11.5	7.0	36.4	29.1	18.4	33.0	23.1	7.8	13.9	7.7	25.1	15.8	14.9	2.3	1.0	5.5	0.6	0.9	0.3	0.5	0.6	0.7	0.7	0.5	0.4	0.4	4.7	0.6	1.2	0.5	0.8	0.5	64.1	73.5	68.4	67.0	65.9	58.2	74.7	61.6	78.1	44.0	60.4	103.6	38.3	60.9	21.6	413.9	9.3	50.9	24.5	15.2	25.0	248.2	33.6	26.5	120.0	14.3	18.1	22.0	579.6	6.9	17.5	26.4	0.0	18.8	85.8	34.6	41.8	39.8	28.8	4.2	297.4	18.1	6.1	42.6	22.4	63.1	7.0	104.6	20.3	37.6	22.1	139.7	281.6	17.7	20.3	22.0	43.5	48.4	18.6	36.8	51.6	75.9	19.5	56.1	6.2	238.8	521.3	23.8	23.4	20.7	21.1	25.8	31.7	14.2	19.9	389.3	19.7	85.4	42.3	37.3	37.7	40.8	59.1	6.7	14.4	63.0	21.3	20.8
KIF1C	"SAX2, SPAX2, SPG58"	ENSG00000129250	"Kinesin family member 1C"	O43896	17	4997950-5028401	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 244.8;choroid plexus: 142.7;heart muscle: 185.0;skeletal muscle: 561.0;tongue: 389.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 315.4;Distal enterocytes: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024602, HPA045020"	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA024602: AB_1852480, HPA045020: AB_2679187"	"unprognostic (3.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.90e-3)"	"prognostic favorable (2.26e-9)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.10e-3)"	54.6	18.6	200.1	25.1	230.9	6.3	36.3	184.0	210.0	33.9	142.7	63.3	53.3	44.4	7.9	75.7	31.5	28.0	185.0	164.4	175.0	37.9	46.4	49.6	10.0	219.0	216.9	24.1	51.6	55.1	10.5	18.6	197.0	36.4	33.2	4.3	38.3	36.7	561.0	53.4	51.4	36.3	200.7	26.5	51.2	17.7	200.8	11.3	38.7	389.2	16.7	51.4	37.3	244.8	104.1	97.6	32.2	69.4	74.5	44.5	51.0	80.8	64.3	63.2	38.3	70.7	24.5	16.6	46.7	127.2	41.2	105.3	58.4	107.2	44.6	40.2	68.7	12.0	124.1	57.4	50.7	4.9	34.6	46.0	109.9	85.2	58.0	59.6	87.2	14.5	45.9	28.4	62.6	61.5	14.7	8.0	25.1	68.1	63.4	15.1	54.1	17.2	55.7	71.9	7.8	15.3	114.2	63.0	34.9	30.6	62.0	14.9	185.5	84.8	63.7	62.2	99.3	10.8	9.9	8.9	62.6	20.9	43.0	0.5	0.4	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.4	0.2	0.2	1.2	0.3	0.2	0.2	0.3	0.1	200.1	230.9	184.0	210.0	164.4	175.0	219.0	216.9	197.0	200.7	200.8	244.8	24.8	54.5	50.6	6.5	6.8	16.8	19.0	25.6	12.5	12.5	24.8	14.2	315.4	48.6	28.1	25.8	0.0	14.8	6.5	168.9	19.6	32.2	71.6	13.0	15.1	37.8	14.4	4.4	5.7	43.1	14.0	21.9	51.0	29.3	12.7	21.6	37.1	82.7	16.1	23.5	7.3	77.3	12.2	18.5	11.0	32.1	16.8	11.9	16.0	10.3	16.1	7.7	6.2	4.5	5.0	63.0	83.8	42.5	11.4	44.1	92.9	42.9	18.4	5.8	6.6	35.0	35.1	18.7	23.6	21.3	20.2	23.3	7.9	12.4	65.4	36.6
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187723	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 24.6;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 6.6;T-reg: 2.5"	"Group enriched"	"Detected in many"	46	"NK-cells: 6.6;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036909, HPA036910"	Approved		Uncertain	"Nucleoplasm,Cytokinetic bridge"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"		"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	0.7	0.8	0.0	4.5	0.1	14.1	1.3	0.1	0.1	1.0	0.1	3.3	3.5	1.4	0.0	6.6	0.4	0.8	0.5	0.0	0.1	0.4	0.9	0.9	8.6	0.1	0.2	0.2	0.2	0.1	0.0	5.4	0.1	0.2	5.1	0.0	1.0	0.1	0.1	4.4	2.8	5.8	0.0	1.9	2.1	11.7	0.5	24.6	0.5	0.1	13.1	1.6	2.0	0.1	87.8	59.5	127.8	84.4	6.7	12.3	53.9	75.0	68.9	162.3	121.4	111.9	80.5	38.8	39.2	96.5	60.6	85.9	121.7	142.5	160.9	56.4	57.4	57.2	101.1	70.7	0.3	28.2	25.1	4.8	2.3	86.2	49.5	27.1	106.7	53.9	24.4	70.4	113.9	81.5	47.6	26.7	80.6	51.8	63.7	51.2	128.5	39.5	43.9	42.3	37.8	37.5	144.1	47.9	30.9	161.6	60.8	28.5	51.1	41.6	60.5	38.0	126.4	36.0	37.5	42.0	26.7	81.1	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.3	0.0	1.7	0.0	0.8	0.4	0.4	2.9	0.0	0.0	1.1	1.3	0.3	0.0	0.7	0.0	0.0	11.0	0.1	2.8	0.0	0.1	1.0	1.0	1.9	1.7	0.0	24.6	0.0	0.0	13.1	3.1	2.6	1.3	4.5	11.1	3.3	0.4	6.1	0.0	0.0	1.6	6.1	2.2	0.4	2.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	3.0	0.3	1.2	0.0	0.9	0.0	0.0	0.5	4.4	21.7	7.5	5.3	0.4	1.0	0.7	0.8	3.4	0.6
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.3;retina: 77.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 308.6;Cone photoreceptor cells: 308.6;Inhibitory neurons: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.1;MAIT T-cell: 3.4;memory CD4 T-cell: 4.4;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.8;NK-cell: 3.0;T-reg: 2.2"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.0;T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 187.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: AB_2683717"	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	6.5	12.1	37.4	3.9	40.0	0.9	6.2	41.4	51.2	12.3	8.0	11.9	9.0	9.2	5.5	20.9	33.7	6.1	19.2	38.2	55.7	26.5	20.5	5.9	2.9	67.4	46.6	4.5	13.2	16.6	16.0	5.7	70.3	11.2	13.1	77.6	23.9	3.1	15.3	12.7	10.3	8.7	39.3	6.5	12.5	12.5	46.5	2.2	8.8	9.5	5.3	5.9	11.4	44.3	18.5	23.2	31.8	13.7	6.0	3.0	25.4	4.5	2.2	5.9	4.1	42.2	22.4	0.0	14.1	1.9	9.4	16.0	18.5	11.2	5.4	36.1	14.7	0.2	40.6	38.6	4.6	31.0	0.1	2.0	24.4	7.4	35.3	13.4	7.7	7.8	35.4	36.9	4.8	11.1	4.0	0.0	42.8	0.0	20.0	0.1	0.0	21.1	22.3	30.1	43.0	187.6	17.7	27.7	10.8	32.1	32.2	3.9	5.6	3.4	13.7	1.1	13.1	16.7	6.1	0.0	8.1	4.4	2.9	0.0	0.0	0.0	7.1	0.0	3.4	0.5	4.4	7.3	0.0	0.0	1.0	4.8	0.1	3.0	0.0	0.0	2.2	1.0	37.4	40.0	41.4	51.2	38.2	55.7	67.4	46.6	70.3	39.3	46.5	44.3	4.1	38.5	17.5	205.7	5.3	18.5	25.1	25.9	4.6	308.6	10.9	11.0	121.9	22.8	53.9	12.9	308.6	15.3	36.2	30.0	9.8	27.8	108.4	78.1	30.2	5.5	24.0	2.5	189.9	41.3	100.8	17.2	36.2	27.7	13.4	92.7	12.8	44.2	3.8	138.0	221.0	28.7	22.4	2.5	2.2	79.9	3.1	2.4	14.2	23.4	7.8	112.3	25.7	124.1	160.3	37.2	20.0	2.6	30.7	37.5	20.7	53.3	193.9	186.1	0.0	26.1	17.4	57.2	24.0	30.5	30.7	59.1	33.5	17.7	29.3	21.7
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805384	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.5;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048213, HPA075670"	Enhanced		Supported	"Nuclear speckles"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA048213: AB_2680316, HPA075670: "	"unprognostic (3.71e-2)"	"prognostic favorable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	9.2	7.0	9.5	19.7	9.9	88.5	13.4	8.1	10.4	10.5	6.9	22.6	16.6	8.2	8.6	22.3	12.3	6.4	10.8	9.5	8.9	11.2	8.3	8.5	34.1	8.4	8.3	8.2	7.3	33.8	9.2	15.7	8.3	24.9	20.6	8.9	10.5	12.0	8.4	32.8	16.9	8.0	8.9	18.6	11.8	28.3	9.4	73.0	26.0	11.0	34.7	10.1	13.3	9.3	89.3	103.9	120.6	87.6	8.0	11.9	104.8	65.8	52.1	123.1	113.9	97.9	103.3	130.6	60.4	34.4	61.2	90.0	118.9	67.5	57.4	84.8	100.4	72.4	115.1	119.0	2.7	79.1	76.0	6.7	17.7	68.5	51.3	17.1	67.2	144.7	109.4	104.1	65.5	186.5	173.1	196.1	101.8	65.7	59.6	237.9	110.6	122.4	44.9	45.0	99.8	65.4	48.5	94.7	33.1	39.4	84.8	105.2	29.8	63.8	66.6	57.7	72.6	96.6	105.3	141.4	41.9	129.0	83.3	58.7	14.1	39.5	49.7	21.1	37.3	30.4	50.0	53.1	14.7	27.3	40.0	38.4	6.2	31.5	18.3	9.6	56.5	40.5	9.5	9.9	8.1	10.4	9.5	8.9	8.4	8.3	8.3	8.9	9.4	9.3	13.9	32.1	115.4	5.5	23.0	30.8	25.8	56.7	52.9	27.5	56.5	56.4	288.7	57.2	38.5	69.9	25.0	81.7	20.1	44.2	62.6	16.6	9.9	29.5	18.9	29.2	41.4	85.2	4.8	50.1	85.4	50.1	25.0	31.1	43.6	29.5	49.2	565.5	46.3	6.7	6.1	39.5	34.6	47.7	40.4	8.5	15.5	36.7	35.6	4.7	38.6	69.8	29.9	4.0	5.3	17.3	44.0	12.8	49.9	26.1	18.0	194.0	29.7	20.5	13.1	23.7	34.2	50.9	61.6	41.4	27.6	76.9	34.2	12.2	42.3	22.5
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF24	"bA571F15.4, C9orf48, FLJ10933, FLJ43884"	ENSG00000186638	"Kinesin family member 24"	Q5T7B8	9	34252381-34311371	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 32.3;Early spermatids: 28.9;Late spermatids: 41.6;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	19	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020643	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA020643: AB_2131749"	"unprognostic (2.68e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	0.2	0.6	0.7	0.9	1.0	2.1	0.7	0.6	0.7	0.6	4.4	0.9	0.6	0.6	1.4	0.9	3.2	0.4	0.5	0.8	0.8	0.9	0.3	0.6	1.3	1.9	2.3	0.4	0.5	1.5	1.0	0.6	1.3	0.4	1.0	0.4	0.3	0.5	0.7	0.9	0.6	0.7	1.5	0.3	0.6	11.1	0.8	3.9	1.2	0.6	1.6	0.3	0.4	0.8	9.8	6.4	7.5	6.2	0.6	1.0	2.8	5.3	3.4	7.0	8.4	3.1	3.0	7.6	1.6	2.5	4.5	4.5	7.6	4.6	7.2	4.9	3.3	3.5	10.7	1.9	0.2	7.2	5.3	0.4	0.9	9.1	3.8	1.3	3.2	5.3	3.6	6.0	3.9	4.0	8.7	6.7	3.0	4.5	3.8	8.0	4.6	2.1	2.9	2.5	3.5	3.4	6.5	3.3	0.9	2.9	3.6	3.5	2.6	6.5	7.1	5.1	6.5	1.7	2.9	4.1	4.4	3.5	8.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.6	0.7	0.8	0.8	1.9	2.3	1.3	1.5	0.8	0.8	0.3	0.0	1.1	32.3	0.7	0.4	0.2	0.7	0.6	0.3	0.7	1.1	0.9	1.5	1.6	1.8	0.0	0.6	0.3	0.7	0.0	0.4	28.9	8.2	0.8	0.4	0.0	3.0	7.2	0.2	1.0	0.7	2.0	0.8	0.0	1.5	0.0	0.0	0.7	0.0	3.5	0.8	2.0	0.3	0.3	41.6	0.9	0.4	0.0	3.7	0.1	0.2	0.0	10.1	9.2	0.2	0.0	1.9	2.1	0.1	0.3	0.4	11.0	0.4	0.0	0.5	0.4	14.5	6.9	1.0	0.9	0.3	0.3	0.8	0.7	0.1
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.1;brain: 4.2;retina: 2.5"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 165.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 2.0"					"Not detected"	"Not detected"			HPA046153	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	3.1	0.1	1.4	0.2	1.7	0.1	1.3	4.2	4.0	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.7	1.1	1.8	0.9	0.6	0.4	0.5	2.2	1.5	0.5	0.0	0.1	0.0	0.4	2.8	0.3	0.1	2.5	0.2	0.0	1.3	0.4	0.3	0.0	1.3	0.2	0.3	0.5	1.9	0.1	0.1	0.0	0.1	0.2	0.1	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.7	4.2	4.0	1.1	1.8	2.2	1.5	2.8	1.3	1.9	2.3	165.2	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	4.2	1.3	1.1	1.0	0.0	0.0	3.7	0.0	1.1	0.3	0.1	0.0	0.2	0.0	0.1	0.4	9.3	0.0	0.0	6.0	0.0	0.3	0.6	0.0	0.3	4.5	0.1	0.7	0.1	0.1	3.3	4.7	0.3	0.0	0.0	0.0	0.5	0.0	0.1	1.8	1.0	0.0	0.7	0.0	3.5	34.4	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.3	3.2	0.0	0.4	0.0	0.1	0.1	0.0	0.2
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	5.0	2.3	2.1	0.7	1.3	2.0	4.6	0.5	1.5	5.0	3.0	2.6	0.4	2.4	0.2	1.4	2.6	0.4	5.7	0.8	1.4	3.8	0.6	2.2	0.3	1.3	1.3	4.1	5.7	0.3	2.9	1.8	1.4	0.8	0.4	0.1	1.0	0.8	2.9	2.8	1.9	0.4	0.9	4.2	1.8	2.8	1.8	0.2	1.5	1.0	0.1	2.0	2.1	0.5	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.3	1.3	1.4	0.9	1.8	0.5	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709432	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2"	"Group enriched"	"Detected in many"	4	"Inhibitory neurons: 282.0;Oligodendrocyte precursor cells: 378.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.5;REH: 15.2;SH-SY5Y: 14.4;U-937: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.1	0.7	2.4	0.3	2.1	0.0	0.4	4.1	3.3	1.1	0.0	0.7	0.1	0.7	0.2	0.2	0.4	0.8	0.5	2.1	3.7	1.0	0.2	1.1	0.2	2.8	6.2	0.1	0.2	0.4	0.4	1.7	3.1	0.8	0.0	0.1	0.4	0.8	0.0	1.2	0.3	0.5	3.2	0.3	0.5	0.5	2.6	0.3	1.0	0.0	0.2	0.4	0.2	1.8	0.0	0.0	2.2	3.9	1.1	1.3	1.5	1.9	2.4	0.1	0.0	2.2	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.1	0.3	16.5	0.7	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	15.2	0.2	0.0	2.0	0.0	4.0	14.4	0.0	0.0	0.0	2.8	0.0	0.9	0.2	3.3	0.0	0.0	1.1	0.0	0.0	0.0	0.7	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.4	2.1	4.1	3.3	2.1	3.7	2.8	6.2	3.1	3.2	2.6	1.8	0.1	0.0	0.5	9.8	0.0	0.9	0.1	0.8	0.6	1.0	0.8	1.7	2.3	0.0	1.1	7.3	4.2	2.4	2.8	0.0	0.0	2.0	2.1	4.3	17.7	0.6	0.0	0.0	34.6	4.8	2.8	2.1	1.5	1.1	0.0	1.4	0.0	0.0	0.8	0.0	282.0	0.0	0.0	0.0	0.4	5.6	0.6	0.6	3.6	66.5	0.8	0.5	0.0	378.0	9.8	9.2	0.0	0.0	0.0	0.2	0.2	0.5	2.0	0.4	0.0	0.8	1.5	1.1	2.0	0.5	1.3	2.5	0.3	0.1	0.5	0.0
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822927-53825193	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	508	"testis: 75.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 744.0;Late spermatids: 623.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	744.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	623.2	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	10.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;retina: 33.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.7;Horizontal cells: 185.1;Inhibitory neurons: 157.0;Spermatocytes: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 68.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 68.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	2.6	8.0	14.3	3.8	15.2	1.6	5.0	9.7	26.3	4.4	0.0	3.4	2.5	4.7	5.0	3.3	7.0	4.0	4.6	16.5	16.7	5.8	1.4	4.5	3.9	12.6	13.1	5.1	2.7	11.8	11.3	3.2	17.6	5.1	2.6	33.9	2.8	4.8	2.5	4.0	2.0	4.5	1.3	2.8	3.7	21.5	8.2	6.0	5.4	3.1	3.7	3.8	3.0	13.8	10.6	12.6	11.4	20.8	7.7	7.8	9.4	8.9	7.0	8.2	10.9	13.0	8.0	29.7	11.6	10.4	24.8	7.2	9.6	17.6	17.2	8.6	10.2	4.3	6.9	4.7	7.9	5.3	11.4	5.8	8.6	12.1	14.0	11.4	10.4	18.8	4.8	15.3	10.1	7.9	34.5	4.2	5.5	3.8	4.8	8.8	9.2	3.2	8.4	9.4	36.2	11.9	12.0	4.3	14.4	18.6	12.8	1.6	10.9	10.1	15.9	7.3	10.6	11.5	19.6	16.4	12.9	4.4	11.1	68.2	0.6	1.9	6.3	1.5	6.9	6.7	6.5	6.1	1.3	4.0	6.4	7.0	0.6	4.8	2.0	1.2	5.4	2.0	14.3	15.2	9.7	26.3	16.5	16.7	12.6	13.1	17.6	1.3	8.2	13.8	10.9	54.5	38.0	65.3	12.0	13.6	15.6	25.5	12.5	76.5	13.7	18.7	29.9	11.5	31.7	38.6	125.1	14.6	18.4	0.8	29.4	20.5	86.2	69.7	20.4	11.3	19.8	3.4	178.7	12.9	11.5	16.8	5.6	23.7	13.9	24.6	13.2	2.4	6.2	185.1	157.0	3.8	54.9	3.5	7.7	25.0	16.4	4.8	42.7	21.5	5.4	47.0	5.2	122.6	100.7	12.4	4.6	24.5	14.4	7.6	1.1	10.8	121.0	99.6	13.1	23.8	40.5	147.1	102.6	9.0	15.9	9.9	23.6	27.7	2.1	6.0
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277651-32335011	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	12.2	14.0	25.1	11.1	25.4	8.5	12.1	18.2	25.5	14.5	34.6	18.7	19.9	11.6	17.5	7.7	20.5	14.9	8.1	30.3	20.8	35.4	17.8	12.9	11.5	20.8	22.7	13.5	23.0	46.7	17.3	8.5	18.8	11.7	19.0	30.8	11.1	10.9	8.4	7.8	24.1	12.1	22.4	9.9	17.6	22.2	26.9	8.2	19.2	5.6	11.9	11.4	8.5	21.4	49.9	33.2	22.6	29.1	29.3	46.3	23.0	24.2	33.7	28.7	22.4	56.9	26.7	26.7	28.4	45.8	40.8	31.4	29.3	35.8	36.3	12.7	13.3	23.1	25.6	28.2	18.6	19.6	16.9	28.6	25.2	49.5	19.5	23.5	23.7	10.7	14.5	10.4	23.4	22.8	9.1	8.9	12.2	26.5	28.8	8.3	37.1	9.7	29.2	36.1	37.0	31.1	63.2	16.7	24.7	18.9	36.8	15.1	28.9	53.4	36.4	31.4	30.2	17.3	26.5	13.5	53.2	33.7	22.2	0.7	1.5	1.9	3.2	2.2	2.6	3.2	2.4	3.0	0.9	3.1	1.4	2.2	1.6	1.4	3.2	1.5	2.0	1.0	25.1	25.4	18.2	25.5	30.3	20.8	20.8	22.7	18.8	22.4	26.9	21.4	10.6	22.4	23.4	11.1	12.2	6.6	8.5	12.8	13.6	32.4	14.1	10.7	9.2	40.0	15.0	12.9	106.3	8.1	10.8	67.9	3.9	34.4	67.1	48.5	21.3	16.8	39.4	6.3	31.4	39.1	6.3	14.2	20.9	31.3	8.2	13.7	13.9	28.7	8.1	32.0	37.7	26.3	14.2	7.7	5.5	88.2	13.4	9.0	0.0	8.4	10.9	19.2	8.2	10.1	11.4	32.4	33.4	20.3	16.3	12.1	82.4	23.7	59.1	63.6	0.0	21.0	11.7	33.4	7.4	10.7	5.1	6.6	12.4	17.6	27.3	9.3
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009015-32056425	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		97000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	59.7	41.8	110.0	46.7	128.2	84.9	45.3	107.7	149.7	47.3	75.6	66.4	52.0	54.1	30.3	52.7	39.2	59.8	87.4	85.8	100.2	44.7	31.9	52.5	39.9	121.9	123.8	27.6	41.8	91.6	22.9	54.4	120.6	65.9	63.6	45.1	39.1	52.0	65.0	38.9	54.7	81.3	128.1	48.1	51.4	64.4	116.8	44.0	50.5	67.3	36.6	60.8	29.8	143.4	115.8	96.4	127.3	89.9	89.2	97.7	54.4	155.6	73.3	117.6	99.6	106.6	124.0	78.7	65.8	185.8	66.9	93.3	117.6	99.4	156.4	68.4	64.1	100.2	87.9	104.5	102.5	70.5	105.6	79.9	138.0	135.8	94.0	93.4	152.8	68.2	122.9	80.5	164.7	69.7	74.0	39.7	20.7	110.1	43.4	95.7	237.2	32.6	90.6	79.5	123.3	89.9	120.4	47.5	117.3	88.0	57.5	99.4	128.4	118.7	111.0	139.3	117.2	24.2	29.8	90.9	113.2	142.2	114.1	41.8	25.9	44.0	19.1	33.0	18.7	23.7	24.0	20.6	24.7	24.3	21.1	20.8	51.1	24.3	35.7	47.9	29.4	18.4	110.0	128.2	107.7	149.7	85.8	100.2	121.9	123.8	120.6	128.1	116.8	143.4	160.3	182.7	206.8	49.3	86.3	213.1	177.7	200.6	66.0	181.9	119.0	103.8	396.0	115.8	198.4	104.8	100.1	121.0	125.5	145.0	45.0	209.4	185.5	167.8	171.4	181.0	132.3	69.2	44.6	176.0	134.9	141.2	85.6	158.9	91.2	159.7	88.5	46.2	132.7	151.4	56.0	227.3	213.6	111.8	129.1	51.8	59.0	137.2	101.4	84.3	169.3	160.5	82.4	61.9	83.3	202.2	164.9	130.9	84.2	254.1	120.2	59.5	206.1	123.8	85.5	176.0	244.8	566.0	195.6	87.6	236.7	331.9	116.0	137.4	208.1	246.8
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875227-149026759	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 252.2;Early spermatids: 568.4;Excitatory neurons: 267.2;Inhibitory neurons: 249.1;Late spermatids: 702.5;Oligodendrocytes: 270.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7;prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA035210: AB_10671931, HPA062272: AB_2732678"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	0.5	5.1	41.3	0.6	17.6	0.0	0.5	13.9	65.2	1.4	0.0	1.1	0.3	0.5	3.7	0.1	0.9	0.1	0.6	28.9	13.7	0.2	0.0	0.2	0.3	15.4	9.0	1.6	2.3	0.3	5.5	0.0	24.6	10.4	0.6	7.8	0.2	2.8	0.3	0.3	0.8	0.4	16.3	0.2	0.6	12.1	49.8	0.1	1.3	0.9	0.2	0.6	1.4	32.0	0.0	0.0	17.8	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.7	0.0	0.2	5.4	0.0	14.1	0.0	1.3	13.7	3.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.7	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	22.4	0.0	9.2	0.0	0.1	0.1	0.0	3.6	117.1	27.1	0.2	0.5	0.2	2.8	0.0	0.0	0.0	0.0	3.3	0.0	3.7	3.0	0.4	0.0	8.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	17.6	13.9	65.2	28.9	13.7	15.4	9.0	24.6	16.3	49.8	32.0	1.8	0.0	0.0	33.6	2.4	1.3	6.1	0.1	2.2	252.2	8.0	3.7	14.9	4.3	0.0	18.4	108.4	0.0	0.8	1.1	0.0	0.3	568.4	0.9	1.6	6.1	129.7	0.0	267.2	0.0	0.1	4.9	2.0	0.2	0.0	1.1	0.7	0.0	0.2	99.3	249.1	2.7	4.1	0.3	1.9	702.5	8.1	0.8	5.4	10.3	0.8	8.5	2.1	125.2	270.7	0.9	3.4	12.8	1.7	35.8	0.1	0.1	0.0	15.1	6.6	1.6	9.1	15.8	10.7	0.2	0.4	0.0	11.9	0.3	4.9	2.3
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725408	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.3;testis: 5.3"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 220.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 22.1;RPMI-8226: 9.2;SCLC-21H: 12.2;SK-MEL-30: 5.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"HPA038811, HPA058624"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	0.3	0.3	8.0	0.1	15.5	0.1	0.5	10.5	9.3	0.3	1.5	0.2	0.5	0.2	0.5	0.3	3.8	0.4	0.3	7.2	8.6	0.3	0.3	0.8	0.3	12.3	9.8	0.2	0.4	0.3	1.2	0.3	11.1	0.2	0.1	3.0	0.1	0.1	0.4	0.2	0.2	0.1	8.0	0.2	0.2	5.3	10.0	0.1	0.6	0.2	0.1	0.0	0.0	18.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.5	0.1	0.0	0.0	0.1	1.0	22.1	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.5	9.2	0.2	0.0	12.2	0.1	0.0	0.1	5.0	0.3	0.1	0.1	0.1	0.0	0.1	2.9	0.7	0.2	0.0	0.0	0.7	0.0	1.5	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.6	0.0	0.0	8.0	15.5	10.5	9.3	7.2	8.6	12.3	9.8	11.1	8.0	10.0	18.3	0.2	0.0	0.6	31.3	0.1	0.1	0.7	1.0	0.0	3.9	0.5	0.5	1.3	0.0	2.2	0.0	10.4	0.3	0.0	0.0	1.9	1.5	9.1	23.9	1.0	0.8	2.4	0.0	8.6	0.9	0.5	2.7	0.0	1.0	0.0	0.4	0.0	0.0	0.3	3.3	15.6	0.0	0.0	0.0	1.5	10.3	0.3	0.3	0.0	1.9	0.1	12.9	0.0	5.0	220.3	0.1	0.1	0.0	0.1	0.3	0.0	3.5	40.0	16.3	0.0	3.1	0.8	17.0	3.1	0.1	0.4	0.3	0.2	2.2	0.0	0.4
KIF7	JBTS12	ENSG00000166813	"Kinesin family member 7"	Q2M1P5	15	89608789-89655467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Repressor"	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.4;Oligodendrocyte precursor cells: 10.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043145	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043145: AB_10969200"	"unprognostic (9.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.74e-3)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.81e-1)"	"unprognostic (3.67e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-8)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.66e-1)"	6.8	3.2	2.0	1.3	1.7	0.2	5.4	1.4	1.7	8.3	3.3	5.6	0.6	7.0	0.5	1.9	7.6	1.2	5.4	1.6	1.7	2.4	0.9	2.2	1.2	1.9	2.0	9.1	1.1	2.2	4.2	1.0	1.8	6.6	0.4	0.2	2.5	2.4	1.3	2.3	3.0	1.4	1.5	2.2	3.4	1.8	2.0	1.0	4.9	0.4	0.3	7.0	4.9	1.1	0.4	2.7	3.9	9.8	9.8	3.6	6.9	15.5	4.9	8.4	6.8	5.4	3.4	0.0	4.0	11.2	2.2	3.7	3.8	0.0	2.0	0.0	15.5	3.5	10.4	6.0	9.3	0.0	0.1	6.7	1.9	5.1	0.0	1.5	3.6	7.9	2.7	0.1	2.9	0.8	5.3	0.5	9.4	0.1	2.4	0.1	0.3	0.0	0.1	1.5	2.2	5.7	16.5	0.2	6.1	2.1	1.8	1.1	7.6	13.5	11.0	33.9	7.3	6.7	2.5	0.0	13.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	1.4	1.7	1.6	1.7	1.9	2.0	1.8	1.5	2.0	1.1	0.5	0.0	0.0	14.4	0.0	0.3	1.0	0.5	2.2	0.9	1.8	1.8	5.4	0.0	0.2	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.5	0.5	4.0	2.1	0.0	0.8	2.9	0.4	0.2	4.3	1.5	0.6	0.0	4.8	1.4	0.1	0.1	0.0	4.5	0.4	0.0	0.0	0.4	0.4	5.6	0.1	0.0	5.6	0.0	1.2	0.0	10.1	0.3	0.1	0.1	4.1	0.0	1.3	0.0	0.3	0.1	0.2	6.6	3.2	3.7	0.7	1.4	0.3	0.4	0.3	0.4	4.2	0.4	0.8
KIF9	MGC104186	ENSG00000088727	"Kinesin family member 9"	Q9HAQ2	3	47228395-47283451	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022031, HPA022033, HPA030429"	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921"	"unprognostic (1.93e-2)"	"unprognostic (6.37e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.17e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.95e-6)"	"unprognostic (4.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.23e-1)"	6.5	7.4	9.3	3.1	10.1	11.8	10.6	8.8	14.4	7.6	23.1	9.1	6.1	7.9	20.5	5.8	26.3	6.4	14.1	10.1	9.8	26.8	6.0	8.6	2.6	12.0	12.9	5.0	12.7	10.1	16.4	3.7	11.4	7.7	8.1	18.7	8.9	4.8	9.4	8.4	5.6	4.5	11.0	5.7	9.3	64.4	10.0	2.3	21.0	5.7	3.1	6.8	5.4	9.5	19.4	21.7	7.6	19.1	3.6	8.7	6.2	5.9	6.1	8.8	7.8	8.4	23.0	12.8	7.3	7.6	11.8	12.0	22.6	15.3	8.7	6.6	14.6	11.9	16.5	26.9	3.4	25.3	3.8	4.5	15.3	12.8	9.6	7.4	19.0	13.5	26.5	5.1	6.6	15.5	13.7	37.6	21.7	44.4	30.5	8.6	5.3	18.3	36.7	10.9	10.8	19.9	6.8	13.0	21.8	3.9	8.4	17.6	9.0	5.1	11.0	8.3	13.6	4.4	19.7	16.1	18.9	25.1	11.3	2.5	3.6	2.1	1.5	2.6	3.0	3.5	1.4	2.3	5.7	0.6	1.7	1.9	6.3	3.5	2.3	3.3	1.0	1.3	9.3	10.1	8.8	14.4	10.1	9.8	12.0	12.9	11.4	11.0	10.0	9.5	34.5	19.2	18.4	4.2	6.7	20.1	53.7	44.3	20.5	7.2	61.4	74.5	28.2	38.6	51.9	64.4	35.5	10.7	7.5	23.8	109.5	45.5	690.3	398.0	17.8	29.3	58.9	20.0	16.6	32.7	11.1	12.1	34.1	38.5	29.1	11.3	17.9	20.7	9.2	5.0	10.3	40.1	52.9	7.2	7.1	160.6	14.0	8.0	16.0	2.8	3.8	17.2	3.1	2.5	3.2	26.0	15.7	13.2	5.7	37.6	15.1	198.1	359.0	44.0	13.1	42.2	16.7	328.8	37.3	17.2	20.2	8.2	7.8	21.8	37.8	37.4
KIFAP3	"FLA3, KAP-1, KAP3, SMAP"	ENSG00000075945	"Kinesin associated protein 3"	Q92845	1	169921326-170085208	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 193.9;Excitatory neurons: 190.5;Inhibitory neurons: 192.4;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023738, HPA023742"	Supported		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA023738: AB_1857285, HPA023742: AB_1857286"	"unprognostic (5.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.22e-2)"	17.8	34.8	46.8	11.9	50.0	6.9	16.4	37.4	60.0	18.8	27.7	19.9	11.6	17.3	23.3	12.6	19.4	15.4	51.1	50.8	55.7	23.5	16.6	15.4	13.1	50.0	43.3	19.2	14.0	27.1	29.1	14.5	52.0	14.4	15.9	56.4	13.0	16.2	22.4	14.1	14.5	15.6	39.2	10.8	10.0	35.1	44.2	18.8	16.7	23.1	13.9	13.5	18.1	49.9	13.0	11.8	17.6	19.0	41.0	43.2	9.9	16.1	19.9	19.7	24.2	5.8	20.5	23.2	23.1	33.3	9.1	27.6	37.7	22.6	18.5	49.3	19.9	56.3	13.8	5.3	20.4	16.6	9.4	30.5	30.3	34.7	30.1	23.3	22.6	29.5	47.7	17.1	24.9	3.5	31.2	9.8	3.8	33.7	10.7	12.3	15.5	14.8	37.2	4.8	20.8	32.0	22.1	17.9	25.1	40.5	16.7	10.4	24.1	42.0	9.7	26.7	19.5	33.0	23.9	21.2	19.6	6.0	27.3	16.8	3.8	14.8	13.0	10.6	15.0	7.5	13.2	14.9	8.8	7.6	14.9	15.3	1.4	22.3	19.3	7.6	18.6	8.4	46.8	50.0	37.4	60.0	50.8	55.7	50.0	43.3	52.0	39.2	44.2	49.9	33.2	32.1	27.8	64.6	14.4	9.1	11.9	12.3	12.0	56.5	13.8	18.2	37.3	28.6	27.6	29.5	43.8	14.2	22.8	14.5	9.8	25.9	193.9	51.5	35.4	20.9	32.2	25.9	190.5	8.2	16.0	32.4	9.2	25.5	31.0	15.5	12.8	13.6	9.8	48.8	192.4	12.5	24.4	13.4	5.9	200.7	38.5	17.1	10.6	51.5	8.6	42.7	29.9	84.4	65.0	12.0	9.4	21.8	27.8	4.9	13.2	37.3	64.3	70.7	0.0	34.5	31.1	77.8	64.0	14.6	10.7	8.8	20.3	17.4	17.0	9.9
KIFBP	"DKFZP586B0923, KBP, KIAA1279, KIF1BP, TTC20"	ENSG00000198954	"Kinesin family binding protein"	Q96EK5	10	68988803-69043544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.5;Cardiomyocytes: 40.7;Cytotrophoblasts: 21.7;Extravillous trophoblasts: 19.5;Fibroblasts: 8.7;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035538, HPA035539"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA035538: AB_10601130, HPA035539: AB_2674676"	"unprognostic (4.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.23e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (6.23e-3)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.19e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	19.9	22.1	21.3	6.7	24.4	1.3	11.2	24.4	32.5	14.0	19.7	11.9	6.4	12.5	15.9	12.2	11.8	12.6	37.3	24.6	23.8	19.5	13.8	9.9	6.7	23.9	22.2	12.3	8.5	33.8	13.6	14.8	24.5	16.6	10.3	25.7	9.8	17.3	30.4	8.7	8.1	15.3	25.7	7.5	11.4	16.2	22.7	7.6	19.2	43.3	9.2	15.2	9.3	28.1	49.1	36.9	33.3	36.1	48.3	42.5	0.2	63.2	58.0	63.4	71.9	40.4	24.7	0.1	20.7	57.3	39.5	40.2	57.0	37.9	63.6	27.5	48.8	9.5	22.0	24.0	32.4	13.3	11.5	26.4	30.4	42.3	37.7	60.5	46.6	15.1	13.1	14.0	78.4	23.3	13.0	15.8	20.7	25.4	84.1	15.5	27.7	7.2	67.4	12.4	25.0	18.1	36.0	48.9	34.8	32.2	60.3	10.2	46.3	28.0	25.7	24.6	64.0	2.8	0.3	9.0	35.9	19.8	15.7	1.8	4.3	2.4	7.3	7.5	8.8	5.1	8.4	7.2	5.5	4.1	9.6	7.8	1.6	6.9	12.9	2.8	8.0	5.0	21.3	24.4	24.4	32.5	24.6	23.8	23.9	22.2	24.5	25.7	22.7	28.1	9.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.0	0.0	21.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	19.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	8.3	0.9	0.0	0.0	0.0
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 59.8;Gastric mucus-secreting cells: 38.7;Inhibitory neurons: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	12.3	17.2	68.7	6.2	78.3	7.2	14.0	58.3	113.7	24.5	33.2	26.5	11.9	11.4	6.7	45.0	15.3	6.1	10.1	74.7	42.9	32.9	20.6	17.2	7.3	54.9	41.1	13.0	24.9	9.6	45.0	3.2	54.6	31.5	6.3	3.8	19.1	8.0	4.2	75.0	24.4	2.5	35.7	27.6	19.7	25.8	46.4	5.4	24.2	1.7	4.8	22.2	31.8	63.9	13.5	12.7	6.1	13.2	8.7	5.2	13.2	5.3	6.4	4.7	4.6	4.9	18.1	11.6	3.6	5.0	7.9	24.2	6.1	8.1	2.0	10.2	3.7	8.6	34.5	6.6	11.1	2.6	23.4	6.7	28.3	4.7	6.1	21.8	3.0	14.7	7.0	15.9	3.6	25.4	10.3	7.1	0.9	16.5	15.2	24.1	0.3	8.8	19.9	23.1	18.4	16.4	6.2	19.3	6.9	4.3	50.4	5.0	7.6	9.0	22.9	9.4	7.7	6.3	2.9	3.9	17.6	12.3	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	78.3	58.3	113.7	74.7	42.9	54.9	41.1	54.6	35.7	46.4	63.9	3.7	9.6	11.3	35.3	4.9	6.0	3.0	2.1	6.2	16.2	7.9	5.8	0.8	7.2	5.2	14.7	6.2	2.0	12.1	29.1	1.9	3.5	13.2	6.8	4.4	2.0	23.4	3.2	59.8	1.4	2.0	2.0	38.7	13.8	8.2	3.3	2.5	8.7	2.7	15.2	39.7	12.2	0.0	5.3	9.1	8.0	7.8	6.4	3.6	12.2	3.5	7.5	3.1	8.5	6.9	2.2	18.5	3.0	7.0	3.4	11.3	5.1	4.5	4.6	0.0	1.8	2.9	7.3	7.5	10.6	11.4	3.0	8.0	6.6	18.0	3.3
KIFC3		ENSG00000140859	"Kinesin family member C3"	Q9BVG8	16	57758217-57863053	"Cancer-related genes, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 169.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Early spermatids: 203.7;Late spermatids: 430.5;Rod photoreceptor cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"A549: 215.1;HMC-1: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021240	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA021240: AB_1852509"	"unprognostic (1.53e-1)"	"unprognostic (3.10e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.33e-2)"	30.5	29.0	25.4	25.9	16.6	14.5	23.8	28.2	35.9	22.7	13.4	21.0	30.7	22.2	30.1	26.2	14.8	21.1	62.7	21.2	38.5	169.2	85.6	45.4	13.5	25.7	14.2	19.0	76.6	26.1	30.9	25.6	29.9	26.3	13.4	82.3	22.1	22.3	13.7	80.0	37.4	13.0	7.3	21.2	24.5	64.9	35.0	4.1	68.1	6.6	9.6	30.3	24.4	46.4	41.5	215.1	15.2	32.8	4.9	10.4	26.8	51.1	65.1	76.4	36.3	58.2	62.6	4.4	64.5	32.8	79.3	43.2	1.8	47.1	25.6	2.1	10.2	34.6	72.9	75.8	28.8	5.0	204.7	14.2	16.6	40.3	40.5	39.1	18.4	11.9	61.7	7.4	28.6	28.2	7.4	60.9	10.3	16.2	45.6	4.6	23.1	33.0	48.9	21.3	5.3	10.7	86.8	60.7	55.8	10.5	18.2	26.0	39.9	98.4	69.3	45.3	71.5	5.9	3.7	4.3	49.9	3.3	94.7	0.1	0.2	0.2	1.5	0.0	0.1	0.7	0.6	1.5	0.1	0.5	0.3	0.4	0.5	0.1	0.7	0.1	0.0	0.6	25.4	16.6	28.2	35.9	21.2	38.5	25.7	14.2	29.9	7.3	35.0	46.4	40.0	48.1	33.3	28.4	0.5	12.6	12.3	8.1	5.7	5.7	5.0	7.4	8.4	38.6	15.3	66.2	141.8	31.8	9.2	0.1	50.9	50.6	203.7	18.5	4.8	25.3	0.0	4.8	15.8	63.6	6.4	11.8	2.0	15.6	3.8	0.9	25.4	16.6	25.7	1.7	14.8	2.1	2.0	6.6	10.2	430.5	12.2	24.7	28.4	16.9	1.1	10.6	15.5	27.2	28.9	67.1	1.2	22.6	0.8	13.8	34.7	51.4	14.9	165.5	19.7	10.3	16.5	7.7	9.9	1.0	8.2	19.4	5.8	10.5	0.9	7.9
KIRREL1	"KIRREL, NEPH1"	ENSG00000183853	"Kirre like nephrin family adhesion molecule 1"	Q96J84	1	157993273-158100262	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.2;Alveolar cells type 1: 19.2;Breast myoepithelial cells: 6.9;Endometrial stromal cells: 19.4;Fibroblasts: 7.2;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 169.8;WM-115: 262.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030458	Approved					NA	NA		890000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"			"HPA030458: AB_10601438"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.76e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (2.11e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.85e-4)"	23.3	13.4	3.2	11.9	2.7	0.1	18.0	3.9	3.0	16.0	8.7	16.8	3.8	22.2	5.0	7.9	17.4	21.3	10.3	1.7	2.9	15.2	2.8	16.8	4.4	3.1	4.4	22.7	4.2	3.2	4.8	27.5	3.0	9.9	8.1	5.9	8.2	16.7	3.7	7.7	8.6	25.0	3.8	8.7	7.7	3.0	4.0	4.6	10.6	5.9	3.6	14.1	10.6	1.4	24.7	31.4	67.2	56.2	100.6	82.4	0.0	65.1	87.7	50.9	42.2	59.3	49.0	0.0	101.0	75.8	36.2	45.5	38.9	56.8	47.9	0.2	7.6	0.1	34.8	0.0	70.6	0.0	0.6	104.2	25.0	84.4	74.9	71.9	33.5	15.4	0.5	0.3	54.1	0.1	9.1	0.1	49.2	0.0	26.4	9.2	30.5	0.4	169.8	0.9	9.6	0.7	55.3	0.2	114.6	75.3	4.4	1.3	59.9	64.5	40.5	64.5	86.5	0.1	0.3	0.3	56.1	0.2	262.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.7	3.9	3.0	1.7	2.9	3.1	4.4	3.0	3.8	4.0	1.4	6.2	19.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.9	4.7	0.0	1.7	19.4	2.4	0.0	0.0	0.0	0.4	0.2	7.2	0.0	3.6	0.0	4.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.4	0.1	5.0	0.0	0.0
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.0"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.5	0.0	0.5	0.2	1.4	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.8	0.4	0.4	0.0	70.0	0.0	0.9	0.1	0.4	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.3	1.0	0.8	0.1	0.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423358-127003460	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 21.5"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	0.2	1.4	17.3	0.5	21.5	0.3	0.1	4.9	19.9	0.6	0.0	3.8	0.4	0.1	0.0	0.4	0.1	0.2	2.1	15.5	8.5	0.2	0.1	0.0	0.6	12.2	14.6	0.5	0.2	0.0	0.1	0.3	7.6	0.3	0.4	2.5	1.4	1.1	0.0	0.1	0.8	0.5	14.0	2.5	0.6	0.2	16.0	0.0	0.1	0.2	0.4	0.6	0.3	17.8	0.4	3.0	0.2	0.0	0.0	0.1	0.2	25.2	14.7	9.3	9.7	0.0	0.1	0.0	0.1	18.3	0.1	0.1	0.0	0.0	5.7	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.7	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	6.1	0.2	0.4	0.5	0.0	0.0	1.3	0.0	0.1	2.8	0.2	0.1	0.2	0.0	0.0	0.1	0.4	0.0	11.3	7.8	4.5	14.1	0.0	0.0	0.0	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	17.3	21.5	4.9	19.9	15.5	8.5	12.2	14.6	7.6	14.0	16.0	17.8	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.2	0.0	17.3	0.1	0.1	2.2	1.5	0.4	0.0	0.0	0.0	5.4	0.9	0.0	0.1	5.2	0.0	0.1	0.2	0.0	0.0	274.4	0.0	0.0	0.5	0.0	0.1	1.3	0.3	0.4	0.0	0.0	0.0	482.6	0.4	2.0	0.0	0.3	12.9	0.0	0.2	1.8	18.7	0.1	0.5	0.0	23.1	390.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196491	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"placenta: 233.1"	"Cell type enriched"	"Detected in many"	26	"Syncytiotrophoblasts: 1336.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	6	"hypothalamus: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"BJ: 145.5;U-2 OS: 59.4"					"Not detected"	"Not detected"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA		860000		"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.0	0.0	0.4	0.0	0.8	0.0	0.1	0.6	0.6	0.3	0.8	0.2	0.9	0.2	0.0	0.1	0.1	0.0	0.1	0.4	10.7	2.4	4.3	1.3	0.0	1.8	0.3	0.0	1.0	0.0	3.1	233.1	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.2	0.2	2.0	3.2	5.2	1.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.4	145.5	1.8	2.5	0.7	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.2	0.0	0.2	0.1	0.0	0.0	0.9	0.2	0.1	0.0	0.7	0.0	0.8	0.2	0.3	0.0	0.1	59.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.6	0.6	0.4	10.7	1.8	0.3	0.4	0.2	1.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	4.0	7.5	0.0	1.0	1.2	0.6	0.0	1.5	2.2	0.0	0.0	9.3	0.0	1.5	0.0	11.3	40.2	0.2	0.0	1.4	0.0	0.0	0.1	4.9	6.9	1.9	4.1	0.5	0.0	0.4	0.7	2.8	15.1	0.0	0.0	0.6	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.5	0.0	0.1	50.1	17.0	1.4	0.4	0.0	0.0	0.0	7.1	0.6	1.1	0.0	0.0	1336.6	0.1	0.1	2.1	14.3
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921005	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 41.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.0	0.0	2.9	0.1	1.8	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	3.8	0.3	0.1	0.1	0.1	4.0	2.2	0.0	1.3	0.3	1.1	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	4.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.7	0.0	0.0	0.3	0.1	0.0	0.6	1.2	0.4	1.0	0.0	37.4	0.0	0.0	7.4	20.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.9	1.8	0.9	3.4	1.3	3.8	4.0	2.2	3.9	1.0	8.5	0.8	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.5	0.0	1.1	1.2	1.4	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	41.9	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.8	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	4.2	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.3	0.3	1.6	0.9	0.2	0.1	0.2
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Collecting duct cells: 69.9;Excitatory neurons: 46.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 299.8;SK-BR-3: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		260000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA070395: AB_2686264"	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	13.2	3.9	2.3	8.2	3.5	0.3	10.6	0.2	3.1	12.9	1.2	18.7	9.6	15.1	2.8	14.3	4.0	18.5	7.0	2.9	0.3	16.0	2.3	31.6	3.3	0.0	2.5	6.0	3.7	3.7	0.2	15.0	0.0	15.1	22.6	2.3	8.8	14.8	3.1	7.1	11.6	18.8	0.3	3.5	17.4	6.3	5.2	5.1	5.9	14.4	10.4	12.3	1.3	6.2	14.3	7.1	7.1	0.9	29.0	61.5	0.0	77.6	60.1	13.5	6.4	299.8	11.0	0.0	2.2	73.3	14.9	49.5	11.5	20.1	14.2	0.1	9.5	0.0	9.5	2.6	4.4	1.9	0.0	53.5	20.6	41.6	26.8	6.3	17.9	0.0	0.0	0.3	6.8	2.5	0.2	0.0	4.8	17.7	17.9	0.0	12.6	0.0	25.0	6.5	2.3	4.8	18.5	118.9	2.2	6.5	57.2	4.3	10.0	60.7	7.4	69.0	6.8	0.0	0.0	0.0	8.4	0.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.2	3.1	2.9	0.3	0.0	2.5	0.0	0.3	5.2	6.2	42.5	19.2	38.3	9.4	0.5	13.5	11.2	7.5	83.6	2.7	12.2	8.1	4.4	1.5	16.5	69.9	0.0	0.1	0.0	12.0	1.9	4.4	0.4	3.1	6.8	43.1	9.5	0.0	46.5	18.2	0.1	34.5	43.3	3.4	0.0	2.1	5.0	0.4	1.2	21.9	61.4	8.5	18.3	3.2	5.7	0.9	14.0	1.9	12.4	18.7	0.0	0.3	0.0	3.0	0.6	8.7	3.0	3.8	1.4	11.2	2.3	1.4	9.8	1.2	13.1	2.2	27.2	0.2	0.5	18.5	5.3	0.0	1.0	4.4	14.7	3.2
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.6;liver: 17.7;pancreas: 6.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000	"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.6	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	17.7	1.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.3	2.8	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 397.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009798, HPA044617, HPA052450"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		14000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	70.8	49.4	282.9	42.2	302.0	50.3	63.0	273.5	358.7	74.8	220.4	89.9	26.2	71.5	43.9	66.0	65.0	38.4	100.0	310.6	299.8	35.6	29.9	66.0	44.2	378.9	305.0	62.8	43.0	48.5	86.7	45.9	397.0	47.1	34.3	158.6	54.2	47.1	123.4	68.2	48.7	58.0	300.0	49.0	53.9	45.6	301.7	40.2	48.6	71.5	47.4	66.5	69.8	304.0	57.0	74.2	138.6	76.3	92.6	102.8	65.5	129.5	105.4	118.6	81.7	64.0	60.8	75.8	65.2	139.3	53.2	93.0	85.8	69.6	112.0	89.9	43.9	41.6	92.8	66.1	106.8	83.4	79.5	73.4	109.3	89.6	112.1	126.5	104.2	52.8	63.5	83.7	104.4	94.6	56.9	74.0	45.6	90.1	140.4	53.0	60.6	38.2	74.7	122.5	165.1	93.5	105.7	52.7	90.2	85.9	47.9	40.1	152.7	88.4	43.5	123.1	74.1	65.9	50.0	83.3	101.7	47.7	97.0	5.5	4.6	9.8	7.3	4.6	6.6	5.0	6.5	7.8	5.1	6.8	5.7	5.0	5.0	3.1	6.5	7.6	7.0	2.9	282.9	302.0	273.5	358.7	310.6	299.8	378.9	305.0	397.0	300.0	301.7	304.0	45.2	44.8	32.6	92.4	24.3	26.0	45.1	30.1	13.6	140.8	18.7	19.7	39.3	15.7	21.5	20.2	52.1	22.6	29.5	17.9	9.8	42.9	8.0	30.8	41.8	45.5	44.9	13.2	84.1	30.7	30.6	37.4	27.0	43.2	33.6	31.5	39.3	18.9	30.5	138.0	80.8	24.3	28.5	19.9	23.8	17.0	38.5	24.4	39.2	73.1	36.3	45.4	20.6	57.3	89.8	71.2	17.3	48.2	26.2	46.6	15.8	5.1	23.8	106.1	26.3	46.4	46.8	64.8	83.3	20.1	17.6	42.1	30.8	17.1	17.5	38.4
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	15.2	18.0	18.8	9.5	25.4	3.6	15.9	33.0	78.1	27.3	0.0	28.5	9.8	27.1	6.3	18.2	21.6	8.9	32.1	26.6	12.7	22.4	8.2	18.9	9.1	39.8	10.8	24.6	15.5	15.2	48.3	7.2	37.0	28.7	4.7	28.4	15.9	16.0	57.8	18.3	16.3	11.2	5.7	13.7	20.2	32.2	23.1	25.1	17.7	14.2	6.4	27.2	21.7	35.8	49.4	58.2	28.3	16.9	16.9	13.5	21.9	34.1	24.2	34.2	26.1	31.9	14.3	21.3	31.9	25.6	43.9	40.7	29.3	33.2	11.4	35.7	37.2	4.4	48.0	22.4	32.1	9.9	22.7	13.5	42.7	40.1	32.8	22.0	16.1	26.2	24.1	29.0	27.8	69.2	56.8	15.0	27.8	14.2	49.2	21.4	14.6	30.1	27.2	27.4	76.3	37.5	24.6	22.1	41.3	15.7	36.3	6.7	26.8	55.5	49.8	68.2	45.5	30.7	27.4	11.9	39.3	6.7	22.9	0.0	0.2	0.5	2.4	0.1	3.1	1.9	1.1	1.6	0.3	3.2	1.1	1.4	0.3	1.3	0.2	2.1	0.3	1.1	18.8	25.4	33.0	78.1	26.6	12.7	39.8	10.8	37.0	5.7	23.1	35.8	4.0	3.2	1.5	8.8	8.9	8.9	9.2	11.1	7.4	34.4	10.1	7.2	2.4	7.2	5.5	12.9	12.5	9.9	5.1	3.1	13.7	14.8	10.1	7.7	6.2	5.2	37.1	0.8	20.7	8.2	18.2	6.5	13.7	9.7	0.0	8.6	3.9	2.3	3.1	55.5	19.0	7.2	18.3	3.2	4.0	4.6	8.7	2.8	12.4	5.6	6.3	14.6	4.1	4.0	6.2	19.1	4.9	13.9	9.1	18.2	3.9	10.3	7.3	35.2	0.0	9.5	13.3	26.2	29.8	8.9	9.7	12.7	8.2	3.4	4.9	8.5
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.1;skin 1: 104.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 142.0;Basal prostatic cells: 50.8;Ductal cells: 39.1;Prostatic glandular cells: 66.9;Suprabasal keratinocytes: 183.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 36.1;HaCaT: 16.2;HBEC3-KT: 10.5;hTCEpi: 12.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Actin filaments"	"Nucleoplasm, Cytosol"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.3	0.2	0.5	0.3	1.1	3.0	3.3	1.3	0.8	10.0	0.0	0.1	0.1	0.2	2.1	26.1	0.3	0.2	0.2	0.4	0.2	5.9	0.2	0.9	0.3	0.5	0.0	0.2	4.0	4.0	2.7	0.2	0.2	2.6	0.2	1.0	11.6	1.0	0.9	104.1	0.3	0.0	0.0	0.3	0.5	3.7	0.2	1.0	0.7	0.0	1.8	0.2	20.5	0.7	36.1	0.2	0.2	0.4	0.1	0.1	2.8	0.2	0.0	0.0	0.1	3.5	6.5	0.3	2.8	0.0	3.7	16.2	2.2	10.5	0.2	0.8	5.3	0.1	1.1	0.7	0.0	0.3	2.2	0.0	12.9	0.1	2.5	0.4	0.0	0.5	0.6	0.4	0.1	4.7	0.1	0.4	0.8	0.6	1.1	5.6	0.0	0.3	0.3	1.3	4.5	0.7	0.3	7.3	1.0	0.4	6.5	0.1	0.0	0.4	3.6	0.3	0.4	0.7	0.8	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.0	0.5	1.1	1.3	0.8	0.4	0.2	0.5	0.0	0.2	0.0	0.2	0.7	0.2	0.0	2.4	0.3	0.0	142.0	50.8	17.5	14.8	0.8	10.3	25.3	0.4	2.8	7.3	1.8	0.0	0.2	0.2	0.2	9.8	39.1	3.0	0.9	0.3	1.7	0.0	2.7	0.3	3.1	0.7	1.4	0.0	2.4	0.0	6.7	0.4	0.0	0.3	1.7	0.4	0.5	6.1	0.0	10.9	12.0	1.8	0.4	14.2	0.0	0.8	0.7	0.0	0.0	0.0	11.8	0.0	0.4	0.0	66.9	0.0	1.4	3.8	2.0	0.0	1.1	2.5	0.6	11.3	25.6	183.3	0.7	1.0	0.0	0.1	22.0
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 81.9;Hepatocytes: 67.8;Paneth cells: 70.4;Proximal enterocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	12.3	17.2	18.8	11.2	19.6	12.4	13.4	21.8	22.8	16.6	18.6	41.1	72.5	15.1	23.0	10.9	17.7	17.9	25.1	18.7	19.0	24.2	89.9	16.5	13.5	21.2	19.2	19.7	17.8	28.7	24.1	12.2	21.2	17.0	34.2	23.8	19.9	15.8	22.9	17.5	63.7	14.0	17.5	12.5	31.8	24.8	19.6	17.1	19.7	22.8	11.1	17.3	12.9	20.9	7.5	6.0	15.9	18.9	15.0	14.7	13.7	5.5	8.5	9.5	15.6	9.8	11.5	9.9	19.7	13.4	12.6	12.3	15.8	14.9	7.2	10.0	19.1	11.4	18.2	44.0	14.5	5.4	9.1	19.3	18.2	11.8	10.8	29.8	12.1	20.5	7.9	12.8	8.0	13.0	16.2	12.2	6.1	65.4	7.9	12.6	9.0	19.3	14.3	6.5	26.7	12.8	10.3	9.6	20.3	14.9	16.4	15.0	10.2	10.6	12.8	5.4	5.9	25.8	9.9	24.1	5.8	8.5	3.9	2.6	2.6	3.2	2.6	2.6	3.4	3.7	3.7	2.5	3.0	3.2	4.5	3.3	6.5	4.9	2.6	8.7	4.5	2.3	18.8	19.6	21.8	22.8	18.7	19.0	21.2	19.2	21.2	17.5	19.6	20.9	4.1	16.0	14.4	23.5	4.3	3.7	9.2	12.5	15.9	21.8	8.0	8.8	10.6	20.0	10.8	14.7	29.2	11.8	11.4	81.9	19.6	8.7	13.4	8.9	3.8	5.8	22.3	9.3	17.2	9.8	4.9	5.9	33.6	7.9	7.0	12.2	7.5	67.8	6.5	11.8	24.2	35.3	10.2	5.7	2.9	6.5	10.2	3.6	3.6	6.5	5.3	16.3	4.1	10.6	9.7	7.6	70.4	6.8	7.4	5.0	143.4	23.5	19.0	28.0	13.1	6.0	5.5	27.3	15.6	9.4	4.5	13.5	5.3	6.2	44.0	6.6
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"bone marrow: 41.2"	"Cell type enriched"	"Detected in some"	199	"Erythroid cells: 519.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.9"	"Group enriched"	"Detected in some"	29	"HEL: 61.6;K-562: 150.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.1	0.0	0.1	41.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	61.6	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	150.5	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.1	0.1
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 319.3;Excitatory neurons: 211.9;Inhibitory neurons: 562.2;Microglial cells: 208.9;Oligodendrocyte precursor cells: 760.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA064146: AB_2685198, HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.9	1.9	4.1	6.1	2.9	3.0	2.9	5.5	5.3	2.3	2.7	3.7	1.5	3.6	11.2	2.0	2.8	3.0	5.3	5.6	4.5	5.5	9.9	2.6	11.3	3.3	4.9	5.2	0.9	0.8	3.4	0.8	3.6	2.5	2.9	8.9	1.4	3.2	3.6	1.6	3.6	3.4	3.1	7.6	2.7	1.6	5.1	10.3	1.6	8.5	9.8	2.6	2.0	3.5	0.0	1.4	13.6	0.0	7.5	16.3	0.1	5.4	2.7	5.9	6.2	1.1	3.4	10.5	2.5	8.1	2.3	3.7	3.6	4.2	15.7	6.9	4.9	0.4	6.3	0.0	2.4	7.0	2.5	14.3	1.1	8.4	6.7	11.4	11.9	8.0	0.0	2.6	18.0	1.1	13.6	0.0	1.9	0.5	2.7	7.4	4.9	0.1	3.3	0.2	3.2	13.8	3.8	1.7	6.3	5.0	0.4	1.1	0.1	11.4	3.5	5.2	2.6	7.0	9.6	3.3	20.2	0.0	5.9	0.6	0.0	0.0	2.0	0.2	2.4	0.8	1.7	2.3	0.2	0.7	1.2	1.9	0.0	1.4	0.3	0.4	0.9	0.8	4.1	2.9	5.5	5.3	5.6	4.5	3.3	4.9	3.6	3.1	5.1	3.5	6.6	6.4	1.8	319.3	30.5	4.2	1.3	4.3	0.6	20.8	5.4	6.2	18.7	5.7	3.7	3.7	37.5	0.1	35.4	3.0	3.9	2.1	0.8	4.6	18.8	8.4	0.0	7.8	211.9	0.0	0.1	12.3	2.0	6.3	0.0	29.2	5.0	20.3	0.1	8.4	562.2	1.5	10.2	8.0	12.1	1.6	20.8	5.0	3.6	208.9	6.4	11.2	43.3	760.0	25.4	0.4	3.2	28.6	21.9	3.3	0.2	7.0	6.0	13.1	0.0	12.2	18.1	0.5	3.5	0.7	6.7	0.1	40.3	4.9	3.9	1.8
KLF14	BTEB5	ENSG00000266265	"Kruppel like factor 14"	Q8TD94	7	130730697-130734207	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.1;testis: 1.0"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 1.8;Early spermatids: 4.1;Late spermatids: 4.1"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.0;RH-30: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044729	Uncertain					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"			"HPA044729: AB_10960356"	"unprognostic (4.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.92e-1)"		"unprognostic (9.90e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	0.6	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357408	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	36.5	6.2	42.2	0.8	50.7	0.1	25.4	45.1	69.5	15.8	37.5	18.6	1.2	19.1	4.1	7.1	29.7	3.5	31.4	41.7	40.6	20.3	92.5	18.6	1.8	64.9	45.9	46.3	48.5	4.5	10.4	1.7	47.2	17.6	0.9	3.9	19.7	5.2	67.3	10.3	10.2	2.5	44.9	3.6	30.2	5.6	44.7	1.2	11.1	32.4	0.8	27.0	12.0	48.4	0.8	0.0	2.2	9.2	57.4	1.0	10.0	0.6	1.4	0.7	1.3	1.1	0.0	3.4	0.9	0.0	1.7	0.1	5.3	0.1	0.2	0.2	2.0	0.1	0.8	7.9	34.8	0.0	0.2	5.4	0.5	0.0	1.2	0.0	0.6	4.5	4.3	7.4	0.2	0.7	0.0	1.3	6.6	1.3	0.3	4.7	0.2	20.2	0.1	0.8	0.7	7.7	0.1	0.3	10.2	3.3	0.5	4.6	0.3	0.3	0.4	0.3	0.3	4.7	0.6	0.7	0.2	1.5	1.3	25.1	7.6	10.3	7.0	10.2	8.2	12.3	7.3	7.4	8.2	11.4	9.4	11.3	16.7	12.8	9.3	9.0	10.5	11.7	42.2	50.7	45.1	69.5	41.7	40.6	64.9	45.9	47.2	44.9	44.7	48.4	1.5	6.4	4.6	22.9	0.8	0.0	2.9	0.2	0.6	1.3	7.8	1.8	29.7	15.7	0.7	0.0	0.0	0.1	0.1	0.0	29.4	0.1	0.1	2.5	4.4	2.1	0.0	2.7	0.6	0.0	0.2	8.1	3.1	3.4	0.0	13.7	8.2	66.9	0.1	0.0	2.8	0.1	0.0	2.6	0.0	0.8	12.2	0.4	1.8	2.8	0.0	12.0	0.0	15.1	5.7	0.4	0.0	19.9	0.9	5.2	0.0	22.1	0.8	3.3	0.0	12.0	5.5	0.1	0.1	0.3	0.0	0.3	0.5	0.6	0.1	1.8
KLF16	"BTEB4, DRRF, NSLP2"	ENSG00000129911	"Kruppel like factor 16"	Q9BXK1	19	1852399-1863579	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 58.7;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052481	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA052481: AB_2681845"	"unprognostic (3.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (5.85e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.76e-2)"	9.1	8.7	31.8	6.5	48.9	13.0	5.6	0.5	35.7	5.3	0.0	9.6	8.5	8.9	1.7	16.1	7.5	2.9	7.8	34.7	6.9	9.3	14.5	10.3	4.4	6.5	3.4	5.8	6.4	2.8	15.3	3.5	6.9	6.4	2.6	11.9	8.0	2.0	3.0	14.5	9.9	3.0	3.0	15.1	7.1	9.6	12.0	3.3	4.5	0.7	3.1	6.7	6.6	9.4	29.8	15.5	7.7	16.2	4.5	5.4	16.9	22.4	5.0	9.1	8.1	12.5	12.9	22.0	18.8	14.5	8.3	27.1	11.9	20.1	5.7	33.8	20.9	22.9	8.1	15.0	10.2	22.0	37.2	8.1	11.9	15.1	18.7	11.1	8.0	14.3	28.6	16.6	7.7	22.5	20.6	27.3	25.4	19.5	22.1	31.8	7.2	24.3	9.7	10.0	33.7	28.4	7.8	11.9	27.1	7.1	11.2	27.4	19.4	14.8	22.6	34.1	30.8	23.3	29.0	25.2	15.3	18.7	15.9	1.3	1.2	1.3	0.8	1.1	0.9	1.2	0.9	0.5	1.0	1.6	0.8	0.6	2.7	0.1	1.1	5.2	1.3	0.7	31.8	48.9	0.5	35.7	34.7	6.9	6.5	3.4	6.9	3.0	12.0	9.4	13.3	0.0	5.8	2.6	10.7	26.8	12.1	6.6	11.4	58.7	30.9	19.6	2.0	7.2	5.5	3.7	22.9	3.7	24.6	38.8	1.9	6.2	49.2	18.6	9.0	10.6	32.9	8.6	2.8	8.1	2.8	6.3	8.2	19.3	4.5	6.8	10.0	15.4	13.4	15.2	1.8	22.6	4.1	10.7	12.5	37.0	5.0	12.7	12.4	5.6	9.6	12.3	1.0	1.5	1.2	12.8	24.9	3.4	8.2	13.2	19.7	6.1	7.7	53.0	0.0	11.6	8.0	1.6	4.3	17.9	27.1	4.0	13.2	7.0	20.6	13.5
KLF17	"FLJ40160, Zfp393, ZNF393"	ENSG00000171872	"Kruppel like factor 17"	Q5JT82	1	44118821-44135140	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 160.6;Late spermatids: 45.3;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.2;HBF TERT88: 1.5;U-138 MG: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024629	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA024629: AB_1668927"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-4)"	"unprognostic (4.02e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (5.17e-2)"		"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.70e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.35e-2)"		"unprognostic (5.54e-2)"	"unprognostic (6.60e-2)"		"unprognostic (8.04e-3)"	0.0	0.6	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	0.1	0.5	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	1.1	0.1	0.0	0.1	8.3	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.3	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	160.6	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	45.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.1	4.9	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.3	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324826-16328685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1043.3;B-cells: 691.8;dendritic cells: 542.9;Endothelial cells: 511.8;Gastric mucus-secreting cells: 561.7;NK-cells: 466.5;Plasma cells: 806.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.8;TIME: 67.8;U-266/70: 45.6;U-266/84: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	153.7	27.1	25.0	61.6	23.2	90.0	108.4	15.4	18.5	59.2	10.9	55.2	9.6	61.5	2.5	32.2	105.9	14.7	118.4	13.6	17.9	41.6	13.4	110.8	45.4	27.3	34.1	152.6	12.5	5.6	28.8	22.4	24.2	41.8	5.0	0.6	35.7	6.8	52.0	65.5	44.6	19.5	14.1	70.9	73.1	18.3	27.9	13.0	53.5	20.5	8.3	86.9	63.8	15.5	7.5	1.8	0.1	1.6	0.4	1.0	2.9	16.6	1.8	5.5	1.8	0.1	24.0	0.7	3.7	6.7	0.9	2.5	0.5	0.0	1.5	0.6	2.0	0.0	1.4	0.2	4.2	0.0	12.1	1.2	0.2	1.4	0.3	7.1	10.9	14.7	0.5	15.4	2.4	0.4	1.5	3.2	0.2	7.3	2.2	0.5	4.3	26.8	0.2	0.3	0.5	0.2	0.9	12.3	10.4	0.1	0.5	8.6	67.8	12.9	9.4	1.0	23.8	45.6	49.3	1.6	5.7	0.0	5.8	63.2	8.3	25.1	42.7	32.9	34.9	44.7	56.6	43.9	3.3	47.5	53.5	44.4	79.5	28.7	29.1	0.6	59.4	20.5	25.0	23.2	15.4	18.5	13.6	17.9	27.3	34.1	24.2	14.1	27.9	15.5	1043.3	35.3	60.0	1.0	691.8	23.8	25.9	7.4	30.1	5.8	69.6	51.8	47.9	31.5	9.0	3.7	8.4	4.5	542.9	151.7	0.0	10.3	2.3	53.8	31.1	511.8	46.4	35.0	0.8	6.0	7.6	350.6	561.7	20.4	33.6	8.1	393.3	10.6	91.3	0.0	1.9	110.5	2.0	242.4	58.5	6.3	89.5	272.9	64.0	48.7	74.1	7.6	466.5	0.5	0.3	64.3	61.3	73.0	806.5	10.7	4.8	1.9	18.2	8.8	65.7	460.9	235.3	0.8	2.9	22.1	26.3	6.6	417.8	57.9	33.7	12.9
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664197-38701517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	27.9	23.8	13.8	22.1	18.4	95.0	20.8	16.5	14.9	30.1	14.1	44.5	38.0	28.0	14.1	56.3	20.2	33.5	14.8	14.6	14.1	16.1	44.2	23.9	16.4	19.8	17.9	44.7	33.4	31.0	11.3	31.5	18.4	23.3	47.4	16.6	31.2	19.7	14.5	65.4	38.7	25.7	15.7	29.2	46.0	5.2	16.1	13.1	28.1	17.9	19.6	42.1	39.2	21.3	21.1	14.1	51.8	10.6	23.3	34.5	16.8	11.3	32.5	7.4	9.2	13.3	37.3	0.0	15.7	24.4	21.6	22.3	14.9	19.8	11.9	0.3	11.5	20.1	20.7	28.5	23.8	5.0	0.2	31.3	53.3	10.8	20.0	14.0	29.0	7.6	58.0	9.7	12.0	4.7	5.4	8.8	12.2	42.6	10.1	7.2	25.2	22.8	26.4	49.1	14.9	19.4	12.3	9.6	24.4	20.8	6.0	6.9	46.2	24.6	14.4	42.2	12.4	13.7	4.6	0.1	10.2	14.9	10.7	10.8	4.4	17.0	6.3	7.6	4.5	5.3	7.0	5.7	3.4	4.2	9.7	5.6	13.4	3.0	12.5	0.8	8.3	2.4	13.8	18.4	16.5	14.9	14.6	14.1	19.8	17.9	18.4	15.7	16.1	21.3	108.7	22.4	29.5	20.9	78.6	121.5	150.9	82.2	99.0	42.8	38.5	29.7	16.2	77.2	76.6	31.3	31.3	27.4	137.3	219.5	11.7	88.3	1.1	87.3	70.8	86.7	86.5	239.3	11.6	86.2	21.8	70.0	230.4	168.2	19.7	35.0	65.7	57.2	56.3	35.3	27.9	170.3	91.6	87.9	78.6	4.1	51.9	94.9	49.8	45.0	64.4	46.7	143.2	36.2	47.8	113.6	145.5	48.2	105.2	143.9	124.6	24.3	39.4	38.1	26.3	55.5	42.6	1.1	5.0	191.6	222.5	27.4	84.3	62.4	128.4	308.7
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 254.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.0;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002926	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	73.5	23.9	5.1	21.0	4.7	50.5	63.7	4.0	7.8	53.2	4.6	87.3	28.4	16.0	5.6	102.1	43.0	44.3	31.0	3.7	5.1	6.2	12.4	44.8	5.6	5.0	4.7	29.0	7.0	5.7	4.9	32.4	5.0	16.7	96.0	0.8	27.5	7.6	14.2	254.7	40.5	40.6	4.1	24.1	58.0	17.8	6.0	17.0	25.2	23.2	14.5	43.9	58.9	4.0	13.3	3.9	0.6	0.1	16.6	39.2	5.2	4.4	27.6	6.7	8.1	1.0	18.0	0.0	0.6	6.9	23.7	8.7	6.1	3.9	3.0	0.0	2.2	0.0	7.5	0.3	21.6	0.0	0.0	5.0	84.4	14.0	54.5	1.5	0.6	0.2	0.6	0.0	4.1	7.3	0.0	1.4	4.1	47.2	25.2	0.3	1.6	0.2	2.3	3.7	0.4	0.2	4.0	11.8	15.2	12.7	1.3	5.4	3.5	3.6	0.1	111.5	2.1	0.2	0.1	0.0	3.4	2.6	6.8	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.1	5.1	4.7	4.0	7.8	3.7	5.1	5.0	4.7	5.0	4.1	6.0	4.0	1054.7	12.8	41.1	0.3	32.2	436.0	284.3	143.0	832.1	0.5	206.7	205.0	70.3	35.8	71.5	1.8	8.4	49.1	15.0	789.2	1.9	24.4	263.1	154.1	216.0	336.6	123.8	4.8	0.0	38.7	75.5	463.2	537.2	297.4	54.7	4.7	216.0	4.6	89.9	0.0	0.2	710.9	83.4	232.9	282.0	163.0	143.8	401.0	206.3	16.9	36.8	2.0	0.0	0.0	0.0	49.3	540.9	60.5	38.3	187.3	198.0	2.1	46.4	2.0	39.5	463.7	130.0	21.6	15.9	639.9	674.0	107.9	26.8	63.5	332.6	236.8
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077541	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 242.0;skin 1: 234.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	21	"basophil: 24.0"	"Lineage enriched"	"Detected in single"	140	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 23.2"	HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	6.5	5.9	4.2	18.0	9.1	63.5	36.2	0.6	3.3	49.9	2.7	161.2	130.4	6.7	6.6	242.0	37.5	55.9	3.3	2.6	3.4	8.5	4.7	29.6	2.0	0.8	3.4	4.5	11.9	0.5	10.9	18.8	0.7	23.1	145.4	0.4	79.8	14.4	19.2	234.9	146.2	6.6	0.5	1.5	82.2	12.0	4.1	12.0	25.7	7.8	53.6	111.5	122.2	1.0	22.3	31.1	0.2	0.4	1.1	1.5	34.1	12.9	29.8	5.6	6.9	28.5	111.8	0.4	68.9	11.4	2.3	128.8	39.0	112.2	8.9	0.9	11.0	0.4	61.9	2.8	7.8	10.5	1.9	8.1	156.1	1.7	61.1	5.7	0.1	3.8	1.6	2.2	25.5	7.9	2.1	0.8	1.4	246.3	43.3	2.0	28.3	2.5	87.3	136.3	2.9	1.3	114.5	18.3	8.5	13.9	2.5	2.5	0.3	7.8	23.1	0.2	5.4	3.7	1.9	3.8	10.8	2.1	9.5	24.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	4.2	9.1	0.6	3.3	2.6	3.4	0.8	3.4	0.7	0.5	4.1	1.0	7.8	163.5	123.3	0.7	5.2	518.9	1105.5	185.6	757.5	0.4	79.9	57.0	6.0	91.5	218.5	36.8	2.1	77.8	4.6	420.7	21.5	31.8	448.3	302.1	44.1	12.5	203.2	0.4	1.6	46.1	98.5	33.4	425.1	678.2	3.8	0.9	2.2	4.7	6.1	10.1	11.6	387.4	46.8	0.9	34.6	241.4	6.5	12.4	58.7	1.9	4.3	0.0	1.0	1.0	0.6	88.6	374.9	1.5	15.7	632.1	260.0	3.5	159.3	0.2	0.0	38.4	32.4	8.8	26.3	1028.4	685.9	58.0	17.4	0.5	505.4	1495.5
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Excitatory neurons: 41.7;Inhibitory neurons: 51.1;Microglial cells: 49.6;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 90.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;ASC TERT1: 5.3;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	5.2	4.2	3.3	2.3	5.1	1.4	4.8	4.5	6.0	6.2	1.5	5.5	1.9	6.0	5.7	2.2	5.8	3.1	4.6	2.8	5.4	3.1	3.5	3.1	3.6	5.0	4.2	9.3	3.8	4.1	6.2	2.6	4.3	4.6	2.3	6.0	3.3	4.3	7.2	5.1	3.8	3.5	3.1	3.8	3.9	4.8	4.0	1.9	5.6	4.7	2.6	4.4	4.8	7.4	0.7	0.3	0.6	0.3	5.7	5.3	0.0	1.5	2.1	0.5	0.3	0.0	1.8	0.3	0.3	0.6	0.5	0.5	0.1	0.0	0.4	1.5	0.5	0.2	0.1	0.0	2.9	0.1	0.7	4.5	0.2	0.2	0.2	2.9	1.2	1.0	0.3	0.0	2.2	0.2	0.4	0.8	0.0	0.2	0.2	0.4	0.5	0.0	1.1	0.2	0.2	1.5	0.2	0.0	0.6	0.7	0.6	1.2	1.7	1.3	1.4	0.5	0.1	0.5	0.0	0.4	1.2	0.2	0.7	0.5	0.4	1.0	0.7	0.8	1.4	1.2	1.0	0.9	0.4	0.8	1.7	1.4	0.0	0.6	0.4	1.4	0.3	0.7	3.3	5.1	4.5	6.0	2.8	5.4	5.0	4.2	4.3	3.1	4.0	7.4	7.6	22.4	6.5	46.4	6.1	3.6	3.4	1.5	4.0	10.4	3.3	2.3	10.1	5.7	5.7	0.0	4.2	1.5	2.7	1.7	9.8	0.8	2.1	3.5	5.4	5.7	1.8	5.2	41.7	0.8	0.8	7.3	2.6	1.9	1.3	4.5	4.6	3.2	2.6	13.5	51.1	2.4	2.0	2.2	3.3	3.3	18.0	2.9	5.4	49.6	2.2	15.0	4.1	45.2	90.5	0.4	2.7	10.1	2.9	1.6	4.2	2.5	3.1	15.8	0.0	9.5	6.1	17.9	7.6	1.3	3.3	0.3	3.7	4.2	1.2	1.8
KLHDC10	"KIAA0265, slim"	ENSG00000128607	"Kelch domain containing 10"	Q6PID8	7	130070534-130135705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020119	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA020119: AB_2249467"	"unprognostic (2.83e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-2)"	12.3	17.3	19.4	9.5	19.8	7.9	14.6	27.0	17.2	12.4	21.6	12.8	11.1	13.0	13.7	12.6	14.9	9.5	13.5	18.5	26.3	21.2	23.2	11.9	8.4	17.4	25.1	14.4	15.4	30.7	14.0	13.9	21.5	12.6	12.7	15.4	10.6	12.2	24.0	13.2	10.4	11.5	16.5	10.8	11.7	38.0	31.1	11.8	18.1	22.0	9.3	8.6	8.9	15.8	24.5	22.5	15.3	83.8	19.9	21.8	7.0	22.9	17.5	17.1	17.7	12.4	18.3	20.7	15.8	21.2	28.4	18.8	24.6	14.6	21.4	16.9	14.8	12.2	24.7	14.6	15.6	22.5	14.4	13.8	24.8	26.2	16.4	21.2	24.4	14.2	59.9	12.7	19.4	20.7	19.5	21.9	2.6	18.0	14.6	15.8	28.6	15.1	23.5	16.7	24.6	19.7	36.8	65.2	18.5	18.5	15.9	16.6	27.7	21.8	9.5	29.5	27.6	16.7	23.6	19.2	45.7	21.4	30.0	0.0	0.4	0.5	0.6	0.6	0.5	0.4	0.4	0.7	0.5	1.1	0.3	0.7	0.4	0.1	0.5	0.4	0.9	0.1	19.4	19.8	27.0	17.2	18.5	26.3	17.4	25.1	21.5	16.5	31.1	15.8	18.6	19.2	20.2	53.8	9.7	23.2	7.8	13.6	14.2	20.1	31.0	20.1	23.1	30.0	19.7	35.0	39.6	11.3	12.6	18.2	3.9	18.3	66.7	31.2	24.9	19.0	19.9	18.7	85.7	23.8	9.6	22.2	13.3	18.4	6.3	19.6	37.9	42.3	12.2	35.3	86.1	15.8	20.3	23.0	12.8	17.4	15.2	11.7	17.8	72.1	15.5	18.4	7.2	82.4	59.9	20.5	9.2	24.5	9.8	13.0	16.2	27.5	27.2	22.1	0.0	30.6	14.7	36.2	6.3	17.5	29.1	11.2	9.6	22.7	20.4	12.2
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49768130-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: AB_2666051"	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favorable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	21.5	22.3	12.8	8.6	13.3	10.1	19.6	13.7	16.1	18.8	15.0	23.8	18.4	20.7	14.8	15.0	17.0	13.8	38.0	14.4	14.0	34.1	49.1	14.5	10.9	12.4	12.3	25.1	30.3	16.8	17.7	12.7	13.9	18.5	18.0	23.9	20.1	20.1	53.0	18.8	21.6	14.1	13.3	12.3	24.4	23.3	12.6	15.2	28.2	38.2	10.5	22.3	16.2	14.9	14.7	12.2	22.5	11.0	31.7	27.5	23.7	15.0	28.8	18.8	19.0	7.1	19.6	29.1	20.4	27.4	10.8	12.8	13.9	13.9	15.9	20.1	14.7	9.1	8.6	17.0	23.1	19.6	7.8	28.6	23.5	8.6	16.9	23.1	17.4	24.6	11.8	21.5	15.1	17.3	20.1	8.6	16.6	17.0	34.8	15.3	24.0	18.1	8.6	31.2	27.4	22.0	25.1	46.4	17.1	17.2	17.8	7.4	14.9	17.2	13.3	13.7	7.8	29.0	19.7	17.1	9.7	10.0	9.2	12.3	9.1	19.9	11.1	6.1	13.8	18.2	16.8	17.4	9.0	19.0	23.5	15.8	8.4	16.8	5.8	6.8	18.0	12.3	12.8	13.3	13.7	16.1	14.4	14.0	12.4	12.3	13.9	13.3	12.6	14.9	40.6	41.7	52.4	30.3	42.1	48.9	53.5	64.8	53.5	65.1	48.6	40.9	9.3	77.2	53.9	47.8	50.1	102.5	40.7	68.9	107.6	59.8	96.8	44.8	41.9	36.4	57.2	47.8	30.6	85.8	68.6	51.2	67.2	38.7	30.4	62.8	45.3	91.8	33.2	65.6	35.4	75.3	63.1	28.7	33.6	27.1	81.4	26.5	39.2	18.7	36.3	73.9	54.6	28.1	33.1	54.8	78.9	77.5	74.5	53.9	143.9	170.1	27.8	98.1	65.7	46.3	90.5	238.7	93.2	42.7	66.3	82.4	44.9	54.7	78.9	55.5
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Mitotic chromosome"	"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	10.6	10.8	7.6	11.6	7.2	13.3	10.7	11.7	9.0	11.8	5.2	14.0	8.9	11.6	4.4	11.9	12.0	6.7	8.9	7.8	7.7	14.0	14.6	11.4	16.1	7.6	7.0	12.2	18.4	10.3	13.1	5.4	7.4	13.2	10.9	6.2	11.8	7.8	12.5	11.9	13.7	7.1	6.3	19.8	14.0	12.5	7.3	15.6	13.1	6.4	13.4	11.5	12.9	7.1	16.6	29.7	14.8	22.8	6.0	7.9	23.3	15.1	14.5	24.8	11.6	43.9	23.3	25.6	19.6	12.1	8.8	26.6	23.1	20.0	18.0	4.2	24.9	15.0	20.6	29.4	14.9	14.3	14.8	3.6	10.7	21.9	25.0	12.4	20.8	42.5	48.3	13.4	17.1	72.0	32.7	40.3	25.5	18.9	21.8	31.3	17.3	15.3	15.0	19.2	22.5	21.4	31.9	16.4	7.8	12.6	25.8	22.0	13.4	13.1	23.3	7.1	29.5	63.2	23.4	112.0	13.2	35.2	9.7	0.0	7.8	5.9	18.3	10.8	16.2	7.8	7.2	14.1	6.0	7.7	7.3	11.3	0.6	25.7	16.0	8.0	6.8	8.7	7.6	7.2	11.7	9.0	7.8	7.7	7.6	7.0	7.4	6.3	7.3	7.1	8.4	0.0	16.8	11.1	14.7	4.6	10.9	6.8	12.5	17.8	12.7	9.9	9.9	14.3	14.2	9.2	27.1	14.4	36.1	16.5	11.7	12.3	61.6	8.9	6.0	8.8	24.0	16.0	9.1	16.7	9.4	9.0	19.4	11.4	3.8	17.7	12.1	13.3	13.3	11.8	10.1	15.9	8.2	13.3	6.1	79.9	6.5	9.9	8.8	7.5	10.2	6.5	77.2	7.1	9.2	13.1	9.3	7.5	35.9	15.1	13.8	25.1	9.0	18.0	0.0	16.7	8.5	22.8	11.8	8.6	6.7	11.9	25.5	11.6	21.8	16.5
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480930-18485974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 8.4;kidney: 19.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 5.7;Collecting duct cells: 9.2;Endometrial ciliated cells: 4.4;Gastric mucus-secreting cells: 5.6;Hepatocytes: 7.6;Proximal tubular cells: 9.9;Respiratory ciliated cells: 5.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.4;CAPAN-2: 10.4;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.5;RT4: 9.5;T-47d: 10.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.5	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	2.3	8.4	0.6	0.4	0.0	0.2	1.3	0.8	1.0	0.0	0.5	0.0	19.5	4.7	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.4	0.7	0.0	1.7	1.1	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.2	0.1	0.0	1.6	0.0	0.0	3.2	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.1	0.0	0.2	0.0	0.0	11.5	9.5	2.8	0.0	0.0	0.8	0.0	1.0	10.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	1.7	0.4	1.2	5.7	2.2	9.2	0.0	0.1	0.0	0.3	1.9	2.0	0.4	4.4	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	5.6	3.0	0.0	0.1	0.0	7.6	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	1.1	0.0	9.9	5.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.2	2.1	0.1	1.0	0.3	0.1	0.2	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.1	0.2	3.7	0.4	0.7	2.3	0.5	0.2	0.0	0.1	13.7	1.0	0.1	0.3	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.4	5.2	2.0	0.0	1.3	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.3	0.2	0.4	0.2	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171598-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 128.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 28.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 28.8;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	29.1	128.7	13.5	5.6	14.0	6.1	24.9	9.4	14.8	20.2	24.8	56.1	7.2	26.2	10.6	31.1	26.5	16.7	70.5	12.4	21.2	16.3	12.6	17.3	9.9	12.4	14.2	70.1	9.4	10.4	10.1	12.3	16.1	16.9	3.6	2.3	14.1	13.5	29.6	28.1	14.0	14.2	11.6	13.2	16.7	15.5	19.1	4.3	26.6	13.4	6.8	29.4	22.5	10.3	2.5	5.5	22.4	11.4	13.5	8.0	6.9	8.4	4.7	8.2	6.6	3.6	7.4	0.0	4.6	14.0	2.3	0.1	5.6	5.1	2.1	4.6	1.5	15.1	15.2	9.6	25.6	0.0	8.5	13.3	23.9	10.6	0.8	18.4	21.2	5.3	23.7	0.2	6.3	0.7	1.6	16.7	7.4	1.3	13.1	2.3	2.1	0.7	6.1	1.3	0.9	25.2	6.7	0.2	17.0	4.7	6.8	7.3	9.3	6.2	17.1	11.2	2.6	2.1	0.7	0.3	4.5	0.0	3.1	0.0	5.4	28.8	1.0	8.0	0.4	0.0	0.5	0.7	0.5	0.1	1.8	1.0	9.7	0.0	8.3	0.8	0.2	2.4	13.5	14.0	9.4	14.8	12.4	21.2	12.4	14.2	16.1	11.6	19.1	10.3	14.1	9.6	10.9	5.9	0.9	7.6	11.5	16.4	10.8	2.2	10.8	9.0	60.7	11.5	14.3	7.3	2.1	10.9	2.4	1.0	17.6	14.3	7.2	6.8	6.9	20.5	6.7	6.5	3.8	5.9	8.5	22.3	2.6	3.3	1.3	7.7	37.1	7.5	41.7	0.0	4.6	3.0	18.3	12.0	2.2	7.7	15.2	10.5	12.4	6.5	2.5	29.4	0.0	3.5	0.7	8.6	1.7	14.3	0.6	8.3	0.7	13.4	4.0	2.7	98.6	28.3	31.1	9.2	8.6	15.5	9.8	49.8	1.5	55.5	1.7	7.9
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 31.4"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocyte precursor cells: 206.1"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021196	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.0	0.1	2.9	0.0	1.9	0.0	0.0	2.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.9	0.0	0.0	0.0	0.0	6.8	31.4	0.0	0.0	0.0	0.4	0.0	10.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.9	2.6	1.5	1.0	10.9	6.8	31.4	10.5	4.5	21.6	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	206.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL10	FLJ32662	ENSG00000161594	"Kelch like family member 10"	Q6JEL2	17	41835685-41848384	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 57.3"	"Group enriched"	"Detected in some"	21	"Early spermatids: 363.3;Late spermatids: 532.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067538	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA067538: AB_2685859"	"unprognostic (3.46e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.17e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.5	0.3	0.0	0.9	0.1	0.4	1.5	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.9	0.2	0.1	0.3	0.7	0.0	0.1	0.4	57.3	0.2	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	363.3	0.1	0.4	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	532.8	3.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	6.0	0.1	0.1	0.0	0.1	0.0	2.6	0.0	0.2	0.2	21.1	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1
KLHL11	FLJ10572	ENSG00000178502	"Kelch like family member 11"	Q9NVR0	17	41848518-41865423	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 108.3;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023021, HPA052403, HPA054269"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432"	"unprognostic (9.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.07e-2)"	2.0	2.5	7.5	2.0	6.9	9.1	3.6	8.7	8.2	2.2	1.6	2.0	1.7	2.8	4.0	1.8	2.5	1.6	2.0	9.7	7.6	2.6	2.5	2.3	2.8	6.8	6.3	3.9	3.0	4.6	0.8	2.0	7.4	2.9	1.8	7.1	2.2	2.7	4.3	3.2	1.7	1.8	5.1	2.8	2.2	9.7	7.5	2.7	4.5	1.9	2.8	1.6	0.8	7.0	3.3	5.6	3.9	10.3	5.3	2.8	6.8	3.1	2.9	3.3	3.1	5.2	2.5	10.7	3.4	3.8	3.0	9.3	10.1	4.4	6.0	4.1	4.5	3.8	8.2	7.1	4.9	4.7	4.1	3.4	4.0	4.4	8.3	3.4	3.4	5.3	3.4	9.1	4.3	4.2	7.1	4.9	3.4	2.9	1.8	6.1	9.5	7.7	3.7	5.7	9.8	4.8	5.4	24.9	4.2	3.8	10.9	3.8	5.3	5.1	6.9	4.9	6.2	5.6	5.1	7.9	5.4	4.9	4.8	0.2	0.5	0.3	0.5	0.7	0.8	0.6	0.6	0.6	0.5	0.8	0.7	0.6	0.2	0.4	0.4	0.3	0.4	0.4	7.5	6.9	8.7	8.2	9.7	7.6	6.8	6.3	7.4	5.1	7.5	7.0	1.2	0.0	0.5	6.8	4.5	0.5	1.4	0.2	14.8	3.8	0.9	1.8	0.2	0.0	1.5	0.0	4.2	0.4	3.6	0.3	0.0	0.4	108.3	1.6	3.4	1.5	0.0	3.0	16.6	0.2	0.4	3.0	10.7	1.9	0.0	1.1	0.0	0.0	0.3	8.4	18.0	0.7	0.0	0.0	1.0	41.8	0.3	1.5	1.8	4.7	0.9	1.8	1.0	11.1	13.9	0.5	0.1	0.0	5.8	0.9	0.9	0.2	0.0	3.6	6.6	2.2	3.2	5.5	2.1	5.5	0.3	0.4	4.6	0.9	0.6	0.9
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.3;plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.7	7.3	4.6	2.6	11.1	0.4	24.6	2.7	4.8	20.5	5.5	5.4	3.1	31.4	7.3	5.9	10.7	5.6	7.8	3.2	5.9	16.0	4.7	1.4	0.6	5.9	10.3	7.4	4.6	3.4	2.2	0.8	6.4	6.2	3.9	4.2	2.2	12.3	3.6	1.1	4.8	29.3	4.0	1.6	3.2	3.6	5.9	5.0	0.8	5.6	1.2	7.5	5.0	3.8	1.1	0.4	6.9	14.5	0.1	0.0	0.2	0.5	0.0	0.4	0.0	9.1	0.1	0.0	16.5	0.0	0.7	16.9	33.8	5.6	0.0	0.0	12.9	0.4	57.3	0.1	0.8	1.1	2.2	1.8	2.3	0.2	0.7	6.9	25.8	0.0	0.0	0.0	0.0	1.4	5.9	1.6	13.4	0.0	9.6	0.0	37.2	0.1	106.0	4.0	0.0	94.3	0.5	1.2	0.9	2.7	20.9	0.2	0.7	2.4	2.9	2.0	8.6	0.4	0.0	0.2	10.2	0.0	4.1	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.6	0.0	1.1	0.0	4.1	0.2	0.3	4.6	11.1	2.7	4.8	3.2	5.9	5.9	10.3	6.4	4.0	5.9	3.8	0.7	0.0	0.0	13.7	0.0	0.8	6.8	5.4	12.0	6.2	2.4	19.9	10.5	0.0	4.8	1.8	0.0	0.2	0.1	1.2	29.4	1.1	0.3	8.0	22.7	1.9	1.2	1.3	8.0	3.4	0.1	8.7	0.0	1.3	0.0	10.0	8.6	1.3	0.6	0.0	29.3	2.1	0.0	0.0	1.2	0.9	6.2	1.0	1.8	30.9	0.2	7.2	0.0	102.5	12.3	0.7	3.4	1.9	0.1	2.7	2.9	12.7	22.3	1.2	6.6	18.1	5.3	1.8	10.6	4.8	0.4	0.0	0.6	6.4	4.1	3.6
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.7;thyroid gland: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.5	0.2	0.2	1.8	0.3	2.4	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.2	0.3	5.0	0.0	0.3	7.1	1.4	2.3	0.3	0.0	6.9	0.3	0.8	0.7	1.4	0.2	4.7	0.4	12.7	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.2	0.3	13.8	0.0	5.3	0.6	0.5	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.2	0.3	1.4	2.3	0.7	0.8	0.2	0.1	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Aggresome	"HPA065730: AB_2685547"	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	4.8	9.6	2.9	3.7	3.7	53.1	3.3	4.0	3.6	4.1	3.9	3.1	2.9	5.1	8.0	8.7	4.2	4.5	3.3	3.3	3.8	5.0	12.8	3.4	4.0	2.8	3.2	5.9	6.4	7.3	3.3	3.4	2.5	5.8	3.1	5.5	2.5	3.9	3.6	2.1	2.9	5.1	2.8	4.0	4.0	18.3	3.2	6.2	5.1	3.2	3.4	3.5	1.8	2.9	5.0	4.8	5.2	7.7	7.6	5.4	5.4	7.9	6.9	3.6	4.3	4.4	4.4	13.2	2.7	5.2	5.6	3.7	8.4	4.3	8.7	5.2	17.2	8.4	13.4	2.3	4.8	11.0	5.6	5.7	2.2	6.2	6.0	3.2	2.6	7.7	5.4	18.0	6.7	1.7	9.9	10.7	9.9	2.5	5.8	7.8	9.5	8.2	3.3	4.4	13.7	6.5	11.0	2.6	9.2	6.5	3.6	9.7	3.3	5.4	3.3	10.9	5.2	9.9	10.6	14.8	4.3	7.0	4.4	0.2	0.2	0.5	0.3	0.4	0.4	0.1	0.3	0.3	0.3	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.3	0.2	2.9	3.7	4.0	3.6	3.3	3.8	2.8	3.2	2.5	2.8	3.2	2.9	20.1	6.4	7.9	4.2	10.4	18.0	4.5	4.0	18.8	8.1	18.7	16.9	11.5	5.7	5.4	3.7	12.5	0.5	12.2	3.9	0.0	1.4	3.1	15.5	20.7	10.5	8.4	6.9	7.0	1.4	1.3	12.7	6.6	31.4	8.2	6.3	8.9	11.9	3.6	20.2	9.1	5.0	2.0	9.1	14.1	2.8	3.4	19.8	12.4	3.7	3.9	7.9	3.1	6.0	5.4	1.6	0.7	4.1	8.8	5.6	3.8	2.4	2.8	7.6	0.0	22.6	16.4	2.8	17.7	15.3	9.9	1.4	11.7	13.3	4.8	3.3
KLHL17		ENSG00000187961	"Kelch like family member 17"	Q6TDP4	1	960584-965719	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031251	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA031251: AB_10601539"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (3.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.73e-2)"	5.3	5.8	5.2	3.8	5.4	3.8	6.0	6.1	8.3	9.7	5.3	6.9	3.5	7.3	0.6	12.3	6.7	2.3	4.8	5.4	4.7	9.0	7.9	7.1	3.7	5.7	5.0	1.9	7.1	2.3	10.4	2.2	5.6	8.2	0.7	1.7	7.5	1.9	2.8	9.5	7.6	1.2	4.6	12.0	7.5	12.4	5.8	3.0	6.5	0.8	1.6	8.2	8.6	5.5	6.8	7.5	9.2	22.1	3.2	3.3	10.1	13.1	3.5	7.2	7.0	9.9	10.1	2.4	9.0	5.8	6.9	14.4	8.5	5.4	1.1	13.9	20.7	4.4	32.2	14.3	2.1	5.1	13.4	2.8	2.6	7.1	2.0	9.0	4.5	14.0	14.9	4.3	3.2	8.0	8.4	17.8	10.0	2.7	11.0	13.5	3.7	4.8	4.0	2.7	22.3	21.0	3.8	11.8	12.4	2.8	6.4	8.9	7.8	13.7	18.5	12.1	11.1	8.5	3.2	5.9	7.9	11.4	6.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	5.4	6.1	8.3	5.4	4.7	5.7	5.0	5.6	4.6	5.8	5.5	2.2	0.0	3.1	6.2	1.7	2.5	1.0	1.2	3.4	5.7	2.6	2.8	3.7	0.0	0.7	3.7	2.1	1.2	4.0	1.1	0.0	1.0	1.3	1.8	4.1	1.2	3.0	0.0	5.9	0.8	1.9	1.8	7.7	2.0	0.0	1.4	3.3	0.7	1.2	6.7	4.6	1.6	0.0	1.0	1.8	2.0	0.3	2.1	3.6	2.8	1.4	1.2	1.0	1.5	2.1	2.0	0.3	1.5	2.2	0.9	1.2	1.2	1.1	6.2	0.0	0.8	2.0	4.7	5.3	1.9	3.0	0.8	2.2	0.2	1.4	1.4
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	5.9	6.2	6.5	6.2	6.9	15.9	4.6	5.9	7.7	5.7	3.9	5.8	4.4	5.3	5.1	8.7	4.6	5.4	6.2	6.8	6.3	6.1	3.7	6.2	6.9	4.9	6.0	3.9	5.5	7.2	6.0	5.5	5.1	5.1	4.6	20.2	4.4	6.2	6.7	13.8	5.6	6.6	5.5	8.8	4.9	6.3	6.7	5.1	7.0	5.6	7.5	6.7	6.7	6.3	11.6	14.6	11.1	16.5	12.0	8.6	7.9	15.6	8.1	15.5	12.6	15.6	7.0	22.6	8.6	13.1	14.2	7.0	33.7	16.5	15.9	18.0	11.3	33.3	20.9	14.3	12.3	17.9	14.7	10.0	12.5	22.4	20.8	8.7	17.5	12.1	41.0	9.2	12.6	9.6	13.7	10.3	20.4	9.4	29.2	9.4	7.3	13.2	14.6	21.6	7.6	10.1	10.9	13.2	7.9	11.3	7.8	9.7	18.4	14.3	14.8	16.6	19.9	10.3	21.9	19.5	9.2	20.5	15.4	6.1	12.1	3.7	2.0	10.7	2.9	3.8	1.6	3.9	7.8	2.4	1.3	2.0	4.9	1.3	18.6	2.0	1.7	5.7	6.5	6.9	5.9	7.7	6.8	6.3	4.9	6.0	5.1	5.5	6.7	6.3	19.6	12.8	13.7	13.1	24.4	11.3	10.6	8.1	12.0	65.2	17.4	13.0	62.1	4.3	7.5	3.7	20.9	10.6	26.1	15.2	21.5	15.5	3.0	15.5	24.8	16.1	9.5	21.7	24.2	14.8	11.9	9.3	12.2	27.5	36.1	11.0	14.3	19.7	29.6	13.5	23.0	11.1	4.1	28.8	14.9	3.5	5.9	26.7	0.0	18.7	22.4	13.9	8.2	15.1	17.4	17.7	10.6	8.2	12.0	9.3	9.8	28.2	6.3	54.2	6.6	19.5	13.5	13.9	14.8	14.8	21.0	14.1	20.8	15.4	10.3	13.0
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786692	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: AB_2682234"	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	13.8	10.2	5.8	7.6	7.1	5.9	8.7	7.3	6.7	11.8	4.7	9.7	6.7	13.6	6.9	9.8	8.1	9.3	10.8	6.5	6.3	10.8	16.2	10.0	9.7	7.4	6.7	12.0	6.0	7.9	5.3	11.4	7.1	13.1	8.9	9.0	6.1	9.3	12.5	9.5	7.8	13.4	6.9	10.3	7.5	15.9	6.5	12.3	8.4	13.9	9.1	10.0	8.2	6.9	12.8	8.0	12.5	13.1	28.7	26.4	10.2	19.7	19.2	14.9	15.6	5.8	8.7	9.0	16.4	21.3	7.9	12.5	11.2	14.2	17.4	11.0	6.0	8.2	10.8	6.9	18.4	15.5	9.3	22.6	16.1	13.8	18.4	17.3	22.2	9.0	18.5	10.0	27.6	4.7	9.1	8.0	13.3	11.3	36.1	9.7	15.4	9.8	11.4	8.1	5.3	14.7	18.0	12.1	12.3	16.9	10.8	18.0	22.2	14.3	8.6	17.6	15.7	13.3	7.4	13.5	9.4	11.0	16.2	7.0	2.9	4.3	4.5	3.2	4.0	3.6	4.4	5.5	2.8	3.5	5.6	5.7	1.6	3.2	2.4	4.6	5.6	2.3	5.8	7.1	7.3	6.7	6.5	6.3	7.4	6.7	7.1	6.9	6.5	6.9	21.8	16.0	25.9	36.2	17.3	11.1	8.1	13.5	8.0	13.3	8.0	8.0	12.8	17.2	12.8	12.9	37.5	13.1	18.1	13.5	1.9	9.9	132.4	4.4	14.0	23.4	9.6	11.1	28.1	12.1	10.1	18.2	16.3	5.6	7.6	14.9	42.1	21.0	11.2	11.8	37.3	9.1	10.2	18.5	9.1	30.2	22.4	10.0	3.6	18.7	9.4	16.4	20.6	33.7	35.2	11.4	8.9	28.6	12.3	8.8	16.3	14.1	8.2	20.7	0.0	20.9	16.4	55.8	35.6	11.3	10.5	9.9	16.9	24.1	9.7	7.8
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 169.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 104.8;Suprabasal keratinocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 21.4;neutrophil: 63.0"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 63.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	Centrosome		"HPA051364: AB_2681455, HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	30.5	29.5	31.3	12.6	37.3	25.5	24.6	33.6	35.9	27.2	73.1	44.7	6.9	35.3	8.7	36.4	24.2	14.4	53.3	32.1	31.5	28.2	22.2	16.4	9.2	41.0	44.0	28.6	33.3	21.5	30.1	6.9	37.4	31.7	5.0	7.6	33.3	28.3	169.9	37.0	15.9	16.4	30.7	17.2	30.0	15.2	35.5	9.7	18.7	101.3	7.6	46.5	25.0	44.3	25.8	15.1	7.5	24.3	41.5	25.8	19.5	35.5	28.1	23.0	13.7	44.1	16.1	0.9	30.8	21.9	20.7	41.7	16.6	39.2	12.8	54.8	26.8	29.7	27.8	40.3	34.4	17.8	17.5	28.9	13.0	52.3	17.6	21.6	9.9	14.8	33.3	23.1	19.0	8.9	18.4	15.7	13.8	13.1	55.5	28.0	31.3	32.3	13.5	7.8	30.2	7.5	27.8	22.0	62.8	6.5	14.5	21.0	33.3	74.4	9.1	68.9	86.1	26.2	35.2	18.0	72.2	33.1	28.4	8.4	6.2	21.4	7.1	2.6	6.2	4.5	6.6	7.0	3.8	2.6	5.3	5.3	63.0	2.9	2.3	3.4	8.2	6.1	31.3	37.3	33.6	35.9	32.1	31.5	41.0	44.0	37.4	30.7	35.5	44.3	11.6	3.2	5.1	19.6	8.9	71.2	46.9	22.3	63.2	4.1	47.1	44.4	68.3	7.2	10.7	9.2	4.2	5.1	15.6	10.1	7.9	12.0	2.7	19.6	14.9	15.6	3.0	2.1	8.2	12.9	7.0	24.7	31.1	35.3	0.0	6.4	7.1	23.6	5.6	5.0	8.9	5.6	14.2	10.4	30.1	7.6	10.8	17.1	26.6	8.4	7.6	12.2	4.1	6.6	14.1	20.0	7.3	15.1	12.6	43.1	5.3	7.6	14.0	5.9	13.1	32.2	25.2	2.0	10.9	104.8	72.0	6.4	15.3	9.2	5.5	31.3
KLHL24	"DRE1, FLJ20059"	ENSG00000114796	"Kelch like family member 24"	Q6TFL4	3	183635610-183684519	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056337	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA056337: AB_2683103"	"unprognostic (3.68e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.02e-2)"	16.5	13.1	8.4	10.5	22.4	41.0	16.1	71.6	33.2	13.7	0.0	14.9	16.0	15.3	10.3	11.5	10.3	13.4	41.3	8.4	9.0	18.5	20.3	18.8	15.8	18.4	17.6	20.0	15.3	41.7	10.4	13.9	21.0	13.9	14.0	16.1	17.8	11.5	48.5	11.2	14.6	11.3	5.1	16.2	15.1	9.0	21.2	17.8	23.3	46.4	14.7	14.0	11.9	28.3	4.4	4.3	9.9	10.5	22.1	12.0	20.6	2.2	16.9	2.7	4.8	2.8	8.0	8.9	30.1	6.1	25.2	6.2	5.7	2.6	4.8	10.1	7.9	5.4	6.9	2.9	18.9	4.7	7.1	24.7	14.0	2.9	9.2	16.7	14.4	13.8	3.5	28.5	3.7	2.1	7.9	6.0	6.4	6.7	6.5	10.0	7.5	28.7	7.8	13.6	17.5	24.5	10.3	32.1	23.5	14.4	11.8	10.4	12.5	3.4	4.4	5.4	2.9	54.1	38.4	37.7	6.0	7.5	2.2	43.1	20.3	25.0	17.3	22.7	14.7	25.7	14.3	15.8	13.8	27.7	20.7	14.8	40.9	16.3	22.5	10.7	20.5	15.3	8.4	22.4	71.6	33.2	8.4	9.0	18.4	17.6	21.0	5.1	21.2	28.3	44.5	112.2	72.3	88.8	73.4	43.6	30.7	21.8	77.4	39.8	33.2	24.8	137.8	27.1	33.4	31.3	70.9	12.1	63.2	32.0	13.7	28.1	16.1	35.5	42.0	39.5	42.3	26.1	99.5	18.9	18.0	44.5	29.6	49.3	26.0	110.1	33.2	47.7	27.1	60.6	104.3	28.5	46.8	51.9	31.4	7.0	30.7	46.5	35.6	68.4	31.3	24.4	41.2	92.0	185.2	18.1	29.3	24.5	48.5	51.9	52.3	27.7	35.8	45.8	32.9	59.7	48.8	27.9	12.4	46.1	43.9	43.8	49.5	45.1	26.0	44.8
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759326-85794925	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 29.1;hippocampal formation: 16.3"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	6.5	2.4	5.6	2.6	7.6	0.5	5.4	5.8	7.5	4.3	4.3	3.8	4.7	6.6	3.1	5.7	4.0	2.2	3.9	6.0	7.6	3.7	15.1	4.3	1.9	5.4	8.2	3.3	1.6	2.2	3.6	1.1	6.9	4.6	1.1	0.8	3.6	3.1	6.5	9.3	3.4	2.8	4.7	1.6	5.0	10.5	7.6	2.0	2.4	3.0	1.3	3.7	5.0	6.7	2.7	8.1	11.6	5.7	2.3	1.2	6.0	3.4	1.6	4.6	3.5	10.9	4.4	1.7	1.7	2.8	2.9	6.6	12.5	6.4	1.0	1.7	5.8	0.5	3.5	8.4	2.7	0.5	2.0	2.4	2.1	4.5	1.5	2.0	2.5	5.8	0.7	1.5	2.0	5.0	4.3	2.6	10.5	4.6	4.2	8.7	6.9	2.8	1.7	5.6	16.1	11.1	4.9	5.6	2.2	4.7	10.2	0.6	2.1	4.9	8.9	3.2	6.2	1.6	3.7	1.7	2.2	3.0	2.8	0.0	0.1	0.2	1.0	1.2	0.5	0.0	1.0	0.7	0.2	0.2	1.7	1.1	0.0	2.5	3.8	0.6	0.9	0.5	5.6	7.6	5.8	7.5	6.0	7.6	5.4	8.2	6.9	4.7	7.6	6.7	0.8	0.0	1.9	3.6	1.2	2.7	4.0	2.1	0.0	3.3	4.0	2.8	4.3	1.5	1.5	0.0	0.0	1.0	3.6	6.3	1.9	2.3	13.0	3.0	3.6	1.8	10.7	0.0	7.7	2.7	1.5	2.4	8.6	3.2	0.0	2.0	2.2	12.4	0.8	13.5	4.1	7.6	4.1	1.3	2.7	4.6	0.9	1.4	7.2	1.0	0.6	2.7	2.1	6.0	0.9	5.3	3.1	1.5	1.3	2.7	2.7	2.1	2.1	1.1	6.6	2.9	2.9	3.3	4.1	4.4	4.7	1.8	4.0	1.4	5.2	4.3
KLHL26		ENSG00000167487	"Kelch like family member 26"	Q53HC5	19	18637025-18671721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023074	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA023074: AB_2671060"	"prognostic favorable (5.01e-4)"	"unprognostic (1.50e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.32e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.77e-2)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.49e-2)"	7.2	4.5	9.2	2.6	10.2	3.1	6.0	7.4	11.9	6.0	1.7	5.8	1.9	5.5	2.2	3.6	6.6	1.7	7.0	9.6	6.9	4.2	3.7	4.5	2.4	7.4	7.0	6.6	5.2	2.6	6.3	1.4	5.2	5.7	1.3	1.6	4.1	3.3	8.1	5.8	4.0	1.5	6.4	3.9	5.7	4.4	7.9	1.9	7.2	3.3	1.1	5.2	4.8	7.9	6.0	2.6	2.2	3.7	5.0	2.2	8.0	2.2	0.6	2.5	1.6	3.6	4.9	4.3	7.5	1.8	1.9	4.5	2.9	1.4	1.1	3.1	7.6	2.2	4.5	3.3	6.4	3.2	3.6	2.2	2.5	1.3	0.9	2.4	1.5	5.0	5.0	4.9	0.9	5.7	7.8	4.8	3.8	3.4	9.0	7.2	0.2	4.5	2.5	2.9	2.4	5.0	5.5	4.0	2.8	1.3	3.6	6.4	4.7	1.2	1.1	0.2	4.2	7.4	4.6	6.5	4.4	5.6	1.7	0.6	1.5	0.8	1.5	0.9	2.4	1.3	1.5	1.8	1.3	1.5	1.5	1.5	1.1	4.4	0.9	1.2	0.6	1.3	9.2	10.2	7.4	11.9	9.6	6.9	7.4	7.0	5.2	6.4	7.9	7.9	2.3	3.2	1.1	7.8	1.9	1.0	1.7	2.1	7.4	4.4	4.2	3.6	3.3	5.7	1.1	0.0	4.2	3.1	2.2	2.4	13.7	3.9	0.8	2.1	2.2	2.2	6.7	2.7	3.3	2.3	1.4	4.7	3.6	2.9	11.4	3.1	2.9	4.0	4.0	6.7	2.1	3.3	6.1	3.5	2.2	0.7	3.1	2.5	1.8	3.7	4.9	11.6	1.0	1.0	3.0	2.8	2.1	2.2	0.7	1.6	1.8	3.4	1.2	2.3	6.6	8.9	4.9	3.2	6.5	3.3	1.8	1.9	3.7	1.7	3.6	1.0
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385179-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 146.4;Inhibitory neurons: 132.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.9;RH-30: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Cytosol	"HPA049057: AB_2680615, HPA057379: AB_2683422"	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	6.6	9.2	3.9	2.2	4.0	0.1	5.8	0.7	8.9	5.3	3.4	8.8	0.9	6.1	1.2	2.9	4.4	3.1	2.5	5.2	3.3	4.2	2.6	3.9	2.6	2.0	2.6	2.5	1.9	2.3	10.2	3.3	2.5	7.7	1.2	7.0	3.0	4.8	10.7	5.7	3.8	3.0	3.0	5.0	3.9	0.9	3.4	1.6	1.6	2.9	1.6	4.4	5.1	4.5	1.4	1.1	7.5	3.8	7.0	4.6	12.9	7.8	6.0	3.1	2.2	0.0	0.4	5.1	2.6	3.0	16.9	0.2	1.7	6.7	2.1	0.0	8.0	0.0	6.7	0.0	2.4	0.0	9.9	3.4	8.9	4.1	11.6	1.0	5.3	0.2	0.0	0.0	1.7	0.7	1.8	0.0	3.7	0.0	2.3	0.5	19.3	0.1	5.8	2.3	11.3	2.3	1.0	0.8	4.5	3.0	0.0	0.1	5.4	3.1	14.4	6.7	2.7	0.2	0.0	0.0	11.8	0.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	4.0	0.7	8.9	5.2	3.3	2.0	2.6	2.5	3.0	3.4	4.5	1.2	6.4	5.3	6.8	0.3	4.7	10.4	2.9	7.4	8.4	0.4	6.0	2.3	4.3	1.3	1.8	27.1	1.2	0.1	0.1	0.0	1.2	1.8	3.5	5.4	2.3	4.2	0.0	146.4	0.2	0.9	3.9	0.0	3.9	0.0	0.2	0.7	0.5	0.3	1.7	132.7	0.7	0.0	0.0	0.0	0.7	5.0	0.4	1.8	7.5	0.0	1.7	0.0	5.5	4.7	0.4	0.4	4.1	0.0	1.9	0.0	1.3	1.7	26.1	6.6	6.5	6.5	0.1	1.1	2.0	5.8	0.8	0.4	0.4	0.8	1.5
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736089	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1;Excitatory neurons: 91.9;Inhibitory neurons: 56.1;Late spermatids: 60.7;Muller glia cells: 46.2;Oligodendrocytes: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 5.8;RT4: 6.1;TIME: 13.5;U-266/70: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051291	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051291: AB_2681423"	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.4	7.1	8.5	2.3	10.6	1.0	3.9	26.7	9.9	5.2	3.4	2.8	1.8	3.3	1.8	2.5	3.7	4.0	16.5	9.5	7.4	8.5	2.5	3.0	3.9	6.8	7.2	5.8	2.4	0.4	8.5	2.3	7.1	3.2	1.6	7.7	2.1	1.5	1.9	2.1	2.9	2.4	5.2	4.2	3.5	6.5	8.3	3.9	9.2	1.6	2.9	3.3	4.7	12.6	0.3	0.3	1.4	0.0	0.8	1.1	0.9	0.3	0.4	0.1	0.2	0.5	5.3	1.3	2.8	0.0	0.0	0.1	0.3	2.5	0.2	1.4	0.6	0.6	1.1	0.0	0.3	0.0	1.0	1.0	0.2	0.6	0.0	2.2	5.8	3.7	0.2	1.1	0.2	0.0	3.0	0.8	2.4	0.0	0.8	2.4	0.0	0.0	0.9	6.1	1.6	0.9	0.3	0.0	0.5	3.8	0.0	0.5	13.5	0.4	0.3	0.0	0.4	7.9	4.7	0.0	5.0	0.1	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.9	0.5	0.0	0.7	0.0	0.4	0.4	0.2	8.5	10.6	26.7	9.9	9.5	7.4	6.8	7.2	7.1	5.2	8.3	12.6	13.3	0.0	2.2	20.2	1.9	1.1	1.7	1.4	1.2	15.6	1.8	1.5	36.4	1.5	1.4	7.3	22.9	0.6	5.6	0.5	1.9	0.8	44.1	7.1	1.8	14.1	15.6	2.7	91.9	0.9	0.1	3.9	9.2	7.1	1.3	6.6	24.7	3.7	0.6	5.0	56.1	1.0	0.0	1.3	1.2	60.7	2.5	0.7	1.8	7.5	1.0	46.2	5.2	30.7	66.4	1.3	0.3	1.9	1.0	0.8	0.5	0.3	2.3	6.6	0.0	3.7	3.9	9.2	8.5	1.8	0.9	0.1	3.2	6.8	1.9	1.2
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.7;Excitatory neurons: 168.8;Inhibitory neurons: 143.9;Oligodendrocyte precursor cells: 197.5;Oligodendrocytes: 724.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.3;HDLM-2: 4.5;RPMI-8226: 2.1;SCLC-21H: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039150: AB_2676367"	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	0.2	0.9	19.6	0.4	40.7	0.1	0.3	24.7	33.3	0.3	1.7	0.6	0.8	0.2	0.4	0.0	6.4	0.3	0.7	21.6	25.9	1.9	0.6	0.7	0.4	31.2	28.2	0.9	1.3	0.7	1.2	0.0	29.9	0.2	0.9	2.5	0.5	0.2	1.2	0.1	1.1	0.1	25.3	0.3	0.5	1.6	29.1	0.7	0.7	0.3	0.4	0.1	0.1	65.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	3.3	0.1	0.0	0.0	0.1	0.3	0.1	0.0	4.5	0.7	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.6	0.0	0.0	0.8	0.2	0.2	0.1	0.1	0.1	0.0	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.3	0.4	1.3	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	1.0	1.7	0.6	0.0	0.7	1.9	2.6	0.0	0.4	0.0	0.0	1.2	0.8	19.6	40.7	24.7	33.3	21.6	25.9	31.2	28.2	29.9	25.3	29.1	65.2	0.2	3.2	0.0	143.7	1.1	0.0	0.3	0.1	0.0	2.5	0.4	0.5	2.6	0.0	0.1	5.5	0.0	0.1	0.2	0.3	3.9	0.2	6.9	7.5	0.1	0.0	11.3	0.0	168.8	0.2	0.0	0.3	1.5	0.2	0.0	3.2	0.4	1.3	0.1	18.5	143.9	4.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0	13.1	0.0	1.1	0.0	197.5	724.3	0.0	0.1	0.0	0.5	0.2	0.5	2.4	15.3	1.1	0.0	0.2	0.1	0.8	1.8	0.0	0.0	0.0	0.7	1.1	0.5	0.0
KLHL33		ENSG00000185271	"Kelch like family member 33"	A6NCF5	14	20425852-20436166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 73.3;tongue: 20.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 5.8"	"Cell line enriched"	"Detected in single"	9	"REH: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049985, HPA056560"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA049985: , HPA056560: AB_2683174"	"unprognostic (6.92e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.32e-5)"	"unprognostic (2.32e-1)"	0.9	0.3	0.5	0.2	0.5	0.2	0.6	1.5	0.6	1.2	0.3	0.8	0.3	1.4	1.0	0.9	0.8	0.8	1.0	0.4	0.5	0.5	0.1	0.4	0.6	0.4	0.6	1.2	0.2	0.5	0.2	0.2	0.4	1.0	0.3	0.3	0.5	1.0	73.3	0.1	0.5	0.5	0.1	0.6	0.3	0.4	0.6	1.0	0.4	20.2	0.6	0.5	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	5.8	0.0	0.1	0.5	0.5	1.5	0.6	0.4	0.5	0.4	0.6	0.4	0.1	0.6	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
KLHL34	"FLJ34960, RP11-450P7.3"	ENSG00000185915	"Kelch like family member 34"	Q8N239	X	21654690-21658330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 25.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.7;Cardiomyocytes: 7.9;Cone photoreceptor cells: 14.6;Horizontal cells: 16.8;Rod photoreceptor cells: 66.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060287	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA060287: AB_2684243"	"unprognostic (2.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.29e-1)"	0.0	0.0	1.9	0.1	0.6	0.0	0.0	1.7	2.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	25.6	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.6	1.7	2.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	0.0	7.7	0.1	0.0	7.9	0.0	0.0	0.0	14.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.8	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.1	4.1	0.1	0.0	66.6	0.0	0.8	0.1	0.2	0.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75433203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.2;testis: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 39.6;Early spermatids: 25.9;Late spermatids: 28.4;Spermatogonia: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.8;HMC-1: 10.3;PC-3: 8.9;SiHa: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	0.6	0.8	3.9	0.0	4.9	0.0	0.9	1.9	3.9	0.7	1.3	0.2	0.0	0.3	0.0	0.4	0.4	0.1	0.8	3.5	5.1	0.3	0.0	0.7	0.0	4.4	3.4	0.2	1.8	0.0	0.9	0.0	5.2	0.2	0.0	0.6	0.8	0.1	0.4	0.9	0.1	0.1	2.7	1.1	1.1	9.3	4.4	0.1	0.6	0.2	0.0	0.3	0.3	3.8	0.0	0.3	0.1	0.0	0.2	1.3	0.0	0.9	0.0	0.9	0.1	15.8	1.3	0.0	4.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.8	4.1	10.3	0.2	0.2	0.0	0.0	0.1	0.4	2.7	0.0	0.0	1.1	0.7	0.3	0.1	0.2	3.2	8.9	0.0	0.0	0.9	0.7	0.2	1.2	1.0	18.4	3.4	0.0	0.0	3.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.2	0.0	0.4	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.9	4.9	1.9	3.9	3.5	5.1	4.4	3.4	5.2	2.7	4.4	3.8	0.7	9.6	3.4	0.3	1.1	1.3	1.8	0.5	4.0	39.6	6.4	4.8	1.0	1.5	2.8	3.7	8.4	1.5	0.7	0.6	3.9	1.7	25.9	2.1	3.0	1.1	4.2	0.4	3.9	3.1	1.7	3.0	2.6	4.0	4.5	1.5	2.9	0.1	1.2	1.7	3.5	1.4	0.0	1.2	2.1	28.4	2.8	2.9	1.8	0.0	1.6	2.5	3.1	0.0	4.4	3.7	0.4	1.2	0.1	1.3	0.3	0.4	1.6	11.1	6.6	1.3	1.6	10.2	56.7	0.9	2.3	2.5	1.1	2.2	0.7	1.4
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648511-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favorable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favorable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	9.3	6.4	7.2	6.1	5.8	13.4	7.7	4.2	7.0	5.7	10.0	7.0	6.8	6.6	2.1	8.9	6.8	3.9	9.8	9.0	4.9	6.9	11.3	8.6	7.7	6.4	4.4	8.7	11.4	8.9	6.1	4.6	3.6	6.6	3.2	1.9	7.6	5.3	5.1	8.1	9.0	4.0	3.9	9.3	8.4	13.8	5.9	4.3	8.8	4.5	4.9	8.2	7.1	4.0	18.9	19.9	5.0	11.9	5.4	8.8	18.9	13.9	9.7	5.8	2.8	17.3	12.7	13.2	18.2	11.3	5.9	20.6	5.5	13.4	4.0	8.1	8.0	4.4	6.7	10.9	7.2	5.4	12.2	8.4	11.2	6.7	8.3	8.6	8.7	4.3	14.3	2.1	6.0	28.7	0.8	8.3	7.6	8.1	8.2	18.1	5.8	6.3	11.1	17.2	5.9	4.4	16.6	4.7	8.8	6.0	17.7	16.6	16.9	7.6	12.9	8.2	8.7	7.1	10.2	22.7	10.3	7.3	22.2	3.5	2.7	6.3	3.2	1.7	2.8	4.5	5.9	4.7	3.7	3.7	6.9	5.0	3.2	2.3	2.0	3.4	3.4	2.8	7.2	5.8	4.2	7.0	9.0	4.9	6.4	4.4	3.6	3.9	5.9	4.0	18.5	19.2	16.2	8.5	24.6	15.9	45.3	23.9	15.9	25.8	23.3	15.7	26.5	32.9	16.8	22.0	35.5	23.7	19.3	28.3	5.9	24.5	41.4	13.8	12.3	19.6	18.6	6.5	11.8	14.5	11.7	20.9	16.3	21.4	7.0	22.7	19.2	21.9	19.3	26.9	10.6	23.3	26.4	21.2	17.6	14.7	23.3	18.0	21.4	15.9	22.4	10.5	18.6	7.5	8.5	22.8	20.0	25.2	10.8	56.0	37.0	28.1	16.3	23.0	32.9	21.7	24.9	21.7	6.1	19.3	17.6	19.3	26.8	12.8	21.3	39.8
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517409-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 21.3"	"Group enriched"	"Detected in some"	4	"Oligodendrocytes: 286.2;Theca cells: 109.4"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;GAMG: 18.2;HUVEC TERT2: 32.0;NTERA-2: 24.3;SuSa: 17.8;TIME: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	1.3	26.5	5.3	0.4	10.2	0.0	0.9	7.3	7.1	1.2	0.6	0.3	0.1	3.0	0.3	0.5	2.5	1.5	0.8	5.2	5.7	1.1	0.6	0.8	0.4	9.6	7.5	7.9	0.3	0.0	0.0	0.1	9.5	0.3	0.3	2.3	0.0	1.4	0.3	0.1	0.3	5.1	7.5	1.3	0.3	7.0	6.7	0.1	0.6	0.3	0.1	0.9	0.2	21.3	0.0	3.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.0	0.1	0.9	0.0	1.4	0.4	0.0	2.6	0.0	11.0	0.2	0.0	1.6	4.7	6.0	1.3	11.6	32.0	0.0	0.2	2.5	8.1	0.0	0.0	0.0	24.3	0.1	5.7	0.0	8.9	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	17.8	0.0	0.1	34.4	0.0	5.6	0.0	0.5	0.2	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	10.2	7.3	7.1	5.2	5.7	9.6	7.5	9.5	7.5	6.7	21.3	1.7	0.0	0.0	2.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	1.5	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	15.0	0.0	0.0	44.4	0.0	0.0	4.4	0.0	0.1	0.0	4.5	14.3	0.2	0.1	0.0	6.6	0.0	0.0	0.3	0.3	1.5	0.9	0.1	0.0	4.7	0.0	1.5	0.0	36.2	286.2	0.1	0.0	1.5	0.1	0.0	0.0	3.4	2.2	4.1	0.0	1.2	0.5	0.4	0.4	0.0	0.3	0.0	0.7	109.4	0.0	0.0
KLHL40	"KBTBD5, NEM8, SRYP"	ENSG00000157119	"Kelch like family member 40"	Q2TBA0	3	42685537-42692544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"skeletal muscle: 431.2;tongue: 162.3"	"Group enriched"	"Detected in some"	17	"Early spermatids: 5.0;Late spermatids: 10.7;Skeletal myocytes: 16.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024463, HPA052201"	Enhanced					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA024463: AB_1852095, HPA052201: AB_2681759"					"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"			"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"		"unprognostic (7.85e-2)"			"unprognostic (2.50e-1)"	"unprognostic (4.04e-1)"		0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.1	4.2	0.0	431.2	0.7	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.0	0.1	162.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KLHL42	"Ctb9, KIAA1340, KLHDC5"	ENSG00000087448	"Kelch like family member 42"	Q9P2K6	12	27780048-27803040	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 172.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020979	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020979: AB_1852559"	"unprognostic (4.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.46e-2)"	"unprognostic (7.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	8.7	7.3	10.8	11.6	12.1	4.6	9.4	8.3	12.7	11.5	1.6	23.0	8.5	19.0	9.6	13.2	13.4	11.7	6.6	13.2	12.3	7.5	6.4	9.2	9.4	9.2	8.9	8.2	21.3	12.3	9.8	14.1	9.3	14.8	12.1	13.9	6.1	18.8	2.6	9.6	10.0	23.1	9.6	8.7	12.2	10.3	11.3	6.6	10.2	2.6	8.1	21.7	9.7	16.1	11.8	14.9	24.2	22.2	25.9	15.9	23.9	22.5	17.0	16.4	17.6	10.5	16.0	14.6	9.5	14.9	12.6	23.8	11.9	15.6	16.4	19.5	14.5	19.4	29.3	6.9	12.0	17.1	15.2	15.7	12.9	14.3	20.4	21.1	18.7	12.0	6.3	8.0	13.3	10.6	11.9	17.1	34.6	7.6	20.6	13.0	22.1	2.8	9.8	19.2	8.4	24.3	16.6	13.2	17.9	33.8	20.0	15.6	30.2	22.8	13.7	27.7	25.1	9.9	5.5	25.5	14.6	11.2	16.2	0.0	0.5	0.2	1.0	0.4	1.0	0.1	1.1	0.7	0.3	0.5	0.8	1.1	0.0	0.8	0.7	0.7	1.8	0.3	10.8	12.1	8.3	12.7	13.2	12.3	9.2	8.9	9.3	9.6	11.3	16.1	16.2	19.2	16.8	33.0	9.3	23.1	12.3	14.9	29.0	49.8	17.0	25.1	9.1	10.0	12.6	7.3	22.9	69.5	13.9	14.6	3.9	8.9	1.7	9.3	28.8	18.8	27.7	16.8	61.5	20.2	19.8	26.2	15.3	23.9	11.4	25.5	19.2	24.7	13.2	35.3	78.9	12.8	12.2	8.8	11.7	6.0	35.1	8.6	28.4	17.8	16.7	73.9	32.0	63.8	95.5	11.2	7.2	172.3	7.6	14.0	8.0	8.8	7.6	25.2	65.7	33.8	34.6	5.0	12.3	13.1	20.5	20.5	14.7	27.9	11.0	7.4
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 186.3;Microglial cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 323.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	41.4	22.4	53.9	32.3	53.8	9.0	18.7	44.8	56.5	17.0	29.4	44.4	12.7	19.1	13.5	32.0	9.4	23.1	14.4	49.8	50.0	25.0	42.3	20.2	33.7	53.5	50.2	18.4	11.3	12.9	7.5	28.0	53.0	35.9	16.1	11.8	10.2	66.0	10.7	6.1	13.2	46.1	56.7	21.0	13.1	11.0	55.2	14.6	21.5	18.9	38.9	34.8	9.5	52.6	56.7	78.2	40.9	30.2	22.9	58.5	59.1	44.2	323.1	36.6	35.4	64.6	40.4	86.4	52.4	45.5	192.7	3.3	50.7	112.3	46.6	8.8	10.1	36.8	71.4	46.5	195.6	10.9	11.9	74.5	61.9	55.5	137.7	134.1	73.7	13.8	28.2	17.0	87.1	23.8	11.5	19.6	12.6	14.3	75.5	20.9	53.7	2.1	31.3	23.0	2.8	29.7	25.0	8.0	21.8	49.0	19.3	22.9	94.2	96.8	65.4	25.5	53.8	19.3	18.7	79.0	78.6	28.3	22.9	5.4	2.2	0.4	0.7	3.2	1.1	5.1	1.4	0.8	2.5	3.7	1.1	0.5	2.3	1.0	1.4	0.9	0.2	0.8	53.9	53.8	44.8	56.5	49.8	50.0	53.5	50.2	53.0	56.7	55.2	52.6	74.9	16.0	1.1	45.7	38.0	3.7	9.4	22.9	7.4	18.8	16.5	11.2	4.5	17.2	33.7	11.0	4.2	1.0	6.3	0.3	17.6	39.3	2.8	4.0	11.1	43.6	1.2	10.9	46.1	21.0	57.9	12.6	3.1	5.3	2.5	9.5	22.9	35.6	13.3	70.7	186.3	0.4	12.2	25.4	25.8	6.6	8.1	28.6	17.8	190.2	27.5	12.1	7.2	69.9	79.0	24.3	0.1	13.9	43.0	31.5	2.0	21.8	32.7	3.4	0.0	14.2	17.3	9.8	5.6	3.3	3.4	5.7	10.7	32.4	0.7	14.1
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487551-183555706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3"	"Low region specificity"	"Detected in all"							HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	1.5	0.7	0.7	11.8	0.8	3.5	0.9	1.0	1.0	0.8	0.7	2.5	2.5	0.6	0.2	0.6	4.8	2.1	0.7	0.6	1.4	0.4	1.0	4.2	29.3	2.6	1.4	0.3	0.6	0.2	0.2	1.9	2.0	0.5	2.3	0.1	1.3	0.1	0.2	0.1	4.8	0.7	1.5	6.3	4.1	0.2	3.1	10.0	0.6	0.3	31.0	1.8	0.3	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	26.6	0.0	0.0	0.0	7.3	26.7	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.4	18.4	0.0	0.0	8.8	4.1	0.0	0.0	0.0	14.8	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	0.0	0.1	0.0	0.1	82.1	45.5	121.3	0.0	8.0	0.0	7.8	2.8	11.8	0.6	2.2	0.7	3.6	2.4	1.0	2.0	2.4	2.9	1.8	2.4	2.2	2.7	4.6	4.2	2.6	0.7	0.8	1.0	1.0	0.6	1.4	2.6	1.4	2.0	1.5	3.1	3.7	4.0	6.4	6.5	0.7	35.7	1.1	1.7	0.6	0.6	0.6	0.3	0.4	4.8	0.0	5.4	0.0	2.1	0.2	16.6	0.2	0.0	0.1	2.0	28.3	0.5	4.6	0.0	7.6	0.3	0.0	0.3	1.7	2.0	0.8	51.1	8.1	1.1	0.2	24.1	0.0	0.3	0.0	0.0	20.7	22.4	0.8	0.3	33.3	8.8	14.0	10.1	0.3	5.2	1.0	0.3	0.0	0.1	0.0	63.6	1.2	0.0	0.4	24.4	0.7	0.0	1.8	1.5	0.3	0.4	0.1	0.6	0.5	16.8	0.0	0.2	1.2
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	9.5	18.8	12.8	7.0	13.3	12.4	13.0	16.3	15.9	10.5	12.1	9.2	7.8	11.5	12.2	9.0	9.7	9.7	50.8	12.5	13.1	11.9	10.4	7.7	8.3	12.6	12.7	11.8	7.7	10.8	7.3	8.6	12.3	10.1	7.9	14.9	8.5	8.1	9.1	10.9	6.9	10.5	12.2	8.0	6.3	42.2	13.4	12.4	9.2	9.7	9.1	8.7	9.4	14.7	24.7	20.7	55.7	66.3	26.8	23.2	20.3	21.3	31.5	30.7	35.6	25.3	17.5	24.1	16.8	26.2	50.5	26.2	21.5	15.0	25.8	6.4	15.5	15.9	16.7	32.9	20.0	32.5	12.0	20.7	19.1	35.2	28.8	24.2	39.6	29.4	28.3	25.5	50.7	28.4	27.3	51.3	77.0	16.7	24.5	23.7	31.2	22.2	29.2	21.0	33.5	32.5	46.2	22.7	23.3	33.9	18.9	16.9	17.0	25.7	26.6	56.9	25.7	39.9	35.3	58.6	17.0	33.8	31.5	44.1	15.3	67.2	13.0	17.9	13.7	9.2	13.8	12.3	11.1	11.9	10.1	10.0	14.4	9.5	15.8	8.0	16.7	12.6	12.8	13.3	16.3	15.9	12.5	13.1	12.6	12.7	12.3	12.2	13.4	14.7	12.1	22.4	5.5	45.7	13.0	23.6	18.2	13.0	18.2	23.7	12.3	13.5	101.2	8.6	11.3	9.2	29.2	20.7	14.4	5.7	11.7	17.7	560.6	18.3	16.7	15.8	10.8	25.6	74.5	17.6	27.1	19.8	10.2	13.2	21.5	16.3	13.2	7.0	19.7	37.0	75.2	7.6	14.2	16.0	17.2	242.7	16.8	12.6	12.4	35.6	13.4	30.3	8.2	168.9	45.6	19.4	1.9	20.7	12.3	11.5	7.4	13.5	18.8	16.3	6.6	14.3	17.9	83.7	19.7	24.6	33.8	23.7	17.2	12.1	7.0	24.0
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329665-21335404	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	11.2	10.2	7.8	10.9	8.4	8.9	16.8	10.2	9.2	14.9	8.4	12.0	7.1	15.5	14.6	10.4	13.3	10.2	7.9	7.3	9.1	14.3	10.9	11.2	12.1	8.0	7.9	19.6	10.8	12.8	5.2	16.8	8.1	15.7	12.1	17.7	12.2	11.3	4.6	8.4	10.4	14.2	8.7	15.2	13.4	7.2	8.0	14.4	16.0	8.4	11.5	10.9	7.1	12.3	12.3	14.7	32.6	17.7	41.3	40.7	7.1	22.5	22.9	16.7	18.8	5.6	9.5	5.5	14.2	33.1	16.8	6.6	19.2	22.0	20.6	30.7	14.0	0.0	27.4	14.5	28.7	9.8	6.5	40.2	23.3	13.1	21.1	27.3	25.8	0.0	0.0	7.0	38.6	7.8	20.4	33.9	13.4	12.7	12.4	0.0	14.3	6.6	20.8	15.1	10.3	19.6	13.0	11.6	14.3	30.0	21.0	0.0	31.2	0.1	11.7	9.4	13.2	7.6	11.2	5.7	0.0	10.1	11.5	8.4	6.0	16.5	4.8	6.8	5.5	3.1	5.9	4.4	4.7	2.3	7.1	4.9	1.9	6.2	7.2	3.5	4.5	4.6	7.8	8.4	10.2	9.2	7.3	9.1	8.0	7.9	8.1	8.7	8.0	12.3	20.3	25.6	20.5	9.1	12.2	10.3	34.3	15.4	22.8	27.3	14.8	12.4	17.9	17.2	25.9	16.5	18.8	16.4	12.7	19.5	11.7	14.8	0.8	12.1	26.2	20.2	27.6	10.5	14.2	15.3	7.8	22.6	25.5	12.7	12.0	24.6	37.9	23.1	15.4	18.5	17.0	22.0	22.4	22.8	8.4	1.9	21.5	14.7	17.8	20.6	14.7	20.1	9.2	15.1	23.8	12.2	13.9	24.0	16.3	25.2	13.7	19.3	20.8	21.4	13.1	20.1	22.0	13.4	9.7	19.5	10.4	10.0	17.2	18.7	16.9	21.0
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819146-50823787	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	84	"pancreas: 9557.9;salivary gland: 5487.3"	"Group enriched"	"Detected in many"	7	"Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 9.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	13	"B-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 43.8"									HPA059690	Approved				"Secreted to digestive system"	NA	NA		10000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA059690: "	"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	1.4	2.4	0.1	4.0	0.0	0.4	1.8	0.0	0.4	1.9	0.0	68.8	9.6	2.0	0.0	1.3	0.6	0.1	3.0	0.3	0.0	89.4	0.6	0.5	0.5	0.0	0.0	4.7	9557.9	0.4	0.2	1.1	0.0	2.7	53.0	0.0	5487.3	0.1	0.2	26.3	9.7	2.8	0.0	3.3	1.4	0.1	0.0	0.2	2.9	0.2	1.5	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.2	0.3	0.5	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	0.1	0.4	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	9.7	0.0	0.1	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.1	4.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	18.9	19.5	1.2	2.9	1.2	0.0	1.0	1.1	0.3	0.0	2.5	0.0	0.0	0.0	0.2	62.2	45.0	3.3	0.6	0.1	1.4	0.4	117.1	0.0	0.0	788.4	0.0	7.7	1.5	0.0	8.9	8.8	0.4	0.0	0.6	0.0	0.0	1317.5	14.2	1.6	5.3	0.3	6.2	1.5	5.4	0.0	6.2	0.0	0.0	0.0	0.0	125.8	134.4	0.0	10.9	9.8	57.1	0.3	0.3	0.0	0.0	0.0	1.1	0.3	0.9	1.7	54.0	0.0	2.1	2.5	148.5	3.8
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 324.2;skin 1: 239.8;vagina: 186.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 53.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;HaCaT: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		1800000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	28.4	0.2	0.0	0.4	0.0	0.0	17.1	0.9	0.1	109.8	44.5	1.9	0.7	7.2	2.6	324.2	34.2	59.3	2.0	1.7	0.0	0.3	0.8	18.9	0.0	0.2	0.1	1.6	89.1	0.0	8.8	0.0	0.3	64.9	0.6	0.7	169.5	4.2	1.9	239.8	1.4	0.3	0.0	0.1	113.3	14.4	0.6	2.5	0.4	0.3	27.2	1.4	186.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	13.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.7	0.0	0.2	0.1	0.3	0.0	0.6	0.0	0.2	86.6	10.4	0.0	0.4	106.9	152.1	131.6	13.1	0.2	33.4	35.3	0.8	88.6	217.9	0.0	0.0	0.0	0.0	0.1	0.0	9.2	111.6	4.7	1.1	3.8	20.3	0.0	0.0	130.2	0.0	9.1	91.3	15.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	10.7	118.0	0.0	11.4	339.0	2.8	1.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	79.4	0.0	0.4	0.5	234.8	0.1	0.0	26.9	1.3	0.0	0.2	7.9	2.1	2.5	176.4	217.1	0.0	1.7	0.0	0.4	186.1
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"cervix: 108.5;esophagus: 208.6;salivary gland: 64.7;vagina: 99.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.7;Enteroendocrine cells: 40.3;Intestinal goblet cells: 24.9;Ionocytes: 14.2;Late spermatids: 34.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favorable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	108.5	2.2	2.1	4.0	0.0	0.0	208.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.1	0.5	0.8	0.0	64.7	0.0	0.0	0.6	5.8	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.1	0.0	8.9	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.5	0.2	0.0	2.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	30.7	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	14.2	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.2	8.4	0.0	0.0	0.0	0.0	1.3	1.7
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51055626-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 519.9"	"Group enriched"	"Detected in some"	4	"Late spermatids: 246.9;Squamous epithelial cells: 68.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 20.6;head and neck cancer: 42.3;melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062136	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA062136: AB_2684694"	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.2	96.3	0.9	0.6	1.6	0.5	0.4	519.9	0.5	1.1	0.2	0.1	0.1	0.1	0.2	0.7	0.0	0.2	0.5	0.2	4.4	0.4	0.3	0.0	0.1	0.6	0.1	0.0	74.9	0.0	0.1	10.8	0.8	0.3	0.1	0.1	1.4	4.3	0.1	0.2	0.3	0.0	63.5	0.2	122.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	27.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.6	1.1	4.0	0.0	0.9	1.9	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.1	0.1	0.3	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	246.9	0.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.7	68.3	1.3	0.0	0.4	0.4	0.0	2.1
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 9.7"	"Cell type enhanced"	"Detected in single"		"Club cells: 2.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.7;HEK 293: 2.9;U-266/84: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB026228	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.5	0.3	2.1	0.2	2.2	0.1	1.6	2.3	3.3	4.2	1.9	0.4	1.3	0.5	0.6	0.9	0.7	0.3	0.8	2.2	1.7	0.5	0.3	0.4	0.3	2.1	1.9	1.1	0.7	0.0	0.6	0.0	2.2	0.8	0.3	0.6	0.8	0.5	0.3	9.7	0.7	0.1	1.6	0.6	0.6	0.9	2.0	0.3	0.4	0.1	0.5	0.6	3.9	2.3	1.4	0.5	0.1	0.6	0.4	0.4	0.6	0.1	0.0	0.0	0.1	1.2	1.4	0.6	0.4	0.2	0.3	10.7	0.1	0.2	0.0	0.3	2.9	0.2	0.9	0.0	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.1	0.1	0.4	0.2	0.3	0.0	0.9	0.2	0.5	0.6	1.2	1.1	0.1	0.1	0.6	0.0	0.6	0.1	0.0	0.2	1.0	0.3	0.2	0.4	0.0	0.0	0.1	0.4	0.6	0.2	2.6	5.5	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	2.3	3.3	2.2	1.7	2.1	1.9	2.2	1.6	2.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.2;salivary gland: 5.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.5;Intestinal goblet cells: 34.6;Late spermatids: 8.8;Spermatocytes: 15.0;Spermatogonia: 9.5"	"Group enriched"	"Detected in some"	4	"prostate cancer: 3.5;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019802	Uncertain				"Secreted to blood"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.2	0.0	5.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	34.6	0.0	0.0	0.0	8.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	9.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	87	"prostate: 566.2"	"Cell type enriched"	"Detected in some"	40	"Prostatic glandular cells: 777.2"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 5.6"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.7	1.1	3.2	1.2	2.3	6.4	0.5	5.2	4.3	0.2	2.2	0.4	1.5	0.6	1.1	0.5	0.3	0.2	0.3	2.6	2.2	0.4	0.8	0.5	1.0	2.2	3.1	0.4	0.0	0.8	0.0	0.2	2.9	566.2	0.3	1.7	1.9	0.4	1.0	0.8	1.0	0.1	0.6	0.7	0.5	3.0	2.4	0.0	1.9	0.0	0.2	0.2	0.0	6.3	0.9	0.6	0.3	0.7	0.0	0.4	3.5	0.2	0.1	0.1	0.1	0.3	0.4	1.0	0.1	0.0	0.3	0.9	0.1	0.0	0.1	0.9	0.6	0.0	0.7	0.0	0.0	0.1	1.7	0.2	0.1	0.1	0.2	0.2	0.0	0.6	0.7	0.9	0.2	1.0	0.6	5.6	0.5	0.9	0.0	0.4	0.0	1.6	0.0	1.1	0.5	0.5	0.1	0.7	0.6	0.1	0.5	0.2	0.4	0.6	1.0	2.6	0.9	0.8	1.8	0.4	1.0	0.6	0.7	0.4	0.6	0.5	0.3	0.3	0.2	0.3	0.2	0.3	0.1	0.6	0.2	0.4	1.7	0.4	0.2	0.5	0.1	0.2	3.2	2.3	5.2	4.3	2.6	2.2	2.2	3.1	2.9	0.6	2.4	6.3	0.0	0.0	0.6	0.0	0.2	0.3	10.2	0.0	0.0	0.0	16.1	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	777.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	19.3	7.2	0.0	0.9	0.0	0.6	1.7	0.0	12.0
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 8011.8"	"Cell type enriched"	"Detected in some"	77	"Prostatic glandular cells: 3438.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	173	"BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000		"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		4.3	7.6	0.0	5.6	0.0	0.0	9.0	0.0	0.0	0.5	0.0	2.6	4.8	1.6	14.4	0.2	4.0	0.0	0.5	0.0	0.0	1.4	1.5	1.2	1.7	0.0	0.0	0.3	0.9	0.6	0.2	0.3	0.0	8011.8	1.1	0.0	4.5	25.0	0.3	0.5	3.7	0.0	0.0	0.2	1.0	6.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	12.4	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	1.8	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3438.6	0.1	0.1	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	4.2	0.2	0.4	44.6
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"prostate: 286.4"	"Cell type enriched"	"Detected in some"	15	"Prostatic glandular cells: 106.1"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.4;HaCaT: 7.9;OE19: 7.3;SK-BR-3: 5.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 4.5"	HPA051839	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"			"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.4	2.9	0.4	1.5	0.3	1.1	1.7	1.7	1.2	6.5	0.0	3.0	7.3	4.4	1.1	2.1	0.6	1.0	0.1	0.3	0.8	0.6	1.2	0.3	0.8	1.6	0.8	0.1	0.9	1.0	0.0	0.3	1.6	286.4	3.6	0.5	4.8	2.7	3.5	8.9	5.1	0.3	0.5	0.3	1.9	1.2	0.6	0.1	3.8	1.3	0.8	1.2	0.2	0.5	4.1	1.6	0.2	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.5	6.4	0.4	0.3	0.1	0.2	7.9	0.0	4.2	0.0	1.1	1.1	1.3	3.8	1.4	0.0	1.4	1.7	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.7	3.3	0.0	1.0	0.1	2.0	0.1	7.3	0.3	0.3	0.4	0.9	0.0	2.6	0.0	0.4	0.3	5.1	0.0	0.2	4.0	0.3	0.9	0.2	0.2	1.0	0.2	2.0	0.9	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	1.2	0.3	0.8	1.6	0.8	1.6	0.5	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.0	0.6	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	106.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	3.3	1.0	2.6
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 202.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 85.4;Late spermatids: 193.2"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 73.1;melanoma: 32.1;ovarian cancer: 112.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	41	"A-431: 485.1;HaCaT: 455.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014343, CAB025503, CAB026341, HPA073512"	Enhanced				"Secreted in other tissues"	NA	NA		2500000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB025503: , CAB026341: , HPA014343: AB_1852603, HPA073512: "	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavorable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavorable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (3.85e-6)"	4.6	0.0	1.1	0.0	1.1	0.0	30.2	0.4	2.6	15.6	0.6	0.0	0.1	0.1	0.0	23.0	0.5	0.0	0.2	1.1	0.8	0.5	0.1	6.1	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	23.6	0.0	1.1	202.7	0.0	0.0	0.5	0.3	0.0	14.2	1.6	0.1	0.1	0.0	0.6	0.0	13.5	0.7	485.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.1	455.4	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	1.1	0.0	1.5	0.1	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.4	2.6	1.1	0.8	1.0	1.0	1.0	0.5	1.6	0.7	0.2	16.0	0.0	0.0	0.0	26.8	1.8	2.4	12.0	0.0	33.0	27.2	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	85.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	193.2	1.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	1.6	0.8	2.8	10.9	0.0	0.3	0.0	0.0	0.1
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 94.7;skin 1: 201.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	7.1	0.1	8.4	0.1	9.2	0.3	11.2	0.9	7.4	19.7	1.0	0.1	0.5	0.7	0.2	94.7	16.3	1.3	0.2	6.5	1.4	12.1	0.1	3.1	0.0	4.3	1.4	0.1	0.1	0.3	0.7	0.0	4.9	0.1	0.0	0.1	21.6	0.2	1.0	201.2	0.0	0.2	2.1	0.8	0.3	0.3	7.4	0.9	0.2	0.0	10.9	0.0	30.9	3.0	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.4	9.2	0.9	7.4	6.5	1.4	4.3	1.4	4.9	2.1	7.4	3.0	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 118.0;skin 1: 87.1;vagina: 47.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	5.7	0.0	0.1	0.0	0.0	0.0	8.4	0.8	0.7	24.7	0.2	0.0	0.0	0.9	0.4	118.0	13.2	0.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	17.1	0.1	0.7	87.1	0.0	0.1	0.0	0.2	0.1	1.2	0.2	1.1	0.5	0.0	9.6	0.0	47.2	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.7	0.2	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51002508-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 11.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.0"									CAB025049	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"				"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.1	1.7	0.7	17.8	0.8	47.4	5.1	0.3	0.8	4.2	0.2	7.7	10.7	1.6	1.4	3.2	1.5	10.7	0.7	0.6	0.7	1.4	11.3	6.7	20.1	0.6	0.6	1.0	0.4	0.2	0.3	1.4	0.6	2.1	8.1	0.1	0.8	1.0	0.7	0.8	20.1	1.6	0.6	28.9	10.1	0.6	0.6	5.7	1.3	0.9	36.4	10.6	1.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.4	0.2	9.5	2.2	1.1	519.7	2.1	2177.1	1.6	307.4	346.1	1.9	1.5	17.1	98.0	10.5	756.7	3.6	3.9	77.9	285.3	0.7	0.8	0.3	0.8	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.8	6.1	0.0	8.9	0.0	19.0	9.7	0.9	0.0	1.2	0.0	5.2	2.5	1.0	4.3	1.3	0.0	0.0	0.4	642.3	1.7	0.0	0.6	0.0	1.9	1.5	6.2	0.0	118.1	0.4	0.0	0.1	7.9	12.2	2.4	0.0	0.0	45.3	10.1	0.9	0.0	0.6	1.0	0.0	36.2	15.8	0.0	0.0	13.2	24.9	0.0	28.1	0.0	1855.8	2.5	0.1	0.0	3.3	0.0	23.0	1.1	0.9	2.0	0.0	0.0	0.0	1.6	4.1	0.0	0.1	1.2	8.8	1.0	790.5	0.0	2.0	1.3
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 740.2;NK-cells: 1316.2;T-cells: 324.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5"	"Group enriched"	"Detected in many"	68	"NK-cells: 737.5;T-cells: 512.6"	"Low cell line specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069688	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"	1.6	1.4	1.5	2.8	1.1	8.4	1.8	2.1	2.1	1.2	0.0	1.6	1.8	1.2	1.5	1.3	1.1	1.6	1.1	1.6	0.7	0.8	4.1	4.7	6.8	0.4	0.2	1.1	2.2	0.5	4.6	1.3	0.4	0.6	0.9	1.3	1.3	0.6	1.2	0.9	3.4	0.7	0.1	17.0	2.1	1.2	1.0	0.5	1.2	0.2	4.0	2.1	0.8	3.0	0.2	0.1	0.2	0.4	0.4	0.2	0.2	0.7	0.0	0.0	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.3	0.0	0.2	0.0	0.5	0.5	0.4	0.7	0.1	0.5	0.3	0.2	0.1	0.5	0.1	0.3	0.3	0.1	0.3	0.3	1.2	0.0	0.5	0.3	0.3	0.3	0.2	0.4	0.1	0.4	0.3	0.2	0.3	0.6	0.2	0.2	0.6	0.1	0.9	0.2	0.6	0.3	0.5	0.9	0.4	0.1	0.5	0.5	0.3	0.7	0.2	0.4	1.7	0.8	1.1	512.6	2.0	58.1	0.8	3.5	217.7	1.6	0.8	1.3	218.7	9.2	737.5	1.5	2.1	1.3	163.0	1.5	1.1	2.1	2.1	1.6	0.7	0.4	0.2	0.4	0.1	1.0	3.0	7.4	0.0	10.5	1.3	5.8	0.5	1.2	0.2	0.6	0.7	1.7	1.0	2.7	7.2	1.9	0.0	6.2	1.8	740.2	0.4	0.0	0.6	9.0	1.1	1.2	7.7	0.0	24.0	3.1	0.0	1.0	4.5	10.7	1.8	2.5	0.4	15.0	4.3	0.7	1.7	2.0	0.2	0.0	18.3	1.2	12.6	0.3	7.0	5.4	4.7	5.1	0.3	1316.2	1.5	1.8	0.0	0.0	0.7	91.0	1.3	0.2	1.1	1.5	1.0	0.0	2.2	1.7	1.9	3.5	0.3	0.6	0.8	324.9	0.0	0.3	1.4
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 390.9;MAIT T-cell: 461.3"	"Lineage enriched"	"Detected in all"	22	"T-cells: 461.3"	"Cell line enhanced"	"Detected in many"		"HEL: 25.1;NTERA-2: 22.1;U-937: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	4.1	1.7	2.4	3.8	2.6	3.0	2.5	4.3	2.9	1.3	1.4	1.5	1.0	1.2	2.1	1.0	1.0	3.3	2.0	2.1	3.2	1.4	3.0	2.2	10.4	2.5	3.4	1.0	0.5	0.4	1.1	0.6	2.3	1.1	1.9	1.3	1.6	0.7	1.7	1.0	2.2	1.6	1.7	8.8	1.6	1.1	2.6	2.5	1.0	1.8	5.0	2.4	0.8	3.8	0.2	3.1	1.6	2.3	3.0	0.7	1.4	0.5	0.3	0.4	1.1	1.1	1.1	4.9	0.1	0.4	2.1	0.2	3.3	0.5	0.4	3.6	1.9	25.1	0.4	1.6	0.8	1.1	1.6	1.4	0.4	0.5	0.0	0.4	7.6	2.5	1.4	0.4	0.2	0.7	1.0	2.0	22.1	1.0	1.7	1.2	1.0	0.0	0.5	0.4	0.4	4.4	1.1	0.5	1.6	4.3	0.3	1.7	0.8	0.7	1.0	0.6	1.4	1.4	4.1	2.6	1.8	17.3	0.2	17.5	2.6	1.5	390.9	2.9	461.3	4.2	85.1	237.7	8.2	5.0	23.5	147.7	5.7	20.9	5.4	3.9	8.7	99.7	2.4	2.6	4.3	2.9	2.1	3.2	2.5	3.4	2.3	1.7	2.6	3.8	12.7	0.0	4.3	2.9	4.7	0.4	0.4	0.0	4.0	5.0	1.0	0.9	2.8	1.5	0.1	0.0	8.4	1.0	93.7	0.1	1.9	0.7	1.6	0.8	0.6	2.9	1.2	24.6	3.8	0.2	0.5	1.3	0.5	0.5	118.9	0.9	25.7	2.0	3.4	5.0	3.6	0.1	0.0	9.1	1.4	3.1	0.6	3.7	1.8	2.8	5.4	1.8	164.8	9.5	6.2	0.3	0.1	0.0	16.9	0.2	0.3	3.1	0.1	3.9	0.0	2.1	1.0	7.8	7.3	1.3	0.0	0.3	109.3	0.7	0.6	0.1
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483673	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.0;salivary gland: 4.3;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 5.2;Collecting duct cells: 7.3;Squamous epithelial cells: 14.2;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.7;HAP1: 15.7;NTERA-2: 8.2;SCLC-21H: 7.4;SK-BR-3: 31.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.0	0.4	2.5	0.0	2.9	0.0	0.1	0.0	0.0	0.1	2.8	0.3	0.4	0.1	0.1	0.1	0.0	4.3	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.9	4.1	0.1	0.7	0.1	1.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	2.0	0.0	0.0	4.3	0.0	0.0	2.2	15.7	0.0	0.0	0.0	3.9	0.0	0.6	0.0	0.1	0.0	0.3	0.0	6.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	2.8	2.5	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	7.4	0.4	2.3	31.9	0.0	6.1	7.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.5	0.8	0.3	5.2	0.0	1.3	1.4	0.5	0.0	0.1	7.3	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	14.2	1.0	7.7	0.0	0.0	0.3	0.5
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 31.5;liver: 91.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	79	"classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	97	"B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4"	"Region enriched"	"Detected in single"	4	"thalamus: 1.1"	"Low region specificity"	"Detected in many"			"HPA031115, HPA056942"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 57: B-cells - Immune response"			"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	1.4	0.8	0.1	5.1	0.2	1.4	5.3	0.1	1.0	0.6	0.5	0.9	0.6	5.4	0.2	0.2	0.2	1.6	0.4	0.3	0.0	31.5	91.7	5.0	8.8	0.0	0.0	0.2	0.1	0.1	0.2	6.8	0.1	0.3	1.1	0.2	0.3	0.2	0.1	0.2	1.2	0.7	0.0	8.4	1.2	1.3	0.8	1.6	0.2	0.0	11.2	5.6	0.1	0.3	0.2	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.2	6.2	0.4	0.0	0.2	2.5	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.2	0.7	0.1	0.2	0.5	0.0	0.4	0.1	0.9	0.0	0.2	0.0	2.4	1.0	0.9	0.4	1.6	0.1	9.1	21.9	4.5	0.3	0.1	0.0	10.9	0.1	2.1	4.3	2.1	0.0	0.0	0.1	0.1	1.6	0.4	0.6	9.4	0.2	2.7	1.8	0.1	11.0	0.2	0.0	32.3	0.0	36.1	0.0	0.0	11.3	42.0	0.0	0.1	0.3	0.0	33.8	24.3	0.0	6.1	0.1	0.2	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.1	0.0	0.5	0.0	33.8	1.0	0.1	13.3	2.2	0.0	1.8	0.8	0.4	2.8	11.1	0.0	0.0	3.6	5.5	0.1	5.9	4.8	4.9	9.5	1.5	0.3	0.0	5.2	6.6	0.2	2.3	0.4	2.0	26.6	0.0	0.1	0.7	46.9	7.0	0.0	30.0	0.0	4.1	22.7	49.4	1.8	0.0	33.0	0.0	0.0	5.5	0.0	1.0	1.0	0.6	1.5	0.0	0.0	11.7	0.2	0.2	63.2	2.3	0.0	0.0	0.1	1.3	1.6	0.3	3.1	1.4	180.1	1.6	0.1	0.0	0.1
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	9.9	6.7	8.0	8.5	8.6	19.5	9.9	21.2	9.3	10.3	1.6	10.8	5.4	10.7	8.2	6.8	10.3	6.4	6.5	7.4	9.6	6.7	6.0	10.5	12.4	6.3	6.3	21.2	11.1	9.8	10.2	5.6	6.6	9.2	6.4	23.9	9.4	8.4	7.4	10.4	9.8	7.6	3.2	9.7	8.2	5.3	7.0	14.1	9.9	8.4	11.3	10.7	9.3	11.9	17.9	8.6	20.1	14.5	11.1	16.1	6.2	8.7	11.8	9.0	9.6	17.3	11.4	23.1	15.9	10.8	14.6	16.0	22.9	7.2	17.9	26.0	10.0	45.7	8.9	9.3	6.1	28.5	7.8	7.2	7.4	20.3	24.0	8.9	12.8	13.3	32.8	18.8	9.2	12.7	18.2	12.7	13.6	6.6	13.7	13.8	21.9	6.9	9.8	13.8	18.0	11.8	22.0	6.7	3.9	9.8	11.9	9.1	20.4	14.1	12.7	9.4	14.7	5.1	4.4	15.6	4.7	17.6	8.3	2.1	0.6	1.9	1.6	0.6	1.6	2.5	1.8	1.5	0.3	1.8	1.8	1.2	0.5	2.0	0.7	1.4	1.7	0.4	8.0	8.6	21.2	9.3	7.4	9.6	6.3	6.3	6.6	3.2	7.0	11.9	87.1	70.5	65.8	93.4	83.4	86.9	67.6	29.4	64.9	158.1	76.8	73.9	44.5	40.0	32.2	38.6	152.2	13.9	81.0	26.2	3.9	33.0	10.1	62.1	101.4	74.4	66.4	67.3	146.0	25.6	10.2	65.6	44.4	85.2	29.0	57.5	60.0	27.3	16.8	195.2	170.1	29.6	20.3	37.0	63.7	5.8	66.8	44.8	42.7	62.8	49.9	98.9	78.2	106.6	131.9	28.2	20.1	78.6	83.3	88.3	22.7	10.5	52.7	152.4	65.7	113.4	84.6	25.5	30.7	46.3	80.6	6.0	102.8	55.8	30.6	64.8
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.9;Cone photoreceptor cells: 50.1;Horizontal cells: 67.3;Rod photoreceptor cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.7;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	3.7	5.9	5.5	1.3	6.0	5.0	4.6	6.4	6.5	5.6	4.3	5.4	3.5	5.0	0.9	4.8	8.6	1.1	4.5	5.1	4.9	5.2	5.1	5.4	1.5	6.1	5.7	6.3	5.9	1.3	11.1	1.9	5.9	6.7	0.9	2.6	5.2	1.3	2.8	9.2	5.0	0.7	4.9	5.7	4.8	7.1	5.8	1.9	4.6	0.6	0.9	4.6	4.5	7.4	6.2	4.1	4.1	3.3	0.8	1.0	10.5	1.8	0.7	0.6	1.5	2.8	5.1	6.2	2.2	1.3	0.3	3.1	2.8	2.2	0.7	5.5	20.7	4.2	3.7	3.0	1.4	2.7	5.7	1.0	2.9	1.9	1.0	1.4	1.3	6.5	12.4	3.6	0.7	7.1	8.6	6.4	7.0	3.8	6.0	12.3	4.7	6.2	1.0	1.5	19.3	8.2	0.9	4.9	2.4	2.6	5.3	3.7	1.4	2.1	4.4	0.9	1.3	9.8	5.2	4.1	1.2	6.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	6.0	6.4	6.5	5.1	4.9	6.1	5.7	5.9	4.9	5.8	7.4	3.3	6.4	4.1	0.0	4.9	0.0	13.5	0.0	7.4	47.9	11.8	9.3	0.0	8.6	3.1	3.7	50.1	31.1	13.3	7.5	1.9	6.6	2.3	27.4	7.5	3.9	7.3	18.9	0.0	2.9	20.4	5.4	16.3	18.0	2.5	11.1	6.1	1.1	9.6	67.3	0.0	15.0	0.0	5.1	0.0	2.4	7.5	6.2	0.0	0.0	2.2	19.9	8.2	0.0	0.0	8.7	11.9	6.4	9.8	10.6	21.1	2.7	3.6	49.7	6.6	5.4	3.0	21.0	30.5	6.5	0.0	19.8	13.0	23.0	11.3	11.8
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160219-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;pituitary gland: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.5	13.7	31.1	0.1	17.9	0.0	0.2	8.4	44.0	2.3	0.0	0.3	0.0	2.8	0.7	0.2	9.0	0.2	0.3	19.8	9.1	0.8	6.5	2.8	0.0	17.3	13.3	8.5	0.5	0.4	27.5	0.4	10.3	1.1	0.0	0.9	0.6	0.9	0.0	0.2	0.2	0.4	3.0	0.5	0.3	1.8	22.7	0.0	2.5	0.0	0.0	0.2	0.9	13.1	0.2	0.3	0.2	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.2	0.0	1.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	31.1	17.9	8.4	44.0	19.8	9.1	17.3	13.3	10.3	3.0	22.7	13.1	0.0	0.0	9.0	93.4	0.2	0.0	0.1	0.4	0.0	1.6	0.2	0.0	2.4	1.5	4.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	1.5	0.2	3.0	0.0	41.9	0.0	0.1	1.4	0.0	0.3	0.0	1.5	0.4	4.6	0.2	1.7	36.3	0.0	0.0	1.0	0.4	1.0	3.7	1.2	0.0	5.6	0.3	4.5	0.0	6.6	2.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	25.9	1.0	0.0	0.1	0.5	0.0	1.7	0.0	0.3	0.1	0.4	1.2	0.0	0.0
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717348-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 3195.2"	"Group enriched"	"Detected in some"	25	"Distal tubular cells: 655.4;Hepatocytes: 1816.9"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	47000000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	464.1	3195.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	48.6	0.0	33.1	0.0	0.0	0.0	1.8	655.4	0.0	0.4	0.0	0.0	1.5	0.0	40.2	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.0	1816.9	0.1	0.0	0.8	0.1	0.0	47.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.5	0.1	1.1	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.7	0.0	0.1	0.1
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701937-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 166.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	7.5	6.8	14.3	6.9	16.9	4.0	11.5	14.6	22.5	9.1	9.7	8.3	7.1	7.0	8.8	10.4	7.4	6.3	7.3	15.5	15.1	9.9	7.9	5.7	9.0	15.9	15.8	11.4	8.6	13.5	6.4	8.8	17.3	7.3	9.1	8.8	12.5	6.8	14.4	13.0	7.3	4.8	13.2	6.4	8.1	8.9	15.6	5.9	6.2	5.4	6.7	7.2	8.8	22.9	30.2	45.4	49.7	37.9	12.1	11.3	25.5	18.3	9.9	17.1	17.2	32.2	25.5	35.7	72.6	11.1	15.0	27.4	38.9	25.1	16.6	24.2	27.2	21.1	25.3	42.7	21.9	33.5	15.9	7.2	35.1	22.4	18.4	15.0	18.3	25.0	66.1	15.6	16.2	39.3	29.7	27.6	96.8	29.7	17.9	63.0	26.7	41.4	18.0	28.4	44.4	37.4	22.7	29.0	31.2	28.1	33.8	22.4	21.3	26.7	27.4	16.5	24.5	23.0	51.3	44.7	14.4	25.2	26.6	0.4	3.0	1.5	4.0	7.1	5.9	5.8	5.6	3.9	3.6	7.1	10.1	5.7	0.8	4.4	6.7	4.6	3.8	3.5	14.3	16.9	14.6	22.5	15.5	15.1	15.9	15.8	17.3	13.2	15.6	22.9	40.3	6.4	17.8	108.7	19.8	12.2	29.9	47.9	17.6	39.2	37.9	31.9	8.9	38.6	29.5	38.6	87.6	57.1	13.6	43.0	46.9	98.2	2.8	33.8	79.8	47.2	15.0	21.7	9.7	66.3	45.4	26.0	26.5	42.1	6.3	66.9	26.0	53.4	36.5	35.3	12.7	41.7	61.1	24.9	12.6	8.5	60.6	17.9	12.4	16.9	27.2	25.8	33.0	15.1	166.6	77.8	19.0	53.8	14.8	46.4	32.3	34.5	21.3	64.1	46.0	18.7	38.9	67.8	125.3	31.5	16.1	24.6	16.8	53.6	64.4	23.3
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	7.1	7.6	3.7	11.7	3.6	42.3	7.6	4.9	5.3	9.1	3.5	9.8	9.0	5.3	5.2	12.2	6.8	3.4	4.1	3.6	3.4	6.7	6.4	8.0	16.4	3.8	3.4	8.2	6.6	2.9	5.7	5.8	3.9	7.3	11.9	5.5	7.7	2.9	2.5	15.1	14.5	4.6	3.1	18.2	7.2	28.2	4.0	17.8	5.4	1.4	17.4	6.2	8.9	5.0	33.8	27.6	77.8	17.9	5.9	10.8	35.0	30.6	19.8	29.7	27.9	26.2	27.6	40.2	15.6	14.9	19.5	45.4	34.1	19.1	39.1	28.8	23.7	49.7	57.1	27.1	2.0	49.3	32.8	5.8	4.3	30.7	20.2	15.5	20.5	50.5	50.4	29.4	22.6	25.0	40.9	113.0	39.4	16.3	34.5	55.4	37.8	44.8	17.8	35.6	24.1	31.0	55.7	11.7	16.7	46.2	44.4	28.1	15.1	33.7	32.3	33.3	36.3	39.3	42.3	61.0	20.1	31.3	39.6	2.5	0.5	1.8	0.7	0.7	0.6	1.6	1.1	1.3	0.5	0.9	0.8	1.0	1.6	0.9	1.0	0.8	0.5	0.3	3.7	3.6	4.9	5.3	3.6	3.4	3.8	3.4	3.9	3.1	4.0	5.0	4.3	0.0	2.6	3.3	8.1	4.2	1.9	1.9	2.2	2.2	3.1	3.4	1.8	0.0	1.9	5.5	4.2	7.0	3.8	3.0	0.0	1.5	30.4	3.3	3.9	2.9	0.0	29.5	6.2	0.4	5.9	2.9	10.2	5.2	1.3	14.7	2.2	1.3	4.8	0.0	4.5	2.3	0.0	2.2	4.7	17.7	4.7	4.0	1.8	4.7	1.6	1.1	2.1	2.5	4.4	0.8	1.0	3.0	28.7	1.0	1.5	0.5	5.0	5.0	6.6	3.1	2.9	40.7	39.9	4.9	2.3	2.9	5.3	2.1	5.8	1.6
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421902-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	20.2	18.4	10.0	19.8	10.6	11.4	11.9	10.6	15.0	14.1	6.7	15.5	13.0	13.6	15.1	21.8	12.9	12.1	20.3	11.6	10.7	16.1	32.0	13.0	15.7	11.2	10.2	10.6	18.8	19.2	9.0	15.9	11.2	15.1	15.4	28.6	12.4	16.3	74.4	13.5	13.6	23.0	11.6	12.3	14.5	20.6	10.7	15.5	17.9	41.0	20.6	22.1	11.4	12.6	75.1	43.4	73.2	37.2	46.6	51.2	23.2	56.5	47.5	60.4	54.4	52.6	35.6	54.1	50.6	62.4	47.8	38.3	58.2	48.2	88.9	14.8	22.1	66.6	37.1	29.5	27.3	59.8	29.5	35.7	61.0	43.7	60.9	29.5	67.3	28.8	47.6	30.5	55.8	34.6	43.7	14.1	31.8	52.5	46.2	44.1	60.8	34.8	26.2	51.8	50.4	30.3	60.5	32.6	50.1	56.9	43.2	34.8	57.9	37.7	41.2	18.7	44.1	29.1	31.8	99.9	52.7	40.9	39.1	27.1	19.3	18.8	17.4	19.5	18.6	15.8	15.2	19.3	25.4	12.7	15.4	15.8	41.5	21.2	29.3	7.9	17.6	18.2	10.0	10.6	10.6	15.0	11.6	10.7	11.2	10.2	11.2	11.6	10.7	12.6	27.9	16.0	31.8	53.5	31.9	41.4	22.2	15.8	28.5	30.1	24.2	12.3	31.1	22.8	32.9	14.7	31.3	21.2	31.5	18.6	13.7	23.2	120.1	35.0	26.1	27.6	16.3	49.2	107.2	33.4	25.9	26.1	19.4	29.5	38.7	18.6	22.5	50.2	23.3	20.2	81.7	19.7	18.3	27.9	47.4	221.8	22.4	30.0	17.8	61.8	31.5	22.2	26.8	59.8	91.7	35.1	19.8	24.8	36.6	34.5	18.6	23.1	44.8	47.4	13.1	25.4	32.1	42.1	18.0	27.1	45.5	24.9	31.3	19.6	14.0	27.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741867	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	4.1	5.4	7.0	5.0	8.2	7.1	6.1	15.9	13.0	6.4	1.9	3.4	3.2	9.4	3.7	5.0	8.1	5.2	4.6	7.6	5.9	5.0	2.5	6.0	8.9	7.7	4.4	19.0	2.5	6.4	4.7	4.4	8.4	6.7	3.2	18.9	4.1	5.3	13.8	3.5	3.6	6.8	3.6	6.5	3.6	44.1	4.8	8.9	10.2	12.7	6.3	4.8	3.6	11.7	2.9	1.7	12.0	7.5	4.4	8.5	4.9	4.2	11.7	7.4	10.5	8.1	3.0	10.8	5.6	4.6	8.4	4.7	6.3	3.7	9.2	6.8	18.1	10.1	5.6	4.5	5.5	7.8	6.0	7.7	2.2	9.0	5.6	8.6	8.3	10.3	15.0	4.6	8.3	3.9	12.5	5.5	5.4	2.0	4.7	10.1	3.9	3.0	5.5	5.5	12.8	11.9	3.2	2.7	4.6	7.7	5.3	7.9	6.8	3.0	6.2	3.2	7.5	11.6	13.4	12.2	3.8	5.6	6.4	27.6	4.7	6.4	13.1	5.1	16.3	25.3	14.8	15.7	2.7	26.6	24.1	17.9	1.3	11.2	6.9	16.7	12.1	4.1	7.0	8.2	15.9	13.0	7.6	5.9	7.7	4.4	8.4	3.6	4.8	11.7	12.5	227.6	240.9	63.0	35.2	13.6	7.1	8.9	13.6	50.9	12.8	13.3	17.1	10.0	118.6	9.2	29.2	4.2	24.2	1.6	9.8	6.1	80.3	22.0	13.0	28.8	33.7	7.6	63.7	5.6	1.8	30.5	6.1	7.9	129.3	18.8	20.3	4.7	4.4	47.1	70.9	7.1	8.2	9.1	9.5	15.2	17.7	21.5	10.6	41.2	7.6	34.7	10.3	64.3	56.7	6.0	1.5	16.6	15.8	8.9	2.4	6.5	143.6	38.8	13.1	16.8	15.4	173.4	10.6	8.8	8.9	3.3	31.9	15.9	4.2	3.8
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KPNA7	IPOA8	ENSG00000185467	"Karyopherin subunit alpha 7"	A9QM74	7	99173572-99250075	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"stomach 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 5.7;Gastric mucus-secreting cells: 5.1;Pancreatic endocrine cells: 11.7;Respiratory ciliated cells: 4.4;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 3.8;CAPAN-2: 2.8;OE19: 2.8;SK-BR-3: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031395	Uncertain					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA031395: AB_10601584"	"unprognostic (7.38e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.35e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.28e-13)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-1)"		"unprognostic (3.54e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.7	0.0	0.5	1.8	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	5.7	0.0	1.3	0.1	0.0	0.0	0.0	0.8	3.1	0.1	0.4	5.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	11.7	2.2	0.0	0.1	1.9	0.1	0.0	4.4	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	11.4
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KPRP	C1orf45	ENSG00000203786	"Keratinocyte proline rich protein"	Q5T749	1	152759561-152762052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 329.1"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 20.0"	"Group enriched"	"Detected in some"	22	"head and neck cancer: 6.9;melanoma: 13.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.9;U-2197: 1.1"	"Not detected"	"Not detected"							"HPA031988, HPA031990"	Enhanced					NA	NA		27000000		"Cluster 61: Skin - Cornification"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"			"HPA031988: AB_10671582, HPA031990: AB_2674102"		"unprognostic (1.03e-1)"				"unprognostic (2.67e-2)"			"unprognostic (1.22e-1)"								"unprognostic (1.03e-1)"	0.2	0.0	0.0	0.0	0.9	0.1	10.3	0.0	0.1	13.9	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	1.7	329.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475150-47484265	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 23.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 23.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	5.2	6.6	5.1	3.0	5.5	5.6	4.7	5.9	8.4	7.2	3.6	6.2	3.4	5.3	1.4	7.7	4.4	2.4	5.8	5.6	5.1	6.3	8.6	4.5	3.4	5.6	5.1	3.2	5.5	4.0	10.0	2.8	5.0	8.0	2.2	1.6	10.1	2.0	6.9	4.8	4.5	2.6	4.6	6.1	4.7	5.4	5.1	8.2	4.8	6.7	2.1	5.1	5.8	5.4	9.7	16.8	12.9	8.6	12.9	10.0	9.3	5.4	9.9	28.4	17.5	12.6	11.3	12.3	4.1	9.5	10.1	11.1	11.0	19.1	7.9	11.4	17.2	5.2	12.2	11.4	11.5	10.1	13.8	11.5	12.3	9.5	8.7	7.2	11.0	15.2	10.1	10.9	8.3	7.8	17.7	44.8	11.6	10.5	10.3	12.6	6.3	4.8	8.8	15.0	27.8	21.1	9.1	10.3	6.8	6.4	8.5	14.5	6.6	6.9	7.6	3.7	12.2	2.8	4.8	5.3	6.1	6.4	10.4	0.0	3.9	1.7	1.4	3.4	0.4	1.5	1.0	1.2	4.6	1.6	1.3	1.1	3.2	1.2	5.3	23.9	1.7	2.2	5.1	5.5	5.9	8.4	5.6	5.1	5.6	5.1	5.0	4.6	5.1	5.4	2.6	3.2	2.7	4.6	4.8	2.8	8.5	13.8	2.8	5.8	5.8	3.9	3.7	4.3	8.9	5.5	6.2	14.5	12.1	3.4	9.8	9.6	0.8	3.1	3.3	3.0	3.0	0.8	4.7	4.2	13.3	5.0	5.1	3.4	2.5	4.9	3.3	6.2	8.5	10.1	3.5	2.5	8.2	5.6	2.8	2.5	1.2	5.8	1.8	1.9	2.5	6.9	5.2	3.0	4.3	5.0	1.8	0.7	6.5	4.4	4.3	8.3	2.9	4.0	0.0	3.5	3.5	4.9	18.9	4.5	3.1	15.3	1.7	8.2	4.0	5.8
KRAS	"KRAS1, KRAS2"	ENSG00000133703	"KRAS proto-oncogene, GTPase"	P01116	12	25205246-25250936	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049830	Approved					NA	NA		3300000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049830: AB_2680903"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (6.42e-2)"	"prognostic favorable (2.75e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.97e-2)"	11.8	9.1	11.0	16.2	12.2	27.8	10.0	11.7	12.3	9.5	4.6	22.0	14.0	11.0	6.8	19.3	7.4	13.1	8.6	12.5	12.0	11.7	15.3	13.2	17.9	8.5	9.7	8.0	12.6	11.1	5.7	17.0	8.7	11.8	23.0	22.7	11.9	8.3	7.6	13.6	19.5	13.6	8.1	12.0	20.3	8.9	12.9	17.2	10.8	10.3	17.4	16.2	11.4	8.6	15.9	14.3	39.4	20.7	14.1	19.9	68.9	17.3	22.8	18.0	21.9	51.5	30.7	38.7	10.4	32.0	23.4	18.6	44.9	17.3	34.3	26.7	15.0	37.6	17.6	15.6	15.8	32.8	25.6	18.1	25.5	21.9	20.2	33.6	27.1	28.7	28.0	17.3	27.6	14.1	46.8	56.6	87.6	25.3	7.4	43.4	39.9	59.9	27.2	22.4	11.2	32.4	20.5	24.9	21.8	97.4	28.9	26.9	28.1	18.7	24.8	38.2	22.0	16.4	28.5	41.9	15.4	20.0	15.0	31.2	8.1	13.7	11.6	16.4	7.9	10.7	10.1	13.1	7.9	10.5	13.8	12.4	19.2	11.2	22.4	7.8	7.6	5.8	11.0	12.2	11.7	12.3	12.5	12.0	8.5	9.7	8.7	8.1	12.9	8.6	73.7	48.1	32.1	16.6	90.8	100.9	96.4	57.2	72.3	63.4	59.9	38.0	16.3	64.3	53.6	38.6	73.0	94.2	66.0	161.9	58.7	77.5	3.9	45.4	40.8	77.3	78.8	60.2	42.0	91.8	21.4	50.1	98.4	53.4	24.1	26.6	77.8	56.9	51.5	92.5	45.3	92.9	36.7	53.9	83.7	5.9	40.7	75.3	62.2	28.1	82.9	41.7	49.4	19.6	16.6	114.2	104.7	51.6	85.0	130.1	63.0	52.3	42.5	65.8	26.3	53.7	52.2	53.0	40.3	93.0	155.7	139.1	83.0	36.5	96.7	176.9
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.2"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	4.1	6.0	6.0	5.0	6.7	3.9	5.4	4.3	10.1	9.2	1.8	9.0	1.5	9.6	2.3	5.7	7.0	4.3	40.2	6.5	4.2	7.6	2.6	4.7	4.6	7.6	4.7	8.9	7.6	6.0	25.2	2.3	4.8	8.9	1.3	4.9	12.9	5.6	6.3	6.9	5.3	6.4	2.6	6.8	7.4	6.8	5.6	3.9	6.1	4.1	3.7	8.1	7.5	7.1	8.0	4.9	9.5	20.0	4.2	4.1	8.3	4.2	5.1	6.6	7.5	0.5	2.1	2.4	8.6	5.3	13.3	7.8	7.2	14.0	3.3	11.1	13.7	4.4	7.5	4.7	5.2	0.0	12.0	9.2	6.5	4.6	2.5	7.8	6.1	13.0	18.4	2.5	3.4	3.2	11.7	6.8	11.4	3.7	4.7	12.2	3.8	1.3	5.1	6.3	7.5	12.7	6.4	18.3	4.5	4.3	3.2	6.8	6.2	8.0	3.4	0.0	5.8	11.7	4.1	10.7	4.7	7.6	8.5	0.0	0.7	0.1	1.4	0.7	0.9	0.6	0.7	0.8	1.0	1.3	1.2	1.0	0.5	0.1	1.6	1.4	1.6	0.7	6.0	6.7	4.3	10.1	6.5	4.2	7.6	4.7	4.8	2.6	5.6	7.1	2.0	0.0	3.2	9.4	1.9	1.8	2.6	2.7	4.6	7.9	4.4	3.9	10.3	5.7	1.6	3.7	4.2	1.2	4.8	0.0	0.0	4.9	0.6	0.8	2.0	1.6	0.0	0.4	6.9	2.7	2.3	3.0	2.6	0.9	0.0	6.3	1.4	1.2	5.2	8.4	6.5	0.1	0.0	2.8	0.9	1.2	4.1	1.8	0.0	1.9	1.6	11.7	2.1	5.5	3.3	1.3	0.0	3.4	1.1	3.0	0.0	1.8	1.6	4.2	6.6	2.8	2.2	1.8	3.5	1.2	1.8	1.2	2.8	3.0	0.1	1.9
KRBA2		ENSG00000184619	"KRAB-A domain containing 2"	Q6ZNG9	17	8356902-8376704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 30.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA022849	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA022849: AB_1852996"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.98e-2)"	"unprognostic (8.35e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.61e-4)"	"unprognostic (6.14e-2)"	"unprognostic (5.02e-7)"	"unprognostic (1.82e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.08e-1)"	1.7	1.9	3.4	1.7	4.8	1.1	2.5	5.3	4.5	2.4	2.5	1.5	1.6	2.4	2.5	1.4	1.7	1.2	6.9	3.4	3.6	3.6	0.8	1.6	1.6	3.8	3.6	2.6	1.7	3.9	1.8	1.8	3.9	2.6	1.6	34.5	2.4	1.7	6.2	3.0	1.7	1.8	2.5	1.7	1.6	2.0	4.1	2.5	2.8	6.8	1.3	1.7	1.5	6.8	0.4	3.6	4.6	4.4	2.0	2.8	2.3	0.6	1.3	1.6	2.3	0.0	1.5	0.3	2.6	0.5	1.1	0.9	1.6	0.5	2.2	1.9	1.0	0.6	2.5	1.3	0.7	0.2	1.0	2.5	0.2	1.8	0.6	1.0	2.9	2.3	0.1	0.6	1.4	0.7	1.9	0.5	0.7	0.2	1.2	3.4	2.5	0.4	1.2	2.4	1.6	3.0	3.4	1.2	1.0	3.1	1.5	0.2	1.5	1.3	2.2	0.5	0.7	1.6	0.9	0.3	1.6	0.1	3.1	10.1	1.3	2.3	2.0	1.2	1.9	1.7	2.0	1.6	0.8	2.9	3.5	1.9	1.6	1.5	2.7	1.6	2.2	0.4	3.4	4.8	5.3	4.5	3.4	3.6	3.8	3.6	3.9	2.5	4.1	6.8	9.9	0.0	1.1	6.2	2.2	0.3	1.3	1.3	4.6	3.6	2.9	3.0	0.7	1.5	0.4	1.8	16.7	2.5	1.7	1.5	3.9	3.4	0.4	0.9	3.0	4.5	4.2	7.4	2.6	1.1	0.6	2.8	2.6	0.9	5.1	3.5	2.2	0.4	0.9	3.3	4.1	1.5	2.0	1.0	1.0	0.6	1.5	1.2	1.8	1.9	1.2	2.9	4.1	5.5	4.1	2.1	0.1	3.0	3.8	0.6	1.3	1.4	2.3	30.2	0.0	2.4	2.9	2.3	2.4	3.1	0.9	1.2	2.4	2.5	1.6	0.3
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88064252	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: AB_2681907"	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	28.2	21.0	20.1	28.7	22.8	10.1	38.4	21.7	28.0	33.0	20.7	45.9	32.0	23.9	41.7	32.2	27.1	22.2	31.7	19.9	21.6	31.9	43.6	21.9	38.0	23.2	22.0	24.6	28.6	34.1	15.7	21.9	23.7	25.2	43.8	14.5	24.8	26.0	29.1	25.8	35.7	22.9	21.8	30.7	27.2	15.2	21.7	31.5	33.2	34.6	32.4	24.4	24.9	24.9	29.4	17.8	27.4	20.1	64.1	75.3	20.2	45.5	50.3	23.7	23.1	1.6	38.5	41.4	16.0	28.9	36.1	14.8	6.3	9.4	26.7	43.7	8.7	8.0	4.4	2.8	46.7	12.2	5.5	38.0	46.3	15.9	33.7	61.9	27.1	32.9	11.5	20.2	51.7	25.0	14.1	16.9	20.9	42.3	11.8	28.3	5.0	4.5	36.0	15.8	21.1	21.3	17.3	23.7	54.8	20.1	16.7	49.2	38.2	28.0	2.1	46.5	14.5	45.3	33.6	32.5	30.1	32.0	67.5	59.4	21.6	77.7	18.8	23.8	21.7	36.6	23.0	23.2	25.7	32.5	25.8	21.0	35.8	31.6	21.5	22.5	34.3	16.8	20.1	22.8	21.7	28.0	19.9	21.6	23.2	22.0	23.7	21.8	21.7	24.9	24.2	35.3	41.7	29.4	61.8	33.0	32.6	49.9	53.5	11.9	50.9	50.9	41.3	40.0	49.0	35.0	2.1	46.1	24.8	109.1	60.7	50.5	16.7	34.4	37.8	31.6	41.6	28.2	14.5	70.9	16.3	42.5	17.3	30.9	43.1	28.4	37.9	59.5	48.6	10.1	13.9	56.8	26.4	40.3	39.8	5.3	47.8	38.8	28.4	44.0	53.6	35.9	58.7	34.7	53.5	51.4	79.6	43.2	29.6	62.6	60.4	76.0	62.6	5.4	19.7	40.3	29.7	41.0	20.7	45.4	42.6	41.9	37.2	32.2	72.4	26.4
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2964216-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 4.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.1	0.1	0.7	0.3	0.7	0.7	0.1	0.0	0.6	1.5	0.0	0.3	0.1	0.1	0.1	2.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	4.1	0.4	0.0	0.3	7.7	0.6	0.0	0.0	0.2	0.2	1.7	0.0	2.1	0.0	0.0	0.8	0.0	0.5	0.1	1.8	1.1	0.4	10.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.2	1.5	7.8	2.1	0.0	1.1	8.6	1.3	0.7	0.0	1.1	1.2	0.5	2.9	2.6	0.0	0.6	29.3	0.2	0.0	0.0	0.1	0.9	0.0	0.8	3.3	2.9	0.0	15.0	1.8	3.5	2.9	3.0	2.2	4.7	11.8	28.8	0.1	0.3	2.9	1.8	2.0	4.7	5.2	0.4	14.9	2.8	0.2	0.9	12.2	1.0	0.7	5.3	1.3	4.7	0.4	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.4	14.1	0.9	0.3	23.3	0.4	1.0	0.9	0.9	0.0	0.0	0.0	6.2	0.2	0.0	1.1	0.0	0.1	0.7	0.4	0.1	0.1	0.0	0.0	0.4	2.7	1.8	0.1	0.0	0.9	4.5	0.0	0.0	0.0	0.1	0.0	0.1	14.0	0.0	0.0	0.6	0.6	0.0	0.2	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.2	1.3	0.0	0.1	2.1	0.5	0.0	0.0	10.9	0.0	0.0	0.3	9.7	18.0	1.2	5.5	0.1	0.6	0.0	0.5	0.4
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
KRIT1	"CAM, CCM1"	ENSG00000001631	"KRIT1 ankyrin repeat containing"	O00522	7	92198969-92246166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049606	Supported		Uncertain	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA049606: AB_2680832"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.04e-1)"	11.4	13.6	6.5	16.2	8.9	8.5	11.8	15.8	11.3	13.1	11.7	12.1	14.5	17.1	14.1	13.3	14.0	15.7	18.9	7.4	9.5	14.1	12.1	10.7	14.7	6.7	6.9	20.3	15.9	23.8	11.4	13.6	7.9	12.1	12.6	16.3	14.1	11.2	16.3	14.0	12.2	14.1	5.7	14.7	13.7	18.8	7.8	19.4	22.4	17.5	15.8	13.6	10.8	14.2	27.6	22.0	26.8	27.4	21.2	15.9	19.6	25.5	18.3	12.0	12.3	18.8	31.1	25.9	24.6	14.8	25.9	24.1	21.9	12.7	18.5	23.0	31.4	25.2	26.6	13.2	15.2	34.9	34.5	22.3	21.8	15.0	16.9	20.7	16.2	21.8	51.4	40.5	18.9	30.7	40.6	26.0	26.6	22.4	16.3	28.4	35.5	34.1	10.8	30.9	27.4	33.5	27.7	38.3	22.9	28.2	22.0	20.6	25.1	37.3	28.2	46.9	18.3	25.6	31.1	50.4	19.5	29.6	34.4	13.4	5.5	5.4	6.5	4.0	6.6	10.8	7.5	9.5	5.6	8.5	9.5	8.3	2.2	12.0	2.9	7.6	7.7	3.3	6.5	8.9	15.8	11.3	7.4	9.5	6.7	6.9	7.9	5.7	7.8	14.2	40.6	16.0	34.3	47.0	38.9	19.9	25.7	27.3	40.5	43.7	35.5	34.3	27.6	20.0	26.8	42.3	33.3	37.3	39.2	22.0	46.9	24.0	29.7	30.0	44.1	36.2	20.4	29.2	76.9	24.2	30.0	39.7	35.7	27.9	36.7	49.4	44.6	29.7	19.3	28.6	92.6	23.1	20.3	22.1	16.2	19.5	51.3	23.4	7.2	35.6	29.9	39.9	41.2	46.8	115.4	22.1	33.1	54.2	38.0	22.4	32.2	36.3	36.9	53.1	39.5	43.8	36.8	177.1	90.1	43.1	25.1	28.0	33.0	41.8	23.7	20.5
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skin 1: 13006.6"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 10030.4"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 313.8;melanoma: 478.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	14	"HaCaT: 94.9;hTCEpi: 39.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002153, HPA017917, HPA062908"	Enhanced					NA	NA		35000000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901"	"unprognostic (8.05e-2)"	"unprognostic (8.49e-3)"	"unprognostic (5.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.23e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.09e-2)"	10.3	1.4	0.0	0.1	0.0	7.7	464.1	0.0	0.1	473.6	0.0	2.6	0.2	1.3	0.4	30.8	0.4	0.3	4.5	0.0	0.0	1.2	3.5	2.6	0.0	0.0	0.0	1.4	3.7	0.0	1.4	1.6	0.0	1.5	0.1	0.0	270.2	0.1	47.8	13006.6	2.0	0.2	0.0	1.6	2.1	1.9	0.0	76.8	2.0	0.8	0.5	0.9	1257.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	39.3	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1681.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	22.3	0.0	0.0	0.0	17.4	0.0	0.0	234.7	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	267.0	0.0	0.0	0.3	265.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.5	0.0	0.0	1.1	10030.4	0.0	7.8	0.0	0.3	0.4
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822614	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"skin 1: 15851.5"	"Cell type enriched"	"Detected in all"	5	"Suprabasal keratinocytes: 12515.3"	"Group enriched"	"Detected in all"	4	"head and neck cancer: 310.0;melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"hTCEpi: 718.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000132, HPA012014"	Enhanced				"Secreted in other tissues"	NA	NA		18000000000	"Cluster 37: B-cells - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	66.1	47.9	9.4	7.6	9.8	13.4	432.0	9.9	14.9	548.0	10.4	45.2	7.9	55.0	5.5	78.6	45.5	2.2	95.7	9.9	9.8	67.2	64.5	39.7	6.2	9.8	9.7	52.3	69.1	8.2	77.2	3.8	9.8	60.0	3.4	6.9	163.9	5.5	123.1	15851.5	48.2	4.0	9.8	56.8	58.0	64.9	9.8	44.0	53.5	5.8	13.7	48.5	1106.2	10.4	30.3	31.2	11.0	12.2	14.4	11.5	10.4	29.9	16.5	11.4	10.6	11.2	11.7	8.7	42.0	13.1	16.2	158.5	5.4	11.3	13.4	20.1	27.0	9.2	44.7	19.4	16.4	17.1	24.9	10.1	718.0	9.0	17.3	15.0	7.4	12.3	102.1	16.0	12.2	17.3	25.5	16.2	14.6	23.1	19.1	17.8	16.7	17.7	12.3	26.3	8.9	11.1	19.9	46.0	39.0	17.3	35.5	24.3	9.3	17.6	29.5	22.5	34.4	0.4	19.8	22.4	24.5	10.4	23.4	12.8	2.6	11.1	4.8	2.3	5.4	11.2	5.4	6.8	4.1	5.6	5.8	5.9	0.8	6.9	3.2	8.1	5.5	1.9	9.4	9.8	9.9	14.9	9.9	9.8	9.8	9.7	9.8	9.8	9.8	10.4	197.8	35.3	40.0	19.2	187.5	2239.7	320.6	370.2	255.6	47.0	304.4	328.2	194.2	174.5	197.2	112.2	20.9	117.4	163.2	138.9	305.2	232.5	150.4	174.3	172.2	170.0	181.1	87.7	19.1	376.9	295.7	204.5	126.9	164.5	74.3	87.0	159.5	237.6	105.0	21.9	16.3	237.6	195.3	90.3	350.7	65.6	216.6	116.8	393.1	20.6	100.1	221.4	162.7	17.6	35.0	236.0	149.8	174.9	311.6	342.0	155.3	233.2	116.8	68.6	105.2	141.0	167.7	345.1	121.2	295.0	12515.3	160.1	164.3	131.4	173.1	515.6
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867223	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 3.9;Paneth cells: 12.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055217, HPA055835"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40925.1;vagina: 13409.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	7.7	7.5	0.0	0.0	0.1	6.8	5.1	0.0	0.0	6884.6	0.0	5.6	0.1	10.2	0.0	40925.1	7.0	8.8	9.2	0.0	0.1	5.6	12.8	6.0	0.3	0.0	0.0	9.9	17.2	0.0	26.9	0.0	0.0	115.2	0.0	0.0	6881.1	3.8	9.8	20.5	8.5	14.2	0.0	7.7	31.3	6.9	0.0	13.6	6.1	0.0	1855.2	924.7	13409.3	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586895	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6940.5"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 5910.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"spinal cord: 36.3"	"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1600000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	15.8	1.2	0.0	0.0	0.0	2.7	332.7	0.0	0.0	412.0	0.0	1.7	0.0	0.9	0.0	1304.2	1.7	0.0	3.5	0.0	0.0	0.8	2.5	1.7	0.0	0.0	0.0	1.3	2.9	0.0	4.3	2.2	0.1	29.1	0.0	0.0	702.1	3.8	15.9	6940.5	2.1	0.1	0.0	0.9	1.7	1.5	0.0	186.7	2.3	0.0	262.3	0.7	846.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.0	4065.2	0.0	2003.9	0.2	0.0	0.0	0.1	1.6	0.0	0.1	0.2	2.5	0.1	2448.6	3.0	794.2	0.0	0.1	0.0	0.5	3.6	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.3	9.1	1.7	696.0	0.0	0.9	0.0	0.0	3.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.5	35588.3	1072.7	181.5	2407.4	0.0	103.5	740.9	0.3	0.0	6.0	0.0	0.0	17.9	3.2	7.3	0.0	0.1	0.0	0.1	0.0	129.0	0.0	0.0	0.0	0.0	127.0	116.5	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.4	0.0	0.0	1833.4	0.0	0.0	9.3	1990.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	9.9	702.0	96.8	0.0	2.3	0.0	0.0	0.0	96.3	0.0	0.1	83.2	11677.1	2.5	62.1	0.1	2.3	100.0
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 307.2;esophagus: 1025.8;skin 1: 360.7;vagina: 489.4"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;hippocampal formation: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 816.8"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		1700000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	7.1	1.4	0.2	0.1	0.3	0.3	17.4	3.9	0.6	307.2	0.0	0.2	0.0	1.0	0.0	1025.8	0.7	2.4	0.5	1.0	0.0	0.8	0.4	0.2	0.1	0.0	0.0	0.3	0.7	0.0	1.4	0.1	0.1	6.3	0.0	0.0	180.6	37.7	0.5	360.7	0.2	0.1	0.0	0.2	0.6	2.6	0.0	16.9	0.3	0.0	112.1	5.5	489.4	0.4	20.0	1.7	0.0	0.0	0.2	0.0	0.2	1.5	0.4	0.5	0.2	0.3	4.9	0.1	2.9	0.1	0.2	24.8	0.0	5.6	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	816.8	0.3	17.6	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.0	0.3	0.0	127.1	0.7	0.0	0.2	98.1	0.8	6.2	0.0	0.0	57.1	1.5	0.0	0.9	0.0	0.0	0.2	0.0	1.6	4.5	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	3.9	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	906.1	596.6	70.1	16.5	0.0	37.8	27.1	0.1	0.0	94.6	1.8	0.0	0.1	0.6	0.0	0.0	1.0	0.0	2.6	0.6	9.2	0.0	0.0	0.0	5.8	3.2	11.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	94.1	0.0	0.3	1.1	64.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	127.3	0.0	0.0	17.1	0.0	0.0	0.0	9.3	0.0	0.3	88.1	1348.4	0.1	3.4	0.0	0.0	506.9
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619442-41624842	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 382.1;skin 1: 949.4;urinary bladder: 632.2"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"hTCEpi: 20287.9;SiHa: 8539.7"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		610000000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	5.1	0.4	4.9	0.8	5.3	2.8	382.1	3.5	5.8	102.2	3.5	2.0	0.8	4.3	14.1	320.4	6.9	1.9	2.7	6.3	3.3	3.1	0.6	9.8	0.3	3.5	3.4	0.9	2.6	0.5	6.6	7.0	3.5	132.4	0.3	0.3	263.2	116.1	0.9	949.4	0.6	1.0	3.4	0.4	2.3	4.5	3.3	142.7	1.6	0.0	97.8	632.2	212.3	4.7	212.5	0.2	0.0	0.0	0.8	0.9	48.8	1.9	0.4	2.8	2.7	16.8	1.9	1.0	14.7	0.2	0.4	2101.7	0.1	2129.1	1.9	0.3	1.6	2.0	910.8	2.0	0.5	1.9	2.2	0.4	20287.9	1.3	1539.9	0.0	1.0	0.0	1.0	1.5	0.4	0.7	0.7	0.3	0.4	237.2	0.0	0.7	3.1	1.7	0.8	770.5	0.3	0.2	8539.7	3.8	0.9	4.8	0.3	1.4	0.8	0.0	401.5	0.2	1.0	0.9	0.4	3.1	1.4	77.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	3.5	5.8	6.3	3.3	3.5	3.4	3.5	3.4	3.3	4.7	5.6	22.4	7.2	0.3	0.5	139.6	13196.1	338.0	327.8	0.2	158.4	792.8	0.1	0.0	415.8	36.8	0.0	21.5	3.8	0.9	0.0	567.7	0.4	116.9	13.5	54.5	1.8	0.0	3.2	202.1	148.5	87.9	0.0	134.1	3.8	0.0	0.0	0.0	3.8	20.2	0.5	0.6	36.7	0.0	14.1	1.6	2.1	37.5	10.6	3.7	6.7	0.0	0.0	0.5	1.4	1754.5	2.5	212.5	0.0	5931.6	0.1	0.4	100.1	0.0	0.0	0.9	101.0	0.3	0.4	48.2	124.3	5.7	60.8	3.1	0.8	8499.3
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952906	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 76.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in many"		"A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 12.1"	"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol		NA	NA		140000000	"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB000008: , CAB000030: , HPA001605: AB_2666381"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	170.3	29.0	2.6	77.5	1.4	1.5	209.8	5.3	1.6	243.5	34.8	424.1	324.3	27.8	226.0	118.4	193.5	180.6	38.3	2.2	6.9	247.2	519.5	177.8	8.6	26.1	4.3	16.4	570.2	79.5	251.9	474.5	30.3	183.3	492.3	0.6	323.4	129.5	2.1	44.5	370.7	23.4	2.5	28.5	289.9	8.3	13.9	10.3	244.1	1.4	27.8	199.7	62.2	2.5	2065.1	5639.4	1.1	7.9	0.7	1.1	3818.0	313.3	349.5	368.4	104.6	6249.4	4576.4	1.4	839.8	318.4	196.5	487.2	79.1	2228.5	217.9	2.6	138.2	19.4	865.7	1743.9	942.1	0.6	1.3	13.6	202.9	323.8	437.1	1046.9	399.0	3.4	511.4	0.2	0.3	8470.0	3.8	37.3	471.0	2740.1	457.9	3.0	0.3	236.1	1803.3	1144.9	65.6	3.7	512.7	4583.8	18.8	2696.0	2446.8	6.6	137.9	5.0	441.8	6.9	68.3	1.1	7.3	4.3	0.9	1.2	36.4	76.7	0.3	2.4	0.6	0.2	2.2	4.6	4.5	1.2	2.2	7.4	11.1	4.1	3.2	2.5	0.0	0.1	0.4	2.9	2.6	1.4	5.3	1.6	2.2	6.9	26.1	4.3	30.3	2.5	13.9	2.5	14.4	862.2	286.4	0.3	29.8	14.8	1605.7	912.1	447.3	0.1	814.6	615.6	5.3	1252.5	877.3	623.5	0.0	3698.8	14.2	1942.9	275.9	6583.8	1.0	462.3	60.3	77.8	642.3	15.4	0.0	4826.1	5496.7	203.5	971.5	742.4	48.9	51.2	57.1	610.9	308.3	1.7	0.0	2492.6	1969.3	9.8	13.8	3.8	10.5	28.3	208.1	1.0	41.5	6.2	0.0	0.0	0.0	6071.5	2164.1	0.0	13.7	1205.1	1912.3	718.5	500.8	0.6	0.0	0.6	298.6	2.7	26.0	395.7	6.7	7643.5	38.1	45.0	1635.0	1512.1
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		300000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	89.3	18.7	2.0	61.7	2.4	0.3	403.3	7.9	2.5	250.0	1.6	525.7	348.3	57.9	72.0	889.0	176.1	298.6	13.5	1.5	1.7	141.8	7.7	204.1	0.4	1.6	2.9	74.4	48.8	14.3	15.6	175.1	2.2	208.3	359.2	0.1	810.7	194.2	1.3	141.9	776.1	46.5	1.4	1.2	631.5	3.4	1.8	127.8	28.3	1.6	98.3	781.4	317.0	1.8	2.6	343.4	0.0	6.3	0.7	1.8	1169.3	412.1	0.5	12.8	2.9	992.6	1945.3	0.4	393.3	199.0	1.5	1044.6	0.1	2945.0	2.5	0.8	10.4	0.2	213.4	692.3	30.3	0.0	82.0	0.7	524.9	9.0	0.4	0.2	26.2	0.0	148.4	2.5	0.1	2220.9	5.9	3.0	18.5	1323.5	492.7	2.9	0.1	5.8	1335.4	3146.7	40.0	1.7	3.3	5446.1	0.1	266.5	3674.2	0.3	1.7	3.6	6.1	7.7	0.7	1.1	0.8	2.0	1.5	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	2.4	7.9	2.5	1.5	1.7	1.6	2.9	2.2	1.4	1.8	1.8	10.5	673.1	185.5	0.0	17.8	5.2	4317.3	7444.0	1715.8	0.0	1393.0	867.5	2.9	662.0	5055.9	892.0	0.0	1160.8	20.5	3599.6	1.9	4717.9	0.1	737.2	102.8	41.9	362.5	0.0	0.1	2589.9	6919.3	171.8	1571.4	1010.7	94.6	1.0	1.1	0.7	179.0	0.0	0.1	1382.4	2720.0	2.6	2.5	2.6	37.9	25.5	190.3	1.0	30.0	0.8	0.0	0.0	0.0	7374.9	3399.6	88.8	19.9	2228.8	8623.3	26.7	1954.3	0.0	0.0	0.0	240.0	1.1	1.6	1302.6	1.1	2127.5	36.1	4.8	1619.0	5959.8
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4660.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	3.0	0.5	0.0	0.1	0.0	1.0	81.9	0.0	0.0	0.8	0.0	0.9	1.6	0.4	0.3	1.1	0.1	0.0	1.7	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	47.8	4660.3	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.8	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875889-40885242	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 646.9"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		NA	NA		30000000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	1.3	0.0	0.0	49.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	597.7	295.9	2.1	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	480.1	0.0	0.0	1.2	0.0	0.1	646.9	27.0	0.0	0.0	124.9	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1328.5	0.0	0.1	0.0	0.0	0.0	0.0	43.9	0.0	0.1	0.0	0.0	0.0	115.7	0.1	13.4	0.0	0.0	0.0	0.1	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1606.6	0.0	0.6	1.9	1107.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	160.4	1.4
KRT222	"KA21, KRT222P, MGC45562"	ENSG00000213424	"Keratin 222"	Q8N1A0	17	40654665-40665181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;retina: 8.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 53.9;Excitatory neurons: 25.9;Horizontal cells: 28.6;Inhibitory neurons: 24.4;Muller glia cells: 46.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 9.7"									"HPA054586, HPA068724, HPA069774"	Enhanced		Approved	"Vesicles,Lipid droplets"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Lipid droplets"		"HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195"	"unprognostic (2.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.41e-2)"	1.2	2.7	4.8	0.1	5.5	0.0	0.3	6.1	9.7	0.4	0.0	0.5	0.4	0.5	5.0	0.3	0.3	3.3	0.3	5.0	4.0	0.5	2.8	0.2	0.1	3.8	3.5	0.1	0.5	0.7	1.8	0.0	3.9	1.1	0.5	8.0	0.2	1.4	0.0	0.1	0.9	0.5	1.8	1.8	0.3	0.3	4.1	0.4	0.7	0.1	0.1	0.3	0.4	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	6.1	9.7	5.0	4.0	3.8	3.5	3.9	1.8	4.1	5.1	1.5	0.0	0.5	1.3	0.0	0.1	0.8	0.0	1.8	53.9	1.0	0.6	0.5	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.4	0.0	0.1	4.3	0.0	0.0	25.9	0.2	0.2	2.5	0.0	0.0	2.5	0.0	2.2	3.5	0.0	28.6	24.4	0.2	0.0	0.3	0.3	0.6	6.5	0.0	0.0	2.8	0.0	46.7	0.0	1.5	2.1	0.1	0.0	0.7	0.0	0.1	1.2	2.7	0.0	8.9	0.0	0.0	0.2	0.2	1.2	0.9	0.0	0.1	0.1	0.0	0.1	0.1
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922700-40937646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"salivary gland: 147.7;skin 1: 172.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1328.6;Cytotrophoblasts: 679.8;Prostatic glandular cells: 2203.0;Syncytiotrophoblasts: 3890.8;Urothelial cells: 1590.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 61.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"HBEC3-KT: 9.6;Hep G2: 11.0;SuSa: 7.1;T-47d: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		NA	NA		590000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.26e-4)"	0.4	0.0	0.0	0.3	0.0	1.1	15.7	0.0	0.0	6.8	0.0	0.1	0.2	1.1	2.1	6.5	3.0	1.5	0.2	0.0	0.0	0.6	1.0	1.4	0.0	0.0	0.0	0.1	3.6	0.1	2.8	15.6	0.0	20.7	0.0	0.6	147.7	0.4	0.3	172.3	0.2	0.0	0.0	3.0	0.2	21.7	0.0	0.4	0.1	0.4	2.5	4.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.0	9.6	0.0	0.0	0.0	0.0	0.1	11.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	7.1	16.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.3	0.3	4.6	1328.6	242.1	0.6	0.0	78.0	27.9	0.4	12.8	390.5	3.7	0.0	679.8	1.1	0.1	1.9	462.9	66.2	49.8	7.8	15.1	7.1	0.0	0.5	0.8	109.3	15.0	0.0	66.4	0.0	0.0	0.0	0.0	63.8	0.0	0.3	0.7	57.0	0.0	0.7	10.6	0.6	3.0	5.4	0.0	5.4	15.8	0.0	0.5	0.3	17.7	1.1	0.7	0.0	2203.0	0.0	0.4	275.0	0.2	0.0	0.0	48.4	62.1	0.7	7.9	8.1	3890.8	7.6	0.1	0.9	1590.3
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703752	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 178.0;lymphoid tissue: 76.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0"	"Group enriched"	"Detected in some"	4	"cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 7.0"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Low region specificity"	"Detected in some"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA		300000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	8.0	0.0	0.1	16.7	178.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	5.8	0.2	2.2	1.6	0.0	0.0	0.3	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	76.3	2.6	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755331	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"skin 1: 112.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.8;Late spermatids: 9.2;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPTEC TERT1: 1.3"	"Region enriched"	"Detected in some"	7	"cerebellum: 8.6"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 7.3;hippocampal formation: 4.8"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			2.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.3	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT26	KRT25B	ENSG00000186393	"Keratin 26"	Q7Z3Y9	17	40766238-40772162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"skin 1: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"basophil: 2.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026890	Enhanced					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 61: Skin - Cornification"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA026890: AB_2672042"																		0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.6	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782550	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"skin 1: 71.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9;thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"hippocampal formation: 80.6"	HPA055114	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	8.8	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792196-40799959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"skin 1: 11.7"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			HPA066890	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA066890: AB_2685742"																		0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT31	"Ha-1, KRTHA1"	ENSG00000094796	"Keratin 31"	Q15323	17	41393721-41397608	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skin 1: 284.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 39.1;Basal squamous epithelial cells: 21.6;Endometrial ciliated cells: 7.2;Glandular and luminal cells: 10.9;Squamous epithelial cells: 16.5;Suprabasal keratinocytes: 7.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049550, HPA055194"	Enhanced					NA	NA		440000000		"Cluster 61: Skin - Cornification"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA049550: AB_2680813, HPA055194: AB_2682733"	"unprognostic (3.92e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.71e-2)"		"unprognostic (4.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.84e-1)"			"unprognostic (4.07e-1)"			"unprognostic (4.26e-2)"	"unprognostic (1.65e-1)"	3.8	0.0	0.4	0.0	0.1	0.0	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	4.7	284.4	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	39.1	0.3	2.9	21.6	0.0	0.2	0.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	10.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	16.5	7.7	0.0	0.1	0.2	0.0	0.0
KRT33A	"Ha-3I, Krt1-3, KRTHA3A"	ENSG00000006059	"Keratin 33A"	O76009	17	41346092-41350828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 47.5"	"Group enriched"	"Detected in some"	8	"Basal squamous epithelial cells: 1.8;Early spermatids: 2.2;Late spermatids: 2.1;Squamous epithelial cells: 4.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055194	Supported					NA	NA		160000000		"Cluster 61: Skin - Cornification"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA055194: AB_2682733"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-2)"				"unprognostic (4.58e-2)"		"unprognostic (4.34e-1)"									"unprognostic (2.16e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.5	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0
KRT33B	"Ha-3II, KRTHA3B"	ENSG00000131738	"Keratin 33B"	Q14525	17	41363498-41369813	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"skin 1: 82.8"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 2.9;Ionocytes: 2.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BJ: 4.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.1"									HPA055194	Supported					NA	NA		350000000		"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA055194: AB_2682733"		"unprognostic (3.34e-2)"				"unprognostic (5.19e-2)"		"unprognostic (3.04e-1)"					"unprognostic (1.55e-2)"				"unprognostic (6.28e-2)"	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skin 1: 66.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 5.4;Late spermatids: 15.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ: 201.8"	"Not detected"	"Not detected"							"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		170000000		"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	1.1	1.8	0.0	1.6	0.0	0.0	0.0	0.1	1.9	0.0	201.8	8.8	23.5	46.4	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.1	26.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 59.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025750, HPA078713"	Enhanced		Approved	"Intermediate filaments"		NA	NA		220000000		"Cluster 61: Skin - Cornification"			"Intermediate filaments"		"HPA025750: , HPA078713: "																		2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	59.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19735.6"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.5	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	513.5	0.0	1.1	0.0	1.2	0.0	19735.6	9.5	3.1	7.2	0.0	0.0	0.9	2.6	17.3	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.3	0.0	0.0	2124.1	0.0	2.6	3.9	1.7	0.9	0.0	1.5	8.6	0.8	0.0	2.0	1.0	0.1	1418.0	4.4	1040.2	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT40	"FLJ36600, KA36"	ENSG00000204889	"Keratin 40"	Q6A162	17	40977716-40987135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pituitary gland: 2.5;retina: 1.8;skin 1: 2.3"	"Group enriched"	"Detected in some"	61	"Enteroendocrine cells: 22.1;Muller glia cells: 27.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075961	Supported					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"			"HPA075961: "	"unprognostic (2.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.92e-1)"		"unprognostic (9.09e-3)"		"unprognostic (2.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.47e-2)"			"unprognostic (9.60e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	22.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487176-52493257	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 2523.3;esophagus: 7338.5;vagina: 4945.4"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 9761.7"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		4500000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	3.1	1.5	0.0	1.9	0.0	0.1	6.9	0.0	0.0	2523.3	0.0	1.2	0.0	1.3	0.0	7338.5	9.1	0.9	1.8	0.0	0.0	1.1	2.6	3.4	0.0	0.0	0.0	2.3	3.3	0.0	3.1	8.8	0.0	5.0	0.0	0.0	1025.5	0.0	1.9	480.0	1.3	0.4	0.0	1.4	4.9	1.0	0.0	33.6	1.5	0.0	628.6	19.7	4945.4	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.9	0.0	0.0	1143.8	0.0	2414.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.6	0.3	9761.7	0.2	306.7	0.0	0.3	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	14.0	0.3	0.1	0.5	0.0	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.2	0.2	0.4	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.5	79.0	674.0	12.0	0.0	0.6	1.7	0.0	0.0	200.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	5.5	0.0	0.0	0.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	100.4	0.0	0.0	24.5	0.0	0.0	0.0	11.8	0.0	0.0	876.0	151.4	0.0	1.7	0.0	0.1	306.8
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 228.2;esophagus: 934.5;skin 1: 285.1;vagina: 229.6"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 217.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 1424.3;melanoma: 472.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 148.7"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.9	0.2	0.0	2.0	0.0	0.1	16.2	0.0	0.0	228.2	0.0	0.5	0.0	0.1	0.0	934.5	0.2	0.2	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	168.6	0.0	0.3	285.1	0.2	0.0	0.0	0.1	0.7	0.2	0.0	2.1	0.1	0.0	74.3	0.2	229.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	27.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.7	1.1	0.0	0.1	13.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	20.6	1.8	40.4	0.0	0.0	28.7	16.8	0.1	0.0	16.3	0.0	0.0	0.0	0.9	0.3	0.0	46.2	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.6	0.0	0.0	2.8	0.0	0.0	0.0	1.4	0.0	0.2	217.5	32.7	0.0	0.3	0.0	0.6	5.9
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 211.7;esophagus: 799.4;vagina: 333.5"	"Cell type enriched"	"Detected in some"	60	"Squamous epithelial cells: 234.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 564.7;melanoma: 242.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 94.1"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	211.7	0.0	0.1	0.0	0.1	0.0	799.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	144.3	0.0	0.1	24.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	9.5	0.1	333.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	1.3	2.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	234.3	2.4	0.0	0.0	0.0	0.2	3.9
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 905.8;thyroid gland: 593.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315, CAB079970"	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA		1300000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	27.1	0.7	0.0	1.4	0.0	0.3	272.9	0.0	0.2	48.4	0.0	1.6	0.4	12.9	15.2	91.7	75.9	82.4	5.6	0.0	0.0	147.5	14.2	325.2	1.7	0.2	0.0	2.4	57.4	5.6	12.0	265.1	0.2	58.1	0.7	0.3	905.8	213.2	1.7	78.3	1.3	0.4	0.1	0.8	17.8	0.8	0.1	3.3	593.0	2.0	6.7	389.8	20.1	0.4	4.9	2418.2	0.6	1.7	2.8	0.0	2737.9	509.6	0.6	261.3	23.6	7.6	1683.1	0.3	1.4	176.3	0.8	1871.6	0.2	6225.3	13.3	3.0	0.0	2.2	1179.8	8.0	57.4	1.5	1.5	1.3	380.7	1.3	2433.8	1.0	267.4	0.0	0.7	2.2	0.1	13.7	1.8	3.7	7.6	1.1	2.6	2.0	4.8	38.6	1520.5	7463.2	3.5	2.4	5833.6	3363.4	0.0	27.5	130.3	0.0	2028.2	1.9	3.7	2.4	1.1	1.8	0.4	2.0	2.0	1.6	1.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	8.1	653.9	109.4	0.0	2.5	3.6	1172.6	173.6	8.0	0.0	451.3	426.3	0.8	724.9	684.8	360.5	0.0	1756.7	8.9	2.2	135.0	2931.3	16.1	106.2	20.4	30.6	6.6	0.0	0.1	2143.5	4196.1	29.9	14.3	253.2	3.8	0.1	4.2	2.9	189.9	0.0	0.0	3.5	954.2	3.4	4.6	140.0	3.7	11.0	131.6	0.0	35.6	0.0	0.0	0.0	0.0	6163.7	0.3	0.4	1.4	2386.6	0.2	8.5	249.2	0.0	0.0	7.6	72.1	0.6	1.3	35.3	2.3	1442.5	9.2	0.0	4.4	1900.8
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553145	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skin 1: 100.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"CACO-2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049404	Enhanced					NA	NA		110000000		"Cluster 61: Skin - Cornification"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049404: AB_2680748"	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 10.5;testis: 23.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced					NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.1	0.1	0.0	0.7	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.5	2.2	0.0	0.0	2.2	0.0	23.7	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	26.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	1.5	0.1	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.0	2.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.2	0.0	0.4	0.0	0.3	0.0	0.1	0.0
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.0"	"Cell type enriched"	"Detected in some"	5	"NK-cells: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	13	"T-cells: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044031	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.3	0.0	0.0	0.7	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	8.8	3.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 5.6;skin 1: 16.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA040655, HPA048596"	Enhanced		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		130000000		"Cluster 61: Skin - Cornification"		"Cluster 31: Spermatids - Spermatogenesis"	"Intermediate filaments"	"Nucleoli, Cytosol"	"HPA040655: , HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434371	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 27.5"	"Cell type enriched"	"Detected in some"	7	"Ductal cells: 20.4"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 38.5;U-2 OS: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000000		"Cluster 61: Skin - Cornification"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	50.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2
KRT76	"HUMCYT2A, KRT2B, KRT2P"	ENSG00000185069	"Keratin 76"	Q01546	12	52768155-52777345	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 2.5;salivary gland: 2.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA019656, HPA019696"	Approved					NA	NA		310000000		"Cluster 16: Immune cells - Immune response"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA019656: AB_1852241, HPA019696: AB_1852243"		"unprognostic (2.00e-1)"				"unprognostic (1.89e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 273.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.6	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	273.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 972.7"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.4;Glandular and luminal cells: 1.9;Spermatocytes: 2.1;Spermatogonia: 8.0;Squamous epithelial cells: 6.7;Suprabasal keratinocytes: 4.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 5.5;RT4: 1.6;SK-BR-3: 3.6;U-87 MG: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039724	Enhanced					NA	NA		70000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.4	0.2	0.0	0.0	0.0	0.1	3.4	0.0	0.5	227.1	0.0	0.1	0.0	0.1	0.0	972.7	0.1	0.9	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	141.7	0.0	0.3	126.7	0.2	0.0	0.0	0.1	1.0	1.5	0.3	0.4	0.3	0.0	134.2	0.4	221.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.5	0.6	0.0	0.8	2.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	8.0	6.7	4.4	0.3	0.0	0.0	0.2	0.5
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 68.3"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000		"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1335.5;stomach 1: 800.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"spinal cord: 44.0"	"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1700000000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	135.0	43.6	2.2	158.6	1.3	1.0	113.8	2.0	1.6	183.4	21.3	1079.2	1112.0	34.7	66.4	48.2	134.3	217.5	147.8	1.9	1.9	240.2	463.9	172.5	7.9	8.3	4.5	10.3	654.1	59.9	278.7	368.7	8.8	151.6	564.2	0.4	318.0	73.6	1.5	49.3	1335.5	50.6	0.4	16.3	800.1	7.6	4.9	47.6	237.5	0.3	13.8	209.0	36.7	1.7	2787.7	6130.6	0.2	7.8	0.7	3.2	3998.7	11.1	47.9	6.1	6.3	7686.4	4774.8	1.1	1130.2	14.7	6.9	947.1	17.6	752.6	5.9	4.6	130.8	4.3	1184.4	2234.2	212.8	1.2	2.4	9.5	12.6	14.8	50.8	419.9	17.0	1.0	484.7	1.7	0.1	10521.8	6.5	10.6	418.5	2740.6	132.8	3.8	2.2	15.2	1198.1	1354.5	129.9	5.0	1063.2	5126.4	7.8	1263.8	4325.7	10.5	18.8	5.7	443.4	9.3	10.0	1.6	7.0	7.6	3.3	1.7	13.4	1.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.5	0.1	1.7	0.1	0.2	2.2	1.3	2.0	1.6	1.9	1.9	8.3	4.5	8.8	0.4	4.9	1.7	7.7	400.6	176.5	0.3	26.9	6.0	1948.0	684.7	303.3	2.3	521.6	342.8	30.2	1069.5	734.8	491.1	0.0	2208.2	8.5	4302.8	297.4	6037.3	13.9	419.2	41.0	42.3	942.5	8.6	0.5	5457.6	5323.4	94.7	1740.1	557.1	76.3	88.0	24.3	310.9	252.2	1.7	0.5	2876.3	1625.5	9.9	7.2	69.9	8.1	22.2	131.6	0.0	55.0	3.4	1.0	1.0	0.3	5278.1	4937.3	1.9	6.6	994.7	6802.6	569.1	594.8	4.3	0.0	2.2	167.4	2.0	11.4	258.9	1.7	5268.8	33.4	13.4	2337.3	1542.5
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"skin 1: 144.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	49	"basophil: 170.8"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 170.8"	"Cell line enhanced"	"Detected in many"		"A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1"									HPA049778	Supported					NA	NA		130000000	"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA049778: AB_2680877"	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	1.4	0.0	0.3	0.2	0.4	0.3	3.1	0.3	0.6	0.1	0.1	0.3	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.1	1.0	0.3	0.3	0.0	0.0	2.1	0.2	0.2	144.7	0.2	0.0	0.3	0.2	0.1	0.4	0.4	0.2	0.9	0.0	0.0	0.1	0.1	0.4	3086.0	2296.0	0.0	0.0	0.0	0.0	0.3	18.6	3.2	23.9	2.2	6.7	0.7	0.0	3.0	0.3	1.6	43.2	0.0	0.0	4.2	4.6	0.0	0.0	1.3	0.2	1.4	0.0	0.2	0.0	0.0	0.4	1.1	32.9	0.0	0.0	0.0	1.6	0.2	700.1	0.3	6.4	0.2	0.1	1088.7	0.5	0.0	10.4	0.6	0.2	0.7	0.0	1.0	179.1	11.1	0.1	0.5	12.9	0.2	0.4	564.4	0.2	2151.1	0.3	4.4	3.1	0.4	7.2	0.2	170.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	3.3	4.4	0.0	0.0	41.0	4.6	0.3	0.0	20.4	0.0	0.0	0.1	12.8	0.1	0.0	67.3	0.9	1.9	0.3	0.4	0.0	0.0	3.9	1.3	2.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	4.1	0.0	0.4	2.5	0.0	0.1	0.0	1.0	0.0	0.0	6.2	0.0	3.3	27.2	0.0	0.0	0.1	2.6	0.0	0.0	2.0	0.0	0.0	1.2	6.8	0.0	0.1	0.0	0.3	2.9	10.5	0.0	0.0	6.0
KRT82	"Hb-2, KRTHB2"	ENSG00000161850	"Keratin 82"	Q9NSB4	12	52393931-52406335	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"skin 1: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058715, HPA067230"	Enhanced					NA	NA		29000000		"Cluster 61: Skin - Cornification"					"HPA058715: AB_2683798, HPA067230: AB_2685807"		"unprognostic (3.04e-1)"				"unprognostic (3.59e-3)"												0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRT83	"Hb-3, KRTHB3"	ENSG00000170523	"Keratin 83"	P78385	12	52314301-52321398	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"skin 1: 66.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 13.3"									HPA049778	Supported					NA	NA		130000000		"Cluster 61: Skin - Cornification"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA049778: AB_2680877"	"unprognostic (7.03e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.30e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-2)"		"unprognostic (2.43e-1)"	"unprognostic (1.12e-3)"	"unprognostic (7.49e-3)"		"unprognostic (2.16e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	1.0	0.0	0.4	0.0	0.7	0.0	0.3	0.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	66.8	0.0	0.0	0.8	0.0	0.0	0.2	0.6	0.2	1.0	0.0	0.0	0.0	0.0	1.8	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.3	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.6	0.5	0.6	0.5	0.6	0.6	0.7	0.8	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 1.5;skin 1: 1.9"	"Cell type enriched"	"Detected in single"	22	"Cardiomyocytes: 2.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported					NA	NA		67000000		"Cluster 31: Skin - Epidermis development"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA039714: AB_2676641"		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"skin 1: 172.7"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"A549: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049778	Supported					NA	NA		110000000		"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049778: AB_2680877"	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	172.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"skin 1: 150.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 33.1;Early spermatids: 35.5;Late spermatids: 24.3;NK-cells: 11.3;T-cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	9	"basophil: 87.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 87.5"	"Cell line enhanced"	"Detected in many"		"A-431: 24.9;A549: 25.7;MCF7: 51.6;RPMI-8226: 32.5;U-251 MG: 14.5"									"HPA039798, HPA049778"	Supported		Approved	Cytosol		NA	NA		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA039798: AB_10674986, HPA049778: AB_2680877"	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	1.2	0.5	0.5	0.2	0.7	2.6	0.5	0.0	0.5	0.2	0.0	0.5	0.4	0.4	0.5	0.1	0.7	0.4	0.1	0.8	0.2	0.2	0.1	0.7	0.0	0.3	0.4	0.1	2.1	0.1	0.1	0.4	0.4	0.3	0.0	0.1	3.8	0.3	0.3	150.5	0.3	0.1	0.2	0.1	0.2	4.0	0.5	0.2	4.1	0.0	0.1	0.8	0.2	1.2	24.9	25.7	0.0	0.0	0.0	0.0	0.3	0.9	0.7	0.3	0.1	0.3	1.3	0.0	1.1	0.0	0.5	1.5	0.0	4.5	0.1	10.9	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.5	12.7	0.0	0.0	0.0	1.8	0.0	51.6	0.0	3.0	0.1	0.2	6.1	0.0	0.0	32.5	0.4	3.2	2.9	0.0	4.5	2.0	2.0	0.0	1.4	0.0	0.8	0.0	1.3	0.1	14.5	0.0	0.0	0.0	0.0	5.3	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.5	0.5	0.7	0.0	0.5	0.8	0.2	0.3	0.4	0.4	0.2	0.5	1.2	0.1	0.0	0.6	0.0	0.3	0.6	2.9	2.0	0.0	0.4	2.8	3.4	0.4	2.8	3.1	0.0	0.0	0.1	33.1	0.2	0.0	2.1	35.5	3.6	0.8	0.2	0.0	0.0	0.5	5.1	1.6	0.3	1.1	4.9	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.0	0.0	1.1	24.3	0.3	0.3	1.8	0.0	0.0	0.2	11.3	0.0	0.5	2.9	0.0	0.0	2.1	2.7	0.0	0.6	1.9	0.3	0.0	1.0	0.4	0.8	0.4	0.0	0.1	1.2	14.2	0.0	0.0	3.5
KRT9	"CK-9, EPPK, K9"	ENSG00000171403	"Keratin 9"	P35527	17	41565836-41572059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 3.4;Breast myoepithelial cells: 2.9;Extravillous trophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	6	"melanoma: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;HaCaT: 16.8;U-2197: 3.0;U-937: 5.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 25.1"					"HPA007261, CAB037322"	Supported					NA	NA		24000000000		"Cluster 63: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB037322: , HPA007261: AB_1079182"	"unprognostic (2.13e-2)"	"unprognostic (5.08e-2)"		"unprognostic (4.97e-2)"		"unprognostic (3.65e-2)"		"unprognostic (2.89e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.92e-7)"	"unprognostic (1.28e-1)"		"unprognostic (3.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (4.15e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.2
KRTAP11-1	KAP11.1	ENSG00000182591	"Keratin associated protein 11-1"	Q8IUC1	21	30880644-30881580	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	65	"skin 1: 194.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"endometrial cancer: 1.3;urothelial cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054008	Enhanced					NA	NA		2700000		"Cluster 61: Skin - Cornification"					"HPA054008: AB_2682341"																		2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP16-1	KAP16.1	ENSG00000212657	"Keratin associated protein 16-1"	A8MUX0	17	41307700-41309253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"skin 1: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070954	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 58: T-cells - T-cell receptor"			"HPA070954: AB_2686327"													"unprognostic (3.65e-5)"	"unprognostic (4.61e-2)"				0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KRTAP2-1	KAP2.1A	ENSG00000212725	"Keratin associated protein 2-1"	Q9BYU5	17	41046541-41047316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	399	"skin 1: 68.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported					NA	NA				"Cluster 61: Skin - Cornification"					"HPA059203: AB_2683947"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRTAP2-2	KAP2.2	ENSG00000214518	"Keratin associated protein 2-2"	Q9BYT5	17	41054498-41055230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	337	"skin 1: 54.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA059203: AB_2683947"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP2-3	KAP2.3	ENSG00000212724	"Keratin associated protein 2-3"	P0C7H8	17	41059240-41060114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	104	"skin 1: 20.6"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 104.8;Endometrial ciliated cells: 22.0;Glandular and luminal cells: 35.5;Pancreatic endocrine cells: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.8;fHDF/TERT166: 22.2;HBF TERT88: 31.9;LHCN-M2: 41.0;U-2 OS: 15.9"									HPA059203	Supported					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA059203: AB_2683947"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-2)"		"unprognostic (3.79e-3)"		"unprognostic (3.25e-3)"		"unprognostic (2.78e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-4)"		"unprognostic (7.83e-6)"			"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.1	0.0	36.8	1.2	9.0	7.6	0.4	0.3	0.0	0.0	22.2	2.2	0.1	0.0	0.6	31.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.6	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	5.4	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	15.9	1.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.5	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	104.8	0.0	22.0	1.6	0.4	0.0	0.0	0.0	0.6	0.4	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0
KRTAP2-4	KAP2.4	ENSG00000213417	"Keratin associated protein 2-4"	Q9BYR9	17	41065116-41065879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	437	"skin 1: 43.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported					NA	NA				"Cluster 61: Skin - Cornification"					"HPA059203: AB_2683947"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP20-3	"KAP19D, KAP20.3, KRTAP19P4"	ENSG00000206104	"Keratin associated protein 20-3"	Q3LI60	21	30642864-30643136	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053598	Uncertain					NA	NA									"HPA053598: AB_2682204"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP21-3		ENSG00000231068	"Keratin associated protein 21-3"	Q3LHN1	21	30718525-30718777	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046554	Uncertain					NA	NA									"HPA046554: AB_2679695"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP24-1	KAP24.1	ENSG00000188694	"Keratin associated protein 24-1"	Q3LI83	21	30281309-30282950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017604	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"					"HPA017604: AB_2669625"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"		NA	NA							"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP27-1		ENSG00000206107	"Keratin associated protein 27-1"	Q3LI81	21	30337013-30337694	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021522, HPA048826"	Approved					NA	NA									"HPA021522: AB_1852643, HPA048826: AB_2680534"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP3-2	KAP3.2	ENSG00000212900	"Keratin associated protein 3-2"	Q9BYR7	17	40999193-40999906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 107.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.2;Squamous epithelial cells: 4.8;Suprabasal keratinocytes: 1.1;Urothelial cells: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Approved					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA042992: AB_2678258"																		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	107.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	2.6
KRTAP3-3	KAP3.3	ENSG00000212899	"Keratin associated protein 3-3"	Q9BYR6	17	40993430-40994164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"skin 1: 129.3"	"Cell type enriched"	"Detected in single"	4	"Enteroendocrine cells: 1.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Supported					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA042992: AB_2678258"																		0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 182.0;Proximal enterocytes: 168.7;Undifferentiated cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.8;memory B-cell: 4.5;memory CD4 T-cell: 5.6;memory CD8 T-cell: 2.6;naive B-cell: 6.4;naive CD4 T-cell: 6.6;naive CD8 T-cell: 2.7;T-reg: 4.4"	"Group enriched"	"Detected in many"	13	"B-cells: 6.4;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"A-431: 84.6;CAPAN-2: 122.5;OE19: 46.6;SCLC-21H: 60.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favorable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	2.2	2.7	3.0	6.3	3.5	3.0	16.0	5.3	5.6	11.8	3.7	39.6	44.3	5.8	1.8	18.3	24.9	9.5	0.7	2.9	3.5	7.9	9.8	11.3	3.3	3.9	3.5	2.4	44.6	18.6	14.1	2.9	3.7	20.9	27.8	7.3	38.5	12.7	3.2	14.1	45.5	1.7	3.0	3.1	42.4	2.2	3.3	3.7	11.5	0.0	5.2	10.0	11.2	4.6	84.6	1.2	6.1	2.7	0.3	0.6	17.4	0.9	0.3	1.0	0.9	32.7	122.5	1.0	1.1	0.2	0.5	28.4	0.9	25.0	0.3	1.0	0.6	2.2	1.9	2.7	0.0	0.3	3.9	1.1	2.7	0.6	1.5	1.2	1.0	2.8	1.8	1.5	0.9	27.2	0.9	7.8	27.7	46.6	1.1	0.8	1.8	2.5	1.7	2.4	60.2	2.2	2.3	25.4	3.6	2.0	2.5	1.4	2.4	3.4	5.4	1.2	1.1	7.0	5.9	1.1	2.3	1.1	0.8	0.0	0.0	0.0	0.6	0.0	6.8	4.5	5.6	2.6	0.0	6.4	6.6	2.7	0.0	0.5	0.0	0.0	4.4	1.5	3.0	3.5	5.3	5.6	2.9	3.5	3.9	3.5	3.7	3.0	3.3	4.6	1.1	22.4	27.9	2.6	2.9	23.3	125.1	135.4	71.7	4.9	100.9	105.2	0.5	88.6	92.5	42.3	8.4	17.0	1.9	74.2	5.9	105.4	6.4	50.9	3.8	2.7	62.0	3.6	1.2	182.0	27.6	3.4	68.3	47.9	4.5	0.9	1.4	15.2	2.1	1.7	1.1	123.6	105.8	1.0	2.5	4.7	0.3	2.0	7.2	1.9	2.9	1.9	2.1	1.5	1.3	108.7	112.9	0.0	0.7	123.7	168.7	7.7	85.2	5.9	0.0	0.9	6.9	3.8	29.4	48.0	15.5	7.9	3.0	0.7	190.2	144.2
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skin 1: 6146.5;vagina: 1735.6"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 5277.0"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"hTCEpi: 100.2"	"Region enriched"	"Detected in single"	6	"white matter: 1.6"	"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	NA	NA		34000000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	5.5	1.0	1.0	0.0	1.6	1.8	406.4	0.9	1.8	845.7	1.1	1.8	0.1	0.8	0.7	111.0	1.3	0.0	2.5	1.0	1.0	0.8	3.0	1.7	0.0	1.1	0.9	1.7	3.4	0.7	1.3	0.0	1.2	1.6	0.0	0.1	205.3	0.3	22.5	6146.5	1.3	0.1	1.0	0.8	1.5	3.3	0.9	20.0	2.5	0.3	90.1	0.7	1735.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.4	100.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.9	1.8	1.0	1.0	1.1	0.9	1.2	1.0	0.9	1.0	0.3	0.0	0.0	0.0	0.0	348.5	0.8	0.4	0.0	0.0	0.5	1.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.4	0.2	0.1	3.6	0.0	0.0	0.1	0.2	0.0	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	63.4	0.9	0.1	42.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	2.4	42.9	19.1	0.0	5277.0	0.0	1.5	0.0	0.0	0.5
KSR1	"KSR, RSU2"	ENSG00000141068	"Kinase suppressor of ras 1"	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 101.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;Glandular and luminal cells: 50.3;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 53.3;Oligodendrocytes: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 393.5;HEL: 140.5;HMC-1: 93.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009623, HPA011215, HPA011878"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB009623: AB_2265455, HPA011215: AB_1852649, HPA011878: "	"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-5)"	"unprognostic (8.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (1.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.61e-2)"	22.6	17.5	19.6	19.9	22.0	16.7	15.6	17.4	35.8	36.9	13.2	13.1	8.1	26.5	9.9	29.8	20.8	21.4	13.6	33.1	19.3	40.7	6.5	26.2	14.3	28.6	20.2	26.4	101.4	7.3	15.1	44.9	23.0	15.6	8.5	19.4	8.4	18.5	30.0	21.6	15.2	20.0	17.5	22.5	9.3	25.3	22.9	11.6	31.0	14.0	14.6	14.6	23.1	26.7	4.6	18.1	11.1	5.8	9.2	6.5	64.7	4.2	9.1	6.2	7.2	55.0	0.8	4.4	9.5	8.0	40.8	2.8	11.0	2.5	3.7	393.5	12.1	140.5	19.3	23.0	16.0	1.8	93.0	8.1	4.0	17.8	0.5	25.3	34.8	6.1	75.0	0.5	3.6	4.4	2.1	5.4	8.3	4.0	3.2	9.1	61.5	3.2	25.1	3.3	17.1	11.3	22.3	5.1	6.0	29.4	0.7	7.5	32.5	1.8	8.2	5.1	3.0	0.5	0.1	0.1	1.8	7.9	10.5	0.0	1.0	3.8	0.3	2.1	0.3	0.4	0.1	0.2	0.5	0.1	0.1	0.1	1.1	0.9	1.1	0.0	0.5	0.4	19.6	22.0	17.4	35.8	33.1	19.3	28.6	20.2	23.0	17.5	22.9	26.7	19.7	6.4	3.4	33.6	4.1	3.1	3.6	3.1	1.8	11.8	1.9	2.3	1.2	1.5	11.9	14.7	73.0	19.2	4.9	7.1	3.9	2.0	33.4	24.0	21.6	9.1	6.6	0.4	26.2	5.3	21.0	8.2	3.6	50.3	0.0	10.8	11.7	1.3	6.7	10.1	50.2	2.2	0.0	8.3	6.9	47.7	1.5	9.0	8.8	27.2	10.4	5.7	4.1	53.3	49.2	2.1	7.1	2.2	2.8	1.6	6.7	3.2	14.9	25.8	0.0	5.3	4.8	2.6	6.1	11.3	6.0	19.4	5.7	8.4	1.2	6.2
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968990	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.0;pituitary gland: 7.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 161.8;Excitatory neurons: 284.7;Inhibitory neurons: 234.9;Oligodendrocyte precursor cells: 95.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.5;SCLC-21H: 3.2;TIME: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.0	0.9	2.3	0.0	2.4	0.0	0.2	1.1	10.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	7.7	0.0	0.7	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.6	7.9	0.0	0.6	0.1	0.3	1.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.3	0.0	0.6	0.0	0.1	0.2	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.4	0.9	3.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	6.9	0.0	0.5	0.0	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.1	10.0	7.7	0.0	0.7	0.0	0.6	0.1	0.3	2.7	0.9	0.0	0.0	17.6	0.5	0.3	1.2	0.1	0.0	55.2	2.8	2.4	2.2	5.7	0.2	161.8	39.6	0.9	0.0	1.3	0.0	2.3	10.8	4.0	0.3	0.5	20.4	5.3	284.7	1.5	0.4	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	47.1	234.9	10.3	2.0	0.3	0.4	12.5	0.0	0.0	0.0	5.6	0.0	2.4	0.0	95.0	4.2	0.4	1.5	0.0	0.0	1.4	0.1	0.8	0.3	28.2	0.0	0.3	0.1	0.6	3.1	0.0	0.3	0.3	0.6	0.0	3.0	1.3
KTI12	"MGC20419, SBBI81, TOT4"	ENSG00000198841	"KTI12 chromatin associated homolog"	Q96EK9	1	52032103-52033810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031203, HPA031204, HPA031205"	Approved		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytoplasmic bodies"		"HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.36e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.08e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.64e-2)"	7.5	10.2	4.2	6.9	4.0	16.7	5.9	4.5	4.4	4.5	4.9	6.5	4.9	7.3	4.7	5.8	6.9	3.8	5.1	4.0	5.0	4.9	6.8	4.2	8.7	4.5	4.1	9.2	6.8	3.9	6.4	4.2	4.1	4.0	4.0	2.5	4.0	4.7	4.6	5.5	7.6	4.7	4.1	8.5	7.1	7.2	4.9	6.6	4.0	3.5	7.6	5.5	3.8	4.4	14.0	13.4	5.3	12.5	17.8	14.8	16.6	13.9	17.0	20.1	17.1	15.2	6.7	16.0	15.3	14.5	29.8	15.6	18.7	16.4	13.9	16.5	20.9	16.6	14.6	14.9	12.3	23.8	15.7	13.9	12.5	16.0	8.6	8.7	13.8	14.0	25.2	7.7	17.1	11.1	17.5	26.7	10.3	12.2	14.9	16.3	14.6	21.5	19.4	10.0	9.3	13.5	13.4	23.3	25.8	12.0	4.5	37.2	10.4	16.2	10.1	19.4	26.3	28.6	25.8	25.4	17.9	25.2	12.1	17.0	21.6	16.4	22.1	24.5	24.9	29.8	24.7	27.0	29.4	22.7	29.0	20.7	4.5	24.2	19.3	44.6	26.9	18.8	4.2	4.0	4.5	4.4	4.0	5.0	4.5	4.1	4.1	4.1	4.9	4.4	10.8	3.2	5.1	0.0	14.3	7.1	13.2	14.1	5.7	6.1	5.3	6.1	3.1	8.6	6.3	3.7	0.0	12.1	17.5	1.8	5.9	11.3	2.3	4.4	10.6	8.4	2.4	8.6	0.0	10.9	17.0	8.6	3.1	3.9	6.3	26.3	9.3	5.9	10.0	10.1	0.0	3.9	6.1	6.6	6.4	1.2	11.5	6.0	5.4	0.0	13.6	9.7	10.3	0.0	0.0	10.5	3.4	10.1	9.5	7.8	3.1	11.6	4.7	4.9	19.7	8.1	10.7	20.3	9.3	6.7	7.4	18.3	10.6	28.1	4.7	11.5
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		55000	"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	81.6	77.7	90.8	52.8	98.9	36.1	81.6	92.8	106.3	61.4	165.0	97.4	43.4	58.1	97.1	72.7	53.2	58.6	134.6	81.0	94.2	104.0	106.6	67.0	61.8	100.2	95.3	63.9	67.2	143.0	67.4	69.4	100.7	77.5	90.8	127.9	73.5	73.5	378.2	137.6	53.2	60.3	95.2	53.4	61.1	145.1	99.4	54.7	107.7	281.6	61.0	113.1	55.2	110.3	200.5	133.4	100.3	106.5	132.8	127.3	140.2	159.7	127.3	97.2	85.2	89.4	233.9	152.8	213.4	166.7	102.7	347.2	122.5	138.2	162.7	251.9	65.2	109.1	223.0	174.4	126.3	160.3	83.3	119.1	124.6	122.1	208.4	208.3	161.9	122.2	107.4	88.1	189.0	154.6	141.3	95.0	76.8	91.1	194.3	109.6	258.2	73.5	244.8	307.0	122.4	100.0	245.8	113.2	143.2	201.7	115.3	101.7	230.0	193.9	250.4	100.0	151.2	38.9	55.9	110.4	229.4	93.4	109.5	117.0	42.7	48.0	56.2	40.3	54.7	95.6	69.4	65.8	44.0	106.6	71.1	62.1	29.6	64.9	52.6	185.8	48.4	16.0	90.8	98.9	92.8	106.3	81.0	94.2	100.2	95.3	100.7	95.2	99.4	110.3	363.1	307.7	239.8	72.5	171.7	654.5	285.8	215.6	270.9	206.5	460.6	348.7	852.7	270.2	214.7	428.6	360.7	155.1	194.9	575.2	31.3	249.7	721.9	351.3	186.6	345.0	224.0	165.3	93.9	304.0	199.1	211.9	95.3	298.1	134.9	384.5	295.9	401.7	116.8	326.4	112.1	226.4	207.5	181.3	261.6	377.9	248.5	168.9	172.5	104.9	194.3	449.2	142.2	90.0	139.8	341.2	325.7	441.6	184.6	283.5	152.6	109.3	319.3	400.9	335.2	333.5	292.1	694.3	386.4	217.8	723.0	164.7	168.3	162.4	282.4	328.0
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	87.5	79.2	89.8	67.9	92.8	75.2	81.3	87.9	94.9	78.8	78.6	90.6	58.4	75.0	54.9	79.3	69.5	52.5	81.5	87.0	89.1	76.1	100.4	79.8	81.2	100.8	95.5	84.9	91.9	46.3	86.2	62.9	95.6	87.7	55.2	48.1	66.2	51.2	97.9	70.8	72.7	63.8	90.8	89.4	78.4	78.8	93.4	58.2	71.3	57.3	72.4	89.9	74.7	104.8	125.1	122.2	98.7	114.0	102.0	117.4	157.3	133.6	108.0	99.2	114.2	102.1	145.3	84.6	153.5	118.7	82.1	92.3	153.0	164.5	89.7	103.3	206.5	91.7	98.5	92.6	116.7	147.2	98.4	123.7	117.6	147.8	175.1	107.7	143.4	114.4	146.7	130.2	105.3	144.5	135.2	109.5	124.2	158.3	187.9	127.0	76.9	126.7	103.5	110.0	91.0	115.7	87.6	79.1	113.8	103.3	66.5	102.4	115.2	88.1	76.8	285.9	177.8	153.9	124.1	128.0	151.9	172.2	131.4	45.3	109.5	97.7	73.7	125.0	68.2	69.8	68.4	74.1	99.5	71.5	54.1	59.0	107.6	83.2	125.1	58.9	103.4	95.9	89.8	92.8	87.9	94.9	87.0	89.1	100.8	95.5	95.6	90.8	93.4	104.8	48.3	19.2	29.3	0.3	41.8	34.5	71.8	68.9	34.1	20.5	46.7	54.7	5.7	35.8	37.8	16.5	12.5	97.8	38.1	45.6	80.3	80.3	179.6	26.3	30.2	57.2	43.1	48.0	2.2	113.3	121.9	50.3	43.8	25.1	43.7	37.4	51.0	33.6	123.5	16.8	2.0	52.0	30.5	56.2	49.5	38.5	33.5	49.7	58.7	0.0	110.5	30.2	61.8	0.5	4.4	94.8	46.9	29.3	47.9	125.7	66.4	51.7	27.6	19.2	39.5	36.2	48.3	45.8	23.2	51.7	41.5	111.5	43.8	37.5	49.5	73.6
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134599923-134651636	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 16.3;skin 1: 9.6;tongue: 27.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.0	2.7	1.7	0.2	1.8	0.3	0.8	1.6	2.9	0.8	0.1	0.9	0.4	1.9	0.8	2.0	1.9	0.4	3.1	1.6	1.7	0.3	0.0	0.1	0.0	1.9	2.3	0.9	0.0	2.2	3.3	0.0	2.1	2.2	0.2	1.7	0.8	1.7	16.3	9.6	0.2	4.2	1.5	0.1	0.7	0.3	2.0	0.9	3.0	27.7	0.0	0.6	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.1	0.7	0.0	5.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	2.9	1.6	1.7	1.9	2.3	2.1	1.5	2.0	1.9	0.0	0.0	0.0	15.0	0.0	0.6	0.1	0.0	0.0	0.4	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.0	0.0	2.5	0.0	24.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Granulosa cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		22000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	3.5	4.7	12.3	3.6	13.3	2.3	4.0	13.0	15.5	7.2	10.6	4.7	2.5	5.8	2.9	5.3	6.4	2.7	10.3	12.1	11.8	7.8	12.7	3.6	5.0	13.2	12.3	6.2	3.1	5.5	8.7	2.5	12.8	7.4	1.3	7.5	4.2	4.3	12.6	7.7	4.2	3.1	12.3	5.4	4.9	5.6	12.9	8.9	6.1	8.7	4.8	7.2	6.7	18.0	4.8	9.8	9.3	10.6	6.9	11.4	3.0	5.5	8.0	6.2	8.0	3.9	9.7	8.3	2.9	4.6	7.0	14.9	13.9	11.1	9.3	10.0	7.3	5.7	27.7	9.6	7.7	5.0	1.9	4.5	7.1	7.1	7.7	21.8	11.3	22.7	8.2	9.0	8.5	3.1	14.0	3.4	15.2	18.3	7.6	16.4	6.4	18.9	8.7	1.7	10.5	7.4	9.9	2.9	6.2	12.8	6.6	1.6	7.0	4.6	7.9	7.1	5.0	15.2	11.0	11.6	9.6	8.3	3.2	0.1	1.4	2.9	5.1	1.8	4.5	7.7	5.7	6.0	5.5	3.3	5.9	6.7	0.9	3.3	2.9	2.4	7.0	3.3	12.3	13.3	13.0	15.5	12.1	11.8	13.2	12.3	12.8	12.3	12.9	18.0	2.6	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.6	0.0	0.0	5.0	0.9	0.0	3.9	1.6	0.0	2.6	3.3	0.7	0.0	0.0	0.0	0.2	2.4	0.7	0.0	4.2	0.0	45.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	7.3	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.3	1.3	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	19.3	22.5	8.3	16.0	9.3	13.4	29.8	10.0	12.2	18.0	12.3	19.9	22.6	21.3	21.7	26.5	18.3	20.0	11.3	9.4	9.5	30.5	27.4	15.4	22.1	8.5	9.5	25.7	30.0	33.4	15.2	22.7	9.2	21.1	21.7	11.0	20.5	22.1	10.6	18.8	17.4	15.7	8.7	17.6	22.7	9.9	8.7	21.6	26.2	10.0	23.7	24.6	14.9	8.9	55.1	11.1	52.2	18.0	19.1	51.2	46.4	31.7	57.2	39.8	49.4	15.6	18.9	35.6	23.8	23.8	27.3	15.7	15.6	25.6	57.7	22.7	21.3	32.4	9.8	26.8	61.8	45.6	8.5	44.9	25.2	29.0	50.1	26.8	37.0	41.0	41.5	19.0	37.9	17.8	48.0	21.6	31.0	42.5	10.3	49.3	36.2	19.2	87.0	49.2	38.9	45.6	44.4	60.0	29.1	31.8	33.3	13.9	27.7	17.5	11.4	55.5	23.1	23.7	13.6	23.6	8.4	19.5	14.7	8.3	12.1	7.5	8.0	7.7	11.1	8.6	10.6	9.5	16.3	8.9	10.6	9.3	8.8	11.3	10.2	5.9	16.3	8.3	8.3	9.3	10.0	12.2	9.4	9.5	8.5	9.5	9.2	8.7	8.7	8.9	10.6	12.8	11.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	13.7	0.0	0.0	8.1	12.9	0.0	70.7	13.1	0.0	25.4	34.4	0.0	12.7	14.1	4.6	0.0	0.0	0.0	38.2	39.9	10.1	0.0	14.3	5.1	17.5	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	1.8	0.0	0.0	35.6	3.6	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	83.5	7.6	43.3	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
L3HYPDH	"C14orf149, FLJ25436"	ENSG00000126790	"Trans-L-3-hydroxyproline dehydratase"	Q96EM0	14	59460363-59484408	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056694	Approved		Uncertain	Vesicles		NA	NA		49000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA056694: AB_2683210"	"unprognostic (3.39e-2)"	"unprognostic (5.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	18.1	14.0	4.8	12.5	5.2	4.8	16.3	9.9	6.6	15.9	10.0	10.6	11.0	16.0	8.5	9.2	15.4	11.5	14.8	5.0	5.8	17.4	17.3	11.2	17.5	7.9	5.8	18.0	12.6	12.2	14.8	10.4	7.4	13.5	10.2	5.2	13.0	11.9	8.9	9.7	13.8	11.9	5.6	13.0	10.5	17.1	4.8	4.3	16.6	5.6	13.7	13.4	14.5	8.3	12.0	31.8	6.8	16.2	14.4	37.6	9.5	31.7	25.1	17.9	17.4	6.4	21.1	4.1	13.0	17.7	31.8	31.8	11.1	17.0	17.7	7.0	14.4	11.0	30.1	23.7	16.2	10.0	7.6	27.3	11.4	18.0	27.6	27.8	22.3	11.3	14.8	18.4	18.8	14.3	3.8	16.4	10.9	4.7	28.5	5.5	11.1	16.6	28.7	6.8	6.9	9.9	29.8	12.2	11.9	5.6	12.8	6.4	31.3	20.9	25.6	16.4	37.5	4.7	2.3	4.0	35.9	8.3	41.7	0.0	3.5	0.5	3.2	5.1	2.4	1.5	1.7	2.0	5.7	1.4	2.5	0.9	0.0	5.6	2.4	3.2	0.8	1.8	4.8	5.2	9.9	6.6	5.0	5.8	7.9	5.8	7.4	5.6	4.8	8.3	11.2	3.2	6.1	11.1	10.9	5.2	5.4	4.2	6.2	2.9	5.6	8.6	8.7	5.7	4.3	3.7	2.1	13.7	3.5	1.0	7.9	7.7	12.2	6.8	17.5	8.1	3.0	5.5	26.7	2.5	11.4	16.0	4.6	2.3	14.0	6.5	11.0	16.8	8.3	1.7	18.9	4.3	4.1	4.6	2.9	7.4	19.3	4.9	3.6	10.3	3.5	4.6	4.1	10.6	17.1	4.4	1.0	12.0	5.5	6.6	3.4	47.0	17.3	2.7	13.1	17.4	11.6	14.1	5.7	7.5	3.4	4.9	6.0	11.9	3.5	2.0
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL histone methyl-lysine binding protein 3"	Q96JM7	6	130013699-130141449	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	4.5	11.0	3.3	9.9	3.3	7.7	4.7	1.7	3.6	9.5	9.6	4.6	2.8	11.2	11.7	2.3	5.5	5.3	2.4	4.1	3.8	4.8	5.8	4.0	11.1	2.5	3.1	10.1	2.3	5.6	5.5	5.7	2.4	7.0	5.0	2.1	4.9	6.2	2.5	2.7	5.1	8.3	2.5	12.6	3.3	7.6	4.5	7.7	6.0	2.1	8.9	5.7	5.3	2.6	1.7	6.5	15.2	2.4	10.4	13.4	3.1	7.8	15.9	3.0	5.5	8.0	8.1	2.7	11.0	9.9	9.3	6.5	8.7	13.6	4.6	6.1	8.8	18.3	3.2	2.0	5.2	10.8	63.5	8.8	9.6	3.6	10.2	15.1	62.5	8.3	13.3	7.1	7.7	0.7	23.2	1.9	7.0	1.7	3.3	8.7	4.2	0.0	9.8	2.5	0.5	2.0	2.9	0.7	6.1	18.2	16.4	9.3	43.0	5.1	6.9	0.9	5.3	1.4	0.1	4.7	2.5	4.5	5.2	8.2	4.9	4.8	3.7	5.5	3.2	10.7	3.5	4.7	1.9	13.4	3.2	4.1	4.9	2.1	22.7	14.8	5.9	1.0	3.3	3.3	1.7	3.6	4.1	3.8	2.5	3.1	2.4	2.5	4.5	2.6	9.1	3.2	6.5	6.5	20.5	5.1	5.1	2.4	10.2	4.2	5.3	2.8	3.9	1.5	3.8	9.2	2.1	13.4	20.7	2.8	1.9	5.6	24.2	6.1	12.8	9.4	3.6	5.0	20.8	5.4	7.1	7.3	4.6	16.1	40.4	24.7	8.9	6.3	4.0	0.0	10.5	9.3	6.1	8.2	4.0	3.1	9.6	9.5	1.8	11.2	12.9	5.3	13.4	15.6	8.5	10.9	5.2	6.0	5.2	4.7	0.5	5.9	4.1	0.7	6.6	11.2	8.6	5.8	7.6	4.0	4.4	6.2	15.6	9.5	5.0	5.5
L3MBTL4	"FLJ35936, HsT1031"	ENSG00000154655	"L3MBTL histone methyl-lysine binding protein 4"	Q8NA19	18	5954706-6415237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 160.4;Late spermatids: 85.8;Microglial cells: 78.7;Oligodendrocyte precursor cells: 191.5;Oligodendrocytes: 252.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 4.8;RPMI-8226: 11.6;SCLC-21H: 5.3;SH-SY5Y: 5.8;U-2 OS: 3.4"	"Low region specificity"	"Detected in some"							"HPA064194, HPA069042"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA064194: AB_2685208, HPA069042: AB_2686071"	"unprognostic (1.33e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	3.0	4.3	7.1	1.8	11.5	1.6	4.9	0.2	8.4	4.3	0.6	2.1	3.0	3.2	3.6	3.6	4.2	2.5	4.9	3.8	6.8	7.1	8.8	3.9	2.0	3.3	8.2	8.5	6.5	8.5	3.2	0.7	4.7	2.0	2.0	1.7	3.4	2.9	1.0	7.3	3.5	1.3	1.6	2.9	3.2	12.7	6.6	2.9	5.8	1.3	1.6	1.4	4.1	14.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	2.4	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	1.4	3.1	0.0	11.6	0.0	2.0	5.3	5.8	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	3.4	0.1	1.4	0.1	0.0	0.0	1.3	0.0	1.7	0.3	1.1	0.0	0.7	0.3	0.0	0.5	0.1	0.1	0.7	2.5	0.1	0.2	0.1	3.6	0.8	0.1	0.0	0.5	7.1	11.5	0.2	8.4	3.8	6.8	3.3	8.2	4.7	1.6	6.6	14.0	6.5	3.2	12.2	56.2	4.8	7.8	7.0	0.8	10.2	2.2	4.5	4.8	6.4	11.5	4.1	5.5	16.7	0.1	2.7	0.3	3.9	7.4	62.5	8.1	1.2	3.6	11.4	0.8	33.9	5.2	0.0	3.4	1.5	16.9	1.3	15.4	2.5	10.0	3.2	0.0	160.4	1.5	0.0	3.2	5.3	85.8	10.2	2.9	1.8	78.7	27.2	1.8	25.7	191.5	252.9	3.5	1.9	12.8	1.5	10.3	3.5	8.1	1.2	0.6	6.6	6.9	7.2	9.3	2.4	6.5	8.2	0.1	2.1	0.5	2.5	4.6
LACC1	"C13orf31, FAMIN, FLJ38725"	ENSG00000179630	"Laccase domain containing 1"	Q8IV20	13	43879284-43893932	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.0;eosinophil: 3.1;intermediate monocyte: 5.2;myeloid DC: 2.7;non-classical monocyte: 8.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.7;granulocytes: 3.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 37.1;TIME: 118.2"	"Low region specificity"	"Detected in all"							"CAB034228, HPA040150, HPA044211"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258"	"unprognostic (2.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	6.4	6.6	12.7	12.2	22.3	1.9	5.4	10.8	20.6	4.5	6.8	10.3	9.9	3.9	3.2	6.8	3.2	9.8	10.1	11.7	13.6	4.8	7.2	6.4	8.8	13.9	14.5	3.4	3.5	9.9	2.8	6.1	15.2	5.4	13.3	0.8	4.6	4.9	1.4	4.8	13.8	5.8	12.5	7.2	6.8	9.4	17.3	6.5	3.5	1.2	8.3	11.1	2.9	27.4	4.7	2.5	1.3	0.0	2.7	12.3	9.5	10.3	25.7	2.8	3.9	5.3	10.5	9.9	2.3	13.8	6.0	6.7	0.3	2.9	4.5	6.6	1.7	12.3	2.6	1.9	12.5	2.9	37.1	16.3	8.5	10.3	12.6	3.4	5.9	1.1	0.0	7.1	6.4	2.3	0.3	3.7	0.9	2.6	2.2	2.3	0.0	5.2	7.4	5.5	1.6	2.5	3.4	1.2	4.9	6.8	1.5	6.2	118.2	3.5	1.1	18.8	0.1	0.0	0.0	2.4	10.0	3.7	8.0	1.0	3.0	3.1	0.7	5.2	0.8	0.8	0.6	0.6	2.7	1.0	0.2	0.3	0.1	0.4	8.0	0.5	0.8	1.0	12.7	22.3	10.8	20.6	11.7	13.6	13.9	14.5	15.2	12.5	17.3	27.4	4.6	12.8	6.8	1.0	5.9	5.7	8.4	8.1	3.4	0.5	5.1	4.6	24.2	4.3	7.8	11.0	0.0	6.5	1.0	7.6	1.9	5.5	1.3	5.1	3.4	7.4	5.4	1.7	2.1	3.8	4.3	4.5	2.0	8.5	8.2	9.7	5.0	5.1	15.3	0.0	6.2	4.4	6.1	17.6	10.3	3.1	2.1	24.2	1.8	1.9	7.8	2.0	1.0	2.0	39.2	8.0	11.2	1.5	0.5	11.4	10.5	8.2	7.2	0.2	6.6	5.3	6.0	17.1	16.7	8.4	10.2	9.2	4.3	4.6	6.7	10.2
LACTB	"FLJ14902, MRPL56"	ENSG00000103642	"Lactamase beta"	P83111	15	63121833-63142061	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protease"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036361, HPA036362"	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036361: AB_10672244, HPA036362: AB_10670798"	"unprognostic (6.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.64e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.88e-3)"	17.3	25.4	7.1	21.2	7.4	57.0	12.5	7.2	8.0	8.4	10.8	18.5	19.6	7.6	8.4	14.9	7.0	14.3	22.2	7.2	7.3	23.6	42.4	19.0	19.8	7.3	7.5	8.1	10.6	9.9	6.7	11.8	7.4	9.2	15.9	4.7	9.9	6.8	49.2	12.0	16.9	9.0	7.2	18.3	12.8	22.1	8.3	9.1	9.3	36.3	13.2	19.7	9.2	8.4	60.3	37.0	10.4	7.3	51.9	27.4	8.7	25.7	39.4	43.3	79.9	9.3	37.5	8.0	31.0	37.5	46.9	16.6	35.6	16.7	54.2	55.1	8.9	15.6	12.2	23.7	48.0	14.2	26.1	37.3	35.1	44.5	36.4	64.9	45.2	46.4	14.9	22.1	74.7	22.6	10.9	17.3	15.6	36.7	11.7	8.0	26.6	18.5	23.6	92.5	9.3	4.4	18.6	20.7	59.0	36.0	15.9	23.4	81.5	57.8	44.8	26.2	32.9	23.3	21.8	2.2	44.3	39.2	27.3	4.4	8.4	4.4	1.1	8.3	1.8	3.1	0.9	0.9	9.8	2.6	0.8	1.4	5.3	2.1	7.3	0.8	3.0	2.2	7.1	7.4	7.2	8.0	7.2	7.3	7.3	7.5	7.4	7.2	8.3	8.4	24.6	25.6	22.6	4.9	25.7	58.2	27.2	12.0	19.9	6.5	21.7	16.1	42.5	22.8	10.9	12.9	12.5	15.8	19.3	26.0	25.4	56.0	62.9	13.2	16.4	31.1	7.3	10.8	12.5	43.1	40.5	26.4	17.3	19.3	66.5	12.1	8.9	57.0	88.6	8.4	14.5	27.1	16.2	71.3	72.5	30.6	14.3	97.0	26.6	15.9	152.9	6.9	7.2	10.1	8.1	75.0	19.0	16.1	21.3	35.6	25.2	79.2	9.2	11.3	6.6	37.9	31.5	122.9	25.6	26.3	60.0	18.1	21.8	23.9	20.4	39.6
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669185	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 437.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		37000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	20.4	39.3	6.4	12.9	8.0	3.2	18.4	8.4	9.0	10.8	8.7	21.9	38.8	9.6	11.5	10.2	9.3	28.7	29.8	5.8	8.3	77.0	96.0	20.1	15.6	8.1	7.9	10.0	14.8	21.0	8.3	10.6	8.9	15.4	21.3	12.7	15.0	9.2	28.2	12.4	33.8	15.7	8.1	11.5	16.0	63.2	7.6	14.5	20.2	32.1	13.5	13.2	7.9	10.6	65.7	66.4	20.8	8.6	35.6	53.7	12.5	36.0	20.7	37.7	28.2	32.3	72.3	0.1	14.4	17.4	75.7	45.9	25.0	38.0	30.2	38.8	26.6	30.5	8.1	18.0	74.0	30.1	25.5	64.6	44.8	18.6	28.2	18.0	10.0	23.2	53.4	60.1	50.6	19.6	17.1	5.5	22.3	88.2	60.3	15.2	12.1	14.0	146.3	33.8	29.6	10.3	79.7	437.8	41.0	27.0	72.7	40.1	16.0	3.0	20.8	67.4	29.4	47.7	38.1	0.2	21.1	50.6	28.7	15.8	13.8	13.0	8.5	16.8	10.6	12.6	8.8	8.4	17.3	11.7	8.3	9.2	5.8	11.0	16.7	11.9	13.4	5.9	6.4	8.0	8.4	9.0	5.8	8.3	8.1	7.9	8.9	8.1	7.6	10.6	15.1	57.7	45.1	3.6	16.0	16.4	22.1	58.9	12.5	15.4	12.1	15.1	38.4	18.6	43.9	18.4	8.4	25.1	12.0	27.2	76.3	51.2	286.3	29.4	11.7	15.3	12.1	19.6	3.9	117.2	15.3	15.1	20.4	31.5	9.5	8.7	19.2	76.1	48.0	8.4	4.6	25.8	34.6	34.5	11.2	40.9	20.5	24.2	16.0	3.7	19.4	35.3	8.2	2.5	10.3	70.2	25.1	15.1	18.3	16.0	59.8	325.7	44.9	14.7	6.6	9.6	14.4	263.1	25.0	12.4	16.8	19.4	13.9	34.2	34.7	11.0
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201380833-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 362.1;skin 1: 215.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.5	0.1	0.0	15.9	0.1	0.1	15.8	0.0	0.2	65.4	0.0	67.6	75.6	5.0	11.0	362.1	14.7	50.2	8.4	0.2	0.6	38.6	21.6	10.6	2.9	0.0	0.0	0.4	50.7	2.4	0.7	4.1	0.0	15.7	51.0	0.0	51.9	22.6	5.1	215.4	74.5	2.9	0.0	1.4	66.9	0.3	0.0	6.2	3.5	0.2	47.7	71.4	135.2	0.0	159.9	1.3	0.0	0.3	0.0	0.0	57.0	0.0	0.0	0.1	0.1	127.3	158.5	0.0	8.9	0.0	0.0	220.4	0.0	190.3	0.1	0.2	0.0	0.0	0.1	79.3	0.0	0.1	0.2	0.1	181.5	0.1	36.8	0.0	0.1	0.0	0.1	0.7	0.1	218.3	0.2	0.4	3.7	246.5	2.6	0.2	7.4	2.3	126.0	164.7	9.1	0.2	0.1	250.6	3.1	5.4	37.6	0.4	0.0	0.1	0.5	0.5	0.6	0.1	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	35.4	0.0	0.9	88.5	112.1	47.2	46.7	0.0	15.4	14.1	2.1	110.1	31.3	31.3	0.0	3.8	0.5	174.7	45.0	178.0	1.1	26.2	2.6	1.6	18.1	0.0	0.0	121.9	5.9	2.6	85.1	34.5	0.0	0.0	0.4	9.0	0.5	0.0	0.0	53.8	18.3	0.6	16.0	3.6	0.0	2.6	10.6	0.0	248.6	0.0	0.0	0.0	0.0	227.0	109.6	0.4	2.9	77.1	214.7	71.8	4.8	0.0	0.0	0.0	3.2	0.0	0.3	265.6	152.7	10.4	1.5	0.0	136.2	150.2
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.6;ovary: 18.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 36.7;Leydig cells: 39.1;Peritubular cells: 69.2;T-cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 12.6;MAIT T-cell: 10.0;memory CD8 T-cell: 11.0"	"Lineage enriched"	"Detected in single"	49	"T-cells: 12.6"	"Cell line enriched"	"Detected in single"	151	"HDLM-2: 147.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Intracellular and membrane"	NA	NA		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	7.3	0.2	1.5	0.9	0.4	0.7	3.8	4.3	4.5	3.3	6.1	2.8	1.3	3.8	1.2	1.5	0.3	0.4	1.0	2.6	2.5	16.2	0.6	0.3	18.6	0.2	0.1	0.7	0.4	0.5	2.6	2.0	0.8	1.1	7.0	0.2	0.4	5.9	1.9	0.7	23.6	2.1	3.4	0.4	1.6	0.8	0.3	10.9	1.6	3.4	0.5	0.1	0.6	0.8	0.5	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.3	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.1	0.0	147.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.4	0.2	0.5	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	10.0	0.0	2.4	11.0	0.0	0.0	0.7	4.2	0.0	0.0	0.0	0.2	2.0	1.1	0.3	0.2	0.4	0.7	0.3	0.4	0.6	0.3	0.5	0.7	0.4	0.5	7.7	0.0	3.3	0.0	1.4	5.1	1.6	0.7	9.6	5.9	12.6	15.5	1.6	0.0	4.3	0.0	10.4	0.3	36.7	2.6	0.0	0.2	0.4	1.2	4.9	4.5	21.7	1.7	0.2	0.0	0.2	7.1	1.5	1.9	0.0	1.0	4.2	3.5	11.5	0.0	0.1	6.3	0.0	4.2	6.2	1.5	39.1	3.3	1.8	0.0	3.4	1.4	2.1	0.0	0.0	0.2	0.8	69.2	10.2	2.4	0.7	0.3	0.3	6.7	6.6	5.9	4.9	0.5	2.4	4.5	3.0	0.1	63.6	0.2	2.9	0.6
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA036122: AB_2674951, HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favorable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	11.9	29.1	41.2	7.7	43.0	19.4	12.1	41.2	52.4	16.9	36.9	14.2	6.8	12.3	8.4	15.0	11.1	5.9	21.9	44.3	40.6	14.2	20.9	10.8	10.2	38.9	38.3	18.5	25.1	8.9	34.0	5.4	40.4	16.7	4.7	4.6	16.5	6.5	24.4	19.8	12.2	4.0	39.9	16.2	15.2	9.6	41.1	13.4	9.7	10.2	8.9	17.2	13.6	43.4	44.7	41.6	15.1	32.1	16.0	13.3	44.7	13.3	9.4	19.7	22.0	27.0	23.4	94.2	118.6	17.5	34.9	19.1	37.5	13.2	6.8	53.9	59.9	34.4	38.3	15.6	27.2	46.1	49.1	20.5	8.6	29.6	7.7	15.0	14.1	44.9	34.2	44.4	27.3	104.6	61.9	134.3	28.5	59.5	99.7	54.0	26.0	106.4	11.6	12.0	41.8	38.8	31.0	73.8	57.1	10.4	32.0	33.5	15.8	14.1	41.9	59.6	51.3	104.2	117.5	145.0	24.8	81.8	33.3	27.1	25.8	10.9	26.4	25.5	33.9	40.4	36.5	38.6	35.6	33.7	82.0	41.7	2.8	47.0	20.8	66.5	31.7	40.0	41.2	43.0	41.2	52.4	44.3	40.6	38.9	38.3	40.4	39.9	41.1	43.4	41.7	9.6	14.7	8.5	57.1	58.0	50.1	68.4	70.6	54.9	84.5	107.8	30.8	58.6	34.2	35.0	8.4	62.4	58.5	40.0	127.2	50.7	2.0	15.3	22.4	46.5	56.4	79.7	10.9	93.4	119.9	40.0	27.5	14.8	46.9	75.7	33.5	49.6	126.3	23.5	8.3	50.8	67.1	37.4	93.1	6.3	41.7	55.6	92.5	3.7	63.4	87.2	74.2	4.5	9.3	40.9	28.4	36.9	65.0	46.1	38.5	72.6	33.0	18.4	6.6	35.3	31.0	43.5	100.9	61.4	56.0	56.8	51.8	56.8	54.3	45.2
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.1;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 106.6;granulocytes: 109.3;Hofbauer cells: 190.9;Kupffer cells: 100.9;Macrophages: 128.9;NK-cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 7.5;Karpas-707: 19.4;THP-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		350000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	23.3	11.6	0.5	3.0	0.3	4.4	12.3	1.6	1.3	4.1	0.5	6.9	0.4	3.8	0.2	2.6	5.5	0.9	3.8	0.4	0.6	4.6	3.5	28.1	5.8	1.0	0.8	2.2	3.8	0.1	4.4	1.0	1.0	5.4	0.2	0.1	5.8	0.2	1.3	2.1	14.3	2.0	0.4	46.3	5.0	1.7	1.1	3.9	3.3	0.1	0.9	6.3	3.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	3.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	19.4	0.0	0.0	2.6	1.8	0.0	0.0	0.0	2.6	0.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.9	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	3.2	0.3	13.1	4.2	11.7	7.7	9.8	4.8	2.1	2.3	4.1	0.1	5.8	3.4	4.4	0.7	6.3	11.0	11.2	1.7	3.8	0.5	0.3	1.6	1.3	0.4	0.6	1.0	0.8	1.0	0.4	1.1	0.9	1.9	16.0	25.6	0.3	26.1	0.6	0.6	0.2	0.0	5.6	1.1	2.9	1.5	1.5	11.2	0.0	37.5	5.3	106.6	0.2	0.0	0.1	32.2	0.6	0.7	5.0	0.0	10.9	0.4	0.0	5.2	2.5	0.0	0.7	109.3	0.6	3.6	1.2	190.9	1.7	0.5	0.0	0.0	100.9	17.7	26.1	0.3	128.9	0.0	13.1	22.5	0.9	98.9	0.0	0.6	0.1	0.0	0.0	5.1	0.7	0.3	0.3	11.0	15.4	0.0	0.9	1.3	2.9	1.0	0.4	1.1	10.0	32.1	0.2	0.2	0.9
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Metabolic proteins, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	926	"breast: 2187.5"	"Cell type enriched"	"Detected in some"	160	"Breast glandular cells: 48911.9"	"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"	NA	NA		91000		"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2187.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.6	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	48911.9	305.6	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.0	0.6	0.0	0.0	15.9	0.0	0.0	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	58.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.7	0.0	0.0	0.0	32.6	0.0	0.0	0.0
LAMA1	LAMA	ENSG00000101680	"Laminin subunit alpha 1"	P25391	18	6941742-7117797	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Distal enterocytes: 173.6;Granulosa cells: 77.3;Intestinal goblet cells: 44.2;Paneth cells: 35.8;Proximal enterocytes: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 56.0;ASC diff: 41.0;BEWO: 199.6;hTEC/SVTERT24-B: 41.7;SK-MEL-30: 38.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB010179	Enhanced				"Secreted to extracellular matrix"	NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB010179: AB_2133741"	"unprognostic (2.75e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.85e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.34e-3)"	0.7	0.0	2.0	0.2	1.5	0.0	1.6	1.9	1.1	0.8	0.5	0.1	0.0	0.9	1.4	0.1	0.2	0.0	0.2	2.0	2.0	2.9	0.1	0.3	0.0	2.0	2.8	1.4	1.1	0.0	1.0	0.1	2.1	0.2	0.0	0.4	1.3	0.6	0.0	0.2	0.0	0.3	2.2	0.1	0.0	5.9	3.0	0.1	2.5	0.0	0.0	0.3	0.2	2.9	0.0	0.0	56.0	0.0	41.0	36.5	199.6	2.0	9.8	9.9	21.5	24.4	0.0	0.0	0.5	3.4	8.0	0.1	0.0	7.3	4.1	0.0	3.2	0.0	11.8	0.0	4.8	0.0	0.0	31.1	1.1	41.7	23.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	2.8	0.0	0.0	38.4	11.6	0.0	0.0	0.0	7.5	20.5	4.2	0.1	0.0	0.0	0.0	3.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	1.9	1.1	2.0	2.0	2.0	2.8	2.1	2.2	3.0	2.9	2.6	6.4	0.0	90.8	0.0	0.0	0.8	0.8	0.6	0.5	2.3	7.2	1.9	4.3	0.0	0.0	0.0	4.1	0.0	173.6	0.0	0.0	1.6	4.1	0.6	0.2	1.2	0.0	1.4	0.5	3.1	4.2	0.0	4.3	0.0	77.3	0.0	0.1	0.9	0.0	1.7	44.2	0.0	0.0	0.0	3.7	0.0	0.2	0.0	15.0	0.0	3.4	0.0	4.0	1.8	0.0	35.8	0.0	0.0	1.0	47.5	1.4	0.1	0.3	0.0	0.6	3.4	0.4	2.5	0.3	0.0	4.8	0.2	4.6	16.5	0.3
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883138-129516566	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 106.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 363.1;Fibroblasts: 151.1;Leydig cells: 184.2;Microglial cells: 692.3;Oligodendrocytes: 160.9;Peritubular cells: 224.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 255.1;ASC TERT1: 184.5;HHSteC: 55.5;HSkMC: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	NA	NA		55000000	"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (3.65e-5)"	37.6	9.2	2.7	2.6	10.2	0.0	25.0	4.1	5.8	24.1	10.8	14.8	1.7	17.1	4.1	8.0	34.9	18.0	64.0	1.8	3.4	4.1	4.4	26.5	1.0	13.8	4.6	53.4	8.0	2.8	6.9	106.0	8.3	7.3	4.7	2.5	14.9	9.0	22.0	14.1	13.7	14.2	4.7	5.0	17.4	9.2	7.5	2.7	14.6	42.9	0.7	18.1	18.1	6.4	0.0	0.1	2.8	0.1	255.1	184.5	0.0	26.1	9.5	0.6	0.6	0.0	0.2	0.0	0.3	28.2	0.2	0.1	1.6	0.1	0.6	0.1	0.0	0.1	0.0	0.0	55.5	0.0	0.3	156.4	0.1	13.5	0.3	0.2	0.3	0.0	0.0	1.0	44.1	0.0	0.0	0.1	0.5	0.8	0.0	0.0	14.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	22.2	1.4	0.1	0.3	8.9	0.3	0.0	1.7	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	2.7	10.2	4.1	5.8	1.8	3.4	13.8	4.6	8.3	4.7	7.5	6.4	7.7	0.0	0.5	24.8	0.0	3.7	2.2	0.5	1.2	1.3	1.1	0.8	90.7	0.0	0.9	0.0	0.0	2.1	0.5	0.0	0.0	1.4	7.5	6.5	75.1	8.5	0.0	0.0	363.1	0.2	1.9	151.1	11.7	6.5	0.0	1.0	3.6	0.0	3.0	0.0	8.6	0.0	0.0	0.0	4.4	11.7	184.2	1.9	1.8	692.3	0.1	11.1	3.1	8.0	160.9	0.9	0.0	224.2	0.5	1.0	0.0	0.6	4.5	1.1	118.3	122.1	8.8	2.6	1.9	1.2	2.8	3.8	1.7	44.5	0.0	1.1
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689453-23956222	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 171.0;Gastric mucus-secreting cells: 138.1;Pancreatic endocrine cells: 585.5;Paneth cells: 170.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 40.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"HBEC3-KT: 1237.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		1800000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	10.0	1.2	8.3	8.5	3.6	0.1	20.3	2.8	5.9	15.4	5.4	13.6	17.8	15.6	4.7	14.5	12.0	7.4	4.2	4.1	3.5	3.2	1.7	20.9	4.1	3.8	5.9	5.7	4.7	10.9	3.0	24.8	3.6	12.2	8.4	3.7	21.3	13.5	2.0	32.1	19.7	6.9	3.5	0.8	31.8	3.3	4.3	9.5	2.3	1.7	4.1	12.2	23.1	2.9	140.5	15.7	0.1	0.1	6.9	1.3	0.3	2.6	1.8	1.3	1.7	5.4	159.5	0.1	17.3	1.8	0.4	248.5	0.2	1237.9	0.9	0.2	8.8	0.0	5.6	2.8	1.2	0.0	0.6	1.6	139.1	0.8	140.0	0.9	5.2	0.2	0.0	0.2	1.6	0.4	0.1	0.1	1.4	42.6	14.4	2.6	0.1	0.2	51.8	15.4	0.6	2.5	4.9	2.0	0.4	0.3	4.5	1.8	12.3	0.9	1.0	6.7	0.6	0.2	0.1	0.6	2.9	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.3	3.6	2.8	5.9	4.1	3.5	3.8	5.9	3.6	3.5	4.3	2.9	28.8	115.4	26.4	13.1	0.7	31.4	104.2	117.1	100.7	6.0	21.8	41.8	2.3	4.3	20.4	1.8	0.0	0.6	0.5	171.0	0.0	30.2	3.9	21.5	4.3	7.5	8.3	0.0	8.3	34.4	0.4	3.6	138.1	24.0	5.7	9.5	2.5	0.9	0.2	0.0	18.5	23.7	4.1	0.0	1.5	4.5	5.9	2.0	1.8	68.4	0.6	0.2	0.0	1.0	2.0	585.5	170.1	3.4	0.2	45.6	39.5	0.0	15.6	2.2	6.6	1.5	22.1	4.5	4.0	28.2	9.9	0.1	1.5	5.9	28.4	18.2
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Cytotrophoblasts: 104.4;Glandular and luminal cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 114.9;CACO-2: 159.6;EFO-21: 114.4;HaCaT: 107.2;HeLa: 118.3;TIME: 138.4"	"Low region specificity"	"Detected in many"							"HPA058389, CAB078157"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		1800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"CAB078157: AB_2665809, HPA058389: "	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	27.1	11.8	4.7	5.0	2.2	1.3	27.0	15.2	7.0	26.3	18.9	66.7	5.3	31.3	1.2	24.5	31.8	7.9	26.6	2.4	2.0	32.7	13.2	43.9	3.0	3.2	1.9	9.3	13.9	4.8	12.1	20.0	2.5	36.7	1.2	0.6	17.8	15.4	11.0	36.0	19.9	7.3	0.6	14.0	25.1	4.6	9.3	2.7	28.6	2.8	1.9	32.6	30.2	0.4	15.1	114.9	2.2	14.8	2.7	31.0	85.9	4.2	2.2	3.3	0.6	159.6	59.1	1.3	114.4	0.1	3.6	107.2	3.1	45.8	0.2	0.3	6.5	3.8	118.3	46.1	9.9	0.0	16.6	1.6	29.6	7.9	8.0	5.7	15.0	0.0	7.0	1.7	0.0	22.3	0.1	0.4	7.3	19.3	65.9	0.2	1.4	12.8	28.6	70.3	1.1	44.5	63.2	62.2	1.2	11.6	62.0	0.9	138.4	1.6	41.2	0.7	18.9	0.8	0.2	0.6	31.7	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	2.2	15.2	7.0	2.4	2.0	3.2	1.9	2.5	0.6	9.3	0.4	60.2	76.9	37.1	19.9	6.9	17.1	16.0	56.8	52.9	3.6	16.7	20.8	20.5	12.8	43.9	38.6	8.4	104.4	3.9	0.6	0.0	28.6	4.3	35.5	11.7	49.6	2.4	6.1	5.9	4.5	23.3	13.0	6.1	82.0	2.5	0.9	18.9	12.7	13.1	3.3	12.7	0.3	14.2	0.6	5.4	1.3	9.9	2.2	1.8	10.3	1.1	8.2	1.0	3.5	1.3	13.2	0.1	19.5	8.5	21.9	0.0	12.2	49.6	1.8	26.3	11.0	39.4	0.6	1.7	23.4	12.6	57.3	2.2	1.7	0.6	27.5
LAMB1	CLM	ENSG00000091136	"Laminin subunit beta 1"	P07942	7	107923799-108003213	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 185.6;Fibroblasts: 99.6;Peritubular cells: 141.8;Theca cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 593.0;ASC TERT1: 815.3;HSkMC: 779.6;TIME: 547.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004056, HPA004132, CAB004256"	Enhanced				"Secreted to extracellular matrix"	NA	NA		250000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.01e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-1)"	141.4	21.8	1.2	26.5	1.6	0.1	74.1	0.9	1.7	46.4	23.0	87.0	29.3	78.9	3.3	25.2	44.1	53.4	53.9	2.4	0.7	81.4	14.7	104.3	9.4	0.0	0.8	29.4	48.2	12.1	11.8	154.3	0.2	18.1	40.4	0.7	24.6	29.7	20.4	39.3	67.5	73.2	0.1	42.4	49.5	11.4	1.4	19.7	43.5	40.6	5.2	53.5	31.0	0.4	94.5	148.6	77.3	3.6	593.0	815.3	291.9	103.5	182.5	68.6	72.1	306.7	166.6	0.0	127.7	200.3	90.8	41.9	24.8	143.6	49.9	0.1	24.8	4.8	52.6	87.9	364.3	0.0	2.8	779.6	49.0	175.9	193.4	409.2	450.0	2.8	17.0	0.0	126.5	29.9	0.1	0.5	42.9	54.9	103.6	0.4	51.9	0.3	238.5	96.0	24.3	142.1	75.1	100.9	68.5	180.2	37.6	1.1	547.1	179.9	44.3	60.2	133.1	0.0	0.2	0.4	89.9	0.0	301.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.9	1.7	2.4	0.7	0.0	0.8	0.2	0.1	1.4	0.4	81.8	0.0	5.6	2.9	2.2	8.9	5.2	16.7	10.8	12.1	2.0	9.5	16.3	15.7	7.6	27.6	4.2	85.5	3.5	10.5	3.9	18.0	2.0	22.6	185.6	57.8	19.2	0.0	51.6	11.2	27.1	99.6	2.6	34.6	2.5	2.9	20.7	3.5	10.1	8.4	23.7	8.0	8.2	2.8	3.8	4.7	71.1	2.4	8.8	11.2	2.0	2.1	5.2	6.0	3.2	21.6	17.0	141.8	0.4	3.6	9.5	11.6	2.9	8.6	52.6	10.2	54.4	5.5	5.1	4.7	6.7	32.6	3.2	174.7	19.2	2.1
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 299.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		25000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	75.2	73.2	12.8	18.2	14.2	2.6	58.2	15.1	14.9	68.0	47.7	63.1	24.6	72.7	25.5	31.9	63.8	62.2	169.1	13.1	14.5	41.3	31.7	55.1	16.9	20.0	14.8	94.4	32.7	104.7	15.4	99.0	15.4	50.4	18.0	11.7	40.3	81.0	67.5	40.9	32.5	80.2	14.1	29.8	48.4	21.4	17.3	6.7	60.2	70.0	12.8	52.2	55.9	13.5	15.7	38.7	34.4	122.0	196.3	201.5	31.1	131.9	161.8	73.8	75.7	18.3	52.0	0.2	44.4	299.0	38.3	49.3	30.0	47.6	52.3	0.1	9.5	6.9	63.4	32.1	132.5	0.3	0.3	176.9	69.4	61.6	62.1	184.3	75.9	0.0	4.1	0.1	61.4	30.3	0.1	0.3	15.1	20.7	32.0	0.2	16.6	0.5	53.5	19.1	0.2	20.4	74.9	42.9	68.3	57.5	93.4	0.9	126.9	82.2	34.9	28.5	35.4	0.1	0.4	0.4	39.1	0.3	57.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	14.2	15.1	14.9	13.1	14.5	20.0	14.8	15.4	14.1	17.3	13.5	83.7	118.6	53.5	26.1	2.4	31.2	13.9	33.6	33.0	1.7	39.4	40.5	151.8	37.1	43.6	55.2	6.2	11.3	0.9	3.6	5.9	26.4	3.5	15.4	24.4	77.8	0.0	0.4	0.2	9.4	6.4	120.1	50.4	27.2	1.3	88.9	94.9	49.9	10.4	8.4	0.4	3.1	32.6	10.1	31.1	12.3	146.3	7.5	42.7	15.9	3.5	46.7	2.1	1.0	0.6	14.1	14.9	140.7	0.5	10.2	16.4	28.6	11.2	2.6	118.3	80.8	92.3	4.3	8.6	14.2	24.4	9.4	3.8	27.6	5.6	9.3
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652425	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.2;urinary bladder: 73.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 370.0;Basal respiratory cells: 447.6;Pancreatic endocrine cells: 853.8;Urothelial cells: 392.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 223.9"	"Region enriched"	"Detected in many"	7	"cerebral cortex: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 353.8;HaCaT: 538.2;HBEC3-KT: 1315.0;hTCEpi: 412.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		20000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	10.9	16.0	2.6	13.1	2.9	10.7	20.7	0.9	21.3	13.2	0.5	26.2	31.5	18.0	2.6	47.2	16.4	11.9	6.8	2.9	2.1	16.3	9.3	28.4	1.2	1.5	1.5	1.1	4.2	0.1	1.7	5.8	1.6	25.9	16.6	0.2	41.5	24.1	6.8	42.1	43.7	2.3	1.7	1.0	73.2	1.0	1.9	5.8	1.2	0.3	13.2	73.1	32.6	2.8	178.4	25.8	0.0	0.4	18.1	11.7	1.0	5.1	15.4	6.0	9.1	68.9	353.8	0.1	15.1	3.7	8.9	538.2	0.1	1315.0	9.1	13.1	1.4	1.1	86.9	1.1	2.4	1.0	1.3	2.6	412.8	19.1	253.4	11.7	6.4	0.1	2.5	6.7	1.9	0.3	0.2	1.2	0.6	81.0	74.0	0.2	17.1	165.4	70.9	109.0	0.5	0.5	73.9	8.5	15.4	1.0	2.0	9.7	138.3	29.1	61.3	1.0	104.6	1.7	3.4	0.4	42.2	0.8	2.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.6	2.9	0.9	21.3	2.9	2.1	1.5	1.5	1.6	1.7	1.9	2.8	0.4	221.2	67.7	1.6	1.2	109.7	370.0	447.6	159.9	0.3	11.5	64.4	8.4	4.3	168.5	47.8	0.0	1.1	0.4	247.5	0.0	180.5	6.0	50.8	10.0	3.5	7.8	0.4	2.5	153.0	1.4	7.5	195.7	135.0	18.4	0.2	0.4	3.9	2.0	3.3	2.3	71.7	18.3	0.3	30.0	10.9	1.8	9.9	8.8	0.0	2.1	0.4	0.0	1.0	1.7	853.8	229.1	0.7	2.1	185.0	111.9	2.3	52.2	0.3	0.0	5.3	10.4	0.3	0.6	51.7	26.0	0.5	4.0	0.0	63.1	392.7
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130361	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 38.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 34.9;Basal squamous epithelial cells: 41.5;Early spermatids: 12.7;Late spermatids: 11.1;Suprabasal keratinocytes: 13.8"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.8;HMC-1: 1.1"					"Low region specificity"	"Detected in all"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.1	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	38.9	0.2	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.0	0.0	34.9	0.0	0.0	41.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	5.9	0.0	12.7	3.8	0.1	0.8	0.0	0.0	2.1	0.2	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	1.9	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	5.1	0.5	4.2	13.8	1.4	0.0	0.1	0.0	0.1
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023420-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 231.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 187.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1582.4;ASC TERT1: 863.5;HSkMC: 980.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		100000000	"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	117.2	16.4	6.3	34.9	7.2	1.1	79.3	9.2	7.1	55.1	13.8	78.3	16.0	63.2	19.3	44.5	63.8	54.7	61.7	7.2	8.7	19.4	13.8	58.7	15.3	6.9	7.7	36.1	19.2	20.0	9.5	231.7	6.0	31.3	34.3	3.7	28.1	50.9	50.5	40.8	48.9	102.3	6.4	8.4	51.1	18.7	8.6	14.7	40.3	60.1	12.0	66.9	47.7	5.4	52.5	83.5	268.4	76.7	1582.4	863.5	405.0	374.8	373.0	147.8	87.1	249.4	58.2	18.8	168.6	180.8	87.9	127.4	51.7	99.2	112.7	0.6	52.6	0.9	71.1	91.3	248.1	16.6	8.9	980.4	52.2	177.0	138.7	262.7	261.0	0.2	0.6	55.5	182.5	22.8	0.2	17.4	109.3	96.0	15.7	13.5	226.2	9.9	237.6	137.0	17.6	50.1	98.9	0.7	95.6	459.0	21.2	43.6	486.5	179.1	70.0	168.2	95.4	21.6	0.3	12.4	148.7	12.3	177.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	7.2	9.2	7.1	7.2	8.7	6.9	7.7	6.0	6.4	8.6	5.4	81.2	35.3	21.6	32.7	8.1	31.4	46.1	44.4	35.9	3.1	7.1	17.4	57.5	27.1	21.0	36.8	4.2	101.9	0.2	1.6	1.9	59.2	5.7	32.5	58.5	80.9	1.2	0.0	69.2	23.3	69.0	187.8	8.6	78.5	2.5	53.0	26.7	19.1	18.7	1.7	50.0	2.4	18.3	10.7	20.6	6.8	120.9	4.5	33.8	106.8	6.0	2.2	1.0	35.2	2.5	44.7	2.6	62.4	11.0	59.9	0.5	12.4	14.8	0.7	72.3	73.9	102.1	17.6	36.8	17.0	16.9	72.1	2.8	74.4	3.5	25.8
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183245127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.3"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 1531.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, HPA046539, CAB078165"	Enhanced		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	No	No		130000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum, Golgi apparatus"		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: "	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	3.5	0.1	0.2	16.2	1.9	0.1	20.9	2.6	0.6	15.1	0.2	12.1	2.6	12.3	2.1	7.7	34.9	13.0	3.0	0.2	0.2	13.8	0.7	24.9	8.0	0.0	0.1	1.0	3.3	0.0	4.2	10.9	0.1	5.4	12.9	0.1	12.9	6.1	1.7	17.5	15.0	3.3	0.0	0.9	14.9	2.8	0.1	11.3	18.5	2.3	12.3	39.3	6.3	0.2	574.7	25.4	0.0	0.7	4.9	11.9	40.2	4.3	4.7	2.1	0.7	41.4	501.6	0.0	207.9	1.4	16.4	252.4	0.1	2492.2	2.7	0.7	0.2	0.0	0.5	0.1	1.2	0.0	0.2	6.1	189.7	6.0	1487.5	2.3	32.6	0.0	0.0	0.2	2.5	1.1	0.0	0.1	4.5	206.7	35.2	0.1	1.2	0.0	579.4	147.1	30.5	0.1	14.7	0.4	0.9	14.9	2.0	2.7	3.8	2.2	30.2	15.0	7.8	0.9	0.7	0.7	4.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	2.6	0.6	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	218.0	17.8	0.0	0.2	86.3	227.1	232.7	105.3	0.0	8.2	26.2	2.3	10.0	56.8	23.9	0.0	30.7	0.4	74.4	0.0	183.4	19.6	68.9	3.6	7.8	9.0	0.0	0.4	94.0	11.7	17.2	59.7	97.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	34.1	14.2	0.0	4.9	11.8	3.4	3.1	8.8	1.0	2.6	0.0	0.0	0.0	0.3	1531.1	91.2	0.4	0.3	302.0	16.7	0.2	69.3	0.0	0.0	3.4	9.6	3.6	1.0	60.3	29.7	83.3	5.3	0.1	15.3	169.9
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009174-131094473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 118.4;Peritubular cells: 364.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022814	Enhanced				"Secreted to extracellular matrix"	NA	NA		1100000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA022814: AB_2670960"	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.5	13.5	1.3	0.3	1.8	0.0	1.5	1.3	2.4	22.3	1.9	1.6	0.4	3.3	3.5	1.7	1.1	2.7	1.2	1.4	1.2	9.2	4.9	23.3	0.0	1.4	1.3	1.7	3.5	0.9	11.6	48.7	1.2	4.2	0.1	0.0	1.4	3.8	0.3	8.6	0.3	0.3	1.2	11.3	0.5	19.0	1.7	0.2	1.2	1.1	0.0	15.0	8.2	2.0	0.0	0.5	4.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.2	0.0	1.5	6.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	2.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.4	0.1	6.7	0.0	2.6	0.4	0.0	0.7	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.3	1.8	1.3	2.4	1.4	1.2	1.4	1.3	1.2	1.2	1.7	2.0	1.5	0.0	0.0	1.0	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.4	1.3	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.1	1.9	1.6	48.5	1.7	0.0	0.0	1.7	0.0	0.8	20.7	0.0	1.1	0.0	27.8	3.6	0.1	1.5	0.0	4.1	0.2	0.0	0.0	10.2	12.6	118.4	0.5	10.6	36.5	0.1	0.0	0.0	0.0	1.0	0.1	0.0	364.1	0.0	0.2	0.0	0.2	0.0	0.0	46.0	0.1	10.0	1.0	3.5	0.0	4.4	1.0	0.8	38.1	0.0	0.1
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297239-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 709.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported					NA	NA		370000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (3.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.15e-5)"	"unprognostic (2.06e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-1)"	139.2	95.3	83.6	84.1	118.7	72.1	124.6	114.3	89.9	119.3	54.5	108.0	109.8	136.0	103.4	125.1	98.7	91.3	101.3	82.9	96.9	149.1	183.8	148.7	77.2	120.6	106.5	101.7	174.3	109.9	95.0	107.9	119.7	98.0	65.9	35.7	145.0	94.8	71.3	182.3	112.7	92.5	104.7	102.3	108.5	84.8	112.6	63.4	126.7	46.6	55.6	118.6	110.9	138.0	271.7	92.3	93.9	258.1	514.7	192.5	176.7	311.9	325.1	189.8	252.1	181.8	491.1	63.7	139.1	318.6	324.9	338.7	92.9	198.1	128.7	133.8	153.1	105.5	167.6	172.5	265.9	324.5	236.2	236.4	264.6	176.3	114.4	308.4	232.2	61.0	89.3	90.9	236.8	108.9	66.0	158.2	71.5	258.4	99.9	96.1	81.4	96.5	172.3	200.9	85.7	90.1	183.3	268.5	187.6	89.8	259.6	228.0	355.1	193.5	208.2	258.8	141.4	169.4	178.8	66.6	323.4	318.8	229.7	3.8	4.9	9.5	4.0	4.0	3.4	2.2	3.1	4.4	2.5	2.1	3.4	2.8	6.8	3.9	4.4	5.4	3.6	2.1	83.6	118.7	114.3	89.9	82.9	96.9	120.6	106.5	119.7	104.7	112.6	138.0	152.4	86.6	67.2	31.3	64.5	140.8	144.5	68.3	70.0	42.4	131.1	92.5	56.9	123.0	51.4	183.9	77.2	195.6	103.6	248.7	41.1	99.0	272.1	72.7	73.4	113.9	119.2	50.9	22.3	62.3	198.5	173.6	60.6	101.3	71.0	71.3	162.1	303.3	282.9	30.3	22.4	111.1	32.6	208.9	56.8	709.0	163.8	167.6	99.6	34.7	77.6	50.1	104.0	29.7	83.2	82.7	199.2	170.4	51.8	101.4	288.1	178.1	45.1	84.5	118.3	85.0	107.1	163.1	124.7	96.1	197.5	312.4	94.8	72.4	128.6	124.0
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 556.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 556.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles		NA	NA		520000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	54.2	68.7	80.3	38.3	144.2	62.8	56.3	109.1	135.5	64.9	52.7	39.2	44.3	44.3	55.1	79.4	44.1	69.6	45.3	81.6	101.8	85.5	129.9	54.2	34.1	113.0	112.6	49.1	57.8	64.2	32.2	47.9	120.6	62.2	35.0	32.6	102.1	55.1	111.6	67.2	42.4	42.8	100.5	39.5	51.8	26.2	100.9	59.3	61.7	67.4	36.6	43.4	63.3	211.7	53.8	47.5	40.1	49.7	367.0	140.9	91.5	79.3	130.4	77.1	134.4	42.7	90.3	47.9	73.1	132.7	236.2	84.9	56.7	67.2	125.5	43.6	37.2	35.8	46.4	54.3	148.1	158.9	73.2	151.5	114.8	108.1	75.1	188.6	107.5	32.5	42.1	122.9	117.2	79.3	45.3	80.2	29.0	63.7	42.6	35.1	65.3	73.1	102.3	36.9	14.0	22.6	99.7	93.0	196.5	57.4	64.7	173.0	122.5	114.1	58.7	176.2	261.5	68.5	78.6	30.2	131.4	182.4	284.4	30.6	114.9	224.1	27.1	97.1	20.6	17.1	24.3	24.5	64.2	22.5	23.4	21.8	556.6	31.8	96.2	33.4	33.4	66.3	80.3	144.2	109.1	135.5	81.6	101.8	113.0	112.6	120.6	100.5	100.9	211.7	75.7	73.7	53.8	52.2	29.8	100.9	92.5	262.7	64.9	17.6	74.0	58.3	37.3	173.0	155.3	66.2	14.6	163.7	44.3	52.1	39.2	217.7	3.3	103.4	74.1	69.9	36.6	14.1	32.4	70.6	128.3	113.7	38.7	168.1	17.7	46.7	87.8	176.8	208.0	18.5	40.7	32.6	134.3	133.1	80.4	8.6	113.7	135.5	131.6	33.7	132.7	116.3	50.4	57.3	507.2	62.5	54.4	109.9	66.6	100.8	97.5	154.7	75.6	11.5	39.5	176.8	61.7	6.4	13.7	78.8	136.2	402.4	34.5	71.0	34.8	92.9
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122215-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lung: 219.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 486.7;monocytes: 339.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 27.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.6;T-cells: 4.8"	"Group enriched"	"Detected in many"	4	"EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7"									"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		59000	"Cluster 13: T-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.7	0.6	0.2	33.1	0.4	0.8	1.3	0.3	0.2	1.4	0.0	3.2	2.7	0.7	2.6	4.4	1.1	3.9	0.3	0.2	0.1	0.6	0.9	219.7	16.1	0.2	0.1	0.3	7.8	1.9	0.5	1.9	0.1	2.7	6.8	0.6	27.2	2.5	0.2	7.0	3.1	4.3	0.2	9.0	4.1	22.7	0.3	28.1	7.5	0.2	21.5	11.2	0.9	0.0	10.7	0.3	0.2	1.7	0.1	0.1	8.7	0.2	2.8	1.8	0.5	2.8	5.3	0.1	169.5	0.9	18.9	1.5	3.7	6.4	0.2	46.6	5.9	0.0	0.3	0.4	60.4	0.0	1.4	0.9	59.1	0.1	7.4	0.0	7.6	52.7	0.4	9.9	0.2	0.2	2.5	0.4	0.3	0.9	2.7	0.0	0.0	0.8	0.2	3.4	0.7	0.4	0.8	0.3	5.0	2.1	3.4	0.4	8.3	0.0	3.0	0.4	0.2	3.5	13.2	0.5	0.0	0.1	0.1	0.3	0.0	5.6	0.2	0.0	2.4	0.1	1.8	1.1	0.0	0.2	2.3	1.3	1.3	0.6	0.0	0.0	4.8	0.7	0.2	0.4	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	64.1	486.7	0.0	2.0	6.0	2.9	2.4	8.6	0.0	0.3	0.6	1.2	1.5	9.5	1.8	0.0	2.9	0.1	0.1	0.0	0.6	34.3	1.3	0.2	0.5	0.0	0.4	0.7	6.1	0.4	1.0	1.5	0.8	18.9	0.4	0.0	0.0	1.3	0.0	0.6	0.2	0.0	0.0	41.1	84.9	0.6	4.8	1.8	0.0	339.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	4.1	1.6	0.1	0.0	11.5	0.0	0.0	0.4	0.3	14.0	0.5	4.0	5.7	1.2	2.3	0.0	0.5	2.2
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.6;retina: 29.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"plasmacytoid DC: 141.3"	"Lineage enriched"	"Detected in many"	31	"dendritic cells: 141.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.3	41.7	1.5	96.6	2.3	0.9	11.0	51.8	8.8	3.7	2.2	1.2	4.8	6.3	0.4	10.6	3.1	0.4	39.1	14.3	0.8	0.2	0.9	5.7	47.7	10.1	21.9	1.2	0.7	6.3	0.1	43.7	2.3	1.2	29.6	1.1	3.8	0.1	0.7	1.3	3.9	29.1	1.8	1.4	0.9	35.3	1.4	0.9	0.2	5.2	0.7	1.2	13.6	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	469.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	86.4	0.0	0.0	0.1	0.4	0.0	169.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	21.1	0.3	4.2	1.7	0.0	0.0	0.3	0.2	4.5	0.0	0.1	9.5	0.5	0.0	0.0	0.4	0.0	0.0	141.3	0.0	2.4	41.7	96.6	11.0	51.8	39.1	14.3	47.7	10.1	43.7	29.1	35.3	13.6	0.5	0.0	1.1	6.2	3.4	0.1	0.0	0.0	0.0	12.3	0.3	4.3	0.3	0.0	0.0	0.0	8.4	0.0	78.4	0.0	0.0	0.8	5.4	0.2	0.7	0.8	0.0	0.0	10.0	0.0	0.0	8.4	0.0	0.7	0.0	22.2	0.0	0.0	1.3	60.6	38.9	0.0	0.0	0.6	0.8	7.5	0.6	3.5	3.6	4.7	5.4	3.9	0.0	13.0	1.5	0.4	0.0	0.0	5.5	0.5	0.0	0.0	0.0	5.7	0.0	0.3	13.9	0.6	1.1	0.0	0.0	0.0	0.9	23.2	0.1	0.0
LAMTOR1	"C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1"	ENSG00000149357	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1"	Q6IAA8	11	72085895-72103297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002997	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA002997: AB_1845531"	"unprognostic (7.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	100.7	143.8	171.2	69.1	177.8	118.6	96.2	173.2	180.4	87.0	162.1	88.6	67.5	86.5	90.0	114.1	74.9	65.8	131.9	163.5	169.5	129.5	114.2	91.3	80.6	177.4	177.2	81.5	85.6	87.0	92.0	67.4	174.9	102.4	76.5	46.6	85.8	71.7	126.4	89.9	82.5	73.7	175.4	130.9	96.6	41.2	176.1	75.4	112.3	109.3	79.4	88.5	77.9	172.5	94.2	181.0	97.3	132.0	224.7	152.3	97.6	129.0	201.6	206.2	151.7	230.9	139.7	93.1	162.3	216.9	214.2	138.1	171.1	260.1	155.8	117.8	99.3	245.6	108.5	156.5	291.4	97.2	147.7	252.3	199.2	224.4	224.0	116.4	173.1	102.5	104.1	96.0	211.4	295.6	86.2	146.1	93.9	291.8	194.9	73.7	178.9	78.8	246.8	195.1	65.7	103.3	127.6	127.5	343.7	106.4	192.6	93.2	125.3	137.5	98.0	323.8	93.0	111.6	139.0	80.4	81.8	81.8	113.0	113.4	414.3	274.1	80.6	228.8	77.7	132.1	75.6	81.1	332.6	146.2	63.4	77.9	229.5	122.8	180.6	197.1	98.8	397.5	171.2	177.8	173.2	180.4	163.5	169.5	177.4	177.2	174.9	175.4	176.1	172.5	132.6	44.8	71.6	9.1	109.7	55.7	161.7	271.1	117.8	58.5	159.9	195.7	66.4	121.5	120.2	128.8	12.5	266.5	110.7	235.4	295.4	276.4	12.4	61.2	98.9	134.9	116.4	133.5	9.8	340.2	300.1	111.6	71.4	85.2	97.7	71.5	142.1	86.9	468.0	77.4	12.9	140.2	170.9	248.5	111.6	19.2	107.8	311.5	113.8	8.4	413.6	223.7	177.1	10.1	24.2	307.3	202.6	102.7	87.9	193.4	230.3	370.9	61.0	56.1	111.7	102.5	116.3	58.7	103.3	126.1	55.4	282.0	89.4	178.5	170.8	157.2
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054782-156058506	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 627.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	64.3	84.4	81.9	41.6	81.4	57.1	57.7	83.9	98.9	44.8	83.0	62.0	51.5	42.3	76.7	75.2	52.1	43.8	96.1	81.6	84.7	91.0	164.3	53.8	56.3	81.6	82.5	26.7	87.8	74.4	44.6	37.5	82.0	50.9	56.5	18.0	59.3	44.0	88.6	57.8	53.7	48.9	82.2	65.7	78.1	26.6	85.8	56.1	44.7	70.2	52.0	53.6	46.7	85.8	63.9	142.3	65.4	90.9	131.9	106.7	72.3	55.7	94.4	68.8	78.1	65.9	106.1	94.0	94.4	108.7	60.0	91.5	67.7	151.1	38.7	78.4	103.0	54.9	96.2	88.6	104.4	78.0	86.5	126.1	93.4	73.1	93.3	94.4	142.6	137.3	50.8	68.1	100.9	128.7	80.6	111.4	69.4	250.9	212.1	67.5	48.7	138.7	152.5	93.2	25.3	145.3	70.4	195.1	116.3	104.1	136.5	227.9	96.6	57.5	52.4	83.4	53.0	101.6	166.5	56.2	102.2	87.3	62.9	281.8	465.8	376.2	172.2	446.9	169.8	290.6	188.2	188.7	537.2	249.4	142.6	152.8	231.8	207.0	363.2	284.1	298.3	389.7	81.9	81.4	83.9	98.9	81.6	84.7	81.6	82.5	82.0	82.2	85.8	85.8	102.5	57.7	46.5	3.6	64.5	48.4	59.5	190.3	43.3	29.4	129.9	123.2	113.5	114.4	120.2	108.5	6.2	146.3	73.9	247.5	387.4	193.0	44.5	113.2	78.7	92.6	126.1	48.0	4.5	179.3	203.1	67.5	68.3	105.0	107.3	56.7	86.7	322.1	416.1	6.7	5.4	164.7	197.4	188.9	150.1	89.0	47.2	165.0	158.3	5.6	297.4	92.8	94.7	4.5	5.8	183.2	267.4	50.8	76.8	80.2	317.8	627.2	144.1	30.5	32.9	38.9	124.6	25.5	33.9	99.4	80.0	77.2	64.2	83.3	166.9	97.7
LAMTOR3	"MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3"	ENSG00000109270	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3"	Q9UHA4	4	99878336-99894428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026858	Supported					NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026858: AB_1853523"	"unprognostic (7.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.75e-9)"	"unprognostic (5.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-2)"	16.9	25.7	14.6	16.4	15.4	32.5	24.9	17.3	26.7	20.8	14.5	24.9	23.5	23.3	39.5	30.1	19.2	19.4	24.3	15.4	15.8	38.1	21.7	17.5	20.4	15.2	16.4	24.3	17.3	36.4	18.9	22.5	15.5	28.3	26.2	23.3	24.6	17.1	21.0	23.8	23.8	19.1	13.6	16.6	21.3	15.6	15.7	20.1	33.9	20.2	21.0	23.8	21.6	14.8	19.9	6.4	26.1	17.5	36.2	35.1	20.2	18.9	18.6	18.3	15.0	15.0	39.0	17.3	18.6	19.5	17.8	9.3	26.1	23.9	25.4	20.5	14.0	12.0	13.1	28.3	35.0	36.1	34.1	23.1	48.9	13.8	15.4	26.9	20.7	12.9	30.4	21.1	35.2	20.4	30.5	35.4	16.1	42.8	10.7	20.2	14.9	19.5	55.2	22.9	20.2	25.2	12.2	40.6	41.0	26.3	20.9	29.3	20.5	14.2	16.7	24.0	14.8	26.5	30.6	33.8	30.0	20.6	20.5	43.5	17.6	38.5	9.8	26.8	12.9	11.4	12.1	11.1	19.0	9.3	14.0	14.1	58.6	18.8	28.4	13.3	13.5	13.8	14.6	15.4	17.3	26.7	15.4	15.8	15.2	16.4	15.5	13.6	15.7	14.8	38.8	57.7	33.7	8.8	35.6	49.6	60.7	77.8	68.3	28.0	53.9	46.1	35.9	24.3	44.2	35.0	12.5	48.8	30.3	95.7	135.0	50.9	12.0	38.3	29.8	27.6	36.1	46.7	15.2	32.6	55.8	37.4	43.8	61.3	41.8	23.9	22.9	25.2	77.8	18.5	13.7	48.9	52.9	41.5	89.8	9.4	40.0	56.9	37.4	3.7	60.7	50.7	38.1	8.5	12.7	43.9	102.5	42.5	30.7	63.9	53.9	130.2	30.3	26.3	19.7	30.9	30.9	72.6	40.2	86.6	64.6	78.4	32.6	22.8	43.3	78.8
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3294.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA020998: AB_1845762"	"prognostic favorable (2.48e-4)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	145.5	144.7	207.2	92.8	215.4	194.6	143.4	221.1	260.4	148.0	204.4	180.6	89.4	116.7	65.9	117.5	123.1	97.7	167.4	205.7	212.3	188.5	139.1	128.0	159.0	222.1	211.3	142.7	124.2	126.7	162.7	68.1	213.3	160.8	105.8	39.9	116.8	76.2	137.5	478.7	151.0	69.0	217.6	251.9	162.2	86.6	215.8	104.8	133.8	106.0	85.5	145.8	126.7	224.1	105.9	250.9	130.2	165.4	135.2	154.9	105.7	62.1	151.0	113.1	138.9	116.9	165.7	169.1	204.7	94.2	205.7	108.9	124.0	160.0	48.1	172.4	353.2	135.2	245.0	205.4	127.4	106.4	187.1	187.3	155.4	118.5	145.6	125.7	174.9	155.3	129.9	264.4	156.1	501.0	104.0	424.7	138.7	291.1	199.9	107.4	107.1	302.8	129.1	126.9	91.6	169.0	114.3	265.8	211.3	99.0	107.1	207.0	118.3	107.1	158.6	223.7	101.7	159.1	231.2	324.2	171.0	293.5	155.9	1033.3	843.2	3121.0	299.6	795.1	251.1	541.8	377.5	312.8	570.0	475.4	381.8	307.2	3294.2	310.1	756.2	482.6	453.0	893.6	207.2	215.4	221.1	260.4	205.7	212.3	222.1	211.3	213.3	217.6	215.8	224.1	181.8	93.0	150.7	18.9	195.8	274.9	194.0	282.0	167.9	65.3	240.8	277.2	176.6	143.0	172.9	218.8	12.5	258.4	199.9	819.7	534.1	167.3	40.0	152.9	125.8	186.7	299.3	99.3	12.0	326.2	196.5	175.6	146.3	131.4	183.2	120.9	239.1	246.3	531.1	58.9	13.6	423.9	252.3	497.4	351.7	46.6	146.3	365.2	434.0	13.1	411.0	229.9	298.6	11.6	26.2	204.2	867.4	120.4	133.0	169.5	511.6	557.5	194.8	67.0	144.7	142.1	196.9	88.1	101.2	151.3	662.9	201.4	195.9	150.8	511.8	219.0
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1113.2;Proximal tubular cells: 2532.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006812	Approved		Supported	Cytosol		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (6.66e-2)"	143.6	134.9	152.2	79.5	156.3	250.3	127.7	167.7	179.0	107.7	168.0	108.3	85.7	86.2	162.6	121.0	93.2	101.9	269.7	150.9	163.6	433.9	150.2	115.2	114.1	159.6	155.4	121.0	95.3	192.3	141.2	120.7	157.9	109.4	110.9	140.0	100.1	77.6	260.3	98.7	102.2	81.5	165.1	126.0	127.8	88.6	161.4	102.2	107.8	277.3	122.6	124.2	109.4	168.1	272.1	223.2	197.3	118.5	325.3	245.3	196.1	224.4	176.5	186.8	176.6	196.0	130.0	214.5	233.0	220.9	228.4	107.5	203.4	189.2	229.8	231.4	227.9	157.7	257.1	402.1	247.1	227.7	188.0	216.3	287.3	193.9	122.6	236.2	227.7	156.9	189.3	196.0	275.8	443.0	208.7	274.7	140.1	151.8	366.9	141.9	355.1	164.2	439.0	302.0	145.4	189.6	198.8	287.7	516.4	169.5	111.0	317.3	217.8	140.5	182.9	355.7	214.4	204.5	250.7	277.2	459.1	225.6	329.6	295.4	223.1	485.8	125.9	229.5	112.1	345.3	146.6	137.6	187.9	322.3	127.1	134.4	347.7	149.2	225.0	321.5	181.1	250.6	152.2	156.3	167.7	179.0	150.9	163.6	159.6	155.4	157.9	165.1	161.4	168.1	131.2	160.3	174.4	16.3	208.2	307.8	284.1	661.5	101.3	111.0	186.0	197.9	597.6	211.6	371.9	445.1	25.0	424.5	141.5	225.1	1113.2	389.2	67.5	215.8	141.8	193.1	222.3	158.9	15.4	331.0	370.7	194.0	99.9	191.1	146.4	97.0	133.9	311.9	424.8	89.2	17.6	302.6	449.6	154.4	189.2	112.8	264.7	175.3	350.4	18.7	320.9	297.9	137.0	9.5	23.3	403.9	296.4	239.2	100.6	360.9	315.4	2532.5	340.9	150.5	170.9	168.2	185.2	297.9	361.3	121.3	322.5	500.5	125.7	163.2	252.0	441.8
LANCL1	"GPR69A, p40"	ENSG00000115365	"LanC like 1"	O43813	2	210431249-210477652	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.5;Inhibitory neurons: 157.1;Oligodendrocytes: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034994	Enhanced		Uncertain	Microtubules		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules		"HPA034994: AB_10601936"	"unprognostic (2.34e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	28.1	26.8	57.3	15.5	91.9	19.1	33.6	85.2	81.5	23.1	21.5	22.1	21.5	28.8	19.6	29.5	23.4	23.0	40.9	59.0	67.7	37.6	23.6	21.2	26.7	95.1	79.4	32.1	24.6	64.9	19.2	22.1	89.0	33.0	22.7	48.5	20.3	31.7	28.5	42.2	20.7	33.0	92.8	23.3	19.0	53.9	77.5	40.0	24.3	51.2	27.7	21.4	16.6	140.7	26.3	29.2	45.9	46.8	51.3	71.9	32.0	39.3	50.3	35.5	46.4	32.8	29.4	22.5	50.3	44.9	57.8	26.6	30.2	63.6	59.4	26.1	32.4	39.6	96.1	58.3	42.5	50.5	13.6	52.1	51.2	46.7	37.8	80.3	52.2	68.3	50.1	35.6	46.4	23.1	68.5	27.9	30.7	31.9	20.2	30.5	64.1	33.4	65.2	25.4	43.6	60.4	46.0	97.5	51.2	67.3	33.2	26.7	53.5	62.2	41.4	32.9	41.8	21.8	43.8	31.3	58.4	38.5	73.4	8.6	2.5	6.8	11.8	5.3	11.5	7.9	10.4	11.8	8.3	8.8	11.0	12.7	0.8	8.1	8.5	7.3	11.7	6.8	57.3	91.9	85.2	81.5	59.0	67.7	95.1	79.4	89.0	92.8	77.5	140.7	13.5	12.8	14.2	36.2	11.6	26.3	10.0	13.2	31.3	27.2	19.0	13.5	35.7	10.0	12.3	20.2	18.8	10.8	12.3	5.9	15.6	8.7	140.5	11.6	12.6	13.4	6.7	17.9	68.4	12.0	5.6	16.1	9.2	10.7	6.3	24.0	11.4	20.1	8.8	50.5	157.1	7.6	12.2	10.3	6.4	114.7	13.1	5.0	16.0	20.6	4.5	20.7	15.5	70.4	599.1	5.3	6.0	19.2	11.0	6.5	9.2	18.8	14.2	24.1	19.7	14.8	22.0	41.7	19.0	25.3	33.1	5.1	13.8	14.8	12.7	8.1
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365337-55433737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3"	"Group enriched"	"Detected in all"	5	"glioma: 52.5;testis cancer: 19.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"A-431: 144.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		13000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.9	6.2	17.4	2.6	18.8	3.9	5.9	11.5	18.6	5.7	8.7	4.9	5.1	10.4	5.1	4.1	5.4	3.8	4.1	21.2	14.2	6.0	5.0	3.1	3.5	12.5	12.9	9.1	4.7	9.2	6.0	4.0	12.4	5.8	4.7	8.4	4.7	6.4	7.0	5.5	5.0	6.7	13.2	3.6	4.4	6.2	14.2	4.7	6.5	5.1	2.9	3.9	4.0	17.4	144.8	4.9	9.7	6.6	2.9	5.0	5.4	6.4	7.6	9.7	8.2	5.0	4.1	10.1	5.9	9.3	9.7	6.4	5.2	3.5	5.9	4.4	10.4	3.6	3.8	5.1	5.1	11.2	6.4	9.0	3.7	7.2	2.3	5.1	4.8	4.7	6.4	6.4	9.1	4.4	2.9	5.2	18.8	3.9	6.1	4.3	4.5	5.0	6.3	11.3	16.9	16.0	9.3	13.6	3.9	3.6	5.6	11.8	8.1	6.1	8.3	11.6	12.5	6.1	7.8	10.6	4.8	2.5	11.8	0.1	1.5	0.3	1.0	1.9	1.7	1.1	1.3	1.5	1.9	1.0	1.2	1.0	0.2	1.5	1.4	1.5	2.6	1.1	17.4	18.8	11.5	18.6	21.2	14.2	12.5	12.9	12.4	13.2	14.2	17.4	3.0	3.2	8.9	28.7	5.9	4.0	6.3	5.5	5.7	8.9	6.8	6.7	9.4	10.0	5.1	11.0	6.2	12.5	5.1	8.8	5.9	7.1	52.5	6.7	11.2	5.4	12.6	12.6	41.7	12.2	12.1	16.3	5.1	7.7	11.4	10.2	7.1	10.0	7.7	15.2	39.6	9.1	4.1	7.3	4.8	55.3	9.0	5.4	0.0	8.4	9.5	10.8	6.2	52.8	67.3	7.8	7.6	7.5	5.1	5.5	9.8	27.7	7.7	7.6	0.0	19.4	5.9	22.7	17.8	7.5	3.8	19.0	4.3	12.8	9.7	6.0
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 8.8;Inhibitory neurons: 20.4;Squamous epithelial cells: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HMC-1: 3.6;K-562: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA005470: AB_2134886, HPA076575: AB_2732315"	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	0.2	0.2	0.1	0.1	0.4	0.2	0.1	2.6	1.0	0.4	0.0	1.0	0.1	0.2	0.0	1.5	0.1	0.1	0.1	0.6	3.7	0.2	0.0	0.3	0.1	1.0	1.6	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.5	0.6	0.4	0.2	0.2	0.7	0.2	0.1	0.5	0.1	0.6	0.2	2.5	0.1	0.1	0.1	0.2	0.3	1.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	1.5	0.2	0.0	0.0	0.2	11.8	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.6	0.0	0.1	0.2	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	1.1	0.5	0.0	0.0	1.8	0.0	0.3	3.8	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.3	0.3	0.1	0.4	2.6	1.0	0.6	3.7	1.0	1.6	1.0	0.5	2.5	0.5	1.3	3.2	4.1	2.9	0.1	8.8	1.2	1.8	6.8	0.8	0.6	0.4	0.9	0.0	1.2	0.0	0.0	0.0	3.0	6.6	0.0	0.0	0.1	0.3	0.6	1.1	1.8	0.8	3.1	0.2	0.2	0.4	4.1	0.7	1.3	0.1	0.0	0.2	0.1	3.3	20.4	0.4	2.0	0.3	0.5	0.0	0.3	0.2	0.0	1.0	0.2	0.5	4.1	1.0	2.0	2.1	1.4	1.5	0.2	0.7	1.6	0.2	0.0	1.4	0.0	1.8	0.9	0.7	3.1	10.1	4.4	0.1	1.4	0.2	1.0	2.5
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LAPTM4A	"HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp"	ENSG00000068697	"Lysosomal protein transmembrane 4 alpha"	Q15012	2	20032650-20051628	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1393.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031402, HPA031404, HPA068554"	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.73e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (8.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (7.98e-3)"	"unprognostic (2.36e-1)"	360.5	451.0	116.8	177.1	114.9	199.5	338.5	120.7	146.8	469.8	150.8	256.2	219.6	507.6	339.7	315.4	370.1	383.7	322.5	112.7	130.2	460.9	409.2	308.0	160.1	123.3	122.2	460.3	290.8	289.2	155.6	397.6	128.1	306.3	233.9	59.1	306.0	611.8	204.4	247.2	227.7	412.2	130.1	190.9	240.5	389.3	125.5	122.8	365.8	234.8	178.5	342.1	248.7	128.0	417.7	228.8	136.4	283.2	1393.4	1031.8	509.1	514.3	651.8	349.3	393.6	180.5	398.4	73.2	116.2	637.9	356.9	400.7	115.0	250.6	317.8	181.2	183.2	112.4	244.3	520.1	534.8	86.7	294.9	691.7	501.2	338.7	386.4	481.9	367.6	62.2	86.6	135.8	527.5	243.3	53.8	114.0	299.2	353.1	207.1	89.3	397.5	139.7	858.6	347.7	214.8	207.3	480.4	390.5	335.9	492.9	169.6	70.1	467.5	575.7	203.8	500.3	336.5	221.7	349.2	118.3	455.3	172.8	234.4	737.8	382.3	289.3	94.6	324.9	116.4	197.4	112.9	106.9	269.2	192.3	126.7	113.7	200.1	124.3	393.4	226.9	119.3	427.0	116.8	114.9	120.7	146.8	112.7	130.2	123.3	122.2	128.1	130.1	125.5	128.0	351.7	195.5	203.1	39.2	156.5	659.0	601.1	1210.5	339.2	24.4	330.3	306.1	211.7	380.3	727.7	553.6	12.5	224.4	109.8	174.8	162.4	539.4	1235.7	195.7	407.1	384.0	138.1	65.0	15.0	347.6	1035.3	896.8	111.6	286.0	521.9	445.7	331.3	519.4	311.3	20.2	14.3	203.6	767.0	299.3	716.0	1080.9	835.3	254.4	588.7	39.4	278.0	315.3	48.4	34.7	18.7	289.4	246.2	600.7	156.8	331.2	171.5	940.9	506.7	24.7	532.5	389.4	583.0	356.3	173.5	268.2	709.8	302.9	146.4	579.1	224.8	500.9
LAPTM4B	LC27	ENSG00000104341	"Lysosomal protein transmembrane 4 beta"	Q86VI4	8	97775057-97853013	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 380.1"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 348.5;Rod photoreceptor cells: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HEL: 611.7;RPTEC TERT1: 549.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020782, HPA068830"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB020782: , HPA068830: AB_2686044"	"prognostic unfavorable (5.63e-4)"	"unprognostic (1.91e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (9.25e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	24.2	43.2	30.2	18.0	29.7	5.3	42.9	37.3	29.6	50.1	78.2	34.0	79.7	71.0	29.3	33.7	67.5	46.3	220.9	23.6	35.3	67.3	25.3	39.6	13.7	42.1	36.1	45.1	28.8	185.5	20.3	28.2	39.5	29.2	32.9	380.1	32.8	44.9	153.7	43.9	43.0	47.8	45.2	38.3	32.2	62.5	44.2	8.6	43.0	117.0	20.2	41.0	28.5	50.1	219.2	170.8	171.9	350.3	80.2	61.0	108.1	98.0	50.1	222.9	188.6	103.1	168.0	1.0	378.0	73.5	75.2	241.2	208.8	94.8	242.9	1.5	282.4	611.7	130.6	169.0	66.1	0.3	101.5	83.8	71.0	130.8	66.0	75.1	29.1	69.5	375.7	0.8	92.4	164.1	54.5	34.1	318.8	116.5	106.5	0.6	90.5	0.7	549.4	100.9	172.8	287.1	133.6	63.8	159.4	188.0	154.3	83.7	8.1	47.7	92.0	99.0	70.7	22.4	68.8	2.2	60.8	0.5	144.9	3.3	0.1	0.0	0.5	0.0	1.4	0.3	0.4	0.3	0.1	0.1	0.8	0.9	0.1	0.3	0.0	0.1	0.2	0.2	30.2	29.7	37.3	29.6	23.6	35.3	42.1	36.1	39.5	45.2	44.2	50.1	60.5	102.5	56.1	8.5	4.9	55.2	68.1	63.9	89.4	195.9	59.8	55.6	208.1	82.9	30.9	106.7	223.1	26.6	3.9	17.9	39.2	244.5	7.1	70.6	59.6	77.4	35.4	36.6	15.0	123.6	33.2	72.2	19.4	105.6	12.7	348.5	132.8	32.6	8.6	134.6	36.6	29.6	59.0	3.7	10.1	8.6	23.9	6.6	42.7	4.7	2.8	135.0	1.0	19.1	20.1	72.1	34.4	30.9	1.7	77.0	95.9	62.1	10.5	575.3	59.2	62.6	75.4	7.4	35.8	45.1	44.3	14.1	10.2	119.9	52.1	86.4
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LARGE2	"FLJ35207, GYLTL1B, PP5656"	ENSG00000165905	"LARGE xylosyl- and glucuronyltransferase 2"	Q8N3Y3	11	45921621-45929096	"Predicted intracellular proteins"		"Glycosyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 36.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 189.8;Syncytiotrophoblasts: 116.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.3;NTERA-2: 32.5;SK-BR-3: 23.5;T-47d: 71.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056621	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA056621: AB_2683194"	"unprognostic (9.82e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (3.04e-12)"	"unprognostic (2.31e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	0.2	2.4	0.0	2.3	0.0	0.5	4.4	0.3	0.1	5.1	12.2	1.0	1.3	2.0	4.9	17.1	3.9	0.6	0.2	0.8	0.0	15.9	3.3	1.9	4.7	0.1	0.1	2.0	27.1	12.5	11.5	36.6	0.0	9.9	0.7	3.5	17.7	8.3	0.6	19.7	3.7	0.1	0.0	2.5	11.2	1.6	0.2	4.1	11.3	0.0	2.3	2.2	6.8	0.1	1.2	1.6	0.1	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	8.5	0.6	0.0	0.9	0.0	0.8	8.0	0.1	15.2	0.0	0.0	4.7	0.0	1.2	9.3	0.2	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.0	9.7	0.0	0.0	2.7	0.2	0.0	32.5	12.2	1.1	0.9	0.0	3.1	0.5	0.6	9.6	1.1	0.3	23.5	0.1	1.9	71.4	0.0	0.0	0.2	10.4	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.1	0.4	0.0	2.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	3.2	2.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	13.5	8.3	0.0	0.0	0.6	7.3	0.0	189.8	0.4	0.0	3.9	4.6	0.0	10.9	3.4	0.9	0.0	0.0	0.0	6.4	11.3	0.9	0.0	28.0	0.0	9.4	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	116.2	0.8	0.1	0.0	0.0
LARP1	"KIAA0731, Lar1, LARP, Lhp1, MGC19556"	ENSG00000155506	"La ribonucleoprotein 1, translational regulator"	Q6PKG0	5	154712843-154817605	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	42.5	50.0	30.9	36.5	28.4	37.0	36.4	12.2	44.8	38.4	15.8	38.4	33.8	43.6	37.4	51.6	39.9	29.3	48.6	34.3	25.8	40.0	36.7	34.8	41.1	26.7	40.3	45.0	103.0	70.3	39.8	37.9	47.2	31.3	34.6	32.1	57.4	32.9	78.8	45.4	37.7	38.7	5.4	35.7	44.0	38.2	27.6	42.1	53.8	46.4	44.8	38.0	40.0	37.4	93.3	140.3	107.6	124.1	93.3	73.1	103.1	99.0	101.8	114.7	110.0	218.1	116.8	252.2	128.0	127.5	168.5	92.9	196.1	185.9	135.7	83.4	94.1	187.1	143.8	106.1	117.6	250.6	81.2	91.2	108.4	144.5	185.2	66.4	103.9	114.0	149.2	180.2	111.9	102.9	156.5	100.0	107.3	89.8	60.5	158.8	97.5	120.5	74.1	120.7	180.7	93.5	132.2	215.4	112.3	112.9	126.0	119.0	130.4	140.3	83.0	106.2	170.3	136.8	126.0	219.5	92.1	134.8	99.1	2.2	2.4	0.7	2.6	3.0	3.3	2.5	3.0	3.0	2.4	3.3	2.5	2.6	1.4	5.9	5.6	3.9	2.1	1.7	30.9	28.4	12.2	44.8	34.3	25.8	26.7	40.3	47.2	5.4	27.6	37.4	37.6	44.8	33.8	67.9	37.2	78.3	39.7	38.0	34.7	64.4	45.1	33.0	104.4	50.1	33.7	40.5	37.5	43.7	35.3	45.1	29.4	42.2	14.4	70.1	70.6	48.8	43.9	73.4	72.0	82.5	35.2	46.2	46.9	65.5	17.2	63.2	47.8	66.9	57.9	87.5	92.5	49.6	18.3	53.3	42.6	12.1	69.6	43.6	37.4	46.9	49.1	26.5	33.0	47.7	69.5	62.1	37.7	80.1	47.3	75.2	53.0	50.1	46.5	38.7	13.1	63.6	39.4	56.2	40.5	54.6	84.5	23.9	34.6	71.6	68.8	53.6
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein 1B"	Q659C4	4	128061286-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.1;Late spermatids: 449.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	10.5	8.2	5.1	8.0	6.1	14.4	11.5	8.5	9.7	11.5	2.1	14.8	14.6	8.9	24.1	11.1	9.6	9.1	11.6	5.9	5.4	14.2	50.7	9.9	6.3	3.5	4.2	10.3	35.6	16.3	12.9	10.5	4.4	11.0	16.3	11.0	13.8	11.7	18.2	11.1	15.5	8.3	2.1	6.2	15.4	55.8	6.0	6.5	13.6	13.3	9.3	13.2	9.9	8.6	21.5	7.4	13.2	16.7	13.7	15.5	26.8	18.0	19.9	16.7	10.7	16.9	16.5	26.1	24.6	17.8	12.7	8.3	32.7	19.9	19.9	24.7	20.9	20.9	13.0	41.5	29.7	40.3	8.2	8.1	28.7	13.4	49.0	16.0	19.8	19.4	37.1	42.4	9.6	25.1	35.2	23.1	15.2	33.0	11.9	19.4	20.3	29.8	19.1	16.4	39.1	15.5	15.6	35.7	16.8	17.5	10.5	17.4	16.1	10.7	11.8	17.5	18.1	55.9	22.7	30.1	13.8	30.7	11.5	0.2	2.1	1.3	1.7	1.6	3.1	1.6	1.9	2.2	2.5	1.4	1.5	1.7	0.5	2.6	1.7	4.6	1.7	0.8	5.1	6.1	8.5	9.7	5.9	5.4	3.5	4.2	4.4	2.1	6.0	8.6	18.4	35.3	35.6	46.0	19.9	27.8	25.7	11.7	10.8	37.0	34.9	18.7	30.2	40.0	32.5	20.2	52.1	31.4	15.2	52.2	13.7	22.1	393.1	41.9	32.3	17.3	34.0	25.0	139.1	29.9	23.2	23.4	29.6	62.6	20.8	12.5	15.0	154.6	11.9	23.5	115.6	115.2	18.3	15.7	16.3	449.5	36.4	15.5	17.8	19.7	16.7	17.5	20.6	55.8	51.8	31.3	36.2	19.9	54.5	46.4	37.4	63.2	29.0	71.5	19.7	20.7	23.1	138.3	21.9	25.3	34.7	51.4	14.3	8.4	55.1	30.6
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	17.4	27.7	9.5	16.2	12.6	14.0	14.6	16.4	10.8	14.1	23.8	15.3	16.7	10.5	11.7	18.9	9.3	12.9	16.3	8.8	13.9	29.0	62.1	13.5	15.6	13.2	14.4	9.4	16.5	21.8	8.8	18.3	14.0	13.9	14.4	20.3	15.9	11.3	26.4	11.2	13.1	11.7	12.2	12.5	17.2	14.9	13.0	15.9	20.0	37.0	15.5	21.5	9.0	17.3	43.9	61.0	40.1	29.6	36.6	30.2	67.9	52.9	31.5	51.3	40.8	120.5	50.2	102.9	63.9	33.2	47.5	41.1	88.2	36.1	67.3	64.3	35.9	83.9	56.1	43.6	34.0	93.9	47.5	27.6	33.9	60.9	65.1	33.9	45.9	37.2	122.8	47.4	48.0	39.3	77.7	31.6	58.2	28.5	52.9	56.6	63.6	61.0	27.8	65.1	47.2	27.7	94.0	48.3	54.9	37.0	42.1	37.4	66.9	34.0	50.2	39.7	50.4	45.9	134.7	90.3	47.0	37.9	28.9	8.2	8.7	6.0	8.1	9.6	7.5	8.6	7.0	4.5	11.7	8.6	8.2	6.7	4.4	8.2	12.1	10.0	7.6	7.7	9.5	12.6	16.4	10.8	8.8	13.9	13.2	14.4	14.0	12.2	13.0	17.3	35.9	48.1	44.7	31.0	26.8	71.0	33.8	23.1	59.7	41.0	34.0	25.1	47.8	22.8	27.7	29.5	87.6	27.4	22.0	29.1	9.8	19.7	8.6	52.9	50.4	28.6	24.0	33.0	38.9	24.0	17.3	31.0	38.7	57.5	19.7	27.9	21.0	129.0	27.3	18.5	45.5	25.8	20.3	33.0	26.6	25.4	14.9	23.0	26.6	24.4	27.6	18.4	13.4	26.7	40.4	27.0	16.1	19.2	56.4	44.3	20.3	54.7	33.0	54.0	6.6	42.2	36.8	37.4	42.5	52.2	74.3	34.2	22.0	34.4	27.5	33.2
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	14.3	19.9	13.1	17.2	13.3	18.5	13.6	15.3	17.4	13.4	20.9	17.0	19.4	13.1	10.3	25.2	13.3	12.8	22.2	16.4	14.9	13.8	13.0	20.2	22.1	16.0	12.0	13.0	16.5	17.1	12.7	15.1	15.6	16.2	15.6	14.5	16.8	12.3	38.7	22.3	18.5	10.9	12.1	19.4	21.9	18.9	13.2	16.0	22.2	22.3	19.7	15.9	16.7	14.1	50.0	42.7	21.7	24.5	19.0	19.1	32.2	33.0	15.7	35.6	34.2	58.1	56.4	59.9	12.0	33.0	10.6	51.6	38.5	28.0	30.5	38.1	27.9	51.6	29.5	33.9	31.3	37.3	42.5	21.2	31.7	36.8	20.4	19.9	24.8	28.8	65.5	39.3	28.9	50.9	53.0	33.8	23.2	49.5	16.5	36.1	18.7	41.5	28.6	38.5	21.4	30.2	32.5	62.5	25.4	21.1	59.3	35.6	34.4	27.6	7.2	87.8	34.2	39.2	51.2	58.3	30.5	30.0	17.6	11.4	8.2	9.7	5.4	9.0	5.7	4.2	6.0	6.2	7.3	5.2	5.7	6.0	8.0	5.4	7.9	8.3	6.1	3.9	13.1	13.3	15.3	17.4	16.4	14.9	16.0	12.0	15.6	12.1	13.2	14.1	23.7	51.3	62.1	59.4	22.4	30.3	15.6	16.2	23.9	20.5	21.6	15.4	43.5	28.6	30.7	23.9	27.1	17.2	24.6	38.5	5.9	17.4	14.7	42.0	24.5	21.2	13.8	22.7	87.7	16.3	13.2	19.4	44.9	43.4	7.6	31.0	14.6	19.1	21.5	23.5	84.1	35.1	18.3	34.7	25.3	7.1	17.4	30.3	17.8	83.4	33.4	15.7	14.4	65.9	71.6	33.2	27.2	24.0	25.5	27.0	32.5	16.2	33.4	22.4	26.3	23.4	18.3	27.8	23.8	28.8	42.6	46.2	20.7	26.1	34.7	35.6
LARP6	"acheron, FLJ11196"	ENSG00000166173	"La ribonucleoprotein 6, translational regulator"	Q9BRS8	15	70829130-70854157	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 232.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020338, HPA049029"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Microtubules	"Cytokinetic bridge"	"HPA020338: AB_1844500, HPA049029: AB_2680604"	"unprognostic (1.35e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (4.51e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.43e-1)"	51.4	9.8	42.8	6.5	69.8	0.1	44.0	56.9	65.5	27.5	22.8	18.5	2.1	22.8	28.4	7.9	29.0	10.9	43.4	44.5	52.0	27.9	10.6	17.9	2.3	57.8	56.6	30.4	10.9	19.6	23.6	7.7	56.4	26.1	4.0	11.8	19.5	14.1	17.6	14.0	10.3	12.1	46.8	2.6	26.9	9.6	55.9	5.1	40.8	26.1	1.5	21.1	31.0	90.4	42.3	44.2	14.1	28.3	70.2	77.9	0.1	127.7	99.0	67.4	71.2	12.9	12.0	0.0	50.9	69.9	65.4	22.7	32.0	11.2	66.4	0.4	78.3	0.2	37.6	12.0	127.1	0.2	0.2	49.0	45.6	67.9	107.5	70.6	22.2	15.4	0.1	0.6	30.4	7.3	0.3	0.3	14.9	0.0	113.9	0.2	50.6	0.3	22.0	35.9	8.4	18.5	42.5	0.5	93.1	21.7	2.3	2.4	29.6	27.4	109.6	232.0	107.5	0.2	0.3	0.4	116.9	0.0	14.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	69.8	56.9	65.5	44.5	52.0	57.8	56.6	56.4	46.8	55.9	90.4	32.3	0.0	1.1	2.9	0.1	18.1	47.7	20.4	9.6	41.4	15.4	18.3	22.2	24.3	11.8	12.9	2.1	0.5	1.0	0.3	54.8	59.4	429.0	24.6	31.8	24.5	12.0	0.0	10.8	25.1	0.8	87.5	4.1	8.4	0.0	7.5	11.4	15.3	1.2	25.2	11.8	1.5	10.2	0.6	13.3	259.8	73.3	3.2	19.6	7.5	0.1	28.5	0.0	5.5	105.9	62.9	0.0	45.9	0.5	61.9	0.0	100.9	16.8	4.8	19.7	28.3	34.8	166.8	11.0	1.4	8.9	0.4	1.9	5.3	0.6	37.7
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein 7, transcriptional regulator"	Q4G0J3	4	112637107-112657592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	37.2	31.6	26.3	32.8	28.3	44.6	35.7	28.6	34.6	28.0	28.0	36.2	33.8	33.3	29.8	31.7	25.8	30.5	59.6	24.9	33.5	40.2	44.1	28.1	44.9	30.2	30.2	34.2	18.3	29.9	20.1	34.1	31.0	32.1	36.7	31.5	23.2	27.2	46.6	30.6	33.2	29.5	28.3	36.9	31.5	24.6	29.1	42.2	38.7	45.3	40.3	33.0	21.8	30.8	42.9	34.9	77.7	44.3	50.7	61.6	44.0	55.3	40.6	45.3	42.0	27.9	62.0	95.4	43.7	46.9	42.2	29.6	75.1	45.2	60.2	86.8	52.1	56.4	35.2	41.9	41.0	131.6	84.6	49.3	50.7	40.4	25.1	62.6	40.4	47.6	71.4	51.1	55.3	35.2	107.4	56.7	182.2	67.5	28.2	62.9	66.2	44.3	68.8	44.8	46.5	64.4	32.0	83.4	55.4	131.4	35.1	61.0	43.7	42.4	49.5	47.7	57.6	34.7	62.5	97.6	57.7	52.4	49.2	70.1	28.1	49.9	32.8	43.1	30.3	48.1	33.9	34.2	25.3	47.4	32.3	31.3	33.2	38.7	60.7	64.0	37.9	20.8	26.3	28.3	28.6	34.6	24.9	33.5	30.2	30.2	31.0	28.3	29.1	30.8	66.1	96.1	79.2	45.1	68.8	24.9	66.5	102.6	34.1	61.3	48.3	50.4	113.2	95.8	91.6	47.8	29.2	79.0	88.7	83.2	111.6	69.3	17.6	78.7	70.5	63.2	38.9	43.6	18.0	64.4	70.2	60.6	32.1	58.8	104.4	51.5	81.4	160.9	70.4	58.9	19.9	79.7	61.1	93.7	27.1	14.9	94.4	67.2	24.9	32.8	96.0	107.1	107.1	20.6	43.1	62.0	85.6	100.1	39.1	38.8	73.1	117.0	109.8	54.1	118.3	74.5	68.3	83.5	87.8	33.3	20.9	100.4	65.9	74.2	75.6	47.9
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LAS1L	"FLJ12525, Las1"	ENSG00000001497	"LAS1 like ribosome biogenesis factor"	Q9Y4W2	X	65438549-65534810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	21.5	19.1	36.9	11.4	37.8	16.0	21.2	35.6	53.7	27.1	34.0	26.4	5.8	23.1	6.8	20.0	25.5	6.3	18.6	34.8	34.8	19.1	19.6	17.4	13.1	36.3	37.1	29.9	21.2	12.2	17.5	8.9	36.8	22.7	8.1	9.4	18.8	11.9	19.3	25.4	18.5	10.3	38.1	22.5	20.0	33.6	37.1	12.8	20.5	6.3	14.0	24.2	21.4	37.8	44.1	63.6	36.3	28.5	12.4	16.1	29.1	28.5	14.9	42.8	36.4	30.4	31.3	95.0	31.3	17.8	28.7	31.3	63.9	39.6	50.6	25.6	52.3	32.2	53.2	32.4	16.6	95.9	26.8	17.8	28.7	40.5	25.6	15.1	26.0	46.1	80.3	71.3	25.5	51.8	62.4	53.6	52.6	49.8	63.1	56.2	67.4	79.9	24.7	17.9	24.6	32.9	51.3	26.0	20.1	25.8	19.5	44.6	22.2	26.4	50.9	73.2	44.4	23.7	37.7	94.6	28.1	92.5	13.6	17.7	17.7	11.2	20.1	24.0	21.3	23.9	18.6	23.5	24.2	26.4	23.2	19.8	2.0	22.9	19.3	19.1	21.7	21.0	36.9	37.8	35.6	53.7	34.8	34.8	36.3	37.1	36.8	38.1	37.1	37.8	15.5	12.8	22.3	23.2	21.6	18.2	21.4	24.8	9.1	34.9	12.7	13.6	9.2	21.5	27.0	3.7	29.2	32.8	13.3	6.9	15.6	27.9	58.0	17.5	20.0	17.2	16.7	18.1	19.6	26.6	31.4	16.8	11.7	12.9	18.3	26.0	8.9	14.8	16.3	45.4	17.7	9.4	18.3	8.5	13.4	148.2	17.4	11.7	10.6	8.4	18.1	16.1	12.3	13.0	12.5	21.4	7.7	15.4	26.3	23.5	10.2	14.3	26.7	34.2	13.1	21.8	22.8	24.1	19.1	17.8	18.6	17.8	17.5	22.3	14.1	14.8
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 591.7;Proximal enterocytes: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		9400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	86.4	38.0	60.8	75.9	56.7	126.4	55.5	45.5	56.7	46.9	48.6	93.0	131.9	43.8	32.3	45.9	46.0	56.8	40.3	56.1	61.0	55.9	76.4	68.6	76.1	56.2	63.5	48.5	59.0	25.5	33.0	81.4	59.0	30.9	92.3	26.8	44.8	33.9	23.7	44.4	168.8	51.2	52.9	74.3	96.2	23.9	67.4	74.1	34.9	27.7	78.2	53.2	37.3	50.1	214.1	441.0	124.1	111.0	182.8	196.9	218.7	267.8	257.8	274.5	198.5	134.3	225.8	98.8	214.1	417.3	154.9	332.4	58.5	204.1	239.6	71.6	31.6	47.5	124.2	235.8	173.0	110.4	134.1	176.3	69.6	234.6	66.1	170.7	188.0	59.0	81.9	30.3	389.4	72.0	127.1	163.6	63.0	189.9	109.4	70.7	67.6	123.8	332.7	187.9	19.0	45.4	159.3	160.5	134.7	233.5	255.7	128.2	331.4	160.0	233.0	189.7	162.0	79.7	115.8	75.2	170.2	96.7	197.2	21.8	31.4	35.0	30.7	33.1	20.3	11.7	15.2	20.4	27.3	10.8	12.7	19.8	67.0	34.2	42.1	20.5	21.4	32.5	60.8	56.7	45.5	56.7	56.1	61.0	56.2	63.5	59.0	52.9	67.4	50.1	54.5	41.7	27.6	17.6	41.8	41.8	21.5	26.0	51.8	66.4	82.4	43.2	1.1	55.8	30.4	73.5	10.4	7.5	69.5	225.2	17.6	65.7	89.6	27.5	31.7	54.3	86.5	21.0	16.4	76.5	59.1	50.1	119.3	46.4	52.0	37.4	64.6	115.4	83.9	26.9	16.0	101.9	28.5	127.7	73.0	591.7	51.9	71.9	35.6	24.4	94.3	22.2	164.8	11.1	4.4	111.0	116.4	39.9	32.8	24.2	292.7	72.9	57.3	23.1	65.7	65.4	53.4	2.9	5.7	62.2	28.4	6.4	63.4	19.2	97.8	31.8
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990784	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8"	"Group enriched"	"Detected in all"	142	"granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8"	"Cell line enhanced"	"Detected in many"		"HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5"	"Not detected"	"Not detected"							"CAB002223, HPA011157, CAB012978, CAB079960"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		140000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	8.1	4.4	9.1	23.9	9.6	17.5	6.6	9.0	11.9	15.6	8.1	31.3	9.2	19.3	5.2	8.1	11.6	9.6	3.9	9.2	8.5	15.3	10.5	14.1	65.9	9.2	8.5	7.7	5.7	2.0	14.2	3.9	9.0	21.6	5.2	3.5	7.8	9.5	4.2	10.7	22.7	5.7	8.0	32.0	13.4	4.1	9.7	117.9	17.6	1.6	29.0	24.7	13.3	8.9	1.0	2.3	1.5	2.5	3.7	2.4	4.9	5.5	1.4	1.7	2.2	2.3	3.0	0.7	7.2	2.2	0.6	2.9	2.6	1.3	0.8	1.6	3.3	189.8	5.4	3.3	1.0	5.9	765.9	2.1	3.8	1.7	0.7	2.8	0.9	62.7	2.6	21.7	0.8	5.6	279.5	38.3	3.4	0.4	2.7	3.2	0.8	24.9	1.9	1.6	5.3	1.0	0.9	1.8	2.7	1.4	2.7	31.7	3.6	3.6	18.0	3.9	1.3	7.6	7.0	3.1	45.5	2.7	2.9	307.7	1.4	0.7	303.4	1.5	212.5	1.7	295.1	307.2	1.1	1.7	276.0	266.9	14.6	114.6	1.3	1.9	410.8	196.5	9.1	9.6	9.0	11.9	9.2	8.5	9.2	8.5	9.0	8.0	9.7	8.9	5.2	0.0	13.1	4.6	6.2	7.1	2.1	1.1	2.8	11.0	3.7	4.3	1.7	7.2	3.1	9.2	6.2	2.6	80.7	1.2	1.9	1.7	0.3	1.5	2.3	4.7	0.0	16.6	4.7	0.5	0.9	3.0	7.7	2.7	78.9	4.9	8.6	2.9	14.3	6.7	5.5	1.5	0.0	7.3	9.4	0.1	1.5	55.9	10.6	5.6	9.2	3.0	152.4	3.0	3.5	1.0	0.7	0.7	17.0	2.2	1.3	1.3	1.3	9.6	0.0	3.0	3.8	1.7	2.1	1.9	5.3	2.7	151.7	1.7	1.4	1.3
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.3;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.6;granulocytes: 171.6;Hofbauer cells: 82.7;Kupffer cells: 71.1;Langerhans cells: 81.9;Macrophages: 89.1;monocytes: 89.6;NK-cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 871.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 192.2;REH: 205.7;RPMI-8226: 73.3;THP-1: 186.5;U-937: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	6.8	5.4	9.7	37.7	11.1	61.3	3.8	11.8	12.8	3.7	9.1	6.5	6.3	2.9	2.5	3.6	4.2	9.1	2.3	10.3	12.2	3.3	4.8	19.2	51.6	18.4	13.6	1.7	3.0	2.2	3.0	7.4	17.7	7.1	7.7	1.2	4.5	3.5	3.3	3.0	13.6	8.8	16.5	47.0	6.5	2.0	15.3	12.2	2.8	2.4	56.6	10.1	2.5	20.1	1.7	1.1	1.1	3.1	0.3	0.0	1.1	1.4	1.2	0.6	0.7	2.3	28.9	19.6	0.4	0.5	6.1	1.2	0.4	1.1	0.6	31.4	1.2	8.6	1.8	1.8	0.1	56.1	55.6	0.4	0.8	2.1	0.6	1.2	0.3	1.1	1.6	9.3	0.5	1.7	1.3	192.2	0.9	5.5	2.0	205.7	1.1	73.3	0.2	1.7	0.9	0.8	0.6	1.2	1.2	0.9	1.1	186.5	2.1	2.1	19.9	0.8	1.8	0.9	6.2	32.2	9.4	177.6	1.5	871.6	276.6	46.0	8.8	159.0	0.9	169.3	2.3	1.4	225.2	191.1	1.0	2.9	491.0	73.9	93.9	8.9	4.9	214.7	9.7	11.1	11.8	12.8	10.3	12.2	18.4	13.6	17.7	16.5	15.3	20.1	1.3	3.2	16.2	0.7	90.6	3.4	0.7	0.0	0.6	0.3	1.0	1.9	1.1	5.7	3.1	3.7	0.0	0.6	47.8	0.2	0.0	0.3	2.4	1.3	0.6	3.9	7.8	16.6	1.7	0.2	1.1	1.7	1.1	2.1	171.6	0.4	3.9	4.5	82.7	0.0	1.4	0.8	0.0	71.1	81.9	3.4	0.0	89.1	1.8	20.6	89.6	0.2	70.0	0.5	0.9	0.6	0.1	0.7	18.7	1.2	0.1	0.2	5.9	1.3	0.0	1.9	0.9	0.4	1.4	0.1	2.6	1.2	27.7	0.3	0.8	0.4
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718105	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"			"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	8.1	8.0	4.8	8.6	4.9	15.4	9.2	11.0	7.0	10.1	5.5	7.3	7.2	12.1	7.4	8.2	9.7	7.7	5.6	5.2	4.6	7.7	7.8	9.1	9.8	4.7	4.3	15.6	6.8	11.7	5.2	8.8	5.0	11.0	8.5	11.0	8.7	7.7	6.4	9.1	7.7	10.7	4.3	10.2	7.7	6.2	5.1	11.7	8.9	8.1	8.4	9.0	7.2	7.6	8.7	6.8	13.7	19.8	12.9	16.6	10.7	11.3	11.4	11.8	11.7	11.1	7.3	14.0	11.1	15.7	9.4	11.8	18.3	12.0	18.5	12.9	14.7	28.1	8.2	9.9	11.9	26.5	19.8	11.3	19.1	13.5	22.7	12.2	14.8	12.1	35.3	13.9	11.9	10.4	13.8	11.0	8.5	8.0	6.5	13.6	16.4	6.5	11.0	12.2	9.3	14.7	16.1	11.5	8.4	9.3	12.0	22.9	18.7	9.5	14.8	11.4	18.2	11.6	13.5	15.8	8.7	14.8	14.3	8.2	3.0	4.8	5.9	5.3	5.3	3.8	4.5	5.0	3.3	4.7	3.8	5.1	2.0	3.0	8.9	2.8	4.8	2.4	4.8	4.9	11.0	7.0	5.2	4.6	4.7	4.3	5.0	4.3	5.1	7.6	21.1	12.8	21.3	33.0	21.9	16.3	11.2	9.7	27.9	20.3	15.2	10.2	9.6	12.8	12.5	7.3	18.8	8.5	18.7	15.3	1.9	7.5	23.0	14.1	23.4	16.2	16.8	17.7	51.4	6.6	11.4	19.7	20.9	17.1	14.0	19.8	21.0	13.3	11.0	13.5	48.0	12.6	6.1	14.7	11.6	6.9	13.7	16.6	14.2	32.8	15.0	10.7	10.3	54.8	64.0	9.9	11.5	25.9	21.9	15.4	13.6	6.6	12.8	22.0	19.7	28.8	15.1	8.8	9.6	18.8	18.0	13.1	23.3	13.8	11.7	11.8
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973036-21061586	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	19.8	12.2	3.9	7.3	4.3	15.1	12.4	4.8	3.7	10.1	7.7	13.1	2.9	12.2	3.0	11.5	9.7	15.1	11.5	5.3	3.3	9.9	9.8	12.4	5.3	5.4	4.6	11.0	10.2	4.3	2.3	13.9	4.5	9.8	4.3	1.3	6.1	8.8	16.7	7.7	6.2	13.1	4.1	11.2	7.8	14.6	5.1	2.4	13.5	13.3	3.3	14.2	8.9	4.7	6.8	7.4	16.0	9.7	18.4	24.1	14.6	22.1	22.8	22.5	19.2	21.1	10.0	0.0	10.5	33.8	8.8	9.6	9.5	10.1	33.1	3.8	2.5	12.4	9.4	16.0	28.6	3.4	4.2	36.0	18.1	14.9	9.9	11.3	32.0	2.8	2.3	0.5	28.9	11.7	0.4	11.6	3.8	7.0	3.5	2.9	28.5	0.0	16.3	3.1	0.3	0.0	17.4	11.3	23.9	13.9	9.8	6.4	40.6	23.8	15.9	17.7	14.1	2.9	1.7	0.0	5.7	3.8	18.6	0.1	0.5	0.5	0.4	0.4	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.1	3.9	4.3	4.8	3.7	5.3	3.3	5.4	4.6	4.5	4.1	5.1	4.7	36.6	41.7	9.9	12.1	2.8	32.9	14.7	8.5	21.6	0.4	12.5	11.0	24.3	15.7	10.5	5.5	0.0	24.8	21.0	6.5	3.9	10.1	139.4	40.3	30.4	35.1	0.0	8.2	0.6	7.3	8.9	37.2	8.6	62.1	5.1	9.8	44.6	19.6	9.9	0.0	0.6	1.9	6.1	17.9	49.3	13.7	25.4	26.0	17.8	21.5	11.0	4.9	13.4	2.0	8.8	18.6	2.8	34.6	8.9	21.7	0.6	9.5	11.6	1.0	6.6	32.3	30.0	8.8	14.5	9.9	25.3	48.0	8.1	7.9	1.5	15.2
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765177-203776372	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 23.2;granulocytes: 82.2;NK-cells: 30.9;Plasma cells: 65.1;T-cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	14	"B-cells: 7.5;NK-cells: 5.2;T-cells: 12.0"	"Group enriched"	"Detected in some"	4	"Karpas-707: 22.8;U-266/70: 28.2;U-266/84: 71.9;U-698: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	0.5	0.6	0.2	8.8	0.3	1.6	1.7	0.4	0.4	1.4	0.3	3.7	3.1	0.3	0.3	0.9	0.4	2.6	0.3	0.3	0.2	0.2	0.9	2.7	11.8	0.5	0.2	0.2	0.4	0.1	0.0	0.1	0.5	0.7	3.4	0.1	1.2	0.4	0.1	0.2	2.0	0.7	0.2	7.2	4.5	0.3	0.3	11.1	0.2	0.3	21.2	5.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	8.0	0.2	22.8	0.0	0.0	8.7	0.0	0.1	0.0	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.2	71.9	24.9	0.0	1.9	0.0	0.3	0.0	0.5	12.0	0.0	9.1	7.5	7.1	9.4	0.0	2.5	5.5	7.1	0.3	5.2	0.0	0.0	8.1	3.5	0.2	0.3	0.4	0.4	0.3	0.2	0.5	0.2	0.5	0.2	0.3	0.7	0.9	0.0	1.9	0.0	14.6	1.1	0.4	0.0	0.0	0.0	0.3	0.1	2.6	0.0	0.6	0.0	0.0	0.1	23.2	0.1	0.0	0.2	0.0	0.4	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.4	82.2	0.0	2.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	1.9	10.6	0.0	0.4	0.0	30.9	0.5	0.0	0.1	0.0	0.0	65.1	0.4	0.6	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.2	0.4	0.0	29.2	0.1	0.3	0.5
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"myeloid DC: 11.2;T-reg: 13.4"	"Group enriched"	"Detected in many"	123	"dendritic cells: 11.2;T-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA		340000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	10.7	2.0	15.6	5.7	21.4	1.0	8.5	15.7	19.6	15.6	13.7	29.2	3.8	15.8	10.1	4.7	17.7	17.0	7.0	16.6	17.1	5.7	0.9	11.3	7.1	17.4	19.7	39.1	2.0	6.4	6.2	14.1	16.3	14.6	3.3	0.8	5.5	17.0	6.1	2.6	10.6	22.5	14.2	8.2	13.1	4.4	18.0	10.3	27.4	6.1	5.0	8.8	12.2	23.7	0.4	3.9	0.8	0.0	25.4	48.0	7.6	150.7	153.7	71.0	96.7	0.2	0.1	0.0	1.4	95.1	18.7	3.2	9.9	0.7	74.2	0.2	0.5	0.8	0.0	0.2	41.7	0.0	0.2	88.8	0.0	30.8	0.2	94.0	0.9	0.0	0.0	0.1	29.4	0.0	0.1	0.1	4.8	0.0	0.0	0.0	11.4	0.2	0.6	0.0	4.9	18.9	0.5	0.2	0.4	34.9	0.1	0.7	0.6	108.8	81.2	1.0	74.3	0.0	0.0	0.2	14.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.4	0.4	15.6	21.4	15.7	19.6	16.6	17.1	17.4	19.7	16.3	14.2	18.0	23.7	22.2	19.2	2.8	0.3	0.3	2.2	48.8	44.8	0.6	0.4	0.7	15.0	2.7	2.8	23.3	0.0	0.0	1.6	2.6	0.0	0.0	6.5	2.5	3.9	7.7	50.9	0.0	2.7	0.3	0.2	2.1	13.1	0.0	0.9	1.3	9.6	6.8	0.1	0.7	0.0	1.4	0.0	6.1	0.6	13.6	1.8	22.7	1.2	0.0	2.8	0.6	0.2	0.0	4.0	30.1	0.8	0.0	55.3	2.8	233.0	0.0	0.2	32.0	0.2	32.9	2.6	17.3	0.1	2.3	0.1	2.3	0.5	14.5	11.2	0.0	50.3
LBH		ENSG00000213626	"LBH regulator of WNT signaling pathway"	Q53QV2	2	30231534-30323730	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 210.6;Pancreatic endocrine cells: 298.9;Smooth muscle cells: 435.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 112.4;MAIT T-cell: 110.2;memory B-cell: 92.0;memory CD4 T-cell: 83.8;memory CD8 T-cell: 86.1;naive B-cell: 123.0;naive CD4 T-cell: 140.2;naive CD8 T-cell: 124.6;T-reg: 89.2"	"Group enriched"	"Detected in all"	7	"B-cells: 123.0;T-cells: 140.2"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 302.4;hTERT-RPE1: 150.6;U-2 OS: 95.1"	"Low region specificity"	"Detected in all"							HPA034669	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA034669: AB_10600820"	"unprognostic (2.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.77e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.67e-1)"	35.2	10.3	8.4	57.4	7.9	28.6	32.0	13.7	22.4	45.6	18.4	27.4	14.4	83.0	27.0	17.0	41.7	44.9	119.3	15.2	33.9	39.3	15.0	130.7	117.8	23.0	17.4	63.3	14.4	84.8	16.7	54.5	18.4	27.3	18.1	70.8	63.9	26.3	14.3	30.3	41.2	48.2	11.2	83.5	22.8	9.8	14.4	125.7	68.9	20.4	100.9	35.5	22.7	11.8	0.1	11.4	14.0	2.5	3.6	2.2	1.1	14.5	19.1	3.8	0.6	59.4	15.2	28.6	33.3	302.4	3.8	19.5	81.1	0.8	0.6	41.3	3.4	4.6	12.2	0.2	10.9	0.4	4.0	13.0	1.1	5.0	0.3	150.6	0.7	19.0	14.6	0.2	14.2	0.2	32.3	0.4	84.6	2.6	0.6	33.1	75.4	9.7	2.6	5.0	3.9	10.0	23.7	2.3	1.0	49.7	0.1	1.2	18.9	26.8	95.1	52.0	1.8	53.8	3.3	2.7	11.9	1.8	8.4	0.7	0.7	1.1	112.4	1.2	110.2	92.0	83.8	86.1	0.8	123.0	140.2	124.6	4.0	18.9	3.2	12.1	89.2	110.4	8.4	7.9	13.7	22.4	15.2	33.9	23.0	17.4	18.4	11.2	14.4	11.8	46.9	109.0	20.0	0.7	167.3	12.4	64.5	51.7	16.5	41.2	13.0	125.0	65.1	12.8	40.8	25.8	210.6	18.3	152.2	6.0	13.7	85.4	39.4	110.5	18.0	81.8	23.8	85.9	2.2	56.9	10.8	54.7	23.4	45.2	15.8	2.3	23.6	1.2	33.2	8.4	16.4	9.3	30.5	10.0	23.1	144.5	10.5	14.3	23.2	14.0	6.7	13.1	163.7	9.5	0.7	298.9	8.7	26.7	26.3	95.3	0.7	21.7	67.8	45.4	177.5	36.3	435.6	0.7	6.6	9.1	10.7	9.3	205.3	8.8	6.3	56.8
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 65.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Respiratory ciliated cells: 8.7;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.8;JURKAT: 53.8"	"Low region specificity"	"Detected in all"							"HPA012127, HPA023592"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.6	13.1	1.8	5.5	1.8	6.3	3.7	2.9	2.8	3.4	2.9	4.7	3.5	2.0	4.2	3.4	3.4	2.6	3.2	1.8	2.0	3.8	8.6	3.5	7.5	2.1	2.2	1.9	3.8	4.1	3.9	1.9	2.2	4.3	3.4	65.9	3.6	3.5	1.8	2.5	6.0	2.3	1.6	9.5	4.5	7.3	2.1	6.0	4.1	0.9	4.7	3.6	2.6	2.4	2.7	4.7	2.8	2.1	4.2	7.9	6.2	3.6	5.3	5.8	4.6	3.7	30.8	9.4	7.7	4.5	6.0	11.8	3.0	8.4	4.5	12.8	9.5	7.9	14.6	2.7	6.2	7.4	9.9	10.9	0.9	10.4	3.2	6.5	3.2	53.8	8.3	8.3	3.7	4.8	4.6	11.0	3.6	6.4	4.0	11.2	6.9	17.4	7.7	5.4	3.2	4.7	4.0	5.4	12.1	3.8	10.1	11.1	2.5	3.6	2.3	3.7	4.0	13.7	12.8	9.1	3.3	7.4	3.8	1.5	3.5	3.4	3.2	2.4	2.9	2.4	1.9	3.5	3.1	2.5	2.6	2.1	0.8	4.8	2.1	3.9	1.2	2.6	1.8	1.8	2.9	2.8	1.8	2.0	2.1	2.2	2.2	1.6	2.1	2.4	0.8	3.2	2.7	0.0	2.0	0.0	0.2	0.0	1.2	2.3	0.6	0.5	0.8	0.0	2.5	0.0	4.2	0.2	2.0	0.2	0.0	0.2	0.0	2.7	1.1	0.5	0.0	0.4	0.3	0.0	0.3	1.0	2.0	0.7	2.5	1.2	0.0	0.6	0.2	1.7	0.3	0.1	0.0	0.3	0.0	0.3	0.3	1.6	0.0	1.0	0.1	1.5	2.1	0.0	0.1	0.2	0.0	0.4	3.9	0.4	0.4	0.3	8.7	7.6	0.0	1.1	0.3	0.7	0.6	0.9	0.0	0.3	1.8	3.6	0.1	0.3
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1338.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.2	0.5	0.0	24.2	0.1	0.5	6.6	0.0	0.2	4.6	0.0	0.5	0.0	2.6	0.0	0.1	0.6	0.2	3.3	0.0	0.0	8.7	1338.5	1.2	2.8	1.1	0.1	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	22.8	0.6	0.6	1.5	0.0	0.5	0.6	0.7	0.4	0.1	3.9	2.0	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.5"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.5	0.4	2.5	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.3;liver: 8.7;stomach 1: 3.2"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.9;olfactory bulb: 1.0"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	1.3	0.3	0.3	0.4	0.3	0.4	0.6	0.9	0.4	0.4	0.0	1.1	5.3	0.3	0.2	0.2	0.2	0.4	0.3	0.1	0.2	1.3	8.7	0.5	0.4	0.5	0.2	0.1	0.7	0.1	0.0	0.5	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.9	4.8	0.2	0.1	1.1	3.2	0.1	0.4	0.0	0.3	0.0	0.1	0.3	0.2	1.3	4.4	1.6	0.0	0.1	2.0	1.5	7.1	0.3	0.2	0.4	0.4	10.5	6.2	0.2	1.7	0.8	0.6	1.7	0.0	0.3	0.0	9.0	1.8	4.7	0.7	22.1	1.4	0.3	3.0	1.9	1.6	1.6	0.3	0.2	1.8	0.1	3.1	2.2	0.3	2.3	0.1	0.7	0.4	1.7	0.2	0.4	0.4	0.2	0.2	1.4	0.2	1.1	2.6	0.4	10.1	0.1	0.2	0.3	4.1	1.5	6.6	8.1	0.2	2.9	2.3	0.2	1.5	0.8	4.8	0.5	1.5	0.1	0.3	0.8	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	0.6	1.1	2.2	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.1	0.2	0.5	0.2	0.5	0.1	0.4	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.7	0.5	0.7	1.5	0.5	1.8	0.0	0.3	0.5	0.9	0.0	0.6	0.0	0.4	0.5	1.0	2.4	0.4	0.0	0.6	0.5	1.3	1.1	0.2	0.0	0.0	1.4	3.7	1.1	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	2.4	7.5	0.7	0.0	6.6	0.0	0.9	0.4	0.1	0.3	0.1	0.5	0.5	0.2	1.0	0.1
LCA5	C6orf152	ENSG00000135338	"Lebercilin LCA5"	Q86VQ0	6	79484991-79537458	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 89.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029053, HPA029055"	Supported					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029053: AB_10602020, HPA029055: AB_2672889"	"unprognostic (8.96e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.09e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.21e-2)"	3.2	1.9	4.4	1.6	3.9	3.6	4.9	4.0	5.0	4.2	16.9	2.5	1.0	5.4	3.7	3.0	9.6	3.0	2.4	6.0	4.6	2.8	1.2	4.0	1.5	4.5	5.8	7.3	2.5	17.2	3.6	3.3	5.1	3.9	1.6	13.7	5.5	4.7	1.1	1.0	1.3	4.2	5.3	1.7	1.6	6.9	2.8	1.1	6.3	2.0	1.0	3.5	2.8	6.1	1.7	1.3	3.9	2.2	4.8	5.3	1.7	3.0	3.6	1.8	3.7	9.9	1.9	0.4	3.9	2.4	3.4	1.8	2.9	1.8	3.3	0.0	2.2	14.6	1.9	1.4	5.0	0.3	1.2	5.0	2.0	3.1	4.0	7.0	5.6	0.1	2.3	0.9	3.0	0.0	0.0	0.0	1.1	1.0	1.5	0.0	6.8	0.7	3.9	0.5	2.9	3.5	2.7	0.4	1.9	4.8	0.3	0.8	3.9	1.9	2.2	0.6	2.6	3.7	1.4	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.9	4.0	5.0	6.0	4.6	4.5	5.8	5.1	5.3	2.8	6.1	6.7	16.0	11.5	17.0	1.1	1.0	12.5	5.9	11.4	12.4	6.5	15.2	5.1	11.5	17.5	11.0	22.9	8.0	0.1	0.1	0.0	15.9	17.3	52.6	8.6	14.4	2.4	4.6	32.8	4.9	3.6	12.0	0.5	3.7	1.3	6.3	9.3	0.1	1.1	10.1	16.2	0.3	8.2	1.3	0.9	5.3	18.0	1.0	3.6	4.7	0.2	13.4	0.0	24.6	21.9	7.1	0.1	15.8	1.6	6.2	0.1	3.3	89.7	30.4	6.6	14.0	12.1	18.0	11.4	5.5	1.0	12.3	1.2	8.4	0.6	9.5
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"Lebercilin LCA5 like"	O95447	21	39405728-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 110.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.7;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: AB_2674110"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.7	0.6	0.4	0.7	0.3	1.7	1.4	1.1	1.8	3.4	0.6	0.4	1.2	7.6	0.4	7.2	0.8	0.5	0.6	0.8	2.4	0.7	1.5	0.3	2.0	2.5	0.9	1.3	2.2	2.0	0.3	1.6	0.8	0.5	10.8	0.9	0.9	2.1	0.9	0.4	0.6	2.0	0.4	0.8	110.5	0.9	0.3	4.3	1.5	0.2	0.5	0.5	1.1	0.9	1.0	0.6	1.7	0.8	0.7	0.1	0.2	0.4	0.5	0.0	0.5	1.0	0.7	0.7	0.9	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.8	0.1	0.7	1.1	0.0	0.6	2.3	1.6	1.7	1.1	0.3	1.0	1.7	0.6	0.6	3.7	0.3	0.4	3.2	0.6	1.0	0.2	0.2	0.7	1.7	0.3	1.1	0.5	2.0	0.8	1.4	0.3	3.9	0.1	0.1	0.3	0.2	0.9	0.2	1.8	1.1	0.1	1.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.4	1.1	0.6	0.8	2.0	2.5	1.6	2.0	0.9	1.1	1.1	3.2	0.5	5.5	0.3	0.5	0.9	2.7	1.2	2.0	4.5	5.0	2.6	1.5	16.8	7.3	6.2	1.1	0.1	0.4	19.6	3.5	1312.6	34.9	2.4	1.6	4.2	0.0	3.8	2.2	0.2	2.2	0.5	2.8	0.0	1.8	1.4	1.6	0.5	1.7	2.6	1.4	0.0	0.6	0.7	472.4	6.5	1.3	1.8	1.0	0.6	3.2	0.0	0.5	2.1	1.6	0.5	7.9	0.0	0.6	0.2	12.0	68.0	17.4	19.7	3.6	1.7	465.8	26.7	0.3	0.6	0.3	0.3	3.2	0.9	0.7
LCE6A	C1orf44	ENSG00000235942	"Late cornified envelope 6A"	A0A183	1	152842856-152843983	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 246.6"	"Cell type enriched"	"Detected in single"	8	"Suprabasal keratinocytes: 2.6"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046376	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"			"HPA046376: AB_10965998"						"unprognostic (4.25e-2)"			"unprognostic (8.73e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	246.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 343.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	12	"gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7"	"Group enriched"	"Detected in all"	12	"NK-cells: 641.5;T-cells: 1682.7"	"Group enriched"	"Detected in some"	6	"JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	3.4	2.2	0.4	50.6	0.5	13.7	2.3	0.4	0.5	2.2	0.7	6.9	7.6	1.7	13.0	3.9	2.1	9.4	1.9	0.5	0.4	3.8	3.8	11.4	111.0	0.8	0.5	1.6	0.9	0.5	0.8	1.1	0.6	2.8	6.5	0.0	4.8	1.4	1.3	1.9	23.1	2.3	0.6	39.9	12.1	1.1	0.5	343.0	3.7	1.4	79.6	13.2	2.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.7	64.1	3.5	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	365.7	0.2	0.0	0.0	0.0	536.9	0.2	5.9	4.6	0.3	20.6	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.3	0.3	0.4	0.6	0.4	0.0	0.0	1.7	0.1	0.1	0.7	0.3	302.7	0.0	0.1	0.0	12.8	5.2	6.0	1109.8	4.9	1034.8	62.0	1123.8	1201.7	5.2	98.9	1260.7	1168.7	33.6	641.5	6.0	7.7	1682.7	1836.9	0.4	0.5	0.4	0.5	0.5	0.4	0.8	0.5	0.6	0.6	0.5	0.6	4.9	0.0	9.3	0.0	23.4	4.6	1.2	0.4	0.0	0.0	3.5	5.2	1.8	4.3	1.6	3.7	0.0	0.3	143.9	0.9	0.0	0.6	0.1	1.0	0.5	3.4	2.4	10.1	0.2	0.5	0.2	3.1	7.7	0.7	5.1	0.0	4.6	1.5	0.3	0.0	0.2	0.3	0.0	7.8	7.3	0.0	0.0	8.1	3.6	0.0	8.7	0.0	272.9	0.5	0.1	4.7	0.0	0.4	15.7	1.0	0.0	1.4	1.8	0.0	0.0	1.5	2.4	4.5	2.0	0.5	3.1	0.4	255.5	2.9	1.3	1.1
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.3;Inhibitory neurons: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	4.2	4.9	6.1	5.0	6.7	9.9	5.3	10.8	9.3	6.7	3.4	7.8	12.3	7.2	9.8	5.1	6.1	6.2	11.3	5.3	7.8	9.5	8.6	5.1	5.4	2.9	3.3	4.9	5.9	6.3	3.2	4.3	3.1	7.8	7.9	10.6	4.6	7.0	9.6	6.6	9.5	8.7	0.8	5.3	5.3	8.3	7.0	6.4	10.9	4.1	5.4	4.9	3.7	10.2	16.9	21.6	11.3	19.3	2.6	5.7	16.3	11.8	11.7	12.3	10.3	21.8	19.0	10.5	10.7	18.4	15.2	18.3	38.8	16.0	12.1	13.6	13.0	19.4	12.8	21.6	12.0	28.1	14.3	4.6	12.4	13.0	18.0	8.0	8.7	6.0	18.3	9.5	9.6	12.8	16.1	16.5	12.5	13.6	12.4	15.6	22.9	21.8	9.7	24.7	13.1	20.5	26.4	17.4	15.7	7.7	12.6	9.5	10.0	22.1	18.2	12.4	18.9	7.0	16.2	23.2	22.7	20.1	17.3	15.9	2.3	5.0	5.2	3.8	6.2	7.5	8.3	6.7	2.8	9.7	11.7	11.5	7.2	4.6	3.6	2.0	4.2	3.0	6.1	6.7	10.8	9.3	5.3	7.8	2.9	3.3	3.1	0.8	7.0	10.2	6.5	9.6	6.9	27.1	11.4	7.1	5.0	8.4	6.8	15.5	6.9	5.3	20.1	18.6	8.7	14.7	27.1	5.2	6.7	10.4	0.0	7.7	3.9	12.0	7.0	7.7	13.1	10.3	67.3	16.4	5.3	6.7	3.1	9.4	3.8	11.6	8.6	21.5	6.1	15.2	86.8	14.3	0.0	5.7	3.9	1.4	5.6	3.4	5.4	45.0	2.4	7.9	5.2	50.8	37.3	12.9	8.6	9.1	5.2	5.4	21.4	12.1	16.6	18.2	6.6	10.9	16.3	13.9	21.0	7.9	6.7	1.9	9.1	10.9	17.0	4.7
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111731-25178231	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	17.5	27.3	41.5	13.3	43.2	19.9	22.5	41.1	44.5	23.9	36.5	22.0	16.8	21.2	31.1	22.8	20.5	13.6	36.1	45.1	42.8	26.9	10.9	14.9	16.7	39.9	39.0	28.1	47.2	32.0	32.9	24.1	42.4	20.8	21.3	21.8	21.2	21.3	52.3	28.2	17.1	18.5	40.2	16.2	22.5	35.4	43.4	21.3	18.6	36.2	20.2	18.1	20.6	43.0	40.3	36.3	33.9	47.2	30.2	42.9	34.9	24.7	40.5	35.7	45.9	46.4	35.7	24.4	34.1	37.6	44.2	20.1	35.9	34.3	47.9	24.9	53.3	13.5	35.4	77.3	67.9	32.0	20.9	48.7	37.7	39.9	41.4	51.3	32.3	54.0	21.5	31.2	39.5	102.3	37.9	60.6	52.1	25.3	37.0	44.3	30.9	47.7	40.7	27.9	55.5	34.1	29.0	45.8	58.2	39.9	46.0	14.9	19.1	34.6	24.3	23.4	25.0	39.8	43.9	25.8	42.3	27.5	26.6	33.4	36.5	46.2	39.4	33.5	43.3	42.0	47.8	42.1	35.0	31.6	42.8	39.2	14.6	33.6	37.6	18.1	82.9	42.2	41.5	43.2	41.1	44.5	45.1	42.8	39.9	39.0	42.4	40.2	43.4	43.0	21.0	16.0	19.8	15.3	23.5	24.1	31.1	55.6	33.6	25.7	39.3	42.0	34.8	15.7	29.6	33.1	2.1	164.5	20.9	60.5	49.0	51.7	76.5	22.7	31.4	22.7	51.4	29.5	29.0	66.7	69.4	29.1	20.9	20.2	9.5	197.7	23.2	9.5	46.8	23.5	30.1	46.9	38.7	33.9	20.0	137.5	26.1	27.0	33.8	17.8	31.3	32.0	32.0	28.1	31.7	46.7	45.1	24.0	28.9	34.6	79.4	90.0	30.0	26.1	26.3	22.9	67.7	67.3	52.9	35.6	31.8	163.8	29.6	78.7	43.7	34.7
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330582	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039401	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA039401: AB_10805478"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	5.1	4.7	5.3	4.8	5.2	1.9	6.3	6.8	10.2	6.3	6.4	4.8	3.4	6.0	7.6	5.0	6.3	3.1	5.5	5.0	6.2	7.3	6.0	4.0	6.5	5.1	5.2	5.7	3.8	8.0	4.2	3.6	5.5	6.2	4.6	7.3	3.9	6.4	4.0	3.8	4.3	5.3	5.2	4.4	4.1	3.9	5.2	7.8	5.7	4.7	9.2	5.2	3.2	5.3	8.8	6.7	15.7	13.7	16.3	5.1	7.7	10.7	12.3	13.2	14.6	10.2	4.0	7.5	20.8	12.0	14.2	20.0	0.0	13.8	10.1	11.6	7.3	13.3	18.3	5.9	9.9	0.0	9.8	7.8	13.0	9.8	9.0	8.9	4.3	16.9	17.1	9.6	16.1	13.4	15.4	6.3	6.8	19.0	5.8	17.8	13.7	7.2	23.4	9.8	21.1	17.6	13.8	11.6	6.0	12.1	14.1	20.2	3.7	15.6	7.1	18.1	17.4	6.5	16.6	3.0	9.7	10.9	16.5	1.7	2.6	3.8	2.3	2.4	3.3	3.2	3.9	2.9	4.4	3.5	6.0	4.1	0.8	2.0	2.2	2.6	3.3	3.2	5.3	5.2	6.8	10.2	5.0	6.2	5.1	5.2	5.5	5.2	5.2	5.3	1.5	0.0	3.1	1.3	3.5	3.1	3.7	1.9	1.8	7.6	2.9	2.8	3.6	5.7	5.7	3.7	8.4	4.3	2.7	2.8	3.9	6.5	2.1	3.6	3.9	3.1	5.4	4.8	1.1	4.0	2.3	3.7	2.0	4.1	1.3	2.2	5.0	4.1	2.7	3.3	1.6	2.2	4.1	1.3	0.8	1.5	5.0	2.7	0.0	1.9	2.4	7.3	4.1	0.5	1.7	3.4	2.1	1.5	2.5	3.3	1.8	4.7	6.2	6.6	6.6	5.1	3.7	23.4	10.5	2.7	2.8	2.5	2.6	2.4	3.3	2.8
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.3"	"Cell type enriched"	"Detected in single"	32	"B-cells: 6.4"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"memory B-cell: 6.5;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"		"Cluster 57: B-cells - Immune response"			"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	3.5	0.1	1.4	1.0	1.3	0.8	2.8	1.2	2.3	6.1	1.2	1.7	0.1	7.7	32.3	1.2	7.8	0.4	8.2	1.3	1.2	0.1	0.1	0.9	1.3	1.3	1.3	2.1	1.0	0.3	0.1	0.0	1.3	2.7	0.7	0.0	1.6	1.0	0.8	0.7	2.7	3.1	1.2	1.6	2.2	1.2	1.6	0.3	2.1	2.0	1.1	3.2	2.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.4	1.3	1.2	2.3	1.3	1.2	1.3	1.3	1.3	1.2	1.6	1.3	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.9;seminal vesicle: 3.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 391.5"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 17.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.3	0.0	2.3	0.0	0.1	2.3	2.7	0.0	2.3	3.0	11.9	0.0	1.4	0.0	0.0	0.0	1.3	2.3	2.3	0.0	0.0	0.0	0.0	2.3	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	1.9	0.0	0.0	3.3	0.6	0.0	3.7	0.0	2.3	0.1	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.3	2.3	2.7	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	1.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.2	0.0	0.6	391.5	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	96.9	24.4	0.3	0.4	2.8	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.8	0.0	14.7	0.0	0.0	0.2	5.5	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.9	0.4
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153453	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 2768.7;gallbladder: 2223.2;salivary gland: 1308.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 944.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	88	"basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	83	"granulocytes: 11.9;monocytes: 4.7"	"Group enriched"	"Detected in many"	11	"CAPAN-2: 3623.8;EFO-21: 1450.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 149.7;spinal cord: 102.4"	"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	590000000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	4.9	3.6	0.0	125.5	0.1	2768.7	22.0	0.1	0.5	810.5	2.0	249.1	34.4	14.2	20.5	677.6	52.6	2223.2	3.1	0.0	0.1	31.6	67.8	76.1	1.1	0.3	0.1	1.1	74.8	7.3	21.2	2.6	0.3	74.5	131.0	0.0	1308.3	13.5	1.2	28.1	157.3	11.9	0.1	82.0	363.9	0.5	0.1	14.2	27.1	0.3	199.1	669.9	480.7	0.1	117.7	35.1	0.0	4.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3623.8	0.2	1450.9	0.0	3.7	236.4	0.0	6.9	0.1	5.3	0.0	30.4	0.0	0.8	0.2	0.0	1.1	0.1	230.4	0.0	12.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	1.9	80.9	0.2	0.2	0.3	0.3	1.0	20.1	0.1	0.1	2.0	65.3	1.0	0.0	8.4	1.8	0.0	2.9	16.9	0.0	2.9	0.6	4.6	4.7	0.2	0.6	2.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	4.7	0.0	0.0	12.1	0.0	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	0.0	20.8	0.0	15.9	0.3	376.6	4054.2	1.8	0.0	38.1	29.3	0.2	1328.2	5757.0	138.0	0.0	0.8	1.2	315.6	0.0	6457.0	2.0	25.6	4.3	11.5	57.9	11.2	0.0	1837.0	0.3	12.2	237.0	52.3	13.4	0.0	2.2	43.2	0.6	0.0	0.0	264.3	956.2	2.7	0.0	15.8	3.4	34.9	0.0	0.0	60.3	0.0	1.0	0.0	0.0	5424.3	183.4	0.0	1.4	420.6	509.8	1.6	3161.5	0.0	0.0	0.0	337.7	0.0	0.3	51.1	0.0	0.3	7.7	0.0	475.5	7112.9
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"BEWO: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"	NA	NA					"Cluster 28: BEWO - Transcription regulation"				"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832254-96995956	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824"	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.16e-4)"	3.7	3.1	7.1	6.2	6.4	25.5	5.0	21.8	6.6	4.3	3.3	8.7	11.2	4.2	4.6	7.0	3.9	3.9	3.7	4.8	15.6	5.3	5.9	4.8	6.3	6.9	5.6	6.4	8.2	4.3	5.3	4.9	6.7	4.7	8.5	15.8	5.6	3.5	9.2	4.1	10.7	3.4	4.8	5.5	8.3	4.6	7.5	6.0	5.4	5.1	6.0	6.8	4.7	15.8	14.7	9.3	16.5	8.9	4.4	6.2	7.9	6.2	6.0	7.5	8.5	12.0	10.0	15.4	7.3	6.4	7.0	12.2	16.5	8.6	13.3	7.4	8.0	17.7	6.0	15.2	8.4	22.1	8.8	4.9	7.5	11.5	20.4	7.7	8.1	7.8	12.7	7.2	11.9	6.7	9.2	8.4	6.3	7.9	4.0	11.2	12.7	4.3	8.6	30.7	7.5	6.6	7.0	4.4	8.8	7.1	8.3	6.9	12.5	5.8	13.0	5.2	11.6	9.4	6.7	17.9	6.1	13.9	3.1	1.7	5.0	8.0	5.8	4.1	4.7	4.6	4.4	5.3	3.7	8.6	4.7	3.7	16.7	5.0	2.0	5.4	3.6	2.5	7.1	6.4	21.8	6.6	4.8	15.6	6.9	5.6	6.7	4.8	7.5	15.8	26.4	19.2	26.8	72.1	36.1	15.4	16.7	31.3	25.6	45.2	37.0	20.3	17.8	37.1	38.2	31.3	77.2	18.8	46.5	85.3	11.7	27.0	0.8	34.6	26.8	23.1	46.9	17.7	138.3	33.9	8.2	17.1	28.1	35.9	26.6	67.1	20.3	22.2	14.1	40.4	151.6	31.2	52.9	30.5	29.7	2.3	10.2	40.0	21.4	103.0	28.1	11.7	24.7	143.2	264.9	41.5	62.0	13.9	36.8	26.9	67.1	25.4	54.1	58.9	19.7	21.6	26.8	21.7	26.3	29.2	12.9	38.6	34.0	22.0	33.6	34.4
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	2.6	3.7	2.8	3.0	3.6	3.7	2.8	6.4	3.4	2.6	2.1	3.2	5.8	3.0	2.8	2.5	2.0	3.4	1.6	2.3	6.9	4.0	3.4	2.8	3.6	3.4	5.0	4.1	3.3	4.6	1.6	3.9	3.6	2.7	3.6	6.5	2.3	2.1	2.8	4.9	7.0	2.7	3.4	3.4	4.5	5.8	6.3	3.9	3.7	2.9	2.7	2.7	1.9	5.5	5.3	3.4	11.5	5.1	7.1	10.5	2.8	5.9	6.3	5.0	6.7	2.1	7.0	11.4	2.7	3.5	8.8	2.2	4.9	2.2	5.4	1.6	3.7	9.7	5.6	2.4	4.6	7.5	6.7	6.0	2.9	3.3	8.1	7.9	7.1	6.9	5.6	12.1	6.3	1.7	7.3	13.0	5.3	4.1	5.3	7.8	9.1	6.1	7.1	3.0	8.7	10.2	4.8	2.7	3.3	5.2	5.0	4.3	5.8	7.9	4.6	6.7	11.5	12.0	6.2	9.6	6.5	7.9	7.1	7.6	3.3	3.3	2.2	3.5	1.7	2.8	1.3	1.3	2.8	3.5	1.5	2.2	2.5	2.3	3.0	2.3	2.2	1.3	2.8	3.6	6.4	3.4	2.3	6.9	3.4	5.0	3.6	3.4	6.3	5.5	16.9	12.8	15.6	65.6	18.2	23.8	4.4	7.9	17.1	18.4	13.0	9.0	9.4	34.3	9.5	7.3	41.7	8.8	20.9	16.1	9.8	12.3	33.2	14.0	13.1	23.4	35.4	10.1	69.2	10.9	9.0	10.2	14.8	11.8	19.6	26.5	12.8	13.6	16.4	20.2	133.6	23.5	8.2	18.9	29.2	20.1	14.6	23.5	3.6	135.9	21.0	10.4	13.4	117.1	164.2	12.4	16.1	7.5	40.7	10.1	34.1	14.6	15.9	22.5	19.7	13.6	12.8	52.2	16.3	13.6	19.0	9.9	11.6	19.8	16.5	6.3
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246233-170297815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 163.9;lymphoid tissue: 115.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004574, HPA036396, HPA036397"	Enhanced					NA	NA		2900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	23.0	14.1	5.0	75.7	5.7	163.9	8.4	5.9	22.9	10.3	6.3	14.6	15.8	8.2	4.9	9.6	6.8	28.6	5.7	5.1	6.9	5.6	26.3	31.5	77.5	12.2	8.4	3.7	7.7	3.3	2.2	21.9	11.6	8.0	16.4	0.8	6.6	6.5	3.2	3.9	24.4	16.6	7.9	81.1	17.6	3.9	10.2	115.1	4.7	6.2	47.3	28.2	3.7	12.7	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	147.0	0.0	0.0	0.0	152.5	375.9	0.0	0.0	0.0	0.0	0.0	0.1	49.7	1.1	80.4	0.0	0.0	91.4	53.2	0.5	0.0	0.0	14.0	0.0	45.5	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.0	80.8	0.1	0.0	0.1	0.2	0.1	1.4	14.6	0.2	0.3	99.9	1.7	56.8	20.4	76.6	40.5	42.5	40.2	2.7	32.4	38.6	26.6	1.0	29.8	31.0	68.9	41.7	65.8	5.3	39.8	22.9	5.0	5.7	5.9	22.9	5.1	6.9	12.2	8.4	11.6	7.9	10.2	12.7	13.4	16.0	29.2	0.7	12.2	3.2	0.2	0.1	0.0	0.2	0.9	2.8	4.8	1.5	5.6	1.8	0.0	0.5	35.2	0.1	0.0	0.2	1.6	0.4	2.4	14.2	0.0	24.0	2.8	0.0	0.8	9.5	5.1	0.7	129.6	0.0	18.9	2.4	57.9	0.0	7.9	0.7	0.0	154.4	49.4	0.9	2.5	158.2	1.8	31.9	48.2	0.0	91.6	0.5	0.5	0.0	0.0	3.0	12.6	0.4	0.0	0.3	2.9	0.0	26.3	1.3	3.1	0.0	0.2	1.0	1.8	0.8	104.6	0.5	0.0	0.3
LDAH	"C2orf43, FLJ21820"	ENSG00000118961	"Lipid droplet associated hydrolase"	Q9H6V9	2	20684014-20823130	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034729, HPA034730"	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA034729: AB_10603684, HPA034730: AB_2674304"	"unprognostic (1.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.09e-6)"	"unprognostic (3.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.97e-2)"	7.3	14.1	5.1	7.3	6.8	5.0	7.6	4.8	5.6	7.9	6.8	10.8	7.4	7.3	9.3	8.0	6.2	6.8	4.3	5.3	6.4	16.8	12.1	5.5	11.1	5.7	5.1	8.0	7.4	9.4	5.8	8.7	5.8	7.0	11.7	8.3	6.9	6.2	1.2	6.1	6.5	8.1	5.9	9.0	7.8	5.0	6.0	11.7	8.2	1.7	13.4	9.7	6.0	7.7	20.2	18.3	45.6	0.0	18.6	24.6	28.5	17.9	12.2	14.5	11.1	19.8	12.3	25.3	0.0	13.1	25.4	16.9	34.8	12.9	14.9	31.6	17.2	37.1	16.6	30.5	19.0	28.2	8.9	20.9	18.9	14.0	3.6	19.7	27.7	33.8	49.7	18.6	25.5	13.0	41.1	19.4	29.1	41.7	0.0	33.1	36.6	28.8	29.0	29.4	25.0	37.9	11.8	18.7	19.9	37.9	15.9	19.7	25.6	13.0	6.6	17.0	10.7	22.7	45.2	11.6	25.3	26.8	24.6	0.9	3.2	0.3	6.6	4.9	4.3	7.8	6.5	5.6	5.8	5.5	5.9	5.9	0.2	5.5	3.9	5.4	6.1	4.2	5.1	6.8	4.8	5.6	5.3	6.4	5.7	5.1	5.8	5.9	6.0	7.7	5.0	16.0	10.6	0.0	9.3	0.0	3.4	0.0	5.7	9.3	5.3	3.9	2.8	7.2	4.3	7.3	16.7	12.0	4.6	3.4	7.9	7.4	8.7	4.2	10.9	6.3	3.6	13.3	0.0	6.4	11.6	5.1	9.7	6.1	6.3	14.8	8.6	7.9	9.0	11.8	0.0	6.0	0.0	9.8	0.0	2.7	7.5	5.5	0.0	0.0	4.7	15.0	5.2	0.0	0.0	6.5	5.5	6.8	9.9	3.7	5.0	12.0	0.0	9.6	6.6	4.2	5.4	4.3	5.2	7.7	0.0	11.5	6.7	15.8	6.1	3.6
LDB1	"CLIM2, NLI"	ENSG00000198728	"LIM domain binding 1"	Q86U70	10	102106489-102120368	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034488	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA034488: AB_10669783"	"unprognostic (8.83e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.26e-2)"	41.3	38.0	48.0	42.9	51.2	122.4	44.0	42.8	57.4	89.1	55.8	73.8	31.1	81.5	38.1	54.1	68.9	49.1	60.6	49.4	47.0	40.5	20.5	46.6	61.5	42.1	42.2	117.9	29.4	55.6	52.3	49.1	40.0	58.4	27.5	41.6	65.6	71.6	52.5	149.9	51.7	52.8	38.2	60.8	44.4	30.6	45.8	59.3	49.5	31.6	55.3	65.4	72.4	48.5	42.6	53.5	105.8	128.0	41.3	44.6	52.7	43.8	70.2	48.7	42.3	38.3	36.3	64.8	60.8	56.7	23.0	85.8	48.9	87.3	25.9	55.7	46.9	208.2	62.7	38.6	49.0	56.1	67.8	97.4	70.0	40.2	46.3	177.3	52.0	59.7	128.3	69.1	38.6	41.9	101.1	89.5	52.1	20.4	26.4	112.0	68.4	46.9	46.7	47.3	42.6	103.8	30.9	34.1	51.6	69.0	162.5	36.3	53.8	29.5	60.0	26.8	37.3	58.7	54.4	44.3	49.7	125.7	27.2	2.9	2.0	1.9	2.1	2.9	1.3	2.0	1.5	2.1	1.3	2.4	2.0	1.6	4.8	2.0	4.9	1.4	1.6	1.3	48.0	51.2	42.8	57.4	49.4	47.0	42.1	42.2	40.0	38.2	45.8	48.5	6.4	32.1	11.0	5.2	8.1	22.8	2.8	4.6	17.6	18.5	8.4	7.9	9.1	2.8	6.9	3.7	4.2	4.8	11.7	3.2	0.0	7.7	2.1	7.7	11.1	6.9	8.3	17.0	9.8	5.6	6.3	7.0	5.6	9.3	9.5	9.5	5.3	2.2	8.9	15.2	10.4	1.4	4.1	5.4	7.5	3.0	6.2	7.3	3.6	12.2	4.0	11.8	6.2	5.5	6.6	7.5	2.0	6.4	7.7	2.7	1.9	1.4	3.5	6.1	0.0	6.9	8.2	7.6	7.3	10.7	21.2	7.8	10.0	10.3	2.6	2.0
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394560-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	444.5	358.1	64.3	139.5	68.4	184.6	330.4	54.0	72.1	203.1	58.4	278.5	158.1	151.1	43.8	450.6	189.2	75.5	361.2	68.4	73.7	440.2	729.2	242.0	97.2	73.6	74.9	149.7	171.5	26.6	95.9	113.9	94.9	170.1	117.4	443.8	267.5	81.8	947.5	468.6	296.6	124.2	58.5	185.3	181.1	95.2	67.4	115.3	180.8	500.3	146.5	266.2	314.4	65.9	1261.4	730.9	28.4	415.2	599.8	399.3	400.6	1186.1	1148.5	936.9	1366.4	324.5	196.6	909.3	380.3	1110.8	727.1	979.2	716.1	1715.1	2082.2	331.3	422.6	329.6	629.4	588.5	148.9	811.2	235.8	411.1	760.3	380.3	373.7	1670.8	550.8	292.3	462.8	431.7	1127.7	319.4	674.8	509.3	182.7	413.2	849.4	432.0	298.0	768.0	1546.6	284.5	220.5	279.3	642.7	518.6	230.8	431.4	241.7	192.9	546.9	1228.3	455.3	1094.7	14.3	348.0	545.1	899.4	1767.1	415.0	434.1	98.4	147.1	79.7	93.8	165.0	105.2	70.4	122.1	99.6	202.1	54.4	78.1	81.0	47.1	91.3	169.3	68.0	140.8	237.6	64.3	68.4	54.0	72.1	68.4	73.7	73.6	74.9	94.9	58.5	67.4	65.9	421.7	73.7	201.6	21.5	220.8	2198.1	475.6	2133.0	523.0	464.2	213.6	229.5	241.8	175.8	837.3	309.0	146.0	509.8	427.2	696.1	434.3	1293.9	204.4	180.0	317.4	492.8	45.6	123.2	38.7	1532.3	2086.2	544.4	163.6	485.8	262.9	205.3	205.6	514.4	659.3	514.8	33.5	285.1	649.0	224.4	1155.1	129.6	287.7	373.9	1177.5	20.6	973.4	444.2	170.0	9.5	12.6	1771.4	590.3	205.0	376.0	546.8	1765.0	682.5	178.1	481.4	190.7	251.6	706.3	195.5	44.0	422.9	1723.2	501.7	410.9	196.2	362.1	530.8
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206843-59208588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 40.6"	"Cell type enriched"	"Detected in some"	13	"Spermatocytes: 101.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.1"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.3"					HPA053962	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.3	0.0	0.2	0.2	0.9	0.0	0.2	0.5	0.9	0.2	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.7	0.2	0.3	0.1	0.1	1.1	0.6	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.5	0.0	0.1	40.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	1.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.5	0.9	0.3	0.7	1.1	0.6	1.2	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1947.7;kidney: 1726.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 6021.8"									"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		560000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	549.9	424.8	509.1	259.2	528.2	352.8	321.1	593.7	617.0	238.6	549.8	320.2	84.4	273.1	169.0	166.6	252.9	232.9	1947.7	484.1	581.9	1726.6	70.5	220.4	425.8	564.4	575.4	472.4	370.3	447.3	161.3	298.2	556.2	240.9	277.0	290.0	162.3	287.2	309.4	81.4	171.3	309.7	537.8	182.0	459.1	119.5	582.5	534.5	348.5	950.4	449.4	417.9	171.2	517.8	647.2	1697.3	1457.5	966.0	1021.7	1126.6	1689.4	879.8	873.0	1201.5	1179.4	2712.9	3.6	2268.6	561.5	597.3	1170.1	315.8	2031.4	1631.4	1518.4	586.5	1413.1	2339.5	1619.0	3.0	975.0	2212.8	967.9	1300.5	572.1	1056.8	1423.4	1416.9	1395.2	1610.8	1304.6	332.6	1342.7	3.2	1895.9	2665.6	4216.4	1051.1	727.7	1681.3	2032.0	1838.7	6021.8	2832.7	467.2	1077.8	403.6	618.1	1586.1	3842.2	5.3	1704.6	548.3	803.7	1048.1	578.5	1684.5	291.0	420.9	2953.4	891.8	1037.5	978.2	540.8	201.9	25.1	346.8	124.7	583.1	349.4	1341.5	723.8	367.2	250.9	1722.4	1124.1	31.7	459.0	95.2	427.7	1405.8	1431.2	509.1	528.2	593.7	617.0	484.1	581.9	564.4	575.4	556.2	537.8	582.5	517.8	89.8	141.1	316.4	68.2	242.2	73.0	439.5	1103.1	221.4	151.5	332.4	325.0	2502.3	298.8	433.9	474.5	68.8	1693.0	208.0	69.6	3306.5	18.4	10.5	224.3	325.0	227.3	92.4	361.2	39.4	314.9	870.1	299.4	222.8	309.4	268.6	412.6	155.7	11.2	612.9	141.3	55.6	152.2	956.2	189.8	104.3	34.3	274.6	174.8	179.7	33.7	197.3	277.6	159.6	47.7	40.3	99.7	84.3	415.2	303.1	310.6	0.2	3483.9	363.0	118.1	236.7	195.2	363.7	21.5	124.3	216.3	64.2	1639.5	398.1	1105.3	257.0	344.9
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412318-18452063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	177	"testis: 265.2"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1441.7;Spermatocytes: 1584.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.1;U-2197: 5.1;U-266/70: 4.5;U-266/84: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA045442	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.2	0.6	0.0	0.6	0.4	0.4	1.2	0.9	0.1	0.4	0.3	0.3	0.0	0.6	0.3	0.6	0.0	0.3	0.7	0.3	0.6	1.4	0.2	0.4	0.3	0.3	0.4	1.4	0.0	0.2	0.1	0.4	0.3	0.0	0.6	0.5	0.0	0.7	0.4	0.7	0.1	0.1	0.1	0.1	265.2	0.5	0.3	0.6	0.2	0.7	0.2	0.0	0.4	0.0	0.0	0.1	1.2	0.9	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.3	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	2.1	0.3	0.0	0.1	0.0	0.5	0.2	1.6	5.1	0.0	4.5	4.2	0.2	0.1	0.0	0.0	0.6	0.2	0.3	0.1	0.3	0.6	0.2	0.5	0.6	0.0	0.7	1.0	0.7	1.1	0.0	0.3	0.9	0.6	0.3	0.6	0.6	1.2	0.9	0.7	0.3	0.3	0.3	0.4	0.1	0.5	0.4	1.9	0.0	0.0	1.3	1.3	0.1	0.8	0.4	1.2	0.1	2.5	3.2	0.9	0.0	1.0	1.8	0.0	0.0	0.1	0.4	3.9	1.6	1441.7	3.7	0.8	2.0	0.0	0.4	1.0	6.3	0.1	1.3	0.5	1.9	0.0	0.3	0.4	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.4	209.5	23.3	2.7	0.0	1.9	0.0	1.5	0.0	1.0	2.0	2.0	0.0	18.0	0.9	0.3	0.0	3.5	1.2	0.6	19.7	1.2	1.2	1584.7	30.7	1.0	0.6	0.0	1.4	0.1	0.0	0.3
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.6;liver: 135.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	24.9	14.4	17.7	2.1	19.7	0.7	11.7	20.5	22.6	5.4	34.1	27.2	8.8	3.5	1.1	10.8	5.5	3.0	85.6	16.1	18.9	36.1	135.5	4.9	0.8	20.8	20.2	16.4	18.7	17.0	11.8	0.7	22.4	8.1	9.7	1.3	21.3	3.2	68.7	5.8	5.7	1.2	17.0	1.1	23.1	1.7	19.3	0.5	10.6	52.7	0.6	2.6	3.7	17.5	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	17.7	19.7	20.5	22.6	16.1	18.9	20.8	20.2	22.4	17.0	19.3	17.5	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089462-11133820	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 112.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 397.4;Alveolar cells type 2: 468.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 46.0"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		23000000	"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	43.6	112.1	6.4	27.3	7.5	27.4	15.6	8.6	13.0	27.5	22.0	20.0	23.6	21.6	3.8	50.1	21.6	36.9	19.3	8.4	10.8	15.2	60.4	54.8	4.8	24.3	14.4	37.7	50.7	10.1	6.9	16.6	20.0	20.2	12.2	2.3	19.1	4.6	3.9	25.5	18.3	28.6	9.9	10.5	36.5	8.4	11.7	4.0	7.7	4.0	5.1	22.6	25.8	14.5	113.6	52.2	61.1	29.9	80.5	152.7	21.0	23.5	89.8	41.3	88.6	52.9	105.3	37.2	94.1	46.1	135.6	88.3	31.1	185.6	19.9	27.5	6.1	18.1	34.5	47.1	120.2	19.2	100.9	192.5	67.5	139.6	30.2	28.5	45.8	29.5	38.9	213.8	31.9	41.4	25.3	25.9	66.4	56.0	67.5	17.1	44.9	48.2	103.1	89.5	14.8	15.4	21.1	45.7	3.8	45.2	19.0	44.6	50.8	36.1	26.3	23.2	44.7	26.8	24.4	23.3	42.8	43.7	83.6	46.0	2.9	0.1	5.4	2.6	1.3	0.6	2.2	1.7	1.6	0.5	2.3	2.2	0.8	2.5	0.8	0.5	1.6	3.2	6.4	7.5	8.6	13.0	8.4	10.8	24.3	14.4	20.0	9.9	11.7	14.5	106.3	397.4	468.6	16.3	8.1	143.4	176.8	182.2	85.4	11.4	144.0	108.7	35.9	92.9	205.7	14.7	6.2	18.4	24.7	273.7	1.9	57.9	1.2	95.3	61.7	75.8	61.9	6.6	10.7	89.0	32.1	42.9	195.2	278.6	75.9	32.9	22.9	149.2	14.9	1.7	8.1	157.2	77.3	16.5	26.5	1.6	19.6	47.4	56.9	7.5	2.7	6.8	8.2	7.5	19.4	86.7	209.7	7.2	30.7	142.7	32.5	0.6	99.1	6.6	6.6	133.4	48.4	4.1	2.8	155.3	197.2	48.2	32.8	214.3	110.7	184.2
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007298-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"fallopian tube: 116.2"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.2;Hep G2: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.5	0.2	0.1	0.1	0.1	0.6	0.6	0.2	4.4	0.2	0.1	0.0	0.7	0.1	0.6	116.2	0.8	0.0	0.1	0.1	0.1	0.1	6.9	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.2	0.1	3.4	0.1	0.2	0.3	0.1	0.0	0.0	0.2	1.4	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.5	0.0	6.4	7.2	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.1	0.1	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	98.1	0.8	0.7	20.9	0.0	0.1	0.2	0.0	1.1	0.0	2.1	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	329.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825225	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Granulosa cells: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 1.2;THP-1: 1.0;TIME: 2.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"basal ganglia: 4.0;midbrain: 5.9"	HPA030478	Approved				"Secreted - unknown location"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	3.7	2.8	0.4	0.8	0.3	1.0	3.0	0.2	0.1	2.7	0.4	4.3	1.6	3.5	0.0	1.7	2.7	0.5	6.8	0.7	1.1	2.2	0.7	1.6	0.7	2.4	3.3	1.1	2.0	0.0	1.5	0.1	1.7	3.7	0.1	0.0	7.2	0.0	1.2	1.3	2.4	0.1	1.7	2.7	3.7	1.4	1.4	0.0	2.2	0.0	0.3	3.9	2.4	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	1.0	2.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.3	0.2	0.1	0.7	1.1	2.4	3.3	1.7	1.7	1.4	0.3	2.2	0.0	0.6	0.0	0.6	0.5	0.1	0.4	0.6	0.0	0.1	0.1	0.7	0.0	0.2	1.8	0.0	0.2	0.3	0.0	0.0	0.2	1.7	0.3	1.2	1.6	0.0	1.3	0.2	0.0	0.6	1.3	0.0	0.9	0.0	4.9	0.7	0.2	0.3	0.0	0.1	0.0	0.0	0.3	0.2	0.4	0.0	0.3	0.0	1.0	0.5	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.3	0.5	0.0	0.0	0.8	0.0	0.0	1.2	0.7	0.6	1.2	0.1	0.4	0.3	0.4	0.4	0.0	0.0
LDLRAD3	LRAD3	ENSG00000179241	"Low density lipoprotein receptor class A domain containing 3"	Q86YD5	11	35943981-36232136	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.4;Excitatory neurons: 68.6;Microglial cells: 104.9;Oligodendrocyte precursor cells: 308.6;Oligodendrocytes: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 4.8;non-classical monocyte: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 63.7;RH-30: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038251	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions"		"HPA038251: AB_10675790"	"unprognostic (1.59e-3)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (9.34e-6)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.05e-8)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (2.14e-5)"	10.9	4.5	9.9	4.7	13.9	1.4	18.6	20.8	10.6	7.7	6.3	3.4	2.0	8.5	3.2	6.7	5.8	4.8	4.0	9.7	12.4	4.4	1.6	3.8	3.6	22.0	16.8	11.2	3.8	1.3	5.1	2.3	18.5	11.2	2.1	1.1	20.6	4.1	5.6	13.7	3.5	5.4	15.8	2.1	3.7	3.5	14.8	3.5	3.3	3.0	3.6	5.8	6.8	19.3	11.5	10.7	32.3	19.7	25.2	27.5	24.7	6.5	5.8	14.3	12.7	8.0	7.0	0.0	4.8	7.1	21.4	5.7	10.0	14.6	19.9	1.0	21.1	36.5	6.6	2.3	33.2	8.0	4.0	33.1	63.7	6.5	56.0	5.8	24.3	0.0	9.6	1.3	26.7	6.4	0.0	1.8	13.3	1.2	18.4	0.0	60.3	3.5	2.5	1.6	11.0	24.8	11.3	12.2	36.6	12.5	16.9	10.6	24.7	17.0	15.3	1.4	21.8	0.7	0.0	0.0	8.6	9.6	31.3	1.4	4.8	0.5	0.0	4.5	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	6.4	0.2	0.0	1.8	9.9	13.9	20.8	10.6	9.7	12.4	22.0	16.8	18.5	15.8	14.8	19.3	3.5	0.0	3.2	92.4	0.5	15.4	7.4	3.6	10.8	0.4	31.1	12.1	0.6	0.0	1.7	0.0	0.0	2.6	0.7	0.2	0.0	3.8	13.0	1.2	10.8	15.4	0.0	2.5	68.6	1.1	13.1	9.1	0.5	0.9	0.0	11.4	25.4	0.6	4.0	0.0	8.4	0.0	0.0	15.4	4.9	22.6	9.6	9.5	7.2	104.9	6.2	0.9	0.0	308.6	215.5	1.2	0.1	24.8	0.1	20.3	0.0	1.8	0.8	0.1	13.1	21.3	9.9	0.4	3.0	19.3	26.0	1.4	1.1	9.8	0.5	3.4
LDLRAD4	C18orf1	ENSG00000168675	"Low density lipoprotein receptor class A domain containing 4"	O15165	18	13217498-13652755	"Predicted intracellular proteins, Predicted membrane proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.2;lymphoid tissue: 49.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 338.9;Inhibitory neurons: 308.5;Late spermatids: 231.5;Microglial cells: 429.1;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 35.3;JURKAT: 37.4;MOLT-4: 131.3;REH: 31.6;U-698: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047633, HPA065246"	Approved		Supported	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA047633: , HPA065246: AB_2685444"	"unprognostic (2.52e-1)"	"unprognostic (4.31e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.94e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.18e-2)"	6.5	4.3	13.9	7.3	38.0	9.7	6.3	34.6	25.9	7.8	37.4	5.8	6.1	12.4	0.9	3.9	11.3	4.6	16.6	10.7	16.4	4.0	10.3	4.6	6.5	46.1	33.2	2.3	3.3	2.9	6.9	6.2	38.6	8.6	2.1	7.0	3.0	5.3	15.4	4.2	7.2	5.7	27.3	5.6	5.0	9.2	48.2	49.3	4.4	9.5	3.8	5.3	5.3	39.6	0.2	0.3	1.4	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.7	1.6	0.8	0.4	0.0	0.0	0.0	17.1	1.7	35.3	7.0	1.2	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.4	37.4	0.4	0.7	0.0	2.6	131.3	1.1	2.9	0.3	8.9	31.6	0.1	1.2	0.0	1.1	2.4	3.9	0.5	2.2	0.0	1.9	3.8	4.7	2.4	1.3	11.5	0.2	1.9	5.6	0.4	26.1	0.0	6.9	6.4	12.8	7.0	2.1	6.5	7.7	5.7	5.2	5.8	5.6	3.9	4.4	8.2	7.6	12.1	9.1	8.5	5.9	3.4	4.5	13.9	38.0	34.6	25.9	10.7	16.4	46.1	33.2	38.6	27.3	48.2	39.6	19.4	3.2	4.7	143.3	79.2	10.5	2.7	0.8	0.0	5.4	26.0	16.9	18.4	0.0	5.0	1.8	70.9	0.6	21.0	6.8	1.9	5.1	135.2	16.3	22.0	16.6	58.7	7.6	338.9	3.6	0.7	16.5	13.3	7.8	23.5	7.6	25.0	24.4	21.1	0.0	308.5	9.1	2.0	27.4	160.5	231.5	11.1	56.2	14.2	429.1	13.6	4.7	3.1	318.7	284.9	0.7	2.6	24.5	11.7	13.5	15.6	2.3	13.7	18.7	6.6	2.3	9.7	5.4	4.9	0.4	7.7	1.6	66.0	0.2	8.8	3.2
LDLRAP1	"ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705"	ENSG00000157978	"Low density lipoprotein receptor adaptor protein 1"	Q5SW96	1	25543606-25568886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Atherosclerosis, Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"NK-cells: 39.5;T-cells: 107.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003705, HPA050358"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules		"CAB003705: AB_425923, HPA050358: AB_2681103"	"unprognostic (2.52e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.49e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.96e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.24e-1)"	11.0	19.7	14.2	18.8	25.0	8.6	11.7	28.4	17.7	11.3	25.5	18.2	11.3	8.8	8.0	19.4	9.8	8.0	12.6	14.4	17.5	14.4	27.2	15.7	37.2	30.6	25.0	9.3	39.6	14.7	19.4	21.1	27.6	21.5	16.4	5.5	30.9	9.8	13.1	21.2	16.8	10.4	21.4	58.1	15.8	5.6	22.7	14.2	17.2	9.3	22.0	9.7	15.4	37.9	32.2	12.5	17.5	18.5	10.7	12.3	14.1	20.0	19.5	30.0	20.8	5.1	26.0	7.1	14.2	27.4	20.9	33.3	11.9	20.3	15.1	8.5	18.5	11.4	14.5	9.8	17.0	13.1	16.4	13.4	28.6	24.2	9.0	7.3	26.1	7.1	16.0	68.1	10.0	18.6	0.2	22.4	22.2	25.7	13.2	1.9	19.7	57.6	11.2	6.6	8.7	4.9	27.8	43.9	32.3	14.1	20.0	22.2	15.7	13.1	19.1	25.0	14.1	64.8	81.6	20.2	44.2	10.9	16.3	0.0	7.0	0.3	23.6	5.7	27.1	10.5	55.2	43.4	9.4	5.4	107.3	89.8	3.1	39.5	5.9	1.3	49.7	50.6	14.2	25.0	28.4	17.7	14.4	17.5	30.6	25.0	27.6	21.4	22.7	37.9	9.8	0.0	11.0	2.6	11.5	8.3	20.6	21.5	15.4	4.0	10.3	13.3	3.6	5.7	21.1	7.3	18.8	35.2	13.3	33.6	3.9	9.7	0.2	2.9	4.1	10.8	6.7	3.8	2.3	17.8	8.6	8.9	4.6	5.4	2.5	8.6	12.1	25.6	11.0	70.7	1.2	23.9	10.2	6.0	3.5	0.0	10.2	23.7	17.8	11.2	6.9	4.0	22.6	2.0	50.1	12.9	23.4	8.6	19.3	19.1	11.9	5.9	6.1	19.5	26.3	16.9	9.1	3.2	10.1	12.4	5.7	23.7	28.7	9.7	22.0	20.0
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1 regulator of NFKB signaling"	O95751	X	141111605-141177129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 123.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 19.2"					"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	32.3	34.0	4.7	0.9	5.5	0.1	28.0	2.9	8.5	45.8	0.2	18.8	0.9	53.9	1.8	21.4	48.5	1.6	15.1	6.2	5.8	33.2	4.8	19.6	0.8	5.3	5.0	46.8	19.3	10.5	123.3	0.0	5.0	34.3	0.3	3.4	55.1	5.9	5.5	31.5	12.5	2.0	1.2	14.2	18.4	10.8	5.0	0.9	53.7	0.4	0.7	33.1	30.6	6.0	0.0	24.7	3.0	8.4	5.0	6.2	0.0	5.0	5.8	6.3	8.8	0.0	8.0	0.0	4.2	7.7	6.1	10.4	3.4	7.1	4.5	0.0	6.6	0.0	11.7	0.0	2.0	0.0	1.9	10.9	3.6	5.5	2.9	5.1	5.7	0.0	0.1	0.0	5.7	31.9	0.0	0.0	3.3	0.0	34.3	0.0	2.7	0.0	7.7	4.7	0.0	3.2	0.0	4.0	0.0	1.6	5.1	0.0	11.9	0.0	6.8	0.0	21.9	0.0	0.0	0.0	3.5	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.8	0.9	2.5	0.8	0.2	2.1	2.2	1.4	0.0	6.4	0.0	1.4	2.6	1.0	4.7	5.5	2.9	8.5	6.2	5.8	5.3	5.0	5.0	1.2	5.0	6.0	8.6	0.0	5.3	4.2	4.9	6.0	16.8	4.6	16.5	29.3	23.8	20.2	2.2	30.0	8.2	23.9	8.4	2.8	5.7	0.1	43.0	13.8	0.7	7.8	13.5	12.8	5.4	0.8	9.4	14.0	1.8	16.1	3.6	6.0	2.5	8.8	12.8	0.1	0.9	20.2	9.9	0.4	8.2	0.3	1.8	1.1	22.1	1.0	3.6	7.5	0.3	21.2	5.2	7.1	15.0	13.7	0.2	38.7	0.9	11.9	0.0	43.8	4.6	13.0	13.1	15.3	26.2	0.9	7.6	16.7	6.8	1.5	5.2	13.5	0.3	15.0
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135954983	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 477.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Region enhanced"	"Detected in some"		"cerebellum: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	5300000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.2	0.5	0.4	0.4	0.8	2.4	0.4	6.3	2.8	0.1	0.0	0.2	0.5	0.3	0.8	0.4	0.1	0.4	0.1	0.9	0.0	0.6	477.9	0.3	0.9	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.1	0.4	0.2	3.1	0.7	0.2	2.1	1.4	0.9	0.1	0.0	0.9	0.3	8.8	0.0	0.2	0.4	0.0	0.2	0.1	0.0	1.1	0.3	0.4	0.5	0.7	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.8	0.6	0.3	0.3	0.5	0.0	0.2	0.0	0.3	1.0	0.7	0.7	1.3	0.3	1.0	0.1	0.2	0.1	0.3	0.3	0.6	0.1	0.8	0.2	0.3	0.6	0.0	0.4	0.4	0.5	0.3	0.6	0.5	0.5	0.2	0.2	0.9	0.3	0.6	0.0	0.2	0.0	0.9	0.1	0.5	0.8	0.3	0.4	0.4	0.1	1.1	0.5	0.3	0.3	0.9	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.8	6.3	2.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.1	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	100.7	0.0	0.0	0.1	0.0	0.0	2.9	0.0	55.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Cell type enhanced"	"Detected in many"		"Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Group enriched"	"Detected in many"	5	"JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	1.0	12.7	10.7	13.8	7.6	11.6	2.0	6.1	7.9	4.2	14.3	1.5	0.7	8.0	4.8	3.2	5.1	3.9	0.2	5.7	9.9	2.5	0.3	3.3	31.3	8.9	11.2	1.1	0.1	0.3	1.0	11.0	9.4	3.7	1.4	0.5	1.0	1.0	0.1	2.8	4.1	3.9	5.9	9.8	1.5	12.3	18.2	349.2	3.0	0.1	22.8	5.5	3.0	5.5	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.2	7.2	1.8	4.7	27.1	0.0	0.0	0.1	0.0	2.5	0.2	7.9	0.0	3.7	0.3	17.6	6.9	0.0	0.0	0.0	23.6	2.9	0.4	0.4	0.0	0.7	3.5	0.0	579.6	14.2	0.0	2.6	1.0	569.0	0.0	1.7	6.3	1.4	454.8	9.1	0.2	2.4	1.3	3.0	5.2	0.0	0.5	83.8	6.7	2.4	0.2	0.0	11.9	10.3	0.0	15.3	38.3	17.0	100.9	7.8	0.0	48.4	0.3	0.2	0.0	8.2	0.0	1.6	0.6	68.3	29.9	0.1	0.9	142.6	102.2	1.9	32.9	0.3	0.5	97.7	36.8	10.7	7.6	6.1	7.9	5.7	9.9	8.9	11.2	9.4	5.9	18.2	5.5	1.4	3.2	1.9	2.0	4.4	3.3	1.4	1.0	24.5	0.1	0.4	5.0	1.6	0.0	0.7	0.0	0.0	0.1	6.2	0.0	13.7	0.0	4.2	5.8	22.3	22.0	0.0	9.2	0.2	0.0	0.2	2.1	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	4.1	0.3	1.4	7.9	0.6	2.0	33.8	145.2	3.5	0.6	10.3	0.5	0.6	0.1	0.0	0.0	5.4	1.8	0.0	0.5	2.3	0.3	0.0	0.6	9.0	16.1	6.6	11.3	1.3	0.4	70.3	0.0	0.9	0.4
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Metabolic proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 68.3;pancreas: 96.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 201.5;Glandular and luminal cells: 175.0;Intestinal goblet cells: 86.1;Paneth cells: 228.9;Undifferentiated cells: 301.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 44.8;endometrial cancer: 36.2;pancreatic cancer: 13.8;testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"basophil: 17.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 17.0"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 50.2"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.3	0.2	2.1	7.8	2.1	0.0	0.4	1.8	2.7	1.4	1.3	68.3	0.2	0.5	6.9	0.1	0.6	0.0	0.4	2.1	1.9	1.7	0.9	0.3	0.0	1.6	1.7	4.1	96.9	0.0	1.0	0.2	1.7	0.9	32.4	0.8	1.5	3.3	0.4	0.2	2.9	0.8	1.6	0.3	1.4	0.8	1.9	0.0	0.1	0.1	0.1	1.5	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.3	0.0	0.0	0.0	4.5	0.1	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	5.4	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	2.1	2.1	1.8	2.7	2.1	1.9	1.6	1.7	1.7	1.6	1.9	1.9	0.2	0.0	0.0	0.7	1.0	0.4	1.6	0.0	0.0	1.8	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.0	0.0	51.7	1.9	20.1	1.8	201.5	9.9	0.3	31.5	0.0	2.3	29.6	0.1	1.6	0.0	175.0	0.0	1.6	0.0	0.2	0.0	0.0	2.3	86.1	0.0	0.0	0.0	3.9	1.5	2.1	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.5	228.9	1.9	0.0	0.8	0.7	6.0	0.0	1.4	0.0	0.0	0.6	2.5	4.2	0.0	0.0	0.0	1.0	1.3	301.0	1.3
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941383	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 74.5;endometrium 1: 170.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 17.4;Endometrial stromal cells: 30.8;Granulosa cells: 43.6;Late spermatids: 34.6;Leydig cells: 18.0;Peritubular cells: 12.0"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;NTERA-2: 44.4;RPMI-8226: 50.9;SuSa: 25.5"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	1.8	1.4	0.2	1.1	0.3	0.0	0.7	0.3	0.3	74.5	15.9	1.2	0.3	170.0	12.1	0.1	3.6	0.4	2.6	0.7	0.2	0.4	0.0	2.4	0.2	0.2	0.3	37.8	0.3	0.0	16.0	3.5	0.2	1.5	0.2	0.9	0.1	12.4	0.7	0.3	0.4	36.9	0.2	0.7	0.3	4.5	0.8	0.2	0.1	0.8	0.0	0.5	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	44.4	0.0	0.0	0.0	0.0	50.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	2.6	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.7	0.2	0.2	0.3	0.2	0.2	0.8	0.3	0.6	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.4	17.4	2.2	30.8	0.6	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.7	0.0	43.6	0.4	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	34.6	18.0	0.3	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	12.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	1.7	6.7	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.1
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"		3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	0.9	1.0	0.7	0.3	1.0	0.2	1.6	0.9	0.7	0.5	1.9	0.6	1.0	0.7	3.4	0.3	3.8	0.4	0.9	0.9	1.1	1.4	0.7	0.6	1.0	1.9	1.7	0.9	1.0	1.5	1.5	0.2	1.5	0.9	0.6	1.8	0.6	0.6	0.2	0.4	0.6	0.4	1.6	0.5	0.9	12.8	1.1	0.7	2.3	0.2	0.4	0.5	0.2	1.0	3.3	1.2	0.0	0.7	0.4	0.2	0.1	0.1	0.5	0.6	0.5	0.1	1.7	0.0	0.9	0.4	1.2	1.2	0.0	0.3	1.3	0.5	0.3	1.0	0.1	0.0	0.0	1.0	0.2	1.5	0.8	0.1	0.9	0.3	0.3	0.0	0.7	0.6	1.2	1.2	0.0	0.7	1.0	0.9	0.7	0.0	0.8	0.8	1.0	0.2	1.9	0.7	1.0	0.7	0.0	0.2	2.2	1.8	0.0	0.1	0.3	0.2	0.5	2.9	0.5	0.0	0.5	0.7	1.0	0.6	0.0	0.0	0.2	0.0	0.4	0.8	0.4	0.0	0.3	0.9	0.4	0.2	0.0	0.7	0.0	0.5	0.6	0.1	0.7	1.0	0.9	0.7	0.9	1.1	1.9	1.7	1.5	1.6	1.1	1.0	0.5	0.0	1.1	19.9	6.3	1.3	1.1	1.4	2.8	1.2	2.7	3.9	1.5	1.5	2.8	3.7	2.1	0.3	0.7	1.5	3.9	0.7	96.8	20.7	1.4	0.6	0.0	2.1	6.5	1.6	0.1	1.1	9.7	2.8	1.3	1.4	0.0	1.8	0.2	3.3	11.8	0.9	0.0	1.6	1.3	47.7	1.5	1.8	1.8	3.7	1.1	1.7	0.0	8.0	8.0	1.0	0.6	1.9	2.5	0.7	1.2	5.4	28.0	4.8	0.0	0.6	1.4	65.2	4.3	2.2	0.9	0.1	2.3	1.1	0.9	0.8
LELP1		ENSG00000203784	"Late cornified envelope like proline rich 1"	Q5T871	1	153203430-153205120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1198	"testis: 1117.6"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 21424.4"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA070231	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA070231: AB_2686237"															"unprognostic (1.77e-1)"			0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.0	0.0	0.1	0.1	1117.6	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3645.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21424.4	88.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.1	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	105.5	54.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LEMD2	"dJ482C21.1, LEM2, NET25"	ENSG00000161904	"LEM domain nuclear envelope protein 2"	Q8NC56	6	33771202-33789130	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	40.5	45.8	46.0	35.0	47.9	63.3	39.6	53.1	50.8	52.6	44.6	45.3	31.9	44.1	29.7	50.2	45.9	30.0	46.7	43.9	44.0	51.5	49.9	51.2	45.4	52.0	47.0	53.7	54.5	39.3	56.5	38.5	47.9	51.9	30.0	29.7	43.3	31.3	37.4	51.8	50.1	30.4	46.3	70.1	44.9	45.5	47.2	46.1	53.0	28.1	41.6	43.8	44.9	54.4	36.6	40.5	67.3	66.1	37.6	40.3	50.9	39.1	59.7	48.5	50.9	30.6	37.8	33.8	53.5	55.6	136.7	62.0	39.4	52.1	34.0	35.9	36.6	12.7	45.8	40.3	78.4	26.1	42.6	44.3	96.5	51.6	88.1	80.0	52.8	43.9	36.3	38.3	42.8	30.8	48.6	64.1	39.2	53.5	23.2	31.8	27.8	28.3	52.0	50.5	47.8	37.8	23.4	74.0	52.6	68.0	49.5	70.7	24.6	67.8	26.3	36.6	46.5	49.8	43.0	24.0	26.7	40.3	83.0	1.6	1.7	3.2	2.3	1.5	2.9	2.2	2.5	2.3	1.7	2.3	2.0	2.3	1.4	1.5	2.1	2.9	2.8	1.2	46.0	47.9	53.1	50.8	43.9	44.0	52.0	47.0	47.9	46.3	47.2	54.4	19.8	3.2	9.0	16.0	17.4	10.8	13.4	7.9	14.2	18.6	10.0	7.1	10.0	8.6	5.2	9.2	18.8	24.9	18.6	24.3	1.9	9.4	24.9	7.5	10.1	18.5	5.4	8.6	14.5	6.8	36.6	12.2	15.3	10.6	12.7	16.6	12.5	7.7	17.5	43.7	17.4	17.7	6.1	14.5	12.4	44.2	10.5	13.5	12.4	14.0	9.4	14.0	13.4	14.6	18.2	13.2	20.1	16.1	11.9	14.6	14.8	6.6	7.2	13.1	19.7	12.7	15.2	24.6	7.4	8.9	10.2	29.8	15.2	12.5	15.9	13.2
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	8.2	8.9	0.2	0.0	0.3	0.1	8.1	0.5	0.3	9.3	0.0	9.4	0.0	8.8	0.2	6.6	9.5	0.0	12.0	0.1	0.2	9.1	8.3	7.1	0.0	0.3	0.3	10.3	10.1	0.1	8.6	0.0	0.9	8.8	0.2	0.2	7.2	0.1	15.2	7.4	8.4	0.0	0.3	11.2	10.0	14.7	0.3	0.1	8.3	0.0	0.1	9.5	7.5	0.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	2.2	0.0	0.6	1.1	0.4	0.5	0.6	0.4	0.9	0.7	0.5	0.6	0.6	0.5	0.8	0.7	0.0	0.4	0.4	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.3	0.3	0.9	0.3	0.3	0.5	28.8	19.2	8.8	2.3	31.4	20.6	22.1	28.6	11.4	10.1	15.2	14.5	7.8	17.2	17.6	18.4	0.0	27.5	30.9	33.7	23.5	21.5	98.8	23.6	18.6	24.2	27.0	17.7	1.1	28.4	14.6	18.3	10.7	17.6	54.6	15.3	29.3	17.0	30.6	6.7	1.2	27.2	34.6	21.8	23.9	15.6	22.4	22.3	21.4	0.0	26.9	19.4	51.5	1.5	4.7	26.1	28.0	15.1	18.0	15.6	35.9	38.2	26.4	15.6	39.5	14.5	24.8	37.3	31.2	10.8	21.5	42.8	38.7	21.3	18.8	16.7
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Rod photoreceptor cells: 598.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 479.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA061571"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	238.9	243.5	53.8	84.3	62.0	79.5	264.9	62.5	94.5	327.4	75.3	317.4	112.6	318.2	40.6	199.0	384.3	25.5	237.5	53.1	75.5	299.0	193.2	293.0	70.8	60.3	53.1	425.1	545.6	15.7	380.6	30.9	59.0	353.6	28.9	223.7	267.0	28.0	134.2	249.1	336.3	41.1	38.1	386.8	300.0	238.5	69.7	38.3	374.8	10.3	34.5	283.9	279.8	90.7	70.5	57.6	68.0	37.1	20.7	33.6	37.8	58.1	8.9	11.2	21.7	45.3	100.8	55.9	24.6	46.5	2.7	91.0	21.7	27.0	8.2	93.9	479.3	84.0	179.4	32.0	24.4	12.9	68.5	74.9	39.5	6.7	26.4	91.4	17.2	42.6	66.7	84.1	14.0	24.6	53.1	66.8	17.6	17.5	11.9	84.3	20.5	78.6	27.1	19.4	54.4	29.9	6.3	42.7	15.1	34.1	42.7	18.1	81.7	47.2	48.3	7.6	63.0	77.7	38.4	25.7	40.7	89.9	32.4	3.2	1.0	1.4	0.8	0.7	0.9	0.7	0.5	0.9	0.6	2.5	0.8	0.7	4.5	0.9	0.5	3.1	0.9	0.4	53.8	62.0	62.5	94.5	53.1	75.5	60.3	53.1	59.0	38.1	69.7	90.7	46.7	19.2	30.7	77.1	50.2	28.8	21.3	26.4	35.9	122.7	57.2	47.1	2.2	44.3	35.7	40.5	112.6	20.2	57.5	73.5	1.9	18.5	35.4	52.4	33.8	32.5	105.0	43.3	62.8	31.6	11.9	35.3	128.4	64.8	11.4	67.4	35.3	39.2	25.3	95.9	53.4	84.9	42.7	48.2	28.0	12.4	43.5	59.6	24.9	52.5	45.9	36.1	25.7	64.3	86.5	30.8	52.2	36.9	48.2	39.9	74.2	9.8	68.9	598.6	19.7	25.6	44.3	23.7	13.9	40.5	38.5	21.1	37.6	45.7	59.5	43.1
LENG9		ENSG00000275183	"Leukocyte receptor cluster member 9"		19	54461732-54463778	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 29.6;Intestinal goblet cells: 33.8;Proximal enterocytes: 48.2;Rod photoreceptor cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.0;HEK 293: 4.5;Karpas-707: 4.1;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051671, HPA053556"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA051671: AB_2681568, HPA053556: AB_2682187"	"unprognostic (8.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.99e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.76e-2)"	4.6	5.0	0.1	0.9	0.2	0.1	3.8	0.3	0.3	4.3	0.0	6.8	2.4	2.9	0.0	7.6	4.2	0.0	3.3	0.2	0.1	5.4	8.2	4.1	0.2	0.6	0.2	3.3	28.9	0.0	1.7	0.2	0.7	9.0	0.2	0.1	7.1	0.2	2.5	3.6	6.1	0.0	0.1	5.7	7.2	2.2	0.2	0.0	2.3	0.0	0.0	5.4	4.4	0.6	2.7	0.4	0.2	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	1.3	2.7	0.0	1.3	0.5	0.0	5.0	0.0	0.5	0.0	3.2	4.5	0.6	0.7	0.2	0.0	0.3	0.7	0.8	1.1	0.0	0.0	0.2	0.0	0.5	0.0	4.1	0.0	0.0	1.0	0.8	1.1	0.8	1.1	2.1	0.2	5.2	0.3	0.5	0.1	0.3	0.8	2.4	1.3	0.1	0.9	0.8	1.6	0.0	0.1	0.2	1.0	0.8	0.0	0.2	0.3	1.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.2	0.7	0.1	0.2	0.6	11.7	0.0	1.1	0.7	5.0	0.9	11.5	2.6	7.4	3.8	5.7	4.2	0.3	4.3	2.8	1.8	2.1	0.3	10.9	20.2	0.0	2.8	1.1	8.6	7.9	5.5	5.4	2.1	2.1	4.3	2.7	5.7	29.6	17.1	0.0	4.4	6.1	2.8	3.5	5.0	1.8	33.8	2.0	10.6	1.9	0.2	6.5	5.2	1.8	3.7	2.9	8.5	7.2	2.5	4.1	2.7	20.9	1.9	7.0	12.9	48.2	3.7	3.5	34.1	0.0	6.3	8.7	0.4	3.6	5.0	3.1	0.4	5.2	11.2	27.0	15.2
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.2	11.4	8.1	13.8	8.8	9.0	15.5	14.7	12.9	11.6	6.4	17.0	13.3	10.4	10.0	19.8	8.7	13.2	8.1	8.0	10.0	13.7	22.2	9.7	18.0	8.0	8.1	8.5	8.1	18.8	9.1	12.1	7.7	12.3	19.2	12.0	18.5	8.6	13.9	20.8	14.5	11.7	6.9	10.5	13.2	9.3	8.3	22.1	11.1	11.7	17.9	19.3	14.0	10.0	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	8.1	8.8	14.7	12.9	8.0	10.0	8.0	8.1	7.7	6.9	8.3	10.0	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241278-128257629	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"adipose tissue: 307.5;breast: 90.1"	"Group enriched"	"Detected in some"	44	"Extravillous trophoblasts: 124.2;Syncytiotrophoblasts: 432.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	19000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	307.5	0.8	0.1	5.0	0.1	0.1	90.1	0.5	0.3	0.1	0.1	2.0	0.1	0.0	0.0	0.2	0.1	1.2	1.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.0	4.6	0.1	0.0	0.4	0.0	1.1	0.0	0.7	3.9	1.2	0.1	0.0	0.2	0.5	0.2	0.1	0.3	0.2	1.2	0.0	1.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.8	0.1	0.6	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	124.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.1	432.2	0.1	0.1	0.0	0.1
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 130.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 80.5;Fibroblasts: 94.2;Hepatocytes: 175.2;Langerhans cells: 66.6;Microglial cells: 129.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"K-562: 114.7;RPTEC TERT1: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Intracellular and membrane"	NA	NA	8240000	14000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	24.3	7.2	5.2	3.9	5.1	5.0	20.6	4.9	6.5	21.5	25.0	5.9	3.9	24.6	6.7	9.2	16.1	14.7	6.9	5.3	12.3	7.8	130.4	22.5	9.5	5.2	5.7	25.0	3.0	2.9	11.7	5.3	5.2	9.0	5.1	2.5	11.9	7.3	2.1	15.1	5.6	18.7	6.3	3.2	13.7	3.9	7.7	4.7	10.4	32.1	5.7	9.1	4.8	5.2	3.3	2.0	2.6	2.9	11.5	10.6	9.0	14.2	8.1	4.8	4.5	1.5	7.6	1.4	10.1	18.0	1.3	2.7	2.2	12.3	12.7	17.2	3.7	18.8	7.9	0.3	7.0	1.4	1.6	29.7	6.8	2.9	10.8	36.2	13.9	1.4	114.7	2.2	22.5	0.9	1.4	0.4	4.2	2.0	0.2	0.4	2.2	0.8	52.3	1.4	1.6	26.3	3.5	1.5	4.0	14.9	5.0	5.0	5.3	4.9	10.0	1.1	7.8	3.0	2.2	0.5	10.2	5.3	4.8	4.5	0.8	1.2	0.5	0.6	0.4	0.2	0.4	0.4	0.7	0.1	0.3	0.5	0.4	0.4	0.7	0.5	1.0	0.7	5.2	5.1	4.9	6.5	5.3	12.3	5.2	5.7	5.2	6.3	7.7	5.2	97.7	0.0	11.3	47.0	2.6	35.3	1.9	3.3	2.2	4.0	3.1	3.3	6.6	11.5	4.2	9.2	0.0	1.6	1.6	0.5	3.9	1.5	1.1	2.0	4.4	80.5	0.0	10.3	20.9	1.1	2.6	94.2	2.6	12.8	1.3	2.6	52.5	175.2	2.0	1.7	21.8	0.8	2.0	6.3	66.6	2.3	34.5	6.1	35.6	129.3	3.4	0.4	2.1	29.1	24.5	1.7	1.9	7.5	2.4	7.5	0.7	6.4	2.6	1.0	0.0	41.1	10.3	1.1	1.2	4.1	29.5	2.6	4.7	3.3	0.8	2.1
LEPROTL1	"my047, Vps55"	ENSG00000104660	"Leptin receptor overlapping transcript like 1"	O95214	8	30095408-30177208	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"T-cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047911	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA047911: AB_2680206"	"unprognostic (4.42e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.04e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.03e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.53e-1)"	37.0	48.5	20.0	32.6	20.7	55.7	25.0	23.8	26.0	20.3	16.7	28.4	20.4	21.4	25.6	18.8	21.1	23.5	34.0	22.7	20.3	29.4	38.8	29.7	39.4	19.1	18.9	20.4	22.7	21.8	15.3	75.9	19.6	17.8	26.0	25.7	20.7	22.1	13.3	21.8	26.5	24.0	19.5	33.1	25.3	34.1	19.8	66.3	15.3	14.9	36.1	26.4	17.6	21.8	39.3	48.9	67.8	52.0	36.2	27.4	27.0	55.6	45.1	37.9	60.7	40.4	41.2	24.3	45.6	51.7	47.9	37.6	52.3	39.2	60.8	32.9	31.3	75.0	35.0	74.6	55.9	23.1	55.3	31.5	41.4	42.7	27.0	43.7	47.0	57.4	79.4	40.1	45.3	49.6	52.4	31.4	47.1	73.9	30.8	41.8	27.1	28.9	48.7	48.3	15.4	55.3	30.4	31.2	50.5	44.8	29.0	22.5	41.2	23.0	114.6	19.1	42.8	15.6	24.0	49.3	33.8	49.4	55.0	252.3	119.8	171.3	142.3	121.9	188.3	38.2	246.6	174.7	83.3	33.4	347.3	259.9	229.9	102.3	160.6	115.4	338.9	284.5	20.0	20.7	23.8	26.0	22.7	20.3	19.1	18.9	19.6	19.5	19.8	21.8	97.7	35.3	42.3	13.7	62.2	29.2	16.5	57.5	21.1	23.2	38.6	29.3	40.9	42.9	42.4	42.3	12.5	56.2	196.6	39.1	19.6	113.4	122.2	44.8	40.3	67.2	33.0	30.1	25.2	102.3	105.2	36.4	35.7	34.3	141.4	149.2	69.3	74.9	98.3	20.2	25.6	35.4	67.1	93.1	70.3	79.7	35.4	85.1	62.2	15.9	86.3	27.6	117.4	24.1	21.5	83.9	36.7	26.4	78.0	15.2	48.7	83.1	65.7	26.3	52.6	21.8	71.3	122.6	68.4	31.1	34.7	51.9	351.9	48.2	33.2	19.3
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856156	"Human disease related genes, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	13.6	16.3	14.3	7.9	13.7	7.7	10.8	11.7	14.6	8.2	10.8	20.3	13.9	8.4	3.2	23.8	8.0	4.5	19.6	13.4	13.2	13.3	16.4	8.9	7.0	12.7	13.5	9.2	12.5	11.4	8.8	4.9	11.9	8.4	10.7	4.5	9.6	4.2	18.7	15.9	11.7	5.1	12.2	10.7	13.8	14.5	15.0	25.7	10.7	10.9	7.9	8.4	10.6	11.6	22.9	38.1	11.6	36.1	17.4	12.2	20.7	22.1	10.7	21.8	16.9	35.5	24.7	37.5	15.4	23.3	34.0	22.7	29.8	31.2	13.2	25.1	31.1	38.4	30.9	25.6	22.6	39.3	30.3	19.9	22.0	24.9	21.8	10.1	19.0	22.6	51.5	22.9	15.3	25.1	57.3	44.7	30.5	24.7	43.2	32.4	16.2	21.9	17.0	31.3	29.5	26.0	25.2	31.5	13.3	10.0	29.7	20.3	28.8	24.8	14.8	21.1	37.3	19.8	32.7	29.3	22.0	33.8	20.2	3.9	3.7	2.0	5.8	5.0	5.7	4.2	4.9	4.9	4.1	3.6	3.2	4.6	0.5	5.9	5.1	12.9	4.2	2.1	14.3	13.7	11.7	14.6	13.4	13.2	12.7	13.5	11.9	12.2	15.0	11.6	12.2	16.0	11.5	15.0	19.2	40.0	40.7	13.4	8.0	19.4	19.7	10.5	23.3	11.5	14.0	27.6	33.3	17.5	24.9	116.1	31.3	25.5	32.2	9.1	19.4	16.7	15.6	20.4	14.3	31.3	22.6	17.0	32.1	14.7	10.2	17.9	16.1	33.3	21.5	15.2	12.4	29.5	12.2	18.4	19.8	45.1	20.2	13.0	19.6	4.7	13.9	12.7	28.8	9.5	13.2	42.4	52.7	16.6	17.8	58.8	48.8	46.1	5.6	28.4	13.1	23.8	16.1	54.2	44.4	25.2	51.1	15.2	16.7	21.9	53.2	48.4
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786291	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA							"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LEXM	"C1orf177, FLJ40201, LEM"	ENSG00000162398	"Lymphocyte expansion molecule"	Q3ZCV2	1	54806063-54842252	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 12.7;testis: 4.8;vagina: 4.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 46.0"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035889, HPA035890"	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 34: Spermatids - Unknown function"			"HPA035889: AB_2674844, HPA035890: AB_10669535"	"unprognostic (1.61e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.69e-2)"		"unprognostic (1.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.81e-1)"	0.0	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.9	1.5	0.0	0.4	1.6	0.0	0.1	12.7	0.1	0.0	0.0	0.1	0.2	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.0	0.0	1.0	1.3	0.0	0.0	0.1	0.2	4.8	0.1	0.0	0.0	0.0	0.5	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	3.8	0.0	0.2	0.0	0.8	2.0	0.0	0.0	0.1	2.5	0.0	2.0	0.0	0.1	0.2	1.0	0.1	1.6	0.1	0.9	0.1	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	37.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	46.0	0.3	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.1	0.0	0.7	0.3	0.0	4.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.6	0.0	0.0	1.0	0.0	0.6	0.2
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570248-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	27	"classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2"	"Group enriched"	"Detected in all"	50	"dendritic cells: 1207.2;monocytes: 1464.7"	"Group enriched"	"Detected in many"	4	"CACO-2: 109.4;Hep G2: 62.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	7.5	1.4	0.6	23.5	1.4	19.2	5.4	0.2	1.1	1.8	0.2	55.0	41.2	3.6	1.0	5.2	4.4	335.5	1.6	0.5	1.0	153.0	5.0	8.6	60.7	1.6	1.2	0.9	211.5	0.2	0.1	1.7	1.4	2.2	81.1	0.1	2.1	0.7	1.9	9.9	198.0	5.2	0.4	59.2	10.7	0.6	1.1	41.3	1.0	0.7	64.0	8.2	0.5	3.4	2.8	1.5	0.9	1.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	109.4	0.1	0.4	0.3	0.0	0.3	1.7	0.0	0.0	0.0	0.2	1.1	0.0	0.0	62.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	2.8	0.0	1.0	0.4	21.2	0.3	0.0	0.9	1.3	0.0	0.0	0.0	0.3	1.7	1.9	2.4	0.5	1.6	1.7	6.4	2.0	1.0	4.3	0.8	0.0	0.2	0.3	2.7	0.2	1.3	7.7	1464.7	8.7	1.8	553.8	3.3	9.9	1.8	2.1	1207.2	2.3	2.3	1.9	26.8	2.3	39.7	9.6	3.0	981.5	0.6	1.4	0.2	1.1	0.5	1.0	1.6	1.2	1.4	0.4	1.1	3.4	1.6	6.4	3.9	0.0	16.4	17.1	0.1	0.5	0.0	0.0	13.2	7.5	0.3	779.2	1.4	29.5	0.0	0.2	7.0	695.4	127.2	26.3	0.1	0.1	0.3	2.3	73.7	4.8	0.1	206.7	0.3	3.2	5.6	0.2	2.5	0.0	0.7	1.9	26.4	0.0	0.1	413.0	0.0	100.8	982.8	0.3	0.6	150.8	24.9	0.0	164.8	0.0	4.1	0.0	0.1	291.6	331.6	0.0	0.9	0.3	2724.7	1764.8	2.1	0.0	0.0	0.3	2.3	0.0	0.4	0.1	12.4	0.3	8.6	0.0	749.3	0.3
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1194.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9"	"Group enriched"	"Detected in all"	13	"dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003162, CAB005191, HPA076528"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1900000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: "	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	404.5	72.0	111.4	219.8	111.8	346.9	323.1	110.7	148.1	331.4	104.3	1194.1	691.9	162.3	53.8	437.8	223.1	273.0	246.2	110.3	109.4	120.0	27.3	356.1	84.5	118.6	111.9	251.4	79.9	19.8	60.6	141.2	108.6	143.1	875.4	68.3	358.6	177.4	78.6	473.1	853.4	158.8	110.4	61.9	340.7	63.5	125.2	53.0	72.3	105.6	114.1	300.8	273.5	114.0	298.6	96.5	3.3	2.5	581.2	1169.3	344.9	226.7	496.2	64.0	113.2	225.4	968.0	0.7	121.3	272.8	114.6	289.0	6.1	245.4	37.5	357.1	4.4	1.0	104.7	103.8	446.8	1.0	1.1	363.4	375.2	73.9	152.8	145.1	101.5	0.7	1.4	283.1	148.8	218.5	1.3	74.4	5.6	1613.0	271.1	0.7	11.3	22.4	604.8	434.2	7.8	22.6	529.0	0.9	2329.1	16.2	242.8	31.4	180.5	297.8	41.5	112.0	4.4	154.0	535.6	2.8	426.8	18.6	31.8	18.5	651.4	32.4	15.7	544.6	99.7	11.5	58.4	44.2	397.8	4.7	2.5	8.3	28.7	24.2	441.2	9.6	251.9	449.6	111.4	111.8	110.7	148.1	110.3	109.4	118.6	111.9	108.6	110.4	125.2	114.0	1157.4	721.1	359.8	33.3	42.0	631.3	624.1	1278.9	241.9	2.9	307.3	478.7	218.2	258.7	1463.3	119.5	0.0	766.1	38.8	4097.0	673.1	605.9	21.7	636.2	742.7	397.8	173.4	578.1	0.2	1057.8	1051.7	666.3	281.4	846.8	580.5	6.3	64.6	2.3	1137.4	1.7	0.5	1733.8	1778.1	287.8	844.6	44.4	555.7	651.2	848.4	14.0	639.1	300.1	9.2	2.0	0.3	1289.6	3445.9	384.0	77.4	708.4	4397.2	81.3	1506.5	14.7	144.7	220.2	521.0	11.5	6.6	524.8	797.6	483.8	119.5	2.9	1880.1	1139.7
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78979947	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"monocytes: 27.2;T-cells: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 862.9;SK-BR-3: 2270.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	NA	NA		7100000000	"Cluster 32: T-cells - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	192.8	218.6	51.2	75.0	91.4	48.6	109.5	95.6	62.3	188.8	159.8	210.8	312.9	121.4	45.2	114.2	155.6	240.8	311.4	46.6	81.4	103.1	68.5	182.8	52.7	145.6	88.3	155.6	79.1	107.8	134.9	147.0	116.8	114.3	92.6	10.0	498.7	154.2	20.0	54.0	260.9	80.2	104.3	76.8	315.6	70.1	89.8	48.8	102.0	20.4	25.3	125.0	119.0	152.5	499.0	255.3	7.2	11.2	157.3	181.4	147.9	55.7	49.0	371.3	725.7	107.5	862.9	2.8	372.7	33.5	361.7	200.1	53.6	203.7	11.5	1.2	319.0	33.8	206.0	481.0	387.7	0.4	31.6	305.8	111.5	197.5	12.6	83.8	9.9	68.7	3.4	1.5	87.7	62.8	151.2	6.0	13.0	163.7	170.7	100.1	209.9	4.8	155.5	352.6	235.1	267.4	52.7	2270.3	754.5	14.0	57.5	16.1	16.3	245.5	169.8	7.1	225.8	0.8	2.2	3.7	332.1	96.8	263.7	0.8	17.7	4.9	12.0	27.2	25.0	4.7	43.3	17.9	7.6	2.4	68.4	33.0	1.2	9.4	14.7	0.6	26.0	25.1	51.2	91.4	95.6	62.3	46.6	81.4	145.6	88.3	116.8	104.3	89.8	152.5	88.0	189.1	144.3	9.8	5.6	31.1	146.8	462.5	60.3	37.2	60.5	43.1	180.7	127.2	306.2	139.8	6.2	179.1	3.4	629.8	17.6	275.0	7.2	77.4	118.7	26.8	168.2	4.4	0.3	136.5	336.0	284.6	257.9	126.9	13.3	316.5	46.8	45.8	88.3	74.0	5.3	328.7	309.3	36.8	23.7	37.1	282.7	36.0	81.8	8.4	27.9	80.8	2.1	11.6	33.9	132.4	584.1	266.3	3.5	72.4	931.4	49.2	123.9	24.3	177.5	80.5	119.6	4.5	2.1	83.8	27.3	108.9	15.4	228.3	400.5	128.2
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"intestine: 1307.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.1	0.4	0.5	5.5	0.5	0.6	1.4	0.2	1307.1	812.2	3.2	0.2	1.4	2.4	137.1	0.9	0.3	0.3	2.9	79.5	1.2	1.1	0.3	0.3	1.6	31.5	0.0	0.8	0.2	0.3	2.3	933.0	0.2	1.1	2.3	1.6	1.6	691.9	55.2	0.2	4.0	135.2	0.9	0.3	0.3	1.7	0.2	0.4	11.2	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 393.1;skin 1: 877.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 275.1;Squamous epithelial cells: 639.7;Suprabasal keratinocytes: 725.7"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 7.1;OE19: 2.2"	"Low region specificity"	"Detected in single"							"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"	NA	NA		4000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	1.0	0.2	0.0	0.0	0.0	0.0	13.6	0.0	0.0	63.2	0.0	0.3	0.0	0.4	0.0	393.1	0.4	0.2	0.5	0.0	0.1	0.7	0.3	0.4	0.0	0.1	0.1	0.3	0.4	0.0	0.4	0.0	0.1	2.0	0.0	0.0	25.5	0.2	10.7	877.2	0.2	0.0	0.0	2.3	0.5	1.5	0.0	0.5	0.7	0.4	2.2	0.3	155.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	275.1	0.9	124.3	89.4	0.0	0.3	2.8	0.2	0.0	57.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	7.5	1.1	0.0	0.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.4	10.7	0.0	0.0	1.7	3.8	1.5	0.8	639.7	725.7	0.0	0.5	0.1	0.0	1.5
LGALS7B	GAL7	ENSG00000178934	"Galectin 7B"	P47929	19	38789200-38791754	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6695.7"	"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 1529.6;Suprabasal keratinocytes: 5136.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 142.7;head and neck cancer: 185.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HaCaT: 3.9;OE19: 3.9"									"HPA001549, CAB025100"	Supported				"Intracellular and membrane"	NA	NA		4000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"CAB025100: , HPA001549: AB_1078938"	"unprognostic (4.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.29e-3)"	6.1	1.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	490.5	0.0	1.8	0.0	1.0	0.0	1463.3	0.9	0.0	2.6	0.0	0.0	2.1	3.0	2.6	0.0	0.0	0.0	1.4	2.7	0.0	2.2	0.0	0.0	5.0	0.0	0.0	167.2	0.1	10.2	6695.7	1.7	0.0	0.0	22.0	3.0	4.9	0.0	0.2	2.3	0.0	1.6	1.0	834.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1529.6	6.3	253.5	102.4	0.0	1.2	13.3	0.4	0.0	64.4	1.8	0.0	0.0	0.0	0.3	0.0	0.0	5.4	3.1	0.2	3.2	1.2	0.0	0.0	0.2	0.1	3.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	41.3	12.3	0.0	0.3	44.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	2.1	0.3	0.3	9.3	0.0	0.0	1.3	4.2	7.5	1.9	329.6	5136.5	0.0	1.6	0.4	0.1	14.0
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 322.8;Late spermatids: 222.6;Syncytiotrophoblasts: 176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 118.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA012734: AB_2668720, HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	28.6	14.3	10.8	26.5	11.3	44.4	23.3	12.4	14.1	17.2	11.5	19.9	21.6	16.7	19.6	21.2	13.8	24.8	55.0	12.5	12.6	23.4	49.5	27.0	24.0	12.9	10.9	21.6	21.8	35.0	12.7	41.0	13.5	22.2	19.9	22.9	22.1	21.3	6.8	32.4	24.1	21.8	11.7	42.6	18.9	57.1	11.4	26.3	17.2	9.4	22.8	32.8	15.3	11.7	52.3	27.5	3.6	20.8	46.6	39.0	55.6	38.0	45.4	49.0	59.3	37.6	63.3	1.5	34.8	33.7	26.8	60.3	11.0	54.7	43.2	31.1	7.3	35.5	20.7	68.1	56.9	46.9	78.9	39.6	45.6	41.0	13.8	42.4	52.5	26.4	40.7	25.1	35.7	33.3	23.2	8.4	12.5	4.1	18.5	27.2	0.8	3.0	35.4	80.8	13.1	25.7	24.4	82.3	13.7	2.1	59.0	33.7	39.1	1.0	22.0	29.9	47.7	10.0	7.4	1.0	50.4	65.7	30.9	118.5	37.4	18.7	12.5	32.9	17.8	10.7	18.4	14.1	31.7	6.8	12.2	12.7	16.1	14.2	24.0	14.2	22.5	24.8	10.8	11.3	12.4	14.1	12.5	12.6	12.9	10.9	13.5	11.7	11.4	11.7	44.0	76.9	54.7	12.1	19.3	32.5	28.5	64.9	44.9	28.1	31.7	22.7	55.2	34.3	68.1	14.7	25.0	64.4	33.9	25.3	5.9	61.8	322.8	18.7	21.9	39.9	18.1	19.0	31.5	39.2	53.5	35.2	23.0	20.8	109.4	38.0	46.1	27.1	57.5	38.7	37.0	18.8	57.0	100.5	23.6	222.6	23.6	45.1	7.2	24.4	38.7	6.5	17.5	18.1	16.7	44.0	36.0	13.9	15.1	20.6	26.4	14.5	53.1	19.4	26.3	22.5	19.6	46.8	8.7	21.3	37.1	176.2	34.4	22.8	17.1	24.4
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.1;stomach 1: 87.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 181.1;Gastric mucus-secreting cells: 174.8;Hofbauer cells: 298.2;Intestinal goblet cells: 183.5;Kupffer cells: 254.2;Paneth cells: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 40.2;HMC-1: 124.9;MOLT-4: 44.8;REH: 48.4;THP-1: 83.2;U-937: 92.1"									"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	448000		"Cluster 7: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favorable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	20.7	6.4	12.6	46.0	13.0	68.5	9.5	13.8	20.8	25.6	14.3	99.1	46.3	12.8	3.0	14.5	28.4	38.2	8.7	12.8	13.4	2.4	11.6	34.2	60.9	21.7	15.2	5.3	5.2	2.8	1.2	16.8	16.5	3.7	89.2	1.0	21.2	7.9	3.8	4.2	41.8	19.4	17.3	50.7	87.5	3.8	17.0	29.1	4.1	4.1	38.9	39.6	1.9	20.1	2.0	0.7	0.6	0.3	0.1	0.2	1.6	0.4	1.3	8.9	29.6	0.1	12.6	1.5	14.2	1.1	1.5	4.1	0.3	0.1	0.5	9.4	0.9	14.9	0.9	0.0	1.0	40.2	124.9	0.3	0.0	0.4	0.0	0.5	16.5	13.6	0.6	0.5	0.0	0.1	44.8	15.0	0.4	28.4	0.0	48.4	0.0	3.6	5.9	1.0	0.3	0.8	0.0	4.4	0.2	0.9	0.2	83.2	3.1	0.0	0.3	0.1	0.2	0.1	0.1	0.3	0.2	92.1	0.2	32.6	116.2	78.2	5.6	214.9	2.6	32.3	15.6	5.9	165.5	41.7	9.6	4.0	41.7	22.0	217.4	28.5	40.3	75.1	12.6	13.0	13.8	20.8	12.8	13.4	21.7	15.2	16.5	17.3	17.0	20.1	32.2	9.6	6.3	2.0	42.2	3.2	7.7	32.9	18.8	0.2	10.5	13.2	1.7	20.0	40.5	7.3	0.0	2.3	19.0	181.1	3.9	124.1	1.5	11.4	11.6	43.5	40.5	64.3	0.4	126.9	3.1	7.4	174.8	12.9	31.1	11.2	26.0	2.2	298.2	0.0	0.6	183.5	26.4	254.2	85.4	2.2	4.4	154.1	1.8	25.3	150.7	0.2	41.2	3.5	0.9	146.0	181.6	3.0	3.5	4.4	20.6	1.4	15.4	0.6	19.7	1.6	6.2	0.1	0.7	8.8	1.7	3.7	19.6	86.2	126.7	31.1
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.4;intestine: 11.1;stomach 1: 30.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"NK-cell: 12.7"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 12.7"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.5;U-937: 2.8"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	1.6	0.0	8.2	3.3	0.0	0.0	15.4	0.0	7.4	0.0	0.1	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.1	0.0	2.2	0.0	0.0	0.6	3.4	0.3	0.0	0.6	30.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.1	12.7	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	2.3	0.3	1.1	0.6	0.0	0.0	0.0	0.1	1.5	2.2	0.0	0.0	0.0	9.9	17.7	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.6	2.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	28.8	0.0	0.0	0.6	42.3	0.0	1.2	0.2	7.7	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	2.1	0.0	6.6	0.3
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.3;intestine: 9.3;stomach 1: 11.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.1;Gastric mucus-secreting cells: 194.2;Intestinal goblet cells: 37.9;Paneth cells: 58.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"neutrophil: 1.9;NK-cell: 5.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;NK-cells: 5.5"	"Not detected"	"Not detected"											"HPA046876, HPA047218"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	9.3	1.1	0.0	0.0	10.3	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	1.6	0.0	0.0	0.2	4.3	0.0	0.0	1.4	11.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	1.9	5.5	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.1	3.4	48.1	0.0	0.2	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	194.2	0.1	0.0	0.0	0.4	0.1	0.7	0.0	0.0	37.9	4.1	2.2	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	9.2	0.0	0.0	0.4	58.4	0.0	0.2	0.0	13.5	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.1	0.0	1.8	0.0	10.8	0.2
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 90.6;skin 1: 93.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.6;Rod photoreceptor cells: 152.8;Suprabasal keratinocytes: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.5;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 50.2;CACO-2: 35.6;HAP1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		NA	NA		4100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	9.3	16.9	7.1	4.1	8.3	8.1	17.2	9.5	8.7	8.8	8.6	12.6	10.1	7.2	8.9	24.6	5.3	6.3	13.5	7.4	8.6	9.2	9.6	15.9	2.1	5.7	5.4	6.4	6.3	19.2	7.5	10.6	5.7	15.5	11.8	90.6	9.3	7.1	60.1	93.6	10.9	7.3	5.4	6.0	8.8	4.3	5.8	2.9	5.3	18.2	15.8	4.4	10.0	6.6	11.6	7.5	20.7	50.2	0.7	0.2	6.2	2.9	8.1	6.3	6.0	35.6	2.4	0.0	4.7	1.6	12.2	14.3	72.8	13.7	5.0	13.8	19.1	0.2	4.0	17.8	6.2	3.4	4.4	3.1	8.6	2.6	9.7	5.6	3.9	7.7	0.1	3.5	0.2	9.3	4.9	0.6	16.8	7.1	8.8	5.3	12.0	3.5	7.5	8.5	3.5	13.1	10.5	7.2	6.2	12.7	5.1	0.5	1.7	4.0	12.4	2.5	6.2	14.7	7.1	10.0	0.0	2.1	5.4	0.0	0.1	1.5	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	7.1	8.3	9.5	8.7	7.4	8.6	5.7	5.4	5.7	5.4	5.8	6.6	28.9	22.4	66.2	2.3	6.0	67.6	25.5	9.7	29.0	31.9	39.0	20.8	16.5	10.0	6.3	11.0	33.3	1.4	1.6	45.2	15.6	6.2	11.8	10.9	8.1	18.2	9.1	0.8	6.6	13.3	2.7	14.8	23.4	23.0	1.3	4.1	17.9	11.9	1.0	13.5	6.0	38.6	6.1	6.6	14.4	6.3	8.1	26.2	10.6	1.9	2.4	95.6	2.1	5.0	2.4	19.9	22.6	4.5	29.8	24.1	31.0	14.3	1.6	152.8	19.7	15.1	45.9	8.1	5.1	51.9	137.0	1.5	2.7	2.8	24.3	36.2
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030946	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"parathyroid gland: 127.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Inhibitory neurons: 33.3;Oligodendrocyte precursor cells: 10.1;Skeletal myocytes: 8.6;Smooth muscle cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.2;HAP1: 5.2;RPMI-8226: 13.3;SCLC-21H: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	3.4	1.6	2.7	7.5	3.5	0.0	0.8	5.7	4.1	1.5	1.0	3.1	0.7	6.7	2.7	1.4	7.8	7.1	3.3	1.9	9.2	4.3	0.3	1.0	2.9	12.0	13.1	2.1	1.7	127.8	0.3	3.9	6.7	0.5	1.6	2.3	0.3	1.2	0.2	0.3	1.8	13.6	4.0	0.9	1.4	0.7	4.2	2.3	1.1	0.4	8.4	3.0	0.7	3.3	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	1.2	13.3	0.5	0.0	18.2	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.3	2.0	0.0	0.8	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	5.7	4.1	1.9	9.2	12.0	13.1	6.7	4.0	4.2	3.3	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	2.0	2.1	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.7	0.0	4.8	1.7	33.3	0.0	0.0	0.6	0.5	0.1	0.6	1.0	0.0	2.8	0.0	0.5	0.0	10.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.6	8.5	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	27	"WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	77.6	5.4	71.2	4.1	72.3	0.2	36.1	70.3	98.4	99.9	52.1	100.5	3.6	35.5	2.3	15.0	43.7	5.0	39.4	67.8	61.3	4.7	8.0	14.3	2.1	86.5	68.4	13.3	6.4	1.4	4.4	3.6	70.1	37.2	3.7	7.2	12.2	13.3	39.1	21.2	35.1	4.8	72.8	1.9	27.0	2.7	72.0	0.5	19.1	5.4	0.5	33.5	79.3	81.4	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.2	72.3	70.3	98.4	67.8	61.3	86.5	68.4	70.1	72.8	72.0	81.4	13.3	0.0	0.0	74.7	0.2	2.5	0.6	0.3	3.4	0.8	1.5	1.5	17.1	0.0	0.8	1.8	2.1	0.0	0.2	33.1	0.0	0.0	0.1	0.2	2.8	5.4	1.8	0.0	21.9	0.0	0.3	12.7	0.0	0.2	0.0	0.0	7.9	2.0	0.1	0.0	2.2	0.9	0.0	0.0	4.6	0.3	14.6	0.7	10.6	5.6	0.1	95.5	0.0	2.0	9.2	0.1	21.8	7.2	0.3	1.2	1.1	0.1	0.9	3.1	78.9	7.9	104.4	2.8	2.8	0.8	2.4	0.0	0.7	0.0	0.7	1.1
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748679	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"plasmacytoid DC: 209.2"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 209.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 898.6;U-266/70: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	173.7	44.4	37.6	82.2	38.6	20.6	69.7	31.7	60.8	52.6	51.2	102.5	110.4	30.8	36.8	64.5	36.6	145.8	85.3	40.0	40.3	205.9	111.1	107.3	177.0	35.6	37.3	33.0	37.9	247.0	24.9	262.1	42.4	51.9	105.9	19.7	56.4	32.2	50.4	32.7	97.6	65.0	35.9	202.2	107.0	29.8	62.8	52.8	93.2	50.4	54.9	144.7	52.1	49.4	33.2	47.5	30.8	57.4	94.3	76.0	108.4	70.3	67.0	71.7	84.2	36.9	58.6	18.2	101.5	116.5	44.3	81.5	0.0	60.8	33.7	1.6	36.2	1.2	24.4	42.8	27.7	1.0	2.7	54.2	29.1	68.4	39.4	21.3	82.1	33.7	7.4	150.9	5.2	45.2	8.9	1.2	15.1	208.2	32.1	8.4	27.1	898.6	59.2	129.1	33.6	23.2	97.9	59.4	53.0	66.8	43.9	0.6	47.2	35.3	44.8	64.5	21.8	462.5	58.0	25.0	20.0	0.2	69.1	1.9	1.6	0.1	0.8	3.1	1.6	17.0	5.1	1.3	19.3	14.5	15.2	9.0	1.6	3.7	1.0	209.2	9.7	7.0	37.6	38.6	31.7	60.8	40.0	40.3	35.6	37.3	42.4	35.9	62.8	49.4	34.9	57.7	128.0	8.8	33.9	23.1	37.5	36.0	22.2	10.6	31.2	37.6	29.8	42.9	48.1	31.3	93.8	181.8	24.5	64.2	9.8	61.3	1.3	79.4	23.5	38.3	36.5	22.7	19.2	50.6	140.2	63.8	73.4	177.7	8.8	17.6	276.3	46.4	1448.9	13.5	41.0	31.1	95.6	317.6	89.0	3.3	30.4	346.1	48.0	27.2	37.5	23.6	2.1	10.6	15.2	50.5	57.1	57.9	24.7	44.6	163.4	220.4	20.9	19.8	19.7	40.4	62.1	19.9	17.6	22.3	17.5	416.3	8.2	15.1	48.3	44.7
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472790	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	16.4	16.8	10.2	8.1	10.2	2.4	16.1	13.0	9.2	7.5	10.2	36.8	22.6	10.2	13.3	13.7	10.2	9.0	19.4	7.8	10.5	51.5	55.7	3.2	1.5	14.1	10.4	22.9	59.7	6.4	6.8	34.4	12.8	15.4	36.8	44.4	18.1	16.1	14.4	18.3	24.7	13.2	13.4	11.7	31.0	13.9	10.1	4.4	15.2	8.2	3.0	10.1	11.7	18.0	28.3	50.7	49.5	5.7	4.5	3.1	56.0	15.7	14.8	13.8	11.8	7.6	0.5	0.1	10.1	21.2	23.2	45.8	83.5	31.1	23.5	0.2	37.0	15.3	28.4	36.1	1.4	1.6	0.1	4.1	19.5	9.5	21.0	57.0	7.0	0.0	4.5	0.1	5.7	9.0	0.1	2.7	47.9	76.3	20.4	0.2	33.8	3.3	100.4	12.1	0.7	6.0	7.7	45.7	4.6	37.6	15.1	23.4	22.6	10.2	8.2	82.6	14.6	18.9	15.2	0.0	17.3	0.0	6.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	10.2	13.0	9.2	7.8	10.5	14.1	10.4	12.8	13.4	10.1	18.0	1.7	3.2	0.5	204.4	1.4	30.3	13.5	33.1	38.7	18.6	17.2	14.1	26.6	24.3	15.4	44.1	25.0	55.1	0.4	123.3	3.9	21.4	7.1	75.4	11.5	3.9	16.8	3.4	35.6	50.7	29.2	14.5	43.3	137.7	0.0	78.6	3.6	60.7	8.1	25.2	51.6	47.1	20.3	5.3	5.7	2.2	5.0	1.6	7.2	15.0	2.1	109.8	0.0	36.7	62.1	31.4	48.8	17.0	0.6	11.7	37.9	19.4	14.5	14.8	6.6	6.9	13.0	1.3	1.4	36.8	21.9	128.6	1.8	6.3	55.5	19.7
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439798-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 37.1;SH-SY5Y: 104.5"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 34.1"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	1.4	1.6	2.7	0.4	7.6	0.0	1.5	4.6	4.7	1.5	0.1	3.3	5.1	4.0	1.1	0.1	16.8	0.4	0.2	2.9	5.7	0.8	0.9	0.9	0.1	9.5	5.2	0.7	0.0	0.2	1.0	19.0	9.0	1.2	3.6	0.2	1.9	7.3	22.3	2.9	5.5	0.2	6.0	0.0	2.3	0.1	5.6	0.1	0.3	0.8	1.7	0.1	0.4	19.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.5	0.0	11.9	0.0	1.0	37.1	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	12.2	1.6	2.4	0.0	0.0	0.0	14.6	0.2	104.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.6	4.6	4.7	2.9	5.7	9.5	5.2	9.0	6.0	5.6	19.2	0.0	0.0	0.0	1.3	0.2	0.9	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	55.2	0.0	1.2	0.0	0.0	0.6	35.7	5.3	0.5	4.9	0.0	6.8	0.0	2.3	1.4	0.0	84.4	0.0	0.0	0.0	1.0	6.4	0.0	12.3	3.0	0.0	0.0	1.6	0.2	0.0	0.4	1.8	0.0	0.0	0.0	0.0	45.2	105.0	0.1	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	3.4	0.0	0.0	0.0	1.3	26.4	0.5	0.0	20.3	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193799-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"T-cells: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 24.4"	"Low region specificity"	"Detected in many"			HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.2	2.3	0.4	5.4	1.4	5.1	8.2	1.5	3.7	0.3	1.4	0.1	1.2	2.2	5.0	8.8	6.2	14.7	1.0	7.2	0.8	2.1	3.4	0.8	14.7	7.6	1.8	0.2	0.0	17.5	0.3	8.0	5.9	0.7	0.0	5.3	1.4	0.3	4.1	1.3	0.3	6.1	6.7	0.6	7.2	9.8	0.3	5.1	0.5	0.3	2.9	3.8	2.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.0	0.0	1.7	9.1	0.0	0.0	0.7	4.8	0.0	0.4	0.0	0.0	0.5	3.4	2.3	5.4	8.2	1.5	1.0	7.2	14.7	7.6	8.0	6.1	9.8	2.0	0.1	0.0	0.0	2.6	0.2	1.3	3.6	0.5	23.3	0.0	1.5	9.0	10.5	0.0	0.6	0.0	0.0	0.9	6.0	0.8	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.4	1.0	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.8	1.6	0.0	0.6	0.3	4.1	0.0	0.2	0.0	1.9	0.0	0.0	4.1	0.0	0.2	0.0	0.7	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	5.6	5.5	3.3	0.3	0.1	0.8	4.3	0.0	2.7	0.9
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319983	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 2.0;liver: 3.8;placenta: 1.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0"	"Cancer enriched"	"Detected in some"	4	"lung cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.0	3.8	0.2	0.0	0.3	0.1	0.0	0.3	0.0	0.0	1.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	2.2	0.0	1.1	1.9	0.1	1.2	2.0	0.0	0.1	0.0	0.0	3.5	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	3.7	0.7	0.0	0.3	0.0	4.4	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.0	0.3	0.0	0.1	0.2	0.1	5.6	3.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.2
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone subunit beta"	P01229	19	49015980-49017091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	248	"pituitary gland: 4493.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.7;Late spermatids: 4.1;Pancreatic endocrine cells: 8.2;Syncytiotrophoblasts: 10.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HEK 293: 1.5;Hep G2: 1.4;K-562: 1.3;U-266/84: 2.0"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	1.0	5.1	0.2	0.0	0.1	0.0	0.6	0.4	0.3	0.5	0.0	0.5	1.3	0.5	0.0	1.3	0.6	0.0	0.9	0.1	0.2	1.4	1.9	0.9	0.2	0.2	0.1	0.6	18.0	0.6	4493.5	0.0	0.2	0.9	0.0	0.0	1.1	0.0	0.5	3.1	1.5	0.0	0.0	1.2	4.5	5.0	0.1	0.0	0.8	0.0	0.0	0.3	0.6	0.3	0.1	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.9	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.5	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.3	0.3	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.7	0.4	0.4	0.0	0.6	1.2	0.6	0.5	0.0	0.6	0.0	0.5	0.0	0.0	0.9	0.6	0.0	0.1	0.1	2.0	0.3	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.0	0.0	0.1	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	3.7	0.3	0.0	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	4.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.2	1.1	1.6	0.0	0.0	10.3	0.1	0.1	0.1	0.1
LHCGR	"HHG, LCGR, LGR2, LHR, ULG5"	ENSG00000138039	"Luteinizing hormone/choriogonadotropin receptor"	P22888	2	48686774-48755730	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;ovary: 2.1;testis: 2.2"	"Cell type enriched"	"Detected in some"	22	"Theca cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009814	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 52: Non-specific - Transcription"			"CAB009814: AB_2135467"	"unprognostic (8.57e-2)"				"unprognostic (1.08e-1)"			"unprognostic (1.54e-1)"		"unprognostic (1.41e-1)"			"unprognostic (3.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.22e-2)"		1.3	0.8	0.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.1	0.0	3.2	0.7	2.1	0.0	0.0	0.5	0.0	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	2.2	0.8	0.2	0.6	0.1	0.0	0.3	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.9	0.5	0.2	0.6	3.2	0.7	2.0	1.6	0.8	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	1.0	1.2	0.1	0.0	6.5	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	143.2	0.0	0.0
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.2;salivary gland: 2.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Inhibitory neurons: 1.1;Ionocytes: 2.0;Microglial cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.6;SuSa: 3.8"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"olfactory bulb: 3.3"	HPA003029	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.0	0.1	4.1	0.1	5.3	0.0	0.6	0.5	2.5	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.7	2.2	6.1	0.1	0.0	0.0	0.1	1.2	11.2	0.3	0.0	0.1	1.3	0.1	4.6	0.3	0.1	0.1	2.9	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	7.3	0.9	0.5	0.7	0.1	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	4.1	5.3	0.5	2.5	2.2	6.1	1.2	11.2	4.6	0.1	7.3	0.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.4	0.9	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.1
LHFPL2	KIAA0206	ENSG00000145685	"LHFPL tetraspan subfamily member 2"	Q6ZUX7	5	78485215-78770021	"Predicted membrane proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.9;Microglial cells: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.9;plasmacytoid DC: 6.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042402, HPA076743"	Uncertain		Approved	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA042402: AB_10794276, HPA076743: "	"unprognostic (2.19e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (3.40e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.85e-2)"	18.2	18.8	10.9	19.6	11.5	18.4	20.5	12.0	13.4	14.0	15.3	17.7	23.8	18.0	18.9	6.3	9.1	22.6	12.2	10.1	11.1	3.1	6.4	19.7	15.2	17.2	13.7	18.5	11.4	10.4	5.7	14.8	14.9	11.4	17.5	5.5	19.3	24.7	2.7	5.7	21.2	22.0	14.6	4.3	14.8	9.1	18.5	14.8	9.1	4.1	14.4	36.3	10.3	18.7	9.8	36.1	10.6	14.1	63.0	18.0	32.7	11.0	28.0	18.7	32.5	12.8	28.4	24.4	4.8	21.7	116.4	16.6	10.2	11.8	30.6	0.2	9.1	24.3	7.2	21.6	46.5	0.1	0.2	20.7	46.6	57.3	88.4	29.6	44.8	0.9	0.2	17.8	42.9	5.2	0.1	1.4	11.8	7.9	10.3	4.7	15.0	6.8	7.1	42.6	2.0	14.4	17.9	6.6	62.5	22.3	3.9	3.0	29.8	21.7	11.8	60.1	33.2	0.7	0.1	34.1	57.5	0.2	39.7	7.9	3.9	4.0	0.0	1.4	0.1	0.6	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	0.5	6.3	0.1	1.3	10.9	11.5	12.0	13.4	10.1	11.1	17.2	13.7	14.9	14.6	18.5	18.7	13.5	3.2	3.4	20.2	5.7	8.7	7.3	5.2	0.6	6.6	18.2	15.6	3.7	1.5	7.6	7.3	0.0	4.0	20.3	34.8	0.0	9.1	1.5	7.5	26.3	21.4	2.4	10.7	15.8	12.9	2.6	38.1	10.7	14.6	0.0	121.9	35.3	1.4	60.1	3.3	7.9	16.3	6.1	40.4	14.7	1.7	19.3	36.3	10.6	209.9	5.5	5.4	0.0	55.3	4.6	17.0	16.1	33.4	3.3	10.4	29.8	0.7	3.9	2.2	6.6	19.1	13.1	0.7	1.7	1.4	4.8	7.3	1.3	22.1	10.0	12.4
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	12.9	32.0	135.1	8.2	173.7	10.5	13.0	159.3	190.6	18.5	104.0	27.1	23.4	20.2	13.4	24.1	10.0	10.2	17.5	129.7	156.5	28.4	60.2	9.2	11.8	179.2	165.8	9.0	15.9	9.2	14.5	8.6	170.7	14.0	8.5	7.5	18.3	12.5	10.2	15.3	21.1	10.2	151.1	14.0	20.1	24.2	156.3	9.7	29.4	4.8	15.2	14.7	16.1	198.8	24.7	12.0	4.7	12.1	18.2	14.7	12.8	8.2	18.0	5.5	10.0	2.1	22.4	24.4	19.7	13.5	6.1	26.1	1.4	4.7	5.7	5.4	16.3	17.6	4.1	11.4	18.5	3.6	27.6	11.0	20.0	5.4	13.0	16.0	8.8	21.4	8.9	9.5	6.9	24.5	12.0	11.3	8.5	10.4	6.8	12.4	5.3	31.8	12.1	3.2	2.7	14.2	6.3	22.6	8.2	6.5	17.2	0.6	4.2	8.5	12.2	7.2	2.3	7.9	2.5	7.8	7.7	6.8	2.0	8.1	28.8	25.3	16.1	24.5	20.8	41.0	18.7	17.2	35.6	43.3	22.4	16.0	4.8	7.9	29.0	13.4	32.1	24.4	135.1	173.7	159.3	190.6	129.7	156.5	179.2	165.8	170.7	151.1	156.3	198.8	5.0	3.2	14.8	22.9	29.1	7.4	9.4	22.1	13.1	6.0	19.8	19.8	15.8	12.8	19.4	7.3	0.0	54.2	6.2	17.9	33.2	5.3	114.9	17.7	12.7	4.6	9.5	19.8	29.4	2.3	24.7	11.2	19.9	8.2	10.8	23.3	6.1	61.1	26.5	11.8	27.8	21.3	24.4	16.0	8.1	163.3	5.9	12.9	17.8	8.4	15.6	9.8	8.2	15.6	76.4	3.3	30.2	10.5	19.7	6.7	80.5	93.8	24.9	6.4	13.1	5.2	9.5	33.1	11.3	30.7	5.4	24.2	12.1	12.4	23.0	16.3
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LHX6	LHX6.1	ENSG00000106852	"LIM homeobox 6"	Q9UPM6	9	122202577-122229626	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 77.2;Endothelial cells: 32.1;Inhibitory neurons: 46.0;Late spermatids: 225.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.2;K-562: 9.8;NB-4: 18.4;PC-3: 12.3;U-87 MG: 9.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 6.5;basal ganglia: 7.1;cerebral cortex: 7.7;hippocampal formation: 7.2;hypothalamus: 2.2"	"HPA047854, HPA058319"	Approved		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA047854: AB_2680183, HPA058319: "	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.72e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.14e-2)"	"unprognostic (5.64e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	15.9	0.8	10.7	1.9	7.1	0.0	11.8	0.0	6.8	4.5	0.0	3.5	1.1	3.5	0.6	2.1	3.5	2.8	5.9	6.5	9.7	1.6	0.2	3.6	1.0	0.0	0.0	2.0	1.1	0.9	0.3	2.7	0.0	2.5	1.3	0.1	2.3	0.8	2.3	2.7	3.4	3.3	0.2	0.1	2.2	5.6	1.3	0.7	3.3	2.8	1.0	5.6	4.0	3.1	2.7	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	13.2	3.3	0.0	2.8	0.0	1.1	0.0	1.4	3.6	0.0	0.0	2.1	0.1	1.0	0.6	0.0	2.5	0.6	0.0	0.8	0.0	0.2	0.0	4.7	0.7	9.8	0.0	0.0	2.8	0.0	18.4	2.8	0.4	12.3	0.0	6.2	0.0	2.2	0.0	1.9	0.4	3.3	1.0	3.3	0.5	2.7	0.0	0.8	0.8	1.3	0.0	0.2	0.3	0.2	0.2	9.6	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	7.1	0.0	6.8	6.5	9.7	0.0	0.0	0.0	0.2	1.3	3.1	13.7	0.0	0.0	0.7	0.0	0.1	0.2	3.6	1.8	0.0	1.3	1.5	2.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.2	0.2	0.1	32.1	0.0	2.7	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	46.0	0.0	0.0	0.3	0.3	225.9	1.2	0.1	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.9	2.5	6.7	0.5	0.3	0.0	0.0	0.1	0.0	0.2
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.2;ovary: 9.2"	"Group enriched"	"Detected in some"	6	"Leydig cells: 157.5;Peritubular cells: 50.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 17.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 272.7"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.3;midbrain: 17.3;thalamus: 12.2"	"Group enriched"	"Detected in many"	5	"midbrain: 16.8;pons: 6.7;thalamus: 14.5"	HPA009695	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.1	0.0	2.5	0.0	0.4	0.0	0.0	0.6	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	4.1	0.0	0.4	1.4	0.0	1.8	17.2	9.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	15.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	27.4	4.3	7.2	0.6	0.0	0.0	0.0	0.1	272.7	0.1	0.0	6.7	0.0	2.3	0.0	0.5	0.0	7.6	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.6	0.1	8.1	7.7	3.1	0.0	0.0	0.0	0.0	6.7	0.0	2.4	1.3	11.7	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.6	0.7	0.6	4.1	1.8	17.2	2.5	0.6	15.4	1.4	0.0	3.2	15.4	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.1	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	157.5	0.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.5	2.5	0.9	0.0	0.0	0.1	0.1	0.1	0.2	0.1
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF interleukin 6 family cytokine"	P15018	22	30240453-30246759	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.7;urinary bladder: 91.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 95.5;Club cells: 56.3;Endometrial ciliated cells: 71.7;Fibroblasts: 51.9;Glandular and luminal cells: 192.9;granulocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 88.3;hTEC/SVTERT24-B: 113.0;hTERT-RPE1: 104.4;U-138 MG: 123.9;U-251 MG: 94.5;U-87 MG: 97.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	37.9	4.3	0.6	22.4	0.7	1.6	4.7	0.6	1.7	6.8	6.6	7.5	6.7	11.7	0.6	3.1	9.8	47.7	18.4	0.9	0.8	14.2	5.0	29.9	4.3	1.2	1.3	2.3	13.4	0.4	10.4	2.7	0.9	12.0	8.0	3.0	4.9	2.1	0.8	10.7	9.3	8.3	1.1	1.5	7.8	0.6	2.6	1.3	5.4	1.0	1.7	91.0	2.4	1.1	29.0	47.9	1.3	10.6	0.0	3.9	17.1	4.1	17.2	5.1	12.1	7.7	47.3	0.0	10.1	0.2	88.3	7.3	1.1	13.1	6.9	6.8	2.1	3.7	19.7	10.9	4.5	0.1	36.7	4.3	2.5	113.0	3.3	104.4	0.0	0.2	0.8	0.1	22.6	21.5	0.6	0.1	1.8	27.0	29.5	0.9	15.9	0.0	40.7	11.0	0.2	0.6	4.9	0.4	8.8	5.0	1.0	0.5	0.3	123.9	45.3	47.3	94.5	0.0	0.2	0.1	97.4	0.1	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.6	1.7	0.9	0.8	1.2	1.3	0.9	1.1	2.6	1.1	0.6	22.4	44.2	0.3	0.0	3.4	14.0	95.5	0.0	0.1	40.0	10.9	0.2	10.0	56.3	5.5	0.0	0.2	2.9	3.9	0.0	39.6	0.3	71.7	16.2	3.6	0.0	0.0	0.0	3.4	0.7	51.9	0.5	192.9	67.0	0.2	0.0	0.0	1.1	0.0	0.0	3.5	10.2	0.6	3.2	0.0	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	40.3	3.8	0.0	0.4	15.7	5.3	1.0	15.6	0.2	0.0	17.7	30.2	0.1	0.2	1.5	2.8	0.3	5.5	0.1	7.1	20.3
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	2.8	3.2	3.3	9.0	3.2	34.5	3.6	3.6	3.5	5.5	2.3	6.8	8.6	4.0	2.5	7.4	5.9	2.3	1.6	2.9	3.2	2.9	4.0	3.4	15.6	4.4	2.9	6.0	7.0	4.2	4.8	5.1	4.5	4.0	4.2	2.7	4.8	3.0	3.8	10.4	9.6	2.2	2.6	6.0	5.2	8.2	3.1	20.7	5.1	1.0	9.7	3.5	5.0	3.9	43.4	64.1	57.1	37.6	2.6	4.2	41.7	27.0	19.1	44.1	47.2	35.0	42.9	83.7	15.3	11.2	11.9	30.1	24.7	26.7	16.9	45.2	48.8	56.4	38.7	47.5	1.0	63.0	43.7	5.7	2.5	23.0	3.4	5.0	24.0	51.0	46.3	29.8	23.3	44.0	107.3	123.7	33.6	46.7	15.9	84.1	48.4	43.6	12.3	64.8	36.3	36.5	32.3	33.6	10.1	12.5	22.7	44.5	22.6	31.7	54.3	23.9	40.3	29.3	49.0	83.1	12.7	38.0	33.3	0.0	1.6	2.6	7.8	6.8	7.7	10.9	8.8	8.3	1.6	10.0	11.5	8.2	1.3	12.1	3.3	1.5	10.9	5.7	3.3	3.2	3.6	3.5	2.9	3.2	4.4	2.9	4.5	2.6	3.1	3.9	3.9	3.2	13.6	5.9	16.1	8.3	9.5	8.7	24.5	21.5	7.8	12.3	3.9	7.2	10.3	3.7	10.4	31.1	9.6	10.2	7.9	5.8	19.3	12.0	5.1	8.3	0.0	36.2	4.2	5.2	35.8	6.8	5.1	8.3	6.3	23.1	5.0	5.3	16.4	8.4	5.6	10.0	6.1	3.5	6.8	8.5	2.1	6.6	3.6	3.7	7.2	10.9	11.3	3.5	8.4	3.0	4.4	1.9	23.0	2.8	7.6	4.7	19.5	11.3	13.1	4.5	6.5	13.5	26.1	15.9	9.1	10.0	13.9	6.0	15.3	8.7
LIG3	"LIG2, LIG3alpha"	ENSG00000005156	"DNA ligase 3"	P49916	17	34980512-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	4.9	6.4	3.2	7.3	3.3	7.1	8.7	3.8	4.4	7.9	4.7	8.2	5.9	12.5	6.4	8.9	11.9	5.3	7.6	3.4	1.9	6.6	6.3	5.2	7.2	2.2	2.0	11.5	8.7	13.7	6.6	8.3	1.8	11.1	9.0	7.2	10.6	9.0	10.6	8.4	6.7	10.2	1.0	7.6	6.6	21.1	2.1	13.9	10.1	9.3	8.5	8.9	7.2	3.1	16.6	32.6	38.3	33.9	7.4	9.3	29.2	15.7	11.4	20.9	20.8	15.8	8.8	27.0	12.7	20.6	20.5	15.2	43.9	20.3	26.7	12.8	29.4	28.4	14.6	23.2	11.7	44.9	48.1	7.0	17.5	15.5	24.0	10.3	25.6	40.8	45.3	30.2	15.2	18.6	56.7	14.1	36.8	20.6	13.7	30.4	35.2	28.6	10.2	17.7	31.2	22.3	23.6	19.0	15.2	55.9	34.5	22.3	12.3	13.5	16.8	16.8	25.6	27.0	31.5	35.1	9.7	20.9	26.5	0.6	3.4	4.2	4.6	5.1	6.7	3.7	3.1	4.1	8.4	3.0	4.1	3.0	0.3	9.3	2.8	4.9	2.1	3.9	3.2	3.3	3.8	4.4	3.4	1.9	2.2	2.0	1.8	1.0	2.1	3.1	7.6	3.2	10.3	1.6	8.0	5.0	10.5	3.6	12.0	18.2	10.0	7.5	10.1	10.0	9.2	12.9	16.7	14.6	11.9	7.0	9.8	6.7	41.8	18.5	11.9	8.5	6.7	8.2	5.0	6.0	17.8	7.3	16.8	15.8	9.5	16.7	3.6	8.9	7.9	16.8	5.2	7.9	8.2	5.3	2.7	80.0	7.2	6.7	3.6	2.8	6.4	7.6	16.5	4.0	5.8	3.6	7.5	7.9	15.4	11.6	6.8	6.5	5.3	17.7	6.6	11.8	7.0	32.7	13.2	11.2	5.3	21.6	8.9	10.8	9.5	10.2
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	7.2	8.3	6.3	8.6	6.5	3.9	5.6	6.1	9.0	4.0	8.7	5.7	7.2	4.4	8.5	4.2	4.5	6.8	6.7	7.1	10.2	8.2	12.0	6.9	11.0	6.8	6.6	5.8	3.8	11.3	5.2	5.8	6.8	5.6	6.6	23.1	4.6	5.2	7.1	5.3	7.0	6.6	6.1	8.3	7.8	9.8	7.1	21.8	7.7	6.5	8.3	6.9	2.3	7.9	15.5	5.8	15.3	10.2	12.4	13.3	5.4	14.9	11.2	11.2	13.3	6.9	6.7	26.0	11.9	9.8	13.7	6.3	10.2	9.9	19.2	15.4	9.8	12.3	13.8	3.6	14.8	16.6	12.5	12.3	16.3	10.8	9.6	10.7	13.5	47.0	4.4	4.7	17.4	8.3	27.7	12.1	3.9	12.6	3.6	25.1	6.0	4.2	14.6	9.7	9.6	9.9	3.3	9.0	11.7	11.7	7.7	25.4	20.1	6.6	7.2	7.5	13.5	12.4	8.7	41.7	25.4	9.4	15.2	0.6	1.6	4.8	1.1	2.5	1.6	1.6	1.2	1.2	1.4	2.2	1.2	1.7	2.2	1.9	8.3	1.0	1.8	1.0	6.3	6.5	6.1	9.0	7.1	10.2	6.8	6.6	6.8	6.1	7.1	7.9	5.6	9.6	9.5	13.4	9.2	2.7	2.8	4.9	3.4	10.7	4.9	2.8	11.6	1.5	10.0	1.8	8.4	2.3	7.3	7.9	9.8	5.3	11.6	8.3	5.7	4.3	9.6	0.4	16.6	7.5	1.0	4.2	7.7	6.0	3.8	3.6	4.6	9.8	5.8	18.5	16.1	5.3	2.0	7.5	3.9	5.1	2.8	7.4	1.8	10.3	9.3	7.3	4.1	13.6	24.9	8.9	6.3	6.0	6.2	2.5	3.5	6.3	21.9	13.6	13.1	4.6	3.8	19.1	4.4	4.0	5.7	1.8	4.1	8.7	2.9	3.7
LILRA4	"CD85g, ILT7"	ENSG00000239961	"Leukocyte immunoglobulin like receptor A4"	P59901	19	54333185-54339162	"CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	26	"dendritic cells: 336.0"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 176.1"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 176.1"	"Not detected"	"Not detected"											HPA049418	Approved					NA	NA		12000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049418: AB_2680756"	"unprognostic (5.11e-2)"	"unprognostic (1.21e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.28e-7)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.86e-2)"	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.7	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.4	10.9	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	1.1	3.9	0.0	0.0	0.0	0.4	0.0	176.1	0.0	1.1	0.2	0.3	0.4	0.3	0.2	0.3	0.8	0.4	0.7	0.4	0.6	0.8	0.0	0.0	0.6	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	336.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.0	1.6	0.0	0.0	5.9	0.0	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.1
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.7;lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 76.9;Hofbauer cells: 127.6;Kupffer cells: 118.9;Macrophages: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 37.3"	"Group enriched"	"Detected in many"	44	"dendritic cells: 37.3;monocytes: 10.8"	"Cell line enriched"	"Detected in some"	32	"Karpas-707: 407.8"									HPA052807	Approved					NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA052807: AB_2681958"	"unprognostic (4.09e-2)"	"unprognostic (5.75e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	8.6	4.6	2.2	10.9	2.5	2.0	3.6	2.7	4.2	1.1	2.2	4.1	1.6	0.9	0.3	1.0	4.0	1.7	2.3	2.2	2.8	2.2	2.9	13.7	11.4	3.8	3.2	0.7	1.6	0.1	2.2	1.4	3.5	1.9	2.3	0.1	3.6	0.3	0.5	0.5	6.3	0.7	3.2	18.8	1.7	0.3	3.0	0.6	2.4	0.0	2.1	6.1	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.4	12.8	0.0	0.2	0.0	0.4	0.0	7.8	0.0	0.0	10.8	0.0	0.2	0.0	0.0	11.7	0.5	0.0	0.0	0.1	0.1	8.9	37.3	0.0	3.8	2.2	2.5	2.7	4.2	2.2	2.8	3.8	3.2	3.5	3.2	3.0	3.3	0.6	0.0	4.1	0.0	13.4	0.4	0.0	0.0	0.0	0.2	0.3	1.7	1.0	1.5	1.3	0.0	0.0	0.3	76.9	0.1	0.0	0.0	0.2	0.0	0.0	4.2	0.0	7.8	0.1	0.0	0.9	0.5	0.0	0.0	1.3	0.0	2.2	0.8	127.6	0.0	0.2	0.0	0.0	118.9	12.6	0.6	0.0	104.0	1.8	14.0	29.3	0.2	1.0	0.0	0.0	0.1	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.2	6.6	0.2	0.1	0.0	0.4	0.1	0.1	0.8	2.2	0.0	0.2	0.1
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249421-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.9;lymphoid tissue: 49.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 61.1;Kupffer cells: 103.4;Macrophages: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012069	Approved					NA	NA		58000000	"Cluster 17: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	17.9	10.3	0.2	1.7	0.5	0.9	7.2	0.3	1.0	1.6	1.3	6.1	4.6	1.1	0.8	1.8	4.4	2.8	5.1	0.2	0.2	1.6	7.1	5.3	1.8	0.5	0.3	1.3	0.8	0.3	0.7	4.8	0.4	0.6	4.8	0.1	2.9	0.6	1.8	2.3	6.8	2.4	0.2	49.1	2.5	1.1	1.0	1.0	1.4	1.3	0.7	4.2	1.2	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.3	1.0	0.2	0.2	0.5	0.3	0.4	0.2	1.0	1.1	0.5	0.0	1.1	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	1.7	0.0	0.1	0.2	0.0	2.7	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.1	8.6	0.9	61.1	0.0	0.0	0.0	0.0	103.4	9.8	1.8	0.0	40.1	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	0.1	0.3	1.1	0.8	0.4	0.5	0.0	0.0
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 553.9;Basal prostatic cells: 646.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 523.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		90000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	122.2	47.1	11.9	39.9	13.6	4.2	89.4	40.3	16.4	63.3	12.3	125.6	112.1	56.8	33.2	37.1	47.9	69.3	31.9	11.7	13.1	48.7	20.7	62.5	32.6	15.4	13.8	38.6	31.1	31.0	24.0	50.6	17.3	45.7	130.5	32.2	47.2	42.2	21.9	47.3	121.8	48.6	13.3	40.8	96.8	16.2	13.1	38.1	33.3	28.3	33.8	96.7	53.2	16.3	154.3	4.5	47.2	69.7	211.9	211.0	177.7	377.2	264.4	296.9	235.8	57.7	220.2	6.8	34.1	523.4	99.7	170.8	42.8	348.7	258.1	98.1	45.1	64.2	16.2	20.5	135.3	23.2	87.5	142.2	100.8	104.6	297.8	89.0	106.2	28.3	45.6	30.3	96.9	26.5	29.0	7.1	24.3	81.0	20.5	28.7	115.2	2.4	68.7	180.3	35.2	75.4	51.5	102.7	166.6	50.0	49.0	14.1	166.7	126.5	98.0	118.4	62.1	16.5	2.0	28.0	137.6	25.3	55.6	0.2	0.2	1.5	6.6	1.1	2.6	0.2	8.2	8.1	4.9	0.6	3.3	6.0	0.1	5.9	2.7	1.2	15.3	3.0	11.9	13.6	40.3	16.4	11.7	13.1	15.4	13.8	17.3	13.3	13.1	16.3	123.2	44.8	91.2	13.4	4.8	553.9	646.1	175.4	283.4	14.6	62.2	73.0	7.3	61.5	179.1	119.5	160.6	128.1	15.5	413.7	15.6	145.6	67.1	75.7	183.9	91.8	122.8	17.5	12.9	307.6	376.9	170.9	126.9	132.6	24.7	15.9	117.8	19.8	34.4	6.7	30.1	138.0	187.2	11.7	59.3	11.7	75.5	19.3	90.7	41.2	9.9	22.7	28.8	78.9	48.4	219.0	244.5	77.5	6.9	221.6	214.8	22.3	67.8	95.4	65.7	54.9	118.0	30.8	10.4	100.0	291.5	64.0	33.3	62.4	244.3	385.1
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 203.9;tongue: 277.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 650.7;Excitatory neurons: 434.8;Inhibitory neurons: 551.3;Oligodendrocytes: 1102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 1.3"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 106.2;HeLa: 180.0;hTERT-RPE1: 146.9;RT4: 181.0;SiHa: 102.5;WM-115: 144.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA		5600	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	42.6	36.4	70.3	4.9	111.3	0.2	22.0	92.2	88.0	11.4	13.5	9.2	4.5	6.4	5.8	17.2	17.3	21.7	96.2	68.6	82.1	29.0	11.8	121.5	2.4	93.9	103.9	35.6	10.5	71.7	16.2	9.5	98.6	55.5	7.4	35.7	72.4	24.7	203.9	12.2	7.2	10.3	90.8	107.8	10.0	9.5	88.8	7.3	41.1	277.5	3.3	25.3	7.6	135.4	2.4	26.7	40.3	2.7	0.1	0.1	3.9	33.9	17.1	33.2	16.7	4.1	10.5	0.1	106.2	90.5	1.0	18.8	23.1	15.6	37.2	0.2	3.1	0.1	180.0	0.2	33.4	0.0	0.2	0.6	44.5	0.0	10.3	146.9	3.3	0.0	0.0	0.1	9.6	14.9	0.1	0.1	2.8	5.8	2.9	0.0	49.2	0.7	27.9	181.0	37.9	76.8	102.5	40.2	0.6	32.2	3.0	0.2	0.1	0.4	38.6	9.3	26.0	0.1	0.1	0.3	2.6	0.0	144.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	111.3	92.2	88.0	68.6	82.1	93.9	103.9	98.6	90.8	88.8	135.4	101.4	650.7	211.5	205.3	0.8	39.0	50.9	5.9	33.6	32.1	80.0	32.3	242.4	28.6	90.1	95.6	37.5	16.4	0.4	4.8	21.5	40.3	107.7	31.0	10.6	77.6	9.6	0.0	434.8	14.0	45.7	51.8	16.3	44.3	5.1	13.8	128.5	11.5	13.0	0.0	551.3	11.7	6.1	13.3	30.9	29.0	1.8	5.2	14.2	121.8	19.5	82.6	0.0	64.8	1102.9	5.5	9.3	7.5	0.3	103.3	4.4	10.6	75.7	69.7	0.0	37.5	12.9	5.0	15.6	25.2	30.5	46.1	2.8	67.9	5.5	52.8
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686341	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA		8100	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	7.1	3.8	4.3	7.8	4.7	6.0	5.4	3.5	4.8	5.4	9.5	7.3	7.1	6.6	4.6	5.6	6.1	7.2	9.7	3.5	3.8	3.7	11.1	17.1	10.6	8.3	5.4	4.1	10.2	9.0	2.8	6.4	6.6	6.2	7.5	2.8	9.8	4.8	17.4	6.5	7.9	5.5	4.7	10.8	8.2	2.5	6.9	8.0	12.2	8.6	8.6	6.0	4.8	6.9	13.3	24.7	8.8	11.9	7.6	14.7	17.7	12.4	17.0	12.7	11.0	11.7	6.8	1.7	8.1	11.4	26.1	8.8	18.8	10.0	10.5	28.1	11.7	14.7	20.5	9.7	7.7	13.3	18.2	6.2	8.3	19.1	10.0	9.2	11.3	14.7	12.4	40.0	12.6	8.7	16.2	8.3	14.2	10.4	23.7	7.9	10.3	20.2	6.8	23.3	4.1	8.0	10.5	18.8	12.4	9.0	11.4	11.8	20.7	14.3	12.9	14.5	13.4	38.1	52.7	6.5	30.9	11.7	16.0	3.8	0.9	1.1	1.0	2.0	0.6	2.4	0.8	0.8	0.9	4.0	0.8	0.8	1.0	0.7	4.0	5.8	0.8	0.8	4.3	4.7	3.5	4.8	3.5	3.8	8.3	5.4	6.6	4.7	6.9	6.9	5.0	38.5	27.4	17.6	17.8	2.9	5.7	4.3	4.0	1.6	5.2	3.8	16.5	21.5	12.4	7.3	2.1	6.4	23.9	8.0	1.9	7.2	1.2	7.9	10.2	5.9	6.7	10.3	1.4	5.3	12.8	9.0	9.7	10.7	3.8	11.1	9.7	22.9	17.1	6.7	3.6	15.9	10.2	17.0	10.1	0.9	11.8	13.5	5.4	18.7	11.1	4.8	12.3	74.4	22.5	6.2	6.9	3.4	9.7	9.1	5.9	2.9	11.9	1.5	6.6	8.2	15.2	1.0	3.5	4.1	2.3	5.3	7.9	2.5	9.6	5.4
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695888-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.1;lymphoid tissue: 222.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 436.9;dendritic cells: 306.6;Kupffer cells: 216.1;monocytes: 188.2;NK-cells: 510.9;T-cells: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 243.0;NB-4: 171.7;SH-SY5Y: 163.3;THP-1: 127.6;U-698: 260.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	12.5	7.9	26.2	106.9	31.3	112.1	8.2	18.8	35.4	12.1	19.1	11.2	13.6	7.8	2.0	6.4	8.9	17.5	9.8	29.9	22.6	17.3	10.4	24.8	222.2	22.9	22.1	7.1	7.1	3.3	10.7	15.5	22.3	16.3	9.4	1.0	12.9	5.5	3.1	6.7	61.0	9.1	21.8	170.8	20.5	14.0	22.8	111.3	9.3	3.4	149.8	20.3	8.2	23.7	0.8	7.7	92.9	22.9	0.8	2.4	2.3	2.6	1.4	9.4	6.4	4.2	1.9	243.0	20.5	11.6	9.4	3.9	20.4	0.9	2.6	84.3	8.7	72.4	1.8	20.6	17.6	95.2	7.6	22.8	1.0	9.6	0.3	11.0	25.5	16.5	6.7	13.8	10.7	1.3	84.7	171.7	50.3	0.0	4.4	34.6	37.4	43.6	13.1	1.0	111.2	163.3	11.8	0.2	22.2	23.9	0.6	127.6	32.2	12.8	28.1	0.7	3.4	2.9	1.0	260.4	1.4	13.3	22.7	2144.2	601.8	1434.7	368.9	716.3	364.8	688.5	512.2	432.9	609.8	855.0	679.3	496.3	1248.9	553.2	783.9	230.5	664.2	991.4	26.2	31.3	18.8	35.4	29.9	22.6	22.9	22.1	22.3	21.8	22.8	23.7	11.0	0.0	4.6	0.7	436.9	7.5	7.7	20.5	2.2	1.9	5.0	7.2	1.0	4.3	8.6	11.0	4.2	1.6	306.6	1.1	5.9	20.5	18.8	2.3	14.2	23.6	22.2	99.2	18.7	8.9	3.6	10.1	5.6	4.2	53.3	15.7	30.4	2.0	137.6	3.3	2.2	2.1	26.4	216.1	93.9	57.5	3.4	148.0	37.4	12.2	188.2	8.4	510.9	3.5	2.9	19.8	4.7	4.9	154.3	17.7	0.4	3.7	2.4	1.1	6.6	2.9	30.5	7.8	7.5	1.1	6.0	1.5	264.3	4.7	2.5	4.3
LIME1	"dJ583P15.4, FLJ20406, LIME"	ENSG00000203896	"Lck interacting transmembrane adaptor 1"	Q9H400	20	63736283-63739103	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 242.8"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 210.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 314.8;MAIT T-cell: 285.2;memory CD4 T-cell: 437.6;memory CD8 T-cell: 412.5;naive CD4 T-cell: 289.4;naive CD8 T-cell: 319.4;plasmacytoid DC: 749.3;T-reg: 689.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 749.3;T-cells: 689.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.9;MOLT-4: 37.9;RPMI-8226: 144.4;U-266/70: 71.1"	"Low region specificity"	"Detected in many"							CAB015363	Approved				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB015363: AB_629890"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (5.04e-5)"	"unprognostic (2.39e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.92e-6)"	8.9	5.6	2.2	5.6	5.6	4.7	5.8	2.6	7.0	8.8	0.8	11.8	2.2	5.9	0.0	11.2	6.8	0.0	5.1	2.9	1.4	54.5	242.8	9.0	10.7	2.8	1.8	9.6	5.1	0.1	11.3	0.1	2.5	13.4	0.3	0.0	12.5	0.4	3.9	13.2	18.7	0.0	1.0	43.2	18.3	5.9	3.5	6.1	11.2	0.0	1.2	7.6	9.2	4.8	2.0	0.6	0.1	0.4	0.0	0.0	4.9	2.6	0.2	0.3	0.0	1.1	2.1	5.7	3.8	0.1	0.0	5.1	0.0	0.3	0.3	2.5	4.8	1.1	2.3	25.4	0.0	1.5	2.1	0.2	0.7	0.0	0.0	0.0	0.0	16.4	2.1	33.9	0.0	1.1	37.9	10.7	2.0	1.3	6.6	25.9	0.8	144.4	0.4	0.3	2.0	2.9	1.3	1.3	2.8	0.0	1.1	0.8	0.5	1.8	2.8	1.9	1.5	71.1	3.0	12.7	1.5	1.1	0.7	1.9	1.5	1.8	314.8	1.0	285.2	76.4	437.6	412.5	2.4	37.2	289.4	319.4	10.6	85.5	1.7	749.3	689.4	193.8	2.2	5.6	2.6	7.0	2.9	1.4	2.8	1.8	2.5	1.0	3.5	4.8	0.0	0.0	0.0	21.5	7.2	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	7.7	0.0	0.0	0.3	22.4	0.0	0.0	0.0	0.4	3.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.6	0.1	0.0	0.0	9.0	9.6	0.0	0.0	0.0	210.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.8	0.1	0.0	36.7	0.0	0.1	0.0
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 379.6;Macrophages: 405.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.5"									"HPA058455, HPA061230"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	41.0	45.0	7.0	33.8	10.4	32.9	28.9	9.4	8.4	22.7	10.8	22.1	16.7	35.8	11.6	26.9	31.5	31.2	38.0	6.9	11.4	16.7	20.1	37.0	37.9	12.9	11.0	20.5	15.0	12.0	8.0	32.2	12.8	19.5	18.0	11.5	17.6	26.7	99.1	14.2	20.0	35.8	11.3	21.0	22.2	16.8	15.0	21.4	24.8	35.8	32.8	30.0	17.6	15.9	44.7	49.0	19.0	22.8	30.8	44.5	91.6	49.0	56.0	37.1	37.6	85.3	93.7	43.1	145.4	63.0	55.0	28.3	29.0	50.2	49.3	106.7	52.0	225.6	32.1	45.8	70.4	42.7	402.5	43.5	45.5	98.3	80.3	44.2	135.9	37.3	81.0	58.2	115.4	36.5	41.4	31.4	37.5	29.0	49.6	52.2	65.9	35.0	70.2	79.5	34.3	46.3	76.6	32.5	34.5	25.0	16.8	39.6	184.2	166.6	75.6	37.5	101.2	56.4	81.6	60.6	139.3	47.6	43.6	211.9	69.6	196.2	16.6	119.3	30.5	18.7	72.3	22.4	59.4	18.0	19.2	7.3	31.6	35.9	156.2	7.7	89.0	140.3	7.0	10.4	9.4	8.4	6.9	11.4	12.9	11.0	12.8	11.3	15.0	15.9	143.5	99.3	55.6	80.6	43.2	74.1	63.0	65.1	63.7	26.2	34.9	37.0	61.6	38.6	53.4	29.5	54.2	45.1	40.6	19.2	39.2	80.9	22.5	266.8	122.9	187.6	118.1	84.5	32.6	233.5	130.3	109.4	32.6	379.6	101.4	107.0	76.1	34.6	189.0	15.2	34.6	24.0	48.8	181.1	265.4	12.0	81.4	405.4	44.4	115.2	118.5	69.2	41.2	54.3	66.8	122.3	17.2	88.0	76.3	82.1	33.5	44.0	84.8	18.8	65.7	116.2	161.2	45.4	51.1	75.2	77.0	27.9	82.4	51.3	32.4	66.4
LIMS2	"PINCH-2, PINCH2"	ENSG00000072163	"LIM zinc finger domain containing 2"	Q7Z4I7	2	127638381-127681786	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 510.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.4;Cardiomyocytes: 91.7;Endothelial cells: 105.1;Granulosa cells: 134.1;Hepatic stellate cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 22.5"	"Group enriched"	"Detected in many"	13	"B-cells: 22.5;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 27.0;fHDF/TERT166: 31.2;HHSteC: 32.7;MOLT-4: 40.2;TIME: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058340	Enhanced		Supported	"Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Focal adhesion sites"		"HPA058340: AB_2683683"	"unprognostic (2.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.53e-7)"	"unprognostic (3.98e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.86e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.00e-2)"	104.6	21.6	29.4	17.9	27.9	0.4	93.9	24.9	32.3	104.4	25.1	510.1	15.8	261.4	16.9	42.1	139.5	25.7	266.4	25.6	24.1	72.7	46.6	114.3	12.9	28.7	27.2	29.0	14.1	6.4	15.6	27.7	29.3	132.1	15.2	0.6	27.1	98.8	33.4	32.8	95.7	81.9	24.3	121.8	123.1	12.0	32.2	13.1	51.6	26.8	5.4	220.5	85.1	24.0	0.8	1.6	0.5	0.0	4.6	1.0	0.3	19.1	27.0	20.2	18.1	4.7	0.1	0.1	10.3	31.2	1.1	0.1	0.3	0.0	4.2	0.0	0.8	0.0	11.9	3.6	32.7	0.0	0.0	0.2	0.0	7.0	0.2	10.7	12.9	15.3	0.0	0.0	10.0	0.0	40.2	1.0	1.3	0.0	2.4	9.0	1.7	1.0	1.3	0.0	0.1	0.2	3.0	1.7	0.7	6.7	0.7	0.0	83.7	0.1	12.9	15.2	0.1	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.3	0.0	15.2	5.3	1.1	0.2	22.5	10.7	4.4	0.3	0.0	0.2	1.2	8.0	2.5	29.4	27.9	24.9	32.3	25.6	24.1	28.7	27.2	29.3	24.3	32.2	24.0	109.4	22.4	6.1	0.3	10.1	9.4	0.3	0.2	1.2	0.2	1.9	17.1	91.7	4.3	1.3	0.0	0.0	0.6	0.8	0.1	0.0	1.2	1.3	2.9	5.3	105.1	0.0	5.7	0.4	0.2	12.4	22.5	1.1	0.9	2.5	134.1	134.6	16.3	1.0	0.0	0.3	0.0	0.0	6.5	13.0	3.1	19.9	1.7	10.6	30.9	0.0	0.3	0.0	4.0	0.3	0.5	0.0	49.7	1.7	0.3	0.0	0.5	0.8	0.9	26.3	4.2	35.4	0.8	2.1	0.6	6.7	1.0	2.3	1.8	0.0	0.3
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 6.5;fallopian tube: 6.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Distal tubular cells: 1.9;Exocrine glandular cells: 1.2;NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.1;HMC-1: 41.3"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	1.7	0.2	2.6	0.2	0.4	0.7	0.2	0.4	1.3	0.2	0.5	0.7	6.5	1.7	1.6	6.4	1.3	1.9	0.2	0.3	2.8	0.2	0.5	0.6	0.4	0.3	2.3	0.9	0.5	0.6	1.5	0.4	0.5	1.2	0.4	1.0	1.0	5.7	0.2	0.8	1.5	0.2	0.5	0.7	1.2	0.3	1.0	0.6	2.0	0.4	1.7	0.3	0.5	0.1	0.1	1.8	2.1	0.7	0.6	0.0	2.2	0.0	0.4	0.9	2.2	0.0	0.0	6.5	0.4	4.2	1.2	0.0	2.6	1.8	3.5	0.0	14.1	0.6	1.3	1.9	2.5	41.3	3.0	1.5	1.6	1.9	0.0	3.5	0.0	3.0	2.3	4.6	0.1	0.0	0.3	2.2	1.4	0.8	2.6	4.4	1.5	1.2	2.2	0.6	5.0	5.7	0.0	1.2	0.1	0.0	0.7	10.4	8.8	8.1	4.6	0.4	0.0	0.0	2.8	1.2	0.0	2.6	5.6	3.2	12.3	0.7	5.4	1.4	0.6	4.7	1.5	2.4	0.2	0.8	0.3	0.6	1.2	5.7	0.2	6.1	8.5	0.2	0.2	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1
LIMS4	LIMS3L	ENSG00000256671	"LIM zinc finger domain containing 4"	P0CW20	2	110446640-110473075	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 1.5;Glandular and luminal cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.0;hTEC/SVTERT24-B: 1.8;HUVEC TERT2: 1.0;U-138 MG: 1.9"									HPA058455	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA					"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.12e-1)"								0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410817-26429728	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 5.2"	"Group enriched"	"Detected in some"	43	"Early spermatids: 35.2;Late spermatids: 69.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 861.2;SuSa: 300.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.1	0.3	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	5.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.3	0.5	0.0	0.0	62.7	0.1	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	861.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	300.9	27.2	0.2	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	69.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.1	0.4	1.2	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.2
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 65.4"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	0.4	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.3	65.4	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	3.2	49.1	10.0	0.0	0.0	252.1	0.1	0.0	0.0	0.0	16.6	0.1	0.1	0.0	0.1	3.0	0.1	31.2	0.0	0.0	0.0	24.1	36.6	0.0	44.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.9	1.2	0.0	0.0	5.6	6.2	44.8	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.1	11.6	0.1	0.3	4.0	44.5	0.0	10.6	1.0	0.1	5.3	0.2	0.1	14.8	22.6	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.8	0.0	1.3	0.6	0.7	0.4	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	6.2	75.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	8.3	0.0	0.0	40.2	0.0	83.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	9.7	1.7	5.7	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.6	0.0	0.0	6.3	9.9	0.0	0.0	55.8	0.0	0.0	0.0	0.0
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	10.1	9.9	21.5	6.7	22.2	9.7	9.1	22.5	26.9	13.0	18.9	11.1	9.2	11.2	7.7	7.0	10.8	6.9	12.6	21.6	22.4	7.4	7.6	7.5	9.6	21.1	21.4	15.9	8.5	9.2	11.0	11.7	21.6	8.9	5.0	8.6	7.9	8.4	15.7	10.4	7.9	8.2	20.5	8.6	7.9	9.0	22.2	9.7	7.8	12.7	7.5	9.5	8.9	21.7	13.7	29.7	11.4	15.5	18.4	14.4	12.0	14.4	15.7	22.8	24.6	9.8	6.3	7.8	16.3	17.1	15.3	6.9	8.2	12.1	8.8	26.5	11.6	10.0	14.6	15.0	42.2	8.0	22.6	13.4	22.1	20.4	34.9	15.0	16.9	20.8	10.4	15.1	16.5	27.6	13.3	11.0	3.2	22.4	12.9	5.9	7.5	8.4	15.1	6.4	9.8	11.2	13.5	26.7	12.5	9.1	11.1	17.0	16.4	17.2	10.1	16.8	18.3	22.3	19.0	7.3	18.3	12.0	12.9	16.8	7.9	26.4	18.3	8.6	17.2	19.6	19.8	21.4	9.0	18.8	20.6	18.7	32.0	18.4	8.1	18.8	22.2	13.7	21.5	22.2	22.5	26.9	21.6	22.4	21.1	21.4	21.6	20.5	22.2	21.7	2.0	0.0	1.1	2.9	5.0	3.8	0.7	2.5	8.0	1.5	2.2	1.4	0.1	1.5	0.8	3.7	2.1	4.2	1.9	2.8	3.9	1.5	5.5	1.0	1.0	2.0	1.2	4.8	5.9	1.2	3.4	3.3	5.6	0.7	4.5	1.0	1.1	1.0	1.9	1.7	5.6	0.7	2.0	3.1	4.4	5.8	4.1	3.2	5.4	0.0	2.6	1.0	3.1	3.5	4.3	2.8	2.8	3.4	7.3	0.7	9.8	3.2	1.3	2.4	6.6	1.5	3.0	9.2	2.3	6.4	5.4	11.5	5.6	1.0	1.3	0.3
LIN52	C14orf46	ENSG00000205659	"Lin-52 DREAM MuvB core complex component"	Q52LA3	14	74084796-74201235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000900, HPA001777"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA000900: AB_2135058, HPA001777: AB_2666431"	"unprognostic (2.34e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.90e-3)"	"prognostic favorable (6.60e-4)"	"prognostic unfavorable (6.08e-5)"	"unprognostic (2.48e-3)"	"unprognostic (9.34e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-1)"	8.0	7.8	8.4	5.4	8.4	3.5	6.3	8.8	10.1	5.8	7.8	4.5	6.5	7.0	5.7	4.9	5.5	4.9	10.2	8.3	10.0	19.3	6.6	5.0	6.1	9.2	8.9	8.5	3.4	6.8	5.7	5.0	9.3	6.4	5.7	10.7	3.9	5.6	5.6	3.8	5.8	6.8	7.9	5.1	4.3	7.5	8.9	10.7	5.1	10.0	6.3	5.8	3.9	8.5	10.5	7.7	26.8	12.8	15.5	6.6	10.5	17.5	16.7	23.0	25.7	14.0	9.6	5.9	5.3	8.6	9.2	9.2	20.4	6.9	35.1	49.1	8.1	9.1	8.9	20.0	16.6	9.4	12.7	8.2	7.7	12.2	15.9	6.3	11.0	18.6	9.7	27.8	11.4	13.4	14.9	12.3	7.7	13.8	12.3	19.0	25.1	9.6	6.0	6.2	19.0	15.5	16.4	12.0	13.7	9.9	16.3	13.5	6.3	10.8	20.3	11.5	14.8	18.2	41.8	13.2	12.5	10.7	18.4	6.2	6.4	20.6	10.7	6.6	16.6	8.7	9.3	10.7	8.6	9.4	13.7	12.5	3.2	11.4	4.8	7.9	13.9	10.1	8.4	8.4	8.8	10.1	8.3	10.0	9.2	8.9	9.3	7.9	8.9	8.5	5.6	9.6	9.0	39.8	10.4	4.8	3.2	3.2	11.4	8.8	7.6	5.3	10.0	10.0	6.6	5.5	8.4	6.3	8.8	3.5	7.9	3.1	0.8	5.9	6.6	7.4	3.0	16.4	47.5	2.4	5.2	8.1	6.1	6.7	2.5	9.0	6.4	12.2	6.3	16.8	65.4	6.0	4.1	4.3	3.7	1.6	5.3	4.5	0.0	26.2	6.6	10.8	10.3	60.3	60.4	2.4	5.0	9.8	27.3	3.3	10.9	22.4	6.2	7.5	6.6	8.1	6.4	16.3	10.4	10.3	5.5	8.8	8.2	3.7	4.7	1.4
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.2;Oligodendrocytes: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA056606: AB_2683187"	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	3.8	3.4	2.6	4.9	4.4	13.1	4.9	5.4	5.1	5.3	0.2	6.0	5.4	4.4	3.8	10.5	3.7	3.9	4.4	2.9	3.2	6.9	8.2	3.9	6.5	4.7	3.5	5.0	2.7	5.9	2.0	6.2	4.2	3.9	6.9	10.0	3.4	4.4	4.4	5.4	4.3	4.5	3.6	4.7	4.5	6.9	3.1	12.8	10.3	5.8	8.6	4.7	3.4	7.8	16.8	9.8	15.1	17.3	7.8	7.5	11.2	26.7	18.5	19.8	18.9	11.7	18.9	18.3	14.4	27.6	13.0	12.9	20.8	8.7	24.1	19.9	9.1	16.8	14.7	13.2	6.8	20.7	117.8	6.3	5.0	21.7	10.4	6.1	12.2	17.0	18.6	35.5	19.4	11.9	44.3	8.6	6.3	20.6	6.5	23.9	16.8	12.8	9.4	14.3	15.7	8.3	16.2	25.7	10.6	9.4	11.2	13.3	9.6	23.6	17.6	22.1	12.2	17.6	14.0	30.6	13.1	12.8	18.9	3.5	2.5	5.5	3.7	2.0	4.2	1.6	3.7	4.2	1.5	2.1	4.6	3.9	5.4	4.7	6.6	1.1	4.7	2.4	2.6	4.4	5.4	5.1	2.9	3.2	4.7	3.5	4.2	3.6	3.1	7.8	7.5	6.4	5.5	10.7	7.2	12.1	3.6	2.4	9.6	8.5	5.5	5.2	6.1	4.3	3.3	5.5	2.1	4.3	8.9	11.3	0.0	3.1	37.2	7.1	6.0	4.9	4.2	15.2	23.4	3.6	4.8	4.9	6.6	12.9	2.5	5.7	5.7	7.5	6.5	5.0	22.1	4.9	2.0	6.3	7.8	14.2	2.5	8.2	8.8	12.2	4.4	7.3	7.2	18.1	60.3	4.0	3.4	4.9	17.2	3.8	4.7	6.2	4.4	8.6	13.1	6.4	6.9	3.1	3.1	14.0	12.5	3.4	9.1	3.5	5.2	8.2
LIN7A	"LIN-7A, MALS-1, TIP-33, VELI1"	ENSG00000111052	"Lin-7 homolog A, crumbs cell polarity complex component"	O14910	12	80792520-80937934	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.9;retina: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.3;Early spermatids: 107.2;Excitatory neurons: 135.5;Inhibitory neurons: 93.1;Late spermatids: 76.9;Spermatocytes: 61.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 18.8;eosinophil: 15.8;neutrophil: 29.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 29.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.3;ASC TERT1: 31.4;HAP1: 25.2;HDLM-2: 29.6;HL-60: 29.1;NB-4: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071562	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071562: AB_2732181"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.63e-11)"	"unprognostic (5.01e-5)"	"unprognostic (7.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	5.0	3.1	5.5	2.4	6.5	27.9	5.4	22.2	8.0	7.9	1.0	1.9	0.5	8.5	0.5	0.9	3.7	4.0	6.3	6.4	6.0	8.7	17.7	5.1	2.6	1.9	6.9	3.7	0.5	0.9	6.0	5.3	3.1	1.8	0.6	26.6	0.8	0.7	1.0	0.7	2.1	4.6	2.3	4.6	1.1	7.1	6.9	0.7	4.2	2.5	1.2	3.9	4.6	3.6	0.0	0.6	5.0	0.0	21.3	31.4	0.0	12.8	5.9	5.1	1.1	9.9	0.0	0.0	0.0	4.9	0.1	0.0	25.2	0.0	1.5	29.6	7.8	0.0	0.2	15.6	2.6	29.1	0.2	7.8	0.0	0.5	0.5	1.2	4.1	0.0	0.0	0.0	2.3	0.3	0.0	27.0	4.7	0.3	0.1	0.0	18.7	0.0	2.9	4.1	10.2	0.0	0.0	0.0	0.1	0.3	1.1	15.5	0.0	4.0	1.5	2.1	0.1	4.4	0.0	0.0	0.4	0.0	0.2	18.8	5.2	15.8	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	29.8	0.0	0.2	0.0	0.1	1.2	5.5	6.5	22.2	8.0	6.4	6.0	1.9	6.9	3.1	2.3	6.9	3.6	4.8	22.4	5.8	18.6	0.0	0.8	4.8	0.0	0.0	77.3	10.8	3.4	22.8	8.6	0.6	25.8	2.1	0.4	0.2	0.3	9.8	1.3	107.2	1.9	8.9	1.9	1.8	0.4	135.5	0.2	0.1	4.9	0.0	3.5	0.0	0.1	1.8	21.5	2.5	30.3	93.1	0.5	0.0	5.2	0.7	76.9	4.7	4.2	0.0	9.4	6.5	42.6	0.0	23.1	2.7	0.0	1.2	1.5	0.4	2.0	20.1	26.5	0.7	11.2	13.1	5.0	19.2	61.3	1.3	0.0	0.4	0.7	0.6	3.5	1.1	1.8
LIN7C	"FLJ11215, LIN-7-C, LIN-7C, MALS-3, VELI3"	ENSG00000148943	"Lin-7 homolog C, crumbs cell polarity complex component"	Q9NUP9	11	27494418-27506769	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051118	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA051118: AB_2681347"	"unprognostic (1.46e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.57e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.09e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.51e-2)"	9.1	10.7	8.9	7.8	8.9	15.8	8.7	29.7	12.0	7.5	9.1	9.4	11.3	7.9	10.5	10.6	6.4	6.1	5.8	9.7	10.4	12.2	24.1	7.4	7.4	7.5	10.1	8.1	10.2	9.0	6.8	8.2	8.0	9.6	9.6	10.5	9.0	5.8	6.1	11.5	8.9	8.5	9.3	9.2	10.0	4.1	11.5	6.3	14.1	7.3	9.3	7.5	8.0	9.4	9.1	14.0	8.5	15.0	11.6	11.1	12.8	13.5	12.4	12.0	12.7	12.1	5.4	18.6	9.6	17.0	11.4	17.0	12.0	19.3	21.9	15.1	9.9	10.3	27.7	18.8	14.9	21.1	13.3	11.8	18.0	8.2	29.1	15.6	10.7	6.2	16.0	25.1	16.1	9.8	13.5	14.0	12.3	18.5	9.3	7.6	37.2	9.3	16.6	22.3	14.5	11.5	25.9	22.4	11.3	9.4	21.9	11.3	14.7	25.3	19.7	29.7	20.3	14.5	10.2	11.8	20.2	13.6	26.3	17.4	8.1	9.7	5.9	8.6	9.0	6.3	7.0	5.6	7.4	5.7	9.4	7.7	3.3	6.6	9.9	4.3	5.3	7.9	8.9	8.9	29.7	12.0	9.7	10.4	7.5	10.1	8.0	9.3	11.5	9.4	23.8	28.9	13.1	10.7	14.7	41.2	31.5	20.9	21.1	33.1	21.5	16.5	13.4	25.8	21.3	27.6	35.5	16.3	21.8	35.2	33.2	14.1	53.8	21.9	19.2	22.9	48.5	19.3	17.0	20.0	16.1	21.0	25.0	27.3	10.8	23.0	18.2	59.4	18.4	33.7	16.7	38.6	22.4	20.1	24.4	12.9	16.1	17.2	14.2	10.3	16.9	44.6	12.3	10.6	12.6	26.1	25.1	18.4	21.4	44.6	33.7	32.7	15.7	49.0	0.0	27.3	25.7	10.1	10.7	41.5	44.8	19.0	16.6	18.4	33.9	43.7
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.2;Spermatocytes: 36.3;Spermatogonia: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030241	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	1.8	1.6	0.9	2.8	1.0	6.6	3.5	3.5	1.6	1.8	0.6	3.2	4.1	3.2	1.6	3.2	2.4	1.5	12.8	0.9	0.7	2.1	1.4	2.5	5.0	0.6	0.8	5.0	2.0	2.2	0.6	4.0	0.7	2.1	3.9	1.8	2.0	1.9	3.6	3.4	3.9	2.8	0.7	2.6	3.0	9.7	0.7	8.1	2.2	3.5	4.8	1.9	1.7	1.1	15.9	10.0	16.2	11.6	1.5	3.8	31.2	11.4	7.3	20.2	18.1	10.8	20.0	15.0	14.1	5.3	8.9	14.4	15.9	6.1	18.0	14.4	28.1	9.4	12.2	7.7	1.4	18.6	9.7	1.5	4.3	10.5	10.6	4.9	10.0	13.7	33.5	17.8	12.3	5.8	19.5	12.0	26.0	20.1	18.2	18.7	27.5	19.4	6.6	8.2	14.2	19.9	20.3	23.6	14.7	10.0	13.4	23.8	4.8	11.4	16.3	15.7	29.4	8.2	20.2	31.0	6.6	16.7	27.2	4.1	1.0	1.1	1.2	1.3	1.9	2.2	1.9	2.7	0.5	1.6	3.4	2.6	0.2	1.7	2.8	0.6	2.8	1.0	0.9	1.0	3.5	1.6	0.9	0.7	0.6	0.8	0.7	0.7	0.7	1.1	3.1	9.6	5.1	3.3	3.3	3.3	1.4	2.8	3.4	1.2	2.1	2.2	15.7	1.5	2.2	0.0	0.0	13.0	2.8	1.6	1.9	2.3	20.2	2.0	3.4	3.1	2.4	16.4	11.1	3.3	6.9	3.3	2.0	1.6	1.3	4.3	2.2	1.4	2.8	3.3	8.7	2.5	0.0	3.5	1.1	4.0	4.4	1.9	0.0	6.5	0.4	1.9	2.1	10.1	4.7	2.8	3.8	4.5	6.4	1.2	2.0	1.7	3.7	1.0	0.0	3.0	4.5	36.3	18.7	5.1	1.8	15.5	2.8	1.9	4.9	1.5
LINC02203		ENSG00000280709	"Long intergenic non-protein coding RNA 2203"		15	21552795-21653276	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	47	"testis: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-2 OS: 5.2"									HPA057442	Uncertain		Approved	Centrosome		NA	NA					"Cluster 9: U-2 OS - Unknown function"		Centrosome		"HPA057442: AB_2683442"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.5;smooth muscle: 8.8"	"Group enriched"	"Detected in some"	29	"Excitatory neurons: 1591.2;Inhibitory neurons: 988.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.8"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1"	"Low region specificity"	"Detected in all"							"HPA016633, CAB025361"	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.4	0.5	0.0	0.8	0.2	0.0	0.0	3.3	0.6	0.0	0.1	0.0	7.5	0.9	0.0	0.4	0.9	0.0	2.9	3.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.6	1.7	0.0	0.6	0.0	2.4	0.0	1.5	0.0	0.1	0.0	8.8	0.1	0.1	0.6	1.7	0.4	0.2	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	9.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.8	0.0	3.3	2.9	3.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	17.5	0.4	4.6	0.2	1.8	0.0	1591.2	0.0	0.1	1.4	0.0	0.9	1.3	29.6	0.0	0.0	0.2	0.0	988.0	0.0	0.0	0.0	0.0	16.4	0.0	0.1	0.0	43.1	0.1	0.9	5.2	17.6	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.3	2.8	1.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0
LINGO3	"LERN2, LRRN6B"	ENSG00000220008	"Leucine rich repeat and Ig domain containing 3"	P0C6S8	19	2289784-2292024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 34.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 39.5;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 34.1"	"Group enriched"	"Detected in some"	5	"basophil: 1.3;eosinophil: 4.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	5	"HMC-1: 17.4;RPMI-8226: 4.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 59.6"	"Group enriched"	"Detected in many"	8	"basal ganglia: 28.8;cerebellum: 19.6;hippocampal formation: 8.4"	"HPA043781, HPA059558"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA043781: AB_2678668, HPA059558: AB_2684062"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.16e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.03e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	0.3	0.2	4.6	1.2	34.1	1.1	0.2	9.3	14.4	0.2	0.0	0.6	0.2	0.3	0.0	0.3	0.3	0.0	0.1	4.6	1.2	0.2	0.2	0.9	1.1	5.1	1.8	0.1	0.2	0.0	0.4	0.0	4.1	0.4	0.0	0.6	0.3	0.0	0.1	0.2	5.0	0.0	2.6	6.3	0.5	0.4	7.6	0.0	0.3	0.0	0.0	0.4	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	2.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	2.4	0.2	0.0	0.1	1.7	0.0	4.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	4.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.3	0.0	4.6	34.1	9.3	14.4	4.6	1.2	5.1	1.8	4.1	2.6	7.6	2.7	0.0	0.0	0.0	1.6	3.1	0.1	0.0	0.0	0.0	39.5	0.2	0.6	0.7	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.4	5.1	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	3.3	3.0	0.0	0.0	2.2	0.6	0.0	0.0	0.8	0.0	1.9	1.3	0.1	5.2	17.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	1.0	0.0	0.2	0.0
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151805419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 21.3;tongue: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4"	"Region enriched"	"Detected in many"	7	"spinal cord: 19.7"	HPA060781	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 80: Striated muscle - Unknown function"		"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.0	0.1	0.1	0.1	0.0	0.1	4.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.7	0.1	0.7	0.3	0.5	0.3	1.1	0.2	0.2	2.8	1.6	0.0	0.4	0.5	1.4	0.0	3.9	0.7	0.1	0.1	0.6	0.2	21.3	0.6	0.2	0.0	1.3	0.1	0.4	0.6	1.6	1.2	0.6	5.6	0.2	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.2	0.3	0.5	2.8	1.6	3.9	1.3	1.6	2.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
LINS1	"LINS, MRT27, WINS1"	ENSG00000140471	"Lines homolog 1"	Q8NG48	15	100559369-100603230	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038578, HPA038579"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA038578: AB_2676095, HPA038579: AB_10697393"	"unprognostic (9.87e-2)"	"unprognostic (3.32e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.28e-2)"	4.2	4.1	2.5	8.3	2.2	5.7	7.7	3.1	3.3	7.2	2.8	5.8	4.1	6.6	9.4	7.0	5.4	4.4	3.1	2.4	1.7	6.0	5.5	6.2	11.5	1.6	1.4	6.4	5.4	6.1	3.5	6.4	1.8	6.1	7.0	6.6	5.1	4.6	4.3	6.9	4.5	6.2	1.1	8.4	6.3	7.6	2.3	9.1	8.4	5.1	10.0	5.8	4.9	2.8	4.4	6.6	8.2	8.2	5.9	8.0	7.5	6.8	7.6	7.6	8.1	6.2	8.4	11.6	3.9	6.2	5.7	18.5	7.8	8.6	7.9	4.0	11.1	10.4	10.7	4.9	4.9	8.9	6.3	7.7	7.4	5.9	9.4	7.6	9.0	6.4	17.3	9.1	4.7	5.7	5.3	7.6	9.6	16.7	8.1	7.8	13.1	10.8	6.6	11.8	4.2	5.5	6.3	6.1	10.2	10.4	10.3	6.7	6.5	9.5	8.5	6.8	8.9	9.7	13.4	10.5	6.1	11.4	7.7	12.4	7.9	11.7	16.3	7.5	23.9	12.7	25.7	18.1	8.4	11.9	35.0	25.1	10.4	15.0	6.7	6.8	17.6	10.5	2.5	2.2	3.1	3.3	2.4	1.7	1.6	1.4	1.8	1.1	2.3	2.8	7.7	19.2	5.9	0.0	16.6	0.0	9.7	0.0	11.4	16.1	11.3	8.3	0.0	5.7	2.5	12.9	18.8	8.8	20.4	4.9	5.9	5.9	10.8	6.6	11.4	5.7	4.9	11.6	0.0	5.1	5.5	7.2	15.3	6.3	1.3	10.3	7.1	7.6	15.3	16.8	0.0	5.8	0.0	6.0	0.0	1.7	12.2	6.9	0.0	0.0	7.9	9.3	26.8	0.0	0.0	5.4	3.2	7.2	12.5	9.0	10.5	4.7	7.3	16.0	13.1	8.5	5.8	20.7	12.9	9.9	0.0	12.4	29.8	18.9	4.8	7.5
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401514-42427388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 834.5;breast: 524.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 76.1;Early spermatids: 127.8;Late spermatids: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	834.5	45.1	22.7	7.7	71.7	5.0	524.7	77.2	41.5	5.1	0.6	10.9	5.3	6.4	1.2	8.6	5.8	3.7	32.5	23.8	42.6	7.7	1.5	3.7	7.3	100.3	73.9	4.9	6.2	4.7	6.9	2.9	90.0	7.1	1.4	2.0	17.2	2.6	19.7	23.6	24.4	2.6	44.0	14.4	8.5	68.6	57.1	6.9	9.6	23.3	3.7	14.2	7.7	116.9	12.7	9.6	6.0	2.3	136.8	1.3	0.1	5.8	3.1	9.2	8.5	2.3	4.6	20.6	6.3	1.8	4.5	5.6	3.7	11.5	1.0	4.0	6.1	5.8	5.3	0.2	2.7	0.1	13.9	1.2	10.7	1.5	2.1	1.3	2.6	8.5	2.7	12.8	1.2	0.1	14.8	0.5	0.8	9.7	2.7	12.2	1.1	6.9	2.6	13.1	8.5	8.8	5.1	5.7	5.6	0.3	1.5	7.5	4.7	2.5	7.8	1.1	5.3	9.7	8.5	15.6	6.3	0.7	8.7	11.0	8.6	3.8	2.5	4.7	2.3	3.4	3.2	3.7	3.6	4.5	2.8	2.5	1.5	3.6	2.7	2.9	3.0	3.1	22.7	71.7	77.2	41.5	23.8	42.6	100.3	73.9	90.0	44.0	57.1	116.9	76.1	0.0	3.3	4.2	8.1	4.1	12.1	2.4	4.6	11.0	4.8	2.9	2.5	0.0	2.0	1.8	10.4	0.1	4.8	1.3	1.9	8.0	127.8	0.9	3.4	10.2	0.0	5.3	4.6	2.7	0.1	2.0	3.6	1.5	0.0	6.6	17.9	0.0	0.6	8.4	6.7	2.0	6.1	2.2	2.4	236.5	3.1	0.8	5.4	4.7	0.9	4.0	6.2	6.0	37.9	1.8	0.7	1.5	3.0	6.7	18.4	1.5	0.8	13.9	0.0	7.2	2.1	39.4	13.1	2.5	2.4	0.0	5.1	5.2	2.9	10.7
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 37213.5"	"Cell type enriched"	"Detected in some"	444	"Gastric mucus-secreting cells: 1509.7"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				6.3	2.8	0.0	0.0	0.0	0.0	4.6	0.1	0.0	3.9	0.0	13.0	262.0	1.9	0.0	117.9	5.4	0.0	3.2	0.0	0.0	11.4	4.9	7.3	0.0	0.3	0.1	2.2	4.5	0.0	7.3	0.5	0.1	6.7	0.0	0.0	2.6	0.0	1.6	2.0	1.9	0.0	0.0	2.6	37213.5	2.9	0.0	0.0	1.3	0.0	0.1	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	3.4	0.0	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1509.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 149.3;thyroid gland: 242.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Extravillous trophoblasts: 67.9;Glandular and luminal cells: 49.0;Hepatocytes: 78.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 122.6;HaCaT: 189.8;RPTEC TERT1: 122.4;TIME: 247.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	810000		"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	4.6	0.2	0.9	16.3	0.6	0.3	1.0	4.0	2.6	0.9	1.7	5.9	6.4	1.4	2.9	1.3	0.5	14.0	1.2	3.2	0.7	6.7	34.7	7.2	1.8	2.8	2.8	0.2	1.9	0.2	0.4	149.3	1.6	1.5	7.2	4.9	0.5	20.9	2.5	1.4	7.2	7.7	1.4	0.4	1.7	7.0	3.7	1.9	242.5	0.1	1.7	14.4	0.6	1.2	2.2	0.3	53.6	122.6	0.5	0.1	0.9	0.6	5.8	0.0	0.1	54.5	19.6	0.2	29.7	0.0	37.2	189.8	8.1	39.0	0.0	0.6	0.3	0.1	0.2	0.3	8.1	0.1	0.8	5.4	43.0	19.1	36.8	0.3	28.0	0.2	0.3	0.3	0.0	0.0	0.0	0.2	8.1	1.4	0.5	0.1	0.0	3.0	122.4	14.8	0.8	0.1	1.0	1.4	0.1	6.9	0.2	0.2	247.4	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	4.0	2.6	3.2	0.7	2.8	2.8	1.6	1.4	3.7	1.2	0.3	0.0	1.1	0.7	0.3	1.8	5.6	3.3	0.0	0.6	2.8	1.9	1.8	24.3	3.5	14.7	60.5	5.5	0.1	9.3	0.0	3.3	8.4	19.1	8.3	7.9	13.8	0.0	0.2	1.4	67.9	6.0	2.6	49.0	0.0	11.5	5.3	78.2	1.8	0.0	0.3	5.3	2.0	1.9	0.0	8.1	0.3	0.8	1.8	2.8	0.7	1.1	0.0	1.0	0.2	12.8	2.7	0.0	0.3	10.6	10.1	1.3	0.5	2.9	0.0	1.0	2.0	1.4	0.9	0.4	2.6	19.4	1.1	0.1	11.2	11.4
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552588	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.7;stomach 1: 48.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 144.2;Club cells: 135.5;Distal enterocytes: 312.3;Gastric mucus-secreting cells: 236.5;Intestinal goblet cells: 139.8;Proximal enterocytes: 226.1;Urothelial cells: 158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 74.1;OE19: 17.2;RPTEC TERT1: 36.7;T-47d: 17.6;U-266/84: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049079	Approved				"Secreted to blood"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favorable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.3	0.3	2.8	0.6	0.1	3.8	0.1	0.6	2.8	6.9	36.3	11.1	0.2	7.1	14.7	1.1	12.3	0.4	0.4	1.6	7.8	0.4	18.3	0.1	0.1	0.1	0.5	5.5	0.0	0.3	0.1	0.1	6.8	37.7	0.2	13.2	2.0	0.5	7.4	11.8	0.6	0.0	0.4	48.2	2.7	0.2	0.3	0.2	0.1	3.0	12.2	4.3	0.1	10.3	13.5	0.1	0.1	0.0	0.2	2.9	0.3	0.0	0.3	0.3	1.3	74.1	0.0	7.5	0.2	2.9	3.6	5.6	0.1	0.4	0.1	1.6	1.8	1.8	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	5.4	0.1	0.0	1.3	0.5	0.1	0.7	17.2	1.1	0.0	0.0	1.0	36.7	9.2	0.0	0.0	1.1	12.2	0.3	0.6	17.6	0.3	0.0	0.1	1.1	0.1	0.2	1.2	18.9	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.6	0.4	1.6	0.1	0.1	0.1	0.0	0.2	0.1	0.1	144.2	38.5	2.0	0.8	0.8	16.3	76.5	0.6	0.7	55.6	12.7	0.4	94.4	135.5	68.0	0.0	0.2	1.0	312.3	1.9	57.8	0.2	7.0	0.5	1.8	22.2	0.0	1.7	24.9	0.1	1.1	236.5	5.7	7.0	36.0	1.1	0.3	0.0	0.0	0.9	139.8	38.7	0.3	0.3	0.1	0.0	2.4	16.0	0.0	0.8	0.3	2.1	2.5	0.4	60.4	102.7	0.0	0.3	72.8	226.1	1.6	105.6	0.9	0.0	0.1	5.5	1.1	0.3	6.9	2.0	0.3	0.8	12.0	102.1	158.0
LIPJ	"bA425M17.2, LIPL1"	ENSG00000204022	"Lipase family member J"	Q5W064	10	88586753-88606976	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"testis: 7.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 67.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048594	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA048594: AB_2680456"	"unprognostic (4.79e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.90e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.21e-4)"	"unprognostic (9.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.88e-1)"	0.2	0.0	0.2	0.1	0.2	0.0	0.2	1.0	0.3	0.1	0.3	0.1	0.3	0.1	0.9	0.0	0.7	0.1	0.1	0.3	0.3	0.2	0.5	0.1	0.3	1.2	0.5	0.1	0.4	0.0	0.1	0.0	0.5	0.3	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.4	0.1	0.2	7.0	0.3	0.4	0.6	0.0	0.3	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.0	0.3	0.3	0.3	1.2	0.5	0.5	0.4	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	67.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.0	0.6	0.0	9.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LIPT1	"MGC12290, MGC13378"	ENSG00000144182	"Lipoyltransferase 1"	Q9Y234	2	99154955-99163157	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 41.0;Spermatocytes: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034802	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA034802: AB_10669851"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (9.60e-8)"	7.1	7.8	6.7	6.8	7.5	12.3	10.9	7.4	8.3	8.1	6.3	6.7	8.4	8.1	14.1	5.1	8.1	6.5	8.5	6.9	7.8	11.2	8.1	5.7	10.7	7.2	7.1	11.8	7.3	6.3	6.7	4.9	7.2	9.2	7.3	7.5	8.9	6.0	9.1	7.0	8.4	5.6	7.2	11.9	6.9	13.5	7.2	5.3	11.3	8.9	7.4	6.3	5.6	10.4	6.2	4.0	5.4	9.2	9.3	11.0	13.0	4.0	4.7	3.1	3.4	9.8	10.3	9.9	8.4	2.4	8.4	5.4	6.6	5.0	6.1	10.6	12.0	10.3	5.1	8.7	9.9	7.0	5.1	6.5	8.0	5.6	12.7	6.3	8.8	11.4	10.0	5.8	5.4	5.0	6.9	13.4	13.8	6.0	9.9	11.7	5.8	10.4	10.1	9.2	5.2	5.0	5.6	6.2	14.8	9.8	6.6	14.2	6.4	4.6	6.4	4.1	3.8	9.1	12.9	10.7	4.8	11.4	6.7	15.4	10.3	16.1	16.8	9.6	20.9	14.2	18.9	18.5	5.6	12.4	23.6	19.9	2.7	18.4	9.5	5.6	12.3	11.6	6.7	7.5	7.4	8.3	6.9	7.8	7.2	7.1	7.2	7.2	7.2	10.4	9.3	3.2	6.7	6.5	7.5	3.6	10.8	14.5	6.2	5.2	3.9	7.9	6.6	2.8	8.5	12.9	2.1	7.6	9.7	3.3	13.7	5.1	41.0	3.6	6.5	7.8	6.1	3.2	5.3	3.4	4.3	7.2	3.1	3.4	5.1	8.3	12.8	2.2	7.2	11.8	5.5	6.1	6.1	7.9	2.2	25.4	9.6	4.6	1.8	1.9	8.5	12.1	18.6	9.5	14.3	3.4	6.9	7.5	2.7	5.6	15.9	11.8	9.0	10.6	6.6	13.1	5.8	40.6	12.8	3.0	4.3	5.3	8.9	5.0	6.2	6.2
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74490519-74493724	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040249	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	1.3	2.0	1.8	1.6	2.0	2.1	2.4	1.8	1.8	1.5	1.2	2.1	3.7	1.6	3.2	1.8	3.2	1.9	1.5	1.6	1.8	4.6	3.1	1.7	2.2	2.4	1.9	3.4	2.9	2.1	2.1	2.1	2.4	1.8	2.3	1.9	2.1	2.7	8.0	1.6	3.6	0.6	1.8	2.1	3.5	12.3	2.8	2.7	3.0	7.1	2.2	1.7	1.2	3.3	2.1	3.3	6.6	3.1	2.1	0.4	6.9	0.8	1.5	3.3	2.3	9.8	3.0	11.5	4.0	0.6	8.0	3.2	2.8	1.9	1.2	2.2	2.6	4.0	3.2	2.9	2.9	4.4	5.0	1.4	2.2	2.2	2.2	1.5	0.2	12.7	3.0	4.1	1.3	4.0	6.6	6.1	4.9	13.0	2.6	4.3	7.0	3.7	2.6	7.3	5.5	3.6	5.6	2.0	8.1	6.2	5.6	3.2	0.6	1.0	2.1	1.5	1.8	5.7	5.8	9.3	0.6	2.7	2.9	0.1	4.7	7.5	5.5	3.0	7.6	10.6	7.3	6.6	5.3	10.5	13.3	10.9	1.1	8.4	3.4	6.3	3.7	4.8	1.8	2.0	1.8	1.8	1.6	1.8	2.4	1.9	2.4	1.8	2.8	3.3	0.6	0.0	0.0	1.0	2.5	0.8	1.1	2.9	4.0	0.9	1.7	1.9	1.1	2.8	1.4	3.7	0.0	13.2	0.7	0.9	5.9	2.6	55.4	1.5	0.7	1.0	0.0	4.0	0.3	4.4	14.1	1.4	2.0	1.1	0.0	1.9	2.2	4.2	5.4	3.3	0.2	3.1	4.1	1.3	0.0	29.4	1.8	2.3	1.8	0.0	0.7	9.8	2.1	0.5	1.1	2.8	0.5	1.2	0.8	1.0	4.3	17.7	1.9	1.6	0.0	1.3	0.9	46.7	10.7	2.9	0.6	8.1	1.4	3.0	3.1	0.3
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LLGL1	"DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1"	ENSG00000131899	"LLGL scribble cell polarity complex component 1"	Q15334	17	18225635-18244875	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022924	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 58: T-cells - T-cell receptor"			"HPA022924: AB_1852926"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (7.71e-2)"	"unprognostic (3.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.40e-2)"	7.8	15.6	17.3	2.9	28.1	2.0	7.6	27.9	21.2	13.2	7.5	9.4	1.8	14.2	1.9	16.3	9.6	3.2	7.1	16.0	18.4	5.7	2.3	5.3	3.4	32.2	24.5	12.0	4.9	2.9	9.5	4.5	29.6	7.5	1.1	1.4	8.5	3.2	10.4	11.2	6.5	2.9	25.5	6.9	6.8	10.9	25.1	3.4	5.5	2.4	2.3	9.7	11.1	45.8	18.3	11.7	29.0	28.2	11.0	9.9	12.0	8.0	12.7	15.4	13.7	26.4	3.5	11.1	13.5	7.0	8.6	16.4	8.6	10.6	4.6	18.3	23.3	5.1	8.7	9.5	5.2	1.9	11.1	12.4	5.7	7.9	3.7	11.7	9.9	13.8	3.8	2.4	6.1	13.1	13.4	3.1	12.3	8.8	6.5	16.7	20.7	6.1	4.6	6.7	7.6	16.3	9.7	4.5	7.7	24.8	5.4	3.1	14.0	12.2	15.3	16.2	12.5	3.6	2.7	3.5	24.1	4.8	10.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	17.3	28.1	27.9	21.2	16.0	18.4	32.2	24.5	29.6	25.5	25.1	45.8	2.6	0.0	1.7	2.3	1.5	2.7	1.1	3.2	3.4	1.7	4.2	3.2	2.2	2.8	1.9	3.7	0.0	2.3	3.0	1.5	0.0	5.4	8.6	0.9	2.7	2.8	3.6	1.7	0.8	4.4	6.5	5.1	3.1	1.2	0.0	2.2	2.2	1.2	2.8	5.0	0.9	2.2	10.2	1.9	1.1	1.8	6.8	1.4	1.8	0.0	1.1	4.0	1.0	0.0	7.9	7.1	0.7	7.9	2.8	1.7	0.6	2.0	2.6	2.2	0.0	3.7	3.7	4.6	8.2	6.5	3.0	2.1	3.8	0.9	2.7	2.6
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL scribble cell polarity complex component 2"	Q6P1M3	17	75525080-75575209	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favorable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	3.9	7.8	2.7	14.2	6.0	4.6	9.0	6.2	3.6	16.3	9.5	64.5	54.5	4.1	24.0	55.5	14.9	21.3	3.4	2.1	4.1	56.7	26.9	27.6	5.1	6.0	5.9	4.9	74.5	17.3	11.2	6.3	6.2	14.7	28.4	10.4	43.4	12.5	1.3	34.1	55.4	1.9	4.0	24.5	64.2	6.9	4.5	2.3	17.8	0.9	5.7	9.6	25.9	9.8	60.1	54.7	0.3	10.4	0.0	0.0	22.7	0.4	0.6	1.1	0.6	92.6	134.2	4.0	13.6	0.2	5.0	73.7	10.1	10.1	0.2	5.1	18.1	4.0	16.1	35.1	0.6	0.6	8.5	0.0	13.6	0.2	2.1	1.3	2.0	5.8	7.9	5.4	0.0	132.1	3.5	7.1	7.4	101.6	21.2	6.9	0.2	14.9	28.4	92.9	22.1	4.5	11.8	127.5	4.0	12.2	96.6	9.4	0.5	0.2	0.6	0.2	1.0	6.4	9.3	1.8	0.4	0.3	2.7	0.0	0.1	0.1	3.1	0.3	0.7	0.3	0.7	2.1	0.1	0.3	0.1	1.2	0.1	2.1	0.1	1.1	0.5	0.4	2.7	6.0	6.2	3.6	2.1	4.1	6.0	5.9	6.2	4.0	4.5	9.8	7.7	89.8	51.6	3.6	9.0	10.6	34.7	17.3	12.0	15.5	28.8	20.1	3.8	74.4	40.5	90.1	166.8	3.7	44.7	297.5	31.3	84.1	0.6	88.7	7.2	9.0	95.1	0.8	1.1	138.9	8.5	3.5	158.5	87.7	22.2	7.2	4.6	25.0	6.0	8.4	0.8	113.0	32.6	3.8	6.0	1.0	4.7	4.7	3.6	5.6	5.5	28.1	50.4	0.5	49.9	249.4	159.8	4.1	16.1	37.6	84.5	47.0	53.9	117.5	6.6	1.3	6.4	1.5	18.9	27.5	21.7	4.4	21.8	7.5	136.1	89.7
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359265	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA		18000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Endoplasmic reticulum"	"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	36.0	43.3	14.8	39.4	16.4	21.7	43.8	16.9	19.4	66.0	20.1	34.1	45.7	46.1	52.9	31.1	48.8	31.9	42.6	13.8	19.4	64.5	181.1	33.6	28.4	17.1	16.0	43.3	53.1	74.3	32.7	54.8	17.4	58.4	39.3	40.0	69.0	43.7	33.3	20.3	49.1	37.7	16.2	27.4	59.3	21.2	16.0	32.1	86.5	41.1	34.8	40.1	21.2	20.4	90.6	52.7	55.1	46.4	125.6	215.6	110.7	159.6	227.9	105.7	140.5	52.7	85.2	16.0	110.7	191.0	75.7	108.1	79.0	90.5	191.0	61.7	50.4	52.5	65.4	109.5	148.9	183.6	77.0	144.7	106.8	102.5	208.1	198.1	108.1	54.3	89.7	173.6	104.2	24.5	53.5	37.9	37.8	45.8	64.5	60.0	100.1	176.0	58.9	67.6	37.5	40.9	80.6	78.0	91.6	76.8	57.8	70.8	89.8	170.5	59.9	55.2	94.0	131.6	71.3	76.2	179.1	96.0	142.6	6.0	2.5	0.7	7.3	3.7	10.0	7.1	7.9	7.7	3.5	5.1	7.5	7.7	0.3	10.0	2.1	8.8	9.6	4.0	14.8	16.4	16.9	19.4	13.8	19.4	17.1	16.0	17.4	16.2	16.0	20.4	120.0	102.5	97.1	15.0	104.0	69.8	120.3	213.5	84.8	39.2	104.5	97.2	134.6	71.4	171.2	80.9	106.3	149.3	86.7	32.8	21.5	130.6	28.1	117.5	203.7	97.7	51.6	49.6	17.2	84.6	304.8	162.4	106.0	200.7	33.6	96.9	75.0	394.0	80.2	58.9	22.1	181.4	107.8	41.9	40.1	10.3	110.6	52.5	67.6	22.5	53.5	76.8	54.6	20.1	33.5	71.6	45.5	85.4	502.1	214.1	95.5	75.6	164.7	66.7	65.7	95.4	142.3	47.2	65.1	80.7	57.0	231.2	69.5	149.6	89.7	129.5
LMAN2	"C5orf8, GP36B, VIP36"	ENSG00000169223	"Lectin, mannose binding 2"	Q12907	5	177331567-177351668	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 530.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003927	Approved					NA	NA		88000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003927: AB_1079257"	"unprognostic (5.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-3)"	"unprognostic (4.56e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (4.43e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.32e-1)"	72.0	79.5	40.1	63.2	43.5	77.6	65.3	42.4	49.3	76.7	62.6	77.0	91.4	74.0	136.1	147.1	70.3	57.0	74.7	44.5	43.0	85.5	207.8	78.8	66.2	45.2	41.5	69.6	155.9	49.9	60.8	72.6	43.1	64.7	40.1	14.7	117.9	48.7	50.6	64.6	81.2	36.2	41.7	86.9	82.4	93.5	46.4	54.8	97.2	29.2	42.7	67.0	73.1	43.6	108.6	196.4	57.3	317.9	201.5	76.2	298.0	122.1	120.8	105.6	132.9	326.2	254.0	115.9	286.2	162.7	196.3	163.9	69.6	242.9	39.6	556.7	166.6	73.9	136.7	196.5	196.2	155.4	210.7	140.5	94.2	106.0	94.8	118.3	142.3	100.3	90.8	452.0	79.3	318.5	115.8	268.3	82.7	159.7	174.8	132.4	97.6	404.9	99.5	122.6	94.9	105.4	113.3	191.9	205.0	51.9	150.4	349.5	145.5	168.2	108.0	89.2	182.7	252.0	200.8	114.8	234.5	217.8	186.6	569.9	411.8	476.9	408.9	379.2	349.7	252.1	295.6	342.9	358.8	256.6	241.0	280.7	552.6	364.8	346.1	500.9	350.2	828.4	40.1	43.5	42.4	49.3	44.5	43.0	45.2	41.5	43.1	41.7	46.4	43.6	82.7	57.7	74.5	12.1	114.8	57.0	147.9	384.3	47.8	33.2	100.9	74.4	44.6	124.4	229.9	108.5	16.7	312.7	147.4	168.3	52.8	233.2	103.8	87.2	99.5	99.5	58.9	71.8	7.0	237.3	444.4	120.4	70.8	131.2	77.4	97.2	81.8	223.4	240.4	55.5	8.3	190.0	266.5	105.0	85.3	28.2	88.0	107.4	120.9	13.1	116.4	89.0	162.7	13.0	9.7	226.1	130.9	63.9	388.4	146.1	186.1	111.9	151.9	46.5	65.7	70.8	108.9	275.8	192.0	134.1	69.9	530.3	112.5	111.8	160.6	165.6
LMAN2L	"DKFZp564L2423, VIPL"	ENSG00000114988	"Lectin, mannose binding 2 like"	Q9H0V9	2	96705929-96740064	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026600	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA026600: AB_1852939"	"unprognostic (3.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.29e-1)"	10.1	11.0	16.5	4.9	17.4	1.3	12.2	16.6	20.0	15.8	15.9	14.4	5.6	13.8	17.2	9.5	17.1	6.7	19.2	16.6	21.9	17.9	18.1	9.8	5.9	18.1	17.7	21.1	11.9	13.7	17.3	11.6	17.9	15.0	10.6	7.7	10.9	13.6	16.7	11.0	8.2	15.6	16.7	8.6	10.8	11.2	22.9	9.1	15.5	19.1	7.1	13.2	12.5	17.2	21.1	33.3	25.6	26.6	31.9	15.1	23.4	19.3	23.9	39.9	43.5	57.4	15.7	10.2	71.4	47.8	99.2	25.1	36.9	30.2	50.2	27.1	20.4	8.9	21.4	49.0	20.1	15.3	14.3	17.4	28.2	30.5	9.6	34.7	23.7	17.2	20.3	20.5	25.5	14.5	11.0	14.5	13.9	14.9	36.0	23.1	21.1	11.6	32.9	10.9	16.2	8.5	21.8	16.6	20.1	46.8	19.8	26.4	17.3	31.8	22.7	25.1	25.9	13.3	46.1	8.6	18.8	18.1	26.3	37.8	17.5	22.4	14.0	10.6	32.0	20.0	16.2	18.9	14.5	16.9	19.6	16.6	9.5	15.9	16.0	20.8	14.8	18.5	16.5	17.4	16.6	20.0	16.6	21.9	18.1	17.7	17.9	16.7	22.9	17.2	4.7	12.8	6.8	12.4	3.2	3.4	5.4	11.1	2.2	3.1	10.5	7.6	12.2	5.7	6.3	12.9	6.2	17.9	5.2	5.4	9.8	13.7	20.6	4.6	6.9	6.1	9.5	6.5	13.4	7.8	10.4	11.8	2.0	5.6	5.1	16.8	9.3	10.7	9.9	1.7	13.4	5.0	0.0	5.6	1.4	18.0	6.8	2.7	3.6	7.5	12.3	12.2	6.2	11.1	11.0	7.5	3.8	8.6	3.1	4.5	4.6	10.1	6.3	5.1	13.1	4.4	8.1	13.3	14.0	2.5	2.7	13.4	4.0	8.6	6.5	2.1
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.7;Inhibitory neurons: 128.7;Microglial cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	10.0	26.0	8.8	8.4	10.4	7.8	10.7	11.3	13.2	13.6	7.8	8.9	8.0	13.2	18.1	9.9	14.1	10.2	11.2	9.7	13.2	15.7	13.8	9.1	9.4	11.0	10.0	16.5	8.8	38.0	7.5	10.1	11.2	12.2	10.3	14.3	8.4	10.7	6.7	8.4	9.3	13.2	8.9	7.6	11.9	17.7	10.6	11.8	17.6	11.4	8.7	11.9	6.0	8.5	26.9	20.6	27.5	33.4	21.1	24.0	16.6	14.5	20.5	14.2	16.8	15.4	42.4	25.3	27.6	19.7	27.3	20.4	28.4	28.9	29.1	19.5	25.5	19.1	11.6	19.7	13.6	23.8	13.6	19.3	27.0	20.4	27.3	22.8	29.6	23.4	35.7	23.8	26.9	24.3	25.1	20.5	29.4	30.4	18.7	13.1	18.1	31.6	22.8	25.1	26.1	51.9	20.4	27.8	15.6	17.8	19.1	14.3	38.4	25.1	9.3	82.7	19.6	25.6	22.6	24.0	40.0	30.2	16.4	1.8	0.7	1.0	0.7	0.4	1.4	0.6	1.2	1.2	1.3	0.8	1.5	1.0	0.6	0.2	0.7	0.9	0.9	0.6	8.8	10.4	11.3	13.2	9.7	13.2	11.0	10.0	11.2	8.9	10.6	8.5	25.6	3.2	8.1	54.5	23.7	10.5	13.7	9.9	43.3	11.5	12.8	8.5	17.1	11.5	7.2	12.9	2.1	14.3	8.4	8.6	5.9	11.0	7.4	17.0	8.6	24.8	8.3	17.4	110.7	10.1	5.6	15.2	23.0	15.7	5.7	43.2	9.3	19.2	10.2	8.4	128.7	9.9	10.2	10.1	8.0	9.7	10.5	9.3	7.2	99.3	8.2	6.7	3.1	72.4	70.4	12.6	6.1	8.6	23.4	20.0	9.7	12.2	9.7	10.9	0.0	11.9	11.0	18.0	28.7	30.9	12.8	23.1	18.0	26.2	11.1	16.6
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098407-36151887	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 71.4;Inhibitory neurons: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	4.6	6.6	4.8	5.0	7.2	1.7	6.1	3.6	9.5	4.7	2.2	6.3	7.0	3.4	4.9	4.7	3.2	4.1	6.0	9.0	4.1	7.2	10.3	4.1	5.9	2.1	3.8	3.2	5.0	10.7	4.7	6.1	2.6	6.6	6.3	6.9	6.0	4.4	5.5	5.5	7.1	3.8	3.7	5.1	7.3	3.8	4.7	5.9	9.0	8.6	5.4	4.2	2.9	5.2	5.5	4.0	4.8	7.9	9.7	8.5	16.8	11.1	5.8	8.0	8.0	5.0	11.7	9.8	5.5	5.9	8.2	7.3	6.4	3.9	13.1	14.1	3.9	7.6	13.6	0.9	6.2	9.3	9.7	5.1	6.7	6.9	6.8	6.0	4.4	7.4	9.1	10.0	9.8	3.6	8.0	6.1	2.6	8.5	5.0	6.0	11.1	6.0	6.8	4.7	8.9	6.9	16.1	9.4	3.9	4.7	10.7	11.1	5.9	9.5	2.5	12.3	6.0	8.2	12.8	8.5	9.0	10.4	6.7	10.6	0.8	1.4	1.0	0.8	0.7	1.0	0.9	0.9	0.7	0.8	1.2	1.2	0.6	0.7	0.8	0.8	1.6	0.5	4.8	7.2	3.6	9.5	9.0	4.1	2.1	3.8	2.6	3.7	4.7	5.2	8.8	9.6	9.8	33.3	10.2	6.9	4.8	6.3	7.4	11.9	10.8	6.1	24.1	12.8	7.3	12.9	8.4	9.0	7.5	19.4	3.9	5.0	2.1	6.8	6.4	7.3	6.7	9.0	71.4	7.6	6.6	10.3	15.8	6.5	7.0	7.3	9.3	30.2	11.8	15.2	51.1	12.6	8.2	11.0	6.0	1.4	4.7	8.7	7.2	14.0	9.7	14.3	6.2	36.2	37.8	6.0	6.5	7.2	11.9	6.3	13.0	12.3	12.0	11.2	13.1	10.5	9.7	27.5	10.0	9.7	10.1	19.4	10.0	7.2	12.0	4.0
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMF2	"TMEM112B, TMEM153"	ENSG00000100258	"Lipase maturation factor 2"	Q9BU23	22	50502949-50507702	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 180.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062626	Approved		Approved	Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Centrosome		"HPA062626: AB_2684812"	"unprognostic (2.69e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (8.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.75e-2)"	50.8	43.9	21.2	20.6	21.6	33.6	46.4	21.4	30.0	49.7	33.6	40.4	25.9	43.9	8.3	48.0	42.0	15.2	37.5	21.6	23.9	48.7	56.6	46.8	22.4	25.7	21.6	47.8	180.8	12.9	63.4	18.0	23.6	51.2	5.6	3.7	49.5	20.0	23.7	36.6	51.4	9.3	21.9	60.6	38.0	42.0	21.7	13.1	56.7	7.6	9.4	45.2	44.5	23.9	48.9	36.0	20.1	38.4	28.6	24.4	46.8	85.4	44.5	53.7	60.0	35.9	24.8	21.4	22.6	45.2	23.9	57.3	6.8	27.0	7.4	17.1	74.7	12.0	69.3	38.4	35.8	22.4	45.1	36.0	24.6	36.7	9.0	23.1	30.1	16.5	14.4	70.0	23.7	35.1	15.9	26.4	12.0	12.4	44.4	35.7	32.3	58.9	22.0	26.1	18.0	26.5	58.2	49.8	40.1	9.7	28.6	15.6	44.3	75.3	42.8	54.6	4.3	26.9	9.4	13.1	54.8	13.6	62.9	16.3	17.9	22.4	26.1	23.5	19.6	13.4	21.6	24.4	18.6	8.6	12.3	13.2	16.5	16.7	20.5	33.8	21.2	18.6	21.2	21.6	21.4	30.0	21.6	23.9	25.7	21.6	23.6	21.9	21.7	23.9	42.0	12.8	10.8	13.4	26.4	18.6	17.1	37.5	19.9	15.7	23.1	18.7	11.4	28.6	24.5	14.7	22.9	64.4	43.1	55.6	3.9	37.1	9.4	7.6	21.7	25.7	15.0	22.9	14.9	74.9	106.4	39.9	27.5	17.3	15.8	32.7	27.8	33.6	43.1	11.8	11.6	29.4	18.3	21.6	26.7	20.5	29.2	26.1	24.9	13.1	21.5	23.3	40.2	12.5	10.1	30.8	55.7	25.6	49.9	10.8	74.4	19.3	9.4	16.0	19.7	17.9	29.6	12.6	20.1	29.9	17.3	28.5	34.8	32.0	34.2	15.0
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 39.7;Endometrial ciliated cells: 35.2;Respiratory ciliated cells: 37.5;Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	2.1	2.6	2.7	1.2	3.4	1.2	2.2	3.6	4.7	3.1	4.7	2.1	1.0	2.2	10.7	2.2	4.9	2.6	3.3	2.7	3.7	3.4	2.2	2.5	1.3	4.2	3.3	3.3	3.8	3.8	6.5	2.0	4.5	2.3	2.0	9.7	2.4	3.4	2.4	3.4	1.4	2.0	3.0	1.5	2.0	10.1	4.0	1.1	4.1	2.0	1.2	1.9	2.3	3.2	7.7	2.8	3.3	4.0	6.4	9.0	2.9	3.9	3.6	6.9	5.6	2.8	2.7	2.4	17.7	2.8	14.9	2.8	3.1	3.1	10.0	0.3	2.3	1.4	2.3	2.1	4.0	4.4	2.0	4.3	6.8	8.6	5.5	4.0	3.0	6.0	7.5	4.5	6.7	5.7	2.6	3.8	3.8	5.5	6.7	3.0	0.8	2.6	7.1	2.0	5.4	1.5	5.4	4.8	3.9	3.7	12.5	3.2	6.6	8.4	1.3	10.3	6.7	8.0	16.7	0.7	12.0	7.4	7.8	0.0	0.1	0.1	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.2	0.4	0.5	0.1	0.3	0.2	0.1	0.0	0.2	2.7	3.4	3.6	4.7	2.7	3.7	4.2	3.3	4.5	3.0	4.0	3.2	4.4	16.0	14.8	24.5	1.7	2.0	1.5	2.6	4.0	8.1	6.4	4.8	11.6	2.8	9.2	9.2	16.7	3.6	1.2	2.2	0.0	3.5	39.7	35.2	11.5	3.2	4.8	0.8	25.3	2.7	2.2	5.5	1.5	11.5	2.5	6.3	4.2	3.1	5.0	8.4	23.1	3.6	0.0	1.9	2.3	21.9	4.7	2.3	3.6	9.4	1.1	5.9	1.0	6.6	13.7	2.1	1.0	5.7	2.1	1.8	0.7	3.5	37.5	17.7	0.0	6.6	3.8	33.2	23.6	3.7	1.7	2.9	2.1	10.6	2.8	1.1
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140081	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1533.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 85.1;T-reg: 83.2"	"Group enriched"	"Detected in all"	8	"dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660"	Supported		Supported	"Nuclear speckles"		NA	NA		5700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	280.2	174.8	17.6	64.9	27.1	58.1	231.5	24.1	20.6	221.7	33.0	183.3	72.8	271.4	14.5	256.2	173.8	92.1	221.7	15.8	23.1	120.9	93.2	188.5	18.2	30.3	25.2	178.2	81.8	21.3	76.9	53.0	26.1	125.3	38.2	4.7	176.1	42.8	190.0	364.3	136.8	78.8	21.0	84.1	160.6	61.9	30.9	15.3	147.4	23.8	22.9	168.7	217.6	41.8	518.8	269.7	26.2	72.4	119.5	238.7	169.4	607.3	379.6	221.3	146.8	68.3	311.9	2.8	338.7	417.9	94.6	515.4	31.4	227.8	70.3	188.6	50.8	175.4	168.4	130.8	124.0	25.7	412.9	133.0	92.0	154.8	134.7	120.2	207.5	0.7	82.8	21.9	205.8	193.1	1.0	67.8	32.1	202.9	706.0	1.6	195.9	137.7	128.9	105.6	33.8	114.9	414.3	154.2	427.4	56.2	230.1	74.2	727.9	241.6	233.0	389.1	393.3	39.5	10.5	4.9	449.2	24.8	760.4	23.9	8.3	0.4	2.8	2.1	2.5	2.4	17.8	7.3	85.1	0.2	0.2	0.7	2.1	3.7	0.2	0.3	83.2	14.6	17.6	27.1	24.1	20.6	15.8	23.1	30.3	25.2	26.1	21.0	30.9	41.8	353.5	262.8	350.0	16.0	179.1	610.5	1235.3	446.2	531.6	7.2	542.5	374.9	94.1	191.6	320.3	161.8	47.9	478.8	239.8	614.1	109.5	429.3	38.6	215.4	209.4	386.0	431.5	70.4	9.9	360.2	387.8	622.1	505.1	270.5	1181.8	145.5	277.7	103.1	343.0	13.5	15.1	601.2	177.0	60.6	1533.4	45.4	288.6	409.0	859.2	10.3	20.4	37.2	3.1	17.1	20.1	513.0	384.1	287.3	331.3	340.6	262.6	125.0	170.5	17.8	203.8	1028.4	766.8	107.4	42.2	404.1	602.4	680.9	472.3	111.6	513.8	942.6
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456959	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 220.2;Extravillous trophoblasts: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	9.7	10.1	8.9	15.3	8.6	17.3	7.7	11.5	9.8	11.9	6.4	13.1	10.9	11.9	2.4	32.1	10.7	3.4	10.6	8.5	10.1	9.5	6.0	11.2	12.8	8.7	9.0	13.4	8.1	3.6	12.3	14.6	8.4	9.8	6.2	3.5	9.1	4.9	14.9	10.6	12.2	5.5	8.0	12.3	10.4	10.9	10.5	23.1	8.7	5.2	10.5	10.0	12.4	8.0	181.5	114.0	80.8	105.7	17.3	27.2	107.5	119.2	57.7	117.7	88.8	152.0	75.6	83.5	47.8	55.9	68.1	185.6	72.4	84.8	60.0	102.4	86.3	66.4	40.3	119.8	20.9	93.5	64.6	24.5	21.4	63.4	49.7	22.0	60.9	76.2	117.8	51.9	56.4	105.4	107.9	51.8	154.0	97.8	98.6	150.1	102.4	70.0	33.7	89.8	118.7	68.8	99.6	65.6	39.6	44.7	65.9	95.7	85.1	112.5	116.6	174.8	180.6	45.6	41.8	83.5	91.3	88.5	148.3	0.0	0.6	0.8	1.0	0.6	1.6	0.4	1.1	1.0	0.8	0.9	1.1	1.3	0.0	0.9	2.1	3.5	0.4	0.6	8.9	8.6	11.5	9.8	8.5	10.1	8.7	9.0	8.4	8.0	10.5	8.0	8.6	3.2	4.2	2.6	9.4	20.6	14.8	7.9	10.2	8.2	8.8	8.1	5.7	2.8	5.3	5.5	8.4	30.4	9.7	17.5	9.8	7.0	220.2	7.7	14.9	12.7	6.0	19.6	3.0	11.8	81.6	14.3	14.3	11.7	4.5	31.4	8.2	2.7	21.2	13.5	3.9	15.1	6.1	6.8	18.2	31.4	9.3	10.3	1.8	3.7	12.2	9.4	11.3	2.0	3.3	12.7	9.1	7.9	25.5	24.4	12.7	4.9	5.7	10.8	13.1	14.3	11.2	8.6	15.0	30.0	20.0	13.8	11.4	12.0	23.1	19.2
LMNTD2	"C11orf35, MGC35138"	ENSG00000185522	"Lamin tail domain containing 2"	Q8IXW0	11	554850-560738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.0;testis: 28.2"	"Group enriched"	"Detected in many"	7	"Early spermatids: 59.7;Late spermatids: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.6;hTERT-RPE1: 21.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058474, HPA073912"	Uncertain		Approved	"Cytoplasmic bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Cytoplasmic bodies"		"HPA058474: AB_2683727, HPA073912: AB_2686642"	"unprognostic (2.20e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (1.33e-3)"	"unprognostic (7.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.02e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.48e-3)"	2.1	2.9	0.3	0.6	1.5	1.6	3.1	2.8	1.6	1.7	0.4	4.6	5.1	1.3	0.0	5.2	4.7	0.2	0.6	0.4	0.3	8.7	24.0	3.2	0.4	0.9	0.5	1.2	8.5	0.0	5.9	0.3	0.7	5.7	0.2	0.4	3.9	0.8	0.4	7.0	5.7	0.2	0.4	5.4	6.5	28.2	0.7	1.3	8.6	0.0	1.1	2.3	2.8	0.1	0.0	2.6	0.6	4.5	0.0	0.0	0.0	0.6	0.3	0.2	0.4	3.8	0.0	2.5	0.0	0.1	1.2	3.4	0.7	1.0	0.1	0.0	0.3	0.6	5.6	2.3	0.4	0.1	1.8	0.4	0.0	0.1	0.1	21.4	0.3	0.6	0.0	2.9	0.0	0.0	0.6	0.0	0.5	2.4	1.2	0.0	0.0	1.5	1.5	0.0	0.3	0.8	0.0	2.5	0.0	4.2	4.9	1.2	0.1	0.4	0.3	0.4	0.4	4.2	1.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	2.8	1.6	0.4	0.3	0.9	0.5	0.7	0.4	0.7	0.1	1.3	0.0	0.0	0.0	4.3	0.0	2.5	0.0	1.8	0.8	4.3	3.4	0.9	10.0	0.0	3.7	0.0	1.8	1.2	2.9	7.9	3.4	59.7	5.0	0.4	0.7	0.0	3.2	0.1	2.2	1.4	0.2	9.2	4.2	0.0	6.1	0.7	5.4	1.2	0.0	0.1	2.5	0.0	1.2	0.0	96.4	2.1	1.1	0.0	2.8	0.9	3.6	2.1	0.0	0.0	3.6	2.7	0.0	0.7	2.0	4.3	2.8	0.0	1.0	0.0	0.1	0.5	1.7	6.3	2.8	0.0	1.0	1.4	4.2	2.8	3.2
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 248.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 1682.7;Urothelial cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	177	"amygdala: 12.6;basal ganglia: 19.9;cerebral cortex: 25.6;hippocampal formation: 14.9;white matter: 15.4"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 343.4;fHDF/TERT166: 568.2;LHCN-M2: 525.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 20.8;basal ganglia: 32.8;cerebral cortex: 26.6;hippocampal formation: 33.8"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		8200	"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	4.4	5.3	12.6	10.6	19.9	4.1	9.3	0.0	25.6	12.8	4.8	47.4	66.3	5.7	12.1	153.7	14.5	43.3	248.8	14.9	0.0	44.1	61.9	178.7	11.0	0.0	0.0	18.6	25.5	11.8	6.4	41.3	0.0	27.3	32.5	4.8	32.4	15.1	143.5	21.1	79.7	7.9	0.0	5.0	62.7	18.2	0.0	56.8	53.5	99.5	37.1	24.5	38.4	15.4	77.8	43.6	1.7	1.3	86.5	61.4	14.9	343.4	168.3	85.4	91.6	107.4	97.8	6.6	25.7	568.2	21.2	73.5	18.9	16.6	97.8	105.4	4.5	47.8	229.2	102.2	25.0	15.3	24.0	42.0	31.1	37.0	42.3	207.9	36.2	14.7	1.7	0.5	525.9	30.4	11.6	6.4	2.2	119.6	65.0	7.2	159.5	1.6	36.0	18.1	5.4	11.6	62.2	10.8	13.8	8.6	14.0	11.3	55.6	208.7	38.7	25.4	84.9	22.6	18.4	27.8	61.6	17.0	97.0	4.5	0.2	2.7	0.6	0.5	0.9	1.1	3.2	1.0	0.4	2.3	13.6	8.6	0.1	0.6	0.4	1.1	1.4	2.6	12.6	19.9	0.0	25.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	15.4	1.5	1682.7	279.7	22.2	4.3	24.0	74.7	59.9	72.8	6.8	10.5	13.2	362.6	51.5	317.2	62.5	2.1	45.5	3.6	378.5	15.6	81.5	6.2	92.0	19.0	9.0	71.2	3.6	162.3	37.8	8.7	38.0	276.3	244.4	20.3	9.5	6.1	72.7	6.0	6.7	82.5	96.6	67.1	3.5	4.4	8.0	42.0	6.4	16.0	39.4	2.8	1.9	3.1	30.7	48.4	228.8	351.2	42.5	2.1	344.9	213.8	15.5	199.5	10.5	13.1	27.2	18.1	11.2	6.3	100.9	45.3	17.0	12.9	2.5	75.2	435.7
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655866-123664290	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"heart muscle: 778.4;skeletal muscle: 933.7;tongue: 793.6"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 1432.4"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA046370, HPA051039"	Enhanced		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA046370: , HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	0.2	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.5	0.0	0.2	0.1	0.0	0.0	0.0	21.2	0.0	0.1	778.4	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.8	0.0	10.2	0.0	0.1	10.0	0.0	933.7	0.4	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.2	793.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1432.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.5	0.4	9.4	0.0	0.0	0.1	0.0	0.1	27.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	7.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106065-69123032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 111.2;skeletal muscle: 459.8;tongue: 228.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 278.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Region enriched"	"Detected in single"	4	"midbrain: 2.3"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HSkMC: 2.9"	"Not detected"	"Not detected"							HPA036034	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.2	0.1	0.3	0.2	0.4	0.2	0.1	0.3	0.5	0.1	0.2	0.1	0.2	0.0	0.2	6.4	0.0	0.3	111.2	0.3	0.3	0.1	0.1	0.5	0.2	0.3	2.3	0.0	0.4	0.0	0.9	0.5	0.3	3.8	0.1	1.3	9.0	0.4	459.8	0.2	0.2	0.1	0.1	0.7	0.4	0.1	0.2	0.1	0.1	228.2	0.0	0.8	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.2	1.6	0.2	0.4	0.2	0.2	0.2	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.4	0.1	0.3	0.4	0.3	0.5	0.3	0.3	0.3	2.3	0.3	0.1	0.2	0.5	0.5	0.0	0.0	0.3	6.2	2.3	1.5	2.1	0.0	5.0	2.4	1.8	278.1	5.7	1.3	0.0	39.6	0.8	10.0	2.4	0.0	1.0	1.6	3.4	1.2	2.4	0.0	0.0	0.1	0.0	2.1	8.2	0.0	10.0	17.8	0.5	0.7	1.2	0.7	6.7	2.0	1.9	6.1	2.2	28.1	0.5	0.3	2.2	12.4	0.0	3.9	1.0	13.4	0.0	0.3	1.1	0.2	1.2	0.9	2.6	6.1	0.4	0.3	18.1	0.0	33.1	3.4	0.6	0.1	0.8	1.4	0.4	8.2	0.9	1.1	2.5
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106862-98209638	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.7;Excitatory neurons: 114.9;Inhibitory neurons: 69.0;Oligodendrocyte precursor cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.2"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	3.5	7.0	4.2	3.9	6.2	13.8	3.6	0.0	25.2	4.9	0.0	9.7	8.8	3.9	3.9	9.5	4.1	4.2	12.4	6.0	0.0	6.6	6.2	6.6	3.6	2.1	0.5	5.0	14.8	10.7	7.0	3.1	1.8	5.1	8.0	8.2	7.9	4.0	11.1	9.0	9.8	3.7	0.0	4.6	6.5	5.2	1.2	4.9	5.8	7.0	4.8	5.8	6.2	8.7	12.5	14.5	11.0	11.4	5.8	4.6	10.2	5.1	5.5	4.9	5.9	11.5	11.1	6.5	14.3	6.5	18.6	13.4	12.8	7.8	7.6	9.4	9.0	4.4	13.0	11.6	7.0	8.0	7.6	3.2	10.5	10.1	13.6	4.9	7.4	7.4	11.8	13.4	4.5	16.9	8.5	4.8	13.4	17.1	7.0	9.2	7.5	13.0	8.2	21.7	7.8	15.7	10.2	18.4	7.4	11.0	5.1	3.2	9.2	10.2	16.6	20.5	11.7	5.9	11.2	12.8	6.8	6.2	12.3	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.4	1.4	0.1	0.3	0.2	0.2	0.1	4.2	6.2	0.0	25.2	6.0	0.0	2.1	0.5	1.8	0.0	1.2	8.7	6.0	28.9	17.0	28.7	7.8	9.7	4.3	6.2	14.8	14.2	5.5	3.9	22.4	15.7	11.8	1.8	14.6	2.8	7.5	50.7	1.9	6.1	1.1	13.2	7.6	5.7	12.0	8.4	114.9	9.1	1.9	5.4	21.4	26.4	2.5	5.3	2.5	8.4	2.2	6.7	69.0	14.7	4.1	1.6	2.3	2.0	1.8	3.2	1.8	16.9	2.8	6.1	7.2	52.3	29.6	10.3	23.8	4.5	12.9	8.8	14.0	3.0	15.8	10.6	0.0	8.6	5.7	6.9	6.3	15.5	10.9	3.0	8.6	2.7	14.7	20.5
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513935	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 44.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 41.4;Excitatory neurons: 37.0;Inhibitory neurons: 38.8;Urothelial cells: 49.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.4;SK-BR-3: 16.4;U-266/70: 9.8;U-266/84: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	0.0	1.7	23.1	0.7	27.5	0.4	0.7	6.1	44.0	0.6	0.0	0.2	3.7	0.1	1.1	0.6	0.3	0.4	0.3	31.7	6.7	1.1	0.0	1.3	1.1	9.9	1.2	0.1	0.8	3.6	5.7	0.6	1.5	1.5	0.0	2.7	2.6	1.1	0.0	0.8	1.9	0.0	0.7	0.6	1.2	0.2	8.4	0.4	0.8	0.0	0.8	0.2	0.0	21.8	6.0	4.4	0.5	0.5	0.0	0.0	5.1	0.1	0.4	0.0	0.2	3.7	5.2	1.6	1.5	0.0	1.4	3.0	0.8	1.9	0.0	0.7	2.8	0.2	2.5	0.9	0.0	0.0	9.4	0.1	1.1	0.3	0.0	2.0	0.0	5.0	1.6	3.6	0.0	7.9	1.1	4.1	1.2	3.4	1.5	4.8	0.0	2.1	1.7	1.2	1.5	2.9	0.2	16.4	0.9	1.2	5.6	0.2	0.1	0.0	1.5	0.1	0.0	9.8	9.3	1.9	0.3	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	23.1	27.5	6.1	44.0	31.7	6.7	9.9	1.2	1.5	0.7	8.4	21.8	0.3	3.2	1.7	11.8	2.1	0.5	13.1	17.0	2.8	15.9	20.5	6.2	2.7	2.8	41.4	7.3	0.0	4.9	0.6	0.4	25.4	21.5	0.1	8.4	0.6	0.5	0.0	0.0	37.0	0.4	2.8	0.9	6.6	8.1	0.0	0.6	1.4	0.4	1.3	18.5	38.8	1.2	8.2	0.6	0.9	0.2	0.6	0.4	3.6	1.9	0.2	6.9	0.0	26.2	9.6	17.2	0.1	0.0	14.5	18.8	3.0	0.6	25.9	2.2	0.0	0.4	3.3	4.0	3.3	7.1	1.8	6.8	1.3	2.9	1.5	49.5
LNPEP	"CAP, IRAP, P-LAP, PLAP"	ENSG00000113441	"Leucyl and cystinyl aminopeptidase"	Q9UIQ6	5	96935394-97037513	"Enzymes, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 257.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043642	Approved				"Intracellular and membrane"	NA	NA		9800000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043642: AB_10964137"	"unprognostic (1.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	11.4	4.4	8.4	12.2	10.6	16.2	8.2	17.9	8.6	6.8	4.0	8.1	5.2	6.5	5.1	9.0	5.7	5.1	12.0	8.5	10.0	8.3	4.3	7.7	19.4	10.0	9.4	8.8	4.9	15.3	5.8	9.1	10.7	8.8	7.9	9.4	6.0	8.5	11.2	16.4	8.2	7.7	8.6	12.5	7.9	4.1	9.2	17.8	8.4	12.7	18.7	7.0	7.0	10.3	10.7	11.9	5.4	5.6	32.5	15.4	6.2	10.5	13.8	12.0	18.1	9.9	16.4	52.2	19.1	14.1	33.7	13.4	6.8	20.1	12.5	18.2	3.8	12.9	8.2	7.3	8.4	15.5	16.9	12.0	12.5	17.5	13.3	13.6	12.8	11.6	5.6	32.7	13.9	9.6	18.1	10.9	1.1	3.4	6.2	12.7	19.8	7.9	44.9	21.2	10.2	2.7	12.8	11.4	6.4	5.2	34.1	20.2	26.6	17.6	9.6	13.9	16.3	7.3	17.4	45.6	16.1	14.5	8.2	4.3	2.6	3.6	5.9	4.2	5.0	2.3	4.4	4.6	2.8	3.1	4.2	4.7	3.1	9.0	11.2	2.6	4.2	3.6	8.4	10.6	17.9	8.6	8.5	10.0	10.0	9.4	10.7	8.6	9.2	10.3	43.4	35.3	41.3	52.2	91.0	59.4	21.3	28.4	37.5	58.9	24.9	18.8	80.8	22.8	27.2	36.8	125.1	12.3	108.4	20.7	5.9	15.4	3.6	21.4	28.9	33.6	25.7	38.9	47.5	14.4	24.3	36.6	30.1	28.9	25.9	29.3	30.7	16.7	16.2	23.5	50.9	29.6	22.4	49.3	35.9	5.3	32.9	52.0	21.4	45.9	59.7	33.6	257.5	49.3	73.9	21.5	17.5	46.6	44.9	27.4	16.6	10.7	25.8	38.4	26.3	46.8	36.6	29.4	27.5	44.4	47.2	27.4	97.3	31.1	25.6	23.2
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923882-176002839	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 159.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		15000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	13.5	8.9	6.3	7.7	10.1	30.1	9.8	10.2	8.7	12.0	4.2	12.0	7.6	8.6	6.2	13.1	6.3	7.7	12.2	7.6	13.2	8.2	14.4	6.7	7.2	11.3	9.2	10.7	5.5	15.6	6.0	6.1	14.1	10.1	10.2	24.1	6.4	8.2	34.1	12.1	7.5	9.6	11.3	5.9	7.8	24.5	9.3	14.0	8.8	26.8	7.9	7.6	9.2	19.0	24.5	12.3	28.3	40.1	58.5	36.1	14.3	70.8	33.7	32.2	45.1	17.0	28.2	24.4	39.4	31.5	42.3	26.5	26.9	18.9	44.6	37.5	27.4	27.6	14.8	15.2	13.8	47.2	32.9	29.9	17.5	31.4	15.4	26.4	6.0	19.3	28.9	31.5	44.9	16.0	31.4	18.8	9.2	24.9	23.4	31.3	28.6	18.0	13.6	22.2	32.6	32.9	31.3	17.5	24.1	26.6	26.2	15.4	9.2	159.0	23.6	53.9	33.7	18.5	36.6	20.3	49.4	15.2	30.4	3.7	4.2	7.9	4.9	4.8	5.8	4.3	4.2	5.4	3.9	3.3	4.2	6.7	3.4	6.5	4.5	4.4	7.8	3.4	6.3	10.1	10.2	8.7	7.6	13.2	11.3	9.2	14.1	11.3	9.3	19.0	10.8	19.2	13.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	19.3	15.0	0.0	0.0	6.2	16.5	0.0	5.7	14.5	0.0	5.9	14.0	0.0	10.1	24.6	3.5	0.0	0.0	0.0	9.6	17.3	12.8	0.0	12.7	11.4	10.6	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	9.1	8.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	8.3	7.2	12.0	0.0	0.0
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	21.9	2.5	2.7	2.1	6.0	1.0	14.3	0.1	10.3	6.1	0.0	6.7	9.4	4.2	0.6	24.4	6.4	5.5	8.7	7.5	0.1	10.6	4.4	2.7	2.1	0.0	0.1	2.1	16.3	11.9	4.3	24.6	0.4	5.9	6.9	3.8	25.1	7.2	5.9	11.8	9.0	3.0	0.0	0.9	9.5	4.4	0.6	3.3	17.9	12.0	4.1	4.3	7.9	3.1	1.4	0.5	1.6	0.9	2.7	5.8	8.0	1.2	0.6	0.0	0.0	2.9	8.9	1.7	1.1	4.3	0.4	1.4	0.0	0.2	0.0	0.4	4.6	2.2	1.5	1.5	1.3	2.4	0.7	4.4	0.2	0.3	0.0	1.9	2.7	0.8	1.9	0.8	6.4	4.5	2.2	1.7	4.3	17.7	0.7	1.2	0.6	0.7	5.6	8.2	2.2	2.1	0.6	10.8	0.9	9.1	5.7	1.1	7.8	10.0	2.6	3.1	1.6	3.6	0.5	1.1	8.7	2.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.2	0.2	0.0	2.7	6.0	0.1	10.3	7.5	0.1	0.0	0.1	0.4	0.0	0.6	3.1	77.5	0.0	3.9	4.9	1.7	8.2	18.0	14.5	24.5	7.5	13.3	7.1	1.6	12.8	15.5	7.3	6.2	30.6	1.5	18.5	19.6	13.7	171.7	37.7	7.6	16.0	13.8	3.6	123.8	11.7	22.1	4.8	14.3	83.0	2.5	1.5	2.9	6.2	2.5	42.1	42.2	13.4	14.2	0.3	2.1	47.9	4.4	1.3	5.4	11.2	0.4	2.2	2.1	43.7	4.0	12.3	26.5	8.6	0.9	8.5	14.5	2.9	17.9	5.8	0.0	10.0	2.2	0.9	2.6	32.2	11.9	14.9	1.9	1.4	14.2	15.2
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545913-27620529	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favorable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	3.2	6.7	2.0	3.7	2.3	3.8	6.9	5.1	3.0	4.0	6.5	10.7	14.2	3.0	4.8	10.6	4.6	7.9	8.7	2.4	2.8	7.9	20.5	11.5	4.0	1.7	1.8	4.3	19.6	7.1	3.2	3.7	1.7	6.4	10.5	8.0	9.4	4.8	5.9	6.6	13.4	3.8	1.9	3.1	9.9	12.3	2.4	7.8	9.9	5.9	5.1	6.2	6.7	1.9	6.4	3.5	6.5	7.2	6.7	3.1	6.8	5.6	4.9	5.4	4.9	12.7	12.5	9.6	4.7	4.9	9.8	12.0	11.8	15.0	7.0	6.0	4.9	12.3	7.2	9.3	10.5	6.6	7.6	2.6	22.8	3.8	14.7	15.4	9.9	9.9	3.8	3.6	7.9	7.9	10.0	4.4	7.2	29.0	3.9	9.2	12.7	5.0	11.9	11.1	16.7	3.5	7.6	15.4	10.1	8.0	10.7	5.2	12.6	3.1	4.3	3.1	4.6	3.5	6.3	9.9	2.0	6.3	4.4	2.0	0.3	0.9	0.5	0.1	0.7	0.5	0.6	0.7	0.3	0.5	0.6	0.6	0.3	1.1	0.2	0.1	1.0	0.2	2.0	2.3	5.1	3.0	2.4	2.8	1.7	1.8	1.7	1.9	2.4	1.9	4.5	32.1	27.6	9.8	5.6	25.4	27.7	15.8	23.9	8.9	13.3	7.6	11.4	25.8	11.4	20.2	2.1	1.5	5.5	27.8	3.9	10.2	16.4	11.0	2.7	7.2	10.2	18.9	23.2	14.2	8.1	3.2	11.7	14.7	1.3	10.8	9.3	59.2	2.3	5.0	8.0	17.0	8.2	5.0	7.7	7.3	2.8	2.8	10.6	21.5	2.3	4.4	5.2	3.0	6.7	11.0	23.5	3.4	5.4	16.8	17.8	7.8	15.9	16.3	0.0	3.1	3.5	15.6	17.5	14.8	22.0	3.0	5.5	11.1	11.9	20.9
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LONP2	"LONP, LONPL, MGC4840"	ENSG00000102910	"Lon peptidase 2, peroxisomal"	Q86WA8	16	48244300-48363122	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008862	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"			"HPA008862: AB_2137156"	"unprognostic (8.08e-3)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.59e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.71e-7)"	"unprognostic (6.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	21.8	19.2	20.4	14.8	22.8	13.5	46.0	23.0	24.7	19.5	27.9	16.7	20.3	19.3	25.9	16.8	22.2	14.8	22.4	23.0	21.2	20.1	86.9	14.6	15.6	20.5	19.8	24.4	22.1	38.2	25.3	13.9	21.8	29.6	18.7	39.0	20.9	22.2	23.7	17.9	18.4	20.9	21.3	17.3	20.0	9.1	20.4	17.1	32.6	22.5	16.4	19.3	16.0	23.5	24.3	33.1	18.3	25.5	42.1	34.6	30.9	30.4	23.1	28.0	12.8	17.3	12.4	11.0	29.2	30.9	14.1	29.8	33.4	33.6	38.7	18.0	21.7	16.1	20.1	38.2	25.8	27.5	20.7	32.2	36.6	26.2	24.4	33.8	21.1	20.7	27.6	12.6	29.2	22.4	26.5	13.6	13.7	22.8	32.5	34.0	33.1	35.1	31.7	16.1	28.6	17.7	34.6	38.1	31.6	22.8	17.6	20.5	28.3	28.7	16.9	25.2	23.7	25.6	22.8	18.0	33.7	18.5	21.3	6.8	11.6	8.0	10.6	12.0	11.7	10.5	12.9	11.2	11.4	11.7	12.3	11.4	4.4	8.4	12.7	8.5	10.7	10.7	20.4	22.8	23.0	24.7	23.0	21.2	20.5	19.8	21.8	21.3	20.4	23.5	33.0	57.7	66.3	70.8	44.6	34.9	43.1	38.3	40.5	104.5	51.0	39.1	62.7	75.8	52.0	27.6	85.5	40.1	37.9	31.9	13.7	35.0	30.8	43.7	48.2	34.2	49.7	23.4	97.2	30.7	29.0	43.3	39.8	53.6	30.4	65.2	42.5	194.6	30.5	85.8	95.4	36.8	38.7	53.8	42.7	10.1	59.0	38.3	39.2	60.0	45.1	63.9	32.0	73.9	87.6	31.3	38.9	54.5	41.5	52.3	40.9	30.0	56.3	141.7	39.5	67.2	42.5	22.0	17.0	36.7	36.8	64.0	39.8	41.4	41.2	45.8
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721906-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.2	5.8	2.8	4.5	2.7	5.9	10.5	3.4	3.7	11.4	1.3	7.7	2.3	11.3	9.6	13.0	10.5	9.5	4.9	3.0	2.3	6.3	9.9	7.3	7.1	2.2	2.1	15.2	7.5	8.0	3.8	10.1	1.9	10.7	4.3	7.9	8.0	10.6	17.2	28.7	4.5	9.2	2.3	8.4	5.4	15.8	2.6	6.8	8.7	11.3	8.1	7.9	8.3	3.0	1.2	3.0	15.0	4.6	15.6	7.4	10.0	3.8	6.3	4.1	5.7	0.9	3.9	24.0	0.9	6.7	12.9	1.8	12.0	4.7	4.6	3.7	6.8	7.9	0.5	6.2	14.4	2.1	3.0	7.0	8.2	2.6	8.9	3.8	6.4	9.7	1.1	56.6	2.7	4.2	10.4	7.0	15.5	4.8	0.9	5.8	10.2	4.3	3.5	10.2	31.2	3.6	2.2	5.1	29.8	10.7	1.0	10.4	2.9	2.2	3.7	8.9	3.0	4.3	20.7	12.4	12.0	7.2	7.0	0.0	0.1	0.6	0.1	0.5	0.3	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	2.8	2.7	3.4	3.7	3.0	2.3	2.2	2.1	1.9	2.3	2.6	3.0	18.9	9.6	16.3	23.2	25.2	60.8	32.8	7.8	52.3	25.1	15.1	10.3	9.7	10.0	13.1	11.0	16.7	3.6	6.3	4.3	7.9	5.3	57.4	12.1	27.9	15.1	2.4	4.6	67.0	4.0	8.2	24.2	5.6	28.3	6.3	27.8	6.1	14.7	5.6	8.4	43.6	6.4	4.1	9.5	27.6	53.5	29.2	17.2	44.4	21.5	3.6	8.3	0.0	42.7	14.9	4.3	6.4	19.9	16.3	26.4	3.8	6.0	8.7	13.0	19.7	36.7	32.7	8.2	19.7	26.4	73.6	7.3	9.7	3.4	5.8	30.1
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100271875-100322501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 42.2;fallopian tube: 45.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.6;Excitatory neurons: 166.8;Horizontal cells: 111.0;Inhibitory neurons: 126.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;GAMG: 7.3;HAP1: 5.8;HEK 293: 6.2;HMC-1: 5.1;PC-3: 5.3;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034595, HPA057366"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034595: , HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	3.2	31.9	20.1	0.5	20.0	0.1	3.2	7.6	25.5	11.6	5.8	5.6	0.5	26.4	42.2	2.6	45.6	2.3	6.4	26.7	40.4	2.2	1.0	1.8	0.5	2.6	3.3	24.3	6.3	9.6	18.0	0.7	9.9	4.1	0.7	11.2	2.4	4.0	7.1	1.1	1.6	28.2	0.2	0.8	4.6	2.2	27.4	0.4	4.9	4.1	0.3	4.2	3.7	9.9	0.0	6.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	1.1	0.0	1.0	0.0	7.3	0.0	5.8	0.0	0.0	0.5	6.2	0.0	0.4	0.0	0.2	0.1	5.1	0.0	0.0	0.2	0.0	0.4	0.0	1.6	3.5	0.1	0.0	4.0	0.0	0.3	0.3	1.1	5.3	0.0	0.0	0.0	1.4	0.2	12.5	3.4	0.0	0.0	0.8	1.9	3.2	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	20.1	20.0	7.6	25.5	26.7	40.4	2.6	3.3	9.9	0.2	27.4	9.9	0.5	0.0	11.7	52.5	0.5	0.8	1.4	0.0	1.2	72.6	5.1	2.3	37.4	8.6	3.1	5.5	31.3	2.3	0.1	0.3	5.9	3.7	0.6	22.5	43.6	1.8	11.4	2.7	166.8	2.2	0.2	12.7	4.1	37.1	5.7	25.8	0.0	0.6	0.4	111.0	126.2	0.5	0.0	0.0	1.2	2.3	3.4	0.6	1.8	7.5	0.0	8.4	0.0	58.3	38.7	1.5	0.1	11.7	0.1	4.9	0.0	0.3	3.4	20.6	6.6	3.3	5.3	0.8	0.6	0.8	0.1	2.9	1.6	0.9	0.4	0.4
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.3	3.3	1.2	1.9	1.1	4.5	1.4	6.6	2.8	1.5	0.0	3.5	2.3	1.9	1.2	1.4	2.0	2.4	2.3	3.3	1.0	2.8	12.7	6.4	0.8	0.9	1.9	1.6	7.0	0.7	0.9	0.8	1.0	1.9	4.3	2.8	4.8	2.4	8.8	0.7	2.0	1.5	1.5	0.6	4.0	1.7	2.0	0.3	8.2	3.9	1.0	3.6	0.7	1.1	5.0	6.9	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	6.0	0.0	3.5	0.0	12.2	0.0	1.3	0.0	0.1	0.1	3.7	6.6	11.8	6.9	3.7	5.7	0.7	0.0	0.0	0.0	0.0	2.1	1.7	0.5	13.8	0.0	0.9	5.5	0.0	2.3	0.0	15.2	16.0	0.0	3.1	0.0	4.2	2.1	0.2	0.0	14.5	0.4	11.8	0.1	0.0	4.5	0.3	0.1	0.2	0.0	7.9	1.4	6.3	0.0	3.2	5.4	3.4	0.0	0.4	0.0	2.4	0.0	3.8	0.0	1.1	0.8	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.4	0.3	1.2	1.1	6.6	2.8	3.3	1.0	0.9	1.9	1.0	1.5	2.0	1.1	2.2	6.4	13.4	7.8	0.4	1.5	16.9	0.2	1.8	3.3	0.8	1.9	4.4	0.0	6.1	1.8	0.0	0.5	5.3	11.2	1.9	3.0	1.6	4.4	6.4	3.3	1.2	0.4	1.8	4.3	0.0	8.0	17.3	13.0	6.3	0.1	2.2	4.1	2.7	1.7	6.0	4.6	0.0	4.7	7.7	1.0	0.9	9.5	3.6	9.4	0.5	3.7	2.1	3.5	0.2	5.2	8.8	1.5	1.3	7.2	1.6	1.5	0.3	0.3	0.0	9.9	2.0	2.4	4.6	1.6	0.1	0.4	2.7	0.2	3.7	12.5
LORICRIN	LOR	ENSG00000203782	"Loricrin cornified envelope precursor protein"	P23490	1	153259687-153262124	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Keratinization		"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"skin 1: 1842.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"melanoma: 45.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	92	"HDLM-2: 35.2"									"HPA076123, HPA077266"	Enhanced					NA	NA		1800000		"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA076123: AB_2732302, HPA077266: AB_2732338"	"unprognostic (1.97e-2)"	"unprognostic (1.93e-2)"			"unprognostic (4.16e-2)"	"prognostic favorable (8.53e-4)"		"unprognostic (1.65e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.41e-1)"			"unprognostic (1.47e-1)"	"unprognostic (3.03e-1)"		"unprognostic (1.02e-2)"	1.1	0.2	0.5	0.2	0.4	0.0	24.2	0.2	0.4	0.8	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.7	0.4	0.9	0.2	0.8	0.4	0.1	0.7	0.5	0.5	0.6	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.7	0.0	10.9	1842.9	0.4	0.0	0.5	0.4	0.3	0.5	1.0	0.6	0.3	0.0	1.8	0.1	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.9	0.7	0.5	0.5	0.5	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.4"	"Lineage enriched"	"Detected in single"	34	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		280000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	12.4	3.1	1.4	5.4	0.8	0.8	6.8	0.2	1.4	12.7	12.3	10.2	1.9	16.0	1.4	4.7	8.3	5.0	27.9	1.7	1.9	8.7	1.5	10.1	4.4	1.4	1.7	8.0	3.3	2.2	9.2	8.0	1.1	15.3	1.4	0.0	7.6	11.9	3.8	6.4	5.6	4.9	0.8	3.2	7.8	2.4	1.9	0.9	5.2	1.9	2.3	16.6	14.8	0.6	3.3	0.0	0.9	0.0	45.6	54.8	2.2	66.5	75.2	27.6	48.7	1.3	1.7	0.0	12.1	49.1	6.9	19.9	0.3	0.2	6.5	0.0	4.3	0.2	2.0	0.3	6.2	0.0	0.1	45.0	0.0	20.8	0.2	73.7	1.0	1.2	0.0	0.3	33.3	2.4	0.4	1.3	6.3	4.4	45.1	0.0	38.7	0.6	2.5	12.0	5.5	0.0	2.0	0.4	0.0	6.5	0.4	0.0	4.9	53.8	47.0	42.8	25.8	0.2	0.0	0.0	61.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	1.3	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	3.4	0.2	1.4	0.8	0.2	1.4	1.7	1.9	1.4	1.7	1.1	0.8	1.9	0.6	4.1	0.0	0.6	3.3	0.1	5.9	7.6	6.0	4.0	0.9	2.3	4.8	92.3	2.8	0.9	9.2	0.0	2.2	0.6	0.1	3.9	5.2	1.7	9.2	8.0	4.1	3.5	0.0	0.5	1.3	145.8	76.0	8.6	9.3	1.3	5.5	12.1	0.1	6.6	0.0	0.4	0.6	2.0	0.0	6.2	1.3	9.9	0.9	10.6	0.0	0.1	6.4	0.0	1.5	0.3	12.2	0.1	21.1	0.1	4.8	0.4	2.5	1.2	0.4	0.0	6.0	32.7	8.9	4.9	2.4	3.4	5.1	3.4	0.3	1.1	5.0
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23296897-23425328	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	30.4	3.3	1.9	15.9	2.7	1.2	18.8	4.7	3.0	10.6	0.8	25.3	9.3	12.0	0.9	3.8	4.9	8.0	10.7	1.8	3.2	6.1	3.9	8.3	11.7	7.7	8.1	12.9	6.5	2.5	2.6	36.2	7.0	7.5	5.4	3.0	4.1	13.0	4.5	5.4	10.3	41.3	4.5	5.0	9.0	2.3	4.5	1.8	5.2	2.6	9.5	12.0	7.3	3.7	58.2	147.7	42.7	35.8	112.4	183.8	19.4	935.5	295.9	415.6	517.3	1.1	4.4	10.7	7.5	602.7	193.2	47.6	2.1	79.0	215.3	1.8	8.5	0.9	19.4	1.0	226.8	0.5	3.8	164.6	3.9	155.0	20.8	274.0	350.7	2.4	0.5	2.0	138.1	32.3	0.6	1.4	29.1	0.4	24.5	1.9	36.7	0.4	120.1	0.3	0.9	13.7	122.9	6.1	8.6	131.3	0.8	1.2	510.7	384.6	103.3	163.8	127.3	4.1	0.8	29.9	905.4	1.4	413.5	0.1	0.2	0.8	0.4	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.2	0.1	0.2	1.9	2.7	4.7	3.0	1.8	3.2	7.7	8.1	7.0	4.5	4.5	3.7	12.9	0.0	3.0	6.8	0.6	2.5	0.3	26.9	0.6	1.5	0.6	9.7	2.6	1.5	4.1	0.0	0.0	2.7	0.4	0.0	0.0	1.9	0.6	1.7	26.9	33.1	0.0	0.0	8.1	1.5	22.0	22.9	1.5	2.1	0.0	2.0	19.6	0.2	1.3	1.7	3.2	0.1	0.0	0.3	5.7	0.4	0.9	0.9	3.6	6.5	0.0	1.2	0.0	7.1	11.9	2.3	0.1	0.4	0.9	0.6	0.2	0.2	1.6	3.2	26.3	2.7	48.1	1.3	1.6	0.5	3.1	1.0	1.0	3.1	0.4	0.2
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268194	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal respiratory cells: 141.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BJ hTERT+: 249.7;CAPAN-2: 301.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	8.2	2.4	0.7	1.6	0.9	0.5	11.9	1.1	0.7	11.8	2.3	10.4	1.9	7.0	3.0	2.0	7.8	1.8	3.0	0.8	1.2	6.6	6.0	4.4	0.4	1.3	1.3	7.1	6.6	1.2	1.9	5.8	1.3	6.6	1.8	2.6	19.6	10.8	8.3	4.0	3.2	7.6	1.0	2.7	2.9	5.5	1.0	1.4	7.0	1.5	0.7	5.0	7.4	1.0	0.0	1.6	0.1	0.3	6.9	29.5	0.9	32.1	249.7	2.6	26.6	5.4	301.6	0.1	28.4	25.1	1.1	0.3	0.1	0.0	2.2	0.0	0.2	0.0	4.4	13.3	6.7	0.0	0.0	3.3	0.0	4.4	0.0	0.4	0.1	0.0	0.3	0.0	0.4	0.0	0.0	2.3	0.6	0.1	0.5	0.1	2.9	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	8.7	0.2	0.7	0.7	0.2	53.7	3.2	1.1	0.0	0.0	0.2	0.5	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.9	1.1	0.7	0.8	1.2	1.3	1.3	1.3	1.0	1.0	1.0	0.3	6.4	1.5	0.7	0.3	0.9	2.1	141.0	0.0	0.4	6.5	6.5	1.6	4.3	17.5	31.3	0.0	0.2	1.7	0.1	0.0	11.1	0.3	1.5	1.2	0.9	0.0	0.0	0.1	0.5	0.4	6.0	0.0	4.2	1.3	1.1	2.2	0.4	0.2	0.0	0.1	0.2	8.2	0.0	2.1	0.4	4.1	0.2	0.0	9.4	0.0	5.4	0.0	0.0	0.0	3.0	0.0	1.5	0.3	7.9	0.0	0.4	6.3	0.1	0.0	5.2	2.2	0.1	0.2	0.1	0.9	0.4	0.2	0.7	0.0	3.4
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	2.0	0.0	1.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.8	6.3	0.5	76.7	0.1	0.0	1.8	1.9	0.2	0.6	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.2	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	1.1	0.8	6.3	1.8	1.9	1.3	0.2	4.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LPAR2	"EDG-4, EDG4, LPA2"	ENSG00000064547	"Lysophosphatidic acid receptor 2"	Q9HBW0	19	19623655-19628930	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 73.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019616	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA019616: AB_1847988"	"unprognostic (1.60e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.61e-7)"	"prognostic favorable (1.43e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.29e-2)"	10.3	3.3	6.6	18.7	6.5	51.9	8.2	5.5	9.2	9.4	7.9	12.9	9.6	4.3	2.5	15.9	10.6	13.0	3.7	7.1	8.5	11.0	6.5	28.5	17.1	8.2	8.0	10.4	27.6	7.8	10.0	4.2	8.1	17.8	7.8	1.7	17.2	4.3	1.4	18.2	23.7	1.9	6.8	76.0	33.6	49.5	9.4	10.0	18.4	1.5	14.7	10.8	11.3	8.5	31.4	3.4	35.7	8.0	9.1	4.4	30.2	2.0	2.9	1.4	2.6	22.0	29.6	19.8	19.5	2.9	1.8	32.1	5.6	11.0	1.4	8.5	9.2	4.4	6.9	1.7	1.2	7.4	73.3	4.9	26.9	1.4	2.0	5.0	0.8	9.7	4.4	7.7	1.2	51.4	4.5	12.3	35.3	42.0	14.2	19.6	2.9	9.1	22.1	45.5	12.6	23.0	8.2	6.6	4.9	19.6	16.9	47.0	9.1	6.8	5.7	12.0	3.0	3.4	10.7	6.8	1.5	53.3	3.4	0.2	1.0	3.8	9.2	1.1	16.2	5.5	20.7	11.8	0.7	2.7	18.2	13.5	10.1	2.8	1.7	1.8	25.7	6.3	6.6	6.5	5.5	9.2	7.1	8.5	8.2	8.0	8.1	6.8	9.4	8.5	0.9	3.2	7.2	0.7	7.1	6.2	11.7	12.4	9.1	0.3	9.7	10.8	2.2	5.7	9.9	7.3	2.1	1.0	6.6	12.2	3.9	14.3	0.4	10.2	2.4	1.0	2.4	3.2	1.9	20.1	6.0	1.9	39.3	18.3	3.8	6.9	1.1	0.6	2.5	1.7	2.2	11.5	6.1	5.6	4.0	2.1	0.6	8.3	0.0	5.6	6.4	4.7	2.1	1.0	0.1	16.9	7.1	0.4	8.7	14.9	10.1	0.7	6.0	1.4	0.0	0.4	2.1	1.3	4.2	7.2	5.1	0.1	20.4	0.2	7.6	11.2
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;ovary: 3.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	0.5	0.0	1.8	0.4	1.3	0.3	0.8	1.1	1.7	0.6	1.1	0.3	0.0	1.1	0.3	0.6	0.3	0.8	0.7	3.0	1.2	0.1	0.1	0.1	0.0	1.8	1.7	3.6	0.4	0.0	0.1	0.0	1.3	0.2	0.4	0.1	0.3	0.1	0.0	0.5	0.3	0.5	2.6	0.1	0.4	0.3	1.1	0.7	0.1	0.3	0.4	0.3	0.2	3.8	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	2.1	0.0	0.4	1.7	15.2	0.0	0.2	0.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	2.6	0.0	0.0	0.2	0.0	0.6	1.2	0.0	0.7	0.7	3.7	1.5	6.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.3	1.1	1.7	3.0	1.2	1.8	1.7	1.3	2.6	1.1	3.8	1.2	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.5	20.2	0.1	1.8	1.0	0.6	1.0	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.3	1.5	0.4	0.0	0.4	0.2	0.0	0.2
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6635960	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 18.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 83.8;T-cells: 66.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA013170	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favorable (6.56e-5)"	"unprognostic (7.43e-2)"	1.9	2.5	6.0	5.3	6.1	1.0	1.3	6.1	5.9	5.8	3.4	8.9	9.7	0.5	2.7	20.9	1.6	1.7	4.1	5.4	6.8	0.7	1.3	1.9	8.9	10.3	8.9	0.7	0.5	0.8	1.0	5.4	9.4	1.0	8.3	0.2	5.5	1.3	0.2	6.9	8.9	1.0	10.2	9.3	7.2	1.6	11.8	2.6	1.6	0.1	12.4	2.1	9.6	14.4	5.8	0.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	10.5	4.3	1.3	0.0	0.1	7.0	0.0	3.2	0.0	0.0	0.0	19.6	0.6	0.4	0.0	0.0	26.0	0.0	3.5	0.1	1.5	0.0	0.0	4.0	14.8	0.0	0.0	0.5	0.6	6.1	0.1	9.4	1.0	4.8	0.0	0.0	0.0	3.3	0.1	0.1	3.0	0.0	0.0	1.1	0.0	2.2	0.1	0.0	3.9	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	10.4	0.3	0.1	66.8	3.4	51.2	83.8	11.2	40.2	17.3	82.7	10.8	24.6	0.8	4.6	6.1	1.1	18.0	20.1	6.0	6.1	6.1	5.9	5.4	6.8	10.3	8.9	9.4	10.2	11.8	14.4	0.2	0.0	0.0	0.0	26.5	1.5	0.4	3.9	1.8	0.0	0.6	0.5	2.8	1.5	4.4	1.8	0.0	0.3	2.8	16.9	0.0	0.3	4.9	0.4	0.1	1.5	1.2	0.8	0.2	0.9	0.2	0.6	3.6	0.7	16.5	0.0	1.1	0.2	38.0	0.0	0.3	11.1	2.0	15.6	7.0	14.5	0.0	13.9	0.0	33.7	4.6	0.1	17.5	0.5	0.1	9.4	16.8	0.0	2.7	0.7	18.4	0.1	0.6	0.1	0.0	0.1	0.2	0.6	1.4	10.3	1.3	0.5	6.9	0.0	13.0	2.2
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 266.1;Basal squamous epithelial cells: 327.2;Early spermatids: 334.0;Langerhans cells: 703.7;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.6;HUVEC TERT2: 35.3;MOLT-4: 20.0"	"Low region specificity"	"Detected in all"							HPA028934	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA028934: AB_2672833"	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	41.0	26.5	14.5	26.8	14.7	6.1	43.0	15.2	27.1	41.9	18.3	22.1	15.0	28.7	39.5	81.8	22.2	35.5	24.9	14.0	15.8	26.2	23.2	34.6	45.6	19.0	16.4	14.9	8.7	9.7	15.9	77.7	18.0	60.7	27.6	5.8	59.7	32.2	9.0	33.9	21.7	27.1	18.2	40.2	21.6	8.1	16.7	36.4	24.3	20.8	41.1	40.8	75.1	21.0	0.1	2.1	21.6	0.1	7.0	8.6	0.2	4.5	12.7	0.9	2.5	0.0	6.4	0.0	0.1	4.9	0.0	12.7	0.6	7.2	0.4	0.0	4.3	0.2	0.2	15.9	4.6	0.1	0.1	11.5	12.4	0.5	7.0	0.0	35.3	7.0	0.0	0.3	4.2	0.0	20.0	6.3	8.6	0.4	5.9	16.9	0.0	0.2	5.9	13.1	0.0	0.1	0.0	0.1	4.5	13.2	2.2	0.1	9.1	2.4	0.0	0.2	1.1	0.0	0.0	0.0	0.7	1.1	7.8	1.3	71.9	0.3	24.6	112.0	13.6	1.2	70.0	29.4	26.0	0.5	49.3	15.6	5.9	6.9	103.6	1.1	83.9	58.2	14.5	14.7	15.2	27.1	14.0	15.8	19.0	16.4	18.0	18.2	16.7	21.0	266.1	3.2	9.7	4.9	5.8	120.6	196.3	155.7	327.2	1.7	30.5	30.5	5.8	17.2	76.2	5.5	0.0	0.8	22.2	4.9	0.0	10.4	334.0	10.1	20.7	140.1	21.4	8.8	1.8	4.1	0.8	23.6	16.8	12.8	7.6	5.8	136.0	2.9	82.9	0.0	1.8	4.9	42.7	74.0	703.7	321.7	22.7	111.9	49.8	177.1	76.4	11.3	18.6	5.0	2.0	6.7	4.1	15.8	6.3	107.1	3.0	25.5	49.4	1.5	13.1	5.4	13.3	2.5	1.7	182.7	142.9	0.8	52.3	14.0	9.6	143.5
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523962	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.3;lymphoid tissue: 38.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 324.0;Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 148.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 79.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 89.1;EFO-21: 82.4;PC-3: 60.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	11.1	9.4	3.4	2.4	3.5	1.4	8.4	0.6	13.3	10.6	3.2	8.8	0.8	12.4	0.1	4.6	10.8	0.8	7.7	6.0	8.3	6.1	3.9	57.3	1.6	3.3	5.0	8.6	5.1	0.6	10.0	1.4	6.3	6.8	0.1	2.1	8.3	0.8	2.5	5.0	11.2	0.4	2.3	38.2	6.9	2.8	5.1	0.5	7.3	0.0	0.3	11.5	7.0	1.0	5.5	8.1	1.5	8.6	1.0	1.3	89.1	19.2	1.1	1.0	0.9	3.1	2.6	17.7	82.4	0.5	3.8	15.7	1.7	0.5	0.5	41.5	36.1	4.4	12.7	5.8	1.7	4.7	11.8	1.5	0.4	1.0	0.2	1.3	1.1	6.2	9.8	3.5	0.0	11.8	17.3	7.3	31.2	0.5	60.7	32.2	1.5	13.7	3.6	7.5	11.5	11.1	16.5	14.8	5.1	0.9	6.9	7.4	9.8	1.6	19.0	6.1	7.3	10.9	11.0	4.4	3.7	7.7	5.5	0.0	0.2	0.2	1.1	0.5	1.1	0.2	0.2	0.5	0.1	0.1	0.0	0.3	0.8	0.5	0.4	0.0	0.2	0.2	3.4	3.5	0.6	13.3	6.0	8.3	3.3	5.0	6.3	2.3	5.1	1.0	12.6	86.6	324.0	18.9	41.9	6.2	2.5	5.3	6.8	65.8	8.9	6.3	4.0	5.7	14.4	14.7	146.0	9.0	97.4	6.7	0.0	22.4	1.7	4.8	13.7	13.5	14.9	3.6	13.9	13.6	81.9	13.1	7.1	5.2	8.2	44.7	16.4	5.2	27.0	23.5	16.7	9.6	2.0	29.2	20.5	2.8	10.8	42.6	7.2	22.5	15.7	30.3	96.8	14.1	1.7	20.3	0.3	15.4	39.9	6.2	2.0	4.6	5.7	148.2	0.0	6.3	11.5	3.4	12.2	1.5	4.0	31.7	30.7	22.5	5.3	1.7
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55509072-55586666	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.3;thyroid gland: 86.3"	"Cell type enhanced"	"Detected in many"		"granulocytes: 173.3;Microglial cells: 224.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 151.4;eosinophil: 199.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 199.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	9.8	9.0	5.6	14.4	7.7	88.3	12.2	10.6	5.2	14.0	10.7	9.0	7.4	18.5	36.7	7.8	8.8	10.5	5.7	4.8	8.5	10.9	3.9	10.4	5.0	13.7	8.5	15.8	5.4	13.6	1.0	16.0	15.9	7.0	9.3	7.7	8.4	28.6	2.2	12.0	9.1	15.0	12.7	11.8	9.0	4.1	7.9	3.5	86.3	5.8	4.0	9.5	7.5	22.4	33.5	4.2	3.5	0.3	10.8	4.1	5.6	14.1	13.5	6.8	6.9	7.5	115.9	0.0	46.6	19.9	5.5	89.2	2.2	19.4	10.9	9.1	9.6	34.2	10.2	17.3	4.1	103.0	161.7	2.1	19.2	7.5	6.3	162.9	53.5	1.8	1.5	0.4	11.6	2.1	0.0	41.8	5.1	9.5	0.4	10.4	3.8	5.1	6.8	12.9	2.2	25.3	27.1	10.8	19.9	15.8	4.6	25.8	60.3	0.3	0.1	6.9	9.6	0.6	0.2	0.2	0.5	49.4	117.8	151.4	17.5	199.2	0.0	27.4	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	47.0	0.0	39.1	0.7	0.0	6.5	5.6	7.7	10.6	5.2	4.8	8.5	13.7	8.5	15.9	12.7	7.9	22.4	68.6	6.4	25.7	2.9	1.1	15.4	37.2	68.3	17.1	5.5	8.8	33.9	2.2	4.3	22.3	68.0	10.4	0.7	3.3	7.0	1.9	8.3	1.7	6.4	4.8	41.0	1.2	9.7	8.1	9.7	7.5	20.7	10.2	13.9	173.3	0.4	12.1	2.0	36.5	0.0	11.7	12.2	18.3	71.9	57.7	3.1	16.4	74.4	17.8	224.9	40.6	24.0	0.0	4.5	66.5	32.8	23.0	12.8	1.0	9.0	3.4	3.5	8.1	5.3	0.0	20.0	4.2	49.6	24.0	14.2	15.3	1.9	5.6	7.0	11.6	17.6
LPCAT4	"AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2"	ENSG00000176454	"Lysophosphatidylcholine acyltransferase 4"	Q643R3	15	34358633-34367196	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.2;Gastric mucus-secreting cells: 131.5;Urothelial cells: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 108.5;OE19: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057321	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA057321: "	"unprognostic (2.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-3)"	19.7	6.2	18.0	12.2	18.3	6.7	17.8	12.8	38.5	21.6	4.0	44.8	30.9	14.4	9.4	36.1	18.7	17.0	26.0	18.8	21.2	9.3	3.4	10.0	9.7	26.2	12.8	11.8	10.2	7.1	11.8	5.1	26.0	11.1	35.9	4.9	11.8	8.8	8.3	18.6	31.2	16.7	8.5	16.3	39.7	3.3	18.1	8.7	8.4	8.0	11.2	22.2	28.9	21.6	13.7	31.9	15.7	12.6	41.4	41.9	7.5	18.8	31.5	17.6	24.0	11.6	36.0	12.4	38.4	26.3	41.3	108.5	13.8	35.5	7.8	25.2	8.2	12.5	13.6	11.3	8.5	13.5	12.3	31.3	15.8	16.6	21.4	40.6	29.0	22.1	8.3	23.6	33.1	13.3	11.9	26.1	15.7	113.7	26.0	14.7	17.6	25.1	38.7	32.4	12.6	9.5	11.3	14.9	7.3	18.2	11.5	17.9	36.4	32.5	19.6	51.8	18.3	28.5	23.9	4.3	24.3	37.0	7.6	0.1	0.8	3.6	2.7	1.1	6.6	1.6	3.2	4.2	1.3	2.3	1.8	1.7	3.5	1.7	1.4	4.6	5.6	0.8	18.0	18.3	12.8	38.5	18.8	21.2	26.2	12.8	26.0	8.5	18.1	21.6	31.0	25.6	5.9	8.8	13.1	4.8	7.8	35.5	15.4	15.5	5.8	8.3	12.8	25.8	63.1	9.2	4.2	4.9	15.7	85.2	1.9	11.6	0.0	7.1	7.8	31.9	25.3	9.2	57.5	9.8	17.1	9.6	131.5	10.1	12.0	5.5	23.6	0.7	7.9	10.1	53.3	58.0	24.4	8.1	9.7	1.2	15.5	6.3	8.8	9.4	5.7	1.7	9.2	12.5	7.2	43.1	83.4	6.8	29.1	9.7	58.7	2.8	40.7	5.9	13.1	5.1	11.9	2.5	8.1	20.3	6.1	2.5	19.9	8.6	71.8	129.9
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340821-41360582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 214.9;Proximal enterocytes: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	19.1	7.3	5.6	3.7	5.4	0.3	18.0	4.6	6.8	19.4	8.4	24.0	41.6	14.1	13.1	32.2	17.7	5.8	17.9	5.6	5.2	31.5	30.0	9.1	2.1	6.1	5.2	14.5	15.1	10.3	12.6	3.6	5.4	19.7	13.2	1.3	16.9	9.6	3.3	40.6	32.4	5.9	5.3	5.7	12.3	3.3	6.2	2.0	26.9	2.5	3.2	13.3	26.2	6.1	12.4	12.0	0.7	7.1	18.6	28.8	9.1	7.5	10.3	9.0	12.1	22.3	10.7	0.6	9.1	16.7	9.5	30.6	3.6	19.6	5.6	0.3	6.9	0.6	19.8	11.5	3.0	0.0	8.1	20.8	24.3	15.3	5.9	10.4	2.3	0.3	3.2	0.4	11.3	26.5	0.1	0.3	1.0	7.6	12.1	0.1	0.2	0.9	30.9	15.5	0.9	0.2	10.0	12.6	6.4	5.6	14.8	6.2	0.7	0.6	2.9	10.1	0.1	5.8	3.3	0.1	0.2	0.1	0.6	0.8	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.6	2.3	0.3	0.2	0.1	0.1	5.6	5.4	4.6	6.8	5.6	5.2	6.1	5.2	5.4	5.3	6.2	6.1	7.2	6.4	12.3	12.1	0.8	14.4	8.2	10.0	3.4	0.0	12.7	11.3	0.8	10.0	6.0	11.0	0.0	2.8	0.2	44.4	5.9	8.7	21.6	10.0	12.5	3.2	14.9	2.7	1.0	3.8	3.5	9.4	19.9	33.1	1.3	16.2	5.0	44.1	3.3	0.0	0.3	21.9	4.1	2.2	6.0	214.9	3.1	1.0	10.6	8.4	0.0	5.2	0.0	1.0	0.2	6.4	28.4	2.6	0.1	3.8	76.9	11.8	4.2	0.5	32.9	8.8	8.2	1.0	2.7	4.7	12.6	2.6	1.0	5.2	23.2	4.8
LPO	SPO	ENSG00000167419	Lactoperoxidase	P22079	17	58218548-58268518	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Antimicrobial, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	404	"salivary gland: 1026.8"	"Group enriched"	"Detected in some"	6	"Breast glandular cells: 25.2;Early spermatids: 8.3;Late spermatids: 14.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"THP-1: 9.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028688	Enhanced	Supported			"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA028688: AB_10601909"	"unprognostic (2.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.22e-1)"	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1026.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	2.5	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	25.2	0.5	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	8.3	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.4	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.0	14.1	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.5	1.4	0.1	0.0	0.3	0.0	0.2	0.1	2.6	0.4	0.0	0.3	0.0	0.2	0.0	0.5	0.5
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 566.5;Late spermatids: 1737.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 97.0;EFO-21: 115.2;U-698: 200.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		2700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	29.3	10.8	6.7	28.4	8.9	9.9	18.8	9.1	9.7	27.5	27.3	73.3	13.8	61.9	11.8	49.4	32.2	21.3	16.7	6.1	11.2	11.5	12.1	19.1	17.2	15.6	7.9	14.7	8.8	9.9	2.9	11.5	12.6	39.0	31.7	2.4	12.0	53.1	12.4	12.0	23.0	81.3	6.6	10.8	32.7	18.6	13.8	8.0	8.8	9.1	21.4	57.0	22.1	7.8	25.6	23.3	16.7	11.3	35.3	36.0	17.9	16.0	20.9	11.8	7.8	42.2	12.1	97.0	115.2	37.3	14.7	10.7	5.2	11.0	29.5	10.7	5.7	4.6	18.4	11.1	15.0	2.0	5.5	25.7	15.3	26.4	22.5	16.9	20.1	5.2	0.2	2.0	21.0	8.1	5.1	2.1	6.6	16.3	7.6	6.2	12.3	0.5	13.1	26.8	1.1	0.3	35.3	11.4	19.2	27.3	9.0	8.8	43.7	27.1	20.8	19.6	41.1	0.2	4.0	200.0	13.6	4.3	24.9	0.8	4.9	2.2	5.1	4.5	3.3	3.3	4.5	3.8	2.6	5.6	2.4	2.9	18.9	4.8	4.6	5.3	1.8	1.9	6.7	8.9	9.1	9.7	6.1	11.2	15.6	7.9	12.6	6.6	13.8	7.8	104.7	89.8	69.8	357.5	48.5	78.0	84.9	65.0	70.0	9.5	141.8	111.5	143.0	100.1	86.2	69.9	14.6	44.7	65.7	207.1	29.4	139.7	566.5	49.3	134.4	91.8	77.5	12.0	132.8	90.9	24.1	124.9	97.9	93.6	18.3	136.6	126.4	94.8	42.5	5.0	191.2	91.7	44.7	65.1	121.0	1737.1	225.3	75.8	80.0	308.2	55.8	24.8	54.6	395.6	214.9	120.2	158.1	476.9	24.6	172.5	127.5	80.2	60.9	7.1	335.2	159.2	368.2	9.8	8.0	64.2	68.2	18.6	55.3	46.8	151.3	149.3
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	10.4	8.3	7.5	48.3	8.2	10.2	10.2	7.8	11.8	7.9	4.5	14.5	10.9	7.4	11.9	5.2	7.6	15.1	5.3	7.1	7.8	10.6	14.0	33.5	87.1	9.1	8.8	9.5	8.6	6.5	7.2	5.2	10.2	9.4	19.6	7.0	11.0	7.1	3.8	5.9	26.2	9.7	8.6	44.1	13.0	10.2	10.0	103.3	10.2	5.1	118.5	32.4	6.0	10.9	1.7	2.1	2.0	3.9	7.4	9.3	1.4	50.5	200.7	12.4	22.0	0.4	5.1	149.8	2.0	61.9	9.2	2.0	1.7	137.7	51.4	65.4	0.9	6.8	1.3	1.0	12.8	41.1	329.3	7.2	3.2	170.8	22.0	12.0	80.9	90.0	1.9	285.0	101.5	1.1	144.8	51.6	1.6	2.3	45.8	2.1	2.5	129.2	8.3	71.2	1.0	1.6	2.2	3.2	20.1	2.8	2.7	11.7	79.8	30.8	9.5	199.5	45.9	18.4	18.9	146.5	71.6	36.8	71.6	6.3	74.3	12.2	101.3	41.8	148.9	71.9	102.9	117.6	137.5	46.2	79.6	95.9	14.1	79.2	22.2	124.4	152.1	98.8	7.5	8.2	7.8	11.8	7.1	7.8	9.1	8.8	10.2	8.6	10.0	10.9	4.1	0.0	6.7	22.9	75.9	9.7	6.6	7.2	3.4	4.1	4.0	4.7	2.3	4.3	2.8	0.0	4.2	2.8	80.7	4.2	3.9	2.5	23.0	2.8	1.9	5.9	6.1	13.3	18.2	5.6	1.3	6.6	13.3	2.3	51.5	5.4	2.5	7.6	44.0	1.7	19.8	3.1	6.1	63.7	154.6	8.7	1.8	81.7	19.6	30.0	52.9	2.8	49.4	11.6	27.3	4.1	5.2	3.8	82.2	3.6	6.9	5.7	4.3	4.4	6.6	3.6	3.8	9.2	4.2	2.6	9.7	2.5	90.3	2.9	5.2	27.6
LRATD1	"FAM84A, FLJ35392, NSE1"	ENSG00000162981	"LRAT domain containing 1"	Q96KN4	2	14632700-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.2;intestine: 41.0"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 35.0"	"Group enriched"	"Detected in many"	7	"amygdala: 19.7;basal ganglia: 10.8;cerebral cortex: 18.1;hippocampal formation: 13.0;white matter: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.5	1.4	19.7	4.9	10.8	0.0	2.4	0.0	18.1	10.6	0.0	41.0	26.3	2.7	32.2	28.6	2.9	3.4	2.1	13.0	2.0	4.0	1.4	3.0	0.2	0.0	0.2	8.2	3.2	5.2	3.3	5.3	0.0	13.6	36.2	0.9	13.9	2.0	0.9	18.5	25.3	2.8	0.0	0.2	3.0	12.3	1.4	1.3	2.2	0.1	1.4	14.8	16.6	6.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	2.5	0.6	0.5	0.0	0.3	0.0	0.0	0.3	0.0	9.4	1.0	4.2	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	18.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	1.3	7.8	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	6.9	49.3	4.3	2.0	0.0	1.8	0.0	0.3	0.0	0.0	2.9	8.2	0.7	0.0	3.2	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	10.8	0.0	18.1	13.0	2.0	0.0	0.2	0.0	0.0	1.4	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	162.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	207.8	0.0	0.0	0.0	0.0
LRATD2	"BCMP101, FAM84B, NSE2"	ENSG00000168672	"LRAT domain containing 2"	Q96KN1	8	126552443-126558478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 43.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.9;Cardiomyocytes: 6.8;Cytotrophoblasts: 5.4;Endothelial cells: 4.0;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 78.5;AN3-CA: 104.6;MCF7: 112.1;PC-3: 72.5;SuSa: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050782, HPA062115"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050782: AB_2681235, HPA062115: AB_2684686"	"unprognostic (2.46e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (2.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.75e-5)"	6.1	2.5	6.1	3.2	7.1	3.0	16.3	7.1	5.2	7.3	25.4	7.6	13.1	7.3	6.8	19.5	8.3	8.1	4.0	5.2	7.1	27.3	8.2	12.0	3.8	8.9	7.5	2.9	16.3	9.2	4.5	7.5	6.9	8.3	8.2	19.1	43.7	6.8	2.5	7.2	7.4	4.6	7.0	3.2	17.6	2.1	5.8	3.2	7.4	5.2	6.3	6.4	5.8	12.6	78.5	9.8	5.8	104.6	0.0	0.0	6.9	1.1	2.7	0.8	1.2	3.0	44.9	0.0	48.5	0.2	8.4	34.3	3.1	14.7	1.3	0.1	63.0	0.0	0.2	0.5	1.4	0.1	1.6	0.6	20.3	0.0	9.0	17.6	6.3	19.7	0.1	0.0	0.5	112.1	2.6	0.0	5.3	65.7	72.5	0.0	2.3	0.8	41.8	32.5	29.7	0.0	2.4	34.9	32.4	162.9	52.0	0.7	0.0	0.3	9.4	0.1	2.0	1.3	0.2	0.1	0.9	5.0	19.6	1.7	0.0	1.5	1.4	0.0	1.4	0.3	1.8	2.7	0.0	0.8	2.0	2.1	0.1	1.1	0.0	0.0	2.6	0.9	6.1	7.1	7.1	5.2	5.2	7.1	8.9	7.5	6.9	7.0	5.8	12.6	20.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	1.5	0.0	0.0	0.0
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	15.1	5.0	4.7	10.7	4.7	8.9	14.6	37.1	6.2	15.9	4.2	15.2	7.9	16.3	7.7	10.0	11.8	12.6	8.4	5.7	6.1	14.9	12.2	13.8	16.3	6.5	7.0	10.1	5.6	5.4	5.8	18.2	7.8	10.8	10.0	10.3	10.0	12.0	3.9	17.9	11.6	17.6	7.9	14.6	13.0	4.6	6.8	18.5	6.5	7.5	15.7	13.5	9.7	7.5	7.4	10.4	9.2	9.6	6.6	12.5	23.6	12.4	16.1	15.0	14.2	23.5	12.3	23.4	3.4	11.7	9.8	10.4	7.1	12.5	21.6	24.2	6.6	21.0	4.3	11.1	8.2	13.8	34.5	7.9	9.7	13.9	16.8	12.3	13.1	15.6	4.2	6.9	11.2	14.2	14.8	17.3	5.2	46.3	5.5	8.0	10.0	6.3	28.1	7.5	14.5	14.6	7.0	6.8	18.8	16.2	5.3	18.3	12.5	8.8	6.0	11.0	11.9	1.3	3.7	10.6	10.3	11.9	10.8	0.6	0.9	0.9	1.5	0.7	0.8	2.2	1.1	1.0	0.8	2.7	0.8	0.9	0.3	2.5	0.5	1.0	0.8	0.9	4.7	4.7	37.1	6.2	5.7	6.1	6.5	7.0	7.8	7.9	6.8	7.5	61.5	6.4	6.1	24.8	26.7	37.5	10.5	6.2	27.3	8.3	12.0	11.8	7.2	17.2	6.5	22.0	22.9	13.4	8.4	6.8	9.8	8.3	1.6	5.4	6.5	32.5	1.8	9.9	89.2	4.2	12.7	14.3	18.8	13.7	27.9	2.8	17.5	9.3	13.4	3.3	117.6	10.6	8.2	16.9	30.7	2.1	13.1	12.3	30.2	183.6	8.4	5.5	8.2	64.8	9.7	13.5	5.5	17.0	12.4	12.9	8.0	8.4	2.6	8.5	13.1	15.6	18.6	1.7	4.1	15.9	33.2	9.7	14.7	15.3	7.8	9.2
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.8;Excitatory neurons: 24.4;Inhibitory neurons: 38.0;Oligodendrocyte precursor cells: 48.2;Oligodendrocytes: 32.0;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 21.4;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003233, HPA076892"	Approved		Approved	"Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003233: AB_2265929, HPA076892: "	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	2.7	4.4	3.9	1.4	4.1	0.0	2.0	4.2	4.7	5.2	0.6	8.2	0.5	5.1	2.1	1.6	3.4	2.6	2.6	4.0	6.8	1.1	0.2	2.8	0.7	3.3	3.8	7.0	0.5	0.3	4.4	7.5	3.5	8.3	1.9	3.6	0.5	7.3	0.5	0.5	2.0	5.1	3.9	1.8	2.0	2.1	6.2	0.5	2.3	1.5	0.2	4.9	3.3	4.3	0.0	0.0	6.4	4.7	6.4	5.3	0.0	4.3	9.2	4.1	9.3	0.0	0.0	0.1	0.1	5.7	3.2	0.3	21.4	0.0	6.2	0.0	5.8	0.0	0.0	0.0	5.1	0.0	0.1	3.1	0.0	1.6	0.3	10.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.2	0.0	4.6	0.0	5.1	0.6	0.0	8.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	2.5	0.1	6.0	14.0	2.5	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.1	4.2	4.7	4.0	6.8	3.3	3.8	3.5	3.9	6.2	4.3	9.3	3.2	12.3	23.8	0.0	0.6	0.1	0.0	0.6	6.9	0.1	0.3	7.5	0.0	0.0	1.8	0.0	0.1	0.0	0.0	1.9	0.0	9.1	0.1	5.9	6.7	0.0	0.0	24.4	0.0	0.2	6.3	0.0	0.1	0.0	8.4	2.9	0.0	0.6	1.7	38.0	0.0	0.0	0.0	1.0	2.9	8.7	0.1	1.8	9.4	0.0	6.4	0.0	48.2	32.0	0.0	0.0	6.4	0.0	1.2	0.0	0.0	0.0	2.5	26.3	3.6	7.8	5.4	2.9	0.0	0.1	0.3	0.2	5.7	0.0	0.1
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 38.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 38.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	13.1	10.2	7.7	12.0	11.9	8.0	11.4	18.7	9.1	16.2	7.3	16.3	7.0	15.5	7.7	10.7	13.7	10.2	14.6	7.7	12.5	8.2	10.3	11.9	17.0	9.8	8.1	18.8	9.5	12.2	12.3	10.1	8.5	13.9	10.2	19.2	12.0	12.1	19.3	10.8	12.8	14.8	6.0	13.9	11.2	13.1	10.1	15.5	9.7	11.5	18.7	14.8	13.8	15.7	30.5	10.0	28.8	17.5	28.9	35.2	11.0	21.5	25.6	25.3	31.5	26.0	15.5	16.1	33.5	24.9	40.7	19.1	25.7	21.2	34.5	13.3	14.4	29.8	16.2	19.2	18.9	21.4	19.3	25.0	10.9	24.7	31.9	23.0	30.7	14.7	18.1	27.5	23.4	25.1	15.9	7.8	19.3	15.8	22.3	16.0	17.6	10.6	11.3	19.4	14.2	14.4	28.5	18.5	20.1	26.4	39.0	17.1	30.1	19.4	12.0	24.4	22.2	24.5	26.9	15.2	19.8	28.0	20.3	38.9	4.7	10.1	7.4	6.9	6.0	9.3	5.8	6.3	4.1	6.6	5.3	7.5	2.3	7.1	6.9	3.5	6.1	5.4	7.7	11.9	18.7	9.1	7.7	12.5	9.8	8.1	8.5	6.0	10.1	15.7	19.2	32.1	27.0	64.6	29.7	10.6	18.1	11.4	8.0	56.0	11.6	8.5	15.4	14.3	17.0	9.2	56.3	8.5	25.8	10.4	1.9	10.1	12.8	12.2	22.9	20.8	6.0	11.1	69.8	9.9	6.6	23.8	10.7	16.4	11.4	23.0	34.6	14.2	9.0	38.7	86.1	11.0	8.2	17.6	17.9	9.6	25.1	14.6	17.8	66.5	30.8	19.8	27.8	102.1	139.2	14.1	9.5	28.6	15.1	15.9	7.1	5.2	15.1	43.1	19.7	31.7	22.8	18.0	17.2	9.4	10.5	6.0	19.9	17.0	11.0	14.7
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586129	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 205.8;Syncytiotrophoblasts: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 79.6;NB-4: 174.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	29.0	37.5	15.8	25.3	18.3	49.2	26.8	16.8	26.1	32.5	17.0	32.7	19.1	28.3	5.1	35.8	33.7	8.5	28.0	15.5	17.7	35.5	30.9	52.0	33.6	21.4	17.1	55.3	33.5	12.7	51.2	10.9	20.5	36.1	5.5	21.4	36.3	8.8	41.4	30.3	71.6	5.3	16.0	130.1	31.2	112.3	20.3	27.1	47.8	7.2	14.7	24.3	29.9	23.1	15.2	9.8	8.5	9.2	6.5	4.3	17.3	14.5	7.3	9.0	7.1	16.6	24.7	9.9	17.0	3.6	10.7	15.9	5.5	7.0	3.0	10.5	12.2	9.8	12.0	8.1	18.4	18.0	79.6	8.0	7.5	7.6	5.5	7.6	10.3	27.6	18.5	18.7	6.6	32.2	21.2	174.5	11.5	20.5	11.2	25.6	7.1	13.9	10.3	4.2	12.5	18.6	7.8	25.6	20.2	16.2	13.6	40.5	14.4	12.2	23.6	15.2	9.1	23.3	9.9	9.9	9.1	51.6	22.3	22.5	10.6	14.6	5.8	8.4	5.5	6.1	5.9	6.8	7.0	6.6	7.9	6.9	30.6	1.6	5.9	7.7	6.3	3.7	15.8	18.3	16.8	26.1	15.5	17.7	21.4	17.1	20.5	16.0	20.3	23.1	7.5	9.6	12.7	7.5	29.4	12.0	15.4	13.0	5.7	15.9	14.8	8.4	0.8	27.1	15.1	22.0	41.7	39.4	42.9	27.2	15.6	32.7	205.8	11.9	7.7	9.9	6.1	12.2	7.3	24.7	13.9	9.1	14.8	13.5	19.6	12.7	15.4	13.8	32.8	13.5	7.9	11.8	20.3	65.9	33.6	32.3	24.8	40.5	14.2	3.7	66.1	13.6	46.4	4.5	5.2	28.9	13.1	10.1	15.7	12.8	41.9	6.9	12.1	33.5	19.7	9.8	13.3	58.3	33.9	9.0	11.5	103.3	33.7	12.0	10.0	16.4
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391591-40587364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.4;retina: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4;cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 1.7;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.0	0.3	1.6	0.0	6.4	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.7	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	6.4	0.0	5.9	1.3	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.3	0.6	0.0	0.1	0.0	62.6	0.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	4.2	0.0	111.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	62.8	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	3.7	0.0	0.8	0.0	49.8	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.3	0.2	0.0	0.1	0.1
LRFN3	"FIGLER1, MGC2656, SALM4"	ENSG00000126243	"Leucine rich repeat and fibronectin type III domain containing 3"	Q9BTN0	19	35935358-35946624	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048923	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA048923: AB_2680558"	"unprognostic (1.88e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.46e-7)"	"unprognostic (6.84e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.03e-1)"	6.2	6.8	3.6	1.7	3.4	0.1	6.4	4.1	6.0	9.2	0.0	6.8	3.1	10.5	1.0	7.0	7.5	1.9	6.4	3.9	1.2	6.2	8.2	5.1	1.2	2.5	1.5	11.7	8.0	3.4	12.9	1.6	1.3	8.0	1.6	2.0	6.8	3.3	8.1	6.0	6.3	2.9	0.2	5.6	6.5	4.9	2.1	1.0	6.1	1.9	1.1	7.4	7.9	2.0	8.8	10.4	5.4	7.8	10.9	5.8	2.0	3.8	5.7	4.3	4.3	1.9	4.3	5.6	7.3	5.3	5.2	3.2	2.3	5.0	2.5	9.8	3.7	0.6	2.1	1.9	4.0	0.3	7.8	6.2	6.7	2.5	2.7	5.2	5.0	6.7	1.5	8.1	3.9	6.4	4.1	0.2	3.5	7.4	4.5	5.6	3.0	0.1	3.0	3.5	6.1	7.3	5.6	4.3	3.2	2.8	3.2	2.5	5.7	8.9	7.0	7.6	6.0	2.7	3.1	0.2	7.8	3.0	6.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.4	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	3.6	3.4	4.1	6.0	3.9	1.2	2.5	1.5	1.3	0.2	2.1	2.0	5.3	0.0	0.0	0.7	0.9	1.1	3.2	1.9	1.8	7.5	2.0	2.3	11.0	1.5	0.9	3.7	2.1	0.4	0.7	5.9	0.0	3.9	0.5	2.1	2.7	3.0	3.0	0.0	4.3	4.3	2.0	4.0	4.6	2.5	0.0	5.7	8.9	4.6	2.1	8.4	4.2	3.5	4.1	1.0	0.5	1.5	4.4	0.5	0.0	2.8	0.3	4.9	2.1	4.0	1.7	4.3	6.6	7.5	0.6	3.9	6.7	2.5	1.0	5.5	6.6	4.0	3.0	0.2	1.7	1.9	1.1	0.1	1.8	3.3	3.6	2.0
LRFN4	"FIGLER6, MGC3103, SALM3."	ENSG00000173621	"Leucine rich repeat and fibronectin type III domain containing 4"	Q6PJG9	11	66856647-66860475	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077570	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077570: "	"unprognostic (2.25e-2)"	"unprognostic (5.90e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.53e-1)"	15.3	13.4	10.8	2.2	9.2	3.9	12.7	10.6	14.1	11.5	0.0	14.8	1.5	13.4	0.1	8.0	11.6	0.7	12.3	10.6	4.5	12.0	2.6	8.4	1.6	3.8	5.2	6.3	3.0	1.2	7.9	0.9	2.3	8.8	1.3	0.5	9.2	2.3	9.6	9.4	5.9	1.0	2.1	7.7	8.3	22.9	6.0	1.2	5.8	2.0	0.6	9.2	10.7	6.3	22.5	18.9	3.0	8.7	2.3	4.5	0.2	14.5	4.7	8.7	4.7	12.0	10.8	10.6	17.1	5.4	9.6	13.2	5.2	5.0	1.0	5.2	16.7	7.8	51.3	4.6	14.6	16.5	19.8	6.6	7.8	4.0	4.0	5.3	6.4	14.4	21.0	0.4	1.3	47.2	30.5	55.0	25.0	10.2	32.4	22.0	11.8	35.0	3.8	0.1	16.6	16.0	21.1	17.5	51.1	0.6	24.0	12.7	15.1	12.1	23.0	35.0	14.0	10.2	10.1	2.3	7.6	18.2	9.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.1	10.8	9.2	10.6	14.1	10.6	4.5	3.8	5.2	2.3	2.1	6.0	6.3	4.8	0.0	1.1	10.7	1.1	2.2	2.5	7.1	0.0	18.7	3.6	5.7	0.7	0.0	2.9	3.7	4.2	0.2	1.9	15.9	0.0	1.6	17.1	7.6	18.4	4.0	1.8	1.3	9.1	0.8	1.2	4.9	4.1	10.2	1.3	9.5	2.2	0.2	5.3	13.5	9.5	12.3	6.1	3.1	2.2	29.6	3.7	4.3	5.4	1.9	7.6	2.0	3.1	5.0	6.8	4.3	9.6	1.5	1.9	5.9	0.3	0.5	2.6	8.6	0.0	3.8	6.0	5.5	2.2	2.1	1.7	0.3	2.1	11.8	16.2	1.8
LRFN5	"C14orf146, FIGLER8, SALM5"	ENSG00000165379	"Leucine rich repeat and fibronectin type III domain containing 5"	Q96NI6	14	41606876-41904549	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;cervix: 10.1;parathyroid gland: 11.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 873.9;Inhibitory neurons: 581.5;Oligodendrocyte precursor cells: 296.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;HSkMC: 3.1;RPTEC TERT1: 5.2;SCLC-21H: 8.8;U-138 MG: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001177	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA001177: AB_1079274"	"unprognostic (5.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.02e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.92e-3)"	1.4	2.2	5.3	1.0	7.5	0.0	1.4	0.0	16.5	10.1	0.0	2.0	0.2	2.5	0.6	0.5	3.3	1.0	0.6	7.9	5.9	0.2	0.3	0.7	0.0	0.8	1.4	1.6	0.3	11.1	0.8	1.1	4.9	2.4	1.0	2.6	0.3	6.4	0.2	0.6	0.4	1.5	0.8	0.6	0.7	0.9	2.0	0.3	0.5	0.5	0.2	6.1	5.2	4.3	0.0	0.0	1.7	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	8.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.5	0.0	16.5	7.9	5.9	0.8	1.4	4.9	0.8	2.0	4.3	0.5	0.0	0.0	29.7	0.0	0.3	0.0	0.0	0.0	8.2	0.1	0.6	1.0	2.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.2	0.3	7.8	0.9	0.0	0.0	873.9	0.0	0.1	7.9	0.0	0.6	0.0	0.2	0.0	0.5	0.1	0.0	581.5	0.0	0.0	0.0	0.8	1.7	8.4	0.1	1.8	24.4	0.0	0.4	0.0	296.1	11.8	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.4	1.5	0.0	2.1	0.0	0.3	0.1	0.2	2.1	0.0	0.1
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 944.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	7.2	4.5	0.6	17.8	0.5	31.4	4.3	1.2	2.6	8.7	1.1	7.3	6.7	1.9	5.9	22.7	10.0	15.5	1.2	0.6	0.6	9.8	944.2	7.8	0.8	0.7	0.7	1.5	44.1	0.1	1.6	1.9	1.9	4.4	4.7	0.1	20.9	6.2	1.0	4.8	3.3	2.2	0.5	16.2	13.6	0.3	0.9	1.2	1.3	1.4	6.5	13.3	3.8	0.9	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.2	2.6	0.6	0.6	0.7	0.7	1.9	0.5	0.9	0.9	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
LRGUK	"CFAP246, FLJ32786"	ENSG00000155530	"Leucine rich repeats and guanylate kinase domain containing"	Q96M69	7	134127299-134264591	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.2;fallopian tube: 3.7;testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 27.6;Endometrial ciliated cells: 13.8;Excitatory neurons: 21.8;Inhibitory neurons: 13.9;Ionocytes: 12.2;Respiratory ciliated cells: 21.5;Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.9;SH-SY5Y: 1.8;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029505, HPA029506"	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029505: AB_10599606, HPA029506: AB_10601752"	"unprognostic (4.08e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.85e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.10e-2)"	0.2	0.2	0.8	0.2	0.9	0.5	0.4	0.0	0.6	0.4	5.2	0.2	0.1	0.3	1.5	0.1	3.7	0.2	0.1	1.3	1.0	0.5	0.4	0.5	0.1	3.0	3.0	0.1	0.8	0.1	0.7	0.0	1.7	0.6	0.2	2.1	0.5	0.1	0.0	0.4	0.2	0.1	1.6	0.5	0.2	4.8	1.4	0.2	0.5	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.2	1.9	0.0	0.4	0.2	0.0	0.0	0.3	0.1	0.6	1.8	0.5	0.0	1.9	0.2	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.4	0.6	0.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.6	1.3	1.0	3.0	3.0	1.7	1.6	1.4	0.6	0.2	0.0	0.0	5.5	0.1	0.0	0.1	0.4	0.6	0.0	0.8	0.5	0.4	1.5	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	27.6	13.8	0.5	0.3	0.0	0.0	21.8	0.4	0.0	0.4	0.0	1.2	0.0	0.8	0.0	0.4	0.2	0.0	13.9	0.0	12.2	0.0	0.3	2.1	0.3	0.2	1.8	5.6	0.0	0.9	0.0	5.0	2.5	0.0	0.0	0.4	0.1	0.1	0.0	0.2	21.5	2.1	0.0	0.3	0.6	8.6	0.9	0.3	0.4	0.3	0.1	0.5	0.0	0.2
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947190-110963965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	6.6	9.4	8.7	10.3	9.1	5.5	11.4	10.7	18.5	6.2	8.5	6.5	6.0	6.8	19.8	5.6	8.1	5.0	14.5	9.2	10.3	7.9	13.2	6.8	16.0	8.4	8.7	15.5	6.1	6.5	7.7	10.0	8.7	8.2	6.4	21.5	7.2	5.4	18.2	9.3	6.0	4.7	8.7	13.0	7.1	25.7	9.5	13.3	10.9	17.3	17.4	7.6	4.5	10.0	33.2	14.4	26.8	18.4	12.3	19.8	30.2	19.9	22.7	33.8	27.2	36.4	40.4	25.2	27.5	15.1	36.5	21.0	12.9	12.0	40.6	45.9	15.2	27.9	14.3	37.4	35.8	52.7	32.5	12.5	32.3	23.5	41.0	14.4	18.6	26.4	88.3	111.5	23.2	11.1	5.4	41.4	40.0	20.1	32.6	35.0	43.4	30.5	8.8	17.0	22.3	24.4	0.1	33.8	59.1	16.3	28.0	83.6	13.5	30.0	1.0	35.4	16.3	51.7	19.4	46.9	17.1	59.2	53.6	24.8	8.3	18.6	21.0	9.4	26.6	29.9	16.6	22.1	16.8	22.7	18.1	24.8	31.4	28.2	13.0	15.0	16.9	12.8	8.7	9.1	10.7	18.5	9.2	10.3	8.4	8.7	8.7	8.7	9.5	10.0	22.5	12.8	8.4	11.8	39.4	14.4	48.4	21.0	19.9	22.4	27.9	35.1	27.8	8.6	17.0	9.2	18.8	19.5	21.9	15.5	15.6	18.8	15.3	15.9	15.2	21.5	11.3	24.8	17.9	19.9	32.3	16.5	23.0	18.5	8.2	11.2	17.5	31.8	13.9	15.2	16.5	13.2	18.3	10.7	53.1	11.4	15.8	23.2	32.0	3.7	20.1	28.6	49.4	4.0	16.1	23.4	12.9	13.9	28.4	56.8	10.0	11.8	22.3	35.1	13.1	20.0	19.0	49.9	54.8	25.1	17.6	37.8	31.5	21.4	11.3	50.9
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073198-113132260	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		2100000	"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	2.6	2.2	3.1	2.1	4.6	1.0	2.7	4.7	3.4	3.2	3.2	2.9	2.8	3.1	3.8	2.3	2.5	1.4	2.4	2.8	3.6	2.2	2.0	2.0	2.6	4.2	3.8	3.8	2.6	2.9	2.9	2.4	3.9	2.5	2.1	6.4	2.4	2.2	3.9	4.5	3.0	1.7	3.8	3.0	2.3	1.7	3.9	2.9	3.4	2.1	2.4	2.5	2.7	6.8	2.6	1.3	3.8	2.9	3.6	3.6	2.1	1.6	2.4	1.9	3.2	2.0	1.6	2.6	2.8	2.0	1.1	2.8	2.6	1.7	3.2	1.8	1.5	2.8	2.9	1.0	3.6	3.4	1.3	3.6	3.1	3.0	4.0	2.9	2.5	3.6	3.4	2.4	2.4	1.9	3.5	3.5	3.5	1.0	2.3	3.1	4.8	1.3	1.9	1.7	2.6	2.1	2.8	1.8	3.6	3.1	1.4	3.8	3.9	3.5	1.9	4.9	2.6	2.6	1.3	2.6	3.8	2.1	3.3	1.9	0.7	0.5	0.8	0.6	1.0	0.9	1.0	0.9	0.6	1.4	1.1	1.0	0.4	1.4	0.7	0.7	0.8	0.5	3.1	4.6	4.7	3.4	2.8	3.6	4.2	3.8	3.9	3.8	3.9	6.8	9.4	0.0	15.5	14.4	12.7	8.4	3.1	5.7	8.0	21.0	7.0	7.2	11.6	7.2	7.1	14.7	37.5	7.8	14.6	13.5	0.0	3.2	1.3	6.9	14.6	9.4	5.4	5.5	22.9	2.6	5.1	10.2	13.7	8.0	5.7	22.0	6.1	5.4	4.8	18.5	23.8	8.7	0.0	8.2	5.6	0.9	18.3	6.4	7.2	19.7	11.9	20.6	17.5	25.1	40.9	3.3	7.5	16.1	7.8	5.5	8.9	4.4	10.8	23.4	0.0	12.6	8.2	11.1	16.1	5.5	6.7	5.3	10.3	20.4	9.8	3.3
LRIG3	"FLJ90440, KIAA3016"	ENSG00000139263	"Leucine rich repeats and immunoglobulin like domains 3"	Q6UXM1	12	58872149-58920504	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 42.8;Basal squamous epithelial cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 49.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010773	Approved		Approved	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA010773: AB_1853275"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.46e-2)"	20.8	2.6	3.5	6.7	4.3	0.1	18.8	2.6	3.3	21.0	11.2	18.6	14.2	12.5	10.6	22.3	14.3	17.7	5.3	3.7	3.0	10.3	10.3	10.4	4.3	4.2	5.4	22.4	18.9	9.1	7.1	11.5	3.4	10.5	25.6	1.8	32.9	10.4	4.0	35.9	13.4	15.4	4.5	8.7	17.9	3.3	4.1	12.2	58.2	7.8	9.6	18.6	18.5	7.6	3.9	3.6	13.6	1.0	24.2	28.0	3.1	9.2	26.4	8.7	9.3	10.9	5.0	3.7	18.3	10.3	10.5	17.9	5.1	23.3	6.3	28.1	17.8	0.9	6.3	5.4	4.7	1.6	0.4	27.9	49.8	9.3	19.8	16.9	24.1	4.2	0.2	4.5	5.8	1.8	4.5	0.1	14.4	4.6	5.5	0.0	11.5	9.2	6.7	19.8	13.8	0.0	8.1	5.0	8.6	19.0	9.3	0.2	10.4	11.8	8.1	7.1	12.2	1.9	0.0	0.0	2.5	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	2.6	3.3	3.7	3.0	4.2	5.4	3.4	4.5	4.1	7.6	17.1	16.0	24.6	17.9	0.1	22.4	8.2	42.8	44.9	3.8	6.3	10.3	3.7	34.3	23.0	1.8	0.0	0.8	0.5	24.5	0.0	11.8	0.3	8.2	37.0	16.2	11.5	0.0	1.8	18.1	0.5	19.6	23.4	4.6	0.0	0.1	12.1	7.3	2.6	3.3	6.0	11.4	16.2	0.3	8.2	1.8	27.1	0.4	3.6	9.4	0.0	3.4	0.0	3.5	22.4	7.4	15.6	29.0	1.8	4.4	8.7	4.9	14.1	0.2	6.6	10.6	11.3	0.5	2.0	25.3	22.4	0.3	1.0	15.0	31.5	4.7
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220571-84225544	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"retina: 59.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.5;Cone photoreceptor cells: 8.4;Rod photoreceptor cells: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	59.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848107-109872315	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"retina: 17.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 33.3;Muller glia cells: 10.2;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.2	0.2	0.4	0.0	0.5	0.1	0.3	0.3	0.6	0.4	0.2	0.2	0.0	0.2	0.3	0.2	0.3	0.0	0.1	0.4	0.2	0.7	0.3	0.2	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.4	0.3	0.0	17.6	0.2	0.1	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.6	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	33.3	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	10.2	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431624-76560168	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.5;epididymis: 59.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	16.1	61.5	8.0	5.4	8.6	27.5	10.3	7.7	7.7	12.0	4.7	8.1	5.8	6.4	59.5	7.5	9.7	10.2	13.3	7.8	8.4	20.6	35.8	12.8	5.2	11.5	9.6	13.0	24.9	20.6	10.1	12.7	11.8	10.7	7.2	2.4	9.2	10.0	2.7	3.1	4.5	9.0	10.2	10.5	16.8	3.7	10.9	4.1	18.6	4.8	5.1	11.4	4.5	11.5	0.3	5.7	0.2	0.1	2.9	3.5	0.1	0.7	0.0	0.3	0.5	7.6	13.4	0.0	25.8	0.0	0.1	0.3	0.0	0.0	0.1	0.5	1.6	1.6	2.9	46.3	1.1	9.4	34.0	1.4	1.0	0.6	0.1	5.5	0.8	0.1	0.0	1.4	0.1	1.0	0.1	65.6	0.3	3.9	2.2	0.1	0.2	0.1	0.6	8.3	0.3	0.4	8.1	0.0	93.0	0.2	0.5	48.7	0.9	0.3	3.1	2.4	5.3	0.4	0.2	0.2	22.6	43.6	11.3	6.4	57.6	22.1	0.1	28.8	0.3	0.1	0.0	0.0	67.5	0.1	0.1	0.1	3.2	7.1	17.1	0.5	0.2	18.9	8.0	8.6	7.7	7.7	7.8	8.4	11.5	9.6	11.8	10.2	10.9	11.5	42.4	22.4	19.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	5.7	0.0	0.0	3.7	12.9	0.0	1.1	0.8	0.0	33.2	16.6	0.0	27.8	2.5	13.2	0.0	0.0	0.0	15.8	0.8	4.5	0.0	10.0	7.6	16.1	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	113.4	6.6	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	1.2	0.6	25.7	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589258	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.7;Excitatory neurons: 78.7;Inhibitory neurons: 53.7;Oligodendrocyte precursor cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 47.0"	"Lineage enriched"	"Detected in many"	32	"granulocytes: 47.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	5.7	4.7	5.1	3.9	8.8	2.2	4.3	4.7	9.4	6.4	3.1	4.8	3.1	16.5	4.0	4.1	5.8	7.5	13.6	13.8	5.3	6.5	1.5	4.6	1.6	1.8	2.3	6.1	4.5	10.0	3.1	5.3	1.1	6.5	4.8	6.1	3.8	5.9	9.3	3.1	3.0	18.5	2.4	3.7	2.8	4.9	3.1	12.9	6.8	17.2	2.3	7.6	3.2	3.9	18.5	10.6	21.1	37.1	23.4	18.4	4.7	51.5	51.3	17.6	24.6	2.4	17.7	0.0	20.2	49.0	21.2	8.1	8.6	22.0	37.7	34.3	8.2	28.7	4.7	0.8	14.4	0.4	22.1	24.8	15.4	29.5	23.7	63.4	9.1	21.9	6.2	0.0	63.9	3.0	26.5	0.6	5.3	1.6	18.2	2.1	20.5	4.0	13.9	0.8	27.0	16.4	16.4	0.7	44.6	15.8	5.0	5.6	25.7	48.1	31.0	15.7	33.6	23.8	20.2	0.2	25.9	0.0	53.9	47.0	0.3	5.8	0.2	0.8	1.4	0.0	1.0	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.5	0.4	0.1	0.4	5.1	8.8	4.7	9.4	13.8	5.3	1.8	2.3	1.1	2.4	3.1	3.9	4.4	16.0	2.2	42.7	0.2	11.5	6.3	12.3	10.8	17.5	3.9	4.3	11.7	7.2	5.2	14.7	6.2	0.2	1.7	2.0	0.0	4.6	4.3	4.4	16.4	5.9	14.4	2.5	78.7	4.5	0.5	12.6	1.5	5.5	8.2	10.9	4.2	0.8	5.3	28.6	53.7	2.5	10.2	7.9	14.3	2.7	8.7	8.2	7.2	9.4	6.1	3.1	1.0	64.3	25.2	5.1	0.3	9.1	0.1	7.7	1.5	3.8	5.3	8.3	6.6	8.2	11.3	8.5	12.0	3.2	10.9	0.3	3.9	4.5	2.3	5.2
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131016	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2119.8;Excitatory neurons: 3755.5;Inhibitory neurons: 2917.8;Oligodendrocyte precursor cells: 5568.9;Oligodendrocytes: 1203.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.8;glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.5;HEK 293: 1.7;U-138 MG: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069094, HPA074788"	Approved		Approved	Vesicles		NA	NA		370000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA069094: AB_2686082, HPA074788: AB_2797273"	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	3.1	1.4	18.6	0.0	22.5	0.0	1.6	7.2	18.7	0.3	0.0	0.3	0.0	0.0	2.2	0.0	0.3	0.1	0.3	21.5	8.7	0.4	0.2	0.1	0.0	6.8	9.4	0.6	0.1	0.1	1.9	0.0	8.2	0.9	0.0	2.6	0.6	1.0	4.4	0.4	0.1	0.0	3.3	0.0	0.4	0.3	11.5	0.2	5.6	3.5	0.0	0.1	0.9	19.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.6	22.5	7.2	18.7	21.5	8.7	6.8	9.4	8.2	3.3	11.5	19.8	1.4	0.0	0.0	2119.8	0.0	0.3	0.5	0.0	3.4	14.9	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.1	1.7	0.2	0.0	0.0	3755.5	0.0	0.0	9.1	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.0	2917.8	0.0	0.0	0.0	0.5	5.4	1.2	0.1	0.0	142.4	0.0	2.4	0.0	5568.9	1203.1	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.8	0.0	1.1	0.4	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.8
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRP2BP	DKFZp761O0113	ENSG00000109771	"LRP2 binding protein"	Q9P2M1	4	185363872-185395924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036664, HPA036665"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036664: AB_10672361, HPA036665: AB_10673660"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.15e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-4)"	"unprognostic (2.17e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-4)"	1.7	2.1	6.7	0.7	6.9	0.4	1.6	15.0	7.9	2.7	9.8	3.6	0.3	1.8	2.3	1.0	6.9	0.9	3.6	6.5	7.5	4.8	1.6	4.4	0.7	11.4	10.0	8.5	3.2	0.2	17.4	0.6	8.7	3.7	0.4	28.9	1.5	0.5	3.0	1.5	1.9	0.3	9.8	2.7	1.7	10.7	8.1	0.2	3.5	0.7	0.1	2.1	1.7	10.8	0.5	0.4	0.5	1.1	0.3	0.1	1.0	1.5	0.4	0.0	0.3	0.5	0.5	1.8	0.1	0.1	0.5	0.3	0.3	0.2	0.2	1.7	0.9	0.4	1.5	1.6	0.2	0.3	0.5	0.3	0.2	0.7	0.2	1.5	0.4	1.3	0.6	1.4	0.4	0.1	0.6	1.2	0.6	0.0	0.2	0.3	0.3	0.4	0.4	0.3	1.2	0.8	0.3	0.4	1.0	0.7	0.4	0.1	1.4	0.8	0.6	0.2	0.8	5.3	0.5	0.3	1.3	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.2	0.0	0.5	0.3	0.2	0.1	0.1	0.1	0.5	0.2	0.0	6.7	6.9	15.0	7.9	6.5	7.5	11.4	10.0	8.7	9.8	8.1	10.8	3.1	9.6	2.6	57.5	3.5	2.4	4.1	1.3	2.8	28.8	3.0	2.4	5.5	0.0	1.8	0.0	33.3	1.2	3.3	1.7	0.0	1.5	62.1	17.6	3.1	3.2	7.8	0.0	28.0	0.9	2.5	2.1	2.6	4.4	0.0	1.9	1.4	0.3	0.5	26.9	34.2	2.4	4.1	1.2	1.4	42.3	2.8	1.9	5.4	3.7	0.8	10.4	0.0	40.2	34.9	1.0	0.2	3.8	2.5	4.3	2.6	1.6	14.1	34.0	0.0	5.4	2.8	8.4	1.9	0.8	3.1	1.6	3.1	2.1	1.0	2.1
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.7;skin 1: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	23.3	0.9	30.5	0.0	1.5	19.1	21.3	2.3	0.0	4.8	3.4	1.6	0.9	1.8	1.4	2.0	6.9	24.2	16.0	0.7	0.2	2.9	0.1	46.7	23.0	4.6	2.2	5.6	2.6	2.6	19.8	2.1	3.4	7.9	1.7	2.3	4.4	31.6	4.9	1.5	21.3	3.9	7.8	1.1	30.9	1.5	2.4	7.7	0.3	0.9	1.4	25.6	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	30.5	19.1	21.3	24.2	16.0	46.7	23.0	19.8	21.3	30.9	25.6	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
LRP5	"BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2"	ENSG00000162337	"LDL receptor related protein 5"	O75197	11	68312591-68449275	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Disease variant, Osteogenesis imperfecta, Osteopetrosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.7"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 84.7;Proximal enterocytes: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013001, HPA030505"	Approved					NA	NA		1500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB013001: AB_2533267, HPA030505: AB_2673505"	"unprognostic (3.67e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.82e-2)"	"prognostic favorable (3.55e-10)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.42e-2)"	35.6	37.6	9.6	6.9	11.4	3.2	36.9	10.9	11.2	26.0	44.4	32.4	43.1	30.6	4.1	18.5	26.4	21.0	35.7	8.6	9.2	30.3	129.7	23.3	4.3	12.6	11.9	27.9	34.9	11.6	15.9	23.2	11.7	25.1	11.2	1.7	73.3	20.0	10.4	19.3	44.8	11.1	10.1	8.9	31.8	5.6	10.2	9.6	33.4	7.3	2.6	24.5	19.4	10.6	30.9	103.6	11.0	25.4	20.6	11.4	47.0	14.0	12.1	8.3	7.5	58.7	104.2	0.0	87.5	18.2	35.1	38.9	9.9	37.3	1.2	5.0	22.6	21.6	52.8	77.2	20.8	15.8	2.0	16.4	12.5	0.4	13.6	22.3	23.7	18.8	38.5	1.6	6.0	69.5	23.7	62.7	19.6	161.2	41.7	29.6	30.1	49.7	14.2	82.1	10.6	21.6	37.0	49.4	41.0	5.3	34.6	36.2	31.5	0.2	9.0	11.6	15.8	6.3	0.8	6.3	0.0	9.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	9.6	11.4	10.9	11.2	8.6	9.2	12.6	11.9	11.7	10.1	10.2	10.6	37.4	6.4	5.4	17.0	1.1	9.2	8.5	11.3	10.8	0.2	24.4	23.2	5.6	21.5	9.6	7.3	0.0	49.0	0.0	42.7	0.0	11.7	1.1	19.2	6.5	20.4	17.5	10.7	1.1	9.8	6.7	10.6	30.5	12.5	1.3	84.7	31.8	52.5	8.4	0.0	5.7	43.0	18.3	3.2	4.6	1.0	3.1	1.7	1.8	11.2	1.3	8.8	0.0	13.0	5.2	12.5	32.4	9.8	5.7	13.0	54.9	8.5	4.8	0.1	6.6	18.5	10.9	0.8	7.3	7.6	5.3	24.8	1.0	1.3	25.1	13.8
LRP6	ADCAD2	ENSG00000070018	"LDL receptor related protein 6"	O75581	12	12116025-12267044	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 96.6;Oligodendrocyte precursor cells: 108.0;Oligodendrocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004490, HPA029925"	Enhanced					NA	NA		390000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB004490: AB_627894, HPA029925: AB_10601768"	"unprognostic (1.80e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.47e-1)"	3.7	2.2	2.0	1.2	3.9	0.2	4.5	2.5	2.0	6.6	13.5	4.6	2.8	6.5	1.9	2.0	4.4	2.8	3.3	2.0	2.8	4.4	7.9	4.6	0.8	2.2	2.7	5.4	4.9	6.2	2.6	8.3	1.7	3.4	2.8	2.8	6.8	3.2	4.5	3.4	2.7	4.1	1.8	0.9	3.4	2.1	2.8	1.2	4.5	4.6	1.0	3.4	5.3	2.9	3.9	13.3	9.9	5.3	6.1	4.0	7.8	5.8	5.4	4.6	5.3	6.5	3.6	0.0	2.8	5.6	3.8	3.7	14.6	3.7	8.7	0.0	3.9	4.1	4.9	3.2	2.1	5.7	2.8	3.2	2.0	6.9	5.4	5.1	4.8	4.1	5.0	0.0	3.0	3.2	4.2	1.1	14.4	2.2	1.7	5.3	9.2	1.0	6.8	7.6	2.0	5.6	7.4	2.5	6.0	11.5	2.0	3.7	6.9	3.6	13.2	2.6	4.9	0.0	0.0	1.9	2.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.9	2.5	2.0	2.0	2.8	2.2	2.7	1.7	1.8	2.8	2.9	21.6	41.7	49.5	96.6	1.0	15.4	8.6	11.9	9.6	28.2	20.1	19.0	15.4	11.5	16.6	14.7	22.9	3.7	0.5	20.4	1.9	9.0	1.0	18.0	39.0	25.9	10.8	0.4	58.2	13.7	3.2	24.0	25.5	29.1	0.0	32.8	22.1	46.7	2.3	6.7	58.0	12.9	10.2	2.4	6.0	5.1	30.4	1.7	14.2	35.6	0.6	19.9	1.0	108.0	97.0	11.3	20.5	38.7	1.6	14.7	15.1	5.2	6.0	29.0	0.0	21.5	17.3	21.5	26.4	11.0	13.8	3.4	1.9	23.7	14.4	8.1
LRP8	"APOER2, HSZ75190, LRP-8, MCI1"	ENSG00000157193	"LDL receptor related protein 8"	Q14114	1	53242364-53328469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.0;thyroid gland: 41.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Bipolar cells: 45.3;Excitatory neurons: 35.9;Granulosa cells: 67.0;Inhibitory neurons: 116.4;Microglial cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073031	Enhanced				"Secreted in other tissues"	NA	NA		2000000	"Cluster 11: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"			"HPA073031: AB_2732217"	"unprognostic (3.83e-2)"	"unprognostic (6.06e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (3.46e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.03e-3)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.88e-16)"	"unprognostic (7.73e-3)"	"unprognostic (5.47e-2)"	"unprognostic (6.98e-2)"	"unprognostic (3.00e-2)"	1.9	1.4	13.6	4.9	14.2	5.3	1.4	13.6	15.4	1.9	15.5	1.4	1.4	1.6	1.8	7.5	2.7	1.3	1.2	13.7	13.3	1.4	0.3	2.9	5.2	11.2	10.6	1.1	0.7	0.4	5.2	2.0	12.9	1.1	1.8	11.9	1.5	1.2	0.7	1.6	2.1	2.0	7.9	2.6	1.0	24.0	13.4	2.8	41.5	0.4	4.8	1.6	2.7	13.3	22.2	37.4	18.0	22.5	10.1	10.3	22.9	30.5	19.1	32.4	24.2	10.4	23.2	29.3	29.5	13.3	48.0	35.7	13.3	25.2	15.9	22.2	11.4	20.8	43.3	20.2	9.5	38.2	31.9	3.4	2.7	33.1	17.0	5.8	26.6	24.8	7.5	14.6	6.5	23.6	21.1	19.8	34.8	21.0	27.4	32.1	25.8	31.6	15.6	15.3	38.7	15.3	13.1	67.0	14.6	11.3	8.4	25.1	25.5	9.5	14.6	23.1	51.4	25.6	37.5	12.8	47.9	54.4	53.3	1.4	0.4	0.2	0.5	0.1	0.4	0.3	0.3	0.3	0.2	0.4	0.2	0.3	1.3	0.4	0.1	1.3	0.5	0.2	13.6	14.2	13.6	15.4	13.7	13.3	11.2	10.6	12.9	7.9	13.4	13.3	0.8	0.0	6.1	30.7	2.2	1.5	2.5	1.6	0.0	45.3	1.2	0.8	2.6	0.0	4.3	0.0	0.0	2.1	8.9	0.3	0.0	2.1	7.4	4.4	2.5	4.1	2.4	3.4	35.9	2.4	1.8	1.7	0.0	10.1	1.3	67.0	0.7	0.1	1.9	26.9	116.4	2.2	2.0	3.2	2.1	5.1	0.6	2.4	0.0	43.1	7.0	1.5	5.2	17.6	2.4	4.4	0.2	2.6	4.4	13.7	0.0	0.1	10.2	2.8	0.0	2.8	2.2	3.6	1.1	4.4	1.4	9.7	3.0	1.8	0.8	8.1
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3503612-3532446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 584.3;Syncytiotrophoblasts: 693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"		NA	NA		810000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	6.6	9.0	6.6	2.6	10.3	6.0	6.4	8.6	7.6	8.9	10.7	7.6	3.3	8.6	3.2	5.8	7.5	1.9	19.3	5.8	8.1	12.7	9.6	8.5	2.1	8.0	6.9	9.5	14.4	7.7	14.4	6.3	7.9	8.2	1.7	2.8	10.1	4.1	8.9	6.3	6.7	1.9	5.2	8.6	9.2	9.2	7.5	1.6	8.9	2.4	1.4	7.3	6.3	6.3	3.7	7.4	5.7	8.2	5.5	2.9	12.5	5.9	4.8	4.3	3.1	14.9	7.0	2.1	6.0	4.2	7.0	6.2	3.4	5.8	2.4	1.6	7.9	2.9	7.8	10.4	4.2	4.7	12.5	4.0	4.3	3.9	1.9	4.7	5.2	3.9	5.1	7.0	3.6	5.9	3.1	18.4	4.9	5.1	7.8	4.3	4.2	7.1	4.8	8.6	5.6	4.6	7.4	3.0	8.1	3.4	6.7	8.6	5.6	5.1	4.7	4.1	8.2	4.2	2.9	2.8	5.9	13.3	7.2	21.9	23.2	60.1	9.3	19.7	8.1	9.9	8.6	8.8	13.3	10.0	9.4	8.6	20.5	11.7	19.1	10.2	11.5	27.3	6.6	10.3	8.6	7.6	5.8	8.1	8.0	6.9	7.9	5.2	7.5	6.3	95.0	109.0	90.9	21.2	78.0	67.8	174.6	267.7	52.9	70.6	75.3	84.2	165.9	108.7	158.7	195.0	45.9	584.3	75.8	147.7	50.9	159.3	40.4	85.5	229.6	88.2	82.6	35.7	22.5	107.9	184.0	152.5	79.0	71.2	81.1	102.3	62.4	92.6	243.1	38.7	20.6	121.6	164.8	100.5	80.2	60.0	126.2	154.2	147.7	16.9	107.1	140.0	91.6	28.1	16.7	95.4	153.4	151.6	205.2	124.5	204.6	273.7	144.8	86.2	78.9	82.8	108.1	272.5	161.4	40.7	61.4	693.5	86.0	99.9	109.9	140.5
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886224-43995989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	32.2	33.2	30.1	23.8	31.3	49.6	41.6	39.3	35.4	23.9	49.2	50.6	33.4	32.5	28.4	28.4	27.6	18.2	47.0	30.8	31.8	63.5	48.3	19.6	31.2	33.0	30.4	34.1	30.4	48.7	19.2	27.2	35.2	27.7	48.9	40.4	27.8	25.3	100.9	30.2	30.3	27.6	30.2	24.3	27.1	33.2	32.1	29.3	31.2	93.5	31.7	27.0	22.5	36.3	127.8	101.9	62.3	80.0	58.1	79.9	108.0	82.7	59.4	88.0	67.3	164.4	65.7	181.7	78.4	50.8	58.8	105.2	118.8	86.3	116.8	110.2	75.2	164.2	76.5	217.9	85.5	239.9	71.4	77.3	73.8	81.6	130.4	49.2	71.2	53.6	246.5	71.5	75.8	68.5	126.8	273.7	104.0	123.8	71.8	139.7	140.7	147.6	95.3	115.3	111.0	107.3	93.6	120.6	154.5	79.2	90.1	140.6	62.6	63.2	86.4	66.9	89.2	72.5	87.4	156.2	60.0	144.1	55.6	10.5	16.5	2.9	13.3	16.2	25.5	22.5	18.0	17.9	23.5	24.5	24.8	21.9	1.2	20.3	18.9	9.6	16.3	20.2	30.1	31.3	39.3	35.4	30.8	31.8	33.0	30.4	35.2	30.2	32.1	36.3	29.2	22.4	34.1	56.8	46.2	46.3	27.2	34.6	46.1	66.4	37.6	30.4	97.2	32.9	35.4	46.0	31.3	37.1	22.5	33.1	21.5	25.6	5.3	31.2	48.2	30.4	27.5	58.4	91.6	17.7	23.6	32.4	40.2	40.1	29.2	51.0	22.1	55.1	25.2	65.6	96.5	49.2	20.3	38.8	25.9	6.3	25.1	28.9	21.4	38.4	36.8	24.5	23.7	55.3	94.9	20.0	33.0	23.7	34.4	31.9	36.6	62.3	25.8	57.0	13.1	45.8	32.6	27.2	33.3	53.9	44.3	33.2	32.2	63.7	76.0	31.9
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	5.5	1.6	9.1	1.7	22.6	5.6	1.7	2.1	3.0	1.6	12.2	9.6	3.7	2.4	6.7	3.3	3.6	3.2	1.5	1.6	3.1	6.1	4.2	14.0	1.8	1.7	2.4	4.3	2.9	1.2	4.0	1.8	3.2	10.0	3.2	4.1	3.4	4.0	4.7	10.1	6.1	1.7	7.5	4.6	29.1	1.8	23.2	3.4	4.8	13.3	5.4	3.5	1.9	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.7	1.7	2.1	1.5	1.6	1.8	1.7	1.8	1.7	1.8	1.9	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 115.1;Late spermatids: 117.0;Oligodendrocytes: 138.8;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	14.0	2.2	8.7	5.1	13.8	2.9	13.3	10.1	11.2	13.2	13.7	25.5	17.3	5.1	7.5	18.2	8.5	7.8	4.2	9.2	10.4	7.7	0.8	7.6	2.7	13.9	10.8	4.8	8.8	22.6	7.9	11.1	14.2	8.7	25.4	7.1	16.7	6.7	1.5	22.5	18.1	5.1	10.9	1.5	14.8	14.5	11.1	13.9	15.3	1.4	10.7	14.5	18.0	24.1	45.2	5.7	6.1	10.9	1.6	0.8	42.8	6.1	12.3	5.2	7.1	49.4	21.7	6.4	4.9	3.9	9.7	21.7	47.9	19.4	6.6	7.9	13.8	3.9	4.5	33.5	15.2	4.9	2.9	1.6	15.8	0.4	11.5	8.1	9.4	23.1	0.9	5.8	2.9	19.7	33.6	0.6	4.8	33.5	4.2	6.8	10.2	3.3	14.1	57.4	15.7	1.5	7.3	31.7	9.9	15.2	20.6	5.0	4.3	3.9	12.6	0.2	5.6	5.8	4.9	4.6	4.4	6.7	4.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	8.7	13.8	10.1	11.2	9.2	10.4	13.9	10.8	14.2	10.9	11.1	24.1	19.8	41.7	3.9	53.2	2.9	52.6	25.5	16.3	12.0	43.0	16.0	8.1	3.5	11.5	20.6	16.5	4.2	54.5	2.3	115.1	7.9	20.5	88.5	38.8	9.4	18.8	18.0	1.7	11.9	15.6	62.0	5.9	26.0	74.3	5.7	10.5	8.6	0.3	5.1	8.4	21.9	23.6	12.2	0.6	7.1	117.0	9.3	1.3	10.6	26.2	2.5	32.7	6.2	35.2	138.8	29.5	62.5	10.1	4.2	18.5	32.5	12.3	14.1	3.0	6.6	3.5	3.7	27.3	7.3	19.9	52.7	107.4	3.1	1.6	24.5	32.5
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508749-61511018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4"	"Region enriched"	"Detected in many"	7	"basal ganglia: 222.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 30.9;hippocampal formation: 24.2"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	3.7	0.9	11.1	0.4	42.4	0.0	2.9	0.5	11.2	5.9	3.6	2.2	0.3	4.9	1.9	0.5	28.7	0.3	1.7	13.5	5.2	2.2	0.1	4.9	0.0	4.0	4.0	2.3	1.3	2.2	33.7	0.5	2.1	1.6	0.3	0.1	1.3	0.5	0.7	0.9	1.4	1.6	3.1	0.4	2.9	5.9	7.9	2.7	1.6	0.9	0.0	1.1	2.5	3.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	5.4	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	42.4	0.5	11.2	13.5	5.2	4.0	4.0	2.1	3.1	7.9	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.6	0.4	1.1	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	3.2	49.3	0.5	0.4	4.2	0.0	1.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	37.2	0.2	19.7	0.7	20.6	0.8	1.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	8.6	13.1	10.4	6.4	9.9	7.5	9.7	14.9	11.8	15.6	3.1	15.0	7.5	16.2	5.8	14.1	13.1	5.7	10.9	11.8	7.1	11.8	11.9	9.8	9.3	9.9	9.0	12.9	16.2	8.3	16.0	4.9	9.4	19.4	5.3	3.3	12.0	8.1	11.4	13.1	13.3	5.6	9.1	14.5	14.2	11.7	9.1	7.1	16.8	5.0	6.6	14.6	12.2	10.8	18.2	36.2	9.7	15.8	10.2	8.3	13.8	15.9	6.8	12.6	10.8	15.9	21.6	14.5	16.5	11.9	7.7	19.4	15.3	15.8	5.7	19.7	34.8	21.9	42.7	6.9	9.5	9.3	17.3	10.1	13.3	12.7	6.2	10.4	10.9	16.6	29.2	17.1	12.4	22.3	34.9	12.2	7.9	15.8	51.8	29.6	8.0	20.9	7.6	15.6	26.4	14.7	24.2	19.3	11.2	5.7	29.8	10.3	11.8	21.4	37.6	19.0	23.7	9.5	6.0	18.2	20.1	21.4	13.4	1.6	7.2	1.6	8.3	6.8	8.0	7.8	6.2	7.8	7.2	7.9	6.7	5.6	3.8	11.4	6.0	8.4	6.7	8.0	10.4	9.9	14.9	11.8	11.8	7.1	9.9	9.0	9.4	9.1	9.1	10.8	6.3	6.4	3.1	6.5	10.9	6.4	5.0	3.4	9.1	11.5	9.8	9.5	4.6	14.3	6.0	9.2	2.1	6.9	6.9	10.3	5.9	5.4	2.8	6.3	6.8	7.3	5.4	8.4	3.8	8.2	6.6	5.8	10.2	6.4	7.0	11.2	8.9	9.8	7.7	11.8	2.8	8.1	2.0	6.0	4.0	3.9	7.5	4.4	1.8	8.4	7.4	9.5	9.2	6.6	3.3	7.3	4.9	7.9	11.1	8.3	6.0	7.4	7.5	7.4	6.6	5.0	6.7	29.3	22.0	6.6	5.8	5.5	9.4	16.8	11.9	3.9
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191495-196334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 34.0;skeletal muscle: 113.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 43.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	34.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.9	0.4	0.0	113.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	4.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	10.1	43.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.5	0.9	0.3	0.0	0.8	0.6	0.5	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRC18	"MGC34773, UNQ933, UNQ9338, VKGE9338"	ENSG00000165383	"Leucine rich repeat containing 18"	Q8N456	10	48909483-48914232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 12.1;fallopian tube: 7.6;testis: 14.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 222.0;Late spermatids: 64.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039256, HPA076699"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA039256: AB_10671873, HPA076699: "	"unprognostic (1.31e-2)"		"unprognostic (3.66e-2)"	"unprognostic (9.83e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.98e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.16e-2)"		"unprognostic (8.57e-3)"	"unprognostic (4.08e-1)"		"unprognostic (1.13e-1)"	0.0	0.0	0.3	0.4	0.2	0.4	0.3	0.5	0.3	0.6	12.1	0.4	0.2	0.2	0.0	0.1	7.6	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.2	1.0	0.9	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.7	0.0	0.1	0.0	0.0	0.8	0.4	0.2	0.6	0.1	0.2	14.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.3	0.8	0.3	1.0	0.9	0.8	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.0	6.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	64.1	1.8	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 101.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli rim"		"HPA037766: AB_10672609, HPA057533: AB_2683459"	"prognostic favorable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	2.5	3.2	11.3	1.1	11.4	2.5	3.6	11.1	11.2	5.2	20.5	3.4	0.9	5.0	12.5	1.8	101.8	3.0	4.7	11.3	12.4	6.2	2.5	8.9	1.8	18.6	22.4	4.8	2.1	6.7	7.4	2.2	16.9	3.6	2.1	25.1	2.8	3.7	6.3	2.4	2.0	3.6	16.6	2.4	3.4	26.3	12.6	3.1	6.2	5.8	2.7	2.9	2.6	13.2	5.2	9.9	1.6	3.6	7.2	5.4	5.8	2.0	7.0	3.3	6.3	2.1	10.4	4.5	2.2	5.4	9.6	1.3	2.9	4.3	7.1	3.6	1.5	3.2	3.7	4.1	5.8	1.8	3.0	3.8	7.8	6.4	5.7	8.6	4.6	11.0	1.9	2.5	3.9	5.9	4.0	1.2	1.0	7.7	2.8	3.7	8.1	5.3	6.6	1.5	2.6	6.3	3.2	4.3	6.6	10.2	2.2	4.1	2.0	3.3	8.6	3.8	2.3	2.3	1.6	3.8	8.1	2.3	4.8	0.6	2.7	6.4	2.2	2.6	3.0	5.7	2.2	1.9	2.6	2.8	2.4	2.4	0.5	4.0	2.6	3.9	0.1	1.3	11.3	11.4	11.1	11.2	11.3	12.4	18.6	22.4	16.9	16.6	12.6	13.2	12.6	0.0	22.4	11.4	12.6	6.5	10.0	15.1	11.4	17.8	15.3	19.3	8.2	20.0	34.4	12.9	50.1	8.2	9.4	5.2	37.2	13.6	43.4	204.6	13.1	9.7	18.0	7.4	5.8	17.3	12.5	12.6	10.7	12.9	5.7	12.1	14.6	7.5	13.5	13.5	4.4	8.6	16.2	11.9	8.9	47.0	8.4	13.7	8.8	6.5	11.0	38.6	11.3	1.5	6.4	15.3	4.7	12.4	10.5	6.4	4.5	46.5	244.2	138.1	13.1	21.1	13.5	63.6	13.1	8.4	5.8	4.5	11.8	7.1	5.6	7.3
LRRC24	LRRC14OS	ENSG00000254402	"Leucine rich repeat containing 24"	Q50LG9	8	144522388-144527033	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 13.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 103.2;Cone photoreceptor cells: 73.0;Horizontal cells: 30.3;Late spermatids: 69.0;Rod photoreceptor cells: 86.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;SCLC-21H: 2.7;SH-SY5Y: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028171, HPA052250"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA028171: AB_2672504, HPA052250: AB_2681774"					"unprognostic (1.75e-1)"					"unprognostic (5.76e-2)"		"unprognostic (2.33e-3)"		"unprognostic (3.63e-2)"				2.1	3.6	6.2	0.1	6.4	0.3	2.3	4.1	7.8	5.0	0.8	3.1	0.3	4.4	0.2	3.8	5.4	0.1	1.9	5.4	9.0	3.7	3.2	2.7	0.2	10.0	8.3	6.1	3.0	1.2	13.3	0.2	6.5	11.5	0.1	1.4	1.5	0.6	1.2	1.8	2.6	0.2	4.5	2.1	2.4	3.0	5.3	0.3	3.4	0.1	0.0	2.9	3.2	4.8	0.2	0.5	0.4	0.9	0.4	0.3	1.1	0.3	0.4	0.4	0.3	0.1	1.0	0.5	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	1.3	0.3	0.6	0.2	0.3	0.0	0.6	0.4	0.2	0.3	0.0	0.2	0.2	0.5	0.6	0.1	0.0	2.6	0.7	1.0	0.1	0.1	0.5	1.1	0.0	0.4	0.1	0.3	2.7	7.4	0.2	0.1	0.2	0.0	2.3	0.8	0.0	0.1	0.7	0.3	0.1	0.5	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.4	4.1	7.8	5.4	9.0	10.0	8.3	6.5	4.5	5.3	4.8	0.7	0.0	2.3	8.5	1.0	0.9	0.5	0.0	0.0	103.2	2.3	2.8	0.0	1.5	0.7	1.8	73.0	0.6	0.5	2.1	3.9	0.2	23.7	1.5	1.5	1.1	10.7	0.8	3.8	0.2	0.4	1.4	3.1	1.6	0.0	4.8	0.7	3.1	0.5	30.3	6.5	2.7	0.0	0.8	1.7	69.0	2.8	0.8	5.4	1.0	0.2	18.6	1.0	4.5	2.2	0.3	1.9	3.0	1.2	1.8	1.9	3.6	0.1	86.2	0.0	2.9	1.9	11.2	3.5	1.7	0.4	0.4	0.6	8.4	1.9	0.9
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391137-18397622	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.4;lymphoid tissue: 61.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7"	"Group enriched"	"Detected in all"	60	"dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029459	Approved		Approved	"Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		630000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Endoplasmic reticulum, Microtubules, Cytosol"		"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	9.4	9.4	2.4	21.8	2.5	32.4	3.1	3.3	2.9	1.8	3.2	3.3	3.7	1.6	0.7	2.3	3.9	5.3	2.5	2.3	3.1	2.4	5.9	11.5	9.9	4.6	4.0	1.5	2.0	0.7	1.2	5.4	4.2	2.0	2.8	0.3	2.6	1.2	3.7	1.0	4.8	6.7	2.8	61.2	2.3	1.2	5.4	3.0	1.2	8.7	4.0	7.0	1.3	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.8	0.4	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	1.5	0.1	55.4	320.6	356.2	0.9	512.1	1.9	7.3	0.6	0.7	229.3	8.4	0.5	0.6	573.0	4.6	706.7	32.1	1.3	229.2	2.4	2.5	3.3	2.9	2.3	3.1	4.6	4.0	4.2	2.8	5.4	4.7	0.7	0.0	1.3	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.3	1.0	0.3	0.0	0.7	0.0	0.0	0.1	2.9	0.1	5.9	0.1	1.9	0.2	0.1	0.9	0.0	2.1	0.1	0.0	0.4	0.5	0.0	0.4	10.2	0.0	1.8	0.5	47.0	0.0	0.1	0.0	0.0	123.6	12.5	0.5	0.0	90.0	1.8	1.0	74.9	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.4	0.2	0.0	0.2	0.0	0.1	0.4	1.1	0.2	0.1	0.1
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 290.0"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.2	0.3	0.4	0.0	7.3	2.6	0.5	0.4	0.0	11.2	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	53.1	0.5	0.0	290.0	0.5	0.0	5.1	7.2	0.0	0.2	0.1	5.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.2	0.4	2.6	0.5	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132381508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 75.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 491.0;Late spermatids: 953.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	3.2	4.1	11.6	1.9	12.1	1.6	5.0	9.4	13.3	4.5	12.0	4.7	2.5	4.5	6.7	2.0	13.1	4.3	3.5	13.0	11.2	7.1	3.0	3.9	2.6	12.1	11.8	6.3	3.9	8.0	8.0	2.6	10.9	5.2	2.5	10.9	3.3	4.7	2.0	2.7	3.3	4.2	11.5	5.5	3.9	75.6	11.8	2.8	6.4	1.6	1.4	4.0	2.8	10.9	3.1	5.6	12.2	17.2	10.4	10.6	1.2	3.0	9.7	4.9	4.4	1.0	6.3	1.7	1.7	7.0	3.7	2.1	2.7	1.5	3.1	3.6	2.4	0.5	4.5	3.0	7.4	1.4	2.0	4.6	9.4	5.0	6.6	21.9	3.5	4.2	1.1	1.3	3.8	5.2	2.7	3.9	3.4	2.2	1.9	2.4	1.9	1.0	8.9	0.8	2.2	6.1	1.5	1.0	3.9	2.4	2.8	3.1	4.7	1.9	2.4	4.4	1.9	0.9	0.4	1.0	8.9	2.7	1.2	4.1	4.7	0.8	1.1	4.1	0.9	2.3	0.7	0.7	5.2	2.9	1.8	1.0	0.6	2.4	2.8	5.6	0.5	2.0	11.6	12.1	9.4	13.3	13.0	11.2	12.1	11.8	10.9	11.5	11.8	10.9	2.9	9.6	12.8	23.8	5.0	2.8	2.5	5.1	3.4	8.2	6.3	3.8	5.2	5.7	6.9	3.7	10.4	3.6	6.0	1.7	19.6	8.2	491.0	18.8	5.4	4.9	5.4	2.5	14.2	5.1	1.3	5.5	7.1	4.8	8.8	10.3	11.4	2.2	7.7	8.4	10.9	2.3	2.0	10.4	6.0	953.9	4.7	6.7	7.2	6.5	9.0	10.5	8.2	8.0	9.3	3.3	1.3	11.7	0.9	2.9	3.8	13.9	37.7	18.3	6.6	3.8	3.5	119.9	19.2	2.3	3.1	1.4	2.9	6.2	3.5	1.8
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	8.1	7.8	4.4	4.4	5.1	8.6	6.4	4.5	5.8	6.1	4.3	8.0	16.9	5.8	7.4	9.7	4.8	9.1	9.7	5.3	3.9	19.4	47.1	5.3	6.9	3.7	3.5	4.9	19.5	9.4	4.1	6.1	3.5	5.3	9.7	6.8	6.1	6.6	18.3	10.4	16.5	7.9	3.3	4.9	8.2	28.5	3.9	22.6	6.6	18.4	9.4	6.5	6.3	4.4	4.0	9.8	9.5	12.3	13.2	18.7	4.0	4.2	11.9	7.1	8.3	7.4	8.6	8.2	7.6	10.1	8.7	8.8	7.0	13.5	10.3	5.0	10.2	5.5	4.0	7.7	11.7	5.5	8.6	11.1	18.2	6.7	13.4	16.0	22.7	13.0	4.9	8.1	14.9	8.0	15.2	8.9	4.0	31.2	3.7	9.3	8.0	7.6	15.1	12.8	4.3	5.5	10.1	5.4	16.4	14.4	8.4	10.2	8.3	7.0	4.8	5.4	8.4	15.9	24.1	5.1	8.8	5.4	13.3	23.4	9.3	32.0	7.2	7.8	5.8	6.2	6.7	7.7	8.4	5.8	6.2	5.4	5.0	5.1	8.0	6.9	10.4	6.1	4.4	5.1	4.5	5.8	5.3	3.9	3.7	3.5	3.5	3.3	3.9	4.4	13.2	16.0	4.1	29.0	13.5	13.8	14.5	14.5	12.5	19.9	8.9	12.4	13.4	12.8	11.0	11.0	22.9	17.5	11.4	18.6	27.4	12.7	159.2	7.4	8.4	11.9	9.1	12.4	127.4	29.5	22.6	8.5	15.8	6.5	2.5	15.0	12.8	37.0	19.3	21.9	86.8	16.0	20.3	19.8	20.1	406.4	12.8	15.3	14.2	37.5	19.1	14.4	14.4	63.3	63.0	14.8	24.2	8.6	14.7	8.4	72.3	74.1	10.1	19.8	0.0	10.7	11.7	77.1	39.0	15.1	15.8	13.0	11.3	18.0	19.5	15.4
LRRC3	"C21orf102, C21orf30, DKFZP434C128, LRRC3DN"	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455510-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.7;U-2 OS: 6.3"	"Low region specificity"	"Detected in all"							HPA017975	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	1.9	1.4	0.8	0.7	0.5	0.6	1.5	0.2	0.7	1.4	0.3	6.6	1.7	1.3	0.4	1.1	1.5	2.2	1.9	0.6	2.0	0.7	15.5	1.6	0.5	0.6	0.9	3.4	0.7	0.3	1.3	0.9	0.6	0.8	0.8	0.3	1.0	0.6	0.4	1.8	1.6	1.5	0.2	1.1	3.8	1.7	1.2	0.5	0.6	1.0	0.3	2.0	1.3	0.6	0.5	0.4	3.5	2.9	0.0	0.0	8.7	1.5	0.0	0.1	0.0	1.3	1.2	0.0	2.6	0.7	1.9	0.1	1.7	0.0	0.0	0.2	3.8	0.0	0.4	4.0	0.6	0.0	2.3	1.1	1.4	0.0	0.0	0.0	1.4	0.6	0.3	4.5	0.0	1.3	0.5	0.2	0.9	4.5	1.4	1.9	0.0	1.5	0.1	0.1	2.8	3.2	1.3	0.3	0.6	1.9	0.8	1.9	2.8	0.0	6.3	0.0	0.0	2.5	5.2	0.0	0.0	1.6	0.5	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.7	0.6	2.0	0.6	0.9	0.6	0.2	1.2	0.6	2.6	0.0	1.5	0.0	0.8	0.6	1.1	0.0	3.4	1.1	0.6	0.9	2.0	1.5	0.0	1.8	0.0	0.2	0.3	1.6	0.0	0.3	0.3	0.2	0.4	0.6	4.2	2.7	0.0	0.4	6.6	2.5	1.5	0.9	1.3	2.4	1.1	30.7	2.5	0.0	0.1	1.8	0.0	2.5	0.5	1.5	0.6	1.1	0.0	0.0	3.2	1.4	1.0	0.0	0.1	1.7	0.3	0.7	0.2	1.3	1.8	0.0	0.0	0.0	0.0	0.8	1.4	0.9	2.0	0.6	0.6	0.3	0.8	0.3	1.7	0.7
LRRC30		ENSG00000206422	"Leucine rich repeat containing 30"	A6NM36	18	7231125-7232047	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	19	"skeletal muscle: 16.2;tongue: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA041039	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"					"HPA041039: AB_2677270"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793003-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	1.5	0.4	1.6	0.6	2.1	1.4	1.1	1.6	2.7	0.9	2.8	0.5	0.2	0.7	0.3	0.2	5.5	0.3	1.1	1.2	2.1	0.7	0.2	1.0	0.8	2.1	2.5	0.8	0.2	0.3	2.8	0.2	2.2	0.6	0.1	5.6	0.3	0.7	0.4	0.5	0.4	0.2	2.1	0.7	0.4	12.8	1.9	0.6	0.9	0.4	0.3	0.4	0.4	1.8	2.3	0.4	0.5	0.0	0.9	3.0	0.0	0.9	1.9	2.4	2.1	0.1	0.0	1.5	0.1	0.6	3.1	0.0	1.8	0.0	0.8	0.4	5.6	8.1	0.2	0.0	0.6	8.9	1.8	0.9	0.4	0.8	0.0	0.1	1.6	7.1	0.2	0.0	0.9	0.0	0.8	1.1	7.7	0.0	2.6	4.0	0.0	0.4	2.1	0.2	4.0	3.1	0.5	0.3	0.0	0.2	0.0	4.2	0.5	0.4	0.0	0.3	0.1	0.1	0.1	1.9	3.5	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	1.6	2.1	1.6	2.7	1.2	2.1	2.1	2.5	2.2	2.1	1.9	1.8	3.9	3.2	2.6	8.5	1.5	0.4	0.9	5.3	0.0	6.9	0.4	0.9	3.2	0.0	12.9	5.5	37.5	0.2	1.6	0.1	1.9	0.5	137.9	33.8	5.8	3.0	4.2	4.2	15.1	0.2	0.3	5.0	0.5	1.0	1.3	1.0	10.4	0.3	2.4	11.8	12.5	0.4	6.1	0.8	1.2	36.3	10.5	1.2	0.0	3.7	3.8	7.4	0.0	9.5	3.6	0.3	0.0	10.5	0.7	0.4	0.0	3.6	129.6	18.8	0.0	3.6	3.7	104.4	9.2	0.1	0.3	0.5	0.9	1.9	0.2	0.4
LRRC36	FLJ11004	ENSG00000159708	"Leucine rich repeat containing 36"	Q1X8D7	16	67326798-67385204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 35.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 94.7;Early spermatids: 192.8;Late spermatids: 118.0;Spermatocytes: 68.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.4;JURKAT: 1.3;TIME: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA058479: AB_2683728"	"unprognostic (4.59e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-5)"	"unprognostic (5.27e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-2)"	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	3.0	0.1	0.0	0.1	0.4	0.3	0.0	4.9	0.2	0.4	0.3	0.1	0.3	0.0	0.1	6.1	0.3	0.0	0.5	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	35.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	0.3	0.2	0.2	0.1	0.4	0.4	0.3	0.3	0.1	0.2	0.0	0.4	3.2	94.7	0.0	0.3	0.3	0.4	0.2	0.0	0.8	0.3	0.3	0.7	0.0	0.8	0.0	0.0	0.1	6.7	0.5	0.0	1.9	192.8	15.4	0.2	3.2	2.4	0.0	1.2	0.0	0.1	1.4	0.0	0.4	8.8	1.5	0.0	0.0	0.2	0.0	2.6	0.6	0.0	0.0	0.7	118.0	2.1	0.7	7.2	1.9	0.7	1.5	0.0	2.0	0.4	0.1	0.3	1.5	0.0	0.1	0.5	1.3	12.0	0.2	0.0	0.7	0.4	68.2	15.1	0.0	0.3	0.3	0.3	0.6	1.7	0.3
LRRC37A	KIAA0563	ENSG00000176681	"Leucine rich repeat containing 37A"	A6NMS7	17	46292733-46337794	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 55.5;Excitatory neurons: 86.9;Inhibitory neurons: 82.8;Microglial cells: 49.6;Oligodendrocyte precursor cells: 60.8;Oligodendrocytes: 48.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.7;HeLa: 2.0"									"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.75e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.37e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.30e-2)"	2.0	1.7	1.0	0.7	1.0	0.5	2.1	1.2	3.1	3.1	0.9	2.3	0.0	2.1	0.0	2.0	3.2	0.1	1.5	1.0	1.1	2.2	1.7	2.2	0.5	1.0	0.9	2.3	2.2	0.3	3.7	0.2	1.1	2.8	0.2	1.6	2.3	0.2	4.7	3.7	2.4	0.1	0.8	2.6	2.0	11.1	1.3	0.4	2.5	0.4	0.3	2.5	2.6	1.1	0.1	0.1	0.7	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.7	0.1	3.7	0.1	0.1	1.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	2.0	1.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.1	0.3	0.5	0.0	0.0	1.3	1.3	0.8	0.0	0.8	0.2	0.4	0.1	0.3	0.0	0.0	0.2	1.7	0.6	0.6	1.0	0.1	0.1	1.5	1.2	0.2	0.6	1.1	1.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.0	1.0	1.2	3.1	1.0	1.1	1.0	0.9	1.1	0.8	1.3	1.1	0.7	3.2	0.5	55.5	1.0	0.1	0.4	0.0	0.6	0.5	0.2	0.0	4.3	0.0	0.2	0.0	0.0	0.1	0.9	1.4	1.9	0.1	21.0	0.3	0.7	0.4	1.2	0.0	86.9	0.4	0.0	0.6	2.0	0.4	1.3	0.4	0.4	0.1	0.3	0.0	82.8	1.1	0.0	2.2	0.8	2.8	0.0	0.6	0.0	49.6	0.1	0.2	0.0	60.8	48.1	0.2	0.8	0.4	0.4	0.1	1.9	0.2	0.9	0.9	0.0	0.7	0.6	1.3	1.1	0.4	0.1	0.1	1.4	0.1	1.1	0.1
LRRC37A2	FLJ45049	ENSG00000238083	"Leucine rich repeat containing 37 member A2"	A6NM11	17	46511511-46555650	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 6.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Early spermatids: 46.8;Excitatory neurons: 55.9;Inhibitory neurons: 55.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 46.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;THP-1: 1.2"									"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.00e-2)"	"unprognostic (3.02e-7)"	"unprognostic (8.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	0.5	0.1	0.2	0.2	0.2	0.5	0.5	0.8	0.2	0.3	0.1	0.3	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.6	0.1	0.3	0.2	0.4	0.1	0.2	0.2	0.4	0.7	0.0	0.3	0.3	0.3	0.4	0.2	0.3	0.6	0.6	0.4	0.2	0.0	0.1	0.2	6.5	0.4	0.4	0.3	0.2	0.2	0.4	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.4	1.2	0.2	0.7	0.6	0.0	0.2	0.4	0.3	0.1	0.0	0.3	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.2	0.1	0.1	0.4	0.1	0.3	0.0	0.4	0.0	2.5	22.4	14.6	34.0	3.8	1.5	4.2	1.0	2.2	7.1	2.6	2.2	2.5	1.5	5.1	0.0	12.5	1.1	8.5	2.3	0.0	2.6	46.8	8.3	5.6	3.0	1.8	0.8	55.9	0.9	0.9	3.2	1.5	5.5	11.4	5.4	1.4	0.8	1.4	13.5	55.5	2.5	0.0	1.2	1.8	11.5	3.4	3.5	0.0	34.7	1.8	2.4	3.1	47.7	46.4	1.0	2.7	1.9	3.0	2.5	1.2	0.4	11.3	8.8	13.1	4.1	2.7	7.9	3.0	1.4	2.3	0.7	6.1	1.7	1.6	2.9
LRRC37A3	"FLJ34306, KIAA0563"	ENSG00000176809	"Leucine rich repeat containing 37 member A3"	O60309	17	64854312-64919480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.6;Excitatory neurons: 143.1;Inhibitory neurons: 161.3;Microglial cells: 75.9;Oligodendrocyte precursor cells: 110.1;Oligodendrocytes: 99.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA042121, HPA043056, HPA045090"	Supported		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211"	"unprognostic (2.28e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.31e-6)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (2.26e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.43e-3)"	4.1	4.2	12.2	2.1	11.5	4.0	5.0	15.4	16.1	6.3	11.5	3.8	1.5	4.2	9.3	3.4	7.6	3.8	3.7	11.2	13.5	14.9	4.3	4.2	2.6	12.2	11.9	7.8	4.7	2.7	22.3	2.6	12.0	8.2	2.1	18.8	3.2	3.3	4.2	4.2	3.0	2.3	9.7	4.4	3.0	28.9	14.7	2.0	17.1	1.0	1.6	3.5	4.4	11.6	2.2	4.4	4.1	9.3	4.6	2.8	2.9	3.0	2.5	2.0	2.3	1.9	3.3	2.2	1.4	1.6	3.6	1.9	1.1	0.9	0.9	2.9	4.2	7.0	3.1	1.3	1.8	2.5	1.6	1.9	1.9	1.5	0.6	9.2	1.4	2.8	1.4	1.2	1.5	6.0	1.3	4.5	3.1	0.5	1.2	1.5	2.2	1.0	4.3	2.0	2.7	10.2	1.2	5.3	1.3	11.6	2.4	4.7	5.1	3.7	1.1	1.5	1.7	1.8	1.9	1.7	2.6	10.7	6.3	2.7	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.3	0.3	0.7	1.1	0.4	0.8	0.3	0.1	12.2	11.5	15.4	16.1	11.2	13.5	12.2	11.9	12.0	9.7	14.7	11.6	2.0	0.0	2.2	82.6	1.8	1.8	1.6	0.5	1.8	11.4	1.6	1.5	2.8	1.5	1.9	1.8	4.2	1.3	1.9	1.5	1.9	3.0	37.9	4.9	2.7	3.6	1.2	0.4	143.1	1.3	0.2	1.9	1.1	2.3	2.5	4.6	4.6	1.0	1.5	25.2	161.3	1.1	0.0	0.9	0.7	8.6	2.1	1.4	1.8	75.9	1.4	3.7	2.1	110.1	99.3	0.7	1.7	3.0	1.8	1.2	0.7	6.9	6.9	4.1	6.6	4.1	1.7	7.3	1.8	1.0	1.0	1.0	1.4	1.3	1.1	1.4
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6"	"Low cell line specificity"	"Detected in all"											HPA015135	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	3.7	7.5	3.7	6.6	25.1	5.2	13.7	10.3	6.9	0.9	4.9	3.4	6.2	4.7	4.2	6.8	3.6	2.6	8.0	4.2	3.6	2.1	5.6	4.6	4.8	3.4	9.1	3.2	5.7	8.3	3.5	5.2	4.7	4.6	6.9	4.7	2.8	3.5	10.5	5.0	5.2	2.2	6.2	5.0	17.9	5.1	10.9	4.1	1.4	4.5	4.6	5.9	7.1	2.7	5.0	15.6	8.9	3.9	4.7	4.8	2.4	9.0	6.9	8.7	6.8	2.6	7.1	5.0	5.5	8.5	3.6	9.3	1.9	5.4	2.2	7.6	3.4	8.1	2.6	5.8	13.3	5.8	5.1	5.9	6.3	15.9	6.6	5.9	12.1	8.2	6.8	2.6	2.5	23.4	20.5	4.8	2.5	3.3	16.2	3.7	5.9	3.9	6.6	2.9	5.0	6.1	3.8	8.8	5.2	10.4	20.9	5.0	4.8	3.2	10.8	6.1	6.8	10.4	7.5	3.4	13.2	3.4	0.0	0.2	1.5	0.5	0.2	1.0	0.1	1.0	1.4	0.4	0.4	1.4	0.4	0.5	3.8	0.1	0.6	2.6	0.3	7.5	6.6	13.7	10.3	8.0	4.2	4.8	3.4	5.2	2.2	5.1	7.1	7.4	6.4	9.1	39.2	5.1	4.1	6.9	3.8	2.8	10.0	7.3	5.6	4.7	7.2	7.1	1.8	0.0	2.3	10.0	2.9	9.8	8.9	101.9	7.9	6.3	6.0	1.8	7.4	45.4	10.5	2.3	6.0	1.5	4.7	3.8	7.0	8.2	2.9	9.7	3.3	33.4	5.7	4.1	8.7	6.9	22.9	6.8	7.9	8.8	14.0	9.3	14.5	20.6	39.7	28.3	9.2	1.8	7.2	3.8	9.1	6.8	8.3	7.8	9.7	0.0	8.9	7.8	66.7	13.0	1.6	5.1	2.2	9.0	4.6	4.8	7.7
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474973-13514003	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 19.6;skeletal muscle: 44.5;tongue: 14.7"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 19.3;Inhibitory neurons: 10.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 0.5;lung cancer: 0.8;testis cancer: 0.6;urothelial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;MOLT-4: 16.7;PC-3: 11.5;U-138 MG: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038778	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.4	19.6	0.2	0.0	0.3	0.1	0.6	2.9	1.1	0.2	0.5	0.1	0.0	0.1	0.2	0.3	0.1	0.1	1.4	0.3	0.6	0.1	0.0	0.0	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.5	0.5	0.2	0.0	3.0	0.6	0.0	44.5	1.2	0.0	0.0	1.1	0.0	0.1	0.4	0.1	1.3	0.0	14.7	0.0	0.3	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	11.5	0.1	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	1.1	0.3	0.6	1.3	1.3	0.5	1.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.5	0.1	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LRRC39	"MGC14816, myomasp"	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148448-100178273	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 107.0;retina: 117.9;skeletal muscle: 431.0;tongue: 172.9"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 96.4;Cone photoreceptor cells: 60.5;Early spermatids: 204.8;Hofbauer cells: 76.4;Inhibitory neurons: 62.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077159	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	2.2	9.8	3.5	1.5	3.6	1.5	1.9	2.8	4.7	1.6	1.1	1.8	1.0	1.4	1.4	4.2	1.7	1.1	107.0	2.8	3.7	1.7	2.6	1.7	2.4	3.8	2.9	1.6	1.6	5.3	2.3	4.2	2.5	4.2	0.6	117.9	2.9	0.5	431.0	3.8	1.7	0.7	1.8	2.3	1.6	6.5	4.2	1.1	1.9	172.9	0.9	1.7	1.3	3.6	0.4	0.5	1.8	2.4	0.4	0.8	1.5	0.8	0.3	0.3	0.7	0.1	1.1	2.0	0.9	0.3	0.4	1.1	0.2	0.2	0.7	0.3	1.7	0.9	2.4	0.4	0.2	0.6	1.1	1.5	0.3	0.3	0.1	0.5	0.3	1.5	0.9	1.7	0.5	0.3	1.0	2.4	0.8	0.5	0.6	1.0	0.8	0.8	0.3	0.6	0.7	2.5	0.5	0.7	6.7	0.6	0.6	1.4	0.5	1.0	0.9	1.3	1.6	3.2	1.6	0.7	1.7	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	2.8	4.7	2.8	3.7	3.8	2.9	2.5	1.8	4.2	3.6	0.3	0.0	1.3	6.8	0.4	0.1	0.1	0.0	0.0	13.1	0.3	0.1	96.4	0.0	0.0	0.0	60.5	0.5	0.3	0.3	0.0	0.2	204.8	0.2	0.5	1.8	0.0	0.0	14.6	0.6	0.6	3.8	0.0	0.5	1.3	0.2	0.7	0.2	76.4	18.5	62.2	0.0	0.0	0.3	0.0	21.7	2.1	8.0	0.0	1.9	0.8	8.1	1.0	5.5	10.2	0.3	0.1	0.4	0.5	0.1	0.0	0.0	0.7	74.2	0.0	8.6	1.4	9.9	1.2	0.0	0.1	0.7	0.4	0.4	0.0	0.0
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26717537	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.0;choroid plexus: 8.7;skeletal muscle: 9.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015568	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.3	0.1	18.7	0.0	21.2	0.0	0.4	28.0	24.4	0.3	8.7	0.5	0.0	0.7	0.0	0.4	0.4	0.0	0.3	23.1	16.2	0.1	0.1	0.0	0.0	17.9	18.4	1.5	0.0	0.0	1.5	0.0	17.6	0.1	0.5	1.1	0.4	0.1	9.5	0.1	0.2	0.4	20.7	0.1	0.5	7.2	18.9	0.7	0.1	0.2	0.0	4.8	0.2	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	21.2	28.0	24.4	23.1	16.2	17.9	18.4	17.6	20.7	18.9	16.1	0.8	0.0	0.0	256.9	0.0	0.1	0.0	0.0	0.0	1.6	1.2	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.2	3.2	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.0	11.6	0.6	0.1	0.0	9.4	0.0	0.8	0.0	38.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	1.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.1
LRRC3C		ENSG00000204913	"Leucine rich repeat containing 3C"	A6NJW4	17	39941474-39944734	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Astrocytes: 11.4;Microglial cells: 3.7;Oligodendrocytes: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071271	Uncertain					NA	NA						"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA071271: AB_2686378"	"unprognostic (1.59e-1)"			"unprognostic (6.57e-2)"	"unprognostic (6.17e-2)"		"unprognostic (2.81e-1)"	"unprognostic (3.16e-4)"		"unprognostic (9.20e-2)"		"unprognostic (4.27e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.90e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026564	Approved		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	9.7	8.4	5.7	9.0	6.6	16.3	11.0	8.3	8.4	7.7	2.3	9.0	14.6	10.3	6.5	9.5	5.4	8.4	11.7	7.0	6.3	14.1	23.6	8.2	13.2	4.6	4.8	8.3	7.1	6.8	3.5	12.0	5.1	8.6	9.7	9.9	5.6	6.9	7.4	7.7	13.5	11.2	5.3	9.3	6.9	11.9	5.3	14.0	8.2	10.0	12.6	9.8	5.1	6.8	26.4	10.9	42.1	33.3	15.1	16.6	25.4	25.0	18.2	37.0	45.4	16.0	14.5	35.4	21.4	19.6	36.6	19.0	100.0	22.3	50.2	28.5	20.0	26.8	18.6	25.9	19.0	35.4	6.2	13.8	12.7	24.7	24.6	17.1	21.7	22.2	33.6	16.7	31.7	6.8	42.8	27.4	55.5	17.3	22.5	33.8	43.5	22.9	34.1	16.0	21.5	21.7	30.2	29.9	28.6	29.6	14.3	19.8	27.2	26.0	20.8	39.7	28.7	14.0	14.4	57.2	21.0	36.6	27.3	5.4	4.6	5.5	5.5	6.0	7.3	7.2	5.8	5.3	6.0	6.7	6.8	5.8	0.7	7.6	5.8	4.6	7.8	4.5	5.7	6.6	8.3	8.4	7.0	6.3	4.6	4.8	5.1	5.3	5.3	6.8	13.9	12.8	12.6	22.2	15.1	12.9	7.8	10.5	17.1	16.4	6.9	6.0	10.4	8.6	9.2	14.7	6.2	16.9	23.2	6.9	11.7	12.7	1.3	6.0	12.1	11.3	23.3	17.2	41.1	8.9	13.3	12.7	5.1	10.8	15.2	11.3	13.2	21.4	11.9	15.2	40.1	6.5	20.3	11.7	12.1	3.0	10.2	9.4	5.4	15.9	13.4	7.6	8.2	22.6	30.9	9.2	4.1	10.1	11.7	5.1	13.2	24.1	6.4	12.5	19.7	12.9	12.9	25.1	28.3	11.7	11.1	7.3	15.8	10.4	8.1	5.0
LRRC41	MUF1	ENSG00000132128	"Leucine rich repeat containing 41"	Q15345	1	46261196-46303616	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051941	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA051941: AB_2681669"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.66e-9)"	"unprognostic (6.09e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-2)"	37.7	43.5	30.4	19.1	31.1	20.0	36.7	29.1	32.7	45.0	28.0	41.4	22.7	50.7	29.0	44.3	45.9	30.9	36.7	31.7	31.4	33.4	36.0	33.7	20.7	31.9	30.2	48.5	41.6	44.1	44.3	34.0	29.8	43.3	19.8	19.4	37.6	41.4	55.3	43.3	29.4	35.4	30.4	28.5	35.1	32.7	30.9	29.9	38.7	33.2	22.7	44.8	39.5	32.6	42.2	30.2	51.1	55.8	67.7	84.0	48.1	42.7	78.6	60.8	40.6	25.7	13.7	26.7	55.5	102.0	81.4	32.0	50.5	60.5	30.7	32.5	54.7	43.5	34.3	37.7	94.6	27.1	22.1	103.8	80.1	56.9	68.2	87.0	78.6	49.3	43.7	26.7	67.5	26.8	36.2	36.0	76.9	27.4	29.3	29.6	26.4	43.4	68.4	50.9	47.4	54.0	57.8	56.6	69.5	78.3	33.5	80.9	52.4	53.0	23.9	44.8	41.5	43.5	21.8	11.8	49.7	20.6	37.6	30.6	32.7	15.5	21.1	30.8	22.6	18.7	22.9	24.0	46.4	22.0	24.9	19.3	3.3	32.7	21.7	26.4	24.4	30.2	30.4	31.1	29.1	32.7	31.7	31.4	31.9	30.2	29.8	30.4	30.9	32.6	19.0	19.2	22.7	17.0	17.9	28.4	36.6	40.4	17.1	23.7	28.6	24.8	11.3	28.6	32.0	35.0	25.0	83.1	20.2	27.4	39.2	42.0	28.2	57.5	36.2	22.0	36.6	24.0	19.8	30.0	48.7	34.8	23.9	133.1	7.0	42.4	25.7	28.0	36.5	47.1	21.1	30.4	30.5	20.6	22.8	19.3	34.8	20.7	10.6	11.2	23.5	25.4	20.6	18.6	22.3	30.1	24.2	33.1	26.5	36.7	38.0	32.7	23.4	27.4	39.5	40.4	32.1	46.6	45.8	21.2	29.0	142.6	18.8	37.7	30.0	34.7
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946085-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.88e-5)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	15.6	29.0	10.5	9.7	10.7	11.8	14.8	9.7	13.6	16.2	14.9	16.4	12.3	18.7	15.3	21.8	16.6	12.5	14.7	10.4	11.7	15.2	24.3	15.3	11.4	10.8	10.4	17.2	13.2	15.4	24.1	22.4	10.0	15.1	13.2	8.6	16.7	14.8	17.6	21.9	11.8	18.1	10.4	9.2	16.7	19.4	12.2	16.4	23.6	15.7	14.4	18.7	18.3	10.8	73.3	26.9	66.0	38.9	34.0	45.9	45.2	56.7	78.7	74.4	100.4	90.8	48.0	41.4	44.4	70.6	88.0	63.5	57.0	81.4	85.4	32.7	35.5	38.2	40.4	57.9	61.7	23.9	35.2	41.8	110.6	64.5	69.5	54.1	47.6	37.7	48.8	10.6	73.2	25.5	45.1	33.1	56.6	53.5	42.0	75.9	70.2	28.8	53.1	54.1	39.3	42.3	76.5	42.7	63.4	103.1	63.4	28.3	39.6	56.1	71.7	50.1	35.9	29.4	36.4	61.7	54.3	24.8	30.4	0.0	3.1	5.7	4.9	3.1	4.3	4.2	4.2	5.9	3.9	2.3	4.2	3.2	4.8	4.9	2.3	6.9	4.8	2.9	10.5	10.7	9.7	13.6	10.4	11.7	10.8	10.4	10.0	10.4	12.2	10.8	7.8	12.8	5.8	3.6	6.7	51.6	36.4	46.6	29.6	4.4	15.9	14.1	10.5	30.0	24.2	11.0	4.2	43.8	5.4	14.9	19.6	35.0	2.9	16.2	17.0	11.1	68.2	16.0	8.0	16.7	31.4	22.6	17.3	16.8	0.0	19.8	8.2	15.0	17.8	10.1	4.9	9.6	30.5	5.7	11.7	3.5	23.9	8.5	10.6	7.5	10.6	28.7	9.2	5.5	8.4	32.6	13.3	17.7	16.7	46.4	9.9	17.6	19.2	3.6	13.1	15.5	22.7	21.9	48.5	25.5	39.1	57.5	7.9	75.7	14.6	41.0
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023305-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.0	6.1	2.3	3.8	2.2	7.0	5.8	7.5	5.4	6.1	2.2	8.7	5.7	5.4	0.9	10.3	9.0	1.6	5.0	2.5	1.9	7.5	18.0	6.4	3.2	3.0	2.8	4.5	10.1	2.0	5.9	2.4	3.0	8.4	1.7	0.6	9.6	2.2	2.5	8.7	8.6	1.2	2.1	9.5	10.5	4.0	2.2	3.1	8.9	0.5	1.5	6.1	6.9	2.3	18.6	20.7	6.2	12.7	2.5	3.3	24.0	12.7	5.2	7.5	6.3	18.6	12.4	13.9	11.2	2.5	7.8	21.3	6.0	7.6	1.7	8.5	38.6	8.8	43.1	25.5	2.1	10.4	21.2	3.3	3.1	4.5	1.2	3.1	11.1	13.0	6.3	6.0	2.0	31.6	23.5	34.5	6.4	15.0	27.4	19.0	12.2	7.8	4.8	16.9	19.1	18.6	5.8	29.9	11.2	3.0	24.4	12.0	6.5	13.1	16.3	20.8	21.9	11.5	3.1	2.1	7.0	8.9	13.9	2.3	1.2	1.5	1.4	0.9	1.4	0.6	1.6	1.6	0.8	0.7	0.8	1.1	0.0	1.1	0.4	1.3	1.4	1.4	2.3	2.2	7.5	5.4	2.5	1.9	3.0	2.8	3.0	2.1	2.2	2.3	3.9	6.4	2.2	4.2	4.1	4.5	5.0	2.9	1.8	5.2	8.5	8.6	2.7	14.3	7.0	3.7	0.0	12.7	7.8	18.1	5.9	7.3	1.5	19.0	3.4	3.7	4.8	10.3	2.5	4.7	27.9	4.8	13.3	5.0	4.5	13.3	7.1	12.6	8.7	5.0	2.9	12.2	4.1	6.3	3.2	4.4	7.2	4.2	8.8	0.0	4.3	5.6	7.2	1.0	1.8	5.8	9.4	6.4	8.5	2.4	10.9	10.2	24.4	4.1	0.0	2.8	5.2	2.3	11.9	6.3	2.4	3.0	7.0	4.9	18.4	3.7
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831634-47837719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 78.4;testis: 54.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 143.1;Endometrial ciliated cells: 166.7;Late spermatids: 61.5;Respiratory ciliated cells: 225.8;Spermatocytes: 125.7"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 11.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.2	0.3	1.4	0.1	1.0	0.5	0.3	1.3	0.8	2.6	4.2	0.1	0.1	1.1	0.9	0.2	78.4	0.2	0.3	1.0	1.8	0.7	0.5	4.8	0.3	2.4	6.7	0.3	0.5	0.2	1.7	0.1	3.2	0.5	0.0	2.3	0.3	0.3	0.1	0.1	0.2	0.0	3.1	0.5	0.2	54.3	1.3	0.4	0.9	0.0	0.1	0.2	0.2	2.1	0.7	2.8	0.3	1.4	0.2	0.4	0.8	0.1	0.8	0.7	1.3	1.1	0.7	0.2	1.7	0.3	0.8	0.7	0.3	0.6	1.1	1.1	1.2	0.6	0.9	0.5	0.1	0.0	0.7	0.0	0.5	1.7	0.5	0.2	0.1	0.4	0.6	0.4	1.1	1.2	1.1	0.0	0.1	0.2	0.4	0.9	0.0	0.6	1.4	0.5	1.2	0.9	0.3	0.0	0.5	0.1	3.6	0.1	0.2	1.6	0.5	0.2	0.2	0.6	0.5	0.5	1.1	0.2	0.1	1.3	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.3	0.7	0.1	0.2	0.0	0.5	0.8	0.4	0.3	0.0	0.1	1.4	1.0	1.3	0.8	1.0	1.8	2.4	6.7	3.2	3.1	1.3	2.1	0.3	0.0	2.3	0.0	0.5	0.0	0.3	9.7	0.0	0.6	0.7	0.9	0.5	1.5	21.9	5.5	2.1	0.1	0.4	0.2	0.0	0.9	143.1	166.7	1.9	0.4	0.0	0.4	0.2	0.0	0.5	1.2	0.0	3.3	0.0	0.3	0.0	0.1	0.5	0.0	0.3	0.6	12.2	0.0	0.3	61.5	2.8	1.0	0.0	1.0	0.8	1.0	0.0	0.0	0.4	0.6	1.1	1.9	0.2	0.3	0.1	1.4	225.8	7.0	0.0	0.4	3.7	125.7	4.2	0.0	0.0	0.1	0.7	0.3	0.0	0.2
LRRC47	"KIAA1185, RP1-286D6.3"	ENSG00000130764	"Leucine rich repeat containing 47"	Q8N1G4	1	3778559-3796498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008512, HPA012018"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		29000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA008512: AB_1853324, HPA012018: AB_1853322"	"unprognostic (2.25e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.25e-1)"	14.7	17.4	17.5	7.0	17.2	11.7	14.6	15.8	18.3	15.2	15.3	19.8	9.9	18.4	8.6	17.6	16.2	6.3	27.3	17.6	18.0	13.7	23.8	11.2	9.9	19.9	17.1	18.7	23.0	12.2	16.3	9.5	17.7	15.9	6.4	8.2	15.9	11.3	69.9	21.8	14.3	8.5	15.7	15.3	17.4	13.5	17.1	9.4	14.3	25.9	8.2	18.6	14.7	18.6	17.9	20.7	14.7	24.2	15.4	12.3	14.6	15.2	11.6	19.6	15.3	25.6	19.4	18.6	21.8	16.5	15.0	24.4	18.1	18.8	10.7	23.8	33.1	34.1	23.5	28.6	23.8	23.3	12.3	14.6	16.3	19.5	15.5	12.7	14.0	23.6	31.9	5.3	14.4	18.9	25.9	27.1	33.4	17.6	31.3	25.1	14.6	22.2	13.6	13.0	30.5	30.1	19.0	28.3	30.5	14.3	15.4	17.4	19.2	16.2	9.4	24.4	20.0	39.6	39.6	21.1	9.7	31.6	6.6	3.8	2.8	1.5	2.3	3.3	2.4	1.7	2.5	3.6	3.5	1.9	2.9	3.0	1.8	3.1	2.6	3.0	2.6	1.7	17.5	17.2	15.8	18.3	17.6	18.0	19.9	17.1	17.7	15.7	17.1	18.6	18.4	16.0	24.1	10.4	20.5	15.6	16.6	8.0	22.2	32.1	18.7	13.1	62.0	27.1	13.3	27.6	14.6	58.3	30.7	22.6	19.6	13.4	1.6	15.6	19.0	16.7	21.6	18.7	11.4	15.0	39.0	22.0	26.5	14.4	11.4	28.2	21.4	33.1	26.7	38.7	11.6	24.7	10.2	17.9	8.8	3.5	22.1	16.8	8.8	7.5	20.6	31.9	29.9	12.5	12.7	13.7	21.6	23.7	21.6	19.5	25.3	22.5	11.4	20.9	13.1	27.3	23.9	20.4	37.1	26.2	21.6	48.2	20.5	32.4	33.1	13.3
LRRC49	FLJ20156	ENSG00000137821	"Leucine rich repeat containing 49"	Q8IUZ0	15	70853239-71053658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 56.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.0;Cardiomyocytes: 145.1;Early spermatids: 92.8;Excitatory neurons: 79.1;Inhibitory neurons: 88.4;Late spermatids: 105.3;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 24.2;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015596	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015596: AB_2669230"	"unprognostic (9.74e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.66e-4)"	"unprognostic (3.02e-1)"	"unprognostic (5.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.09e-2)"	2.4	2.8	7.9	0.8	10.4	0.3	2.7	13.7	11.2	6.6	7.3	3.9	0.4	8.7	29.6	1.9	9.0	3.7	56.3	6.7	10.7	4.6	0.5	2.7	0.7	12.2	10.5	11.1	1.4	9.1	11.6	1.0	13.2	5.3	1.7	26.8	1.8	4.8	1.1	1.7	1.7	5.0	5.1	0.8	2.7	11.9	18.8	1.0	4.8	1.7	0.8	4.5	3.8	6.1	2.1	3.9	8.5	14.9	3.8	6.4	0.1	3.6	6.3	2.4	5.8	1.3	1.6	0.0	2.6	1.5	6.0	3.5	8.4	4.3	2.0	0.0	4.5	1.0	4.1	0.1	24.2	0.1	0.5	2.9	1.5	7.2	12.3	12.5	6.5	0.0	0.1	0.0	3.6	0.7	0.0	0.7	5.0	0.3	2.8	0.0	5.7	0.0	8.0	4.5	17.2	18.0	4.3	2.0	4.0	3.1	4.6	1.4	5.9	2.9	9.0	5.4	6.2	1.1	4.3	0.0	6.8	0.2	2.2	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	10.4	13.7	11.2	6.7	10.7	12.2	10.5	13.2	5.1	18.8	6.1	4.3	3.2	3.7	63.3	0.7	2.3	22.9	11.5	5.7	85.0	2.2	3.0	145.1	1.5	13.0	7.3	62.6	0.1	0.1	1.5	5.9	7.0	92.8	30.8	8.0	7.2	18.5	0.0	79.1	0.9	0.1	11.6	2.6	4.3	0.0	8.0	2.5	0.0	0.1	30.3	88.4	1.9	0.0	0.3	0.7	105.3	5.6	0.7	0.0	19.7	0.0	10.9	0.0	63.8	34.1	1.7	1.6	9.8	0.2	11.7	0.3	3.5	54.8	37.3	0.0	7.4	8.0	91.9	11.4	0.7	1.6	0.3	0.8	2.5	1.2	8.0
LRRC4B	"DKFZp761A179, HSM, LRIG4"	ENSG00000131409	"Leucine rich repeat containing 4B"	Q9NT99	19	50516892-50568435	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.2;cervix: 41.3;pituitary gland: 31.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.9;Bipolar cells: 19.6;Excitatory neurons: 32.1;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 48.9"	"Group enriched"	"Detected in many"	9	"glioma: 36.5;testis cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.7;HMC-1: 32.1;REH: 8.7;SH-SY5Y: 27.5;U-2 OS: 25.3;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058986	Uncertain					NA	NA		2700000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA058986: AB_2683871"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.39e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.15e-5)"	"unprognostic (4.29e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.17e-1)"	2.8	5.3	54.4	0.9	35.6	0.0	2.1	20.7	61.2	41.3	0.0	2.8	0.8	16.2	0.1	1.9	10.0	1.2	1.8	49.3	33.2	1.8	1.3	5.8	1.3	50.9	47.6	5.1	0.8	0.2	31.9	4.2	33.3	3.3	0.1	1.6	0.8	1.0	0.7	1.2	3.3	1.3	19.9	0.8	2.9	2.4	38.2	0.0	2.6	0.1	0.5	5.8	13.0	38.1	0.0	0.5	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.9	0.0	0.7	0.1	0.1	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.1	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.5	0.0	1.0	0.1	0.0	8.2	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	5.7	0.2	0.0	0.3	0.0	0.0	25.3	0.0	0.0	0.6	0.1	0.1	0.1	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	35.6	20.7	61.2	49.3	33.2	50.9	47.6	33.3	19.9	38.2	38.1	0.7	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.5	0.9	0.0	0.0	32.1	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.7	0.0	0.1	10.1	38.5	0.0	0.0	0.0	0.3	2.2	2.8	0.0	0.0	2.8	0.0	1.6	0.0	29.7	48.9	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	5.8	4.8	8.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 17.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 5497.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 19.1;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	0.7	3.4	11.4	0.8	14.1	0.0	1.4	0.5	15.4	3.0	0.0	2.5	0.4	1.2	0.3	0.4	0.5	0.8	2.1	14.4	9.6	0.3	1.1	0.8	0.7	7.8	10.7	0.6	0.3	1.7	4.0	0.0	5.7	0.6	0.7	17.1	0.6	1.6	0.3	0.2	0.8	1.3	4.6	0.6	0.5	0.2	8.1	0.6	2.3	0.7	0.7	0.7	2.0	9.2	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	20.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.1	0.5	15.4	14.4	9.6	7.8	10.7	5.7	4.6	8.1	9.2	0.2	0.0	1.3	498.2	0.2	0.1	0.0	1.4	0.0	35.5	4.2	3.0	1.2	0.0	1.4	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.9	0.3	10.5	1.4	0.0	0.0	1171.8	0.0	0.0	5.6	0.0	0.9	0.0	0.1	0.0	0.0	0.1	8.4	1274.6	0.0	0.0	0.0	1.9	0.2	2.1	0.4	1.8	49.6	0.0	93.6	0.0	5497.5	221.3	0.3	0.0	1.5	0.1	0.1	0.0	0.7	0.0	99.7	0.0	2.0	0.7	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0
LRRC53		ENSG00000162621	"Leucine rich repeat containing 53"	A6NM62	1	74469376-74512611	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 1.0"	"Cell type enriched"	"Detected in single"	8	"Enteroendocrine cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA054062	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA054062: AB_2682364"					"unprognostic (3.67e-1)"													0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 15.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 19.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 105.4"	"Low region specificity"	"Detected in all"			HPA014053	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.4	0.5	4.7	1.0	2.8	0.0	0.1	0.8	3.5	0.1	0.0	0.5	0.3	1.8	0.0	0.0	0.3	0.2	0.3	4.1	6.7	0.3	1.2	0.2	2.1	15.0	11.7	0.0	0.2	0.0	0.0	0.9	3.7	0.0	0.5	0.1	0.6	0.0	0.3	0.1	0.4	1.0	8.4	1.3	0.1	0.2	5.9	0.9	0.1	0.3	0.5	0.0	0.0	6.8	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.8	0.8	3.5	4.1	6.7	15.0	11.7	3.7	8.4	5.9	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC56	"DKFZp761L1518, FLJ00101"	ENSG00000161328	"Leucine rich repeat containing 56"	Q8IYG6	11	537527-554912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.3;testis: 22.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 68.0;Late spermatids: 141.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.8;Daudi: 1.3;Karpas-707: 2.4;SK-BR-3: 1.6;T-47d: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038728	Approved					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA038728: AB_10671864"	"unprognostic (2.77e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.29e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.17e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-3)"	0.8	0.8	0.5	0.1	1.9	0.2	1.6	0.3	0.5	2.4	0.6	1.7	0.1	0.9	1.3	2.7	6.4	0.0	0.5	0.8	0.3	3.2	1.6	2.9	0.0	0.5	0.3	1.8	2.4	0.0	12.3	0.0	0.1	3.7	0.0	0.1	2.0	0.3	1.2	2.5	2.2	0.0	0.4	2.2	2.1	22.3	0.6	0.1	2.7	0.0	0.2	1.2	2.0	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.4	1.1	0.4	0.8	0.0	0.2	0.0	0.0	0.5	0.0	2.4	0.0	0.0	0.1	0.7	0.0	0.7	0.7	0.0	0.0	0.5	0.2	0.0	0.3	0.2	0.0	1.6	0.0	0.0	2.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.3	0.5	0.8	0.3	0.5	0.3	0.1	0.4	0.6	0.3	0.5	0.0	3.4	3.3	3.0	1.7	1.5	1.5	0.0	1.1	2.1	0.9	0.6	1.5	2.4	3.7	16.7	0.3	0.6	4.9	0.0	1.1	68.0	11.6	0.6	0.5	12.5	0.4	5.2	0.4	0.2	1.1	1.5	1.3	0.0	0.5	1.1	0.3	0.3	6.7	3.8	2.1	6.1	0.6	0.3	141.2	1.2	0.3	1.8	1.0	0.0	2.7	1.0	1.5	2.8	0.5	1.4	1.2	0.1	1.2	0.2	0.8	14.4	7.0	0.0	0.2	0.6	6.6	2.2	0.6	0.9	0.5	1.4	0.7	0.6	0.8
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040894	Approved		Approved	Mitochondria,Cytosol		NA	NA		26000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	7.7	7.3	4.8	5.5	4.6	22.0	7.5	4.8	8.5	7.3	3.3	9.3	6.5	7.7	5.5	9.6	8.3	5.3	6.9	6.1	3.1	8.0	6.1	8.6	6.6	3.6	3.4	8.6	7.3	14.0	6.0	7.9	4.1	6.6	10.7	14.9	8.0	5.8	6.0	9.6	8.1	7.3	3.2	6.7	7.8	5.7	3.7	9.6	7.0	6.9	7.4	6.8	8.6	5.4	14.7	11.0	19.5	13.8	16.5	12.7	9.7	20.5	11.2	14.7	15.4	23.3	11.0	6.8	13.8	16.9	16.5	22.7	13.2	16.7	14.7	12.8	12.2	27.7	23.6	10.7	14.7	17.8	15.0	14.0	22.8	13.2	17.1	10.1	23.7	17.3	21.9	14.5	13.6	6.6	9.8	7.5	4.6	26.6	8.5	15.1	19.6	10.5	9.8	24.4	9.8	11.9	24.8	16.3	11.8	12.7	16.1	19.6	24.3	16.5	11.4	17.5	15.5	11.9	36.4	29.0	8.9	16.4	21.0	36.9	9.7	32.0	7.4	14.6	9.3	5.8	7.2	7.2	10.2	7.1	5.8	7.3	12.2	16.9	19.3	5.9	8.5	6.9	4.8	4.6	4.8	8.5	6.1	3.1	3.6	3.4	4.1	3.2	3.7	5.4	16.3	9.6	10.8	6.8	10.4	5.7	13.6	6.5	6.8	13.6	9.6	8.1	11.1	15.7	7.3	9.2	60.5	11.6	18.8	16.4	13.7	10.9	18.7	13.5	13.8	17.3	12.5	15.8	17.1	9.8	19.3	12.7	9.2	13.2	14.5	10.2	19.2	7.5	14.1	20.2	8.8	13.1	6.1	14.2	4.8	20.0	9.6	13.1	7.2	7.5	21.9	21.1	20.6	11.6	8.3	15.2	15.9	16.1	8.4	12.4	15.2	8.4	14.8	87.4	6.6	16.9	10.1	7.8	6.4	11.4	5.5	15.9	11.3	18.4	12.2	12.8
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	10.6	22.8	8.4	8.8	11.9	9.0	12.0	11.0	9.3	9.0	9.5	7.7	7.5	10.2	8.3	9.2	6.6	7.4	5.5	7.1	8.6	14.9	11.2	7.4	10.2	11.8	11.3	14.6	10.3	13.7	4.1	9.6	12.6	9.7	7.5	7.2	8.5	8.6	5.0	10.9	7.4	9.7	10.8	9.1	7.3	4.5	9.7	12.2	14.2	5.8	8.8	7.4	6.5	14.8	52.6	18.1	12.2	15.6	27.5	26.1	19.3	18.5	16.0	19.2	23.8	17.0	15.8	34.1	22.4	19.9	27.3	22.4	22.7	18.1	36.5	13.3	14.0	36.5	23.5	19.9	18.5	59.8	18.0	19.3	22.7	23.4	29.9	12.4	11.5	21.5	21.0	42.6	20.9	23.9	47.2	19.1	12.3	23.1	32.8	10.4	32.6	22.1	14.6	19.1	15.6	20.6	32.4	21.9	46.2	8.5	24.1	26.7	17.2	32.0	35.7	21.7	23.5	36.3	44.9	70.6	32.2	44.2	27.4	1.4	2.7	1.1	1.9	2.4	2.7	2.5	2.3	2.4	2.6	2.3	3.5	2.7	1.5	1.6	1.9	2.9	2.6	1.9	8.4	11.9	11.0	9.3	7.1	8.6	11.8	11.3	12.6	10.8	9.7	14.8	26.0	73.7	59.9	18.3	30.8	50.9	20.7	15.9	32.5	32.3	34.0	25.8	17.3	24.3	29.0	18.4	56.3	17.3	33.3	17.9	11.7	22.0	7.8	24.4	48.8	24.1	16.8	34.3	23.8	31.0	28.2	50.0	18.3	27.0	35.4	33.9	27.1	43.0	28.7	25.2	27.1	24.3	12.2	49.0	33.9	7.3	55.9	34.4	33.8	14.0	42.3	46.5	30.9	25.1	34.8	28.8	18.6	73.0	33.0	37.0	24.8	39.6	32.3	26.5	26.3	52.7	33.9	19.5	22.8	31.2	57.0	13.5	28.7	94.6	32.3	17.5
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397523	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		740000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	49.6	82.6	18.5	54.1	20.5	79.3	34.1	18.4	21.7	60.4	19.0	72.1	46.8	32.2	55.5	47.9	29.4	32.2	33.0	19.1	18.6	41.1	75.0	45.8	30.9	18.2	19.3	21.7	119.4	34.8	21.8	51.7	18.6	35.3	72.0	21.7	56.2	35.7	32.6	24.3	46.0	52.3	18.3	33.0	73.8	29.2	22.0	29.3	36.0	17.0	42.8	56.6	30.1	19.9	390.5	289.9	81.8	123.6	135.3	158.7	146.2	310.7	172.3	284.5	249.4	668.8	109.0	168.8	207.8	356.4	174.3	138.1	205.2	265.2	336.3	90.4	298.6	295.9	154.8	361.8	283.7	294.1	134.8	140.8	211.3	305.2	351.7	82.6	213.3	95.7	278.9	155.6	189.4	264.3	209.0	139.0	92.5	364.2	419.1	175.9	261.9	323.6	156.0	194.9	199.1	165.4	107.5	119.3	161.9	120.4	201.1	157.9	229.6	327.4	135.5	306.2	410.4	232.3	205.1	213.6	222.2	195.9	210.8	22.8	21.9	19.8	9.4	26.9	11.7	11.0	9.5	11.5	20.3	8.5	6.1	7.9	10.9	8.6	27.8	16.5	10.3	13.0	18.5	20.5	18.4	21.7	19.1	18.6	18.2	19.3	18.6	18.3	22.0	19.9	33.1	22.4	23.7	5.2	61.2	139.4	102.1	54.7	43.9	20.4	55.0	30.9	4.1	40.0	50.0	20.2	2.1	90.8	38.4	101.6	29.4	165.0	67.1	53.6	53.8	45.6	38.3	36.6	5.5	187.0	272.2	64.5	104.5	96.3	30.4	28.9	27.1	69.1	103.3	21.9	5.5	178.3	26.4	29.0	111.1	18.7	35.4	45.1	65.8	3.7	45.6	26.5	30.9	2.0	6.8	187.7	75.7	29.0	211.3	164.8	63.5	48.0	26.5	15.5	13.1	59.1	92.8	61.3	27.7	66.1	132.7	236.0	33.2	38.3	127.1	146.7
LRRC6	"CILD19, LRTP, tilB, TSLRP"	ENSG00000129295	"Leucine rich repeat containing 6"	Q86X45	8	132570416-132675592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 23.2;testis: 26.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.5;Endometrial ciliated cells: 101.5;Excitatory neurons: 85.8;Inhibitory neurons: 67.1;Late spermatids: 62.1;Respiratory ciliated cells: 152.7;Spermatocytes: 102.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.5;RPTEC TERT1: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028058	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028058: AB_1853337"	"unprognostic (1.53e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.98e-4)"	"unprognostic (4.17e-2)"	3.1	4.3	9.4	1.9	12.2	3.5	2.7	5.6	14.1	4.9	23.2	2.4	0.9	3.1	5.6	1.2	19.5	3.6	2.3	9.7	8.3	11.5	1.5	4.1	0.9	12.8	12.8	3.5	2.8	5.6	8.3	1.7	9.1	2.3	1.5	13.8	2.0	2.2	0.4	1.3	2.6	1.8	10.6	4.0	1.3	26.2	9.1	0.8	7.7	0.6	0.7	2.1	2.2	10.4	0.4	2.2	3.5	0.0	2.9	4.8	7.5	0.3	0.5	1.7	1.5	0.4	8.5	0.0	2.5	3.1	2.4	0.0	0.6	1.1	1.7	0.3	0.0	0.0	0.6	0.1	1.2	0.0	3.8	4.2	2.1	3.9	0.1	4.0	0.8	3.6	0.3	0.0	2.2	2.8	0.0	0.1	5.6	2.6	2.1	0.0	0.1	1.2	15.7	0.0	1.8	2.6	0.3	0.0	0.4	5.4	0.9	0.5	0.0	2.0	7.2	6.3	0.7	0.0	1.0	0.2	5.3	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.3	9.4	12.2	5.6	14.1	9.7	8.3	12.8	12.8	9.1	10.6	9.1	10.4	2.2	6.4	0.5	24.5	0.5	1.3	3.7	7.7	1.8	2.5	3.3	3.7	2.8	1.5	18.0	9.2	8.4	0.0	0.2	1.7	21.5	6.4	228.5	101.5	7.3	3.1	1.2	0.8	85.8	1.8	0.2	4.4	0.0	7.3	0.0	2.9	4.2	0.5	2.1	1.7	67.1	0.7	8.2	0.8	1.4	62.1	3.7	2.8	0.0	11.2	0.6	7.2	1.0	6.6	5.3	0.7	1.4	4.5	0.0	1.2	2.6	34.7	152.7	13.7	0.0	1.3	4.5	102.6	10.5	1.2	1.1	0.0	0.5	6.0	1.7	1.9
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150323263-150338156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 80.6;Hep G2: 53.3;NTERA-2: 67.0"	"Low region specificity"	"Detected in all"							HPA019355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	4.0	18.3	9.5	4.5	8.4	1.6	4.5	6.9	8.7	7.5	9.8	5.7	4.3	6.5	2.0	8.8	14.5	4.0	4.1	7.7	13.1	12.1	23.4	4.4	7.3	9.7	10.1	15.2	11.2	11.4	13.5	3.8	10.4	6.6	1.9	2.8	5.3	4.3	2.2	6.8	5.8	2.0	8.2	6.1	6.1	9.1	13.4	11.5	8.7	2.3	3.9	4.7	6.5	6.7	20.0	0.5	0.6	0.1	0.0	0.0	9.0	0.2	0.0	2.4	7.8	37.9	19.4	6.2	8.2	0.3	0.0	17.6	0.0	0.0	1.3	80.6	24.4	7.4	23.5	53.3	13.8	0.0	3.7	1.6	7.9	0.0	0.0	0.6	0.1	40.2	25.9	11.5	0.0	36.5	37.5	3.2	67.0	13.8	0.0	0.0	0.1	16.5	5.7	13.2	34.6	33.4	33.6	7.2	13.7	5.6	5.6	4.5	0.1	0.0	0.1	0.0	0.1	12.5	4.4	0.0	0.0	0.0	0.0	2.8	2.9	8.5	10.8	1.1	8.3	8.7	7.3	8.2	3.0	10.7	7.0	8.4	13.1	8.7	1.3	17.9	12.7	5.7	9.5	8.4	6.9	8.7	7.7	13.1	9.7	10.1	10.4	8.2	13.4	6.7	0.3	6.4	1.5	2.3	7.1	1.1	4.7	16.5	8.6	7.8	8.0	8.9	2.2	11.5	6.8	16.5	0.0	25.2	11.1	9.4	19.6	27.3	5.7	20.9	1.6	1.7	19.3	3.8	1.7	28.4	24.5	4.7	7.1	5.8	1.3	22.9	1.8	22.6	6.0	13.5	3.6	6.7	18.3	1.3	0.0	16.3	10.2	3.3	3.6	0.0	16.5	13.7	11.3	4.5	0.3	27.9	11.2	5.7	3.5	4.0	11.7	48.7	20.1	4.5	0.0	5.3	3.2	20.8	23.7	8.1	2.7	27.0	7.4	9.0	10.6	3.0
LRRC63	RP11-139H14.4	ENSG00000173988	"Leucine rich repeat containing 63"		13	46211940-46277366	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 10.0;testis: 3.4"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocytes: 255.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039318, HPA039763"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA039318: AB_10796224, HPA039763: AB_10795408"	"unprognostic (3.40e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.33e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.18e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.31e-2)"	0.1	0.3	1.8	0.1	5.0	0.3	0.1	4.9	2.9	0.2	0.7	0.1	0.0	0.0	2.4	0.0	1.1	0.1	0.1	1.7	2.9	0.1	0.1	0.4	0.2	6.6	4.0	0.0	0.0	0.1	0.0	0.1	6.2	0.5	0.0	2.4	0.3	0.1	0.0	0.0	0.0	0.1	4.8	0.1	0.1	3.4	4.1	1.3	0.0	0.1	0.1	0.0	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.7	0.6	0.0	2.1	0.0	0.2	0.0	0.1	1.7	0.5	0.7	0.0	0.0	0.1	0.4	1.1	0.4	0.0	0.2	0.0	0.0	0.0	3.0	0.0	1.6	0.0	0.0	1.0	0.3	0.1	0.0	0.2	0.2	0.0	0.2	0.3	0.0	0.5	0.6	0.0	0.0	0.7	0.8	0.0	0.5	0.3	0.2	0.1	0.0	0.3	0.6	1.3	0.1	2.0	1.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.1	1.8	5.0	4.9	2.9	1.7	2.9	6.6	4.0	6.2	4.8	4.1	10.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	34.1	3.1	0.1	0.1	0.0	1.3	0.9	0.0	0.1	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.5	0.0	5.2	0.0	0.0	0.8	0.3	8.4	0.0	0.2	0.0	1.9	0.0	0.1	0.0	4.0	255.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	2.8	0.0	0.0	0.2	3.8	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.5;skeletal muscle: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.9;Distal enterocytes: 9.0;Excitatory neurons: 9.4;Gastric mucus-secreting cells: 6.1;Inhibitory neurons: 7.3;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 8.8;Paneth cells: 7.3;Proximal enterocytes: 21.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;CAPAN-2: 2.0;OE19: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.4	0.3	0.9	0.9	1.0	0.0	0.3	1.3	1.4	0.6	0.5	6.1	22.5	0.5	0.2	0.1	0.5	1.8	1.0	1.0	0.8	1.1	0.5	0.2	0.1	1.2	0.8	0.4	0.3	0.3	2.4	0.0	1.2	0.5	5.8	0.8	0.3	0.2	8.0	0.2	18.7	0.6	0.8	0.3	5.0	0.8	1.1	0.1	0.2	2.1	0.0	0.5	0.3	1.2	0.0	0.0	0.1	0.2	0.6	1.5	0.0	0.2	0.4	0.1	0.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.3	1.4	1.0	0.8	1.2	0.8	1.2	0.8	1.1	1.2	0.2	0.0	0.0	5.9	0.1	0.0	0.0	0.2	0.0	1.6	0.1	0.4	1.1	1.5	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.2	1.3	0.4	0.2	0.1	0.0	0.0	9.4	1.2	0.0	0.6	6.1	0.2	0.0	0.1	0.7	0.1	0.0	0.0	7.3	4.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.9	0.6	0.1	0.0	8.0	8.8	0.5	7.3	0.4	0.0	0.0	21.8	0.4	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1
LRRC69		ENSG00000214954	"Leucine rich repeat containing 69"	Q6ZNQ3	8	91101832-91219236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 77.3;Late spermatids: 18.0;Microglial cells: 27.2;Oligodendrocytes: 27.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.3;SuSa: 5.2;U-266/70: 16.0;U-266/84: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046337	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA046337: AB_2679626"	"unprognostic (1.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-6)"	"unprognostic (6.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.68e-5)"	0.3	0.5	0.2	0.9	0.6	0.1	0.6	0.6	0.4	0.3	0.8	0.3	0.2	0.2	0.9	0.3	0.2	0.4	0.5	0.2	0.4	0.5	0.3	0.4	1.1	0.8	0.5	0.2	0.3	0.9	0.2	0.4	0.8	0.5	0.7	0.6	0.7	0.3	0.5	1.7	0.4	0.8	0.5	0.7	0.4	2.9	0.5	0.8	0.5	0.4	0.7	0.7	0.3	1.0	0.6	0.6	0.1	0.4	0.6	1.3	1.0	0.3	0.1	0.2	0.3	0.9	0.8	0.9	0.4	0.2	0.1	0.6	0.7	1.1	0.3	0.3	6.3	1.4	1.8	0.4	0.2	0.5	1.0	0.4	1.0	0.4	0.7	0.4	0.1	1.1	1.0	0.5	0.4	0.2	0.3	0.4	0.6	1.0	0.4	0.8	0.0	0.7	0.2	0.7	0.0	0.2	0.0	0.4	1.0	5.2	1.4	1.0	0.5	0.2	0.6	0.1	0.8	16.0	9.5	3.8	0.1	2.1	0.8	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	0.4	0.4	0.2	0.0	0.1	0.1	0.4	0.5	0.0	0.2	0.6	0.6	0.4	0.2	0.4	0.8	0.5	0.8	0.5	0.5	1.0	1.1	0.0	1.1	16.0	1.5	4.7	2.9	1.3	0.6	1.9	1.6	0.6	2.9	0.0	1.5	3.7	4.2	2.3	2.0	1.1	3.9	1.5	77.3	1.2	0.4	2.7	2.4	0.8	5.3	1.2	1.9	1.7	0.0	0.6	0.0	1.0	4.2	0.6	0.9	0.0	6.4	2.2	6.1	1.3	7.0	18.0	2.8	1.6	7.2	27.2	4.2	1.1	2.1	7.5	27.9	1.8	1.6	1.2	0.2	5.3	0.4	0.9	6.1	3.2	0.0	4.7	2.7	4.2	4.0	0.7	5.3	1.0	2.2	0.9	1.7	2.3
LRRC70	"LOC100130733, SLRN"	ENSG00000186105	"Leucine rich repeat containing 70"	Q7Z2Q7	5	62578819-62581446	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 3.6;Endothelial cells: 4.9;Erythroid cells: 1.7;Fibroblasts: 1.8;granulocytes: 3.8;Hepatic stellate cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"HUVEC TERT2: 17.6;TIME: 9.6"					"Low region specificity"	"Detected in all"			HPA013409	Uncertain					NA	NA		17000	"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013409: AB_10601911"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.7	0.8	0.5	1.4	0.4	3.6	4.7	0.5	1.2	3.9	0.6	1.4	0.8	1.9	1.0	1.7	3.3	3.6	1.8	0.4	0.4	1.9	1.4	1.9	1.9	0.7	0.8	2.9	0.9	1.2	1.4	4.6	0.6	2.0	1.4	1.0	1.2	0.5	0.7	2.7	1.4	3.4	0.6	4.1	1.1	1.7	0.5	1.0	4.0	0.6	0.7	1.7	2.8	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	17.6	0.3	0.2	0.7	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	9.6	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.4	0.5	1.2	0.4	0.4	0.7	0.8	0.6	0.6	0.5	0.8	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.1	4.9	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.1	3.8	0.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.4	0.3	0.0	0.3	0.0	0.0	0.0
LRRC72	"CFAP279, FAP279"	ENSG00000205858	"Leucine rich repeat containing 72"	A6NJI9	7	16526825-16581568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Group enriched"	"Detected in some"	83	"Early spermatids: 114.1;Late spermatids: 36.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA020554	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA020554: AB_1859508"															"unprognostic (1.58e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	36.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 44.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 411.0;Spermatocytes: 121.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	0.2	6.4	4.6	0.0	4.8	0.0	0.3	0.0	8.9	0.9	0.6	0.4	0.6	0.6	0.3	0.2	5.1	0.5	1.5	5.6	2.4	2.6	0.5	0.9	0.0	1.3	1.4	0.9	1.2	2.9	4.7	0.2	1.5	1.0	0.1	1.3	0.6	0.6	0.0	0.3	0.2	0.3	0.2	0.5	1.0	44.2	3.5	0.0	1.1	0.0	0.0	0.4	0.3	3.7	0.3	0.7	0.4	3.1	0.5	1.5	0.1	0.1	0.9	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.4	1.2	0.3	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.6	1.0	0.1	1.5	0.1	0.1	0.2	0.3	0.6	3.2	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.8	0.0	1.1	1.3	0.3	0.2	0.1	0.0	3.2	0.0	0.1	0.2	0.3	1.1	0.1	0.3	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.8	0.0	8.9	5.6	2.4	1.3	1.4	1.5	0.2	3.5	3.7	0.3	0.0	0.0	1.0	0.0	0.4	3.1	0.7	0.0	5.6	0.8	1.3	1.0	1.5	1.6	3.7	0.0	0.1	0.0	1.0	7.9	0.6	411.0	27.1	4.0	0.6	5.4	0.0	3.3	0.9	0.1	0.8	1.5	1.3	0.0	0.6	0.0	0.8	0.1	28.6	3.3	2.2	0.0	0.0	0.0	58.3	4.4	0.4	1.8	0.0	0.0	8.7	0.0	0.0	0.3	0.2	0.1	4.1	0.0	2.8	2.2	9.4	12.6	8.4	6.6	0.3	0.9	121.6	12.4	0.0	0.0	0.3	0.1	7.1	0.8	0.6
LRRC74A	"C14orf166B, LRRC74"	ENSG00000100565	"Leucine rich repeat containing 74A"	Q0VAA2	14	76826372-76870302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 3.9"	"Group enriched"	"Detected in some"	84	"Early spermatids: 58.0;Late spermatids: 111.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035094	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA035094: AB_10600793"	"unprognostic (7.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	111.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRC74B		ENSG00000187905	"Leucine rich repeat containing 74B"	Q6ZQY2	22	21045960-21064168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;choroid plexus: 4.0;fallopian tube: 3.8"	"Cell type enhanced"	"Detected in some"		"Club cells: 12.4;Endometrial ciliated cells: 25.8;Respiratory ciliated cells: 72.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049947	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA049947: AB_2680966"	"unprognostic (3.43e-2)"	"unprognostic (1.76e-1)"		"unprognostic (3.28e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.44e-3)"		"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.57e-9)"	"unprognostic (4.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.92e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.6	4.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.0	1.2	1.7	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.9	1.2	1.7	0.5	1.4	0.1	0.3	0.1	0.0	1.8	2.9	0.1	0.0	0.7	0.0	0.0	1.1	0.3	0.5	0.6	0.0	12.4	0.0	4.2	0.2	0.5	0.0	0.0	0.0	3.7	25.8	0.5	0.5	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.9	0.0	0.1	0.4	0.4	0.1	1.7	0.6	0.0	0.0	0.0	0.0	1.0	0.3	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	72.1	1.5	0.0	2.5	0.4	4.6	3.1	0.0	0.0	0.3	0.4	0.5	0.1	0.1
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 62.1;SK-MEL-30: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	5.5	21.5	6.8	6.4	5.0	16.1	0.5	1.8	7.7	1.3	0.1	20.2	47.4	4.0	0.2	2.1	1.3	3.1	2.4	6.8	6.5	2.0	0.6	4.6	5.6	4.1	6.7	4.4	7.0	4.7	3.1	3.4	5.1	1.9	9.0	2.3	1.3	1.1	2.9	2.2	44.0	2.3	3.4	21.5	7.4	10.6	5.1	0.5	4.9	0.6	1.6	1.5	0.5	5.3	8.9	6.3	7.6	6.0	0.2	0.2	1.3	2.4	0.4	1.8	1.5	7.9	2.6	0.6	6.6	0.2	3.7	3.7	0.2	0.0	0.0	3.4	6.5	62.1	3.9	0.0	0.3	1.5	7.3	0.0	0.0	0.4	0.0	3.2	2.3	9.4	3.9	1.7	0.1	12.8	15.3	6.7	1.7	20.3	0.7	5.8	5.5	0.8	0.4	1.8	16.6	4.6	0.6	1.8	21.7	3.3	1.4	1.4	0.0	2.2	10.5	6.7	11.9	12.2	2.6	2.0	0.8	5.1	7.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.3	0.4	1.0	0.0	0.0	0.4	6.8	5.0	1.8	7.7	6.8	6.5	4.1	6.7	5.1	3.4	5.1	5.3	40.5	41.7	69.7	10.7	21.6	0.0	9.6	0.0	2.2	9.1	24.9	13.3	0.7	14.3	19.8	1.8	6.2	16.1	24.8	52.5	19.6	3.9	7.1	30.0	61.0	14.7	24.7	9.7	5.3	7.1	20.4	30.5	2.0	58.7	29.7	25.0	11.0	10.0	12.0	3.3	3.6	52.2	0.0	13.9	0.0	8.0	16.4	22.9	0.0	1.0	7.7	21.3	2.1	4.0	4.2	6.2	36.0	11.3	12.0	8.7	65.4	19.4	8.7	18.2	13.1	22.9	19.4	8.0	6.5	1.1	0.0	16.7	18.6	66.3	66.0	7.5
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatocytes: 25.6;Muller glia cells: 39.9;Proximal enterocytes: 46.7;Proximal tubular cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 5.3;MCF7: 5.0;SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	1.8	0.7	5.8	0.0	5.5	0.3	1.8	5.7	7.4	1.9	3.6	3.2	0.0	1.0	0.5	2.1	1.5	0.0	2.9	5.2	6.0	5.6	3.6	0.8	0.0	6.0	6.1	3.2	3.5	0.0	1.3	0.1	5.7	2.8	0.1	0.6	2.0	0.4	2.5	1.8	1.6	0.0	5.9	0.5	2.5	7.5	5.9	0.1	1.6	0.0	0.1	3.5	1.9	5.8	0.1	2.8	0.0	1.5	0.3	1.1	0.2	0.4	0.4	0.9	1.0	2.0	0.0	0.0	0.7	0.8	0.8	3.0	0.2	1.5	0.0	0.9	1.8	0.2	0.3	5.3	2.6	0.0	0.0	0.0	1.1	1.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	5.0	0.0	1.0	1.3	3.4	1.1	0.0	0.1	0.0	1.2	0.3	1.4	4.2	1.4	0.4	0.5	0.3	0.0	0.5	1.5	1.6	0.9	0.6	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.8	5.5	5.7	7.4	5.2	6.0	6.0	6.1	5.7	5.9	5.9	5.8	1.6	12.8	5.9	9.4	0.3	0.0	2.5	0.0	2.2	2.8	16.2	18.7	4.4	34.3	0.0	7.3	0.0	2.5	0.9	10.7	11.7	9.8	1.6	2.3	3.6	1.8	1.2	1.3	3.8	8.9	0.4	7.1	14.3	6.1	0.0	7.2	2.9	25.6	1.1	1.7	4.1	8.0	0.0	1.6	0.0	7.9	12.8	1.4	0.0	1.0	0.3	39.9	0.0	7.1	2.2	4.0	6.2	9.8	0.6	8.0	46.7	44.5	0.0	1.8	0.0	4.5	4.2	0.5	1.3	2.5	0.0	1.1	0.8	2.0	6.4	1.3
LRRC8B	"KIAA0231, TA-LRRP"	ENSG00000197147	"Leucine rich repeat containing 8 VRAC subunit B"	Q6P9F7	1	89524829-89597861	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.0;Excitatory neurons: 177.4;Inhibitory neurons: 197.3;Oligodendrocytes: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017950	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 58: Brain - Synaptic function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017950: AB_1853346"	"unprognostic (2.50e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.15e-4)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	6.6	14.6	3.9	3.7	8.1	3.0	5.3	0.0	13.5	2.8	0.0	4.4	6.1	1.8	5.5	4.0	3.2	5.0	2.4	13.0	0.0	3.7	3.8	4.7	4.5	0.4	0.4	1.6	6.6	5.3	3.3	1.8	0.8	4.3	5.2	12.9	4.2	1.1	4.0	5.8	4.1	2.7	1.4	3.6	5.2	15.4	0.0	3.8	4.9	3.1	5.0	5.0	2.2	16.0	13.0	4.7	3.8	13.2	18.5	10.8	15.3	0.4	4.0	1.7	2.3	7.9	8.4	1.2	4.8	1.9	5.0	6.7	35.6	2.8	1.9	6.4	6.3	28.9	3.7	7.4	1.9	13.6	17.7	5.6	11.5	1.5	5.6	0.6	18.7	10.6	30.3	9.3	2.1	7.9	5.3	6.2	20.7	6.1	7.1	13.0	1.7	5.3	4.5	16.8	10.6	17.5	7.2	18.3	12.7	4.6	10.7	6.1	6.0	1.5	8.4	3.8	4.1	5.9	4.7	6.7	2.1	3.0	3.3	0.7	0.7	0.5	0.4	0.3	0.3	0.8	0.6	0.4	0.7	0.6	0.9	0.8	0.3	0.3	0.4	0.6	1.0	0.5	3.9	8.1	0.0	13.5	13.0	0.0	0.4	0.4	0.8	1.4	0.0	16.0	5.8	16.0	13.9	15.7	11.4	33.0	12.4	13.6	14.8	32.9	15.2	8.4	7.0	17.2	17.7	7.3	47.9	3.2	2.8	8.9	1.9	13.0	97.0	13.5	1.9	12.7	26.9	3.8	177.4	18.9	18.2	4.4	10.2	8.4	2.5	13.3	16.1	6.7	7.0	0.0	197.3	14.2	8.2	12.8	17.3	72.7	2.5	9.8	1.8	26.2	7.9	5.8	1.0	45.2	140.7	15.4	6.0	2.6	11.1	18.6	4.3	5.7	26.8	22.4	6.6	9.4	14.8	7.3	3.8	13.9	27.6	2.5	8.0	8.0	13.2	12.4
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 28: Placenta - Pregnancy"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	14.3	7.6	3.8	9.0	4.5	8.0	7.7	4.5	5.8	3.2	11.4	3.2	3.2	7.3	1.9	2.9	2.8	6.6	6.2	4.1	4.1	2.5	3.3	7.7	12.2	4.6	5.0	5.3	1.8	2.8	2.3	6.6	5.1	2.3	3.7	1.6	2.0	2.0	2.7	6.0	3.8	15.8	4.8	9.2	2.9	4.0	4.7	5.6	3.5	8.0	7.7	6.2	2.0	6.0	0.3	3.8	3.0	2.7	9.1	10.2	1.4	19.3	21.6	8.7	8.0	0.0	1.3	6.0	5.3	8.5	14.9	13.1	10.1	29.0	20.9	14.8	6.1	5.7	2.9	0.3	7.4	26.6	1.9	4.4	5.8	18.8	10.0	5.8	35.6	9.2	3.9	7.9	7.5	0.7	3.9	26.2	3.3	0.1	7.8	26.5	1.4	2.0	1.8	3.2	2.3	10.7	7.1	0.7	16.2	4.7	0.2	41.3	29.9	15.3	7.3	5.3	14.9	2.9	2.6	3.1	4.7	19.6	2.6	0.4	6.0	0.0	3.8	5.2	3.3	0.7	6.1	5.1	8.9	0.5	4.8	4.5	0.8	2.0	6.6	0.7	11.3	3.2	3.8	4.5	4.5	5.8	4.1	4.1	4.6	5.0	5.1	4.8	4.7	6.0	73.5	3.2	3.6	31.3	7.6	45.4	3.8	5.6	3.4	2.3	1.7	2.9	6.3	2.8	2.7	0.0	0.0	0.1	24.6	0.3	0.0	1.7	36.3	0.2	1.9	47.3	1.2	4.8	73.6	2.4	1.1	8.7	2.6	0.6	0.0	58.5	28.9	0.1	13.6	1.7	99.2	0.3	2.0	29.5	36.9	21.3	0.0	27.8	26.6	185.5	21.3	0.5	13.4	22.1	85.2	12.8	1.9	0.7	20.8	2.1	0.3	0.6	2.9	1.2	0.0	2.2	24.2	3.9	2.0	1.3	44.9	0.3	27.1	3.4	0.3	2.5
LRRC8E	FLJ23420	ENSG00000171017	"Leucine rich repeat containing 8 VRAC subunit E"	Q6NSJ5	19	7888505-7902021	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.6;Glandular and luminal cells: 13.0;Squamous epithelial cells: 11.6;Suprabasal keratinocytes: 11.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020466	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"			"HPA020466: AB_1853352"	"unprognostic (3.79e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (7.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-6)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-1)"	0.6	4.9	0.4	0.8	0.5	1.9	4.6	1.0	0.6	3.3	0.6	1.0	0.9	1.4	6.2	6.4	2.1	2.3	0.9	0.5	0.1	1.9	4.1	4.3	0.7	0.4	0.2	0.3	7.2	3.3	0.5	1.3	0.7	3.5	1.1	0.4	7.7	2.1	0.5	10.6	0.5	0.4	0.0	0.3	3.6	0.7	0.3	0.1	2.0	0.4	2.8	2.9	4.7	1.4	23.5	6.0	0.2	0.6	1.1	5.6	3.5	10.1	8.7	15.8	12.3	7.7	5.3	0.6	7.5	9.8	22.5	18.3	7.7	9.8	14.9	0.4	8.5	0.3	3.1	8.2	4.1	0.3	0.5	9.1	13.9	10.5	7.8	21.2	2.0	4.1	6.5	0.8	1.9	11.9	0.1	0.5	1.7	4.3	21.9	1.4	0.2	0.6	12.0	21.3	0.5	0.4	7.6	9.6	0.3	1.7	12.8	0.5	2.6	4.8	8.7	13.2	5.8	1.5	2.9	0.3	36.4	0.8	1.7	1.7	0.4	0.5	0.5	0.3	0.6	0.6	0.4	0.4	0.1	0.8	0.5	0.6	1.5	1.1	0.4	0.5	0.4	0.2	0.4	0.5	1.0	0.6	0.5	0.1	0.4	0.2	0.7	0.0	0.3	1.4	0.1	3.2	5.5	0.0	0.1	9.6	5.0	1.5	6.2	0.0	8.2	5.7	0.2	1.5	5.4	1.8	0.0	0.7	0.0	1.1	0.0	6.2	0.0	7.7	2.4	0.5	0.0	0.0	0.1	6.0	1.0	1.0	3.6	13.0	1.3	0.4	0.0	3.2	0.1	0.0	0.1	1.2	4.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.0	5.0	0.1	0.5	6.5	0.0	0.0	0.8	0.9	0.0	0.3	11.6	11.2	1.9	0.5	0.1	1.3	5.9
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;choroid plexus: 12.4;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.3	0.1	0.9	0.0	1.6	0.1	0.0	1.0	0.6	0.0	12.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	5.2	5.4	0.0	0.0	0.7	0.5	0.0	3.7	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	8.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.0	0.6	1.0	1.7	5.2	5.4	3.7	4.3	1.9	5.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.6	1.5	0.1	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	18.0	0.0	0.0	0.0	0.0	75.8	0.9	0.1	0.0	1.9	0.0	0.8	0.0	5.5	2.0	0.0	0.0	0.7	0.0	0.7	0.4	0.0	2.9	0.2	0.0	0.0	0.0	10.3	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
LRRCC1	"CLERC, KIAA1764, VFL1"	ENSG00000133739	"Leucine rich repeat and coiled-coil centrosomal protein 1"	Q9C099	8	85107215-85146080	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 33.5"	"Group enriched"	"Detected in all"	5	"Early spermatids: 192.2;Late spermatids: 166.0;Spermatocytes: 224.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012893, HPA075880"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA012893: AB_1852434, HPA075880: "	"unprognostic (1.01e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.52e-1)"	4.9	4.8	5.8	3.8	6.6	7.4	6.4	6.1	9.7	4.9	4.5	9.0	6.7	6.3	3.8	3.8	4.4	4.1	4.1	5.5	6.2	5.4	3.9	5.2	4.9	6.5	6.4	8.1	3.7	3.8	1.8	2.1	6.8	5.0	9.0	3.0	2.6	5.1	0.7	5.9	6.5	4.5	6.3	4.3	6.0	33.5	6.4	6.6	8.7	1.9	3.6	4.3	4.2	7.0	7.3	1.6	13.4	3.1	6.3	5.6	10.4	7.4	4.8	1.6	2.9	3.5	10.2	5.4	1.2	4.6	8.6	9.8	16.0	4.5	2.6	41.9	1.4	21.2	4.0	5.4	1.9	8.1	5.5	3.1	1.2	4.6	1.0	3.0	1.8	13.7	24.1	4.8	8.5	2.6	24.9	6.3	4.6	28.0	3.3	18.2	8.3	3.7	4.5	5.5	1.7	4.5	3.7	7.1	2.8	8.6	15.8	17.5	2.4	6.3	8.5	6.8	10.3	6.4	6.9	10.5	5.1	20.6	12.5	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	0.5	0.8	0.2	0.4	0.7	0.0	0.7	0.3	0.5	1.1	0.1	5.8	6.6	6.1	9.7	5.5	6.2	6.5	6.4	6.8	6.3	6.4	7.0	12.2	32.1	32.8	6.5	5.8	9.3	11.8	7.7	13.1	7.2	11.3	9.8	12.6	11.5	22.1	25.8	12.5	8.0	9.9	9.3	33.2	7.7	192.2	14.1	12.6	12.0	7.8	33.6	5.3	7.6	11.7	13.9	12.8	8.1	15.2	13.1	11.4	6.8	6.9	25.2	8.3	14.4	2.0	4.1	8.7	166.0	10.2	10.1	5.4	5.6	6.3	10.8	12.3	22.1	13.8	2.9	5.9	14.3	9.1	5.6	7.7	7.9	20.7	5.0	19.7	13.3	15.5	224.3	38.3	14.1	6.5	1.1	6.5	9.8	20.6	10.8
LRRD1	IMAGE:4798971	ENSG00000240720	"Leucine rich repeats and death domain containing 1"	A4D1F6	7	92141643-92179531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 16.5"	"Group enriched"	"Detected in some"	90	"Early spermatids: 258.1;Late spermatids: 869.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055670, HPA079440"	Enhanced		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Vesicles	"HPA055670: , HPA079440: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.13e-3)"	0.0	0.0	0.4	0.0	0.5	0.3	0.1	1.7	0.8	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.5	0.9	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.5	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	16.5	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.4	0.5	1.7	0.8	0.5	0.9	0.6	0.4	0.8	0.2	0.8	1.1	0.1	0.0	0.6	1.6	0.0	0.3	0.5	0.0	0.0	0.6	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.0	0.0	258.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.3	1.3	0.4	0.0	0.0	0.1	1.7	2.8	0.0	0.0	0.0	0.7	869.3	4.7	0.5	0.0	1.0	0.0	0.3	0.0	1.5	1.4	0.0	0.0	3.0	0.0	0.4	0.1	0.1	1.5	0.9	0.0	1.2	0.3	6.2	2.6	0.0	0.3	0.0	0.5	0.3	0.1	0.3
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052626-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: AB_2677802"	"unprognostic (2.03e-3)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	23.4	24.0	43.7	20.1	46.9	44.3	22.3	43.6	49.0	46.0	33.6	38.3	35.4	31.8	19.7	52.6	25.8	22.0	75.8	38.8	44.4	24.0	48.5	27.0	18.1	43.4	42.0	27.4	19.2	33.3	18.6	20.8	44.8	41.0	34.2	36.0	28.5	24.3	97.9	37.0	36.2	31.5	41.0	45.0	26.5	71.8	46.4	18.8	27.5	45.3	23.2	24.2	40.9	60.9	56.6	30.8	34.9	27.7	45.5	69.3	30.5	149.9	148.2	82.6	94.3	29.0	25.3	22.2	24.0	145.4	40.8	28.8	25.8	74.2	134.3	49.7	20.2	39.8	44.0	28.6	64.8	31.9	23.3	31.1	52.1	107.8	110.4	45.8	58.2	34.0	32.3	37.8	69.5	14.4	27.2	17.0	23.0	23.0	39.2	13.0	99.2	22.6	58.4	21.7	12.6	19.9	57.9	53.0	49.4	28.0	30.6	32.6	56.5	63.1	42.6	93.4	71.5	29.1	57.1	33.9	37.1	28.1	91.4	20.5	21.4	33.8	8.8	14.9	11.3	9.7	9.3	9.5	14.1	8.5	6.8	8.3	19.2	16.9	26.9	7.9	13.0	11.7	43.7	46.9	43.6	49.0	38.8	44.4	43.4	42.0	44.8	41.0	46.4	60.9	47.8	28.9	36.5	98.6	29.1	136.1	143.0	41.3	113.8	36.3	64.7	53.2	123.1	38.6	53.7	23.9	29.2	29.2	28.7	117.2	64.6	89.8	516.2	78.9	44.0	59.9	54.0	60.0	169.8	94.3	46.1	57.4	37.8	127.3	52.6	29.4	56.7	58.8	24.9	122.8	197.7	45.6	28.5	35.6	128.3	330.7	42.3	48.2	74.7	62.8	67.7	51.9	30.9	130.7	309.0	109.9	90.1	57.6	45.8	325.6	125.8	46.1	36.2	51.9	39.5	32.4	72.8	159.9	73.4	139.3	170.5	39.3	34.1	90.0	66.0	303.2
LRRIQ1	"FLJ12303, KIAA1801"	ENSG00000133640	"Leucine rich repeats and IQ motif containing 1"	Q96JM4	12	85036314-85264457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.1;choroid plexus: 18.1;fallopian tube: 13.7;retina: 8.8;testis: 15.5"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 185.6;Early spermatids: 423.8;Endometrial ciliated cells: 287.5;Late spermatids: 248.1;Respiratory ciliated cells: 381.5;Rod photoreceptor cells: 257.6;Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.1;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046162	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA046162: AB_10963055"	"unprognostic (3.55e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.69e-2)"		"unprognostic (4.81e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.64e-1)"	0.1	0.7	2.8	0.1	3.2	0.0	1.0	1.9	2.5	1.6	18.1	0.1	0.0	1.4	2.4	0.0	13.7	0.4	0.2	2.9	3.8	2.0	0.0	2.6	0.0	11.1	8.5	0.4	0.3	3.0	1.4	0.0	6.5	1.4	0.0	8.8	0.4	0.7	0.0	0.0	0.0	0.6	6.7	0.1	0.2	15.5	3.7	0.1	2.4	0.0	0.0	0.1	0.1	4.3	0.0	0.3	2.0	0.0	0.5	1.3	0.2	0.3	0.2	0.8	0.2	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.6	0.8	0.2	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.5	1.8	0.8	0.9	1.5	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.4	0.0	3.1	0.0	1.6	2.5	0.1	0.0	0.2	0.4	0.9	0.1	0.1	1.8	0.5	0.7	0.1	0.0	0.5	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.2	1.9	2.5	2.9	3.8	11.1	8.5	6.5	6.7	3.7	4.3	0.2	3.2	4.8	22.2	0.0	0.4	1.6	12.0	0.0	11.1	2.9	3.2	1.3	4.3	49.2	16.5	185.6	0.1	0.0	0.2	9.8	11.3	423.8	287.5	2.1	1.6	11.5	0.0	24.5	1.3	0.0	1.3	0.0	7.1	1.3	3.9	0.0	0.0	0.1	0.0	4.8	0.3	14.2	0.0	0.3	248.1	4.4	1.2	3.6	2.8	0.0	16.7	0.0	1.5	1.8	1.6	0.1	4.1	0.1	3.1	0.0	6.1	381.5	257.6	13.1	2.4	3.3	190.8	46.3	0.0	0.0	0.1	0.3	0.7	0.2	0.3
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 20.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.9;JURKAT: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.6	0.7	0.5	0.7	0.5	0.1	0.7	0.6	0.7	0.2	1.2	0.3	0.2	0.2	0.3	0.1	2.1	0.4	0.3	0.4	0.6	2.0	0.9	0.3	0.7	0.7	0.8	0.3	0.2	1.2	0.5	0.2	0.7	0.4	0.2	0.5	0.7	0.4	0.1	0.1	0.2	0.0	0.6	0.4	0.3	20.4	0.7	1.0	1.5	0.5	0.6	0.2	0.1	0.7	0.2	1.0	0.1	0.4	1.0	0.4	0.6	0.6	0.4	0.8	0.9	0.1	1.4	1.4	1.2	0.1	7.9	0.1	2.1	2.0	1.0	3.5	0.0	1.3	0.3	0.7	0.1	2.3	0.7	0.7	1.0	1.4	0.5	0.3	0.4	4.8	1.1	1.9	1.4	0.0	0.9	0.3	1.1	2.5	0.6	1.1	0.8	1.4	1.2	0.1	1.0	0.7	0.1	0.1	3.1	0.2	0.9	1.3	0.1	0.1	0.7	0.5	1.2	2.0	0.7	1.1	1.5	0.2	1.1	0.0	0.0	0.8	0.9	0.5	1.1	1.6	1.0	1.1	0.1	0.7	0.9	1.3	0.0	0.4	0.1	0.4	1.6	0.3	0.5	0.5	0.6	0.7	0.4	0.6	0.7	0.8	0.7	0.6	0.7	0.7	1.0	0.0	1.5	2.0	2.8	1.1	1.2	4.0	0.0	1.0	2.0	2.8	1.2	2.8	2.6	0.0	4.2	1.7	0.5	0.3	13.7	1.5	258.5	21.6	0.8	0.8	3.0	0.4	4.1	1.7	1.5	0.3	0.0	1.5	0.0	3.2	0.7	1.8	1.3	0.0	3.9	0.6	0.0	0.6	0.2	103.6	1.8	0.5	0.0	1.9	0.8	1.2	2.1	2.0	4.0	0.9	0.1	1.5	0.6	0.9	0.1	6.3	36.0	0.7	0.0	0.2	1.5	204.8	31.3	0.0	0.1	0.3	1.5	3.6	0.7	1.2
LRRIQ4	LRRC64	ENSG00000188306	"Leucine rich repeats and IQ motif containing 4"	A6NIV6	3	169821922-169837775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Group enriched"	"Detected in some"	17	"Early spermatids: 42.8;Late spermatids: 27.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.6;T-47d: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036271, HPA036706"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA036271: , HPA036706: AB_2675264"	"unprognostic (5.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-4)"	"unprognostic (5.26e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.56e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.7	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.0	0.0	0.0	1.6	0.6	0.2	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	42.8	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919327-101078257	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Microglial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.6"	"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 27.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	2.9	1.0	1.3	5.8	0.5	6.4	2.3	0.0	3.6	3.8	0.0	5.3	3.8	3.8	1.7	4.5	4.9	3.2	1.4	0.8	0.0	0.9	0.8	3.3	7.2	0.0	0.0	3.8	5.9	2.0	0.9	4.1	0.1	4.0	5.1	0.2	3.9	3.5	1.0	4.7	5.0	3.0	0.0	6.2	3.7	5.2	0.0	2.2	1.6	1.3	7.9	2.9	3.0	1.3	4.5	15.3	0.3	0.0	4.9	3.9	1.8	3.7	7.1	2.3	2.0	3.1	7.2	20.2	4.2	6.3	0.0	17.3	5.2	2.8	2.8	3.1	2.8	17.4	12.8	0.0	2.0	5.2	9.0	3.3	4.7	3.0	6.3	2.3	2.4	0.4	3.6	18.4	1.1	0.4	0.0	4.2	1.4	5.1	5.2	2.9	2.0	15.3	0.0	0.6	0.4	3.3	8.8	2.5	6.2	0.4	1.5	4.4	6.3	0.0	3.1	5.2	0.1	15.9	18.2	27.4	1.1	2.1	6.7	0.0	0.4	1.2	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.0	1.3	0.5	0.0	3.6	0.8	0.0	0.0	0.0	0.1	0.0	0.0	1.3	8.3	16.0	13.6	2.9	17.3	3.2	8.0	3.5	7.4	0.9	5.7	5.1	2.9	2.8	6.0	0.0	6.2	9.6	13.6	19.8	0.0	4.5	3.7	12.6	19.4	8.8	13.8	3.4	64.6	3.3	4.2	11.5	3.6	6.6	1.3	1.4	9.7	0.4	10.7	0.0	10.0	11.7	0.0	24.8	10.1	4.6	32.3	19.9	3.6	107.7	28.3	0.6	1.0	12.5	1.2	7.5	11.4	21.4	14.2	10.7	11.6	0.3	6.3	0.7	6.6	11.2	3.9	6.5	1.5	6.6	3.4	3.6	1.3	2.8	12.5	9.9
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	1.1	10.1	1.9	9.0	2.6	0.9	2.1	5.1	1.2	4.3	0.6	4.8	1.9	7.0	4.1	6.2	3.9	1.3	1.1	10.9	5.6	52.4	6.8	1.7	1.1	5.4	3.6	8.4	2.1	1.2	1.4	2.6	1.8	1.5	3.5	2.0	5.5	2.1	3.6	4.0	1.1	10.8	2.1	0.8	1.2	2.5	2.9	7.9	5.4	4.5	5.5	1.9	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	1.1	1.9	0.9	2.1	1.3	1.1	1.7	1.1	1.4	1.1	1.2	1.9	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
LRRN1	FIGLER3	ENSG00000175928	"Leucine rich repeat neuronal 1"	Q6UXK5	3	3799431-3849834	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 418.2"	"Cancer enhanced"	"Detected in many"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 106.6;CAPAN-2: 37.9;HAP1: 32.3;NTERA-2: 62.7;SuSa: 104.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011071	Enhanced					NA	NA		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA011071: AB_1853355"	"unprognostic (1.27e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.25e-2)"	0.8	0.1	7.7	0.4	13.1	1.2	4.2	6.5	7.2	3.6	0.2	0.2	0.9	2.4	1.1	0.8	1.3	2.4	0.1	6.6	5.0	0.5	0.2	1.0	0.3	13.7	14.1	5.3	1.9	4.5	2.0	0.2	12.8	4.0	0.3	1.3	5.2	4.2	5.7	1.3	1.2	1.5	5.9	1.2	1.3	6.0	18.2	2.9	2.4	2.8	0.8	3.7	0.8	3.9	0.0	0.0	106.6	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	32.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	19.9	0.0	4.7	0.0	8.1	0.0	0.0	1.1	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	7.0	0.0	0.0	0.0	104.4	4.0	0.0	0.0	0.0	12.5	0.0	1.2	11.1	23.3	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.7	13.1	6.5	7.2	6.6	5.0	13.7	14.1	12.8	5.9	18.2	3.9	0.4	3.2	0.0	63.0	3.5	2.2	1.8	8.7	1.8	3.0	7.6	13.3	0.4	10.0	6.6	0.0	0.0	0.1	0.7	0.4	0.0	1.6	3.2	0.5	1.5	1.0	0.0	0.4	52.7	2.2	0.2	3.0	2.0	1.2	2.5	1.1	0.0	0.0	0.1	0.0	48.1	1.0	0.0	0.0	0.8	1.1	2.5	0.3	1.8	1.9	0.0	3.4	1.0	418.2	5.3	9.9	2.5	0.7	2.9	2.4	0.3	0.7	3.0	0.5	0.0	14.9	0.9	0.0	0.9	0.5	0.3	0.0	0.6	0.1	1.4	1.0
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685738	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Distal enterocytes: 18.1;Excitatory neurons: 57.8;Horizontal cells: 52.2;Inhibitory neurons: 40.0;Oligodendrocyte precursor cells: 39.2"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.3;NTERA-2: 18.0;RPMI-8226: 29.0;SuSa: 9.8;T-47d: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	6.1	4.4	18.4	2.8	18.6	1.7	2.5	6.9	19.6	3.3	20.4	8.0	1.1	5.5	0.3	1.8	7.6	4.3	8.2	20.5	18.5	17.4	1.0	2.8	2.1	11.0	13.6	2.5	1.9	14.7	12.9	0.7	13.8	1.5	5.3	3.8	3.0	2.2	1.6	0.4	4.9	7.2	7.7	7.6	2.0	4.2	20.2	3.0	3.1	3.2	0.7	1.4	2.2	13.2	0.0	4.3	3.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	9.3	0.6	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	1.5	0.0	18.0	0.0	0.1	0.2	0.0	29.0	0.0	0.2	2.4	0.4	5.6	0.1	0.0	9.8	10.1	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	18.6	6.9	19.6	20.5	18.5	11.0	13.6	13.8	7.7	20.2	13.2	3.9	0.0	0.0	22.2	0.3	0.4	0.7	0.1	0.0	7.0	0.6	1.9	1.5	0.0	0.1	1.8	2.1	0.1	0.0	18.1	0.0	3.8	0.0	0.5	0.2	2.3	11.4	2.7	57.8	0.9	0.1	2.9	0.0	0.8	0.0	0.1	3.3	0.0	7.0	52.2	40.0	2.3	2.0	0.3	1.1	0.5	0.0	0.2	0.0	9.4	0.2	4.6	0.0	39.2	1.6	4.9	5.6	0.0	0.1	0.3	0.0	5.5	0.0	1.1	0.0	0.9	0.5	0.1	0.3	0.5	0.1	0.4	0.2	1.4	1.0	0.4
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2;thyroid gland: 19.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.2	23.2	11.9	1.2	12.8	0.6	1.7	10.4	14.7	2.5	4.3	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	11.9	10.4	0.4	2.2	7.5	3.0	6.8	8.5	6.3	0.9	0.2	3.0	5.8	8.6	2.6	1.0	6.3	1.2	4.9	4.1	0.3	1.4	0.4	7.7	1.4	0.4	14.9	13.2	10.5	19.6	0.5	3.6	0.8	0.9	8.9	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	11.9	12.8	10.4	14.7	11.9	10.4	6.8	8.5	8.6	7.7	13.2	8.9	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686406-62689530	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4"	"Low region specificity"	"Detected in many"							HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	23.3	6.6	0.4	2.5	0.4	0.5	16.0	1.5	1.3	22.4	2.6	15.1	1.8	29.7	3.7	4.5	18.2	3.6	7.2	0.6	0.6	1.0	0.1	3.5	0.5	0.5	0.3	21.0	1.1	0.3	1.7	0.7	0.4	6.1	2.1	0.4	5.5	5.8	4.8	10.6	7.2	9.1	0.2	0.2	8.2	1.5	0.5	0.4	4.2	5.6	0.3	9.7	16.1	0.7	0.0	0.1	0.2	0.3	7.7	25.3	0.3	2.8	4.0	0.3	1.4	0.2	0.1	0.2	0.3	4.6	0.1	0.3	0.1	0.0	0.4	0.2	0.2	0.5	0.2	0.2	19.8	0.2	0.2	10.6	0.1	0.6	0.0	0.2	0.1	0.4	0.3	0.1	13.4	0.1	0.3	0.6	0.6	0.1	0.1	0.1	1.7	0.3	0.0	0.2	0.8	0.3	0.4	0.3	0.8	0.1	0.2	0.3	0.3	2.4	0.2	2.7	0.1	0.2	0.2	0.3	1.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.4	0.4	1.5	1.3	0.6	0.6	0.5	0.3	0.4	0.2	0.5	0.7	4.0	0.0	1.8	0.0	0.1	6.6	2.1	0.0	0.0	2.1	0.5	0.8	1.5	0.0	0.6	0.0	2.1	0.1	0.2	0.0	0.0	0.0	1.0	0.5	11.0	3.7	1.2	0.0	0.1	0.0	0.2	62.1	0.5	0.4	1.3	0.2	1.4	0.1	0.4	1.7	0.3	0.3	0.0	0.6	8.3	0.5	27.1	1.1	33.8	1.9	0.1	0.2	1.0	0.0	0.1	0.0	0.1	17.3	0.4	1.4	0.1	0.3	0.0	1.0	0.0	33.0	2.8	0.4	0.3	0.5	7.0	0.1	1.1	1.2	0.1	1.3
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.4;salivary gland: 12.8"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.5	0.9	6.4	0.3	13.4	0.0	0.1	0.0	10.0	2.2	0.0	3.7	0.6	0.6	0.3	0.3	1.2	0.2	1.3	16.3	5.2	0.3	0.4	0.1	0.0	0.9	9.4	0.3	0.1	0.0	1.9	0.0	2.0	1.0	0.3	0.4	12.8	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.7	0.2	22.4	0.0	1.6	0.1	0.0	0.6	0.8	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.4	0.0	10.0	16.3	5.2	0.9	9.4	2.0	0.2	22.4	4.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRSAM1	"CMT2P, FLJ31641, RIFLE, TAL"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451489-127503499	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	7.2	9.8	8.6	3.4	8.6	2.0	7.3	7.3	12.5	10.7	5.2	16.5	3.4	9.0	5.9	8.7	7.8	3.9	17.3	8.8	8.8	9.0	8.8	7.4	4.5	11.1	7.6	10.7	5.7	6.9	9.0	3.4	11.4	9.1	2.6	2.3	7.5	5.6	13.5	21.2	9.1	5.0	7.0	9.5	9.5	4.3	7.9	3.4	8.8	7.2	3.2	12.3	10.2	9.0	5.7	10.8	4.8	10.7	9.8	9.1	8.3	5.3	8.1	10.0	7.6	8.9	5.9	9.8	5.9	9.9	3.6	18.7	7.8	13.3	3.8	11.5	5.3	5.2	9.0	10.2	9.4	6.2	7.3	6.1	7.9	6.1	12.2	10.7	11.2	7.6	4.8	7.6	4.5	17.6	3.9	4.5	4.7	17.4	9.3	7.1	5.6	18.4	11.5	5.1	9.8	9.2	4.1	12.6	8.8	4.3	26.5	3.2	10.2	4.6	5.6	4.2	2.5	6.2	7.9	1.1	9.1	4.5	2.6	18.5	4.8	21.3	3.7	6.5	4.7	3.7	2.8	3.5	6.1	2.7	1.1	1.4	4.0	1.3	6.8	3.6	2.3	3.8	8.6	8.6	7.3	12.5	8.8	8.8	11.1	7.6	11.4	7.0	7.9	9.0	5.3	9.6	3.9	32.0	5.1	1.1	3.1	2.9	4.6	6.7	5.2	5.0	20.4	4.3	7.3	0.0	6.2	5.0	5.3	6.0	5.9	7.1	0.6	3.6	4.7	4.8	1.2	2.5	28.6	1.4	2.1	4.9	12.2	4.6	9.5	6.6	3.3	7.1	6.3	11.8	26.9	5.8	14.2	5.6	3.7	1.2	2.8	7.4	3.6	10.3	7.4	4.7	3.1	18.1	21.0	4.7	5.0	5.3	3.9	5.0	6.6	5.8	6.0	5.2	0.0	5.1	6.0	5.7	3.6	5.8	2.7	7.0	5.6	3.9	4.8	3.3
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836753	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 11.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 4.3;SCLC-21H: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	2.9	0.0	11.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	0.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.4	0.0	3.8	3.9	3.6	0.6	4.8	0.5	0.2	11.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q96E66	11	72080337-72096895	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 67.1;testis: 49.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 574.9;Late spermatids: 2222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039949	Approved		Uncertain	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	5.0	4.5	21.1	2.5	21.8	2.1	8.7	19.5	24.2	8.7	25.1	5.4	3.7	7.2	17.1	3.8	67.1	3.4	3.7	19.1	19.2	11.7	7.9	7.7	3.2	23.0	25.7	8.1	8.9	10.3	8.9	5.4	21.4	9.3	7.7	19.7	4.4	5.4	7.5	5.8	3.4	5.7	23.4	4.0	5.5	49.3	21.0	4.5	11.0	4.6	3.6	4.1	3.8	22.0	3.9	13.7	8.9	6.9	7.3	6.7	2.1	4.4	3.6	4.0	3.5	6.6	20.4	5.1	6.6	7.8	9.6	7.3	6.3	10.8	4.5	9.4	6.2	3.5	6.3	4.8	1.3	3.0	3.9	2.9	5.4	6.0	4.6	6.4	1.5	10.2	4.0	7.8	6.0	13.6	9.0	6.0	4.4	22.8	3.6	10.8	8.6	7.7	15.9	4.7	8.2	6.2	8.7	19.4	10.4	6.1	39.6	3.3	6.5	4.0	5.7	11.3	3.1	8.0	9.4	5.8	4.0	2.5	4.5	1.8	1.7	3.5	2.0	1.9	1.9	3.2	2.1	1.6	1.0	3.5	1.8	1.8	6.1	6.6	1.3	2.8	4.6	1.4	21.1	21.8	19.5	24.2	19.1	19.2	23.0	25.7	21.4	23.4	21.0	22.0	4.6	0.0	1.5	3.3	2.5	2.3	7.5	10.0	1.8	3.5	8.4	7.5	2.2	5.7	10.7	3.7	12.5	12.7	1.4	4.4	11.7	7.5	574.9	84.3	3.0	6.5	1.2	3.6	2.0	2.5	7.7	5.3	4.1	7.2	0.0	2.2	3.6	6.0	3.1	6.7	1.9	10.8	10.2	1.6	2.8	2222.2	14.9	3.3	1.8	1.9	1.4	21.3	4.1	2.0	3.6	2.0	2.5	10.1	5.1	6.8	4.0	19.9	113.1	16.6	6.6	6.1	7.9	90.3	28.1	2.2	2.4	13.1	1.7	2.9	3.4	6.5
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464956-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"testis: 275.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1002.6;Spermatocytes: 677.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	8.2	16.8	10.7	6.8	10.7	14.9	7.9	11.4	13.1	10.4	10.7	8.9	5.3	10.0	2.3	7.7	13.8	3.9	9.7	13.0	11.5	11.4	15.0	10.1	8.1	12.1	14.4	9.4	9.3	8.7	17.6	3.1	12.2	8.6	2.3	3.4	7.6	6.1	13.2	6.7	17.1	4.2	10.8	24.3	9.0	275.2	12.1	8.7	10.0	5.3	7.3	8.9	7.3	10.2	18.6	24.6	13.0	36.8	9.4	7.2	21.0	19.6	11.9	30.5	20.9	23.7	10.3	44.8	27.5	13.9	36.3	19.2	18.7	16.4	9.0	16.6	39.2	10.0	11.1	14.8	12.7	17.6	17.4	6.7	9.9	35.4	7.5	10.2	16.2	33.9	44.5	13.3	16.8	54.3	53.4	42.1	28.7	22.0	37.8	28.2	12.2	48.5	9.2	11.3	17.7	50.7	21.0	20.1	19.3	14.6	11.2	14.4	11.1	17.3	37.7	54.8	30.8	50.5	94.3	43.6	19.3	17.1	31.4	10.6	2.6	9.9	9.7	4.0	9.0	10.0	8.4	8.4	2.7	11.8	5.2	6.9	5.5	10.5	3.8	9.7	9.3	6.0	10.7	10.7	11.4	13.1	13.0	11.5	12.1	14.4	12.2	10.8	12.1	10.2	9.1	0.0	1.1	5.5	10.6	10.5	6.4	16.5	3.4	11.7	5.5	5.0	0.8	2.8	12.8	12.9	2.1	9.2	10.8	8.6	7.9	12.3	1002.6	54.4	7.3	6.5	7.8	13.7	4.7	10.5	12.4	7.0	10.7	13.7	0.0	14.8	5.7	7.2	8.8	5.0	5.0	9.8	18.3	3.4	4.0	172.3	19.0	5.0	5.4	2.8	7.2	7.9	10.3	4.5	2.8	12.4	11.2	15.8	20.2	3.9	8.6	15.9	65.3	11.4	0.0	5.4	13.6	677.0	38.3	4.5	9.8	6.2	9.3	22.2	7.5	3.4
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743712-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	2.0	2.1	3.6	1.9	3.8	1.7	2.2	3.8	4.8	4.3	0.2	6.4	2.3	5.3	1.5	2.2	3.1	2.3	1.2	4.0	2.3	1.3	1.3	1.8	2.1	2.7	3.0	3.4	1.9	1.8	2.2	2.1	3.0	4.3	2.6	7.1	1.8	4.7	1.4	2.2	2.3	3.3	3.0	1.6	2.3	4.1	2.7	1.8	1.2	1.4	2.1	9.8	3.5	3.0	3.2	2.3	6.2	6.6	2.7	3.5	5.4	4.3	1.9	3.6	4.7	6.9	3.1	7.0	4.9	2.5	2.5	3.7	8.1	4.7	3.9	5.0	7.6	2.9	8.6	4.4	1.0	8.7	3.5	1.6	3.1	4.3	4.4	4.0	5.9	5.7	5.5	3.7	3.9	3.0	4.9	5.1	1.8	2.6	6.9	7.7	7.7	2.9	1.8	2.9	3.6	5.7	2.8	3.8	3.8	4.5	3.2	5.3	4.2	6.9	2.7	4.1	6.9	3.0	2.0	6.9	2.8	8.9	3.1	0.4	0.1	0.0	0.2	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.4	0.0	0.0	0.2	0.1	3.6	3.8	3.8	4.8	4.0	2.3	2.7	3.0	3.0	3.0	2.7	3.0	3.6	6.4	4.1	2.3	2.7	3.6	3.5	1.3	2.2	26.1	3.3	2.5	2.2	1.5	3.1	3.7	6.2	2.1	4.7	3.1	0.0	1.7	10.6	0.8	3.7	3.2	3.0	1.3	11.7	0.9	4.8	3.6	2.0	1.6	1.3	5.5	3.9	2.2	2.2	8.4	11.8	2.0	0.0	4.2	5.7	15.7	1.5	2.6	0.0	1.0	3.5	2.2	4.1	1.5	2.4	1.8	6.2	4.1	2.4	3.7	2.1	1.5	1.9	7.8	0.0	4.3	9.1	10.5	10.9	1.9	4.3	1.2	2.8	2.1	5.5	4.0
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034328-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 267.0;Late spermatids: 568.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051934	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA051934: AB_2681666"	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	20.0	21.9	20.0	16.9	20.5	29.6	18.6	19.9	24.7	16.1	18.4	19.7	17.2	17.5	25.0	28.1	15.1	15.5	22.6	20.8	23.5	20.8	29.3	16.8	20.8	20.9	22.5	15.4	23.9	21.5	14.2	23.0	20.6	16.8	23.6	31.3	18.1	15.4	37.1	16.7	16.9	20.4	19.6	17.2	19.9	24.0	21.6	19.9	18.2	23.7	24.8	22.8	17.4	21.0	47.4	51.3	35.7	56.3	45.9	49.4	65.2	52.3	51.6	65.5	65.3	59.2	50.5	78.6	36.8	59.8	51.9	37.9	75.7	67.7	97.7	59.5	78.5	54.5	38.7	72.6	42.4	95.6	55.9	44.4	53.8	61.3	88.0	42.7	57.1	50.2	81.0	56.6	44.8	46.5	91.4	53.1	52.8	46.7	72.5	57.3	69.8	76.2	61.4	68.5	49.6	32.9	42.4	45.3	55.9	74.0	94.5	62.5	51.8	82.7	49.0	45.1	86.5	44.4	48.3	83.6	70.2	66.9	64.0	43.8	61.7	28.3	48.3	80.3	54.0	46.7	53.5	51.8	70.7	41.0	46.9	46.6	32.6	47.1	78.4	71.9	58.2	61.2	20.0	20.5	19.9	24.7	20.8	23.5	20.9	22.5	20.6	19.6	21.6	21.0	37.9	16.0	17.5	4.6	32.0	50.3	44.0	36.7	42.1	41.4	58.4	44.6	19.3	27.1	27.4	16.5	87.6	48.0	50.4	43.9	43.0	62.7	267.0	57.2	51.2	35.5	39.9	45.8	13.3	101.6	94.0	37.2	28.5	52.3	7.6	39.6	28.9	48.6	43.8	35.3	14.3	46.5	26.4	38.0	64.4	568.8	35.1	44.6	33.8	14.0	50.1	35.4	39.1	8.0	14.8	85.2	38.5	31.6	48.0	76.7	30.3	58.4	22.7	63.1	26.3	35.5	57.9	59.7	70.0	50.5	48.9	83.7	37.8	63.7	48.5	78.6
LSM14A	"C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A"	ENSG00000257103	"LSM14A mRNA processing body assembly factor"	Q8ND56	19	34172504-34229288	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Repressor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017961	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Cytoplasmic bodies"	Cytosol	"HPA017961: AB_1845610"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.62e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.56e-1)"	43.9	38.5	26.4	27.5	26.2	72.0	42.0	28.0	39.2	46.2	29.4	49.4	24.8	47.8	31.7	41.2	40.6	22.7	36.4	25.5	26.0	37.7	37.6	37.7	46.5	26.1	27.1	51.7	32.9	33.8	30.4	37.5	26.4	36.5	29.2	52.8	36.4	32.3	74.2	47.1	38.2	33.0	28.3	36.7	32.8	33.1	26.1	50.7	45.9	43.7	40.8	44.2	41.8	27.7	66.0	46.1	62.9	49.7	33.4	42.9	20.4	24.7	39.5	43.9	42.9	50.2	27.7	107.9	28.9	46.7	14.7	17.6	57.0	42.7	70.8	71.5	10.4	102.2	30.0	50.5	58.7	82.1	34.6	39.4	63.0	33.3	47.8	56.1	63.3	36.3	56.6	44.8	45.6	32.0	64.8	62.2	59.9	61.0	7.5	42.7	44.1	40.7	58.4	32.9	52.8	40.8	56.7	85.2	61.5	56.2	54.8	102.0	38.7	66.3	25.6	25.5	53.1	43.3	59.0	78.6	42.0	57.5	40.4	16.5	9.3	18.9	11.4	12.1	15.2	11.9	13.4	12.8	10.9	8.0	14.3	12.7	8.1	17.8	14.6	5.2	13.4	11.1	26.4	26.2	28.0	39.2	25.5	26.0	26.1	27.1	26.4	28.3	26.1	27.7	64.3	25.6	42.8	81.9	118.7	123.9	70.2	64.6	86.0	92.3	68.1	50.0	70.6	61.5	58.4	58.8	20.9	161.2	108.2	39.0	68.4	77.7	65.6	54.3	64.2	75.5	57.2	100.4	68.0	54.1	176.6	70.1	37.8	57.0	62.1	64.6	63.9	50.6	67.0	62.2	70.1	52.7	73.2	63.7	96.7	75.5	126.2	73.5	67.6	85.3	137.2	104.3	232.8	92.0	113.4	59.6	40.2	127.2	80.2	110.0	49.9	88.0	47.6	78.8	78.9	64.2	78.8	194.9	151.6	75.4	131.6	137.4	101.5	69.2	51.4	71.7
LSM14B	"bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B"	ENSG00000149657	"LSM family member 14B"	Q9BX40	20	62122461-62135374	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"Early spermatids: 215.2;Late spermatids: 560.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041274, HPA061189"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA041274: AB_2677388, HPA061189: AB_2684448"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.93e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.98e-1)"	19.7	23.9	29.3	21.0	30.1	26.7	19.8	39.5	34.5	27.5	21.6	27.4	23.4	31.2	14.2	31.6	25.7	14.5	37.7	32.3	24.1	19.0	24.4	19.3	23.5	24.2	26.6	37.4	30.4	21.3	24.9	14.9	25.9	22.0	14.3	31.2	23.7	17.4	71.6	34.6	22.8	17.6	23.2	21.7	23.3	51.9	27.1	28.8	20.9	45.3	17.8	26.5	27.3	27.2	44.4	41.6	65.0	62.5	29.0	30.3	55.3	46.0	34.1	93.7	40.9	123.4	30.1	46.5	51.7	31.9	67.9	62.9	31.5	39.6	46.4	19.2	22.9	112.3	57.8	74.3	40.0	48.6	65.1	26.1	70.4	39.1	36.1	36.7	24.3	53.8	61.4	32.7	33.0	58.7	81.2	72.7	40.2	70.8	61.0	104.3	128.5	36.9	25.5	51.7	88.8	77.0	83.9	73.5	61.3	37.5	91.6	60.9	31.8	132.9	90.0	69.1	47.3	40.8	52.1	56.8	58.5	31.7	43.4	0.0	0.4	2.2	0.3	0.3	0.1	0.5	0.2	0.4	0.3	0.5	0.2	0.3	0.6	0.0	0.2	0.4	0.2	0.1	29.3	30.1	39.5	34.5	32.3	24.1	24.2	26.6	25.9	23.2	27.1	27.2	8.6	9.6	6.8	9.1	7.3	9.7	3.5	4.7	5.2	15.1	8.4	7.1	22.8	7.2	7.9	1.8	8.4	6.4	15.3	13.5	1.9	5.0	215.2	13.3	14.1	8.0	13.9	9.5	6.2	5.3	6.0	7.5	8.2	10.3	5.1	14.8	5.0	11.6	8.6	8.4	6.8	12.0	6.1	13.2	6.8	560.0	13.4	8.8	3.6	7.5	8.2	17.2	7.2	5.0	8.4	7.1	8.2	15.8	4.7	9.2	9.7	6.7	12.1	20.3	0.0	9.5	6.4	11.2	23.1	7.6	10.1	5.2	6.9	13.4	12.4	3.0
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178817-14201122	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		30000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	12.6	10.8	12.1	11.0	12.6	18.9	12.6	13.2	16.6	8.7	12.1	12.1	12.4	9.1	10.4	12.1	8.2	6.5	17.4	12.6	12.7	23.3	18.4	8.2	12.9	12.3	12.0	9.4	9.5	11.0	9.0	10.3	12.5	9.8	11.2	10.7	9.2	8.3	30.1	10.1	12.9	8.1	12.4	9.7	10.5	12.3	12.6	16.8	10.7	22.4	11.8	10.3	8.7	13.2	36.0	28.6	30.1	31.3	13.8	16.0	76.3	29.0	19.3	36.6	34.8	32.6	27.6	39.5	23.5	20.3	25.7	16.4	34.5	28.4	36.0	37.5	42.3	41.8	38.1	31.5	7.1	47.3	29.0	12.0	20.2	36.8	15.6	16.4	19.1	34.0	45.9	30.7	27.4	41.5	50.4	64.2	52.1	40.2	38.5	27.4	37.3	43.5	34.6	36.7	16.8	27.2	33.2	46.1	28.6	34.3	53.2	59.7	17.3	23.3	37.2	28.3	50.6	21.4	67.3	73.6	29.5	45.9	33.8	44.1	18.9	30.0	14.8	23.7	17.7	27.3	17.1	17.5	18.3	21.7	18.4	19.7	17.8	21.9	20.3	28.7	22.9	25.7	12.1	12.6	13.2	16.6	12.6	12.7	12.3	12.0	12.5	12.4	12.6	13.2	114.2	67.3	94.3	11.4	118.2	97.8	135.4	328.8	115.5	52.5	124.2	171.4	263.4	155.8	164.6	126.9	18.8	391.8	114.2	158.2	485.2	220.4	337.8	111.2	97.8	104.5	104.7	111.9	8.3	265.5	409.6	120.0	67.8	115.2	138.2	142.4	128.8	234.8	235.5	55.5	8.3	195.4	175.0	132.9	115.0	153.1	140.1	119.6	97.8	5.6	202.4	180.7	170.0	7.1	13.3	219.2	196.7	139.9	154.2	110.2	203.9	752.2	122.3	68.2	105.2	111.5	117.9	288.5	295.5	150.8	101.2	318.4	93.6	144.6	205.7	177.2
LSM4	YER112W	ENSG00000130520	"LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Z0	19	18306236-18323112	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 705.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040932	Uncertain		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA040932: AB_10795529"	"unprognostic (2.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.34e-1)"	56.5	130.5	97.9	31.8	101.8	62.9	55.1	99.7	111.7	52.7	111.4	86.4	57.6	51.6	36.3	100.5	52.8	17.4	108.2	102.8	104.9	118.8	122.8	60.9	41.4	99.6	102.5	50.6	57.4	48.5	72.5	35.5	105.1	64.2	45.2	33.1	55.2	39.6	149.1	70.4	77.1	27.3	95.9	71.1	78.4	126.8	104.8	78.9	62.2	89.4	38.9	62.1	59.7	97.3	294.3	151.2	252.3	226.2	95.4	91.4	291.8	132.2	113.6	167.9	158.7	137.0	305.5	172.0	274.5	139.0	152.5	192.3	276.4	274.5	127.1	201.1	524.0	156.1	247.0	167.5	94.9	148.9	89.2	83.3	160.5	156.9	182.9	94.2	139.6	248.6	333.0	172.3	177.3	479.7	411.0	321.6	327.1	419.2	475.4	229.4	112.0	320.5	212.9	102.0	283.8	264.9	113.0	141.3	204.2	174.8	140.4	157.8	81.0	98.0	113.2	244.3	250.5	160.2	147.7	204.4	131.4	289.3	170.4	171.5	223.2	163.8	148.3	258.5	182.5	163.5	158.3	154.4	252.8	164.5	169.7	171.4	18.4	220.4	205.6	359.0	166.9	283.9	97.9	101.8	99.7	111.7	102.8	104.9	99.6	102.5	105.1	95.9	104.8	97.3	76.8	28.9	38.8	7.5	85.1	67.4	92.4	183.1	46.7	72.0	141.7	134.9	53.2	74.4	90.5	115.8	14.6	270.4	95.8	179.1	299.3	196.7	280.8	102.8	55.1	75.7	124.4	109.8	11.5	182.1	489.1	67.9	68.8	96.9	117.4	115.7	54.3	89.3	288.4	58.9	11.1	194.5	154.6	85.4	129.0	705.7	62.4	109.1	104.9	7.5	243.2	115.6	130.7	7.1	13.4	159.3	205.5	47.4	98.3	153.1	225.3	347.7	94.6	73.0	46.0	38.5	80.7	203.1	378.6	125.5	71.9	170.5	87.7	174.2	237.1	119.9
LSM5	YER146W	ENSG00000106355	"LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Y9	7	32485338-32495283	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019054	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA019054: AB_10960217"	"unprognostic (1.92e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (7.53e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	35.8	41.9	26.2	35.8	27.0	77.6	62.6	27.0	40.3	33.7	25.4	58.1	42.4	34.0	35.5	46.6	34.5	28.1	50.1	26.2	26.9	46.8	76.0	28.1	61.7	26.0	26.6	36.4	54.7	30.0	29.1	28.8	26.5	34.3	60.0	28.8	31.4	27.8	57.6	33.8	39.4	36.5	26.7	41.0	47.0	22.5	26.3	67.9	44.4	51.1	72.2	37.6	34.4	27.0	204.6	121.9	162.8	229.4	56.0	62.2	80.9	94.9	79.9	119.3	125.6	168.9	170.0	118.8	49.0	67.7	290.9	119.1	121.1	118.7	161.2	84.6	132.7	124.6	193.5	233.7	49.6	267.4	123.3	52.4	85.1	116.7	137.4	79.2	132.9	203.4	261.0	90.5	169.2	246.3	140.3	598.9	267.9	296.7	139.4	122.3	128.4	200.9	107.3	97.8	140.5	206.4	84.9	237.0	114.6	243.5	148.4	331.6	63.9	102.5	252.6	95.8	246.2	149.2	339.9	354.5	96.9	314.9	296.6	17.9	35.0	34.2	38.6	57.4	58.2	69.2	62.9	50.7	50.7	60.2	89.3	68.9	6.0	44.9	49.5	100.1	57.4	45.2	26.2	27.0	27.0	40.3	26.2	26.9	26.0	26.6	26.5	26.7	26.3	27.0	68.9	32.1	50.6	13.7	135.3	146.4	152.0	254.1	109.8	52.5	201.8	262.4	109.7	94.4	116.7	114.0	22.9	211.9	93.4	95.6	277.8	137.0	16.1	91.1	68.2	81.0	50.5	184.5	15.9	216.6	286.2	98.8	98.8	74.6	72.2	148.2	79.6	285.6	189.8	43.7	20.4	164.9	175.0	117.9	158.2	21.2	75.8	100.1	122.7	13.1	163.9	94.3	78.2	10.1	13.9	146.3	118.2	82.4	187.0	146.9	107.6	343.4	137.5	59.7	65.7	81.9	141.9	88.5	133.2	167.7	177.6	100.6	111.8	123.2	233.2	152.8
LSM6	YDR378C	ENSG00000164167	"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62312	4	146175703-146200000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing, tRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045079	Approved		Approved	"Actin filaments"		NA	NA		30000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Actin filaments"		"HPA045079: AB_10961320"	"unprognostic (5.04e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.36e-1)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.08e-3)"	11.2	6.2	6.2	10.0	6.7	11.4	6.9	9.6	13.5	5.3	4.5	10.1	5.8	5.5	5.8	5.2	5.4	4.6	4.4	5.4	7.1	7.9	9.9	6.2	18.3	6.9	7.3	6.8	6.4	3.9	4.3	9.1	6.8	7.4	7.6	8.3	6.8	4.5	4.3	4.8	8.2	4.9	6.9	10.4	8.9	7.5	6.9	12.5	4.2	5.7	14.2	8.5	4.4	6.6	21.1	11.1	28.0	11.3	9.4	9.7	19.2	17.7	17.8	17.2	18.9	12.1	23.7	27.9	6.3	10.3	16.3	8.8	22.7	10.8	27.5	35.1	15.7	18.4	8.9	32.2	16.0	50.1	16.1	7.0	15.9	17.2	7.8	10.5	16.6	19.7	25.4	31.0	13.7	17.5	56.4	37.0	21.7	21.9	14.3	29.9	14.8	14.3	13.4	23.2	23.8	11.3	9.7	12.6	22.0	15.3	9.8	37.1	12.2	16.2	17.9	11.8	29.9	17.7	23.5	32.9	20.2	16.0	18.6	3.5	27.4	18.4	18.2	43.9	24.1	32.3	23.8	21.6	26.6	33.3	26.6	24.1	16.2	26.8	59.6	21.3	28.3	30.8	6.2	6.7	9.6	13.5	5.4	7.1	6.9	7.3	6.8	6.9	6.9	6.6	143.3	22.4	34.1	11.8	86.7	69.3	91.2	141.8	56.9	22.5	55.3	88.0	25.1	51.5	55.9	27.6	2.1	132.7	53.5	38.2	68.4	67.2	3.6	53.4	44.9	68.7	23.4	82.6	12.3	67.1	183.4	65.6	30.1	33.1	56.4	52.1	54.7	65.8	124.9	18.5	13.3	66.2	61.1	96.2	98.0	13.8	76.1	98.2	51.6	7.5	171.2	33.7	74.2	16.6	13.1	53.1	83.6	57.9	60.6	162.8	92.7	111.5	64.3	25.0	32.9	47.5	82.2	107.3	196.2	78.0	71.7	73.7	77.1	71.6	85.5	99.8
LSM7	YNL147W	ENSG00000130332	"LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9UK45	19	2321520-2328611	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041850	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA041850: AB_10964065"	"unprognostic (8.33e-2)"	"prognostic favorable (3.28e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (4.19e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-3)"	"unprognostic (9.65e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.65e-3)"	"unprognostic (9.48e-3)"	"unprognostic (8.45e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.96e-4)"	62.0	54.2	54.0	51.5	55.3	111.9	64.7	58.1	84.1	77.3	52.5	73.9	62.3	63.7	22.9	88.9	61.8	20.7	64.1	53.9	58.4	64.7	65.8	53.3	70.9	58.1	58.4	74.6	53.2	33.2	80.5	38.5	56.9	63.5	32.7	15.1	52.7	31.9	68.3	69.9	77.7	28.2	58.0	82.5	55.8	44.0	55.8	77.6	50.9	31.0	46.2	62.9	68.5	61.2	276.5	171.3	167.5	192.4	74.3	70.8	139.6	131.7	93.6	147.2	114.1	326.3	105.8	329.4	139.5	105.4	84.9	140.4	161.1	183.3	68.6	232.3	376.0	230.3	152.3	430.5	73.7	437.9	164.8	83.2	106.6	97.9	99.0	62.9	129.5	251.3	296.6	245.6	66.5	357.2	381.5	371.7	314.3	246.6	228.9	276.0	185.3	479.5	91.2	221.5	311.0	224.3	147.8	113.9	179.3	87.1	96.8	301.5	135.7	106.9	146.5	176.6	250.1	210.1	259.3	425.4	103.9	388.2	186.8	120.3	202.8	189.5	162.3	244.9	162.9	469.0	224.7	189.8	279.6	410.8	214.8	197.1	43.9	187.3	209.6	291.2	243.0	242.2	54.0	55.3	58.1	84.1	53.9	58.4	58.1	58.4	56.9	58.0	55.8	61.2	153.9	96.1	81.3	17.0	276.3	231.0	196.8	348.4	162.8	44.3	188.3	328.5	99.5	88.6	183.4	126.9	33.3	377.6	142.1	221.5	195.6	210.7	12.9	186.1	197.8	130.0	168.0	154.1	7.6	220.1	353.0	157.9	136.6	232.9	115.9	252.0	83.9	88.0	220.4	35.3	9.5	350.5	219.7	115.1	270.7	21.0	115.5	144.6	140.5	12.2	159.0	104.4	171.0	9.5	19.0	262.0	229.6	90.7	210.1	298.0	215.3	198.0	132.2	62.5	85.5	138.4	168.5	61.4	223.3	257.2	216.4	242.6	164.3	165.5	357.3	236.7
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184144-118204035	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	26.8	19.1	6.2	22.3	8.3	44.8	25.6	16.5	7.7	20.5	6.2	22.0	15.5	19.9	16.5	24.4	18.7	9.2	19.2	6.3	7.5	23.7	18.5	21.2	28.9	7.5	7.4	19.8	24.9	8.4	16.3	10.1	7.7	20.8	14.2	16.7	22.7	7.8	21.7	21.6	26.0	8.3	6.8	30.9	21.3	17.3	7.2	18.2	22.1	7.8	27.5	20.0	20.6	10.5	37.2	21.2	53.7	43.6	11.3	19.4	25.3	36.1	26.4	19.2	21.5	16.8	35.6	70.0	78.9	13.4	51.5	28.2	23.1	16.3	18.6	35.9	27.7	49.5	63.3	48.6	29.2	63.9	59.1	20.8	19.6	24.6	25.8	17.7	19.6	55.8	45.8	71.2	26.1	13.2	142.9	155.6	43.6	28.9	26.0	40.8	32.0	53.3	20.3	27.8	28.2	41.6	29.2	83.0	89.1	36.9	17.3	72.7	17.4	36.9	27.7	56.3	51.2	69.9	52.0	101.1	29.1	66.9	61.5	65.3	46.5	45.5	61.8	66.7	59.8	68.0	67.8	75.6	51.5	58.0	64.6	67.5	15.4	43.9	65.7	93.2	74.2	39.5	6.2	8.3	16.5	7.7	6.3	7.5	7.5	7.4	7.7	6.8	7.2	10.5	108.5	25.6	58.6	15.0	130.3	0.0	93.6	0.0	82.6	41.5	71.8	92.1	43.5	74.4	35.3	62.5	47.9	133.2	141.2	76.8	90.1	101.2	54.6	76.1	92.8	79.6	86.4	83.1	19.5	172.0	193.6	69.0	66.3	76.4	101.4	87.1	88.5	75.3	139.8	42.1	22.4	99.1	0.0	148.9	0.0	19.1	97.3	102.2	0.0	36.5	184.9	52.6	158.6	23.6	39.1	144.8	109.0	76.0	95.6	108.6	83.6	106.8	36.5	42.0	85.5	65.3	66.2	135.3	117.8	106.7	0.0	120.8	121.1	76.1	100.7	121.2
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 81.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HeLa: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3"	"Low region specificity"	"Detected in many"			"HPA013753, HPA047988"	Uncertain		Supported	Vesicles,Cytosol		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Vesicles	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	2.2	2.1	1.2	0.2	1.7	0.3	1.5	2.1	2.5	1.7	1.1	2.0	0.5	1.0	1.0	2.0	1.6	0.1	2.9	1.2	1.7	4.0	7.2	4.3	0.1	1.2	1.1	1.7	5.5	0.0	2.3	0.2	1.1	2.5	0.3	0.8	1.7	0.3	81.6	1.4	2.2	0.1	0.8	4.2	2.7	2.9	1.3	0.1	2.2	17.0	0.0	1.8	2.2	1.5	0.0	0.1	0.1	0.6	0.5	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	8.7	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.7	1.3	0.0	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	2.1	2.5	1.2	1.7	1.2	1.1	1.1	0.8	1.3	1.5	16.8	0.0	2.8	5.9	5.1	5.5	2.7	1.3	9.6	2.1	12.8	23.4	9.9	2.8	2.2	1.8	2.1	1.3	9.5	17.5	0.0	0.8	49.2	12.7	18.4	5.3	3.0	0.0	8.5	0.9	1.1	7.2	7.7	27.7	0.0	0.5	1.1	1.0	4.0	0.0	7.6	5.7	0.0	1.2	4.8	67.8	0.9	13.6	1.8	3.7	1.8	0.6	0.0	1.5	5.0	0.8	7.1	0.4	4.2	6.1	5.2	0.5	1.4	3.2	0.0	22.3	8.1	0.5	0.5	9.5	4.7	1.9	6.3	2.2	5.4	3.6
LSP1	WP34	ENSG00000130592	"Lymphocyte specific protein 1"	P33241	11	1850904-1892267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 224.7;lymphoid tissue: 245.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 492.2;Langerhans cells: 553.6;monocytes: 1505.6;NK-cells: 352.2;Plasma cells: 338.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 278.5;HDLM-2: 978.9;Karpas-707: 215.4;RPMI-8226: 500.2;U-937: 173.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017781, HPA019693"	Enhanced					NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB017781: , HPA019693: AB_1853387"	"unprognostic (7.53e-3)"	"prognostic favorable (3.56e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.54e-4)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (1.43e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.29e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-2)"	75.6	224.7	2.1	148.8	2.6	167.3	51.2	2.4	6.4	63.8	5.3	39.2	33.6	36.8	3.8	42.5	41.7	32.6	48.2	3.8	3.4	6.4	12.1	49.8	154.8	6.0	2.6	5.3	10.7	3.8	7.4	21.8	4.5	13.4	22.3	1.0	52.8	8.1	28.4	98.0	76.6	12.5	4.3	245.0	52.1	8.1	6.0	65.5	24.7	29.4	85.0	83.7	51.4	11.6	0.3	1.2	0.0	0.0	41.0	125.2	0.4	0.0	0.0	0.0	0.0	0.1	0.2	278.5	1.5	0.2	0.3	0.4	0.0	0.0	0.0	978.9	0.0	0.5	0.2	0.4	7.9	1.0	0.9	32.0	0.5	0.1	1.3	0.4	0.1	2.2	0.9	215.4	24.7	0.1	19.6	28.2	0.5	0.0	0.0	1.1	13.6	500.2	0.0	0.0	0.4	3.3	0.2	0.0	0.3	0.0	0.3	0.9	0.5	0.7	4.6	0.3	0.8	1.0	0.7	38.4	0.4	173.0	0.3	365.1	803.6	785.5	384.3	863.3	222.6	452.1	249.1	346.8	896.6	298.8	161.3	260.8	1574.3	279.6	888.2	669.7	491.4	1293.0	2.1	2.6	2.4	6.4	3.8	3.4	6.0	2.6	4.5	4.3	6.0	11.6	18.3	16.0	7.9	0.0	312.8	118.3	14.0	43.0	76.8	0.8	3.9	4.3	2.7	8.6	37.6	3.7	0.0	3.6	295.4	0.4	1.9	1.3	3.4	1.2	13.3	11.4	1.2	40.6	0.2	8.9	4.4	160.4	15.3	1.4	12.6	0.9	11.0	2.3	492.2	1.7	0.2	0.8	16.2	118.4	553.6	7.8	89.8	310.9	65.8	0.0	1505.6	0.2	352.2	0.5	0.1	1.4	1.4	30.1	338.4	1.1	1.2	12.9	36.6	1.0	0.0	182.1	15.9	0.4	1.3	16.7	114.7	6.4	310.1	92.7	3.2	67.3
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 335.6;Ductal cells: 260.5;Exocrine glandular cells: 278.9;Pancreatic endocrine cells: 336.0;Paneth cells: 273.6;Syncytiotrophoblasts: 248.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 500.5;CACO-2: 215.6;CAPAN-2: 225.3;HaCaT: 203.9;OE19: 300.4;RT4: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007270, HPA075309"	Approved		Supported	"Plasma membrane"		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA007270: AB_1079253, HPA075309: "	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	15.7	31.3	15.7	17.8	13.6	3.6	25.4	13.2	14.7	20.4	39.0	96.9	85.0	14.4	13.9	60.0	29.7	36.4	7.7	12.5	13.2	28.9	144.8	30.0	14.4	17.1	14.8	6.4	114.2	16.8	27.3	46.9	15.5	25.6	43.7	8.6	69.4	18.5	4.4	51.9	75.0	5.3	12.9	17.9	133.1	27.2	17.7	6.6	32.9	2.7	14.1	29.9	29.3	14.8	500.5	8.1	0.7	1.0	1.4	0.5	86.8	1.2	1.9	2.2	1.6	215.6	225.3	19.6	73.0	1.3	7.2	203.9	44.3	75.0	0.3	30.1	82.6	0.2	6.5	96.1	1.7	0.3	0.9	1.0	81.2	2.0	24.2	1.0	0.8	0.6	80.2	17.2	1.1	177.4	0.9	1.1	69.0	300.4	3.2	3.8	0.8	54.6	46.2	198.2	37.7	1.4	40.9	130.5	35.8	21.7	112.5	2.6	0.4	3.9	44.7	3.1	2.2	27.2	52.5	45.7	3.4	0.8	12.4	6.4	0.2	0.1	2.5	0.0	2.6	4.3	5.8	5.4	0.1	3.0	4.2	4.9	0.0	5.6	0.0	0.2	4.1	2.9	15.7	13.6	13.2	14.7	12.5	13.2	17.1	14.8	15.5	12.9	17.7	14.8	38.2	16.0	21.7	0.3	26.3	51.7	123.4	90.7	50.1	2.1	60.9	49.7	5.6	78.6	71.2	36.8	16.7	210.3	4.7	335.6	11.7	260.5	9.4	41.7	27.4	44.6	56.4	3.2	0.8	278.9	93.0	11.9	214.1	61.5	31.1	30.3	20.3	89.7	21.7	0.0	0.9	145.5	73.2	2.2	14.3	2.9	6.5	4.6	14.2	22.5	7.2	11.5	3.1	1.5	0.8	336.0	273.6	3.4	41.1	113.6	117.8	24.6	43.8	12.3	0.0	4.1	24.4	7.9	19.1	57.2	51.7	248.0	24.3	3.4	124.2	206.3
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 132.0;Oligodendrocytes: 158.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 234.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"	29.3	38.9	20.0	10.8	30.8	5.7	22.3	38.9	33.5	20.8	7.1	22.9	28.5	26.6	12.1	39.7	18.0	9.0	25.1	15.7	26.2	10.7	54.8	24.1	9.4	62.3	40.7	30.3	19.4	12.2	25.9	8.0	65.7	24.0	10.7	6.8	16.1	12.4	29.0	27.6	17.4	12.2	28.4	7.6	23.3	17.5	40.4	12.3	10.2	19.5	8.0	20.2	19.6	58.7	70.4	22.2	70.9	30.6	94.1	90.6	20.3	26.8	186.4	32.1	62.7	73.9	54.4	15.4	22.3	51.7	234.6	32.7	63.2	110.9	12.9	14.9	34.5	37.7	38.6	48.3	85.5	13.7	25.1	89.0	41.4	59.7	25.6	22.2	26.9	72.1	37.4	87.3	27.8	23.8	29.9	19.7	115.4	11.3	20.1	34.9	21.9	92.2	82.8	38.1	41.4	36.7	31.4	24.0	27.5	30.6	38.0	33.7	40.8	37.9	30.2	33.8	21.1	31.8	29.5	30.6	39.7	59.4	16.6	4.6	2.1	2.2	4.0	1.8	2.8	3.1	2.9	4.9	2.4	1.5	2.4	3.6	0.0	1.7	1.5	5.0	1.4	3.6	20.0	30.8	38.9	33.5	15.7	26.2	62.3	40.7	65.7	28.4	40.4	58.7	13.8	12.8	36.8	66.6	7.2	37.0	3.8	30.2	8.0	16.0	15.3	8.0	13.7	14.3	18.7	11.0	4.2	3.7	11.8	10.4	0.0	10.5	6.5	6.6	16.4	10.3	19.7	16.8	21.2	17.2	6.7	19.7	13.3	14.6	3.8	20.6	11.4	132.0	9.7	23.5	24.2	11.6	16.2	7.5	13.7	6.6	21.1	4.9	21.4	21.5	12.0	7.5	5.2	22.1	158.8	14.0	2.7	13.5	6.3	16.2	5.0	4.1	11.0	16.4	0.0	9.8	8.5	20.3	18.1	12.6	54.0	6.3	7.9	18.0	10.9	4.6
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 1.9;lymphoid tissue: 5.6;testis: 4.2"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;MOLT-4: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150			"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.2	0.0	0.1	0.6	0.1	0.8	0.1	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.4	2.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	1.9	0.0	0.1	5.6	0.1	4.2	0.1	0.0	0.2	0.0	2.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.0	1.1	2.3	13.7	0.1	0.1	0.0	0.6	0.6	0.5	1.3	2.5	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.4	0.4	0.0	0.3	0.0	1.0	0.4	0.0	1.0	2.5	2.4	0.1	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.3	1.8	0.5	0.5	0.4	0.0	14.5	0.1	0.0	0.0
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1087.8;dendritic cells: 183.5;Ductal cells: 280.4;Pancreatic endocrine cells: 296.2;T-cells: 554.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.6;Daudi: 127.4;HDLM-2: 82.2;HMC-1: 38.1;NB-4: 62.3;REH: 58.6;U-698: 90.8"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	3.5	0.7	0.2	82.6	0.3	19.1	1.3	0.1	0.5	1.3	0.2	6.7	8.2	1.2	0.0	4.3	1.2	4.8	1.1	0.1	0.2	10.3	4.8	8.7	103.9	0.4	0.2	0.4	2.5	0.2	0.7	0.9	0.3	2.4	2.7	0.0	4.2	0.3	1.0	2.2	66.7	1.9	0.2	229.2	13.9	0.2	0.3	83.3	3.8	1.4	47.6	8.7	1.4	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	35.6	127.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	82.2	0.0	1.4	0.0	0.0	0.0	0.4	38.1	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	18.5	62.3	0.0	0.0	0.0	58.6	0.0	11.4	32.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.8	90.8	0.0	0.0	0.0	79.2	9.2	542.5	95.7	55.9	646.7	1027.3	924.3	419.4	14.5	1021.9	713.6	317.0	327.8	142.5	94.5	412.0	672.0	308.9	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.2	0.3	0.2	0.3	0.2	3.0	0.0	9.0	1.3	1087.8	16.3	0.5	45.7	2.2	0.7	2.9	3.7	0.5	2.8	4.7	90.1	0.0	0.9	183.5	0.9	1.9	280.4	3.5	2.2	2.0	8.4	0.0	11.2	0.9	113.1	0.3	6.3	3.1	1.5	14.0	0.1	10.8	3.5	10.1	0.0	0.9	0.4	160.7	31.0	112.1	0.2	0.6	49.8	42.7	0.0	72.3	1.8	99.9	0.0	0.3	296.2	1.6	0.0	13.6	3.0	0.0	11.6	0.9	0.2	6.6	1.3	4.3	0.4	1.2	1.2	12.4	0.3	554.0	0.3	3.6	0.3
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.1;skin 1: 110.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 45.5;Macrophages: 28.0;Suprabasal keratinocytes: 47.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 100.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 100.3;monocytes: 38.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 20.3;Karpas-707: 17.4"					"Low region specificity"	"Detected in single"			HPA003873	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	12.5	12.5	1.3	5.0	1.4	16.0	11.8	1.6	1.4	33.3	1.5	6.2	4.2	6.6	5.3	103.1	10.4	2.2	5.4	1.2	1.3	10.3	18.0	15.4	5.4	1.6	1.4	8.4	7.7	0.5	10.8	2.2	1.6	16.8	1.6	4.2	23.5	2.2	5.8	110.1	12.2	1.6	1.5	40.7	6.0	7.8	1.8	4.0	10.2	0.7	9.2	6.8	51.5	1.6	2.7	5.7	2.0	1.6	1.3	1.3	8.4	1.1	0.8	1.2	1.4	4.2	3.2	4.2	1.9	1.1	2.1	20.3	1.8	3.1	1.7	11.5	6.3	4.0	8.4	2.9	0.6	5.7	5.9	0.7	5.5	2.3	3.0	1.8	2.0	6.8	3.7	17.4	0.5	5.6	2.5	10.1	1.4	0.2	4.3	9.9	1.8	7.4	0.7	4.3	4.3	1.7	5.3	2.9	3.0	3.5	4.9	6.2	1.3	4.3	4.2	4.2	1.5	9.9	2.3	7.1	0.9	14.9	2.8	17.0	38.4	40.5	3.4	4.9	2.4	0.0	2.5	2.7	11.2	0.2	1.2	0.8	100.3	2.1	1.2	1.1	0.6	13.7	1.3	1.4	1.6	1.4	1.2	1.3	1.6	1.4	1.6	1.5	1.8	1.6	10.1	0.0	0.6	3.6	2.5	24.0	10.5	18.5	12.0	3.0	6.3	5.0	1.4	5.7	4.3	0.0	6.2	0.9	14.2	2.2	0.0	2.1	0.3	4.6	1.8	5.6	0.0	1.3	1.5	6.1	0.8	2.5	3.1	4.5	1.3	1.4	7.9	4.1	15.6	0.0	1.3	2.8	8.2	45.5	3.7	1.1	3.4	28.0	3.6	2.8	25.4	1.6	18.6	1.0	1.2	4.6	5.4	1.5	6.2	2.7	5.4	0.9	6.4	10.8	6.6	2.0	1.8	1.5	1.4	22.6	47.0	0.8	13.5	1.3	3.2	2.5
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 46.4"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	5.1	5.8	0.4	2.1	0.5	5.4	4.7	0.5	0.4	15.8	0.4	2.7	2.6	3.0	0.8	37.7	4.0	0.9	2.2	0.3	0.3	2.8	4.0	4.7	2.0	1.2	0.4	4.9	4.7	0.2	3.9	1.0	0.5	5.0	0.5	2.1	11.7	1.2	3.0	46.4	5.1	0.5	0.5	13.5	2.7	4.2	0.6	1.7	3.9	0.1	3.2	2.7	21.6	0.8	2.4	3.9	1.6	1.7	0.3	0.5	7.1	0.8	0.4	1.2	0.7	3.1	1.3	2.9	1.4	0.5	1.6	15.0	1.1	2.5	0.8	3.7	4.4	2.0	3.7	1.5	0.4	3.4	3.7	0.5	3.1	1.7	2.0	1.0	0.5	5.3	2.6	3.3	0.5	4.4	1.8	3.5	0.9	0.1	4.7	7.4	1.5	1.7	0.3	2.8	3.1	1.5	1.5	1.8	1.3	1.7	3.4	2.5	1.5	2.3	2.8	3.6	1.3	7.1	2.1	4.7	0.5	5.5	1.8	0.0	0.5	0.3	0.6	0.3	0.3	0.0	0.5	0.5	0.5	0.0	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.4	0.5	0.5	0.4	0.3	0.3	1.2	0.4	0.5	0.5	0.6	0.8	2.3	0.0	0.0	0.0	0.7	0.3	3.4	0.1	18.2	0.4	0.6	1.3	0.0	0.0	0.0	1.8	0.0	0.2	1.2	0.5	0.0	0.2	0.0	1.9	0.2	1.6	1.8	2.1	0.0	1.4	0.1	0.5	1.5	0.4	0.0	0.2	1.1	1.0	0.7	3.3	0.0	0.4	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.4	1.2	0.0	3.0	0.4	1.1	0.3	0.7	0.5	0.0	0.3	0.2	0.9	0.2	15.7	0.1	0.3	2.3	0.3	0.8	0.8
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946953-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 161.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Fibroblasts: 116.1;Leydig cells: 90.4;Peritubular cells: 161.0;Skeletal myocytes: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 569.4;HSkMC: 185.3;HUVEC TERT2: 194.5;U-2197: 181.1;U-87 MG: 255.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025428	Approved				"Secreted to extracellular matrix"	NA	NA		96000000	"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025428: "	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	22.9	13.1	7.8	22.1	9.4	11.5	14.5	7.1	7.5	161.4	10.5	27.2	10.2	58.9	37.8	21.2	37.0	73.0	89.0	8.8	9.1	38.6	18.6	27.5	6.9	12.1	10.6	30.2	7.9	2.4	9.0	73.2	9.2	46.9	16.5	0.7	14.6	73.6	15.7	10.8	15.0	96.7	9.1	8.3	32.8	17.9	8.8	8.2	6.5	28.4	18.7	53.9	28.3	13.4	0.3	12.5	31.3	0.3	26.1	569.4	13.5	46.5	95.7	6.4	9.3	25.3	4.6	41.3	1.0	6.0	8.8	2.4	0.7	1.5	22.0	0.6	15.3	135.6	15.0	4.1	118.6	0.5	15.7	185.3	4.4	141.2	6.9	61.8	194.5	6.3	8.7	0.3	51.1	19.9	5.5	0.2	22.4	1.0	39.2	4.7	65.8	0.6	0.4	22.4	6.3	3.4	9.5	72.1	0.8	49.1	27.9	0.4	126.4	6.4	26.2	181.1	37.6	74.8	80.0	58.8	255.9	5.2	10.8	3.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	5.3	7.8	9.4	7.1	7.5	8.8	9.1	12.1	10.6	9.2	9.1	8.8	13.4	33.6	0.0	0.6	108.4	0.4	13.5	5.6	13.0	10.2	0.0	6.9	6.6	80.9	4.3	3.6	1.8	0.0	45.2	0.3	12.9	0.0	9.6	6.3	7.3	18.3	28.1	1.2	30.3	30.4	6.5	23.4	116.1	10.2	10.5	0.0	11.8	20.3	11.0	7.6	0.0	54.3	2.8	2.0	0.3	18.1	7.1	90.4	12.0	19.6	39.4	0.4	0.2	0.0	70.4	52.4	19.1	3.3	161.0	1.3	19.1	0.7	0.3	6.3	0.3	59.2	85.8	67.9	0.7	11.9	6.9	9.8	43.5	2.0	2.6	4.1	33.4
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498183-74612378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease variant, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.3;olfactory bulb: 2.4"	"Region enhanced"	"Detected in many"		"olfactory bulb: 15.4"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		14000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	34.2	4.0	1.1	15.2	2.9	0.6	24.4	4.1	5.6	66.2	9.5	6.6	3.1	22.5	23.9	10.7	11.7	33.1	45.4	1.2	1.1	4.1	2.1	64.9	8.3	2.2	1.1	39.4	8.7	9.6	7.3	28.0	1.4	15.7	2.6	2.3	26.7	19.6	13.6	12.6	6.9	16.0	2.2	3.9	8.5	5.4	1.9	3.1	53.0	21.4	6.1	14.2	21.6	1.0	2.5	4.9	1.2	0.2	36.9	67.7	0.2	47.4	16.2	9.2	5.7	0.0	17.4	0.4	13.8	240.8	4.1	4.8	0.2	17.7	3.8	0.2	0.8	0.8	2.2	2.1	8.8	0.1	0.6	70.2	7.7	50.7	29.1	68.9	129.1	0.1	0.2	0.1	129.4	1.1	0.1	0.3	0.3	0.2	4.5	0.5	1.1	0.1	11.3	6.7	1.0	3.3	33.1	0.1	1.1	3.4	1.1	0.2	564.5	3.3	54.0	17.0	18.0	0.7	0.7	0.1	13.1	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	2.9	4.1	5.6	1.2	1.1	2.2	1.1	1.4	2.2	1.9	1.0	3.8	0.0	2.2	2.3	0.1	5.6	15.1	13.0	13.1	2.1	1.9	60.6	6.4	0.0	6.1	0.0	0.0	0.5	1.2	0.1	5.9	1.4	1.2	0.5	7.9	6.5	0.0	5.7	1.1	0.4	0.3	59.5	1.5	0.9	1.3	1.9	9.3	0.4	4.2	3.3	0.7	0.0	20.3	0.3	5.8	5.8	16.4	3.7	0.0	22.5	0.1	0.4	0.0	1.0	0.3	4.4	0.0	82.4	0.3	10.7	0.0	0.0	0.3	1.0	6.6	3.2	10.8	2.8	3.8	5.2	1.0	1.2	0.9	2.2	0.1	2.1
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LTBR	"D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3"	ENSG00000111321	"Lymphotoxin beta receptor"	P36941	12	6375045-6391571	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1"	"Group enriched"	"Detected in many"	36	"dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 393.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026202, HPA061617"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus"		"CAB026202: , HPA061617: AB_2732666"	"unprognostic (2.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.24e-3)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (3.66e-2)"	"unprognostic (9.84e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.86e-1)"	67.6	64.4	13.9	36.4	14.6	11.7	60.3	14.7	15.9	65.8	18.0	72.7	48.6	68.1	20.7	81.3	49.6	48.3	37.2	13.3	15.8	55.1	135.8	66.0	14.6	19.6	17.3	46.3	78.7	54.9	26.3	48.6	18.8	61.9	34.3	1.9	61.5	44.0	26.3	75.1	51.1	62.6	17.4	44.8	67.7	13.3	18.1	11.7	57.2	23.5	18.0	65.8	65.1	17.0	98.2	130.3	0.0	41.1	245.9	183.7	89.9	67.9	153.1	98.8	101.1	62.0	148.7	0.1	39.5	145.7	0.5	112.2	0.5	140.5	38.9	0.0	0.2	58.1	53.2	36.6	393.1	4.1	94.6	270.8	255.2	70.7	197.1	102.6	91.2	0.0	55.5	0.5	115.0	93.5	0.4	29.3	1.2	155.7	74.4	0.0	6.6	0.2	149.2	112.2	0.7	0.5	63.6	122.9	143.6	5.0	20.5	105.3	58.0	34.6	39.6	129.0	72.1	0.0	0.4	0.1	14.6	35.9	129.5	5.4	71.3	0.5	0.2	66.3	0.0	0.1	0.1	0.1	49.8	0.1	0.3	0.2	45.0	1.5	50.1	11.8	0.1	27.2	13.9	14.6	14.7	15.9	13.3	15.8	19.6	17.3	18.8	17.4	18.1	17.0	47.0	60.9	68.9	2.9	3.6	39.0	87.2	46.4	72.3	4.1	33.9	35.9	15.5	45.8	60.7	31.3	0.0	31.3	12.4	78.3	9.8	52.2	0.7	23.8	48.6	49.3	52.0	15.8	0.5	99.8	43.6	50.5	89.7	45.2	29.7	30.1	50.7	66.5	48.7	0.0	0.5	57.1	34.6	77.3	34.6	5.1	52.8	50.8	23.2	14.0	43.1	9.6	11.3	5.5	1.1	69.5	82.3	39.9	3.3	110.7	136.9	30.1	42.8	1.6	26.3	33.1	42.0	1.6	0.9	78.9	61.7	37.5	4.9	28.0	63.4	97.6
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 4255.5;salivary gland: 1162.5"	"Cell type enriched"	"Detected in many"	5	"Breast glandular cells: 1519.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"neutrophil: 5.4;non-classical monocyte: 17.0"	"Group enriched"	"Detected in many"	23	"granulocytes: 5.4;monocytes: 17.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 43.2;TIME: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted to blood"	NA	NA		350000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	6.9	1.2	2.5	36.1	3.4	4255.5	333.3	4.6	4.2	658.3	2.2	2.8	1.2	4.1	157.5	23.0	4.3	7.5	5.7	3.7	6.2	105.3	3.3	29.4	8.6	4.8	21.5	0.5	18.6	6.2	7.0	3.1	12.6	154.2	2.2	0.9	1162.5	378.9	1.7	11.8	5.1	1.9	7.1	70.5	331.6	0.4	14.5	29.8	10.1	1.6	345.7	2.4	1.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	43.2	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.3	1.2	0.1	0.6	0.0	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	17.0	0.4	0.0	29.5	2.5	3.4	4.6	4.2	3.7	6.2	4.8	21.5	12.6	7.1	14.5	9.9	15.5	0.0	2.8	0.7	4.3	1.1	8.6	82.8	0.0	0.0	1519.6	198.4	1.0	2.8	298.0	71.7	0.0	0.0	6.2	0.1	0.0	1.4	1.2	0.3	0.2	8.8	0.0	3.0	0.1	0.9	0.2	2.5	56.1	2.3	1.3	0.1	5.0	0.0	0.0	0.0	0.0	0.2	14.2	0.0	0.7	1.5	5.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	78.6	0.0	18.6	14.9	0.0	0.0	0.3	9.9	0.2	0.1	15.4	0.1	0.1	4.0	0.1	0.1	101.7
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859"	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	7.7	8.4	4.5	9.3	7.8	16.5	12.4	7.0	6.2	9.3	5.3	9.2	8.8	10.7	10.2	9.1	7.0	7.4	7.7	4.1	6.6	8.3	11.0	7.4	12.0	6.1	5.9	10.1	9.4	9.9	3.9	18.6	6.7	12.7	10.6	11.6	10.1	8.1	9.5	9.4	9.0	9.1	6.2	10.3	11.0	13.6	6.1	11.3	12.1	11.2	10.5	8.3	5.9	13.1	20.4	8.6	17.5	7.9	14.6	19.9	17.7	16.8	13.6	14.2	19.4	12.1	16.5	13.3	8.0	15.1	12.2	10.2	18.8	13.8	25.5	15.7	13.0	39.8	11.9	9.7	11.0	13.3	14.8	13.9	12.1	20.1	16.6	13.9	15.2	9.5	33.0	31.0	16.4	6.3	8.6	12.9	25.1	16.8	10.1	11.4	34.9	28.0	16.0	17.3	9.5	19.7	19.3	14.5	17.0	16.3	14.8	18.6	20.2	12.4	22.9	16.8	14.3	25.1	25.1	18.5	19.3	28.3	15.0	12.6	4.9	7.9	6.3	7.6	5.2	5.8	4.2	4.2	4.9	5.1	4.5	3.4	8.6	7.0	10.7	3.1	5.0	2.6	4.5	7.8	7.0	6.2	4.1	6.6	6.1	5.9	6.7	6.2	6.1	13.1	42.1	16.0	22.6	36.6	30.7	30.2	26.3	22.8	30.7	28.4	22.8	17.4	25.8	12.8	24.0	11.0	33.3	19.3	26.8	18.4	1.9	14.4	213.7	21.6	45.9	27.5	22.7	18.7	47.1	14.0	18.8	30.3	38.2	36.2	27.8	24.2	14.3	19.7	13.2	42.1	54.8	18.9	22.4	18.1	13.2	73.1	26.8	23.5	12.4	25.3	28.2	44.9	18.6	53.8	90.8	20.2	14.2	21.1	43.9	31.5	16.6	16.9	22.6	30.5	13.1	29.3	28.6	46.8	23.9	30.1	32.0	29.8	30.5	34.3	20.8	29.8
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843338-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	26.3	22.6	12.2	22.4	13.2	52.5	24.1	13.4	16.3	18.8	12.9	20.3	15.7	22.2	15.6	23.3	19.4	12.4	18.7	12.6	13.7	18.5	24.6	19.0	26.2	13.0	12.9	21.2	23.5	14.1	14.0	19.6	13.0	17.5	20.5	10.3	18.0	17.4	36.9	29.3	20.0	21.0	12.6	22.2	20.6	20.7	13.5	16.8	17.0	18.5	25.6	23.1	19.4	14.7	42.5	39.0	45.3	101.4	32.9	39.7	52.5	64.5	47.2	69.7	55.2	63.6	21.6	88.7	50.6	58.7	76.5	46.8	76.3	63.2	96.8	51.2	74.4	175.8	45.1	98.4	57.9	219.0	97.8	45.1	45.5	77.7	84.4	28.7	49.0	51.1	170.3	57.2	54.4	71.7	75.2	92.8	53.6	48.5	42.5	64.1	85.6	40.1	51.9	58.1	40.0	48.2	65.8	53.8	62.3	41.1	30.2	138.1	44.7	44.4	51.6	100.0	120.0	70.9	93.6	118.9	44.5	112.3	63.8	2.0	16.7	7.3	18.9	21.8	20.6	28.6	19.6	20.5	25.3	24.5	21.5	24.9	0.5	36.0	19.5	30.7	18.7	14.2	12.2	13.2	13.4	16.3	12.6	13.7	13.0	12.9	13.0	12.6	13.5	14.7	19.8	6.4	34.1	9.1	22.1	25.6	22.3	28.8	13.1	9.9	10.8	15.7	25.6	10.0	28.3	7.3	2.1	25.5	22.1	9.0	13.7	29.4	25.0	11.5	29.0	20.6	19.7	18.3	13.7	28.7	30.5	27.6	12.8	14.0	24.7	17.6	11.4	18.0	27.9	11.8	14.2	13.3	38.7	13.1	14.8	10.7	25.7	17.0	5.4	10.3	33.6	9.9	23.7	13.6	13.7	29.9	10.4	27.4	17.6	21.9	6.9	17.3	24.1	10.2	6.6	29.0	24.5	57.5	62.5	18.9	32.1	16.3	16.2	57.8	19.7	16.3
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	32.9	47.3	46.0	16.5	46.5	24.0	32.2	47.8	62.9	58.9	46.4	42.8	17.1	40.8	28.2	31.8	40.8	19.4	33.5	46.8	47.1	54.6	43.0	31.9	27.6	45.6	44.9	48.3	48.9	14.9	58.8	18.4	45.4	68.6	13.8	19.6	27.4	18.5	23.3	26.0	40.7	16.2	43.8	63.7	39.2	41.8	45.6	20.3	72.9	12.9	16.9	34.7	36.7	48.3	14.6	62.5	65.1	25.0	24.0	18.8	29.2	26.2	19.7	40.6	29.7	65.8	16.7	27.1	33.5	14.8	22.2	18.5	77.5	23.5	41.2	46.7	53.9	31.7	48.2	77.7	27.4	37.8	34.2	17.0	26.8	33.9	13.3	35.3	31.8	22.1	38.7	16.9	33.8	68.6	60.4	63.8	98.1	32.2	30.0	52.3	28.6	27.8	59.1	15.4	38.8	43.1	28.3	19.6	25.9	38.4	25.2	20.3	27.2	30.5	45.6	13.1	32.2	18.2	25.6	28.2	9.3	26.4	28.1	0.3	9.3	3.9	6.3	11.0	5.1	6.4	6.1	6.4	10.2	2.8	3.5	2.7	1.1	4.5	13.3	11.4	7.5	5.9	46.0	46.5	47.8	62.9	46.8	47.1	45.6	44.9	45.4	43.8	45.6	48.3	64.2	51.3	67.9	59.4	46.9	53.2	39.9	36.4	47.8	48.9	33.1	32.8	22.3	12.8	46.7	23.9	37.5	30.1	63.1	27.2	11.7	35.8	56.7	48.9	81.6	48.2	42.3	26.9	56.7	21.1	42.9	44.4	52.5	55.5	41.1	66.9	26.0	12.7	24.3	45.4	54.0	26.0	28.5	16.6	54.9	21.5	32.6	34.0	39.2	30.0	32.2	24.4	17.5	54.8	40.6	25.8	28.0	32.4	47.4	43.5	27.9	15.5	34.6	59.7	26.3	50.0	50.4	82.1	56.7	29.3	54.3	49.9	45.4	42.5	26.2	37.6
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA		28000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	38.6	32.2	43.0	29.9	43.4	79.4	46.5	45.0	63.4	51.9	37.0	40.4	26.0	40.4	39.7	44.4	46.7	33.0	40.8	41.2	49.4	42.5	49.0	34.2	49.5	42.2	41.8	50.8	46.0	40.3	26.1	36.6	42.4	46.4	35.2	43.6	38.1	37.1	62.3	49.3	37.3	35.5	38.6	40.0	40.6	35.8	43.4	62.7	60.8	41.4	53.6	41.9	45.2	52.9	65.7	37.4	79.3	73.6	53.0	43.6	58.0	74.4	71.6	71.5	74.6	41.4	61.2	108.5	43.4	60.7	44.6	46.3	96.5	75.7	100.7	51.1	94.7	92.5	56.1	41.9	44.8	150.2	75.4	38.6	93.6	67.3	81.9	49.5	58.5	56.1	119.5	57.1	78.6	62.5	180.4	140.9	65.2	87.6	53.1	107.7	77.7	98.7	81.9	72.7	68.2	65.2	82.0	82.5	75.5	59.3	55.8	59.1	56.0	54.7	31.8	61.1	68.3	86.5	88.0	230.1	60.5	143.8	74.3	10.7	9.4	17.9	17.7	14.3	19.8	16.0	17.3	18.6	12.8	14.9	21.3	18.3	8.7	16.3	17.1	13.2	19.0	12.3	43.0	43.4	45.0	63.4	41.2	49.4	42.2	41.8	42.4	38.6	43.4	52.9	53.5	54.5	56.8	0.0	63.0	0.0	74.8	0.0	72.8	54.0	54.4	45.1	0.0	35.8	39.6	38.6	52.1	77.0	48.5	16.5	54.8	45.1	18.7	31.4	43.1	46.8	21.9	102.9	0.0	38.5	74.3	48.2	57.1	32.8	60.5	37.7	42.1	58.5	43.9	43.7	0.0	29.0	0.0	42.5	0.0	8.5	53.1	41.9	0.0	0.0	46.4	46.7	43.3	0.0	0.1	34.9	18.7	67.7	68.6	62.0	34.6	40.8	37.2	49.2	59.2	54.9	45.6	74.1	68.7	51.5	0.1	82.4	63.7	43.0	28.0	56.2
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719565-50756219	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		15000	"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	86.8	108.2	128.2	91.1	134.2	75.9	96.4	165.6	193.2	172.2	131.4	163.3	99.4	144.8	88.1	98.3	157.5	63.8	102.8	126.1	138.7	112.7	90.8	119.0	132.4	131.3	128.4	223.5	111.6	63.6	172.0	78.5	132.5	141.3	75.1	175.8	94.8	73.4	151.9	105.3	131.2	65.8	124.6	133.6	113.7	73.7	133.5	84.1	144.0	43.2	88.4	130.1	136.5	148.4	176.7	114.3	222.8	143.1	91.5	87.9	105.5	162.8	63.0	77.0	92.1	214.5	132.4	212.5	171.1	65.2	87.5	148.8	149.4	67.5	132.2	226.6	242.5	251.5	445.3	174.9	50.5	223.4	136.0	84.2	94.5	84.2	48.7	193.7	79.9	164.9	202.9	188.0	99.1	99.1	221.4	218.0	146.2	125.3	83.4	238.2	208.4	224.0	105.5	109.8	158.1	163.2	96.8	121.5	179.3	192.6	196.3	164.9	113.7	170.9	146.3	72.8	171.5	167.8	191.7	265.1	108.1	152.5	123.9	49.1	32.3	32.6	32.0	24.0	28.2	67.3	35.7	27.6	21.2	55.4	37.1	30.5	47.8	23.3	19.8	64.7	29.6	12.1	128.2	134.2	165.6	193.2	126.1	138.7	131.3	128.4	132.5	124.6	133.5	148.4	129.7	150.6	194.2	231.8	177.8	216.2	200.9	99.4	200.3	512.3	121.1	129.5	111.5	70.1	148.3	93.8	229.4	104.8	237.1	130.8	74.3	102.6	18.9	111.1	171.8	151.9	207.8	191.2	121.5	85.3	108.5	149.8	99.4	144.8	148.0	364.8	94.2	83.1	76.4	380.2	145.9	151.8	81.4	87.4	122.5	48.4	394.5	105.1	96.0	107.7	184.2	207.8	197.8	181.5	239.1	86.5	158.0	355.0	134.5	151.2	157.8	56.2	130.1	402.2	236.7	204.5	172.3	122.2	159.3	135.7	177.0	99.9	162.8	253.1	141.7	191.7
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 140.9;Late spermatids: 335.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.4;RPTEC TERT1: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	2.1	3.5	2.4	0.9	6.5	1.7	2.1	5.7	5.7	4.5	2.5	3.1	0.8	3.2	2.2	2.0	3.3	1.7	5.4	3.1	4.7	5.3	0.4	1.6	0.5	9.7	5.4	3.9	0.3	9.5	2.1	0.9	7.3	4.6	1.0	1.3	2.6	4.8	1.1	2.0	1.3	2.7	4.0	1.6	2.7	8.9	6.2	1.2	10.5	1.0	0.8	3.8	4.0	13.6	0.1	0.1	2.1	0.1	2.8	3.8	2.1	1.5	3.8	2.0	2.3	0.1	0.1	0.2	0.1	3.6	0.7	0.2	2.2	4.8	1.6	0.4	1.0	0.2	0.5	0.2	0.8	0.1	0.1	1.8	3.0	4.0	1.8	5.4	3.0	0.5	1.9	0.3	1.1	0.2	0.2	0.2	0.8	0.0	0.3	0.7	1.0	0.0	5.3	0.0	0.3	0.8	0.0	0.1	3.4	0.8	1.1	0.2	0.2	1.2	1.5	1.0	0.3	0.1	0.1	0.2	1.2	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.8	0.3	0.1	0.2	0.0	0.1	2.4	6.5	5.7	5.7	3.1	4.7	9.7	5.4	7.3	4.0	6.2	13.6	2.2	0.0	0.0	6.8	0.0	5.0	15.6	4.5	8.0	0.2	2.7	4.1	3.1	0.0	1.3	11.0	0.0	4.1	0.1	0.2	15.6	0.1	140.9	1.3	1.6	2.9	1.2	0.0	10.0	0.4	2.3	4.0	0.0	1.3	0.0	2.5	3.3	0.1	4.4	0.0	5.5	0.3	0.0	0.3	3.3	335.2	9.3	1.2	14.2	5.6	0.7	2.0	1.0	1.0	25.3	0.0	0.1	9.8	0.0	8.6	0.1	5.3	3.3	0.2	6.6	2.6	4.7	36.3	2.2	2.7	3.4	7.7	0.2	2.7	0.1	5.5
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, LRAP35b, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775020-12823060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 90.2;Paneth cells: 88.8;Prostatic glandular cells: 104.3;Urothelial cells: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 100.6;hTERT-HME1: 81.9;T-47d: 118.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	14.6	9.3	3.4	5.5	4.6	0.1	10.6	11.8	6.1	10.9	2.5	19.9	4.1	6.2	3.3	4.6	6.6	11.8	4.4	3.5	4.2	5.4	32.2	25.0	3.9	5.2	4.6	4.2	19.6	0.8	5.5	21.0	5.0	6.9	9.4	4.7	27.7	6.7	2.5	12.2	9.2	8.3	5.7	10.4	12.5	0.5	4.7	1.2	8.7	3.4	2.0	12.1	12.4	5.8	2.2	7.1	0.0	2.3	11.0	15.1	0.0	3.9	20.2	5.1	5.4	0.0	2.6	0.0	1.5	20.6	24.3	3.0	0.0	0.4	3.9	0.0	0.8	1.1	6.7	4.0	100.6	0.0	0.0	6.0	9.7	17.4	81.9	8.6	3.3	0.0	0.0	25.8	3.1	1.8	0.0	0.0	0.1	9.6	7.8	0.0	1.3	0.1	20.7	1.2	15.5	1.5	4.7	2.9	3.8	1.7	118.5	0.4	1.3	4.5	0.7	11.7	2.8	0.1	0.0	0.0	7.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	4.6	11.8	6.1	3.5	4.2	5.2	4.6	5.0	5.7	4.7	5.8	9.6	9.6	18.4	1.3	0.7	90.2	34.4	19.3	5.2	10.2	60.1	26.2	7.1	20.0	40.2	1.8	2.1	1.0	0.5	58.7	7.9	66.6	5.0	11.5	3.2	7.8	26.7	0.0	18.4	11.8	2.7	19.7	10.2	29.2	10.8	12.9	1.8	30.2	0.6	18.5	41.6	12.8	24.4	0.0	8.4	0.8	9.3	2.3	26.6	6.5	0.0	4.3	0.0	8.0	44.1	27.5	88.8	3.0	0.0	104.3	20.7	5.5	16.1	10.2	39.5	8.0	47.4	0.1	0.6	2.9	64.4	1.1	1.9	1.3	49.5	140.4
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 349.1;Early spermatids: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	11.5	14.3	6.0	9.2	8.1	14.2	7.3	6.3	24.6	10.1	4.1	13.1	22.7	11.9	5.4	9.3	6.3	13.0	13.6	7.6	10.9	10.7	3.6	10.4	6.4	13.7	8.1	7.6	6.1	20.1	3.8	12.7	13.9	9.8	13.2	5.4	6.9	9.6	3.3	8.9	24.7	12.8	5.1	10.7	5.2	11.4	12.3	9.8	9.5	6.6	7.1	10.4	7.4	11.0	26.4	17.7	24.5	28.5	24.6	31.3	17.8	25.3	40.1	31.0	32.4	10.1	12.0	0.5	22.6	43.0	19.9	34.8	24.5	68.5	37.6	9.6	16.2	36.6	21.8	9.6	16.2	18.5	22.5	27.7	26.4	45.6	35.6	25.6	70.6	10.0	13.6	2.0	25.2	7.0	12.6	7.9	20.8	8.1	18.9	18.9	36.7	3.1	14.0	17.1	4.5	11.6	60.4	16.8	20.3	48.9	9.6	9.6	127.0	36.2	27.2	27.2	25.4	3.0	7.8	9.8	15.9	29.8	31.8	39.8	7.6	8.4	11.5	5.4	13.1	3.2	8.7	7.5	7.6	5.8	6.9	6.9	4.1	7.1	10.9	15.8	5.1	3.3	6.0	8.1	6.3	24.6	7.6	10.9	13.7	8.1	13.9	5.1	12.3	11.0	103.5	9.6	14.1	58.1	17.1	135.2	349.1	64.7	117.8	23.7	31.3	41.7	54.7	27.1	33.7	20.2	2.1	25.6	34.1	100.3	15.6	58.6	291.4	35.6	83.0	138.2	21.5	9.5	113.2	30.6	53.7	49.4	14.3	54.1	22.8	21.9	68.6	11.5	27.3	21.9	111.3	55.8	61.1	18.0	77.9	52.9	36.4	36.4	33.8	65.6	83.7	17.4	33.0	38.2	7.2	75.9	54.0	43.6	19.5	83.5	117.3	23.3	24.0	8.4	32.9	43.7	67.5	84.6	85.9	72.9	70.8	24.8	46.3	38.4	54.9	183.0
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082638	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 30.6"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1890.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	0.3	6.5	8.6	0.1	8.5	0.1	0.5	11.8	8.0	0.1	1.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	6.3	15.1	0.2	0.9	0.2	0.0	10.8	30.6	0.0	0.0	0.0	0.6	0.0	17.2	2.4	0.6	1.1	0.1	0.1	0.0	0.1	0.2	0.3	17.6	0.1	0.1	0.5	15.3	0.0	0.0	0.6	0.0	0.3	0.1	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	4.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	11.8	8.0	6.3	15.1	10.8	30.6	17.2	17.6	15.3	16.5	0.3	0.0	0.0	11.4	0.0	0.6	0.1	0.0	1.8	6.9	0.3	1.7	0.6	0.0	0.0	3.7	0.0	0.0	0.1	1.2	0.0	0.0	33.7	0.6	0.7	0.1	0.0	0.0	149.4	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	371.4	1.7	0.0	0.0	0.0	6.4	0.9	0.1	0.0	4.7	0.0	0.3	0.0	1890.0	9.1	0.2	23.9	0.0	0.0	4.5	0.0	0.7	0.0	0.8	0.0	0.4	0.3	0.3	0.6	0.9	0.3	0.1	0.0	2.4	1.5	1.6
LUZP4	"CT-8, CT28, HOM-TES-85"	ENSG00000102021	"Leucine zipper protein 4"	Q9P127	X	115289715-115307563	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	82	"testis: 8.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 35.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 13.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046436, HPA051999"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046436: AB_10964168, HPA051999: AB_2681688"															"unprognostic (1.84e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 11.1;placenta: 21.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.3;Extravillous trophoblasts: 33.1;Late spermatids: 68.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 2.5"	HPA053254	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"		"Cluster 50: Fibroblasts - ECM organization"			"HPA053254: AB_2682092"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	11.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	21.8	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.4	0.8	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	29.3	0.0	0.1	0.1	0.0	0.0	2.1	0.0	33.1	7.9	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	68.1	4.7	0.3	0.0	1.9	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.3	0.1	0.0	10.7	0.0	1.0	0.0	0.1
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672648	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 97.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 123.0;Respiratory ciliated cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 1196.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		4700000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	59.0	47.0	3.7	21.5	6.4	27.1	22.4	7.3	4.4	20.3	14.1	42.0	30.3	13.7	23.7	9.9	34.3	40.5	23.1	4.5	5.4	21.6	5.6	26.3	18.6	3.9	4.3	49.7	14.1	14.0	16.0	22.0	4.1	36.9	44.0	3.6	42.4	17.9	5.4	12.4	26.1	22.9	3.6	10.2	15.0	4.5	6.2	13.8	18.3	7.8	14.3	97.7	14.4	4.2	0.1	40.7	3.1	0.5	17.0	58.2	3.4	31.3	80.4	7.6	15.2	0.1	91.3	0.3	28.2	8.7	0.2	14.1	8.1	12.7	11.2	0.1	40.2	19.6	33.0	0.4	19.5	5.0	0.5	131.5	2.3	14.5	2.4	1196.4	296.5	0.1	0.3	0.9	0.0	167.0	2.1	0.0	3.6	7.3	10.5	5.5	0.0	40.0	27.6	113.4	5.1	0.1	0.0	42.5	10.4	9.4	0.3	0.1	42.8	0.3	0.3	42.3	0.1	0.6	0.0	0.2	14.8	1.6	0.5	28.8	5.8	8.6	5.6	5.8	5.8	10.3	11.7	9.3	7.3	6.9	12.9	7.2	36.7	9.8	3.6	7.6	29.8	6.5	3.7	6.4	7.3	4.4	4.5	5.4	3.9	4.3	4.1	3.6	6.2	4.2	71.0	16.0	9.2	0.3	4.4	5.6	84.1	27.0	4.6	0.3	17.3	21.2	3.8	11.5	38.7	16.5	4.2	13.4	5.5	34.1	15.6	18.5	3.9	20.7	16.5	88.5	35.2	86.3	0.5	26.4	16.2	28.8	6.1	7.6	123.0	3.6	77.8	0.8	22.9	0.0	0.3	73.1	22.4	6.3	18.1	7.9	8.4	8.0	19.6	4.7	17.7	8.9	6.2	0.0	0.3	15.1	58.4	2.6	2.8	49.8	48.6	15.5	120.3	1.2	13.1	1.3	29.4	0.9	10.8	8.6	8.2	4.0	6.5	5.9	30.8	77.0
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784882-142786539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2074.3;skin 1: 850.4;vagina: 491.2"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 1171.6;Squamous epithelial cells: 1913.0;Suprabasal keratinocytes: 3866.1"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"A-431: 162.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					NA	NA		210000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	1.7	47.6	0.6	0.2	0.6	0.0	20.4	0.5	1.4	297.4	0.5	0.9	0.0	0.3	0.0	2074.3	1.0	1.4	0.8	0.6	0.5	0.3	0.8	0.5	0.0	0.5	0.5	0.5	1.0	0.0	1.0	2.5	0.5	15.3	0.2	0.0	235.4	0.3	2.6	850.4	0.5	0.0	0.5	0.5	12.4	0.4	0.5	4.6	0.4	0.0	75.6	65.2	491.2	0.7	162.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	6.0	0.0	1.3	0.0	0.2	0.0	0.0	4.0	11.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	1.2	4.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.4	0.6	0.5	0.5	0.5	0.5	0.5	0.5	0.7	0.1	3.2	0.0	0.0	0.0	1171.6	9.4	244.9	138.3	0.0	14.8	14.1	0.2	0.0	154.0	1.8	0.0	0.9	0.1	0.4	1.9	1.1	0.0	0.4	0.1	10.7	0.0	0.0	0.3	0.2	5.7	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	22.4	0.0	137.3	0.0	0.0	0.8	163.7	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	2.5	18.9	0.0	1.2	12.2	0.0	0.0	0.6	16.1	0.0	0.0	1913.0	3866.1	8.2	4.0	0.0	0.4	164.6
LY6G5B	"C6orf19, G5b"	ENSG00000240053	"Lymphocyte antigen 6 family member G5B"	Q8NDX9	6	31670167-31673776	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA048307	Approved				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA048307: AB_2680348"	"unprognostic (2.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (8.34e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-4)"	"unprognostic (7.27e-3)"	"unprognostic (1.98e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.98e-4)"	30.1	13.5	3.0	9.5	3.4	29.9	25.9	7.4	7.2	26.3	3.1	25.6	6.9	24.9	11.1	15.8	25.0	6.3	15.0	3.2	3.9	15.5	15.0	27.8	12.1	3.5	3.3	33.2	14.5	2.8	20.8	8.2	3.6	22.1	11.4	11.3	20.3	7.4	15.4	44.6	27.8	9.4	2.7	30.6	19.2	13.0	3.8	7.7	24.7	3.3	13.1	21.1	20.4	3.7	5.4	5.8	11.4	15.5	2.6	5.5	14.5	10.4	3.3	7.3	7.2	7.1	6.8	12.9	2.8	13.0	4.7	8.6	2.7	13.7	11.6	5.2	18.0	12.4	8.1	5.7	2.2	15.6	9.9	11.8	7.9	10.7	5.0	10.3	3.9	9.7	7.7	7.8	5.0	4.9	8.4	12.0	6.4	1.5	2.6	11.8	3.5	5.7	3.4	14.7	8.0	12.9	4.7	1.8	3.6	13.9	4.7	10.3	7.6	14.2	7.5	6.6	2.6	13.6	10.1	11.5	5.1	14.6	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	7.4	7.2	3.2	3.9	3.5	3.3	3.6	2.7	3.8	3.7	0.3	3.2	0.0	0.0	1.4	1.0	1.2	0.7	0.0	1.1	0.7	0.3	0.1	1.5	0.2	0.0	0.0	0.4	0.8	0.6	0.0	0.1	0.0	0.4	0.8	0.5	1.2	0.0	0.5	0.2	0.4	0.9	1.1	1.1	0.0	1.2	0.4	0.4	0.5	0.0	0.6	0.9	0.0	0.0	2.2	0.0	0.6	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.6	1.1	1.8	0.0	0.1	2.3	0.0	1.5	0.8	0.1	0.3	0.4	1.3	0.5	1.4	0.4	1.0	0.8
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.3	0.2	0.0	0.6	0.4	0.3	0.2	0.2	1.0	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.5	0.3	0.0	0.0	0.5	0.3	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.9	0.1	0.3	0.4	0.0	0.6	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.6	0.3	1.7	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	0.4	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	7.8	3.2	1.5	0.3	1.4	1.7	1.8	2.0	0.0	2.8	7.7	8.0	1.2	1.5	2.1	1.8	2.1	0.5	4.2	3.8	3.9	2.1	21.4	6.9	1.4	5.6	3.5	3.0	0.8	4.9	0.2	1.6	3.1	1.8	5.1	1.4	10.4	2.2	6.2	0.0	1.2	2.0	8.2	5.5	3.1	7.5	1.2	11.6	1.8	0.0	3.7	6.0	2.1	1.0	0.6	3.4	3.1	1.5	3.2	2.1	3.0	4.6	16.1	1.1	0.0	2.6	1.7	15.9	13.9	2.0	0.9	0.3	5.2	1.3	3.1	1.9
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 24.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 6.1"					HPA054412	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	3.9	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.1	0.0	0.0	1.4	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706866-31710679	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;lymphoid tissue: 1.2;skin 1: 1.3"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enriched"	"Detected in single"	379	"HEL: 37.8"	"Low region specificity"	"Detected in many"							HPA008053	Uncertain					NA	NA		380000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.5	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	9.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LY6G6F-LY6G6D	"G6F-LY6G6D, MEGT-1, MEGT1"	ENSG00000250641	"LY6G6F-LY6G6D readthrough"		6	31706904-31717918	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"skin 1: 5.4;testis: 2.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA008053	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 33: Fibroblasts - ECM organization"			"HPA008053: AB_1840160"			"unprognostic (5.02e-2)"		"unprognostic (1.31e-1)"	"unprognostic (3.47e-1)"				"unprognostic (5.90e-2)"		"unprognostic (1.07e-2)"			"unprognostic (2.66e-1)"	"unprognostic (2.42e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.7;choroid plexus: 35.0;pituitary gland: 55.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.0;Endothelial cells: 18.7;Enteroendocrine cells: 54.9;Excitatory neurons: 24.8;Inhibitory neurons: 47.8;Ionocytes: 22.4;Oligodendrocyte precursor cells: 22.6;Spermatogonia: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 2.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077218	Enhanced				"Intracellular and membrane"	NA	NA		12000		"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	2.2	0.4	78.5	0.2	90.6	0.0	0.8	35.7	114.7	1.5	35.0	24.0	2.5	1.6	0.0	1.3	2.0	0.0	0.3	97.9	111.5	0.6	0.1	1.4	0.1	43.4	56.3	1.0	1.0	0.0	55.5	0.0	48.7	0.9	0.0	0.5	0.1	0.0	0.2	0.4	6.6	0.4	46.2	0.2	11.8	5.8	92.6	0.0	0.9	0.0	0.0	0.6	0.4	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	90.6	35.7	114.7	97.9	111.5	43.4	56.3	48.7	46.2	92.6	54.3	20.0	0.0	0.0	9.1	0.0	0.6	0.2	0.3	0.0	5.8	0.6	0.0	6.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	18.7	54.9	0.0	24.8	0.0	0.1	3.7	12.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	47.8	0.9	22.4	0.0	0.0	2.2	0.0	0.1	0.0	13.1	0.0	2.3	0.0	22.6	5.9	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.2	3.5	0.0	0.1	0.4	1.9	22.4	0.3	0.0	0.0	0.0	2.5	0.2	0.5
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.5;testis: 36.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017770, CAB075742, CAB075743, CAB079929"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	5.4	0.2	0.6	0.2	0.6	0.3	4.4	0.9	1.7	3.3	0.0	0.5	0.3	0.5	0.2	12.5	1.2	0.4	1.5	0.8	1.0	3.0	0.2	0.8	0.2	1.7	0.8	0.7	0.3	0.0	0.4	2.4	2.0	1.1	0.0	2.4	1.7	0.8	5.4	6.8	0.3	0.1	1.1	0.2	1.1	36.0	0.7	0.6	1.0	1.3	0.6	1.0	5.1	1.1	125.2	2.0	0.0	6.3	2.4	7.9	1.5	131.9	15.3	39.9	24.0	0.2	0.5	0.0	10.9	15.0	14.3	10.8	0.0	7.5	33.5	1.2	0.2	0.1	142.4	0.3	1.9	0.0	0.0	11.7	21.1	29.7	38.0	0.1	3.7	0.0	0.0	0.6	76.2	1.0	0.2	0.3	4.2	4.1	2.0	0.3	0.5	0.2	6.7	1.7	3.7	0.5	206.3	2.7	41.3	6.6	0.5	0.2	5.4	1.9	11.8	273.2	0.2	0.2	0.1	0.3	0.6	0.1	13.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.9	1.7	0.8	1.0	1.7	0.8	2.0	1.1	0.7	1.1	25.6	3.2	0.5	0.0	0.4	38.9	54.2	4.3	21.6	0.6	15.1	49.8	0.2	5.7	9.8	25.8	0.0	13.5	0.3	0.0	0.0	0.8	7.7	3.1	8.5	9.2	0.0	0.0	0.0	0.0	186.7	8.0	0.0	9.0	0.0	0.0	3.3	0.1	6.0	0.0	0.0	0.0	6.1	0.3	28.7	14.8	4.1	4.6	12.4	0.0	0.0	0.5	0.0	0.0	0.1	6.7	1.1	3.0	0.0	105.2	0.0	0.2	3.6	0.6	0.0	17.8	13.1	404.4	105.8	32.2	44.9	25.3	0.7	0.1	0.0	131.4
LY75	"CD205, CLEC13B, DEC-205"	ENSG00000054219	"Lymphocyte antigen 75"	O60449	2	159803355-159904756	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 78.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 27.8;monocytes: 96.5;Proximal enterocytes: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.8;HDLM-2: 21.7;Karpas-707: 85.3;RT4: 30.1;THP-1: 22.3"									"CAB001450, HPA049108, HPA054073"	Enhanced		Approved	"Golgi apparatus"		NA	NA		1300000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus"		"CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370"	"unprognostic (7.29e-3)"	"unprognostic (1.92e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.86e-4)"	2.0	1.9	1.1	18.7	1.0	9.6	9.4	1.1	1.2	7.3	0.7	12.4	18.0	2.6	0.7	5.0	8.5	7.7	1.0	0.9	1.3	3.7	2.0	7.7	30.3	1.7	1.1	1.0	1.4	1.1	0.6	1.3	1.6	1.8	11.9	0.7	7.8	2.6	0.3	7.4	17.6	2.3	1.8	18.4	7.1	0.4	1.2	78.4	17.3	0.9	22.1	10.3	2.2	1.8	3.5	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	9.1	21.8	15.7	0.7	0.0	0.0	0.4	0.0	0.1	0.0	21.7	0.0	4.4	0.2	0.1	0.4	3.3	0.1	0.3	0.1	0.6	0.2	0.0	11.1	0.0	0.0	85.3	0.0	0.0	0.0	5.8	0.5	0.5	0.0	6.0	0.0	3.8	6.4	30.1	0.0	0.0	7.0	5.0	0.0	0.2	0.0	22.3	16.7	0.0	0.0	0.0	0.0	13.2	2.4	3.0	0.0	7.7	0.0	2.6	1.2	2.4	4.2	1.7	4.6	3.7	3.8	4.8	2.9	2.7	4.3	5.1	3.7	5.2	0.7	1.0	3.0	1.4	1.1	1.0	1.1	1.2	0.9	1.3	1.7	1.1	1.6	1.8	1.2	1.8	1.7	0.0	3.4	0.0	15.4	7.5	2.2	5.6	7.4	0.2	9.9	12.1	0.5	4.3	6.3	23.9	2.1	0.1	10.6	27.8	0.0	0.8	0.6	15.4	1.3	3.3	1.8	6.9	0.0	5.5	0.1	1.8	8.6	9.4	11.4	1.7	2.2	0.2	3.9	0.0	0.0	9.8	4.1	10.1	11.3	0.3	2.5	11.5	5.4	0.0	96.5	0.2	13.4	0.0	0.0	4.9	10.9	0.4	8.1	1.3	33.5	2.0	20.7	0.2	0.0	3.7	1.3	0.0	0.7	4.5	6.7	0.3	14.2	0.9	12.3	5.6
LY75-CD302		ENSG00000248672	"LY75-CD302 readthrough"		2	159771851-159904710	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;intestine: 1.8;lymphoid tissue: 2.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.1;Club cells: 1.3;granulocytes: 1.3;Microglial cells: 1.0;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;HDLM-2: 7.4;Karpas-707: 27.6;RT4: 11.7;TIME: 7.3"									HPA049108	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA049108: AB_2680635"	"unprognostic (2.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.33e-1)"			"unprognostic (1.86e-1)"		"unprognostic (9.04e-2)"			"unprognostic (1.68e-4)"		"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.88e-1)"	0.1	0.0	0.1	2.3	0.0	2.4	0.7	0.2	0.1	0.3	0.0	1.2	1.8	0.2	0.0	0.0	0.4	0.4	0.2	0.0	0.2	0.2	0.1	1.2	0.7	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	1.2	0.2	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.6	0.3	0.1	0.2	1.9	0.6	0.0	0.4	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	7.0	3.5	1.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	7.4	0.0	4.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.0	3.3	0.0	0.0	27.6	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.0	11.7	0.0	0.0	3.2	0.7	0.0	0.1	0.0	1.2	7.3	0.0	0.0	0.0	0.0	2.4	0.5	0.8	0.0	1.7	0.0	2.5	2.9	3.4	1.1	3.1	1.6	0.9	1.0	1.3	7.3	1.0	1.1	0.9	5.5	0.6	1.4	1.6	1.3	2.4	0.1	0.0	0.2	0.1	0.0	0.2	0.5	0.1	0.3	0.2	0.2	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.4	0.9	0.1	13.7	0.2	11.5	2.0	0.1	0.2	0.8	0.2	3.9	4.0	0.6	0.4	0.9	0.9	2.5	0.5	0.1	0.2	1.1	2.3	3.8	30.2	0.3	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.1	3.8	0.0	7.1	0.4	0.3	0.8	12.0	0.5	0.3	26.7	6.0	0.2	0.2	25.5	1.4	0.2	31.1	3.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	28.0	0.0	0.0	2.3	0.5	0.1	0.8	0.0	1.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	70.7	29.3	0.3	0.0	4.0	0.0	1.2	0.8	0.4	112.9	1.1	113.5	56.1	97.6	109.8	5.2	52.8	109.6	112.3	2.4	22.2	0.8	72.8	80.3	53.5	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.0	1.8	0.3	244.0	1.0	0.5	0.1	0.0	0.0	0.4	0.8	0.9	0.0	0.0	0.0	0.0	0.1	36.2	0.1	0.0	0.0	0.1	0.1	0.1	0.7	1.2	28.0	0.1	0.2	0.0	1.4	0.5	0.1	0.0	0.0	1.8	0.4	1.9	0.0	0.1	0.0	0.0	3.2	31.9	0.0	0.0	6.3	71.2	1.9	2.1	0.0	22.6	0.0	0.1	0.1	0.0	0.0	102.5	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.5	1.0	0.1	44.8	0.0	0.3	0.3
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	14.8	8.4	7.8	19.8	8.4	20.4	11.2	8.2	13.0	10.0	7.1	10.8	8.8	9.1	5.7	15.9	10.4	8.2	15.6	8.0	9.0	8.8	10.4	11.8	24.3	9.0	8.6	12.4	9.6	5.3	8.4	11.1	8.9	7.8	10.1	11.1	7.3	6.7	21.2	9.2	9.3	9.0	7.9	18.7	7.9	102.1	8.5	12.8	6.7	11.7	17.8	18.8	10.8	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	7.8	8.4	8.2	13.0	8.0	9.0	9.0	8.6	8.9	7.9	8.5	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.8;retina: 3.5;skin 1: 8.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.7;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.6;Horizontal cells: 15.2;Inhibitory neurons: 17.5;Rod photoreceptor cells: 29.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 4.8"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.7;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039179	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.2	0.1	0.4	0.1	0.5	0.5	0.0	4.8	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	3.5	0.3	0.0	0.3	8.8	0.1	0.0	0.0	0.2	0.2	1.4	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.4	0.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	1.0	0.2	0.6	0.3	0.0	1.2	0.2	0.6	0.4	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.4	0.3	1.7	0.6	0.6	0.4	0.1	0.4	0.2	0.8	0.1	0.3	2.5	0.4	0.0	0.2	0.1	0.3	0.0	0.2	0.6	0.8	0.4	0.0	1.1	0.3	0.3	0.1	0.2	0.0	0.9	0.1	0.0	0.4	0.5	4.8	1.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.9	0.0	0.0	5.5	1.2	0.6	0.5	0.3	0.0	13.7	0.8	0.9	0.3	5.7	0.1	0.0	14.6	0.9	1.6	0.1	0.0	0.1	6.1	0.6	0.9	0.7	0.0	0.0	19.6	0.0	0.2	0.8	0.0	0.3	0.0	0.5	1.1	0.0	0.2	15.2	17.5	0.0	0.0	0.9	0.3	2.2	0.0	0.2	1.8	0.0	0.2	6.9	4.1	7.5	8.9	0.1	0.0	0.7	0.0	0.7	0.3	0.3	0.0	29.9	0.0	2.0	0.9	1.8	1.6	0.0	0.4	0.3	0.9	0.2	0.4	0.1
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879835-56014169	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.8;lymphoid tissue: 85.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 64.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 198.4;HMC-1: 193.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		770000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	17.2	7.3	3.9	79.2	4.0	73.8	9.2	7.4	8.7	11.0	7.8	14.2	36.3	6.2	4.8	8.6	10.0	23.5	5.4	4.4	5.5	5.9	14.9	28.2	49.2	9.4	7.2	3.6	9.5	6.3	4.8	23.5	8.3	5.6	13.3	8.9	17.0	9.7	1.6	3.7	31.6	14.2	7.2	85.4	13.3	3.1	9.0	10.4	10.6	4.4	53.1	29.7	5.7	11.2	47.2	24.6	6.9	0.7	0.5	0.0	43.6	34.6	54.7	21.0	15.7	18.0	15.5	41.2	15.0	12.1	15.3	19.3	22.2	23.8	14.6	70.0	19.8	198.4	6.9	5.5	4.0	20.6	193.4	0.8	7.8	0.6	13.6	13.1	27.2	0.0	98.3	90.2	3.0	3.3	0.1	21.5	38.6	72.9	2.1	3.3	9.6	5.0	9.8	24.9	4.5	74.8	17.3	0.1	7.5	44.9	3.4	41.4	33.1	0.0	10.0	0.1	15.0	26.4	13.2	102.4	1.5	38.8	1.7	4.5	12.2	22.7	1.6	28.3	1.3	15.9	0.3	0.6	10.3	16.1	0.2	0.7	64.4	4.3	49.1	16.2	0.0	5.0	3.9	4.0	7.4	8.7	4.4	5.5	9.4	7.2	8.3	7.2	9.0	11.2	21.0	35.3	37.5	27.7	237.5	5.4	23.8	32.4	4.6	6.3	10.3	7.0	2.2	18.6	44.5	9.2	2.1	2.9	130.0	14.5	0.0	21.8	0.9	14.6	26.2	28.1	6.0	40.4	1.1	53.0	65.2	13.6	18.8	15.9	72.8	0.5	22.9	13.2	126.6	0.0	2.5	14.1	14.2	183.7	96.1	2.4	3.4	226.0	5.4	92.8	182.6	54.3	94.7	13.0	1.7	40.7	13.3	1.2	58.9	62.9	26.0	2.1	40.9	2.6	19.7	3.7	6.4	1.2	2.1	4.9	5.8	38.7	25.0	62.5	17.1	82.4
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"esophagus: 347.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 97.0;Club cells: 378.7;Ionocytes: 71.2;Respiratory ciliated cells: 77.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9;ovarian cancer: 46.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	13	"non-classical monocyte: 440.1"	"Lineage enriched"	"Detected in many"	22	"monocytes: 440.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HaCaT: 2.8;OE19: 1.9"	"Low region specificity"	"Detected in many"							HPA028599	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA028599: AB_10603777"		"prognostic favorable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favorable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.4	15.0	0.0	0.0	0.0	0.0	0.0	347.8	0.3	0.2	2.9	0.0	0.0	0.1	1.3	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	27.0	0.0	0.1	28.8	0.1	0.0	0.0	0.2	23.2	0.0	0.1	2.5	0.0	0.0	26.3	0.0	48.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	33.7	0.4	2.0	0.1	0.2	20.1	0.0	0.2	0.1	0.0	0.0	440.1	1.6	0.1	10.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	97.0	0.0	0.0	0.1	0.0	0.0	0.0	378.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	5.7	0.4	0.4	0.0	0.0	0.0	71.2	1.3	0.0	0.1	0.0	25.3	0.0	0.0	11.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.0	0.0	0.0	22.3	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.2
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1066.8;skin 1: 669.3;vagina: 487.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 158.5;head and neck cancer: 235.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 5.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		7600000	"Cluster 32: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	1.7	3.5	0.7	1.7	0.8	6.6	32.1	0.6	1.0	259.1	1.4	1.1	0.5	7.6	1.8	1066.8	3.5	1.3	1.3	0.7	0.9	2.9	1.2	1.6	2.6	0.7	0.8	8.9	1.3	1.8	2.3	12.3	0.7	11.9	0.7	1.0	183.3	1.3	2.8	669.3	1.6	0.8	0.7	2.1	3.3	1.1	0.8	12.2	1.2	0.2	131.9	55.0	487.0	0.7	38.6	0.6	0.2	0.6	0.3	0.0	15.3	1.5	3.9	1.4	1.9	0.5	42.5	0.4	1.7	1.1	5.6	99.5	0.2	4.4	0.7	0.0	0.3	0.7	4.5	0.8	0.4	0.0	0.9	1.7	37.2	0.2	0.3	1.7	0.0	3.1	0.2	0.1	0.1	114.2	0.9	0.0	0.2	24.3	8.3	0.5	0.0	0.2	1.0	108.2	0.1	0.3	0.5	158.9	1.8	4.7	17.7	0.1	0.0	0.0	0.7	0.5	0.7	0.6	3.0	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.0	1.1	0.1	2.9	1.1	2.6	0.0	5.5	4.7	2.1	0.0	0.0	0.3	0.9	1.2	0.7	0.8	0.6	1.0	0.7	0.9	0.7	0.8	0.7	0.7	0.8	0.7	0.9	0.0	1.1	0.0	1.3	504.7	102.5	161.2	111.0	0.7	66.6	38.0	0.6	2.8	72.6	14.7	0.0	96.5	2.1	0.9	1.9	1.6	0.1	4.5	4.4	7.5	0.0	0.4	0.0	0.2	87.2	18.1	3.6	24.5	5.7	0.5	0.0	0.3	14.0	3.3	0.1	2.2	24.4	0.3	139.8	0.0	0.6	23.2	147.7	0.0	0.7	4.5	0.0	0.0	0.2	4.7	0.2	0.4	0.0	40.4	0.3	0.7	5.7	0.5	0.0	1.5	10.5	0.1	0.9	811.7	2306.1	715.8	9.6	0.5	1.1	642.9
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43785874-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.0;HaCaT: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.1	0.6	2.6	1.4	2.5	0.1	2.9	1.8	6.0	9.3	0.0	2.3	0.1	0.9	1.4	11.4	0.8	1.1	1.5	3.0	2.9	3.0	0.4	4.0	0.7	6.8	3.2	0.4	0.3	0.6	1.6	1.0	6.6	1.3	0.8	2.0	3.1	0.8	0.2	50.6	1.2	1.1	1.7	4.8	1.0	3.8	4.1	0.9	1.4	0.4	1.7	1.9	9.0	4.1	3.5	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.6	0.4	1.2	0.2	0.7	0.4	1.4	5.2	0.0	0.7	0.3	0.6	0.0	0.1	0.4	0.0	1.5	0.1	0.0	1.7	1.5	0.2	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	1.9	1.2	0.0	0.0	0.0	0.3	0.6	0.2	0.1	0.7	0.7	0.0	1.1	0.4	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	2.6	2.5	1.8	6.0	3.0	2.9	6.8	3.2	6.6	1.7	4.1	4.1	0.5	0.0	0.0	4.6	0.0	3.6	2.6	1.6	4.0	1.4	1.8	1.5	0.7	0.0	0.4	0.0	0.0	1.6	0.1	3.7	3.9	0.6	33.0	0.2	0.1	3.1	0.0	0.0	7.7	0.9	8.4	1.2	0.0	0.2	0.0	0.5	0.7	0.0	2.4	0.0	8.8	1.9	0.0	0.6	0.8	81.8	0.3	0.5	17.8	1.0	0.0	0.9	0.0	9.5	7.8	0.3	2.3	1.2	0.0	1.4	0.2	0.0	1.4	0.9	0.0	1.0	0.2	9.9	2.6	3.7	2.8	21.6	0.1	0.1	0.8	6.2
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;placenta: 15.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Early spermatids: 59.7;Inhibitory neurons: 65.9;Late spermatids: 230.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.6;fHDF/TERT166: 48.2;HBF TERT88: 25.0;LHCN-M2: 46.2;RT4: 39.9"	"Low region specificity"	"Detected in all"							HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	1.4	0.3	8.0	0.6	4.6	0.0	9.3	4.5	5.5	0.9	1.2	1.5	1.7	2.1	0.1	0.5	1.6	11.1	0.6	4.7	9.8	2.0	0.3	0.2	0.2	6.8	24.0	0.6	1.9	1.4	0.3	15.7	6.7	1.4	2.5	7.0	0.2	1.3	0.1	0.6	1.4	2.9	5.6	0.6	3.9	6.8	16.1	0.3	0.2	0.1	1.3	2.6	0.4	4.2	0.2	0.0	6.8	37.6	0.0	0.1	0.5	15.0	6.6	18.9	11.7	0.2	3.0	0.0	0.8	48.2	9.1	3.8	5.3	0.1	25.0	0.0	1.7	0.1	9.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.0	0.4	0.3	0.0	0.0	0.0	46.2	6.7	0.0	3.6	5.4	3.2	4.3	0.0	20.1	0.0	2.3	39.9	1.5	6.7	10.1	11.2	1.2	12.2	1.5	0.8	0.0	0.4	5.7	0.5	8.2	0.0	0.0	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.6	4.5	5.5	4.7	9.8	6.8	24.0	6.7	5.6	16.1	4.2	0.1	0.0	0.0	40.8	0.0	0.1	0.6	1.0	1.2	2.7	11.7	6.6	0.4	10.0	2.0	0.0	0.0	0.0	0.0	0.4	3.9	2.6	59.7	1.7	0.4	0.9	0.0	0.0	0.3	0.9	0.2	1.4	10.7	2.5	0.0	0.7	0.4	0.0	0.3	0.0	65.9	2.8	0.0	0.0	0.0	230.4	3.1	0.0	0.0	1.0	0.0	4.1	0.0	13.6	1.0	4.5	0.4	0.4	0.1	2.1	1.7	0.0	0.8	3.4	0.0	0.1	0.2	1.0	5.2	0.7	0.0	0.3	0.1	0.0	2.0	1.7
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 95.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"			"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.3	0.2	3.5	0.4	2.5	0.2	16.4	1.6	5.3	2.8	1.6	1.7	2.6	0.9	1.2	4.1	23.4	37.3	0.0	4.3	4.1	20.5	0.9	1.7	0.4	2.3	7.3	0.4	12.3	16.1	0.4	0.8	3.0	11.1	3.3	1.0	5.8	15.2	0.2	95.5	1.2	0.3	1.9	2.8	41.3	34.1	8.0	0.3	0.2	0.0	1.9	14.2	6.3	2.1	1.4	0.0	0.0	1.5	0.0	0.1	0.1	8.0	1.5	6.6	2.5	1.0	0.0	0.0	0.0	64.8	0.0	14.0	1.5	1.3	20.6	0.0	7.4	0.0	1.9	0.0	0.2	0.0	0.1	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	102.3	24.3	0.0	34.7	2.0	14.6	0.3	0.0	0.4	4.3	3.2	54.7	3.9	0.1	0.4	32.1	0.0	6.3	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	13.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	2.5	1.6	5.3	4.3	4.1	2.3	7.3	3.0	1.9	8.0	2.1	0.5	0.0	2.0	2.3	5.5	29.8	21.0	30.6	6.2	0.0	23.4	17.1	1.4	42.9	23.9	46.0	0.0	0.1	0.1	4.0	7.9	12.4	245.7	5.2	0.3	1.0	2.4	2.7	4.6	19.1	0.7	0.8	87.7	5.7	0.0	0.4	0.0	0.1	0.1	0.0	77.8	3.9	8.2	0.0	2.8	118.5	2.1	0.4	5.4	0.0	0.6	0.0	0.0	0.0	0.4	30.9	6.0	0.0	4.5	40.6	5.7	0.2	21.4	0.0	0.0	0.0	1.3	4.2	1.7	3.5	69.0	0.3	1.1	0.0	3.5	53.7
LYPLA1	"APT-1, LPL1"	ENSG00000120992	"Lysophospholipase 1"	O75608	8	54046367-54102017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 787.7;Late spermatids: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		330000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	25.8	30.3	8.8	31.8	7.6	43.6	45.0	10.5	12.7	23.3	14.7	42.6	44.4	19.7	16.1	55.0	22.9	25.9	40.9	7.9	10.8	63.4	83.5	25.9	49.0	9.9	9.5	11.7	23.8	40.8	8.8	50.4	9.1	35.0	42.1	45.9	35.5	15.0	54.5	41.4	42.8	24.3	9.7	30.2	35.4	65.1	10.3	28.8	28.4	70.7	52.0	63.1	27.5	10.0	124.0	69.3	85.9	78.7	31.0	49.4	109.8	71.7	41.6	65.0	61.1	53.2	116.7	214.8	83.6	47.2	70.5	80.7	122.8	119.9	89.8	78.9	70.0	148.8	37.9	80.0	50.8	91.4	196.1	44.6	103.8	50.8	114.0	55.6	171.6	91.6	154.5	63.4	91.3	32.7	141.1	69.9	129.3	206.3	31.5	85.3	45.2	99.3	100.2	163.6	45.2	77.6	50.1	93.6	113.4	81.0	137.0	81.7	83.4	39.0	56.9	68.7	67.8	89.3	143.8	194.0	52.9	97.1	78.7	93.7	80.7	111.1	44.8	79.6	44.6	73.0	42.2	43.5	92.3	64.4	42.1	41.1	49.3	69.6	108.2	59.7	75.5	98.3	8.8	7.6	10.5	12.7	7.9	10.8	9.9	9.5	9.1	9.7	10.3	10.0	60.4	28.9	53.3	19.9	83.8	61.7	94.8	96.6	82.6	34.9	103.8	64.0	70.8	57.2	71.8	62.5	52.1	199.7	74.5	70.4	303.3	82.8	787.7	86.6	34.7	69.3	57.5	50.0	30.0	89.0	318.3	36.4	74.9	96.3	49.5	31.5	81.4	120.1	121.0	18.5	43.7	77.3	99.7	108.4	83.3	796.2	28.3	82.6	74.7	25.3	102.1	36.9	69.0	20.6	9.8	127.4	63.7	23.0	104.5	171.0	91.6	194.3	62.9	70.3	46.0	24.5	43.1	92.1	239.1	118.2	81.1	334.2	57.0	94.0	90.2	229.7
LYPLAL1	Q96AV0	ENSG00000143353	"Lysophospholipase like 1"	Q5VWZ2	1	219173869-219212865	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 209.4;Proximal tubular cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045806	Approved		Supported	Cytosol		NA	NA		8600	"Cluster 30: Non-specific - Translation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA045806: AB_10966647"	"unprognostic (1.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	9.3	17.9	7.5	3.8	7.6	1.1	10.0	7.8	11.3	8.5	7.2	5.6	8.6	7.3	3.6	7.9	5.4	8.6	36.5	7.3	8.5	42.3	27.3	7.0	8.6	7.9	7.5	9.8	7.6	11.8	5.8	8.2	7.9	13.2	5.9	6.5	8.5	6.5	7.4	9.6	7.5	7.8	8.0	4.4	6.1	6.5	7.4	5.8	16.2	12.1	7.7	6.0	3.9	8.8	9.1	9.4	4.1	0.0	8.1	16.3	10.3	5.3	5.9	4.8	5.6	4.3	12.9	10.0	13.9	4.5	4.7	4.9	8.6	12.1	7.3	13.7	9.3	5.8	4.9	9.8	32.9	12.6	4.3	19.5	11.1	4.8	12.1	11.3	14.5	9.5	16.8	10.2	11.4	6.1	6.1	10.3	7.8	8.6	15.4	3.3	10.5	17.5	19.9	7.1	10.1	5.6	6.3	16.9	17.7	13.5	16.2	15.6	7.8	4.0	2.0	8.2	6.2	8.7	5.3	6.8	13.5	10.1	9.0	0.9	2.0	1.5	0.8	1.8	1.9	3.3	1.3	1.0	1.8	2.0	2.3	1.8	2.2	1.4	1.8	1.5	1.6	1.3	7.5	7.6	7.8	11.3	7.3	8.5	7.9	7.5	7.9	8.0	7.4	8.8	23.6	25.6	35.5	93.0	37.1	22.2	18.7	75.5	29.0	28.5	23.9	25.4	105.9	31.5	42.0	51.5	8.4	89.5	12.8	10.8	209.4	49.3	40.9	7.7	17.4	16.3	18.6	10.3	50.2	53.2	35.4	29.7	11.7	23.6	17.1	18.5	22.9	39.8	64.8	18.5	51.7	18.0	44.7	26.8	21.2	7.8	27.1	49.3	42.7	79.6	27.1	108.7	20.6	82.9	123.4	37.5	16.9	30.9	15.0	13.0	33.4	349.2	38.2	28.9	13.1	24.8	23.3	36.0	24.8	24.9	29.3	62.5	14.2	26.5	15.8	12.3
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063932	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA063932: AB_2685155"	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	10.7	15.9	11.6	10.3	12.3	14.8	14.1	11.2	12.3	9.4	9.1	13.7	8.6	11.1	14.3	12.3	13.4	10.2	17.4	12.5	12.4	17.4	12.4	10.1	12.8	11.2	11.9	9.9	10.5	22.5	10.7	13.9	11.1	13.2	16.1	9.0	9.8	8.6	21.3	6.2	9.5	11.9	12.5	9.0	13.0	8.7	12.5	9.2	25.2	16.9	10.9	10.7	6.6	12.7	18.4	9.6	32.1	19.7	16.0	24.0	12.8	31.3	22.2	24.0	23.8	8.6	9.6	25.1	29.5	29.6	35.7	16.5	20.6	29.7	30.8	32.0	36.5	39.8	9.9	7.3	24.0	42.6	29.7	29.7	28.2	27.2	36.5	19.4	18.8	27.0	41.8	32.0	27.9	16.5	10.0	15.3	7.6	14.9	12.5	20.7	40.1	18.9	27.2	18.1	35.7	24.2	18.3	11.1	31.1	14.6	15.8	43.0	30.2	15.0	13.2	27.4	44.0	22.9	35.1	13.0	31.6	30.3	28.9	16.4	21.0	14.3	21.5	24.8	23.1	32.6	24.0	28.4	19.7	30.9	26.8	25.1	6.0	27.3	33.9	26.1	24.2	14.8	11.6	12.3	11.2	12.3	12.5	12.4	11.2	11.9	11.1	12.5	12.5	12.7	37.1	41.7	50.3	11.8	47.6	11.9	29.0	43.1	29.0	27.0	37.6	45.7	87.5	27.1	48.3	27.6	16.7	87.6	33.9	31.3	93.9	40.1	66.0	86.2	56.6	30.7	40.7	35.3	17.6	49.4	32.9	35.6	37.2	55.8	32.9	33.9	24.7	27.1	57.8	25.2	19.7	43.4	44.7	35.1	12.9	18.7	30.7	39.9	30.2	15.9	44.8	100.6	44.3	13.0	26.4	40.1	32.8	27.1	30.9	25.9	29.3	68.8	70.6	45.3	52.6	39.2	41.1	57.0	31.6	43.3	16.2	72.4	37.5	81.8	39.8	26.2
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5103629-5260950	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.9	18.8	22.8	14.6	22.5	19.0	19.0	21.4	31.0	16.2	24.0	14.7	7.7	18.1	18.1	13.4	19.1	11.2	20.5	22.3	22.1	14.5	13.6	12.1	22.9	22.7	21.7	27.1	19.4	15.9	20.4	14.2	22.3	12.3	16.2	15.9	13.0	10.2	14.4	17.1	10.4	16.6	22.3	15.9	14.1	16.0	21.8	20.8	19.5	11.0	21.8	16.9	14.2	24.1	28.9	27.4	41.1	32.0	41.3	60.1	37.1	27.1	44.0	36.9	38.0	57.8	19.2	44.7	51.7	35.8	51.6	25.4	58.9	34.2	41.0	79.4	45.9	19.7	20.9	77.4	25.9	52.2	19.2	47.9	53.1	33.1	43.3	34.9	35.8	42.4	64.3	15.2	32.1	15.6	49.6	70.5	39.6	45.9	42.1	49.2	30.8	82.2	38.6	23.4	55.2	35.6	23.8	14.6	65.5	58.6	39.8	44.7	29.5	39.2	26.3	32.9	44.8	22.4	82.4	42.7	19.0	36.6	54.2	1.9	18.8	2.1	11.7	19.8	15.6	31.3	17.5	13.3	34.4	26.2	26.6	24.6	4.3	23.6	17.5	23.0	19.1	17.6	22.8	22.5	21.4	31.0	22.3	22.1	22.7	21.7	22.3	22.3	21.8	24.1	75.6	25.6	16.2	28.4	45.0	73.5	55.6	80.9	25.0	16.4	51.9	48.4	29.1	28.6	33.9	18.4	8.4	49.5	23.0	12.3	31.3	44.1	38.8	26.0	29.3	40.3	32.3	32.0	103.4	43.8	72.2	37.6	11.2	19.0	41.3	39.6	41.7	35.9	65.2	11.8	57.4	26.5	32.6	46.8	93.0	91.7	46.3	31.7	69.4	32.8	74.2	45.1	23.7	80.4	50.8	34.1	15.3	35.3	32.6	108.9	7.2	90.0	26.6	16.8	32.9	32.2	34.8	79.4	78.7	32.1	82.8	47.2	29.5	43.9	38.6	63.5
LYRM7	"C5orf31, FLJ20796, MZM1L"	ENSG00000186687	"LYR motif containing 7"	Q5U5X0	5	131170944-131205428	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 33.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.3;Late spermatids: 209.3;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050053	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA050053: AB_2680999"	"unprognostic (1.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (9.84e-6)"	"unprognostic (6.61e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.20e-1)"	8.3	5.2	5.3	6.8	6.5	6.1	5.4	5.9	7.9	4.0	3.4	9.4	7.6	5.5	2.9	6.4	3.8	3.6	12.2	5.6	6.6	8.4	8.6	3.7	8.5	5.8	5.8	7.0	2.5	8.0	3.0	3.8	6.2	6.0	6.4	8.9	4.0	3.9	27.2	6.8	6.3	5.2	5.1	6.6	5.3	23.0	7.1	7.7	8.3	33.7	6.6	3.9	3.6	8.6	15.1	5.3	7.7	21.0	17.3	16.1	28.1	20.0	4.2	9.7	9.7	13.5	22.5	37.9	23.4	5.5	27.2	20.4	13.5	17.1	17.4	34.3	13.6	20.4	13.7	7.3	7.8	20.7	10.8	10.1	21.7	9.4	20.8	4.3	7.0	19.3	28.1	17.0	12.3	7.9	23.4	17.0	10.2	18.4	9.6	23.0	28.9	28.9	6.8	13.3	17.2	13.5	13.6	11.5	17.7	12.9	19.8	17.0	7.0	20.1	21.8	15.2	26.0	15.9	51.4	50.9	12.5	37.1	16.0	2.5	8.0	6.4	11.9	10.7	16.0	21.0	16.9	14.8	12.4	22.3	22.5	21.8	4.8	13.5	10.8	17.3	13.3	11.6	5.3	6.5	5.9	7.9	5.6	6.6	5.8	5.8	6.2	5.1	7.1	8.6	15.9	3.2	11.2	15.0	28.6	13.8	10.3	19.8	17.1	40.0	13.4	11.4	82.6	12.8	19.6	16.5	20.9	15.1	19.9	21.9	43.0	9.9	161.3	15.0	18.3	16.7	13.1	30.3	20.6	8.9	30.5	17.6	6.1	9.7	17.7	20.0	22.9	28.2	18.1	30.3	27.7	16.3	14.2	18.1	19.2	209.3	27.1	15.3	8.8	8.4	17.5	32.3	27.8	14.6	27.5	8.0	12.3	27.1	15.5	7.7	31.4	28.8	34.4	34.2	0.0	21.0	16.1	135.6	22.2	22.8	18.6	5.5	21.6	21.4	25.4	7.1
LYRM9	"C17orf108, HSD24"	ENSG00000232859	"LYR motif containing 9"	A8MSI8	17	27878314-27894752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 78.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023051	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA023051: AB_10602333"	"unprognostic (1.31e-1)"	"unprognostic (6.20e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.75e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.93e-3)"	19.4	43.9	32.2	5.5	33.4	6.4	18.2	18.9	34.4	17.0	22.8	15.6	7.8	17.4	32.9	6.3	19.0	10.5	16.5	35.8	31.9	32.5	15.6	10.2	12.2	25.8	24.8	26.8	22.8	24.5	27.9	4.7	24.9	16.5	6.0	7.4	14.3	18.9	20.8	15.6	11.2	9.3	23.2	15.6	13.7	18.2	37.5	7.2	34.4	10.9	8.5	12.2	11.1	26.6	1.1	1.3	4.8	5.1	9.5	9.7	6.9	2.2	3.7	1.1	0.6	10.5	2.0	0.6	7.4	2.4	0.7	0.3	0.5	2.4	0.6	7.3	3.4	3.2	0.2	0.6	14.1	0.2	1.6	14.3	4.8	0.5	4.4	4.2	2.5	11.4	1.0	1.2	5.4	6.1	2.2	0.4	2.5	4.6	0.1	2.1	0.2	0.0	8.2	2.3	3.4	3.0	5.8	8.6	11.1	2.6	23.1	1.5	2.8	2.0	1.3	5.9	1.1	3.1	0.6	0.1	2.2	0.8	2.3	5.1	3.0	2.3	5.9	5.6	6.0	7.6	8.1	6.1	3.9	11.2	14.8	10.1	8.0	4.3	7.5	2.5	9.5	6.0	32.2	33.4	18.9	34.4	35.8	31.9	25.8	24.8	24.9	23.2	37.5	26.6	15.4	9.6	9.7	10.7	13.7	6.5	7.4	11.4	5.7	17.8	19.0	23.5	13.3	20.0	5.4	53.3	14.6	18.7	5.3	1.4	78.2	13.6	3.9	10.5	5.4	12.2	9.0	6.1	19.5	23.4	6.7	14.7	6.1	5.6	11.4	14.9	13.2	14.1	10.0	16.8	18.8	6.1	12.2	8.0	12.3	2.2	18.6	7.0	39.2	2.8	15.4	31.5	16.5	9.5	14.5	8.4	3.1	23.3	2.0	5.2	11.9	40.9	16.3	14.5	26.3	11.4	11.8	35.4	39.5	3.4	6.5	4.5	13.2	25.5	8.9	5.3
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	4.9	7.0	7.4	2.7	7.6	1.1	5.6	9.5	10.1	7.2	6.9	6.8	6.1	6.2	4.2	5.0	7.1	3.4	8.6	7.4	7.4	5.4	6.5	3.3	3.2	7.5	7.0	10.9	4.9	9.8	5.5	7.4	7.7	5.6	5.4	9.6	4.9	6.3	13.8	6.5	4.2	5.9	6.6	4.2	5.8	4.2	7.3	6.2	6.2	13.5	3.3	7.2	6.1	7.8	5.0	5.3	11.4	8.9	6.5	7.2	8.9	7.2	6.2	8.4	7.5	3.4	5.9	6.6	8.6	4.6	4.3	8.6	8.9	5.1	6.2	12.8	9.8	3.8	8.7	3.6	10.2	4.0	6.0	10.1	10.9	7.9	11.2	11.3	3.5	14.9	7.7	6.2	5.8	7.9	10.3	5.0	7.2	5.0	6.8	7.2	8.3	3.9	6.1	2.3	13.6	16.6	5.4	16.4	9.5	14.3	10.0	13.4	3.6	6.4	3.5	4.1	9.6	19.6	16.0	3.1	5.5	1.6	6.2	1.6	0.8	1.4	0.8	0.5	0.9	0.7	1.0	0.5	0.7	1.7	1.3	1.4	3.1	1.3	0.8	1.4	1.5	0.3	7.4	7.6	9.5	10.1	7.4	7.4	7.5	7.0	7.7	6.6	7.3	7.8	2.2	0.0	0.5	3.3	0.3	0.9	0.9	0.8	1.8	4.0	4.1	2.0	8.8	0.0	2.8	5.5	6.2	4.6	0.1	3.4	3.9	1.8	0.3	2.9	5.1	2.0	4.2	3.2	3.1	0.6	3.1	3.0	0.0	2.1	0.0	5.0	3.9	4.2	0.6	1.7	3.4	1.7	2.0	0.0	0.8	0.4	4.4	0.2	1.8	1.0	0.1	3.7	0.0	2.5	4.3	2.2	1.1	6.0	0.3	1.1	3.8	8.2	2.4	8.0	0.0	2.5	3.9	2.0	2.7	1.3	1.1	2.9	0.5	3.0	2.7	1.0
LYSMD2	MGC35274	ENSG00000140280	"LysM domain containing 2"	Q8IV50	15	51723011-51751585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 164.4;monocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040460	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nuclear bodies"	"HPA040460: AB_10794874"	"unprognostic (7.71e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.98e-1)"	"unprognostic (4.17e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	11.6	19.7	33.0	22.2	34.0	15.1	8.7	30.9	42.0	10.4	22.3	12.7	15.8	10.7	11.1	8.7	10.9	11.4	7.1	33.8	39.6	11.5	21.1	14.4	29.0	34.1	33.2	8.5	12.9	10.7	22.8	9.5	39.3	9.4	9.7	7.6	7.3	13.8	18.3	5.6	13.6	11.7	32.4	21.3	12.0	11.0	35.0	17.9	8.1	13.1	25.7	12.8	8.8	29.4	14.6	10.6	1.7	13.2	4.4	8.4	0.1	16.8	9.2	20.0	25.8	1.3	13.0	56.9	2.4	9.0	23.1	21.0	11.0	11.1	14.0	55.1	5.4	15.9	8.9	0.2	9.3	38.2	6.9	8.4	22.0	8.2	8.6	9.0	12.1	20.5	0.7	0.0	6.5	21.0	14.8	47.6	4.6	0.6	14.5	23.1	0.2	20.6	19.9	11.5	45.3	11.5	16.2	0.4	29.8	2.5	11.7	28.5	7.8	19.8	11.1	20.9	23.7	0.0	0.0	0.2	10.1	77.4	15.1	0.3	39.5	76.6	29.8	48.8	42.3	47.0	29.1	36.3	33.4	49.7	35.6	29.4	112.5	34.9	62.0	54.4	19.4	40.4	33.0	34.0	30.9	42.0	33.8	39.6	34.1	33.2	39.3	32.4	35.0	29.4	45.7	3.2	4.8	18.3	70.8	19.4	31.2	8.0	20.5	16.7	17.5	23.4	3.3	22.8	6.4	14.7	0.0	1.2	89.1	4.1	25.4	16.7	164.4	2.6	2.8	32.3	79.8	17.2	25.4	18.3	0.8	15.6	15.3	0.9	12.7	4.3	27.8	14.6	38.0	32.0	28.7	16.2	8.2	46.4	24.7	71.2	16.1	49.0	7.2	23.4	97.4	7.0	45.3	15.1	7.3	10.8	17.1	15.8	5.1	38.5	32.6	29.0	9.9	4.1	26.3	14.1	24.0	5.0	8.3	31.7	16.2	0.8	51.3	12.4	21.2	24.6
LYSMD3	FLJ13542	ENSG00000176018	"LysM domain containing 3"	Q7Z3D4	5	90515611-90529584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018024	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018024: AB_2138525"	"unprognostic (4.50e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (5.59e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (1.81e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.46e-2)"	10.4	14.3	4.2	12.6	4.5	11.7	11.6	7.9	6.3	14.2	10.8	12.3	12.8	12.1	5.2	10.2	7.4	13.4	12.0	4.4	5.4	13.6	24.1	13.3	12.6	4.3	5.7	15.0	9.0	18.2	7.5	17.1	4.5	13.1	11.3	11.4	11.5	10.2	9.7	6.3	11.9	11.0	4.4	11.4	9.7	6.0	5.2	12.5	18.0	16.3	12.6	10.6	5.5	6.3	17.5	11.6	14.5	15.4	22.2	22.4	14.3	27.3	29.5	18.6	30.2	9.9	17.6	21.6	11.5	24.1	29.1	8.7	22.5	26.6	36.3	16.0	14.2	16.4	14.2	16.2	23.0	13.9	26.5	16.6	18.4	17.1	28.5	19.9	27.1	13.6	15.9	32.1	21.1	15.5	16.1	8.1	7.1	4.4	19.4	14.8	24.5	31.0	20.5	11.9	4.4	8.8	16.2	12.1	22.6	11.4	14.0	12.9	34.1	11.2	15.8	24.8	20.1	36.2	24.7	18.2	18.9	23.3	17.9	53.7	11.5	18.1	9.2	14.4	14.7	9.6	10.5	11.4	11.2	8.4	14.1	12.3	17.2	18.5	15.3	5.3	12.7	11.4	4.2	4.5	7.9	6.3	4.4	5.4	4.3	5.7	4.5	4.4	5.2	6.3	18.6	35.3	27.1	8.8	22.0	14.3	10.1	9.7	11.4	10.3	20.3	14.6	25.0	7.2	18.0	12.9	4.2	10.2	27.3	16.6	1.9	7.1	1.2	17.1	21.7	15.7	21.6	12.6	13.4	8.1	10.8	20.0	15.8	24.6	26.0	10.6	21.4	32.9	8.7	20.2	13.5	17.3	10.2	16.7	23.5	1.9	16.8	19.2	7.2	10.3	13.5	21.5	11.3	14.6	18.8	7.7	9.2	13.2	41.5	16.4	14.5	12.9	14.5	13.7	19.7	15.9	16.7	7.5	5.5	13.4	16.6	14.0	21.5	10.9	12.0	13.0
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	7.1	5.5	6.3	1.7	6.8	3.1	6.7	6.3	7.1	8.4	6.2	9.7	4.8	9.4	3.4	11.1	8.1	1.5	20.2	6.4	6.0	11.8	11.8	7.6	2.3	5.9	6.4	8.9	8.0	5.7	7.1	2.8	6.2	9.5	3.2	5.2	9.5	4.2	10.3	16.7	7.9	3.8	5.9	8.0	7.8	7.7	7.0	3.9	5.0	5.9	3.8	7.9	9.4	6.8	3.5	3.3	6.5	3.8	7.1	6.4	3.9	3.9	2.7	3.3	4.8	8.2	3.0	3.8	2.3	3.6	5.8	10.1	5.1	6.3	3.8	0.8	9.2	2.5	7.2	5.7	4.1	1.8	4.6	3.7	9.2	3.0	3.6	2.0	4.5	10.9	6.2	4.8	2.2	4.1	4.8	5.1	4.3	9.7	3.7	3.4	4.6	1.9	5.9	9.0	3.7	3.3	7.2	2.2	3.9	8.3	1.5	3.5	5.8	2.7	7.3	3.7	1.7	6.3	9.1	3.1	3.5	4.5	2.9	0.0	1.3	5.3	2.1	1.9	1.7	1.0	3.0	2.6	0.6	1.7	3.5	1.6	0.4	0.7	2.7	3.0	3.2	2.4	6.3	6.8	6.3	7.1	6.4	6.0	5.9	6.4	6.2	5.9	7.0	6.8	7.0	6.4	3.3	4.6	2.5	8.7	8.1	4.6	8.0	8.0	3.5	6.3	12.8	7.2	3.9	3.7	10.4	2.6	4.9	4.4	1.9	4.1	7.3	1.3	3.0	4.8	3.0	6.1	9.8	9.7	2.0	6.8	3.6	1.7	0.0	2.9	3.9	3.4	4.3	10.1	11.4	6.2	6.1	2.2	3.7	8.1	5.3	3.9	1.8	8.4	8.1	11.6	3.1	6.0	7.4	7.2	3.0	6.8	3.9	2.1	3.9	5.3	2.5	10.0	13.1	3.9	5.7	12.7	11.3	8.1	9.1	1.4	2.9	2.2	2.6	3.5
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 126.4;placenta: 149.3"	"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 81.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.8"	"CAB025860, HPA042953"	Supported					NA	NA		3300000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	126.4	68.9	2.7	19.3	3.5	0.9	37.3	2.0	5.1	17.6	8.9	19.9	13.3	8.1	5.7	26.2	23.0	20.2	13.5	2.9	2.4	8.1	44.2	23.8	8.4	3.0	2.2	11.8	4.9	2.3	2.7	149.3	3.1	4.0	20.0	0.3	5.4	11.2	5.0	7.1	17.6	67.1	2.1	61.6	10.5	4.3	3.3	1.7	13.5	27.4	3.0	35.1	6.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	81.6	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	3.5	2.0	5.1	2.9	2.4	3.0	2.2	3.1	2.1	3.3	3.2	5.7	0.0	2.8	8.1	2.1	3.7	0.1	0.0	0.0	0.0	0.5	0.3	4.6	8.6	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.0	0.0	0.2	102.7	0.0	5.3	0.8	0.0	5.7	3.4	0.0	0.0	1.3	0.0	238.8	4.5	807.4	0.0	0.4	0.0	0.0	338.1	10.7	2.3	3.7	86.0	7.2	12.2	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.4	2.7	0.2	0.0	0.0	1.5	0.0	13.1	3.4	6.8	0.0	0.0	1.4	3.3	11.1	1.4	0.7	0.0	0.2
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397083-42410610	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"testis: 52.1"	"Group enriched"	"Detected in some"	46	"Early spermatids: 386.3;Late spermatids: 158.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"OE19: 3.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	158.8	3.1	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYZL6	"LYC1, PRO1485, TKAL754"	ENSG00000275722	"Lysozyme like 6"	O75951	17	35934518-35943713	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	132	"testis: 47.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 387.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025734, HPA053073"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA025734: AB_1853444, HPA053073: AB_2682034"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	47.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	387.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	15.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 119.0;Endometrial ciliated cells: 56.7;Respiratory ciliated cells: 142.2;Spermatocytes: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.2	6.2	7.1	4.5	8.2	6.0	12.4	5.8	10.1	12.4	17.5	5.7	7.0	13.2	15.0	5.5	18.9	6.9	4.6	8.7	7.7	12.0	10.0	9.0	4.7	6.7	7.3	11.4	5.6	14.2	11.7	5.9	6.5	7.9	6.2	15.8	7.2	8.8	2.8	6.0	5.7	8.4	6.6	6.0	5.8	25.4	7.1	30.7	18.9	3.5	5.7	4.7	4.1	6.9	10.1	5.0	7.8	5.1	7.2	17.9	4.0	5.3	10.0	12.2	15.8	2.4	7.5	2.7	3.1	7.5	15.2	6.4	9.5	8.6	15.9	0.2	6.1	2.6	6.7	4.5	9.4	9.9	2.8	9.3	29.6	16.8	10.8	7.8	6.0	16.5	8.9	6.7	5.9	1.6	34.1	9.6	8.1	6.7	4.2	3.7	0.8	10.7	14.7	4.7	5.4	11.0	7.0	6.0	13.2	8.7	7.1	18.3	9.9	4.5	3.1	12.2	7.1	18.3	10.0	0.1	14.3	11.7	3.7	0.0	0.9	0.4	1.3	1.2	1.7	4.3	1.1	1.2	2.3	2.4	1.8	1.7	1.0	1.5	0.8	2.5	2.0	1.6	7.1	8.2	5.8	10.1	8.7	7.7	6.7	7.3	6.5	6.6	7.1	6.9	7.6	28.9	25.2	7.8	10.8	13.5	10.5	14.9	12.0	7.9	16.9	14.9	7.6	11.5	23.6	14.7	14.6	3.1	8.4	3.7	15.6	13.3	119.0	56.7	10.5	10.2	11.4	11.6	22.3	6.9	5.1	13.3	6.1	12.3	8.2	10.1	11.7	13.5	6.6	23.5	9.9	10.4	10.2	7.3	7.0	19.2	9.9	5.3	8.8	5.6	10.8	17.8	7.2	6.6	12.2	5.6	5.6	13.5	11.6	5.9	3.2	23.0	142.2	14.6	13.1	15.7	9.2	170.0	24.1	8.4	9.9	2.1	10.5	14.2	8.9	5.6
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982269-20999032	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	18.4	15.2	9.0	8.9	9.7	6.0	17.3	8.9	10.1	20.1	7.2	20.1	9.9	23.3	4.4	12.6	18.5	9.4	13.4	9.1	9.1	15.8	12.0	16.0	7.3	10.3	9.5	19.5	12.4	11.5	24.7	9.8	10.8	16.2	6.4	3.4	13.0	8.6	14.7	13.6	15.9	11.3	8.1	18.3	13.9	8.2	8.9	6.5	18.8	8.0	5.7	18.1	15.8	9.3	10.3	8.4	12.2	15.0	27.6	18.9	9.6	20.8	14.6	11.6	15.8	4.9	4.2	11.0	7.6	23.4	10.7	13.7	9.3	17.1	4.7	20.5	21.0	11.8	11.8	7.4	14.6	6.4	14.9	17.5	8.5	14.7	10.6	18.4	22.9	10.0	49.8	18.5	13.4	6.3	11.5	6.0	3.8	12.6	9.1	13.4	17.8	4.4	9.2	13.9	11.9	17.9	11.3	19.5	12.4	7.4	9.1	11.7	20.6	27.0	13.3	12.3	11.5	8.0	7.4	3.2	12.2	6.2	13.5	0.0	0.5	0.0	0.7	0.7	0.4	0.4	0.3	0.8	0.4	0.1	0.4	0.3	0.0	0.3	1.0	0.3	0.1	0.5	9.0	9.7	8.9	10.1	9.1	9.1	10.3	9.5	10.8	8.1	8.9	9.3	12.4	12.8	8.6	20.5	7.9	2.2	1.8	3.7	4.0	9.5	7.5	7.6	11.7	5.7	5.2	9.2	6.2	4.1	11.9	10.7	1.9	7.0	0.9	5.5	12.7	10.1	9.1	2.5	14.2	4.9	4.0	10.9	11.2	8.4	5.7	14.7	12.1	8.5	7.7	3.3	13.2	10.0	6.1	8.8	3.5	1.6	8.7	7.1	7.2	14.0	5.0	5.6	5.2	8.0	17.6	6.1	8.9	9.8	9.2	2.3	7.0	7.6	7.3	9.8	0.0	7.0	11.6	4.5	1.5	5.9	3.7	3.6	7.7	10.1	6.7	1.4
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.8;parathyroid gland: 54.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	3.7	1.7	13.1	1.5	11.6	0.1	3.0	0.0	14.8	2.0	0.0	1.3	0.5	2.9	0.9	5.3	1.6	3.5	5.0	14.5	0.6	4.7	0.7	7.0	1.1	0.0	0.1	1.2	1.5	54.2	2.2	6.5	0.3	2.8	0.4	3.5	1.4	1.1	1.9	4.6	0.9	2.5	0.0	0.5	1.4	7.5	2.3	1.9	2.7	2.0	0.5	2.3	1.7	9.2	0.1	0.0	9.7	8.3	0.0	0.0	1.2	5.0	0.1	4.3	3.7	0.3	0.1	11.1	3.5	3.1	1.6	0.2	0.5	0.2	2.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	1.7	0.9	0.1	1.8	0.0	0.6	0.0	11.7	0.0	0.1	14.4	0.0	19.7	0.1	12.2	0.0	0.0	0.0	15.6	0.0	2.7	0.4	14.8	12.9	0.0	0.0	75.0	8.2	0.1	0.4	0.0	5.1	3.5	0.1	1.5	0.1	0.1	23.2	0.1	1.1	50.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	11.6	0.0	14.8	14.5	0.6	0.0	0.1	0.3	0.0	2.3	9.2	3.9	0.0	0.0	1.6	0.0	1.3	0.8	1.0	17.6	1.8	0.3	11.3	4.6	0.0	0.1	0.0	4.2	7.1	0.4	0.0	1.9	0.0	0.5	0.6	1.3	3.2	0.0	0.0	26.2	0.0	2.3	2.4	0.0	0.5	0.0	3.5	0.0	0.0	0.9	20.2	2.9	0.0	2.0	0.0	0.0	0.8	1.2	0.2	19.6	1.9	0.0	0.9	0.0	6.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	18.5	65.7	1.1	15.4	0.2	1.1	7.3	0.1	0.8	1.4	2.5	0.0	0.0
LZTS2	"KIAA1813, LAPSER1"	ENSG00000107816	"Leucine zipper tumor suppressor 2"	Q9BRK4	10	100996618-101007836	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044956	Approved		Approved	"Plasma membrane,Cytosol"		No	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA044956: AB_10795989"	"unprognostic (1.42e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.76e-3)"	69.9	66.0	46.8	14.9	65.5	14.4	63.3	58.0	54.1	74.3	25.8	96.3	17.5	90.3	17.7	41.0	69.2	19.8	58.9	41.2	45.8	51.8	18.0	57.1	12.1	63.7	64.3	78.6	29.5	29.1	43.6	28.5	58.5	69.5	8.9	5.9	44.3	40.6	37.8	48.9	43.0	26.6	49.0	44.4	54.9	36.2	64.1	10.8	57.6	18.0	8.1	84.1	54.4	78.9	32.9	43.1	34.6	59.7	45.0	36.3	70.8	38.7	72.8	31.9	36.0	50.5	26.6	13.1	35.1	52.5	23.0	54.6	21.5	28.2	7.8	12.8	31.9	12.1	46.4	66.3	63.6	6.4	15.2	66.1	20.2	25.1	30.1	67.3	32.8	15.6	38.7	7.3	28.7	31.6	5.8	15.8	38.8	12.6	35.2	74.7	101.3	13.5	24.4	39.3	8.4	62.8	26.3	11.9	99.9	18.6	61.0	51.6	42.1	37.9	42.6	40.5	20.7	14.0	10.2	3.3	64.0	17.7	19.4	0.0	0.7	0.4	2.7	0.4	3.7	2.3	3.4	3.0	1.1	2.9	3.5	3.0	0.3	2.9	0.1	1.8	3.0	1.5	46.8	65.5	58.0	54.1	41.2	45.8	63.7	64.3	58.5	49.0	64.1	78.9	34.7	16.0	10.5	20.2	5.3	13.4	9.0	12.4	19.4	14.4	21.7	20.3	5.2	11.5	9.4	5.5	6.2	18.6	1.9	8.0	7.9	19.1	6.8	7.9	20.5	22.9	16.7	5.0	6.8	12.6	13.2	21.8	14.8	13.0	1.3	38.9	18.5	2.6	22.2	18.5	7.7	17.8	16.2	7.2	9.2	4.1	25.7	8.4	16.0	13.1	4.8	18.9	4.1	9.0	70.3	13.3	7.9	29.3	5.4	18.1	6.5	8.3	6.1	4.0	26.3	21.1	40.7	3.8	15.0	10.8	12.1	47.1	6.0	26.9	15.1	9.7
LZTS3	"KIAA0552, ProSAPiP1"	ENSG00000088899	"Leucine zipper tumor suppressor family member 3"	O60299	20	3162617-3173592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Astrocytes: 17.9;Excitatory neurons: 52.5;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031008, HPA031009"	Approved		Approved	Vesicles		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA031008: AB_10601610, HPA031009: AB_10670162"	"unprognostic (4.09e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (5.92e-8)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.38e-1)"	4.0	5.9	57.3	1.2	80.0	1.8	5.3	57.7	77.9	14.5	1.6	5.9	9.8	7.6	3.6	3.0	10.0	7.5	12.2	67.2	21.5	27.8	7.1	9.5	1.0	25.6	21.1	16.1	30.7	9.5	15.1	2.0	27.2	11.2	2.0	54.0	43.4	7.9	11.8	4.0	9.8	2.6	11.8	2.4	21.1	6.1	23.8	1.4	18.5	4.5	0.7	7.6	6.0	55.5	3.5	3.3	4.6	5.2	6.3	1.8	3.2	3.5	7.5	5.8	8.5	19.2	9.9	6.0	1.9	6.9	7.5	1.7	2.6	3.7	4.4	0.1	3.3	0.2	0.7	15.9	14.2	0.3	1.6	2.3	8.1	8.1	3.1	2.1	0.9	5.5	3.5	1.9	2.8	1.6	0.5	0.7	10.4	8.2	3.2	1.6	1.5	6.6	7.4	1.3	18.1	5.6	2.9	4.0	2.8	6.7	9.5	0.2	5.4	6.2	11.7	2.5	1.1	3.7	0.6	1.8	3.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	80.0	57.7	77.9	67.2	21.5	25.6	21.1	27.2	11.8	23.8	55.5	2.6	19.2	10.3	17.9	1.3	1.5	0.0	3.3	0.0	0.0	7.4	6.3	16.6	0.0	12.9	11.0	0.0	1.6	0.4	0.9	11.7	4.9	0.0	9.7	5.7	1.6	1.8	0.0	52.5	5.1	0.4	3.7	0.0	11.9	0.0	2.2	0.0	0.0	0.3	0.0	27.7	0.0	6.1	0.0	1.1	0.0	0.0	0.5	3.6	3.7	0.0	0.0	0.0	20.6	7.1	8.2	0.0	0.0	0.3	0.0	0.0	11.2	11.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.0	1.6	0.5	1.5	0.6	0.0
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.0"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 16.2;Spermatogonia: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 2.1;RT4: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoli	"HPA045420: AB_10961177, HPA059302: AB_2683972"	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.3	0.2	1.1	0.1	0.7	2.5	0.5	0.0	1.2	2.5	0.8	0.1	0.1	1.1	0.3	0.1	2.6	0.1	0.0	1.1	0.6	1.0	0.0	0.4	0.1	0.0	0.2	0.0	0.3	1.3	1.8	0.1	0.0	0.1	0.0	0.5	0.9	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.4	8.0	1.7	0.6	2.0	0.0	0.3	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	1.2	1.1	0.6	0.0	0.2	0.0	0.2	1.7	0.3	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.4	0.4	0.0	0.1	3.7	0.0	0.5	0.1	0.2	0.0	0.3	3.1	2.2	0.1	0.0	0.0	0.4	3.1	0.0	1.6	0.0	0.0	0.9	0.0	0.0	0.0	0.1	3.8	0.0	1.0	0.8	0.0	1.6	0.8	3.9	0.0	2.0	0.0	2.8	0.4	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.5	0.2	0.0	0.1	1.8	1.4	0.0	0.1	0.0	16.2	22.5	0.0	0.0	0.3	0.1	0.0	0.1	0.1
M6PR	"CD-M6PR, CD-MPR"	ENSG00000003056	"Mannose-6-phosphate receptor, cation dependent"	P20645	12	8940361-8949761	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 859.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034464, HPA040445"	Approved					NA	NA		100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB034464: AB_2139108, HPA040445: AB_2676989"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.98e-1)"	76.6	64.8	79.5	113.9	83.3	104.1	81.5	80.7	95.5	61.5	79.2	78.4	61.1	73.7	63.1	63.3	70.4	74.0	82.0	83.5	85.9	79.1	78.9	97.5	138.8	85.7	83.8	62.8	59.6	95.0	34.0	78.6	86.2	64.9	91.8	73.7	79.2	74.5	51.9	60.4	64.5	81.1	84.0	132.5	74.8	59.7	90.8	105.4	96.4	56.0	125.4	98.0	37.5	96.4	103.6	159.7	103.0	122.0	187.7	86.8	306.2	129.7	159.4	186.2	210.7	176.4	268.4	188.9	48.9	133.0	374.4	160.0	142.7	131.2	218.8	859.9	86.6	331.3	125.0	122.4	213.7	355.6	566.6	126.0	166.3	184.4	232.5	179.2	105.5	123.3	93.0	114.6	165.2	103.7	120.7	142.3	412.8	189.0	72.4	118.0	248.0	108.4	151.9	241.2	26.5	109.9	159.8	159.4	223.9	363.8	39.0	251.3	106.0	156.3	175.1	186.6	193.2	139.3	253.5	201.4	183.2	226.4	120.5	706.9	292.0	319.1	177.4	477.6	201.5	123.2	210.7	195.5	334.0	111.4	152.7	170.6	44.5	186.3	567.4	205.0	182.3	497.3	79.5	83.3	80.7	95.5	83.5	85.9	85.7	83.8	86.2	84.0	90.8	96.4	49.9	57.7	57.0	13.4	75.2	44.1	73.0	73.1	43.9	46.1	50.1	40.8	10.7	44.3	68.0	31.3	22.9	64.4	107.0	23.4	19.6	91.8	7.9	31.3	36.7	39.6	38.3	60.1	25.9	66.9	71.4	37.2	30.5	33.7	132.3	39.9	37.1	28.3	242.8	55.5	29.0	30.5	40.7	138.9	95.4	7.9	35.1	166.4	67.6	21.5	212.2	35.8	159.6	17.1	22.7	56.1	29.5	32.0	73.7	65.4	25.7	41.8	53.1	37.4	26.3	52.5	43.7	117.5	54.4	51.6	40.5	53.1	96.4	55.8	43.8	68.2
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MET transcriptional regulator MACC1"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 102.4;Glandular and luminal cells: 100.5;Pancreatic endocrine cells: 136.4;Respiratory ciliated cells: 93.4;Urothelial cells: 238.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 98.0;CAPAN-2: 22.2;HaCaT: 66.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	0.6	2.3	1.4	1.3	0.6	1.0	4.3	1.0	1.4	2.9	0.0	2.7	9.8	0.8	0.7	8.8	0.9	2.9	0.2	1.0	0.3	6.6	0.4	5.4	0.9	1.1	0.7	0.1	3.3	0.4	0.3	0.2	1.4	1.0	3.2	0.6	5.6	2.6	0.1	2.9	11.7	0.3	0.2	0.8	4.9	0.5	0.9	0.6	1.1	0.0	3.5	3.9	3.0	1.3	98.0	0.4	0.4	0.0	0.1	0.2	0.9	0.1	0.0	0.0	0.0	21.6	22.2	13.8	1.0	0.0	0.1	66.9	0.2	0.9	0.0	0.1	0.4	13.0	0.3	0.0	0.0	5.5	0.4	0.0	0.7	0.0	0.1	0.2	0.1	0.3	14.2	6.5	0.1	8.1	0.0	1.4	1.0	19.1	0.1	0.0	0.6	10.5	16.5	6.7	0.3	0.5	0.0	7.5	0.1	0.4	3.9	0.2	0.4	0.2	0.2	0.1	0.2	20.1	1.0	5.0	0.1	0.7	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	1.4	0.6	1.0	1.4	1.0	0.3	1.1	0.7	1.4	0.2	0.9	1.3	4.1	70.5	57.4	0.7	6.5	2.8	75.8	11.3	2.8	3.3	22.2	7.5	0.6	24.3	102.4	40.5	2.1	0.8	2.2	16.9	7.9	51.4	2.9	59.6	16.3	4.1	38.7	4.2	1.0	63.8	0.2	5.7	18.3	100.5	12.6	0.4	2.2	0.8	4.4	1.7	2.9	19.5	34.6	0.9	3.8	1.2	2.1	11.0	1.8	0.0	8.4	0.3	1.0	0.0	0.9	136.4	20.4	2.6	6.3	72.8	40.2	17.5	93.4	1.3	0.0	0.8	3.6	0.4	0.6	13.2	4.0	0.3	2.9	0.3	17.5	238.8
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MACIR	"C5orf30, FLJ25291"	ENSG00000181751	"Macrophage immunometabolism regulator"	Q96GV9	5	103258763-103278660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Inflammatory response, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 37.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.6"	"Cell line enhanced"	"Detected in many"		"BJ: 177.1;fHDF/TERT166: 108.5;U-138 MG: 115.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043434	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA043434: AB_2678480"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.59e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.83e-2)"	8.0	4.1	21.6	4.4	24.3	31.4	9.9	22.0	33.6	3.5	17.8	22.6	9.6	2.2	3.1	4.8	6.1	8.1	4.0	24.2	20.5	5.8	1.0	3.8	2.7	22.5	23.0	4.6	8.0	11.3	4.0	7.6	22.0	6.5	21.7	20.8	3.2	5.0	8.4	5.9	11.7	3.4	22.5	4.3	13.2	5.9	24.4	4.1	5.2	3.4	2.5	2.8	2.7	32.9	10.6	22.2	21.8	12.9	12.0	14.2	13.9	177.1	50.1	21.4	19.5	1.4	23.2	0.1	17.1	108.5	12.6	12.2	12.6	15.1	33.5	30.1	20.6	18.0	28.3	7.1	6.1	9.1	11.4	10.9	19.5	8.7	17.1	38.3	12.8	13.2	9.1	24.2	24.8	13.5	5.2	13.2	14.9	5.7	13.6	26.4	14.5	38.7	9.2	10.1	23.0	21.2	6.3	11.7	45.2	15.4	24.3	10.3	33.6	115.6	9.5	24.8	29.9	13.6	22.6	19.6	14.5	5.1	45.7	37.6	3.6	6.2	3.4	3.2	2.9	4.1	2.8	3.6	3.5	2.0	2.5	2.4	3.2	7.3	3.7	2.0	7.3	3.0	21.6	24.3	22.0	33.6	24.2	20.5	22.5	23.0	22.0	22.5	24.4	32.9	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	22.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	103.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	21.5	0.5	0.0	0.0	0.0
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"Mono-ADP ribosylhydrolase 2"	A1Z1Q3	20	13995369-16053197	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 13.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	1.9	3.1	3.9	2.2	8.4	1.2	2.8	2.3	4.7	3.1	0.1	1.3	0.7	5.0	2.3	1.4	7.3	2.8	1.1	4.8	2.8	3.9	1.8	10.9	4.0	3.3	3.6	2.9	2.9	2.5	2.2	1.1	3.7	4.7	1.3	4.9	1.3	9.9	1.5	2.7	0.9	4.0	2.1	5.0	2.3	5.1	7.3	1.8	2.6	0.6	5.3	4.5	1.2	4.3	1.0	0.4	3.0	1.2	0.8	0.7	0.5	0.3	2.1	1.2	0.7	0.4	0.7	2.0	15.5	1.4	2.6	1.5	0.3	0.7	1.9	1.0	0.9	1.2	1.2	2.4	3.4	0.3	0.3	1.9	1.3	0.0	0.5	1.1	1.1	0.2	1.4	19.1	3.1	0.5	0.5	0.8	0.9	7.1	0.6	1.2	0.5	4.0	2.2	8.4	10.6	1.9	1.6	0.2	0.6	1.1	1.0	1.8	0.7	1.4	3.2	0.3	0.0	0.7	0.3	2.1	0.9	1.0	1.7	0.1	0.5	0.5	0.2	1.2	0.2	8.9	0.2	0.2	0.4	13.2	0.2	0.3	3.4	0.1	1.6	0.2	0.0	0.5	3.9	8.4	2.3	4.7	4.8	2.8	3.3	3.6	3.7	2.1	7.3	4.3	1.6	51.3	203.8	349.7	18.3	4.5	49.8	1.4	5.2	94.0	7.6	6.9	5.9	11.5	37.5	12.9	39.6	7.1	0.1	1.8	9.8	11.9	35.4	8.6	2.5	3.0	1.2	0.4	752.7	1.6	0.4	4.6	9.2	6.7	1.3	7.6	7.1	4.8	0.9	8.4	1058.5	4.5	0.0	0.3	2.1	62.2	3.4	0.9	3.6	87.1	0.0	10.2	0.0	672.0	301.4	6.6	1.7	17.7	2.8	6.2	2.4	8.6	9.8	20.3	6.6	2.1	6.0	23.7	18.8	5.8	6.7	2.1	0.9	13.2	2.8	5.4
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MACROH2A2	H2AFY2	ENSG00000099284	"MacroH2A.2 histone"	Q9P0M6	10	70052544-70112282	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 12.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	3.8	3.2	5.3	5.6	4.5	1.9	10.2	7.3	6.3	14.7	3.3	10.8	9.5	18.3	11.6	17.4	16.5	8.7	13.5	4.1	4.9	15.2	5.2	5.6	4.9	3.8	3.9	13.3	7.8	14.9	14.0	2.1	3.7	13.1	10.5	3.2	10.9	14.4	6.5	10.7	10.1	15.3	3.6	2.7	8.6	11.8	4.2	7.4	10.2	8.6	7.2	13.2	11.8	4.4	4.7	31.1	173.9	111.5	2.5	5.1	0.1	8.6	0.3	16.2	11.0	0.5	55.8	0.0	23.5	2.8	9.1	27.4	15.3	44.8	5.1	81.1	63.4	0.0	0.2	59.1	11.2	1.9	0.8	8.1	30.4	6.4	8.5	23.4	0.0	6.3	0.1	0.6	15.7	37.5	0.2	0.9	74.8	0.2	44.9	0.4	0.5	0.6	30.7	34.0	137.0	132.4	28.6	0.2	0.0	35.2	41.5	20.3	0.0	0.3	32.3	12.4	6.2	0.4	0.1	0.3	0.0	0.2	0.3	1.6	2.4	0.8	0.6	5.4	1.1	0.3	0.9	0.8	12.6	0.3	0.8	0.9	1.4	1.1	3.0	0.2	0.5	1.6	5.3	4.5	7.3	6.3	4.1	4.9	3.8	3.9	3.7	3.6	4.2	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 316.9;Late spermatids: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	9.4	6.0	6.2	11.1	8.3	14.9	9.0	4.6	8.4	11.4	5.1	7.7	6.0	9.3	2.5	9.2	7.4	4.8	8.8	5.6	6.7	6.5	6.4	10.2	17.8	7.8	6.6	7.4	5.6	4.1	7.1	5.0	7.6	8.2	3.4	4.0	7.3	5.6	13.6	14.5	9.7	5.3	5.5	18.2	6.6	10.7	7.0	15.3	8.6	5.0	10.7	8.3	10.1	9.4	37.2	15.5	16.5	30.1	11.1	11.2	26.5	25.6	13.0	26.0	20.7	28.5	21.5	23.4	10.4	14.7	39.9	28.5	12.4	18.3	15.7	11.1	17.8	30.1	19.4	45.0	15.7	21.1	55.1	13.9	13.3	28.8	14.0	6.3	14.9	13.7	30.3	17.4	10.3	45.4	8.7	61.0	30.7	5.8	20.5	38.5	16.7	17.5	12.7	18.7	10.7	33.4	20.0	24.9	65.2	11.2	17.1	48.9	17.6	21.8	60.0	62.3	26.0	30.3	31.4	27.3	18.1	60.6	80.3	60.4	36.2	25.4	71.3	62.4	66.6	54.6	69.2	72.3	63.4	63.0	92.0	66.0	8.6	22.7	60.1	26.0	131.5	53.6	6.2	8.3	4.6	8.4	5.6	6.7	7.8	6.6	7.6	5.5	7.0	9.4	9.3	3.2	10.4	12.1	33.8	17.6	13.9	14.0	15.4	8.3	6.2	6.5	7.4	14.3	11.9	7.3	10.4	16.2	35.7	12.4	15.6	12.3	316.9	5.5	6.7	10.7	32.4	19.1	20.9	11.4	16.3	11.4	11.7	6.9	41.8	15.5	6.4	36.4	39.6	23.5	24.4	9.4	16.2	31.4	84.1	685.9	12.5	28.2	37.4	21.5	25.7	24.3	47.4	16.1	32.4	16.5	7.9	10.5	14.9	9.4	5.4	15.2	6.6	13.9	19.7	11.2	10.2	60.3	33.8	9.3	21.5	24.5	43.1	17.5	8.8	9.7
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055623-120066858	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.9;lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	0.3	0.4	0.5	2.1	0.6	5.9	1.2	0.8	0.7	0.5	0.2	2.2	1.8	0.7	0.3	1.6	1.4	0.4	0.5	0.5	0.5	0.4	0.5	0.4	4.0	0.4	0.4	0.5	0.2	0.4	0.1	1.4	0.5	0.6	2.6	1.0	0.3	0.5	0.2	1.0	1.9	0.8	0.4	0.8	0.9	2.3	0.4	5.7	0.4	0.2	3.6	0.7	0.5	0.6	27.2	11.6	26.9	17.5	2.8	3.4	11.5	21.0	11.8	21.5	16.5	15.7	16.3	39.6	6.8	7.6	9.5	7.1	27.1	16.1	30.0	18.8	18.8	22.0	10.5	14.9	0.8	36.3	12.0	1.9	2.3	14.6	9.1	5.4	12.6	16.4	26.7	22.0	11.4	12.0	35.0	15.6	18.3	14.1	13.0	17.8	35.9	16.2	8.7	10.3	28.4	20.1	10.5	12.8	6.5	12.9	8.4	13.0	7.8	14.2	16.1	14.6	27.0	20.1	23.2	25.7	13.3	18.4	19.1	0.9	0.1	0.1	0.4	0.1	0.6	0.5	1.2	1.0	0.1	0.4	1.1	1.1	0.3	0.9	0.2	0.7	1.3	0.5	0.5	0.6	0.8	0.7	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.6	2.4	0.0	1.3	1.0	11.5	17.3	7.3	23.5	4.0	9.7	7.2	8.3	3.4	1.5	6.0	7.3	2.1	52.0	7.6	7.5	0.0	3.4	2.4	31.3	6.0	5.4	1.8	81.8	1.3	1.5	119.2	13.7	8.6	7.8	15.2	34.6	3.9	2.9	27.9	20.2	1.2	13.7	36.7	7.3	13.4	4.8	4.7	6.1	8.8	0.0	3.1	12.3	5.2	0.5	1.0	1.6	3.7	1.5	33.1	5.0	3.7	7.2	12.9	3.8	13.1	7.3	14.9	127.8	76.2	26.0	8.9	10.8	20.1	11.9	29.2	8.7
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.1;Late spermatids: 522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	25.6	19.5	30.3	22.2	32.0	59.8	25.2	33.2	35.9	23.5	27.6	24.6	11.6	19.3	15.0	14.6	20.4	13.4	26.5	30.2	33.1	37.7	49.8	29.6	27.7	34.9	30.2	21.7	39.9	13.3	22.7	10.6	31.7	22.3	7.5	5.0	28.6	11.2	49.3	23.5	17.1	15.5	31.6	25.2	28.8	64.3	35.3	55.1	15.4	31.5	26.1	23.1	17.8	35.9	62.8	57.2	90.8	106.8	28.6	55.1	37.3	56.5	64.8	110.4	97.8	75.2	59.2	87.6	67.6	58.1	64.4	27.4	115.1	60.1	60.5	133.3	129.6	40.1	87.5	93.4	50.2	80.5	62.7	36.1	60.7	81.0	68.9	41.6	51.4	116.7	165.6	138.3	55.5	94.6	365.6	381.3	235.1	25.9	91.2	245.6	100.2	109.6	40.8	13.5	167.8	118.1	93.6	36.5	168.1	61.2	52.6	172.1	26.8	90.7	114.1	85.6	81.8	109.5	82.0	233.7	67.2	281.5	71.8	45.3	85.2	42.8	82.1	97.3	66.8	58.5	55.4	64.8	100.8	43.8	37.0	54.9	36.7	43.3	86.8	139.1	69.9	92.0	30.3	32.0	33.2	35.9	30.2	33.1	34.9	30.2	31.7	31.6	35.3	35.9	24.8	0.0	5.0	4.2	26.1	38.6	26.5	35.7	18.8	5.7	26.9	26.9	15.9	11.5	14.1	14.7	4.2	18.2	49.6	3.7	50.9	40.8	148.1	8.4	21.6	28.2	34.0	69.5	1.7	76.6	50.7	30.6	12.2	11.4	14.0	17.3	29.6	59.1	41.7	11.8	2.3	10.6	54.9	36.4	88.1	522.5	31.1	32.5	48.0	1.9	82.6	10.8	53.5	4.0	5.5	40.7	4.5	17.0	42.9	35.8	4.5	29.6	6.0	3.5	39.5	25.1	26.5	76.0	40.6	14.3	34.7	8.3	37.7	18.8	8.6	17.6
MADCAM1	MACAM1	ENSG00000099866	"Mucosal vascular addressin cell adhesion molecule 1"	Q13477	19	489176-505343	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.7;lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Endothelial cells: 7.6;Muller glia cells: 5.4;Rod photoreceptor cells: 5.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;Hep G2: 1.8;U-266/70: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB075699, HPA077998"	Enhanced					NA	NA		80000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB075699: , HPA077998: "	"unprognostic (2.30e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.17e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.42e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.07e-2)"	0.9	0.7	2.7	13.9	3.3	0.2	1.1	5.2	5.2	0.6	0.4	6.6	2.8	0.5	0.3	1.5	0.5	2.2	0.5	2.6	2.5	0.6	1.0	0.4	0.4	3.2	4.3	0.6	3.0	2.2	1.7	0.2	3.4	0.8	2.5	0.8	0.6	0.1	0.6	0.5	11.7	0.1	2.2	8.6	2.9	1.6	2.6	0.0	2.0	0.1	0.2	0.6	0.6	4.4	0.3	0.0	0.0	0.4	0.3	0.0	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.9	0.0	0.1	0.5	0.0	0.0	0.0	1.1	1.4	0.0	1.1	1.8	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.6	0.1	1.0	0.1	0.5	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.8	0.7	0.3	0.0	0.4	0.0	0.0	0.3	0.8	0.3	0.3	0.4	0.3	0.2	0.2	0.0	0.6	0.7	0.7	7.0	0.3	0.2	0.2	0.0	0.1	2.7	3.3	5.2	5.2	2.6	2.5	3.2	4.3	3.4	2.2	2.6	4.4	1.4	0.0	0.0	1.0	1.5	0.5	0.5	0.2	2.8	6.8	1.0	1.4	0.8	1.5	0.0	3.7	0.0	0.6	2.2	0.3	0.0	0.2	0.3	0.6	0.9	7.6	0.0	0.4	1.6	0.0	0.3	2.8	1.1	0.3	0.0	2.8	1.4	0.3	0.5	1.7	1.7	0.8	0.0	0.6	0.7	0.5	0.9	0.3	0.0	0.0	0.4	5.4	4.1	1.0	0.8	0.1	0.1	0.7	1.0	0.5	0.2	0.8	0.8	5.6	0.0	0.8	0.8	2.1	2.1	0.7	0.4	0.3	1.5	1.1	0.1	0.4
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 133.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 33.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 33.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	15.1	24.6	32.4	17.7	32.2	28.4	14.8	46.7	44.5	16.1	0.3	17.9	12.4	15.1	12.0	11.1	14.0	12.2	24.6	40.5	21.2	17.1	13.0	19.0	20.9	18.2	18.8	18.8	17.5	18.4	65.7	16.0	22.1	20.7	16.6	133.2	16.6	17.1	30.1	22.8	19.0	14.6	7.0	22.0	18.8	28.5	16.7	23.6	14.4	23.4	17.9	18.7	15.0	32.1	14.0	28.7	30.8	27.6	20.6	14.3	6.9	19.3	25.8	24.2	25.9	21.0	12.9	29.6	6.0	21.3	31.1	27.2	25.2	13.6	20.8	33.1	25.6	52.7	55.0	18.3	14.8	36.1	69.4	13.9	14.3	12.7	15.9	16.4	22.4	18.7	34.5	21.1	21.5	19.7	17.2	38.6	18.4	32.8	19.6	23.2	49.5	19.7	12.4	66.0	48.4	31.5	24.9	29.0	17.6	18.1	22.8	27.0	19.2	22.4	14.1	32.3	13.2	24.9	27.9	16.6	20.9	25.1	21.5	33.3	3.4	6.5	5.6	5.6	5.0	4.0	3.9	4.6	5.2	4.2	4.5	3.6	0.9	5.7	7.9	2.7	7.5	6.2	32.4	32.2	46.7	44.5	40.5	21.2	18.2	18.8	22.1	7.0	16.7	32.1	10.6	12.8	9.2	21.5	11.7	10.7	4.1	6.1	6.8	80.9	11.3	10.2	23.4	7.2	5.8	7.3	125.1	4.6	29.0	21.2	0.0	7.5	14.6	5.3	7.0	11.5	16.3	8.6	37.4	4.9	2.3	7.8	23.4	8.3	26.6	13.9	14.6	7.0	11.5	132.9	33.7	17.7	4.1	19.4	14.9	4.9	7.2	14.9	10.6	21.5	11.1	14.4	23.7	14.1	22.4	12.0	12.2	12.8	17.7	8.0	12.2	5.1	6.2	106.8	6.6	8.7	7.7	14.9	23.2	6.7	8.2	4.4	15.4	16.2	13.7	5.9
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
MAEL	"CT128, FLJ14904, SPATA35"	ENSG00000143194	"Maelstrom spermatogenic transposon silencer"	Q96JY0	1	166975582-167022214	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 159.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1324.3;Late spermatids: 406.1;Spermatocytes: 573.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 3.4"	"Region enriched"	"Detected in single"	5	"thalamus: 1.1"	"Low region specificity"	"Detected in all"			HPA078602	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA078602: AB_2732386"	"unprognostic (1.36e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	0.1	0.2	1.7	0.0	1.9	0.0	0.1	1.2	2.2	0.1	0.9	1.2	0.0	0.0	1.3	0.2	0.1	0.3	5.6	2.1	1.1	1.5	0.3	0.2	0.1	1.2	1.4	0.1	0.2	0.0	0.8	6.5	1.2	0.7	0.0	4.3	0.3	1.0	0.3	0.0	0.1	0.4	1.2	0.0	0.1	159.2	1.6	0.1	0.1	0.3	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	1.9	1.2	2.2	2.1	1.1	1.2	1.4	1.2	1.2	1.6	1.7	0.2	0.0	0.0	8.8	0.1	0.1	0.5	0.0	0.0	1.4	0.1	0.1	4.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1324.3	0.0	0.0	1.3	0.0	0.0	11.5	0.2	0.4	4.8	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	3.9	0.0	0.0	0.0	0.3	406.1	10.8	0.8	0.0	1.0	0.0	45.3	0.0	8.0	3.3	0.0	0.0	10.1	0.0	0.2	0.0	5.6	0.0	1.5	0.0	3.4	0.4	573.7	156.3	0.0	0.0	0.3	0.2	0.2	0.0	0.2
MAF	c-MAF	ENSG00000178573	"MAF bZIP transcription factor"	O75444	16	79585843-79600737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Mental retardation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 407.6;Hofbauer cells: 273.6;Inhibitory neurons: 378.7;Kupffer cells: 394.7;Proximal enterocytes: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 38.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 38.1"	"Group enriched"	"Detected in some"	13	"Karpas-707: 207.0;RPMI-8226: 355.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010296, HPA028289"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB010296: AB_638562, HPA028289: AB_10602024"	"unprognostic (6.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (4.54e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	27.8	15.4	14.6	20.7	14.5	4.0	17.3	10.3	13.5	35.0	14.2	11.4	70.3	23.5	6.0	22.6	20.1	16.7	6.8	13.7	13.0	48.2	25.7	18.8	30.9	19.0	22.6	39.2	3.2	50.8	5.3	36.1	17.6	18.4	10.7	4.7	11.8	15.4	49.6	57.8	83.0	17.8	18.7	26.0	13.0	10.0	28.7	17.9	23.1	19.8	23.9	17.7	30.5	29.8	0.0	0.0	22.4	0.0	0.8	0.0	0.5	2.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.0	0.8	0.7	0.4	0.0	7.2	8.3	0.0	0.0	0.2	1.0	0.1	14.3	0.1	6.4	0.0	0.2	0.0	0.0	0.3	2.4	207.0	1.5	0.1	0.2	0.4	13.5	0.0	0.0	0.1	6.2	355.1	0.0	1.9	0.5	0.3	0.9	0.2	0.6	8.7	0.2	0.0	4.5	0.0	6.9	0.5	0.9	0.0	0.0	0.0	0.9	0.0	1.4	38.1	0.3	0.0	1.1	1.1	8.6	0.0	3.2	2.7	0.1	0.0	0.2	0.5	0.0	0.9	0.3	0.0	4.7	0.6	14.6	14.5	10.3	13.5	13.7	13.0	19.0	22.6	17.6	18.7	28.7	29.8	40.2	9.6	14.6	24.8	10.4	88.3	3.7	30.1	51.2	9.7	8.5	33.1	8.2	57.2	7.7	3.7	0.0	1.7	71.5	18.2	11.7	1.7	1.1	8.1	114.1	42.7	3.0	8.4	5.1	0.8	3.0	73.0	12.8	6.6	22.1	73.0	407.6	63.7	273.6	0.0	378.7	8.9	16.2	394.7	57.9	9.0	149.8	127.2	44.4	122.7	2.7	78.1	40.2	67.3	20.0	4.0	9.9	115.1	48.1	33.9	288.9	146.6	3.0	2.7	13.1	42.7	40.0	1.1	2.0	107.4	141.2	4.2	122.2	28.0	10.1	5.4
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104461-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: AB_2671696, HPA058548: AB_2683751"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	96.2	84.4	86.6	61.7	89.7	164.4	92.4	87.3	98.3	97.1	82.5	186.9	62.1	101.9	63.6	81.8	93.3	63.0	193.4	83.5	82.7	89.8	61.1	78.0	78.6	91.2	87.6	110.3	84.6	87.4	71.0	65.1	86.4	103.6	58.3	35.4	77.5	94.6	413.1	69.6	92.2	80.5	85.3	96.5	102.1	76.4	88.7	90.8	78.6	294.7	69.5	130.7	84.1	90.5	119.8	187.1	85.4	86.3	229.0	113.3	68.9	91.8	151.0	140.5	142.1	69.2	129.1	131.0	150.4	154.9	78.1	71.4	117.4	129.9	103.0	115.4	139.5	144.5	127.8	109.6	154.1	62.0	94.4	100.7	150.0	112.8	211.4	156.7	153.6	94.1	112.5	86.9	85.0	281.2	230.9	112.3	64.0	216.3	490.2	90.3	119.7	141.8	89.0	88.8	123.8	102.2	122.0	156.7	152.6	79.5	106.7	93.9	93.0	65.0	146.0	116.1	117.5	102.7	86.0	62.2	107.8	113.7	44.0	50.4	98.0	126.5	72.8	76.1	81.0	110.2	105.0	117.5	107.6	129.9	110.9	105.0	52.9	93.1	78.4	81.0	84.1	111.9	86.6	89.7	87.3	98.3	83.5	82.7	91.2	87.6	86.4	85.3	88.7	90.5	76.8	16.0	15.6	6.8	95.2	92.9	92.4	51.6	53.5	41.4	76.5	77.8	54.2	42.9	24.8	44.1	14.6	106.4	113.9	82.6	105.7	101.1	86.1	30.0	39.3	69.7	93.3	129.0	5.0	107.9	103.6	66.3	28.5	43.6	32.5	77.3	67.5	29.3	97.6	37.0	5.5	89.7	32.6	72.3	85.6	41.0	88.3	84.9	78.2	6.5	138.0	82.0	138.0	7.1	10.7	106.0	97.4	93.3	60.3	170.3	155.0	110.2	12.9	37.6	98.6	65.5	84.8	96.1	43.3	54.0	89.8	144.3	87.6	72.4	88.5	122.4
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216507	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.9;NK-cells: 21.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 5.6"	"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	102.9	22.8	9.4	12.9	9.0	36.2	69.9	9.3	10.7	37.4	9.4	26.6	8.1	28.8	2.1	53.4	64.2	41.4	53.8	8.2	11.9	32.0	30.8	59.2	4.7	14.5	10.0	53.9	19.7	5.3	19.5	34.5	13.4	39.5	10.3	19.6	28.6	5.5	73.3	45.7	19.6	23.2	10.5	9.3	45.4	3.0	14.1	7.4	25.0	6.9	11.3	53.8	41.4	16.6	20.8	3.3	4.4	6.6	6.9	21.3	20.6	41.4	54.2	19.8	21.0	6.1	16.0	0.7	3.9	16.9	29.5	13.5	1.1	15.7	33.2	3.9	0.6	2.1	2.1	5.2	18.0	1.3	7.1	9.3	25.7	79.2	43.6	17.6	42.1	1.9	4.2	18.6	15.6	4.9	0.8	5.2	3.3	22.0	16.8	1.4	3.8	4.3	19.9	30.6	2.2	3.7	6.1	15.4	104.9	10.7	3.3	1.5	57.9	24.7	19.2	18.8	13.7	7.2	8.0	0.7	37.4	1.4	15.9	23.9	0.4	0.3	2.9	0.7	2.8	0.8	1.7	2.1	1.4	0.5	2.1	1.6	8.7	21.1	3.5	0.2	0.7	1.8	9.4	9.0	9.3	10.7	8.2	11.9	14.5	10.0	13.4	10.5	14.1	16.6	215.4	54.5	43.4	1.0	19.3	125.9	344.1	56.8	169.0	2.9	302.9	214.1	18.6	67.2	49.5	11.0	0.0	37.8	112.5	134.2	7.9	49.9	0.5	284.7	149.3	97.3	104.8	5.7	0.8	24.2	77.5	134.7	132.5	682.0	22.2	11.5	22.1	8.2	26.0	0.0	1.6	112.5	34.6	14.0	131.1	0.4	9.9	113.5	58.7	1.0	10.2	36.0	17.5	1.5	1.3	76.0	181.0	3.8	25.8	258.4	67.6	3.7	37.9	3.6	19.7	265.2	153.1	2.4	1.0	139.5	103.1	479.1	59.0	8.4	75.5	409.2
MAFG	"MGC13090, MGC20149"	ENSG00000197063	"MAF bZIP transcription factor G"	O15525	17	81918270-81927735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025573	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB025573: "	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (3.00e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (9.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.05e-2)"	"unprognostic (5.97e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.54e-3)"	13.5	12.9	24.3	9.8	23.3	40.6	9.6	18.5	26.3	11.1	13.6	17.7	11.1	15.3	5.0	19.2	13.4	10.7	18.6	25.3	26.7	13.0	11.0	22.1	8.0	26.9	28.4	14.0	10.0	13.6	13.0	8.2	33.5	11.6	6.8	4.9	10.5	9.5	44.9	11.8	14.9	10.8	21.3	15.5	15.2	14.0	27.1	7.1	14.6	19.7	6.7	18.3	11.4	21.7	18.2	61.2	13.0	12.9	22.5	17.1	23.1	20.6	21.8	17.2	15.9	20.1	30.7	8.1	20.6	16.0	52.4	21.1	13.9	9.7	11.4	14.3	18.5	37.1	85.5	25.8	33.9	33.4	61.8	14.1	20.7	24.1	22.2	26.9	21.2	16.9	49.9	38.8	17.3	8.0	15.9	37.4	15.6	37.7	21.2	19.9	20.6	15.0	7.6	18.7	22.4	26.7	15.1	18.9	47.1	21.8	8.0	91.0	26.3	37.6	29.9	32.1	27.7	27.2	18.2	12.7	31.0	35.7	49.8	12.2	2.8	1.5	0.2	0.9	0.4	0.7	0.3	0.0	2.3	0.4	0.2	0.3	3.2	0.3	1.1	1.7	0.3	1.2	24.3	23.3	18.5	26.3	25.3	26.7	26.9	28.4	33.5	21.3	27.1	21.7	33.4	22.4	9.8	19.2	19.8	74.4	108.5	12.6	27.3	29.4	63.0	33.8	18.0	32.9	12.4	11.0	22.9	8.8	12.0	52.5	5.9	17.3	88.0	41.1	23.1	53.8	45.2	49.9	14.6	19.8	13.9	47.8	36.2	74.3	18.4	22.0	30.0	16.7	26.5	43.7	14.5	22.3	12.2	50.8	90.1	97.6	24.5	55.2	33.8	12.2	29.1	24.0	2.1	11.1	9.5	29.4	37.6	19.9	11.8	116.6	37.6	12.4	16.6	28.2	13.1	37.2	41.6	8.7	14.1	38.8	89.4	35.3	19.0	12.4	32.4	132.8
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313807	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 731.4"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 267.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enriched"	"Detected in some"	22	"WM-115: 36.6"	"Region enhanced"	"Detected in all"		"white matter: 2742.2"	"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	0.3	1.3	121.5	0.0	366.4	0.0	0.3	314.0	237.4	0.3	4.2	0.1	0.0	0.2	0.0	0.0	4.2	0.0	0.5	157.7	195.2	0.3	0.2	0.3	0.1	459.9	317.3	22.4	0.1	0.0	0.5	0.3	417.5	0.3	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.0	247.8	1.1	0.1	0.6	303.0	0.0	1.0	0.0	0.0	0.2	0.5	731.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	121.5	366.4	314.0	237.4	157.7	195.2	459.9	317.3	417.5	247.8	303.0	731.4	1.2	0.0	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	4.4	4.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	1.9	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.5	0.5	5.4	2.7	0.0	0.0	4.5	21.0	12.8	0.0	1.0	0.0	0.6	0.0	0.0	0.6	0.0	0.1	1.8	1.2	0.0	1.0	0.1	0.0	0.0	0.5	267.8	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	4.3	0.0	0.0	0.3	0.4	11.0	0.0	0.0
MAGEA1	"CT1.1, MAGE1, MGC9326"	ENSG00000198681	"MAGE family member A1"	P43355	X	153179284-153183880	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 4.5"	"Group enriched"	"Detected in some"	36	"Spermatocytes: 26.2;Spermatogonia: 38.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 74.4;HMC-1: 123.9;RPMI-8226: 64.3;U-2 OS: 117.8;U-266/70: 177.4;U-266/84: 305.3"									CAB002620	Enhanced		Supported	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB002620: "						"unprognostic (8.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"				"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	74.4	12.9	0.0	0.0	0.0	123.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.1	0.0	64.3	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	7.8	0.5	0.0	0.0	117.8	0.5	0.7	177.4	305.3	0.1	8.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"placenta: 9.5;testis: 2.6"	"Cell type enhanced"	"Detected in some"		"Sertoli cells: 6.6;Spermatocytes: 57.3;Spermatogonia: 26.2;Syncytiotrophoblasts: 11.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"GAMG: 78.6"					"Not detected"	"Not detected"			"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.2	4.9	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	6.0	0.0	0.4	0.0	12.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	57.3	26.2	0.0	0.0	11.2	0.0	0.0	0.0	0.1
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 20.2;Spermatocytes: 48.7;Spermatogonia: 179.8;Syncytiotrophoblasts: 33.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 19.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 440.0;AN3-CA: 263.1;HMC-1: 496.1;U-266/84: 836.2"									"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	440.0	0.0	0.0	263.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	496.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.1	0.2	4.1	0.0	0.5	132.0	0.0	2.4	105.9	836.2	0.7	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	48.7	179.8	0.0	0.0	33.0	0.0	0.0	0.0	0.0
MAGEA8	"CT1.8, MAGE8, MGC2182"	ENSG00000156009	"MAGE family member A8"	P43361	X	149881141-149885835	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 13.3"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.6;Extravillous trophoblasts: 35.2;Syncytiotrophoblasts: 77.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"U-2 OS: 33.8;U-266/70: 63.6"									HPA003998	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003998: AB_10965020"	"unprognostic (6.81e-2)"	"unprognostic (7.56e-2)"		"unprognostic (1.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	63.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.9	6.3	0.0	0.0	77.7	0.0	0.0	0.0	0.0
MAGEB1	"CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322"	ENSG00000214107	"MAGE family member B1"	P43366	X	30243730-30252040	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 15.5"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 14.2;Spermatogonia: 14.6"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	70	"K-562: 25.1;U-266/70: 53.8;U-266/84: 40.5"									"HPA001193, HPA002820"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA001193: AB_1079296, HPA002820: AB_1079295"															"unprognostic (1.26e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	53.8	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB10	FLJ32965	ENSG00000177689	"MAGE family member B10"	Q96LZ2	X	27807990-27823014	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 2.4"	"Group enriched"	"Detected in some"	12	"Spermatocytes: 7.5;Spermatogonia: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA000611	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA000611: AB_2138307"															"unprognostic (2.77e-1)"			0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.5	10.4	0.0	0.4	0.0	0.1	0.0	0.0	0.1
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	33	"testis: 3.3"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 7.4;Spermatogonia: 13.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB17		ENSG00000182798	"MAGE family member B17"	A8MXT2	X	16167481-16171464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 2.0;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 2.7;U-2 OS: 6.0;U-266/70: 14.8"									HPA003756	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA003756: AB_2250114"	"unprognostic (1.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.04e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.44e-2)"	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.5	0.0	0.0	2.7	6.0	0.0	0.1	14.8	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB18	MGC33889	ENSG00000176774	"MAGE family member B18"	Q96M61	X	26138343-26140736	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046141	Enhanced					NA	NA					"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA046141: AB_2679554"															"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215563-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	60	"testis: 29.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.7;Spermatogonia: 95.8"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	92.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	77.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.5	0.0	14.8	0.2	0.0	89.9	0.3	0.3	149.7	168.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	24.7	95.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0
MAGEB3	CT3.5	ENSG00000198798	"MAGE family member B3"	O15480	X	30230436-30237492	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	114	"epididymis: 17.7;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 13.0;Spermatogonia: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SuSa: 1.3;U-266/70: 2.1"					"Not detected"	"Not detected"			HPA072203	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA072203: AB_2686492"															"unprognostic (3.34e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB4	"CT3.6, MGC33144"	ENSG00000120289	"MAGE family member B4"	O15481	X	30242000-30244187	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	100	"epididymis: 27.2;testis: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA030456	Enhanced					NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA030456: AB_10602707"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB5	"CT3.3, MAGE-B5"	ENSG00000188408	"MAGE family member B5"	Q9BZ81	X	26216169-26218270	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Early spermatids: 6.0;Late spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA052627	Uncertain					NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA052627: AB_2681890"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB6	"CT3.4, FLJ40242, MAGE-B6, MAGEB6A"	ENSG00000176746	"MAGE family member B6"	Q8N7X4	X	26192440-26195646	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 3.1"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 23.5;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"K-562: 4.6"									"HPA041853, HPA076711"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA041853: AB_10796785, HPA076711: "									"unprognostic (2.05e-1)"						"unprognostic (1.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.3"	"Group enriched"	"Detected in some"	9	"Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.1	33.8	65.4	0.1	46.5	44.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	17.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202342-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 19.6"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 84.6;Spermatogonia: 91.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 87.3;U-266/84: 99.8"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.9	3.7	0.0	0.0	0.0	0.2	5.7	0.9	11.3	0.0	0.1	99.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	84.6	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC3	"CT7.2, HCA2, MAGE-C3"	ENSG00000165509	"MAGE family member C3"	Q8TD91	X	141838316-141897832	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 9.8;Inhibitory neurons: 10.9;Oligodendrocytes: 36.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 2.1"									HPA052067	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA052067: AB_2681717"	"unprognostic (3.45e-1)"				"unprognostic (2.39e-1)"			"unprognostic (4.01e-1)"		"unprognostic (2.95e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.35e-11)"		"unprognostic (3.21e-2)"	"unprognostic (4.29e-2)"		0.1	0.0	2.2	0.0	2.4	0.0	0.1	1.6	3.0	0.1	1.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.2	2.2	2.5	0.2	0.0	0.0	0.0	2.5	2.1	0.1	0.0	0.1	0.7	0.0	2.6	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.9	1.0	0.0	1.1	2.3	0.0	0.2	0.0	0.0	0.1	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	1.6	3.0	2.2	2.5	2.5	2.1	2.6	1.9	2.3	5.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	81.6	125.1	102.3	52.8	97.8	31.8	162.6	104.9	112.2	174.5	111.7	106.8	54.3	134.3	101.9	67.4	149.0	94.3	142.2	95.5	121.9	141.0	57.5	85.9	48.0	125.4	118.4	255.9	75.5	148.0	195.3	177.1	128.8	208.8	53.5	74.4	103.3	169.9	88.9	60.5	62.5	140.6	108.5	60.8	77.6	63.1	110.1	68.8	149.2	91.4	46.2	111.7	95.7	108.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	102.3	97.8	104.9	112.2	95.5	121.9	125.4	118.4	128.8	108.5	110.1	108.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MAGED4	"KIAA1859, MAGE-E1, MAGE1, MGC3210"	ENSG00000154545	"MAGE family member D4"	Q96JG8	X	52184823-52192268	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;ASC TERT1: 2.7;Hep G2: 7.7"									HPA003554	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA003554: AB_1853497"					"unprognostic (7.71e-2)"					"unprognostic (8.21e-2)"				"unprognostic (4.07e-4)"	"unprognostic (6.15e-2)"			0.1	0.2	2.0	0.1	1.6	0.0	0.3	0.3	3.8	0.2	0.8	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.1	1.5	3.5	0.1	0.0	0.0	0.0	1.4	1.2	0.2	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.0	0.5	0.5	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	7.7	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	1.6	0.3	3.8	1.5	3.5	1.4	1.2	1.3	1.0	4.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED4B		ENSG00000187243	"MAGE family member D4B"	Q96JG8	X	52061827-52069248	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;pituitary gland: 22.2"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	22	"B-cells: 5.1;dendritic cells: 3.8;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 49.7;NTERA-2: 40.6;SuSa: 43.0"									HPA003554	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA003554: AB_1853497"					"unprognostic (7.75e-2)"			"unprognostic (2.19e-1)"		"unprognostic (2.37e-2)"				"unprognostic (7.01e-6)"	"unprognostic (6.45e-2)"			2.4	3.4	22.1	2.3	22.4	0.3	2.8	4.1	18.6	7.7	2.8	7.1	1.9	10.2	0.9	1.3	6.7	3.7	1.2	17.1	47.2	1.5	0.3	1.2	1.1	16.6	22.1	10.1	3.2	1.4	22.2	3.0	15.7	4.4	1.1	1.8	3.8	2.0	0.2	1.3	3.9	4.6	21.4	1.4	3.1	1.1	40.9	2.3	4.2	0.2	0.9	2.4	4.8	12.5	0.0	2.1	49.7	16.4	13.7	10.3	16.4	28.3	19.8	7.3	14.2	0.0	3.5	0.0	5.6	31.7	17.3	0.0	20.5	0.0	4.2	0.0	3.4	0.0	0.1	24.1	10.9	0.0	6.7	23.7	0.0	15.7	0.5	19.4	14.0	13.4	0.0	0.2	13.0	2.1	5.7	0.0	40.6	0.0	1.4	0.0	29.2	0.0	5.5	0.0	2.1	30.7	0.0	0.0	4.2	43.0	0.0	0.0	1.8	13.6	19.9	0.0	0.0	0.1	0.0	1.1	18.0	0.0	25.0	0.0	0.0	0.0	0.1	0.0	0.3	1.8	1.6	0.8	0.0	5.1	0.0	0.3	0.0	0.1	0.0	3.8	3.7	0.6	22.1	22.4	4.1	18.6	17.1	47.2	16.6	22.1	15.7	21.4	40.9	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MAGEE2	HCA3	ENSG00000186675	"MAGE family member E2"	Q8TD90	X	75782987-75785254	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 1.6"	"Cancer enriched"	"Detected in single"	9	"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA030625	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 56: Bipolar cells - Visual perception"			"HPA030625: AB_10601863"	"unprognostic (5.92e-2)"				"unprognostic (9.33e-2)"			"unprognostic (2.24e-2)"		"unprognostic (6.92e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-3)"	"unprognostic (5.79e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.43e-2)"		0.0	0.7	2.2	0.0	2.2	0.0	0.0	1.7	4.1	0.2	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.2	1.7	2.9	0.1	0.0	0.1	0.0	1.7	1.5	0.4	0.0	0.0	0.8	0.0	1.5	0.1	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	1.7	4.1	1.7	2.9	1.7	1.5	1.5	1.0	2.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MAGEF1		ENSG00000177383	"MAGE family member F1"	Q9HAY2	3	184710364-184712064	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046899, HPA054190"	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Actin filaments"		"HPA046899: AB_2679859, HPA054190: AB_2682411"	"unprognostic (7.36e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.46e-3)"	"unprognostic (2.34e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.59e-4)"	"unprognostic (7.65e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.19e-1)"	16.8	26.9	28.9	16.4	29.3	2.7	24.0	29.6	33.4	33.7	31.3	28.2	17.4	32.4	35.9	20.7	26.1	15.5	26.2	29.1	37.7	36.3	25.4	20.3	21.3	29.0	29.8	27.4	29.3	35.5	56.3	23.1	29.2	30.3	17.1	27.0	25.9	26.8	32.6	22.7	20.3	19.1	29.7	19.1	27.0	12.3	31.8	21.7	29.7	21.7	17.6	27.3	21.7	27.9	86.3	22.3	89.8	56.1	32.0	12.9	61.8	32.1	34.9	53.2	53.3	54.8	31.3	59.1	65.2	29.2	88.1	60.0	46.2	27.7	49.0	96.2	65.1	17.3	32.9	77.4	31.5	27.4	27.4	29.7	34.4	33.9	10.7	25.4	13.0	19.3	30.3	40.0	31.5	108.8	10.4	60.8	56.9	54.6	38.4	29.9	72.6	18.4	39.5	56.4	99.0	94.6	49.5	83.1	77.4	50.0	132.4	10.1	9.1	35.0	61.6	41.1	62.9	82.9	65.6	78.7	27.6	9.8	46.3	0.1	1.4	2.5	1.6	0.3	0.6	2.8	2.2	1.8	5.7	4.7	6.1	3.1	0.2	1.2	0.2	0.4	2.3	0.9	28.9	29.3	29.6	33.4	29.1	37.7	29.0	29.8	29.2	29.7	31.8	27.9	6.5	32.1	25.8	10.4	22.1	18.7	52.7	56.9	30.1	60.3	37.5	33.7	19.2	48.6	33.0	42.3	10.4	103.2	6.0	9.2	146.8	54.3	1.2	27.0	22.3	16.0	49.3	13.2	14.6	41.3	56.4	37.3	27.5	19.0	5.7	36.1	20.3	26.2	68.6	63.9	15.1	46.1	71.2	8.1	36.3	3.9	55.3	10.1	24.9	6.5	32.3	67.3	20.6	13.6	12.6	30.0	22.4	57.2	26.5	44.3	11.2	64.8	30.1	49.2	32.9	30.7	33.4	21.3	8.9	29.6	13.8	60.5	11.4	56.8	32.5	72.3
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452127-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"epididymis: 515.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	20.2	29.9	46.8	17.6	48.2	5.1	18.4	40.9	59.3	29.6	59.4	21.0	10.2	30.9	515.9	10.0	45.3	18.1	24.1	47.1	60.0	25.5	19.6	23.5	22.7	41.9	47.7	36.3	28.1	25.5	54.1	20.9	45.7	48.8	11.5	22.0	18.6	44.3	12.9	11.3	17.1	27.3	45.5	20.4	25.3	33.8	50.3	32.0	28.6	16.9	17.0	17.9	16.7	48.8	0.1	5.7	32.6	0.0	51.5	31.0	0.4	36.0	32.9	9.7	26.0	0.1	7.4	0.0	48.2	36.4	18.4	4.9	12.5	13.5	15.2	42.5	2.0	11.4	0.0	4.6	17.0	0.6	14.1	25.8	1.2	5.6	4.1	9.1	15.0	12.0	6.5	43.8	10.8	22.0	30.8	9.8	9.3	0.0	6.8	19.1	4.1	24.0	17.9	0.0	0.2	24.5	0.0	9.5	15.5	24.4	4.7	8.5	17.7	13.3	15.4	8.2	1.9	25.9	35.1	4.9	24.8	15.8	17.2	14.0	9.0	20.5	21.5	14.3	19.4	18.9	35.4	24.6	13.7	17.9	48.2	30.5	1.2	18.9	18.5	28.5	52.1	19.0	46.8	48.2	40.9	59.3	47.1	60.0	41.9	47.7	45.7	45.5	50.3	48.8	24.9	6.4	14.4	4.9	18.3	8.0	7.8	20.0	5.2	36.7	8.0	14.1	10.4	18.6	12.5	12.9	10.4	2.8	15.7	1.9	13.7	32.2	1.6	2.8	33.5	29.0	15.8	3.0	14.2	10.7	2.0	42.9	3.1	1.9	12.7	11.1	32.9	14.0	15.0	37.0	17.5	8.4	4.1	3.8	11.2	4.0	47.2	6.2	21.4	6.5	9.3	56.8	23.7	18.6	28.4	4.7	8.8	63.9	39.8	13.7	0.8	20.1	6.7	19.6	26.3	44.5	35.0	1.4	2.7	3.3	6.3	1.6	19.9	19.7	4.6	4.8
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	11.3	5.0	3.7	1.3	4.8	0.0	12.5	6.3	5.9	5.5	3.9	9.7	5.0	6.2	2.0	8.0	5.8	5.3	9.0	4.7	5.3	10.2	13.4	8.8	1.1	3.7	3.8	2.7	12.6	5.9	7.7	5.3	2.6	7.1	4.2	7.0	11.6	4.9	3.8	12.5	6.4	3.1	2.7	11.9	14.7	10.3	4.1	2.0	13.4	4.1	1.8	5.4	7.2	4.9	4.1	2.2	12.3	1.3	2.4	1.7	5.5	7.0	5.9	2.6	4.0	15.1	3.5	0.0	1.0	8.3	2.1	1.2	3.4	2.4	4.1	0.0	1.9	36.1	4.3	10.2	1.5	0.0	1.1	2.7	2.0	8.9	1.8	6.8	6.0	4.7	15.6	0.0	2.8	3.1	0.0	0.0	16.6	12.2	2.1	0.0	3.5	0.9	3.1	13.5	3.9	10.8	2.7	3.3	0.1	8.0	6.4	0.0	1.6	8.2	6.0	2.1	2.9	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.8	6.3	5.9	4.7	5.3	3.7	3.8	2.6	2.7	4.1	4.9	102.8	76.9	29.8	204.7	1.3	22.3	17.7	7.9	26.2	98.3	46.5	37.5	35.6	102.9	22.5	23.9	75.0	20.2	0.5	51.0	3.9	44.3	179.1	35.8	35.5	55.5	36.5	2.7	497.7	31.8	2.4	9.6	47.4	50.8	1.3	78.4	82.5	60.9	4.8	232.2	809.8	40.3	12.2	5.0	3.6	27.0	6.5	1.8	5.4	170.5	0.6	15.2	0.0	368.4	532.1	40.3	25.4	8.6	0.2	14.7	33.2	12.2	40.3	26.4	32.9	7.0	17.5	44.7	12.3	12.7	18.8	5.1	2.7	27.1	26.3	11.9
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017055-79453667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in many"	7	"Astrocytes: 1765.2;Excitatory neurons: 2453.9;Inhibitory neurons: 2438.2;Oligodendrocyte precursor cells: 1208.9;Oligodendrocytes: 4001.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 7.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	4.0	5.9	11.9	1.1	16.4	0.8	3.1	0.0	27.1	4.3	0.0	3.8	1.8	4.1	3.6	2.1	3.9	3.0	2.6	14.1	0.0	5.3	1.4	2.8	0.7	0.7	1.3	8.2	3.3	12.5	6.9	1.2	0.0	8.5	1.6	11.6	1.6	8.1	1.9	1.3	2.0	2.5	0.0	1.9	2.2	3.6	10.8	0.6	6.5	2.3	0.4	4.4	3.0	17.0	0.1	0.6	19.5	0.3	4.0	6.2	0.3	3.5	6.4	0.7	1.0	0.1	0.3	0.1	0.1	2.2	2.6	0.3	1.1	0.1	0.9	1.0	0.8	0.3	0.5	1.1	5.8	0.5	1.0	4.7	0.3	0.4	0.2	3.6	0.9	0.7	0.6	81.9	1.7	0.8	0.2	0.4	4.3	0.7	0.2	0.3	0.2	1.4	0.2	0.3	2.9	4.9	0.8	0.3	1.9	2.9	0.4	0.6	1.1	2.8	1.0	7.6	0.5	0.4	0.0	0.2	1.8	0.1	1.2	0.8	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.9	0.2	0.2	0.3	0.1	0.0	11.9	16.4	0.0	27.1	14.1	0.0	0.7	1.3	0.0	0.0	10.8	17.0	7.9	9.6	12.5	1765.2	0.3	1.0	1.3	0.6	6.2	29.3	3.2	6.7	7.5	4.3	3.3	1.8	20.9	0.4	0.7	1.6	5.9	0.4	25.1	9.1	18.3	5.8	2.4	0.0	2453.9	1.0	0.1	11.0	0.5	4.5	0.0	11.6	2.2	2.0	0.2	47.1	2438.2	1.6	0.0	0.0	0.3	32.5	6.5	1.0	1.8	327.9	0.0	24.5	0.0	1208.9	4001.5	0.4	1.5	19.9	0.5	3.5	1.1	1.7	2.1	23.3	13.1	11.0	12.8	4.8	0.9	1.3	1.0	0.4	0.7	8.9	1.4	0.7
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex subunit"	P61326	1	53226900-53238518	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	51.4	48.5	36.5	59.0	36.5	141.1	51.8	37.8	47.1	41.0	38.4	61.2	53.1	57.2	59.0	48.1	55.9	37.9	43.3	36.6	38.1	53.6	76.4	44.8	85.0	37.5	37.1	49.2	43.8	50.4	34.9	67.9	37.9	39.9	55.5	34.4	44.5	37.4	43.8	42.9	55.2	50.7	37.5	55.2	46.8	32.3	36.8	101.7	51.7	42.5	86.3	62.1	38.9	38.1	207.8	101.0	169.4	150.2	88.1	56.9	197.6	152.3	92.0	202.4	204.5	233.2	97.1	293.5	168.8	93.1	248.4	125.9	228.3	136.7	242.3	197.1	249.6	266.1	127.4	253.3	141.4	459.3	143.3	62.7	95.3	184.4	150.6	77.7	136.8	260.8	279.6	63.8	109.9	169.3	377.2	316.0	310.0	171.1	218.4	256.1	323.2	154.5	109.1	208.3	142.7	115.7	202.0	161.2	250.1	206.8	85.1	330.2	122.0	122.6	167.7	170.7	354.9	93.6	184.8	453.4	109.4	289.5	127.0	31.5	34.8	53.9	49.3	51.9	48.1	47.4	46.9	51.5	50.0	42.9	42.6	44.9	41.9	52.9	50.2	58.6	54.2	32.7	36.5	36.5	37.8	47.1	36.6	38.1	37.5	37.1	37.9	37.5	36.8	38.1	134.5	51.3	47.6	10.1	93.5	144.4	121.3	231.6	99.0	31.0	62.1	85.9	50.6	60.1	106.9	57.0	14.6	206.9	123.5	47.0	178.1	96.2	44.9	123.9	83.7	89.6	54.4	90.9	13.0	84.9	195.4	83.5	46.9	102.2	83.6	78.4	57.8	44.2	116.0	23.5	12.4	89.2	130.2	47.8	103.2	16.1	75.5	80.0	81.8	7.5	102.5	67.2	84.5	10.6	15.1	87.4	70.9	68.1	62.6	92.3	69.0	152.0	100.4	36.4	59.2	93.9	148.1	90.0	67.9	82.7	120.8	241.9	107.6	89.5	87.1	92.1
MAGOHB	"FLJ10292, MGN2"	ENSG00000111196	"Mago homolog B, exon junction complex subunit"	Q96A72	12	10604193-10613609	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 119.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043036, HPA047754"	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"			"HPA043036: AB_2678279, HPA047754: AB_2680148"	"unprognostic (1.16e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.27e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (5.56e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.04e-8)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-2)"	7.7	8.2	7.1	7.1	7.3	7.2	9.2	7.8	11.1	7.5	7.3	8.9	5.3	6.5	11.7	8.0	4.3	4.7	7.7	6.7	6.9	11.2	14.4	5.0	9.4	6.9	6.8	4.0	5.9	7.1	7.3	7.4	6.8	6.8	8.8	4.0	5.1	6.2	3.2	5.6	6.2	7.7	6.9	7.1	6.0	3.4	6.9	11.1	6.4	2.4	12.1	7.0	4.5	7.5	39.4	53.0	55.7	38.7	13.0	17.7	55.0	56.0	16.7	46.0	33.3	69.4	37.4	64.5	8.7	38.1	42.0	21.3	50.2	33.1	59.2	39.4	70.0	53.6	54.4	47.4	16.9	110.0	29.2	12.6	12.5	36.7	22.7	12.9	28.9	76.5	52.7	9.9	42.0	56.9	71.9	72.2	113.7	40.8	47.2	63.1	92.6	39.4	36.7	46.5	15.2	31.3	38.9	43.0	40.6	106.7	20.9	95.8	16.5	26.1	88.3	38.2	82.0	14.2	42.5	128.1	61.3	56.9	72.0	0.5	7.8	3.0	14.2	13.6	15.3	12.1	13.6	15.9	11.6	12.7	15.3	18.7	1.4	20.1	13.1	32.9	13.4	8.3	7.1	7.3	7.8	11.1	6.7	6.9	6.9	6.8	6.8	6.9	6.9	7.5	21.8	19.2	18.8	4.2	27.1	14.1	27.8	61.4	14.8	12.2	22.3	26.8	25.5	17.2	32.7	22.0	8.4	67.5	34.8	13.3	70.5	43.8	9.9	21.1	29.8	24.4	22.7	36.4	7.6	34.3	119.6	30.4	19.4	31.4	24.1	33.6	19.2	38.5	49.6	0.0	7.9	32.7	40.7	14.5	14.1	6.5	18.0	18.5	30.2	5.6	30.8	18.4	30.9	14.1	10.3	25.3	11.3	15.4	26.4	33.5	16.2	48.3	22.3	15.1	26.3	19.7	49.1	24.7	54.3	21.6	13.2	46.8	24.1	17.8	25.5	26.4
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B, SLC58A1"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77825747-77895593	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 145.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049851: AB_2680913"	"prognostic unfavorable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	25.3	22.6	12.9	24.2	19.4	20.8	36.5	17.2	17.4	39.4	14.4	28.3	25.7	27.5	53.7	25.6	25.9	25.1	37.5	13.0	16.4	41.9	71.2	26.8	22.5	20.9	18.5	23.6	31.9	38.4	18.5	36.4	21.9	33.5	27.0	5.2	34.6	28.0	17.1	18.3	26.2	24.3	16.6	23.5	29.4	11.3	17.9	21.0	78.0	21.9	23.5	29.1	18.2	27.0	62.5	34.1	41.7	48.8	75.0	49.3	64.8	66.9	67.4	51.7	56.5	45.6	99.5	45.6	90.9	71.7	53.3	56.4	88.4	50.8	80.0	32.3	55.4	30.6	46.2	42.5	66.6	64.9	31.1	45.3	43.5	64.6	56.7	55.1	74.0	31.2	36.5	123.2	64.7	40.4	36.2	23.9	56.1	64.6	41.3	43.3	72.5	84.7	61.9	45.8	14.1	26.3	91.6	64.8	58.0	43.6	43.8	35.3	75.2	45.6	51.1	71.7	33.2	44.8	103.1	58.1	49.7	60.5	61.0	15.3	12.9	13.7	17.2	19.7	18.4	12.5	15.6	16.6	11.1	10.7	14.9	17.7	11.0	18.6	21.0	22.2	12.8	15.7	12.9	19.4	17.2	17.4	13.0	16.4	20.9	18.5	21.9	16.6	17.9	27.0	50.2	41.7	53.6	9.8	37.3	33.0	55.3	51.6	24.5	5.2	39.1	25.1	53.4	42.9	51.6	40.5	4.2	33.3	43.4	44.8	3.9	35.3	2.2	23.7	38.9	40.7	22.7	33.0	6.1	34.9	59.3	43.7	33.1	58.0	30.4	24.5	43.2	145.6	42.3	1.7	6.3	39.6	32.6	49.8	46.1	2.5	30.7	45.1	33.8	15.9	33.9	17.1	18.6	13.6	28.0	36.2	37.2	27.1	87.4	65.4	31.2	32.0	20.7	5.2	19.7	38.7	31.2	6.6	16.7	36.5	45.6	81.3	36.0	31.2	26.0	69.4
MAIP1	"C2orf47, DKFZp666A212, FLJ22555"	ENSG00000162972	"Matrix AAA peptidase interacting protein 1"	Q8WWC4	2	199955317-200008540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 30.0;Distal tubular cells: 37.2;Ductal cells: 31.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 33.8;Proximal tubular cells: 84.2;Syncytiotrophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064013, HPA072231"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064013: AB_2685175, HPA072231: AB_2732196"	"unprognostic (4.89e-2)"	"unprognostic (7.36e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.02e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-2)"	11.1	16.1	7.0	8.3	7.2	18.7	11.3	10.1	8.4	7.3	6.5	14.4	21.1	7.8	7.4	11.7	9.0	8.1	16.6	7.5	6.5	31.1	46.2	7.4	8.8	6.7	6.5	7.5	10.3	12.2	5.8	9.3	7.3	9.1	13.1	7.2	9.6	9.0	22.2	9.7	16.8	7.5	7.1	8.5	12.6	4.9	6.8	9.3	9.7	16.8	10.4	9.2	8.2	8.6	23.9	21.8	19.3	15.2	16.8	16.9	44.5	21.1	20.2	30.7	29.3	59.5	21.0	15.7	29.6	14.6	25.4	25.8	28.7	22.7	28.8	24.7	32.9	26.4	18.5	54.7	22.6	36.7	18.0	18.1	18.3	20.3	21.9	17.6	19.7	29.9	35.2	19.8	20.2	31.4	27.8	34.0	24.7	25.2	51.6	26.4	22.9	31.6	36.6	30.5	21.8	15.1	21.7	24.4	40.1	24.3	21.6	22.1	17.6	17.9	25.6	15.6	23.7	18.8	23.6	33.7	27.0	21.1	18.7	9.9	12.9	9.4	10.8	12.8	13.3	13.8	10.6	7.7	16.8	14.1	10.0	8.6	2.0	8.9	12.6	13.5	13.9	8.2	7.0	7.2	10.1	8.4	7.5	6.5	6.7	6.5	7.3	7.1	6.8	8.6	11.7	9.6	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.8	14.1	0.0	0.0	5.0	3.7	0.0	30.0	7.0	0.0	37.2	31.4	0.0	10.0	10.2	6.1	0.0	0.0	0.0	28.0	33.8	6.2	0.0	11.9	3.8	12.2	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	21.2	0.0	0.0	1.3	0.0	0.0	84.2	5.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	32.0	4.0	18.3	0.0	0.0
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33485182-33501262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	9.9	6.2	4.7	9.3	4.8	9.2	8.9	5.1	5.7	6.6	4.1	5.7	5.4	7.2	5.1	8.0	5.9	6.5	7.0	4.5	6.4	7.2	9.0	5.6	11.1	5.3	6.3	7.5	9.3	5.9	4.5	7.8	5.8	6.1	6.5	4.0	5.6	5.6	8.4	7.4	5.0	7.7	5.3	6.5	5.4	5.6	5.5	8.8	8.5	8.0	10.8	12.2	5.1	6.0	14.1	19.3	13.2	30.6	15.2	18.1	19.9	25.0	16.2	26.4	24.6	28.5	12.0	49.7	23.8	22.1	22.5	18.3	45.6	27.8	35.0	10.8	12.3	46.9	13.2	25.6	22.9	19.3	27.4	19.1	24.8	34.8	40.4	9.4	19.6	33.5	59.5	27.5	22.0	16.1	68.9	22.4	71.4	34.4	13.2	23.9	20.1	22.2	22.2	23.7	33.6	26.7	15.5	21.1	30.4	16.2	14.7	19.5	17.8	24.9	19.3	32.6	28.9	13.8	16.4	50.4	15.3	39.7	27.0	0.0	2.4	0.6	3.2	5.0	3.6	2.0	3.2	2.8	2.9	2.5	4.0	4.3	0.4	4.4	7.9	3.0	2.6	2.3	4.7	4.8	5.1	5.7	4.5	6.4	5.3	6.3	5.8	5.3	5.5	6.0	12.8	16.0	9.7	3.6	12.8	15.6	15.2	5.6	13.1	5.1	7.9	9.0	12.9	10.0	11.3	9.2	2.1	11.5	7.8	3.9	7.9	10.6	1.8	9.8	19.8	12.7	1.8	15.8	5.8	7.8	15.8	15.8	8.2	10.5	9.5	10.8	5.3	7.3	8.7	10.1	6.0	6.7	6.1	5.3	4.7	1.3	9.0	7.8	1.8	2.8	7.7	2.9	10.3	7.1	4.7	11.5	5.0	7.5	12.1	15.3	4.1	10.2	10.5	5.1	6.6	17.6	14.4	13.8	19.2	12.7	14.9	7.5	9.9	13.8	7.4	12.3
MAL2		ENSG00000147676	"Mal, T cell differentiation protein 2"	Q969L2	8	119165034-119245673	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 259.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 389.9;Distal enterocytes: 433.3;Pancreatic endocrine cells: 329.8;Suprabasal keratinocytes: 455.8;Urothelial cells: 594.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1042.5;HaCaT: 451.8;OE19: 1132.4;RPTEC TERT1: 385.4;SK-BR-3: 1439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043831	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043831: "	"prognostic unfavorable (4.57e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.27e-3)"	14.1	1.8	8.5	10.6	13.4	0.0	65.6	15.3	28.0	41.9	0.0	102.9	64.3	6.7	14.2	259.2	54.4	33.1	2.1	22.2	17.0	85.7	47.0	81.6	1.3	0.0	4.2	0.5	37.4	43.5	35.8	12.0	0.0	26.9	94.2	2.6	62.6	41.2	0.4	121.0	53.0	2.6	0.0	0.4	137.6	12.5	8.3	4.3	147.5	0.1	56.0	69.0	102.6	3.4	1042.5	0.0	1.0	0.3	0.2	0.0	92.9	0.1	2.3	1.2	1.6	87.7	329.0	0.3	56.2	0.0	0.4	451.8	0.8	32.9	0.5	0.9	2.6	0.0	13.8	86.1	0.3	0.6	0.3	0.0	225.5	0.0	34.3	1.7	0.3	0.0	0.2	0.5	0.0	244.9	0.8	0.3	8.2	1132.4	309.2	0.6	0.0	0.7	385.4	257.4	56.7	0.3	17.8	1439.4	2.7	6.8	191.4	3.0	0.0	0.6	3.1	1.3	1.9	5.5	0.8	1.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	13.4	15.3	28.0	22.2	17.0	0.0	4.2	0.0	0.0	8.3	3.4	0.5	112.2	130.8	4.2	2.7	114.7	79.9	59.3	19.9	1.5	118.9	50.7	1.6	90.1	119.7	389.9	0.0	25.0	0.4	433.3	109.5	206.0	0.5	71.8	10.3	3.7	41.9	0.0	62.4	178.6	23.5	4.7	149.9	139.4	14.7	0.0	3.6	44.9	2.9	5.0	9.8	145.9	71.2	0.3	14.3	2.2	0.6	2.3	16.0	3.7	3.6	1.0	0.0	3.5	3.6	329.8	252.9	0.0	1.2	285.4	70.2	19.9	107.5	1.0	0.0	0.0	7.0	1.9	9.7	268.8	455.8	9.3	2.8	0.0	122.5	594.5
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116022	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 368.5;intestine: 235.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 857.8;Ductal cells: 299.2;Pancreatic endocrine cells: 354.9;Paneth cells: 374.4;Proximal enterocytes: 742.2;Urothelial cells: 426.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 8.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"A-431: 267.4;A549: 269.9;CAPAN-2: 347.7;fHDF/TERT166: 380.9;HaCaT: 276.4;PC-3: 158.3"	"Not detected"	"Not detected"							HPA051410	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	17.2	2.9	3.9	17.2	3.7	2.4	13.4	3.6	3.8	58.2	4.7	114.1	235.4	6.3	5.7	368.5	8.4	20.3	18.6	3.6	4.9	7.0	3.1	79.9	6.1	4.1	4.2	2.0	4.4	97.8	2.6	9.3	4.6	18.9	95.1	0.4	40.8	4.2	6.3	43.7	218.8	14.4	4.9	5.0	9.2	9.7	6.9	3.1	28.6	10.8	55.0	98.6	148.1	4.2	267.4	269.9	0.2	0.9	0.1	0.1	0.8	48.5	2.1	0.2	0.2	44.3	347.7	0.6	127.6	380.9	0.1	276.4	0.0	12.6	0.1	0.7	0.2	1.8	7.3	0.1	1.9	0.1	0.6	4.8	13.9	1.2	0.0	0.0	111.9	0.0	0.1	0.4	0.0	10.0	0.0	1.0	0.2	117.8	158.3	0.1	0.1	1.2	30.4	15.3	0.7	0.2	0.2	9.3	0.7	0.4	0.3	1.4	130.9	0.4	0.9	0.7	0.8	0.3	0.4	31.7	0.4	0.4	0.2	8.4	0.4	0.6	0.2	0.2	0.2	0.5	0.5	0.4	0.2	0.5	0.3	0.5	2.5	1.2	0.1	0.4	0.3	0.3	3.9	3.7	3.6	3.8	3.6	4.9	4.1	4.2	4.6	4.9	6.9	4.2	45.1	41.7	185.9	0.3	2.0	16.4	107.2	38.6	3.4	0.0	10.9	6.1	3.2	2.8	64.6	1.8	0.0	0.3	0.4	857.8	0.0	299.2	26.3	3.2	1.8	50.6	17.5	0.0	0.8	66.1	0.1	8.2	2.6	7.6	7.0	0.4	33.9	0.5	8.2	0.0	0.1	51.2	30.5	0.9	3.8	9.7	2.5	2.9	14.2	2.8	1.0	0.1	0.0	0.0	0.0	354.9	374.4	1.2	0.0	187.4	742.2	14.6	19.4	0.1	0.0	1.1	5.6	27.2	1.3	57.9	13.2	0.5	2.4	0.6	97.4	426.0
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048801-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 31.1"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9;stomach cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 44.2"	"Not detected"	"Not detected"							"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.7	1.9	0.2	1.9	0.4	0.6	1.0	1.6	0.7	1.3	0.5	30.6	0.6	2.2	0.2	0.2	0.4	1.4	1.8	2.1	1.5	0.1	0.9	0.1	1.5	1.7	1.2	0.1	0.0	1.5	0.4	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.2	31.1	0.4	1.7	0.2	0.3	2.1	1.9	1.9	0.5	0.1	0.0	0.6	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.2	0.0	4.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	1.9	1.0	1.6	1.8	2.1	1.5	1.7	1.5	1.7	1.9	1.5	0.0	0.0	1.8	37.9	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.9	0.1	7.9	0.1	0.3	0.1	0.0	4.2	11.6	0.0	0.8	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	11.0	9.5	0.0	0.0	0.3	1.8	0.0	0.0	0.0	5.6	0.0	1.4	0.0	76.4	4.9	0.0	13.8	0.7	0.0	0.2	69.3	0.2	0.0	0.0	0.0	0.1	0.2	9.0	4.1	0.1	0.1	0.3	0.0	1.9	9.7	0.0
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	2.6	3.2	2.8	1.6	2.9	2.0	2.2	3.3	3.7	1.9	3.7	2.7	1.0	1.8	2.3	3.9	2.3	1.4	5.1	2.7	2.7	3.1	5.6	2.0	2.9	2.5	2.5	2.6	2.9	2.3	2.0	3.4	2.5	1.6	1.7	1.8	1.9	2.3	6.3	1.8	1.8	1.8	2.4	1.8	2.2	4.9	2.9	1.5	3.3	6.4	1.9	2.1	1.9	3.0	9.2	11.4	8.8	47.8	7.8	5.4	7.6	6.1	5.0	6.2	5.7	19.7	8.1	8.8	7.0	4.4	27.5	8.7	7.9	4.3	7.6	4.2	12.9	5.2	15.0	30.4	5.0	12.2	3.2	4.6	6.5	5.3	5.8	41.5	5.8	8.5	16.5	2.3	7.9	6.4	8.4	37.2	15.1	18.0	29.0	6.5	6.7	12.4	6.1	8.1	7.0	8.5	5.0	8.9	16.1	17.2	4.5	7.3	9.8	5.2	4.0	10.0	12.5	2.6	8.6	14.7	20.6	15.0	17.3	0.7	1.0	0.7	0.8	0.8	1.0	1.0	1.2	1.0	1.0	1.0	1.4	0.9	0.7	0.9	0.7	0.9	1.2	1.0	2.8	2.9	3.3	3.7	2.7	2.7	2.5	2.5	2.5	2.4	2.9	3.0	40.5	38.5	41.7	12.7	32.1	43.7	54.8	58.3	30.1	29.1	38.6	60.8	97.1	37.1	40.0	44.1	16.7	77.6	25.7	22.3	115.4	90.6	168.5	50.2	31.9	38.9	19.2	35.3	14.7	96.3	68.7	44.9	16.3	31.7	14.5	41.5	44.3	106.8	54.0	18.5	16.6	32.5	50.8	26.3	15.1	33.6	49.4	22.3	35.6	8.4	44.5	46.8	30.9	18.6	20.2	73.2	28.2	49.2	34.9	61.2	38.1	117.6	44.6	35.8	32.9	35.6	65.6	82.2	75.2	42.4	44.2	49.8	25.2	61.7	44.4	49.2
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043848-70226972	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 74.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.5;Excitatory neurons: 37.0;Fibroblasts: 38.7;Inhibitory neurons: 42.9;Leydig cells: 96.6;Microglial cells: 45.9;Peritubular cells: 82.0;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.7;HHSteC: 57.2;LHCN-M2: 75.0;TIME: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (2.79e-3)"	17.2	8.2	1.0	1.2	1.2	0.2	15.6	0.8	1.6	30.4	2.3	45.5	8.4	74.5	19.1	21.2	58.5	13.0	15.4	0.7	1.5	2.6	1.2	37.2	0.5	0.7	1.2	49.1	3.7	1.8	0.8	4.3	0.7	7.7	12.3	5.7	9.9	10.8	6.6	9.2	21.6	25.3	0.7	16.1	19.1	7.5	1.8	1.6	8.0	17.1	3.1	32.3	18.5	1.1	0.3	0.0	0.7	0.0	55.7	18.8	1.7	11.1	5.0	2.7	4.6	0.0	1.2	0.0	0.7	2.1	1.5	9.1	0.1	0.8	2.3	0.0	0.0	0.0	15.6	0.1	57.2	0.0	0.0	3.6	0.7	1.7	0.9	19.9	4.9	0.0	0.0	0.5	75.0	0.0	0.0	0.1	7.7	0.1	0.0	0.0	8.8	7.3	24.6	0.0	0.7	0.0	0.1	0.1	0.0	20.8	0.0	0.0	71.0	0.0	1.8	0.1	2.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.6	0.7	1.5	0.7	1.2	0.7	0.7	1.8	1.1	2.0	0.0	1.5	20.2	0.5	6.1	0.5	0.4	0.6	0.8	0.5	10.8	4.3	0.0	0.1	3.7	4.2	0.2	0.2	0.2	0.0	0.1	42.5	0.7	13.7	3.9	0.0	0.0	37.0	0.2	6.6	38.7	0.5	0.5	1.3	0.3	0.4	0.0	3.3	0.0	42.9	0.1	0.0	0.0	17.5	11.4	96.6	13.6	10.6	45.9	0.0	13.8	0.0	11.6	23.3	0.4	0.2	82.0	0.0	0.1	0.0	0.5	0.1	0.5	39.5	4.8	22.4	0.4	0.4	1.1	4.8	0.3	0.8	0.1	0.1	0.1
MAML1	"KIAA0200, Mam-1"	ENSG00000161021	"Mastermind like transcriptional coactivator 1"	Q92585	5	179732822-179777283	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 11.2;hTCEpi: 11.3;SK-MEL-30: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037687, HPA057531"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA037687: AB_10672604, HPA057531: AB_2683458"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (3.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.69e-2)"	14.6	15.8	0.4	2.5	0.6	4.9	14.0	0.6	0.8	17.2	0.4	17.7	3.3	17.8	5.1	15.3	16.9	0.0	12.2	0.3	0.3	11.1	11.0	13.9	1.6	0.5	0.4	20.2	15.2	0.0	12.7	3.0	0.4	15.7	2.6	1.5	13.4	0.0	12.5	16.5	14.7	3.7	0.3	16.2	13.9	9.7	0.4	0.0	14.4	3.7	0.0	15.8	15.4	0.5	0.0	0.0	0.0	0.0	9.3	9.1	0.0	5.9	10.8	11.2	8.1	0.0	0.0	7.1	8.2	0.0	0.0	0.3	0.0	0.0	7.1	0.0	0.0	0.0	8.7	0.0	8.2	0.0	0.1	0.0	11.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.0	0.0	0.2	19.8	10.1	8.9	0.0	9.0	0.1	1.4	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.4	0.2	0.1	0.7	0.2	0.3	0.1	0.5	0.2	0.2	0.7	0.2	0.5	0.2	0.1	0.3	0.4	0.6	0.6	0.8	0.3	0.3	0.5	0.4	0.4	0.3	0.4	0.5	15.0	16.0	9.3	11.8	14.0	25.0	12.1	12.1	20.5	12.5	13.9	15.2	7.2	15.7	7.5	9.2	18.8	10.1	20.8	12.0	1.9	6.4	2.4	10.1	15.6	26.4	9.0	16.2	18.1	6.5	12.0	11.6	13.7	13.9	56.0	14.4	33.5	9.9	13.0	21.9	18.2	11.6	12.2	24.2	26.7	2.3	17.4	16.6	5.4	9.4	19.6	7.9	13.4	18.6	14.8	6.7	6.4	25.2	14.0	12.6	7.7	3.9	6.1	9.4	13.1	11.6	14.1	6.1	10.0	19.7	29.8	9.3	17.1	9.7	12.3	16.0
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 16.8"	"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;NK-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	3.3	3.4	1.5	2.4	0.9	3.2	3.4	16.8	2.1	5.0	0.1	3.8	4.8	6.7	5.3	5.9	5.5	4.1	2.0	2.2	2.8	2.0	2.6	3.8	2.6	3.4	2.3	8.6	6.8	3.3	4.5	5.0	3.4	4.9	3.9	1.7	5.9	4.5	1.7	7.8	4.5	6.0	2.4	3.3	3.4	3.0	2.2	6.0	4.3	2.1	2.3	3.6	5.1	2.2	0.5	8.1	5.4	2.7	2.1	4.4	4.9	1.0	4.4	0.5	0.3	3.2	2.2	1.8	0.4	0.8	0.3	0.1	2.1	1.8	0.3	0.0	1.2	5.9	1.9	0.3	0.4	2.8	8.7	4.3	1.5	0.1	0.9	3.3	15.0	0.1	1.6	0.0	0.3	0.9	0.5	1.2	1.4	3.6	3.5	3.5	0.5	3.6	2.5	11.2	15.7	23.9	0.0	4.2	5.5	4.2	2.3	0.8	13.1	0.6	1.3	0.1	1.7	2.9	3.5	0.1	0.8	9.2	20.2	12.2	1.5	2.9	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.4	0.4	0.4	3.6	3.4	0.9	1.2	0.0	1.2	1.5	0.9	16.8	2.1	2.2	2.8	3.4	2.3	3.4	2.4	2.2	2.2	21.2	3.2	11.5	39.5	3.1	8.0	8.1	4.2	7.4	4.6	12.6	9.3	3.0	11.5	8.7	5.5	18.8	5.8	3.9	13.6	5.9	5.1	3.6	12.6	9.4	11.7	14.9	9.4	60.2	5.1	7.3	5.3	8.6	19.9	19.6	34.4	13.2	17.5	7.5	11.8	125.6	12.1	2.0	22.6	13.3	9.0	4.1	19.6	3.6	355.1	18.3	3.1	1.0	7.5	150.8	3.0	14.0	3.8	2.1	5.7	8.2	6.1	7.2	3.7	0.0	2.9	13.7	0.5	2.2	19.0	13.5	8.2	5.3	8.5	11.0	8.9
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.0;Excitatory neurons: 27.5;Leydig cells: 33.8;Oligodendrocyte precursor cells: 81.4;Peritubular cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 23.3;U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	4.7	2.6	4.9	1.4	5.6	1.6	3.4	0.1	4.6	4.2	0.0	3.1	0.9	5.3	2.2	1.7	5.0	2.4	2.0	4.3	9.3	1.9	1.7	4.8	1.6	1.8	1.3	12.9	3.1	2.0	4.3	1.7	4.4	3.1	1.1	2.9	1.8	6.6	4.5	1.8	1.3	3.1	1.0	1.4	1.9	10.3	11.1	0.8	1.1	1.9	1.0	3.7	2.3	0.1	7.3	2.9	3.8	7.6	10.9	4.1	0.0	6.8	14.3	10.3	23.3	0.0	0.4	0.0	3.4	16.3	8.1	0.2	4.2	3.2	14.0	10.4	0.3	0.1	8.8	0.2	8.1	0.4	0.0	5.6	0.6	11.7	1.4	5.2	2.2	0.6	0.2	0.0	9.9	1.4	0.0	0.1	0.7	0.0	5.4	0.5	14.7	0.4	1.7	0.1	0.9	0.8	2.4	0.2	3.8	0.9	0.2	0.1	2.8	5.5	6.9	36.8	12.2	0.4	0.5	0.2	15.2	2.9	7.6	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.3	0.0	0.2	0.3	0.7	0.1	0.1	0.0	0.0	0.5	0.2	4.9	5.6	0.1	4.6	4.3	9.3	1.8	1.3	4.4	1.0	11.1	0.1	3.3	0.0	0.5	33.0	0.4	3.4	0.9	1.2	0.0	1.5	1.9	0.9	1.9	5.7	0.2	0.0	10.4	0.0	0.1	0.0	1.9	3.2	1.1	1.4	5.2	5.5	3.6	3.2	27.5	2.5	0.0	4.8	0.0	3.3	0.0	5.4	4.6	4.8	0.5	13.5	18.3	0.6	0.0	0.8	20.5	4.6	33.8	2.3	3.6	11.2	0.6	2.2	0.0	81.4	5.0	2.2	0.1	24.0	0.3	3.1	0.0	0.4	0.1	0.6	6.6	2.8	3.4	0.3	0.4	0.2	4.1	0.0	1.9	8.3	0.0	0.4
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		2000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	15.6	11.7	6.7	13.0	12.0	6.3	12.9	8.8	11.6	17.5	7.7	12.5	11.1	16.4	13.7	15.2	14.2	12.3	11.0	7.2	8.5	15.3	21.1	10.8	14.1	1.6	5.0	14.3	36.2	32.9	6.7	21.7	1.6	14.4	12.5	18.2	14.0	13.1	8.4	10.3	11.6	18.0	1.0	12.2	14.2	10.8	6.2	14.7	25.4	10.1	13.8	17.8	7.7	9.8	32.4	13.8	23.2	20.1	29.8	35.7	74.2	26.3	40.9	11.6	10.9	10.7	18.2	24.2	47.4	33.9	10.8	18.7	11.0	22.3	26.0	30.3	16.4	14.4	18.5	11.8	18.1	22.7	31.6	24.2	23.5	17.8	15.5	21.3	35.0	16.7	23.5	36.1	24.5	62.6	14.0	7.2	11.9	16.4	14.4	12.5	50.5	16.7	15.9	43.3	12.6	18.4	26.2	27.6	21.1	30.1	13.8	14.2	33.6	26.0	21.4	18.6	27.2	24.4	18.0	15.9	34.4	17.8	63.1	0.9	1.5	2.6	3.0	1.2	3.6	1.9	2.4	2.5	1.4	1.9	2.0	2.9	1.2	3.8	1.1	2.7	6.3	1.5	6.7	12.0	8.8	11.6	7.2	8.5	1.6	5.0	1.6	1.0	6.2	9.8	40.3	38.5	33.4	71.5	45.1	31.0	34.8	26.7	39.3	63.5	43.3	46.0	101.8	35.8	39.1	44.1	22.9	55.1	52.6	24.7	17.6	32.3	33.1	43.2	52.0	40.6	21.7	43.8	188.5	60.4	236.1	50.7	28.5	54.7	16.4	32.3	42.1	88.7	29.4	43.7	238.0	37.1	20.3	36.2	22.0	22.5	53.7	37.2	40.9	101.2	39.2	51.3	55.6	136.7	149.1	37.5	25.1	65.5	120.2	43.0	28.6	22.1	40.9	42.2	39.5	69.1	53.5	72.9	56.2	53.0	34.5	380.5	45.8	68.3	30.8	47.3
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086985-137109183	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051516	Approved		Uncertain	Vesicles		NA	NA		940000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	25.3	32.2	21.3	12.1	21.2	9.1	25.1	21.1	32.9	22.6	26.3	24.1	15.5	20.7	20.4	32.1	22.0	20.1	27.3	22.4	23.1	31.8	39.6	23.0	15.4	22.6	22.7	28.0	36.0	20.0	32.6	21.4	25.2	26.1	9.9	3.6	34.2	15.2	17.6	32.6	22.9	12.1	21.7	28.7	25.6	28.3	22.9	13.8	27.1	9.9	10.1	22.0	21.9	22.8	22.8	50.7	18.2	49.9	67.0	57.7	57.0	37.9	78.4	48.6	43.7	24.9	67.4	20.0	118.8	64.7	69.2	74.3	11.0	36.3	9.1	27.7	17.3	8.7	41.2	33.2	59.6	16.0	33.1	65.1	66.9	29.1	25.1	67.1	32.4	26.5	24.5	32.7	36.4	45.0	16.7	37.8	23.5	67.3	50.0	9.7	30.6	63.9	41.6	11.3	20.4	18.3	55.2	55.9	38.7	9.6	63.5	31.5	46.5	69.6	25.9	52.9	43.6	13.0	11.1	13.3	84.6	19.9	61.6	17.9	31.2	27.0	32.4	34.4	30.2	19.1	25.1	30.4	36.0	16.4	24.3	25.0	9.0	31.0	42.2	26.6	34.5	32.1	21.3	21.2	21.1	32.9	22.4	23.1	22.6	22.7	25.2	21.7	22.9	22.8	18.8	19.2	27.3	23.5	18.3	11.6	12.6	33.0	12.0	20.7	23.5	21.7	10.3	14.3	21.5	25.8	16.7	53.2	24.3	39.1	7.9	32.0	5.8	21.5	16.4	19.7	30.5	14.3	13.0	32.0	72.4	26.9	23.4	20.3	21.0	47.8	25.0	25.2	32.1	30.3	10.2	28.1	22.4	22.9	17.4	6.8	21.1	21.8	23.2	11.2	29.3	16.0	16.5	6.6	12.8	27.6	25.0	21.8	25.4	9.0	35.9	15.9	24.9	19.3	13.1	19.4	20.2	16.1	28.4	16.3	16.2	45.4	21.5	41.1	25.6	8.2
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25616791-25786206	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	12.5	11.6	13.3	9.4	15.2	2.2	6.2	16.6	16.1	19.6	27.3	10.0	4.5	14.5	7.5	7.0	9.7	18.6	10.1	15.9	16.9	25.4	29.6	9.2	12.4	45.1	23.2	17.3	3.6	24.0	17.1	21.1	26.1	17.6	4.6	11.0	5.7	17.9	4.6	8.1	6.1	19.9	29.4	19.3	7.3	4.2	16.4	10.5	26.0	5.5	9.4	12.3	9.1	37.8	0.1	0.4	30.5	6.4	22.4	17.2	8.6	0.4	5.8	1.4	0.4	0.6	0.2	0.1	0.3	2.3	3.9	0.4	3.0	0.3	0.6	9.8	1.3	0.6	0.5	0.1	2.6	5.2	12.0	108.9	0.5	0.7	0.0	0.4	0.1	1.2	0.1	1.3	0.0	1.6	0.0	5.8	7.8	0.1	0.2	0.6	18.9	0.6	0.2	0.7	17.7	0.6	0.7	4.7	1.5	5.5	2.4	3.6	0.1	0.0	1.6	20.1	0.7	31.7	0.1	0.1	4.6	10.7	1.5	0.3	0.9	0.4	0.3	0.6	0.5	0.2	2.1	0.9	0.3	0.5	4.7	2.7	0.6	0.4	0.8	0.2	0.5	0.7	13.3	15.2	16.6	16.1	15.9	16.9	45.1	23.2	26.1	29.4	16.4	37.8	5.8	3.2	3.2	18.3	2.0	6.6	2.9	3.6	5.2	23.5	1.1	1.5	7.0	4.3	7.3	22.0	54.2	10.6	1.6	0.5	9.8	1.0	0.3	0.4	8.1	8.4	3.0	2.7	72.8	3.8	0.9	23.3	1.1	0.6	2.5	0.3	63.9	57.8	24.8	21.9	65.8	0.1	16.2	19.0	4.3	2.1	27.1	6.8	1.8	39.4	3.3	17.8	3.1	25.1	21.7	1.4	0.3	22.2	2.2	2.0	0.0	23.3	2.2	4.4	6.6	17.0	7.1	0.2	2.9	1.0	5.3	42.7	6.9	0.7	0.2	1.9
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689927-109869625	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.8"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 2117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	11.2	17.0	28.0	13.9	66.1	12.7	11.3	41.4	29.6	13.8	3.8	20.7	30.1	12.0	4.2	8.5	9.0	18.1	3.7	21.7	31.5	17.4	42.4	10.1	15.8	64.5	49.9	9.8	22.2	20.7	0.9	15.3	62.1	9.1	20.8	1.7	6.5	10.2	6.0	7.4	25.7	18.3	39.4	14.1	15.7	9.5	42.8	22.7	14.7	11.5	14.7	16.1	2.7	107.8	23.1	18.6	26.5	11.0	56.2	42.2	97.5	49.3	78.0	26.1	46.7	23.2	37.0	17.4	30.7	63.3	18.5	26.5	14.5	56.0	59.7	16.3	9.7	32.6	13.5	30.7	34.6	15.9	15.5	39.7	25.0	43.4	61.4	37.3	54.5	16.9	8.8	87.0	70.5	13.8	27.6	9.1	20.4	17.9	7.3	10.8	40.0	78.5	34.1	32.8	3.7	3.3	22.6	24.9	16.1	29.1	20.5	17.1	56.4	53.7	21.3	30.1	32.9	48.7	58.7	13.6	41.8	22.4	30.3	4.1	2.0	0.6	1.6	2.8	1.3	1.9	2.8	2.8	1.8	1.6	3.3	2.7	1.6	0.5	4.4	2.0	2.8	1.1	28.0	66.1	41.4	29.6	21.7	31.5	64.5	49.9	62.1	39.4	42.8	107.8	20.9	6.4	8.4	100.9	41.1	17.8	15.8	12.7	29.6	0.6	20.0	9.5	7.6	34.3	14.7	31.3	0.0	19.4	28.9	65.8	1.9	27.1	13.7	10.2	35.8	21.6	24.7	29.2	220.8	35.3	98.0	32.3	45.3	33.3	15.2	19.2	36.8	130.3	18.0	0.0	115.2	35.2	22.4	74.8	24.6	8.3	9.9	47.4	26.6	102.1	39.6	5.9	13.4	46.8	2117.7	28.8	28.4	6.8	84.0	39.8	60.6	24.7	12.1	0.2	19.7	52.6	16.5	16.5	19.9	33.6	23.7	23.7	34.7	14.2	49.6	24.2
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368612	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	49.3	66.1	20.2	23.9	21.1	37.6	49.3	17.7	28.8	52.1	18.6	41.8	25.5	49.3	12.1	29.9	50.5	16.4	55.6	20.0	17.8	52.8	50.0	50.3	20.3	22.8	18.1	58.5	49.1	26.3	56.6	21.1	20.9	49.4	14.9	14.8	37.3	19.5	58.5	36.8	41.6	18.6	17.5	54.7	46.0	34.8	19.8	17.1	64.8	24.5	12.7	45.7	41.5	22.0	11.0	25.5	21.3	15.7	23.8	20.4	27.1	25.3	23.5	12.9	10.9	20.3	38.3	5.7	14.6	18.6	11.8	33.0	11.7	17.1	8.4	30.8	26.1	34.0	58.5	18.1	35.3	23.1	5.7	25.3	17.0	12.3	15.3	27.3	30.9	16.9	20.5	27.4	10.7	22.1	11.9	25.2	9.0	13.2	11.8	16.0	11.0	34.6	16.8	49.8	13.2	22.7	16.4	23.9	11.5	15.6	26.1	26.1	61.5	27.1	18.7	19.0	25.5	27.9	7.1	9.3	17.6	25.9	27.6	4.0	19.8	3.5	9.2	23.0	9.1	3.2	6.9	6.8	22.6	2.6	9.5	6.9	2.2	6.0	18.9	9.2	10.2	14.3	20.2	21.1	17.7	28.8	20.0	17.8	22.8	18.1	20.9	17.5	19.8	22.0	34.1	22.4	51.7	29.0	12.5	13.5	15.2	13.0	11.4	30.7	18.2	16.3	2.8	5.7	19.2	9.2	54.2	17.2	17.2	22.4	3.9	11.4	10.4	10.1	18.3	23.2	34.2	7.6	28.9	8.7	10.9	20.4	39.3	12.7	31.7	46.8	32.5	22.4	20.4	28.6	23.8	19.5	12.2	29.8	20.2	14.0	23.3	26.3	16.0	15.0	31.4	17.3	19.6	18.1	19.5	11.2	20.0	12.4	12.9	16.0	27.9	15.9	19.3	52.4	26.3	25.6	16.3	21.1	10.4	14.9	8.5	21.2	16.2	17.0	24.0	15.3
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MANBAL	dJ1141E15.2	ENSG00000101363	"Mannosidase beta like"	Q9NQG1	20	37289638-37317260	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052348	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA052348: AB_2681795"	"unprognostic (1.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (7.07e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.70e-2)"	51.5	70.5	68.6	23.4	68.2	7.3	51.6	67.3	76.3	67.5	68.8	92.7	35.0	86.1	57.1	64.4	71.6	30.6	43.5	70.0	71.3	57.8	42.0	40.5	16.7	69.4	68.8	66.9	45.5	49.8	57.5	33.2	70.2	77.4	40.1	28.0	45.9	61.8	24.4	58.3	48.7	65.4	68.4	34.2	60.3	42.7	71.9	22.6	55.1	17.9	25.4	81.2	58.5	68.3	66.0	126.5	63.0	63.9	101.0	73.1	54.5	89.9	93.1	85.1	66.6	150.3	87.4	16.9	104.8	109.8	86.7	88.5	60.3	140.2	57.9	12.7	62.5	17.8	51.3	135.3	109.0	19.1	10.8	80.1	97.8	79.3	130.1	85.4	60.2	22.1	29.1	18.1	86.2	77.3	24.0	25.1	50.4	109.6	117.0	14.4	82.7	19.9	81.6	90.3	60.4	68.9	91.1	135.1	76.3	53.7	91.1	30.2	66.6	155.5	58.1	88.6	70.3	24.0	34.9	14.0	111.8	10.4	82.3	12.3	22.8	33.2	14.9	27.0	17.0	24.3	17.9	18.0	21.0	25.6	21.4	20.9	33.8	21.1	21.4	29.2	12.8	16.7	68.6	68.2	67.3	76.3	70.0	71.3	69.4	68.8	70.2	68.4	71.9	68.3	19.9	25.6	27.1	10.1	9.5	30.1	87.3	84.2	33.0	22.7	41.3	47.9	19.6	35.8	42.1	44.1	4.2	97.0	9.1	24.7	39.2	74.5	6.6	23.8	26.6	28.5	30.5	2.1	8.6	109.3	133.4	42.6	23.9	20.4	7.6	31.5	28.9	22.5	30.3	20.2	10.7	36.7	50.8	15.1	20.6	8.0	46.9	12.3	46.2	6.5	18.0	71.4	18.6	13.0	8.4	103.2	48.4	68.4	16.8	96.0	40.9	61.1	29.9	15.4	19.7	27.4	38.7	26.4	43.8	36.5	30.4	76.9	8.4	40.7	34.8	124.7
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577535-95609452	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.8;Plasma cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	11.9	6.9	3.1	7.9	3.6	3.3	8.9	3.7	3.7	8.4	4.2	8.1	8.8	6.8	6.3	8.0	6.4	7.9	5.6	2.5	3.7	12.0	24.0	7.3	9.2	4.3	3.3	9.7	8.4	11.1	2.1	6.3	4.4	7.0	8.7	6.1	5.6	7.9	1.4	6.8	8.8	6.7	3.6	9.6	12.1	6.1	3.7	9.1	11.6	3.4	11.2	9.0	3.5	5.6	6.5	5.3	20.4	16.6	33.1	38.5	7.7	17.7	16.2	10.1	14.8	6.1	16.0	12.3	21.7	11.7	14.9	10.4	14.1	12.0	23.2	20.9	12.6	16.6	4.7	10.2	11.5	22.3	14.4	38.4	13.7	12.0	8.5	14.6	24.3	12.1	26.2	28.1	22.0	4.5	13.1	9.5	3.0	17.1	5.5	15.4	19.9	18.8	15.5	11.2	16.3	8.8	10.0	7.2	6.5	14.3	11.4	20.7	22.0	10.1	7.1	18.4	17.8	20.9	12.9	15.2	18.2	19.1	23.6	8.5	2.3	1.3	3.2	4.1	4.6	4.5	3.9	3.8	2.5	2.3	4.5	3.1	0.5	2.9	3.7	1.0	7.7	2.4	3.1	3.6	3.7	3.7	2.5	3.7	4.3	3.3	4.4	3.6	3.7	5.6	11.6	12.8	8.4	7.8	15.5	7.4	4.4	6.4	8.6	8.1	8.4	7.4	4.5	10.0	7.4	12.9	4.2	5.4	5.4	1.8	5.9	4.1	16.7	7.3	14.4	10.7	1.8	8.2	6.0	7.3	5.6	12.0	8.2	8.1	2.5	17.8	28.2	59.8	11.0	11.8	7.3	4.6	0.0	12.0	5.8	11.7	5.9	7.9	8.8	8.4	6.8	10.5	3.1	16.1	18.7	3.4	2.8	15.8	113.4	3.4	4.8	8.5	8.5	5.3	13.1	9.8	17.1	7.1	12.1	11.8	7.0	1.4	9.2	13.5	5.0	3.5
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"	P55145	3	51385291-51389397	"Plasma proteins, Predicted secreted proteins"	"Stress response, Unfolded protein response"	"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 426.1;Syncytiotrophoblasts: 459.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 109.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		7500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	39.4	36.7	34.4	70.9	34.5	35.3	41.8	37.8	50.5	59.4	44.2	55.4	42.5	48.2	169.3	53.2	42.8	32.1	51.1	34.8	42.7	48.6	109.2	44.3	50.5	38.4	35.7	28.7	81.1	38.8	56.4	59.9	37.2	51.3	58.8	17.7	51.0	50.5	12.4	36.6	39.5	47.2	36.2	56.1	59.5	43.2	37.9	47.7	117.8	20.8	76.1	67.8	35.5	38.1	128.6	61.2	164.7	207.7	107.8	139.4	173.8	200.2	160.6	194.0	184.5	99.6	292.6	271.6	162.6	121.9	449.8	77.7	201.4	200.0	187.3	128.9	92.2	220.2	93.5	230.3	349.8	108.2	137.1	60.6	168.5	201.3	271.7	189.9	252.7	112.3	48.3	299.5	181.6	75.5	184.8	215.6	144.6	298.0	237.6	76.4	105.3	288.7	162.8	86.9	64.4	201.6	165.3	104.2	130.3	175.8	83.7	141.2	129.3	117.4	112.1	140.4	222.6	247.9	105.0	186.5	195.4	217.5	221.2	73.2	15.3	9.4	28.8	13.0	35.5	17.4	20.2	27.5	16.0	12.1	14.9	16.0	8.5	26.0	8.3	109.8	13.4	16.9	34.4	34.5	37.8	50.5	34.8	42.7	38.4	35.7	37.2	36.2	37.9	38.1	55.9	32.1	21.5	5.2	134.1	163.1	223.7	232.5	31.3	15.1	50.5	40.5	69.3	61.5	104.0	55.2	6.2	188.1	142.8	75.7	43.0	172.6	99.0	73.3	101.9	88.3	116.6	26.1	5.8	124.6	387.0	101.2	71.9	99.4	62.9	77.9	79.6	156.1	179.5	11.8	8.5	235.9	118.0	36.1	170.6	123.3	60.0	63.0	181.5	7.5	79.1	39.6	117.4	5.0	9.5	167.8	90.5	51.6	426.1	245.0	47.7	78.9	71.1	19.1	65.7	59.7	194.2	176.8	91.1	42.8	160.5	459.0	94.8	40.6	120.9	202.0
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350242	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"neutrophil: 98.3"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 98.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9"	"Low region specificity"	"Detected in all"							"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	18.9	12.1	3.4	4.3	4.1	3.5	19.5	3.9	6.5	16.9	5.0	22.9	11.7	22.1	11.5	42.3	16.6	10.2	11.2	4.1	3.0	13.2	9.7	12.3	2.3	3.2	3.3	11.3	25.2	11.3	17.9	9.5	3.2	15.1	15.8	5.4	70.0	10.8	4.0	21.7	15.2	12.1	2.6	11.3	21.5	8.4	3.8	1.4	13.8	4.4	6.4	16.3	20.6	4.0	0.3	5.7	1.8	0.1	5.6	5.5	6.2	3.9	4.6	2.0	2.5	4.8	18.2	0.0	4.2	3.9	2.1	0.8	7.1	3.3	1.5	0.0	6.9	8.3	6.4	4.2	0.9	1.4	2.3	3.5	5.3	1.3	0.9	13.8	50.7	0.1	5.6	0.1	0.6	11.0	0.0	0.6	6.5	54.3	3.0	0.2	0.0	0.1	25.9	18.8	2.6	10.3	2.1	16.9	6.0	2.8	15.4	5.0	20.5	2.8	2.3	0.7	5.5	0.4	0.2	2.8	2.0	0.0	2.1	6.6	1.2	1.0	0.1	0.9	0.0	0.2	0.3	0.0	0.6	0.4	2.5	0.4	98.3	0.6	0.4	0.1	0.0	0.6	3.4	4.1	3.9	6.5	4.1	3.0	3.2	3.3	3.2	2.6	3.8	4.0	29.0	9.6	21.2	8.8	3.3	4.0	7.1	7.2	6.2	6.1	21.2	13.5	2.6	28.6	11.9	23.9	8.4	35.4	4.5	33.6	1.9	19.0	0.9	15.1	5.2	28.8	21.7	3.6	16.6	37.9	7.4	10.4	23.0	20.5	2.5	8.6	37.1	9.8	8.0	10.1	13.5	33.4	8.2	5.5	0.7	2.2	13.7	2.0	0.0	15.0	2.7	11.4	9.2	7.5	11.4	16.3	25.2	16.6	1.0	7.4	16.7	3.0	18.1	13.1	0.0	4.8	6.5	2.1	1.5	22.1	4.7	17.0	3.0	9.7	26.5	8.8
MANSC4		ENSG00000205693	"MANSC domain containing 4"	A6NHS7	12	27762427-27780236	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.1;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039454, HPA039682"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"		"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039454: AB_2676515, HPA039682: AB_10805483"	"unprognostic (1.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.50e-3)"	"unprognostic (7.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.10e-2)"	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.6	0.3	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.5	0.3	0.1	0.2	0.2	0.0	0.7	0.5	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	1.5	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 230.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Supported	Mitochondria,Cytosol		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	143.9	27.7	24.7	8.6	27.6	0.4	71.6	26.5	26.6	26.6	13.9	116.4	163.4	24.0	14.1	46.7	39.1	16.9	49.6	22.3	31.7	76.9	119.1	63.5	2.4	26.9	32.5	40.7	39.1	31.4	4.0	30.2	56.4	46.3	117.9	28.2	77.3	35.0	33.5	37.4	230.3	24.0	21.3	6.3	55.9	3.7	41.4	9.9	118.4	34.3	5.3	65.0	38.8	19.0	0.0	3.7	0.6	9.9	162.1	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	4.6	17.2	6.1	22.3	0.1	0.0	2.5	6.9	0.5	18.6	302.9	0.0	16.9	76.1	87.2	0.2	45.2	0.1	20.0	0.0	0.3	0.4	5.7	2.9	0.1	0.8	1.6	20.7	5.0	0.0	0.3	0.5	22.3	131.8	3.1	7.8	0.0	0.0	0.3	0.4	0.5	0.0	8.7	0.0	8.2	0.7	0.0	0.3	0.0	0.0	9.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	27.6	26.5	26.6	22.3	31.7	26.9	32.5	56.4	21.3	41.4	19.0	35.2	70.5	146.9	23.2	4.6	11.0	177.7	32.3	116.7	5.0	13.6	10.2	101.3	94.4	49.3	60.7	22.9	11.5	0.2	248.0	121.3	36.7	25.2	50.4	42.5	43.6	38.0	4.8	4.0	13.4	21.3	24.3	40.2	175.1	5.7	7.3	53.6	193.7	6.6	3.3	5.0	137.5	67.1	12.2	2.1	33.9	5.6	6.7	10.6	21.5	17.1	25.4	0.0	7.5	1.3	49.5	140.5	0.0	2.6	64.6	819.8	569.9	32.8	27.4	6.6	4.4	30.5	1.3	0.8	120.6	14.3	207.0	3.7	3.5	285.1	129.0
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766610-43882450	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 317.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 120.6;granulocytes: 137.8;Hepatocytes: 221.1;Peritubular cells: 95.2;Proximal enterocytes: 178.8;Proximal tubular cells: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 41.4;SiHa: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		110000		"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	78.0	51.1	99.3	6.5	102.8	0.1	45.7	89.1	117.7	32.3	83.5	46.5	73.5	119.4	55.0	31.4	98.0	17.3	97.8	93.9	149.1	124.2	317.6	33.0	6.1	143.8	134.2	155.4	10.9	15.6	25.9	11.2	125.9	82.9	16.5	13.9	78.5	155.5	114.6	9.9	79.0	103.3	115.8	2.4	23.7	9.0	145.2	3.8	5.6	65.1	7.1	28.3	25.4	115.8	0.0	1.0	0.1	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	5.4	4.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	8.1	41.4	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.1	1.1	78.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	99.3	102.8	89.1	117.7	93.9	149.1	143.8	134.2	125.9	115.8	145.2	115.8	5.9	0.0	4.1	53.5	0.4	5.5	0.4	1.2	1.8	1.4	3.5	22.4	120.6	52.9	1.9	5.5	4.2	0.4	0.0	10.2	62.6	20.1	0.4	26.4	81.6	10.3	0.0	2.7	36.9	2.8	0.5	17.0	16.3	6.0	137.8	69.6	7.5	221.1	1.5	15.2	7.6	6.4	12.2	4.3	3.6	2.1	46.0	1.8	7.2	9.4	0.0	27.2	0.0	11.6	1.3	7.9	7.8	95.2	0.3	0.6	178.8	182.6	11.8	1.0	13.1	2.6	18.4	0.3	0.4	2.3	4.0	0.4	5.5	0.5	10.5	0.5
MAP10	"KIAA1383, MTR120"	ENSG00000212916	"Microtubule associated protein 10"	Q9P2G4	1	232804892-232808407	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.3;Cone photoreceptor cells: 22.9;Spermatocytes: 11.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 6.8;NB-4: 6.7;REH: 5.5;THP-1: 10.1;U-937: 6.9"	"Low region specificity"	"Detected in all"							HPA052496	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA052496: AB_2681852"	"unprognostic (2.70e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.60e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.98e-2)"	1.0	1.0	0.5	1.2	0.7	0.7	1.8	0.2	0.8	1.6	0.0	0.9	1.4	1.1	2.6	0.5	1.3	1.3	2.6	0.6	0.6	1.1	2.5	1.2	2.7	0.7	0.2	2.2	1.7	0.7	0.8	1.1	0.6	1.0	0.8	3.6	1.5	0.9	2.6	0.4	1.7	1.3	0.2	1.5	1.5	3.1	0.2	3.7	2.2	1.5	2.0	0.9	0.5	0.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.3	0.0	4.0	0.0	2.0	1.6	0.0	0.0	0.0	0.9	0.6	1.5	0.0	0.2	0.2	0.0	1.7	2.6	0.0	2.4	0.2	0.2	0.0	0.3	3.1	0.0	1.0	0.0	1.4	1.9	6.8	6.7	0.0	1.7	0.0	5.5	0.0	1.9	1.4	1.6	3.3	2.7	0.0	0.3	0.0	0.9	0.6	10.1	0.7	0.0	1.7	0.2	1.2	1.9	0.0	0.0	1.5	6.9	0.1	5.1	1.9	1.7	0.5	1.4	0.6	0.6	0.8	0.2	2.5	1.3	1.2	0.9	0.0	1.2	3.2	2.9	1.4	0.7	0.5	0.7	0.2	0.8	0.6	0.6	0.7	0.2	0.6	0.2	0.2	0.5	4.4	0.0	1.1	0.7	1.6	0.4	0.3	1.0	1.2	12.3	1.0	1.0	4.9	5.7	2.1	0.0	22.9	0.7	1.9	0.7	0.0	2.9	3.1	1.0	2.2	2.6	0.0	0.4	4.2	3.0	0.5	1.8	1.5	0.5	1.3	3.4	0.4	1.3	1.5	0.0	3.5	2.3	6.1	1.2	0.8	2.2	0.6	1.1	0.0	1.0	5.6	3.2	2.1	2.5	3.2	1.7	0.3	0.7	0.7	0.2	1.9	0.2	1.5	8.5	0.0	2.4	1.2	11.2	6.1	0.8	0.3	0.3	1.3	4.4	2.0	0.4
MAP11	"C7orf43, FLJ10925, TRAPPC14"	ENSG00000146826	"Microtubule associated protein 11"	Q8WVR3	7	100154420-100158723	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 7.0;Extravillous trophoblasts: 7.2;Hofbauer cells: 7.7;Syncytiotrophoblasts: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.5	13.3	9.4	16.7	9.6	11.9	8.4	9.6	10.7	9.7	7.4	20.0	14.2	11.8	6.4	15.9	9.5	7.1	7.3	10.4	12.1	16.6	17.2	10.7	20.7	11.5	11.4	6.7	13.8	17.6	17.9	7.3	12.3	12.8	11.5	4.9	15.3	8.4	5.6	25.0	22.5	5.7	7.0	32.2	17.8	30.3	12.0	13.9	15.5	3.8	12.4	9.4	10.9	9.4	7.6	9.7	11.1	18.8	6.8	3.7	12.5	13.9	10.8	9.4	6.8	7.6	8.8	9.6	12.4	10.5	14.6	14.4	5.3	11.0	3.6	18.1	10.6	7.3	13.5	6.7	8.1	9.0	32.1	7.5	7.4	9.1	7.0	6.8	8.3	9.7	15.9	16.9	12.4	23.6	20.7	19.3	12.4	14.0	13.9	12.3	5.1	10.7	8.2	8.6	14.0	14.8	12.5	35.7	7.6	7.3	7.2	10.7	11.5	18.6	15.7	24.7	10.9	24.8	25.4	9.7	10.5	12.3	20.2	0.6	0.3	1.4	0.6	0.6	0.5	0.2	0.8	0.6	0.2	0.6	0.4	0.7	1.9	0.2	0.6	0.2	0.0	0.2	9.4	9.6	9.6	10.7	10.4	12.1	11.5	11.4	12.3	7.0	12.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MAP1LC3A	"ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3"	ENSG00000101460	"Microtubule associated protein 1 light chain 3 alpha"	Q9H492	20	34546854-34560345	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 674.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 85.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 57.5;HSkMC: 71.2;SK-BR-3: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007649, CAB037174, HPA042824, HPA052474, HPA052484"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.76e-1)"	53.0	26.6	120.8	13.7	122.1	16.4	40.6	114.4	177.2	49.6	69.7	56.3	30.6	44.9	17.8	22.6	41.7	23.9	81.7	123.7	148.4	54.2	53.2	39.4	28.1	137.1	135.6	38.3	24.8	23.7	84.8	12.4	155.9	46.6	19.7	31.6	31.0	20.3	54.7	64.8	44.9	19.1	101.2	22.0	36.6	52.8	116.2	6.9	52.9	34.1	30.4	39.1	43.5	123.3	0.0	7.0	4.2	0.0	28.4	37.3	0.2	26.1	21.9	16.3	14.9	0.1	0.5	0.0	0.3	21.3	39.5	4.8	0.1	8.1	3.2	6.2	2.0	0.1	17.2	0.0	57.5	0.0	14.0	71.2	1.4	11.4	4.9	0.1	13.5	0.0	0.0	0.1	17.4	0.0	0.2	0.5	1.6	5.3	5.2	0.0	0.0	0.0	0.0	0.0	41.4	31.9	29.6	62.2	0.0	16.3	0.3	22.7	20.5	45.2	0.4	9.8	11.2	0.0	6.5	0.0	29.4	0.0	16.1	4.0	3.2	11.0	5.1	4.8	3.7	9.4	5.5	5.4	1.0	6.0	1.7	3.4	85.4	3.3	1.7	4.5	12.1	2.9	120.8	122.1	114.4	177.2	123.7	148.4	137.1	135.6	155.9	101.2	116.2	123.3	107.4	0.0	6.6	19.2	18.3	57.7	123.0	50.5	12.5	127.2	41.9	57.8	25.4	41.5	27.1	46.0	85.5	25.7	26.1	67.3	113.5	42.0	137.3	98.4	78.4	64.4	165.1	3.6	48.4	23.5	15.8	75.4	34.1	90.6	18.4	90.8	75.7	44.6	37.9	70.7	58.8	70.5	136.3	16.1	47.1	674.0	95.1	17.5	62.2	14.0	21.0	98.7	7.2	12.5	54.6	44.7	82.5	108.7	10.1	146.3	149.4	120.0	40.7	127.7	138.1	77.7	119.3	53.0	21.6	5.8	51.4	211.8	26.4	79.8	76.7	98.1
MAP1LC3B	ATG8F	ENSG00000140941	"Microtubule associated protein 1 light chain 3 beta"	Q9GZQ8	16	87383953-87404779	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037216, HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (4.70e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.98e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (2.77e-7)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	92.0	82.9	108.4	37.5	112.9	245.6	72.9	123.7	135.3	46.1	110.7	46.2	25.5	52.6	44.7	45.0	48.2	57.0	102.7	105.2	130.1	71.3	50.3	50.9	52.5	131.5	132.0	43.3	37.1	74.2	51.1	75.6	140.8	43.6	47.1	125.9	49.2	49.3	195.2	62.5	36.9	66.6	120.5	44.4	42.3	51.8	126.5	54.9	63.5	176.7	51.4	57.3	42.0	123.8	56.9	33.7	63.8	59.2	188.5	145.3	41.9	111.4	130.1	88.0	59.9	56.0	42.4	37.7	82.0	155.7	97.5	50.8	95.2	72.3	125.3	49.9	81.0	39.4	40.2	94.4	313.4	28.3	40.0	194.9	234.8	137.0	326.0	131.1	101.1	57.2	107.4	79.0	150.4	61.5	48.4	64.0	66.1	27.7	81.2	76.2	42.2	37.6	119.0	28.4	53.0	60.3	174.8	29.4	230.8	85.2	48.0	34.0	134.1	94.7	59.7	86.4	65.3	99.4	131.5	137.7	133.9	68.3	69.6	312.5	86.8	198.1	78.6	81.6	80.5	72.5	75.8	81.1	69.2	58.2	58.4	62.0	214.3	104.7	85.3	75.1	108.2	109.2	108.4	112.9	123.7	135.3	105.2	130.1	131.5	132.0	140.8	120.5	126.5	123.8	523.1	89.8	90.5	15.7	185.3	221.0	203.1	176.2	301.7	70.4	183.9	227.3	180.7	72.9	117.2	77.3	52.1	130.6	242.7	309.1	262.2	310.9	222.1	283.6	235.9	191.7	132.2	364.2	29.2	134.8	140.2	177.7	96.4	530.5	131.1	49.3	80.7	70.1	206.4	87.5	41.4	137.3	238.0	150.9	268.5	269.7	90.7	262.2	188.5	19.7	207.0	194.3	143.2	14.6	26.9	322.8	407.6	89.1	202.0	209.3	217.4	236.9	133.5	124.0	59.2	129.5	168.2	361.2	206.7	221.8	213.5	631.5	221.6	85.7	122.4	294.5
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576606	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 40.5;Langerhans cells: 33.4;Paneth cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.2"									"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Nucleoplasm	"HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	1.8	2.2	0.3	0.7	0.4	3.9	1.5	2.0	0.6	0.7	0.8	0.9	1.2	1.3	1.2	1.8	1.0	1.6	2.4	0.3	0.8	1.3	1.1	1.2	1.1	0.5	0.6	1.4	0.8	0.1	0.9	0.7	0.7	0.8	1.5	0.9	1.2	0.0	4.2	1.6	1.4	1.5	0.5	0.8	0.8	1.1	0.4	0.7	0.9	0.5	1.5	0.8	0.9	0.7	1.4	0.7	1.5	1.8	0.4	0.5	1.6	2.8	0.2	0.0	0.1	2.7	2.0	1.1	1.8	0.2	3.4	1.0	0.4	0.3	0.5	1.0	1.9	0.6	2.7	4.9	0.9	0.9	1.0	0.1	0.4	0.9	0.7	3.9	1.9	1.2	3.3	3.0	0.3	2.7	1.0	1.9	0.8	1.2	2.6	1.4	0.2	3.6	0.2	1.5	1.5	2.3	1.9	0.6	7.2	2.8	1.0	0.4	0.7	2.6	0.9	2.2	1.4	2.2	3.3	3.6	3.9	1.4	1.3	38.6	11.6	34.2	7.8	11.8	7.2	9.0	8.8	7.9	9.4	7.7	6.1	7.0	43.5	9.8	14.2	9.6	15.9	13.6	0.3	0.4	2.0	0.6	0.3	0.8	0.5	0.6	0.7	0.5	0.4	0.7	1.9	0.0	1.7	10.7	4.0	24.2	17.3	6.1	0.0	1.5	1.1	2.5	40.5	1.5	4.6	0.0	0.0	2.5	2.8	22.7	7.9	0.2	12.3	2.8	2.2	8.0	1.8	24.0	4.4	0.0	2.4	8.3	0.0	5.9	7.0	0.9	2.5	2.0	4.5	13.5	8.6	7.5	12.2	7.2	33.4	14.2	4.7	5.5	10.6	1.0	2.4	0.5	7.2	4.0	1.7	0.4	63.1	3.8	0.1	12.5	2.5	8.1	3.1	1.1	0.0	9.0	8.0	20.8	11.5	0.0	21.5	11.4	8.2	0.8	5.9	21.8
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734513	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.9"	"Group enriched"	"Detected in all"	4	"Early spermatids: 98.1;Late spermatids: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	20.5	13.9	48.2	8.7	51.9	11.2	19.1	36.8	82.9	18.9	30.1	21.5	7.7	24.8	5.4	11.9	19.2	7.9	18.8	51.4	40.5	15.4	12.4	23.5	9.0	44.7	41.1	21.6	15.6	5.4	22.0	9.7	43.3	17.4	2.4	2.8	19.7	6.5	32.4	12.2	17.7	3.6	39.2	18.3	20.1	74.7	40.6	6.1	16.1	5.4	3.9	21.6	14.6	47.7	30.1	43.2	12.4	16.9	10.4	15.4	34.0	18.3	8.8	10.9	12.3	61.3	16.0	17.3	33.8	11.4	12.8	15.3	10.5	14.5	4.6	21.8	61.1	15.1	36.3	39.2	22.1	16.8	20.9	16.7	8.3	16.7	10.5	7.9	22.6	12.5	24.2	9.5	6.0	39.0	20.8	42.0	28.7	17.1	50.8	33.3	10.2	17.5	14.8	43.4	23.0	26.5	10.7	14.8	18.9	9.0	9.9	17.8	37.3	19.7	18.2	40.7	27.2	18.1	23.3	17.4	23.7	26.7	25.1	18.5	22.6	25.9	15.7	22.2	15.1	15.7	12.3	15.6	25.9	15.5	10.1	13.9	31.4	13.0	17.9	21.2	12.2	19.0	48.2	51.9	36.8	82.9	51.4	40.5	44.7	41.1	43.3	39.2	40.6	47.7	11.1	3.2	7.5	4.2	14.7	10.3	14.0	13.1	13.1	11.1	12.3	8.6	5.5	15.7	12.1	3.7	8.4	21.7	14.0	30.9	3.9	22.2	98.1	12.9	11.5	18.5	20.4	3.8	8.4	17.2	16.9	12.3	19.4	26.9	10.2	12.0	20.7	4.8	26.1	40.4	5.5	16.6	12.2	18.7	25.1	293.2	22.4	20.7	1.8	2.8	17.4	8.1	8.2	4.5	7.1	24.2	15.8	31.6	8.8	14.9	19.0	5.9	6.2	6.3	13.1	7.7	13.0	25.9	21.4	5.4	3.3	33.8	11.3	8.1	18.3	13.7
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 253.3;retina: 411.0"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.5	11.6	89.2	1.2	115.9	0.3	5.5	2.7	253.3	4.3	0.0	2.9	0.9	2.3	3.9	6.5	2.5	7.6	8.4	135.2	215.6	5.4	3.8	13.5	1.8	37.7	52.2	7.4	10.7	15.5	33.8	0.8	75.3	7.6	1.7	411.0	7.8	4.9	1.7	16.9	1.6	2.8	14.5	1.7	3.3	6.5	123.9	3.5	16.7	4.6	2.4	1.6	5.3	88.2	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	89.2	115.9	2.7	253.3	135.2	215.6	37.7	52.2	75.3	14.5	123.9	88.2	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386837-66491544	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.5;Langerhans cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	57.9	31.0	47.6	38.3	79.7	63.7	32.5	30.2	61.3	31.1	22.5	26.5	19.4	26.3	29.6	51.8	23.7	27.0	40.7	69.4	44.3	31.2	105.3	34.7	49.5	31.6	32.6	25.7	22.4	38.5	26.8	29.6	40.1	26.2	23.6	34.1	29.3	21.8	85.5	23.7	27.0	31.9	35.7	32.6	24.1	15.2	42.8	33.8	22.8	51.3	55.4	31.2	33.7	49.9	105.8	55.3	94.4	39.0	55.3	41.3	53.8	83.6	61.6	76.6	68.1	79.0	82.1	96.8	93.2	59.9	58.2	93.3	88.8	106.4	89.8	79.1	56.8	30.9	50.4	40.7	45.1	41.0	45.3	32.3	64.0	55.9	81.6	81.5	60.7	48.0	54.3	116.7	113.4	40.3	33.5	51.9	47.9	93.9	42.9	39.2	58.1	84.7	74.8	48.5	58.3	31.7	60.8	45.5	63.0	74.9	41.0	33.7	90.8	99.5	63.8	71.1	112.4	74.0	143.1	60.6	105.1	69.9	48.4	3.0	7.5	5.4	6.4	7.7	5.8	2.8	5.6	6.1	7.7	4.6	6.9	4.2	3.5	8.3	7.7	15.1	4.6	2.8	47.6	79.7	30.2	61.3	69.4	44.3	31.6	32.6	40.1	35.7	42.8	49.9	24.5	28.9	24.8	24.2	40.0	82.8	45.9	32.3	21.1	10.0	22.2	10.2	21.5	40.0	24.9	25.8	14.6	48.1	45.0	25.1	46.9	69.4	12.1	16.3	13.9	34.6	21.7	19.0	69.7	23.1	48.8	30.3	17.9	35.4	8.9	19.8	18.9	172.5	51.4	10.1	46.4	15.4	20.3	90.7	265.3	23.6	22.4	115.1	53.4	48.7	87.9	34.9	35.0	28.1	31.7	103.9	23.5	21.8	49.1	87.7	22.2	35.9	17.7	7.8	6.6	16.3	52.4	35.6	42.7	30.3	67.3	51.7	54.0	5.9	19.1	65.4
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124122	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 724.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA		140000	"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	73.9	118.4	145.5	54.1	143.1	102.4	69.1	151.5	190.7	76.6	150.4	103.4	134.0	72.3	23.2	121.6	64.7	30.4	156.6	145.9	147.3	82.6	123.3	66.8	57.1	149.6	152.9	84.1	134.3	54.9	99.3	36.4	154.3	93.9	42.7	68.0	79.6	37.6	289.0	95.8	101.0	31.7	143.5	89.1	92.7	131.6	150.7	69.3	74.6	132.1	41.0	77.2	75.2	142.8	163.1	175.4	93.7	132.8	127.1	151.9	93.8	104.5	138.8	139.6	125.8	153.0	85.5	137.7	95.9	120.0	111.9	114.3	74.2	111.6	107.4	118.1	90.4	50.5	91.4	171.7	194.0	93.6	101.8	168.8	106.8	98.2	129.5	185.5	125.2	123.0	98.1	263.1	119.3	203.5	186.3	130.6	107.8	118.6	125.9	140.7	61.9	159.1	123.5	102.7	126.8	126.3	95.7	130.6	344.1	107.3	101.0	158.5	111.8	113.6	98.2	293.4	163.9	263.1	172.4	100.2	176.5	166.8	199.3	27.5	13.0	45.4	16.9	16.6	13.6	13.0	13.3	17.2	15.9	18.2	12.3	15.9	21.2	18.8	14.1	9.0	14.3	7.3	145.5	143.1	151.5	190.7	145.9	147.3	149.6	152.9	154.3	143.5	150.7	142.8	77.7	9.6	31.9	22.5	62.3	35.4	93.3	21.3	15.4	85.1	92.9	95.4	62.9	44.3	22.8	40.5	41.7	28.7	102.3	300.5	146.8	20.7	248.1	59.5	68.3	52.1	63.2	123.1	17.6	45.5	38.6	60.3	64.7	48.8	19.7	124.4	49.2	48.1	55.0	121.1	23.2	107.7	16.2	56.0	38.2	724.3	35.8	65.6	42.7	10.3	28.5	121.1	62.8	13.0	24.2	47.0	151.8	23.0	79.9	103.2	166.1	92.8	18.9	106.8	26.3	93.1	71.8	23.5	17.4	42.9	63.9	35.6	77.0	120.2	119.9	113.1
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315232	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 212.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 325.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	47.3	32.5	12.9	35.3	12.1	212.4	30.7	17.6	23.2	22.7	22.6	33.1	49.0	17.1	14.5	62.7	29.9	40.0	66.7	11.5	14.4	45.7	95.7	67.5	34.0	13.6	14.3	12.6	33.6	17.9	37.1	28.9	14.2	28.9	24.1	6.0	45.3	16.5	132.7	53.1	41.0	22.5	14.3	60.4	42.8	6.2	15.8	20.9	24.0	74.6	41.1	54.1	33.4	17.0	75.5	73.9	9.7	44.5	57.7	36.6	36.3	113.0	121.8	88.3	80.5	82.9	46.6	68.1	44.7	178.3	74.2	72.4	31.0	100.5	62.1	69.5	56.9	39.2	42.0	76.1	18.2	51.9	76.7	28.5	28.2	120.6	35.9	27.7	40.0	38.6	7.7	33.2	74.7	74.1	25.5	49.3	28.1	134.1	42.3	53.0	62.2	50.0	50.5	77.4	26.3	9.4	41.7	45.9	82.0	95.7	22.5	17.7	36.8	83.0	68.4	90.1	73.9	39.8	21.8	88.1	80.2	44.3	44.1	54.1	49.3	77.8	35.9	72.1	31.1	33.3	29.1	33.6	49.6	25.5	17.9	24.1	145.6	15.3	104.7	35.4	44.5	35.6	12.9	12.1	17.6	23.2	11.5	14.4	13.6	14.3	14.2	14.3	15.8	17.0	44.2	38.5	53.6	2.6	51.5	258.0	188.4	57.0	97.9	7.1	69.3	51.3	21.9	44.3	50.5	22.0	4.2	73.3	117.4	109.1	74.3	99.1	1.5	130.5	44.8	49.4	120.4	325.0	7.2	79.8	82.0	43.7	68.3	237.8	94.0	11.5	22.1	73.1	49.0	18.5	8.0	77.0	28.5	59.4	278.7	1.8	12.2	118.1	87.2	4.7	48.3	17.3	35.0	5.5	2.0	129.1	135.3	16.6	85.2	158.7	60.8	44.2	40.4	7.4	0.0	61.9	42.4	1.1	5.3	97.3	218.1	67.0	62.6	10.5	58.5	255.7
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020829-12143830	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.9;Inhibitory neurons: 189.3;Oligodendrocyte precursor cells: 148.3;Oligodendrocytes: 203.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 177.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	11.4	13.1	27.3	10.1	30.2	3.6	14.5	18.7	44.8	12.0	8.7	12.0	10.1	12.1	17.5	18.8	11.4	10.9	15.8	32.7	28.5	16.2	21.8	11.7	11.7	30.0	21.8	12.6	11.5	19.4	13.8	15.8	30.9	14.3	13.1	15.4	10.5	12.7	24.1	15.1	10.5	13.8	19.0	11.6	11.2	11.0	25.9	15.2	16.7	28.2	14.4	14.7	13.0	30.1	31.1	26.2	33.8	17.5	18.3	23.5	21.3	20.6	27.1	23.1	21.9	15.6	10.4	12.8	16.4	32.4	15.2	20.2	29.7	28.8	34.3	22.7	33.7	14.2	14.1	29.8	21.4	13.7	20.5	19.6	27.9	27.0	28.0	23.9	21.3	17.8	15.4	7.3	29.4	11.5	16.8	12.9	19.6	33.2	12.4	20.3	37.8	8.9	31.6	19.7	6.8	19.9	23.8	12.7	20.3	177.7	16.1	10.0	19.6	11.3	17.4	15.8	24.9	14.2	16.9	9.9	21.3	10.7	16.8	0.4	2.1	1.7	2.2	1.2	1.9	2.1	1.8	1.8	1.5	2.7	1.5	2.4	10.4	2.7	3.9	1.5	2.2	1.8	27.3	30.2	18.7	44.8	32.7	28.5	30.0	21.8	30.9	19.0	25.9	30.1	13.9	9.6	19.4	71.8	27.1	41.4	36.1	12.7	66.0	15.3	20.4	16.3	22.6	7.2	18.3	14.7	8.4	12.6	17.7	19.1	25.4	12.3	7.2	16.9	16.4	12.0	12.0	14.5	226.9	14.3	10.3	19.4	42.3	27.3	1.3	20.1	11.0	20.8	11.7	18.5	189.3	13.1	20.3	19.9	14.7	8.9	11.8	15.4	12.4	68.4	24.1	11.3	14.4	148.3	203.0	16.9	9.3	12.8	26.9	37.7	11.0	25.2	8.6	10.0	13.1	19.2	20.2	7.3	9.3	56.7	39.2	25.3	20.7	15.0	13.3	41.5
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542703-67807117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Astrocytes: 119.5;Early spermatids: 138.1;Excitatory neurons: 201.4;Inhibitory neurons: 169.3;Late spermatids: 212.4;Microglial cells: 87.1;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 146.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	14.3	14.8	9.2	6.3	9.8	10.3	12.4	11.2	14.1	13.2	4.6	15.7	9.2	11.5	6.1	8.7	12.1	8.8	15.0	11.6	9.9	9.9	10.0	9.7	8.5	9.6	6.5	17.2	13.2	18.8	10.2	11.1	9.4	9.4	8.8	11.2	10.5	10.6	23.2	14.5	10.1	8.9	5.6	9.0	11.6	13.8	7.3	17.2	10.6	17.8	7.6	11.8	11.1	12.3	9.0	23.4	13.8	16.3	20.0	34.9	10.9	8.8	17.8	16.3	17.7	9.4	15.8	14.8	18.2	14.8	17.7	13.3	23.8	14.3	13.4	21.6	23.7	20.2	17.0	10.3	25.1	12.3	12.1	23.9	18.3	11.8	26.6	35.7	21.7	33.6	18.0	24.1	13.6	11.6	20.1	14.7	19.4	10.4	11.3	19.7	16.0	24.9	9.8	16.3	8.6	13.4	9.9	14.5	36.5	23.6	18.2	23.7	18.2	16.7	10.9	11.7	12.1	33.7	43.4	17.5	22.4	27.6	12.3	10.9	5.8	5.6	5.6	4.4	8.3	4.8	5.3	6.7	8.1	4.3	7.3	7.0	1.4	9.4	5.4	3.0	6.2	4.4	9.2	9.8	11.2	14.1	11.6	9.9	9.6	6.5	9.4	5.6	7.3	12.3	7.9	6.4	5.8	119.5	10.0	6.9	8.1	3.7	8.6	12.6	8.6	6.1	8.1	5.7	3.2	5.5	10.4	13.4	10.2	13.2	7.9	9.3	138.1	4.4	5.0	7.6	9.5	9.4	201.4	8.5	10.7	9.7	7.7	3.9	2.5	12.3	12.5	8.7	10.0	5.0	169.3	9.2	4.1	10.1	6.1	212.4	12.5	7.9	10.6	87.1	7.2	17.9	11.3	146.3	146.5	7.5	12.5	11.7	5.6	5.3	12.2	9.7	4.0	8.2	0.0	7.9	6.3	11.9	13.0	9.9	8.2	9.9	10.4	11.6	10.4	4.6
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.2	1.3	4.2	8.4	4.0	15.9	20.4	11.6	4.0	27.0	7.6	30.7	10.3	6.1	3.2	3.1	4.5	7.2	1.4	2.7	6.2	5.5	12.2	1.8	8.0	5.4	3.8	3.1	8.3	0.3	1.6	1.6	3.9	3.3	31.7	5.8	2.5	3.1	40.5	2.0	10.8	3.3	4.4	4.0	7.4	1.3	5.7	11.5	3.3	21.1	5.9	3.3	1.2	7.7	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	4.2	4.0	11.6	4.0	2.7	6.2	5.4	3.8	3.9	4.4	5.7	7.7	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	19.1	17.0	17.9	11.7	17.8	19.4	19.5	16.8	19.0	25.1	10.4	24.4	13.1	26.1	3.7	20.2	20.5	5.9	20.8	14.8	15.2	18.7	24.7	17.1	11.7	17.3	17.3	23.2	21.6	9.6	23.4	9.2	17.1	21.0	4.6	5.6	19.2	7.9	52.4	27.9	20.1	6.2	15.1	24.5	18.8	17.5	17.3	10.9	19.0	16.4	6.1	22.0	22.4	19.9	25.8	14.4	12.2	20.2	9.7	9.3	22.8	16.5	8.0	11.0	11.3	20.9	15.2	30.5	25.9	8.8	10.7	22.9	10.7	12.8	4.3	24.7	53.3	21.4	20.9	15.6	12.4	20.1	26.0	10.8	16.1	8.7	9.8	14.5	10.0	21.9	31.9	38.5	6.5	13.4	28.8	48.6	21.7	13.6	32.0	28.5	13.4	31.0	9.8	21.0	22.4	22.5	11.3	19.4	23.9	7.3	21.0	22.7	15.3	33.2	19.0	23.7	22.7	55.5	27.7	28.8	16.6	29.2	13.6	0.0	0.8	0.6	0.6	0.8	0.4	0.7	0.5	0.6	0.4	1.0	0.5	0.7	1.5	1.0	0.5	0.8	0.2	0.4	17.9	17.8	16.8	19.0	14.8	15.2	17.3	17.3	17.1	15.1	17.3	19.9	15.4	25.6	18.1	11.1	27.0	38.6	37.2	22.7	22.2	52.9	23.5	16.5	14.4	24.3	14.5	20.2	77.2	28.3	27.8	31.1	13.7	22.8	4.8	16.2	20.3	19.5	36.5	23.6	9.9	19.0	31.1	18.5	16.3	24.8	10.8	33.3	21.4	22.2	18.6	57.2	11.0	24.0	32.6	22.2	17.1	11.7	28.9	20.5	32.0	6.5	25.3	23.9	46.4	9.0	15.0	25.7	20.8	12.4	30.4	39.8	38.7	18.4	15.3	65.7	32.9	30.2	22.1	17.7	36.4	22.7	42.6	49.3	30.3	30.3	27.6	33.2
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815549-56896152	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.5;THP-1: 51.0"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 18.2"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	5.5	3.8	3.0	13.3	2.6	24.0	20.1	4.0	2.1	7.0	6.2	5.4	6.3	7.5	6.6	10.0	9.7	5.7	3.7	2.1	2.7	9.9	6.0	7.5	18.1	3.9	3.2	7.2	9.8	7.1	1.3	11.4	3.7	5.4	6.3	26.9	18.5	8.3	1.7	19.7	6.5	5.7	3.8	20.5	8.1	8.3	3.5	9.9	16.2	4.4	24.0	6.7	6.4	3.9	13.3	7.9	12.1	8.1	1.9	1.5	20.3	2.5	3.3	7.6	10.6	37.1	9.7	11.9	0.9	3.0	6.5	6.7	10.1	4.6	10.5	4.0	4.4	6.6	3.4	17.5	4.7	10.6	17.6	1.9	4.8	2.4	3.8	2.1	3.3	4.0	5.8	20.7	2.0	5.8	7.4	14.2	5.6	6.8	1.0	11.5	8.6	41.1	13.2	13.6	5.1	52.5	7.6	9.5	21.5	10.7	26.0	51.0	9.8	0.7	6.4	2.9	4.7	15.0	8.2	22.1	1.2	6.1	13.2	6.3	3.1	0.7	0.8	4.5	0.7	4.0	2.4	1.1	1.8	3.3	1.5	0.5	1.7	1.7	4.9	1.0	3.8	1.7	3.0	2.6	4.0	2.1	2.1	2.7	3.9	3.2	3.7	3.8	3.5	3.9	20.8	6.4	9.8	17.9	102.5	52.4	15.1	17.1	43.9	14.9	73.2	30.6	3.5	48.6	15.9	36.8	47.9	15.1	31.9	7.3	7.9	18.9	2.0	25.0	20.6	24.0	10.2	14.5	11.7	14.8	8.6	10.7	14.3	43.7	7.6	20.0	21.8	15.0	32.3	28.6	31.8	11.4	6.1	76.0	48.4	3.6	5.3	66.5	37.4	69.3	99.1	11.6	9.2	210.1	12.5	12.9	7.7	1.9	41.5	14.8	10.6	20.7	11.0	38.5	6.6	9.3	11.9	8.6	17.9	69.1	54.7	6.7	31.6	15.4	9.7	12.0
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191426-40215575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.9;Horizontal cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 22.8;basal ganglia: 17.5;cerebral cortex: 46.2;hippocampal formation: 37.7;white matter: 11.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	6.9	8.3	22.8	2.3	17.5	1.9	6.5	0.0	46.2	7.7	0.0	8.6	2.0	7.9	0.3	5.3	6.6	1.8	10.7	37.7	0.1	7.4	5.2	6.7	2.3	3.2	0.6	7.3	6.9	3.3	14.3	1.6	0.0	8.1	0.6	1.4	5.9	2.0	16.8	7.1	6.3	1.8	0.0	8.1	7.1	11.1	2.4	1.8	6.9	4.3	0.9	7.2	6.6	11.6	6.3	7.2	2.2	5.2	2.0	1.2	6.2	4.3	2.0	1.9	1.9	1.7	1.7	5.7	4.4	1.4	4.6	1.9	0.8	2.2	0.2	10.9	6.8	1.4	3.3	1.7	3.8	1.2	3.4	1.1	5.0	2.0	1.4	2.0	1.7	7.6	5.5	9.1	0.5	3.7	4.5	2.2	2.6	2.0	4.7	5.8	2.3	3.4	1.7	3.8	7.4	10.7	4.9	1.7	10.0	1.3	2.4	2.2	2.9	4.9	4.8	7.3	8.3	12.7	7.7	2.6	5.7	2.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	17.5	0.0	46.2	37.7	0.1	3.2	0.6	0.0	0.0	2.4	11.6	5.6	0.0	0.0	6.5	4.2	1.5	1.8	1.1	1.2	14.9	2.9	2.4	2.8	5.7	0.5	7.3	8.4	0.9	3.3	2.4	0.0	2.5	2.8	2.4	3.6	3.6	4.2	5.3	18.9	4.3	0.8	2.6	5.6	3.8	0.0	10.3	3.9	3.2	2.5	23.5	15.9	1.7	0.0	1.6	2.9	7.6	3.1	2.7	1.8	9.4	2.5	5.7	4.1	9.0	12.4	3.7	2.9	4.9	1.5	2.5	1.7	3.1	0.6	7.7	6.6	4.5	4.0	4.1	1.8	1.8	2.7	1.4	4.4	3.2	2.4	2.0
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597756-65615382	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	47.6	32.6	39.9	36.9	51.7	24.4	42.9	45.1	48.4	27.2	27.2	40.0	48.3	29.7	7.4	35.6	31.3	13.5	53.2	36.1	38.8	48.5	95.3	62.7	23.7	48.8	50.3	21.0	35.8	12.1	27.8	21.6	44.6	39.2	11.7	2.8	29.1	12.6	20.1	35.9	51.0	10.0	41.5	78.3	36.3	21.3	50.5	19.3	37.3	10.4	11.3	29.2	28.3	60.1	48.0	43.4	23.1	22.6	7.0	8.0	21.7	19.3	11.9	19.9	14.9	43.4	43.9	16.4	65.5	13.0	33.0	40.9	12.2	19.5	7.1	40.2	15.5	50.0	28.2	50.9	18.6	28.9	71.2	12.4	19.1	14.5	13.3	21.6	57.4	21.5	21.6	32.7	10.9	58.2	34.0	50.9	24.2	31.0	48.1	56.1	13.3	36.2	19.2	43.1	19.6	22.9	22.0	58.1	107.7	10.4	46.6	45.8	68.8	31.3	35.8	48.1	32.4	23.3	27.5	15.8	35.3	33.1	75.1	7.5	10.5	13.1	3.1	15.3	3.0	2.7	3.2	4.5	10.1	3.0	2.4	1.8	17.3	2.4	15.4	3.0	1.8	9.5	39.9	51.7	45.1	48.4	36.1	38.8	48.8	50.3	44.6	41.5	50.5	60.1	70.0	22.4	21.1	4.2	22.1	21.0	25.3	18.4	20.5	24.4	28.9	23.4	8.7	31.5	14.1	11.0	25.0	24.7	26.4	123.5	19.6	21.9	13.5	15.4	11.3	78.9	41.9	13.0	4.1	27.5	17.7	11.4	44.4	26.1	26.0	19.6	58.5	56.2	53.3	18.5	3.5	54.9	20.3	50.6	65.5	68.5	9.6	48.3	21.4	21.5	50.2	16.1	23.7	3.0	29.5	33.7	99.0	6.4	15.5	28.1	113.1	27.6	10.3	54.7	32.9	10.5	12.8	12.2	18.3	24.8	30.0	34.3	24.0	28.9	55.2	34.6
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	12.6	7.6	12.9	5.4	15.2	3.2	10.3	25.9	19.6	23.5	4.3	13.3	3.2	22.9	4.8	4.0	18.5	14.0	8.6	15.6	11.3	8.5	1.7	11.2	4.4	11.9	11.1	21.6	3.6	7.3	22.7	6.4	13.2	9.6	3.8	13.6	4.9	10.9	2.7	5.7	8.9	14.4	8.0	9.0	7.3	9.0	13.0	6.0	8.6	6.3	2.7	14.0	12.2	13.7	0.5	15.1	8.6	14.2	55.9	28.9	1.2	10.1	18.9	10.8	11.0	0.3	1.8	3.5	5.4	10.8	8.7	0.1	4.3	6.8	4.3	4.9	5.4	3.5	8.3	0.0	53.7	0.1	3.6	51.8	5.2	14.6	7.8	69.1	16.9	7.8	0.1	15.7	10.0	6.7	3.8	0.9	3.2	0.0	5.5	5.4	6.3	1.0	5.4	0.1	9.3	12.4	5.6	6.8	14.9	1.8	4.6	10.3	12.9	10.2	10.8	4.5	2.5	6.1	8.0	0.0	16.8	6.9	10.4	0.0	0.5	0.0	0.4	0.4	0.8	0.1	0.5	0.6	0.2	0.0	0.2	0.3	1.0	0.2	0.1	0.0	0.1	0.1	12.9	15.2	25.9	19.6	15.6	11.3	11.9	11.1	13.2	8.0	13.0	13.7	11.4	6.4	14.6	21.5	8.1	0.8	2.4	0.5	4.6	28.9	5.6	5.2	0.8	7.2	6.4	1.8	37.5	1.9	12.2	4.8	9.8	6.7	1.5	11.5	27.6	10.4	3.5	1.3	21.1	1.8	2.2	11.0	2.0	15.8	12.7	7.0	15.0	7.8	4.1	30.3	19.1	2.8	2.0	10.3	2.2	1.8	8.1	8.6	0.0	8.4	8.5	19.9	5.2	10.6	11.0	4.4	2.1	8.2	6.7	5.3	7.1	14.8	5.5	85.0	6.6	23.5	10.2	2.5	2.1	2.5	1.0	2.2	11.6	12.5	4.1	3.9
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489094	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	14.7	34.0	18.5	13.0	19.8	15.8	21.0	23.2	25.8	17.0	18.5	24.6	24.3	17.9	56.8	19.7	20.2	18.1	10.4	19.7	20.4	30.9	29.6	17.5	11.7	20.7	21.7	22.2	25.9	34.6	20.7	13.1	21.1	19.7	26.2	36.2	26.2	14.9	4.7	14.0	25.0	17.0	21.2	13.1	23.9	18.8	21.5	11.1	25.7	6.8	15.0	23.2	15.8	23.5	73.9	14.5	27.4	0.7	24.4	29.9	16.1	16.5	11.2	26.2	31.5	27.9	27.0	0.6	55.1	30.4	43.7	41.1	0.8	38.4	46.5	82.1	36.8	0.3	18.9	23.3	26.5	39.2	20.1	27.2	32.8	22.6	28.1	27.1	29.6	0.7	0.9	57.5	23.8	23.0	4.6	18.2	31.5	56.5	33.4	0.6	32.8	40.5	46.9	18.8	44.7	29.8	28.0	41.5	59.9	29.8	62.8	21.5	19.7	21.5	27.8	39.4	36.5	29.3	40.8	24.4	31.4	19.5	36.1	14.0	21.6	9.4	16.6	22.1	25.7	42.8	19.6	21.0	37.4	34.9	27.2	26.6	35.9	20.8	15.9	16.4	8.6	12.4	18.5	19.8	23.2	25.8	19.7	20.4	20.7	21.7	21.1	21.2	21.5	23.5	69.5	54.5	82.7	80.0	41.8	141.6	219.1	196.7	100.7	117.9	144.0	115.1	25.2	144.4	131.6	79.1	91.8	139.5	22.9	96.1	287.6	106.6	134.8	76.5	50.7	65.9	106.4	43.8	170.7	127.5	38.9	49.0	72.4	73.1	29.8	96.6	93.5	99.4	64.9	45.4	184.5	130.9	138.4	53.2	193.0	213.0	43.2	52.7	85.4	28.1	283.9	137.5	22.6	102.1	89.8	137.5	95.1	54.2	40.6	322.2	111.6	283.9	125.7	88.8	46.0	38.5	62.7	119.5	39.1	94.6	145.6	203.4	32.2	50.0	109.3	279.4
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263119-45317029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 40.6;U-251 MG: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	5.9	4.7	2.6	12.5	5.0	5.2	6.4	2.9	2.3	7.1	2.8	15.6	8.1	5.7	1.9	7.8	6.6	5.9	9.9	3.2	2.7	5.1	7.3	8.1	17.7	3.6	4.6	6.0	8.3	4.6	5.9	2.7	3.1	7.0	5.2	2.2	8.1	4.7	28.0	8.5	10.3	5.9	2.5	12.4	7.6	6.9	4.8	13.4	5.8	9.9	16.0	7.2	7.1	2.1	17.1	40.6	3.6	6.5	2.4	7.1	9.4	4.5	3.4	14.9	9.1	5.5	21.0	7.4	24.1	5.3	14.6	11.6	1.5	6.5	7.6	24.3	3.1	1.4	10.1	2.1	7.1	1.1	6.9	10.0	3.6	7.3	3.6	15.6	3.0	3.2	2.7	30.1	8.1	6.1	6.8	1.7	1.8	11.1	5.1	9.5	12.1	17.9	10.5	2.6	3.5	3.0	7.6	3.4	5.0	5.5	2.8	0.4	5.6	6.5	10.2	5.7	43.1	29.1	12.1	4.1	3.9	4.0	9.2	0.0	2.0	0.8	1.6	1.8	1.0	4.2	1.1	1.0	1.4	4.4	1.2	0.9	1.6	2.0	0.6	1.7	2.9	1.6	2.6	5.0	2.9	2.3	3.2	2.7	3.6	4.6	3.1	2.5	4.8	2.1	5.8	3.2	12.8	23.5	15.3	0.0	14.7	0.0	14.8	4.5	5.6	4.8	2.3	18.6	2.5	0.0	4.2	0.9	14.5	13.9	0.0	4.8	4.7	7.0	4.0	6.1	13.1	1.3	8.9	2.7	1.5	6.3	10.2	5.6	1.3	2.1	6.4	9.2	4.9	1.7	15.6	7.8	0.0	9.4	0.0	6.2	4.7	11.3	0.0	26.2	33.4	1.9	5.2	6.6	5.5	3.3	9.6	1.2	8.5	6.2	13.4	3.8	5.1	2.9	0.0	12.9	2.8	4.2	3.0	7.9	0.0	0.0	10.6	2.4	8.5	6.8
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	12.6	8.9	12.1	13.4	16.3	37.6	10.5	13.5	15.9	12.0	9.9	12.5	15.3	11.2	8.3	9.5	9.0	12.9	6.6	10.3	14.3	11.9	22.3	10.8	12.9	18.0	14.9	10.6	10.6	14.0	7.8	9.9	17.4	8.9	10.1	15.6	10.2	9.0	13.4	12.6	14.1	12.7	15.2	13.5	14.7	11.3	18.3	14.4	17.9	9.1	13.8	10.4	8.3	24.8	29.4	12.3	9.6	9.7	13.2	17.4	16.0	17.9	19.4	17.2	13.9	14.8	12.7	19.2	30.0	25.7	16.0	24.3	15.6	12.0	19.3	48.6	12.1	17.9	22.3	13.0	15.2	18.2	37.2	15.7	12.9	21.0	25.5	15.1	8.1	14.2	8.6	37.3	17.2	10.7	21.4	12.9	9.9	8.2	15.8	14.0	18.0	14.5	7.0	27.1	19.0	10.2	26.1	15.8	16.4	7.8	10.3	13.7	18.7	33.6	31.3	15.7	24.5	38.4	30.0	19.5	16.1	11.7	14.8	3.4	2.5	1.7	1.3	1.5	1.6	2.7	1.2	1.3	2.1	2.2	1.5	1.6	11.3	2.0	2.0	4.2	1.1	1.0	12.1	16.3	13.5	15.9	10.3	14.3	18.0	14.9	17.4	15.2	18.3	24.8	45.7	83.3	46.0	53.8	88.9	72.0	36.9	34.3	55.2	53.6	42.2	32.1	30.1	45.8	44.2	29.5	106.3	20.5	107.9	72.6	13.7	21.2	4.6	77.0	71.0	36.9	45.4	27.8	60.6	34.0	19.8	54.9	42.3	90.2	60.9	42.2	25.4	69.1	47.7	72.3	57.7	40.1	30.5	80.1	113.7	7.6	42.3	107.7	56.9	50.6	79.1	25.9	30.9	49.8	87.7	49.0	28.8	51.9	57.3	48.3	54.5	33.1	58.5	59.2	19.7	69.2	47.4	42.3	52.6	43.5	78.6	26.3	65.5	51.7	31.8	46.1
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268015	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9;tongue: 279.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 15.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.5;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	71.0	11.4	9.5	20.5	9.7	4.7	21.4	10.3	8.5	44.9	15.7	65.8	13.0	76.4	18.6	50.0	48.0	31.4	195.7	9.3	12.1	7.5	25.2	22.5	9.8	13.8	14.7	69.5	11.7	49.3	3.8	27.6	11.2	44.0	20.9	2.5	12.4	57.1	261.9	14.1	19.2	75.0	11.1	12.5	31.5	10.6	12.5	11.5	16.4	279.7	10.2	56.1	21.2	9.4	34.6	28.6	22.0	29.1	62.7	92.5	13.8	121.9	94.7	55.9	59.6	19.5	22.2	26.5	31.2	122.5	48.8	22.9	33.1	64.6	124.2	52.0	22.0	43.3	30.5	4.1	24.8	39.3	43.8	74.7	27.2	105.2	164.2	46.3	37.5	28.5	19.8	4.9	36.8	14.8	24.8	19.0	12.2	28.9	16.0	36.2	45.0	0.1	13.6	19.6	12.9	12.4	47.0	11.3	19.7	35.6	12.9	20.9	37.9	176.3	71.4	53.1	27.9	0.1	0.1	5.5	126.2	10.6	18.9	0.2	9.4	0.0	1.0	8.3	1.0	1.6	0.8	1.7	15.5	2.5	0.0	0.8	2.6	0.5	8.2	0.3	0.8	3.4	9.5	9.7	10.3	8.5	9.3	12.1	13.8	14.7	11.2	11.1	12.5	9.4	57.5	38.5	57.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	20.0	44.4	0.0	0.0	7.4	11.0	0.0	52.6	2.3	0.0	1.9	43.9	0.0	36.7	96.7	14.1	0.0	0.0	0.0	27.6	21.9	36.5	0.0	35.6	5.1	100.7	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	38.6	0.0	0.0	1.4	0.0	0.0	1.9	13.1	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	21.6	3.6	70.5	0.0	0.0
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327724-233385148	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 20.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 10.0;Collecting duct cells: 14.7;Ductal cells: 11.9;Exocrine glandular cells: 9.8;Glandular and luminal cells: 11.7;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.7	3.8	1.8	1.3	1.6	2.1	2.5	5.2	2.4	1.0	0.7	6.3	11.7	1.2	3.3	2.5	4.6	1.7	0.4	1.4	1.4	13.5	5.4	4.5	0.9	1.5	0.3	0.7	20.3	4.3	2.1	0.3	1.7	1.3	6.9	1.0	3.8	2.7	0.0	3.3	10.1	0.6	0.2	0.5	12.4	9.4	1.8	0.4	2.3	0.0	1.3	1.2	1.8	1.3	11.6	19.4	0.4	0.0	0.0	0.0	9.6	0.3	0.0	0.4	0.8	10.8	9.8	1.1	7.7	0.2	3.6	6.0	14.4	5.9	1.2	21.6	27.4	0.1	11.4	0.0	0.7	19.0	4.3	0.2	7.8	0.3	10.9	2.2	0.7	8.7	0.2	3.7	0.0	2.6	6.1	6.8	13.6	13.4	8.4	0.0	0.0	20.7	13.1	4.8	13.9	3.7	6.6	0.3	0.0	1.5	5.6	6.0	0.0	0.0	1.8	0.1	11.5	3.4	4.6	0.0	1.8	5.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.8	1.6	5.2	2.4	1.4	1.4	1.5	0.3	1.7	0.2	1.8	1.3	0.9	35.3	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	6.5	0.0	0.0	0.6	14.7	0.0	0.0	0.4	0.0	3.9	11.9	0.0	5.7	1.0	0.3	0.0	0.0	0.0	9.8	0.0	0.5	0.0	11.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696305	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	30.1	12.3	11.3	23.7	12.4	31.5	23.6	13.9	12.3	21.6	13.6	28.8	8.7	23.8	6.5	17.7	24.2	21.8	40.9	10.5	12.1	22.9	13.9	28.7	22.3	14.9	12.7	24.0	12.9	15.2	13.8	22.9	13.2	22.2	8.5	6.9	15.1	18.4	23.7	19.3	18.7	22.0	13.1	34.5	18.7	17.2	12.9	15.1	18.0	30.3	14.5	23.4	19.1	13.6	22.6	16.3	20.4	20.1	37.7	30.2	9.4	22.0	24.4	27.0	21.2	7.8	4.5	24.2	15.0	43.2	18.7	8.3	13.4	15.5	16.9	21.7	29.3	19.6	22.6	11.0	19.5	15.6	20.1	22.3	10.4	33.6	17.1	16.3	65.7	17.4	12.2	31.1	21.4	15.9	27.3	15.9	12.5	4.5	16.8	14.3	53.0	15.6	9.4	10.3	10.6	25.3	14.6	17.1	17.9	24.9	17.3	14.8	60.5	67.8	17.8	37.3	26.9	30.3	33.6	8.9	14.4	12.0	18.0	15.0	11.4	15.3	2.8	11.8	3.0	2.0	3.4	2.8	4.9	2.4	3.3	3.2	25.1	1.9	12.5	1.9	2.9	3.5	11.3	12.4	13.9	12.3	10.5	12.1	14.9	12.7	13.2	13.1	12.9	13.6	31.6	19.2	14.5	23.5	11.0	7.8	5.4	3.9	5.7	15.8	9.5	8.9	10.3	12.8	5.1	16.5	14.6	3.2	25.8	3.3	9.8	4.5	8.3	10.0	12.3	33.0	4.2	2.1	39.8	8.1	3.3	13.6	3.1	9.3	3.8	7.1	48.2	10.1	16.3	18.5	34.2	3.9	2.0	47.1	13.0	6.4	14.9	35.1	23.2	54.4	42.7	8.8	24.7	31.2	36.1	5.2	1.9	13.2	8.3	8.2	3.7	2.4	5.4	14.0	19.7	21.9	12.9	23.9	17.8	6.1	11.2	1.4	15.6	6.2	4.5	3.8
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 31.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	4.9	3.9	5.1	6.4	4.4	5.8	6.0	9.4	7.7	7.8	0.0	6.0	5.3	9.3	3.6	8.5	7.2	4.5	5.5	6.4	4.8	5.0	4.5	6.2	7.3	2.7	2.0	8.6	6.4	8.0	3.9	7.1	3.6	7.3	5.3	4.1	7.3	6.3	11.1	8.5	5.5	7.6	2.7	6.3	5.8	7.5	3.1	9.6	5.5	10.2	9.8	7.1	6.7	5.6	8.1	9.0	16.8	14.7	9.9	11.9	11.1	9.0	7.9	10.2	10.7	12.6	5.8	16.7	6.4	23.2	14.6	19.7	17.4	18.0	12.4	12.4	14.3	21.8	8.5	12.9	7.9	22.9	10.1	7.6	20.5	10.7	9.6	15.8	13.5	12.4	56.1	18.8	11.0	8.3	15.6	11.9	10.3	5.8	13.8	16.9	15.6	13.3	9.0	5.8	9.7	8.5	17.0	17.8	1.5	14.7	7.4	27.6	13.0	12.4	15.9	11.7	43.3	10.8	9.3	15.3	14.6	23.2	13.2	31.5	4.0	2.7	5.2	3.2	9.3	6.7	7.5	4.8	4.9	9.1	5.2	5.2	0.2	4.1	1.9	6.1	5.7	3.0	5.1	4.4	9.4	7.7	6.4	4.8	2.7	2.0	3.6	2.7	3.1	5.6	19.9	19.2	12.2	32.7	20.8	9.8	10.5	9.7	30.7	18.5	13.3	16.8	20.9	10.0	14.9	14.7	22.9	20.6	17.0	7.1	3.9	9.7	5.5	35.3	55.4	14.5	15.4	12.8	66.1	7.5	11.5	16.1	15.8	39.4	3.8	35.3	6.1	8.3	7.3	23.5	64.5	9.3	6.1	8.2	6.4	4.4	11.5	15.3	0.0	45.9	18.8	14.9	10.3	87.4	57.1	12.5	8.1	12.4	18.2	13.6	9.3	6.9	10.6	29.8	6.6	21.8	19.4	14.7	25.7	28.1	11.8	33.1	25.2	8.1	11.7	16.7
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557046-136792477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 88.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	13.2	88.1	21.7	11.7	23.6	14.1	9.5	21.6	18.9	8.4	7.0	8.7	7.3	11.3	7.7	10.0	12.9	7.5	11.3	18.6	18.9	10.6	9.0	11.9	12.1	17.2	20.7	49.3	30.9	1.9	16.2	5.3	16.1	18.0	9.7	14.5	7.1	7.1	6.3	8.0	9.0	5.1	16.6	11.7	14.8	12.0	24.8	8.2	12.8	6.1	12.3	18.5	9.2	15.7	5.6	3.4	0.0	0.0	7.6	20.2	1.9	8.0	42.6	4.0	3.8	0.3	5.6	3.3	11.5	11.1	3.0	7.6	13.6	4.1	10.5	4.6	10.6	28.9	7.6	0.0	36.3	13.6	0.1	26.8	5.3	6.3	17.9	15.4	13.6	4.1	7.3	31.2	28.7	10.9	0.3	11.6	1.3	10.9	4.5	7.6	8.9	13.2	16.2	35.3	9.7	6.4	6.6	6.3	1.8	1.4	1.4	12.0	12.0	6.7	2.1	0.4	7.5	25.3	18.0	0.0	5.3	18.6	6.0	3.5	1.8	2.1	1.5	1.4	2.9	1.1	2.5	2.2	1.5	1.5	0.2	0.8	5.2	2.3	1.4	1.5	4.6	0.9	21.7	23.6	21.6	18.9	18.6	18.9	17.2	20.7	16.1	16.6	24.8	15.7	11.9	6.4	22.0	383.6	14.3	5.0	20.5	32.0	3.4	18.2	10.0	5.0	21.2	4.3	35.1	11.0	6.2	1.0	25.9	12.3	3.9	3.0	6.4	17.3	31.4	7.7	34.8	14.9	170.4	23.1	1.1	12.1	20.9	62.5	5.7	67.7	9.7	11.2	8.0	0.0	204.8	18.2	14.2	23.5	10.2	4.2	23.6	26.6	0.0	216.4	21.7	43.3	12.3	210.1	4.2	17.8	8.7	14.3	13.5	18.8	7.2	8.3	20.5	2.6	13.1	5.3	17.9	3.4	15.5	13.1	10.1	2.7	18.5	16.2	11.2	23.4
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587072	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	11.8	12.5	13.1	12.5	15.1	8.7	14.3	15.6	17.3	14.3	11.7	11.6	9.2	16.6	16.5	10.6	11.0	12.7	16.9	14.7	14.9	11.4	11.6	10.4	16.4	15.3	13.7	15.8	9.7	16.3	13.0	17.4	15.8	14.9	10.9	23.5	12.1	13.3	16.9	13.9	9.8	14.0	15.3	17.6	10.8	9.9	13.8	20.8	14.7	18.4	16.8	14.3	12.2	22.4	16.7	14.4	41.3	35.6	29.5	39.1	29.0	32.7	37.7	28.8	36.1	18.6	15.5	36.9	20.4	35.6	25.6	17.3	26.3	25.5	48.7	19.0	27.7	32.9	19.9	24.9	30.8	36.9	24.4	32.5	30.5	28.2	34.2	33.1	27.4	31.8	67.0	29.3	41.8	20.3	17.2	31.2	34.0	25.7	18.0	29.3	73.9	18.0	24.2	18.4	20.8	29.5	22.9	15.6	24.8	32.2	15.5	64.7	26.5	23.3	14.7	21.6	30.9	25.9	24.7	15.8	35.7	39.7	35.0	18.2	11.5	18.4	12.8	15.9	14.5	13.0	12.3	12.5	14.6	9.9	13.7	13.4	11.5	17.9	17.6	8.9	20.8	13.4	13.1	15.1	15.6	17.3	14.7	14.9	15.3	13.7	15.8	15.3	13.8	22.4	16.1	16.0	26.9	47.0	24.3	36.3	20.8	19.5	21.6	23.3	17.9	12.3	31.0	14.3	16.9	16.5	27.1	31.8	17.8	12.4	7.9	17.6	3.6	10.9	19.8	21.2	12.1	14.1	85.7	20.9	34.6	23.2	16.3	14.8	13.9	25.9	25.7	20.7	24.3	28.6	63.8	13.7	20.3	27.3	24.6	3.2	26.8	21.7	21.4	36.5	35.2	19.6	16.5	50.8	137.2	20.1	9.1	41.0	18.8	30.1	11.1	16.6	21.4	21.5	19.7	28.0	18.5	25.9	24.9	21.3	37.2	48.4	22.7	18.1	15.1	24.8
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.2;tongue: 45.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 77.2;monocytes: 24.7;Smooth muscle cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 53.1"	"Group enriched"	"Detected in all"	8	"B-cells: 22.8;granulocytes: 53.1;monocytes: 14.1"	"Cell line enriched"	"Detected in many"	4	"RH-30: 231.7"					"Not detected"	"Not detected"			"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	5.4	7.1	6.5	8.3	4.2	4.3	3.8	2.7	6.0	4.4	1.8	3.5	2.3	6.0	4.9	3.6	4.8	5.5	29.2	4.5	5.1	6.4	5.4	10.5	9.5	6.8	5.2	5.1	7.9	3.0	3.8	2.8	5.0	7.1	3.7	2.5	2.5	3.3	41.2	4.9	4.9	5.7	4.0	6.2	3.5	5.3	4.0	3.8	3.2	45.6	9.1	5.1	3.1	6.0	3.3	1.0	0.4	1.3	0.6	18.9	0.7	5.1	11.6	10.6	29.4	5.5	1.4	22.5	1.6	19.7	0.4	0.0	0.4	15.5	51.8	6.1	0.2	3.0	3.1	0.4	2.8	0.0	0.2	6.5	26.8	37.6	38.5	5.4	2.2	0.9	3.1	12.0	55.9	0.7	0.8	0.2	1.6	2.5	1.3	0.1	231.7	0.4	1.4	0.9	1.7	0.9	0.0	0.0	1.6	4.3	0.3	1.6	2.3	23.5	18.8	5.5	0.8	5.6	1.8	1.2	4.1	2.2	5.3	53.1	14.1	3.4	1.7	11.3	3.9	18.0	1.2	1.7	2.0	22.8	1.8	3.1	21.1	2.1	5.3	2.2	3.1	95.7	6.5	4.2	2.7	6.0	4.5	5.1	6.8	5.2	5.0	4.0	4.0	6.0	4.0	0.0	3.0	5.9	9.4	8.5	7.5	5.8	2.8	2.5	1.7	1.1	1.5	2.8	1.2	0.0	2.1	0.4	3.3	0.7	0.0	1.4	1.2	2.0	2.3	4.9	4.8	0.8	4.0	1.5	0.5	3.7	0.5	1.8	1.3	1.7	1.4	4.5	3.3	0.0	6.2	2.9	0.0	16.5	5.8	1.3	0.6	77.2	5.4	16.9	24.7	1.4	19.6	14.1	3.6	4.0	3.1	4.5	1.0	3.1	4.8	3.9	2.0	1.7	19.7	19.2	47.7	1.2	1.7	3.1	9.5	0.4	4.9	3.4	1.8	2.9
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;retina: 9.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.6;Inhibitory neurons: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.2	1.0	3.3	1.0	4.6	0.7	1.3	10.7	22.7	0.9	0.4	1.5	1.5	0.4	1.5	5.1	1.0	0.4	0.5	4.0	3.2	1.4	0.7	1.9	1.4	8.6	3.0	0.6	2.2	2.7	1.1	0.6	7.7	0.9	1.5	9.6	1.7	0.5	0.8	4.0	1.4	0.2	0.3	0.9	1.6	5.5	10.0	0.9	2.7	0.4	3.6	0.7	1.8	6.8	22.3	10.5	2.0	2.5	0.0	0.0	6.7	0.5	0.3	2.1	1.9	7.8	8.6	4.5	2.8	0.1	4.7	10.3	6.5	12.8	2.2	3.0	1.7	0.2	4.1	5.2	0.3	0.5	0.9	0.1	6.5	1.5	12.7	3.7	0.0	4.1	1.7	1.0	0.5	9.4	3.7	0.5	4.2	9.0	4.5	1.3	3.9	0.9	4.6	10.9	13.8	3.0	6.3	7.7	1.2	3.7	6.9	0.8	0.0	0.0	8.5	0.0	3.5	2.2	5.6	2.4	3.4	0.4	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	3.3	4.6	10.7	22.7	4.0	3.2	8.6	3.0	7.7	0.3	10.0	6.8	0.3	6.4	13.4	6.8	3.9	8.7	13.7	9.4	6.8	17.7	11.2	4.8	2.3	14.3	12.4	7.3	12.5	2.8	1.7	5.7	1.9	6.1	19.8	7.4	0.7	0.8	8.4	0.0	49.6	4.8	1.6	1.0	4.1	8.5	1.3	1.8	1.1	4.8	1.2	30.3	58.1	4.0	4.1	0.8	1.9	20.0	0.6	0.8	3.6	5.6	0.4	3.2	0.0	8.5	1.3	11.1	3.9	0.0	2.8	15.8	2.6	2.8	7.1	12.7	0.0	0.8	1.3	8.0	8.4	12.6	9.1	4.0	3.7	6.0	5.8	27.9
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 743.9"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038149, HPA038150"	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA		880000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	127.4	55.7	475.5	50.4	483.4	16.1	98.0	433.2	406.8	118.0	215.5	193.2	35.1	111.7	69.7	90.7	94.7	52.9	380.9	351.2	408.7	88.3	66.0	105.0	35.0	567.9	490.6	90.0	71.4	31.4	56.1	64.8	509.2	92.7	47.6	149.0	71.4	88.1	743.9	120.6	80.6	94.5	526.1	64.0	93.9	80.0	552.3	42.1	61.1	491.0	37.8	135.5	115.2	533.2	121.9	95.7	117.1	89.3	168.6	298.5	49.5	222.6	241.2	184.1	204.9	81.3	74.4	102.3	50.7	337.9	172.8	79.2	151.4	201.6	204.7	148.7	63.8	69.3	102.8	106.0	228.6	48.6	53.9	251.4	246.4	224.0	271.6	167.1	245.1	70.6	91.2	115.3	146.9	69.1	69.5	58.9	70.9	59.9	195.0	36.6	110.1	128.1	118.2	100.1	46.4	72.3	171.0	68.3	118.6	163.0	50.1	44.8	334.5	172.7	132.3	182.9	144.4	80.4	66.9	47.8	222.2	58.6	167.3	10.5	6.6	3.7	15.6	10.6	7.5	12.3	10.2	12.7	7.1	11.5	4.9	7.6	2.6	13.4	27.3	10.8	13.0	9.7	475.5	483.4	433.2	406.8	351.2	408.7	567.9	490.6	509.2	526.1	552.3	533.2	147.9	70.5	48.2	124.4	45.1	74.8	55.4	53.1	42.7	392.2	34.7	36.2	921.5	48.6	53.4	80.9	625.5	33.8	54.6	43.7	27.4	97.8	116.2	78.2	143.2	110.4	28.8	21.6	63.7	65.3	81.0	105.5	39.8	93.4	27.8	81.6	50.0	57.3	38.0	47.1	71.2	31.7	34.6	28.3	50.5	38.8	77.0	40.0	78.2	95.5	72.0	82.8	47.4	77.9	167.2	92.0	28.0	103.0	47.2	89.0	37.1	39.2	43.6	97.5	72.3	149.0	119.0	65.6	64.3	58.7	69.6	22.4	60.5	137.4	39.5	44.7
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.7	1.5	0.6	14.6	0.7	9.2	1.7	0.7	1.2	1.6	0.7	5.0	2.7	1.3	0.8	2.8	1.8	2.3	1.7	0.7	0.8	2.7	3.0	6.2	32.2	1.0	0.8	0.9	1.2	0.2	1.8	1.8	0.9	2.5	2.3	16.1	2.8	0.5	0.8	1.9	30.1	0.9	0.8	56.9	3.1	1.5	0.9	13.1	3.2	0.2	29.3	2.9	2.1	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.8	1.0	0.8	0.9	0.8	0.9	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784918-64803241	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	5.0	3.9	8.9	6.9	7.2	15.5	4.1	9.8	9.9	4.6	4.9	5.6	3.3	4.8	2.5	2.7	3.8	4.2	4.3	7.6	7.0	5.4	2.0	9.7	17.6	7.8	8.0	3.4	5.0	3.2	5.8	8.9	8.1	4.7	3.0	5.3	6.6	5.8	2.5	3.5	8.9	3.7	6.6	18.0	5.2	4.6	9.7	7.4	7.0	1.5	14.2	4.6	3.5	8.8	9.4	8.4	5.4	9.8	4.7	2.9	12.7	7.0	6.5	8.2	5.8	3.7	4.3	16.4	12.6	8.0	14.5	2.8	6.5	6.8	4.9	21.5	3.1	28.9	12.0	7.9	5.8	15.3	10.4	2.9	3.4	6.4	4.1	5.7	20.3	28.0	2.5	1.5	2.5	11.8	9.2	15.2	3.6	5.6	11.2	18.8	0.6	18.9	4.6	4.7	6.4	9.3	6.0	7.8	6.4	6.1	15.5	23.2	15.8	6.8	15.0	6.3	2.9	1.8	3.8	18.1	6.0	22.8	5.1	2.2	4.3	5.9	4.9	12.5	4.9	9.9	6.5	4.4	4.4	6.6	7.7	6.0	8.0	2.5	15.8	5.0	9.5	7.3	8.9	7.2	9.8	9.9	7.6	7.0	7.8	8.0	8.1	6.6	9.7	8.8	21.6	3.2	4.8	6.8	32.9	1.3	2.8	1.8	6.2	20.6	8.1	10.4	4.7	7.2	2.4	1.8	25.0	7.6	9.4	6.8	3.9	1.7	33.8	2.6	3.8	20.0	6.0	5.0	5.9	1.7	11.3	4.9	9.2	6.0	1.3	7.7	24.3	2.0	11.0	11.8	4.6	1.8	6.1	8.9	3.1	46.8	4.1	16.2	1.8	18.7	13.4	7.2	14.4	2.0	7.2	0.9	16.2	7.2	15.6	1.8	1.6	3.6	1.5	14.6	6.6	3.7	4.3	2.1	13.8	5.2	1.4	5.1	19.9	22.6	2.2	2.0
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437301	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 118.8;Excitatory neurons: 201.0;Inhibitory neurons: 198.3;Microglial cells: 144.3;Oligodendrocyte precursor cells: 160.4;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"AF22: 102.3;RT4: 97.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	15.8	17.1	11.6	6.7	12.5	10.5	16.6	21.6	16.7	15.0	15.3	15.5	13.2	17.2	13.4	10.2	13.6	14.7	19.3	14.2	11.2	24.5	15.1	13.3	6.1	9.9	10.0	20.2	12.2	25.3	12.2	27.4	10.0	16.9	13.0	28.0	10.8	14.0	30.9	16.4	14.3	14.5	11.3	11.6	26.6	21.3	10.2	8.1	24.4	22.2	6.1	18.3	11.4	14.4	25.6	15.6	102.3	16.3	16.3	32.4	28.0	22.1	28.3	21.6	18.3	13.3	12.6	5.5	24.3	15.3	22.1	13.6	39.0	19.7	32.6	6.3	16.0	9.2	10.8	30.9	42.3	4.0	14.5	29.3	19.0	28.1	30.1	22.6	18.8	5.0	12.1	9.9	29.2	13.9	9.0	6.0	30.7	24.0	23.4	9.9	33.3	4.2	28.3	97.3	18.2	20.7	12.9	20.7	58.8	32.0	13.9	5.6	15.4	16.7	19.7	15.0	12.1	15.1	9.3	1.9	20.5	6.6	19.0	0.7	0.1	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	11.6	12.5	21.6	16.7	14.2	11.2	9.9	10.0	10.0	11.3	10.2	14.4	36.2	3.2	8.4	118.8	8.1	17.6	17.9	11.0	16.5	24.7	14.1	12.3	38.2	21.5	16.5	22.0	25.0	13.1	4.1	12.5	19.6	10.3	45.1	22.3	19.9	20.6	9.6	4.6	201.0	12.4	6.7	18.2	25.5	59.4	2.5	15.6	14.3	18.6	9.7	6.7	198.3	13.9	2.0	10.9	20.6	103.0	20.8	14.4	5.4	144.3	4.4	13.2	3.1	160.4	129.2	17.5	5.7	17.7	14.3	18.6	14.0	11.9	19.5	37.9	19.7	18.7	17.6	22.6	19.8	11.8	19.2	10.4	5.9	17.4	10.6	30.2
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 472.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 337.3;Oligodendrocytes: 1134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	54.1	9.1	272.6	42.9	316.1	72.5	32.2	208.8	252.5	23.9	95.0	21.1	10.6	27.4	12.1	35.2	19.7	34.5	44.8	219.4	256.3	15.0	32.8	29.2	54.1	317.5	286.1	23.1	16.1	15.0	10.0	49.4	273.1	13.9	17.8	22.7	19.3	10.2	37.4	21.1	17.7	28.7	246.7	24.2	22.0	40.1	348.5	44.3	15.8	30.6	60.1	33.1	25.6	472.1	112.7	83.8	175.2	84.3	162.4	288.6	219.5	139.8	114.3	122.2	100.1	139.5	145.6	163.1	118.3	210.3	36.0	45.5	56.0	123.2	121.1	219.8	38.0	122.4	62.5	367.7	136.7	59.1	5.5	261.3	55.3	301.9	133.5	122.1	322.5	90.3	80.9	0.4	325.4	61.3	137.8	36.5	89.2	42.5	131.5	164.1	120.0	0.6	81.2	38.8	68.5	113.6	96.5	0.4	104.0	160.8	22.4	105.1	409.1	240.5	102.9	70.6	168.6	0.3	0.4	96.7	155.2	73.2	180.1	8.8	3.2	0.0	2.3	3.2	1.6	3.4	2.9	1.5	1.1	5.0	2.2	2.5	13.5	1.1	3.1	6.0	3.7	1.5	272.6	316.1	208.8	252.5	219.4	256.3	317.5	286.1	273.1	246.7	348.5	472.1	104.3	19.2	23.9	283.0	64.5	30.0	41.9	17.4	12.5	109.1	14.3	17.4	71.0	28.6	29.6	18.4	50.1	13.1	38.4	12.0	0.0	57.4	31.5	67.2	77.1	84.2	17.4	48.0	197.5	53.2	23.4	49.7	26.5	101.0	24.0	151.8	67.1	39.2	38.8	35.3	122.4	13.6	14.2	26.9	245.9	46.0	55.0	54.7	19.6	337.3	88.0	49.2	10.3	228.7	1134.5	128.1	12.0	17.3	18.0	72.1	5.3	6.3	22.9	10.4	52.6	65.2	73.3	29.0	82.1	24.3	24.6	7.8	38.4	17.2	14.4	40.4
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"	Q9Y4K4	14	50418501-50561126	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 332.7;Oligodendrocytes: 707.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 66.7;eosinophil: 26.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 66.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036696, HPA078030"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA036696: AB_10672362, HPA078030: "	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	20.5	12.8	16.2	13.2	31.1	22.1	22.2	20.7	21.5	30.6	3.9	20.8	13.1	33.4	12.9	20.5	19.0	21.5	10.9	18.3	23.9	11.9	10.0	17.1	12.4	28.4	22.0	32.4	14.2	14.8	11.8	19.8	24.8	17.9	16.6	18.6	18.0	21.1	12.3	28.5	14.7	24.7	17.6	15.7	16.8	7.9	23.8	11.6	17.0	14.2	13.2	20.2	23.8	58.1	51.7	15.2	36.5	31.5	33.0	34.5	35.6	59.2	53.0	39.4	34.9	19.3	35.2	35.3	34.3	54.6	20.9	36.1	34.3	31.9	59.7	29.4	24.8	21.7	27.1	17.5	27.9	19.6	33.0	25.2	25.7	34.8	36.1	63.0	52.6	31.7	20.8	22.5	58.6	19.4	26.6	18.7	17.7	16.6	29.5	31.8	55.4	13.5	39.2	39.5	11.7	26.5	33.5	23.0	23.4	29.3	25.8	14.7	53.8	50.9	35.7	35.2	28.2	16.3	18.0	23.6	19.2	13.5	37.2	66.7	2.8	26.3	6.7	3.3	3.8	6.1	4.2	5.9	3.0	9.7	4.4	4.6	1.0	10.1	2.2	4.9	1.0	1.9	16.2	31.1	20.7	21.5	18.3	23.9	28.4	22.0	24.8	17.6	23.8	58.1	40.5	41.7	20.8	135.2	29.9	70.0	42.9	21.4	56.3	56.7	32.6	26.5	10.5	30.0	27.4	27.6	47.9	11.4	30.6	27.5	19.6	29.5	3.7	25.7	52.2	40.4	23.4	46.7	144.2	20.9	19.5	50.1	43.8	49.1	29.8	37.8	38.6	9.0	8.1	33.7	144.1	16.4	8.2	12.3	24.8	3.7	42.6	25.1	23.2	101.2	18.3	19.5	18.6	332.7	707.2	25.9	20.2	51.1	27.0	57.4	10.9	12.0	25.6	33.1	13.1	49.7	41.7	10.6	14.1	54.9	86.1	6.6	31.5	22.4	18.6	61.7
MAP6	"FLJ41346, KIAA1878, MAP6-N, STOP"	ENSG00000171533	"Microtubule associated protein 6"	Q96JE9	11	75586918-75669038	"Predicted intracellular proteins"	Transport	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 76.8;retina: 96.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015442, CAB022600, HPA039061, HPA039062"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326"	"unprognostic (3.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.99e-2)"	"unprognostic (7.99e-2)"	"prognostic favorable (3.41e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.09e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	4.8	19.0	68.3	2.0	68.0	0.0	3.5	50.7	70.6	10.6	64.4	23.0	1.7	18.1	21.0	4.2	40.7	6.4	8.6	67.7	71.5	17.0	1.2	7.8	0.7	70.2	64.6	8.0	3.6	22.0	76.8	1.5	70.8	17.8	3.5	96.1	3.6	21.1	1.0	8.1	4.8	13.1	52.9	2.4	10.7	18.6	68.5	0.8	7.9	1.3	0.5	7.1	8.4	59.7	0.2	0.7	37.8	0.1	0.1	0.0	0.0	3.8	0.2	0.3	0.0	38.1	0.1	0.6	1.4	6.3	1.3	0.0	3.4	0.5	0.0	21.5	0.5	0.0	0.0	0.0	1.0	0.0	0.0	2.1	0.5	0.1	0.2	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.9	0.0	2.9	0.0	0.0	0.1	0.1	0.5	62.4	31.7	4.6	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.3	68.0	50.7	70.6	67.7	71.5	70.2	64.6	70.8	52.9	68.5	59.7	1.2	3.2	3.7	25.8	0.1	0.8	1.7	0.7	0.0	81.2	0.8	1.8	8.4	1.5	3.1	11.0	158.4	0.2	0.2	0.0	1.9	0.1	27.7	28.2	4.6	1.6	13.1	0.0	75.8	0.2	0.0	2.9	0.0	0.8	0.0	0.8	2.2	0.3	0.1	50.5	43.3	0.0	6.1	0.0	1.1	41.9	7.5	0.3	5.4	1.9	0.0	18.7	0.0	13.0	13.3	0.2	0.0	18.4	0.1	1.4	0.0	1.2	25.4	10.2	0.0	1.9	5.7	23.5	4.3	0.1	0.4	0.0	0.3	0.1	0.0	0.4
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815922-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.6;choroid plexus: 24.9;skeletal muscle: 26.9"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocytes: 101.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"T-47d: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	0.8	0.9	40.9	0.3	66.1	0.2	0.9	60.3	73.2	1.1	24.9	1.3	0.7	1.0	0.9	1.4	1.1	0.4	1.8	40.9	44.5	1.2	1.2	0.7	0.7	67.1	59.1	1.1	4.7	0.4	2.2	0.3	60.4	3.4	0.3	1.0	1.2	0.7	26.9	3.6	1.0	0.4	53.0	1.3	0.7	1.3	56.3	3.6	1.0	14.3	0.4	1.0	1.2	102.6	3.5	2.1	3.6	0.7	0.9	1.2	2.8	4.2	0.8	7.3	5.3	2.5	0.1	0.3	5.4	6.1	3.6	2.7	6.9	1.6	4.5	2.3	11.8	0.5	0.0	0.0	2.3	4.5	1.5	0.5	0.6	1.7	0.8	0.4	1.7	5.5	0.5	0.0	0.7	14.8	10.0	5.8	2.2	2.0	6.7	5.0	5.7	0.0	0.4	0.0	11.7	2.1	2.9	2.2	4.4	2.5	63.9	4.2	0.8	1.8	2.5	2.7	6.1	2.4	1.6	1.4	0.6	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	40.9	66.1	60.3	73.2	40.9	44.5	67.1	59.1	60.4	53.0	56.3	102.6	0.0	0.0	0.0	4.9	0.1	1.1	0.7	0.9	0.6	2.5	0.0	0.0	2.4	0.0	0.4	0.0	2.1	0.3	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.4	7.4	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.7	0.4	0.9	1.7	3.5	0.4	4.1	0.0	0.7	2.2	0.9	0.3	0.0	0.0	0.5	0.8	1.0	7.1	101.3	0.0	0.1	0.0	0.2	2.4	0.2	0.0	0.3	1.9	0.0	1.6	0.4	2.9	2.1	1.0	1.4	0.7	0.3	0.0	0.3	0.7
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 130.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Microtubules	"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.7	8.4	36.6	4.9	81.2	4.8	13.1	53.0	49.8	6.1	0.6	24.6	29.0	2.4	19.5	15.8	10.0	8.2	1.4	40.2	59.8	32.6	17.2	7.0	1.5	78.0	67.2	1.5	25.1	24.9	12.0	6.8	75.8	20.0	23.2	57.3	20.3	6.4	0.8	17.1	26.6	2.4	43.3	1.8	18.7	27.4	63.0	5.1	16.1	0.2	5.1	12.0	9.6	130.4	25.6	39.2	0.3	0.1	0.2	0.2	40.4	0.7	1.2	0.4	0.7	59.8	26.3	0.1	5.3	0.8	6.7	38.2	11.1	34.6	0.7	0.2	24.6	26.6	69.2	0.5	0.3	26.1	3.0	0.1	31.5	0.2	2.4	1.0	0.2	2.0	18.4	0.6	0.1	88.5	0.2	2.6	5.2	55.3	5.7	0.1	1.0	4.8	23.6	68.4	24.4	5.2	27.4	51.7	0.6	9.1	20.5	2.6	0.5	0.1	1.9	0.4	1.7	4.6	6.4	0.2	0.5	10.1	0.7	2.8	2.3	0.0	0.0	1.6	0.3	1.4	0.5	0.0	5.7	1.6	0.1	0.0	12.2	0.7	3.1	0.0	0.2	0.7	36.6	81.2	53.0	49.8	40.2	59.8	78.0	67.2	75.8	43.3	63.0	130.4	4.0	57.7	51.4	117.2	1.9	28.2	48.7	21.7	33.6	367.0	29.5	18.4	3.0	28.6	42.9	18.4	146.0	33.1	0.7	67.9	31.3	35.8	293.9	30.4	5.9	4.9	117.7	35.1	217.1	49.0	23.1	4.4	42.8	60.8	0.0	1.2	0.7	37.0	16.3	304.5	258.6	81.5	22.4	3.2	8.5	53.1	6.8	6.2	17.8	15.0	3.2	50.9	0.0	26.2	1501.2	37.2	51.9	3.4	4.4	56.6	60.7	81.8	56.0	104.7	19.7	2.0	5.2	37.5	23.4	49.0	30.4	76.2	3.4	2.8	64.2	62.8
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 286.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	67.9	23.2	41.7	41.5	60.7	36.2	47.1	50.7	52.2	38.9	0.4	84.1	18.9	50.0	3.9	48.8	34.8	28.8	122.4	40.8	43.5	21.8	7.7	53.2	25.0	74.7	58.2	24.8	14.7	12.5	36.5	24.0	78.4	39.5	9.4	13.0	33.5	28.2	286.0	71.6	31.4	34.0	23.3	33.5	39.3	12.6	67.3	22.6	33.1	106.5	17.6	62.1	41.2	96.2	104.8	60.3	92.7	58.9	55.6	41.9	68.3	102.3	102.8	105.4	92.5	33.9	104.6	43.8	85.7	93.5	57.7	112.3	38.3	139.1	34.4	74.9	34.4	29.7	42.5	13.2	87.3	44.0	73.3	73.4	38.6	142.6	87.8	81.5	72.9	59.8	29.1	65.3	59.3	21.0	81.6	37.2	84.7	14.7	33.5	83.8	68.4	41.5	53.0	35.7	35.7	68.6	58.7	32.3	79.6	49.7	21.6	30.9	138.3	123.6	94.4	105.5	140.6	64.4	20.6	52.5	105.8	29.7	75.9	0.1	0.4	0.4	0.3	0.2	0.4	0.0	0.2	0.2	0.2	0.1	0.5	0.2	1.4	0.1	0.1	0.2	0.1	0.0	41.7	60.7	50.7	52.2	40.8	43.5	74.7	58.2	78.4	23.3	67.3	96.2	40.6	44.8	14.4	12.1	26.5	143.1	147.3	18.4	47.8	35.4	44.0	26.3	172.6	17.2	17.9	23.9	10.4	48.3	58.2	39.9	17.6	43.3	36.9	32.1	38.6	46.7	10.1	16.2	17.4	27.4	111.3	48.0	29.6	60.1	12.7	56.3	30.7	9.7	69.9	48.8	35.1	14.9	10.2	40.6	125.3	77.1	30.7	65.1	32.0	9.4	35.9	32.3	75.2	9.5	62.3	66.1	29.2	47.8	53.2	98.5	63.0	14.3	10.0	39.8	19.7	51.6	55.8	17.6	16.1	62.7	141.8	130.2	59.8	17.0	19.5	157.6
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 264.2;Late spermatids: 288.5;Spermatogonia: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035598, HPA058101"	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Centrosome	Cytosol	"HPA035598: AB_10671108, HPA058101: AB_2683604"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.38e-5)"	18.1	4.5	1.4	5.8	1.5	5.0	11.4	1.2	1.8	7.4	2.9	8.3	2.2	9.7	6.1	6.1	13.2	6.0	8.7	1.2	1.7	3.7	4.1	5.9	6.6	1.8	1.6	16.8	2.1	5.8	4.7	7.1	2.0	3.7	3.3	1.5	3.0	4.1	11.5	4.5	5.6	8.8	1.5	6.3	5.0	15.8	1.8	5.3	8.2	9.1	5.0	7.7	6.4	1.9	33.6	11.8	8.7	15.0	19.3	20.1	12.1	31.6	17.4	25.3	34.6	11.7	16.5	17.3	50.0	27.9	26.8	15.7	25.6	16.9	33.5	15.9	25.6	10.3	18.0	0.0	21.0	25.2	10.2	41.1	9.5	26.0	32.0	14.2	20.0	28.1	9.0	26.1	18.8	20.9	30.4	10.2	12.4	8.1	0.3	29.5	23.5	8.4	0.8	5.1	6.1	13.0	18.4	6.7	11.4	14.5	0.1	11.5	60.3	26.9	15.5	34.6	40.6	17.8	22.7	19.3	18.5	42.3	13.0	6.6	3.5	1.1	5.2	4.2	6.5	7.5	4.9	5.8	4.4	6.4	5.2	4.1	0.7	6.6	7.9	4.6	3.8	2.9	1.4	1.5	1.2	1.8	1.2	1.7	1.8	1.6	2.0	1.5	1.8	1.9	36.6	16.0	6.7	4.2	18.5	7.1	7.2	15.4	14.8	0.7	5.1	9.1	41.5	11.5	8.7	18.4	0.0	10.3	13.8	3.7	1.9	8.6	264.2	13.7	47.3	24.9	5.4	12.6	1.9	14.7	103.4	46.5	2.0	5.1	35.5	15.2	50.7	30.4	15.4	20.2	1.0	2.8	8.2	17.3	7.8	288.5	63.3	15.0	7.2	5.6	23.4	12.2	22.6	1.5	3.6	13.0	14.1	47.8	10.0	13.5	0.7	54.6	6.5	2.9	39.5	29.8	61.5	53.2	106.9	5.3	4.8	13.4	18.6	15.9	3.3	2.4
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 902.0;Excitatory neurons: 1018.9;Inhibitory neurons: 727.8;Late spermatids: 400.5;Oligodendrocyte precursor cells: 596.6;Oligodendrocytes: 302.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"AF22: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	26.1	15.6	45.2	5.1	61.6	14.5	7.4	25.4	91.3	17.5	23.5	5.7	3.6	14.5	18.8	9.8	15.8	13.8	6.9	60.4	24.9	20.4	3.2	8.6	5.2	29.0	36.2	14.7	7.4	10.3	25.5	4.3	31.4	22.4	5.4	18.3	4.7	24.2	2.6	4.6	5.1	15.5	24.9	7.4	6.6	26.4	39.2	3.4	20.5	4.2	4.6	14.0	18.4	55.6	2.9	4.9	155.0	4.8	4.1	3.6	5.6	3.2	2.9	2.7	1.2	3.3	4.4	7.1	5.1	1.9	3.8	9.4	1.8	4.2	4.3	4.9	4.0	5.7	7.3	4.6	3.6	2.7	3.1	4.1	1.9	3.7	5.0	5.5	3.5	4.8	5.2	27.9	1.7	3.5	4.4	3.1	8.8	0.7	3.2	4.9	4.0	2.5	10.7	16.9	9.2	8.4	3.3	5.9	2.2	5.0	8.8	3.3	7.5	6.3	6.4	3.0	2.7	8.2	5.1	4.4	9.9	3.5	3.8	3.3	0.7	1.2	0.8	0.7	1.0	1.3	0.7	1.0	0.6	1.1	1.0	1.4	4.4	1.2	0.7	1.2	1.2	0.9	45.2	61.6	25.4	91.3	60.4	24.9	29.0	36.2	31.4	24.9	39.2	55.6	4.3	22.4	33.8	902.0	1.6	0.8	15.7	5.5	4.0	26.1	3.2	3.7	1.6	8.6	12.8	22.0	6.2	0.3	0.1	0.0	11.7	2.4	219.5	61.1	25.1	1.3	2.4	0.0	1018.9	0.0	0.5	16.9	2.0	7.1	2.5	6.2	1.1	0.0	0.3	38.7	727.8	0.0	4.1	0.3	0.0	400.5	26.4	1.5	1.8	185.5	0.0	15.7	0.0	596.6	302.8	2.0	0.0	54.9	0.1	7.6	0.0	22.6	68.9	10.8	6.6	7.2	18.5	10.5	5.5	1.3	1.0	0.1	0.9	28.5	0.0	22.6
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.5;Astrocytes: 16.6;Endothelial cells: 21.1;Excitatory neurons: 15.8;Hepatic stellate cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	27.5	6.8	52.3	7.9	56.0	1.1	24.0	48.2	70.9	15.1	40.6	7.3	1.9	15.5	5.8	9.4	16.7	8.7	18.9	55.2	49.6	18.6	4.8	16.8	9.4	48.2	47.2	12.5	5.7	5.4	28.4	8.3	48.2	18.2	2.6	8.6	7.2	7.2	6.4	7.5	8.3	9.4	47.4	16.3	10.9	6.1	50.2	3.5	11.0	5.8	6.1	11.6	12.3	51.0	2.8	6.8	7.4	27.8	9.5	14.3	0.2	10.2	7.4	6.8	2.7	2.8	5.2	0.0	8.7	9.9	11.3	6.9	4.9	4.2	0.5	13.9	3.4	10.1	10.4	0.6	10.9	2.5	15.0	19.9	12.3	1.9	0.8	7.7	15.2	10.6	8.1	26.8	6.9	12.4	0.5	9.4	0.6	8.4	7.7	26.7	0.1	9.9	10.3	0.0	6.8	18.4	9.0	3.7	7.7	0.9	12.2	7.9	24.0	20.4	16.5	1.5	3.7	1.2	3.2	11.8	10.4	2.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	56.0	48.2	70.9	55.2	49.6	48.2	47.2	48.2	47.4	50.2	51.0	29.5	0.0	1.1	16.6	2.2	1.9	1.8	3.2	8.0	3.3	1.1	1.5	6.6	1.5	1.7	0.0	6.2	0.0	1.8	0.1	1.9	1.0	4.7	0.6	1.8	21.1	0.0	0.4	15.8	0.2	0.4	2.7	0.5	1.7	0.0	0.1	20.0	2.1	0.3	0.0	3.6	0.2	2.0	1.3	2.1	9.7	3.1	0.5	5.4	13.1	0.1	5.9	0.0	1.0	0.9	0.7	0.0	2.2	1.6	2.9	0.0	1.9	1.3	11.4	0.0	0.6	1.8	1.3	3.2	1.8	1.3	0.0	3.3	0.7	0.1	1.1
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	14	"cerebellum: 37.5"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	8.7	55.9	3.1	8.8	3.0	9.4	14.2	0.5	4.4	18.6	0.0	44.6	30.9	3.4	11.5	102.4	7.6	7.5	2.5	2.9	2.2	17.3	6.7	23.8	7.9	0.6	0.0	5.4	47.7	38.9	33.3	5.6	0.2	16.7	24.4	2.7	49.5	15.5	1.2	74.1	40.1	1.9	0.1	16.1	24.1	40.0	4.2	6.9	18.9	1.0	12.4	12.2	39.3	2.7	31.4	0.3	0.7	0.5	2.4	11.2	4.3	3.3	0.4	0.3	0.8	22.3	28.4	7.0	2.0	2.5	4.6	24.4	0.3	63.8	0.7	20.0	7.9	0.2	1.2	22.8	4.0	0.4	2.2	9.2	25.9	4.3	1.0	4.5	4.1	1.2	0.6	9.4	0.9	12.7	0.4	2.6	0.4	30.9	0.4	21.0	0.5	40.2	11.6	47.0	30.5	0.7	2.5	0.5	0.2	1.3	33.0	4.1	6.3	2.4	0.4	1.0	0.7	0.8	12.7	2.3	0.1	1.3	0.2	7.6	0.4	6.5	18.3	0.1	12.3	13.9	14.5	15.4	0.1	22.0	12.8	14.4	4.6	3.8	0.1	0.2	38.0	8.6	3.1	3.0	0.5	4.4	2.9	2.2	0.6	0.0	0.2	0.1	4.2	2.7	1.5	28.9	33.0	1.0	16.4	27.3	43.5	24.9	15.4	0.7	58.8	17.7	1.7	25.8	27.3	29.5	6.2	55.3	14.9	146.2	15.6	56.9	110.3	9.1	2.8	2.1	65.5	0.0	10.0	115.9	11.8	5.0	32.1	26.2	2.5	21.1	1.1	1.7	40.3	0.0	6.7	83.2	34.6	6.8	3.3	282.5	7.2	8.8	17.8	3.7	14.2	2.1	21.6	1.5	1.2	103.6	102.2	9.8	11.4	37.1	178.4	11.5	3.7	2.4	0.0	2.2	3.4	56.6	2.9	62.6	53.3	32.3	18.5	2.5	93.0	59.9
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;neutrophil: 24.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 79.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		970000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	29.9	26.1	15.2	31.5	16.5	89.3	23.8	19.2	17.1	30.8	19.3	26.6	27.9	37.2	15.8	32.3	25.7	23.5	25.7	17.2	18.2	23.9	41.4	28.3	28.0	11.5	11.7	22.2	18.3	20.6	19.3	44.6	12.1	19.6	29.0	14.8	21.0	24.4	33.5	34.4	26.2	39.0	13.0	44.9	22.5	9.1	18.1	38.6	31.1	31.9	33.3	32.3	29.2	13.8	49.7	26.7	28.3	44.9	60.0	59.8	62.2	50.2	64.8	58.7	60.3	67.3	24.8	40.4	49.6	54.9	28.0	34.8	47.2	43.7	60.9	47.3	37.6	94.9	37.2	53.1	33.2	60.3	54.9	43.1	40.5	42.2	40.9	47.6	67.1	67.2	52.4	49.1	40.3	21.1	62.2	62.5	17.0	29.9	26.2	71.7	45.5	37.5	38.5	67.6	21.8	17.2	46.0	33.5	50.3	34.1	40.8	99.9	47.9	52.5	29.8	33.6	47.7	24.3	59.8	39.5	23.2	112.1	43.9	79.0	10.3	6.3	4.5	7.2	5.5	3.1	4.4	5.1	8.2	5.3	4.6	4.7	24.9	6.1	10.8	4.0	5.8	5.1	15.2	16.5	19.2	17.1	17.2	18.2	11.5	11.7	12.1	13.0	18.1	13.8	24.4	32.1	13.9	37.2	22.6	15.9	11.0	13.9	28.5	18.9	14.0	11.7	25.0	14.3	18.5	18.4	31.3	45.4	26.8	29.0	1.9	13.9	3.6	18.7	25.8	22.6	16.8	47.1	104.9	11.3	18.7	25.9	21.9	30.7	21.0	17.7	28.9	52.9	25.3	11.8	79.2	25.4	10.2	51.7	24.9	5.2	24.5	38.5	10.6	52.5	58.7	10.9	39.1	46.8	69.6	22.8	16.2	26.7	27.7	10.3	33.7	17.2	20.9	22.5	13.1	20.4	15.7	9.9	8.5	27.1	19.0	23.9	28.0	12.3	18.8	10.7
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051647-55070194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	31.2	26.3	15.6	27.5	16.5	83.2	26.5	16.7	22.3	26.0	15.4	24.4	18.9	30.2	29.4	27.6	28.9	26.4	33.3	16.0	19.6	42.0	27.3	25.7	29.5	18.0	17.8	34.6	21.9	23.4	22.3	30.2	17.5	24.6	24.8	19.1	30.2	24.6	25.7	27.0	21.2	35.6	17.0	24.2	23.1	21.6	18.0	23.9	25.8	19.9	36.5	34.2	21.8	18.1	49.0	42.3	73.1	46.8	57.8	56.6	56.5	53.7	56.8	65.2	75.2	34.1	42.2	56.3	44.4	72.0	39.2	52.5	79.3	81.3	90.7	51.4	50.6	54.3	39.4	51.7	63.0	67.3	57.4	73.6	60.0	54.5	85.9	47.5	87.9	35.4	51.2	48.7	95.6	59.0	56.9	51.7	53.1	46.2	70.4	48.1	80.4	34.0	89.9	54.1	47.5	55.0	51.9	36.7	51.6	65.1	65.5	38.4	66.8	66.6	87.0	41.7	48.6	29.9	46.3	73.3	53.3	34.7	49.0	44.1	26.7	32.1	24.2	37.4	32.0	31.8	28.3	26.3	29.0	27.4	26.0	26.1	19.7	26.0	36.4	37.2	37.9	25.1	15.6	16.5	16.7	22.3	16.0	19.6	18.0	17.8	17.5	17.0	18.0	18.1	73.5	70.5	66.9	25.5	106.3	71.9	164.0	77.3	53.5	22.9	44.1	36.2	71.2	40.0	66.3	47.8	37.5	121.2	78.0	60.3	70.5	65.0	28.5	73.7	57.1	69.5	57.9	57.7	34.3	69.4	112.3	60.7	70.3	86.2	83.1	41.5	43.2	51.5	75.1	38.7	32.2	54.8	50.8	64.4	88.4	14.1	51.3	72.9	49.8	28.1	65.0	60.0	49.4	27.2	38.1	94.4	44.2	54.2	109.5	104.8	44.1	103.4	39.6	24.9	32.9	59.1	66.5	81.1	60.6	53.6	71.6	151.3	86.4	40.5	46.9	145.3
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 336.9;Early spermatids: 267.2;Proximal enterocytes: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 49.1;neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Supported	Nucleoplasm		NA	NA		46000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (5.03e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.70e-3)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-2)"	99.5	64.3	178.7	42.4	162.3	45.2	86.3	113.0	200.9	93.3	86.0	117.2	103.1	74.9	27.4	129.6	71.6	65.3	65.4	168.6	132.7	49.4	21.2	71.3	37.8	135.6	148.7	78.7	33.7	61.2	55.8	70.2	142.3	49.2	91.9	71.5	61.0	43.3	51.7	77.6	113.2	58.7	127.4	57.4	86.4	31.6	129.5	31.4	58.0	57.0	49.3	64.8	89.0	130.9	56.3	30.0	62.2	35.7	153.7	202.4	35.1	40.7	101.1	63.4	75.3	36.4	110.0	56.3	39.7	115.5	73.2	20.6	53.3	47.8	61.0	106.9	61.8	17.3	31.6	61.8	154.2	13.0	46.2	125.8	27.3	72.5	32.2	96.1	163.7	60.3	24.3	70.0	85.2	147.1	59.2	21.5	16.9	113.6	26.1	68.9	37.3	127.4	58.0	35.0	55.2	39.3	23.2	81.8	24.1	50.5	53.5	30.7	117.2	41.7	35.4	48.4	14.5	79.1	39.3	29.6	83.3	27.1	30.0	6.2	5.1	49.1	1.6	3.7	2.6	2.3	3.7	3.0	2.8	2.5	2.6	2.9	21.5	2.2	2.0	2.8	6.6	2.8	178.7	162.3	113.0	200.9	168.6	132.7	135.6	148.7	142.3	127.4	129.5	130.9	95.5	22.4	17.5	7.5	10.7	9.8	22.2	11.4	5.7	30.4	23.3	19.9	15.4	20.0	13.0	9.2	22.9	77.6	15.2	336.9	23.5	39.8	267.2	24.8	25.1	68.1	54.7	6.1	7.7	61.2	134.2	34.7	79.0	15.7	2.5	19.1	71.7	7.0	45.2	8.4	10.3	159.3	22.4	26.4	12.3	176.0	32.3	20.6	23.2	7.5	24.5	67.0	13.4	7.1	9.8	118.8	167.2	27.4	6.2	13.5	235.6	23.9	24.7	41.5	19.7	18.8	29.3	10.9	19.8	15.8	13.2	33.8	14.5	40.0	94.9	22.4
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067375	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005184, HPA030262, HPA047825"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: "	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	10.9	7.0	8.6	12.1	11.1	32.4	13.9	14.5	13.3	15.3	7.6	20.3	17.5	16.4	10.9	28.0	8.2	17.5	7.7	10.5	10.5	15.2	35.3	8.8	10.8	10.5	10.8	6.2	8.3	11.0	8.0	12.6	10.6	10.1	18.7	17.9	15.3	8.7	27.7	23.1	24.5	13.7	9.7	8.3	16.9	29.3	10.6	14.5	13.9	32.9	13.6	27.3	21.3	12.0	27.1	36.0	69.1	26.7	21.1	34.3	50.5	38.0	38.0	34.2	40.1	43.3	15.9	38.9	26.0	48.9	50.0	37.5	53.8	72.4	46.5	24.0	16.8	58.0	20.3	68.9	50.4	43.9	118.6	36.8	130.0	41.5	106.8	36.4	32.7	26.1	76.5	64.3	44.2	61.3	30.8	34.4	24.7	33.6	17.2	26.8	44.5	62.3	32.8	112.3	33.8	31.9	30.7	24.6	56.5	94.9	22.6	64.3	32.9	40.7	43.9	26.8	51.4	33.2	104.4	47.5	50.4	62.9	51.2	1.7	2.5	0.7	1.9	2.3	2.3	2.5	2.8	2.2	2.3	1.3	2.6	1.9	0.3	3.6	1.5	1.0	4.3	1.9	8.6	11.1	14.5	13.3	10.5	10.5	10.5	10.8	10.6	9.7	10.6	12.0	31.3	28.9	31.5	24.5	24.2	111.9	123.8	50.6	24.5	55.6	39.3	19.3	21.9	25.8	43.1	16.5	16.7	16.9	15.9	110.2	17.6	35.2	147.5	61.3	75.7	28.8	31.0	17.1	29.1	50.1	39.5	39.2	35.7	126.4	137.9	19.3	17.9	59.6	28.0	33.7	31.0	42.9	42.7	41.8	66.6	218.1	22.7	50.5	30.2	17.8	15.7	32.3	11.3	28.6	63.7	69.1	46.5	23.7	35.3	89.0	110.6	60.3	42.9	23.8	19.7	24.7	33.9	72.7	81.0	49.6	110.7	33.1	23.0	13.9	28.6	174.0
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MAPK8	"JNK, JNK1, PRKM8, SAPK1"	ENSG00000107643	"Mitogen-activated protein kinase 8"	P45983	10	48306639-48439360	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 160.5;Excitatory neurons: 199.1;Inhibitory neurons: 218.2;Oligodendrocyte precursor cells: 233.7;Oligodendrocytes: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004463, CAB069396"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB004463: AB_675868, CAB069396: AB_1619977"	"unprognostic (7.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (4.23e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (6.06e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.01e-3)"	7.2	6.7	11.3	7.0	12.6	11.3	13.8	18.3	12.8	8.8	4.5	9.0	10.4	11.0	7.7	9.4	7.5	9.2	7.2	12.5	9.4	13.6	15.6	6.7	7.8	11.6	9.7	11.0	7.5	8.6	7.9	8.3	13.1	8.3	9.9	21.9	9.6	8.2	11.7	6.5	11.2	9.6	8.8	6.7	8.1	13.1	10.9	13.8	14.1	9.6	9.6	8.3	7.0	12.8	29.2	7.2	21.8	12.8	11.3	10.4	16.5	37.9	23.6	20.0	17.8	7.7	19.2	10.9	10.5	21.3	10.7	13.1	10.2	15.2	31.2	45.4	16.5	15.9	6.8	12.7	16.0	24.2	13.2	9.5	18.5	14.4	21.8	12.5	22.0	22.4	25.1	14.5	13.2	8.6	22.1	15.4	14.4	10.0	4.7	17.8	25.8	12.6	17.1	11.1	38.3	34.8	13.5	11.9	16.1	14.8	12.4	11.4	16.7	14.4	31.9	14.6	30.4	6.2	18.0	16.4	14.3	24.9	8.7	0.0	1.1	1.4	1.1	1.1	2.1	0.6	1.7	1.3	1.0	0.8	1.7	1.0	0.8	1.3	1.4	1.8	1.1	1.0	11.3	12.6	18.3	12.8	12.5	9.4	11.6	9.7	13.1	8.8	10.9	12.8	21.2	3.2	17.1	145.3	21.9	44.7	50.6	19.3	20.5	56.2	34.4	17.7	10.0	22.8	18.0	7.3	31.3	15.5	22.3	19.1	11.7	28.9	160.5	25.7	21.9	22.0	31.0	12.4	199.1	25.3	7.4	21.8	16.3	42.9	12.0	25.8	10.4	22.3	9.8	70.7	218.2	16.5	28.5	11.0	34.9	99.2	14.6	18.4	21.4	93.7	25.4	18.9	11.3	233.7	163.0	35.9	22.5	10.1	31.2	39.3	25.4	24.3	16.6	34.6	6.6	23.0	24.5	28.1	28.1	17.5	36.7	15.7	21.6	41.0	11.9	45.5
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.8;pituitary gland: 118.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	4.8	23.3	127.9	2.3	131.0	1.3	4.8	122.0	147.7	8.2	29.6	8.3	1.4	10.9	3.5	2.2	11.3	3.5	5.5	166.8	120.6	11.5	5.6	4.0	0.6	154.9	130.9	9.1	43.1	19.2	118.2	1.4	142.6	11.6	1.2	11.5	11.4	6.1	2.4	4.0	3.7	5.7	124.6	2.3	9.0	27.7	139.3	1.0	7.0	2.5	0.4	6.7	4.8	164.4	0.0	7.1	9.4	26.2	3.4	1.8	0.3	5.1	4.6	9.9	7.2	6.3	1.1	0.4	2.5	5.9	16.8	5.8	10.2	4.8	4.4	4.0	13.1	0.1	8.6	4.1	3.1	0.6	4.4	2.4	1.0	6.4	1.3	6.6	2.2	0.9	11.5	1.6	2.8	3.9	0.4	0.6	24.9	3.3	10.5	0.6	15.4	0.3	4.6	0.2	76.4	28.5	8.4	6.8	10.0	3.6	11.0	0.4	2.1	12.5	19.1	19.0	9.3	1.1	1.3	0.5	7.9	0.2	3.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	127.9	131.0	122.0	147.7	166.8	120.6	154.9	130.9	142.6	124.6	139.3	164.4	1.7	6.4	4.1	7.2	0.9	2.4	5.8	2.0	2.8	34.4	6.1	5.3	1.1	5.7	3.3	11.0	22.9	1.6	0.4	2.2	13.7	6.9	43.8	23.9	15.9	2.9	40.2	0.0	10.3	28.9	0.6	6.5	4.1	19.9	0.0	2.8	0.4	4.6	0.5	67.3	11.6	1.6	4.1	0.8	3.5	39.2	6.2	1.1	3.6	1.0	1.6	41.3	0.0	3.5	48.7	11.6	0.5	6.4	0.1	6.3	1.4	8.9	10.9	18.3	0.0	14.2	6.0	10.6	8.2	0.9	1.0	5.7	1.3	7.7	0.9	5.5
MAPK8IP2	"IB2, JIP2, PRKM8IPL"	ENSG00000008735	"Mitogen-activated protein kinase 8 interacting protein 2"	Q13387	22	50600793-50613981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.0;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034780	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034780: AB_10670283"	"unprognostic (7.82e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.78e-3)"	"unprognostic (6.33e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.75e-2)"	1.4	9.2	54.7	0.3	50.2	0.0	1.4	27.5	67.8	1.4	0.0	2.1	0.2	2.1	0.3	1.2	1.5	0.0	0.4	53.7	35.1	0.7	0.5	0.5	0.0	78.0	27.0	7.0	1.8	2.0	35.2	0.3	84.0	1.9	0.1	9.6	2.8	0.2	0.3	1.5	1.0	0.2	18.6	0.8	1.5	7.1	39.4	0.2	1.0	0.1	0.0	0.3	1.0	49.2	0.3	1.1	4.7	4.1	0.4	0.0	3.7	0.0	0.0	1.0	0.6	2.4	0.8	0.6	1.0	0.0	19.3	0.0	6.6	0.0	0.0	0.3	11.0	0.0	0.4	1.2	0.5	0.0	0.8	0.3	5.5	0.0	0.1	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	3.4	0.8	1.8	1.1	0.7	0.0	0.0	0.1	15.7	19.8	3.7	4.6	0.2	0.9	0.9	0.0	0.0	0.1	0.1	0.6	0.0	1.1	3.1	0.5	0.5	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.2	27.5	67.8	53.7	35.1	78.0	27.0	84.0	18.6	39.4	49.2	0.6	3.2	2.0	6.5	0.1	0.4	1.6	0.5	0.6	57.8	2.3	3.9	2.3	2.8	2.7	0.0	16.7	0.2	0.0	0.5	0.0	3.0	0.6	0.7	1.7	0.7	32.3	0.0	15.6	2.5	1.1	0.7	0.0	1.5	0.0	0.5	0.0	0.3	0.1	99.3	13.1	0.5	4.1	0.0	0.4	1.8	5.9	0.3	7.2	3.7	0.2	11.2	0.0	6.0	3.2	0.7	0.1	0.7	0.1	1.2	0.3	0.7	0.3	26.7	0.0	1.3	1.0	3.4	2.7	0.6	0.6	1.1	0.3	0.5	0.6	0.5
MAPK8IP3	"JIP3, JSAP1, KIAA1066, syd"	ENSG00000138834	"Mitogen-activated protein kinase 8 interacting protein 3"	Q9UPT6	16	1706183-1770351	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 62.1;Horizontal cells: 87.5;Inhibitory neurons: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005580, HPA041785, HPA069311"	Approved		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 57: B-cells - Immune response"	Vesicles		"CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.83e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (3.95e-4)"	25.1	32.2	29.3	13.5	36.5	26.4	26.1	16.2	64.9	38.6	0.0	26.9	13.5	25.9	4.0	20.2	31.7	7.9	39.3	39.7	18.5	34.1	30.8	31.7	16.3	39.5	17.4	46.8	39.3	7.0	78.6	8.5	34.9	43.6	3.8	11.3	28.8	7.4	22.1	37.0	39.4	4.4	7.9	49.8	25.9	32.0	18.4	11.8	38.3	4.3	6.5	35.2	30.5	44.9	6.5	12.2	12.7	11.4	6.1	10.3	9.9	10.7	4.0	5.2	4.6	17.3	21.0	7.5	6.6	6.7	3.7	12.1	3.1	7.0	1.7	11.9	14.1	10.0	33.6	13.4	8.4	6.5	16.9	20.7	9.2	7.6	3.7	22.9	6.9	14.1	8.6	14.1	5.5	16.6	10.2	28.5	8.5	3.2	6.9	44.1	6.3	12.9	6.4	8.4	26.4	21.0	12.8	11.8	5.3	5.8	6.4	9.1	21.9	21.8	12.2	9.4	8.6	31.4	5.8	9.7	5.7	6.7	11.1	0.0	0.2	0.5	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	29.3	36.5	16.2	64.9	39.7	18.5	39.5	17.4	34.9	7.9	18.4	44.9	9.1	3.2	7.8	46.7	30.5	9.8	4.3	10.0	13.1	40.8	7.9	7.5	6.6	10.0	10.5	3.7	37.5	5.6	10.4	16.8	1.9	4.9	24.9	13.2	13.0	7.8	10.2	8.6	62.1	3.8	5.7	7.5	34.7	21.9	1.3	23.4	6.4	9.7	7.2	87.5	65.2	11.1	10.2	10.3	12.5	23.4	7.8	13.5	7.2	31.9	8.7	11.9	9.2	32.6	52.8	7.7	9.5	9.1	17.6	4.7	10.3	1.2	15.9	19.2	6.6	7.3	8.2	19.8	5.1	10.8	9.7	5.6	11.8	5.9	11.7	6.0
MAPK9	"JNK2, p54a, PRKM9, SAPK"	ENSG00000050748	"Mitogen-activated protein kinase 9"	P45984	5	180233143-180292099	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 16.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 211.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008910, HPA072462"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nuclear speckles"	"CAB008910: , HPA072462: "	"unprognostic (5.04e-3)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (8.53e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.06e-3)"	"unprognostic (6.83e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.40e-1)"	19.3	21.1	28.4	18.4	32.6	21.3	17.5	36.5	41.4	17.7	7.2	22.4	18.5	15.3	16.2	15.4	15.3	13.9	25.7	34.2	25.8	21.1	17.7	19.5	19.9	25.7	19.7	14.6	45.7	30.1	12.9	19.7	26.4	20.0	26.4	21.4	19.1	21.6	40.8	11.7	19.3	19.9	16.9	16.6	22.5	17.8	22.2	22.5	26.7	34.8	21.1	17.4	11.1	29.8	52.7	42.7	37.0	46.5	35.7	39.3	79.4	49.6	43.5	40.5	40.5	56.4	36.7	55.9	83.1	52.6	89.3	39.6	38.4	82.8	47.5	211.8	36.9	23.2	46.8	40.3	27.1	49.0	39.2	29.3	36.5	39.5	38.0	42.5	48.9	43.0	26.2	39.5	55.9	68.9	49.2	20.4	25.8	64.8	25.0	46.9	62.7	26.9	30.8	49.7	42.5	29.9	58.2	55.8	40.4	45.8	56.9	41.7	35.5	48.3	49.2	69.3	75.2	28.2	35.6	37.9	51.5	44.8	32.9	16.3	0.5	2.2	1.6	1.1	1.6	0.8	1.2	1.4	0.8	1.3	0.8	0.9	0.7	1.2	2.3	1.2	2.7	0.3	28.4	32.6	36.5	41.4	34.2	25.8	25.7	19.7	26.4	16.9	22.2	29.8	20.5	32.1	14.4	26.1	10.5	10.1	7.0	6.5	9.1	21.9	16.8	12.2	27.6	12.8	8.5	9.2	16.7	15.3	20.5	20.7	5.9	8.0	1.2	17.6	14.2	12.2	16.7	9.5	62.5	16.0	23.3	11.1	15.8	18.6	11.4	14.5	12.5	16.7	11.7	13.5	64.3	17.9	4.1	24.2	20.5	3.1	10.5	15.0	5.4	31.9	13.9	11.4	15.5	25.1	32.9	13.1	12.3	13.5	15.6	10.2	13.4	11.0	6.9	14.8	13.1	13.5	13.7	17.0	17.1	9.4	11.4	17.8	14.7	8.2	15.4	8.8
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"MAPK associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	42.9	47.1	43.4	36.7	48.6	34.7	32.8	39.2	45.6	36.4	44.9	47.3	30.4	29.1	35.9	44.0	29.2	28.0	69.7	44.3	41.6	48.0	46.0	30.1	34.8	47.8	46.2	26.1	36.9	53.3	19.2	30.2	41.9	30.3	38.5	42.9	42.1	36.1	103.7	26.2	32.6	46.2	43.2	28.8	36.2	42.0	51.6	36.6	47.4	76.4	37.9	39.4	31.6	40.9	87.4	97.1	64.3	68.3	86.7	82.2	107.9	108.6	110.0	82.0	57.2	97.9	94.9	89.1	65.9	151.6	89.7	119.1	99.5	126.9	110.8	101.8	41.1	64.3	111.9	95.1	97.3	116.0	72.1	80.9	114.6	117.0	121.7	91.2	123.0	85.8	103.6	67.7	176.4	180.3	87.5	46.8	102.4	204.3	122.0	72.4	152.0	119.3	90.2	62.3	77.9	76.7	109.7	100.9	70.0	86.6	115.8	67.1	79.7	115.3	76.1	140.5	182.5	86.1	225.2	89.9	165.5	52.5	127.6	4.4	6.1	5.7	4.3	6.0	5.9	8.2	4.7	4.8	4.9	7.4	4.1	7.1	19.1	5.8	5.6	7.2	5.8	2.5	43.4	48.6	39.2	45.6	44.3	41.6	47.8	46.2	41.9	43.2	51.6	40.9	22.3	12.8	17.0	64.6	33.5	15.8	30.2	15.3	25.6	25.6	30.6	24.1	68.3	22.8	27.5	14.7	41.7	35.4	31.7	28.9	54.8	48.3	80.2	26.2	42.6	27.1	9.6	22.3	82.6	65.6	50.9	27.0	32.1	29.3	17.7	31.2	19.6	34.5	50.7	32.0	80.1	20.8	22.4	29.5	23.4	116.9	19.0	37.3	23.2	59.0	55.1	30.1	35.0	97.0	96.4	59.2	20.1	17.7	32.3	45.2	27.2	84.6	14.6	26.2	6.6	29.1	33.0	75.4	71.4	29.1	19.5	50.9	29.5	38.4	27.6	37.8
MAPKAPK2	MK2	ENSG00000162889	"MAPK activated protein kinase 2"	P49137	1	206684905-206734281	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 21.9"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 21.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	61.9	80.4	34.8	56.2	39.1	174.6	50.5	36.9	33.9	47.3	38.7	50.3	65.5	53.3	24.1	55.8	50.8	52.5	190.1	30.8	36.6	79.5	66.8	79.3	57.8	53.1	42.1	44.8	53.8	38.0	63.3	25.7	43.9	42.8	35.3	17.6	54.9	33.1	196.7	54.4	61.7	45.4	40.1	78.3	68.2	46.9	45.2	45.6	47.7	94.3	54.4	63.5	46.6	38.6	85.4	33.1	44.8	50.6	128.4	75.0	55.1	57.3	130.0	86.0	80.7	63.8	40.4	40.6	38.8	116.9	54.1	63.0	33.8	61.7	61.4	46.5	25.4	69.1	41.7	41.3	99.0	102.3	219.5	104.1	77.3	82.8	91.3	71.8	71.7	54.1	79.7	180.2	70.5	105.2	41.2	73.3	51.5	29.9	45.1	103.7	94.0	13.5	64.9	51.5	35.7	45.7	68.0	114.2	83.1	83.0	55.4	97.2	68.7	77.6	64.7	91.0	79.7	232.0	220.6	33.2	87.8	60.9	26.0	1.6	0.8	1.8	1.8	1.4	1.6	1.1	1.3	1.7	0.7	1.2	0.6	1.2	3.7	2.6	1.3	21.9	1.8	0.7	34.8	39.1	36.9	33.9	30.8	36.6	53.1	42.1	43.9	40.1	45.2	38.6	49.2	54.5	49.9	15.7	27.9	85.4	52.3	18.3	20.5	12.4	61.4	37.8	102.5	37.1	26.8	31.3	20.9	6.4	185.9	51.9	15.6	30.6	76.2	32.2	40.9	43.7	61.7	15.4	4.7	58.5	9.2	33.4	32.1	46.6	34.9	24.8	19.2	40.0	24.8	0.0	10.6	38.1	16.2	34.6	82.7	36.1	22.7	60.9	33.8	13.1	23.7	21.7	74.2	8.5	17.4	61.6	34.4	17.3	69.6	67.3	22.2	25.0	14.4	16.0	26.3	36.9	48.5	13.7	10.3	31.5	72.0	16.6	46.0	19.2	30.5	75.0
MAPKAPK5	"MK5, PRAK"	ENSG00000089022	"MAPK activated protein kinase 5"	Q8IW41	12	111842228-111902222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	18.1	20.8	12.6	17.9	14.4	27.1	20.4	14.9	15.0	15.2	15.7	28.2	25.5	15.7	20.7	17.2	16.1	12.2	16.7	15.3	14.3	20.3	19.4	17.5	20.7	12.3	12.4	18.1	20.4	21.4	11.6	20.3	11.8	17.0	30.7	27.2	17.4	15.6	30.4	20.1	28.2	18.9	11.3	15.6	18.0	15.9	12.9	23.2	19.3	25.3	19.3	18.5	14.4	13.8	32.4	42.1	40.0	33.7	28.2	28.4	60.6	31.7	38.1	47.7	32.7	54.8	25.9	48.6	22.9	37.7	28.4	31.6	53.1	33.2	44.4	32.6	29.0	43.4	29.5	44.2	34.1	55.1	29.4	30.2	46.7	45.6	53.7	36.0	35.6	43.4	61.0	18.7	35.3	36.4	55.2	86.6	56.9	79.1	29.4	53.7	29.1	46.9	37.9	46.2	49.0	41.4	36.1	60.5	46.3	36.2	49.1	62.0	31.2	26.8	27.2	27.9	40.4	37.8	50.1	57.4	32.7	39.4	38.9	1.1	3.3	2.3	4.2	2.4	2.2	3.5	2.7	3.0	2.2	3.1	4.2	3.1	1.6	2.9	8.8	2.6	4.8	1.8	12.6	14.4	14.9	15.0	15.3	14.3	12.3	12.4	11.8	11.3	12.9	13.8	16.9	3.2	23.1	12.1	22.3	20.5	22.3	12.5	21.1	47.0	18.3	14.0	20.1	22.8	15.4	3.7	41.7	29.9	32.4	34.1	13.7	28.2	17.2	14.2	17.3	16.0	36.6	15.8	24.6	29.6	33.3	19.4	20.9	15.2	2.5	22.3	14.6	13.4	19.9	23.5	22.3	47.3	14.2	21.2	17.7	7.3	15.5	15.0	8.8	14.0	27.8	19.6	25.7	15.6	21.8	36.3	27.4	17.7	21.6	37.5	63.6	21.8	12.0	36.4	19.7	22.6	19.8	30.7	40.3	23.6	21.3	30.1	22.2	22.5	32.3	32.3
MAPKBP1	"KIAA0596, NPHP20"	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	6.2	10.5	10.9	4.6	12.4	4.4	7.7	31.1	13.7	11.1	10.1	10.2	9.6	9.9	4.5	18.6	10.4	4.6	6.4	9.9	8.5	7.1	4.1	6.0	3.9	9.0	8.0	15.1	5.5	4.2	12.7	5.4	9.0	8.9	3.6	9.0	7.5	5.9	5.1	24.2	9.9	9.0	5.3	8.0	9.3	34.4	9.1	6.3	13.4	3.7	6.8	12.2	12.0	10.2	7.4	3.8	10.0	9.5	10.9	10.8	6.9	10.1	25.5	9.1	6.6	7.6	2.7	1.8	8.1	8.3	12.5	17.2	9.8	28.5	6.5	6.7	2.7	7.3	12.8	2.6	4.7	4.7	14.5	5.6	22.3	14.3	25.9	14.8	13.4	11.9	4.6	3.4	12.9	1.5	4.0	4.2	1.1	4.3	7.6	4.3	7.2	0.7	5.3	8.1	11.3	6.3	5.7	5.9	4.5	10.2	7.1	3.7	10.6	13.0	6.2	12.4	10.0	7.3	12.7	4.3	8.7	6.3	11.0	1.1	0.4	0.3	0.8	0.1	0.6	0.4	0.4	0.3	0.5	0.4	0.6	0.5	0.1	0.6	0.5	0.1	0.2	0.5	10.9	12.4	31.1	13.7	9.9	8.5	9.0	8.0	9.0	5.3	9.1	10.2	7.1	6.4	10.3	33.0	3.5	54.7	10.0	8.6	36.5	14.5	5.4	8.9	3.4	2.8	7.3	3.7	204.3	6.8	5.6	4.0	0.0	3.0	15.7	10.9	7.1	9.5	4.8	0.8	62.2	3.7	4.4	5.8	9.2	8.9	1.3	12.2	5.3	2.6	3.9	15.2	55.1	1.7	4.1	2.5	6.1	27.1	7.2	5.0	8.8	33.7	4.2	4.4	3.1	34.7	51.9	4.6	1.8	7.9	5.1	12.5	8.1	0.5	13.0	8.9	13.1	7.8	5.7	12.7	4.2	27.7	53.6	5.3	5.8	8.0	2.5	15.2
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819954-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"		NA	NA		11000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	66.7	44.5	41.2	69.7	46.7	192.7	48.3	45.3	45.5	45.9	41.9	69.0	39.7	61.0	52.9	62.7	44.8	57.4	58.2	37.0	50.0	54.1	30.4	50.6	75.8	48.0	52.5	37.8	40.4	38.3	24.3	66.8	47.9	56.0	58.0	16.1	32.7	70.6	34.1	34.7	41.2	91.3	47.7	57.7	43.9	54.4	47.5	88.0	74.1	39.7	69.3	83.1	37.8	47.0	179.7	161.4	176.6	102.0	93.5	84.3	250.7	171.3	106.3	261.0	191.0	470.0	161.9	271.2	167.4	154.8	265.6	159.9	213.1	191.6	283.7	92.4	83.1	523.3	105.0	253.2	98.7	190.6	222.8	91.6	94.1	213.8	141.7	89.3	165.0	151.4	240.0	150.6	232.4	111.0	263.0	166.2	127.6	182.7	147.5	174.4	312.8	145.9	143.0	121.8	109.7	115.3	307.2	134.3	179.4	160.6	194.3	140.0	147.5	291.9	157.7	147.3	224.7	131.5	194.5	289.6	154.9	428.3	166.0	256.8	125.8	262.1	100.1	150.8	104.0	75.1	94.1	92.9	97.4	81.8	94.6	104.3	139.7	111.1	170.6	89.5	107.1	185.6	41.2	46.7	45.3	45.5	37.0	50.0	48.0	52.5	47.9	47.7	47.5	47.0	71.6	19.2	30.2	8.1	67.0	132.8	194.4	48.1	62.0	11.1	54.7	42.3	36.5	25.8	44.5	55.2	8.4	108.0	82.0	67.6	84.1	68.8	90.2	43.5	44.7	64.8	71.5	52.8	7.8	78.3	130.0	61.4	40.8	60.9	115.4	45.7	39.3	14.9	107.0	10.1	8.5	43.6	36.7	94.6	121.2	76.6	35.8	99.5	71.2	12.2	120.5	36.5	92.7	7.5	12.6	75.0	40.5	64.3	71.1	115.3	32.6	74.3	39.4	11.5	65.7	61.5	102.8	72.1	62.1	65.2	110.8	169.2	89.8	76.6	44.4	123.1
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970637-27027219	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 428.2;Late spermatids: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	24.0	23.1	100.7	7.3	102.4	1.3	23.6	73.5	133.2	26.6	50.8	25.4	7.2	24.8	10.4	12.2	42.2	12.6	45.2	108.8	105.2	30.4	37.6	17.8	5.9	94.4	82.9	46.1	14.7	36.8	101.7	10.8	98.1	26.1	9.8	70.5	18.3	15.0	146.6	43.3	10.5	12.9	66.5	15.8	23.2	56.4	107.0	7.6	24.4	56.8	6.5	22.0	19.0	95.8	19.8	15.2	13.6	24.0	24.4	13.5	3.9	15.3	12.2	12.7	12.9	5.7	25.8	0.0	14.4	19.1	33.5	10.1	7.6	16.3	7.5	16.5	18.7	2.9	8.1	1.3	22.4	2.3	36.5	11.1	28.5	6.4	11.9	34.6	3.1	1.7	19.4	15.1	7.7	9.0	0.1	1.0	6.0	69.2	23.9	0.1	0.3	2.0	8.8	13.0	34.4	17.0	10.6	7.5	11.0	8.9	8.0	1.4	3.3	11.1	11.4	16.0	13.7	11.5	4.4	0.1	39.9	1.5	22.6	0.2	1.3	0.3	0.7	1.4	0.4	0.6	0.3	0.2	0.8	0.3	0.5	0.1	3.5	0.5	1.7	0.0	0.1	0.7	100.7	102.4	73.5	133.2	108.8	105.2	94.4	82.9	98.1	66.5	107.0	95.8	13.7	3.2	2.8	25.8	2.6	8.8	21.8	15.2	11.4	44.0	6.4	8.8	8.3	5.7	6.6	3.7	25.0	1.4	1.6	32.3	17.6	11.5	428.2	64.7	11.2	5.5	25.1	2.5	43.7	4.6	4.6	11.2	11.2	4.1	38.1	13.8	14.3	8.6	2.1	58.9	45.0	1.9	18.3	2.8	4.5	311.4	12.8	4.6	7.2	5.6	0.8	69.3	4.1	26.2	27.4	12.0	8.4	11.7	2.7	9.6	0.2	6.8	48.8	44.6	32.9	10.2	14.0	21.0	14.4	6.5	13.8	18.9	3.4	38.6	3.0	15.0
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skeletal muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.7	4.3	26.2	0.3	27.1	0.0	9.1	8.3	67.7	2.4	0.0	8.4	0.5	1.0	0.2	8.4	1.0	0.8	9.4	30.0	20.4	14.7	0.6	0.8	0.3	11.6	11.4	0.6	1.5	2.9	29.5	3.4	22.4	5.4	0.3	17.6	8.5	3.4	79.0	6.3	1.8	0.3	2.7	0.4	1.7	20.3	14.8	0.4	0.9	27.4	0.2	10.2	2.3	19.7	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	26.2	27.1	8.3	67.7	30.0	20.4	11.6	11.4	22.4	2.7	14.8	19.7	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MARCHF10	"FLJ35757, MARCH-X, MARCH10, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 137.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.1	0.2	1.3	0.2	1.6	0.0	0.1	1.2	0.9	1.4	10.5	1.1	0.0	0.4	7.5	0.1	12.8	0.1	0.1	1.1	1.3	1.5	0.0	2.7	0.0	3.6	5.0	0.1	0.2	0.3	12.7	0.0	2.6	0.6	0.0	0.1	0.3	0.1	0.0	0.2	0.4	0.0	3.6	0.1	0.4	137.6	1.3	0.2	0.1	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	1.1	0.1	0.8	0.2	0.0	0.0	0.0	4.7	0.3	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.6	0.0	1.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	8.3	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.1	1.3	1.6	1.2	0.9	1.1	1.3	3.6	5.0	2.6	3.6	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MARCHF3	"MARCH-III, MARCH3, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 43.8;Syncytiotrophoblasts: 98.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.5;naive B-cell: 12.1"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.4;HUVEC TERT2: 27.4;TIME: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	5.6	2.8	6.1	2.9	5.6	3.7	2.6	5.3	4.1	0.9	1.9	5.3	0.9	1.4	0.0	1.4	1.5	5.2	7.8	3.9	5.7	0.8	0.7	2.4	2.5	11.5	7.1	1.1	2.4	0.3	2.4	1.7	7.9	0.6	5.6	7.4	4.6	0.2	6.5	5.8	2.4	2.9	8.3	1.6	2.4	5.6	7.8	1.3	1.4	3.3	2.1	7.6	0.7	8.5	0.4	1.8	3.9	2.1	3.4	3.2	1.2	14.2	5.9	11.1	16.3	1.9	0.8	3.8	1.3	1.9	2.4	1.1	4.9	2.5	15.3	0.8	4.7	12.2	3.2	1.9	5.6	5.0	3.0	2.4	0.7	40.4	4.8	2.6	27.4	0.6	5.1	0.7	9.3	1.3	0.5	2.3	3.3	3.0	4.6	1.5	15.5	1.2	0.9	2.0	1.3	0.9	3.3	0.5	1.6	1.9	2.9	5.0	33.5	2.2	1.8	12.6	1.6	1.9	2.3	2.3	8.3	3.8	2.0	0.0	0.2	2.8	0.5	0.4	0.1	10.5	0.6	0.3	0.1	12.1	2.3	0.5	0.8	2.3	0.3	0.7	2.9	0.8	6.1	5.6	5.3	4.1	3.9	5.7	11.5	7.1	7.9	8.3	7.8	8.5	3.8	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	43.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	98.6	0.6	0.0	0.0	0.0
MARCHF4	"KIAA1399, MARCH-IV, MARCH4, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372483	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"brain: 4.4;pituitary gland: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 69.0;fHDF/TERT166: 43.8;TIME: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014348	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.0	0.7	2.6	0.0	3.9	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.4	0.0	6.2	0.6	1.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.5	2.5	0.0	0.0	0.2	1.6	0.0	69.0	23.2	14.5	5.1	0.1	1.0	0.0	10.5	43.8	24.2	0.1	0.0	26.7	14.1	0.0	0.0	5.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	13.3	19.6	9.3	19.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.4	1.9	0.1	0.0	0.0	2.2	0.0	0.0	32.7	22.7	23.9	0.1	18.6	0.0	0.0	0.0	5.2	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.9	0.0	4.4	3.1	2.2	0.5	4.1	1.1	2.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MARCHF6	"MARCH-VI, MARCH6, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353695-10440388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.5;Cardiomyocytes: 102.5;Cytotrophoblasts: 54.4;dendritic cells: 25.8;Extravillous trophoblasts: 30.0;Hofbauer cells: 36.4;Syncytiotrophoblasts: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.1	25.5	16.1	20.3	23.7	76.5	25.9	28.3	20.7	20.1	2.9	26.9	32.8	22.7	25.5	20.9	24.9	24.5	30.8	22.0	30.4	34.1	32.5	25.1	24.7	13.7	17.5	36.0	39.3	62.4	20.8	22.8	16.9	22.7	19.8	36.6	25.6	23.8	48.4	24.8	30.3	18.9	13.8	28.2	30.2	29.9	27.9	32.3	29.3	51.8	23.3	23.7	18.6	33.5	37.4	55.1	90.1	69.9	50.6	40.4	73.7	57.7	53.7	48.9	61.8	52.8	97.0	39.4	85.4	54.4	67.2	52.3	48.2	37.7	65.4	82.9	43.0	50.7	179.7	36.2	35.6	61.4	54.6	47.4	40.6	49.0	53.1	50.0	45.8	41.4	62.1	85.1	45.0	42.4	33.1	47.2	32.8	29.9	38.5	50.9	37.6	57.0	38.0	72.4	38.7	56.0	107.2	57.9	38.4	41.3	48.2	32.5	44.8	58.4	56.8	29.1	43.7	59.3	94.1	55.7	43.1	40.7	42.8	15.6	7.4	12.6	11.2	8.4	12.8	11.7	10.8	11.0	6.3	9.6	12.5	12.4	12.1	9.1	11.1	5.0	10.4	9.1	16.1	23.7	28.3	20.7	22.0	30.4	13.7	17.5	16.9	13.8	27.9	33.5	38.5	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	0.0	0.0	54.4	25.8	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	30.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	81.3	5.8	0.0	0.0	0.0
MARCHF7	"AXOT, MARCH-VII, MARCH7, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 33.3;Cardiomyocytes: 88.4;Cytotrophoblasts: 36.2;dendritic cells: 28.2;Extravillous trophoblasts: 38.8;Hofbauer cells: 34.0;Syncytiotrophoblasts: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	38.3	30.0	16.4	37.9	21.7	43.2	48.2	32.3	21.5	38.6	25.1	33.2	30.0	45.0	34.2	67.3	37.5	38.1	48.9	15.8	16.1	32.8	40.1	38.2	47.9	17.4	17.1	47.5	22.3	36.6	22.7	46.9	17.7	38.1	36.9	37.9	26.9	36.3	55.2	38.6	30.0	50.6	14.9	45.1	33.5	62.0	17.1	60.8	47.5	44.1	52.2	39.0	37.5	21.8	50.3	35.3	88.7	40.7	61.9	81.9	89.1	83.9	81.1	82.5	73.9	70.9	57.5	71.0	36.8	84.2	46.8	61.3	55.4	74.5	102.9	75.9	43.2	96.0	53.8	53.3	60.7	79.9	72.6	72.7	83.0	99.5	86.5	92.5	99.3	50.7	75.6	65.6	82.9	44.2	52.4	73.8	84.6	54.6	47.3	75.0	64.5	59.3	74.6	112.1	51.9	48.6	65.6	48.2	67.0	94.3	56.9	94.4	93.5	86.9	51.9	53.9	47.2	51.5	61.0	96.8	54.1	46.8	84.0	83.5	28.8	59.6	28.6	29.5	33.3	27.6	30.4	32.4	27.6	26.4	36.3	35.9	127.5	39.4	43.4	22.3	34.3	30.9	16.4	21.7	32.3	21.5	15.8	16.1	17.4	17.1	17.7	14.9	17.1	21.8	33.3	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	36.2	28.2	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	38.8	13.5	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	44.2	5.8	0.0	0.0	0.0
MARCHF8	"c-MIR, CMIR, MARCH-VIII, MARCH8, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014597	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	14.3	19.2	11.8	12.4	18.5	49.1	16.8	19.3	13.1	13.8	11.7	21.3	14.2	14.4	10.4	10.6	15.3	13.4	20.5	11.1	13.1	15.5	16.9	15.0	16.9	18.8	14.2	19.5	26.5	19.8	16.0	12.2	17.3	11.5	18.3	18.2	14.8	15.2	14.7	10.5	22.4	13.8	14.7	18.7	14.4	57.1	16.1	17.8	16.3	15.4	20.3	11.4	9.0	26.7	16.6	16.4	13.7	12.4	19.4	24.2	10.1	7.5	35.0	13.6	14.8	4.2	16.8	23.8	12.6	21.9	12.3	3.0	15.2	12.4	12.6	36.3	16.7	9.2	7.4	10.0	13.6	11.3	39.1	19.8	16.3	6.8	17.9	13.4	22.5	22.4	26.5	23.2	10.5	5.8	11.5	7.1	4.5	2.4	5.3	12.7	13.7	7.0	10.2	9.5	12.2	17.0	14.7	3.5	14.0	13.3	21.2	5.2	15.1	10.6	13.6	15.6	12.0	39.8	34.2	10.5	21.0	15.5	2.9	13.9	1.1	10.8	3.0	1.9	4.5	3.5	3.4	3.3	1.6	5.4	2.5	3.2	14.1	8.5	0.9	1.6	3.6	2.5	11.8	18.5	19.3	13.1	11.1	13.1	18.8	14.2	17.3	14.7	16.1	26.7	6.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	2.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333839-32336233	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 712.7"	"Cell type enhanced"	"Detected in many"		"monocytes: 941.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"eosinophil: 252.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 252.7"	"Cell line enhanced"	"Detected in many"		"AF22: 1016.3;NTERA-2: 984.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	Yes		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: AB_2673514"	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	63.4	59.9	363.5	82.1	510.3	50.1	102.9	540.1	438.2	81.2	206.4	108.1	61.8	93.4	155.8	15.1	72.2	97.2	55.0	343.0	408.0	51.1	38.7	40.0	176.0	631.5	504.7	358.0	23.7	6.5	22.9	42.9	534.9	84.7	116.5	37.9	75.9	49.9	8.7	28.3	56.1	42.7	467.9	63.1	132.8	139.2	466.4	166.0	110.3	11.0	199.5	77.8	27.1	712.7	82.9	73.3	1016.3	418.6	22.5	8.3	181.0	34.0	21.2	99.9	66.0	176.0	59.9	185.7	124.4	23.2	0.3	43.0	333.1	3.8	73.3	4.5	246.5	10.0	27.0	392.4	68.7	48.8	0.9	114.8	13.7	75.0	2.1	154.2	295.0	312.6	291.5	2.2	135.7	197.5	613.5	205.9	984.3	267.4	168.1	754.8	109.4	87.7	152.1	163.1	629.0	597.8	178.8	194.2	587.8	411.9	135.4	85.8	87.8	41.8	241.3	3.9	66.1	27.8	2.3	489.8	4.7	73.6	225.7	3.1	4.0	252.7	3.8	23.1	1.4	20.0	7.4	4.9	6.6	27.7	15.3	6.4	18.2	1.1	30.3	9.0	4.8	4.9	363.5	510.3	540.1	438.2	343.0	408.0	631.5	504.7	534.9	467.9	466.4	712.7	242.5	0.0	1.3	27.1	191.1	93.7	114.7	43.5	40.5	27.7	465.7	385.8	8.5	178.7	68.8	60.7	6.2	16.1	110.1	194.1	82.2	389.7	37.4	68.7	190.3	326.9	746.2	74.4	4.2	307.2	116.4	124.3	246.2	115.2	22.3	378.6	462.3	5.3	21.2	10.1	21.9	514.2	236.0	61.0	365.3	66.7	613.3	82.0	300.6	9.4	941.4	464.3	46.4	93.0	428.3	751.6	292.8	641.3	39.5	418.8	30.2	9.8	15.6	14.8	131.5	40.3	210.0	14.8	102.7	22.5	83.1	13.4	89.8	172.0	447.1	586.9
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 94.9;lung: 199.6;lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 4.1;thalamus: 12.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	64.7	31.1	0.4	87.9	1.4	3.4	7.4	0.7	4.1	0.7	4.4	5.7	2.0	0.7	1.3	2.4	25.5	2.4	19.0	0.9	1.0	1.6	94.9	199.6	17.7	1.2	1.7	7.5	0.8	0.3	1.5	2.8	1.9	1.8	2.1	0.0	4.4	2.3	1.5	2.5	3.1	29.8	1.2	37.1	3.5	2.0	12.6	1.3	1.5	5.0	1.1	25.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.4	1.4	0.7	4.1	0.9	1.0	1.2	1.7	1.9	1.2	12.6	0.7	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MARF1	"KIAA0430, LKAP, LMKB, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594387-15643154	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	10.5	7.1	2.1	10.8	5.2	9.7	9.4	1.5	6.6	10.0	3.7	16.0	10.4	12.8	1.0	12.3	13.7	12.5	9.2	4.5	3.4	13.5	8.3	9.3	14.6	3.6	4.5	18.2	12.9	12.3	5.9	9.4	2.6	10.4	12.1	8.4	14.4	13.7	18.3	10.5	11.2	12.0	0.0	12.1	10.1	4.9	4.4	12.7	14.8	15.2	22.0	12.1	8.8	4.5	8.3	9.4	15.0	8.2	12.1	22.4	7.2	9.6	12.4	8.2	13.5	2.7	6.2	29.8	17.0	12.3	6.7	5.6	7.7	12.4	13.6	11.6	5.0	13.1	12.3	10.4	13.4	15.7	10.5	13.4	13.4	15.3	15.5	16.9	19.5	12.8	12.6	13.3	15.6	7.7	13.9	2.6	5.6	7.1	7.2	19.5	22.0	5.9	7.1	6.4	9.1	10.8	7.7	8.9	14.3	6.7	9.2	13.2	19.7	11.2	5.5	11.6	6.3	12.3	12.9	15.9	12.4	9.6	16.4	2.5	0.7	4.6	1.1	1.2	0.7	4.1	1.7	1.3	0.8	5.2	1.9	1.4	7.1	0.9	1.8	0.3	1.7	0.9	2.1	5.2	1.5	6.6	4.5	3.4	3.6	4.5	2.6	0.0	4.4	4.5	21.4	22.4	28.7	0.0	10.7	0.0	0.0	0.0	0.0	0.0	26.3	19.8	0.0	0.0	18.6	23.9	0.0	5.7	14.7	0.0	15.6	10.4	0.0	17.8	27.5	8.4	0.0	0.0	0.0	14.2	5.9	7.7	0.0	20.0	11.4	23.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	7.2	0.0	0.0	0.0	0.0	13.7	0.0	0.0	6.8	0.0	0.0	19.0	17.5	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	7.7	7.8	17.9	0.0	0.0
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528136-220664461	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.8;Excitatory neurons: 171.3;Inhibitory neurons: 170.1;Oligodendrocyte precursor cells: 167.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 11.3;RT4: 33.7;SuSa: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	6.3	1.8	6.9	1.4	7.1	0.0	4.9	6.4	10.0	4.6	8.4	5.4	0.4	4.2	9.7	4.8	3.3	1.7	8.0	7.4	6.7	2.3	0.3	3.1	0.5	6.4	6.8	1.7	0.9	2.4	6.9	1.1	7.4	3.0	1.2	9.3	3.7	4.0	2.2	2.5	2.5	3.9	5.7	1.3	2.8	6.9	6.5	1.4	4.3	3.5	1.9	5.3	5.1	6.4	0.4	0.0	5.4	1.1	0.0	0.0	1.8	1.6	2.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	2.5	2.5	11.3	6.0	1.0	0.0	8.4	0.0	2.3	0.0	0.0	0.7	0.8	0.9	4.7	0.0	3.0	0.8	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.5	1.8	0.0	7.4	0.0	0.0	33.7	6.4	6.2	0.3	0.3	0.5	12.2	0.5	0.0	0.0	0.0	2.4	4.0	7.1	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.1	6.4	10.0	7.4	6.7	6.4	6.8	7.4	5.7	6.5	6.4	3.2	0.0	0.5	73.8	0.5	3.4	2.6	10.0	13.1	28.6	1.6	3.8	21.9	0.0	4.7	3.7	31.3	2.1	0.0	0.7	0.0	1.6	7.3	19.3	6.4	3.4	9.0	0.0	171.3	0.0	2.3	6.3	2.6	35.5	0.0	13.6	3.3	0.0	0.3	10.1	170.1	0.4	4.1	0.3	1.5	3.6	2.1	0.2	0.0	15.0	0.0	12.3	0.0	167.9	45.9	0.1	0.0	6.4	0.6	4.8	1.5	0.2	4.1	11.9	0.0	6.9	17.5	17.4	5.1	13.1	3.3	1.0	0.4	1.1	0.9	4.8
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	11.3	13.8	12.6	21.1	16.1	24.0	16.8	8.1	16.3	18.5	10.8	25.9	26.1	14.6	7.7	51.8	16.6	14.1	20.9	14.9	9.3	13.9	13.1	17.0	21.5	11.8	9.3	12.0	22.4	19.4	19.8	14.9	11.5	20.5	22.4	8.8	27.0	13.1	20.8	40.9	25.1	16.3	7.3	24.1	20.9	10.6	9.5	23.2	19.5	13.7	24.0	19.3	25.0	17.9	52.0	34.1	26.6	28.6	14.6	18.6	35.2	20.8	20.0	29.5	22.3	34.1	49.5	37.8	35.6	20.8	32.0	57.5	26.9	28.7	24.6	26.7	20.9	40.7	23.9	20.3	17.0	45.9	51.4	10.9	36.8	27.0	21.4	13.5	24.7	33.6	35.7	36.5	19.5	64.4	49.3	29.9	31.7	36.0	24.2	39.9	20.4	39.7	19.1	39.8	37.9	25.4	34.7	90.2	24.3	28.9	65.1	26.4	22.7	30.3	19.1	39.6	23.4	24.5	28.8	36.7	20.1	23.2	25.3	1.4	0.7	2.1	1.3	0.7	2.1	0.9	1.0	1.3	1.0	1.6	0.8	0.9	3.6	1.6	1.1	0.9	0.6	0.7	12.6	16.1	8.1	16.3	14.9	9.3	11.8	9.3	11.5	7.3	9.5	17.9	17.3	6.4	6.8	29.7	18.5	25.2	21.1	9.1	19.4	26.8	30.0	18.2	12.8	27.1	11.9	20.2	8.4	26.0	33.4	90.3	1.9	20.2	0.6	29.5	15.8	14.7	29.9	14.7	43.6	21.4	20.6	11.7	27.0	41.0	17.2	21.1	13.6	13.0	17.9	20.2	30.3	39.9	10.2	26.7	18.5	0.9	12.8	25.0	3.6	29.0	17.0	18.8	36.0	31.7	51.8	27.3	39.4	10.9	15.6	30.4	33.4	8.1	14.5	18.1	19.7	19.6	13.1	9.1	18.4	39.9	34.4	65.0	23.6	16.0	33.6	44.3
MARK3	"CTAK1, KP78, PAR-1A"	ENSG00000075413	"Microtubule affinity regulating kinase 3"	P27448	14	103385377-103503831	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	32	"eosinophil: 101.5"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 101.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024652	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA024652: AB_1853582"	"unprognostic (6.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.60e-1)"	34.6	52.5	14.9	23.0	15.9	53.2	27.5	16.0	22.1	29.8	15.1	34.8	20.4	31.3	26.7	39.8	36.8	20.8	71.5	14.5	14.8	38.7	30.8	38.3	24.9	15.1	15.0	33.7	46.7	33.8	32.0	22.8	16.2	30.5	21.3	23.2	29.2	24.2	71.0	27.3	31.8	30.8	15.0	42.6	46.5	38.4	14.7	31.0	33.2	42.7	26.2	32.1	28.5	15.6	28.1	33.3	52.8	34.7	64.3	43.6	40.9	54.9	56.8	66.3	62.4	23.3	46.2	36.3	31.9	52.5	27.0	51.5	58.3	56.6	81.2	39.4	28.0	46.8	34.9	30.8	123.5	53.4	27.2	56.1	51.5	53.1	105.0	51.9	61.0	33.0	45.4	77.1	51.2	61.6	34.9	38.4	42.0	57.7	56.0	44.9	56.2	30.1	54.1	52.3	44.5	43.1	59.0	36.6	52.1	58.7	50.8	47.1	50.2	34.8	23.4	62.1	48.4	44.4	67.0	42.1	41.5	40.8	48.0	0.3	1.5	101.5	1.4	1.1	0.9	1.5	2.2	2.8	1.8	0.6	2.4	1.6	2.3	1.4	1.1	1.2	3.1	0.7	14.9	15.9	16.0	22.1	14.5	14.8	15.1	15.0	16.2	15.0	14.7	15.6	38.0	57.7	79.1	154.1	43.6	44.2	57.2	28.7	33.0	78.7	26.3	21.7	74.6	47.1	45.2	38.6	162.6	33.3	47.9	36.6	11.7	46.8	38.0	47.5	63.7	50.9	31.2	187.1	153.5	42.0	31.0	47.3	52.0	62.1	48.2	128.7	63.9	30.1	30.2	58.9	145.0	32.3	30.5	40.4	63.0	52.4	60.9	42.6	37.4	70.3	57.5	34.4	61.8	138.2	172.3	60.4	34.0	59.0	55.9	67.4	34.6	21.5	36.8	86.7	32.9	38.9	44.1	74.6	72.4	36.1	52.1	49.1	54.8	98.9	33.7	114.6
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305284	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 119.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	13.1	13.5	27.5	7.2	31.4	8.5	13.0	16.1	37.7	17.1	11.3	16.5	5.0	15.5	16.6	16.4	14.8	10.6	17.3	31.6	19.6	13.5	21.8	13.9	8.3	24.0	25.2	21.7	14.0	20.5	16.6	11.6	22.6	16.2	5.8	26.0	12.7	13.0	38.7	26.9	9.1	14.6	14.1	11.4	14.3	40.4	29.9	13.1	12.7	12.0	9.6	19.0	16.7	26.1	20.3	7.7	36.6	23.8	25.3	36.8	8.8	15.3	25.1	21.8	20.8	4.0	10.8	8.5	12.0	28.9	20.6	13.5	26.4	22.5	14.2	15.7	16.0	20.7	8.5	17.0	47.6	4.4	15.1	48.1	31.9	18.7	22.8	43.3	29.5	22.1	22.6	21.8	24.9	14.4	16.7	14.5	12.3	18.6	4.7	61.5	11.4	6.3	23.4	16.0	58.8	27.1	20.5	17.5	12.5	35.9	9.0	29.3	21.6	16.7	12.9	12.2	9.0	22.7	21.8	10.8	17.9	8.4	12.7	1.1	1.0	0.2	1.0	0.7	0.2	0.2	0.3	1.3	0.3	0.2	0.6	0.7	0.9	0.7	0.7	0.9	0.8	0.4	27.5	31.4	16.1	37.7	31.6	19.6	24.0	25.2	22.6	14.1	29.9	26.1	8.7	12.8	3.1	30.7	6.0	25.0	11.3	7.2	15.4	20.9	10.2	7.0	9.1	11.5	4.4	9.2	25.0	4.3	8.1	3.7	11.7	8.4	2.3	6.6	9.5	12.2	6.1	6.1	31.1	6.1	1.5	8.4	10.2	10.5	2.5	18.9	18.5	10.7	7.0	119.5	36.5	4.7	4.1	9.5	11.0	6.3	16.1	8.2	3.6	16.9	5.9	19.6	12.3	23.1	16.4	9.5	3.5	13.9	7.7	13.0	4.7	6.5	2.5	15.6	0.0	7.6	8.4	1.2	8.3	12.5	24.2	11.5	10.3	26.1	3.2	15.5
MARS1	"CMT2U, MARS, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase 1"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.9;Cytotrophoblasts: 29.5;Extravillous trophoblasts: 22.0;Hofbauer cells: 19.3;Syncytiotrophoblasts: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 738.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		23000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	35.9	47.2	63.1	35.9	65.2	31.6	31.5	62.0	83.6	30.8	61.6	47.6	21.5	40.7	39.0	54.3	30.1	19.3	50.5	67.5	67.5	55.7	60.6	42.7	34.5	64.2	65.5	24.2	64.4	40.7	58.9	27.3	68.1	38.7	29.6	39.6	39.6	34.0	48.5	33.0	37.3	41.3	63.5	53.9	53.2	50.7	65.6	32.6	40.0	33.1	44.4	44.8	33.6	67.9	110.6	149.6	99.7	171.9	107.1	64.6	180.2	149.0	178.4	158.1	168.6	162.9	119.0	192.3	97.6	187.2	98.3	119.4	226.0	196.4	166.2	167.4	96.9	136.7	52.8	89.4	238.1	207.7	147.5	96.2	302.9	181.5	467.5	76.6	114.8	238.1	212.9	400.3	112.1	150.4	187.9	148.1	184.8	173.0	162.3	155.5	738.3	200.0	117.0	86.4	131.6	134.0	79.8	120.9	215.8	109.6	161.0	260.7	86.9	57.5	162.8	82.8	91.6	357.5	395.8	232.5	139.7	154.8	199.1	29.9	29.8	39.3	35.1	53.6	31.7	24.4	23.4	32.0	57.9	14.7	20.0	27.4	14.5	30.0	45.6	55.9	26.3	34.2	63.1	65.2	62.0	83.6	67.5	67.5	64.2	65.5	68.1	63.5	65.6	67.9	5.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	29.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	38.0	1.2	0.0	0.0	0.0
MARS2	"mtMetRS, SPAX3"	ENSG00000247626	"Methionyl-tRNA synthetase 2, mitochondrial"	Q96GW9	2	197705369-197708395	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.1;Suprabasal keratinocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035589, HPA035590"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"			"HPA035589: AB_10601870, HPA035590: AB_2674693"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (6.14e-5)"	"unprognostic (1.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.74e-2)"	3.0	4.7	1.8	4.7	2.9	3.6	4.1	3.0	3.0	1.8	1.4	5.4	4.7	1.9	1.4	4.9	2.3	2.2	4.1	2.1	2.5	4.0	5.7	2.0	6.5	2.7	2.7	1.6	5.3	4.1	0.9	2.5	3.2	2.0	5.0	1.7	3.1	1.7	4.8	3.2	3.7	2.5	2.5	4.5	3.3	1.9	2.7	3.2	3.1	6.0	6.6	4.2	2.2	4.1	6.9	8.2	7.7	13.0	7.2	3.5	14.5	5.2	4.1	9.8	7.3	21.1	6.3	43.4	7.6	3.0	5.2	12.8	27.2	11.2	10.3	11.8	15.9	26.7	9.7	18.7	6.8	39.7	12.3	3.7	14.0	6.6	11.3	2.6	6.5	12.6	31.7	15.1	5.6	11.7	20.3	18.7	13.3	16.1	20.6	20.7	8.1	30.7	11.8	12.2	13.6	6.5	6.5	17.5	11.9	10.0	7.5	13.8	5.2	8.0	6.3	6.1	15.4	10.0	8.0	35.7	6.0	23.8	7.5	0.0	2.5	0.7	4.3	4.0	5.0	2.7	3.5	3.9	4.0	3.0	5.6	6.3	0.1	8.6	1.9	2.8	6.6	3.6	1.8	2.9	3.0	3.0	2.1	2.5	2.7	2.7	3.2	2.5	2.7	4.1	0.7	0.0	1.1	0.7	5.3	17.1	6.2	2.6	9.1	1.7	3.3	1.4	1.9	0.0	1.8	3.7	0.0	1.8	2.1	3.7	5.9	2.1	2.8	0.6	1.7	2.2	0.0	7.2	1.7	1.8	1.3	1.6	3.1	0.9	4.5	1.5	1.1	7.7	2.6	0.0	1.7	1.6	0.0	2.2	4.2	0.8	1.5	0.8	5.4	2.8	1.7	1.6	0.0	1.5	2.0	1.2	2.4	0.4	2.1	3.1	1.1	4.4	1.3	2.3	0.0	2.5	3.1	3.5	2.7	7.3	18.9	0.8	3.9	4.1	5.4	4.8
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159890988-159917447	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.1;hippocampal formation: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HMC-1: 7.5"	"Group enriched"	"Detected in many"	22	"amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1"	"Group enriched"	"Detected in some"	4	"amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1"	HPA079325	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.0	0.0	1.7	0.0	0.7	0.3	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	5.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.2	0.6	0.0	2.0	0.0	1.4	0.0	0.0	1.2	0.1	0.3	0.8	0.0	0.6	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.8	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	0.7	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.3	0.0	2.1	0.0	1.3	1.0	0.4	0.5	0.0	0.0	0.3	0.5	0.2	0.2	1.9
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.1;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036122	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 170.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.9;Inhibitory neurons: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	18.3	11.8	16.2	11.0	15.5	8.0	18.7	15.4	17.5	57.4	7.3	39.1	21.9	43.5	12.8	14.7	31.2	19.0	65.3	15.2	19.4	12.2	18.9	17.8	8.9	19.7	27.7	51.9	9.2	13.9	27.0	8.6	26.4	40.0	25.3	24.0	18.4	15.4	170.6	14.6	30.7	26.3	14.6	7.2	24.0	56.3	18.3	5.8	13.2	73.1	11.1	46.9	28.8	15.7	31.7	25.1	24.7	19.2	30.7	41.4	27.6	32.2	22.8	29.4	32.6	29.4	10.1	48.8	15.2	38.6	59.9	15.7	30.1	18.8	30.4	23.7	16.4	22.2	29.2	27.4	28.4	12.0	27.3	34.1	23.7	49.8	37.0	35.2	27.5	12.5	17.3	14.6	34.2	21.9	17.7	12.5	20.4	21.2	28.2	25.6	40.7	9.4	16.1	16.8	34.0	20.6	38.0	50.4	16.3	26.9	22.8	11.9	27.9	55.7	36.8	30.1	33.0	19.5	18.9	17.5	38.0	16.0	24.2	0.0	0.3	0.4	0.3	0.2	0.4	0.0	0.2	0.4	0.6	0.1	0.1	0.2	0.0	0.5	1.5	0.0	0.0	0.2	16.2	15.5	15.4	17.5	15.2	19.4	19.7	27.7	26.4	14.6	18.3	15.7	5.5	0.0	2.0	32.0	2.3	4.2	4.1	3.0	8.0	15.8	8.2	6.7	46.5	4.3	5.5	3.7	54.2	6.1	2.4	66.9	1.9	4.6	38.0	4.4	17.0	7.3	12.1	6.5	45.4	6.3	4.8	12.0	12.8	7.8	0.0	13.0	3.6	6.6	6.2	5.0	86.6	24.6	0.0	2.8	7.8	57.7	9.0	5.3	7.2	30.9	2.5	3.7	7.2	52.3	52.5	8.3	33.9	10.1	5.5	10.7	50.2	5.7	3.1	12.8	6.6	11.7	9.0	28.0	13.2	6.3	2.7	5.5	3.5	12.4	22.4	7.4
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.6;Oligodendrocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.9	4.8	49.9	9.2	53.4	14.4	3.7	0.0	62.1	9.4	0.0	7.3	9.6	5.3	4.7	3.3	7.1	3.1	3.7	61.6	0.0	7.6	14.5	9.1	11.2	5.3	1.9	7.1	20.2	5.0	15.5	2.6	4.3	5.6	4.3	1.0	4.8	3.9	3.0	7.3	12.4	3.0	0.0	19.2	4.5	3.6	13.7	4.2	4.5	1.6	10.1	3.7	4.9	47.4	3.5	5.1	2.3	10.2	6.7	5.4	5.5	3.5	2.2	2.4	3.4	5.2	4.7	9.0	5.1	3.5	2.6	1.9	3.4	2.0	1.7	7.7	4.2	4.1	5.7	8.3	5.6	2.2	13.2	6.2	5.7	3.6	1.4	3.2	1.1	6.1	4.3	5.8	2.8	6.3	4.7	7.3	2.4	7.7	6.2	12.6	2.0	6.6	1.9	1.5	3.8	6.2	4.9	2.8	2.1	1.6	3.2	5.1	4.0	3.0	3.2	13.1	1.5	6.2	9.0	8.0	6.7	11.6	2.9	0.3	6.2	14.8	11.7	8.0	8.4	5.9	6.3	4.7	3.2	5.9	4.9	8.4	32.9	8.1	14.7	15.4	7.6	6.1	49.9	53.4	0.0	62.1	61.6	0.0	5.3	1.9	4.3	0.0	13.7	47.4	2.6	6.4	9.4	5.5	13.5	0.5	0.8	2.8	2.8	3.0	2.6	2.8	1.5	7.2	3.6	9.2	2.1	0.5	19.0	30.0	3.9	2.9	9.3	2.8	5.4	3.8	2.4	1.3	62.6	10.5	1.5	3.4	7.7	1.5	2.5	3.0	4.6	16.3	7.7	0.0	6.1	8.5	0.0	21.7	6.3	30.8	4.1	13.3	5.4	19.7	19.6	0.9	32.0	8.0	63.7	7.1	7.9	6.8	5.1	1.2	16.7	8.8	4.2	0.7	0.0	2.1	3.0	0.6	3.9	2.3	2.3	0.4	11.0	5.3	13.0	0.6
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 519.7;Basal prostatic cells: 507.3;Excitatory neurons: 636.6;Inhibitory neurons: 489.6;Suprabasal keratinocytes: 399.2;Urothelial cells: 676.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 27.7"	"Immune cell enhanced"	"Detected in many"		"basophil: 15.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.2;HDLM-2: 43.2;HEL: 35.5;RT4: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	14.9	11.0	4.6	4.5	5.2	1.9	11.1	0.9	27.7	12.1	0.0	6.0	5.1	10.0	5.0	27.0	9.4	8.0	29.5	4.2	5.4	12.0	8.4	11.0	4.4	5.0	5.5	16.4	4.6	15.3	4.6	8.8	1.2	7.6	4.1	4.7	11.5	6.6	11.2	14.8	4.5	9.3	1.1	5.0	7.0	10.0	3.3	16.8	6.5	7.2	10.1	16.0	21.2	11.4	14.6	7.8	3.8	0.2	12.4	10.9	9.0	3.2	4.9	1.1	1.0	7.3	3.9	1.0	6.5	2.7	2.9	12.8	11.8	33.2	1.3	43.2	3.8	35.5	4.7	3.1	0.9	0.1	11.9	18.4	17.8	7.1	14.2	13.3	26.2	3.2	3.5	3.9	8.9	12.6	5.1	0.2	2.5	1.2	6.3	1.1	3.3	0.7	3.1	42.9	5.5	4.4	4.3	1.7	0.2	2.7	2.8	0.2	25.2	3.0	4.1	4.6	5.4	9.9	4.8	0.2	7.7	0.1	2.4	15.2	0.3	0.8	0.9	0.4	2.5	2.9	4.0	1.0	0.4	2.5	4.2	1.8	3.5	2.3	0.9	1.0	6.9	1.3	4.6	5.2	0.9	27.7	4.2	5.4	5.0	5.5	1.2	1.1	3.3	11.4	130.2	32.1	53.3	519.7	11.4	368.6	507.3	127.9	114.9	15.9	79.3	38.1	139.1	27.1	78.7	18.4	2.1	40.7	4.9	24.4	37.2	59.0	129.2	35.8	5.3	111.8	32.2	5.5	636.6	115.8	50.0	33.2	28.5	55.3	93.8	19.4	70.6	42.2	5.1	8.4	489.6	18.1	40.7	6.9	33.7	127.4	41.3	9.8	48.0	78.7	2.1	55.2	4.1	165.9	108.4	70.8	27.2	32.7	13.5	355.5	14.8	93.9	57.2	4.5	39.5	15.9	31.1	14.8	9.2	211.7	399.2	137.2	21.0	14.7	16.1	676.4
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27187953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	5.0	3.9	1.7	6.2	1.9	18.7	5.3	2.3	2.3	3.8	2.1	4.1	4.4	3.9	4.5	5.9	3.0	3.9	2.5	1.9	2.0	3.9	4.9	4.0	8.9	2.0	2.0	3.4	3.3	6.0	3.1	6.5	2.1	3.1	5.2	2.7	4.1	3.0	2.3	6.0	4.3	4.5	1.6	4.6	4.7	6.5	2.0	10.4	4.7	2.2	7.1	4.5	4.3	2.3	29.4	22.0	43.8	15.5	6.2	9.1	25.4	43.3	18.0	68.4	83.8	26.7	27.2	22.4	16.1	18.4	33.5	26.8	27.9	16.0	48.2	20.2	26.5	26.9	14.5	15.5	3.8	10.4	19.8	5.6	7.5	41.6	7.9	9.0	14.7	18.2	21.1	49.9	41.5	17.9	34.8	11.2	32.0	15.9	8.9	22.2	71.9	18.9	17.4	10.6	19.2	26.8	26.0	17.6	19.1	28.1	17.2	21.4	12.6	17.0	36.3	44.0	37.4	5.9	10.3	34.7	18.3	31.1	14.8	0.2	1.8	1.7	0.7	1.7	1.1	1.1	0.9	0.7	1.0	1.6	0.9	0.8	2.3	1.0	1.8	1.1	1.6	0.8	1.7	1.9	2.3	2.3	1.9	2.0	2.0	2.0	2.1	1.6	2.0	2.3	4.3	6.4	7.8	2.6	7.4	11.0	4.9	4.4	4.0	1.7	4.2	4.8	3.0	2.8	7.0	1.8	0.0	8.6	10.1	7.0	0.0	4.0	3.0	9.7	5.3	4.6	4.2	7.8	4.3	2.5	24.9	7.3	6.1	17.9	12.7	6.9	2.5	2.5	5.8	3.3	4.3	3.7	4.1	7.8	19.3	1.7	3.1	11.3	0.0	3.7	5.1	1.8	3.1	3.5	4.9	4.4	2.9	2.6	7.1	5.0	2.8	1.9	4.0	1.0	0.0	3.8	5.3	14.9	14.1	10.9	9.9	6.2	11.6	5.4	4.5	6.6
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1346.5"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.4	0.1	0.8	0.0	0.4	0.1	0.5	0.2	0.9	0.2	0.2	0.1	57.5	0.1	1.2	0.0	0.2	0.2	0.2	0.9	1346.5	0.4	0.1	0.6	0.8	6.3	43.8	0.1	0.8	0.1	0.4	0.0	0.0	0.0	0.3	1.9	0.0	4.2	0.0	0.2	0.8	0.5	0.2	3.7	0.2	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.5	0.2	0.2	0.6	0.8	0.4	0.8	0.2	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519354	"Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"		NA	NA		1100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	36.6	54.6	31.1	64.7	32.4	31.1	50.5	35.3	39.8	46.9	37.5	61.5	86.9	45.4	59.4	40.9	66.7	42.1	75.3	32.8	33.7	104.8	82.7	56.1	102.6	32.2	35.3	73.3	23.9	69.2	22.0	48.9	33.3	46.1	66.5	47.8	64.3	53.2	57.8	34.6	84.4	44.4	34.6	84.5	57.2	31.7	33.3	89.6	81.4	63.7	92.7	60.9	33.2	34.0	72.4	60.0	100.6	55.1	73.4	72.9	62.2	61.8	68.5	67.7	99.4	41.5	128.5	74.8	127.6	66.0	99.5	56.6	84.8	125.4	89.1	254.5	69.6	67.3	63.3	62.1	95.9	71.0	44.7	60.4	101.1	86.1	66.4	81.8	149.5	76.6	54.8	90.8	84.0	40.7	99.2	85.9	38.6	43.9	40.0	112.4	49.2	123.4	111.7	76.6	40.4	57.9	82.8	58.2	93.8	44.1	76.5	95.1	121.2	73.6	48.5	51.8	107.7	78.4	82.3	68.3	54.1	129.1	51.3	619.4	227.5	477.4	321.5	274.3	355.8	359.1	351.2	349.3	204.6	345.3	352.7	341.4	357.8	401.5	302.4	167.2	528.3	689.9	31.1	32.4	35.3	39.8	32.8	33.7	32.2	35.3	33.3	34.6	33.3	34.0	24.9	48.1	43.3	8.8	90.1	42.7	35.1	75.6	129.1	23.2	26.0	20.7	57.7	41.5	48.1	44.1	8.4	61.3	62.8	49.2	62.6	38.8	39.0	63.5	36.2	38.9	15.0	79.3	15.0	26.2	29.7	34.6	36.2	44.2	28.4	28.1	35.7	58.3	45.3	18.5	12.8	40.8	61.1	83.3	55.3	13.3	34.5	48.5	42.7	18.7	70.6	41.7	80.3	9.0	16.2	28.9	38.1	31.2	65.7	46.8	53.4	103.7	72.6	17.6	46.0	21.7	35.6	23.6	30.5	69.8	36.2	37.6	84.2	23.3	51.3	45.7
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	4.7	1.3	18.3	6.6	21.3	20.5	2.5	2.9	41.9	1.1	1.6	2.1	6.6	0.9	0.1	2.1	4.0	4.4	1.4	25.9	8.7	2.4	3.2	9.9	9.4	10.4	11.0	0.7	1.2	0.7	2.7	1.0	8.8	1.3	1.1	2.2	3.2	0.7	0.8	1.9	6.2	0.8	4.7	16.5	4.0	3.1	14.1	3.8	1.6	0.2	4.0	1.6	1.1	23.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.2	1.7	0.0	1.0	10.6	13.8	0.4	0.0	0.0	18.1	12.0	1.5	2.9	0.0	108.3	30.9	0.1	0.0	0.2	0.1	0.0	0.0	1.2	48.9	0.1	0.0	34.4	0.3	74.8	8.4	9.0	0.3	0.0	0.1	0.0	0.0	0.0	30.9	0.1	0.1	0.1	0.1	0.9	0.0	27.4	3.3	0.0	0.6	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	46.2	0.0	31.3	0.0	5.7	29.3	0.8	0.9	2.7	16.4	1.0	76.8	0.2	0.3	0.4	7.6	18.3	21.3	2.9	41.9	25.9	8.7	10.4	11.0	8.8	4.7	14.1	23.6	1.4	0.0	1.1	0.3	11.1	0.4	0.1	0.0	0.0	1.4	4.9	7.2	1.3	0.0	0.0	0.0	12.5	0.3	177.0	0.3	0.0	0.0	2.0	0.2	0.5	1.9	7.1	28.6	17.7	0.0	0.5	0.8	11.7	0.5	44.5	0.1	8.6	1.1	57.4	0.0	8.3	0.3	0.0	6.0	14.6	5.1	0.0	11.5	1.8	4.7	3.0	1.3	422.2	2.0	1.6	0.0	1.1	0.0	17.1	0.1	0.3	0.2	0.7	2.0	0.0	0.5	1.2	0.4	4.5	1.3	1.1	0.3	99.7	0.0	1.1	0.0
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1"	P21941	1	30711277-30723585	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.3;retina: 5.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 1.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028580	Supported				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"		"Cluster 57: B-cells - Immune response"			"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.0	0.1	0.4	0.3	0.5	0.7	0.0	0.4	0.4	0.5	0.0	0.0	0.1	0.4	0.1	0.1	0.2	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.2	0.0	0.2	0.3	0.7	0.1	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.1	0.2	0.4	0.0	0.3	0.0	0.0	0.1	0.2	1.3	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.5	0.4	0.4	0.2	0.4	0.6	0.4	0.7	0.3	0.4	1.3	0.3	0.0	0.5	0.0	4.1	0.1	0.6	0.1	0.0	0.0	0.4	1.0	0.5	0.0	0.6	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.1	0.4	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.5	0.2	0.8	0.5	0.5	0.1	0.3	0.5	0.3	0.0	0.1
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293674-139331677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		260000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	112.9	127.9	145.2	93.6	156.1	323.5	161.0	172.2	224.5	144.1	109.6	106.3	76.9	166.6	124.0	103.3	131.1	115.3	111.4	158.4	146.1	150.1	112.9	115.2	157.9	126.2	132.1	199.3	102.8	168.6	95.1	122.9	131.4	130.2	106.5	223.4	93.5	133.2	119.6	82.0	90.0	142.4	144.8	124.5	89.1	114.9	139.3	221.7	190.5	114.0	170.2	133.5	91.2	156.3	209.0	191.1	559.5	260.7	192.4	212.5	283.2	172.2	300.9	300.4	347.5	273.1	208.8	351.2	236.8	244.1	284.8	135.8	376.8	269.6	403.0	278.4	189.1	236.5	205.0	285.0	183.2	262.5	174.4	222.5	203.7	247.4	226.3	247.1	296.1	219.4	216.9	170.3	313.8	186.7	496.0	285.8	303.6	205.2	182.6	304.7	416.4	217.8	278.0	316.5	279.5	348.7	248.3	176.7	264.6	426.3	194.4	254.5	192.2	272.0	177.7	180.6	246.3	171.0	300.4	423.0	189.8	226.5	268.0	187.0	71.2	116.3	109.6	82.2	134.8	116.3	114.3	124.6	92.6	97.7	124.4	116.5	34.7	150.9	106.7	50.7	136.1	159.8	145.2	156.1	172.2	224.5	158.4	146.1	126.2	132.1	131.4	144.8	139.3	156.3	0.1	44.8	50.2	83.6	17.6	114.6	0.8	99.2	15.9	1.8	0.3	0.3	0.7	0.0	92.0	0.0	2.1	1.2	0.0	27.6	0.0	0.0	0.3	0.2	0.2	13.6	83.5	15.5	155.9	0.0	1.0	17.5	5.1	0.4	100.3	0.1	0.0	0.0	1.3	1.7	160.2	35.3	87.5	0.0	122.3	0.6	0.6	4.7	103.2	60.9	0.1	0.7	0.0	117.6	162.4	0.1	12.4	0.7	7.3	0.7	0.8	0.2	127.9	1.3	0.0	1.0	33.3	1.1	0.5	15.1	111.2	0.8	21.8	0.5	41.9	1.0
MATR3		ENSG00000280987	"Matrin 3"		5	139273752-139331671	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA036564, HPA036565"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (3.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.69e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.91e-10)"	"unprognostic (2.91e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-2)"	10.5	13.5	14.6	24.4	14.6	25.1	31.1	9.9	24.5	9.7	5.5	22.4	16.2	15.3	34.0	17.8	19.2	9.6	30.6	15.4	12.9	10.2	9.7	8.4	36.1	18.4	10.9	14.3	7.5	8.3	2.2	10.3	18.8	15.5	29.3	11.8	26.4	8.6	41.2	20.4	12.1	14.8	13.9	19.9	17.7	18.6	13.5	17.4	9.7	38.4	33.7	14.7	2.8	21.2	81.0	58.9	30.2	162.9	65.9	79.7	58.6	42.8	36.4	69.4	87.0	101.7	71.7	284.8	60.7	61.2	45.0	91.2	257.9	136.3	120.5	48.7	125.6	190.2	100.3	89.8	57.6	176.9	67.9	93.7	95.4	79.6	90.7	38.6	78.9	103.7	143.2	50.3	74.0	31.7	98.5	53.4	122.7	35.4	38.8	199.0	92.8	125.1	40.3	55.7	92.6	56.5	49.4	60.7	113.6	77.3	57.0	71.1	56.3	52.8	78.5	43.7	63.7	23.3	33.6	153.2	45.8	148.1	61.6	0.1	0.8	0.1	0.5	1.2	1.3	3.4	1.7	2.4	3.2	2.0	2.6	1.7	0.2	0.9	0.4	0.1	1.4	1.2	14.6	14.6	9.9	24.5	15.4	12.9	18.4	10.9	18.8	13.9	13.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		600000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	14.2	12.5	13.0	11.5	16.0	10.3	13.0	13.9	13.6	11.6	14.1	19.4	14.8	12.0	8.4	14.9	13.2	6.7	21.3	12.1	11.5	15.8	15.5	13.3	9.9	18.6	15.7	16.8	17.6	15.4	12.1	9.4	15.9	14.2	15.4	8.1	13.0	10.3	37.5	18.9	16.9	9.6	14.0	14.3	15.4	4.9	16.1	10.4	14.0	29.2	10.8	14.3	11.0	16.6	31.6	36.0	14.3	17.9	38.8	26.2	11.2	18.7	23.8	19.5	14.2	28.4	19.9	13.6	11.1	26.4	55.6	38.7	17.3	28.0	19.9	8.4	8.4	26.3	14.6	45.5	21.4	16.6	10.6	26.7	23.4	33.2	19.6	19.4	20.1	17.6	30.2	10.1	19.3	28.5	25.3	14.1	9.2	15.7	19.6	18.8	19.9	13.7	20.8	31.2	10.7	11.2	21.3	41.0	18.1	20.3	21.9	15.3	30.5	26.5	9.7	31.7	22.1	20.7	26.6	9.4	10.5	20.1	13.7	1.7	2.1	2.0	1.4	1.6	1.0	1.1	1.1	1.1	1.4	1.3	1.2	1.2	1.9	1.8	1.9	1.7	0.9	1.6	13.0	16.0	13.9	13.6	12.1	11.5	18.6	15.7	15.9	14.0	16.1	16.6	16.6	57.7	48.5	24.8	17.3	2.2	13.9	3.7	19.4	34.0	19.9	13.2	61.0	58.6	21.7	29.5	16.7	33.6	22.5	100.0	13.7	25.9	1.1	16.1	27.5	26.8	34.7	17.1	13.6	30.5	27.5	22.8	25.0	16.6	8.8	36.5	44.3	45.7	25.5	45.4	15.9	32.6	2.0	37.7	2.9	3.2	30.7	20.7	1.8	15.9	32.4	20.7	20.6	12.5	19.9	32.7	29.5	28.2	14.2	18.1	42.8	19.6	16.2	33.7	32.9	26.2	17.5	6.2	4.1	15.6	2.0	18.1	16.7	27.5	57.9	16.6
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 390.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (6.03e-2)"	48.1	36.3	57.4	43.5	63.2	105.1	41.2	74.6	62.9	61.0	44.8	51.1	41.3	51.1	29.2	75.8	67.2	36.2	52.8	55.0	59.4	39.5	36.8	51.6	63.7	65.5	61.8	56.2	29.3	31.3	32.5	39.8	65.0	52.2	31.8	23.6	43.5	38.7	43.8	55.3	51.7	39.5	59.4	66.3	39.4	21.5	62.1	63.7	42.7	54.0	55.1	51.3	68.7	65.3	117.1	40.4	27.8	44.6	73.4	58.0	35.4	39.9	62.3	47.5	58.4	29.1	86.7	88.1	33.1	48.8	45.0	60.4	63.4	52.7	37.3	84.5	40.5	143.4	29.9	32.0	90.9	56.2	390.3	67.6	43.5	42.7	54.9	71.9	54.9	71.8	66.8	42.4	53.1	63.9	140.1	217.6	36.3	71.3	70.6	75.2	42.7	47.3	49.2	38.8	61.8	38.2	49.6	60.6	60.4	25.1	58.0	71.6	69.7	47.8	55.8	42.0	33.6	50.7	43.6	61.7	56.9	56.1	46.0	667.6	141.9	540.8	125.7	126.4	140.1	115.7	147.5	130.5	119.9	114.9	151.1	127.9	305.1	126.9	120.3	114.6	194.0	314.2	57.4	63.2	74.6	62.9	55.0	59.4	65.5	61.8	65.0	59.4	62.1	65.3	45.8	28.9	27.4	31.0	74.5	170.2	66.0	63.3	126.3	28.2	59.8	43.1	27.4	32.9	42.0	18.4	20.9	38.4	79.1	116.3	52.8	38.8	45.5	38.1	43.6	59.9	44.3	40.4	50.7	31.4	43.4	46.7	32.6	36.0	62.8	38.2	71.0	23.8	59.9	47.1	43.3	49.7	38.7	81.8	66.7	115.6	77.9	147.2	56.9	32.8	67.1	47.3	69.0	28.1	60.4	61.6	96.7	60.2	58.0	80.3	100.6	66.4	32.9	16.9	138.1	47.4	76.3	43.2	28.4	84.8	180.6	54.0	83.9	25.4	29.7	76.2
MAZ	"Pur-1, ZF87, Zif87, ZNF801"	ENSG00000103495	"MYC associated zinc finger protein"	P56270	16	29806106-29811164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048315, HPA059495, HPA065930"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579"	"unprognostic (1.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (7.08e-2)"	71.0	91.7	156.7	92.1	153.0	270.3	65.5	147.4	179.9	87.4	125.2	139.4	92.7	90.1	51.4	92.6	88.6	73.6	74.4	158.9	134.8	63.6	101.2	73.2	123.9	140.4	144.6	96.7	105.4	113.3	83.0	61.8	136.6	122.9	101.0	50.8	86.2	75.4	126.2	96.3	87.7	75.8	134.8	97.8	85.5	89.9	143.9	256.0	79.5	93.1	111.2	94.4	68.4	145.2	227.2	294.8	298.8	326.9	158.4	149.6	268.4	161.0	130.6	246.0	177.4	378.5	316.5	402.4	205.2	316.9	121.6	201.3	494.2	210.9	87.5	329.9	792.4	267.7	641.3	526.2	222.1	668.7	318.8	160.7	292.1	207.2	232.5	228.7	249.4	556.7	398.5	343.3	118.3	927.1	644.8	566.3	303.7	246.1	227.6	627.9	281.3	468.5	202.3	242.2	456.1	355.1	153.8	330.1	204.6	190.5	284.3	633.7	172.8	269.8	215.4	103.6	256.1	249.3	344.4	448.5	131.9	435.4	227.9	18.1	14.7	23.9	58.8	24.0	63.6	13.5	39.1	56.5	19.4	10.2	31.6	47.3	11.9	40.1	16.4	19.9	45.8	21.3	156.7	153.0	147.4	179.9	158.9	134.8	140.4	144.6	136.6	134.8	143.9	145.2	52.1	6.4	5.4	9.4	35.3	32.9	14.7	26.7	35.3	61.6	77.8	66.9	0.3	31.5	14.5	11.0	12.5	26.8	106.7	111.5	29.4	31.6	2.5	58.5	59.0	41.0	133.3	90.3	12.8	41.9	55.6	46.3	34.7	39.6	33.0	103.1	30.7	37.7	57.5	47.1	13.0	103.6	32.6	47.8	47.8	6.6	28.0	47.6	46.2	8.4	26.4	35.6	50.4	9.5	14.2	36.3	68.5	36.9	41.6	32.8	37.8	21.9	25.6	35.1	32.9	30.1	49.1	22.2	24.5	38.6	35.5	16.7	67.5	70.9	126.8	14.9
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	8.1	4.6	1.2	1.5	1.2	0.3	43.4	1.2	2.2	2.9	0.9	14.6	1.8	2.3	0.3	736.1	18.7	4.1	13154.5	1.0	1.9	2.8	5.8	14.9	5.3	1.4	1.4	5.3	26.9	16.1	10.6	3.1	1.2	214.2	12.9	0.2	367.1	0.5	40709.4	23.0	11.1	1.4	1.2	2.1	3.8	4.5	1.5	0.8	8.5	29085.2	1.8	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.2	1.0	1.9	1.4	1.4	1.2	1.2	1.5	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192917856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 4.2;T-reg: 3.9"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	3.7	4.2	2.5	3.2	2.8	1.3	3.4	3.3	3.1	2.8	1.6	3.0	8.8	5.1	1.9	2.0	3.6	4.7	4.0	2.8	2.3	4.2	1.5	3.6	1.2	2.1	2.0	4.1	1.9	2.3	3.5	13.3	1.8	1.9	2.9	2.0	1.5	1.9	2.7	4.7	9.3	5.6	1.5	2.2	3.5	7.1	1.9	1.4	1.7	1.6	1.7	8.8	2.4	2.3	26.6	3.7	6.3	19.0	3.9	5.8	11.2	18.8	17.5	33.4	19.9	17.0	4.2	0.0	11.0	46.6	13.8	11.5	14.6	4.8	36.2	114.8	8.1	3.3	1.8	2.0	7.4	0.4	1.6	7.6	7.4	9.4	5.8	2.7	6.6	3.3	0.2	1.5	5.8	19.8	0.3	0.0	13.1	14.4	45.9	0.6	10.5	5.6	7.8	15.1	9.8	5.0	4.1	12.8	1.9	12.9	19.9	0.4	2.1	6.3	18.4	11.1	36.3	48.1	41.0	0.0	4.4	4.0	8.6	0.0	0.2	0.0	0.2	0.3	1.9	0.1	4.2	1.0	0.4	0.0	2.6	0.7	0.0	0.0	0.0	0.0	3.9	0.9	2.5	2.8	3.3	3.1	2.8	2.3	2.1	2.0	1.8	1.5	1.9	2.3	2.9	6.4	0.5	16.6	1.2	9.2	0.9	2.0	1.2	10.9	4.6	3.2	1.8	1.5	3.2	0.0	2.1	63.8	0.3	2.4	0.0	6.5	0.2	12.4	2.0	7.7	10.2	0.0	28.6	0.2	9.5	5.9	1.5	15.9	0.0	5.8	9.7	0.2	5.6	8.4	53.0	2.8	4.1	3.8	85.0	1.4	3.1	10.4	14.2	17.8	13.4	1.1	0.0	68.9	30.6	2.2	6.1	6.0	4.2	0.8	15.4	9.6	2.8	1.3	13.1	3.3	4.5	1.8	16.5	1.8	8.7	110.4	3.3	5.4	3.7	2.6
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 97.4;Spermatocytes: 136.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	28.5	39.8	23.9	26.2	25.9	44.2	29.1	24.8	28.2	32.3	19.3	35.7	24.8	32.1	20.5	39.2	31.6	19.6	35.7	26.7	22.2	32.5	35.7	29.9	30.2	23.1	22.0	34.8	34.5	32.4	42.8	24.6	21.1	33.0	17.7	24.0	30.5	23.5	51.0	43.4	33.7	20.4	19.5	41.0	33.6	88.1	23.1	29.6	35.4	28.6	24.2	35.3	32.2	25.6	30.9	28.6	31.5	35.9	33.2	26.9	33.9	36.2	41.4	49.2	37.7	21.6	23.9	48.5	25.8	35.3	28.8	54.4	36.3	63.4	28.4	54.7	23.2	30.6	43.8	23.1	63.9	74.8	62.1	31.5	100.4	56.2	127.2	31.1	40.9	47.4	39.3	73.8	38.3	28.5	63.3	38.9	29.8	16.1	22.7	57.8	23.3	53.2	24.4	13.8	41.5	39.5	27.0	25.5	33.2	25.4	32.4	67.4	44.7	53.0	24.1	17.3	37.2	135.8	62.2	51.6	34.3	56.8	49.0	16.0	11.2	22.7	15.3	9.7	14.6	11.6	13.5	12.9	11.2	11.4	13.8	11.4	14.5	14.3	7.8	10.2	13.8	12.6	23.9	25.9	24.8	28.2	26.7	22.2	23.1	22.0	21.1	19.5	23.1	25.6	17.7	9.6	24.6	19.6	20.1	22.7	13.9	18.2	23.3	15.1	16.5	14.5	28.1	14.3	20.5	16.5	18.8	31.1	25.0	24.5	13.7	15.7	85.1	17.1	16.1	17.6	13.1	9.7	20.4	13.8	24.2	16.5	28.1	17.3	8.8	17.7	13.9	18.1	18.7	15.2	17.3	19.5	24.4	15.8	11.1	97.4	15.5	17.5	16.0	9.4	15.7	17.4	14.4	12.1	16.4	21.1	24.5	19.2	34.6	14.4	21.3	9.7	16.9	20.3	13.1	14.8	18.9	136.0	32.5	21.6	29.3	51.4	20.0	28.1	18.6	17.0
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151606-54224669	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	26.9	10.5	6.5	19.2	8.9	20.3	19.9	9.5	9.4	16.0	6.5	17.3	12.0	11.3	15.8	29.5	11.3	11.5	14.9	6.8	8.9	16.7	16.9	16.4	32.1	7.6	8.3	11.4	17.4	16.5	9.2	18.8	7.7	13.4	16.4	14.3	19.4	15.1	15.4	25.4	15.5	11.9	7.0	21.2	13.9	31.5	7.9	20.1	31.0	16.8	35.2	21.0	20.1	8.2	29.1	13.2	23.2	11.7	27.3	23.0	22.5	26.5	33.9	30.6	26.6	8.5	15.8	68.7	13.1	42.1	13.5	45.1	20.1	36.6	33.4	50.2	11.1	10.2	20.4	18.3	28.2	32.7	17.7	20.2	40.3	23.5	34.1	20.3	35.9	20.7	8.0	62.0	28.0	14.0	33.1	18.1	24.2	11.3	17.2	21.8	13.9	27.9	44.5	29.9	25.6	10.8	21.0	21.1	14.7	30.3	10.9	16.3	31.2	31.1	14.1	10.9	24.4	65.1	38.3	52.5	27.4	27.4	19.0	0.0	1.4	0.7	0.6	2.6	0.9	0.7	0.7	1.0	0.8	1.3	0.3	0.6	1.2	0.2	5.0	0.7	1.5	0.4	6.5	8.9	9.5	9.4	6.8	8.9	7.6	8.3	7.7	7.0	7.9	8.2	71.1	28.9	21.0	30.3	44.9	49.3	37.3	21.2	13.1	19.3	46.0	35.3	35.8	24.3	23.0	33.1	16.7	14.3	57.6	51.2	7.9	26.3	1.9	62.1	48.9	38.0	16.3	22.7	42.5	58.4	49.4	32.7	21.9	103.3	8.2	32.0	32.2	25.2	30.3	21.9	38.3	35.9	10.2	142.6	38.7	4.8	25.1	82.2	26.6	43.1	69.3	45.9	8.2	32.2	49.5	54.3	28.0	26.4	53.7	51.5	35.7	23.5	30.0	27.0	26.3	39.0	35.2	6.5	6.1	54.6	62.5	18.3	47.7	43.0	38.7	79.5
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592865	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	40.1	46.1	12.7	7.0	11.3	12.8	36.2	18.2	16.5	41.5	7.2	45.8	7.6	46.2	7.6	42.4	40.6	6.6	60.3	13.7	9.0	45.3	59.3	38.3	9.6	12.9	11.7	48.9	32.8	7.4	50.0	9.0	10.7	54.8	6.4	4.1	30.4	7.0	74.0	40.2	34.6	7.4	10.1	49.8	39.0	43.4	12.2	9.0	45.3	4.7	9.1	41.1	33.8	13.0	26.4	56.3	22.5	34.9	21.6	15.0	20.8	20.9	13.5	21.5	19.5	44.9	15.6	49.9	12.1	26.7	7.5	35.8	37.8	23.7	13.0	41.2	36.8	24.6	77.4	27.9	17.6	28.2	24.5	20.3	23.1	35.6	17.4	14.2	25.2	25.7	55.8	34.2	17.6	56.6	32.7	30.5	29.4	12.6	25.5	31.1	23.3	21.2	14.1	50.0	64.5	36.8	25.2	18.3	12.6	12.2	23.5	21.1	20.0	28.9	15.5	65.5	42.1	31.8	39.8	38.6	21.2	37.0	27.7	0.7	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.4	0.3	0.3	0.5	0.3	0.2	0.5	0.1	0.2	12.7	11.3	18.2	16.5	13.7	9.0	12.9	11.7	10.7	10.1	12.2	13.0	21.6	12.8	24.3	14.4	10.6	10.8	8.9	9.4	5.2	22.6	23.8	20.6	20.8	12.8	11.0	11.0	14.6	46.4	17.4	48.1	5.9	15.0	3.1	9.8	20.5	19.8	14.9	14.9	8.4	26.2	42.7	20.0	18.3	16.1	3.8	48.4	24.7	42.6	27.2	18.5	9.2	26.4	14.2	32.0	10.3	8.1	22.4	16.9	5.4	15.9	17.5	40.5	14.4	10.6	12.3	19.3	16.8	25.6	9.7	14.9	20.8	19.1	4.8	11.3	39.5	21.6	18.7	9.2	10.3	11.0	12.8	121.5	10.8	36.0	40.6	8.8
MBD3L1	MBD3L	ENSG00000170948	"Methyl-CpG binding domain protein 3 like 1"	Q8WWY6	19	8832398-8843340	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 27.0"	"Group enriched"	"Detected in some"	24	"Early spermatids: 374.9;Late spermatids: 138.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA043121, HPA046753"	Supported					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA043121: AB_2678327, HPA046753: AB_2679786"				"unprognostic (1.10e-3)"						"unprognostic (1.24e-1)"				"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	374.9	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	138.4	3.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	10.3	2.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430947-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.6	18.4	16.8	34.0	18.4	44.2	21.6	19.6	20.7	33.2	16.8	19.3	23.7	23.3	24.8	16.4	19.3	21.3	25.3	17.0	17.4	25.4	38.0	22.9	66.5	17.5	17.2	30.3	22.9	18.1	19.3	19.7	17.7	18.7	22.9	19.6	19.5	17.8	25.8	23.7	27.5	19.7	17.3	39.2	27.8	17.3	18.4	30.0	19.3	22.3	74.0	18.5	17.5	20.6	46.2	27.4	32.5	36.5	36.8	32.8	37.5	39.0	36.9	36.7	43.3	33.8	30.1	64.6	31.1	24.5	33.7	40.7	25.2	24.1	44.2	37.0	16.6	38.9	32.0	24.6	58.7	71.2	49.2	39.1	33.8	31.2	27.4	36.5	35.1	37.2	43.9	47.1	27.5	43.3	41.4	50.0	28.7	38.8	23.5	38.7	19.2	44.7	40.9	22.7	36.5	20.3	49.3	25.3	42.5	28.0	32.3	62.5	23.6	34.5	26.3	37.6	26.2	31.9	20.9	111.9	29.4	40.1	29.2	80.3	25.0	35.2	31.1	23.1	24.0	116.5	33.2	30.9	21.0	110.8	40.6	33.3	43.0	28.9	30.0	25.2	31.5	25.6	16.8	18.4	19.6	20.7	17.0	17.4	17.5	17.2	17.7	17.3	18.4	20.6	36.5	19.2	52.9	15.3	111.2	17.3	32.5	38.4	29.6	37.0	26.7	29.6	35.9	27.1	36.4	44.1	18.8	49.2	61.4	22.4	45.0	32.1	19.8	49.6	41.2	33.5	33.6	46.3	18.1	69.0	46.2	35.6	55.0	45.0	58.9	33.1	31.4	32.1	71.8	21.9	12.8	27.5	40.7	41.8	24.7	10.6	32.9	48.0	21.4	24.4	62.9	21.2	54.6	14.1	22.0	39.3	23.4	36.5	75.5	31.1	29.4	55.5	39.5	46.3	39.5	39.6	30.9	49.5	71.6	30.4	19.6	37.1	54.2	33.2	26.3	35.6
MBD6	KIAA1887	ENSG00000166987	"Methyl-CpG binding domain protein 6"	Q96DN6	12	57520710-57530148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in all"		"RH-30: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038948, HPA038949"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA038948: AB_2676285, HPA038949: AB_10671868"	"unprognostic (2.56e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.01e-2)"	32.8	40.0	18.7	34.5	22.1	57.1	36.5	19.5	21.3	43.3	21.9	38.8	41.6	46.9	17.9	35.8	40.7	19.1	25.8	17.7	22.8	38.8	44.2	34.4	26.1	24.1	20.8	43.8	44.5	23.0	105.0	25.6	20.0	38.6	20.7	38.5	46.9	27.1	34.1	37.8	44.9	19.8	17.2	64.9	42.6	57.5	25.0	27.9	110.2	18.8	18.8	34.3	35.0	26.8	22.7	31.7	24.2	26.0	16.6	11.9	33.9	25.7	15.8	16.6	12.3	33.0	35.3	22.8	19.3	14.0	16.2	31.3	22.3	19.4	11.6	45.2	22.5	40.2	33.4	22.8	20.3	24.2	99.7	20.8	33.7	17.8	24.8	25.1	22.3	19.3	26.1	58.7	13.5	23.3	25.3	23.9	23.3	16.7	23.2	24.6	116.7	17.7	14.3	44.4	33.3	20.2	20.5	40.6	25.0	14.2	45.7	38.7	21.9	17.8	29.0	18.2	17.4	60.5	22.4	15.7	23.2	15.1	30.6	0.0	1.0	0.4	1.3	0.9	0.5	1.3	0.2	0.4	0.5	0.8	0.5	0.5	13.6	0.7	0.4	0.3	0.2	0.6	18.7	22.1	19.5	21.3	17.7	22.8	24.1	20.8	20.0	17.2	25.0	26.8	24.7	6.4	17.8	12.4	14.1	11.0	13.4	11.9	22.2	55.5	27.5	22.4	6.2	25.8	13.0	9.2	27.1	12.4	12.6	20.6	5.9	9.4	13.3	18.9	19.7	16.7	15.6	18.7	5.4	12.0	8.8	12.2	29.0	32.8	19.0	21.7	14.6	24.3	14.0	25.2	6.6	20.5	8.2	23.8	11.0	9.4	14.6	23.1	12.4	15.0	9.1	30.4	11.3	6.6	8.1	9.2	20.7	12.8	14.8	12.3	20.8	4.4	16.3	69.4	19.7	14.9	17.3	51.7	30.8	23.7	12.4	22.6	16.8	16.9	16.8	15.8
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298564-36320637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 30.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	16.2	19.4	17.4	12.1	18.5	35.1	24.9	20.7	22.0	27.9	17.9	17.0	16.9	26.6	21.3	16.5	16.5	16.5	14.2	16.7	19.7	26.2	29.0	76.7	17.4	15.9	17.5	32.2	17.6	19.7	22.4	19.1	16.4	18.5	22.2	22.3	15.9	16.3	7.2	28.5	17.3	20.2	17.2	15.6	31.2	18.2	20.0	17.9	81.7	9.3	16.0	15.2	13.5	21.4	29.6	15.4	31.7	32.1	31.3	30.0	24.1	24.8	30.7	32.2	33.6	31.2	28.9	28.0	36.8	32.1	16.8	22.1	33.7	22.9	39.3	40.5	25.5	16.4	14.7	55.0	33.9	33.8	17.5	30.8	35.1	21.1	27.2	33.2	20.4	38.3	28.4	33.8	24.2	28.8	32.5	27.7	26.9	25.2	44.6	15.4	27.7	19.5	37.2	22.7	47.3	18.8	20.4	19.5	33.4	27.3	31.9	21.6	16.0	35.6	23.2	26.3	26.0	27.8	34.5	44.0	13.6	17.3	25.3	2.0	12.6	3.0	14.6	9.9	18.5	16.4	17.6	18.0	12.8	12.3	22.6	18.5	7.0	12.9	8.1	14.5	23.6	13.3	17.4	18.5	20.7	22.0	16.7	19.7	15.9	17.5	16.4	17.2	20.0	21.4	16.0	218.0	316.0	18.3	14.9	90.2	30.7	41.5	22.2	24.9	15.3	23.0	10.7	10.0	106.7	25.8	2.1	24.7	12.2	16.1	58.7	21.2	4.2	20.9	28.2	18.3	31.5	9.7	21.2	19.0	21.1	29.7	13.3	35.6	13.3	30.2	16.1	25.2	18.7	92.5	24.8	15.5	20.3	9.5	15.4	4.2	32.0	14.5	21.4	9.4	11.5	29.0	12.3	31.7	27.0	17.8	18.6	27.1	18.9	29.0	18.9	49.6	34.9	24.1	13.1	18.0	27.8	50.1	35.5	17.9	65.5	19.8	20.6	25.5	21.1	21.4
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2810	"liver: 280.9"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
MBLAC1	MGC49416	ENSG00000214309	"Metallo-beta-lactamase domain containing 1"	A4D2B0	7	100126785-100128495	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071574	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA071574: AB_2686419"	"unprognostic (8.28e-3)"	"unprognostic (4.83e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.38e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.90e-5)"	"unprognostic (7.83e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.88e-2)"	1.7	2.3	2.9	0.9	3.1	1.0	1.9	5.1	5.5	3.3	0.0	2.7	2.7	3.2	0.5	2.8	3.0	0.6	3.1	2.8	0.8	2.8	2.3	1.3	1.0	1.8	0.9	3.5	2.2	1.2	3.9	0.4	1.8	4.0	0.6	1.1	2.8	1.7	2.6	2.3	2.1	0.7	0.4	2.0	2.3	2.8	1.1	1.2	2.5	0.6	0.5	2.8	2.7	2.8	2.5	2.7	1.3	1.5	1.5	0.3	1.9	2.8	1.0	1.2	1.0	3.3	1.8	1.5	2.5	1.2	3.8	1.2	0.5	0.0	0.2	5.3	3.0	0.8	1.8	2.6	1.3	2.7	2.3	0.9	0.2	0.8	0.6	1.2	1.0	2.0	2.0	7.0	0.9	2.8	5.1	1.8	1.6	0.3	5.2	3.4	2.0	2.7	0.4	3.0	1.9	4.1	4.3	6.2	2.4	0.4	0.7	1.0	1.3	3.3	5.8	2.2	4.1	4.2	2.9	6.0	1.2	2.1	3.8	0.0	0.2	0.7	0.3	0.2	0.3	0.1	0.5	0.6	0.2	0.9	0.7	0.7	0.9	0.4	0.6	0.2	0.0	0.1	2.9	3.1	5.1	5.5	2.8	0.8	1.8	0.9	1.8	0.4	1.1	2.8	1.7	0.0	1.1	2.9	1.6	0.5	4.3	0.6	1.8	5.7	3.3	3.0	3.9	2.8	1.3	3.7	4.2	1.7	3.4	4.0	11.7	3.8	0.4	2.2	2.3	2.1	3.0	2.7	2.1	5.0	1.2	2.9	0.0	2.1	0.0	2.7	3.3	2.5	2.8	5.0	1.8	2.5	2.0	0.6	1.0	1.2	7.5	1.6	0.0	1.9	2.8	6.2	3.1	1.5	1.1	3.0	1.6	4.1	1.0	3.1	3.2	8.2	0.7	4.7	6.6	3.5	2.9	2.3	2.1	2.3	1.1	2.1	2.2	3.7	2.0	2.4
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458209-90474771	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	2.6	3.8	4.3	3.3	4.4	1.5	5.2	4.7	5.9	4.4	1.2	3.1	3.3	5.1	3.3	3.8	3.8	2.4	2.8	4.6	4.8	5.0	6.3	2.3	4.2	3.0	5.1	8.6	3.1	8.1	2.4	2.9	3.5	4.5	3.2	3.4	4.6	3.9	2.3	5.2	3.0	3.7	3.3	3.8	2.6	3.1	6.4	4.3	5.2	2.2	3.9	2.5	2.9	4.7	6.4	2.7	4.6	5.9	6.0	8.0	5.6	5.0	4.5	4.2	4.4	2.1	4.7	14.9	2.9	4.4	5.8	6.4	6.0	7.5	6.6	8.5	4.1	6.7	4.6	4.8	6.3	6.7	2.8	7.0	9.9	3.0	11.6	4.9	5.4	7.9	10.2	8.0	7.2	3.9	6.5	9.1	3.0	1.3	13.1	6.9	7.7	20.5	6.3	2.3	7.9	9.3	4.5	6.5	12.1	2.7	5.4	4.9	6.7	5.2	3.6	6.4	6.5	5.6	6.8	6.5	4.5	13.8	7.2	0.0	0.7	0.5	1.4	1.8	1.6	1.3	1.5	1.5	1.3	2.4	2.0	1.6	0.0	1.6	0.9	0.4	0.6	1.1	4.3	4.4	4.7	5.9	4.6	4.8	3.0	5.1	3.5	3.3	6.4	4.7	3.8	3.2	3.6	2.9	4.7	2.7	1.2	2.8	8.6	8.1	4.6	5.0	4.9	2.8	1.7	1.8	8.4	3.9	3.9	1.9	1.9	1.6	0.3	2.0	5.0	4.2	4.2	6.3	14.4	1.3	3.1	3.5	3.1	2.0	0.0	5.3	3.6	5.8	2.6	3.3	16.4	2.9	4.1	5.1	1.0	0.6	4.1	2.1	1.8	6.5	2.1	5.5	3.1	8.5	15.6	1.8	1.8	5.3	2.1	1.2	3.0	5.5	2.4	6.7	0.0	4.3	4.9	2.5	6.1	7.3	3.3	0.8	3.7	12.6	3.9	0.7
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 537.7;Oligodendrocytes: 471.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	116.4	35.8	18.2	105.0	24.9	90.4	48.1	22.9	22.3	76.9	18.9	69.0	43.6	68.0	30.1	65.3	38.4	75.2	63.2	18.7	23.0	31.5	47.6	78.1	138.4	25.5	20.1	45.1	24.3	26.5	11.8	29.9	26.0	55.1	71.1	17.7	32.3	66.0	188.8	61.5	58.3	116.5	25.0	92.3	40.5	14.9	25.2	108.4	31.8	131.0	135.1	78.4	32.7	32.5	133.8	107.8	17.3	38.9	132.5	135.8	12.7	163.3	131.5	105.6	87.8	48.0	76.3	136.3	81.3	230.8	32.8	59.7	32.1	94.5	155.0	106.9	43.7	149.3	52.2	22.7	73.8	180.5	104.5	63.8	50.2	121.9	94.0	80.8	219.5	54.1	77.3	180.5	103.6	45.9	169.0	66.0	7.2	38.9	85.4	170.5	53.0	171.6	53.7	66.3	13.8	15.7	71.1	38.2	69.8	6.2	53.1	270.5	186.6	143.6	55.1	96.4	142.7	186.9	115.9	154.6	83.8	220.6	79.1	95.3	53.7	90.1	79.4	61.7	84.4	56.2	64.5	66.5	70.1	49.7	80.6	70.7	78.4	79.6	54.7	24.9	62.6	104.3	18.2	24.9	22.9	22.3	18.7	23.0	25.5	20.1	26.0	25.0	25.2	32.5	175.5	150.6	193.7	179.2	252.1	213.6	49.0	25.9	156.0	28.5	51.8	48.0	179.8	52.9	89.5	38.6	64.6	26.1	266.0	164.7	21.5	36.0	2.6	64.0	92.2	142.9	47.3	160.2	258.6	63.6	9.2	122.9	78.0	68.5	162.6	31.5	90.0	91.5	60.9	32.0	185.5	68.8	14.2	216.4	195.5	9.7	89.5	235.0	103.2	537.7	249.4	18.2	230.7	224.7	471.9	57.3	90.3	71.5	181.3	61.2	121.4	42.2	63.1	84.1	98.6	102.7	145.6	4.3	12.7	149.4	243.6	14.8	340.1	46.8	80.7	50.1
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.3;placenta: 170.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 123.8;Hep G2: 171.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.8	11.6	1.3	8.7	1.9	14.8	4.7	1.7	1.0	3.7	2.4	11.7	9.9	4.9	24.3	10.9	9.4	5.7	9.7	1.1	4.4	8.0	59.3	5.9	13.8	3.6	3.1	4.8	10.0	4.2	1.6	170.8	3.2	4.0	11.5	0.1	6.6	11.1	0.6	12.6	9.8	4.0	2.0	11.3	13.0	42.8	1.6	14.3	8.2	3.4	15.1	8.5	2.8	3.7	7.2	0.0	8.6	1.4	1.6	3.6	15.7	0.5	3.2	1.1	0.0	123.8	22.7	32.6	0.7	1.3	1.1	7.7	19.8	8.2	0.8	3.3	7.6	29.1	25.9	171.5	1.5	32.9	10.2	1.5	7.1	0.0	3.6	0.1	1.1	20.4	2.6	9.2	1.6	19.2	56.3	12.5	1.3	27.5	1.6	53.2	10.7	18.6	5.7	18.6	3.1	10.5	14.8	8.6	4.3	15.1	3.1	8.4	3.9	6.3	1.2	8.2	6.7	18.2	13.0	47.0	1.2	21.8	20.2	11.9	7.9	5.5	16.6	9.9	14.4	20.6	9.8	11.6	8.8	25.5	10.0	11.2	1.2	18.7	21.7	17.0	2.2	9.1	1.3	1.9	1.7	1.0	1.1	4.4	3.6	3.1	3.2	2.0	1.6	3.7	4.1	3.2	6.8	16.0	16.9	8.8	2.2	2.1	5.2	0.7	3.5	3.6	14.7	41.5	5.0	11.0	0.0	328.3	9.5	12.8	3.9	1.5	5.8	12.6	1.3	3.6	6.7	55.8	0.9	5.4	56.6	7.5	15.3	6.6	8.8	6.8	6.4	119.6	29.3	0.0	0.9	9.8	0.0	27.2	6.5	9.4	23.0	9.6	7.2	30.0	10.6	0.2	9.2	0.0	20.6	1.3	3.6	50.8	12.2	1.4	6.4	9.7	4.5	1.9	0.0	3.1	2.7	2.1	1.7	13.6	8.5	344.1	10.3	5.7	10.3	3.3
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003709	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.1;Erythroid cells: 162.6;Excitatory neurons: 134.6;Horizontal cells: 141.3;Oligodendrocyte precursor cells: 177.4;Oligodendrocytes: 230.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.7;eosinophil: 1.7;neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.2	2.1	16.4	2.4	23.6	26.9	9.0	20.5	18.4	7.7	26.2	7.6	2.4	4.6	2.7	15.8	2.9	3.6	4.6	18.9	21.9	7.0	0.8	6.7	1.9	21.8	22.2	5.8	1.4	29.3	5.4	3.2	22.4	14.4	8.5	15.6	5.7	2.3	1.1	11.6	3.7	3.9	20.6	2.4	6.1	2.1	21.9	2.4	4.5	1.1	4.8	3.8	8.4	29.3	14.0	4.2	12.7	5.4	5.6	12.5	7.3	6.5	2.4	8.5	5.6	1.1	21.9	3.9	7.5	15.9	6.8	10.5	11.4	13.5	12.6	12.3	19.0	16.7	5.9	0.0	6.9	0.0	5.0	9.1	7.8	8.1	5.6	18.5	4.5	5.5	14.4	3.0	7.5	3.6	4.9	0.3	5.0	6.4	15.8	7.4	20.0	0.1	12.6	2.0	7.6	23.0	6.9	41.1	6.6	6.2	7.7	4.8	2.5	14.7	7.7	11.6	19.0	1.1	0.4	4.3	23.3	2.4	5.1	4.7	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.0	0.2	16.4	23.6	20.5	18.4	18.9	21.9	21.8	22.2	22.4	20.6	21.9	29.3	7.7	19.2	12.7	171.1	1.7	3.3	4.6	33.1	0.6	20.6	18.1	12.1	12.2	7.2	54.7	40.5	8.4	3.9	1.1	28.2	5.9	5.6	9.7	3.2	19.4	13.4	37.6	162.6	134.6	1.5	1.4	12.7	21.4	2.9	8.2	14.7	4.6	0.2	1.8	141.3	107.8	59.3	32.6	1.9	17.7	12.7	5.3	5.0	14.2	33.7	29.0	98.7	0.0	177.4	230.5	88.1	42.9	7.5	0.3	19.5	1.6	10.4	45.7	8.8	6.6	10.5	15.2	12.1	24.8	24.4	5.1	1.9	2.0	1.9	12.7	66.4
MBOAT7	"BB1, hMBOA-7, LENG4, LPLAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 108.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 265.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 216.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	14.9	108.4	17.6	13.4	14.8	13.1	13.7	0.0	21.4	19.0	0.0	27.8	27.0	19.0	6.6	20.6	20.1	9.2	12.8	17.6	34.4	19.2	16.0	23.6	4.8	24.9	27.8	23.0	21.0	18.9	22.8	6.9	29.2	17.3	5.3	1.0	18.6	20.2	7.9	21.1	25.3	4.4	2.7	26.6	19.9	36.3	28.7	3.2	15.9	1.1	2.3	32.5	18.1	4.8	66.8	43.2	3.8	50.8	21.0	15.4	57.1	90.5	42.6	32.9	49.2	22.1	64.3	11.3	46.5	34.4	10.9	111.9	0.3	26.1	9.0	16.1	54.6	12.8	30.0	12.6	18.9	29.0	216.2	31.0	17.9	17.3	9.8	44.1	46.0	11.0	51.6	42.2	9.2	32.2	10.9	22.7	22.0	21.1	60.1	28.4	7.3	24.9	47.0	71.1	2.3	14.3	57.3	37.0	16.3	4.2	34.5	2.8	73.1	49.4	16.0	12.1	40.8	17.4	31.0	6.4	66.1	25.8	27.9	157.3	22.5	265.9	2.2	11.8	3.3	1.8	3.2	1.7	24.8	1.5	1.1	1.7	239.1	7.8	7.0	7.0	1.9	8.6	17.6	14.8	0.0	21.4	17.6	34.4	24.9	27.8	29.2	2.7	28.7	4.8	11.8	12.8	26.4	11.4	11.3	13.9	66.4	29.2	14.8	15.4	31.1	19.8	8.4	31.5	23.2	44.1	6.2	43.5	15.2	88.8	5.9	52.2	1.1	28.7	22.1	18.5	42.5	13.9	18.7	33.1	52.2	16.3	10.7	26.4	76.8	25.3	15.0	22.7	32.2	30.3	13.6	49.6	16.2	36.8	38.1	4.3	19.3	52.5	8.8	8.4	48.9	24.6	3.1	5.5	9.3	28.6	43.0	15.4	9.3	44.5	101.1	14.5	28.5	8.5	39.5	7.7	19.6	5.1	15.0	17.9	21.6	51.6	23.0	46.3	46.6	47.2
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	142	"brain: 30812.9;choroid plexus: 9144.9"	"Cell type enriched"	"Detected in many"	11	"Oligodendrocytes: 2895.5"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 99.3;SK-MEL-30: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA		54000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	27.3	7.1	15448.6	20.9	21296.6	43.0	20.9	19749.8	26916.8	17.3	9144.9	19.0	18.6	13.2	7.9	20.5	31.5	17.2	24.1	12696.6	16271.8	28.7	23.5	20.0	26.9	30812.9	22193.8	22.3	22.8	47.5	26.7	4.7	25986.2	15.3	16.9	7.5	22.0	13.0	140.8	28.7	20.7	8.7	23219.4	28.0	17.5	6.1	19406.0	12.5	22.2	81.6	27.8	19.0	20.2	30044.2	26.1	22.4	0.2	0.8	35.8	53.1	8.5	0.6	0.6	0.8	0.6	3.2	39.2	15.9	4.4	1.7	0.2	49.9	3.8	22.1	0.7	60.7	5.3	10.4	3.9	5.2	22.5	99.3	65.3	7.7	18.4	19.8	30.3	16.4	6.5	37.9	0.0	3.6	0.0	3.2	4.1	50.6	2.2	15.6	18.1	1.5	0.4	35.9	34.5	34.3	1.8	0.3	3.2	0.0	204.7	6.1	0.6	60.5	0.1	0.2	0.5	0.2	2.8	0.1	0.5	16.9	5.8	62.0	2.5	21.7	8.5	32.4	21.6	8.1	13.1	5.9	15.4	28.1	9.2	5.1	9.1	17.0	39.5	28.0	8.1	11.9	14.9	11.6	15448.6	21296.6	19749.8	26916.8	12696.6	16271.8	30812.9	22193.8	25986.2	23219.4	19406.0	30044.2	5.5	48.1	39.5	10.7	86.8	118.8	61.1	28.1	84.2	52.8	24.2	22.7	45.0	35.8	50.3	103.0	2.1	0.7	221.8	48.7	41.1	43.7	5.9	159.8	11.2	9.4	49.8	68.8	32.4	35.8	0.8	36.2	59.1	161.1	71.5	2.1	10.0	30.2	44.4	1.7	47.1	51.4	44.7	78.3	123.1	6.3	28.3	98.2	92.5	45.0	84.4	25.7	247.2	124.7	2895.5	60.4	25.5	14.3	45.3	117.6	37.5	36.0	54.0	6.1	0.0	88.7	8.4	7.7	1.1	75.6	154.7	0.7	151.6	0.0	42.1	103.7
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	7.2	5.3	4.9	5.4	6.0	10.8	11.4	8.2	6.9	8.6	4.6	7.1	7.9	8.5	7.7	7.2	7.0	5.0	4.5	4.9	5.3	6.1	9.8	6.1	8.7	5.3	5.2	11.8	8.6	5.7	5.5	8.6	5.4	6.8	7.8	10.0	6.9	4.8	6.3	14.4	8.1	5.6	5.1	8.7	8.3	25.4	5.1	14.4	8.3	6.8	7.9	6.9	8.3	7.1	6.6	6.1	32.0	12.9	7.5	8.8	16.7	5.0	6.2	5.3	6.4	7.2	8.3	25.7	11.5	3.8	3.9	6.3	14.8	3.7	9.8	7.4	13.4	26.7	7.5	11.1	5.0	18.0	7.7	7.5	7.0	4.0	7.2	10.5	9.4	22.3	21.0	6.3	4.3	6.7	24.8	18.8	18.1	14.0	5.5	28.4	19.3	12.9	8.0	12.4	20.1	30.7	4.5	8.6	10.7	26.6	12.2	35.0	5.7	5.7	5.8	4.2	5.4	15.4	10.5	22.8	3.4	11.8	3.3	2.6	0.1	0.7	0.2	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.3	0.3	0.0	4.9	6.0	8.2	6.9	4.9	5.3	5.3	5.2	5.4	5.1	5.1	7.1	11.2	16.0	15.0	47.7	10.3	17.2	6.5	5.4	17.1	9.0	14.7	11.7	7.3	17.2	7.1	7.3	16.7	7.9	9.6	7.8	1.9	5.4	51.6	11.8	15.0	11.3	13.8	17.7	61.5	5.1	5.1	10.8	17.9	16.0	5.1	18.8	10.4	12.8	5.8	10.1	59.9	13.5	6.1	12.3	8.5	12.4	14.6	11.5	10.6	56.2	16.4	4.1	11.3	78.4	94.9	6.4	9.0	10.5	5.1	10.8	10.1	4.6	6.2	12.0	0.0	10.2	13.0	47.8	19.2	10.5	22.0	8.6	8.6	15.6	12.1	9.7
MBTPS1	"KIAA0091, PCSK8, S1P, SKI-1"	ENSG00000140943	"Membrane bound transcription factor peptidase, site 1"	Q14703	16	84053761-84116942	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056109	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA056109: AB_2683040"	"unprognostic (1.50e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	45.8	33.7	12.7	26.2	16.4	24.6	42.8	17.6	13.3	41.2	18.1	38.7	26.0	40.8	25.6	28.2	45.6	32.2	44.6	13.1	17.8	36.7	27.5	35.5	27.5	6.3	8.0	49.4	36.4	58.5	38.8	37.1	8.9	37.3	33.7	108.7	42.4	40.3	18.9	27.8	26.4	41.2	5.9	30.1	30.7	19.6	16.5	33.4	53.9	35.6	29.9	35.2	21.3	8.6	49.4	61.3	53.8	75.2	124.2	100.1	42.2	81.2	124.4	70.2	52.6	43.7	71.0	47.0	82.0	117.3	55.8	52.9	50.2	56.3	77.9	42.6	55.9	34.4	55.8	61.3	59.9	84.2	72.7	103.6	79.9	64.8	55.5	100.3	92.4	62.2	45.6	40.3	43.1	85.0	46.6	46.4	50.3	27.7	43.2	59.6	28.7	34.1	56.1	40.2	41.0	51.2	156.9	42.9	62.1	58.3	134.3	76.4	99.0	72.3	52.5	43.7	38.7	50.5	102.6	90.5	52.6	50.6	45.2	8.0	16.3	15.0	16.3	13.8	16.8	11.3	14.0	15.4	12.8	9.6	16.9	15.3	4.5	17.0	11.6	7.1	9.6	18.3	12.7	16.4	17.6	13.3	13.1	17.8	6.3	8.0	8.9	5.9	16.5	8.6	54.3	48.1	50.7	27.1	33.5	13.8	24.2	25.9	19.9	68.4	62.2	56.1	50.5	44.3	41.9	25.8	166.8	24.4	41.0	28.9	11.7	24.1	0.9	70.4	67.8	39.8	34.9	19.4	50.4	27.5	21.4	48.4	23.0	92.7	29.1	103.1	36.0	33.8	16.7	84.1	53.5	26.6	28.5	21.0	10.8	5.5	53.4	23.3	19.6	36.5	22.5	44.4	29.9	57.8	39.0	30.2	24.8	50.4	59.3	30.1	20.3	17.5	56.4	318.6	26.3	60.9	42.2	12.6	24.2	23.4	15.8	21.6	34.3	75.5	33.8	28.6
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MC2R	ACTHR	ENSG00000185231	"Melanocortin 2 receptor"	Q01718	18	13882044-13915707	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"adrenal gland: 57.9"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079148	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA079148: "											"unprognostic (2.09e-1)"			"unprognostic (3.63e-2)"	"unprognostic (1.85e-2)"			0.0	57.9	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MC3R	MC3	ENSG00000124089	"Melanocortin 3 receptor"	P41968	20	56248732-56249815	"G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	114	"brain: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hypothalamus: 14.4;thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.8;hypothalamus: 4.5;thalamus: 1.3"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 2.2;thalamus: 2.6"	HPA074739	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA074739: "																		0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	14.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.1	0.7	14.4	0.0	0.6	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371062-60372775	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 3.5;fallopian tube: 3.0;retina: 3.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 7.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	70	"fHDF/TERT166: 94.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 10.2"	HPA016719	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"			"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.0	0.2	2.2	0.0	2.4	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.0	0.0	0.0	1.8	3.5	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.1	2.7	0.3	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.1	1.7	1.8	3.5	1.0	1.5	0.7	0.4	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.4;lymphoid tissue: 1.0"	"Cell type enriched"	"Detected in single"	17	"Squamous epithelial cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA042365, HPA058088"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA042365: AB_2677961, HPA058088: "	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132209-43143398	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA003122: AB_2666795, HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favorable (2.18e-4)"	"prognostic favorable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.2	21.6	11.8	5.7	12.5	9.0	11.7	11.1	14.4	9.2	17.1	12.5	6.7	11.5	9.9	15.5	14.3	6.6	18.2	13.6	12.5	25.1	22.7	8.7	5.1	11.9	11.6	11.3	15.0	17.6	16.6	4.6	12.2	13.5	7.1	7.2	13.3	6.6	21.9	14.9	8.6	5.8	10.6	8.1	14.8	17.1	12.0	7.8	13.1	10.1	6.1	10.8	10.3	11.0	14.1	18.2	12.6	22.3	10.4	11.0	12.9	15.4	13.6	20.3	18.8	18.3	14.1	23.6	15.5	11.5	11.5	23.3	24.1	20.4	15.1	8.2	71.3	8.8	21.6	20.6	16.6	42.3	10.3	8.3	19.5	19.9	15.7	11.8	14.7	14.1	21.1	9.4	10.1	26.0	19.9	46.0	12.3	19.8	31.8	26.0	12.4	37.7	25.7	12.1	16.6	8.8	16.6	32.0	24.3	5.7	16.5	27.1	8.9	8.8	17.4	19.2	22.0	16.6	18.4	17.1	19.0	16.0	10.8	0.0	11.4	0.8	8.8	11.1	11.5	9.4	9.7	11.4	16.4	12.4	10.9	7.9	2.9	14.5	6.9	16.2	7.0	7.3	11.8	12.5	11.1	14.4	13.6	12.5	11.9	11.6	12.2	10.6	12.0	11.0	8.0	6.4	6.8	3.9	6.9	17.8	12.3	19.6	5.7	11.2	13.6	11.4	9.5	31.5	10.6	20.2	0.0	18.7	5.7	12.3	50.9	32.0	23.4	28.5	8.3	9.4	14.5	17.9	3.6	21.8	11.9	8.8	12.2	9.2	3.8	10.8	17.5	22.3	15.5	6.7	3.7	14.7	14.2	6.3	4.3	11.8	7.5	6.1	7.2	0.0	8.2	12.5	4.1	1.5	2.1	23.7	15.2	16.6	5.6	17.3	12.5	94.3	27.7	9.6	19.7	11.2	10.0	30.0	11.7	9.0	21.0	9.2	4.8	30.5	22.4	11.5
MCC		ENSG00000171444	"MCC regulator of WNT signaling pathway"	P23508	5	113022099-113488823	"Predicted intracellular proteins"	"Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 70.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.7;Bipolar cells: 115.5;Inhibitory neurons: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 52.9;hTCEpi: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Cytoplasmic bodies"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	10.0	2.9	8.2	4.8	11.6	0.4	8.4	12.4	8.8	18.1	1.7	3.7	2.3	12.1	5.1	12.8	12.1	5.0	12.7	6.4	15.0	5.2	18.9	6.2	4.6	15.7	24.5	70.6	3.1	32.9	3.1	10.7	11.0	10.3	3.1	14.6	7.9	12.8	8.3	20.8	2.9	9.1	11.6	5.0	4.9	3.5	18.9	4.7	4.3	6.3	6.4	12.4	11.9	8.2	0.8	0.2	13.5	1.0	10.9	9.8	12.8	2.2	5.7	2.4	2.8	0.5	12.5	0.1	14.3	1.0	6.6	15.7	8.2	52.9	1.2	4.6	5.0	0.1	4.9	3.6	3.3	0.7	0.3	12.9	34.5	6.7	24.2	12.4	16.0	1.6	0.1	20.3	5.2	1.0	0.2	0.3	7.3	0.0	1.0	0.2	11.8	3.5	0.2	30.7	5.7	12.8	11.2	0.1	29.8	4.6	3.7	0.1	19.3	8.7	7.9	14.5	4.3	5.9	0.1	0.0	24.6	0.1	9.7	0.0	0.1	0.0	0.2	0.1	0.6	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.7	0.7	0.0	8.2	11.6	12.4	8.8	6.4	15.0	15.7	24.5	11.0	11.6	18.9	8.2	50.2	0.0	1.1	170.7	1.8	37.6	27.3	27.3	23.9	115.5	11.7	8.8	16.8	11.5	10.4	3.7	56.3	0.8	8.5	0.2	0.0	3.5	12.5	11.5	50.1	32.1	4.8	0.0	29.5	1.4	2.4	30.2	4.1	25.4	0.0	22.9	24.7	56.9	2.3	37.0	128.7	0.2	12.2	2.9	12.3	34.3	21.1	2.2	16.0	72.1	3.2	7.1	3.1	34.7	13.2	4.6	1.3	27.1	5.4	8.5	0.0	2.2	7.1	9.2	0.0	22.0	13.1	7.9	9.3	33.4	47.2	1.2	8.0	24.9	0.5	16.0
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 153.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	37.9	22.6	9.5	9.5	10.9	13.9	33.2	9.9	13.4	12.3	13.8	17.4	16.1	10.1	14.6	17.6	12.2	11.9	34.2	9.2	9.3	58.8	59.3	17.9	11.7	9.5	9.1	17.2	31.2	18.7	8.4	6.3	10.6	15.1	18.6	10.8	18.0	13.4	21.9	12.2	13.8	10.6	9.3	11.8	21.7	9.1	11.1	16.0	18.9	26.3	15.5	26.5	9.4	13.3	43.1	16.5	10.3	10.6	42.6	19.1	20.4	19.5	26.4	21.1	23.5	22.9	17.1	47.6	31.0	17.2	35.8	22.0	15.4	12.9	26.4	16.6	17.0	40.0	18.3	23.9	28.7	27.5	22.0	21.6	14.5	10.0	23.3	14.0	28.6	40.7	22.7	24.7	23.6	35.4	27.1	15.9	11.2	66.3	17.9	22.4	22.6	60.1	32.2	67.2	22.0	16.4	75.3	100.1	21.1	10.7	153.9	37.8	14.0	15.8	12.5	12.8	28.6	24.3	48.8	48.2	16.8	38.4	15.2	14.4	13.3	25.0	10.7	15.6	12.3	17.9	14.1	11.8	26.6	15.4	14.7	13.1	2.1	25.4	16.8	17.3	9.6	10.7	9.5	10.9	9.9	13.4	9.2	9.3	9.5	9.1	10.6	9.3	11.1	13.3	6.2	9.6	53.9	44.7	14.6	7.0	20.1	17.9	15.9	13.0	10.6	9.5	32.8	31.5	20.2	27.6	10.4	35.4	6.3	7.2	33.2	25.3	5.4	11.0	10.2	6.6	6.0	10.9	66.6	17.2	5.4	10.3	21.4	21.9	7.6	19.0	6.1	36.5	16.5	8.4	56.9	13.6	16.2	11.1	8.6	5.5	8.7	10.5	7.2	44.0	10.5	12.0	4.1	47.7	61.6	13.4	15.8	10.5	12.5	10.4	13.5	40.6	21.4	11.2	6.6	11.6	9.6	8.1	4.4	22.3	5.8	28.3	10.1	24.3	20.5	21.7
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658706	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.5"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 107.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 81.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	21.3	47.6	13.4	13.5	13.7	6.0	60.0	12.4	15.5	21.3	24.9	30.5	27.2	14.4	38.9	25.4	17.2	15.2	54.9	12.0	13.1	73.3	120.5	13.4	17.8	14.8	13.4	14.2	24.6	32.8	14.1	14.2	14.8	48.2	35.9	12.2	28.2	20.6	34.4	19.8	20.7	11.7	16.3	15.6	25.8	8.6	16.0	14.2	44.6	35.4	21.5	27.0	15.0	18.4	38.5	52.4	21.4	82.5	22.4	23.0	36.9	16.4	29.4	35.7	25.7	91.1	46.9	90.4	62.8	25.9	28.0	30.8	37.8	58.8	44.3	47.6	45.6	48.2	24.7	100.5	39.2	24.4	42.8	29.5	30.1	32.6	25.8	15.8	31.7	24.9	63.2	31.6	24.9	103.0	0.3	42.9	29.0	33.2	27.2	46.3	64.5	130.9	92.5	66.9	32.9	36.7	80.1	111.8	38.8	10.1	92.7	59.6	22.7	14.4	22.1	26.1	49.9	22.4	46.2	54.6	23.7	66.3	36.6	2.0	8.4	1.9	6.5	13.5	8.5	9.7	8.4	7.4	19.4	9.9	8.3	9.1	1.3	14.7	8.1	8.1	12.1	8.3	13.4	13.7	12.4	15.5	12.0	13.1	14.8	13.4	14.8	16.3	16.0	18.4	9.1	16.0	23.6	27.4	26.8	13.3	17.5	20.2	22.2	12.6	54.9	28.3	61.5	20.0	22.3	16.5	6.2	48.5	17.6	26.3	21.5	20.6	4.3	94.0	24.0	15.1	29.5	13.9	22.2	18.2	23.0	13.1	30.1	107.0	12.7	22.7	9.7	93.1	18.0	3.3	21.6	22.8	8.2	12.1	11.2	9.8	13.7	14.0	12.4	11.2	17.9	15.4	20.6	30.2	28.0	15.3	17.0	20.3	27.2	29.6	23.6	59.1	17.7	10.8	6.6	15.2	9.0	4.2	12.0	35.9	13.8	63.6	17.9	30.9	33.9	20.9
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit"	Q8NI22	2	46901870-46941855	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 253.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022410, HPA034593"	Supported				"Intracellular and membrane"	NA	NA		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"CAB022410: , HPA034593: AB_2674239"	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.64e-4)"	52.0	155.5	41.3	35.6	43.1	34.7	55.1	38.1	40.3	50.4	69.5	32.2	32.5	54.5	42.1	45.9	41.9	44.9	42.3	41.3	46.8	59.4	111.8	45.0	32.1	33.5	41.3	79.2	104.1	52.5	38.7	70.1	41.6	54.0	26.9	83.3	149.7	82.9	83.3	26.0	33.4	52.5	28.0	44.6	33.9	30.9	48.6	30.8	121.0	84.6	34.2	41.2	29.2	34.7	147.7	86.9	74.7	59.7	151.5	215.1	115.4	248.4	254.1	129.4	116.8	116.9	109.4	96.4	297.7	294.7	154.3	81.8	67.0	127.0	207.7	64.5	67.2	101.9	87.1	182.5	236.5	94.8	158.6	163.2	77.8	206.7	178.7	247.9	210.8	28.0	199.3	56.0	266.8	48.7	56.9	67.6	63.9	102.3	84.1	68.3	133.2	106.7	80.3	59.3	23.9	62.2	93.1	46.9	116.0	86.3	33.1	80.6	341.1	298.3	130.5	97.0	164.2	42.0	43.8	76.4	320.2	88.0	100.8	27.2	21.4	29.7	9.6	23.3	12.2	12.5	10.9	10.2	18.4	12.8	14.3	9.8	12.0	9.9	18.3	16.9	9.7	14.0	41.3	43.1	38.1	40.3	41.3	46.8	33.5	41.3	41.6	28.0	48.6	34.7	50.8	105.8	89.1	16.6	29.6	48.2	56.5	65.3	36.5	69.3	64.4	48.5	70.3	38.6	68.8	47.8	39.6	75.5	25.4	26.6	21.5	88.6	144.3	76.4	60.2	64.7	26.8	28.2	19.6	178.5	64.5	70.1	20.4	69.9	50.5	44.1	53.9	155.1	54.5	38.7	23.8	28.5	18.3	40.5	31.3	113.7	62.7	39.2	12.4	7.5	33.8	253.2	12.3	16.1	16.2	152.7	23.1	59.5	43.8	82.4	42.2	41.3	69.6	51.3	65.7	63.9	55.4	48.9	32.6	39.6	44.9	102.1	23.4	74.3	22.8	75.8
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219564-55227315	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	Activator	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 2.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 4.9;HeLa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"		"HPA049981: , HPA058073: AB_2683596"	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.9	0.4	0.0	0.6	0.0	0.0	4.9	0.0	0.0	0.4	0.7	4.0	4.4	0.0	0.4	0.0	1.2	0.7	2.9	0.2	0.0	0.2	4.0	0.0	6.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	1.9	1.4	0.0	0.0	1.6	0.0	0.1	0.2	0.7	2.2	0.8	1.5	0.0	1.7	2.6	1.3	0.0	2.1	0.5	2.2	0.0	4.0	0.4	0.0	0.0	3.4	0.2	0.1	3.3	4.2	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.9	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	30.5	14.2	9.1	16.7	10.5	10.0	26.1	12.9	11.9	23.8	9.7	25.9	13.3	26.7	10.8	25.0	23.7	12.1	18.2	9.4	10.4	16.1	18.6	24.9	18.9	11.3	10.2	22.2	17.0	16.1	11.0	25.3	11.5	15.2	16.6	12.3	20.5	13.7	30.1	25.6	19.6	18.3	11.5	19.5	20.3	11.8	9.9	20.7	17.5	15.9	19.7	25.1	24.1	12.4	54.4	28.6	49.6	40.3	24.0	27.1	27.0	49.2	55.9	62.2	63.3	42.5	32.9	69.7	20.3	34.8	20.7	46.8	65.1	46.8	74.1	46.0	50.3	34.7	20.8	38.3	35.7	71.3	80.6	24.1	25.8	47.4	60.7	27.6	38.9	37.5	35.3	43.9	41.7	28.5	77.4	52.6	33.3	34.7	26.5	49.8	104.0	30.8	29.0	30.0	25.0	28.7	32.9	33.1	39.3	33.0	20.4	50.2	34.3	26.5	24.1	29.8	56.3	36.1	37.7	71.1	35.5	46.1	16.2	9.8	2.3	1.4	2.0	4.2	2.0	2.0	2.0	1.9	3.2	0.9	2.0	2.2	3.0	1.8	2.5	1.5	1.9	1.1	9.1	10.5	12.9	11.9	9.4	10.4	11.3	10.2	11.5	11.5	9.9	12.4	39.0	16.0	16.5	11.8	26.2	42.8	35.0	12.3	24.5	11.4	18.1	14.2	18.6	25.8	15.6	20.2	4.2	40.5	35.4	23.7	13.7	11.7	4.6	18.8	31.7	38.3	10.8	25.0	14.0	13.7	52.6	27.4	12.2	26.2	18.3	18.2	26.7	25.6	38.5	32.0	17.3	20.8	12.2	35.5	35.0	6.2	30.1	35.9	23.2	15.0	34.2	18.3	26.8	17.6	25.3	15.8	11.9	22.6	28.0	32.8	15.6	18.7	12.5	18.3	19.7	32.8	27.4	42.5	68.7	29.9	42.8	39.7	31.6	12.7	29.1	29.1
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.1;lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.7"	"Group enriched"	"Detected in many"	14	"B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019114	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	0.7	8.8	0.2	5.3	0.2	2.9	1.0	1.0	0.4	1.1	0.7	10.2	1.7	1.0	4.0	0.7	2.6	1.6	0.4	0.3	0.1	1.1	0.7	5.4	12.9	0.4	0.1	0.5	0.8	1.1	0.6	2.6	0.3	0.7	15.1	0.1	0.8	0.2	0.2	2.1	5.5	0.6	0.1	6.7	2.1	1.5	0.3	2.3	0.5	0.2	13.1	1.6	0.7	0.5	1.5	1.6	0.0	4.0	0.8	0.2	0.3	1.0	5.5	1.6	2.0	0.0	0.1	21.9	0.5	0.0	2.6	0.1	14.7	1.8	1.5	26.9	13.6	1.9	0.4	0.0	1.3	0.0	1.8	0.3	0.0	1.3	1.0	0.1	0.0	5.1	0.0	0.0	0.3	0.5	0.3	0.0	1.6	0.0	2.9	0.0	3.3	0.0	0.1	0.2	0.9	0.0	0.1	0.2	9.2	0.2	2.4	28.5	0.1	1.3	2.1	0.0	4.2	0.0	0.0	18.5	1.2	0.0	4.0	0.1	0.3	0.0	5.9	1.1	2.1	10.3	5.0	8.9	7.1	3.7	0.6	4.5	0.2	0.4	0.2	29.7	0.2	2.6	0.2	0.2	1.0	0.4	0.3	0.1	0.4	0.1	0.3	0.1	0.3	0.5	0.4	0.0	0.6	0.0	26.3	4.5	0.4	0.1	1.2	0.0	1.1	1.8	0.5	0.0	1.3	1.8	0.0	0.1	43.6	31.4	0.0	0.1	53.1	12.3	6.0	0.4	2.4	1.3	0.9	1.4	0.1	1.5	1.5	24.5	0.0	0.1	0.7	0.0	0.7	0.0	0.5	4.5	0.0	1.3	100.8	19.6	0.0	14.4	8.8	2.8	32.3	0.0	1.0	0.0	1.4	0.4	4.7	0.0	13.8	0.6	0.0	2.3	1.5	0.0	0.0	0.7	0.3	1.6	4.3	0.0	3.3	0.3	21.8	1.6	5.4	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048500	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 43.5;epididymis: 13.9;parathyroid gland: 35.3"	"Group enriched"	"Detected in many"	7	"Enteroendocrine cells: 113.6;Melanocytes: 151.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.0;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.9;HAP1: 12.7;RH-30: 15.7;SK-MEL-30: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	3.0	43.5	0.7	0.2	0.2	0.0	2.2	0.0	4.0	5.1	3.3	1.0	5.4	5.7	13.9	0.3	1.7	0.3	4.4	3.5	0.1	5.0	0.1	4.5	0.1	0.0	0.1	2.1	7.4	35.3	7.0	2.5	0.1	0.3	1.0	0.1	3.7	0.6	0.2	4.3	2.2	1.9	0.2	0.9	2.6	0.6	0.5	4.3	1.9	1.1	0.2	0.4	2.4	0.0	9.0	2.0	0.0	0.0	6.6	5.9	2.4	0.1	12.9	3.2	8.8	0.6	1.5	0.0	0.9	0.1	3.0	0.0	12.7	4.2	2.0	3.6	8.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	1.5	2.6	1.5	3.2	0.0	0.0	0.0	0.0	6.3	0.7	0.0	0.0	1.0	0.0	1.1	0.0	15.7	0.0	0.4	0.0	0.5	0.0	0.4	0.0	29.3	0.9	5.2	6.5	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	4.0	3.5	0.1	0.0	0.1	0.1	0.2	0.5	0.0	16.6	16.0	1.7	0.0	0.0	8.7	3.5	7.0	0.6	0.0	4.2	1.9	6.8	11.5	2.5	3.7	0.0	9.0	0.1	0.3	0.0	1.7	0.4	0.8	8.1	2.0	113.6	0.0	1.2	9.6	0.2	18.4	1.5	1.9	0.0	0.3	0.0	0.1	3.5	0.0	0.4	2.5	6.1	0.0	7.1	0.1	1.8	3.2	151.2	2.8	1.6	0.0	0.0	0.0	0.1	3.6	12.9	0.0	0.3	1.4	4.1	3.4	0.7	0.0	6.6	6.3	1.2	1.8	4.1	0.4	3.4	2.6	1.4	1.0	3.8	0.6
MCPH1	"BRIT1, FLJ12847"	ENSG00000147316	"Microcephalin 1"	Q8NEM0	8	6406596-6648508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 107.5;Inhibitory neurons: 94.3;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008238, HPA012064, CAB012177"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: "	"unprognostic (1.00e-1)"	"unprognostic (2.17e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.79e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.94e-1)"	5.7	3.7	1.9	2.9	2.1	12.3	5.7	2.9	2.4	5.7	2.2	5.0	2.4	5.7	2.5	4.7	5.2	2.5	4.3	1.9	1.9	4.3	3.8	4.4	4.7	1.9	1.9	5.4	5.1	3.3	3.8	4.0	1.9	4.6	2.8	3.3	5.9	2.7	9.8	5.2	4.6	3.4	1.7	4.7	4.7	6.1	2.1	5.5	4.6	3.9	4.2	5.4	5.1	2.7	4.5	3.9	7.0	4.9	3.4	6.1	5.9	6.7	5.8	8.3	6.2	5.0	3.3	8.7	1.8	5.5	7.6	5.1	8.9	6.3	9.8	3.6	4.9	11.1	3.9	6.7	5.6	5.6	8.4	5.8	6.4	5.7	8.1	5.8	6.2	9.2	13.7	8.5	6.4	2.9	15.1	6.1	12.0	8.2	3.9	8.9	6.6	5.3	4.8	8.2	4.8	6.4	4.9	5.2	7.4	7.7	4.5	7.8	5.2	6.4	3.5	2.1	6.4	3.9	5.7	12.7	5.9	6.4	9.0	1.6	2.1	8.7	3.1	2.5	4.1	4.0	2.7	3.7	2.1	4.4	3.4	3.7	0.3	4.3	3.2	2.8	3.0	2.1	1.9	2.1	2.9	2.4	1.9	1.9	1.9	1.9	1.9	1.7	2.1	2.7	21.3	3.2	16.1	50.6	28.3	4.6	14.5	7.1	10.8	13.4	9.7	9.0	13.7	10.0	17.7	14.7	16.7	10.9	28.2	4.6	3.9	10.9	46.6	20.0	21.2	15.6	0.0	17.9	107.5	10.5	10.6	14.2	14.8	25.9	19.7	15.5	11.4	6.9	7.0	30.3	94.3	6.1	2.0	12.2	2.7	30.6	12.2	12.1	0.0	69.3	14.2	13.1	19.6	78.4	79.5	10.4	7.8	13.2	27.0	9.7	6.3	8.7	25.6	10.6	6.6	20.2	13.8	29.5	12.6	10.9	6.0	12.3	23.5	12.8	7.2	10.1
MCRIP1	"FAM195B, GRAN2, MCRIP"	ENSG00000225663	"MAPK regulated corepressor interacting protein 1"	C9JLW8	17	81822361-81833302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 116.5;Exocrine glandular cells: 243.8;Extravillous trophoblasts: 154.1;Hofbauer cells: 161.7;Pancreatic endocrine cells: 137.0;Proximal tubular cells: 140.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045542	Approved		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA045542: AB_2679363"	"unprognostic (3.11e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (2.26e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.86e-1)"	93.2	76.0	70.1	18.7	68.1	27.4	87.6	65.7	98.5	98.8	46.6	139.6	9.1	100.8	10.4	35.6	87.3	18.3	150.1	68.0	66.0	97.7	82.6	77.6	24.1	72.8	70.8	94.5	97.6	16.8	94.1	18.1	69.7	108.6	3.7	7.3	54.6	15.6	52.2	46.3	57.3	15.9	65.5	85.1	71.5	168.4	71.6	19.9	85.5	16.5	8.0	106.0	65.2	67.0	25.8	38.0	42.8	44.8	26.7	30.1	32.8	29.7	21.1	34.8	37.8	9.9	24.8	15.6	17.3	24.6	12.7	5.8	5.1	17.0	8.6	17.1	52.5	28.0	7.1	38.4	26.2	18.7	25.4	32.7	16.4	19.7	8.5	18.9	61.3	35.5	22.7	13.0	23.1	16.8	60.2	42.4	27.0	10.2	21.5	24.0	27.4	7.1	11.9	22.7	36.0	111.7	14.9	19.5	93.2	16.3	17.9	25.0	39.8	50.1	55.0	56.0	55.3	6.8	2.3	10.8	46.6	16.6	40.5	65.7	31.8	45.4	37.8	43.2	29.2	23.7	29.6	34.0	29.4	33.8	23.7	27.3	24.9	28.3	46.3	39.9	39.5	40.3	70.1	68.1	65.7	98.5	68.0	66.0	72.8	70.8	69.7	65.5	71.6	67.0	84.9	19.2	35.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	69.4	76.6	0.0	0.0	11.2	38.6	0.0	116.5	57.9	0.0	74.3	113.5	0.0	27.5	48.5	38.9	0.0	0.0	0.0	243.8	154.1	38.3	0.0	37.7	20.2	70.7	0.0	0.0	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.0	49.1	0.0	0.0	0.0	0.0	137.0	0.0	0.0	6.1	0.0	0.0	140.0	13.8	0.0	0.0	0.0	54.3	0.0	0.0	0.0	0.0	98.6	23.3	50.9	0.0	0.0
MCRIP2	"C16orf14, FAM195A, MGC15416"	ENSG00000172366	"MAPK regulated corepressor interacting protein 2"	Q9BUT9	16	636817-648474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.1;liver: 56.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 189.2;Distal tubular cells: 183.9;Hofbauer cells: 133.9;Proximal tubular cells: 310.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060363	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA060363: AB_2684263"	"unprognostic (7.14e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.96e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (7.23e-4)"	9.0	31.4	5.1	2.1	4.8	1.7	5.2	7.0	8.6	4.0	17.3	21.0	6.8	4.0	0.0	8.6	4.3	0.5	48.1	4.8	4.3	25.5	56.1	5.7	0.8	4.6	4.4	4.3	12.5	2.6	12.7	2.2	5.0	8.1	0.9	0.1	8.8	1.5	39.2	2.9	10.7	0.3	3.8	9.5	14.6	5.6	6.3	0.3	7.3	3.3	0.6	9.4	4.3	3.6	14.7	3.4	0.4	6.0	1.3	3.7	7.1	7.8	2.4	3.8	2.1	3.9	6.8	23.9	18.8	0.7	2.2	15.0	2.4	6.0	0.1	19.0	30.4	10.6	3.5	3.1	6.8	18.2	14.4	2.2	5.4	1.7	2.0	1.4	1.3	6.3	23.6	3.0	0.7	4.4	1.7	30.0	9.2	7.5	37.1	25.9	0.1	34.5	3.1	1.1	15.3	7.7	13.9	9.9	26.0	0.3	8.8	14.4	6.1	0.3	7.8	8.6	10.9	37.6	47.0	35.9	1.4	15.8	0.9	0.0	11.3	3.1	1.2	12.9	3.1	10.5	3.3	3.7	10.0	6.8	4.2	2.8	0.2	2.5	14.5	0.3	3.9	3.5	5.1	4.8	7.0	8.6	4.8	4.3	4.6	4.4	5.0	3.8	6.3	3.6	11.3	3.2	12.4	0.0	10.0	0.0	0.0	0.0	0.0	0.0	55.5	53.8	0.0	0.0	1.8	64.4	0.0	189.2	7.9	0.0	183.9	62.7	0.0	17.3	13.1	4.6	0.0	0.0	0.0	70.8	27.6	7.5	0.0	16.9	5.1	51.1	0.0	0.0	133.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	40.3	0.0	0.0	0.0	0.0	67.4	0.0	0.0	1.7	0.0	0.0	310.2	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	79.6	6.3	50.3	0.0	0.0
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568145	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	22.3	29.7	29.2	27.3	29.9	32.1	23.4	28.3	33.4	26.4	27.8	30.3	27.3	31.3	23.7	34.9	30.1	22.9	68.2	29.6	27.2	34.5	24.6	24.3	33.2	29.9	28.1	23.6	32.7	35.7	24.0	24.5	28.5	31.3	25.9	17.2	27.0	26.9	53.2	26.9	29.2	26.1	28.2	32.8	31.8	35.2	29.4	39.4	35.5	61.4	31.1	29.3	26.2	31.4	43.8	81.5	62.9	54.5	33.2	40.9	69.3	37.5	40.4	95.7	53.2	127.3	69.7	72.6	76.4	66.0	43.7	48.5	97.8	89.0	38.3	57.6	120.3	72.4	53.4	46.9	59.6	85.0	76.0	47.7	68.3	63.8	51.3	56.0	71.0	66.0	90.9	48.0	55.4	77.8	59.1	51.1	87.4	40.7	60.1	69.1	50.7	84.0	59.4	40.3	60.6	63.5	40.8	51.7	36.5	42.8	84.4	101.7	51.6	45.8	58.4	44.7	56.7	47.3	50.9	69.2	60.1	49.8	27.8	96.2	63.7	76.4	63.2	82.7	49.1	44.5	53.6	68.1	79.1	46.1	46.8	51.0	31.8	90.7	64.7	53.5	60.4	76.3	29.2	29.9	28.3	33.4	29.6	27.2	29.9	28.1	28.5	28.2	29.4	31.4	17.0	35.3	13.8	6.2	23.3	10.7	25.1	38.5	10.8	15.6	19.8	19.7	24.2	28.6	22.4	23.9	8.4	52.1	22.1	34.3	52.8	37.7	32.1	16.3	15.3	17.4	27.5	35.1	12.8	36.1	51.8	20.2	39.8	15.7	27.3	24.3	15.0	10.5	40.6	23.5	12.6	27.2	28.5	22.0	12.5	37.8	27.4	20.9	28.4	9.4	38.0	28.1	40.2	7.1	12.3	39.7	37.1	27.1	24.3	26.7	34.1	45.4	22.8	20.5	6.6	14.7	26.9	41.6	64.0	27.4	12.6	59.2	25.6	23.7	33.8	27.0
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 53.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	6.1	3.8	2.8	7.4	2.5	19.9	5.7	10.4	3.6	8.3	6.4	28.7	27.8	8.9	3.0	14.2	10.8	12.7	7.8	3.9	2.8	10.6	7.0	10.2	4.9	3.4	3.2	4.9	5.5	10.0	1.9	12.8	3.2	5.8	30.8	2.3	6.7	5.7	41.8	6.8	24.5	13.5	3.0	5.0	43.2	4.3	3.3	5.7	6.4	53.7	7.7	14.9	5.1	2.8	41.7	66.1	16.8	12.2	25.0	28.0	17.1	25.0	35.5	24.5	26.0	39.6	38.6	17.7	19.6	30.8	13.3	36.9	22.2	29.8	32.5	19.5	20.8	22.1	23.5	22.1	19.5	56.0	17.9	28.7	24.9	22.0	46.6	38.4	29.8	18.5	14.0	12.9	23.0	24.3	15.2	12.0	18.5	45.2	13.6	15.7	35.8	4.7	32.7	22.4	17.8	7.9	30.8	34.1	7.5	20.2	6.8	14.5	24.3	11.8	19.9	25.7	16.9	9.4	12.8	12.1	15.8	27.5	9.2	1.8	6.7	18.6	3.0	7.3	3.1	3.5	2.9	3.6	5.8	1.7	2.3	2.6	8.8	2.2	8.9	2.0	5.2	4.2	2.8	2.5	10.4	3.6	3.9	2.8	3.4	3.2	3.2	3.0	3.3	2.8	13.7	35.3	17.0	21.2	4.2	11.7	14.4	8.9	10.8	3.0	5.9	3.9	6.6	8.6	22.0	18.4	2.1	7.3	4.8	38.2	1.9	11.1	14.5	23.3	9.9	9.7	8.4	10.8	58.2	25.2	10.1	7.2	68.3	26.4	8.2	3.4	8.9	5.8	6.7	0.0	65.6	28.2	12.2	6.0	2.9	7.2	5.3	6.7	8.8	37.5	5.7	5.4	2.1	72.4	40.3	40.7	15.6	4.1	5.7	9.7	19.8	8.6	22.6	3.9	13.1	6.8	12.1	5.1	5.2	6.2	12.4	9.3	5.0	12.7	24.5	26.8
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative subunit beta"	Q9NWR8	4	109560209-109688719	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	10.2	2.0	2.6	18.4	3.0	10.6	7.6	2.1	3.4	7.0	3.5	5.3	3.8	8.8	1.5	6.8	5.8	7.8	10.5	2.7	4.6	3.5	2.2	7.2	32.2	4.3	3.0	5.6	1.5	1.2	3.7	6.1	3.2	3.0	6.3	3.7	4.9	2.1	1.4	6.2	7.8	8.2	3.7	13.5	4.6	3.0	5.2	31.4	3.3	3.5	25.7	9.2	7.5	4.6	26.9	11.7	6.4	32.6	6.9	18.1	23.9	23.3	14.2	24.9	22.1	0.6	21.6	93.0	4.6	20.2	13.8	7.6	24.1	14.0	21.9	59.2	18.4	11.3	11.6	1.6	12.1	23.6	0.4	11.7	3.8	15.1	13.0	17.7	33.9	35.0	3.3	59.4	19.2	34.0	54.1	0.4	28.2	4.8	15.6	20.4	47.7	10.8	29.6	12.1	25.6	11.1	24.2	73.4	7.7	5.3	9.2	1.2	23.9	9.8	12.6	51.8	40.2	22.3	16.4	22.7	29.9	4.9	6.9	0.4	51.4	0.8	18.9	32.2	26.6	43.6	79.1	56.5	49.8	50.7	114.7	66.2	3.6	65.0	24.4	35.1	74.9	92.2	2.6	3.0	2.1	3.4	2.7	4.6	4.3	3.0	3.2	3.7	5.2	4.6	21.5	9.6	5.2	0.0	19.5	0.0	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.0	2.5	5.5	0.0	127.7	36.0	0.0	0.0	25.2	0.0	7.0	5.9	11.7	0.0	0.0	0.0	111.4	91.9	15.1	0.0	8.9	1.3	9.1	0.0	0.0	106.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	67.9	0.0	0.0	5.8	0.0	0.0	0.9	2.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	73.5	28.2	7.4	0.0	0.0
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 81.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 238.5;Rod photoreceptor cells: 293.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	9.7	5.4	20.2	7.2	21.0	7.1	10.0	19.6	32.6	7.8	18.5	10.8	19.1	7.0	13.1	10.0	4.6	5.5	12.2	20.9	21.3	22.6	9.2	8.6	6.6	21.0	20.8	3.9	12.6	9.0	5.9	8.7	22.0	6.4	9.7	81.6	9.1	7.6	19.3	18.3	16.5	5.1	20.0	7.6	6.4	4.8	22.5	8.1	16.0	15.8	9.4	6.2	7.7	19.7	23.4	6.9	34.4	34.6	19.8	17.0	21.8	21.0	19.9	22.4	23.4	24.0	11.3	31.6	41.0	15.1	35.2	10.2	21.5	17.7	25.4	21.2	13.1	32.3	12.2	24.0	19.4	32.4	12.6	11.9	16.9	29.1	20.9	16.7	8.1	38.7	24.4	16.3	15.8	9.7	40.1	49.0	22.2	59.9	9.0	29.2	30.3	45.2	27.4	14.2	22.0	24.9	14.0	35.4	58.1	53.1	13.2	14.6	11.5	33.5	18.8	24.2	29.3	20.0	71.9	45.4	15.6	19.0	46.4	4.2	1.3	0.3	1.5	1.2	1.8	1.9	2.1	2.2	3.2	1.7	1.6	1.5	0.8	1.7	1.7	2.0	1.3	2.9	20.2	21.0	19.6	32.6	20.9	21.3	21.0	20.8	22.0	20.0	22.5	19.7	40.5	16.0	25.0	13.1	33.2	44.7	24.2	16.9	39.3	48.0	62.8	54.1	43.6	28.6	15.1	57.0	120.9	45.3	27.2	75.0	138.9	27.4	48.9	29.3	83.5	38.7	15.6	62.9	16.7	31.7	66.9	30.5	7.1	31.3	7.0	16.7	28.2	72.4	91.6	26.9	11.5	49.6	24.4	34.7	80.2	6.8	22.1	60.1	51.6	10.3	36.6	50.4	25.7	7.5	13.4	29.2	91.3	27.1	80.7	60.2	161.6	238.5	11.2	293.7	19.7	20.7	34.5	13.1	52.4	47.3	57.4	86.2	21.0	31.0	37.5	31.1
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654244	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	33.0	4.3	3.9	5.7	4.2	0.2	23.1	4.1	5.8	23.2	4.3	2.5	1.7	5.8	1.2	44.7	10.0	12.8	8.8	3.5	4.3	5.5	1.5	18.6	1.7	8.2	5.8	15.6	3.2	1.6	9.1	11.0	6.3	14.3	0.4	0.1	22.4	2.2	0.9	15.4	3.2	2.5	3.6	0.3	4.6	5.0	4.6	1.5	4.6	1.1	2.5	13.6	27.1	4.2	60.1	0.2	50.4	0.1	0.1	0.0	80.5	0.0	0.0	0.0	0.0	0.0	28.2	0.1	18.2	0.0	0.3	48.4	13.8	117.2	0.0	0.0	0.0	0.4	0.0	2.5	2.2	0.0	0.3	3.6	53.3	0.6	24.6	0.0	38.4	16.1	0.2	0.3	0.0	0.0	41.8	0.4	34.4	100.0	1.6	315.3	29.6	0.5	3.3	9.2	9.4	23.2	0.6	43.1	0.0	34.5	0.2	4.0	40.3	0.1	44.1	0.5	1.7	0.1	0.3	0.1	0.3	2.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.2	4.1	5.8	3.5	4.3	8.2	5.8	6.3	3.6	4.6	4.2	1.8	0.0	0.0	0.0	0.0	24.5	48.6	36.8	12.0	0.5	18.9	16.9	0.9	0.0	8.2	5.5	0.0	221.7	0.2	0.4	0.0	33.8	0.5	0.5	1.7	12.7	0.0	0.0	0.1	51.2	113.7	12.8	0.0	0.7	0.0	10.0	7.9	0.1	19.6	0.0	0.3	1.2	6.1	0.0	4.5	0.5	39.1	0.4	0.0	2.8	0.6	0.0	0.0	4.5	0.2	134.9	0.0	6.0	0.0	55.6	0.0	0.0	3.5	0.0	0.0	19.7	9.1	0.1	7.9	10.7	9.1	138.7	0.6	2.7	0.3	73.5
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922359-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 139.7;Skeletal myocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 109.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	44.9	17.3	4.9	22.5	4.3	11.1	14.5	4.7	5.2	21.1	25.5	10.6	7.2	20.6	5.1	17.2	12.2	13.2	24.6	4.1	7.2	12.6	13.3	23.3	32.1	12.1	9.0	16.1	5.0	16.7	4.6	20.2	8.8	10.2	10.3	21.1	15.7	11.1	27.6	10.3	9.4	17.7	12.8	33.7	10.5	1.8	6.0	17.2	19.3	14.2	30.0	16.4	8.2	9.2	0.1	13.2	18.3	0.1	37.8	52.0	7.1	69.9	83.9	15.9	19.8	0.4	41.7	9.8	0.8	46.4	25.4	7.7	5.7	12.2	27.1	34.0	12.3	0.0	16.8	0.0	19.5	22.2	14.2	43.7	11.5	35.7	11.1	40.2	10.7	9.7	0.0	66.8	54.2	0.2	0.1	1.8	14.8	0.6	15.6	0.2	53.5	21.5	16.2	16.9	0.7	0.0	30.5	28.3	32.5	24.7	9.0	19.7	30.2	58.2	16.4	109.1	34.1	27.5	0.1	0.2	40.8	0.1	50.9	0.2	0.9	0.6	1.8	1.2	2.8	2.3	4.1	3.6	1.5	2.4	2.3	2.1	0.0	1.6	1.8	5.5	3.5	0.7	4.9	4.3	4.7	5.2	4.1	7.2	12.1	9.0	8.8	12.8	6.0	9.2	61.3	16.0	26.1	32.7	41.5	9.4	7.0	2.2	17.6	0.5	13.1	10.2	24.8	24.3	12.2	14.7	0.0	7.5	58.1	1.5	9.8	2.3	2.5	9.4	12.7	42.8	0.0	1.7	27.2	2.9	5.3	25.8	5.6	1.3	2.5	29.9	59.6	18.6	21.9	0.0	5.4	2.7	0.0	55.6	34.0	1.3	4.4	41.1	37.4	55.3	22.0	139.7	21.6	6.6	0.8	9.2	2.0	2.6	63.2	6.6	0.1	5.1	15.1	5.0	6.6	131.8	13.8	0.2	1.0	20.0	13.8	3.7	70.6	38.2	4.6	10.2
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 79.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 79.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	2.6	2.9	4.2	2.6	3.9	0.3	1.6	79.9	5.3	5.4	0.0	2.6	0.5	3.4	1.8	3.7	2.7	3.2	2.3	8.8	4.9	1.2	0.6	3.1	2.6	4.3	4.7	6.5	2.4	4.1	4.8	0.3	7.4	2.1	1.1	4.0	1.1	1.3	1.1	4.9	2.8	2.5	1.0	3.1	2.0	1.5	2.1	0.8	1.4	1.7	2.1	1.9	4.4	3.2	0.2	3.5	4.8	2.4	12.3	4.3	2.2	2.8	2.2	3.5	3.2	0.0	0.0	0.7	0.5	1.7	3.0	5.4	0.5	0.0	1.0	4.9	3.4	0.0	0.3	0.0	0.5	0.0	1.1	1.0	0.0	1.4	0.0	6.8	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.4	5.9	1.7	0.0	0.8	3.7	4.3	0.0	1.5	0.3	2.6	0.2	3.1	0.6	0.3	3.4	1.4	1.2	4.3	0.0	0.1	0.0	4.2	1.0	2.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	4.2	3.9	79.9	5.3	8.8	4.9	4.3	4.7	7.4	1.0	2.1	3.2	3.0	9.6	0.5	12.7	2.0	2.3	2.4	0.7	1.2	34.0	0.4	0.6	5.7	1.5	0.8	3.7	50.1	0.2	3.1	0.0	0.0	0.5	2.6	0.6	1.8	1.6	1.8	0.0	4.9	0.0	1.4	4.4	0.5	0.5	0.0	1.1	1.4	0.0	0.1	57.2	4.9	0.0	0.0	0.3	1.1	0.2	10.2	0.3	1.8	1.9	0.0	2.6	4.1	4.0	2.1	0.6	0.0	4.9	1.7	2.0	0.0	0.5	1.9	2.0	0.0	2.6	3.0	2.1	1.3	2.8	3.0	0.7	2.9	0.2	0.0	5.1
MDGA2	MAMDC1	ENSG00000139915	"MAM domain containing glycosylphosphatidylinositol anchor 2"	Q7Z553	14	46839629-47675605	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 8.0;retina: 4.4;testis: 3.8"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 1559.3;Inhibitory neurons: 1208.8;Oligodendrocyte precursor cells: 1972.9"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.1;T-47d: 2.5;U-138 MG: 5.6;U-2 OS: 4.0;U-87 MG: 2.1;WM-115: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003084	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003084: AB_1079302"	"unprognostic (3.27e-1)"			"unprognostic (5.38e-2)"	"unprognostic (9.13e-2)"		"unprognostic (8.92e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.49e-3)"	"unprognostic (3.62e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.89e-1)"		0.1	0.2	5.4	0.0	6.3	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.4	0.1	0.1	0.0	0.0	7.0	2.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.4	0.1	0.0	0.0	0.3	0.0	0.0	4.9	0.0	0.2	3.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	2.5	0.0	0.0	5.6	4.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.3	0.1	6.1	6.1	6.4	7.0	2.7	8.0	4.9	3.1	5.1	0.0	0.0	0.0	24.2	0.1	0.4	0.0	0.0	0.0	50.6	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.9	0.0	0.0	0.1	0.0	0.0	1559.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1208.8	0.0	0.0	0.0	0.0	7.1	0.3	0.0	5.4	52.5	0.0	0.3	0.0	1972.9	209.4	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.2	4.4	6.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765328	"Metabolic proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.7;fallopian tube: 22.5;testis: 24.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 186.0;Endometrial ciliated cells: 50.1;Late spermatids: 33.7;Respiratory ciliated cells: 100.5;Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.6;SCLC-21H: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.4	1.5	2.2	0.2	2.5	0.1	1.2	1.9	2.4	1.7	15.7	1.2	0.0	1.7	1.7	0.5	22.5	0.8	1.3	2.4	2.8	3.1	0.3	2.0	0.3	4.2	5.3	1.0	0.9	4.2	9.3	0.0	3.9	0.9	0.5	8.5	1.0	1.3	0.4	0.4	0.3	0.8	3.5	0.2	0.7	24.5	2.8	0.5	4.8	0.5	0.2	0.5	0.4	3.0	0.3	1.2	0.9	2.5	0.1	1.1	0.3	0.0	0.4	0.5	0.3	0.1	0.8	0.5	0.5	0.1	1.1	0.6	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.8	0.5	0.4	1.2	0.7	0.2	0.0	0.1	0.5	0.7	1.1	0.0	0.7	0.3	1.5	0.8	0.3	1.6	0.1	1.4	1.6	0.9	0.0	3.6	0.2	3.5	0.7	1.1	0.5	0.3	0.5	1.1	0.0	0.0	0.6	0.6	0.1	0.3	0.3	1.6	0.2	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	1.9	2.4	2.4	2.8	4.2	5.3	3.9	3.5	2.8	3.0	0.2	6.4	1.5	6.8	0.0	0.8	1.4	3.9	1.8	3.0	2.1	2.4	1.3	2.8	6.4	0.0	0.0	0.1	0.0	0.0	13.7	1.3	186.0	50.1	1.2	0.6	1.2	0.0	8.9	0.0	0.1	1.3	1.5	1.6	0.0	1.1	0.0	0.0	0.1	3.3	6.3	0.0	10.2	0.0	0.2	33.7	1.8	0.5	1.8	1.9	0.0	9.6	0.0	1.0	1.3	0.1	0.0	3.0	0.0	0.4	0.0	6.0	100.5	10.2	0.0	0.5	1.7	114.9	5.1	0.5	0.3	0.0	0.2	1.6	0.1	0.9
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MDK	"FLJ27379, MK, NEGF2"	ENSG00000110492	Midkine	P21741	11	46380756-46383837	"Cancer-related genes, Predicted secreted proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 529.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 1010.4;Granulosa cells: 726.2;Paneth cells: 1272.7;Proximal enterocytes: 883.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.8;neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 888.4;REH: 1343.8;SH-SY5Y: 1093.6"									"CAB010055, HPA057126"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	158000	960000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"CAB010055: AB_627949, HPA057126: AB_2683344"	"unprognostic (8.87e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (8.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	41.1	98.0	23.3	22.9	23.3	11.7	82.2	27.0	37.0	379.4	16.3	78.0	263.3	208.2	60.3	38.1	170.3	140.0	36.1	21.6	40.7	35.9	8.5	48.5	20.3	31.8	27.5	529.1	30.5	103.9	370.4	32.0	22.6	128.7	38.0	5.9	137.4	84.1	7.6	26.9	211.3	49.5	24.6	78.1	108.3	16.8	31.5	92.9	26.8	9.8	15.9	84.1	129.3	24.6	51.1	66.5	758.4	2.5	5.2	62.2	18.6	39.2	77.0	145.6	128.8	505.2	219.5	3.4	528.6	58.5	6.3	429.6	431.8	0.7	13.3	157.0	91.6	22.5	5.6	703.6	336.2	1.7	3.5	100.0	13.2	89.2	0.5	31.0	214.3	28.9	385.2	3.5	83.3	348.6	19.8	9.4	888.4	275.9	388.0	1343.8	28.8	4.4	1.8	1.6	418.1	1093.6	128.9	11.3	11.0	665.8	347.3	349.5	59.0	221.1	526.2	3.1	27.2	2.9	11.0	5.1	6.5	13.7	197.3	0.0	0.0	0.0	0.1	0.2	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.0	2.1	0.1	0.2	0.1	0.9	0.4	23.3	23.3	27.0	37.0	21.6	40.7	31.8	27.5	22.6	24.6	31.5	24.6	108.2	0.0	5.4	5.5	9.6	11.1	162.1	392.4	12.5	1.3	245.2	218.7	7.0	34.3	393.6	47.8	0.0	162.3	5.4	499.0	1.9	286.0	26.4	134.6	490.2	115.0	1010.4	2.5	2.1	104.5	123.5	275.2	162.1	228.2	4.5	726.2	102.4	4.6	48.3	0.0	1.9	368.8	286.8	4.2	12.0	126.3	109.6	10.0	37.4	7.5	9.4	47.1	0.0	4.5	1.3	221.1	1272.7	18.8	18.6	163.6	883.4	19.6	109.5	1.1	85.5	26.1	197.0	31.8	34.3	26.2	8.1	153.1	11.4	8.9	187.6	511.1
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 44.0;Spermatocytes: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040411, HPA041594"	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favorable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	5.3	5.7	6.3	9.5	7.2	16.5	9.1	6.8	7.2	9.0	13.2	25.7	4.8	13.9	11.2	4.3	18.2	5.9	4.7	5.7	7.5	8.1	4.6	6.4	13.0	8.5	9.1	9.6	5.3	7.1	9.4	5.6	8.2	9.3	9.8	29.2	6.4	13.9	3.0	3.7	7.1	13.0	9.2	9.4	6.6	20.6	7.3	15.2	10.0	3.3	13.0	10.9	6.4	8.5	8.4	6.9	13.0	12.7	6.3	8.5	10.0	11.0	6.1	17.2	15.7	8.3	3.8	19.3	7.1	5.0	8.4	8.6	9.0	5.9	19.4	25.4	8.6	42.5	9.1	5.7	9.8	23.8	16.1	3.9	7.6	11.6	11.2	9.3	9.9	21.9	8.2	21.1	10.0	6.1	33.7	16.7	6.9	8.3	8.4	32.8	11.7	5.7	8.2	7.3	11.8	6.3	10.6	6.3	11.1	10.3	15.1	16.9	5.2	13.7	6.0	8.7	10.3	10.9	34.0	13.3	7.2	15.3	8.9	9.9	5.1	15.0	5.0	12.0	8.1	7.5	6.5	5.2	4.4	6.9	7.6	6.2	3.3	7.2	19.4	2.5	6.7	5.7	6.3	7.2	6.8	7.2	5.7	7.5	8.5	9.1	8.2	9.2	7.3	8.5	8.3	3.2	4.6	14.0	12.9	4.8	3.9	5.3	5.2	16.0	8.0	9.0	10.8	2.8	6.8	7.3	0.0	4.7	13.2	2.8	9.8	4.8	26.0	35.4	16.0	6.6	2.4	25.2	12.5	3.5	4.2	5.7	5.6	5.3	7.0	12.0	6.1	4.9	6.3	8.4	11.7	2.8	10.2	4.7	5.1	13.5	9.0	14.5	16.0	8.4	7.3	25.7	18.6	9.5	18.7	3.0	4.7	13.5	9.3	1.8	1.8	10.4	44.0	34.6	6.6	7.4	8.2	56.3	22.3	6.3	4.1	0.3	13.9	8.6	4.9	1.7
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808177-68850686	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 257.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 504.6;U-698: 517.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303, CAB079977"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: "	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	14.0	11.6	5.4	10.4	10.0	28.6	11.9	7.4	7.6	13.9	28.0	20.7	6.4	9.5	7.1	13.0	14.1	12.0	6.8	3.8	7.4	9.5	26.9	14.3	13.8	9.9	8.5	10.8	14.3	10.9	5.0	16.4	9.2	11.3	21.9	14.2	9.6	11.5	18.6	10.9	7.5	12.4	6.0	11.4	10.0	6.6	9.2	15.6	15.4	12.9	17.0	15.1	10.8	12.8	18.7	42.1	43.5	22.6	55.9	51.5	223.4	49.7	50.3	26.2	41.5	26.8	8.4	188.6	13.5	34.7	7.3	11.0	31.4	504.6	42.1	51.0	22.0	35.3	36.0	115.0	55.7	32.6	31.0	77.8	46.5	101.5	69.4	26.9	73.7	32.1	37.1	45.4	50.8	28.0	43.1	10.7	36.9	10.1	8.2	149.4	31.7	16.2	16.0	146.0	34.3	20.2	32.0	25.0	11.3	88.8	58.3	21.4	82.3	20.2	38.0	16.8	18.5	68.2	47.7	517.6	31.3	12.8	81.2	6.1	5.4	5.2	4.1	4.1	3.7	4.7	3.5	4.1	3.0	5.4	3.6	3.5	19.2	3.7	7.2	3.9	4.1	3.6	5.4	10.0	7.4	7.6	3.8	7.4	9.9	8.5	9.2	6.0	9.2	12.8	23.1	32.1	56.3	26.1	36.4	15.6	30.5	42.6	22.8	26.8	21.4	17.1	20.9	24.3	75.8	25.8	33.3	47.5	32.1	19.3	13.7	19.5	2.5	257.4	34.5	22.0	25.1	29.9	28.8	24.2	28.0	31.9	28.5	74.8	32.9	33.2	15.7	45.0	18.3	30.3	32.9	23.4	32.6	49.0	25.0	2.9	19.3	44.9	12.4	37.5	35.4	27.8	10.3	25.6	71.8	22.4	20.1	15.1	117.7	39.8	15.8	21.3	141.7	35.3	19.7	30.0	32.4	17.3	20.0	59.5	22.0	94.3	31.8	49.4	20.9	82.0
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4 regulator of p53"	O15151	1	204516379-204558120	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA018919: AB_1853694, HPA048821: AB_2680531"	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.87e-4)"	"prognostic unfavorable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.49e-4)"	13.7	10.5	9.2	13.4	18.7	56.1	14.3	16.3	12.1	17.6	35.0	12.4	5.8	12.0	18.6	11.5	13.6	6.7	11.4	10.6	17.8	14.4	14.8	16.3	18.8	17.5	14.6	18.9	18.8	5.3	16.3	10.1	17.5	14.6	9.6	25.2	11.9	7.3	10.5	20.7	16.7	7.1	10.5	22.6	13.2	19.9	15.9	30.4	15.8	4.2	17.4	12.1	13.7	36.0	6.5	12.7	12.5	17.3	8.6	9.4	58.7	4.8	4.9	6.1	8.9	6.6	8.7	22.4	4.5	6.7	5.1	6.8	8.5	7.2	8.2	6.8	6.0	17.8	32.0	7.6	6.5	14.0	16.9	9.4	4.5	9.9	17.4	6.3	6.0	14.2	10.4	31.5	5.4	21.9	8.6	12.3	17.3	2.4	5.3	10.1	10.2	7.5	6.0	31.1	5.6	12.6	4.9	9.1	9.1	12.4	18.0	8.1	6.1	6.8	12.1	4.5	7.9	15.8	6.2	18.2	4.7	5.9	10.1	7.5	4.3	5.8	5.7	4.2	4.9	7.9	4.4	4.1	3.6	11.9	6.1	5.4	6.4	4.1	3.8	7.8	2.6	2.5	9.2	18.7	16.3	12.1	10.6	17.8	17.5	14.6	17.5	10.5	15.9	36.0	73.6	28.9	56.9	76.0	118.1	61.6	48.2	31.0	22.8	96.0	55.2	33.7	38.5	47.1	51.2	69.9	168.9	52.0	135.7	35.5	13.7	29.9	82.3	39.6	74.2	54.5	65.0	64.4	61.8	26.7	26.1	53.0	36.7	63.2	65.9	82.6	87.1	61.0	35.5	42.1	65.7	48.3	54.9	96.4	128.3	160.2	80.2	62.0	42.7	83.4	81.8	40.1	90.6	106.6	170.3	26.5	42.3	54.2	81.0	66.3	49.0	18.6	32.0	192.7	52.6	99.6	50.5	75.7	64.8	23.0	68.3	60.9	73.7	58.2	51.1	48.3
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213943-24216070	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		29000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	14.0	18.6	6.8	3.2	6.8	3.9	14.6	7.0	7.5	14.7	6.4	12.6	3.1	11.5	7.9	7.3	12.1	4.0	18.2	7.0	6.9	16.8	10.3	9.2	5.8	6.7	6.8	12.3	15.3	5.8	20.1	4.0	6.9	13.7	3.5	4.1	10.6	4.8	15.0	12.6	9.5	4.5	7.2	11.6	11.9	7.8	6.6	5.3	13.6	4.8	4.7	12.5	11.1	7.8	4.1	9.5	7.2	4.7	6.9	6.3	0.3	4.2	8.9	8.2	8.4	5.0	10.9	15.7	10.4	4.3	2.4	3.7	3.4	8.2	5.0	5.4	3.9	6.0	3.3	12.1	6.7	7.9	4.2	4.5	7.7	4.9	9.4	8.3	5.9	11.1	1.9	11.4	7.4	21.1	11.7	12.6	2.2	7.8	16.9	8.0	5.0	12.6	8.0	5.7	8.7	8.6	6.6	14.3	9.4	3.9	8.3	4.5	3.5	8.8	8.7	3.9	4.4	18.6	8.4	11.7	8.3	3.8	6.9	5.1	13.9	16.5	7.7	15.2	7.3	13.4	9.9	9.0	16.1	12.9	11.7	9.9	4.6	12.4	13.0	29.9	16.3	10.3	6.8	6.8	7.0	7.5	7.0	6.9	6.7	6.8	6.9	7.2	6.6	7.8	6.6	6.4	12.9	0.0	11.0	4.6	3.5	5.6	16.5	3.9	8.2	11.7	0.0	4.3	2.1	5.5	0.0	3.7	7.3	5.9	13.7	13.8	5.7	4.6	5.5	8.2	11.5	7.8	0.0	19.6	5.3	8.1	9.2	4.3	5.1	4.3	8.6	5.8	7.9	3.3	0.0	10.8	12.2	3.3	8.7	3.0	6.2	10.6	17.8	0.0	21.9	5.2	4.1	0.0	0.0	11.7	6.2	7.5	25.8	2.9	23.7	21.7	13.2	2.9	13.1	7.7	8.7	4.4	3.5	11.5	4.5	2.5	9.7	3.4	8.8	2.6
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50879080-50954257	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 176.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.1	15.7	12.7	21.9	13.6	15.6	9.3	14.1	16.8	8.9	55.5	30.6	38.3	9.0	8.9	12.8	8.5	12.7	45.0	14.8	15.4	12.6	15.1	11.6	25.8	15.6	16.2	8.0	20.9	32.2	10.0	13.1	16.2	13.8	32.4	14.6	7.2	19.9	26.2	8.8	32.3	18.1	13.9	27.2	26.5	18.8	15.4	21.4	10.9	22.9	22.6	16.8	3.4	14.3	40.5	39.9	52.0	61.0	23.2	25.6	24.2	33.2	24.7	42.2	35.5	18.4	21.8	143.3	12.8	29.7	38.5	32.6	78.1	33.3	48.2	60.0	11.6	36.5	22.8	21.5	68.1	123.9	42.5	16.0	40.3	53.1	85.8	27.8	55.0	83.5	39.9	34.1	29.1	8.4	90.4	12.3	34.8	29.0	15.9	58.0	25.8	41.1	45.9	8.6	63.9	34.0	31.0	18.7	33.0	31.0	14.4	59.0	34.6	30.0	32.7	15.8	44.7	62.9	27.1	70.6	30.2	86.5	32.5	7.5	16.4	20.7	6.5	19.0	5.1	7.1	4.2	7.9	13.3	7.2	3.6	4.5	18.1	9.8	25.7	4.4	4.4	7.4	12.7	13.6	14.1	16.8	14.8	15.4	15.6	16.2	16.2	13.9	15.4	14.3	20.9	9.6	11.9	40.1	32.8	15.2	20.2	13.6	12.5	17.0	10.9	10.0	103.6	11.5	22.6	14.7	14.6	16.7	37.9	39.0	39.2	31.9	18.0	18.5	22.6	18.7	12.0	16.6	35.6	38.6	16.3	19.1	43.3	19.1	16.4	176.4	24.3	9.1	89.7	8.4	45.9	27.3	18.3	93.8	15.1	6.7	11.5	54.5	12.4	47.8	48.3	18.0	48.4	52.3	32.5	35.6	22.3	16.6	61.5	25.0	72.4	17.1	10.6	55.0	6.6	23.0	23.2	59.8	30.6	13.2	10.7	8.6	28.1	22.4	36.5	17.4
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 54.2;Excitatory neurons: 103.7;Inhibitory neurons: 147.8;Oligodendrocyte precursor cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 54.4;hTERT-RPE1: 64.1;HUVEC TERT2: 36.3;TIME: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA038473	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	17.4	24.4	25.5	5.0	27.2	6.2	19.5	12.2	31.5	24.5	14.4	16.4	7.1	16.7	5.6	4.2	13.6	11.5	26.2	27.0	15.7	25.1	6.2	11.3	4.2	24.8	25.9	27.9	15.9	16.2	22.4	4.7	22.9	19.9	13.7	10.8	12.6	9.0	21.9	4.5	8.9	14.1	5.3	10.9	21.0	13.0	20.4	3.5	12.5	19.5	2.4	17.1	14.2	16.5	0.0	18.1	5.2	0.0	7.9	16.6	0.1	5.9	9.6	12.9	16.0	14.0	54.4	0.0	5.3	5.7	31.5	0.2	0.0	0.1	5.6	9.2	0.0	9.6	16.8	0.0	11.9	1.2	0.0	11.8	2.8	10.2	0.1	64.1	36.3	0.0	0.2	0.0	9.1	1.8	2.7	0.1	1.2	1.7	7.7	8.3	0.0	0.6	11.4	21.4	6.2	0.1	3.8	0.1	0.0	2.1	0.9	1.5	40.0	1.5	1.2	26.3	0.9	0.1	3.3	0.0	1.4	17.1	1.6	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.7	1.2	2.3	0.0	0.9	1.1	0.0	1.0	0.1	0.3	0.0	0.5	25.5	27.2	12.2	31.5	27.0	15.7	24.8	25.9	22.9	5.3	20.4	16.5	13.6	3.2	3.3	30.3	1.1	2.3	4.6	5.4	5.7	16.5	7.5	9.1	54.2	2.8	8.1	3.7	0.0	0.3	1.9	19.2	43.0	9.1	0.7	3.2	6.1	11.5	9.0	4.2	103.7	7.9	0.4	8.4	19.9	1.6	0.0	33.4	14.6	1.6	6.8	20.2	147.8	14.8	4.1	1.6	3.5	2.5	6.2	1.8	1.8	14.0	1.1	2.0	1.0	75.4	4.8	11.5	21.1	6.4	0.5	6.4	3.5	6.5	14.9	2.5	13.1	7.0	8.2	0.4	0.2	2.6	1.6	0.0	1.6	38.8	11.0	6.6
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663775	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	16.0	0.9	7.3	7.3	7.2	1.4	12.3	8.5	7.3	21.3	2.4	24.9	19.8	17.3	4.4	13.5	23.4	8.3	13.0	4.9	6.3	41.3	1.4	25.5	1.5	9.1	7.2	2.3	23.3	1.7	4.2	17.4	8.9	6.9	30.0	1.8	8.8	8.0	4.3	2.6	10.2	8.0	4.1	6.2	73.3	3.0	8.1	2.0	5.7	12.0	5.3	30.4	7.5	6.3	25.8	0.7	0.9	0.2	3.7	2.7	1.1	3.7	4.2	1.1	2.2	10.7	26.1	0.9	39.1	0.6	5.5	13.4	10.2	15.7	3.1	1.4	16.6	16.7	7.6	1.1	0.4	0.3	5.1	5.7	2.2	1.0	12.1	12.0	55.5	1.4	13.0	1.8	10.3	9.8	0.9	0.4	1.7	13.5	6.6	9.8	13.1	0.3	71.2	119.6	1.0	3.1	1.3	6.7	0.3	1.5	7.1	1.1	53.4	9.7	6.6	2.5	16.9	1.4	0.7	0.9	4.8	1.0	1.6	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.4	0.5	1.6	0.1	0.0	7.3	7.2	8.5	7.3	4.9	6.3	9.1	7.2	8.9	4.1	8.1	6.3	80.2	60.9	184.8	16.0	0.6	2.2	33.3	29.4	10.2	0.0	1.2	0.9	11.4	2.8	69.6	125.0	0.0	1.1	0.1	25.5	52.8	1.6	10.4	71.9	5.8	70.5	19.9	7.4	10.3	75.4	0.2	4.8	111.1	107.7	9.5	0.8	69.3	0.2	0.0	0.0	9.1	29.0	20.3	0.6	1.9	3.2	0.3	2.6	1.8	346.6	1.0	0.0	0.0	6.0	13.8	49.8	19.3	0.0	0.3	13.9	6.2	0.7	53.2	0.1	0.0	1.4	5.7	3.0	1.2	39.4	1.4	0.4	1.3	0.5	53.9	45.4
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 47.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favorable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	21.0	17.7	11.2	13.4	12.8	24.9	18.0	19.4	17.1	24.0	6.6	21.8	9.9	19.0	10.8	14.4	21.7	10.8	23.3	12.0	13.4	17.8	16.5	24.6	13.4	13.7	13.7	24.8	14.8	14.7	22.8	8.6	12.7	23.9	5.3	23.0	14.4	15.6	33.5	14.8	16.1	11.5	9.1	23.6	15.4	8.6	13.6	15.6	18.9	14.4	9.1	20.0	19.3	16.9	34.4	19.2	15.9	18.6	13.1	8.8	12.7	17.0	14.6	14.9	25.2	14.1	13.3	37.4	39.5	13.3	28.9	16.0	19.3	15.9	8.8	32.5	27.8	13.6	17.6	9.4	14.9	18.2	28.2	8.7	10.0	15.6	13.2	15.4	12.9	17.5	17.3	28.9	11.1	17.9	23.1	21.8	11.2	21.9	19.9	20.0	16.2	13.2	9.2	13.3	21.9	13.6	13.0	14.1	31.6	7.7	8.8	24.8	18.0	14.5	28.8	29.2	35.6	41.0	32.6	41.7	19.6	33.2	25.1	47.8	4.7	19.5	9.1	4.7	6.2	7.8	6.1	7.2	3.5	6.8	5.8	5.4	22.7	4.4	8.2	6.0	7.2	2.7	11.2	12.8	19.4	17.1	12.0	13.4	13.7	13.7	12.7	9.1	13.6	16.9	53.9	6.4	34.4	26.4	74.7	30.8	43.4	28.3	21.6	88.0	40.7	24.6	41.2	34.3	34.9	46.0	206.4	17.0	130.8	23.9	66.5	39.4	1.4	28.2	34.4	41.0	36.5	48.4	31.7	30.7	17.7	38.5	16.3	22.7	52.6	32.2	66.4	38.1	25.6	99.3	35.3	21.0	52.9	45.5	68.7	3.5	53.4	54.1	30.2	45.0	58.9	39.8	85.5	30.2	45.0	36.2	30.3	73.7	56.1	34.8	36.7	44.5	28.1	92.7	32.9	53.6	57.1	16.0	39.0	18.1	29.0	18.5	93.6	25.6	17.3	36.4
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192657-29230942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 82.5;Rod photoreceptor cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	14.7	14.6	5.1	1.7	5.1	1.8	13.4	3.3	6.2	10.2	3.1	10.3	1.4	12.9	2.5	12.5	9.4	1.3	24.8	6.0	3.9	14.1	15.8	7.3	2.0	5.2	4.0	10.0	8.9	4.5	7.2	3.5	5.4	7.9	2.6	9.9	12.3	3.0	42.1	15.4	7.2	3.1	3.2	6.7	11.1	7.6	4.3	1.4	8.3	5.8	2.1	9.6	9.6	5.2	3.9	4.5	3.2	4.6	2.9	2.5	6.8	3.7	3.8	4.7	3.9	2.3	5.6	7.3	5.1	3.7	1.3	3.0	5.4	6.3	4.0	4.4	6.9	6.4	3.4	4.1	6.6	6.1	1.9	4.3	5.9	3.1	11.0	3.8	3.5	6.9	5.8	4.2	4.7	4.5	3.9	2.9	6.5	5.8	4.3	3.5	4.2	9.3	5.9	2.4	5.1	4.5	4.1	4.7	7.0	4.4	2.3	5.4	3.8	2.4	2.9	4.1	4.7	2.7	2.2	5.0	3.9	8.4	5.2	0.1	2.2	0.0	1.5	2.1	4.1	2.2	1.6	1.7	1.9	1.1	2.3	1.6	0.3	2.9	1.6	2.5	2.4	1.2	5.1	5.1	3.3	6.2	6.0	3.9	5.2	4.0	5.4	3.2	4.3	5.2	8.8	12.8	3.9	14.7	9.1	5.6	15.6	26.9	7.4	12.8	12.0	14.6	19.8	21.5	21.4	20.2	10.4	46.0	3.8	7.4	41.1	24.3	40.8	19.7	13.6	9.1	7.8	10.1	25.1	19.7	42.4	12.8	4.6	12.8	5.7	17.5	7.1	19.7	20.8	8.4	20.3	9.4	12.2	6.0	5.1	82.5	13.7	5.3	16.0	3.7	10.8	14.5	10.3	11.6	15.2	16.3	8.0	10.9	10.3	20.6	10.9	46.0	11.3	68.5	13.1	13.2	12.9	8.5	16.1	14.0	7.4	27.9	6.0	25.8	18.3	20.5
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451272	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 206.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: AB_2681962"	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	10.3	8.7	7.2	11.3	7.7	12.9	10.6	8.5	8.2	9.7	7.4	10.6	7.7	11.0	5.9	9.8	9.3	7.6	9.6	6.9	7.4	8.8	9.0	8.7	13.3	7.2	7.3	11.3	7.9	16.8	6.0	10.4	7.5	8.3	9.5	8.0	8.6	7.7	13.7	11.1	9.7	11.2	7.4	11.2	8.6	10.7	7.7	16.9	9.1	12.2	14.7	10.9	9.1	8.8	20.1	24.5	32.5	22.7	23.1	23.7	25.8	24.0	25.6	30.6	30.1	24.9	20.1	51.4	26.2	28.9	37.2	38.3	38.0	22.9	50.0	49.2	31.8	32.3	24.1	24.0	24.4	59.8	33.9	22.1	23.6	39.3	55.0	20.1	28.1	30.6	42.1	28.4	25.7	10.7	56.5	23.2	20.9	19.4	15.1	41.3	43.1	22.9	18.5	22.4	20.3	23.2	30.9	206.2	27.6	28.0	38.5	33.4	23.7	24.8	31.1	28.1	42.3	25.3	36.4	53.6	24.3	28.4	32.0	1.3	1.4	1.8	1.6	1.4	1.9	2.2	1.8	1.8	1.5	2.0	1.8	2.1	1.2	1.9	0.8	1.5	1.5	1.0	7.2	7.7	8.5	8.2	6.9	7.4	7.2	7.3	7.5	7.4	7.7	8.8	18.8	25.6	13.9	10.1	24.7	27.1	14.2	13.1	19.4	13.7	18.0	13.8	18.9	12.8	21.0	9.2	14.6	17.2	20.6	12.7	3.9	12.3	7.9	19.0	27.1	21.2	13.8	26.9	13.4	12.0	12.8	19.7	10.7	27.0	9.5	19.9	17.2	20.2	14.9	11.8	13.9	14.8	16.2	20.0	16.5	7.7	14.6	16.4	21.4	11.2	21.0	13.5	17.5	11.1	16.0	13.7	12.1	18.0	20.2	19.9	9.4	8.5	17.4	12.0	19.7	26.1	21.2	22.3	17.0	21.7	32.7	22.2	22.8	18.7	15.0	18.7
MED11	"HSPC296, MGC88387"	ENSG00000161920	"Mediator complex subunit 11"	Q9P086	17	4731428-4733608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056669	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear bodies"		"HPA056669: AB_2683204"	"unprognostic (4.01e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (8.24e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	20.5	41.3	28.6	22.5	32.0	11.2	20.3	32.3	33.8	21.1	28.2	25.4	27.2	18.9	25.3	29.2	24.4	19.0	29.5	28.2	30.5	32.7	38.6	22.9	28.5	31.9	31.2	16.8	29.0	35.6	19.1	16.4	31.6	23.3	23.4	17.2	26.6	19.5	39.0	27.2	26.5	16.9	30.4	34.5	30.6	16.2	31.3	25.3	22.4	32.9	26.5	22.3	21.3	35.3	26.2	73.5	26.9	27.8	28.6	34.6	20.7	18.4	30.8	26.4	33.0	25.6	19.7	35.7	18.9	22.3	17.2	38.8	27.1	51.9	20.5	42.5	63.1	17.8	42.6	40.6	17.7	12.9	20.7	30.1	35.6	28.3	17.3	28.2	30.3	36.4	18.1	26.5	23.4	37.6	24.8	16.8	16.0	39.3	23.6	24.5	19.7	23.3	54.3	27.5	10.9	18.1	23.7	31.5	18.5	22.0	28.4	15.1	18.1	14.1	14.1	27.4	29.3	12.5	11.8	14.2	24.4	22.0	18.8	49.1	31.0	79.3	41.6	45.6	45.4	62.8	40.8	41.8	31.0	61.9	48.3	53.1	136.3	40.9	68.0	49.8	33.7	38.5	28.6	32.0	32.3	33.8	28.2	30.5	31.9	31.2	31.6	30.4	31.3	35.3	12.5	6.4	23.5	7.8	31.5	12.2	28.8	42.6	19.4	22.1	20.0	17.8	15.1	32.9	32.3	14.7	10.4	45.4	34.3	32.8	64.6	37.0	1.2	35.1	24.8	15.8	10.8	13.5	5.5	35.3	34.2	17.3	28.5	25.0	29.1	9.3	22.5	29.4	33.8	30.3	7.2	30.9	48.8	31.5	21.1	3.8	17.4	25.5	10.6	5.6	44.6	20.9	50.4	5.0	14.6	22.4	51.1	13.9	18.8	22.9	66.4	99.5	36.9	26.6	19.7	16.5	18.2	56.6	49.9	31.3	18.8	25.0	27.3	33.8	29.7	28.6
MED12	"ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230"	ENSG00000184634	"Mediator complex subunit 12"	Q93074	X	71118556-71142454	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003184, HPA003185"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA003184: AB_1079349, HPA003185: AB_1079350"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.89e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.16e-2)"	18.9	32.3	10.1	13.4	11.6	15.1	19.3	10.8	12.2	20.3	9.3	15.2	8.1	18.1	10.7	13.4	17.8	8.5	13.4	9.7	10.5	13.1	10.3	15.2	13.6	12.3	10.9	28.9	14.9	14.1	16.3	16.8	11.3	17.4	9.2	8.2	14.3	12.6	15.4	14.7	15.9	12.6	10.2	28.4	15.5	13.4	11.2	19.1	18.1	10.6	12.2	15.2	17.1	12.0	14.2	16.4	25.5	15.3	18.3	16.1	37.1	9.9	14.0	15.2	10.8	19.8	13.1	18.5	12.7	17.2	10.5	13.8	29.7	12.3	12.1	19.6	23.0	30.7	37.9	27.5	14.3	28.8	26.2	18.9	13.2	20.0	23.3	19.6	23.8	23.1	29.0	31.6	15.2	24.3	30.5	16.3	14.7	18.2	21.3	28.0	28.5	14.0	11.8	27.5	14.0	16.9	22.7	11.8	12.2	26.2	13.9	14.2	21.1	16.5	19.7	15.4	7.0	15.4	9.5	13.7	9.8	15.8	11.2	6.9	2.1	4.3	3.0	1.9	2.5	2.0	2.1	2.8	2.1	1.9	2.3	2.0	4.1	2.7	1.3	2.8	4.4	2.4	10.1	11.6	10.8	12.2	9.7	10.5	12.3	10.9	11.3	10.2	11.2	12.0	15.4	9.6	4.2	7.2	8.4	6.0	6.3	6.5	4.6	7.2	8.6	11.0	9.3	11.5	7.6	9.2	6.2	20.7	10.9	10.8	1.9	6.9	0.4	7.9	8.9	12.8	7.8	13.7	3.8	6.3	8.0	8.2	8.6	7.1	9.5	21.1	14.6	4.4	9.1	13.5	4.2	5.8	2.0	6.5	9.8	2.3	14.0	8.9	5.4	6.5	7.4	6.3	13.4	4.0	4.2	9.4	10.0	13.5	7.3	7.5	7.5	2.7	7.5	4.9	0.0	10.0	7.6	6.6	7.3	6.1	5.7	27.2	8.8	27.9	6.8	8.6
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12L"	Q86YW9	3	151085697-151437072	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 24.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 383.3;Excitatory neurons: 302.4;Inhibitory neurons: 120.7;Oligodendrocyte precursor cells: 225.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.3;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 20.9;JURKAT: 13.0;MOLT-4: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	0.7	1.5	0.7	0.4	2.6	4.3	0.2	0.3	5.6	1.0	24.1	0.2	1.0	0.4	1.9	0.1	0.3	0.5	0.2	2.4	0.7	0.1	0.0	0.2	1.0	0.2	0.9	0.2	0.1	0.2	1.7	1.2	0.0	0.6	0.0	3.0	0.3	0.3	0.3	0.1	0.4	0.3	0.0	0.4	0.2	4.5	3.6	0.5	0.4	0.0	1.0	0.3	0.4	0.6	0.9	0.4	2.9	0.2	0.1	0.1	18.5	0.0	0.3	0.7	0.8	1.0	0.3	0.0	0.2	0.1	2.1	0.1	3.8	0.3	0.8	0.0	1.8	20.9	0.1	0.1	0.0	0.7	7.1	0.0	0.1	0.1	0.1	0.1	0.0	13.0	0.0	3.1	0.0	3.1	9.9	0.0	3.4	0.1	0.7	0.1	1.1	0.5	0.3	3.0	4.9	0.7	0.4	0.2	0.0	5.2	1.0	0.1	0.0	0.0	2.2	0.0	1.5	5.9	0.0	7.3	0.2	1.8	1.1	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.7	2.6	0.3	5.6	2.4	0.7	0.2	0.9	0.0	0.0	3.6	0.6	0.1	0.0	0.0	383.3	1.0	1.1	1.1	0.3	2.8	11.1	0.5	0.4	1.2	0.0	1.3	1.8	4.2	18.6	0.4	0.2	0.0	0.1	13.2	1.1	0.4	0.4	0.0	13.0	302.4	0.6	1.5	0.9	0.0	0.3	0.0	0.2	0.4	0.2	1.9	33.7	120.7	0.0	0.0	1.6	1.1	7.3	0.9	1.7	0.0	52.5	1.3	26.2	0.0	225.7	9.6	0.2	0.0	0.4	1.3	1.1	0.0	0.5	0.9	1.9	0.0	0.3	0.5	8.2	4.3	0.4	0.1	27.0	0.2	1.1	0.0	0.4
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13L"	Q71F56	12	115957905-116277693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"T-47d: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	18.4	7.9	5.5	15.8	7.3	52.7	20.8	27.0	6.3	15.8	5.3	12.9	10.3	20.5	6.5	13.8	12.5	13.2	11.5	6.4	5.9	12.4	7.9	14.4	14.6	9.2	7.3	24.3	17.5	15.3	5.5	16.3	6.9	12.7	13.5	12.6	14.8	12.8	18.6	19.0	13.4	15.9	6.3	16.6	12.2	13.8	7.7	39.1	18.0	25.8	16.2	13.1	12.7	10.7	16.9	33.2	19.6	16.9	23.6	42.0	16.5	15.8	21.3	23.7	16.3	25.2	5.9	13.3	13.6	29.0	14.5	9.9	20.4	14.2	29.6	24.3	14.0	26.9	10.0	7.2	26.2	24.8	28.6	30.6	21.8	26.8	40.7	17.4	15.9	28.2	28.9	11.4	18.7	21.8	42.1	22.2	10.5	7.1	8.2	28.7	25.0	24.8	11.1	18.4	17.7	12.4	14.2	7.8	15.0	34.9	124.8	39.9	20.7	26.0	16.8	17.2	19.5	17.9	9.7	21.6	12.0	22.3	12.8	1.5	0.6	1.5	0.2	0.3	0.2	0.3	0.5	0.2	0.7	0.7	0.3	0.4	3.5	0.3	0.4	1.1	0.0	0.1	5.5	7.3	27.0	6.3	6.4	5.9	9.2	7.3	6.9	6.3	7.7	10.7	84.4	64.1	54.9	303.9	47.5	99.2	38.4	21.7	70.6	52.4	51.4	42.4	35.6	21.5	35.5	25.8	54.2	9.4	38.5	30.5	3.9	13.5	84.0	42.5	115.2	56.9	31.3	49.6	311.5	26.0	19.6	56.0	29.0	96.7	14.0	93.4	53.6	30.6	21.1	57.2	321.0	31.8	14.2	48.7	60.6	47.2	92.2	60.5	32.0	427.2	56.4	22.8	17.5	352.8	305.4	26.8	21.0	67.0	65.6	49.4	22.7	12.3	27.2	44.6	46.0	61.9	57.0	20.3	23.3	48.0	101.6	14.2	30.5	23.7	25.9	51.0
MED15	"Arc105, CAG7A, PCQAP, TIG-1, TNRC7"	ENSG00000099917	"Mediator complex subunit 15"	Q96RN5	22	20495913-20587632	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 240.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003179	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA003179: AB_1079581"	"unprognostic (7.98e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.57e-2)"	33.0	32.6	16.4	28.5	20.5	42.1	28.7	24.8	33.5	31.0	12.9	34.1	31.7	40.5	6.2	33.4	26.2	23.1	26.4	17.9	18.4	24.1	14.9	35.8	31.6	14.9	15.7	26.5	22.4	15.2	20.6	25.0	18.5	26.2	11.9	8.8	26.7	14.9	55.1	36.1	30.9	17.3	9.1	31.8	23.9	20.1	13.5	23.2	23.3	15.8	16.1	33.9	30.7	26.2	73.6	38.5	24.2	29.3	25.0	24.2	44.3	72.9	52.9	56.4	51.9	58.8	32.5	29.6	32.9	51.8	25.4	74.1	22.1	54.2	22.7	42.5	39.5	56.4	42.2	43.2	41.4	51.7	49.6	29.7	41.7	44.7	45.0	31.8	44.3	22.2	240.2	26.8	36.4	49.0	21.7	29.4	26.2	32.2	26.0	37.7	54.7	12.1	34.3	52.7	22.7	39.0	55.0	54.9	77.4	15.7	31.0	28.7	80.4	90.3	67.6	48.7	59.4	35.3	34.3	22.6	65.3	31.5	82.5	6.3	11.8	10.5	24.3	12.4	11.5	5.7	16.9	27.8	10.1	6.3	9.7	16.4	13.0	21.9	23.1	9.0	28.9	15.0	16.4	20.5	24.8	33.5	17.9	18.4	14.9	15.7	18.5	9.1	13.5	26.2	24.4	51.3	30.9	26.4	19.4	29.8	26.3	25.1	22.8	20.2	18.7	17.5	4.6	12.8	26.5	25.8	18.8	48.9	33.4	46.9	15.6	32.3	34.3	36.3	24.9	25.6	18.0	10.3	31.4	28.6	42.0	21.4	39.8	49.1	20.8	21.3	23.6	9.7	31.4	15.2	32.7	26.0	14.2	24.1	35.1	19.8	14.3	31.1	24.9	34.7	30.7	13.8	47.4	21.6	28.2	67.8	43.4	14.7	24.8	40.2	36.5	11.9	33.1	16.3	46.0	23.2	23.3	22.6	15.4	26.2	27.6	61.8	43.7	24.7	25.4	36.5
MED16	"DRIP92, THRAP5, TRAP95"	ENSG00000175221	"Mediator complex subunit 16"	Q9Y2X0	19	867630-893218	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030685, HPA046495"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA030685: AB_10601872, HPA046495: AB_2679674"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-2)"	"unprognostic (4.93e-3)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.83e-2)"	"unprognostic (5.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-2)"	49.7	38.2	33.8	19.4	32.9	13.9	41.1	27.0	57.4	46.9	24.3	38.2	15.4	34.6	1.9	44.3	35.0	11.8	34.9	33.4	29.5	44.2	68.6	32.7	16.2	32.9	31.3	44.3	55.3	12.8	39.3	13.5	29.0	54.1	5.8	5.0	36.1	10.1	44.5	43.0	35.7	8.6	28.5	46.0	39.7	36.4	32.8	10.5	38.2	10.0	7.5	45.0	41.3	29.6	29.4	25.1	24.7	17.0	10.2	10.8	27.5	20.3	19.1	29.7	22.4	32.6	27.3	29.8	23.6	18.1	9.9	23.4	9.3	24.3	5.0	37.8	29.6	29.9	18.5	30.4	20.3	29.0	26.6	18.9	12.1	18.2	11.7	17.4	23.1	31.5	36.3	69.8	17.9	44.5	47.3	34.1	38.3	11.0	33.5	48.1	17.9	38.3	20.5	45.3	30.6	29.5	27.2	18.3	22.5	9.2	21.4	22.3	22.4	30.1	30.2	46.3	23.6	50.6	19.8	28.4	39.2	27.2	22.7	53.0	31.5	40.7	50.2	34.2	45.4	53.7	56.0	57.8	40.7	44.0	46.2	43.8	44.1	40.4	36.6	27.3	82.3	52.7	33.8	32.9	27.0	57.4	33.4	29.5	32.9	31.3	29.0	28.5	32.8	29.6	15.5	35.3	24.8	6.5	19.0	11.6	11.3	15.6	12.0	15.9	16.9	17.7	7.1	15.7	15.2	22.0	6.2	62.6	11.9	57.5	17.6	24.4	3.6	15.5	16.9	15.2	25.7	14.1	3.2	24.3	32.3	19.4	44.9	27.3	14.5	32.4	14.6	24.0	25.3	15.2	2.6	34.8	18.3	16.1	5.7	6.5	13.7	14.6	10.6	4.7	23.8	15.8	12.3	3.0	4.7	23.0	29.4	14.7	23.2	11.3	34.6	17.4	12.9	20.4	6.6	12.3	16.4	13.9	28.8	12.0	16.1	63.8	19.7	30.4	34.1	15.0
MED18	"FLJ20045, p28b, SRB5"	ENSG00000130772	"Mediator complex subunit 18"	Q9BUE0	1	28329002-28335965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027429	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA027429: AB_10610137"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.78e-3)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.38e-5)"	"prognostic favorable (6.72e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.69e-2)"	4.9	7.7	1.8	3.9	1.8	2.8	4.9	2.0	2.3	4.0	2.5	9.4	4.2	5.7	3.6	10.0	4.8	2.2	7.0	1.8	2.0	7.6	15.3	3.9	5.6	2.0	1.9	3.3	6.7	2.4	4.6	3.1	2.0	4.8	4.3	1.8	5.8	2.8	9.2	7.2	9.4	2.9	1.8	10.2	7.8	5.8	2.1	3.8	4.1	3.1	6.0	5.6	5.2	2.2	12.6	6.1	6.0	5.2	7.9	7.6	6.7	7.4	8.7	9.4	8.1	3.5	11.6	15.6	7.5	7.6	5.7	7.7	9.7	9.1	7.3	10.6	6.9	12.0	5.4	7.7	10.9	7.3	12.3	8.1	11.0	7.4	11.2	5.6	8.2	7.6	11.6	4.0	8.9	6.1	9.3	9.2	7.1	6.9	3.4	6.7	8.7	8.3	8.3	6.2	5.8	6.1	7.4	7.5	10.9	6.3	6.3	6.9	10.0	5.7	6.4	9.4	7.8	6.9	9.8	8.5	8.4	15.2	4.1	3.6	3.4	5.1	3.2	3.3	2.4	3.7	2.5	2.7	2.9	2.7	3.1	3.2	5.0	2.5	4.2	3.9	3.7	3.4	1.8	1.8	2.0	2.3	1.8	2.0	2.0	1.9	2.0	1.8	2.1	2.2	3.3	9.6	4.8	0.7	5.1	0.8	4.0	7.9	1.8	3.1	1.8	2.4	5.9	4.3	7.6	1.8	12.5	11.9	12.0	7.9	7.9	7.9	0.4	7.1	4.8	2.7	3.5	3.2	0.8	6.0	13.5	3.0	4.6	4.6	1.3	3.4	4.2	4.3	7.9	10.1	0.8	5.9	6.1	4.1	0.9	0.7	4.7	3.5	1.8	0.0	7.0	4.5	10.3	0.0	0.7	5.7	7.2	5.3	2.6	3.1	8.0	8.6	5.9	4.6	19.7	2.5	5.4	7.5	7.7	1.9	1.3	14.8	4.6	4.8	4.6	6.0
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	11.3	18.1	22.7	6.2	23.7	6.8	11.6	20.7	41.5	11.0	21.0	10.0	9.6	11.6	13.4	15.5	9.2	6.1	11.3	23.4	22.6	14.7	13.2	8.9	7.5	21.4	22.9	9.6	11.6	9.8	16.0	10.2	22.2	12.5	7.8	12.0	12.1	8.9	10.6	15.5	9.7	8.1	22.2	10.8	11.1	22.8	26.0	8.2	13.6	9.2	9.4	10.1	11.9	23.7	30.3	19.1	22.7	21.0	23.6	21.4	27.0	25.4	19.7	23.9	24.0	13.6	23.0	16.6	38.5	24.4	21.0	22.6	17.1	16.1	21.0	21.8	18.6	14.3	11.3	12.7	35.5	15.7	16.4	17.5	28.9	23.8	46.6	16.7	31.1	13.3	15.9	16.1	29.1	14.5	22.3	29.2	19.8	21.4	37.7	21.1	32.2	20.2	15.9	12.6	17.6	24.7	20.5	20.7	47.2	19.1	43.8	16.0	25.7	20.7	24.8	49.2	22.6	19.9	20.5	15.7	28.3	11.5	22.1	27.9	25.8	31.3	29.2	37.2	31.6	45.0	32.8	31.4	25.6	39.4	34.0	32.0	16.4	24.6	39.2	36.9	33.9	26.0	22.7	23.7	20.7	41.5	23.4	22.6	21.4	22.9	22.2	22.2	26.0	23.7	40.7	9.6	27.1	4.6	32.5	87.6	60.9	72.0	62.0	38.6	37.4	39.8	14.7	30.0	40.2	51.5	35.5	58.2	32.2	36.2	39.2	44.1	12.2	33.3	37.8	39.3	23.3	21.4	9.2	45.4	48.6	38.1	20.9	34.0	22.2	39.2	36.0	26.3	29.3	37.0	8.3	38.3	54.9	17.6	31.4	15.4	28.3	18.6	37.4	2.8	26.3	37.4	24.7	5.5	7.2	40.6	33.2	29.7	22.9	53.6	32.9	47.2	42.1	59.7	19.7	31.3	50.5	111.7	97.9	42.7	82.3	73.1	35.8	37.5	31.8	52.8
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	8.1	11.8	6.3	7.7	7.3	6.1	10.9	9.1	8.0	10.6	7.9	10.6	10.5	9.7	13.5	9.8	9.9	7.7	11.6	6.5	7.1	12.8	10.4	7.4	10.0	6.6	6.6	8.2	9.3	10.6	6.4	13.6	7.0	11.2	11.8	5.9	8.7	10.2	14.5	9.7	8.7	12.0	5.8	9.2	9.7	7.4	7.2	12.7	11.9	16.6	13.3	10.2	7.6	9.0	28.5	23.0	25.7	32.1	23.1	24.8	31.7	18.2	17.1	25.9	20.5	29.5	20.3	41.4	34.3	23.0	15.5	22.0	39.7	26.4	31.2	22.2	14.7	37.5	19.6	28.6	23.9	30.5	22.2	18.6	36.8	22.5	33.3	19.6	33.9	36.4	49.0	19.3	32.7	25.7	36.3	22.3	35.1	93.5	19.3	48.0	29.4	15.1	34.9	19.9	23.7	18.6	25.3	12.6	26.5	28.7	24.7	32.4	33.2	18.2	38.9	11.4	22.5	19.3	27.1	85.7	9.9	33.3	26.3	18.7	24.9	18.4	10.7	29.4	14.0	19.0	7.3	12.2	26.1	23.6	9.4	11.3	9.3	17.4	20.7	23.5	14.4	16.7	6.3	7.3	9.1	8.0	6.5	7.1	6.6	6.6	7.0	5.8	7.2	9.0	4.4	9.6	3.9	2.3	6.6	3.7	4.2	7.2	6.8	2.4	7.0	5.1	5.2	2.8	6.8	7.3	0.0	22.7	7.3	6.6	7.9	6.9	0.6	5.1	7.1	4.2	9.6	8.0	2.8	3.3	18.6	5.0	6.1	6.7	7.0	8.3	8.6	8.3	8.7	1.7	2.8	5.6	14.2	6.3	2.6	0.7	3.4	3.7	1.8	4.7	6.3	3.7	7.2	5.5	3.0	4.9	3.1	6.8	5.7	4.7	5.8	10.1	4.6	4.2	0.0	3.6	4.9	8.3	13.6	5.8	5.7	24.9	3.0	7.1	7.2	5.4
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	16.7	24.9	10.5	9.9	11.4	29.0	18.2	14.6	15.2	25.2	11.2	20.4	12.2	20.3	15.0	23.9	19.2	15.0	25.4	11.2	11.6	26.2	16.1	16.6	13.0	9.4	9.5	24.9	13.3	25.7	17.8	16.4	9.6	18.3	16.9	12.4	20.9	17.0	27.9	15.8	12.0	21.8	10.1	12.0	16.3	29.7	10.5	21.1	18.9	35.5	17.1	22.6	23.8	11.3	36.6	40.5	18.6	27.5	41.3	36.1	29.7	46.2	24.5	30.2	32.5	42.5	37.3	21.4	25.9	26.5	54.2	30.7	41.1	36.3	53.8	21.6	36.8	36.5	37.9	22.4	22.0	41.3	21.2	31.1	46.4	45.3	50.0	54.0	46.6	30.8	25.8	28.2	34.7	27.1	38.1	63.8	54.3	50.1	49.8	29.3	133.5	23.7	28.1	37.4	13.4	17.7	57.3	18.2	26.1	79.9	34.6	26.4	39.0	34.8	28.7	43.3	40.3	9.6	21.4	37.8	34.7	39.4	23.3	54.9	23.8	33.6	26.2	26.0	25.4	28.8	30.0	30.8	22.5	26.9	35.2	30.4	18.7	19.0	24.6	18.3	34.5	26.9	10.5	11.4	14.6	15.2	11.2	11.6	9.4	9.5	9.6	10.1	10.5	11.3	30.9	16.0	23.0	7.8	35.4	98.9	121.4	95.1	72.8	9.9	39.4	33.5	32.1	22.8	45.0	53.3	0.0	62.0	33.1	18.5	93.9	41.7	228.6	32.7	26.3	33.0	17.9	68.8	23.8	38.0	56.8	50.8	18.8	35.1	18.4	31.3	25.7	21.8	31.7	13.5	17.6	20.8	65.1	21.7	50.2	87.8	48.4	22.4	71.2	7.5	29.1	27.1	11.3	10.6	14.4	33.4	19.9	47.4	24.5	85.3	22.4	109.3	20.8	13.6	19.7	37.4	54.8	157.7	61.8	70.5	101.3	61.0	46.7	30.6	20.4	145.8
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338312-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	14.1	20.4	7.1	6.2	7.1	4.9	14.0	7.3	7.2	22.1	6.3	24.6	5.2	23.2	2.8	15.6	20.4	3.4	22.2	6.8	6.8	19.5	12.1	15.1	6.3	8.4	7.2	21.4	14.8	6.7	16.7	4.4	7.3	21.7	2.9	2.8	14.3	7.4	13.3	14.3	17.6	5.6	7.5	21.9	15.7	10.2	6.9	4.6	19.2	3.3	5.0	23.2	16.2	7.1	10.0	11.5	17.7	12.7	3.8	6.5	20.5	11.9	8.3	14.5	9.6	25.4	9.1	20.0	6.9	8.5	12.6	19.4	13.3	11.5	6.0	15.7	7.7	10.6	28.8	6.9	6.4	13.7	10.5	5.0	9.0	13.0	8.6	6.8	7.0	11.5	15.7	9.3	6.9	13.8	19.5	11.4	24.8	12.4	13.8	26.4	14.1	18.4	6.0	7.2	14.3	11.6	13.8	17.4	10.4	7.1	19.7	4.7	9.5	18.7	13.0	13.0	15.8	6.4	9.4	19.4	10.8	10.6	15.8	1.1	1.5	2.6	0.7	1.2	0.9	1.1	0.8	0.9	1.1	1.5	0.9	0.7	2.3	0.6	2.2	1.5	0.7	1.1	7.1	7.1	7.3	7.2	6.8	6.8	8.4	7.2	7.3	7.5	6.9	7.1	6.4	22.4	11.7	4.6	8.3	8.3	10.6	4.0	4.0	13.6	6.9	5.2	9.9	7.2	3.1	16.5	0.0	6.1	12.8	8.8	3.9	5.8	1.9	3.7	6.7	8.4	6.7	3.8	3.0	5.3	5.1	11.2	6.1	6.2	7.6	8.4	6.4	4.3	7.8	13.5	3.3	6.5	4.1	7.2	8.3	2.8	11.8	8.3	1.8	3.7	5.6	9.6	5.2	3.0	5.3	8.1	2.1	16.6	6.8	8.4	8.3	5.2	1.7	12.1	26.3	14.8	15.2	13.2	13.7	5.2	6.5	5.5	5.8	5.9	5.9	4.7
MED25	"ACID1, ARC92, DKFZp434K0512, TCBAP0758"	ENSG00000104973	"Mediator complex subunit 25"	Q71SY5	19	49818282-49840383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068802	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA068802: AB_2686039"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (6.67e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.02e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.04e-3)"	21.6	76.1	16.2	18.5	14.4	34.5	23.7	14.7	23.4	28.6	28.4	30.5	18.6	36.2	8.7	32.3	33.3	14.8	42.5	16.3	15.5	27.7	15.8	26.4	18.3	16.3	17.5	44.9	30.6	15.8	43.7	18.9	15.8	23.8	13.2	16.0	26.9	11.9	97.8	28.7	27.9	16.0	13.2	30.5	39.3	82.1	16.6	16.9	39.8	18.4	17.8	27.3	26.4	12.9	44.6	65.3	30.5	33.3	20.8	18.4	30.7	23.6	27.4	37.3	36.6	58.7	50.1	51.2	16.3	30.9	25.6	38.4	32.8	34.0	23.1	30.9	58.3	33.7	45.6	41.2	24.6	36.0	46.1	22.7	28.3	32.8	22.9	31.4	32.3	29.0	61.6	36.3	20.8	25.5	36.0	69.8	22.5	36.9	40.6	43.5	30.3	53.3	33.6	64.1	54.4	50.1	32.4	48.9	15.2	23.3	29.1	27.1	39.3	40.1	29.2	19.4	26.6	41.3	63.1	55.3	35.6	30.8	24.4	0.8	2.2	3.8	1.3	1.7	1.5	2.3	1.1	1.4	1.8	3.3	1.2	0.8	13.8	0.9	1.6	2.2	1.4	2.0	16.2	14.4	14.7	23.4	16.3	15.5	16.3	17.5	15.8	13.2	16.6	12.9	10.6	35.3	22.9	17.0	18.5	5.6	15.8	16.0	10.2	10.8	17.7	13.3	5.7	8.6	16.8	20.2	43.8	27.5	16.1	28.8	1.9	23.6	54.3	58.3	18.3	10.8	44.3	54.7	10.5	24.3	22.8	15.8	23.0	24.1	7.6	62.5	7.1	5.8	21.5	8.4	12.6	18.8	18.3	13.8	11.6	111.7	15.8	16.5	3.6	7.5	22.8	9.1	11.3	10.6	10.9	28.7	28.6	11.3	20.4	8.8	27.8	17.6	77.4	28.3	13.1	11.9	19.8	49.1	39.0	11.3	5.3	33.8	14.5	62.0	18.0	16.5
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	4.5	3.8	4.4	3.8	4.0	11.0	4.1	5.1	4.7	4.0	4.0	4.1	2.4	4.3	1.8	5.2	3.2	2.3	3.2	5.0	5.1	2.8	3.7	4.0	4.9	5.2	4.7	4.7	3.9	3.5	3.6	3.2	4.7	4.2	1.9	2.0	4.5	2.4	6.9	6.4	3.6	2.5	3.6	4.7	3.6	35.9	4.5	4.4	3.1	3.2	4.6	3.9	4.6	4.2	11.1	4.2	3.8	8.3	4.8	3.8	11.1	6.3	4.4	6.7	6.0	6.3	6.5	17.6	6.5	4.0	2.1	8.2	5.9	6.3	4.6	13.0	12.2	6.9	4.2	5.1	4.7	7.9	6.3	4.6	6.1	5.7	5.9	4.0	3.6	9.1	11.5	20.7	4.2	11.1	8.4	7.4	9.0	5.2	13.4	8.7	5.8	19.3	4.0	4.3	10.0	5.4	5.5	5.3	6.4	2.7	3.9	10.3	4.5	8.5	6.8	10.4	8.5	14.3	12.6	14.4	6.0	10.4	5.0	0.7	0.1	0.1	0.5	0.3	0.1	0.4	0.0	0.2	0.2	0.7	0.3	0.0	0.3	0.4	0.1	1.4	0.7	0.1	4.4	4.0	5.1	4.7	5.0	5.1	5.2	4.7	4.7	3.6	4.5	4.2	13.7	3.2	12.7	11.4	11.8	14.1	5.0	3.8	11.4	4.2	14.3	12.2	1.1	2.8	3.0	5.5	10.4	6.2	15.8	5.9	3.9	4.4	65.4	12.9	7.7	6.1	2.4	5.0	8.6	4.0	11.1	7.0	5.6	16.6	1.3	5.8	4.2	5.6	5.0	5.0	7.6	4.7	2.0	8.5	10.7	67.4	6.5	9.9	1.8	1.9	4.9	6.0	4.1	7.1	8.5	6.0	3.0	3.8	15.9	6.7	3.6	2.0	3.5	6.4	0.0	17.7	8.0	54.1	19.4	11.5	10.7	16.8	11.0	6.1	5.1	8.7
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131852928-132079867	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 87.7;Oligodendrocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	14.6	14.7	20.4	10.1	22.7	18.4	14.8	19.6	22.1	14.0	17.6	16.6	8.3	19.0	23.5	17.0	15.2	9.6	18.5	22.8	19.7	14.6	9.9	14.0	15.4	20.3	19.2	12.8	9.0	15.8	17.1	13.1	19.6	15.5	11.1	13.7	11.3	13.7	20.9	20.5	11.7	16.7	19.3	14.2	12.9	18.2	19.3	28.2	13.3	14.4	14.1	17.3	13.7	21.7	33.1	29.8	40.9	32.0	28.4	24.7	33.3	34.7	48.8	73.9	58.8	53.0	29.4	31.7	21.5	39.3	48.1	60.9	54.5	51.8	46.8	34.6	36.1	24.5	31.1	31.3	42.7	43.2	33.4	28.9	37.9	57.9	61.4	22.9	41.4	52.1	36.7	29.0	57.2	57.8	52.4	30.8	40.6	36.5	62.6	44.7	51.0	43.6	31.0	17.8	72.5	28.9	44.4	22.7	26.5	25.7	37.6	22.1	29.5	71.8	31.4	52.6	51.5	10.8	32.0	57.2	40.3	33.9	50.6	5.7	18.1	21.2	26.5	28.6	21.5	16.7	20.2	26.3	28.3	19.3	16.5	21.8	7.0	27.8	24.9	29.2	30.0	18.7	20.4	22.7	19.6	22.1	22.8	19.7	20.3	19.2	19.6	19.3	19.3	21.7	10.4	16.0	7.8	55.8	12.0	6.0	14.4	28.2	18.8	24.6	3.8	6.7	6.2	2.8	17.2	12.9	18.8	33.1	14.5	4.7	13.7	15.0	14.3	8.6	10.3	12.4	5.3	6.3	87.7	16.7	20.4	12.0	10.2	8.3	10.8	12.6	6.8	5.2	17.5	21.9	63.3	5.5	18.3	3.1	5.0	8.4	14.3	9.1	7.2	33.7	10.1	25.0	3.1	69.4	130.0	16.1	2.0	17.0	13.9	7.0	2.3	7.8	9.2	20.0	6.6	16.7	17.0	24.2	28.7	10.9	5.1	54.7	15.5	18.8	4.8	10.1
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614641-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	6.9	5.6	8.8	7.5	9.3	12.2	9.2	9.4	8.8	12.2	8.8	9.8	5.9	11.5	9.7	7.9	10.6	5.2	6.4	8.4	9.4	7.7	6.2	9.7	10.8	9.4	8.8	14.8	7.3	6.6	10.3	8.5	8.4	9.1	6.9	11.7	9.2	7.3	12.6	10.2	9.6	7.2	8.6	10.2	8.7	6.0	9.6	11.2	9.8	5.9	11.1	9.1	9.9	11.9	4.6	2.9	23.2	11.7	10.0	7.8	9.4	6.5	7.7	8.6	7.8	8.1	10.9	12.6	4.5	6.0	7.6	4.5	14.1	7.0	8.6	5.0	7.0	22.2	10.1	12.3	7.0	15.7	10.7	7.6	9.6	5.4	4.5	9.0	7.5	18.0	20.0	11.3	7.7	4.5	23.3	27.0	16.1	9.1	4.8	17.8	8.5	5.9	8.2	6.8	16.6	8.3	5.7	4.9	5.7	13.6	9.3	16.0	9.4	5.6	3.9	4.0	6.2	8.4	4.0	16.1	5.1	14.9	6.1	5.2	6.6	6.5	4.5	5.2	4.4	5.5	4.9	4.2	6.4	5.6	6.4	5.0	9.0	5.5	4.4	4.4	4.2	7.5	8.8	9.3	9.4	8.8	8.4	9.4	9.4	8.8	8.4	8.6	9.6	11.9	45.7	19.2	27.6	4.9	67.6	92.2	114.0	86.2	46.1	42.6	54.9	65.8	19.5	38.6	55.2	22.0	16.7	114.5	69.9	25.9	84.1	61.6	11.6	31.2	47.3	63.9	44.3	93.2	5.1	53.8	167.8	57.9	19.4	35.5	59.1	78.4	52.5	31.5	93.9	33.7	5.8	41.2	65.1	74.1	103.0	20.4	56.5	61.7	60.5	5.6	115.4	58.9	94.7	9.5	8.9	57.2	47.4	47.0	33.0	110.2	33.6	58.8	40.6	35.1	32.9	50.5	74.7	76.0	100.5	46.0	93.5	134.6	61.3	62.7	47.5	104.6
MED31	"CGI-125, Soh1"	ENSG00000108590	"Mediator complex subunit 31"	Q9Y3C7	17	6643311-6651634	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035947	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035947: AB_10696646"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.87e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	12.1	22.4	17.2	9.3	19.3	9.9	14.4	17.2	26.4	13.2	17.6	9.6	8.7	11.2	26.5	25.0	12.8	12.5	15.6	18.3	19.7	16.6	18.2	11.0	14.8	17.1	17.8	12.8	9.7	13.1	25.3	9.7	18.6	12.5	8.5	10.8	12.8	8.9	14.4	21.1	10.3	12.4	17.5	16.5	10.9	17.5	19.4	13.7	14.7	10.6	14.7	14.2	14.4	17.1	37.7	41.2	36.4	23.2	32.5	27.4	13.1	28.8	29.5	43.6	56.6	20.6	19.2	5.0	35.6	14.3	32.3	40.5	29.2	35.7	37.7	27.1	48.9	9.3	34.5	32.3	24.4	10.5	18.8	15.2	37.8	39.6	13.4	23.2	32.8	20.0	16.5	9.4	32.2	13.7	20.2	27.4	13.0	16.9	23.5	15.0	16.2	13.6	36.7	18.4	14.5	16.0	14.8	11.8	33.1	17.2	12.3	11.5	14.8	21.3	18.6	27.1	29.2	8.5	11.9	12.8	29.4	12.4	15.4	77.7	22.6	38.6	26.0	16.4	24.7	22.7	24.2	25.7	19.9	23.7	21.5	23.1	63.3	23.7	20.0	25.6	31.2	20.2	17.2	19.3	17.2	26.4	18.3	19.7	17.1	17.8	18.6	17.5	19.4	17.1	34.1	16.0	22.9	13.4	37.0	106.9	48.3	92.3	68.3	8.4	38.0	35.3	4.8	37.1	47.6	33.1	10.4	40.8	29.1	23.1	54.8	36.4	34.2	78.8	31.9	35.7	12.6	30.5	32.7	31.5	40.3	31.5	15.3	38.6	26.6	21.4	39.3	57.1	33.7	13.5	24.6	23.1	59.0	23.9	37.9	62.5	44.4	25.1	40.9	12.2	29.3	22.9	21.6	18.1	21.9	46.4	15.3	26.4	34.4	51.0	22.4	81.8	97.2	12.8	39.5	29.7	33.7	101.9	81.3	46.6	120.2	47.9	37.5	35.6	19.3	66.6
MED4	"DRIP36, HSPC126, TRAP36, VDRIP"	ENSG00000136146	"Mediator complex subunit 4"	Q9NPJ6	13	48053323-48095131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006232	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA006232: AB_1079351"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.79e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.84e-1)"	44.2	34.1	26.5	34.0	26.0	78.6	46.7	33.6	35.1	37.2	25.2	41.3	40.6	40.3	43.5	41.1	31.2	32.9	49.4	26.5	26.7	38.4	51.4	36.9	46.7	25.7	25.5	31.9	27.4	43.2	31.4	45.6	27.0	36.7	46.4	41.4	33.6	38.5	57.7	39.9	41.1	43.2	25.7	35.9	33.9	55.9	26.2	63.7	41.1	58.4	55.5	43.4	35.8	28.4	40.2	25.8	86.1	47.8	55.8	71.4	59.5	57.1	70.9	66.8	47.1	49.3	66.9	65.2	16.0	60.5	41.3	59.6	63.1	54.2	86.7	85.0	51.9	85.6	49.5	77.6	51.7	128.1	76.4	49.6	75.2	39.7	58.2	65.2	63.1	64.8	61.9	40.7	75.5	40.6	121.3	121.4	85.4	128.2	33.5	87.4	58.3	52.9	87.0	61.7	38.0	61.2	46.5	57.8	63.4	55.5	49.3	94.6	51.1	37.5	43.4	47.0	52.7	39.2	61.7	100.2	32.2	65.9	72.6	105.0	65.5	106.3	74.6	70.0	82.6	65.4	84.2	76.6	64.5	58.0	80.4	77.0	69.8	86.6	74.3	58.5	101.6	91.2	26.5	26.0	33.6	35.1	26.5	26.7	25.7	25.5	27.0	25.7	26.2	28.4	71.3	96.1	53.4	12.7	71.1	91.3	72.8	164.9	34.7	51.5	48.1	42.9	100.8	60.1	116.5	57.0	16.7	116.4	96.0	51.7	152.6	79.4	87.9	46.4	69.8	73.8	26.9	106.9	24.7	63.4	104.4	74.1	31.6	60.5	98.1	43.9	59.3	66.8	70.3	37.0	20.1	51.2	124.1	51.9	65.4	185.6	76.7	51.2	78.2	14.0	136.6	65.2	102.0	20.1	20.4	66.8	67.4	77.5	46.5	69.7	66.1	100.1	62.8	50.2	52.6	58.7	78.7	141.4	162.8	48.6	97.3	134.9	79.4	61.1	56.9	71.5
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030764: AB_2673601, HPA069039: AB_2686070"	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	13.0	14.9	13.3	14.0	13.3	21.6	17.2	22.5	17.3	14.8	10.6	13.2	11.8	14.8	17.7	17.2	15.0	12.2	14.6	12.6	13.8	11.5	16.8	13.0	24.3	10.3	11.6	19.0	11.2	12.2	12.1	15.3	10.8	11.2	13.0	22.0	12.3	12.4	23.2	18.6	12.2	14.4	10.1	15.0	12.4	13.7	12.9	24.3	14.8	22.6	26.5	16.4	13.9	13.3	81.0	43.5	56.1	24.2	29.6	32.0	44.9	39.6	42.7	60.8	60.3	43.8	48.9	60.9	22.7	34.6	36.0	37.9	67.5	41.0	64.4	44.0	35.7	44.8	31.6	59.5	36.0	39.5	34.4	36.1	47.2	43.1	39.7	26.7	48.1	45.8	42.3	37.4	45.2	60.3	56.7	53.2	41.9	56.7	53.7	46.5	51.9	32.0	37.8	42.4	37.9	40.3	41.8	44.3	47.0	32.6	69.2	49.1	37.7	49.7	71.2	24.8	37.3	39.2	63.7	85.8	43.1	34.1	34.7	19.1	16.2	24.6	17.6	18.9	20.9	17.9	23.1	20.3	18.5	20.2	21.3	21.7	15.8	22.6	22.9	13.9	23.4	14.1	13.3	13.3	22.5	17.3	12.6	13.8	10.3	11.6	10.8	10.1	12.9	13.3	36.7	19.2	25.7	16.0	48.7	19.4	34.2	50.3	28.5	73.5	23.0	21.1	7.4	12.8	34.5	18.4	79.2	39.1	49.4	13.9	5.9	30.3	7.6	22.7	24.9	27.6	22.1	22.5	27.1	23.1	44.3	30.1	24.5	30.5	46.3	29.5	25.4	15.0	26.2	26.9	24.2	14.0	20.3	19.2	15.4	6.3	27.1	21.4	17.8	16.9	30.4	38.5	47.4	18.6	18.6	27.2	19.5	29.3	41.6	38.3	22.5	14.1	37.2	97.7	26.3	28.0	26.4	25.3	37.7	23.5	20.0	49.0	44.7	25.2	14.8	39.2
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	30.4	27.8	24.0	20.9	25.1	27.0	26.5	24.6	29.1	24.0	27.3	25.1	23.1	21.8	24.0	43.5	20.6	16.8	20.7	24.6	25.1	27.3	43.6	24.4	21.7	26.8	25.0	21.9	29.5	20.9	36.3	25.5	26.1	23.7	24.7	40.3	26.9	20.5	22.4	36.4	22.9	24.3	24.8	25.9	28.2	22.3	25.3	17.5	25.6	14.5	28.1	24.1	27.3	27.2	56.8	35.3	31.8	38.0	48.7	48.2	42.7	56.5	51.4	65.8	69.3	65.7	40.7	33.2	39.7	71.8	43.2	34.7	50.2	47.7	62.9	47.9	48.5	56.5	60.5	82.8	82.3	50.7	57.5	47.5	60.6	71.2	84.6	39.4	53.3	31.1	50.8	57.1	42.9	36.4	26.1	40.8	30.5	52.3	39.9	30.9	37.3	53.6	43.5	35.8	33.2	25.1	33.2	53.7	111.9	43.6	36.3	97.8	39.9	29.2	52.0	55.9	80.5	67.5	83.4	40.2	60.8	61.2	39.0	44.7	57.0	54.9	33.6	53.1	32.1	44.5	30.5	38.0	57.0	36.8	30.7	32.0	45.3	32.6	48.4	26.2	43.3	38.8	24.0	25.1	24.6	29.1	24.6	25.1	26.8	25.0	26.1	24.8	25.3	27.2	25.6	16.0	12.9	5.9	25.8	18.7	23.2	35.6	11.4	27.7	23.9	23.4	12.6	27.1	28.2	14.7	14.6	52.9	26.2	26.4	33.2	51.1	13.6	16.3	23.9	25.1	19.3	42.5	11.5	75.6	72.3	30.3	23.0	19.7	31.7	21.8	16.4	27.8	60.4	16.8	8.0	29.2	28.5	18.2	32.0	22.8	24.5	26.2	19.6	4.7	35.9	32.3	28.8	6.6	13.8	57.9	30.0	21.8	41.2	24.6	40.8	48.5	16.0	58.7	26.3	12.3	42.9	64.6	45.0	24.3	25.4	88.4	23.3	31.9	22.6	39.9
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476994-17493221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	9.3	14.9	21.6	4.9	23.0	10.6	10.3	20.6	28.0	12.4	19.2	11.3	8.2	12.1	11.9	10.2	8.6	4.6	32.7	22.5	21.0	20.4	23.6	7.3	6.8	21.8	22.1	9.4	10.0	18.3	12.8	5.7	20.6	11.8	7.4	9.9	12.9	8.5	27.3	14.2	9.4	5.8	20.9	10.4	12.4	10.9	22.3	11.6	13.8	41.5	6.7	8.8	9.4	21.8	12.0	15.0	12.7	13.7	10.0	9.0	11.0	9.6	11.9	14.5	13.0	22.0	5.9	14.7	10.8	9.9	8.8	15.3	16.3	13.2	13.5	9.6	26.3	9.0	10.0	15.9	10.8	7.2	7.5	14.6	12.3	12.2	12.5	10.8	10.0	21.3	10.7	6.7	9.7	10.1	32.7	14.9	11.7	24.8	15.4	24.8	28.7	9.8	13.0	8.4	8.2	13.0	12.6	9.8	21.7	47.6	11.6	9.3	6.8	10.6	12.3	18.6	15.3	12.4	9.9	8.2	13.3	12.5	11.5	2.6	7.0	11.8	9.3	9.5	12.3	9.9	9.7	9.7	7.7	9.1	10.2	11.4	2.3	10.7	12.4	12.5	10.2	7.8	21.6	23.0	20.6	28.0	22.5	21.0	21.8	22.1	20.6	20.9	22.3	21.8	6.0	3.2	4.4	10.1	5.8	4.6	8.9	5.5	5.2	25.9	8.2	6.7	19.6	10.0	5.0	9.2	14.6	8.6	8.1	9.1	11.7	6.6	8.7	6.0	6.3	6.0	15.7	4.2	14.4	4.5	5.8	5.6	11.7	8.8	0.0	14.5	7.5	5.5	6.1	16.8	12.9	9.6	8.2	4.4	2.8	8.9	5.6	4.0	1.8	1.9	4.7	24.1	10.3	14.1	6.5	3.3	5.7	9.4	7.2	8.4	9.5	6.1	4.0	25.0	0.0	6.0	6.9	10.9	29.9	5.6	4.8	9.6	6.6	13.4	8.1	9.0
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004499: AB_627921, HPA046597: AB_2679714"	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.93e-4)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	32.8	22.9	18.7	20.3	25.4	18.3	22.1	16.4	27.6	27.7	12.9	23.5	12.8	34.5	23.8	21.7	21.8	22.6	89.7	21.9	12.1	24.8	24.5	30.4	25.0	17.4	20.7	30.1	12.8	37.6	9.8	26.4	15.4	23.0	15.0	24.2	19.5	23.7	61.5	54.8	17.6	35.7	18.4	27.2	17.8	15.0	28.4	23.3	19.7	81.9	22.9	22.5	16.6	25.7	17.9	10.1	16.7	8.5	20.7	26.3	8.2	17.8	40.8	14.4	19.5	10.4	24.4	22.3	24.5	38.6	22.1	19.3	17.1	14.1	18.6	15.3	24.8	45.2	22.3	9.4	35.4	18.1	21.3	17.6	23.2	19.3	39.7	59.6	26.5	18.3	16.3	41.6	27.0	7.4	29.7	26.3	8.9	11.9	14.6	43.3	36.1	18.5	29.5	24.9	10.7	14.8	27.2	11.6	51.0	17.6	11.0	16.4	43.7	39.8	21.9	19.9	21.7	22.6	27.8	48.5	27.8	19.6	38.7	7.7	12.1	14.3	3.9	15.6	3.3	15.8	3.6	3.6	13.3	12.1	5.0	3.9	10.8	6.5	19.3	7.8	2.6	5.6	18.7	25.4	16.4	27.6	21.9	12.1	17.4	20.7	15.4	18.4	28.4	25.7	152.7	80.1	43.9	113.9	87.2	88.6	31.7	26.9	62.0	52.0	31.6	37.0	175.8	20.0	40.7	29.5	50.1	7.7	32.9	26.5	25.4	18.0	10.4	80.3	60.6	100.6	12.7	24.8	262.8	18.8	3.4	61.5	34.7	130.7	31.0	30.5	50.3	41.0	39.5	30.3	174.9	17.2	12.2	107.5	63.1	7.8	55.9	104.1	35.6	708.3	65.8	25.2	23.7	157.3	264.4	26.8	22.6	64.7	55.6	27.0	18.9	19.7	51.7	44.9	72.3	62.4	69.4	29.9	29.6	29.4	50.4	9.2	27.8	28.8	17.9	26.8
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145567-19192131	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 39.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"Daudi: 223.4;U-266/70: 217.6;U-698: 299.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	3.0	1.8	4.4	13.9	5.4	2.3	2.6	4.4	6.1	4.0	4.4	3.1	1.8	2.3	0.7	2.2	3.5	1.4	2.2	4.5	4.7	2.7	3.8	2.6	39.3	5.2	4.9	3.9	1.5	0.4	2.6	1.0	4.8	4.5	1.1	0.9	2.6	1.3	1.0	2.8	4.9	1.3	4.3	8.8	2.6	3.2	5.2	1.8	3.4	0.7	31.5	2.3	3.3	6.1	2.3	0.5	1.5	2.1	1.3	2.5	2.2	1.3	0.9	1.8	2.2	0.0	3.2	223.4	1.0	0.9	0.5	2.0	0.3	0.8	0.3	1.0	5.1	1.4	0.6	1.1	2.8	1.2	2.0	1.0	1.8	1.1	1.6	1.0	0.1	4.2	0.9	3.9	0.8	3.9	1.6	1.8	0.2	0.2	12.8	4.6	0.9	5.2	0.5	0.3	0.3	1.8	2.5	0.3	1.7	0.0	0.0	2.5	0.7	1.1	4.0	6.9	1.8	217.6	24.0	299.5	2.6	3.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	4.4	5.4	4.4	6.1	4.5	4.7	5.2	4.9	4.8	4.3	5.2	6.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500779	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 170.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	33.3	32.6	15.7	24.4	22.6	79.8	27.5	21.8	24.9	43.5	0.0	43.6	16.0	48.9	14.3	19.2	39.1	20.2	54.9	24.1	4.8	17.8	19.6	37.0	21.1	1.3	3.2	44.5	31.6	27.9	26.1	22.9	1.0	31.1	13.9	50.0	21.6	24.1	170.9	32.8	27.0	25.6	1.5	29.4	28.2	14.7	2.7	27.5	25.2	69.2	14.8	33.8	32.8	14.0	19.7	32.2	7.2	10.7	15.6	22.2	12.4	26.1	29.6	12.0	12.5	10.4	24.1	42.5	30.3	31.4	12.7	18.8	8.2	13.2	7.1	65.7	11.6	10.8	42.1	6.2	19.2	25.6	32.8	24.5	21.6	21.0	27.9	24.8	22.5	13.5	8.6	72.7	19.1	16.6	18.6	56.4	10.6	10.2	20.5	80.6	16.5	48.3	10.4	8.7	12.0	19.2	24.1	48.2	39.6	13.4	13.7	211.3	40.2	29.1	29.3	22.1	19.7	193.0	214.3	81.3	24.5	19.2	15.9	1.1	1.4	1.7	1.3	0.7	1.5	1.1	0.9	1.2	1.0	1.0	0.5	0.8	5.3	1.1	1.4	5.8	1.3	0.7	15.7	22.6	21.8	24.9	24.1	4.8	1.3	3.2	1.0	1.5	2.7	14.0	21.8	6.4	18.6	21.9	29.8	37.2	10.9	10.6	25.6	82.3	25.2	19.7	42.0	17.2	16.2	1.8	173.0	5.0	72.5	60.6	0.0	7.7	2.5	26.4	26.0	24.0	21.5	11.0	28.7	11.1	4.9	25.1	25.0	43.1	3.8	9.0	22.9	13.2	18.0	70.7	18.8	32.2	8.2	25.4	64.1	4.4	31.4	35.5	14.2	20.6	17.7	19.0	33.0	13.0	20.2	25.8	46.3	32.4	44.6	19.7	17.2	3.4	9.1	85.3	98.6	48.8	46.1	5.1	10.7	16.6	38.1	15.3	33.1	11.0	14.0	19.3
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3487951-3611508	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted to blood"	Yes	No		1700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	25.9	4.3	2.9	3.9	2.7	10.8	20.0	2.6	2.8	14.5	1.4	14.1	2.1	9.6	1.4	13.2	28.9	11.2	14.2	1.9	3.2	5.9	5.0	22.1	5.5	3.5	5.8	18.0	6.5	0.4	4.1	2.8	3.6	26.5	1.1	1.8	19.3	4.7	4.8	44.6	10.0	1.4	2.1	10.7	10.1	3.3	3.7	3.4	11.6	1.9	3.4	11.0	22.8	1.9	11.6	14.1	4.3	6.6	0.4	0.3	1.0	51.1	14.1	5.2	1.6	3.3	10.4	0.0	13.8	24.6	4.4	6.7	0.0	0.5	1.7	0.0	0.4	0.0	56.3	3.3	0.0	0.2	0.9	0.1	0.6	0.4	0.8	69.7	5.6	0.1	0.0	0.0	0.1	6.0	0.0	10.9	2.7	3.3	0.9	2.2	3.0	6.2	1.1	3.8	3.8	3.1	18.8	1.1	6.4	11.4	4.9	1.5	2.2	19.6	1.7	55.6	3.9	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.0	0.8	0.1	2.9	2.7	2.6	2.8	1.9	3.2	3.5	5.8	3.6	2.1	3.7	1.9	5.0	22.4	20.6	8.8	2.7	18.4	7.1	3.9	23.3	0.8	3.6	3.0	3.3	5.7	4.4	1.8	0.0	0.2	0.4	0.6	0.0	3.6	0.2	1.4	0.6	7.0	0.0	4.8	6.5	1.4	1.3	9.4	6.6	5.0	1.3	9.8	16.8	0.9	1.0	0.0	7.2	1.4	0.0	0.3	7.5	0.5	11.5	2.8	19.6	5.6	0.7	14.7	1.0	4.5	5.2	4.5	0.1	3.4	0.4	4.0	0.5	1.2	0.3	1.2	0.0	0.5	2.7	0.3	1.1	7.6	11.4	0.4	3.6	0.1	1.1	2.7
MEGF8	"C19orf49, EGFL4, FLJ22365, SBP1"	ENSG00000105429	"Multiple EGF like domains 8"	Q7Z7M0	19	42325609-42378769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 38.7;Cone photoreceptor cells: 77.2;Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049248	Approved					NA	NA		510000000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA049248: AB_2680691"	"unprognostic (5.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (6.03e-4)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.17e-7)"	"unprognostic (1.18e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	13.0	12.3	23.4	4.3	20.9	2.3	10.0	11.1	30.6	10.4	6.7	11.8	4.8	11.9	7.0	7.3	9.7	4.6	16.6	21.7	18.0	11.3	6.9	6.8	3.9	16.1	19.7	13.5	8.7	20.5	12.3	6.1	17.4	10.0	4.3	10.9	8.5	8.1	10.2	6.8	8.6	6.7	12.1	9.1	9.3	7.9	23.0	3.8	10.7	6.8	3.3	10.2	7.9	17.3	12.7	21.1	22.2	5.5	48.6	23.1	8.2	10.6	14.8	6.0	9.3	4.2	11.6	10.7	22.4	14.7	7.9	6.6	16.2	13.8	6.0	13.1	14.1	8.0	10.3	6.9	18.7	10.9	9.5	28.0	13.6	7.3	10.9	39.9	20.7	3.1	11.8	4.7	11.3	8.3	2.5	6.6	11.3	11.5	3.5	10.4	20.0	2.4	16.1	16.6	11.5	29.3	13.0	6.8	14.4	23.8	7.2	24.3	31.1	12.7	12.3	4.0	14.6	10.9	6.4	5.9	13.8	6.5	31.2	0.4	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.1	23.4	20.9	11.1	30.6	21.7	18.0	16.1	19.7	17.4	12.1	23.0	17.3	6.2	6.4	10.8	13.7	3.2	2.2	2.4	7.3	4.6	38.7	5.7	6.3	15.9	2.8	10.3	7.3	77.2	3.7	3.2	8.4	0.0	7.2	3.4	7.9	9.8	7.0	13.2	1.7	24.4	3.7	1.5	9.2	4.6	6.7	3.8	26.2	7.1	8.9	5.9	40.4	27.2	6.7	6.1	4.7	3.9	1.2	12.8	3.2	8.8	8.4	4.0	13.1	2.1	10.1	10.0	4.6	3.1	14.3	3.2	2.6	5.4	4.4	7.2	16.3	0.0	11.9	8.9	5.9	4.2	5.7	1.0	2.3	2.5	18.9	10.9	1.4
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600811-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 68.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.0;Cone photoreceptor cells: 212.7;Oligodendrocytes: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.2;monocytes: 7.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		96000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	18.1	10.1	24.1	11.5	28.7	18.8	13.6	28.7	26.1	12.0	4.8	7.2	7.0	6.3	5.6	14.0	14.0	8.5	6.4	26.0	34.4	13.5	38.7	20.3	6.5	37.2	33.6	9.7	5.6	11.5	5.3	5.1	27.3	8.7	6.0	68.2	7.7	6.6	7.3	21.5	7.2	8.9	28.2	15.2	8.0	3.3	34.0	5.6	28.4	8.5	6.2	9.7	7.4	37.3	5.0	19.4	16.7	5.2	22.6	13.9	5.3	5.0	4.4	1.3	1.8	1.1	2.9	18.6	7.4	4.8	6.0	21.2	24.1	8.7	3.6	15.2	6.9	2.5	34.1	8.1	9.6	7.5	15.3	6.5	26.1	8.2	6.6	46.0	11.8	9.9	6.0	8.6	13.9	14.4	14.8	2.7	0.7	11.1	5.2	11.2	18.6	7.9	34.0	16.1	16.4	13.9	6.0	4.8	14.7	2.7	14.5	7.5	13.9	5.0	2.8	18.4	7.7	15.5	19.5	6.0	7.0	8.7	28.8	0.6	7.4	5.1	0.8	2.5	0.3	0.4	0.7	0.6	3.0	0.4	0.6	0.5	25.2	0.5	4.5	0.2	0.7	1.9	24.1	28.7	28.7	26.1	26.0	34.4	37.2	33.6	27.3	28.2	34.0	37.3	6.5	86.6	65.0	143.0	8.4	27.4	5.6	8.4	25.0	31.5	30.3	12.8	28.2	14.3	15.6	23.9	212.7	0.5	10.8	7.5	0.0	4.0	0.9	11.8	5.8	7.6	6.6	18.9	85.9	5.4	1.9	10.3	14.3	19.3	7.0	8.4	10.0	48.0	5.8	13.5	63.8	4.7	16.2	45.2	13.9	2.7	11.5	41.3	26.6	22.5	107.2	30.9	13.4	93.0	240.7	13.8	8.6	11.7	11.5	8.3	7.4	6.6	6.1	75.4	13.1	26.5	9.3	14.8	7.3	41.3	43.9	1.2	11.4	4.8	5.5	6.2
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699503-41799456	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.4"	HPA049240	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favorable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	1.3	1.0	2.3	6.7	4.0	12.1	3.0	2.1	2.9	1.5	1.7	6.4	2.6	0.7	0.3	1.6	1.8	1.3	1.0	2.1	2.2	2.8	1.4	4.5	6.6	2.5	3.5	0.8	0.6	0.1	0.9	0.8	2.3	1.5	3.0	1.3	7.0	0.5	0.5	1.2	8.5	0.8	2.1	22.4	4.4	39.5	4.9	2.5	2.3	0.1	8.1	2.7	1.3	2.6	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.3	0.6	0.2	0.5	0.5	0.2	0.2	0.2	0.0	0.0	0.0	6.7	0.0	2.0	11.6	1.3	1.8	1.4	8.5	0.1	0.1	0.0	0.0	0.3	0.5	0.8	0.4	26.8	0.1	0.0	0.0	6.5	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	3.7	1.0	0.5	0.0	0.0	0.1	29.9	5.1	1.2	0.4	2.8	0.1	18.5	7.2	15.7	29.9	5.6	29.1	21.7	30.1	25.8	6.5	15.4	21.7	24.0	1.3	16.9	2.3	2.3	57.2	18.1	2.3	4.0	2.1	2.9	2.1	2.2	2.5	3.5	2.3	2.1	4.9	2.6	0.7	0.0	3.2	0.0	32.8	0.9	0.3	0.3	0.0	0.6	0.3	0.3	0.9	0.0	0.1	0.0	0.0	0.1	19.9	0.0	0.0	0.1	61.3	0.3	1.0	1.4	0.0	0.4	2.1	0.0	0.2	2.0	2.0	0.1	14.0	0.5	3.3	0.5	7.0	0.0	1.1	2.9	0.0	1.2	3.5	50.8	0.6	11.1	17.8	3.7	15.5	0.1	29.9	1.0	1.1	5.3	0.0	1.2	94.7	0.3	0.1	0.4	0.1	1.1	0.0	0.7	1.7	38.1	26.1	0.0	1.0	0.0	28.4	0.1	0.4	0.3
MEIOC	"C17orf104, FLJ35848"	ENSG00000180336	"Meiosis specific with coiled-coil domain"	A2RUB1	17	44656404-44690308	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 47.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 274.0;Late spermatids: 545.2;Spermatocytes: 242.4;Spermatogonia: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 16.9;HMC-1: 25.4;NTERA-2: 8.7;SiHa: 9.5;SuSa: 12.0;THP-1: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027266	Enhanced		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Cell Junctions"		"HPA027266: AB_1848900"	"unprognostic (5.82e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.83e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (8.89e-3)"	0.2	0.2	0.2	0.2	0.4	0.8	0.3	1.0	0.7	0.3	0.0	0.3	0.2	0.2	0.0	0.3	0.2	0.2	0.4	0.5	0.1	0.7	0.7	0.2	0.5	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.3	0.0	1.6	0.3	0.0	2.2	0.9	0.3	0.0	0.0	0.3	0.2	47.7	0.1	0.0	0.3	0.0	0.1	0.3	0.2	0.4	0.2	7.7	1.0	1.3	0.2	0.0	0.5	1.0	0.0	0.6	2.1	0.4	0.3	0.8	1.9	0.5	0.2	0.2	16.9	0.0	0.2	0.7	6.8	0.6	0.9	0.4	0.0	0.6	25.4	0.0	0.0	0.9	0.0	1.7	0.0	1.6	0.5	0.7	0.2	1.5	0.5	1.5	8.7	0.2	0.7	0.3	0.8	0.5	0.0	0.2	1.7	2.1	9.5	0.2	0.1	12.0	1.1	12.9	0.3	0.4	0.3	1.9	0.8	0.6	1.1	0.2	0.6	0.9	1.5	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.2	0.4	1.0	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.2	0.0	1.1	0.0	0.4	0.0	1.0	0.0	1.2	2.0	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.2	0.8	0.0	3.9	0.1	274.0	0.9	0.7	0.6	0.0	0.8	0.0	0.2	0.4	0.4	0.5	1.0	0.0	0.6	0.0	1.0	0.4	0.0	0.0	0.1	0.0	1.3	0.0	545.2	4.7	0.8	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	3.8	0.4	0.6	0.1	1.2	0.0	2.6	19.7	1.2	0.3	242.4	125.5	0.2	0.0	0.3	0.6	0.3	0.2	0.8
MEIOSIN	"BHMG1, HMGDC"	ENSG00000237452	"Meiosis initiator"	C9JSJ3	19	45733439-45764541	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"testis: 7.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Daudi: 1.5;K-562: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049521	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"		Nucleoplasm		"HPA049521: AB_2680803"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.08e-1)"	"unprognostic (6.53e-12)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.87e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	21.8	52.0	7.0	12.0	10.4	2.5	13.1	33.1	8.7	89.8	4.0	72.2	5.7	84.0	23.0	23.0	82.7	15.7	13.8	4.1	8.0	9.5	3.8	34.1	2.3	14.0	10.5	43.6	45.0	6.9	1.6	15.3	18.1	33.8	12.2	43.0	39.0	35.4	5.6	11.7	19.7	50.0	11.3	18.4	31.7	2.9	8.8	4.7	5.8	3.4	6.9	39.2	55.9	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.0	10.4	33.1	8.7	4.1	8.0	14.0	10.5	18.1	11.3	8.8	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 2.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 114.0;SH-SY5Y: 104.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 68.4;olfactory bulb: 177.4"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	11.1	21.9	14.4	5.3	50.4	0.0	7.4	11.7	24.9	20.9	0.6	33.2	20.6	37.0	4.1	14.2	23.3	17.8	15.7	16.0	14.7	11.1	6.9	8.4	3.4	19.2	25.7	21.1	13.4	3.5	16.4	8.6	20.0	37.7	6.4	18.8	56.8	21.6	0.7	4.4	8.3	36.3	18.0	7.6	14.1	1.6	11.8	11.1	5.4	9.5	3.4	25.6	13.5	20.3	13.3	12.0	15.3	43.6	16.7	20.6	3.6	28.3	15.6	32.9	18.4	17.2	10.8	7.6	0.7	114.0	20.8	22.4	26.9	7.2	18.1	10.9	17.3	58.8	15.8	13.9	28.6	17.5	57.2	27.3	6.3	22.3	6.6	43.2	19.1	2.8	20.1	0.1	6.4	14.3	0.1	6.7	0.2	15.8	3.9	0.0	11.1	4.1	0.0	25.7	11.9	104.0	10.8	7.1	8.0	16.5	3.4	13.3	27.3	37.6	4.6	10.1	12.1	7.5	8.1	14.6	44.3	9.7	9.6	2.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	50.4	11.7	24.9	16.0	14.7	19.2	25.7	20.0	18.0	11.8	20.3	6.5	0.0	7.3	522.3	3.4	17.5	97.3	14.1	79.1	43.8	21.0	16.3	23.9	77.2	11.4	1.8	254.4	23.3	1.0	1.0	0.0	58.4	15.2	10.5	17.1	67.2	1.8	5.3	164.7	27.1	10.0	61.7	25.5	0.8	63.3	14.9	207.4	9.6	3.4	3.3	5.0	0.4	30.5	6.5	6.1	7.4	47.8	1.1	8.8	21.5	0.6	10.7	0.0	262.4	219.7	25.7	0.3	41.3	1.8	38.3	1.4	0.1	26.5	135.9	32.9	14.7	46.4	3.6	3.1	23.8	6.1	4.5	2.3	31.2	1.0	54.1
MEIS3	"DKFZp547H236, MRG2"	ENSG00000105419	"Meis homeobox 3"	Q99687	19	47403124-47419527	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.3;endometrium 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Endometrial stromal cells: 23.5;Excitatory neurons: 39.1;Horizontal cells: 45.4;Late spermatids: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046699	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA046699: AB_2616456"	"unprognostic (3.27e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.49e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (9.29e-3)"	"unprognostic (9.21e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.80e-3)"	13.1	6.9	68.8	9.0	64.3	0.0	16.3	20.5	102.3	41.7	15.7	18.7	6.6	77.3	2.3	10.8	51.8	11.2	10.2	69.2	50.4	7.5	2.0	8.1	2.9	19.8	22.4	21.8	4.2	6.6	17.2	13.7	21.6	18.9	3.9	8.0	6.9	10.9	2.5	6.0	14.1	38.9	16.3	6.7	6.3	12.2	36.4	1.2	6.2	2.7	1.6	17.1	15.7	46.8	1.0	33.4	76.3	0.3	42.0	36.4	1.3	33.1	53.8	27.5	47.5	3.0	5.3	0.3	3.8	58.2	22.6	3.8	8.1	9.6	8.8	50.4	11.3	0.0	12.7	0.3	26.4	0.6	65.0	26.5	1.9	10.5	5.6	9.5	0.0	0.0	0.8	7.7	3.0	32.2	0.0	0.4	22.1	1.0	1.9	0.1	5.8	0.8	1.8	2.4	3.1	59.9	29.3	2.6	14.4	30.5	1.8	9.8	0.0	20.2	49.3	15.1	4.7	0.1	0.0	0.1	56.3	3.2	41.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.8	64.3	20.5	102.3	69.2	50.4	19.8	22.4	21.6	16.3	36.4	46.8	1.7	0.0	3.2	2.3	0.0	0.8	1.2	0.6	0.0	10.0	8.7	4.6	1.4	0.0	1.9	3.7	6.2	0.2	0.1	0.0	0.0	0.1	22.4	0.7	23.5	0.9	0.0	0.0	39.1	0.0	0.4	11.1	0.5	1.6	0.0	0.3	1.4	0.1	0.7	45.4	11.2	0.0	0.0	0.0	1.9	57.4	11.5	0.4	7.2	4.7	0.0	17.0	0.0	13.0	2.0	0.1	0.0	4.1	0.3	4.0	0.0	0.0	1.5	2.9	13.1	0.9	11.8	3.1	4.8	0.1	1.0	0.8	1.2	0.9	0.0	0.9
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 21.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017214	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	0.9	0.5	0.0	5.7	0.0	10.0	1.4	0.0	0.1	1.3	0.0	6.8	5.2	1.0	0.0	7.9	0.3	0.6	0.2	0.0	0.0	0.3	0.7	0.9	10.0	0.0	0.1	0.2	0.3	0.1	0.0	5.3	0.1	0.3	8.5	0.0	1.2	0.1	0.0	3.4	4.4	2.4	0.0	2.0	3.2	9.2	0.3	21.0	0.3	0.1	11.7	1.7	2.3	0.0	123.4	62.1	81.6	48.5	11.1	18.8	47.1	88.8	62.2	121.5	148.2	47.8	47.3	40.9	27.8	43.8	106.5	41.0	71.7	55.5	133.1	112.3	28.6	32.0	69.1	48.1	4.3	50.2	39.0	6.9	9.8	93.9	53.0	15.6	62.2	61.9	41.7	63.2	100.9	40.9	63.1	23.4	65.1	55.1	47.9	57.4	54.9	25.8	37.7	40.7	55.1	40.8	47.4	45.3	28.6	45.2	38.0	23.7	30.8	65.4	81.8	56.1	82.3	12.3	47.9	60.7	41.2	36.8	91.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.9	4.6	0.9	3.5	0.0	0.0	0.9	0.8	0.4	0.0	2.0	0.0	0.0	16.1	0.7	4.5	0.0	1.1	2.8	2.9	1.4	1.3	0.0	15.2	0.8	1.1	44.1	3.3	4.6	2.1	0.0	7.8	1.4	0.7	10.1	0.0	0.7	4.7	4.1	1.6	3.0	2.7	1.2	1.9	0.0	0.0	3.1	0.0	2.1	1.0	0.4	1.7	2.7	0.0	10.2	0.5	0.6	0.1	2.0	0.0	0.0	0.0	3.7	23.2	21.3	9.3	1.7	8.9	2.7	0.7	8.9	2.3
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029817	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1;salivary gland: 68.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 162.1;SK-MEL-30: 201.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	NA	NA		41000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	10.0	1.7	2.3	3.8	1.7	2.3	7.4	2.1	3.8	8.1	27.2	4.0	2.4	6.8	0.7	2.9	8.6	1.6	7.5	2.5	1.9	35.1	1.6	1.9	1.9	0.6	2.8	1.2	4.6	10.3	2.9	1.5	0.4	4.1	2.1	0.3	68.7	5.5	1.1	16.4	9.9	1.2	0.5	1.1	1.7	3.4	6.5	2.9	3.1	1.0	1.6	3.2	7.3	2.0	162.1	34.6	0.4	1.2	4.8	6.0	4.0	2.8	1.5	5.2	6.3	9.8	23.6	4.5	33.3	5.6	4.5	49.6	1.8	0.1	2.3	7.4	10.8	5.6	7.9	4.1	30.5	0.8	30.8	33.0	4.3	4.3	0.4	0.2	0.8	8.9	4.3	30.5	3.1	9.8	9.3	0.0	3.6	6.9	22.5	13.4	5.3	2.0	0.8	1.5	3.1	11.3	32.5	2.8	201.4	3.8	9.5	4.8	1.2	1.2	26.8	5.5	19.9	5.3	46.0	4.5	3.9	9.5	0.2	0.0	0.1	0.0	0.2	0.2	0.8	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	2.3	1.7	2.1	3.8	2.5	1.9	0.6	2.8	0.4	0.5	6.5	2.0	0.8	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	21.1	20.6	0.0	0.0	1.8	14.7	0.0	0.2	1.0	0.0	0.0	28.3	0.0	3.2	6.1	0.6	0.0	0.0	0.0	5.7	0.3	3.7	0.0	4.4	0.0	3.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	66.4	0.0	0.0	1.7	0.0	0.0	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0
MEMO1	"C2orf4, CGI-27, MEMO"	ENSG00000162959	"Mediator of cell motility 1"	Q9Y316	2	31865060-32011230	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 115.0;Inhibitory neurons: 111.2;Microglial cells: 100.2;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042603, HPA057952"	Approved		Approved	Vesicles		NA	NA		9100	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042603: AB_10806243, HPA057952: AB_2683562"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.94e-5)"	"unprognostic (1.02e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.95e-9)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.23e-2)"	17.2	23.7	15.0	23.2	13.7	45.7	14.7	14.0	14.1	15.1	9.9	17.5	16.7	14.4	16.7	33.6	13.1	13.4	36.3	13.4	13.7	16.4	35.9	13.9	31.9	14.2	14.2	10.7	17.3	14.6	11.9	20.6	13.9	14.2	20.7	11.7	16.8	13.6	58.8	19.2	16.7	19.5	13.4	20.3	17.3	62.2	14.4	31.5	12.5	36.5	34.2	26.3	19.3	16.8	87.7	37.4	40.5	37.8	34.8	49.4	73.0	73.6	45.7	41.1	31.5	51.0	48.2	92.4	23.2	50.6	54.2	43.4	48.4	63.9	54.0	61.8	26.4	67.0	22.8	62.7	48.6	67.7	53.7	37.2	40.7	40.6	40.7	46.7	65.1	21.8	49.0	41.4	72.2	38.3	81.5	137.8	60.0	74.9	46.2	54.4	46.0	71.4	81.8	83.6	34.2	63.3	38.0	90.7	59.2	33.9	38.2	80.4	61.0	57.0	63.4	45.8	82.1	42.8	69.8	79.7	51.7	96.1	45.7	1.8	16.6	17.1	7.5	23.4	5.7	9.6	9.2	9.0	24.4	7.5	6.6	6.5	13.4	12.6	27.9	9.1	17.1	10.1	15.0	13.7	14.0	14.1	13.4	13.7	14.2	14.2	13.9	13.4	14.4	16.8	6.7	6.4	13.3	70.8	19.1	27.8	17.2	10.3	17.6	15.3	10.6	6.3	4.7	12.8	9.3	11.0	16.7	13.3	9.0	8.3	1.9	4.9	3.6	5.2	9.1	11.3	13.1	18.3	115.0	2.6	10.5	9.6	11.2	8.7	10.1	10.2	14.3	14.0	10.1	11.8	111.2	7.0	8.2	19.2	18.4	3.0	13.1	15.2	12.4	100.2	21.8	4.6	14.4	106.1	134.4	7.5	8.3	8.6	11.2	19.7	8.5	2.4	8.8	10.5	6.6	12.5	6.0	12.2	6.4	26.9	16.6	16.6	12.8	7.9	10.4	16.8
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	15.1	24.2	13.1	8.4	13.7	6.5	15.7	12.7	15.0	19.3	13.0	16.8	7.8	17.4	8.1	23.9	16.3	5.5	12.4	14.3	12.7	19.4	30.3	16.1	10.9	12.5	12.5	20.8	26.2	6.3	21.7	7.8	12.6	20.2	4.7	4.7	21.3	7.7	11.0	24.0	20.9	5.3	11.9	25.5	20.6	16.3	13.5	17.1	24.5	5.8	10.2	16.4	18.7	12.9	30.8	33.7	22.4	37.7	30.4	17.4	24.8	19.2	23.3	35.6	21.2	19.0	25.5	43.6	33.8	16.7	29.8	39.0	36.4	28.3	19.3	30.5	48.1	35.6	17.3	30.9	27.2	23.6	22.8	19.2	18.2	26.8	21.9	16.5	33.7	49.3	51.5	15.7	18.9	54.2	60.3	29.3	36.7	30.3	54.7	45.1	29.8	44.1	23.2	22.8	33.6	28.9	26.0	36.9	27.9	16.5	56.6	27.1	17.4	23.5	28.8	36.5	16.7	21.8	30.4	22.1	25.5	16.2	21.0	0.5	0.5	1.4	1.5	0.6	1.8	1.8	1.1	1.9	0.6	1.8	1.9	0.9	0.1	0.9	0.2	1.3	0.9	0.5	13.1	13.7	12.7	15.0	14.3	12.7	12.5	12.5	12.6	11.9	13.5	12.9	6.9	3.2	5.4	5.9	10.6	5.7	4.6	5.3	7.4	8.5	10.2	11.0	4.5	4.3	2.8	3.7	6.2	19.4	8.0	9.2	3.9	8.9	0.9	7.9	11.0	7.0	4.2	10.8	7.4	7.1	21.7	6.9	13.7	12.1	1.3	14.1	7.9	10.9	9.0	3.3	6.2	9.0	6.1	3.1	2.3	0.9	12.2	4.8	8.8	8.4	6.3	7.7	6.2	4.5	5.0	7.5	10.7	3.8	8.4	6.1	9.3	8.0	4.0	6.5	13.1	5.4	5.6	14.2	13.0	9.4	7.0	16.3	8.9	14.3	10.2	3.3
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MEOX2	"GAX, MOX2"	ENSG00000106511	"Mesenchyme homeobox 2"	P50222	7	15611212-15686683	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.9;placenta: 42.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 84.7;Endothelial cells: 37.2;Leydig cells: 40.4;Peritubular cells: 25.2;Sertoli cells: 26.3;Smooth muscle cells: 27.0"	"Cancer enriched"	"Detected in many"	8	"glioma: 15.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 248.8;U-138 MG: 62.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"medulla oblongata: 3.5;spinal cord: 9.5"	HPA053793	Enhanced					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA053793: AB_2682264"	"unprognostic (1.10e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.82e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-5)"	"unprognostic (3.67e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.46e-4)"	37.9	1.1	0.6	2.9	0.3	0.0	26.2	0.3	0.7	4.3	0.2	5.7	0.4	2.9	2.4	2.4	5.0	6.1	11.8	0.3	0.7	0.5	0.7	12.9	9.1	2.2	0.9	2.4	1.6	1.2	1.2	42.1	1.0	1.9	1.9	0.2	4.4	1.5	9.9	6.9	2.2	4.5	0.7	0.9	2.3	2.3	1.0	3.3	8.6	13.3	5.3	6.1	4.8	0.5	0.0	0.0	0.0	248.8	2.4	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	62.9	0.0	25.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.7	0.3	0.7	2.2	0.9	1.0	0.7	1.0	0.5	84.7	0.0	0.5	0.7	0.3	8.2	0.0	0.0	0.6	0.0	0.5	1.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	37.2	0.0	0.0	3.8	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	3.7	0.0	0.0	0.0	9.6	0.2	40.4	0.3	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	25.2	0.0	0.1	0.0	0.0	0.0	0.0	26.3	1.5	27.0	0.1	0.1	0.1	7.0	0.1	0.8	0.7	0.0	0.0
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793389-46839778	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"intestine: 467.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2"									"CAB025163, HPA029416"	Enhanced					NA	NA		2100000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.2	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	115.6	269.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	4.2	0.0	0.0	0.5	0.1	0.1	102.5	0.0	0.0	0.2	0.0	0.0	467.7	2.6	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	309.4	0.0	0.0	7.7	0.1	0.0	0.0	15.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	87.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.0	156.9	0.4	0.0	0.0	902.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	45.8	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"intestine: 363.9"	"Cell type enriched"	"Detected in some"	42	"Proximal enterocytes: 231.8"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		310000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 45: Enterocytes - Digestion"			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.3	0.0	0.0	8.2	249.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	363.9	0.3	0.1	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.9	0.0	3.8	0.0	0.1	0.2	231.8	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.1
MEPCE	"BCDIN3, FLJ20257"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434118	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	26.4	41.0	27.5	19.4	28.3	28.3	24.2	30.4	31.5	26.1	23.6	25.8	18.5	28.8	27.8	27.5	27.0	19.4	26.8	26.7	27.0	37.0	36.9	21.9	29.0	27.6	27.3	36.0	22.5	35.0	23.6	20.9	27.4	26.5	12.9	9.9	24.9	20.7	38.5	34.5	27.2	18.0	26.8	56.6	24.6	79.8	28.0	28.1	36.5	31.5	24.2	28.3	21.9	28.2	42.6	53.6	38.9	41.9	36.8	36.7	29.1	46.4	66.5	48.7	37.4	43.8	60.1	87.1	75.5	29.1	38.5	38.4	43.0	34.9	32.0	39.4	49.4	45.1	41.5	33.3	30.9	58.0	53.0	38.2	40.9	55.7	70.0	26.5	41.1	27.4	90.6	62.2	47.2	155.6	66.3	129.8	72.1	35.0	58.9	53.0	31.5	79.1	32.7	25.6	58.5	50.6	72.5	139.1	49.1	19.3	35.6	52.1	36.2	81.5	63.5	55.9	62.0	41.0	42.4	96.3	45.8	71.1	72.9	2.6	2.6	3.7	3.8	2.3	4.6	6.2	4.4	4.2	3.3	6.6	6.2	5.5	6.4	5.9	1.9	6.3	4.5	7.5	27.5	28.3	30.4	31.5	26.7	27.0	27.6	27.3	27.4	26.8	28.0	28.2	34.2	9.6	18.9	5.5	33.8	30.2	17.3	7.1	19.9	9.9	30.2	21.6	25.6	20.0	7.8	22.0	8.4	15.8	34.3	32.2	15.6	10.3	29.6	18.3	13.1	21.7	10.7	9.9	2.8	12.0	8.5	17.3	54.6	18.8	18.3	14.5	28.9	22.1	12.7	11.8	2.6	26.1	8.2	26.7	16.9	66.5	17.4	32.9	8.8	7.5	18.1	19.4	15.5	2.5	2.7	10.4	23.6	15.4	14.9	15.6	39.9	14.4	10.4	9.5	6.6	35.0	17.9	44.8	15.1	22.3	25.1	21.2	25.0	19.5	20.3	9.9
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	107	"brain: 10.6"	"Cell type enriched"	"Detected in single"	18	"Inhibitory neurons: 12.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		810000		"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.0	0.0	4.6	0.0	1.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	0.0	10.6	0.9	4.0	0.3	0.0	0.9	0.2	0.1	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	14.4	17.4	11.9	13.7	13.6	5.4	13.9	13.7	13.0	17.8	14.6	14.6	12.8	11.3	42.7	14.6	12.4	11.5	12.8	11.7	14.2	14.4	20.6	14.1	14.0	13.4	13.1	17.4	19.2	14.0	17.8	26.9	13.8	18.2	14.5	10.4	18.4	14.3	7.7	10.9	12.7	11.1	13.4	13.8	15.3	9.8	13.8	14.2	33.7	10.6	13.2	15.4	14.4	15.0	26.8	40.2	34.6	22.3	57.1	32.4	54.0	40.0	47.4	42.7	51.6	36.0	72.9	22.4	45.4	32.3	45.1	43.8	54.1	41.1	40.3	50.2	35.5	28.3	33.0	61.9	43.7	33.8	30.0	33.9	46.6	36.1	42.4	35.7	41.1	27.0	34.7	55.5	36.7	34.0	20.9	28.3	41.9	39.3	16.4	31.7	21.3	59.7	35.6	36.3	29.9	17.6	43.9	29.3	70.0	62.4	34.0	26.8	32.4	40.9	39.1	22.1	52.2	35.0	48.0	30.2	38.5	59.7	43.8	39.4	26.1	19.1	35.6	24.9	41.8	34.5	37.2	35.4	27.2	35.4	34.6	34.7	8.1	44.8	22.5	45.2	42.5	31.1	11.9	13.6	13.7	13.0	11.7	14.2	13.4	13.1	13.8	13.4	13.8	15.0	59.7	80.1	59.6	0.0	20.6	0.0	0.0	0.0	0.0	0.0	51.0	44.2	0.0	0.0	27.9	58.8	0.0	341.4	41.6	0.0	13.7	100.9	0.0	41.4	79.4	36.9	0.0	0.0	0.0	111.9	279.3	48.4	0.0	69.8	36.6	56.4	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	86.3	0.0	0.0	0.0	0.0	82.5	0.0	0.0	18.8	0.0	0.0	48.8	43.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	436.0	25.8	63.6	0.0	0.0
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 7.5;hippocampal formation: 6.6;midbrain: 2.5;pons: 4.9;white matter: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 203.8;CAPAN-2: 219.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	100000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	10.3	0.8	0.1	3.4	0.6	7.4	8.9	0.1	7.5	13.1	9.6	9.7	6.5	6.4	2.5	6.1	4.7	11.9	6.2	6.6	0.8	20.1	42.9	20.3	2.3	1.1	2.5	0.8	6.6	0.8	3.8	26.4	4.9	6.7	9.3	3.9	8.7	11.2	14.3	7.7	8.2	5.7	0.3	6.0	15.4	0.5	0.5	3.7	17.6	11.0	3.2	18.4	4.4	7.8	203.8	115.3	0.1	0.6	8.6	8.7	7.9	113.7	48.2	60.3	51.1	25.0	219.0	8.4	179.0	72.1	163.3	51.8	19.7	110.0	123.7	0.3	23.4	0.1	112.5	21.4	1.5	0.3	0.2	11.4	42.4	40.6	129.1	109.4	42.4	0.2	4.5	0.8	114.1	5.0	0.1	0.1	17.3	32.9	113.0	0.2	95.3	0.2	105.8	24.0	16.5	0.0	45.4	15.4	44.9	19.8	0.4	0.9	72.3	89.7	30.6	46.7	88.9	2.5	19.1	1.5	99.3	0.3	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	7.5	6.6	0.8	1.1	2.5	4.9	0.3	0.5	7.8	32.6	28.9	103.6	0.3	1.0	39.0	70.5	58.1	38.1	6.7	6.5	6.9	12.3	11.5	99.8	31.3	0.0	76.0	0.4	20.5	0.0	38.5	0.0	52.5	11.6	20.1	7.2	0.0	2.6	46.9	7.5	7.4	32.6	161.4	0.0	0.0	3.9	30.5	7.0	0.0	1.0	20.5	18.3	1.3	2.2	0.1	0.6	4.4	3.6	1.9	1.0	7.6	0.0	0.5	7.7	93.9	5.5	0.0	0.4	149.3	11.2	15.6	34.5	0.3	0.0	37.8	5.2	0.0	0.6	7.9	17.8	21.8	1.2	0.0	16.4	128.6
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999943-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.5;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299, HPA077742"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421, HPA077742: "	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	4.4	4.9	4.3	2.4	4.5	3.5	3.9	3.7	5.0	5.4	3.7	4.6	2.3	4.5	2.8	3.4	6.7	2.0	4.8	4.1	5.1	4.5	6.0	2.3	2.8	4.1	4.1	11.9	8.1	2.2	4.3	1.8	4.6	5.6	3.2	2.5	4.1	3.7	7.8	3.4	4.1	2.8	3.6	5.8	4.6	2.8	4.3	1.2	3.6	5.6	2.0	4.2	3.8	5.0	3.6	2.8	4.1	13.5	5.9	7.7	8.3	4.1	4.1	6.4	4.1	6.4	4.7	1.8	7.2	4.3	6.6	6.4	9.1	7.2	6.5	6.3	10.6	10.2	7.8	8.6	6.2	6.1	2.6	5.8	10.9	6.4	10.2	5.5	3.6	6.9	14.8	5.1	4.9	4.4	3.5	8.2	7.4	10.4	3.4	7.7	3.5	3.3	4.5	5.0	8.4	3.2	2.9	5.8	10.2	3.6	6.7	8.1	4.4	8.1	6.4	5.0	4.0	6.3	6.1	4.0	5.8	11.9	7.9	0.0	0.0	0.0	0.4	0.4	0.2	0.3	0.5	0.2	0.1	0.7	0.5	1.1	0.0	0.4	0.0	0.0	0.4	0.2	4.3	4.5	3.7	5.0	4.1	5.1	4.1	4.1	4.6	3.6	4.3	5.0	6.1	0.0	4.6	23.8	15.4	5.6	10.3	7.5	22.8	5.8	9.2	8.9	4.5	7.2	3.5	3.7	2.1	4.1	2.7	1.3	7.9	2.5	1.2	2.7	14.7	5.4	0.0	16.8	19.6	3.5	4.7	10.9	8.2	2.5	4.5	17.9	6.4	6.4	3.9	5.0	39.5	2.9	2.0	2.5	2.2	2.3	33.5	2.2	5.4	14.0	1.0	3.7	9.2	35.7	35.5	1.4	1.3	26.4	9.9	4.3	0.6	5.7	2.0	6.1	13.1	18.1	9.5	9.8	12.2	11.6	5.7	1.9	7.5	14.5	5.7	5.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		70000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	52.5	58.0	41.1	51.6	44.5	102.2	55.0	45.0	53.2	46.0	39.7	50.7	36.7	54.2	52.6	54.7	42.6	47.0	65.9	40.2	49.9	55.6	84.5	49.0	78.0	46.5	43.8	60.5	52.7	52.3	36.6	51.3	48.8	43.3	50.9	30.8	40.6	101.0	119.5	58.3	37.7	54.9	42.4	40.3	37.4	61.8	44.7	69.1	51.8	78.7	125.0	62.2	41.5	50.2	192.3	157.8	163.7	129.6	98.4	156.4	125.9	186.0	127.6	177.7	125.7	228.0	88.6	542.1	113.5	133.4	101.9	120.5	187.4	142.4	203.8	131.2	161.2	244.9	113.7	165.6	104.5	313.5	117.1	137.5	148.1	164.9	164.0	210.7	192.9	184.2	321.8	60.5	135.3	125.8	230.3	213.0	204.5	109.4	233.4	179.6	141.5	178.5	123.5	198.3	127.0	165.3	166.0	132.7	169.0	140.6	159.4	146.5	165.1	100.7	98.5	115.0	195.7	87.7	246.8	585.1	58.1	173.7	129.9	77.5	70.5	32.0	60.0	52.2	74.3	114.2	66.8	67.8	66.0	101.8	79.2	74.1	3.4	72.8	65.6	85.3	71.6	46.4	41.1	44.5	45.0	53.2	40.2	49.9	46.5	43.8	48.8	42.4	44.7	50.2	87.0	282.0	238.9	22.9	101.3	233.2	130.2	141.3	97.3	70.6	119.7	95.9	143.6	100.1	133.3	290.6	66.7	146.2	87.7	96.8	164.4	115.2	189.5	114.9	260.0	110.2	91.7	278.4	35.1	145.8	161.5	112.2	53.0	153.7	122.9	140.5	112.1	314.6	98.1	75.7	49.5	119.7	73.2	141.0	89.8	123.3	100.3	83.8	92.5	20.6	103.5	72.6	81.4	26.2	41.4	130.1	105.8	106.8	87.0	108.1	93.4	186.6	92.4	83.8	98.6	137.4	133.4	378.4	207.6	95.2	215.0	172.0	80.7	101.4	144.8	110.5
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715118-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 299.3;choroid plexus: 238.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 1153.9"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5"	"Region enhanced"	"Detected in all"		"cerebellum: 612.9"					HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	16.1	36.3	238.0	4.0	233.8	1.5	14.1	203.7	299.3	15.5	238.6	30.7	4.1	17.3	3.0	10.4	37.0	2.5	56.8	209.7	210.3	29.2	49.9	16.8	2.1	258.1	239.0	5.2	46.1	5.5	88.0	3.7	208.5	25.4	1.2	3.0	25.2	13.1	23.3	11.9	12.0	2.9	244.4	12.3	22.2	15.3	258.3	2.4	30.6	5.1	1.8	20.5	11.3	237.4	8.9	73.4	14.2	72.4	24.6	13.8	22.9	17.5	8.7	6.9	4.4	11.0	21.5	1.5	39.6	12.4	26.3	32.6	2.1	17.0	1.1	4.7	32.0	2.9	13.3	57.1	15.1	6.5	9.2	33.3	18.3	2.1	4.2	21.3	2.3	20.3	5.3	1.7	5.2	178.2	2.4	22.0	5.2	9.8	133.1	24.3	16.4	24.4	18.4	2.6	22.5	28.5	6.9	18.9	93.5	1.6	28.6	12.6	8.0	19.4	36.8	22.7	15.4	11.0	3.3	1.7	30.3	4.8	46.6	0.0	0.1	0.2	0.8	0.3	0.5	1.2	0.4	0.8	0.0	0.1	0.2	0.5	0.0	0.5	0.3	0.2	1.0	0.1	238.0	233.8	203.7	299.3	209.7	210.3	258.1	239.0	208.5	244.4	258.3	237.4	46.7	0.0	2.2	91.4	8.5	3.8	17.1	3.3	0.0	45.5	79.5	75.8	16.3	48.6	1.8	16.5	14.6	0.6	26.7	29.0	50.9	8.4	8.0	230.7	54.8	21.5	27.4	2.7	6.6	5.1	2.1	15.1	5.6	14.4	0.0	2.7	20.0	39.5	6.4	70.7	5.7	10.7	2.0	7.8	6.5	25.8	11.1	6.6	10.6	8.4	1.1	1153.9	23.7	44.2	57.6	5.3	26.7	9.4	7.9	27.7	6.2	55.6	9.5	37.9	26.3	11.8	26.7	4.6	11.7	1.4	3.0	0.4	12.7	5.2	9.2	16.2
METRNL		ENSG00000176845	"Meteorin like, glial cell differentiation regulator"	Q641Q3	17	83079609-83095122	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 252.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 640.2;Macrophages: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 119.5;U-2197: 162.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023792	Uncertain				"Secreted to blood"	NA	NA	445000	1300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA023792: AB_2144182"	"unprognostic (7.99e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.41e-3)"	"unprognostic (7.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-2)"	105.4	24.0	7.8	13.2	6.9	21.9	66.8	6.7	8.9	89.0	33.4	57.0	26.6	33.8	2.1	184.1	39.3	12.2	95.8	7.2	6.8	71.4	19.1	80.3	5.1	9.6	9.7	23.0	24.4	25.1	36.5	14.5	7.8	26.4	4.1	3.4	52.9	3.7	15.3	252.9	50.0	4.3	7.3	41.0	41.1	32.4	15.1	3.2	61.3	1.5	4.7	47.4	103.4	6.7	11.4	0.3	5.4	7.3	5.9	21.8	26.7	11.7	5.1	8.4	9.6	1.4	7.8	0.7	4.6	9.1	6.4	29.8	1.9	0.7	5.6	8.6	4.4	26.8	32.0	3.3	14.1	7.8	49.5	10.5	2.2	36.1	2.4	5.3	4.2	0.0	17.1	0.0	7.2	19.0	0.7	23.9	1.1	16.6	16.6	8.2	11.4	3.9	1.3	4.3	0.5	3.6	16.0	29.5	14.2	5.3	27.3	8.2	10.9	119.5	12.5	162.6	3.6	0.0	0.0	0.4	28.1	3.1	7.5	6.8	3.2	10.5	1.8	6.0	0.1	1.4	0.3	1.3	4.5	0.1	0.0	0.5	5.5	3.2	8.1	1.7	1.8	1.5	7.8	6.9	6.7	8.9	7.2	6.8	9.6	9.7	7.8	7.3	15.1	6.7	39.0	25.6	31.1	6.5	28.0	22.9	19.9	4.7	1.2	3.3	19.7	16.5	40.5	14.3	12.3	49.7	6.2	12.4	640.2	110.2	3.9	11.5	9.5	72.6	27.1	16.8	6.0	3.2	0.7	13.9	5.1	56.1	18.3	103.4	32.9	41.5	25.0	1.0	53.8	1.7	2.1	41.4	6.1	62.2	133.6	1.5	7.8	162.0	16.0	1.9	13.7	90.6	25.7	4.0	0.3	19.7	64.9	3.4	95.8	18.4	53.4	8.3	7.4	22.2	0.0	75.4	35.5	5.9	3.4	13.5	49.2	19.2	98.8	0.5	35.1	62.2
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772119	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	13.6	23.2	8.9	9.8	9.2	11.0	12.8	8.7	11.9	9.8	9.9	8.4	4.0	10.8	20.8	13.1	10.2	5.5	10.3	9.2	9.4	22.0	17.5	9.3	8.1	9.2	9.3	11.3	28.0	9.1	12.7	8.7	9.0	13.4	10.8	3.7	10.6	7.1	15.5	11.7	6.9	12.3	8.9	9.0	9.8	9.9	9.6	4.8	14.3	6.9	9.3	16.5	9.4	9.0	24.7	44.1	17.7	14.9	22.6	15.7	23.4	24.8	23.1	41.9	24.7	32.0	32.6	28.8	45.7	33.0	23.1	27.9	27.4	39.8	38.0	17.2	32.6	34.9	17.4	35.0	17.9	39.0	17.4	14.7	32.7	47.8	33.5	18.9	22.2	17.8	34.1	28.2	23.1	47.0	26.1	39.6	40.6	29.1	41.5	23.0	293.1	43.1	33.6	29.8	18.7	16.2	26.9	29.6	22.9	16.0	38.5	32.0	17.1	17.4	18.0	29.6	34.0	13.2	9.3	32.6	24.4	25.3	34.5	0.0	7.1	0.0	8.0	10.8	27.4	6.9	10.0	9.6	16.3	10.5	13.4	13.2	1.1	12.9	1.8	19.3	5.1	7.5	8.9	9.2	8.7	11.9	9.2	9.4	9.2	9.3	9.0	8.9	9.6	9.0	6.3	9.6	3.3	0.7	8.3	10.5	17.1	14.8	13.6	3.7	12.2	12.4	4.3	10.0	14.1	5.5	0.0	18.7	3.1	6.3	25.4	16.8	12.1	5.3	13.2	8.2	6.6	6.3	0.8	24.1	25.3	11.3	10.2	8.9	12.7	8.7	3.3	7.9	22.7	3.3	0.6	8.4	12.2	2.2	9.8	10.9	11.1	6.4	7.2	0.0	16.7	2.6	3.1	3.5	1.1	12.3	2.3	4.9	14.9	15.4	1.1	60.4	2.6	5.4	0.0	9.7	13.0	8.0	17.7	12.1	10.4	9.7	4.1	14.0	10.7	11.3
METTL11B	"C1orf184, HOMT1B"	ENSG00000203740	"Methyltransferase like 11B"	Q5VVY1	1	170145959-170168866	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 1.7;skeletal muscle: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"NTERA-2: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028049	Uncertain					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"				"HPA028049: AB_10610139"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.62e-2)"		"unprognostic (7.59e-2)"	"unprognostic (7.25e-2)"		"unprognostic (1.19e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.76e-3)"			"unprognostic (5.43e-2)"	"unprognostic (4.56e-1)"		"unprognostic (5.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	6.8	6.2	4.4	6.6	6.2	8.8	7.8	5.1	5.2	7.2	4.3	6.0	5.3	9.5	5.7	5.9	9.1	4.9	7.2	4.0	4.4	6.3	3.8	7.0	8.3	4.7	5.2	12.3	7.5	10.1	4.5	4.2	4.9	7.4	5.8	7.7	6.6	7.0	6.6	6.4	5.2	8.5	5.0	6.9	4.7	5.4	4.8	10.4	9.3	7.4	8.3	6.4	5.3	7.9	9.0	25.3	12.7	12.9	9.7	12.1	12.3	11.8	9.6	12.4	10.3	34.5	6.1	28.1	11.9	10.1	13.3	12.5	30.2	15.3	16.8	11.0	20.7	14.2	21.2	16.0	10.8	13.3	11.0	10.2	14.0	17.3	24.9	8.5	13.0	16.1	19.1	14.8	8.4	11.0	19.1	7.8	14.9	10.9	10.1	31.8	13.8	12.7	9.2	8.3	6.8	11.4	16.7	9.3	9.0	13.5	11.9	8.6	10.2	11.6	7.3	16.3	16.3	8.3	11.3	19.4	15.5	11.1	15.8	1.6	2.1	0.8	3.5	1.4	4.4	3.5	3.3	3.4	1.5	2.9	4.9	3.7	0.0	1.3	1.0	2.0	2.3	1.4	4.4	6.2	5.1	5.2	4.0	4.4	4.7	5.2	4.9	5.0	4.8	7.9	17.5	12.8	33.5	19.2	25.7	11.5	21.4	12.6	9.6	28.7	14.9	14.1	15.8	15.7	25.8	7.3	45.9	8.9	19.3	11.8	13.7	9.9	20.8	18.8	21.7	13.9	20.4	6.3	20.9	10.8	9.1	18.9	15.3	15.0	24.7	25.5	17.5	9.2	10.4	26.9	21.6	13.7	10.2	10.0	5.9	7.6	14.9	11.6	8.8	17.8	13.7	20.2	30.9	23.6	42.2	9.7	6.3	12.8	14.5	20.1	23.2	9.0	26.3	37.4	6.6	28.0	21.3	11.8	16.7	14.7	12.8	6.0	25.5	28.7	16.8	17.0
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794963	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	5.6	5.3	5.4	6.2	5.7	4.0	10.5	6.5	6.8	5.8	5.7	6.5	5.2	6.0	8.7	5.2	7.5	4.8	6.1	5.0	5.5	7.4	6.2	5.5	14.1	5.4	5.5	9.2	4.9	22.4	3.4	6.0	5.7	6.8	6.2	7.3	6.3	5.9	4.3	6.2	6.0	5.0	5.8	8.8	7.3	6.5	5.5	10.3	9.0	6.9	11.6	5.6	3.8	6.7	13.0	7.5	11.6	8.3	6.6	12.2	8.6	5.9	6.9	7.8	6.6	9.6	20.7	22.2	16.2	7.7	10.8	14.5	11.5	13.6	9.9	14.0	9.9	15.9	6.6	8.0	13.7	16.9	7.2	5.6	14.2	7.5	8.1	7.6	14.2	16.8	17.1	10.8	10.1	6.3	18.0	11.1	14.9	27.7	18.7	13.0	12.0	16.8	11.7	12.9	8.6	13.4	13.2	14.4	18.2	17.1	19.3	18.1	6.7	9.3	9.0	9.9	13.8	19.8	27.6	29.9	7.1	13.4	9.9	18.2	9.5	23.1	24.8	10.6	31.7	21.6	27.1	28.8	10.0	24.2	31.8	30.9	5.5	24.0	6.6	7.7	34.5	18.3	5.4	5.7	6.5	6.8	5.0	5.5	5.4	5.5	5.7	5.8	5.5	6.7	5.8	3.2	4.6	1.0	9.5	1.5	6.1	10.8	1.8	7.4	4.6	5.2	5.0	2.8	8.5	5.5	0.0	13.7	4.5	3.7	25.4	12.1	16.9	3.7	5.1	8.3	3.0	8.6	1.4	8.0	5.5	5.5	2.0	2.8	7.0	13.4	7.5	2.9	7.7	6.7	1.9	3.6	10.2	5.9	3.2	5.4	6.2	3.7	5.4	2.8	2.6	12.0	14.4	1.5	4.0	5.3	5.7	5.3	2.5	3.1	5.7	11.6	10.9	8.5	0.0	6.1	6.5	16.7	10.2	2.4	0.9	11.5	10.1	10.0	5.5	4.2
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	11.1	9.0	18.9	10.8	20.3	22.7	7.9	24.8	24.6	8.9	14.7	9.4	8.2	9.7	7.9	6.7	7.9	7.0	13.7	17.7	19.9	11.2	23.7	9.0	16.5	20.1	19.2	11.1	8.8	9.9	9.9	12.5	20.1	8.4	8.9	16.0	8.6	6.5	21.9	9.2	8.8	7.6	15.1	16.2	12.1	7.6	21.6	17.6	12.4	8.8	15.0	8.5	6.8	27.6	18.4	16.8	27.4	20.8	11.9	12.4	53.0	10.1	12.3	15.9	16.0	32.3	28.6	26.2	21.5	7.7	27.8	10.4	39.6	13.2	13.1	15.3	27.1	30.9	26.7	53.6	21.0	40.7	30.0	11.1	17.2	7.9	13.2	19.5	18.1	43.3	45.0	15.1	10.6	29.7	41.2	69.4	45.5	24.9	11.8	30.1	11.4	38.2	23.0	15.3	32.3	26.5	21.8	7.4	21.6	37.8	10.3	59.4	9.3	13.8	30.6	12.9	17.8	22.3	29.8	54.1	22.6	31.5	20.9	32.8	28.6	54.8	9.5	29.0	16.0	54.2	14.4	13.7	24.1	44.8	26.8	17.4	10.4	16.9	45.6	30.0	12.7	16.6	18.9	20.3	24.8	24.6	17.7	19.9	20.1	19.2	20.1	15.1	21.6	27.6	30.8	16.0	25.3	16.0	55.0	15.9	38.1	25.7	5.7	22.0	16.6	16.4	23.8	21.5	23.1	11.0	8.4	35.5	24.3	17.1	29.4	27.9	31.4	12.5	10.1	24.6	5.4	42.5	20.6	25.1	31.3	16.9	18.3	8.5	46.3	17.7	20.7	12.3	29.9	18.5	17.6	16.3	69.2	22.2	93.7	45.6	9.9	32.8	44.4	44.0	29.7	17.4	16.5	20.6	25.9	23.8	114.4	7.5	16.6	48.1	8.9	23.4	23.3	20.3	13.1	9.6	16.0	24.8	19.1	9.3	12.6	10.5	23.0	15.6	18.6	19.6
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 14.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	29	"T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	1.8	1.6	1.4	1.6	2.3	0.0	1.7	2.1	1.9	3.9	8.1	5.9	1.4	7.5	2.2	4.0	6.0	5.8	3.0	1.7	1.8	3.9	0.9	1.6	0.1	1.6	2.2	5.6	1.3	2.5	2.1	0.4	1.4	4.9	4.2	1.4	0.4	7.1	0.0	0.5	2.1	14.2	2.0	0.7	2.4	2.1	1.8	1.0	1.3	1.1	0.6	4.7	1.6	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.3	2.1	1.9	1.7	1.8	1.6	2.2	1.4	2.0	1.8	1.2	0.0	0.0	0.0	30.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.4	1.5	0.1	0.0	0.0	23.8	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.7	28.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.7	0.0	0.6	0.0	31.7	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	2.1	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358528-82479239	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 68.2;Excitatory neurons: 63.2;Inhibitory neurons: 58.4;Microglial cells: 45.9;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Enhanced		Uncertain	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	3.1	3.1	2.5	3.0	3.2	3.1	5.7	2.7	23.5	3.9	3.3	4.1	4.1	3.7	4.5	3.5	3.6	2.8	4.7	3.2	4.4	4.5	2.5	3.5	4.8	14.0	1.9	5.4	2.6	4.1	2.6	3.5	10.5	3.2	4.7	6.0	4.2	2.9	4.5	3.6	3.1	3.4	1.0	3.7	2.8	5.9	6.8	4.3	4.7	3.7	4.0	3.6	3.1	14.0	1.2	2.8	3.8	0.9	4.0	4.6	3.6	5.6	3.3	2.9	2.2	3.1	3.0	7.3	1.2	4.3	0.7	1.2	7.5	1.0	1.9	6.3	5.6	3.7	1.4	3.4	2.3	6.4	4.1	3.5	3.4	1.0	0.0	5.8	6.2	2.6	2.3	3.1	3.1	4.1	2.7	5.5	5.6	3.2	1.0	1.7	2.2	3.9	9.2	3.9	2.7	2.1	2.2	3.5	3.7	3.0	2.9	6.0	2.5	1.4	1.4	2.3	3.3	3.9	2.4	2.9	2.2	3.9	3.0	19.0	6.5	3.9	4.3	6.0	6.1	5.3	4.6	3.7	4.9	7.2	6.0	4.9	12.2	10.0	5.5	11.1	4.3	3.6	2.5	3.2	2.7	23.5	3.2	4.4	14.0	1.9	10.5	1.0	6.8	14.0	7.9	9.6	9.6	68.2	7.6	4.6	7.3	12.4	4.6	7.0	8.1	8.5	12.7	8.6	8.4	3.7	6.2	11.8	11.5	5.5	7.9	5.5	4.9	5.6	6.6	7.0	7.3	1.7	63.2	3.2	5.4	7.4	8.2	5.9	3.8	7.1	10.8	4.5	5.6	3.3	58.4	4.1	12.2	3.8	5.2	1.7	4.7	6.4	5.4	45.9	14.7	4.2	4.1	89.0	98.9	4.3	5.6	10.5	11.6	3.4	6.3	8.4	12.7	11.5	0.0	12.3	7.2	12.9	9.5	10.6	6.1	7.8	6.4	8.7	6.0	4.4
METTL26	"C16orf13, MGC13114"	ENSG00000130731	"Methyltransferase like 26"	Q96S19	16	634427-636366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 172.6;Distal tubular cells: 168.3;Extravillous trophoblasts: 187.2;Proximal tubular cells: 289.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044004, HPA067414"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA044004: AB_10964777, HPA067414: "	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.93e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.72e-2)"	55.7	71.7	97.8	14.5	100.4	23.6	49.9	90.3	158.9	55.2	90.2	65.7	18.6	57.0	23.8	47.4	50.3	10.6	82.3	102.3	95.8	68.8	75.5	44.9	12.0	92.5	92.7	65.5	50.3	30.2	54.3	13.7	93.0	59.0	10.5	5.2	49.1	22.3	91.3	54.0	39.7	13.6	91.4	47.3	56.0	55.1	97.2	25.8	46.3	35.1	11.8	55.2	47.9	97.7	59.6	60.7	20.0	48.6	28.7	47.2	72.5	46.5	39.2	40.1	30.3	55.6	50.2	71.8	77.7	38.2	47.9	74.5	28.7	73.8	12.5	54.1	140.1	45.9	86.6	83.0	68.5	68.6	41.5	43.1	41.3	53.5	39.9	47.0	48.8	87.7	55.5	29.2	23.3	94.0	75.8	120.4	61.7	83.5	174.9	105.2	23.1	147.6	64.2	25.4	86.9	60.1	43.0	77.9	57.5	14.3	57.4	67.7	35.1	40.4	52.9	67.1	46.5	69.8	47.2	52.7	41.2	43.6	35.7	102.9	119.8	68.3	110.1	145.3	121.6	145.4	114.9	109.2	150.7	124.1	108.6	105.2	26.2	123.0	167.7	162.7	160.0	120.9	97.8	100.4	90.3	158.9	102.3	95.8	92.5	92.7	93.0	91.4	97.2	97.7	70.2	32.1	61.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	119.6	172.6	0.0	0.0	19.2	49.7	0.0	113.3	52.9	0.0	168.3	118.6	0.0	72.7	73.3	29.2	0.0	0.0	0.0	94.1	187.2	42.7	0.0	59.0	25.2	119.7	0.0	0.0	106.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	41.3	0.0	0.0	0.0	0.0	91.8	0.0	0.0	8.4	0.0	0.0	289.7	28.4	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	57.9	30.9	125.9	0.0	0.0
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 29.4;Ductal cells: 16.5;Endometrial ciliated cells: 66.7;Proximal tubular cells: 68.8;Respiratory ciliated cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.7;RPMI-8226: 82.2;T-47d: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA074662	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	2.6	1.5	1.8	0.4	1.4	0.2	2.9	3.4	2.2	6.4	7.9	2.9	1.9	4.1	1.1	1.6	7.2	2.0	0.7	1.6	1.5	10.7	2.0	2.6	1.2	2.3	3.0	2.7	8.9	6.7	3.1	2.0	2.0	5.2	0.7	0.4	5.1	3.3	0.6	1.8	2.6	0.7	1.7	3.1	1.5	5.2	1.5	1.0	3.9	0.1	0.3	2.5	2.8	1.5	12.8	15.5	0.1	1.2	2.3	6.6	2.5	0.1	0.2	0.5	0.4	0.8	18.7	3.1	2.8	2.6	10.7	1.2	0.0	5.0	0.2	2.1	0.1	0.1	4.7	4.8	2.6	0.0	0.1	2.6	1.1	7.8	3.8	0.8	2.9	1.0	0.3	2.6	1.8	3.6	0.1	0.0	0.3	10.2	4.0	0.9	3.4	82.2	4.1	2.4	1.3	0.5	1.7	1.3	1.4	3.5	23.0	0.7	3.4	4.9	1.2	9.4	5.1	3.5	1.3	0.0	1.0	0.1	1.5	0.0	0.6	1.3	0.0	2.2	0.0	2.1	0.3	0.0	0.9	0.6	0.7	0.5	0.6	0.0	0.5	0.7	6.3	0.2	1.8	1.4	3.4	2.2	1.6	1.5	2.3	3.0	2.0	1.7	1.5	1.5	3.8	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.3	0.0	0.0	2.5	20.2	0.0	5.4	0.5	0.0	29.4	16.5	0.0	66.7	5.2	1.2	0.0	0.0	0.0	2.3	2.2	2.2	0.0	6.1	2.5	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	68.8	30.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.9	0.2	0.0	0.0
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA040061: AB_10697713, HPA046734: AB_2732532"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	7.4	4.9	5.2	7.9	6.0	5.5	5.8	5.7	7.0	8.4	5.6	5.9	5.7	7.5	5.4	6.1	6.2	5.7	5.6	4.9	5.7	6.4	5.0	6.2	11.5	6.3	5.6	6.8	4.4	6.4	5.2	5.9	6.5	6.6	6.7	5.1	5.5	7.1	3.4	5.9	7.9	6.7	6.1	10.4	5.8	7.3	5.6	10.4	8.9	5.5	11.0	6.8	7.8	7.6	12.7	5.0	15.1	8.3	5.9	8.7	19.0	19.9	15.7	18.2	16.9	10.8	9.2	24.3	11.5	8.3	16.4	10.7	24.7	9.3	21.2	18.6	9.1	10.6	10.5	7.9	9.0	23.1	12.0	7.1	19.3	19.6	12.0	10.3	17.8	15.9	14.0	33.8	14.3	5.7	16.0	7.4	9.2	10.5	8.2	12.5	13.6	16.7	8.9	7.0	27.6	12.8	16.2	9.3	18.6	11.6	10.8	14.8	11.1	21.9	28.9	19.4	26.3	16.1	47.6	15.7	14.1	15.5	23.8	18.6	2.7	7.3	6.1	2.6	7.0	6.2	7.0	8.5	1.9	7.3	8.5	7.9	10.0	5.9	2.2	3.8	8.8	4.9	5.2	6.0	5.7	7.0	4.9	5.7	6.3	5.6	6.5	6.1	5.6	7.6	24.3	12.8	8.2	8.5	21.1	4.8	13.6	6.5	10.8	9.6	7.6	7.4	3.8	10.0	10.3	3.7	14.6	7.5	13.7	10.1	0.0	5.9	6.9	7.5	9.1	10.0	2.4	11.0	17.0	7.3	9.4	7.3	12.2	7.4	7.0	10.3	11.4	4.9	6.0	8.4	20.3	7.6	4.1	7.0	6.5	3.3	12.8	7.0	3.6	14.0	4.5	6.6	13.4	18.1	25.8	8.3	4.0	10.9	15.0	10.8	10.1	5.1	12.0	6.5	13.1	8.3	6.8	30.5	21.8	9.0	4.8	10.4	18.3	8.5	6.2	19.4
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038223	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	51.1	39.5	41.3	27.7	42.5	34.0	50.2	41.0	57.0	30.4	36.1	53.7	29.4	29.4	63.0	36.6	29.2	25.1	65.5	41.9	45.2	38.5	46.9	24.1	35.4	41.0	42.5	25.7	54.1	36.7	30.2	30.7	42.4	32.5	42.2	30.5	47.1	32.1	92.9	32.7	33.0	36.6	43.7	26.4	43.0	24.3	45.1	30.8	37.7	73.5	38.4	42.3	31.5	45.0	97.1	52.5	74.6	83.1	66.9	99.6	122.6	80.1	74.8	95.4	76.1	164.2	111.2	122.8	95.0	66.0	126.8	98.5	103.0	167.9	133.3	95.3	73.8	185.8	40.6	181.8	90.9	235.9	87.6	73.6	220.2	121.2	147.7	99.4	90.0	165.8	176.0	99.9	123.1	93.8	113.7	190.5	101.4	125.5	98.5	113.7	70.0	190.6	167.0	87.5	90.5	67.6	51.5	80.2	146.0	84.2	75.7	104.6	62.2	103.4	84.5	65.4	104.3	97.0	158.8	206.3	86.3	113.7	95.3	45.5	26.0	21.1	39.9	32.5	61.5	65.0	54.8	53.9	32.0	56.3	56.5	52.3	7.7	45.3	31.8	49.5	57.8	34.8	41.3	42.5	41.0	57.0	41.9	45.2	41.0	42.5	42.4	43.7	45.1	45.0	67.1	12.8	28.8	6.8	49.1	38.6	88.9	105.2	47.8	24.8	64.0	111.4	83.1	50.1	65.4	44.1	16.7	96.1	43.2	36.1	111.6	115.6	3.9	61.0	34.8	48.6	60.6	70.9	10.8	146.2	117.4	43.8	24.5	43.1	46.3	35.1	46.4	49.5	77.2	23.5	11.0	66.7	59.0	36.9	33.3	8.7	50.4	35.9	55.2	9.4	53.7	51.6	53.5	7.1	13.2	149.7	48.8	60.2	48.1	92.5	72.2	115.8	61.3	23.0	52.6	47.2	66.5	49.2	97.4	56.2	40.9	39.1	47.6	48.4	69.3	89.2
METTL6	MGC24132	ENSG00000206562	"Methyltransferase like 6"	Q8TCB7	3	15381275-15440566	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 223.0;Late spermatids: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035166	Uncertain		Approved	Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA035166: AB_10602709"	"unprognostic (2.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (3.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	7.9	7.0	13.7	7.5	13.8	5.3	9.7	13.9	15.9	9.0	6.5	6.1	6.2	8.9	8.8	8.2	9.5	6.2	7.8	14.4	13.3	6.9	6.3	6.7	9.2	11.0	10.9	12.2	6.5	9.2	8.3	9.2	11.4	8.5	7.1	13.2	5.7	9.1	7.0	8.1	5.8	10.3	11.6	7.5	7.0	18.0	14.0	10.2	9.5	7.7	10.0	7.6	6.5	16.8	13.5	21.4	23.4	20.2	21.0	23.7	59.3	24.0	24.5	28.4	29.9	12.9	17.2	22.3	16.1	22.7	24.2	11.0	23.3	20.8	30.0	15.9	25.6	21.4	20.6	19.9	39.7	20.5	18.5	21.3	25.6	34.1	17.1	22.9	26.6	22.8	22.5	22.4	28.6	28.0	22.7	17.0	23.7	14.2	25.6	17.4	29.0	22.0	17.1	18.6	10.1	18.7	20.9	19.1	19.8	16.9	27.9	17.6	18.1	22.0	14.1	22.3	22.0	24.1	43.9	26.7	23.6	19.5	21.1	7.2	8.1	12.2	9.7	10.7	9.6	7.6	9.1	9.7	9.2	9.6	9.1	10.0	4.7	11.8	10.5	12.4	9.1	6.9	13.7	13.8	13.9	15.9	14.4	13.3	11.0	10.9	11.4	11.6	14.0	16.8	5.6	3.2	5.5	20.5	6.8	4.0	8.0	13.9	10.2	17.4	5.9	6.5	5.5	1.5	7.8	9.2	6.2	9.2	5.0	1.3	5.9	10.2	223.0	5.9	10.7	7.7	1.8	6.3	37.4	13.5	21.5	8.2	4.1	5.4	5.1	14.2	5.3	2.3	9.0	20.2	38.2	2.3	4.1	4.4	4.2	121.3	9.0	6.8	5.4	9.4	8.0	11.9	13.4	17.1	22.0	9.2	2.7	9.1	10.3	5.5	4.6	4.9	9.3	15.9	6.6	8.7	8.6	31.3	17.6	6.3	2.8	11.6	8.2	11.4	3.7	5.3
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681678-55684611	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1;heart muscle: 124.2;liver: 284.3"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"glioma: 97.9;liver cancer: 97.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	45	"B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038644	Enhanced		Approved	Vesicles,Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Microtubules	Vesicles	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (2.43e-1)"	2.1	1.7	5.5	1.8	5.9	1.2	0.9	4.9	10.8	0.4	5.9	28.5	59.6	0.4	133.1	0.1	3.1	11.7	124.2	13.1	5.9	52.1	284.3	1.6	2.3	8.4	5.5	0.1	2.9	0.2	3.1	10.9	5.0	0.3	23.6	1.3	0.5	0.8	7.4	0.9	55.3	2.1	5.7	4.3	4.2	0.7	11.6	0.2	3.3	10.0	0.5	1.3	0.1	7.7	0.4	21.8	0.1	0.5	4.3	15.3	0.3	0.8	3.2	0.2	1.4	28.4	56.6	11.6	41.3	1.2	1.1	0.1	4.1	0.3	0.8	0.0	5.4	1.2	3.2	28.7	0.0	0.6	0.0	4.0	0.0	1.0	0.0	4.2	0.0	0.0	0.2	0.0	47.0	20.2	0.0	0.4	5.7	32.5	2.7	0.0	1.5	2.7	0.5	0.1	0.1	0.3	2.2	0.0	3.9	0.2	3.8	42.2	0.0	3.1	3.5	0.4	2.9	0.0	0.6	3.5	41.9	9.9	0.2	0.0	0.8	0.0	0.0	4.5	0.0	0.5	0.0	0.0	7.0	1.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	5.5	5.9	4.9	10.8	13.1	5.9	8.4	5.5	5.0	5.7	11.6	7.7	0.0	0.0	1.5	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	26.5	22.8	0.6	0.0	0.0	0.5	0.0	29.0	3.9	3.9	0.0	0.1	0.0	0.5	1.2	4.0	0.7	5.1	0.5	2.0	2.6	0.2	0.0	0.8	1.1	83.9	72.7	0.0	0.1	14.0	0.0	17.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	4.6	20.7	1.2	0.0	0.1	192.4	55.6	0.0	0.0	0.0	7.8	0.6	0.0	0.1	0.0	0.0	0.7	0.3	0.1	22.2	0.1
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"		2	171317405-171434802	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	3.6	2.8	2.8	3.2	4.7	3.6	3.7	2.5	3.9	3.4	1.8	5.3	2.2	3.0	2.1	8.6	2.4	2.8	2.5	2.6	1.9	3.1	3.6	2.0	3.5	2.7	2.4	2.2	1.7	2.1	1.2	2.6	2.9	3.9	5.2	1.6	2.1	4.0	3.6	6.8	3.6	6.4	2.0	3.3	2.1	4.2	2.8	2.1	1.8	2.3	3.9	5.2	3.8	4.0	10.3	7.4	5.0	13.0	11.7	14.1	19.1	12.8	9.8	11.1	10.0	13.8	13.5	25.1	9.5	8.1	8.2	10.0	17.7	19.4	13.9	10.8	9.9	15.0	6.5	25.0	11.1	17.0	9.1	12.5	24.7	16.0	28.1	2.6	18.6	10.9	26.7	4.1	9.7	13.5	14.3	4.8	16.9	8.3	8.8	7.0	15.4	21.9	9.1	6.8	12.2	5.1	14.5	11.4	9.2	6.6	9.4	7.0	13.8	11.4	6.1	7.6	7.5	3.6	13.0	15.0	7.2	15.9	11.2	0.5	2.1	0.5	3.4	2.7	4.4	3.4	4.4	3.3	2.1	5.1	1.9	2.1	0.7	3.7	1.6	6.7	4.8	2.5	2.8	4.7	2.5	3.9	2.6	1.9	2.7	2.4	2.9	2.0	2.8	4.0	8.1	6.4	6.1	25.1	72.3	25.5	10.7	18.3	27.9	8.4	10.6	9.1	8.2	14.3	14.1	3.7	2.1	15.5	13.1	8.4	11.7	7.6	13.3	4.0	19.2	8.2	6.7	16.2	28.7	6.2	21.2	14.9	6.1	6.1	6.3	18.5	7.5	10.6	11.8	11.8	33.0	5.7	12.2	9.8	10.2	4.1	14.0	11.9	10.6	17.8	11.4	6.3	7.2	29.1	48.2	8.8	5.3	16.1	24.2	20.4	9.8	18.3	6.4	9.2	6.6	10.8	10.8	11.8	21.3	32.8	26.7	12.9	18.3	23.0	13.7	10.0
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046119	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 14.0;testis: 46.8"	"Group enriched"	"Detected in many"	8	"Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.2	0.4	1.7	1.5	1.6	2.0	1.5	2.8	2.8	14.0	0.0	3.4	0.6	6.2	0.5	0.9	1.3	2.5	2.7	1.8	0.7	0.7	0.9	1.5	2.7	0.7	0.9	5.6	0.6	0.2	0.8	2.3	0.7	2.5	0.7	0.8	2.6	3.2	1.6	1.1	1.1	1.4	0.3	1.1	1.0	46.8	1.9	6.4	0.8	2.0	1.0	1.4	4.1	1.0	0.2	2.5	17.2	65.9	1.4	2.0	4.9	2.1	1.0	3.6	3.2	0.5	0.4	3.2	1.2	3.9	1.1	0.5	8.2	0.3	2.5	0.7	5.3	49.2	2.8	2.2	2.8	0.6	15.1	1.0	1.3	2.0	4.0	8.4	7.6	6.1	2.4	0.0	6.2	1.6	8.3	4.2	22.4	0.1	0.6	11.4	10.4	1.7	0.1	0.0	13.7	26.2	3.5	0.6	2.4	4.8	0.2	0.8	6.9	9.0	10.3	5.0	3.1	6.1	3.4	3.7	2.9	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	2.8	2.8	1.8	0.7	0.7	0.9	0.7	0.3	1.9	1.0	3.6	0.0	0.6	0.0	1.3	2.8	0.4	1.4	5.2	3.1	6.0	8.0	4.5	1.5	0.4	0.0	2.1	11.3	1.6	0.7	0.0	0.8	204.7	1.8	13.5	5.3	1.2	7.2	2.1	0.2	8.7	8.3	0.5	1.3	1.3	99.5	2.5	0.2	1.5	0.0	3.4	1.0	0.0	1.0	9.8	201.1	6.5	5.0	7.2	1.0	0.5	5.2	0.0	4.0	1.3	0.5	0.2	4.5	0.8	0.8	0.0	0.0	0.3	2.9	6.6	1.9	16.8	2.7	18.8	5.8	2.0	2.5	2.0	1.0	1.4	0.2
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218333	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 118.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 555.3;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	17.6	13.5	9.1	17.0	9.9	49.4	17.4	12.5	12.3	16.4	9.0	13.5	12.6	17.6	10.4	15.5	14.0	18.6	10.8	10.5	9.8	11.9	14.0	13.7	23.6	10.5	10.0	23.5	14.7	17.9	1.7	16.1	10.6	11.5	14.1	14.8	9.6	12.2	9.7	9.2	13.4	20.1	10.7	22.3	13.3	118.4	9.3	40.9	16.1	17.1	26.6	20.2	2.4	11.6	23.8	19.6	71.2	26.8	27.7	36.8	49.6	32.8	37.4	18.9	22.2	33.6	17.3	53.0	13.2	44.2	30.4	44.6	27.9	42.7	31.0	43.0	12.5	10.7	19.1	29.0	44.5	75.2	22.3	28.2	46.5	26.9	76.4	47.0	41.8	36.0	11.3	95.7	40.0	18.0	63.8	24.3	32.1	13.3	15.0	61.7	36.5	46.7	31.1	9.5	34.8	39.1	30.4	12.4	117.7	54.3	13.5	34.3	43.2	46.3	30.9	15.1	28.1	64.5	12.4	87.2	32.9	31.3	110.7	9.7	1.2	1.5	2.3	1.0	2.0	1.9	2.4	2.4	1.4	1.1	0.9	2.3	0.4	3.4	0.7	1.1	2.0	1.4	9.1	9.9	12.5	12.3	10.5	9.8	10.5	10.0	10.6	10.7	9.3	11.6	25.2	19.2	5.0	6.8	18.6	38.2	10.3	12.4	11.4	12.6	25.9	23.2	14.5	14.3	11.2	3.7	20.9	5.2	56.6	9.0	5.9	12.1	555.3	18.9	22.7	30.0	6.7	7.4	8.0	8.5	7.0	18.2	6.1	34.9	12.7	79.3	10.4	7.6	7.7	11.8	7.9	9.4	12.2	10.9	20.5	514.0	16.1	13.8	19.6	5.6	8.2	10.0	34.0	14.1	13.3	16.5	3.9	15.1	20.6	15.4	9.1	9.3	6.4	14.8	0.0	30.2	17.7	14.4	14.2	18.1	45.9	4.2	24.2	14.9	11.5	19.6
MEX3D	"KIAA2031, OK/SW-cl.4, RKHD1, RNF193, Tino"	ENSG00000181588	"Mex-3 RNA binding family member D"	Q86XN8	19	1554669-1568058	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 78.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 340.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065385	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA065385: AB_2685482"	"unprognostic (2.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.74e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.75e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.36e-2)"	8.2	3.9	11.5	2.6	10.7	0.3	8.1	8.7	10.6	9.2	0.1	8.2	4.6	12.6	5.9	9.6	7.7	2.8	6.5	8.0	5.3	4.8	5.5	7.7	1.2	16.2	10.1	12.3	6.2	2.2	4.9	6.9	9.9	6.9	2.7	0.8	9.2	2.7	1.7	10.8	5.2	3.6	8.9	2.7	6.9	78.3	10.8	1.6	6.1	1.5	2.1	7.7	9.3	18.0	40.6	3.1	17.5	20.3	6.4	6.1	43.2	24.9	5.4	9.6	10.0	9.9	6.9	12.9	27.5	9.3	2.4	20.5	7.7	6.2	11.7	21.2	9.5	3.1	3.3	12.2	5.1	9.4	8.5	4.6	9.0	5.2	4.1	7.6	15.4	6.7	18.7	12.2	11.4	8.1	22.2	10.0	36.5	8.8	11.6	67.4	18.5	10.0	8.7	6.1	26.2	29.6	20.3	11.1	15.2	14.6	14.2	10.4	28.0	19.6	27.4	30.4	32.3	13.6	5.8	13.5	8.3	13.8	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	10.7	8.7	10.6	8.0	5.3	16.2	10.1	9.9	8.9	10.8	18.0	18.1	12.8	8.4	2.0	0.6	14.8	3.5	3.8	6.2	2.4	23.4	13.2	7.3	8.6	4.2	9.2	0.0	5.2	3.4	10.8	0.0	11.9	73.8	15.6	15.6	10.5	18.6	4.0	0.9	9.6	12.8	11.0	2.6	19.9	1.3	8.2	12.5	13.6	2.4	1.7	0.6	7.3	6.1	2.5	8.1	340.7	14.9	3.3	7.2	0.0	1.2	6.0	1.0	3.0	3.5	20.9	6.4	9.4	0.8	8.9	6.2	2.7	1.7	1.7	0.0	5.9	13.6	3.7	4.3	10.1	17.6	16.6	2.5	2.6	9.6	5.1
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980632	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 81.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA		210000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	36.6	4.2	0.4	13.3	0.6	0.1	22.7	0.5	1.1	81.8	1.6	15.0	5.0	61.4	22.1	6.1	19.0	73.2	13.8	0.5	0.6	9.4	1.6	20.1	4.2	0.7	0.9	35.8	18.8	4.5	13.2	42.4	0.7	22.1	4.8	4.9	16.5	12.1	2.6	27.6	12.1	30.6	0.5	2.7	8.3	11.2	0.7	1.6	9.5	3.0	2.3	22.5	36.7	0.6	0.0	0.2	93.2	0.3	249.4	249.6	6.2	26.3	102.5	39.7	73.7	24.1	1.1	0.0	82.6	89.7	0.1	0.1	7.2	7.7	15.9	0.1	78.0	0.0	37.1	2.1	23.4	0.1	0.1	104.4	18.8	109.4	42.7	113.1	263.1	0.0	0.2	16.2	19.2	12.5	0.1	0.1	108.8	0.5	0.8	1.5	0.0	4.0	0.9	0.3	5.0	212.1	9.0	36.6	9.6	71.1	11.9	13.0	75.6	65.6	128.4	51.7	2.8	0.1	0.3	0.2	53.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	1.1	0.5	0.6	0.7	0.9	0.7	0.5	0.7	0.6	5.5	0.0	1.7	0.0	0.1	6.6	7.8	28.7	8.0	0.2	2.1	3.9	0.9	2.8	10.7	3.7	0.0	4.5	0.0	0.1	0.0	1.3	12.9	5.6	28.7	7.1	10.1	0.0	0.0	0.8	197.8	75.8	2.0	8.3	0.0	93.3	1.4	0.0	7.4	0.0	0.0	0.4	12.2	0.0	7.7	7.6	53.7	0.6	17.8	2.8	0.0	27.7	0.0	0.0	0.0	1.9	0.0	63.9	0.5	1.5	0.0	0.0	1.9	0.8	0.0	3.3	14.7	3.2	8.7	0.6	6.3	29.0	0.9	0.5	0.2	1.2
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038959-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	16.0	8.5	5.4	13.2	5.4	12.1	12.5	8.1	7.0	13.2	10.1	10.8	9.5	12.0	9.8	14.7	9.7	11.8	14.1	5.3	6.3	13.5	13.7	11.3	10.6	5.8	6.2	9.4	7.1	24.4	3.1	19.6	6.3	9.4	10.8	12.2	7.2	9.0	10.4	7.6	9.6	16.6	6.5	11.4	9.6	5.7	5.7	11.8	13.4	17.1	13.0	16.1	6.5	6.0	14.9	19.7	36.5	37.7	29.8	24.7	31.5	26.4	28.0	27.0	37.1	27.4	34.1	25.0	30.6	26.3	25.8	33.5	32.5	35.6	41.9	9.5	21.0	15.7	26.5	12.9	29.5	27.7	16.0	29.2	32.4	35.0	29.1	22.6	38.4	19.9	17.5	20.5	21.4	11.0	15.2	9.9	20.0	16.0	9.9	14.6	40.7	20.8	20.8	21.0	32.1	40.3	27.4	35.0	31.1	30.1	34.6	14.8	32.9	34.3	26.4	19.4	26.9	25.7	33.5	21.4	18.7	19.2	27.4	6.7	7.5	11.9	5.0	7.9	6.9	2.4	4.0	3.5	8.1	2.5	5.2	4.1	6.8	6.5	5.6	3.7	3.9	4.3	5.4	5.4	8.1	7.0	5.3	6.3	5.8	6.2	6.3	6.5	5.7	6.0	9.7	0.0	0.5	14.0	3.5	6.0	1.0	6.1	6.2	3.2	1.6	1.5	2.7	0.0	3.9	5.5	6.2	4.3	2.7	1.9	1.9	1.4	7.1	1.4	4.3	7.6	0.0	9.1	24.3	1.1	3.0	3.9	4.1	2.2	4.5	2.1	1.4	1.9	1.9	3.3	24.5	1.2	8.2	0.6	4.4	4.9	1.8	2.7	8.8	17.8	0.7	6.9	1.0	12.1	15.1	1.1	0.3	0.0	9.5	1.3	2.1	1.1	4.6	4.6	0.0	1.5	3.3	3.9	2.0	4.3	5.5	6.0	4.0	1.2	1.0	1.5
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 242.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.5;Extravillous trophoblasts: 1015.1;Fibroblasts: 579.7;Syncytiotrophoblasts: 252.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 31.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 172.2;BJ: 63.7;EFO-21: 150.4;HeLa: 55.9;SuSa: 137.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 42.6"	HPA010553	Enhanced				"Secreted to extracellular matrix"	NA	NA		3200000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.81e-4)"	141.7	10.9	3.5	5.4	5.0	3.5	79.7	31.7	9.2	59.9	1.8	37.8	7.2	242.1	11.1	35.0	25.8	28.2	54.4	4.8	0.8	3.1	12.7	8.7	4.8	2.9	0.4	2.4	5.5	2.4	3.7	94.5	1.9	6.4	42.0	7.9	17.2	49.7	28.5	38.7	19.0	142.1	0.0	1.9	23.6	6.9	1.7	3.2	14.4	118.1	3.4	43.1	60.7	6.6	1.4	5.7	1.6	2.6	29.4	12.4	172.2	63.7	1.2	0.8	1.1	2.3	1.0	0.6	150.4	19.8	1.6	9.1	0.6	13.1	0.0	0.5	0.4	1.6	55.9	1.9	0.4	1.3	0.6	8.7	4.4	7.3	0.0	3.3	0.0	2.0	2.7	3.7	52.7	0.8	1.9	0.8	3.2	0.9	2.9	1.2	1.3	6.5	6.5	2.6	0.7	0.9	1.9	0.7	1.0	137.1	24.0	0.8	2.3	10.7	21.5	45.7	3.0	2.1	1.9	2.3	6.0	0.7	0.1	2.9	0.8	0.7	0.2	0.7	0.4	0.1	0.1	0.1	0.4	0.3	0.4	0.1	1.1	0.2	0.5	0.3	0.0	0.3	3.5	5.0	31.7	9.2	4.8	0.8	2.9	0.4	1.9	0.0	1.7	6.6	61.5	12.8	5.8	0.3	0.5	23.1	0.4	1.8	0.6	0.2	0.6	0.9	7.0	0.0	2.0	0.0	0.0	140.5	0.5	0.0	0.0	0.5	0.3	5.1	3.9	20.1	0.0	0.0	0.2	0.0	1015.1	579.7	3.6	28.0	0.0	0.2	4.2	0.0	27.7	0.0	0.1	0.0	0.0	9.5	36.3	0.5	61.2	8.8	12.4	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.9	0.0	40.2	35.2	0.1	0.2	0.6	18.0	252.3	5.3	0.1	0.0	0.3
MFF	"C2orf33, GL004"	ENSG00000168958	"Mitochondrial fission factor"	Q9GZY8	2	227325151-227357836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 985.9;Late spermatids: 1746.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010968, HPA074625"	Enhanced		Supported	Mitochondria		No	No		62000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA010968: AB_1845714, HPA074625: AB_2686704"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.22e-1)"	52.3	58.0	61.2	29.3	66.6	48.1	46.9	67.4	71.8	49.0	63.5	60.9	41.0	46.6	37.9	48.4	49.0	31.0	66.2	60.0	67.3	68.8	44.2	38.9	39.4	66.4	61.7	51.6	57.2	60.0	42.7	33.4	66.1	42.5	40.9	80.4	43.8	47.9	100.4	44.8	40.5	42.3	67.3	38.7	49.0	199.2	63.5	51.5	37.1	86.5	44.5	50.1	45.9	74.5	71.1	60.6	72.4	100.5	92.7	88.6	95.3	69.1	93.7	82.6	88.7	66.4	49.8	40.3	80.1	76.9	87.5	57.8	121.0	88.5	112.6	86.4	97.3	85.8	144.5	165.0	122.4	84.2	73.6	79.6	113.9	79.0	84.3	109.6	72.7	91.6	76.7	117.8	75.3	72.5	88.9	127.3	98.6	76.7	62.5	79.0	91.8	78.7	124.2	66.5	76.3	70.8	153.3	68.7	106.7	59.4	44.8	82.0	49.7	80.6	67.0	119.2	78.3	95.2	69.6	81.9	106.1	73.6	111.7	118.5	66.8	133.6	65.2	74.0	69.9	84.0	67.5	63.9	72.0	77.9	70.4	60.2	65.1	67.7	70.0	71.9	97.5	76.3	61.2	66.6	67.4	71.8	60.0	67.3	66.4	61.7	66.1	67.3	63.5	74.5	40.4	32.1	46.7	53.8	74.8	48.3	62.1	70.3	90.5	33.1	54.9	64.1	79.3	44.3	57.0	60.7	31.3	95.3	49.8	46.2	127.2	95.2	985.9	36.7	40.3	45.6	32.3	73.6	95.8	94.8	89.8	67.6	42.8	52.0	22.1	66.4	43.5	56.1	78.4	40.4	97.7	60.3	61.1	61.5	56.4	1746.9	88.0	63.0	81.8	47.8	64.0	204.4	74.2	135.2	151.3	91.7	63.8	85.7	127.7	66.5	69.5	135.7	32.3	65.5	59.2	69.1	62.1	392.3	96.9	87.6	47.3	91.9	57.2	63.7	73.0	71.6
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule EGF and factor V/VIII domain containing"	Q08431	15	88898683-88913381	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	237.2	95.2	44.2	45.2	49.6	3.7	226.7	56.4	61.8	272.8	52.4	113.7	21.2	444.7	77.0	67.6	361.8	120.2	485.8	41.6	47.2	69.0	15.6	137.2	47.4	55.9	47.4	228.5	36.5	18.9	49.3	79.6	55.6	129.3	29.3	68.7	97.1	195.8	264.3	118.9	106.9	162.7	47.0	40.7	124.9	38.3	46.5	18.8	90.6	124.1	36.9	163.6	223.4	55.6	19.7	85.4	78.7	98.7	1784.6	918.2	6.9	482.7	142.4	95.4	110.3	90.5	23.5	0.0	147.5	660.4	144.6	10.2	27.6	95.8	31.1	82.3	64.7	138.1	4.6	10.2	469.8	0.2	50.1	935.7	251.8	73.5	122.5	205.3	37.0	35.3	23.4	41.1	185.1	6.2	22.6	3.2	405.4	8.3	38.4	22.7	74.4	26.4	32.6	7.3	8.2	42.9	28.0	2.5	226.1	165.6	2.4	11.1	42.0	233.2	127.8	62.3	36.3	145.3	30.5	15.9	31.6	12.2	91.5	5.3	0.2	0.4	1.3	0.0	4.2	1.2	4.2	2.9	0.0	0.9	4.3	3.3	0.0	7.7	0.1	0.1	14.9	2.1	44.2	49.6	56.4	61.8	41.6	47.2	55.9	47.4	55.6	47.0	46.5	55.6	72.1	12.8	5.4	39.2	4.0	48.7	32.2	116.3	24.5	22.1	407.0	190.4	92.8	8.6	25.5	3.7	385.7	4.5	13.1	1.6	0.0	15.7	11.0	33.3	202.2	66.9	44.8	3.8	5.1	4.3	18.6	220.0	12.8	29.7	5.1	30.1	22.1	15.5	8.1	16.8	0.4	6.4	36.7	32.9	39.7	27.9	187.0	12.9	119.2	15.0	1.8	75.9	9.2	5.5	9.6	28.3	0.2	109.1	8.8	15.8	0.1	0.2	8.3	978.7	1084.7	51.8	476.0	3.3	9.0	21.7	35.9	5.3	12.5	25.8	2.0	10.2
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893630	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.4;Glandular and luminal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 128.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	5.8	2.0	7.3	7.9	6.9	11.9	3.6	7.5	8.7	6.3	4.1	12.8	6.1	5.1	3.3	5.3	6.6	5.5	6.6	8.3	6.4	13.5	6.0	9.9	10.4	6.1	7.4	3.4	4.6	5.7	2.0	8.8	6.5	5.3	11.4	5.4	3.4	4.4	2.4	6.1	7.0	8.2	6.5	11.1	6.3	6.0	9.0	9.0	5.4	2.7	8.6	9.2	3.5	6.2	19.5	14.4	8.6	6.6	8.0	10.1	28.3	7.9	17.0	5.6	7.6	23.3	3.7	28.5	9.5	7.6	16.2	6.5	9.1	7.3	4.9	37.0	8.1	2.1	5.3	15.1	9.5	8.2	2.9	5.5	15.0	7.6	7.5	6.0	12.5	34.8	13.4	0.0	4.7	7.0	128.0	7.2	16.8	25.8	6.1	17.4	13.1	4.4	39.3	20.0	13.6	11.0	4.6	7.2	12.7	14.6	4.9	11.1	5.3	6.8	10.1	27.3	15.4	1.5	6.9	21.7	12.6	10.8	4.2	0.0	0.1	0.0	0.9	0.0	0.7	0.4	1.3	0.8	0.2	0.3	0.6	0.5	0.0	0.1	0.0	0.0	1.2	0.3	7.3	6.9	7.5	8.7	8.3	6.4	6.1	7.4	6.5	6.5	9.0	6.2	10.7	54.5	43.9	105.4	6.5	37.5	24.5	6.0	2.8	19.0	6.2	3.2	17.2	20.0	16.5	31.3	4.2	3.7	6.5	30.9	13.7	12.0	2.5	50.8	20.3	19.2	18.8	71.4	46.9	15.4	3.2	17.8	8.2	119.2	22.2	5.4	25.4	17.8	31.8	3.3	56.8	29.3	10.2	27.5	21.0	3.4	11.5	13.0	10.6	61.8	8.0	24.3	14.4	38.2	6.2	28.5	20.7	8.2	2.1	47.5	6.7	16.5	5.4	8.1	0.0	4.5	24.1	1.9	21.7	2.4	50.0	2.3	24.0	1.7	36.3	16.9
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"	Q8IWA4	3	179347709-179394936	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	9.5	9.0	5.6	9.4	6.6	8.4	11.0	8.8	8.5	9.5	8.8	12.5	8.9	11.4	14.9	14.1	10.2	9.6	23.4	5.6	5.5	10.4	8.8	8.8	12.8	6.3	5.8	9.1	17.9	13.3	6.7	7.9	6.0	12.4	10.5	10.3	14.1	9.6	14.0	14.5	9.8	11.4	5.2	9.9	10.8	9.0	5.7	8.6	10.4	16.4	11.9	12.7	8.9	9.5	32.2	9.4	17.9	29.1	25.1	23.2	23.6	19.6	20.2	20.2	23.9	23.5	13.0	10.8	20.0	29.1	40.9	18.5	25.4	19.4	35.3	17.2	19.5	17.8	19.4	13.1	20.5	9.5	16.3	16.2	16.7	21.9	15.4	16.8	26.0	17.9	13.2	14.1	28.6	17.1	14.0	7.1	21.3	32.1	17.3	9.7	28.1	40.4	19.1	33.4	16.8	23.9	18.3	48.5	26.6	18.2	66.6	6.8	22.0	17.6	19.4	27.6	29.0	18.6	21.9	18.0	19.7	15.8	19.5	4.2	2.5	5.8	2.6	3.1	4.5	5.1	3.0	2.7	2.3	6.2	2.7	3.2	5.8	2.9	2.4	2.8	2.9	1.4	5.6	6.6	8.8	8.5	5.6	5.5	6.3	5.8	6.0	5.2	5.7	9.5	21.3	25.6	36.8	39.8	27.3	16.7	12.3	12.6	20.5	18.8	19.1	14.4	29.3	14.3	23.7	18.4	39.6	11.2	20.9	18.2	9.8	12.6	6.6	36.9	28.5	16.3	10.2	24.0	77.2	17.4	11.0	22.6	26.0	43.4	8.8	22.1	14.6	18.3	7.8	11.8	92.5	18.2	12.2	11.7	11.4	3.3	13.4	14.9	12.4	28.1	12.2	11.2	18.6	56.8	85.1	16.5	11.8	17.7	21.2	20.0	10.4	13.4	31.9	16.5	6.6	26.8	21.2	33.2	13.7	24.9	27.0	13.1	15.1	25.3	16.6	20.7
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486393	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	22.2	7.1	8.9	37.0	8.9	40.3	14.8	8.4	10.8	8.9	6.4	10.5	8.6	9.7	2.4	7.5	11.0	14.5	14.6	7.9	9.2	9.5	7.1	26.3	69.1	18.1	10.8	3.1	3.9	2.6	3.1	30.3	20.5	6.6	7.8	0.7	5.4	5.7	7.5	5.0	24.0	11.5	10.2	58.9	8.6	2.9	11.0	50.5	9.6	8.8	42.5	13.9	6.2	10.3	6.0	2.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	7.1	3.0	174.6	0.7	0.0	0.8	10.8	45.1	8.7	0.2	81.6	1.0	143.4	0.6	1.5	0.6	220.9	266.9	0.0	2.6	1.7	3.2	0.9	232.9	69.0	0.7	73.8	0.0	1.5	27.8	3.0	0.4	6.1	1.0	67.0	1.8	128.7	0.4	0.1	94.1	0.9	0.5	0.3	0.3	0.8	1.3	14.1	134.7	0.0	5.8	22.8	0.6	0.4	0.4	166.8	1.1	201.1	2.7	210.3	198.9	386.5	196.1	196.1	214.5	103.0	222.7	206.1	204.1	113.5	243.4	209.9	127.9	217.1	218.7	51.7	284.3	314.0	8.9	8.9	8.4	10.8	7.9	9.2	18.1	10.8	20.5	10.2	11.0	10.3	51.4	0.0	3.8	0.0	35.4	3.7	0.4	0.2	0.0	6.3	1.0	1.3	1.6	5.7	3.1	0.0	0.0	0.3	54.6	1.1	0.0	2.9	0.2	0.4	0.2	37.1	1.2	30.1	0.1	0.9	0.3	1.1	2.0	1.0	31.6	0.1	53.2	1.5	31.9	0.0	0.1	2.1	0.0	45.8	20.2	0.3	0.0	33.5	3.6	6.5	40.6	0.1	72.1	0.0	0.0	3.7	4.0	0.0	35.0	0.5	2.3	0.3	0.1	0.6	0.0	1.6	1.0	0.1	0.7	0.3	2.4	0.7	51.0	0.1	0.8	0.4
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934834	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 251.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 275.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	35.2	20.2	15.8	9.9	16.4	66.1	30.5	13.6	24.1	43.1	19.3	30.3	12.3	34.7	3.3	27.6	36.9	12.5	26.5	16.1	14.4	33.6	10.8	36.9	13.2	16.9	14.7	41.6	29.0	3.6	28.7	11.5	14.7	34.3	3.8	1.1	30.4	11.3	14.0	22.0	31.0	7.6	13.2	36.1	31.6	15.6	17.6	6.3	37.6	3.4	6.3	34.6	32.8	14.3	50.4	46.2	13.3	33.7	21.7	15.5	36.0	45.1	21.9	21.5	24.6	24.7	117.3	8.8	23.7	28.4	40.0	45.9	12.1	65.6	5.8	56.9	40.7	19.1	39.2	25.9	36.5	59.9	27.1	23.5	37.5	24.5	15.4	33.4	24.7	20.0	26.4	18.0	16.5	53.8	16.9	275.6	43.0	38.9	54.5	20.7	6.4	41.8	32.9	30.6	34.2	40.7	10.8	31.5	49.1	13.5	82.9	112.9	37.1	17.7	30.4	22.2	36.6	12.2	5.8	13.8	50.0	153.3	27.8	64.7	55.0	117.4	73.0	71.2	62.6	45.1	46.8	82.1	57.4	35.2	23.3	41.1	44.2	45.9	95.8	45.7	34.4	42.6	15.8	16.4	13.6	24.1	16.1	14.4	16.9	14.7	14.7	13.2	17.6	14.3	64.6	38.5	29.1	17.6	41.3	31.4	78.8	251.5	28.5	9.2	56.3	68.1	5.0	28.6	123.2	46.0	8.4	67.4	71.0	37.8	3.9	96.0	11.7	41.5	33.4	41.1	28.2	13.3	21.5	45.9	93.0	42.9	33.6	44.3	32.4	50.7	45.7	3.1	69.6	15.2	14.8	37.2	93.6	49.3	36.7	18.8	36.4	45.6	42.7	9.4	62.1	11.0	64.9	9.5	8.8	86.0	51.5	22.6	28.1	92.1	60.0	17.9	104.9	10.0	92.1	27.0	56.6	15.5	16.1	26.9	26.9	83.7	62.4	44.7	49.4	100.5
MFSD11	"FLJ20226, FLJ22196"	ENSG00000092931	"Major facilitator superfamily domain containing 11"	O43934	17	76735865-76781449	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 246.0;Early spermatids: 193.4;Late spermatids: 213.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022001	Uncertain					NA	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"			"HPA022001: AB_2297599"	"unprognostic (2.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.90e-4)"	14.5	13.8	8.9	13.2	9.9	16.5	15.5	12.0	10.2	14.3	5.9	19.7	16.3	12.6	16.4	17.8	11.9	13.1	19.1	9.7	8.7	11.9	16.9	16.1	12.8	10.0	9.0	9.7	15.1	22.2	15.5	19.9	11.6	11.5	20.5	38.1	15.4	12.2	27.8	18.3	16.8	15.3	7.2	14.2	20.2	23.0	9.9	14.0	15.7	21.1	14.7	12.1	16.4	11.7	25.0	13.8	16.0	15.1	33.7	20.3	18.8	21.6	20.0	20.4	18.1	28.1	44.5	20.1	17.9	22.2	22.4	23.5	11.5	11.3	21.2	9.3	22.8	19.3	27.1	19.6	16.1	10.6	19.1	24.4	18.0	26.3	11.8	29.5	39.6	26.3	24.5	29.0	26.4	18.6	24.7	17.7	6.7	28.3	8.0	19.2	20.7	41.9	15.9	18.3	15.4	26.1	20.7	29.0	19.3	23.4	51.0	16.3	27.9	36.9	17.8	23.5	18.1	32.1	13.7	29.9	28.6	9.3	25.0	14.5	15.2	13.4	15.9	17.7	6.6	7.6	14.2	16.1	16.7	9.1	8.6	10.6	18.7	7.9	14.7	11.8	21.1	9.4	8.9	9.9	12.0	10.2	9.7	8.7	10.0	9.0	11.6	7.2	9.9	11.7	15.9	12.8	14.0	45.4	21.3	16.8	16.3	21.1	48.9	39.3	20.5	14.7	18.1	12.8	22.7	14.7	246.0	38.6	19.5	34.3	5.9	15.3	193.4	12.5	14.9	19.5	16.8	30.9	51.9	18.0	78.0	18.9	25.5	14.1	27.3	12.0	17.9	19.4	33.7	40.4	68.2	14.6	20.3	23.9	19.0	213.9	18.3	24.9	19.6	40.3	22.8	24.6	20.6	48.7	63.1	20.9	14.0	13.9	47.3	16.3	23.2	9.9	13.5	103.3	6.6	15.6	15.7	37.8	18.0	33.9	17.2	41.3	27.0	11.5	18.3	15.8
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Melanin biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.7;Extravillous trophoblasts: 142.4;Melanocytes: 195.7;Syncytiotrophoblasts: 92.6"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 261.4;SK-MEL-30: 339.8;WM-115: 628.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	23.3	26.4	25.8	24.1	26.4	30.5	19.3	21.8	33.0	18.9	9.3	17.7	15.0	18.0	12.9	22.7	21.8	9.5	17.6	41.2	18.1	55.0	35.8	29.2	20.3	29.0	23.8	14.7	38.5	13.9	25.9	17.6	28.9	21.4	6.1	10.8	29.7	11.2	16.4	53.7	27.2	11.6	19.2	37.9	22.8	13.6	29.9	24.7	19.0	4.0	10.8	19.5	17.0	58.0	97.6	76.4	18.6	48.9	37.9	29.2	66.9	58.3	31.2	66.6	72.7	33.1	32.4	27.3	43.2	31.2	106.4	60.1	24.3	30.2	23.8	60.0	69.0	15.9	261.4	34.9	47.4	34.9	51.1	26.2	44.9	68.6	15.9	25.5	18.1	40.2	77.1	38.2	17.3	58.0	35.0	61.8	34.9	42.9	62.1	24.3	26.2	115.1	27.9	41.0	70.0	35.5	115.0	53.4	339.8	23.1	18.2	71.6	75.8	30.1	44.4	123.8	67.1	43.8	26.9	25.1	132.4	88.2	628.4	0.1	3.7	2.6	1.8	7.7	1.8	2.3	2.8	1.4	2.7	1.4	2.4	1.9	1.2	0.5	7.7	12.1	0.5	1.7	25.8	26.4	21.8	33.0	41.2	18.1	29.0	23.8	28.9	19.2	29.9	58.0	15.4	6.4	2.8	5.5	12.9	26.5	6.8	4.9	1.8	15.6	19.9	14.0	1.9	8.6	6.1	20.2	6.2	16.8	21.5	11.6	0.0	23.1	120.7	26.9	20.9	13.1	28.1	3.8	10.2	31.4	142.4	10.9	14.8	42.5	0.0	57.3	6.4	22.3	76.9	37.0	8.0	18.4	2.0	24.8	54.4	30.4	2.5	47.7	195.7	13.1	20.7	9.3	5.2	7.5	25.5	34.2	16.2	3.4	12.6	16.7	18.7	34.0	8.1	12.7	13.1	5.4	12.0	4.0	9.0	8.4	25.4	92.6	10.9	11.1	13.2	13.8
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	2.3	2.5	10.0	3.2	13.0	5.2	2.1	14.1	12.8	2.4	2.3	5.0	5.5	3.1	0.7	3.0	2.3	2.3	3.2	10.8	7.2	2.5	6.3	9.0	3.2	7.7	7.7	1.4	3.8	1.7	4.1	2.3	7.8	3.1	3.2	4.9	1.8	0.9	2.3	11.7	4.4	2.5	6.5	6.9	4.0	3.7	9.2	1.8	5.4	1.4	3.6	2.2	2.6	9.4	12.0	5.4	4.0	9.6	0.4	0.4	6.2	2.3	6.0	4.6	10.5	10.7	16.0	10.6	11.8	0.9	4.4	14.6	7.4	6.3	1.7	13.5	6.8	13.1	8.2	5.6	10.1	6.7	12.3	5.2	2.6	2.6	4.6	3.7	5.3	14.2	3.0	5.7	0.4	2.4	11.3	4.3	6.8	10.5	5.2	13.6	0.6	1.8	2.0	3.1	10.0	9.5	2.2	1.2	5.2	1.4	6.0	4.0	1.6	2.1	2.5	2.6	3.3	1.9	5.5	14.0	11.6	10.9	2.9	0.4	4.3	3.5	2.9	3.2	2.8	3.4	2.7	2.3	4.5	1.4	2.8	3.2	2.5	1.2	1.8	0.4	0.8	2.6	10.0	13.0	14.1	12.8	10.8	7.2	7.7	7.7	7.8	6.5	9.2	9.4	4.1	19.2	15.4	0.0	1.1	0.0	1.5	0.0	0.6	8.2	1.5	1.9	0.0	1.5	0.6	1.8	4.2	1.8	5.7	2.6	0.0	2.8	1.8	1.0	1.0	3.8	2.4	3.6	0.0	3.6	2.6	1.6	5.6	1.6	1.3	2.8	6.4	4.0	15.7	21.9	0.0	3.8	0.0	4.8	0.0	1.0	0.9	8.7	0.0	0.0	5.6	3.2	2.1	0.0	0.0	3.2	4.6	2.2	0.8	1.4	5.6	1.5	0.7	13.8	0.0	2.8	1.1	4.5	3.0	2.4	0.0	28.5	3.2	4.0	4.5	1.4
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038095-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 131.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 303.1;Late spermatids: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	29.1	28.5	18.1	26.2	21.1	90.3	27.4	21.2	24.7	25.9	20.8	26.8	19.6	35.3	26.0	29.0	26.6	25.2	19.6	18.2	21.1	29.7	29.5	28.8	28.4	23.3	20.2	30.5	31.5	131.4	18.7	34.1	22.1	33.4	21.8	19.6	23.0	31.4	15.0	24.9	19.6	35.5	21.9	28.4	22.4	35.3	20.0	31.1	27.9	20.1	29.2	33.5	24.0	25.7	54.3	22.2	48.9	25.4	56.0	52.8	41.3	38.9	65.9	51.5	59.9	18.9	37.0	40.5	61.7	50.6	34.1	51.0	44.0	42.8	49.2	35.6	34.8	40.1	32.8	28.6	49.4	65.0	50.2	43.3	64.1	45.5	57.9	45.3	40.2	45.1	49.8	77.2	48.1	16.0	49.3	38.1	56.4	26.2	32.4	34.1	59.6	39.8	54.8	46.9	50.7	45.2	43.8	63.0	66.6	30.9	24.6	65.3	44.5	42.3	29.6	44.9	40.9	72.8	82.4	56.0	46.1	46.6	18.6	80.1	56.0	54.6	49.5	51.4	55.9	46.2	49.6	54.4	55.2	38.8	54.8	51.5	94.8	59.9	45.2	25.6	60.3	72.0	18.1	21.1	21.2	24.7	18.2	21.1	23.3	20.2	22.1	21.9	20.0	25.7	4.5	6.4	11.5	0.0	33.5	0.0	47.5	0.0	43.3	17.8	3.4	1.5	0.0	27.1	3.7	3.7	10.4	37.5	7.8	6.5	1.9	10.1	303.1	1.0	1.7	20.8	13.3	35.8	0.0	7.2	33.5	19.5	18.3	1.5	2.5	0.6	19.6	17.1	23.1	13.5	0.0	9.4	0.0	26.4	0.0	373.8	22.7	15.8	0.0	0.0	22.2	25.1	33.0	0.0	0.0	6.5	17.1	30.5	41.9	56.3	8.1	1.1	5.8	11.6	13.1	25.6	12.8	28.2	22.5	43.4	0.0	58.3	33.7	0.4	9.6	52.3
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"bone marrow: 11.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 25.1;Erythroid cells: 65.2;Prostatic glandular cells: 41.0;Urothelial cells: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	14	"HEL: 8.3;K-562: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA044145: AB_2678833"	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.3	0.2	0.4	0.5	0.3	0.1	0.3	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.0	1.3	0.3	1.6	10.1	25.1	0.7	0.0	0.9	0.3	0.3	4.6	1.5	0.5	0.0	4.2	6.9	0.2	0.9	3.9	5.0	0.6	0.1	0.3	1.7	1.2	65.2	0.3	1.8	4.4	1.6	0.0	0.3	5.1	0.3	0.4	0.0	3.1	0.0	0.5	2.9	2.0	1.4	5.9	0.8	0.0	4.5	0.0	1.0	0.6	0.1	0.0	0.0	0.3	10.6	2.3	0.0	0.2	41.0	3.1	0.2	0.0	1.5	0.0	1.1	0.7	0.9	2.1	0.0	11.2	7.5	1.1	0.0	5.5	30.3
MFSD3		ENSG00000167700	"Major facilitator superfamily domain containing 3"	Q96ES6	8	144509070-144511213	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056013	Uncertain		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA056013: AB_2683009"	"unprognostic (7.92e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (2.00e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.44e-7)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	8.4	22.6	9.2	3.4	8.0	1.8	10.7	7.2	12.0	8.0	6.4	22.6	13.5	8.3	4.1	16.1	8.4	2.5	21.8	8.8	6.7	27.5	44.6	7.6	2.8	10.8	7.1	6.7	18.8	12.3	17.8	1.5	9.4	19.2	3.3	1.5	19.6	5.4	23.5	17.8	15.4	1.2	5.4	10.8	15.6	6.3	9.5	2.3	23.9	6.1	1.7	9.7	9.2	7.0	16.2	21.7	5.4	4.6	5.9	4.4	17.6	5.1	5.3	2.8	4.2	7.3	11.2	23.3	17.3	4.8	5.6	15.5	2.5	12.1	0.5	11.0	44.0	7.5	19.9	18.3	11.0	3.6	9.9	6.5	22.3	1.8	7.7	12.1	7.3	16.0	14.2	6.2	6.8	53.7	9.0	18.9	14.3	22.9	36.9	9.9	2.8	41.7	13.2	9.5	39.1	19.7	13.0	31.6	11.3	3.4	33.1	5.2	7.9	3.7	9.9	4.2	7.1	6.0	2.6	8.1	8.0	11.3	6.5	1.8	7.4	3.8	3.9	6.7	3.7	4.9	3.9	4.0	11.0	2.5	3.5	3.6	0.4	3.8	3.6	19.2	4.4	4.1	9.2	8.0	7.2	12.0	8.8	6.7	10.8	7.1	9.4	5.4	9.5	7.0	3.0	3.2	3.7	6.5	8.0	6.0	10.3	17.3	8.6	8.2	18.8	14.5	9.3	30.0	11.8	27.6	10.4	16.5	3.7	31.3	37.2	17.6	0.6	5.1	3.9	3.8	19.8	8.2	6.2	21.0	15.0	4.0	16.3	7.4	0.0	9.7	3.3	27.6	15.5	16.8	6.2	19.6	24.4	7.0	3.2	1.8	4.4	6.4	8.8	1.9	7.5	14.8	6.2	2.5	3.8	15.7	19.1	4.9	14.8	12.8	33.1	63.6	3.2	10.0	0.0	7.0	3.4	3.8	11.7	19.0	7.1	9.3	3.5	16.9	27.1	9.8
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 66.7;stomach 1: 132.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"amygdala: 11.4;basal ganglia: 8.4;cerebral cortex: 18.4;hippocampal formation: 14.1;white matter: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.8"	HPA055407	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA055407: "	"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	2.2	0.4	11.4	1.1	8.4	0.0	2.7	0.6	18.4	8.5	0.0	13.8	1.9	1.0	9.2	1.4	2.5	16.8	0.9	14.1	0.0	66.7	0.2	6.8	0.4	0.0	0.0	0.6	1.4	0.4	1.5	6.2	0.0	1.4	18.2	14.0	17.1	0.6	0.3	5.1	1.4	0.8	0.0	0.6	132.6	0.5	0.0	0.6	0.4	0.7	1.3	0.7	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	8.4	0.6	18.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	6.4	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	2.9	0.0	0.0	6.2	9.2	0.0	0.5	0.7	0.0	13.7	1.4	0.0	9.9	6.0	2.5	0.0	0.0	0.0	6.2	0.1	0.5	0.0	40.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	7.7	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0
MFSD4B	"KIAA1919, MGC33953"	ENSG00000173214	"Major facilitator superfamily domain containing 4B"	Q5TF39	6	111259327-111445354	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.7;Cytotrophoblasts: 24.5;Glandular and luminal cells: 22.4;granulocytes: 20.2;Granulosa cells: 34.4;Syncytiotrophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031784	Approved				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA031784: AB_10603775"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.50e-5)"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.98e-4)"	1.3	1.7	1.5	1.8	1.6	2.2	2.1	2.0	1.5	2.3	7.2	1.4	3.6	1.5	2.4	1.3	1.7	1.3	1.1	1.3	1.6	2.9	2.6	1.4	1.6	1.0	0.7	1.1	1.3	1.8	1.6	4.7	0.5	1.3	1.7	3.0	1.7	1.8	2.0	2.5	3.4	1.6	0.1	1.6	1.6	4.3	1.7	1.4	2.0	0.9	1.3	1.5	1.1	0.8	1.5	3.3	2.8	7.1	2.8	1.7	4.4	2.1	3.1	3.2	4.2	5.5	2.7	3.9	3.3	2.7	3.1	3.4	5.5	2.2	5.1	2.6	1.4	5.0	5.4	3.6	3.9	3.9	8.3	1.2	3.8	3.7	3.0	4.2	2.7	4.9	5.5	5.9	3.5	2.7	3.5	2.4	2.2	3.5	0.9	3.9	2.4	1.6	4.1	4.0	2.0	2.5	2.2	2.7	1.3	3.0	2.2	5.4	2.1	3.3	1.8	16.7	4.0	2.0	2.9	3.9	4.5	3.2	4.0	4.4	1.4	1.9	1.7	1.7	2.0	2.1	1.1	1.1	1.5	1.2	1.5	1.7	1.9	1.7	1.6	1.8	0.9	1.0	1.5	1.6	2.0	1.5	1.3	1.6	1.0	0.7	0.5	0.1	1.7	0.8	4.2	9.6	30.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.7	2.2	0.0	0.0	13.6	5.5	0.0	24.5	5.3	0.0	1.9	5.6	0.0	15.0	9.4	4.1	0.0	0.0	0.0	3.6	11.5	4.9	0.0	22.4	20.2	34.4	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.8	0.0	0.0	6.6	10.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	31.1	2.8	5.7	0.0	0.0
MFSD5	"HsMOT2, MGC11308"	ENSG00000182544	"Major facilitator superfamily domain containing 5"	Q6N075	12	53251251-53254406	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039773	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039773: AB_10793920"	"unprognostic (9.42e-3)"	"unprognostic (9.03e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.19e-2)"	18.5	28.8	15.9	12.2	16.9	22.1	16.5	18.1	17.7	19.7	18.8	19.1	13.5	16.6	12.8	61.3	13.3	11.4	21.8	16.0	17.0	19.3	15.8	15.6	14.7	17.4	17.2	9.9	22.1	19.8	11.7	16.1	17.2	15.7	14.6	26.9	26.1	13.3	19.0	60.1	18.5	13.4	17.4	20.4	19.6	10.6	17.7	9.8	12.9	14.0	20.3	18.2	30.6	18.9	23.8	51.1	15.2	27.9	57.7	32.7	17.6	34.7	43.3	36.4	34.1	27.2	43.8	19.4	29.6	50.1	34.4	43.1	24.9	28.7	24.2	25.0	34.7	14.8	18.6	36.2	40.0	28.6	35.8	40.8	39.5	34.5	17.1	39.4	33.7	18.7	27.8	34.4	35.5	89.2	14.0	35.3	26.4	27.3	44.5	17.1	15.3	26.3	26.8	41.1	12.5	18.8	25.0	34.3	28.0	17.8	59.6	26.4	32.2	30.9	20.0	32.0	22.8	20.8	27.3	15.1	41.1	27.4	30.2	58.3	32.3	103.7	26.6	25.9	32.7	50.1	31.4	30.2	38.1	44.6	23.4	22.4	17.5	27.8	17.7	31.9	27.9	23.4	15.9	16.9	18.1	17.7	16.0	17.0	17.4	17.2	17.2	17.4	17.7	18.9	5.5	9.6	10.6	6.2	12.1	13.0	5.8	15.9	14.2	5.4	9.4	7.4	9.5	10.0	18.1	12.9	31.3	38.4	7.8	20.3	5.9	20.4	0.5	5.2	8.0	10.8	2.4	9.9	2.2	26.5	24.5	12.1	9.2	7.7	5.7	7.6	11.4	10.9	28.6	3.3	2.7	10.9	10.2	18.8	13.4	2.0	6.2	11.7	16.0	0.0	17.2	7.8	14.4	3.5	3.4	21.9	13.3	4.9	10.9	8.7	12.0	10.9	10.3	14.3	6.6	7.7	8.4	4.7	14.2	21.3	17.0	33.2	12.1	6.2	8.5	7.9
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	20.8	40.3	29.1	12.7	31.7	7.6	21.3	37.0	40.3	21.8	0.0	31.8	19.8	10.5	32.8	40.6	19.5	15.8	17.9	35.5	27.6	10.8	2.3	26.4	14.8	45.8	48.3	4.1	16.8	64.5	35.4	8.6	52.4	23.0	28.9	14.9	30.8	32.3	6.4	29.8	24.6	14.4	28.6	20.9	32.1	7.9	38.3	19.9	38.9	14.2	20.6	22.9	21.5	51.2	25.1	15.2	0.5	5.2	10.6	13.6	20.4	12.7	25.3	8.4	10.5	5.6	31.1	39.1	5.8	26.4	15.6	41.5	7.4	22.1	9.5	79.7	11.6	20.9	14.2	2.9	4.2	8.3	6.4	2.1	39.3	12.5	8.1	27.1	3.0	30.5	5.4	42.2	2.2	9.7	38.8	1.8	3.4	27.1	16.1	8.6	1.2	34.1	15.9	45.1	47.5	12.2	17.9	41.7	24.9	1.7	13.6	9.5	12.6	1.4	2.9	16.6	19.7	19.3	8.6	13.8	13.5	16.9	6.9	4.6	1.1	0.4	1.4	0.3	1.5	1.6	1.8	2.0	1.5	0.7	0.9	1.9	0.1	2.1	0.5	0.7	3.5	0.8	29.1	31.7	37.0	40.3	35.5	27.6	45.8	48.3	52.4	28.6	38.3	51.2	48.6	32.1	20.0	7.2	7.6	6.4	11.5	11.7	10.8	9.7	16.8	9.8	21.4	5.7	30.3	23.9	8.4	0.2	14.9	25.1	0.0	13.2	46.8	27.9	5.9	26.7	35.4	7.8	55.7	20.5	0.2	8.9	31.1	22.5	24.0	8.7	16.1	0.8	4.0	28.6	47.9	42.7	12.2	4.0	8.0	13.7	5.6	12.3	8.8	11.2	9.7	6.8	3.1	41.7	110.6	24.9	20.8	5.3	14.9	13.5	13.6	1.0	88.5	7.9	0.0	16.7	7.2	1.0	1.4	28.8	18.3	0.0	17.0	18.6	21.1	22.7
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.8	0.0	2.7	2.3	0.1	1.3	0.6	2.0	0.7	0.2	0.0	0.0	1.6	0.0	0.3	0.0	0.1	0.1	0.0	9.4	4.1	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.0	0.2	4.0	25.5	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102714630-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	2.8	2.2	1.4	2.9	1.4	4.1	2.6	4.3	2.0	3.6	1.8	6.4	8.7	1.8	2.8	4.5	1.8	2.3	1.4	1.9	1.7	4.6	10.5	2.2	3.2	1.4	1.6	2.4	9.2	4.1	3.4	2.4	1.5	2.6	5.8	2.4	4.9	3.1	1.3	2.9	7.2	1.9	1.3	2.7	4.7	1.2	1.7	4.5	2.9	1.2	3.6	3.3	2.2	1.2	3.1	2.4	3.0	5.2	3.6	1.6	6.1	1.9	1.9	2.8	2.8	8.6	4.1	2.7	3.1	1.2	4.3	4.7	4.8	1.8	1.8	11.5	4.4	4.5	3.1	10.9	3.0	3.6	6.2	1.6	6.1	1.7	0.9	2.9	1.8	8.8	2.7	1.3	1.4	2.9	3.7	7.2	2.3	7.4	3.1	2.8	4.9	2.8	5.9	9.4	5.8	4.1	1.7	6.1	6.9	3.2	2.3	5.7	1.3	1.9	4.0	3.2	2.7	3.6	2.9	1.8	2.1	8.4	2.6	1.3	0.3	1.5	1.2	0.6	0.9	0.8	0.9	0.8	0.6	0.6	0.9	1.1	1.0	1.0	0.5	1.2	0.7	0.7	1.4	1.4	4.3	2.0	1.9	1.7	1.4	1.6	1.5	1.3	1.7	1.2	1.6	0.0	1.5	1.0	4.1	3.3	3.2	3.7	2.8	1.5	4.1	1.3	3.1	1.5	5.4	7.3	4.2	8.2	4.3	15.9	0.0	5.8	12.8	3.3	2.0	1.6	3.0	1.7	5.4	8.6	9.1	3.3	7.1	5.3	3.8	3.0	1.4	11.5	4.8	0.0	12.2	8.7	10.2	2.9	1.4	4.5	0.9	2.6	0.0	1.9	4.3	1.4	7.2	4.0	1.3	11.4	8.0	1.2	8.9	4.2	10.4	3.6	3.9	2.8	6.6	2.1	2.4	1.0	5.3	4.3	4.4	11.5	5.1	3.1	7.2	8.2
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MAX dimerization protein MGA"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: AB_2683632"	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	3.9	5.2	7.0	5.4	12.1	8.7	7.2	33.6	8.5	7.3	0.0	4.5	3.7	7.4	6.0	4.5	5.8	4.2	4.5	4.9	11.6	5.2	4.6	4.3	7.6	6.4	6.9	12.0	5.0	6.0	3.9	6.9	8.8	5.7	5.1	7.0	5.1	5.5	5.1	6.2	3.9	5.7	3.8	6.8	4.6	8.7	8.6	11.6	7.5	7.8	7.6	5.4	3.9	17.3	2.4	13.5	16.6	10.9	12.8	10.1	13.3	6.7	6.8	7.8	7.7	14.5	7.8	16.2	11.8	7.8	14.2	9.3	25.9	5.9	10.7	7.7	8.5	34.3	22.1	12.8	11.3	31.9	16.4	7.7	7.2	10.9	10.7	3.2	10.3	15.5	40.7	7.2	7.1	6.7	19.4	12.3	10.3	7.0	6.9	21.7	16.9	8.5	4.1	9.8	15.7	15.3	24.0	8.2	4.3	12.1	6.6	20.1	11.0	9.5	13.3	9.8	8.0	9.8	15.7	15.3	6.0	11.9	4.8	3.6	1.4	1.6	2.5	1.0	2.5	2.8	2.1	2.9	1.4	3.0	2.1	2.4	0.6	5.8	3.3	2.4	1.1	1.0	7.0	12.1	33.6	8.5	4.9	11.6	6.4	6.9	8.8	3.8	8.6	17.3	18.5	22.4	19.8	56.5	28.1	7.9	10.9	7.2	13.6	25.5	11.1	8.9	29.5	5.7	16.2	12.9	33.3	18.1	23.6	9.7	7.9	11.8	16.7	16.8	35.4	18.6	7.8	28.6	62.4	5.3	12.0	20.5	18.8	24.9	14.5	32.9	15.0	9.3	11.8	13.5	60.1	10.0	8.2	11.9	8.8	7.0	20.8	17.1	8.8	44.0	13.2	16.0	25.7	64.8	122.6	8.1	13.5	20.7	16.4	16.2	7.6	5.2	14.9	23.6	39.5	35.6	19.2	45.4	40.4	11.7	11.2	26.0	27.5	23.5	11.3	10.7
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.8;pancreas: 4.0;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.4	0.0	0.2	1.5	11.8	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.6	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266165-139280225	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 228.0;retina: 116.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 151.3;Granulosa cells: 93.5;Horizontal cells: 208.6;Muller glia cells: 508.9;Theca cells: 474.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 20.4;fHDF/TERT166: 30.7;HHSteC: 23.6;HUVEC TERT2: 61.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	9.4	228.0	3.2	0.3	3.2	0.1	1.8	7.8	4.6	2.0	3.1	1.0	0.2	5.0	1.8	0.4	2.2	0.9	3.0	3.1	4.0	1.8	0.2	0.7	0.9	3.7	4.0	23.9	0.3	0.2	11.8	0.3	3.7	2.6	0.3	116.9	0.4	4.0	0.8	0.4	0.3	3.8	3.2	0.8	0.4	8.6	3.6	0.3	0.8	0.3	0.6	1.1	2.5	3.6	0.0	1.1	0.6	0.5	1.5	0.7	0.1	20.4	0.1	3.0	0.1	0.1	0.2	0.1	0.2	30.7	8.7	0.5	4.4	0.1	1.7	0.0	2.0	0.0	0.1	0.2	23.6	0.2	0.2	7.2	0.7	3.3	0.2	7.1	61.7	0.2	0.4	0.4	5.1	0.1	0.8	0.5	1.1	0.4	0.1	0.1	0.0	0.0	0.7	0.3	0.6	1.2	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.8	0.7	0.5	8.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.2	7.8	4.6	3.1	4.0	3.7	4.0	3.7	3.2	3.6	3.6	0.6	0.0	0.0	0.0	0.2	1.7	0.7	0.4	1.2	151.3	0.7	10.8	3.5	0.0	0.1	0.0	8.4	0.2	0.3	0.1	1.9	0.0	0.3	0.8	1.2	1.1	0.0	0.0	1.3	0.0	0.2	10.7	0.0	0.3	0.0	93.5	0.4	0.4	0.5	208.6	2.5	0.0	0.0	0.0	0.3	0.6	17.1	0.6	0.0	0.0	0.0	508.9	2.1	5.0	0.7	0.1	0.0	24.8	0.3	0.3	0.1	9.2	0.0	32.6	0.0	1.9	3.4	0.8	0.4	0.7	0.9	0.3	0.6	474.8	0.1	0.3
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	P26572	5	180784780-180815652	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 280.2;Syncytiotrophoblasts: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved					NA	NA		12000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	130.4	66.7	44.0	65.8	43.8	60.6	113.7	40.7	59.9	70.7	64.6	69.8	50.2	75.2	28.2	103.2	85.8	39.9	103.2	38.4	42.0	63.3	146.9	113.3	68.5	56.7	43.2	75.1	115.3	20.3	61.7	67.3	54.0	75.5	30.1	29.2	82.0	37.1	61.1	73.4	82.2	40.9	47.4	139.9	78.1	36.4	64.9	38.3	96.1	35.6	42.2	85.0	72.3	49.3	58.3	58.2	30.9	66.3	149.6	68.7	111.0	130.1	154.4	77.4	96.7	79.4	45.6	50.2	77.3	122.3	78.2	68.8	17.0	190.8	46.1	271.6	47.6	44.2	34.1	61.7	72.8	40.6	137.6	79.7	91.5	63.1	62.9	53.6	67.9	34.2	26.1	84.7	70.9	78.3	38.9	55.2	29.6	37.5	72.0	46.2	44.5	66.8	30.9	67.3	27.2	32.1	54.6	56.5	115.7	27.2	43.8	68.5	72.9	94.7	44.7	42.7	61.1	165.9	149.2	44.7	77.6	78.9	49.8	93.0	228.6	104.6	83.5	186.7	91.6	48.3	60.2	70.3	161.7	42.0	51.4	59.1	152.2	70.4	149.4	152.9	75.3	235.1	44.0	43.8	40.7	59.9	38.4	42.0	56.7	43.2	54.0	47.4	64.9	49.3	157.8	48.1	31.1	9.8	57.7	61.2	44.6	52.8	50.1	20.7	41.5	29.7	18.4	44.3	32.7	29.5	56.3	94.9	114.7	43.8	37.2	49.0	31.7	26.2	34.2	94.2	49.8	47.6	7.5	79.0	280.2	80.5	33.6	48.7	30.4	27.2	125.7	88.1	200.5	63.9	8.5	54.9	20.3	195.5	142.1	43.2	62.7	234.9	81.8	26.2	112.1	18.9	87.6	8.0	14.6	54.0	34.7	76.0	169.7	76.9	57.2	22.5	20.4	78.8	32.9	72.1	51.5	26.8	22.5	46.8	63.9	384.9	59.3	43.7	36.7	56.8
MGAT2	GNT-II	ENSG00000168282	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	Q10469	14	49620799-49623481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	Yes		5100000	"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	16.8	17.6	5.9	24.3	5.8	10.3	13.3	6.9	6.8	17.4	9.0	23.6	23.1	12.7	21.7	11.8	11.9	15.2	11.7	5.6	6.7	14.2	40.7	13.8	25.3	6.4	6.3	13.1	23.8	8.2	7.9	22.0	6.6	14.1	21.9	8.2	15.8	13.7	5.0	9.3	22.5	16.0	6.9	20.2	21.0	24.3	7.2	16.4	13.3	5.6	25.1	20.9	8.8	7.3	63.5	30.7	23.2	39.2	53.6	51.7	15.1	68.6	67.7	62.2	55.8	37.5	47.1	63.7	56.9	62.9	36.0	49.5	32.9	39.7	66.7	65.5	29.1	40.7	21.7	37.2	42.3	94.5	91.2	39.8	31.2	36.8	51.8	45.5	75.5	31.4	31.7	170.4	66.3	24.2	32.9	60.1	23.8	22.2	49.1	36.7	67.1	55.6	49.3	36.2	24.0	25.6	49.3	12.9	39.8	22.2	39.1	63.6	78.9	56.1	60.8	41.1	49.6	182.8	94.6	56.7	27.3	46.5	38.6	49.4	38.6	39.3	36.6	34.1	39.3	25.1	33.3	33.1	39.9	15.9	19.3	26.8	11.6	22.3	39.8	47.2	31.6	44.8	5.9	5.8	6.9	6.8	5.6	6.7	6.4	6.3	6.6	6.9	7.2	7.3	17.4	12.8	8.6	2.0	31.7	15.7	25.7	28.8	14.2	13.7	15.5	8.9	0.1	24.3	18.0	11.0	4.2	26.4	46.9	34.6	9.8	31.0	7.9	12.5	20.7	20.8	12.1	19.0	3.0	34.4	40.3	24.3	13.7	11.7	17.1	27.7	27.1	63.0	37.2	18.5	4.3	20.5	40.7	34.5	28.8	6.0	17.4	26.3	21.4	2.8	40.6	16.7	63.8	6.0	4.5	36.5	25.1	22.2	77.1	27.0	26.7	15.2	23.5	15.8	6.6	15.8	34.6	56.4	13.0	15.2	14.1	5.3	31.5	23.2	20.0	25.5
MGAT3	GNT-III	ENSG00000128268	"Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase"	Q09327	22	39457012-39492194	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.0;intestine: 28.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Bipolar cells: 30.7;Excitatory neurons: 25.1;Inhibitory neurons: 27.4;Oligodendrocytes: 45.7;Proximal enterocytes: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.4;eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.1;HMC-1: 56.0;OE19: 58.8;U-266/70: 73.6;U-266/84: 32.6;U-698: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"	NA	NA		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	7.8	1.1	26.8	4.0	20.9	10.8	6.4	7.6	47.0	6.2	0.0	5.2	21.5	3.8	0.8	1.1	3.4	3.8	4.8	30.3	10.0	3.0	0.2	14.9	7.6	28.1	15.6	1.2	3.1	0.4	1.8	10.5	21.8	1.2	4.6	6.7	1.8	1.0	1.5	2.3	28.4	2.8	4.8	4.8	7.4	5.4	23.9	1.8	1.5	1.8	9.0	1.6	1.5	27.3	0.3	0.4	10.4	1.0	0.0	0.0	65.1	0.5	0.7	0.5	0.0	14.9	3.7	23.4	8.1	0.0	0.2	1.3	5.4	0.0	0.1	0.0	0.5	18.9	0.0	0.2	0.2	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	15.8	2.9	0.0	0.2	0.6	1.4	3.1	58.8	0.0	1.2	0.0	3.9	0.4	0.6	6.0	4.4	0.0	0.0	0.0	18.5	0.8	1.0	0.0	0.1	8.1	0.1	0.1	73.6	32.6	32.6	0.2	0.1	1.7	1.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.8	20.9	7.6	47.0	30.3	10.0	28.1	15.6	21.8	4.8	23.9	27.3	2.0	44.8	3.0	6.5	2.2	0.4	0.1	1.8	0.0	30.7	0.6	1.1	1.9	1.5	3.7	0.0	6.2	5.5	0.0	4.1	0.0	0.0	19.1	0.9	11.0	2.5	7.8	13.7	25.1	0.2	12.0	2.3	10.2	2.0	2.5	0.0	0.0	0.0	1.5	13.5	27.4	3.8	2.0	0.0	2.3	16.6	4.4	0.9	0.0	0.0	0.1	1.5	0.0	21.6	45.7	1.8	6.1	3.8	1.7	0.3	37.4	1.8	5.2	2.3	6.6	0.3	4.3	0.7	1.2	0.2	0.6	3.7	0.5	0.6	4.5	1.5
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A"	Q9UM21	2	98619106-98731132	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 175.2;Proximal enterocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	11.2	7.8	13.2	20.8	17.8	96.0	12.5	26.1	15.6	8.9	15.1	24.4	29.5	5.8	3.7	6.3	7.0	12.7	7.6	13.1	15.2	27.5	9.7	16.9	21.1	16.4	15.8	3.2	38.8	28.0	9.8	19.6	15.5	7.5	25.5	5.4	25.9	6.4	3.8	4.1	43.8	11.5	18.1	8.1	11.3	6.3	15.5	20.5	8.7	4.7	18.2	13.1	4.7	22.9	8.8	1.7	3.4	7.3	0.0	0.0	127.2	0.0	0.1	0.9	0.0	21.0	10.6	0.0	18.9	0.0	2.4	0.4	7.2	1.0	0.2	10.6	7.9	0.5	0.0	36.7	0.2	17.8	6.4	0.0	4.7	0.0	0.7	0.3	48.3	86.5	1.6	9.2	0.0	17.3	39.3	30.9	1.1	7.6	1.4	9.8	0.0	10.5	24.8	17.6	10.4	3.3	2.5	32.2	4.8	9.2	7.6	23.8	78.8	0.0	4.0	0.1	2.6	3.2	7.6	2.2	0.0	26.7	0.6	7.0	5.1	12.7	20.8	1.0	27.5	3.6	25.2	23.7	3.8	2.5	32.6	27.2	14.0	15.3	2.5	17.1	16.0	12.5	13.2	17.8	26.1	15.6	13.1	15.2	16.4	15.8	15.5	18.1	15.5	22.9	80.8	54.5	25.7	19.2	22.7	9.9	21.1	6.1	11.4	19.8	28.2	15.6	13.4	11.5	17.6	22.0	4.2	6.2	116.9	92.4	21.5	20.8	12.7	14.2	3.8	39.8	53.0	6.3	58.0	29.8	77.9	7.2	19.4	35.1	13.3	5.1	18.9	10.4	57.2	48.8	48.6	41.3	34.6	33.9	18.3	17.5	2.5	54.5	10.6	175.2	21.0	13.4	89.6	36.7	42.0	21.6	58.2	2.2	31.4	17.8	132.4	27.3	7.1	4.8	6.6	6.8	4.9	2.5	7.7	8.6	10.5	14.9	112.2	0.7	40.9	30.2
MGAT4B	GnT-Ivb	ENSG00000161013	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B"	Q9UQ53	5	179797597-179806952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 277.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 224.7;Proximal enterocytes: 224.5;Undifferentiated cells: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		19000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	48.4	105.0	17.2	19.0	16.9	24.6	39.9	16.8	19.3	37.0	18.1	147.0	134.1	36.9	13.4	75.1	37.2	23.5	103.3	18.9	14.2	124.8	277.1	61.2	15.5	16.3	15.0	41.1	63.3	22.9	37.7	17.9	15.1	42.3	65.0	4.4	57.9	11.9	43.8	53.4	168.3	14.9	14.6	52.8	96.3	30.6	18.0	10.5	60.1	14.9	16.0	38.7	42.1	16.2	84.2	85.3	40.8	93.7	117.4	65.1	71.1	48.3	98.3	44.4	34.8	91.7	226.4	14.4	122.3	108.2	193.1	61.6	57.9	110.1	32.2	121.0	33.0	43.5	75.1	78.4	85.9	53.7	13.4	70.5	76.6	44.1	53.0	165.2	89.1	16.9	28.7	38.5	73.6	92.6	8.4	47.4	24.7	123.7	35.1	21.6	31.4	40.4	132.3	158.5	67.5	39.7	73.7	75.2	139.1	33.8	51.3	56.3	109.2	106.6	48.6	61.2	80.2	32.5	39.5	35.4	125.0	68.2	78.7	0.0	0.4	5.5	0.1	0.1	0.0	0.0	0.3	0.1	0.3	0.9	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.2	17.2	16.9	16.8	19.3	18.9	14.2	16.3	15.0	15.1	14.6	18.0	16.2	35.7	12.8	9.2	9.4	7.7	12.5	17.8	12.5	5.2	15.5	29.6	30.7	24.1	37.1	11.1	27.6	4.2	8.1	22.1	224.7	3.9	66.7	0.7	27.2	17.8	24.3	22.9	5.5	11.4	54.0	11.1	15.3	78.5	50.5	5.1	39.5	26.7	89.9	17.7	30.3	10.0	72.2	14.2	20.7	11.7	2.6	15.2	24.5	10.6	9.4	16.8	25.7	6.2	4.5	6.3	89.9	114.6	17.0	7.0	49.0	224.5	22.4	7.7	11.1	13.1	16.2	24.7	1.5	6.5	21.1	11.9	14.0	12.5	24.9	131.8	64.8
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.7;pituitary gland: 3.1;testis: 4.7;thyroid gland: 6.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	0.3	0.8	1.7	0.0	2.0	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.0	0.0	3.7	0.0	0.1	0.1	1.7	1.0	1.8	0.0	0.1	0.1	0.0	1.0	2.4	0.0	0.1	0.0	3.1	0.0	1.6	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.7	2.3	0.0	6.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.2	1.4	1.0	1.8	1.0	2.4	1.6	1.1	2.3	0.7	0.1	6.4	1.1	876.3	0.0	0.1	0.2	1.5	0.0	11.2	0.0	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	123.9	0.1	0.1	4.2	0.0	0.0	988.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1438.9	0.0	4.1	0.0	0.0	98.9	16.1	0.3	0.0	34.7	0.2	0.5	0.0	32.2	17.2	0.4	0.0	4.1	0.0	0.3	0.0	0.1	0.0	1.8	0.0	0.4	0.2	3.8	1.5	0.0	0.1	0.0	0.5	6.2	0.0	0.3
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"testis: 22.7"	"Group enriched"	"Detected in some"	19	"Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAT5	"GNT-V, MGAT5A"	ENSG00000152127	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase"	Q09328	2	134119983-134454621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.5;Inhibitory neurons: 134.5;Microglial cells: 141.5;Oligodendrocyte precursor cells: 124.7;Oligodendrocytes: 495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010919	Approved				"Intracellular and membrane"	NA	NA		440000	"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA010919: AB_10601864"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.41e-3)"	"unprognostic (5.68e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-1)"	9.4	10.4	15.4	15.0	25.2	15.5	7.9	29.6	17.9	9.1	8.5	12.6	16.1	8.8	6.6	9.0	19.0	11.1	39.0	13.3	32.1	15.3	3.7	10.4	24.6	30.5	32.9	12.0	10.9	16.3	6.2	15.1	32.1	8.4	15.0	11.6	14.6	9.4	2.2	6.8	18.1	11.2	18.4	16.2	16.9	7.2	24.2	19.1	11.3	4.6	25.4	13.2	5.0	26.4	27.9	11.0	27.3	19.7	23.8	45.3	19.1	36.4	55.0	14.4	12.0	4.7	13.4	44.3	27.1	29.2	16.4	9.7	21.6	17.0	27.3	43.9	12.7	25.0	13.7	58.0	15.5	24.5	85.1	12.5	17.4	30.3	18.6	19.6	108.7	22.1	13.0	29.6	26.3	17.9	13.3	11.6	12.5	28.9	27.0	16.2	32.3	28.6	11.1	33.7	45.1	55.4	11.7	9.9	69.3	18.3	7.7	16.8	49.5	45.1	24.0	33.1	19.3	8.3	4.1	16.5	37.8	34.4	73.1	0.6	0.4	1.0	0.8	0.3	1.3	3.0	1.5	1.0	0.3	3.7	0.6	0.8	1.1	1.3	0.4	0.9	1.0	0.6	15.4	25.2	29.6	17.9	13.3	32.1	30.5	32.9	32.1	18.4	24.2	26.4	13.2	3.2	2.4	66.6	63.2	8.0	5.7	10.3	8.0	43.6	11.6	9.9	67.3	8.6	8.5	1.8	2.1	3.2	14.9	36.9	0.0	9.0	15.6	22.6	7.6	12.5	7.2	4.4	109.5	9.0	26.3	9.0	37.2	21.0	0.0	23.1	11.7	3.0	15.5	16.8	134.5	20.3	30.5	13.5	9.9	15.1	4.4	12.9	14.2	141.5	5.3	11.4	9.2	124.7	495.5	13.0	13.2	9.4	9.0	9.7	17.6	2.4	22.6	5.2	0.0	8.8	14.3	0.6	6.1	7.3	7.2	5.3	22.4	16.6	9.9	14.5
MGLL	"HU-K5, MAGL, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-128052190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 84.7;plasmacytoid DC: 89.8"	"Group enriched"	"Detected in all"	14	"dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7"	"Cell line enhanced"	"Detected in many"		"BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	174.8	16.1	100.8	22.9	91.0	18.9	92.0	87.2	123.4	26.8	48.0	81.9	36.9	17.7	9.9	139.9	34.3	44.8	101.9	96.9	75.9	71.0	106.9	72.0	13.5	72.5	86.6	6.1	7.8	3.6	12.5	41.6	70.9	25.8	60.4	6.2	102.1	27.5	66.0	38.1	50.3	27.8	63.0	44.9	38.2	6.2	107.2	10.0	18.9	64.9	21.3	42.5	39.4	88.6	52.4	46.2	0.1	0.5	76.8	90.0	6.2	209.1	238.6	45.3	72.2	1.2	21.0	14.0	56.9	71.3	13.7	2.1	0.4	27.9	25.2	23.5	0.9	1.6	31.4	0.4	27.7	0.3	1.7	34.2	16.1	85.0	92.4	25.6	97.5	1.0	0.3	3.0	191.3	5.6	0.5	0.9	0.5	33.6	71.5	0.2	24.6	109.4	170.4	5.9	26.5	2.1	36.3	70.4	12.6	2.0	3.5	2.1	125.9	49.5	14.8	121.0	29.1	0.5	0.4	43.4	102.4	3.4	156.6	20.6	8.3	36.0	0.5	84.7	2.8	4.9	0.5	1.1	9.2	0.5	0.2	0.2	1.5	2.0	57.2	89.8	0.0	17.1	100.8	91.0	87.2	123.4	96.9	75.9	72.5	86.6	70.9	63.0	107.2	88.6	565.4	195.5	108.6	83.2	8.5	22.8	11.9	14.1	5.7	22.8	25.2	19.9	53.7	118.7	32.2	42.3	0.0	84.6	16.1	398.7	168.3	99.4	4.1	100.0	36.4	207.7	88.6	30.7	39.0	160.7	154.6	71.5	47.9	132.1	8.8	0.1	17.2	148.7	123.9	0.0	48.9	239.1	63.1	32.8	86.3	5.8	32.6	77.8	21.4	52.5	235.2	54.5	2.1	43.2	5.8	535.2	201.0	69.6	36.2	18.5	134.2	102.0	48.0	7.8	85.5	22.3	141.4	0.7	1.7	64.7	22.3	72.7	9.3	1.1	74.0	6.0
MGME1	"bA504H3.4, C20orf72, DDK1"	ENSG00000125871	"Mitochondrial genome maintenance exonuclease 1"	Q9BQP7	20	17969018-17991122	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040913	Approved		Supported	Mitochondria		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA040913: AB_10962835"	"unprognostic (5.81e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (5.31e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.89e-2)"	6.5	14.4	7.5	11.7	8.2	16.0	18.4	8.0	9.7	7.3	7.9	11.4	13.4	5.2	10.4	13.1	6.2	7.3	10.8	7.2	7.5	12.8	14.4	7.7	19.9	8.6	8.1	5.9	8.8	7.8	4.7	12.8	8.7	7.5	13.4	7.8	9.0	7.4	21.3	34.2	11.9	6.7	8.3	17.7	9.3	10.7	7.9	19.8	11.9	12.1	20.8	8.9	9.5	9.3	44.7	51.0	41.0	38.7	16.5	29.0	54.9	36.8	27.1	34.8	47.4	63.4	44.7	53.4	20.3	16.4	39.6	64.9	43.1	55.1	52.7	19.9	34.7	34.7	29.6	97.2	12.3	22.9	56.2	17.6	37.3	52.3	27.4	16.3	28.2	26.0	48.0	33.3	70.7	33.4	40.5	29.9	36.3	26.8	44.0	30.5	91.4	50.8	30.1	32.3	31.6	26.1	26.1	62.8	57.7	33.2	59.7	15.5	22.8	59.1	48.1	29.8	40.3	24.6	59.6	45.3	15.2	17.3	44.7	57.5	15.2	44.6	8.1	14.9	10.9	21.0	10.5	10.9	12.6	24.2	7.5	6.9	14.4	16.7	15.0	19.5	17.1	8.4	7.5	8.2	8.0	9.7	7.2	7.5	8.6	8.1	8.7	8.3	7.9	9.3	10.6	0.0	10.0	19.9	24.6	46.4	15.7	12.7	40.9	7.9	19.9	39.4	12.6	15.7	11.9	7.3	8.4	22.9	21.0	14.3	39.2	13.1	9.8	11.2	15.6	11.9	7.2	52.6	3.1	10.2	25.9	8.1	5.1	13.3	48.0	25.5	20.0	9.9	31.4	8.4	2.9	12.1	6.1	34.4	15.4	5.5	8.4	18.8	21.4	9.4	16.4	11.4	28.8	17.6	12.6	10.4	10.6	5.7	13.2	12.3	31.0	26.5	5.9	10.0	13.1	10.3	10.8	38.6	47.0	20.5	46.9	18.1	14.9	27.1	19.0	12.8
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467190-129770983	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 465.7;Proximal tubular cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	21.5	17.0	14.7	10.3	15.1	12.7	20.4	14.8	18.6	13.9	16.6	14.7	16.9	13.3	8.1	15.9	23.7	19.6	18.5	14.1	14.5	23.5	89.3	11.7	19.4	15.9	15.4	16.9	26.5	12.3	9.5	6.8	16.0	15.0	5.0	3.9	22.7	7.8	25.5	17.1	15.3	8.0	14.7	14.3	18.2	15.2	15.0	23.2	16.3	16.0	11.1	18.4	13.8	15.2	0.0	7.0	7.1	35.2	14.9	30.9	27.1	15.6	17.0	10.9	10.7	44.0	45.6	33.0	24.6	20.2	0.0	20.8	4.5	16.4	4.6	0.0	2.7	6.6	16.2	28.6	22.7	0.7	17.8	19.7	0.0	6.6	0.0	0.0	0.1	53.5	0.1	22.0	14.0	60.0	26.1	34.0	1.6	29.9	27.8	29.3	0.1	12.7	20.7	16.0	7.2	18.0	18.3	7.7	0.0	5.5	29.8	25.3	0.0	14.6	7.1	0.1	0.0	0.0	0.0	17.1	0.0	10.8	0.0	9.6	37.2	17.1	43.9	39.2	43.6	49.7	40.4	42.0	39.0	48.2	39.6	42.8	4.6	49.5	37.2	43.7	54.0	42.1	14.7	15.1	14.8	18.6	14.1	14.5	15.9	15.4	16.0	14.7	15.0	15.2	106.0	12.8	19.0	32.0	59.2	51.2	80.6	91.5	49.5	17.4	69.0	112.9	49.3	94.4	48.7	103.0	8.4	51.3	51.1	55.6	127.2	50.0	107.6	138.0	29.6	70.4	54.5	48.2	28.5	58.7	67.0	59.2	31.1	34.1	64.7	93.9	108.1	465.7	89.7	15.2	16.9	73.1	50.8	75.0	48.7	140.6	67.4	44.6	65.8	62.8	56.4	37.2	78.2	23.1	30.7	82.4	57.9	55.3	37.0	47.1	108.4	340.3	102.5	45.6	46.0	48.6	70.6	45.3	81.4	46.9	42.6	26.8	52.5	87.4	63.8	75.2
MGP		ENSG00000111341	"Matrix Gla protein"	P08493	12	14880864-14885857	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 9375.3;Breast myoepithelial cells: 4639.0;Fibroblasts: 4233.6;Hepatic stellate cells: 1826.5;Leydig cells: 2016.2"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 845.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in many"	5	"AN3-CA: 9874.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013949	Approved				"Secreted to blood"	NA	NA		29000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 35: Glandular cells - Unknown function"			"HPA013949: AB_1853599"	"unprognostic (5.71e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.97e-3)"	1737.5	1510.2	50.6	187.4	63.8	1.6	3734.8	48.9	253.3	1738.8	198.1	1827.5	69.8	2043.8	752.9	218.2	2280.1	1083.5	2854.4	49.0	48.2	1316.9	58.1	1269.6	107.0	57.0	49.1	838.7	218.9	109.7	923.0	204.2	51.2	1955.5	277.3	7.5	2112.7	1140.7	177.0	357.6	819.0	1310.0	53.9	142.2	905.9	142.3	58.4	99.5	1500.7	275.0	65.9	987.7	1266.3	48.8	0.9	0.0	0.1	9874.6	1624.2	2.4	3.7	31.8	1.0	0.0	0.0	0.0	12.7	0.2	0.5	3.1	0.4	0.1	0.2	0.2	0.0	0.3	0.3	0.0	1.3	0.0	55.0	0.2	0.2	33.6	0.0	0.0	1.5	3.2	105.4	0.0	0.0	0.3	0.0	0.9	1.2	4.8	7.0	2.2	0.0	0.4	0.2	2.6	0.0	10.5	4.8	31.1	2.0	8.9	0.6	2.8	1810.9	0.1	21.7	11.1	1.2	3.6	28.7	0.5	0.1	1.1	9.0	0.6	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	50.6	63.8	48.9	253.3	49.0	48.2	57.0	49.1	51.2	53.9	58.4	48.8	451.0	19.2	72.8	1.3	29.9	149.3	220.4	0.3	19.9	0.5	9375.3	4639.0	70.2	8.6	187.5	115.8	4.2	19.0	85.7	0.1	1.9	2.3	16.9	14.7	355.8	856.1	0.0	18.7	0.2	83.4	13.5	4233.6	86.2	10.9	13.9	0.3	1826.5	6.0	30.8	0.0	0.1	0.0	0.0	9.4	219.9	67.9	2016.2	36.1	225.9	23.4	2.6	28.8	0.0	0.0	0.2	1.8	1.1	1301.8	17.0	164.3	0.0	0.7	25.8	6.8	841.5	558.8	847.0	8.2	6.1	25.8	118.5	39.5	54.5	140.6	0.0	74.6
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 16.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	23.3	34.3	18.6	25.0	20.6	32.6	22.8	11.9	25.4	28.3	4.9	30.6	28.9	36.9	6.8	20.4	32.1	19.7	26.9	26.4	11.4	24.0	53.5	30.3	18.1	14.1	10.4	30.5	34.6	18.5	33.2	18.5	8.8	30.1	10.9	9.0	25.6	20.5	52.1	23.0	29.9	17.5	8.1	37.7	35.3	18.0	12.0	11.7	28.8	16.7	10.9	28.2	20.6	24.3	13.6	63.9	32.4	33.2	19.0	18.4	44.0	28.7	20.0	23.6	20.0	42.5	31.4	40.0	36.2	35.0	17.6	21.4	26.0	23.6	7.0	56.0	28.8	22.0	45.2	59.6	34.7	32.1	52.3	34.2	15.0	33.0	14.1	17.0	23.0	26.0	32.7	28.6	16.4	59.7	33.3	42.9	48.0	19.2	27.4	60.7	17.0	54.3	20.8	39.3	51.8	42.8	47.6	50.6	28.2	14.8	30.7	31.4	40.8	43.7	24.1	124.3	25.0	44.6	37.8	27.2	18.6	31.8	32.0	5.4	3.5	3.8	2.5	3.9	2.3	1.3	1.4	2.3	2.4	1.5	3.2	1.9	16.2	1.4	2.6	4.1	1.7	3.7	18.6	20.6	11.9	25.4	26.4	11.4	14.1	10.4	8.8	8.1	12.0	24.3	14.7	25.6	34.0	24.2	22.2	9.2	29.5	10.0	6.2	27.3	15.8	11.0	11.4	22.8	9.6	18.4	43.8	23.5	28.2	27.7	5.9	18.6	16.2	20.1	24.2	16.9	37.0	13.7	26.6	22.7	17.7	19.0	44.9	24.5	14.0	30.4	15.0	34.8	30.4	25.2	25.0	23.5	4.1	30.1	21.4	27.2	26.8	27.0	21.4	8.4	36.5	20.8	23.7	18.6	29.8	32.0	15.8	24.8	29.0	23.7	31.7	13.9	11.1	35.2	0.0	20.4	17.6	9.3	12.5	11.9	16.3	34.2	24.0	29.8	23.1	27.8
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1096.9;adrenal gland: 1137.3;liver: 3104.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1205.9;Club cells: 1308.7;Hepatocytes: 4345.6;Proximal tubular cells: 1265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 170.2;myeloid DC: 123.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 123.5;monocytes: 170.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 5391.4;ASC TERT1: 2078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		19000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	1096.9	1137.3	139.2	76.1	143.9	79.3	574.8	131.4	200.7	69.7	111.9	315.5	128.9	32.7	43.9	195.3	78.4	200.8	135.1	133.9	165.4	392.9	3104.7	177.2	3.5	156.5	155.7	11.4	131.3	0.8	52.6	14.2	166.6	161.2	212.8	7.0	155.3	55.8	25.5	88.8	119.5	44.7	146.4	7.3	131.4	20.2	147.5	14.0	272.3	43.3	7.7	267.9	114.7	132.9	1.4	495.2	115.6	139.4	5391.4	2078.4	1.5	408.5	418.5	220.6	339.1	186.0	838.6	0.4	48.5	535.8	694.2	2.4	317.0	663.5	202.9	1.1	41.4	175.7	256.6	664.8	1252.0	350.4	1.2	1375.9	714.7	671.2	710.5	540.4	393.1	0.1	126.7	0.6	486.3	101.2	0.3	137.0	987.6	0.7	391.2	0.4	69.3	229.3	503.3	982.1	21.8	17.1	645.8	411.8	17.5	630.1	442.5	190.8	248.0	226.1	30.5	447.3	541.1	0.6	1.7	1.5	748.1	538.5	7.1	11.3	170.2	1.8	0.1	26.3	0.5	1.0	0.2	0.1	123.5	0.0	0.1	0.1	5.9	0.2	5.9	34.1	1.1	55.9	139.2	143.9	131.4	200.7	133.9	165.4	156.5	155.7	166.6	146.4	147.5	132.9	39.6	266.0	651.3	130.2	14.0	25.6	130.2	1205.9	91.0	0.0	383.8	262.6	5.1	574.7	1308.7	71.7	0.0	2.9	9.8	288.1	181.9	26.9	25.4	299.9	198.2	19.6	45.6	92.8	4.4	434.1	218.1	404.5	153.9	947.9	34.1	26.3	67.5	4345.6	160.2	0.0	0.5	280.5	740.6	176.4	52.0	17.9	33.2	75.7	39.2	6.5	224.4	1.0	5.2	1.0	0.8	322.7	175.0	113.2	6.0	467.2	209.5	1265.6	526.1	1.3	0.0	11.3	124.3	0.7	2.3	510.3	17.6	7.9	22.1	152.4	534.1	883.3
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165631213-165661796	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 2092.0;Syncytiotrophoblasts: 2371.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 793.9;OE19: 781.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	260.2	163.3	218.0	57.7	224.9	126.2	196.5	245.4	273.1	96.6	214.1	219.6	358.6	91.9	520.6	97.6	112.3	114.4	770.2	232.6	258.0	254.3	166.8	117.5	48.9	239.5	228.8	118.0	90.1	139.1	86.1	173.2	248.3	113.4	217.8	89.9	164.0	114.8	568.0	87.8	301.6	118.8	227.4	54.4	163.0	64.2	230.3	51.9	142.9	578.7	47.7	107.2	90.0	240.5	178.2	128.0	150.0	106.1	533.4	312.1	653.1	158.1	244.2	119.1	205.2	126.8	219.1	10.9	117.1	198.6	117.8	204.7	36.2	155.2	118.5	793.9	94.5	27.1	84.7	60.4	144.9	45.0	58.9	284.2	107.5	178.0	62.3	239.4	202.0	54.2	72.3	65.6	233.6	37.0	48.9	97.4	292.3	781.6	165.8	44.8	63.0	22.2	599.8	159.4	104.1	134.2	148.7	181.1	313.2	308.4	139.1	215.9	174.7	135.8	82.6	92.9	110.8	49.7	37.0	5.8	239.8	109.7	92.3	44.8	172.9	81.2	107.2	150.2	107.9	79.3	130.5	117.3	138.0	78.2	81.4	89.1	32.3	62.3	195.0	58.2	125.5	185.0	218.0	224.9	245.4	273.1	232.6	258.0	239.5	228.8	248.3	227.4	230.3	240.5	915.1	102.5	164.8	48.3	87.6	228.3	251.8	603.8	111.0	144.6	177.0	267.6	670.1	301.7	292.6	557.3	266.9	2092.0	96.5	500.3	1001.8	380.2	18.2	325.6	132.6	268.0	152.8	785.4	75.8	425.9	1327.2	300.3	193.7	257.7	91.8	519.5	257.7	295.0	837.4	131.2	86.4	302.9	374.3	130.0	243.1	46.1	388.0	234.9	519.4	43.1	296.6	257.9	87.6	45.8	90.6	401.8	613.9	399.8	92.9	173.9	1004.1	1227.6	459.9	162.5	506.2	197.5	652.1	23.1	40.4	157.1	232.6	2371.4	123.1	288.6	440.7	237.6
MIA	CD-RAP	ENSG00000261857	"MIA SH3 domain containing"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.9;pituitary gland: 76.2;salivary gland: 43.3;stomach 1: 65.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 51.4;Breast myoepithelial cells: 171.7;Melanocytes: 103.2;monocytes: 30.0;Pancreatic endocrine cells: 66.8;Respiratory ciliated cells: 53.9"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Group enriched"	"Detected in some"	29	"AN3-CA: 90.1;CAPAN-2: 80.6;SK-MEL-30: 271.9;WM-115: 247.7"									HPA042369	Approved				"Secreted to blood"	NA	NA	8270000	64000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 4: Stomach - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA042369: AB_10794420"	"prognostic favorable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	2.6	2.9	4.9	6.9	5.9	2.9	57.9	5.7	7.5	8.3	5.4	16.9	2.0	1.2	2.0	6.6	3.7	2.9	5.3	4.4	4.8	2.4	2.7	1.9	2.0	5.3	5.0	7.0	1.4	0.0	76.2	2.1	5.6	6.4	4.2	0.4	43.3	3.3	0.7	9.6	5.9	7.6	4.8	7.0	65.8	1.7	5.5	2.4	2.9	1.7	1.6	4.0	5.2	7.9	0.3	0.9	1.5	90.1	1.3	1.2	1.0	0.0	0.0	0.0	0.5	0.5	80.6	0.2	0.0	0.0	0.3	0.2	0.4	4.9	0.1	2.9	0.9	0.0	1.0	0.1	0.4	0.2	0.4	0.7	4.2	0.0	1.5	1.4	0.0	1.4	0.0	0.9	0.0	0.0	0.1	0.0	0.2	5.9	0.3	0.1	0.2	0.0	2.5	0.0	0.2	0.1	0.1	0.0	271.9	3.4	0.5	1.2	0.0	0.2	3.4	0.1	1.0	0.0	0.2	0.9	0.1	0.4	247.7	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	4.9	5.9	5.7	7.5	4.4	4.8	5.3	5.0	5.6	4.8	5.5	7.9	1.0	0.0	0.5	0.0	0.3	5.2	0.1	11.2	0.6	0.0	51.4	171.7	0.6	0.0	4.9	0.0	0.0	0.8	0.5	1.7	0.0	0.5	0.0	0.9	0.0	1.4	0.0	0.0	0.0	3.2	0.1	1.1	14.3	0.2	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.1	4.1	0.0	0.7	0.3	0.6	0.2	103.2	0.0	30.0	0.0	0.0	0.0	0.0	66.8	5.1	0.0	0.1	0.8	0.4	0.0	53.9	0.0	0.0	0.2	1.3	0.1	0.6	6.1	1.3	0.7	0.3	0.8	4.1	0.5
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA SH3 domain ER export factor 3"	Q5JRA6	1	222618097-222668007	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA055922, HPA056816"	Supported		Enhanced	Vesicles		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	25.6	22.0	11.0	23.4	13.1	33.2	21.4	12.9	14.9	23.9	13.2	24.3	23.9	23.7	29.2	13.7	16.0	20.6	20.6	10.9	13.6	21.1	74.5	21.5	26.9	10.8	12.3	25.4	38.7	30.1	15.2	23.1	11.7	39.3	29.5	24.4	33.2	22.1	23.7	17.4	25.9	23.8	10.7	27.3	45.0	36.5	11.5	25.7	31.7	20.5	26.2	21.0	14.1	12.8	24.8	18.8	26.5	42.5	92.8	47.1	46.5	34.8	49.4	36.2	43.1	16.6	26.2	24.0	33.0	41.8	20.5	39.9	28.5	31.3	37.8	38.1	21.6	27.7	21.5	31.5	88.6	50.7	34.7	45.2	35.0	35.9	60.8	44.8	41.4	28.9	34.8	44.4	30.7	15.9	34.3	33.8	33.2	76.8	27.5	24.4	70.8	47.8	23.1	22.8	30.4	31.3	38.6	36.2	30.4	36.2	38.2	37.5	31.7	27.5	17.9	44.5	41.3	48.4	30.9	23.8	36.7	25.4	37.5	26.8	15.6	36.5	17.6	22.4	17.7	20.7	14.7	17.5	11.7	18.6	16.4	17.8	27.1	22.5	26.0	13.2	19.2	13.5	11.0	13.1	12.9	14.9	10.9	13.6	10.8	12.3	11.7	10.7	11.5	12.8	48.5	70.5	49.6	31.3	46.9	18.7	26.8	20.4	29.0	60.9	24.3	35.3	65.0	25.8	47.1	5.5	31.3	28.6	73.8	35.2	0.0	25.1	37.0	34.9	72.5	36.4	60.4	26.3	51.4	34.8	17.0	53.0	79.5	42.0	17.7	44.2	25.4	63.3	20.4	45.4	58.0	95.3	32.6	22.0	14.0	24.9	37.0	32.9	19.6	35.6	32.1	31.8	44.3	41.2	29.1	26.4	25.8	48.9	54.4	39.0	41.3	19.4	44.7	41.5	19.7	57.9	46.6	55.7	42.1	21.9	16.1	35.8	47.8	70.2	24.6	29.4
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	8.1	6.3	9.1	6.0	9.1	4.9	11.2	9.2	8.5	11.0	8.0	7.1	5.1	13.0	9.5	8.0	7.1	8.6	6.0	8.4	9.2	11.1	10.4	7.2	7.6	9.5	10.2	11.7	8.1	9.8	5.2	11.0	8.6	10.1	7.0	8.3	8.4	8.5	5.8	9.1	5.2	10.2	10.1	7.2	7.6	8.7	10.3	11.5	13.6	7.0	7.9	8.4	8.2	9.6	19.9	7.6	36.4	25.8	19.5	23.0	9.0	15.6	17.2	10.8	15.6	11.3	7.1	16.9	14.1	21.4	11.8	13.2	21.4	21.0	24.4	22.4	10.4	18.8	9.7	15.9	15.8	38.3	7.8	14.8	23.0	12.6	32.0	16.0	27.8	6.6	26.5	47.5	17.2	9.5	18.9	14.7	9.5	12.2	10.2	121.1	30.3	42.5	18.7	16.9	12.1	30.1	26.8	12.4	13.9	18.6	8.8	25.1	23.9	27.8	14.2	11.7	21.1	25.6	9.5	25.4	11.8	24.1	16.9	0.7	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.5	0.1	0.2	0.4	0.1	9.1	9.1	9.2	8.5	8.4	9.2	9.5	10.2	8.6	10.1	10.3	9.6	35.7	48.1	22.7	68.2	11.9	21.9	15.1	19.8	24.5	28.8	24.1	19.7	18.1	25.8	31.8	16.5	25.0	13.3	18.2	20.8	3.9	13.4	7.0	29.0	59.2	30.8	24.0	23.1	106.7	12.9	7.5	33.1	10.2	32.4	14.5	16.8	24.3	30.0	12.9	15.2	92.6	17.1	26.4	17.2	16.2	5.6	20.5	14.2	26.6	67.5	19.4	17.7	15.5	121.2	109.6	18.8	7.0	24.8	18.1	48.5	8.7	15.9	30.6	14.5	0.0	35.4	26.9	26.2	12.0	23.4	24.6	25.3	14.5	21.8	10.4	25.3
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 130.9;Late spermatids: 242.0;Suprabasal keratinocytes: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.2;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	4.5	7.3	2.8	1.1	2.4	0.9	3.9	0.4	7.7	7.6	2.8	7.5	1.2	6.8	0.1	19.9	7.0	0.4	16.4	3.4	2.8	8.5	9.6	4.1	0.4	6.0	0.3	8.3	8.7	0.8	15.6	0.5	0.7	6.8	0.4	0.4	5.7	1.5	44.0	18.9	5.7	0.4	0.0	6.5	6.6	9.6	0.6	0.5	6.2	2.2	0.0	7.3	7.1	1.5	7.6	1.1	0.5	1.7	1.9	0.7	10.2	3.5	1.6	1.1	2.5	1.5	1.9	0.8	4.9	1.0	0.5	15.2	0.5	2.3	0.0	4.0	6.3	0.6	2.5	1.5	2.6	1.0	2.5	1.5	1.6	0.7	0.2	0.7	0.6	3.4	3.1	1.3	0.3	1.2	4.2	9.7	1.3	1.9	11.8	7.1	2.1	10.8	0.1	0.9	15.7	5.7	5.9	0.8	6.5	0.3	1.1	3.7	0.7	1.0	2.4	5.7	1.0	7.6	2.4	2.2	2.6	3.1	1.3	0.0	0.1	1.7	3.2	0.1	3.2	2.6	2.4	3.5	0.0	3.3	2.9	2.2	0.3	6.3	0.0	7.3	2.0	0.8	2.8	2.4	0.4	7.7	3.4	2.8	6.0	0.3	0.7	0.0	0.6	1.5	15.2	0.0	8.4	21.5	20.0	130.9	16.2	17.1	86.0	35.1	18.5	18.4	11.2	18.6	11.3	23.9	12.5	11.1	61.2	50.8	9.8	7.9	75.9	19.0	12.2	12.1	15.0	5.7	18.5	1.3	10.3	16.0	34.7	13.1	20.3	32.5	17.5	10.6	6.6	26.9	13.5	35.7	8.2	11.6	22.2	242.0	21.1	12.4	17.8	4.7	8.9	30.0	110.2	10.1	11.9	5.8	50.3	15.8	19.5	12.1	44.6	20.8	10.2	35.7	0.0	17.0	20.1	22.3	45.6	85.6	126.0	15.1	43.3	20.6	38.2	18.3
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 148.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	20.6	6.3	17.8	27.6	17.5	65.9	14.2	17.8	25.6	48.6	16.1	21.7	37.8	29.6	2.5	11.8	32.7	14.7	11.1	17.8	19.9	18.8	5.4	35.2	32.8	20.7	18.4	13.6	8.7	9.2	17.9	10.7	20.6	30.8	10.1	6.2	11.0	18.8	5.1	16.0	43.2	9.1	18.1	56.7	18.3	18.7	20.3	18.3	12.6	3.9	16.6	62.2	30.8	22.4	4.1	5.1	15.8	0.2	55.9	43.6	10.7	31.3	22.0	6.7	11.0	7.3	4.7	23.2	6.6	33.1	19.4	5.4	9.6	12.3	2.8	20.3	4.0	9.9	12.0	11.5	22.8	6.5	0.3	25.7	6.2	15.5	12.6	25.2	20.0	14.0	2.7	40.2	40.6	5.1	8.0	36.0	9.9	5.5	5.4	21.9	10.0	3.3	15.0	10.0	5.3	28.1	2.9	2.7	50.4	10.0	4.9	148.8	21.6	16.7	5.9	9.8	12.2	29.7	9.6	20.8	13.9	21.4	12.3	14.6	7.3	13.6	6.5	13.2	3.9	3.5	6.4	5.2	12.8	5.1	4.3	3.1	9.3	5.1	14.2	14.4	9.4	6.8	17.8	17.5	17.8	25.6	17.8	19.9	20.7	18.4	20.6	18.1	20.3	22.4	5.3	44.8	14.4	3.3	26.2	6.1	1.3	2.3	1.2	3.4	2.5	3.6	4.4	0.0	4.2	1.8	4.2	1.3	31.0	24.9	1.9	7.8	13.2	2.0	29.8	5.9	32.2	4.6	13.8	6.5	10.9	9.7	76.9	2.4	15.2	3.1	4.6	0.3	32.2	0.0	12.9	34.9	6.1	28.3	44.5	23.1	20.8	34.7	16.0	8.4	34.0	2.2	21.6	12.5	4.2	11.6	27.6	37.6	15.4	1.3	49.6	4.6	10.7	18.3	0.0	31.6	27.3	7.9	9.5	0.7	4.8	4.8	22.5	2.9	13.9	1.5
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	O94851	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 109.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.7	3.8	13.9	12.2	13.6	11.6	2.5	61.6	38.1	6.9	42.6	18.8	9.8	12.3	7.2	18.6	7.4	10.0	42.2	37.8	0.0	2.3	2.9	17.5	3.3	0.0	0.0	3.9	4.1	1.0	0.2	7.3	0.0	2.9	16.3	4.0	0.8	9.6	16.8	14.0	10.8	30.8	0.0	3.3	6.7	32.5	0.0	1.9	6.1	4.1	2.5	12.4	0.3	19.9	29.1	9.7	0.4	2.7	2.3	6.8	14.2	32.1	53.7	16.2	28.3	24.3	23.3	0.2	8.4	25.3	47.7	25.0	4.0	65.1	41.6	35.9	4.8	27.5	4.1	0.9	12.8	5.3	2.7	12.7	11.1	76.0	54.6	25.3	46.9	1.6	43.5	0.8	22.9	1.2	0.3	1.6	1.2	13.6	9.8	0.3	15.2	14.2	2.1	35.5	14.3	0.8	8.6	38.6	2.9	9.9	4.5	2.3	42.6	109.6	35.0	17.4	39.6	0.9	2.6	1.5	64.3	5.2	1.4	0.1	4.2	0.5	1.3	0.7	1.5	0.1	0.8	0.4	3.4	0.2	0.0	0.4	8.9	2.2	0.4	0.9	0.7	1.5	13.9	13.6	61.6	38.1	37.8	0.0	0.0	0.0	0.0	0.0	0.0	19.9	3.2	41.7	37.1	7.2	1.2	10.1	11.8	4.5	4.0	5.7	4.2	5.3	32.2	7.2	8.5	3.7	0.0	2.6	11.2	66.5	0.0	10.2	74.4	7.8	8.9	9.2	22.6	35.6	193.5	14.3	12.6	9.0	12.2	11.4	1.3	1.4	12.8	19.6	3.4	0.0	108.8	10.6	6.1	10.1	5.6	192.7	21.1	11.1	5.4	4.7	21.6	0.5	8.2	6.6	17.5	42.5	24.0	112.8	2.1	8.9	18.3	0.9	5.5	1.6	13.1	1.9	29.4	1.2	1.3	1.7	9.5	2.3	10.8	0.7	14.5	11.9
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MICALL2	"FLJ23471, JRAB, MGC46023, MICAL-L2"	ENSG00000164877	"MICAL like 2"	Q8IY33	7	1428465-1459470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.2;Distal enterocytes: 85.4;Gastric mucus-secreting cells: 171.8;Proximal enterocytes: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.7;OE19: 30.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025695	Enhanced					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA025695: AB_10610140"	"unprognostic (2.46e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (3.51e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (6.53e-9)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.84e-2)"	4.9	18.4	1.0	4.9	0.2	7.6	4.7	0.5	2.4	6.8	0.0	13.9	12.4	5.2	0.2	8.2	5.5	3.4	4.9	0.8	0.3	8.1	5.4	7.9	2.2	0.3	1.5	1.4	4.6	0.7	6.6	0.7	0.4	9.5	1.8	0.0	8.3	2.1	1.5	6.8	18.6	2.2	0.0	15.4	12.8	2.7	1.2	1.7	6.7	0.0	1.0	9.8	6.2	0.9	16.6	1.8	0.5	2.2	1.7	4.2	4.5	7.6	2.9	3.4	1.2	2.2	6.3	0.3	4.6	2.4	6.9	9.4	0.0	8.8	0.2	1.2	2.0	11.0	3.0	1.3	2.1	0.5	27.7	5.5	2.0	2.4	0.3	2.1	3.9	1.5	18.3	0.5	1.6	17.4	0.4	17.6	1.5	30.2	5.3	2.9	3.1	11.7	2.3	4.5	0.4	1.5	6.3	11.5	6.0	0.7	9.6	6.3	13.4	2.5	19.6	9.3	7.7	0.8	0.2	0.0	8.1	6.0	16.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.5	2.4	0.8	0.3	0.3	1.5	0.4	0.0	1.2	0.9	5.3	3.2	10.8	103.2	2.0	8.7	7.0	39.0	16.5	1.9	13.2	10.9	7.7	18.6	22.5	14.7	2.1	0.5	1.9	85.4	1.9	11.4	5.9	13.5	7.7	10.0	6.0	7.8	13.0	15.4	6.6	9.9	171.8	14.3	5.7	5.4	10.4	3.2	3.3	3.3	10.0	49.0	18.3	3.5	6.2	5.3	4.1	3.3	3.6	4.7	2.3	1.2	0.0	29.1	5.7	18.4	51.9	0.4	1.5	12.8	70.2	1.5	25.3	1.6	6.6	4.1	11.4	5.3	6.2	14.6	6.1	1.2	1.7	3.3	36.9	8.0
MICOS10	"C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial contact site and cristae organizing system subunit 10"	Q5TGZ0	1	19484403-19629821	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059930	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	4.9	5.0	11.5	3.1	11.6	2.6	6.0	11.9	13.6	8.6	11.0	9.3	5.1	7.0	6.2	7.2	7.3	4.1	12.6	11.5	13.1	9.7	4.0	4.6	4.3	12.9	11.7	6.4	5.2	11.1	9.5	4.0	13.1	8.5	8.8	5.9	5.1	8.3	14.3	4.8	6.0	7.0	11.3	3.6	6.7	3.4	13.8	4.0	6.5	16.8	5.9	7.0	6.2	11.1	10.0	13.3	7.3	8.4	13.7	13.6	4.5	8.3	9.6	9.5	10.1	9.3	8.7	8.1	6.8	11.0	7.7	6.9	12.8	10.9	15.2	12.7	9.1	7.1	21.2	13.0	6.0	11.6	5.1	10.7	17.5	9.5	11.6	7.4	14.1	6.0	15.8	5.9	14.4	17.2	5.8	15.0	6.2	12.5	16.7	5.7	9.3	10.8	23.3	5.9	15.4	6.7	9.6	7.4	7.1	5.7	7.1	6.7	9.3	7.4	5.7	9.5	8.3	3.8	6.8	8.4	5.8	21.3	7.1	3.8	4.8	5.7	3.6	6.6	3.3	4.3	4.9	4.1	5.1	4.1	6.3	4.5	3.2	2.3	7.0	5.0	4.9	5.9	11.5	11.6	11.9	13.6	11.5	13.1	12.9	11.7	13.1	11.3	13.8	11.1	63.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.9	0.0	0.0	0.0	0.0	283.4	25.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	279.7	52.8	0.0	0.0	0.0	0.0	0.0	0.0	531.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	183.5	5.3	0.0	0.0	0.0
MICOS13	"C19orf70, MIC13, P117, QIL1"	ENSG00000174917	"Mitochondrial contact site and cristae organizing system subunit 13"	Q5XKP0	19	5678421-5680516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 344.8;Cytotrophoblasts: 154.4;Extravillous trophoblasts: 196.7;Hofbauer cells: 242.2;Syncytiotrophoblasts: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	71.0	68.8	139.7	48.4	143.6	54.1	59.3	153.6	180.2	44.4	137.0	76.5	78.6	46.9	44.0	86.9	67.3	53.8	271.2	141.2	154.5	93.5	78.3	44.2	60.4	148.7	143.8	44.7	86.7	97.4	59.8	37.9	147.1	50.1	40.7	18.6	95.3	60.7	279.3	59.7	66.7	43.8	142.0	45.0	61.8	149.2	151.4	38.8	57.9	186.5	35.2	61.3	49.3	146.7	175.7	167.9	43.4	87.6	98.3	117.1	58.7	100.7	121.0	142.6	120.3	132.6	85.2	82.0	157.6	105.2	65.3	124.7	25.8	175.5	34.6	128.9	311.9	76.1	101.2	153.4	162.5	105.8	79.2	133.0	157.9	71.5	92.6	68.0	104.9	112.5	120.5	220.6	101.2	186.3	145.7	129.2	45.1	118.5	474.3	79.5	57.8	286.7	145.3	126.1	111.5	134.8	37.8	198.1	152.2	25.2	128.3	123.8	87.4	121.9	50.5	217.4	169.2	315.8	280.6	66.9	174.5	183.6	126.0	76.8	214.3	77.8	198.9	274.7	237.5	291.6	228.5	225.8	261.4	235.7	222.8	211.3	29.6	192.1	238.8	302.5	211.1	278.1	139.7	143.6	153.6	180.2	141.2	154.5	148.7	143.8	147.1	142.0	151.4	146.7	44.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.8	0.0	0.0	0.0	0.0	154.4	24.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	196.7	46.9	0.0	0.0	0.0	0.0	0.0	0.0	242.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	125.9	5.8	0.0	0.0	0.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MICU3	"DKFZp313A0139, EFHA2"	ENSG00000155970	"Mitochondrial calcium uptake family member 3"	Q86XE3	8	17027238-17122642	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.9;Excitatory neurons: 161.4;Inhibitory neurons: 167.3;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 141.9;Rod photoreceptor cells: 82.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HBF TERT88: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024771, HPA024779"	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA024771: AB_1848022, HPA024779: AB_1848023"	"unprognostic (2.99e-2)"	"unprognostic (7.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.25e-2)"	"unprognostic (9.01e-5)"	"unprognostic (9.82e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.65e-2)"	6.4	7.5	8.7	1.5	11.2	0.6	4.4	23.2	19.5	6.3	0.3	3.8	0.9	6.7	4.2	3.0	4.5	3.6	4.4	11.3	7.8	4.4	10.3	3.4	2.6	6.7	5.6	8.2	2.9	7.7	8.2	6.7	6.8	5.9	1.9	14.9	3.2	4.4	3.6	1.8	2.1	4.8	5.9	4.6	2.6	5.3	7.7	1.4	5.0	6.5	1.9	4.9	4.2	11.6	0.0	1.2	6.0	2.3	4.5	6.7	1.5	9.0	12.7	6.8	5.5	0.0	0.2	0.2	1.8	4.7	4.8	0.0	2.7	1.8	12.7	0.0	1.6	0.0	0.0	2.2	7.8	0.0	0.3	5.1	0.0	5.7	5.7	6.3	2.6	4.6	0.4	1.7	6.4	0.0	0.8	1.1	4.2	0.0	1.5	0.0	2.7	0.0	4.7	0.0	9.8	4.6	0.0	0.0	3.7	2.6	0.0	0.0	3.4	2.9	1.1	0.4	1.6	1.7	1.4	3.1	5.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.7	11.2	23.2	19.5	11.3	7.8	6.7	5.6	6.8	5.9	7.7	11.6	18.2	6.4	6.0	68.9	12.3	0.9	8.1	0.4	12.0	82.9	5.8	12.7	15.5	10.0	2.0	5.5	41.7	1.8	2.9	0.0	7.9	5.4	6.8	0.9	30.2	10.0	0.0	4.2	161.4	2.9	1.2	19.0	2.6	1.0	8.2	14.3	7.1	14.1	0.6	74.0	167.3	0.0	0.0	2.2	1.5	7.2	27.4	2.7	1.8	68.4	1.6	24.0	3.1	96.5	141.9	2.8	0.0	24.0	0.9	5.6	0.0	3.9	1.7	82.2	39.5	14.9	40.1	23.7	11.8	3.1	1.6	7.3	4.6	34.1	0.0	2.7
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 129.3;Basal squamous epithelial cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 156.1;AF22: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Uncertain	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	5.9	2.5	6.9	5.0	7.7	1.7	5.3	17.2	5.0	7.0	6.5	17.3	5.7	8.9	4.9	7.0	6.4	6.8	9.3	7.0	4.9	7.3	4.2	6.5	2.2	3.6	10.4	4.4	3.5	2.8	4.2	6.2	4.9	10.4	10.6	12.3	4.9	12.9	0.7	2.9	5.8	12.3	2.1	1.0	3.8	3.6	8.2	2.3	4.2	2.2	3.1	11.7	6.2	4.4	33.2	156.1	132.5	16.7	8.1	9.2	14.6	16.2	17.8	19.7	20.7	31.0	9.7	10.6	6.5	21.9	58.4	22.5	11.0	15.1	23.0	1.3	11.0	2.7	24.3	1.1	2.8	0.3	1.2	12.1	7.0	16.1	15.8	20.4	23.1	5.1	2.1	3.2	9.6	8.0	5.3	0.5	32.7	5.1	10.0	3.9	28.9	0.4	18.7	36.2	7.1	3.5	7.4	23.5	10.1	42.7	19.2	0.2	13.7	7.2	1.0	34.1	17.0	2.8	1.2	0.4	13.5	0.3	31.3	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.0	0.1	0.4	0.0	0.1	6.9	7.7	17.2	5.0	7.0	4.9	3.6	10.4	4.9	2.1	8.2	4.4	16.5	35.3	20.7	129.3	0.7	21.4	31.5	24.7	82.6	10.7	8.5	13.2	4.8	8.6	19.6	23.9	18.8	9.1	1.3	22.6	1.9	13.4	2.2	39.8	8.9	25.4	12.1	2.7	15.5	8.7	26.9	16.2	10.7	38.5	1.3	13.4	69.9	4.0	1.5	69.0	44.3	9.0	2.0	2.5	5.8	7.9	30.1	1.2	3.6	23.4	0.0	37.0	0.0	66.4	59.2	7.3	17.2	41.3	0.2	8.2	11.3	1.5	19.3	2.9	6.6	3.7	3.3	0.3	2.4	36.1	10.1	20.0	0.8	9.7	20.0	49.2
MID1IP1	"FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL"	ENSG00000165175	"MID1 interacting protein 1"	Q9NPA3	X	38801432-38806537	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 217.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038816	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA038816: AB_10670908"	"unprognostic (5.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.31e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (8.06e-4)"	40.2	34.1	102.1	13.9	143.4	103.6	34.5	106.6	105.3	20.4	50.4	45.0	17.0	18.3	6.9	35.5	30.9	7.5	39.5	78.6	91.9	29.5	56.1	43.7	11.1	115.4	123.4	33.4	78.7	4.0	15.4	8.7	107.4	23.0	5.0	3.4	25.0	13.3	150.2	28.7	25.1	9.3	99.2	12.3	49.7	23.0	127.8	9.1	13.8	25.9	6.2	35.5	24.3	139.5	60.3	55.2	14.3	10.9	67.9	31.8	15.4	33.2	23.2	7.1	13.5	18.5	44.3	57.7	28.4	10.7	6.0	55.3	47.7	39.4	4.7	39.9	18.7	49.4	48.7	14.9	51.6	23.1	36.7	46.4	31.1	27.7	24.2	19.1	7.2	68.9	46.5	60.7	10.1	50.4	40.8	64.3	49.5	17.6	95.9	111.2	17.6	116.4	18.5	29.8	34.0	41.3	17.6	34.0	90.9	28.2	28.0	70.5	10.0	20.2	22.4	25.5	24.6	155.5	65.0	53.6	61.1	37.4	22.3	3.8	1.9	15.7	0.9	1.3	1.0	0.5	1.4	1.0	1.3	0.7	1.2	1.2	8.0	0.8	2.0	1.3	0.5	0.9	102.1	143.4	106.6	105.3	78.6	91.9	115.4	123.4	107.4	99.2	127.8	139.5	20.3	80.1	217.9	11.4	17.4	23.7	48.5	63.0	44.3	12.5	22.4	21.1	40.5	52.9	28.2	20.2	4.2	3.7	16.6	23.3	37.2	36.7	8.3	65.6	25.0	25.3	25.8	54.1	1.7	70.0	20.2	57.7	49.5	20.8	48.8	13.2	24.3	40.5	40.4	15.2	2.7	33.2	63.1	53.2	73.8	12.7	39.4	60.5	26.6	5.6	130.4	20.7	8.2	3.5	47.6	67.0	24.4	49.7	6.9	36.7	18.1	47.9	48.0	12.4	39.5	42.7	52.8	2.4	3.7	63.0	16.3	4.9	35.4	16.3	25.5	116.9
MIDEAS	"C14orf117, C14orf43, ELMSAN1, LSR68"	ENSG00000156030	"Mitotic deacetylase associated SANT domain protein"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	9.0	5.0	4.1	9.3	4.2	14.5	6.6	5.1	5.2	6.4	0.4	7.1	7.7	7.3	1.3	9.3	6.7	9.2	6.7	2.6	4.0	3.0	4.7	6.9	9.3	5.3	2.3	11.3	5.9	9.7	2.6	8.8	1.6	5.7	3.9	2.9	7.8	5.8	10.1	11.8	8.8	6.5	0.4	13.7	7.5	5.4	5.5	5.8	6.2	5.9	5.6	5.7	6.2	7.9	12.8	14.1	5.0	9.4	4.6	7.8	9.6	5.1	8.7	7.0	6.3	12.5	14.8	18.5	5.6	7.0	7.3	19.3	8.3	14.5	2.8	24.6	5.1	29.7	12.8	4.5	7.4	5.2	61.9	10.4	8.8	6.1	7.6	6.1	11.2	6.4	15.5	16.7	3.4	29.7	12.0	8.3	1.6	6.4	11.7	13.8	27.0	4.9	10.4	13.5	6.4	5.3	19.3	26.4	10.3	2.8	20.3	10.8	22.6	14.3	16.3	10.8	5.6	13.0	6.7	20.4	11.7	6.3	17.0	0.6	0.5	0.2	0.3	0.2	0.4	0.4	0.1	0.3	0.6	0.7	0.2	0.2	0.8	0.5	0.3	1.2	0.4	0.4	4.1	4.2	5.1	5.2	2.6	4.0	5.3	2.3	1.6	0.4	5.5	7.9	59.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	41.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	32.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	29.4	3.6	0.0	0.0	0.0
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 455.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	71.4	61.9	25.6	25.2	25.0	82.6	42.7	24.9	32.3	48.0	16.1	53.9	22.3	34.2	6.3	99.2	64.6	31.4	72.9	21.1	32.1	46.9	50.5	67.0	19.1	44.8	30.1	61.4	37.4	8.2	81.9	15.5	29.8	39.2	12.0	12.4	46.6	11.5	141.6	79.1	52.6	12.4	29.8	50.3	56.1	19.6	32.4	19.0	35.0	17.4	15.1	42.2	55.7	23.1	14.7	31.8	53.5	25.0	11.2	19.0	39.2	25.0	14.9	12.6	8.9	41.8	16.1	23.3	26.6	18.9	6.8	29.6	16.3	26.5	4.9	32.9	30.0	32.8	21.8	33.3	22.7	33.3	46.9	29.4	24.4	15.1	14.3	19.5	20.8	27.3	42.7	24.0	13.5	58.9	44.6	13.6	117.6	28.6	21.1	68.8	15.2	10.7	23.8	17.2	42.7	55.9	52.9	50.1	33.7	27.7	20.2	37.7	26.2	22.9	25.4	106.2	27.3	22.4	13.2	32.2	43.9	14.6	79.5	1.6	1.0	1.1	1.0	1.0	0.7	0.2	0.3	0.7	0.4	0.3	0.2	0.5	11.8	1.3	1.1	0.4	0.1	0.7	25.6	25.0	24.9	32.3	21.1	32.1	44.8	30.1	29.8	29.8	32.4	23.1	330.7	38.5	60.5	17.3	101.1	98.9	128.3	114.4	175.8	53.9	290.6	224.2	84.3	117.2	86.2	134.3	31.3	15.8	184.8	455.8	19.6	125.5	34.7	220.6	84.5	186.1	164.5	19.4	8.0	155.5	47.3	84.0	132.0	294.7	61.5	60.6	197.4	80.9	77.9	21.9	5.6	219.5	59.0	100.0	134.9	33.3	49.7	150.9	42.7	24.4	49.7	77.8	96.8	32.2	10.3	259.0	306.8	33.1	69.9	190.9	242.1	35.8	109.6	35.7	39.5	219.8	142.4	3.3	12.0	227.3	148.0	81.3	122.9	33.2	167.8	190.7
MIEF2	"MGC23130, MiD49, SMCR7"	ENSG00000177427	"Mitochondrial elongation factor 2"	Q96C03	17	18260597-18266552	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042334	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"			"HPA042334: AB_10794418"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-2)"	"prognostic favorable (1.75e-7)"	"unprognostic (4.68e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	4.8	9.9	3.6	1.5	3.8	1.6	6.0	4.9	4.4	8.8	4.5	6.4	3.6	7.6	4.1	11.4	8.2	2.0	17.1	3.6	3.2	11.9	6.5	5.7	2.3	4.6	3.6	10.2	7.7	6.0	10.5	2.4	3.7	7.8	1.5	2.1	10.6	3.3	24.6	9.6	5.7	1.9	3.0	5.7	6.6	4.9	3.2	1.9	9.8	12.0	1.7	6.2	8.1	3.7	24.0	7.0	2.5	5.5	1.8	2.1	4.4	8.1	4.7	6.6	3.3	9.8	7.4	3.4	8.6	4.0	3.1	17.4	1.8	6.1	3.3	3.3	10.6	1.2	12.0	4.6	3.3	0.6	2.9	2.0	6.3	3.3	2.3	5.4	2.8	4.6	2.9	0.9	2.5	6.8	3.0	2.3	2.1	5.6	3.4	4.2	7.4	4.5	9.2	4.4	1.9	4.3	6.0	7.4	3.4	16.0	18.0	2.1	3.4	4.6	7.5	7.3	3.7	3.6	2.3	1.0	6.6	1.2	2.5	1.6	1.9	6.4	3.5	1.8	3.3	2.1	2.8	2.9	2.0	3.3	3.2	3.4	3.2	7.7	4.7	3.0	3.7	2.1	3.6	3.8	4.9	4.4	3.6	3.2	4.6	3.6	3.7	3.0	3.2	3.7	2.9	16.0	6.0	2.6	4.6	1.9	3.9	6.8	2.8	16.9	5.2	5.5	16.2	1.5	5.6	11.0	16.7	12.0	3.4	6.4	9.8	15.1	14.6	11.4	2.7	4.0	4.2	2.5	2.5	6.0	5.5	4.6	1.5	8.4	2.5	7.0	3.9	3.8	4.1	38.7	3.7	5.4	6.1	2.5	1.1	2.3	8.1	1.6	0.0	1.0	1.9	11.2	6.2	1.5	1.4	21.8	8.6	10.1	3.4	4.2	5.8	5.6	12.5	20.6	6.6	5.2	5.5	2.0	3.8	2.1	1.7	7.7	2.8	10.6	4.6	2.9
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730532	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 1667.9;SK-BR-3: 502.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	29.1	35.9	33.4	17.5	35.4	27.0	31.5	36.2	44.8	31.1	34.2	42.4	26.3	29.0	14.6	47.3	27.2	12.1	49.5	32.5	35.3	57.2	53.7	29.6	20.2	34.5	34.8	18.5	40.7	21.6	39.6	13.5	34.5	46.3	12.8	4.8	46.2	13.8	47.2	35.0	37.5	9.5	32.9	36.2	48.5	41.3	35.4	13.9	37.0	5.3	13.7	31.0	32.0	37.2	38.8	59.7	13.4	34.5	16.3	12.0	16.2	40.7	21.4	24.2	23.6	12.9	27.2	28.1	55.5	15.1	39.0	47.1	15.6	13.8	8.2	58.2	65.8	26.5	29.8	36.5	28.2	33.9	39.2	10.8	23.3	11.7	12.0	18.8	15.6	52.9	38.2	48.9	14.7	22.5	70.1	38.2	12.5	1667.9	26.4	32.2	23.6	56.8	12.2	21.8	43.6	41.7	40.8	502.3	70.7	12.0	66.1	48.1	41.5	16.4	41.8	78.9	47.1	62.3	62.8	55.1	64.5	41.1	32.4	138.5	76.2	107.3	80.1	100.9	43.4	109.2	56.2	72.3	54.5	88.3	43.9	63.1	132.9	58.7	104.2	79.4	94.6	119.9	33.4	35.4	36.2	44.8	32.5	35.3	34.5	34.8	34.5	32.9	35.4	37.2	59.8	44.8	64.2	7.8	60.9	60.2	138.1	185.1	95.6	25.7	127.0	114.2	59.6	82.9	129.3	99.3	4.2	150.2	69.1	226.6	303.3	137.0	136.2	81.6	48.7	58.9	188.8	72.0	11.0	176.1	74.4	50.9	76.5	77.3	81.8	43.8	54.7	118.9	148.0	35.3	9.6	178.3	254.3	101.3	42.8	76.7	42.3	81.3	138.7	12.2	80.1	90.7	130.7	4.5	20.8	216.8	283.7	49.7	54.0	194.8	188.5	224.9	122.1	17.3	46.0	31.5	61.1	108.5	68.0	131.7	70.3	266.1	65.4	51.7	128.1	204.0
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 97.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019589: AB_1853953, HPA050306: AB_2681080"	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	18.6	20.8	10.7	18.4	12.4	97.9	16.5	12.8	13.8	19.7	10.4	27.5	15.5	18.7	13.5	16.6	13.1	18.8	11.4	8.9	11.6	16.2	24.6	16.3	20.7	11.4	10.8	20.7	9.1	12.3	7.8	20.2	12.1	14.4	23.5	18.9	11.3	17.1	8.2	12.6	16.1	17.9	11.0	20.0	18.8	18.2	10.9	24.4	14.1	13.1	19.6	18.5	11.8	14.8	29.7	16.8	20.4	36.8	41.9	27.2	22.7	30.3	33.5	29.7	32.1	13.7	17.7	29.8	11.1	34.3	26.7	19.2	24.9	33.1	42.5	34.6	19.3	65.2	44.0	21.8	33.2	52.5	36.9	28.2	24.5	33.3	34.3	34.5	32.9	35.6	34.6	25.6	35.6	9.4	76.0	18.8	29.2	13.4	10.8	32.7	49.1	20.4	25.5	32.6	12.0	23.7	45.5	27.9	29.8	19.3	14.4	34.2	39.7	34.5	24.2	33.7	28.4	31.8	31.6	42.5	28.1	22.5	21.2	43.7	10.9	26.8	18.5	12.4	21.5	11.2	16.4	16.5	8.6	13.1	16.6	16.3	37.1	15.8	20.8	11.7	15.1	8.7	10.7	12.4	12.8	13.8	8.9	11.6	11.4	10.8	12.1	11.0	10.9	14.8	77.4	16.0	45.7	40.8	65.7	48.3	40.5	37.3	51.2	37.7	45.9	44.7	32.9	35.8	35.0	27.6	25.0	41.6	92.1	125.7	45.0	36.8	55.3	54.3	56.8	54.7	42.1	50.1	50.6	40.6	26.8	62.8	34.1	70.6	92.4	48.9	40.4	50.3	22.2	40.4	48.6	54.6	34.6	45.6	38.3	49.3	81.4	56.1	14.2	46.9	69.8	68.7	86.5	40.7	83.8	54.1	77.7	93.3	48.1	52.4	41.3	34.1	35.2	48.5	78.9	64.7	77.5	53.0	62.9	42.0	34.7	34.3	97.1	35.7	53.5	60.4
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.89e-4)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	25.0	13.1	14.0	4.5	12.7	2.1	21.2	10.9	18.8	21.6	7.9	17.3	4.5	22.9	2.9	19.7	16.6	3.2	34.3	12.1	11.6	17.7	8.4	28.1	3.8	13.7	13.0	15.3	11.5	2.3	15.7	6.3	12.6	23.1	1.2	2.0	12.9	4.6	18.1	25.5	14.2	2.8	11.1	33.4	13.4	29.4	12.6	3.4	17.1	7.8	1.8	19.7	19.8	11.6	12.8	7.9	7.0	8.1	2.5	3.7	15.1	10.3	4.8	7.6	7.9	12.3	4.0	6.6	5.4	5.4	3.0	10.7	4.5	6.0	2.3	16.0	21.8	3.9	6.9	9.5	7.5	0.0	30.1	4.8	4.6	6.2	2.2	5.1	8.6	8.8	11.3	0.1	4.3	13.5	10.5	14.3	18.1	3.8	0.0	9.1	2.3	1.8	3.7	7.2	11.2	10.1	6.0	4.5	10.7	4.2	5.1	7.1	9.3	10.3	7.2	15.8	11.6	18.5	9.9	5.5	9.7	5.7	10.4	3.7	3.6	2.5	1.1	3.1	0.9	0.5	1.4	1.6	3.9	1.0	1.8	1.2	0.2	0.9	3.5	2.1	0.7	2.3	14.0	12.7	10.9	18.8	12.1	11.6	13.7	13.0	12.6	11.1	12.6	11.6	28.7	0.0	5.4	4.2	5.0	11.2	11.2	8.8	7.4	7.6	7.7	6.9	1.3	7.2	6.0	3.7	16.7	22.3	3.7	4.4	1.9	9.2	6.4	3.4	6.3	24.1	10.7	6.1	4.9	5.4	19.2	6.9	10.2	4.8	0.0	6.9	7.9	2.3	10.2	3.3	4.4	4.6	4.1	8.5	6.3	19.0	6.2	8.7	5.4	13.1	6.7	7.4	5.2	3.0	6.7	8.5	5.9	5.7	4.5	11.9	3.8	0.9	5.7	12.8	6.6	4.1	5.7	18.4	25.1	6.3	10.7	29.4	5.5	6.5	4.9	12.7
MIER3	"DKFZp686L09111, DKFZp781I1119, FLJ35954"	ENSG00000155545	"MIER family member 3"	Q7Z3K6	5	56919602-56971675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Distal enterocytes: 128.8;Paneth cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058349, HPA065946"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA058349: AB_2683688, HPA065946: AB_2685583"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.31e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-3)"	6.8	6.8	4.5	7.4	5.7	11.0	8.8	12.7	6.4	8.0	4.4	30.6	22.8	10.1	8.8	6.3	7.4	6.3	5.1	3.7	5.2	7.5	11.1	5.2	8.5	4.9	4.9	11.7	8.2	12.5	4.7	6.9	5.2	8.1	22.0	16.9	5.9	6.6	6.3	6.5	15.5	9.1	4.7	6.8	7.2	15.8	4.6	10.0	9.1	10.7	7.9	7.5	6.0	8.1	10.0	14.2	19.5	36.9	12.8	10.0	26.9	9.2	11.9	17.1	19.0	22.9	8.3	10.7	10.8	10.8	15.6	12.3	24.9	9.8	18.3	5.7	11.4	9.2	17.6	11.0	9.6	12.6	18.3	11.7	12.2	12.7	10.6	10.5	11.3	13.0	12.2	17.9	10.0	11.0	19.3	14.5	15.5	4.5	8.3	31.9	18.4	11.1	8.2	19.7	16.2	25.8	28.0	10.2	14.2	15.5	14.8	12.0	10.9	4.9	15.2	8.8	16.8	11.1	16.0	26.7	9.3	9.6	10.9	0.2	0.9	1.6	1.1	1.6	1.6	1.3	0.9	2.0	1.3	1.3	1.5	1.1	0.8	1.5	1.2	1.6	0.9	1.3	4.5	5.7	12.7	6.4	3.7	5.2	4.9	4.9	5.2	4.7	4.6	8.1	7.7	16.0	5.4	14.0	7.8	13.5	4.7	4.6	13.1	8.0	11.1	5.8	8.2	11.5	6.7	3.7	14.6	3.9	8.5	128.8	5.9	4.0	15.4	12.0	13.6	7.5	12.0	1.7	11.5	5.9	3.6	8.8	5.1	15.5	4.5	8.3	7.5	9.1	4.1	10.1	12.1	17.4	10.2	5.5	10.7	8.5	5.9	6.2	1.8	14.0	8.6	7.1	5.2	17.6	18.1	7.1	78.7	8.6	9.0	9.4	18.1	6.1	5.9	13.9	13.1	10.8	10.7	11.3	6.0	6.6	9.8	6.8	8.4	4.8	14.0	8.0
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271231	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: AB_2681393"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	29.7	22.5	15.6	18.7	17.7	43.6	23.4	16.9	16.4	22.2	12.9	24.1	12.6	23.1	8.2	28.4	18.2	17.3	23.0	15.1	16.5	24.5	17.6	25.4	33.2	17.3	17.2	14.2	27.6	21.5	11.8	12.3	18.4	16.4	15.1	6.0	19.9	14.4	63.2	32.8	25.1	16.9	17.4	35.7	19.5	17.9	16.6	24.5	16.6	26.8	27.0	23.7	21.6	18.6	25.6	43.5	8.9	20.3	17.9	5.4	12.7	6.2	19.1	13.0	9.5	14.4	29.8	38.7	11.7	11.9	14.6	19.8	13.6	24.4	10.5	19.2	27.3	20.2	16.5	14.1	19.9	18.9	20.4	4.8	37.7	8.7	39.7	17.7	27.3	44.7	25.7	50.0	3.6	47.6	58.6	39.0	3.5	29.0	21.3	36.6	11.3	58.6	29.4	14.1	11.7	17.1	13.9	34.5	33.0	23.4	65.9	41.2	9.7	5.6	13.8	7.2	12.1	67.8	17.5	33.3	11.7	31.3	8.7	27.5	77.6	44.4	54.6	41.1	56.6	49.3	43.0	47.9	91.4	44.2	37.1	39.9	13.1	56.4	55.4	226.4	68.3	60.3	15.6	17.7	16.9	16.4	15.1	16.5	17.3	17.2	18.4	17.4	16.6	18.6	33.2	0.0	11.0	3.3	30.5	11.5	14.8	11.1	5.2	3.8	23.8	23.4	4.2	31.5	15.3	12.9	0.0	15.0	73.4	12.1	21.5	45.2	32.6	11.6	4.7	20.1	15.6	11.1	3.0	43.4	9.4	12.3	9.2	12.0	31.8	13.0	17.5	9.0	44.9	1.7	3.1	18.0	28.5	47.4	45.1	19.8	9.3	45.4	16.0	7.5	47.7	30.5	53.5	5.0	8.2	24.8	22.7	15.8	22.5	14.3	22.3	29.3	17.6	6.0	19.7	13.0	22.0	19.6	22.1	23.2	18.9	9.3	33.5	7.4	16.9	14.1
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	8.8	7.9	6.0	5.4	10.3	6.8	14.2	8.2	9.1	7.2	0.0	6.2	7.3	8.8	5.2	6.3	6.5	7.7	6.5	6.7	9.3	14.9	8.5	6.1	5.3	10.8	9.0	9.0	6.1	18.9	3.4	7.7	11.0	9.6	5.7	5.6	9.2	6.6	7.1	4.6	8.1	7.4	9.5	5.9	7.5	5.2	8.5	4.5	16.5	9.4	4.2	6.0	3.6	19.3	11.8	7.5	4.6	5.9	11.1	14.3	12.1	16.7	7.8	9.6	9.8	7.7	8.0	5.1	18.0	11.5	11.6	7.9	6.3	9.9	18.0	7.4	6.4	6.0	8.9	3.9	11.4	5.6	4.5	10.4	10.5	19.7	14.2	13.8	9.8	4.5	3.4	6.7	14.8	1.9	5.5	3.2	3.9	5.8	9.2	2.9	11.3	2.6	11.6	12.5	9.2	7.4	7.7	11.4	21.8	7.6	4.4	3.6	15.8	13.7	6.3	20.9	17.6	4.0	6.0	3.2	12.1	4.8	6.0	3.7	2.2	2.7	2.1	2.7	2.2	1.7	1.6	1.7	1.5	2.1	2.4	2.1	1.2	2.4	1.7	1.1	1.7	1.2	6.0	10.3	8.2	9.1	6.7	9.3	10.8	9.0	11.0	9.5	8.5	19.3	33.2	35.3	26.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	28.1	20.6	0.0	0.0	10.5	23.9	0.0	17.0	16.5	0.0	5.9	16.4	0.0	15.6	27.0	9.9	0.0	0.0	0.0	14.7	14.0	12.9	0.0	29.1	12.6	18.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	18.9	0.0	0.0	5.5	0.0	0.0	31.2	8.7	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	13.3	7.5	16.2	0.0	0.0
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 18.7;Theca cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	6.7	13.6	7.5	5.3	7.6	12.6	5.8	8.4	8.1	6.2	5.1	11.8	15.2	7.2	2.9	11.9	6.7	3.9	17.3	7.0	8.4	7.8	7.8	4.8	4.6	10.4	8.3	6.8	4.7	6.6	8.1	1.6	9.1	9.3	3.1	2.3	7.3	6.9	9.8	10.1	14.0	4.3	7.0	7.0	10.1	4.6	9.1	4.4	9.2	7.7	3.6	9.3	6.3	7.6	4.8	9.7	2.9	14.9	7.9	4.1	6.5	8.4	6.3	9.5	6.0	8.4	9.8	7.2	3.7	6.6	8.3	22.3	4.0	6.3	1.4	6.6	5.9	5.2	20.4	6.3	8.7	6.0	11.5	5.8	4.9	8.6	4.4	3.1	6.6	6.7	7.7	2.9	5.2	12.7	6.0	12.3	6.7	11.4	13.9	12.2	8.7	12.0	5.0	9.2	9.3	6.6	9.4	14.7	5.2	1.7	10.6	6.4	6.7	6.1	7.0	10.4	6.5	4.0	6.2	6.7	8.7	4.7	7.4	7.2	1.5	1.4	1.5	1.6	3.3	1.2	1.1	2.0	1.6	1.3	1.1	0.7	2.5	0.6	0.9	2.2	1.0	1.2	7.5	7.6	8.4	8.1	7.0	8.4	10.4	8.3	9.1	7.0	9.1	7.6	7.1	3.2	7.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	7.1	7.2	0.0	0.0	3.1	7.3	0.0	3.3	8.1	0.0	1.9	5.4	0.0	4.2	4.4	1.8	0.0	0.0	0.0	4.7	2.6	2.4	0.0	7.3	0.0	18.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.8	0.0	0.0	4.5	2.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.6	3.0	22.1	0.0	0.0
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"HDLM-2: 362.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	15.6	9.6	12.3	12.3	12.8	43.5	15.0	12.0	16.3	15.8	8.7	16.8	7.2	20.8	2.3	10.5	18.0	5.6	16.0	11.7	11.1	12.3	16.3	17.5	14.2	13.1	12.2	23.8	17.4	5.5	9.1	7.2	12.3	14.5	2.3	2.8	12.5	8.5	28.0	14.8	15.8	6.6	12.1	26.1	13.3	26.8	13.4	7.5	15.7	7.8	5.4	17.2	12.4	13.2	20.4	13.4	10.4	20.8	5.7	6.3	36.3	10.9	5.6	20.9	15.1	26.8	32.2	25.8	25.3	5.8	14.7	21.0	7.9	12.3	2.7	362.4	29.4	16.3	22.8	28.5	11.7	24.6	47.4	8.3	15.7	18.6	7.9	3.6	11.7	33.7	49.1	23.4	6.5	20.8	24.6	37.5	19.0	15.2	19.7	34.6	13.3	39.8	9.1	6.2	19.2	20.2	15.9	20.3	39.1	5.8	13.5	42.2	12.3	19.2	20.2	38.8	17.0	19.3	26.4	35.7	12.5	43.0	20.1	18.0	68.7	22.8	25.1	82.2	23.3	44.1	25.9	22.1	43.5	41.5	16.1	12.6	55.7	33.8	90.8	139.5	60.1	41.3	12.3	12.8	12.0	16.3	11.7	11.1	13.1	12.2	12.3	12.1	13.4	13.2	16.4	12.8	7.7	12.4	28.7	13.0	7.4	11.6	9.1	14.0	29.5	17.4	5.4	5.7	7.2	9.2	8.4	37.8	35.5	17.0	25.4	13.8	40.6	7.9	17.2	12.7	16.7	26.7	4.1	18.5	95.9	14.4	14.3	7.3	17.7	17.9	8.9	13.5	39.7	8.4	4.6	10.7	10.2	23.2	20.7	55.6	8.4	30.8	16.0	4.7	56.6	15.4	26.8	5.0	5.0	16.7	16.8	6.8	16.6	11.4	26.0	15.1	8.1	15.3	13.1	12.4	16.2	24.7	48.2	9.9	17.2	33.1	23.6	16.6	16.9	6.2
MILR1	"Allergin-1, C17orf60, MCA-32"	ENSG00000271605	"Mast cell immunoglobulin like receptor 1"	Q7Z6M3	17	64449037-64468643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.5;granulocytes: 34.8;Hofbauer cells: 78.5;Kupffer cells: 33.3;Macrophages: 30.1;Microglial cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 85.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 47.4;CAPAN-2: 120.3;Daudi: 60.4;REH: 45.6;U-698: 63.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014347	Enhanced					NA	NA		50000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA014347: AB_2732408"	"unprognostic (8.40e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (2.51e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.99e-2)"	8.4	5.0	3.7	25.3	4.1	17.8	5.0	3.6	5.1	7.3	4.3	4.9	4.7	3.4	4.3	3.0	2.7	8.1	4.7	3.9	4.0	2.7	4.0	9.4	24.3	7.3	5.5	3.0	1.8	1.8	1.8	16.3	6.9	2.8	8.4	0.8	3.4	2.4	1.3	1.8	5.9	8.3	5.5	17.0	3.0	2.4	6.7	4.3	2.7	0.7	21.3	8.9	2.1	9.5	7.2	1.7	0.2	0.3	4.5	47.4	0.6	0.1	5.2	0.9	10.3	0.1	120.3	60.4	2.6	0.5	23.2	1.4	0.0	2.0	3.1	0.0	0.1	1.5	1.2	0.0	1.0	4.0	37.2	4.4	0.3	13.7	2.1	5.8	4.5	0.5	4.4	6.9	29.2	0.0	0.7	8.7	0.4	0.8	8.6	45.6	8.1	27.1	1.8	0.4	0.2	0.1	3.9	0.4	8.2	0.0	0.4	35.0	16.0	0.3	1.5	0.1	2.9	0.4	0.1	63.6	30.3	7.2	0.0	85.0	47.3	2.8	0.9	40.2	0.7	25.9	0.6	0.6	30.6	16.7	0.7	0.8	14.0	1.5	27.8	53.9	0.6	14.5	3.7	4.1	3.6	5.1	3.9	4.0	7.3	5.5	6.9	5.5	6.7	9.5	3.0	0.0	0.5	0.3	7.5	0.5	2.7	2.7	0.6	0.4	3.1	1.9	0.7	1.5	2.1	0.0	0.0	0.7	40.5	1.1	0.0	0.1	0.7	1.4	2.3	2.7	4.9	1.7	0.5	0.0	2.4	6.1	0.5	2.1	34.8	2.8	1.8	0.1	78.5	0.0	0.5	0.7	2.0	33.3	13.9	0.4	4.1	30.1	0.0	43.1	10.1	0.5	4.1	1.5	0.5	0.0	1.4	1.5	1.2	2.4	0.2	0.0	0.2	1.4	0.0	14.9	3.0	0.3	0.4	0.2	1.7	1.2	1.5	0.1	1.9	2.4
MINAR1	"KIAA1024, UBTOR"	ENSG00000169330	"Membrane integral NOTCH2 associated receptor 1"	Q9UPX6	15	79432336-79472304	"Predicted membrane proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.3;brain: 4.7;retina: 6.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011545	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"		"Golgi apparatus"		"HPA011545: AB_1852361"	"unprognostic (5.45e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.66e-13)"	"unprognostic (7.08e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	0.1	10.3	1.0	0.1	0.8	0.4	0.3	4.7	0.7	0.3	0.2	0.2	0.0	0.2	0.3	0.2	0.1	0.3	0.1	0.6	1.6	0.1	0.0	0.1	0.4	3.2	3.5	0.1	2.1	0.0	0.7	0.2	3.4	0.7	0.2	6.8	2.8	0.1	0.1	0.2	0.2	0.1	1.5	0.3	0.3	0.2	1.8	0.2	0.2	0.0	0.2	0.1	0.2	1.1	0.3	0.2	0.4	0.5	1.1	0.9	0.4	0.5	0.8	0.4	0.4	0.0	0.3	0.7	0.1	0.8	0.5	0.2	0.9	0.1	0.3	0.8	1.0	1.9	0.5	0.0	0.6	2.7	0.9	0.4	0.2	0.7	0.1	0.8	0.4	0.8	0.1	0.0	0.1	0.0	0.3	1.0	0.4	0.4	0.4	0.4	0.1	0.4	0.1	0.0	1.8	1.0	0.2	1.6	1.0	0.7	0.2	1.3	0.3	8.7	0.3	0.0	1.9	1.1	1.4	0.3	0.9	1.5	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.8	4.7	0.7	0.6	1.6	3.2	3.5	3.4	1.5	1.8	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MINAR2	KIAA1024L	ENSG00000186367	"Membrane integral NOTCH2 associated receptor 2"	P59773	5	129748094-129766732	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA013760	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA013760: AB_1852363"				"unprognostic (1.77e-1)"										"unprognostic (5.13e-1)"				0.2	0.1	1.1	0.0	1.0	0.1	0.2	1.1	1.4	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.0	1.2	0.0	0.1	0.2	0.1	1.1	1.0	0.0	0.1	0.0	0.0	0.4	1.0	0.1	0.0	0.2	0.0	0.1	35.9	0.1	0.0	0.1	0.7	0.4	0.1	0.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.4	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.4	0.5	0.3	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.2	1.4	0.0	0.9	0.2	0.0	0.3	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.7	1.3	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.6	0.1	0.2	0.8	0.1	0.0	1.1	1.0	1.1	1.4	1.0	1.2	1.1	1.0	1.0	0.7	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 98.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		220000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	13.8	13.0	24.9	8.2	49.9	7.2	15.0	42.7	33.7	19.0	30.9	18.4	16.8	18.1	7.0	37.1	17.4	14.0	33.5	22.2	30.7	30.4	19.0	12.9	6.4	58.7	43.9	21.7	47.6	30.1	15.1	6.8	53.4	14.3	17.2	13.3	29.6	13.7	16.7	20.6	14.8	15.6	33.3	15.1	25.9	23.6	43.1	3.6	47.3	18.0	8.7	15.0	20.1	75.6	11.3	7.3	7.7	10.8	13.4	11.1	6.4	3.6	9.1	5.0	7.9	15.6	26.3	0.7	8.4	4.7	1.5	5.5	6.1	6.8	2.2	8.6	9.2	11.0	13.8	13.5	3.0	3.3	4.3	9.1	5.9	9.0	2.5	16.8	12.9	3.8	7.0	27.5	5.3	17.4	0.6	7.4	3.5	3.5	2.5	8.3	1.4	34.8	23.4	22.1	13.1	9.7	6.9	12.4	7.4	3.6	49.5	11.1	12.0	4.3	5.5	2.2	3.1	10.1	9.9	37.5	10.2	7.2	20.4	98.4	9.3	56.2	0.4	4.1	0.3	0.8	3.5	1.0	11.5	1.5	5.8	2.0	85.4	4.7	2.8	1.7	4.8	9.9	24.9	49.9	42.7	33.7	22.2	30.7	58.7	43.9	53.4	33.3	43.1	75.6	4.5	9.6	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.8	5.8	0.0	0.0	3.7	3.7	0.0	3.8	1.4	0.0	39.2	11.6	0.0	3.4	3.7	3.7	0.0	0.0	0.0	7.0	0.8	2.9	0.0	4.5	3.8	6.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	12.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.8	5.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	9.4	5.4	9.3	5.7	9.6	3.8	6.6	15.0	10.4	7.0	8.9	5.4	3.5	7.1	4.6	7.1	6.8	6.3	10.8	8.0	11.6	10.1	3.5	7.7	4.1	10.5	11.0	6.8	3.3	7.3	4.9	9.0	10.0	8.9	3.9	16.3	4.9	6.1	3.4	7.1	3.6	8.5	9.2	6.1	4.8	3.9	11.2	5.9	9.6	8.9	3.7	8.0	5.2	10.3	10.9	5.3	7.3	4.4	10.7	19.7	11.5	9.8	20.8	3.0	4.3	8.4	5.4	5.6	10.5	11.8	5.3	10.3	13.4	7.9	4.6	5.6	4.9	7.8	5.7	7.6	6.6	5.9	6.9	8.7	12.9	3.5	8.0	11.3	7.4	5.9	13.7	6.1	7.1	1.4	7.4	4.4	15.7	1.4	2.7	3.3	21.0	6.0	8.9	12.1	6.7	4.9	7.1	10.0	17.9	15.3	3.0	12.5	8.7	4.2	3.7	72.5	4.3	5.4	8.3	5.4	9.4	9.5	10.2	3.0	0.7	1.3	1.1	0.6	2.1	0.9	1.0	1.3	0.2	1.6	0.8	1.2	1.4	0.8	1.4	1.1	0.9	0.5	9.3	9.6	15.0	10.4	8.0	11.6	10.5	11.0	10.0	9.2	11.2	10.3	65.2	147.4	39.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	43.8	44.8	0.0	0.0	18.0	82.8	0.0	65.2	27.5	0.0	46.9	44.4	0.0	66.4	46.8	19.8	0.0	0.0	0.0	21.2	108.7	21.7	0.0	73.2	11.4	11.6	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	32.4	0.0	0.0	7.5	0.0	0.0	14.2	28.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	53.2	11.3	17.6	0.0	0.0
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	15.0	22.4	12.8	8.6	16.3	19.1	19.2	21.9	19.0	18.6	2.9	15.0	9.3	19.5	20.6	14.1	15.6	14.2	9.9	14.7	10.5	16.8	17.5	12.1	12.4	10.6	11.4	18.5	13.7	20.5	5.3	21.1	10.9	19.3	18.7	20.0	11.5	16.4	4.3	16.4	11.6	16.4	11.3	10.5	15.7	21.3	15.5	7.5	18.3	2.4	11.6	15.3	10.3	17.7	12.4	11.1	21.5	22.9	30.9	28.9	17.9	38.1	19.4	28.4	33.1	9.6	19.0	9.2	7.2	41.8	19.9	11.2	18.5	22.8	25.5	28.2	25.5	30.0	16.0	10.8	39.3	6.2	24.3	22.5	19.6	25.3	18.1	27.4	23.1	21.7	18.6	7.6	28.5	13.4	13.2	7.5	7.8	19.9	21.6	6.5	12.5	6.4	32.1	9.2	17.6	19.2	18.5	17.5	16.1	19.2	20.4	13.4	23.9	18.5	14.4	31.4	11.2	45.6	18.8	15.7	21.2	13.6	15.1	2.6	1.7	1.5	2.2	3.5	1.8	1.3	1.5	2.4	1.9	1.9	1.0	2.0	1.5	1.7	4.0	2.0	3.1	1.5	12.8	16.3	21.9	19.0	14.7	10.5	10.6	11.4	10.9	11.3	15.5	17.7	17.3	22.4	14.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	9.7	7.4	0.0	0.0	3.7	14.7	0.0	18.7	10.7	0.0	19.6	11.6	0.0	8.2	18.1	5.2	0.0	0.0	0.0	8.3	17.0	7.5	0.0	9.7	1.3	11.5	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	9.0	0.0	0.0	4.0	0.0	0.0	17.7	11.7	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	32.7	3.0	13.7	0.0	0.0
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	6.7	3.7	2.1	1.2	3.5	2.4	4.4	0.4	4.2	5.7	10.6	4.6	1.3	5.4	8.4	2.9	11.5	5.6	4.7	1.9	1.8	4.9	2.1	9.5	1.2	2.8	4.5	8.9	3.4	4.8	5.6	3.3	2.2	5.9	2.1	2.1	3.1	8.1	2.3	3.2	2.2	5.9	1.8	1.2	3.2	9.0	2.4	1.2	6.7	3.5	0.9	4.3	3.7	2.5	2.4	6.0	3.1	9.5	2.7	10.3	4.5	3.5	6.0	2.6	2.2	0.0	4.4	0.0	3.9	2.3	3.6	2.6	2.1	2.0	2.5	0.0	3.5	1.9	3.2	0.0	3.3	2.7	1.3	5.3	3.1	7.7	1.5	0.2	3.8	1.7	19.2	1.1	2.2	0.0	1.5	0.8	8.9	8.5	1.4	0.4	0.0	0.6	7.1	1.2	5.7	7.7	2.3	12.5	1.3	3.5	6.4	2.0	2.3	0.1	1.4	2.7	1.5	2.5	3.5	0.0	4.9	0.1	11.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	3.5	0.4	4.2	1.9	1.8	2.8	4.5	2.2	1.8	2.4	2.5	5.2	9.6	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	1.8	12.9	0.0	2.3	0.5	0.0	3.9	2.8	0.0	36.7	8.9	2.3	0.0	0.0	0.0	1.3	4.1	2.7	0.0	3.9	2.5	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.4	18.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.2	4.1	0.0	0.0
MINK1	"B55, MAP4K6, MINK, YSK2, ZC3"	ENSG00000141503	"Misshapen like kinase 1"	Q8N4C8	17	4833340-4898061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056296	Approved					NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA056296: AB_2683090"	"unprognostic (2.80e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.77e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (8.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.62e-1)"	22.8	21.5	32.4	24.9	29.8	22.7	24.7	13.0	34.4	32.0	0.0	36.9	43.0	19.1	5.7	72.1	21.3	18.6	15.4	50.7	15.1	23.0	17.5	35.6	23.9	17.7	16.2	36.9	29.4	23.2	25.7	23.2	15.3	25.5	28.1	18.2	32.4	12.2	12.5	76.9	41.7	14.6	13.4	27.6	29.0	14.2	26.4	16.8	21.9	9.9	18.8	21.8	46.6	20.2	46.9	83.6	20.2	31.2	29.7	21.8	56.0	37.4	34.2	27.6	24.7	32.3	31.3	34.5	41.5	38.2	30.0	91.8	15.5	64.2	20.2	49.0	41.2	23.9	62.8	25.3	18.8	9.1	45.2	22.4	44.1	27.1	25.2	24.9	30.8	10.8	25.6	27.4	22.9	27.8	14.8	20.2	15.6	30.4	28.4	17.9	16.9	20.4	42.2	53.9	20.9	16.6	40.1	30.7	23.9	24.2	27.7	12.2	45.0	29.6	13.7	52.8	35.6	16.8	14.6	7.3	26.7	19.2	20.5	0.0	0.7	2.9	1.0	0.6	1.2	1.1	1.1	0.8	0.5	0.7	0.7	0.3	0.6	0.1	0.3	0.3	1.3	1.2	32.4	29.8	13.0	34.4	50.7	15.1	17.7	16.2	15.3	13.4	26.4	20.2	18.1	0.0	2.0	51.9	12.7	41.0	14.7	22.0	37.5	7.2	17.3	18.8	1.4	22.8	9.9	5.5	39.6	18.9	10.2	47.3	5.9	9.5	3.6	10.6	8.6	15.4	18.7	13.0	25.5	10.5	13.3	8.5	51.0	12.7	8.2	21.1	16.1	9.8	18.3	13.5	24.7	30.3	16.2	12.3	16.7	6.8	16.1	13.9	16.0	37.5	29.5	6.9	9.2	13.0	48.1	14.8	46.7	14.7	9.7	19.9	29.3	13.0	12.8	16.9	13.1	6.9	7.6	5.8	13.8	40.9	60.5	19.6	15.9	28.3	27.4	20.1
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553461	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		370000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	8.5	21.3	6.6	7.2	6.7	31.1	9.4	6.9	9.1	8.8	9.4	12.6	17.6	7.0	10.0	3.6	8.5	8.4	5.8	6.8	8.0	17.5	29.1	8.3	7.7	6.4	6.8	8.8	11.9	9.0	8.1	18.9	6.4	11.7	12.9	11.9	6.9	7.6	4.9	9.1	13.6	7.6	6.9	6.9	8.5	7.9	7.7	8.1	11.6	5.7	7.0	8.6	5.7	7.4	18.6	28.1	28.1	40.9	46.4	38.1	23.2	29.5	51.1	28.8	38.3	15.0	35.5	16.4	27.0	35.9	19.4	28.2	29.9	27.1	33.2	37.1	35.7	41.1	10.4	55.7	34.6	18.0	36.0	33.7	34.7	32.6	19.5	52.5	37.0	14.3	24.5	75.9	34.4	13.8	11.9	25.6	20.0	14.2	20.2	0.0	15.8	11.0	38.5	10.4	10.2	31.5	28.1	5.9	51.5	31.5	16.7	14.7	32.4	18.3	21.9	22.1	28.7	24.5	27.1	4.2	29.3	26.8	13.7	10.5	10.8	4.9	11.5	13.8	10.1	8.7	10.8	13.0	14.3	8.2	10.2	11.4	0.7	11.7	12.5	8.2	17.3	10.5	6.6	6.7	6.9	9.1	6.8	8.0	6.4	6.8	6.4	6.9	7.7	7.4	11.7	6.4	12.8	9.1	8.1	2.8	8.3	25.5	8.0	14.4	9.0	4.3	4.9	15.7	16.2	7.3	2.1	20.4	4.9	14.0	5.9	17.2	15.9	7.1	13.4	10.5	13.1	288.9	18.3	16.7	19.2	17.9	7.1	6.7	24.7	17.8	16.4	58.3	12.9	10.1	20.8	25.5	20.3	16.0	5.8	4.0	9.3	8.7	10.6	7.5	11.7	11.1	10.3	25.6	19.1	10.5	17.2	8.2	18.6	6.8	17.1	26.0	19.0	14.8	0.0	4.8	11.1	10.6	12.1	4.0	3.4	8.1	8.2	13.7	11.6	4.4
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	10.0	9.5	7.0	15.2	6.6	18.8	14.5	12.1	8.7	12.3	26.8	11.3	8.8	9.9	10.4	22.9	10.8	9.9	11.9	5.7	9.3	12.6	17.3	11.7	22.4	6.7	7.4	13.3	17.3	28.1	8.9	11.6	6.1	21.7	13.0	18.8	13.5	11.2	85.5	18.1	9.3	12.2	6.7	15.3	13.4	19.2	7.2	16.2	9.3	51.1	29.9	13.9	14.3	8.2	42.4	18.8	21.8	26.4	17.1	35.9	18.3	32.9	26.8	20.6	20.6	23.2	16.5	37.1	9.9	19.7	55.3	37.6	23.1	24.2	27.0	14.8	19.5	9.5	22.5	16.1	24.3	40.1	10.2	30.9	29.0	18.3	46.2	20.1	18.2	12.4	47.2	29.4	88.0	29.1	9.2	17.0	45.3	21.3	19.8	27.4	33.4	36.3	19.0	21.3	23.0	37.2	17.7	49.1	19.3	40.5	26.7	35.1	15.7	31.3	33.2	17.4	27.7	25.9	30.9	33.2	27.6	23.0	37.2	0.0	5.4	8.8	4.3	9.9	3.6	10.1	4.6	4.2	7.6	8.8	6.0	4.9	0.6	5.4	5.0	4.5	5.1	4.0	7.0	6.6	12.1	8.7	5.7	9.3	6.7	7.4	6.1	6.7	7.2	8.2	8.2	9.6	11.9	18.6	30.3	12.1	14.8	6.6	15.4	8.2	13.2	10.8	18.2	12.8	9.2	7.3	12.5	16.8	12.2	9.0	17.6	11.7	38.5	22.7	11.4	7.5	4.2	15.6	22.9	17.5	8.7	9.3	16.3	18.6	9.5	15.4	6.8	17.0	15.5	11.8	21.0	7.2	4.1	22.7	12.2	57.9	5.9	18.4	7.2	27.2	10.1	9.4	13.4	23.1	18.2	14.1	11.3	7.5	19.4	24.9	6.7	11.3	11.0	17.0	13.1	13.1	9.3	36.0	30.4	24.8	18.9	21.2	15.3	15.3	11.1	19.7
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"kidney: 700.9"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 4564.6"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.9;Hep G2: 5.7;Karpas-707: 12.8;U-266/70: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.8	0.5	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	5.3	0.0	0.2	0.2	700.9	0.4	0.0	0.7	0.2	0.2	0.0	1.2	0.0	0.1	0.1	0.3	0.5	0.0	0.1	0.3	0.1	0.0	0.3	0.2	0.0	0.1	0.2	1.1	0.2	0.2	0.2	14.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.1	2.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.6	0.4	0.0	0.2	0.2	0.0	0.0	24.9	0.0	0.2	0.4	5.7	2.8	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	12.8	0.0	1.2	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.6	0.5	0.1	1.4	0.0	0.0	0.5	0.1	0.1	7.8	0.7	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.0	1.7	0.0	13.0	0.8	0.9	0.1	0.0	0.6	0.7	0.8	0.1	1.5	0.0	99.3	0.0	0.0	0.3	0.3	424.6	0.0	0.0	0.1	0.2	0.2	1.2	0.0	0.0	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	23.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	4564.6	0.0	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.3	7.8	0.0	0.1	0.9
MIP	"AQP0, LIM1, MP26"	ENSG00000135517	"Major intrinsic protein of lens fiber"	P30301	12	56449502-56469166	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Transport, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.6;Horizontal cells: 1.7;Late spermatids: 2.8;Spermatocytes: 7.3;Spermatogonia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014940	Supported					NA	NA						"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014940: AB_2669122"	"unprognostic (6.48e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.14e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.51e-5)"	"unprognostic (4.56e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.82e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.1	0.2	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	7.3	1.6	0.0	0.0	0.3	0.0	0.3	0.0	0.1
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.2;Excitatory neurons: 159.4;Inhibitory neurons: 141.1;Late spermatids: 129.2;Oligodendrocyte precursor cells: 91.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA002893: AB_1079386, HPA050179: AB_2681043"	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	2.5	2.7	1.8	1.2	1.6	0.4	4.0	1.0	1.6	4.7	1.8	2.7	1.3	4.4	2.2	3.4	3.4	3.3	2.8	1.4	1.7	4.0	1.9	2.4	0.3	1.9	1.7	6.2	4.5	6.5	2.8	1.4	1.8	5.5	2.1	2.9	3.4	3.3	2.0	1.8	1.2	3.5	1.8	1.2	3.5	7.9	1.8	0.9	5.3	2.8	0.6	3.4	3.5	1.9	5.3	2.2	0.8	7.4	5.3	8.7	0.0	4.8	3.2	4.0	5.9	2.9	3.2	0.0	4.6	4.0	1.6	6.1	0.0	6.6	5.4	0.0	7.8	0.0	3.6	12.8	3.4	0.0	0.1	5.5	6.6	1.1	12.8	4.9	25.2	0.0	10.5	0.1	6.0	5.3	0.0	0.0	3.1	3.5	16.3	0.0	0.7	0.0	5.8	5.9	6.2	0.0	6.2	5.3	5.5	5.4	6.6	0.0	13.4	0.0	3.9	0.0	5.5	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.8	1.6	1.0	1.6	1.4	1.7	1.9	1.7	1.8	1.8	1.8	1.9	7.9	76.9	59.2	41.4	1.2	4.2	15.7	5.8	18.2	13.8	8.0	6.6	14.3	11.5	55.8	9.2	52.1	0.1	0.7	1.6	9.8	4.9	138.2	5.6	13.8	10.4	9.1	1.3	159.4	7.4	0.1	16.2	14.3	6.0	46.7	10.8	3.9	3.0	0.1	11.8	141.1	1.9	6.1	1.6	5.7	129.2	8.4	5.2	7.2	45.0	0.2	6.0	1.0	91.0	24.9	11.3	0.8	9.1	0.1	16.2	0.9	4.0	70.0	23.0	0.0	19.9	16.7	36.2	15.1	6.3	6.3	0.0	4.7	16.2	3.5	8.6
MIS12	"hMIS12, KNTC2AP, MGC2488, MTW1"	ENSG00000167842	"MIS12 kinetochore complex component"	Q9H081	17	5486285-5490814	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 117.7;Late spermatids: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044482	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044482: AB_10963834"	"unprognostic (3.86e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.41e-2)"	"prognostic favorable (8.00e-4)"	"unprognostic (4.13e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (3.65e-2)"	11.9	11.3	10.2	16.1	12.6	17.6	15.5	11.0	12.3	12.1	10.6	12.1	12.2	13.6	31.7	10.1	13.3	10.1	9.7	9.6	10.5	13.8	16.3	10.9	21.5	11.7	11.7	11.9	14.8	10.6	13.8	10.7	12.7	12.0	14.0	28.1	11.0	12.9	13.6	10.4	13.9	13.1	10.7	18.2	11.7	15.0	11.1	26.1	18.8	12.9	21.2	13.3	8.8	15.8	19.0	21.8	45.4	28.7	18.5	18.4	23.4	26.9	20.1	40.6	36.2	20.4	14.0	47.7	22.9	14.4	19.7	42.2	36.9	25.3	41.3	28.0	24.9	26.7	42.1	24.0	32.6	15.7	31.0	18.4	38.3	34.9	54.3	19.4	21.4	36.8	29.9	46.5	26.0	11.9	34.8	15.6	25.6	24.6	19.4	31.6	44.2	23.0	16.3	19.3	15.7	30.8	28.3	13.2	30.0	32.8	20.0	13.1	14.2	25.8	20.7	22.6	34.0	22.1	21.6	26.8	23.2	22.6	23.9	6.5	8.5	6.6	14.6	9.8	15.5	11.9	12.3	14.4	9.7	9.2	15.5	14.8	4.4	16.1	13.8	12.9	8.8	10.3	10.2	12.6	11.0	12.3	9.6	10.5	11.7	11.7	12.7	10.7	11.1	15.8	13.6	12.8	15.3	14.0	21.0	12.9	25.8	9.7	19.4	14.4	15.4	12.3	7.6	14.3	12.3	5.5	14.6	13.1	18.7	16.5	23.5	10.4	117.7	11.0	13.1	14.2	21.4	16.8	7.0	7.1	12.7	12.8	10.2	10.3	32.4	11.7	10.0	13.0	10.1	5.0	7.2	20.7	18.3	9.9	17.2	235.3	5.9	9.9	10.6	6.5	7.3	19.9	17.5	7.1	22.2	9.9	19.8	9.4	23.7	19.8	7.9	7.6	13.9	22.1	19.7	16.7	12.2	27.2	11.5	11.7	18.0	21.9	19.5	11.3	13.4	20.6
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268228-32279049	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 109.9;Spermatogonia: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	4.3	5.4	4.3	7.5	4.3	16.9	7.6	5.0	5.6	4.1	3.9	9.5	8.3	6.6	6.3	8.5	5.7	3.2	3.6	4.6	4.2	6.3	6.1	3.7	11.1	4.1	4.0	9.6	4.2	4.0	3.0	7.5	4.0	5.4	10.6	4.2	5.2	3.9	3.2	8.3	9.1	4.9	4.0	6.0	6.7	21.4	4.0	16.4	3.7	2.4	12.1	4.9	5.1	4.7	63.6	15.5	43.8	42.2	6.5	11.2	67.0	32.6	16.8	31.5	27.1	31.0	34.2	69.0	23.6	12.5	37.8	21.1	43.3	24.8	37.6	39.7	48.3	79.3	16.8	40.4	4.3	68.7	25.8	4.9	10.6	26.5	18.9	10.3	22.4	68.9	93.9	56.3	31.1	43.5	79.0	61.9	90.7	43.7	45.0	68.1	65.4	64.4	22.1	21.4	52.4	25.8	49.9	41.7	30.9	31.3	50.8	41.4	13.2	39.2	72.6	30.9	34.1	30.3	51.8	86.8	25.0	108.9	36.4	4.6	7.7	13.0	14.3	10.6	14.4	30.0	15.7	16.6	7.4	29.6	21.4	15.7	2.5	16.9	19.8	20.0	23.5	9.3	4.3	4.3	5.0	5.6	4.6	4.2	4.1	4.0	4.0	4.0	4.0	4.7	8.4	19.2	8.9	1.6	9.5	15.6	7.7	16.9	9.1	9.2	15.0	17.5	5.3	11.5	10.9	11.0	4.2	36.8	11.2	5.6	13.7	13.2	7.5	16.6	12.8	8.4	6.1	22.9	6.8	12.3	53.1	12.4	5.1	15.0	3.8	29.7	12.5	7.4	16.6	8.4	5.2	21.1	14.2	6.3	6.2	7.4	10.5	6.5	5.4	2.8	7.8	10.1	18.6	5.5	6.5	10.8	6.2	10.1	13.9	5.6	3.0	17.2	10.6	7.3	19.7	16.1	12.0	109.9	86.0	20.1	14.8	14.6	7.8	16.5	20.0	5.9
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 40.7"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 145.1;monocytes: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	8.6	3.7	1.5	14.1	1.4	40.7	10.7	0.9	1.6	7.3	1.1	8.0	8.4	10.2	5.3	7.1	6.7	7.7	3.8	1.4	1.7	3.7	4.1	9.5	23.2	2.1	1.9	12.2	4.6	2.3	1.3	10.6	2.4	6.3	10.1	1.2	6.7	5.8	1.3	8.6	9.6	9.6	1.9	15.2	8.5	13.5	1.5	24.4	6.8	3.8	21.7	7.8	3.9	2.8	54.1	20.0	40.7	18.0	12.1	17.2	30.0	36.4	19.2	29.7	36.5	10.7	50.7	73.6	15.5	18.5	12.8	37.0	23.9	18.5	55.3	39.5	15.3	44.5	23.2	13.8	8.1	103.7	39.7	12.5	7.4	17.6	16.5	19.4	36.7	14.1	19.7	17.2	29.1	19.9	44.1	45.9	30.8	26.5	24.9	51.5	16.4	28.5	15.3	22.3	28.4	12.3	16.2	24.6	13.1	24.1	29.5	58.1	20.4	15.7	47.4	19.5	16.6	15.3	21.5	34.5	8.8	42.6	22.8	64.5	28.8	35.8	7.9	28.5	8.5	28.5	7.5	6.8	21.5	25.5	5.0	5.1	17.8	10.8	53.8	31.0	10.9	9.1	1.5	1.4	0.9	1.6	1.4	1.7	2.1	1.9	2.4	1.9	1.5	2.8	54.6	25.6	27.8	6.8	87.7	20.1	11.6	17.7	19.4	8.4	24.3	27.3	13.3	7.2	26.1	9.2	16.7	40.9	91.6	17.1	5.9	14.0	3.5	29.2	47.6	43.5	27.6	72.6	34.5	11.1	42.5	32.5	35.7	28.0	43.6	145.1	30.4	7.3	35.4	0.0	7.6	25.8	18.3	89.8	30.9	6.8	55.3	115.7	5.4	74.0	150.1	5.1	55.6	9.5	11.1	13.5	47.7	60.5	73.5	25.0	12.1	5.0	20.9	7.6	0.0	13.9	23.3	80.0	105.4	32.5	26.3	19.4	54.5	77.9	29.9	24.6
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751112-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 196.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	1.3	0.0	0.3	12.1	0.3	0.0	0.9	0.5	0.4	4.4	0.1	95.5	171.0	0.7	0.0	0.3	9.8	11.3	0.0	0.4	0.3	8.8	0.1	9.3	0.1	0.5	0.5	0.3	1.7	0.0	8.1	1.2	0.5	5.6	48.4	0.0	1.0	0.5	0.0	0.6	196.6	3.3	0.2	0.0	22.9	0.5	0.3	0.3	0.1	0.0	0.0	9.0	0.6	0.2	30.4	121.4	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	42.1	44.2	10.8	11.5	0.0	0.1	90.2	0.0	37.7	0.0	0.0	0.1	0.0	47.0	13.3	0.0	0.0	1.9	0.0	82.6	0.3	4.5	0.0	0.0	0.0	0.0	0.4	0.2	63.2	0.1	0.7	0.1	76.9	24.6	0.2	0.4	1.0	30.1	33.7	1.4	0.4	42.9	134.3	0.1	0.1	29.3	0.0	0.0	0.0	14.8	1.8	0.2	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.3	0.2	0.1	38.5	8.0	0.3	2.9	0.1	4.5	22.5	0.0	0.0	4.7	2.3	0.5	10.0	39.7	11.0	0.0	0.6	0.0	793.4	1.9	39.9	0.6	40.5	1.5	0.8	58.0	0.0	0.2	46.0	6.0	2.4	56.6	14.3	8.9	0.0	0.0	0.0	0.1	0.0	0.3	230.9	28.5	0.0	0.0	0.9	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.2	157.7	646.7	0.0	0.1	41.6	1115.2	27.5	41.3	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.3	2.1	1.6	0.0	220.7	62.1
MISP3		ENSG00000141854	"MISP family member 3"	Q96FF7	19	14072536-14075062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 20.8;Collecting duct cells: 14.7;Distal tubular cells: 35.2;Endometrial ciliated cells: 12.4;Exocrine glandular cells: 11.5;Proximal tubular cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;OE19: 11.3;RPMI-8226: 6.3;U-266/84: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042225	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"HPA042225: AB_10795396"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.52e-4)"	"prognostic favorable (3.11e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.78e-2)"	1.4	2.1	7.2	0.3	7.3	0.5	2.0	7.6	10.3	2.0	6.3	7.6	3.9	1.0	0.4	3.0	3.0	0.3	6.3	7.6	8.1	17.7	5.6	2.9	0.0	7.4	7.4	0.5	12.1	2.8	2.6	0.5	7.6	3.6	1.4	1.1	7.8	1.0	2.5	7.9	5.2	0.1	7.7	1.3	11.1	0.9	7.5	0.2	3.0	1.0	0.1	1.7	2.8	7.8	1.7	0.9	0.3	0.7	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.1	1.1	0.1	0.0	0.6	0.8	0.0	0.0	2.1	1.5	0.2	0.3	0.8	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.7	0.2	1.0	0.2	5.3	0.0	3.0	0.3	0.7	0.0	11.3	0.7	0.5	0.1	6.3	1.1	0.0	1.5	0.4	0.0	0.5	0.6	0.0	0.9	0.0	0.1	0.0	0.4	0.5	0.0	3.6	4.3	0.4	0.8	1.3	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	7.2	7.3	7.6	10.3	7.6	8.1	7.4	7.4	7.6	7.7	7.5	7.8	3.2	9.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	19.3	20.8	0.0	0.0	1.8	14.7	0.0	0.2	3.7	0.0	35.2	2.5	0.0	12.4	0.8	0.7	0.0	0.0	0.0	11.5	0.1	1.0	0.0	5.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.3	0.0	0.0	22.8	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	1.5	0.3	0.0	0.0
MITD1	LOC129531	ENSG00000158411	"Microtubule interacting and trafficking domain containing 1"	Q8WV92	2	99161427-99181058	"Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036162, HPA036163"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036162: AB_10672236, HPA036163: AB_2674978"	"prognostic favorable (5.96e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.39e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.32e-11)"	"unprognostic (2.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.91e-2)"	"prognostic favorable (5.46e-8)"	17.9	16.8	12.3	25.1	12.9	13.2	17.1	12.3	15.5	17.2	11.8	17.5	15.4	16.8	14.3	17.9	15.8	12.7	13.6	11.9	12.9	18.7	17.3	14.2	36.5	13.0	12.7	17.0	11.7	9.1	11.0	16.6	12.9	13.5	20.0	22.1	13.5	11.9	10.7	15.8	19.1	17.0	12.4	22.3	17.4	7.0	12.7	27.0	15.1	11.2	29.1	16.8	16.2	13.7	58.0	15.3	30.5	11.8	35.1	45.2	41.9	27.1	37.8	37.2	50.3	18.8	47.6	40.0	30.4	22.2	84.9	43.0	30.0	29.9	61.7	57.2	20.6	35.4	22.3	40.4	52.2	60.2	20.1	35.9	25.4	32.6	31.2	34.3	42.4	37.8	29.6	24.1	34.0	13.8	57.8	88.5	25.8	37.1	30.0	32.4	43.8	34.7	47.2	32.1	10.0	14.7	26.5	24.3	35.0	52.8	12.9	47.1	32.1	23.0	30.2	24.3	34.1	28.2	23.6	55.5	41.7	50.2	23.4	19.2	24.7	18.2	17.5	22.8	19.7	30.6	24.8	20.8	22.0	28.4	23.6	19.3	28.0	26.0	21.8	29.8	23.1	12.8	12.3	12.9	12.3	15.5	11.9	12.9	13.0	12.7	12.9	12.4	12.7	13.7	31.0	25.6	19.9	22.9	51.2	18.9	30.3	78.2	22.2	13.4	19.5	22.9	12.3	31.5	41.6	35.0	14.6	48.2	39.1	28.1	45.0	46.9	18.8	28.2	34.8	33.1	15.7	27.3	18.3	61.2	34.9	27.6	19.9	24.7	30.4	20.2	30.0	31.2	51.0	11.8	16.9	25.5	40.7	24.5	22.3	6.2	51.0	31.0	23.2	11.2	50.5	26.2	40.2	15.6	38.4	57.3	33.5	39.5	23.3	20.2	32.9	63.4	34.5	55.4	39.5	22.4	24.4	14.4	15.5	20.0	17.5	22.6	42.4	26.4	27.5	19.6
MITF	"bHLHe32, MI, WS2, WS2A"	ENSG00000187098	"Melanocyte inducing transcription factor"	O75030	3	69739464-69968336	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Albinism, Cancer-related genes, Deafness, Disease variant, Microphthalmia, Osteopetrosis, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 133.5;Melanocytes: 585.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 240.3"	"Cancer enriched"	"Detected in all"	4	"melanoma: 39.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 5.2;classical monocyte: 9.4;intermediate monocyte: 3.3;myeloid DC: 6.1;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.1;granulocytes: 5.2;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 89.1;SK-MEL-30: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002578, HPA003259"	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB002578: AB_564111, HPA003259: AB_1079381"	"unprognostic (3.29e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.35e-10)"	"unprognostic (6.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	13.8	4.4	5.1	3.8	9.2	1.7	10.0	9.4	6.3	51.3	21.2	18.8	2.8	46.2	4.5	8.9	10.3	16.8	31.1	5.2	9.3	20.0	2.2	9.7	3.4	12.5	9.5	18.7	4.2	16.8	3.8	3.3	10.4	8.4	4.5	1.2	5.1	14.1	50.6	11.0	5.8	46.0	7.0	2.0	9.4	2.3	10.3	2.2	7.6	43.3	1.5	10.6	16.6	13.8	17.2	12.2	1.3	5.1	18.8	0.3	2.0	16.9	9.9	7.8	4.8	6.1	0.8	0.0	4.0	0.3	21.6	8.6	3.7	9.4	8.6	0.0	2.5	37.1	24.5	0.3	4.5	0.8	89.1	15.3	3.9	2.2	8.6	29.1	2.4	0.0	12.3	5.2	5.4	1.2	0.7	1.0	0.7	0.7	8.3	0.1	1.9	7.7	45.2	9.0	0.4	1.9	8.8	3.1	254.1	2.0	0.7	2.3	0.1	3.8	13.3	5.1	3.5	0.6	1.0	0.1	7.7	2.6	9.2	5.2	9.4	0.0	0.0	3.3	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.7	1.1	5.9	0.5	0.0	3.1	5.1	9.2	9.4	6.3	5.2	9.3	12.5	9.5	10.4	7.0	10.3	13.8	4.6	28.9	6.8	34.3	0.2	42.8	3.6	16.7	7.4	1.6	1.8	1.8	109.5	11.5	18.2	14.7	0.0	1.3	0.6	0.4	50.9	14.7	1.6	24.5	94.3	7.4	1.2	8.6	14.7	8.8	1.0	38.3	9.7	71.2	106.8	10.9	4.6	2.1	45.8	6.7	133.5	0.3	12.2	30.8	30.9	3.4	44.4	24.3	585.2	50.6	10.6	1.4	0.0	166.9	240.3	7.7	0.0	50.4	0.4	5.2	0.2	24.3	12.5	0.2	13.1	17.8	22.6	4.0	6.3	7.2	18.9	1.1	3.8	5.5	0.6	7.1
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MKKS	BBS6	ENSG00000125863	"McKusick-Kaufman syndrome"	Q9NPJ1	20	10401009-10434222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041071, HPA044233"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Centrosome		"HPA041071: AB_10960408, HPA044233: AB_10962986"	"unprognostic (9.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.84e-5)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.79e-9)"	"unprognostic (3.69e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.01e-1)"	12.0	13.3	15.3	6.7	16.6	1.9	12.3	17.9	19.2	14.3	19.6	18.9	17.3	12.6	13.7	12.7	13.1	12.7	20.6	17.0	17.2	28.8	26.0	9.9	8.4	16.4	15.2	13.8	12.4	25.5	14.8	9.6	17.0	15.0	19.4	22.8	13.0	15.4	25.4	9.3	14.5	14.3	15.4	11.8	13.9	16.2	16.3	12.2	17.6	40.6	10.7	14.4	13.3	16.0	18.9	23.3	21.7	32.9	23.3	20.9	6.7	12.7	14.4	16.6	13.3	7.7	9.6	16.2	5.3	12.4	30.0	25.0	27.6	25.1	20.6	2.9	10.4	37.1	5.8	20.9	15.8	23.4	7.5	18.5	47.5	16.0	31.7	28.0	13.5	14.8	18.8	11.7	19.7	7.1	22.3	14.2	15.6	60.8	16.4	13.2	21.5	14.5	25.7	8.6	33.0	20.9	11.9	61.3	29.7	14.5	16.8	15.5	6.3	14.6	12.4	17.8	23.3	8.6	36.3	6.9	12.1	24.3	15.3	19.5	16.0	13.4	11.7	14.2	13.8	11.3	13.0	9.9	16.8	7.8	15.1	14.1	7.9	11.9	16.9	10.8	11.0	16.4	15.3	16.6	17.9	19.2	17.0	17.2	16.4	15.2	17.0	15.4	16.3	16.0	15.0	3.2	17.9	20.5	29.8	33.9	56.5	143.1	39.9	39.1	11.5	13.7	225.7	118.7	67.0	9.2	12.5	101.6	50.3	116.4	68.4	27.0	95.4	14.7	11.5	41.2	71.2	43.5	30.2	19.8	83.4	40.1	37.8	11.5	22.8	9.1	57.5	182.4	127.1	69.0	36.1	90.0	89.5	62.5	67.5	41.7	62.4	34.5	49.8	11.2	51.1	70.7	55.6	25.6	24.7	17.6	92.9	63.9	31.5	87.4	99.6	47.4	54.7	40.1	52.6	43.9	51.5	229.1	73.6	86.4	42.8	96.9	23.5	13.0	100.7	75.5
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 455.1;Excitatory neurons: 336.5;Inhibitory neurons: 256.4;Oligodendrocyte precursor cells: 369.5;Oligodendrocytes: 332.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: AB_2677686"	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	12.6	12.1	20.0	6.9	22.3	9.1	13.6	23.1	17.8	10.8	19.1	7.5	9.0	10.1	11.8	7.5	11.9	7.1	8.9	17.1	22.3	13.8	14.7	7.6	8.8	19.4	24.7	13.8	7.7	10.0	4.6	11.6	22.8	16.0	7.3	22.0	11.3	13.4	10.5	9.6	8.4	9.0	18.8	8.7	8.4	9.5	21.4	8.6	11.3	13.5	7.7	7.2	5.4	21.5	14.1	16.0	13.6	13.8	32.8	29.6	8.5	13.3	30.7	14.8	18.8	7.3	11.9	14.6	9.0	16.7	29.3	9.5	14.4	13.1	24.2	14.5	7.0	6.2	13.1	8.5	15.7	10.4	8.7	17.7	8.8	20.6	10.0	15.9	13.7	8.8	23.3	10.2	18.6	5.2	12.3	11.1	15.5	11.4	8.3	7.7	16.0	10.1	16.4	8.1	7.0	15.2	25.7	25.7	12.9	14.1	5.0	12.9	14.1	11.5	6.5	21.1	11.0	24.7	10.0	24.6	39.6	12.3	17.2	1.2	0.7	1.4	1.1	0.9	0.8	0.9	1.1	0.9	0.8	1.6	1.7	1.4	9.5	0.7	1.3	1.2	0.7	0.5	20.0	22.3	23.1	17.8	17.1	22.3	19.4	24.7	22.8	18.8	21.4	21.5	54.4	51.3	43.7	455.1	42.6	44.1	29.3	22.9	31.9	49.7	34.6	21.5	24.9	38.6	27.4	46.0	70.9	17.3	37.6	33.2	7.9	23.0	5.7	30.5	60.4	50.5	37.1	38.9	336.5	23.7	17.4	46.3	36.7	46.9	34.2	42.9	64.2	78.3	21.7	53.8	256.4	29.4	28.5	41.9	52.1	7.8	68.0	35.1	35.6	210.8	44.9	44.1	26.8	369.5	332.5	27.1	36.5	84.2	40.2	49.3	38.7	31.4	25.9	64.9	85.5	64.3	56.9	41.1	28.0	28.9	45.9	14.8	37.9	35.9	28.4	39.1
MKNK1	MNK1	ENSG00000079277	"MAPK interacting serine/threonine kinase 1"	Q9BUB5	1	46557407-46616843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 142.8;Microglial cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	30.6	21.8	15.5	23.5	14.4	30.3	23.1	19.0	18.0	22.8	17.0	27.4	15.6	18.5	12.0	23.5	21.4	16.1	22.3	15.1	14.6	17.5	21.8	31.5	17.0	14.2	13.3	19.0	128.6	12.0	18.4	22.1	14.4	19.4	17.7	3.9	16.7	8.5	23.9	18.0	24.9	18.4	13.7	48.1	23.1	12.4	16.6	22.6	16.2	23.9	13.8	20.1	20.7	16.5	34.1	21.7	13.5	15.7	12.0	17.9	18.0	16.7	16.4	20.7	27.1	26.4	13.5	23.1	20.2	17.8	23.0	38.5	23.8	27.5	23.1	37.7	21.4	47.8	28.3	21.7	17.3	25.4	34.8	22.0	17.7	25.2	13.4	10.8	24.1	26.2	24.7	16.6	12.2	21.5	18.3	21.8	9.9	19.6	24.8	16.7	30.5	22.1	20.2	35.2	10.4	9.0	32.3	27.9	25.6	26.5	21.5	28.6	18.5	7.6	1.4	22.2	19.9	12.6	23.7	21.2	14.6	31.9	13.4	9.7	26.3	36.1	15.3	25.7	44.7	9.9	12.9	14.2	13.1	11.6	9.2	13.9	69.7	11.2	20.6	9.7	10.6	14.5	15.5	14.4	19.0	18.0	15.1	14.6	14.2	13.3	14.4	13.7	16.6	16.5	20.3	12.8	21.5	41.4	15.3	13.9	17.8	15.2	9.1	19.4	17.8	12.3	19.2	15.7	17.8	22.0	2.1	21.6	23.7	27.9	7.9	18.9	15.5	12.5	12.8	18.3	16.8	21.9	42.2	37.1	34.2	20.5	11.7	13.3	12.0	22.8	18.2	22.7	142.8	18.5	52.7	12.0	4.1	84.5	61.0	23.8	21.5	49.9	10.6	100.2	26.7	5.2	21.6	21.6	8.5	32.3	17.7	36.5	13.3	19.5	27.8	15.7	11.1	5.0	6.6	31.2	15.0	15.3	17.2	22.6	11.1	18.5	25.2	35.1	15.0	29.6
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAPK interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 475.7;tongue: 551.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 367.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	87.2	50.2	70.5	51.3	78.0	133.6	39.5	109.2	131.2	41.9	80.6	55.2	47.4	24.7	47.8	114.5	38.1	26.7	54.8	67.2	65.4	27.6	71.2	51.8	66.8	80.3	70.7	34.5	191.9	34.5	39.6	35.3	74.6	38.6	30.0	35.7	133.8	39.7	475.7	63.8	57.3	21.8	68.2	80.2	55.1	21.6	75.7	34.5	54.6	551.1	58.6	39.9	60.9	91.0	64.9	71.8	30.1	66.3	219.5	79.0	65.1	37.3	27.1	26.5	26.8	45.5	111.8	88.2	50.7	77.4	27.9	78.4	38.4	110.9	12.0	122.1	34.4	36.8	62.1	49.2	367.4	72.3	61.6	84.1	262.0	50.8	107.2	61.9	63.5	59.2	62.0	155.4	18.6	37.7	42.8	59.3	78.6	49.6	78.1	81.8	8.6	113.1	48.1	41.2	39.9	48.2	89.0	125.1	166.4	33.5	52.7	89.5	96.5	9.5	37.5	38.5	46.0	238.9	97.0	85.7	78.2	53.5	17.9	4.4	9.2	9.8	8.1	10.2	7.5	16.9	8.4	9.4	7.7	15.0	5.4	6.6	41.7	9.5	13.6	9.2	12.5	3.6	70.5	78.0	109.2	131.2	67.2	65.4	80.3	70.7	74.6	68.2	75.7	91.0	102.2	38.5	56.5	9.8	91.4	82.5	105.6	84.5	50.1	55.7	99.0	103.5	54.5	38.6	65.5	36.8	25.0	23.5	106.5	155.3	9.8	27.3	8.7	60.2	28.0	51.9	150.2	80.2	5.6	56.6	47.2	45.0	57.6	76.2	29.2	14.5	82.5	60.3	36.9	42.1	5.9	104.1	46.8	52.5	134.6	13.0	20.2	68.0	56.9	8.4	41.8	63.6	30.9	6.0	5.2	47.2	86.6	20.3	55.4	94.2	98.8	18.6	55.2	47.5	19.7	132.6	48.7	18.1	19.5	97.8	117.2	56.5	69.3	18.1	79.7	114.0
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557057-12586208	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"Early spermatids: 572.9;Late spermatids: 774.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	16.3	11.5	15.1	10.9	15.1	3.5	13.8	16.9	17.6	15.7	13.5	16.3	13.0	16.6	12.0	17.9	14.7	11.6	32.5	15.1	17.0	16.0	15.1	13.4	14.5	15.5	15.9	21.7	24.1	23.9	12.8	16.7	16.1	12.5	13.5	11.4	14.0	14.0	32.0	14.5	12.2	18.9	16.7	10.7	13.7	56.3	16.7	21.4	21.1	24.5	17.3	15.3	14.3	17.6	20.6	18.8	24.5	17.4	45.2	44.3	40.6	30.0	35.5	41.7	34.1	19.2	18.8	26.7	16.9	37.7	18.8	10.9	38.4	33.1	37.1	30.9	29.2	40.3	19.1	31.1	51.9	38.8	14.4	46.8	30.6	47.6	30.2	34.8	34.9	39.1	39.7	30.8	37.7	25.9	51.4	17.8	16.5	21.7	40.4	45.9	26.0	32.2	30.4	24.8	14.8	26.4	28.4	12.8	30.4	17.3	29.7	38.0	31.1	23.0	23.0	28.5	43.0	26.6	62.8	60.8	28.8	49.5	41.1	20.9	17.9	32.9	20.7	16.4	26.4	21.3	21.4	22.0	19.8	16.5	22.8	20.8	13.2	27.8	23.3	15.9	24.5	20.2	15.1	15.1	16.9	17.6	15.1	17.0	15.5	15.9	16.1	16.7	16.7	17.6	15.4	19.2	9.6	9.8	13.8	9.6	9.9	13.5	10.2	13.8	8.5	8.9	14.7	1.5	14.2	5.5	4.2	19.7	20.8	7.6	19.6	16.1	572.9	9.7	13.8	14.1	2.4	5.0	15.9	16.8	19.6	11.4	5.1	10.1	19.0	17.3	7.9	5.8	15.5	11.8	15.5	10.0	6.1	7.2	9.1	774.2	20.5	9.6	16.0	6.5	20.1	19.1	20.6	14.1	11.1	16.0	10.8	20.7	14.7	9.5	12.0	11.6	14.2	13.2	13.1	11.3	17.4	66.5	38.4	8.1	9.2	16.1	15.7	23.6	10.1	9.8
MKRN2OS	"C3orf83, MKRN2-AS1"	ENSG00000225526	"MKRN2 opposite strand"	H3BPM6	3	12514934-12561059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 9.2;intestine: 8.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065586, HPA065753"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA065586: AB_2685514, HPA065753: AB_2685553"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.03e-3)"	"unprognostic (3.81e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.53e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-3)"	0.1	0.0	0.1	0.4	0.4	0.0	1.3	4.4	0.8	1.8	0.0	4.3	8.0	0.2	9.2	4.6	1.9	2.2	2.0	0.2	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.2	4.1	1.0	1.6	0.4	0.2	0.9	5.0	1.3	7.0	1.9	0.4	2.5	7.6	0.0	0.0	0.0	5.1	0.1	0.1	0.2	0.6	0.0	0.9	0.9	1.1	0.1	2.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	13.8	0.0	0.3	0.0	0.0	0.6	0.0	3.4	0.0	0.0	0.9	0.0	0.6	0.2	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	2.0	5.7	0.2	0.0	0.0	0.8	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.4	0.8	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.1	0.3	0.5	0.0	0.7	0.0	1.8	0.7	2.9	1.3	0.7	2.8	0.6	3.7	0.0	2.7	0.0	1.9	0.0	1.7	1.5	3.0	0.5	0.2	0.0	0.0	2.3	2.2	0.6	0.0	6.6	2.8	0.0	0.2	0.0	0.0	0.2	0.0	2.6	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.8	2.1	2.2	0.0	0.2	0.4	7.5	1.1	4.4	1.0	0.0	0.1	0.1	0.2	0.1	3.4	0.0	0.3	0.0	0.1	2.1	0.9
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MKS1	"BBS13, FLJ20345, MKS, POC12"	ENSG00000011143	"MKS transition zone complex subunit 1"	Q9NXB0	17	58205441-58219605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021372, HPA021812"	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021372: AB_1848746, HPA021812: AB_2142654"	"unprognostic (3.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.27e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.64e-3)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (9.86e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	6.6	9.9	4.2	3.6	4.7	5.8	8.3	6.9	6.1	10.6	3.6	7.8	4.5	9.6	4.3	9.0	13.9	3.9	6.9	4.2	4.3	10.4	8.7	6.2	4.6	5.2	4.9	13.4	11.4	5.7	12.2	3.6	4.8	9.1	3.2	6.1	9.2	3.4	6.7	10.8	7.7	5.0	3.5	8.2	8.5	13.3	4.4	5.8	8.9	3.1	3.9	7.8	8.4	5.7	14.2	12.0	14.5	15.9	5.2	6.4	14.7	7.0	5.9	15.6	9.5	8.4	10.2	7.3	29.5	9.0	9.2	7.7	14.8	10.1	10.8	24.5	16.5	10.2	10.6	14.1	12.5	16.0	6.4	7.0	9.4	8.7	9.3	6.6	8.7	25.5	20.1	5.4	9.2	22.5	27.8	9.7	6.4	12.3	12.0	20.8	18.5	14.6	10.8	7.9	21.4	13.7	10.7	5.9	11.9	6.7	27.8	10.5	6.5	10.6	15.7	8.1	8.8	6.9	7.6	8.6	9.7	9.2	8.3	10.4	6.3	4.2	6.0	6.2	8.7	7.3	9.6	9.3	13.1	4.1	8.9	8.4	1.9	15.7	5.1	8.3	7.8	5.9	4.2	4.7	6.9	6.1	4.2	4.3	5.2	4.9	4.8	3.5	4.4	5.7	4.0	3.2	3.1	10.1	3.3	2.5	5.1	7.9	8.6	6.4	6.6	6.9	3.6	5.7	4.6	9.2	12.5	11.5	1.8	2.9	15.6	7.4	9.5	17.7	6.1	5.1	2.4	14.9	5.8	4.0	9.6	5.6	6.1	4.4	5.7	10.9	5.0	6.3	6.0	0.0	5.3	4.9	8.2	2.5	1.8	8.3	5.3	3.1	1.8	5.6	1.7	5.5	5.2	8.0	9.2	4.8	3.1	6.8	4.3	1.5	5.0	8.2	27.4	10.5	0.0	4.9	4.6	14.0	10.7	5.5	3.3	3.1	3.8	10.2	7.8	2.1
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672874-27746060	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.1;prostate: 15.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Granulosa cells: 11.1;Inhibitory neurons: 15.7;Peritubular cells: 7.2;Respiratory ciliated cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 51.3;BJ hTERT+: 29.4;BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.6;fHDF/TERT166: 148.4;SiHa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	2.7	2.2	1.1	0.7	1.5	0.0	1.1	5.1	8.5	2.8	0.0	3.3	0.2	1.2	2.3	1.0	5.2	1.3	0.4	1.0	3.9	0.2	1.2	0.7	0.2	5.0	3.8	11.1	0.5	1.3	4.9	0.0	4.9	15.7	0.9	0.3	0.3	5.3	0.3	0.6	0.3	0.6	4.4	0.4	2.0	0.8	0.9	0.0	3.3	0.0	0.0	4.2	0.9	3.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	51.3	29.4	33.1	22.6	0.2	0.1	0.0	0.1	148.4	1.3	0.0	0.4	0.0	8.8	0.0	3.3	0.0	9.1	0.1	1.3	0.0	0.0	1.4	2.2	0.0	0.1	0.0	0.0	3.3	0.0	6.3	0.8	0.0	0.2	0.0	0.7	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.5	0.0	21.4	0.0	0.0	0.2	3.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	5.1	8.5	1.0	3.9	5.0	3.8	4.9	4.4	0.9	3.6	0.0	0.0	1.9	4.6	0.1	0.0	0.0	0.2	0.6	0.3	0.0	0.1	1.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	0.1	0.1	0.0	0.0	39.1	0.2	0.0	2.2	0.0	0.1	0.0	11.1	0.0	0.8	0.0	0.0	15.7	0.0	0.0	0.0	0.8	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.5	1.2	0.1	0.0	7.2	0.1	0.1	0.0	0.1	7.3	0.1	0.0	0.0	1.0	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890889-5910606	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 42.9"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 1718.2"	"Cancer enriched"	"Detected in single"	556	"melanoma: 277.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	406	"SK-MEL-30: 703.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000057, HPA048662"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB000057: AB_442107, HPA048662: AB_2680485"	"unprognostic (2.52e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.43e-2)"	0.1	0.2	0.3	0.4	0.5	0.7	1.4	2.0	0.6	0.1	5.9	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.4	0.1	0.4	0.5	0.3	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.3	1.1	0.0	0.3	42.9	0.1	0.0	0.1	0.2	0.2	0.3	0.6	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.8	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.2	1.7	1.3	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.3	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.4	0.1	703.0	0.1	0.1	0.3	0.6	0.2	0.4	0.1	0.7	0.2	0.7	0.3	0.2	0.4	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.5	2.0	0.6	0.2	0.1	0.5	0.3	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.3	0.0	73.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.9	0.0	0.0	1.3	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	15.5	0.9	0.0	0.2	1718.2	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.3	14.5	0.0	0.5	0.1	0.0	0.0
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.3;testis: 393.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 4964.0;Late spermatids: 12837.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 84.0"	"Low region specificity"	"Detected in all"							"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	10.9	6.8	16.8	3.0	19.8	3.2	17.4	17.3	22.0	9.8	34.5	10.0	1.8	15.9	14.8	10.2	67.9	15.1	138.9	19.1	19.3	21.2	3.6	17.9	2.9	25.1	25.2	12.8	9.6	20.2	18.1	2.7	24.0	6.2	4.7	46.9	5.1	4.6	182.3	6.2	4.0	14.2	22.0	3.5	6.2	393.7	19.4	2.3	16.5	107.2	4.8	14.1	4.2	24.2	84.0	7.7	28.4	0.1	13.8	18.1	7.8	6.8	8.4	31.9	30.5	0.0	44.8	0.0	29.3	13.1	42.8	16.3	0.3	14.2	44.5	0.0	15.3	3.9	6.3	0.9	10.2	0.0	6.4	10.5	22.3	13.8	8.8	28.2	7.3	0.0	6.3	0.1	22.2	12.5	0.0	0.2	7.6	46.4	21.3	0.0	15.4	0.7	25.0	6.4	34.8	21.7	38.1	13.7	43.9	27.7	41.1	8.9	3.8	27.2	27.2	35.4	31.0	15.6	8.2	0.1	20.0	0.1	20.6	0.0	0.0	0.0	2.8	0.0	1.4	0.5	6.9	6.9	0.2	0.3	1.5	3.2	0.3	0.9	0.3	0.1	8.7	2.0	16.8	19.8	17.3	22.0	19.1	19.3	25.1	25.2	24.0	22.0	19.4	24.2	42.0	25.6	28.2	11.8	6.0	44.7	143.4	35.3	27.3	14.9	52.8	68.7	231.2	17.2	55.2	20.2	33.3	0.7	12.0	12.8	72.4	26.9	4964.0	203.9	29.3	28.4	33.9	3.6	20.2	7.6	5.0	56.3	18.8	24.0	43.8	10.0	18.5	0.2	8.0	10.1	14.1	29.3	28.5	4.1	19.7	12837.2	69.9	11.5	23.2	3.7	1.0	28.5	3.1	9.0	12.7	10.2	14.3	50.4	3.4	37.4	1.3	36.6	329.7	71.1	19.7	131.0	40.5	854.2	192.2	10.4	34.2	1.6	25.3	55.9	14.7	83.1
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	121.0	199.0	214.6	67.9	225.7	123.8	109.8	206.5	243.7	119.8	215.4	161.8	106.3	148.5	85.2	168.6	120.6	68.1	181.8	234.6	219.0	163.3	298.7	107.0	66.2	208.0	205.8	116.3	111.0	158.2	145.1	79.4	205.8	142.7	74.1	78.2	131.6	96.3	192.8	144.6	117.8	93.0	205.4	101.5	135.9	97.6	211.1	78.3	114.1	129.2	71.2	135.2	117.5	223.6	222.0	354.3	179.1	294.4	159.3	157.9	283.1	216.6	230.6	318.8	286.9	353.8	195.5	163.1	55.0	265.5	228.1	173.5	220.1	295.3	220.0	274.9	239.3	115.3	174.0	200.7	176.0	128.9	143.0	151.7	240.8	255.2	209.8	257.4	140.7	152.0	152.5	61.8	247.8	320.7	165.7	197.9	554.2	236.1	141.2	102.5	160.2	134.0	310.8	247.7	111.2	224.8	188.8	303.6	203.4	385.8	89.8	186.4	133.7	191.4	279.3	213.5	299.9	80.9	98.2	208.9	259.0	102.2	231.2	259.6	120.3	461.0	82.0	109.9	80.9	85.6	63.7	78.3	134.0	97.6	66.2	75.3	528.0	76.6	129.2	231.6	69.7	115.3	214.6	225.7	206.5	243.7	234.6	219.0	208.0	205.8	205.8	205.4	211.1	223.6	106.3	38.5	30.9	19.2	77.9	136.5	149.3	230.2	261.2	110.2	157.7	156.3	71.9	92.9	108.7	110.3	41.7	264.3	92.4	120.6	279.7	169.9	12.1	64.6	70.7	86.4	100.7	74.9	36.2	125.9	213.7	100.6	91.7	74.9	84.9	84.1	71.0	168.6	147.7	80.8	32.7	138.6	197.4	57.8	70.6	13.3	114.0	78.9	103.2	13.1	138.9	142.7	39.1	19.1	23.5	153.8	124.7	107.2	108.2	202.6	219.6	324.7	58.6	63.5	52.6	77.1	131.8	96.6	80.8	193.1	125.6	427.6	70.2	138.3	145.0	174.6
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.6	17.9	7.3	17.4	8.0	22.1	15.4	7.1	9.1	17.4	7.6	17.4	12.0	16.3	14.0	14.3	14.9	11.1	35.4	6.9	8.3	16.0	19.1	15.8	21.9	8.6	7.4	15.1	16.6	22.4	22.7	14.8	7.6	16.2	14.5	9.6	12.1	14.0	49.1	13.4	13.4	19.2	7.1	18.8	15.5	25.4	7.7	28.4	19.2	42.2	24.3	17.2	14.0	9.0	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.3	8.0	7.1	9.1	6.9	8.3	8.6	7.4	7.6	7.1	7.7	9.0	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 209.2;liver: 131.3;skeletal muscle: 246.6;tongue: 149.5"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 224.9;Excitatory neurons: 244.1"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;head and neck cancer: 0.5;liver cancer: 1.9;melanoma: 1.4"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 15.4;hippocampal formation: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 19.6;SK-MEL-30: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	3.7	4.3	0.1	0.1	2.2	0.0	3.5	0.0	15.4	1.7	0.0	0.9	0.3	0.2	0.9	12.6	0.7	1.6	209.2	6.0	0.0	0.9	131.3	0.4	0.2	0.0	0.0	0.2	0.8	0.3	0.5	0.1	0.0	1.6	0.7	0.9	6.9	0.3	246.6	17.4	2.6	0.5	0.0	0.1	0.3	1.0	0.0	0.3	6.9	149.5	5.2	1.3	2.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.0	0.0	19.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.4	0.0	0.0	0.5	19.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	15.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.4	0.1	0.5	0.6	0.1	0.2	0.0	224.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	15.7	0.5	0.5	2.6	0.0	2.7	244.1	0.0	0.0	4.9	0.0	0.4	0.0	0.1	0.7	20.0	0.0	13.5	4.6	3.7	0.0	0.8	0.6	12.9	0.3	0.2	7.2	16.9	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.6	0.1	0.0	17.8	1.9	1.5	0.4	4.1	2.0	0.0	0.1	0.1	0.1	0.1
MLLT1	"ENL, LTG19, YEATS1"	ENSG00000130382	"MLLT1 super elongation complex subunit"	Q03111	19	6210381-6279975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 570.1;Syncytiotrophoblasts: 1138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031166	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA031166: AB_10601874"	"unprognostic (3.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.93e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-3)"	28.9	22.4	33.3	16.5	31.5	8.7	26.4	32.2	38.0	42.9	26.7	41.4	12.2	40.5	13.2	25.6	42.6	9.9	35.5	36.4	26.2	30.0	37.5	33.5	10.9	25.8	28.3	47.7	26.8	20.9	28.9	42.6	21.8	40.8	5.6	13.5	24.0	15.6	34.8	30.8	24.3	13.3	19.8	27.0	30.0	16.8	29.9	11.9	36.8	12.7	7.5	37.3	28.8	27.0	49.5	23.8	28.7	34.1	22.0	19.0	33.3	29.9	19.3	24.7	25.1	39.5	16.2	35.6	38.1	39.4	27.6	30.2	22.9	29.4	14.6	30.2	35.9	44.3	66.0	30.1	42.2	29.0	39.0	30.7	25.2	23.6	19.1	27.1	28.2	31.5	43.6	40.4	16.4	27.1	49.8	27.8	35.0	24.6	49.5	42.3	21.4	28.7	13.4	30.1	49.7	45.2	30.9	33.8	37.8	14.1	30.6	34.1	29.8	34.3	26.5	53.7	41.8	49.1	41.0	28.0	39.6	49.3	49.9	0.1	0.8	0.2	0.7	1.2	0.9	0.5	0.4	0.7	0.6	0.5	0.4	0.5	2.0	0.8	1.5	2.0	0.2	0.7	33.3	31.5	32.2	38.0	36.4	26.2	25.8	28.3	21.8	19.8	29.9	27.0	20.5	22.4	32.7	12.1	5.2	0.1	13.2	0.0	2.8	29.8	13.6	13.5	23.4	5.7	8.6	12.9	18.8	570.1	11.1	5.8	7.9	12.6	27.5	34.8	21.7	21.7	4.9	1.3	10.8	16.6	38.6	14.8	13.3	14.5	10.1	16.2	23.6	18.9	60.9	58.9	13.3	9.9	0.0	15.6	0.0	57.8	19.0	12.1	0.0	11.2	13.2	35.6	10.3	8.0	16.7	13.0	3.6	18.4	8.6	17.8	8.4	6.9	4.4	15.8	26.3	20.7	11.0	10.6	5.7	7.2	0.1	1138.2	5.8	19.5	9.6	14.7
MLLT10	AF10	ENSG00000078403	"MLLT10 histone lysine methyltransferase DOT1L cofactor"	P55197	10	21524646-21743630	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 201.3;Spermatocytes: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005736, HPA005747, HPA072790"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005736: , HPA005747: AB_1079393, HPA072790: "	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (1.03e-3)"	"unprognostic (9.56e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	15.6	13.0	11.9	12.0	13.6	30.5	14.4	21.5	16.0	18.2	16.6	20.8	9.1	18.7	16.0	16.1	17.4	11.4	17.1	11.5	15.2	15.1	15.6	14.6	15.3	14.6	11.9	24.7	13.5	18.6	12.6	16.4	14.1	13.0	12.7	20.6	13.7	11.8	15.6	25.4	13.2	16.8	11.9	12.8	12.3	93.0	13.7	23.2	21.8	14.2	14.5	19.1	16.5	18.6	32.1	29.6	38.3	22.2	23.3	25.0	44.1	19.6	10.6	21.7	21.6	29.5	31.3	34.9	10.8	20.7	21.1	24.1	43.3	25.1	22.2	25.0	21.9	59.2	24.5	44.5	29.6	1.6	33.4	21.3	28.6	17.7	19.2	21.8	30.1	34.3	65.4	26.5	19.3	28.1	44.1	28.5	17.3	17.5	9.2	36.6	23.5	31.7	23.2	12.6	13.8	39.6	24.7	29.0	45.8	30.7	13.3	37.1	29.8	14.7	24.6	26.7	18.9	23.5	32.2	43.4	15.4	21.5	9.9	10.3	6.5	13.5	5.0	4.1	4.6	5.3	6.1	6.1	5.1	4.3	6.6	6.0	4.8	4.6	4.7	7.5	5.5	2.5	11.9	13.6	21.5	16.0	11.5	15.2	14.6	11.9	14.1	11.9	13.7	18.6	33.3	28.9	40.4	155.7	25.1	37.7	17.4	22.4	44.3	38.4	19.9	20.7	31.5	18.6	19.6	18.4	43.8	34.0	24.9	13.3	13.7	14.6	66.1	16.1	26.6	28.7	3.5	30.9	201.3	12.8	58.6	26.6	21.9	21.3	25.2	28.6	26.0	22.7	28.9	30.3	169.6	16.3	26.4	36.1	23.0	109.0	39.4	28.6	48.0	107.7	29.7	17.8	21.6	148.3	160.0	13.2	14.6	48.2	23.5	22.7	18.8	23.1	18.7	53.7	39.5	31.4	35.7	233.8	57.4	48.5	43.9	50.2	29.5	24.2	18.0	13.5
MLLT11	AF1Q	ENSG00000213190	"MLLT11 transcription factor 7 cofactor"	Q13015	1	151060397-151069544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6"	"Cancer enriched"	"Detected in all"	4	"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	5.3	19.0	59.4	4.7	61.8	2.0	2.5	41.1	109.3	4.5	8.8	7.2	1.6	10.7	1.3	4.0	6.2	6.0	38.1	66.2	80.6	3.8	2.0	3.8	2.1	63.1	50.5	8.2	3.1	16.2	10.4	1.0	66.1	4.3	3.6	35.6	3.8	1.5	11.3	2.6	4.9	13.8	29.9	4.6	5.1	2.8	49.7	20.6	3.8	10.8	2.1	4.0	3.9	57.1	6.3	31.0	216.7	34.4	3.5	5.8	1.4	11.6	15.2	13.2	24.0	3.0	12.6	10.0	164.9	10.6	35.9	4.5	54.3	13.0	7.6	65.8	14.5	28.9	17.7	0.9	6.9	0.8	1.0	9.9	1.6	73.5	2.9	42.2	100.1	43.3	30.8	2.3	43.6	1.4	106.4	19.0	95.7	0.6	4.4	99.8	28.1	0.6	25.5	1.7	132.8	238.6	0.8	1.3	6.9	142.5	5.3	2.7	65.9	27.0	29.0	9.2	24.7	2.4	3.2	207.1	70.0	0.6	51.7	1.1	0.3	1.4	5.9	0.6	2.7	2.5	3.9	6.2	0.7	1.9	5.3	9.1	1.6	4.0	0.9	1.4	4.1	3.2	59.4	61.8	41.1	109.3	66.2	80.6	63.1	50.5	66.1	29.9	49.7	57.1	1.4	0.0	1.1	11.8	4.2	3.6	5.0	14.6	4.6	54.1	2.5	4.8	10.2	1.5	2.2	3.7	8.4	2.9	15.3	0.1	17.6	3.9	76.9	0.8	11.3	5.2	10.7	6.3	57.9	1.2	2.5	17.5	2.0	0.9	4.5	4.3	4.2	0.4	6.0	37.0	40.6	0.1	16.2	6.6	14.5	215.6	2.1	12.3	5.4	10.3	33.3	20.6	19.6	16.1	14.4	3.0	0.2	3.8	4.8	1.3	0.2	2.4	0.6	26.3	0.0	3.4	30.0	8.6	12.3	2.8	3.4	7.4	9.9	3.0	0.2	4.3
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3 super elongation complex subunit"	P42568	9	20341669-20622499	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 5.1;T-cells: 16.3"	"Cell line enriched"	"Detected in many"	5	"HEL: 316.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	6.7	15.4	11.6	10.0	16.0	37.3	12.7	9.7	16.4	11.7	2.6	28.8	8.1	12.6	10.6	8.8	12.8	13.9	8.9	17.4	10.9	12.3	2.4	12.6	11.3	6.4	7.8	11.9	4.8	10.1	9.8	11.9	6.6	12.7	37.8	8.2	25.3	12.8	11.1	7.0	15.7	12.3	6.4	6.9	20.1	4.2	9.1	24.3	27.2	11.1	8.3	10.6	6.3	12.0	8.7	24.4	8.4	9.6	19.8	11.7	5.4	22.3	37.8	9.6	11.5	22.8	8.2	36.1	11.9	10.6	3.2	4.4	8.5	38.0	9.2	68.0	23.6	316.4	68.3	12.3	13.8	4.9	20.1	9.4	15.4	3.8	25.3	34.7	9.8	13.8	0.4	42.5	21.7	6.8	24.9	18.6	5.1	50.8	6.8	0.0	15.4	8.8	50.0	13.4	27.2	11.0	18.1	10.2	10.1	8.4	9.3	11.9	6.5	0.0	5.6	6.0	8.3	18.4	18.7	13.1	0.4	10.6	4.8	2.3	0.4	0.6	4.5	0.3	4.3	0.6	8.6	6.5	0.9	1.4	16.3	10.3	0.1	5.1	0.4	0.6	10.8	3.6	11.6	16.0	9.7	16.4	17.4	10.9	6.4	7.8	6.6	6.4	9.1	12.0	20.0	28.9	30.0	144.6	8.0	8.3	15.9	18.7	21.1	7.8	21.2	12.3	13.5	18.6	32.5	22.0	33.3	0.9	17.3	23.5	13.7	29.2	3.0	10.3	17.5	13.7	33.0	28.4	284.0	8.2	6.1	18.0	23.0	19.5	12.0	8.7	11.4	2.2	2.4	5.0	288.4	112.3	16.2	1.9	6.5	7.4	13.7	7.1	23.2	114.3	2.7	31.9	17.5	254.3	216.6	27.3	23.6	9.4	18.2	14.5	13.8	9.0	11.7	2.2	0.0	25.2	21.6	1.0	10.5	14.2	8.4	1.6	33.3	9.8	27.0	15.7
MLLT6	"AF17, FLJ23480"	ENSG00000275023	"MLLT6, PHD finger containing"	P55198	17	38705273-38729795	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 291.2;Cone photoreceptor cells: 204.3;NK-cells: 218.3;Rod photoreceptor cells: 200.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.9;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004021	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA004021: AB_1853995"	"prognostic favorable (4.18e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.12e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-3)"	38.0	45.5	1.7	2.8	1.1	2.0	42.5	2.4	2.0	55.0	0.2	49.8	3.0	46.0	1.3	35.2	63.7	0.9	48.8	0.9	0.0	56.5	20.7	45.3	2.2	0.7	0.0	81.1	52.8	0.9	79.2	1.2	0.1	52.1	0.8	3.7	44.4	1.5	81.8	36.6	54.4	1.1	0.0	67.0	48.5	33.4	0.6	0.8	70.5	1.0	0.8	44.7	40.7	0.0	2.1	3.8	0.8	1.2	0.8	0.8	0.9	3.3	0.3	0.3	0.6	2.3	1.5	5.4	3.7	0.5	1.1	4.2	0.1	1.2	0.6	14.9	6.5	3.2	7.4	3.5	0.0	2.5	2.6	0.7	0.1	1.1	0.5	2.4	0.9	1.5	2.4	4.4	0.5	1.0	3.7	0.8	0.9	0.3	1.3	2.5	2.8	1.5	0.2	4.6	3.8	4.0	2.1	1.2	1.5	0.8	2.2	0.1	3.9	1.3	2.3	3.2	3.4	10.0	5.8	4.6	1.4	1.8	1.0	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.7	1.1	2.4	2.0	0.9	0.0	0.7	0.0	0.1	0.0	0.6	0.0	60.8	48.1	46.8	46.4	35.3	30.5	25.2	20.2	18.2	291.2	41.2	35.6	32.2	24.3	31.5	33.1	204.3	20.1	69.5	24.4	11.7	25.5	3.2	25.0	35.0	46.0	49.7	9.9	24.5	42.4	4.5	27.9	22.4	35.5	37.3	49.1	31.8	12.6	13.6	119.5	18.8	31.5	10.2	18.0	39.9	6.0	46.9	22.7	19.6	45.0	28.4	36.2	218.3	32.6	26.5	32.2	25.6	42.2	28.0	40.0	37.1	15.7	25.8	200.9	32.9	51.3	37.0	17.1	23.4	27.1	29.1	38.3	65.0	27.9	39.3	29.4
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804003	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	331	"intestine: 254.8"	"Cell type enriched"	"Detected in single"	11	"Enteroendocrine cells: 3.5"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;SuSa: 1.1;TIME: 1.3"					"Low region specificity"	"Detected in many"			"HPA069392, HPA077622"	Enhanced				"Secreted to blood"	NA	NA	450000	200000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA069392: AB_2686136, HPA077622: "					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	254.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.3	43.3	0.0	0.2	0.0	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.5	0.7	0.4	0.7	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MLPH	"exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a"	ENSG00000115648	Melanophilin	Q9BV36	2	237485428-237555322	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 135.9;salivary gland: 122.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA014685	Enhanced					NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA014685: AB_1853997"	"unprognostic (3.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (2.26e-4)"	"unprognostic (1.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.34e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-3)"	13.2	1.4	0.6	2.4	0.7	0.1	56.9	0.7	1.6	69.3	1.3	20.4	8.8	18.1	8.9	6.4	18.0	31.0	69.2	1.1	0.7	4.3	39.0	62.7	0.6	1.1	1.0	11.8	16.1	9.0	2.1	1.9	0.8	135.9	21.7	0.3	122.0	13.0	6.6	11.6	15.2	2.8	0.6	0.2	98.1	2.5	0.8	0.9	39.9	2.5	1.2	22.1	21.9	0.9	0.3	133.7	0.3	0.3	58.5	39.5	0.4	26.8	31.5	14.7	18.5	1.1	101.1	0.2	0.1	49.6	51.0	0.3	0.1	0.9	13.0	0.1	0.3	0.1	0.1	0.0	23.3	0.1	0.7	48.1	14.7	43.4	56.2	75.6	0.1	0.0	0.1	0.3	142.9	255.4	0.4	0.6	0.4	105.4	77.1	0.5	0.1	0.2	0.5	3.2	1.5	0.2	0.1	234.5	182.2	0.7	61.5	1.7	26.8	80.1	2.3	0.9	38.0	0.2	0.2	0.2	236.0	0.1	63.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	1.6	1.1	0.7	1.1	1.0	0.8	0.6	0.8	0.9	12.3	125.0	389.7	0.0	0.8	4.1	17.3	6.0	0.0	0.0	95.6	59.7	63.2	52.9	64.2	12.9	0.0	0.4	0.7	34.9	1.9	12.0	0.2	9.5	10.1	10.1	14.4	0.0	0.2	41.3	0.3	4.5	251.8	17.5	187.3	0.2	1.4	28.8	1.2	0.0	0.1	189.0	32.6	0.8	2.9	0.7	8.4	7.4	30.2	5.6	0.6	0.0	0.0	0.0	0.0	58.1	22.4	3.0	0.8	54.4	9.1	0.6	48.5	0.0	0.0	3.1	3.7	0.3	0.6	1.2	2.4	0.7	6.1	0.4	30.5	38.6
MLST8	"GbetaL, GBL, Lst8, Pop3"	ENSG00000167965	"MTOR associated protein, LST8 homolog"	Q9BVC4	16	2204248-2209453	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019935, HPA041841"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Cell Junctions"	"CAB019935: AB_561447, HPA041841: AB_2677701"	"unprognostic (2.19e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.70e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.60e-4)"	"unprognostic (8.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	16.7	29.4	31.5	9.8	31.8	13.3	17.1	31.4	51.1	16.0	25.5	17.3	12.5	15.5	5.6	24.8	14.6	9.1	25.0	32.4	29.9	26.0	31.3	13.3	10.5	32.0	31.0	19.4	35.8	13.3	19.8	11.1	32.4	20.5	4.6	5.7	19.7	8.0	39.4	22.2	15.6	4.5	29.4	16.5	22.3	33.6	32.5	9.7	22.4	21.8	5.2	16.7	15.5	34.1	20.5	61.9	23.1	60.5	29.6	20.8	38.2	17.9	20.4	26.7	22.9	83.4	29.5	51.3	40.6	20.1	12.7	25.8	23.1	51.4	3.1	39.4	113.4	36.0	61.0	51.7	44.7	57.3	49.7	29.7	34.8	31.7	41.8	22.6	28.6	74.1	54.9	35.9	14.8	89.4	55.5	74.9	47.3	18.1	57.4	55.6	23.4	93.8	20.7	13.4	73.5	40.1	26.6	62.1	46.3	8.7	38.6	54.2	22.4	33.5	38.9	27.3	23.7	43.0	26.4	57.8	17.6	47.5	29.9	0.0	25.0	4.2	14.1	29.9	11.8	14.4	13.1	15.2	24.6	12.5	15.0	15.1	2.8	14.6	30.1	13.3	13.1	20.7	31.5	31.8	31.4	51.1	32.4	29.9	32.0	31.0	32.4	29.4	32.5	34.1	11.5	6.4	16.0	10.4	24.6	14.7	16.2	29.6	21.6	31.5	24.7	29.8	3.3	15.7	16.2	16.5	20.9	63.2	13.0	44.6	35.2	34.4	48.7	9.6	13.1	16.8	28.8	26.9	8.9	42.6	50.4	19.2	42.8	11.2	8.2	26.8	20.3	16.7	46.9	30.3	8.4	37.9	22.4	19.1	14.6	105.4	14.9	18.4	17.8	1.0	28.0	29.4	19.6	5.5	5.9	28.6	37.9	15.1	34.1	17.9	43.2	36.3	11.1	30.6	19.7	11.6	16.5	34.7	28.2	29.4	15.5	52.7	15.4	26.8	49.3	17.4
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MAX dimerization protein MLX"	Q9UH92	17	42567072-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	31.3	28.0	15.8	21.7	16.4	16.4	26.2	16.6	18.0	19.3	19.1	38.5	47.5	15.7	16.6	29.1	17.2	20.3	55.5	16.2	16.9	28.7	51.5	27.9	27.5	16.9	15.9	14.8	32.7	19.6	18.8	21.5	16.8	18.2	38.8	9.3	24.7	18.1	74.4	25.6	42.2	20.3	16.7	24.1	35.4	8.1	16.8	30.1	24.8	86.4	29.4	27.9	20.8	17.2	36.8	41.5	32.1	33.1	48.0	55.3	22.0	53.5	47.5	57.1	51.4	38.0	37.5	43.6	36.8	46.4	51.6	54.4	59.4	34.8	50.0	35.2	55.5	45.4	27.2	43.1	56.3	61.6	63.4	47.9	38.4	45.6	41.8	38.9	42.9	52.2	50.7	38.3	66.2	49.3	87.0	31.3	22.9	90.9	37.3	39.2	66.1	47.5	46.8	44.7	49.9	24.6	23.9	31.2	61.8	42.5	63.3	72.1	30.2	50.7	32.5	55.7	80.8	38.7	47.2	41.2	56.5	39.2	60.8	43.3	64.0	91.4	34.2	80.1	37.6	35.2	35.0	34.6	66.5	30.2	30.5	31.1	82.7	33.7	90.9	35.7	48.0	68.3	15.8	16.4	16.6	18.0	16.2	16.9	16.9	15.9	16.8	16.7	16.8	17.2	31.6	67.3	69.8	9.4	35.6	41.9	28.1	41.5	33.0	29.4	39.8	30.4	24.1	40.0	47.2	27.6	25.0	37.8	35.8	97.7	60.7	48.9	19.1	30.5	29.1	28.2	25.8	42.7	8.0	68.9	49.5	26.0	55.5	26.3	46.7	18.7	27.8	49.7	68.6	25.2	8.1	46.9	30.5	63.4	62.3	24.5	35.1	59.5	32.0	7.5	58.3	13.1	51.5	5.5	7.1	77.5	86.4	31.2	61.8	24.4	132.3	62.1	30.4	31.7	52.6	22.9	31.4	9.3	41.2	45.2	49.9	44.1	38.3	48.0	54.2	36.4
MLXIP	"bHLHe36, KIAA0867, MIR, MONDOA"	ENSG00000175727	"MLX interacting protein"	Q9HAP2	12	122078756-122147344	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.0"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 769.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023084	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA023084: AB_1854005"	"unprognostic (4.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (2.72e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.40e-2)"	26.0	28.5	10.6	29.7	9.5	35.8	21.0	14.3	12.1	24.4	10.0	74.8	26.6	30.4	25.3	15.5	33.3	21.3	23.3	9.7	9.7	25.3	31.1	29.9	17.2	10.5	8.7	47.2	61.5	12.8	21.4	12.5	11.0	27.2	44.2	11.1	32.0	18.9	130.0	25.1	38.9	32.2	7.3	35.1	40.8	16.4	9.9	14.1	41.5	42.0	13.5	45.9	17.3	13.3	25.1	21.6	12.5	26.3	20.1	16.8	4.7	13.8	8.3	6.3	5.3	23.2	9.8	8.4	16.5	13.3	9.3	28.2	24.0	31.8	7.9	16.4	24.9	28.1	15.8	18.3	33.7	12.5	18.4	29.5	24.9	16.2	20.2	17.0	33.1	22.4	54.8	8.0	13.8	16.9	17.5	30.5	12.0	17.8	14.6	26.1	27.4	11.5	19.3	28.2	21.0	12.0	35.3	17.0	18.3	11.2	17.6	27.9	49.1	14.4	13.9	25.6	20.4	18.6	13.6	11.7	18.6	17.2	22.8	2.5	3.7	1.2	1.9	1.4	1.4	1.8	1.9	1.6	2.3	2.3	2.7	3.3	2.9	2.1	2.4	3.1	1.7	1.9	10.6	9.5	14.3	12.1	9.7	9.7	10.5	8.7	11.0	7.3	9.9	13.3	66.7	25.6	31.2	18.6	31.2	57.2	36.5	19.0	25.0	52.0	37.2	26.0	17.4	54.3	29.8	31.3	769.4	2.8	32.9	195.2	13.7	56.7	22.7	58.5	71.1	44.4	180.6	59.1	31.7	149.6	2.8	44.4	29.6	60.6	8.8	23.2	72.5	32.9	28.0	28.6	32.1	128.9	32.6	65.7	65.7	39.8	50.7	39.4	32.0	28.1	57.2	8.1	30.9	26.2	29.3	127.5	105.3	88.8	35.0	59.0	36.2	14.3	58.0	33.5	19.7	66.2	39.9	20.7	25.0	20.0	61.1	5.3	29.8	42.9	231.2	47.7
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899115-83951445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 97.5;Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031625	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favorable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	2.5	2.1	1.9	1.0	2.5	0.4	1.4	1.5	2.4	1.1	2.7	1.7	1.7	1.3	1.2	1.0	1.4	0.7	9.5	1.7	1.9	2.7	5.7	1.2	1.2	2.5	2.5	1.9	5.1	2.0	1.2	0.9	2.0	1.2	1.7	2.4	2.1	1.5	8.2	1.0	1.4	1.2	1.6	1.0	2.5	1.3	3.2	1.0	1.5	21.5	0.9	1.6	0.9	2.5	0.6	1.9	1.6	1.9	2.5	0.9	2.9	0.8	1.2	0.7	0.4	0.9	1.5	0.1	2.4	1.2	2.6	1.5	1.4	0.6	0.7	0.8	1.9	0.9	0.8	1.9	3.0	1.2	2.1	1.1	1.4	0.4	0.4	1.3	0.8	1.4	1.4	0.4	1.1	2.4	0.7	2.7	1.6	2.7	0.4	2.2	1.1	1.1	1.6	1.1	1.4	0.9	3.0	1.1	2.4	2.1	3.4	2.5	0.6	1.8	0.3	1.0	0.2	2.1	1.3	2.0	1.0	0.9	1.9	0.5	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.5	1.5	2.4	1.7	1.9	2.5	2.5	2.0	1.6	3.2	2.5	6.1	6.4	7.3	8.5	10.9	2.0	7.4	1.5	4.6	25.2	7.2	5.2	97.5	17.2	5.5	23.9	125.1	20.2	10.6	12.9	31.3	5.7	4.6	10.4	6.9	8.2	10.2	9.1	3.1	5.5	11.1	10.5	15.3	8.7	5.7	20.1	12.8	46.2	12.3	16.8	6.2	15.2	4.1	10.1	2.0	8.6	14.6	8.2	3.6	3.7	7.7	14.7	27.8	12.5	8.2	6.7	13.1	19.5	6.5	10.4	19.4	19.4	2.4	53.3	6.6	19.0	8.1	12.1	14.4	5.2	2.0	8.2	9.0	17.5	17.1	8.6
MMAA	cblA	ENSG00000151611	"Metabolism of cobalamin associated A"	Q8IVH4	4	145599042-145660033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Supported	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	4.1	3.2	1.4	3.0	1.9	1.7	4.2	2.7	2.3	3.0	1.3	5.8	7.4	2.4	4.0	4.1	2.7	3.8	3.3	1.5	1.4	7.3	24.5	3.7	3.1	1.3	1.5	2.3	2.0	4.2	0.7	2.8	1.3	2.3	5.3	1.9	3.5	2.8	4.7	3.8	6.2	2.6	1.2	3.5	3.6	4.5	1.3	5.2	3.1	6.0	3.7	4.7	0.8	1.6	2.5	1.4	4.0	2.1	8.4	9.8	1.1	7.1	4.0	2.3	1.4	1.7	4.3	12.1	2.1	4.4	1.1	2.2	2.0	4.4	1.7	7.5	0.8	4.0	1.3	1.5	6.5	5.6	3.3	5.5	6.1	2.6	5.8	3.7	7.2	8.1	1.1	4.6	5.1	3.4	7.2	1.4	1.5	6.2	2.7	3.7	2.2	1.4	13.3	1.3	1.9	1.4	3.5	6.0	3.3	2.4	3.9	1.5	7.0	2.8	1.4	5.0	1.6	2.2	2.0	3.3	4.4	5.5	2.8	3.9	3.1	3.0	4.5	6.1	4.0	3.1	5.3	4.6	3.2	2.6	4.0	5.3	0.5	4.8	7.4	3.3	5.2	2.3	1.4	1.9	2.7	2.3	1.5	1.4	1.3	1.5	1.3	1.2	1.3	1.6	3.6	12.8	5.6	5.5	3.6	2.9	10.4	7.7	5.7	3.4	3.0	2.4	7.6	14.3	13.0	11.0	2.1	7.9	6.5	7.7	15.6	11.1	10.5	5.0	4.5	4.1	2.4	1.7	5.7	12.5	2.8	4.8	7.1	5.7	8.2	3.4	7.9	31.8	4.9	0.0	5.7	6.5	8.2	4.1	1.6	6.3	4.7	3.6	1.8	3.7	5.6	2.3	9.2	8.0	7.4	8.4	7.3	3.0	2.8	6.5	10.9	21.1	6.8	1.6	0.0	4.2	3.8	8.7	5.2	4.4	1.1	7.7	4.5	5.7	6.7	12.2
MMAB	"cblB, CFAP23"	ENSG00000139428	"Metabolism of cobalamin associated B"	Q96EY8	12	109553715-109573580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Supported		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	15.5	51.2	17.8	6.3	18.3	5.8	15.8	18.8	26.9	12.4	18.6	15.8	13.0	10.7	21.2	29.1	13.0	6.0	30.0	17.0	18.8	32.8	103.6	14.9	6.2	22.2	19.0	18.9	23.0	9.8	20.5	4.9	21.3	26.5	7.9	7.3	17.1	6.3	21.1	18.2	14.0	5.6	19.0	12.4	17.7	12.6	18.9	5.5	22.1	16.2	6.5	14.1	14.7	22.9	32.2	22.3	22.2	17.6	8.8	17.7	11.3	7.1	16.2	10.3	10.8	25.8	29.5	21.0	19.9	8.0	19.1	32.9	14.6	54.9	4.6	8.2	60.9	8.6	15.9	42.1	31.3	18.4	7.2	24.0	33.5	22.2	9.7	12.3	9.7	16.4	27.5	15.5	7.3	74.7	16.6	29.2	27.3	3.3	31.6	13.6	8.7	53.9	45.3	30.3	34.1	14.8	15.8	29.2	12.7	6.2	60.5	50.5	5.4	8.6	3.6	6.1	10.4	11.9	9.6	24.0	19.0	22.2	23.9	7.4	7.2	1.0	15.3	10.0	12.2	13.6	11.1	12.1	11.3	17.8	15.2	14.6	1.9	11.2	10.9	9.2	5.8	10.3	17.8	18.3	18.8	26.9	17.0	18.8	22.2	19.0	21.3	19.0	18.9	22.9	25.1	35.3	80.8	9.8	20.4	10.3	33.1	105.6	17.1	32.9	59.6	47.0	52.3	60.1	68.9	42.3	29.2	55.4	15.2	33.6	150.6	49.7	41.3	23.8	10.0	22.1	33.0	34.1	6.4	71.3	37.6	24.7	28.5	16.5	16.5	34.3	28.5	225.3	34.8	104.3	8.5	50.4	71.2	20.4	10.2	82.9	40.4	13.5	26.6	4.7	25.1	30.6	30.9	6.6	21.5	29.7	30.0	30.5	18.1	31.8	61.9	143.6	62.1	29.7	13.1	17.9	26.3	26.0	15.8	44.7	19.7	61.8	16.1	121.1	56.6	30.3
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMADHC	"C2orf25, cblD, CL25022"	ENSG00000168288	"Metabolism of cobalamin associated D"	Q9H3L0	2	149569637-149587778	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037531, HPA037532"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA037531: AB_10671628, HPA037532: AB_2675526"	"unprognostic (5.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	64.9	62.5	32.0	53.0	33.3	144.3	96.7	36.1	40.7	71.0	38.9	78.0	66.4	68.3	55.5	88.7	64.6	58.0	113.9	32.9	34.7	97.1	195.1	53.7	75.3	33.8	33.0	67.6	86.9	91.7	38.6	76.5	34.5	76.7	90.1	37.8	86.0	69.5	201.2	85.5	62.1	79.0	35.5	56.2	68.7	70.4	34.3	88.8	65.8	187.8	93.3	85.7	57.6	36.9	124.8	90.8	113.9	282.4	134.4	222.9	173.9	198.7	262.0	204.8	175.1	174.8	135.3	199.0	109.5	214.0	121.1	156.7	160.8	203.2	257.5	134.9	130.4	159.0	111.0	193.4	218.0	241.0	145.6	180.2	204.4	265.7	273.1	190.3	233.8	130.5	216.2	205.3	245.0	134.7	106.3	151.8	163.6	168.5	182.9	129.2	130.5	170.9	219.4	209.6	144.0	80.4	148.4	135.4	196.7	122.7	139.6	133.4	160.1	162.5	153.4	120.8	155.2	130.1	177.2	213.9	159.5	143.9	220.6	183.5	77.1	129.6	75.0	87.4	88.3	103.2	94.0	83.4	113.8	85.2	98.4	81.5	150.0	119.7	106.0	96.3	124.0	119.8	32.0	33.3	36.1	40.7	32.9	34.7	33.8	33.0	34.5	35.5	34.3	36.9	50.3	48.1	57.4	12.1	78.3	131.7	183.9	262.2	106.4	24.7	64.2	70.0	162.8	80.1	147.3	49.7	12.5	150.4	63.2	76.7	201.5	148.8	179.9	68.6	48.0	77.5	97.4	156.5	14.7	186.0	178.7	86.5	82.6	53.5	66.0	47.5	79.9	135.6	129.5	20.2	21.1	128.2	166.8	101.9	69.3	46.4	66.5	67.2	78.2	11.2	93.8	55.9	87.6	18.1	19.1	154.5	80.1	78.2	125.8	177.3	95.9	215.0	143.2	19.2	98.6	74.3	89.7	223.0	53.6	114.2	141.5	245.0	68.1	90.3	87.1	237.0
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2633016	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.2;Late spermatids: 36.1;Paneth cells: 54.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	2.9	1.4	0.6	0.0	0.6	0.0	3.0	0.5	0.9	3.2	0.4	3.7	2.6	0.7	0.9	4.8	2.9	0.0	0.5	0.5	0.8	3.7	0.5	2.8	0.0	1.0	1.0	0.4	2.0	0.6	0.7	0.0	0.8	6.5	0.3	0.1	1.6	0.3	0.2	0.7	4.2	0.0	0.7	2.5	8.2	24.6	0.7	0.0	1.1	0.0	0.0	3.1	3.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	14.2	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.0	4.7	0.3	2.6	0.2	0.4	1.0	0.4	0.7	0.0	2.7	1.3	0.6	1.8	3.6	0.1	4.2	1.7	0.6	0.6	0.5	0.9	0.5	0.8	1.0	1.0	0.8	0.7	0.7	0.6	5.9	0.0	0.0	0.3	0.4	0.0	5.2	5.2	1.2	0.0	10.3	8.9	1.1	20.0	10.2	18.4	0.0	0.0	0.3	12.1	0.0	9.4	131.2	7.1	0.5	2.3	1.2	2.5	0.1	3.4	0.0	1.3	8.6	7.3	0.0	0.0	1.4	0.2	1.2	0.0	0.2	16.5	2.0	1.0	0.2	36.1	1.8	2.4	0.0	0.0	0.9	0.5	0.0	0.5	0.0	4.0	54.9	1.2	0.2	6.7	20.8	0.1	8.8	0.2	0.0	0.0	0.6	0.6	1.1	0.6	0.0	0.0	0.8	0.4	9.7	12.6
MMGT1	"EMC5, TMEM32"	ENSG00000169446	"Membrane magnesium transporter 1"	Q8N4V1	X	135960588-135974029	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032037	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA032037: AB_10670705"	"prognostic unfavorable (8.54e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (1.94e-5)"	"unprognostic (6.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	17.5	11.0	8.8	12.2	9.3	26.3	12.4	8.3	9.1	15.3	6.2	15.2	11.3	16.3	11.4	17.1	13.7	15.9	18.1	7.9	14.3	17.2	9.0	13.1	11.3	9.3	9.9	14.1	13.4	17.3	9.3	12.4	9.2	12.1	15.1	13.3	14.2	11.6	17.4	10.6	12.8	16.5	8.9	10.3	12.2	4.3	11.0	14.6	24.2	20.0	12.4	15.2	9.6	9.8	28.6	12.9	16.5	25.5	29.6	32.6	21.9	33.1	31.1	27.1	53.2	15.1	43.3	18.7	61.0	32.2	30.3	23.7	45.0	22.9	39.3	22.3	26.3	13.3	16.5	8.9	22.8	26.5	18.9	27.3	36.1	46.1	29.2	27.0	20.1	21.5	18.1	38.9	26.8	20.8	21.2	12.6	12.4	30.9	27.2	17.7	27.6	36.7	20.2	14.2	23.2	23.8	18.2	17.6	41.2	23.5	17.7	12.9	21.9	32.4	18.6	50.7	42.7	23.1	41.4	22.8	28.5	35.6	37.5	12.9	12.1	7.5	8.2	11.8	10.1	7.0	10.5	9.7	11.1	5.7	10.5	9.1	6.6	9.8	13.0	6.7	13.4	10.0	8.8	9.3	8.3	9.1	7.9	14.3	9.3	9.9	9.2	8.9	11.0	9.8	17.6	12.8	13.7	5.5	25.3	22.2	19.8	12.0	37.0	16.6	14.8	15.1	25.3	11.5	12.0	14.7	8.4	7.9	17.9	19.4	7.9	12.1	0.3	12.3	24.4	15.5	25.8	18.7	5.9	12.4	12.6	20.1	13.3	17.1	14.0	3.9	15.7	10.2	14.1	20.2	5.6	15.1	18.3	33.7	23.2	0.6	13.7	29.7	26.6	1.0	25.1	17.9	7.2	6.0	7.4	13.7	9.2	19.2	28.7	23.6	17.0	13.4	9.2	12.6	6.6	20.6	25.0	2.2	7.5	35.6	24.7	11.5	22.3	4.4	17.9	19.6
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 265.4"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Region enhanced"	"Detected in single"		"thalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.4	1.1	265.4	0.0	0.2	0.0	1.3	0.0	0.2	0.3	0.1	1.0	2.0	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.3	1.4	0.2	0.0	1.6	0.0	0.0	0.1	0.8	0.2	0.0	0.0	2.9	0.5	1.9	0.6	0.0	0.2	0.7	4.4	3.2	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.1	0.3	0.3	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 64.8;endometrium 1: 142.8;placenta: 39.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 84.9;Extravillous trophoblasts: 37.6;Granulosa cells: 61.9;Smooth muscle cells: 35.8"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 119.1"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.4;hTERT-RPE1: 19.7;REH: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA055204, HPA068864"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		640000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Cytosol	"CAB002593: , HPA055204: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	3.3	1.6	0.4	1.4	0.3	0.5	2.2	0.3	1.2	64.8	0.3	3.9	6.8	142.8	0.1	1.0	5.7	6.8	7.2	0.3	0.4	2.5	0.6	1.4	3.9	0.4	0.4	12.5	1.3	3.3	0.5	39.6	0.4	1.9	3.5	0.0	5.3	1.5	0.9	3.8	6.0	9.4	0.4	1.4	2.6	6.7	0.4	3.1	1.3	0.9	1.7	2.9	3.6	0.4	0.3	0.0	4.8	38.4	5.7	8.3	0.1	0.6	10.4	1.3	0.8	0.4	1.3	1.3	5.1	2.8	1.8	0.2	2.2	0.0	0.4	0.0	0.8	0.0	0.0	2.2	4.2	0.0	0.0	5.4	0.9	1.1	0.1	19.7	6.0	0.4	0.6	0.0	1.4	0.3	0.1	0.1	1.4	1.2	0.2	16.6	0.0	0.4	0.7	0.0	6.0	10.3	3.9	0.6	0.0	5.9	3.6	0.0	2.7	0.6	0.0	1.6	0.1	0.1	0.2	5.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.4	0.3	0.3	1.2	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.2	0.0	2.5	0.3	3.4	1.0	0.8	0.8	0.6	0.4	1.9	0.5	6.1	1.5	0.1	0.0	0.0	0.7	1.8	0.4	1.9	8.6	10.3	4.4	84.9	0.9	1.8	0.0	0.2	0.7	37.6	8.4	1.5	4.1	1.3	61.9	1.1	0.0	0.8	0.0	0.4	1.3	2.0	0.0	1.1	10.5	0.6	1.0	1.8	1.0	0.0	0.3	0.0	0.0	0.2	1.4	0.2	0.4	0.2	0.5	0.1	2.2	0.8	0.5	0.0	2.7	35.8	3.1	5.5	0.5	0.6	18.6	2.0	5.7	1.0	0.3
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955732	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"urinary bladder: 12.9"	"Cell type enriched"	"Detected in some"	12	"Basal respiratory cells: 426.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 17.9;PC-3: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	12.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	17.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	426.0	0.0	0.0	0.0	0.0	0.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.8
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025754-58046901	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	11.9	3.8	8.9	4.4	6.0	0.4	7.6	7.3	11.2	5.7	5.8	28.0	40.2	3.5	1.1	4.6	6.1	14.3	41.2	6.9	8.7	14.9	50.1	9.9	2.1	15.8	10.6	1.1	18.5	12.7	8.8	28.4	16.8	4.4	14.3	1.5	8.4	9.5	7.0	4.3	33.0	3.7	5.8	9.3	29.6	34.9	18.7	1.0	46.7	5.6	1.3	5.1	2.8	8.6	15.3	11.4	5.8	30.4	6.0	0.3	93.6	1.4	0.8	5.4	1.2	9.1	38.3	0.2	17.7	1.6	4.2	21.0	5.1	4.4	1.6	0.1	10.0	0.1	4.9	51.1	7.7	0.3	19.5	3.1	7.8	0.9	2.3	8.4	3.7	8.5	12.9	0.1	1.8	7.6	0.7	2.6	17.2	44.6	3.2	7.6	0.7	8.3	16.6	5.4	1.6	10.4	20.0	47.3	9.5	13.2	5.2	8.2	3.4	0.4	9.1	3.5	1.3	0.2	0.1	0.3	1.9	2.3	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.9	6.0	7.3	11.2	6.9	8.7	15.8	10.6	16.8	5.8	18.7	8.6	14.3	19.2	14.4	9.1	0.7	2.5	1.0	4.9	2.8	3.4	5.0	3.0	24.7	55.8	12.6	18.4	16.7	48.2	1.6	109.3	1.9	35.7	5.0	3.6	1.1	17.2	11.4	2.7	1.4	12.0	49.2	4.5	35.2	6.4	0.0	18.6	13.6	39.2	12.9	1.7	1.2	33.3	10.2	3.0	0.3	6.9	0.9	0.9	1.8	1.0	0.0	2.1	0.0	4.5	1.4	13.3	38.5	3.4	0.3	1.3	67.3	7.3	6.0	1.9	0.0	0.7	2.4	0.9	4.6	3.3	2.3	48.4	0.7	23.2	45.0	1.7
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032011-88328025	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 2402.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	0.7	0.3	4.6	0.3	5.8	0.0	1.8	2.2	5.4	1.7	0.0	0.8	0.1	1.6	0.6	0.4	0.6	2.6	0.8	5.1	3.9	0.1	0.1	0.2	0.2	1.0	1.5	1.0	0.6	0.2	0.5	1.0	1.3	0.9	0.4	0.4	0.3	0.7	0.1	0.2	0.3	1.3	1.4	0.4	0.3	0.4	3.0	0.4	1.0	0.5	0.2	0.9	0.5	3.3	0.0	0.2	7.9	29.4	1.0	2.0	0.0	10.9	1.6	3.0	1.8	0.0	0.1	0.0	0.0	4.9	1.8	0.0	5.8	0.0	3.7	0.0	3.4	0.0	0.0	0.0	2.4	0.0	0.5	1.4	0.0	4.4	1.3	5.4	12.8	0.1	0.0	1.1	1.7	0.0	0.0	0.0	1.7	0.0	3.0	0.3	0.6	0.0	0.6	0.1	0.2	16.2	0.0	0.0	0.2	2.2	1.1	0.0	7.1	13.7	7.7	0.2	4.2	0.0	0.0	0.0	5.7	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	2.2	5.4	5.1	3.9	1.0	1.5	1.3	1.4	3.0	3.3	2.2	0.0	0.0	20.5	0.1	1.1	0.0	0.0	0.6	4.4	0.8	1.4	1.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	1.9	0.0	6.5	0.5	15.9	5.2	0.0	0.0	443.4	0.0	0.1	16.0	0.0	0.4	0.0	1.9	1.4	0.0	0.4	1.7	300.3	0.0	0.0	0.0	1.6	6.5	0.9	0.4	1.8	10.3	0.0	3.0	0.0	2402.1	13.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.7	2.9	0.0	1.1	0.2	0.1	0.0	0.2	3.4	0.0	0.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 40.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	3.4	1.0	6.1	0.5	5.8	0.7	0.5	40.0	8.1	0.7	3.5	0.7	2.1	1.3	0.1	0.3	2.2	0.6	0.6	6.0	5.6	7.8	0.5	4.7	0.4	4.4	5.6	0.4	5.8	0.3	3.8	0.2	5.4	1.7	0.2	2.5	0.5	4.2	0.3	1.2	1.4	2.0	2.7	0.4	0.6	0.4	7.2	0.0	0.7	0.1	0.0	0.4	0.3	4.8	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.1	5.8	40.0	8.1	6.0	5.6	4.4	5.6	5.4	2.7	7.2	4.8	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046062-3060726	"Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.1;lymphoid tissue: 81.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"basophil: 18.3;neutrophil: 20.3"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 20.3"	"Cell line enriched"	"Detected in some"	15	"HMC-1: 102.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	5.8	0.4	0.5	15.1	0.4	33.1	1.4	0.3	1.6	0.7	0.6	1.7	1.1	0.5	0.1	1.3	6.2	1.1	2.4	0.3	0.3	1.4	2.9	14.4	2.6	0.6	0.5	0.4	1.2	0.2	0.8	1.0	0.6	1.0	1.4	0.0	1.2	0.1	0.5	0.7	3.5	0.9	0.3	81.8	1.9	0.4	0.7	1.4	1.2	3.5	1.9	2.2	0.9	0.3	0.0	0.0	1.2	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.0	6.7	0.5	0.0	0.0	0.0	0.0	0.2	102.2	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.7	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	7.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	18.3	0.2	4.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	20.3	0.5	0.0	0.4	0.2	0.0	0.5	0.4	0.3	1.6	0.3	0.3	0.6	0.5	0.6	0.3	0.7	0.3	1.0	3.2	6.7	0.0	0.7	0.4	0.4	0.2	0.0	0.8	2.0	1.3	1.0	0.0	0.8	1.8	0.0	0.0	1.8	0.2	0.0	0.4	0.0	1.2	1.2	1.0	0.0	2.7	1.6	0.6	0.2	0.6	1.1	3.8	1.3	0.2	0.0	0.3	0.1	0.0	1.9	0.2	0.0	3.5	5.8	0.0	0.0	3.3	0.0	1.0	15.0	0.3	3.1	1.5	0.5	1.3	0.0	0.7	0.8	0.4	1.2	0.2	0.1	0.0	0.0	0.7	0.9	0.1	0.2	0.6	0.3	0.0	4.0	0.1	0.3	0.3
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705769	"Enzymes, Predicted intracellular proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.7;salivary gland: 1.9;skin 1: 2.4"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Fibroblasts: 4.2;Langerhans cells: 1.8;Suprabasal keratinocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"	NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 50: Fibroblasts - ECM organization"			"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				1.2	0.0	0.0	0.0	0.0	1.3	4.7	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.4	2.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843609	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;salivary gland: 286.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Region enriched"	"Detected in some"	4	"thalamus: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	460000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	90.7	0.1	0.3	20.1	0.4	0.0	36.6	0.2	1.6	0.3	0.1	6.1	2.4	38.1	0.2	0.8	0.2	1.9	0.2	0.4	1.6	0.4	1.6	0.3	0.0	0.4	0.4	0.1	0.3	0.1	0.9	0.4	0.3	2.2	2.3	0.0	286.1	2.2	39.6	63.7	4.5	1.6	0.3	0.0	10.5	0.1	7.3	0.1	2.6	0.4	1.3	13.9	0.5	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1545.7	4229.3	27.0	8.7	0.1	0.2	0.0	0.0	1846.6	96.9	0.0	0.1	0.1	45.1	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	4.6	0.2	122.0	5.3	0.0	0.0	0.0	0.2	0.3	4.7	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.9	0.0	0.3	0.0	140.5	13.1	1.6	0.5	0.0	0.0	0.2	56.8	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.6	0.4	1.6	0.4	0.4	0.3	0.3	7.3	0.3	0.0	3.2	0.0	0.0	0.0	8.4	20.4	25.8	0.0	0.0	0.1	0.1	0.3	4.3	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	24.2	0.0	0.3	0.5	0.0	0.0	0.2	1.4	13.4	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	2.2	1.2	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	4.0	0.0	0.0	11.9	1.0	0.9	0.1	0.0	0.0	1.8	10.2	0.0	1.8	0.0	3.4	0.3	0.6	0.0	0.8	7.4
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530750	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2"	"Cell type enriched"	"Detected in many"	8	"Ductal cells: 8176.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000	35000		"Cluster 5: Breast - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	3.8	0.1	0.0	2.0	0.0	0.3	168.7	0.0	0.3	13.3	0.0	1.6	0.6	97.4	27.9	21.3	91.2	509.9	0.2	0.0	0.0	140.2	3.4	31.6	1.9	0.0	0.0	0.7	85.2	0.0	0.3	0.8	0.0	54.0	1.0	0.0	267.9	34.9	0.1	32.4	0.6	4.8	0.0	0.2	7.3	0.6	0.4	3.3	0.4	0.0	29.3	211.2	1.7	0.0	0.2	145.9	0.0	0.4	0.0	0.0	0.2	0.0	2.1	0.1	0.1	1.9	815.9	0.0	189.8	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.6	1.0	0.1	0.2	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	11.8	0.0	0.0	0.0	0.0	350.1	1.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.1	0.0	0.7	3.0	0.0	1.6	0.1	0.6	0.4	1.0	5.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	86.6	43.3	0.0	1.5	1.0	382.2	135.4	1.2	0.0	124.2	93.7	0.7	100.1	401.2	1017.0	0.0	0.7	2.9	1.2	0.0	8176.2	6.1	62.1	3.3	8.8	0.0	0.0	0.0	209.4	0.3	3.4	0.0	124.6	2.5	0.0	0.0	0.0	98.0	0.0	0.0	0.0	38.7	0.6	0.3	10.3	11.8	12.6	0.0	0.0	65.2	0.0	0.0	0.0	0.0	850.9	0.0	0.0	0.1	603.3	0.0	33.9	72.6	0.0	0.0	0.0	31.4	0.1	0.2	17.0	2.4	0.8	3.6	0.0	2.3	840.8
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711796-102727050	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 501.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 4.0;Macrophages: 1.5"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.7"	"Cell line enriched"	"Detected in some"	8	"WM-115: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA021763, HPA022935"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		360000	"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	0.5	0.0	0.0	0.3	0.1	501.1	0.2	0.1	0.2	0.0	0.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.0	13.8	0.1	0.0	0.6	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 158.0;Hepatic stellate cells: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"NK-cell: 6.3;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.2;NK-cells: 6.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 1242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	22.6	3.8	0.8	10.9	0.8	1.8	27.3	0.8	1.1	28.5	1.4	9.9	5.4	15.0	2.8	14.5	23.1	21.1	3.6	0.6	0.9	1.1	8.7	16.1	14.0	1.4	1.4	4.9	3.4	0.5	0.7	40.1	1.2	3.8	14.9	0.5	2.7	4.6	1.1	8.2	13.5	16.8	1.1	0.6	5.2	12.7	1.5	3.7	23.1	6.6	7.6	19.6	9.8	1.1	0.0	0.0	94.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1242.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	6.3	0.0	2.2	0.2	1.2	0.8	0.8	0.8	1.1	0.6	0.9	1.4	1.4	1.2	1.1	1.5	1.1	15.4	0.0	12.0	0.3	2.3	4.2	0.1	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.6	0.0	0.0	0.0	3.9	0.0	1.9	0.0	17.7	0.3	0.7	158.0	0.0	25.9	0.2	0.0	0.0	1.9	0.0	0.4	2.5	0.1	146.3	2.4	0.6	0.0	0.1	0.0	0.0	5.7	5.9	7.7	0.3	9.1	1.8	21.5	0.7	0.8	2.1	0.0	0.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	1.5	0.4	0.0	0.3	0.9	15.4	0.0	0.8	4.5	0.0	1.6	0.0	0.0	0.1
MMS19	"CIAO4, hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051936: AB_2681668, HPA056299: AB_2683091"	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.39e-4)"	25.9	23.3	45.1	14.9	47.1	16.4	27.0	45.7	66.4	27.7	45.3	26.1	14.2	24.6	18.3	32.8	24.8	13.1	39.3	47.6	44.0	37.3	24.0	25.1	22.3	44.7	44.2	30.3	30.6	17.1	35.7	20.6	45.2	23.5	17.5	28.8	26.7	15.8	38.0	44.4	28.4	17.8	43.4	33.4	27.9	47.2	45.8	25.8	23.5	29.2	22.7	25.6	30.3	44.9	39.1	36.5	43.3	61.1	41.4	49.9	26.3	30.7	61.6	45.8	53.5	48.9	49.7	59.9	32.5	42.1	30.4	43.5	71.5	82.7	43.1	26.3	54.5	32.0	30.5	51.8	31.3	42.7	29.9	41.5	35.7	40.7	86.3	88.8	78.2	44.7	45.5	32.8	45.1	35.1	40.5	77.3	24.6	39.0	29.8	32.1	33.0	27.1	55.0	27.9	17.8	29.5	17.8	23.4	48.3	53.7	47.9	37.8	45.0	21.1	26.0	14.2	35.6	29.5	35.0	34.6	31.5	62.3	17.3	10.5	6.1	4.6	5.4	6.6	9.3	6.0	7.2	6.8	8.5	5.0	8.7	7.1	1.2	5.7	5.2	6.3	7.2	6.3	45.1	47.1	45.7	66.4	47.6	44.0	44.7	44.2	45.2	43.4	45.8	44.9	9.4	22.4	16.0	21.2	10.0	10.5	6.2	11.3	12.5	10.6	9.2	11.2	18.0	12.8	8.2	5.5	18.8	13.7	13.4	8.7	11.7	11.1	9.6	5.6	12.1	13.0	10.2	11.6	32.8	8.1	18.8	9.9	16.8	9.0	3.8	12.8	15.4	14.4	12.4	10.1	29.7	14.6	4.1	12.6	9.6	7.4	15.5	9.0	14.2	7.5	15.6	6.4	6.2	27.6	38.6	9.7	4.1	11.3	10.7	6.1	9.1	6.7	7.6	22.2	13.1	9.1	8.8	22.2	28.5	12.7	11.5	8.8	9.7	9.7	13.1	4.9
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	19.8	23.3	12.1	11.5	13.2	8.6	18.4	14.2	16.2	14.0	19.3	22.6	27.1	15.2	15.6	17.9	13.9	14.2	31.0	12.1	13.5	50.6	199.0	12.5	11.8	13.0	12.7	24.2	24.6	31.1	11.7	13.2	13.2	20.8	21.5	17.2	18.7	15.8	23.6	15.0	20.1	14.9	14.1	9.4	20.1	14.6	13.3	12.2	19.2	36.1	11.2	13.0	11.9	16.3	23.9	8.3	24.6	28.8	47.8	45.1	13.6	20.9	27.3	21.6	31.7	9.7	12.1	21.9	16.3	22.4	32.6	13.3	27.6	14.8	30.2	18.9	20.0	11.7	17.5	25.4	34.8	15.1	10.8	27.4	21.6	22.0	25.4	19.3	21.1	23.4	21.6	25.6	25.7	15.0	17.9	14.9	10.5	25.0	6.0	15.8	30.8	30.7	24.9	22.6	22.7	15.8	23.0	16.3	35.7	25.6	14.2	23.9	15.4	20.0	14.6	27.4	28.7	10.0	12.2	18.8	28.1	17.6	17.9	16.0	6.5	11.4	6.4	8.8	8.2	7.6	7.7	8.1	7.8	6.9	9.6	7.2	3.8	12.5	14.7	5.5	10.9	5.8	12.1	13.2	14.2	16.2	12.1	13.5	13.0	12.7	13.2	14.1	13.3	16.3	6.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	26.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801756	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.7;skeletal muscle: 61.6;tongue: 42.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Early spermatids: 22.3;Fibroblasts: 13.9;Langerhans cells: 11.2;Late spermatids: 15.2;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.7;HeLa: 12.7;hTERT-RPE1: 13.7;RH-30: 12.4;TIME: 20.1;U-2 OS: 16.3;U-2197: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	4.1	0.8	6.0	1.6	20.7	1.3	2.3	6.4	9.5	2.2	0.5	6.1	0.8	2.7	1.0	3.6	4.3	3.0	6.7	1.9	5.3	0.9	0.4	3.3	0.1	4.3	13.0	9.6	0.7	0.1	2.7	1.3	6.8	2.3	0.9	1.8	2.7	1.2	61.6	1.8	2.1	2.5	2.1	0.4	4.0	0.8	8.5	0.3	2.1	42.6	0.7	3.3	3.5	3.1	0.0	1.5	30.7	0.9	0.6	1.3	0.0	0.7	1.1	0.0	0.0	0.0	0.1	0.0	3.1	5.7	1.3	2.7	1.5	1.8	0.0	0.0	0.8	0.0	12.7	0.0	0.7	0.0	0.3	0.1	3.5	0.7	3.0	13.7	0.3	0.0	0.0	0.2	1.0	0.0	0.0	0.4	4.0	0.0	2.8	5.3	12.4	0.0	0.4	0.0	0.1	0.4	2.7	0.0	0.0	7.5	0.3	0.1	20.1	1.0	16.3	17.9	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.0	20.7	6.4	9.5	1.9	5.3	4.3	13.0	6.8	2.1	8.5	3.1	2.1	3.2	2.3	12.1	0.3	4.2	0.1	2.6	3.4	8.4	1.8	0.6	7.4	1.5	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.4	22.3	1.4	1.0	6.6	0.0	0.0	6.4	1.0	0.1	13.9	0.5	3.1	0.0	0.6	2.5	0.6	0.3	0.0	9.6	0.0	2.0	1.4	11.2	15.2	5.0	2.7	0.0	2.8	0.3	3.9	0.0	13.0	4.3	2.8	0.0	10.1	1.3	0.2	0.0	0.1	0.1	0.7	0.0	2.4	2.3	0.4	1.1	1.9	2.7	0.0	0.3	0.4	0.0	0.2
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1 component of CDK activating kinase"	P51948	14	60734742-60969965	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	21.5	20.4	25.0	9.5	26.9	14.0	25.8	27.8	31.6	21.0	16.7	18.5	8.8	18.1	18.9	16.8	24.7	14.1	21.0	25.3	26.0	27.0	23.5	14.3	13.5	22.9	22.9	22.4	14.7	55.3	22.2	16.0	22.2	20.8	12.7	29.2	25.7	15.7	79.9	13.0	10.7	19.3	21.3	11.6	16.8	12.2	27.2	26.1	18.3	65.3	17.3	19.8	16.4	28.7	203.9	38.5	47.0	33.3	53.5	58.6	51.3	73.1	78.4	87.5	70.2	30.9	69.4	48.6	53.9	53.9	47.3	63.2	53.0	84.1	124.7	61.0	55.0	32.9	36.2	45.9	66.4	77.0	16.8	36.0	60.5	56.5	62.1	84.1	84.6	69.6	49.6	45.3	98.5	69.5	48.2	48.2	25.8	38.3	85.1	49.4	127.9	30.9	102.9	94.3	41.9	28.5	56.0	46.6	71.7	54.0	72.2	37.0	64.9	66.8	70.7	31.8	55.6	19.7	17.8	70.4	53.9	12.9	49.4	12.2	6.1	22.3	14.3	8.6	14.7	26.9	15.3	15.3	11.9	19.8	17.6	17.8	0.5	34.6	10.1	46.6	13.6	6.6	25.0	26.9	27.8	31.6	25.3	26.0	22.9	22.9	22.2	21.3	27.2	28.7	30.1	32.1	25.5	91.1	31.1	24.9	59.4	88.3	23.3	43.0	28.0	35.6	58.4	22.8	50.8	29.5	31.3	50.6	51.1	6.1	80.3	35.2	6.1	85.6	34.6	28.9	17.4	14.5	365.2	44.5	36.3	33.9	25.5	60.4	32.9	23.3	18.5	23.3	20.2	23.5	223.4	13.8	52.9	6.9	10.7	6.9	30.1	13.3	14.2	119.9	12.6	50.3	44.3	196.6	148.1	59.3	9.3	30.5	30.1	48.1	4.3	74.3	81.4	59.2	52.6	77.5	52.2	50.9	41.2	26.6	18.2	36.0	35.3	26.9	16.0	44.2
MND1	GAJ	ENSG00000121211	"Meiotic nuclear divisions 1"	Q9BWT6	4	153344649-153415118	"Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.3;lymphoid tissue: 26.7;testis: 15.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.9;Erythroid cells: 30.9;Spermatocytes: 55.5;Spermatogonia: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.3;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043499	Supported					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA043499: AB_2732506"	"unprognostic (2.21e-2)"	"unprognostic (6.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.71e-8)"	"unprognostic (7.65e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.84e-2)"	"unprognostic (7.64e-2)"	0.5	0.5	1.1	4.7	1.2	13.3	2.5	1.0	2.0	0.7	0.7	4.4	3.0	0.7	1.2	3.3	0.5	1.0	0.4	1.1	1.3	0.6	1.3	0.8	12.0	1.4	1.1	0.3	0.3	0.0	0.3	2.4	1.2	0.5	5.1	0.0	0.9	0.9	1.3	2.1	2.6	1.5	1.1	1.8	1.6	15.9	1.3	26.7	0.4	0.5	14.0	1.3	1.3	1.7	38.6	17.7	52.7	30.6	0.7	7.2	20.9	35.1	15.4	31.4	25.6	32.8	26.1	74.4	5.8	8.5	29.5	15.7	52.3	15.8	39.9	47.7	19.9	39.1	17.3	42.9	1.1	88.2	17.9	1.9	3.3	24.4	21.1	7.8	10.7	86.0	71.0	91.9	26.8	21.5	124.1	116.0	39.1	17.9	17.8	74.1	18.2	35.8	19.3	9.7	26.5	23.3	15.7	17.7	30.0	26.5	14.7	72.1	2.6	24.1	34.8	28.1	32.6	79.0	96.0	58.8	24.1	69.6	28.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.0	0.4	0.0	0.1	1.7	0.1	1.1	1.2	1.0	2.0	1.1	1.3	1.4	1.1	1.2	1.1	1.3	1.7	0.2	0.0	0.5	2.6	1.9	2.8	1.8	5.1	0.0	0.0	2.2	4.6	0.6	2.8	0.7	0.0	0.0	14.5	1.0	4.1	1.9	0.3	25.9	3.5	1.6	1.3	0.0	30.9	1.6	0.5	20.6	3.6	2.0	5.7	0.0	11.8	1.4	1.0	12.5	0.0	2.6	4.3	4.1	2.5	5.0	20.5	0.9	2.4	3.6	1.9	0.1	0.0	1.0	2.0	23.3	0.6	1.6	2.2	7.7	1.2	0.7	0.1	1.0	0.0	6.6	0.9	8.6	55.5	96.3	10.2	1.4	2.5	2.5	1.5	10.3	2.7
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 48.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.9	1.4	2.6	1.6	2.4	4.6	3.1	10.1	2.9	3.5	12.3	1.9	2.3	3.6	1.3	2.7	21.2	3.3	2.5	2.2	2.4	10.5	1.9	3.4	1.3	7.2	6.8	4.0	2.4	0.6	3.5	1.6	5.1	2.3	2.0	4.7	2.0	1.7	1.0	1.4	2.1	1.3	6.1	1.4	2.2	48.2	2.7	5.6	2.9	1.1	1.2	1.3	2.5	3.9	32.1	7.4	3.8	11.3	3.1	6.7	0.7	7.6	4.4	8.8	18.6	10.5	15.0	17.8	9.4	3.2	12.8	12.3	4.7	4.4	17.9	0.0	1.9	22.9	8.8	1.8	1.1	7.9	2.4	2.7	0.2	17.9	2.6	3.7	1.6	6.8	5.2	0.0	7.6	4.2	0.3	9.8	1.2	16.4	4.3	15.0	22.6	0.2	8.7	6.1	29.5	8.9	12.7	3.8	13.6	0.9	9.1	12.1	0.7	12.0	13.6	11.6	18.8	3.6	11.9	0.3	13.4	18.3	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	10.1	2.9	2.2	2.4	7.2	6.8	5.1	6.1	2.7	3.9	0.7	0.0	4.7	1.0	0.8	3.3	8.8	9.3	1.8	10.5	4.7	8.3	6.0	4.3	28.3	35.0	25.0	1.8	0.2	3.7	11.7	10.9	504.6	256.5	7.8	2.0	1.2	3.0	4.9	1.9	3.9	14.0	5.1	7.2	0.0	11.0	6.8	0.4	7.0	15.2	3.7	4.5	10.2	1.0	5.5	60.8	12.8	2.0	0.0	0.0	0.8	12.4	0.0	1.5	2.8	1.2	0.1	8.6	0.5	3.0	0.3	12.3	232.5	32.6	0.0	21.6	6.5	249.6	25.0	7.1	1.4	0.5	1.0	6.4	6.0	3.5
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182199-93184923	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.7	32.2	39.9	11.3	39.8	40.5	19.0	17.8	54.6	25.8	9.4	36.2	13.9	20.9	26.8	17.4	24.0	17.1	55.8	46.4	59.2	30.8	20.3	21.5	19.4	30.1	25.1	19.1	19.3	45.7	37.0	16.2	39.9	32.4	15.9	92.4	20.9	30.6	44.2	17.5	22.2	22.3	22.1	19.2	26.6	10.3	33.7	23.2	24.1	34.6	17.6	24.1	12.3	38.8	9.8	8.2	19.1	25.0	16.3	6.4	11.1	10.2	14.4	12.4	11.5	8.4	8.9	30.4	19.7	14.6	8.5	16.5	13.9	12.7	13.9	10.7	15.8	16.2	17.4	11.5	19.7	15.8	25.0	9.3	18.4	7.6	13.4	30.3	15.9	35.6	6.2	15.6	11.5	40.4	24.1	10.8	7.5	20.8	8.6	12.7	23.3	14.7	29.4	28.7	36.7	31.0	9.1	16.4	48.4	14.8	25.3	12.1	14.6	4.1	5.6	9.9	5.1	30.9	31.3	15.1	12.8	10.2	7.5	53.5	5.9	19.6	15.5	6.9	19.8	6.8	19.1	19.4	6.2	11.9	23.1	21.1	6.1	16.1	8.8	5.4	16.6	12.1	39.9	39.8	17.8	54.6	46.4	59.2	30.1	25.1	39.9	22.1	33.7	38.8	20.4	32.1	32.1	11.8	21.8	16.2	18.2	11.4	13.1	91.8	18.7	12.4	71.9	24.3	13.9	20.2	50.1	28.9	33.7	10.2	41.1	36.2	4.7	26.5	15.3	18.2	48.5	9.9	37.4	15.1	5.7	16.3	12.2	60.6	27.8	36.0	16.8	8.2	16.5	84.1	35.0	21.0	34.6	13.7	9.8	1.7	17.7	15.9	12.4	12.2	16.1	85.4	50.4	18.1	16.3	22.3	7.5	27.4	15.8	21.2	15.7	19.4	7.5	96.0	19.7	15.5	21.8	27.9	22.2	10.5	15.5	47.7	28.2	23.7	16.2	23.9
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	7.3	7.5	9.4	9.6	12.0	30.0	8.4	5.4	13.0	7.5	19.4	5.8	4.8	7.8	5.0	7.5	8.9	6.9	8.5	19.1	13.5	22.5	6.5	9.6	11.3	9.7	11.3	7.8	8.6	12.5	4.0	8.8	10.0	9.6	6.3	4.9	8.5	5.4	6.1	8.8	5.4	7.7	12.9	8.8	8.1	6.0	8.1	20.0	11.0	6.3	10.3	6.9	5.3	15.8	8.2	6.6	24.2	19.9	12.9	16.2	20.2	24.2	13.2	13.3	11.5	8.8	15.3	45.6	11.5	21.6	9.1	5.7	15.2	20.3	31.9	25.1	5.5	71.5	7.4	6.8	12.9	15.6	13.8	13.5	10.9	14.9	12.0	14.8	15.9	23.4	45.0	14.5	21.3	8.9	49.2	9.7	8.0	5.3	8.5	15.6	23.5	6.1	22.1	14.1	8.4	16.5	10.6	4.7	32.9	12.9	10.9	10.0	19.3	36.6	18.9	16.8	10.0	9.2	3.4	19.1	12.8	11.5	17.2	0.3	1.2	1.1	0.5	0.6	0.4	0.1	0.2	0.2	1.7	0.2	0.3	0.2	0.1	0.2	0.4	2.1	0.6	0.5	9.4	12.0	5.4	13.0	19.1	13.5	9.7	11.3	10.0	12.9	8.1	15.8	11.1	25.6	19.1	42.4	8.9	17.8	6.0	6.1	18.8	3.3	13.7	8.8	17.4	5.7	10.2	44.1	18.8	5.6	31.5	2.6	9.8	5.4	0.8	27.2	16.0	12.8	37.8	99.1	38.4	4.6	5.6	12.1	7.1	25.6	10.8	24.5	9.7	7.1	11.2	6.7	36.5	8.9	4.1	29.2	39.7	1.6	4.4	33.5	10.6	65.6	45.6	6.0	8.2	41.7	12.1	9.4	2.1	8.6	6.9	11.5	1.4	17.1	16.9	4.5	26.3	8.7	23.0	6.4	9.0	15.1	17.0	5.7	10.3	23.4	6.6	9.4
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	32.3	19.6	34.7	19.2	36.3	24.2	28.3	37.8	39.7	27.4	36.2	61.1	18.0	30.7	36.5	51.9	34.4	27.8	43.5	35.3	36.5	18.6	20.0	24.7	26.8	36.1	36.8	28.1	32.8	34.9	11.2	25.7	36.5	32.5	34.8	14.6	35.2	42.3	50.9	50.0	28.6	49.0	36.1	25.1	27.9	14.2	37.1	34.1	24.2	70.4	27.0	39.9	31.6	37.8	29.3	31.2	18.3	15.7	44.2	30.8	17.1	22.5	30.9	40.4	31.8	20.1	39.0	20.9	16.7	50.6	26.0	34.8	28.1	48.6	24.3	28.8	44.3	16.0	11.7	26.2	30.2	21.2	24.2	25.1	57.9	21.9	25.3	32.7	43.6	27.0	26.3	21.2	20.7	20.6	27.4	37.7	23.0	54.3	29.4	19.9	19.0	22.2	34.4	26.9	34.6	37.3	27.3	34.0	27.9	23.0	15.9	21.3	37.7	25.6	13.1	8.3	14.5	21.6	22.3	21.8	17.9	20.3	19.8	9.7	8.7	11.9	16.2	9.2	13.6	8.1	14.1	13.7	10.6	11.0	11.6	10.2	7.1	12.1	13.4	7.5	15.3	10.6	34.7	36.3	37.8	39.7	35.3	36.5	36.1	36.8	36.5	36.1	37.1	37.8	84.8	6.4	10.0	6.5	20.2	82.2	30.1	39.4	12.0	18.4	27.8	33.3	14.8	12.8	18.4	7.3	12.5	31.1	64.5	58.6	27.4	33.5	24.3	18.9	17.7	58.2	20.9	36.2	15.2	38.5	31.0	23.3	16.8	29.2	24.8	20.3	33.9	9.0	26.4	43.7	10.9	32.8	32.6	18.2	39.3	12.1	23.9	28.1	56.9	11.2	29.4	21.5	81.4	6.6	14.8	39.6	63.2	51.1	17.0	48.6	54.3	23.9	12.9	21.4	85.5	20.8	68.3	29.8	41.1	13.7	82.0	59.4	36.4	20.2	27.7	37.6
MOB4	"2C4D, CGI-95, DKFZP564M112, MOB3, MOBKL3, PHOCN, PREI3"	ENSG00000115540	"MOB family member 4, phocein"	Q9Y3A3	2	197515571-197553699	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 367.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034082, HPA044125"	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB034082: AB_1127220, HPA044125: AB_2678822"	"unprognostic (4.60e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (3.35e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.07e-2)"	22.1	88.5	16.4	18.1	17.1	64.8	28.5	20.6	25.2	23.1	13.0	25.0	18.4	27.5	23.8	42.9	18.8	22.1	41.1	17.5	18.2	21.9	21.5	20.1	23.7	15.4	16.7	23.6	17.8	28.7	11.9	32.3	16.2	28.2	26.5	13.9	19.4	22.2	36.1	21.1	20.6	32.4	17.9	19.1	19.0	10.9	17.5	23.8	24.6	36.9	28.7	31.0	19.4	19.0	51.6	27.1	68.2	26.1	54.3	51.3	63.9	57.3	57.1	77.5	64.2	64.8	39.5	46.5	52.4	65.2	54.6	30.2	56.0	57.5	92.2	36.8	41.1	61.4	46.8	62.6	49.5	50.6	50.2	51.1	40.1	52.8	37.7	49.3	53.6	34.5	33.3	28.1	75.0	57.0	31.6	84.2	62.7	51.5	63.8	32.6	55.4	36.2	72.8	84.5	33.3	46.0	42.0	58.5	54.9	89.2	38.6	55.0	46.1	54.6	27.5	58.3	60.6	30.0	43.9	58.7	44.8	35.2	56.6	24.8	9.2	18.2	9.7	11.7	12.1	12.8	10.9	13.0	11.4	10.9	12.9	14.0	22.8	14.7	12.3	10.5	16.9	10.8	16.4	17.1	20.6	25.2	17.5	18.2	15.4	16.7	16.2	17.9	17.5	19.0	53.6	28.9	26.1	0.0	70.5	77.5	50.8	107.0	56.9	39.8	38.3	36.4	54.3	32.9	60.2	20.2	10.4	145.8	77.9	45.3	88.0	64.3	1.7	23.3	28.2	54.1	34.0	31.5	0.0	50.4	101.6	49.5	32.6	23.4	41.3	18.8	40.0	25.9	57.8	47.1	0.0	48.3	97.6	33.7	98.6	4.6	42.6	42.3	58.7	0.0	50.8	56.2	54.6	0.0	0.0	66.4	35.7	38.4	61.7	54.4	34.2	66.7	44.4	32.5	52.6	39.3	74.8	54.3	43.3	54.7	83.5	367.4	82.9	58.5	36.6	65.7
MOBP		ENSG00000168314	"Myelin associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 918.8"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 1607.0"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"HAP1: 18.6"	"Low region specificity"	"Detected in all"							HPA035152	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	366.9	0.1	539.9	0.0	0.1	443.3	488.6	0.2	112.1	0.7	0.0	0.5	0.0	0.0	1.5	0.1	0.2	308.8	382.8	0.3	0.1	0.7	0.0	836.4	490.3	0.8	0.1	2.5	0.4	0.0	714.6	0.1	0.2	0.2	0.3	0.0	0.2	0.2	0.1	0.1	565.7	0.0	0.1	5.5	519.1	0.0	0.1	0.0	0.0	0.3	0.1	918.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	366.9	539.9	443.3	488.6	308.8	382.8	836.4	490.3	714.6	565.7	519.1	918.8	0.1	0.0	0.0	3.3	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	105.1	1.5	0.1	0.2	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.8	11.4	40.9	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.6	113.0	1.5	0.2	0.0	1.0	0.0	0.2	0.0	4.0	1607.0	0.1	0.4	0.7	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.5	41.8	6.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187497-36272157	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 10.3;liver: 16.0"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 18.8;Hepatocytes: 39.4;Proximal enterocytes: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 40.7;hTERT-HME1: 49.7;SiHa: 54.9;SK-MEL-30: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	2.0	10.3	0.3	0.9	0.3	0.3	2.5	0.5	0.5	0.9	0.5	1.6	6.1	0.8	1.9	3.8	1.7	1.4	0.3	0.4	0.4	1.2	16.0	1.6	0.2	1.2	0.3	6.4	0.8	2.3	2.0	1.0	1.3	1.3	1.6	0.7	1.8	3.3	0.6	2.0	6.4	0.6	0.2	0.3	1.6	0.9	0.6	0.1	1.2	0.4	1.2	2.7	0.7	0.3	14.3	4.8	0.2	0.1	4.3	5.5	2.9	8.2	4.6	3.9	10.0	3.1	4.4	0.1	2.5	13.4	1.0	8.6	2.9	12.9	5.4	2.4	2.3	0.2	13.5	11.8	14.6	0.1	3.8	8.7	40.7	15.2	49.7	0.5	0.6	0.1	4.9	0.1	6.2	3.6	0.0	0.1	0.8	3.4	4.1	0.0	0.1	0.0	5.5	18.5	0.1	1.2	54.9	3.3	38.8	0.9	2.5	0.2	2.7	3.0	3.7	6.7	1.4	0.1	0.1	0.1	7.8	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.5	0.4	0.4	1.2	0.3	1.3	0.2	0.6	0.3	0.9	12.8	5.0	0.3	0.9	0.6	1.4	3.7	1.8	0.3	4.5	1.9	1.0	4.3	6.4	0.0	2.1	0.5	0.2	2.2	0.0	3.1	7.2	5.9	3.4	0.8	3.0	0.0	0.9	12.4	4.3	2.4	1.5	18.8	0.0	2.0	0.4	39.4	0.6	0.0	1.1	3.1	6.1	0.6	2.6	3.2	1.8	1.0	3.6	4.7	11.9	6.6	0.0	1.0	0.3	4.6	2.3	9.1	0.9	2.3	22.4	0.2	4.5	0.5	0.0	6.5	1.2	0.1	0.3	5.1	1.3	2.3	0.5	2.7	4.5	2.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
MOCS2	"MOCO1, MOCS2A, MOCS2B"	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 573.2;Proximal tubular cells: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	48.7	79.4	79.1	24.9	84.9	9.1	42.1	80.3	107.6	34.7	74.4	41.9	40.8	30.0	45.9	35.2	26.5	31.3	87.0	84.3	86.3	114.8	126.2	28.2	26.1	79.2	80.5	43.5	42.4	89.6	30.5	35.9	82.4	36.8	32.3	59.3	48.9	44.9	109.3	16.6	40.2	34.4	85.6	23.6	37.2	26.0	88.0	28.3	55.4	111.8	25.2	30.8	24.6	87.4	79.4	62.7	42.9	109.9	85.0	83.2	51.6	99.5	91.9	74.4	89.8	79.7	56.5	76.7	143.5	69.9	127.1	45.0	91.7	96.7	117.2	19.6	84.8	61.7	58.2	75.9	94.4	65.0	43.0	65.1	41.7	91.7	83.5	81.0	85.1	101.4	58.7	44.2	129.5	115.5	72.7	31.8	37.0	34.2	130.1	36.0	93.0	67.0	144.1	56.6	29.4	33.7	69.4	57.3	72.9	56.9	107.2	15.4	55.6	76.9	81.0	69.1	120.5	49.4	84.8	91.5	106.7	16.8	125.1	14.5	21.8	15.6	36.9	26.9	46.2	37.5	42.7	42.8	29.8	40.5	55.3	49.2	3.8	43.5	25.4	27.8	44.9	28.9	79.1	84.9	80.3	107.6	84.3	86.3	79.2	80.5	82.4	85.6	88.0	87.4	51.7	54.5	29.7	14.4	23.5	13.4	40.1	48.5	19.9	30.2	55.7	50.5	122.9	62.9	37.9	69.9	27.1	95.4	19.4	18.2	573.2	43.7	7.3	22.6	29.0	37.6	26.4	18.7	19.1	43.7	37.3	55.7	19.9	26.8	10.1	38.8	26.0	132.6	41.3	6.7	18.4	22.7	44.7	31.2	20.1	14.6	50.7	28.7	23.2	6.5	12.2	67.5	29.9	4.5	11.9	22.1	18.2	68.8	26.7	34.5	65.7	281.7	32.9	21.7	32.9	73.8	49.4	46.7	62.9	37.5	15.6	32.3	25.8	64.2	30.9	34.5
MOCS3	"dJ914P20.3, UBA4"	ENSG00000124217	"Molybdenum cofactor synthesis 3"	O95396	20	50958818-50963929	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis, tRNA processing"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9;Late spermatids: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027556	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA027556: AB_2672333"	"unprognostic (1.29e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.76e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (8.39e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	1.5	1.9	1.8	1.9	1.6	1.0	1.8	1.8	1.9	1.6	1.7	1.8	2.1	1.8	2.7	2.3	2.6	1.4	1.6	1.6	1.8	1.8	2.5	1.5	2.4	1.5	1.5	2.7	2.2	2.1	1.2	1.8	1.5	1.7	1.6	1.4	2.3	1.8	2.4	2.1	2.2	1.4	1.2	2.3	2.0	5.0	1.8	2.0	2.2	1.4	2.2	1.9	1.3	1.6	3.5	5.9	3.6	5.0	5.0	4.1	6.6	4.1	4.4	10.1	4.3	12.8	5.1	5.3	5.3	3.7	6.6	10.0	3.8	10.1	6.4	1.9	4.0	4.2	4.7	7.4	5.1	4.2	4.3	4.6	8.4	4.2	4.1	3.3	3.5	4.6	6.2	3.1	3.8	5.8	7.0	5.1	5.3	5.4	10.2	2.7	5.6	4.7	4.0	5.4	5.2	6.0	6.4	20.3	6.8	4.0	8.5	8.0	4.2	7.6	4.3	4.2	4.5	7.7	7.4	2.2	6.8	2.5	3.3	2.8	4.1	3.8	3.2	3.8	4.2	4.7	3.4	3.6	4.8	3.3	5.6	4.4	2.1	4.5	5.9	2.6	5.9	3.9	1.8	1.6	1.8	1.9	1.6	1.8	1.5	1.5	1.5	1.2	1.8	1.6	2.2	0.0	1.5	0.3	3.7	1.8	5.0	5.2	5.7	5.6	3.8	3.8	2.0	4.3	4.6	0.0	4.2	10.3	1.3	4.0	1.9	7.8	90.9	7.4	5.3	2.7	2.4	5.2	1.7	8.0	6.3	3.4	2.0	5.5	0.0	6.6	6.1	7.5	4.9	0.0	1.8	3.8	4.1	3.8	1.1	26.2	5.0	3.2	3.6	0.0	5.2	6.9	5.2	0.5	1.0	5.9	2.5	3.0	2.0	3.2	3.7	7.3	7.7	5.9	13.1	2.2	3.3	20.0	7.6	5.4	3.8	11.6	3.1	5.8	4.6	4.8
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29657002-29672372	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 73.8"	"Cell type enriched"	"Detected in some"	49	"Oligodendrocytes: 472.3"	"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 73.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 1396.5"	"Low region specificity"	"Detected in all"			HPA021873	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			0.0	0.0	4.9	0.0	11.0	0.0	0.0	8.6	73.8	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	6.8	8.4	0.1	0.0	0.0	0.0	9.9	8.4	0.1	0.0	0.0	0.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	11.0	8.6	73.8	6.8	8.4	9.9	8.4	10.1	8.1	8.4	17.8	0.0	0.0	1.1	0.7	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	9.5	472.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.3
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671658-222709930	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"gallbladder: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Breast glandular cells: 7.2;Cholangiocytes: 7.2;Endometrial ciliated cells: 3.9;Exocrine glandular cells: 5.1;Glandular and luminal cells: 4.9;Hepatocytes: 3.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049944, HPA076308"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 30: Mammary glandular cells - Lactation"	Cytosol	"Endoplasmic reticulum"	"HPA049944: AB_2680964, HPA076308: "	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		0.9	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	16.8	0.4	0.1	0.1	0.8	3.1	0.4	0.0	0.1	0.6	0.0	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.4	0.6	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.3	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	3.9	0.6	0.1	0.0	0.0	2.5	5.1	0.0	0.1	0.0	4.9	0.0	0.2	0.0	3.2	0.9	0.0	1.9	0.0	0.0	0.3	0.3	0.1	0.0	1.3	0.0	0.0	0.6	1.5	0.0	1.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.9	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.2;liver: 25.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	13.9	44.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.6	0.0	0.2	0.2	0.0	0.6	48.2	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201038	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 24.4;liver: 18.9"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"CACO-2: 2.9;Hep G2: 10.7"									HPA011940	Approved		Approved	Centrosome		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.1	0.1	0.5	1.7	0.4	0.9	0.1	1.4	0.7	0.0	0.2	13.4	24.4	0.2	0.2	0.2	0.1	0.2	0.1	0.5	0.2	1.2	18.9	0.1	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.1	7.2	0.4	0.1	0.1	0.5	0.4	23.8	0.8	0.0	0.2	0.2	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.9	0.8	0.1	0.4	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	10.7	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.0	0.3	0.4	0.4	0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.6	0.6	0.1	0.6	0.3	0.2	0.1	0.0	0.6	0.3	0.8	0.8	0.2	0.3	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.4	0.2	0.3	1.6	0.5	0.2	0.3	0.1	0.1	0.5	0.4	1.4	0.7	0.5	0.2	0.3	0.1	0.4	0.0	0.4	1.1	0.3	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	81.9	0.0	0.1	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.1	7.4	0.0	0.0	0.0	14.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.3	0.0	0.0	0.2	88.9	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.5	0.1	26.3	0.4
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	18.4	18.3	8.1	20.2	9.1	8.5	18.6	9.0	13.3	19.2	9.2	22.8	41.7	18.3	5.5	22.5	20.0	14.4	16.9	8.3	9.0	20.9	34.3	24.9	21.6	9.4	8.7	18.6	42.3	21.5	21.7	34.5	9.9	23.3	13.4	9.6	31.1	14.6	21.3	24.9	29.7	11.4	9.3	31.7	35.5	19.0	8.9	19.8	21.9	16.2	18.1	20.1	19.1	9.8	53.1	46.2	23.5	29.6	55.3	38.9	90.1	38.7	58.3	59.8	58.2	81.9	58.7	45.2	34.9	36.3	46.7	50.6	40.2	43.3	32.5	46.7	39.9	20.3	14.4	68.6	54.9	49.8	46.6	25.6	77.1	41.9	39.0	62.2	68.4	27.8	39.6	51.6	28.5	58.8	32.3	62.0	42.6	64.1	22.5	35.5	57.4	74.1	38.0	19.5	19.7	29.2	15.5	84.8	62.7	21.8	38.7	34.3	40.1	26.5	49.7	36.3	56.5	66.5	36.5	22.7	46.9	49.3	39.0	6.7	2.4	1.9	2.6	1.5	3.3	1.2	2.3	2.5	2.1	1.9	1.4	1.6	0.4	8.4	3.3	2.1	3.3	1.7	8.1	9.1	9.0	13.3	8.3	9.0	9.4	8.7	9.9	9.3	8.9	9.8	13.9	6.4	15.9	16.3	22.0	15.8	21.8	20.8	18.2	14.9	18.9	12.8	8.6	24.3	21.3	23.9	18.8	39.5	34.6	18.7	5.9	21.9	65.6	12.4	12.2	13.3	13.9	16.4	13.9	26.1	50.5	12.3	40.8	17.4	4.5	20.9	17.9	25.6	19.9	6.7	12.1	25.7	20.3	12.9	14.8	222.0	15.2	17.9	10.6	12.2	25.5	7.0	30.9	11.1	10.7	22.3	19.7	7.2	43.6	22.7	37.7	7.4	17.7	14.1	13.1	9.4	12.7	13.0	5.1	15.2	17.3	52.0	21.2	16.5	23.3	19.6
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA053752: AB_2682250, HPA058032: AB_2683584"	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	6.2	8.2	15.1	3.1	15.4	2.1	5.5	12.9	18.1	6.1	9.7	10.0	15.2	7.1	1.3	7.7	4.4	1.9	8.8	14.8	13.7	7.6	11.8	5.3	2.7	13.7	14.1	4.7	7.1	3.1	9.5	2.3	14.2	6.8	1.7	1.6	4.8	3.0	14.6	6.7	9.8	2.8	13.3	5.4	7.0	13.7	14.0	3.8	7.7	5.3	2.1	7.9	6.2	14.3	5.7	4.7	2.8	8.9	8.9	5.2	4.0	8.0	3.9	7.6	8.5	7.0	3.7	17.4	7.2	7.5	6.6	7.1	6.2	10.1	3.2	14.5	15.6	7.6	5.5	9.2	11.0	8.9	10.5	7.3	10.8	14.8	5.1	3.9	11.1	7.3	11.9	5.9	5.8	9.4	10.2	13.1	6.4	12.4	23.9	6.3	3.2	13.4	5.4	4.1	8.1	5.0	3.4	6.6	8.4	1.9	5.1	6.0	8.9	5.0	6.0	14.0	13.0	12.3	13.2	10.7	7.7	13.7	7.6	0.2	8.0	4.3	13.8	6.2	15.9	12.2	11.6	14.3	9.8	5.2	14.1	11.6	2.5	17.7	5.2	4.9	13.1	10.4	15.1	15.4	12.9	18.1	14.8	13.7	13.7	14.1	14.2	13.3	14.0	14.3	8.8	3.2	5.4	5.2	3.5	14.9	2.5	6.1	9.1	3.3	4.5	3.6	7.3	1.5	4.2	1.8	4.2	4.6	5.0	5.9	1.9	4.8	14.9	2.5	3.8	6.1	6.7	7.8	5.1	6.7	3.3	3.9	8.2	2.1	4.5	2.8	4.6	14.3	5.4	0.0	5.1	5.6	6.1	3.5	4.2	33.4	3.4	2.4	5.4	1.9	3.0	4.5	7.2	4.5	4.2	12.9	5.9	5.7	8.1	6.0	15.9	13.1	3.6	2.9	0.0	4.5	7.3	16.2	7.2	11.1	9.1	4.0	6.1	6.5	7.1	2.6
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	12.9	9.6	19.3	17.2	25.5	15.7	9.0	20.8	18.9	11.1	9.4	15.6	16.3	10.6	12.0	13.2	10.8	13.2	10.5	18.1	19.1	10.6	12.4	12.6	18.3	24.9	24.0	8.8	13.7	17.5	8.3	8.1	21.2	19.7	13.1	21.0	13.9	10.2	11.4	13.6	16.0	9.7	20.6	15.2	13.7	5.6	22.6	15.3	19.7	7.7	15.5	11.8	7.1	23.0	14.8	35.7	15.0	15.5	16.0	15.9	20.5	14.6	17.4	13.0	13.9	20.9	22.4	26.9	24.1	11.9	23.3	29.8	15.7	14.5	11.5	19.6	17.9	19.0	12.7	20.5	22.4	20.9	52.5	15.7	28.5	19.3	17.2	14.0	24.5	24.7	25.6	9.0	11.3	29.9	26.3	24.6	15.5	19.9	9.6	34.0	10.3	30.4	14.9	11.9	22.4	18.8	25.5	10.2	17.6	10.7	23.3	30.6	26.2	16.2	18.5	18.4	13.0	30.0	21.4	72.9	28.7	21.4	20.3	17.8	9.7	16.6	9.5	16.3	9.8	6.0	7.6	8.8	8.3	7.0	5.6	7.2	21.7	10.3	11.1	4.7	9.9	9.0	19.3	25.5	20.8	18.9	18.1	19.1	24.9	24.0	21.2	20.6	22.6	23.0	19.4	38.5	34.8	1.6	17.3	7.5	10.0	12.7	8.0	15.0	16.6	14.4	12.6	12.8	19.8	14.7	18.8	10.5	16.9	42.3	3.9	14.0	17.8	13.1	15.6	20.7	24.0	16.2	1.9	19.5	12.4	12.6	21.9	20.0	12.7	17.4	19.6	28.4	13.2	8.4	3.0	27.9	10.2	32.0	7.8	14.1	9.0	18.7	8.8	4.7	26.1	21.5	26.8	3.0	5.0	20.0	18.7	10.1	13.8	21.0	23.8	11.7	14.6	23.5	19.7	21.6	11.0	10.4	5.3	14.6	9.5	16.8	17.2	10.9	23.5	18.8
MON2	KIAA1040	ENSG00000061987	"MON2 homolog, regulator of endosome-to-Golgi trafficking"	Q7Z3U7	12	62466817-62600476	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 197.9;Inhibitory neurons: 172.7;Oligodendrocyte precursor cells: 177.9;Oligodendrocytes: 271.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038697, HPA057607"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA038697: AB_10697396, HPA057607: AB_2683482"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.36e-2)"	9.9	8.7	4.8	9.1	11.2	9.1	9.5	9.4	7.3	11.7	10.4	9.0	8.3	10.7	8.6	9.0	8.3	8.7	6.3	5.6	6.0	10.3	14.2	8.7	9.5	9.5	7.5	12.8	13.7	15.5	7.1	10.4	10.5	9.9	10.5	17.5	12.4	8.0	6.4	9.1	7.8	9.2	7.0	9.4	10.7	7.0	7.4	12.6	13.0	7.5	9.8	8.9	6.8	20.9	13.5	20.3	15.0	7.9	19.0	17.8	13.6	14.2	12.0	12.9	12.7	9.2	5.3	9.6	10.8	13.8	10.0	12.6	15.0	10.4	17.4	12.2	11.7	15.0	15.2	9.6	8.1	13.1	10.2	12.0	7.8	14.0	17.1	17.1	12.6	8.6	14.3	22.2	11.4	15.4	11.6	6.2	8.9	8.3	11.1	10.6	13.4	13.3	7.1	17.9	6.4	7.0	24.0	12.9	9.8	15.3	28.0	9.5	17.7	12.4	9.0	15.9	9.3	12.3	12.1	10.7	13.2	8.1	14.2	1.1	3.0	3.2	2.4	3.1	3.2	2.5	2.0	3.4	2.7	2.8	2.8	3.2	4.4	1.9	2.3	1.5	2.6	1.8	4.8	11.2	9.4	7.3	5.6	6.0	9.5	7.5	10.5	7.0	7.4	20.9	29.4	35.3	22.9	113.9	31.5	16.8	13.9	11.7	29.0	36.2	21.5	14.4	16.9	15.7	22.5	27.6	58.4	14.1	29.9	21.9	0.0	7.2	2.7	20.7	38.1	22.6	14.4	18.5	197.9	11.0	7.0	26.9	47.4	28.7	17.1	49.8	23.2	34.8	10.7	21.9	172.7	23.0	12.2	21.4	13.4	2.6	21.8	27.3	8.8	99.3	21.0	11.9	15.5	177.9	271.5	10.9	18.4	18.0	48.7	17.6	17.0	6.7	22.4	55.8	26.3	38.7	24.3	8.0	9.5	26.7	19.6	20.4	28.0	21.1	16.7	18.1
MORC1	"CT33, MORC, ZCW6"	ENSG00000114487	"MORC family CW-type zinc finger 1"	Q86VD1	3	108958248-109118134	"Predicted intracellular proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 16.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 46.8;Late spermatids: 30.4;Microglial cells: 17.8;Spermatocytes: 51.4;Spermatogonia: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"Karpas-707: 2.5;RPMI-8226: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036413	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA036413: AB_10669989"					"unprognostic (1.66e-1)"				"unprognostic (4.30e-2)"	"unprognostic (2.17e-2)"		"unprognostic (2.63e-1)"	"unprognostic (7.45e-6)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.6	0.0	0.0	3.2	0.0	30.4	0.9	0.3	0.0	17.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	49.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000436, HPA077137"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000436: AB_1079404, HPA077137: "	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	15.6	14.4	6.6	7.0	6.7	6.6	16.6	8.5	8.3	20.6	6.6	20.7	5.3	18.1	6.8	17.0	18.7	5.3	19.2	6.6	6.5	16.7	26.9	14.6	9.0	6.6	6.9	20.0	20.1	7.4	16.6	7.5	6.7	21.8	5.9	5.8	14.8	7.7	26.8	19.5	15.6	7.7	6.4	19.5	16.2	45.2	7.0	8.0	15.6	10.2	7.3	21.2	18.5	7.3	19.2	12.2	20.2	23.3	21.4	18.3	15.5	15.6	12.9	16.1	16.7	17.5	10.2	26.9	11.7	14.3	9.4	17.2	17.7	6.9	18.2	15.5	23.8	20.5	12.4	15.3	15.6	18.1	19.8	15.3	12.1	15.1	18.9	12.0	14.0	9.5	26.3	19.0	17.2	23.7	16.2	17.9	23.0	23.9	12.6	31.5	12.8	22.9	12.5	19.1	20.5	17.2	18.8	21.9	8.8	19.6	16.2	21.2	16.3	17.8	18.7	14.3	12.3	15.0	19.0	22.2	10.3	9.1	13.3	0.8	1.6	1.0	12.0	2.9	10.0	2.3	15.1	9.6	1.6	2.1	15.2	11.0	0.3	1.8	3.3	3.2	16.5	5.2	6.6	6.7	8.5	8.3	6.6	6.5	6.6	6.9	6.7	6.4	7.0	7.3	8.7	0.0	4.6	14.0	4.5	7.4	7.3	3.9	6.2	7.9	8.8	9.1	4.6	2.8	6.2	11.0	10.4	8.4	5.9	6.0	3.9	7.3	30.8	6.1	7.8	7.3	9.0	8.6	9.5	8.0	11.4	6.2	4.1	6.0	1.3	8.9	5.7	8.8	5.4	13.5	11.7	4.8	6.1	3.8	4.1	10.3	7.8	4.5	7.2	10.3	2.8	4.1	6.2	11.1	8.8	11.7	4.1	10.1	3.2	11.6	4.6	3.7	3.8	10.4	19.7	7.7	7.7	26.6	24.1	6.0	9.2	6.3	7.8	7.0	7.3	5.6
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	11.2	7.5	6.3	17.3	7.9	34.5	13.9	13.6	7.7	14.6	4.7	10.9	10.9	17.3	9.4	17.7	12.0	12.6	11.6	6.4	6.6	9.4	14.1	12.9	20.3	7.2	6.2	23.8	11.1	10.4	6.5	17.2	8.0	13.6	11.6	7.7	11.5	11.8	17.7	14.9	11.0	13.9	8.6	18.6	13.0	10.8	7.2	19.4	11.7	15.8	20.0	15.4	13.8	11.8	19.7	7.8	19.1	12.8	16.5	16.3	25.1	17.9	30.0	20.3	17.5	12.8	12.9	9.4	7.0	19.9	21.0	9.8	12.9	16.9	18.8	18.7	10.3	37.2	8.2	7.2	11.4	23.4	34.7	12.0	21.3	18.3	26.5	22.2	14.5	14.6	31.0	24.3	14.9	5.8	14.1	9.8	14.2	24.9	7.9	16.4	7.5	17.8	6.6	20.1	7.1	17.4	22.2	12.3	22.8	14.3	14.9	16.3	23.3	17.7	4.9	14.3	15.2	10.9	9.8	8.9	12.7	32.3	13.2	32.5	8.9	19.5	9.1	10.9	9.0	11.3	9.9	8.6	8.8	12.6	12.6	9.1	13.5	9.9	13.6	5.7	13.4	7.9	6.3	7.9	13.6	7.7	6.4	6.6	7.2	6.2	8.0	8.6	7.2	11.8	29.0	28.9	24.1	44.4	49.6	68.3	65.7	33.1	36.5	19.4	19.6	17.4	20.4	14.3	28.9	22.0	8.4	16.1	44.3	14.7	3.9	17.8	51.7	20.9	30.1	24.1	11.4	63.3	36.4	12.5	19.7	31.0	19.4	28.0	47.5	22.4	16.8	16.5	17.5	16.8	37.1	17.1	18.3	26.8	56.8	18.3	18.6	35.8	24.9	52.5	41.4	12.2	40.2	41.7	55.3	23.3	14.5	26.7	17.1	42.0	9.5	7.1	33.5	12.2	13.1	44.8	41.5	33.5	31.4	45.8	81.7	25.2	44.6	16.7	11.1	68.1
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898139	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: AB_2684655"	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	272.8	306.3	183.9	237.6	193.6	427.6	241.5	197.6	285.5	283.8	188.9	270.1	169.4	305.1	213.0	201.1	257.9	256.5	396.6	187.9	240.5	332.2	258.9	243.4	251.8	232.8	221.6	318.2	165.5	263.6	175.1	300.9	223.4	228.7	225.7	265.5	195.9	282.7	559.3	140.5	187.4	331.5	205.4	217.4	186.9	588.7	220.1	297.6	270.2	425.2	279.6	266.2	184.3	227.9	362.0	480.3	863.5	355.4	603.2	620.4	453.2	644.3	636.0	570.7	554.0	436.9	532.7	446.7	517.2	649.1	376.0	442.1	1054.3	432.8	534.3	446.0	420.3	493.5	483.5	406.5	617.9	410.4	424.3	436.7	482.5	323.1	447.6	550.1	689.1	309.7	526.3	398.2	659.2	335.3	392.9	301.6	930.7	472.9	208.5	431.8	673.0	431.0	459.2	488.1	443.6	457.7	578.1	367.2	825.7	871.1	441.7	533.9	543.1	667.2	471.6	359.0	549.6	256.4	770.6	499.2	412.3	647.4	501.4	118.5	195.0	197.5	123.0	188.4	149.4	172.7	176.9	141.6	225.5	163.7	241.9	174.2	154.9	145.1	155.8	214.4	214.2	318.6	183.9	193.6	197.6	285.5	187.9	240.5	232.8	221.6	223.4	205.4	220.1	227.9	374.2	301.3	249.0	38.2	300.0	418.1	624.1	724.2	256.6	104.5	236.1	198.9	372.2	286.0	512.3	290.6	62.6	611.9	309.4	173.4	686.7	545.5	740.6	377.8	352.6	391.1	275.2	298.0	69.6	312.8	815.0	468.2	153.4	282.5	465.8	179.5	372.3	328.6	379.1	200.2	68.5	263.6	451.6	310.9	601.3	504.6	389.5	325.7	501.6	52.5	450.8	322.0	306.9	40.2	80.0	407.4	185.5	464.9	232.0	489.8	178.6	805.1	582.5	97.5	315.5	368.3	500.6	1322.3	467.9	185.3	370.4	663.0	338.2	279.9	199.0	597.1
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031872: AB_2674081, HPA054102: AB_2682379"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	142.9	184.7	173.9	97.3	180.9	99.0	179.3	156.9	261.5	249.3	183.1	113.4	89.5	262.5	217.7	121.1	209.8	129.2	138.4	180.9	210.1	130.2	204.9	132.6	72.5	170.8	180.3	358.2	137.2	137.2	198.8	242.6	191.2	161.9	140.1	94.1	121.2	191.6	175.6	103.9	99.6	328.5	166.9	90.6	118.0	90.1	183.6	79.3	159.2	130.7	109.6	172.1	143.1	179.1	404.7	257.2	372.6	167.3	541.7	388.2	486.6	533.0	479.4	437.1	462.2	259.6	369.5	289.1	401.4	533.5	522.0	272.0	477.1	406.9	535.6	120.9	219.0	157.5	413.9	308.9	602.7	212.2	141.6	449.6	351.2	380.8	489.6	389.2	478.9	142.2	249.5	383.0	551.5	403.7	188.0	207.6	355.5	512.0	322.3	186.9	340.9	292.1	456.5	221.4	347.3	275.5	425.7	310.1	418.5	385.2	203.3	198.1	433.8	263.2	171.2	459.1	289.3	179.3	221.3	241.2	472.1	420.1	403.8	54.1	40.9	32.9	41.2	44.0	46.9	37.0	38.9	38.2	41.8	32.3	41.7	37.0	16.1	46.0	47.3	70.2	36.1	40.3	173.9	180.9	156.9	261.5	180.9	210.1	170.8	180.3	191.2	166.9	183.6	179.1	102.5	125.0	160.1	39.8	75.8	363.5	572.5	292.0	75.1	46.9	198.6	103.6	130.1	123.0	242.0	110.3	10.4	443.3	106.2	103.2	246.5	269.1	46.9	231.7	235.5	146.6	178.6	68.5	109.6	129.9	1214.1	266.0	90.7	187.2	155.8	153.5	118.5	196.8	163.6	58.9	104.4	202.0	219.7	61.7	254.9	34.2	330.9	90.8	188.5	32.8	68.7	117.0	40.2	59.3	78.2	176.8	118.9	574.8	120.9	332.7	105.1	282.9	429.7	38.8	144.7	164.9	287.9	37.2	48.0	112.7	317.8	583.5	118.2	171.5	134.4	396.8
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.4;Endometrial ciliated cells: 38.1;Late spermatids: 25.1;Respiratory ciliated cells: 36.7;Spermatocytes: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	2.5	2.7	2.5	1.5	3.2	1.0	4.2	14.3	4.7	7.1	8.2	3.7	1.9	5.3	4.4	3.1	15.7	2.3	1.9	2.6	2.4	6.4	3.2	3.8	1.5	4.6	5.7	9.8	4.0	2.7	10.0	0.9	2.5	6.0	1.1	3.9	4.4	3.2	2.3	2.9	2.6	1.1	3.2	2.2	2.8	14.8	3.1	2.0	13.5	1.0	1.4	3.0	4.0	2.1	6.4	7.6	5.2	4.8	1.7	0.8	5.4	1.9	1.3	3.0	2.5	3.6	7.0	1.7	4.0	1.2	2.2	7.7	1.1	3.0	2.9	3.9	8.0	1.6	16.4	4.0	1.5	2.1	0.9	1.0	0.6	2.8	2.5	2.3	2.1	3.2	2.7	1.9	1.1	8.9	2.1	0.7	3.1	3.3	6.5	2.2	4.7	2.7	2.3	2.8	8.6	4.2	5.0	8.9	4.1	2.3	4.8	0.6	0.7	3.4	5.0	2.5	2.2	4.5	1.8	1.1	6.9	1.2	2.4	0.0	0.3	0.1	0.5	0.1	0.3	0.4	0.6	0.4	0.4	0.8	0.9	0.4	1.7	0.3	2.0	1.5	0.0	0.4	2.5	3.2	14.3	4.7	2.6	2.4	4.6	5.7	2.5	3.2	3.1	2.1	1.7	3.2	3.2	9.8	3.7	1.7	4.1	4.6	1.8	8.9	5.3	5.2	3.3	4.3	3.9	14.7	20.9	3.6	1.0	2.1	3.9	2.2	25.4	38.1	4.4	1.4	5.4	4.8	17.7	1.4	1.8	2.5	5.6	4.3	5.7	3.4	1.1	1.8	2.9	10.1	10.7	0.9	6.1	0.6	0.7	25.1	2.5	1.0	1.8	4.7	1.2	7.1	4.1	3.5	2.9	1.3	0.6	3.0	2.1	2.0	2.3	9.7	36.7	21.5	0.0	5.7	3.6	25.3	6.4	2.5	2.3	1.9	2.0	2.8	2.2	3.2
MORN3		ENSG00000139714	"MORN repeat containing 3"	Q6PF18	12	121648742-121672631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.1;fallopian tube: 3.9;testis: 4.5"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 2271.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"BEWO: 13.6;CACO-2: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038709, HPA038710"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038709: AB_2676164, HPA038710: AB_2676165"	"prognostic favorable (1.16e-4)"	"unprognostic (2.70e-3)"	"unprognostic (5.56e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	0.2	0.3	1.4	0.5	1.6	0.9	0.4	1.3	1.6	0.4	4.1	0.2	0.2	0.3	0.5	0.1	3.9	0.4	0.2	1.5	1.5	0.7	0.1	1.0	1.2	1.7	2.2	0.3	0.3	2.3	1.3	0.8	1.1	0.2	0.2	0.6	0.4	0.3	0.2	2.0	0.4	0.2	1.3	0.7	0.6	4.5	1.6	0.9	0.6	0.0	0.6	0.2	0.2	1.4	0.2	0.1	0.4	0.2	0.0	0.3	13.6	0.2	0.1	0.0	0.1	8.3	0.4	0.2	0.2	0.1	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.5	0.2	0.5	0.9	0.1	0.3	0.4	0.0	0.1	0.3	1.0	0.2	0.3	0.1	0.3	0.9	0.7	0.3	0.0	0.1	0.4	0.0	0.1	0.5	0.2	1.2	1.1	0.1	0.2	0.0	0.6	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.1	0.4	1.0	0.4	0.2	1.3	0.3	0.1	0.7	0.1	0.8	0.3	0.8	0.4	0.1	0.5	0.7	0.5	1.2	0.9	0.3	0.5	0.8	0.2	1.4	1.6	1.3	1.6	1.5	1.5	1.7	2.2	1.1	1.3	1.6	1.4	1.1	3.2	1.3	0.0	1.6	3.2	1.2	3.3	0.0	1.3	2.5	1.8	1.4	4.3	8.2	1.8	0.0	0.5	6.6	0.0	7.9	4.4	352.0	34.1	1.2	2.1	0.0	0.0	2.7	1.4	0.7	1.4	0.0	3.0	2.5	2.5	0.7	0.0	0.9	0.0	2.3	0.0	4.1	0.0	0.3	2271.5	9.3	1.7	0.0	0.0	1.8	5.4	5.2	0.0	0.1	2.2	0.0	9.4	3.5	0.7	0.1	1.1	51.7	2.2	0.0	1.5	1.4	8.7	6.7	0.0	4.0	7.3	6.7	3.4	0.2	1.1
MORN4	"bA548K23.4, C10orf83, FLJ25925, rtp"	ENSG00000171160	"MORN repeat containing 4"	Q8NDC4	10	97614553-97633500	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.5;Distal tubular cells: 90.1;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052718	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA052718: AB_2681926"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.15e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.32e-1)"	4.0	8.9	24.2	1.7	26.0	1.8	6.6	18.2	27.2	9.4	18.5	7.3	0.9	7.6	11.6	2.5	9.6	5.0	16.9	24.2	31.0	15.8	5.4	4.6	1.9	20.5	23.3	12.3	10.0	24.3	26.7	3.4	23.2	10.1	3.0	15.4	4.9	9.2	6.1	5.3	2.9	5.6	18.5	3.9	6.6	8.8	28.1	2.2	10.3	5.7	1.6	6.4	5.6	20.9	12.0	13.6	17.1	41.5	6.2	18.5	1.5	9.4	14.0	9.8	13.9	6.1	16.4	0.0	14.2	6.8	28.9	8.1	0.0	11.1	10.4	9.7	13.5	2.0	6.9	14.2	16.6	2.8	1.0	10.0	34.3	14.9	19.2	34.9	14.1	12.0	7.6	7.1	9.9	8.7	0.0	0.2	12.2	7.2	15.6	0.0	1.6	0.0	10.4	5.1	12.0	25.4	13.6	3.7	25.5	9.3	16.0	2.2	3.9	10.5	9.1	11.6	11.2	15.1	20.0	0.1	18.8	0.1	5.5	0.6	0.2	0.4	2.0	0.2	2.3	2.5	1.7	1.5	0.1	0.6	2.7	1.9	0.4	0.5	0.1	1.0	2.2	0.6	24.2	26.0	18.2	27.2	24.2	31.0	20.5	23.3	23.2	18.5	28.1	20.9	1.7	6.4	2.0	10.1	2.5	4.2	3.9	7.5	8.6	5.5	5.2	7.1	51.5	5.7	7.3	11.0	0.0	2.1	0.3	1.0	90.1	5.9	13.0	8.9	5.4	2.9	9.0	3.4	22.9	8.0	1.4	7.8	5.1	6.6	5.7	8.3	3.3	2.5	2.7	1.7	23.8	2.4	6.1	0.3	2.3	16.3	7.5	0.8	5.4	4.7	1.8	9.1	1.0	18.6	9.7	6.9	0.4	9.1	2.4	3.7	0.4	51.9	16.1	4.9	0.0	3.7	5.8	7.7	2.2	3.3	3.1	2.1	1.8	5.4	2.3	2.8
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887632-134915257	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Endometrial ciliated cells: 80.3;Erythroid cells: 150.1;Late spermatids: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031158	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	5.1	14.0	4.1	4.9	4.1	15.4	8.3	4.5	5.5	8.7	12.4	6.7	5.9	16.2	12.8	15.2	26.9	7.1	20.0	4.0	4.4	10.9	7.6	7.5	6.2	4.8	4.4	10.9	7.7	15.1	3.4	11.8	4.5	8.4	7.4	6.7	9.4	7.7	21.5	10.4	5.6	11.3	4.4	6.4	5.4	10.4	4.4	9.7	9.6	14.1	8.5	10.6	8.8	4.5	19.6	15.1	12.5	8.7	19.5	11.4	27.3	32.2	58.2	30.4	29.4	37.2	7.6	6.5	43.7	20.6	54.9	6.9	19.6	16.7	39.9	21.9	11.5	5.6	36.7	15.1	82.2	15.6	9.1	20.6	20.0	34.2	14.7	34.5	22.6	13.3	7.0	25.9	37.3	27.2	11.2	7.1	12.8	10.2	34.1	8.3	22.2	12.4	13.0	55.3	7.4	9.2	16.3	16.2	56.7	60.6	6.5	9.7	11.3	14.9	9.2	56.0	29.0	20.1	29.0	10.4	20.2	26.4	19.9	4.9	5.4	10.5	5.8	4.3	7.9	4.7	6.9	6.4	6.3	4.1	7.7	7.6	3.5	5.1	5.1	6.7	12.4	4.1	4.1	4.1	4.5	5.5	4.0	4.4	4.8	4.4	4.5	4.4	4.4	4.5	13.2	6.4	5.8	3.9	11.0	21.3	10.6	13.8	29.6	8.5	10.8	9.4	43.7	4.3	11.8	11.0	2.1	9.0	6.9	7.6	21.5	26.3	106.9	80.3	10.5	12.2	4.2	150.1	7.6	12.4	16.0	10.5	8.6	12.0	5.7	21.5	13.9	6.7	14.9	5.0	8.8	6.9	16.2	11.9	7.7	82.9	6.8	7.5	30.2	4.7	7.4	9.3	11.3	9.0	4.4	20.9	12.7	10.9	14.7	11.8	5.7	27.9	20.0	8.5	6.6	6.8	16.9	3.8	6.6	12.2	20.5	26.1	13.2	15.8	7.1	9.9
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873421-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.9"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 53.4"	"Group enriched"	"Detected in all"	6	"granulocytes: 53.4;monocytes: 15.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	8.3	6.9	9.8	10.7	19.8	8.1	8.5	17.2	21.3	10.7	1.3	6.7	8.2	8.9	7.4	13.1	6.8	11.5	5.1	10.0	12.0	8.6	9.5	14.2	11.6	25.9	15.8	10.5	5.4	6.5	3.6	15.4	24.8	7.1	7.2	7.3	6.6	6.9	2.4	19.4	7.7	8.6	15.7	14.0	8.0	4.0	19.0	8.7	15.0	4.5	9.9	8.6	8.0	48.9	9.4	13.4	9.6	4.9	33.1	20.8	9.4	22.8	21.4	16.2	19.2	7.0	11.1	13.0	6.1	39.0	25.0	15.4	12.6	9.8	20.7	9.0	11.1	4.5	12.5	5.5	20.4	8.6	10.0	19.0	13.5	14.4	19.0	15.6	14.4	12.7	5.8	12.5	15.3	4.5	7.9	7.0	6.6	8.7	12.0	8.2	12.7	10.6	13.2	6.2	3.0	6.9	17.1	7.8	38.5	36.8	6.6	12.7	14.9	13.9	5.6	48.9	8.8	7.6	9.7	8.1	18.3	6.6	20.3	11.8	14.7	6.6	2.7	14.4	3.3	2.1	3.0	2.2	5.1	3.1	3.2	3.4	53.4	5.4	15.8	1.6	3.6	5.8	9.8	19.8	17.2	21.3	10.0	12.0	25.9	15.8	24.8	15.7	19.0	48.9	18.3	22.4	18.2	16.3	15.5	8.5	7.3	5.7	14.8	7.3	10.2	8.3	6.0	11.5	10.9	22.0	6.2	15.5	12.6	9.1	9.8	7.0	5.8	20.3	10.6	14.4	12.6	6.7	17.2	6.1	9.4	14.3	12.2	16.6	7.6	8.7	18.9	8.2	21.8	6.7	17.2	6.7	10.2	28.9	7.1	24.3	10.5	32.7	10.6	23.4	32.5	8.0	8.2	14.1	125.8	6.9	5.7	15.1	12.6	6.7	7.8	11.4	15.4	4.7	13.1	11.6	13.4	9.9	7.9	16.8	12.8	23.5	10.3	11.4	6.4	6.7
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.7	36.6	14.9	5.6	14.1	13.8	16.8	12.6	19.0	22.1	11.2	17.2	6.8	18.7	3.1	33.5	16.2	8.3	15.1	13.4	14.0	21.0	38.9	13.6	8.0	15.5	13.6	19.2	18.4	7.8	15.6	4.1	13.7	18.1	3.0	2.1	19.6	7.0	10.7	41.8	12.8	5.1	13.3	16.3	19.6	57.9	14.4	7.1	14.9	5.4	5.3	17.4	23.4	13.3	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	14.9	14.1	12.6	19.0	13.4	14.0	15.5	13.6	13.7	13.3	14.4	13.3	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MOV10L1	"CHAMP, DJ402G11.8, DKFZp434B0717"	ENSG00000073146	"Mov10 like RISC complex RNA helicase 1"	Q9BXT6	22	50089879-50161690	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 42.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 118.9;Late spermatids: 310.8;Spermatocytes: 80.3;Spermatogonia: 46.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.5;HUVEC TERT2: 12.5;TIME: 5.8"	"Not detected"	"Not detected"							HPA019034	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA019034: AB_1854070"	"unprognostic (1.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	0.6	0.1	1.2	0.2	1.1	0.2	0.4	4.0	1.5	3.3	0.0	2.0	0.1	4.4	1.6	0.6	2.1	1.0	0.8	1.1	0.5	0.5	0.8	0.6	0.2	1.2	0.6	3.0	0.2	0.0	1.0	0.6	1.4	2.1	0.2	1.3	0.5	0.1	0.0	0.3	1.1	1.6	0.2	0.0	0.2	42.6	0.7	0.0	0.5	0.0	0.2	0.5	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.4	0.7	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	1.1	0.1	0.0	0.0	0.0	0.1	12.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	4.0	1.5	1.1	0.5	1.2	0.6	1.4	0.2	0.7	0.6	0.3	0.0	0.0	1.3	0.0	0.3	0.1	0.1	0.0	3.1	0.1	0.3	1.6	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	118.9	0.3	5.2	0.8	0.0	0.0	5.5	0.4	0.1	0.6	0.0	0.5	0.0	0.7	0.4	0.1	1.7	5.0	3.2	0.0	0.0	0.0	0.0	310.8	1.5	0.2	0.0	8.4	0.0	2.3	0.0	1.5	1.1	0.0	0.0	3.0	0.0	0.1	0.0	1.7	0.0	3.7	13.1	0.2	0.3	80.3	46.7	0.1	0.0	0.1	0.1	0.3	0.0	0.1
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916675-167937072	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2288.1;Late spermatids: 5134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056091	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	53.6	89.9	32.3	15.8	37.1	63.3	50.7	34.2	39.0	34.3	35.0	80.3	47.8	30.6	15.8	38.8	34.5	19.6	174.0	36.8	35.6	148.1	266.6	35.1	14.0	31.8	33.4	35.3	52.4	35.6	73.5	13.8	31.6	89.3	33.7	28.4	55.3	16.0	162.1	42.5	65.8	14.8	31.5	28.9	140.4	240.4	34.9	20.1	32.3	66.3	15.0	43.0	35.4	34.4	40.7	43.2	14.6	32.3	31.5	26.2	4.1	70.2	26.9	23.7	27.2	92.3	19.6	75.0	49.4	29.1	21.4	31.4	17.0	28.1	20.3	98.3	34.5	33.2	34.1	60.7	22.4	38.1	21.9	19.6	23.6	41.8	21.8	20.0	20.3	52.5	39.6	34.9	38.7	18.1	52.4	31.4	26.2	73.7	45.2	27.8	31.3	54.7	155.0	30.5	25.8	28.4	41.6	39.1	34.3	29.2	73.9	38.9	30.4	27.8	24.8	45.3	29.9	61.2	65.9	74.5	73.5	28.6	14.6	95.0	33.1	92.5	44.1	30.5	45.7	50.2	51.6	45.8	58.7	41.3	48.6	46.7	61.4	55.6	38.5	40.2	81.3	84.2	32.3	37.1	34.2	39.0	36.8	35.6	31.8	33.4	31.6	31.5	34.9	34.4	81.6	35.3	43.7	14.4	75.0	126.1	157.7	213.8	52.9	54.5	167.2	166.9	428.0	513.3	119.2	130.6	22.9	468.6	78.2	267.5	1025.2	206.1	2288.1	153.3	38.5	75.0	331.5	388.3	23.5	145.5	55.3	119.3	112.1	98.3	88.2	332.1	55.3	679.5	159.6	45.4	19.9	326.4	146.5	77.1	113.3	5134.8	106.2	93.9	120.9	15.9	272.9	123.8	76.2	13.0	16.8	100.5	237.2	112.8	84.7	245.6	516.2	974.3	175.3	69.7	65.7	90.3	147.1	788.0	170.5	75.3	114.4	343.1	94.9	705.0	415.5	173.9
MPDU1	"CDGIf, Lec35, PQLC5, SL15, SLC66A5"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	31.9	41.1	33.0	32.8	34.1	63.3	39.2	35.5	34.5	33.3	41.9	65.5	53.3	17.4	33.5	37.7	32.0	35.7	20.4	31.7	34.2	72.2	107.0	33.3	30.7	34.3	33.9	10.9	39.7	57.4	15.6	37.1	33.7	33.7	69.6	25.4	33.6	18.4	21.3	29.0	48.5	28.7	34.2	28.4	54.5	14.5	36.2	25.9	35.7	21.3	38.0	43.2	21.9	34.9	51.0	111.8	75.9	54.1	83.8	74.4	50.5	81.1	104.6	142.4	98.6	58.0	85.0	28.8	54.8	128.1	65.0	98.4	102.2	134.3	116.6	63.8	118.8	55.7	65.8	98.7	101.0	49.3	89.8	77.9	105.2	133.4	76.4	64.7	105.8	84.9	87.1	38.6	151.6	70.1	35.9	48.4	85.2	107.4	55.8	81.6	56.4	60.7	145.1	52.1	45.8	90.1	104.4	75.9	34.4	59.5	83.8	50.1	76.5	67.5	36.9	36.8	111.2	20.3	34.6	27.0	97.1	62.3	103.5	16.8	44.2	14.0	16.9	73.1	12.8	18.1	16.1	22.1	52.4	16.5	15.4	18.3	6.5	17.4	69.1	48.5	26.4	24.9	33.0	34.1	35.5	34.5	31.7	34.2	34.3	33.9	33.7	34.2	36.2	34.9	30.1	9.6	23.0	5.5	30.4	10.7	34.9	51.0	22.2	18.1	34.7	22.7	5.1	34.3	31.0	23.9	12.5	111.5	26.5	106.8	35.2	62.7	3.2	22.2	23.3	28.2	37.2	96.8	4.5	76.1	93.8	27.5	53.5	28.1	14.5	28.6	25.0	49.7	79.7	16.8	5.6	68.9	40.7	30.5	23.6	5.7	17.1	46.1	24.9	4.7	35.9	28.5	21.6	6.6	9.3	69.7	76.8	6.4	38.5	37.1	78.0	48.0	20.3	23.3	26.3	30.6	24.7	22.9	26.4	20.7	12.6	157.6	26.0	37.1	77.1	40.9
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105706-13279692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 85.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.5;Excitatory neurons: 213.6;Inhibitory neurons: 271.3;Oligodendrocyte precursor cells: 158.8;Oligodendrocytes: 279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.1;HUVEC TERT2: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Enhanced					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	22.7	9.9	18.0	5.3	23.2	0.2	13.2	20.3	20.6	14.3	21.7	16.1	2.8	17.8	15.3	7.6	17.5	11.7	29.8	18.0	20.4	18.8	85.7	11.1	3.9	19.8	22.4	25.6	4.6	11.3	10.7	24.7	20.3	19.2	5.3	33.0	6.3	23.2	19.9	3.8	6.4	18.6	21.4	11.1	7.6	11.5	17.7	4.3	11.7	31.3	1.8	12.6	9.9	35.3	16.1	21.2	58.1	26.0	39.2	35.4	11.8	15.9	16.4	13.8	13.1	0.0	0.0	0.0	4.5	39.6	14.2	0.3	17.3	8.8	22.3	0.0	10.2	10.5	21.9	3.9	20.8	0.1	5.4	26.5	3.6	9.7	6.6	35.3	53.5	0.0	0.3	0.1	12.5	4.2	0.0	0.2	24.9	0.0	9.0	0.0	14.2	0.0	13.7	8.5	7.2	26.9	12.6	2.8	15.5	39.7	8.1	0.1	42.8	14.1	2.7	4.7	12.4	0.0	0.0	0.0	6.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	23.2	20.3	20.6	18.0	20.4	19.8	22.4	20.3	21.4	17.7	35.3	70.9	32.1	7.9	121.5	0.2	5.1	10.1	4.8	3.4	30.9	8.6	15.6	109.7	1.5	14.7	7.3	39.6	16.1	0.4	0.1	1.9	4.2	4.2	27.0	12.4	44.6	1.8	2.1	213.6	2.0	22.9	27.4	1.5	6.3	1.3	39.5	42.5	74.4	5.8	26.9	271.3	0.2	6.1	0.6	6.8	3.7	24.2	0.9	17.8	60.9	0.6	40.2	0.0	158.8	279.6	1.8	0.0	33.8	0.1	12.9	0.0	16.4	36.6	25.4	39.5	35.1	40.8	6.7	13.9	0.1	4.0	10.8	0.8	7.6	0.0	4.7
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212927	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 207.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 204.9;monocytes: 290.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046801	Approved				"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	29.2	15.8	1.5	112.4	1.6	21.3	13.5	1.7	2.4	11.6	3.2	32.9	40.9	10.9	3.7	12.6	6.9	36.2	10.3	1.4	2.1	6.0	41.1	35.4	96.3	3.3	1.9	4.9	4.6	4.6	1.6	35.8	2.5	8.0	43.4	0.3	7.3	9.3	3.9	7.1	52.8	28.2	2.9	207.4	19.2	4.5	4.0	42.8	5.9	8.3	75.2	42.7	2.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	290.5	8.4	0.5	209.9	0.5	12.6	0.3	0.2	144.7	14.0	0.2	0.1	38.5	1.2	245.2	204.9	0.6	214.5	1.5	1.6	1.7	2.4	1.4	2.1	3.3	1.9	2.5	2.9	4.0	4.0	0.7	0.0	7.9	0.0	33.8	1.1	0.0	0.0	1.2	0.0	0.3	0.9	1.7	1.5	0.6	0.0	0.0	0.3	156.0	0.1	0.0	0.0	0.2	0.0	0.1	1.7	0.0	4.4	0.0	0.0	0.6	0.8	0.5	0.1	2.5	0.0	4.6	3.7	52.4	0.0	0.0	0.0	0.0	409.8	48.0	0.6	0.0	174.6	1.8	10.3	218.2	0.2	7.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	6.6	0.7	0.4	0.0	0.0	0.3	1.6	0.3	2.7	0.0	0.0	0.1
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85851	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	45.6	63.1	28.6	24.5	28.4	32.8	45.8	28.3	43.8	45.5	25.8	43.0	23.7	46.6	9.4	39.8	40.4	27.5	59.7	28.1	28.7	33.6	66.9	44.6	40.4	27.4	27.5	43.1	59.2	11.9	44.4	21.2	27.4	50.3	7.6	2.0	55.6	21.2	69.2	37.9	37.1	14.7	28.3	53.0	46.8	16.2	29.5	14.2	46.6	21.1	15.1	46.7	38.4	28.5	50.2	70.4	18.1	54.9	34.1	77.2	51.9	78.0	95.1	44.1	49.3	44.2	61.5	40.2	65.0	39.8	20.5	64.7	13.1	30.4	6.7	67.6	59.3	25.3	34.3	67.1	99.3	25.4	141.9	75.4	41.9	50.0	20.4	57.4	80.0	39.9	56.1	58.6	57.8	167.5	43.6	118.1	36.4	27.3	86.1	84.2	25.7	140.5	37.5	17.1	15.5	42.5	41.0	36.2	91.9	8.3	54.1	119.4	80.6	34.1	47.9	49.4	34.4	67.7	23.6	49.6	67.8	71.2	129.9	47.3	75.3	80.9	60.6	56.6	55.0	92.5	57.1	60.3	80.3	85.9	42.5	43.7	38.9	130.2	47.6	110.3	90.8	67.0	28.6	28.4	28.3	43.8	28.1	28.7	27.4	27.5	27.4	28.3	29.5	28.5	72.6	3.2	25.6	14.0	73.9	35.8	82.9	102.9	47.8	13.8	76.8	80.4	1.3	37.1	63.0	40.5	4.2	78.7	74.2	59.1	33.2	76.4	9.9	33.5	63.1	59.3	49.8	39.9	14.2	114.2	89.4	78.7	43.8	36.1	56.3	57.1	62.8	55.6	89.8	10.1	13.9	92.5	83.4	69.4	43.7	5.0	65.9	55.6	56.9	10.3	77.9	39.8	66.9	14.1	12.9	134.8	78.6	57.9	80.1	110.6	83.1	67.7	43.5	11.4	85.5	51.5	73.3	15.1	36.7	53.9	41.1	61.8	59.8	197.2	68.3	114.0
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170224	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	19.8	21.3	26.7	25.5	26.8	20.0	72.5	29.6	32.8	23.6	19.1	22.7	13.8	25.8	22.4	36.2	15.9	16.5	13.9	26.7	28.3	17.8	15.9	18.7	24.7	22.1	24.7	13.4	9.0	16.2	21.3	24.4	23.1	15.3	24.9	31.6	26.0	13.0	18.0	40.1	15.9	22.8	21.7	16.7	15.7	14.1	27.5	20.7	11.6	17.5	26.2	34.7	21.0	28.4	67.8	36.2	79.0	38.9	37.7	52.7	43.5	71.1	84.7	60.6	29.3	58.5	38.4	55.2	42.0	39.2	44.7	69.2	76.2	73.6	80.8	41.3	49.9	44.5	31.2	106.5	37.5	111.9	65.9	33.6	64.7	36.2	102.8	30.5	70.6	75.7	106.2	15.3	93.4	54.8	86.5	131.2	72.4	83.4	49.5	105.5	36.6	36.5	55.3	69.8	54.1	23.3	119.6	52.5	53.6	32.4	92.2	68.6	56.0	56.5	56.3	50.2	51.3	22.4	58.0	217.9	51.0	89.9	73.2	26.1	38.3	36.9	38.2	46.5	48.5	35.6	38.7	39.9	44.9	29.2	41.1	38.8	4.9	33.1	33.8	27.2	44.3	28.3	26.7	26.8	29.6	32.8	26.7	28.3	22.1	24.7	23.1	21.7	27.5	28.4	13.2	19.2	38.3	20.5	22.9	38.7	40.3	123.9	19.4	14.5	74.3	50.0	31.5	14.3	66.2	20.2	10.4	56.9	23.0	21.7	50.9	45.2	6.5	13.9	18.5	19.3	9.0	23.1	38.5	28.1	46.1	31.4	15.8	22.0	18.3	21.9	20.0	19.0	49.6	20.2	35.6	20.7	40.7	29.1	42.7	7.5	11.1	55.9	32.0	12.2	56.0	61.1	34.0	29.7	17.1	56.4	28.4	10.1	22.3	38.6	12.2	46.5	32.7	24.5	19.7	15.4	30.1	36.9	57.5	30.6	54.0	32.8	27.4	26.3	34.0	48.1
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633659-19673441	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	29.0	32.5	32.4	30.0	31.9	27.9	28.7	36.5	48.7	38.6	31.1	39.7	22.5	36.1	31.6	23.3	34.0	23.4	36.1	31.6	40.2	22.9	21.1	28.7	39.2	31.8	35.7	51.4	28.2	26.3	31.6	25.4	31.5	31.2	24.4	36.9	32.3	31.2	23.4	33.6	33.3	26.6	26.8	39.9	28.3	21.5	33.6	23.2	32.9	18.5	26.4	32.3	31.7	36.5	26.0	16.4	23.9	39.0	30.3	38.2	42.2	38.2	27.5	23.6	20.1	25.1	44.5	40.8	29.7	23.1	36.6	42.2	44.4	26.7	30.2	51.1	22.7	65.7	27.8	30.8	27.0	47.8	51.4	22.8	33.8	18.6	26.1	35.8	31.6	32.5	32.5	25.5	22.2	25.1	36.8	39.9	23.4	48.0	18.1	29.3	55.2	32.6	40.7	19.8	32.7	20.0	35.7	32.3	35.3	39.8	19.7	39.1	37.3	18.1	16.4	34.8	19.6	17.2	19.2	40.1	13.8	43.4	28.7	133.6	23.4	42.5	31.5	18.2	28.1	64.3	35.6	31.1	11.4	54.1	42.5	34.8	69.2	30.4	27.8	35.8	30.9	9.9	32.4	31.9	36.5	48.7	31.6	40.2	31.8	35.7	31.5	26.8	33.6	36.5	117.3	93.0	110.6	42.1	129.7	69.0	102.1	99.0	97.3	201.0	74.8	95.0	94.4	110.1	92.2	103.0	83.4	151.1	132.0	95.1	49.0	57.6	84.3	82.3	129.2	109.0	58.8	78.9	94.7	54.6	83.7	118.8	62.7	118.8	144.2	101.0	133.2	81.3	72.9	210.3	89.4	113.2	67.1	74.5	55.5	37.9	179.3	71.4	67.6	51.5	99.8	114.9	166.9	56.3	78.7	48.2	99.7	157.2	118.5	80.8	100.5	61.6	66.6	219.0	177.5	111.5	118.5	211.0	203.7	57.9	74.0	58.7	142.7	105.3	86.8	65.3
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centrosome"	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	4.6	5.4	13.7	8.0	15.2	26.2	5.0	21.6	19.8	4.7	18.9	6.1	6.8	5.3	11.1	3.1	5.3	3.6	5.6	14.3	13.2	6.2	9.6	3.9	12.1	13.8	13.7	4.5	4.0	8.9	4.4	5.2	13.9	4.6	6.8	21.3	5.5	4.4	6.8	5.0	5.2	5.2	13.4	8.1	5.1	12.4	14.4	32.8	5.2	7.8	10.3	4.2	1.9	16.0	15.0	15.9	23.9	28.0	10.7	10.1	9.1	15.7	7.8	18.7	15.2	15.1	7.2	29.6	10.6	10.1	15.7	10.2	30.3	11.1	26.0	17.6	20.7	30.5	17.9	15.0	6.6	27.0	24.6	10.5	4.7	18.2	16.1	15.6	19.5	40.1	21.4	12.7	17.3	12.9	32.6	44.6	17.1	9.4	17.2	27.6	24.9	19.1	14.7	14.8	31.4	15.0	23.7	9.3	15.4	22.4	17.5	21.2	11.1	15.3	21.5	17.5	22.1	19.0	33.8	24.4	12.2	26.4	32.4	11.5	3.7	5.4	10.1	3.7	7.2	6.5	8.4	9.5	3.7	6.0	11.6	12.0	0.8	10.1	3.3	5.3	7.8	2.8	13.7	15.2	21.6	19.8	14.3	13.2	13.8	13.7	13.9	13.4	14.4	16.0	7.3	9.6	9.5	50.3	15.6	4.5	4.5	5.7	8.6	43.5	5.8	5.2	16.3	10.0	7.2	7.3	114.7	12.2	25.3	2.8	5.9	4.8	57.9	21.2	12.4	8.5	14.3	33.6	87.7	1.8	7.1	10.6	5.1	6.5	2.5	23.6	7.9	31.1	8.6	53.8	84.7	5.6	6.1	15.3	7.4	73.3	7.2	10.4	3.6	24.4	17.0	14.7	32.0	46.3	48.1	1.8	1.6	11.3	21.4	3.0	4.3	11.0	14.9	65.9	0.0	11.6	7.2	31.7	20.4	8.4	2.3	1.6	26.8	17.2	9.8	2.7
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		350000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	18.9	50.5	45.4	16.7	47.3	11.7	20.1	52.2	49.2	23.9	41.1	31.8	45.6	23.6	35.3	27.7	27.8	16.0	44.8	46.6	47.9	31.2	39.1	14.9	20.9	55.5	50.1	30.6	31.8	31.1	22.9	16.2	56.2	27.5	31.4	33.6	23.7	22.9	52.2	16.5	33.0	22.5	45.7	23.0	20.9	26.2	50.0	23.2	23.2	70.9	24.2	24.2	19.5	47.1	27.2	36.9	29.8	34.0	66.7	32.2	26.0	22.8	37.2	38.4	53.4	36.7	35.0	38.3	48.6	33.6	30.6	65.9	60.0	66.7	36.2	29.4	74.9	68.8	35.3	39.9	47.5	32.0	19.4	43.1	16.9	36.2	64.4	58.1	52.9	45.2	23.4	30.7	50.1	23.2	34.6	14.2	16.4	40.9	31.0	35.0	28.0	94.9	45.5	30.4	55.7	24.4	26.7	47.5	28.7	43.5	65.3	21.9	24.1	22.9	19.4	17.3	22.6	75.0	48.4	25.1	47.9	45.8	17.1	2.3	16.2	5.7	28.2	17.0	37.0	27.4	38.3	32.6	23.0	31.9	56.0	40.8	2.7	43.1	15.5	19.1	53.1	29.0	45.4	47.3	52.2	49.2	46.6	47.9	55.5	50.1	56.2	45.7	50.0	47.1	5.6	6.4	15.0	7.8	10.8	1.9	7.6	16.4	5.2	23.4	9.2	10.7	54.1	7.2	10.9	14.7	4.2	31.8	9.1	28.3	15.6	19.6	18.9	5.6	9.2	9.6	10.8	4.2	4.9	8.8	11.4	10.9	6.1	8.5	15.2	13.3	6.1	18.8	23.9	35.3	6.1	19.0	8.2	7.2	2.2	31.3	11.1	6.6	3.6	3.7	9.7	20.7	12.3	2.0	6.9	12.2	33.2	8.6	11.8	7.2	70.1	31.4	7.8	16.7	6.6	8.2	10.1	34.5	9.0	9.1	2.7	16.3	11.1	21.0	16.4	6.2
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126027-40134622	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	2.9	3.8	2.6	2.0	2.6	2.4	2.8	4.7	3.0	2.8	3.0	2.8	2.2	2.6	2.0	3.1	2.5	1.2	2.1	2.6	2.3	4.2	8.0	2.1	2.6	2.4	2.3	2.8	2.9	2.5	3.0	1.8	2.6	2.5	1.8	3.1	2.7	1.5	2.4	3.0	2.6	1.1	2.0	3.1	2.4	2.3	2.5	3.3	3.0	1.4	2.0	2.5	2.7	4.0	8.2	2.5	4.8	6.6	4.3	4.9	4.9	3.1	3.3	4.4	4.3	3.1	4.0	6.8	4.2	3.0	8.7	10.3	3.0	5.3	5.6	5.2	9.2	5.4	3.7	6.9	4.9	6.7	5.2	4.8	6.7	3.4	4.1	4.5	5.1	7.5	13.1	5.5	4.4	4.1	6.8	20.4	6.7	6.7	7.4	9.6	3.3	8.9	5.0	2.1	7.1	8.4	5.0	4.8	7.7	6.2	6.1	9.3	5.5	2.8	7.5	3.6	4.7	8.6	9.6	10.9	4.4	10.5	7.6	20.6	11.2	16.8	8.0	10.8	9.0	16.9	10.1	9.4	11.8	15.3	11.3	9.9	9.2	10.6	10.4	13.1	14.2	13.1	2.6	2.6	4.7	3.0	2.6	2.3	2.4	2.3	2.6	2.0	2.5	4.0	49.8	51.3	34.5	6.5	53.3	110.1	96.2	151.8	58.6	43.5	53.8	66.2	18.0	67.2	79.6	58.8	25.0	110.8	41.3	60.3	117.4	66.6	118.4	73.6	62.3	58.0	48.6	52.2	7.4	54.6	79.7	51.1	35.7	56.6	51.3	63.6	47.2	133.4	69.0	53.8	8.1	63.4	85.5	59.3	62.6	38.6	75.8	50.4	58.7	7.5	74.6	52.9	66.9	12.1	12.5	59.9	97.2	55.3	36.3	76.2	61.6	190.5	91.1	50.1	52.6	57.1	58.4	66.6	53.9	67.1	134.1	95.6	46.8	125.7	82.3	105.7
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 84.7;Paneth cells: 42.7;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	10.5	21.9	22.6	9.3	22.4	15.8	10.7	27.1	35.0	13.2	20.8	25.4	30.6	11.9	8.6	18.1	11.5	9.5	22.4	23.1	20.5	22.7	46.5	12.6	11.7	22.7	20.7	13.0	24.4	15.4	11.0	6.9	23.3	19.0	16.2	4.0	17.2	9.6	23.2	15.6	19.8	6.5	19.4	15.2	20.1	6.6	20.6	10.2	13.3	14.4	7.1	15.2	12.7	25.0	16.0	13.2	21.3	24.6	13.1	6.1	21.7	7.6	7.2	6.2	7.6	25.6	8.1	14.4	23.3	9.9	18.2	16.1	9.8	13.2	3.4	16.4	21.5	11.0	18.4	37.4	10.0	14.9	19.1	9.4	9.4	6.8	7.1	9.3	18.9	37.4	6.0	36.4	7.8	41.8	35.4	12.6	9.8	26.5	18.2	28.8	6.5	21.0	15.5	25.4	23.7	24.3	13.5	19.4	9.9	12.1	13.0	18.1	7.3	9.8	10.4	60.4	15.4	30.1	20.1	9.7	10.9	8.3	11.5	9.3	3.1	1.5	1.3	3.7	2.1	1.0	1.6	1.9	2.9	1.6	1.0	1.1	0.8	1.7	1.8	2.9	3.7	1.3	22.6	22.4	27.1	35.0	23.1	20.5	22.7	20.7	23.3	19.4	20.6	25.0	6.1	0.0	3.7	1.6	5.1	5.4	8.4	1.4	3.4	8.2	9.5	8.5	13.9	11.5	2.7	11.0	2.1	13.6	9.8	84.7	0.0	4.1	0.8	8.0	6.1	6.0	16.7	2.5	2.6	5.1	11.9	5.2	9.2	8.9	4.5	7.8	5.7	23.5	14.8	6.7	2.4	31.2	2.0	26.0	9.6	3.9	6.2	14.4	3.6	1.9	8.8	8.6	21.6	3.5	2.1	4.3	42.7	3.8	7.7	6.9	50.7	15.0	2.3	5.6	6.6	6.1	11.7	0.2	7.6	7.8	8.4	10.4	6.3	9.1	34.6	9.6
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 215.7;neutrophil: 202.1"	"Group enriched"	"Detected in all"	8	"dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8"	"Cell line enhanced"	"Detected in many"		"HEL: 218.0;REH: 136.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		650000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	24.1	27.2	21.0	27.1	22.0	116.8	16.5	26.2	29.7	11.6	18.6	17.2	59.4	13.4	5.3	10.5	15.7	24.3	26.0	22.5	25.2	42.9	37.5	28.3	24.9	28.3	21.9	10.6	34.6	30.7	9.7	86.5	30.7	15.5	17.6	10.6	23.7	18.1	29.2	10.2	47.3	19.7	22.5	40.9	11.8	7.1	27.3	72.8	14.0	27.2	12.5	21.3	10.0	28.2	41.4	8.3	18.7	18.7	19.0	20.1	59.5	15.3	23.3	25.3	30.8	23.7	3.7	32.8	29.3	17.1	67.9	4.6	21.6	6.9	19.9	34.9	38.0	218.0	5.7	25.3	28.6	44.4	121.4	19.4	9.0	28.2	7.0	25.9	58.5	42.1	96.1	5.3	28.7	0.2	102.6	60.3	1.9	3.8	28.2	136.0	4.8	15.5	14.8	3.3	4.7	7.5	12.7	1.2	13.3	18.5	3.2	25.8	26.6	23.2	12.5	51.8	41.7	36.6	52.9	12.5	32.7	61.7	11.1	49.7	95.6	215.7	5.1	76.6	6.0	7.8	5.9	5.7	57.7	2.7	15.4	7.9	202.1	10.1	98.8	15.5	3.5	79.1	21.0	22.0	26.2	29.7	22.5	25.2	28.3	21.9	30.7	22.5	27.3	28.2	18.3	3.2	11.2	8.1	6.3	8.7	4.8	0.2	8.0	10.2	7.1	5.1	17.0	41.5	6.2	7.3	4.2	410.9	6.9	16.3	21.5	11.7	0.6	3.5	5.7	18.9	11.5	393.8	16.1	2.8	27.0	11.4	1.1	6.4	90.6	9.6	11.7	10.6	291.9	16.8	17.1	4.4	0.0	104.7	30.2	2.4	8.7	155.9	10.6	15.9	52.5	15.4	9.2	6.0	5.9	3.7	4.1	13.2	8.1	3.1	57.4	66.3	2.2	8.2	0.0	8.6	10.3	0.7	6.8	6.4	6.0	454.4	9.9	14.5	5.8	1.2
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.0;Early spermatids: 69.6;Horizontal cells: 35.3;Oligodendrocytes: 59.6;Spermatogonia: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026486, HPA073483"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 56: Bipolar cells - Visual perception"	"Mitochondria, Cytosol"		"HPA026486: AB_1854085, HPA073483: "	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.5	3.8	22.2	1.3	25.7	0.5	3.3	25.0	27.0	5.3	7.3	9.4	1.1	5.6	26.0	3.0	5.0	2.2	8.9	23.3	24.2	1.6	0.2	1.4	0.5	30.0	27.1	3.2	3.4	15.8	13.7	2.5	26.5	7.5	1.2	15.7	1.4	8.7	1.0	1.8	2.5	5.0	24.7	0.7	3.7	16.9	28.0	0.7	3.5	1.5	0.6	6.7	4.4	41.6	7.2	10.5	11.0	15.7	1.4	1.0	6.0	2.5	0.3	9.9	9.0	3.7	4.7	10.4	5.7	2.5	12.2	2.9	15.1	6.0	7.0	0.0	11.5	0.9	9.2	0.2	0.3	0.0	2.9	1.5	0.5	6.8	0.1	5.4	0.7	16.6	3.9	0.0	2.5	2.8	1.5	0.8	19.7	0.8	6.4	7.4	15.5	0.7	0.2	0.2	11.6	10.7	3.0	1.0	4.1	9.8	24.5	4.9	0.1	10.5	13.2	4.0	4.5	3.4	7.4	0.0	15.8	6.9	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	22.2	25.7	25.0	27.0	23.3	24.2	30.0	27.1	26.5	24.7	28.0	41.6	2.1	0.0	0.0	11.1	0.0	0.4	1.4	1.0	0.0	91.0	0.5	2.9	10.5	0.0	0.0	0.0	2.1	5.8	0.1	0.1	0.0	0.7	69.6	0.1	0.4	1.4	0.0	0.0	20.4	0.4	0.4	2.7	0.0	0.1	0.0	1.2	0.0	0.0	0.7	35.3	19.0	0.0	0.0	0.0	0.4	21.1	3.7	0.2	0.0	1.9	0.0	16.1	0.0	13.6	59.6	0.5	0.0	5.7	0.1	0.0	0.0	0.1	0.0	7.1	0.0	1.5	1.9	23.2	31.4	0.2	0.1	2.7	0.3	0.1	0.0	0.0
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;heart muscle: 11.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.2;Early spermatids: 38.4;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	1.4	0.6	2.4	0.3	1.5	0.0	1.4	10.2	2.0	1.5	2.8	0.9	0.4	0.7	1.8	1.0	1.1	0.7	11.8	1.9	2.4	1.1	0.3	2.2	0.2	4.9	2.2	0.6	2.2	0.3	1.8	0.4	4.4	1.6	0.3	0.9	0.5	0.9	0.2	1.0	0.5	0.6	1.5	1.2	1.0	0.8	3.4	0.0	0.7	0.1	0.2	0.8	1.1	2.0	0.5	1.4	0.5	0.6	0.9	1.2	0.0	1.1	0.4	1.1	0.4	0.9	0.8	0.0	0.3	0.8	0.7	0.5	1.1	1.1	1.6	0.0	1.3	0.2	3.3	0.7	0.1	0.0	0.0	0.7	2.3	1.5	2.1	1.4	0.3	0.0	0.5	0.0	0.6	1.1	0.0	0.0	0.6	0.5	1.1	0.0	0.9	0.0	1.8	0.0	4.8	1.1	0.7	1.5	0.3	0.8	2.6	1.1	1.0	1.2	1.9	0.5	1.4	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.5	10.2	2.0	1.9	2.4	4.9	2.2	4.4	1.5	3.4	2.0	12.1	12.8	4.1	3.9	0.0	4.0	8.3	2.7	5.7	2.7	3.2	4.8	29.2	7.2	5.4	1.8	0.0	0.1	0.0	1.2	0.0	3.9	38.4	0.8	1.9	5.3	1.2	0.8	3.6	1.4	0.6	3.3	12.8	1.9	1.3	1.1	3.6	0.7	1.1	10.1	5.4	1.2	0.0	0.0	3.9	76.0	3.7	1.1	1.8	1.0	1.9	0.8	0.0	3.5	10.0	2.9	3.4	2.6	0.0	8.1	0.4	0.3	0.8	1.7	6.6	0.8	2.9	0.8	2.6	4.7	2.7	0.1	0.5	0.3	2.3	3.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MPP6	"p55T, PALS2, VAM-1"	ENSG00000105926	"Membrane palmitoylated protein 6"	Q9NZW5	7	24573268-24694193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;testis: 25.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Excitatory neurons: 140.1;Inhibitory neurons: 146.6;Spermatocytes: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 8.3"	"Group enriched"	"Detected in many"	4	"B-cells: 8.3;dendritic cells: 2.9;T-cells: 2.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019085, HPA020456"	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019085: AB_1858713, HPA020456: AB_1858714"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.18e-3)"	"unprognostic (3.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.94e-1)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.88e-3)"	3.8	2.7	10.0	3.4	16.0	3.1	4.1	3.9	14.2	1.7	0.0	1.6	3.5	1.9	1.1	3.0	2.6	19.1	1.6	20.0	24.1	8.6	9.4	1.9	4.9	10.2	17.2	9.4	7.7	0.4	1.5	0.8	8.5	2.6	1.4	2.5	2.8	1.2	9.2	2.3	4.5	3.1	9.5	2.0	2.5	25.0	20.8	4.3	6.0	3.2	4.9	1.9	2.9	12.8	24.4	14.2	15.2	22.7	16.6	11.8	11.1	18.1	10.0	12.3	15.5	42.6	18.1	43.1	14.4	11.1	32.1	15.0	26.7	21.6	24.4	17.1	21.5	7.1	23.6	10.4	12.9	29.2	5.0	12.3	9.1	14.7	26.1	9.0	19.6	25.3	46.7	16.5	14.3	9.7	18.9	7.7	83.9	11.5	22.6	22.9	26.5	23.1	17.2	33.1	11.8	48.4	20.8	20.4	6.3	30.3	10.3	4.2	18.8	8.0	33.7	25.0	34.8	62.4	6.8	83.8	14.3	10.9	30.1	0.2	0.1	0.1	1.9	0.8	1.2	5.7	0.9	2.2	0.2	8.3	2.3	2.0	0.2	1.0	0.0	2.9	0.8	0.4	10.0	16.0	3.9	14.2	20.0	24.1	10.2	17.2	8.5	9.5	20.8	12.8	0.8	6.4	3.2	74.1	16.9	11.1	16.2	6.3	15.9	2.5	13.0	8.5	5.6	47.1	5.0	5.5	43.8	2.9	8.3	0.8	3.9	36.2	31.9	1.3	9.5	3.0	3.0	8.0	140.1	18.0	2.1	13.2	3.6	3.3	0.0	53.3	2.9	16.0	1.4	3.3	146.6	9.2	2.0	1.8	2.9	30.1	5.3	1.8	1.8	8.4	1.6	1.8	3.1	30.7	4.2	12.6	25.0	7.2	9.7	20.5	26.3	31.0	1.0	5.9	0.0	34.7	16.0	71.7	24.1	9.4	8.8	0.5	10.9	6.8	6.3	10.2
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	3.8	2.7	0.1	5.7	1.0	8.8	9.7	4.7	2.2	6.4	0.1	10.7	6.0	5.1	1.9	37.1	11.8	6.4	6.6	0.4	0.0	12.2	1.9	10.1	2.6	0.0	0.0	3.4	12.1	11.8	2.2	11.7	0.1	8.0	9.3	9.7	7.6	4.8	13.8	24.8	7.2	8.7	0.0	2.4	8.8	9.0	0.0	3.2	14.4	14.3	6.9	9.7	9.6	1.1	5.9	0.1	0.6	0.0	0.1	0.1	23.3	1.2	0.9	4.7	7.4	45.2	27.9	0.0	0.3	3.4	3.4	10.4	3.9	7.5	10.9	0.0	7.5	0.0	1.3	2.8	0.0	0.0	0.0	0.3	11.6	0.7	0.4	0.0	0.0	2.2	1.1	0.0	6.2	10.9	2.3	0.0	1.4	8.9	2.1	1.2	13.3	0.0	0.4	19.0	1.1	0.0	2.3	11.3	0.0	3.6	89.3	1.1	0.0	1.8	12.5	0.0	1.0	0.2	0.0	0.1	0.1	10.7	0.0	0.0	7.7	9.0	3.8	2.5	5.6	0.6	4.2	2.6	7.8	0.5	7.9	5.7	3.1	5.0	1.5	0.1	1.1	5.1	0.1	1.0	4.7	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	1.6	44.8	48.3	10.4	5.5	23.1	10.9	9.5	7.4	1.1	14.7	8.6	12.1	10.0	24.3	14.7	16.7	50.0	9.8	15.3	9.8	5.5	82.3	9.3	0.6	11.7	6.7	4.2	76.7	12.9	3.5	2.6	11.2	6.6	1.3	0.7	2.9	3.2	5.4	3.3	30.3	10.4	8.2	4.7	5.3	20.3	0.9	8.1	7.2	12.2	16.2	24.0	4.1	4.5	2.5	6.6	7.8	0.4	5.1	7.5	12.1	9.5	19.3	8.5	0.0	1.5	7.6	5.4	9.5	48.0	61.1	46.5	16.3	0.1	11.3	17.4
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042457-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 60.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 60.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		29000	"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	126.1	110.0	166.8	74.9	213.0	68.1	102.7	165.7	184.3	128.6	113.4	128.4	78.6	172.7	83.7	151.7	120.5	73.8	245.6	184.5	142.9	156.8	129.1	144.5	80.4	165.5	157.1	90.3	137.5	96.7	116.0	70.5	170.7	113.0	59.9	59.0	83.2	91.8	168.3	96.2	103.3	133.6	145.0	102.2	141.2	99.2	173.6	89.7	139.4	84.6	76.9	133.0	135.3	168.2	328.5	241.7	103.6	85.1	107.2	79.3	146.0	155.2	117.6	131.9	96.9	189.2	242.3	129.3	151.0	251.4	108.9	292.1	133.4	227.3	139.3	127.7	69.8	70.3	216.9	68.6	72.3	38.6	49.4	76.8	133.4	149.9	114.0	189.8	138.9	97.9	43.5	73.1	213.3	113.0	158.1	131.9	46.6	324.2	275.9	127.6	162.4	48.9	101.6	155.3	57.3	94.4	174.7	144.2	81.4	414.0	68.8	60.3	130.8	118.4	128.0	321.3	280.2	51.6	45.0	61.1	221.3	69.1	297.7	2.4	2.5	3.5	8.5	1.9	18.3	9.3	34.8	14.4	2.4	6.9	24.8	12.1	1.1	4.5	1.8	10.0	60.9	9.9	166.8	213.0	165.7	184.3	184.5	142.9	165.5	157.1	170.7	145.0	173.6	168.2	75.9	32.1	48.0	87.1	22.2	27.0	27.9	22.7	12.5	104.6	26.2	29.2	59.9	31.5	30.6	25.8	81.3	25.9	32.9	46.9	3.9	31.8	28.5	43.7	47.4	62.1	22.7	25.0	94.0	28.7	36.2	39.7	72.4	79.4	16.5	51.3	37.9	21.7	12.3	97.6	75.6	17.3	26.4	14.3	18.6	32.4	29.2	17.7	32.0	43.1	13.5	31.3	17.5	73.4	84.4	92.4	26.4	43.2	19.0	40.2	27.9	9.2	30.6	49.3	78.9	71.0	110.4	24.3	31.4	22.4	27.4	31.7	35.0	49.4	27.1	103.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.5;SK-BR-3: 8.2"					"Low region specificity"	"Detected in all"			HPA041180	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favorable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	1.8	2.5	1.2	1.8	0.1	4.4	6.4	1.9	2.2	2.8	0.0	2.3	3.4	2.0	0.3	1.0	1.8	2.4	1.6	0.1	0.0	3.3	9.1	0.9	2.3	0.1	0.0	2.1	14.1	2.4	3.2	0.6	0.3	2.0	1.0	4.4	7.1	1.8	8.0	4.5	2.3	0.8	0.0	1.8	1.8	1.0	0.5	0.2	2.2	2.4	0.6	1.9	1.3	0.4	1.0	1.9	0.8	0.8	0.2	0.1	1.2	0.5	0.0	0.0	0.0	1.9	3.4	1.5	1.3	0.6	0.5	1.5	3.0	0.0	0.0	1.2	0.8	5.9	4.6	3.9	0.3	3.6	29.5	0.3	0.4	0.1	0.2	0.5	0.0	1.6	2.3	3.3	0.1	1.9	1.4	2.3	1.7	0.3	0.1	2.0	0.6	1.6	0.5	0.8	4.8	1.6	2.7	8.2	0.2	0.9	1.8	2.6	2.6	1.3	0.8	1.1	1.1	1.4	0.6	1.7	0.7	1.7	0.5	1.7	1.2	0.2	0.8	0.9	0.6	0.8	0.5	0.8	0.4	1.2	0.4	0.8	1.8	1.1	0.4	0.7	0.4	0.6	1.2	0.1	1.9	2.2	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.4	2.5	6.4	8.8	3.9	2.0	7.9	14.4	8.2	0.0	12.8	11.4	6.0	6.0	14.3	13.1	0.0	10.4	0.5	4.1	2.7	15.6	7.5	4.6	5.4	9.2	6.6	1.2	2.1	5.6	12.9	0.5	8.1	2.0	10.7	6.3	7.6	4.2	29.1	1.0	8.4	5.9	8.7	2.0	13.6	20.6	0.8	7.2	6.0	21.4	2.8	0.7	6.2	0.0	7.5	3.2	5.9	15.3	14.3	1.4	9.6	9.3	19.9	21.0	16.6	0.0	23.5	6.7	9.0	2.0	0.6	11.5	0.5	9.9	4.4	12.1	10.1
MPV17L2	"FKSG24, MGC12972"	ENSG00000254858	"MPV17 mitochondrial inner membrane protein like 2"	Q567V2	19	18193218-18196948	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043111	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA043111: AB_10794176"	"unprognostic (3.71e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.20e-2)"	9.2	22.3	10.5	6.4	11.1	3.9	9.7	10.6	12.5	7.3	10.5	15.6	5.3	8.9	8.9	9.2	9.1	4.6	19.3	10.4	11.0	14.5	22.1	9.3	7.1	11.2	11.3	8.8	12.6	10.1	11.8	4.8	11.3	10.7	5.0	4.3	9.5	9.9	15.4	9.3	9.7	7.4	11.0	10.4	13.8	6.8	11.2	5.6	10.0	16.5	7.1	10.8	6.9	11.9	13.7	15.3	15.7	23.1	11.1	7.0	31.3	17.7	16.6	31.9	28.7	17.3	12.5	17.3	34.3	10.9	23.3	15.9	29.4	22.1	15.3	12.7	36.2	13.5	11.0	22.9	17.8	17.4	19.7	10.0	18.2	18.4	21.5	5.9	14.4	26.2	28.4	17.1	16.3	48.2	26.3	19.6	19.3	31.2	59.3	22.6	13.8	24.0	20.8	9.2	17.8	13.2	15.6	21.7	14.3	10.9	9.4	16.0	13.3	18.3	9.5	56.8	20.5	13.3	26.6	26.0	12.6	29.0	19.6	13.4	19.4	18.2	16.1	27.1	19.3	25.8	12.7	12.6	25.3	16.2	10.2	12.9	5.5	18.3	19.0	24.2	18.0	11.9	10.5	11.1	10.6	12.5	10.4	11.0	11.2	11.3	11.3	11.0	11.2	11.9	9.5	6.4	3.9	2.9	14.1	10.6	5.8	10.3	15.4	8.1	14.2	11.8	8.2	7.2	7.8	11.0	2.1	22.0	9.4	5.8	23.5	17.9	1.4	3.2	7.4	11.5	6.6	2.5	1.2	26.0	29.4	7.0	5.1	6.1	1.3	6.4	5.7	7.8	18.5	6.7	1.1	9.5	12.2	6.3	24.5	0.2	3.4	13.0	12.4	3.7	32.3	7.8	8.2	3.0	3.3	22.5	6.2	5.3	14.9	10.1	6.2	8.2	2.1	9.8	0.0	3.0	9.7	9.1	8.4	5.4	11.1	22.8	6.6	12.8	9.8	3.9
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB, P0"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309968	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Skeletal myocytes: 9.3"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"WM-115: 139.3"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 2.9;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	10	"spinal cord: 2142.4"	HPA068925	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	19.1	6.9	2.1	2.1	3.0	1.1	12.6	2.5	2.7	8.3	1.4	22.3	1.6	2.0	2.0	4.4	5.3	2.4	15.2	1.9	3.9	6.3	5.4	2.9	1.1	3.0	2.2	3.1	2.3	0.6	6.2	0.6	9.9	12.2	2.7	1.2	15.8	8.0	5.1	9.1	8.5	0.8	3.3	4.4	7.6	2.4	2.0	1.4	3.7	18.4	0.9	9.5	15.9	2.2	0.4	0.0	0.3	0.1	2.7	1.3	0.3	0.3	0.5	0.1	1.6	0.0	0.1	2.3	1.5	0.4	0.5	0.1	1.8	0.6	0.1	1.1	0.0	1.0	0.4	31.0	1.2	4.7	3.7	4.2	0.0	6.2	0.3	0.0	2.8	1.9	9.9	0.0	4.3	0.0	0.7	7.6	1.4	0.0	0.0	0.3	0.2	1.4	0.3	0.1	2.0	0.3	0.0	0.0	14.0	0.8	0.1	9.5	2.7	0.3	0.4	2.7	0.2	0.9	0.9	1.2	4.8	17.5	139.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	3.0	2.5	2.7	1.9	3.9	3.0	2.2	9.9	3.3	2.0	2.2	1.7	3.2	0.6	1.0	2.1	0.5	3.1	0.4	4.0	2.5	0.4	1.3	0.7	0.0	0.5	3.7	2.1	0.5	1.6	0.1	0.0	0.2	5.5	0.3	0.2	1.5	1.8	1.3	1.7	1.2	0.7	2.5	0.0	0.1	0.0	0.8	1.8	1.0	1.6	1.7	2.2	0.7	2.0	1.9	0.8	1.8	1.5	2.0	3.6	1.0	3.8	0.5	0.0	0.5	1.6	0.1	0.1	0.4	1.4	0.9	0.3	1.0	0.6	1.1	6.6	9.3	3.9	0.4	0.6	1.1	0.4	0.3	1.6	0.4	0.4	2.0
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 183.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 183.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: AB_2685034"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.27e-6)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (4.21e-2)"	74.8	34.1	23.1	49.2	21.6	8.3	91.6	22.0	21.8	63.1	40.1	60.1	40.8	50.0	27.4	52.9	60.1	67.7	52.4	22.1	28.3	28.6	23.0	42.3	35.2	25.7	30.0	46.4	27.5	28.4	33.0	68.9	30.7	41.8	59.4	12.7	73.1	38.9	14.7	34.0	41.0	62.6	26.4	29.2	43.8	48.2	28.6	29.3	39.5	26.8	45.9	74.7	51.3	24.9	88.5	126.3	96.9	75.8	303.4	137.2	304.8	134.5	172.7	86.3	106.4	234.4	119.5	31.0	152.9	171.6	76.1	144.2	97.5	149.0	72.6	70.9	52.8	25.5	63.5	56.7	188.5	30.2	16.1	126.1	183.5	137.8	153.4	121.4	116.4	93.6	97.1	63.5	103.0	29.3	103.6	36.2	61.9	176.7	53.5	62.5	82.7	137.5	131.4	84.6	55.7	91.8	119.6	122.4	69.7	221.9	66.6	16.0	132.8	97.9	44.1	127.5	73.8	94.0	157.2	142.8	140.8	35.3	15.8	7.7	29.1	20.0	2.8	24.8	1.3	14.7	2.8	4.1	38.5	8.8	7.7	2.6	183.8	10.4	34.6	43.9	0.5	11.0	23.1	21.6	22.0	21.8	22.1	28.3	25.7	30.0	30.7	26.4	28.6	24.9	52.9	28.9	30.0	31.0	15.1	76.3	78.5	57.6	35.9	8.8	75.9	73.9	6.3	20.0	49.6	20.2	6.2	128.7	21.1	67.1	5.9	63.2	1.8	14.5	40.4	56.7	47.8	10.1	32.8	75.6	145.2	118.2	41.3	23.0	3.8	75.3	24.3	23.3	37.7	10.1	27.9	39.7	20.3	28.2	31.9	4.9	69.9	23.5	16.0	60.0	84.0	11.8	3.1	141.8	1.7	81.0	41.6	83.8	23.5	141.7	55.5	10.1	28.3	13.9	19.7	18.6	48.6	8.9	26.8	41.2	55.5	76.9	8.6	49.4	61.0	57.7
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.5;HSkMC: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	75.6	166.5	0.1	1.8	0.1	0.0	44.2	0.0	0.5	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.0	0.6	2.0	0.1	0.0	0.3	2.4	1.0	0.1	0.2	0.0	2.0	0.7	0.0	0.1	1.7	0.1	0.0	0.2	1.0	2.0	0.0	0.2	1.3	3.5	0.1	0.0	0.0	0.6	0.5	0.0	0.1	0.7	0.2	0.0	1.4	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.7	0.2	0.4	0.2	0.8	0.2	0.5	0.0	1.9	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.0	0.0	43.7	0.0	1.7	0.1	43.7	0.6	0.0	0.0	0.0	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	1.6	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 202.3;heart muscle: 132.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	9	"monocytes: 25.0"	"Cell line enhanced"	"Detected in many"		"BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	91.9	67.7	112.7	10.8	130.6	1.7	46.7	118.2	105.5	17.3	48.9	24.2	3.3	28.7	7.1	7.9	26.4	12.0	132.9	105.6	132.8	22.9	5.5	18.4	5.2	126.1	135.9	48.6	5.7	8.2	17.7	10.6	112.9	15.3	4.1	15.9	13.4	15.0	80.4	12.2	8.7	23.2	110.3	12.2	12.0	9.6	202.3	4.9	26.4	48.0	3.3	29.1	12.1	97.8	0.8	7.9	15.8	24.5	59.6	29.2	40.0	92.9	16.0	7.3	8.2	3.3	3.1	0.3	113.7	70.4	18.6	0.1	9.0	1.8	6.1	7.7	3.1	0.5	4.8	20.1	15.9	0.0	1.9	41.5	5.9	0.7	1.4	13.6	1.3	0.0	10.7	0.8	31.4	3.7	0.0	20.4	19.1	0.0	2.7	1.1	33.8	0.2	30.4	2.0	18.6	42.0	62.8	0.7	45.9	10.9	16.1	37.7	0.6	23.7	25.3	24.3	2.4	0.1	1.0	1.2	21.4	0.1	11.4	0.2	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.8	25.0	0.1	0.0	0.8	112.7	130.6	118.2	105.5	105.6	132.8	126.1	135.9	112.9	110.3	202.3	97.8	8.9	9.6	1.5	54.2	0.8	2.2	3.0	3.4	1.2	5.6	28.8	34.8	121.7	2.8	3.5	9.2	10.4	20.1	0.2	0.0	58.7	8.6	11.6	1.0	21.4	14.5	1.8	0.0	25.5	3.2	3.2	23.0	2.0	1.5	6.3	35.2	12.8	1.6	26.3	28.6	20.6	0.0	2.0	15.1	18.4	40.0	23.3	18.2	28.4	20.6	12.2	24.3	0.0	28.6	11.0	3.8	0.0	34.3	0.1	3.3	0.0	27.5	1.3	9.6	6.6	20.8	18.9	7.3	18.6	0.4	1.0	14.4	0.8	59.1	0.0	0.6
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 122.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 19.3;TIME: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		170000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	54.4	28.7	0.8	24.0	1.7	0.7	16.3	0.3	3.5	17.2	9.2	16.1	9.9	7.2	1.7	13.1	11.9	27.7	10.2	1.1	0.7	7.6	40.9	122.3	15.2	1.4	0.9	6.2	8.1	4.6	1.5	54.3	1.1	2.2	18.5	0.1	4.9	8.0	1.8	2.8	17.5	30.3	0.7	50.6	9.7	7.5	2.8	8.0	5.5	8.7	3.0	29.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.3	3.5	1.1	0.7	1.4	0.9	1.1	0.7	2.8	1.3	4.0	32.1	43.5	1.3	3.5	0.4	0.0	0.0	0.0	0.0	128.9	1.7	3.6	11.5	7.4	0.0	0.0	0.9	1.0	1.4	0.0	0.1	27.3	0.0	0.1	39.0	0.0	3.2	0.8	0.4	1.4	2.5	0.0	0.1	13.9	0.1	397.7	13.1	176.1	0.0	1.3	0.9	0.0	361.4	46.8	19.4	1.5	316.5	0.0	60.9	0.5	0.0	0.0	0.5	0.5	0.1	1.5	0.0	1.0	0.0	2.2	0.1	5.8	0.0	32.9	3.0	2.2	0.4	2.3	1.2	0.4	2.1	4.7	1.7	0.8	0.1
MRC2	"CD280, CLEC13E, ENDO180, KIAA0709"	ENSG00000011028	"Mannose receptor C type 2"	Q9UBG0	17	62627670-62693597	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 93.9;Endometrial stromal cells: 65.2;Fibroblasts: 141.6;Late spermatids: 82.8;Leydig cells: 71.7;Peritubular cells: 102.3;Theca cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 210.9;fHDF/TERT166: 164.9;HSkMC: 148.6;hTERT-RPE1: 150.6;U-138 MG: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041991	Enhanced					NA	NA		36000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041991: AB_10794166"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (7.70e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (5.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	24.5	8.6	4.8	13.7	7.9	5.3	16.2	5.6	5.3	39.3	22.5	12.3	6.6	31.3	9.6	21.2	26.3	32.4	45.2	4.3	5.1	18.1	2.8	35.0	4.5	9.3	9.1	45.8	7.5	1.2	17.4	9.6	8.9	25.7	3.2	0.7	9.0	20.8	12.2	28.8	10.9	21.3	9.9	16.3	9.0	16.2	6.0	4.5	7.0	6.5	2.0	17.9	28.2	11.2	0.1	35.1	23.3	29.7	64.1	115.4	3.1	210.9	138.8	34.3	40.8	2.1	0.4	0.0	15.2	164.9	15.1	17.8	4.0	19.0	8.8	26.7	5.4	17.6	27.2	0.0	97.2	22.9	0.2	148.6	9.5	29.6	3.4	150.6	15.4	10.6	9.3	0.0	47.8	6.3	6.6	70.6	4.9	0.0	2.4	22.3	15.4	0.2	3.2	0.4	2.9	52.2	14.1	0.4	0.3	14.3	0.6	97.1	68.5	216.6	83.9	36.2	43.6	0.2	0.0	0.0	66.8	22.6	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	7.9	5.6	5.3	4.3	5.1	9.3	9.1	8.9	9.9	6.0	11.2	8.6	3.2	35.9	5.9	0.4	11.3	5.8	20.7	25.0	11.1	1.6	11.4	4.4	0.0	2.3	1.8	0.0	0.7	0.6	0.1	0.0	0.3	93.9	22.6	65.2	5.2	0.0	28.4	3.3	0.2	2.7	141.6	2.0	2.9	2.5	13.8	5.3	0.0	6.8	0.0	0.9	0.1	0.0	9.2	11.1	82.8	71.7	7.0	5.4	57.1	0.6	0.8	1.0	3.5	0.9	0.6	0.0	102.3	0.3	2.1	0.0	0.0	1.4	0.6	0.0	31.4	23.3	11.7	9.3	34.6	7.7	1.9	2.7	71.0	0.2	1.4
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	9.1	6.1	3.4	11.7	3.7	22.6	13.9	6.8	3.4	8.8	6.0	7.6	6.8	11.7	8.9	7.1	7.9	7.3	5.0	3.3	3.5	6.0	6.4	7.7	12.6	5.1	4.4	11.1	7.5	5.6	3.1	12.1	3.8	9.3	11.5	6.3	7.8	7.3	5.0	15.6	7.7	9.9	4.0	12.7	7.3	8.3	4.4	14.3	7.4	5.4	16.1	8.5	7.4	6.7	21.5	21.5	39.9	5.0	13.1	18.2	22.8	29.4	19.0	25.9	30.6	39.4	43.3	55.8	47.0	15.3	32.5	40.1	33.7	22.1	34.1	37.5	20.0	48.7	31.5	22.7	6.0	32.7	33.6	12.8	13.4	33.7	21.0	11.7	23.0	26.8	34.9	35.6	20.9	15.5	33.2	30.5	13.0	49.3	23.3	29.0	35.3	28.1	16.8	29.6	14.1	19.8	40.6	26.0	8.6	33.2	43.4	19.3	16.9	38.7	28.6	33.9	21.5	8.8	33.2	54.4	10.4	50.3	31.5	5.7	8.0	6.5	8.2	10.0	8.3	6.4	6.0	8.9	11.6	6.9	5.1	8.4	3.8	8.6	8.4	8.7	8.8	6.7	3.4	3.7	6.8	3.4	3.3	3.5	5.1	4.4	3.8	4.0	4.4	6.7	23.6	28.9	14.3	0.0	6.3	0.0	0.0	0.0	0.0	0.0	12.5	13.7	0.0	0.0	9.3	9.2	0.0	39.2	20.8	0.0	3.9	11.4	0.0	19.5	22.2	8.4	0.0	0.0	0.0	8.1	15.8	8.9	0.0	16.3	17.7	34.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	8.8	0.0	0.0	6.1	0.0	0.0	6.5	11.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	28.0	7.2	16.8	0.0	0.0
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796473-62801729	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 124.0;Late spermatids: 408.9;Spermatocytes: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017012	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	7.0	7.5	8.8	5.5	8.9	6.7	6.8	9.4	9.8	7.9	7.9	8.8	8.1	6.7	3.2	7.5	6.8	4.6	9.8	8.7	8.7	8.4	13.6	7.1	7.8	8.7	8.8	10.8	6.7	8.7	7.8	7.3	8.7	7.1	4.0	6.6	7.4	4.4	9.2	7.2	8.8	3.2	8.0	9.7	7.6	48.0	9.0	7.0	7.5	6.7	5.3	7.3	7.5	10.2	32.2	20.0	16.1	24.8	8.7	13.1	15.6	18.2	23.5	69.2	30.0	71.5	25.1	29.3	35.4	14.1	34.3	26.7	18.5	30.7	38.9	9.2	15.8	21.4	22.9	41.8	13.5	25.2	38.7	11.3	22.2	18.9	20.0	14.7	16.6	27.8	29.6	15.7	17.5	48.8	48.0	47.7	13.6	33.5	35.7	42.5	30.5	21.8	10.5	13.1	22.6	18.2	25.9	22.9	33.9	8.9	28.3	36.5	17.4	42.9	44.6	29.4	39.2	20.9	13.7	34.9	42.3	24.8	24.6	0.0	0.6	0.9	0.5	1.0	0.7	0.4	0.6	0.7	0.4	0.4	0.5	1.0	0.7	0.1	0.4	0.5	0.8	0.3	8.8	8.9	9.4	9.8	8.7	8.7	8.7	8.8	8.7	8.0	9.0	10.2	15.2	0.0	2.2	6.2	17.1	14.7	14.8	9.0	13.1	12.3	14.4	11.9	9.4	18.6	5.3	12.9	8.4	12.6	18.0	9.2	19.6	23.3	124.0	9.3	11.5	12.0	2.4	12.8	7.9	22.2	24.7	13.1	12.8	9.7	1.3	14.5	11.0	14.5	14.3	13.5	7.3	9.6	8.2	11.3	16.5	408.9	12.2	16.1	7.2	2.8	12.4	16.5	8.2	5.0	5.2	24.3	8.0	7.9	18.8	23.5	12.4	18.6	3.2	14.5	0.0	10.2	13.8	113.0	27.8	16.4	13.1	14.6	15.6	19.5	12.0	17.6
MRGPRD	mrgD	ENSG00000172938	"MAS related GPR family member D"	Q8TDS7	11	68980021-68980986	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031346	Uncertain					NA	NA									"HPA031346: AB_10602710"										"unprognostic (1.92e-1)"		"unprognostic (7.14e-2)"		"unprognostic (1.72e-1)"				0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.2	0.0	0.7	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRE	"GPR167, mrgE"	ENSG00000184350	"MAS related GPR family member E"	Q86SM8	11	3225030-3232417	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"brain: 27.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.9"	"Group enriched"	"Detected in many"	4	"medulla oblongata: 27.9;pons: 26.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 1.0;RPMI-8226: 2.7;SCLC-21H: 3.9"	"Low region specificity"	"Detected in all"							HPA046556	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046556: AB_10961404"	"unprognostic (1.18e-1)"			"unprognostic (7.52e-4)"	"unprognostic (1.04e-1)"			"unprognostic (9.09e-2)"		"unprognostic (6.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.22e-2)"		"unprognostic (1.19e-1)"		0.0	0.3	0.4	0.0	0.2	0.6	0.1	4.0	0.7	0.7	0.1	0.2	0.0	0.5	0.3	0.1	0.6	0.1	0.4	0.3	6.5	0.0	0.0	0.0	0.0	27.9	2.6	0.0	0.1	0.0	0.1	0.1	26.2	0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.1	0.2	3.2	0.4	0.0	0.0	1.2	0.0	0.2	0.1	0.0	0.1	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.0	0.7	0.3	6.5	27.9	2.6	26.2	3.2	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MRGPRG	"GPR169, mrgG"	ENSG00000182170	"MAS related GPR family member G"	Q86SM5	11	3217944-3218813	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA058909	Uncertain					NA	NA									"HPA058909: AB_2683852"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRX2	MRGX2	ENSG00000183695	"MAS related GPR family member X2"	Q96LB1	11	19054455-19060717	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skin 1: 1.0"	"Cell type enhanced"	"Detected in single"		"Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055220	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA055220: AB_2682743"						"unprognostic (1.56e-2)"											"unprognostic (1.79e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764522-13774282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		880000	"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	15.8	19.2	7.9	9.0	8.2	9.5	18.5	9.3	8.5	24.8	7.0	17.3	9.6	21.6	4.1	20.5	21.8	5.3	12.9	7.6	7.5	22.3	23.8	15.8	10.5	8.9	7.7	24.4	19.6	7.8	18.0	11.9	8.7	19.3	6.4	5.3	20.5	8.8	11.6	26.0	21.1	5.2	7.1	23.1	18.3	3.6	8.4	7.8	23.0	4.4	8.7	17.6	22.4	10.9	14.7	9.3	5.5	13.1	6.1	9.5	13.0	17.9	9.3	13.8	12.4	9.9	11.5	7.9	6.5	6.6	7.3	25.4	24.5	15.5	10.8	12.6	39.3	6.6	18.5	12.0	4.7	20.3	14.8	9.9	9.4	7.1	6.0	14.3	13.7	7.9	11.6	0.6	7.4	18.7	21.9	14.3	9.1	6.0	27.2	20.5	7.6	17.4	8.1	11.4	10.4	9.9	6.6	13.9	14.5	7.7	11.1	8.2	8.2	8.2	7.6	29.3	8.8	11.0	11.3	2.4	6.8	22.5	9.7	3.4	1.8	0.7	1.7	1.7	1.8	1.5	1.7	2.2	1.4	1.6	1.3	1.1	1.6	1.8	1.1	2.7	1.5	1.3	7.9	8.2	9.3	8.5	7.6	7.5	8.9	7.7	8.7	7.1	8.4	10.9	9.2	9.6	19.8	15.0	10.8	11.1	8.9	10.8	6.8	4.3	9.0	8.4	0.9	8.6	13.4	16.5	8.4	13.2	17.2	8.1	5.9	9.2	0.7	11.5	14.4	13.8	9.1	13.3	22.3	12.7	8.7	12.3	14.3	14.2	13.3	9.9	12.8	10.0	7.2	1.7	19.6	9.3	6.1	7.2	8.4	1.7	17.4	7.4	1.8	9.4	10.5	5.0	17.5	18.1	15.2	6.8	11.0	15.1	13.3	4.7	16.5	10.5	19.2	9.3	26.3	10.8	13.3	0.3	4.5	13.3	11.4	5.3	16.0	22.2	9.8	6.8
MRM1	FLJ22578	ENSG00000278619	"Mitochondrial rRNA methyltransferase 1"	Q6IN84	17	36601583-36608964	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021598	Supported		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA021598: AB_1854097"	"unprognostic (9.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.74e-2)"	3.4	6.0	2.2	1.1	2.6	2.1	3.9	1.8	4.5	4.5	1.1	6.0	2.8	4.5	1.4	5.2	4.1	0.3	7.4	2.0	2.3	5.7	7.3	2.8	3.0	2.2	2.2	5.0	6.2	2.6	2.9	0.7	2.3	4.8	3.1	0.6	4.1	2.4	8.1	3.6	6.0	0.7	1.8	5.9	4.6	2.3	2.5	1.9	4.2	4.7	0.6	5.8	4.3	2.6	1.5	8.7	0.0	5.0	4.3	5.1	15.5	0.3	0.0	0.0	0.0	0.7	0.2	0.7	9.5	0.0	4.0	20.0	0.2	0.4	0.0	7.5	2.9	15.2	5.1	8.9	2.2	7.9	7.5	4.0	0.4	10.2	0.0	1.4	5.2	6.7	9.9	4.9	6.0	0.2	14.6	4.6	0.2	19.9	0.1	12.1	0.0	19.5	4.4	9.3	4.1	3.1	0.0	6.1	6.5	5.5	6.8	2.6	2.0	5.0	8.9	5.7	0.1	11.9	15.3	6.5	0.0	8.0	4.0	0.0	2.0	0.0	2.8	3.0	5.3	4.4	2.2	2.7	2.1	3.9	3.5	3.8	0.0	6.0	1.5	2.4	2.0	2.4	2.2	2.6	1.8	4.5	2.0	2.3	2.2	2.2	2.3	1.8	2.5	2.6	1.3	0.0	1.5	4.9	3.8	1.1	2.9	2.7	2.8	1.1	2.6	1.7	7.8	2.8	1.6	3.7	4.2	7.0	0.6	5.3	9.8	4.2	0.1	1.0	2.9	2.9	1.8	5.0	9.6	1.8	7.4	1.8	3.1	1.3	0.0	3.9	1.8	2.1	6.2	6.7	8.2	5.3	2.0	1.0	0.4	0.0	3.4	1.5	1.8	0.0	2.2	1.7	2.1	5.5	4.0	2.2	5.4	1.5	2.2	5.6	5.4	5.1	0.6	1.2	0.0	1.9	2.0	1.3	3.0	3.3	0.4	1.8	2.2	4.5	9.0	2.2
MRM2	"FJH1, FTSJ2, RRMJ2"	ENSG00000122687	"Mitochondrial rRNA methyltransferase 2"	Q9UI43	7	2234195-2242205	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 59.7;Distal tubular cells: 31.3;Extravillous trophoblasts: 37.0;Hofbauer cells: 35.8;Syncytiotrophoblasts: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019826, HPA049622"	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA019826: AB_2670282, HPA049622: AB_2680834"	"unprognostic (8.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (8.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.48e-1)"	9.3	12.8	12.7	12.1	13.3	6.1	13.0	13.5	15.7	9.2	14.2	10.7	10.8	8.2	11.5	11.5	10.8	6.7	14.1	12.5	13.2	12.6	17.3	11.0	17.8	13.9	13.2	11.7	8.0	13.3	6.9	13.7	13.5	10.0	10.8	8.0	10.1	12.0	21.7	11.2	9.1	9.1	14.0	12.8	9.7	10.7	13.4	12.2	8.5	12.6	18.3	10.4	7.9	14.0	62.2	39.9	34.2	25.2	21.3	22.3	24.8	35.3	35.5	45.3	43.9	56.7	29.8	57.5	15.8	27.4	37.5	48.0	49.3	40.0	49.0	22.2	37.9	36.6	37.0	35.0	25.8	54.3	34.5	19.1	34.2	30.4	35.4	19.6	20.2	35.3	59.3	33.0	35.6	73.4	17.1	68.7	94.9	38.6	38.0	34.1	42.5	45.1	31.9	46.4	31.2	44.3	28.9	81.1	34.1	44.8	70.0	81.6	15.1	27.4	64.2	53.8	56.0	29.1	43.4	59.0	31.7	55.9	85.2	17.2	49.1	32.9	28.0	57.1	33.9	52.1	29.9	32.1	71.8	48.8	36.9	32.1	3.7	47.8	48.9	37.8	36.5	40.4	12.7	13.3	13.5	15.7	12.5	13.2	13.9	13.2	13.5	14.0	13.4	14.0	11.3	22.4	19.8	0.0	5.1	0.0	0.0	0.0	0.0	0.0	15.0	19.6	0.0	0.0	8.1	11.0	0.0	59.7	6.6	0.0	31.3	24.1	0.0	7.7	14.3	6.0	0.0	0.0	0.0	19.9	37.0	7.2	0.0	6.7	11.4	15.9	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.9	0.0	0.0	20.4	9.5	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	37.1	3.6	28.8	0.0	0.0
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782353-792509	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	9.3	12.9	7.9	6.8	8.4	17.6	8.7	9.9	9.2	6.7	9.7	9.7	7.8	7.6	5.2	11.6	8.0	4.8	17.3	8.2	7.9	9.7	20.5	6.0	10.4	8.2	8.7	8.7	19.6	9.1	6.2	6.9	8.6	7.5	7.5	4.3	9.5	6.0	29.4	14.7	8.2	6.6	7.7	9.9	13.0	18.6	8.6	8.3	7.0	18.7	9.3	8.6	7.2	8.3	26.4	53.9	11.3	19.8	16.2	13.8	22.5	13.6	12.8	27.3	22.8	31.8	12.0	47.3	14.1	10.6	13.1	21.7	33.0	12.0	24.8	16.2	55.9	18.3	30.6	27.9	16.7	15.8	16.0	16.7	16.2	29.0	23.9	13.6	20.7	28.3	31.3	20.1	14.5	28.5	27.5	20.8	16.9	19.3	28.2	33.1	7.9	25.3	18.2	14.2	15.1	17.6	19.8	16.6	26.5	9.0	20.6	14.2	16.6	14.6	11.2	21.0	38.3	8.0	11.8	18.9	18.3	22.1	20.0	12.5	24.6	14.7	25.0	20.6	27.0	38.2	27.1	30.8	25.8	38.4	32.8	28.4	1.8	32.7	21.1	20.8	31.9	26.8	7.9	8.4	9.9	9.2	8.2	7.9	8.2	8.7	8.6	7.7	8.6	8.3	11.3	6.4	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	9.8	10.4	0.0	0.0	1.3	5.5	0.0	27.1	7.6	0.0	19.6	18.9	0.0	8.3	8.0	5.1	0.0	0.0	0.0	18.4	24.6	4.1	0.0	8.8	3.8	15.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.5	0.0	0.0	20.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	19.6	4.4	28.9	0.0	0.0
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Endometrial ciliated cells: 49.7;Glandular and luminal cells: 31.3;Respiratory ciliated cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA043975: AB_2678754"	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	7.8	7.2	10.5	3.5	10.6	1.4	9.5	13.1	12.9	21.8	11.5	12.3	2.5	11.4	5.9	6.4	16.7	2.2	7.1	10.6	10.3	13.1	10.0	8.9	5.5	10.8	10.6	21.0	10.3	5.2	19.2	1.5	10.8	15.4	2.8	3.0	9.9	7.1	5.4	7.9	17.1	3.8	10.0	19.0	8.8	10.1	10.6	2.7	15.5	2.7	5.3	12.7	13.7	11.8	1.0	1.9	3.5	8.4	7.4	6.6	4.0	2.5	2.3	3.2	4.8	2.5	3.2	4.1	2.9	1.3	1.4	2.6	4.4	8.3	2.6	3.7	3.5	1.3	4.3	2.1	4.6	1.7	1.6	4.9	7.0	3.7	3.0	2.4	3.6	4.1	2.0	1.8	3.5	3.9	2.8	1.7	1.7	1.3	1.9	3.3	1.4	3.2	5.7	0.8	6.6	2.1	1.2	3.3	3.1	2.6	4.1	1.4	0.7	1.8	1.4	1.4	1.5	2.2	1.4	2.9	1.7	2.7	1.3	1.5	0.6	2.9	2.7	0.7	3.8	8.0	4.0	3.2	0.8	10.2	6.4	4.5	0.9	3.5	0.9	4.9	2.6	1.9	10.5	10.6	13.1	12.9	10.6	10.3	10.8	10.6	10.8	10.0	10.6	11.8	22.4	16.0	15.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	13.7	21.1	0.0	0.0	11.8	18.4	0.0	10.5	11.6	0.0	46.9	5.1	0.0	49.7	19.0	5.8	0.0	0.0	0.0	2.2	6.8	9.7	0.0	31.3	11.4	20.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.0	0.0	0.0	14.5	29.9	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.3	7.6	18.4	0.0	0.0
MRO	"B29, C18orf3, FLJ30140"	ENSG00000134042	Maestro	Q9BYG7	18	50795120-50825402	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 44.7;kidney: 24.1;testis: 28.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 30.0;Granulosa cells: 11.3;Hepatic stellate cells: 37.5;Kupffer cells: 13.0;Proximal enterocytes: 20.0;Proximal tubular cells: 16.0"	"Cancer enriched"	"Detected in some"	7	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 2.4;ASC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022011	Approved					NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022011: AB_2670880"	"unprognostic (9.21e-5)"	"unprognostic (5.22e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.99e-3)"	"unprognostic (6.06e-4)"	2.3	2.5	36.6	0.5	42.7	0.2	0.6	32.5	33.1	0.3	18.4	0.2	8.0	0.2	3.1	0.5	0.3	1.0	3.0	33.3	44.7	24.1	7.2	0.2	0.3	35.9	38.5	3.3	1.8	5.3	1.3	0.7	34.4	0.2	0.2	1.6	0.3	2.2	2.0	0.1	4.7	0.3	33.8	2.2	1.3	28.9	40.8	1.2	6.0	1.3	0.1	0.4	0.2	31.0	0.0	0.0	0.0	0.2	2.4	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.3	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	36.6	42.7	32.5	33.1	33.3	44.7	35.9	38.5	34.4	33.8	40.8	31.0	0.2	0.0	0.0	30.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.8	1.5	0.0	0.0	2.1	0.0	0.0	0.2	5.9	0.0	0.8	0.2	0.0	0.9	0.0	0.0	1.5	1.0	0.8	0.8	1.1	0.1	0.0	11.3	37.5	4.7	8.4	0.0	1.1	0.1	0.0	13.0	0.3	3.3	1.2	1.8	0.0	3.7	0.0	3.9	1.0	5.0	0.3	0.1	0.0	0.7	0.0	0.1	20.0	16.0	0.0	0.2	0.0	0.4	0.1	1.2	0.5	0.0	0.0	0.1	0.1	4.3	0.6	0.1
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.8"	"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	9.2	17.0	7.3	6.3	6.9	18.0	11.0	5.4	15.5	10.5	6.4	16.2	13.3	9.1	5.3	17.0	11.0	3.6	14.0	7.5	2.7	17.2	11.7	17.0	7.0	11.8	4.2	7.7	26.7	5.6	22.3	5.5	10.9	17.2	3.4	0.9	17.3	5.7	5.2	17.8	17.6	2.1	1.1	21.7	18.9	13.0	4.9	4.2	58.8	2.1	3.7	12.9	12.6	3.8	17.0	6.9	0.9	6.5	3.1	3.3	29.3	7.3	5.1	4.0	5.5	11.6	29.7	8.9	10.5	4.2	9.8	15.9	1.0	11.2	1.8	5.1	9.5	10.8	22.1	10.7	7.8	4.8	11.0	6.1	11.4	6.4	9.2	4.7	5.8	7.2	4.5	3.9	4.5	36.3	8.4	10.2	2.5	11.6	32.0	10.8	2.2	9.3	5.9	33.0	7.4	6.4	18.3	17.5	5.4	2.5	12.8	6.7	14.6	8.1	15.2	16.6	6.1	6.8	3.6	9.5	16.0	14.3	4.9	4.8	5.7	1.5	1.8	7.5	1.3	0.9	1.5	1.8	4.3	1.5	1.4	1.0	1.1	0.8	6.8	1.3	4.6	2.2	7.3	6.9	5.4	15.5	7.5	2.7	11.8	4.2	10.9	1.1	4.9	3.8	5.2	9.6	26.3	33.0	6.5	6.2	8.5	9.2	6.8	36.4	12.6	9.5	12.4	5.7	16.6	5.5	12.5	31.3	7.0	39.8	3.9	12.2	5.1	17.8	6.7	7.8	23.4	1.7	56.7	16.6	19.2	6.4	63.7	25.2	14.5	14.3	3.9	7.0	19.7	37.0	61.2	24.8	18.3	11.9	11.4	12.2	3.1	14.5	1.8	13.1	11.4	5.7	7.2	14.6	7.9	18.6	17.5	2.6	9.7	17.6	30.7	5.8	18.8	3.5	6.6	7.2	6.7	19.1	26.2	9.7	5.8	50.1	9.1	7.8	22.3	14.8
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	3.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.3
MROH2B	"DKFZp781F0822, FLJ40243, HEATR7B2"	ENSG00000171495	"Maestro heat like repeat family member 2B"	Q7Z745	5	40998017-41071342	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	222	"testis: 30.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 21.0;Late spermatids: 40.2;Spermatocytes: 10.4"	"Cancer enriched"	"Detected in single"	6	"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059457	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA059457: AB_2684026"							"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (1.08e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.91e-5)"	"unprognostic (2.51e-3)"	"unprognostic (2.53e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MROH6	C8orf73	ENSG00000204839	"Maestro heat like repeat family member 6"	A6NGR9	8	143566192-143572772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 23.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.8;Hepatocytes: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.6;HaCaT: 13.6;OE19: 14.8;SK-BR-3: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068049	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068049: AB_2685945"	"unprognostic (2.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.04e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.18e-1)"	2.5	3.1	1.1	0.5	1.2	1.7	2.1	1.2	1.4	6.5	1.0	4.5	2.0	2.4	0.1	23.4	2.4	0.7	1.4	1.2	0.9	3.7	7.4	4.0	0.3	1.2	1.2	3.2	1.1	0.2	1.9	0.2	1.1	2.8	0.0	0.1	4.2	0.4	0.9	13.9	5.0	0.1	1.0	4.6	2.9	5.8	1.2	0.3	1.7	0.1	0.7	3.3	8.5	1.0	11.6	2.0	0.2	0.4	0.7	0.7	0.5	0.5	0.4	0.5	0.2	0.4	6.0	1.1	0.6	0.2	0.0	13.6	0.0	2.7	0.0	1.2	1.2	1.3	4.3	0.3	0.6	0.5	1.1	0.7	0.7	0.0	0.0	0.0	0.2	0.4	0.6	0.7	0.0	2.8	0.6	0.3	0.0	14.8	1.1	0.7	0.4	1.1	0.7	1.1	0.2	0.3	0.6	30.0	0.7	0.0	1.3	0.9	0.0	0.4	3.9	0.7	1.2	0.5	0.4	0.3	0.5	6.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.2	1.2	1.4	1.2	0.9	1.2	1.2	1.1	1.0	1.2	1.0	4.0	0.0	4.7	3.9	1.6	2.8	2.2	1.4	4.0	1.4	7.2	4.3	1.5	7.2	2.7	9.2	0.0	1.0	3.7	13.8	1.9	1.3	0.0	1.5	2.9	2.4	1.8	6.1	1.4	0.7	3.4	3.0	6.6	3.0	1.3	3.6	1.1	13.4	5.2	1.7	1.3	4.5	0.0	8.1	3.7	1.3	4.7	6.0	3.6	0.0	3.3	3.5	4.1	0.5	0.3	7.2	6.0	2.6	3.1	2.1	7.3	2.3	0.9	0.3	0.0	2.8	2.3	0.7	7.6	3.2	2.6	1.0	2.6	2.3	8.2	2.8
MROH7	"C1orf175, FLJ46354, HEATR8"	ENSG00000184313	"Maestro heat like repeat family member 7"	Q68CQ1	1	54641754-54710266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 55.5"	"Group enriched"	"Detected in some"	57	"Early spermatids: 179.0;Late spermatids: 546.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071840	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA071840: AB_2732187"	"unprognostic (1.52e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.15e-2)"	0.2	0.6	2.2	0.0	2.5	0.7	0.2	2.9	2.8	0.7	7.0	3.1	0.1	1.1	1.0	0.6	1.3	0.2	2.7	2.3	2.4	2.3	1.1	0.4	0.1	2.9	3.1	2.9	0.3	0.5	4.3	0.0	2.6	2.3	0.3	0.5	1.8	0.7	0.7	1.0	1.4	0.1	2.5	0.2	1.7	55.5	3.2	0.0	5.3	0.2	0.0	1.8	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	2.9	2.8	2.3	2.4	2.9	3.1	2.6	2.5	3.2	2.5	0.0	0.0	1.3	0.0	0.2	0.9	0.9	0.1	0.0	1.7	0.3	0.5	4.0	0.0	1.4	0.0	0.0	0.0	0.0	4.0	0.0	0.1	179.0	1.1	0.2	0.3	2.4	0.0	0.0	0.4	0.0	0.2	0.0	1.2	5.1	0.3	0.4	0.3	0.4	0.0	0.0	3.0	0.0	1.0	0.7	546.1	4.4	0.5	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.1	6.1	4.5	0.0	0.3	5.0	0.2	1.0	0.4	0.0	1.9	0.2	6.3	2.8	0.0	0.4	0.1	0.2	0.5	2.2	1.1
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862830-77952785	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043656	Supported		Approved	Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	19.4	17.7	17.1	17.4	17.7	26.9	24.4	16.8	20.9	16.5	15.7	28.3	19.5	18.6	21.0	20.5	17.0	11.8	41.7	17.9	18.2	38.1	33.8	13.1	23.6	17.3	17.1	19.0	14.1	21.4	8.1	21.4	17.9	16.0	29.4	14.5	19.3	15.0	67.3	14.6	18.6	21.4	17.1	15.0	17.8	8.8	17.8	19.3	17.7	67.6	24.2	19.8	9.2	17.7	40.5	26.2	47.3	40.7	36.6	47.4	41.2	44.6	28.6	57.4	39.3	55.0	71.6	71.4	53.9	37.1	35.8	32.8	71.1	82.5	75.6	47.6	37.6	61.1	27.6	60.4	47.5	126.2	28.3	37.7	76.7	51.2	53.0	37.8	70.4	50.1	90.3	24.1	73.6	46.0	76.0	84.9	52.0	92.0	34.3	90.7	60.6	41.1	113.3	43.2	52.1	25.9	36.1	88.7	84.5	38.0	43.7	61.0	41.9	37.5	54.3	37.7	65.1	21.1	28.1	74.6	31.9	71.8	49.3	9.0	11.5	7.0	20.6	19.0	20.6	27.8	22.2	23.1	22.1	25.5	26.8	29.5	1.7	23.2	16.9	18.0	25.8	15.4	17.1	17.7	16.8	20.9	17.9	18.2	17.3	17.1	17.9	17.1	17.8	17.7	40.1	25.6	35.7	22.5	45.7	12.7	17.1	68.6	13.6	24.6	31.6	37.2	122.1	57.2	33.5	33.1	18.8	72.7	75.5	22.2	135.0	46.0	15.5	33.9	40.9	34.9	47.9	34.9	45.9	36.7	51.9	27.5	18.8	38.5	42.4	38.7	40.7	134.3	47.7	25.2	39.7	60.5	61.1	25.1	12.7	9.3	31.1	23.5	16.0	35.6	34.1	26.7	64.9	45.2	47.7	28.3	24.9	33.4	38.6	14.7	36.0	144.8	20.6	42.4	39.5	31.4	45.9	21.1	48.0	23.1	12.8	34.9	65.8	61.7	70.9	15.5
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831541	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	32.1	32.8	35.6	14.4	36.6	24.7	29.7	36.9	39.7	30.1	33.2	40.9	25.6	31.4	22.8	27.1	29.8	21.9	58.1	34.9	36.7	31.2	29.9	20.1	26.2	36.5	36.0	48.8	41.0	28.9	17.3	23.2	36.2	24.8	23.1	21.7	22.1	25.5	64.2	23.8	26.7	26.5	35.7	28.2	36.2	20.1	37.4	25.9	23.1	52.4	26.9	37.9	25.4	36.8	36.8	80.0	33.4	33.0	78.3	71.3	61.6	32.2	54.0	54.2	46.4	155.7	49.2	59.1	71.9	42.0	36.0	33.6	48.3	62.6	48.0	57.6	76.4	47.2	41.7	110.0	67.4	42.8	25.5	80.8	53.2	64.4	90.7	63.7	52.9	58.4	64.8	56.6	42.3	73.3	43.2	55.0	55.1	64.0	76.5	34.7	63.7	66.5	59.9	35.8	39.2	63.2	23.9	26.9	68.7	62.9	81.2	45.5	32.3	47.5	39.0	32.3	45.1	100.1	82.4	48.0	41.4	32.3	32.4	29.8	37.3	18.5	61.6	39.6	59.1	31.8	42.4	55.3	43.0	36.6	35.6	42.2	14.5	26.6	32.9	26.0	52.5	42.0	35.6	36.6	36.9	39.7	34.9	36.7	36.5	36.0	36.2	35.7	37.4	36.8	17.1	6.4	13.6	4.2	19.2	12.5	20.8	42.5	27.9	15.3	25.3	31.5	31.5	20.0	19.5	14.7	6.2	90.5	50.9	17.9	46.9	43.8	22.0	7.9	16.3	21.7	8.5	30.3	5.4	54.7	60.0	23.3	20.4	11.0	8.8	31.8	20.7	15.6	41.7	32.0	6.6	20.7	32.6	31.4	10.8	30.5	24.5	17.3	16.0	2.8	31.8	24.4	44.3	7.1	8.2	40.4	14.7	24.0	22.8	18.4	30.8	47.5	6.1	13.7	6.6	17.5	28.0	23.2	29.2	24.1	12.5	77.3	48.5	49.4	31.9	18.8
MRPL11		ENSG00000174547	"Mitochondrial ribosomal protein L11"	Q9Y3B7	11	66435075-66466738	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057685	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA057685: AB_2683502"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	14.6	11.0	12.5	11.8	13.2	23.0	17.3	13.1	21.8	12.8	14.6	21.8	16.5	13.8	16.0	19.4	16.6	8.0	20.6	12.8	12.8	17.1	22.1	10.3	19.0	12.8	12.8	17.7	18.9	17.1	7.9	12.2	13.0	11.6	23.7	11.1	18.0	13.1	49.3	13.3	17.2	14.4	12.6	14.3	17.3	9.8	14.2	18.5	11.6	35.9	20.5	14.7	12.7	12.8	62.1	48.3	44.9	43.3	22.0	24.5	64.2	35.2	40.0	65.8	50.2	135.8	74.7	77.3	59.8	33.6	73.0	52.9	66.5	69.1	46.2	35.8	44.1	48.6	42.6	72.9	26.4	81.4	31.4	29.3	40.6	40.6	49.9	31.7	49.5	73.1	72.1	32.9	28.9	105.6	94.1	129.5	82.3	165.7	69.8	59.2	89.5	97.6	29.1	42.0	47.0	40.8	38.9	58.0	127.4	37.9	66.0	42.4	28.1	39.3	53.1	37.6	42.1	24.1	40.3	87.0	40.7	51.8	27.1	2.1	34.3	7.7	35.9	44.9	38.1	51.6	39.1	35.3	54.5	40.3	40.9	37.8	2.3	37.9	40.7	32.9	43.8	42.5	12.5	13.2	13.1	21.8	12.8	12.8	12.8	12.8	13.0	12.6	14.2	12.8	45.7	12.8	28.3	3.6	61.9	49.8	94.2	80.8	58.1	21.8	69.4	96.3	66.6	60.1	49.0	33.1	8.4	139.6	46.5	66.3	123.3	67.7	40.7	38.0	47.3	51.8	51.0	63.9	4.5	85.6	196.6	54.2	47.4	35.2	31.6	93.9	50.7	82.9	126.2	20.2	4.7	97.3	30.5	60.6	60.3	11.1	50.7	59.5	67.6	1.9	77.6	32.3	66.9	2.5	4.5	59.6	69.4	45.9	61.4	75.0	94.4	124.5	43.7	22.1	26.3	48.9	77.1	78.9	60.5	95.7	49.0	77.4	51.7	68.5	165.2	91.4
MRPL12	"MRPL7, MRPL7/L12, RPML12"	ENSG00000262814	"Mitochondrial ribosomal protein L12"	P52815	17	81703367-81707517	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 303.2;Undifferentiated cells: 364.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043"	Supported		Supported	Mitochondria		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.97e-2)"	"unprognostic (5.97e-3)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (1.78e-1)"	"unprognostic (6.47e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.26e-2)"	57.8	73.7	39.4	28.4	39.9	31.0	44.0	46.8	51.9	34.4	50.4	79.7	47.3	39.1	11.0	96.8	35.1	10.9	209.9	39.0	42.2	86.9	184.9	34.9	25.5	40.7	43.1	26.7	60.6	45.9	39.1	19.5	41.0	44.9	37.3	7.3	48.1	21.5	169.7	51.1	51.3	20.6	38.8	53.8	57.9	32.3	46.2	20.1	34.0	148.1	27.7	45.4	46.5	39.4	153.6	256.8	67.5	78.2	50.2	55.0	124.3	117.0	71.3	173.2	128.3	216.5	71.6	236.5	69.2	77.5	116.7	127.1	87.6	150.7	87.6	55.9	438.3	181.1	140.2	246.5	74.0	200.5	90.9	63.4	108.5	119.4	132.4	55.4	146.1	115.6	179.4	75.6	87.1	194.2	171.6	295.9	106.0	165.9	330.6	160.7	109.5	176.4	129.8	126.1	171.4	220.7	86.1	366.1	199.8	69.1	186.2	180.5	76.7	131.0	155.8	103.4	241.2	146.2	54.3	137.0	89.3	143.0	100.6	17.7	63.1	9.0	37.9	84.8	52.6	66.2	37.8	42.6	93.7	62.1	39.2	36.0	6.9	43.5	49.8	77.0	35.8	48.9	39.4	39.9	46.8	51.9	39.0	42.2	40.7	43.1	41.0	38.8	46.2	39.4	43.0	19.2	12.8	4.9	42.2	53.3	83.7	101.7	8.6	17.1	67.2	85.0	88.7	84.4	47.6	46.0	4.2	172.4	29.1	303.2	219.2	113.0	38.9	40.6	39.8	47.8	104.0	40.4	4.5	118.5	187.2	38.9	28.5	33.6	30.5	75.7	39.7	223.4	167.0	23.5	6.0	257.7	44.7	62.2	34.5	127.2	39.4	36.8	58.7	1.9	59.7	29.7	45.3	3.0	4.6	126.5	126.9	32.7	24.4	137.1	196.2	258.5	35.0	17.3	32.9	30.8	65.1	46.5	56.9	30.1	60.5	112.5	25.2	126.0	364.0	109.8
MRPL13	"L13, L13A, L13mt, RPL13, RPML13"	ENSG00000172172	"Mitochondrial ribosomal protein L13"	Q9BYD1	8	120380761-120445402	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 497.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060899	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA060899: AB_2684382"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.84e-1)"	21.3	37.8	18.2	19.1	18.5	22.1	26.6	19.5	27.3	17.0	20.0	37.6	24.4	16.3	24.2	35.6	16.2	15.8	38.2	17.7	20.3	45.6	51.1	16.4	24.8	18.9	19.0	13.1	18.1	33.5	15.2	20.9	19.1	18.2	36.5	21.4	22.0	14.6	33.8	17.7	22.5	19.3	20.1	18.3	24.2	15.1	19.2	28.2	18.2	47.2	25.0	24.7	21.8	20.4	106.5	53.8	62.8	52.7	43.0	62.7	51.2	58.3	57.1	81.3	88.5	56.6	80.2	78.8	85.4	49.4	54.6	56.5	82.1	74.9	114.2	107.4	84.2	99.6	39.0	81.8	51.8	62.7	47.1	48.7	123.2	68.6	71.8	46.4	67.2	78.7	103.8	56.5	73.4	59.7	101.8	60.9	60.5	194.0	122.7	52.9	61.1	107.7	90.7	57.1	74.0	38.1	41.0	497.7	78.4	55.1	96.0	65.9	39.3	42.0	87.1	53.3	107.7	45.2	98.9	110.7	77.8	112.6	76.3	48.4	59.7	66.0	47.6	92.2	56.1	58.9	57.4	62.4	89.8	46.8	55.1	56.4	10.4	68.3	103.1	72.4	77.2	92.2	18.2	18.5	19.5	27.3	17.7	20.3	18.9	19.0	19.1	20.1	19.2	20.4	48.4	70.5	41.9	5.5	37.2	33.6	55.9	235.1	46.7	18.3	37.8	52.1	119.6	44.3	117.8	55.2	20.9	134.2	33.2	56.4	262.2	121.0	10.4	68.4	53.1	45.6	45.0	54.5	14.7	100.7	171.0	49.1	30.5	51.4	36.8	39.3	35.0	78.1	103.3	16.8	14.1	93.3	177.0	33.6	31.4	9.4	38.2	47.5	32.0	9.4	80.1	49.9	32.0	10.1	14.3	95.1	84.9	35.3	42.3	46.5	81.9	264.8	140.7	25.6	39.5	29.0	66.4	103.2	64.8	65.3	45.3	115.9	39.9	114.0	100.8	70.2
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113451-44127452	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 622.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	26.5	41.0	25.7	22.4	26.1	20.7	25.0	25.2	28.5	23.7	24.7	38.0	36.1	29.4	25.5	41.9	22.9	16.2	48.8	25.8	25.3	34.7	80.3	57.8	26.0	25.5	24.7	16.2	24.9	20.6	23.2	26.3	25.5	25.0	34.8	23.6	30.0	19.2	182.1	43.4	29.5	27.7	25.8	26.0	30.1	51.4	26.2	35.3	24.3	109.4	28.6	35.9	27.6	26.5	216.0	90.2	62.5	87.1	53.0	51.4	79.6	78.5	77.8	102.6	101.6	189.1	73.8	93.1	86.7	67.4	98.2	85.9	71.2	127.9	80.8	111.2	193.8	96.1	77.2	235.1	65.3	92.1	64.8	48.2	68.5	96.7	57.1	78.7	85.9	78.8	205.9	58.3	91.7	216.3	111.4	144.6	54.8	622.6	85.8	78.8	70.2	126.7	170.8	104.9	138.8	54.2	50.4	97.5	101.7	53.9	89.5	93.1	69.1	90.4	135.6	65.6	137.9	71.9	68.3	221.8	102.3	90.5	67.4	45.3	115.6	26.3	79.0	113.7	95.1	111.9	100.3	90.5	108.3	105.3	79.2	81.1	6.7	171.4	78.4	122.2	76.1	107.1	25.7	26.1	25.2	28.5	25.8	25.3	25.5	24.7	25.5	25.8	26.2	26.5	48.2	375.0	250.0	3.6	64.5	231.1	200.5	362.7	65.4	29.8	126.6	146.3	136.9	112.9	217.2	57.0	31.3	179.5	51.1	257.9	203.5	205.3	293.1	94.9	66.0	82.0	93.4	78.4	5.0	220.2	206.2	76.4	82.0	101.5	44.4	83.4	50.3	341.2	279.8	33.7	5.3	158.3	219.7	52.0	164.6	122.9	74.6	66.1	69.4	3.7	152.9	66.0	85.5	4.5	7.3	333.0	278.5	53.4	73.7	376.8	203.7	258.7	157.5	70.0	46.0	63.3	149.4	199.2	122.3	116.6	281.3	160.1	56.3	100.5	199.5	376.3
MRPL15	"HSPC145, L15mt, MRP-L15, MRP-L7, RPML7"	ENSG00000137547	"Mitochondrial ribosomal protein L15"	Q9P015	8	54135241-54148514	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.2;tongue: 279.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 248.4;Syncytiotrophoblasts: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044425	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA044425: AB_10969629"	"unprognostic (5.67e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (9.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.06e-2)"	42.5	34.4	33.2	36.4	34.1	25.1	49.3	37.0	50.5	32.6	38.7	70.8	58.6	28.6	27.7	48.8	35.6	29.0	169.6	33.5	38.3	83.8	89.2	26.5	42.9	36.6	35.7	30.5	29.2	83.4	18.6	49.6	35.8	27.5	67.5	63.1	41.4	29.0	291.2	38.5	50.6	45.4	33.8	27.3	38.4	14.7	38.3	38.1	35.2	279.4	57.4	64.1	26.3	33.0	164.1	118.9	98.0	122.6	76.1	110.5	125.8	128.4	93.0	173.3	150.2	134.1	197.1	253.9	170.3	112.1	164.4	161.5	206.2	165.5	190.4	109.9	109.5	165.8	62.4	168.5	114.5	92.0	168.9	103.3	167.4	159.5	165.6	74.7	366.7	89.4	208.2	80.8	251.3	156.1	262.4	177.3	206.2	313.9	60.8	169.5	63.6	136.3	210.8	147.1	56.5	83.7	66.8	204.0	167.0	97.4	195.2	96.6	129.6	95.8	111.7	139.5	151.5	94.6	128.4	207.1	88.8	137.8	153.4	40.1	93.8	27.3	50.7	123.4	63.8	100.6	64.8	68.4	141.1	76.6	59.0	56.9	3.3	54.0	115.7	88.9	79.8	85.8	33.2	34.1	37.0	50.5	33.5	38.3	36.6	35.7	35.8	33.8	38.3	33.0	28.0	25.6	14.4	9.4	33.1	23.6	40.7	114.5	19.4	28.2	25.0	37.2	120.9	55.8	50.4	36.8	29.2	160.3	17.6	38.7	248.4	103.2	18.7	34.0	34.4	34.8	18.0	31.7	10.9	70.9	155.2	32.8	23.9	39.2	25.4	37.9	26.4	59.2	106.1	25.2	12.4	52.5	75.3	44.5	22.9	4.3	24.8	37.9	33.8	7.5	56.5	37.4	20.6	11.1	6.0	97.5	34.3	22.6	35.3	33.9	66.8	127.0	32.1	58.8	13.1	32.1	70.1	14.8	34.3	37.3	34.4	198.9	19.7	91.3	78.3	41.8
MRPL16	"FLJ20484, PNAS-111"	ENSG00000166902	"Mitochondrial ribosomal protein L16"	Q9NX20	11	59806140-59810778	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054133	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054133: AB_2682394"	"prognostic favorable (1.04e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.01e-2)"	35.2	61.4	44.1	29.6	44.7	57.0	34.6	45.6	54.7	30.4	45.4	49.7	42.1	32.7	23.1	33.7	29.0	20.6	85.7	44.2	45.3	51.2	78.3	25.6	44.3	43.4	44.0	31.5	38.6	56.1	23.0	29.8	43.8	25.3	48.3	21.4	43.2	28.8	85.8	24.6	34.7	36.3	44.5	41.6	44.3	34.1	45.3	50.7	20.7	103.5	46.0	29.4	25.7	44.8	76.3	75.4	53.4	50.1	74.9	59.1	48.0	52.1	68.9	93.9	80.1	75.1	79.5	174.0	87.0	68.2	50.3	72.8	178.0	96.9	84.0	58.9	89.5	92.7	69.9	89.5	57.8	139.4	55.1	71.1	52.4	78.8	56.4	54.5	92.4	112.6	278.4	51.2	70.9	150.6	97.8	224.1	84.1	89.8	124.2	85.4	78.6	91.1	137.2	103.3	50.2	34.9	83.4	83.8	134.3	49.4	100.1	132.0	46.3	36.9	50.7	77.4	63.7	57.9	69.8	240.7	44.9	88.1	40.8	80.8	95.1	72.9	87.4	118.1	91.0	118.7	96.5	91.5	116.1	121.2	102.8	91.4	18.1	116.8	94.5	166.9	108.2	149.7	44.1	44.7	45.6	54.7	44.2	45.3	43.4	44.0	43.8	44.5	45.3	44.8	44.3	48.1	31.4	10.4	43.6	31.9	19.7	87.9	34.1	9.9	29.4	47.0	146.1	31.5	42.6	42.3	12.5	94.2	45.9	35.5	248.4	47.9	18.0	28.5	41.5	41.0	34.1	64.8	9.0	53.4	74.1	46.7	46.9	28.5	61.4	104.6	35.7	73.6	75.3	8.4	10.9	67.7	46.8	45.6	24.4	11.8	39.7	34.5	44.4	10.3	54.4	45.4	42.2	9.5	8.0	43.0	42.2	37.6	66.0	19.4	65.6	125.2	44.0	17.0	72.3	34.1	53.1	54.8	46.5	64.4	36.8	28.5	34.9	120.3	82.2	22.3
MRPL17	"MRP-L26, RPML26"	ENSG00000158042	"Mitochondrial ribosomal protein L17"	Q9NRX2	11	6680385-6683340	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043666, HPA050552"	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043666: AB_2678607, HPA050552: AB_2681172"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (4.12e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	"unprognostic (2.71e-1)"	19.8	32.0	9.1	16.3	9.4	9.3	15.5	8.4	10.7	11.8	9.2	14.3	15.0	12.8	4.8	29.0	11.0	17.2	29.2	8.7	10.1	22.3	14.7	15.6	22.4	9.3	9.3	10.6	20.2	9.0	26.7	14.9	8.9	12.4	6.4	7.4	19.6	7.8	25.3	14.8	12.0	7.7	9.1	18.7	16.5	12.0	9.8	8.2	20.7	10.3	8.4	15.7	13.8	9.3	108.9	77.6	20.0	11.3	18.8	21.8	45.4	107.0	35.7	43.5	58.3	56.2	70.9	46.5	59.7	21.1	21.7	54.4	17.9	41.6	22.2	75.6	57.7	40.5	45.2	51.8	13.4	41.3	36.3	14.1	18.3	29.9	23.5	17.1	38.3	27.4	20.7	25.1	32.5	79.8	60.4	41.6	41.0	20.6	69.0	43.7	26.6	31.2	29.2	50.5	39.7	30.9	59.3	49.7	65.5	6.4	41.3	35.0	84.7	50.6	49.4	106.8	77.8	33.7	72.9	55.8	89.8	73.9	43.3	6.5	26.8	15.7	25.0	36.3	32.2	39.0	41.5	30.5	35.6	34.1	40.8	28.6	3.6	28.2	24.7	63.5	42.3	30.3	9.1	9.4	8.4	10.7	8.7	10.1	9.3	9.3	8.9	9.1	9.8	9.3	66.8	16.0	17.2	4.6	26.7	52.9	44.2	75.4	38.7	18.0	35.3	46.9	57.1	30.0	42.9	33.1	8.4	101.0	28.4	20.3	121.3	64.8	54.3	38.0	50.5	62.6	21.0	27.3	5.1	72.5	141.5	39.5	30.5	30.8	8.2	34.7	75.7	30.3	89.4	33.7	6.1	44.9	59.0	28.5	23.6	29.5	39.1	27.8	42.7	5.6	39.0	35.1	32.0	5.0	5.8	61.6	27.6	27.1	42.8	53.9	31.1	155.2	38.6	26.7	13.1	23.0	40.9	82.7	35.9	63.7	54.7	36.7	20.4	118.7	49.4	37.4
MRPL18	HSPC071	ENSG00000112110	"Mitochondrial ribosomal protein L18"	Q9H0U6	6	159789812-159798436	"Predicted intracellular proteins, Ribosomal proteins"	Transport	"Chaperone, Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028774, HPA028775"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA028774: AB_10600113, HPA028775: AB_10601440"	"unprognostic (4.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (3.51e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.22e-2)"	45.1	55.8	75.0	42.0	77.6	45.8	39.0	78.6	122.5	41.1	76.3	55.6	43.0	45.8	51.3	52.0	53.7	35.9	64.6	76.1	77.4	55.1	65.2	36.8	54.8	76.6	75.0	42.9	40.6	43.6	38.4	41.2	76.8	42.4	46.5	28.1	44.5	43.9	77.4	40.9	38.8	48.7	77.4	35.0	45.0	30.2	77.0	50.3	34.9	74.1	48.6	50.1	42.8	82.3	77.5	148.5	55.1	140.1	78.4	86.7	109.7	105.6	89.7	124.1	128.8	172.4	68.5	118.1	88.5	88.8	185.9	107.4	205.1	129.9	118.4	81.4	166.7	117.9	119.8	303.1	87.6	117.6	100.4	67.9	113.0	132.5	97.1	80.0	110.3	121.4	172.4	120.2	115.1	119.5	155.4	256.2	77.2	149.2	143.6	106.6	54.6	196.1	140.3	49.6	92.2	59.1	102.6	165.9	65.7	56.0	102.3	283.7	70.5	93.8	106.0	159.8	212.8	98.5	196.7	139.8	142.7	245.1	116.6	130.6	116.3	108.9	92.6	152.9	107.6	154.3	118.2	103.9	134.4	132.2	131.4	117.6	23.2	110.8	175.9	167.9	137.5	193.0	75.0	77.6	78.6	122.5	76.1	77.4	76.6	75.0	76.8	77.4	77.0	82.3	93.8	51.3	30.5	9.1	62.2	127.3	271.8	170.1	63.2	29.8	98.3	127.6	61.4	108.7	98.6	53.3	16.7	103.8	66.1	94.9	211.3	125.4	226.8	95.9	74.2	73.6	143.5	49.2	11.8	110.9	194.2	77.5	44.9	74.0	93.4	56.0	41.4	86.7	126.8	23.5	12.7	131.5	124.1	48.9	170.4	58.8	90.4	106.1	106.7	11.2	81.7	92.1	75.2	8.5	15.6	126.7	116.2	83.1	54.5	210.4	75.6	192.5	120.4	42.4	85.5	51.1	106.3	258.2	125.8	72.8	119.2	74.8	90.1	108.9	138.7	172.6
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	31.3	30.1	21.8	18.9	27.4	13.9	28.6	26.5	23.5	29.1	14.8	27.8	23.7	21.7	25.2	25.0	18.1	20.7	35.0	18.8	26.7	56.0	63.7	17.8	20.3	23.4	24.4	17.4	23.6	45.2	12.2	25.7	25.4	21.6	30.9	19.3	24.1	25.1	66.4	23.9	19.9	29.0	26.8	16.9	18.4	16.5	24.9	24.3	36.9	44.8	25.1	24.5	15.1	32.5	100.7	57.5	53.3	48.3	57.0	68.1	75.6	63.4	57.0	78.5	62.2	88.5	40.6	56.5	62.1	69.2	73.8	69.5	83.7	95.8	117.8	63.2	72.4	77.4	44.4	114.3	61.0	82.9	44.5	45.6	72.4	79.7	72.3	49.6	84.1	60.8	86.4	32.3	78.5	61.9	76.1	64.9	69.9	102.9	65.2	94.5	116.5	74.5	134.1	61.9	58.8	50.2	62.2	71.2	72.4	53.3	61.1	32.8	57.0	68.3	75.4	61.2	94.6	33.3	53.8	47.1	53.9	81.0	61.1	17.7	20.2	14.2	22.1	26.8	25.1	26.8	22.7	23.8	29.7	22.7	19.9	24.6	1.4	24.4	24.9	35.0	26.5	17.2	21.8	27.4	26.5	23.5	18.8	26.7	23.4	24.4	25.4	26.8	24.9	32.5	31.8	19.2	29.6	10.7	27.4	29.1	28.6	77.8	21.1	38.3	32.4	29.5	40.2	25.8	49.4	49.7	52.1	90.3	26.3	24.0	125.2	88.7	27.6	42.7	48.4	27.7	27.6	32.8	13.9	61.1	87.3	33.7	36.7	50.3	19.0	35.8	27.1	67.6	47.3	48.8	14.3	36.5	44.7	14.6	17.0	11.2	35.4	23.7	33.8	12.2	35.0	39.6	34.0	15.1	20.0	53.6	27.7	36.5	36.5	36.1	36.5	167.7	32.8	50.9	19.7	31.4	38.1	55.5	17.6	44.3	28.3	57.7	25.3	62.2	50.7	35.6
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059438	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	26.5	32.4	27.9	12.6	28.8	20.0	26.0	31.0	37.6	23.2	27.9	27.5	25.6	23.5	13.7	24.6	22.2	10.1	48.2	28.3	31.7	33.7	51.2	18.6	13.4	29.8	28.9	24.5	27.1	29.6	29.5	13.3	30.1	22.0	16.8	10.9	22.6	17.6	75.1	25.1	20.3	12.0	27.4	19.9	23.6	19.7	29.0	17.7	26.7	56.7	14.4	22.6	21.4	28.9	47.9	43.1	20.3	39.3	28.4	20.7	38.9	20.4	24.8	47.3	41.3	109.0	15.4	61.8	42.3	24.6	36.2	49.9	50.5	48.7	27.8	30.4	90.9	46.8	34.9	109.5	57.2	43.5	21.0	27.6	51.4	52.5	82.8	22.6	32.6	68.7	84.6	36.6	23.6	84.0	48.1	127.1	22.7	175.7	49.5	59.0	25.1	77.3	38.2	26.3	51.3	27.4	18.2	39.4	73.4	18.6	41.4	73.9	27.3	27.6	40.0	35.7	58.7	47.7	44.9	115.2	21.5	65.2	27.8	17.5	37.8	30.2	28.4	40.9	36.5	46.5	31.8	33.6	54.3	48.6	32.7	32.3	9.8	38.5	33.7	56.1	39.2	31.3	27.9	28.8	31.0	37.6	28.3	31.7	29.8	28.9	30.1	27.4	29.0	28.9	36.8	22.4	18.6	5.5	27.5	24.3	32.0	86.5	19.4	22.7	25.9	30.0	37.5	38.6	48.9	60.7	27.1	74.0	21.3	43.1	185.9	59.1	94.0	30.6	34.1	32.1	30.6	35.3	5.3	53.7	53.1	31.1	30.1	32.5	28.5	43.1	33.2	75.9	49.3	5.0	5.8	44.2	69.2	23.7	26.6	37.0	55.0	22.9	53.4	2.8	41.3	44.7	43.3	2.0	5.5	44.2	51.3	51.6	35.6	31.6	77.6	159.4	40.4	23.4	26.3	32.5	82.7	53.1	41.7	35.7	27.1	63.5	27.2	59.0	65.7	28.7
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401909-1407293	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	111.5	120.2	144.2	81.8	156.1	72.1	110.0	144.3	178.5	86.5	148.7	126.7	83.6	89.7	135.0	117.2	90.2	68.5	189.8	146.7	154.3	140.9	152.7	86.7	100.4	152.4	154.1	84.2	136.6	100.6	117.3	68.6	147.2	110.9	86.9	59.6	131.9	90.3	277.2	97.7	91.3	75.4	158.1	100.2	116.8	60.5	168.6	71.8	102.3	160.9	102.5	107.6	87.6	158.1	216.1	204.2	149.7	152.8	113.4	122.7	110.6	188.3	143.8	240.7	171.1	244.9	255.4	228.5	256.8	162.9	111.4	133.8	247.6	203.8	185.9	199.0	350.3	247.0	369.0	244.8	156.5	367.3	152.7	143.9	76.8	184.8	196.4	138.4	181.1	213.8	254.6	131.8	204.8	216.3	285.2	279.2	155.8	249.6	409.1	186.0	138.3	291.3	189.9	142.8	265.4	218.5	179.2	369.9	288.7	124.7	158.8	268.0	155.2	144.9	170.0	219.6	236.2	200.6	313.5	450.5	224.2	296.4	103.7	124.6	191.2	146.5	164.8	190.1	183.7	189.3	181.9	163.3	198.2	177.2	204.1	199.0	89.2	163.1	150.8	289.2	175.0	219.6	144.2	156.1	144.3	178.5	146.7	154.3	152.4	154.1	147.2	158.1	168.6	158.1	97.5	67.3	115.5	19.9	120.3	130.3	134.8	206.8	99.0	77.8	153.0	171.4	255.2	145.8	166.0	161.8	35.5	234.5	129.2	138.6	530.2	232.6	39.3	153.1	121.8	118.4	138.2	152.7	13.7	325.9	265.0	113.6	87.7	126.3	106.2	92.7	131.0	384.0	220.6	50.5	13.8	185.5	177.0	139.7	111.0	30.7	107.8	117.9	138.7	11.2	200.8	279.3	183.4	9.5	20.8	261.8	167.4	110.9	163.3	254.8	194.1	543.9	146.9	107.7	65.7	121.8	135.7	131.7	202.7	179.9	157.7	226.2	109.2	121.9	216.1	170.2
MRPL21		ENSG00000197345	"Mitochondrial ribosomal protein L21"	Q7Z2W9	11	68891276-68903835	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051657	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051657: AB_2681565"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.12e-1)"	43.5	44.4	56.0	34.0	57.3	60.5	52.5	62.8	71.9	45.3	57.7	67.1	38.7	50.4	48.4	58.4	45.2	27.1	120.2	57.6	59.5	68.0	66.1	31.5	43.8	59.5	57.4	48.6	53.6	56.3	44.7	33.1	59.6	44.1	42.5	29.7	99.5	39.1	131.0	50.4	46.0	35.1	56.9	37.0	53.0	47.0	57.9	37.2	44.7	109.1	42.9	49.8	44.9	56.9	105.2	145.6	86.0	82.3	59.1	63.5	101.4	71.8	77.2	132.8	90.4	297.3	132.7	163.5	157.2	78.0	122.0	129.9	143.8	138.6	102.8	109.7	112.6	114.4	102.4	181.0	116.6	201.4	83.4	95.0	69.4	134.1	156.0	64.7	93.7	115.1	229.2	119.4	80.7	196.7	95.5	210.5	78.0	307.6	210.3	135.2	102.9	253.0	134.0	120.8	139.3	111.3	91.1	181.6	302.7	68.7	188.7	115.4	79.3	90.6	90.6	201.3	135.5	88.9	149.5	232.3	120.6	120.4	125.7	79.6	113.0	61.6	72.4	122.8	77.1	162.2	94.5	78.8	124.2	105.8	89.3	74.1	32.1	93.3	114.2	92.0	113.2	114.0	56.0	57.3	62.8	71.9	57.6	59.5	59.5	57.4	59.6	56.9	57.9	56.9	38.9	35.3	38.7	5.5	47.4	50.2	76.8	145.1	68.9	36.3	56.5	65.4	179.8	67.2	82.0	80.9	8.4	122.8	34.6	127.7	299.3	106.7	176.9	72.2	59.8	50.4	61.7	56.0	5.6	105.3	114.8	53.9	42.8	63.0	65.2	31.8	40.7	115.9	110.4	11.8	6.4	115.6	85.5	56.3	41.3	227.3	74.9	47.0	78.2	1.0	69.8	69.0	34.0	2.0	5.1	86.3	93.0	72.2	63.8	79.6	150.6	272.9	72.8	51.4	26.3	59.3	85.8	86.6	60.5	83.2	51.9	81.3	44.2	55.0	141.6	75.0
MRPL22	"HSPC158, MRP-L25, RPML25"	ENSG00000082515	"Mitochondrial ribosomal protein L22"	Q9NWU5	5	154941073-154969411	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047063	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047063: AB_2679919"	"unprognostic (9.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.29e-2)"	23.9	38.4	18.4	20.3	18.4	40.9	26.3	20.0	27.9	20.7	17.7	28.4	26.1	20.5	26.0	30.8	18.9	15.4	46.3	18.5	19.0	37.5	49.3	19.6	28.5	19.5	18.8	18.1	30.3	31.2	23.8	24.2	19.7	19.4	28.0	17.0	24.8	19.3	38.5	23.6	22.9	20.0	18.7	26.2	27.1	29.4	18.8	28.2	23.3	34.5	27.1	24.6	21.6	19.6	68.5	65.8	57.1	79.7	43.7	55.0	67.9	47.6	55.9	93.9	118.3	191.5	82.8	93.7	82.9	40.1	100.0	61.2	83.2	90.0	99.8	32.2	94.3	36.1	64.1	110.1	57.1	81.5	47.2	36.5	59.4	63.4	76.9	41.8	161.8	84.6	55.2	81.9	58.8	100.8	74.1	78.3	43.5	74.0	50.6	67.4	49.6	97.9	93.1	50.9	65.4	24.3	62.5	89.1	104.9	41.0	130.2	71.3	47.5	57.7	57.5	51.1	89.3	43.4	57.5	104.4	57.9	99.7	55.4	35.9	49.0	44.1	47.5	59.7	48.7	72.3	51.5	51.3	66.6	61.5	47.7	54.6	19.8	64.0	60.4	51.9	75.1	62.4	18.4	18.4	20.0	27.9	18.5	19.0	19.5	18.8	19.7	18.7	18.8	19.6	55.2	25.6	28.1	11.1	52.2	63.9	54.4	191.6	43.9	28.1	45.9	67.9	213.2	64.3	95.6	60.7	27.1	144.6	37.9	46.6	223.0	114.9	56.2	49.6	44.4	69.2	49.6	64.0	13.0	127.1	132.6	64.7	27.0	41.3	45.0	56.2	51.4	85.2	99.3	32.0	11.8	65.6	79.3	33.2	57.1	29.3	66.2	35.7	51.6	2.8	61.3	35.9	56.7	11.1	20.1	113.9	83.4	75.2	71.1	47.2	68.1	203.7	89.0	27.1	32.9	48.5	86.7	167.7	67.0	50.3	65.8	78.5	48.4	122.2	78.5	54.6
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 342.1"									HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	67.5	123.1	18.3	16.4	19.2	42.4	66.3	19.4	26.0	64.2	20.3	74.8	27.1	54.0	14.3	125.9	57.8	10.9	128.4	18.8	20.1	96.6	140.1	67.4	26.7	19.7	18.7	90.8	118.0	23.5	92.3	8.5	19.6	71.8	19.1	7.0	90.4	14.6	159.5	124.0	67.1	13.1	19.3	81.7	94.3	27.1	19.0	17.7	71.5	39.6	23.9	59.7	70.9	20.5	69.3	74.9	39.7	49.2	15.9	44.0	67.4	20.9	28.0	31.8	23.4	4.8	79.2	72.9	43.6	44.4	44.5	70.6	64.5	88.8	15.0	75.4	342.1	28.1	24.5	98.2	41.7	65.2	40.8	34.9	34.0	22.0	6.4	37.3	23.0	38.3	24.9	34.6	46.5	71.4	57.9	55.8	64.1	58.5	71.9	77.7	27.2	92.0	28.4	25.0	86.5	81.6	25.0	56.2	45.6	22.0	1.4	78.1	30.8	43.6	32.4	11.0	44.0	58.4	47.7	68.7	68.2	56.0	0.1	2.7	18.5	16.8	8.0	14.5	6.4	36.4	11.8	9.4	23.9	34.6	25.7	8.1	1.0	8.3	10.4	10.6	20.0	5.2	18.3	19.2	19.4	26.0	18.8	20.1	19.7	18.7	19.6	19.3	19.0	20.5	33.9	12.8	6.3	17.0	79.1	186.3	69.9	154.6	19.4	7.0	105.4	111.6	69.7	95.8	88.7	38.6	0.0	125.3	43.6	298.1	123.3	126.6	10.2	57.9	29.1	37.5	136.2	117.8	9.4	232.6	224.4	43.3	54.6	40.2	96.6	54.7	57.8	178.9	178.5	5.0	9.9	258.7	99.7	163.9	214.3	18.5	23.0	78.4	200.9	3.7	133.6	30.6	63.8	7.5	12.2	171.1	273.6	36.5	76.8	61.9	175.4	245.0	98.7	11.7	39.5	33.5	69.2	24.4	39.8	47.5	258.7	90.6	50.2	67.0	256.1	82.8
MRPL24	MRP-L18	ENSG00000143314	"Mitochondrial ribosomal protein L24"	Q96A35	1	156737303-156741590	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 213.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030295, HPA054323"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030295: AB_10600932, HPA054323: AB_2732583"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.47e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	78.1	93.8	75.4	43.0	78.6	24.0	69.8	79.6	81.2	51.3	71.4	70.3	40.7	58.3	94.6	55.4	72.7	33.8	108.4	74.0	77.4	77.9	130.6	37.2	46.1	77.7	75.9	65.6	100.2	86.1	41.1	41.5	78.9	49.1	67.8	26.9	71.2	65.7	149.6	50.7	41.8	76.6	76.3	43.1	62.0	37.4	77.3	42.8	52.5	143.0	57.1	67.1	48.0	82.0	146.0	238.2	50.2	62.0	157.0	167.6	98.7	115.6	72.2	153.6	86.5	96.5	149.7	112.1	189.3	153.2	74.9	141.3	121.8	238.9	153.3	136.6	152.7	104.9	164.9	94.7	176.8	115.9	70.8	156.5	205.0	232.3	243.4	92.9	136.4	136.5	105.4	129.2	155.1	259.9	130.6	115.2	93.0	495.3	289.8	83.7	134.7	229.1	192.3	105.2	64.0	129.4	70.3	391.6	192.5	95.4	233.9	130.6	104.1	141.8	108.9	141.1	200.3	144.1	131.5	116.1	133.8	135.5	143.8	38.3	62.3	11.2	63.1	77.4	95.8	87.2	82.3	77.5	81.5	86.9	81.4	86.0	3.3	97.1	75.0	68.4	72.0	93.5	75.4	78.6	79.6	81.2	74.0	77.4	77.7	75.9	78.9	76.3	77.3	82.0	26.3	32.1	31.6	3.9	33.7	30.5	67.0	65.4	39.3	13.8	46.8	51.3	157.0	80.1	49.1	42.3	4.2	92.4	27.5	28.0	154.6	53.5	26.7	31.5	45.0	40.9	36.0	22.9	5.7	76.6	87.9	51.0	36.7	37.0	60.3	30.9	35.7	133.6	79.7	15.2	6.3	45.7	36.7	27.3	29.4	13.4	55.9	29.1	74.7	1.9	47.9	22.2	36.0	4.5	10.0	40.2	35.3	53.0	43.4	53.7	44.9	213.2	41.7	13.7	32.9	53.0	62.0	46.8	48.5	66.1	36.7	40.8	28.7	59.7	69.5	62.1
MRPL27		ENSG00000108826	"Mitochondrial ribosomal protein L27"	Q9P0M9	17	50367857-50373207	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 377.6;Proximal tubular cells: 409.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021416: AB_1854103"	"unprognostic (2.09e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.76e-3)"	51.4	92.4	103.3	36.8	105.9	35.7	55.2	108.9	129.4	48.5	105.6	73.5	53.8	46.2	115.5	72.8	44.1	29.9	106.5	102.6	106.3	90.7	109.4	37.3	44.8	106.6	105.7	45.9	59.2	75.5	52.3	57.2	107.4	58.2	84.4	32.9	50.3	45.0	141.1	60.2	52.2	50.9	106.1	45.6	91.2	42.4	109.0	61.2	49.7	140.5	64.7	58.0	51.0	108.0	160.2	231.3	105.5	69.8	66.5	98.9	154.3	117.1	111.8	216.9	195.5	535.5	82.6	139.3	143.5	146.0	168.0	97.3	160.9	177.8	176.2	142.2	273.0	145.5	199.8	393.1	123.4	121.9	125.3	114.3	242.9	172.8	103.0	94.7	149.0	75.8	157.4	81.0	153.4	304.2	135.6	154.0	76.4	279.4	252.4	74.4	143.6	114.5	187.8	213.6	108.1	130.4	55.0	71.3	104.9	140.0	171.2	100.6	89.8	145.0	110.5	109.4	192.1	97.6	120.5	127.8	97.6	101.7	76.4	212.7	175.6	124.6	99.3	209.2	82.9	211.4	117.2	104.5	177.1	186.4	113.9	99.0	27.9	108.7	153.6	193.5	159.0	179.3	103.3	105.9	108.9	129.4	102.6	106.3	106.6	105.7	107.4	106.1	109.0	108.0	33.6	38.5	43.7	12.7	50.7	60.0	97.2	220.9	56.9	35.5	50.1	65.8	180.5	88.6	111.2	90.1	14.6	240.7	36.8	179.7	377.6	136.5	27.7	60.1	61.7	58.1	103.0	55.3	10.0	146.5	181.9	70.6	99.9	63.9	29.7	52.1	57.8	221.4	150.6	15.2	12.9	193.3	132.2	52.5	33.9	31.1	83.0	52.0	69.4	12.2	88.8	72.5	42.2	15.6	14.5	153.8	139.0	83.8	58.2	83.9	199.5	409.5	73.5	42.1	72.3	57.1	85.8	88.7	74.6	81.6	75.4	273.4	36.4	97.5	155.3	102.6
MRPL28	"MAAT1, p15"	ENSG00000086504	"Mitochondrial ribosomal protein L28"	Q13084	16	366969-371289	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030594, CAB033542, HPA055589"	Supported		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855"	"unprognostic (2.39e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.45e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.56e-2)"	43.3	63.2	43.2	25.8	46.6	43.7	43.6	41.6	55.9	40.8	39.9	48.9	31.4	47.0	20.6	58.0	39.4	23.3	101.0	46.9	42.7	74.9	79.9	38.7	30.4	41.2	41.7	36.4	32.2	46.6	44.0	21.1	42.5	45.3	18.1	20.4	37.9	23.8	87.6	45.9	43.0	25.8	41.2	52.2	43.8	85.2	42.2	36.8	44.2	59.3	27.1	43.1	42.3	43.9	72.8	135.8	68.3	82.9	37.9	48.6	90.1	82.6	107.3	147.2	143.2	175.4	95.9	105.5	88.6	85.0	75.3	87.6	107.8	172.6	78.2	95.4	211.8	78.7	110.0	149.2	123.9	98.1	96.1	73.8	84.6	136.3	110.5	69.0	109.5	99.5	143.8	75.6	93.0	249.0	152.9	98.2	109.1	72.3	82.5	181.7	85.2	149.1	121.4	41.3	115.2	102.4	102.5	100.3	84.6	66.4	131.1	92.4	85.5	86.0	118.6	70.8	92.4	111.1	100.3	143.0	60.0	68.4	140.8	95.4	105.7	122.1	71.0	107.2	59.1	93.3	62.0	68.9	96.6	105.0	43.0	54.7	120.5	79.3	115.1	119.0	125.8	97.9	43.2	46.6	41.6	55.9	46.9	42.7	41.2	41.7	42.5	41.2	42.2	43.9	44.2	38.5	34.1	8.5	43.6	34.7	50.4	134.5	25.6	34.8	35.6	36.4	55.4	40.0	69.0	69.9	8.4	87.0	46.8	70.2	193.7	112.5	97.7	35.3	30.0	44.9	64.1	51.3	5.8	111.9	108.0	41.2	37.2	31.2	26.6	57.2	47.2	66.6	99.7	28.6	5.0	54.6	77.3	66.5	36.1	232.6	38.2	47.8	71.2	2.8	136.1	56.1	45.3	3.0	5.4	107.0	76.5	38.4	47.2	46.7	106.3	180.0	55.4	42.5	39.5	31.0	61.9	122.2	50.5	38.9	32.4	45.8	37.1	86.6	65.8	52.9
MRPL3	"MRL3, RPML3"	ENSG00000114686	"Mitochondrial ribosomal protein L3"	P09001	3	131462212-131502983	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043665, HPA060132"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043665: AB_2678606, HPA060132: AB_2684209"	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.61e-3)"	"unprognostic (7.83e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.33e-7)"	"unprognostic (1.54e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (1.36e-4)"	"prognostic unfavorable (3.51e-6)"	"unprognostic (2.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-1)"	46.2	44.3	22.9	45.1	24.2	32.0	65.4	23.0	28.7	47.0	29.4	60.8	48.7	40.8	71.6	51.0	59.3	34.9	48.6	24.2	28.0	75.2	65.6	29.9	51.4	22.9	23.8	47.9	61.1	80.9	38.2	39.6	24.9	45.7	65.9	33.8	57.5	48.1	78.6	34.5	41.3	50.4	25.6	29.8	46.7	51.1	25.6	53.1	64.2	78.0	60.9	65.8	35.0	26.9	263.1	108.9	119.8	135.0	110.5	142.4	216.4	139.7	122.6	177.0	156.7	241.4	148.5	212.3	184.3	140.8	138.9	168.5	205.9	200.8	269.6	138.4	160.1	197.2	112.3	204.8	129.2	399.8	121.7	112.7	163.6	136.4	241.0	96.1	116.4	159.7	183.3	113.0	148.2	200.1	201.3	199.6	255.2	278.6	193.7	79.4	153.8	326.3	176.3	182.1	194.1	130.5	125.4	141.4	206.3	100.0	165.5	211.6	105.8	127.2	132.5	181.6	196.8	107.0	116.0	380.4	135.6	189.6	178.6	12.8	79.0	19.7	58.7	105.9	91.2	71.9	71.9	70.2	147.5	76.3	82.7	75.1	4.5	98.3	80.5	51.5	77.1	124.6	22.9	24.2	23.0	28.7	24.2	28.0	22.9	23.8	24.9	25.6	25.6	26.9	32.5	25.6	26.9	22.5	54.4	45.9	89.0	106.8	49.5	28.3	54.2	52.8	35.7	37.1	63.8	31.3	8.4	100.2	37.6	26.6	152.6	115.7	86.4	39.0	58.6	31.6	30.1	57.2	38.3	101.9	135.4	53.3	42.8	65.2	28.6	55.1	31.1	50.7	65.9	30.3	30.3	76.2	67.1	54.1	37.3	24.2	55.6	51.5	42.7	19.7	55.5	35.6	49.4	33.7	30.3	92.4	31.9	51.6	72.9	97.8	47.4	167.2	38.9	21.9	32.9	59.8	54.2	149.3	85.4	67.6	47.5	63.9	42.5	95.0	81.3	84.0
MRPL30	"MRP-L28, RPML28"	ENSG00000185414	"Mitochondrial ribosomal protein L30"	Q8TCC3	2	99181152-99199561	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047255	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA047255: AB_2680002"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.77e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.72e-1)"	9.9	12.5	4.0	5.0	4.1	3.4	9.3	4.8	4.5	10.0	2.8	9.8	7.1	9.8	4.1	14.6	8.0	4.0	16.7	4.3	4.1	12.4	13.6	6.0	5.2	3.2	3.3	9.6	11.3	7.4	7.2	5.1	3.4	8.6	6.8	6.0	9.9	5.6	29.6	10.6	8.1	5.3	3.2	7.1	10.1	4.0	4.1	7.4	7.0	21.1	7.0	9.3	10.1	4.3	30.7	8.5	14.4	10.6	9.6	15.7	14.3	12.7	11.1	15.3	12.3	23.3	7.4	22.8	7.7	11.3	9.2	15.1	25.9	30.8	24.9	14.8	21.3	23.4	10.9	25.3	13.0	19.8	8.2	13.6	10.6	12.3	23.1	11.8	26.3	12.3	36.3	14.2	14.8	10.8	29.0	16.6	15.6	10.2	24.5	28.1	28.4	19.9	17.7	17.5	20.2	20.3	9.8	21.4	29.3	14.5	17.1	16.4	13.0	20.7	11.2	10.8	15.6	17.2	22.7	33.7	14.2	17.3	22.1	3.1	4.7	3.2	3.5	4.9	3.6	4.6	2.7	5.1	4.0	4.2	3.6	3.4	1.5	3.8	3.1	3.8	4.3	3.3	4.0	4.1	4.8	4.5	4.3	4.1	3.2	3.3	3.4	3.2	4.1	4.3	15.9	9.6	7.5	11.8	16.2	0.6	12.7	1.0	20.5	9.4	14.0	15.7	27.3	15.7	6.7	11.0	6.2	22.5	15.1	15.4	35.2	23.3	3.0	16.9	28.1	11.5	13.8	16.6	18.9	24.7	25.3	13.6	13.7	20.2	6.3	15.1	14.3	25.8	19.9	16.8	17.3	19.5	2.0	19.7	0.5	2.4	22.4	14.9	1.8	11.2	24.2	9.8	21.6	9.0	17.2	29.7	11.9	22.6	19.1	9.0	20.6	34.6	5.3	9.3	0.0	10.8	12.3	7.5	13.8	22.9	0.9	13.4	14.4	17.9	19.8	10.3
MRPL32	"bMRP-59b, HSPC283, L32mt, MRP-L32"	ENSG00000106591	"Mitochondrial ribosomal protein L32"	Q9BYC8	7	42932376-42948958	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048965	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA048965: AB_2680576"	"unprognostic (1.15e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.22e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.05e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-2)"	44.7	71.4	35.8	32.3	37.1	28.4	41.8	36.5	42.8	29.4	46.1	47.4	46.7	33.4	57.2	38.7	38.5	42.1	74.1	36.8	39.7	82.5	120.3	28.7	39.2	36.9	36.7	45.4	52.1	53.0	26.3	34.6	36.8	57.3	45.7	15.9	46.2	34.7	53.6	26.9	39.5	34.4	36.4	29.8	43.7	25.5	36.8	36.9	42.2	66.3	43.3	55.2	27.5	37.8	67.9	94.3	63.3	99.7	97.0	79.9	72.8	101.9	74.2	84.3	95.9	116.3	71.7	145.3	95.8	59.4	141.3	150.3	98.6	112.0	99.1	94.2	116.6	70.7	75.4	128.5	142.2	121.4	66.8	91.8	84.0	62.6	109.2	72.7	106.0	97.6	132.5	73.4	108.1	104.4	83.2	207.1	160.9	160.2	139.3	81.3	73.6	150.4	188.2	138.7	77.4	69.1	82.4	224.2	89.0	92.2	126.3	90.4	93.4	72.5	117.3	77.3	143.6	120.9	215.1	160.4	55.0	156.6	157.9	181.9	89.7	147.1	77.8	101.6	104.3	154.6	114.1	102.3	95.9	122.9	120.3	113.9	18.3	102.9	91.0	94.3	160.6	117.9	35.8	37.1	36.5	42.8	36.8	39.7	36.9	36.7	36.8	36.4	36.8	37.8	53.3	54.5	39.8	6.2	47.8	131.5	88.5	191.2	55.2	20.5	68.7	87.4	93.3	70.1	92.7	58.8	8.4	110.9	47.6	46.1	180.0	111.5	8.3	50.8	70.5	68.7	46.8	44.4	16.5	101.0	98.4	61.5	38.7	57.4	64.0	43.5	57.8	104.1	61.8	16.8	14.1	64.2	101.7	40.6	50.2	8.4	52.8	34.1	64.0	5.6	57.7	16.3	35.0	11.6	17.1	97.6	55.4	50.8	43.8	103.1	77.4	211.7	70.1	23.2	52.6	73.1	113.5	34.3	72.5	65.2	109.4	89.6	45.4	117.4	104.6	105.1
MRPL33	"C2orf1, RPL33L"	ENSG00000243147	"Mitochondrial ribosomal protein L33"	O75394	2	27771717-27988087	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1318.9;Distal tubular cells: 710.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066872	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA066872: AB_2685739"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.68e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.20e-2)"	157.7	642.9	142.0	66.7	146.7	98.2	131.4	145.2	215.2	127.7	146.4	233.3	76.8	145.7	151.2	94.1	140.8	81.8	555.1	142.2	146.0	297.4	135.6	131.6	79.8	143.2	141.5	132.5	120.0	161.0	189.2	74.2	142.9	151.1	98.0	135.8	114.8	120.7	716.4	79.0	114.8	121.2	142.6	122.9	166.7	108.6	143.0	110.5	112.8	650.0	81.9	162.7	110.1	148.5	378.2	168.6	302.0	124.0	186.5	209.7	141.3	233.7	294.8	230.7	300.9	151.0	288.2	108.1	286.5	246.9	347.4	112.8	171.6	186.1	328.9	169.6	325.9	211.0	161.8	272.2	282.7	213.4	120.5	270.6	162.2	209.1	364.8	370.9	297.2	163.5	167.6	178.4	307.1	126.0	147.6	231.8	170.4	384.0	241.9	73.8	341.1	152.1	711.5	150.6	172.8	248.4	161.7	205.2	268.1	277.6	92.0	216.5	253.1	145.8	314.7	143.3	375.0	205.5	347.2	325.7	200.8	346.6	137.1	502.5	203.4	211.2	126.7	160.5	136.8	128.3	143.8	135.6	284.0	112.3	121.5	147.2	154.2	125.9	160.6	183.3	175.0	125.4	142.0	146.7	145.2	215.2	142.2	146.0	143.2	141.5	142.9	142.6	143.0	148.5	213.3	179.5	144.5	10.4	104.3	56.0	107.2	283.5	66.0	48.6	171.2	190.4	1318.9	165.8	205.6	321.8	25.0	138.1	103.8	132.3	710.2	202.8	97.0	249.6	143.3	207.1	153.2	66.3	16.3	349.6	131.4	131.1	81.1	229.1	190.4	91.7	165.0	259.2	150.2	42.1	17.2	186.8	207.5	161.3	120.2	53.2	170.6	119.3	154.7	6.5	200.7	134.4	141.1	12.1	16.8	239.3	151.3	197.8	84.7	134.7	134.9	386.1	191.5	64.9	164.3	134.3	184.0	214.9	152.4	71.4	57.1	104.0	113.0	101.8	173.9	129.9
MRPL34	"L34mt, MGC24974, MGC2633"	ENSG00000130312	"Mitochondrial ribosomal protein L34"	Q9BQ48	19	17292609-17306843	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 403.0;Proximal tubular cells: 414.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049276	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA049276: AB_2680697"	"unprognostic (1.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-2)"	69.6	115.4	64.0	27.5	67.0	26.2	64.7	69.2	72.2	51.4	96.7	99.7	71.5	58.7	23.5	62.8	45.6	17.6	178.2	63.4	69.5	126.0	195.0	47.1	28.6	64.3	64.1	40.9	69.5	91.8	74.1	20.3	64.6	55.3	29.8	31.6	65.3	40.2	210.5	60.6	75.8	18.3	64.1	55.8	87.7	93.6	70.7	38.0	61.5	139.6	21.8	64.0	50.6	66.0	91.9	55.3	35.4	45.4	88.2	48.7	132.1	45.4	47.7	36.6	44.8	53.6	64.2	115.2	126.7	25.2	50.7	73.6	57.1	53.5	25.9	171.3	198.5	81.4	87.2	119.2	78.7	89.2	103.9	56.6	71.2	38.0	52.1	38.9	57.8	95.5	119.6	136.4	35.7	86.7	113.4	187.4	97.6	147.2	293.8	97.9	52.0	160.9	107.9	68.6	84.1	136.7	42.6	67.2	105.9	37.0	58.7	74.3	49.0	52.7	32.8	151.6	87.4	186.5	305.3	129.0	65.4	161.7	49.1	169.6	162.3	159.5	172.4	177.0	192.5	204.0	203.5	177.3	178.1	211.0	197.5	172.2	52.3	141.7	107.0	233.6	210.8	276.7	64.0	67.0	69.2	72.2	63.4	69.5	64.3	64.1	64.6	64.1	70.7	66.0	64.4	35.3	41.4	13.7	51.7	60.7	33.0	128.5	74.0	50.2	81.7	108.2	153.4	91.5	64.6	82.8	20.9	118.5	94.1	138.9	403.0	88.5	57.6	48.1	46.7	54.2	68.3	45.5	16.1	68.8	112.1	55.6	60.1	45.4	39.3	37.1	59.6	290.3	172.4	42.1	16.7	125.4	134.3	70.1	55.9	31.9	82.0	61.4	81.8	6.5	90.0	45.0	97.9	6.0	12.8	64.7	99.1	91.7	80.3	45.7	219.5	414.8	42.3	49.7	72.3	48.1	69.7	233.1	14.9	93.2	72.0	78.3	62.0	109.5	130.6	36.7
MRPL35		ENSG00000132313	"Mitochondrial ribosomal protein L35"	Q9NZE8	2	86199355-86213790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043482	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043482: AB_10959449"	"unprognostic (3.68e-2)"	"unprognostic (6.24e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.96e-6)"	"unprognostic (1.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.52e-3)"	25.0	29.7	19.6	24.7	22.0	20.5	25.3	21.2	26.1	18.9	18.8	55.5	57.9	17.8	13.6	31.2	21.9	19.9	83.8	20.1	21.9	47.5	46.1	15.5	35.6	19.7	19.6	17.3	19.7	45.9	12.0	20.9	20.9	19.1	58.7	23.2	24.3	25.1	69.4	14.3	43.3	30.1	20.5	21.6	32.2	16.2	21.7	29.1	19.9	113.5	40.0	32.2	18.0	21.2	83.4	35.8	53.6	55.0	55.1	51.6	77.2	71.5	51.5	88.0	64.9	31.4	69.1	154.1	79.0	61.6	70.9	71.2	109.3	64.2	98.1	89.0	51.0	88.5	25.9	80.5	44.7	143.0	68.0	38.6	75.0	95.4	46.4	42.3	81.4	82.6	111.4	66.1	82.0	50.2	82.0	97.3	56.2	107.0	46.4	71.4	143.1	129.8	90.6	60.2	45.2	43.7	66.1	106.8	116.8	37.5	43.7	57.0	62.2	70.4	85.9	89.8	112.6	49.9	157.4	170.0	61.7	150.1	65.6	30.4	36.0	19.0	21.4	48.4	24.0	45.2	31.9	28.0	41.9	41.4	37.4	29.7	5.1	23.5	50.8	42.2	40.4	32.4	19.6	22.0	21.2	26.1	20.1	21.9	19.7	19.6	20.9	20.5	21.7	21.2	17.3	22.4	15.0	7.2	17.5	7.1	20.3	67.4	11.4	21.9	17.0	20.1	135.9	18.6	42.2	18.4	31.3	49.2	15.0	46.7	97.8	42.0	3.7	22.0	28.3	19.2	26.5	35.1	11.6	43.0	49.7	19.8	23.4	22.1	21.0	21.9	15.7	52.9	65.3	23.5	12.7	31.4	48.8	23.8	6.1	5.0	12.8	23.7	10.6	12.2	32.1	21.5	19.6	5.0	11.5	41.8	29.5	17.7	29.5	17.3	52.6	82.8	24.9	25.4	26.3	17.2	47.2	14.6	26.3	29.0	8.5	27.0	14.6	38.1	56.3	25.2
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798385-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 472.3;Late spermatids: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	46.2	60.4	35.6	24.7	36.9	19.2	42.1	40.9	44.2	31.5	36.3	49.6	27.9	38.6	26.3	51.1	32.3	22.0	77.3	36.6	38.4	70.4	76.1	28.6	30.1	37.8	36.9	35.1	44.4	34.6	29.1	21.8	38.4	44.0	20.0	22.6	36.5	21.6	140.2	39.3	33.7	26.9	38.3	34.3	44.9	97.4	38.3	29.1	27.4	86.1	25.9	38.8	34.2	38.3	93.3	134.9	61.7	116.9	111.3	91.2	80.9	79.4	69.4	92.7	88.2	98.4	73.4	124.2	140.2	85.7	136.1	99.1	139.9	130.9	66.8	136.1	155.8	60.2	285.1	158.4	142.0	78.9	45.5	80.9	98.9	103.6	133.4	80.8	91.1	72.3	93.4	77.9	133.6	169.4	93.2	177.5	60.1	102.2	164.0	73.8	46.0	149.6	84.6	74.9	68.5	46.8	172.6	133.1	89.8	56.3	78.2	84.5	55.5	79.9	87.1	54.7	89.4	74.0	100.3	167.4	100.4	144.5	111.3	88.4	103.2	68.6	90.6	104.8	109.6	132.6	101.5	111.1	127.3	103.3	89.1	106.3	29.7	101.7	92.9	476.0	143.0	142.0	35.6	36.9	40.9	44.2	36.6	38.4	37.8	36.9	38.4	38.3	38.3	38.3	52.6	32.1	29.0	6.8	37.6	106.0	108.8	150.2	89.4	23.0	61.5	93.2	163.1	50.1	83.6	58.8	6.2	93.4	66.0	47.3	307.2	84.1	472.3	45.4	63.9	63.7	26.4	50.9	7.9	75.0	74.0	62.7	35.2	33.1	27.9	46.2	35.7	118.2	88.2	15.2	7.9	53.8	107.8	43.0	52.4	471.3	74.9	32.0	60.5	2.8	62.5	76.0	70.0	7.1	9.6	92.1	58.7	59.8	45.6	148.8	79.2	199.6	63.2	31.2	65.7	51.1	68.6	188.6	76.2	92.4	124.9	87.4	37.3	79.8	65.7	112.6
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	44.7	73.8	28.6	32.4	30.6	67.4	41.5	35.5	37.2	36.1	42.7	50.7	51.5	34.7	26.9	65.8	38.2	25.5	86.3	31.5	29.8	55.4	108.1	30.2	41.1	32.5	30.3	41.0	67.7	47.2	20.8	31.5	33.2	33.8	53.5	21.8	41.3	29.8	167.9	56.2	41.0	41.6	27.4	34.6	49.2	31.4	30.8	41.2	28.5	154.2	51.3	37.9	40.5	28.7	168.3	94.9	84.6	114.5	83.4	110.9	150.5	111.2	103.5	194.0	167.7	190.7	75.4	226.1	98.2	125.3	184.8	131.6	168.2	164.6	150.6	111.1	211.7	194.8	186.9	194.8	142.9	233.3	87.1	123.2	138.7	201.8	156.5	108.7	176.1	174.2	219.2	66.1	140.2	123.3	161.7	226.4	173.5	134.4	208.2	175.3	171.7	191.6	110.8	123.4	166.3	77.6	153.8	261.4	214.0	110.6	113.2	260.7	88.5	123.6	112.2	157.7	227.1	83.1	126.0	175.5	161.1	234.2	119.9	53.0	103.4	45.4	67.5	91.8	79.1	120.4	81.9	76.1	120.4	105.1	82.0	72.8	5.6	94.0	88.7	101.5	116.4	126.6	28.6	30.6	35.5	37.2	31.5	29.8	32.5	30.3	33.2	27.4	30.8	28.7	24.0	22.4	18.7	3.9	33.4	34.7	43.8	84.6	45.5	8.9	46.3	57.0	71.3	55.8	43.1	18.4	2.1	118.0	15.5	36.6	80.3	81.2	31.0	25.7	23.2	30.3	33.1	103.3	7.5	96.3	145.8	37.3	41.8	33.1	14.5	40.6	37.5	156.5	87.0	6.7	8.4	53.0	52.9	43.6	25.6	57.5	26.1	30.9	23.2	4.7	53.1	9.2	24.7	4.5	5.4	69.0	41.1	28.6	72.2	54.2	73.8	105.2	29.4	8.7	13.1	28.8	34.3	23.6	50.4	79.6	37.4	73.9	24.5	57.2	86.0	55.2
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898644-75905093	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.7;Gastric mucus-secreting cells: 35.2;Plasma cells: 60.1;Squamous epithelial cells: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (9.21e-5)"	23.3	34.7	37.5	16.3	37.4	21.9	22.8	39.7	48.9	20.2	37.8	31.1	26.8	24.0	14.4	30.0	30.6	14.6	51.5	37.7	38.2	31.3	46.8	18.2	23.8	39.4	37.6	22.3	36.8	28.7	19.6	17.3	39.8	22.6	19.2	6.7	36.6	26.2	103.2	26.9	21.9	20.3	38.1	22.5	28.6	25.3	40.4	23.8	20.6	84.7	22.4	25.9	21.0	38.6	82.2	114.2	28.3	39.2	32.5	26.5	86.5	26.4	44.5	96.3	69.5	134.4	49.3	72.7	31.2	45.9	55.1	59.1	79.2	71.1	27.3	24.0	130.5	51.0	39.9	133.7	72.0	69.5	48.6	36.6	77.3	66.8	52.4	29.3	92.6	89.7	64.6	45.6	36.6	163.0	92.9	75.1	33.6	101.8	97.2	69.1	74.7	92.3	76.3	51.0	48.6	51.4	45.3	121.3	104.5	26.1	112.4	74.4	26.3	45.8	67.2	38.6	75.4	51.1	32.1	24.7	50.0	57.1	41.3	24.4	74.1	37.9	84.2	80.8	84.0	101.8	86.0	79.1	106.7	113.7	84.8	81.7	7.0	95.7	69.1	78.1	93.7	83.6	37.5	37.4	39.7	48.9	37.7	38.2	39.4	37.6	39.8	38.1	40.4	38.6	1.7	19.2	7.3	14.7	19.3	1.5	0.8	2.7	34.7	1.0	2.4	1.1	2.3	0.0	5.5	3.7	0.0	5.1	6.6	11.4	3.9	23.8	1.1	2.2	1.8	4.7	10.3	20.2	11.9	21.4	3.7	8.1	35.2	1.8	3.8	1.0	2.5	2.4	3.3	1.7	13.2	13.9	2.0	0.8	1.9	1.9	3.1	6.1	7.2	5.6	14.2	0.9	5.2	7.5	15.7	19.2	17.9	3.0	60.1	1.3	16.3	5.6	9.8	2.9	0.0	0.9	8.3	1.9	1.9	46.2	1.4	3.4	13.6	1.2	20.9	0.8
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.5;Spermatocytes: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	23.1	35.6	18.2	19.7	19.6	22.7	26.7	22.1	28.7	16.7	18.4	29.2	25.5	18.0	41.7	26.5	20.4	13.5	51.4	18.3	19.2	40.4	55.3	15.3	34.2	18.7	18.1	17.6	25.2	71.0	13.4	26.2	19.8	20.0	32.1	21.5	21.8	17.8	58.6	20.3	23.1	22.0	19.0	17.6	22.9	54.7	18.2	24.9	20.1	56.7	37.3	22.3	18.8	21.6	89.6	43.0	60.1	38.1	29.7	42.9	92.3	56.1	50.0	77.0	64.7	85.2	49.2	97.9	30.9	35.4	69.8	25.5	128.5	76.4	85.9	49.1	66.3	100.1	43.0	91.4	34.6	102.4	31.7	34.8	66.7	76.3	62.2	42.7	58.2	99.6	112.3	78.4	77.1	56.0	67.5	55.5	95.6	88.9	65.4	77.8	97.0	103.1	80.6	35.7	37.9	36.3	51.6	94.5	76.3	42.3	68.3	57.6	36.4	40.8	61.0	43.9	69.6	54.9	74.6	121.9	61.2	109.1	62.5	41.9	16.9	20.7	37.0	30.3	46.9	62.0	45.0	42.3	31.0	49.1	43.9	39.3	2.8	36.7	21.6	43.2	56.4	18.6	18.2	19.6	22.1	28.7	18.3	19.2	18.7	18.1	19.8	19.0	18.2	21.6	18.3	25.6	10.5	9.8	17.6	20.0	20.3	71.0	7.4	20.4	14.0	23.5	78.2	10.0	36.2	25.8	10.4	46.8	14.1	8.7	31.3	36.0	241.5	20.9	12.7	22.2	7.8	22.3	11.4	33.8	41.7	19.4	7.1	11.8	15.2	11.3	18.9	19.8	30.8	10.1	11.7	11.4	30.5	10.6	15.7	37.0	14.9	11.3	19.6	9.4	17.1	19.0	11.3	9.5	13.2	26.5	9.3	23.3	13.6	13.2	20.4	46.8	41.8	15.0	46.0	18.1	25.4	103.0	29.4	10.7	16.9	36.9	14.9	25.7	20.1	17.3
MRPL4	CGI-28	ENSG00000105364	"Mitochondrial ribosomal protein L4"	Q9BYD3	19	10251901-10260055	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 1034.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051261	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051261: AB_2681413"	"unprognostic (3.33e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.15e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	42.5	65.9	35.6	27.6	36.4	37.5	40.2	37.2	51.2	36.3	33.4	49.3	33.1	41.0	8.7	73.2	37.3	12.2	83.6	35.4	35.4	54.6	90.9	31.0	30.8	39.4	35.1	49.9	31.8	25.9	35.7	21.8	39.3	38.9	13.4	8.7	38.3	21.1	79.1	62.0	40.5	14.9	33.1	46.5	45.1	31.4	37.2	19.5	40.4	49.3	19.4	45.4	42.8	37.2	146.6	81.9	34.4	95.2	26.9	35.6	76.0	66.3	41.4	86.7	70.6	138.1	55.2	215.6	148.5	36.5	51.3	128.0	71.6	93.2	26.6	80.4	302.6	181.0	62.6	136.4	80.9	136.1	96.7	46.5	63.1	58.7	54.2	27.2	53.4	97.8	155.7	100.8	33.7	213.0	189.6	1034.0	98.3	91.4	300.4	140.3	51.1	219.8	53.2	89.1	85.6	75.4	56.6	124.2	104.6	16.5	67.3	90.4	71.2	83.7	75.3	182.3	134.8	148.5	189.7	218.2	72.7	189.2	74.0	6.4	53.7	17.5	35.1	74.0	38.2	36.9	34.4	39.5	83.2	41.1	31.1	31.4	4.9	47.4	60.1	71.7	43.2	36.8	35.6	36.4	37.2	51.2	35.4	35.4	39.4	35.1	39.3	33.1	37.2	37.2	46.9	16.0	27.4	11.4	53.0	86.2	60.4	115.9	76.8	50.4	58.5	85.0	12.9	44.3	49.8	40.5	8.4	187.6	43.0	57.8	144.8	74.0	25.4	44.0	52.2	39.7	44.9	37.0	17.5	77.7	76.6	46.8	63.7	45.3	26.0	81.6	25.7	80.5	95.0	32.0	17.6	70.1	52.9	36.1	38.7	10.8	51.0	42.4	46.2	8.4	58.0	45.0	45.3	10.6	12.3	84.8	39.7	50.4	79.4	79.7	59.6	133.5	27.6	35.8	13.1	39.8	61.4	38.7	42.2	120.4	98.7	149.4	42.5	141.3	104.9	78.0
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19432545-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	39.4	54.4	59.9	26.1	61.6	28.3	47.6	63.9	79.7	50.0	60.3	33.6	26.1	31.3	77.4	35.6	54.8	31.5	100.7	59.0	62.3	69.1	118.8	28.9	35.5	62.5	60.6	44.5	57.1	85.0	11.2	30.7	62.5	46.4	35.9	35.0	72.1	43.0	135.8	29.2	24.7	32.6	63.6	27.1	33.8	31.4	61.7	29.7	79.0	142.0	40.9	36.4	7.0	65.0	84.8	83.8	26.9	64.0	111.5	98.8	45.4	62.1	95.6	116.9	133.6	105.5	49.0	73.2	71.0	93.7	67.8	82.9	118.8	141.2	122.6	69.8	129.7	72.8	76.0	184.4	158.1	117.7	46.1	102.3	123.6	101.1	179.8	77.3	95.6	35.0	265.8	91.2	127.5	106.9	44.9	77.6	22.7	190.2	100.3	49.7	110.6	44.2	135.9	67.9	45.6	48.3	100.7	94.0	159.7	60.2	80.2	52.9	60.6	118.6	127.3	41.6	64.0	78.1	115.7	147.6	79.2	71.6	99.5	45.1	88.3	76.6	71.7	108.9	82.7	162.7	72.4	74.6	100.1	155.6	85.9	75.6	10.4	90.5	90.2	106.5	91.9	103.5	59.9	61.6	63.9	79.7	59.0	62.3	62.5	60.6	62.5	63.6	61.7	65.0	43.3	44.8	35.3	8.8	53.8	40.4	73.3	181.9	52.3	31.0	59.4	85.9	86.1	71.4	106.6	47.8	12.5	129.6	42.9	35.2	260.3	83.8	114.9	104.4	61.9	40.3	34.9	27.1	3.6	97.9	128.9	55.9	32.1	46.1	33.7	44.2	40.0	146.3	135.6	21.9	5.8	47.8	91.6	43.6	40.0	152.4	72.4	42.9	85.4	4.7	73.9	120.4	37.0	3.5	12.0	73.9	48.6	72.2	92.6	53.6	89.8	254.9	163.5	50.3	46.0	53.9	74.3	82.9	72.1	64.8	38.5	62.9	35.1	103.8	49.3	52.2
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551879-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.5;skeletal muscle: 407.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 909.5;Distal tubular cells: 972.4;Hepatocytes: 856.2;Late spermatids: 839.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 503.2;PC-3: 471.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	83.7	74.7	222.0	22.9	206.1	26.1	57.4	203.8	340.5	53.9	169.2	66.4	45.4	45.9	8.4	42.4	46.6	14.8	325.4	210.3	190.6	79.8	157.8	42.1	24.6	209.0	190.7	61.1	44.8	42.2	55.1	12.2	187.9	113.0	17.4	9.9	69.6	26.2	407.5	58.6	56.8	12.2	183.4	54.2	79.1	40.3	227.1	16.1	44.9	129.4	13.1	59.4	45.4	188.9	93.7	165.9	25.5	61.9	40.7	35.5	122.1	112.8	33.1	59.1	47.4	122.6	49.6	71.0	148.4	31.5	78.0	186.5	37.4	60.0	6.4	97.9	208.6	62.0	91.9	193.6	92.8	101.1	211.4	67.3	85.4	51.5	18.2	23.4	55.4	58.7	147.8	26.8	32.6	503.2	33.7	337.6	94.6	118.0	471.6	40.1	44.0	95.9	50.5	67.7	85.7	88.6	78.0	138.6	194.5	15.2	124.0	91.5	95.4	93.1	121.3	162.9	153.4	78.4	146.2	133.7	101.8	104.4	70.9	425.2	305.5	251.8	225.6	272.9	211.5	313.8	235.0	257.0	260.3	249.7	221.0	206.2	38.3	180.8	254.2	422.6	332.2	350.3	222.0	206.1	203.8	340.5	210.3	190.6	209.0	190.7	187.9	183.4	227.1	188.9	99.0	28.9	33.6	59.7	90.7	140.1	138.3	239.3	121.3	52.4	193.9	221.5	909.5	178.7	121.1	263.0	10.4	115.9	89.7	670.5	972.4	157.8	299.6	165.2	136.0	103.1	268.5	66.0	30.6	192.1	147.7	127.1	192.7	136.7	54.0	85.4	102.1	856.2	244.8	28.6	47.7	332.9	229.9	122.7	115.4	839.0	121.8	106.0	224.1	15.9	162.1	102.7	95.8	8.0	31.1	222.8	446.5	104.6	146.9	223.1	458.4	657.6	134.9	47.5	111.7	66.8	143.8	112.6	79.7	175.6	166.1	82.2	112.8	249.9	348.8	176.8
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467514-93516214	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	15.7	26.7	6.8	8.8	8.3	13.9	14.9	11.6	9.0	15.7	9.9	16.9	13.5	14.5	10.9	19.3	14.2	8.1	17.2	7.9	9.8	21.4	20.4	12.8	12.2	7.5	8.3	14.3	13.8	23.4	15.4	11.3	8.6	15.9	16.8	6.1	14.0	10.5	12.0	14.9	13.5	13.8	6.3	10.8	15.9	14.4	7.7	19.2	14.0	14.4	14.9	16.6	16.6	11.7	30.5	42.3	53.5	33.8	25.5	36.8	36.5	43.0	33.0	45.4	32.9	51.8	11.6	49.9	16.3	32.1	29.8	22.4	61.5	48.0	74.3	50.6	40.5	45.0	26.8	61.9	41.9	74.0	21.3	31.0	44.4	48.4	60.5	42.2	46.5	53.0	61.3	19.0	54.0	36.1	67.2	49.3	65.1	52.8	55.9	48.1	25.5	40.4	49.2	77.0	39.8	32.0	36.0	39.3	41.3	42.0	35.5	33.4	29.1	26.5	22.1	21.3	49.6	31.2	49.0	46.1	12.2	45.7	41.5	21.0	14.4	20.4	14.7	21.2	18.9	25.9	19.4	16.6	16.4	23.7	21.3	21.8	8.3	27.0	20.4	11.2	28.1	16.3	6.8	8.3	11.6	9.0	7.9	9.8	7.5	8.3	8.6	6.3	7.7	11.7	55.0	28.9	35.5	13.4	59.9	67.3	97.6	131.6	50.1	34.9	48.7	38.1	82.6	42.9	82.5	46.0	60.5	96.7	41.4	38.2	213.2	86.2	397.6	87.5	61.3	48.7	93.2	66.7	16.2	77.4	133.1	54.5	48.9	48.6	58.4	50.7	32.9	48.4	54.0	47.1	22.1	66.8	107.8	34.1	47.9	165.0	51.6	32.6	60.5	6.5	35.2	22.1	54.6	20.1	20.3	89.8	49.9	56.1	59.8	109.8	44.9	146.5	96.7	41.6	52.6	42.3	59.8	230.5	66.6	59.7	75.0	95.5	51.7	100.1	82.1	115.4
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957463-223967714	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: AB_2675863"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.2	26.9	16.2	14.9	17.4	45.4	17.6	17.1	20.3	12.9	19.0	21.8	19.3	12.7	13.2	18.0	16.3	17.5	33.8	17.1	18.8	37.4	39.3	12.5	32.5	16.2	16.1	15.2	17.4	19.7	11.6	20.0	16.8	15.3	22.9	10.0	16.1	13.2	42.6	15.7	17.9	14.4	17.5	17.8	16.2	18.2	17.8	21.4	16.2	40.6	26.5	17.1	11.5	17.9	27.3	22.6	33.1	38.3	30.6	36.1	52.4	30.0	33.6	48.0	50.4	81.0	33.4	41.1	31.9	26.0	43.9	35.3	54.5	41.5	44.1	39.0	38.7	45.0	24.0	64.4	44.9	50.0	33.1	42.5	50.9	29.1	38.7	40.4	47.8	41.4	43.7	31.6	38.9	31.9	37.8	62.9	49.4	54.8	23.6	43.8	40.6	25.5	64.3	22.8	45.0	25.7	22.0	49.0	74.8	48.6	41.4	71.2	31.5	31.8	24.7	27.3	24.5	34.5	25.9	58.7	32.2	47.4	35.6	55.7	44.5	35.3	28.5	44.8	36.5	45.9	30.4	34.4	42.2	42.3	36.5	32.3	58.1	33.8	41.2	33.9	33.7	36.3	16.2	17.4	17.1	20.3	17.1	18.8	16.2	16.1	16.8	17.5	17.8	17.9	11.7	6.4	13.1	3.9	31.3	17.8	27.4	52.6	23.9	17.3	15.6	17.4	10.4	27.1	30.0	27.6	0.0	95.3	29.5	25.0	82.2	45.3	8.1	17.1	22.3	20.7	13.1	26.5	6.5	35.1	64.8	24.9	14.3	26.6	18.4	22.0	20.7	51.5	46.6	11.8	6.9	22.0	48.8	33.3	14.5	7.9	18.0	25.4	33.8	4.7	35.3	16.5	20.6	7.5	9.7	37.2	18.1	18.0	24.8	21.7	23.6	106.1	25.6	12.7	19.7	14.2	18.8	41.1	56.3	22.8	16.6	48.7	20.9	40.9	28.3	37.6
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 8.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 35.7;Daudi: 80.9;K-562: 57.0;REH: 43.2;RPMI-8226: 34.4;RT4: 33.9;U-266/84: 52.1;U-698: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	24.0	26.7	1.5	2.2	1.9	1.9	24.1	1.6	8.4	21.1	2.2	24.6	0.0	21.4	0.0	25.3	19.8	4.0	32.1	1.6	1.6	26.0	30.7	15.2	8.0	1.7	1.6	28.3	36.8	9.0	13.1	1.7	1.7	18.0	5.7	1.3	22.4	0.0	61.8	26.5	19.6	0.7	1.5	16.3	30.0	9.5	1.6	2.6	18.2	0.0	6.9	22.1	20.1	1.6	0.0	0.5	35.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	26.8	80.9	0.2	0.0	24.2	0.5	0.2	0.0	0.1	0.0	0.3	31.1	0.0	2.1	12.7	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	57.0	0.0	0.2	0.0	23.1	0.0	0.3	0.1	0.0	43.2	0.2	34.4	0.0	33.9	0.1	0.2	0.2	0.6	0.2	0.1	0.1	0.2	0.5	15.1	0.1	0.0	0.3	23.2	52.1	56.9	0.1	0.0	0.4	0.6	6.7	2.2	5.3	8.2	6.4	7.6	7.7	4.1	11.3	6.8	9.8	6.6	0.2	9.8	2.3	4.8	6.6	6.3	1.5	1.9	1.6	8.4	1.6	1.6	1.7	1.6	1.7	1.5	1.6	1.6	20.4	12.8	12.1	6.8	23.8	30.2	39.3	54.6	42.7	10.9	41.3	37.7	46.5	32.9	23.9	25.8	8.4	69.3	16.3	11.3	60.7	41.5	18.3	21.6	25.6	26.9	16.3	45.9	10.4	37.5	67.7	25.1	24.5	21.1	23.5	31.4	22.5	30.4	42.6	16.8	12.0	27.4	34.6	39.1	21.1	15.0	20.8	22.2	19.6	1.9	43.8	13.0	22.6	7.5	9.2	29.6	15.5	16.6	23.7	28.8	32.0	64.0	21.6	11.1	6.6	28.4	25.2	30.6	18.0	31.9	32.4	71.1	19.3	42.6	41.8	33.3
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459477-88467390	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Proximal tubular cells: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050166, HPA076046"	Approved		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039, HPA076046: "	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	25.1	51.5	20.3	12.9	21.7	11.3	22.7	23.7	25.4	14.6	22.0	24.2	20.0	17.1	18.2	26.4	17.1	13.0	76.1	20.8	23.6	34.7	70.9	12.7	20.9	23.1	22.1	17.2	16.2	24.6	16.2	19.6	23.6	14.9	23.6	16.8	17.1	15.2	73.3	17.9	19.7	18.4	21.7	19.1	24.8	28.1	22.7	18.9	17.2	84.6	20.3	20.7	16.2	22.6	27.8	87.2	27.2	29.8	38.0	28.6	51.5	38.6	35.5	56.9	50.4	108.6	59.3	64.9	38.6	34.9	51.0	65.9	107.4	47.4	44.8	26.3	86.4	53.6	61.5	114.3	24.6	54.2	40.4	32.7	56.6	42.8	28.7	29.0	50.2	63.2	60.7	26.6	42.7	59.6	44.2	68.4	43.5	50.5	52.9	51.9	37.9	49.2	44.5	88.2	42.1	26.5	36.6	57.7	81.8	44.6	64.8	65.7	31.3	44.0	41.9	23.3	56.4	24.2	55.7	53.0	48.5	58.1	34.2	27.1	45.5	33.7	60.0	60.5	69.6	78.8	63.3	58.7	58.7	69.5	69.5	61.6	7.9	62.9	45.0	50.5	68.0	61.5	20.3	21.7	23.7	25.4	20.8	23.6	23.1	22.1	23.6	21.7	22.7	22.6	18.9	0.0	10.3	5.2	21.0	13.8	22.4	59.8	9.6	21.2	17.3	21.3	70.4	37.1	32.3	36.8	27.1	94.3	10.7	20.4	119.3	35.0	67.1	20.0	16.6	18.4	28.3	17.7	4.2	38.0	42.1	19.2	19.9	19.5	22.2	25.8	17.2	105.0	35.6	15.2	5.9	20.6	44.7	13.4	5.5	16.3	14.3	10.8	7.2	3.7	42.1	25.1	20.6	4.5	6.1	31.7	18.4	18.8	17.3	21.9	32.1	133.6	26.2	28.4	26.3	19.5	25.5	55.3	27.4	27.1	23.3	80.7	18.5	66.9	36.1	29.4
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604649	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.7;Spermatocytes: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	27.2	34.8	30.6	24.0	31.7	48.8	27.2	34.2	41.1	19.4	34.2	32.1	23.7	23.0	22.8	31.8	18.9	18.5	54.9	29.4	34.7	44.4	35.5	20.1	30.0	32.0	31.8	16.6	17.4	33.9	24.0	22.2	32.6	20.6	31.8	26.6	21.1	18.9	52.5	21.5	22.6	24.7	33.3	24.3	26.2	53.1	32.6	33.3	21.0	56.9	30.4	32.0	21.7	34.2	128.6	48.6	83.0	76.7	51.5	53.5	95.2	73.2	65.1	112.3	93.2	198.6	51.8	104.7	140.6	62.5	137.2	94.5	103.5	76.9	120.5	121.0	90.9	99.8	46.1	112.5	99.8	182.2	54.2	49.6	65.7	83.4	84.7	53.1	77.2	95.9	59.5	81.4	88.1	98.9	98.4	168.4	144.3	115.4	114.6	102.7	81.1	175.3	120.4	79.6	71.8	83.5	80.7	128.6	151.2	61.9	198.6	136.6	61.6	60.7	87.4	77.1	204.5	102.1	182.4	229.3	70.7	147.4	75.8	38.2	32.4	44.2	31.7	43.8	32.2	35.1	35.1	34.7	48.4	31.8	30.4	31.7	8.5	41.5	54.4	41.9	48.9	35.8	30.6	31.7	34.2	41.1	29.4	34.7	32.0	31.8	32.6	33.3	32.6	34.2	45.3	22.4	21.7	5.5	51.4	74.9	82.0	179.7	38.7	20.2	36.4	33.4	89.7	54.3	78.6	57.0	10.4	100.0	61.2	46.3	258.2	112.3	399.7	72.8	56.0	55.5	54.9	62.9	7.1	115.9	109.6	51.8	36.2	50.0	56.4	34.0	44.3	62.5	99.3	10.1	9.2	52.8	105.8	42.4	55.7	95.4	42.9	53.5	48.0	4.7	80.3	43.4	39.1	7.1	12.4	118.7	53.6	49.2	54.6	72.6	45.2	201.7	85.5	26.0	59.2	57.9	68.2	301.2	54.0	52.2	70.5	104.1	57.8	102.3	71.9	83.8
MRPL48	CGI-118	ENSG00000175581	"Mitochondrial ribosomal protein L48"	Q96GC5	11	73787872-73865133	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040241, HPA040864"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA040241: AB_2676899, HPA040864: AB_2677175"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.30e-1)"	10.8	17.4	30.3	10.2	33.8	12.1	13.3	33.6	50.0	16.8	31.1	17.5	14.1	12.3	14.8	16.6	13.6	5.6	22.5	30.0	31.9	24.2	21.2	10.2	12.8	35.5	32.3	14.2	19.3	21.2	10.9	10.6	36.5	14.6	15.8	11.5	13.9	10.0	28.6	12.5	14.8	8.1	31.6	14.5	15.1	5.8	31.9	23.2	14.1	26.9	14.4	12.3	14.6	41.5	29.6	33.2	36.7	20.8	20.9	16.8	16.2	18.0	20.3	27.9	23.0	63.9	26.6	71.0	35.7	25.6	18.7	35.6	37.3	37.7	24.6	28.3	40.9	36.3	33.3	45.4	24.5	61.5	24.9	14.1	41.0	23.8	33.0	24.5	39.1	40.5	46.9	37.7	28.1	47.1	72.9	58.9	27.5	95.5	35.0	32.1	43.8	81.3	31.0	35.3	28.9	28.0	14.2	48.8	156.9	17.0	31.4	38.5	13.6	21.6	27.9	15.3	24.2	18.1	39.3	103.1	9.5	39.8	18.0	40.7	23.6	12.5	25.8	30.4	27.3	27.5	30.1	31.6	33.6	29.8	32.3	31.3	4.1	28.1	28.1	37.6	35.3	29.5	30.3	33.8	33.6	50.0	30.0	31.9	35.5	32.3	36.5	31.6	31.9	41.5	17.3	9.6	20.5	11.1	29.4	19.2	35.3	66.7	25.6	10.2	28.5	35.1	33.0	21.5	33.9	25.8	4.2	92.0	27.6	28.3	88.0	37.1	6.3	31.0	21.0	18.9	24.1	36.6	16.1	39.7	73.5	22.5	19.9	22.9	21.0	32.5	16.4	28.0	42.9	15.2	22.6	38.0	42.7	25.4	19.4	16.5	18.3	20.5	44.4	3.7	29.4	16.6	22.6	24.6	45.2	30.9	36.1	18.0	30.0	22.0	63.4	76.5	39.1	8.5	0.0	22.5	29.7	18.6	26.3	38.2	19.7	59.8	26.8	26.6	49.1	37.1
MRPL49	"C11orf4, L49mt, NOF, NOF1"	ENSG00000149792	"Mitochondrial ribosomal protein L49"	Q13405	11	65122183-65127371	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 93.9;Syncytiotrophoblasts: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046778	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046778: AB_2679802"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.21e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.22e-15)"	"unprognostic (9.09e-3)"	"unprognostic (1.12e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.45e-3)"	23.1	87.3	25.5	21.9	26.5	26.7	35.2	24.1	27.5	29.4	29.5	33.6	28.1	28.3	41.8	43.0	42.1	21.3	32.4	26.6	29.2	55.1	50.9	28.1	30.9	26.3	25.7	42.8	26.9	42.8	36.0	27.0	26.2	35.4	34.8	16.9	29.2	39.4	38.0	41.6	28.3	30.0	25.3	26.0	29.1	18.1	29.0	33.9	45.8	36.4	44.1	31.1	28.5	23.6	68.7	64.0	48.0	44.0	39.7	26.4	47.9	49.4	73.8	98.9	70.2	77.4	95.2	68.7	70.9	56.2	93.6	69.3	97.7	71.1	78.9	57.5	33.5	64.0	43.3	62.0	63.7	65.8	54.6	43.3	61.7	81.6	119.7	54.6	61.2	82.4	82.7	40.1	59.2	99.4	82.3	70.9	79.8	77.9	87.5	71.2	46.0	91.0	81.5	51.9	69.3	48.9	76.7	98.2	89.3	38.1	174.4	51.1	31.2	41.7	62.5	61.6	46.5	75.5	110.0	141.4	57.2	44.7	72.7	133.5	39.3	78.4	68.2	39.5	77.8	77.9	73.6	83.8	52.1	74.8	81.2	69.3	32.7	95.8	56.8	50.2	74.8	96.2	25.5	26.5	24.1	27.5	26.6	29.2	26.3	25.7	26.2	25.3	29.0	23.6	19.8	16.0	15.9	2.3	20.6	11.1	22.8	21.1	13.1	15.3	22.7	21.6	16.6	20.0	16.6	12.9	10.4	60.4	21.6	23.1	93.9	31.6	1.0	17.4	11.2	16.0	22.7	44.8	5.3	20.3	51.1	14.9	10.2	16.2	12.6	21.6	12.8	17.9	21.5	11.8	4.8	23.5	18.3	6.5	9.9	3.4	14.6	12.4	23.2	1.9	35.4	31.1	13.4	0.5	4.3	28.2	16.6	24.5	24.3	20.8	22.3	49.2	28.6	17.9	6.6	10.4	24.6	5.9	15.6	12.8	16.1	111.0	24.6	77.9	22.9	21.4
MRPL50	"FLJ20493, MRP-L50"	ENSG00000136897	"Mitochondrial ribosomal protein L50"	Q8N5N7	9	101387633-101398618	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 203.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022925	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA022925: AB_1854117"	"unprognostic (6.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.21e-10)"	"unprognostic (7.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	9.6	16.0	10.6	8.3	11.6	4.0	11.8	15.8	13.5	7.8	9.7	8.1	8.6	7.8	12.7	7.1	8.0	7.2	14.5	11.1	11.2	13.3	14.0	7.1	11.0	10.0	11.1	11.9	11.9	13.1	8.9	8.2	10.3	9.8	8.6	19.0	8.4	8.0	10.9	5.7	8.3	7.2	10.8	9.4	10.1	6.5	10.8	8.6	9.1	14.9	11.6	10.3	5.7	11.5	12.6	14.9	23.3	13.6	16.0	17.0	16.5	16.0	15.2	17.3	14.6	20.4	12.3	30.6	10.1	12.5	21.3	28.4	23.0	19.2	18.6	18.6	13.7	15.0	16.4	59.0	17.2	27.5	13.9	14.0	21.9	14.0	25.5	13.0	15.9	15.9	32.1	16.1	17.8	20.7	17.0	20.3	25.6	73.9	20.2	17.1	33.1	19.2	25.8	13.7	22.4	16.6	17.0	16.9	18.5	15.9	11.9	17.0	13.2	11.8	17.6	20.7	15.4	12.0	38.0	12.8	15.0	16.0	16.9	9.8	12.5	9.9	13.9	15.2	16.8	20.6	19.3	16.0	16.3	19.5	22.4	20.3	2.2	14.7	15.9	13.0	23.1	16.8	10.6	11.6	15.8	13.5	11.1	11.2	10.0	11.1	10.3	10.8	10.8	11.5	33.0	16.0	20.8	11.4	46.4	90.5	133.6	203.4	51.2	19.1	31.0	31.9	76.0	35.8	86.9	57.0	12.5	74.8	29.3	15.3	152.6	66.8	10.4	31.4	33.6	41.0	19.8	30.1	12.5	69.4	73.8	46.9	23.4	25.7	44.5	24.0	32.2	43.9	51.9	5.0	15.1	28.0	162.8	25.9	50.6	7.4	34.2	28.3	30.2	5.6	32.1	21.9	27.8	8.0	17.2	66.8	32.7	40.6	39.4	112.8	26.4	186.5	67.4	18.2	46.0	37.6	52.4	44.7	39.3	41.6	99.3	76.5	43.2	63.1	34.3	130.4
MRPL51	"bMRP64, CDA09, HSPC241, MRP64"	ENSG00000111639	"Mitochondrial ribosomal protein L51"	Q4U2R6	12	6491886-6493841	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039923	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039923: AB_10795373"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.33e-2)"	95.7	128.2	151.3	77.1	158.1	88.1	83.2	161.6	239.9	88.4	151.8	119.2	65.5	80.2	99.3	146.1	82.4	49.4	252.5	151.0	159.2	157.9	158.5	75.9	104.5	158.5	155.3	78.9	119.7	128.2	109.3	70.0	158.6	105.8	91.5	64.4	87.0	63.7	262.7	93.2	85.9	70.9	157.3	99.6	112.3	233.3	156.2	131.4	90.6	240.5	126.7	104.2	90.7	165.5	263.4	286.8	334.5	244.1	235.8	212.8	390.6	187.7	222.5	277.1	258.1	398.4	325.4	376.3	124.4	278.2	330.2	220.8	272.4	298.1	409.8	456.3	294.7	256.3	415.2	340.8	217.7	352.4	206.2	205.7	237.2	251.1	331.4	357.9	265.4	291.0	186.1	114.0	356.2	374.3	356.7	463.3	707.1	471.1	287.1	248.2	384.5	264.8	232.6	319.7	126.4	222.2	320.9	355.8	305.4	662.7	107.6	323.7	218.1	226.0	318.5	188.8	406.3	109.0	177.7	850.0	279.8	243.3	305.6	224.5	202.0	231.8	181.6	196.4	206.8	229.3	193.2	201.4	234.6	211.9	196.4	201.4	77.5	203.3	197.8	318.4	234.4	294.0	151.3	158.1	161.6	239.9	151.0	159.2	158.5	155.3	158.6	157.3	156.2	165.5	98.5	105.8	77.4	11.4	113.8	136.1	167.4	410.5	131.5	47.1	180.4	265.8	302.6	178.7	195.4	171.0	12.5	277.1	111.8	126.2	469.5	239.1	950.6	159.7	159.1	129.5	149.9	152.5	9.6	277.8	404.4	146.6	65.7	122.2	92.6	202.3	144.2	374.1	263.9	43.7	10.0	188.3	244.1	147.6	117.9	523.6	153.1	109.4	193.9	10.3	301.6	133.8	121.5	7.1	16.1	247.4	160.3	147.8	171.9	250.0	153.9	538.2	157.5	47.5	111.7	132.7	155.7	534.2	195.4	188.4	157.0	215.5	98.1	244.4	221.2	182.8
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MRPL53		ENSG00000204822	"Mitochondrial ribosomal protein L53"	Q96EL3	2	74471982-74472687	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034612, HPA056185"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA034612: , HPA056185: AB_2683060"	"unprognostic (2.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.16e-8)"	"unprognostic (8.76e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.45e-2)"	60.9	82.9	68.8	46.8	72.2	61.8	38.9	77.0	98.9	31.3	79.2	41.5	48.0	28.7	39.1	41.0	50.2	34.0	114.4	67.1	72.3	54.5	65.1	34.2	78.4	72.3	69.3	61.5	118.0	72.1	35.1	34.8	72.7	46.0	20.3	27.1	107.1	36.2	169.7	27.3	45.9	24.4	74.2	54.7	55.0	23.1	70.2	50.3	47.1	89.0	42.3	44.7	27.0	76.5	101.5	271.0	60.0	58.5	77.9	69.7	103.4	79.8	73.7	70.5	60.9	224.7	130.1	87.6	78.8	61.4	97.3	76.3	32.5	105.7	24.5	174.6	188.3	77.7	115.6	133.7	70.7	88.4	85.6	96.7	75.1	90.4	59.0	82.3	75.3	109.0	93.0	156.6	63.8	316.5	118.6	163.3	57.5	166.0	204.5	89.1	196.0	212.9	88.9	115.6	103.5	128.0	74.1	195.6	137.3	40.8	102.3	111.1	83.6	115.9	119.6	101.7	135.2	292.3	260.6	141.1	116.4	94.8	125.8	244.9	293.8	133.8	168.2	277.6	188.5	350.0	215.9	173.1	250.3	367.5	282.0	211.4	185.5	167.6	271.8	360.3	275.3	345.5	68.8	72.2	77.0	98.9	67.1	72.3	72.3	69.3	72.7	74.2	70.2	76.5	5.2	9.6	23.2	4.6	18.0	17.2	6.0	9.7	12.0	2.0	24.0	16.4	1.6	4.3	12.1	11.0	0.0	14.7	10.5	29.5	21.5	32.8	8.9	7.2	4.3	11.2	39.7	18.9	3.4	56.9	17.5	10.9	15.3	4.7	33.6	3.0	16.1	23.8	18.0	1.7	3.5	27.2	6.1	25.9	23.9	2.3	8.7	15.6	26.6	2.8	35.8	4.6	15.5	2.0	7.1	35.8	43.5	4.5	34.8	4.9	41.8	45.3	46.1	4.0	6.6	7.7	11.2	11.2	6.8	16.6	25.1	15.7	14.6	3.3	21.7	6.9
MRPL54		ENSG00000183617	"Mitochondrial ribosomal protein L54"	Q6P161	19	3762682-3768575	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042117, HPA046767"	Uncertain		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA042117: AB_2677856, HPA046767: AB_2679795"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.54e-3)"	56.1	85.5	68.9	41.0	69.0	109.0	54.8	70.6	80.0	47.0	70.5	54.9	53.8	49.8	36.3	58.4	57.8	34.6	78.6	67.5	70.4	78.7	122.9	43.1	63.5	69.5	68.4	46.9	87.8	71.3	64.0	31.4	69.8	57.9	44.0	38.1	71.9	37.1	57.8	55.9	48.8	37.6	69.8	54.4	70.7	54.4	70.1	63.4	57.8	57.8	50.5	50.4	43.8	72.0	115.1	64.4	58.4	57.6	34.2	54.6	49.6	53.8	69.0	126.8	108.5	55.7	39.8	82.1	54.4	66.8	47.6	71.3	77.6	70.9	53.8	53.0	118.4	41.8	33.6	72.0	89.1	89.7	95.0	64.2	121.3	53.2	92.7	49.0	105.8	56.4	80.2	157.1	67.3	77.9	81.1	94.5	77.8	79.8	46.9	69.4	33.2	122.8	97.8	57.9	81.6	67.6	43.8	103.4	83.4	27.8	69.7	126.6	75.5	79.5	45.8	136.5	117.2	95.4	140.5	82.4	78.6	142.3	60.6	96.9	121.2	81.9	103.4	132.8	96.0	139.1	112.5	122.3	134.7	125.8	107.6	99.1	35.3	133.0	133.7	122.7	168.4	144.1	68.9	69.0	70.6	80.0	67.5	70.4	69.5	68.4	69.8	69.8	70.1	72.0	61.1	76.9	79.3	5.5	101.2	49.1	91.9	111.1	63.2	55.6	89.2	98.8	55.2	91.5	91.7	79.1	18.8	134.4	69.7	183.5	358.1	112.7	94.2	90.1	54.7	60.5	105.4	63.1	3.6	193.6	125.7	62.8	90.7	78.8	106.5	47.6	62.4	249.8	157.7	38.7	4.7	234.8	79.3	115.3	65.4	63.0	56.2	90.9	71.2	2.8	120.7	105.1	106.1	2.0	10.1	128.7	185.4	44.8	123.2	116.2	234.4	427.8	76.0	90.9	26.3	65.7	64.4	113.4	47.1	106.7	57.3	176.9	94.6	109.3	171.5	118.2
MRPL55		ENSG00000162910	"Mitochondrial ribosomal protein L55"	Q7Z7F7	1	228106679-228109312	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 249.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027641	Supported				"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027641: AB_10600825"	"unprognostic (4.84e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.03e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.15e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (5.54e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	42.4	59.7	50.9	14.9	51.8	49.9	43.5	54.3	67.1	38.8	44.4	48.2	24.5	38.2	16.8	41.6	38.5	16.5	75.2	52.0	54.6	57.7	93.2	33.7	21.8	56.0	52.1	38.8	47.2	28.2	52.3	14.2	53.5	48.2	7.8	8.0	43.5	23.7	76.1	42.4	35.6	12.1	52.1	40.3	48.8	41.3	53.6	15.9	43.3	20.6	10.9	40.5	34.6	55.0	59.8	89.3	18.7	34.2	21.5	23.6	75.7	40.0	21.4	43.5	36.6	90.3	56.1	46.2	82.4	27.6	22.5	50.1	18.5	43.6	10.4	39.7	202.3	21.3	68.9	100.9	36.1	56.1	23.3	26.5	35.3	39.1	21.5	17.8	35.5	70.7	54.7	48.6	20.5	69.2	66.5	84.6	63.1	58.6	249.7	58.4	36.7	124.1	27.0	31.4	49.2	49.2	33.1	100.4	75.1	6.4	84.4	50.4	30.7	36.3	41.0	69.7	78.0	42.9	58.3	57.9	60.5	47.9	73.5	62.5	107.6	83.6	86.8	113.5	104.3	121.0	99.2	95.8	107.3	152.1	101.9	108.1	67.9	94.1	96.3	147.8	128.7	104.3	50.9	51.8	54.3	67.1	52.0	54.6	56.0	52.1	53.5	52.1	53.6	55.0	41.6	44.8	59.4	9.1	58.9	76.3	71.5	131.8	44.3	35.9	108.1	112.3	93.1	87.2	82.0	93.8	8.4	142.0	50.4	80.7	236.7	70.2	121.0	44.6	43.2	55.7	78.2	57.4	12.0	94.5	127.2	59.3	37.2	46.1	48.1	53.5	73.2	262.4	124.3	23.5	10.4	105.1	105.8	64.5	128.9	216.3	77.6	54.9	72.9	3.7	98.6	68.7	70.0	4.5	8.3	87.0	69.8	70.0	79.3	74.7	190.3	270.1	73.6	40.7	78.9	46.5	69.8	77.4	80.9	59.4	97.0	110.5	50.6	57.4	94.1	76.1
MRPL57	MRP63	ENSG00000173141	"Mitochondrial ribosomal protein L57"	Q9BQC6	13	21176658-21179084	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 719.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039779, HPA059370"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039779: AB_10673362, HPA059370: AB_2683993"	"unprognostic (1.00e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.68e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.78e-2)"	13.6	27.0	16.0	8.4	16.1	11.0	13.9	16.8	18.3	12.1	15.3	17.2	10.8	12.9	11.7	17.6	13.4	5.2	28.1	16.7	20.5	24.7	29.1	11.7	8.8	16.8	17.0	16.1	16.9	15.3	27.9	7.1	16.9	17.9	6.8	15.5	14.9	8.4	38.8	14.9	13.7	5.6	16.3	14.8	16.2	11.8	17.3	17.0	16.4	18.3	6.6	14.8	12.4	16.5	16.9	30.3	20.8	19.0	15.6	12.8	21.9	20.0	12.4	18.5	13.9	39.6	30.6	9.7	22.7	12.5	14.5	28.7	18.3	19.0	13.9	25.8	30.8	44.2	21.3	45.3	23.2	24.6	21.3	13.2	20.8	14.8	13.9	11.2	17.9	39.0	19.5	12.4	13.2	59.3	53.7	64.8	15.1	54.8	35.0	32.1	31.4	17.2	23.1	20.3	41.4	19.4	16.2	20.1	31.2	14.0	20.2	22.8	12.6	9.6	17.9	20.5	17.9	17.2	14.9	17.7	8.6	28.5	24.6	51.1	70.4	56.3	49.8	59.0	56.4	63.1	62.4	53.2	64.0	60.5	69.6	55.6	10.4	54.5	50.4	102.2	70.2	72.4	16.0	16.1	16.8	18.3	16.7	20.5	16.8	17.0	16.9	16.3	17.3	16.5	93.3	80.1	124.4	12.1	95.4	0.0	107.2	0.0	84.2	88.3	172.1	195.7	495.7	140.2	56.3	176.6	45.9	233.6	118.8	171.7	508.7	159.8	256.0	188.6	98.8	91.6	149.5	165.6	16.8	245.1	205.0	94.2	116.2	107.6	72.2	104.5	117.8	478.4	231.4	77.4	21.3	218.9	0.0	126.6	0.0	341.6	115.2	104.1	0.0	8.4	166.2	181.4	109.2	6.6	17.9	171.6	190.7	98.9	141.9	160.4	266.5	719.5	80.9	100.7	52.6	69.0	74.0	83.6	48.9	175.7	0.0	223.1	99.0	179.5	204.1	112.2
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MRPL9		ENSG00000143436	"Mitochondrial ribosomal protein L9"	Q9BYD2	1	151759647-151763496	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008579	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA008579: AB_1079412"	"unprognostic (2.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.43e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.30e-2)"	33.2	27.6	26.2	28.6	27.3	41.1	33.5	29.5	29.3	28.7	24.9	35.1	27.0	33.0	30.9	32.2	28.8	21.2	31.0	26.9	29.4	35.6	29.8	25.4	39.9	28.4	27.7	32.6	30.4	49.0	22.6	29.1	28.2	30.8	28.0	18.1	40.4	28.6	71.3	35.1	29.4	28.9	28.2	32.2	30.7	24.5	27.4	46.5	30.8	55.3	38.8	32.2	28.4	28.8	120.3	98.6	63.8	74.6	44.9	50.5	103.9	66.4	62.7	102.3	80.5	151.9	113.3	79.5	126.7	67.8	65.7	106.3	111.8	84.8	81.6	107.3	107.2	64.0	81.7	99.5	71.4	177.1	56.7	56.3	77.7	89.7	113.6	68.3	100.2	119.7	133.3	104.4	80.5	284.6	112.9	134.8	134.6	139.4	141.1	93.6	74.0	155.7	63.0	96.5	103.2	108.2	79.5	113.1	98.7	88.6	169.4	210.1	69.4	79.2	79.5	66.6	149.5	113.2	168.1	252.5	96.2	116.8	91.7	58.1	42.7	29.5	82.0	54.4	94.7	96.2	94.4	96.3	98.7	89.0	89.1	84.8	5.2	85.4	49.0	83.0	122.0	73.5	26.2	27.3	29.5	29.3	26.9	29.4	28.4	27.7	28.2	28.2	27.4	28.8	31.5	28.9	21.8	8.1	41.0	31.4	48.0	52.9	30.7	19.9	46.2	51.3	4.3	28.6	38.1	33.1	6.2	98.4	43.4	17.2	64.6	69.6	100.0	21.9	27.6	43.8	28.7	39.5	7.5	64.4	124.4	29.2	19.4	22.1	41.1	44.8	43.9	28.4	65.6	18.5	7.7	31.6	42.7	32.4	38.2	36.0	39.1	26.6	35.6	3.7	64.0	32.1	54.6	7.1	7.8	67.1	24.6	47.0	26.9	44.6	29.5	86.8	33.4	19.8	72.3	37.6	35.5	56.3	36.4	33.0	31.7	74.6	43.9	42.5	46.8	40.2
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206807-42217861	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 295.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	24.7	24.0	16.3	20.3	17.1	24.1	21.6	16.8	18.4	19.4	16.1	20.3	19.1	18.3	18.1	43.3	14.5	15.9	46.6	17.3	17.7	29.1	37.5	15.7	24.3	16.5	16.8	14.6	17.2	22.9	13.2	21.6	16.7	18.4	23.6	18.3	19.9	17.0	73.6	18.4	17.7	22.1	16.1	18.8	18.3	16.2	17.5	24.9	24.1	61.8	27.7	24.2	23.7	18.0	99.4	35.1	36.1	61.8	49.4	47.6	32.2	64.3	63.3	61.0	53.3	40.3	38.2	70.2	41.7	60.2	68.3	35.3	60.3	87.5	81.6	64.5	49.3	62.5	30.9	67.2	51.4	93.1	38.8	41.3	65.9	57.2	121.1	41.4	62.8	73.5	110.5	53.4	74.7	63.5	61.0	67.1	30.7	295.3	57.1	51.7	54.3	66.8	105.1	44.2	55.0	40.6	36.9	49.9	122.0	33.5	83.0	125.2	40.7	51.7	51.0	50.3	96.9	39.6	64.4	149.1	35.3	91.7	52.6	22.4	26.0	20.1	23.9	30.4	28.2	30.1	29.2	28.7	29.4	27.1	29.6	28.9	13.1	29.8	28.8	37.7	35.1	28.0	16.3	17.1	16.8	18.4	17.3	17.7	16.5	16.8	16.7	16.1	17.5	18.0	40.4	22.4	21.6	6.8	41.8	40.5	53.6	61.5	22.8	26.8	35.3	33.4	131.8	20.0	39.6	38.6	31.3	102.0	48.0	25.2	92.0	66.5	7.6	35.3	52.4	41.3	14.9	74.5	7.6	47.0	67.5	42.9	23.4	26.8	32.9	46.1	24.7	58.9	52.8	32.0	9.0	27.6	67.1	24.4	28.0	8.8	28.9	34.8	30.2	2.8	110.6	47.8	60.8	7.5	9.5	61.1	30.5	36.5	41.9	64.9	30.0	86.9	60.5	57.3	19.7	35.2	43.0	75.5	83.8	62.2	40.6	75.4	33.8	65.7	35.3	69.4
MRPS11	"FLJ22512, FLJ23406, HCC-2"	ENSG00000181991	"Mitochondrial ribosomal protein S11"	P82912	15	88467453-88480776	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043752, HPA050345"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043752: AB_2678653, HPA050345: AB_2681100"	"unprognostic (2.66e-1)"	"prognostic favorable (3.60e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.45e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.44e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	9.4	16.9	12.0	4.0	12.1	2.8	8.6	12.8	18.3	5.3	11.4	9.3	7.9	5.3	3.8	10.9	4.8	4.5	26.1	12.5	12.1	14.0	20.5	5.2	5.6	12.7	12.3	3.5	10.5	3.8	7.6	2.3	12.9	7.4	3.5	2.5	6.0	3.4	24.7	7.2	7.4	4.3	11.7	8.0	9.6	9.0	12.7	5.1	9.6	15.0	4.4	8.4	5.6	12.1	10.5	41.1	6.1	10.4	13.8	6.6	16.1	8.3	14.6	10.7	11.5	28.9	16.0	9.7	17.0	7.1	11.3	14.8	17.9	11.5	5.5	12.8	43.8	13.2	23.1	32.0	16.5	4.5	8.3	13.4	11.1	9.2	9.2	5.8	14.3	12.3	9.6	4.3	18.1	45.1	9.3	19.0	16.3	13.4	43.8	19.0	11.6	23.0	15.5	28.4	19.3	9.6	8.6	21.6	33.6	5.3	19.8	24.7	6.8	15.2	16.8	9.9	12.5	8.5	16.5	11.7	18.3	11.2	16.3	31.1	25.1	19.3	15.1	27.6	17.6	27.5	17.2	17.8	29.5	18.2	18.1	17.6	9.5	30.1	17.8	31.9	35.1	26.0	12.0	12.1	12.8	18.3	12.5	12.1	12.7	12.3	12.9	11.7	12.7	12.1	42.1	6.4	20.4	10.4	30.4	22.8	27.5	69.2	31.9	36.9	38.1	47.2	6.3	35.8	39.6	46.0	47.9	91.0	34.6	85.5	135.0	63.9	30.2	27.1	37.8	34.2	24.7	40.6	14.0	66.8	89.7	32.7	25.0	32.5	33.6	40.4	44.6	92.6	90.5	26.9	15.0	60.3	50.8	33.1	24.5	34.2	33.2	31.0	32.0	8.4	65.0	44.4	72.1	16.6	16.8	67.0	70.7	42.5	36.5	32.2	90.8	145.3	29.7	45.1	19.7	29.7	51.8	90.3	42.0	49.1	28.3	89.6	32.3	96.0	64.6	34.5
MRPS12	"RPMS12, RPS12, RPSM12"	ENSG00000128626	"Mitochondrial ribosomal protein S12"	O15235	19	38930944-38933168	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 287.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 226.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046775, HPA050633"	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046775: AB_2679800, HPA050633: AB_2681195"	"unprognostic (3.78e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.10e-3)"	"unprognostic (6.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.25e-3)"	"unprognostic (4.48e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.55e-2)"	26.6	43.4	16.2	11.4	16.0	14.5	23.8	18.1	20.2	18.4	16.4	33.0	18.2	20.7	4.0	45.2	19.4	4.6	71.6	16.2	17.1	51.3	71.8	20.4	10.9	16.6	16.7	17.3	32.2	13.9	15.0	6.0	17.1	24.4	6.5	2.4	26.2	7.9	53.6	32.9	27.3	5.3	17.0	32.7	41.1	19.5	18.3	8.2	19.1	17.4	7.5	24.8	23.3	18.0	56.5	226.3	9.9	27.5	12.9	14.1	34.8	33.4	21.0	34.7	30.2	93.4	43.8	60.1	62.4	17.2	26.8	30.4	28.3	53.8	9.2	53.2	64.4	45.0	37.8	62.1	41.4	48.4	39.2	29.1	35.3	30.2	15.3	12.8	32.4	39.4	48.9	32.5	20.7	104.5	54.2	39.4	23.1	81.4	94.4	50.8	33.1	60.5	32.2	73.6	28.9	32.3	32.3	86.1	35.4	8.9	43.0	41.2	29.5	30.7	35.7	45.8	65.7	39.7	40.4	54.4	48.0	52.1	36.4	42.6	76.1	33.1	72.5	91.9	71.9	91.8	66.3	62.0	96.5	92.2	57.1	63.6	9.6	69.1	72.9	110.7	76.8	91.6	16.2	16.0	18.1	20.2	16.2	17.1	16.6	16.7	17.1	17.0	18.3	18.0	32.1	22.4	26.7	3.6	54.5	91.9	72.6	126.2	64.3	17.7	67.2	73.8	59.8	82.9	56.5	66.2	22.9	120.1	61.5	99.6	287.6	111.6	34.2	30.1	44.5	43.2	51.8	61.0	3.9	114.0	161.4	41.8	65.2	42.0	27.8	56.9	27.5	143.2	101.5	23.5	4.8	116.6	71.2	55.5	52.8	72.5	37.3	47.4	53.4	1.9	103.7	23.6	97.9	4.5	5.0	129.4	59.0	32.7	72.5	127.4	151.2	220.9	31.3	25.9	32.9	27.5	48.6	21.0	32.1	91.8	107.3	103.0	43.9	121.8	163.7	101.6
MRPS14	HSMRPS14	ENSG00000120333	"Mitochondrial ribosomal protein S14"	O60783	1	175010789-175023425	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051087	Uncertain		Supported	"Nuclear membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	"Nuclear membrane"	"HPA051087: AB_2681339"	"unprognostic (9.24e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-2)"	17.2	20.3	24.9	11.2	26.8	4.5	20.6	26.5	28.3	16.2	20.0	13.4	12.4	17.4	21.7	9.5	15.4	13.9	15.1	23.4	26.9	20.4	19.2	13.2	15.8	26.7	25.8	18.4	14.8	28.0	12.2	13.9	26.7	20.2	15.7	22.5	17.0	16.9	13.0	11.4	11.9	14.9	26.6	14.3	14.1	11.2	25.0	17.5	23.2	14.2	15.1	12.0	9.3	28.3	16.2	12.8	29.5	10.5	32.6	23.4	9.4	13.8	16.8	23.0	23.7	16.7	13.9	20.4	16.5	18.6	10.1	14.0	18.5	16.1	24.3	22.6	25.4	16.8	25.6	19.2	13.8	18.9	14.5	25.6	19.4	13.6	9.4	20.3	19.4	17.4	20.7	17.6	16.2	8.9	20.8	13.7	16.2	30.1	6.7	17.8	15.6	24.4	15.8	12.8	24.8	17.4	20.0	18.3	13.8	23.1	21.7	19.7	15.9	7.8	8.6	16.4	12.5	19.1	17.5	25.1	11.1	17.5	16.6	9.3	15.2	7.7	14.8	15.1	21.2	17.5	15.5	15.8	16.2	17.3	20.8	17.6	5.2	18.2	12.3	14.0	19.0	14.3	24.9	26.8	26.5	28.3	23.4	26.9	26.7	25.8	26.7	26.6	25.0	28.3	29.8	28.9	24.5	5.5	38.4	22.0	52.6	105.9	22.2	17.5	31.6	33.8	78.1	44.3	64.0	55.2	14.6	95.4	26.7	26.4	137.0	69.8	23.8	26.5	35.8	39.1	31.8	46.3	7.8	44.8	107.0	41.4	20.4	26.6	18.3	34.8	33.9	67.2	80.7	1.7	9.4	35.8	103.7	34.7	23.9	12.9	46.6	25.6	49.8	9.4	73.9	46.1	45.3	6.6	10.4	47.7	45.7	42.9	48.7	50.0	35.3	126.1	50.6	22.6	39.5	25.1	66.4	96.9	39.1	36.7	29.3	56.1	28.8	43.0	48.8	52.6
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464384	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 287.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 776.7;Late spermatids: 2209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	77.3	68.9	54.1	37.4	55.7	81.7	62.4	58.5	70.4	38.8	61.8	63.7	41.1	42.5	62.6	70.9	37.1	30.2	133.8	54.8	59.8	82.0	122.1	47.4	45.4	57.9	56.8	33.2	63.2	77.0	46.3	45.0	58.3	45.1	50.7	21.0	58.1	37.8	287.3	53.0	41.6	40.0	54.4	41.3	68.7	151.2	58.1	44.1	40.0	196.9	47.9	54.2	43.0	56.0	162.3	88.7	94.4	115.8	91.9	132.6	233.9	88.3	126.1	214.3	195.7	157.9	169.3	148.8	140.0	117.3	128.1	138.9	139.5	223.3	192.3	97.4	177.0	152.5	104.1	175.2	171.6	190.2	103.2	123.1	196.1	191.2	153.7	82.5	178.0	109.5	168.1	114.0	134.5	112.2	184.7	203.8	169.8	137.2	154.2	140.4	165.6	218.6	193.0	135.1	139.4	77.0	122.2	153.9	236.0	139.7	95.1	129.0	84.3	119.7	126.8	149.0	189.4	113.2	169.1	211.3	136.1	128.1	170.8	18.7	78.9	22.3	61.8	89.7	77.3	72.5	70.3	71.2	122.0	73.5	65.6	64.4	5.3	64.5	61.2	83.6	87.8	90.7	54.1	55.7	58.5	70.4	54.8	59.8	57.9	56.8	58.3	54.4	58.1	56.0	50.6	38.5	52.0	10.1	57.2	65.4	70.3	119.6	55.8	23.2	85.6	79.9	136.7	65.8	74.7	71.7	14.6	245.9	49.2	84.8	322.9	132.8	776.7	53.2	58.6	62.6	66.0	118.2	8.7	162.4	260.3	61.7	69.3	75.4	42.5	71.1	62.4	140.6	153.8	13.5	8.7	97.7	85.5	81.1	68.9	2209.2	62.7	75.7	56.9	4.7	86.7	31.3	56.7	5.5	7.2	143.1	64.2	74.4	108.4	128.8	118.3	361.6	50.3	23.5	65.7	56.3	103.2	502.4	76.0	107.0	80.4	281.6	59.0	113.1	127.2	118.3
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	24.0	37.8	12.0	18.3	12.7	20.2	22.6	13.3	13.8	18.7	15.8	27.5	24.8	21.6	14.5	32.1	19.1	12.6	47.2	12.3	12.3	32.0	39.5	17.5	22.3	13.0	12.3	18.5	27.4	21.8	20.5	12.9	12.4	19.6	22.0	8.3	23.7	15.3	76.1	25.3	22.4	16.7	12.6	23.3	27.3	21.0	12.8	21.4	17.7	46.3	22.5	20.8	20.2	14.8	84.5	120.5	40.7	55.6	29.1	27.2	65.7	36.7	62.7	49.6	50.5	147.1	78.4	97.8	40.3	36.9	45.2	74.5	43.1	73.2	30.6	54.6	50.4	59.6	61.0	108.5	58.4	79.3	51.4	40.5	54.5	51.4	120.4	37.9	54.2	83.3	92.4	52.2	49.7	92.3	83.4	70.1	52.7	53.7	211.1	75.1	56.1	69.4	48.4	51.3	26.9	49.8	43.5	164.2	83.7	22.5	121.1	38.1	44.8	46.9	83.3	50.3	74.6	79.0	91.4	75.0	50.5	89.5	32.1	31.3	33.0	26.3	26.1	37.3	28.2	42.9	28.4	24.8	27.3	47.5	29.9	26.9	15.0	28.1	30.1	41.8	31.4	39.5	12.0	12.7	13.3	13.8	12.3	12.3	13.0	12.3	12.4	12.6	12.8	14.8	38.0	6.4	32.4	13.7	59.9	35.1	73.9	103.1	42.7	28.0	76.5	87.6	101.1	58.6	71.4	47.8	31.3	118.0	34.0	77.4	248.4	103.7	68.1	54.6	57.8	56.3	54.5	79.8	18.2	119.7	160.7	45.0	52.0	48.4	30.4	52.5	46.8	157.2	154.5	20.2	19.3	102.8	75.3	64.5	36.0	37.8	62.1	57.2	65.8	13.1	78.3	47.9	52.5	9.0	10.7	127.5	55.9	41.8	88.8	126.6	88.6	239.2	51.1	36.2	0.0	38.7	69.0	124.5	70.8	92.8	44.2	106.9	42.6	87.5	114.9	99.0
MRPS17	"HSPC011, MRP-S17, RPMS17"	ENSG00000239789	"Mitochondrial ribosomal protein S17"	Q9Y2R5	7	55951877-55956500	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 195.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047159	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047159: AB_2679961"	"unprognostic (3.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-1)"	9.6	13.6	14.8	7.8	15.0	10.2	11.2	14.8	18.3	7.4	11.6	13.0	8.9	9.9	9.2	13.5	10.1	5.1	20.0	15.6	15.1	16.8	22.1	6.9	9.1	14.3	13.9	9.5	13.6	9.7	8.3	6.5	14.8	10.4	9.8	5.6	9.0	10.5	32.9	8.2	9.1	9.3	13.0	10.2	11.6	11.9	15.9	9.1	8.2	32.7	9.3	11.0	7.8	14.6	195.1	25.3	17.4	36.6	17.3	16.9	22.0	20.6	20.3	25.0	28.4	31.0	26.0	49.3	29.6	16.9	57.9	43.3	38.6	39.3	30.1	20.7	30.0	14.7	35.8	32.2	24.9	37.4	14.5	19.4	31.6	25.0	41.2	18.3	26.5	27.8	57.9	19.2	22.6	21.8	29.9	51.4	37.4	47.7	43.2	23.9	16.8	38.9	40.4	23.4	25.7	22.6	23.4	76.1	28.5	29.6	49.9	29.3	17.9	8.3	40.8	60.2	47.8	16.7	34.2	83.2	8.4	18.9	38.2	3.6	8.7	2.7	10.5	10.7	12.7	17.1	14.4	15.2	13.3	14.2	16.1	14.3	2.3	12.5	11.0	13.2	15.5	7.9	14.8	15.0	14.8	18.3	15.6	15.1	14.3	13.9	14.8	13.0	15.9	14.6	9.6	22.4	11.7	2.6	12.3	0.0	21.3	0.0	26.7	6.7	14.3	14.4	0.0	22.8	14.2	5.5	0.0	30.4	8.7	8.2	29.4	48.1	22.6	18.5	9.5	11.3	4.9	30.9	3.5	54.5	26.2	9.9	23.0	10.0	5.1	10.3	18.9	33.7	19.2	18.5	3.9	15.5	0.0	11.6	0.0	5.5	9.3	9.1	0.0	1.0	20.6	10.6	21.6	3.0	4.6	46.0	14.8	10.9	21.3	19.9	24.2	28.9	13.8	7.0	6.6	10.0	11.2	29.2	12.0	31.2	0.0	21.3	10.7	10.8	21.8	11.9
MRPS18A	"FLJ10548, MRPS18-3"	ENSG00000096080	"Mitochondrial ribosomal protein S18A"	Q9NVS2	6	43671202-43687791	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 370.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035450, HPA035451"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA035450: AB_10670701, HPA035451: AB_10602029"	"unprognostic (9.85e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.03e-5)"	"unprognostic (9.35e-2)"	34.5	44.1	37.0	21.0	37.9	21.5	33.3	37.8	43.4	31.5	53.8	42.6	36.3	32.4	20.9	58.3	30.1	20.4	66.7	39.2	37.7	46.9	63.3	25.6	22.7	38.8	38.1	21.9	32.3	39.1	19.5	22.7	37.7	39.5	45.4	15.0	35.1	26.8	149.4	41.7	31.3	27.1	38.2	32.1	56.1	17.5	39.4	26.4	28.4	103.4	33.1	34.8	33.9	38.1	71.0	57.7	45.2	63.9	45.2	30.4	51.4	32.9	50.2	78.6	77.3	118.7	28.4	29.6	55.4	46.0	64.1	56.6	64.3	92.5	40.9	45.6	76.5	55.7	44.3	104.5	78.1	76.1	32.4	41.4	73.5	66.6	100.6	40.2	59.9	73.0	97.9	61.4	47.0	115.2	58.3	63.4	33.6	370.3	46.2	48.8	35.9	95.9	59.1	79.9	72.5	38.9	34.7	64.5	121.8	32.1	65.5	106.7	32.6	49.4	56.4	40.2	60.2	67.1	60.2	110.3	66.2	52.8	134.8	106.6	69.8	76.8	79.1	60.9	74.8	135.4	73.6	76.0	82.3	98.3	73.0	67.9	32.5	93.3	45.2	91.2	86.9	84.1	37.0	37.9	37.8	43.4	39.2	37.7	38.8	38.1	37.7	38.2	39.4	38.1	27.1	32.1	24.5	5.2	31.8	33.4	44.6	97.7	12.0	13.6	29.1	26.4	1.3	30.0	61.2	33.1	2.1	72.7	15.6	96.0	99.7	78.2	16.5	26.2	26.2	25.3	32.3	23.5	5.1	67.4	64.0	24.6	56.6	43.7	26.6	28.8	30.4	51.8	51.1	8.4	4.5	73.4	73.2	17.5	19.8	35.2	22.7	16.5	40.9	7.5	51.7	23.4	29.9	9.0	5.2	69.3	94.2	21.1	42.9	45.0	73.4	115.4	34.7	15.5	32.9	24.7	25.8	27.3	36.2	31.0	27.3	67.5	19.5	61.7	97.2	77.9
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617840-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	37.2	52.0	43.6	27.6	45.7	20.3	61.0	46.8	44.3	41.1	43.2	52.3	49.8	31.3	57.6	39.3	62.5	27.4	108.1	40.5	44.1	77.9	99.8	39.4	43.6	46.0	45.2	63.0	47.0	74.0	29.2	38.4	46.2	32.0	62.3	41.6	58.0	42.4	180.2	45.1	39.4	38.1	45.2	39.3	44.4	22.0	46.1	43.7	54.1	229.0	63.6	33.0	29.4	48.2	112.7	68.3	51.1	73.5	72.9	101.8	92.6	39.8	92.6	122.8	75.5	117.7	51.8	112.6	91.5	61.7	91.3	86.1	115.0	109.9	122.0	68.7	122.9	107.9	45.1	124.2	67.2	105.7	45.4	88.8	139.4	99.5	273.8	82.7	72.4	104.7	171.3	107.7	112.2	83.1	70.6	111.4	40.6	86.1	81.8	91.2	69.8	220.7	114.8	49.5	111.3	38.4	34.7	147.1	163.0	46.0	190.6	58.4	39.6	79.2	80.8	47.3	70.8	89.5	114.1	99.2	38.3	154.6	121.7	79.2	72.4	42.5	77.0	94.4	104.7	153.5	104.3	86.3	79.8	140.3	129.6	103.5	7.2	120.3	101.4	74.3	108.1	108.4	43.6	45.7	46.8	44.3	40.5	44.1	46.0	45.2	46.2	45.2	46.1	48.2	59.4	60.9	56.1	7.2	58.4	36.8	65.9	114.0	58.6	47.4	56.6	73.0	175.5	117.2	75.0	47.8	64.6	121.2	43.7	39.1	193.7	103.8	54.2	37.5	42.8	59.4	31.3	45.4	6.0	92.1	124.9	47.4	39.3	30.8	37.4	53.1	61.8	121.6	81.4	43.7	7.9	59.5	75.3	53.2	30.4	37.4	70.2	39.7	60.5	1.9	80.0	46.9	70.0	4.5	14.4	69.5	49.9	44.8	56.8	53.2	89.6	201.6	60.4	69.4	52.6	50.0	53.0	29.6	57.4	61.7	44.9	96.5	43.9	144.4	85.3	50.1
MRPS18C	"CGI-134, FLJ11146, FLJ22967, MRPS18-1"	ENSG00000163319	"Mitochondrial ribosomal protein S18C"	Q9Y3D5	4	83455932-83469735	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050404	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA050404: AB_2681115"	"unprognostic (4.53e-3)"	"unprognostic (7.58e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.25e-2)"	"unprognostic (8.26e-3)"	"prognostic favorable (2.90e-5)"	"unprognostic (1.52e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.31e-3)"	26.5	33.6	27.1	24.0	28.1	26.7	25.1	29.6	42.7	23.2	27.1	26.2	24.8	24.5	17.7	33.6	25.2	14.4	46.7	27.6	29.6	36.4	44.3	21.6	24.6	28.2	27.7	22.3	22.0	20.0	20.1	20.7	28.5	16.8	25.9	19.6	21.1	14.8	85.2	24.2	25.4	21.0	28.2	25.0	24.7	19.5	27.6	25.1	19.4	53.4	32.5	22.7	23.3	29.5	74.4	76.2	58.9	45.3	36.3	24.1	56.9	78.1	39.6	60.5	51.6	136.2	66.8	69.8	86.8	38.5	68.9	39.4	61.0	47.3	71.2	62.7	48.8	59.6	105.6	136.5	49.3	143.2	74.5	25.3	41.0	49.4	58.4	34.9	39.8	86.1	86.5	55.7	39.8	142.9	95.3	87.6	35.4	109.7	53.3	53.6	51.0	55.8	46.4	66.8	61.7	33.2	41.9	82.9	68.0	57.4	36.1	85.7	47.8	53.5	82.5	53.3	104.7	50.7	70.3	158.5	51.1	73.2	67.4	126.2	122.9	196.1	105.9	139.5	108.6	174.7	126.3	117.2	142.5	164.4	130.8	116.5	56.0	117.2	117.3	164.7	195.5	113.5	27.1	28.1	29.6	42.7	27.6	29.6	28.2	27.7	28.5	28.2	27.6	29.5	102.2	51.3	61.3	4.6	67.8	68.1	73.7	169.1	47.8	33.3	54.3	87.2	81.3	90.1	93.3	77.3	37.5	132.4	62.7	57.1	229.0	139.1	117.0	75.9	59.6	77.3	33.6	117.0	8.7	187.8	119.7	57.2	33.1	54.5	109.5	57.1	77.1	180.6	112.6	32.0	8.0	59.3	91.6	65.4	46.8	25.2	82.0	58.1	62.2	6.5	72.9	80.7	96.8	8.0	9.7	134.6	84.1	77.5	63.6	62.7	101.8	211.0	124.7	47.7	59.2	71.2	93.7	109.0	71.6	70.4	64.1	96.2	55.7	70.3	79.9	61.9
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	32.6	56.9	30.7	14.7	31.3	23.2	30.8	30.3	37.9	29.2	34.9	35.4	23.0	29.6	12.9	37.7	35.7	15.8	67.0	31.2	30.2	46.1	79.7	22.0	21.0	29.9	31.3	34.9	45.8	32.2	26.4	16.8	31.1	33.1	17.3	7.7	31.3	21.2	75.5	39.1	28.1	15.2	29.7	32.0	39.3	17.0	33.1	16.2	25.8	50.4	17.7	33.8	28.8	30.8	59.9	98.4	35.3	48.0	39.1	43.5	60.0	43.0	39.0	71.7	53.0	149.0	55.4	75.4	57.2	40.1	75.8	132.6	88.9	101.4	27.7	46.2	137.4	37.4	96.1	101.8	68.4	76.6	44.3	58.6	77.6	78.3	55.6	45.7	67.9	74.2	125.1	54.3	42.3	185.8	73.9	133.7	80.2	110.8	153.9	81.3	57.3	159.5	59.9	50.8	104.9	55.2	58.8	110.9	63.2	23.6	92.4	60.5	42.4	52.3	58.4	90.3	78.8	58.9	124.5	84.1	53.0	69.2	49.1	8.4	28.4	13.6	30.0	27.5	34.5	34.4	30.1	32.4	29.1	34.3	32.4	32.9	2.4	28.7	24.0	25.1	41.8	26.4	30.7	31.3	30.3	37.9	31.2	30.2	29.9	31.3	31.1	29.7	33.1	30.8	23.8	12.8	14.1	4.9	32.5	44.7	38.8	55.0	33.0	22.2	37.3	51.7	31.2	42.9	31.6	12.9	6.2	71.3	19.0	21.5	72.4	50.7	14.7	27.8	34.2	32.6	21.7	41.4	4.6	38.6	65.8	27.9	21.4	77.7	8.2	37.9	21.8	46.5	42.5	25.2	5.9	37.9	28.5	17.6	15.4	32.5	24.2	21.0	19.6	1.9	31.7	24.8	20.6	4.0	4.5	39.9	27.1	23.0	38.6	48.6	36.3	84.5	14.7	17.0	32.9	27.1	29.4	13.3	21.5	47.1	45.7	37.4	23.4	77.5	55.7	35.5
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	25.5	55.6	23.1	20.7	24.2	37.9	25.2	27.2	31.5	21.9	22.2	35.0	37.0	20.2	19.3	37.4	20.5	17.3	61.3	23.4	27.3	38.0	57.4	17.0	22.8	24.9	23.4	22.6	32.0	31.7	13.7	25.6	26.0	17.1	31.9	17.9	22.0	20.2	83.0	21.8	33.1	23.9	25.8	17.0	25.0	35.4	24.4	23.5	22.8	77.3	24.4	27.3	21.6	27.4	101.2	40.4	40.0	44.5	49.1	41.7	79.1	58.9	72.3	97.1	80.7	130.0	68.3	66.5	106.9	67.1	98.9	109.9	64.6	76.5	96.4	39.0	64.1	105.2	35.8	97.2	56.2	99.3	58.1	45.2	59.6	58.3	61.8	49.2	61.0	76.2	149.2	41.7	61.2	72.4	51.9	85.9	64.4	102.3	73.3	65.0	61.3	98.9	75.0	61.4	43.4	40.4	94.2	141.4	154.6	37.0	97.1	93.7	47.5	42.4	42.3	82.4	55.9	66.3	38.5	119.5	56.9	70.6	42.3	42.8	38.4	36.1	34.9	53.4	43.0	40.3	37.5	39.4	45.8	36.1	41.0	38.9	9.2	38.1	53.6	29.7	47.6	36.3	23.1	24.2	27.2	31.5	23.4	27.3	24.9	23.4	26.0	25.8	24.4	27.4	30.7	19.2	13.4	8.8	21.8	22.8	29.7	63.3	19.4	19.9	15.3	18.0	50.3	25.8	33.3	18.4	14.6	62.9	24.9	26.5	68.4	47.5	84.3	19.9	30.5	26.6	15.6	31.2	8.7	60.3	48.0	27.7	16.3	22.0	27.3	24.9	18.2	38.9	48.6	20.2	13.8	26.5	32.6	21.9	16.1	14.3	23.3	22.5	16.0	4.7	38.0	21.8	24.7	10.1	10.1	42.0	27.1	23.7	38.4	16.6	45.4	59.4	35.5	26.2	39.5	32.2	39.1	102.2	51.4	34.8	20.5	75.4	24.7	74.1	46.5	31.2
MRPS23	"CGI-138, HSPC329, MRP-S23"	ENSG00000181610	"Mitochondrial ribosomal protein S23"	Q9Y3D9	17	57834781-57850056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 187.7;Proximal tubular cells: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023453	Supported		Supported	"Nuclear membrane,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear membrane"	"HPA023453: AB_1854125"	"unprognostic (3.84e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (3.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.39e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.83e-1)"	21.7	37.5	22.7	26.4	23.5	24.4	25.4	22.9	29.6	17.8	21.4	22.2	23.8	25.3	29.7	25.1	24.8	16.7	86.3	23.6	23.3	38.5	24.5	21.9	31.1	23.3	23.7	20.2	39.6	47.5	20.3	20.6	24.8	36.2	20.3	31.9	20.9	24.8	61.5	19.8	20.7	21.8	23.5	21.7	39.4	23.4	23.2	30.3	36.7	44.5	26.9	28.2	18.0	25.2	137.6	137.0	71.7	75.7	42.6	49.5	82.5	86.9	64.9	118.4	90.8	102.6	80.1	173.1	251.9	67.0	109.3	66.3	113.8	102.3	98.2	137.7	135.9	125.4	51.3	179.9	80.9	165.7	115.9	45.4	89.9	87.9	90.8	54.0	75.8	90.9	190.5	60.4	94.0	117.8	154.8	96.1	86.8	153.7	142.8	111.1	120.4	144.0	91.7	65.1	95.8	149.2	65.5	54.5	177.6	52.0	169.1	121.8	66.9	100.0	127.5	100.8	186.3	131.6	301.3	197.5	95.1	102.3	93.7	67.7	41.2	66.2	39.2	51.5	41.2	44.3	38.9	39.9	57.8	47.9	41.3	41.5	6.6	47.2	37.8	54.6	41.3	45.8	22.7	23.5	22.9	29.6	23.6	23.3	23.3	23.7	24.8	23.5	23.2	25.2	34.9	48.1	33.6	3.6	30.2	33.4	40.4	109.4	26.7	41.6	30.1	42.4	187.7	27.1	60.5	47.8	12.5	81.6	30.0	18.4	148.7	84.8	5.9	42.5	37.0	40.0	22.1	28.4	6.1	100.0	87.0	37.4	29.6	36.3	23.4	43.9	24.3	39.7	85.5	50.5	6.8	29.2	69.2	35.2	23.5	10.0	32.6	31.5	40.9	4.7	67.1	63.1	48.4	2.5	10.0	87.7	25.5	39.5	29.1	58.9	20.8	190.8	55.6	64.4	26.3	37.5	43.8	38.3	85.9	39.3	32.5	42.5	27.4	65.4	40.9	34.2
MRPS24	"HSPC335, MRP-S24"	ENSG00000062582	"Mitochondrial ribosomal protein S24"	Q96EL2	7	43866558-43869893	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 455.8"	"Group enriched"	"Detected in many"	5	"Basal squamous epithelial cells: 109.3;Erythroid cells: 54.7;Gastric mucus-secreting cells: 84.6;Plasma cells: 184.7;Squamous epithelial cells: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073947	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA073947: "	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.63e-3)"	"unprognostic (9.42e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.03e-1)"	"unprognostic (6.86e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (9.89e-4)"	"unprognostic (2.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.95e-1)"	81.4	160.7	98.6	41.6	98.8	93.6	81.9	103.5	116.1	82.3	103.6	107.5	71.6	79.2	43.3	148.5	79.7	34.0	233.6	100.1	104.1	142.9	172.6	64.4	49.4	96.2	97.7	95.8	151.1	92.0	68.3	39.7	96.2	82.4	47.0	31.3	101.2	40.1	455.8	91.7	77.7	37.8	97.1	76.9	126.8	83.5	106.1	47.9	65.3	281.0	48.3	87.3	88.4	94.7	165.2	260.4	80.2	165.8	82.7	141.4	132.3	155.4	386.0	206.2	203.3	236.7	152.8	140.1	182.8	160.1	278.8	204.7	115.8	142.9	160.9	131.8	287.2	86.1	286.2	287.7	122.7	140.5	106.5	133.8	142.6	161.0	192.1	130.8	120.3	136.8	281.4	103.3	131.6	262.7	170.6	313.4	200.5	184.8	261.0	137.3	113.9	540.5	150.9	139.3	159.5	180.4	156.7	386.3	162.2	102.9	261.5	252.1	96.8	191.6	263.6	116.1	225.7	310.4	258.8	182.5	232.3	186.1	305.7	41.4	175.4	95.6	114.1	181.6	124.8	222.5	167.5	137.5	241.0	195.6	165.0	142.6	14.7	124.1	181.0	162.8	214.1	177.5	98.6	98.8	103.5	116.1	100.1	104.1	96.2	97.7	96.2	97.1	106.1	94.7	1.2	6.4	19.1	0.0	24.1	4.5	2.6	2.5	109.3	4.9	8.2	5.3	0.4	8.6	13.2	5.5	6.2	1.4	2.9	1.8	3.9	7.1	1.8	9.4	16.5	7.8	4.2	54.7	0.0	0.7	3.8	20.4	84.6	12.1	3.8	2.3	8.9	21.7	1.2	0.0	0.0	1.5	0.0	8.6	6.3	1.0	0.3	24.4	3.6	0.0	3.1	0.9	4.1	0.0	0.0	2.9	0.7	0.7	184.7	1.8	1.6	1.9	21.9	7.7	0.0	1.7	13.8	1.0	1.4	204.4	5.8	1.9	19.4	1.7	2.1	3.2
MRPS25	"DKFZp313H0817, FLJ00023, MRP-S25, RPMS25"	ENSG00000131368	"Mitochondrial ribosomal protein S25"	P82663	3	15042460-15065317	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 367.5;Late spermatids: 1316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043490	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA043490: AB_10794888"	"unprognostic (3.98e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (3.60e-7)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.91e-3)"	20.5	23.7	14.4	18.1	14.2	12.5	19.1	15.0	15.3	21.7	23.6	33.0	29.7	20.0	11.0	25.4	22.7	8.2	68.0	13.4	13.9	33.4	46.5	22.7	17.6	13.2	13.9	25.9	21.1	19.1	32.1	10.3	13.8	22.6	20.8	43.4	19.6	13.6	54.8	22.2	29.8	12.6	11.8	26.0	26.3	35.2	14.0	9.7	43.5	28.8	17.6	25.9	21.9	12.4	18.0	26.1	20.9	29.2	21.7	18.4	66.8	24.1	9.3	19.0	16.3	29.9	19.1	46.8	12.5	10.6	12.6	22.8	30.5	22.8	16.3	18.8	42.9	38.9	60.2	37.6	15.1	34.7	28.5	22.4	21.2	29.9	9.1	12.9	17.9	31.2	42.0	27.3	14.3	57.3	27.3	33.5	21.7	41.6	41.1	36.5	18.1	48.7	23.9	30.7	16.5	24.9	17.6	33.0	35.9	12.8	44.7	29.9	22.1	17.1	25.2	23.7	30.6	26.3	30.1	33.7	17.3	43.8	16.3	3.3	27.2	7.2	17.4	34.6	20.2	39.4	16.2	18.0	29.3	35.2	25.6	21.0	1.8	13.8	37.2	24.0	14.2	18.1	14.4	14.2	15.0	15.3	13.4	13.9	13.2	13.9	13.8	11.8	14.0	12.4	22.8	51.3	34.6	47.3	49.4	38.5	61.0	76.2	31.9	58.2	37.2	39.9	271.5	44.3	57.7	36.8	164.7	94.6	30.5	78.5	223.0	50.0	367.5	31.1	45.1	31.0	54.0	36.6	37.7	34.0	74.6	40.0	51.0	28.3	26.0	45.5	21.0	101.0	93.4	67.3	43.9	81.3	54.9	29.8	36.6	1316.8	46.0	35.3	37.4	8.4	41.0	25.7	43.3	32.2	29.3	47.4	49.5	30.1	41.6	74.4	152.8	201.6	40.7	106.2	72.3	35.6	43.0	139.1	30.0	56.1	48.6	72.7	28.4	97.4	125.8	73.9
MRPS26	"C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13"	ENSG00000125901	"Mitochondrial ribosomal protein S26"	Q9BYN8	20	3046052-3048250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045472, HPA054610"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045472: AB_10962052, HPA054610: AB_2682541"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.14e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.93e-3)"	36.9	69.5	61.1	17.1	62.4	18.1	38.3	63.9	69.6	41.6	64.2	50.8	26.9	40.9	34.8	48.6	42.4	11.3	69.7	59.7	65.3	60.6	104.1	27.9	19.2	64.8	62.0	48.0	50.0	38.9	64.8	19.4	63.5	56.3	18.8	14.2	41.0	30.4	56.7	48.6	35.7	19.8	60.6	34.9	45.4	21.3	63.5	18.3	51.1	25.6	20.9	48.6	38.3	63.7	119.0	157.5	34.7	63.6	37.3	28.4	91.0	45.4	30.6	51.4	39.2	138.9	53.0	117.7	56.3	23.7	67.0	109.9	69.6	94.1	29.9	30.2	149.0	53.6	60.8	234.6	51.9	85.2	25.3	32.0	72.0	42.7	64.2	35.7	38.7	68.9	88.1	27.0	31.1	103.6	88.4	149.6	170.8	89.9	154.0	96.4	60.0	126.5	51.2	78.9	108.9	140.7	52.0	171.7	109.2	34.3	77.4	47.5	36.2	33.2	52.6	60.0	84.9	120.0	169.0	72.6	21.6	70.7	37.8	36.1	64.2	33.0	68.6	77.5	87.9	114.4	76.3	74.6	87.5	104.9	87.3	74.9	5.1	97.0	63.6	53.3	65.9	73.2	61.1	62.4	63.9	69.6	59.7	65.3	64.8	62.0	63.5	60.6	63.5	63.7	50.9	16.0	26.8	18.3	61.4	82.0	62.9	113.7	86.6	40.0	87.4	136.5	64.6	54.3	61.5	55.2	35.5	188.1	50.2	72.6	209.4	77.6	4.3	56.9	70.8	43.1	55.1	49.2	20.3	54.8	117.5	57.6	60.1	50.3	14.0	94.0	32.5	120.0	81.1	47.1	20.3	104.1	103.7	23.6	37.5	10.6	69.0	29.2	67.6	5.6	35.3	88.5	56.7	18.1	19.3	52.6	62.0	61.7	46.2	115.3	108.6	239.8	44.4	45.4	59.2	47.3	66.8	60.8	68.7	101.9	92.2	78.5	44.8	164.6	124.2	54.0
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219403-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	25.5	36.1	23.8	21.8	25.3	18.9	31.8	23.6	27.8	27.0	33.8	26.2	20.4	25.8	27.6	32.4	31.3	19.0	55.5	25.0	23.1	30.5	38.5	17.5	36.9	24.6	24.1	39.5	27.1	32.7	20.9	21.2	24.6	25.2	31.5	17.7	22.4	30.3	58.7	31.7	22.0	26.9	24.5	25.9	25.7	15.1	25.0	30.7	35.6	89.1	41.9	29.7	26.0	24.1	49.7	65.2	56.8	94.4	73.1	93.5	73.0	46.7	66.4	86.9	69.7	81.9	68.5	128.2	63.8	54.8	94.9	54.0	111.8	166.1	93.6	48.6	69.2	66.0	71.3	91.1	72.7	58.4	49.0	88.1	68.7	91.3	101.5	79.0	94.2	92.2	67.2	37.5	73.0	59.7	87.8	70.4	65.7	35.8	40.4	92.0	94.4	131.5	80.7	52.4	87.5	46.7	78.5	63.8	58.5	52.2	97.8	69.9	54.1	35.3	51.8	50.3	85.2	37.7	61.0	89.1	60.9	94.6	57.0	15.5	23.4	8.1	24.9	27.5	37.1	36.1	30.6	30.4	44.2	32.1	35.2	37.9	3.2	43.3	23.0	16.6	34.6	31.5	23.8	25.3	23.6	27.8	25.0	23.1	24.6	24.1	24.6	24.5	25.0	24.1	13.9	9.6	11.7	32.7	27.6	20.4	22.3	21.6	23.3	11.4	26.5	22.2	101.9	7.2	15.6	11.0	16.7	41.5	18.6	9.1	25.4	20.5	2.2	16.1	21.8	17.2	16.2	36.8	43.9	17.3	48.2	18.8	17.9	12.1	7.6	29.3	15.7	34.8	24.8	10.1	38.4	21.0	8.2	28.6	13.3	4.4	19.0	15.0	10.6	30.0	31.4	15.3	17.5	38.7	51.1	14.9	15.3	25.2	16.8	13.5	10.7	28.8	12.6	13.2	13.1	18.2	17.6	10.3	18.7	32.3	17.6	28.9	21.2	30.4	31.4	14.8
MRPS28	"HSPC007, MRP-S28, MRPS35"	ENSG00000147586	"Mitochondrial ribosomal protein S28"	Q9Y2Q9	8	79918717-80030289	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 359.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027202	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA027202: AB_1854126"	"unprognostic (3.63e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.55e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.48e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-2)"	47.5	88.8	65.1	32.9	67.7	29.1	47.5	70.0	85.3	33.3	73.0	52.9	30.9	27.3	38.3	41.0	35.2	28.8	104.0	64.0	70.2	79.2	110.9	30.4	37.7	70.1	69.8	28.6	32.3	69.6	40.4	40.9	70.1	31.3	41.0	51.7	35.4	33.4	160.3	29.0	29.4	32.8	69.7	26.7	35.3	24.3	66.9	44.9	53.7	137.7	37.9	39.0	30.7	75.3	85.2	84.1	73.0	17.3	60.9	77.2	79.8	94.3	85.7	122.1	104.2	74.0	66.4	107.2	105.3	75.6	124.2	68.5	102.1	105.5	99.0	85.3	89.8	128.8	74.8	114.4	67.7	57.6	55.3	66.4	88.9	71.8	97.4	67.1	81.0	85.2	93.4	42.3	123.7	81.3	133.8	93.5	29.8	219.5	139.5	89.9	58.1	62.0	158.0	81.8	34.8	58.6	41.1	359.5	91.1	83.8	86.6	68.1	59.0	45.8	116.4	81.6	82.7	46.5	81.4	97.2	77.4	66.7	36.8	95.4	53.8	29.1	48.2	77.3	52.3	51.2	52.8	59.4	98.8	54.4	64.1	62.1	11.1	71.5	70.1	111.1	73.0	49.8	65.1	67.7	70.0	85.3	64.0	70.2	70.1	69.8	70.1	69.7	66.9	75.3	32.5	22.4	22.2	57.8	20.8	35.2	19.5	124.5	36.5	10.9	23.4	28.1	51.6	42.9	67.0	33.1	4.2	78.7	20.9	18.1	101.8	67.3	15.1	28.5	16.1	26.2	37.3	21.7	39.0	47.4	74.3	21.2	17.9	24.1	50.0	10.5	23.9	65.5	49.5	5.0	42.5	23.5	69.2	25.5	28.5	10.4	17.7	26.9	44.4	70.3	40.0	23.7	26.8	93.5	81.8	36.0	20.6	22.2	19.9	13.4	24.5	126.9	79.7	17.2	32.9	31.1	26.1	18.6	33.4	41.6	37.8	59.4	20.0	23.2	36.4	16.0
MRPS30	"PAP, PDCD9"	ENSG00000112996	"Mitochondrial ribosomal protein S30"	Q9NP92	5	44808947-44820428	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018686, HPA021149"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA018686: AB_1854127, HPA021149: AB_1854128"	"unprognostic (1.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.87e-9)"	"unprognostic (2.20e-2)"	"unprognostic (5.04e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.70e-3)"	13.1	13.4	4.0	8.5	6.3	25.3	14.1	7.3	9.0	9.5	2.6	13.8	13.4	10.3	5.9	16.6	10.5	5.8	24.5	6.2	2.1	15.1	21.4	8.5	11.7	0.5	1.9	9.4	12.9	12.7	6.4	7.5	1.1	8.7	10.8	6.4	11.6	6.4	35.6	20.5	12.0	7.3	1.9	11.3	12.0	11.5	3.5	10.1	12.0	26.7	9.6	11.4	10.9	7.6	33.2	32.5	19.2	36.9	14.0	16.3	61.9	16.2	17.4	22.8	16.1	51.9	40.5	50.4	55.1	10.7	52.6	30.6	37.7	24.2	20.3	32.7	64.5	37.5	67.8	40.8	31.1	51.5	29.8	16.2	24.4	23.9	29.4	17.2	21.7	27.4	58.5	45.6	21.4	28.3	33.3	67.7	32.4	26.0	57.6	31.3	32.1	67.6	34.6	24.1	29.3	22.9	75.1	40.1	52.2	14.5	36.2	38.0	21.4	26.8	39.6	22.3	51.0	24.4	31.0	41.0	22.6	68.4	27.7	26.0	24.0	18.7	30.9	27.2	32.3	37.8	34.2	34.2	25.6	31.7	40.0	33.9	4.4	35.2	33.3	19.4	46.1	33.6	4.0	6.3	7.3	9.0	6.2	2.1	0.5	1.9	1.1	1.9	3.5	7.6	22.1	25.6	16.5	4.6	31.7	48.8	38.8	63.3	26.7	31.3	23.6	21.1	60.2	17.2	31.5	5.5	18.8	40.0	37.6	21.4	33.2	36.5	105.1	21.3	29.4	23.9	28.7	18.7	14.4	33.1	38.0	24.1	21.4	22.5	19.0	24.1	17.9	26.9	32.5	32.0	8.0	24.5	30.5	16.6	15.7	14.3	20.8	18.9	17.8	3.7	26.3	20.4	26.8	3.5	6.9	29.6	22.8	18.0	20.1	27.6	25.6	35.4	21.9	26.3	13.1	24.9	28.7	43.4	26.4	28.6	75.0	18.6	32.6	32.6	37.0	42.3
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729128-40771190	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	11.7	14.8	9.1	14.0	9.6	14.4	16.9	10.5	12.5	10.7	9.1	15.8	14.8	16.6	13.8	14.7	15.1	10.2	24.0	8.7	9.5	19.6	28.8	11.5	23.5	9.6	9.7	19.2	10.4	14.3	7.5	12.6	10.1	11.3	15.6	13.7	13.7	11.0	27.5	13.5	15.3	15.2	9.3	13.2	15.0	17.9	9.2	17.8	19.6	26.2	24.9	13.2	10.0	11.8	19.0	17.9	29.5	19.5	19.8	23.2	29.6	23.7	16.5	30.7	20.5	46.0	27.4	110.5	22.6	13.7	41.3	48.8	37.4	29.6	36.2	29.4	28.1	45.9	12.7	29.7	16.5	47.4	21.3	18.8	21.4	25.3	21.2	20.3	23.8	31.2	31.3	11.3	19.8	21.5	37.2	46.2	28.7	64.2	20.9	35.0	24.3	20.8	40.3	21.6	12.9	18.7	16.5	27.0	39.3	35.1	23.7	41.5	14.6	9.5	16.0	22.3	24.9	8.7	17.4	55.7	19.5	33.3	18.6	30.9	15.3	24.9	29.4	16.4	28.8	36.8	32.5	29.9	19.5	33.5	38.5	34.3	11.3	28.7	18.4	19.1	36.5	17.8	9.1	9.6	10.5	12.5	8.7	9.5	9.6	9.7	10.1	9.3	9.2	11.8	27.5	48.1	19.2	24.5	35.0	9.7	33.0	106.0	33.0	35.1	22.4	31.6	73.7	28.6	77.2	22.0	18.8	62.7	31.2	18.7	109.5	43.0	74.9	55.5	38.6	32.5	23.4	29.8	28.8	33.6	41.5	27.9	18.8	38.1	23.4	32.8	37.9	76.9	26.0	42.1	37.8	37.4	91.6	17.0	12.5	14.2	35.4	18.1	19.6	26.2	39.8	32.3	32.0	36.7	45.1	30.0	19.5	30.5	52.1	15.8	32.4	93.4	412.5	51.2	46.0	39.5	38.1	72.6	49.8	30.2	13.4	68.0	37.7	45.2	35.5	25.5
MRPS33	CGI-139	ENSG00000090263	"Mitochondrial ribosomal protein S33"	Q9Y291	7	141002610-141015228	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 354.1;Proximal tubular cells: 386.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030425	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030425: AB_10602030"	"unprognostic (9.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.03e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.94e-3)"	"unprognostic (4.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.52e-2)"	37.7	64.4	43.9	27.5	46.9	25.0	58.5	46.4	68.8	30.3	47.7	65.3	50.1	25.5	79.1	46.3	35.1	22.4	114.5	45.3	48.0	72.7	83.7	20.8	41.0	46.6	45.9	35.2	67.6	81.2	49.1	24.4	48.0	36.6	69.8	29.4	50.0	31.2	173.7	35.9	44.5	26.5	46.8	30.9	44.3	45.3	45.4	41.9	51.7	171.5	43.5	36.9	30.2	47.8	79.0	110.5	61.8	65.7	77.1	104.9	67.6	69.5	68.7	65.1	73.2	67.6	104.9	107.7	100.0	67.3	140.9	50.5	69.5	102.6	89.3	96.6	83.1	67.8	20.6	130.8	93.8	98.3	39.2	99.8	103.0	100.8	89.4	73.3	53.9	108.4	113.3	84.0	128.2	124.8	110.1	153.3	129.3	140.0	125.6	28.4	48.5	186.1	114.9	99.8	111.7	88.2	93.7	93.2	145.5	65.3	79.4	90.8	41.8	56.6	38.4	137.5	75.8	128.3	155.7	126.8	125.3	99.8	95.1	13.0	47.6	37.9	48.9	68.7	61.9	85.4	85.5	61.1	79.5	66.8	98.3	83.5	4.9	79.8	60.5	93.8	77.3	61.2	43.9	46.9	46.4	68.8	45.3	48.0	46.6	45.9	48.0	46.8	45.4	47.8	30.3	38.5	43.6	11.1	54.6	42.6	72.1	207.7	51.2	27.1	101.1	104.6	333.5	82.9	96.5	114.0	31.3	145.4	39.5	96.9	354.1	101.0	136.8	124.2	60.1	42.8	89.7	46.3	8.9	136.8	133.0	55.3	50.0	70.6	48.2	71.4	42.5	221.8	114.1	57.2	9.1	148.3	109.9	59.8	38.1	41.0	57.8	45.7	76.5	8.4	97.4	47.8	51.5	9.0	18.0	95.6	80.6	42.5	88.9	67.1	199.0	386.1	122.5	32.9	19.7	41.0	57.1	157.7	50.8	84.4	45.7	116.8	49.6	82.8	202.3	79.0
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773150	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 354.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	40.2	84.4	15.0	8.2	15.6	14.9	38.9	18.8	30.2	39.6	8.4	56.9	17.6	41.4	1.8	74.2	38.1	3.9	66.5	14.3	14.7	53.4	83.8	33.1	9.6	20.1	14.9	32.5	85.4	7.5	43.2	6.0	18.3	44.2	3.0	1.5	51.9	9.7	88.1	63.3	48.9	3.0	17.3	59.4	55.9	22.3	17.2	6.6	35.2	6.2	4.3	43.9	43.6	19.7	72.4	77.1	10.6	26.9	9.1	10.7	86.5	75.8	14.9	26.2	20.2	51.7	40.7	89.1	120.7	9.6	14.9	82.3	15.7	37.3	4.0	63.2	354.6	63.9	68.2	56.3	19.9	116.7	63.3	9.8	17.5	16.1	7.1	11.8	20.4	45.1	105.7	18.6	7.5	113.3	63.1	209.4	101.5	19.1	229.5	137.9	51.9	201.0	10.2	19.4	132.2	100.6	85.8	42.4	82.5	2.9	54.9	46.5	51.9	28.2	88.9	37.1	62.8	154.8	116.9	141.9	22.1	65.3	36.1	68.6	185.4	108.3	144.9	172.6	153.3	189.3	160.0	154.2	205.6	224.2	150.2	135.6	40.6	165.1	153.9	192.1	204.7	189.6	15.0	15.6	18.8	30.2	14.3	14.7	20.1	14.9	18.3	17.3	17.2	19.7	72.0	38.5	31.7	13.1	92.5	100.3	60.8	132.6	103.6	45.6	108.8	127.9	59.9	101.5	77.3	97.5	10.4	181.3	87.9	170.1	250.5	116.1	5.9	65.3	82.8	59.6	91.1	90.6	10.1	182.5	181.9	66.2	105.0	66.2	36.1	75.6	65.3	168.1	173.3	55.5	12.0	174.0	109.9	96.1	66.2	11.6	72.7	74.8	81.8	8.4	108.8	87.8	110.2	11.6	17.1	155.4	153.4	70.0	183.8	94.0	265.6	261.8	43.1	38.2	19.7	48.2	73.7	30.9	49.2	192.3	120.6	68.4	83.2	140.7	232.3	75.7
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710822-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 242.6;Proximal tubular cells: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	27.3	42.1	25.0	26.8	26.1	31.2	42.7	26.7	33.4	23.8	28.0	59.2	52.6	25.8	29.4	35.8	29.4	24.1	62.2	26.0	27.2	78.6	77.7	21.6	31.9	25.7	26.0	26.2	27.8	46.9	14.0	29.1	26.5	31.5	61.1	18.4	29.6	24.1	83.3	23.5	46.4	29.8	26.7	21.0	43.9	18.0	26.4	28.3	44.2	72.5	32.1	35.3	20.4	27.9	95.0	102.1	42.4	65.1	58.9	71.8	156.0	61.4	52.6	84.4	76.2	125.0	132.4	88.2	87.5	63.3	65.5	70.0	88.0	77.9	99.1	74.2	82.8	100.2	39.2	103.7	58.5	138.1	51.1	61.4	95.1	71.1	143.2	77.3	69.6	73.0	110.1	58.6	77.9	57.9	96.7	227.0	158.9	231.8	147.7	101.1	109.8	145.3	130.8	77.3	24.0	48.5	84.4	131.0	106.1	93.9	133.6	108.2	54.5	51.4	54.9	117.8	111.4	22.8	36.9	186.8	68.6	104.5	68.5	11.0	21.5	7.8	15.1	38.3	24.1	20.7	18.9	18.7	30.5	19.7	22.3	20.4	1.2	25.9	46.4	14.4	26.4	23.8	25.0	26.1	26.7	33.4	26.0	27.2	25.7	26.0	26.5	26.7	26.4	27.9	25.0	73.7	40.3	13.4	38.2	47.3	42.3	65.0	46.1	20.8	49.8	43.8	94.8	50.1	55.4	51.5	4.2	104.0	21.2	51.8	242.6	92.0	12.6	42.0	42.4	30.1	60.3	26.3	28.0	59.2	113.4	35.9	72.4	40.0	54.5	34.5	18.9	67.1	73.1	18.5	28.0	81.2	40.7	38.4	28.8	9.1	25.4	42.9	42.7	8.4	64.7	27.1	34.0	19.6	25.4	62.2	52.3	24.5	32.1	55.4	63.6	231.4	70.2	18.0	26.3	35.8	39.8	23.9	27.2	68.7	52.1	61.7	34.8	83.8	116.5	46.1
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230158	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 546.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA035802: AB_10600933, HPA056795: AB_2683237"	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	20.3	18.4	20.1	12.7	20.3	21.0	16.5	21.3	26.3	12.7	20.2	23.6	24.1	12.8	15.4	20.3	12.7	10.4	67.3	20.1	21.5	49.2	38.0	14.7	15.1	20.3	20.6	12.4	14.7	31.3	9.8	13.0	20.6	14.4	24.3	18.9	13.7	12.1	47.0	12.6	24.0	12.4	20.3	11.6	21.8	8.6	20.8	15.7	17.2	67.7	16.7	16.6	14.0	20.5	29.2	27.6	19.1	26.4	32.8	33.1	50.3	25.6	24.5	32.1	39.4	38.6	31.8	31.2	51.9	21.8	71.8	29.3	32.1	38.8	31.7	36.8	33.6	21.3	31.4	43.4	38.7	22.9	27.9	34.6	27.3	30.7	14.5	33.4	24.0	31.9	25.7	22.9	28.7	31.8	35.3	34.9	14.2	26.8	31.9	20.6	33.2	47.9	56.4	32.5	26.6	25.9	26.2	37.9	46.3	30.9	29.0	32.9	17.6	14.3	24.5	32.0	44.5	23.9	41.9	41.6	25.0	42.1	19.1	36.3	22.1	29.3	22.7	32.0	25.4	31.1	25.7	25.8	27.9	25.0	22.8	24.7	25.1	26.5	30.2	27.4	40.3	17.7	20.1	20.3	21.3	26.3	20.1	21.5	20.3	20.6	20.6	20.3	20.8	20.5	64.5	115.4	83.6	16.3	76.5	81.4	101.1	204.0	83.1	26.3	72.4	109.3	333.1	97.2	104.3	88.3	14.6	126.8	67.5	220.5	401.1	118.4	127.7	123.3	79.5	57.2	92.8	97.2	20.4	139.5	192.4	68.6	67.2	113.0	56.4	41.4	52.1	216.1	127.1	28.6	21.4	162.8	120.1	102.4	67.5	45.2	64.7	72.9	106.7	10.3	142.0	61.8	56.7	10.6	17.1	137.1	190.1	69.2	60.5	100.5	256.6	546.3	86.4	45.9	72.3	78.7	92.3	66.1	37.9	86.9	76.9	123.3	64.2	76.9	168.1	114.6
MRPS5	"MRP-S5, S5mt"	ENSG00000144029	"Mitochondrial ribosomal protein S5"	P82675	2	95085369-95149434	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055765	Approved		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055765: AB_2682911"	"unprognostic (1.18e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (7.98e-7)"	"unprognostic (7.51e-3)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (7.73e-5)"	"unprognostic (8.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.25e-1)"	26.0	33.6	5.6	3.8	5.7	7.6	22.3	6.9	7.1	24.4	6.3	34.5	6.9	24.1	4.7	34.5	24.3	3.6	53.6	5.7	5.6	34.6	53.6	24.3	5.5	5.7	5.5	24.9	24.1	6.8	19.9	3.7	5.8	18.5	6.9	5.0	24.7	2.9	71.2	19.4	26.8	5.1	5.1	25.0	30.1	19.5	5.8	6.2	23.8	13.7	5.4	23.7	24.8	6.3	18.8	14.8	8.1	7.8	8.6	10.6	15.3	9.5	4.2	7.1	7.6	28.7	12.9	18.4	7.5	8.4	17.1	11.3	14.0	11.8	13.8	13.0	11.2	11.6	12.3	22.8	11.6	16.5	7.3	10.5	9.3	12.0	12.5	9.0	12.3	10.4	18.0	7.8	10.4	15.1	18.6	17.8	9.0	16.5	13.5	10.5	8.0	21.3	17.4	18.5	12.4	7.8	8.2	17.2	17.6	12.8	7.4	16.0	9.5	10.6	12.9	15.1	15.5	7.6	8.9	14.0	8.8	16.3	9.6	2.5	5.4	3.8	3.6	7.2	4.4	4.5	4.8	4.2	4.8	3.3	4.2	4.4	2.2	3.6	7.4	3.3	5.9	4.2	5.6	5.7	6.9	7.1	5.7	5.6	5.7	5.5	5.8	5.1	5.8	6.3	46.3	80.1	84.6	33.3	52.3	34.8	59.1	112.5	56.9	52.8	42.1	40.5	130.2	58.6	74.4	66.2	50.1	81.8	51.2	68.3	185.9	74.8	68.3	48.5	69.9	48.1	59.4	79.3	31.8	55.4	83.8	53.9	51.0	43.0	40.4	90.7	50.3	129.8	74.1	47.1	29.3	65.0	109.9	51.8	41.2	48.9	51.3	55.3	44.4	7.5	61.5	29.7	44.3	30.7	40.3	50.2	44.2	53.4	69.7	68.1	87.3	131.8	72.3	69.0	39.5	52.2	59.5	80.9	99.1	78.7	32.0	39.4	57.4	60.7	104.5	48.2
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 281.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 747.4;Prostatic glandular cells: 568.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	67.6	72.5	53.9	33.8	56.1	15.6	46.1	53.0	118.1	42.7	85.9	81.6	22.7	37.1	50.7	31.3	37.9	24.8	57.3	55.4	60.8	281.0	50.6	37.8	46.7	54.7	56.5	41.7	22.2	24.2	39.4	51.8	55.6	33.1	36.5	25.6	26.2	41.6	96.1	53.5	39.0	36.7	58.9	28.6	51.3	44.8	63.3	38.3	97.5	76.8	49.8	50.6	33.7	57.8	70.8	56.6	211.0	77.2	74.1	72.9	71.4	79.5	185.4	68.7	70.0	181.8	134.9	105.6	51.7	104.0	92.8	28.7	124.6	106.0	73.4	193.5	65.4	89.6	34.3	47.8	35.4	45.2	31.7	35.0	107.8	127.2	116.5	104.2	47.4	45.2	116.5	28.0	140.7	66.0	73.4	104.1	136.9	135.4	122.1	99.6	37.4	101.5	307.4	60.4	187.5	50.0	84.5	46.2	103.6	112.6	87.3	58.7	24.3	62.8	36.6	115.4	46.3	132.5	125.8	96.3	204.2	118.4	62.8	67.0	53.8	60.4	90.3	53.7	66.6	74.9	67.0	81.4	56.1	48.4	83.8	87.3	46.8	115.7	57.5	101.4	74.0	79.6	53.9	56.1	53.0	118.1	55.4	60.8	54.7	56.5	55.6	58.9	63.3	57.8	45.1	22.4	40.9	32.3	83.9	266.8	229.8	226.6	126.9	40.5	78.9	125.9	59.8	28.6	75.8	252.0	10.4	195.2	103.0	56.3	747.4	41.1	83.1	85.2	88.6	58.0	91.5	45.4	25.7	36.7	237.0	111.7	32.6	58.6	137.7	184.5	25.7	95.7	126.5	8.4	57.9	211.0	75.3	36.4	207.6	73.1	28.0	104.8	101.4	32.8	164.0	37.9	108.1	45.2	6.2	52.8	138.5	102.7	102.0	568.4	61.0	159.2	66.0	26.5	118.3	26.9	104.8	90.4	136.5	71.0	331.0	182.4	124.2	49.8	99.9	335.6
MRPS7	"MRP-S, RP-S7, RPMS7"	ENSG00000125445	"Mitochondrial ribosomal protein S7"	Q9Y2R9	17	75261674-75266376	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022522, HPA023007"	Supported		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA022522: AB_1854131, HPA023007: AB_1854132"	"unprognostic (1.24e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (5.82e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.05e-3)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.95e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.15e-1)"	44.3	58.4	55.5	38.1	55.9	32.9	41.2	60.0	61.9	28.7	59.0	49.9	48.9	28.3	24.4	58.5	39.2	27.1	129.0	55.1	59.3	66.1	64.6	32.4	41.3	57.2	57.5	29.2	39.0	76.6	36.0	40.8	57.6	34.1	48.2	47.3	41.1	35.7	201.3	32.6	40.0	33.8	57.8	39.5	47.5	29.9	59.8	33.6	35.9	212.3	43.6	42.6	35.0	56.3	113.8	188.6	78.8	57.6	63.9	35.7	139.4	73.3	60.9	137.4	101.1	209.8	93.5	96.4	66.4	79.8	91.4	104.5	122.3	135.8	82.2	50.8	173.5	131.8	133.6	201.3	62.5	134.3	69.6	60.0	131.8	108.6	109.6	69.2	177.3	117.8	130.1	93.3	91.1	203.5	151.8	104.7	85.4	157.7	176.2	100.7	229.5	145.2	128.4	124.6	135.8	122.8	93.8	249.9	150.0	83.9	188.4	108.7	72.2	124.0	125.3	68.2	155.7	97.9	61.5	106.6	89.5	88.3	96.9	43.2	155.1	48.2	115.7	161.6	124.2	140.2	112.0	126.0	172.0	128.1	128.6	120.7	11.0	130.5	138.5	164.9	141.6	236.0	55.5	55.9	60.0	61.9	55.1	59.3	57.2	57.5	57.6	57.8	59.8	56.3	44.1	51.3	48.3	12.1	69.3	39.5	75.1	148.1	37.0	65.8	56.5	63.0	77.8	70.1	74.3	57.0	98.0	192.9	63.3	94.1	230.9	112.9	139.2	50.9	43.2	55.6	47.5	61.4	11.8	104.1	175.3	50.2	55.5	43.5	39.3	68.6	45.3	91.7	148.8	47.1	14.0	84.3	77.3	60.0	35.6	454.3	48.4	52.6	42.7	3.7	107.0	85.6	73.2	9.5	11.3	89.8	69.3	39.9	87.7	85.3	129.2	219.3	81.0	114.4	59.2	40.8	73.0	60.5	68.5	68.5	41.9	137.9	53.8	110.0	133.8	77.4
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105038069-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	17.2	33.5	21.4	17.9	22.7	24.6	23.3	24.1	26.5	18.3	25.7	29.8	29.5	20.7	19.2	23.8	24.2	13.4	64.1	21.4	23.3	32.7	31.8	15.4	24.7	24.0	22.8	30.8	24.2	32.8	19.6	12.9	24.3	23.4	33.3	22.3	23.3	21.6	98.6	21.9	23.4	19.8	22.7	18.5	25.9	33.5	22.8	30.8	21.4	97.0	27.1	20.2	17.9	25.1	68.2	28.9	59.4	55.1	30.6	31.5	69.6	42.6	40.6	66.2	59.2	155.0	46.4	70.6	41.1	33.9	68.9	59.8	118.0	62.1	69.9	44.0	77.5	69.7	42.4	94.4	51.0	52.2	29.9	37.9	41.5	54.6	45.4	38.3	51.6	84.8	101.5	35.9	45.7	54.9	70.6	68.6	93.9	57.4	62.6	88.9	50.9	98.3	83.2	47.3	51.4	30.9	49.4	71.5	59.9	58.0	58.9	52.2	34.0	38.8	78.2	38.9	46.6	32.6	41.5	56.3	33.6	79.1	33.3	21.7	23.8	10.1	39.3	31.5	43.3	44.4	43.0	41.7	43.0	35.3	42.9	42.4	2.8	46.0	39.9	32.1	49.9	31.7	21.4	22.7	24.1	26.5	21.4	23.3	24.0	22.8	24.3	22.7	22.8	25.1	18.2	22.4	28.2	28.1	21.0	19.5	25.3	56.4	22.2	24.7	15.4	22.2	110.2	22.8	30.4	22.0	12.5	39.9	29.1	17.7	107.6	40.7	51.7	35.9	18.6	22.5	19.7	47.5	43.4	42.7	40.7	21.2	18.8	12.9	22.8	34.6	18.2	31.2	28.8	8.4	54.2	27.9	24.4	15.2	9.9	14.6	23.9	15.9	30.2	17.8	26.2	21.2	29.9	49.3	69.4	22.6	18.3	27.1	25.0	17.4	23.1	72.3	42.1	32.0	39.5	24.8	28.1	112.8	40.7	23.4	13.2	20.4	25.2	62.9	40.5	19.0
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331337	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 210.0;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	18.9	19.3	10.4	12.1	10.7	14.2	19.3	11.7	13.3	13.9	15.3	25.1	23.7	10.1	13.1	25.5	11.4	8.8	28.2	10.6	11.3	23.4	24.3	13.3	14.0	11.4	10.9	11.3	18.3	23.2	12.5	9.0	11.3	14.7	28.6	14.5	15.3	10.6	40.6	22.1	18.5	10.1	10.6	15.6	14.4	18.1	11.3	13.8	16.3	32.1	20.4	16.9	16.4	11.5	34.7	45.8	25.6	43.0	35.7	32.5	48.7	33.7	43.0	44.5	26.0	55.0	40.6	75.0	16.7	27.0	35.5	99.3	74.1	78.8	36.3	25.2	30.3	25.6	53.4	30.5	23.6	72.3	32.7	30.5	52.7	40.0	70.8	22.4	50.4	29.6	44.2	27.8	45.1	55.1	36.2	23.6	30.0	86.0	45.7	26.8	48.8	79.7	76.6	34.8	30.3	19.9	36.2	58.3	27.9	24.3	62.8	18.2	27.1	19.5	29.6	51.0	42.0	19.1	50.1	33.0	36.8	42.4	22.8	4.7	17.5	6.0	13.3	29.0	14.2	15.6	13.3	12.5	29.8	12.7	13.8	16.5	2.0	22.9	31.3	12.9	16.3	11.1	10.4	10.7	11.7	13.3	10.6	11.3	11.4	10.9	11.3	10.6	11.3	11.5	22.7	3.2	9.1	21.9	18.8	15.4	22.1	30.3	26.2	13.2	20.1	17.3	21.8	18.6	17.8	14.7	12.5	29.0	10.8	21.4	35.2	36.0	210.0	16.2	15.7	22.5	7.8	29.3	28.6	29.5	49.2	11.1	23.9	12.1	24.7	14.5	14.3	19.2	30.4	5.0	39.1	22.0	18.3	17.0	16.5	191.7	9.6	16.0	14.2	20.6	18.3	6.3	11.3	22.1	31.0	24.0	20.6	7.5	19.4	18.1	41.2	37.3	16.2	23.5	19.7	15.1	11.7	30.2	16.6	32.5	22.4	37.1	12.3	31.1	33.9	22.7
MRS2	MRS2L	ENSG00000124532	"Magnesium transporter MRS2"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.6	17.0	10.7	12.0	11.8	6.7	14.3	17.1	13.7	10.9	15.4	14.1	15.4	10.3	14.1	14.1	10.2	9.3	30.7	11.2	12.2	24.2	20.5	10.9	14.9	10.8	11.7	12.3	18.8	22.5	13.4	16.4	11.2	12.8	15.4	30.1	15.9	13.4	52.9	12.3	12.1	10.7	10.9	11.4	15.7	6.3	12.2	8.7	16.3	49.4	14.8	13.2	11.5	11.4	36.7	21.0	24.7	46.3	15.9	14.4	54.8	16.6	19.3	20.5	18.5	80.9	16.9	21.2	67.3	14.6	32.2	21.8	25.6	31.6	22.0	26.8	44.9	33.6	16.4	93.7	23.0	38.7	30.0	22.8	24.7	20.9	16.7	23.8	22.2	27.2	49.5	0.0	22.6	28.9	37.1	35.3	64.6	20.6	18.9	0.2	4.3	48.4	90.5	37.1	39.3	23.7	28.1	84.9	46.5	72.0	43.3	26.3	9.6	9.1	13.8	18.9	30.8	37.4	68.1	29.4	11.3	45.4	38.3	3.4	16.8	7.3	11.6	20.2	14.9	14.4	12.4	12.5	24.8	11.9	13.4	12.6	1.9	15.3	18.8	14.8	11.5	12.1	10.7	11.8	17.1	13.7	11.2	12.2	10.8	11.7	11.2	10.9	12.2	11.4	10.5	35.3	20.0	18.6	18.0	7.1	13.6	18.8	16.5	33.5	15.7	10.4	55.6	20.0	16.4	20.2	39.6	46.5	23.3	13.6	52.8	22.6	0.6	15.7	11.5	11.3	9.6	17.1	33.7	19.1	24.6	14.8	13.3	12.9	12.0	23.3	11.4	14.4	21.9	50.5	35.6	15.4	22.4	15.8	10.0	0.7	12.2	14.8	7.2	9.4	19.6	21.8	16.5	15.1	16.5	15.9	14.9	16.6	19.7	14.7	20.0	40.7	14.4	43.6	19.7	9.2	12.9	5.4	11.6	22.7	11.2	25.3	13.1	27.2	22.3	15.7
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MRTFB	"FLJ31823, MKL2, MRTF-B"	ENSG00000186260	"Myocardin related transcription factor B"	Q9ULH7	16	14071319-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	170	"amygdala: 9.4;basal ganglia: 15.1;cerebral cortex: 21.4;hippocampal formation: 21.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	21.4	7.3	9.4	8.6	15.1	3.8	18.3	0.0	21.4	19.0	0.0	9.9	9.7	14.9	9.1	14.5	14.0	13.3	11.8	21.7	0.0	8.4	5.9	13.2	7.6	0.0	0.0	7.1	12.1	22.2	4.9	21.7	0.0	15.5	10.8	8.6	11.6	15.2	11.9	16.6	7.9	15.6	0.0	5.1	10.1	17.5	0.0	10.3	16.9	14.5	8.1	11.3	12.2	0.0	17.6	17.8	17.8	13.2	5.9	11.0	8.0	4.9	13.3	7.4	10.6	7.7	16.4	9.4	12.4	8.4	9.3	13.8	12.9	14.4	13.5	23.1	7.0	6.0	13.6	13.3	8.2	4.2	5.4	8.4	14.6	12.8	8.3	7.8	14.7	12.2	7.9	9.7	5.6	15.1	13.4	2.8	6.0	4.7	4.8	20.5	13.7	8.1	7.3	17.3	6.2	10.8	23.9	10.2	4.9	8.2	18.0	3.5	9.4	15.3	14.9	4.4	6.4	6.6	8.8	8.4	16.6	7.1	11.7	0.2	0.5	0.0	1.1	0.7	1.7	3.7	1.9	0.9	0.7	1.5	2.4	1.3	0.3	1.1	0.8	1.7	0.9	0.6	9.4	15.1	0.0	21.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	9.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	10.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	10.4	0.4	0.0	0.0	0.0
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	149.7	0.0	19.1	0.8	0.0	0.1	0.5	0.1	9.0	3.0	2.2	1.0	4.2	0.5	8.4	1.8	0.0	0.1	3.4	2.1	4.0	500.4	0.2	0.0	0.3	0.2	7.3	0.3	0.9	0.1	5.1	10.6	0.0	8.9	0.3	0.8	0.1	123.5	1.2	0.1	253.8	18.4	1.2	0.1	50.6	6.7	0.1	673.3	16.3	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785333-60801305	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"intestine: 85.8"	"Cell type enriched"	"Detected in some"	25	"Proximal enterocytes: 319.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014778	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.2	0.0	0.2	0.3	72.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	85.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.2	319.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.3	0.3
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"intestine: 254.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 1139.3"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.2	0.0	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	234.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	254.3	0.0	0.0	0.5	0.0	0.0	0.3	4.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1139.3	0.0	0.0	0.4	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.6	0.1	27.8	0.0
MS4A13		ENSG00000204979	"Membrane spanning 4-domains A13"	Q5J8X5	11	60515392-60542721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 25.0;Late spermatids: 47.0;Spermatocytes: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045017, HPA063626"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA045017: AB_10962976, HPA063626: AB_2685065"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	47.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.0"	"Group enriched"	"Detected in some"	44	"Early spermatids: 262.3;Late spermatids: 672.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.5;non-classical monocyte: 8.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 8.0"	"Cell line enriched"	"Detected in single"	23	"THP-1: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058973	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	5.1	3.7	6.2	3.5	5.6	0.6	3.6	5.8	8.8	1.2	7.5	2.7	0.7	0.9	0.6	0.9	1.3	0.9	2.6	5.8	6.3	1.8	2.0	11.9	1.3	7.7	6.8	0.7	1.3	0.3	1.5	2.4	7.2	1.8	1.1	0.4	1.9	0.5	0.9	0.9	2.7	1.2	6.0	10.4	1.2	73.0	8.5	0.3	1.5	0.3	1.9	2.0	1.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.9	6.2	5.6	5.8	8.8	5.8	6.3	7.7	6.8	7.2	6.0	8.5	8.0	0.2	0.0	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	262.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.3	5.5	672.0	4.1	10.4	0.0	3.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.7	0.0	6.6	0.1	0.0	6.5	3.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0
MS4A18		ENSG00000214782	"Membrane spanning 4-domains A18"	Q3C1V0	11	60729304-60744212	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	24	"breast: 7.7;intestine: 23.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 5.1;Late spermatids: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045121	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 34: Spermatids - Unknown function"			"HPA045121: AB_10969456"	"unprognostic (1.02e-1)"											"unprognostic (8.87e-2)"		"unprognostic (2.51e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.6"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.6	0.2	0.3	2.4	0.3	0.9	2.7	0.5	0.5	6.3	0.6	4.9	5.5	4.2	3.7	4.8	0.9	8.2	0.6	0.3	0.3	0.5	0.4	12.6	1.1	0.4	0.3	0.1	0.5	0.3	0.1	0.3	0.4	3.0	5.4	0.0	1.8	2.4	2.9	2.5	6.7	4.1	0.3	0.2	5.3	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.3	0.5	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071115	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	93	"bone marrow: 420.2"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	1478	"basophil: 2686.3"	"Lineage enriched"	"Detected in single"	4507	"granulocytes: 2686.3"	"Cell line enhanced"	"Detected in some"		"HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.1	0.0	0.0	0.3	0.0	420.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	4.5	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.9	0.0	0.0	0.0	17.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	319.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	126.2	0.0	2686.3	0.1	1.8	0.1	0.1	0.3	0.2	0.4	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.5	0.2	0.1	8.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	0.0	0.0	0.8	0.0	3.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0
MS4A4A	"CD20L1, MS4A4, MS4A7"	ENSG00000110079	"Membrane spanning 4-domains A4A"	Q96JQ5	11	60185657-60318080	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 63.1"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7"	"Group enriched"	"Detected in many"	30	"dendritic cells: 27.7;monocytes: 82.9"	"Cell line enhanced"	"Detected in some"		"HEL: 35.6;HMC-1: 45.8;K-562: 154.9"									HPA029323	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"			"HPA029323: AB_10601866"	"unprognostic (7.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.56e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.21e-2)"	42.8	24.7	3.5	16.5	3.6	6.1	12.3	3.7	8.6	14.1	4.4	14.0	5.2	4.9	3.4	8.9	11.6	25.8	8.4	3.5	3.9	4.8	15.4	28.0	31.3	4.2	3.4	4.1	4.0	3.3	3.3	63.1	3.6	3.4	16.1	2.0	7.6	4.9	2.3	2.9	13.5	20.0	2.5	33.3	6.6	3.0	5.5	11.5	3.7	10.4	7.5	28.0	3.3	4.3	0.3	0.1	0.1	0.6	0.0	0.2	0.7	0.6	0.0	0.2	0.4	0.3	0.9	0.8	0.4	0.0	0.4	0.3	0.5	0.1	0.6	1.6	0.0	35.6	0.7	0.6	0.1	1.2	45.8	0.4	0.3	0.2	0.8	0.2	0.0	0.4	154.9	4.2	0.6	0.7	0.6	0.9	0.7	0.3	0.1	0.7	0.0	2.5	0.1	1.5	0.5	0.5	0.3	0.3	0.1	0.7	0.7	8.9	0.8	1.5	0.6	0.4	0.2	6.0	0.7	0.5	0.2	0.8	0.2	0.1	9.9	0.0	0.1	61.2	0.2	1.0	0.1	0.1	27.6	0.3	0.2	0.1	0.9	1.8	82.9	27.7	0.1	6.0	3.5	3.6	3.7	8.6	3.5	3.9	4.2	3.4	3.6	2.5	5.5	4.3	2.3	0.0	7.9	0.0	3.0	1.8	0.1	0.0	0.6	0.0	0.3	2.2	3.4	2.8	2.5	0.0	0.0	1.8	7.5	0.0	0.0	0.0	0.7	0.0	0.0	5.7	0.0	13.0	0.1	0.0	2.0	1.6	0.0	0.0	7.6	0.0	47.5	4.6	376.8	0.0	0.1	0.0	0.0	445.0	24.9	1.0	0.9	264.6	3.6	10.3	8.3	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	13.1	1.2	1.1	0.1	0.2	0.7	1.8	3.6	1.5	0.1	0.0	0.1
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60200270-60243137	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.4;Erythroid cells: 1.3;Kupffer cells: 3.4;Macrophages: 5.4;Microglial cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.1"									HPA040075	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	5.9	4.0	5.4	3.5	5.1	7.7	3.7	8.1	6.7	1.1	6.5	2.8	3.3	1.8	2.8	1.6	1.5	3.0	1.3	6.0	4.7	1.8	5.5	2.9	2.8	5.4	4.1	1.6	1.5	1.3	0.0	1.8	4.6	2.0	2.7	4.5	1.7	1.2	4.4	4.2	4.5	2.9	2.6	4.7	2.7	2.9	5.3	1.1	1.2	0.8	1.9	1.5	0.0	5.8	4.2	1.7	0.9	2.2	0.7	0.4	3.2	1.7	0.2	0.2	0.3	1.2	1.8	1.3	1.7	0.1	1.2	3.4	0.3	0.2	0.3	5.0	1.1	2.3	3.5	2.0	0.6	1.3	8.1	0.5	1.5	0.5	0.7	0.9	0.2	1.8	2.4	4.2	0.2	1.6	1.9	2.6	1.8	2.0	1.3	1.6	1.7	1.8	0.5	2.1	1.3	2.2	4.9	1.8	2.4	2.0	2.4	2.4	1.1	1.7	7.8	4.8	1.6	5.6	4.7	1.9	0.9	2.8	1.5	17.8	1.4	0.2	0.4	1.6	0.3	0.5	0.3	0.2	2.5	0.7	0.3	0.4	2.7	0.9	1.4	1.4	0.2	0.3	5.4	5.1	8.1	6.7	6.0	4.7	5.4	4.1	4.6	2.6	5.3	5.8	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	5.4	0.0	1.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A5	CD20L2	ENSG00000166930	"Membrane spanning 4-domains A5"	Q9H3V2	11	60429572-60455214	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	167	"testis: 44.5"	"Group enriched"	"Detected in some"	66	"Early spermatids: 700.0;Late spermatids: 1017.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043732	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA043732: AB_10959759"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	700.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1017.8	5.6	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	13.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 580.8;Hofbauer cells: 376.8;Kupffer cells: 1649.6;Langerhans cells: 470.0;Macrophages: 675.9;monocytes: 429.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 406.4;classical monocyte: 1095.3;intermediate monocyte: 345.6;myeloid DC: 638.8;plasmacytoid DC: 454.4"	"Group enriched"	"Detected in all"	74	"dendritic cells: 638.8;granulocytes: 406.4;monocytes: 1095.3"	"Cell line enriched"	"Detected in some"	8	"THP-1: 47.9"									"HPA011391, HPA076623"	Approved		Approved	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA011391: AB_10603876, HPA076623: AB_2686809"	"unprognostic (1.17e-1)"	"prognostic favorable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	72.6	42.3	10.7	57.5	10.9	33.5	40.0	10.8	22.5	28.1	14.7	41.0	27.8	14.3	9.6	25.7	16.8	61.4	22.8	10.0	11.8	11.5	108.6	56.4	109.1	15.8	13.7	12.3	7.8	8.7	9.8	65.2	14.8	12.4	54.9	1.4	16.0	18.3	5.3	7.3	45.1	52.6	12.4	121.5	24.5	7.8	13.6	32.2	10.0	17.7	47.6	59.9	8.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.1	0.0	406.4	1095.3	8.2	1.6	345.6	3.4	9.6	2.2	1.4	638.8	1.5	1.0	1.0	72.8	2.1	24.4	454.4	1.9	752.8	10.7	10.9	10.8	22.5	10.0	11.8	15.8	13.7	14.8	12.4	13.6	17.6	5.3	6.4	22.9	0.0	16.1	9.3	0.6	0.0	1.2	0.3	2.2	8.0	3.3	17.2	2.5	3.7	0.0	2.0	220.6	0.3	0.0	0.0	2.2	0.4	0.2	12.8	0.0	43.9	0.1	0.0	2.7	4.3	2.6	0.2	13.9	0.1	580.8	20.5	376.8	0.0	0.1	0.1	0.0	1649.6	470.0	5.1	1.5	675.9	14.2	40.3	429.2	0.0	11.3	0.5	0.1	0.0	1.2	0.0	2.0	0.2	0.0	0.5	1.5	0.6	46.0	3.0	4.4	0.5	1.1	2.4	8.0	2.1	10.4	0.1	0.2	0.3
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378485-60395951	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 196.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 311.4;Kupffer cells: 1060.3;Macrophages: 567.5;monocytes: 184.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 747.4;non-classical monocyte: 1486.0"	"Lineage enriched"	"Detected in many"	12	"monocytes: 1486.0"	"Cell line enriched"	"Detected in some"	25	"THP-1: 114.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA017418, CAB026387"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	46.9	37.6	6.3	50.9	5.0	10.7	30.7	4.5	13.7	18.2	13.9	21.4	17.6	7.6	4.1	12.7	6.6	46.8	9.9	4.2	8.7	8.0	66.5	75.7	23.2	12.8	10.4	6.0	6.0	9.0	4.7	43.9	11.4	4.9	23.3	1.2	6.7	9.0	1.9	2.3	25.1	15.9	7.4	196.6	14.8	4.7	17.1	18.2	7.3	4.1	18.6	41.2	3.9	18.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.1	1.1	0.1	0.1	0.0	2.8	0.0	0.1	0.1	0.8	0.5	0.0	0.0	114.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	3.0	0.0	3.1	0.0	8.3	188.0	2.5	0.8	747.4	1.1	22.3	0.6	0.5	120.9	19.7	0.8	0.4	9.3	0.8	1486.0	3.2	0.9	137.8	6.3	5.0	4.5	13.7	4.2	8.7	12.8	10.4	11.4	7.4	17.1	18.3	5.0	12.8	31.4	0.0	30.6	2.7	0.8	0.0	0.6	3.6	14.7	9.9	2.1	0.0	3.7	9.2	0.0	1.0	1.4	0.3	0.0	0.0	2.4	0.1	0.0	12.2	0.0	10.1	0.1	0.2	1.7	3.9	1.5	0.1	13.9	0.1	11.0	4.7	311.4	0.0	0.2	0.0	0.0	1060.3	93.4	1.2	1.2	567.5	1.8	59.0	184.8	0.4	4.1	0.0	0.3	0.1	1.1	0.0	1.8	1.1	0.0	0.7	7.3	0.5	19.7	2.2	1.2	0.0	0.4	0.9	1.8	1.9	5.3	0.3	0.1	1.0
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699585-60715807	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 129.7;intestine: 197.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.9;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007319	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.0	0.8	1.6	3.5	1.3	0.0	0.0	0.0	1.1	25.6	5.4	18.2	189.8	8.2	0.0	0.3	129.7	10.8	0.0	0.6	0.4	0.1	0.0	16.6	0.2	0.0	0.2	0.3	2.2	0.7	7.5	0.1	0.0	1.7	16.9	0.0	0.6	7.1	4.6	0.0	197.7	1.0	0.0	0.0	45.7	0.5	0.9	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	1.1	0.6	0.4	0.0	0.2	0.0	0.0	0.9	0.0	0.0	6.4	6.4	0.0	0.2	0.0	0.2	11.9	0.0	0.0	0.0	0.0	0.3	18.6	58.8	1.8	0.0	0.0	0.0	15.0	0.0	0.3	1.3	376.4	3.2	0.3	473.4	0.0	0.4	2.5	0.0	2.0	14.3	11.6	1.3	0.0	0.0	0.0	0.0	0.0	0.1	42.5	140.4	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.1	0.0	0.0	1.7	694.6	0.2	502.8	0.0	0.0	0.0	3.5	0.3	0.7	0.0	0.0	0.0	0.5	0.2	24.7	0.4
MSANTD2	"C11orf61, FLJ23342"	ENSG00000120458	"Myb/SANT DNA binding domain containing 2"	Q6P1R3	11	124766498-124800706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038694, HPA038695"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"HPA038694: AB_2676155, HPA038695: AB_10674693"	"unprognostic (2.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.77e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.65e-4)"	9.8	6.3	8.0	3.8	9.0	0.7	9.9	8.2	10.8	16.2	8.5	10.2	4.0	11.5	7.5	7.5	12.8	2.8	7.2	7.4	8.6	19.1	8.3	9.3	4.5	8.4	8.6	14.1	14.2	3.2	15.3	5.1	8.6	13.5	3.8	5.9	9.3	4.0	4.7	8.4	10.1	2.8	7.8	13.7	10.5	4.7	8.4	3.4	25.3	1.9	3.9	9.4	11.4	10.9	3.0	0.9	10.5	9.9	5.2	6.7	6.1	6.4	3.6	2.3	3.0	4.3	6.2	3.5	5.9	3.3	3.4	5.5	4.5	2.1	3.6	5.8	4.0	3.3	3.9	4.5	2.6	1.9	2.7	3.4	3.8	4.0	3.3	9.1	5.3	3.0	3.9	4.7	5.8	2.6	1.4	9.4	8.0	5.5	14.4	4.2	2.6	3.3	4.4	2.6	3.3	13.0	2.9	3.7	1.9	7.7	8.6	2.1	6.8	15.4	4.3	4.5	6.4	3.0	2.2	2.1	3.2	3.4	8.0	0.0	0.2	0.6	0.6	0.4	0.3	0.3	0.5	0.9	0.3	0.8	0.5	0.4	0.0	0.2	0.5	0.2	1.1	0.2	8.0	9.0	8.2	10.8	7.4	8.6	8.4	8.6	8.6	7.8	8.4	10.9	10.9	3.2	10.3	28.7	7.7	8.8	4.4	2.5	9.6	8.7	6.7	6.7	3.3	5.7	1.8	7.3	2.1	2.9	7.7	3.4	3.9	4.6	5.2	3.2	11.1	9.4	1.2	1.3	33.5	1.0	4.4	10.1	6.6	5.6	1.3	9.0	10.4	3.0	3.0	13.5	30.6	3.1	4.1	3.8	7.3	1.5	9.6	4.1	1.8	31.9	4.4	5.6	8.2	33.7	48.4	4.6	4.0	7.2	4.3	5.0	2.2	3.6	2.9	6.2	13.1	11.3	14.0	2.4	1.6	4.4	4.1	1.9	5.8	7.3	5.0	3.2
MSANTD4	KIAA1826	ENSG00000170903	"Myb/SANT DNA binding domain containing 4 with coiled-coils"	Q8NCY6	11	105995623-106022403	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.3;Muller glia cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014411	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA014411: AB_2668995"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.04e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.90e-1)"	8.4	10.1	11.7	8.4	13.4	3.2	8.3	15.5	16.0	11.7	6.6	7.1	5.2	11.6	6.9	8.8	7.4	7.1	15.8	12.4	11.3	9.5	7.0	8.5	9.9	11.9	12.0	10.8	9.6	8.2	9.7	7.3	10.4	9.6	6.2	33.3	7.3	12.0	11.9	4.4	5.8	10.6	9.5	8.5	7.2	10.3	12.7	8.3	13.4	16.6	10.0	8.8	5.6	15.2	8.3	12.0	26.6	0.2	28.4	31.2	0.2	23.1	31.7	17.7	22.5	21.2	15.9	18.1	38.3	19.6	19.5	21.0	30.1	14.8	22.0	33.3	14.5	35.5	14.3	13.2	42.6	28.0	26.9	21.3	17.8	24.0	47.2	22.1	16.0	19.2	16.8	11.4	26.3	3.4	26.4	14.0	10.3	12.3	24.3	17.7	34.4	26.1	24.3	10.2	17.5	33.5	6.1	20.8	16.8	16.4	16.5	14.2	23.0	26.1	20.3	13.8	23.5	11.3	13.9	9.5	12.1	11.0	19.4	2.4	5.7	3.2	8.7	8.7	8.6	6.5	7.8	6.2	7.2	7.5	9.2	8.0	1.4	8.5	5.2	6.1	6.4	5.4	11.7	13.4	15.5	16.0	12.4	11.3	11.9	12.0	10.4	9.5	12.7	15.2	5.8	16.0	15.4	16.6	6.9	5.4	3.3	6.4	6.2	48.3	6.2	6.3	25.1	10.0	14.4	3.7	20.9	1.6	6.2	2.4	1.9	6.7	39.0	6.6	16.8	8.3	8.4	2.5	8.6	5.8	1.3	13.0	5.6	7.2	6.3	11.9	6.1	6.2	5.3	37.0	10.3	3.3	8.2	9.5	5.3	16.0	14.0	6.2	12.4	5.6	8.8	140.7	8.2	31.7	17.3	6.5	1.0	9.8	6.4	2.0	1.8	10.2	9.0	20.1	0.0	15.0	8.2	12.3	6.9	6.1	5.8	0.3	7.4	10.8	3.2	1.5
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.7	22.7	9.3	17.7	13.7	24.0	16.2	15.0	12.7	15.5	12.7	13.0	9.0	27.7	10.2	11.7	17.8	10.9	9.3	8.9	11.5	12.1	19.8	11.6	28.4	12.7	11.7	53.0	31.3	17.0	9.8	20.3	13.0	15.0	12.4	21.6	10.8	15.6	10.5	13.1	9.8	27.2	10.7	12.7	10.9	35.3	11.3	36.3	17.2	11.2	31.0	12.8	12.2	19.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.3	13.7	15.0	12.7	8.9	11.5	12.7	11.7	13.0	10.7	11.3	19.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369164	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 104.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 55.4;Late spermatids: 58.2;Muller glia cells: 82.4;Rod photoreceptor cells: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 119.7;HAP1: 55.3;NTERA-2: 62.6;SCLC-21H: 88.4;SH-SY5Y: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.5	5.1	11.3	0.3	10.6	0.1	0.8	8.8	11.6	3.2	18.2	1.5	6.1	3.5	1.1	0.9	2.6	0.9	3.3	11.6	10.7	1.0	0.6	0.5	0.3	13.0	13.3	1.8	5.0	1.5	13.7	0.9	9.9	4.0	1.0	104.3	0.7	1.7	22.5	0.7	4.1	1.4	11.0	0.3	4.3	16.2	11.9	0.0	0.8	0.1	0.0	0.5	1.1	8.4	0.1	1.4	119.7	30.5	0.0	0.0	15.2	0.1	0.0	0.8	1.3	21.7	0.6	0.1	1.7	0.0	0.7	0.4	55.3	0.0	0.4	0.6	12.6	0.1	0.5	2.6	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	16.2	0.2	0.3	62.6	0.6	0.7	0.3	0.0	0.5	0.0	0.1	88.4	42.9	0.1	1.0	1.0	11.4	18.5	0.1	0.1	0.5	15.9	0.2	0.1	1.6	0.5	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	10.6	8.8	11.6	11.6	10.7	13.0	13.3	9.9	11.0	11.9	8.4	0.1	0.0	0.0	23.8	0.0	1.0	1.4	0.0	1.8	18.4	4.8	2.8	3.3	0.0	0.0	0.0	54.2	0.2	0.0	1.1	1.9	1.2	55.4	3.8	2.1	1.3	10.1	0.0	1.1	5.2	0.6	2.0	0.0	3.5	0.0	1.2	0.0	0.0	0.1	3.3	2.5	3.5	0.0	0.0	0.4	58.2	0.3	0.1	0.0	1.9	0.6	82.4	0.0	9.5	0.5	1.2	12.0	0.4	0.0	8.3	1.2	0.0	0.0	109.9	13.1	4.6	3.2	7.6	3.1	0.1	0.0	0.4	0.1	0.1	8.6	0.6
MSI2		ENSG00000153944	"Musashi RNA binding protein 2"	Q96DH6	17	57255851-57684689	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 830.2;Cone photoreceptor cells: 754.8;Rod photoreceptor cells: 500.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 184.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022300, HPA068990"	Approved		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB022300: , HPA068990: "	"unprognostic (4.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.22e-8)"	"prognostic favorable (2.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"	7.5	69.1	52.2	13.2	52.8	20.2	18.9	53.0	43.4	12.1	105.7	14.1	10.3	14.0	49.9	9.3	22.9	18.3	33.4	42.0	74.6	36.8	7.5	8.3	22.2	82.5	88.6	46.4	12.8	88.6	44.7	22.6	63.4	21.5	15.6	126.0	17.0	21.0	60.7	8.0	11.7	7.6	63.5	17.2	16.6	15.4	58.8	46.5	25.6	43.4	19.6	19.8	8.2	56.0	11.8	18.8	79.0	28.6	7.7	7.8	53.9	13.7	16.4	16.8	10.1	23.6	20.4	56.9	47.1	9.4	13.1	11.8	50.6	18.1	34.8	77.1	31.7	26.2	46.5	58.7	17.8	28.0	23.9	10.4	24.3	2.4	29.9	24.1	19.3	46.6	52.5	42.3	67.6	27.1	136.8	7.2	26.0	64.0	33.2	184.3	109.8	45.5	46.2	84.0	76.6	154.5	22.1	22.9	63.7	33.8	36.9	21.0	22.4	11.2	27.2	9.2	23.0	57.3	51.7	68.8	29.9	16.7	70.2	2.7	0.1	1.9	0.7	0.1	0.6	0.7	0.8	0.7	0.2	0.4	0.6	0.7	0.1	0.8	0.8	1.1	1.6	0.2	52.2	52.8	53.0	43.4	42.0	74.6	82.5	88.6	63.4	63.5	58.8	56.0	20.5	6.4	28.7	830.2	50.5	24.0	74.9	54.5	34.7	202.1	53.2	33.9	99.1	54.3	42.3	75.4	754.8	117.9	37.5	29.5	123.3	49.3	15.3	150.2	30.8	28.1	98.2	35.5	67.6	14.2	25.9	34.2	34.1	70.8	41.8	178.7	29.6	31.5	20.4	294.4	175.5	51.8	109.9	12.6	16.4	27.2	64.7	20.1	39.2	158.3	13.2	220.6	22.6	249.3	111.6	12.8	24.3	77.5	88.8	74.7	11.6	51.2	106.0	500.1	13.1	42.3	30.6	3.1	7.6	28.2	16.1	149.3	50.6	113.5	37.8	92.4
MSL1	"DKFZp686P24239, hMSL1, MSL-1"	ENSG00000188895	"MSL complex subunit 1"	Q68DK7	17	40121971-40136917	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 358.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022800, HPA023567"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA022800: AB_1853057, HPA023567: AB_1853059"	"unprognostic (1.94e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (2.92e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.61e-2)"	60.2	52.0	34.3	48.0	33.6	56.7	56.7	26.1	39.6	76.6	16.1	62.7	51.7	75.1	55.9	48.1	77.5	38.6	46.8	32.1	26.5	57.1	43.9	61.5	50.8	24.1	25.7	58.3	59.3	47.8	78.8	48.5	22.2	59.8	46.8	41.1	56.5	51.9	63.6	60.8	61.6	53.7	21.8	88.2	57.1	66.2	27.9	62.3	79.8	51.6	51.6	53.3	62.0	27.7	35.9	42.2	88.3	57.9	78.5	67.6	45.0	61.6	65.3	76.1	68.4	42.4	37.8	78.8	45.6	65.0	48.4	65.2	74.7	40.5	78.2	68.0	59.6	43.6	60.5	50.6	40.9	59.7	81.6	56.9	63.6	56.1	46.5	77.4	71.0	47.2	69.3	62.8	61.4	22.8	95.0	64.8	37.6	39.4	27.2	77.1	48.7	72.1	55.4	38.9	80.9	48.0	57.5	358.8	46.5	80.1	83.5	81.0	58.7	51.0	56.4	37.8	52.3	98.5	58.5	77.7	52.0	43.7	60.7	0.0	1.0	0.8	1.7	0.6	0.8	1.1	0.9	1.3	0.7	0.9	0.9	0.8	8.7	0.7	0.8	1.4	0.6	0.5	34.3	33.6	26.1	39.6	32.1	26.5	24.1	25.7	22.2	21.8	27.9	27.7	44.1	28.9	40.7	42.7	22.7	50.0	37.8	21.7	69.4	55.2	41.6	32.3	29.5	25.8	25.8	11.0	12.5	15.4	43.8	36.4	3.9	17.2	16.1	35.8	53.9	43.3	31.2	22.3	39.8	20.7	15.4	37.4	20.4	48.1	3.8	24.8	36.4	35.9	25.2	52.2	33.4	29.1	8.2	36.4	42.8	28.5	58.4	34.2	32.0	33.7	30.6	31.3	30.9	25.1	32.4	24.7	32.1	39.9	26.8	72.7	35.4	9.0	32.7	28.4	39.5	29.2	40.7	71.8	49.2	57.5	65.8	17.0	29.9	27.5	31.4	58.7
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148917-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	11.9	9.4	6.0	21.3	8.7	57.9	13.8	18.8	8.6	14.7	5.0	12.9	13.3	15.2	9.2	12.7	15.5	12.8	9.5	6.3	7.3	11.3	14.1	14.5	33.1	6.5	7.2	20.9	11.5	15.3	8.0	13.1	9.2	12.0	12.7	14.8	13.0	11.5	12.6	11.4	14.8	12.1	6.0	25.8	14.7	17.4	7.2	60.3	17.0	17.2	31.7	13.3	10.1	12.1	26.5	7.5	20.8	23.2	14.4	15.6	33.1	16.1	16.0	14.9	14.9	19.4	15.0	52.1	21.2	14.3	17.0	20.4	24.6	16.2	23.5	25.3	11.9	59.6	19.8	11.0	14.8	51.7	26.1	12.6	17.7	11.7	34.0	14.2	15.1	48.1	22.0	47.7	12.5	15.8	93.8	26.7	25.3	14.7	13.1	40.5	33.5	35.3	7.1	21.2	25.2	16.8	37.7	16.1	26.5	16.2	14.7	28.5	20.6	19.0	15.0	17.4	15.1	47.5	28.0	78.7	15.9	20.2	13.2	5.1	2.5	4.1	5.1	2.9	6.2	3.1	4.7	6.0	2.7	5.4	9.6	6.4	5.9	5.1	2.2	1.5	3.9	4.2	6.0	8.7	18.8	8.6	6.3	7.3	6.5	7.2	9.2	6.0	7.2	12.1	15.0	19.2	11.2	18.9	30.4	28.0	15.6	5.6	23.3	12.9	15.8	9.5	15.2	8.6	7.0	12.9	4.2	8.9	47.1	9.3	3.9	5.1	4.1	9.6	15.3	13.9	18.0	23.1	28.0	5.6	6.3	14.7	9.2	12.9	7.0	12.6	16.8	23.4	8.5	16.8	31.6	14.1	2.0	24.2	25.4	3.7	9.3	18.9	21.4	37.5	21.4	8.0	30.9	39.2	55.1	6.4	5.6	8.6	27.8	14.5	7.7	7.4	5.7	9.7	6.6	18.6	12.3	16.0	12.5	22.8	26.7	4.8	36.2	8.5	12.2	14.0
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775772	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favorable (3.28e-4)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favorable (2.17e-4)"	17.6	11.8	13.4	23.1	14.3	17.0	15.9	12.7	15.4	12.9	13.1	15.4	8.6	13.4	5.4	17.8	14.0	10.0	12.9	14.5	15.0	12.5	13.9	21.9	31.3	13.3	14.1	12.1	11.0	6.8	11.1	10.4	13.4	14.5	8.5	5.7	14.4	8.5	35.8	16.0	25.4	9.9	13.8	49.3	13.6	15.7	16.2	38.8	14.5	22.6	27.0	14.8	14.5	13.2	18.6	20.3	28.0	15.0	21.6	30.1	10.2	24.0	21.9	25.2	30.9	13.7	16.8	22.5	25.2	21.6	16.2	14.0	29.7	17.0	34.1	12.6	20.2	14.0	23.0	7.0	18.5	19.6	20.8	18.7	21.6	29.1	10.9	20.6	38.4	26.6	22.2	14.2	24.5	18.3	19.0	19.3	22.3	21.2	32.7	10.8	25.8	34.1	16.1	21.2	17.8	20.8	22.0	10.4	16.9	23.5	18.0	13.0	34.4	23.7	18.2	40.0	22.6	10.6	20.1	32.9	18.1	12.4	21.0	46.6	53.6	37.2	36.6	47.0	31.9	41.7	42.6	41.3	42.3	45.9	57.9	52.2	66.2	39.4	60.4	41.5	60.4	62.1	13.4	14.3	12.7	15.4	14.5	15.0	13.3	14.1	13.4	13.8	16.2	13.2	30.1	9.6	19.2	7.8	52.7	13.3	15.1	10.7	22.2	10.4	19.1	17.9	16.1	17.2	12.7	7.3	8.4	22.9	73.5	12.7	9.8	18.0	57.0	32.0	30.1	29.1	6.7	24.4	10.7	17.1	33.7	18.2	15.8	25.2	26.6	24.3	27.8	16.8	21.9	8.4	7.3	16.4	8.2	58.2	36.1	24.5	12.5	46.9	14.2	14.0	68.4	10.9	41.2	8.5	8.3	22.5	8.7	16.6	41.3	12.6	12.2	15.2	23.2	7.7	6.6	20.5	21.8	41.8	24.8	24.9	18.5	11.8	54.5	21.6	13.6	13.2
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 93.4;fallopian tube: 278.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	93.4	0.2	0.7	1.1	1.0	3.2	0.5	0.6	1.5	15.9	0.3	8.9	7.1	6.2	24.1	7.1	278.2	16.4	8.4	0.7	0.8	6.5	0.2	71.8	0.2	1.9	1.2	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.3	9.9	0.0	1.4	2.9	3.4	1.0	0.4	13.0	1.1	1.2	0.8	0.2	0.0	27.2	2.9	2.9	1.0	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	1.0	0.6	1.5	0.7	0.8	1.9	1.2	1.3	1.0	1.2	1.0	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MSMB	"IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94"	ENSG00000263639	"Microseminoprotein beta"	P08118	10	46033307-46048180	"Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"prostate: 9384.0"	"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 10715.4"	"Cancer enriched"	"Detected in many"	42	"prostate cancer: 3435.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB026357, HPA051257"	Enhanced				"Secreted in male reproductive system"	NA	NA		6000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB026357: , HPA051257: AB_2681410"	"unprognostic (6.47e-2)"	"unprognostic (7.21e-3)"		"unprognostic (1.37e-2)"		"unprognostic (8.18e-3)"	"unprognostic (4.28e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"		"unprognostic (2.01e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.19e-4)"	5.1	4.5	0.0	3.0	0.0	0.1	20.5	0.0	0.0	3.2	0.0	2.8	10.3	0.3	45.1	12.3	4.6	3.0	0.5	0.0	0.0	1.8	1.8	29.9	0.2	0.0	0.0	0.3	2.3	0.2	0.5	0.6	0.0	9384.0	0.1	0.0	31.9	0.6	0.4	39.7	2.3	0.0	0.0	0.7	552.3	10.1	0.0	1.0	0.7	0.0	10.0	7.2	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	21.6	0.2	0.0	0.0	0.0	0.0	11.3	0.0	1.6	1.0	6.1	0.0	5.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.3	0.0	195.9	586.4	0.0	0.0	6.4	1.3	0.0	4.3	2203.2	0.0	0.0	2.1	0.1	0.3	0.0	0.1	48.9	0.6	0.0	10.7	0.0	0.0	0.1	0.2	0.4	9.5	404.2	0.2	1.3	0.0	0.0	1.2	0.2	0.0	0.0	0.8	419.1	0.0	0.0	78.8	0.3	30.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	29.6	0.0	0.8	10715.4	0.3	0.0	570.6	0.0	0.0	0.0	271.0	0.5	1.4	0.0	0.4	1.5	14.3	0.0	0.1	192.4
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327667-165343164	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 575.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 532.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 416.2;Karpas-707: 412.3;RPTEC TERT1: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055073, HPA056127"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA055073: , HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	18.3	95.2	36.7	20.9	48.2	10.4	66.2	45.1	47.5	57.1	37.4	39.2	75.7	19.1	97.0	145.7	20.9	21.7	18.5	43.9	59.2	52.6	575.6	70.3	20.7	90.5	58.4	25.7	22.6	42.9	18.4	22.9	78.6	58.9	32.9	26.1	34.7	12.1	5.5	82.5	38.1	16.5	45.0	11.0	31.5	52.8	48.4	13.4	22.4	6.5	27.0	20.2	67.0	61.1	89.1	21.7	198.8	36.4	97.7	312.0	37.5	35.3	159.0	44.7	123.4	41.5	372.9	43.4	20.6	43.1	416.2	71.7	101.6	366.3	49.4	37.7	63.0	20.0	20.0	127.6	194.9	35.8	26.8	192.6	237.6	163.6	100.6	61.1	58.8	55.7	35.3	412.3	74.6	45.7	32.6	58.2	115.6	46.9	21.0	16.8	21.8	132.3	399.5	102.5	39.7	30.0	54.5	77.9	33.9	121.7	36.1	44.7	67.6	20.6	36.1	18.5	24.7	75.9	86.5	58.6	43.9	36.0	28.5	13.7	8.6	8.8	34.0	11.6	25.4	40.6	31.8	31.4	15.0	37.6	34.3	35.6	6.1	24.9	20.5	19.3	31.0	29.2	36.7	48.2	45.1	47.5	43.9	59.2	90.5	58.4	78.6	45.0	48.4	61.1	16.9	51.3	168.0	70.5	28.9	36.1	70.1	189.2	21.6	33.8	81.9	23.0	10.7	40.0	160.0	69.9	27.1	55.6	20.7	130.8	35.2	67.9	6.4	27.6	12.2	30.4	60.7	53.9	33.6	71.7	87.0	24.1	35.2	44.4	47.7	83.0	27.8	532.0	28.3	35.3	22.8	72.8	170.9	28.0	11.5	7.0	24.8	18.3	32.0	10.3	23.6	27.2	17.5	42.7	49.6	86.8	85.7	18.8	10.9	138.3	46.0	38.4	103.2	50.4	19.7	5.6	35.1	8.7	15.4	84.6	115.1	123.0	22.3	136.1	36.9	129.0
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2"	"Group enriched"	"Detected in some"	50	"Early spermatids: 96.3;Late spermatids: 216.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 85.7;PC-3: 108.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in other tissues"	No	No		30000	"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.4	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.2	1.5	0.4	0.0	0.0	0.0	1.5	1.2	0.9	0.0	0.1	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.3	0.4	0.8	0.3	0.3	1.5	0.4	0.9	0.6	0.3	0.4	1.3	0.0	1.1	0.0	1.1	0.4	1.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.4	96.3	0.6	0.1	3.1	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.2	0.0	0.5	2.5	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.8	216.6	0.3	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.1	0.7	0.1	1.5	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.1	0.3	0.2	0.1	0.3	1.3
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 337.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		130000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	213.3	83.3	66.6	259.8	71.4	269.8	144.6	80.0	70.9	113.9	79.6	116.0	43.9	155.8	45.0	87.9	110.0	123.1	130.2	64.8	95.9	139.7	91.8	281.5	207.5	101.9	79.6	91.9	41.0	39.2	48.2	150.6	98.8	72.5	78.4	24.0	76.0	126.6	56.2	100.7	96.6	251.6	91.8	200.0	78.4	21.9	87.3	177.0	152.5	75.7	242.2	154.8	98.0	95.5	298.3	223.2	214.0	177.9	250.6	328.9	1.9	733.9	472.2	397.3	305.5	0.6	50.9	247.7	638.8	654.4	210.3	199.4	228.5	523.4	514.1	461.7	63.0	687.5	355.0	0.6	236.0	845.3	1063.8	248.1	110.7	733.1	641.5	384.2	892.3	338.5	339.5	747.1	638.4	0.6	503.0	631.0	266.1	0.3	418.9	259.8	384.0	189.0	426.5	0.2	1.7	0.8	590.6	4.4	231.5	239.7	2.7	453.8	1426.9	449.5	285.3	613.2	494.6	268.6	438.4	262.5	328.9	1053.3	513.0	219.9	312.4	194.0	214.8	359.3	160.4	91.9	116.9	170.6	225.3	76.9	78.3	121.9	334.3	177.5	460.3	31.9	97.0	673.8	66.6	71.4	80.0	70.9	64.8	95.9	101.9	79.6	98.8	91.8	87.3	95.5	243.4	179.5	163.0	19.9	140.8	205.5	62.2	56.5	38.7	0.7	27.9	30.9	27.5	11.5	45.4	68.0	4.2	6.0	227.3	7.5	29.4	177.3	1.4	35.7	64.9	256.2	0.0	71.9	2.2	170.0	16.0	85.7	16.3	62.9	164.6	22.6	100.3	51.2	167.2	5.0	3.8	3.2	2.0	255.3	206.2	5.3	73.7	251.9	69.4	67.5	291.9	43.6	337.8	7.1	14.7	327.7	3.3	109.4	105.7	102.2	0.0	113.6	25.6	2.4	72.3	85.0	131.0	1.9	3.6	24.3	149.5	4.2	206.9	24.4	2.2	54.0
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 120.1"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 137.3;Kupffer cells: 322.8;Langerhans cells: 86.0;Macrophages: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.9"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 105.2;REH: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					NA	NA		67000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	25.9	18.4	4.2	17.5	5.4	13.0	9.7	5.5	10.6	11.6	13.6	8.5	6.6	8.0	6.3	6.2	5.6	29.8	8.7	3.8	6.5	6.7	24.9	120.1	7.0	15.0	7.5	6.1	11.4	6.3	2.6	27.4	10.8	3.6	10.6	5.9	6.3	6.4	2.3	3.5	9.4	17.9	6.9	16.0	6.2	6.2	16.9	4.4	5.2	1.4	2.9	17.4	1.9	22.9	1.5	2.1	3.0	1.5	1.4	1.3	1.4	0.7	105.2	0.3	0.6	3.7	0.4	3.4	5.1	1.0	0.7	0.7	0.7	1.0	2.0	0.4	4.3	4.6	5.1	4.2	0.9	2.4	2.5	0.7	0.8	0.8	1.5	1.8	0.2	1.9	1.7	2.9	1.9	4.3	1.4	1.4	0.5	1.6	1.3	40.7	2.3	1.0	2.0	5.8	2.8	1.2	1.0	2.8	0.2	5.0	0.4	1.2	2.4	2.8	0.9	10.8	2.8	9.5	8.6	7.4	1.1	1.5	2.2	1.7	3.3	0.6	1.0	16.9	0.4	1.1	0.7	0.7	1.1	1.5	1.3	0.9	3.2	0.4	8.8	0.5	0.7	0.8	4.2	5.4	5.5	10.6	3.8	6.5	15.0	7.5	10.8	6.9	16.9	22.9	2.0	22.4	35.9	0.0	2.7	2.7	0.0	0.0	0.0	1.6	0.5	1.4	2.0	2.8	8.1	3.7	25.0	0.5	0.1	0.0	1.9	0.0	2.9	0.0	0.0	6.3	0.0	2.7	0.3	0.0	1.0	2.1	0.0	0.0	17.7	0.1	4.6	1.7	137.3	0.0	3.0	0.1	0.0	322.8	86.0	3.6	1.8	172.5	0.0	28.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.4	6.6	0.7	19.7	1.0	0.7	4.2	1.3	0.1	2.0	0.8	2.6	0.2	0.0	0.3
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MSRB2	"CBS-1, CBS1, CGI-131, MSRB, PILB"	ENSG00000148450	"Methionine sulfoxide reductase B2"	Q9Y3D2	10	23095579-23122013	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 269.1;Proximal tubular cells: 463.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027933	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027933: AB_10601867"	"unprognostic (4.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	16.2	17.3	29.0	6.6	30.8	7.7	11.0	29.5	40.5	13.2	26.8	22.7	9.4	15.8	16.8	10.8	17.6	7.7	61.6	29.5	32.2	19.0	31.0	9.8	3.9	30.4	30.9	11.9	5.4	23.1	14.4	8.2	30.5	14.3	11.4	13.1	9.1	19.5	42.2	5.5	11.9	16.3	29.1	9.3	11.4	3.9	30.8	8.4	14.1	51.7	4.1	17.1	11.0	29.4	7.3	10.4	19.0	11.6	19.3	17.3	5.7	11.5	6.4	7.2	8.3	7.2	15.5	5.9	10.0	24.6	10.9	4.6	6.3	8.6	5.9	40.3	7.0	4.3	17.7	4.1	27.2	0.9	5.0	22.2	14.3	8.4	2.0	15.7	10.4	11.5	5.9	10.3	16.0	21.9	7.0	5.5	10.5	41.4	6.0	8.0	10.9	1.5	9.1	2.8	3.8	26.1	14.2	12.4	23.9	15.9	8.4	17.1	7.7	6.2	5.8	14.0	6.9	13.3	4.4	0.2	8.8	12.7	5.3	0.9	1.4	2.3	0.3	1.1	0.3	0.2	0.3	0.2	0.8	0.0	0.6	0.4	3.4	0.2	0.8	1.6	0.4	0.2	29.0	30.8	29.5	40.5	29.5	32.2	30.4	30.9	30.5	29.1	30.8	29.4	29.0	0.0	16.4	27.1	11.4	18.2	52.1	33.1	59.2	68.2	69.6	79.1	269.1	80.1	21.1	90.1	22.9	116.1	10.6	86.7	176.1	130.4	1.4	49.3	71.6	34.4	55.7	30.7	9.5	63.4	61.2	70.7	23.4	46.5	29.2	114.0	42.1	195.4	109.6	112.7	16.9	54.8	26.4	70.5	25.1	4.4	49.7	54.2	72.9	11.2	29.7	126.6	7.2	14.6	26.1	90.3	79.6	62.4	24.7	34.9	80.8	463.9	24.3	57.5	59.2	52.6	71.6	4.4	7.7	66.7	17.5	69.6	13.5	60.9	71.0	54.3
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 927.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 362.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	29.3	28.0	8.1	1.0	8.3	6.3	8.2	8.8	14.0	12.6	8.1	5.1	50.6	8.9	11.3	7.3	10.5	7.4	4.9	8.1	8.4	96.9	927.9	5.9	3.6	8.4	8.4	12.5	16.4	9.4	29.3	5.8	8.3	12.9	2.1	5.3	8.1	5.1	3.6	14.8	31.1	2.1	8.1	13.9	8.8	34.9	8.2	2.2	36.4	2.9	1.7	6.0	6.9	8.3	0.2	0.4	1.2	2.0	3.7	7.6	3.7	1.1	1.4	0.6	0.8	3.9	1.2	0.3	2.6	1.3	0.5	0.8	0.6	1.5	0.6	1.3	0.7	0.6	2.6	84.6	5.8	0.0	1.6	10.2	2.6	0.7	2.1	14.1	1.4	3.5	0.7	9.9	1.9	0.6	0.5	17.3	0.2	1.1	1.0	0.4	0.5	2.2	4.2	0.6	0.2	2.8	0.0	1.6	0.4	2.5	1.5	5.7	0.9	1.9	0.6	0.1	0.2	21.8	2.9	0.5	2.2	3.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	8.3	8.8	14.0	8.1	8.4	8.4	8.4	8.3	8.1	8.2	8.3	3.1	6.4	3.9	10.1	3.5	2.9	4.6	5.8	6.8	8.2	6.1	10.2	2.2	45.8	5.4	27.6	8.4	4.8	1.0	5.1	62.6	6.9	7.6	2.3	3.5	3.4	8.3	29.7	1.1	3.9	19.7	5.2	9.2	3.2	1.3	36.9	10.0	362.8	1.4	1.7	2.0	8.9	6.1	10.7	1.4	2.6	3.1	1.2	3.6	2.8	0.1	8.9	0.0	3.0	2.9	2.1	7.2	1.9	1.6	1.3	57.0	61.9	6.7	6.9	0.0	2.3	10.9	21.8	9.2	2.6	4.7	5.1	2.1	22.8	13.7	3.4
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.3;stomach 1: 42.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	5.1	0.3	1.1	5.1	1.1	0.2	3.8	1.1	1.7	5.7	1.3	26.5	25.2	1.3	1.2	17.5	1.7	11.4	3.2	1.1	0.9	3.4	1.1	9.5	2.5	0.9	0.8	1.0	5.8	0.1	2.7	0.8	0.9	4.7	20.1	0.2	5.4	1.0	1.3	62.3	23.9	2.0	0.8	1.6	42.6	8.4	0.9	8.8	3.4	0.7	5.6	9.2	11.5	1.0	39.3	14.4	0.1	0.6	0.0	0.0	2.2	0.5	0.1	0.0	0.0	4.1	98.8	1.7	8.8	0.5	0.1	56.3	0.0	59.4	0.0	0.9	1.0	0.1	25.9	0.9	0.9	0.0	1.2	0.3	83.4	0.2	11.7	0.2	0.1	0.2	0.8	0.3	0.0	5.1	0.1	0.1	0.3	33.1	34.6	2.9	0.0	1.1	35.8	67.9	1.0	0.1	11.5	22.6	0.2	0.1	17.7	0.9	0.3	0.0	0.3	0.3	0.1	0.5	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	1.1	1.1	1.7	1.1	0.9	0.9	0.8	0.9	0.8	0.9	1.0	1.6	25.6	10.3	0.7	1.0	8.8	2.2	14.2	6.8	0.0	2.8	2.5	1.0	0.0	10.6	0.0	0.0	0.1	0.2	53.9	0.0	6.4	15.4	2.9	0.8	0.6	4.2	0.0	1.1	10.0	0.4	0.8	108.6	5.3	0.0	0.1	0.0	0.0	0.1	0.0	1.1	25.7	2.0	0.0	1.4	10.5	0.3	0.5	0.0	1.0	0.6	0.0	1.0	2.0	0.1	31.2	30.3	0.0	0.5	2.2	27.6	0.1	7.6	0.0	0.0	0.5	0.9	1.3	1.5	3.2	4.7	0.0	0.5	0.0	20.1	6.2
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055700-190062729	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 10.1;tongue: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.7;Cone photoreceptor cells: 4.2;Early spermatids: 17.8;Late spermatids: 4.2;Muller glia cells: 19.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"LHCN-M2: 25.9;RH-30: 52.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	NA	NA		7600000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	0.4	0.9	0.6	0.0	0.6	0.0	0.3	0.7	0.9	1.2	0.1	0.6	0.2	0.8	0.5	1.1	0.3	0.1	0.3	0.7	0.5	0.5	0.1	0.2	0.0	0.6	0.6	0.4	0.2	0.0	0.6	0.0	0.6	0.4	0.4	3.1	0.4	0.1	10.1	0.5	0.2	0.3	0.4	0.2	0.2	0.3	0.5	0.0	0.4	15.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.9	0.7	0.5	0.6	0.6	0.6	0.4	0.5	0.5	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	17.8	0.1	0.1	0.1	0.0	0.0	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	19.1	0.0	0.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.7	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MSTO1	"FLJ10504, LST005, misato, MST"	ENSG00000125459	"Misato mitochondrial distribution and morphology regulator 1"	Q9BUK6	1	155610205-155614951	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1482.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005899, HPA005914, HPA006075"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: "	"unprognostic (1.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.28e-1)"	18.5	18.2	7.9	10.2	8.2	7.3	18.9	9.0	9.4	18.0	7.6	11.7	8.7	16.1	18.0	14.7	16.7	7.2	14.1	9.0	8.8	17.8	31.7	12.7	11.5	10.0	9.4	17.0	25.1	14.9	24.3	8.6	10.3	20.7	9.0	7.8	14.4	14.8	6.8	11.9	15.7	11.8	7.9	21.2	14.6	23.1	10.0	8.6	18.5	4.7	10.7	15.9	12.8	8.4	23.0	31.1	26.7	41.1	21.9	18.5	33.3	28.8	24.5	35.1	27.9	30.8	14.3	39.5	26.1	25.9	22.6	24.7	40.2	38.8	24.2	15.3	33.6	34.1	29.5	17.8	34.8	36.7	26.4	19.2	19.4	38.8	55.7	15.6	29.2	28.5	28.4	17.3	29.3	37.7	24.7	24.9	35.4	38.6	40.8	21.2	25.0	35.4	29.6	23.1	22.0	26.7	20.2	60.6	26.3	31.2	33.5	49.2	19.5	22.2	24.3	24.0	44.9	36.4	33.8	29.3	25.0	35.6	30.9	3.5	5.9	0.4	10.0	8.3	11.2	7.4	9.4	9.1	8.4	5.5	9.8	6.2	0.7	9.6	5.5	8.4	7.5	6.8	7.9	8.2	9.0	9.4	9.0	8.8	10.0	9.4	10.3	7.9	10.0	8.4	4.6	6.4	6.0	3.9	8.8	2.7	6.1	8.6	5.2	9.1	6.6	4.4	9.7	2.8	7.2	7.3	22.9	7.9	5.8	2.9	3.9	9.6	324.5	4.2	8.2	6.1	5.4	3.8	2.0	13.4	23.7	6.3	12.8	4.7	14.5	9.5	2.2	7.1	8.7	11.8	2.1	4.9	2.0	2.6	3.5	1482.8	9.0	5.5	3.6	1.0	6.3	4.6	3.1	2.5	2.2	8.0	0.9	11.3	17.0	5.5	2.8	9.9	10.9	9.7	0.0	6.7	6.4	23.0	12.6	6.3	1.4	6.6	7.2	7.1	4.6	2.8
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 57.0;choroid plexus: 98.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.4	6.0	12.2	0.7	11.8	0.2	12.8	12.2	16.9	57.0	98.0	1.8	0.5	17.5	0.3	0.9	9.6	1.3	10.3	18.8	12.2	2.9	0.5	4.3	0.6	17.2	11.8	3.5	2.3	0.4	21.1	4.1	11.8	5.5	0.1	0.6	8.8	3.6	20.1	5.2	1.1	3.2	15.1	4.5	2.0	0.7	13.0	0.2	9.2	2.0	0.4	11.2	14.5	12.3	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	12.2	11.8	12.2	16.9	18.8	12.2	17.2	11.8	11.8	15.1	13.0	12.3	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 222644.8;heart muscle: 255389.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 54167.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	22006.8	46968.9	171347.0	8727.7	151652.8	11321.8	17952.5	132201.9	222644.8	10440.9	179120.2	42606.0	27505.7	11582.9	14226.0	20791.8	10700.5	11452.7	255389.3	151507.6	137459.2	63061.8	96575.5	12744.7	9111.4	176794.8	152802.2	8124.5	19467.4	41236.2	7420.2	10527.8	168465.9	12427.0	28389.7	12503.0	23260.1	17753.2	147209.5	26849.0	35366.3	13146.2	138626.1	16284.7	44852.9	10932.5	176888.2	7461.1	14056.3	184587.7	8381.2	17415.3	10559.7	131378.4	5837.6	8554.3	11384.1	12431.0	25510.2	11563.1	12037.2	12867.2	4284.9	3189.4	5257.4	10383.6	18320.5	15138.9	6040.7	9857.6	3118.2	21430.9	1326.6	11407.4	4515.1	7226.0	8040.6	9130.6	54167.9	19725.4	3521.2	5336.1	11055.5	13603.9	11589.8	3149.9	6917.5	14668.4	3902.1	8485.5	5916.3	10551.1	9525.6	14037.0	4378.4	23591.9	2905.0	7814.2	6900.5	5664.0	3401.6	9177.9	15910.6	15016.1	5414.7	7189.1	4466.7	17018.9	8305.7	13626.1	9809.7	17703.3	15637.8	12617.8	8438.9	12565.9	6642.1	4951.2	5072.9	3542.6	6235.7	13711.8	6294.4	5305.8	9759.2	3824.6	3085.1	4907.9	3420.5	5374.6	3047.3	3425.6	3444.6	5567.3	3080.8	3911.2	1900.4	3759.1	5775.1	4847.5	2947.7	3929.0	171347.0	151652.8	132201.9	222644.8	151507.6	137459.2	176794.8	152802.2	168465.9	138626.1	176888.2	131378.4	3924.0	2900.6	3897.1	0.0	13282.9	9769.7	9713.9	22625.0	20857.7	0.0	12033.2	11841.6	107039.5	30777.5	16135.4	19596.3	0.0	0.0	9288.4	40726.1	4255.4	7191.4	1555.3	13044.7	9033.9	7847.9	7514.7	45610.3	0.0	5089.4	0.0	6305.3	19235.7	25645.6	3832.6	20400.0	25951.4	59794.3	0.0	0.0	0.0	24302.1	19071.0	45533.4	7744.0	7398.4	11696.4	12124.7	6894.2	0.0	15180.0	0.0	8901.3	0.0	0.0	6410.5	23865.9	8490.1	13829.3	9441.3	98329.8	33652.6	10474.0	0.0	13614.6	11019.8	9403.5	12096.5	14338.7	27110.9	11475.1	0.0	11502.4	15179.6	27138.6	21770.7
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164780.5;heart muscle: 210840.8"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 709929.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 73985.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		240000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	27287.7	50118.4	114427.0	5960.9	114629.6	9211.1	23112.5	102567.5	164780.5	8637.9	123709.0	47542.8	18239.3	10045.0	10813.1	24529.5	11015.1	5914.4	210840.8	108795.0	110116.5	112074.1	105449.6	14032.6	6314.3	129884.9	115346.3	7950.6	24515.9	29782.0	16861.9	10397.8	125082.8	25688.4	24989.1	8983.3	21379.6	12907.0	93258.6	22997.0	36121.9	9693.6	102620.8	18194.3	45409.4	14516.5	123032.8	6034.4	16877.7	109930.2	7889.2	21068.8	13184.5	102646.5	6276.2	9796.4	12777.6	12396.3	25548.5	9745.3	9393.2	7927.6	6429.8	4420.4	6584.3	10616.0	13681.5	12924.1	6467.6	11751.8	4522.1	23074.6	1724.1	16319.1	5925.8	10089.3	8726.0	9297.7	73985.8	20756.8	5543.0	7919.2	9987.0	14433.8	23568.7	2276.3	8072.8	14337.8	4979.3	12668.7	8862.9	12216.0	12212.6	13490.3	5804.8	22519.7	3353.4	12256.7	6160.6	5998.2	3899.6	10866.7	17578.2	17096.2	4758.2	7830.6	6527.3	15842.4	11881.3	18742.2	11084.6	31596.4	12345.0	10576.0	9043.3	10116.0	5740.6	6151.2	6563.0	7590.8	5638.0	15586.1	7129.7	20953.0	13541.7	15753.7	5586.8	8887.6	6782.0	11844.8	6189.5	6338.9	6316.7	10947.0	6386.1	7947.1	5329.9	6846.5	10055.3	8426.1	5367.4	7670.7	114427.0	114629.6	102567.5	164780.5	108795.0	110116.5	129884.9	115346.3	125082.8	102620.8	123032.8	102646.5	4337.7	1445.5	1999.8	0.0	11825.3	6754.0	8961.4	22171.6	22140.9	0.0	11994.6	16742.4	709929.9	18464.2	10323.3	18597.6	0.0	0.0	7569.1	29582.2	3709.5	3684.4	1119.7	12108.5	6979.9	16215.0	6396.9	27238.9	0.0	4873.7	0.0	10942.5	19089.4	20683.3	2144.6	17185.5	15141.7	53416.5	0.0	0.0	0.0	17158.1	14290.0	26774.7	4814.0	5284.9	7663.3	9292.7	5140.4	0.0	7967.0	0.0	6828.1	0.0	0.0	4709.1	15133.6	5123.0	14109.6	5949.4	40280.5	22569.2	7617.1	0.0	7060.4	9361.8	14171.2	7120.5	8965.1	26952.2	6702.8	0.0	8863.0	13639.8	19371.4	14261.8
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 189825.4;heart muscle: 231090.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 98114.9;Proximal enterocytes: 47697.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 47821.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	27612.7	53681.0	106768.6	6403.7	100201.0	11914.6	26962.2	92217.9	189825.4	9972.2	122787.3	41553.8	21299.6	10118.8	12166.4	23137.6	10414.1	8134.8	231090.6	101700.1	98402.0	135745.7	93934.0	11738.0	7309.6	111323.1	103274.0	9356.4	21307.1	30833.6	18098.1	9332.4	106050.0	25270.8	25404.7	14193.4	21229.0	16620.0	98348.0	28350.1	31017.2	10682.4	91790.3	14201.4	41772.3	19009.4	106894.6	5959.0	20136.7	138793.4	9366.6	19763.5	13535.9	91700.3	6374.2	7329.2	11033.5	15732.2	21484.7	8772.8	6020.3	8032.3	4753.9	3111.6	4736.6	9884.1	9176.0	14020.9	3392.6	6719.8	3380.0	16891.6	1769.9	9653.6	5455.7	4794.4	7644.1	7478.3	47821.5	16704.0	4327.8	4505.2	9419.7	8504.4	13400.6	3422.1	5046.7	10915.4	5848.3	7900.3	6047.2	13759.0	10367.7	12916.5	4589.9	25941.9	2461.0	9979.3	5226.1	4852.9	3482.9	10181.9	19232.2	10970.2	4917.9	6797.0	3741.8	4032.3	8135.9	15244.2	8471.0	19585.6	9432.2	5152.8	8782.1	9756.5	5388.8	5622.3	3881.6	8183.5	5151.5	14362.6	3475.8	2863.0	4714.1	2004.7	1562.3	1885.5	1896.8	2933.1	1703.2	1823.0	1927.4	3253.5	2137.7	2759.1	3629.6	2089.5	1920.3	1612.4	1186.9	2432.3	106768.6	100201.0	92217.9	189825.4	101700.1	98402.0	111323.1	103274.0	106050.0	91790.3	106894.6	91700.3	2817.9	1910.3	2767.0	0.0	9010.7	8343.8	9724.5	21550.3	14394.8	0.0	8643.0	8027.7	98114.9	20354.3	11786.8	16547.0	0.0	0.0	5698.3	25285.3	4368.9	5152.0	1929.0	10274.3	6922.4	7282.3	6805.3	29321.2	0.0	6670.2	0.0	5902.5	8605.1	22503.2	2090.9	20302.5	15810.3	44494.8	0.0	0.0	0.0	19209.5	11157.0	28166.3	5603.1	9286.2	11579.8	7637.7	5553.1	0.0	9746.7	0.0	6001.1	0.0	0.0	5901.3	16542.9	7809.0	8204.1	6813.7	47697.3	33390.3	6427.3	0.0	12142.0	15068.6	7967.9	11927.7	12469.2	17772.8	8480.1	0.0	7584.6	21335.3	22667.3	15127.4
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Cataract, Deafness, Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 130283.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 87067.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 14365.7;HeLa: 18945.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400, HPA074796"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: "	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	17885.7	25075.8	39972.4	2636.6	41108.8	2926.5	15122.5	36592.4	54341.4	6621.5	47885.4	19364.4	8941.2	7119.4	6555.4	10592.2	7498.6	3433.7	130283.4	39044.7	39534.1	60620.7	59133.6	6549.1	2529.8	46506.6	40032.7	6068.7	15418.7	9106.2	11552.0	5320.4	42841.1	15142.5	8793.2	8513.5	12205.1	7331.2	52625.7	13392.0	17520.7	5804.8	34579.6	7362.7	25263.2	7372.2	41908.6	1737.2	9758.2	63751.5	3582.0	12844.4	7620.0	35340.5	2322.4	3039.1	3687.6	3950.3	14365.7	2287.8	2963.8	2587.3	1076.5	668.0	1136.3	3013.8	4943.2	5840.7	1240.7	3087.3	794.6	7063.3	556.2	3180.7	1613.0	2880.4	2458.9	3277.0	18945.0	5461.7	2697.8	1862.5	3828.3	4981.3	4631.2	1257.6	2679.7	4457.1	1715.5	2341.4	1709.0	3565.6	3417.2	6354.8	1735.3	3789.4	824.1	2230.7	2036.7	2028.2	1449.8	3681.4	5134.1	5275.9	1308.0	2302.7	1802.1	3352.1	2587.4	5497.2	4911.1	6332.5	5398.3	2302.7	2984.2	4256.3	2037.2	972.6	1390.1	2557.4	1385.7	2822.6	1485.0	8811.6	3750.4	4806.7	1834.1	1738.1	2355.1	2806.2	2123.9	2376.2	1485.5	3034.9	2241.0	2781.9	2755.9	1680.5	1944.8	1468.0	1511.0	1612.6	39972.4	41108.8	36592.4	54341.4	39044.7	39534.1	46506.6	40032.7	42841.1	34579.6	41908.6	35340.5	3091.7	1185.9	1390.0	0.0	5710.5	3319.9	7605.2	9945.0	8512.3	0.0	4026.8	5510.1	87067.0	11564.1	5338.9	7470.6	0.0	0.0	3723.1	10971.1	2163.9	2555.0	789.7	9063.7	5550.2	5673.6	2863.2	16130.5	0.0	3523.1	0.0	4692.6	4895.1	15794.2	1889.0	16261.2	9871.2	17132.6	0.0	0.0	0.0	9502.4	5486.9	14290.0	2254.1	3983.1	7943.2	4269.6	2612.9	0.0	4118.1	0.0	2612.8	0.0	0.0	2977.1	8823.6	5402.0	5725.9	4425.8	25108.7	14736.3	4210.2	0.0	5798.2	9579.6	5914.9	4807.6	4136.3	9142.3	3422.9	0.0	5502.2	11093.2	10319.6	9796.7
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease variant, Epilepsy, FDA approved drug targets, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111350.7;heart muscle: 127951.9"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 101184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 9432.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 9432.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 28480.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033779, HPA066847"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB033779: AB_2149736, HPA066847: "	"prognostic favorable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	19099.4	24937.1	77977.0	2682.9	79000.3	3456.4	17901.1	73833.1	111350.7	4652.6	82243.3	19464.4	6416.3	5929.7	6428.9	8365.1	6119.1	2846.9	127951.9	74131.5	81543.6	47946.3	45024.8	7877.3	2245.9	84675.5	84925.4	4636.3	15523.0	12519.5	7993.9	5163.4	88069.3	11358.6	8792.2	6455.8	11429.4	7047.3	69102.4	14504.0	16935.3	3849.2	68588.4	8228.4	26033.5	12223.4	81883.1	2158.8	7231.1	61460.4	2986.2	10333.3	5443.7	72626.3	3533.6	3499.2	2812.3	2571.1	10434.4	1879.8	3604.8	2946.1	872.8	805.7	835.0	6132.0	3710.1	4259.8	1831.7	2239.3	810.9	2285.7	316.3	1774.7	1592.0	3064.7	2432.6	4755.7	28480.4	8841.6	2231.9	2279.1	4495.2	4494.5	4734.4	1241.1	1773.2	3240.7	877.2	1226.5	2235.4	2580.5	2400.4	4813.7	1841.1	9325.6	757.8	2191.3	2603.6	1916.7	1277.6	2295.7	4312.3	5574.2	1165.0	1844.2	1632.5	2572.1	2943.6	3403.7	2306.2	7771.2	4632.1	2652.3	2396.0	3427.2	2511.3	2841.3	1883.7	2015.4	1784.6	3937.3	744.7	9432.2	1265.2	2347.3	512.4	662.6	732.0	1155.4	614.6	683.5	439.9	1185.3	800.8	960.2	3270.7	759.6	733.2	677.2	480.0	507.7	77977.0	79000.3	73833.1	111350.7	74131.5	81543.6	84675.5	84925.4	88069.3	68588.4	81883.1	72626.3	1754.9	1352.6	1511.3	0.0	3159.5	2265.8	3355.3	1632.2	2928.1	0.0	3174.3	3513.1	101184.9	9771.1	1985.3	4610.8	0.0	0.0	2175.7	12456.8	1033.1	1511.9	1087.5	3160.1	1985.1	4881.6	3135.6	8308.9	0.0	3595.1	0.0	2970.8	2347.6	5039.6	1402.2	7165.4	7745.2	16276.4	0.0	0.0	0.0	10835.1	927.7	12435.2	1651.4	5233.2	7049.5	2982.5	1497.7	0.0	4450.1	0.0	2385.2	0.0	0.0	2180.4	8080.9	3546.9	2046.0	3735.0	18353.7	8183.6	1760.8	0.0	6409.6	6534.6	4075.7	4806.0	5071.3	2061.1	2073.2	0.0	2839.0	4329.0	10735.4	5236.0
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 184151.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37883.1;Proximal enterocytes: 23257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 23280.2;HeLa: 21694.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	31356.6	42036.1	79316.1	3483.1	80070.8	4077.5	25368.6	75454.6	124729.8	8985.8	81148.8	26406.1	11478.9	8410.1	8217.8	12712.6	10495.3	3610.0	184151.1	75602.8	85299.8	84244.0	72988.4	9018.3	3610.8	89729.0	83678.9	9439.2	26008.9	14199.5	13387.4	6281.1	85648.8	23996.0	10095.2	6318.4	14787.5	8355.4	70313.2	16879.7	21792.1	4960.7	71704.7	11407.9	36122.2	10815.9	84470.1	3654.8	14626.9	73367.5	3934.1	18841.5	10373.7	74059.9	3324.0	5255.7	3450.6	3399.1	23280.2	4613.0	2871.7	2717.2	1592.1	1441.9	1616.6	7973.2	5004.1	3408.8	4095.7	3519.2	2600.2	6710.1	1504.4	5941.5	2461.9	4945.3	7153.7	3371.4	21694.2	13369.3	3629.0	5018.8	4874.1	8076.0	10704.2	2416.7	2704.4	8547.3	2285.4	3853.4	2711.1	3864.5	2747.1	10748.2	2646.2	6609.3	1779.4	9407.1	4824.1	2262.5	3389.7	3164.0	8729.4	8962.3	1417.0	3058.9	1310.8	2587.7	5763.8	8928.3	6011.6	7960.5	3898.6	2207.0	3378.3	3876.8	2982.9	1492.1	2128.5	7735.7	1794.0	2976.6	1284.1	2263.7	612.4	386.5	336.6	346.8	441.9	672.5	393.0	417.4	321.5	686.4	568.4	769.3	968.2	447.0	335.5	312.1	262.5	353.1	79316.1	80070.8	75454.6	124729.8	75602.8	85299.8	89729.0	83678.9	85648.8	71704.7	84470.1	74059.9	4254.0	701.9	879.1	0.0	6320.6	1987.5	2507.9	1722.8	5384.4	0.0	3350.4	5821.1	37883.1	9781.1	1560.8	5041.1	0.0	0.0	5039.9	14324.8	1164.1	1320.8	1023.5	11751.2	6030.4	3302.6	2852.4	14390.0	0.0	2870.2	0.0	3063.4	6039.9	17552.8	1453.7	17373.9	10407.8	20920.6	0.0	0.0	0.0	11328.3	870.8	16584.4	1757.6	5643.0	9133.7	4877.6	1858.7	0.0	4964.0	0.0	2775.5	0.0	0.0	2194.1	9034.9	4865.3	6343.6	1554.6	23257.1	8457.2	2113.9	0.0	7001.2	6561.9	3856.1	5442.6	3706.2	3801.0	1888.8	0.0	4844.1	3423.5	10381.8	2314.6
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 196536.0"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 253563.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13456.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 41594.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053928	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	23701.9	43566.1	86386.5	4193.8	83474.8	3652.7	19363.5	76852.9	119139.4	8711.6	100909.6	30312.4	11021.5	10764.3	6795.9	15885.7	10624.6	4622.9	196536.0	81116.7	85290.4	76204.1	101401.1	11855.8	3820.4	102081.7	90689.2	8957.6	21476.2	15709.9	12834.3	7692.4	97098.9	22214.5	15007.9	14112.1	17508.5	11691.2	61489.1	18268.8	25046.6	7116.7	75024.9	12782.7	39594.1	13571.1	91494.4	3233.7	14785.3	70605.7	4913.1	19417.4	10309.3	74806.7	4251.7	4285.9	5449.6	8075.1	12523.6	3123.1	3808.6	4184.0	1603.2	958.4	1834.2	6555.4	4688.4	7428.4	3608.7	3590.8	1396.3	7685.0	496.1	6777.9	1691.7	4330.2	2654.6	4592.7	41594.9	11166.3	1884.9	4672.8	5223.9	5330.2	7007.6	1403.3	4977.9	8925.4	2344.4	3683.1	3908.9	8930.2	3461.9	9508.0	1848.1	10481.0	1551.2	3650.3	2876.4	2481.0	1712.1	4518.2	6770.1	8938.3	1999.0	2694.8	2434.3	7967.3	4267.8	9600.3	5601.2	10888.7	6532.2	3851.7	3726.9	5232.7	3330.8	5307.6	2292.6	3407.7	2514.1	7881.4	2100.8	13456.8	3334.1	7103.1	1902.0	2192.8	2614.3	3555.5	2129.5	2285.7	1616.0	3624.4	2452.9	3095.1	2513.1	2106.5	2329.2	2112.6	1668.2	1840.0	86386.5	83474.8	76852.9	119139.4	81116.7	85290.4	102081.7	90689.2	97098.9	75024.9	91494.4	74806.7	3065.0	1269.2	1516.1	0.0	6183.3	4404.5	9073.3	7719.8	2713.0	0.0	6210.4	6965.6	253563.4	15377.3	4975.3	12806.1	0.0	0.0	4005.7	20185.0	2435.8	2924.2	1109.7	6731.7	4298.6	9316.2	5090.0	20898.0	0.0	4058.3	0.0	5843.3	5601.5	11920.4	2188.6	15486.9	13931.3	35046.7	0.0	0.0	0.0	14557.8	5771.7	22254.8	3452.7	5132.5	8834.9	4749.3	3799.3	0.0	6280.7	0.0	4212.2	0.0	0.0	3710.0	12363.2	5788.3	3409.4	5872.9	28978.7	17714.1	4527.9	0.0	6310.9	8264.3	7732.9	6461.4	6003.0	3008.8	4937.6	0.0	5125.3	7671.5	15595.2	11405.7
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 488.0;liver: 430.8"	"Group enriched"	"Detected in many"	6	"Adipocytes: 797.9;Fibroblasts: 244.1;Hepatocytes: 343.8;Skeletal myocytes: 561.9;Smooth muscle cells: 889.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 33.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.4;ASC TERT1: 27.9;HHSteC: 19.7;HMC-1: 29.5;hTEC/SVTERT24-B: 80.2;NTERA-2: 40.1"					"Low region specificity"	"Detected in single"			"CAB002161, CAB013056"	Approved					NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	488.0	64.3	9.8	10.8	12.3	0.0	208.1	9.8	14.1	62.0	8.2	28.9	7.7	13.6	1.3	33.4	68.7	30.2	63.3	9.3	10.7	136.8	430.8	115.2	0.6	10.6	10.8	19.8	90.3	2.1	25.9	0.7	11.7	33.1	13.1	4.4	18.9	2.9	100.0	26.1	23.4	16.9	11.5	3.4	42.9	8.4	10.8	6.1	67.7	6.1	0.7	34.0	22.6	9.7	0.0	6.2	0.0	0.1	18.4	27.9	0.4	1.9	7.9	1.2	1.5	2.3	4.8	0.0	2.4	1.1	0.0	0.5	0.0	0.4	2.9	0.0	0.0	0.0	2.5	9.9	19.7	0.2	29.5	8.2	0.0	80.2	0.0	0.0	7.7	0.0	0.7	0.0	5.5	0.0	0.0	0.1	40.1	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.9	0.0	0.3	6.3	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	9.8	12.3	9.8	14.1	9.3	10.7	10.6	10.8	11.7	11.5	10.8	9.7	797.9	9.6	1.7	0.7	1.8	27.4	11.3	1.9	5.7	0.0	11.7	15.4	5.4	8.6	5.1	0.0	0.0	1.1	1.0	11.1	13.7	2.7	0.1	11.9	6.9	63.2	3.6	29.5	0.0	1.8	12.8	244.1	5.1	23.8	3.8	0.3	15.7	343.8	0.3	0.0	0.0	32.3	0.0	10.4	39.6	0.7	55.0	12.4	33.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.6	12.8	1.2	27.9	86.5	16.1	3.0	0.0	26.3	561.9	889.5	0.0	0.3	2.1	19.5	0.5	6.6	0.4	34.7	13.7
MT1E	"MT1, MTD"	ENSG00000169715	"Metallothionein 1E"	P04732	16	56625475-56627112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1787.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 4001.6;Paneth cells: 4625.0;Proximal enterocytes: 5720.1;Proximal tubular cells: 8933.3;Undifferentiated cells: 2966.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.8;T-cells: 20.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 1095.1;LHCN-M2: 827.5;RPTEC TERT1: 946.2;U-2 OS: 527.7"									HPA041152	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041152: AB_2732490"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.86e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.78e-2)"	927.5	339.2	364.4	52.2	378.0	2.8	264.0	393.5	510.1	109.2	317.9	261.4	105.1	60.3	12.6	135.4	299.6	40.9	128.8	354.1	378.2	497.9	1787.5	230.3	11.7	376.7	390.6	72.4	537.3	16.3	53.3	19.1	394.6	240.3	189.3	36.8	94.7	20.6	323.0	192.4	357.7	85.5	366.2	30.3	584.7	11.5	400.8	4.0	382.6	92.5	8.0	89.1	140.9	355.9	102.2	0.0	0.0	0.0	154.5	177.0	1.6	263.8	278.6	70.7	82.1	0.9	133.0	0.0	20.3	91.6	10.7	216.7	241.2	1095.1	96.8	102.7	0.0	4.1	139.4	17.5	69.2	0.6	0.6	122.7	362.4	185.5	211.6	426.7	43.5	0.1	0.2	0.7	827.5	0.2	0.4	67.3	94.3	0.0	1.1	0.3	0.0	2.9	946.2	0.0	14.2	0.7	0.7	0.2	1.0	17.4	0.5	124.1	108.6	0.4	527.7	82.5	51.5	0.5	1.9	2.8	296.9	170.2	0.9	0.0	2.9	0.0	14.7	2.1	5.0	0.5	8.2	20.3	5.8	0.0	3.7	14.7	0.1	0.2	1.8	0.3	20.6	3.8	364.4	378.0	393.5	510.1	354.1	378.2	376.7	390.6	394.6	366.2	400.8	355.9	1237.9	394.2	158.2	83.9	59.6	178.6	240.1	86.9	306.2	0.0	214.2	311.0	106.8	589.0	168.4	496.6	0.0	18.4	32.7	2403.7	1402.9	392.8	1.8	710.8	161.7	210.0	241.9	186.9	0.2	193.7	908.6	522.8	880.2	1646.2	28.5	184.3	222.8	4001.6	34.9	0.0	0.2	2467.0	22.4	110.6	29.0	4.6	149.5	121.0	110.3	8.4	61.9	0.0	1.0	7.5	2.0	314.3	4625.0	51.1	20.6	998.6	5720.1	8933.3	137.6	0.0	216.9	818.8	513.7	3.2	3.7	286.4	148.0	79.8	96.0	14.7	2966.9	84.3
MT3	GIF	ENSG00000087250	"Metallothionein 3"	P25713	16	56589074-56591088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	57	"brain: 6445.7;choroid plexus: 3969.5"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 228.8"	"Cancer enriched"	"Detected in many"	58	"glioma: 392.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive CD8 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	51	"T-cells: 5.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.4;RPMI-8226: 6.2;SCLC-21H: 11.0;U-87 MG: 18.3"					"Low region specificity"	"Detected in all"			"HPA004011, CAB017779"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB017779: , HPA004011: AB_1854158"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.26e-2)"	4.2	91.7	4616.8	0.9	4744.4	0.1	2.8	4634.5	6445.7	6.0	3969.5	15.7	0.2	0.5	0.0	3.0	3.7	0.4	12.2	4519.6	4483.6	7.6	2.2	1.6	0.7	4417.7	4500.0	4.7	1.9	2.2	40.3	1.5	4413.7	7.1	2.5	63.3	44.0	0.6	4.3	3.7	4.8	0.3	4335.2	0.9	6.5	10.1	4826.7	1.9	2.1	5.6	12.8	3.8	9.6	4588.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	6.2	0.0	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.4	0.0	0.0	1.2	5.0	0.0	0.0	0.0	0.0	0.0	0.5	4616.8	4744.4	4634.5	6445.7	4519.6	4483.6	4417.7	4500.0	4413.7	4335.2	4826.7	4588.2	0.4	0.0	0.5	228.8	0.0	0.3	0.1	10.7	0.0	0.0	0.0	0.5	29.6	0.0	4.0	0.0	0.0	0.0	0.0	9.9	45.0	1.7	8.0	8.3	0.1	0.5	10.3	0.0	14.3	0.0	0.1	2.9	0.0	1.8	0.0	3.9	0.7	0.2	0.3	0.0	10.0	12.3	4.1	0.0	0.0	9.7	1.2	0.3	0.0	16.9	0.0	0.0	1.0	43.7	28.2	0.0	3.2	0.4	0.0	0.3	0.3	0.7	18.4	0.0	0.0	3.8	0.7	4.0	2.5	0.0	0.0	0.0	1.5	20.4	8.3	0.1
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.1	23.8	24.1	10.8	23.4	15.4	24.6	23.7	31.0	31.7	19.4	31.2	13.1	29.9	11.6	22.6	31.8	6.2	39.2	24.1	20.1	24.7	24.1	19.6	12.1	22.2	21.5	38.6	30.1	9.4	36.9	9.2	20.1	31.8	5.6	8.3	23.6	12.7	25.6	21.1	22.1	9.0	20.0	26.7	22.5	37.6	22.5	16.5	30.4	7.7	9.1	29.2	24.4	22.3	33.6	26.3	47.9	48.2	18.0	30.5	42.3	26.2	19.9	25.4	24.3	34.4	44.1	65.4	26.7	19.3	17.9	45.3	35.1	25.0	17.1	43.2	59.0	34.1	25.2	35.5	39.6	43.2	25.3	34.4	30.9	18.0	41.1	35.5	36.4	48.0	39.3	27.7	13.4	60.4	78.3	85.2	69.1	47.7	55.1	73.1	29.1	21.5	20.6	26.0	76.9	80.1	35.5	40.5	40.8	24.3	36.7	40.7	26.6	20.4	21.6	34.1	27.8	55.9	28.9	41.3	25.6	28.7	36.6	0.1	0.2	0.8	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.0	0.4	0.1	0.9	0.2	0.2	24.1	23.4	23.7	31.0	24.1	20.1	22.2	21.5	20.1	20.0	22.5	22.3	32.1	3.2	16.0	37.9	20.9	15.6	28.8	14.6	13.1	0.0	64.8	38.6	9.2	27.1	15.2	35.0	0.0	11.6	17.7	17.2	17.6	13.2	32.8	25.0	28.4	20.4	18.6	25.4	17.2	19.6	8.0	21.8	28.1	23.9	5.7	47.6	18.2	15.5	11.0	0.0	16.1	21.6	10.2	18.5	13.5	11.3	36.1	15.7	12.4	21.5	13.8	0.0	20.6	32.6	27.0	16.3	11.5	32.0	17.8	45.4	18.5	8.8	27.0	0.0	19.7	30.5	25.4	21.5	13.3	16.8	19.0	9.3	18.7	27.1	24.9	46.2
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	11.8	41.8	16.4	5.6	18.9	1.6	14.9	9.1	19.4	18.5	7.1	16.6	7.8	16.8	27.5	21.8	16.1	10.0	12.4	21.9	14.9	13.6	7.9	8.8	10.7	12.3	13.9	29.2	18.8	17.3	15.1	15.3	18.8	14.4	13.2	9.3	13.6	16.8	9.1	19.1	11.4	12.0	11.7	7.8	16.8	21.0	16.1	70.4	12.6	9.9	14.5	15.3	17.8	14.8	13.0	16.6	20.1	14.3	17.4	28.0	46.6	7.4	18.6	21.7	19.2	22.2	26.2	45.4	12.6	22.1	15.9	8.2	51.6	25.2	34.2	14.1	21.0	6.7	8.8	36.4	21.9	5.0	29.0	29.5	29.1	13.4	16.6	28.1	30.4	23.9	16.5	6.1	25.7	27.8	30.3	22.0	84.4	20.8	9.7	18.4	18.9	0.0	25.7	12.1	12.3	37.1	13.5	45.5	17.8	61.6	23.2	7.0	14.2	8.9	12.1	7.2	8.1	11.5	4.7	63.5	12.6	5.7	11.1	2.5	0.9	0.0	1.7	0.6	2.6	1.2	2.0	2.9	1.5	1.3	4.4	3.0	0.2	1.8	0.9	0.4	1.1	1.5	16.4	18.9	9.1	19.4	21.9	14.9	12.3	13.9	18.8	11.7	16.1	14.8	12.7	12.8	12.5	60.4	10.8	15.3	21.1	33.0	15.4	0.0	24.6	19.6	12.5	15.7	25.7	22.0	0.0	58.5	5.1	19.1	17.6	22.9	10.7	44.5	23.1	13.1	9.6	2.5	137.0	28.0	42.0	21.7	31.1	32.3	12.0	72.3	20.7	13.3	12.4	0.0	81.8	20.0	50.8	6.6	7.1	26.0	33.8	5.2	17.8	53.4	6.9	0.0	9.2	106.1	65.9	20.2	21.8	39.9	10.9	17.7	25.2	33.1	18.4	0.0	13.1	15.8	35.9	25.5	41.1	24.5	18.3	59.9	12.6	44.5	21.5	17.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTARC1	"FLJ22390, MARC1, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786913-220819659	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 192.3;breast: 86.2;liver: 84.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 109.8;Extravillous trophoblasts: 47.9;Syncytiotrophoblasts: 75.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 30.2;classical monocyte: 33.6;eosinophil: 12.3;neutrophil: 42.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 42.8;monocytes: 33.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 126.5;HeLa: 56.2;Hep G2: 67.6;NTERA-2: 57.8;OE19: 49.4"									HPA028702	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	192.3	7.4	9.4	6.8	10.5	17.9	86.2	9.8	13.2	7.9	7.9	18.9	7.6	2.8	14.0	7.6	6.2	4.1	8.4	10.0	11.7	10.2	84.5	9.3	2.8	10.1	11.8	5.5	9.6	5.4	7.0	16.0	9.6	36.2	17.3	5.7	27.2	13.5	11.0	3.6	9.7	4.0	9.1	10.2	9.3	1.4	14.3	1.6	53.5	9.2	2.1	8.8	5.0	8.5	15.0	7.8	5.9	0.2	1.3	0.3	126.5	1.4	1.2	0.8	1.5	45.4	1.0	0.1	5.3	1.6	0.1	0.1	28.3	2.9	2.1	0.2	25.7	0.1	56.2	67.6	2.7	0.3	0.5	4.5	1.3	0.2	0.0	0.2	1.1	0.1	4.3	0.3	1.1	14.7	0.1	31.9	57.8	49.4	23.8	0.1	0.0	0.3	7.1	17.4	16.4	36.1	8.1	11.4	0.2	16.4	38.5	34.7	0.4	0.1	12.6	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.1	30.2	33.6	12.3	0.1	2.5	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.0	42.8	0.0	1.3	0.3	0.0	9.2	9.4	10.5	9.8	13.2	10.0	11.7	10.1	11.8	9.6	9.1	14.3	8.5	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	47.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	0.0
MTARC2	"FLJ20605, MARC2, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 132.5;liver: 223.6"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 36.0;TIME: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	30.4	17.9	10.3	6.2	11.8	0.6	16.5	7.8	15.4	11.6	54.5	17.9	59.1	6.7	15.6	9.7	10.8	21.6	25.0	11.2	10.1	132.5	223.6	31.2	7.4	7.9	11.7	21.9	29.9	125.0	9.5	12.7	8.3	20.2	20.5	3.0	36.3	12.5	34.5	4.7	58.2	9.5	8.2	11.6	27.9	11.0	11.9	3.1	42.1	21.4	8.2	12.5	10.4	9.9	9.5	7.8	4.1	5.4	10.1	4.6	3.2	6.7	11.7	8.0	8.1	5.3	11.9	0.0	4.6	6.5	4.3	1.3	0.0	9.4	7.5	0.0	15.7	0.0	16.5	11.0	9.3	4.5	0.0	8.0	14.1	3.0	0.0	12.1	22.2	0.0	6.3	0.1	5.1	2.3	0.0	15.7	6.6	3.2	7.8	0.0	13.0	0.2	28.2	10.3	2.3	6.1	10.6	0.1	15.2	4.5	36.0	5.6	33.9	0.0	4.8	10.6	12.0	2.0	0.1	0.0	1.7	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	11.8	7.8	15.4	11.2	10.1	7.9	11.7	8.3	8.2	11.9	9.9	7.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	1.3	1.1	1.0	2.5	1.2	4.0	2.6	3.6	1.7	1.6	0.7	1.7	1.5	2.1	2.4	1.4	1.7	1.2	0.6	1.0	0.9	1.0	0.8	1.3	4.3	1.0	1.0	2.4	0.9	1.0	0.8	2.1	1.2	1.5	2.6	4.3	1.1	1.0	0.7	3.0	1.3	2.0	0.9	1.8	1.1	5.0	1.1	4.6	0.8	0.8	4.0	1.0	1.3	1.4	15.3	4.5	14.6	6.0	2.1	3.5	7.1	11.4	6.5	16.4	21.0	4.9	8.3	13.8	11.2	3.8	4.9	13.0	13.9	6.8	20.3	11.5	10.6	11.6	6.7	5.6	1.1	12.4	8.6	1.3	2.9	12.7	8.1	2.5	7.3	12.6	7.6	10.2	9.7	6.9	19.8	7.6	6.5	12.0	9.0	11.3	15.0	9.8	3.9	5.3	7.4	8.6	7.7	44.8	7.0	7.9	8.5	8.9	4.5	7.0	12.7	9.0	18.6	3.9	8.9	8.0	6.6	15.1	8.3	0.0	0.1	0.1	0.3	0.6	0.5	0.7	0.5	0.7	0.2	0.5	0.8	0.7	0.0	0.5	0.3	0.0	0.7	0.3	1.0	1.2	3.6	1.7	1.0	0.9	1.0	1.0	1.2	0.9	1.1	1.4	1.6	0.0	1.5	7.5	2.9	0.8	1.7	1.5	1.8	0.0	1.4	1.3	1.1	0.0	1.1	1.8	0.0	2.3	2.5	0.5	0.0	0.9	0.8	1.3	2.6	1.1	0.0	12.8	14.7	1.8	3.0	2.5	2.6	1.5	2.5	5.0	1.8	0.9	1.6	0.0	9.1	0.9	0.0	0.3	1.8	0.4	1.5	1.7	1.8	3.7	1.0	0.0	2.1	9.0	16.1	0.6	0.1	1.2	2.3	1.2	0.3	0.3	2.4	0.0	0.0	5.6	2.6	16.2	10.2	1.4	0.6	0.7	3.3	1.5	0.8	0.8
MTCH1	"CGI-64, PSAP, SLC25A49"	ENSG00000137409	"Mitochondrial carrier 1"	Q9NZJ7	6	36968141-36986298	"Predicted membrane proteins, Transporters"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1002.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015971	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015971: AB_1854171"	"unprognostic (3.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.32e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.70e-2)"	151.0	279.7	314.7	97.4	331.9	194.1	140.2	290.1	341.2	194.5	257.9	151.7	93.7	136.3	312.1	130.8	154.2	99.6	259.7	326.1	333.3	168.1	117.2	202.5	95.4	306.1	310.3	177.3	165.4	142.1	284.8	106.0	333.1	183.1	96.4	92.0	144.2	196.5	133.7	176.6	125.2	114.7	305.1	148.7	156.2	81.1	349.0	88.2	364.1	89.0	88.6	156.4	166.2	340.8	196.3	130.8	173.3	214.0	254.7	171.9	99.0	225.3	208.2	312.1	322.1	218.0	118.3	97.1	197.7	379.8	301.8	167.1	189.2	181.8	360.2	104.5	183.9	101.3	223.4	165.4	184.1	65.7	92.1	194.5	140.5	289.7	140.5	271.8	269.3	133.0	186.1	97.5	199.8	221.4	134.3	149.8	170.1	175.2	147.5	122.9	135.4	102.6	169.1	160.5	278.8	119.9	163.9	141.2	206.8	173.6	182.5	181.9	299.6	311.5	246.1	241.3	247.3	85.3	92.5	1002.9	112.1	179.4	250.1	11.0	34.7	45.4	14.5	34.9	13.5	18.8	27.5	29.2	31.1	31.2	26.2	15.4	37.8	18.4	44.7	17.3	22.4	17.3	314.7	331.9	290.1	341.2	326.1	333.3	306.1	310.3	333.1	305.1	349.0	340.8	133.7	48.1	99.1	47.3	79.1	113.7	177.1	138.6	71.7	0.0	152.7	125.2	162.5	117.2	101.2	69.9	0.0	183.5	91.8	149.9	168.3	213.0	8.2	99.0	139.4	112.3	149.3	67.6	54.1	170.0	224.0	163.4	94.3	177.3	29.2	193.6	85.6	50.9	189.2	0.0	52.8	133.0	105.8	97.2	150.6	16.3	138.2	109.5	136.9	44.0	173.2	0.0	55.6	28.1	106.4	181.7	162.3	132.4	57.6	255.0	144.3	129.4	68.0	0.0	52.6	108.8	133.5	18.5	46.4	86.2	123.5	248.3	85.8	118.5	145.1	208.5
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642607	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 569.2;Proximal tubular cells: 508.1;Spermatocytes: 435.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038390	Approved		Approved	Mitochondria		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	28.8	40.3	13.2	14.1	14.1	12.6	25.3	14.3	15.7	20.5	12.7	41.7	38.9	26.8	19.4	50.3	18.9	11.9	41.0	13.8	15.1	57.3	115.3	20.0	14.7	13.3	14.0	13.6	22.6	21.2	18.5	9.9	13.7	18.3	32.7	16.2	29.8	11.9	81.8	28.7	37.6	21.4	12.8	19.6	22.6	69.8	14.7	14.6	21.6	47.5	23.0	23.2	26.1	14.9	47.8	51.2	42.9	57.9	49.7	45.8	31.6	50.5	46.1	66.7	62.6	40.9	47.2	65.4	26.8	62.3	71.7	58.5	77.7	66.4	80.9	33.0	73.4	37.5	69.3	82.5	68.2	79.1	36.1	52.1	51.5	44.3	65.8	38.6	61.1	55.1	70.9	38.0	82.9	69.3	61.1	59.5	46.4	92.4	77.0	56.1	65.4	47.0	78.5	60.6	51.0	35.7	69.1	68.8	37.1	40.3	99.2	36.4	51.2	60.9	52.9	102.4	65.8	40.5	49.3	73.2	50.4	67.7	55.7	13.3	33.8	14.1	20.3	37.6	19.6	25.1	17.7	19.2	44.0	19.5	15.1	17.6	3.2	22.2	31.5	28.9	24.0	34.1	13.2	14.1	14.3	15.7	13.8	15.1	13.3	14.0	13.7	12.8	14.7	14.9	28.4	22.4	35.9	54.9	39.2	47.0	56.0	169.3	44.9	0.0	50.7	41.3	67.8	71.4	84.0	53.3	0.0	82.8	41.2	98.1	181.9	153.3	569.2	48.8	37.5	31.6	79.8	74.6	47.0	109.4	119.1	40.0	46.4	40.1	37.3	29.3	33.2	289.4	164.2	0.0	50.9	97.0	150.5	65.7	40.3	166.5	28.9	67.5	81.8	22.5	103.9	0.0	30.9	58.8	58.6	93.0	69.7	58.3	70.9	84.9	213.3	508.1	79.0	0.0	32.9	30.0	141.3	435.4	104.4	129.8	54.1	127.8	34.5	74.4	165.5	65.2
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 90.1;intestine: 28.1;retina: 34.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 26.0;Excitatory neurons: 86.4;Granulosa cells: 28.9;Inhibitory neurons: 80.4;Oligodendrocyte precursor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 90.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 32.0"	HPA046245	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.6	0.9	0.0	2.5	0.6	0.5	1.4	90.1	10.1	4.7	0.0	28.1	1.8	2.3	0.7	2.7	1.0	8.1	2.9	0.7	0.5	2.5	1.3	1.2	0.8	4.9	2.6	1.1	3.7	2.8	5.6	2.3	7.3	1.7	1.7	34.0	1.4	3.0	2.1	2.5	4.3	5.2	0.9	0.6	8.9	8.0	0.0	3.7	0.4	1.1	0.5	9.4	4.6	6.3	16.8	35.3	17.4	10.2	7.6	14.1	0.7	22.9	16.9	18.6	13.4	10.4	5.8	10.5	12.8	16.1	13.9	2.5	5.5	9.4	8.5	2.1	4.5	5.1	10.1	9.4	10.9	0.1	7.3	8.3	6.8	10.5	7.2	12.1	14.8	8.8	1.1	17.8	8.7	5.0	0.7	2.5	7.9	40.2	15.2	14.0	12.5	3.8	26.9	29.9	39.3	8.8	10.5	3.0	2.7	14.3	1.0	0.6	28.2	33.8	17.6	27.4	23.8	3.4	2.8	5.1	8.4	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	90.1	10.1	0.7	0.5	4.9	2.6	7.3	0.9	0.0	6.3	0.4	0.0	1.1	9.4	1.3	0.0	2.8	0.0	4.6	0.0	1.5	1.9	6.5	8.6	0.6	1.8	0.0	5.0	1.8	1.8	1.9	5.6	26.0	2.8	2.3	2.1	1.2	4.6	86.4	3.5	0.4	1.5	5.6	7.8	2.5	28.9	4.6	1.0	0.6	0.0	80.4	1.5	0.0	0.6	0.0	8.8	1.2	0.3	0.0	8.4	0.1	0.0	0.0	24.1	18.3	8.6	0.2	0.4	1.9	4.6	0.2	1.9	0.0	0.0	0.0	0.8	1.9	0.9	5.2	3.0	0.0	1.0	0.4	1.3	1.2	1.3
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644184-97730260	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	53.3	41.4	18.6	56.0	26.7	109.9	39.0	26.2	24.5	52.6	27.2	51.3	51.2	50.1	33.7	52.2	41.1	41.2	35.7	17.2	21.2	40.8	89.6	40.7	59.3	28.3	23.2	50.7	30.4	53.4	13.4	28.9	28.6	44.7	47.5	44.8	29.3	41.4	60.2	27.0	52.2	62.5	25.9	41.6	48.1	39.6	23.3	65.9	62.7	50.6	61.0	56.3	22.7	37.1	191.5	96.4	61.1	84.7	97.3	102.7	30.7	167.8	139.0	104.2	79.4	59.9	137.0	173.5	181.5	164.6	114.1	121.6	150.3	115.2	143.6	189.5	79.9	320.0	97.5	69.6	118.2	170.5	142.4	78.6	109.3	128.1	282.2	97.3	119.3	126.2	215.5	300.2	108.4	77.6	286.0	43.2	38.9	160.9	113.0	187.2	73.0	255.4	64.5	108.6	92.3	69.2	118.3	101.3	132.0	58.6	158.0	105.1	126.8	146.7	52.7	135.8	123.6	166.1	196.4	174.5	134.3	194.5	130.9	57.0	71.5	38.1	35.7	49.2	49.7	71.6	51.1	52.8	87.0	51.4	51.9	45.7	10.1	51.4	54.6	112.2	33.3	31.9	18.6	26.7	26.2	24.5	17.2	21.2	28.3	23.2	28.6	25.9	23.3	37.1	185.1	128.2	109.2	69.2	294.6	261.7	233.0	178.9	194.1	0.0	166.1	150.7	109.9	201.6	146.1	141.6	0.0	10.0	231.7	140.5	25.4	230.9	267.4	156.0	269.9	185.1	121.8	205.7	96.4	231.7	98.6	227.2	156.5	178.5	137.1	183.1	164.6	438.0	267.5	0.0	97.0	249.9	146.5	258.7	273.9	163.5	195.4	266.5	184.9	86.2	258.2	0.0	195.7	110.6	141.8	241.8	137.8	216.3	675.9	374.7	160.8	99.2	87.2	0.0	223.5	237.8	334.5	162.1	129.6	249.8	314.8	13.7	200.3	285.6	251.6	315.0
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880702	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	4.7	6.1	4.0	7.9	5.1	10.1	9.2	4.7	5.1	5.5	4.1	7.6	7.0	7.0	7.6	7.3	5.9	5.4	5.9	4.2	5.2	8.4	11.3	5.2	14.0	4.5	4.1	8.3	5.9	6.5	5.0	7.1	5.0	6.1	7.8	6.5	7.5	5.9	5.0	6.3	6.8	6.1	4.1	9.7	8.1	6.6	4.8	11.4	7.5	8.9	13.3	5.7	5.8	6.8	17.3	15.0	13.3	9.0	12.2	13.9	12.6	14.2	14.3	15.8	19.6	16.9	17.7	36.8	11.9	11.0	21.3	15.2	21.3	13.4	23.9	1.9	14.5	16.1	17.2	13.4	11.6	29.3	15.7	17.2	16.3	15.8	18.5	11.4	12.9	8.1	31.2	15.0	18.1	22.2	31.5	27.0	22.2	20.1	16.5	9.3	19.2	23.4	15.8	17.5	12.8	23.4	13.9	30.1	29.0	24.3	10.9	19.4	9.5	18.4	22.2	25.4	14.9	19.4	21.9	48.7	13.0	9.4	26.9	46.0	12.9	18.5	14.6	11.2	18.5	22.0	19.2	21.9	14.1	23.9	26.1	20.7	6.2	16.1	13.5	11.2	20.1	15.1	4.0	5.1	4.7	5.1	4.2	5.2	4.5	4.1	5.0	4.1	4.8	6.8	5.5	9.6	10.6	6.2	10.5	0.0	3.9	0.0	14.8	0.0	5.3	6.7	5.3	5.7	2.5	3.7	0.0	9.3	8.0	3.4	5.9	5.9	1.5	4.5	7.0	4.9	1.2	8.2	7.9	5.2	6.3	6.2	7.7	4.0	5.1	8.3	6.4	9.6	5.1	0.0	7.2	2.6	0.0	6.0	0.0	2.1	6.8	5.9	0.0	5.6	7.1	0.0	10.3	8.0	15.2	4.1	3.1	7.2	12.6	3.9	7.2	8.2	1.5	0.0	13.1	5.0	5.3	14.0	10.5	6.3	0.0	4.5	8.0	8.5	4.1	2.7
MTERF2	"FLJ14062, MTERFD3"	ENSG00000120832	"Mitochondrial transcription termination factor 2"	Q49AM1	12	106977277-106987160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003526	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA003526: AB_1079423"	"unprognostic (1.54e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-3)"	14.3	24.8	23.3	6.3	23.5	6.4	17.3	31.1	27.7	19.6	23.6	25.7	17.5	16.0	13.1	9.6	16.9	12.9	31.5	23.0	24.8	28.1	29.1	15.1	8.1	22.2	23.1	21.5	34.0	12.7	20.2	7.1	22.9	22.5	9.8	30.2	15.5	11.8	23.0	22.3	16.6	11.7	22.4	15.1	22.4	17.6	24.6	6.5	30.4	16.3	5.5	16.0	13.3	23.2	10.3	13.0	14.5	20.6	16.7	8.5	7.0	10.0	5.2	8.1	8.5	8.2	7.2	7.0	10.5	6.7	6.6	10.0	11.1	5.4	6.7	14.2	13.2	23.9	18.4	14.5	12.6	0.0	7.8	15.2	9.7	8.1	5.9	13.0	10.5	0.5	31.8	6.9	9.8	7.8	3.3	10.6	7.4	4.2	13.0	10.3	13.0	4.4	14.6	11.9	14.3	16.5	13.4	18.0	18.4	13.4	26.0	9.3	10.0	9.1	6.1	7.3	8.3	14.7	19.4	6.7	3.5	2.4	13.8	0.3	0.7	3.0	11.8	2.1	10.1	2.8	11.1	9.3	5.2	2.8	9.1	9.8	5.0	7.2	1.3	11.0	10.7	5.8	23.3	23.5	31.1	27.7	23.0	24.8	22.2	23.1	22.9	22.4	24.6	23.2	11.7	35.3	11.4	24.8	4.3	0.0	20.2	0.0	8.0	0.0	23.6	21.7	20.1	27.1	4.3	14.7	0.0	10.8	19.3	1.8	39.2	6.3	32.3	10.7	16.6	9.1	3.6	12.4	13.9	6.4	8.7	12.7	10.2	10.7	5.1	15.0	10.4	16.8	7.0	0.0	20.6	4.4	0.0	3.2	0.0	12.1	20.2	3.8	0.0	2.8	4.3	0.0	16.5	16.1	15.3	3.6	7.6	24.8	4.8	6.7	8.5	27.1	6.6	0.0	13.1	27.1	10.3	17.7	10.7	5.7	0.0	4.2	10.8	20.6	8.1	7.3
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MTF1		ENSG00000188786	"Metal regulatory transcription factor 1"	Q14872	1	37809574-37859592	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028604, HPA028689"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028604: AB_10600304, HPA028689: AB_10611384"	"unprognostic (5.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.19e-1)"	4.7	3.5	4.6	5.2	6.0	20.5	4.1	4.7	5.4	4.7	5.5	4.4	2.8	4.2	2.6	8.4	5.6	3.5	2.7	4.2	4.3	3.8	2.5	4.3	4.0	5.6	5.6	5.5	4.0	6.1	3.4	3.3	5.2	3.3	4.6	4.8	3.2	3.1	5.3	4.5	3.0	4.6	4.6	4.5	3.3	6.6	5.1	4.3	3.8	6.4	5.8	5.3	4.0	6.2	7.5	4.5	4.4	3.9	11.0	7.6	8.4	7.2	7.4	8.4	8.0	4.9	4.2	7.9	5.4	8.2	5.5	6.8	7.6	6.0	9.7	27.5	4.7	7.5	6.4	3.8	6.2	8.9	8.0	7.1	10.4	11.9	12.0	6.0	5.4	5.6	4.9	6.2	6.3	4.2	4.5	4.6	6.2	3.9	4.4	4.7	10.4	4.8	5.6	7.3	6.7	4.9	8.6	6.9	6.2	6.1	4.2	7.3	7.7	5.2	5.9	6.0	9.6	11.4	13.8	4.4	7.1	9.1	4.6	2.8	3.7	2.4	1.8	3.6	1.5	1.3	1.5	1.3	2.3	1.6	1.6	1.3	3.7	1.1	6.0	0.8	1.1	1.8	4.6	6.0	4.7	5.4	4.2	4.3	5.6	5.6	5.2	4.6	5.1	6.2	9.7	9.6	10.3	10.7	15.4	20.6	11.4	11.0	15.9	0.0	13.2	10.8	12.7	8.6	8.8	7.3	0.0	10.0	11.2	20.4	1.9	11.8	50.0	30.0	14.2	13.0	23.8	9.9	16.3	15.6	23.2	10.7	9.2	30.4	16.5	9.2	13.2	7.2	10.2	0.0	14.3	8.8	16.2	20.1	9.1	18.2	9.6	22.6	7.2	8.4	26.8	0.0	11.3	9.5	20.7	12.9	8.6	11.7	15.7	14.8	11.5	6.2	28.8	0.0	6.6	18.2	12.1	33.7	22.5	23.2	29.7	17.1	12.9	7.1	9.2	16.0
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	1.6	2.2	2.6	0.7	2.9	1.9	1.6	3.8	3.1	2.4	4.0	2.5	1.5	2.5	1.5	2.2	2.6	0.9	4.3	2.5	3.4	2.4	3.5	1.5	1.3	2.5	2.2	2.7	1.4	1.7	2.2	0.8	2.5	2.8	1.5	1.6	1.8	1.3	3.0	1.7	2.2	1.7	1.9	2.3	2.0	1.5	2.9	1.0	1.7	1.5	1.2	2.5	2.1	2.6	1.4	1.9	1.8	3.2	2.5	1.7	1.7	1.3	2.2	1.6	1.5	1.2	1.5	4.7	1.7	2.3	2.7	4.0	3.3	2.2	1.5	1.9	2.8	1.9	1.9	1.3	2.9	2.7	0.6	2.3	2.8	0.9	1.9	2.2	1.5	4.2	2.3	2.2	2.4	1.9	2.3	3.1	2.4	4.0	3.6	2.0	2.5	2.2	2.7	1.6	1.8	1.8	3.1	2.7	2.5	2.2	1.6	2.0	2.8	1.9	1.9	2.4	2.6	1.9	3.1	1.8	1.7	4.6	1.9	3.7	3.3	2.6	4.8	3.1	4.8	4.8	4.7	5.0	6.0	4.7	5.1	5.4	16.5	4.5	2.2	10.1	5.4	2.3	2.6	2.9	3.8	3.1	2.5	3.4	2.5	2.2	2.5	1.9	2.9	2.6	8.5	3.2	9.7	17.0	11.8	3.3	15.2	19.1	14.8	0.0	7.0	7.7	15.8	10.0	10.5	3.7	0.0	11.4	18.1	10.5	25.4	11.8	1.7	7.8	11.6	8.2	7.8	9.4	49.8	10.0	11.7	11.8	8.6	7.0	8.8	8.0	12.8	12.2	16.5	0.0	44.2	8.9	2.0	12.2	12.2	1.7	15.5	9.7	8.8	27.2	7.1	0.0	11.3	19.1	12.9	10.3	15.9	15.4	10.3	16.7	17.5	25.1	5.1	0.0	0.0	12.5	14.5	13.3	20.7	10.7	4.5	8.9	10.1	11.4	15.7	14.5
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 365.5;Late spermatids: 792.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	9.9	15.2	4.4	6.2	6.1	4.9	10.0	4.7	6.9	9.8	4.6	11.3	12.4	8.4	12.0	10.2	6.3	6.6	7.6	4.3	4.9	31.8	34.9	5.9	4.7	5.2	5.5	6.2	8.8	11.6	3.9	7.6	5.1	7.3	12.0	34.0	8.4	8.5	9.7	8.2	12.5	9.5	4.5	4.0	14.7	19.7	5.3	4.6	11.5	7.3	6.8	8.9	7.6	6.6	34.3	25.1	19.7	22.7	25.7	25.6	15.7	22.3	20.3	26.8	27.9	21.5	34.5	19.0	7.0	21.7	26.6	21.9	44.3	30.0	35.6	6.9	24.0	23.6	16.8	43.1	32.7	6.2	10.9	17.5	31.1	34.7	107.9	15.2	33.1	13.8	32.8	19.0	30.8	30.9	21.1	14.2	20.5	74.9	22.5	10.7	26.9	15.9	32.5	30.2	8.6	12.9	21.9	36.7	29.6	19.6	40.5	13.3	25.8	15.9	22.4	38.8	19.6	18.4	12.9	13.6	19.8	25.0	21.6	1.3	0.8	0.3	0.5	0.6	0.7	0.4	0.7	0.6	0.8	0.3	0.6	0.7	0.2	0.2	0.3	0.5	0.7	0.4	4.4	6.1	4.7	6.9	4.3	4.9	5.2	5.5	5.1	4.5	5.3	6.6	6.8	19.2	9.8	5.9	6.1	16.8	12.3	13.5	10.2	0.0	9.7	4.8	7.4	18.6	12.2	11.0	0.0	25.0	6.9	11.9	56.7	22.6	365.5	7.5	10.0	10.0	4.8	12.6	13.1	24.1	29.0	10.1	14.3	8.2	5.1	9.2	8.9	39.9	9.7	0.0	16.4	12.6	20.3	6.3	7.0	792.9	16.8	6.5	14.2	11.2	3.8	0.0	4.1	18.6	42.4	20.0	9.6	12.0	10.7	20.6	20.0	112.7	16.1	0.0	6.6	7.5	13.1	93.0	35.9	18.4	19.5	39.1	4.5	20.6	15.7	16.6
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 161.1;Early spermatids: 216.1;Late spermatids: 590.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favorable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	39.0	138.0	79.6	22.2	82.8	17.8	37.4	80.0	88.4	51.0	84.6	74.1	46.8	51.0	57.8	39.4	44.9	32.7	169.1	81.7	81.3	71.7	91.3	32.4	25.8	80.2	83.8	68.4	46.0	106.0	51.6	40.7	79.6	55.8	37.3	62.1	43.3	70.1	221.8	35.6	46.9	50.0	78.6	44.2	56.6	82.5	83.2	24.7	48.1	239.7	26.3	58.3	40.5	78.5	19.5	26.7	53.2	53.6	67.6	63.8	22.2	44.7	63.7	45.2	49.9	8.7	39.7	6.6	38.9	80.1	40.0	17.4	44.1	38.6	44.8	43.9	39.8	55.6	44.3	35.9	64.6	45.5	52.9	65.3	36.4	48.3	36.1	67.0	37.9	27.0	34.7	29.2	66.1	21.6	26.3	33.6	29.4	26.0	39.4	26.0	47.4	19.8	47.1	18.3	53.6	48.5	33.6	32.4	67.8	35.8	26.7	43.1	38.6	36.7	28.9	86.6	28.5	30.5	19.3	23.2	63.6	62.5	41.2	71.7	50.5	111.7	25.7	50.8	15.6	28.1	24.1	22.9	55.0	28.8	25.4	23.1	13.6	27.6	58.3	22.7	27.3	51.1	79.6	82.8	80.0	88.4	81.7	81.3	80.2	83.8	79.6	78.6	83.2	78.5	18.7	16.0	24.5	24.2	14.1	13.5	20.8	38.6	25.0	0.0	21.6	23.6	161.1	25.8	21.7	22.0	0.0	55.9	14.8	15.7	103.7	32.4	216.1	11.3	16.7	17.1	15.6	12.4	18.2	33.5	36.7	28.4	21.4	10.6	36.1	21.9	21.4	35.5	34.9	0.0	24.1	14.9	34.6	15.1	17.3	590.4	34.2	25.6	44.4	6.5	43.5	0.0	12.3	12.5	15.2	27.7	15.0	39.1	15.4	16.2	39.3	70.6	10.5	0.0	26.3	23.3	31.3	144.7	49.9	15.4	12.9	59.4	13.1	29.8	18.0	16.5
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 6.4;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	0.8	0.5	0.4	3.6	0.3	16.3	1.0	0.4	0.6	0.6	0.2	2.9	2.8	0.5	0.3	2.6	0.3	0.3	0.3	0.4	0.3	0.6	0.4	1.2	6.4	0.4	0.5	0.3	0.4	0.0	0.4	1.8	0.3	0.4	3.8	0.5	0.8	0.2	1.2	1.9	2.3	1.1	0.4	2.2	1.2	7.0	0.4	6.2	0.3	0.1	5.3	0.8	0.9	0.4	15.2	11.5	9.7	18.2	1.6	2.8	17.4	19.6	13.6	22.8	31.7	20.7	12.2	39.2	11.7	7.9	30.1	23.1	22.3	14.4	33.8	22.1	17.1	31.0	7.8	18.9	1.0	57.4	28.1	2.3	3.1	25.5	16.1	2.7	12.4	33.8	33.9	29.6	17.2	20.2	32.5	47.8	9.8	20.2	14.1	29.3	15.5	19.7	9.9	11.6	7.7	7.6	12.4	21.5	11.3	11.9	9.1	39.1	6.8	11.3	11.8	40.2	30.4	11.2	28.3	26.1	6.5	38.5	17.6	0.0	0.2	0.0	0.3	0.9	0.1	0.4	0.4	0.7	0.9	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.7	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.4	0.5	0.3	0.4	0.4	0.4	2.0	0.0	1.1	0.0	2.2	1.0	0.6	3.1	0.0	0.0	3.4	3.6	0.4	0.0	2.3	0.0	0.0	8.4	1.3	2.2	0.0	1.1	7.9	2.4	1.3	1.7	0.0	9.9	0.5	2.5	23.6	1.5	2.6	2.5	1.3	3.5	0.7	0.5	6.6	0.0	0.4	2.1	4.1	3.8	2.1	5.9	0.3	2.5	0.0	1.0	2.3	0.0	1.0	0.5	0.0	1.3	0.4	0.0	7.4	1.2	1.3	1.4	2.5	0.0	0.0	5.3	1.8	27.6	13.0	5.3	0.3	3.0	3.1	0.8	4.6	0.9
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133422520	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037826, HPA037827"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.03e-5)"	15.1	28.1	10.0	13.6	9.9	12.5	16.3	11.0	12.2	17.0	11.4	16.0	19.7	15.2	2.8	21.4	15.0	8.4	15.0	9.7	9.6	27.1	48.4	13.0	16.2	10.8	9.9	17.2	19.7	17.6	16.2	11.2	10.2	19.3	11.2	3.4	16.3	10.4	18.5	17.7	18.9	10.1	9.3	26.1	18.4	31.2	10.4	12.7	18.0	13.0	14.1	15.4	15.4	9.9	42.5	43.3	28.3	63.4	17.0	12.5	42.0	24.2	20.8	38.5	31.4	55.0	25.8	31.2	36.2	20.5	16.3	33.5	30.6	43.2	17.4	29.8	37.7	30.5	23.5	52.1	40.2	20.6	30.4	31.5	22.9	37.3	58.6	27.7	56.5	27.9	26.2	28.0	30.6	47.4	20.2	28.9	39.3	45.2	14.4	29.6	28.0	7.1	34.6	29.6	10.7	37.9	36.4	32.1	51.4	15.8	28.2	29.6	37.1	14.2	29.2	14.6	26.1	13.5	8.3	43.3	25.2	18.3	19.8	0.5	21.5	23.0	26.9	35.5	27.7	41.5	23.8	22.7	20.3	48.8	18.6	19.2	3.1	47.5	42.9	42.8	27.5	20.3	10.0	9.9	11.0	12.2	9.7	9.6	10.8	9.9	10.2	9.3	10.4	9.9	4.5	9.6	3.6	30.7	27.1	4.2	5.9	8.8	33.0	0.0	6.1	5.3	1.6	8.6	5.9	3.7	0.0	9.4	8.1	8.4	5.9	13.5	2.2	5.9	9.9	7.7	12.6	26.1	25.1	9.6	7.3	9.0	43.8	5.9	6.3	10.8	7.5	5.5	5.4	0.0	31.8	7.5	4.1	6.3	4.7	5.4	9.0	7.1	5.4	21.5	8.1	0.0	12.3	29.7	33.9	10.4	9.2	4.9	37.5	7.2	12.5	6.9	6.1	0.0	13.1	6.1	6.0	9.0	9.3	32.9	3.4	6.7	16.6	6.7	10.1	7.4
MTG2	"dJ1005F21.2, FLJ10741, GTPBP5, ObgH1"	ENSG00000101181	"Mitochondrial ribosome associated GTPase 2"	Q9H4K7	20	62183028-62203568	"Predicted intracellular proteins"	"Ribosome biogenesis, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047379	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA047379: AB_10965845"	"unprognostic (5.52e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.16e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.56e-1)"	"prognostic favorable (6.31e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.10e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.30e-2)"	11.8	18.5	5.1	7.8	5.3	8.3	11.3	6.2	6.0	10.8	5.1	11.1	10.6	11.3	3.0	10.5	10.5	6.2	12.9	5.0	5.3	10.7	29.8	9.0	7.3	5.2	5.1	11.5	11.9	8.5	13.8	6.1	4.9	11.4	4.8	2.9	10.8	4.8	28.0	13.6	10.2	5.6	4.5	12.6	11.4	14.5	5.3	9.2	11.9	10.5	5.8	10.7	9.9	5.3	32.3	19.7	6.1	16.9	11.5	11.0	25.3	14.0	10.3	43.0	17.4	72.0	27.2	34.1	45.0	8.8	20.5	23.9	8.8	19.6	8.3	7.9	10.5	48.7	26.4	18.2	13.0	34.2	10.1	20.3	25.5	25.2	19.2	5.7	12.1	13.8	30.3	14.0	12.3	9.1	18.6	15.9	7.5	31.1	35.7	14.9	31.6	34.6	10.6	16.9	12.9	16.7	47.5	25.5	24.5	3.0	30.3	35.6	10.4	29.2	18.0	15.0	37.6	27.5	36.2	13.4	22.1	11.9	15.8	4.8	4.1	3.9	5.1	4.3	4.3	3.8	3.9	3.9	4.9	3.2	3.8	2.4	9.8	4.8	2.9	3.6	3.5	3.5	5.1	5.3	6.2	6.0	5.0	5.3	5.2	5.1	4.9	4.5	5.3	5.3	9.5	22.4	11.9	16.0	13.6	9.2	11.1	9.6	10.8	0.0	10.3	9.3	11.4	10.0	12.0	20.2	0.0	15.0	12.8	14.2	9.8	11.5	65.3	11.2	11.1	9.7	9.1	24.2	24.8	14.0	11.8	11.8	13.7	8.1	11.4	23.8	9.3	33.5	13.8	0.0	28.5	11.9	2.0	12.0	8.2	23.7	9.6	11.9	8.8	15.0	19.7	0.0	14.4	21.1	24.8	14.7	12.1	11.7	21.7	14.1	20.3	28.2	17.6	0.0	0.0	9.1	11.3	17.3	19.3	14.1	11.9	17.8	12.5	26.5	12.3	9.7
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"		14	64388031-64463457	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in all"	6	"liver: 356.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 142.9;Proximal tubular cells: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	56.4	18.0	8.6	20.0	17.4	27.0	29.8	8.3	12.3	16.9	15.0	23.3	19.7	16.1	9.9	25.1	16.0	13.1	28.1	12.9	8.1	55.3	356.9	15.4	23.6	7.5	7.8	24.9	23.8	27.5	9.2	13.3	7.0	12.9	27.5	3.6	15.6	13.8	64.1	17.1	18.9	20.0	7.2	14.5	17.9	4.7	8.9	30.2	20.5	61.9	27.7	18.6	16.6	8.3	294.1	164.9	58.5	143.6	70.5	53.4	95.7	106.4	83.3	148.1	147.4	161.2	144.2	103.3	49.6	67.1	68.3	146.0	177.6	111.2	160.4	107.3	117.9	122.2	143.5	131.8	50.6	104.5	81.2	43.0	37.3	124.3	66.4	57.5	93.1	98.1	108.5	98.7	114.7	270.1	179.9	62.3	118.0	186.5	160.4	138.3	201.2	114.4	110.5	160.9	128.7	49.0	183.7	111.4	58.3	54.0	164.4	58.6	51.5	115.1	184.1	102.2	134.2	58.8	65.6	177.9	107.4	125.2	134.8	0.4	11.7	0.1	9.7	19.5	13.0	27.0	10.1	12.3	17.7	15.3	7.8	10.7	0.9	17.8	16.7	4.0	19.5	12.2	8.6	17.4	8.3	12.3	12.9	8.1	7.5	7.8	7.0	7.2	8.9	8.3	8.1	19.2	23.5	15.0	16.2	13.8	14.2	14.7	13.6	0.0	9.8	8.1	43.9	15.7	19.5	16.5	0.0	30.6	10.8	7.9	41.1	16.9	1.4	6.8	11.7	12.3	3.0	42.3	19.5	10.3	30.9	14.9	15.3	8.7	50.7	27.2	12.8	142.9	25.3	0.0	15.6	14.3	2.0	13.0	11.0	1.5	13.1	12.3	14.2	8.4	13.3	0.0	8.2	14.1	10.9	11.7	6.3	13.2	24.1	10.2	8.2	75.3	11.5	0.0	19.7	13.1	19.3	0.9	8.9	19.5	10.7	9.9	16.6	21.4	24.6	12.7
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865679-151101887	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Extravillous trophoblasts: 166.5;Granulosa cells: 86.9;Microglial cells: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA		89000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	12.5	12.2	7.1	11.4	6.7	13.2	7.9	25.1	7.4	7.1	8.3	7.4	3.2	8.4	6.2	6.7	7.1	5.9	11.5	6.4	9.8	12.7	5.6	19.5	11.1	11.5	10.1	14.6	10.7	6.8	9.2	14.3	11.0	5.5	7.9	7.5	3.2	7.0	1.3	6.0	5.2	10.0	11.6	9.2	6.0	9.9	8.4	8.6	10.9	0.5	10.8	12.8	4.2	15.4	40.6	35.1	44.9	110.0	11.5	40.0	108.4	63.0	68.3	62.1	75.7	71.8	37.4	152.3	41.1	96.9	36.8	42.7	72.4	61.8	76.8	63.4	65.3	62.7	60.4	66.1	72.4	115.7	9.8	47.7	76.9	60.6	109.8	55.5	105.5	81.6	150.9	76.2	65.0	86.1	57.1	23.9	45.5	40.7	32.1	67.2	33.2	67.1	42.1	19.6	44.1	32.5	83.9	36.7	53.0	40.6	11.5	79.5	80.6	41.4	90.6	91.9	90.5	62.3	63.5	154.0	68.8	105.7	54.0	0.0	0.2	0.0	0.2	0.3	0.4	0.2	0.6	0.7	1.1	0.3	0.5	0.6	0.0	0.3	0.3	0.5	1.8	0.2	7.1	6.7	25.1	7.4	6.4	9.8	11.5	10.1	11.0	11.6	8.4	15.4	6.9	0.0	1.7	47.7	6.9	6.5	8.0	15.7	1.8	0.0	3.3	4.1	2.4	1.5	9.8	14.7	0.0	25.8	1.4	2.6	7.9	9.0	44.9	11.3	18.4	10.7	1.2	5.0	84.0	18.1	166.5	14.4	8.2	22.2	0.0	86.9	6.1	1.7	24.9	0.0	73.8	3.0	46.8	3.0	13.3	6.2	0.6	13.8	35.6	126.5	2.4	0.0	2.1	60.8	59.3	19.2	1.4	7.9	14.0	31.3	0.9	15.2	5.3	0.0	0.0	8.7	13.1	0.5	6.8	2.3	3.4	73.6	4.0	42.9	4.0	35.1
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74186172-74217565	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 243.6;monocytes: 184.1;Smooth muscle cells: 239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	40.0	12.3	11.2	54.5	13.0	25.8	34.8	12.7	14.7	28.5	11.2	30.6	18.6	21.5	14.5	23.0	34.2	20.1	19.6	10.0	16.6	19.6	7.3	23.0	45.6	16.6	15.8	11.7	65.9	9.8	18.0	17.7	17.1	16.3	33.7	2.9	17.7	16.7	36.7	11.8	16.0	27.3	14.8	19.0	36.1	17.7	13.1	28.5	18.5	55.3	57.8	48.0	20.5	15.7	197.4	107.8	89.2	235.6	90.0	113.9	186.1	286.2	185.2	156.2	216.7	242.8	81.8	391.0	65.4	154.2	167.5	70.7	296.7	142.0	314.9	248.9	100.9	424.6	55.4	181.9	319.8	360.1	234.8	202.9	423.4	188.5	794.4	74.8	99.0	636.5	192.2	548.0	157.5	159.6	209.5	261.0	161.1	293.3	95.8	222.6	266.3	339.4	72.0	80.8	198.2	143.8	97.4	238.3	549.7	56.9	208.5	324.4	52.9	39.1	359.9	97.7	286.5	484.5	257.6	379.2	111.4	304.1	132.5	43.9	24.0	31.1	8.5	56.6	13.0	13.4	15.2	10.1	34.9	12.2	11.5	7.9	3.2	29.3	57.0	13.0	36.8	22.0	11.2	13.0	12.7	14.7	10.0	16.6	16.6	15.8	17.1	14.8	13.1	15.7	19.7	16.0	20.2	0.3	49.7	89.3	58.8	54.1	27.3	0.0	53.2	38.0	11.5	4.3	28.2	1.8	0.0	31.5	48.2	19.9	3.9	55.7	3.9	9.7	104.7	35.1	19.1	104.1	1.0	107.9	56.9	45.6	68.8	21.7	53.3	8.7	19.2	0.8	66.2	0.0	3.7	64.0	38.7	61.6	243.6	3.8	22.7	100.6	71.2	12.2	184.1	0.0	27.8	6.6	1.1	81.2	7.5	21.1	141.2	95.7	3.3	3.3	8.5	0.0	138.1	126.3	239.0	36.5	54.9	42.0	74.6	14.0	71.4	21.6	34.0	64.2
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	1.6	3.7	5.6	1.2	5.4	1.7	3.3	3.5	6.5	1.4	1.1	1.6	1.6	1.6	3.4	1.9	1.5	1.1	6.0	4.1	8.5	1.9	7.0	1.3	1.2	5.0	5.0	1.6	1.6	2.5	1.5	1.7	5.1	1.5	1.1	2.6	1.4	1.7	2.7	1.2	1.0	1.2	5.4	1.4	1.4	0.9	5.8	3.4	2.0	3.9	1.1	1.3	1.2	7.6	2.8	2.8	4.0	3.6	1.4	2.1	0.9	3.3	2.6	2.2	2.4	2.2	2.6	3.0	4.5	1.5	1.6	1.7	3.2	2.2	3.3	3.1	2.0	3.7	1.9	2.6	2.4	5.8	0.7	1.5	5.1	3.3	7.9	4.1	4.7	6.7	6.6	3.6	2.7	2.7	10.9	8.3	1.2	4.5	3.1	10.9	2.7	5.1	14.2	1.4	3.7	8.0	1.8	2.8	3.5	4.3	1.5	4.0	4.9	2.5	3.8	4.8	5.6	3.6	5.0	8.8	15.5	1.3	3.8	0.3	0.9	0.4	0.3	0.9	0.3	1.8	0.2	0.4	1.5	0.6	0.8	0.9	0.6	1.1	3.5	1.6	1.4	1.0	5.6	5.4	3.5	6.5	4.1	8.5	5.0	5.0	5.1	5.4	5.8	7.6	23.3	22.4	19.6	57.5	18.9	16.6	63.5	31.1	30.1	0.0	90.5	53.6	24.5	30.0	27.6	49.7	0.0	17.9	17.1	23.3	84.1	24.0	85.7	67.1	11.0	19.9	37.2	44.2	41.2	19.1	8.8	13.5	35.7	50.4	10.2	35.5	25.0	104.7	24.5	0.0	41.0	34.7	69.2	27.3	23.0	23.2	12.8	30.4	16.0	20.6	17.3	0.0	12.3	74.9	73.1	15.6	19.4	8.6	20.9	69.2	18.3	51.3	30.1	0.0	26.3	19.4	21.1	8.1	12.3	44.0	22.6	12.3	11.1	36.8	36.4	71.9
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	12.3	11.3	7.1	10.8	10.3	28.9	10.2	12.8	8.8	9.0	5.0	11.1	10.8	8.9	53.5	10.3	12.3	10.1	23.9	10.4	6.2	12.8	13.1	16.8	12.3	9.9	7.0	19.7	11.4	6.6	17.7	7.1	9.4	10.2	8.7	12.6	6.8	6.7	17.9	13.4	14.7	10.8	5.1	18.3	14.6	10.9	8.0	7.9	16.3	16.8	12.2	10.3	7.9	8.9	2.2	9.4	10.9	12.3	10.2	15.1	2.0	5.2	14.6	6.0	5.1	8.1	13.2	18.0	3.6	7.5	16.3	4.1	8.1	7.7	2.4	9.3	6.8	13.4	13.3	3.2	13.7	7.4	16.4	13.6	6.1	8.0	6.4	10.0	10.7	17.2	44.1	11.0	6.7	3.3	8.2	3.5	3.6	9.5	3.0	8.9	6.0	20.3	8.8	11.7	10.5	17.6	8.1	7.8	10.9	6.2	12.9	11.7	8.5	6.0	4.9	7.2	1.6	6.4	9.4	32.8	7.6	16.8	5.6	0.7	2.3	1.1	2.7	4.3	0.9	1.6	0.8	1.4	1.7	2.3	1.2	1.4	2.5	2.0	6.1	0.9	0.6	1.6	7.1	10.3	12.8	8.8	10.4	6.2	9.9	7.0	9.4	5.1	8.0	8.9	15.9	25.6	48.0	8.1	18.3	8.4	6.8	11.9	15.9	0.0	17.9	10.8	37.0	11.5	13.0	27.6	0.0	5.1	6.0	44.2	1.9	8.9	18.2	32.0	25.8	16.9	12.1	29.5	15.8	25.3	3.3	21.0	52.5	55.5	8.2	10.7	37.5	23.4	22.2	0.0	15.2	18.0	6.1	39.3	39.9	42.4	18.3	32.1	12.4	16.9	26.5	0.0	20.6	9.0	13.3	21.9	20.6	9.1	10.3	10.2	36.0	17.2	12.3	0.0	19.7	22.8	23.3	6.8	5.2	15.0	9.2	2.9	10.6	21.3	18.6	9.6
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 253.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 134.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 134.1;monocytes: 49.1"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	21.9	19.8	8.0	4.6	8.2	5.0	19.0	9.6	12.7	9.9	6.9	12.0	13.7	9.0	10.3	10.1	9.4	7.0	19.0	8.0	9.2	53.1	253.4	17.8	6.4	8.7	9.3	8.6	32.8	26.3	21.5	8.3	9.1	19.5	6.4	5.9	13.6	5.5	20.2	6.2	14.5	6.2	8.8	14.9	19.5	12.1	8.7	10.6	15.9	11.1	10.8	12.4	9.9	9.1	12.6	35.8	5.0	2.6	15.8	12.0	11.9	8.8	13.0	16.4	10.5	34.5	22.4	15.1	25.1	15.5	15.0	19.5	31.9	10.7	15.4	14.7	28.4	14.8	22.9	39.8	25.3	7.8	0.8	17.5	27.8	8.1	23.0	19.6	7.4	16.0	28.8	12.0	17.4	36.0	10.2	36.1	15.6	51.4	17.0	10.8	17.2	25.8	35.1	34.3	8.9	4.8	25.1	14.2	43.8	20.0	17.3	13.0	3.3	5.7	11.1	3.6	7.1	6.8	20.2	17.8	3.3	25.9	6.2	17.5	25.7	73.5	9.4	35.3	12.4	13.5	13.7	12.9	12.3	11.1	16.5	12.6	134.1	17.8	49.1	13.3	15.7	19.1	8.0	8.2	9.6	12.7	8.0	9.2	8.7	9.3	9.1	8.8	8.7	9.1	11.3	19.2	44.0	0.0	20.7	10.7	9.9	63.0	35.9	0.0	25.5	32.5	0.7	58.6	34.3	22.0	0.0	68.1	10.1	10.0	64.6	55.8	2.2	11.9	7.8	10.5	17.6	36.6	0.0	75.7	37.1	13.5	39.8	11.0	8.8	7.2	21.8	205.5	45.7	0.0	0.0	18.7	24.4	22.1	34.8	3.8	13.7	29.3	21.4	0.0	150.8	0.0	35.0	0.0	0.0	75.3	35.9	15.8	13.3	13.3	101.7	201.6	29.9	0.0	13.1	8.4	10.5	6.7	8.5	21.1	8.1	253.8	22.2	9.2	24.9	7.7
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530178-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	7.2	8.2	5.3	8.7	6.5	6.3	10.4	6.3	6.2	9.2	7.6	8.7	7.4	9.6	10.6	10.1	13.0	8.4	7.9	5.2	5.1	7.6	7.9	8.3	11.7	6.4	6.2	11.5	9.9	11.8	9.3	8.1	6.4	10.2	10.5	6.6	11.0	8.1	11.3	12.7	8.6	8.3	6.1	10.6	9.7	17.7	6.4	10.6	11.0	8.3	11.7	8.9	8.8	9.6	15.7	14.6	14.2	12.3	11.8	18.0	17.0	15.3	11.1	19.0	9.4	13.0	25.8	14.2	16.3	13.4	10.2	21.4	15.8	15.0	17.7	9.4	12.8	12.9	20.0	12.0	16.0	10.1	6.9	11.4	23.4	24.4	20.9	16.4	11.5	20.5	26.9	0.0	13.9	19.8	12.6	15.0	9.3	12.9	18.3	38.6	8.0	11.2	11.1	9.4	13.8	9.5	34.7	6.8	12.6	14.1	34.5	10.3	11.9	18.3	15.7	12.2	15.1	11.1	14.7	41.6	16.7	15.8	18.2	5.9	4.8	2.4	4.7	3.5	5.0	4.6	5.2	4.9	6.0	3.4	4.2	5.0	1.9	6.3	4.3	2.7	4.5	4.8	5.3	6.5	6.3	6.2	5.2	5.1	6.4	6.2	6.4	6.1	6.4	9.6	6.4	6.4	5.9	10.4	6.4	1.1	2.7	4.2	1.2	0.0	6.8	7.1	4.4	2.8	4.7	5.5	0.0	7.9	5.6	7.2	11.7	5.2	35.6	7.4	5.9	4.6	4.2	7.4	6.6	4.2	4.5	4.5	2.6	4.9	4.5	9.4	5.7	3.4	6.1	0.0	7.1	5.3	2.0	5.5	2.0	18.8	6.5	4.3	3.6	3.7	4.7	0.0	6.2	5.5	13.5	3.6	3.6	8.2	4.1	2.6	5.3	4.4	8.2	0.0	6.6	2.2	5.5	11.4	4.0	4.5	1.4	7.7	3.8	5.7	5.5	2.0
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA006021: AB_2147687, HPA061422: AB_2684514"	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	17.5	18.2	14.8	16.7	16.6	14.2	19.6	17.0	18.0	14.4	19.1	27.7	27.2	10.8	17.8	18.7	13.0	11.6	31.9	15.0	17.4	24.8	33.0	12.3	20.6	16.8	16.1	11.4	26.7	24.2	10.9	13.4	17.0	14.4	31.5	15.5	18.5	14.0	44.2	16.1	22.0	12.4	16.4	17.4	20.7	12.2	16.8	16.8	20.5	48.8	20.3	15.0	13.2	18.1	42.4	39.8	23.2	40.2	27.8	37.7	53.1	37.8	29.9	35.5	30.9	48.0	39.8	69.1	69.6	34.5	39.7	36.7	55.2	54.5	58.3	77.1	42.6	63.3	30.9	89.4	53.4	101.6	36.4	41.7	54.9	49.1	101.9	31.4	29.1	37.8	114.4	38.4	37.0	35.2	31.5	68.2	49.3	52.2	48.5	32.7	74.3	67.1	34.4	36.8	41.3	26.2	33.7	54.8	71.0	27.8	28.9	33.6	28.5	37.0	42.5	44.6	62.8	71.3	68.3	18.8	39.3	74.3	29.7	5.6	10.3	9.7	9.0	12.7	11.7	7.5	9.2	8.6	13.5	9.5	11.2	11.5	4.0	16.7	10.8	6.6	12.2	6.8	14.8	16.6	17.0	18.0	15.0	17.4	16.8	16.1	17.0	16.4	16.8	18.1	10.9	22.4	23.6	9.8	16.6	7.6	19.1	18.8	13.6	0.0	15.5	14.2	80.7	22.8	16.9	7.3	0.0	32.1	22.2	18.7	29.4	33.6	16.9	24.0	17.6	13.5	19.2	22.1	8.9	33.5	31.1	14.0	17.3	15.6	21.5	26.7	10.4	29.9	23.8	0.0	9.7	19.3	18.3	25.1	7.0	18.2	9.0	19.0	8.8	12.2	35.5	0.0	21.6	8.5	13.6	29.8	15.3	10.5	21.5	11.8	26.3	25.7	22.5	0.0	6.6	14.0	20.6	30.1	17.8	20.3	7.4	16.3	13.3	29.0	33.3	15.1
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 610.0;Proximal tubular cells: 475.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	61.8	55.0	59.5	29.2	59.8	17.1	51.0	61.0	93.4	36.7	60.4	46.7	42.8	28.4	67.1	39.9	30.4	37.0	133.4	59.0	61.7	63.1	65.5	29.2	44.5	60.9	60.2	37.1	54.4	43.4	50.8	30.9	60.9	45.3	44.6	74.7	82.9	43.9	90.8	39.9	41.8	30.5	58.8	49.6	48.1	61.8	60.6	47.3	36.9	109.8	46.1	36.7	34.0	62.0	29.9	21.9	48.5	23.5	53.2	78.8	22.6	44.0	51.1	33.8	33.8	28.3	37.5	33.3	28.4	50.8	22.8	25.1	27.2	37.1	46.3	34.3	31.2	42.6	19.1	36.7	52.2	43.8	38.8	44.6	65.5	27.7	35.1	75.6	60.0	33.8	24.0	13.6	51.2	54.0	39.7	54.2	24.4	100.1	24.0	22.8	24.3	37.5	69.8	31.3	32.9	20.6	28.4	39.1	50.7	51.8	31.3	62.5	38.1	21.4	12.5	56.1	29.5	10.0	14.9	19.1	21.5	44.3	31.1	85.8	53.0	75.4	30.8	51.2	32.9	49.1	38.9	31.1	55.2	42.8	34.0	35.2	36.5	37.2	48.3	88.2	47.4	41.3	59.5	59.8	61.0	93.4	59.0	61.7	60.9	60.2	60.9	58.8	60.6	62.0	88.5	28.9	47.4	29.0	74.0	34.0	34.0	103.9	43.9	0.0	91.6	95.4	179.1	87.2	76.3	115.8	0.0	102.6	60.4	102.2	326.8	89.6	610.0	93.7	63.4	70.3	64.1	59.7	22.8	104.1	67.0	62.7	47.4	74.5	71.7	50.6	79.9	223.0	102.3	0.0	26.4	112.8	103.7	114.8	50.2	283.4	139.8	67.7	106.7	24.4	106.4	0.0	80.3	30.7	43.7	98.3	108.8	124.8	71.1	43.7	142.8	475.5	83.2	0.0	124.9	48.8	69.2	243.6	87.6	62.8	42.5	56.8	58.5	69.6	96.8	44.8
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765108	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 79.3;Excitatory neurons: 61.2;Inhibitory neurons: 58.1;Oligodendrocyte precursor cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 104.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018502, HPA075953"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA018502: AB_1854185, HPA075953: "	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.7	7.2	11.3	11.1	13.0	11.9	12.5	11.7	13.0	9.3	7.1	10.2	9.0	7.9	7.1	20.6	9.7	7.2	12.2	17.3	10.8	8.3	9.0	9.5	21.8	7.5	10.0	8.5	10.0	17.9	9.2	14.2	7.6	10.9	9.4	22.1	12.4	10.9	22.9	21.4	10.4	7.3	9.2	14.3	10.7	8.0	11.9	31.3	10.0	16.0	25.5	12.6	13.5	8.7	32.3	20.3	21.5	17.7	4.9	5.7	28.8	28.1	36.0	28.0	39.4	19.8	24.9	70.2	40.1	22.9	27.1	28.4	43.9	40.8	43.2	28.4	26.3	4.4	31.6	8.5	14.5	20.7	14.6	15.6	27.7	30.8	0.4	26.8	17.1	22.9	13.8	17.5	20.3	27.7	30.6	5.3	9.9	35.9	30.3	16.0	34.1	31.2	22.0	36.4	31.9	19.9	10.7	23.7	8.8	17.0	30.3	11.8	21.7	18.3	14.6	2.3	42.1	22.2	24.6	104.8	3.7	13.3	14.4	0.0	0.5	5.0	2.1	0.9	1.5	1.7	2.3	1.9	1.4	1.9	2.0	2.8	1.5	3.9	0.9	5.0	3.2	1.2	11.3	13.0	11.7	13.0	17.3	10.8	7.5	10.0	7.6	9.2	11.9	8.7	3.7	16.0	6.5	79.3	11.4	11.2	11.0	8.0	6.8	0.0	7.8	5.5	8.2	2.8	7.5	5.5	0.0	10.1	19.3	4.6	0.0	5.9	0.0	10.0	3.7	3.6	9.6	6.5	61.2	6.6	7.3	4.5	7.7	9.2	1.3	4.8	2.9	8.0	4.6	0.0	58.1	5.5	8.2	9.4	8.8	1.7	5.6	4.8	3.6	30.0	6.2	0.0	8.2	54.8	22.6	10.6	8.6	5.3	7.9	11.0	3.8	3.1	8.4	0.0	6.6	6.7	3.9	2.5	3.0	10.3	16.8	10.4	8.8	5.9	5.9	12.5
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 139.2;Intestinal goblet cells: 79.2;Paneth cells: 98.9;Proximal enterocytes: 133.2;Undifferentiated cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.7;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.7;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.0;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.6	12.3	3.5	2.9	3.6	0.1	4.1	3.2	4.0	11.0	7.3	22.2	20.3	9.5	6.9	4.3	8.4	12.9	3.2	3.1	3.9	6.9	1.4	3.8	0.7	5.1	4.3	15.2	2.1	5.1	5.3	4.2	3.9	4.7	26.7	1.0	2.2	7.7	1.0	9.4	23.4	13.8	4.5	1.8	3.9	4.9	3.8	0.7	1.6	2.7	0.9	6.9	6.9	4.4	3.1	7.3	3.1	2.6	8.6	10.1	6.6	3.1	10.0	4.0	4.9	0.2	12.9	0.0	6.7	10.6	4.9	4.3	0.3	5.2	2.4	0.2	0.1	0.0	2.3	0.9	2.2	0.0	0.2	6.3	1.7	4.1	6.8	17.0	4.8	0.1	0.2	0.3	7.8	9.9	0.0	0.1	0.7	20.5	2.9	0.0	1.0	0.1	5.8	0.9	0.2	0.2	1.7	2.9	1.1	2.0	3.0	0.0	3.3	4.5	5.4	4.0	2.7	0.6	1.5	0.0	3.9	0.0	0.5	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	3.5	3.6	3.2	4.0	3.1	3.9	5.1	4.3	3.9	4.5	3.8	4.4	2.2	0.0	0.6	2.6	0.5	4.1	3.8	8.9	5.2	0.0	3.0	4.1	6.4	5.7	3.6	14.7	0.0	14.1	0.4	139.2	1.9	15.0	0.6	1.7	3.1	4.5	15.7	0.0	4.0	17.0	10.7	7.0	19.4	2.2	0.0	3.0	3.9	1.5	4.8	0.0	4.9	79.2	0.0	11.3	6.1	0.3	5.6	15.7	1.8	1.0	43.8	0.0	0.0	0.0	3.6	45.1	98.9	12.0	0.3	4.9	133.2	18.5	4.5	0.0	6.6	0.5	7.3	0.4	0.6	3.4	6.5	28.5	0.9	6.4	56.5	4.1
MTMR12	"3-PAP, 3PAP, FLJ20476, KIAA1682, PIP3AP"	ENSG00000150712	"Myotubularin related protein 12"	Q9C0I1	5	32226994-32312987	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051333	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051333: AB_2681445"	"unprognostic (3.18e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.09e-1)"	18.4	7.6	7.9	10.8	11.2	13.4	17.4	6.3	10.6	9.2	4.8	12.1	9.6	16.0	8.8	13.8	21.0	13.3	9.1	10.5	3.6	15.8	16.7	15.7	17.5	3.0	3.8	17.8	24.7	21.5	7.4	11.9	3.1	14.2	8.5	7.5	17.0	12.2	6.0	13.3	8.2	16.6	3.6	11.3	14.9	19.1	4.5	12.4	14.6	6.7	16.1	10.1	8.3	7.9	18.7	16.7	17.6	34.3	19.8	11.5	24.6	17.0	13.6	21.0	13.1	16.3	13.1	68.4	21.0	17.5	35.8	12.4	30.2	16.5	25.3	24.0	14.9	22.6	32.4	27.2	13.9	16.1	16.1	10.3	15.3	21.0	21.9	15.2	25.3	14.5	16.9	24.6	14.1	13.7	17.3	12.4	22.8	20.2	17.5	17.5	25.3	8.8	16.8	16.8	6.2	11.6	46.8	28.1	20.6	18.3	23.2	16.6	21.3	16.2	22.4	16.2	23.8	21.4	36.1	37.9	16.5	26.6	20.1	7.5	1.8	3.1	3.1	4.7	2.5	2.8	1.4	2.1	2.4	1.8	1.2	1.4	3.0	2.3	2.2	2.9	1.8	2.5	7.9	11.2	6.3	10.6	10.5	3.6	3.0	3.8	3.1	3.6	4.5	7.9	31.1	32.1	37.8	30.7	16.0	7.0	7.2	7.2	9.6	0.0	28.1	23.4	13.8	15.7	16.4	14.7	0.0	7.5	30.5	8.6	7.9	31.1	1.7	43.1	16.2	21.9	12.0	20.4	71.6	23.6	7.7	12.6	19.4	29.8	15.2	9.3	23.6	26.7	10.1	0.0	47.2	7.5	10.2	16.1	14.8	4.0	6.5	13.9	3.6	15.9	10.2	0.0	12.3	32.2	30.7	18.2	8.2	7.2	19.0	12.2	8.2	16.4	28.2	0.0	6.6	13.1	12.8	20.8	22.3	14.1	8.4	7.5	14.1	7.2	7.7	7.1
MTMR14	"C3orf29, FLJ22405, FLJ90311, hEDTP, hJumpy"	ENSG00000163719	"Myotubularin related protein 14"	Q8NCE2	3	9649433-9702393	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054063	Approved				"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"			"HPA054063: AB_2682365"	"unprognostic (9.50e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (2.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-3)"	18.3	18.0	15.7	22.1	16.4	56.0	15.5	15.6	15.7	12.4	28.1	18.5	17.7	12.7	11.2	15.9	13.5	13.4	34.4	14.8	16.3	18.4	19.5	21.6	37.3	16.4	16.0	13.9	11.8	14.9	10.2	20.1	16.8	12.1	18.4	9.2	13.9	10.7	45.3	19.8	17.9	13.4	15.9	27.8	16.5	16.9	16.6	24.4	15.3	35.6	41.6	18.3	12.7	18.8	18.9	29.1	19.1	11.1	25.6	17.1	106.4	15.0	28.6	29.3	33.6	22.1	27.7	38.2	16.0	24.2	37.8	11.3	23.4	34.2	24.7	34.5	32.5	40.0	24.4	31.9	45.6	35.3	70.6	31.9	22.9	36.9	38.4	19.9	33.2	28.6	25.0	34.0	20.5	60.4	26.1	28.9	31.3	28.2	23.8	27.0	23.1	41.1	26.4	32.6	10.2	28.7	16.7	21.6	29.3	26.0	28.9	57.3	26.0	13.7	21.5	24.9	21.5	37.0	63.3	49.6	31.0	44.0	18.2	116.9	139.9	107.1	44.7	148.1	44.5	76.5	43.3	45.5	177.8	63.4	39.6	40.6	87.7	58.0	145.1	97.2	55.5	113.7	15.7	16.4	15.6	15.7	14.8	16.3	16.4	16.0	16.8	15.9	16.6	18.8	19.3	16.0	6.4	21.5	41.7	10.8	12.2	22.6	8.0	0.0	13.2	12.1	23.8	18.6	14.8	9.2	0.0	47.6	34.2	22.0	29.4	38.3	13.8	10.4	10.5	20.0	12.5	24.8	12.2	28.2	39.0	13.0	27.0	19.6	19.7	15.0	26.4	16.7	67.7	0.0	10.3	14.6	22.4	65.3	28.3	12.8	13.1	55.8	12.4	28.1	68.4	0.0	22.6	9.5	19.9	41.9	25.9	13.2	25.0	15.2	33.2	37.3	10.1	0.0	6.6	15.2	14.0	39.0	40.0	14.7	18.0	64.7	27.0	40.5	16.8	12.7
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95821766-95925315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 120.1;Oligodendrocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	14.7	9.3	11.0	11.2	16.8	4.4	11.8	16.3	18.3	12.2	12.2	12.9	7.1	12.3	6.2	14.7	12.4	14.3	13.5	10.8	14.3	16.4	4.3	12.3	9.5	15.1	14.4	11.5	7.8	12.7	6.4	24.5	15.8	16.1	13.9	18.6	20.5	11.4	6.2	8.2	8.3	18.0	13.5	8.6	13.0	31.0	14.1	15.1	9.9	8.9	12.1	15.2	10.4	22.4	24.1	25.3	54.1	39.2	19.2	29.0	47.5	43.3	37.9	42.4	37.8	57.3	47.1	16.2	50.3	45.5	35.9	30.9	47.7	48.2	38.9	30.8	21.3	31.5	55.0	33.0	42.8	59.3	26.7	24.0	31.2	56.6	54.5	41.8	64.4	35.4	44.7	14.2	39.6	17.9	29.0	27.2	46.6	59.0	34.9	23.2	32.2	16.8	43.9	125.0	35.6	40.6	43.6	36.4	19.2	35.1	27.6	26.5	64.4	47.7	45.1	34.4	41.1	13.1	42.4	14.3	20.4	15.6	50.6	9.8	3.9	1.7	12.4	4.7	13.4	5.8	7.9	15.7	7.6	4.9	4.0	11.3	0.9	14.1	7.2	3.7	8.1	7.8	11.0	16.8	16.3	18.3	10.8	14.3	15.1	14.4	15.8	13.5	14.1	22.4	19.6	3.2	8.6	28.7	9.6	10.3	15.0	9.0	8.6	0.0	8.0	6.7	17.3	0.0	11.6	9.2	0.0	9.0	8.8	9.1	9.8	17.8	74.8	18.1	14.1	20.2	16.2	12.8	69.8	16.9	34.3	17.0	9.7	8.7	19.0	49.1	11.0	1.0	12.5	0.0	37.5	9.8	24.4	10.3	8.2	120.1	11.1	8.3	3.6	40.3	6.8	0.0	14.4	63.8	226.6	17.7	4.7	12.0	7.0	15.1	6.0	29.3	17.0	0.0	32.9	7.9	29.0	46.8	19.2	15.4	6.0	9.0	8.8	12.9	10.6	15.6
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969651-92985066	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.1;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"GAMG: 4.9;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA074024	Supported					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.0	0.0	2.2	0.0	2.8	0.0	0.0	0.7	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	3.0	2.8	0.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.7	1.1	2.3	1.2	3.0	2.8	3.1	2.1	1.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	5.8	5.6	3.3	5.5	3.4	4.1	6.0	5.6	4.9	6.6	3.1	6.7	6.1	5.6	4.4	6.3	6.4	3.5	8.3	3.3	3.2	11.6	17.6	5.0	7.8	3.3	2.9	7.3	6.2	9.3	5.7	4.1	3.4	6.2	6.6	6.7	5.6	4.6	9.3	5.3	7.5	5.2	2.7	9.8	6.5	9.9	3.4	7.2	6.3	9.8	9.3	6.8	6.7	4.6	6.5	6.0	8.0	5.9	12.4	13.7	4.3	13.5	14.7	15.7	15.7	13.2	4.1	13.7	9.4	13.9	9.5	10.1	18.6	12.5	24.9	7.6	9.6	15.7	12.0	13.5	16.3	27.0	7.1	9.2	17.4	16.0	16.7	7.8	11.3	14.6	22.5	16.8	14.4	10.9	6.4	9.0	6.5	9.4	5.8	11.3	27.8	25.8	9.2	12.0	5.5	3.9	5.5	14.2	12.2	7.1	7.6	24.1	6.9	7.9	6.6	5.1	13.0	8.5	15.1	6.6	4.7	17.8	11.6	1.3	4.5	3.8	5.9	6.1	9.2	6.2	7.1	5.7	4.7	5.4	7.9	5.9	1.6	8.2	6.0	4.5	12.0	7.0	3.3	3.4	5.6	4.9	3.3	3.2	3.3	2.9	3.4	2.7	3.4	4.6	9.4	16.0	17.9	11.1	22.7	7.8	14.5	13.2	4.6	0.0	5.7	5.0	15.7	11.5	12.1	11.0	0.0	12.1	19.9	6.7	21.5	7.3	127.7	12.0	13.7	11.7	8.4	5.0	14.3	7.5	8.6	10.9	10.2	22.7	6.3	8.4	10.0	22.6	8.7	0.0	15.8	9.0	6.1	8.2	7.2	20.1	11.1	10.6	0.0	11.2	15.1	0.0	18.6	11.1	21.9	7.0	6.9	9.8	20.1	14.4	16.0	17.4	7.5	0.0	6.6	19.7	10.4	42.9	11.6	7.2	10.1	10.3	21.2	11.5	11.7	10.8
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262551	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	16.3	19.4	18.2	13.5	19.0	14.0	16.8	18.4	20.1	15.2	18.6	22.8	11.0	17.5	21.8	18.3	14.6	9.0	23.6	19.7	17.7	24.1	27.6	15.2	15.3	16.5	21.2	14.2	18.3	20.6	21.8	11.8	18.4	19.8	16.0	26.9	16.5	13.8	36.4	17.1	19.6	13.8	14.6	21.2	18.7	33.8	22.7	19.2	17.8	17.8	15.9	17.1	14.9	18.7	28.5	25.2	33.3	25.4	39.4	18.6	16.6	23.4	22.3	30.6	29.9	26.0	25.5	31.4	19.6	27.8	18.8	33.1	45.3	35.8	39.3	25.2	33.2	41.7	53.8	33.4	24.7	41.1	29.7	24.0	26.8	43.7	44.0	14.5	39.3	29.6	47.4	26.1	21.6	32.4	28.5	31.2	25.3	29.6	23.5	28.2	39.2	21.0	27.2	25.3	33.4	24.5	50.1	26.8	31.2	36.5	21.8	24.0	42.3	26.5	23.9	20.5	31.8	25.5	25.5	60.5	19.1	43.6	28.6	0.3	1.1	1.3	1.9	2.4	1.6	1.4	1.1	1.0	1.6	1.1	1.3	1.1	0.8	1.1	1.3	1.2	2.4	1.0	18.2	19.0	18.4	20.1	19.7	17.7	16.5	21.2	18.4	14.6	22.7	18.7	9.2	16.0	11.8	40.8	10.0	3.4	5.2	7.6	8.6	0.0	7.7	7.5	25.1	2.8	10.3	9.2	0.0	7.9	9.8	9.4	1.9	8.5	42.0	13.8	16.1	11.0	10.3	14.3	43.8	6.2	7.2	9.2	16.8	18.6	13.3	12.9	5.3	13.4	6.9	0.0	49.2	7.8	6.1	8.2	4.1	36.1	7.8	9.1	8.8	36.5	9.2	0.0	10.3	38.2	37.4	10.4	5.4	8.2	17.2	8.9	7.0	4.5	6.3	0.0	39.5	11.4	12.1	49.3	37.4	15.6	5.7	9.9	9.8	15.3	10.0	5.7
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	8.9	7.4	4.9	10.3	4.8	36.8	9.7	12.6	6.7	6.1	3.1	9.6	10.6	9.0	6.2	8.3	6.6	5.2	8.8	4.8	4.3	9.6	10.6	6.3	10.7	3.4	3.5	8.2	10.0	8.4	2.7	9.6	3.9	7.2	11.0	7.1	8.0	4.9	13.2	8.4	9.0	9.1	3.2	9.3	7.1	5.1	3.6	9.2	10.2	12.0	10.3	8.1	5.2	6.2	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	4.9	4.8	12.6	6.7	4.8	4.3	3.4	3.5	3.9	3.2	3.6	6.2	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926760-135977359	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	68.9	49.5	66.7	65.1	75.5	151.1	50.7	41.6	79.4	67.1	45.6	50.5	40.2	65.1	50.9	125.5	62.2	50.5	77.1	79.5	65.0	58.5	49.7	57.8	89.4	77.7	60.0	49.2	23.8	75.9	34.0	61.7	54.0	52.9	55.4	39.9	36.8	51.3	47.6	46.8	46.6	66.1	56.3	79.7	41.2	56.6	65.2	72.5	88.2	48.0	107.8	67.2	58.5	53.3	126.0	90.6	111.5	170.4	160.3	187.2	55.8	189.5	208.0	129.3	137.7	104.5	139.4	229.7	132.7	255.6	188.6	78.9	107.1	161.1	246.1	153.1	84.2	152.9	94.6	77.2	127.3	211.5	213.5	136.5	158.5	152.9	147.7	180.1	205.5	163.6	182.3	138.1	253.2	94.3	208.4	163.0	155.9	121.9	118.9	120.0	83.8	187.7	144.5	103.1	140.6	248.3	157.1	105.8	158.4	102.8	75.4	130.7	215.2	193.5	85.0	192.3	189.7	103.8	160.2	325.9	307.5	185.0	420.2	117.4	75.4	85.2	54.7	105.7	46.0	107.9	33.5	41.7	89.3	125.0	21.5	31.7	180.3	46.0	169.4	82.8	32.6	70.5	66.7	75.5	41.6	79.4	79.5	65.0	77.7	60.0	54.0	56.3	65.2	53.3	110.6	48.1	40.6	0.0	149.8	119.2	58.9	86.8	72.8	0.0	68.6	72.8	82.0	70.1	61.9	69.9	0.0	63.4	131.6	67.1	90.1	69.6	77.8	83.8	153.3	108.5	33.0	91.9	0.0	51.3	73.1	92.4	45.9	131.9	98.6	64.8	87.4	59.2	100.5	0.0	0.0	46.9	46.8	247.5	232.7	28.6	86.3	214.0	101.4	0.0	234.2	0.0	125.7	0.0	0.0	99.9	67.0	123.8	59.2	96.2	52.6	88.3	50.0	0.0	92.1	99.8	79.8	65.8	123.8	143.3	149.0	68.8	86.1	106.5	52.4	106.9
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795260-236921278	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	9.1	6.6	4.3	6.9	5.4	4.6	8.0	5.2	5.4	10.1	6.5	11.1	4.8	10.2	10.5	5.0	11.9	8.9	15.0	4.9	4.6	12.7	6.0	7.1	8.1	6.7	5.3	14.6	13.0	20.2	6.4	11.6	6.9	7.6	5.0	5.6	6.4	9.1	16.6	9.3	7.1	8.7	4.8	9.4	9.0	9.0	4.8	10.0	13.4	18.1	7.0	10.3	7.6	6.5	17.6	11.0	13.0	8.8	22.6	20.3	15.3	14.9	14.8	18.8	19.0	12.6	12.5	40.0	13.2	16.6	8.7	10.6	18.4	13.1	20.4	19.8	13.7	23.7	14.2	18.3	15.1	37.2	13.3	28.9	7.0	22.9	17.9	11.5	22.3	19.8	33.1	16.4	13.1	10.1	19.6	10.3	16.2	12.9	5.4	20.9	24.8	24.2	11.2	21.3	11.1	27.8	17.7	11.9	14.8	9.3	16.7	13.0	28.8	24.1	9.1	19.6	18.8	34.4	12.3	22.7	17.2	21.1	26.2	0.6	0.5	1.5	1.1	0.8	2.3	0.7	1.4	1.4	0.7	0.8	1.4	1.5	0.0	0.9	0.5	0.5	0.9	0.9	4.3	5.4	5.2	5.4	4.9	4.6	6.7	5.3	6.9	4.8	4.8	6.5	23.0	57.7	35.0	53.8	25.8	8.2	8.3	8.3	17.1	0.0	10.7	11.9	100.0	20.0	10.9	40.5	0.0	24.2	25.9	3.4	1.9	13.8	9.8	57.5	80.1	21.4	8.4	23.5	87.7	14.8	9.2	22.8	15.8	130.9	30.4	35.0	15.4	10.8	14.4	0.0	106.8	7.7	4.1	16.6	6.8	6.2	23.9	17.1	10.6	47.8	15.3	0.0	19.6	62.8	73.6	12.3	8.0	33.1	20.3	14.9	9.7	9.1	13.3	0.0	6.6	39.4	23.2	17.2	22.0	11.5	5.1	22.6	26.1	40.2	12.0	6.4
MTRES1	"C6orf203, HSPC230, PRED31"	ENSG00000130349	"Mitochondrial transcription rescue factor 1"	Q9P0P8	6	107028199-107051586	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 47.4;Cytotrophoblasts: 31.6;Extravillous trophoblasts: 14.3;Hofbauer cells: 24.3;Syncytiotrophoblasts: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049535	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA049535: AB_2680808"	"unprognostic (1.34e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.09e-5)"	"unprognostic (2.64e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.19e-2)"	"prognostic favorable (2.11e-5)"	14.5	33.1	22.3	8.8	22.6	5.6	12.5	23.9	35.7	11.0	24.7	19.6	17.4	11.4	19.0	14.7	11.1	8.2	33.9	22.2	23.3	25.1	28.7	7.9	11.3	22.2	22.6	11.2	13.7	14.0	12.1	8.8	22.0	11.1	17.8	12.3	16.1	11.7	41.8	10.8	14.8	10.1	22.1	13.1	15.4	9.5	22.4	10.4	16.3	36.8	12.2	13.3	11.4	23.1	11.6	7.1	21.5	30.5	39.1	33.6	8.9	24.1	19.1	15.7	20.2	4.6	8.7	31.8	17.6	17.5	17.2	16.1	15.4	20.9	21.6	25.9	11.5	19.5	7.0	7.7	26.0	23.0	10.2	24.3	29.2	13.6	19.6	21.1	22.3	24.5	22.7	23.8	33.5	15.9	10.5	34.3	10.3	36.9	12.0	19.0	17.8	14.7	41.0	16.2	13.6	14.1	11.9	15.6	22.5	16.0	12.6	40.7	17.4	10.6	10.3	13.4	13.0	5.0	7.8	17.2	18.5	35.6	22.7	1.4	14.9	14.2	16.0	15.9	16.7	20.6	18.4	17.8	21.1	19.6	25.0	21.8	1.7	20.3	14.6	21.0	26.5	13.6	22.3	22.6	23.9	35.7	22.2	23.3	22.2	22.6	22.0	22.1	22.4	23.1	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	31.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	14.3	5.6	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	18.2	0.2	0.0	0.0	0.0
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MTRF1	"MGC47721, MTTRF1, RF1"	ENSG00000120662	"Mitochondrial translation release factor 1"	O75570	13	41216369-41263577	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.6;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043316	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043316: AB_10795038"	"unprognostic (3.87e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.27e-3)"	"unprognostic (5.07e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-2)"	5.1	9.7	5.7	8.7	5.8	10.9	6.9	6.6	8.1	6.2	10.1	8.4	10.8	6.2	12.0	8.5	5.1	11.0	7.2	5.7	6.1	11.7	11.4	5.8	12.5	6.5	5.9	6.1	12.4	7.5	6.7	6.0	6.8	7.3	11.9	5.1	6.7	6.2	13.8	10.0	9.3	6.9	5.6	11.4	10.8	14.0	6.3	10.2	7.1	12.7	11.6	7.1	6.2	6.1	9.2	12.1	14.8	12.6	16.2	18.7	10.0	13.0	9.3	15.4	15.2	29.0	23.1	25.3	8.6	10.5	25.4	26.3	21.7	14.0	20.6	15.6	18.0	23.8	17.9	23.7	10.3	21.3	21.6	10.6	12.7	14.0	8.3	11.7	22.3	26.0	15.9	5.9	18.9	9.1	18.9	21.8	13.8	33.6	9.1	14.8	12.4	12.0	16.0	7.8	3.7	8.9	11.9	10.7	12.6	17.8	7.3	11.2	9.8	12.4	5.3	11.7	12.9	6.8	12.0	22.4	17.3	14.8	13.2	3.3	2.5	4.9	3.9	3.3	5.2	5.0	2.8	4.0	5.4	2.8	5.4	7.9	1.5	3.2	2.5	3.4	4.8	2.5	5.7	5.8	6.6	8.1	5.7	6.1	6.5	5.9	6.8	5.6	6.3	6.1	3.7	3.2	3.6	5.5	8.3	3.6	5.3	8.8	5.2	0.0	4.6	4.7	9.4	10.0	9.5	9.2	0.0	7.2	10.0	4.3	11.7	6.2	28.6	5.0	4.7	4.8	4.2	7.4	10.1	7.5	9.2	5.1	7.1	4.4	5.1	5.7	5.7	4.6	6.1	0.0	9.4	4.6	14.2	3.5	1.6	8.0	1.5	6.2	1.8	6.5	5.4	0.0	3.1	10.1	11.7	7.2	4.4	3.8	7.5	3.7	5.2	15.5	3.9	0.0	0.0	5.6	5.4	26.6	8.7	6.4	3.4	4.2	7.6	7.3	5.7	6.2
MTRF1L	"HMRF1L, mtRF1a"	ENSG00000112031	"Mitochondrial translational release factor 1 like"	Q9UGC7	6	152987362-153002709	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036367	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036367: AB_10670715"	"prognostic unfavorable (4.82e-4)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.56e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.80e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.84e-1)"	6.8	6.2	8.4	5.8	10.3	7.1	4.6	12.6	10.3	4.8	13.0	7.6	8.2	4.0	5.9	5.4	3.6	5.1	11.4	8.3	9.6	10.1	7.7	4.6	6.6	9.7	9.5	4.2	6.2	8.6	3.8	5.5	11.0	5.1	6.2	10.3	5.5	5.5	17.9	7.7	6.2	6.7	9.4	5.4	5.7	4.6	9.7	4.8	7.6	21.9	5.8	6.0	3.5	10.7	7.8	8.9	14.8	20.4	16.1	8.5	14.7	13.9	13.4	12.8	18.6	15.4	6.1	14.0	10.7	14.3	22.0	11.7	21.3	12.3	18.5	16.0	14.7	14.0	12.8	20.9	13.9	14.3	14.4	13.4	14.1	16.2	17.9	12.4	18.4	15.3	22.4	8.8	15.4	12.8	10.8	12.1	8.9	17.2	13.1	10.3	11.0	11.2	19.2	13.7	15.6	19.6	18.1	12.9	10.3	16.4	8.6	15.6	12.8	10.2	16.3	17.3	18.2	15.6	15.7	14.8	19.6	10.7	13.1	10.3	3.5	7.1	3.2	5.2	2.8	3.3	3.4	2.9	3.7	2.4	3.1	3.5	3.4	3.3	6.9	2.7	4.0	4.0	8.4	10.3	12.6	10.3	8.3	9.6	9.7	9.5	11.0	9.4	9.7	10.7	29.9	12.8	16.4	11.8	19.9	33.9	24.2	14.5	20.5	0.0	13.8	11.4	28.0	8.6	13.7	18.4	0.0	15.7	15.7	26.3	25.4	34.1	59.8	15.2	22.8	34.5	17.3	14.9	13.0	26.7	24.3	23.6	14.3	20.3	18.4	17.7	62.8	17.6	17.1	0.0	13.2	12.9	12.2	21.2	15.4	54.5	20.2	23.5	16.0	9.4	31.2	0.0	21.6	11.1	11.8	34.0	22.9	25.6	24.0	21.2	27.9	39.2	6.8	0.0	39.5	23.7	30.0	43.4	13.8	29.1	32.7	19.7	16.5	33.8	17.9	23.4
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.1;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	11.2	10.6	5.1	9.5	11.2	5.7	6.3	10.1	10.9	7.2	3.4	8.3	8.9	11.7	12.3	9.3	9.6	11.8	14.4	6.5	9.0	18.7	19.4	13.1	11.1	10.9	10.4	11.4	11.9	12.8	6.7	10.8	10.6	9.0	10.1	19.2	10.5	7.1	28.9	9.1	10.2	12.0	8.2	6.7	6.7	7.1	9.3	7.5	9.0	32.9	10.6	14.4	5.5	20.0	19.3	18.1	10.2	20.0	34.0	13.6	25.1	31.1	18.5	16.5	15.4	27.8	15.1	32.6	27.9	24.6	27.4	11.8	17.0	14.2	27.9	22.9	15.8	14.6	62.0	15.3	21.9	23.4	6.8	18.3	11.4	24.6	18.4	20.4	10.4	8.0	21.9	24.2	9.8	4.2	14.2	11.7	7.3	29.4	19.0	12.4	9.5	14.1	16.2	16.0	14.0	2.5	51.6	33.7	28.6	18.1	10.7	17.5	14.6	31.9	19.7	24.1	22.7	34.7	13.5	27.3	23.1	50.5	19.1	5.3	4.0	3.0	4.1	5.5	7.0	3.3	6.5	5.7	3.6	3.3	4.1	3.6	0.1	3.1	4.4	2.3	9.1	3.3	5.1	11.2	10.1	10.9	6.5	9.0	10.9	10.4	10.6	8.2	9.3	20.0	7.7	16.0	70.1	10.1	11.1	16.3	9.4	4.6	12.0	0.0	9.7	5.1	12.9	5.7	9.0	9.2	0.0	9.9	11.4	11.0	21.5	10.2	50.1	10.0	10.7	8.0	9.6	12.4	25.4	5.5	8.9	11.8	9.2	6.7	10.2	6.5	8.6	19.3	7.7	0.0	20.8	9.1	0.0	11.1	9.4	99.2	10.5	9.7	1.8	15.0	8.1	0.0	7.2	20.1	50.9	7.2	6.0	11.7	26.5	14.3	8.7	28.9	10.1	0.0	6.6	10.7	10.1	17.4	13.1	10.5	20.6	11.2	13.8	11.8	9.4	8.7
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MTSS2	"ABBA, ABBA-1, LOC92154, MTSS1L"	ENSG00000132613	"MTSS I-BAR domain containing 2"	Q765P7	16	70661204-70686053	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 372.5"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 48.0"	"Cancer enhanced"	"Detected in all"		"glioma: 26.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048531, HPA066469"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Focal adhesion sites"		"HPA048531: AB_2680430, HPA066469: AB_2685671"	"prognostic unfavorable (2.85e-4)"	"unprognostic (8.85e-2)"	"unprognostic (7.01e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.25e-2)"	31.7	40.5	299.2	20.9	295.8	9.4	26.9	283.7	279.1	66.1	102.2	89.2	14.3	78.9	6.1	50.7	47.4	29.0	36.7	296.0	324.9	25.3	106.0	47.2	10.1	372.5	316.2	35.6	13.7	12.8	25.0	36.0	311.5	42.1	8.2	25.6	30.6	37.1	81.1	32.6	27.4	60.0	254.5	58.3	29.9	10.8	313.2	42.5	21.3	29.9	7.9	46.6	46.0	278.5	67.2	157.4	38.9	40.4	31.6	31.2	146.4	98.8	122.0	83.0	68.5	63.8	41.9	0.8	34.6	155.5	33.0	136.9	42.5	43.2	31.5	1.2	56.9	23.2	137.7	299.9	278.1	35.0	1.1	129.3	92.6	38.6	133.0	35.7	27.6	35.0	88.8	1.4	74.8	164.1	33.4	177.8	34.2	22.6	33.1	70.6	72.5	0.4	72.4	99.0	91.1	61.0	210.5	90.6	27.2	36.6	69.9	67.2	41.9	64.3	72.6	59.0	62.7	23.4	6.4	1.2	58.3	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	299.2	295.8	283.7	279.1	296.0	324.9	372.5	316.2	311.5	254.5	313.2	278.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	48.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 275.2;liver: 266.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	0.9	0.2	0.9	0.0	0.2	0.8	0.9	0.1	0.3	1.3	243.2	0.1	1.0	0.1	0.6	1.3	0.9	0.8	1.5	12.9	266.6	0.3	0.3	1.1	1.6	2.0	0.0	0.0	0.5	0.0	1.3	0.5	0.3	5.6	0.1	0.2	0.4	0.1	275.2	0.5	1.2	0.0	0.8	9.6	1.2	0.2	0.1	0.3	0.1	0.9	0.0	1.9	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	0.9	0.8	1.5	1.1	1.6	1.3	1.2	1.2	1.9	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134986-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	14	"brain: 1933.2;choroid plexus: 740.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5"	"Cancer enhanced"	"Detected in all"		"glioma: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.2;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HEL: 96.2;SCLC-21H: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	88.4	10.8	1190.3	9.7	1373.7	23.3	41.6	1103.3	1933.2	25.7	740.3	35.8	5.4	19.4	95.3	19.5	21.1	10.4	25.0	946.3	1044.1	50.3	4.1	20.9	5.4	1359.2	1275.8	33.4	12.9	15.7	17.4	7.5	1312.7	19.2	10.0	41.0	35.2	23.8	36.6	23.2	13.8	17.0	1311.0	8.3	26.4	10.9	1260.6	7.5	14.7	59.8	5.4	32.1	20.0	1483.6	12.5	2.1	7.1	7.6	52.9	35.9	6.4	6.0	7.0	2.0	2.8	1.0	5.0	0.7	4.8	13.3	11.0	2.4	16.4	23.6	6.4	5.4	13.2	96.2	16.1	6.7	4.1	4.8	30.8	17.9	10.8	6.2	10.9	8.6	3.2	13.1	6.4	5.0	13.8	4.8	5.6	2.3	4.9	11.6	7.5	0.5	16.3	21.4	24.1	5.1	68.7	18.2	3.8	19.1	19.4	6.6	13.5	7.1	15.5	7.8	8.5	16.6	8.5	8.3	12.7	1.1	10.4	10.3	4.0	8.2	0.3	3.6	0.3	0.2	0.1	0.5	0.2	0.1	0.4	0.3	0.1	0.3	2.2	2.1	0.0	1.0	0.7	1.4	1190.3	1373.7	1103.3	1933.2	946.3	1044.1	1359.2	1275.8	1312.7	1311.0	1260.6	1483.6	38.9	16.0	20.0	18.6	5.6	37.5	17.8	6.6	13.1	0.0	48.3	40.8	27.6	17.2	10.2	44.1	0.0	2.6	32.1	3.2	156.5	8.3	14.1	46.6	16.9	18.9	54.1	35.1	55.9	8.6	7.3	24.6	7.7	52.6	6.3	16.6	26.0	5.0	5.3	0.0	34.7	9.1	0.0	23.4	16.8	32.5	17.1	29.3	55.2	37.5	12.1	0.0	6.2	16.6	77.1	10.4	5.9	12.4	4.9	26.6	0.4	11.2	26.6	0.0	6.6	17.8	30.2	2.0	7.3	11.4	36.8	2.2	7.4	5.9	6.0	23.0
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820339-29505947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 50.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 548.4;Inhibitory neurons: 671.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 13.2;HeLa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge"		"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.2	0.2	0.4	0.1	1.7	0.1	0.1	1.2	9.7	0.6	1.8	0.9	0.1	1.5	0.0	0.3	0.8	0.1	50.2	1.0	0.0	0.1	0.9	0.1	0.6	0.0	0.1	7.5	4.8	0.0	6.1	0.0	0.0	0.3	0.2	4.6	1.0	0.1	0.1	0.2	0.4	1.2	2.2	0.5	1.3	1.2	1.0	0.2	0.5	0.1	0.1	1.3	0.2	2.4	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	13.2	0.4	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	2.3	1.6	0.1	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.7	1.2	9.7	1.0	0.0	0.0	0.1	0.0	2.2	1.0	2.4	0.1	0.0	0.5	10.4	0.1	0.5	0.7	0.1	0.0	0.0	0.3	0.4	145.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.3	1.0	0.7	0.0	0.8	548.4	0.6	0.0	5.9	0.0	1.1	0.0	1.2	0.4	0.5	0.1	0.0	671.8	0.7	0.0	0.0	0.8	3.3	0.9	0.2	1.8	15.0	0.1	0.0	0.0	18.1	16.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.0	0.0	1.6	1.0	0.1	4.1	1.8	0.1	0.3	0.3	19.6	0.0	1.1
MTX1	"MTX, MTXN"	ENSG00000173171	"Metaxin 1"	Q13505	1	155208695-155213824	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 601.3;Late spermatids: 1473.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011543	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA011543: AB_1853824"	"unprognostic (2.57e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-2)"	29.3	33.2	23.9	16.1	24.5	39.1	28.2	25.2	29.2	22.3	29.2	25.9	18.9	25.3	17.8	33.0	31.0	13.1	22.1	23.2	24.2	34.1	44.8	22.9	19.6	24.8	24.7	17.6	27.7	37.7	20.3	20.8	24.5	22.1	18.8	3.7	31.6	21.7	17.5	25.5	23.0	18.6	24.7	29.3	28.1	90.3	24.8	20.9	24.4	16.7	21.2	20.7	21.2	25.3	54.3	87.6	27.3	39.3	49.9	44.8	86.4	27.4	55.0	79.4	55.1	109.5	88.2	44.3	88.2	63.4	25.2	52.8	40.6	77.4	28.8	32.9	95.4	28.3	64.0	107.1	78.8	52.5	38.0	57.5	71.2	82.2	54.9	30.4	71.2	64.4	58.1	21.5	47.9	131.7	59.6	65.9	54.7	76.5	100.2	48.3	17.2	105.4	73.1	46.2	44.5	55.3	34.0	106.3	31.0	41.6	86.2	84.1	30.0	37.8	42.6	25.4	46.9	41.1	37.3	46.2	50.1	26.8	41.3	32.8	69.0	17.4	24.2	38.3	23.2	41.6	29.6	25.7	60.8	37.7	29.3	26.5	114.2	34.6	22.2	32.9	39.0	40.6	23.9	24.5	25.2	29.2	23.2	24.2	24.8	24.7	24.5	24.7	24.8	25.3	26.0	9.6	17.0	4.9	28.9	20.3	42.0	91.3	26.7	0.0	41.8	42.4	1.1	27.1	45.1	35.0	0.0	107.5	17.1	36.5	97.8	80.1	601.3	56.6	35.1	24.7	19.8	14.7	2.8	84.7	130.7	33.6	40.8	30.1	26.6	42.2	23.9	54.4	97.3	0.0	3.6	42.3	54.9	37.1	23.3	1473.9	43.2	38.9	49.8	1.0	65.1	0.0	37.0	3.0	4.8	72.7	48.4	39.5	39.3	41.6	44.3	144.6	61.2	0.0	46.0	29.2	58.4	105.2	52.9	34.9	21.0	88.7	22.5	43.9	54.6	42.6
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Spermatocytes: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	20.4	37.4	31.8	15.2	33.6	9.2	27.0	32.8	46.7	22.1	35.9	31.2	22.8	18.7	39.3	38.1	28.9	14.5	49.8	33.3	34.4	46.4	30.8	15.6	14.2	33.9	32.0	21.1	26.3	48.1	29.5	25.8	33.2	26.4	35.5	47.3	20.4	22.6	74.4	23.4	20.2	25.7	34.0	15.6	24.4	64.3	33.5	18.2	20.4	70.9	20.8	25.1	24.7	35.6	52.2	31.0	60.8	37.8	40.0	45.9	58.3	54.5	52.0	49.8	58.3	53.1	55.8	66.4	91.4	49.1	79.9	34.5	67.1	67.6	67.9	66.6	49.4	63.9	39.1	94.9	62.7	98.9	20.7	51.1	83.5	52.2	89.1	60.3	72.0	64.3	86.8	50.2	59.6	47.4	34.9	102.9	58.3	101.8	45.5	0.0	44.0	60.8	142.4	93.3	87.0	74.4	45.7	60.9	120.7	116.4	33.7	64.0	63.5	49.2	43.5	52.1	57.9	55.4	62.1	79.8	61.1	49.7	60.8	8.0	9.3	4.1	9.6	15.8	13.1	18.9	12.4	11.1	14.8	13.7	14.9	15.4	0.0	19.6	14.4	12.1	16.9	9.9	31.8	33.6	32.8	46.7	33.3	34.4	33.9	32.0	33.2	34.0	33.5	35.6	34.4	19.2	22.6	50.6	20.8	31.1	36.2	130.9	37.5	0.0	38.2	43.8	69.2	31.5	63.6	57.0	0.0	78.8	11.1	38.8	201.5	51.8	22.3	60.9	25.7	31.4	41.5	19.5	106.0	39.5	63.3	30.2	28.1	33.9	43.1	25.7	16.4	33.7	47.8	0.0	106.3	47.7	103.7	21.7	15.7	18.8	35.4	19.6	35.6	43.1	26.1	0.0	12.3	93.5	180.2	49.8	26.1	32.7	23.1	48.2	39.6	106.3	63.8	0.0	39.5	24.9	52.4	247.8	127.1	56.5	41.9	65.0	18.8	55.8	52.6	53.7
MTX3		ENSG00000177034	"Metaxin 3"	Q5HYI7	5	79976716-79991262	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047858, HPA062061"	Approved		Approved	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 51: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA047858: AB_2680185, HPA062061: AB_2684672"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (5.08e-5)"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (8.58e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.28e-1)"	6.8	10.0	5.9	6.2	6.8	6.4	8.1	6.0	7.1	8.2	4.8	8.6	4.4	9.2	6.7	7.9	8.3	3.9	7.7	6.9	5.9	6.9	5.6	5.5	8.3	6.2	6.1	12.5	7.2	11.8	7.3	4.5	6.7	7.8	4.9	11.9	8.3	6.8	8.7	7.6	9.6	6.1	5.4	8.3	7.4	5.1	6.8	3.8	8.8	5.5	7.9	7.9	7.6	6.2	8.6	4.9	13.1	7.1	6.3	11.3	3.3	8.2	5.9	6.6	7.3	2.1	9.1	13.6	2.4	7.7	11.0	9.9	0.0	18.1	12.4	3.6	8.0	5.7	14.7	6.8	11.8	0.0	6.7	9.0	18.0	11.4	20.1	9.3	4.6	0.0	3.0	7.5	11.3	9.2	0.0	0.1	13.4	2.8	5.1	0.0	19.7	5.8	6.0	9.7	17.1	13.2	10.8	7.4	15.9	10.1	12.1	9.7	5.3	11.9	9.7	9.2	18.0	10.5	10.8	11.9	17.8	0.0	15.0	0.3	0.2	0.2	0.6	0.2	0.4	0.8	0.6	0.5	0.1	0.5	0.8	0.6	0.2	0.4	0.1	0.2	0.4	0.2	5.9	6.8	6.0	7.1	6.9	5.9	6.2	6.1	6.7	5.4	6.8	6.2	7.6	28.9	5.3	18.9	8.4	1.5	4.9	2.7	9.6	0.0	9.8	6.7	9.4	15.7	8.0	12.9	0.0	5.1	6.2	2.5	5.9	3.9	2.7	9.2	16.4	7.2	0.0	3.8	27.1	2.5	3.2	9.9	5.1	8.6	1.3	20.6	10.8	7.9	3.2	0.0	24.5	4.4	4.1	3.5	1.7	4.1	12.8	3.4	0.0	5.6	2.8	0.0	5.2	23.6	25.0	5.3	5.3	12.4	5.1	8.7	3.9	8.6	12.5	0.0	13.1	13.4	9.8	8.8	7.5	11.5	3.4	1.8	8.1	15.5	6.0	5.8
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 485.8;stomach 1: 1064.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1370.0;Collecting duct cells: 491.1;Exocrine glandular cells: 1164.9;Gastric mucus-secreting cells: 640.6;Pancreatic endocrine cells: 1074.8;Respiratory ciliated cells: 555.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 1146.1;OE19: 548.3;RPTEC TERT1: 870.2;T-47d: 383.6"	"Not detected"	"Not detected"							"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	15.2	6.3	5.3	21.9	5.7	9.4	78.2	4.7	8.6	194.2	4.7	176.0	21.4	40.2	61.6	209.9	120.0	125.8	6.8	5.1	5.7	485.8	3.9	321.5	1.8	7.8	6.3	9.8	358.5	1.0	14.1	3.3	6.0	43.9	103.6	1.3	135.0	34.4	1.9	20.6	35.2	20.0	6.1	5.4	1064.7	47.9	6.8	1.2	54.8	0.7	18.8	102.0	50.0	5.2	15.3	8.2	5.1	4.8	3.9	4.2	1.7	5.6	12.2	6.2	15.2	0.2	1146.1	0.0	81.9	9.5	2.7	23.2	1.0	0.3	1.8	10.4	0.8	1.8	101.5	0.0	2.4	0.4	36.1	9.5	2.1	2.8	2.2	12.7	2.1	1.9	9.2	15.4	4.3	120.0	1.6	1.2	3.5	548.3	2.1	2.3	0.6	29.3	870.2	0.9	5.1	2.1	28.0	48.3	1.5	4.1	383.6	5.6	2.2	3.9	6.7	10.5	1.2	17.7	9.8	0.2	5.9	1.1	1.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.1	5.3	5.7	4.7	8.6	5.1	5.7	7.8	6.3	6.0	6.1	6.8	5.2	2.3	432.7	1370.0	5.9	6.4	0.6	18.5	126.4	0.0	1.3	219.2	48.5	0.4	327.5	374.9	491.1	4.2	0.5	1.5	271.8	35.2	177.3	32.7	245.2	28.8	8.0	30.6	1.3	0.3	1164.9	1.1	7.0	640.6	282.8	48.0	0.3	1.8	0.9	0.2	1.7	0.3	351.5	164.8	2.2	1.0	81.0	2.5	7.2	5.4	1.0	24.3	1.7	0.0	0.5	0.1	1074.8	60.5	1.5	1.3	16.3	6.8	1.3	555.3	0.2	0.0	2.0	22.0	5.8	0.8	3.5	1.1	0.3	10.3	0.1	220.8	154.5
MUC12	MUC11	ENSG00000205277	"Mucin 12, cell surface associated"	Q9UKN1	7	100969623-101018949	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 67.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1187.9;Intestinal goblet cells: 132.3;Paneth cells: 550.8;Undifferentiated cells: 265.8"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 13.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA023835	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023835: AB_1854199"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.33e-7)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	49.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	67.9	0.0	0.0	0.1	0.0	0.0	2.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.2	3.8	13.1	2.2	0.0	0.0	0.1	0.0	2.7	0.0	2.7	1.8	0.0	0.4	1.4	1187.9	0.0	7.9	13.0	17.2	16.6	1.2	47.5	0.0	3.0	2.8	2.2	15.6	9.2	0.6	8.9	1.6	0.7	0.1	1.9	0.0	0.7	132.3	4.1	1.6	16.0	5.7	0.9	4.0	3.6	1.0	0.0	0.0	0.0	0.0	0.3	8.3	550.8	3.4	2.8	9.5	53.1	0.2	15.7	0.0	0.0	2.2	4.4	11.5	3.8	0.1	3.0	0.5	5.7	5.3	265.8	5.3
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 614.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 220.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045163, HPA079663"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045163: AB_10960396, HPA079663: "	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.8	0.8	0.0	62.0	0.0	0.1	0.5	0.0	0.1	0.8	0.0	304.6	614.6	1.5	0.0	0.8	2.8	47.9	0.1	0.0	0.0	17.5	3.7	0.3	0.4	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.3	2.1	301.3	0.0	0.0	0.8	0.0	0.1	503.8	10.9	0.0	0.1	35.3	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.1	6.4	13.6	0.0	0.8	0.2	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	220.9	1.1	0.0	0.1	2.7	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	25.8	0.8	0.0	0.0	0.0	0.0	853.2	0.0	24.7	0.9	120.0	1.5	0.4	153.8	0.0	0.1	31.4	0.0	0.0	36.7	6.1	8.9	0.0	0.0	0.0	0.0	0.0	0.2	418.5	0.0	0.3	0.0	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.8	641.9	0.7	0.0	1.5	422.5	7.7	10.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.0	207.9	1.4
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559032-26572263	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"epididymis: 1949.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Respiratory ciliated cells: 168.3;Syncytiotrophoblasts: 665.9"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 11.7;SK-BR-3: 18.0;SuSa: 12.0;U-266/70: 7.8;U-266/84: 21.1"	"Group enriched"	"Detected in some"	4	"cerebellum: 1.2;thalamus: 1.4"	"Low region specificity"	"Detected in many"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.1	0.3	0.4	0.0	4.5	0.0	15.4	0.0	0.6	6.5	1.1	0.0	0.0	0.4	1949.7	17.4	6.7	0.1	0.0	0.3	0.0	24.1	0.1	12.3	0.1	0.0	0.0	0.0	7.8	0.0	1.4	14.8	0.1	0.9	0.0	0.0	52.2	6.8	0.0	29.4	0.0	0.0	0.0	0.0	1.0	0.2	0.0	3.6	75.7	0.0	7.7	2.5	11.6	0.1	0.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.6	0.0	18.0	0.0	12.0	0.2	0.0	0.0	0.0	3.1	0.0	0.0	7.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	109.0	32.5	0.0	0.1	3.4	12.5	7.5	4.6	0.0	43.0	6.9	0.0	0.0	55.1	49.7	0.0	68.7	0.0	0.0	31.3	4.6	0.6	39.8	5.4	0.7	0.0	0.0	0.2	0.0	19.2	1.3	0.0	53.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	8.2	0.0	0.6	0.2	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	168.3	0.0	0.0	0.0	2.2	0.2	0.2	26.5	29.7	665.9	0.4	0.0	0.0	12.6
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 7.2;cervix: 15.9;fallopian tube: 5.9;salivary gland: 6.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"ovarian cancer: 21.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 23.3;HeLa: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"	NA	NA		25000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.9	0.0	0.0	0.0	2.1	0.0	0.3	5.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.6	2.8	0.0	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.3	0.1	40.3	0.0	0.0	4.1	0.9	3.4	1.5	81.8	0.0	0.0	2.1	0.2	0.0	0.0	0.2	14.3	74.3	14.8	1.2	0.0	0.0	0.4	0.0	0.4	1.0	0.0	157.8	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	99.7	0.3	0.0	16.4	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	197.4	0.0	0.0	0.0	8.6	0.3	0.2	0.0	0.3	3.3	0.6	0.0	0.0	0.7
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058859	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"intestine: 42.7"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 320.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031634	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	42.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	14.8	0.0	0.0	0.1	320.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.0	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	12	"intestine: 133.8"	"Cell type enriched"	"Detected in some"	12	"Intestinal goblet cells: 745.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 93.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			CAB016275	Enhanced				"Intracellular and membrane"	NA	NA						"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.6	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.8	31.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	91.7	0.0	0.0	0.5	0.0	0.0	79.9	4.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.0	0.0	0.0	60.3	0.0	0.3	0.0	0.1	0.0	0.6	14.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	745.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	31.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	34.3	0.0
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 135.8;esophagus: 696.3;vagina: 244.5"	"Group enriched"	"Detected in some"	5	"Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052028	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	135.8	0.0	0.1	0.0	0.1	0.0	696.3	0.2	0.0	0.1	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	106.8	0.0	0.3	0.2	0.1	0.0	0.0	0.1	1.7	0.1	0.1	0.0	0.1	0.0	13.4	0.2	244.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.3	0.1	0.0	32.0
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949534-100968347	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 13.8;intestine: 41.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 220.6;Intestinal goblet cells: 114.2;Paneth cells: 157.1;Proximal enterocytes: 360.1;Undifferentiated cells: 129.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 16.4;pancreatic cancer: 14.0;stomach cancer: 29.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;CAPAN-2: 2.4;MCF7: 1.6;OE19: 3.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 16.5"					"HPA010871, HPA047868"	Uncertain		Uncertain	"Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA010871: AB_1854201, HPA047868: "	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	1.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	9.4	41.7	0.0	0.0	0.0	0.0	13.8	3.2	0.0	0.8	0.2	8.7	0.2	0.3	0.0	0.3	0.0	0.5	0.8	0.0	0.0	0.0	3.1	11.9	0.0	0.1	0.0	5.0	0.1	33.5	0.8	0.0	0.1	2.7	0.1	0.1	9.9	0.8	0.5	0.3	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.3	2.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	1.0	0.4	2.1	28.6	0.0	1.8	0.0	0.7	0.0	220.6	0.0	18.8	0.8	0.0	0.1	0.8	10.3	0.0	0.1	28.8	1.1	0.4	15.8	0.0	0.0	0.0	0.4	5.3	0.3	0.0	0.0	114.2	0.0	0.8	0.0	0.4	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	28.9	157.1	0.0	0.0	65.7	360.1	0.3	0.0	0.0	0.0	0.4	6.4	0.8	6.8	0.0	0.1	0.3	0.4	0.0	129.5	21.3
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195811973	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 19.2;intestine: 31.1;prostate: 14.8;vagina: 15.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 3.4"	"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	5.4	0.0	31.1	0.0	0.0	0.0	19.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.8	0.0	7.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	1.2	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	6.4	15.6	0.3	2.1	0.0	18.5	82.1	0.6	0.0	25.7	2.9	2.5	0.0	193.7	0.0	0.0	0.1	0.3	185.1	0.0	1.6	3.5	6.2	0.2	0.7	16.4	0.0	0.9	5.2	4.3	0.6	163.1	5.1	2.5	0.1	0.0	0.0	0.1	0.0	1.0	193.3	40.7	0.0	0.0	0.7	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	37.5	64.3	0.4	0.8	12.4	1.1	0.2	336.1	0.0	0.0	0.5	11.1	2.1	1.9	0.4	0.0	0.1	1.2	2.3	174.5	319.4
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"stomach 1: 185.1"	"Cell type enriched"	"Detected in some"	248	"Gastric mucus-secreting cells: 10434.9"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 25.3;stomach cancer: 61.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"A549: 19.9;OE19: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	17.4	0.0	0.1	5.4	0.0	0.0	0.1	0.0	2.7	0.0	42.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	2.8	10434.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	4.1	0.0	0.0	0.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	30.0	8.9	0.0	0.0	10.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.1	7.9	0.0	0.0	28.1
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012823-1036718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 171.2;stomach 1: 409.9"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 278.8"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 42.9;stomach cancer: 58.0"	"Region enhanced"	"Detected in single"		"amygdala: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 1.7"	"Not detected"	"Not detected"							CAB002165	Enhanced				"Secreted to digestive system"	NA	NA		75000		"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.5	0.2	1.2	0.0	0.6	0.0	0.9	0.3	0.5	26.3	0.0	3.0	15.6	2.1	0.9	5.2	2.5	0.3	0.2	0.8	0.0	2.6	5.4	0.2	0.0	0.0	0.0	0.2	171.2	0.0	0.2	0.0	0.0	4.3	0.0	0.0	0.1	28.0	0.1	0.1	0.1	0.0	0.0	0.3	409.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.3	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	11.3	2.8	1.7	54.3	0.0	9.2	0.0	0.0	0.2	0.1	0.0	12.2	0.1	0.5	0.1	0.1	0.0	0.0	1.2	19.1	0.0	0.1	278.8	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	59.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	875	"salivary gland: 26019.1"	"Cell type enriched"	"Detected in some"	12	"Melanocytes: 12.4"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									1.2	5.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	2.1	0.0	0.0	6.6	0.0	0.0	1.0	3.7	0.6	0.0	0.0	0.7	6.5	29.7	0.0	1.9	3.2	0.0	0.8	0.0	0.0	26019.1	0.0	2.6	3.6	1.5	0.0	0.0	1.0	1.1	1.5	0.2	0.0	1.3	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.4	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830518-54896008	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 3241.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4494.5;Breast myoepithelial cells: 1273.2;Melanocytes: 1060.1"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;hTCEpi: 1.3;MCF7: 2.1;SK-BR-3: 4.8;SuSa: 3.3"									HPA039093	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	35.4	0.4	0.2	1.1	0.4	0.0	3241.2	0.2	0.6	1.3	0.1	1.8	0.0	0.2	1.5	0.4	2.1	0.2	2.6	0.3	0.2	2.3	1.0	1.1	0.1	0.2	0.2	0.3	0.3	0.0	0.3	0.4	0.2	1.1	0.0	0.0	207.3	0.0	1.9	762.2	0.3	0.1	0.2	0.2	0.7	1.2	0.2	2.4	0.2	0.0	0.0	1.2	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.8	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.5	10.4	0.0	1.1	0.0	3.8	188.4	0.4	2.1	0.0	0.0	4494.5	1273.2	0.1	0.0	3.4	0.0	0.0	0.0	12.9	0.0	3.9	0.0	0.0	1.8	0.0	3.4	0.0	0.0	1.4	0.2	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.0	0.0	14.1	0.2	0.0	45.5	1060.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.9	0.0	0.1	2.6	0.0	0.0	0.0	6.1	0.2	0.6	0.0	10.1	0.0	2.5	0.1	0.0	3.8
MUCL3	"bCX105N19.6, C6orf37, DPCR1, PBLT"	ENSG00000168631	"Mucin like 3"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"stomach 1: 202.8"	"Cell type enriched"	"Detected in some"	20	"Pancreatic endocrine cells: 239.5"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014036	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.5	0.0	9.9	0.0	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: AB_2684052"	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	20.6	18.0	15.2	13.3	15.6	11.3	20.3	15.7	20.0	32.0	14.4	31.4	16.9	35.4	7.7	16.9	30.8	10.9	25.3	14.6	13.4	28.8	19.4	21.6	18.6	16.6	15.6	29.8	19.9	10.2	22.4	11.0	15.9	26.2	7.1	8.1	16.6	15.9	24.3	14.1	23.7	12.4	14.8	29.0	22.5	16.6	16.7	16.1	23.5	16.9	13.6	29.7	22.5	18.8	21.6	13.3	22.1	22.0	9.5	11.5	28.2	22.7	17.9	28.2	18.8	17.7	34.4	20.4	30.0	17.8	35.2	20.6	19.9	19.9	6.3	44.5	14.7	37.3	39.8	10.8	29.0	26.9	38.2	18.3	36.2	35.8	28.0	20.7	24.0	36.5	22.9	55.4	18.7	14.2	38.1	41.0	16.1	14.1	29.2	37.2	10.6	39.7	21.5	13.3	22.1	25.3	15.5	27.7	48.7	13.5	32.6	27.3	21.5	21.2	18.0	27.3	24.9	37.6	26.9	29.7	24.1	17.5	36.3	22.6	13.7	27.4	21.0	16.3	21.0	13.1	15.9	18.4	14.7	10.4	12.3	15.4	9.4	13.3	18.5	14.7	15.1	13.0	15.2	15.6	15.7	20.0	14.6	13.4	16.6	15.6	15.9	14.8	16.7	18.8	19.3	12.8	18.4	15.0	17.2	8.0	21.5	13.5	10.2	19.2	11.8	15.6	10.0	11.5	16.0	7.3	20.9	20.8	22.0	27.0	5.9	24.7	62.8	12.2	22.0	16.1	16.8	25.7	9.0	22.2	23.6	13.5	27.0	13.0	14.0	15.0	16.8	9.2	19.6	23.5	8.8	23.9	10.2	13.3	8.8	130.0	21.8	14.3	10.6	9.4	27.1	15.0	32.0	8.5	12.9	26.6	24.5	27.1	12.6	11.0	36.1	12.4	16.0	24.7	39.5	11.5	21.9	27.9	16.7	8.4	7.4	19.7	19.9	15.0	21.4	10.2
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
MVB12A	"FAM125A, FLJ32495"	ENSG00000141971	"Multivesicular body subunit 12A"	Q96EY5	19	17405722-17433724	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041885, HPA042231"	Approved		Supported	Vesicles		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041885: AB_10964218, HPA042231: AB_10961043"	"unprognostic (1.34e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.96e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.93e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.33e-2)"	21.3	28.4	10.5	17.3	11.5	18.2	21.4	11.4	12.3	18.6	11.8	16.7	29.1	17.3	7.4	29.5	22.0	18.7	13.1	10.0	10.3	20.2	19.9	15.5	21.7	14.0	11.0	34.0	20.0	22.2	7.4	19.2	11.6	13.7	11.6	1.2	24.2	17.5	14.4	24.7	22.0	11.6	12.3	22.3	20.9	5.2	11.4	24.0	21.2	12.4	19.3	17.0	18.0	13.5	51.2	23.4	12.1	33.9	15.7	28.8	71.1	18.3	28.4	33.8	40.8	20.1	60.5	32.7	52.7	28.2	28.8	25.5	19.5	35.5	9.0	37.6	60.7	9.5	41.8	44.0	50.3	13.0	29.1	28.2	28.5	29.1	18.0	25.5	40.7	29.9	26.8	65.2	15.6	32.2	24.6	26.2	17.0	40.8	63.9	34.7	14.8	53.1	32.4	21.2	25.3	40.7	19.6	30.2	77.6	10.9	40.1	30.9	21.7	31.5	18.4	35.1	20.5	59.3	72.9	35.0	34.1	49.3	38.9	57.4	61.7	42.9	33.0	66.9	31.0	23.3	34.0	32.0	60.5	29.8	28.0	27.5	36.0	38.2	53.4	53.3	57.2	36.2	10.5	11.5	11.4	12.3	10.0	10.3	14.0	11.0	11.6	12.3	11.4	13.5	67.5	9.6	8.2	5.9	16.4	39.0	41.4	65.1	42.1	5.3	53.6	61.8	5.6	48.6	33.5	46.0	6.2	60.7	18.1	85.0	54.8	78.7	13.5	30.1	26.8	47.7	26.5	8.4	2.2	48.4	99.0	38.6	43.3	30.2	21.6	45.7	62.4	28.0	72.3	3.3	3.2	48.5	50.8	44.9	30.8	16.3	43.5	31.2	32.0	11.2	46.7	32.7	19.6	4.0	7.3	63.4	84.1	47.0	23.5	19.0	104.4	61.3	36.4	13.8	6.6	22.8	40.9	11.8	12.3	58.3	43.9	40.6	21.2	44.3	57.1	45.0
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	20.3	51.1	24.2	15.7	27.5	7.0	16.4	26.2	37.5	30.5	19.3	32.3	35.1	20.3	2.2	77.8	13.5	4.9	22.8	24.7	27.8	28.8	78.8	31.0	12.3	32.4	27.8	19.6	25.3	8.3	18.9	6.3	39.3	23.5	4.2	3.4	25.1	6.5	27.2	52.3	26.6	5.7	24.0	24.6	31.5	42.3	24.7	7.0	21.1	8.3	6.8	17.6	36.9	25.6	50.6	34.2	52.4	33.1	18.1	38.7	29.5	25.1	26.0	17.7	14.6	86.1	119.7	24.4	39.8	15.7	63.7	72.8	25.0	133.1	4.9	15.7	38.3	17.8	18.2	127.0	35.9	11.6	11.8	30.9	24.6	46.6	13.5	8.7	18.0	58.0	51.7	13.1	10.2	115.9	39.3	56.6	61.5	17.7	31.3	40.2	15.0	62.3	49.8	33.0	52.2	17.9	62.0	13.3	18.5	11.4	67.8	51.3	39.0	14.7	29.8	27.2	14.2	34.9	17.6	83.2	17.9	55.7	25.7	5.6	12.6	2.4	26.8	13.7	20.4	16.1	18.0	17.9	15.0	22.6	13.2	16.6	1.8	28.3	15.4	28.0	20.4	15.4	24.2	27.5	26.2	37.5	24.7	27.8	32.4	27.8	39.3	24.0	24.7	25.6	17.2	25.6	48.2	22.2	21.5	15.2	12.9	106.3	4.0	27.2	26.5	14.1	16.7	21.5	56.9	20.2	6.2	20.2	79.6	117.5	25.4	30.8	61.6	17.7	10.0	15.8	32.9	26.5	23.4	62.3	29.2	15.5	41.8	26.5	16.5	27.4	20.7	147.2	38.6	23.5	17.0	75.3	32.6	25.5	21.6	96.2	8.1	20.3	21.4	6.5	32.2	16.5	55.6	11.1	14.5	30.0	79.4	9.1	46.3	20.1	47.1	22.6	21.5	18.1	6.6	7.0	20.7	50.8	13.0	13.8	21.6	48.8	36.3	35.5	65.2	20.6
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598125	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 60.5;Horizontal cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	7.9	29.8	12.7	6.1	13.7	8.3	14.7	16.7	15.0	14.5	9.6	11.2	13.9	7.3	10.2	45.5	6.3	5.3	9.4	11.1	13.2	32.1	69.1	11.4	6.9	36.1	15.5	10.7	10.0	11.5	11.6	5.4	38.6	12.3	8.6	7.3	13.7	7.0	12.1	33.3	9.8	5.0	15.3	6.7	11.8	28.5	15.3	4.2	15.1	8.8	9.1	9.5	20.1	24.4	30.1	25.0	29.9	13.7	11.2	27.3	14.4	9.5	21.7	30.0	32.8	31.4	33.8	17.7	7.8	11.7	48.1	36.0	31.6	50.0	13.2	19.0	18.1	9.9	15.7	53.7	31.5	11.1	13.0	27.2	42.1	48.8	13.6	12.6	20.9	19.0	18.7	17.4	13.6	34.5	12.0	34.6	22.6	14.9	32.3	10.5	22.1	37.0	67.4	40.9	25.1	18.7	19.8	58.7	14.0	11.0	59.7	21.1	14.1	13.2	14.5	12.0	12.8	13.3	20.6	28.2	16.1	29.2	16.6	1.0	6.9	4.0	12.6	6.5	11.3	9.4	7.4	12.4	8.6	14.1	10.9	8.3	1.6	11.0	4.6	7.0	7.6	6.4	12.7	13.7	16.7	15.0	11.1	13.2	36.1	15.5	38.6	15.3	15.3	24.4	6.1	12.8	12.4	6.8	8.3	4.7	5.2	39.7	4.6	12.4	13.1	11.0	5.7	11.5	25.8	14.7	18.8	33.0	7.3	10.4	21.5	15.6	60.5	5.8	2.3	7.1	9.0	4.8	5.1	18.1	15.3	6.8	9.7	5.1	1.3	14.7	6.4	32.7	15.6	62.2	5.2	7.8	10.2	3.4	2.2	42.5	8.1	4.8	7.2	3.7	10.3	10.6	10.3	4.0	15.3	13.2	3.2	7.2	4.1	5.5	16.4	52.4	13.5	12.2	6.6	4.0	8.2	33.9	16.8	12.0	8.5	47.9	6.1	44.8	11.1	4.6
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 504.7;Exocrine glandular cells: 310.8;Paneth cells: 338.3;Proximal enterocytes: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 429.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol		NA	NA		110000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342"	"prognostic favorable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	84.4	181.7	26.2	96.0	35.7	46.4	71.0	29.9	33.7	76.6	32.5	165.6	154.7	73.1	14.3	75.4	73.3	74.3	64.4	26.0	31.9	113.4	66.9	121.9	71.1	43.1	36.4	103.3	101.9	18.9	47.5	38.0	35.5	59.7	96.5	6.3	77.1	38.9	50.6	61.1	158.9	69.0	32.6	114.0	107.8	39.4	42.3	31.3	60.6	32.4	47.6	80.0	72.9	38.3	64.8	191.8	0.8	1.7	212.0	275.0	25.9	163.4	258.5	88.0	121.4	24.7	216.8	3.1	134.9	231.0	108.9	78.1	0.8	129.5	42.2	166.4	1.8	3.0	81.6	87.6	190.1	2.3	60.2	366.9	96.1	207.0	58.3	170.5	274.5	6.2	0.5	92.1	167.7	18.3	0.8	4.3	2.4	93.4	11.6	2.1	0.7	32.5	229.1	114.6	10.5	7.6	41.8	53.8	31.8	6.5	9.5	18.7	429.3	124.2	59.4	119.9	62.0	66.6	45.1	2.7	294.6	4.8	24.9	50.4	140.8	56.3	70.9	214.3	55.1	36.6	80.7	73.6	113.1	27.2	59.4	54.0	160.0	73.7	204.0	69.2	90.7	164.4	26.2	35.7	29.9	33.7	26.0	31.9	43.1	36.4	35.5	32.6	42.3	38.3	34.2	48.1	115.5	9.8	31.2	19.6	39.3	120.3	16.5	4.8	17.9	10.0	12.9	82.9	112.0	69.9	2.1	113.6	31.2	504.7	45.0	272.7	4.9	43.9	25.9	40.9	56.5	8.6	3.2	310.8	71.4	52.8	120.8	65.9	33.7	14.8	36.4	23.8	78.0	8.4	3.4	177.1	95.6	41.0	27.1	21.1	57.5	55.0	32.0	9.4	223.3	3.0	59.8	0.0	23.1	278.5	338.3	47.8	36.4	25.0	514.8	194.8	110.3	4.9	19.7	23.8	51.3	2.7	1.8	20.7	21.9	264.5	45.1	24.7	206.8	56.7
MX1	"IFI-78K, lncMX1-215, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420020-41470071	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 127.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.8;Extravillous trophoblasts: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3"					"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	25.6	14.9	17.5	29.0	18.9	51.7	23.8	19.4	18.2	37.7	14.4	19.7	30.7	15.9	20.5	42.4	25.2	37.7	22.7	14.3	27.8	27.5	25.3	31.7	38.8	35.9	22.5	27.0	13.1	15.3	30.3	20.7	30.2	15.1	11.6	4.3	127.0	16.4	7.6	11.6	28.8	24.4	62.5	75.3	35.3	8.6	23.2	65.0	26.6	9.7	36.8	29.7	24.4	21.5	16.4	0.5	0.7	1.2	0.6	6.8	0.2	1.0	25.6	820.2	734.3	5.3	33.6	0.2	6.5	2.7	7.8	1.6	0.3	0.8	15.9	4.2	0.2	0.9	2.3	1.9	7.3	0.4	0.4	7.4	2.3	48.8	1.1	0.4	2.8	2.7	0.0	160.6	0.4	1.3	14.5	1.8	2.6	0.5	8.3	12.6	0.1	26.4	3.3	9.9	0.7	0.3	1.1	1.3	259.3	0.1	10.6	6.7	1.7	0.8	0.7	0.1	0.7	35.9	37.6	1.0	0.9	2.2	1.8	31.6	45.0	25.6	17.9	47.6	25.8	38.6	27.3	21.9	31.0	36.7	23.3	16.9	64.7	18.9	44.5	44.7	51.9	35.0	17.5	18.9	19.4	18.2	14.3	27.8	35.9	22.5	30.2	62.5	23.2	21.5	101.8	32.1	25.3	2.6	41.9	6.4	17.6	13.0	15.9	3.7	8.0	8.9	8.8	11.5	22.4	23.9	0.0	3.2	47.2	10.1	19.6	38.6	0.7	16.0	11.1	66.8	0.0	2.1	7.7	56.1	77.3	21.5	34.1	15.9	1.3	38.1	20.3	5.8	53.3	1.7	7.1	16.7	2.0	20.8	16.2	1.2	10.8	50.9	19.6	24.4	32.0	6.8	11.3	2.5	1.2	38.8	4.3	16.6	28.7	9.9	29.2	5.0	32.1	2.4	0.0	7.7	17.8	0.4	4.0	32.6	3.4	4.1	28.3	13.4	7.5	34.2
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 173.4;esophagus: 130.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 507.0;Langerhans cells: 224.8;Paneth cells: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 496.3"	"Lineage enriched"	"Detected in all"	49	"granulocytes: 496.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	13.5	3.6	6.2	40.4	6.9	173.4	7.0	10.0	15.8	35.2	6.4	30.3	28.8	5.4	1.9	130.0	8.1	9.4	8.3	6.5	7.8	6.8	11.3	36.5	3.9	7.1	6.3	6.1	4.6	6.8	6.7	10.9	8.1	5.5	28.9	15.6	17.4	2.0	6.0	12.8	43.7	9.1	5.4	32.8	16.9	6.3	10.7	13.9	7.5	6.5	15.1	17.4	50.6	10.5	5.0	2.1	3.0	2.2	6.5	3.2	11.2	5.5	3.1	2.6	1.9	6.8	3.8	2.8	2.8	2.1	2.5	17.3	5.8	10.7	2.7	1.6	6.9	5.9	6.6	7.0	21.9	7.3	5.7	3.7	17.8	5.9	27.0	3.2	3.4	2.8	10.4	10.9	1.6	4.0	3.4	14.1	0.8	7.3	3.5	1.6	3.1	7.1	3.4	5.8	9.8	4.1	7.3	9.3	3.9	3.4	1.4	4.1	13.2	3.7	1.0	4.1	5.2	7.5	13.7	1.1	3.8	12.5	1.4	124.0	10.2	105.7	2.3	6.4	2.5	1.1	1.6	1.7	5.2	1.3	1.8	1.9	496.3	2.8	5.5	1.6	1.5	4.5	6.2	6.9	10.0	15.8	6.5	7.8	7.1	6.3	8.1	5.4	10.7	10.5	18.0	38.5	23.7	16.0	25.4	25.7	31.6	61.8	21.6	29.8	51.6	29.3	6.9	10.0	44.7	1.8	54.2	10.1	46.2	507.0	7.9	12.9	17.0	34.3	17.5	12.0	97.5	17.7	23.6	16.5	8.0	17.9	110.1	81.6	27.3	3.0	5.7	6.8	28.6	10.1	20.2	155.5	71.2	56.5	224.8	17.8	4.7	190.8	16.0	11.2	40.7	62.1	18.6	20.1	21.7	70.1	369.6	2.6	33.1	43.3	178.8	6.9	24.2	21.7	0.0	14.7	18.3	19.9	2.7	88.2	56.4	105.9	30.3	5.2	65.9	126.7
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346652	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 35.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 38.5;Collecting duct cells: 31.3;Exocrine glandular cells: 60.7;Fibroblasts: 56.0;Pancreatic endocrine cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 31.4;BJ hTERT+: 125.8;fHDF/TERT166: 59.8;HaCaT: 52.4;HSkMC: 24.7"					"Low region specificity"	"Detected in all"			"HPA000508, HPA076518"	Uncertain		Uncertain	Mitochondria	"Secreted to extracellular matrix"	NA	NA		2600000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA000508: AB_2147995, HPA076518: "	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.94e-4)"	12.0	10.3	0.2	9.4	0.3	0.0	13.5	0.0	0.4	35.0	0.0	7.5	4.4	6.8	2.7	9.4	3.0	8.0	11.1	0.2	0.1	5.3	4.5	5.3	1.6	0.3	0.3	2.9	16.1	1.7	0.9	5.8	0.2	7.3	10.4	0.0	6.1	10.4	1.5	29.6	4.6	15.9	0.5	3.6	10.3	0.1	1.2	5.7	9.8	5.1	3.7	19.9	7.2	0.1	0.0	0.0	0.8	0.0	0.2	31.4	0.0	19.6	125.8	0.2	0.2	0.0	0.6	0.0	1.7	59.8	0.2	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.7	5.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.2	0.1	0.3	0.3	0.2	0.5	1.2	0.1	10.3	0.0	0.0	0.0	0.0	38.5	7.1	10.5	20.5	0.0	2.0	4.6	1.9	0.0	3.7	31.3	0.0	0.1	0.3	0.9	0.0	2.2	0.0	1.0	8.4	4.6	0.0	0.0	0.7	60.7	0.7	56.0	0.0	1.6	0.0	0.0	10.8	0.1	0.3	0.0	1.1	0.0	0.0	0.3	16.9	0.0	0.0	0.3	17.8	4.7	0.6	0.0	0.0	0.5	0.2	42.8	0.0	1.5	0.1	0.2	0.1	0.1	1.0	0.2	0.0	7.3	9.8	0.0	0.0	5.5	21.7	0.3	1.1	0.9	0.4	2.0
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 663.8"									"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	189.2	244.3	111.9	53.4	175.1	13.5	133.5	114.5	136.5	149.4	263.7	310.7	37.5	268.3	208.8	157.0	181.0	103.6	526.4	123.4	118.4	83.0	29.9	124.9	31.8	130.3	122.7	185.4	90.3	235.7	48.8	102.8	125.3	154.3	76.1	514.6	62.0	314.8	68.8	73.0	89.4	284.4	122.1	149.7	124.0	115.7	115.4	44.6	272.1	75.9	33.3	250.5	123.1	120.4	19.1	56.1	82.4	155.3	424.0	384.4	41.0	263.8	212.8	188.8	182.8	75.1	2.9	0.5	116.8	368.0	196.8	75.7	92.5	146.5	306.4	1.4	91.7	48.7	39.2	126.8	258.4	22.9	5.9	241.1	171.2	219.3	178.7	421.8	282.0	12.3	35.2	1.2	440.8	5.3	2.9	15.9	26.5	30.0	156.7	43.2	322.2	16.5	153.1	4.8	28.8	207.3	78.5	1.0	152.6	231.6	51.5	29.3	348.5	422.7	90.1	174.3	282.6	24.5	4.9	1.4	663.8	9.9	62.5	1.3	2.8	0.5	4.0	0.8	3.1	2.3	2.1	4.5	2.1	0.4	1.3	2.9	1.1	5.4	0.3	2.4	0.5	3.4	111.9	175.1	114.5	136.5	123.4	118.4	130.3	122.7	125.3	122.1	115.4	120.4	128.3	16.0	14.6	8.5	2.0	10.3	27.0	15.0	13.6	142.0	9.4	42.5	117.3	2.8	10.3	31.3	95.9	1.4	62.6	1.3	1.9	25.5	3.5	48.7	203.7	56.1	6.7	0.8	19.3	4.1	8.1	97.2	2.0	63.9	2.5	64.7	52.5	4.2	3.5	111.0	27.9	7.5	10.2	5.0	13.3	12.4	101.2	7.4	14.2	10.3	1.3	365.7	6.2	15.1	8.9	6.5	0.3	143.3	11.0	21.2	1.6	8.1	10.2	163.8	13.1	132.1	83.6	2.3	10.7	6.0	8.8	0.8	19.7	218.5	1.5	21.1
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
MYADML2	LOC255275	ENSG00000185105	"Myeloid associated differentiation marker like 2"	A6NDP7	17	81939645-81947233	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 84.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.0;Cardiomyocytes: 4.2;Early spermatids: 1.5;Excitatory neurons: 1.5;Horizontal cells: 1.7;Inhibitory neurons: 2.4;Skeletal myocytes: 1.0;Undifferentiated cells: 1.0"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041856, HPA048476"	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 37: Myocytes - Muscle contraction"			"HPA041856: AB_2677709, HPA048476: AB_2680410"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.90e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	1.2	0.0	1.6	0.0	0.0	1.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	3.6	0.8	1.5	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.2	0.0	0.2	0.0	2.2	0.6	0.0	0.4	1.0	0.0	84.0	0.0	0.3	0.0	0.2	0.0	0.1	0.8	1.8	0.0	0.0	16.8	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.0	2.5	0.8	1.5	2.0	1.1	2.2	0.2	1.8	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYBPC1	ssMyBP-C	ENSG00000196091	"Myosin binding protein C1"	Q00872	12	101568353-101686028	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	87	"skeletal muscle: 11290.5;tongue: 5207.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.6;Breast glandular cells: 102.4;Breast myoepithelial cells: 81.4;Cardiomyocytes: 64.7;Skeletal myocytes: 184.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 33.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"HAP1: 6.8"	"Group enriched"	"Detected in many"	9	"cerebellum: 39.6;olfactory bulb: 10.6"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"HPA021004, HPA027614"	Enhanced					NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA021004: AB_1854232, HPA027614: AB_10602711"	"prognostic favorable (4.76e-5)"	"unprognostic (7.72e-2)"	"unprognostic (1.09e-1)"		"unprognostic (1.81e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.55e-3)"	1.5	0.3	55.5	0.1	66.5	0.0	63.7	60.4	71.6	1.9	36.3	4.5	0.1	0.2	1.1	94.7	0.8	0.3	1.8	50.1	59.5	0.3	0.7	0.7	0.0	52.3	64.5	0.5	1.1	0.0	0.3	0.0	55.0	83.5	0.8	0.0	48.4	0.3	11290.5	6.1	7.4	0.0	49.4	0.4	1.3	3.4	68.4	2.6	1.2	5207.7	4.0	0.3	0.7	49.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	66.5	60.4	71.6	50.1	59.5	52.3	64.5	55.0	49.4	68.4	49.9	1.3	0.0	0.0	34.6	0.3	0.0	2.2	0.0	0.0	0.0	102.4	81.4	64.7	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	16.5	0.1	0.1	1.2	0.0	0.0	5.3	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.8	0.3	23.7	0.6	1.2	1.8	1.0	0.0	0.0	0.0	0.5	0.5	0.1	1.6	0.4	0.0	16.3	0.3	0.1	0.0	0.0	0.0	184.6	2.7	1.4	1.4	0.0	0.0	0.0	0.7	0.0	0.3	2.9
MYBPC2	"fsMyBP-C, MGC163408, MYBPCF"	ENSG00000086967	"Myosin binding protein C2"	Q14324	19	50432892-50466321	"Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 4338.8;tongue: 1199.2"	"Cell type enriched"	"Detected in some"	29	"Skeletal myocytes: 56.9"	"Cancer enriched"	"Detected in some"	9	"head and neck cancer: 9.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HDLM-2: 58.7;Karpas-707: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042991	Enhanced					NA	NA		420000	"Cluster 37: B-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA042991: AB_2678257"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.15e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.38e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-8)"	"unprognostic (1.85e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.73e-1)"	0.3	0.0	0.2	1.1	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.3	0.2	0.4	0.3	0.1	0.2	1.1	0.4	0.4	0.1	0.3	212.6	0.2	0.0	0.5	6.7	0.2	0.0	12.5	0.0	4338.8	0.8	0.4	0.0	0.2	0.3	0.2	0.3	0.3	1.4	1.0	1199.2	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.4	0.4	0.4	0.5	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	56.9	0.5	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYBPC3	"CMH4, cMyBP-C, FHC"	ENSG00000134571	"Myosin binding protein C3"	Q14896	11	47331406-47352702	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	584	"heart muscle: 1725.4"	"Cell type enriched"	"Detected in some"	42	"Cardiomyocytes: 1876.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-937: 6.4"	"Region enriched"	"Detected in some"	33	"cerebellum: 34.4"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					NA	NA		21000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.4	2.9	0.0	0.7	0.0	1.5	0.7	0.2	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	1725.4	0.0	0.0	0.3	0.3	2.0	0.5	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.6	0.0	0.4	0.2	0.3	0.1	0.0	2.8	2.8	1.4	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.9	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1876.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.3	0.0	0.0	14.3	0.0	0.0	0.2	0.0	0.0	43.9	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	19.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.9	0.0	0.0	0.3	0.0	17.4	0.6	0.0
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175826	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 16.2;skeletal muscle: 74.2;tongue: 19.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Hofbauer cells: 1.0;Microglial cells: 1.0;Skeletal myocytes: 2.5"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.5"	"Group enriched"	"Detected in some"	5	"CACO-2: 30.6;HSkMC: 56.7;THP-1: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		9700	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.2	0.0	0.7	0.5	1.3	0.2	0.5	0.7	2.0	0.1	0.9	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.1	0.9	0.7	1.9	3.4	0.3	0.1	1.7	1.3	0.0	0.0	0.0	1.3	0.1	3.3	3.3	0.0	0.1	16.2	0.0	74.2	0.5	0.0	0.0	0.0	1.0	0.0	0.0	2.8	1.8	0.1	19.6	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	56.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.7	1.3	0.7	2.0	0.9	0.7	1.7	1.3	3.3	0.0	2.8	1.0	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127742951	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 254.6;skin 1: 289.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1013.3;Basal prostatic cells: 1080.5;Basal squamous epithelial cells: 1270.8;Squamous epithelial cells: 768.8;Suprabasal keratinocytes: 1070.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 1069.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"	254.6	59.8	2.6	62.3	2.2	53.7	115.8	3.7	3.3	54.4	3.0	57.9	30.6	53.8	3.8	99.5	167.5	83.3	45.5	2.3	6.3	20.0	64.9	47.0	49.4	9.2	5.0	100.0	103.1	7.0	12.3	33.4	6.0	32.7	36.8	0.7	42.2	14.1	50.6	289.1	48.6	54.8	4.5	60.1	70.6	12.5	5.5	47.2	27.0	15.7	39.2	63.2	96.3	4.4	56.8	89.3	9.3	100.9	166.6	209.8	28.4	72.2	31.6	87.5	72.7	137.0	150.2	587.3	86.4	43.0	82.4	122.2	383.8	226.5	67.8	128.9	167.0	370.7	189.5	203.6	150.0	282.0	52.0	138.8	560.4	55.5	490.8	74.8	104.3	217.3	549.8	315.5	49.7	151.9	394.4	616.9	27.4	273.2	204.0	203.7	46.1	1069.6	79.2	61.9	660.7	64.9	32.6	270.7	195.9	17.5	106.4	172.2	120.5	63.4	71.6	49.7	87.2	5.5	8.7	275.9	55.3	286.2	30.8	3.0	39.5	0.7	31.5	36.0	161.5	92.0	114.3	67.4	33.5	71.4	195.2	128.0	4.1	85.5	26.9	1.4	95.6	88.9	2.6	2.2	3.7	3.3	2.3	6.3	9.2	5.0	6.0	4.5	5.5	4.4	218.0	57.7	70.4	0.7	108.0	1013.3	1080.5	278.9	1270.8	0.6	251.3	207.3	10.9	44.3	98.4	12.9	0.0	20.6	20.9	23.0	1.9	78.3	1.0	43.9	224.5	158.0	12.5	189.1	1.6	43.6	61.2	337.9	46.4	72.0	57.0	47.6	141.0	25.8	26.9	0.0	1.1	67.8	97.6	43.7	133.1	3.9	98.8	23.3	168.9	1.0	17.0	1.4	5.2	0.0	0.2	66.5	40.4	67.4	45.7	364.8	4.8	13.3	21.5	0.3	46.0	458.5	349.1	0.6	0.6	768.8	1070.1	5.9	75.0	56.0	117.7	409.4
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862493-38873368	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	11.5	11.0	2.6	16.9	3.4	16.1	18.7	3.4	4.3	12.5	3.7	22.6	16.3	9.6	17.4	23.1	27.1	11.3	8.4	2.4	2.9	18.0	11.5	12.4	16.3	5.6	7.4	6.7	16.1	18.6	8.7	19.3	4.5	14.9	22.5	8.6	16.8	16.1	12.1	13.2	21.6	11.7	2.7	11.2	16.1	15.5	3.2	12.6	18.5	5.6	17.9	16.8	11.7	5.6	51.3	22.5	18.0	13.0	10.7	18.4	74.4	38.9	12.9	38.6	29.7	27.8	56.5	42.1	43.3	18.3	6.5	35.8	29.1	51.9	46.0	52.3	49.7	44.1	29.5	26.7	2.8	107.7	38.9	16.4	38.9	32.3	20.3	14.7	28.3	45.6	64.1	35.8	41.4	31.3	35.1	54.9	47.3	75.3	53.4	33.4	54.4	58.0	50.3	40.6	34.9	23.5	37.0	47.5	25.7	42.4	33.5	52.6	23.2	20.4	33.5	31.2	45.6	25.3	48.7	45.1	20.5	63.9	26.0	51.6	32.8	85.2	18.8	39.7	21.6	22.0	22.1	22.5	40.9	17.7	18.8	21.4	64.4	27.2	38.0	54.3	33.8	22.6	2.6	3.4	3.4	4.3	2.4	2.9	5.6	7.4	4.5	2.7	3.2	5.6	9.2	9.6	13.1	0.0	18.7	10.6	15.7	31.8	22.2	0.7	25.9	14.1	7.9	20.0	37.5	27.6	0.0	106.0	26.7	35.1	64.6	27.0	68.3	84.1	11.4	11.8	9.6	38.7	0.0	27.2	86.2	9.5	21.9	17.9	26.1	9.3	8.9	15.3	21.0	10.1	0.0	25.2	26.4	15.0	14.8	25.2	7.2	20.5	19.6	0.0	31.0	5.5	18.6	0.0	0.0	29.7	40.2	9.1	69.6	18.2	31.2	50.3	142.2	5.0	6.6	6.7	14.8	29.9	64.5	53.4	17.8	88.1	19.3	14.0	31.5	22.4
MYCBPAP	"AMAP-1, DKFZp434N1415"	ENSG00000136449	"MYCBP associated protein"	Q8TBZ2	17	50508384-50531501	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 65.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 224.2;Late spermatids: 145.2;Respiratory ciliated cells: 40.4;Spermatocytes: 69.9;Theca cells: 54.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;JURKAT: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023257, HPA024405"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA023257: AB_2671126, HPA024405: "	"unprognostic (2.05e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.13e-3)"	"unprognostic (3.98e-5)"	"unprognostic (8.62e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.02e-2)"	0.7	0.8	1.7	0.6	1.8	1.3	0.4	2.4	3.4	1.2	3.4	0.4	0.2	0.9	1.1	0.8	5.3	1.0	0.6	1.3	1.0	0.8	0.2	1.5	1.0	2.9	2.4	2.5	0.2	0.4	0.9	0.3	1.4	1.0	0.4	1.1	0.8	1.3	1.1	1.0	0.3	0.9	1.5	0.6	0.4	65.1	1.6	0.9	0.8	0.3	0.6	0.3	0.5	1.1	0.1	0.8	0.3	0.3	0.8	0.4	0.8	0.7	0.3	0.2	0.2	0.4	2.0	0.2	0.1	0.2	0.8	0.3	0.1	0.9	0.2	4.4	0.2	1.3	1.3	0.4	0.7	0.1	0.2	1.2	0.2	0.4	1.8	0.8	0.6	3.8	0.2	0.4	0.6	0.1	0.2	0.3	0.1	0.1	0.5	0.1	0.2	0.2	0.0	0.2	0.6	1.6	0.3	0.2	0.1	0.5	0.3	0.8	2.0	0.3	0.4	0.1	0.1	2.3	0.8	0.1	0.5	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	1.8	2.4	3.4	1.3	1.0	2.9	2.4	1.4	1.5	1.6	1.1	0.3	0.0	1.7	7.2	0.7	0.1	1.4	0.7	0.0	3.6	0.4	0.3	0.9	0.0	6.5	1.8	0.0	2.4	1.7	0.4	0.0	0.1	224.2	18.6	1.2	1.1	0.0	3.6	2.5	0.4	0.3	2.0	0.0	0.6	0.0	5.6	0.0	0.0	0.4	0.0	2.2	1.8	0.0	0.6	0.5	145.2	6.8	0.6	0.0	2.8	0.0	4.3	3.1	0.5	1.0	0.1	0.1	3.8	0.6	1.1	1.4	0.2	40.4	0.5	0.0	2.7	1.4	69.9	7.6	0.1	0.4	0.1	1.4	54.9	0.4	0.8
MYD88		ENSG00000172936	"MYD88 innate immune signal transduction adaptor"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 172.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	20.1	14.2	6.9	43.5	7.4	51.8	15.0	7.2	7.5	15.2	8.0	30.3	32.2	12.1	18.6	36.6	14.4	23.5	9.4	6.7	7.7	13.7	61.1	42.6	35.2	9.5	7.5	11.4	11.6	11.6	9.2	22.6	8.0	14.3	31.7	2.1	18.0	12.0	3.2	17.7	32.2	24.5	8.6	40.7	27.6	7.7	9.2	38.3	9.4	8.8	41.6	47.4	20.3	8.5	25.1	34.2	5.9	33.2	25.0	32.0	10.8	23.6	39.0	68.1	72.9	22.7	30.9	52.8	13.8	44.7	15.8	30.9	43.2	24.2	22.1	39.5	8.7	28.5	16.6	36.6	21.4	36.2	72.0	38.4	26.6	39.2	15.3	13.2	39.9	40.3	13.3	22.3	36.8	25.7	61.3	12.2	22.1	52.8	35.7	24.8	7.0	23.1	37.6	58.9	3.0	12.0	33.4	172.1	22.3	4.8	25.8	40.8	35.5	13.8	7.9	60.6	24.0	28.9	32.9	38.5	25.0	63.0	28.9	288.5	236.9	296.9	67.2	333.6	58.1	43.7	60.6	69.3	203.6	35.2	42.1	59.5	284.7	54.6	436.1	99.9	87.4	257.3	6.9	7.4	7.2	7.5	6.7	7.7	9.5	7.5	8.0	8.6	9.2	8.5	13.4	6.4	15.2	2.0	19.5	14.4	13.5	12.7	14.2	1.0	11.3	10.8	1.6	5.7	16.4	5.5	0.0	14.6	35.3	40.8	7.9	24.5	1.4	10.9	30.2	15.9	9.6	9.7	0.2	27.3	24.4	10.8	23.9	18.6	24.1	10.0	10.4	33.2	32.2	0.0	0.4	14.9	10.2	75.4	40.5	0.9	13.7	61.5	3.6	1.9	58.1	4.1	28.8	2.5	0.3	64.0	34.8	10.5	12.9	16.0	28.0	12.2	12.1	0.1	13.1	4.3	7.2	8.6	0.6	15.1	17.2	12.0	19.6	10.2	15.9	49.4
MYDGF	"C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20"	ENSG00000074842	"Myeloid derived growth factor"	Q969H8	19	4641374-4670362	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 768.1;Plasma cells: 857.6;Syncytiotrophoblasts: 581.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1043.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041872, HPA046744"	Approved				"Secreted to blood"	NA	NA	285000	2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041872: AB_2677718, HPA046744: AB_2679783"	"unprognostic (3.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (4.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.99e-12)"	"unprognostic (4.42e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	84.7	94.2	42.5	83.8	43.5	92.0	73.2	44.4	48.7	79.1	47.6	81.4	75.7	75.1	114.6	67.5	71.0	44.1	66.3	43.1	48.1	70.8	259.5	91.7	61.9	45.7	44.0	72.1	210.0	41.7	126.1	76.1	45.8	84.2	65.5	13.0	135.6	52.8	24.7	59.3	71.1	52.9	45.5	123.0	94.5	54.5	45.0	30.8	75.4	15.1	45.5	74.3	63.3	50.2	250.5	118.7	74.6	189.8	228.0	190.2	133.0	449.6	378.1	210.8	263.8	194.9	155.8	145.0	206.5	455.4	171.9	122.7	88.6	157.7	121.8	137.7	152.0	87.6	212.7	250.0	353.9	310.9	201.6	159.0	187.8	154.6	292.3	263.0	233.0	78.8	155.4	1043.7	194.9	134.4	83.9	174.1	94.5	235.3	417.1	80.0	126.3	701.0	169.1	114.2	114.1	117.0	151.0	189.1	227.5	64.2	111.4	366.6	268.9	162.8	135.1	449.2	325.9	505.8	229.6	122.2	401.8	405.8	260.1	156.8	216.6	82.6	148.7	232.2	151.6	123.6	118.7	121.1	264.0	101.0	99.8	107.0	13.8	151.5	209.0	426.0	96.3	225.2	42.5	43.5	44.4	48.7	43.1	48.1	45.7	44.0	45.8	45.5	45.0	50.2	134.4	44.8	68.1	4.6	185.1	0.0	160.1	0.0	46.1	31.0	153.8	133.9	6.6	110.1	18.6	77.3	4.2	284.0	135.6	39.8	43.0	355.9	8.7	65.9	168.2	131.9	31.5	55.3	7.3	351.1	768.1	177.0	92.8	158.8	16.4	135.8	126.7	207.3	415.6	26.9	9.6	96.2	0.0	118.8	0.0	12.8	140.5	155.4	0.0	9.4	250.8	51.3	116.4	8.0	10.6	401.8	71.3	91.0	857.6	342.0	182.9	86.8	9.5	32.7	92.1	92.7	157.1	183.2	125.1	64.4	0.0	581.6	84.9	145.5	101.0	260.7
MYEF2	"FLJ11213, HsT18564, KIAA1341, MEF-2"	ENSG00000104177	"Myelin expression factor 2"		15	48134632-48178353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 87.8;Oligodendrocyte precursor cells: 88.4;Spermatocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 101.9;SCLC-21H: 90.8;SK-MEL-30: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA004883: AB_1079436"	"unprognostic (4.30e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.76e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.55e-5)"	"unprognostic (1.32e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.05e-1)"	4.7	15.0	17.2	4.9	18.1	1.6	7.7	26.0	23.5	2.3	13.5	11.4	3.6	5.7	10.0	2.5	12.1	6.9	8.8	17.4	21.1	17.8	0.5	5.8	7.0	17.6	17.1	1.7	14.2	13.9	22.8	1.4	16.9	8.9	4.9	33.1	6.4	10.5	1.4	4.4	4.9	7.5	17.2	6.2	9.2	28.2	17.4	10.4	5.5	2.2	7.6	3.7	1.3	20.8	0.3	30.1	101.9	63.9	1.0	0.1	0.0	31.4	8.3	15.7	6.9	12.1	12.8	22.1	40.2	7.1	10.9	0.2	43.1	1.9	20.9	60.3	16.5	13.5	0.0	5.1	5.1	15.6	10.5	0.5	1.2	0.2	2.1	47.5	28.5	30.5	2.2	30.5	12.8	17.6	24.0	0.2	44.1	7.5	5.3	0.0	8.0	0.7	51.2	5.8	90.8	69.7	0.0	9.2	91.9	47.6	49.3	19.7	18.6	5.0	24.3	18.9	73.6	13.5	54.4	0.1	9.3	0.1	20.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.2	0.0	17.2	18.1	26.0	23.5	17.4	21.1	17.6	17.1	16.9	17.2	17.4	20.8	15.9	12.8	16.8	56.8	13.9	0.8	2.3	1.2	1.2	80.4	26.2	17.0	9.4	7.2	11.6	49.7	79.2	0.6	7.9	3.3	31.3	20.5	70.7	40.1	3.0	10.9	52.1	8.8	80.8	11.3	0.2	5.5	4.1	18.3	4.5	47.6	6.8	0.1	0.4	82.4	87.8	8.2	2.0	1.0	6.8	41.0	2.1	3.9	10.6	22.5	3.8	33.5	3.1	88.4	43.9	11.0	6.8	1.2	5.8	7.3	0.5	26.7	47.7	61.0	0.0	7.1	13.2	106.1	25.3	0.5	1.0	0.0	7.8	2.8	6.9	1.6
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294151-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.4;breast: 5.3;esophagus: 9.6;stomach 1: 6.0"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 199.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	5.4	0.1	0.0	0.6	0.0	0.1	5.3	0.0	0.0	1.8	0.0	0.5	0.3	0.0	0.7	9.6	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	4.1	0.2	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	3.9	0.0	172.8	83.5	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.5	24.3	0.5	6.3	0.0	0.1	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.1	8.5	0.0	2.4	0.2	0.1	3.8	0.1	0.1	0.2	3.4	6.8	0.0	0.1	3.5	0.6	0.2	0.0	0.0	0.0	2.4	0.6	0.0	2.9	0.7	1.6	0.1	36.1	0.0	1.4	0.3	1.7	0.2	0.2	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	0.8	0.8	3.8	0.0	0.0	30.7	37.7	0.4	0.0	17.6	3.7	0.0	0.0	0.9	7.8	0.0	12.6	12.7	1.2	0.1	0.5	0.0	0.0	0.0	9.4	0.4	3.4	23.9	1.5	0.0	0.1	0.0	0.2	2.4	0.0	0.0	1.3	2.0	0.0	0.0	6.9	0.3	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	199.3	22.3	0.0	3.9	1.4	0.0	0.0	1.5	0.0	0.0	0.1	2.9	0.0	0.4	3.4	1.3	0.1	0.4	0.0	2.7	8.5
MYG1	"C12orf10, Gamm1, MYG"	ENSG00000139637	"MYG1 exonuclease"	Q9HB07	12	53299695-53307177	"Disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 16.4;Cytotrophoblasts: 38.4;Extravillous trophoblasts: 60.7;Hofbauer cells: 70.1;Syncytiotrophoblasts: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038626, HPA038627"	Approved	Supported	Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA038626: AB_10674692, HPA038627: AB_2676123"	"unprognostic (5.33e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	33.8	35.8	40.0	18.0	41.4	20.8	31.8	45.5	66.7	35.0	40.4	33.2	18.6	32.8	21.2	24.9	35.7	20.7	32.0	39.7	44.0	36.9	28.0	20.8	22.5	45.4	45.6	40.6	45.4	31.4	29.0	15.4	46.8	25.3	14.9	17.3	26.1	20.8	48.0	31.3	21.1	19.8	41.9	20.5	33.2	104.8	43.5	22.7	30.6	26.3	19.9	34.4	27.5	42.2	42.3	78.0	33.8	53.5	35.1	52.4	3.9	27.3	43.6	62.0	44.1	74.5	44.9	40.6	63.2	38.3	35.1	46.6	46.8	60.8	32.8	34.0	78.9	41.7	60.4	91.5	81.0	43.8	27.1	49.7	40.1	57.4	58.1	61.7	53.8	46.8	2.4	81.0	41.5	164.8	58.9	71.0	55.0	42.7	73.9	54.9	31.9	93.6	53.7	41.0	66.7	63.9	30.9	60.3	68.3	19.3	94.8	42.0	37.3	60.3	55.8	43.7	43.9	73.3	81.8	43.8	75.7	37.2	47.6	24.2	55.0	26.1	35.8	44.4	52.6	49.9	46.3	35.5	63.5	41.5	47.8	44.3	14.6	42.4	32.9	39.8	69.5	50.1	40.0	41.4	45.5	66.7	39.7	44.0	45.4	45.6	46.8	41.9	43.5	42.2	13.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	38.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	60.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	25.9	1.5	0.0	0.0	0.0
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518542	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	137	"skeletal muscle: 7882.0"	"Cell type enriched"	"Detected in some"	10	"Skeletal myocytes: 77.4"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		98000000		"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	2.6	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	3.5	0.1	0.1	0.6	0.3	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	1.3	0.0	0.0	9.1	0.1	7882.0	0.7	0.2	0.1	0.0	0.1	0.2	1.8	0.0	0.0	0.5	57.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.6	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYH15	KIAA1000	ENSG00000144821	"Myosin heavy chain 15"	Q9Y2K3	3	108380368-108529322	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;retina: 2.8;tongue: 1.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Excitatory neurons: 8.8;Inhibitory neurons: 6.3;Muller glia cells: 8.0;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 10.6;Rod photoreceptor cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.4;Karpas-707: 2.3;PC-3: 5.1;SH-SY5Y: 1.8;U-87 MG: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034871, HPA057915"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Vesicles	"HPA034871: AB_10669996, HPA057915: "	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.57e-2)"	0.1	0.2	1.5	0.1	1.9	0.1	0.0	1.4	1.4	0.1	0.6	0.4	0.4	0.0	0.3	0.0	0.1	0.2	0.4	1.5	1.7	0.0	0.0	0.3	0.1	1.7	1.5	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.3	2.8	0.1	0.0	0.2	0.5	0.6	0.0	1.5	0.2	0.1	0.6	1.6	0.1	0.1	1.8	0.0	0.0	0.0	1.6	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.9	0.1	0.2	0.0	0.4	0.0	0.1	0.0	4.4	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.5	1.2	0.2	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.9	1.4	1.4	1.5	1.7	1.7	1.5	1.5	1.5	1.6	1.6	0.0	0.0	0.5	14.0	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.1	0.4	0.0	0.2	3.0	1.0	0.1	0.1	0.0	0.0	8.8	0.2	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	6.3	1.1	0.0	0.0	0.3	0.9	0.0	0.1	1.8	1.0	0.0	8.0	0.0	5.0	10.6	0.5	0.0	0.0	1.6	0.4	0.1	0.1	0.0	5.1	0.0	0.1	0.6	1.1	0.6	0.0	0.1	0.0	0.1	0.5	1.2	0.1
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549700	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	84	"skeletal muscle: 12790.2;tongue: 6140.2"	"Cell type enriched"	"Detected in some"	18	"Skeletal myocytes: 129.6"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HSkMC: 1.9;NTERA-2: 8.3;SuSa: 1.7"									"HPA001349, CAB010760"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		81000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			0.5	0.1	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	46.5	0.3	0.0	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	21.5	0.0	0.0	113.1	1.0	12790.2	1.1	0.2	0.4	0.0	0.1	0.2	0.2	0.0	0.3	0.9	6140.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.0;seminal vesicle: 18.3;skeletal muscle: 20.6"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 411.9"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"HSkMC: 59.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA021808	Enhanced					NA	NA		29000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.6	0.9	1.8	1.1	1.7	0.8	1.5	1.5	1.9	2.9	1.5	7.9	1.1	3.4	1.2	9.1	2.6	0.5	1.0	1.6	1.6	2.1	3.3	1.2	1.3	1.8	1.8	2.3	2.4	0.3	1.5	0.4	1.7	29.0	1.0	1.8	1.5	18.3	20.6	2.8	2.5	1.7	1.4	2.6	1.7	4.6	1.8	3.0	3.4	6.0	0.6	4.4	3.8	1.8	0.2	1.1	0.8	1.1	1.0	0.3	1.0	0.8	0.4	0.5	0.5	1.0	0.1	0.7	0.3	0.4	0.2	1.1	0.5	0.2	1.0	0.7	0.9	1.0	0.3	1.6	0.3	0.6	1.4	59.6	0.4	0.6	0.8	0.1	0.1	1.3	0.4	0.1	0.2	0.7	1.0	2.3	0.9	0.3	0.6	0.8	0.8	0.3	0.3	0.3	0.0	0.4	0.4	0.0	0.3	0.7	0.3	0.3	0.3	0.1	1.0	0.3	0.1	1.3	1.1	0.3	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.5	1.9	1.6	1.6	1.8	1.8	1.7	1.4	1.8	1.8	0.5	0.0	9.8	4.6	0.7	2.9	0.9	0.1	0.6	4.9	0.7	1.8	3.6	1.5	0.7	0.0	6.2	0.4	0.8	0.9	0.0	0.6	411.9	0.5	0.8	1.4	0.0	2.7	3.9	0.6	0.8	1.1	1.1	0.5	7.6	0.8	0.4	0.6	0.1	0.0	3.4	0.5	0.0	0.8	0.3	56.0	2.8	1.2	1.8	1.9	0.2	1.8	0.0	7.5	5.4	0.7	0.2	2.6	0.0	1.5	1.8	0.3	0.3	4.6	0.0	5.5	0.8	10.7	4.2	0.3	1.6	0.5	1.4	0.2	0.8	0.3
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"skeletal muscle: 10.6"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"OE19: 9.0"									HPA001349	Supported		Uncertain	"Focal adhesion sites"		NA	NA		86000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381982-23408273	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"heart muscle: 2882.7"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 8051.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"NTERA-2: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		25000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2882.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.9	5.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	1.9	0.0	53.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	50.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8051.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	31.7	0.0	2.7	0.1	0.0	0.0	449.6	0.0	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	60.3	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	71	"heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8"	"Cell type enriched"	"Detected in some"	127	"Cardiomyocytes: 10295.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"HSkMC: 11.4"	"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		43000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	2.0	1.3	1.4	0.0	1.9	0.1	2.5	0.1	1.1	0.3	1.4	1.2	0.5	0.4	0.0	129.2	0.1	1.1	7569.2	1.2	2.9	0.9	1.4	3.2	1.5	0.8	1.6	0.7	7.8	0.0	1.5	0.0	0.9	76.8	0.0	0.0	37.0	0.0	14554.3	4.8	0.9	0.0	0.9	0.5	0.9	1.4	3.2	0.1	1.8	5378.8	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.1	1.1	1.2	2.9	0.8	1.6	0.9	0.9	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10295.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	80.9	0.0	0.0	0.2	3.1	0.0	70.5	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.2	51.2	0.1	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"esophagus: 15.9;lymphoid tissue: 10.7;skeletal muscle: 16.7;tongue: 10.0"	"Group enriched"	"Detected in some"	8	"Proximal tubular cells: 84.8;Skeletal myocytes: 52.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"HSkMC: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		53000000		"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	10.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	0.0	52.0	0.1	0.5	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315174	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	88	"skeletal muscle: 21805.2;tongue: 15591.3"	"Cell type enriched"	"Detected in some"	246	"Skeletal myocytes: 492.9"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HSkMC: 51.4"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.0"	"Low region specificity"	"Detected in all"			"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	NA	NA		21000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavorable (6.59e-4)"									"unprognostic (1.88e-1)"			2.3	0.5	0.1	0.0	0.1	0.0	3.3	0.0	0.1	0.1	0.0	1.1	0.0	0.5	0.0	212.7	0.0	0.0	2.0	0.1	0.0	0.7	1.0	0.9	0.0	0.0	0.0	0.6	1.1	0.0	0.4	0.0	0.0	164.2	0.0	0.0	170.2	0.0	21805.2	4.0	0.7	0.0	0.0	0.4	0.7	0.5	0.0	7.4	2.3	15591.3	0.9	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	492.9	2.0	0.1	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1
MYL10	"MGC3479, MYLC2PL, PLRLC"	ENSG00000106436	"Myosin light chain 10"	Q9BUA6	7	101613330-101629296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Peritubular cells: 2.6;Skeletal myocytes: 3.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.2;PC-3: 2.4;RH-30: 4.2;SuSa: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019763, HPA039262"	Uncertain		Uncertain	Microtubules		NA	NA			"Cluster 11: Basophils - Unknown function"		"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Microtubules		"HPA019763: AB_1854243, HPA039262: AB_2676418"		"unprognostic (2.32e-2)"		"unprognostic (3.09e-1)"					"unprognostic (1.11e-1)"		"unprognostic (1.74e-2)"	"unprognostic (2.78e-3)"		"unprognostic (5.04e-3)"	"unprognostic (8.93e-2)"		"unprognostic (1.10e-2)"	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.8	0.5	0.7	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.6	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	2.4	0.0	4.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.0	1.9	0.1	0.0	0.1	0.3	1.0	0.0	0.1	0.2	0.1	0.8	0.0	0.2	0.0	1.9	0.3	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.1	0.3	0.4	0.1	0.1	0.1	0.8	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL12A	"MLCB, MRCL3, MRLC3, MYL2B"	ENSG00000101608	"Myosin light chain 12A"	P19105	18	3247481-3256236	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 4234.5;skeletal muscle: 3072.7;tongue: 2082.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 6094.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004503, HPA039262, HPA045244, HPA059197"	Supported					NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.14e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.58e-3)"	"unprognostic (7.13e-2)"	492.0	246.2	83.6	358.2	86.6	455.0	423.8	91.2	123.7	311.2	114.1	448.8	315.2	258.1	267.0	410.9	274.7	354.6	4234.5	81.0	97.2	427.9	462.3	564.8	562.8	101.2	89.5	191.4	228.8	364.4	106.9	445.4	101.7	247.4	486.6	50.7	282.4	245.6	3072.7	280.7	332.6	317.3	97.0	566.3	369.0	106.8	93.5	461.6	314.3	2082.4	601.6	408.3	240.5	96.8	467.6	298.1	580.7	257.3	701.6	691.8	386.7	1045.3	1176.5	827.9	895.4	440.7	543.5	224.6	263.9	1412.9	627.3	192.7	360.9	601.0	736.0	326.9	129.4	236.6	297.2	360.0	1118.3	658.7	401.0	1129.5	803.3	698.0	420.0	799.7	1332.7	272.6	292.6	694.7	1748.4	793.6	282.9	571.7	253.3	496.5	199.3	167.0	341.1	384.7	1827.8	680.1	86.7	211.5	840.9	333.1	674.0	541.8	233.8	918.2	1717.0	212.6	508.4	635.5	828.0	166.9	278.8	351.6	665.5	249.5	798.1	3164.3	1120.8	2382.2	2287.2	1192.8	2280.2	1588.6	2106.9	2315.1	1639.0	1353.6	1901.6	2215.8	1785.1	1629.3	1464.6	2487.8	2068.3	4517.7	83.6	86.6	91.2	123.7	81.0	97.2	101.2	89.5	101.7	97.0	93.5	96.8	1206.6	737.2	291.0	4.6	530.9	635.9	973.5	1804.3	259.6	29.4	294.8	396.4	6094.3	449.0	949.8	511.3	12.5	748.1	1090.0	1033.5	471.6	1335.5	32.4	570.0	312.1	938.8	105.4	244.9	1.7	1487.7	1168.6	453.0	318.5	662.3	521.0	301.7	870.6	272.5	844.2	57.2	2.9	570.4	889.0	605.3	992.8	32.8	334.6	924.2	442.9	26.2	1616.2	92.6	1388.3	4.0	9.0	2236.5	977.2	396.5	207.4	817.8	758.0	757.7	673.1	42.4	571.9	378.7	757.0	78.9	166.5	262.6	545.1	666.0	1078.8	303.7	429.6	698.2
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261479-3278461	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	360.1	441.4	172.7	232.6	179.2	301.8	377.8	181.2	233.2	317.9	206.8	436.4	420.1	265.9	482.9	509.1	297.0	278.9	312.6	185.2	186.5	559.9	406.1	426.9	272.3	186.2	180.1	231.7	224.3	418.7	189.7	405.2	184.9	244.1	439.6	103.9	364.9	273.0	269.7	342.1	403.5	248.4	180.4	274.1	321.4	152.9	183.3	303.8	340.5	214.7	314.8	404.3	347.9	181.5	565.6	294.1	253.8	247.3	726.9	598.1	437.1	839.9	719.9	751.9	769.3	611.7	439.0	282.5	360.1	1154.6	576.7	277.3	424.3	967.7	748.6	166.1	180.7	285.0	297.2	482.8	744.0	645.0	428.0	533.6	879.0	512.7	320.4	659.9	1128.1	283.3	247.8	266.3	971.9	1146.7	372.0	450.3	170.1	666.5	249.7	181.0	320.2	228.5	1572.8	995.6	208.1	217.4	836.3	497.2	524.7	403.6	429.2	379.3	1422.8	736.3	1111.3	654.0	1036.9	148.1	153.2	342.8	448.2	256.9	586.8	1484.7	500.6	1513.2	643.7	666.4	548.3	436.8	619.3	701.5	582.0	360.0	501.2	582.5	1141.6	485.2	799.0	797.2	742.7	1294.1	172.7	179.2	181.2	233.2	185.2	186.5	186.2	180.1	184.9	180.4	183.3	181.5	846.5	807.7	516.2	16.3	279.4	634.5	889.6	2141.6	412.6	82.6	394.7	556.9	755.3	444.7	1157.4	542.6	25.0	1084.6	470.9	1301.7	1048.7	1453.7	164.3	617.3	362.5	674.4	243.9	269.7	21.9	1470.9	1082.5	447.4	290.0	705.2	446.8	372.9	683.9	292.2	614.1	65.6	20.4	590.3	990.7	375.7	450.1	225.0	446.4	448.1	345.1	52.5	911.6	185.7	461.4	14.1	21.6	2199.0	1180.2	433.3	121.6	814.9	1459.2	1477.9	891.9	94.5	355.0	269.5	542.6	240.0	208.9	486.5	568.4	1402.6	532.9	671.1	568.9	1097.6
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110921443	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	72	"heart muscle: 27910.5;skeletal muscle: 28967.7;tongue: 19823.2"	"Cell type enriched"	"Detected in some"	80	"Cardiomyocytes: 27611.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Region enriched"	"Detected in some"	6	"hypothalamus: 6.0"	"Group enriched"	"Detected in some"	12	"memory B-cell: 1.1;naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		NA	NA		180000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Microtubules		"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavorable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		7.3	4.5	0.0	0.1	0.0	0.7	29.4	0.0	0.0	1.5	0.0	4.7	0.6	2.2	0.0	357.0	0.5	9.5	27910.5	0.0	6.0	3.0	5.4	5.0	15.2	0.6	1.0	2.4	5.8	0.0	2.5	0.1	0.3	249.8	0.1	0.0	108.7	0.2	28967.7	19.3	3.2	0.3	0.0	2.1	3.5	2.1	0.0	1.0	13.3	19823.2	1.1	2.2	4.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.0	0.1	0.0	0.0	1.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.6	1.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	27611.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	235.7	0.0	0.0	0.0	0.0	0.0	53.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	342.2	138.8	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46835111-46882172	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2"	"Cell type enriched"	"Detected in some"	53	"Cardiomyocytes: 3626.2"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		7300000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	5.8	4.1	11.3	0.9	11.1	1.5	8.9	11.4	14.8	6.7	8.4	2.5	1.6	3.3	3.4	157.0	4.2	3.6	9155.0	11.0	12.8	50.3	4.1	5.7	3.3	15.2	13.0	5.2	2.7	1.3	1.7	4.7	12.1	25.1	0.8	1.9	19.6	1.5	5135.3	4.0	2.3	2.0	13.2	7.9	2.1	2.3	12.6	0.7	2.4	2074.2	0.5	2.4	4.7	13.2	0.5	0.7	0.4	0.3	4.4	1.5	3.6	0.7	0.4	0.4	0.6	8.6	0.8	1.6	1.4	0.1	0.2	0.5	0.4	0.1	0.7	0.3	0.1	0.8	2.6	0.3	0.7	0.9	0.8	8.7	0.2	0.3	0.1	0.2	0.1	0.5	0.4	1.2	0.2	1.2	0.3	0.5	1.0	0.4	0.4	0.9	0.3	0.1	34.2	1.3	0.6	0.4	0.3	0.7	0.1	0.7	0.3	0.5	0.2	1.0	0.8	0.6	0.3	0.5	0.4	0.7	0.3	0.8	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	11.3	11.1	11.4	14.8	11.0	12.8	15.2	13.0	12.1	13.2	12.6	13.2	0.7	0.0	0.0	1.0	0.0	0.8	0.2	0.0	0.0	0.2	2.3	0.1	3626.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	54.8	0.0	2.4	0.1	2.2	32.8	0.0	0.0	0.1	0.0	16.4	23.7	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	12.8	1.2	0.7	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	68.1	0.0	0.4	6.6	27.9	20.4	0.2	0.5	0.0	0.4	0.8	0.4	0.1	0.0	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"heart muscle: 6347.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.1	0.5	0.2	0.4	0.3	134.6	2.7	0.2	0.4	0.4	0.4	0.8	0.8	0.8	0.0	0.6	0.5	1.0	6347.0	0.3	0.4	1.3	1.4	9.4	0.9	0.3	0.3	0.8	8.6	0.3	0.5	9.1	0.4	1.1	0.3	42.2	3.0	0.2	3.5	1.2	1.3	0.8	0.2	3.1	3.4	15.5	0.3	2.4	11.0	6.4	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.3	0.2	0.4	0.3	0.4	0.3	0.3	0.4	0.2	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 66.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.3;Proximal enterocytes: 55.5;Rod photoreceptor cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 60.4"					"Not detected"	"Not detected"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	17.9	21.4	21.8	7.0	21.8	11.4	16.6	21.9	36.0	10.6	19.4	20.7	20.7	7.4	17.8	20.0	7.9	8.3	10.4	21.0	20.4	19.4	22.2	11.0	11.0	22.8	21.1	7.7	9.9	15.3	13.7	5.1	22.3	18.2	13.0	66.1	13.3	8.9	24.6	18.6	25.2	5.6	20.9	16.1	12.3	22.2	21.9	10.0	13.6	8.3	10.3	11.2	13.3	23.5	4.3	6.9	24.8	13.2	60.4	41.2	11.9	10.2	13.6	10.2	9.3	8.4	17.7	4.9	4.8	16.6	7.3	6.2	4.0	7.0	3.0	9.2	5.0	7.4	11.7	7.9	21.0	11.3	6.5	31.3	6.5	8.1	8.4	14.8	6.3	10.4	7.7	6.5	12.7	8.0	6.1	7.8	5.2	8.8	10.4	5.4	5.3	3.0	16.9	19.9	11.3	6.4	3.4	8.5	7.2	8.0	13.7	10.2	10.4	8.7	1.6	7.5	6.0	24.7	5.3	2.9	9.5	10.1	4.6	15.5	8.2	1.5	3.3	5.5	4.2	8.7	5.6	2.0	7.7	12.7	6.7	6.8	5.8	18.4	12.3	14.5	2.6	5.8	21.8	21.8	21.9	36.0	21.0	20.4	22.8	21.1	22.3	20.9	21.9	23.5	4.5	0.0	11.9	2.3	11.7	12.0	6.8	12.8	18.2	6.3	12.9	14.5	1.4	7.2	5.7	7.3	20.9	7.3	9.2	22.7	11.7	9.6	22.2	9.1	6.9	5.9	5.4	4.2	1.4	4.7	5.4	7.5	13.7	5.3	13.9	4.9	10.4	18.3	22.7	11.8	1.3	11.4	6.1	21.2	8.6	87.3	7.2	12.4	7.2	1.0	22.8	22.2	13.4	0.5	1.6	6.1	13.2	3.8	5.1	8.3	55.5	42.6	8.2	74.3	6.6	21.7	5.6	14.1	4.4	21.2	13.4	5.5	5.9	14.7	15.4	9.7
MYL6	"ESMLC, MLC1SM, MLC3NM"	ENSG00000092841	"Myosin light chain 6"	P60660	12	56158346-56163496	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046859, HPA063034"	Approved					NA	NA		60000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (1.10e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.01e-1)"	2247.0	1427.5	830.7	1207.0	830.7	1756.5	1977.9	864.2	962.6	1767.3	901.0	5900.2	1027.9	2971.8	1635.0	1777.8	2197.9	905.8	1153.9	809.9	863.8	1915.8	1172.0	1946.7	882.9	900.5	874.9	1155.2	1032.8	1466.7	747.7	1441.7	869.2	2037.5	2360.3	927.1	1167.6	2912.2	411.1	1090.1	1867.5	4209.9	858.5	1547.8	2128.0	494.6	899.3	1151.3	1316.7	578.7	1404.7	3041.7	1685.0	869.9	1924.9	1739.1	3199.3	958.8	2063.5	2065.5	1755.8	4056.4	4162.8	5469.7	3191.3	2738.5	1720.0	735.0	2274.3	5778.4	1417.7	1222.8	1995.9	2846.0	3556.8	1423.1	666.5	1311.5	2481.7	1536.9	1512.2	913.8	2304.1	2389.9	2013.5	3242.3	1263.1	4706.8	4854.4	867.2	708.1	2121.5	4585.6	2052.1	1291.6	1402.8	1629.5	1071.6	1746.1	1027.3	1265.3	932.9	5125.1	2361.7	1169.2	862.9	4456.0	1380.0	760.4	2312.4	2148.7	2383.0	5212.3	1486.3	1011.6	2077.3	2746.8	635.3	1150.3	867.7	1953.3	1168.9	1578.1	11449.4	4509.8	13302.4	3191.2	5016.0	2404.9	2844.7	2828.6	2994.0	4747.3	2558.5	2020.7	2528.3	8440.7	2233.9	6531.2	5167.0	4209.8	14776.8	830.7	830.7	864.2	962.6	809.9	863.8	900.5	874.9	869.2	858.5	899.3	869.9	2044.5	1733.9	1161.8	16.0	704.4	2114.0	2470.4	2988.3	746.1	278.4	896.3	1394.8	672.8	946.5	2016.5	1475.0	316.9	1704.4	1144.5	2568.2	2406.5	4126.7	292.4	1134.2	1714.2	1628.1	1017.3	857.4	15.6	4820.4	2604.5	1264.0	871.6	1676.6	994.3	1307.8	1328.6	887.8	3370.3	80.8	19.8	1572.3	1845.3	1148.3	2472.8	910.7	1064.0	1872.2	1469.2	39.4	4426.3	820.8	1195.7	17.6	31.3	6222.1	2715.8	2775.1	892.8	1762.1	3007.9	2956.9	1870.9	763.7	1735.5	685.8	3305.2	76.2	115.0	1139.6	2066.1	1929.9	1191.9	1039.1	1406.1	2558.6
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 635.0;tongue: 390.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 340.7;Late spermatids: 1215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 18.4"	"Group enriched"	"Detected in all"	5	"B-cells: 6.3;dendritic cells: 18.4;T-cells: 14.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced					NA	NA		7200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	22.7	27.3	133.2	13.8	134.3	17.0	23.8	125.1	177.1	39.5	110.9	23.1	7.5	27.1	34.5	23.4	36.3	27.6	44.8	135.2	133.9	41.4	17.0	16.3	21.9	126.5	128.9	54.3	12.7	77.5	72.0	14.1	130.4	36.2	10.2	23.6	23.1	21.2	635.0	20.4	14.4	22.8	124.0	16.2	18.2	140.0	129.2	43.1	29.3	390.4	25.8	19.0	26.4	125.3	34.1	57.4	152.1	146.4	31.6	112.7	106.0	39.0	170.0	150.8	146.4	41.3	55.4	56.6	83.6	83.9	57.8	19.1	72.2	94.4	80.6	102.9	104.9	59.6	54.8	73.6	99.5	43.7	40.0	189.4	37.6	140.0	54.1	320.2	165.6	134.8	64.2	56.6	126.0	44.5	121.0	145.3	128.3	32.1	97.5	125.7	94.4	75.1	117.0	22.7	139.3	204.6	43.1	52.6	80.4	110.6	43.0	74.0	93.2	88.3	75.1	46.1	84.8	79.9	49.2	47.5	94.7	43.9	98.8	0.9	2.8	0.9	2.0	2.7	1.1	6.3	4.0	3.3	6.4	4.0	3.0	2.5	2.1	2.3	1.1	18.4	14.9	4.3	133.2	134.3	125.1	177.1	135.2	133.9	126.5	128.9	130.4	124.0	129.2	125.3	29.4	67.3	32.4	13.4	28.2	33.1	54.6	72.4	67.7	59.6	67.4	101.7	17.6	38.6	30.6	110.3	25.0	34.2	24.1	21.5	150.6	50.4	340.7	83.0	58.9	44.0	157.4	24.6	18.9	20.2	68.3	55.3	26.0	93.1	12.7	134.9	53.9	32.2	43.5	33.7	23.7	35.0	46.8	22.3	25.0	1215.9	80.8	19.1	40.9	6.5	47.7	149.9	4.1	11.6	7.6	26.9	19.5	66.5	44.2	39.4	28.0	156.4	23.9	51.4	52.6	63.2	53.0	126.4	54.4	71.3	25.4	22.6	15.6	52.2	32.7	47.9
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1061	"heart muscle: 23165.6"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 10772.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BEWO: 35.6;CACO-2: 124.6;SuSa: 47.6"	"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	3.2	1.1	3.9	0.0	3.5	0.0	6.4	3.6	4.1	1.2	3.0	1.9	0.0	1.4	0.2	1.1	0.8	0.6	23165.6	3.3	4.1	1.0	2.3	21.8	0.8	3.6	3.8	4.3	18.4	0.4	9.7	2.2	3.6	2.0	0.0	0.2	11.6	0.3	3.0	2.3	2.0	0.0	3.3	0.9	1.3	1.0	4.4	0.0	3.5	0.0	0.0	0.4	1.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.4	0.0	124.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.9	0.4	0.0	47.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.5	3.6	4.1	3.3	4.1	3.6	3.8	3.6	3.3	4.4	3.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	30.5	10772.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	78.5	0.0	2.7	0.3	0.0	0.2	695.9	0.0	0.0	0.0	24.9	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541497-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 8015.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 860.2;Cardiomyocytes: 1856.1;Peritubular cells: 1891.9;Sertoli cells: 2143.1;Smooth muscle cells: 2525.7;Theca cells: 881.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.2;neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 783.3;BJ: 1047.3;fHDF/TERT166: 844.3;hTERT-RPE1: 645.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 76.1"	"HPA039262, HPA045244, HPA059197"	Supported					NA	NA		34000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	944.6	948.6	61.6	347.0	76.7	5.2	649.5	63.3	132.2	1083.0	104.6	8015.9	270.5	2897.3	238.2	999.8	1643.3	364.3	2294.5	61.4	63.1	352.2	116.6	617.9	56.4	66.3	66.3	717.2	82.0	45.4	91.2	160.3	66.1	2347.4	345.8	22.8	200.7	2248.7	164.3	289.2	1287.7	2107.8	62.0	274.3	1946.4	260.7	66.5	27.4	431.7	111.4	23.2	4176.1	943.6	63.3	79.4	1.3	60.3	1.2	783.3	298.6	264.5	1047.3	450.9	541.3	349.9	612.3	9.1	0.2	535.6	844.3	120.6	29.4	0.2	2.4	125.7	0.9	0.2	16.7	114.4	57.3	500.4	0.4	17.7	420.8	54.4	359.9	1.6	645.9	19.2	0.0	2.4	28.0	461.7	0.2	0.3	7.8	24.0	16.1	5.6	0.4	0.0	5.8	4.6	5.8	0.6	4.1	11.1	26.6	0.6	257.5	232.9	15.6	137.0	510.9	220.1	75.5	1.0	0.8	4.0	2.3	194.3	0.8	0.6	0.0	0.1	2.2	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.2	0.0	0.0	1.9	0.2	0.0	0.4	0.0	7.2	61.6	76.7	63.3	132.2	61.4	63.1	66.3	66.3	66.1	62.0	66.5	63.3	325.3	394.2	52.3	0.0	6.6	60.7	320.2	167.1	21.6	1.4	36.8	860.2	1856.1	24.3	50.8	90.1	0.0	37.0	6.3	0.1	27.4	310.3	9.3	13.1	419.9	179.7	0.0	5.7	0.2	116.0	78.3	410.4	10.2	9.3	15.2	234.3	169.9	2.7	32.0	1.7	0.1	1.2	14.2	5.0	76.6	55.4	331.8	111.7	72.9	30.9	19.4	230.4	6.2	0.0	0.5	47.9	2.5	1891.9	6.4	156.9	105.5	42.1	31.8	6.1	2143.1	65.9	2525.7	16.3	9.5	6.5	53.4	26.8	14.7	881.1	2.0	61.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 732.0"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	0.1	0.0	0.6	0.1	0.6	0.4	0.1	0.6	0.7	0.0	0.5	0.2	0.0	0.1	0.1	4.7	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.1	0.0	0.6	0.7	0.1	5.5	0.0	0.1	0.0	0.7	1.1	0.0	0.0	2.4	0.0	732.0	0.6	0.1	0.1	0.6	0.3	0.2	0.2	0.7	0.2	0.2	60.3	0.0	0.0	0.0	0.6	0.3	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	1.3	0.8	0.5	0.1	4.1	0.1	0.6	0.5	0.3	0.5	0.0	0.3	0.6	10.5	8.8	0.0	0.1	0.5	0.5	2.7	0.1	0.0	0.1	0.1	0.1	2.1	0.2	0.7	0.4	2.4	0.0	0.8	0.2	0.1	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.7	0.7	0.6	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46702282-46790407	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.6;hippocampal formation: 5.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.5"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	1.9	0.1	1.7	0.3	0.1	1.1	2.3	0.4	1.7	0.0	0.1	0.3	0.8	4.3	1.7	0.2	103.4	2.5	2.8	1.1	0.1	0.4	0.2	9.8	12.2	0.3	0.1	0.0	0.4	0.5	8.2	2.2	0.1	0.2	2.1	0.1	46.5	0.1	0.1	0.2	5.9	0.1	0.1	6.0	1.9	0.1	0.1	72.6	0.1	0.0	0.0	3.0	0.0	0.1	0.1	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	2.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.5	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	7.9	0.2	3.5	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.9	1.7	1.1	2.3	2.5	2.8	9.8	12.2	8.2	5.9	1.9	3.0	0.2	0.0	3.3	0.7	0.5	0.0	0.7	0.0	0.0	0.9	1.3	0.0	169.0	0.0	3.7	0.0	2.1	2.0	0.2	0.0	0.0	0.0	8.1	44.8	7.1	1.7	0.0	0.0	0.9	0.2	0.5	6.7	0.0	2.2	1.3	1.6	0.7	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	7.2	0.6	0.8	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.2	8.7	1.3	0.0	4.9	2.7	1.0	0.7	0.0	0.0	0.3	0.8	0.7	0.0	0.8
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750922	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 30.1;tongue: 72.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	1.2	0.5	0.6	0.3	0.6	0.8	1.0	0.6	0.9	0.6	0.7	0.4	0.3	0.6	0.7	1.3	0.5	0.4	1.4	0.7	0.7	3.0	0.5	1.2	0.4	0.4	0.5	0.4	0.9	0.9	1.3	0.6	0.4	0.7	0.3	0.8	2.4	0.6	30.1	1.4	0.6	0.3	0.4	0.6	0.6	0.4	0.6	0.3	0.8	72.1	0.7	0.6	0.8	0.6	0.1	0.1	0.3	0.6	0.5	0.6	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.6	0.9	0.4	0.1	1.0	0.1	0.2	0.3	0.1	0.3	7.2	0.4	0.0	0.2	0.2	0.3	0.8	0.3	0.0	0.6	0.3	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.5	0.3	0.1	0.1	0.3	0.5	0.2	0.5	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.7	0.7	0.4	0.5	0.4	0.4	0.6	0.6	0.5	3.2	1.1	1.6	0.5	0.1	0.1	0.5	0.6	1.0	0.6	0.3	1.9	1.5	1.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.1	0.7	0.6	1.2	0.0	7.8	0.2	0.0	0.5	0.0	0.2	0.0	0.6	1.1	0.2	0.3	1.7	7.2	0.0	0.0	0.8	1.2	0.2	0.3	0.4	0.0	4.7	1.1	0.3	0.0	8.0	2.9	0.0	0.0	1.5	0.0	0.2	0.1	4.5	0.3	0.3	0.0	0.8	0.3	0.0	0.3	0.3	0.9	0.3	0.2	0.4	0.3	0.2
MYLPF	"HUMMLC2B, MRLC2, MYL11"	ENSG00000180209	"Myosin light chain, phosphorylatable, fast skeletal muscle"	Q96A32	16	30370934-30377991	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	108	"skeletal muscle: 19905.3;tongue: 5921.7"	"Cell type enriched"	"Detected in many"	29	"Skeletal myocytes: 654.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	73	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	73	"dendritic cells: 19.6"	"Group enriched"	"Detected in some"	18	"BEWO: 75.4;HSkMC: 166.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039262, HPA055059"	Enhanced					NA	NA		1000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA039262: AB_2676418, HPA055059: AB_2732591"	"unprognostic (8.81e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.88e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.44e-2)"	2.0	0.5	0.1	0.2	0.0	0.6	3.3	0.3	0.3	0.3	0.0	1.0	0.0	0.5	0.1	69.9	0.0	0.0	1.7	0.1	0.0	0.4	1.2	0.9	0.3	0.1	0.1	0.7	1.3	0.0	0.5	1.2	0.1	44.7	0.1	0.1	119.3	0.1	19905.3	2.7	0.7	0.2	0.0	0.5	0.7	4.8	0.0	10.0	2.0	5921.7	0.6	0.1	0.8	0.3	0.0	0.2	0.0	0.4	0.0	0.0	75.4	0.1	0.0	0.1	0.0	3.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.2	166.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.3	0.7	0.4	0.1	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.6	1.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	19.6	0.0	0.2	0.1	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	1.6	3.2	2.3	0.3	2.5	0.9	1.7	8.3	0.6	1.1	8.6	7.2	1.9	4.3	5.0	7.3	0.0	15.9	13.2	2.2	0.0	0.8	14.9	3.0	3.8	3.0	3.6	0.4	0.4	0.9	16.5	2.4	1.1	6.2	8.8	0.7	5.3	1.3	4.2	0.0	0.5	2.9	2.0	4.7	11.5	22.4	1.2	5.3	1.8	1.0	3.1	1.6	19.6	1.0	1.2	0.4	5.7	0.4	2.9	1.5	1.1	4.2	3.8	1.9	0.0	654.1	5.9	4.7	1.7	1.2	1.1	6.6	4.8	0.4	2.2	2.7
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"HSkMC: 15.2;RH-30: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA051846, HPA055785"	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.5	0.2	0.1	0.5	0.2	0.4	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216926-44218234	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 7.7;breast: 6.9;pancreas: 5.6;stomach 1: 2.3"	"Group enriched"	"Detected in some"	4	"Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	106	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	106	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	31	"RH-30: 134.6"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	7.7	0.1	0.0	0.2	0.0	0.0	6.9	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.5	1.0	0.0	0.0	0.7	0.1	0.4	0.6	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.4	0.9	0.5	0.1	0.0	0.8	2.3	0.4	0.0	0.8	0.4	0.2	0.3	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	134.6	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.2	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169773396-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	6.0	5.3	3.4	6.5	4.1	14.8	9.7	7.2	4.5	7.9	4.4	5.7	5.1	10.3	6.3	7.1	6.8	6.2	5.8	3.1	3.4	6.8	7.9	6.4	8.7	3.0	3.5	10.0	7.3	8.4	3.6	7.1	3.3	7.2	7.0	15.3	6.3	6.3	7.9	7.8	6.8	8.4	3.5	7.9	7.0	9.9	3.4	7.6	8.5	10.8	9.8	7.4	5.5	5.2	13.1	6.0	6.9	13.6	14.2	12.2	8.7	8.6	12.4	13.0	14.3	7.3	13.1	19.7	15.3	9.4	10.3	10.2	12.5	10.9	17.2	17.7	9.8	18.4	9.1	7.2	12.0	17.1	12.9	10.8	13.9	7.9	22.8	10.5	11.7	8.6	7.9	18.9	13.0	11.0	10.1	8.8	10.4	16.1	6.6	11.1	9.7	21.4	8.6	22.1	9.6	11.3	10.4	23.5	14.8	9.0	29.0	12.5	8.7	11.9	5.4	11.1	16.6	21.6	16.4	26.8	9.5	10.6	11.7	22.2	4.8	11.2	7.3	5.2	10.0	8.1	8.4	7.1	5.5	7.9	10.0	7.7	6.7	10.8	4.5	5.5	9.1	7.7	3.4	4.1	7.2	4.5	3.1	3.4	3.0	3.5	3.3	3.5	3.4	5.2	25.8	28.9	21.6	10.7	25.2	41.3	31.1	21.4	46.7	9.0	14.9	12.1	14.7	14.3	20.3	11.0	22.9	14.6	20.1	9.8	13.7	10.4	46.3	15.8	14.8	20.3	14.3	14.5	15.6	9.4	17.0	16.6	19.4	20.3	7.6	12.7	11.4	7.3	8.2	10.1	15.0	8.4	20.3	7.5	14.0	12.6	17.1	12.3	16.0	13.1	12.7	13.3	19.6	12.5	14.0	9.9	9.4	18.8	31.6	18.1	12.2	12.3	18.3	31.7	6.6	15.7	14.7	34.9	18.8	27.3	38.4	20.8	25.5	12.0	9.6	25.7
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661907-16936288	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.5;Muller glia cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 182.1;SK-MEL-30: 205.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli rim"	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	13.8	3.0	47.4	6.2	46.3	3.2	7.9	24.6	41.1	6.7	55.1	19.3	22.8	6.2	3.5	9.3	4.3	8.4	4.5	39.8	24.8	14.7	7.7	19.0	1.3	32.6	30.9	15.8	32.2	10.7	9.5	31.5	27.6	5.8	19.1	15.1	11.0	5.0	8.2	15.6	19.5	4.9	27.3	13.9	32.0	15.6	46.4	4.9	37.5	4.4	2.0	11.1	7.8	45.7	68.2	108.3	31.3	14.9	24.7	17.0	35.1	117.2	89.2	35.5	27.4	63.1	10.2	1.5	78.9	52.9	42.3	33.4	139.1	73.7	57.1	0.2	16.7	0.1	182.1	13.7	81.5	0.4	1.5	30.9	26.8	78.5	92.1	57.4	110.5	0.2	0.2	4.8	28.7	10.5	0.2	0.4	80.5	56.6	37.2	26.1	10.3	66.9	22.0	49.6	5.2	2.8	27.0	11.4	205.0	53.2	8.1	9.1	137.8	77.6	23.6	0.7	61.1	0.7	0.5	0.5	38.3	11.2	76.2	0.5	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	0.3	0.1	2.5	0.1	0.1	0.1	47.4	46.3	24.6	41.1	39.8	24.8	32.6	30.9	27.6	27.3	46.4	45.7	53.5	35.3	34.6	158.7	1.4	40.9	31.0	23.0	29.6	11.0	18.6	11.6	3.8	55.8	26.3	31.3	18.8	20.4	0.3	46.4	17.6	110.8	30.2	118.5	20.8	61.3	74.0	0.0	3.9	40.6	63.4	13.7	68.3	116.0	27.8	189.5	77.1	1.7	5.6	82.4	5.4	53.2	20.3	7.1	4.8	9.5	12.8	5.7	67.6	87.1	3.8	233.8	0.0	103.5	23.5	114.7	50.3	19.2	0.4	42.6	28.3	4.2	18.8	9.2	65.7	8.2	31.5	3.8	12.2	30.7	31.8	147.8	2.4	4.1	66.9	38.6
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179802	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"pituitary gland: 62.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 69.9;Late spermatids: 53.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078501	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA078501: AB_2732383"	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.4	0.5	0.3	0.4	0.1	0.6	0.5	1.5	1.3	0.0	0.7	0.3	1.0	1.5	0.3	1.4	0.2	0.6	0.0	0.6	0.6	1.9	0.9	0.1	1.8	0.5	2.2	0.5	0.8	62.9	0.1	2.1	0.9	0.3	0.3	0.6	0.9	0.4	0.3	0.6	0.2	0.5	0.5	0.6	7.2	1.4	0.8	0.9	0.0	0.2	0.7	0.8	0.4	0.0	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.5	1.5	0.0	0.6	1.8	0.5	2.1	0.5	1.4	0.4	0.3	0.0	1.1	0.7	0.8	1.5	2.1	0.2	1.2	2.9	0.9	0.6	4.0	1.5	0.1	0.0	0.0	0.5	0.3	0.7	0.0	0.8	69.9	0.8	0.9	1.0	4.2	0.0	8.5	0.9	0.3	1.4	0.5	1.2	6.3	1.3	0.4	1.7	0.6	10.1	4.5	0.5	0.0	0.8	1.4	53.6	1.2	0.8	3.6	1.0	1.3	2.6	2.1	1.5	0.9	0.6	0.1	1.2	0.1	1.9	0.4	0.3	0.2	2.5	0.0	4.6	1.1	9.2	13.4	0.4	1.3	0.7	0.6	0.7	0.8	1.0
MYO16	"KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107"	ENSG00000041515	"Myosin XVI"	Q9Y6X6	13	108596152-109208005	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4"	"Group enriched"	"Detected in some"	8	"Inhibitory neurons: 460.0;Oligodendrocyte precursor cells: 299.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SH-SY5Y: 4.5;U-2197: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 72.6"	"Low region specificity"	"Detected in all"			"HPA040110, HPA058769, HPA071948"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475"	"unprognostic (7.55e-3)"	"unprognostic (7.74e-3)"	"unprognostic (4.52e-4)"	"unprognostic (5.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.01e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.68e-4)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.34e-2)"	1.4	0.7	2.5	0.2	4.9	0.0	0.2	1.2	3.7	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.9	5.4	1.8	0.0	1.9	0.2	0.2	0.6	1.5	0.0	0.1	0.0	1.7	0.1	2.3	0.2	0.1	0.4	0.1	0.7	0.0	0.1	0.0	0.4	2.6	0.0	0.0	1.1	2.6	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.9	1.2	3.7	5.4	1.8	0.6	1.5	2.3	2.6	2.6	0.9	1.0	0.0	0.6	19.6	0.0	0.3	0.0	0.4	0.0	4.2	0.1	0.3	3.7	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.5	11.3	0.5	1.1	0.1	0.0	3.4	44.6	0.0	0.1	0.8	0.0	0.3	1.3	0.1	0.0	5.9	0.1	0.0	460.0	0.0	0.0	0.0	0.3	11.4	0.9	0.1	1.8	8.4	0.0	2.8	0.0	299.6	4.7	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.1	5.0	7.7	0.0	0.0	0.3	0.3	1.6	0.0	0.0
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071122-29180398	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 404.2;tongue: 124.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 33.6;Oligodendrocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019646	Supported					NA	NA		3400000	"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	9.2	4.0	16.0	7.5	36.0	12.9	10.5	13.3	28.0	13.1	0.0	16.4	14.1	15.3	2.9	19.0	10.6	10.4	95.5	11.9	18.3	5.7	20.4	7.2	6.6	37.2	27.1	7.1	14.8	8.4	5.4	4.5	38.4	10.6	5.9	3.8	15.9	5.9	404.2	20.6	14.4	7.6	8.7	6.3	14.4	5.1	35.6	4.1	7.8	124.0	4.8	12.4	14.4	56.3	29.6	40.9	15.5	8.0	4.0	7.0	24.8	13.8	13.7	11.8	8.2	10.3	20.5	3.1	15.2	10.0	17.3	33.2	6.0	23.1	4.6	34.4	11.4	2.6	12.9	11.3	6.1	3.7	3.6	8.1	13.2	7.2	3.2	19.5	4.3	12.3	37.1	5.3	5.9	10.2	10.8	2.9	3.2	60.1	9.0	37.3	17.3	9.1	9.0	21.7	8.1	8.3	13.7	45.5	9.8	10.2	10.6	4.4	5.0	7.7	9.3	5.2	9.6	10.0	18.1	5.9	9.7	2.6	20.9	0.6	0.2	0.4	0.3	0.3	0.4	0.1	0.3	0.3	0.3	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.2	0.1	16.0	36.0	13.3	28.0	11.9	18.3	37.2	27.1	38.4	8.7	35.6	56.3	14.8	12.8	7.0	13.4	5.4	1.0	1.0	0.5	10.8	7.1	3.7	3.3	33.6	2.8	8.3	1.8	10.4	0.4	2.8	8.6	0.0	2.9	1.4	1.9	4.4	8.1	2.4	9.0	13.6	1.4	2.7	4.9	21.4	2.3	1.3	15.3	2.2	5.0	1.1	1.7	13.3	4.0	0.0	0.6	1.3	0.6	2.1	6.1	0.0	9.4	2.0	2.6	2.1	14.6	38.8	4.2	5.1	3.0	6.8	1.0	5.0	1.7	1.7	4.2	0.0	4.7	2.0	1.3	1.3	9.5	0.9	0.3	5.5	3.2	4.1	1.1
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"	Q8IUG5	22	25742144-26031045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 120.8;skeletal muscle: 262.7;tongue: 55.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 95.5;Early spermatids: 61.4;Late spermatids: 37.3;Skeletal myocytes: 32.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.8"	"Region enhanced"	"Detected in single"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;REH: 15.0;RH-30: 30.5;U-2 OS: 13.2;U-266/70: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.3	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	120.8	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.8	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.0	0.0	2.7	0.0	262.7	0.5	0.0	0.0	0.2	0.0	1.5	10.2	2.3	1.9	0.1	55.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	5.3	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.0	4.0	0.0	0.4	1.6	0.0	0.0	0.0	15.0	30.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.0	0.0	9.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.3	0.8	0.3	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.2	1.2	0.0	0.0	1.8	0.0	0.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495636-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	7.8	5.5	2.3	7.1	2.6	13.1	8.0	2.3	3.0	11.3	3.5	11.7	13.0	7.3	5.2	22.1	7.5	4.9	5.6	2.3	2.4	13.5	11.1	7.8	5.7	3.0	2.4	6.8	13.2	17.0	9.5	6.4	3.2	7.9	14.6	2.1	15.4	3.9	8.5	24.2	13.0	7.2	2.2	8.4	14.4	9.6	2.9	6.4	9.4	4.5	10.0	7.3	14.5	3.1	41.6	47.3	21.7	25.1	10.1	12.5	32.5	34.0	27.0	53.2	57.9	42.6	46.4	21.9	15.6	23.3	20.0	66.5	48.0	38.3	36.8	18.9	24.0	30.6	58.8	29.4	8.4	36.5	40.0	6.9	20.2	41.6	40.8	13.5	22.2	29.7	46.5	24.2	28.2	28.9	25.3	29.4	23.9	44.1	20.4	32.8	30.7	28.4	27.7	32.3	37.9	18.5	44.9	31.7	15.4	30.3	55.2	17.6	15.9	32.8	41.1	47.5	65.3	19.8	41.4	21.3	22.8	24.7	44.5	0.5	0.6	0.4	1.1	0.4	0.9	0.6	0.7	1.1	1.2	0.5	0.6	1.2	0.0	1.4	0.2	0.6	0.6	0.4	2.3	2.6	2.3	3.0	2.3	2.4	3.0	2.4	3.2	2.2	2.9	3.1	13.1	9.6	12.0	23.8	12.3	29.6	12.3	14.4	23.9	18.4	11.0	12.3	4.4	17.2	8.6	5.5	35.5	12.0	9.6	24.4	1.9	10.7	81.4	10.6	12.7	10.6	10.8	24.6	25.8	13.3	21.6	9.6	23.9	16.7	2.5	20.4	6.8	9.5	10.9	3.3	36.4	23.5	14.2	7.9	10.1	20.8	12.5	7.8	3.6	10.3	11.0	3.9	15.5	22.6	24.4	16.4	13.9	9.8	19.4	26.4	23.0	4.4	6.4	24.8	0.0	13.3	9.0	19.7	19.4	29.1	23.4	7.3	13.0	9.9	32.5	16.3
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 330.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 8.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.1	0.4	0.1	0.1	0.8	0.2	0.0	0.7	68.3	330.0	0.4	0.0	0.2	0.1	4.1	0.0	0.1	0.2	0.1	0.1	0.2	0.3	2.1	2.0	0.0	0.2	0.0	0.1	0.2	1.8	0.1	65.7	0.1	0.0	0.2	0.1	0.1	309.8	3.0	3.7	0.1	16.3	1.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.2	0.1	0.2	2.1	2.0	1.8	3.7	0.6	8.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 255.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	42.9	7.3	9.2	15.4	7.8	0.6	27.4	3.5	11.4	13.3	5.8	23.7	13.2	16.2	16.6	15.9	9.2	26.7	19.1	7.1	5.3	25.6	255.5	74.9	11.3	4.2	8.9	14.0	49.3	34.6	5.8	48.4	6.0	15.1	22.0	21.5	12.8	17.7	9.2	15.3	13.4	20.1	3.9	8.2	12.2	9.6	13.2	17.4	19.3	13.6	10.5	25.4	14.3	6.7	102.5	51.7	82.6	24.9	22.4	95.0	74.6	190.8	93.9	129.0	127.4	63.9	8.9	0.1	31.0	220.5	52.1	221.0	27.4	164.3	161.1	0.3	23.9	0.2	22.6	82.3	52.1	2.2	0.6	38.6	111.1	135.0	360.0	47.6	23.8	42.4	0.2	0.4	120.7	43.5	39.7	12.4	53.9	6.7	81.2	50.5	52.6	7.7	51.0	42.8	41.8	109.0	64.5	11.1	57.9	70.2	10.1	3.1	29.1	122.7	61.5	75.0	22.7	0.9	0.5	1.1	74.4	0.4	69.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	7.8	3.5	11.4	7.1	5.3	4.2	8.9	6.0	3.9	13.2	6.7	95.8	330.2	112.5	1.6	3.6	76.7	58.2	78.7	31.9	1.4	29.0	22.9	7.9	45.8	84.3	69.9	0.0	5.2	0.8	30.4	0.0	120.4	2.9	13.0	20.2	60.5	58.5	10.7	22.3	44.6	26.5	40.3	18.3	18.1	3.8	129.1	5.0	414.2	4.2	0.0	38.0	24.6	34.6	10.5	10.0	3.8	5.0	2.3	26.6	70.3	1.0	72.2	0.0	1.0	0.8	38.1	54.1	9.1	0.4	112.2	4.5	1.2	48.2	2.7	203.8	32.6	160.1	2.4	21.0	13.9	28.1	3.4	3.3	44.9	38.0	47.1
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492686	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		3800000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	169.3	27.0	12.4	34.4	11.8	4.9	115.9	13.3	12.7	77.4	17.1	104.9	47.4	97.1	21.5	64.7	66.4	46.1	97.5	10.2	14.7	56.8	39.5	87.2	24.1	14.8	11.2	43.6	69.3	34.3	22.9	56.9	14.6	69.9	41.7	2.1	91.7	58.2	49.5	57.7	65.6	65.7	11.9	30.8	76.3	17.1	13.7	21.3	60.6	35.8	25.1	86.3	67.8	10.8	169.8	182.1	19.3	79.5	88.8	87.6	74.2	168.6	138.9	108.7	91.0	122.3	90.7	16.9	118.7	261.1	72.7	139.9	29.2	117.2	56.3	75.2	74.5	16.2	96.4	46.2	131.7	1.6	81.5	68.7	57.3	100.2	57.3	99.5	141.7	10.5	13.1	13.7	93.5	129.5	1.9	1.4	12.4	105.8	34.0	6.9	26.4	30.7	100.5	86.9	7.8	43.0	105.9	152.6	67.4	47.5	125.3	8.7	187.9	156.6	119.1	77.7	147.8	10.7	9.1	7.2	124.7	4.1	138.8	0.1	0.9	0.0	0.9	2.0	0.4	4.8	2.1	0.9	1.1	3.8	0.7	0.4	0.5	0.0	1.7	1.0	1.9	1.5	12.4	11.8	13.3	12.7	10.2	14.7	14.8	11.2	14.6	11.9	13.7	10.8	133.7	125.0	35.9	5.5	20.8	39.8	38.2	27.8	31.9	4.1	44.0	33.0	75.4	48.6	36.3	86.5	0.0	57.8	2.5	159.0	21.5	62.3	17.4	26.3	44.4	78.0	39.5	13.5	2.5	52.0	28.4	51.8	66.3	75.5	12.0	25.4	83.6	38.5	20.0	5.0	3.8	111.8	14.2	14.5	43.4	11.4	42.3	16.7	64.0	15.0	20.3	5.6	0.0	2.5	1.0	92.8	88.7	48.5	12.8	64.7	92.8	15.4	12.9	2.1	118.3	37.7	90.6	9.4	7.5	39.5	42.6	47.6	10.0	10.6	88.1	39.2
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 111.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 193.1;Excitatory neurons: 201.4;Oligodendrocytes: 578.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.7;CACO-2: 148.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA054744: AB_2682589"	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.53e-6)"	37.7	27.5	10.4	15.6	27.3	3.7	21.0	24.1	15.5	25.5	12.7	111.2	84.4	21.0	22.3	36.0	16.6	31.3	13.2	10.7	13.0	27.1	14.3	31.9	6.3	26.5	22.3	24.6	26.2	27.2	12.3	13.9	25.0	17.8	91.6	1.7	33.1	13.0	5.5	40.6	83.7	18.2	18.5	9.5	26.7	9.8	22.4	7.0	41.0	3.6	14.3	24.6	25.8	52.9	32.3	1.5	0.9	0.3	105.7	60.0	1.2	18.9	36.5	3.4	20.9	148.0	50.0	18.2	3.9	83.7	0.8	29.6	3.8	47.0	5.3	2.3	38.6	16.5	0.1	10.5	6.8	0.0	8.6	17.3	29.3	26.7	24.0	0.4	45.8	9.5	28.2	28.9	16.3	38.6	0.1	0.5	5.8	36.2	28.0	0.0	21.1	21.0	14.6	61.8	36.3	6.2	6.4	11.4	93.2	9.1	50.1	0.2	57.2	16.3	8.2	0.6	0.4	35.2	43.4	0.2	21.6	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	10.4	27.3	24.1	15.5	10.7	13.0	26.5	22.3	25.0	18.5	22.4	52.9	14.3	22.4	13.1	5.5	8.4	8.0	10.1	11.7	26.2	0.9	8.8	8.4	5.0	20.0	12.9	23.9	18.8	19.4	2.7	193.1	5.9	20.8	126.0	7.2	2.8	12.3	26.5	8.2	201.4	23.8	3.1	11.4	30.1	21.3	1.3	24.5	3.9	11.0	8.8	0.0	28.9	93.4	10.2	1.6	8.2	37.6	5.9	4.4	16.0	18.7	0.3	1.2	4.1	9.0	578.3	46.4	94.4	18.4	42.8	18.7	126.5	2.5	25.2	0.9	6.6	5.3	22.8	20.5	7.2	25.4	11.2	12.4	5.7	9.8	81.7	23.3
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372871	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 319.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 224.1;HaCaT: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	30.6	7.1	19.4	32.9	34.9	1.8	19.5	32.2	30.7	27.7	43.6	54.3	25.3	31.0	29.6	37.6	17.4	38.7	13.3	19.6	24.9	47.7	52.2	19.9	36.9	38.6	35.0	10.3	12.0	22.4	9.3	34.7	39.4	22.9	34.4	9.9	18.7	21.6	11.9	45.6	44.2	22.2	28.4	17.1	32.5	8.3	33.1	7.6	15.2	10.9	41.2	38.1	28.1	57.1	133.3	224.1	12.1	8.2	92.4	74.8	62.2	52.9	25.7	28.8	33.6	55.7	50.5	52.7	37.0	41.3	117.5	208.6	18.9	81.5	38.2	24.1	10.5	0.5	178.4	50.3	85.5	0.3	7.2	103.4	48.8	37.0	107.4	90.7	47.8	0.9	0.3	0.8	49.2	12.4	0.6	1.2	29.3	21.5	49.8	0.2	53.8	32.4	156.9	61.8	6.5	21.9	117.1	24.2	45.8	36.5	16.3	5.8	58.4	57.5	16.6	177.1	52.0	0.3	3.3	1.3	105.4	0.6	53.2	0.0	4.5	0.0	0.2	4.6	0.0	9.2	0.0	0.0	15.4	8.6	0.0	0.0	0.6	3.6	1.6	23.7	0.5	2.5	19.4	34.9	32.2	30.7	19.6	24.9	38.6	35.0	39.4	28.4	33.1	57.1	31.0	6.4	7.7	27.1	19.6	24.9	40.0	24.7	24.5	0.2	9.3	10.2	3.9	17.2	15.4	25.8	0.0	4.3	19.9	73.6	3.9	39.8	4.2	49.4	30.2	30.4	19.7	2.5	9.3	18.1	23.8	14.9	86.6	47.3	4.5	6.7	5.0	13.0	33.5	0.0	8.7	31.2	8.2	5.0	50.1	8.5	9.3	17.6	19.6	56.2	9.0	11.3	3.1	6.6	319.1	64.0	60.0	12.0	9.2	28.3	37.4	3.1	40.9	0.9	13.1	33.7	25.0	1.3	5.1	30.1	24.0	12.9	4.7	6.7	29.3	56.9
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYO1H	FLJ37587	ENSG00000174527	"Myosin IH"		12	109347903-109455523	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 3.8;Early spermatids: 5.0;Endometrial ciliated cells: 1.6;Late spermatids: 3.5;Skeletal myocytes: 1.4;Spermatogonia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA039516	Uncertain					NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039516: AB_10794198"	"unprognostic (1.92e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.07e-7)"	"unprognostic (7.13e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.52e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.0	1.6	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.1	0.5	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 14.1;kidney: 5.3;parathyroid gland: 8.8;retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 85.5;Early spermatids: 34.2;Inhibitory neurons: 18.3;Late spermatids: 29.6;Rod photoreceptor cells: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 11.2;HEL: 8.8;RT4: 11.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 5.2"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	14.1	0.4	0.6	0.1	0.0	0.0	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.3	0.0	0.0	0.0	0.0	5.8	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.4	1.3	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	11.2	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.3	0.6	0.5	0.3	0.0	3.1	0.2	0.3	0.7	0.0	0.5	3.7	85.5	0.0	0.6	0.1	13.7	0.3	34.2	5.3	0.4	0.3	1.8	0.0	1.8	0.0	0.0	0.8	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	18.3	0.6	0.0	0.3	1.1	29.6	0.3	0.2	0.0	1.9	0.0	3.0	0.0	5.5	2.9	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	51.0	0.0	1.7	0.5	1.5	0.8	0.3	0.4	0.1	0.3	0.3	0.0	0.1
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 201.0;RPMI-8226: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	10.3	8.3	17.0	12.1	20.8	21.8	6.5	3.0	39.1	6.8	0.0	6.1	3.8	5.0	3.7	5.3	4.0	8.5	5.8	19.0	3.6	5.3	2.9	8.8	15.0	9.6	4.2	5.7	5.2	47.4	8.9	6.3	9.8	5.1	5.9	26.1	5.2	3.5	5.4	11.8	5.0	9.4	0.0	9.5	4.7	5.9	6.6	11.0	8.4	5.0	13.1	9.7	5.3	20.8	19.5	33.7	17.6	21.3	16.2	19.3	19.0	34.7	31.1	18.1	14.0	3.2	7.8	18.7	8.9	41.8	26.5	15.7	40.7	35.6	22.3	105.5	9.6	16.7	8.8	4.2	8.3	9.0	16.3	13.0	21.9	26.6	52.4	17.6	106.8	12.0	0.7	201.0	34.8	34.4	8.2	1.2	8.1	0.5	26.6	14.5	27.8	140.8	15.1	14.0	12.7	7.8	32.3	26.2	59.4	13.1	14.0	9.1	52.0	36.4	15.7	17.1	34.1	20.9	49.9	22.0	39.4	25.1	53.5	0.4	2.4	3.1	1.4	1.7	2.1	1.1	1.3	0.9	2.7	0.7	0.2	0.4	3.0	0.3	1.4	1.5	2.2	1.1	17.0	20.8	3.0	39.1	19.0	3.6	9.6	4.2	9.8	0.0	6.6	20.8	11.2	12.8	11.4	68.2	19.8	20.8	9.3	10.5	7.4	75.1	6.7	5.5	12.1	2.8	19.8	14.7	39.6	0.6	18.4	0.3	0.0	5.4	18.0	9.3	8.0	12.7	1.2	2.5	353.0	6.3	0.4	7.5	3.1	6.7	22.8	5.0	2.5	1.3	24.4	26.9	241.0	0.2	2.0	27.1	28.0	10.8	3.7	50.2	97.8	52.5	36.7	6.0	15.5	330.8	404.2	6.1	2.5	1.9	32.4	10.2	0.0	2.8	11.1	28.7	6.6	16.7	10.8	14.0	9.4	3.9	11.6	1.1	23.7	2.1	0.3	7.3
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822789-50195147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 147.3;Inhibitory neurons: 90.5;Pancreatic endocrine cells: 106.6;Proximal enterocytes: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 65.5;HaCaT: 100.3;RH-30: 152.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	3.2	1.7	1.0	7.9	3.3	0.1	13.7	0.5	3.6	17.7	15.9	45.3	60.2	2.6	18.5	37.4	12.2	11.3	2.7	4.4	10.4	19.7	18.7	11.9	2.6	0.5	3.4	0.5	16.6	23.0	13.4	3.8	1.6	10.1	43.6	40.9	25.4	7.1	0.4	27.4	62.0	3.1	0.4	1.7	33.3	11.4	1.9	3.1	29.4	0.2	13.0	14.2	21.6	1.4	65.5	17.3	0.3	0.3	0.0	0.0	34.0	0.3	2.6	1.4	0.1	45.8	27.2	0.1	15.6	0.1	5.0	100.3	22.6	27.3	1.3	0.2	6.9	0.2	7.5	32.8	0.0	0.2	0.2	0.0	23.6	0.6	16.2	5.1	2.3	0.3	0.5	24.7	2.7	25.3	0.0	0.2	4.6	37.8	7.0	0.0	152.5	11.0	56.8	13.2	33.7	0.7	24.4	28.3	0.0	8.6	16.8	0.2	1.5	0.0	34.0	0.4	6.8	16.7	11.2	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	3.3	0.5	3.6	4.4	10.4	0.5	3.4	1.6	0.4	1.9	1.4	0.1	54.5	15.8	2.6	1.6	0.4	9.0	7.9	2.2	7.7	14.3	7.7	3.5	15.7	21.5	7.3	10.4	4.4	0.3	147.3	5.9	49.0	22.4	38.5	3.1	1.1	6.7	5.3	4.4	47.3	1.1	3.7	48.4	29.1	0.0	27.1	0.0	18.4	0.9	0.0	90.5	35.4	2.0	1.3	0.8	4.5	0.9	1.0	3.6	3.7	2.0	31.9	0.0	2.0	9.0	106.6	70.7	0.7	1.4	60.1	177.6	18.9	38.1	30.2	0.0	0.9	2.3	9.5	6.7	8.3	6.5	4.7	0.7	0.1	46.7	56.2
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295804	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159"	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favorable (2.47e-5)"	"prognostic favorable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.1	1.5	3.0	2.8	3.3	0.8	13.2	7.9	3.1	14.1	17.0	14.0	5.3	4.2	12.8	7.0	11.5	6.9	1.6	2.6	2.9	5.6	3.4	13.8	1.9	5.1	2.8	1.6	27.3	13.7	7.3	2.5	6.3	10.3	17.7	1.6	21.1	4.4	2.1	4.8	5.1	4.0	7.3	3.5	19.4	4.7	3.3	1.9	17.9	2.6	2.4	4.4	4.4	5.9	21.4	25.4	3.5	0.0	0.0	0.1	3.0	0.0	0.3	0.1	0.0	3.9	8.8	1.2	5.3	0.1	0.2	3.4	5.3	7.4	0.0	1.1	8.4	0.1	17.3	15.7	0.0	0.0	0.2	0.0	7.2	0.0	6.8	3.6	5.6	0.9	0.0	0.3	0.1	46.3	1.3	0.2	1.4	41.2	12.0	17.6	2.1	10.6	19.5	26.4	3.5	3.9	1.6	34.0	0.0	5.4	40.9	0.0	0.0	0.0	0.2	0.0	3.3	0.7	0.7	2.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.0	3.3	7.9	3.1	2.6	2.9	5.1	2.8	6.3	7.3	3.3	5.9	68.5	131.4	84.5	3.9	1.5	0.6	20.5	10.2	2.2	0.4	22.4	10.9	4.9	18.6	47.1	22.0	0.0	2.3	0.3	26.5	3.9	21.1	2.8	34.1	4.8	26.1	5.4	2.1	29.3	29.6	1.5	3.7	41.3	50.4	3.8	5.1	2.5	5.1	0.9	0.0	3.9	47.1	22.4	0.8	3.1	3.2	1.8	1.4	7.2	14.0	0.1	5.6	1.0	8.0	2.8	39.0	21.5	0.4	2.7	28.1	2.1	1.3	49.8	0.5	0.0	1.3	1.5	9.0	5.9	14.1	1.4	0.7	1.6	2.0	25.8	38.7
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128246-77215241	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 41.9;choroid plexus: 53.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.6;intermediate monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB034059	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB034059: AB_2148626"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.2	41.9	2.5	3.0	2.9	1.0	3.1	2.2	2.7	1.9	53.2	2.8	2.2	1.5	1.2	1.0	2.7	2.8	2.5	4.0	8.6	4.3	23.3	2.3	2.9	5.0	8.3	5.2	5.4	0.5	19.1	16.0	8.4	2.4	1.2	27.4	1.5	0.8	1.4	0.8	2.8	2.2	3.5	15.8	2.2	24.5	5.1	1.4	2.0	0.7	1.1	2.0	1.6	4.4	0.0	1.3	0.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	9.0	2.0	0.0	2.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	5.7	0.2	0.4	0.0	0.1	0.0	0.0	0.5	0.0	3.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.3	0.0	19.5	13.8	0.0	0.3	2.9	0.9	0.1	10.5	0.1	2.2	1.3	1.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	2.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	2.5	2.9	2.2	2.7	4.0	8.6	5.0	8.3	8.4	3.5	5.1	4.4	1.7	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	14.2	0.5	0.5	4.4	4.3	0.0	0.0	47.9	42.3	0.3	0.2	0.0	0.6	1.9	0.1	0.5	2.2	1.2	0.0	0.7	1.7	10.5	1.4	5.6	0.3	0.0	0.8	16.4	16.1	30.1	0.0	0.8	0.7	0.0	17.8	0.9	6.4	3.1	7.3	0.0	6.5	0.8	17.0	0.0	3.0	0.1	0.7	0.2	0.4	0.1	0.1	1.7	2.7	0.1	31.4	0.0	5.2	0.3	0.4	0.6	0.1	0.3	16.1	1.4	3.2	0.6	0.2
MYO7B		ENSG00000169994	"Myosin VIIB"	Q6PIF6	2	127535802-127637729	"Predicted intracellular proteins"	Differentiation	"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 113.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 127.7;Intestinal goblet cells: 48.3;Paneth cells: 74.9;Proximal enterocytes: 151.4;Undifferentiated cells: 45.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7;naive B-cell: 5.9"	"Group enriched"	"Detected in many"	22	"B-cells: 5.9;dendritic cells: 2.6;monocytes: 5.7"	"Cell line enriched"	"Detected in some"	10	"MOLT-4: 286.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039131	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA039131: AB_10672771"	"unprognostic (4.10e-3)"	"unprognostic (3.81e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.80e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.88e-1)"	0.1	0.0	0.2	4.9	0.2	6.5	0.1	0.2	0.3	0.0	0.0	35.9	113.2	0.0	6.7	0.3	0.4	13.0	0.2	0.7	1.8	8.5	0.3	1.0	4.0	0.5	1.1	0.0	0.2	0.0	0.0	1.7	1.1	0.1	25.3	0.0	0.1	0.2	0.8	0.3	84.4	1.2	0.5	11.3	0.4	1.4	0.3	9.0	0.2	0.0	1.6	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	14.5	5.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.2	0.0	28.1	0.0	0.0	0.2	0.0	286.1	0.8	0.0	0.5	1.7	0.5	1.9	0.3	0.5	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.1	0.5	0.1	0.6	8.6	0.4	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.1	0.0	2.2	0.0	0.8	0.0	0.0	2.6	5.9	0.0	0.2	0.1	0.0	1.4	0.7	0.0	2.4	0.2	0.2	0.2	0.3	0.7	1.8	0.5	1.1	1.1	0.5	0.3	0.8	2.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	12.8	0.0	5.5	0.0	0.1	1.5	127.7	1.9	0.2	0.1	0.0	0.0	1.0	25.8	0.0	0.2	0.2	2.0	0.1	1.5	0.0	0.0	0.1	2.9	0.2	0.1	0.0	0.4	48.3	0.0	0.0	0.3	0.4	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	1.6	74.9	0.0	0.0	0.0	151.4	9.9	0.0	0.0	0.0	2.8	0.1	0.6	1.1	0.0	0.1	0.3	0.6	0.0	45.7	0.1
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822291-72118577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 61.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.5;Inhibitory neurons: 192.9;Rod photoreceptor cells: 462.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	6.5	3.9	11.3	4.8	14.9	4.8	10.7	14.3	13.3	8.7	2.5	7.1	2.1	9.9	7.4	7.7	7.2	5.2	6.7	12.8	9.2	13.7	3.7	8.8	6.4	8.7	8.0	12.1	3.3	7.4	4.7	7.6	9.2	8.0	6.3	61.7	4.5	7.5	8.1	8.7	4.6	10.2	6.7	7.3	5.2	28.7	9.5	6.7	13.2	14.9	6.4	6.5	6.1	13.5	9.7	14.6	9.6	6.8	14.2	16.5	5.7	9.1	9.8	9.0	9.1	7.1	6.6	43.3	5.4	17.9	11.8	9.0	19.2	10.3	11.9	9.5	11.1	11.1	8.9	3.2	9.0	11.2	8.5	9.5	10.2	10.6	15.2	7.6	11.5	7.7	7.2	10.3	12.2	6.0	6.4	4.5	5.2	3.5	5.9	4.6	18.2	4.3	10.9	14.3	5.4	5.9	12.0	10.0	9.5	11.6	8.0	5.3	15.5	18.0	8.7	29.7	10.4	6.5	17.3	11.3	10.8	9.2	8.1	1.7	1.5	3.7	3.6	1.4	4.9	3.1	3.5	3.0	1.6	4.0	3.6	3.4	0.2	2.8	2.6	6.3	3.1	0.9	11.3	14.9	14.3	13.3	12.8	9.2	8.7	8.0	9.2	6.7	9.5	13.5	37.0	115.4	77.4	145.6	18.4	20.9	22.2	12.4	20.5	56.3	26.2	25.0	35.5	5.7	24.1	29.5	54.2	11.9	30.2	21.1	17.6	6.1	131.8	27.9	47.3	29.6	12.6	19.6	225.5	8.0	11.3	35.6	15.8	41.2	10.1	53.1	22.1	5.7	9.0	53.8	192.9	9.7	8.2	54.8	10.0	161.9	38.8	17.7	23.2	113.4	13.0	24.0	14.4	177.0	180.2	10.9	15.5	42.9	12.2	25.0	10.4	14.1	28.3	462.1	19.7	54.9	32.6	115.2	41.8	18.4	23.9	12.0	18.5	17.0	12.8	15.7
MYO9B	CELIAC4	ENSG00000099331	"Myosin IXB"	Q13459	19	17075781-17214537	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 204.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037190, HPA042043"	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB037190: AB_477214, HPA042043: AB_10796897"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.53e-2)"	41.0	43.6	38.6	52.6	53.3	98.9	32.3	46.7	56.7	44.9	32.6	45.3	17.5	44.5	12.4	32.9	30.3	20.6	37.2	39.2	46.8	26.9	39.1	78.2	60.3	60.3	53.5	22.5	26.4	6.9	25.6	21.3	56.4	46.1	14.8	40.2	28.3	13.5	12.7	29.6	62.0	17.4	45.8	158.1	36.2	64.2	61.3	33.1	26.3	5.1	35.9	48.1	41.5	77.6	55.6	25.4	33.2	38.9	23.7	24.7	95.7	51.6	26.4	31.8	27.8	20.5	27.7	51.4	28.0	45.5	28.4	34.3	14.2	25.2	23.9	92.4	29.4	62.1	31.2	19.7	30.2	49.1	95.8	22.8	13.0	44.1	17.1	19.5	33.6	22.5	25.9	34.1	22.2	23.1	66.8	90.8	25.0	17.8	55.4	72.3	24.9	14.8	12.6	46.4	11.3	25.3	32.1	25.2	67.8	17.8	25.0	50.7	65.7	58.9	26.2	92.1	44.1	48.7	33.6	32.8	58.2	63.4	75.0	4.5	3.2	6.1	2.7	4.0	1.7	2.8	2.0	2.2	1.9	2.4	1.3	1.9	12.2	2.6	2.6	3.7	3.5	2.0	38.6	53.3	46.7	56.7	39.2	46.8	60.3	53.5	56.4	45.8	61.3	77.6	20.5	9.6	23.0	17.0	47.2	19.6	70.3	9.9	10.8	11.9	15.3	13.7	10.3	11.5	10.7	5.5	204.3	17.3	43.5	34.2	1.9	7.8	6.0	14.5	45.3	28.9	7.2	19.8	36.0	7.7	24.8	22.2	35.7	28.1	22.1	24.1	23.2	15.8	74.8	8.4	26.0	14.8	8.2	68.5	91.0	13.6	12.5	103.6	44.4	49.6	65.4	11.1	66.9	40.7	112.8	12.4	18.2	17.0	37.2	40.7	10.9	3.2	9.6	98.8	6.6	16.1	24.6	8.5	14.3	10.5	18.0	14.4	47.0	18.9	17.1	46.9
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652688	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 110.8"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 244.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	47.1	1.1	0.0	0.0	0.0	0.0	19.2	0.2	0.0	1.8	0.0	13.0	3.5	16.5	4.9	19.6	15.3	1.5	18.3	0.0	0.1	0.2	0.1	7.4	0.1	0.5	0.1	1.3	3.0	0.1	0.2	0.2	0.2	5.3	3.5	0.0	14.0	6.4	33.8	4.7	4.8	2.9	0.0	0.0	50.2	1.4	0.1	14.1	28.7	110.8	0.2	22.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.1	0.1	12.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.1	3.1	0.0	0.0	0.1	0.0	0.0	244.4	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	1.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	2.4	0.1	0.0	0.0	0.0	0.0	0.0	15.1	6.3	0.1	0.1	1.1	0.0	0.0	1.1	0.2	0.0	0.0
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.2	1.0	0.4	4.3	0.7	0.0	1.2	0.3	0.8	9.4	1.6	24.2	2.6	13.0	2.4	13.1	8.5	4.6	14.2	0.4	0.4	0.7	0.2	2.7	0.1	0.5	0.5	4.4	0.3	0.1	0.2	3.4	0.8	8.8	4.9	0.0	0.2	20.7	0.5	1.3	5.1	15.8	0.5	0.6	6.1	2.1	0.8	0.1	0.7	0.8	0.1	17.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.8	0.4	0.4	0.5	0.5	0.8	0.5	0.8	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	47.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.0	48.5	1.2	7.8	0.0	1.2	0.2	0.1	3.6	0.0	1.0	0.0	8.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.5	0.6	0.2	0.0	9.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	100.8	0.0	0.1	0.0	0.1	0.0	0.0	26.3	0.2	32.9	0.3	0.8	0.1	0.9	0.5	0.4	6.0	0.0	0.1
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482334	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 20.4;non-classical monocyte: 26.6"	"Group enriched"	"Detected in many"	57	"dendritic cells: 8.1;monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 452.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	31.7	8.1	2.9	20.6	4.1	1.5	43.3	5.0	2.5	56.4	37.4	22.4	5.3	27.5	7.1	36.4	36.9	26.6	13.8	3.4	4.1	10.9	2.9	32.2	4.4	8.9	6.8	9.8	5.9	23.8	3.8	55.2	8.1	27.5	29.3	0.9	19.7	31.4	3.6	56.1	9.0	44.3	6.2	6.5	13.4	2.2	5.4	5.1	35.7	6.2	9.1	62.0	29.4	6.2	228.9	206.3	21.4	14.6	159.4	318.4	62.0	190.3	452.7	110.1	109.2	51.1	177.1	0.0	76.9	353.7	116.2	350.0	1.8	204.7	82.6	1.4	0.9	0.0	80.8	2.1	55.2	0.0	0.2	183.0	71.6	77.7	323.8	289.4	299.7	0.0	0.0	0.5	275.6	39.4	0.1	0.9	1.6	72.0	171.6	0.0	15.8	0.1	314.3	281.5	0.1	0.0	130.4	29.7	46.1	83.1	141.5	4.7	378.5	167.3	11.8	111.3	113.9	0.2	0.3	0.3	128.2	2.6	201.0	0.0	5.4	0.0	0.0	20.4	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	26.6	2.8	0.2	1.6	2.9	4.1	5.0	2.5	3.4	4.1	8.9	6.8	8.1	6.2	5.4	6.2	42.5	60.9	52.5	1.6	1.2	23.7	63.0	101.4	39.3	0.1	48.4	34.3	9.2	14.3	91.5	22.0	0.0	56.6	3.8	74.1	1.9	54.8	0.6	50.9	45.9	28.8	1.8	0.0	2.7	33.7	23.7	38.1	23.0	123.4	1.3	1.7	35.7	0.4	22.9	0.0	0.8	29.6	42.7	29.2	20.2	0.6	5.9	28.5	8.8	60.0	12.8	0.1	0.0	2.0	0.7	153.7	22.2	9.1	0.8	86.7	0.6	1.5	60.7	0.8	6.6	15.9	39.6	0.1	0.3	53.4	30.7	51.2	1.9	8.3	18.7	100.7
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 412.8;skeletal muscle: 845.6;tongue: 435.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.1	2.2	7.5	1.3	9.0	0.6	4.1	7.8	6.4	3.0	3.4	14.1	1.9	6.4	2.9	14.1	6.8	14.6	412.8	5.7	11.5	1.5	24.7	1.5	1.3	11.1	12.0	2.9	11.5	0.4	1.6	1.6	11.3	12.4	2.4	2.0	5.3	4.5	845.6	1.6	4.6	11.9	8.6	0.9	3.2	5.7	8.0	0.8	2.8	435.6	0.7	7.6	2.4	8.6	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.5	9.0	7.8	6.4	5.7	11.5	11.1	12.0	11.3	8.6	8.0	8.6	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
MYOM2		ENSG00000036448	"Myomesin 2"	P54296	8	2045046-2165552	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 342.6;skeletal muscle: 387.9"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 632.6;dendritic cells: 234.9;NK-cells: 268.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEK 293: 5.3;SCLC-21H: 2.2;U-266/84: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001765, HPA005953"	Enhanced		Approved	Mitochondria		NA	NA		290000		"Cluster 38: Heart - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA001765: AB_1079443, HPA005953: AB_1854258"	"unprognostic (2.81e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.30e-5)"	"unprognostic (1.10e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.14e-1)"	0.1	0.2	0.3	0.1	1.1	0.2	6.1	1.8	1.6	0.2	0.0	0.6	0.2	0.3	0.7	1.2	0.3	0.1	342.6	1.0	0.0	2.7	0.4	0.7	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.3	0.0	3.7	0.1	0.4	1.9	0.6	387.9	0.8	0.4	0.4	0.0	2.2	0.3	0.4	0.1	0.0	0.1	62.4	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.8	1.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	3.7	6.4	3.0	11.8	1.6	3.6	2.7	2.0	1.2	3.2	2.7	5.1	632.6	20.0	1.0	3.7	0.0	0.0	234.9	1.8	13.7	4.6	15.2	2.7	1.8	5.6	0.0	3.6	21.8	1.7	0.1	26.7	0.5	1.9	5.7	1.5	4.6	6.8	1.4	6.7	2.8	2.1	2.0	2.7	5.1	8.3	0.6	4.8	3.6	3.7	3.0	7.3	268.8	1.5	2.0	2.5	0.8	1.5	11.1	1.2	1.2	26.0	5.3	4.8	0.0	11.6	13.9	55.9	21.4	1.3	2.8	0.1	22.3	1.5	1.2	1.4
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366666-34376898	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	8.1	6.2	30.6	3.4	30.3	2.0	3.4	27.1	31.5	1.7	16.8	19.0	27.3	2.7	1.9	5.3	4.5	6.1	3.9	28.4	28.2	14.5	41.5	3.2	1.5	34.0	33.5	1.0	11.1	1.5	5.5	19.8	28.7	3.2	16.2	3.4	5.6	5.2	84.2	3.7	25.8	4.4	24.5	1.4	15.0	1.3	31.8	1.1	1.9	39.2	1.8	3.1	2.4	24.2	8.1	5.5	9.2	5.6	3.8	1.2	19.7	1.4	1.1	0.8	1.3	13.9	8.3	4.4	15.9	1.4	4.0	16.4	6.7	15.5	1.1	1.4	3.6	0.8	24.6	35.4	0.5	0.8	2.7	1.8	7.2	2.6	3.0	4.3	3.8	3.3	1.1	4.2	2.0	13.4	2.5	1.2	5.5	27.4	4.4	4.0	4.6	1.3	4.9	2.9	1.3	13.0	10.8	56.8	0.9	7.8	52.8	1.3	3.2	1.8	11.0	1.6	3.5	2.8	6.5	1.6	1.6	3.1	1.6	0.4	0.1	0.2	0.7	0.1	0.5	0.2	0.4	0.4	0.0	0.2	0.2	0.3	0.3	0.4	0.1	0.1	0.6	0.1	30.6	30.3	27.1	31.5	28.4	28.2	34.0	33.5	28.7	24.5	31.8	24.2	3.9	9.6	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	2.5	3.7	0.0	55.5	0.3	0.0	1.9	5.7	0.0	3.4	0.7	2.1	0.0	0.0	0.0	11.8	3.6	1.1	0.0	2.0	1.3	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	9.2	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	17.4	0.3	0.1	0.0	0.0
MYOT	"LGMD1, LGMD1A, TTID"	ENSG00000120729	Myotilin	Q9UBF9	5	137867858-137887851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"skeletal muscle: 2183.8;tongue: 2038.6"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 40.9;Skeletal myocytes: 42.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037733, HPA037734"	Enhanced					NA	NA		9100		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA037733: AB_10697082, HPA037734: AB_2675638"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.85e-4)"	"unprognostic (8.03e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.56e-4)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	0.8	1.7	5.7	1.4	9.3	0.0	0.8	5.8	9.8	3.3	3.9	8.0	2.1	0.4	0.5	34.6	0.7	0.7	17.0	5.4	5.8	0.9	0.4	0.2	0.1	6.2	7.2	0.4	0.4	1.1	0.5	0.0	6.0	20.0	1.6	0.5	19.4	3.7	2183.8	1.0	3.1	1.0	5.3	0.6	1.9	0.2	6.8	0.2	1.0	2038.6	0.3	2.3	3.7	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	9.3	5.8	9.8	5.4	5.8	6.2	7.2	6.0	5.3	6.8	7.8	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.0	1.2	0.0	0.0	0.1	40.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	0.0	2.3	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.5	3.6	0.0	0.0	0.0	0.0	2.0	8.2	0.0	0.1	0.0	0.1	0.3	0.3	0.2	0.1	0.8	0.0	42.0	1.3	0.2	0.2	0.2	0.0	0.0	0.3	0.1	0.5	0.1
MYOZ1	"CS-2, FATZ, MYOZ"	ENSG00000177791	"Myozenin 1"	Q9NP98	10	73631612-73641474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	82	"skeletal muscle: 7134.0;tongue: 3308.1"	"Cell type enriched"	"Detected in some"	11	"Skeletal myocytes: 144.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BEWO: 44.6"	"Region enriched"	"Detected in single"	17	"olfactory bulb: 3.9"	"Low region specificity"	"Detected in all"			"HPA037848, HPA038437"	Enhanced					NA	NA		71000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA037848: AB_10670156, HPA038437: AB_2676009"	"unprognostic (4.55e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.09e-1)"	3.0	0.7	2.9	0.2	3.1	0.0	2.6	2.8	3.9	1.4	2.6	0.7	0.0	1.0	23.2	63.9	1.5	1.4	45.2	2.6	3.4	2.9	0.6	5.0	0.4	3.0	2.8	1.8	0.6	0.2	2.7	2.2	3.0	22.1	0.3	1.1	36.9	3.4	7134.0	2.1	0.5	0.9	2.9	1.6	0.6	2.1	3.0	0.9	4.4	3308.1	0.4	0.9	1.6	3.0	0.0	0.0	0.3	0.0	0.0	0.0	44.6	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	7.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	2.8	3.9	2.6	3.4	3.0	2.8	3.0	2.9	3.0	3.0	0.2	0.0	0.0	0.3	0.0	0.3	1.6	0.3	0.6	2.7	1.0	1.9	9.3	0.0	1.3	5.5	0.0	0.4	0.0	0.0	7.9	0.1	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.2	2.5	1.5	0.0	0.0	0.0	0.9	0.0	0.0	6.3	0.0	0.1	0.0	2.0	0.0	0.8	1.2	0.9	0.7	0.0	0.0	0.0	6.1	0.0	0.5	0.1	0.0	0.0	7.5	0.0	0.3	0.0	0.4	0.1	0.6	13.1	144.4	11.6	0.4	2.2	0.1	0.3	0.1	0.6	3.0	0.0	0.3
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.6	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.7	0.0	1.0	0.0	2.0	0.3	1.0	1.0	0.3	771.4	0.2	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	225.5	0.5	0.4	0.8	0.2	0.6	0.6	1.0	0.3	0.3	0.3	173.4	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOZ3	"CS-3, CS3, FATZ-3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660882-150679368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"skeletal muscle: 234.2;tongue: 198.4"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 44.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;NTERA-2: 9.2;REH: 14.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039166	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"			"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.4	0.5	1.9	0.1	1.5	1.1	0.6	1.3	0.8	1.7	0.1	0.3	0.3	1.5	1.4	5.4	0.8	1.4	5.3	1.4	2.6	0.6	0.1	0.8	0.1	8.0	2.6	0.9	0.2	0.0	1.3	0.1	3.0	4.2	0.2	0.2	3.3	1.0	234.2	0.2	0.7	0.8	5.6	0.2	0.5	3.8	2.7	0.4	0.7	198.4	0.0	0.7	0.5	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.7	0.0	0.0	0.1	0.0	0.7	1.4	9.2	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.5	1.3	0.8	1.4	2.6	8.0	2.6	3.0	5.6	2.7	2.8	3.5	0.0	0.0	1.0	0.1	0.4	0.4	0.5	0.6	1.1	1.7	1.5	2.9	0.0	0.1	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.3	0.5	0.7	2.5	0.0	0.0	0.9	0.2	0.3	1.8	0.0	1.4	0.0	4.3	2.9	0.0	0.2	0.0	3.0	0.3	2.0	0.3	1.1	1.2	3.1	0.7	0.0	1.0	0.1	0.5	1.0	0.0	0.2	0.0	0.1	44.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	7.0	0.8	0.4	1.5	0.0	0.4	0.7	0.5	0.4	0.5	0.1
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor like"	Q96LU7	12	69825227-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"intestine: 23.0"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 102.3;Late spermatids: 30.4;Oligodendrocyte precursor cells: 70.4;Proximal enterocytes: 30.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.2;SK-BR-3: 2.6;T-47d: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.4	1.3	0.0	1.2	0.0	0.5	3.1	1.7	0.1	1.3	0.2	23.0	0.1	0.9	0.1	0.1	0.1	0.4	1.5	1.3	2.0	0.3	0.2	0.2	2.1	1.1	0.0	0.7	0.0	0.9	0.2	2.1	0.7	0.1	0.5	0.6	0.4	0.0	1.4	21.2	0.1	0.9	0.1	0.1	2.5	1.5	0.2	0.2	0.0	0.4	0.0	0.1	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.0	0.0	0.0	0.9	0.8	0.0	0.2	0.1	0.0	2.6	0.0	0.9	11.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	3.1	1.7	1.5	1.3	2.1	1.1	2.1	0.9	1.5	1.4	0.0	0.0	0.0	3.6	0.0	0.1	0.1	0.0	0.0	0.7	0.7	0.1	1.5	0.0	0.3	5.5	0.0	0.2	0.0	0.3	3.9	0.7	13.9	0.4	0.0	0.0	0.0	0.4	9.4	0.0	0.0	0.4	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.0	102.3	3.2	0.0	0.0	0.0	30.4	0.9	0.1	0.0	1.0	0.0	0.2	0.0	70.4	10.8	0.4	4.8	0.4	0.0	0.1	30.8	0.8	0.7	0.2	0.0	0.5	0.2	1.0	0.6	0.0	1.1	0.0	0.1	0.1	4.7	0.0
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591904-57685364	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"heart muscle: 588.9"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 481.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1"									HPA039827	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	65.3	54.7	2.0	2.6	2.4	4.0	22.3	6.3	1.8	17.3	1.3	18.1	16.8	29.4	1.8	41.4	4.7	4.8	588.9	1.8	2.5	5.7	2.4	31.8	6.0	6.7	2.8	5.1	35.1	0.6	1.7	56.6	7.7	19.8	11.8	1.3	18.3	38.2	11.6	9.6	15.4	17.2	1.6	12.4	23.4	2.5	3.5	1.4	3.7	15.5	8.6	84.1	26.9	1.7	6.0	1.7	0.0	10.5	2.3	0.1	3.2	0.9	8.6	1.4	1.7	7.3	4.1	0.1	0.7	0.0	8.9	2.6	0.0	4.4	1.7	0.0	0.2	137.3	1.7	0.1	0.4	0.0	0.1	0.0	3.1	0.3	24.0	0.1	28.3	0.2	1.9	0.0	0.7	2.3	0.0	0.1	0.1	47.5	2.4	0.0	11.4	0.3	0.0	25.1	0.0	4.1	0.6	5.9	0.0	1.2	7.9	0.1	33.1	0.1	2.6	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.0	3.4	2.0	0.0	0.5	0.0	0.8	0.0	0.2	2.4	2.0	2.4	6.3	1.8	1.8	2.5	6.7	2.8	7.7	1.6	3.5	1.7	22.9	9.6	0.6	0.0	0.3	0.0	10.2	0.0	0.0	0.3	3.0	1.0	481.4	5.7	0.6	25.8	0.0	4.4	0.0	26.9	7.9	32.5	0.1	1.1	3.0	15.1	1.8	1.3	0.0	18.9	2.4	9.8	7.1	3.5	0.0	65.1	4.6	0.2	1.4	0.0	0.0	7.9	0.0	7.9	0.0	0.7	4.7	8.7	0.0	0.0	3.4	0.6	0.0	0.0	0.0	21.5	24.9	17.0	0.0	11.0	18.1	0.3	0.7	0.2	0.0	0.2	8.1	0.0	1.6	0.0	0.0	1.2	0.2	13.2	6.6	22.4
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387467-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.8;lymphoid tissue: 272.2"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 4000.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 160.4;plasmacytoid DC: 569.3"	"Group enriched"	"Detected in many"	116	"B-cells: 160.4;dendritic cells: 569.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 581.5;RPMI-8226: 2193.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		350000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	4.4	9.1	0.0	87.4	0.1	33.0	21.0	0.0	0.7	18.3	0.2	70.1	89.8	1.8	0.4	10.1	5.7	14.3	2.3	0.0	0.0	5.9	5.8	15.9	123.2	0.1	0.0	4.9	1.3	0.0	0.7	0.0	0.1	5.1	39.9	0.0	56.7	4.9	0.1	0.4	47.8	2.1	0.4	272.2	66.6	2.4	0.1	147.3	9.1	0.0	117.8	58.7	3.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	256.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	144.6	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.5	581.5	0.0	0.0	227.8	2.2	0.0	0.0	0.0	90.1	0.3	2193.9	0.0	0.0	0.3	0.8	0.0	11.4	0.0	0.0	3.1	0.1	0.6	0.0	1.8	0.1	0.0	262.0	16.7	223.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.1	3.0	160.4	0.6	1.1	0.5	75.6	0.1	0.2	3.1	2.7	0.0	569.3	0.2	26.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.4	6.4	10.1	0.0	665.7	2.5	1.3	0.1	0.0	0.0	3.7	3.2	1.1	4.3	2.0	0.0	0.0	0.1	235.0	0.9	0.0	0.1	0.1	1.8	0.4	2.0	1.2	49.3	0.0	0.0	0.1	2.0	6.1	0.4	2.5	0.1	11.4	14.0	0.1	0.0	0.0	1.1	0.0	7.1	3.4	1.1	0.0	4.7	540.7	0.0	1.0	0.0	4.1	0.0	0.0	0.1	0.4	0.0	4000.1	3.0	1.2	1.9	1.2	0.0	0.0	1.7	2.1	0.1	0.1	0.4	2.4	2.2	100.7	0.5	9.7	0.4
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.0;HeLa: 41.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.5	13.5	5.4	6.5	5.5	5.8	8.5	6.5	8.5	14.7	12.7	11.3	11.6	12.0	7.0	9.6	17.5	4.4	7.5	5.5	5.1	13.5	11.4	10.0	5.9	8.1	6.6	15.8	11.4	6.7	16.9	3.6	6.3	15.4	4.0	9.2	10.1	6.0	10.8	10.3	10.4	4.3	5.4	8.2	12.8	6.6	6.2	4.5	19.0	2.4	2.9	10.7	10.6	7.2	8.0	19.9	8.1	5.0	4.5	4.0	10.1	7.2	3.5	1.2	2.4	4.3	9.4	5.7	3.5	1.9	5.9	9.0	2.0	4.7	0.6	10.3	46.0	6.0	41.5	2.6	2.7	4.5	10.0	2.7	12.3	1.8	5.3	7.7	4.1	6.4	5.0	7.0	1.8	8.8	2.7	2.6	3.1	4.6	8.1	7.4	2.0	10.5	4.1	16.9	7.9	11.0	3.7	6.7	4.6	1.6	7.1	6.1	5.1	13.0	4.1	2.3	3.7	12.6	15.3	4.9	10.5	5.0	3.4	0.0	0.9	0.4	2.1	0.6	3.2	2.1	3.6	2.6	1.6	2.7	5.9	3.8	1.7	5.3	0.7	0.4	2.4	2.4	5.4	5.5	6.5	8.5	5.5	5.1	8.1	6.6	6.3	5.4	6.2	7.2	7.9	12.8	17.0	28.4	15.0	8.0	11.4	11.9	22.2	39.4	22.0	22.4	5.9	10.0	8.0	11.0	33.3	6.0	11.1	20.3	3.9	8.3	22.1	39.1	9.8	7.2	16.8	10.7	23.4	5.4	3.6	8.8	43.3	16.7	4.5	15.8	9.7	10.7	4.9	30.3	20.1	14.5	16.2	5.3	3.3	28.7	10.5	7.6	10.6	7.5	4.2	19.4	15.5	10.6	21.3	6.5	13.4	13.2	9.0	9.6	14.7	10.6	29.8	47.8	19.7	16.6	7.7	10.2	3.8	11.2	8.2	6.4	12.5	16.3	11.9	7.8
MZT1	"C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2"	ENSG00000204899	"Mitotic spindle organizing protein 1"	Q08AG7	13	72708367-72727629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063299, HPA066715"	Approved					NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA063299: AB_2684980, HPA066715: AB_2685709"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.65e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.28e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (9.01e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	9.0	15.1	11.8	11.6	15.5	26.3	11.6	12.6	18.4	8.6	10.2	8.8	8.3	8.3	9.1	9.8	6.1	6.1	12.0	12.3	12.7	11.1	5.5	8.1	17.2	10.4	11.3	7.3	5.8	8.2	6.7	10.6	10.1	10.3	10.0	9.9	9.5	6.3	19.2	9.6	7.4	7.2	11.3	9.8	9.2	6.4	13.1	17.5	12.1	15.0	13.1	9.3	6.1	10.8	97.5	15.4	53.1	39.4	10.8	18.0	43.5	77.1	31.9	47.7	54.8	28.9	62.3	66.9	57.5	30.9	30.1	30.8	53.6	28.7	86.1	80.6	54.5	86.9	30.0	44.0	15.0	147.1	68.1	9.8	28.8	28.9	59.4	28.8	49.1	76.7	48.7	51.1	95.1	17.5	75.2	81.9	40.5	58.7	28.7	52.6	60.7	33.2	42.9	23.8	62.3	56.9	32.7	47.8	48.4	29.0	36.1	72.1	33.5	41.9	47.7	59.5	94.8	46.5	77.0	53.1	98.2	88.8	87.6	16.2	3.8	8.5	4.8	6.9	6.0	7.7	6.5	6.0	4.8	7.3	8.3	6.7	2.0	7.2	7.6	6.3	9.9	3.8	11.8	15.5	12.6	18.4	12.3	12.7	10.4	11.3	10.1	11.3	13.1	10.8	29.3	0.0	15.2	5.5	49.9	55.1	27.6	32.2	30.7	29.3	32.8	24.5	17.8	12.8	18.7	31.3	14.6	57.3	38.3	10.3	58.7	25.9	4.5	20.5	18.0	26.5	21.7	122.3	15.2	24.4	98.8	23.1	18.3	18.8	18.4	27.0	20.7	8.8	41.3	63.9	17.1	17.6	38.7	32.3	46.4	4.2	19.9	33.1	60.5	3.7	36.0	31.1	23.7	6.0	10.0	25.1	15.2	16.6	47.9	33.7	8.1	46.5	12.9	27.7	32.9	21.4	26.8	52.0	38.2	51.9	57.4	30.2	43.8	17.6	24.2	32.3
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 252.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 79.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 421.1"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"prognostic favorable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	41.7	68.6	31.8	11.6	28.4	40.5	44.4	16.1	74.7	82.9	23.9	59.7	31.8	60.7	2.5	102.7	85.8	6.6	252.2	32.6	24.5	50.8	81.1	28.3	19.2	22.5	23.1	87.9	94.7	14.4	38.2	4.7	24.8	74.4	2.6	0.7	52.6	9.1	48.0	54.5	45.8	2.1	15.3	37.8	64.8	36.8	27.7	7.2	55.0	5.6	4.2	55.1	69.8	23.9	212.0	115.2	3.0	40.9	3.3	7.7	44.1	70.6	17.3	27.8	28.2	286.2	71.3	136.7	88.3	3.4	2.8	94.6	7.2	49.8	1.0	54.5	346.6	56.8	135.3	353.8	17.3	100.7	20.4	22.3	27.8	18.7	8.8	6.4	23.8	122.7	114.1	138.7	6.9	196.1	137.1	421.1	73.0	28.1	259.8	114.5	37.3	317.5	18.7	102.2	160.1	20.4	71.6	46.5	135.2	2.1	74.7	177.8	61.6	70.2	168.9	28.3	68.6	128.9	105.6	116.9	97.2	64.3	41.3	22.1	2.0	79.5	8.5	1.4	9.4	32.4	18.9	10.9	7.7	18.8	20.7	10.2	1.1	7.1	0.8	12.0	21.7	4.9	31.8	28.4	16.1	74.7	32.6	24.5	22.5	23.1	24.8	15.3	27.7	23.9	60.4	16.0	13.8	11.8	126.6	148.1	138.9	81.9	124.1	55.6	196.7	284.6	305.6	111.5	47.3	71.7	20.9	88.7	101.1	159.7	170.2	210.3	25.5	42.2	89.7	68.7	108.8	75.7	15.8	167.8	223.9	100.4	115.2	70.4	23.6	189.2	99.2	128.0	123.1	26.9	16.4	240.7	54.9	79.4	138.1	89.8	152.8	71.4	103.2	4.7	105.2	112.9	114.4	10.1	13.0	269.2	167.0	205.4	140.8	163.1	240.1	255.6	28.9	41.9	92.1	83.2	85.9	44.4	166.3	269.5	142.9	42.4	155.8	156.7	270.4	133.6
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 962.4"					"Low region specificity"	"Detected in all"			"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	125.3	170.2	161.7	59.9	150.5	159.3	130.6	131.7	284.6	169.3	145.5	174.2	79.5	140.6	18.2	164.8	162.4	16.4	401.3	150.5	141.8	143.8	199.5	86.3	60.3	150.0	142.2	190.3	250.9	49.3	117.1	32.9	133.9	144.2	19.6	11.4	172.6	41.2	202.4	147.1	102.8	20.4	133.4	103.6	160.7	195.1	157.4	48.1	159.0	29.9	25.5	131.8	143.1	151.4	462.9	239.6	38.6	173.1	20.7	49.8	190.5	203.1	56.7	72.2	59.6	384.0	168.3	251.5	288.1	39.5	47.2	223.4	19.7	68.9	11.2	376.3	667.0	132.8	313.5	485.9	71.5	155.1	97.1	65.7	77.6	45.4	26.9	58.4	80.6	251.8	189.6	268.9	35.8	572.5	336.0	962.4	137.8	85.7	435.8	447.0	105.4	626.6	55.3	140.2	304.7	377.8	121.3	201.1	369.8	15.1	218.5	374.8	164.7	199.8	354.7	155.3	203.4	378.1	257.5	257.9	244.6	203.3	133.3	0.4	19.9	83.0	18.6	21.5	16.5	37.6	25.5	24.7	25.4	38.5	29.1	24.2	10.7	27.3	20.4	48.1	21.3	12.2	161.7	150.5	131.7	284.6	150.5	141.8	150.0	142.2	133.9	133.4	157.4	151.4	240.2	41.7	29.4	20.5	253.6	297.2	321.4	193.4	248.2	175.2	543.9	739.1	326.5	243.1	104.6	242.8	43.8	282.8	238.0	378.4	467.6	358.4	327.3	115.5	326.7	210.0	173.0	308.2	21.7	591.7	466.6	250.1	166.7	171.7	50.8	484.6	250.2	363.5	342.0	131.2	22.8	453.0	99.7	232.7	365.6	1258.6	249.8	202.4	268.6	14.0	179.7	358.3	150.4	16.6	24.5	584.9	281.6	143.7	278.7	375.9	181.7	801.3	61.7	110.6	164.3	169.1	277.3	165.4	183.3	418.2	377.2	165.1	282.3	338.4	360.7	358.0
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	9.3	6.7	8.0	7.3	7.8	10.3	9.0	9.7	8.0	10.2	7.9	8.8	5.9	8.6	8.3	18.9	8.4	6.3	7.9	7.6	11.0	7.4	7.0	14.7	7.5	8.5	7.8	9.7	7.6	11.4	9.1	7.5	8.2	8.8	6.3	6.9	10.7	6.4	10.5	19.9	9.3	6.3	7.1	10.9	9.2	4.7	10.7	10.3	8.3	7.9	9.0	8.1	11.3	8.4	7.1	11.8	8.3	8.5	11.4	9.0	6.9	6.5	9.9	12.4	6.3	9.3	5.8	7.9	5.9	10.0	5.5	14.4	7.5	10.3	6.8	4.9	6.2	4.1	4.7	8.3	11.1	6.2	10.8	13.0	15.5	4.4	6.4	9.1	6.3	8.1	6.4	8.2	7.5	4.0	7.4	11.2	6.6	7.3	6.7	11.1	13.5	12.4	6.2	11.9	9.3	6.6	5.5	10.0	9.2	8.6	4.2	8.5	9.3	6.3	5.6	3.5	3.9	12.2	7.8	12.0	7.3	4.9	5.6	0.9	1.3	1.8	1.0	1.2	1.3	0.9	1.3	1.6	0.8	0.6	1.1	1.1	8.4	0.4	0.9	1.0	1.0	0.6	8.0	7.8	9.7	8.0	7.6	11.0	8.5	7.8	8.2	7.1	10.7	8.4	41.2	134.6	32.7	28.4	15.3	20.0	21.6	32.4	19.4	24.1	21.3	21.2	15.1	22.8	25.8	7.3	16.7	13.4	53.8	35.4	5.9	8.4	6.4	36.8	35.8	25.7	9.6	6.5	47.5	13.2	10.5	20.1	30.5	113.8	12.6	23.1	24.3	13.4	19.5	26.9	50.1	21.2	6.1	25.9	40.3	3.7	16.1	36.5	5.4	58.1	31.9	15.3	21.6	38.7	54.8	26.7	21.6	20.7	30.2	30.6	16.1	9.4	18.4	23.0	0.0	26.3	17.6	12.6	24.4	26.8	22.7	28.5	36.5	23.8	13.4	47.5
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 23.8;JURKAT: 22.2;NB-4: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038971, HPA057219"	Approved		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA038971: AB_10673408, HPA057219: "	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	24.8	11.9	34.0	14.9	33.8	49.5	26.9	32.9	41.1	23.7	32.3	20.3	15.6	19.5	16.1	11.2	26.3	12.6	12.4	34.2	36.2	15.4	85.6	30.2	26.6	29.0	31.1	45.2	20.3	8.6	37.1	13.5	28.4	21.7	14.6	7.9	12.4	11.6	13.8	27.5	21.1	13.0	28.9	30.1	13.8	4.4	37.2	32.0	17.0	9.7	17.9	16.6	20.5	32.7	0.9	0.3	1.3	0.5	5.0	4.0	0.4	0.6	2.2	1.2	2.0	3.8	5.1	10.3	1.4	1.1	3.7	0.1	3.7	0.3	1.6	15.5	2.3	23.8	1.4	11.4	7.8	9.0	1.4	2.8	0.8	1.0	1.0	9.0	0.8	22.2	0.0	18.3	1.0	0.8	18.6	61.4	1.9	0.0	0.5	17.5	0.6	8.8	4.9	1.8	3.4	4.2	3.7	0.1	1.7	2.4	0.5	16.8	0.4	0.5	0.3	0.3	0.1	10.4	6.6	0.5	0.6	3.4	0.7	59.0	49.3	13.9	18.0	47.2	15.9	28.6	17.5	22.4	43.7	33.0	23.9	20.8	12.5	32.1	34.4	56.0	27.9	36.7	34.0	33.8	32.9	41.1	34.2	36.2	29.0	31.1	28.4	28.9	37.2	32.7	46.1	44.8	27.6	53.2	51.4	30.1	29.6	8.7	23.9	10.6	26.6	22.6	4.3	17.2	16.5	5.5	0.0	22.3	74.8	5.5	9.8	15.0	22.5	23.0	5.7	36.1	37.9	25.5	71.7	8.5	1.1	26.2	6.1	4.8	8.8	16.0	21.0	67.2	22.5	0.0	60.4	9.2	24.4	46.6	102.7	22.7	27.4	54.6	30.2	40.3	110.2	7.2	47.4	72.9	43.4	4.4	12.5	22.2	38.4	24.5	25.8	9.8	8.1	2.2	78.9	48.9	40.4	1.4	2.8	15.2	35.4	10.4	44.0	2.5	12.9	16.5
N4BP2L2	"CG005, PFAAP5"	ENSG00000244754	"NEDD4 binding protein 2 like 2"	Q92802	13	32432417-32538885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039338, HPA039434, HPA059327"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981"	"unprognostic (1.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.51e-2)"	"unprognostic (8.95e-2)"	"unprognostic (6.29e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.03e-3)"	29.0	28.4	29.7	19.9	33.1	26.4	40.9	39.3	36.3	28.7	25.8	26.0	17.9	39.1	37.8	23.3	27.3	29.0	42.7	26.6	29.2	30.8	36.8	34.9	28.4	28.3	28.4	47.5	18.1	33.7	23.0	23.4	29.4	36.1	28.2	38.0	24.0	30.3	65.3	29.2	24.9	31.6	30.0	31.7	26.1	20.0	27.9	33.0	36.6	60.8	25.0	31.5	19.8	37.0	18.1	13.7	35.0	25.4	31.6	39.1	29.7	34.0	31.8	28.3	25.7	24.1	44.7	19.4	18.2	37.4	44.7	30.2	36.1	32.6	37.7	46.7	17.9	35.6	30.9	29.4	50.1	46.0	20.3	42.4	42.4	26.1	31.2	47.7	43.9	34.4	28.6	18.2	39.8	24.1	36.1	44.5	31.4	79.2	15.6	29.7	32.0	21.5	36.2	24.9	12.8	32.1	22.2	25.0	48.4	39.9	27.6	64.7	33.5	15.4	17.1	17.1	16.4	17.3	19.6	16.4	21.2	30.5	25.7	35.4	13.7	29.3	17.1	16.4	23.7	18.1	20.3	18.0	13.0	16.1	23.4	20.1	20.3	21.2	23.0	16.6	20.1	12.2	29.7	33.1	39.3	36.3	26.6	29.2	28.3	28.4	29.4	30.0	27.9	37.0	269.4	173.1	174.2	321.3	275.3	137.9	319.5	236.5	166.8	222.0	167.1	144.8	186.6	138.7	180.1	217.0	248.1	182.4	311.3	208.5	92.0	132.9	132.3	164.3	180.6	199.5	175.8	118.9	354.5	74.7	81.8	189.0	175.8	139.2	212.8	256.3	198.5	134.6	119.1	249.0	386.1	173.0	217.7	161.6	129.6	140.2	370.0	175.9	124.5	244.5	308.4	108.4	382.1	367.4	586.4	116.7	282.3	301.7	187.9	253.3	338.7	92.3	175.1	335.8	315.5	234.5	197.3	187.6	89.8	89.3	137.7	191.5	292.6	180.5	122.4	275.1
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113532-178126081	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 35.7;Extravillous trophoblasts: 130.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.7;naive B-cell: 1.6;naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	16	"B-cells: 1.7;dendritic cells: 2.1;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.9;MCF7: 21.2;RH-30: 20.3;SK-BR-3: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	1.9	0.8	1.6	1.0	1.0	2.9	2.5	3.0	3.7	2.6	0.6	1.4	0.5	0.8	0.3	15.7	1.0	0.7	2.3	1.0	2.1	3.1	0.1	3.9	1.8	2.6	1.8	0.5	0.7	4.1	2.2	8.3	2.7	1.0	0.4	4.7	6.8	0.8	4.4	7.8	1.8	0.5	0.2	1.8	2.2	0.9	4.1	0.9	1.4	3.0	2.9	1.4	4.0	2.1	0.1	0.1	2.3	1.7	0.2	0.0	14.9	0.0	0.0	0.0	0.0	3.3	1.1	1.4	2.0	0.0	0.1	4.7	0.4	0.1	0.0	2.5	0.8	4.1	1.8	0.1	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.0	12.0	1.3	2.6	0.9	0.0	21.2	0.2	0.3	11.2	3.6	0.1	11.6	20.3	5.4	1.2	2.4	1.7	0.8	0.6	72.2	4.9	2.8	2.8	0.1	2.4	0.0	1.7	0.0	0.0	3.2	2.3	13.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.1	0.1	0.0	1.6	0.4	1.2	0.0	0.1	0.0	2.1	0.0	0.2	1.6	1.0	3.0	3.7	1.0	2.1	2.6	1.8	2.7	0.2	4.1	2.1	7.8	3.2	0.6	0.0	12.7	9.4	13.1	6.7	4.0	35.7	7.3	3.6	1.7	2.8	3.4	1.8	12.5	3.0	10.4	9.4	13.7	3.4	0.4	1.9	1.1	15.7	4.2	0.0	2.9	0.8	130.4	1.6	6.6	5.8	4.5	0.5	0.4	0.2	2.3	1.7	4.9	3.7	6.1	0.0	1.7	0.8	0.6	1.0	12.4	3.7	1.1	2.0	0.0	0.5	0.2	7.3	8.7	1.9	6.1	10.3	0.1	0.8	0.3	9.2	0.0	2.5	0.7	0.2	8.1	14.1	6.8	23.1	3.0	0.7	3.5	12.1
N6AMT1	"C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	2.4	5.0	4.9	2.5	5.6	0.9	5.0	4.8	5.3	6.2	4.8	3.4	3.2	6.4	6.1	2.5	4.7	2.8	5.3	4.5	5.3	4.9	2.8	2.5	3.4	5.7	5.0	7.9	2.9	5.7	4.4	6.4	5.6	4.6	3.4	8.4	3.1	4.0	6.1	3.8	2.8	3.5	4.7	3.6	3.1	3.7	5.0	2.2	5.3	5.6	3.3	3.9	4.1	8.8	2.8	2.5	6.2	8.6	5.1	5.6	4.8	6.1	2.5	3.5	2.0	3.2	5.0	3.1	3.0	3.3	6.2	3.3	5.4	3.0	4.3	4.0	4.1	6.7	4.2	4.0	4.5	4.0	2.5	2.9	6.4	3.5	2.4	6.3	2.6	3.8	8.4	5.5	7.3	2.9	1.9	3.2	7.9	6.0	3.5	2.8	5.9	2.4	6.0	4.1	4.7	6.6	5.5	1.9	2.3	5.6	2.7	3.5	5.4	2.9	5.2	5.4	3.7	3.3	4.0	1.7	4.6	10.4	5.5	0.3	0.4	0.6	0.5	0.7	0.6	0.7	1.0	0.7	0.6	0.6	1.4	1.0	0.1	1.4	0.5	0.5	0.4	0.5	4.9	5.6	4.8	5.3	4.5	5.3	5.7	5.0	5.6	4.7	5.0	8.8	7.8	3.2	5.4	5.2	7.1	1.9	5.8	10.3	1.8	10.8	6.3	6.5	17.0	7.2	8.7	12.9	8.4	18.3	4.0	1.5	7.9	11.0	2.9	10.7	9.6	6.9	0.0	13.0	4.6	6.4	12.2	7.9	8.6	4.2	1.3	15.1	5.3	3.5	7.2	10.1	5.1	3.0	10.2	1.3	0.9	4.5	9.6	2.6	1.8	1.0	2.7	11.1	4.1	6.6	15.1	7.7	4.3	10.1	1.2	4.5	2.5	9.3	15.8	10.5	0.0	7.7	8.9	4.5	10.5	4.2	3.7	14.9	5.1	20.1	3.1	4.8
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N-alpha-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929225-153935080	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	38.4	39.5	19.6	17.2	20.1	13.2	34.6	20.4	27.2	26.5	19.2	34.1	15.3	32.3	15.1	40.5	24.4	10.3	56.3	20.0	21.8	34.1	35.9	26.0	19.7	20.8	20.3	23.8	45.8	13.7	22.5	12.5	20.8	27.6	10.2	7.3	25.3	12.2	98.4	30.9	24.9	18.1	20.4	28.8	35.9	9.1	21.2	10.2	21.7	24.9	15.3	35.9	26.8	20.4	133.4	136.0	25.8	83.0	36.7	36.9	71.2	46.3	28.6	63.8	57.0	88.5	41.0	102.0	147.6	38.7	79.2	63.0	57.9	56.8	23.9	42.1	255.2	36.8	85.8	91.3	49.1	71.4	76.8	28.8	62.2	57.9	59.1	30.7	72.0	39.2	75.1	41.5	41.6	172.8	115.0	106.4	42.9	124.4	189.0	90.1	65.7	111.5	47.7	59.7	54.0	65.7	18.7	71.0	113.7	23.9	38.4	58.8	41.1	25.6	88.5	89.5	142.0	86.3	107.2	196.0	34.7	91.0	75.5	35.3	53.1	81.3	60.0	65.3	78.1	75.2	63.4	65.6	69.4	77.7	37.4	56.7	49.8	64.7	76.0	75.9	102.9	70.6	19.6	20.1	20.4	27.2	20.0	21.8	20.8	20.3	20.8	20.4	21.2	20.4	126.9	9.6	30.2	27.1	76.0	70.1	66.1	90.6	68.3	29.5	82.6	113.8	45.1	47.1	52.8	38.6	12.5	125.9	77.0	94.5	95.9	121.1	2.9	46.0	60.7	98.7	58.1	78.9	18.6	149.9	179.0	57.3	76.5	43.4	67.9	64.2	77.8	78.7	123.1	37.0	14.6	92.2	54.9	66.5	96.0	12.5	46.6	66.4	119.2	9.4	84.8	37.9	85.5	14.1	19.1	144.6	75.2	46.6	104.3	136.9	91.5	197.0	40.2	30.4	65.7	56.6	98.3	7.6	33.1	120.7	90.5	108.8	74.8	97.7	110.3	85.9
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 2.6;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.1	0.1	0.2	0.5	0.4	0.3	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N-alpha-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301505-139420033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		140000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	9.1	8.9	6.5	11.4	7.3	16.4	9.9	12.4	8.3	7.3	7.3	8.4	7.6	8.9	6.0	12.5	7.1	7.0	10.0	6.5	6.7	7.5	10.9	6.4	14.5	7.3	6.8	7.9	7.8	9.7	5.8	10.6	7.7	8.3	9.1	9.2	6.2	7.2	17.0	9.3	7.0	8.7	6.9	8.5	7.9	13.1	6.9	13.4	9.0	16.3	15.5	14.5	7.7	10.5	44.7	32.1	30.4	49.2	21.7	26.4	37.3	42.2	27.6	39.9	30.6	45.3	38.2	91.1	25.3	35.0	34.6	28.1	80.5	51.7	57.2	42.8	29.6	49.0	29.6	29.8	23.0	90.5	30.5	18.7	31.0	50.4	39.1	21.1	40.5	35.2	92.1	38.7	42.9	35.6	86.8	26.8	50.7	83.4	25.0	53.4	40.9	47.0	31.8	37.2	39.3	30.8	28.2	45.7	28.8	30.6	27.8	35.2	35.0	38.3	27.0	36.7	48.7	46.5	89.0	88.7	32.9	64.6	37.4	4.2	3.4	1.1	5.0	3.9	5.9	4.8	5.3	5.9	4.7	5.3	5.1	5.8	2.6	4.5	3.9	4.0	5.5	2.1	6.5	7.3	12.4	8.3	6.5	6.7	7.3	6.8	7.7	6.9	6.9	10.5	28.4	48.1	33.8	28.4	39.7	93.4	69.6	20.7	29.0	34.0	28.1	15.7	46.9	22.8	32.3	20.2	20.9	39.9	22.8	14.4	15.6	28.1	9.0	40.3	38.9	31.5	15.6	34.5	44.0	19.5	50.8	32.9	21.4	40.5	34.8	35.7	16.8	28.1	32.5	40.4	45.9	20.8	18.3	24.1	35.0	11.3	25.4	27.8	28.4	29.0	26.6	27.7	32.0	42.3	57.6	26.5	16.2	29.0	23.4	53.8	10.2	16.4	34.0	36.3	32.9	69.0	47.4	90.0	59.7	44.0	99.3	41.7	31.7	32.1	32.5	70.2
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N-alpha-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311267-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 23.5;pancreas: 20.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	3.2	2.7	1.8	5.0	2.1	23.5	3.9	4.9	2.2	5.0	1.6	2.8	4.3	6.3	2.7	4.2	4.3	3.5	2.4	1.5	2.4	3.1	2.9	3.7	6.5	1.8	2.0	5.9	20.5	3.5	1.9	3.8	2.0	4.7	3.2	5.9	3.9	3.8	4.4	4.1	4.1	3.7	1.1	4.5	4.8	7.5	2.2	5.9	3.7	4.5	4.0	3.9	3.5	3.4	7.3	6.0	14.9	10.8	5.1	6.5	5.7	8.9	7.4	8.6	7.5	7.1	5.6	12.1	4.1	7.2	3.5	10.0	7.7	5.7	10.5	7.5	15.5	15.0	6.3	7.2	5.5	16.8	9.7	4.5	4.2	3.6	6.8	5.8	8.6	11.7	6.8	6.5	5.6	6.0	17.5	4.8	12.6	10.1	8.1	12.9	6.1	10.1	6.8	6.6	5.0	11.6	8.0	7.7	3.3	8.6	4.7	9.3	6.2	5.8	4.9	9.3	7.0	4.5	5.4	14.0	7.5	7.2	7.1	4.4	1.5	3.1	2.3	0.8	2.1	1.0	2.6	2.4	0.8	1.6	4.5	4.7	0.8	3.4	1.2	1.6	2.0	1.3	1.8	2.1	4.9	2.2	1.5	2.4	1.8	2.0	2.0	1.1	2.2	3.4	15.0	9.6	16.7	34.0	19.6	17.7	21.9	9.5	18.8	27.9	10.3	10.2	12.0	10.0	12.4	9.2	14.6	8.8	20.2	5.6	1.9	12.5	17.9	17.2	26.7	16.7	7.7	15.4	53.5	20.5	7.8	18.8	19.9	22.1	3.8	18.9	13.6	8.7	19.1	38.7	66.9	5.5	4.1	8.5	11.7	26.3	30.1	14.3	14.2	45.0	12.0	11.3	21.6	68.9	57.1	13.1	6.9	19.9	28.3	20.0	7.3	7.0	17.3	33.6	19.7	17.0	24.7	39.2	28.8	17.0	14.6	2.9	31.7	17.1	9.7	21.2
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N-alpha-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415906	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA057824: AB_2683539"	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	9.6	7.7	9.7	7.2	11.3	15.0	9.6	10.6	11.8	7.8	6.5	8.4	9.9	9.1	7.1	11.3	7.4	7.1	14.2	11.6	11.6	12.4	16.7	6.4	9.0	8.6	9.3	14.9	9.0	12.5	5.7	13.4	9.2	10.1	7.9	12.0	8.0	10.1	31.8	8.3	8.7	10.1	9.3	8.3	7.0	18.5	12.4	9.0	10.6	27.3	9.1	8.2	6.0	9.4	19.4	18.2	10.2	16.7	16.8	21.9	17.1	22.1	21.3	16.5	15.0	16.5	13.9	14.1	19.0	18.4	12.5	20.1	18.5	14.3	27.4	24.7	9.4	11.4	10.1	14.5	17.5	23.1	12.8	15.0	20.7	15.0	24.9	18.4	25.8	17.3	11.3	13.6	22.1	22.1	19.5	13.4	11.0	17.8	20.0	15.3	29.4	11.0	16.9	17.4	21.8	11.5	18.7	18.3	23.0	18.2	23.6	11.9	22.7	25.7	27.0	14.2	14.3	10.1	13.2	16.9	17.1	11.5	18.7	0.8	0.4	0.2	1.2	0.9	1.2	1.0	1.1	1.8	0.3	1.1	1.2	1.2	0.2	2.4	2.8	0.6	1.7	0.4	9.7	11.3	10.6	11.8	11.6	11.6	8.6	9.3	9.2	9.3	12.4	9.4	11.8	9.6	6.3	10.1	16.7	41.0	11.8	8.6	25.0	13.5	16.5	10.9	34.9	17.2	8.0	3.7	18.8	18.3	20.1	11.6	9.8	12.5	107.1	9.0	13.1	17.0	21.0	9.0	20.3	11.6	15.6	13.1	12.8	10.8	7.0	14.9	11.0	25.5	9.9	10.1	20.3	13.7	6.1	13.2	12.1	37.6	13.7	8.2	23.2	10.3	9.9	13.3	8.2	16.6	18.9	14.5	13.8	13.5	18.1	18.9	13.6	17.9	9.5	15.3	19.7	13.3	15.4	69.2	20.5	25.5	41.2	22.2	17.0	13.3	12.6	16.7
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N-alpha-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86025462	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	7.7	12.2	6.9	6.3	7.3	6.6	9.3	9.8	7.0	8.9	8.2	11.1	8.6	9.4	7.8	10.9	8.4	5.7	8.8	6.9	7.2	8.4	8.7	7.1	6.2	6.3	6.0	9.9	10.8	9.4	12.0	7.4	6.2	9.7	10.5	14.3	10.1	6.8	17.4	9.1	8.1	7.0	6.4	6.5	8.8	15.4	8.4	7.3	10.4	13.2	7.2	9.0	9.1	8.9	25.4	15.8	17.7	13.5	9.8	13.1	24.8	15.5	15.1	16.1	13.1	12.4	15.7	8.4	8.5	15.4	13.1	34.9	15.0	18.4	16.8	22.3	13.1	21.6	19.9	14.6	16.6	30.4	17.6	13.1	15.2	17.0	24.6	12.4	14.0	15.6	25.3	15.6	14.9	14.6	15.7	16.0	17.8	28.0	18.2	14.4	26.9	12.6	17.3	20.4	16.7	15.5	17.6	15.8	13.6	17.0	11.9	11.7	14.0	11.2	12.4	16.9	15.0	22.3	29.1	5.7	16.3	12.5	10.2	1.7	2.5	5.1	3.4	2.6	4.3	9.5	3.5	3.1	3.0	9.3	4.6	3.4	1.3	3.5	1.9	2.2	3.1	2.6	6.9	7.3	9.8	7.0	6.9	7.2	6.3	6.0	6.2	6.4	8.4	8.9	14.6	3.2	14.1	58.4	16.8	16.3	20.2	19.0	19.9	25.5	18.0	13.1	23.3	18.6	22.8	11.0	22.9	22.6	14.9	20.2	1.9	19.7	8.7	29.4	18.6	14.3	20.9	14.5	51.8	25.8	18.9	13.6	16.3	22.5	12.0	32.9	9.3	9.8	12.2	21.9	58.7	14.5	30.5	11.0	8.4	5.3	9.3	10.7	14.2	52.5	12.3	18.7	14.4	44.7	68.8	18.3	16.6	11.7	17.1	22.0	12.0	8.9	33.7	36.6	13.1	21.4	24.7	56.7	36.3	17.7	16.6	31.1	15.8	24.4	16.6	19.2
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N-alpha-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716458-113746300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 320.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved		Supported	Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	88.2	64.2	21.8	72.0	24.7	87.3	58.4	25.2	29.4	49.2	27.2	62.5	48.9	50.1	31.4	93.4	38.5	50.6	50.9	23.7	24.4	64.4	90.3	43.5	84.9	23.6	25.0	51.7	58.7	59.8	23.1	45.0	25.3	52.8	54.1	31.5	69.7	42.1	320.7	53.4	47.5	51.2	25.2	52.6	65.6	53.2	26.6	56.8	58.5	154.4	90.7	87.6	46.3	28.2	589.6	250.7	135.2	158.5	179.4	144.6	281.4	308.5	172.4	186.0	212.4	362.3	205.7	403.4	185.8	164.6	146.9	236.5	238.0	211.1	338.6	85.2	121.5	435.7	182.7	220.3	164.4	459.1	135.7	124.0	163.0	208.8	298.3	122.1	168.7	167.3	279.3	157.8	194.3	277.0	306.2	99.3	303.4	228.3	365.3	309.5	207.2	318.9	141.7	439.9	207.4	119.6	223.6	164.1	229.0	116.5	228.1	150.4	156.9	255.1	253.9	109.1	235.7	174.1	314.2	736.0	200.2	253.2	160.6	17.7	40.8	22.5	45.5	40.5	40.6	55.2	33.7	43.1	44.4	37.1	29.4	39.1	51.8	31.8	38.1	25.6	39.9	52.5	21.8	24.7	25.2	29.4	23.7	24.4	23.6	25.0	25.3	25.2	26.6	28.2	33.9	48.1	39.9	24.8	75.7	168.4	86.6	42.6	76.2	24.8	52.3	31.6	47.5	25.8	45.8	36.8	8.4	46.0	78.2	51.3	78.2	52.9	68.0	44.4	53.1	45.7	19.9	79.5	41.5	55.1	94.6	55.2	35.7	94.3	47.5	45.5	29.3	66.1	61.9	40.4	39.0	31.5	42.7	55.3	148.8	50.7	30.7	60.1	62.2	20.6	49.9	29.7	29.9	33.2	28.4	65.2	36.8	31.2	74.9	142.0	31.4	71.0	30.0	18.4	19.7	53.1	64.1	53.5	60.8	99.8	177.9	62.5	74.7	37.7	49.3	193.3
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N-alpha-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443649-3486953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	25.5	45.4	31.5	16.9	30.0	20.1	25.1	37.5	35.9	28.4	22.7	40.4	40.5	31.6	18.7	31.0	28.2	20.3	48.9	31.9	27.5	52.4	67.5	32.0	20.2	30.8	30.5	26.8	47.9	49.1	41.6	19.5	29.3	35.2	22.6	16.3	26.0	23.9	42.9	24.2	39.3	19.1	28.8	42.9	58.9	32.7	31.2	19.5	32.0	21.2	16.7	28.4	23.2	30.3	16.8	61.9	40.1	44.1	26.5	19.4	39.1	26.9	25.0	29.3	26.6	43.9	30.5	31.7	30.0	29.6	21.0	37.4	40.1	31.2	29.4	49.7	27.8	35.4	25.7	53.0	32.9	53.1	45.6	24.4	27.9	20.4	38.9	29.2	45.1	29.4	44.8	41.4	19.4	73.6	33.4	36.3	50.1	35.8	18.1	42.3	30.8	47.5	27.7	29.7	21.6	42.5	45.8	48.3	24.6	38.5	40.2	34.7	30.8	36.0	27.7	12.8	26.7	35.2	33.6	30.5	12.1	29.0	29.2	33.3	18.6	53.8	17.7	20.6	19.2	11.6	15.8	17.7	18.1	11.0	12.3	16.4	20.0	18.4	23.6	11.6	20.1	19.5	31.5	30.0	37.5	35.9	31.9	27.5	30.8	30.5	29.3	28.8	31.2	30.3	26.3	9.6	16.0	24.8	17.7	0.1	13.4	0.1	17.6	21.2	24.5	16.4	15.5	38.6	5.6	12.9	6.2	28.3	22.7	66.7	43.0	30.1	55.7	33.3	25.7	21.0	27.0	18.7	22.2	41.7	40.0	18.0	37.2	30.9	30.4	18.4	26.7	53.5	32.1	11.8	26.5	43.1	0.0	34.8	0.3	54.4	11.5	23.6	0.0	25.3	27.0	29.3	26.8	22.1	34.8	37.0	54.3	15.8	15.4	20.2	84.2	49.0	3.7	15.3	26.3	16.8	17.7	19.6	24.5	16.5	0.3	33.0	22.9	21.1	35.3	23.5
NAA80	"FUS2, NAT6"	ENSG00000243477	"N-alpha-acetyltransferase 80, NatH catalytic subunit"	Q93015	3	50296402-50299416	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 65.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 6.5;Exocrine glandular cells: 8.8;monocytes: 9.3;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 7.5;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 56.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 56.3"	"Cell line enhanced"	"Detected in all"		"HMC-1: 60.5"	"Low region specificity"	"Detected in all"							HPA039576	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA039576: AB_10794750"	"prognostic favorable (3.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.55e-1)"	13.4	12.2	8.2	7.6	9.2	32.4	13.9	10.9	15.2	16.8	3.1	12.3	6.4	13.3	7.0	15.4	15.4	6.3	17.2	8.8	6.5	19.3	14.6	15.5	10.3	11.6	8.0	17.5	15.1	9.0	14.3	5.8	11.9	19.1	7.7	3.8	13.8	10.6	18.0	22.5	13.4	6.8	5.3	16.5	17.7	65.5	7.3	8.2	14.4	7.2	9.7	13.1	15.9	8.9	8.0	6.2	9.0	9.5	10.7	12.3	6.0	7.4	14.6	11.5	9.9	5.4	15.0	24.6	5.5	12.9	9.4	9.9	5.3	24.2	4.7	15.6	9.0	49.2	37.7	12.3	9.4	8.3	60.5	14.8	16.8	19.3	13.3	17.0	14.1	13.2	4.4	22.7	10.5	8.3	9.9	37.7	5.0	3.6	19.9	6.4	3.2	29.9	19.4	3.9	6.3	8.9	8.4	17.5	3.5	5.5	7.6	23.4	11.7	9.2	9.2	11.4	7.3	15.4	8.9	6.1	15.9	15.5	8.8	13.7	3.1	56.3	7.1	4.2	10.3	10.4	9.7	8.6	5.2	7.5	7.6	6.4	0.9	9.8	2.7	2.6	9.4	5.5	8.2	9.2	10.9	15.2	8.8	6.5	11.6	8.0	11.9	5.3	7.3	8.9	6.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.8	4.1	0.0	0.0	0.0	3.7	0.0	5.4	4.5	0.0	3.9	4.8	0.0	3.1	3.4	2.1	0.0	0.0	0.0	8.8	5.1	2.1	0.0	3.2	0.0	3.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.1	2.1	6.4	0.0	0.0
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913660-75941013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 142.2;Kupffer cells: 115.8;Langerhans cells: 109.9;Proximal enterocytes: 167.7"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 672.4;non-classical monocyte: 583.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 672.4"	"Cell line enhanced"	"Detected in many"		"U-2197: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	19.0	14.6	9.2	30.0	10.0	18.5	37.4	10.9	10.8	23.0	14.1	61.8	30.9	12.9	9.1	28.4	16.4	15.7	19.9	9.5	13.3	40.6	68.4	23.0	48.4	11.2	11.1	8.2	7.6	11.7	7.7	19.4	11.7	70.9	69.9	32.7	31.5	11.4	8.6	22.8	60.7	15.4	9.5	63.8	18.5	3.4	13.2	16.3	15.9	13.0	27.9	20.0	18.4	14.5	11.9	26.6	1.1	0.7	62.4	62.8	1.1	17.5	11.6	11.8	4.0	9.3	41.1	1.0	8.9	43.5	0.4	23.1	34.8	13.4	7.1	17.0	1.3	8.4	19.4	22.6	14.3	31.4	29.6	16.0	10.0	10.3	3.5	18.4	19.1	18.7	9.6	35.9	10.6	43.5	20.2	20.5	13.5	53.4	10.5	13.5	0.4	55.6	12.4	6.7	15.9	2.3	18.1	56.2	5.4	1.8	63.3	54.1	28.8	0.7	1.5	78.6	0.8	8.8	3.8	5.9	14.8	44.5	7.4	48.6	270.1	110.3	62.0	672.4	67.5	58.8	78.4	61.8	143.2	40.4	65.2	54.5	90.3	35.5	583.3	53.2	114.6	233.7	9.2	10.0	10.9	10.8	9.5	13.3	11.2	11.1	11.7	9.5	13.2	14.5	10.6	0.0	7.3	7.2	31.2	11.3	18.8	5.7	4.0	11.5	31.3	14.2	4.4	25.8	10.9	5.5	18.8	24.6	19.5	142.2	13.7	5.7	0.5	12.1	18.1	14.6	48.0	10.8	17.7	8.4	19.2	28.2	3.1	11.9	15.2	3.5	18.5	37.2	39.7	11.8	27.4	45.4	8.2	115.8	109.9	0.0	10.5	80.3	17.8	7.5	77.8	7.7	16.5	5.0	4.8	4.1	46.7	7.5	16.8	55.4	167.7	12.4	27.7	86.9	0.0	31.8	16.7	1.1	0.9	15.9	18.9	13.3	34.8	9.1	24.4	14.0
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.9;testis: 13.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	3.8	10.0	2.3	0.4	3.3	0.1	3.3	1.5	5.3	10.3	0.0	1.9	0.2	4.1	1.9	0.8	3.4	1.2	2.1	2.4	2.8	1.5	0.9	2.1	0.4	3.6	3.5	7.4	0.7	0.1	19.9	3.5	3.4	3.2	0.6	3.5	1.1	1.2	1.1	0.7	1.3	1.1	2.0	2.6	1.2	13.9	3.0	0.1	1.4	0.7	0.1	2.2	4.0	4.2	0.1	0.2	1.8	0.1	0.5	0.1	2.2	0.1	0.1	0.1	0.0	19.2	0.7	0.3	0.2	0.0	0.3	0.3	1.3	0.0	0.0	0.0	0.3	1.9	0.4	1.7	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.5	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.8	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.1	0.0	0.2	0.0	4.3	0.2	0.4	2.4	0.1	1.4	0.3	0.3	1.0	0.3	0.3	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	3.3	1.5	5.3	2.4	2.8	3.6	3.5	3.4	2.0	3.0	4.2	2.6	0.0	0.0	3.3	0.1	0.3	0.1	0.0	0.0	17.3	0.0	0.0	2.4	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.1	39.7	0.8	13.7	1.2	0.0	0.0	109.3	0.0	0.6	7.5	1.1	0.6	0.0	1.7	0.7	0.2	0.3	70.7	110.2	0.0	0.0	7.2	0.4	17.7	11.1	0.5	0.0	12.2	0.0	8.4	0.0	153.8	83.7	0.0	0.0	14.7	0.4	0.4	0.0	0.1	0.0	2.4	0.0	6.4	4.6	0.6	11.3	0.4	0.0	0.8	0.2	19.4	0.2	0.1
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058553	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"intestine: 99.3"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	13.9	3.2	4.4	6.6	4.1	21.1	12.1	4.7	6.0	23.5	7.0	18.4	19.8	18.8	4.6	7.3	15.2	9.4	10.5	3.9	4.1	7.4	2.6	10.9	10.9	4.7	4.3	16.6	2.3	2.0	6.0	2.3	4.6	13.8	7.1	1.9	4.9	11.5	2.7	5.4	99.3	10.5	4.6	15.3	8.2	8.7	4.4	3.4	5.7	4.1	6.9	12.7	14.5	4.0	0.0	0.0	0.1	0.2	0.5	5.8	1.0	2.3	0.0	2.8	1.3	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.2	0.1	0.9	0.4	0.0	0.2	3.5	20.2	0.0	0.0	13.5	0.0	2.7	0.0	0.1	3.6	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.0	0.1	0.1	0.1	0.0	1.0	0.2	0.0	10.5	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.8	0.0	0.1	0.1	182.0	21.2	35.9	29.6	14.6	15.8	25.7	23.8	14.8	16.3	29.8	27.0	15.0	3.7	80.2	8.8	0.7	45.2	24.6	4.4	4.1	4.7	6.0	3.9	4.1	4.7	4.3	4.6	4.6	4.4	4.0	19.1	0.0	0.0	0.0	8.0	3.6	3.4	5.6	6.2	2.0	0.8	9.1	1.8	1.5	0.4	0.0	0.0	0.2	9.8	31.3	3.9	0.1	0.8	0.4	5.8	11.1	1.2	2.5	0.3	0.8	0.3	11.4	1.1	0.2	19.7	4.3	16.8	0.4	2.8	10.1	0.4	21.0	2.0	5.6	5.7	2.6	11.8	5.2	16.0	1.0	17.3	12.2	41.2	1.0	0.1	0.2	50.0	18.0	1.1	0.5	588.6	0.5	0.5	0.9	0.0	8.3	11.1	1.6	3.5	1.3	3.3	0.4	11.1	3.9	11.8	0.4
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810548	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 311.5;Inhibitory neurons: 135.1;Microglial cells: 155.5;Oligodendrocyte precursor cells: 468.0;Oligodendrocytes: 532.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.5;BJ hTERT+: 5.4;fHDF/TERT166: 6.4;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	2.4	1.1	1.1	1.0	2.3	0.2	5.8	1.2	1.4	6.3	1.1	3.0	1.7	3.7	5.5	1.5	3.8	4.2	2.6	1.4	0.6	3.3	2.9	2.0	0.5	2.2	1.3	3.9	2.2	10.2	0.5	1.2	1.8	4.9	2.4	1.6	5.8	3.7	1.0	0.8	1.6	3.5	1.4	1.9	2.7	0.9	1.5	1.2	2.3	1.7	0.5	3.8	1.2	3.3	0.0	0.0	0.3	0.0	4.4	14.5	0.1	3.1	5.4	0.7	0.9	0.2	1.7	0.0	0.6	6.4	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	4.1	0.8	0.1	0.0	3.8	0.5	0.0	0.0	0.1	3.1	0.6	0.2	0.0	0.0	2.2	0.0	0.0	0.2	0.1	2.2	0.3	0.1	0.1	0.3	0.3	1.2	0.3	4.0	0.2	0.7	2.9	0.1	0.1	0.6	0.0	0.0	0.0	1.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	2.3	1.2	1.4	1.4	0.6	2.2	1.3	1.8	1.4	1.5	3.3	5.1	0.0	11.5	311.5	0.1	2.3	8.9	2.7	1.2	7.7	35.1	13.7	3.0	12.8	9.1	12.9	12.5	19.6	0.3	11.1	7.9	10.1	74.9	23.7	8.7	2.8	9.0	2.7	113.4	2.5	1.4	15.0	23.9	30.2	4.5	3.4	2.9	4.5	1.8	0.0	135.1	2.6	10.2	0.3	3.0	39.6	15.2	1.1	3.6	155.5	0.0	6.7	0.0	468.0	532.9	3.6	4.4	12.0	0.0	13.6	13.2	2.4	21.9	6.2	0.0	23.4	4.9	3.2	2.8	5.3	1.8	12.3	0.8	5.7	16.4	16.0
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	29.3	20.3	19.4	23.5	16.7	18.6	34.8	50.4	23.5	28.1	7.4	22.8	15.8	32.3	50.1	36.3	27.5	28.0	28.5	18.7	9.7	19.9	37.8	22.8	26.8	13.4	13.2	26.0	17.9	23.5	21.1	26.4	14.9	18.5	25.6	41.4	20.7	20.9	8.0	66.7	17.1	25.2	14.9	19.8	37.9	26.0	13.8	21.2	37.9	17.2	26.3	31.2	24.2	25.9	35.5	25.8	65.0	22.6	24.5	42.7	111.0	35.5	55.7	26.4	29.8	62.8	38.4	39.6	40.6	28.3	48.9	88.4	37.4	45.9	51.8	126.1	31.0	46.7	96.3	30.2	15.8	19.8	22.4	24.6	70.4	55.9	17.1	37.4	41.5	23.9	46.3	33.2	40.6	17.4	28.7	20.0	22.8	38.4	35.2	35.0	46.7	15.9	19.3	34.5	57.9	46.9	41.8	13.9	37.3	82.8	11.4	30.6	29.0	54.5	43.0	31.0	21.6	25.7	30.3	29.5	57.3	17.6	43.7	0.0	1.3	0.6	1.3	1.1	1.9	0.7	1.3	1.7	0.9	0.4	1.4	1.5	2.9	2.6	3.7	0.8	3.3	0.8	19.4	16.7	50.4	23.5	18.7	9.7	13.4	13.2	14.9	14.9	13.8	25.9	24.1	6.4	21.2	14.0	5.9	102.0	23.1	24.6	31.3	26.1	19.7	19.7	18.2	11.5	29.8	12.9	12.5	4.3	9.2	11.4	3.9	10.3	1.4	17.5	10.8	30.1	14.4	12.0	37.2	8.0	11.1	25.2	21.4	23.4	20.3	14.2	44.6	25.7	6.7	6.7	21.2	17.5	14.2	17.3	77.4	3.2	13.4	20.7	39.2	24.4	10.6	12.4	11.3	29.1	28.3	10.2	26.3	14.7	14.9	30.5	4.8	5.1	22.3	15.5	46.0	24.6	39.2	1.7	27.3	55.7	138.9	1.2	16.7	7.3	16.0	29.9
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57089043-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	21.8	16.1	25.2	9.9	26.8	6.8	14.2	30.3	31.0	33.7	24.0	29.8	10.1	32.3	21.0	24.5	31.0	17.4	20.5	28.3	25.0	20.1	22.3	24.0	12.0	23.2	23.1	51.1	10.2	19.5	35.4	11.1	22.1	25.4	5.0	10.7	11.6	16.6	7.6	33.4	15.7	13.4	21.6	16.9	15.9	16.8	25.4	17.4	20.7	9.9	10.4	27.7	33.8	24.8	15.2	9.8	49.2	45.2	43.3	56.7	5.5	44.1	40.8	28.0	23.1	15.6	8.7	9.6	17.6	44.4	8.1	27.0	16.9	34.0	14.3	4.0	4.5	11.4	8.1	16.6	33.2	9.1	26.5	64.4	36.1	32.6	10.9	43.7	7.5	7.2	26.5	9.6	32.4	73.4	14.0	44.5	9.9	12.9	16.6	10.4	64.1	5.1	11.8	6.0	5.5	13.1	21.9	12.5	98.3	12.3	28.0	20.0	8.4	40.7	34.1	28.8	13.2	22.7	6.0	5.1	39.5	5.9	25.1	0.0	1.1	0.2	0.5	2.7	0.6	0.9	0.9	0.7	0.6	2.3	1.1	1.1	0.4	0.4	2.9	0.0	1.0	0.6	25.2	26.8	30.3	31.0	28.3	25.0	23.2	23.1	22.1	21.6	25.4	24.8	7.6	12.8	13.0	5.9	11.6	29.6	19.5	23.4	39.3	20.3	17.3	13.8	2.9	2.8	13.6	9.2	2.1	3.7	4.9	1.1	7.9	7.4	0.6	22.9	21.2	13.7	6.6	4.8	11.4	1.4	10.5	19.7	8.6	25.4	17.1	7.8	18.2	17.1	11.2	10.1	5.4	1.1	10.2	16.3	43.7	2.9	19.6	14.3	21.4	8.4	1.6	7.9	1.0	1.0	1.9	4.1	0.0	18.8	8.7	12.9	8.7	5.6	5.9	4.4	19.7	9.8	16.3	2.6	18.7	23.4	32.5	56.2	10.7	2.5	1.5	8.6
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	21.7	39.4	31.6	17.9	34.3	18.8	20.7	33.5	39.5	21.2	28.9	27.1	23.0	23.6	19.0	21.7	21.2	14.9	23.3	31.8	33.4	25.8	23.1	15.4	20.1	33.2	33.2	24.5	34.6	21.8	24.9	8.4	33.0	20.5	19.4	24.8	17.3	18.0	59.2	21.1	23.0	16.2	32.2	18.0	23.5	24.4	35.4	17.5	19.6	32.2	19.6	25.5	18.5	34.5	74.8	75.9	70.3	78.4	30.8	33.1	13.8	43.5	36.6	63.0	37.9	45.8	65.7	56.3	85.8	41.1	44.6	57.8	66.5	56.1	48.0	107.1	64.1	94.7	49.2	36.0	32.4	67.9	89.0	28.6	44.5	75.4	60.3	53.5	41.9	69.0	50.1	94.9	46.2	67.4	94.1	78.6	51.8	45.0	74.3	83.2	65.2	84.9	31.3	30.4	89.1	65.6	69.0	86.3	62.5	11.2	98.9	60.8	29.8	43.8	41.3	92.0	81.2	64.2	104.5	36.1	81.0	63.9	82.9	33.0	15.6	14.9	26.5	22.7	29.6	26.4	21.9	23.9	21.4	21.2	13.4	22.4	3.0	42.7	25.9	21.6	34.3	16.6	31.6	34.3	33.5	39.5	31.8	33.4	33.2	33.2	33.0	32.2	35.4	34.5	17.2	16.0	18.9	5.2	17.5	18.6	18.5	25.0	21.1	15.3	22.5	27.1	9.6	31.5	12.0	23.9	2.1	28.4	13.6	27.3	49.0	36.7	88.4	11.3	17.1	20.7	18.0	30.3	6.7	70.8	40.0	20.6	13.7	13.4	17.7	17.6	22.9	22.5	31.2	15.2	6.6	27.5	16.2	17.7	20.3	243.5	23.6	16.0	32.0	1.9	27.6	35.8	33.0	2.5	6.4	38.4	22.7	34.3	30.9	13.3	41.6	43.1	11.6	14.8	19.7	23.2	22.9	20.2	25.0	22.1	17.0	15.2	20.1	23.0	37.9	15.1
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080437-45088969	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.2;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	3.3	5.2	23.4	1.2	50.2	0.1	3.2	54.2	42.1	6.2	0.0	8.3	0.7	7.9	0.8	2.0	5.5	1.8	4.5	26.3	34.6	2.1	0.2	2.5	0.7	58.9	48.3	8.9	1.0	0.8	24.3	1.9	58.6	4.3	0.8	3.7	1.7	3.0	1.2	1.7	3.0	4.3	32.7	1.6	3.9	3.7	57.4	0.3	1.3	1.0	0.3	5.0	4.6	84.2	0.0	0.0	2.5	0.1	1.6	0.7	0.1	2.9	3.5	7.7	4.8	0.2	0.1	0.0	2.2	5.1	33.4	0.2	2.2	1.9	2.7	0.0	0.8	0.0	1.7	0.0	1.8	0.0	0.0	1.6	0.0	3.3	0.3	4.1	2.4	0.0	0.0	3.5	2.0	0.0	0.0	0.0	2.3	0.0	2.2	0.0	0.9	0.0	0.3	0.0	25.6	17.7	0.0	0.1	0.1	6.7	0.0	0.1	0.9	0.0	0.0	0.2	0.5	1.8	1.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.4	50.2	54.2	42.1	26.3	34.6	58.9	48.3	58.6	32.7	57.4	84.2	0.3	0.0	0.0	6.8	0.0	0.6	3.5	0.9	1.2	5.5	0.4	1.8	6.0	0.0	0.2	1.8	0.0	0.1	0.4	0.1	0.0	0.6	2.9	0.5	3.1	0.9	1.2	0.0	4.4	0.2	0.1	3.9	1.1	1.2	1.3	3.9	0.7	0.0	0.1	32.0	5.2	0.0	0.0	0.0	0.0	4.9	6.8	0.7	1.8	1.9	1.0	2.7	0.0	3.0	23.1	0.1	0.0	12.0	0.1	2.3	0.0	0.4	0.8	2.8	6.6	5.3	4.2	1.5	1.4	0.2	0.1	0.1	0.3	9.6	0.1	0.9
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13116862-13141147	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724"	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.6	19.5	31.0	14.6	19.2	8.8	10.3	7.1	26.6	9.7	0.0	17.3	13.3	18.4	7.9	27.6	11.9	6.4	20.9	25.7	7.4	14.8	20.5	16.7	12.1	13.4	15.9	7.7	12.2	10.7	14.8	12.4	15.1	14.6	6.6	3.7	15.8	11.2	24.2	17.4	16.0	7.7	8.9	15.9	16.0	17.0	20.6	11.3	14.0	7.9	8.8	15.0	12.6	16.4	98.8	110.0	28.0	59.6	15.0	17.7	74.9	47.4	34.2	42.4	32.4	114.8	40.4	50.9	104.1	39.8	37.3	49.0	34.8	80.7	16.2	89.1	52.5	32.4	87.9	84.7	35.5	52.0	82.3	28.8	28.0	46.1	24.7	36.5	50.2	46.4	72.5	19.8	22.9	206.1	82.9	39.6	123.6	28.9	101.7	47.8	32.9	49.5	28.2	101.1	58.2	37.7	49.6	64.9	39.1	29.8	59.3	46.4	76.7	94.6	58.8	67.2	87.0	53.4	88.1	42.4	99.7	52.8	58.9	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	31.0	19.2	7.1	26.6	25.7	7.4	13.4	15.9	15.1	8.9	20.6	16.4	4.9	0.0	1.7	6.2	5.6	12.1	7.5	11.8	2.8	16.6	11.5	7.5	2.1	12.8	8.5	16.5	2.1	19.0	12.9	22.7	7.9	12.3	2.3	10.9	8.9	8.1	4.9	12.2	7.2	8.8	20.0	5.2	10.7	17.6	10.2	13.3	8.6	18.0	21.1	26.9	5.9	16.2	14.2	9.6	9.6	2.0	4.4	8.8	5.4	3.7	10.5	12.0	10.3	5.5	5.4	21.7	11.1	9.4	5.6	16.5	14.0	15.0	5.9	7.7	6.6	7.5	7.0	11.1	15.6	8.4	13.9	27.1	7.9	15.2	15.4	17.2
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095289	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 120.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	12.3	11.4	80.9	8.7	100.0	2.0	8.0	115.6	74.1	9.7	26.5	32.7	6.2	20.9	4.1	8.5	12.8	7.2	16.7	52.8	81.0	7.5	9.6	9.5	3.4	113.2	104.9	7.7	7.6	4.6	6.4	2.6	112.3	11.8	3.8	4.9	7.9	17.3	17.0	4.5	9.9	15.6	85.8	8.1	13.6	6.5	120.6	1.0	5.8	6.8	2.0	23.2	7.3	91.9	6.1	32.7	3.6	49.0	15.4	8.6	4.5	14.6	9.7	4.6	1.6	14.0	10.6	0.0	17.1	23.2	7.4	23.3	7.9	7.9	1.5	18.6	7.1	4.1	33.3	17.6	15.6	0.0	7.4	14.4	7.2	4.3	4.3	18.8	13.0	0.0	12.8	0.1	9.0	20.5	0.0	11.6	11.0	9.7	20.2	0.0	3.8	10.0	19.2	6.9	1.2	1.5	20.6	17.0	18.2	16.2	17.4	37.9	21.6	12.3	13.9	10.5	10.1	0.1	0.0	0.3	16.2	1.4	25.2	1.9	2.2	0.8	0.8	1.7	0.3	0.0	0.3	0.7	1.2	0.0	0.2	0.2	2.7	0.2	1.7	0.1	0.2	0.8	80.9	100.0	115.6	74.1	52.8	81.0	113.2	104.9	112.3	85.8	120.6	91.9	14.3	12.8	5.0	69.9	0.8	4.6	4.9	9.0	3.4	3.4	6.7	5.6	28.5	7.2	7.9	5.5	0.0	0.7	7.0	12.4	0.0	12.6	76.2	18.9	9.8	18.5	2.4	1.7	2.5	13.4	2.1	10.9	7.7	6.0	2.5	1.5	17.9	33.2	7.8	3.3	21.1	4.4	0.0	38.4	8.0	305.5	18.0	16.6	5.4	21.5	45.3	17.1	12.3	40.7	45.1	18.3	9.2	19.2	2.1	11.8	6.7	13.6	12.5	1.9	26.3	14.0	15.8	2.4	12.6	6.8	5.1	0.4	5.7	1.4	5.3	7.6
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 506.2"	"Group enriched"	"Detected in all"	7	"granulocytes: 506.2;monocytes: 162.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	53.6	81.8	24.8	37.5	26.6	100.7	44.7	22.1	29.0	28.6	27.8	45.1	38.0	30.9	13.3	29.9	36.1	23.3	28.7	24.1	24.3	30.2	134.0	40.3	41.2	25.4	24.6	37.2	38.9	17.2	26.4	26.0	25.0	32.9	25.4	10.9	40.2	17.4	19.6	28.3	43.3	19.8	24.5	93.1	43.2	27.5	26.5	16.4	31.7	19.2	26.6	32.3	27.1	23.8	41.6	39.3	34.4	50.7	47.8	34.5	44.2	40.9	35.5	45.6	40.3	42.1	74.2	54.5	30.4	30.5	14.7	34.6	37.3	32.5	20.3	53.5	59.1	44.7	65.0	73.6	46.2	63.4	72.1	40.6	28.9	28.4	40.3	24.8	44.9	42.6	55.9	75.8	34.4	47.4	48.1	54.8	23.5	69.4	43.8	60.4	29.4	113.1	39.7	33.9	46.2	35.2	45.8	99.2	43.7	20.3	34.2	43.6	43.8	33.1	23.7	34.6	37.5	67.1	32.7	121.8	32.7	69.3	17.6	84.2	141.3	329.7	7.4	158.6	8.8	10.8	4.3	5.9	45.9	12.1	2.8	4.1	506.2	3.8	162.6	37.9	7.0	82.9	24.8	26.6	22.1	29.0	24.1	24.3	25.4	24.6	25.0	24.5	26.5	23.8	29.0	12.8	30.7	14.4	27.2	9.8	15.7	11.2	13.6	7.9	21.4	17.9	6.8	25.8	21.6	14.7	16.7	24.5	46.8	57.8	15.6	19.1	14.9	18.7	22.2	20.8	22.8	15.8	10.2	29.4	26.3	18.7	52.0	22.8	2.5	21.2	22.5	94.3	36.6	6.7	10.4	38.7	16.2	58.4	13.7	26.7	37.6	45.0	8.8	9.4	67.3	5.7	27.8	10.6	11.1	28.7	34.6	34.6	26.0	34.7	28.6	24.3	13.5	17.7	13.1	12.6	18.2	12.4	22.4	19.5	12.8	42.8	15.4	44.2	31.0	27.5
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192589-36242279	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"liver: 328.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 105.4;Early spermatids: 324.5;Hepatocytes: 211.9;Late spermatids: 154.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 36.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		30000	"Cluster 24: B-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	13.6	20.1	26.6	9.3	23.3	10.6	15.4	21.9	24.2	13.7	14.0	13.9	16.6	13.3	7.9	10.4	12.7	11.9	20.2	22.2	27.1	23.2	328.0	8.4	9.5	25.4	27.4	19.6	26.9	10.7	5.5	16.9	25.3	19.0	13.8	11.2	13.0	16.2	29.4	6.6	12.9	14.2	31.0	8.6	17.1	18.2	25.3	10.3	17.3	29.8	11.4	27.9	8.8	30.3	21.5	14.6	22.4	23.5	32.2	27.2	27.5	19.5	13.2	17.5	13.2	41.4	27.4	74.3	14.0	23.3	23.0	14.9	20.0	14.3	24.2	21.2	16.3	22.0	43.1	23.9	22.7	46.5	8.0	28.9	22.5	21.6	29.9	22.4	18.4	30.2	52.0	27.8	18.0	9.0	42.3	18.2	10.7	18.1	19.2	40.2	51.6	15.8	24.2	18.2	8.7	20.1	102.0	32.4	10.5	16.7	22.9	39.8	15.1	34.1	18.2	27.0	23.9	23.7	30.3	23.2	14.5	57.2	14.2	8.2	1.2	1.1	1.3	1.4	1.8	1.3	1.9	1.5	2.3	5.3	1.6	1.4	0.1	6.7	3.3	1.2	2.1	1.4	26.6	23.3	21.9	24.2	22.2	27.1	25.4	27.4	25.3	31.0	25.3	30.3	9.6	3.2	6.9	105.4	7.5	6.8	6.8	5.4	6.2	5.7	18.3	11.2	29.3	25.8	7.1	5.5	8.4	9.2	9.6	7.4	25.4	5.0	324.5	6.1	9.4	6.8	7.2	13.7	23.8	9.5	8.9	12.5	5.6	7.1	1.3	10.0	12.1	211.9	8.9	3.3	18.3	11.7	4.1	10.4	9.6	154.9	19.9	6.4	14.2	11.2	3.7	16.9	5.2	21.1	23.6	6.9	8.8	23.0	14.3	14.9	6.6	23.1	7.2	5.4	0.0	11.6	13.5	35.1	11.0	7.7	5.7	7.3	6.9	26.4	11.6	12.3
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	29.5	34.1	18.8	24.1	20.4	67.6	26.2	18.5	21.2	30.4	20.3	48.6	39.5	26.0	24.2	56.3	31.2	25.8	20.3	17.8	18.3	33.2	49.8	35.3	33.3	22.4	19.6	27.6	29.5	13.4	36.0	16.5	21.0	45.3	36.0	6.9	32.9	22.8	11.0	31.1	51.1	19.3	18.8	58.4	34.3	25.6	21.7	27.9	31.8	5.1	28.2	43.4	33.4	24.4	15.9	37.8	12.0	21.6	35.0	50.6	32.4	29.7	27.2	15.4	17.0	32.4	25.7	13.4	33.1	35.3	20.7	55.2	15.9	42.6	8.2	27.9	12.8	22.2	27.6	36.3	43.3	45.1	40.9	72.0	65.8	19.9	17.8	34.9	54.6	24.2	11.9	18.5	21.9	49.7	22.4	29.9	7.0	69.6	21.3	27.5	37.2	13.5	37.8	72.1	8.9	12.7	21.2	27.9	56.0	17.9	24.9	24.4	66.2	16.7	14.2	30.9	11.8	24.3	11.0	11.7	29.9	25.6	12.0	6.1	28.0	17.3	15.3	25.0	12.7	12.2	13.5	13.8	31.1	9.2	8.8	11.4	17.7	16.3	22.6	23.0	17.7	21.4	18.8	20.4	18.5	21.2	17.8	18.3	22.4	19.6	21.0	18.8	21.7	24.4	12.6	22.4	32.3	4.2	24.0	6.2	17.8	18.4	26.2	7.8	13.5	10.9	8.3	12.8	19.8	11.0	4.2	17.4	27.3	65.3	3.9	16.5	22.6	21.1	11.1	15.6	23.4	20.2	5.1	17.3	14.5	12.8	51.0	19.7	22.1	23.1	13.9	16.7	20.1	13.5	5.8	30.3	16.2	23.2	18.5	60.9	9.3	25.4	8.8	8.4	25.8	5.9	29.9	7.5	18.5	20.0	55.8	10.1	18.0	17.9	73.3	16.2	16.5	7.3	13.1	9.6	9.8	15.9	5.0	38.3	12.8	17.2	22.3	17.1	43.7	24.2
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.9	28.3	26.0	26.0	26.0	38.8	32.5	28.8	29.6	23.0	27.1	31.9	32.4	32.9	35.2	30.3	26.8	24.2	29.7	25.5	27.1	26.5	28.6	22.5	36.1	25.8	26.1	35.6	27.3	41.5	22.6	28.4	27.1	28.8	35.3	33.9	25.9	26.7	35.0	33.1	33.2	30.3	27.0	22.2	21.6	47.1	27.1	35.0	32.3	33.0	31.6	28.6	22.1	30.3	107.6	81.1	140.4	139.4	55.1	78.9	116.9	79.9	80.3	115.6	139.8	99.5	80.9	118.1	89.1	60.4	74.8	105.6	107.7	96.5	162.0	43.8	122.1	83.9	53.6	153.9	63.2	157.3	100.7	64.0	69.6	92.8	80.7	61.0	82.5	141.2	201.9	40.3	89.9	37.5	165.7	177.7	196.2	83.4	144.6	175.7	167.8	157.7	89.1	92.6	151.3	110.6	239.5	50.7	94.7	86.0	54.2	105.2	64.7	80.2	80.1	84.7	93.9	75.3	125.3	423.8	72.3	103.0	99.7	2.8	6.0	13.4	27.3	5.8	34.9	18.2	29.0	30.1	8.2	14.4	31.0	31.4	2.7	17.1	6.5	12.2	27.4	18.3	26.0	26.0	28.8	29.6	25.5	27.1	25.8	26.1	27.1	27.0	27.1	30.3	29.2	32.1	32.2	23.5	30.1	33.0	66.6	87.2	17.1	52.0	28.4	31.4	30.7	18.6	53.4	31.3	12.5	101.3	33.9	28.0	39.2	70.0	4.6	27.7	23.2	30.7	22.9	38.9	41.3	60.2	70.9	38.4	20.9	22.9	35.4	55.9	19.2	21.3	28.6	50.5	40.7	33.3	67.1	10.4	13.5	14.3	48.7	16.2	49.8	17.8	25.7	68.4	51.5	33.2	39.8	65.0	114.3	54.2	32.0	68.8	34.7	48.2	44.8	35.9	19.7	41.0	63.7	145.4	219.3	33.6	32.1	52.4	36.9	49.4	42.5	49.5
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166890	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	9.5	8.1	4.7	7.6	5.9	7.6	8.3	3.9	7.1	8.7	9.2	7.2	4.7	10.4	6.1	7.0	12.3	7.0	6.5	6.2	3.5	6.8	7.1	7.0	8.7	2.4	3.7	10.9	7.7	10.7	4.8	6.6	1.8	8.5	8.1	13.5	7.6	8.6	19.4	8.3	4.9	8.7	3.1	7.3	6.0	13.3	2.5	7.1	10.2	10.3	7.9	9.5	4.8	4.0	15.2	12.7	16.0	16.4	9.2	14.5	18.8	17.6	11.7	15.1	15.0	14.4	17.8	39.4	5.0	10.9	12.2	12.5	32.7	18.9	19.7	17.5	20.2	41.7	11.4	12.3	16.1	27.2	14.3	13.7	16.5	18.5	14.9	15.6	13.6	12.5	47.7	20.3	20.4	15.0	31.8	15.5	20.9	11.5	12.5	26.1	11.8	20.7	15.0	6.9	17.3	13.1	11.6	20.9	13.0	13.9	11.3	11.8	14.4	18.0	15.6	14.1	20.2	12.7	19.1	30.2	17.1	15.6	18.2	0.0	0.5	0.0	0.7	0.5	0.2	0.6	0.7	1.0	0.8	0.7	1.0	0.7	0.0	0.4	0.5	0.8	0.2	0.5	4.7	5.9	3.9	7.1	6.2	3.5	2.4	3.7	1.8	3.1	2.5	4.0	15.2	6.4	16.7	24.8	25.9	32.4	23.6	10.5	19.4	10.9	10.7	12.8	4.0	11.5	8.0	9.2	18.8	14.3	19.0	4.2	3.9	9.8	48.0	35.7	13.3	9.2	19.2	11.1	44.8	6.8	15.6	25.1	9.2	22.1	10.8	10.2	12.1	5.0	11.7	8.4	30.9	8.2	4.1	17.9	13.3	19.1	6.8	32.8	8.8	19.7	6.0	10.3	4.1	31.7	29.8	7.8	4.0	5.3	16.4	14.4	2.8	8.9	30.3	14.7	32.9	29.8	24.7	23.6	16.2	14.8	41.1	21.3	24.9	13.0	8.0	13.1
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079808	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 216.9;Syncytiotrophoblasts: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 391.8;granulocytes: 288.7;monocytes: 594.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	41.2	36.0	47.0	61.2	48.0	21.9	35.1	49.5	52.1	57.5	47.0	37.7	21.0	33.6	40.6	156.2	29.0	44.1	31.4	46.9	52.9	35.1	42.8	39.6	79.6	50.9	50.4	31.0	42.2	80.7	42.3	44.3	53.7	30.0	34.2	16.5	75.0	37.9	26.6	63.0	33.6	50.1	48.3	88.9	33.9	50.2	49.0	60.8	27.4	32.3	98.4	71.7	59.7	52.1	55.9	39.2	22.6	25.8	114.2	67.5	98.3	119.0	65.5	95.6	86.8	54.3	29.5	30.3	29.3	107.4	113.5	25.7	22.4	43.9	62.7	44.9	16.4	17.0	12.6	37.5	91.6	10.5	37.7	60.7	49.6	101.8	16.4	68.3	107.7	31.7	8.1	34.8	143.4	52.2	28.6	40.2	28.7	53.5	38.4	22.1	64.2	15.8	65.5	91.4	25.1	13.0	35.2	62.1	45.1	50.7	30.4	13.9	66.0	99.0	37.8	36.9	44.8	23.0	24.8	18.0	69.6	31.5	54.5	86.6	594.1	245.1	36.9	526.5	39.2	102.5	44.2	37.0	391.8	103.7	36.7	30.0	288.7	65.3	378.2	318.5	54.7	466.2	47.0	48.0	49.5	52.1	46.9	52.9	50.9	50.4	53.7	48.3	49.0	52.1	22.9	38.5	34.2	15.0	48.6	26.9	28.4	60.8	19.4	46.1	27.4	27.6	18.0	17.2	56.9	38.6	22.9	146.0	67.4	13.9	41.1	66.1	151.3	22.5	26.1	31.7	23.4	12.8	11.5	45.7	144.0	35.6	15.8	24.9	51.9	31.1	30.0	12.9	216.9	47.1	15.2	20.4	28.5	121.8	67.5	33.0	30.1	106.0	39.2	26.2	118.6	45.4	17.5	17.1	24.0	59.1	32.3	37.6	51.2	15.5	23.3	64.7	35.2	55.6	19.7	31.8	37.4	68.0	25.6	39.9	41.6	318.8	29.1	32.2	16.2	34.7
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536241-42544449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		270000000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	41.6	37.9	12.5	14.8	21.6	20.3	35.3	16.6	16.7	31.1	28.7	25.1	24.3	34.7	12.8	19.5	27.6	27.4	20.1	12.0	15.0	39.3	59.3	30.8	24.0	18.0	19.2	35.2	63.8	21.3	22.5	26.1	20.1	28.3	16.4	3.1	37.7	18.4	16.0	25.1	30.9	13.8	14.2	40.7	35.1	8.7	19.5	17.1	37.6	9.7	13.4	28.9	23.9	30.0	16.0	55.3	10.8	24.6	106.6	34.5	36.4	24.0	56.9	24.9	31.7	14.9	40.4	20.3	23.7	37.4	54.7	38.3	9.7	11.7	5.5	15.8	20.2	11.2	31.3	31.8	35.3	13.3	27.7	41.4	17.8	13.6	16.9	27.3	32.8	3.6	16.6	39.3	27.9	38.9	2.2	23.0	12.6	34.6	7.0	8.7	23.6	47.2	33.1	36.1	16.2	24.4	12.9	17.6	20.4	15.6	82.1	14.1	25.8	59.3	9.7	23.8	15.7	52.6	25.8	17.6	35.9	14.4	43.1	1.1	2.4	1.9	2.5	1.8	2.4	2.4	1.0	1.3	2.1	1.8	1.8	1.4	1.1	2.1	2.9	2.8	0.2	1.1	12.5	21.6	16.6	16.7	12.0	15.0	18.0	19.2	20.1	14.2	19.5	30.0	14.1	12.8	7.8	17.3	9.0	2.8	6.1	3.9	2.2	15.5	14.2	8.9	3.8	18.6	4.9	18.4	4.2	23.8	11.4	21.1	3.9	18.4	0.3	5.8	14.5	12.2	6.7	4.4	2.3	33.2	14.5	26.4	27.0	12.1	2.5	40.1	24.3	43.7	37.6	15.2	3.1	17.6	0.0	26.0	3.5	2.4	19.9	19.0	16.0	10.3	5.9	13.2	8.2	6.0	19.2	15.8	5.4	12.8	12.9	10.7	23.0	31.8	3.7	6.7	6.6	18.0	12.8	0.4	6.0	6.1	3.4	18.5	6.0	74.6	15.0	6.0
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAIP	"BIRC1, NLRB1"	ENSG00000249437	"NLR family apoptosis inhibitory protein"	Q13075	5	70968166-71025339	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 31.6"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 138.4;Macrophages: 97.4;Microglial cells: 113.4;Oligodendrocytes: 177.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 8.4;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	16	"dendritic cells: 5.3;granulocytes: 4.4;monocytes: 8.4"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;SiHa: 2.1;T-47d: 2.3"									HPA042438	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042438: AB_10796578"	"unprognostic (9.03e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.96e-2)"	5.5	2.7	1.1	2.7	0.8	1.6	3.4	1.8	1.7	3.0	1.0	3.2	0.3	2.1	0.8	1.4	4.5	1.1	2.9	1.0	0.8	2.7	3.4	6.8	2.4	0.8	0.5	2.9	3.3	0.2	1.4	0.6	1.0	2.2	0.5	2.1	1.8	0.5	1.0	2.2	4.6	0.8	0.5	31.6	2.8	4.1	1.2	0.4	3.6	0.0	0.2	3.0	2.7	1.0	0.0	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.5	0.7	0.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.4	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.4	0.0	2.1	0.0	0.1	0.4	2.3	0.0	0.0	0.6	0.2	0.1	0.0	0.5	0.0	0.3	0.1	0.1	0.4	0.2	8.4	0.0	0.2	2.0	0.1	0.0	0.0	0.1	5.3	0.2	0.2	0.1	4.4	0.3	0.4	0.3	0.1	2.5	1.1	0.8	1.8	1.7	1.0	0.8	0.8	0.5	1.0	0.5	1.2	1.0	8.5	19.2	9.7	60.7	9.4	3.6	2.4	2.2	2.8	16.2	10.2	4.6	3.2	11.5	8.2	5.5	22.9	3.7	7.3	4.1	0.0	1.9	44.0	10.0	15.1	11.1	10.7	18.3	50.2	2.3	2.4	8.2	14.3	10.9	5.1	15.8	9.3	7.3	69.3	16.8	46.4	5.6	2.0	138.4	16.4	11.6	10.8	97.4	1.8	113.4	44.2	6.7	4.1	67.8	177.5	1.6	2.5	7.2	9.8	2.3	1.6	1.3	6.9	38.4	6.6	12.8	5.5	13.7	4.4	3.6	3.8	2.9	8.5	6.0	4.0	1.5
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.1"	"Group enriched"	"Detected in some"	10	"Astrocytes: 125.4;Excitatory neurons: 265.8;Inhibitory neurons: 277.4;Oligodendrocyte precursor cells: 324.7;Oligodendrocytes: 477.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 14.2;HHSteC: 14.4;hTERT-RPE1: 11.0;TIME: 19.8;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	0.5	4.3	7.5	0.4	9.8	0.6	2.7	6.4	10.3	1.5	0.0	0.4	0.6	0.5	1.5	0.2	1.0	2.3	3.3	8.6	10.2	0.3	1.2	1.1	0.3	8.2	5.8	2.8	1.3	2.9	6.8	3.0	7.0	0.3	0.6	6.1	0.8	1.0	0.3	0.5	0.5	0.5	6.8	0.4	0.7	0.6	8.3	0.0	2.4	0.2	0.1	0.5	0.2	13.1	0.1	7.8	1.4	0.2	0.7	0.3	0.1	0.8	0.8	1.8	0.4	0.2	8.9	0.0	0.3	3.6	0.8	14.2	0.0	2.2	5.5	0.0	1.2	0.4	3.8	0.1	14.4	0.2	0.3	0.4	0.5	1.7	4.6	11.0	8.2	0.1	0.1	0.4	5.9	0.0	0.1	0.0	0.4	1.3	1.8	0.0	0.0	0.0	4.6	1.9	1.2	0.6	0.1	0.0	0.8	0.9	0.2	0.1	19.8	0.4	0.1	0.3	1.8	0.1	0.1	0.1	11.4	0.1	0.3	2.6	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	7.5	9.8	6.4	10.3	8.6	10.2	8.2	5.8	7.0	6.8	8.3	13.1	0.1	0.0	0.0	125.4	0.0	0.3	0.0	0.3	0.6	15.4	3.5	4.6	6.2	0.0	0.1	0.0	6.2	1.0	0.0	0.0	0.0	0.8	4.5	0.1	0.2	0.6	0.0	0.0	265.8	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	26.9	277.4	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	23.4	0.0	2.0	0.0	324.7	477.4	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	2.6	0.0	3.6	0.5	0.2	0.8	0.0	0.1	0.5	0.0	0.1	0.0	0.0
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248298-106285966	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 279.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 279.2"	"Cell line enhanced"	"Detected in all"		"HHSteC: 387.5;U-87 MG: 434.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	308.5	74.2	14.4	360.5	15.6	312.5	103.3	15.2	35.4	47.3	21.7	62.5	38.5	38.6	6.9	228.2	107.6	113.7	103.1	15.2	20.9	82.9	317.9	218.5	23.2	75.7	24.9	58.4	80.9	25.9	30.1	87.3	30.3	70.1	30.3	17.2	126.0	13.4	135.9	54.1	55.9	48.0	21.3	88.2	102.4	11.7	46.3	15.6	42.2	44.4	39.9	283.3	86.7	21.5	103.6	41.0	14.6	16.8	85.8	95.0	34.4	26.1	194.7	57.0	90.6	25.7	38.7	77.7	78.8	32.1	131.5	58.2	38.8	88.1	93.8	50.5	51.7	35.8	17.2	22.6	387.5	61.3	49.4	94.8	94.2	114.9	115.0	70.6	187.3	32.0	70.5	225.6	68.1	49.4	58.1	19.4	36.6	33.6	59.7	25.8	30.4	147.6	46.2	60.8	33.4	19.3	46.0	61.1	107.9	43.0	25.4	9.4	168.2	75.6	52.9	105.9	51.9	212.1	142.7	115.7	434.3	69.3	105.6	39.6	6.5	16.0	1.8	21.8	2.4	3.9	2.2	2.7	7.0	3.4	2.8	2.2	279.2	4.4	30.5	5.5	7.1	4.8	14.4	15.6	15.2	35.4	15.2	20.9	75.7	24.9	30.3	21.3	46.3	21.5	323.8	131.4	245.7	12.1	78.0	207.6	321.0	105.7	169.0	23.8	184.2	132.0	94.8	197.3	161.4	42.3	12.5	26.2	67.5	105.8	46.9	320.6	12.2	128.0	160.8	192.8	25.1	29.5	25.3	141.3	58.9	239.6	132.0	296.5	188.4	18.8	159.5	580.0	107.0	40.4	28.8	51.9	63.1	390.3	1123.7	6.9	40.4	947.3	161.9	46.9	102.7	22.6	9.2	12.1	22.4	138.1	49.7	31.2	93.7	364.0	112.8	50.7	94.1	30.8	26.3	264.6	185.6	30.5	65.8	98.3	207.8	25.3	110.3	38.4	79.4	334.5
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.7	0.4	0.1	1.9	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.7	1.9	0.4	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
NANOGNB		ENSG00000205857	"NANOG neighbor homeobox"	Q7Z5D8	12	7765216-7774121	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	18	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060371	Uncertain					NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA060371: AB_2684266"															"unprognostic (2.76e-1)"			0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029714-119033730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	9.5	11.3	7.4	0.3	7.3	0.2	8.3	7.4	7.7	1.9	5.0	2.9	0.3	2.1	1.7	1.0	1.0	0.2	10.3	5.9	11.8	4.6	0.3	1.1	0.4	8.8	8.9	0.3	2.2	0.3	2.8	6.3	8.5	1.0	0.4	4.1	1.3	0.9	38.6	1.6	0.9	1.8	7.1	0.3	3.4	1.9	9.2	0.3	7.1	1.7	0.3	3.3	1.0	10.9	16.4	1.3	2.2	0.4	7.4	1.1	9.7	0.4	0.5	0.4	0.2	2.0	5.6	8.7	2.2	0.1	0.0	5.8	2.7	2.9	0.7	2.6	6.6	0.2	3.8	1.8	3.5	1.0	0.0	1.5	11.7	0.1	1.6	2.4	0.4	3.0	1.7	1.0	0.5	2.3	2.2	2.8	7.1	3.4	1.3	0.0	2.7	5.9	3.1	1.3	6.3	80.4	4.7	46.7	37.4	12.2	7.4	4.7	0.5	0.0	3.4	0.1	0.8	2.4	8.6	3.2	0.7	2.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	7.3	7.4	7.7	5.9	11.8	8.8	8.9	8.5	7.1	9.2	10.9	5.7	6.4	1.1	2.0	1.3	0.8	5.0	1.3	0.6	4.1	10.2	6.1	11.3	1.5	1.2	1.8	10.4	6.5	6.3	4.4	0.0	0.6	0.2	3.9	2.8	1.7	3.0	0.0	0.5	0.2	0.4	4.0	1.1	3.7	0.0	2.6	0.7	0.1	0.7	1.7	2.3	3.8	0.0	0.0	2.1	0.1	1.8	0.9	0.0	0.0	0.0	14.7	1.0	2.0	0.2	0.3	0.1	0.7	1.6	2.9	0.2	0.5	1.2	2.1	0.0	7.7	3.9	0.4	1.0	0.8	1.3	1.0	2.9	0.7	2.1	1.3
NANOS2	"NOS2, ZC2HC12B"	ENSG00000188425	"Nanos C2HC-type zinc finger 2"	P60321	19	45913214-45914778	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.6"	"Cell type enriched"	"Detected in single"	16	"Spermatogonia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014190	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA014190: AB_2668950"					"unprognostic (2.65e-1)"					"unprognostic (1.01e-1)"					"unprognostic (3.69e-1)"			0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOS3	"NANOS1L, NOS3, ZC2HC12C"	ENSG00000187556	"Nanos C2HC-type zinc finger 3"	P60323	19	13862063-13880757	"Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.6;testis: 4.1"	"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.2"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 132.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA062989	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA062989: AB_2684916"	"unprognostic (9.42e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.23e-3)"	"unprognostic (4.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.9	1.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.2	0.0	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.1	4.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.9	1.6	0.5	0.5	0.5	0.5	0.5	0.3	0.4	0.7	0.8	0.0	2.4	0.7	0.4	1.8	1.0	1.9	0.0	1.0	5.6	5.5	0.5	0.0	1.1	1.8	0.0	0.0	0.1	0.2	0.0	2.0	1.1	1.7	0.2	1.1	1.2	0.4	5.1	1.2	0.2	0.8	0.0	2.0	1.3	0.7	0.4	0.2	0.4	0.0	4.5	0.7	0.0	0.8	5.5	3.0	0.0	0.6	3.6	1.9	2.7	4.9	0.0	2.5	0.5	3.2	0.2	0.7	0.2	1.8	0.4	0.0	0.9	0.8	0.0	2.8	1.4	0.2	20.2	0.0	1.3	0.1	0.7	0.0	0.4	1.2
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624014	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	3.3	3.8	1.4	2.6	1.4	3.4	3.0	2.8	1.4	2.3	1.7	2.1	2.9	2.3	2.4	2.8	2.1	2.5	2.5	1.3	1.8	4.4	4.8	2.4	2.0	1.3	1.5	2.7	3.2	2.8	1.5	2.6	1.4	2.3	2.5	2.9	2.1	1.9	1.7	2.0	2.0	2.8	1.1	1.9	2.3	2.8	1.7	4.9	3.0	3.7	2.4	2.9	1.9	1.4	14.2	8.5	6.7	9.4	10.7	11.0	9.5	7.1	13.9	9.3	11.8	7.4	9.7	4.9	7.9	13.6	11.0	8.9	10.6	10.7	17.9	1.7	5.9	13.3	3.8	20.1	9.1	10.0	3.7	9.9	5.1	10.7	13.6	5.1	8.2	17.8	11.1	8.5	11.7	8.0	19.4	4.8	4.8	12.6	12.6	9.3	14.1	6.4	5.7	7.7	12.6	5.2	8.0	12.7	8.7	6.6	5.3	8.5	6.8	14.5	10.9	13.6	10.2	4.3	4.1	12.4	4.3	22.7	9.1	0.3	2.3	0.9	1.3	2.4	2.0	0.6	0.9	1.0	3.3	0.6	0.8	1.4	0.3	2.2	1.4	0.7	0.8	1.1	1.4	1.4	2.8	1.4	1.3	1.8	1.3	1.5	1.4	1.1	1.7	1.4	3.6	3.2	1.5	4.2	1.9	5.9	5.8	4.6	2.8	4.5	3.0	2.3	2.8	5.7	3.6	7.3	0.0	4.1	5.2	1.7	13.7	5.2	0.3	2.0	4.7	4.4	3.0	16.0	3.3	4.2	2.1	4.9	4.6	2.0	5.7	3.4	3.6	5.3	4.6	6.7	3.6	2.3	6.1	4.1	4.8	0.8	3.1	2.8	5.4	1.9	2.4	5.5	9.2	2.5	2.3	4.8	2.0	2.6	3.5	5.1	1.8	8.2	2.1	7.3	0.0	4.6	3.4	5.5	11.3	2.6	5.1	1.9	1.9	7.4	2.2	3.1
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NAP1L1	"MGC23410, MGC8688, NAP1, NAP1L, NRP"	ENSG00000187109	"Nucleosome assembly protein 1 like 1"	P55209	12	76036585-76084735	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028861	Approved		Uncertain	Microtubules		NA	NA		10000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Microtubules		"HPA028861: AB_10603880"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.29e-9)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.14e-13)"	"unprognostic (5.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.15e-1)"	270.7	293.7	240.6	215.5	261.7	337.4	248.4	224.3	295.7	341.7	182.2	255.2	76.7	274.1	172.3	156.9	260.9	217.2	250.2	207.8	239.1	155.4	113.2	320.7	456.3	249.6	239.0	602.9	137.4	125.5	175.6	201.9	257.8	228.5	123.5	199.8	193.1	211.0	378.2	142.5	175.1	190.2	285.6	278.3	158.5	127.7	254.0	341.4	178.1	144.9	386.7	253.7	244.1	275.2	765.7	575.6	1061.5	673.3	667.4	1066.2	596.5	479.3	655.2	724.9	532.1	633.5	278.5	1791.9	521.0	601.8	305.7	496.1	636.3	763.4	892.0	570.1	627.7	667.6	407.6	646.4	950.1	1075.1	624.2	748.0	810.0	502.4	842.5	1778.1	891.6	640.5	995.1	379.3	1162.6	366.2	1380.9	868.2	1214.7	278.7	529.9	1071.8	1053.2	748.8	640.6	421.8	455.7	654.4	400.9	580.4	1180.9	818.0	860.4	765.8	704.5	561.5	635.1	403.2	687.9	472.7	601.0	1115.1	343.2	552.1	371.0	6.9	114.4	183.5	95.1	350.0	192.7	248.1	218.5	154.4	226.1	205.7	250.8	207.1	28.1	153.6	732.5	165.3	242.4	225.4	240.6	261.7	224.3	295.7	207.8	239.1	249.6	239.0	257.8	285.6	254.0	275.2	184.6	166.7	227.5	77.4	506.6	459.2	637.5	478.4	352.3	158.1	308.0	327.8	453.8	197.3	271.3	136.1	79.2	523.7	313.5	39.7	238.7	360.5	225.9	333.6	833.9	340.2	247.1	254.9	181.9	281.7	460.0	386.6	66.8	198.3	435.9	345.2	260.9	125.6	428.1	252.4	149.0	160.6	195.3	546.8	738.3	249.5	709.3	644.0	403.8	93.7	839.2	372.8	241.0	92.5	109.3	397.4	61.3	832.8	183.4	601.2	9.7	266.6	341.6	127.0	374.7	457.2	448.4	350.7	159.2	268.7	337.6	417.0	408.4	353.4	182.9	430.0
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695913-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.6"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	9.3	27.7	41.3	4.5	35.7	7.2	5.9	24.1	53.9	7.0	11.6	5.7	2.1	7.9	12.9	4.8	5.8	6.7	7.3	34.1	72.9	7.5	6.2	3.6	3.8	38.0	49.1	9.9	3.3	9.0	23.0	6.0	55.3	8.1	3.5	21.0	2.8	10.4	2.8	2.1	2.8	8.0	25.5	4.4	3.9	6.2	37.6	3.8	11.6	4.0	2.7	7.6	3.5	26.7	0.0	1.9	12.4	7.6	17.7	11.3	0.0	13.5	8.2	6.8	10.5	0.0	1.6	0.0	5.4	7.9	3.0	2.6	22.2	5.4	12.2	4.3	0.0	23.8	7.9	1.9	15.4	12.4	15.0	18.0	1.7	8.0	1.2	8.7	12.2	13.1	6.8	0.1	20.1	0.2	15.3	0.9	5.1	6.6	0.0	8.2	3.6	1.4	4.5	5.7	16.4	49.6	0.0	2.4	10.4	13.2	0.0	3.5	8.8	7.7	1.9	4.9	6.8	3.4	0.0	0.0	16.4	0.0	6.1	0.0	0.1	0.1	1.4	0.1	0.9	0.0	0.6	1.0	0.3	0.2	1.2	1.1	0.2	0.5	0.3	0.3	0.7	0.3	41.3	35.7	24.1	53.9	34.1	72.9	38.0	49.1	55.3	25.5	37.6	26.7	6.4	3.2	6.7	8.5	4.2	1.8	3.8	2.2	5.2	32.4	3.0	5.2	5.3	1.5	4.7	5.5	14.6	16.0	12.2	0.6	15.6	1.8	1.0	2.8	13.0	7.2	17.3	10.5	21.2	2.6	2.2	12.8	4.6	3.3	31.1	5.6	16.8	3.0	5.6	15.2	30.8	2.2	2.0	0.9	3.1	0.7	10.8	2.9	5.4	3.7	1.8	36.8	8.2	5.5	7.6	1.0	1.3	18.0	4.3	2.0	0.1	5.9	1.4	16.1	19.7	9.2	14.5	8.6	3.0	2.2	1.4	22.2	9.0	16.3	0.9	2.2
NAPA		ENSG00000105402	"NSF attachment protein alpha"	P54920	19	47487637-47515091	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010100, HPA046149, HPA050196"	Approved		Uncertain	Cytosol		NA	NA		2200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048"	"unprognostic (9.83e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.72e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.09e-3)"	"prognostic favorable (4.26e-9)"	"unprognostic (4.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.90e-2)"	83.0	147.5	104.8	56.8	112.1	115.2	83.6	112.4	146.1	87.2	89.8	79.5	61.9	102.0	54.5	122.7	86.0	63.7	112.9	125.1	102.5	98.6	153.2	79.8	57.0	120.9	99.8	66.4	92.0	101.1	96.5	56.9	119.3	105.1	50.8	83.7	124.3	94.6	180.2	131.9	62.4	72.6	97.3	66.4	83.6	79.3	111.2	85.2	74.6	116.8	53.1	76.7	85.7	112.8	73.1	99.3	48.1	85.3	100.4	80.9	36.7	78.1	98.7	189.3	229.1	76.1	44.3	55.8	41.5	110.4	119.1	56.3	77.7	98.1	72.8	89.2	84.6	70.1	88.5	93.6	256.9	80.6	124.5	122.0	70.2	77.0	47.6	38.1	92.1	74.9	67.0	150.0	123.7	66.2	115.7	284.6	40.5	110.7	75.7	79.8	42.2	82.6	149.6	133.5	174.9	67.6	101.0	126.4	76.6	43.8	98.9	136.9	91.0	97.4	51.3	83.9	93.6	94.5	143.7	76.9	176.3	89.5	102.5	196.4	165.0	313.1	96.1	189.8	81.3	68.7	82.9	94.3	132.3	70.3	84.8	85.3	187.9	111.1	201.1	209.9	112.2	209.4	104.8	112.1	112.4	146.1	125.1	102.5	120.9	99.8	119.3	97.3	111.2	112.8	59.1	12.8	41.5	19.9	48.6	63.3	91.1	73.5	92.2	55.1	69.5	63.5	3.8	72.9	44.5	51.5	27.1	106.4	73.3	89.1	178.1	110.9	44.2	40.8	37.5	49.3	83.6	89.9	30.5	99.8	69.0	48.0	94.8	70.0	64.7	23.8	39.7	89.6	131.1	35.3	21.7	62.6	99.7	58.4	69.1	37.4	42.9	87.7	97.8	14.0	79.1	76.7	66.9	11.1	21.8	100.2	69.8	46.3	92.9	50.5	80.3	99.0	20.1	47.3	92.1	44.3	63.0	119.0	73.7	97.4	68.6	228.9	58.0	61.7	50.7	75.5
NAPB	"SNAP-BETA, SNAPB"	ENSG00000125814	"NSF attachment protein beta"	Q9H115	20	23374519-23421519	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 126.9;retina: 154.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.4;Cone photoreceptor cells: 66.7;Excitatory neurons: 68.8;Horizontal cells: 67.3;Late spermatids: 75.6;Rod photoreceptor cells: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.8;U-937: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037225, CAB037227, HPA046149, HPA050196"	Supported		Uncertain	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048"	"unprognostic (3.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.46e-3)"	"unprognostic (7.52e-3)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	6.7	24.3	89.3	5.2	98.3	10.6	6.5	53.4	126.9	10.7	8.1	10.0	5.0	7.4	8.8	7.3	9.4	4.8	7.1	102.4	92.6	8.3	7.3	8.3	5.8	90.7	42.4	13.3	6.6	7.8	18.5	8.7	90.5	8.0	6.7	154.1	6.9	5.9	6.4	7.7	8.0	6.0	38.0	8.7	7.1	8.9	48.3	6.1	9.0	3.1	4.4	8.2	9.5	84.1	5.8	3.7	6.0	6.2	6.6	6.1	8.5	7.4	4.0	5.9	5.1	4.4	5.1	8.6	8.6	4.4	4.3	7.3	7.8	5.0	7.1	2.8	5.8	9.4	5.4	10.5	7.8	7.0	5.4	6.1	6.5	4.2	5.2	5.4	4.4	8.6	8.0	11.0	9.4	4.0	7.2	6.4	2.6	4.7	6.7	4.8	4.9	6.5	7.7	6.2	31.8	10.1	4.3	4.1	7.1	8.7	4.2	4.4	5.2	5.6	4.1	6.2	5.4	8.0	6.7	3.8	2.9	32.9	5.7	2.5	0.5	0.0	1.9	0.5	0.6	0.6	0.8	0.9	0.8	1.2	0.7	1.2	0.6	0.6	0.9	0.6	1.0	0.9	89.3	98.3	53.4	126.9	102.4	92.6	90.7	42.4	90.5	38.0	48.3	84.1	4.1	12.8	6.5	30.0	6.6	8.7	5.6	4.1	6.2	203.4	4.2	2.9	6.0	7.2	6.8	14.7	66.7	7.0	5.9	3.6	0.0	3.3	39.9	4.4	5.8	7.5	10.2	2.5	68.8	1.4	5.4	7.4	3.1	3.8	11.4	14.3	9.7	5.5	5.2	67.3	63.8	2.7	14.2	7.2	10.2	75.6	9.0	4.0	10.6	24.4	7.9	20.5	15.5	38.2	37.2	2.9	1.8	9.1	4.7	6.4	9.2	3.6	6.1	84.8	6.6	5.4	5.5	13.4	11.2	3.9	8.4	6.2	6.5	9.3	4.2	4.6
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 128.0;Excitatory neurons: 99.2;Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 193.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	2.0	4.6	1.6	3.6	3.7	2.0	1.7	1.5	4.2	3.6	0.0	7.7	14.5	3.6	2.2	1.9	5.3	5.9	4.0	1.7	0.0	14.9	7.4	3.0	3.3	0.4	1.1	8.6	3.5	6.0	1.5	2.2	0.8	4.5	7.5	4.8	1.7	3.4	2.4	3.1	9.7	3.0	0.5	6.4	9.9	6.7	2.5	3.0	8.2	2.4	2.7	3.5	1.8	9.2	6.9	7.4	5.1	4.3	4.9	4.9	0.9	5.4	3.1	1.6	3.3	2.7	6.3	5.2	7.7	1.7	6.3	5.6	3.3	0.5	3.8	6.9	6.0	1.9	4.1	1.5	1.1	3.3	2.2	2.8	0.9	1.6	0.0	12.5	3.5	3.5	2.0	4.8	5.0	2.2	5.1	2.4	4.7	9.4	9.7	3.6	2.8	1.9	10.5	2.9	3.8	4.6	10.7	3.7	2.7	3.1	2.4	4.4	4.6	7.7	4.0	17.8	4.9	6.8	8.6	3.7	7.6	2.9	14.8	0.1	1.9	3.7	2.7	2.9	2.3	4.6	3.1	3.4	2.1	4.5	4.4	3.2	0.2	1.5	1.9	1.7	2.9	1.4	1.6	3.7	1.5	4.2	1.7	0.0	0.4	1.1	0.8	0.5	2.5	9.2	4.6	19.2	10.0	38.8	13.2	6.6	5.5	5.3	9.6	78.1	5.7	5.0	12.3	17.2	6.8	53.3	52.1	8.1	5.6	37.5	9.8	5.3	128.0	27.5	10.7	5.2	13.8	36.6	99.2	2.6	4.0	7.3	41.3	42.9	4.5	12.0	4.6	19.1	3.9	50.5	56.7	27.0	4.1	5.5	1.8	43.8	31.7	4.4	14.2	21.5	7.2	16.1	18.6	126.7	193.3	5.0	28.7	33.4	10.6	6.5	46.5	32.6	3.0	35.4	6.6	7.8	6.3	21.1	12.2	3.1	2.8	2.9	8.1	18.9	26.8	7.8
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552764	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane"		NA	NA		8800	"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.3	14.8	18.4	9.7	18.6	7.2	11.8	21.1	25.3	10.5	13.9	11.9	9.3	10.7	12.0	12.1	11.0	13.4	19.9	25.9	20.8	16.4	13.6	9.7	9.6	30.3	20.1	7.5	12.6	12.4	9.9	13.9	32.6	13.7	13.7	12.6	11.7	10.7	10.2	9.9	10.7	11.8	19.4	9.4	13.7	7.4	20.1	9.0	14.5	14.6	11.2	14.3	10.1	21.7	9.4	5.6	9.6	8.3	27.1	18.4	14.0	19.8	28.1	19.0	24.0	12.4	14.1	12.3	15.5	27.3	17.4	9.0	12.7	17.7	26.9	11.0	7.8	9.2	9.8	12.8	25.9	26.0	16.6	20.3	20.6	21.8	16.2	12.4	18.0	16.0	15.1	29.0	28.2	13.2	20.0	11.1	7.7	72.3	8.3	8.7	15.8	21.2	22.5	22.0	38.3	10.1	16.1	16.9	23.1	15.5	7.7	17.2	20.5	29.8	14.4	27.8	21.2	18.8	20.4	13.6	20.1	17.7	14.2	12.5	4.9	14.1	5.1	6.1	4.7	7.5	4.1	5.2	3.8	3.3	5.6	4.8	8.1	5.8	6.1	4.1	4.4	3.1	18.4	18.6	21.1	25.3	25.9	20.8	30.3	20.1	32.6	19.4	20.1	21.7	32.2	28.9	34.7	33.6	29.1	24.3	31.1	26.9	21.6	62.0	21.8	17.4	35.1	21.5	27.5	27.6	12.5	23.6	32.9	30.8	41.1	53.3	18.1	27.9	33.2	23.4	23.4	33.2	68.5	42.5	30.3	25.3	28.5	49.5	45.0	13.6	20.0	21.7	25.4	45.4	53.8	22.3	28.5	22.1	16.1	4.6	7.8	24.5	26.6	30.9	22.4	31.3	22.6	34.7	52.9	77.7	34.1	21.1	36.2	34.8	20.8	39.5	20.8	34.0	26.3	30.5	29.6	26.6	39.9	30.8	21.2	45.1	26.2	28.4	19.0	56.5
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 597.2;Proximal tubular cells: 203.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 49.8;RPMI-8226: 73.4;SK-BR-3: 84.1"	"Low region specificity"	"Detected in all"							"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	15.7	13.6	4.1	6.3	4.7	21.9	14.6	3.9	8.7	15.8	4.6	22.2	61.4	9.7	1.7	37.1	10.6	5.8	10.8	4.3	4.8	15.7	63.1	13.8	6.6	5.4	4.1	9.6	12.4	5.0	6.0	5.4	4.0	11.3	3.9	0.2	29.2	10.5	10.1	27.9	47.3	2.9	4.4	19.4	22.5	10.5	4.7	4.1	9.8	4.6	5.2	13.2	18.1	5.6	14.8	7.2	0.6	1.4	3.2	2.0	4.0	0.7	7.5	4.5	1.7	5.6	34.3	1.8	7.8	0.5	0.0	25.6	1.8	34.6	0.4	4.3	12.1	16.7	25.5	1.9	42.5	2.1	14.8	3.2	16.6	0.3	0.0	0.1	18.1	32.9	21.5	8.8	0.1	11.1	6.7	8.0	5.6	49.8	4.2	13.8	0.3	73.4	16.0	2.0	7.4	0.9	9.1	84.1	30.7	0.6	2.1	20.3	3.8	0.9	10.1	8.0	2.9	0.8	0.8	3.1	1.8	41.8	16.1	6.9	11.4	14.1	2.9	12.7	1.9	2.0	4.4	1.9	6.7	1.3	1.3	2.4	10.6	0.8	23.0	6.9	1.9	5.8	4.1	4.7	3.9	8.7	4.3	4.8	5.4	4.1	4.0	4.4	4.7	5.6	50.6	35.3	23.1	7.5	16.2	0.0	64.9	0.0	24.5	12.1	18.3	14.7	10.0	54.3	9.3	75.4	18.8	48.8	21.8	88.0	68.4	62.7	44.2	18.5	26.0	32.7	10.9	63.8	3.8	54.3	74.8	20.6	100.9	26.8	7.6	21.7	49.6	117.4	80.6	16.8	3.2	70.4	0.0	89.7	0.0	59.8	32.0	55.0	0.0	7.5	108.9	23.7	28.8	1.5	2.8	111.7	124.6	21.8	12.7	44.2	597.2	203.7	1.5	13.4	13.1	15.8	16.5	41.7	16.0	35.9	0.0	56.2	17.2	29.7	100.9	73.9
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 1075.5"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 3072.3"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 4.3;dendritic cells: 8.7"	"Cell line enriched"	"Detected in some"	31	"U-698: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		1500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.4	0.9	0.8	1.6	0.9	0.1	0.5	0.9	0.9	0.7	0.7	0.6	0.4	0.5	2.0	0.4	1.0	0.1	0.4	0.8	0.9	106.3	1.2	1075.5	1.2	0.9	0.8	2.1	1.0	0.2	0.6	0.4	0.9	1.0	0.4	0.4	0.6	1.0	0.2	1.1	1.5	0.1	0.8	1.1	0.9	1.8	1.0	0.4	1.7	0.0	0.5	0.4	0.7	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.4	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.7	0.2	0.5	0.2	0.3	0.4	0.6	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	1.0	0.0	0.2	0.4	42.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	4.3	0.2	0.3	2.6	1.7	0.4	0.4	0.5	0.4	0.7	8.7	0.0	1.1	0.8	0.9	0.9	0.9	0.8	0.9	0.9	0.8	0.9	0.8	1.0	1.1	0.3	522.4	3072.3	0.3	3.8	0.1	0.5	0.2	0.0	1.3	0.8	0.9	0.4	1.5	45.9	46.0	4.2	0.5	0.4	0.8	9.8	0.6	47.2	12.6	0.4	6.2	0.0	0.4	0.5	0.8	0.3	5.8	0.5	1.5	69.4	1.0	0.4	0.4	0.3	0.0	0.5	1.0	0.0	1.6	5.3	9.1	0.9	7.9	0.0	1.9	0.2	1.5	1.0	0.0	1.4	0.1	2.3	0.4	0.6	0.4	2.0	276.1	16.4	0.9	0.0	0.3	0.3	1.4	1.4	0.0	0.6	0.1	12.9	0.4	0.9	0.1
NARS1	NARS	ENSG00000134440	"Asparaginyl-tRNA synthetase 1"	O43776	18	57600656-57622213	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 221.3;Cytotrophoblasts: 116.0;Extravillous trophoblasts: 85.2;Hofbauer cells: 117.4;Syncytiotrophoblasts: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol		NA	NA		76000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB034257: AB_2151043, HPA040017: AB_2676801"	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	67.2	65.9	51.7	62.1	53.8	48.8	68.3	58.8	77.7	57.5	60.1	108.7	87.3	52.7	66.5	64.2	58.5	56.0	94.8	53.4	60.4	135.1	75.5	51.7	52.8	59.6	55.6	45.4	63.1	125.3	33.2	56.1	58.5	68.4	99.5	68.2	68.8	65.4	127.2	49.6	72.0	65.5	55.9	46.8	79.4	32.7	63.7	59.1	95.0	130.6	67.3	78.0	41.9	60.1	215.1	133.2	129.6	199.1	172.8	130.7	202.5	302.5	161.7	179.2	215.4	100.3	97.0	270.7	136.2	208.7	172.1	241.7	211.0	191.6	259.0	127.5	75.5	217.8	105.4	171.8	299.9	433.0	212.5	146.0	331.2	233.8	245.8	130.6	154.6	169.4	246.5	201.6	200.9	86.2	172.4	111.9	189.6	145.1	118.6	139.8	154.5	229.9	340.3	224.4	140.9	147.6	153.1	184.0	309.4	137.3	108.8	242.6	179.7	190.5	127.7	78.8	215.8	449.1	559.2	260.3	175.1	285.7	227.7	50.9	108.5	38.8	41.8	92.6	50.9	52.6	43.3	44.7	71.7	51.4	58.2	52.6	34.4	43.6	76.8	64.0	49.4	74.9	51.7	53.8	58.8	77.7	53.4	60.4	59.6	55.6	58.5	55.9	63.7	60.1	26.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.3	0.0	0.0	0.0	0.0	116.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	85.2	23.1	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	158.6	3.5	0.0	0.0	0.0
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 476.2;Spermatogonia: 514.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		170000	"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	66.2	39.6	57.4	55.9	62.6	165.0	58.8	60.6	95.7	67.4	57.1	52.7	34.6	54.6	29.9	55.2	65.6	26.7	51.0	57.2	68.0	48.6	52.0	50.4	91.5	65.0	61.6	72.4	34.9	41.1	40.9	61.9	63.0	54.1	51.5	38.2	43.5	43.4	41.7	46.7	58.3	45.1	56.0	83.3	47.3	108.9	62.4	100.7	48.1	22.2	97.7	51.1	56.0	65.3	191.3	110.8	520.2	184.6	85.8	44.9	243.8	150.9	112.4	230.5	286.5	205.7	134.4	357.9	103.5	65.8	251.9	180.2	351.9	161.0	291.5	164.0	222.9	462.7	201.6	326.9	30.2	489.3	186.4	52.5	38.3	254.0	87.6	60.1	159.5	294.8	396.3	204.1	157.6	131.4	559.6	445.0	755.5	189.5	93.1	697.4	454.0	343.8	115.3	189.4	198.3	239.8	248.7	140.4	159.7	389.2	100.8	377.0	86.7	105.5	322.8	204.4	250.0	124.5	251.2	616.2	107.6	306.7	107.3	6.4	9.4	10.9	14.1	12.1	16.4	16.1	16.1	16.3	14.3	22.3	13.9	13.7	4.0	9.7	7.3	14.7	22.0	9.1	57.4	62.6	60.6	95.7	57.2	68.0	65.0	61.6	63.0	56.0	62.4	65.3	196.5	57.7	106.7	70.8	136.1	78.1	135.2	72.4	133.7	45.3	77.4	87.4	58.4	37.1	99.1	36.8	37.5	319.3	150.8	64.8	31.3	55.0	16.6	119.6	138.1	138.4	51.3	142.8	32.7	37.4	223.2	100.6	81.1	137.9	115.2	134.2	90.3	38.6	108.1	43.7	34.8	68.1	44.7	43.7	62.6	26.6	94.8	82.7	40.9	31.9	52.3	60.9	62.8	63.8	160.3	29.8	44.9	78.2	107.4	88.6	28.9	36.6	109.1	77.3	85.5	148.1	106.6	476.2	514.5	92.1	57.0	268.2	142.2	90.7	101.7	85.3
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 24.2;Paneth cells: 32.7;Respiratory ciliated cells: 32.0"	"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB017782, HPA043704"	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.6	1.5	0.5	5.4	0.7	3.2	5.9	0.8	0.9	6.5	0.8	14.2	11.7	2.4	15.2	2.5	4.4	3.6	1.8	0.5	0.7	5.7	10.4	3.5	6.0	1.2	0.7	2.9	1.8	1.1	1.0	4.1	0.8	7.3	12.8	0.3	1.9	2.9	0.4	2.4	8.9	3.6	0.8	4.1	4.9	1.8	0.8	4.6	2.1	1.5	6.7	4.5	1.3	1.0	22.6	2.7	2.5	3.3	6.3	6.3	5.3	8.0	8.5	8.8	10.2	4.0	4.7	11.0	6.2	5.2	8.1	3.6	4.5	5.4	8.9	10.3	2.3	7.6	3.0	3.0	6.0	3.3	9.7	5.2	6.5	6.0	0.5	2.2	7.9	9.3	6.6	2.9	10.0	4.0	9.8	10.3	2.4	17.8	3.4	4.9	2.5	4.3	9.3	12.6	1.3	1.7	0.3	9.5	5.5	5.2	7.7	9.7	8.5	5.3	3.1	8.0	1.3	2.0	4.0	9.3	4.6	7.5	2.4	5.4	4.6	9.4	3.3	5.3	2.4	4.4	3.4	3.4	6.1	3.9	3.2	3.9	8.2	6.3	5.4	3.5	6.3	2.7	0.5	0.7	0.8	0.9	0.5	0.7	1.2	0.7	0.8	0.8	0.8	1.0	4.6	0.0	3.6	0.7	4.7	0.4	0.8	9.1	1.2	0.0	3.5	1.9	1.6	0.0	11.3	5.5	0.0	5.9	2.3	24.2	1.9	5.7	10.8	3.9	3.2	3.0	3.6	0.8	0.8	6.9	7.7	2.1	3.6	2.8	2.5	1.1	2.2	12.7	7.2	0.0	0.2	10.7	8.2	6.3	2.6	2.2	4.1	5.3	3.6	1.9	4.9	2.5	4.1	0.0	0.5	5.8	32.7	5.7	2.6	2.3	12.7	16.6	32.0	0.0	0.0	0.7	3.4	4.2	0.6	2.2	0.6	10.9	4.1	3.2	8.4	2.5
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170496-101180293	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 2.7;pancreas: 2.3;pituitary gland: 3.6;retina: 6.9;thyroid gland: 1.8"	"Cell type enriched"	"Detected in some"	36	"Horizontal cells: 292.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;melanoma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.4;SH-SY5Y: 3.4;SK-MEL-30: 2.7;U-2 OS: 2.9;U-87 MG: 1.7"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.0	0.1	1.5	0.0	1.4	0.2	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.7	0.0	0.1	0.0	0.0	0.8	1.2	0.0	2.3	0.3	3.6	0.0	0.5	0.0	0.0	6.9	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.4	0.1	2.5	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.1	0.0	2.4	0.0	0.2	0.0	3.4	0.0	0.1	2.7	0.2	0.1	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.5	1.4	0.7	2.7	1.0	2.7	0.8	1.2	0.5	0.2	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	292.7	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.5	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391282-18401218	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 33.5;liver: 128.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 14.8;Hepatocytes: 59.0;Paneth cells: 15.9;Proximal enterocytes: 36.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.0;RT4: 1.6;SCLC-21H: 2.2;SK-BR-3: 1.4"									HPA043704	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"			"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.1	0.1	0.2	1.6	0.2	0.0	1.1	0.2	0.6	0.5	0.1	15.0	33.5	0.9	0.7	0.1	0.2	0.2	0.2	0.2	0.2	1.9	128.6	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.1	0.4	13.2	0.0	0.0	0.5	0.0	0.0	25.6	1.6	0.2	1.3	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	1.0	1.6	2.2	0.0	0.0	1.4	0.0	0.1	0.3	0.2	0.5	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.0	0.0	14.8	5.9	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	59.0	0.2	0.0	0.0	7.4	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	2.6	0.0	0.0	36.0	0.8	0.3	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	4.4	0.1	0.8	6.7	0.1
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640723-73642422	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 732.4"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 2565.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Hep G2: 10.7"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.1	0.3	1.1	0.1	0.5	0.1	0.2	0.1	0.7	0.2	0.0	1.1	4.6	0.1	0.0	0.0	1.2	0.6	0.1	0.8	0.8	732.4	82.7	0.2	0.0	0.6	0.3	1.3	0.2	0.0	0.6	0.0	0.1	0.2	0.1	1.8	0.1	0.1	0.0	0.0	7.2	0.1	0.4	1.1	0.6	0.5	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.1	0.7	0.8	0.8	0.6	0.3	0.1	0.4	1.0	0.8	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	36.8	0.0	0.0	0.0	0.3	187.9	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.9	51.1	0.0	0.0	0.0	1.1	0.0	1.0	0.4	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	61.3	2565.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.6	0.1
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770529-74776367	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	18.2	57.5	24.0	11.4	24.6	13.5	18.1	25.8	27.6	23.3	25.0	17.3	8.0	18.7	23.2	16.3	21.5	8.9	19.4	23.6	24.2	25.1	29.9	17.6	13.6	25.2	24.9	31.0	25.2	18.0	29.4	14.2	25.2	27.7	9.8	11.5	17.1	12.5	16.4	16.0	15.8	11.1	24.4	20.8	19.3	20.9	24.5	13.7	24.4	11.0	11.3	21.7	18.2	25.6	20.9	30.0	18.7	17.2	29.9	37.4	22.3	39.5	34.2	40.7	35.1	51.3	22.8	57.4	14.7	31.2	26.2	22.8	25.6	42.9	25.9	12.0	37.0	37.0	24.6	46.2	34.9	19.1	22.9	34.2	31.9	40.5	61.2	33.7	44.7	36.2	46.8	17.6	30.2	19.9	38.9	15.6	14.5	40.5	42.8	25.6	55.7	33.4	29.2	33.5	27.0	35.7	16.5	48.1	78.0	25.5	44.4	24.7	26.2	47.0	37.7	20.4	37.5	24.1	9.4	32.0	19.4	12.9	30.5	20.4	16.2	7.4	9.2	24.0	18.9	20.7	16.7	13.8	19.9	30.5	28.5	21.1	4.2	16.7	13.9	15.2	9.8	12.0	24.0	24.6	25.8	27.6	23.6	24.2	25.2	24.9	25.2	24.4	24.5	25.6	15.3	6.4	14.5	15.7	22.6	35.1	41.7	25.9	12.5	39.5	24.7	18.9	5.6	5.7	16.4	18.4	47.9	23.3	20.3	14.5	7.9	14.9	5.5	7.6	13.3	14.3	26.4	10.3	24.4	19.5	19.2	17.3	17.3	13.1	1.3	33.0	9.3	9.9	18.0	45.4	20.2	17.7	20.3	14.1	21.0	4.0	29.5	16.8	10.6	5.6	20.7	11.3	18.6	15.6	16.4	18.3	17.0	17.0	15.8	43.7	11.8	14.5	13.5	46.4	6.6	15.1	16.1	20.5	26.4	9.0	29.7	22.2	14.3	23.7	20.8	39.0
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.4;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.1;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"TIME: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	19.6	2.7	17.4	8.2	18.3	1.6	15.2	8.0	17.7	11.7	0.0	12.3	3.7	10.1	4.3	8.6	7.2	7.5	26.6	17.5	20.3	4.6	1.9	11.1	4.1	24.6	17.9	3.7	4.4	5.2	5.2	11.8	15.1	7.5	5.4	5.4	7.8	6.7	4.8	7.7	6.2	10.3	9.9	3.6	5.3	4.4	21.8	2.8	9.4	6.7	3.7	14.9	12.6	32.5	1.6	2.9	29.0	3.8	84.3	69.5	51.7	44.6	43.0	35.5	30.9	0.0	15.7	0.6	0.7	61.4	19.4	21.5	22.0	14.9	28.4	2.5	3.2	1.4	5.6	0.0	22.5	0.2	19.1	30.6	5.4	62.4	36.0	94.9	80.7	1.8	0.8	2.6	29.8	0.4	0.0	0.1	42.4	0.7	1.7	3.9	65.0	9.3	4.8	4.3	21.9	4.5	11.1	47.6	14.5	19.2	0.4	1.2	187.8	54.5	11.1	54.7	39.4	8.1	2.3	0.2	59.2	5.9	47.5	3.4	0.5	0.1	0.2	0.3	0.1	0.3	0.2	0.0	2.1	0.3	0.2	0.1	0.0	0.1	0.3	0.5	0.0	0.3	17.4	18.3	8.0	17.7	17.5	20.3	24.6	17.9	15.1	9.9	21.8	32.5	77.4	3.2	1.5	169.1	3.1	11.0	2.2	5.9	8.0	34.6	4.8	4.3	29.2	1.5	4.8	12.9	0.0	14.9	0.9	4.7	0.0	13.0	3.6	1.6	6.4	39.3	52.8	1.7	98.2	8.3	54.1	45.8	8.2	4.4	17.7	54.5	21.0	0.7	14.5	25.2	161.7	3.4	6.1	18.3	15.8	3.8	10.8	15.1	23.2	69.3	60.6	11.8	1.0	713.8	224.6	21.7	4.2	0.7	4.9	2.3	0.9	0.6	3.5	4.0	6.6	119.3	18.8	0.6	2.6	16.9	7.0	15.7	2.0	6.6	5.0	3.2
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121601	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.7;heart muscle: 61.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	7.4	1.6	11.6	3.3	18.8	1.8	12.0	16.1	10.8	6.3	3.5	16.2	4.4	7.6	11.1	6.5	4.4	1.8	61.2	9.6	13.8	9.5	14.9	9.5	1.8	55.7	43.7	3.1	8.8	6.0	5.1	14.8	36.5	6.2	4.9	8.7	15.0	9.3	2.6	6.7	4.1	8.5	39.3	1.4	7.2	0.9	27.7	2.5	16.9	9.4	3.9	5.7	7.4	35.6	16.2	4.7	10.2	1.4	33.7	21.6	11.0	13.3	22.6	17.2	13.0	18.2	2.1	0.1	0.6	20.1	28.0	1.9	0.6	10.4	20.1	3.8	1.2	0.4	25.1	20.9	6.1	0.0	0.5	14.1	26.5	8.3	89.9	12.7	23.2	0.1	1.9	8.0	50.2	17.2	0.0	0.1	26.4	5.3	13.1	0.1	47.1	2.6	14.8	4.6	18.2	81.9	10.3	7.9	14.8	54.2	0.3	0.0	65.2	39.6	6.3	47.7	12.7	2.7	2.0	0.1	13.5	0.8	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.6	18.8	16.1	10.8	9.6	13.8	55.7	43.7	36.5	39.3	27.7	35.6	5.5	64.1	22.6	466.8	1.4	4.2	23.6	13.8	14.2	4.6	33.6	31.0	14.3	8.6	18.3	20.2	0.0	31.8	0.8	2.8	13.7	20.3	2.6	34.4	4.6	14.5	10.8	0.0	333.8	21.3	23.3	16.5	11.2	62.1	1.3	152.4	11.7	47.0	10.7	26.9	525.7	10.1	18.3	1.4	5.0	7.9	0.9	3.2	16.0	194.9	1.0	28.9	0.0	863.6	354.4	37.5	0.8	4.1	0.4	33.7	1.8	0.4	24.0	2.4	0.0	30.7	17.8	1.5	0.6	23.1	3.7	14.6	1.7	54.7	9.2	17.8
NAV3	"KIAA0938, POMFIL1"	ENSG00000067798	"Neuron navigator 3"	Q8IVL0	12	77324641-78213010	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3;ovary: 18.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 882.1;Excitatory neurons: 1473.6;Inhibitory neurons: 753.8;Microglial cells: 534.0;Oligodendrocyte precursor cells: 786.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 9.7;basal ganglia: 15.0;cerebral cortex: 17.3;hippocampal formation: 13.6;white matter: 10.3"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.0;THP-1: 41.8;U-138 MG: 30.8;WM-115: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032111, HPA061392"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane"	Cytosol	"HPA032111: AB_10603881, HPA061392: "	"unprognostic (3.51e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.68e-7)"	"unprognostic (6.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.29e-3)"	3.8	4.8	9.7	1.0	15.0	0.5	4.0	0.9	17.3	1.2	0.0	1.7	0.3	2.0	2.9	1.9	2.2	5.1	1.9	13.6	0.0	0.4	1.0	3.3	0.6	0.7	0.4	18.3	0.5	0.4	3.1	2.2	0.0	2.1	0.8	5.2	0.9	2.5	1.3	2.6	0.6	2.5	1.4	8.0	0.8	2.8	1.6	1.9	1.2	3.4	0.4	3.3	1.7	10.3	3.5	8.7	0.6	0.2	8.5	18.1	0.3	26.5	20.9	10.7	5.3	1.7	0.6	0.2	1.9	22.0	7.2	2.5	7.8	4.0	19.3	0.1	0.2	0.2	3.9	0.2	6.7	0.1	0.2	6.2	0.2	47.0	11.1	9.3	16.4	0.1	0.0	0.1	26.2	0.5	0.2	12.0	2.7	0.3	2.1	1.0	2.1	0.0	1.7	0.1	0.6	0.0	1.6	0.3	3.5	0.8	0.1	41.8	14.1	30.8	8.1	12.0	18.2	1.2	0.0	0.7	8.8	0.5	38.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.7	15.0	0.9	17.3	13.6	0.0	0.7	0.4	0.0	1.4	1.6	10.3	11.1	19.2	10.0	882.1	0.0	3.6	8.4	0.2	0.0	5.0	3.8	3.8	3.4	0.0	7.5	0.0	0.0	0.1	0.0	0.2	0.0	4.2	10.4	4.2	8.2	5.6	16.4	0.0	1473.6	1.6	0.1	18.7	0.5	10.3	11.4	0.8	3.9	0.0	7.3	50.5	753.8	0.0	0.0	0.0	3.7	4.7	23.9	1.4	12.4	534.0	0.1	18.3	0.0	786.1	144.1	19.2	0.0	7.5	1.2	18.0	0.0	0.3	8.7	2.0	0.0	28.8	5.3	0.3	0.8	0.2	1.4	0.3	1.3	73.7	0.0	2.9
NAXD	"CARKD, FLJ10769, LP3298"	ENSG00000213995	"NAD(P)HX dehydratase"	Q8IW45	13	110615545-110639996	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.8;Distal tubular cells: 39.2;Extravillous trophoblasts: 26.7;Granulosa cells: 27.6;Syncytiotrophoblasts: 30.9;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010551	Approved					NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"			"HPA010551: AB_1848669"	"unprognostic (1.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.36e-3)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.62e-2)"	17.3	37.1	44.0	16.0	43.7	8.2	19.4	43.6	46.3	16.7	40.8	23.1	22.9	18.7	26.6	23.4	22.6	21.3	26.4	45.7	42.8	24.9	65.4	18.8	20.8	45.9	45.0	39.0	36.2	28.4	22.4	23.3	44.5	25.8	19.7	14.3	22.8	28.9	31.9	30.5	23.0	21.7	43.9	21.8	30.3	24.2	46.2	18.3	25.4	33.6	17.1	17.3	15.0	45.2	36.0	15.7	28.1	24.3	29.8	23.6	35.4	27.9	22.7	24.6	26.2	43.9	35.1	7.3	28.4	21.7	25.3	28.1	16.3	24.4	16.0	31.6	27.4	22.5	47.9	23.5	34.2	29.3	20.2	29.1	42.4	19.8	17.7	32.5	21.9	31.8	19.6	0.2	22.3	30.0	23.1	48.4	21.2	64.4	17.2	8.2	14.4	5.9	30.3	30.1	42.5	28.6	16.8	75.4	21.6	18.5	39.7	54.4	25.3	17.1	14.3	0.1	22.4	25.6	18.7	0.3	27.7	8.7	28.9	0.0	8.3	0.8	9.6	9.0	6.3	8.4	9.6	8.9	10.4	8.2	9.9	9.1	1.0	9.2	6.5	10.1	10.5	8.3	44.0	43.7	43.6	46.3	45.7	42.8	45.9	45.0	44.5	43.9	46.2	45.2	9.3	19.2	12.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	14.2	11.3	0.0	0.0	9.9	22.0	0.0	34.8	5.4	0.0	39.2	15.0	0.0	7.3	10.5	4.0	0.0	0.0	0.0	11.8	26.7	6.2	0.0	8.8	1.3	27.6	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.6	0.0	0.0	2.1	0.0	0.0	22.4	8.7	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	30.9	2.1	24.4	0.0	0.0
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591756-156609507	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	47.1	74.8	61.0	20.9	63.7	22.2	47.9	66.1	69.6	56.8	71.1	62.9	45.5	68.8	88.7	58.0	59.5	26.5	111.1	60.9	64.3	83.8	86.5	43.6	27.0	62.7	64.8	46.5	69.7	104.7	70.0	23.7	61.8	62.5	41.6	17.4	53.9	48.3	71.8	55.8	48.3	39.7	64.7	43.2	67.5	40.8	63.5	30.6	59.8	68.2	34.3	55.0	47.8	70.5	114.2	155.4	43.9	84.4	64.0	43.8	55.5	29.5	62.3	69.5	72.6	130.6	76.8	62.4	113.4	52.5	55.9	111.1	49.4	99.0	47.5	81.2	98.5	58.1	76.2	86.1	75.1	60.0	60.9	44.2	123.7	87.9	81.9	53.4	95.4	104.7	54.7	70.1	71.6	209.6	83.3	98.0	43.1	158.1	118.2	87.7	40.2	212.6	93.0	93.6	114.7	102.9	90.4	172.4	141.6	66.4	178.3	117.5	51.1	45.1	64.8	64.6	70.6	180.1	110.3	53.0	63.1	37.0	70.4	25.4	96.3	52.9	121.2	111.3	121.3	236.2	109.4	124.3	89.1	186.5	122.8	114.9	11.4	141.3	89.1	225.7	110.1	186.6	61.0	63.7	66.1	69.6	60.9	64.3	62.7	64.8	61.8	64.7	63.5	70.5	29.5	41.7	32.9	0.0	14.8	0.0	0.0	0.0	0.0	0.0	87.5	96.0	0.0	0.0	23.5	68.0	0.0	136.7	28.7	0.0	201.5	112.8	0.0	27.3	29.9	18.4	0.0	0.0	0.0	100.1	43.1	27.2	0.0	32.0	5.1	53.5	0.0	0.0	92.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	91.0	0.0	0.0	6.2	0.0	0.0	219.6	11.7	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	81.3	13.4	48.1	0.0	0.0
NBAS	NAG	ENSG00000151779	"NBAS subunit of NRZ tethering complex"	A2RRP1	2	15166914-15561334	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.8;Inhibitory neurons: 187.9;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036817	Approved		Approved	"Nuclear membrane,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nuclear membrane, Nucleoli"	"HPA036817: AB_10670925"	"unprognostic (1.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (5.84e-5)"	16.8	21.0	37.4	7.2	38.8	16.1	15.9	37.7	42.7	18.8	35.7	22.7	8.2	18.4	13.7	17.2	18.8	8.1	38.3	37.2	36.3	19.9	21.6	15.8	9.4	37.0	35.2	22.5	34.4	16.3	29.6	10.1	38.7	19.0	10.5	13.4	15.4	10.4	30.5	21.8	20.1	11.8	34.4	21.1	24.5	41.2	37.2	14.5	17.4	17.7	9.1	19.7	16.5	38.1	10.5	13.7	14.8	10.7	37.8	41.5	15.2	19.1	20.8	14.5	14.6	13.8	15.0	13.4	4.3	29.3	15.1	12.5	16.5	23.9	17.2	13.5	10.4	51.3	11.5	38.8	38.8	13.4	25.1	27.3	18.9	19.2	32.8	30.2	30.4	18.7	40.6	15.0	22.4	13.0	11.2	30.1	12.8	17.1	12.8	11.7	26.0	16.2	30.5	14.0	8.7	14.2	16.2	13.4	25.2	18.3	9.4	12.0	26.6	18.5	11.2	13.5	13.9	22.1	20.3	18.7	33.1	15.5	16.8	1.5	4.4	2.5	5.7	3.1	6.7	4.1	4.2	7.3	4.0	3.4	4.2	4.3	0.8	7.2	7.5	4.5	5.3	2.9	37.4	38.8	37.7	42.7	37.2	36.3	37.0	35.2	38.7	34.4	37.2	38.1	16.1	19.2	13.8	96.6	15.1	7.4	9.3	11.9	12.0	17.3	11.7	9.4	32.3	17.2	13.8	18.4	29.2	11.5	15.1	9.4	0.0	11.1	39.3	22.2	21.3	14.6	7.3	38.7	217.8	14.0	13.1	13.4	20.9	14.8	38.6	30.2	8.9	9.1	9.0	13.5	187.9	14.8	10.2	6.9	8.0	61.9	11.5	11.6	5.4	106.8	18.4	12.5	9.2	159.3	159.2	8.6	9.5	16.6	27.2	9.2	39.3	8.5	26.0	25.5	0.0	24.7	16.3	33.7	22.4	12.9	11.2	10.4	19.9	70.0	12.5	7.6
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942270-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 23.5;retina: 65.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.1;SH-SY5Y: 80.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	2.4	7.2	7.7	1.5	10.7	0.3	4.9	19.0	23.5	3.5	2.8	5.8	1.4	6.1	2.2	3.3	5.5	3.4	6.9	17.4	2.8	4.1	0.6	2.0	1.6	4.1	0.1	6.2	3.1	7.1	8.3	0.6	4.8	6.6	2.5	65.7	4.7	8.4	5.6	1.5	2.5	6.5	0.4	3.2	2.7	3.5	0.0	5.6	6.3	5.7	1.2	3.6	2.8	4.5	0.0	4.5	10.9	6.1	0.7	0.1	0.3	7.0	10.8	7.9	6.6	0.1	1.0	3.0	0.0	12.9	4.7	0.3	3.7	1.5	16.3	1.4	3.6	0.0	3.4	1.2	0.5	1.9	4.7	2.1	1.2	0.1	0.7	33.1	1.8	1.2	0.1	17.6	1.1	1.9	1.1	0.0	4.6	6.2	2.0	1.1	4.7	0.9	9.3	2.1	6.2	80.1	5.4	0.1	3.6	8.1	2.0	0.4	0.1	2.0	1.2	0.0	1.6	1.9	0.5	1.3	5.4	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	7.7	10.7	19.0	23.5	17.4	2.8	4.1	0.1	4.8	0.4	0.0	4.5	19.7	28.9	9.2	132.9	5.2	1.0	5.3	2.7	1.2	124.8	5.0	6.5	51.8	11.5	14.1	9.2	146.0	0.1	4.4	0.3	1.9	9.2	19.3	5.6	18.4	10.1	22.9	0.8	1016.1	1.8	0.1	12.3	2.0	0.6	25.2	20.7	11.0	0.3	0.9	47.1	953.0	2.1	6.1	3.5	3.9	13.6	17.7	3.5	7.2	150.9	1.2	69.1	0.0	466.9	163.7	2.3	0.1	19.2	5.8	8.5	0.2	7.6	56.5	87.0	6.6	22.2	13.1	8.5	8.0	0.3	0.9	0.0	1.2	11.9	1.1	13.5
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	3.0	2.1	1.5	1.7	3.3	1.1	3.3	4.1	1.9	2.7	8.5	6.9	4.6	2.6	2.1	2.1	3.4	3.1	2.6	1.2	2.2	6.5	5.7	4.4	1.1	2.7	2.2	3.7	2.9	2.9	0.9	2.8	2.7	2.2	6.7	3.9	1.7	1.8	1.5	2.2	5.5	2.7	1.6	1.7	7.1	3.6	2.6	1.3	4.6	3.9	1.3	2.9	1.7	3.6	4.2	3.9	1.6	1.4	9.7	7.5	2.3	4.0	2.9	2.1	3.2	4.4	2.1	0.9	3.2	6.8	4.1	3.4	3.2	4.7	4.8	1.9	1.4	1.6	6.0	2.5	2.3	1.5	1.8	2.9	3.0	3.4	4.2	5.0	3.3	1.7	2.9	1.4	4.8	2.9	0.6	0.8	0.8	1.8	3.6	0.7	2.6	1.0	5.8	7.8	1.0	0.8	3.4	2.5	2.5	3.9	2.9	1.5	5.7	5.5	4.6	2.6	1.8	2.4	1.9	1.2	3.3	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	1.5	3.3	4.1	1.9	1.2	2.2	2.7	2.2	2.7	1.6	2.6	3.6	53.0	38.5	72.2	103.5	145.5	1030.4	399.8	231.1	117.8	18.4	81.2	89.2	21.4	223.1	94.4	38.6	27.1	205.9	58.8	173.8	84.1	57.4	30.9	57.8	73.5	155.1	293.5	49.0	88.0	99.2	276.5	154.4	103.9	69.3	107.2	43.3	287.0	203.7	154.5	82.4	79.7	515.3	91.6	531.4	1016.1	49.5	274.3	78.0	629.7	81.5	186.0	19.5	171.9	105.1	130.9	78.5	335.8	129.4	52.4	304.8	343.9	103.1	59.2	26.9	118.3	388.6	265.6	45.1	41.2	118.4	1304.2	229.3	182.3	31.4	528.3	305.2
NBEAL2	KIAA0540	ENSG00000160796	"Neurobeachin like 2"	Q6ZNJ1	3	46979666-47009704	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.2"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HEL: 69.1;SK-BR-3: 64.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051969	Approved					NA	NA		31000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA051969: "	"unprognostic (3.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.99e-3)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-2)"	16.7	16.0	4.0	23.3	3.6	92.1	19.3	3.3	5.7	34.3	4.4	21.5	12.8	10.5	4.6	103.2	14.7	11.0	15.2	3.3	3.4	36.9	11.2	54.0	20.9	4.2	3.8	7.9	40.7	6.7	11.3	4.8	4.5	21.5	8.4	0.8	35.6	8.4	6.5	86.0	31.0	5.6	3.8	70.0	42.5	6.3	4.6	11.2	14.7	2.9	15.8	16.6	56.8	3.7	20.2	22.1	4.0	11.3	2.3	0.8	12.9	2.8	1.7	3.8	2.5	19.4	14.2	17.4	7.7	2.4	3.7	13.0	8.3	9.0	1.9	15.4	12.4	69.1	27.8	12.2	2.2	11.9	48.5	1.9	14.8	3.9	6.0	4.6	34.2	36.2	14.6	26.3	1.9	31.2	20.5	32.7	10.6	31.9	10.0	21.6	0.5	23.0	9.1	41.1	6.1	9.9	2.4	64.4	5.7	4.9	31.5	19.9	25.3	0.3	11.7	5.1	8.9	20.1	20.7	16.3	5.1	55.0	2.9	0.2	0.6	0.4	0.5	0.6	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.1	4.4	0.4	0.4	0.1	0.2	0.3	4.0	3.6	3.3	5.7	3.3	3.4	4.2	3.8	4.5	3.8	4.6	3.7	15.0	12.8	9.4	7.8	10.0	3.3	5.5	2.4	5.7	1.3	16.3	18.2	4.3	8.6	9.3	33.1	18.8	2.2	30.8	15.1	1.9	22.9	1.4	20.0	4.1	9.8	7.2	10.3	4.0	23.1	1.1	3.0	144.3	23.9	6.3	5.1	11.7	1.2	11.1	0.0	1.5	11.5	4.1	12.9	8.3	1.0	1.2	27.9	0.0	6.5	14.6	1.5	26.8	1.0	1.4	31.4	5.6	0.0	14.2	6.2	3.4	1.3	6.6	1.9	13.1	3.4	3.5	0.5	2.4	33.6	8.0	1.9	26.3	4.5	15.1	21.0
NBL1	"D1S1733E, DAN, DAND1, NB, NO3"	ENSG00000158747	"NBL1, DAN family BMP antagonist"	P41271	1	19596979-19658456	"Predicted intracellular proteins, Predicted secreted proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 676.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 395.1;Leydig cells: 386.8;Paneth cells: 313.2;Peritubular cells: 356.9;Prostatic glandular cells: 293.3;Proximal enterocytes: 413.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 431.7;HSkMC: 305.6;SK-MEL-30: 473.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007394, CAB026132"	Uncertain				"Secreted in other tissues"	NA	NA		8100000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026132: , HPA007394: AB_10601272"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.26e-2)"	166.3	27.7	116.1	61.4	115.2	5.7	183.3	90.6	156.0	676.6	125.7	259.3	195.0	253.9	48.3	206.8	281.5	202.6	119.1	147.1	117.1	67.2	5.8	312.0	57.3	101.7	140.7	635.9	27.1	48.3	125.3	21.6	117.0	376.0	109.3	14.5	65.4	113.5	26.6	199.1	314.1	113.0	95.0	25.8	139.9	44.5	109.5	25.3	85.9	28.4	22.4	246.5	373.8	97.3	138.8	42.9	7.2	38.5	431.7	222.7	19.7	195.5	238.6	64.1	64.7	11.8	242.6	0.2	122.2	245.7	44.8	153.4	40.8	180.1	19.6	132.9	23.0	6.8	40.5	72.4	69.4	0.5	3.1	305.6	162.0	94.6	57.6	19.1	48.7	8.0	1.4	0.4	20.6	20.4	0.4	11.7	2.9	142.3	65.2	6.4	0.1	4.7	122.5	16.6	3.1	102.2	31.2	1.2	473.8	7.1	160.2	24.3	68.9	62.4	49.7	180.0	30.3	0.9	1.1	0.8	45.4	0.6	19.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.4	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.1	116.1	115.2	90.6	156.0	147.1	117.1	101.7	140.7	117.0	95.0	109.5	97.3	150.4	3.2	2.3	0.0	2.9	174.6	237.3	22.6	107.0	35.5	41.5	32.8	43.5	55.8	11.9	36.8	6.2	1.0	5.1	395.1	3.9	43.0	2.0	15.6	55.7	84.3	54.5	3.4	0.0	7.7	2.6	241.4	39.8	10.1	13.4	80.9	47.8	1.5	54.6	6.7	0.0	244.6	12.2	2.2	76.6	13.1	386.8	6.6	60.5	0.0	5.8	13.4	0.0	0.0	0.0	97.5	313.2	356.9	1.1	293.3	413.8	19.7	24.5	10.2	131.5	14.0	142.9	1.4	7.6	61.4	202.4	1.4	29.6	15.1	220.4	206.5
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933331-90003228	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 265.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	22.5	12.4	9.2	27.8	12.8	54.0	25.4	9.3	10.0	16.9	7.4	18.3	15.1	22.3	11.4	20.0	14.5	22.5	12.1	10.2	12.5	20.7	22.3	18.1	24.3	10.7	8.6	16.9	15.5	15.4	9.0	14.1	9.9	17.5	22.5	9.8	16.6	14.9	10.0	10.3	16.0	24.2	11.0	23.4	12.7	16.4	11.0	19.0	22.7	16.2	26.4	21.8	9.6	15.0	54.8	30.1	29.3	15.6	16.5	38.7	18.9	37.9	49.5	46.6	50.8	17.2	41.8	83.8	42.2	35.5	19.1	17.7	35.7	35.7	59.8	38.0	19.7	67.7	16.8	23.6	30.8	40.0	35.2	30.5	18.3	27.2	57.9	22.8	39.5	33.9	50.6	46.6	55.3	46.9	65.6	26.0	8.5	39.5	31.4	42.3	25.3	47.0	62.8	73.8	8.1	26.6	23.5	265.1	23.1	16.3	49.8	31.4	29.2	40.9	28.0	25.5	38.0	21.2	25.0	45.5	41.3	39.4	39.1	32.4	17.7	32.9	11.9	19.7	12.7	15.2	8.5	8.8	18.9	8.9	8.1	9.0	34.4	16.1	31.5	10.4	5.9	13.1	9.2	12.8	9.3	10.0	10.2	12.5	10.7	8.6	9.9	11.0	11.0	15.0	36.9	48.1	14.2	24.5	39.8	11.9	13.5	20.4	23.9	25.4	29.7	22.9	30.3	14.3	33.7	27.6	2.1	23.0	29.3	11.2	43.0	35.1	17.6	45.4	46.9	22.9	12.1	31.7	45.0	32.0	19.7	36.3	19.9	31.2	79.7	38.3	18.9	30.6	25.9	13.5	39.9	16.9	16.2	29.2	27.1	7.2	19.0	51.1	12.4	32.8	54.7	29.4	36.0	40.7	40.3	24.7	9.9	26.4	38.8	11.6	9.9	40.5	36.4	11.2	6.6	50.3	31.7	20.2	46.0	31.5	13.5	10.8	35.3	68.7	19.4	11.0
NBPF1	"FLJ20719, KIAA1693"	ENSG00000219481	"NBPF member 1"	Q3BBV0	1	16562319-16613562	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 73.8;Distal enterocytes: 66.4;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (8.16e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.15e-5)"	"unprognostic (2.16e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-1)"	8.8	32.6	4.0	2.5	5.1	2.0	9.5	5.0	4.3	16.4	2.7	14.9	3.5	10.6	2.5	6.4	10.7	3.3	6.1	3.2	4.5	9.0	8.2	6.2	1.3	5.3	4.8	18.1	7.4	6.0	9.0	4.6	5.1	9.9	5.3	2.9	9.3	4.2	5.5	7.2	13.6	5.7	4.6	8.2	8.8	23.0	5.0	1.7	7.2	2.6	1.8	13.6	11.0	6.0	6.1	8.6	8.4	5.1	2.3	2.7	1.5	4.1	5.4	7.7	6.8	3.1	2.4	4.8	1.2	11.7	3.0	5.5	3.9	2.5	8.9	3.0	4.5	1.5	3.0	3.0	3.7	2.4	3.6	2.9	3.1	11.1	3.2	4.0	3.5	10.9	5.2	2.6	3.0	4.7	10.5	1.8	1.6	1.1	16.3	8.9	4.6	0.5	2.2	1.2	10.4	10.3	10.6	4.3	5.8	2.4	6.6	1.7	4.1	6.7	3.6	9.2	3.6	1.3	6.7	2.7	1.5	3.5	2.8	0.1	0.1	1.3	0.3	0.2	0.4	0.3	0.3	0.4	0.1	0.5	0.3	0.4	0.0	0.1	0.3	0.2	0.0	0.1	4.0	5.1	5.0	4.3	3.2	4.5	5.3	4.8	5.1	4.6	5.0	6.0	5.2	16.0	14.8	73.8	5.7	8.2	3.0	10.9	29.0	7.5	8.4	8.6	14.5	8.6	11.6	11.0	8.4	6.3	3.5	66.4	3.9	5.5	10.4	4.4	8.2	10.2	3.0	5.9	33.6	3.5	7.9	19.7	12.2	3.1	6.3	17.1	3.6	6.1	12.8	10.1	52.1	25.4	12.2	6.6	15.9	6.9	6.8	7.1	8.8	47.8	4.4	5.0	9.2	68.3	87.9	6.1	19.3	7.2	5.3	3.8	24.0	10.8	15.5	6.5	6.6	7.9	10.0	52.5	24.3	14.7	7.7	3.1	4.0	43.2	15.2	3.1
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064711-146229000	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	3.7	1.1	3.4	2.8	2.8	7.6	4.3	2.2	6.4	4.9	7.4	2.8	1.1	3.5	3.8	2.8	3.0	2.2	1.3	3.6	2.2	1.9	3.2	3.3	2.5	3.8	3.1	5.4	3.3	3.2	0.3	2.5	2.9	2.7	2.8	4.6	2.0	3.0	1.0	7.4	1.2	3.4	1.7	4.4	1.8	3.3	4.5	2.7	2.3	2.2	2.4	2.2	1.4	4.1	6.4	1.7	3.6	2.4	11.3	13.6	3.0	3.3	4.5	3.3	3.3	1.5	3.0	2.7	0.7	6.4	3.2	3.0	4.0	4.5	6.7	3.4	3.0	6.3	5.0	0.8	4.5	2.7	1.9	12.4	4.1	9.2	8.8	10.6	3.9	1.7	2.0	8.7	7.1	7.3	1.1	2.4	1.5	1.6	4.7	1.4	2.6	3.6	2.3	4.5	0.4	0.4	5.1	4.9	1.8	5.8	4.2	3.6	12.3	3.2	2.9	2.9	4.4	5.8	2.3	3.4	2.9	2.9	2.7	2.2	2.0	2.7	0.3	1.0	0.4	1.5	0.3	0.3	0.8	1.5	0.3	0.2	5.6	0.3	2.3	2.2	0.3	0.1	3.4	2.8	2.2	6.4	3.6	2.2	3.8	3.1	2.9	1.7	4.5	4.1	0.5	76.9	46.1	13.7	12.8	57.0	4.9	15.4	5.2	0.5	3.7	2.0	8.4	2.8	22.0	0.0	0.0	0.7	9.2	1.5	0.0	5.3	15.1	2.8	2.8	3.4	0.0	10.5	0.8	2.7	5.0	18.2	3.1	6.1	20.2	6.4	0.7	1.8	1.4	0.0	1.1	2.7	14.2	5.0	100.9	3.3	6.5	17.7	30.2	4.7	14.2	2.0	9.2	5.0	0.1	5.5	25.3	8.2	5.7	2.1	2.2	0.2	19.6	2.0	0.0	7.6	9.9	9.9	5.4	23.8	105.8	0.5	6.6	1.4	3.4	4.5
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	9.5	7.6	4.0	5.7	5.0	7.6	9.5	4.1	5.4	11.7	4.6	8.5	4.2	9.5	17.0	6.5	10.3	3.8	5.6	3.9	4.0	7.3	18.1	7.0	7.5	6.1	4.6	11.6	12.1	7.7	7.8	4.6	6.0	9.8	5.7	7.2	8.8	7.0	3.3	12.3	10.6	6.5	4.8	12.6	12.0	6.6	5.1	6.1	9.8	1.5	7.7	9.0	8.5	7.1	5.4	4.4	8.6	8.3	5.8	4.7	5.8	4.7	4.5	3.9	4.2	3.4	5.4	9.3	3.7	5.8	3.7	7.1	5.4	1.8	4.8	5.1	5.8	4.2	15.6	3.8	4.1	5.9	14.4	4.1	5.0	5.1	9.8	6.0	3.0	7.9	6.8	0.4	4.0	11.0	6.9	11.0	7.5	12.6	5.6	9.1	4.8	3.6	4.0	10.8	3.4	8.9	7.8	5.3	8.0	11.2	7.7	10.1	7.3	5.0	4.3	7.8	6.1	5.3	4.7	6.3	4.9	3.7	2.9	3.7	0.9	3.0	1.8	0.6	1.3	1.6	1.6	1.1	0.9	2.2	1.6	1.3	0.1	0.5	1.9	1.9	0.6	0.6	4.0	5.0	4.1	5.4	3.9	4.0	6.1	4.6	6.0	4.8	5.1	7.1	6.0	12.8	12.0	19.9	11.9	1.1	2.3	0.3	9.6	4.5	7.8	6.2	6.9	5.7	5.2	3.7	10.4	4.9	9.1	5.5	0.0	3.4	9.7	4.3	4.5	6.9	3.5	8.8	28.1	3.3	4.2	7.0	11.2	7.5	13.9	6.6	7.5	19.1	3.3	5.0	16.8	8.0	0.0	9.6	3.4	1.4	5.3	6.6	7.2	24.4	15.9	3.8	6.2	30.7	29.9	4.1	16.0	2.6	6.9	1.5	4.9	2.7	3.8	6.8	6.6	4.4	5.5	6.9	3.9	8.6	1.4	2.9	8.1	3.3	8.4	1.1
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"	Q5TAG4	1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"pancreas: 80.1;stomach 1: 57.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	10.7	7.8	8.4	9.4	11.1	17.5	10.2	7.5	10.6	11.0	5.9	9.7	8.3	10.8	10.7	7.4	9.9	5.9	5.9	6.8	7.5	7.5	22.3	10.1	11.6	13.2	8.8	12.3	80.1	9.8	10.9	4.8	13.0	9.5	6.5	13.9	9.7	6.7	5.0	10.6	12.3	9.0	7.6	11.7	57.3	9.6	11.7	10.5	11.2	5.4	9.9	9.5	8.6	17.5	8.1	6.2	13.0	11.1	5.7	5.4	8.5	8.3	6.0	5.7	5.6	5.7	7.4	17.9	5.0	6.9	6.2	5.9	9.4	4.5	5.3	6.7	6.5	7.8	16.1	5.0	4.9	5.9	11.0	5.8	8.1	5.4	12.7	7.2	5.1	12.7	12.6	2.8	4.4	11.9	12.8	7.5	7.5	9.7	8.1	12.3	4.8	4.2	4.1	17.3	6.5	13.5	10.7	9.4	5.5	19.2	7.9	17.5	6.2	4.7	8.1	11.6	11.4	10.5	8.2	7.2	5.1	4.0	5.8	2.9	1.0	0.8	1.2	0.4	0.7	1.5	0.8	0.7	0.4	1.3	0.9	0.7	0.2	0.3	0.6	1.0	0.9	0.3	8.4	11.1	7.5	10.6	6.8	7.5	13.2	8.8	13.0	7.6	11.7	17.5	6.3	32.1	24.0	18.6	15.2	3.8	3.0	3.3	11.4	17.0	7.0	4.4	10.9	2.8	7.8	5.5	45.9	4.4	12.9	6.2	0.0	11.8	14.0	2.7	4.0	6.1	10.7	12.8	21.4	8.7	4.7	9.2	6.1	5.2	24.6	4.7	7.9	12.9	3.8	10.1	15.1	9.6	0.0	14.0	6.4	3.8	5.6	11.0	1.8	6.5	16.4	9.4	8.2	24.6	29.3	12.7	15.7	10.5	6.4	1.9	15.9	2.0	6.5	16.7	6.6	6.0	8.6	12.2	6.8	11.4	4.3	1.9	12.1	2.6	10.5	1.5
NBPF14	DJ328E19.C1.1	ENSG00000270629	"NBPF member 14"		1	148531385-148679742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Astrocytes: 95.0;Paneth cells: 174.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 128.6"									"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.28e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.92e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.69e-4)"	"unprognostic (7.23e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.15e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.52e-2)"	31.3	10.3	18.1	26.1	16.8	44.2	26.1	11.0	31.9	21.4	40.8	19.6	9.1	29.4	22.4	24.2	22.5	19.9	9.3	23.5	12.1	13.9	21.2	22.1	22.2	21.2	17.3	45.2	26.9	18.4	3.9	15.7	14.4	19.3	20.1	26.1	16.3	14.7	13.6	51.8	11.3	27.5	10.4	31.9	11.4	23.6	25.1	16.3	16.5	12.2	18.6	16.6	15.7	20.7	80.9	12.9	30.7	21.1	64.1	90.4	14.4	26.5	25.4	16.9	20.2	11.5	21.3	16.0	6.6	32.0	25.1	23.7	20.0	26.4	29.4	29.4	21.3	36.5	47.1	2.3	22.8	30.9	14.9	83.2	23.9	55.7	58.5	97.3	29.2	11.5	13.9	50.8	43.8	44.2	7.8	20.8	13.1	14.8	31.4	11.7	25.4	39.8	17.9	34.0	0.4	0.5	54.4	28.6	15.6	30.2	36.7	26.7	128.6	23.4	23.2	22.9	50.1	41.7	16.2	35.5	39.1	27.0	31.1	11.9	16.2	15.2	2.0	8.3	1.0	11.8	1.5	1.3	4.5	11.3	2.0	1.8	34.9	2.4	15.6	17.7	1.8	1.7	18.1	16.8	11.0	31.9	23.5	12.1	21.2	17.3	14.4	10.4	25.1	20.7	2.9	89.8	83.7	95.0	34.8	2.2	47.3	0.6	10.8	2.0	16.9	9.3	20.2	11.5	15.2	12.9	4.2	1.3	28.1	10.7	0.0	37.4	47.3	11.4	8.5	3.7	3.6	15.5	3.7	16.2	14.0	31.8	6.1	20.0	53.7	21.2	3.3	9.9	13.7	0.0	4.4	7.4	0.0	45.3	3.4	43.8	28.3	49.6	1.8	17.8	61.8	13.3	6.2	28.1	0.7	26.4	174.5	17.0	13.3	22.2	6.9	8.6	9.1	9.8	13.1	14.0	18.1	47.5	13.0	38.2	6.3	1.5	12.4	8.4	21.0	41.3
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 1.3;NK-cells: 1.3;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	17.2	13.9	7.8	10.1	8.0	2.3	18.7	11.3	8.5	21.9	7.2	20.4	3.9	17.4	20.2	13.7	20.0	7.6	13.4	7.6	8.3	17.2	36.5	24.1	16.8	7.4	7.3	21.2	21.3	8.9	17.0	9.8	7.2	18.0	7.8	18.6	14.4	7.4	5.6	15.2	19.3	12.0	6.4	28.9	14.2	6.9	8.4	2.4	25.8	2.9	12.3	15.3	17.2	6.2	13.7	9.3	15.8	29.8	18.2	28.6	19.5	24.6	24.2	15.0	15.2	7.9	14.8	7.0	6.6	18.5	16.9	10.5	17.5	8.0	23.0	23.4	9.6	0.4	23.6	9.6	14.0	0.4	6.5	23.8	13.5	17.7	36.4	20.7	21.1	2.7	3.1	20.5	36.0	29.7	0.3	6.0	6.5	5.0	19.8	6.4	9.2	11.1	16.2	12.4	1.4	35.7	10.5	15.7	17.5	20.1	16.2	5.9	22.6	23.7	15.3	21.0	23.5	18.2	21.0	11.8	0.3	0.7	11.4	0.0	0.2	0.0	0.5	0.0	0.8	1.3	1.5	1.1	0.1	0.9	1.8	0.7	0.1	1.3	0.2	0.0	2.5	0.8	7.8	8.0	11.3	8.5	7.6	8.3	7.4	7.3	7.2	6.4	8.4	6.2	5.9	44.8	20.8	5.9	14.8	2.0	1.5	0.7	22.8	2.7	5.1	3.2	10.3	4.3	12.8	1.8	6.2	1.7	4.9	1.6	0.0	6.4	5.3	2.6	9.6	9.7	6.1	1.7	16.9	4.4	3.2	12.2	11.2	3.8	15.2	5.3	6.1	8.9	1.6	3.3	10.4	3.0	0.0	7.5	1.4	1.4	8.7	8.1	1.8	14.0	6.2	3.1	1.0	7.1	3.4	6.6	23.6	10.5	10.3	1.5	1.4	1.0	5.0	7.1	0.0	3.5	8.7	3.7	1.9	17.6	1.3	0.3	8.4	3.8	5.2	0.4
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149475338-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 73.1;Paneth cells: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	38.1	9.0	11.7	31.4	5.4	55.7	28.7	3.7	35.0	25.8	37.6	19.1	10.6	28.8	24.4	24.6	29.5	16.7	10.2	9.7	3.4	14.3	18.9	27.3	30.2	5.9	10.2	48.8	33.7	17.4	3.8	14.9	8.2	24.8	21.7	57.6	20.6	15.5	15.0	63.4	13.4	30.4	0.4	36.8	13.2	28.6	19.9	33.5	20.7	18.2	26.6	19.1	9.2	7.8	62.9	16.4	33.8	18.0	65.9	55.4	16.0	29.8	22.4	20.2	19.4	14.7	21.9	18.1	7.0	45.4	26.7	27.8	47.8	27.6	30.9	32.6	26.8	51.6	49.1	5.2	13.1	51.9	18.0	38.5	12.1	58.7	73.5	27.6	13.3	25.1	12.7	27.6	43.3	45.9	28.3	31.1	30.7	17.6	25.4	25.5	35.7	29.1	12.5	30.0	2.8	7.1	71.5	23.9	13.0	47.7	44.7	70.4	80.2	40.7	30.5	23.9	46.9	23.1	14.5	54.9	45.6	35.4	12.4	15.1	22.2	7.8	8.9	8.6	6.1	3.3	5.0	3.3	4.4	7.1	6.5	8.6	24.0	9.3	7.1	16.1	2.1	2.4	11.7	5.4	3.7	35.0	9.7	3.4	5.9	10.2	8.2	0.4	19.9	7.8	2.3	51.3	59.2	61.0	12.9	0.0	18.5	0.0	19.4	8.1	13.9	7.6	22.4	2.8	9.9	3.7	27.1	1.5	24.4	2.6	1.9	21.2	57.8	13.9	13.0	2.6	1.2	12.8	7.6	6.2	7.1	14.0	4.6	23.2	20.2	9.2	2.2	7.3	6.6	3.3	6.7	3.1	0.0	40.9	0.0	8.0	32.3	43.8	0.0	12.2	73.1	16.6	36.0	22.1	0.6	10.0	123.8	30.1	17.1	6.8	6.3	0.5	11.7	48.7	19.7	15.9	12.4	30.4	6.2	33.9	0.0	1.4	26.3	2.8	6.0	11.5
NBPF20		ENSG00000162825	"NBPF member 20"	P0DPF2	1	145289900-145405778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.6;Early spermatids: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (6.25e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.54e-1)"	"unprognostic (4.26e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.45e-4)"	"unprognostic (9.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.70e-1)"	3.7	3.6	10.3	4.3	6.0	4.0	4.2	48.5	8.6	3.7	2.2	3.2	1.8	4.0	4.6	2.3	2.7	3.0	2.1	5.2	4.7	2.7	6.0	3.3	4.3	12.7	41.5	5.1	3.5	6.9	1.9	2.0	15.6	4.1	3.6	9.0	4.6	4.8	3.1	5.8	3.2	4.5	5.2	4.0	2.8	7.9	15.4	5.4	2.7	3.5	4.4	3.2	1.2	9.9	25.7	12.0	3.4	9.8	20.4	35.6	8.5	12.3	2.9	4.1	4.4	13.4	3.0	5.8	4.7	12.0	7.0	7.5	11.9	14.0	11.7	11.9	14.4	3.9	17.6	9.7	4.2	7.1	6.4	10.6	10.4	22.8	18.9	7.7	10.9	3.2	15.5	9.0	17.0	16.0	1.0	3.2	3.2	5.4	19.3	5.8	9.7	3.7	5.9	4.5	6.0	10.6	23.8	12.6	6.6	8.6	9.3	9.2	20.5	20.0	25.5	11.3	27.3	5.2	4.5	13.0	11.3	2.9	3.0	0.5	1.5	0.5	0.9	0.7	0.7	1.3	0.6	0.8	0.4	3.3	0.9	0.7	0.8	2.4	2.0	11.5	0.9	0.4	10.3	6.0	48.5	8.6	5.2	4.7	12.7	41.5	15.6	5.2	15.4	9.9	2.1	22.4	30.6	3.6	3.1	2.9	1.9	2.1	1.2	4.7	3.4	1.8	3.9	1.5	3.0	0.0	18.8	1.3	10.9	1.2	0.0	8.0	25.9	2.4	3.4	4.7	6.1	2.1	6.6	11.2	5.1	7.1	0.5	3.5	7.6	1.6	2.9	16.5	1.8	1.7	3.3	2.4	0.0	4.6	5.8	2.9	5.6	3.3	3.6	1.9	7.5	1.8	2.1	2.0	2.5	11.3	9.8	3.8	3.3	1.5	2.1	0.4	5.4	8.6	0.0	2.6	3.4	11.8	8.1	2.2	3.1	0.7	3.7	1.8	3.3	0.8
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723949-120842110	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;B-cells: 36.4;Basal squamous epithelial cells: 37.0;Erythroid cells: 55.5;Macrophages: 54.4;Squamous epithelial cells: 106.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	14.7	7.2	5.4	21.9	5.1	13.2	11.0	7.6	6.3	14.9	13.7	10.2	2.5	15.1	20.1	20.7	11.2	13.3	6.5	3.8	5.8	4.9	10.4	13.3	12.5	5.4	4.4	17.0	8.9	4.3	4.7	8.5	3.6	12.6	9.3	23.1	10.2	8.9	6.4	39.0	8.6	17.3	2.0	13.9	7.5	10.3	8.0	11.9	12.2	5.4	8.5	7.9	11.5	5.8	56.7	0.3	16.4	17.8	18.3	16.9	1.3	19.9	10.1	12.5	12.9	12.2	2.3	4.4	17.2	17.5	21.6	14.4	27.8	28.7	17.4	25.1	1.3	40.1	7.5	4.8	9.1	16.0	11.4	10.2	11.8	31.1	32.6	40.5	0.8	10.5	3.0	30.1	29.5	28.7	4.2	24.6	6.3	2.0	21.5	5.5	15.3	8.2	7.3	19.9	1.5	1.3	22.1	30.5	16.6	19.5	1.0	6.7	17.3	14.0	36.3	43.7	15.7	13.5	4.1	16.2	11.6	23.5	2.2	2.4	5.1	4.6	1.4	2.3	0.7	0.8	1.0	1.2	1.4	2.0	1.0	1.5	13.3	1.3	7.3	1.3	0.5	0.7	5.4	5.1	7.6	6.3	3.8	5.8	5.4	4.4	3.6	2.0	8.0	5.8	0.8	54.5	28.7	3.9	36.4	0.0	2.2	0.0	37.0	0.6	3.9	2.4	2.7	0.0	3.7	0.0	0.0	0.5	4.7	0.6	3.9	4.8	7.6	7.2	4.8	1.4	0.0	55.5	0.4	3.1	2.4	14.9	16.3	7.8	16.4	2.5	1.1	1.4	0.2	0.0	0.3	1.0	0.0	4.4	0.0	0.9	6.5	54.4	0.0	1.0	6.5	0.6	2.1	0.5	0.1	4.0	27.3	4.5	28.0	1.0	1.7	0.7	3.6	2.1	0.0	3.1	6.7	4.9	2.5	106.5	0.0	0.4	21.1	0.9	2.2	0.8
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.8;Excitatory neurons: 17.6;Inhibitory neurons: 18.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.0;HHSteC: 12.0"									"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	1.4	2.0	1.4	0.7	1.4	0.7	1.7	1.4	2.1	1.8	1.3	1.9	0.1	0.9	1.3	1.2	1.3	0.1	1.1	1.3	1.3	2.1	1.6	0.8	0.9	1.5	1.3	1.5	1.4	1.4	2.2	1.6	1.3	1.5	0.9	1.5	1.5	0.9	0.7	1.7	1.6	1.0	1.3	1.5	2.0	9.8	1.4	1.1	1.7	0.0	1.4	1.5	1.1	1.3	1.6	1.6	0.0	4.3	2.9	1.1	4.9	3.7	12.0	3.3	2.9	2.9	4.3	3.0	1.2	6.9	0.8	0.2	2.2	2.6	0.3	1.7	3.0	2.3	0.2	0.9	12.0	1.1	1.3	0.8	0.8	3.1	0.1	1.2	0.4	0.0	0.2	0.6	0.4	5.3	0.0	2.6	0.7	2.1	3.3	0.0	0.0	2.4	0.3	1.5	3.4	3.7	5.2	1.0	3.5	1.0	1.3	1.7	3.5	1.1	2.2	4.6	1.1	0.0	1.8	4.7	0.3	2.2	1.4	0.0	0.2	1.0	1.7	0.3	2.4	0.4	0.7	1.4	0.1	0.2	1.2	1.6	0.1	0.7	0.0	0.0	0.8	0.9	1.4	1.4	1.4	2.1	1.3	1.3	1.5	1.3	1.3	1.3	1.4	1.3	1.6	0.0	3.7	14.0	1.9	1.3	2.8	1.2	2.8	1.8	3.8	2.8	2.9	1.5	1.3	1.8	6.2	3.7	2.7	0.8	0.0	1.2	33.8	1.9	1.5	2.3	0.0	2.1	17.6	2.5	1.1	3.4	4.1	3.2	2.5	1.8	3.6	1.1	0.9	0.0	18.4	2.8	4.1	1.6	6.7	4.3	2.8	3.0	0.0	6.5	1.9	1.0	0.0	29.1	17.2	2.4	0.2	1.9	0.9	1.6	1.4	2.2	5.9	2.0	0.0	2.8	2.3	15.7	8.0	2.2	3.0	2.5	3.4	4.0	1.1	2.2
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;intestine: 1.2;testis: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	3.1	0.0	12.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.1	3.8	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HeLa: 1.9;K-562: 11.6;SK-BR-3: 2.4;SK-MEL-30: 1.9"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.9	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF9	AE01	ENSG00000269713	"NBPF member 9"	P0DPF3	1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Hepatocytes: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 49.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 49.5;monocytes: 14.2"	"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	15.8	10.5	8.8	11.5	8.6	8.9	13.7	17.3	9.1	16.6	11.4	14.4	6.4	14.2	17.0	9.6	14.6	9.5	10.0	9.0	8.9	11.5	33.8	17.2	13.6	9.6	10.2	14.9	18.6	9.6	13.8	7.5	8.7	12.8	9.0	21.4	10.2	7.2	6.8	12.8	15.2	11.5	7.5	15.5	13.2	10.7	10.6	4.0	25.9	2.6	10.7	12.4	12.5	8.1	50.1	21.4	26.2	35.5	23.0	28.1	20.7	44.7	32.5	23.1	25.0	16.2	21.0	11.9	12.1	23.1	27.8	14.7	18.2	20.9	39.4	30.2	19.1	3.8	41.2	9.7	26.7	5.0	13.8	27.8	15.4	25.4	44.1	42.7	20.5	9.0	14.1	30.1	28.4	38.8	1.4	7.4	9.8	8.8	28.8	13.5	16.3	18.0	18.8	22.9	16.9	34.9	14.8	35.7	19.5	16.0	26.5	9.3	48.6	52.0	15.2	38.2	69.8	36.7	20.8	23.0	18.9	3.2	18.6	49.5	14.2	0.6	0.6	5.1	1.0	2.7	1.8	0.6	1.9	5.5	2.5	1.4	8.2	7.8	2.0	7.7	2.5	1.4	8.8	8.6	17.3	9.1	9.0	8.9	9.6	10.2	8.7	7.5	10.6	8.1	2.5	38.5	16.0	8.5	9.0	5.5	8.7	2.6	2.8	4.8	4.7	2.8	4.2	4.3	12.5	5.5	6.2	2.9	7.2	0.8	0.0	3.4	11.1	8.6	8.7	5.3	1.8	2.1	8.5	2.0	4.0	12.4	4.1	8.8	18.9	7.3	2.2	28.2	3.6	0.0	6.2	1.0	4.1	12.1	17.0	3.8	7.2	12.7	3.6	6.5	14.3	3.7	3.1	7.5	3.2	2.9	7.7	4.1	9.8	3.6	1.6	1.0	6.8	12.0	6.6	7.0	5.2	9.9	4.2	5.9	14.2	1.4	6.3	3.8	1.1	5.9
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1 autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 276.9;Late spermatids: 909.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	45.7	52.3	48.4	39.4	54.5	20.1	55.9	52.1	48.2	52.0	51.2	66.2	70.1	48.9	39.9	40.3	53.4	44.5	67.3	43.7	49.9	84.7	91.3	47.3	41.0	52.2	50.4	69.7	43.9	97.1	28.8	60.1	52.9	64.7	70.4	80.1	49.4	52.0	112.2	42.9	73.8	49.3	52.1	53.0	52.6	141.0	51.6	59.0	68.2	116.0	45.4	47.3	34.5	65.2	42.3	49.8	42.6	44.6	93.5	95.2	41.0	77.1	147.2	60.5	50.4	26.6	65.1	22.7	77.8	105.1	62.6	46.1	48.5	97.4	90.3	70.0	51.2	27.1	62.0	60.0	89.4	23.2	40.1	108.4	111.6	67.2	133.7	127.3	96.0	50.8	58.1	58.7	83.7	23.9	48.9	17.7	13.6	50.0	32.8	16.5	65.6	73.3	81.6	48.0	25.9	45.8	53.1	26.1	79.8	70.7	70.7	38.0	82.2	89.9	34.1	42.7	31.5	69.9	61.8	29.1	61.8	31.5	63.6	41.6	25.7	40.1	20.3	23.3	20.7	13.7	18.1	19.6	19.3	9.4	17.0	16.6	34.4	24.3	36.4	12.0	26.4	25.0	48.4	54.5	52.1	48.2	43.7	49.9	52.2	50.4	52.9	52.1	51.6	65.2	36.9	41.7	44.1	24.5	21.9	23.8	29.2	28.1	54.1	37.3	33.8	27.4	86.4	35.8	40.4	36.8	39.6	28.0	34.6	94.2	19.6	25.4	276.9	40.5	30.4	39.0	40.2	53.2	24.7	21.9	19.4	37.6	31.1	33.0	25.9	53.1	45.3	67.8	22.0	20.2	28.2	56.4	20.3	62.9	19.9	909.9	58.7	35.7	26.6	29.0	35.6	49.3	44.3	33.2	41.4	25.8	64.5	44.4	26.1	41.1	100.3	57.4	63.4	56.9	39.5	33.9	36.2	49.6	30.9	26.7	27.3	15.7	31.9	68.6	52.4	38.7
NCALD		ENSG00000104490	"Neurocalcin delta"	P61601	8	101686542-102124907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 100.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.6;Inhibitory neurons: 460.2;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 87.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 87.3;T-cells: 42.2"	"Cell line enhanced"	"Detected in many"		"AF22: 136.4;HDLM-2: 159.9;U-266/70: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043245: AB_2678385"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.30e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.00e-2)"	21.4	7.3	30.3	9.4	43.4	1.8	44.0	0.0	62.5	13.5	0.0	22.3	6.0	7.6	4.4	12.6	39.6	12.6	12.1	52.4	11.3	14.9	15.1	19.7	13.6	3.6	13.3	37.5	10.0	1.9	13.7	10.0	15.3	12.3	8.8	15.9	100.6	14.9	15.4	18.0	10.2	11.0	1.2	8.3	11.2	7.3	29.4	5.5	5.2	11.6	11.1	11.1	4.0	21.6	6.9	9.8	136.4	0.5	1.1	22.3	0.0	2.3	0.3	0.1	0.0	0.1	0.1	9.0	3.0	10.4	0.6	0.0	1.0	0.0	0.0	159.9	1.0	0.7	0.0	0.0	0.0	6.1	0.9	4.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	19.3	0.8	0.2	1.2	2.4	1.5	0.0	0.0	3.7	0.0	0.4	22.0	0.3	0.6	13.4	0.0	3.1	5.7	22.5	0.9	4.8	0.2	1.6	0.3	0.2	0.4	39.3	5.6	0.1	0.3	0.1	2.2	0.4	0.3	0.3	42.2	0.2	37.1	0.9	16.0	24.8	5.0	0.6	3.9	20.6	1.3	87.3	0.3	0.4	17.5	13.6	30.3	43.4	0.0	62.5	52.4	11.3	3.6	13.3	15.3	1.2	29.4	21.6	17.3	0.0	2.6	11.8	0.5	4.2	0.5	1.0	0.0	14.6	88.6	74.4	7.5	14.3	3.2	0.0	25.0	3.2	28.9	1.7	7.9	9.6	12.8	32.2	5.0	11.3	21.0	4.0	251.6	1.2	13.0	39.8	4.1	23.8	2.5	20.5	14.6	15.0	1.9	13.5	460.2	4.3	61.1	2.6	6.9	6.6	2.8	2.8	103.2	75.9	0.8	46.6	64.9	281.0	26.5	3.5	0.5	1.5	7.1	1.3	0.0	19.5	26.0	4.7	26.3	91.0	24.5	1.5	1.8	3.0	3.1	3.0	17.4	19.4	0.4	1.1
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 290.1;heart muscle: 145.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.7"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA	1200000	2300000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	4.6	65.7	124.0	3.9	169.1	1.5	2.7	118.1	140.3	35.1	0.0	47.8	4.6	62.7	3.5	7.0	40.4	4.8	145.5	135.6	179.1	3.2	2.9	1.8	1.3	140.4	134.2	43.8	2.6	0.0	22.2	0.5	147.4	14.9	6.6	117.7	3.6	17.7	31.2	2.1	18.3	46.9	129.7	4.7	23.0	5.0	137.0	0.4	30.2	29.5	1.0	34.8	24.3	290.1	0.1	0.0	20.8	0.3	0.2	0.5	0.3	1.0	0.0	0.7	1.2	0.3	0.3	3.1	18.2	20.1	0.8	0.3	0.1	0.0	0.0	0.4	12.1	61.3	0.1	0.0	2.1	0.0	9.5	12.4	0.1	0.1	18.6	0.1	0.0	0.1	0.0	1.0	20.8	0.0	0.2	5.2	1.8	0.0	0.4	0.1	132.5	10.0	0.0	0.0	107.4	52.7	0.1	0.5	0.1	2.0	0.2	0.8	0.2	72.8	33.4	0.3	31.8	0.1	0.5	0.1	8.3	28.4	79.0	0.0	0.2	0.0	3.6	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	1.4	0.7	53.7	0.0	0.0	0.2	1.9	124.0	169.1	118.1	140.3	135.6	179.1	140.4	134.2	147.4	129.7	137.0	290.1	13.7	0.0	0.0	530.8	0.4	1.7	0.5	0.0	0.0	123.5	5.7	0.6	131.7	0.0	0.0	0.0	37.5	0.6	27.7	0.1	1.9	18.3	6.7	0.3	2.4	2.8	5.4	0.0	461.4	0.0	0.2	12.8	5.1	0.5	1.3	11.7	7.1	0.7	0.4	175.0	441.2	0.0	8.2	4.7	3.8	5.9	15.2	1.8	0.0	35.6	1.2	216.6	59.8	939.0	1013.5	1.3	0.0	10.1	5.6	0.4	0.0	0.2	0.7	98.0	0.0	107.5	4.8	1.0	2.8	0.4	1.7	0.1	13.4	5.6	0.0	0.2
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"brain: 73.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.8	0.0	53.1	0.0	0.0	15.2	73.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	44.2	0.0	0.0	0.0	0.0	33.3	32.3	0.0	0.0	0.0	0.3	0.0	38.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.9	61.5	0.1	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	53.1	15.2	73.6	55.6	44.2	33.3	32.3	38.1	21.5	61.5	49.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes		34000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	8.3	7.4	7.3	21.5	11.4	35.5	10.9	9.9	8.3	10.2	7.4	17.9	17.0	10.7	10.6	15.9	11.2	9.8	7.6	7.2	8.0	7.4	4.8	10.6	38.1	11.0	10.0	8.0	7.7	11.3	5.5	17.5	11.7	9.4	20.4	11.1	11.8	10.2	7.9	21.9	16.0	13.4	8.4	16.1	12.1	18.2	10.2	76.8	11.3	10.2	44.8	10.1	9.3	13.9	125.3	99.3	134.6	97.9	29.9	28.4	159.2	76.1	69.8	138.3	109.1	123.5	150.8	135.8	24.2	63.2	126.7	128.6	188.0	105.4	194.1	214.1	92.8	112.2	113.8	79.4	12.5	145.0	96.5	20.5	31.6	112.4	107.8	61.9	89.9	94.0	71.0	63.4	104.7	79.6	162.2	73.8	207.5	129.9	78.2	153.7	260.6	77.7	39.5	64.1	54.0	61.9	121.5	64.9	44.3	189.1	27.0	101.7	51.0	94.1	149.6	60.8	168.4	45.3	51.7	181.0	55.7	92.2	126.1	11.0	1.7	3.7	7.1	2.8	5.3	5.1	6.4	7.3	3.4	3.5	7.3	7.3	1.4	8.1	2.2	4.1	8.3	3.9	7.3	11.4	9.9	8.3	7.2	8.0	11.0	10.0	11.7	8.4	10.2	13.9	4.3	6.4	7.4	4.9	11.0	3.6	3.8	4.4	17.1	3.7	4.7	6.9	4.1	5.7	3.4	1.8	8.4	13.5	8.9	7.3	0.0	4.5	18.3	5.3	6.3	5.4	1.2	48.0	5.6	3.7	17.8	6.4	7.1	5.8	3.8	20.0	8.9	3.3	10.1	5.0	5.0	9.9	6.1	16.4	4.4	34.3	5.9	10.8	0.0	2.8	9.5	11.8	15.5	2.5	17.8	5.3	4.6	6.0	22.6	4.1	6.0	2.4	4.2	8.4	0.0	4.2	5.2	21.3	13.7	19.3	3.4	6.3	12.0	6.1	14.7	4.1
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810979-17844865	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.6"	"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes		9500	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	0.7	0.5	0.1	4.1	0.1	13.9	0.9	0.5	0.1	0.7	0.2	3.0	3.8	0.6	0.0	3.5	0.2	0.9	0.3	0.0	0.2	0.2	0.7	0.6	8.7	0.6	1.2	0.2	0.2	0.1	0.1	3.0	0.7	0.3	2.4	0.3	0.7	0.0	0.2	3.5	3.2	1.0	1.2	2.1	1.9	5.6	0.3	15.8	0.3	0.1	8.7	1.2	1.0	0.2	45.1	28.3	63.8	42.2	4.0	7.8	23.1	56.8	22.2	55.0	55.8	36.3	26.8	66.8	11.3	16.0	47.6	19.9	54.5	22.1	74.8	30.5	27.0	53.6	37.3	29.8	0.2	38.4	20.3	1.5	1.5	40.7	18.6	8.8	27.9	28.9	53.1	74.1	55.0	13.4	44.1	36.9	32.8	26.1	27.9	42.8	57.4	28.0	16.6	13.9	50.0	29.7	51.2	10.9	15.7	27.2	25.6	21.3	23.2	52.5	23.6	30.0	78.9	23.2	23.3	56.1	21.7	39.1	35.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.5	0.1	0.0	0.2	0.6	1.2	0.7	1.2	0.3	0.2	0.3	0.0	1.1	0.0	3.3	2.4	0.6	1.9	1.2	0.2	0.6	0.6	0.2	0.0	0.8	0.0	0.0	11.7	1.6	2.9	0.0	0.1	15.8	0.9	1.9	1.7	1.8	59.3	0.2	0.0	26.6	3.8	7.1	2.3	1.3	14.2	2.2	0.5	9.5	0.0	0.4	3.1	2.0	2.6	2.9	9.5	0.6	3.7	1.8	1.0	0.7	0.3	3.1	0.5	0.5	0.2	0.1	0.0	20.4	0.4	0.2	0.0	0.0	0.2	0.0	0.2	4.3	63.7	24.3	11.0	1.1	2.2	3.7	0.7	5.6	1.3
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633668-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	10.9	11.0	11.9	16.0	13.7	29.5	11.7	28.3	13.6	10.5	13.7	15.4	12.7	11.7	10.0	12.3	8.8	11.4	12.2	11.8	11.8	11.0	16.6	9.7	19.8	11.6	11.1	12.7	13.2	10.1	10.5	14.6	11.7	12.2	17.9	30.6	10.8	10.2	18.7	15.8	12.6	11.4	11.2	13.3	13.0	16.9	10.9	21.3	15.7	14.9	18.7	14.0	10.6	17.4	57.7	40.6	44.2	41.0	30.8	30.9	41.6	41.2	25.9	40.1	37.4	54.7	30.2	49.0	17.9	41.1	38.5	62.1	72.3	51.6	57.3	33.8	22.2	45.8	58.5	34.4	30.0	60.8	43.2	23.5	25.0	47.3	35.8	28.5	42.4	35.4	68.6	27.0	68.5	43.5	44.3	33.5	46.4	85.4	39.8	41.9	100.4	20.4	33.0	42.9	55.2	35.4	44.2	38.5	23.5	37.9	23.7	38.7	35.2	31.1	28.0	61.9	44.5	21.7	34.3	25.7	27.3	48.6	40.9	14.0	10.0	9.4	7.2	13.4	8.0	5.3	7.7	7.2	12.7	6.5	6.6	8.0	2.9	12.7	13.9	4.5	7.9	7.4	11.9	13.7	28.3	13.6	11.8	11.8	11.6	11.1	11.7	11.2	10.9	17.4	9.8	6.4	11.1	34.9	13.9	13.6	6.8	9.3	13.1	21.9	7.9	5.6	23.4	10.0	13.7	9.2	20.9	13.7	9.7	16.0	3.9	8.9	20.3	12.2	16.7	10.4	9.1	21.4	26.1	6.9	15.0	11.7	17.3	13.2	8.2	12.8	7.1	16.5	11.3	21.9	25.5	12.1	14.2	12.0	9.6	9.8	6.5	12.0	5.4	12.2	15.8	8.9	11.3	20.1	24.4	9.7	7.8	7.5	15.9	7.9	9.0	5.3	15.1	23.4	6.6	10.4	11.2	29.4	14.1	14.3	7.4	14.4	15.0	9.5	10.9	8.4
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCBP2L		ENSG00000170935	"Nuclear cap binding protein subunit 2 like"	A6PVI3	X	107774899-107795829	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.1;testis: 2.6"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 40.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	79	"basophil: 8.3"	"Lineage enriched"	"Detected in single"	79	"granulocytes: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA010664	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA010664: AB_1079451"	"unprognostic (3.22e-1)"				"unprognostic (8.00e-2)"						"unprognostic (5.64e-2)"	"unprognostic (7.29e-2)"				"unprognostic (2.64e-1)"		0.0	1.1	0.2	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0
NCBP3	"C17orf85, ELG, HSA277841"	ENSG00000074356	"Nuclear cap binding subunit 3"	Q53F19	17	3802158-3846246	"Predicted intracellular proteins"	"Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008959, HPA013195"	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA008959: AB_2668184, HPA013195: AB_2668800"	"unprognostic (1.39e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.36e-2)"	9.4	8.2	8.1	7.9	10.2	17.1	8.8	8.8	9.6	11.3	7.7	10.0	8.4	8.3	3.5	9.6	10.7	4.9	9.4	8.5	9.2	8.5	6.9	8.1	6.5	8.7	9.7	10.8	12.0	5.8	6.8	7.1	9.7	8.5	5.8	10.4	9.4	4.3	8.8	11.8	10.3	5.8	8.6	10.8	9.4	16.8	9.1	13.9	8.4	3.3	5.4	9.5	9.4	15.2	12.4	15.8	14.3	10.6	7.3	5.3	7.0	8.3	5.6	11.4	7.2	6.3	4.7	10.9	7.3	8.8	5.4	22.2	10.8	10.9	14.5	13.6	14.9	8.9	7.7	7.0	6.1	5.4	12.6	8.2	4.6	10.9	11.5	9.1	9.6	16.0	11.2	11.1	8.5	4.1	19.7	9.6	13.1	5.6	5.9	33.8	11.3	7.1	5.9	6.3	5.2	11.2	17.4	5.9	11.9	11.6	9.1	11.2	9.8	6.5	8.9	10.3	18.2	5.9	6.0	9.3	8.3	9.6	10.3	0.9	2.0	2.6	2.2	1.3	1.9	1.7	1.8	3.0	1.3	1.1	3.0	2.5	2.8	1.4	0.8	2.1	3.2	1.2	8.1	10.2	8.8	9.6	8.5	9.2	8.7	9.7	9.7	8.6	9.1	15.2	45.1	51.3	41.2	0.0	31.2	0.0	26.8	0.0	26.2	44.8	32.2	27.3	0.0	22.8	24.1	25.8	35.5	93.6	59.5	13.1	13.7	24.8	13.5	49.8	63.2	27.8	10.9	21.7	0.0	23.5	21.0	31.1	29.6	48.2	24.0	56.7	29.6	21.5	23.3	33.7	0.0	16.6	0.0	29.9	0.0	17.0	24.8	28.3	0.0	0.0	36.7	20.9	46.4	0.0	0.0	26.8	16.9	18.8	37.7	28.6	20.3	18.2	35.0	45.4	32.9	42.4	27.8	48.0	50.6	30.9	0.0	99.3	34.3	34.1	19.4	28.4
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"NCCRP1, F-box associated domain containing"	Q6ZVX7	19	39196964-39201884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 453.4;skin 1: 273.2;vagina: 181.7"	"Cell type enriched"	"Detected in some"	12	"monocytes: 563.9"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 30.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.6"	"Low region specificity"	"Detected in some"			HPA052812	Approved					NA	NA		400000	"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.3	0.2	1.3	2.1	0.9	1.0	6.3	1.9	1.8	97.0	0.0	0.4	2.0	0.6	0.8	453.4	1.1	0.8	0.4	1.0	0.8	2.8	0.2	0.4	2.7	1.0	0.9	0.4	8.8	1.4	0.4	1.1	1.3	1.4	1.9	1.7	54.0	1.2	0.9	273.2	0.7	0.5	0.9	1.4	0.5	0.5	1.0	4.1	0.6	0.0	124.9	5.2	181.7	1.4	0.2	0.2	1.1	0.2	0.1	0.7	2.4	0.1	0.0	0.1	0.2	0.5	0.5	0.7	2.3	0.4	0.2	1.0	1.7	0.7	0.5	0.0	0.4	0.2	0.9	0.1	0.2	0.5	0.3	0.5	0.5	0.1	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.2	0.2	0.7	0.2	0.2	0.2	0.4	0.4	0.1	0.6	0.6	1.0	2.9	30.8	0.2	0.9	0.4	0.9	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.5	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	1.3	0.9	1.9	1.8	1.0	0.8	1.0	0.9	1.3	0.9	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	1.6	8.5	0.0	0.3	4.7	2.4	0.3	0.0	30.8	3.7	0.0	0.4	0.2	0.1	0.0	2.7	0.0	0.7	0.4	0.2	0.0	0.0	0.0	2.3	3.1	1.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	4.7	0.2	0.0	0.7	1.8	0.0	563.9	0.3	0.0	0.0	0.0	4.2	0.7	0.0	1.2	1.1	0.0	0.1	1.6	0.0	0.0	0.1	2.0	0.1	0.5	7.3	7.1	11.1	0.2	0.1	0.0	46.4
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 424.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.7;Inhibitory neurons: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	10.7	23.9	197.0	9.4	424.1	4.9	9.8	51.0	360.4	20.5	0.0	16.9	5.3	17.1	6.5	12.1	16.1	9.7	23.1	364.2	118.3	13.4	10.3	11.8	9.6	114.1	115.9	18.9	10.0	10.6	38.7	6.7	112.0	17.2	3.4	21.3	11.0	11.3	14.6	10.1	10.6	9.6	168.3	11.4	14.9	15.3	215.9	7.4	16.6	9.0	6.6	16.2	15.9	191.3	17.3	20.5	16.8	26.6	23.8	29.4	11.6	22.3	22.9	23.0	18.3	20.6	24.8	19.6	21.1	20.7	16.5	26.0	16.6	27.1	8.4	19.2	34.3	24.4	32.2	10.7	33.0	22.3	26.9	28.2	22.2	40.7	16.3	18.9	12.3	11.6	26.9	30.4	18.9	31.0	20.5	14.2	75.7	19.1	35.6	16.6	9.4	25.4	15.6	19.0	20.9	30.0	25.4	23.2	32.1	13.3	22.2	14.4	17.0	29.1	20.9	21.5	30.9	42.4	32.6	14.7	36.3	35.1	27.1	0.0	2.6	0.4	1.6	1.5	2.0	3.7	2.5	2.5	1.5	1.4	3.3	2.9	0.3	1.8	2.6	0.9	1.5	3.8	197.0	424.1	51.0	360.4	364.2	118.3	114.1	115.9	112.0	168.3	215.9	191.3	3.8	3.2	12.0	15.7	1.9	3.4	0.5	4.0	1.8	4.7	5.8	7.1	13.8	2.8	12.6	7.3	0.0	5.6	2.0	2.9	1.9	3.7	2.5	3.9	8.1	4.4	3.6	2.1	39.7	4.4	2.6	6.1	8.6	5.1	3.8	6.5	3.3	4.3	3.5	6.7	35.0	3.5	6.1	6.7	1.0	1.4	6.5	2.6	5.4	12.2	1.7	2.1	2.1	9.5	16.4	3.8	2.1	4.1	6.5	0.6	0.8	4.7	14.7	2.9	0.0	1.7	5.4	5.1	2.2	2.7	3.0	5.6	4.9	8.0	1.7	0.6
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.2;Pancreatic endocrine cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 287.7;LHCN-M2: 133.1;U-251 MG: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	3.8	16.2	8.7	8.7	15.8	8.3	5.6	2.3	27.5	4.3	0.0	11.6	4.2	4.6	3.2	3.9	3.4	6.9	14.2	12.5	4.3	21.5	4.9	19.9	14.3	9.3	4.9	1.5	4.7	8.0	3.2	6.7	9.6	6.7	12.0	19.6	10.3	4.4	6.1	1.4	4.8	3.4	3.5	11.2	12.8	1.6	7.8	4.9	4.5	7.4	11.2	8.5	2.1	6.9	98.1	55.3	1.9	3.0	3.3	3.4	7.8	71.8	47.5	46.5	27.2	14.0	287.7	8.1	105.4	43.4	44.4	19.2	2.0	35.1	107.0	27.1	4.5	5.6	8.5	10.8	3.9	14.8	19.9	1.7	3.5	32.3	47.5	43.6	31.5	4.4	1.4	6.9	133.1	8.0	2.5	5.1	2.6	27.4	43.5	2.3	5.2	10.0	83.0	12.6	1.6	0.8	43.6	45.2	9.6	3.1	15.4	6.8	86.9	71.3	10.7	34.1	132.0	8.2	16.4	6.8	53.3	14.1	55.4	6.8	17.9	0.7	2.6	11.6	1.7	3.3	1.6	1.9	12.8	2.2	1.6	2.0	0.6	3.4	7.8	0.7	1.7	6.4	8.7	15.8	2.3	27.5	12.5	4.3	9.3	4.9	9.6	3.5	7.8	6.9	6.6	48.1	17.9	35.9	6.6	6.8	18.3	5.2	1.8	14.8	11.5	3.7	31.6	22.8	20.1	16.5	22.9	9.0	4.7	43.0	3.9	64.1	7.5	41.2	6.4	8.5	7.8	50.5	83.2	31.0	5.2	6.6	25.0	64.1	5.1	5.5	6.8	2.4	49.7	5.0	68.2	11.5	4.1	42.8	15.2	4.1	0.9	32.8	5.4	22.5	12.2	5.4	3.1	15.6	5.4	72.9	13.0	2.6	2.9	30.6	7.3	24.6	27.4	20.5	6.6	8.6	7.0	0.0	1.1	4.3	3.4	10.5	4.6	9.3	7.8	27.3
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.4;lymphoid tissue: 97.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 293.0;dendritic cells: 157.3;Kupffer cells: 119.9;Macrophages: 153.4;monocytes: 329.9;Plasma cells: 205.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 2128.0;monocytes: 673.5"	"Group enriched"	"Detected in some"	5	"Daudi: 96.2;HMC-1: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	7.5	3.8	1.9	38.7	2.2	86.4	2.7	4.6	2.9	1.7	0.9	7.2	7.6	1.3	0.5	3.3	3.2	5.5	3.0	2.8	2.0	2.9	5.0	17.7	56.8	5.0	3.4	1.1	1.5	0.7	1.2	5.0	4.5	2.1	4.5	1.6	4.2	1.4	1.5	1.8	26.6	4.0	2.4	97.5	6.6	0.8	2.3	7.5	2.6	4.8	37.5	7.6	1.8	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	96.2	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.6	2.9	1.4	0.9	0.0	0.8	130.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	16.8	0.3	0.0	0.0	1.6	0.0	3.4	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	20.6	0.2	0.1	0.3	0.2	0.0	0.6	0.3	16.5	0.2	8.1	0.2	1165.0	673.5	1467.3	4.2	242.3	9.8	257.0	10.0	6.7	77.7	276.6	15.4	9.4	2128.0	10.7	60.2	280.9	11.1	514.1	1.9	2.2	4.6	2.9	2.8	2.0	5.0	3.4	4.5	2.4	2.3	6.6	5.0	0.0	2.8	0.0	293.0	3.1	1.1	29.6	5.2	0.2	3.1	3.2	0.6	4.3	10.9	3.7	0.0	0.6	157.3	0.0	0.0	1.3	8.7	0.8	1.0	3.6	0.0	6.1	0.0	0.6	12.2	1.5	10.2	2.5	14.5	0.1	3.9	3.6	39.3	3.3	0.1	0.3	2.0	119.9	23.4	6.4	0.0	153.4	10.6	1.0	329.9	0.3	10.3	0.0	0.1	1.2	4.2	0.4	205.7	1.0	0.4	1.9	17.6	0.5	0.0	1.4	1.5	0.2	0.7	5.0	1.7	4.5	63.6	0.1	0.3	2.2
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878017	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.2;lymphoid tissue: 162.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1235.8"	"Cell line enhanced"	"Detected in some"		"HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA		7800	"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	29.5	14.4	4.8	43.1	5.0	180.2	12.7	4.9	7.5	4.6	6.4	19.2	11.7	4.5	1.0	7.2	13.9	13.0	9.4	4.9	5.4	8.9	10.1	45.1	39.8	6.8	5.9	3.3	4.1	1.4	5.3	24.3	6.4	7.4	11.8	0.1	10.7	4.5	3.6	4.9	42.6	10.5	5.8	162.3	9.3	1.8	8.6	12.9	8.1	7.1	33.5	18.7	7.2	7.1	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	78.3	0.0	0.0	0.0	12.8	396.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	26.8	0.0	0.8	0.0	148.7	0.0	0.0	0.0	76.5	0.0	144.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	137.9	0.0	0.0	0.2	0.1	0.2	0.5	0.1	23.7	0.1	76.8	0.1	657.3	184.6	750.1	2.3	92.5	9.8	108.2	32.0	6.9	86.1	85.9	1.9	2.1	1235.8	4.4	62.0	100.7	96.3	106.3	4.8	5.0	4.9	7.5	4.9	5.4	6.8	5.9	6.4	5.8	8.6	7.1	1.5	3.2	18.7	0.0	70.9	2.8	2.2	1.3	0.6	0.0	3.1	2.5	2.1	0.0	5.8	1.8	0.0	3.2	21.1	1.3	0.0	0.6	0.2	0.2	0.1	3.6	0.0	28.8	0.0	3.1	16.0	1.8	2.0	0.4	74.1	0.0	1.4	0.7	198.4	0.0	0.0	0.5	2.0	85.3	55.8	1.0	0.6	85.7	14.2	3.7	38.5	0.0	3.1	0.0	0.1	0.9	22.5	0.0	68.2	0.3	0.2	0.2	0.9	0.3	0.0	0.5	1.6	0.0	0.4	0.5	2.3	13.0	17.5	0.7	1.7	4.3
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136951606	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: AB_2673602"	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	34.4	17.9	12.8	26.2	13.0	32.0	28.6	17.0	15.3	27.3	20.4	27.7	15.3	23.7	17.0	38.7	20.4	20.1	20.2	12.9	14.6	16.1	30.9	27.0	41.8	14.2	14.3	23.3	17.2	24.2	13.7	30.7	14.2	21.4	27.8	18.4	24.6	19.2	27.5	30.2	15.8	23.6	12.8	28.8	18.4	19.6	13.9	52.9	26.9	29.1	44.5	29.3	36.2	15.8	50.1	22.0	28.4	23.4	65.3	62.7	31.5	36.6	65.3	41.8	43.4	32.3	49.9	49.0	74.9	43.0	54.5	37.9	40.3	37.1	54.3	35.7	16.3	43.0	31.1	25.4	106.0	31.3	28.2	57.4	47.3	40.8	80.0	41.9	64.4	46.1	26.3	42.7	44.2	28.2	71.8	25.3	26.8	45.6	27.6	37.6	26.4	47.6	38.9	34.4	19.8	19.2	66.5	28.1	62.2	34.2	42.0	33.8	32.5	27.1	17.1	38.8	21.3	42.2	36.6	62.5	27.8	27.6	29.3	61.1	22.3	24.7	32.8	50.5	33.6	13.9	25.7	33.7	24.4	14.2	20.8	24.5	12.8	21.6	26.4	9.4	27.6	23.6	12.8	13.0	17.0	15.3	12.9	14.6	14.2	14.3	14.2	12.8	13.9	15.8	58.6	9.6	15.9	25.5	41.6	74.8	77.1	225.1	79.6	20.1	23.7	19.9	11.1	27.1	144.3	9.2	6.2	45.4	54.0	29.6	15.6	50.4	11.6	27.9	31.9	61.4	13.8	17.5	28.6	27.3	52.7	42.8	9.2	31.2	9.5	14.9	31.8	37.5	48.3	25.2	37.9	17.7	46.8	36.6	62.8	8.9	44.1	38.0	42.7	70.3	49.6	20.2	88.6	42.7	36.9	37.9	25.3	26.7	36.2	98.0	15.6	23.9	75.7	14.6	13.1	24.9	32.1	55.2	36.6	66.1	83.3	61.0	70.4	21.8	18.8	142.9
NCK2	NCKbeta	ENSG00000071051	"NCK adaptor protein 2"	O43639	2	105744912-105894274	"Plasma proteins, Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 184.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016116, HPA031004"	Approved					NA	NA		87000	"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"			"CAB016116: AB_2150588, HPA031004: AB_10795571"	"unprognostic (2.39e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.21e-3)"	"unprognostic (4.22e-2)"	37.8	19.7	18.6	20.5	19.2	17.6	33.6	26.3	29.0	36.4	16.7	39.1	54.7	29.7	18.9	68.8	25.4	19.0	31.9	27.9	18.4	28.9	11.1	37.1	27.6	21.8	22.4	25.1	39.8	13.6	19.7	36.8	22.0	24.7	16.4	10.3	46.8	18.7	53.5	33.4	51.7	17.9	22.5	52.0	40.3	27.3	23.9	18.6	28.3	27.2	19.1	35.6	50.4	20.4	25.8	20.2	51.6	23.9	15.0	10.7	73.3	19.0	25.0	21.6	12.5	58.8	20.9	11.2	23.4	24.2	31.0	25.1	21.9	47.7	14.6	79.5	24.5	5.0	9.4	37.8	39.2	28.1	9.8	21.4	34.0	23.5	30.0	18.7	22.0	27.3	7.7	38.5	17.9	21.7	29.3	48.2	28.8	21.6	23.0	23.4	36.2	41.7	28.1	51.2	32.9	45.4	14.4	37.2	184.4	30.4	13.6	70.3	25.0	37.9	55.2	1.0	27.2	28.8	19.6	3.8	16.7	24.5	61.6	26.2	1.0	12.5	7.0	1.0	9.2	7.7	13.1	11.8	1.2	11.1	13.6	12.5	9.3	11.9	1.0	1.8	24.5	5.0	18.6	19.2	26.3	29.0	27.9	18.4	21.8	22.4	22.0	22.5	23.9	20.4	41.8	16.0	7.9	28.1	32.8	17.6	13.9	14.2	7.4	13.5	27.1	35.9	21.3	71.4	9.6	16.5	12.5	39.0	30.3	31.2	7.9	28.1	15.5	18.0	21.8	23.7	19.2	2.5	60.0	18.8	15.2	16.2	13.3	19.9	5.7	33.0	18.2	2.3	26.0	82.4	48.4	23.1	18.3	14.2	13.9	9.2	23.6	18.7	10.6	77.8	10.5	61.4	18.6	24.6	18.3	29.9	29.2	28.2	15.8	17.7	51.3	8.4	18.9	4.6	32.9	33.1	54.4	4.2	9.6	10.7	16.8	29.7	52.4	18.1	31.2	30.0
NCKAP1	"HEM2, Nap1, NAP125"	ENSG00000061676	"NCK associated protein 1"	Q9Y2A7	2	182909115-183038858	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020449	Enhanced		Approved	Cytosol		NA	NA		60000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA020449: AB_1854327"	"unprognostic (7.92e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	51.5	44.3	48.3	25.6	57.6	1.0	48.7	45.9	58.7	55.0	43.5	59.4	55.9	52.8	52.9	81.3	42.1	42.3	71.8	72.8	47.2	70.6	41.2	40.3	10.3	36.9	46.2	45.0	43.0	88.4	34.0	50.1	41.9	55.4	48.5	58.4	43.2	65.4	89.5	51.1	51.3	74.1	37.9	20.5	57.7	32.1	45.4	15.2	85.4	87.3	24.6	60.8	49.1	44.4	107.1	66.0	99.1	63.6	136.8	132.3	110.2	136.5	123.4	90.6	113.3	102.9	89.2	0.6	89.2	163.1	136.1	99.0	84.6	128.6	150.2	25.7	66.1	23.7	69.4	85.4	140.5	0.2	19.9	99.5	155.4	131.4	213.8	123.7	146.3	6.4	58.7	0.4	173.3	68.5	2.3	0.4	102.1	85.8	112.7	6.9	108.2	0.4	127.9	141.9	72.7	69.3	123.6	97.0	130.0	156.2	52.0	0.7	160.0	153.2	86.1	87.1	84.7	13.4	26.5	0.5	118.6	0.1	79.5	0.4	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	48.3	57.6	45.9	58.7	72.8	47.2	36.9	46.2	41.9	37.9	45.4	44.4	75.3	48.1	47.1	129.9	2.1	87.2	64.7	50.1	38.1	83.9	54.2	39.9	103.9	48.6	57.0	80.9	70.9	33.1	3.7	52.4	27.4	54.3	4.5	56.4	57.9	82.8	50.4	0.8	174.2	62.0	50.2	62.3	49.5	106.6	14.0	43.8	72.8	42.4	5.3	122.8	143.9	58.8	50.8	5.5	23.1	9.0	78.6	4.6	55.2	72.1	0.7	90.7	6.2	136.7	98.8	95.7	69.8	105.3	1.4	116.8	64.3	66.4	40.2	59.9	59.2	86.1	84.1	42.4	28.7	83.6	112.5	52.1	5.5	55.6	55.5	117.3
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497752-54548243	"Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.2;dendritic cells: 92.3;Hofbauer cells: 115.5;Kupffer cells: 175.1;Macrophages: 108.1;monocytes: 153.2;NK-cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 112.4;HMC-1: 112.4;NB-4: 82.6;REH: 59.1;THP-1: 121.3;U-937: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Plasma membrane"	"HPA039490: AB_2676540, HPA040772: AB_2677129"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	9.7	4.6	3.3	34.8	4.0	28.4	4.7	3.6	3.7	4.0	4.0	19.7	5.8	2.5	1.3	6.1	3.4	7.3	2.6	2.9	3.7	2.3	7.1	20.2	42.5	6.9	4.8	1.8	1.6	4.0	1.5	11.0	6.5	4.7	9.7	0.4	3.5	5.2	1.2	2.3	18.1	10.3	5.4	44.9	6.7	1.2	6.8	37.4	2.2	2.0	43.4	27.9	2.8	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.3	47.9	0.0	0.0	0.0	112.4	112.4	0.0	0.0	0.0	0.0	0.0	0.7	40.1	7.7	43.7	0.0	0.0	47.9	82.6	0.1	0.0	0.0	59.1	0.2	47.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	121.3	0.0	0.2	0.0	0.1	0.1	2.4	2.9	38.4	0.2	70.4	0.0	31.7	68.6	55.0	31.7	103.9	26.2	30.2	28.3	32.7	72.0	28.8	17.9	26.4	16.9	36.1	121.3	40.8	45.1	65.1	3.3	4.0	3.6	3.7	2.9	3.7	6.9	4.8	6.5	5.4	6.8	8.4	1.0	0.0	11.6	0.3	66.2	1.3	0.3	0.0	0.0	1.3	0.6	2.2	1.5	4.3	1.8	0.0	0.0	0.7	92.3	0.2	0.0	0.1	0.9	0.2	0.3	3.6	0.0	22.1	0.8	0.4	1.0	2.7	2.0	0.3	56.3	0.1	7.5	1.4	115.5	0.0	0.5	0.0	0.0	175.1	28.5	2.3	1.2	108.1	5.4	42.2	153.2	0.4	113.3	0.5	0.0	0.0	0.1	0.0	40.0	0.1	0.0	0.3	0.7	0.9	0.0	0.8	1.3	0.9	1.6	0.1	0.6	1.4	59.7	0.2	0.0	0.2
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671788-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.8;lung: 11.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	1.9	1.0	9.6	0.5	31.3	0.0	3.0	18.6	12.3	1.2	2.5	1.2	2.2	0.4	0.6	4.0	0.4	0.7	2.6	9.5	14.5	4.1	3.9	11.4	1.3	23.4	28.6	2.4	0.9	0.6	0.6	2.6	22.9	0.8	1.0	4.7	2.1	0.3	0.5	2.1	3.2	0.4	10.1	1.7	1.7	1.1	28.6	0.8	1.1	0.6	1.0	0.5	2.0	34.8	0.0	2.2	46.2	0.0	0.1	0.4	0.2	0.7	8.3	0.7	0.8	0.0	0.1	3.6	0.0	0.5	0.5	0.2	0.3	0.7	2.5	0.0	0.3	0.0	7.1	0.0	0.0	0.0	0.0	0.5	3.8	4.4	0.6	7.2	0.8	0.0	0.0	0.0	1.3	0.5	0.0	0.0	1.1	0.3	1.4	0.4	0.0	1.9	1.1	1.1	0.2	1.4	0.0	1.7	2.4	0.4	0.7	0.0	2.4	0.3	0.4	6.7	0.1	0.2	0.0	1.3	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	31.3	18.6	12.3	9.5	14.5	23.4	28.6	22.9	10.1	28.6	34.8	6.0	262.8	13.3	478.6	0.6	8.9	0.7	1.4	15.4	179.6	14.5	10.8	16.8	0.0	28.6	1.8	41.7	0.1	0.1	5.3	3.9	0.3	6.8	1.1	1.1	2.9	3.6	0.0	16.4	0.2	0.2	6.8	7.7	1.4	1.3	0.0	0.7	6.3	0.6	33.7	41.3	5.4	10.2	7.9	32.2	3.3	26.4	6.2	1.8	147.1	4.1	56.9	0.0	774.6	2156.8	1.0	5.2	7.5	0.0	0.5	20.7	14.0	1.2	7.8	6.6	8.7	24.7	0.1	1.3	15.5	2.8	0.0	0.7	0.0	1.6	1.5
NCKAP5L	KIAA1602	ENSG00000167566	"NCK associated protein 5 like"	Q9HCH0	12	49791146-49828750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Leydig cells: 68.3;Peritubular cells: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041034	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"			"HPA041034: AB_10796235"	"unprognostic (3.35e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.15e-1)"	13.3	27.6	9.9	6.4	12.1	3.1	11.2	9.8	14.1	14.7	8.6	12.3	2.9	12.4	1.4	6.3	11.9	5.4	22.2	10.0	9.9	12.8	10.9	16.2	4.4	13.7	11.4	14.6	7.9	5.0	14.0	9.0	11.7	15.0	1.0	2.6	8.3	4.6	10.0	6.6	6.7	4.7	9.1	13.1	8.7	15.7	12.8	5.8	14.0	4.6	1.9	11.6	10.3	15.7	5.3	8.9	15.5	15.4	9.7	7.2	20.6	8.9	9.6	12.8	10.6	12.4	1.6	3.2	15.0	9.1	4.9	1.8	6.4	9.4	3.4	3.3	9.0	11.7	11.3	12.1	24.4	4.6	24.4	17.0	10.8	13.8	6.4	16.1	15.1	11.7	11.4	0.1	8.3	12.9	12.0	16.5	18.7	1.7	9.9	14.5	16.0	0.9	9.9	7.3	5.4	24.3	13.6	14.6	25.4	8.4	25.6	9.4	11.9	11.9	12.5	6.1	4.3	0.3	0.0	4.1	9.6	5.3	3.6	0.0	0.6	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.2	0.2	0.4	0.5	0.0	0.3	9.9	12.1	9.8	14.1	10.0	9.9	13.7	11.4	11.7	9.1	12.8	15.7	18.0	6.4	1.1	16.6	7.6	12.7	8.2	8.4	22.8	44.6	19.2	15.6	2.7	5.7	6.2	11.0	112.6	10.6	19.2	1.2	0.0	5.3	1.2	15.6	16.9	11.6	9.0	1.7	10.0	3.8	12.9	17.4	3.1	8.6	0.0	29.5	10.8	4.6	15.9	30.3	13.2	1.3	8.2	12.9	24.8	4.8	68.3	20.7	5.4	13.1	12.4	7.0	7.2	13.0	21.8	3.2	0.4	82.8	2.2	5.7	0.2	2.4	6.6	25.2	0.0	49.3	15.5	3.0	4.8	8.2	7.2	2.5	10.0	43.2	1.6	3.5
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NCMAP	"C1orf130, FLJ42528, MP11"	ENSG00000184454	"Non-compact myelin associated protein"	Q5T1S8	1	24556087-24609328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 7.3;pancreas: 8.5;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 17.7;Ductal cells: 19.3;Exocrine glandular cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;RPTEC TERT1: 1.6;T-47d: 4.0;U-266/70: 3.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"spinal cord: 147.1"	HPA013656	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA013656: AB_2275006"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.83e-6)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.27e-3)"	0.3	0.2	0.4	0.2	0.5	0.5	1.5	1.2	0.7	1.1	0.3	0.6	5.0	0.4	0.2	0.2	1.0	7.3	0.1	0.4	0.5	1.2	4.7	3.9	0.3	0.5	0.3	0.1	8.5	0.0	3.4	0.8	0.8	1.4	0.3	1.3	7.8	0.1	0.3	0.4	2.2	0.0	0.2	0.1	4.9	0.1	0.5	0.0	4.2	0.4	0.4	0.6	0.1	1.7	0.1	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.5	1.6	0.5	0.1	0.1	0.0	0.1	0.0	0.5	4.0	0.1	0.3	0.1	0.1	0.1	0.1	3.0	0.4	0.0	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.7	0.4	0.5	0.5	0.3	0.8	0.2	0.5	1.7	0.0	3.2	17.7	0.3	0.1	0.0	1.6	0.7	0.0	0.4	3.6	1.9	1.1	8.6	3.2	3.7	4.2	1.4	0.2	0.8	0.0	19.3	0.0	1.8	1.0	0.3	1.8	0.0	0.6	48.3	0.2	0.4	0.5	5.7	1.3	0.0	0.0	2.0	0.1	0.0	0.6	0.7	4.1	0.0	0.4	0.0	0.0	0.2	3.6	7.5	1.1	3.6	0.0	0.5	1.2	10.4	1.7	0.0	2.8	2.3	4.2	1.1	1.0	0.5	0.0	1.4	0.3	0.1	0.1	0.0	0.1	9.3	0.6	0.0	0.9	2.2
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501887-47656877	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 155.8;Plasma cells: 168.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 187.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	14.7	8.2	4.7	22.9	4.7	13.4	11.5	5.7	9.0	11.1	3.8	9.9	8.8	11.8	7.1	14.3	10.7	10.3	13.3	4.0	5.5	9.4	10.5	14.8	35.0	6.5	5.3	14.1	11.1	11.2	6.0	28.1	6.9	9.6	11.2	11.6	11.3	8.8	25.2	14.0	14.8	11.5	5.3	27.5	14.8	7.5	5.9	17.9	12.9	16.5	39.2	15.3	12.5	6.4	17.6	50.1	16.1	21.5	37.5	41.9	105.2	16.4	24.2	27.3	14.1	25.2	19.0	61.8	11.0	28.5	36.1	43.2	12.2	20.7	20.9	31.3	6.4	8.1	15.3	39.3	22.6	6.8	43.3	19.9	61.2	24.4	30.3	23.5	20.0	10.0	18.7	14.0	16.2	187.0	9.9	12.8	5.8	14.2	20.6	17.8	11.0	27.4	16.8	38.2	3.1	5.7	41.0	53.7	18.8	18.0	24.3	17.8	35.8	16.4	12.9	20.5	7.4	38.5	35.9	60.6	19.4	7.0	10.8	2.8	3.9	3.0	2.5	5.2	2.2	9.3	2.3	2.2	5.0	6.8	2.6	2.9	4.5	2.1	5.0	4.2	3.1	2.6	4.7	4.7	5.7	9.0	4.0	5.5	6.5	5.3	6.9	5.3	5.9	6.4	86.7	12.8	23.7	27.7	155.8	34.5	15.7	25.0	52.9	18.1	23.8	13.8	26.1	20.0	29.0	14.7	8.4	69.5	39.9	12.5	5.9	12.9	12.1	36.4	29.1	49.8	14.9	14.9	48.5	19.6	26.2	26.4	26.5	78.8	8.8	15.3	68.2	20.0	22.8	13.5	64.3	10.7	36.7	46.8	62.2	6.0	24.8	58.2	33.8	109.6	46.1	9.3	28.8	49.3	54.1	21.0	16.9	27.4	168.8	28.1	9.0	6.5	39.8	23.8	19.7	19.7	30.3	43.2	30.0	63.3	51.7	89.2	47.6	14.2	11.7	59.2
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 476.2;Macrophages: 316.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: AB_2681412, HPA065208: AB_2685432"	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	117.1	67.8	45.6	91.5	52.5	189.5	96.9	56.1	50.9	85.1	50.7	110.3	249.7	70.2	74.6	110.3	62.6	87.8	156.8	40.6	55.8	159.7	372.9	108.3	102.6	52.4	53.5	65.5	64.6	97.9	25.2	131.3	53.6	132.2	115.7	33.7	79.2	78.7	163.5	71.1	155.9	98.3	52.6	148.1	90.3	43.6	51.6	124.4	87.0	193.6	150.3	104.6	46.8	60.0	142.7	58.5	68.0	70.4	176.9	159.4	170.3	128.3	204.8	122.1	119.6	91.0	102.3	161.2	149.2	211.2	69.1	141.8	72.6	142.3	137.1	114.4	74.1	108.4	74.3	263.5	124.0	279.9	229.7	156.1	139.2	104.2	175.7	131.6	185.5	79.5	119.7	93.5	171.9	64.0	136.1	104.3	41.4	110.2	34.8	79.5	99.3	96.7	148.9	119.4	68.2	46.1	128.9	146.2	131.5	133.5	105.7	135.3	171.6	75.8	89.9	81.3	87.5	69.3	79.1	156.9	94.6	231.2	41.2	692.1	363.6	611.8	78.9	223.6	86.2	57.6	73.3	74.9	251.9	53.8	78.2	66.4	839.6	119.0	275.3	77.4	92.8	559.4	45.6	52.5	56.1	50.9	40.6	55.8	52.4	53.5	53.6	52.6	51.6	60.0	44.5	51.3	95.2	13.4	44.6	49.5	39.3	126.2	50.7	14.3	49.6	38.5	161.3	45.8	96.2	44.1	29.2	104.7	58.2	108.8	80.3	45.3	105.4	45.1	37.7	52.9	26.9	476.2	17.4	51.8	107.2	45.3	42.3	56.9	195.2	28.2	55.3	166.7	181.4	20.2	20.5	45.4	59.0	254.5	74.2	72.4	37.3	316.1	51.6	16.9	158.4	38.2	44.3	18.6	22.9	47.8	63.9	47.4	37.6	62.0	162.5	128.8	59.7	13.0	13.1	36.7	46.7	24.5	16.5	71.9	56.7	158.2	41.3	60.7	71.3	52.0
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060991-46089962	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	19.1	17.0	15.8	18.5	16.7	9.5	19.6	21.7	17.4	25.1	17.2	22.2	14.2	24.8	19.4	18.6	21.8	12.2	15.6	16.1	17.6	18.8	15.3	15.2	25.1	16.5	15.7	28.5	20.5	20.3	21.8	18.7	15.2	21.4	16.3	23.1	20.4	14.6	19.6	21.9	21.6	17.7	15.7	25.7	19.2	25.8	16.9	26.2	20.7	14.6	25.0	20.8	19.6	17.4	39.5	34.2	47.4	49.0	22.2	23.3	37.8	26.7	24.0	42.5	34.7	47.8	30.6	64.3	44.0	26.0	36.1	51.2	39.6	33.5	36.5	39.1	19.9	38.7	33.4	40.7	23.5	53.4	36.1	16.8	43.8	22.5	20.4	22.2	30.6	33.1	36.3	50.9	33.9	50.9	74.2	41.3	43.2	33.3	41.8	55.6	31.4	28.0	25.1	44.3	42.5	38.5	42.8	51.7	37.3	26.9	41.1	62.3	28.7	44.6	33.8	27.1	42.2	32.9	50.5	43.2	31.1	31.1	29.1	3.9	9.5	13.4	13.4	10.3	15.4	13.1	14.3	13.6	9.8	17.7	13.3	12.4	7.0	8.8	10.7	21.6	10.0	7.1	15.8	16.7	21.7	17.4	16.1	17.6	16.5	15.7	15.2	15.7	16.9	17.4	7.3	9.6	12.6	24.2	12.5	6.4	3.1	6.7	10.8	13.2	9.7	8.0	5.2	10.0	7.3	9.2	22.9	11.2	11.8	8.2	0.0	8.9	7.5	6.9	11.7	9.1	9.5	9.7	29.4	12.4	8.8	7.9	12.2	7.7	1.3	11.6	9.3	9.3	7.8	3.3	31.6	10.4	4.1	10.1	3.2	5.0	13.7	6.7	3.6	42.2	9.2	7.4	13.4	19.6	35.8	11.7	3.2	15.4	12.1	4.4	4.5	5.2	8.6	9.0	6.6	10.7	7.0	28.1	15.7	8.7	5.4	6.7	8.7	8.4	9.2	3.6
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825651	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004198: AB_1078228, HPA050211: AB_2681052"	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	10.2	9.0	5.2	9.1	6.7	14.0	9.2	12.7	12.4	10.8	4.8	12.9	13.2	10.7	12.2	11.7	11.3	8.8	9.2	6.1	8.2	9.9	8.4	10.4	8.9	6.3	4.6	11.6	12.6	22.0	10.0	13.5	4.6	9.8	14.5	26.7	12.9	11.3	12.7	13.5	12.0	13.2	2.3	9.4	11.4	18.8	7.4	18.1	13.8	13.1	10.3	10.4	10.5	9.6	25.2	14.7	32.6	19.7	17.5	19.4	21.3	12.0	15.3	21.1	16.9	37.9	17.2	17.7	12.9	21.5	25.8	30.0	29.3	20.2	23.9	9.0	13.2	41.6	16.7	22.4	19.3	23.5	29.4	14.8	36.5	19.8	24.5	14.6	20.2	20.1	21.5	23.7	17.7	16.3	37.5	14.8	6.7	21.0	21.1	24.9	39.3	15.9	15.6	16.6	27.2	18.5	22.0	52.5	20.5	15.0	22.2	18.5	20.0	34.1	20.7	25.6	20.2	26.9	24.3	20.0	22.5	13.5	15.5	1.1	0.6	2.5	0.9	0.5	0.8	1.0	0.8	0.8	1.1	0.8	0.7	0.5	1.5	0.7	0.7	1.0	0.5	0.5	5.2	6.7	12.7	12.4	6.1	8.2	6.3	4.6	4.6	2.3	7.4	9.6	17.3	25.6	16.0	54.9	11.0	17.0	9.1	10.6	13.6	28.8	14.3	10.9	20.1	18.6	11.6	16.5	29.2	13.0	12.2	31.9	5.9	12.5	23.5	16.4	21.3	14.0	10.8	13.3	50.9	12.4	12.1	14.5	15.8	23.3	6.3	18.5	13.9	12.1	10.8	33.7	58.8	17.4	20.3	12.2	10.3	17.3	18.0	13.0	10.6	45.9	17.6	11.5	13.4	54.3	130.4	15.4	12.4	13.5	14.2	16.9	20.3	9.3	17.5	29.8	26.3	16.6	16.9	25.6	27.1	19.2	20.9	15.9	13.1	13.6	17.6	14.6
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	22.1	18.3	37.8	28.1	39.7	42.8	29.0	60.8	84.7	27.3	41.0	44.0	47.1	30.7	20.3	30.6	25.1	26.4	23.4	39.3	34.7	33.6	46.2	26.9	29.9	32.7	35.7	33.5	34.2	42.3	17.1	28.3	31.0	27.6	40.6	41.4	22.4	31.4	42.0	31.6	38.2	29.7	28.2	29.3	42.7	32.4	35.4	51.9	34.8	39.9	34.7	28.8	18.3	43.4	68.0	110.6	77.7	65.1	62.4	47.1	38.6	48.9	54.8	52.4	47.1	59.8	30.3	70.9	33.6	85.9	39.3	50.4	96.4	59.2	77.3	95.6	71.1	70.7	96.3	71.1	60.8	45.3	80.7	48.5	60.6	81.2	94.4	45.2	73.9	98.0	63.0	28.8	52.3	44.3	79.3	29.1	38.6	118.6	29.9	78.1	78.5	33.5	54.9	76.0	26.5	43.8	80.7	34.7	37.7	197.5	33.5	50.3	65.5	53.7	32.6	39.9	68.3	19.7	25.0	40.4	51.0	52.4	47.0	408.4	104.8	240.4	126.9	86.0	106.7	188.4	144.0	141.0	76.3	191.4	139.8	139.0	205.2	139.9	112.3	130.3	144.7	98.8	37.8	39.7	60.8	84.7	39.3	34.7	32.7	35.7	31.0	28.2	35.4	43.4	90.9	80.1	113.2	116.2	130.0	67.8	106.2	91.3	86.0	150.3	76.8	60.8	91.5	82.9	86.9	53.3	158.4	102.1	121.7	198.1	35.2	95.5	69.7	75.7	109.5	88.4	87.9	132.1	127.0	96.5	101.7	77.1	149.4	103.7	87.3	88.9	67.5	126.4	76.1	129.5	122.2	118.8	81.4	81.9	76.7	43.6	101.5	96.7	37.4	107.7	172.8	83.1	197.8	123.1	151.4	111.7	148.3	121.5	88.5	95.6	194.4	46.7	63.8	167.1	92.1	106.0	106.2	98.7	90.2	78.0	68.2	87.6	142.1	89.5	153.0	122.9
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.0;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.0;monocytes: 2.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	48.1	51.1	41.2	34.3	15.8	29.9	49.7	27.2	45.6	62.9	13.6	56.2	25.2	58.6	9.0	33.3	49.0	21.4	56.7	61.3	12.6	37.6	27.5	62.8	19.5	56.4	29.2	70.8	49.3	18.1	84.1	20.2	53.0	57.7	10.9	20.7	55.1	22.0	109.2	56.2	36.8	22.5	5.4	35.7	45.8	26.1	26.4	19.9	40.5	19.9	11.2	47.4	43.9	27.0	78.6	143.6	40.4	38.7	23.0	31.1	120.4	79.3	39.0	45.2	20.1	76.9	56.3	78.7	57.0	65.1	40.7	72.6	16.2	84.7	18.5	83.6	31.5	63.6	142.1	48.0	46.0	48.3	77.5	50.1	30.9	56.6	33.4	69.2	43.7	35.5	83.3	22.9	41.2	67.4	174.3	55.5	56.4	29.8	139.0	55.8	67.1	40.2	21.6	89.9	106.0	77.1	97.3	81.1	47.7	30.2	66.3	59.8	212.0	104.5	178.9	104.3	170.5	43.5	48.0	48.1	59.4	35.4	100.1	6.0	0.4	1.0	1.0	0.2	0.3	0.3	0.3	0.8	0.2	0.1	0.3	0.2	0.9	0.1	2.5	0.9	0.0	0.3	41.2	15.8	27.2	45.6	61.3	12.6	56.4	29.2	53.0	5.4	26.4	27.0	30.6	115.4	58.9	46.4	14.7	33.3	24.6	22.2	33.0	95.3	33.3	28.3	30.4	18.6	38.8	18.4	39.6	8.8	27.4	39.1	3.9	22.1	2.2	28.0	53.4	28.2	18.7	11.6	61.9	27.2	39.7	50.6	37.8	32.4	42.3	43.5	18.5	19.0	28.4	121.1	37.0	20.3	4.1	50.0	48.7	7.1	62.1	44.8	16.0	51.5	27.0	28.0	20.6	70.9	65.9	38.0	22.2	65.1	22.6	23.7	25.4	8.0	16.8	65.9	6.6	63.0	35.5	1.8	11.6	17.7	24.4	12.6	25.1	69.4	21.9	23.1
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335608-41350889	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.7;plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.8;NK-cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA067249	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"			"Cluster 63: NK-cells & T-cells - Immune response"			"HPA067249: AB_2685811"		"unprognostic (5.81e-2)"				"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"		"unprognostic (2.12e-2)"				"unprognostic (1.65e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0
NCR3LG1	"B7-H6, DKFZp686O24166"	ENSG00000188211	"Natural killer cell cytotoxicity receptor 3 ligand 1"	Q68D85	11	17351800-17377341	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 7.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.2;Inhibitory neurons: 29.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 53.8;K-562: 30.8"									HPA024137	Uncertain					NA	NA		21000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA024137: AB_1859534"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.03e-5)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (4.21e-12)"	"unprognostic (7.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	1.1	0.5	0.3	1.1	0.5	1.9	0.5	4.7	4.7	0.6	3.7	3.4	4.5	1.0	0.4	0.7	1.4	0.9	1.0	0.3	0.6	2.5	0.4	1.1	0.5	0.1	0.0	1.2	0.8	7.5	1.7	0.4	0.1	0.6	5.1	1.9	0.8	0.6	0.4	0.8	3.3	1.0	0.0	0.6	1.3	2.3	0.0	1.3	2.6	0.1	0.7	1.1	0.5	0.7	3.9	1.3	8.8	1.2	3.0	8.1	0.6	2.8	5.2	3.8	9.0	7.3	1.5	22.4	0.4	3.1	1.2	4.0	14.4	3.6	3.1	3.9	23.8	20.6	10.0	7.2	12.5	53.8	0.9	6.7	1.8	5.3	12.8	1.6	4.2	8.1	30.8	0.1	1.2	0.4	5.2	4.7	0.5	14.4	2.1	1.7	4.6	0.3	3.1	1.4	9.3	3.5	3.1	0.7	2.5	0.1	2.1	11.9	6.1	0.7	1.2	2.3	1.6	2.4	4.5	25.1	3.9	17.6	1.8	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	4.7	4.7	0.3	0.6	0.1	0.0	0.1	0.0	0.0	0.7	0.8	0.0	2.0	8.1	1.4	2.5	2.1	2.1	5.2	7.2	1.9	0.4	0.8	2.8	1.7	1.8	2.1	0.1	3.1	6.8	0.0	2.3	13.6	2.3	3.2	1.6	1.8	1.3	32.2	0.9	0.0	4.0	5.6	3.2	0.0	1.5	3.6	0.5	0.9	5.0	29.3	6.6	0.0	1.6	13.6	2.5	0.6	4.4	3.6	4.7	0.4	1.4	2.1	8.5	1.7	1.2	5.4	0.4	0.8	1.8	4.1	1.1	5.3	1.1	0.0	3.1	1.9	0.7	1.1	4.1	3.7	1.5	1.6	5.6	7.5	0.9
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172404-130237303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 272.0;intestine: 123.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.9;Horizontal cells: 112.7;Inhibitory neurons: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		10000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	8.3	26.2	183.3	13.4	96.0	8.4	5.1	0.0	227.7	22.6	0.0	123.6	5.2	70.7	5.7	40.6	29.3	13.9	12.6	272.0	20.8	17.6	2.8	9.5	1.9	17.0	23.4	10.8	4.9	2.3	14.5	1.7	16.6	36.1	10.1	8.5	8.1	65.1	3.1	18.3	19.8	58.6	2.3	1.2	25.1	3.1	75.5	4.2	32.8	1.9	3.8	63.8	20.8	85.8	25.6	50.8	25.9	51.9	15.9	35.3	12.3	64.3	29.6	48.2	32.0	24.3	12.8	0.1	22.8	81.6	56.5	45.2	42.5	56.3	21.5	75.3	13.0	0.1	32.3	26.5	24.4	2.2	30.2	41.2	28.0	54.7	34.4	42.9	46.2	9.9	18.8	0.3	70.8	73.1	4.9	25.6	39.6	13.7	21.2	0.1	81.5	17.3	47.4	15.9	67.9	63.9	39.5	18.7	37.7	19.4	34.8	16.2	36.7	92.9	75.4	75.5	84.1	0.1	0.1	0.2	108.7	7.1	102.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.3	96.0	0.0	227.7	272.0	20.8	17.0	23.4	16.6	2.3	75.5	85.8	0.5	0.0	0.0	26.1	0.1	9.7	10.5	16.6	15.4	7.7	3.0	10.0	2.9	1.5	6.3	11.0	4.2	0.1	5.3	0.8	5.9	7.9	0.4	27.8	10.5	1.0	1.2	14.7	40.9	2.9	1.6	9.1	1.1	12.4	3.8	4.4	0.7	0.5	3.7	112.7	42.5	1.0	0.0	0.6	5.8	0.9	1.2	2.5	5.4	2.8	9.8	19.2	0.0	8.0	7.8	5.3	0.1	1.5	1.3	11.0	0.2	17.3	9.7	4.3	0.0	4.2	19.0	0.0	1.9	6.0	7.0	0.5	2.6	1.2	0.5	3.3
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343316-160358952	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	51.0	36.6	30.6	42.1	36.1	38.1	43.9	38.5	32.5	52.4	42.0	58.4	80.4	40.3	56.4	35.1	49.7	42.9	50.6	29.9	35.8	59.7	59.3	56.0	38.3	40.0	34.0	51.7	63.8	86.0	30.1	98.7	41.6	45.2	60.9	48.1	60.5	47.3	37.6	38.9	63.5	52.1	37.3	46.2	45.7	41.8	36.4	40.0	63.8	38.4	43.0	45.6	31.5	48.9	52.1	57.4	100.4	82.8	301.0	153.4	108.3	104.0	177.0	95.4	109.9	47.9	140.0	36.6	208.6	209.3	67.1	81.5	47.3	95.9	82.4	56.5	42.3	36.6	70.9	70.0	118.6	82.8	152.0	155.7	92.3	94.3	93.6	207.2	139.9	54.3	66.9	100.2	142.2	34.3	26.8	39.8	82.2	130.6	33.8	35.1	59.9	103.6	130.5	69.9	34.2	75.6	109.1	118.5	70.9	158.0	108.2	186.3	125.5	70.3	46.4	48.8	79.9	130.8	194.4	38.6	106.6	49.8	129.4	71.4	79.0	67.8	27.4	79.0	26.2	31.1	23.5	24.0	75.1	27.8	23.9	23.3	69.2	36.6	79.6	45.1	26.5	52.2	30.6	36.1	38.5	32.5	29.9	35.8	40.0	34.0	41.6	37.3	36.4	48.9	28.0	6.4	9.3	0.0	23.0	10.5	23.8	59.5	15.9	20.0	27.9	23.1	14.6	45.8	42.6	53.3	52.1	107.7	27.8	53.3	7.9	38.9	2.6	19.2	19.7	23.9	20.3	17.2	0.0	27.0	95.7	33.7	17.9	30.2	13.3	25.8	29.6	31.4	58.0	18.5	0.0	31.8	46.8	47.1	18.8	4.7	27.1	33.4	17.8	0.0	31.7	35.0	20.6	0.0	0.0	34.8	33.4	21.1	33.2	15.6	66.1	24.7	28.7	26.3	26.3	23.8	19.6	44.6	35.9	15.5	11.4	147.4	16.5	32.5	29.6	20.5
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NDE1	"FLJ20101, NDE, nudE"	ENSG00000072864	"NudE neurodevelopment protein 1"	Q9NXR1	16	15643267-15734691	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein"	Lissencephaly	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 21.8;monocytes: 11.7;NK-cells: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024075	Approved					NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA024075: AB_1854336"	"unprognostic (1.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	9.2	5.8	12.1	13.0	23.6	25.6	9.4	22.5	15.6	14.6	6.9	25.0	7.5	11.6	2.6	17.7	11.1	9.8	10.6	11.2	16.1	6.3	4.2	11.1	20.4	30.0	24.5	7.5	4.0	4.0	3.1	10.0	26.5	14.2	7.3	2.0	12.2	5.1	7.3	27.6	12.9	10.7	17.0	12.5	10.1	11.1	21.3	23.4	6.3	7.9	20.9	15.3	19.8	43.2	37.0	33.0	34.2	39.9	11.4	18.6	10.4	15.4	21.0	30.4	34.5	18.3	58.3	21.9	24.0	23.2	16.7	34.5	25.3	47.3	20.8	33.7	16.0	24.6	35.3	51.7	16.3	33.3	37.2	6.6	28.9	28.8	52.0	16.9	40.6	27.9	20.5	80.5	26.6	43.9	43.0	30.5	30.5	26.5	14.3	64.8	32.3	34.8	11.6	24.1	17.0	21.0	27.5	40.7	27.6	25.9	42.8	34.3	12.5	26.9	17.6	43.2	36.1	17.4	13.1	38.1	27.5	43.0	55.0	5.1	4.7	15.0	3.0	3.8	1.7	3.3	3.0	1.3	3.4	1.9	1.8	2.0	21.8	8.5	11.7	3.1	3.3	3.9	12.1	23.6	22.5	15.6	11.2	16.1	30.0	24.5	26.5	17.0	21.3	43.2	11.7	3.2	4.4	11.1	36.1	26.0	32.7	19.0	24.5	7.0	9.5	10.4	2.0	4.3	8.9	5.5	6.2	3.9	25.0	9.6	0.0	4.5	46.9	17.1	23.1	11.6	4.2	49.0	2.1	5.3	5.3	11.8	19.4	15.0	10.8	15.5	8.6	1.7	10.1	3.3	2.4	7.4	2.0	15.8	11.0	58.5	15.8	19.3	12.4	22.5	53.0	7.4	50.4	9.5	105.5	7.1	4.2	6.0	16.6	26.3	4.6	1.9	13.3	6.5	6.6	6.9	9.5	13.8	10.0	18.8	30.7	2.5	28.3	9.8	10.2	21.6
NDEL1	"MITAP1, NDE1L1, NDE2, NUDEL"	ENSG00000166579	"NudE neurodevelopment protein 1 like 1"	Q9GZM8	17	8413131-8490411	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.5;Suprabasal keratinocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017916	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA017916: AB_1854337"	"unprognostic (6.34e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.95e-3)"	"unprognostic (4.66e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.73e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.63e-3)"	42.8	60.3	18.2	37.0	23.1	109.8	33.2	19.4	26.2	36.6	17.6	30.9	18.4	29.2	20.3	54.7	32.1	40.7	30.0	23.8	20.9	19.8	43.9	44.4	23.2	18.0	19.2	46.6	27.8	18.0	35.0	39.9	20.9	25.5	23.1	25.3	32.5	22.3	43.6	91.3	24.8	26.7	15.3	29.0	25.8	26.4	20.6	24.4	23.2	31.1	26.8	37.8	39.8	23.5	41.9	36.6	34.2	29.4	50.9	61.9	28.1	87.2	72.6	61.4	64.0	32.0	22.2	24.0	28.9	97.1	34.8	47.7	30.9	34.6	62.9	40.1	50.1	48.0	59.8	38.7	54.5	18.4	98.4	41.2	66.7	52.8	60.0	44.7	49.8	37.0	29.0	27.6	54.1	17.9	27.2	15.7	14.9	26.2	20.4	28.2	26.9	19.8	27.7	23.6	16.2	17.8	52.9	25.4	29.4	36.0	17.3	12.6	65.6	48.7	18.4	45.4	48.4	19.3	42.5	19.3	61.0	27.4	50.3	85.5	28.3	98.2	35.1	27.6	37.0	25.5	31.3	34.8	23.9	26.1	30.4	27.9	175.0	32.8	24.7	20.6	36.5	36.3	18.2	23.1	19.4	26.2	23.8	20.9	18.0	19.2	20.9	15.3	20.6	23.5	48.4	12.8	20.9	12.1	33.8	79.0	55.3	18.3	27.3	13.9	24.1	20.4	17.5	12.8	18.1	12.9	20.9	18.9	39.7	36.8	9.8	13.6	86.8	34.8	21.5	26.4	4.2	37.5	27.0	12.2	37.1	26.4	47.9	63.5	80.5	13.3	18.5	12.8	14.1	8.4	22.0	37.1	20.3	13.2	74.0	134.5	12.8	40.8	32.0	18.7	13.2	8.8	19.6	14.6	19.6	24.0	42.6	14.7	38.2	36.0	21.8	5.8	11.3	14.1	6.6	24.7	40.1	8.3	10.0	25.0	136.7	57.3	40.1	11.8	17.6	73.4
NDFIP1	"MGC10924, N4WBP5"	ENSG00000131507	"Nedd4 family interacting protein 1"	Q9BT67	5	142108779-142154440	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 678.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009682	Approved				"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA009682: AB_1079455"	"unprognostic (2.78e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.74e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (6.95e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (2.39e-7)"	"unprognostic (9.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.76e-2)"	62.1	81.6	87.4	33.8	93.8	26.2	56.3	63.1	100.7	54.7	70.8	40.3	49.3	45.2	135.9	30.2	46.4	45.4	55.1	94.2	96.8	94.8	120.2	49.7	39.0	70.7	73.6	61.5	64.5	152.6	51.7	45.2	77.2	67.7	38.4	164.1	99.5	63.5	45.7	26.6	47.6	40.9	75.3	56.4	50.4	40.8	90.8	41.9	103.4	40.9	34.8	48.3	31.1	73.9	53.3	35.2	61.8	83.6	128.2	72.5	41.4	56.6	59.1	48.0	54.6	39.5	87.3	4.8	115.0	62.2	66.4	51.9	39.6	59.6	56.2	61.2	48.8	69.2	30.8	28.7	55.8	38.3	23.9	55.8	55.3	33.8	43.6	68.4	55.9	54.0	23.4	83.3	60.1	27.4	42.9	12.0	33.2	52.0	33.4	16.1	34.2	122.1	119.1	56.0	65.0	67.3	61.9	91.7	88.3	46.0	64.7	37.6	64.5	58.7	22.1	48.0	56.8	53.6	65.8	22.0	62.1	24.9	45.6	70.4	32.1	26.4	22.9	39.9	29.2	12.8	40.6	28.2	37.0	10.4	80.9	63.9	19.5	23.5	40.1	11.2	50.6	62.4	87.4	93.8	63.1	100.7	94.2	96.8	70.7	73.6	77.2	75.3	90.8	73.9	100.3	57.7	62.6	74.7	76.4	111.5	176.4	133.4	82.0	196.4	134.3	68.5	70.0	143.0	101.4	154.5	141.8	146.9	94.0	98.0	140.8	207.4	20.2	69.5	91.5	103.7	137.6	184.9	189.5	145.3	263.8	164.1	62.7	118.2	60.2	365.2	116.0	169.8	154.1	318.0	184.9	81.9	177.0	205.9	154.9	15.4	116.5	137.0	170.7	69.3	176.1	300.6	87.6	114.1	125.4	179.8	100.5	156.9	107.6	262.6	198.5	173.0	67.7	322.9	131.5	74.3	149.3	26.6	33.2	71.1	101.3	191.5	156.4	678.1	83.3	256.2
NDFIP2	"KIAA1165, N4wbp5a"	ENSG00000102471	"Nedd4 family interacting protein 2"	Q9NV92	13	79481124-79556075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 342.7;Late spermatids: 290.4;Suprabasal keratinocytes: 367.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.1;eosinophil: 22.7;naive CD4 T-cell: 5.6"	"Group enriched"	"Detected in many"	16	"granulocytes: 22.7;T-cells: 5.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009160	Uncertain		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"HPA009160: AB_1079456"	"unprognostic (2.56e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.95e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.02e-1)"	13.9	19.2	17.0	11.4	20.9	2.6	22.7	10.0	25.2	15.5	7.0	42.7	52.7	10.1	22.5	54.4	17.1	20.1	26.0	27.1	8.1	45.9	46.3	17.7	13.0	10.1	7.3	7.0	31.8	29.6	6.4	31.9	12.3	22.7	47.0	21.7	21.4	15.6	30.9	71.3	64.3	9.1	10.6	11.7	25.9	18.1	9.2	16.0	19.3	19.9	19.6	35.6	25.2	21.5	134.6	22.6	23.2	29.4	27.7	50.3	43.6	48.5	66.9	50.1	83.0	49.9	146.1	5.6	32.6	64.0	28.5	178.2	20.5	84.9	75.3	69.7	57.1	6.2	66.5	27.1	50.5	106.2	17.8	40.4	109.3	33.4	52.7	55.8	24.1	10.4	27.5	10.0	56.8	19.3	8.7	24.1	17.1	109.7	22.7	0.5	45.7	25.2	123.1	76.7	23.3	33.4	54.9	52.4	40.0	37.8	43.8	88.2	20.4	16.0	20.4	31.1	32.8	37.6	44.2	21.1	65.6	0.5	65.6	12.1	0.0	22.7	3.2	0.0	2.7	0.2	2.8	2.6	0.0	0.6	5.6	3.1	0.1	0.8	0.0	0.2	3.2	2.4	17.0	20.9	10.0	25.2	27.1	8.1	10.1	7.3	12.3	10.6	9.2	21.5	17.5	41.7	28.9	26.4	4.4	342.7	137.0	180.6	118.4	30.9	32.7	18.8	29.4	57.2	93.2	47.8	6.2	112.6	6.9	161.0	23.5	85.6	271.2	51.5	17.2	22.0	69.4	4.2	189.0	72.2	152.7	33.2	31.1	49.8	88.2	11.5	20.7	69.2	14.4	16.8	44.2	88.1	95.6	17.0	23.5	290.4	17.4	4.0	33.8	27.2	2.7	22.8	5.2	42.3	100.3	101.7	96.7	12.8	13.8	105.6	204.3	104.6	112.6	15.5	13.1	22.2	24.0	56.5	45.1	102.2	367.7	109.7	24.9	35.2	73.3	145.5
NDOR1	"bA350O14.9, CIAE1, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Oligodendrocytes: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	6.5	8.2	8.7	9.8	9.6	17.2	6.9	7.9	12.5	8.1	5.4	8.4	9.6	7.8	2.0	8.3	7.9	4.6	6.6	8.3	7.1	9.0	7.1	8.6	11.5	10.7	9.0	7.0	8.9	4.0	8.2	4.0	10.2	9.6	2.9	3.9	8.6	5.2	4.0	9.5	10.6	3.7	7.9	14.2	8.7	10.5	9.9	8.9	10.1	1.5	5.4	7.8	7.2	12.9	14.2	21.2	13.8	21.8	5.7	5.6	42.7	20.4	9.1	19.1	13.0	21.6	16.3	19.9	15.6	7.7	15.3	52.1	10.0	14.3	3.8	25.9	16.3	17.6	59.7	11.6	9.6	19.9	36.2	7.8	9.7	21.6	7.9	5.3	8.9	25.9	29.2	20.6	7.0	25.8	21.0	35.8	22.5	12.9	26.0	38.0	16.5	28.2	6.0	12.4	17.6	17.5	16.8	17.0	10.6	6.1	27.2	22.8	12.0	35.3	22.9	41.7	23.2	12.5	26.8	20.7	15.4	18.1	20.7	1.1	2.1	3.1	1.3	2.2	1.1	0.5	1.2	1.2	1.7	1.0	0.6	0.6	2.9	0.7	1.7	1.1	1.8	1.5	8.7	9.6	7.9	12.5	8.3	7.1	10.7	9.0	10.2	7.9	9.9	12.9	1.4	0.0	2.6	13.4	3.9	0.5	0.7	1.0	5.2	0.4	1.5	1.3	1.6	1.5	1.6	3.7	0.0	4.5	1.4	3.3	1.9	1.1	0.8	1.3	1.9	1.8	2.4	1.3	8.6	1.1	3.5	1.6	5.1	2.1	1.3	2.0	1.1	0.8	2.5	0.0	7.5	1.9	2.0	3.2	1.3	1.1	0.6	2.7	1.8	6.5	5.4	0.1	5.2	3.5	10.5	1.6	1.5	0.4	6.9	0.7	2.6	1.2	0.3	0.9	0.0	0.9	1.4	1.9	1.2	3.2	0.3	3.7	3.8	1.6	2.2	0.8
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237175-133302022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 613.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol		NA	NA		200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	161.2	72.9	299.1	55.9	523.6	130.0	107.6	413.5	300.2	169.4	132.8	130.0	242.2	92.9	34.3	343.1	106.4	87.8	99.8	254.5	316.6	192.4	49.6	116.6	38.7	523.2	500.0	126.1	52.8	69.1	82.2	110.8	476.8	354.3	77.8	86.0	130.8	60.0	28.2	262.6	258.1	61.9	333.7	39.4	154.0	28.1	423.1	55.1	80.5	44.6	88.1	105.5	273.8	613.9	191.6	24.0	1.7	0.8	116.3	86.8	26.0	13.7	103.0	9.8	52.5	12.5	27.6	1.5	133.0	58.0	21.9	62.4	1.7	316.8	18.0	13.3	226.8	1.9	55.6	14.7	46.3	7.0	4.6	79.2	606.9	51.2	1226.9	124.2	45.2	27.9	2.0	138.3	17.2	11.0	19.1	20.8	3.0	69.8	155.8	1.7	19.4	86.2	29.7	28.0	13.8	13.0	31.0	312.1	73.3	48.6	1.3	20.0	58.5	84.4	43.6	40.7	10.4	96.3	280.3	0.8	772.5	69.5	161.5	10.9	4.3	0.0	5.8	3.4	9.1	1.6	5.3	6.9	6.0	1.4	3.9	3.1	4.0	1.5	4.2	13.0	8.1	3.7	299.1	523.6	413.5	300.2	254.5	316.6	523.2	500.0	476.8	333.7	423.1	613.9	123.0	144.2	47.4	14.4	23.6	571.9	141.3	207.3	42.1	68.8	28.6	31.2	20.6	80.1	102.9	187.6	2.1	12.8	68.1	405.4	33.2	33.2	5.3	57.4	59.0	217.7	22.1	17.4	7.7	13.7	138.2	90.5	151.4	167.7	22.2	41.0	112.8	64.0	16.5	588.9	5.7	140.9	83.4	31.1	109.5	5.9	49.0	42.7	101.4	28.1	25.7	81.2	14.4	20.6	136.2	62.9	155.9	44.0	23.5	264.3	402.5	87.5	38.7	40.3	46.0	65.2	44.3	1.2	7.1	113.0	667.4	43.4	45.7	32.6	124.7	280.8
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDRG3		ENSG00000101079	"NDRG family member 3"	Q9UGV2	20	36651766-36746090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.7"	"Group enriched"	"Detected in all"	10	"Early spermatids: 962.7;Late spermatids: 356.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017851, HPA018256"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA017851: AB_1854340, HPA018256: AB_1854341"	"unprognostic (4.59e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.48e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.61e-1)"	16.2	38.2	45.6	14.3	47.5	8.2	18.4	63.2	67.9	22.8	21.4	25.9	19.2	22.6	15.9	18.6	18.9	15.6	30.6	58.5	50.3	18.3	8.1	16.9	18.3	63.6	42.6	27.3	14.4	39.6	22.3	11.6	66.3	54.6	21.5	114.7	18.5	17.1	20.8	17.3	17.4	24.5	40.4	18.6	15.0	75.5	54.9	20.9	15.5	16.5	21.7	16.4	19.1	51.2	49.3	27.3	34.9	20.8	36.2	39.5	11.5	20.2	24.3	33.8	33.0	52.9	25.0	24.9	23.0	41.4	53.2	44.9	45.5	71.1	38.1	18.8	33.7	69.4	37.0	59.6	19.0	18.2	21.0	37.2	40.3	28.8	8.3	38.5	43.2	43.7	27.6	52.1	30.3	18.4	25.2	25.4	10.5	62.0	47.2	21.9	54.9	18.2	40.0	22.4	31.0	26.6	31.4	136.5	30.7	28.1	63.6	16.0	18.9	32.7	21.2	13.2	25.6	24.3	21.6	15.8	61.2	31.3	17.7	6.7	7.2	14.9	16.9	9.6	17.5	12.9	17.4	16.0	11.1	8.8	14.6	15.5	10.6	27.3	12.0	5.7	18.3	10.2	45.6	47.5	63.2	67.9	58.5	50.3	63.6	42.6	66.3	40.4	54.9	51.2	12.9	22.4	6.9	22.2	13.4	11.1	15.3	11.4	15.9	49.8	10.3	8.9	24.6	11.5	9.6	7.3	50.1	9.8	10.4	15.0	27.4	14.0	962.7	6.7	11.3	11.5	7.3	5.0	64.6	14.2	12.5	14.0	12.2	7.5	5.7	14.2	11.4	5.2	27.1	21.9	65.3	9.4	18.3	23.4	12.7	356.6	27.7	14.6	12.4	22.5	9.6	25.9	17.5	39.7	29.1	13.2	6.0	27.8	10.8	13.2	13.1	12.0	9.9	65.2	26.3	12.8	16.8	22.4	20.2	25.2	7.7	6.8	17.5	13.8	13.3	8.8
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 380.7;heart muscle: 352.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 433.0;Horizontal cells: 516.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	16.4	128.8	122.7	2.9	136.0	0.1	11.4	239.4	248.6	25.3	0.0	6.5	3.7	25.5	6.8	20.8	8.0	3.6	352.7	195.0	170.4	1.6	1.0	17.7	4.1	379.4	113.0	1.8	2.7	12.0	71.6	2.0	380.7	3.1	3.2	115.5	5.3	30.2	8.7	21.5	3.9	13.3	41.6	21.9	4.1	48.1	190.9	4.5	2.7	3.6	4.0	3.7	57.5	91.7	0.2	16.9	15.8	3.1	0.4	2.9	1.3	5.2	8.2	2.5	1.7	6.5	4.3	0.4	32.5	4.0	28.6	1.5	1.2	0.9	2.2	0.0	3.3	0.7	3.3	4.7	4.4	0.3	0.3	3.6	0.3	1.6	0.0	26.8	21.0	0.1	0.3	0.2	2.4	4.3	1.7	0.2	1.4	0.6	12.4	0.4	4.4	0.4	0.7	10.6	49.2	18.4	0.5	1.4	0.1	2.0	0.6	0.2	7.7	2.1	6.0	0.6	0.8	0.9	0.5	5.7	11.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.7	136.0	239.4	248.6	195.0	170.4	379.4	113.0	380.7	41.6	190.9	91.7	8.9	0.0	1.9	53.5	0.2	2.0	6.8	0.6	1.2	52.3	0.7	1.5	433.0	0.0	0.3	0.0	4.2	0.0	0.1	0.6	0.0	4.0	5.9	4.0	5.6	17.0	1.8	0.0	95.7	0.2	0.1	10.1	1.5	11.5	0.0	13.6	29.3	0.3	0.0	516.5	94.3	0.1	2.0	1.0	1.2	10.8	4.4	0.3	7.2	22.5	0.0	82.6	0.0	29.7	14.1	3.7	0.0	2.6	0.0	4.9	0.0	0.2	0.2	33.4	6.6	3.5	6.7	4.8	6.5	14.5	5.8	0.0	0.3	0.3	0.0	8.8
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 1.4;classical monocyte: 5.5;eosinophil: 3.6;intermediate monocyte: 1.7;myeloid DC: 4.2;neutrophil: 5.4;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.2;granulocytes: 5.4;monocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1400000	"Cluster 14: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	37.2	22.7	39.4	14.0	45.1	7.6	28.6	43.8	38.9	16.0	3.9	17.6	12.5	17.3	7.9	38.8	14.7	15.2	26.8	30.8	30.7	15.4	42.6	34.3	7.3	62.6	48.8	23.0	39.7	20.5	6.7	12.2	50.3	14.5	9.5	13.9	37.4	16.8	23.6	34.2	17.4	19.2	47.8	43.4	16.0	14.5	51.5	4.2	22.9	13.0	9.9	14.1	18.7	60.0	32.4	28.3	46.1	56.4	45.3	44.9	46.3	58.1	75.9	56.8	84.8	84.1	33.3	22.0	57.6	116.8	91.0	54.4	25.1	118.0	37.6	2.6	38.9	26.0	18.5	13.2	33.5	19.5	45.5	61.6	48.1	68.7	31.0	56.9	78.3	12.9	25.3	7.8	56.3	27.5	2.3	6.2	21.6	9.1	33.0	37.6	38.4	9.8	33.4	32.5	13.8	48.3	35.2	108.5	46.3	32.7	58.3	4.8	38.8	96.4	86.2	42.3	48.3	17.1	4.7	8.1	79.2	30.1	38.0	1.4	5.5	3.6	0.1	1.7	0.0	0.4	0.0	0.4	4.2	0.1	0.0	0.2	5.4	0.0	4.7	0.3	0.0	2.8	39.4	45.1	43.8	38.9	30.8	30.7	62.6	48.8	50.3	47.8	51.5	60.0	29.8	38.5	8.7	23.8	1.9	5.7	3.5	14.4	6.2	11.6	29.9	15.4	11.5	17.2	9.6	16.5	8.4	8.6	0.5	20.9	1.9	10.4	0.7	5.5	7.7	35.5	1.2	3.2	12.0	10.5	11.3	11.0	2.0	6.8	1.3	20.4	31.8	47.5	7.7	13.5	11.7	5.3	8.2	14.4	7.6	1.9	12.5	8.7	10.6	16.9	7.4	12.1	0.0	12.1	39.7	18.8	6.6	32.0	3.7	7.9	17.8	8.8	3.8	11.3	0.0	8.7	11.5	0.7	1.6	17.4	12.4	4.5	1.2	11.8	5.8	5.3
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.8;liver: 1.3;lymphoid tissue: 2.9;retina: 2.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 299.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.0	0.5	1.2	0.0	4.8	0.0	0.0	3.3	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	1.0	0.1	1.3	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.4	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.8	3.3	2.8	1.5	1.0	0.6	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	299.6	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.6	0.1	6.7	128.6	0.2	0.0	42.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.1	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 9.0"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 29.3;Oligodendrocyte precursor cells: 15.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"hypothalamus: 2.3;medulla oblongata: 8.3;midbrain: 3.5;pons: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CACO-2: 3.7;RH-30: 14.5;T-47d: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011129	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	8.3	3.5	1.5	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.7	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.2	0.6	2.3	8.3	3.5	9.0	0.6	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	15.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871832-119876662	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	260.4	276.7	541.8	179.3	547.2	316.3	275.0	560.4	746.6	226.5	637.9	467.4	387.4	132.4	323.9	145.0	193.2	133.0	983.7	539.2	555.3	495.1	449.6	153.8	186.7	549.0	541.6	149.3	228.5	773.9	121.4	171.4	551.2	185.8	371.3	398.6	280.0	240.2	1381.0	90.8	334.6	180.7	545.6	169.4	297.4	65.8	551.2	273.2	173.3	1367.9	219.4	228.5	90.5	549.6	436.8	561.9	342.0	365.6	466.3	317.8	423.6	346.6	395.9	297.8	368.1	326.5	377.8	385.1	509.4	431.0	514.7	416.5	555.7	392.8	354.6	492.2	751.7	380.6	1110.1	750.5	357.0	575.9	387.2	485.4	577.0	296.5	232.5	413.2	389.1	372.4	230.9	553.4	435.6	965.3	412.5	563.2	489.1	1214.3	988.4	405.3	315.2	1169.8	887.0	765.2	255.9	319.8	714.9	871.1	479.6	476.5	224.2	653.8	395.1	209.4	198.2	422.7	672.5	469.4	798.3	524.9	377.5	719.5	262.1	1064.7	680.6	822.0	486.1	726.1	468.4	560.6	540.8	516.7	745.6	447.7	435.9	523.1	851.5	468.5	815.5	809.1	675.4	780.5	541.8	547.2	560.4	746.6	539.2	555.3	549.0	541.6	551.2	545.6	551.2	549.6	251.9	160.3	188.6	10.7	261.6	213.7	251.4	991.0	194.1	156.2	268.0	322.7	3202.9	511.9	445.8	562.8	79.2	396.5	273.9	1264.2	2191.3	503.6	34.2	332.0	237.9	228.9	459.0	272.3	12.3	512.5	416.1	266.9	322.1	348.9	210.3	177.5	260.3	1022.5	661.7	82.4	14.8	907.2	581.8	413.5	350.6	43.8	294.5	329.3	570.9	14.0	492.3	364.2	277.1	8.0	16.5	506.4	1024.5	285.1	389.2	228.8	1546.3	1764.0	443.2	231.2	216.9	208.4	289.9	50.8	105.2	394.3	249.3	380.6	255.7	126.7	887.7	339.3
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025743	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 332.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756"	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	55.4	91.1	36.3	29.6	40.2	50.3	50.3	39.8	51.2	41.0	38.9	83.2	81.6	37.8	28.3	74.6	43.6	31.2	184.8	41.7	36.0	94.2	103.6	35.4	32.3	41.9	39.4	45.4	58.5	99.3	38.5	37.9	41.3	33.1	84.3	31.2	55.9	33.1	206.4	72.4	64.3	39.8	34.0	37.7	71.7	35.3	37.7	45.3	38.8	332.0	49.7	47.3	49.2	39.4	74.4	65.5	46.3	81.5	54.8	95.4	75.5	49.0	70.9	71.3	77.8	72.8	82.8	51.0	31.8	64.2	60.8	96.2	109.8	103.1	92.6	59.7	90.9	72.9	65.6	174.6	72.4	96.9	58.6	95.5	80.3	68.5	85.0	66.6	96.6	74.6	102.0	34.8	81.8	124.8	95.6	110.5	56.3	114.4	81.0	93.2	114.4	81.2	108.7	152.1	70.5	54.6	55.3	131.8	108.9	33.3	121.2	97.4	69.9	52.7	60.7	70.7	75.8	77.3	24.6	79.2	60.3	80.9	72.8	30.2	106.3	47.1	72.9	115.8	93.8	95.4	70.7	77.5	147.9	77.0	68.2	69.4	26.7	97.6	103.3	49.7	92.7	104.6	36.3	40.2	39.8	51.2	41.7	36.0	41.9	39.4	41.3	34.0	37.7	39.4	66.8	76.9	74.1	31.6	63.5	104.9	96.5	193.5	60.3	80.8	88.4	89.5	354.8	87.2	114.0	77.3	62.6	216.4	58.1	137.3	311.0	112.5	47.5	66.8	83.2	67.4	92.9	57.6	83.1	78.5	124.0	71.7	62.2	76.6	65.9	103.7	66.4	139.1	125.2	50.5	68.5	152.3	103.7	90.5	82.0	85.3	50.1	65.2	112.1	27.2	107.8	72.2	53.5	37.7	71.4	77.7	125.5	49.2	56.7	62.1	182.7	303.0	77.7	110.4	65.7	74.6	77.3	84.2	73.4	107.2	118.9	218.1	63.0	185.3	234.2	110.0
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003748	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 558.6;tongue: 563.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	100.2	94.1	158.6	73.9	162.8	93.2	77.1	168.9	228.1	67.8	159.8	148.6	109.3	66.8	87.1	89.8	77.8	52.9	361.8	161.3	172.6	133.8	143.7	70.3	92.5	166.4	162.1	64.7	59.6	159.5	73.5	79.5	164.1	74.7	143.9	106.8	75.3	77.8	558.6	74.2	101.5	98.4	162.6	97.6	87.7	58.9	165.1	108.9	89.6	563.1	122.0	81.0	73.0	161.1	255.3	281.1	223.6	160.8	183.3	171.8	165.8	118.8	178.5	258.5	234.6	347.6	125.8	293.7	68.8	187.6	141.1	188.2	236.1	278.4	296.7	254.8	282.9	241.2	218.6	358.8	186.3	344.0	285.3	183.0	352.4	215.7	266.9	270.4	222.2	246.0	235.2	130.4	260.8	381.1	238.6	533.6	167.0	313.7	484.0	179.9	189.4	335.2	262.5	393.9	213.2	128.5	201.3	287.3	164.6	193.9	287.2	226.9	243.5	134.1	134.0	195.0	204.2	207.5	349.9	443.7	80.6	293.6	211.2	643.9	420.5	228.2	354.8	512.5	336.4	482.8	479.5	429.9	576.2	415.5	631.9	455.9	62.0	464.6	506.6	355.5	570.8	814.8	158.6	162.8	168.9	228.1	161.3	172.6	166.4	162.1	164.1	162.6	165.1	161.1	213.5	73.7	68.4	26.8	81.3	108.6	163.9	364.5	71.2	67.4	87.9	171.7	2159.0	135.8	168.3	108.5	64.6	254.0	127.9	172.0	620.3	162.0	240.0	110.3	98.9	206.0	85.3	86.5	19.6	163.9	254.5	172.6	67.2	100.7	58.3	103.5	109.2	149.1	192.3	37.0	29.0	171.8	244.1	103.6	161.9	122.1	97.6	111.1	160.1	13.1	203.5	141.6	199.8	20.6	22.3	234.6	228.8	133.5	98.8	123.8	229.9	338.3	134.7	130.5	105.2	120.8	291.2	156.3	109.8	127.9	127.7	209.6	120.2	181.9	219.2	182.0
NDUFA13	"B16.6, CDA016, CGI-39, GRIM-19, GRIM19"	ENSG00000186010	"NADH:ubiquinone oxidoreductase subunit A13"	Q9P0J0	19	19515736-19529054	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2947.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041213	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA041213: AB_10794988"	"unprognostic (2.87e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-2)"	268.1	248.1	586.0	184.1	601.2	318.9	226.6	612.2	726.3	188.2	632.2	324.0	268.5	129.8	414.0	288.3	253.0	165.0	987.1	577.4	609.2	274.5	301.3	154.8	234.9	600.9	585.1	168.3	274.3	541.3	154.7	186.6	588.3	216.1	212.4	100.7	272.8	220.4	1093.2	183.1	245.1	193.5	593.6	160.6	251.2	208.5	624.2	254.5	221.2	1102.9	178.5	250.9	103.5	607.7	371.4	405.5	443.7	531.6	460.2	416.2	606.4	345.8	488.3	500.0	492.2	639.4	584.9	442.6	952.2	495.2	261.4	307.2	313.0	477.6	177.3	276.5	1052.6	308.9	590.9	834.1	448.0	601.1	517.0	546.5	483.7	322.7	335.5	296.3	382.8	533.1	428.6	728.2	400.3	1115.4	811.2	880.9	528.4	846.6	1004.4	536.0	263.0	830.2	711.1	782.6	508.9	633.2	350.0	551.7	481.1	225.2	367.7	1035.9	307.3	538.4	177.5	583.8	541.0	543.6	430.6	510.3	428.4	624.2	390.8	1210.3	1162.6	963.4	758.6	1263.4	678.0	1284.6	874.1	838.9	1165.9	1097.3	831.6	775.7	411.9	779.9	1054.3	979.4	1246.2	2090.8	586.0	601.2	612.2	726.3	577.4	609.2	600.9	585.1	588.3	593.6	624.2	607.7	155.1	131.4	184.8	33.0	194.5	129.0	75.9	346.9	117.8	64.8	211.3	181.2	514.5	224.4	251.2	250.1	25.0	426.6	136.6	951.6	610.5	566.0	411.8	154.5	111.5	131.4	556.3	185.3	22.7	578.5	357.2	173.1	225.3	130.5	259.3	51.3	182.4	422.6	333.6	42.1	27.2	719.7	268.5	307.4	197.9	2947.1	153.4	198.3	263.3	19.7	456.7	186.3	183.4	17.6	41.2	490.5	931.9	129.1	272.0	75.0	1114.7	772.0	236.5	84.2	92.1	91.6	196.2	80.6	111.5	210.0	127.0	498.4	177.5	48.0	683.0	87.4
NDUFA2	B8	ENSG00000131495	"NADH:ubiquinone oxidoreductase subunit A2"	O43678	5	140638740-140647771	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1052.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035933	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA035933: AB_10669661"	"unprognostic (4.48e-1)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.30e-3)"	76.1	127.9	131.0	52.3	131.3	96.0	67.3	139.0	156.1	49.2	139.8	81.0	90.2	43.8	79.0	73.5	50.3	45.8	197.3	129.8	137.1	144.9	145.1	53.3	66.1	133.3	131.0	54.9	81.5	99.8	79.1	47.3	133.3	68.7	60.9	51.8	102.2	46.8	283.8	52.4	86.1	31.6	135.8	72.6	90.8	79.7	134.9	78.1	64.2	233.0	48.2	55.5	51.3	142.3	131.1	202.5	91.3	195.9	113.6	84.5	117.8	76.6	69.0	99.4	120.4	328.1	149.5	125.4	191.2	65.9	122.9	103.7	88.4	153.9	57.1	120.6	226.6	80.1	170.6	248.3	67.7	138.7	102.6	100.6	116.6	65.4	47.5	84.3	101.2	111.8	86.9	194.4	93.1	204.9	168.4	285.9	97.5	152.8	203.6	144.7	110.4	212.7	167.5	146.4	119.6	99.4	104.7	292.2	221.8	81.9	269.7	216.3	70.1	113.9	84.8	96.3	125.9	214.2	339.4	190.1	132.3	152.8	65.0	195.0	304.6	311.5	133.1	270.1	137.4	222.0	141.1	143.0	258.1	178.0	127.0	135.6	255.8	156.8	219.9	273.3	205.6	322.8	131.0	131.3	139.0	156.1	129.8	137.1	133.3	131.0	133.3	135.8	134.9	142.3	138.4	109.0	125.4	10.4	127.5	97.8	116.4	311.1	105.3	87.4	182.2	203.5	314.4	200.1	199.7	244.6	37.5	294.1	168.0	499.6	815.9	187.8	526.6	194.5	114.1	115.8	193.2	222.2	6.5	220.4	231.0	115.9	122.9	171.9	92.5	121.2	169.6	516.1	291.9	53.8	7.7	337.9	258.4	251.3	144.6	435.1	165.0	168.0	190.3	5.6	265.1	227.3	211.2	5.5	12.9	194.7	474.4	153.4	151.8	153.8	682.9	1052.3	207.9	113.0	118.3	104.8	139.0	182.7	237.0	165.8	117.1	222.5	124.3	196.1	367.5	164.4
NDUFA3	B9	ENSG00000170906	"NADH:ubiquinone oxidoreductase subunit A3"	O95167	19	54102728-54109257	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 625.9;skeletal muscle: 492.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1133.8;Late spermatids: 2033.9;Proximal tubular cells: 1213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 74.0"	"Low region specificity"	"Detected in all"							HPA046976	Supported					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046976: AB_10960994"	"unprognostic (3.04e-2)"	"unprognostic (4.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (9.91e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	"prognostic favorable (4.80e-4)"	134.4	192.6	20.7	3.2	21.1	6.5	108.0	27.2	28.0	96.2	23.5	142.8	11.2	102.6	5.2	127.7	95.8	5.4	625.9	21.3	21.4	259.5	248.2	102.5	5.1	22.3	20.2	104.5	124.0	4.8	225.9	3.3	21.4	122.5	8.1	6.5	113.4	3.7	492.4	84.8	117.6	4.0	17.3	133.5	160.7	164.3	24.3	3.5	152.4	10.8	5.4	97.6	92.3	26.6	9.1	9.7	8.4	11.6	10.3	10.7	5.2	7.6	9.3	6.5	7.3	10.1	7.2	8.2	5.3	7.4	6.1	6.6	6.9	16.7	3.5	11.5	32.0	9.5	9.6	11.9	7.6	9.2	2.3	6.2	15.1	5.2	8.5	3.1	11.7	7.3	4.9	3.5	6.9	32.3	7.3	10.5	7.4	74.0	15.2	4.3	5.0	17.7	4.9	23.2	14.1	6.9	6.9	17.7	4.3	10.3	23.4	9.6	8.7	7.4	4.5	4.0	13.2	6.9	5.7	3.9	9.1	10.5	4.5	25.2	12.9	20.9	12.6	15.3	13.0	18.4	13.0	12.9	14.3	16.1	13.5	13.6	12.5	18.0	12.3	23.7	14.5	22.3	20.7	21.1	27.2	28.0	21.3	21.4	22.3	20.2	21.4	17.3	24.3	26.6	146.9	96.1	117.4	4.6	168.1	39.8	53.5	266.5	58.6	37.7	196.2	212.6	1133.8	203.0	171.4	393.6	10.4	164.1	158.3	544.0	815.9	183.6	497.6	239.6	124.9	118.2	300.5	169.0	5.2	192.5	171.9	122.9	174.8	180.2	116.5	138.3	194.9	527.7	306.9	23.5	6.4	380.2	209.5	267.4	114.4	2033.9	163.1	181.6	218.7	1.9	300.4	146.3	265.7	3.0	7.7	204.2	448.8	141.4	232.7	67.5	705.7	1213.0	225.1	71.0	85.5	62.5	125.8	215.3	69.8	122.6	62.5	148.4	168.6	75.3	404.2	66.6
NDUFA4	"CI-9k, COXFA4, MLRQ"	ENSG00000189043	"NDUFA4 mitochondrial complex associated"	O00483	7	10931943-10940153	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 513.5;skeletal muscle: 525.0;tongue: 652.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Approved		Supported	Mitochondria		NA	NA		50000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	78.6	90.1	188.7	40.8	196.2	67.5	76.0	192.9	263.4	54.7	192.8	84.1	74.2	74.2	81.1	66.9	69.5	36.2	513.5	201.9	205.0	156.6	140.3	62.8	42.5	194.4	189.6	60.1	61.3	251.9	23.3	31.6	197.6	66.0	56.6	128.4	108.6	84.4	525.0	58.3	58.8	60.9	194.1	59.6	107.0	24.3	194.3	64.0	66.3	652.5	46.1	73.7	54.1	200.1	55.3	90.9	155.0	176.8	84.0	78.4	70.3	68.2	63.2	61.3	53.6	115.2	144.7	104.6	63.0	96.7	168.0	94.1	102.1	79.4	66.5	52.2	74.0	88.2	93.4	108.6	73.2	123.3	84.3	84.8	78.4	75.4	66.0	116.7	86.6	92.7	133.2	139.0	129.8	103.8	56.2	109.3	169.2	364.2	181.6	74.7	108.6	118.6	158.0	115.4	95.2	99.7	106.9	303.7	64.7	210.3	191.6	149.6	76.8	73.3	102.0	107.0	115.0	84.6	115.8	120.5	101.3	130.8	232.5	236.7	110.2	160.6	74.3	135.8	88.3	95.7	103.3	93.9	138.9	74.6	106.1	93.3	25.3	79.4	146.4	131.2	131.6	192.8	188.7	196.2	192.9	263.4	201.9	205.0	194.4	189.6	197.6	194.1	194.3	200.1	422.2	490.4	470.7	52.9	366.9	407.1	605.8	1642.7	307.9	521.0	742.3	936.0	4615.5	843.6	879.3	952.7	266.9	875.9	357.5	543.8	3960.0	865.1	160.6	626.2	471.6	447.0	209.7	358.3	54.1	955.5	763.9	557.9	404.7	477.7	576.4	507.5	656.1	1887.5	964.5	158.2	72.7	780.8	1373.2	589.0	589.8	106.8	493.6	517.6	916.0	49.6	596.6	721.5	374.9	36.7	57.9	776.6	626.7	784.3	467.9	696.6	596.2	3331.1	803.0	666.0	335.2	546.5	846.5	172.7	295.5	581.7	482.9	658.8	389.1	443.5	712.4	803.2
NDUFA4L2	"COXFA4L2, FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4 mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 304.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 627.0;Sertoli cells: 1130.7;Smooth muscle cells: 525.6"	"Cancer enriched"	"Detected in all"	5	"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"AN3-CA: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	85.6	14.0	41.6	6.8	40.1	0.2	55.1	41.4	61.5	109.3	36.8	17.4	5.8	20.7	2.4	304.9	15.5	17.1	180.1	40.3	41.1	47.6	20.9	62.6	5.8	43.0	42.7	14.0	14.5	12.1	30.9	71.7	48.8	27.3	1.9	29.4	55.8	9.8	43.8	206.9	14.2	7.5	38.9	74.1	18.0	8.7	43.5	3.2	54.5	29.2	4.8	27.7	183.5	45.4	0.9	1.3	0.3	133.9	5.4	3.1	0.4	2.1	1.5	0.6	1.3	0.0	1.5	5.5	5.6	2.1	0.1	1.2	0.7	1.0	0.0	3.0	0.2	0.6	0.3	0.1	18.6	4.1	2.0	12.0	2.5	0.2	4.7	0.9	0.0	7.6	0.5	7.2	0.4	2.7	1.1	0.2	0.3	0.6	2.4	2.1	1.0	11.0	0.1	0.1	7.1	2.5	0.2	0.3	4.7	0.1	1.5	14.5	0.6	1.2	0.1	1.1	0.7	10.0	3.5	2.5	4.9	9.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	41.6	40.1	41.4	61.5	40.3	41.1	43.0	42.7	48.8	38.9	43.5	45.4	156.0	0.0	0.5	2.6	2.6	151.2	0.9	89.2	6.8	30.6	2.6	5.8	1.2	0.0	24.8	0.0	18.8	1.0	0.9	0.1	0.0	1.6	1.7	0.4	3.0	91.8	0.0	0.0	2.2	0.0	1.5	21.5	4.6	0.3	8.9	0.1	2.9	1.3	1.9	11.8	3.0	0.2	54.9	0.0	28.9	3.0	3.1	2.0	30.2	18.7	1.0	627.0	0.0	0.5	0.4	4.7	0.0	2.2	1.4	2.0	0.1	0.3	6.2	25.7	1130.7	13.0	525.6	12.3	5.5	20.3	161.4	1.1	1.9	2.5	0.2	1.4
NDUFA5	"B13, CI-13kB, CI-13KD-B, NUFM, UQOR13"	ENSG00000128609	"NADH:ubiquinone oxidoreductase subunit A5"	Q16718	7	123536997-123557904	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 403.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 717.3;Distal tubular cells: 1070.2;Proximal tubular cells: 667.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043175	Supported					NA	NA		81000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043175: AB_10793992"	"prognostic favorable (8.47e-5)"	"unprognostic (4.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.20e-2)"	"prognostic favorable (3.99e-9)"	"unprognostic (3.39e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.73e-3)"	55.2	129.2	94.7	34.1	99.9	34.8	68.8	94.2	130.1	51.3	93.4	78.5	77.6	47.5	71.5	51.0	51.8	47.0	215.7	100.5	108.4	175.3	114.9	44.4	40.0	92.4	97.6	42.2	41.2	170.1	58.3	39.7	98.5	72.8	73.3	127.1	75.6	63.1	285.1	27.2	72.7	46.9	92.6	35.4	77.4	38.3	94.4	52.8	136.6	403.3	42.5	57.8	33.5	91.6	65.9	41.8	76.3	76.6	64.5	58.6	39.5	57.4	63.1	46.8	61.1	47.1	58.2	108.6	54.8	58.8	91.0	60.7	83.9	75.2	74.3	89.6	71.7	68.8	85.9	78.1	62.7	140.5	56.4	58.6	65.9	45.3	47.3	84.1	68.4	75.4	213.9	104.9	84.4	45.5	127.3	162.1	100.3	154.3	107.0	69.2	75.0	146.6	129.5	63.7	144.9	86.3	76.1	286.2	90.3	102.5	65.6	104.7	53.1	58.9	31.7	262.0	88.5	111.2	109.4	116.4	112.7	106.2	75.7	57.8	26.2	31.5	38.2	48.7	55.4	53.6	48.6	44.9	37.1	41.6	52.5	54.0	9.2	52.7	54.8	40.0	55.8	60.4	94.7	99.9	94.2	130.1	100.5	108.4	92.4	97.6	98.5	92.6	94.4	91.6	99.2	102.5	100.4	38.2	108.7	112.5	146.2	280.3	74.6	183.6	113.0	100.8	717.3	102.9	160.6	165.5	83.4	160.6	105.6	119.0	1070.2	132.2	359.6	123.4	91.1	91.8	138.0	91.1	65.2	89.6	156.8	110.5	108.6	128.6	88.7	59.2	66.0	170.6	109.6	127.9	48.5	168.6	295.0	67.2	92.5	77.5	90.1	94.9	202.7	19.7	65.7	264.6	77.2	32.2	29.2	86.2	130.9	112.1	82.0	107.1	210.2	667.6	158.6	214.7	118.3	97.4	133.7	179.0	99.0	94.7	110.2	158.4	102.3	116.9	172.2	147.0
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321375	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.6"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 167.5;Proximal enterocytes: 183.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA059251: AB_2683960, HPA071866: AB_2686465"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	39.4	87.5	86.2	19.8	90.0	34.2	33.1	89.8	96.1	21.3	95.9	46.6	24.2	27.7	53.5	57.6	42.3	25.1	168.1	87.6	90.0	88.3	83.4	31.0	29.6	87.1	88.1	25.1	37.1	103.7	86.4	23.4	87.3	41.2	33.5	32.3	43.5	20.7	245.6	30.7	34.0	22.8	87.3	42.0	54.7	18.7	89.1	40.8	41.3	244.7	32.2	35.5	28.2	87.7	78.9	62.8	64.7	43.3	42.6	32.3	44.2	16.5	18.0	56.0	44.1	57.7	59.7	36.1	25.1	42.6	35.0	65.1	29.0	97.4	33.8	88.3	173.6	26.6	90.1	157.7	63.9	45.8	45.1	43.3	61.7	25.2	39.1	57.1	72.3	141.2	57.0	217.7	80.6	89.4	93.5	236.1	65.1	119.9	187.7	52.2	13.7	99.0	117.6	40.8	65.9	50.5	19.0	90.6	58.5	40.1	33.0	74.8	26.4	42.5	34.0	61.6	60.1	79.2	58.0	49.9	67.8	80.2	77.3	61.9	104.5	80.2	62.1	124.6	65.4	83.3	66.7	58.2	130.5	81.6	66.0	61.6	30.5	81.8	117.6	186.1	95.3	82.6	86.2	90.0	89.8	96.1	87.6	90.0	87.1	88.1	87.3	87.3	89.1	87.7	19.5	44.8	68.4	10.1	28.4	0.0	10.3	0.0	21.1	14.9	51.6	38.1	0.0	44.3	20.4	53.3	6.2	62.0	32.6	57.6	99.7	147.3	38.9	36.1	10.5	19.8	87.4	44.2	9.5	157.2	45.4	15.0	28.1	19.4	21.5	8.4	27.5	64.0	52.8	8.4	13.3	101.6	0.0	42.7	0.0	17.7	13.4	30.4	0.0	10.3	122.5	27.9	45.3	9.5	13.2	167.5	110.2	13.2	61.6	14.7	183.8	97.6	70.7	17.1	6.6	7.3	19.6	24.8	27.5	53.3	0.0	46.9	20.9	11.7	107.6	12.1
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159779	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 380.1;tongue: 363.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 579.5;Distal tubular cells: 614.3;Early spermatids: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	54.2	74.2	139.4	33.9	146.0	28.6	53.9	146.0	159.3	44.8	142.6	101.4	65.8	46.6	86.8	57.1	62.3	39.3	380.1	144.7	148.4	97.9	81.5	37.0	43.0	141.4	139.7	35.7	46.1	137.4	56.9	48.2	141.6	57.9	88.2	72.0	72.3	61.9	259.1	44.2	53.6	73.9	138.7	41.4	75.3	95.5	145.8	48.6	53.3	363.3	56.2	57.8	40.9	141.7	84.8	154.1	99.5	132.0	105.7	96.4	123.3	96.0	114.1	130.0	108.5	197.0	81.9	123.1	92.6	113.6	234.6	206.8	191.3	208.7	127.0	121.5	132.6	96.9	254.2	172.6	113.3	172.7	95.5	106.1	200.3	130.0	82.9	118.1	189.1	134.8	151.0	89.6	150.3	215.6	108.1	112.1	91.2	377.1	293.1	85.0	156.7	179.4	189.4	116.0	172.1	67.6	151.0	176.7	122.6	100.9	187.6	82.1	123.2	71.2	70.9	135.2	109.3	100.1	176.1	123.8	148.0	110.7	120.2	17.4	82.1	66.8	78.3	100.9	76.2	88.0	71.3	77.3	109.2	92.8	76.0	80.3	13.7	79.0	88.7	114.2	91.9	74.7	139.4	146.0	146.0	159.3	144.7	148.4	141.4	139.7	141.6	138.7	145.8	141.7	70.6	28.9	40.4	16.3	38.6	48.3	73.8	298.1	43.9	47.2	61.0	73.5	579.5	48.6	128.0	82.8	29.2	130.5	34.1	87.3	614.3	103.8	499.0	80.1	52.4	98.5	77.4	100.6	19.4	101.6	113.1	70.3	47.9	52.9	20.3	68.5	60.7	110.9	124.4	45.4	26.0	105.7	185.1	40.5	42.0	121.1	56.5	48.8	94.3	18.7	72.9	91.3	65.9	14.1	17.9	100.8	80.3	75.2	56.9	91.1	163.4	249.8	113.0	59.0	26.3	52.5	114.8	294.9	116.2	67.0	56.8	126.6	36.6	104.4	136.3	86.4
NDUFA9	"CI-39k, COQ11, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 617.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	19.6	29.2	25.6	14.8	26.5	35.3	19.1	29.1	38.5	18.4	29.5	41.1	30.6	20.4	14.7	30.9	17.5	6.1	116.7	26.1	25.7	43.4	49.4	18.0	11.8	26.0	25.5	14.7	24.2	34.2	21.9	10.2	26.7	21.4	31.2	20.1	24.3	11.1	110.3	24.1	31.0	12.7	25.7	23.7	31.6	14.3	26.4	18.1	19.3	110.6	14.5	21.2	19.8	27.0	29.8	52.5	25.3	33.9	18.3	18.1	73.1	22.1	22.4	41.9	31.6	114.4	58.0	33.2	11.6	24.2	47.5	48.9	37.1	32.9	27.0	64.8	65.3	32.5	51.0	88.1	40.0	48.0	33.8	23.3	31.2	28.7	38.6	26.0	32.0	46.8	23.1	60.8	31.5	57.6	48.5	55.1	65.5	55.6	43.2	67.4	37.5	34.5	59.2	66.6	18.2	20.6	27.9	74.4	41.9	54.4	15.4	45.4	22.2	31.8	64.7	29.3	52.3	11.9	15.1	57.1	33.2	29.4	35.7	75.9	134.3	53.3	99.2	165.1	102.1	148.3	102.4	109.3	161.9	110.0	88.9	91.1	11.8	107.5	133.5	168.0	143.6	265.0	25.6	26.5	29.1	38.5	26.1	25.7	26.0	25.5	26.7	25.7	26.4	27.0	37.5	28.9	32.1	26.1	45.2	48.6	63.7	199.3	21.6	48.6	40.1	37.0	185.1	45.8	99.4	64.4	58.4	111.1	45.7	89.4	166.3	130.0	112.2	29.3	29.6	46.4	47.4	36.0	21.0	131.3	118.7	38.5	35.2	26.0	57.7	36.6	34.6	78.5	114.7	33.7	26.3	125.4	140.4	35.6	31.8	617.2	28.3	41.8	55.2	15.9	60.0	48.2	49.4	27.2	20.1	108.0	83.5	36.9	50.8	40.5	108.5	163.2	74.9	67.8	19.7	32.0	54.8	30.6	31.3	38.5	47.2	99.9	43.4	66.3	147.7	69.4
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581014-23596316	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 588.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	89.7	127.1	104.3	49.6	106.8	60.4	81.0	114.8	157.6	64.0	117.4	123.0	102.9	68.8	50.1	98.8	66.5	32.0	588.8	107.1	113.5	132.9	165.8	61.9	52.2	110.4	105.6	54.3	84.5	110.4	94.2	47.5	112.0	63.5	89.0	91.9	75.7	58.6	425.0	71.9	90.1	51.1	107.5	72.1	109.6	61.7	108.2	60.2	66.0	432.0	59.2	79.8	70.7	106.9	172.8	125.6	151.8	136.8	107.5	116.0	212.9	129.4	96.8	129.2	105.7	110.1	135.8	284.0	206.6	94.7	158.2	138.6	271.2	155.4	102.6	161.8	312.6	151.8	203.0	507.0	112.2	284.8	121.0	108.0	212.6	95.2	102.2	120.0	167.0	249.5	326.6	139.6	142.7	262.1	221.6	431.9	394.7	254.5	288.5	299.5	171.0	389.3	120.2	140.6	209.8	163.1	144.6	260.8	258.2	167.2	211.2	235.0	131.1	116.5	122.4	113.4	180.5	175.2	283.2	321.9	130.2	228.7	134.9	77.1	179.9	80.0	127.0	222.8	142.3	171.7	150.7	143.4	239.4	151.6	139.0	145.8	37.9	117.8	175.8	268.1	177.6	204.7	104.3	106.8	114.8	157.6	107.1	113.5	110.4	105.6	112.0	107.5	108.2	106.9	136.2	99.3	99.7	9.8	96.1	122.1	142.9	416.9	79.6	91.1	131.7	191.5	1366.5	105.8	200.3	112.2	45.9	290.9	101.3	210.9	708.3	187.3	129.5	185.5	113.2	129.4	202.4	125.1	13.1	210.2	312.2	153.3	119.3	110.8	84.9	124.4	93.9	300.6	263.2	52.2	14.3	253.5	321.4	109.0	89.1	39.6	96.9	114.3	156.5	5.6	179.6	165.0	109.2	7.5	13.2	227.1	174.8	121.5	166.9	180.3	316.8	611.4	261.6	127.6	92.1	134.0	261.9	142.9	118.8	181.5	142.2	224.5	94.5	256.6	360.0	190.7
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387218-41409403	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 85.3;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	16.0	33.4	20.0	9.5	20.7	4.2	12.4	21.6	29.6	9.7	22.8	12.7	12.6	10.5	15.5	13.8	9.8	7.7	42.7	20.7	21.4	29.0	38.7	9.3	11.5	21.1	21.0	9.7	11.8	18.3	11.5	8.0	21.3	10.1	10.4	12.4	12.2	13.2	63.5	9.7	10.9	10.8	21.5	11.9	14.1	21.1	20.8	10.9	10.5	60.9	13.1	12.8	9.9	22.9	15.9	13.3	16.4	13.3	30.0	28.3	14.9	26.1	25.1	23.6	21.3	22.5	8.1	16.7	38.2	24.9	17.5	25.0	20.1	15.9	19.3	32.9	23.9	22.4	25.0	13.8	27.1	24.7	17.0	30.0	18.5	20.8	18.0	19.9	19.0	31.9	38.2	17.2	30.6	17.5	19.9	28.6	12.6	27.5	17.9	15.0	17.4	40.6	41.9	27.8	17.5	13.8	13.2	31.8	12.6	16.9	25.1	50.2	15.4	18.0	10.1	30.5	24.2	15.8	34.7	28.0	24.0	43.5	19.3	35.0	12.8	16.2	7.8	15.0	9.1	13.8	9.6	9.5	11.8	11.8	10.6	8.6	9.4	13.4	13.3	18.2	16.8	8.5	20.0	20.7	21.6	29.6	20.7	21.4	21.1	21.0	21.3	21.5	20.8	22.9	7.7	12.8	10.1	6.5	14.6	4.7	15.8	43.8	9.6	15.7	12.3	11.9	58.7	15.7	27.3	22.0	12.5	36.3	19.8	8.5	64.6	30.5	59.5	14.2	14.2	11.1	6.7	13.5	8.8	31.3	34.6	12.5	12.2	13.1	7.0	16.3	8.6	28.2	28.8	6.7	9.1	8.5	30.5	12.8	7.0	15.0	16.4	16.2	10.6	3.7	23.4	20.7	16.5	4.0	10.3	20.9	3.7	16.1	15.0	11.8	23.3	85.3	30.6	19.2	26.3	15.3	17.3	84.7	21.6	11.3	7.7	50.3	12.3	32.6	11.9	16.3
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945177-61154531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	42.7	39.2	34.8	23.3	35.7	18.0	38.5	34.6	56.0	34.7	33.0	48.3	21.0	31.6	17.5	36.4	31.3	17.0	57.7	34.8	37.5	37.4	32.2	24.9	19.7	36.2	37.9	37.7	35.7	31.2	45.1	14.5	37.3	31.9	26.2	22.0	25.8	23.0	80.2	22.6	24.9	25.9	34.4	18.3	35.9	31.2	35.4	13.0	23.0	46.5	18.8	43.4	33.4	35.0	109.0	51.9	41.6	129.1	80.7	113.8	70.3	129.8	71.1	85.2	103.7	99.4	84.0	150.8	127.5	91.2	141.2	44.2	72.6	113.8	103.6	66.0	104.3	52.1	95.7	99.4	115.6	72.5	26.2	59.7	119.2	74.9	226.0	53.9	74.7	64.0	79.5	76.3	90.9	89.6	64.2	108.0	35.3	41.2	135.0	77.3	115.1	192.7	83.1	46.1	84.8	33.0	74.7	72.7	136.0	35.8	86.1	40.4	68.6	55.5	82.8	125.3	134.2	46.0	73.2	170.8	75.9	123.2	66.3	0.4	18.3	2.4	17.3	19.1	21.1	23.0	22.3	21.1	32.1	15.2	18.6	20.1	0.8	27.1	15.8	11.0	31.7	12.2	34.8	35.7	34.6	56.0	34.8	37.5	36.2	37.9	37.3	34.4	35.4	35.0	40.8	12.8	28.0	23.8	32.8	60.5	64.6	62.2	34.1	27.9	47.9	59.8	87.6	45.8	39.6	38.6	12.5	20.8	18.7	29.8	93.9	55.1	175.7	41.8	95.1	35.8	24.7	28.8	62.2	56.6	49.2	60.4	28.5	40.3	20.3	27.2	31.8	94.6	51.4	42.1	68.8	59.3	40.7	29.5	59.1	22.2	76.7	29.0	44.4	40.3	24.7	34.0	22.6	61.9	71.3	69.8	52.2	62.1	29.0	144.1	32.2	151.4	25.9	29.1	26.3	55.2	60.1	108.4	73.9	63.0	63.6	14.2	34.0	48.5	65.7	71.1
NDUFAF3	"2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527"	ENSG00000178057	"NADH:ubiquinone oxidoreductase complex assembly factor 3"	Q9BU61	3	49020459-49023495	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 329.8"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 475.4;Early spermatids: 1124.6;Late spermatids: 1303.4;Proximal tubular cells: 658.1;Spermatocytes: 913.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035376, HPA035377"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA035376: AB_2674597, HPA035377: AB_10673219"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.60e-1)"	69.0	121.9	112.1	36.4	119.9	51.7	60.7	124.3	123.6	58.4	117.3	43.5	34.9	58.6	47.7	48.5	61.7	32.3	166.0	109.4	117.8	88.6	85.2	52.2	45.3	121.2	116.5	59.4	48.8	84.1	99.0	29.9	120.2	57.2	27.0	26.2	70.7	51.5	127.0	33.1	41.4	30.7	120.5	53.9	49.8	329.8	118.0	52.0	71.2	99.6	37.7	51.1	45.7	126.8	47.7	68.4	60.6	59.9	78.5	66.6	35.0	59.6	57.5	82.8	64.5	98.9	75.1	55.1	68.5	92.1	113.4	34.9	43.3	95.4	29.6	72.9	76.8	109.5	129.9	124.8	110.4	92.2	50.8	68.5	72.5	116.6	85.8	98.9	73.0	169.4	31.4	136.0	90.8	73.9	134.1	46.5	20.1	78.1	183.0	41.1	24.3	169.3	136.7	97.4	52.9	61.6	55.0	115.1	59.1	27.3	66.5	177.6	64.4	76.4	52.0	108.0	100.1	110.8	79.3	86.6	93.2	48.4	121.8	144.3	164.6	143.9	157.6	175.3	168.4	244.1	172.6	160.6	144.9	234.0	223.3	170.2	51.8	154.9	201.2	297.8	180.5	250.4	112.1	119.9	124.3	123.6	109.4	117.8	121.2	116.5	120.2	120.5	118.0	126.8	117.4	93.0	95.2	7.2	95.3	53.3	143.7	113.6	66.0	60.4	119.4	125.5	198.0	104.4	109.6	150.8	2.1	135.2	81.9	124.6	475.4	171.7	1124.6	123.4	81.8	104.3	132.0	118.2	7.2	155.7	128.0	121.2	50.0	58.2	117.3	73.1	114.9	150.6	217.8	69.0	8.3	118.1	103.7	114.1	73.8	1303.4	170.2	129.5	136.9	11.2	149.6	171.5	103.0	6.6	19.6	139.5	148.0	120.7	151.1	175.5	176.9	658.1	199.2	52.8	72.3	87.5	106.4	913.0	88.6	108.4	54.8	106.9	91.2	105.6	109.4	154.9
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889315-96897891	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	5.7	7.9	13.3	3.4	14.7	2.2	7.0	16.8	21.4	6.4	10.4	7.4	4.9	5.5	4.7	5.4	4.4	4.5	25.6	14.7	15.6	12.6	9.3	3.2	4.7	14.9	14.5	7.8	5.5	10.1	2.5	4.8	15.6	7.2	7.5	9.8	6.2	9.6	23.2	4.8	4.4	5.6	12.3	4.9	4.7	4.6	16.6	5.3	7.4	31.1	4.7	7.8	3.7	13.7	2.2	6.1	10.5	14.3	10.3	5.9	5.6	6.0	5.6	8.8	6.6	8.4	3.7	20.6	10.7	5.6	8.4	4.4	24.7	9.3	8.5	14.5	19.5	23.0	3.2	7.4	11.2	24.4	9.2	5.7	14.2	7.6	7.7	4.4	6.9	14.3	21.0	13.6	13.9	7.0	15.7	13.1	20.1	11.3	10.0	7.4	5.9	10.7	14.6	6.0	17.9	8.4	3.1	10.7	17.5	10.2	3.3	16.1	5.8	4.6	3.5	16.2	9.9	3.1	5.4	20.0	6.2	18.1	6.9	0.2	1.8	0.5	4.0	3.6	5.3	5.1	5.2	5.4	3.3	5.4	7.6	6.9	0.3	3.0	2.3	3.8	5.9	3.2	13.3	14.7	16.8	21.4	14.7	15.6	14.9	14.5	15.6	12.3	16.6	13.7	31.9	9.6	19.8	9.8	43.2	108.8	74.4	82.6	60.9	15.1	28.5	48.1	126.9	25.8	37.3	23.9	0.0	49.6	27.9	23.5	168.3	37.7	3.3	19.2	18.3	30.7	39.3	23.3	18.5	27.6	47.6	34.4	33.6	15.9	20.3	42.5	26.0	51.8	53.9	26.9	17.8	44.3	67.1	18.3	33.7	6.2	26.1	20.2	55.2	11.2	19.7	20.7	24.7	8.0	13.1	21.4	19.7	24.8	40.6	63.7	24.2	118.0	16.6	16.6	26.3	57.8	49.1	42.3	63.7	63.1	96.7	32.8	34.3	43.4	58.1	46.4
NDUFAF5	"C20orf7, dJ842G6.1"	ENSG00000101247	"NADH:ubiquinone oxidoreductase complex assembly factor 5"	Q5TEU4	20	13785007-13821580	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Oxidoreductase, Transferase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051184	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051184: AB_2681377"	"unprognostic (3.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.41e-2)"	"prognostic favorable (2.27e-6)"	"unprognostic (5.38e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.58e-2)"	3.2	3.8	4.3	1.2	4.2	5.9	3.0	4.8	5.0	2.8	4.1	5.1	3.6	3.2	0.9	3.1	2.7	1.5	10.4	4.2	4.0	5.0	4.8	2.6	1.5	3.8	3.7	2.2	2.5	4.4	3.4	2.1	4.0	3.3	2.6	3.7	2.9	1.9	20.5	3.4	3.1	3.0	3.5	2.4	3.6	3.9	4.3	2.7	2.4	17.1	1.7	3.3	3.0	4.3	6.5	6.3	7.4	5.1	5.7	1.7	3.7	4.6	3.6	6.0	5.0	13.8	4.7	10.8	4.6	4.9	11.3	8.6	13.9	9.1	4.9	5.1	8.0	9.6	3.9	16.8	7.3	8.6	4.7	3.4	6.4	7.3	4.8	2.6	5.2	10.2	7.6	5.2	5.9	8.4	12.3	7.8	2.6	7.3	6.7	8.1	9.1	6.6	6.8	8.5	7.4	7.5	5.0	13.5	15.0	2.4	6.8	6.0	5.6	7.1	3.6	6.0	7.4	5.7	9.2	8.7	3.1	3.6	7.4	1.2	2.1	4.0	2.4	2.7	1.7	2.5	2.0	1.6	3.0	2.2	2.3	2.3	0.5	3.5	1.9	3.6	2.4	1.1	4.3	4.2	4.8	5.0	4.2	4.0	3.8	3.7	4.0	3.5	4.3	4.3	9.0	0.0	11.2	18.3	8.3	6.2	8.6	15.1	6.8	46.6	6.5	10.4	42.4	4.3	7.4	11.0	27.1	15.9	12.4	8.6	29.4	12.1	68.2	6.5	8.8	8.7	12.5	3.4	27.0	5.6	8.4	10.5	13.3	7.3	7.6	15.9	3.9	11.4	14.0	11.8	29.3	14.1	22.4	8.8	5.9	12.7	6.8	7.7	1.8	12.2	7.9	13.9	13.4	20.6	19.3	9.8	6.2	12.4	8.8	8.9	12.8	33.1	7.4	25.0	0.0	8.8	18.0	35.9	26.7	9.9	7.4	14.6	10.7	18.5	11.7	12.9
NDUFAF6	"C8orf38, MGC40214"	ENSG00000156170	"NADH:ubiquinone oxidoreductase complex assembly factor 6"	Q330K2	8	94895767-95116455	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047148, HPA050545"	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA047148: AB_2679954, HPA050545: AB_2681166"	"unprognostic (1.97e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.04e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.32e-3)"	4.7	3.1	6.9	4.1	7.7	5.5	5.3	8.8	8.1	1.9	5.1	4.4	2.1	3.2	5.7	4.3	4.2	1.9	8.8	6.4	7.8	4.4	10.9	2.6	4.9	6.9	7.6	3.9	3.1	3.5	2.6	3.6	7.3	3.5	5.5	7.4	2.2	3.4	14.6	5.6	3.0	3.2	6.7	3.1	4.3	4.0	7.6	4.7	6.3	13.8	5.2	2.5	1.7	8.9	7.7	4.5	5.4	5.1	3.5	4.3	11.1	8.0	5.0	6.6	4.8	3.6	3.7	14.8	5.3	3.7	2.0	6.3	7.8	5.4	4.9	3.7	15.1	13.7	10.0	6.7	5.4	5.1	6.9	6.5	9.0	3.8	6.1	3.0	3.8	12.1	9.9	8.0	8.0	6.8	13.0	16.5	5.9	10.0	10.6	8.6	4.3	11.3	6.1	7.3	10.1	5.5	4.1	2.5	10.8	6.5	10.1	4.2	4.8	4.7	3.7	3.7	5.8	10.7	8.5	12.4	3.9	13.5	2.7	1.9	1.8	3.0	2.3	1.1	2.9	5.8	3.2	2.2	2.4	5.4	3.1	2.3	0.9	2.9	2.2	2.1	2.9	1.9	6.9	7.7	8.8	8.1	6.4	7.8	6.9	7.6	7.3	6.7	7.6	8.9	23.4	12.8	15.9	35.3	23.6	9.7	10.1	21.5	19.4	22.7	25.7	27.4	32.0	28.6	21.2	12.9	16.7	24.0	14.3	18.5	43.0	15.8	28.5	13.5	9.1	14.8	12.5	23.3	31.8	34.7	30.2	9.4	10.7	9.8	31.8	21.5	12.1	28.3	22.6	25.2	37.0	15.3	24.4	7.3	5.6	8.1	10.5	10.1	14.2	33.7	12.0	25.6	6.2	43.2	58.3	19.3	18.2	13.9	53.1	11.2	23.2	38.2	24.7	23.6	13.1	11.9	21.4	28.4	43.9	17.9	11.9	10.9	13.0	16.5	19.4	9.5
NDUFAF7	"C2orf56, MidA, PRO1853"	ENSG00000003509	"NADH:ubiquinone oxidoreductase complex assembly factor 7"	Q7L592	2	37231631-37253403	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 196.6;Late spermatids: 109.6;Spermatocytes: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045217	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 43: Testis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045217: AB_10960395"	"unprognostic (6.38e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (3.08e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.67e-3)"	6.2	12.7	6.7	5.4	7.1	6.0	6.0	7.7	7.8	8.0	6.2	12.1	4.6	7.8	8.0	5.6	6.0	5.9	15.5	7.3	6.6	9.3	10.6	5.5	6.9	6.5	6.5	7.0	5.7	8.2	6.8	5.9	6.8	6.6	5.9	10.0	5.7	5.4	20.4	4.9	5.7	7.3	5.8	6.6	6.2	38.8	6.2	8.2	5.1	24.4	5.9	6.7	6.1	7.1	20.2	10.6	13.2	11.6	8.3	17.6	7.3	6.6	10.5	11.1	14.1	22.9	8.5	17.1	8.1	6.0	18.9	14.8	16.2	8.3	13.1	11.9	12.1	12.6	13.1	21.1	10.2	12.6	6.1	13.8	13.6	9.1	5.6	11.8	17.4	6.4	15.5	11.1	6.7	7.4	12.6	13.5	17.3	15.9	9.5	11.3	10.2	14.4	15.4	7.4	13.7	11.0	8.2	13.9	14.3	18.6	8.4	4.9	3.4	9.2	12.3	11.6	12.1	9.7	6.0	19.8	13.4	16.9	7.9	3.0	4.3	2.6	4.1	3.7	1.8	4.7	3.6	3.5	5.3	4.1	3.5	3.1	2.7	4.1	2.7	4.2	4.6	2.0	6.7	7.1	7.7	7.8	7.3	6.6	6.5	6.5	6.8	5.8	6.2	7.1	10.9	9.6	10.0	12.7	15.5	4.8	9.5	12.3	11.4	18.1	6.4	5.6	13.4	2.8	8.4	11.0	22.9	15.0	16.1	3.7	17.6	10.5	196.6	6.6	12.1	9.4	2.4	6.5	30.5	6.3	10.8	9.7	8.6	7.2	7.6	11.9	7.5	5.6	9.4	11.8	26.9	5.5	12.2	7.3	7.8	109.6	13.4	9.4	3.6	15.0	10.5	7.6	10.3	13.6	15.4	8.8	2.0	16.6	9.3	5.9	7.7	14.8	11.3	21.8	6.6	10.1	18.0	118.4	14.4	7.4	4.0	11.5	13.6	16.1	6.2	6.3
NDUFAF8	C17orf89	ENSG00000224877	"NADH:ubiquinone oxidoreductase complex assembly factor 8"	A1L188	17	81239305-81241310	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 264.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 130.5;Breast myoepithelial cells: 162.6;Distal tubular cells: 279.7;Proximal tubular cells: 337.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057732	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA057732: AB_2683513"	"unprognostic (4.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (5.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	47.8	65.1	164.7	28.2	167.7	37.0	40.3	159.5	264.3	32.9	156.0	49.5	21.8	30.4	33.6	45.9	32.0	9.8	110.7	161.5	158.1	68.6	79.1	27.5	26.5	160.1	160.0	33.6	56.3	40.1	54.2	14.5	159.1	44.1	29.4	24.0	36.7	20.2	144.5	33.0	31.6	21.8	161.1	40.4	45.5	30.7	166.1	30.8	38.7	93.0	32.1	45.2	31.6	159.9	142.1	199.9	73.2	72.1	80.4	84.9	79.0	122.1	49.3	82.0	47.1	102.5	60.0	131.6	60.2	86.2	68.2	69.2	69.2	117.4	97.8	33.3	437.1	99.8	222.2	233.3	84.7	139.2	60.8	113.5	140.2	59.3	124.8	87.8	133.0	103.6	132.5	77.3	106.8	130.4	194.6	145.1	41.1	114.6	288.2	121.6	104.8	96.7	89.5	96.1	84.1	107.7	100.5	82.2	126.1	107.2	115.1	127.7	81.5	101.4	154.8	73.2	123.2	110.2	41.1	124.0	91.7	72.8	79.9	41.2	80.1	69.1	73.4	67.1	73.4	103.6	80.4	88.9	82.0	87.6	96.4	94.4	10.3	78.0	76.2	138.0	87.3	77.5	164.7	167.7	159.5	264.3	161.5	158.1	160.1	160.0	159.1	161.1	166.1	159.9	47.9	19.2	17.3	0.0	24.9	0.0	0.0	0.0	0.0	0.0	130.5	162.6	0.0	0.0	9.3	101.2	0.0	120.5	41.0	0.0	279.7	98.1	0.0	59.8	75.1	21.6	0.0	0.0	0.0	124.6	99.0	32.0	0.0	48.1	1.3	73.5	0.0	0.0	129.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	117.4	0.0	0.0	10.6	0.0	0.0	337.8	3.6	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.0	45.6	23.1	96.8	0.0	0.0
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2435.4;Hepatocytes: 1690.0;Proximal tubular cells: 1614.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Nuclear speckles"	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	260.8	396.4	370.4	109.0	381.4	167.4	231.8	388.5	588.6	178.3	409.2	313.4	165.7	164.9	178.3	281.5	177.1	61.2	1221.5	381.0	401.1	512.7	503.2	182.3	118.4	379.8	374.6	162.7	206.3	373.5	314.7	61.1	383.2	221.5	122.4	260.9	233.5	59.5	862.6	153.6	225.9	69.4	381.2	214.0	292.4	112.3	376.4	230.6	250.4	1053.8	106.1	192.1	202.4	391.0	198.3	388.3	332.5	208.4	219.1	160.7	143.0	243.2	143.7	147.5	135.4	236.9	341.0	187.0	215.7	151.3	205.8	249.6	198.4	212.3	133.9	280.8	425.1	361.3	665.8	308.5	178.2	290.4	196.4	202.5	132.0	159.5	140.7	334.8	136.7	353.7	199.0	370.1	211.8	759.0	286.6	250.0	166.4	779.6	492.1	253.3	309.7	274.2	397.7	491.3	210.8	152.8	486.6	289.7	338.3	277.7	432.0	435.0	291.8	89.3	173.0	181.3	161.7	288.4	477.2	422.0	278.4	208.5	187.9	456.1	566.8	447.5	247.4	409.6	288.5	373.7	361.5	286.0	508.6	306.8	355.4	343.9	721.3	296.6	386.6	604.6	438.9	653.6	370.4	381.4	388.5	588.6	381.0	401.1	379.8	374.6	383.2	381.2	376.4	391.0	158.5	166.7	227.4	11.4	187.4	128.7	102.1	334.5	96.8	84.6	328.2	353.6	2435.4	467.5	237.0	389.9	39.6	260.3	170.4	627.2	1166.1	245.4	175.8	326.0	208.6	188.2	317.4	256.1	18.4	427.7	118.8	203.6	189.6	225.8	215.8	96.2	397.3	1690.0	422.3	55.5	21.7	515.9	268.5	619.8	179.3	57.3	262.5	281.7	332.6	10.3	478.1	223.3	241.0	11.1	15.0	294.4	628.7	241.1	201.6	97.9	845.2	1614.3	337.6	183.3	223.5	172.4	188.2	138.8	151.5	204.5	176.2	205.8	163.7	97.4	540.6	116.3
NDUFB10	PDSW	ENSG00000140990	"NADH:ubiquinone oxidoreductase subunit B10"	O96000	16	1959538-1961975	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 774.5;skeletal muscle: 1298.5;tongue: 1013.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1191.7;Late spermatids: 1040.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073189	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA073189: AB_2686579"	"unprognostic (3.56e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.43e-6)"	"unprognostic (1.24e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.43e-1)"	"unprognostic (8.76e-2)"	132.0	132.6	143.8	58.1	151.3	72.6	123.2	156.7	173.0	103.8	139.2	215.8	132.1	123.4	90.4	130.8	109.9	48.1	774.5	148.5	150.6	195.7	206.4	91.1	64.6	147.6	144.8	88.4	155.6	175.0	87.5	60.7	149.8	115.2	115.2	64.6	139.9	86.9	1298.5	122.6	144.9	71.7	142.9	106.5	186.4	104.0	147.7	69.0	102.9	1013.2	74.1	135.3	105.4	149.2	103.2	311.7	146.2	170.9	144.9	137.9	144.9	126.2	159.7	149.9	100.9	233.3	139.9	209.5	208.5	165.9	77.4	215.4	161.5	197.8	113.5	192.4	598.3	162.5	242.1	269.6	185.6	266.7	150.8	154.1	180.2	141.3	160.6	161.3	177.7	191.8	153.6	206.6	195.1	457.9	316.6	284.9	183.8	287.6	335.7	367.6	151.3	461.5	222.7	110.8	320.9	203.1	236.6	390.3	172.4	85.9	232.8	181.6	149.7	132.5	124.1	189.3	139.9	326.8	274.0	283.3	95.0	131.6	142.8	280.4	288.9	273.4	210.5	254.0	206.7	257.6	258.5	266.3	309.0	230.0	203.5	213.8	160.5	215.8	225.8	331.2	346.3	355.0	143.8	151.3	156.7	173.0	148.5	150.6	147.6	144.8	149.8	142.9	147.7	149.2	216.7	115.4	84.9	22.2	146.8	170.5	168.9	296.0	186.7	95.6	208.5	307.2	1191.7	261.7	165.1	218.8	18.8	355.8	135.2	589.3	982.2	299.7	341.7	163.5	132.6	174.2	203.8	173.0	10.9	414.9	333.2	181.2	167.7	142.0	111.1	145.8	163.5	417.6	321.7	79.1	13.4	478.8	229.9	200.9	195.2	1040.9	158.1	160.0	277.5	10.3	252.8	236.6	150.4	11.1	22.7	298.8	488.9	156.1	209.0	136.1	918.2	877.6	209.4	112.1	190.7	171.6	260.2	195.4	123.2	240.0	182.7	200.0	150.1	142.8	489.6	192.1
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145038	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 717.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	71.1	133.8	136.0	73.2	141.2	133.2	89.8	147.7	170.6	74.6	158.5	112.5	96.7	54.4	104.6	95.2	84.1	46.2	251.4	140.3	142.3	108.9	164.4	62.2	90.3	144.7	139.0	58.5	158.2	122.9	92.7	62.4	142.0	73.9	98.2	59.2	128.2	79.2	717.0	76.1	96.1	72.2	138.3	74.5	97.8	26.8	146.3	97.8	95.6	378.4	106.3	68.0	66.5	139.3	173.5	297.9	198.7	242.4	173.6	166.1	221.1	125.2	180.5	231.5	224.4	292.6	224.2	218.5	101.8	163.4	222.3	216.2	267.0	157.3	162.0	212.4	663.1	129.5	371.2	271.3	184.7	203.2	188.2	176.9	140.0	191.2	126.8	137.8	193.9	286.8	158.6	282.6	139.3	437.2	269.1	622.5	308.5	219.2	517.2	259.7	210.9	513.6	254.0	210.1	391.2	283.1	231.9	289.2	198.8	259.8	418.2	279.7	130.3	152.7	190.5	239.1	149.0	244.0	270.0	258.5	155.0	138.4	204.2	255.4	410.3	188.6	294.2	306.5	362.1	541.7	408.9	342.6	491.6	470.0	454.3	359.3	84.9	279.7	233.8	636.5	476.3	626.1	136.0	141.2	147.7	170.6	140.3	142.3	144.7	139.0	142.0	138.3	146.3	139.3	154.0	105.8	132.5	16.6	270.9	259.5	252.1	514.5	267.5	89.2	343.7	520.1	236.6	265.9	284.7	290.6	37.5	456.9	227.6	400.0	583.0	314.9	5.2	193.4	229.7	165.6	330.7	246.3	10.2	369.1	429.2	192.1	200.8	267.1	194.1	219.2	203.8	657.2	391.0	55.5	16.7	495.1	333.7	321.7	290.9	16.3	181.7	229.1	265.1	12.2	336.9	238.9	183.4	14.1	25.3	291.8	391.2	176.4	445.1	258.6	360.1	756.8	180.9	109.8	164.3	157.6	248.9	16.8	36.9	358.0	290.5	450.9	228.9	342.6	447.4	334.9
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3191.4;Distal tubular cells: 1997.6;Proximal tubular cells: 2437.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	187.2	225.3	347.4	123.4	363.9	143.1	159.9	377.3	441.6	142.0	374.0	239.9	166.0	153.4	171.5	196.9	129.6	141.8	847.4	343.6	369.1	420.0	281.2	140.1	164.8	359.0	355.8	108.0	159.4	362.6	182.3	105.9	361.1	152.0	183.0	175.9	197.6	152.3	834.7	152.0	161.1	154.8	369.8	155.1	216.4	125.5	378.3	162.3	350.5	913.1	134.0	186.6	145.5	377.6	322.5	497.0	182.1	400.9	291.9	297.5	259.9	227.0	207.6	241.4	229.1	389.7	317.3	243.1	331.7	289.9	441.7	155.4	167.0	333.4	194.1	399.5	556.9	179.1	442.3	461.3	230.0	279.2	231.0	331.6	287.5	227.0	138.2	201.3	368.1	338.8	311.2	289.9	343.2	945.8	448.2	719.4	424.0	670.0	585.0	251.1	174.6	569.4	492.0	634.2	369.0	359.3	310.4	513.8	281.0	205.7	222.9	315.7	295.2	307.0	179.2	365.6	401.5	267.6	567.2	457.2	469.0	447.7	395.8	713.9	1045.5	503.4	779.4	1117.0	673.3	1009.8	755.0	768.2	1161.9	787.8	800.5	793.7	85.6	823.9	1037.9	926.9	772.0	1795.1	347.4	363.9	377.3	441.6	343.6	369.1	359.0	355.8	361.1	369.8	378.3	377.6	262.7	189.1	238.4	25.5	191.1	226.5	289.3	693.4	128.1	181.9	458.3	514.8	3191.4	351.8	398.1	673.1	98.0	555.4	275.3	776.2	1997.6	373.9	901.2	294.2	298.4	283.6	428.7	143.7	19.9	314.4	466.6	327.2	307.3	366.3	280.6	212.8	205.6	1079.3	710.8	139.7	22.7	576.3	687.7	280.3	337.3	246.9	222.7	336.5	434.0	13.1	356.7	367.2	465.5	19.6	42.3	279.4	647.9	243.8	210.7	440.1	867.3	2437.9	370.2	284.1	197.2	199.2	372.0	77.0	208.6	321.9	280.6	515.0	241.7	288.6	669.6	435.8
NDUFB3	B12	ENSG00000119013	"NADH:ubiquinone oxidoreductase subunit B3"	O43676	2	201071433-201085750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 704.3;tongue: 727.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1711.2;Distal tubular cells: 1064.4;Proximal tubular cells: 780.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034596	Enhanced					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA034596: AB_10602712"	"unprognostic (5.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.81e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.27e-2)"	119.4	114.4	151.2	88.9	152.7	79.7	105.5	165.7	227.5	69.9	161.9	185.7	136.7	46.4	132.2	98.4	66.1	66.3	389.3	151.5	165.1	247.1	195.3	63.5	103.7	158.2	155.4	46.2	54.7	219.3	57.8	78.0	158.1	77.1	174.6	140.8	100.8	75.8	704.3	52.0	127.9	73.8	157.2	61.6	115.5	83.1	158.2	143.4	96.0	727.7	128.8	95.4	53.7	160.6	180.1	148.9	227.5	122.0	226.3	207.0	183.1	224.8	160.1	171.9	200.3	347.2	211.3	144.4	249.8	211.4	261.9	154.5	209.6	287.7	269.4	294.5	460.6	349.0	363.8	394.8	141.2	500.9	170.5	180.1	223.6	203.3	119.2	211.3	250.3	259.2	311.1	240.3	313.1	234.4	313.8	459.8	129.9	392.4	536.7	215.6	200.4	388.0	380.6	278.7	209.5	150.1	176.0	153.2	258.2	353.2	150.7	373.0	227.3	144.8	179.7	150.9	222.8	174.5	435.3	452.6	246.0	284.4	172.6	205.2	135.4	159.4	116.1	205.3	129.2	148.8	132.7	135.7	177.3	117.3	115.2	140.9	267.3	141.6	213.3	211.8	183.1	109.6	151.2	152.7	165.7	227.5	151.5	165.1	158.2	155.4	158.1	157.2	158.2	160.6	95.3	80.1	57.7	18.9	100.9	78.1	100.0	433.7	66.6	52.9	101.7	128.1	1711.2	141.5	205.1	187.6	12.5	254.6	83.5	473.9	1064.4	247.0	218.1	191.6	93.9	101.9	146.4	113.8	13.2	201.7	208.9	103.4	118.7	135.2	78.0	61.0	86.7	260.5	288.2	32.0	14.7	299.0	248.2	121.6	107.1	59.9	95.4	126.8	168.9	10.3	292.9	184.6	116.4	7.5	19.9	177.3	411.0	101.5	135.2	72.5	496.3	780.3	229.2	92.0	92.1	82.3	125.4	270.0	89.7	169.2	91.9	157.6	89.7	113.9	322.1	132.9
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596328-120602507	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 945.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1493.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	148.6	338.4	159.7	90.3	169.1	112.4	145.1	175.9	203.2	126.2	173.2	170.0	147.8	117.9	133.8	159.5	113.0	85.7	619.5	163.5	178.4	232.4	187.4	102.9	93.8	168.3	163.0	119.8	137.4	260.3	170.2	76.8	168.6	118.1	148.7	100.2	148.4	117.4	945.3	144.5	135.6	103.4	170.7	112.1	162.3	106.5	161.7	125.6	113.1	562.2	114.2	133.5	142.1	172.8	294.8	204.3	246.7	248.5	151.0	181.4	199.2	157.0	212.1	205.4	224.5	200.9	219.8	147.8	311.6	177.8	255.6	272.5	191.3	202.7	155.7	227.5	212.6	226.1	205.7	208.1	90.4	202.7	256.8	161.3	268.5	98.9	125.8	246.0	258.5	271.7	138.5	219.2	220.9	224.1	398.6	294.8	193.9	478.9	554.7	228.8	141.0	325.8	337.3	177.9	273.8	283.4	186.5	205.7	360.0	162.0	348.0	319.9	199.8	179.0	233.2	76.9	226.5	263.2	260.1	454.3	283.6	279.8	250.8	205.0	164.8	197.2	156.0	229.5	162.2	231.6	215.2	176.8	213.9	176.3	182.2	181.8	101.6	152.7	238.2	267.9	300.6	205.7	159.7	169.1	175.9	203.2	163.5	178.4	168.3	163.0	168.6	170.7	161.7	172.8	274.1	163.5	162.6	36.9	167.0	222.3	289.0	612.6	190.6	137.8	290.1	351.3	1493.1	311.7	348.3	320.0	58.4	366.0	158.1	472.4	1226.7	556.7	999.2	259.9	188.9	235.7	298.7	196.9	22.6	620.9	421.0	213.7	175.3	293.5	174.8	139.4	183.5	513.9	330.3	84.1	22.0	526.3	451.6	240.2	247.9	164.6	275.2	196.2	434.0	15.9	339.2	340.7	186.4	13.0	31.2	567.9	581.8	277.2	283.2	243.2	613.4	1225.1	266.2	168.4	256.4	208.1	259.0	418.9	87.5	288.4	251.5	352.4	168.1	271.3	462.8	344.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 241.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	61.0	88.4	35.6	29.0	38.5	19.5	47.8	39.4	57.3	37.7	52.8	64.0	75.1	30.2	15.6	56.7	33.4	28.8	217.0	38.4	40.0	93.5	74.0	34.4	36.1	37.1	36.6	41.9	52.3	66.6	40.2	27.0	37.4	32.6	36.1	22.7	43.7	20.2	241.4	43.6	57.0	22.3	35.4	46.3	63.8	42.2	39.8	31.4	41.6	166.9	24.8	46.2	41.5	38.9	96.5	23.2	51.2	66.8	52.3	66.0	75.6	58.5	42.0	48.1	50.7	79.8	53.4	72.7	193.4	32.7	119.5	89.9	48.9	47.4	38.9	182.5	43.1	90.4	31.2	44.8	52.3	97.9	64.0	64.9	60.7	31.2	51.0	61.0	62.8	62.1	71.2	98.7	51.8	68.8	55.8	60.5	80.2	138.7	80.8	64.2	63.3	205.1	82.5	46.8	41.1	62.4	34.9	169.9	126.7	36.2	265.9	151.2	64.5	46.6	47.8	61.7	139.9	158.0	193.6	122.5	75.8	91.7	67.9	94.6	104.5	49.9	43.8	127.8	64.5	90.2	60.0	51.6	145.5	67.2	59.8	62.9	18.9	48.1	154.8	81.0	84.0	105.6	35.6	38.5	39.4	57.3	38.4	40.0	37.1	36.6	37.4	35.4	39.8	38.9	113.6	48.1	48.5	17.3	90.2	85.1	115.2	374.4	73.4	45.9	121.0	138.6	362.3	88.6	164.3	88.3	33.3	234.0	54.5	115.9	508.7	132.5	162.6	118.4	79.0	89.2	117.5	75.3	16.1	105.7	150.0	87.1	77.5	62.9	93.8	120.1	105.7	118.3	253.5	40.4	22.6	196.0	266.5	261.3	133.0	28.9	81.1	133.6	135.2	15.9	180.0	107.2	70.0	19.6	25.8	81.5	163.4	70.0	75.0	89.8	293.5	462.8	157.9	73.4	72.3	87.1	98.5	265.7	128.3	105.9	88.7	230.0	72.9	257.4	268.8	163.4
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32553001-32573184	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 583.9;Distal tubular cells: 534.1;Early spermatids: 889.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	38.6	50.8	42.7	30.7	45.3	31.0	35.9	47.1	48.1	34.1	42.8	41.8	44.6	38.1	26.8	43.8	36.0	17.6	144.9	44.5	46.5	73.6	66.7	30.5	26.9	44.5	42.9	29.7	31.0	41.8	40.3	22.5	44.6	28.5	29.1	30.7	37.0	22.0	168.0	28.2	43.6	26.7	45.9	28.8	43.5	53.5	44.3	28.7	33.2	101.8	24.5	34.1	33.4	47.1	106.4	63.7	69.6	80.1	46.7	43.0	44.5	69.5	56.5	62.8	68.8	62.8	46.5	78.4	70.5	48.2	65.1	58.8	66.5	76.8	47.0	108.6	106.0	187.2	88.8	65.9	45.2	94.4	46.3	44.8	36.7	56.8	42.9	47.5	57.6	118.4	61.0	86.1	71.9	61.2	128.1	221.2	73.6	90.7	140.1	86.7	58.4	73.1	72.0	39.3	69.7	78.4	80.2	91.1	50.7	52.0	86.3	72.0	51.4	67.9	103.8	75.7	103.8	38.0	77.0	131.5	113.7	65.6	32.7	126.3	97.6	136.1	76.9	94.3	74.5	106.0	81.4	80.0	108.8	89.0	82.3	87.4	302.1	91.9	116.3	152.7	112.4	110.2	42.7	45.3	47.1	48.1	44.5	46.5	44.5	42.9	44.6	45.9	44.3	47.1	69.5	125.0	111.6	15.3	76.2	94.2	106.2	222.9	90.0	44.1	64.6	72.6	583.9	101.5	141.4	108.5	6.2	191.8	69.4	115.8	534.1	172.5	889.5	106.9	86.1	101.0	64.6	196.7	21.8	166.7	143.0	109.5	83.6	86.4	90.5	64.3	74.3	182.2	160.8	18.5	23.8	152.5	209.5	55.0	96.4	146.9	91.6	78.4	160.1	3.7	108.6	115.3	90.6	18.1	21.3	144.4	124.9	89.9	165.7	80.0	201.0	520.3	152.3	56.5	105.2	94.8	151.3	182.0	125.9	139.7	96.7	104.1	81.0	95.6	167.3	103.8
NDUFB7	"B18, CI-B18, MGC2480"	ENSG00000099795	"NADH:ubiquinone oxidoreductase subunit B7"	P17568	19	14566078-14572066	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002817	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002817: AB_1079462"	"unprognostic (2.80e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.25e-3)"	203.1	216.1	209.9	66.1	218.4	103.7	188.8	232.4	325.4	153.6	216.5	256.3	124.6	169.4	51.1	230.7	152.3	57.7	695.8	204.8	222.5	291.7	335.7	127.8	70.4	222.2	221.3	137.3	213.5	143.2	182.8	61.6	218.9	171.0	55.9	28.6	198.7	93.2	709.4	189.4	163.2	50.6	213.2	150.0	231.9	132.8	230.2	50.6	189.7	266.9	39.5	167.3	161.2	222.6	242.1	237.4	95.0	203.1	80.4	80.5	167.4	110.1	120.6	200.0	189.2	317.9	130.2	109.4	322.0	102.9	87.5	185.0	62.6	241.1	26.7	170.1	320.8	212.2	380.9	334.6	142.1	138.7	141.5	131.7	196.6	105.7	49.6	56.1	161.7	194.9	132.9	194.8	94.2	452.7	227.0	308.0	242.4	228.1	773.2	174.3	112.8	264.6	143.0	253.3	204.4	217.6	114.9	265.6	303.4	24.6	175.0	245.1	122.0	253.5	123.2	324.4	207.0	264.4	295.5	144.1	243.7	267.8	174.5	355.6	414.5	140.4	432.9	395.5	403.8	368.6	291.4	368.9	415.4	327.7	241.3	315.5	119.4	422.4	389.5	460.4	373.3	562.3	209.9	218.4	232.4	325.4	204.8	222.5	222.2	221.3	218.9	213.2	230.2	222.6	196.4	76.9	95.9	19.9	155.6	133.4	177.9	358.5	126.9	117.4	285.4	363.9	670.4	245.9	214.2	259.3	56.3	359.7	155.5	937.3	1154.3	324.9	81.8	162.8	133.9	163.5	332.1	152.9	7.4	455.3	330.5	185.2	194.7	152.1	102.2	197.4	203.1	589.1	377.5	72.3	11.4	639.3	299.1	237.9	158.0	252.0	207.5	173.9	378.8	10.3	327.3	236.4	365.6	8.5	25.5	367.9	720.8	200.1	197.5	175.4	916.4	1041.9	193.1	152.4	236.7	193.6	330.8	133.7	252.1	235.7	161.2	225.6	138.6	197.5	631.6	220.1
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 876.5;Proximal tubular cells: 881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	152.6	199.3	431.2	103.4	439.3	171.5	135.8	427.1	606.3	127.3	416.7	237.8	161.0	145.8	163.0	170.2	132.4	88.0	482.4	444.8	441.9	249.9	262.0	108.6	132.0	438.5	439.4	130.4	115.5	331.0	186.7	83.0	441.9	132.2	145.0	127.1	163.6	135.8	408.9	128.2	147.8	125.5	411.8	133.3	201.0	66.2	442.5	140.6	130.1	512.8	119.9	162.9	132.9	448.3	250.2	419.6	222.3	383.1	159.6	158.8	238.5	168.1	370.9	259.3	278.8	575.4	278.1	260.7	146.4	185.6	189.1	289.5	162.9	269.7	194.5	172.9	417.8	183.9	350.3	465.7	217.6	379.3	302.6	191.6	240.7	249.2	329.3	180.4	283.7	361.1	194.5	159.3	218.4	304.1	369.7	472.9	144.7	324.3	377.9	252.4	237.6	346.1	298.8	281.3	147.9	209.7	122.0	227.4	250.9	147.3	338.2	332.8	185.5	139.5	158.7	151.5	296.8	288.4	286.4	334.8	277.6	398.2	159.3	299.4	530.8	478.1	406.0	558.8	483.1	616.1	498.0	468.1	589.7	546.7	538.1	514.0	122.7	478.0	489.6	655.0	817.6	1113.4	431.2	439.3	427.1	606.3	444.8	441.9	438.5	439.4	441.9	411.8	442.5	448.3	184.8	76.9	132.7	41.8	107.6	0.0	187.1	0.0	12.5	186.4	162.2	210.2	392.9	204.5	48.3	198.6	58.4	333.1	175.8	109.0	876.5	268.1	24.9	105.8	86.3	142.7	105.6	114.3	72.6	264.7	305.1	128.8	35.2	87.1	109.7	112.0	153.8	346.5	399.1	153.1	82.6	171.6	0.0	184.4	0.0	56.0	218.1	142.2	0.0	33.7	231.0	219.5	158.6	40.2	62.3	250.6	191.7	217.4	59.3	203.2	560.2	881.6	85.2	183.5	170.9	117.2	176.0	85.5	83.1	31.5	0.0	307.7	112.9	225.5	237.6	221.5
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539101-124580648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1314.9;tongue: 1486.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 2950.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	155.6	158.2	259.0	78.5	263.8	265.2	157.8	281.1	381.2	109.7	245.0	226.4	184.6	129.5	147.4	209.2	126.0	70.4	789.5	257.6	288.7	324.9	325.0	122.9	96.5	279.3	277.8	107.1	209.4	282.9	124.0	81.2	281.5	117.8	191.0	135.8	210.9	115.1	1314.9	149.3	162.9	111.1	253.4	116.8	241.2	204.7	286.2	102.8	154.2	1486.4	104.1	139.9	124.7	274.1	348.2	316.8	236.1	321.2	240.6	204.2	196.0	165.2	189.3	297.4	222.4	417.7	327.6	341.0	421.0	193.6	153.9	385.5	347.3	266.7	279.9	395.8	464.8	831.3	199.6	505.9	320.8	261.8	218.2	239.6	382.1	271.9	587.9	160.1	275.9	241.1	523.7	277.6	243.4	1089.0	415.8	522.7	237.5	1247.0	692.7	276.3	179.9	468.0	400.0	288.8	326.6	255.0	362.4	2950.7	382.8	141.1	407.3	348.2	219.7	172.5	444.1	162.9	399.5	354.8	517.7	392.5	298.6	515.4	233.1	302.2	253.1	136.2	210.5	179.2	209.6	260.9	275.8	237.1	247.5	201.4	269.1	223.9	49.2	188.9	136.1	183.1	346.0	345.8	259.0	263.8	281.1	381.2	257.6	288.7	279.3	277.8	281.5	253.4	286.2	274.1	169.0	125.0	124.8	7.8	147.7	217.8	277.5	448.3	178.7	77.4	247.3	313.0	1005.6	260.2	267.3	286.9	98.0	494.6	119.9	525.0	800.3	338.0	389.8	120.7	100.6	164.1	233.7	227.6	10.5	405.7	296.0	187.9	169.7	109.2	139.4	149.9	167.4	517.7	380.6	37.0	14.9	421.0	488.3	206.0	137.6	865.4	158.8	183.0	247.3	15.9	226.3	144.1	171.0	7.1	18.2	378.1	450.0	152.7	169.1	290.3	584.6	789.7	208.6	91.1	170.9	221.2	511.8	317.6	264.8	377.0	188.4	523.0	155.6	216.0	521.7	315.8
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 83.5;skeletal muscle: 268.3;tongue: 158.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	9.5	15.3	19.9	8.0	20.4	9.1	11.0	22.4	28.6	7.4	21.3	18.6	23.8	8.1	14.3	10.5	10.5	5.4	83.5	19.6	20.8	26.7	24.1	8.8	10.1	20.3	21.0	10.0	14.8	22.9	15.8	5.9	21.6	9.7	19.0	23.5	18.9	14.4	268.3	13.2	18.6	7.4	19.5	10.4	17.0	12.7	20.5	8.6	14.8	158.5	11.0	8.6	7.9	22.4	21.4	5.9	19.2	30.8	17.7	22.7	20.5	20.1	13.1	11.1	10.4	13.1	23.7	7.7	7.7	15.5	14.9	10.5	38.6	18.2	15.0	13.0	13.5	11.9	13.5	23.0	18.1	11.2	10.1	24.5	18.2	14.4	21.6	16.8	17.5	17.8	25.3	33.8	11.0	17.8	17.8	32.1	16.3	44.1	11.7	14.9	10.6	52.6	24.6	14.2	14.6	14.7	13.8	23.2	10.5	15.6	23.7	23.2	8.1	24.2	6.4	13.0	13.5	23.2	49.5	18.5	18.9	26.7	13.8	26.2	10.1	13.1	8.5	10.3	11.6	7.1	11.7	11.5	8.9	15.9	10.5	11.4	3.0	10.1	14.2	16.2	18.2	10.8	19.9	20.4	22.4	28.6	19.6	20.8	20.3	21.0	21.6	19.5	20.5	22.4	201.8	89.8	145.7	15.7	95.8	140.2	173.3	402.7	185.0	120.4	240.3	349.6	1840.3	221.6	240.1	439.6	33.3	147.4	71.7	343.0	1136.7	270.3	409.9	333.5	115.5	162.7	221.4	175.2	10.9	336.9	166.2	176.9	158.0	196.8	73.3	151.2	133.5	432.9	225.1	119.5	14.3	340.5	276.7	102.0	65.7	70.9	169.3	115.6	266.8	6.5	185.5	446.6	79.3	8.0	13.3	265.3	355.8	206.5	155.6	173.7	471.7	1449.6	297.1	139.1	98.6	159.3	184.4	439.0	197.4	290.1	179.3	118.1	83.5	224.7	343.7	176.0
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068297-78079862	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	202.3	278.0	118.8	84.5	126.1	126.1	143.0	128.7	150.7	103.0	125.6	143.6	218.4	125.3	68.4	142.6	120.2	108.6	240.7	129.0	145.8	151.1	286.8	100.0	109.1	121.6	117.1	96.2	168.8	186.1	133.5	74.8	124.2	88.7	66.1	59.8	275.1	83.2	487.6	121.9	194.3	63.6	136.8	96.2	130.0	103.0	126.1	73.5	207.0	254.0	62.8	97.1	100.1	136.3	287.6	342.2	183.3	118.8	168.3	105.6	227.2	335.7	190.9	252.4	179.9	910.4	311.8	166.3	583.3	155.8	210.2	293.1	136.1	190.9	99.5	318.8	386.7	183.8	337.4	727.9	270.9	409.7	164.2	147.9	177.8	195.6	75.2	156.0	172.9	158.8	365.3	278.4	137.9	478.7	254.5	722.4	212.4	670.4	415.6	224.5	352.5	570.5	196.4	420.7	261.2	229.0	235.0	499.5	182.3	158.8	391.4	328.2	241.0	256.4	314.9	611.8	297.9	251.5	541.9	400.4	146.4	236.6	251.0	374.5	337.6	354.0	150.1	293.0	138.3	230.8	172.4	163.4	363.5	212.1	144.5	159.8	102.2	225.4	243.0	290.4	202.7	410.9	118.8	126.1	128.7	150.7	129.0	145.8	121.6	117.1	124.2	136.8	126.1	136.3	256.6	166.7	194.7	0.0	106.4	95.5	166.1	443.7	40.5	145.8	346.2	414.0	240.9	243.1	288.2	391.8	66.7	408.8	166.4	206.3	305.2	395.6	311.8	413.8	129.3	183.7	167.9	106.5	0.0	431.5	392.8	165.7	43.3	241.7	153.2	158.1	184.9	856.9	346.2	90.9	0.0	317.9	429.3	174.5	110.7	84.7	215.6	129.4	245.5	0.0	246.7	310.0	175.1	0.0	0.0	456.5	329.1	201.6	102.5	239.0	461.8	454.6	300.0	131.6	236.7	154.5	222.7	384.4	162.1	67.5	114.4	387.1	109.9	226.3	373.2	215.6
NDUFC2-KCTD14		ENSG00000259112	"NDUFC2-KCTD14 readthrough"	E9PQ53	11	78016971-78079865	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Club cells: 1.3;Excitatory neurons: 4.0;Inhibitory neurons: 3.2;Melanocytes: 1.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.4;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 58.3;EFO-21: 47.1"									"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"																		6.8	6.4	5.3	3.3	5.9	10.6	6.1	6.3	9.4	3.5	3.6	5.1	12.3	1.9	0.9	4.0	7.1	3.6	10.5	6.0	5.9	2.8	5.6	3.6	7.8	5.4	4.8	1.7	2.7	4.8	0.3	2.9	4.9	5.2	2.7	1.3	11.6	11.8	10.9	4.9	8.1	3.6	5.1	2.5	7.2	2.3	4.7	10.4	10.1	17.0	3.8	3.6	0.4	5.8	4.6	12.6	4.2	1.2	4.2	2.7	6.4	12.8	13.1	14.8	10.8	58.3	6.1	6.6	47.1	6.8	11.1	5.8	4.5	11.5	1.9	17.2	18.1	3.5	3.9	42.1	26.7	3.0	15.7	3.4	4.8	11.3	3.0	8.6	11.0	28.9	9.0	3.8	10.7	19.9	18.8	13.3	5.9	36.1	27.0	9.8	5.6	23.9	7.1	8.3	4.9	8.0	12.0	2.6	6.3	1.8	7.0	8.5	5.1	3.7	19.4	17.4	5.0	7.5	16.7	14.4	2.5	7.9	5.8	113.1	104.9	108.0	98.8	82.2	84.2	119.8	98.4	93.8	131.3	103.5	89.8	84.1	31.4	69.4	93.3	213.4	135.7	194.6	5.3	5.9	6.3	9.4	6.0	5.9	5.4	4.8	4.9	5.1	4.7	5.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.0	0.0	2.5	2.4	0.0	0.2	0.0	0.0	0.1	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159509	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 181.7;skeletal muscle: 221.6;tongue: 225.2"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA		48000	"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	27.1	61.6	8.3	13.3	10.8	13.2	23.8	14.9	16.1	19.5	39.7	35.3	29.9	19.3	10.8	36.2	16.3	10.5	181.7	10.7	13.7	48.0	51.8	18.3	12.6	10.1	10.1	14.6	19.2	47.2	20.2	14.4	11.7	15.8	30.0	24.4	27.7	15.6	221.6	26.6	26.1	16.4	9.2	16.8	37.1	20.8	14.2	15.6	17.9	225.2	16.9	22.4	22.4	12.5	28.3	27.6	39.2	28.6	35.8	28.9	45.4	40.4	43.4	66.0	47.6	72.0	32.1	31.7	34.8	50.8	65.5	38.5	52.9	39.2	58.2	14.6	24.9	63.5	65.1	64.9	37.0	46.2	27.5	35.3	22.5	51.9	40.4	29.6	52.3	39.3	69.8	31.1	43.6	35.2	38.5	30.7	36.5	47.2	48.6	38.3	54.7	55.1	54.7	50.7	38.1	29.8	46.7	45.1	67.1	53.3	39.8	44.2	40.1	36.2	32.0	35.8	39.1	29.8	38.4	46.9	36.3	37.5	37.8	14.1	12.9	15.7	12.4	15.2	9.6	9.6	10.8	11.8	14.7	9.0	9.6	11.1	9.2	12.5	22.5	7.8	15.9	9.5	8.3	10.8	14.9	16.1	10.7	13.7	10.1	10.1	11.7	9.2	14.2	12.5	32.4	60.9	33.0	45.1	23.8	16.2	21.7	40.8	30.1	97.1	19.3	14.0	582.5	48.6	42.8	38.6	120.9	48.4	18.8	74.5	93.9	44.2	14.5	49.8	49.8	36.6	51.0	42.0	67.8	28.2	33.7	42.3	48.4	54.5	37.3	42.3	29.3	94.5	34.0	117.8	72.8	47.9	54.9	31.2	10.7	7.0	33.5	27.7	30.2	28.1	37.2	62.7	27.8	45.2	41.6	32.1	46.4	44.8	31.0	19.9	77.8	102.3	53.5	81.5	32.9	55.2	60.8	58.2	49.5	40.8	16.6	52.5	23.7	71.5	69.9	26.6
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214723	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 464.8;tongue: 633.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	60.2	98.2	38.7	37.4	41.6	39.5	49.6	46.4	48.8	40.2	76.6	96.5	102.4	41.4	33.4	62.0	52.5	36.8	273.7	40.5	47.5	137.0	177.4	48.5	42.4	49.5	40.7	51.6	47.7	156.5	35.8	41.6	53.1	45.7	101.8	36.2	53.5	49.0	464.8	51.4	81.5	58.6	41.6	43.6	73.3	29.5	47.9	48.3	45.0	633.7	60.1	57.5	40.0	49.2	101.8	129.4	95.2	104.0	115.1	102.8	77.0	85.7	105.8	139.6	107.5	143.9	98.5	108.4	168.1	113.0	81.3	135.9	129.1	131.8	122.1	84.2	108.0	105.9	109.5	136.5	117.7	116.0	105.3	147.2	112.3	121.1	137.2	96.8	160.5	115.4	139.9	72.7	132.5	93.5	81.7	58.4	175.3	288.5	116.5	72.0	83.3	172.0	157.8	109.4	97.2	152.0	93.0	237.0	151.5	116.4	221.7	342.2	108.6	84.5	66.3	65.5	123.7	125.2	172.0	95.1	123.6	109.3	105.4	150.0	159.3	85.7	82.0	193.2	82.6	81.4	86.6	86.3	217.8	68.4	86.6	88.1	86.7	93.5	190.7	128.7	130.8	167.5	38.7	41.6	46.4	48.8	40.5	47.5	49.5	40.7	53.1	41.6	47.9	49.2	70.5	35.3	45.7	30.7	47.1	38.9	52.4	277.8	52.9	74.6	58.9	50.7	232.6	74.4	148.4	77.3	31.3	146.8	47.6	187.5	332.6	184.3	11.3	43.5	57.0	67.5	72.0	78.9	28.0	143.2	111.3	69.7	80.5	41.3	69.7	99.7	65.7	206.5	150.5	92.5	30.1	122.6	242.1	87.8	42.0	7.8	43.5	66.5	83.6	14.0	97.9	57.0	35.0	18.1	48.3	147.7	105.1	33.4	49.5	25.6	221.9	345.5	103.0	57.3	46.0	41.9	176.6	42.0	27.5	68.8	43.3	158.4	50.0	192.0	172.5	57.5
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 292.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 405.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	52.4	91.3	47.4	16.5	52.6	44.1	50.7	55.6	50.2	43.5	59.4	97.5	53.8	49.7	26.2	78.7	42.6	18.1	210.3	49.3	51.9	94.2	96.2	40.5	25.5	48.8	49.3	37.3	56.7	53.6	67.5	17.6	49.4	44.0	52.7	23.5	60.9	27.5	292.3	66.2	69.4	26.6	50.3	55.5	81.4	48.2	54.7	33.8	49.7	194.2	33.3	51.4	52.0	47.7	37.7	68.7	59.8	62.9	48.8	52.3	48.2	35.0	60.3	84.6	80.4	103.6	65.1	81.8	34.8	49.7	63.0	64.9	81.7	61.8	69.4	44.2	137.2	49.5	90.6	106.5	49.7	121.5	62.1	50.1	46.6	32.0	52.2	37.5	55.3	69.2	73.7	57.1	57.7	118.6	87.0	164.9	83.6	109.6	97.7	100.7	81.8	68.7	76.4	60.2	63.9	47.1	43.4	76.9	83.5	35.2	84.4	118.2	37.0	49.3	56.4	57.0	80.4	61.2	93.5	91.8	50.1	94.9	51.3	38.3	69.3	48.9	43.2	79.8	46.4	60.6	45.2	47.5	83.3	59.2	42.4	46.0	18.4	45.6	66.7	89.3	61.3	90.3	47.4	52.6	55.6	50.2	49.3	51.9	48.8	49.3	49.4	50.3	54.7	47.7	54.7	54.5	42.6	23.5	54.6	65.6	67.4	217.5	62.6	45.6	60.2	72.5	176.9	81.5	108.5	69.9	41.7	122.0	70.8	183.1	405.0	113.0	132.3	56.8	58.6	60.0	84.7	73.8	12.7	111.3	116.5	60.8	81.1	40.5	57.7	67.1	58.5	126.3	195.9	60.6	14.5	162.8	173.0	66.9	59.3	63.2	67.4	62.8	119.2	7.5	83.9	117.9	58.7	12.5	13.1	91.7	109.3	69.2	69.8	53.0	257.8	297.0	109.7	59.5	105.2	55.5	154.8	85.5	74.7	115.3	75.9	89.1	55.5	128.3	210.7	85.3
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683338	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 397.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 553.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favorable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	94.2	80.6	71.3	37.0	71.8	50.9	99.9	75.1	101.8	82.0	70.6	93.2	83.6	65.0	68.6	80.6	69.5	50.2	190.5	70.3	78.3	137.2	147.9	55.7	45.7	72.3	70.4	101.7	45.4	125.8	58.2	63.0	73.8	65.9	89.6	59.1	63.6	73.6	346.2	76.7	71.9	72.2	75.3	42.9	80.7	37.9	75.1	59.8	74.0	397.4	60.7	71.3	73.0	77.7	118.8	102.9	200.5	119.1	133.9	192.7	167.9	140.7	136.6	153.0	185.8	126.7	151.4	83.9	180.2	121.1	146.3	85.3	72.0	167.9	175.4	77.4	137.2	57.8	97.1	115.6	142.4	141.0	95.8	161.2	190.2	105.8	184.8	167.7	135.1	93.4	50.2	88.5	141.9	110.5	106.7	116.9	60.9	45.3	115.1	126.4	113.1	166.2	165.1	113.0	92.7	99.5	96.4	92.5	175.2	106.8	148.2	145.2	104.4	93.6	98.9	68.7	186.9	67.6	91.5	102.1	99.7	202.7	137.3	19.4	83.9	7.9	49.1	101.8	55.3	72.7	61.9	58.0	121.6	50.3	68.2	70.0	6.8	79.4	108.3	93.8	72.4	68.2	71.3	71.8	75.1	101.8	70.3	78.3	72.3	70.4	73.8	75.3	75.1	77.7	62.1	38.5	56.6	49.0	52.6	125.8	150.4	382.0	56.3	44.8	100.0	119.1	328.4	82.9	170.6	84.6	41.7	168.4	43.2	124.5	553.7	174.1	61.5	65.5	87.7	84.6	90.4	47.1	55.9	167.3	163.3	113.1	47.9	68.7	76.0	146.9	99.2	137.8	144.3	30.3	73.2	135.3	215.7	76.4	127.3	61.5	157.5	70.4	117.4	38.4	161.4	113.6	63.8	52.8	68.4	179.4	153.4	152.7	38.4	95.3	188.7	425.9	112.2	76.0	124.9	145.1	173.4	76.8	75.0	79.3	101.4	179.9	50.0	96.4	171.2	158.2
NDUFS5	CI-15k	ENSG00000168653	"NADH:ubiquinone oxidoreductase subunit S5"	O43920	1	39026318-39034636	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2057.9;Proximal tubular cells: 1739.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042582	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA042582: AB_2678062"	"unprognostic (1.49e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.97e-3)"	"unprognostic (8.96e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.08e-2)"	343.8	373.0	538.9	184.4	542.6	266.0	296.9	532.6	830.4	253.2	515.0	461.2	220.1	315.4	565.3	363.3	265.7	167.1	1277.8	542.3	540.7	399.5	379.3	236.9	176.8	552.2	538.3	304.8	234.1	354.2	333.3	170.2	541.7	292.4	342.3	206.7	274.1	299.5	954.0	284.9	240.5	259.4	524.1	185.2	339.9	121.3	543.4	240.1	250.6	1115.6	245.5	322.3	273.9	568.5	447.7	781.3	548.2	698.8	593.9	622.8	749.7	501.6	406.3	488.6	490.3	868.9	596.3	469.0	700.2	541.6	248.9	308.9	732.5	688.3	543.1	546.2	856.8	491.8	1291.1	1622.7	407.4	1015.6	366.8	650.5	816.8	537.4	476.0	497.3	858.3	500.8	817.0	430.9	250.4	1030.4	468.4	1291.3	1000.5	654.5	785.8	648.7	815.5	806.7	1027.9	1482.9	741.7	710.6	583.9	773.6	712.8	1174.2	520.2	753.1	545.7	390.9	463.1	409.8	874.3	353.5	770.5	732.6	449.7	1110.5	567.4	186.2	264.6	159.6	227.6	293.9	262.8	196.4	353.2	268.4	275.3	158.3	359.9	316.3	51.7	205.9	282.5	340.5	361.7	341.2	538.9	542.6	532.6	830.4	542.3	540.7	552.2	538.3	541.7	524.1	543.4	568.5	260.1	166.7	196.0	16.6	197.1	460.9	390.6	958.6	187.2	128.6	337.9	400.8	2057.9	391.7	407.6	551.8	37.5	638.9	248.2	570.5	1367.6	581.1	134.7	487.4	454.0	288.4	407.8	230.8	17.0	543.4	647.0	377.8	246.2	508.5	209.8	544.6	271.6	638.8	545.9	99.3	18.7	652.0	539.1	298.1	385.5	121.4	351.9	297.5	457.2	10.3	361.8	307.3	207.0	13.6	24.0	609.1	517.7	422.8	247.6	484.1	576.2	1739.7	343.3	180.6	282.7	417.4	450.5	121.8	99.2	418.8	460.3	525.2	292.2	275.9	697.1	454.2
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801407-1816048	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 972.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1796.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA064221: AB_2685217"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	110.8	84.1	111.5	83.9	111.9	116.4	51.0	116.6	146.9	44.8	117.4	123.2	146.4	48.4	51.9	79.8	50.2	38.9	265.4	110.3	123.2	96.0	116.5	51.8	75.2	116.1	114.2	42.4	107.7	122.5	40.9	57.2	115.3	70.8	68.1	49.3	110.9	57.3	615.4	69.8	115.4	51.5	110.4	71.2	106.5	56.5	115.5	70.4	51.1	304.4	61.6	58.1	41.9	115.2	241.2	487.3	206.4	310.5	81.7	74.9	483.3	180.6	108.8	161.7	139.8	556.8	291.0	344.0	531.4	117.6	261.5	247.6	174.3	221.5	91.9	404.3	576.4	250.4	1796.7	476.9	155.0	320.8	230.0	106.8	157.4	136.0	103.7	85.0	158.6	226.8	344.6	314.2	181.6	607.0	433.4	679.5	218.8	355.9	678.9	345.0	211.5	477.9	162.9	388.6	237.1	213.7	638.5	507.5	275.2	110.3	341.1	403.3	206.2	221.6	386.0	201.5	355.1	283.2	512.4	443.0	250.5	511.4	243.6	239.5	283.7	233.5	207.5	342.7	207.9	246.2	213.6	209.2	349.1	197.9	177.9	196.9	124.8	218.9	307.5	347.1	261.1	261.5	111.5	111.9	116.6	146.9	110.3	123.2	116.1	114.2	115.3	110.4	115.5	115.2	166.4	67.3	107.6	12.7	129.7	125.5	153.6	328.8	82.6	95.5	164.5	206.0	698.3	198.8	164.8	207.8	47.9	358.0	142.9	574.7	972.4	270.1	246.9	165.2	132.4	155.6	267.1	162.0	10.6	341.5	246.0	146.8	170.2	133.5	104.7	163.1	153.8	526.3	413.9	65.6	11.3	468.0	236.0	224.6	167.8	308.1	154.7	162.9	218.7	12.2	239.8	208.5	178.2	9.5	20.1	296.2	447.5	157.2	178.7	186.2	615.8	868.5	158.8	166.9	164.3	147.0	188.1	288.0	159.1	227.7	167.5	245.2	124.7	200.4	480.7	219.2
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 833.5;Late spermatids: 797.2;Proximal tubular cells: 927.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	99.2	308.4	141.2	38.8	153.2	56.2	87.7	157.2	180.4	73.2	172.3	142.0	81.4	89.2	27.2	115.3	81.3	29.1	468.2	144.2	152.0	188.6	152.0	73.1	42.2	149.6	144.9	68.2	97.7	74.6	130.6	33.6	145.8	118.2	36.7	49.5	96.2	66.7	406.4	93.0	84.4	39.0	142.2	76.9	137.8	104.7	154.0	40.3	101.8	275.5	30.1	94.4	76.0	150.2	152.9	366.4	94.6	137.0	70.9	63.5	132.4	102.3	88.5	155.6	118.9	338.4	159.6	118.4	186.8	85.9	134.6	181.2	108.8	128.4	53.1	139.4	264.9	107.2	217.1	186.3	171.8	99.1	112.1	80.5	126.5	111.1	124.8	82.0	106.2	159.9	110.3	121.1	99.2	358.6	219.2	216.9	125.2	377.7	308.0	154.4	95.9	384.9	192.8	123.3	125.5	102.2	75.7	171.7	392.3	66.5	245.6	105.9	84.1	155.6	133.9	224.8	148.8	165.2	188.5	99.7	252.3	121.8	111.2	84.7	220.1	124.0	182.4	232.0	170.1	183.3	154.6	165.5	309.4	156.3	146.2	164.2	20.7	309.6	131.7	324.3	202.2	232.4	141.2	153.2	157.2	180.4	144.2	152.0	149.6	144.9	145.8	142.2	154.0	150.2	88.7	89.8	90.1	18.6	92.3	85.4	95.5	284.3	104.7	83.4	147.2	156.7	301.9	143.0	164.9	213.3	54.2	279.6	97.8	301.0	833.5	200.8	225.7	101.1	74.8	85.3	205.0	149.8	13.6	199.3	165.9	109.6	147.3	79.7	95.8	156.5	73.5	231.7	276.6	50.5	19.3	277.2	240.1	124.1	108.0	797.2	100.6	128.7	163.7	13.1	187.4	143.6	128.8	12.1	15.4	173.7	194.9	108.0	157.8	118.6	337.1	927.8	120.8	118.7	59.2	81.2	208.6	105.9	72.7	209.7	116.2	172.4	102.7	278.7	318.2	139.1
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67605653-67612554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 526.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 482.4;Proximal tubular cells: 499.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No		37000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	95.0	126.5	87.6	52.5	93.7	72.5	90.9	105.6	107.1	93.9	104.8	142.3	124.5	85.2	33.8	114.0	84.6	47.1	400.2	91.6	97.0	188.4	187.0	77.1	66.7	103.3	91.5	101.9	117.2	169.8	84.5	46.7	110.4	77.4	73.7	81.6	90.2	73.2	526.2	117.7	96.6	51.1	86.9	98.8	132.0	76.0	104.9	51.6	107.6	440.5	62.8	88.1	88.6	99.9	132.9	133.6	68.8	141.3	85.6	83.4	130.6	84.1	76.4	122.2	82.6	256.8	155.3	241.9	167.3	69.2	99.7	176.8	146.1	126.4	38.4	125.2	114.9	100.0	189.1	127.9	119.0	136.9	106.9	126.7	119.0	100.4	88.0	76.9	109.3	173.9	180.9	192.6	75.8	190.2	163.1	268.0	68.5	295.3	168.8	184.5	135.8	399.1	99.3	95.3	109.9	104.6	104.3	347.4	275.3	46.0	177.4	138.0	90.7	118.9	88.8	172.3	87.5	187.7	116.8	122.6	138.0	144.6	117.7	39.0	72.8	38.1	65.1	83.4	71.6	59.8	55.0	63.2	110.7	60.1	50.2	63.7	13.1	104.0	51.2	73.0	78.1	77.0	87.6	93.7	105.6	107.1	91.6	97.0	103.3	91.5	110.4	86.9	104.9	99.9	54.6	60.9	75.0	33.3	76.2	80.3	95.9	187.6	77.4	68.7	82.1	94.4	482.4	61.5	120.7	86.5	50.1	203.5	72.8	235.7	397.2	114.9	74.0	43.1	47.5	56.7	98.5	85.0	32.9	112.1	158.8	82.4	137.1	55.2	61.4	99.6	56.4	136.2	136.5	63.9	36.5	155.9	152.5	68.8	81.4	222.7	65.6	68.4	113.8	13.1	81.0	89.3	60.8	19.1	34.6	70.1	122.8	59.0	146.6	55.0	199.4	499.2	80.3	78.5	46.0	90.8	136.9	100.7	83.3	127.0	80.6	189.1	79.3	145.9	274.8	111.7
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 606.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003404, HPA077896"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No		7600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	97.4	171.6	94.3	69.2	97.4	149.8	101.7	106.8	139.7	63.9	106.0	124.2	102.3	69.7	91.1	142.6	64.0	68.7	419.3	96.7	106.0	180.7	404.2	88.6	105.0	105.9	104.4	52.4	111.6	136.7	72.1	73.7	105.9	88.5	119.8	129.9	97.4	72.4	606.9	94.7	100.5	80.6	103.7	86.4	133.8	79.6	102.7	90.2	72.7	538.3	105.1	122.1	76.5	104.6	136.5	139.8	159.1	148.4	116.6	164.0	133.4	165.4	266.5	217.7	205.5	265.1	109.4	209.4	149.5	158.6	200.3	66.9	157.5	175.5	208.8	104.6	136.6	133.0	135.3	364.8	133.6	373.8	159.2	139.2	144.3	134.9	146.2	156.8	239.3	184.3	216.5	644.0	204.6	171.6	263.5	328.9	131.4	750.5	172.3	124.5	118.2	794.2	354.3	218.7	167.0	122.3	164.6	188.0	220.3	113.6	174.2	282.8	145.8	273.4	194.3	198.8	223.0	180.4	292.3	237.1	195.4	166.0	181.0	250.8	161.8	194.2	118.1	196.1	148.3	237.6	176.9	140.5	237.9	201.1	153.5	142.7	76.0	124.2	187.9	315.1	231.9	231.8	94.3	97.4	106.8	139.7	96.7	106.0	105.9	104.4	105.9	103.7	102.7	104.6	107.3	80.1	145.8	17.6	143.1	148.0	319.0	629.4	159.4	101.2	165.0	167.3	69.9	178.7	339.5	150.8	87.6	344.1	146.6	211.0	876.5	415.2	271.5	160.3	108.2	117.3	106.5	165.4	32.9	531.4	323.3	122.0	144.3	183.9	120.3	109.7	96.4	351.5	313.5	94.2	37.3	201.7	480.1	115.7	267.1	186.2	122.1	170.2	231.3	17.8	293.2	167.1	96.8	32.2	46.5	530.3	201.2	102.0	244.9	554.3	349.9	810.6	293.4	184.2	105.2	124.0	196.3	217.4	175.0	226.5	147.6	289.4	165.7	266.7	227.3	469.0
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	20.5	18.1	9.2	3.2	9.3	6.8	17.5	9.5	8.9	16.6	7.5	24.2	5.1	19.1	7.9	18.9	17.3	2.4	47.2	7.6	8.0	18.0	26.9	13.7	3.1	9.5	9.7	19.1	24.0	7.5	16.6	3.0	9.2	16.3	4.1	7.7	17.3	4.0	88.0	19.0	16.1	3.6	8.4	17.0	19.7	20.9	9.2	2.5	14.9	21.1	3.2	18.4	15.9	10.1	3.3	4.9	9.1	8.1	7.9	5.0	10.4	6.6	4.2	5.2	3.4	10.6	6.2	4.9	4.2	4.1	11.7	5.4	8.8	8.1	3.5	2.8	7.4	20.1	8.7	9.0	9.4	6.0	7.8	8.0	8.2	6.9	12.0	4.2	6.1	5.6	13.5	7.3	5.6	10.5	3.7	6.2	10.2	15.7	6.9	4.6	5.3	12.3	9.5	7.5	5.8	4.7	9.0	10.3	4.8	4.4	10.2	4.6	8.9	3.2	3.0	4.4	4.8	12.1	7.1	3.5	5.7	7.7	4.6	3.1	5.7	3.8	2.8	7.1	2.4	2.9	2.4	2.2	5.0	3.5	2.9	2.8	3.3	4.4	6.6	4.4	2.7	2.8	9.2	9.3	9.5	8.9	7.6	8.0	9.5	9.7	9.2	8.4	9.2	10.1	42.8	54.5	46.7	14.4	36.5	19.9	53.7	97.7	24.5	81.2	64.9	65.7	770.8	92.9	58.6	90.1	68.8	57.5	32.5	89.3	230.9	86.5	502.9	84.5	64.9	48.1	78.3	112.4	19.4	101.5	59.5	57.2	55.5	56.9	31.6	45.5	68.2	334.5	114.4	57.2	22.1	114.8	87.5	88.3	38.1	1712.0	66.5	62.3	37.4	17.8	86.4	88.7	49.4	15.6	19.5	98.6	80.9	62.4	39.0	109.3	176.4	372.6	85.9	104.7	72.3	54.0	66.1	243.5	77.1	50.0	23.4	89.9	29.9	83.8	95.4	65.3
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	69	"skeletal muscle: 9300.2;tongue: 2495.6"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 662.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8"	"Group enriched"	"Detected in some"	6	"cerebellum: 6.5;olfactory bulb: 4.0"	"Region enriched"	"Detected in some"	6	"cerebellum: 11.8"	HPA016601	Enhanced					NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	2.3	6.4	2.2	0.7	5.0	1.3	2.9	4.0	2.6	0.5	1.4	1.3	1.1	0.6	1.6	16.2	0.5	12.7	40.7	2.2	5.4	3.3	4.9	2.3	1.3	2.9	2.9	0.9	2.0	0.1	2.6	0.8	2.4	22.1	0.1	3.5	85.9	0.2	9300.2	9.3	1.8	0.2	2.0	3.0	1.1	1.7	2.9	1.1	13.0	2495.6	0.8	0.4	1.2	2.9	0.5	0.5	0.8	0.7	0.1	0.1	2.3	0.4	0.0	0.0	0.0	6.1	0.7	1.7	1.2	0.1	0.2	1.2	0.1	0.0	0.0	0.8	0.9	0.6	1.1	2.0	0.0	1.1	1.5	5.0	0.3	0.1	0.0	0.3	0.8	0.5	1.2	8.8	0.5	0.7	0.6	1.1	1.4	3.0	1.0	1.6	34.3	0.2	0.1	1.2	2.0	0.3	0.3	0.4	0.2	1.3	0.9	1.1	0.8	0.9	1.2	0.1	1.2	12.8	2.0	0.4	0.2	0.8	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.2	5.0	4.0	2.6	2.2	5.4	2.9	2.9	2.4	2.0	2.9	2.9	0.3	0.0	1.1	14.0	2.0	0.8	1.2	0.2	2.8	2.4	0.5	0.4	82.6	18.6	0.7	0.0	0.0	0.5	1.2	0.0	0.0	0.5	7.6	1.4	1.5	2.1	1.8	0.0	13.1	0.0	0.4	10.6	2.0	2.5	1.3	2.2	0.7	2.4	0.7	3.3	9.2	0.0	4.1	1.3	0.7	7.6	0.6	2.7	0.0	7.5	0.2	0.4	0.0	6.0	5.2	0.1	0.0	0.0	2.0	1.1	0.3	0.4	0.1	1.7	0.0	662.8	1.9	1.4	1.6	0.2	1.3	0.8	1.1	1.5	0.0	0.2
NEBL	"bA165O3.1, C10orf113, LASP2, LNEBL"	ENSG00000078114	Nebulette	O76041	10	20779973-21293011	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"heart muscle: 312.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 951.0;Cardiomyocytes: 2413.0;Excitatory neurons: 359.0;Inhibitory neurons: 436.6;Oligodendrocyte precursor cells: 352.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;SCLC-21H: 31.0;SH-SY5Y: 7.2;SK-BR-3: 8.0;TIME: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013994, HPA013995"	Approved					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA013994: AB_1854359, HPA013995: AB_1854360"	"unprognostic (3.79e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.20e-3)"	"unprognostic (2.36e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.77e-8)"	"unprognostic (3.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (5.56e-4)"	2.4	2.6	26.3	0.2	25.8	0.0	6.1	29.9	19.1	5.9	0.1	1.3	0.0	0.6	0.1	16.1	0.6	0.4	312.0	26.6	29.6	13.1	1.2	16.2	0.2	31.0	35.2	1.1	7.0	1.2	22.1	3.7	27.5	8.7	1.0	2.6	18.0	2.9	0.6	14.9	1.3	0.4	28.6	0.2	3.2	2.7	35.2	0.6	21.5	0.4	1.2	2.1	12.8	24.9	0.4	3.5	3.8	0.1	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.9	0.5	0.5	5.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	3.5	0.0	1.8	0.0	2.9	0.0	0.0	3.3	3.6	0.0	0.6	0.0	0.0	0.2	0.3	0.5	0.0	3.5	0.1	0.0	1.0	0.7	1.9	0.0	0.0	0.1	0.3	0.6	31.0	7.2	1.5	8.0	0.0	0.2	4.7	0.0	6.6	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	25.8	29.9	19.1	26.6	29.6	31.0	35.2	27.5	28.6	35.2	24.9	17.2	218.0	67.2	951.0	0.0	18.4	12.6	6.1	0.0	91.4	51.6	24.8	2413.0	15.7	19.9	33.1	39.6	15.3	1.0	7.5	29.4	2.9	331.4	17.4	3.9	20.8	18.0	0.0	359.0	7.1	11.1	61.0	8.6	47.3	0.0	1.0	0.7	0.2	2.1	146.4	436.6	19.5	14.2	0.6	2.3	61.7	3.7	1.2	12.4	206.1	5.9	4.0	0.0	352.3	9.0	12.9	25.7	4.9	0.0	17.3	5.5	7.7	39.1	10.3	0.0	0.8	14.8	2.8	1.1	33.8	46.2	36.8	1.8	4.5	13.7	33.9
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791741-90959393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 59.4;choroid plexus: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 374.6;Oligodendrocytes: 307.8"	"Cancer enhanced"	"Detected in many"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 4.0;MOLT-4: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.2	3.5	20.5	0.9	28.2	2.4	1.6	6.7	59.4	3.3	24.3	8.3	0.6	5.5	3.1	2.2	3.4	1.8	9.0	33.2	20.0	2.3	0.2	5.4	0.4	8.4	12.7	3.2	0.3	0.5	3.8	1.7	7.2	3.3	0.1	0.9	1.3	0.8	0.3	1.7	1.6	0.2	12.4	1.4	2.9	4.8	27.1	0.0	2.0	0.1	0.0	4.5	2.4	41.2	0.1	0.1	1.4	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.7	4.0	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	3.9	0.0	1.0	2.8	2.8	0.0	3.7	4.2	2.2	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	2.8	0.1	0.0	1.4	1.7	0.0	0.1	1.0	2.5	2.4	0.0	1.0	3.8	2.4	2.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	20.5	28.2	6.7	59.4	33.2	20.0	8.4	12.7	7.2	12.4	27.1	41.2	0.8	19.2	69.7	20.9	0.0	0.5	0.2	0.1	0.0	4.8	0.2	0.8	64.0	0.0	2.5	12.9	0.0	0.0	0.4	0.1	0.0	0.0	4.4	0.4	2.2	3.4	0.0	12.2	374.6	0.2	0.0	6.4	0.0	0.2	1.3	0.2	0.7	0.0	0.1	0.0	63.5	0.0	0.0	0.0	0.6	1.4	2.5	0.3	3.6	38.4	0.0	0.4	0.0	17.6	307.8	0.1	0.0	2.2	0.1	0.1	0.0	9.0	0.0	0.5	6.6	1.0	6.1	4.6	2.2	0.1	0.9	0.0	0.2	0.5	0.0	0.0
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968244-84002776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	66	"neutrophil: 55.4"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2"	"Low region specificity"	"Detected in all"							"HPA013998, HPA014144, CAB068211"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	0.9	0.5	67.8	0.6	73.0	0.5	0.7	20.3	106.4	2.0	24.9	1.3	1.2	1.2	0.3	0.1	0.4	0.5	1.2	80.5	62.0	11.1	26.0	0.5	0.2	32.1	50.7	0.5	1.9	6.7	16.2	0.3	80.2	0.3	0.2	3.1	0.1	0.1	0.2	0.2	1.2	0.4	24.9	1.6	1.8	10.5	59.4	0.2	0.5	0.2	0.0	0.3	0.2	31.4	0.2	4.4	10.1	0.0	0.0	1.4	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.0	1.6	0.2	0.8	0.0	1.9	0.0	0.0	0.1	2.9	0.0	0.0	0.5	0.1	0.0	1.7	0.5	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.0	6.8	0.0	0.0	5.0	0.4	0.6	0.1	0.0	0.6	0.0	0.0	37.6	1.5	0.0	0.2	3.1	1.4	5.2	1.4	0.3	0.2	2.8	0.4	0.0	0.1	0.0	0.0	12.2	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.1	67.8	73.0	20.3	106.4	80.5	62.0	32.1	50.7	80.2	24.9	59.4	31.4	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	16.6	0.0	0.1	0.1	7.2	0.0	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	10.7	3.4	0.0	22.2	0.0	0.0	0.0	0.0	49.2	0.3	0.3	0.0	3.7	0.2	17.8	0.0	4.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	27.8	0.0	0.3	0.0	0.1	0.0	2.1	3.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	10.2	55.9	20.1	2.2	21.2	1.5	10.4	18.9	33.9	11.8	20.4	14.4	13.6	9.1	6.9	8.9	10.9	4.5	45.7	21.7	21.2	13.3	13.3	11.1	2.3	23.3	19.1	41.2	19.1	17.5	10.3	3.9	24.4	27.2	4.4	6.5	13.6	7.8	60.3	6.9	10.6	3.7	16.6	6.5	30.5	10.6	23.2	1.9	19.2	31.7	1.7	14.6	10.0	22.3	8.2	7.1	5.1	10.5	4.0	7.8	24.6	11.2	4.2	7.1	6.2	33.2	5.3	9.1	26.2	6.6	16.7	9.7	5.3	3.3	2.6	3.2	7.7	8.7	30.7	39.3	10.5	2.1	8.0	9.7	4.8	6.6	2.1	7.6	4.8	4.8	12.6	4.8	9.3	12.5	3.3	8.6	2.2	8.7	17.5	9.7	13.3	15.9	6.6	6.1	32.4	9.0	26.1	28.7	12.0	5.6	36.6	10.4	4.0	8.6	12.4	11.3	12.7	17.7	7.8	17.1	16.9	4.0	3.8	0.0	1.3	1.8	0.3	1.3	0.9	0.2	0.6	0.3	1.2	0.9	0.4	0.1	0.0	1.2	3.5	0.0	1.6	0.6	20.1	21.2	18.9	33.9	21.7	21.2	23.3	19.1	24.4	16.6	23.2	22.3	5.4	16.0	45.5	14.7	4.1	3.1	6.5	2.7	8.6	19.4	20.5	11.6	29.9	10.0	5.9	5.5	8.4	20.6	3.8	22.5	33.2	3.7	93.1	5.7	7.2	2.4	19.9	4.0	13.0	7.5	26.1	12.5	26.5	5.4	3.8	14.0	2.2	9.1	8.9	8.4	14.5	16.2	4.1	6.0	6.2	54.0	26.4	5.5	12.4	1.0	3.6	18.2	2.1	6.0	4.5	4.4	15.1	23.7	11.7	14.2	45.9	12.2	3.8	20.8	6.6	9.2	12.1	20.5	20.6	9.3	3.1	20.7	5.4	23.9	20.0	10.0
NECAP1	DKFZP566B183	ENSG00000089818	"NECAP endocytosis associated 1"	Q8NC96	12	8076939-8097881	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053980, HPA063300"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"HPA053980: AB_2682331, HPA063300: AB_2684981"	"unprognostic (1.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.72e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.94e-2)"	11.7	23.7	25.4	11.8	23.2	8.0	13.6	19.3	39.6	14.9	1.0	17.8	15.6	10.2	8.7	12.1	15.5	9.9	12.7	25.5	44.0	15.8	14.4	11.2	8.0	13.0	11.1	16.1	22.3	27.5	24.7	15.9	17.8	15.7	16.9	42.5	15.9	12.4	7.9	9.4	15.6	11.4	13.8	10.1	16.1	13.6	15.2	14.2	12.6	12.2	10.4	16.9	10.1	15.9	20.4	18.8	12.6	17.6	29.6	22.0	28.2	41.8	26.6	36.1	36.2	40.9	23.1	9.2	7.3	20.9	26.2	14.0	35.2	23.1	31.2	28.2	27.4	11.6	21.2	21.4	26.9	10.7	29.2	28.7	26.3	40.4	48.0	27.7	26.2	15.0	27.3	14.8	38.8	25.8	17.3	2.8	35.1	57.2	15.4	6.8	32.0	9.7	24.6	32.0	20.7	14.3	21.3	29.7	15.9	40.7	10.1	8.9	26.6	16.9	33.3	20.3	30.1	9.4	18.4	19.9	30.6	11.7	26.0	28.8	16.6	36.4	10.9	15.7	12.7	9.8	10.3	11.2	11.9	10.2	12.1	11.0	28.7	10.6	22.7	7.2	16.8	13.0	25.4	23.2	19.3	39.6	25.5	44.0	13.0	11.1	17.8	13.8	15.2	15.9	18.9	38.5	24.0	11.4	36.1	25.5	22.0	16.0	25.6	49.0	17.5	10.5	10.4	7.2	18.7	23.9	27.1	14.6	32.9	19.8	25.4	15.3	25.4	11.3	20.9	18.1	16.2	17.0	29.4	16.7	14.5	17.9	17.3	16.1	29.2	33.5	15.4	15.2	13.8	28.6	28.4	16.1	12.2	19.8	39.0	13.7	23.3	22.4	28.4	11.2	14.8	30.7	20.6	14.6	21.3	19.0	16.0	14.7	33.7	21.8	23.9	17.8	13.1	46.3	6.6	17.7	21.3	17.4	22.3	21.0	21.3	22.4	35.6	25.2	14.1	22.0
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440721-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 314.8;monocytes: 202.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	38.1	37.9	28.4	51.7	31.0	29.0	34.3	30.7	32.8	31.6	29.5	30.9	23.4	22.8	19.2	43.5	32.8	30.5	22.2	27.0	30.4	33.2	31.7	51.7	77.6	34.6	29.5	36.8	22.1	23.7	19.8	59.9	31.5	25.4	29.5	14.2	26.6	21.0	8.6	45.7	32.0	30.2	32.0	73.3	30.5	33.7	32.5	55.9	25.7	12.8	63.3	44.4	31.1	32.7	54.1	29.2	30.5	36.0	60.6	65.0	17.9	59.6	83.3	76.8	67.9	32.1	87.1	47.8	70.4	111.2	35.4	35.8	43.1	60.3	63.9	100.0	44.3	46.7	33.4	44.6	78.9	59.8	41.7	73.0	61.6	54.7	44.9	66.2	129.1	54.4	67.0	153.7	69.1	35.3	55.8	63.3	26.6	41.1	41.9	61.2	27.0	79.6	76.9	30.5	19.1	48.6	46.4	27.1	61.9	45.1	30.9	66.1	148.0	49.2	26.8	57.4	41.1	72.5	74.5	47.9	41.6	85.7	49.0	90.2	173.1	112.3	96.1	241.2	95.6	108.8	165.8	114.5	120.1	98.8	168.2	106.6	68.2	121.6	274.7	71.0	214.7	269.9	28.4	31.0	30.7	32.8	27.0	30.4	34.6	29.5	31.5	32.0	32.5	32.7	53.6	22.4	25.0	10.1	47.6	52.3	34.1	60.4	27.3	25.7	37.9	35.1	7.0	22.8	32.2	20.2	314.8	49.0	42.5	34.6	23.5	71.3	61.1	27.0	29.5	67.8	18.7	40.8	7.0	54.2	62.0	33.3	23.9	27.6	27.8	33.0	96.4	11.0	125.7	15.2	7.7	31.8	36.7	94.5	81.8	34.3	29.8	60.5	24.9	7.5	202.0	23.8	55.6	11.6	11.4	121.9	45.8	33.8	24.3	46.6	30.8	22.8	37.4	54.3	39.5	14.7	27.2	26.8	27.4	33.3	56.0	49.4	59.4	72.7	24.0	58.8
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729200	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 128.8;skin 1: 134.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	NA	NA		180000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	4.4	4.0	14.8	4.7	25.6	24.3	8.2	17.4	32.3	14.0	0.0	12.4	16.6	3.4	2.3	128.8	4.0	3.4	8.1	30.5	15.3	5.1	4.3	3.4	2.1	23.8	26.5	2.3	18.8	2.7	7.8	7.3	18.4	12.8	12.9	18.5	18.0	6.2	1.9	134.4	12.0	4.5	16.3	3.3	4.6	1.3	26.9	6.7	2.2	1.6	27.9	28.9	36.8	38.8	16.6	13.6	12.6	18.2	6.5	2.1	88.2	6.6	6.1	5.4	3.8	28.8	55.2	21.8	26.1	7.6	10.9	229.2	32.5	117.6	2.4	51.8	4.9	3.0	4.4	13.2	2.6	14.9	35.4	2.0	139.2	17.1	62.5	2.1	16.3	6.2	0.6	113.2	7.2	42.7	0.3	9.0	41.6	55.3	18.7	1.2	75.7	26.3	5.1	157.4	30.6	68.6	22.1	57.4	1.8	18.8	52.3	2.2	9.0	4.8	17.6	39.2	5.9	20.6	28.0	0.2	1.7	11.9	11.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	1.6	0.0	0.0	14.8	25.6	17.4	32.3	30.5	15.3	23.8	26.5	18.4	16.3	26.9	38.8	4.2	0.0	3.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	12.1	27.3	0.0	0.0	4.3	1.8	0.0	4.1	4.1	0.0	0.0	8.7	0.0	4.6	3.2	1.3	0.0	0.0	0.0	12.3	1.3	2.1	0.0	10.9	0.0	68.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.5	0.0	0.0	1.9	0.0	0.0	3.3	1.5	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	8.9	1.3	1.7	0.0	0.0
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889223	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 136.6;Ductal cells: 215.6;Exocrine glandular cells: 154.2;Glandular and luminal cells: 126.1;Pancreatic endocrine cells: 241.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 10.4"	"Lineage enhanced"	"Detected in many"		"granulocytes: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"		NA	Yes		5900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	71.4	79.1	30.8	32.1	28.4	15.8	66.0	29.8	34.3	41.7	44.3	42.3	55.3	45.0	58.2	76.3	43.9	52.5	71.3	29.2	33.1	79.6	118.5	72.9	15.8	35.8	33.0	41.7	55.0	61.5	39.1	77.2	32.9	69.2	32.8	16.7	62.6	30.4	20.1	52.5	47.5	31.3	31.8	58.1	75.4	65.8	34.7	6.9	57.4	17.7	25.3	55.8	49.3	28.9	73.8	89.3	118.3	140.6	59.3	35.8	123.7	62.6	83.9	120.4	136.6	194.8	171.0	0.6	79.2	79.0	61.1	98.5	106.6	55.6	91.7	3.2	53.2	43.0	30.8	128.6	145.0	0.7	117.9	64.9	22.5	56.2	44.8	123.2	149.3	3.0	71.1	0.7	59.2	146.4	0.6	5.6	92.8	249.8	27.7	4.3	37.7	3.2	139.5	100.1	5.4	15.2	74.9	127.0	28.7	210.4	97.2	47.1	140.1	31.3	105.5	23.7	48.6	9.0	25.8	0.6	57.3	10.0	83.0	1.8	2.0	10.4	0.0	0.7	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	0.0	0.4	0.3	0.0	0.7	30.8	28.4	29.8	34.3	29.2	33.1	35.8	33.0	32.9	31.8	34.7	28.9	136.6	35.3	31.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	108.4	54.9	0.0	0.0	6.8	58.8	0.0	109.3	2.6	0.0	3.9	215.6	0.0	73.8	66.3	58.8	0.0	0.0	0.0	154.2	97.8	30.4	0.0	126.1	3.8	75.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	80.1	0.0	0.0	0.0	0.0	241.8	0.0	0.0	0.1	0.0	0.0	27.1	3.6	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	101.8	2.2	58.3	0.0	0.0
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Syncytiotrophoblasts: 117.3;Theca cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 117.4;TIME: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		41000000		"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cell Junctions"	"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favorable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	8.9	4.8	3.9	4.7	6.0	0.2	4.3	6.2	7.5	7.3	0.0	23.0	32.9	7.6	1.5	4.6	9.7	8.2	5.3	6.6	5.0	12.0	29.4	10.4	3.0	10.8	5.6	16.1	7.1	4.6	1.1	22.7	6.7	11.7	23.1	7.3	5.6	8.4	1.7	1.4	21.2	13.6	7.3	3.9	24.6	54.7	12.4	1.5	42.5	7.1	3.1	6.0	3.0	8.8	0.2	36.2	117.4	7.7	45.7	85.3	7.2	78.6	82.7	47.8	39.7	33.4	16.7	0.0	25.4	112.4	26.6	0.6	33.2	11.4	87.4	0.9	8.8	0.1	12.1	2.4	77.2	5.9	1.1	43.6	4.6	31.7	30.3	42.5	40.8	1.5	0.0	30.2	104.2	0.2	7.8	0.0	33.0	11.0	12.9	0.0	58.2	0.2	26.9	19.2	2.9	20.8	1.6	0.0	15.7	38.9	1.3	0.5	170.4	58.8	24.9	11.1	47.2	17.2	0.0	0.2	37.9	0.1	56.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	6.0	6.2	7.5	6.6	5.0	10.8	5.6	6.7	7.3	12.4	8.8	8.3	25.6	11.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	3.1	12.9	0.0	3.9	4.5	0.0	0.0	6.5	0.0	9.0	11.4	4.4	0.0	0.0	0.0	18.9	9.4	9.5	0.0	13.7	1.3	6.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	2.8	0.0	0.0	7.1	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	117.3	5.3	31.5	0.0	0.0
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.9;skin 1: 113.6;vagina: 57.3"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.4	0.1	0.1	0.5	0.1	0.7	13.7	0.3	0.2	26.5	0.0	1.5	0.7	1.2	6.9	98.9	2.9	3.8	0.1	0.1	0.0	3.1	0.1	3.5	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.2	0.1	9.4	1.7	0.1	33.6	4.3	0.6	113.6	0.6	0.1	0.0	0.0	8.8	0.6	0.3	0.8	0.2	0.0	14.5	16.8	57.3	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"NEDD1 gamma-tubulin ring complex targeting factor"	Q8NHV4	12	96907224-96953780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.8;Late spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 133.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Centrosome"		"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.94e-4)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	9.1	5.8	3.4	9.7	4.3	15.2	12.8	4.0	3.9	9.9	7.7	8.3	7.1	12.7	6.4	10.0	9.1	7.5	9.2	3.1	4.7	8.9	6.3	8.8	15.4	5.0	4.5	9.8	7.1	14.9	3.8	11.0	4.7	10.6	9.7	7.2	6.8	8.2	38.0	8.2	6.9	13.1	4.8	13.4	7.2	23.6	3.7	22.5	10.5	25.6	15.2	9.6	6.1	6.3	39.4	25.8	43.3	26.8	21.1	19.0	30.7	133.1	47.0	60.5	51.7	17.0	14.2	24.1	12.6	107.7	28.8	34.5	29.5	31.0	80.7	46.7	26.2	30.2	16.1	15.1	17.5	41.8	26.2	14.1	24.9	37.2	28.3	39.8	30.0	41.0	17.8	17.3	43.9	16.3	76.1	19.0	23.8	20.6	80.8	40.0	43.7	24.0	25.0	25.7	13.4	23.6	37.4	20.9	23.7	33.5	28.2	14.6	21.5	38.0	28.8	27.2	31.9	17.0	22.0	32.3	11.7	20.9	46.7	14.1	8.5	25.6	13.8	13.8	15.8	11.1	15.4	15.0	7.4	10.4	15.7	12.5	6.3	19.9	10.2	5.7	17.8	9.4	3.4	4.3	4.0	3.9	3.1	4.7	5.0	4.5	4.7	4.8	3.7	6.3	18.8	9.6	11.5	11.4	19.1	19.4	28.1	7.3	13.1	8.0	10.4	6.9	10.5	21.5	11.9	16.5	0.0	8.2	20.5	6.3	9.8	9.8	255.8	15.3	10.0	14.6	6.1	34.1	3.7	8.2	13.9	13.3	8.6	9.7	16.5	9.3	15.0	4.8	8.6	18.5	3.0	7.5	4.1	8.1	9.2	92.0	12.5	9.4	7.2	15.9	7.5	11.5	17.5	9.0	15.1	8.3	8.3	10.1	13.3	49.6	4.7	11.2	21.8	8.4	19.7	13.9	13.6	34.3	26.0	12.0	14.1	4.0	24.6	9.8	8.0	18.3
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"NEDD4 like E3 ubiquitin protein ligase"	Q96PU5	18	58044226-58401540	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Excitatory neurons: 280.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 5.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	11.2	16.8	20.9	6.7	34.4	27.0	25.8	25.1	31.3	7.6	0.7	38.8	18.7	5.3	10.0	12.0	9.1	9.5	26.9	32.3	16.2	53.4	36.5	47.9	4.1	10.9	18.4	6.4	60.5	13.6	28.4	12.0	10.4	64.2	42.8	20.5	27.5	20.4	34.0	11.2	33.8	6.2	8.6	7.9	51.5	7.8	16.7	4.5	17.4	13.1	7.9	19.4	5.9	16.3	70.7	24.5	14.6	20.9	5.1	2.1	49.8	19.2	88.2	48.6	74.6	28.6	37.1	15.1	57.7	7.4	51.3	50.3	19.5	86.1	100.8	34.9	15.5	10.6	14.3	111.3	2.4	0.5	6.0	13.0	54.6	66.4	78.8	39.1	4.0	13.2	18.7	6.3	20.0	16.2	1.0	1.0	12.2	26.7	33.3	14.3	20.1	17.6	47.0	88.7	17.5	5.0	16.1	5.1	146.1	28.3	29.4	5.6	28.8	131.5	38.5	7.5	83.4	8.3	15.3	9.5	27.6	10.8	10.8	0.7	0.3	1.2	0.2	0.3	0.5	0.8	0.6	0.1	0.1	0.3	0.3	0.2	0.2	0.3	0.1	0.1	5.1	0.3	20.9	34.4	25.1	31.3	32.3	16.2	10.9	18.4	10.4	8.6	16.7	16.3	6.0	253.2	144.8	110.4	5.1	112.8	161.2	34.0	86.6	18.1	99.5	65.9	47.8	64.3	112.8	62.5	173.0	13.0	3.6	144.5	49.0	35.7	22.6	64.0	7.3	14.7	45.2	57.9	280.9	49.2	4.7	9.5	114.7	75.0	3.8	4.7	17.5	41.3	7.3	62.2	173.3	201.5	101.7	8.4	8.2	6.6	3.4	13.3	14.2	88.1	7.3	45.2	2.1	11.1	105.0	49.9	145.3	17.7	12.7	126.9	127.3	91.6	72.7	10.0	0.0	34.3	6.0	1.1	12.5	62.3	53.0	80.0	6.6	8.2	72.9	155.5
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEDD8-MDP1		ENSG00000255526	"NEDD8-MDP1 readthrough"		14	24213955-24232352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.3;testis: 1.3"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 2: 3.1;granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;MCF7: 1.5;MOLT-4: 2.3"									"HPA003064, HPA060254"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA003064: AB_10602350, HPA060254: AB_2732644"	"unprognostic (2.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.83e-2)"	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	1.3	0.3	0.4	0.1	0.0	0.1	0.2	1.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.3	0.5	0.1	0.5	0.3	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.2	0.0	0.6	0.1	0.0	0.1	1.5	2.3	0.2	0.1	0.8	0.0	0.1	0.0	0.8	0.1	0.0	0.3	0.1	0.0	0.3	0.5	0.1	0.2	0.4	0.0	0.0	0.7	0.0	0.4	1.3	0.9	0.9	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
NEFH	"NF-H, NFH"	ENSG00000100285	"Neurofilament heavy"	P12036	22	29480218-29491390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 544.0;prostate: 245.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 20.9;monocytes: 34.6;Prostatic glandular cells: 44.0;Spermatogonia: 29.5;Theca cells: 49.7"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 130.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.7"	"Cell line enriched"	"Detected in many"	5	"SiHa: 182.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 1241.2"	"CAB007786, HPA061615"	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"CAB007786: AB_598179, HPA061615: AB_2684568"	"prognostic favorable (2.33e-6)"	"unprognostic (6.17e-3)"	"unprognostic (9.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.47e-1)"	0.6	21.1	17.7	1.6	18.9	0.6	1.4	143.1	544.0	0.6	0.0	1.4	0.4	0.5	0.7	0.3	0.5	0.4	0.4	7.8	57.3	0.9	0.3	0.4	0.9	494.1	56.2	20.0	0.3	0.9	15.4	0.6	376.1	245.9	0.5	39.6	0.9	0.6	0.3	0.2	0.9	1.0	58.3	1.2	0.6	7.7	172.9	0.7	0.3	0.3	1.0	0.4	1.2	147.3	0.0	0.0	2.4	0.6	0.1	0.3	1.8	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.9	9.5	0.1	0.0	0.0	0.0	9.0	34.2	0.1	24.2	0.0	1.4	0.2	10.5	3.5	0.0	0.5	0.0	0.0	1.3	0.0	28.0	0.0	11.7	0.0	12.0	1.2	17.4	0.0	0.0	0.1	0.1	1.9	0.0	0.0	1.5	19.5	182.2	0.1	0.0	5.9	0.0	9.9	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.0	0.4	2.7	0.8	0.1	0.5	0.4	0.6	0.0	0.1	0.5	0.0	0.2	4.7	0.1	0.2	0.6	17.7	18.9	143.1	544.0	7.8	57.3	494.1	56.2	376.1	58.3	172.9	147.3	0.7	0.0	0.0	3.9	1.0	0.1	1.0	0.1	2.2	3.2	1.4	5.3	0.9	1.5	0.0	1.8	2.1	1.4	1.6	0.5	0.0	0.2	0.4	0.3	7.7	1.0	0.0	5.9	13.6	0.4	1.1	2.4	0.0	0.8	1.3	8.8	0.0	0.0	5.6	8.4	20.9	0.0	0.0	4.2	2.3	1.0	5.9	5.2	1.8	5.6	34.6	3.6	0.0	2.0	2.6	0.3	0.0	3.0	1.7	44.0	0.2	1.0	0.0	9.9	6.6	1.3	2.0	4.4	29.5	3.0	0.1	0.4	1.7	49.7	0.2	0.7
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24956721	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 675.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2"	"Lineage enriched"	"Detected in single"	113	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"HEK 293: 456.2;PC-3: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		Yes	NA		200000	"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.1	18.0	35.4	1.3	36.7	0.0	0.0	103.6	675.9	2.0	0.0	2.5	0.6	0.1	0.3	5.4	1.3	0.1	0.1	50.9	75.6	5.0	0.0	0.0	0.1	425.7	41.1	0.2	0.2	0.1	4.0	0.0	231.3	1.8	1.5	89.5	0.0	15.6	0.0	0.9	1.9	1.1	33.9	0.2	0.8	1.7	216.1	12.7	0.7	0.1	0.3	0.0	1.4	184.0	0.0	0.6	68.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.6	0.0	0.0	456.2	0.0	0.0	0.0	21.6	0.0	1.0	8.3	2.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	18.8	0.0	145.4	0.0	0.0	0.0	31.7	4.2	30.9	31.6	11.2	0.0	1.9	2.2	0.0	0.0	0.0	2.2	31.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.2	1.5	35.4	36.7	103.6	675.9	50.9	75.6	425.7	41.1	231.3	33.9	216.1	184.0	0.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.6	32.7	0.0	0.0	3.2	0.0	0.0	0.0	8.4	0.0	0.1	0.1	103.7	0.1	0.4	0.1	0.3	3.7	33.3	0.0	64.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	30.3	29.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	27.2	0.1	27.8	0.0	14.6	18.4	0.0	0.1	9.4	0.0	0.0	0.0	0.2	0.0	110.0	0.0	0.1	0.2	0.0	13.2	1.5	0.0	0.0	1.6	1.4	0.0	0.0
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913758-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 689.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"HEK 293: 3890.8"									"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA		220000		"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	0.3	19.5	61.1	0.9	27.9	0.0	0.1	150.0	689.9	9.6	0.0	2.8	0.1	4.0	0.0	4.0	5.3	0.2	0.2	57.7	54.0	1.9	0.1	0.2	0.1	610.3	89.1	1.7	2.0	0.0	17.9	0.2	487.1	1.5	0.7	90.8	0.3	27.6	1.7	0.6	1.3	2.5	86.8	0.1	0.9	18.9	430.5	1.7	0.1	0.7	0.5	0.4	6.5	203.6	0.0	0.0	154.3	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3890.8	0.0	0.0	0.0	79.4	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.2	5.9	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.7	32.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	27.9	150.0	689.9	57.7	54.0	610.3	89.1	487.1	86.8	430.5	203.6	3.1	0.0	0.0	12.4	0.0	1.3	0.2	0.1	9.1	30.9	1.1	21.2	2.4	0.0	0.6	0.0	6.2	0.0	3.2	0.1	0.0	0.1	92.6	0.7	19.5	2.9	3.5	0.0	46.6	0.2	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	20.2	17.5	0.0	0.0	0.0	0.7	114.6	0.9	0.7	1.8	13.1	0.0	22.8	0.0	9.5	13.6	0.0	0.0	4.5	0.4	0.3	0.0	0.4	0.0	69.1	0.0	3.3	5.7	43.8	1.0	14.0	0.3	0.0	4.1	0.0	0.1	0.4
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357115	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8"	"Group enriched"	"Detected in many"	11	"B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;HeLa: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	8.0	14.6	2.0	3.1	3.1	4.3	11.6	6.2	5.0	14.7	2.0	9.3	5.8	10.0	1.7	7.3	12.9	3.9	5.8	2.2	1.7	8.8	12.8	8.3	6.1	1.4	0.4	13.3	10.9	3.3	11.0	2.5	0.7	12.4	1.1	2.6	16.6	4.1	9.0	8.9	8.3	1.9	0.0	8.8	10.5	3.7	1.1	2.7	10.7	0.6	3.0	8.2	10.9	2.2	2.2	3.6	2.3	1.4	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.5	2.1	0.2	1.1	6.1	1.4	0.4	0.0	5.7	9.1	2.0	11.8	1.7	0.9	2.1	2.6	0.3	1.7	0.6	0.0	5.6	1.4	1.1	1.4	3.3	0.3	2.9	0.4	6.3	2.1	0.4	0.8	2.1	1.5	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.2	1.2	4.2	3.5	6.3	1.3	2.3	1.8	1.2	5.2	5.5	9.7	1.1	9.4	1.2	0.0	0.6	0.0	5.2	0.3	1.3	4.8	0.9	1.2	0.2	6.4	1.4	1.4	0.8	15.8	0.2	0.3	0.3	1.4	2.0	3.1	6.2	5.0	2.2	1.7	1.4	0.4	0.7	0.0	1.1	2.2	15.9	22.4	19.2	19.9	33.7	6.4	15.4	10.1	23.3	20.0	22.1	15.9	2.9	10.0	21.9	14.7	10.4	10.8	19.1	13.6	1.9	9.0	20.4	31.8	7.3	16.9	21.6	8.0	33.5	8.3	3.6	7.7	22.4	15.4	11.4	105.6	24.3	11.5	3.4	10.1	29.9	20.0	10.2	5.7	7.0	2.6	19.0	3.3	8.8	8.4	1.7	14.6	55.6	5.5	4.5	7.3	16.0	13.5	9.1	9.2	21.4	8.9	41.9	6.5	6.6	6.6	6.4	1.6	1.5	11.0	5.8	4.8	10.0	2.0	14.5	8.7
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392809-169612627	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	6.0	6.1	5.1	4.9	6.8	4.2	5.2	7.1	5.3	7.6	2.7	4.0	3.2	7.3	2.8	4.6	9.3	6.1	6.9	3.5	8.8	5.9	4.2	4.6	5.3	7.5	7.7	9.4	4.0	6.5	2.9	4.3	7.6	6.7	4.4	8.7	4.2	6.0	3.3	2.3	3.5	6.6	7.6	5.1	4.9	11.8	5.3	6.8	7.9	4.6	4.6	5.6	2.8	7.7	5.8	2.5	10.0	11.0	15.5	17.1	3.3	11.9	10.6	9.3	8.8	3.3	6.7	15.4	2.2	10.4	9.0	1.9	9.7	10.1	10.5	16.9	6.5	10.3	10.4	3.9	9.0	10.6	7.9	13.7	5.9	9.5	16.7	19.1	9.3	14.5	18.6	28.2	12.1	3.7	13.6	4.6	3.3	3.6	6.0	8.4	6.5	4.9	9.7	6.8	11.0	12.5	8.6	4.2	8.1	7.7	5.3	4.6	11.2	6.0	5.4	6.2	8.1	11.3	18.6	11.6	9.7	5.1	10.7	5.1	0.9	0.9	1.9	1.5	2.2	2.0	1.5	1.2	0.7	2.0	2.2	2.3	0.6	1.1	0.7	1.6	1.6	0.7	5.1	6.8	7.1	5.3	3.5	8.8	7.5	7.7	7.6	7.6	5.3	7.7	12.2	12.8	16.4	162.6	34.2	9.6	15.8	12.1	21.1	21.8	11.3	12.7	37.2	4.3	17.8	18.4	29.2	20.8	17.0	6.4	17.6	10.4	109.7	67.2	21.6	13.2	7.2	26.7	126.3	6.2	8.6	25.0	17.3	23.7	18.3	20.1	9.7	7.8	10.7	18.5	170.5	5.6	20.3	7.0	7.4	48.2	23.6	14.5	5.4	53.4	6.6	26.1	15.5	115.1	196.1	8.9	4.0	31.6	23.2	6.9	5.3	9.6	68.4	24.9	13.1	32.8	25.5	67.9	37.3	21.3	6.3	29.6	22.0	26.0	6.3	9.2
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.6;tongue: 20.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.2	0.3	3.0	0.3	5.3	0.3	14.0	0.0	9.4	1.4	3.3	2.0	2.5	0.8	8.3	1.8	11.0	1.4	3.3	9.6	5.0	1.7	2.5	2.4	0.5	3.3	5.7	0.7	0.7	0.4	3.4	0.1	2.7	1.7	0.5	6.2	0.3	1.2	12.4	0.3	0.8	0.3	2.3	0.4	1.0	36.6	6.1	0.5	0.7	20.0	0.6	1.2	0.2	0.9	0.8	1.6	0.8	0.9	0.6	1.5	0.3	6.0	0.9	1.6	1.4	0.0	0.4	0.5	1.4	2.5	1.1	0.1	0.4	0.4	1.7	1.1	0.6	0.1	3.4	2.9	0.1	0.3	0.8	1.8	0.4	2.5	0.1	2.0	1.1	3.4	0.1	0.6	8.2	0.1	0.6	0.4	0.5	0.2	0.2	0.8	0.3	0.2	3.0	0.5	0.1	0.2	0.9	0.3	0.4	0.5	4.8	0.3	0.7	4.3	6.8	0.2	0.6	0.2	0.2	0.4	3.6	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	5.3	0.0	9.4	9.6	5.0	3.3	5.7	2.7	2.3	6.1	0.9	1.5	6.4	0.0	11.4	0.3	0.3	0.3	3.2	0.0	14.5	25.8	7.4	12.9	4.3	9.3	1.8	87.6	0.0	0.8	0.2	0.0	0.4	123.5	59.3	1.3	2.4	0.0	0.0	131.4	0.0	0.3	3.1	0.0	7.7	0.0	1.1	0.7	1.3	0.2	0.0	130.2	0.4	12.2	1.0	0.8	61.7	1.8	1.1	0.0	32.8	0.1	1.0	1.0	20.6	12.9	0.2	2.7	1.2	0.1	1.9	2.1	0.3	104.2	19.1	0.0	14.9	2.4	32.2	2.2	0.1	0.4	0.0	1.1	3.7	0.6	0.4
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.1	4.3	8.3	0.5	8.3	0.1	6.6	6.9	7.7	5.4	26.2	2.1	1.3	4.9	7.1	2.3	21.4	4.6	2.1	7.3	9.0	6.3	0.6	4.3	1.0	14.2	15.5	6.4	2.2	4.8	5.6	2.2	12.4	2.9	2.4	5.6	2.9	3.7	1.1	2.2	1.8	2.7	12.8	1.2	1.6	15.5	9.3	0.9	9.6	0.8	1.2	2.8	2.5	12.8	5.7	2.2	1.6	4.8	6.2	9.3	0.9	2.7	5.0	4.1	3.1	2.1	7.7	0.2	1.9	4.8	3.9	3.0	0.4	4.6	5.6	0.5	0.6	0.8	0.3	1.0	2.1	0.6	1.3	3.9	7.7	4.2	1.9	4.3	0.8	2.4	0.2	0.8	6.9	3.9	0.1	0.4	0.5	0.9	2.1	0.0	0.1	0.1	9.3	2.2	2.0	2.2	1.3	0.1	1.9	0.7	4.4	0.1	0.9	4.1	2.0	3.3	1.3	1.2	2.2	0.1	2.9	0.2	0.7	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.3	0.0	8.3	8.3	6.9	7.7	7.3	9.0	14.2	15.5	12.4	12.8	9.3	12.8	2.5	16.0	3.2	60.7	1.5	4.2	3.4	4.5	4.6	2.6	7.3	7.5	1.6	4.3	18.8	1.8	6.2	1.0	1.4	3.3	5.9	6.4	156.4	69.2	6.1	3.5	2.4	0.4	91.0	2.5	1.1	7.7	2.6	6.6	0.0	8.1	5.7	0.6	2.0	0.0	42.0	3.5	6.1	0.3	1.7	109.2	6.8	2.0	0.0	21.5	0.8	6.4	1.0	38.7	38.9	3.7	3.9	6.0	0.8	1.6	1.7	10.6	102.7	7.3	6.6	7.2	3.7	33.4	5.2	2.6	2.0	1.6	1.4	11.5	2.4	2.7
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK3	"HSPK36, MGC29949"	ENSG00000136098	"NIMA related kinase 3"	P51956	13	52132639-52159861	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 87.0;Spermatocytes: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA019062: AB_2670037, HPA043230: AB_2678374"	"unprognostic (8.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.34e-2)"	12.4	3.8	13.7	6.2	18.5	8.6	10.6	12.5	21.8	10.8	11.2	16.2	9.3	9.9	6.9	4.2	8.7	7.4	7.8	12.9	14.2	10.1	7.3	9.0	5.0	18.2	17.8	8.2	8.3	3.8	5.2	17.4	17.3	8.2	16.8	4.7	7.0	5.0	6.0	7.2	12.7	8.6	12.9	8.0	6.7	18.1	19.9	3.2	6.3	3.3	5.4	8.3	7.4	26.3	0.3	2.7	20.2	11.4	6.2	10.8	0.3	6.5	6.2	7.6	8.3	8.6	11.1	0.0	0.4	8.4	6.3	1.5	0.4	4.8	4.8	15.1	11.8	1.9	2.7	23.0	7.6	19.4	10.9	7.2	9.5	4.2	17.6	5.6	13.5	1.0	3.1	7.1	9.0	5.1	1.1	23.4	19.7	4.4	0.5	0.5	1.7	7.6	11.4	1.9	2.2	14.0	2.9	6.4	12.8	19.6	2.5	26.3	12.2	1.0	5.9	6.0	6.7	7.5	2.5	13.1	1.8	6.8	10.8	7.1	6.3	5.1	1.6	5.8	1.0	3.6	1.9	1.0	6.7	1.9	1.4	0.4	0.4	1.6	1.2	5.8	2.9	1.4	13.7	18.5	12.5	21.8	12.9	14.2	18.2	17.8	17.3	12.9	19.9	26.3	28.8	6.4	6.5	9.1	5.9	2.8	4.4	2.8	5.7	3.9	5.5	6.7	7.7	5.7	5.8	7.3	0.0	13.0	8.3	20.1	13.7	7.9	11.5	9.8	14.0	22.7	6.0	3.4	0.6	17.3	14.4	8.7	10.2	11.0	10.1	11.6	18.2	7.4	19.1	3.3	3.4	13.7	6.1	12.4	8.1	4.6	7.2	10.4	12.4	18.7	25.4	3.0	7.2	9.0	87.0	15.6	17.9	6.8	6.0	3.3	22.4	6.8	7.1	5.8	0.0	7.1	9.0	49.7	25.5	3.5	3.4	4.8	4.0	3.9	20.1	5.2
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708444-52770946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.0"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	6.3	8.2	6.1	7.4	6.7	7.0	9.4	9.1	7.4	8.5	8.6	7.3	6.5	8.7	8.9	6.7	13.6	6.2	6.1	5.9	7.8	9.7	10.8	6.7	8.3	6.8	8.9	13.3	8.1	11.5	7.3	7.6	6.3	7.7	8.2	16.9	7.3	9.0	8.0	3.5	5.6	8.1	6.9	7.2	9.6	46.0	7.8	9.5	13.5	6.1	9.4	7.9	4.9	5.9	19.9	15.2	20.5	16.2	18.2	13.1	22.1	13.9	18.6	25.3	25.4	13.5	14.4	20.4	6.4	13.6	27.9	9.2	25.2	16.3	33.8	20.4	10.6	16.0	18.4	17.3	11.4	39.4	15.4	8.1	14.8	32.5	21.5	13.5	9.6	17.4	20.2	16.1	16.1	17.1	21.4	14.4	17.7	20.9	14.9	18.5	17.8	15.1	14.3	28.3	15.0	9.0	29.1	17.7	14.1	15.7	16.5	23.4	8.9	16.9	17.1	27.3	26.0	17.8	27.9	19.7	19.3	18.2	18.7	13.6	9.8	5.0	3.5	6.1	3.7	2.8	3.0	3.6	5.2	3.5	3.6	3.1	1.4	4.0	4.2	2.6	2.6	5.2	6.1	6.7	9.1	7.4	5.9	7.8	6.8	8.9	6.3	6.9	7.8	5.9	6.2	12.8	8.2	19.2	11.8	4.1	5.3	3.4	4.6	14.1	10.6	6.2	4.6	2.8	11.6	5.5	12.5	7.0	4.8	6.5	9.8	7.0	20.7	24.0	10.6	7.3	4.8	13.3	30.5	9.6	8.1	7.8	12.8	9.9	7.6	14.0	6.8	14.5	8.2	6.7	29.4	9.3	6.1	16.8	4.6	19.5	14.6	10.4	1.8	7.5	14.0	19.4	10.3	16.6	19.3	8.5	2.9	12.4	10.6	5.3	5.4	17.1	22.4	18.9	6.6	12.6	7.3	75.9	27.9	6.9	4.1	6.7	5.8	11.8	9.1	5.2
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129092	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;choroid plexus: 7.4;fallopian tube: 8.8;testis: 10.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 57.9;Endometrial ciliated cells: 75.8;Late spermatids: 32.0;Respiratory ciliated cells: 98.6;Spermatocytes: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;OE19: 2.4;T-47d: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035565, HPA041399"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035565: AB_10672095, HPA041399: AB_2677453"	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.1	0.1	1.1	0.2	1.5	0.3	0.4	0.7	0.7	0.3	7.4	0.1	0.1	0.5	0.3	0.0	8.8	0.1	0.4	1.5	1.7	0.4	0.0	1.3	0.1	5.1	5.1	0.1	0.1	0.7	0.1	0.4	2.5	0.5	0.2	1.6	0.1	0.1	0.3	0.2	0.1	0.2	3.6	0.2	0.1	10.8	2.6	0.3	0.3	0.1	0.1	0.1	0.0	2.7	0.1	0.1	0.1	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.4	0.6	0.1	0.2	0.0	0.1	0.1	0.0	1.2	0.4	0.2	0.0	0.5	0.1	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.3	0.2	0.0	0.2	0.3	1.1	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.1	1.5	0.7	0.7	1.5	1.7	5.1	5.1	2.5	3.6	2.6	2.7	1.4	0.0	2.0	2.6	1.5	0.0	1.9	0.3	0.0	9.2	3.0	1.8	2.0	2.8	12.1	7.3	14.6	2.6	2.5	0.5	1.9	1.3	57.9	75.8	1.9	3.0	1.8	0.8	3.8	2.9	2.4	1.6	0.0	2.8	2.5	1.2	0.4	1.2	1.2	13.5	3.1	0.4	2.0	0.3	0.4	32.0	2.1	0.6	0.0	4.7	1.4	2.1	3.1	1.0	6.6	0.8	0.7	2.2	0.5	3.7	1.3	1.5	98.6	13.2	6.6	4.6	1.3	32.2	12.9	0.3	0.1	1.9	1.0	1.2	1.1	1.3
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040661, HPA040679"	Approved		Approved	"Nuclear speckles,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Microtubules	"Nuclear speckles, Mitotic spindle"	"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	1.5	3.1	1.7	3.3	1.9	1.7	2.4	1.4	1.9	2.5	3.8	2.4	3.0	1.5	3.2	2.5	3.9	2.0	1.0	1.4	1.6	9.1	5.2	3.3	5.8	2.0	1.7	1.9	4.5	2.9	4.4	2.6	1.7	4.0	2.2	0.6	3.7	2.6	0.5	3.1	4.2	1.2	1.6	5.8	3.4	3.8	1.9	2.7	7.2	0.4	5.0	2.6	2.2	2.3	2.1	3.4	3.5	2.8	1.9	2.1	10.9	0.9	2.1	1.3	1.7	5.4	5.0	13.1	3.5	2.8	2.5	3.8	5.2	4.8	1.3	3.5	6.4	2.9	5.8	10.1	3.3	1.8	3.7	4.8	1.8	2.5	5.8	1.8	0.9	1.9	4.3	1.3	1.5	4.7	1.9	3.4	3.3	3.7	1.0	4.9	2.3	5.9	7.0	5.7	6.4	1.5	3.0	6.3	1.6	4.7	9.3	2.4	0.8	1.3	2.2	1.6	1.0	1.5	1.8	8.9	2.0	1.6	3.1	3.3	0.9	1.2	0.7	0.5	0.8	2.8	0.6	0.7	0.1	4.2	0.7	1.0	0.4	1.3	1.1	14.8	0.5	0.8	1.7	1.9	1.4	1.9	1.4	1.6	2.0	1.7	1.7	1.6	1.9	2.3	2.7	9.6	19.3	3.9	22.9	2.8	9.2	8.3	7.4	2.8	10.1	14.1	1.7	12.8	11.6	25.8	8.4	17.6	19.1	14.9	7.9	5.8	9.5	12.8	6.0	2.9	10.3	7.0	0.7	6.0	9.2	3.9	6.1	15.2	26.6	3.2	3.3	9.4	3.9	1.7	0.5	14.4	10.2	5.0	2.7	2.0	3.4	4.4	3.6	2.8	4.0	2.6	3.1	1.5	1.6	3.9	17.2	2.6	7.2	8.6	13.4	4.3	14.3	1.8	0.0	11.7	3.0	19.9	11.4	8.8	1.6	11.1	4.9	7.8	15.9	4.2
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	24.2	18.5	6.7	18.6	8.4	11.8	17.3	7.5	7.9	24.3	9.0	14.3	15.5	26.0	10.5	17.8	25.2	17.9	37.2	6.1	7.8	18.4	21.0	18.8	21.0	8.2	7.7	35.8	16.0	34.2	3.1	21.2	7.9	23.5	16.3	16.5	12.4	28.1	43.6	8.1	16.9	32.2	7.5	19.7	13.1	20.4	7.7	28.3	19.7	36.9	23.5	16.3	2.9	9.1	21.3	30.8	44.8	45.4	86.3	88.8	37.9	32.4	54.6	29.7	29.4	25.5	24.7	52.7	0.1	54.2	23.1	31.8	45.0	27.0	38.5	38.2	16.8	23.0	27.3	17.3	48.6	10.8	26.8	76.6	32.8	31.8	26.7	71.6	46.1	36.2	23.8	31.4	40.2	4.8	35.5	11.5	21.9	43.3	18.8	53.5	49.4	23.9	21.3	28.2	19.5	41.3	39.5	19.3	30.0	50.4	41.7	37.6	46.3	30.2	12.7	31.5	15.8	34.3	36.5	49.6	24.9	24.8	26.4	3.4	3.5	3.1	2.5	3.4	4.0	1.3	2.4	2.3	5.0	1.9	3.1	2.8	1.2	3.3	2.5	1.1	1.5	2.9	6.7	8.4	7.5	7.9	6.1	7.8	8.2	7.7	7.9	7.5	7.7	9.1	15.3	12.8	30.2	49.3	21.2	8.8	7.7	6.6	21.1	16.8	14.5	12.4	55.7	12.8	14.8	11.0	35.5	17.4	11.1	10.2	7.9	6.9	11.9	13.3	23.1	17.6	5.4	16.2	31.3	4.9	16.2	18.1	10.7	10.4	16.4	36.8	17.9	30.3	13.9	13.5	35.9	10.7	6.1	18.6	11.8	8.3	24.8	17.0	3.6	30.9	16.0	12.0	15.5	41.2	59.5	5.3	11.7	26.4	14.7	7.4	13.1	8.4	17.4	23.1	0.0	18.9	16.7	28.8	13.9	17.4	10.2	14.0	16.5	20.8	10.5	5.6
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"		9	137255327-137273542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	25.7	24.5	40.1	21.8	36.4	23.9	25.1	33.6	52.1	28.8	28.0	29.5	23.9	24.9	6.9	34.6	23.2	15.7	37.1	38.5	35.0	32.8	30.2	25.0	27.4	41.4	40.1	28.2	37.4	18.2	20.6	18.5	36.4	30.5	11.5	7.6	29.6	16.1	36.3	36.2	26.6	13.0	36.4	31.5	30.3	28.4	40.0	21.6	24.0	21.2	16.7	29.0	27.9	35.3	50.4	79.5	41.1	53.1	34.8	24.8	62.1	42.0	28.4	48.0	33.9	84.7	56.9	70.2	60.8	40.0	56.3	96.0	41.0	47.8	14.0	68.2	64.9	45.4	97.9	69.7	35.3	66.5	54.2	29.7	47.2	44.3	25.8	28.9	45.0	46.9	77.8	57.7	28.6	116.8	51.0	106.2	67.2	88.8	92.9	83.6	76.1	114.7	27.1	43.9	60.8	57.2	56.7	59.7	40.6	21.4	79.3	79.7	59.9	71.1	56.1	113.4	65.9	32.1	55.2	59.1	56.9	47.4	64.6	1.1	3.3	5.5	4.3	2.8	2.9	3.5	3.6	3.3	2.9	3.5	3.3	3.5	1.9	4.0	2.7	4.7	4.3	2.2	40.1	36.4	33.6	52.1	38.5	35.0	41.4	40.1	36.4	36.4	40.0	35.3	31.6	6.4	17.9	16.6	11.7	14.9	11.8	12.7	5.7	19.7	21.8	20.6	12.4	17.2	14.1	23.9	18.8	24.3	24.7	40.0	13.7	27.9	3.7	14.7	18.1	19.8	28.2	13.0	8.9	38.5	27.8	17.4	13.3	21.8	18.4	39.1	20.3	19.5	26.5	43.7	8.4	37.2	12.2	14.0	15.6	5.6	23.3	17.6	7.2	11.2	37.7	33.8	22.6	9.5	11.7	33.5	18.7	20.7	13.8	18.9	29.2	13.9	9.9	17.1	39.5	15.5	20.6	10.7	23.6	12.6	13.9	15.6	15.4	35.0	31.5	13.5
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"	Q8IXH7	20	58981208-58995133	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	18.9	29.5	20.5	17.7	22.8	23.8	24.5	21.7	23.4	20.7	21.2	18.2	19.3	18.2	16.3	32.9	24.4	16.2	16.9	19.6	21.0	31.7	31.2	14.7	26.4	21.2	20.9	25.2	21.2	30.7	31.8	25.6	21.8	20.4	17.9	31.9	30.0	17.1	29.4	25.9	19.6	14.1	20.8	20.7	19.3	27.9	21.5	31.5	28.5	20.5	27.9	22.6	22.7	24.3	54.7	57.6	68.5	71.9	22.5	38.9	49.6	42.4	38.8	117.1	66.8	189.6	70.7	68.3	64.0	39.8	60.8	89.1	90.1	98.0	94.8	22.4	64.1	90.5	72.4	150.5	26.7	64.2	60.1	40.9	34.3	44.2	32.8	32.8	68.3	54.0	118.1	51.8	53.3	198.2	135.6	95.4	40.3	151.5	122.9	78.4	56.6	121.1	49.0	76.5	75.9	112.6	126.0	148.3	85.9	38.2	157.5	75.0	30.2	91.6	88.8	36.3	67.7	44.4	80.0	71.1	53.7	57.3	80.6	20.0	44.6	22.9	42.0	51.5	50.0	48.6	39.7	51.2	64.9	44.5	37.7	40.1	5.6	47.1	68.8	33.0	39.7	49.0	20.5	22.8	21.7	23.4	19.6	21.0	21.2	20.9	21.8	20.8	21.5	24.3	23.0	9.6	27.6	18.3	50.5	30.2	62.6	43.8	40.9	67.3	32.7	34.2	10.9	47.1	24.3	22.0	41.7	133.1	35.5	14.5	50.9	57.0	18.8	26.2	33.3	26.7	23.4	60.0	23.0	31.4	69.2	26.2	26.5	27.4	16.5	50.9	23.2	24.1	36.9	55.5	22.8	21.9	26.4	15.3	24.0	32.1	37.0	24.0	26.6	10.3	48.1	52.9	49.4	21.1	23.6	34.9	14.4	26.4	37.4	37.8	27.8	49.9	15.0	61.5	39.5	31.6	34.2	63.1	94.9	40.5	31.4	103.0	48.5	43.9	36.2	52.8
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959038	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 635.4;Late spermatids: 1699.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	51.9	48.5	37.4	15.2	38.2	23.5	49.4	38.6	40.3	47.9	36.6	45.9	12.7	50.1	26.9	51.7	46.9	11.9	57.1	35.8	39.2	50.0	24.5	43.6	16.9	39.1	38.3	47.4	52.4	41.1	42.5	20.5	37.4	35.4	24.2	6.3	40.5	26.7	58.2	51.3	37.2	27.7	38.7	38.7	46.6	166.2	39.2	36.8	39.6	30.8	25.4	44.1	43.5	39.6	51.8	59.9	55.5	48.4	54.7	59.9	50.9	40.3	73.8	90.1	74.6	69.5	35.7	49.0	41.3	79.0	117.1	44.0	47.4	85.7	64.5	39.4	63.2	35.9	41.9	80.5	110.6	43.4	29.0	63.2	119.2	96.2	113.5	75.6	84.2	87.6	51.6	56.6	90.2	89.6	77.1	44.6	22.9	79.6	68.1	63.0	49.1	95.2	61.0	49.8	42.3	52.8	30.4	44.4	80.1	48.4	66.0	89.6	37.1	39.7	63.5	34.5	67.8	65.9	77.8	47.6	26.0	36.4	69.8	44.9	60.4	58.7	49.4	68.8	46.2	50.9	45.4	47.2	56.9	49.9	41.9	41.0	31.4	48.8	67.8	45.4	49.0	55.4	37.4	38.2	38.6	40.3	35.8	39.2	39.1	38.3	37.4	38.7	39.2	39.6	49.0	16.0	27.9	4.6	42.8	47.2	69.0	61.5	40.5	15.5	55.1	62.5	47.2	72.9	43.1	33.1	12.5	98.4	37.7	84.6	133.1	93.3	635.4	68.4	40.8	49.8	34.2	52.2	6.2	136.5	112.1	47.7	31.1	45.6	45.6	46.7	45.3	34.8	82.8	11.8	6.2	71.1	46.8	55.3	42.6	1699.6	71.1	45.0	49.8	3.7	73.2	65.5	51.5	6.6	9.9	113.1	99.1	45.1	68.6	79.6	124.8	107.7	112.5	25.6	32.9	48.7	84.9	224.7	91.0	54.2	41.8	114.4	41.7	41.0	72.4	64.6
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575686	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;kidney: 16.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	NA	NA		160000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.3	0.1	4.5	0.1	5.5	0.0	0.0	0.0	8.2	0.3	0.0	0.2	0.0	0.3	1.6	0.6	0.1	0.4	0.0	10.2	2.0	16.6	0.0	0.4	0.0	2.4	1.9	0.1	0.0	0.0	3.5	0.0	2.5	5.1	0.3	0.8	0.4	2.5	0.0	0.6	0.1	0.1	0.0	0.1	0.6	1.0	1.5	1.2	0.0	0.3	0.7	0.1	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.7	0.0	0.0	0.1	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.5	0.0	8.2	10.2	2.0	2.4	1.9	2.5	0.0	1.5	4.2	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.7	0.0	0.0	1.8	0.0	0.8	0.0	0.0	5.9	0.0	28.8	0.8	0.1	0.0	0.0	0.0	279.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	175.8	0.0	0.0	0.0	0.0	22.3	0.3	0.0	0.0	13.1	0.0	0.0	0.0	323.2	7.6	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.2
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 105.5;choroid plexus: 59.5;fallopian tube: 60.1;retina: 85.2"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Group enriched"	"Detected in many"	15	"amygdala: 48.9;basal ganglia: 60.0;cerebral cortex: 105.5;hippocampal formation: 89.6;white matter: 42.0"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	4.6	16.9	48.9	10.9	60.0	7.3	1.9	1.3	105.5	23.1	59.5	2.0	26.3	2.2	0.4	1.2	60.1	1.9	0.4	89.6	4.5	1.2	1.0	5.0	20.7	0.0	0.0	0.8	0.9	0.2	34.6	0.3	0.0	27.2	2.1	85.2	1.4	2.0	0.3	13.4	15.3	2.8	0.0	6.2	2.9	3.0	0.8	8.7	6.5	0.6	15.7	4.1	4.2	42.0	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	48.9	60.0	1.3	105.5	89.6	4.5	0.0	0.0	0.0	0.0	0.8	42.0	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NEMP1	"KIAA0286, TMEM194, TMEM194A"	ENSG00000166881	"Nuclear envelope integral membrane protein 1"	O14524	12	57055643-57088063	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014394	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA014394: AB_2204899"	"unprognostic (9.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.05e-2)"	6.2	5.1	3.3	8.0	3.5	6.8	6.3	3.6	3.9	6.6	3.7	8.7	3.8	8.2	5.3	5.6	6.3	4.3	3.0	3.2	3.3	4.3	6.1	6.3	12.2	3.3	3.2	7.2	4.0	3.7	3.5	7.8	3.7	6.8	6.8	9.3	4.5	5.2	2.3	10.8	7.5	7.4	3.3	7.3	5.4	7.7	3.2	16.1	5.4	3.0	11.6	6.5	5.7	4.2	20.0	16.8	37.5	40.5	12.3	12.0	21.5	30.2	17.1	41.1	33.3	20.0	37.2	47.2	38.1	10.4	35.0	28.8	50.4	13.0	47.0	25.3	22.9	27.9	19.5	10.6	5.2	35.0	30.7	4.1	12.3	33.8	21.0	17.1	11.6	42.2	57.5	91.2	35.0	10.9	38.5	29.7	21.0	18.8	18.4	38.5	53.2	21.5	9.0	12.2	22.3	15.1	25.7	21.3	24.1	26.4	38.5	34.7	8.3	39.0	22.5	36.4	28.6	40.8	83.2	40.5	23.1	32.9	41.1	2.4	0.5	0.8	1.1	1.5	1.5	1.9	1.2	1.5	0.5	1.6	1.8	1.6	0.2	2.4	0.9	0.9	1.2	0.8	3.3	3.5	3.6	3.9	3.2	3.3	3.3	3.2	3.7	3.3	3.2	4.2	4.7	22.4	2.6	0.0	7.1	0.0	3.1	0.0	8.0	2.6	5.0	2.9	1.6	2.8	1.8	5.5	4.2	5.0	4.1	1.4	0.0	1.8	1.2	3.3	4.4	4.0	0.0	12.2	0.0	0.8	3.6	4.4	3.1	3.7	0.0	11.1	5.7	3.6	5.8	1.7	0.0	1.8	0.0	7.1	0.0	1.0	6.2	7.2	0.0	0.0	4.4	3.5	3.1	0.0	0.0	2.0	0.7	5.3	4.9	4.1	1.0	1.3	2.9	4.0	13.1	3.6	3.4	12.2	7.4	7.6	0.0	3.0	4.1	3.1	2.2	2.4
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432920-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 512.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain				"Secreted to blood"	NA	NA		4000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA026763: AB_1854379, HPA028488: AB_2672638"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	63.9	53.4	132.2	16.8	149.0	26.9	65.7	141.3	188.1	82.8	137.7	53.8	19.8	59.8	70.2	45.9	58.3	23.9	141.0	130.9	138.5	70.0	62.7	45.4	16.4	142.5	142.7	82.7	68.7	64.1	148.1	29.4	143.2	69.4	36.1	22.7	72.4	50.5	95.0	55.6	35.2	44.7	142.7	33.6	47.7	16.7	138.3	23.0	57.6	104.5	25.6	58.0	57.7	156.0	78.8	65.3	26.6	103.2	155.3	116.6	38.9	39.5	94.5	67.5	65.7	74.0	49.8	36.0	29.0	93.0	68.4	49.7	55.1	56.0	55.1	45.7	107.2	26.5	39.9	24.4	59.3	25.1	66.2	83.9	82.5	47.8	40.0	76.1	44.1	54.1	60.2	39.0	60.5	40.2	45.4	95.3	39.0	73.9	137.9	42.1	62.6	50.2	70.3	23.1	43.2	77.5	59.2	89.6	74.0	40.4	70.8	75.2	9.1	54.9	49.0	76.8	73.3	36.2	62.6	26.9	57.5	36.0	43.0	0.9	4.8	2.1	3.9	7.1	6.9	8.1	4.7	8.8	7.8	5.3	6.1	6.2	0.5	0.9	5.0	13.5	5.8	2.5	132.2	149.0	141.3	188.1	130.9	138.5	142.5	142.7	143.2	142.7	138.3	156.0	124.8	12.8	21.6	14.0	72.0	166.2	233.0	10.8	173.6	44.0	322.5	418.5	152.9	163.0	13.4	248.3	12.5	291.4	64.3	101.0	164.4	50.9	5.3	40.7	119.1	87.4	135.8	135.0	11.9	49.0	182.0	219.7	65.7	58.4	47.1	45.7	145.3	211.8	189.3	38.7	12.6	143.7	6.1	149.4	198.1	23.9	297.6	127.2	186.7	11.2	69.2	329.6	34.0	21.6	80.5	32.7	70.7	223.8	136.0	322.9	56.1	512.7	7.6	28.4	118.3	162.1	233.9	13.3	138.5	158.8	170.6	184.4	70.4	61.8	157.0	264.5
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305205	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		390000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	9.6	7.4	28.9	8.9	43.8	1.5	16.7	38.1	31.4	18.2	10.7	46.0	27.3	19.6	9.9	11.5	21.9	19.6	7.8	29.4	29.2	23.4	8.7	15.9	3.9	34.6	38.0	24.8	17.2	41.8	6.7	1.7	35.6	33.0	55.1	19.5	18.3	36.0	30.9	37.5	26.5	23.3	28.7	5.3	22.9	13.5	36.6	7.2	18.2	24.8	6.2	10.5	9.6	60.0	8.9	42.9	50.1	33.2	29.6	8.6	12.5	3.3	4.1	8.2	1.7	6.4	42.8	2.5	4.9	9.4	30.8	1.9	35.3	19.5	3.5	15.8	26.0	29.0	0.5	6.0	8.6	0.8	0.9	21.3	35.4	1.6	16.2	9.5	0.0	22.3	0.2	53.9	2.0	26.8	10.5	0.7	47.9	6.7	3.6	23.9	26.8	5.8	15.8	23.7	22.7	32.1	40.2	17.6	20.7	39.9	18.6	5.3	0.1	38.0	19.9	12.5	9.3	22.8	45.2	6.2	8.2	8.3	10.9	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	28.9	43.8	38.1	31.4	29.4	29.2	34.6	38.0	35.6	28.7	36.6	60.0	3.1	9.6	10.4	231.8	2.3	14.1	8.2	20.7	13.6	15.7	14.2	18.2	6.9	21.5	11.4	22.0	14.6	0.5	4.8	55.6	1.9	11.6	3.3	14.4	13.4	3.4	60.1	3.0	124.5	6.4	0.8	14.6	20.9	24.6	0.0	11.8	5.7	8.9	0.9	10.1	72.8	51.2	10.2	1.2	2.7	7.1	31.7	1.2	10.6	62.8	0.1	12.5	2.1	120.1	439.4	9.9	40.0	62.8	2.6	11.5	39.6	15.5	12.7	21.9	6.6	22.2	10.2	11.8	20.3	14.7	25.4	0.3	6.0	3.1	60.5	7.2
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677407	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 161.6"	"Group enriched"	"Detected in many"	4	"Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5"	"Cancer enhanced"	"Detected in all"		"glioma: 147.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No		100000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	40.0	8.5	24.4	13.8	24.8	0.0	28.2	27.2	22.7	27.1	16.5	16.8	5.3	41.1	12.9	8.2	30.3	11.3	161.6	21.1	26.5	35.2	4.8	42.1	4.8	32.8	27.1	10.1	5.6	10.4	12.8	16.7	25.8	21.2	6.6	8.2	9.7	36.1	55.7	8.6	12.5	30.3	30.0	49.1	10.8	6.2	26.4	2.7	19.9	47.3	2.3	24.2	19.0	30.9	0.2	2.5	627.3	134.7	1.3	33.4	0.6	154.7	120.7	2.3	3.4	102.5	1.9	0.6	35.8	14.9	0.1	2.8	63.9	0.0	1.8	0.0	1.1	0.9	9.7	47.3	5.5	0.3	37.1	28.5	0.0	5.7	0.0	5.3	321.5	0.1	4.9	0.2	512.6	4.3	0.0	0.3	102.3	6.0	88.1	0.7	518.3	0.4	0.6	0.0	1.6	100.4	3.6	4.5	124.9	340.7	1.3	0.9	235.1	0.8	34.5	4.1	8.8	0.2	24.0	0.2	13.4	0.1	247.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.8	27.2	22.7	21.1	26.5	32.8	27.1	25.8	30.0	26.4	30.9	102.2	0.0	4.4	0.0	0.7	2.4	0.4	0.2	0.6	0.5	9.4	32.9	279.9	0.0	0.6	18.4	0.0	0.2	1.0	0.6	0.0	2.1	0.4	2.1	31.9	105.5	0.0	0.0	0.3	0.0	1.9	29.4	0.5	2.7	0.0	0.2	26.7	0.1	1.8	0.0	0.6	0.2	0.0	0.8	3.1	0.1	8.1	1.7	1.8	12.2	1.0	17.4	0.0	3.0	2.2	0.3	0.1	4.1	0.1	0.5	0.0	0.1	0.0	1.5	105.2	10.9	70.5	0.5	5.0	1.2	2.4	0.1	1.1	1.4	0.3	0.5
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412557-5459056	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 252.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	48.8	10.8	35.5	23.4	34.2	40.5	52.8	38.5	57.6	43.7	52.8	92.2	56.2	41.8	56.2	68.4	46.2	35.9	13.2	30.2	32.4	49.3	45.1	22.2	26.7	41.8	37.2	28.5	37.9	5.4	10.6	65.7	43.8	41.3	88.2	6.5	93.1	24.3	25.0	39.8	74.7	36.9	37.5	8.1	77.8	14.4	41.1	30.4	26.2	28.0	33.0	60.8	59.3	40.1	115.9	67.7	45.2	51.0	26.8	11.9	252.9	69.1	37.6	53.4	50.4	36.4	215.2	40.6	27.7	42.4	11.4	185.5	54.9	104.3	63.9	38.1	38.5	77.5	22.9	84.0	7.2	21.5	31.1	18.2	61.0	54.0	12.3	47.6	31.1	42.6	138.5	64.4	30.0	54.3	74.3	30.6	61.5	158.6	51.0	45.0	85.0	32.4	33.4	57.6	38.5	20.6	60.7	110.9	20.3	76.2	36.7	65.3	29.5	20.3	30.9	30.7	56.0	39.3	23.1	53.4	18.1	33.1	43.4	2.0	0.6	1.4	0.6	1.0	0.0	1.4	1.2	0.4	4.9	0.6	8.7	1.7	0.1	0.8	0.4	2.0	4.0	2.2	35.5	34.2	38.5	57.6	30.2	32.4	41.8	37.2	43.8	37.5	41.1	40.1	18.4	32.1	55.8	2.6	12.7	40.3	127.2	49.0	103.0	11.0	52.6	28.3	12.1	41.5	84.3	12.9	4.2	110.2	8.4	242.2	5.9	13.1	2.4	97.7	30.6	42.7	80.8	54.1	5.1	24.4	109.1	33.2	107.0	131.4	15.2	16.9	12.5	55.7	14.5	3.3	7.7	145.3	34.6	10.5	59.8	2.4	21.8	31.2	35.6	44.0	48.7	3.8	0.0	8.5	5.7	62.1	148.3	87.6	39.2	67.8	123.6	29.2	85.7	3.5	111.7	183.0	185.0	26.3	16.0	158.1	32.4	117.5	9.3	2.9	145.0	186.5
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143945	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	2.7	7.2	6.1	6.4	19.8	2.4	2.8	3.6	9.3	1.6	1.0	8.5	1.6	2.2	0.6	6.1	0.8	4.8	2.6	4.1	8.3	2.7	0.7	5.9	6.3	6.9	0.8	1.6	2.5	10.7	1.2	3.4	6.4	1.1	2.4	7.5	2.7	1.2	4.4	1.8	2.8	1.6	1.7	22.7	2.2	8.0	3.5	5.4	8.8	2.2	6.2	4.9	2.9	4.2	86.8	94.4	133.9	0.3	19.3	111.6	22.2	84.0	13.2	72.9	39.3	19.9	54.0	21.3	50.4	18.0	70.2	37.9	86.4	83.6	89.0	0.3	55.7	17.2	32.8	21.3	23.9	55.8	43.7	67.9	54.7	29.5	41.2	70.5	49.2	50.5	25.9	25.7	47.4	23.5	31.9	30.4	64.7	25.8	68.8	0.1	26.2	43.0	51.4	18.3	87.8	63.5	110.9	8.6	12.5	21.8	1.7	40.3	24.1	0.1	0.3	0.1	0.5	27.5	24.7	47.6	58.9	38.9	59.6	0.3	0.9	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.1	6.1	19.8	3.6	9.3	4.1	8.3	6.9	0.8	6.4	1.7	3.5	4.2	4.9	0.0	4.5	4.6	6.5	7.8	0.6	10.4	13.1	2.2	5.2	8.9	1.3	0.0	3.6	0.0	0.0	1.4	2.1	15.9	0.0	0.4	3.1	2.1	4.0	10.6	10.8	0.4	96.5	3.1	0.5	4.9	1.5	0.9	2.5	18.0	2.9	0.4	6.6	0.0	176.6	2.6	6.1	11.4	14.6	5.7	0.6	16.6	3.6	8.4	7.3	39.9	1.0	79.4	3.1	1.3	1.5	0.0	13.7	4.9	2.9	0.1	2.4	1.6	6.6	5.3	3.6	17.9	22.2	18.8	3.3	0.8	5.2	98.7	2.8	1.4
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"skin 1: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	CAB022336	Uncertain					NA	NA		25000		"Cluster 61: Skin - Cornification"					"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 75.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.9	0.2	2.3	0.1	2.5	3.5	0.2	2.2	4.4	0.5	0.6	15.5	10.7	0.2	0.0	0.0	0.7	0.4	0.3	2.1	2.5	1.8	75.8	0.4	0.0	5.0	2.8	0.3	0.1	0.0	1.1	0.0	2.7	0.4	2.2	0.1	0.8	0.0	9.0	0.1	9.2	0.0	2.6	0.3	0.1	0.7	2.7	0.0	0.3	0.8	0.0	0.1	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.5	2.2	4.4	2.1	2.5	5.0	2.8	2.7	2.6	2.7	2.9	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 146.9;tongue: 60.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"intermediate monocyte: 45.1;non-classical monocyte: 112.0"	"Lineage enriched"	"Detected in many"	19	"monocytes: 112.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	0.5	4.6	25.5	3.8	29.6	2.2	0.4	20.8	37.4	14.1	0.0	15.2	10.9	25.8	15.1	4.3	2.6	1.9	0.5	32.2	7.2	2.4	1.2	0.9	0.8	1.7	4.1	1.9	18.8	8.3	15.9	4.6	1.3	1.4	10.3	39.5	2.9	1.3	146.9	1.8	17.2	5.2	0.0	1.9	5.2	13.0	5.0	1.1	0.5	60.5	0.5	18.7	2.6	17.2	0.9	0.2	1.3	0.0	0.2	0.1	13.7	0.5	0.9	0.2	0.1	0.3	0.2	0.4	0.7	0.1	0.9	0.6	0.4	0.2	0.1	0.4	0.8	0.2	8.6	0.3	0.0	0.3	6.9	0.2	0.5	0.1	0.7	0.2	0.0	7.4	2.3	0.5	0.2	1.2	1.4	0.9	0.0	0.5	4.2	0.2	0.7	1.5	0.0	0.5	17.1	5.9	8.8	0.0	0.4	2.5	0.7	1.7	0.0	0.1	0.9	0.3	0.2	1.0	0.2	0.3	0.5	0.0	0.4	0.8	2.8	0.5	0.7	45.1	1.1	1.1	1.0	1.1	5.8	0.7	1.2	0.8	2.3	0.6	112.0	4.7	0.4	4.1	25.5	29.6	20.8	37.4	32.2	7.2	1.7	4.1	1.3	0.0	5.0	17.2	0.3	0.0	0.6	1.3	1.5	0.5	1.5	0.2	0.0	53.2	2.0	2.7	1.6	0.0	0.2	0.0	93.8	4.6	3.1	7.9	0.0	12.0	128.7	0.0	0.8	2.2	78.3	4.6	47.9	0.7	12.9	2.2	13.3	0.1	0.0	1.2	0.0	0.2	4.5	3.3	32.9	105.4	32.6	4.6	2.4	461.2	5.6	4.8	0.0	0.0	5.5	9.0	2.1	1.0	4.2	0.5	183.4	5.3	0.6	1.3	7.2	0.0	0.2	88.0	6.6	2.4	1.0	56.6	33.6	0.0	1.8	113.4	1.7	8.4	9.4	0.7
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641263-172691540	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 82.8;Distal enterocytes: 82.5;Endothelial cells: 53.8;Leydig cells: 54.7;Paneth cells: 42.1;Proximal enterocytes: 53.4;Smooth muscle cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 43.7;T-47d: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	"Actin filaments,Cytosol"		NA	Yes				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Actin filaments"	"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	25.0	16.0	8.4	5.2	10.3	2.0	21.1	2.3	24.1	18.3	3.4	28.4	6.9	24.7	24.1	13.5	22.0	11.7	32.2	17.1	6.9	11.0	6.0	12.6	3.7	3.5	4.6	14.7	5.3	3.2	8.2	6.1	3.8	17.6	13.7	0.3	6.6	32.1	14.0	18.1	17.6	20.4	3.6	0.7	7.7	4.3	6.3	5.9	10.3	16.0	3.9	25.7	17.3	6.5	7.2	3.7	2.0	8.9	0.6	0.3	0.1	8.0	3.5	4.1	6.0	13.7	3.2	0.0	2.1	5.2	5.0	2.1	0.7	3.6	2.8	13.2	0.5	9.8	13.3	0.1	0.6	0.0	2.9	0.0	15.1	0.9	4.1	1.2	0.6	1.4	0.0	3.0	8.9	8.0	2.3	0.2	1.3	3.1	0.3	43.7	9.4	1.4	0.1	1.6	1.6	8.9	7.6	11.9	0.3	3.5	20.0	1.5	1.3	3.1	18.1	2.2	5.1	1.2	0.4	0.0	9.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	10.3	2.3	24.1	17.1	6.9	3.5	4.6	3.8	3.6	6.3	6.5	82.8	0.0	1.9	0.3	0.6	4.8	0.7	3.0	0.6	0.6	1.5	1.3	9.3	1.5	4.8	0.0	0.0	0.3	0.4	82.5	0.0	0.7	2.6	1.9	2.5	53.8	13.9	11.4	5.2	0.7	0.2	10.3	2.0	0.6	0.0	4.9	30.4	0.3	0.3	0.0	1.0	10.2	2.0	1.9	2.6	6.6	54.7	2.2	7.2	4.7	0.7	0.7	0.0	5.0	13.0	4.5	42.1	12.4	0.1	1.9	53.4	0.8	12.8	0.3	26.3	11.6	58.8	2.5	3.4	7.7	5.4	0.1	0.7	2.5	20.0	1.2
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891208	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 26.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 13.1;Proximal tubular cells: 17.3;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;Hep G2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA043402: AB_2678464, HPA059842: AB_2684139"	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	14.1	9.1	1.8	2.6	3.0	1.3	6.9	4.0	3.1	5.2	4.5	7.3	4.3	6.2	3.0	2.6	7.4	2.9	8.9	2.0	2.1	26.7	8.2	3.9	1.5	2.4	2.3	9.4	4.4	3.8	4.1	3.1	2.3	4.4	2.2	4.2	5.5	2.7	18.1	4.7	6.5	4.0	2.0	5.9	5.0	2.5	2.1	7.6	5.8	8.9	1.3	7.9	4.3	3.2	0.9	0.7	1.9	1.6	3.1	1.3	1.6	1.2	1.4	1.3	0.6	8.2	5.2	1.0	1.7	0.9	2.3	2.7	1.6	0.0	0.8	0.6	1.4	0.6	6.4	8.5	3.9	0.6	1.4	2.9	1.1	1.3	0.5	2.0	1.0	1.6	0.8	2.1	0.7	3.2	1.0	0.6	0.9	0.5	2.9	1.7	1.4	0.5	0.8	0.7	4.2	3.0	1.7	4.1	5.2	0.4	3.1	1.7	2.0	1.5	1.3	1.2	1.2	6.0	1.3	0.2	1.7	0.8	1.4	0.0	0.6	1.8	0.4	0.3	0.2	2.8	0.7	0.6	0.2	1.0	1.5	1.3	0.2	1.0	0.2	0.3	0.5	0.3	1.8	3.0	4.0	3.1	2.0	2.1	2.4	2.3	2.3	2.0	2.1	3.2	1.7	0.0	0.0	2.0	2.3	0.1	2.1	1.0	2.8	3.5	2.2	3.4	5.7	0.0	0.4	0.0	4.2	0.7	0.5	5.0	7.9	3.2	2.8	0.8	2.3	2.7	3.0	1.3	1.4	2.0	0.9	3.3	3.1	0.9	0.0	7.8	5.7	5.7	13.1	0.0	2.3	2.3	0.0	5.1	0.3	8.6	5.3	1.2	0.0	1.0	1.5	2.5	2.1	2.0	1.4	2.9	0.7	3.8	2.2	2.3	6.7	17.3	0.5	3.4	13.1	3.2	6.1	0.0	0.3	1.8	1.1	0.5	0.7	11.0	2.1	1.7
NEURL4	KIAA1787	ENSG00000215041	"Neuralized E3 ubiquitin protein ligase 4"	Q96JN8	17	7315628-7329393	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043678, HPA055314"	Uncertain					NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA043678: AB_10963092, HPA055314: AB_2682782"	"unprognostic (4.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.96e-3)"	"prognostic favorable (2.34e-5)"	"unprognostic (4.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.12e-2)"	7.3	6.7	2.6	3.3	3.1	3.0	7.9	1.2	4.2	10.7	0.6	11.9	3.9	11.4	1.7	7.0	10.3	2.4	9.0	3.1	1.2	7.9	5.7	6.9	3.9	1.8	1.6	12.8	8.7	4.6	12.3	2.3	1.5	10.0	1.8	2.5	8.4	3.3	18.8	9.4	9.8	2.4	0.3	9.3	8.6	9.8	1.6	3.8	12.4	5.2	2.3	10.0	8.6	2.4	3.3	11.5	7.3	11.7	4.4	2.8	8.7	5.0	3.2	6.0	4.9	8.0	2.7	10.2	5.1	3.0	4.9	9.4	7.8	4.7	2.6	5.5	12.3	5.1	13.2	4.7	3.0	5.0	6.9	2.7	4.8	6.2	3.5	4.7	3.8	8.5	7.3	2.1	2.6	4.2	7.5	9.3	5.1	3.9	5.6	12.9	5.8	4.1	3.7	3.4	6.8	5.7	5.2	5.2	2.0	3.7	4.4	3.5	4.8	5.5	4.2	4.6	5.6	4.3	2.9	4.3	3.5	4.6	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.1	1.2	4.2	3.1	1.2	1.8	1.6	1.5	0.3	1.6	2.4	3.4	0.0	2.2	10.4	2.4	2.5	0.8	2.3	0.6	11.4	4.9	5.3	1.6	4.3	2.3	5.5	14.6	2.3	1.9	5.4	1.9	2.5	2.0	4.3	4.1	2.9	4.2	2.1	8.4	1.4	1.8	2.1	8.2	3.8	2.5	6.4	4.6	3.4	2.6	5.0	7.0	5.0	4.1	2.5	1.8	1.6	2.8	3.5	0.0	4.7	1.9	3.1	5.2	4.5	6.4	2.4	2.1	1.9	2.0	1.6	5.1	5.8	2.5	8.7	0.0	2.7	3.7	4.2	4.5	3.4	2.8	1.9	2.5	3.2	5.7	0.6
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NEUROD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680547	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 61.4;retina: 125.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 77.5;Cone photoreceptor cells: 150.1;Enteroendocrine cells: 424.2;Rod photoreceptor cells: 203.7"	"Group enriched"	"Detected in some"	4	"glioma: 1.9;pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 61.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	74	"SCLC-21H: 321.5"	"Region enriched"	"Detected in all"	14	"cerebellum: 216.2"	"Region enriched"	"Detected in many"	19	"cerebellum: 217.0"	"HPA003278, CAB022450"	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favorable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.0	0.1	3.0	0.1	2.1	0.1	0.0	61.4	7.2	0.0	0.7	1.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.7	0.0	0.0	0.0	0.0	0.9	2.4	0.0	10.2	0.0	0.7	0.0	5.2	0.0	1.4	125.7	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.4	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	321.5	4.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.1	3.0	2.1	61.4	7.2	9.2	0.7	0.9	2.4	5.2	0.9	0.8	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	77.5	0.0	0.0	0.5	0.0	0.0	0.0	150.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	424.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	23.8	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.1	1.7	12.6	0.0	0.0	0.2	0.7	0.1	0.0	203.7	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.2
NEUROD4	"ATH-3, Atoh3, bHLHa4, MATH-3"	ENSG00000123307	"Neuronal differentiation 4"	Q9HD90	12	55019974-55030017	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"pituitary gland: 8.1;retina: 30.2"	"Cell type enriched"	"Detected in some"	21	"Bipolar cells: 217.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 1.3;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015545	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA015545: AB_2669215"					"unprognostic (1.78e-2)"													0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.6	0.0	0.0	2.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337465-31340726	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"brain: 24.5"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 20.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	6	"amygdala: 8.1;basal ganglia: 10.2;cerebral cortex: 15.3;hippocampal formation: 24.5;white matter: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	66	"SCLC-21H: 6.5"	"Region enhanced"	"Detected in all"		"hippocampal formation: 225.0"	"Group enriched"	"Detected in many"	9	"cerebral cortex: 20.9;hippocampal formation: 81.8"	HPA074530	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074530: AB_2732257"					"unprognostic (3.68e-2)"													0.0	0.0	8.1	0.0	10.2	0.0	0.0	2.2	15.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.5	1.3	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.2	2.2	15.3	24.5	1.3	1.4	1.7	1.3	1.7	1.2	6.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516180	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.3;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 203.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	10	"hippocampal formation: 12.3"	CAB012342	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.0	0.0	0.8	0.0	1.2	0.0	0.2	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	2.0	203.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	2.1	3.3	0.2	0.2	0.1	0.1	0.1	0.2	0.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573422	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 5.4;intestine: 2.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Group enriched"	"Detected in some"	20	"cerebral cortex: 4.5;hippocampal formation: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"THP-1: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.1	0.9	3.0	0.1	3.1	0.0	0.3	1.0	2.5	0.4	0.0	0.8	0.1	0.5	0.2	0.3	0.3	0.1	0.0	2.6	6.7	0.7	0.0	0.1	0.1	0.3	0.7	0.4	1.5	1.8	1.7	0.1	0.5	0.9	0.3	1.0	0.4	0.6	0.0	0.3	0.4	0.7	0.2	0.1	0.6	0.2	4.8	0.0	0.4	0.1	0.1	0.2	0.2	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.9	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.1	1.0	2.5	2.6	6.7	0.3	0.7	0.5	0.2	4.8	0.7	0.3	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 254.0;Excitatory neurons: 325.3;Inhibitory neurons: 412.5;Oligodendrocyte precursor cells: 428.2;Oligodendrocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	7.4	8.4	8.9	7.1	10.7	3.4	11.5	13.2	12.2	10.0	1.6	8.5	6.8	10.2	10.0	6.1	9.0	8.0	11.3	9.7	11.7	12.0	9.4	7.3	7.7	11.7	9.2	13.5	10.4	15.9	7.8	12.4	9.1	9.5	8.8	20.9	9.1	9.5	8.1	7.4	7.5	8.7	8.2	7.1	8.2	10.0	11.8	13.5	19.5	10.6	7.8	10.4	6.8	14.4	15.8	20.3	24.2	13.1	20.1	25.8	12.2	13.4	24.1	19.5	21.8	18.4	10.5	15.2	3.8	25.1	22.9	26.8	22.2	18.7	32.6	7.5	14.1	13.4	18.8	9.5	14.2	24.4	10.6	20.7	11.8	20.8	25.1	21.8	9.5	15.7	19.8	14.8	18.8	12.4	20.4	8.8	7.1	9.7	6.8	15.8	36.8	12.3	14.7	22.5	10.0	14.9	25.4	8.3	13.8	16.8	25.0	15.3	14.1	15.3	21.5	18.8	5.1	13.2	6.9	16.3	12.6	10.0	16.2	4.4	0.3	0.6	1.5	0.1	1.0	1.4	2.8	2.5	0.4	1.2	2.0	2.0	0.7	0.7	0.3	0.4	5.9	0.6	8.9	10.7	13.2	12.2	9.7	11.7	11.7	9.2	9.1	8.2	11.8	14.4	30.9	32.1	31.1	254.0	18.3	38.6	48.1	38.9	31.9	62.7	33.7	24.9	43.9	41.5	29.8	40.5	137.6	57.5	23.8	37.8	23.5	27.1	210.4	27.4	39.4	35.8	19.8	9.7	325.3	22.5	26.6	39.1	39.3	45.8	10.8	44.0	33.2	35.7	22.5	70.7	412.5	24.3	38.7	27.6	34.1	94.6	37.3	28.2	21.4	215.5	20.9	47.5	21.6	428.2	317.4	33.3	43.0	50.4	30.8	54.2	32.1	28.6	36.9	62.8	46.0	51.9	43.3	30.5	28.7	19.8	34.0	49.3	19.8	36.1	27.4	64.5
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.1;Late spermatids: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	8.8	13.6	19.7	8.4	17.2	8.0	7.6	13.6	28.7	8.9	10.7	10.8	6.2	11.1	6.2	13.4	8.6	5.3	21.4	27.3	13.9	17.2	10.5	9.3	6.4	14.4	18.1	8.5	12.7	27.4	9.5	4.6	14.3	9.9	5.4	7.3	8.5	6.7	22.8	10.2	8.8	8.0	14.3	9.9	10.0	20.9	17.6	9.3	11.1	19.1	7.1	9.3	7.7	16.6	75.8	36.7	12.2	74.3	21.5	22.0	7.7	57.3	37.9	74.1	53.7	32.7	18.4	21.1	50.4	69.9	48.9	27.1	25.1	37.8	52.0	31.9	12.5	26.8	24.4	26.4	22.4	35.1	28.6	20.1	16.4	53.3	51.0	21.8	47.7	13.7	12.0	18.7	64.5	35.1	21.4	16.6	8.3	16.9	20.4	24.2	56.8	18.8	68.5	37.3	17.0	11.6	36.0	24.5	14.0	9.4	14.9	15.4	92.7	101.1	109.6	44.8	112.5	30.0	26.7	25.5	27.0	14.5	68.5	10.0	10.0	4.2	15.5	14.7	13.1	8.3	11.5	10.4	15.1	8.6	9.7	9.2	2.3	13.2	21.0	10.2	10.7	12.2	19.7	17.2	13.6	28.7	27.3	13.9	14.4	18.1	14.3	14.3	17.6	16.6	8.1	6.4	20.1	14.7	9.4	14.1	11.6	9.8	8.6	16.3	14.5	9.0	23.1	18.6	10.0	14.7	10.4	11.7	12.7	9.0	21.5	40.0	77.1	14.5	17.7	13.2	13.1	13.9	27.5	24.9	6.7	12.5	7.7	15.2	22.9	12.2	11.7	14.4	13.5	30.3	27.1	7.9	6.1	14.7	7.5	121.4	7.2	10.2	8.8	18.7	8.6	19.1	14.4	17.6	16.7	40.1	14.5	12.4	14.7	13.6	10.5	30.1	8.6	9.6	6.6	13.7	15.6	29.5	8.1	15.5	14.3	3.8	12.9	17.4	11.2	9.5
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.0;Excitatory neurons: 148.4;Horizontal cells: 220.4;Inhibitory neurons: 139.0;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 226.6;Rod photoreceptor cells: 195.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 27.6;fHDF/TERT166: 50.3;hTERT-RPE1: 24.0;SCLC-21H: 22.8;U-138 MG: 62.7;U-87 MG: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced					NA	NA		2200000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	5.2	7.5	7.8	3.7	31.5	0.1	3.2	8.4	15.2	5.0	0.0	8.6	4.5	8.3	9.0	10.0	12.1	5.9	15.3	10.7	5.6	9.8	1.9	5.0	2.3	13.1	14.1	10.1	5.9	1.0	5.6	10.6	7.8	7.5	5.9	22.6	2.1	16.3	3.0	4.3	5.0	14.2	3.9	6.5	4.4	1.5	35.6	0.6	2.9	3.8	2.9	9.4	7.7	50.1	0.0	0.1	3.1	0.1	0.4	1.0	0.1	27.6	0.0	19.9	5.9	0.2	0.1	0.0	0.1	50.3	18.5	13.4	0.6	0.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	12.7	0.7	24.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	7.0	0.9	0.3	0.0	2.3	0.0	0.0	0.0	22.8	1.3	0.0	1.5	0.0	2.0	0.3	0.0	0.0	62.7	13.5	0.1	0.0	0.0	0.0	0.0	31.3	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	31.5	8.4	15.2	10.7	5.6	13.1	14.1	7.8	3.9	35.6	50.1	2.5	0.0	0.6	64.3	0.0	2.2	1.5	1.9	0.6	151.0	1.7	10.5	23.9	1.5	1.5	0.0	12.5	0.5	0.0	0.3	0.0	0.2	7.3	0.5	0.4	7.6	37.8	0.0	148.4	0.0	0.5	14.2	1.1	0.1	0.0	0.1	3.3	1.7	0.4	220.4	139.0	6.0	0.0	0.6	1.9	17.9	6.5	0.4	1.8	15.0	0.0	14.2	0.0	87.9	226.6	0.5	0.5	5.7	0.0	1.1	0.0	1.5	5.9	195.5	52.6	2.3	49.9	1.7	3.9	5.5	4.7	0.7	0.3	0.7	1.0	0.8
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 281.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	2.3	3.1	0.6	2.8	1.2	5.6	2.1	0.5	3.7	3.7	0.0	2.0	0.7	3.3	0.7	2.9	1.9	1.5	2.0	1.4	2.2	2.6	2.3	3.1	1.1	0.0	0.6	2.5	1.6	4.0	2.0	4.2	0.0	2.3	1.5	4.2	3.7	2.4	2.7	3.5	1.9	1.8	0.0	2.5	2.3	1.4	3.0	2.2	3.6	4.8	1.4	2.7	3.1	0.0	8.4	10.1	4.8	5.0	5.8	6.0	6.4	7.2	8.6	6.6	4.2	4.5	4.2	4.5	5.8	5.8	3.4	7.3	3.9	3.1	4.2	2.9	3.2	2.6	2.8	6.2	3.4	3.5	5.5	3.5	1.1	6.4	5.9	5.4	5.5	2.3	7.2	1.1	3.3	3.2	2.8	1.7	2.5	1.1	2.5	4.5	2.2	1.7	2.5	8.0	3.1	0.9	22.2	1.3	2.6	4.1	3.3	1.3	13.1	5.7	5.6	4.8	2.2	4.6	4.9	7.3	5.1	3.4	3.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.6	1.2	0.5	3.7	1.4	2.2	0.0	0.6	0.0	0.0	3.0	0.0	65.0	48.1	49.7	236.7	55.7	148.1	94.8	42.5	155.4	51.8	61.6	42.9	9.2	30.0	43.3	145.3	85.5	60.6	69.4	27.8	5.9	17.8	7.2	93.7	87.8	93.6	24.5	27.3	281.8	12.7	15.9	60.9	38.2	158.3	19.7	31.0	52.8	28.3	17.6	60.6	189.3	29.1	28.5	21.7	169.5	6.9	59.4	58.2	58.7	172.4	37.4	45.7	36.0	177.4	167.2	23.7	29.3	54.9	50.2	83.1	24.7	14.6	31.8	62.4	26.3	72.0	51.4	84.5	48.8	77.9	140.1	50.9	57.4	43.1	20.8	105.7
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 50.4;Skeletal myocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: AB_2686439"	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.8	4.6	4.8	11.7	6.0	3.9	10.6	5.6	4.1	6.0	27.9	10.1	3.0	7.7	0.9	3.0	8.0	10.0	15.5	4.3	5.4	4.8	2.7	13.6	21.2	8.3	7.2	7.2	7.0	4.1	3.4	4.1	6.4	6.4	1.5	0.5	6.4	2.9	32.7	10.6	13.2	3.2	7.5	18.7	5.4	8.5	7.2	8.3	7.7	9.3	13.5	7.1	6.1	6.4	0.0	4.0	1.9	3.6	3.3	3.6	6.9	2.4	0.3	0.6	0.3	0.3	3.6	22.0	1.5	3.2	5.6	0.4	9.9	0.0	0.8	15.3	8.0	15.4	0.9	0.1	7.3	4.9	8.2	4.3	0.0	1.2	0.1	0.0	12.2	9.0	12.5	4.5	2.4	8.4	12.8	1.7	3.5	2.9	2.6	4.0	2.5	5.0	1.8	1.6	0.0	0.0	3.2	2.6	5.6	4.2	3.2	19.7	11.4	5.0	20.9	0.0	0.3	0.1	0.1	60.2	0.0	6.6	9.3	1.8	3.4	7.5	4.0	9.1	4.2	7.6	6.2	5.5	3.1	10.0	5.2	3.7	2.9	2.1	13.6	3.0	5.0	4.7	4.8	6.0	5.6	4.1	4.3	5.4	8.3	7.2	6.4	7.5	7.2	6.4	19.4	0.0	6.0	13.4	50.4	37.2	30.0	7.0	6.2	0.1	19.2	13.5	8.4	5.7	8.1	0.0	0.0	0.3	11.8	0.1	0.0	5.7	12.1	10.6	5.4	25.2	0.0	5.9	0.2	4.0	7.2	24.3	8.6	16.1	31.8	1.2	39.3	0.6	12.3	0.0	0.2	0.0	2.0	12.6	35.4	20.3	8.4	21.9	10.6	9.4	6.9	2.5	13.4	4.0	1.3	4.9	0.0	9.8	8.9	12.0	0.0	0.5	4.4	0.1	0.0	52.1	14.2	11.4	13.2	1.5	29.7	0.5	29.4	2.1	0.1	7.7
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 96.5;NK-cells: 105.0;Skeletal myocytes: 152.0;T-cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.5;HMC-1: 26.8;SK-MEL-30: 20.4;WM-115: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	7.6	2.1	2.8	7.4	5.4	4.8	4.6	2.8	3.2	3.8	26.0	4.2	7.9	3.9	3.4	3.6	4.2	16.5	3.1	2.1	3.6	1.7	6.1	4.8	16.1	6.5	7.4	2.1	8.0	3.1	1.4	7.5	4.6	2.4	3.7	0.1	4.8	2.5	3.3	3.8	6.1	2.8	3.5	12.6	10.7	1.6	6.7	5.0	3.5	0.9	13.6	6.5	2.0	3.7	2.7	2.9	0.0	3.6	0.0	0.0	7.5	0.4	1.9	1.2	0.6	14.0	2.5	18.7	2.1	0.9	2.5	0.0	0.9	0.0	1.1	24.5	0.4	8.0	2.1	3.6	0.0	2.2	26.8	0.0	0.0	1.0	0.1	0.2	8.4	6.5	8.0	12.1	0.0	3.1	3.3	13.3	0.3	1.7	6.6	1.4	0.0	8.3	0.4	0.0	0.3	0.0	8.6	2.1	20.4	1.7	3.3	5.3	0.9	1.7	3.0	4.1	0.2	10.2	7.2	18.6	1.7	8.7	41.1	0.4	0.0	3.1	5.3	0.5	2.2	1.3	2.9	4.3	1.2	1.1	1.6	3.0	0.1	5.7	0.2	0.5	1.7	1.3	2.8	5.4	2.8	3.2	2.1	3.6	6.5	7.4	4.6	3.5	6.7	3.7	16.0	6.4	5.4	14.0	38.1	14.4	16.1	0.9	0.6	0.0	8.7	4.3	3.6	4.3	5.6	0.0	0.0	3.3	42.7	1.9	1.9	3.7	1.6	13.1	12.1	28.0	7.8	18.1	1.7	5.6	0.8	37.2	23.4	12.2	15.2	0.2	30.7	7.5	37.1	0.0	1.0	6.2	0.0	32.5	56.6	0.8	2.1	19.0	62.2	96.5	5.0	0.0	105.0	2.5	5.0	11.4	1.8	0.4	55.8	5.3	1.4	0.3	9.3	0.0	0.0	152.0	15.2	0.4	0.7	3.8	12.9	1.0	65.5	0.0	7.0	6.6
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"		No	No				"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805"	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	48.4	54.9	9.1	6.0	9.4	0.6	47.2	8.6	10.5	126.0	9.0	71.9	4.5	82.1	13.7	22.2	82.6	17.8	30.2	9.0	9.3	35.5	5.6	30.2	4.8	10.3	9.4	142.7	13.8	9.0	37.9	18.2	8.8	51.5	5.0	2.8	20.5	16.2	9.0	25.0	29.9	18.8	8.2	17.7	35.5	42.7	9.7	1.7	50.4	2.5	3.6	66.2	65.9	8.5	0.0	0.1	17.8	0.0	25.4	36.8	0.1	17.3	49.5	23.0	20.0	0.0	14.6	14.9	0.5	25.0	1.6	0.0	7.1	0.3	13.9	0.0	0.6	11.3	20.6	0.0	12.3	0.0	0.0	26.8	0.3	13.9	0.1	42.5	18.2	4.7	3.7	0.0	4.5	0.8	0.0	1.7	2.3	1.0	0.1	1.1	1.6	2.0	0.0	0.2	2.9	11.9	0.0	3.3	5.7	8.7	10.3	4.5	10.3	21.3	4.4	20.5	0.0	10.4	1.6	11.0	4.4	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.4	8.6	10.5	9.0	9.3	10.3	9.4	8.8	8.2	9.7	8.5	4.1	3.2	8.1	58.8	1.1	4.5	0.9	1.9	0.6	1.3	3.3	2.8	7.8	0.0	4.8	0.0	0.0	0.6	0.0	0.8	0.0	2.8	4.4	2.5	28.3	4.6	7.7	0.0	0.1	0.2	0.6	22.8	3.6	6.4	0.0	4.1	1.4	0.2	0.6	0.0	0.2	3.4	10.2	0.0	6.8	6.5	17.4	0.4	7.2	13.1	0.0	7.6	0.0	1.0	0.2	0.6	0.3	7.5	0.2	0.8	0.4	0.2	2.1	1.5	26.3	4.3	27.1	12.5	2.9	1.0	3.4	0.5	0.9	6.0	1.6	2.3
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 112.5;lymphoid tissue: 45.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.8	0.3	0.5	6.2	0.7	112.5	0.6	0.5	1.0	1.4	1.4	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.9	0.5	0.5	1.4	2.6	13.0	0.3	0.7	0.6	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.3	4.8	0.6	1.9	0.5	45.3	0.8	1.2	0.6	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.5	0.7	0.5	1.0	0.5	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NFE2L2	NRF2	ENSG00000116044	"Nuclear factor, erythroid 2 like 2"	Q16236	2	177227595-177392697	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002990, CAB020317, HPA043438"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.77e-3)"	87.0	73.6	64.8	65.4	83.9	58.9	78.3	74.9	86.7	83.2	78.7	83.4	100.1	92.6	97.2	257.0	88.5	97.7	77.6	66.5	71.6	143.5	176.6	88.5	50.4	82.0	77.5	137.3	47.3	60.4	58.4	80.4	84.5	72.7	85.8	68.2	79.7	90.5	64.4	162.3	82.9	91.8	70.4	69.0	176.9	65.2	75.7	68.2	130.4	65.9	93.8	160.7	108.7	91.8	53.1	57.3	52.2	56.4	181.4	190.2	61.7	91.8	124.9	81.4	90.5	75.9	97.9	52.8	93.8	102.8	148.4	96.9	65.1	136.7	111.5	40.8	41.1	65.9	95.9	156.3	231.2	39.3	60.6	134.0	314.5	115.5	169.3	184.4	80.9	39.7	72.7	91.4	111.8	49.8	42.3	101.9	58.8	277.2	58.9	34.0	46.5	54.6	120.9	182.1	69.0	45.0	202.9	64.8	216.6	147.8	49.1	105.0	119.9	80.4	54.5	89.5	54.7	70.1	44.7	43.1	81.6	43.3	159.4	130.6	89.3	55.4	55.2	84.3	62.9	61.8	64.0	57.0	100.4	51.9	101.2	66.8	103.2	68.1	83.0	38.8	66.6	66.0	64.8	83.9	74.9	86.7	66.5	71.6	82.0	77.5	84.5	70.4	75.7	91.8	193.3	157.0	93.5	66.3	143.3	295.8	241.8	448.4	306.7	61.3	90.0	113.7	67.9	117.2	247.0	154.5	16.7	113.2	249.1	120.7	393.2	154.5	81.4	238.1	126.9	139.6	75.6	58.0	25.3	170.8	34.5	206.6	170.7	279.9	212.7	141.5	120.0	93.2	88.1	57.2	26.6	73.5	321.4	111.6	569.9	39.0	287.7	266.0	96.0	88.1	170.6	191.4	55.6	63.8	113.0	128.3	91.8	214.0	118.8	150.5	94.9	85.0	205.9	48.4	39.5	211.8	152.4	66.1	32.1	617.9	315.4	186.2	150.6	153.5	119.6	225.2
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152198-26187137	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 34.4"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 305.9;Syncytiotrophoblasts: 698.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 133.5;NTERA-2: 113.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.6	3.1	4.2	10.6	7.3	2.5	2.2	19.5	19.7	1.5	2.3	6.3	8.0	2.2	0.2	2.4	1.6	4.3	1.4	6.3	4.8	2.5	1.6	4.8	8.0	7.0	4.6	1.1	4.8	0.4	1.3	34.4	7.2	1.4	4.8	5.1	3.2	0.6	2.7	7.3	5.7	1.0	5.1	7.6	7.3	1.4	6.3	5.9	1.0	0.2	7.0	4.8	1.5	10.8	40.9	3.5	1.6	4.0	0.0	0.0	133.5	7.9	15.2	15.0	27.3	26.2	68.8	3.0	51.2	0.8	57.5	8.6	6.0	13.4	33.7	27.9	8.5	5.7	7.0	19.8	10.5	5.0	52.3	1.3	1.6	6.2	2.3	22.4	35.0	11.3	8.6	69.9	3.0	5.5	3.5	8.8	113.9	11.1	13.9	5.0	0.4	20.5	20.5	40.5	12.3	14.7	0.2	3.2	1.2	37.5	1.9	3.0	76.0	1.4	2.3	0.6	32.6	42.0	72.2	3.4	0.2	17.5	53.1	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.4	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.0	0.2	0.6	0.1	4.2	7.3	19.5	19.7	6.3	4.8	7.0	4.6	7.2	5.1	6.3	10.8	14.6	6.4	2.8	3.9	4.6	1.8	4.2	12.7	5.2	1.4	3.1	2.3	1.9	14.3	6.9	11.0	0.0	305.9	1.6	6.1	0.0	13.0	1.0	6.1	1.8	7.6	1.2	12.0	3.8	5.3	33.9	2.8	14.3	6.4	27.9	35.2	2.2	0.3	24.3	0.0	4.4	6.6	12.2	15.6	17.2	0.3	0.0	16.7	1.8	2.8	11.1	1.1	4.1	1.5	11.6	15.6	4.1	0.0	18.2	10.4	2.7	0.5	8.9	1.9	0.0	2.9	2.7	0.6	7.1	5.5	1.6	698.6	9.0	4.8	9.8	6.7
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462788	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 777.3;Oligodendrocyte precursor cells: 606.7;Peritubular cells: 438.5;Skeletal myocytes: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	23.0	12.4	28.4	5.2	37.7	10.0	15.1	75.9	24.6	18.3	31.8	14.2	7.2	8.9	11.7	18.8	15.6	14.3	16.9	28.4	31.3	10.8	40.5	8.4	5.1	51.5	33.4	15.7	13.5	10.9	5.4	4.3	34.9	15.0	9.1	4.2	17.5	11.6	13.8	8.7	6.4	13.2	37.3	9.4	9.7	5.8	33.6	8.6	27.4	15.8	6.8	13.8	10.3	27.1	5.0	6.8	1.0	74.2	31.8	20.2	0.2	1.6	5.1	1.6	2.4	0.4	4.8	10.9	4.8	2.7	0.7	7.2	3.1	15.4	0.9	23.4	6.6	0.4	15.2	4.8	7.3	1.2	1.8	25.7	14.9	6.8	27.6	5.5	19.1	3.0	5.1	16.9	1.5	3.6	0.3	0.3	2.9	6.9	6.6	1.1	6.9	18.2	4.3	13.1	4.8	5.7	4.1	28.2	10.3	0.8	30.2	0.5	15.5	1.3	8.5	15.2	3.1	1.2	3.1	0.1	1.7	0.2	1.7	3.2	2.7	1.5	1.9	1.9	2.9	0.6	2.3	3.0	1.3	0.3	2.2	2.7	0.1	0.5	2.5	1.0	0.1	1.8	28.4	37.7	75.9	24.6	28.4	31.3	51.5	33.4	34.9	37.3	33.6	27.1	232.1	35.3	44.7	777.3	4.4	85.0	68.8	72.1	220.9	42.6	140.7	107.4	192.9	148.7	68.1	47.8	2.1	5.7	8.1	28.4	27.4	38.0	28.9	85.8	69.8	132.7	25.2	163.7	142.3	47.8	1.1	265.6	30.5	68.2	27.3	11.6	197.0	304.5	14.8	42.1	125.7	46.8	36.7	60.8	42.6	26.4	408.8	19.2	46.2	259.5	14.9	150.2	5.2	606.7	431.3	20.8	37.6	438.5	8.0	53.0	19.1	109.9	82.6	6.9	144.7	513.1	133.7	5.0	13.5	148.4	76.3	1.6	15.0	34.9	69.7	57.1
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 542.6;Oligodendrocyte precursor cells: 565.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 160.3;HBEC3-KT: 65.9;HEL: 61.3;HUVEC TERT2: 64.8;TIME: 64.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	28.3	8.8	22.6	7.2	19.3	0.2	36.8	35.7	25.9	12.5	5.8	16.8	10.1	13.0	15.1	9.8	17.5	15.9	25.7	23.7	9.1	16.7	20.3	15.9	7.8	13.2	14.7	14.1	15.6	5.0	4.9	13.0	13.1	20.3	8.7	10.0	39.7	16.9	21.5	22.0	13.0	15.7	17.6	9.7	14.2	2.4	10.9	7.1	17.4	18.9	5.6	17.7	13.3	15.2	19.7	14.7	8.6	160.3	39.8	22.9	0.5	0.5	0.0	3.7	13.7	0.2	7.9	0.5	12.1	1.2	12.0	4.3	7.8	65.9	7.3	2.8	7.4	61.3	31.6	1.8	13.2	1.8	0.3	20.3	9.0	14.2	49.5	15.4	64.8	0.0	1.8	0.5	5.3	9.0	0.1	0.4	3.0	8.8	15.9	0.2	7.5	0.2	11.9	7.4	13.5	49.9	13.5	16.9	5.7	0.5	34.0	0.1	64.6	12.1	18.1	9.7	12.2	1.6	1.4	4.8	11.2	0.3	15.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	22.6	19.3	35.7	25.9	23.7	9.1	13.2	14.7	13.1	17.6	10.9	15.2	328.7	51.3	31.4	542.6	4.6	268.9	165.7	63.0	115.5	60.8	238.6	317.4	195.6	214.4	59.1	46.0	0.0	5.1	2.1	42.1	39.2	70.7	3.6	147.8	39.0	230.9	22.8	2.7	278.5	125.2	1.2	190.9	62.2	135.9	3.8	5.7	228.5	104.0	2.2	0.0	352.9	35.4	28.5	8.4	48.9	5.0	133.9	7.3	94.3	157.4	1.7	238.0	0.0	565.5	206.0	68.1	48.7	48.5	4.1	166.2	101.9	190.7	55.6	11.5	85.5	270.5	160.8	0.9	9.7	78.6	169.2	1.6	7.1	6.5	74.2	64.3
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 293.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 168.4;U-2197: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	42.9	51.0	18.8	18.0	28.4	9.3	38.5	27.2	46.4	50.5	14.1	58.9	9.2	53.6	10.1	32.5	44.7	16.3	62.6	15.5	17.1	21.2	56.8	34.7	6.3	40.0	33.6	52.3	68.7	29.5	29.2	7.5	39.4	39.2	7.7	10.5	45.3	33.1	293.6	42.0	22.9	28.8	31.4	20.1	43.1	13.1	35.7	7.8	33.7	63.1	5.7	46.3	36.3	30.0	63.5	92.8	1.1	53.7	47.9	41.2	5.6	55.6	30.3	36.9	25.7	2.3	20.8	0.5	19.2	51.1	26.4	30.1	15.4	37.8	15.6	44.6	13.7	11.6	75.1	19.2	37.2	19.0	22.8	34.8	25.9	50.2	19.8	24.3	34.9	3.6	32.8	55.3	28.1	45.7	11.1	4.0	3.0	2.8	37.8	28.1	34.0	23.1	14.7	13.3	12.6	32.1	168.4	16.4	17.0	0.8	48.7	14.1	49.5	61.7	56.2	164.1	76.3	1.9	2.5	0.5	83.9	38.6	91.8	1.5	4.1	1.8	2.3	4.0	1.9	1.5	2.2	2.2	3.1	1.6	1.5	1.5	8.7	5.9	0.9	1.2	0.8	3.0	18.8	28.4	27.2	46.4	15.5	17.1	40.0	33.6	39.4	31.4	35.7	30.0	96.4	80.1	82.6	40.8	18.9	100.1	136.5	85.5	174.8	189.5	117.1	101.2	124.8	270.2	50.0	92.0	58.4	9.7	12.4	25.6	52.8	146.5	32.0	77.7	156.3	101.9	47.9	31.1	42.2	190.8	5.9	174.6	80.5	140.1	26.0	85.5	112.5	394.2	55.9	80.8	34.4	41.9	63.1	146.1	50.2	22.0	252.5	58.2	46.2	46.9	56.8	151.1	11.3	21.1	44.5	113.8	32.0	253.2	20.8	175.1	27.0	59.4	67.7	65.4	72.3	285.7	110.8	14.6	39.2	124.7	97.7	8.5	26.1	62.3	59.3	101.2
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423832	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 57.9;neutrophil: 26.9"	"Lineage enriched"	"Detected in many"	35	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	149.8	84.1	11.1	37.5	12.1	211.2	80.2	16.5	17.0	75.6	14.0	55.3	18.1	62.0	15.0	22.9	94.0	47.5	60.9	11.9	13.8	36.2	121.6	68.7	9.4	15.7	14.6	92.6	30.3	15.9	31.6	47.4	14.7	59.9	21.8	33.6	22.9	16.4	133.5	59.5	29.3	52.5	13.2	20.0	44.1	18.5	13.7	18.2	26.7	24.9	11.6	61.2	64.9	12.9	18.3	10.7	12.8	7.1	152.6	117.9	62.1	21.3	61.1	23.8	35.8	7.4	8.9	7.9	12.9	17.8	69.5	11.7	14.9	21.4	27.1	179.1	6.4	8.7	10.2	62.2	124.4	12.1	50.8	120.3	141.2	21.5	149.2	13.5	10.8	20.2	14.3	89.6	15.8	9.2	1.3	16.1	9.8	31.3	9.7	29.3	13.9	11.7	29.5	8.7	16.0	11.8	14.9	13.2	21.5	22.6	7.4	15.8	11.6	52.0	11.5	45.2	10.9	76.3	18.9	3.5	27.8	11.3	9.4	57.9	1.6	10.3	1.2	0.7	0.6	0.4	0.0	0.3	0.9	0.1	0.1	0.2	26.9	0.1	1.0	0.6	0.0	0.6	11.1	12.1	16.5	17.0	11.9	13.8	15.7	14.6	14.7	13.2	13.7	12.9	60.1	22.4	32.4	1.3	7.8	46.1	14.7	15.2	22.2	17.7	31.7	28.6	81.8	8.6	16.4	0.0	16.7	9.6	75.6	23.7	9.8	10.5	24.1	122.0	127.4	34.3	16.1	1.3	5.1	9.8	24.9	55.0	9.7	152.6	9.5	27.5	13.9	29.4	10.6	20.2	5.6	9.5	6.1	25.3	78.0	6.4	10.8	75.4	33.8	2.8	15.4	17.8	6.2	3.5	2.9	7.8	9.1	11.7	24.3	25.6	17.7	10.0	10.3	15.5	6.6	60.2	83.8	0.8	3.9	23.3	39.5	23.1	22.6	6.8	9.6	13.1
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 168.0;Karpas-707: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	26.5	21.0	7.6	44.4	7.4	69.3	19.6	7.1	9.2	22.9	8.5	39.1	15.5	21.6	2.3	17.7	20.4	18.5	20.6	7.2	7.2	34.6	28.2	41.0	40.7	8.5	7.5	21.4	24.1	6.1	10.8	14.7	8.0	29.0	6.8	1.1	21.3	9.1	18.4	20.0	26.5	12.2	7.5	50.6	22.7	10.0	8.4	16.9	20.1	7.6	25.7	37.0	19.1	8.0	67.9	48.6	7.7	31.7	11.1	16.6	19.3	18.5	61.0	19.6	25.9	28.6	55.2	32.9	43.5	11.9	48.8	40.9	20.5	28.2	6.8	168.0	11.2	7.0	11.7	15.9	30.1	5.1	45.5	22.0	14.6	34.1	32.3	26.5	7.8	16.1	7.6	157.8	7.4	26.4	7.1	22.7	10.3	15.7	16.6	16.8	24.5	27.0	34.3	22.1	1.7	8.2	16.2	36.7	26.3	7.2	29.3	16.4	21.2	19.0	28.9	25.4	47.0	113.1	105.0	32.6	31.1	14.8	10.9	0.0	1.3	0.0	0.7	0.9	0.7	2.6	0.8	0.7	0.7	2.1	0.8	0.8	5.6	0.8	2.1	0.6	1.1	0.5	7.6	7.4	7.1	9.2	7.2	7.2	8.5	7.5	8.0	7.5	8.4	8.0	20.8	9.6	8.8	3.3	88.3	43.5	59.3	41.2	34.7	2.2	17.1	14.5	3.1	25.8	29.9	18.4	16.7	6.3	39.0	33.3	5.9	33.2	1.1	33.7	14.4	26.1	16.3	0.4	0.1	21.0	15.8	26.0	80.0	52.0	71.8	5.5	11.7	3.7	20.9	0.0	0.1	30.4	22.4	19.4	122.9	1.7	7.5	52.5	30.2	1.9	75.1	3.9	12.3	1.5	0.7	44.9	37.4	4.9	49.1	49.3	33.2	8.6	19.9	5.3	0.0	36.4	43.6	4.7	11.1	17.5	44.6	23.1	54.6	8.8	17.9	45.6
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401513-35404749	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1114.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 391.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favorable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	281.0	171.3	75.6	150.7	78.0	1114.7	171.4	75.4	92.5	123.8	78.3	121.0	61.2	95.5	29.6	151.8	141.2	130.4	145.5	71.4	75.9	104.5	208.1	366.0	122.6	90.1	76.2	255.7	101.9	68.8	92.4	92.7	81.6	112.6	80.9	18.7	118.3	110.0	139.7	260.5	148.5	92.7	77.0	226.2	130.7	31.7	84.9	123.2	111.9	138.3	181.4	366.2	166.8	79.8	62.5	54.1	20.1	18.2	114.7	75.9	71.1	25.2	240.7	53.3	47.3	16.9	36.5	37.5	66.1	40.2	125.2	79.5	38.3	104.9	76.1	229.2	14.9	18.6	39.9	101.4	68.6	29.9	15.0	83.1	103.5	36.4	92.2	35.5	48.6	18.4	15.9	58.4	38.6	73.0	39.2	71.0	18.6	60.0	33.1	87.8	23.1	31.6	92.8	391.7	17.9	31.2	67.2	115.9	29.7	41.0	66.1	62.2	91.7	72.8	26.5	21.3	41.0	70.9	77.7	64.5	60.8	22.0	15.3	322.0	444.9	301.4	175.3	267.2	264.0	258.4	207.1	182.5	428.9	329.7	178.1	153.0	942.9	285.9	183.7	233.0	154.9	506.4	75.6	78.0	75.4	92.5	71.4	75.9	90.1	76.2	81.6	77.0	84.9	79.8	802.9	535.2	914.0	14.4	505.6	4056.6	1862.8	2061.4	1729.6	27.0	430.7	414.0	188.6	367.4	719.2	62.5	12.5	196.4	762.2	447.8	195.6	875.0	4.3	703.8	935.6	1079.8	203.5	87.8	7.1	394.8	174.9	1145.1	333.8	1440.1	906.1	68.2	313.4	147.2	791.2	48.8	5.1	453.0	634.7	491.4	4828.7	14.7	153.1	1609.0	1085.1	39.4	428.1	95.2	97.9	6.6	8.6	383.5	511.5	116.2	1039.4	1412.0	1051.6	115.9	298.2	37.4	203.8	956.9	847.2	3.3	26.4	1544.6	3420.6	660.0	838.4	91.8	346.0	1004.6
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 406.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 33.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 24.7;monocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.1;RPTEC TERT1: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	57.5	12.0	2.8	44.4	5.2	406.0	31.7	4.7	6.0	13.4	19.1	24.5	52.6	36.3	3.7	26.9	64.8	51.3	23.6	3.4	4.8	29.2	52.4	48.2	27.2	6.7	4.2	19.1	27.0	3.6	12.5	22.3	5.5	26.6	30.6	8.0	80.8	7.4	4.6	45.7	23.2	54.6	6.2	26.9	30.5	3.7	6.8	18.8	24.7	10.2	22.7	71.3	18.3	5.0	6.5	5.2	3.5	4.4	9.7	16.7	5.3	26.2	72.1	11.3	10.7	6.3	7.8	12.2	32.4	7.2	34.8	20.5	2.5	11.4	29.2	35.9	2.3	11.7	10.2	3.4	14.7	0.8	0.7	11.6	17.3	30.5	13.7	27.8	8.4	0.3	2.0	24.6	16.2	8.1	0.2	6.9	6.0	2.3	15.3	1.5	15.7	1.5	71.0	42.7	1.5	1.9	4.4	5.3	29.6	7.4	6.3	4.8	10.6	18.1	18.0	6.9	8.6	20.4	7.8	8.1	32.9	2.2	2.5	11.7	5.9	1.7	1.4	13.1	1.7	2.9	2.1	1.6	3.8	4.6	6.0	4.2	24.7	0.8	33.9	6.0	1.3	2.3	2.8	5.2	4.7	6.0	3.4	4.8	6.7	4.2	5.5	6.2	6.8	5.0	199.5	86.6	266.6	10.7	91.3	281.7	61.2	123.0	103.0	9.0	108.7	105.8	20.6	84.4	143.0	66.2	2.1	19.3	98.6	157.8	0.0	213.0	4.6	116.1	221.4	135.3	73.6	21.0	23.7	132.1	41.0	214.2	277.8	291.9	381.8	17.9	82.1	65.2	56.5	10.1	20.2	69.7	59.0	150.6	291.5	1.3	20.2	318.4	71.2	16.9	79.0	25.7	12.3	17.1	79.3	127.6	115.8	0.7	128.5	88.8	91.2	5.6	117.3	8.9	19.7	218.4	131.1	0.6	2.6	136.4	251.7	25.6	134.0	19.2	111.7	70.5
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1 cysteine desulfurase"	Q9Y697	20	35668052-35699355	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	12.0	28.7	17.8	7.7	19.0	4.5	10.6	19.5	20.4	11.6	19.0	13.1	12.4	9.1	10.3	11.0	12.5	8.5	22.6	18.2	20.0	42.2	37.7	6.8	8.6	17.4	17.7	13.1	11.9	25.9	12.3	8.6	19.8	9.9	14.1	17.1	13.5	12.6	25.3	10.6	11.1	11.0	17.3	7.7	12.1	19.0	19.6	9.3	10.7	36.5	12.1	9.7	9.1	19.4	29.6	36.0	12.3	13.0	32.7	29.9	24.9	21.9	23.1	32.2	20.9	65.4	16.3	25.1	42.1	20.6	33.3	36.3	42.6	44.5	29.3	11.3	20.0	53.7	37.6	51.4	27.1	22.9	9.9	24.2	41.6	25.5	27.9	24.1	24.6	29.0	38.9	16.3	23.1	45.3	25.8	24.0	14.3	67.1	53.3	10.1	39.9	42.2	33.0	19.6	15.4	14.1	54.9	52.3	36.9	28.6	46.9	20.1	18.2	36.4	17.4	21.6	21.9	23.5	34.3	22.6	30.9	24.2	18.5	3.0	6.8	6.5	5.8	6.7	7.7	8.4	6.7	8.9	9.4	5.6	7.8	7.2	2.7	10.6	5.2	4.5	9.6	5.5	17.8	19.0	19.5	20.4	18.2	20.0	17.4	17.7	19.8	17.3	19.6	19.4	9.7	6.4	15.0	9.4	8.0	6.1	8.1	16.7	6.2	14.9	11.7	10.3	20.6	21.5	10.4	18.4	10.4	35.2	5.4	12.3	33.2	15.9	6.0	7.2	8.5	6.9	6.7	13.9	9.0	11.2	22.5	10.7	11.2	8.8	7.0	8.7	6.8	26.8	16.1	15.2	9.9	7.0	16.2	8.9	4.8	4.4	5.6	7.0	10.6	6.5	12.3	15.2	5.2	4.5	12.6	10.9	11.0	10.5	5.8	5.6	17.3	56.6	7.6	13.5	13.1	8.6	9.1	50.7	19.7	9.1	5.7	21.1	7.4	25.4	14.8	7.9
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69396113-69437628	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 189.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	66.8	46.3	36.8	22.5	39.3	33.4	56.8	40.0	56.0	35.6	37.4	51.4	31.3	35.9	51.9	27.9	35.3	29.0	110.4	37.5	40.9	64.2	39.5	31.8	30.0	40.2	39.7	38.0	39.9	43.3	45.1	38.1	41.4	34.3	38.1	56.9	41.2	36.5	140.8	22.3	33.4	33.1	39.9	31.0	43.8	34.6	39.0	22.8	41.9	120.2	29.5	44.8	31.1	42.0	59.3	59.2	56.1	55.5	70.4	75.4	61.6	61.0	62.0	59.0	47.8	114.7	56.9	42.4	30.0	57.0	85.6	25.4	63.7	64.2	79.5	77.8	62.3	43.5	38.2	102.0	70.1	73.7	59.2	58.4	37.2	67.5	41.2	56.0	65.6	41.8	80.1	41.8	99.1	11.9	39.1	119.0	53.9	62.9	64.3	42.6	85.5	15.6	83.5	57.6	45.9	34.3	35.2	32.2	92.5	57.6	40.8	49.4	67.8	71.3	47.1	52.2	80.8	53.8	48.4	23.1	54.2	74.7	55.8	20.2	13.6	25.5	15.9	18.6	15.6	21.7	16.3	18.9	12.4	25.1	16.9	18.6	4.3	18.0	28.5	25.0	24.8	12.3	36.8	39.3	40.0	56.0	37.5	40.9	40.2	39.7	41.4	39.9	39.0	42.0	30.6	32.1	22.5	9.8	37.0	16.2	35.9	96.7	21.1	23.9	33.2	29.6	92.3	37.1	42.6	38.6	12.5	113.9	34.1	34.6	189.8	56.9	111.0	40.0	27.1	34.9	53.3	25.7	15.4	60.9	70.5	30.9	20.4	25.3	58.3	21.6	33.5	32.0	82.6	18.5	18.8	47.7	57.0	35.8	24.0	34.2	34.8	30.2	39.2	10.3	66.8	55.6	46.4	21.1	27.1	50.3	39.7	36.9	25.4	28.8	56.3	163.0	58.9	33.4	46.0	36.9	44.1	82.9	60.4	18.8	14.9	61.3	33.3	42.7	46.3	35.4
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 213.2;Spermatocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	3.0	2.2	1.6	4.4	1.8	4.2	6.4	3.2	1.9	5.4	1.1	3.7	4.6	5.3	10.9	3.8	5.4	3.3	1.8	1.3	1.6	4.1	3.9	3.0	4.1	1.9	1.9	6.1	4.6	6.6	3.2	3.8	1.9	5.0	4.8	3.7	5.2	4.4	2.7	3.9	3.9	5.0	2.0	3.7	4.8	13.7	2.3	4.3	10.1	2.8	4.6	4.3	3.6	1.8	7.0	4.4	4.8	9.9	8.9	14.6	16.2	4.7	6.7	7.6	9.3	7.4	15.6	5.5	8.8	3.1	14.6	7.1	12.4	9.4	8.9	4.3	4.8	6.0	8.7	13.6	11.5	14.8	11.5	9.6	12.3	5.2	30.7	8.9	6.6	11.5	10.8	6.7	7.8	7.0	11.7	6.9	11.6	9.7	6.7	10.3	9.2	9.3	9.6	13.2	15.1	7.3	3.5	9.8	6.8	9.1	6.8	4.2	5.5	9.8	6.2	4.6	10.6	10.8	7.0	11.2	5.7	8.2	8.8	0.0	0.5	0.6	0.7	0.7	0.9	0.8	1.0	0.8	0.5	0.8	1.1	1.0	1.9	0.4	0.4	0.6	0.7	0.6	1.6	1.8	3.2	1.9	1.3	1.6	1.9	1.9	1.9	2.0	2.3	1.8	6.9	6.4	8.7	15.0	6.3	5.4	4.0	5.2	7.4	19.6	10.0	7.0	213.2	11.5	9.9	7.3	10.4	5.6	10.5	6.2	11.7	9.2	36.9	15.7	16.7	7.8	11.4	6.9	35.6	7.1	11.5	27.3	7.1	18.4	2.5	10.9	7.9	7.5	4.8	8.4	35.0	11.2	12.2	6.5	4.3	20.2	12.8	9.9	1.8	17.8	7.3	11.0	8.2	33.7	30.7	7.4	4.7	10.1	13.8	7.0	6.5	4.2	9.9	16.5	0.0	8.1	9.1	81.1	27.2	9.9	4.3	6.7	6.8	5.5	8.1	5.2
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	10.8	8.9	13.3	14.0	18.1	40.7	15.6	14.3	13.2	11.3	9.6	11.9	9.9	14.9	14.7	10.8	11.6	12.5	8.8	12.5	13.4	10.1	14.3	11.8	19.5	15.8	16.6	18.7	11.5	15.3	9.0	13.8	15.5	13.6	14.6	21.5	9.4	8.0	9.3	10.6	11.2	10.8	13.6	14.5	12.6	38.5	14.8	41.5	18.4	12.4	20.5	14.6	9.4	24.3	32.8	26.3	49.2	82.7	19.9	19.3	20.9	24.2	22.4	37.2	31.4	34.6	23.3	39.4	19.7	16.0	19.6	21.0	30.1	29.1	40.9	28.4	38.0	51.7	23.2	49.4	14.1	55.0	43.3	12.3	24.4	29.8	40.0	18.1	32.6	64.5	51.4	46.4	36.9	32.4	62.5	22.1	22.1	95.8	25.9	50.3	27.1	29.6	27.2	43.8	49.8	34.3	21.1	18.9	37.5	31.2	17.7	55.1	32.2	65.7	35.6	13.2	46.9	18.2	19.8	64.2	13.0	46.2	26.5	2.7	2.9	4.8	5.8	3.9	7.6	3.7	5.4	6.4	3.3	4.1	5.7	6.3	8.0	6.5	3.5	4.3	6.7	3.2	13.3	18.1	14.3	13.2	12.5	13.4	15.8	16.6	15.5	13.6	14.8	24.3	7.6	9.6	3.9	6.2	11.1	14.5	9.9	4.2	2.8	4.1	13.2	7.1	4.7	11.5	5.3	11.0	4.2	7.7	11.7	9.3	1.9	11.3	41.4	7.4	7.7	7.5	4.8	12.2	4.4	7.4	12.5	6.8	5.1	8.1	2.5	11.9	7.5	7.0	10.0	0.0	5.1	4.2	4.1	9.3	14.0	44.4	3.7	6.4	7.2	10.3	7.2	3.3	7.2	5.0	13.8	9.6	9.6	3.0	5.6	12.8	5.1	2.6	6.9	5.0	0.0	4.3	8.3	20.0	8.2	6.3	15.9	10.8	10.1	5.6	7.6	18.7
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 57.9;pituitary gland: 16.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 6.1;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042615, HPA058596"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.1	7.5	20.6	0.2	17.2	0.0	0.0	11.8	26.8	0.0	10.7	5.5	0.2	0.0	0.1	0.1	1.3	0.0	0.0	15.2	57.9	0.0	0.0	0.0	0.0	24.8	29.0	0.0	5.0	0.0	16.9	0.0	29.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.0	0.1	15.5	0.0	1.0	0.5	40.9	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	17.2	11.8	26.8	15.2	57.9	24.8	29.0	29.9	15.5	40.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469689-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	32.2	26.4	25.6	23.3	28.4	64.4	40.3	30.5	37.7	30.5	25.0	30.1	23.4	34.7	32.5	26.2	32.0	17.6	23.7	25.9	26.6	31.3	32.9	24.2	35.3	27.1	27.0	39.6	25.7	33.3	20.8	29.2	27.7	24.8	29.0	25.2	24.6	26.6	53.4	35.2	26.8	31.4	27.7	28.6	27.0	28.6	26.9	37.5	28.4	39.2	36.8	32.3	27.7	31.7	37.6	73.1	54.5	51.5	52.0	37.3	72.1	48.6	50.7	101.3	81.4	72.1	66.8	92.6	35.0	44.7	71.1	63.7	109.0	60.1	118.7	61.8	57.3	83.2	44.1	229.3	70.5	110.4	56.9	46.5	75.0	79.9	94.4	39.6	52.2	69.5	93.6	64.1	50.4	88.8	82.3	86.0	69.5	84.8	97.1	67.1	65.6	47.9	65.7	70.4	55.6	62.8	57.6	68.3	83.8	55.0	42.2	70.4	39.8	47.8	57.3	45.1	71.3	79.4	148.7	133.3	20.6	56.1	52.2	67.0	62.3	58.5	88.0	71.8	93.5	129.0	94.6	89.9	74.8	107.7	121.3	95.5	19.1	109.5	71.7	79.1	116.1	93.3	25.6	28.4	30.5	37.7	25.9	26.6	27.1	27.0	27.7	27.7	26.9	31.7	33.8	35.3	29.2	2.9	52.1	70.6	63.8	78.2	72.8	23.2	25.5	31.2	20.2	21.5	46.8	27.6	16.7	59.3	45.3	19.9	33.2	38.6	7.2	24.3	25.9	36.5	24.6	35.1	7.5	36.0	43.3	34.4	16.3	27.5	45.0	23.2	25.4	21.4	29.8	25.2	6.8	22.7	28.5	19.2	39.0	6.9	35.1	21.1	32.0	9.4	34.3	26.8	46.4	4.0	11.0	31.1	22.8	28.2	30.4	42.9	25.8	35.5	36.6	28.6	19.7	51.5	36.0	68.7	64.2	39.6	67.6	57.2	47.6	20.5	27.2	49.5
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.2;brain: 129.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 129.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.2	16.3	2.2	129.6	0.1	1.9	0.0	59.4	4.1	0.0	14.2	42.7	5.0	4.1	10.3	4.8	3.1	2.2	19.8	0.0	7.0	35.5	0.7	0.2	0.0	0.0	2.0	6.0	11.9	2.7	0.3	0.0	1.8	10.5	1.4	2.0	0.7	0.9	30.3	31.3	6.7	0.0	0.4	10.7	3.7	0.2	0.0	0.9	0.7	0.3	1.8	5.2	29.4	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	129.6	0.0	59.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515008	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.4;Basal squamous epithelial cells: 36.5;Ionocytes: 89.5;Leydig cells: 96.0;Muller glia cells: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	7	"RH-30: 200.1;WM-115: 225.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.1"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		490000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (3.40e-4)"	36.8	20.7	4.1	8.2	12.1	0.4	20.3	17.3	63.6	13.1	1.4	16.8	2.4	12.0	4.0	6.5	20.2	9.4	40.9	3.2	25.1	8.0	22.8	2.9	5.0	16.9	15.2	4.1	10.9	1.3	10.5	14.7	15.1	19.1	2.4	45.1	21.2	7.6	4.8	15.9	8.0	8.2	10.9	23.0	7.9	7.7	17.2	2.0	28.9	1.3	3.9	15.3	13.2	27.8	0.0	0.1	6.3	10.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.1	0.0	2.1	0.1	3.4	4.8	1.5	4.6	0.0	0.4	0.7	0.4	0.0	3.8	0.4	0.3	0.3	20.9	0.3	0.6	1.5	0.1	0.0	0.0	0.0	0.1	29.5	0.6	0.0	0.1	3.8	0.0	0.2	3.9	200.1	0.2	0.0	0.0	1.9	1.3	0.1	0.0	14.0	7.4	0.4	0.2	0.0	0.1	3.4	0.6	10.2	0.2	0.3	0.1	0.2	1.9	225.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	4.1	12.1	17.3	63.6	3.2	25.1	16.9	15.2	15.1	10.9	17.2	27.8	1.2	0.0	0.0	0.0	1.1	3.6	33.1	52.4	36.5	4.8	2.4	10.9	0.7	0.0	3.8	0.0	4.2	0.5	4.0	0.0	0.0	0.1	0.7	0.2	0.6	1.3	0.0	0.0	0.1	0.0	0.5	7.3	0.5	0.2	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	89.5	0.0	3.1	2.9	96.0	0.7	16.0	0.0	0.0	151.7	0.0	0.0	6.5	0.0	0.0	27.8	1.0	3.7	0.0	0.1	1.7	7.0	32.9	1.7	12.9	0.4	0.9	1.8	1.7	0.1	2.3	0.4	0.0	2.9
NGLY1	"FLJ11005, PNG-1, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 594.1;Late spermatids: 963.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.8	13.7	6.9	15.1	7.1	25.6	15.6	10.0	9.2	12.3	10.5	17.9	14.6	9.7	16.2	12.3	11.5	9.8	16.1	7.5	8.0	17.8	22.4	11.4	25.9	8.1	9.2	11.8	15.9	11.6	5.9	11.9	8.2	14.2	20.6	13.5	14.9	9.9	49.5	9.8	15.4	12.1	6.7	15.5	15.3	55.8	9.1	27.4	13.6	38.1	25.3	16.1	9.9	8.6	27.6	24.2	12.8	27.4	23.5	22.7	15.0	21.6	20.4	29.7	25.5	14.8	20.9	64.3	24.5	19.9	28.3	12.1	45.5	14.0	39.2	27.8	18.5	49.9	15.1	24.8	29.0	48.3	25.7	20.3	17.5	33.6	31.5	32.2	31.3	32.8	47.9	49.1	30.3	11.7	60.7	26.8	17.4	33.2	43.5	54.2	16.5	54.6	27.1	31.1	8.3	9.5	35.1	33.3	23.3	24.0	31.1	40.6	15.7	15.5	20.1	27.5	29.9	60.4	60.7	48.8	25.1	52.8	18.1	48.8	19.7	27.8	22.9	19.4	26.0	42.2	23.2	23.5	31.6	33.4	21.8	23.6	18.3	45.0	16.0	65.1	19.0	20.7	6.9	7.1	10.0	9.2	7.5	8.0	8.1	9.2	8.2	6.7	9.1	8.6	24.3	19.2	17.3	34.0	84.1	12.6	23.7	25.0	16.5	22.3	19.8	16.8	30.3	27.1	21.4	5.5	12.5	40.5	74.7	25.0	35.2	30.6	594.1	20.0	19.4	20.9	7.2	26.9	51.7	44.2	31.7	19.2	17.3	19.2	20.8	77.7	17.5	25.1	23.4	11.8	64.2	29.3	14.2	22.2	63.6	963.6	14.9	33.6	24.9	31.9	30.0	20.7	45.3	54.3	59.4	27.2	27.3	15.8	87.1	27.8	26.0	38.2	25.2	22.7	0.0	26.0	17.9	105.7	52.7	18.8	13.8	56.6	41.1	26.3	30.3	20.6
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219069357-219160865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.8;Microglial cells: 11.2;Oligodendrocytes: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: AB_2678707"	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	10.2	8.4	2.4	4.4	2.5	4.5	8.5	3.8	3.8	9.4	2.2	14.0	6.9	8.7	4.3	7.2	7.4	4.8	6.2	2.4	2.9	12.8	8.1	6.9	6.1	3.3	2.5	9.1	8.4	3.4	2.8	4.6	3.2	6.7	8.4	3.4	5.7	4.3	17.1	8.4	12.2	8.1	2.7	6.9	9.0	18.7	2.7	6.1	4.6	7.6	5.8	10.4	8.7	3.5	5.5	8.2	13.9	12.6	15.6	17.9	8.0	10.9	9.6	13.2	15.4	25.4	5.9	12.2	8.4	11.4	13.4	7.2	20.5	10.9	11.8	13.8	9.0	18.1	10.0	17.5	12.5	8.5	13.9	15.5	21.2	10.5	12.5	8.9	11.1	7.8	22.3	11.8	10.7	4.6	11.5	10.3	15.9	5.1	8.0	14.6	10.2	9.8	10.5	8.2	10.2	11.4	5.0	7.1	15.8	15.6	6.4	8.0	9.9	10.0	9.3	4.4	9.1	6.3	8.0	13.2	6.1	16.2	10.3	6.3	11.9	6.6	7.0	17.7	12.2	12.0	11.4	9.3	8.7	9.0	14.1	10.4	3.3	11.6	15.6	4.8	12.8	9.1	2.4	2.5	3.8	3.8	2.4	2.9	3.3	2.5	3.2	2.7	2.7	3.5	0.3	0.0	0.0	5.9	3.5	0.4	0.0	0.2	5.7	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.2	1.7	7.8	0.0	1.6	0.7	0.1	0.3	1.0	2.4	3.8	4.7	1.9	0.3	0.6	5.6	0.2	0.0	0.0	0.0	0.3	0.3	0.0	5.1	3.4	0.0	0.0	0.0	0.2	0.3	2.1	0.0	11.2	3.1	0.0	0.0	5.0	8.1	1.0	2.9	0.0	6.1	0.2	3.4	0.4	0.0	0.0	0.0	0.1	1.3	0.2	0.5	5.9	0.0	0.3	2.6	0.2	3.1	0.0
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 58.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.0	0.0	2.0	0.0	1.4	0.0	0.1	5.9	2.1	0.3	0.2	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	3.2	4.0	0.0	0.0	0.2	0.0	3.8	5.1	0.0	0.0	0.0	0.2	0.0	7.4	0.2	0.0	2.1	0.4	0.1	0.2	3.3	0.0	0.0	2.5	0.0	0.2	0.4	6.7	0.0	0.0	0.0	0.0	0.0	0.7	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	5.9	2.1	3.2	4.0	3.8	5.1	7.4	2.5	6.7	3.0	0.0	0.0	0.0	0.3	0.0	2.8	2.8	3.3	14.8	3.9	0.0	0.6	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	1.8	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.5	7.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.4	0.0	3.5	0.3	5.1	3.4	7.0	2.3	0.0	0.0	0.0	0.0	0.4
NHLRC2	"DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492"	ENSG00000196865	"NHL repeat containing 2"	Q8NBF2	10	113854661-113917194	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038493, HPA057564"	Approved		Approved	Nucleoplasm		NA	NA		120000	"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA038493: AB_10672519, HPA057564: AB_2683469"	"unprognostic (7.09e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.88e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-2)"	5.9	5.6	4.4	4.9	5.1	4.2	6.2	5.8	5.2	7.0	7.6	6.5	5.4	6.2	6.9	4.7	5.7	4.1	16.5	3.5	4.3	5.4	8.7	6.6	5.9	5.1	4.8	7.2	7.9	10.5	5.3	6.4	5.1	8.8	5.8	10.1	6.7	4.8	10.6	7.0	6.2	5.2	4.2	7.2	6.4	3.8	4.6	4.6	7.6	7.5	5.5	6.2	6.2	6.0	10.8	6.8	13.1	10.8	4.7	8.4	8.3	7.4	8.8	6.3	6.9	4.7	10.3	5.8	5.2	7.5	5.5	9.4	10.8	6.1	10.7	7.0	5.4	6.2	5.7	6.7	7.1	8.9	6.8	5.8	7.4	7.0	14.4	12.2	7.7	4.1	7.4	6.5	8.6	5.0	5.1	6.9	3.9	6.6	3.4	4.7	18.8	3.4	7.8	5.9	3.4	6.9	5.8	7.3	9.1	6.1	5.3	6.6	9.9	7.5	7.6	4.8	11.3	4.4	2.3	5.7	6.2	14.0	5.1	0.9	0.5	0.7	0.6	0.4	0.6	0.6	0.4	0.7	0.6	0.6	0.4	0.5	0.3	0.6	0.9	0.8	0.5	0.3	4.4	5.1	5.8	5.2	3.5	4.3	5.1	4.8	5.1	4.2	4.6	6.0	22.4	19.2	21.3	40.5	13.7	7.9	13.1	8.9	11.4	20.8	15.2	9.7	74.4	18.6	18.8	36.8	14.6	16.8	8.3	8.5	7.9	10.9	5.4	15.6	24.1	19.4	10.3	27.6	45.5	12.3	12.9	19.3	16.3	14.4	10.8	23.3	19.2	28.2	10.1	28.6	34.7	15.8	10.2	17.6	6.7	8.6	18.0	13.7	7.2	44.0	13.2	20.6	13.4	58.3	55.2	11.1	15.4	26.4	9.1	17.3	12.4	11.8	8.9	25.7	65.7	29.1	19.1	16.0	11.4	9.9	8.4	18.2	10.9	18.7	12.3	14.1
NHLRC3		ENSG00000188811	"NHL repeat containing 3"	Q5JS37	13	39038306-39050109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013738	Uncertain				"Secreted to blood"	NA	NA		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"			"HPA013738: AB_1854455"	"unprognostic (7.92e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.81e-2)"	18.5	12.0	7.8	10.9	8.6	7.4	15.2	7.6	10.5	12.1	9.7	12.9	11.6	13.5	20.6	7.4	10.7	13.0	10.2	7.9	8.5	16.7	25.9	13.9	14.3	10.1	8.1	15.8	13.4	8.4	11.4	19.4	9.5	11.0	16.6	12.9	12.2	9.8	10.8	12.0	12.3	11.8	8.6	16.1	16.7	8.7	8.5	8.1	16.9	10.4	12.0	10.1	9.8	10.4	5.1	3.1	13.5	6.5	15.4	16.0	20.9	7.8	9.7	8.2	10.9	9.8	22.6	13.9	14.5	5.2	10.3	10.5	5.4	4.5	7.1	20.3	5.8	11.1	6.9	11.2	9.8	11.1	15.8	13.0	5.8	5.7	5.5	12.3	5.2	11.2	4.0	16.9	7.6	3.8	8.7	17.2	3.7	11.8	3.2	9.2	36.2	7.8	12.6	10.1	3.1	5.6	5.0	6.9	18.4	7.5	9.0	17.5	6.0	11.2	5.4	14.7	8.3	13.5	12.3	5.5	14.9	11.9	8.2	1.5	6.8	0.8	4.5	6.9	5.0	4.1	3.2	3.7	6.0	3.0	3.3	4.8	0.6	4.5	6.8	5.4	4.1	3.7	7.8	8.6	7.6	10.5	7.9	8.5	10.1	8.1	9.5	8.6	8.5	10.4	20.6	12.8	20.2	22.9	36.7	8.4	16.9	40.8	15.9	70.8	22.2	13.5	13.0	18.6	35.8	35.0	56.3	78.4	52.5	22.5	9.8	21.0	6.7	14.1	25.3	22.4	13.8	23.3	37.4	16.5	14.9	21.8	17.9	14.6	15.8	76.7	42.5	34.5	43.6	79.1	45.8	28.6	42.7	57.6	27.0	4.6	61.2	35.2	17.8	27.2	47.7	33.5	102.0	40.2	131.7	17.2	25.0	41.8	30.7	10.2	34.8	16.3	32.1	93.1	59.2	14.2	18.7	51.1	41.0	9.0	8.9	24.2	30.5	50.2	28.4	11.7
NHP2	"FLJ20479, NOLA2"	ENSG00000145912	"NHP2 ribonucleoprotein"	Q9NX24	5	178149463-178153894	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 1398.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044171, HPA050400"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044171: AB_2678844, HPA050400: AB_2681113"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (8.87e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.63e-2)"	101.1	106.0	100.4	76.2	108.4	111.6	102.0	106.0	129.1	102.7	86.8	91.8	56.9	99.8	40.8	185.4	89.0	41.6	110.2	105.7	105.4	109.4	107.4	70.4	96.8	101.3	101.5	107.6	114.6	52.7	79.0	51.1	101.7	89.9	45.1	31.0	90.0	51.1	133.2	129.8	68.3	49.5	105.4	77.1	89.6	64.2	104.1	64.8	78.3	58.1	68.3	104.9	111.0	109.1	288.3	474.1	148.2	417.3	99.9	133.1	499.8	216.1	119.0	260.4	222.5	290.8	252.4	413.6	396.3	133.4	233.8	185.3	225.7	514.8	131.8	778.2	789.2	216.4	343.0	319.3	168.1	371.8	229.6	162.3	240.5	199.6	176.9	96.7	243.6	294.0	226.5	273.5	143.6	1398.1	529.0	280.1	215.9	271.9	739.0	362.6	190.9	641.5	192.3	195.5	375.2	407.7	167.9	470.0	426.5	89.7	227.1	274.6	222.4	253.3	274.0	207.6	513.3	316.8	679.2	494.1	250.1	519.9	284.6	58.3	218.3	32.8	188.4	254.5	265.5	335.5	232.7	218.7	310.1	347.2	238.9	245.3	16.8	260.1	188.2	507.4	245.0	363.7	100.4	108.4	106.0	129.1	105.7	105.4	101.3	101.5	101.7	105.4	104.1	109.1	94.4	60.9	67.3	9.4	123.7	193.2	226.4	222.9	155.4	46.8	228.2	309.9	11.6	131.5	139.5	126.9	18.8	233.7	85.4	88.0	358.1	230.6	59.2	75.2	165.5	116.6	126.6	100.7	9.2	302.4	359.6	113.8	76.5	83.2	79.3	133.0	84.3	172.3	172.6	30.3	9.1	151.8	97.6	78.4	131.8	114.0	134.8	81.3	145.9	5.6	117.2	78.3	93.7	9.0	14.0	231.0	71.2	97.4	128.7	389.5	54.5	320.7	73.1	36.7	59.2	100.0	139.4	107.5	129.2	343.9	242.9	166.9	87.0	183.3	207.7	289.4
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	3.2	4.1	2.9	1.3	2.4	0.4	2.8	0.0	4.2	6.1	6.8	4.1	0.8	4.8	2.8	1.8	2.7	1.6	0.9	1.8	2.5	5.1	0.2	1.1	0.5	3.3	2.8	3.5	0.5	0.3	2.8	2.6	3.0	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	1.7	1.0	2.2	2.5	3.8	2.2	2.6	0.7	0.5	4.0	3.7	0.9	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	2.9	2.4	0.0	4.2	1.8	2.5	3.3	2.8	3.0	1.7	3.8	0.9	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.6;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.2;TIME: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	4.1	1.2	15.7	2.4	14.1	0.3	2.5	9.7	8.5	2.4	16.6	13.2	15.8	1.2	4.6	10.4	1.0	3.0	15.7	14.6	11.2	5.8	14.8	12.8	1.0	16.2	15.9	0.5	3.3	2.1	1.1	4.3	10.7	0.8	11.4	2.6	3.5	0.5	0.5	11.4	23.2	3.2	9.2	2.6	7.8	0.4	14.4	0.6	1.4	0.8	2.1	2.7	4.5	5.6	5.5	4.7	32.8	13.8	9.4	11.4	12.2	4.8	2.3	1.7	1.6	6.2	3.1	0.0	6.0	4.1	3.1	12.3	20.0	12.5	0.9	0.4	13.4	3.4	2.2	46.2	13.8	12.4	2.3	16.7	7.0	0.9	14.1	1.8	23.3	1.9	0.0	1.8	7.2	10.7	1.3	1.0	13.1	3.1	8.8	14.1	3.4	1.0	11.2	13.7	12.4	0.0	5.1	10.3	33.4	21.5	3.3	3.9	64.3	4.6	4.5	4.6	13.3	1.2	2.7	0.0	0.4	5.0	25.5	0.4	1.2	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.2	15.7	14.1	9.7	8.5	14.6	11.2	16.2	15.9	10.7	9.2	14.4	5.6	6.2	60.9	66.9	502.1	0.5	42.8	3.1	6.6	4.0	0.6	4.1	6.0	22.7	15.7	9.9	29.5	29.2	14.2	0.1	84.1	9.8	3.7	1.1	19.0	1.8	9.3	20.3	2.7	3.3	3.6	3.5	15.6	16.8	16.9	8.8	1.5	26.4	38.1	4.5	37.0	2.9	32.3	6.1	9.4	7.1	0.4	0.6	7.5	21.4	104.0	0.6	15.4	0.0	79.9	2.3	3.9	43.0	0.0	0.1	5.4	87.3	15.8	22.0	1.4	6.6	2.3	4.7	0.0	1.1	7.7	49.2	43.4	1.8	0.8	45.4	10.5
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049771, HPA075115"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA049771: AB_2680872, HPA075115: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	4.7	1.3	8.1	3.0	9.6	2.2	3.2	11.8	6.6	3.2	12.3	4.9	0.8	3.2	1.4	3.1	2.3	4.3	2.2	6.6	5.9	1.1	0.9	3.4	0.8	1.5	9.1	1.6	0.6	1.6	2.6	2.2	4.6	3.5	1.9	0.3	1.5	4.8	0.8	1.4	1.7	6.9	0.8	2.8	1.9	2.4	6.9	1.0	2.7	2.4	0.9	3.7	2.3	0.0	0.4	0.6	25.2	0.1	0.3	1.0	0.2	0.9	4.7	0.1	0.4	0.1	0.0	0.2	29.5	2.6	0.1	0.0	1.6	0.0	0.6	0.1	0.6	0.1	0.1	0.0	0.1	0.1	1.4	0.5	0.0	0.9	0.0	0.1	27.8	0.1	0.0	4.1	0.2	0.2	0.1	2.1	4.8	0.0	0.0	0.1	1.4	0.0	0.1	2.9	0.6	5.7	0.0	0.0	0.0	7.1	0.1	1.7	16.3	0.0	1.6	2.0	0.0	0.1	0.0	0.1	1.1	20.5	0.0	5.0	7.1	14.3	2.0	4.7	1.9	0.0	1.0	1.7	4.1	0.0	0.1	0.2	15.6	1.0	3.7	0.0	0.1	2.3	8.1	9.6	11.8	6.6	6.6	5.9	1.5	9.1	4.6	0.8	6.9	0.0	29.2	0.0	1.9	1.0	7.3	0.5	101.2	0.0	0.6	0.9	5.0	3.7	19.6	21.5	0.0	1.8	0.0	17.9	10.1	2.0	0.0	0.2	4.7	3.3	2.8	32.9	1.2	17.3	7.8	0.7	24.3	15.2	0.5	9.0	7.6	0.9	51.0	19.0	19.1	0.0	5.8	3.7	0.0	49.0	0.5	7.4	31.7	19.7	1.8	19.7	57.7	1.5	32.0	5.5	1.1	0.6	3.1	21.4	2.8	90.5	7.8	2.9	0.0	0.5	26.3	39.7	12.6	2.7	3.7	0.3	0.3	24.9	17.0	2.9	3.8	80.7
NIBAN1	"C1orf24, FAM129A, GIG39, NIBAN"	ENSG00000135842	"Niban apoptosis regulator 1"	Q9BZQ8	1	184790724-184974508	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 164.1"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 692.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 72.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 72.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.8;Karpas-707: 85.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	18.2	7.8	1.4	38.9	1.6	8.8	24.0	1.5	1.9	14.8	3.1	104.7	8.5	24.2	6.2	61.2	22.1	27.7	164.1	1.5	2.0	3.3	2.7	18.1	11.3	3.9	2.4	4.9	85.7	4.2	2.1	6.2	3.1	59.6	15.9	0.8	100.6	43.1	60.9	8.8	18.5	41.0	2.8	12.3	58.9	1.9	2.2	12.2	15.3	41.2	17.3	105.8	14.6	3.2	42.0	0.5	0.2	0.1	28.0	42.2	1.6	21.1	42.9	17.7	22.3	0.0	17.3	0.0	13.6	54.2	4.6	46.0	2.4	1.5	28.4	83.8	3.2	17.5	8.2	0.0	65.2	57.2	19.1	39.1	65.3	52.1	62.4	12.6	0.1	6.3	4.2	85.5	0.5	0.2	1.9	10.0	11.1	0.0	4.3	13.3	9.9	0.8	24.5	0.8	2.3	2.1	0.4	0.1	29.9	7.0	9.0	17.9	3.3	35.0	0.1	6.3	43.5	71.1	30.2	8.7	68.8	23.4	35.3	20.4	3.6	10.9	5.1	2.1	4.4	1.0	4.7	5.0	5.2	0.3	0.4	1.8	72.1	5.7	0.8	0.5	11.9	2.2	1.4	1.6	1.5	1.9	1.5	2.0	3.9	2.4	3.1	2.8	2.2	3.2	20.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	692.7	0.0	0.0	0.0	0.0	0.4	52.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	24.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.4	27.4	0.0	0.0	0.0
NIBAN2	"bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Niban apoptosis regulator 2"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 606.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	48.7	107.5	26.7	36.6	24.7	27.3	42.0	25.2	24.5	96.0	45.3	74.6	50.8	38.9	12.6	606.7	39.4	39.6	39.4	22.7	35.0	72.3	16.7	121.9	6.6	48.9	34.3	31.6	142.6	26.2	34.0	84.8	36.3	66.5	30.3	2.7	142.1	32.2	13.6	111.3	53.9	22.0	39.7	32.2	83.3	11.0	34.7	5.6	110.6	11.3	53.6	68.4	189.6	31.9	134.0	149.8	29.9	39.3	87.9	170.1	138.2	259.1	238.5	140.1	86.4	48.2	143.7	0.4	100.4	295.5	172.9	217.5	25.9	192.2	45.9	25.2	27.5	22.8	218.9	50.4	173.1	1.0	62.0	187.3	118.3	231.4	80.8	256.8	213.6	8.4	43.5	1.2	269.8	157.3	1.6	37.6	30.9	228.0	194.4	16.0	99.9	70.1	120.5	105.6	47.4	22.1	212.3	149.0	93.4	42.1	98.2	7.5	279.9	143.1	62.4	182.2	218.0	2.5	5.1	0.6	403.3	21.6	271.1	0.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	26.7	24.7	25.2	24.5	22.7	35.0	48.9	34.3	36.3	39.7	34.7	31.9	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	73.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	40.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	120.9	0.1	0.0	0.0	0.0
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Cell type enriched"	"Detected in some"	8	"B-cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	19	"Daudi: 50.1;REH: 23.8;U-698: 33.2"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.4	0.0	0.0	10.7	0.1	15.4	0.1	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.5	0.3	0.4	26.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	16.6	0.0	0.0	34.7	0.7	0.5	0.0	1.8	0.6	0.0	12.2	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	52.1	0.0	0.1	0.0	0.0	0.0	110.7	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065109	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 230.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 362.9;Fibroblasts: 137.6;Hepatic stellate cells: 191.3;Leydig cells: 177.3;Peritubular cells: 125.6;Sertoli cells: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"classical monocyte: 5.7;intermediate monocyte: 11.2;myeloid DC: 4.4;non-classical monocyte: 7.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 4.4;monocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1569.3;ASC TERT1: 726.8;HSkMC: 619.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010044	Approved				"Secreted to extracellular matrix"	NA	NA		150000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	110.0	35.5	4.1	30.5	6.8	2.6	88.9	3.4	7.4	78.9	8.8	95.9	21.7	87.6	21.3	26.8	88.1	66.2	53.7	3.8	4.3	28.4	76.9	56.4	12.3	4.2	4.0	77.7	18.3	12.6	10.4	230.9	3.9	33.1	21.3	2.0	17.3	40.2	25.1	24.6	61.0	79.8	3.9	38.0	67.0	6.2	5.3	5.4	27.6	26.9	6.1	62.9	53.4	3.8	1.2	5.3	55.3	0.1	1569.3	726.8	106.2	128.1	105.3	78.0	50.7	30.5	39.8	0.0	25.0	191.2	21.3	4.5	36.3	0.4	45.2	0.2	61.3	8.1	5.9	46.3	295.6	0.0	0.7	619.5	5.3	38.2	1.5	30.3	165.7	0.0	0.0	0.0	26.9	0.0	0.1	0.3	56.9	0.0	6.7	0.0	0.1	0.1	0.0	16.6	0.3	47.0	1.0	0.0	10.2	21.3	0.1	52.1	146.5	67.5	44.8	0.1	57.4	0.1	0.0	0.1	0.8	0.0	105.4	0.2	5.7	0.0	0.0	11.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.1	7.3	0.0	0.0	2.1	4.1	6.8	3.4	7.4	3.8	4.3	4.2	4.0	3.9	3.9	5.3	3.8	48.7	3.2	1.5	18.9	1.7	6.0	1.3	1.5	0.0	0.2	1.2	2.0	24.0	10.0	2.0	0.0	0.0	13.5	0.6	0.0	0.0	0.5	1.4	11.5	362.9	49.4	0.0	5.3	0.6	0.9	10.2	137.6	0.5	9.6	1.3	2.1	191.3	73.4	8.0	3.3	3.3	0.0	10.2	15.1	19.3	5.7	177.3	9.9	17.8	30.0	10.0	2.2	1.0	1.0	0.3	4.3	0.0	125.6	0.0	5.3	0.0	8.6	0.1	0.1	243.3	18.7	92.3	0.8	0.2	0.8	5.3	15.7	2.9	5.7	0.1	7.3
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		6300000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	28.3	5.2	0.9	9.2	1.2	0.7	9.6	0.6	1.4	7.5	44.0	8.8	2.3	17.4	5.8	5.4	6.7	19.0	15.6	1.4	0.5	4.8	5.9	6.1	3.5	1.8	0.6	18.9	3.4	13.2	2.5	60.8	0.5	8.4	6.8	0.1	3.6	10.4	4.3	1.7	3.5	11.4	1.1	1.9	6.8	1.4	0.9	2.1	31.6	5.5	1.4	15.4	5.4	1.6	0.0	3.4	76.6	0.0	285.4	113.0	0.2	152.1	131.8	14.5	15.0	0.4	0.0	0.0	22.2	17.3	0.0	10.7	9.9	0.1	3.9	0.1	2.0	0.0	3.0	0.0	158.1	0.0	0.0	591.5	0.0	59.6	0.1	82.5	8.1	0.1	0.0	0.0	8.6	0.0	0.0	0.4	3.3	0.0	5.1	23.5	0.2	0.1	19.9	0.0	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.0	0.9	54.4	0.6	33.0	0.0	0.0	0.0	0.1	17.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.6	1.4	1.4	0.5	1.8	0.6	0.5	1.1	0.9	1.6	31.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	1.4	0.2	0.3	2.1	0.0	0.0	1.8	0.0	0.7	0.7	3.7	0.0	0.1	14.0	1.5	11.3	19.7	0.0	0.0	0.8	0.0	1.1	46.0	1.1	0.4	1.3	0.4	8.6	0.0	1.6	0.0	1.7	2.0	0.0	0.3	1.2	4.4	6.2	0.3	3.6	19.7	1.0	0.0	0.0	2.0	4.8	0.2	1.3	8.6	0.1	0.2	1.7	0.4	0.0	0.8	6.6	6.1	22.6	0.2	0.1	0.1	1.0	0.8	0.4	19.1	3.0	0.2
NIF3L1	"ALS2CR1, CALS-7, MDS015"	ENSG00000196290	"NGG1 interacting factor 3 like 1"	Q9GZT8	2	200889327-200903938	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036335, HPA036336, HPA061466"	Supported		Approved	Vesicles		NA	NA		9800000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (2.48e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.04e-3)"	"unprognostic (8.61e-2)"	13.2	19.2	14.1	15.2	15.8	11.0	24.3	15.7	23.8	17.7	13.7	21.8	16.5	15.9	26.3	16.7	22.5	13.2	21.5	14.9	14.8	24.3	22.9	15.6	26.5	15.3	13.8	21.4	15.5	27.0	9.7	19.1	16.2	17.2	28.0	32.7	19.8	19.8	23.5	21.6	15.7	19.1	15.6	18.1	20.1	18.5	14.1	26.5	19.4	30.6	32.4	17.1	12.7	17.5	39.5	42.1	66.9	41.3	29.8	37.1	45.9	42.6	45.4	88.6	71.3	66.1	44.7	31.8	40.2	36.5	64.1	42.7	96.8	56.0	94.6	42.4	90.8	47.4	73.6	70.9	27.0	56.8	31.3	31.7	52.3	58.6	55.8	39.9	29.9	65.6	70.2	31.4	52.7	51.4	69.9	71.1	79.1	44.7	73.5	41.1	37.1	61.6	46.8	40.6	42.3	49.5	36.6	36.8	51.9	94.4	36.5	50.5	15.6	42.2	39.8	38.3	39.0	28.4	58.3	68.4	41.4	45.6	41.6	70.1	23.0	30.7	27.8	34.9	29.1	31.4	31.8	35.3	28.8	23.7	35.4	29.1	7.8	33.6	31.1	29.8	32.0	24.2	14.1	15.8	15.7	23.8	14.9	14.8	15.3	13.8	16.2	15.6	14.1	17.5	6.0	0.0	7.0	2.6	11.7	3.7	7.7	43.1	12.5	90.5	6.9	9.3	13.9	10.0	26.5	5.5	14.6	34.3	8.0	7.5	15.6	20.3	16.2	10.2	9.3	7.0	1.8	23.2	6.2	18.2	35.6	9.8	9.7	7.8	9.5	12.7	6.8	9.3	17.2	18.5	5.7	10.5	26.4	7.3	2.2	6.5	16.1	9.5	5.4	5.6	17.2	18.8	8.2	2.5	5.7	13.2	9.2	19.2	23.9	6.3	10.1	21.3	24.9	27.4	6.6	7.2	14.5	30.9	24.4	12.9	8.2	22.6	10.0	11.1	11.4	6.2
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831162	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.5;Muller glia cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Centrosome"	Nucleoplasm	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	11.2	4.4	10.1	19.9	10.8	43.2	8.9	9.5	15.0	7.2	0.0	8.3	4.8	7.7	2.8	12.9	10.5	8.9	18.2	10.4	0.9	6.7	5.7	9.5	25.9	0.0	1.3	9.7	7.2	9.0	8.9	16.8	0.0	6.9	8.6	19.1	5.4	5.4	6.0	12.9	7.1	10.3	0.0	16.2	9.3	5.2	3.0	19.9	7.7	7.4	23.7	13.6	5.7	7.5	29.1	21.6	42.4	36.8	16.7	26.8	20.4	26.5	22.1	21.4	18.0	14.7	14.6	48.5	17.7	35.5	19.9	32.5	34.2	16.3	45.3	34.7	10.4	25.1	13.2	12.3	9.8	41.6	57.5	18.4	11.4	37.2	14.9	13.3	34.6	25.9	6.6	26.3	31.8	36.8	22.6	14.0	6.4	10.1	23.6	37.1	81.6	5.7	20.1	42.9	18.6	22.2	34.0	9.6	25.1	10.2	21.2	39.3	50.9	55.2	74.3	20.5	29.0	18.6	12.1	34.3	14.4	32.8	30.4	31.9	2.9	24.0	3.9	2.5	3.3	8.9	2.4	6.2	2.0	6.2	5.1	4.7	9.6	2.9	2.1	7.7	2.5	1.4	10.1	10.8	9.5	15.0	10.4	0.9	0.0	1.3	0.0	0.0	3.0	7.5	34.0	6.4	7.7	100.2	85.6	18.4	9.1	10.2	18.8	13.3	13.3	10.9	68.0	14.3	27.1	11.0	62.6	12.4	102.7	8.7	3.9	7.3	22.2	17.3	28.5	26.7	12.6	29.0	240.5	4.2	11.3	32.9	7.7	14.9	31.6	3.9	21.8	4.4	22.7	6.7	110.4	5.7	20.3	46.8	42.2	10.4	8.4	61.3	23.2	63.7	63.2	150.2	57.7	105.6	75.1	5.2	6.2	9.4	48.1	16.5	3.2	7.3	29.4	21.0	32.9	44.9	24.1	0.2	4.3	20.1	21.0	9.7	56.2	21.8	6.9	15.5
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121496-93134251	"Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 286.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 539.9;Langerhans cells: 741.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1668.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 1668.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 197.5;MCF7: 191.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"			"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	60.9	129.8	51.0	39.9	48.9	286.9	53.0	47.9	58.7	47.6	50.2	60.1	27.0	36.5	20.2	25.7	47.6	39.2	64.0	44.2	51.9	100.4	118.0	65.0	41.5	54.5	53.2	35.9	35.0	137.7	59.2	66.6	53.3	58.9	16.5	6.1	77.3	56.2	38.0	80.4	37.6	36.0	57.6	89.9	42.5	37.6	57.2	30.5	71.4	30.0	19.6	100.5	37.9	59.2	45.0	68.2	13.2	30.0	47.4	19.1	51.6	30.2	85.9	43.5	26.7	29.5	15.5	0.6	15.0	29.7	47.6	44.8	14.7	84.6	9.4	103.3	28.7	6.8	17.2	197.5	163.7	4.8	13.8	62.5	80.9	41.1	22.5	132.4	41.3	16.3	5.0	49.6	9.9	191.1	13.9	13.8	18.7	51.9	53.0	24.6	10.3	79.0	35.0	18.6	4.3	18.4	67.3	105.4	41.9	22.0	81.9	31.3	31.1	15.8	44.6	33.2	22.9	26.2	11.4	1.0	48.2	14.8	12.1	152.9	313.3	824.9	69.8	315.4	94.5	7.8	65.0	59.3	75.9	2.4	76.5	55.1	1668.9	44.7	355.8	10.7	73.8	219.1	51.0	48.9	47.9	58.7	44.2	51.9	54.5	53.2	53.3	57.6	57.2	59.2	15.7	28.9	41.6	6.5	24.3	114.6	75.8	273.0	130.3	1.8	117.8	96.6	31.6	62.9	80.7	40.5	0.0	128.3	45.8	19.4	129.1	95.2	3.9	22.9	20.9	46.9	18.0	3.0	3.4	101.7	78.3	64.9	20.9	24.5	47.0	13.8	23.6	48.5	539.9	1.7	3.9	21.3	111.9	176.9	741.7	21.1	42.0	278.1	147.7	18.7	214.9	76.1	33.0	3.0	1.7	68.7	23.7	72.6	32.5	60.3	75.5	240.6	18.8	3.8	13.1	45.7	53.3	0.9	11.4	36.3	135.7	73.3	54.7	4.5	19.7	76.9
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452697-25585531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	4.0	8.6	4.9	2.0	5.9	0.6	4.0	10.4	6.1	10.1	8.8	9.8	3.2	7.2	7.2	5.8	5.2	3.3	4.0	4.4	6.9	15.1	8.1	4.1	2.2	7.9	7.1	18.9	5.4	8.2	9.9	1.5	7.0	8.8	2.1	4.7	4.4	3.7	4.5	2.4	3.9	3.5	5.5	4.9	6.3	7.7	6.5	15.7	10.2	1.2	2.2	3.6	8.5	6.8	1.0	10.8	23.0	15.1	2.6	7.5	7.1	3.6	3.1	3.1	4.4	2.8	7.5	0.6	5.0	5.6	7.6	0.8	3.4	0.7	2.6	0.5	4.7	1.6	5.0	37.5	5.4	0.6	0.1	9.2	0.7	3.6	0.0	8.8	6.8	17.8	1.9	0.3	3.8	9.6	21.7	0.7	6.5	0.1	1.1	0.5	17.9	0.8	1.5	1.3	22.7	16.0	8.2	3.0	9.1	18.3	4.9	6.4	0.3	0.1	8.6	0.1	0.2	2.3	4.4	0.1	0.2	0.6	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.9	10.4	6.1	4.4	6.9	7.9	7.1	7.0	5.5	6.5	6.8	1.2	0.0	14.6	42.4	0.8	2.0	4.9	2.5	5.7	3.0	2.8	3.3	6.5	12.8	4.8	7.3	25.0	2.8	0.6	0.4	0.0	5.6	0.6	4.2	7.3	2.3	6.1	0.0	7.4	1.2	1.3	8.7	4.6	3.4	0.0	29.6	8.9	8.4	2.3	8.4	32.6	2.3	8.2	0.3	2.0	2.7	13.1	0.8	0.0	12.2	0.0	3.2	2.1	47.3	19.4	2.8	1.5	12.4	0.9	4.5	0.7	8.8	13.7	1.9	6.6	10.8	4.7	2.5	5.0	4.3	0.9	1.5	1.1	21.0	2.5	1.9
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"Nucleolar pre-rRNA processing protein NIP7"	Q9Y221	16	69337996-69343106	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.9	14.1	7.1	17.9	7.5	26.2	16.0	7.8	8.1	11.4	9.6	16.6	14.4	11.3	14.2	17.2	12.1	12.9	7.7	7.8	7.3	13.2	17.2	10.6	23.6	7.7	7.3	7.4	10.3	11.4	5.2	14.5	8.1	9.8	16.1	3.5	8.5	8.9	8.7	12.7	12.0	14.1	7.6	13.1	11.5	12.3	8.1	21.4	11.2	9.8	26.9	24.9	8.6	8.5	57.9	39.7	31.2	43.0	44.0	38.5	48.8	52.7	40.6	87.8	62.7	66.7	61.6	105.5	57.1	48.3	36.5	60.1	63.7	80.0	112.5	28.9	51.2	53.8	27.0	83.6	42.6	118.1	34.0	42.2	63.1	83.1	88.7	25.7	50.5	60.7	115.1	17.5	62.3	69.8	78.6	81.9	94.4	50.9	47.7	108.6	34.3	95.7	54.6	38.8	41.3	57.8	107.8	31.0	59.8	35.0	44.3	72.4	43.5	63.5	54.7	49.5	97.0	54.4	45.0	250.2	37.9	69.4	63.4	16.7	12.7	9.8	28.4	14.9	29.9	28.9	25.2	33.3	22.8	21.1	23.3	30.1	4.3	24.8	21.4	20.7	28.9	16.9	7.1	7.5	7.8	8.1	7.8	7.3	7.7	7.3	8.1	7.6	8.1	8.5	28.2	3.2	12.7	3.9	33.7	53.7	58.1	34.6	45.5	8.8	21.7	18.3	5.5	14.3	21.1	20.2	16.7	33.2	33.2	14.7	21.5	35.9	43.8	24.5	32.0	28.3	3.0	37.9	5.1	26.1	36.5	24.0	11.2	23.2	17.7	20.5	18.2	12.1	24.8	11.8	4.5	12.7	30.5	12.2	19.2	41.4	17.1	14.7	19.6	1.9	18.3	9.2	35.0	3.0	6.4	37.5	16.6	17.3	15.6	46.2	14.6	28.9	25.6	8.1	13.1	35.2	25.9	40.7	43.8	43.0	52.6	25.6	33.2	36.2	20.8	42.2
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"NIPA magnesium transporter 1"	Q7RTP0	15	22773063-22829789	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023269	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.1	4.2	27.7	3.7	36.9	1.2	2.8	36.8	38.1	3.7	17.9	4.6	6.5	2.2	2.1	4.3	2.5	4.8	3.5	22.8	28.7	6.2	5.7	4.7	5.3	35.4	36.9	1.5	5.7	8.7	3.6	3.5	33.8	6.7	4.3	6.2	3.6	3.4	2.5	4.9	6.6	2.6	36.1	4.2	6.4	4.3	36.0	8.2	7.3	3.5	5.5	3.2	3.5	40.2	14.9	17.4	5.4	12.4	6.9	5.6	3.8	17.6	12.7	8.5	7.1	13.3	7.4	6.9	13.5	7.3	17.4	9.7	16.0	4.6	10.1	40.2	9.8	10.8	10.8	11.4	8.3	0.1	20.8	1.7	15.2	5.5	9.2	13.6	8.2	15.2	8.4	11.3	4.8	5.6	5.9	9.7	5.9	15.9	18.2	12.1	7.7	5.4	13.0	14.9	15.2	15.4	13.2	1.6	16.7	7.0	10.3	13.8	15.4	23.9	12.2	10.1	27.2	12.7	13.6	12.4	12.3	0.0	15.6	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.7	0.6	0.5	1.1	0.4	0.3	0.3	0.3	0.0	3.9	0.8	0.3	27.7	36.9	36.8	38.1	22.8	28.7	35.4	36.9	33.8	36.1	36.0	40.2	5.9	12.8	5.9	14.4	7.4	8.8	4.0	5.9	2.2	4.1	4.4	3.0	4.3	15.7	5.2	5.5	6.2	2.6	10.5	9.9	3.9	5.7	3.3	3.6	2.4	5.9	3.0	4.0	36.2	11.6	2.1	4.5	10.2	5.7	0.0	4.1	4.6	6.0	4.1	5.0	33.8	7.1	2.0	4.4	6.9	4.2	2.1	2.9	5.4	4.7	3.8	4.7	4.1	15.6	65.2	17.7	6.8	3.0	7.2	8.6	11.8	5.8	6.2	6.6	19.7	3.0	3.6	3.4	8.5	4.2	14.9	1.5	7.1	1.6	7.5	7.3
NIPA2	SLC57A2	ENSG00000140157	"NIPA magnesium transporter 2"	Q8N8Q9	15	22838644-22869362	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	24.0	26.9	15.5	35.0	15.4	30.6	20.7	14.8	16.3	21.2	19.1	40.5	39.7	21.1	18.5	25.5	17.1	24.7	18.9	15.5	17.3	31.0	27.3	23.0	36.3	15.3	17.4	15.0	24.2	25.5	18.5	28.7	17.1	26.4	38.9	15.9	26.6	17.1	27.5	15.3	35.7	24.4	16.3	27.1	28.5	16.9	16.5	28.7	26.8	27.2	42.9	34.8	15.3	16.6	103.6	103.7	51.7	61.7	55.9	58.1	57.3	117.3	99.1	78.4	90.4	76.5	64.3	101.0	70.6	71.7	88.6	82.6	99.9	58.3	77.3	109.7	61.0	89.9	66.4	61.2	72.3	127.0	81.8	54.9	61.2	64.2	65.5	51.6	87.7	79.2	137.4	117.1	99.8	39.2	40.1	56.0	60.2	109.9	99.9	88.3	87.0	74.9	71.6	120.9	69.4	71.7	95.6	84.8	98.9	48.4	74.4	114.3	91.4	104.0	65.6	73.2	237.5	90.0	153.3	107.4	76.3	129.9	88.2	72.1	44.5	38.9	41.1	55.4	46.9	76.3	36.9	45.4	54.9	67.1	34.2	34.6	32.7	48.6	55.7	82.0	52.8	49.2	15.5	15.4	14.8	16.3	15.5	17.3	15.3	17.4	17.1	16.3	16.5	16.6	26.0	16.0	23.1	10.7	62.9	45.0	41.3	26.1	20.5	9.4	25.2	16.5	3.8	22.8	25.0	12.9	12.5	39.9	45.0	53.7	21.5	39.6	10.7	21.7	24.5	28.5	24.4	29.2	14.7	43.8	65.4	23.4	26.0	27.6	10.1	26.2	22.9	22.1	48.3	21.9	15.4	30.2	38.7	30.3	41.3	3.3	13.4	35.5	23.2	14.0	31.4	27.3	35.0	9.5	13.3	57.8	31.1	21.1	60.8	56.5	31.8	23.3	20.6	13.0	13.1	17.6	28.6	32.8	35.2	28.8	57.8	84.4	37.3	38.7	38.1	89.7
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.8;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036765	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.3	0.1	0.1	1.7	0.3	0.2	3.6	0.3	0.3	2.0	0.3	14.1	5.4	0.3	7.3	21.8	2.1	1.4	0.1	0.1	0.4	3.3	16.2	0.4	0.1	0.2	0.2	0.0	1.9	3.7	0.6	1.8	0.2	2.1	13.3	1.8	5.1	1.2	1.6	25.7	7.1	0.5	0.1	0.2	7.1	0.6	1.0	0.3	1.6	0.1	3.0	7.7	4.8	0.1	13.3	0.2	0.0	0.0	0.0	0.0	2.1	2.4	2.3	1.8	3.2	7.8	11.6	0.0	1.7	0.0	3.3	15.3	2.2	11.1	4.7	0.1	2.8	0.0	0.1	0.5	0.0	0.1	0.1	0.1	4.0	0.2	2.6	3.1	0.6	0.8	0.1	0.0	2.6	5.1	0.1	0.1	1.9	9.1	3.4	0.0	0.0	0.0	6.4	17.9	1.1	0.3	1.2	4.3	1.9	1.0	2.7	0.0	5.0	0.1	4.5	0.0	0.3	0.1	0.2	0.0	0.2	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.4	0.2	0.2	0.2	0.1	1.0	0.1	0.3	9.6	6.1	0.0	0.4	14.4	42.0	6.4	4.6	0.2	9.9	5.0	2.8	4.3	12.6	42.3	0.0	2.1	0.2	56.2	0.0	15.7	0.7	7.3	1.1	1.1	11.5	0.0	0.9	6.7	1.4	1.5	11.2	14.2	0.0	0.3	0.4	18.5	0.4	0.0	1.0	27.5	4.1	1.2	2.1	0.3	0.0	0.6	1.8	1.0	0.6	0.7	0.0	0.5	0.1	16.1	31.2	0.0	1.4	27.4	31.8	1.0	3.2	5.1	0.0	1.9	2.8	1.3	2.8	44.4	33.0	3.6	1.0	0.1	38.6	55.2
NIPAL2	"FLJ13955, NPAL2"	ENSG00000104361	"NIPA like domain containing 2"	Q9H841	8	98189826-98294393	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 124.5;Squamous epithelial cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.5;OE19: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071759	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071759: AB_2686443"	"unprognostic (5.14e-3)"	"unprognostic (6.43e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.72e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.76e-2)"	12.6	12.5	6.1	7.8	6.6	6.4	17.7	4.2	13.5	22.9	5.2	17.8	9.2	14.5	41.0	30.1	12.2	15.4	8.6	7.7	5.1	5.9	7.8	10.3	8.6	3.7	3.5	27.5	16.8	11.7	21.9	8.5	3.8	22.9	24.1	11.7	20.6	15.9	2.3	53.2	11.7	7.8	5.0	8.1	19.7	4.9	4.3	3.4	7.2	2.6	13.0	13.2	21.8	8.8	7.9	3.1	1.0	0.1	45.5	27.5	0.2	13.9	17.6	2.5	3.4	0.0	22.7	14.7	15.7	19.5	3.7	9.2	0.7	8.3	1.9	1.3	2.8	5.4	2.1	1.1	5.8	5.7	5.5	28.4	21.6	2.6	7.6	1.4	3.2	0.1	0.0	29.1	10.2	10.9	0.2	3.1	1.8	38.1	1.1	0.0	0.2	1.7	9.1	17.7	1.5	3.0	10.1	8.6	3.5	1.2	9.2	10.5	9.2	1.9	0.2	7.0	0.1	0.3	0.0	0.1	3.4	18.2	9.5	0.1	2.0	2.9	0.7	1.9	0.0	1.7	0.6	0.6	3.7	2.6	0.0	0.5	0.3	1.7	1.6	1.5	2.0	1.6	6.1	6.6	4.2	13.5	7.7	5.1	3.7	3.5	3.8	5.0	4.3	8.8	6.1	3.2	9.3	3.6	11.0	15.3	8.4	19.2	22.8	16.5	10.4	10.8	5.2	7.2	15.8	3.7	2.1	0.2	3.0	20.6	0.0	8.2	7.3	4.6	21.1	8.0	7.2	11.2	124.5	12.8	1.1	13.2	30.5	5.4	5.7	4.1	8.6	3.6	4.6	21.9	30.5	26.3	6.1	6.8	9.4	4.0	25.7	8.5	3.6	26.2	6.0	9.7	10.3	10.6	3.4	9.4	11.0	23.0	6.6	13.4	8.6	1.2	14.3	2.6	6.6	3.3	6.8	0.8	0.7	57.3	22.9	0.3	3.0	12.4	17.2	22.7
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415802-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	8.4	7.4	49.6	8.4	67.3	8.4	12.9	67.7	58.5	9.6	25.8	13.8	11.3	6.2	11.7	15.9	14.6	8.9	12.8	43.6	58.1	13.8	3.5	13.9	11.6	61.8	58.6	7.2	17.1	21.9	7.3	3.5	65.0	55.9	14.4	27.7	15.2	7.6	5.9	14.0	12.7	12.3	56.1	7.8	14.8	4.9	65.0	13.2	29.2	11.9	13.1	8.0	10.4	88.5	32.4	12.1	1.1	4.2	18.9	20.7	4.5	101.8	71.7	35.0	26.2	4.5	36.4	15.4	30.2	55.2	7.3	31.5	12.5	37.1	37.3	29.5	38.1	16.0	18.5	5.4	17.7	14.2	14.4	20.7	36.1	22.3	75.7	34.8	12.2	27.5	9.5	9.7	22.4	7.2	11.5	6.6	8.3	15.4	34.0	5.5	0.1	17.1	41.6	10.1	44.6	4.3	13.1	19.5	26.9	8.6	26.0	10.6	17.9	31.5	6.7	10.9	22.9	29.4	24.1	5.4	21.4	26.8	28.8	16.9	5.8	7.9	16.7	5.7	16.9	22.1	28.8	22.5	11.2	20.1	38.9	24.8	2.5	15.6	4.2	14.6	31.8	16.0	49.6	67.3	67.7	58.5	43.6	58.1	61.8	58.6	65.0	56.1	65.0	88.5	17.1	48.1	27.5	8.8	15.4	9.2	13.5	25.7	14.8	50.3	15.9	12.2	25.9	15.7	24.7	40.5	110.5	3.8	32.1	25.0	3.9	13.1	3.6	11.0	3.5	10.2	18.7	26.1	29.3	15.5	4.7	7.4	16.8	18.3	13.3	10.5	9.3	3.8	4.5	13.5	32.2	16.7	16.2	7.0	7.8	8.0	4.1	5.5	14.2	10.3	8.6	18.7	23.7	24.6	91.8	22.6	22.6	5.3	16.0	34.5	33.2	4.5	16.5	53.6	0.0	4.4	5.9	2.6	6.0	20.0	16.3	4.2	25.3	8.2	17.2	20.9
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460213-157474722	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7;skin 1: 61.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0;urothelial cancer: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 1.6;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"B-cells: 4.8"	"Group enriched"	"Detected in some"	8	"hTCEpi: 31.7;RT4: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038259	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.82e-4)"	0.4	0.0	3.5	2.0	9.7	3.4	2.2	8.5	7.1	5.9	1.1	3.7	0.3	1.2	0.1	15.1	0.1	0.5	1.5	3.9	6.2	0.0	0.0	0.7	0.4	12.4	8.7	0.0	0.0	0.0	0.5	0.6	10.5	1.5	0.6	0.1	1.9	1.4	0.2	61.2	0.9	1.1	7.6	0.2	2.5	0.1	8.0	0.4	0.3	0.0	5.8	11.5	15.1	18.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.1	1.1	0.0	0.0	0.7	0.4	0.0	6.3	0.3	2.7	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	31.7	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	108.1	0.0	0.4	0.0	0.0	0.0	8.5	1.6	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	9.7	8.5	7.1	3.9	6.2	12.4	8.7	10.5	7.6	8.0	18.7	0.0	0.0	0.5	0.0	2.4	29.7	9.8	0.6	2.2	0.6	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	0.3	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.3	3.8	0.0	0.0	0.1	1.1	0.0	5.2	0.3	0.0	0.1	9.8	42.1	0.0	0.2	0.0	0.0	4.4
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581327	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 291.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.7;Proximal tubular cells: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059227	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	10.7	43.9	35.4	17.5	37.8	15.5	31.5	31.8	38.5	21.5	33.4	37.4	67.0	19.4	24.9	25.8	26.8	19.8	21.8	37.6	41.7	117.8	291.8	17.8	23.3	37.1	36.5	32.3	24.4	68.0	36.5	17.3	39.3	23.9	38.5	46.2	26.0	27.2	4.4	20.6	49.2	17.8	30.7	19.1	29.3	11.9	36.7	36.7	32.9	5.4	28.3	20.1	18.3	31.7	69.1	81.1	165.3	206.9	29.2	59.4	30.7	39.5	70.7	53.2	68.7	55.5	90.6	48.8	76.8	56.9	56.0	68.2	87.7	100.7	65.1	98.8	90.5	16.8	37.0	173.5	44.1	36.5	23.0	59.5	50.8	44.1	55.0	129.0	73.4	105.3	31.8	78.9	49.2	156.4	59.3	50.1	140.0	106.2	67.5	115.9	51.7	142.6	128.3	59.1	203.9	179.5	46.1	83.2	92.1	79.5	137.1	57.7	34.7	23.2	79.6	28.6	31.9	106.4	56.5	45.6	62.1	57.3	39.4	10.8	9.4	15.9	34.2	17.4	41.2	29.0	34.4	36.2	21.6	27.3	32.6	39.5	13.8	39.5	10.7	11.0	44.9	22.1	35.4	37.8	31.8	38.5	37.6	41.7	37.1	36.5	39.3	30.7	36.7	31.7	7.4	25.6	15.7	6.8	16.3	4.8	12.6	15.8	18.8	22.6	25.5	18.5	22.9	28.6	18.6	42.3	10.4	44.4	9.2	14.4	68.4	45.8	2.1	6.2	13.7	10.1	41.9	24.6	16.9	18.5	14.6	14.2	25.5	12.0	26.0	33.5	11.7	116.7	14.4	10.1	19.9	31.5	26.4	8.7	4.3	6.1	11.1	8.1	5.4	3.7	21.3	38.7	28.8	6.6	10.3	17.8	20.2	14.3	7.3	6.8	35.2	134.7	9.8	24.4	13.1	7.2	12.3	1.4	8.3	20.5	8.1	14.8	20.5	48.1	47.4	8.8
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 266.5;skeletal muscle: 645.5;tongue: 784.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 226.9;Endometrial ciliated cells: 107.5;Proximal tubular cells: 106.8"	"Cancer enhanced"	"Detected in all"		"glioma: 73.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 301.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	61.2	70.3	46.0	25.4	48.4	39.2	59.0	47.2	56.9	45.4	50.8	56.0	31.4	41.1	36.6	49.0	50.4	27.5	266.5	45.1	49.5	63.8	14.5	36.9	26.4	45.2	48.7	34.7	49.2	70.4	27.1	31.0	47.1	53.4	53.8	27.6	79.2	55.9	645.5	21.9	32.4	46.6	49.0	26.1	46.5	20.5	50.0	40.1	86.5	784.2	28.7	40.8	26.0	47.6	301.3	52.3	67.5	112.6	38.7	65.8	33.1	24.7	58.2	69.7	53.5	36.5	64.9	43.8	40.5	46.6	67.5	39.1	51.4	52.2	68.7	27.9	75.4	31.1	27.6	46.9	54.6	68.0	30.2	60.3	78.4	23.8	64.5	79.1	74.6	62.2	56.2	41.9	54.8	13.4	68.1	70.4	66.7	66.5	52.3	68.0	31.3	90.8	94.6	46.7	71.7	80.8	56.2	67.0	78.3	53.0	129.9	72.3	43.9	31.7	47.4	11.3	52.0	34.1	30.9	81.2	35.1	41.9	95.7	48.2	86.6	39.1	22.6	86.4	27.2	37.7	28.8	23.8	91.7	37.0	34.2	25.2	15.3	41.9	69.1	38.1	37.9	72.4	46.0	48.4	47.2	56.9	45.1	49.5	45.2	48.7	47.1	49.0	50.0	47.6	45.4	51.3	57.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	80.4	63.8	0.0	0.0	43.3	62.5	0.0	76.0	20.1	0.0	226.9	74.8	0.0	107.5	56.1	22.1	0.0	0.0	0.0	57.2	56.4	23.4	0.0	57.6	16.4	64.7	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	39.8	0.0	0.0	0.0	0.0	46.2	0.0	0.0	5.2	0.0	0.0	106.8	88.2	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	51.4	12.3	74.0	0.0	0.0
NIPSNAP3A	"DKFZp564D177, FLJ13953, HSPC299, MGC14553"	ENSG00000136783	"Nipsnap homolog 3A"	Q9UFN0	9	104747683-104760120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042491	Approved					NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA042491: AB_2678023"	"unprognostic (1.03e-1)"	"unprognostic (9.13e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	27.6	38.9	18.0	15.1	18.0	40.2	28.0	19.6	25.5	26.3	16.7	38.3	25.4	19.5	19.7	25.2	20.4	16.3	31.2	18.1	21.0	29.6	51.1	22.8	17.1	23.8	20.8	13.8	12.8	15.1	18.0	33.1	21.2	21.4	38.9	8.6	14.1	21.5	13.5	21.2	24.3	25.4	21.7	22.7	29.4	15.7	18.2	20.5	23.2	17.6	17.2	20.8	19.4	26.5	18.8	16.3	9.4	8.5	16.9	29.9	19.5	57.9	22.4	56.6	48.0	19.0	29.8	29.8	24.2	47.7	17.4	31.9	30.5	25.2	30.7	17.4	28.3	52.5	22.3	22.0	30.6	65.3	38.8	36.2	65.5	23.5	17.6	31.7	64.7	44.0	56.3	19.2	44.2	40.3	54.4	37.1	10.6	44.9	29.1	42.8	32.9	30.1	49.8	11.1	32.4	21.4	36.4	22.8	16.7	26.0	55.0	55.4	47.1	28.9	16.8	30.9	17.2	13.5	16.8	16.2	29.4	55.1	15.9	43.0	51.5	36.2	11.5	63.7	14.2	19.5	11.6	12.7	88.5	13.8	14.2	14.0	3.5	32.5	56.7	45.3	12.7	38.2	18.0	18.0	19.6	25.5	18.1	21.0	23.8	20.8	21.2	21.7	18.2	26.5	23.7	22.4	15.5	3.9	16.2	28.2	18.8	55.6	18.2	7.9	18.1	16.3	13.3	22.8	34.9	29.5	2.1	37.9	14.4	27.4	103.7	28.1	3.8	30.9	14.4	22.5	25.2	47.3	9.9	27.6	31.2	18.4	16.3	30.7	52.0	19.9	24.3	45.5	84.9	3.3	9.8	35.5	46.8	40.5	48.1	4.3	19.0	37.5	37.4	8.4	68.9	9.7	13.4	3.0	15.7	28.1	17.5	21.8	9.5	11.6	21.0	52.9	26.2	6.0	26.3	6.9	24.5	13.0	13.7	41.4	38.8	30.8	11.3	40.2	35.3	22.2
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764129-104777764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 20.4;tongue: 19.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 11.8;Cardiomyocytes: 21.6;Excitatory neurons: 10.7;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"REH: 3.0;SH-SY5Y: 2.1;THP-1: 2.2;U-266/70: 2.3"									HPA042491	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	6.6	5.1	1.8	1.1	1.9	0.7	4.3	1.2	2.2	2.3	1.6	1.1	0.5	3.1	3.4	1.0	1.9	1.3	12.8	1.9	2.0	1.5	0.5	1.4	1.5	1.5	1.5	3.3	1.9	1.0	2.7	3.0	1.6	2.7	0.9	2.5	1.4	3.6	20.4	1.3	1.2	1.6	1.2	2.0	1.1	1.0	1.8	0.8	2.0	19.5	1.8	0.9	1.5	1.5	0.0	0.3	0.4	0.1	0.4	0.4	0.7	0.1	0.2	0.2	0.1	0.3	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.5	1.4	1.2	0.1	0.4	0.2	0.4	0.4	0.1	0.3	0.0	0.5	0.1	0.7	1.2	0.0	0.0	0.2	0.6	1.2	0.2	0.0	0.2	3.0	0.0	0.1	0.1	0.0	0.9	2.1	1.2	0.0	0.1	0.2	1.1	2.2	0.1	0.2	0.4	0.2	0.1	2.3	0.8	0.2	0.0	0.2	0.0	2.8	0.0	0.6	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	1.8	1.9	1.2	2.2	1.9	2.0	1.5	1.5	1.6	1.2	1.8	1.5	11.8	0.0	1.1	2.0	8.5	0.4	1.5	0.8	1.2	4.0	0.9	1.7	21.6	0.0	0.3	3.7	0.0	0.8	0.1	0.0	5.9	0.7	0.0	2.2	2.0	3.4	1.2	5.9	10.7	0.2	0.2	3.9	2.6	1.2	1.3	2.5	6.1	0.3	6.2	0.0	9.8	0.3	4.1	0.9	3.9	0.9	2.5	3.0	0.0	16.9	4.1	1.2	0.0	4.5	1.1	0.2	0.0	6.8	2.3	0.3	0.0	0.4	3.2	0.5	0.0	2.0	3.7	0.8	1.1	1.7	0.9	0.8	1.1	0.8	0.2	0.2
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493068	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 169.3;Peritubular cells: 246.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	55.2	69.8	46.5	28.7	55.5	38.7	60.5	78.2	56.6	105.8	22.2	68.5	24.3	76.2	34.0	51.3	72.0	29.9	48.5	56.3	38.7	54.6	45.6	56.2	32.5	20.9	32.6	93.0	54.1	32.5	181.8	39.1	32.9	107.5	20.6	19.0	53.6	51.6	36.3	80.7	55.3	33.0	9.1	54.1	52.7	84.5	35.2	30.1	60.8	16.3	23.3	78.1	71.6	35.2	15.6	16.0	48.8	40.1	35.7	39.2	40.0	32.8	21.5	25.7	26.0	24.2	22.8	21.7	9.0	45.6	21.0	20.4	26.1	35.7	15.1	22.3	28.2	39.2	65.2	23.9	32.4	23.2	33.6	61.9	28.2	27.7	23.5	54.0	42.0	42.4	21.1	23.4	24.3	22.2	41.8	51.2	30.1	19.8	27.1	24.5	13.4	25.4	29.2	30.6	20.6	35.9	35.6	9.3	23.1	42.3	28.9	38.5	46.3	36.0	34.1	36.9	24.1	38.7	23.8	27.3	24.7	37.3	22.4	5.2	4.5	3.5	3.0	4.0	3.1	2.5	2.6	4.0	2.3	2.8	3.1	3.3	1.5	3.2	0.6	3.4	3.0	3.6	46.5	55.5	78.2	56.6	56.3	38.7	20.9	32.6	32.9	9.1	35.2	35.2	26.1	25.6	32.3	34.0	14.9	27.5	14.6	23.3	40.5	40.9	29.2	37.1	20.4	8.6	19.1	14.7	8.4	32.4	24.2	20.5	9.8	12.1	10.3	14.5	26.7	22.1	169.3	4.6	64.9	9.4	14.0	23.4	23.4	18.9	25.3	40.2	46.1	15.3	30.5	28.6	44.0	19.1	22.4	50.5	14.5	25.9	88.3	24.3	19.6	15.0	13.0	12.1	17.5	21.1	26.1	10.0	14.2	246.0	12.4	12.6	16.5	15.6	15.2	22.4	26.3	17.2	24.8	31.2	18.0	16.7	22.3	24.2	18.4	47.6	15.7	11.7
NIT1		ENSG00000158793	"Nitrilase 1"	Q86X76	1	161118086-161125445	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 101.5;Proximal tubular cells: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006657	Approved					NA	NA		89000	"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006657: AB_1079485"	"unprognostic (3.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.94e-2)"	22.4	61.7	22.2	12.5	22.7	9.3	21.8	22.7	23.5	22.3	24.8	30.2	26.7	19.9	17.5	22.5	19.7	11.0	29.1	22.6	23.8	39.9	63.2	20.8	14.5	23.8	22.6	21.1	29.7	29.6	28.1	11.8	24.2	24.4	19.2	12.3	20.3	18.1	22.7	20.9	32.6	15.0	22.1	26.6	23.1	16.7	23.7	17.7	25.5	17.4	14.7	22.1	20.1	23.5	19.5	27.0	26.7	7.6	34.7	20.7	15.7	15.5	21.2	18.0	16.6	18.3	35.8	21.1	24.3	21.1	25.1	19.8	15.7	34.2	14.9	18.1	13.5	14.3	17.3	20.3	26.4	9.0	10.9	25.4	33.4	34.2	35.2	29.3	25.7	31.1	15.6	12.7	28.4	17.1	17.7	11.1	11.8	35.5	22.8	18.9	14.5	26.5	37.3	12.1	10.8	14.6	20.9	31.9	20.9	51.7	35.1	20.1	15.6	7.9	18.1	13.8	11.7	41.3	25.3	18.5	16.5	8.3	11.4	43.0	20.5	19.3	10.3	18.7	10.7	11.5	10.9	8.5	17.0	11.2	10.2	8.9	15.5	9.1	25.5	18.3	12.0	11.7	22.2	22.7	22.7	23.5	22.6	23.8	23.8	22.6	24.2	22.1	23.7	23.5	18.7	19.2	15.6	13.4	15.1	8.7	22.3	32.6	18.2	13.3	17.3	19.3	6.6	35.8	20.6	23.9	18.8	47.4	19.3	43.0	64.6	31.6	7.0	17.8	11.6	16.5	11.5	13.9	11.4	30.9	29.0	15.6	20.4	15.9	12.0	20.2	17.2	63.8	40.3	18.5	11.9	24.9	20.3	15.2	12.3	4.9	16.1	19.7	16.0	15.9	21.8	24.6	13.4	8.0	19.0	25.7	25.9	22.6	17.6	14.1	101.5	116.1	25.9	17.7	39.5	12.9	16.7	33.5	22.5	15.6	12.8	56.0	12.5	35.2	28.8	21.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;brain: 19.9;skeletal muscle: 19.4;tongue: 11.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.2	8.1	0.2	15.6	0.0	0.4	17.3	11.6	0.3	3.1	0.3	0.1	0.6	3.4	0.6	0.1	0.0	0.0	11.5	10.6	0.2	0.0	0.0	0.0	17.9	16.4	0.1	0.2	0.6	2.2	0.3	19.9	1.0	0.1	1.5	0.4	0.3	19.4	1.7	0.1	0.2	6.8	0.0	0.1	0.3	12.2	0.2	0.0	11.9	0.0	0.0	0.5	18.6	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	15.6	17.3	11.6	11.5	10.6	17.9	16.4	19.9	6.8	12.2	18.6	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 68.1;choroid plexus: 20.3;kidney: 52.2"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029876	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	0.1	0.8	41.3	0.2	41.0	0.1	0.1	28.7	68.1	2.3	20.3	1.7	0.3	0.4	0.4	0.0	0.3	0.1	0.0	45.7	44.7	52.2	0.0	0.1	0.0	39.1	40.3	0.1	0.1	0.0	2.4	2.8	39.9	0.1	0.1	3.1	0.1	0.1	0.0	0.4	0.4	0.0	37.5	0.1	0.3	2.2	40.3	1.2	0.8	0.1	0.0	0.1	0.6	36.1	0.1	2.0	7.5	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	1.3	0.8	0.0	3.9	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	42.8	0.0	5.2	0.0	0.1	7.8	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.1	9.3	29.5	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.5	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	41.0	28.7	68.1	45.7	44.7	39.1	40.3	39.9	37.5	40.3	36.1	0.0	0.0	0.0	23.8	1.9	0.3	0.0	1.7	0.0	2.6	0.0	0.1	0.3	0.0	0.1	11.0	0.0	3.3	0.0	0.0	5.9	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.6	3.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.3	1.5	0.0	1.0	0.0	80.8	0.0	76.4	0.1	4.2	0.0	0.0	0.0	0.0	0.0	264.8	0.1	1.9	0.0	0.0	0.3	0.4	6.0	0.0	0.0	2.3	0.8	0.1	0.0	0.1
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943751	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	9.5	13.1	10.6	9.8	11.5	13.6	10.6	11.8	16.2	9.2	11.1	9.8	10.3	10.6	10.7	7.3	11.0	8.9	11.0	10.5	11.6	11.3	14.5	10.5	14.4	11.9	11.5	14.1	10.1	14.2	2.7	13.5	11.4	10.4	10.1	9.6	9.9	13.5	18.2	7.4	12.7	10.3	11.2	12.5	9.3	8.5	11.0	12.7	10.1	14.4	13.0	9.7	2.4	13.0	25.0	24.3	17.6	22.3	15.3	24.7	28.9	17.7	20.4	23.4	17.2	15.9	20.9	17.6	29.9	14.6	45.8	18.3	33.7	20.6	27.9	29.6	31.2	11.1	20.6	23.3	25.1	25.2	20.4	17.9	26.4	25.1	24.7	25.3	23.2	23.8	30.6	25.5	18.4	33.8	21.4	47.0	23.6	32.4	32.8	22.8	24.3	32.7	17.5	9.6	19.2	27.2	36.8	19.7	52.3	20.9	16.8	21.1	17.4	14.8	9.0	38.4	27.4	25.4	26.7	30.2	20.4	18.9	26.1	39.7	23.5	55.6	20.8	20.0	21.6	32.2	25.4	21.2	20.6	36.6	25.6	24.3	44.5	22.2	23.1	32.5	26.6	14.3	10.6	11.5	11.8	16.2	10.5	11.6	11.9	11.5	11.4	11.2	11.0	13.0	39.9	22.4	40.4	5.2	36.1	25.9	36.1	45.5	26.7	34.0	26.2	33.3	30.3	15.7	42.3	20.2	25.0	62.5	36.0	17.5	37.2	36.7	8.8	33.6	37.4	40.3	22.8	20.6	7.2	44.3	132.0	39.1	17.9	26.7	47.4	41.6	41.4	46.3	53.0	55.5	9.0	27.9	22.4	28.0	23.2	8.9	45.1	33.9	35.6	4.7	35.3	56.3	36.0	7.5	11.0	37.5	23.3	55.3	30.6	40.3	25.8	51.3	49.4	38.5	13.1	33.4	45.0	82.7	69.6	19.6	28.7	72.9	41.5	48.3	23.1	33.7
NKAPD1	"C11orf57, FLJ10726"	ENSG00000150776	"NKAP domain containing 1"	Q6ZUT1	11	112074086-112085150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039493, HPA039892"	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA039493: AB_10795036, HPA039892: AB_10795372"	"unprognostic (5.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.41e-1)"	14.2	11.4	9.5	11.6	10.2	13.0	16.7	12.9	11.8	12.1	8.4	12.2	11.3	15.3	11.8	13.9	13.7	11.8	13.0	9.4	10.4	14.6	11.8	11.0	14.2	9.6	9.7	20.1	12.3	14.1	7.7	15.8	10.5	10.7	11.6	33.4	13.7	11.2	18.6	12.1	11.0	12.5	9.6	12.6	11.5	13.6	9.7	16.9	16.0	10.1	14.0	11.5	9.6	11.4	19.5	12.8	26.6	42.9	26.8	31.0	19.5	28.0	23.8	23.1	26.4	39.8	34.2	54.1	41.8	25.3	26.1	27.4	32.1	30.1	30.0	39.0	22.3	41.6	12.7	19.2	24.8	63.3	26.3	31.8	40.5	27.8	63.7	35.1	20.9	44.0	62.4	32.5	23.4	11.8	57.0	39.2	26.5	32.7	28.3	43.5	32.7	44.6	26.6	17.3	22.1	40.4	29.0	35.3	26.1	23.3	44.2	25.9	21.4	30.7	34.4	19.1	24.5	24.5	58.4	111.4	13.0	58.6	31.7	9.1	7.3	4.8	9.8	7.8	10.2	8.4	10.4	6.8	8.1	9.1	10.9	9.5	4.2	13.4	8.9	20.6	9.0	4.8	9.5	10.2	12.9	11.8	9.4	10.4	9.6	9.7	10.5	9.6	9.7	11.4	19.9	32.1	20.7	0.0	9.4	0.0	0.0	0.0	0.0	0.0	24.5	21.0	0.0	0.0	17.3	16.5	0.0	19.6	15.1	0.0	13.7	20.2	0.0	26.0	35.4	8.7	0.0	0.0	0.0	21.4	17.8	11.3	0.0	20.9	8.8	21.8	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	13.9	0.0	0.0	0.0	0.0	20.0	0.0	0.0	5.0	0.0	0.0	32.9	17.5	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	20.0	6.0	35.6	0.0	0.0
NKD1		ENSG00000140807	"NKD inhibitor of WNT signaling pathway 1"	Q969G9	16	50548396-50649249	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 45.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 27.4;Smooth muscle cells: 13.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;CACO-2: 13.6;Hep G2: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041352, HPA049413"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center"		"HPA041352: AB_2677428, HPA049413: AB_2680753"	"unprognostic (1.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.02e-3)"	"unprognostic (5.59e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.88e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.44e-2)"	1.7	0.7	7.3	0.7	7.9	0.1	1.0	7.1	4.6	2.5	2.1	4.8	1.1	6.0	4.2	3.2	4.7	2.8	0.5	4.0	5.5	1.6	0.6	6.8	0.4	9.3	12.8	2.9	1.2	0.2	0.4	1.9	7.2	3.5	1.4	0.7	0.5	2.7	0.3	2.0	2.0	5.7	7.0	1.5	2.1	1.1	14.6	0.7	0.3	0.2	0.5	2.2	1.2	7.7	0.0	0.1	6.3	0.5	2.4	0.0	0.2	0.0	0.0	0.0	0.0	13.6	0.3	0.0	0.2	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.7	0.7	0.0	36.5	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.1	1.4	0.5	0.6	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.9	7.1	4.6	4.0	5.5	9.3	12.8	7.2	7.0	14.6	7.7	0.3	0.0	0.0	4.2	0.2	1.5	1.2	0.2	0.0	2.1	0.3	0.8	0.8	0.0	0.5	0.0	6.2	2.5	0.7	0.2	0.0	0.4	7.4	0.5	2.0	0.9	1.8	0.4	0.4	0.4	0.4	3.8	1.5	0.7	0.0	3.7	0.4	1.7	0.4	0.0	1.0	0.5	0.0	0.0	3.0	2.2	1.8	0.8	8.8	45.9	0.2	6.7	0.0	57.3	27.4	0.3	0.0	3.4	0.5	0.9	0.2	0.1	0.1	0.8	13.1	0.4	13.4	1.1	7.1	0.6	1.1	2.3	2.4	0.0	0.5	1.4
NKD2	Naked2	ENSG00000145506	"NKD inhibitor of WNT signaling pathway 2"	Q969F2	5	1008802-1038943	"Predicted intracellular proteins"	"Exocytosis, Transport, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 42.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 6.8;Fibroblasts: 11.6;Langerhans cells: 7.1;Melanocytes: 7.2;Microglial cells: 7.5;Muller glia cells: 7.1;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.4;HEK 293: 14.4;MOLT-4: 7.3;NB-4: 13.4;REH: 8.8;RPMI-8226: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049463	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049463: AB_2680777"	"unprognostic (6.23e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.87e-3)"	"unprognostic (4.43e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-1)"	4.7	5.1	0.7	0.2	1.3	0.0	3.8	0.0	2.4	1.6	0.0	4.0	0.1	1.1	0.0	8.5	3.1	0.1	5.5	2.4	0.0	6.9	3.1	42.1	0.0	0.6	0.0	1.3	4.2	0.1	2.0	0.4	0.0	6.1	0.0	0.1	4.9	0.0	0.3	9.6	3.5	0.0	0.0	15.3	2.4	8.0	0.0	0.9	2.3	0.0	0.1	3.8	2.5	0.1	0.0	0.2	0.5	0.2	0.0	0.0	24.4	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	1.2	7.3	13.4	0.2	1.9	0.0	8.8	0.0	22.1	0.0	1.7	0.2	0.0	0.2	0.0	1.2	0.1	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	2.4	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	6.1	2.8	0.5	4.6	0.2	0.8	1.9	3.3	2.8	0.1	0.0	2.1	0.1	0.2	0.0	0.0	2.9	0.6	2.1	6.8	2.0	0.0	0.0	1.5	0.0	0.1	11.6	0.0	0.5	0.0	0.0	0.7	0.0	0.3	1.7	1.4	0.0	0.0	0.0	7.1	1.3	0.3	0.5	7.2	7.5	0.0	7.1	0.0	0.0	0.2	0.1	0.0	0.4	0.1	2.7	0.0	2.0	0.0	0.1	0.0	0.1	1.9	1.0	11.3	0.5	5.7	0.0	1.3	0.0	0.0	1.2
NKIRAS1	"kappaB-Ras1, KBRAS1"	ENSG00000197885	"NFKB inhibitor interacting Ras like 1"	Q9NYS0	3	23889951-23946591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6;Rod photoreceptor cells: 59.7;Spermatocytes: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077387	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Cytosol"		"HPA077387: "	"unprognostic (1.36e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (1.08e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.30e-2)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.69e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.71e-13)"	"unprognostic (1.98e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-3)"	10.0	13.4	23.0	4.5	23.4	8.0	8.7	23.9	29.9	9.0	16.0	9.4	3.4	8.7	8.4	8.4	7.9	6.2	16.4	24.1	25.1	16.4	25.0	6.2	4.4	22.8	22.9	11.9	5.2	37.8	14.9	6.3	23.9	9.5	4.0	47.3	6.9	13.1	32.8	4.9	4.1	9.2	20.9	5.9	6.2	22.9	22.1	3.8	9.8	27.2	4.5	6.6	6.1	21.7	13.3	12.9	11.0	11.7	31.6	14.6	11.4	32.4	19.8	23.5	18.9	10.9	3.6	7.0	14.4	18.8	13.9	7.0	20.4	14.1	20.0	28.7	13.8	3.4	10.2	10.5	17.1	6.0	3.4	12.1	19.1	30.3	13.9	21.3	7.0	6.6	6.7	26.6	26.1	6.4	4.5	5.5	15.2	8.2	15.6	6.7	17.3	6.0	16.2	5.2	4.3	21.6	11.0	14.5	23.4	11.4	11.7	9.9	12.6	10.9	11.8	28.2	26.5	57.1	64.0	4.2	14.4	10.3	9.0	13.9	5.1	6.7	8.9	4.1	9.8	6.1	6.2	8.5	5.1	8.1	9.6	7.8	2.4	4.3	4.3	3.6	5.3	4.5	23.0	23.4	23.9	29.9	24.1	25.1	22.8	22.9	23.9	20.9	22.1	21.7	5.7	6.4	8.2	7.5	5.3	11.2	10.3	18.0	13.6	34.1	9.0	8.3	22.3	4.3	13.1	5.5	64.6	12.2	6.0	3.0	15.6	7.5	27.5	18.0	12.0	5.5	1.2	3.0	15.3	4.5	9.7	11.6	3.1	21.0	7.0	5.7	6.1	13.3	7.3	13.5	16.9	2.2	14.2	3.2	12.9	7.7	7.5	6.8	10.6	5.6	4.6	44.0	3.1	11.6	10.7	5.3	2.4	9.1	4.2	8.1	4.1	23.2	17.2	59.7	13.1	7.3	12.9	68.6	41.1	7.9	9.9	10.4	6.7	10.7	3.0	7.2
NKPD1	FLJ33600	ENSG00000179846	"NTPase KAP family P-loop domain containing 1"	Q17RQ9	19	45149750-45160815	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 15.9"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 5.0;Spermatocytes: 2.4;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.4;SiHa: 1.2;U-266/70: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043339	Uncertain					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA043339: AB_10962493"	"unprognostic (3.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.30e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.77e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	0.1	0.1	0.4	0.0	0.1	0.2	0.5	0.2	0.4	1.3	0.0	0.0	0.0	0.1	0.2	1.0	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.5	0.0	0.5	0.8	0.0	0.3	0.5	0.5	0.1	15.9	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.2	3.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.3	0.2	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.7	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.1	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.4	0.0	0.6	0.9	0.2	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.1	5.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.2	0.5	1.3	0.1	0.0	0.2	0.0	0.1
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600655-42648735	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	17.4	19.2	16.4	17.6	18.7	46.5	19.3	22.3	17.1	28.4	17.9	17.7	13.2	18.4	22.4	17.0	23.0	11.4	17.8	15.0	20.3	18.2	21.1	23.9	22.1	20.5	16.4	29.0	22.1	10.6	36.5	11.1	17.6	23.2	13.4	41.3	17.5	10.5	19.5	32.6	25.4	10.7	14.0	36.7	16.3	18.0	18.2	15.4	25.4	10.4	20.0	18.3	22.6	27.8	15.1	7.7	32.3	15.6	16.6	19.3	14.9	22.8	6.8	9.9	12.9	14.7	13.3	25.9	10.7	9.1	9.0	12.6	16.1	8.4	19.2	11.0	13.1	31.4	30.5	24.6	7.3	25.4	19.9	9.6	12.2	18.4	10.5	19.1	17.4	7.1	30.3	20.2	18.6	6.9	17.8	35.5	23.1	7.6	12.3	17.3	12.0	10.5	15.7	12.7	9.4	8.5	24.1	11.1	4.8	16.3	17.5	17.8	28.0	18.0	13.1	21.4	23.2	17.2	21.7	17.7	10.1	30.0	11.3	7.8	3.6	7.5	5.7	4.6	5.3	5.5	5.6	4.9	2.9	5.3	5.6	4.9	5.3	7.0	6.8	5.1	5.3	2.3	16.4	18.7	22.3	17.1	15.0	20.3	20.5	16.4	17.6	14.0	18.2	27.8	221.8	109.0	141.4	169.4	129.5	59.0	60.3	57.8	66.0	200.0	76.3	69.8	68.7	65.8	73.2	88.3	246.0	72.5	156.0	60.3	17.6	47.3	23.9	114.4	125.5	166.2	71.8	76.6	143.5	38.8	51.1	83.3	86.6	132.4	96.8	210.0	110.7	58.6	45.9	132.9	170.0	70.2	61.1	53.8	70.2	21.8	167.7	78.9	51.6	194.9	97.4	101.9	163.7	180.0	267.2	47.6	59.2	134.3	131.3	77.5	106.8	17.0	53.3	279.9	92.1	103.5	88.9	246.2	186.1	42.4	57.3	31.3	164.4	104.5	75.0	54.2
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406442	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029367	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA						"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445243-124450035	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Basal squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029367	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA					"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	5.7	0.5	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.1	12.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lung: 53.1;thyroid gland: 172.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Region enhanced"	"Detected in many"		"thalamus: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SCLC-21H: 78.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 4.3;hypothalamus: 10.4"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.0	0.1	1.1	0.0	2.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	10.1	0.0	0.0	53.1	0.0	0.0	0.3	0.1	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	17.8	0.0	172.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	78.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.0	4.0	0.1	10.1	0.0	0.3	0.0	0.0	17.8	0.1	0.0	137.8	124.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0
NKX2-2	"NKX2.2, NKX2B"	ENSG00000125820	"NK2 homeobox 2"	O95096	20	21511017-21514064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 37.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 166.1;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 73.1"	"Group enriched"	"Detected in many"	5	"glioma: 9.5;pancreatic cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;T-47d: 4.9;U-138 MG: 17.1;U-2 OS: 3.6;WM-115: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003468	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA003468: AB_1079490"	"unprognostic (5.13e-3)"		"unprognostic (5.54e-2)"		"unprognostic (3.10e-1)"	"unprognostic (2.29e-1)"			"unprognostic (1.75e-2)"		"unprognostic (2.93e-3)"	"unprognostic (1.10e-1)"		"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"			0.0	0.0	10.2	0.0	26.1	0.0	0.0	21.6	15.3	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	14.4	0.0	0.0	0.0	0.0	30.5	22.1	0.0	4.8	0.0	7.5	0.0	26.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	16.5	0.0	2.5	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	17.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	26.1	21.6	15.3	9.7	14.4	30.5	22.1	26.9	16.5	21.1	37.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	166.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	56.8	73.1	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532942-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 38.9;lymphoid tissue: 31.4;salivary gland: 15.7"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 2.2;Hepatic stellate cells: 4.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.7;REH: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA				"Cluster 14: B-cells - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli, Cytosol"		"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	1.4	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.9	11.5	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	4.9	0.0	15.7	0.0	0.0	0.0	22.4	3.6	0.0	31.4	2.5	0.1	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580004-36582614	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;esophagus: 2.6;testis: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;PC-3: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.0	0.0	0.4	0.0	1.1	0.0	0.0	1.2	0.5	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.0	2.3	1.3	0.0	0.0	0.1	1.1	0.0	2.4	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	7.9	2.1	0.0	1.4	0.0	0.0	0.0	0.0	4.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	1.2	0.5	0.2	2.1	2.3	1.3	2.4	2.0	2.1	4.4	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.9	6.8	0.0	1.0	1.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	3.4	0.4	0.0	0.0	0.0	0.0	0.4
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678697-23682938	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 303.3"	"Group enriched"	"Detected in many"	6	"Basal prostatic cells: 51.0;Prostatic glandular cells: 124.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 54.0;neutrophil: 51.6"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 54.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.7;SiHa: 26.1;U-138 MG: 25.8;U-251 MG: 23.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	1.7	3.9	1.0	1.5	1.2	2.2	2.1	1.4	1.4	1.1	0.9	1.4	1.4	1.5	1.3	3.7	1.8	1.1	2.6	1.2	1.6	1.4	4.1	1.4	1.2	1.8	1.5	2.8	1.8	1.0	0.9	0.8	1.6	303.3	0.5	1.7	62.0	1.8	3.2	0.4	1.0	1.9	1.7	0.8	1.4	24.0	1.5	0.5	0.7	3.9	1.6	2.9	1.9	1.4	4.9	3.7	0.0	8.7	3.1	0.7	7.1	6.7	4.2	13.8	16.2	2.1	5.5	0.0	1.0	5.0	25.7	1.2	3.5	7.6	10.9	0.0	1.8	3.4	2.6	5.5	6.0	0.0	1.2	1.2	2.0	14.0	0.8	8.5	0.7	20.1	0.2	0.0	5.5	1.6	11.8	1.0	2.0	0.0	2.6	0.0	5.5	0.5	0.8	5.7	1.6	0.4	26.1	4.8	0.4	9.9	3.5	0.5	0.9	25.8	9.1	2.0	23.0	0.0	0.0	0.0	12.5	2.6	3.2	10.2	0.0	54.0	1.0	0.1	0.2	2.2	0.4	1.0	0.1	1.8	1.4	2.5	51.6	0.6	0.1	0.0	0.0	0.3	1.0	1.2	1.4	1.4	1.2	1.6	1.8	1.5	1.6	1.7	1.5	1.4	6.0	3.2	5.3	0.0	4.1	5.6	51.0	4.1	4.6	3.7	13.5	6.5	9.8	1.5	4.7	0.0	8.4	0.3	0.3	1.0	0.0	2.7	2.7	1.3	2.0	6.8	6.6	0.0	0.4	7.0	1.4	9.1	5.1	2.2	0.0	0.8	4.6	4.9	0.3	3.3	0.4	1.2	2.0	0.3	9.4	6.1	2.1	2.5	1.8	0.0	0.6	4.9	0.0	0.5	0.1	5.2	0.1	6.4	1.0	124.8	0.4	0.7	1.4	4.5	0.0	11.4	5.1	1.8	2.1	2.5	2.0	0.3	2.5	0.8	1.1	12.2
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13544508	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 18.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.2;Cardiomyocytes: 4.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.3;NB-4: 11.3;NTERA-2: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.0	18.7	0.6	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.1	0.6	0.0	0.0	0.4	1.0	0.0	0.1	0.2	0.0	0.1	1.8	1.4	0.0	2.3	1.8	0.7	0.0	0.0	0.2	0.4	0.0	0.0	1.4	0.0	0.0	0.4	2.0	1.8	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	4.3	0.0	0.0	0.0	2.2	0.6	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.5	1.4	0.0	0.6	0.0	0.3	11.3	6.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.9	6.6	0.0	0.5	2.5	0.1	0.4	1.7	0.0	0.0	0.4	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491985-84499292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.2;esophagus: 9.2;pancreas: 6.4"	"Group enriched"	"Detected in some"	5	"Ductal cells: 9.3;Early spermatids: 25.8;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HAP1: 6.2;HEK 293: 5.0;HMC-1: 4.1;PC-3: 3.0;U-2197: 6.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Group enriched"	"Detected in many"	5	"hypothalamus: 2.5;medulla oblongata: 3.4;midbrain: 3.8;pons: 3.8;spinal cord: 7.9"	"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.0	0.0	0.7	0.0	1.0	0.0	0.2	0.6	0.6	0.0	0.6	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.1	0.0	4.2	14.2	0.1	6.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.7	2.2	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.3	0.2	0.1	4.4	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	2.0	0.0	6.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	3.0	0.0	2.0	0.0	0.0	0.3	1.1	0.0	0.7	0.0	0.0	1.3	0.0	0.5	0.0	0.0	1.8	6.8	2.0	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.6	0.6	0.6	2.8	4.2	14.2	4.0	4.2	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	25.8	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	16.7	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128730-35142304	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	7.3	7.4	5.0	5.8	5.0	6.2	8.8	5.1	5.3	7.4	3.4	5.6	4.0	6.8	2.9	8.4	7.4	3.1	4.2	5.0	4.5	6.5	7.3	4.6	6.8	4.7	4.0	12.0	23.7	3.9	4.2	4.9	4.0	6.0	4.0	2.5	7.6	4.6	8.0	6.8	5.1	4.1	3.5	6.2	7.6	4.4	5.0	6.6	5.1	3.5	5.4	7.4	5.8	4.6	15.9	36.8	12.5	22.7	6.9	11.4	19.6	14.0	12.7	24.4	19.3	26.1	14.8	34.9	18.6	12.0	18.0	21.0	26.8	35.6	15.1	5.6	44.2	14.9	18.2	33.2	10.3	29.9	12.0	12.9	19.0	25.6	38.3	10.7	15.5	33.9	42.4	12.7	14.6	22.1	47.1	25.5	23.6	13.5	16.6	37.6	20.9	38.5	14.3	14.8	25.6	14.8	13.1	13.4	17.1	11.1	32.4	22.4	14.5	13.3	18.3	13.0	47.4	9.8	7.8	29.1	9.3	24.9	25.8	0.1	2.2	0.0	4.0	2.4	6.2	3.4	3.8	4.2	3.4	4.6	5.2	3.5	0.3	1.8	1.2	0.8	2.1	2.2	5.0	5.0	5.1	5.3	5.0	4.5	4.7	4.0	4.0	3.5	5.0	4.6	4.7	3.2	1.1	0.3	8.6	8.7	8.6	7.4	9.6	4.7	12.3	14.0	2.6	10.0	3.7	3.7	2.1	12.1	2.4	3.9	0.0	8.9	1.0	2.1	5.4	5.0	4.9	8.8	1.3	15.4	20.9	7.4	6.6	2.8	3.8	9.4	5.3	6.6	7.6	1.7	1.5	8.1	2.0	4.6	2.6	5.4	4.1	2.8	1.8	1.0	3.8	1.9	2.1	1.0	0.7	8.5	3.6	4.9	5.1	8.6	3.4	7.1	2.8	3.1	0.0	6.5	7.2	4.2	6.5	12.5	10.1	4.9	4.1	9.2	13.4	5.5
NLGN1	KIAA1070	ENSG00000169760	"Neuroligin 1"	Q8N2Q7	3	173396284-174286644	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biological rhythms, Cell adhesion"		"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 13.8"	"Group enriched"	"Detected in many"	31	"Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9"	"Group enriched"	"Detected in some"	9	"glioma: 3.8;melanoma: 2.2;renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006572, HPA006680, CAB033261"	Enhanced		Uncertain	"Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	NA		82000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear bodies"	"CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400"	"unprognostic (2.81e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.08e-5)"	"unprognostic (7.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.07e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.37e-2)"	2.0	1.0	12.6	0.5	10.8	0.0	0.7	31.0	12.1	3.1	0.0	2.0	0.2	2.1	2.5	2.5	3.0	1.6	3.2	12.5	15.2	2.9	0.0	0.4	0.2	5.3	5.4	1.3	0.8	0.7	1.8	0.5	4.0	2.2	0.9	13.8	0.3	3.0	0.2	0.3	0.6	2.7	4.4	0.0	0.8	7.0	20.5	0.2	0.9	1.0	0.1	2.9	1.3	7.2	0.1	0.0	6.1	0.0	11.8	12.4	0.0	5.2	12.8	0.6	0.8	0.0	0.5	0.0	0.2	25.9	4.7	0.0	3.7	0.0	1.3	0.0	6.0	1.7	0.1	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	10.0	24.9	0.0	0.0	1.7	0.1	0.0	0.0	0.0	7.2	0.0	1.7	0.0	26.2	6.4	4.7	0.1	2.5	1.7	0.0	0.0	12.3	1.1	0.6	0.0	3.1	13.5	1.3	9.9	11.6	11.7	0.0	0.0	4.6	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	10.8	31.0	12.1	12.5	15.2	5.3	5.4	4.0	4.4	20.5	7.2	0.3	0.0	0.5	66.6	0.0	0.8	0.4	0.0	0.6	14.3	0.1	0.0	4.4	0.0	0.0	3.7	4.2	0.3	0.0	0.0	0.0	0.3	55.9	0.6	12.4	0.8	0.0	0.0	1484.7	0.0	0.2	8.2	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1700.0	0.0	0.0	0.0	0.3	12.5	25.7	0.4	14.2	60.9	0.0	24.9	0.0	4004.1	1261.9	0.1	0.0	14.3	0.0	2.6	0.0	8.5	0.0	10.3	6.6	2.9	2.1	0.4	1.6	0.1	0.9	0.1	0.1	1.6	0.0	0.3
NLGN2	KIAA1366	ENSG00000169992	"Neuroligin 2"	Q8NFZ4	17	7404874-7419860	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 32.7;Horizontal cells: 57.2;Oligodendrocyte precursor cells: 45.8;Sertoli cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 42.2"	"Low region specificity"	"Detected in all"							"HPA055321, HPA069278"	Enhanced		Approved	Mitochondria		NA	NA		14000		"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA055321: AB_2682783, HPA069278: AB_2686105"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.81e-2)"	25.0	18.1	25.6	4.8	26.0	0.4	21.2	13.5	25.3	61.9	0.0	36.4	1.5	57.9	7.5	10.2	46.1	7.7	18.2	23.7	18.6	16.6	9.3	16.7	2.7	18.1	15.2	66.6	9.4	7.6	23.7	3.8	13.9	29.7	2.2	15.5	13.6	9.0	11.7	14.8	16.6	12.3	12.1	16.9	16.3	6.7	20.9	0.8	14.2	2.4	1.8	31.2	32.4	19.0	7.1	9.8	42.2	24.4	12.6	18.0	1.0	11.6	18.2	19.4	17.9	2.2	2.4	0.1	5.5	16.4	11.4	3.9	7.9	4.9	10.0	10.8	7.9	3.1	9.6	1.6	6.3	3.1	10.4	14.1	3.8	15.9	2.4	29.1	6.5	3.9	2.9	5.6	7.9	6.6	1.4	3.1	7.2	0.4	4.7	12.9	5.0	1.4	5.6	1.5	0.6	17.0	5.3	2.5	3.0	8.3	6.9	0.4	9.0	16.6	20.6	10.5	5.7	6.4	2.2	1.2	17.3	2.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	26.0	13.5	25.3	23.7	18.6	18.1	15.2	13.9	12.1	20.9	19.0	5.4	0.0	2.6	25.8	0.5	4.7	3.1	3.3	7.4	32.7	5.6	5.2	11.0	5.7	1.0	0.0	8.4	0.4	3.4	0.1	0.0	2.7	2.0	1.5	25.3	6.8	0.0	0.0	23.5	0.4	6.3	11.5	0.5	2.3	0.0	5.8	6.1	3.2	1.0	57.2	24.8	0.3	0.0	0.8	1.8	2.9	17.1	0.7	1.8	5.6	0.6	22.3	0.0	45.8	13.6	1.6	0.0	22.2	0.3	3.0	0.1	1.3	0.8	16.8	32.9	10.8	10.7	0.5	1.1	1.2	3.8	0.8	1.7	4.3	0.3	1.2
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;seminal vesicle: 12.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	0.5	6.6	10.1	0.8	8.5	1.4	0.4	6.4	11.1	1.9	0.0	1.8	0.2	2.7	6.4	0.6	4.3	1.4	1.1	10.3	10.2	0.3	0.1	0.6	0.4	7.3	7.0	4.4	0.3	0.5	1.0	0.6	4.8	6.0	0.5	1.9	0.6	12.5	0.1	0.7	0.7	1.9	5.5	0.6	0.6	2.6	7.3	0.4	0.4	0.4	0.2	0.7	1.2	9.7	0.0	0.5	6.7	0.2	1.6	0.6	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.1	0.0	0.1	0.2	0.0	0.1	0.4	0.9	0.4	0.4	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.0	0.3	0.1	2.0	0.5	1.5	0.0	0.3	0.5	1.2	5.3	0.0	0.0	0.6	0.2	0.3	0.0	0.8	1.7	2.5	0.2	0.0	0.6	0.8	0.0	0.3	0.1	0.1	0.8	0.2	0.0	1.1	1.1	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	8.5	6.4	11.1	10.3	10.2	7.3	7.0	4.8	5.5	7.3	9.7	0.3	0.0	0.0	19.6	0.0	0.6	0.3	0.2	1.2	2.6	0.3	0.9	0.4	0.0	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.1	1.3	0.2	1.1	0.5	0.0	0.0	11.3	0.0	0.2	1.3	0.0	0.4	0.0	1.0	0.7	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.8	3.9	2.1	0.2	0.0	2.8	0.1	2.5	0.0	92.0	43.7	0.2	0.1	17.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	0.4	0.3	0.2	4.5	0.1	0.3
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.8	1.8	10.1	0.0	2.2	9.8	12.7	5.1	0.0	3.4	1.3	2.3	0.4	0.7	2.0	2.5	4.5	14.8	28.5	0.3	1.3	1.1	0.8	6.5	5.6	11.6	0.4	5.2	1.7	3.6	4.4	1.1	1.9	9.2	0.8	1.9	0.3	0.6	2.6	3.7	1.6	2.2	1.1	2.6	8.9	14.3	0.7	0.2	0.5	2.1	1.4	4.2	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.1	9.8	12.7	14.8	28.5	6.5	5.6	4.4	1.6	8.9	4.2	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NLGN4Y	KIAA0951	ENSG00000165246	"Neuroligin 4 Y-linked"	Q8NFZ3	Y	14522573-14845650	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 6.3;seminal vesicle: 7.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Basal squamous epithelial cells: 45.5;Excitatory neurons: 146.1;Inhibitory neurons: 108.0;Oligodendrocyte precursor cells: 220.7;Oligodendrocytes: 46.7"	"Cancer enhanced"	"Detected in many"		"glioma: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.1;fHDF/TERT166: 25.3;HDLM-2: 30.2;hTCEpi: 21.1;SuSa: 19.9;U-138 MG: 23.1"									HPA001651	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA001651: AB_1079470"			"unprognostic (2.31e-1)"		"unprognostic (9.19e-2)"	"unprognostic (2.84e-5)"	"unprognostic (7.85e-2)"	"unprognostic (6.46e-2)"	"unprognostic (8.80e-3)"		"unprognostic (7.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.89e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.88e-1)"		"unprognostic (5.65e-2)"	1.2	1.3	1.3	0.5	1.5	0.0	1.1	1.7	4.1	0.0	0.3	2.0	0.4	0.0	1.8	2.0	0.0	2.4	0.5	2.1	1.6	1.3	2.1	0.6	0.4	0.8	0.6	0.0	1.6	1.7	2.1	0.3	0.8	6.3	1.4	1.3	1.8	7.5	0.3	1.1	0.9	0.0	0.9	0.4	0.9	0.5	0.5	0.1	1.1	2.2	1.1	3.4	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.1	32.1	2.0	2.6	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	5.0	30.2	0.0	0.0	0.0	4.9	3.3	0.1	0.0	10.7	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	2.2	0.0	6.4	0.1	0.0	0.0	2.0	0.0	7.5	12.4	4.2	0.0	0.0	0.0	0.1	19.9	0.0	0.7	9.3	23.1	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.5	1.7	4.1	2.1	1.6	0.8	0.6	0.8	0.9	0.5	2.5	0.0	0.0	1.3	48.0	1.1	3.4	10.8	12.0	45.5	9.0	0.0	0.0	1.0	5.7	6.4	7.3	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.0	3.0	0.0	0.0	146.1	0.0	0.2	8.6	2.0	0.0	0.0	0.0	0.0	0.6	0.2	6.7	108.0	0.0	4.1	0.0	5.1	0.2	2.8	0.1	1.8	29.0	2.6	4.3	0.0	220.7	46.7	0.0	0.0	8.2	0.4	14.1	0.0	0.8	3.3	0.7	0.0	4.7	1.1	0.4	0.8	12.3	3.1	0.3	0.9	0.0	0.2	11.8
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722205-65871725	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.8;Excitatory neurons: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		64000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	2.2	1.0	3.8	2.4	3.9	1.5	3.7	2.9	5.3	1.8	1.6	3.6	1.1	2.7	2.4	2.5	1.5	1.2	2.6	3.8	3.6	3.9	9.9	1.7	1.7	3.9	3.4	1.8	2.5	1.5	0.9	2.4	4.0	2.6	3.2	2.5	1.9	1.1	8.9	2.8	2.7	2.7	3.3	1.3	4.0	1.1	3.9	0.9	2.7	6.5	2.0	2.7	1.5	4.8	13.3	12.5	7.2	12.0	9.0	15.3	14.5	13.1	5.5	7.6	8.2	7.2	7.7	18.8	16.1	15.8	15.1	10.3	9.5	20.2	13.1	5.6	6.4	5.2	8.7	18.5	7.7	12.0	3.0	11.7	10.8	10.5	12.4	6.3	21.7	8.3	11.4	3.9	16.5	10.2	8.3	10.8	22.2	6.7	3.6	9.6	15.3	29.9	12.6	5.9	22.3	11.5	10.6	10.7	11.0	19.4	12.9	14.1	12.5	5.0	5.9	7.4	10.0	3.3	7.1	8.2	7.7	23.2	7.7	0.1	2.6	0.1	0.1	3.4	0.1	0.4	0.2	0.1	2.2	0.4	0.3	0.2	0.3	0.5	2.3	0.1	0.0	1.0	3.8	3.9	2.9	5.3	3.8	3.6	3.9	3.4	4.0	3.3	3.9	4.8	5.9	6.4	2.8	19.6	4.0	5.7	9.0	6.2	8.6	2.4	10.1	8.9	14.5	7.2	8.5	12.9	4.2	5.3	0.6	52.8	5.9	17.8	0.3	7.4	12.9	8.3	1.8	9.0	58.9	14.5	14.0	7.1	20.4	20.9	15.2	16.2	4.6	32.4	28.8	5.0	32.2	5.8	6.1	22.9	8.9	0.4	4.4	13.5	1.8	5.6	17.9	13.1	2.1	22.6	44.5	30.2	35.9	2.2	4.9	16.5	32.3	22.4	3.1	4.7	0.0	19.7	8.1	2.1	5.2	15.3	5.3	2.9	2.3	15.8	8.2	6.1
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 561.7;Muller glia cells: 151.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.4;Karpas-707: 90.9;U-266/70: 45.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	27.9	4.0	3.6	27.8	3.7	25.0	22.1	3.2	5.3	22.9	3.5	10.8	5.8	13.8	1.8	16.2	14.4	13.4	15.7	2.9	3.7	9.4	5.3	26.9	38.1	5.5	3.8	5.8	3.2	1.8	4.1	12.1	5.5	13.2	7.8	0.3	10.8	9.0	7.7	50.8	31.1	9.7	3.7	56.3	6.9	6.1	4.0	15.1	21.8	7.7	32.4	15.8	27.7	4.1	14.2	0.0	0.0	0.0	8.6	10.2	1.8	6.9	6.3	2.6	5.7	0.2	5.5	5.3	20.8	7.6	1.1	6.5	0.0	23.4	4.0	55.4	0.0	1.4	4.8	0.5	7.1	0.0	1.6	6.6	14.5	20.7	13.7	10.4	25.6	1.1	13.0	90.9	11.8	0.0	0.1	4.6	0.0	0.0	0.3	6.0	4.0	23.0	0.0	4.8	0.7	0.0	0.0	0.2	0.4	0.6	0.0	0.5	25.2	5.3	3.0	3.2	1.1	45.0	15.9	4.1	8.7	0.6	0.3	18.3	7.1	5.0	5.9	4.9	6.6	4.4	5.1	6.3	5.0	4.9	5.5	5.2	18.9	4.2	8.6	0.5	7.7	4.6	3.6	3.7	3.2	5.3	2.9	3.7	5.5	3.8	5.5	3.7	4.0	4.1	46.4	0.0	7.8	1.3	29.0	17.7	7.1	8.0	15.4	60.6	2.7	6.2	4.9	2.8	10.4	7.3	4.2	0.8	30.3	0.3	3.9	0.4	561.7	4.9	18.0	26.9	77.9	3.6	2.9	0.0	1.1	31.6	3.6	1.0	3.8	7.8	44.6	0.6	7.0	85.8	1.5	1.2	0.0	23.0	24.3	93.4	25.4	26.2	7.2	56.2	27.0	151.8	26.8	1.5	0.8	7.0	0.0	28.2	25.9	2.0	0.0	0.4	12.7	11.6	6.6	33.1	17.3	25.0	11.0	10.7	24.9	1.5	37.6	3.6	0.2	8.0
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7957537-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 6.3"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7"	"Region enhanced"	"Detected in some"		"olfactory bulb: 2.1"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"		Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.1	0.0	0.3	0.1	5.9	2.8	1.3	2.8	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;liver: 1.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.0;Late spermatids: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 115.6;RPMI-8226: 66.1;U-266/70: 110.2;U-266/84: 51.2;U-698: 83.9"					"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA046402: AB_10962951, HPA078027: AB_2732369"	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	115.6	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.4	0.7	0.1	0.0	0.4	0.0	2.0	66.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.1	1.8	1.9	0.1	0.1	110.2	51.2	83.9	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.3	5.1	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	0.9	0.0	0.1	2.2	0.1	6.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.1	4.3	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	3.8	0.0	56.9	18.1	23.2	0.0	5.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	29.8	0.0	3.0	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	6.4	7.4	0.0	0.5	0.4	1.0	0.1	0.0	0.7	0.2	0.1	0.5	0.0	3.7	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.7	0.0	0.2	1.5	0.0	0.3	7.6	0.2	0.7	0.0	2.4	0.0	0.8	0.0	0.0	11.2	1.6	0.2	0.3	7.8	1.8	0.0	20.5	0.2	2.1	0.0	0.5	0.1	0.0	0.0	0.3	0.8	0.0	0.1	2.2	0.7	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.7
NLRP13	"CLR19.7, NALP13, NOD14, PAN13"	ENSG00000173572	"NLR family pyrin domain containing 13"	Q86W25	19	55891699-55932336	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060459	Uncertain					NA	NA						"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA060459: AB_2684284"												"unprognostic (2.16e-1)"			"unprognostic (4.66e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020479-7071526	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.3;Bipolar cells: 2.2;Cone photoreceptor cells: 2.1;Distal tubular cells: 1.9;Early spermatids: 2.2;Excitatory neurons: 2.2;Rod photoreceptor cells: 3.2;Spermatocytes: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol		NA	NA						"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.5	0.1	0.1	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	2.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	Activator	"Amyloidosis, Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 53.8"	"Cell type enriched"	"Detected in many"	6	"Macrophages: 254.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 129.4"	"Group enriched"	"Detected in many"	23	"dendritic cells: 37.3;granulocytes: 129.4;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	4	"THP-1: 78.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	8.3	1.4	1.0	10.0	0.8	53.8	3.5	0.8	1.0	1.8	0.8	1.5	0.8	0.9	0.4	2.7	1.4	6.5	1.0	0.9	1.6	0.6	2.1	4.6	2.5	2.0	1.4	0.7	1.6	0.9	0.5	3.4	2.1	0.8	1.8	0.3	0.8	0.7	0.5	0.4	2.4	4.8	1.9	4.6	1.4	0.3	1.6	1.7	1.0	0.5	1.7	6.4	0.4	3.4	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	2.2	2.9	0.5	0.0	1.3	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.0	0.4	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	78.4	0.1	3.2	2.5	0.0	0.2	0.0	0.0	0.0	7.2	18.9	2.4	129.4	35.6	0.2	0.6	21.7	1.7	0.0	2.9	1.2	37.3	0.1	1.1	0.7	8.6	0.0	11.5	1.8	0.1	12.2	1.0	0.8	0.8	1.0	0.9	1.6	2.0	1.4	2.1	1.9	1.6	3.4	2.2	0.0	0.5	0.3	2.6	1.0	0.1	0.0	0.6	0.3	0.6	1.1	0.6	0.0	0.0	0.0	0.0	0.7	6.0	0.0	0.0	0.0	0.3	0.1	0.5	2.3	0.0	1.7	2.6	0.0	0.4	1.2	1.5	0.1	2.5	0.2	0.4	0.3	16.2	0.0	1.2	0.2	0.0	35.4	41.4	0.2	0.0	254.2	0.0	17.8	14.5	0.7	1.0	1.0	0.4	0.1	0.0	0.4	4.0	0.0	0.0	0.2	0.0	0.4	0.0	1.0	1.1	0.4	0.4	1.3	0.6	1.4	10.2	0.1	0.0	0.0
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"parathyroid gland: 22.4"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Karpas-707: 1.3;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047260, HPA056271"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"HPA047260: , HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278407-285388	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 39.9"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 9.9;T-cells: 2.6"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 3.6"	"Group enriched"	"Detected in many"	4	"neutrophil: 15.4;non-classical monocyte: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"REH: 2.0;U-266/70: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043681, HPA048500"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.7	0.0	0.1	2.2	0.2	0.5	0.2	0.1	3.6	0.1	0.2	0.6	39.9	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.5	1.3	2.6	0.9	1.2	0.9	0.3	0.0	0.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.1	38.0	0.1	0.3	3.6	0.3	0.2	0.3	0.3	0.1	0.1	0.3	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	0.2	0.4	0.1	0.0	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.6	1.1	0.1	0.1	1.8	2.3	15.4	1.0	4.6	0.0	0.0	0.7	0.1	0.2	0.1	3.6	0.1	0.5	0.9	0.3	0.6	0.3	0.3	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.7	0.0
NLRP7	"CLR19.4, NALP7, NOD12, PAN7, PYPAF3"	ENSG00000167634	"NLR family pyrin domain containing 7"	Q8WX94	19	54923509-54966312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	30	"testis cancer: 146.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0"									HPA051382	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA051382: AB_2681461"	"unprognostic (2.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.25e-8)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	8.2	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.9	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.6	0.0	0.0	1.9	0.3	0.0	0.0	0.6
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA056989	Uncertain					NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056989: AB_2683301"	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
NLRP9	"CLR19.1, NALP9, NOD6, PAN12"	ENSG00000185792	"NLR family pyrin domain containing 9"	Q7RTR0	19	55708438-55738402	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	40	"Extravillous trophoblasts: 61.2"	"Cancer enriched"	"Detected in single"	59	"testis cancer: 14.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042623	Uncertain					NA	NA						"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042623: AB_10965692"	"unprognostic (2.50e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.82e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.09e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	61.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	8.1	10.7	4.9	4.7	5.0	6.5	7.0	4.7	5.5	10.5	6.4	10.8	4.8	10.1	3.4	43.2	9.8	5.2	17.0	4.7	4.6	8.8	9.1	5.5	5.0	5.3	5.1	4.0	9.6	6.0	4.8	4.2	5.4	8.3	3.4	2.7	10.3	6.8	24.1	21.5	6.4	5.8	5.1	8.1	7.3	3.5	5.1	4.7	7.9	13.7	10.5	9.6	16.5	5.2	5.3	15.6	1.6	12.2	5.1	5.9	2.4	7.0	8.0	3.4	5.9	0.9	13.0	9.5	21.0	8.9	5.1	13.1	4.7	4.0	1.1	12.5	5.0	12.6	5.5	8.6	7.7	4.4	7.0	6.6	16.4	4.5	8.7	6.9	7.0	12.5	0.1	6.2	3.6	14.2	7.5	10.7	7.5	6.9	8.6	14.6	2.1	3.1	8.2	6.8	2.3	7.9	10.4	5.5	4.5	2.4	17.7	13.0	8.2	6.8	6.0	6.1	3.6	2.2	2.6	3.3	1.0	13.4	4.9	2.8	3.5	15.4	0.8	1.5	1.0	0.5	0.8	1.2	2.1	0.4	0.9	1.0	8.1	1.4	1.4	0.9	1.4	2.3	4.9	5.0	4.7	5.5	4.7	4.6	5.3	5.1	5.4	5.1	5.1	5.2	3.0	0.0	7.9	5.9	3.2	2.5	1.7	4.5	2.8	1.3	4.1	4.2	12.8	2.8	4.2	7.3	2.1	3.6	1.4	7.3	1.9	7.1	2.0	8.7	2.8	3.8	2.4	3.8	5.9	3.8	2.2	3.5	8.2	4.1	0.0	5.7	5.3	10.2	6.5	0.0	4.0	3.7	2.0	6.0	1.8	4.7	1.2	4.0	1.8	2.8	6.2	6.1	5.2	5.5	2.8	5.5	7.6	1.2	1.8	1.6	3.9	5.3	7.2	3.2	0.0	2.9	2.7	1.9	2.0	10.8	4.7	0.5	2.8	2.1	5.5	1.2
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.3;brain: 58.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 90.1"	"Region enriched"	"Detected in all"	16	"olfactory bulb: 168.0"	"Group enriched"	"Detected in all"	5	"olfactory bulb: 43.3;pons: 14.1"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	68.3	24.0	19.9	4.1	17.9	6.0	30.7	18.2	23.5	8.3	16.3	5.3	3.1	7.5	4.9	6.9	8.6	4.8	5.4	21.4	58.9	10.7	3.1	6.2	5.7	29.3	22.7	7.1	8.4	4.5	9.8	1.9	26.2	5.0	2.9	3.0	7.4	2.5	2.5	4.9	4.1	4.7	22.4	4.8	5.5	11.9	21.4	4.5	17.7	3.1	3.0	8.5	6.5	44.7	90.1	35.3	6.1	1.3	17.1	7.7	0.8	4.7	10.5	12.5	16.6	12.9	23.5	3.4	12.9	14.7	0.1	15.0	34.0	7.0	7.4	30.3	36.7	12.4	13.2	59.7	4.4	8.2	13.6	7.6	2.8	18.2	7.2	7.6	17.9	23.3	0.2	1.4	6.9	55.2	8.8	30.0	22.9	18.0	8.9	25.7	0.1	38.7	11.5	7.3	3.1	34.6	8.2	5.1	40.5	6.0	5.9	33.8	4.0	2.4	10.3	10.3	7.9	0.7	9.9	8.2	26.3	52.9	14.1	0.0	1.0	7.8	7.9	0.7	2.9	5.9	5.9	7.7	4.5	11.3	5.8	4.1	1.6	1.8	0.5	13.4	7.6	3.4	19.9	17.9	18.2	23.5	21.4	58.9	29.3	22.7	26.2	22.4	21.4	44.7	39.0	3.2	2.7	5.5	13.6	15.6	29.5	319.5	21.6	1.9	30.7	37.6	3.5	20.0	164.2	31.3	0.0	2.4	25.3	5.3	13.7	123.9	33.7	21.3	7.3	19.6	18.6	7.4	0.6	58.2	14.1	19.7	11.2	15.6	5.7	12.0	7.5	3.7	32.3	5.0	1.2	6.5	18.3	8.8	86.4	29.0	4.4	26.0	33.8	1.9	18.5	6.5	25.7	2.0	1.0	45.2	5.1	3.8	32.5	39.3	0.8	32.0	57.8	4.1	13.1	22.5	28.6	24.0	21.6	29.5	12.8	3.1	19.7	8.2	9.1	60.6
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 51.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 43.5;Basal keratinocytes: 38.4;Basal respiratory cells: 23.3;Club cells: 31.1;granulocytes: 22.7;Langerhans cells: 35.0;Melanocytes: 23.2;Suprabasal keratinocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.3	21.0	7.2	15.1	7.4	10.9	8.7	6.5	10.3	8.7	6.3	6.7	3.6	9.3	0.8	14.7	9.4	2.2	9.9	8.7	6.8	12.4	16.4	9.2	8.7	7.8	6.7	5.6	16.6	6.4	11.9	7.1	7.8	6.8	2.9	51.2	13.8	2.2	12.9	12.2	4.9	6.8	6.5	7.9	9.0	3.0	7.7	6.2	7.4	3.6	3.7	13.1	9.9	7.3	22.4	5.5	21.2	48.3	27.9	13.1	7.7	32.3	20.8	15.9	9.5	11.1	8.6	30.1	34.3	41.3	33.2	21.9	25.1	44.7	8.8	51.0	46.6	15.2	9.1	22.7	30.5	25.5	42.2	25.4	36.2	21.2	31.4	49.6	28.0	38.8	21.2	36.7	12.3	14.6	141.2	37.4	19.6	66.5	9.5	49.5	21.0	85.0	23.0	9.4	70.1	56.4	13.9	112.7	38.3	37.8	87.8	86.3	34.1	57.0	14.6	76.8	26.2	60.8	52.2	41.4	26.7	24.6	46.4	0.4	16.0	0.7	18.2	24.1	26.9	14.1	15.7	17.1	45.9	23.4	13.9	16.9	1.7	14.4	11.9	28.4	16.9	20.8	7.2	7.4	6.5	10.3	8.7	6.8	7.8	6.7	7.8	6.5	7.7	7.3	0.0	16.0	43.5	0.0	1.5	38.4	0.0	23.3	2.2	0.0	0.0	0.0	2.2	0.0	31.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.2	0.2	5.1	1.8	0.4	3.9	0.0	0.1	12.1	1.5	0.2	22.7	0.1	0.4	0.6	0.0	0.0	3.5	7.2	10.2	0.0	35.0	0.0	0.3	6.8	23.2	0.0	0.0	0.0	0.0	2.0	0.9	0.0	1.1	0.0	2.0	0.0	0.0	0.1	16.3	0.0	0.0	0.0	16.4	0.1	0.0	3.8	51.9	0.0	3.0	0.0	7.8	0.1
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 918.0;Gastric mucus-secreting cells: 438.3;Plasma cells: 778.5;Squamous epithelial cells: 1490.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	503.5	428.3	308.0	259.5	319.0	329.4	489.1	328.0	379.9	439.2	431.1	409.2	335.1	383.4	236.1	610.6	350.6	187.0	403.9	313.7	338.6	478.1	428.4	339.6	288.9	326.6	320.7	500.1	632.0	201.8	234.9	204.8	321.3	367.7	330.4	63.3	432.4	247.5	545.7	540.3	307.6	286.2	326.8	336.0	403.5	77.8	333.3	190.0	305.3	353.7	289.1	463.5	464.2	333.4	1638.6	2233.9	466.1	913.7	969.3	1399.2	1449.2	1091.7	954.0	1404.8	1053.5	1789.7	792.3	1314.3	1662.9	913.0	706.6	956.2	947.3	1273.3	1035.7	1604.8	3283.2	1120.3	1345.8	2513.4	1116.1	1736.0	760.5	1324.1	1420.0	901.9	1466.4	914.6	860.9	856.5	1541.7	773.7	956.1	2741.9	931.3	2144.8	831.4	2974.6	3364.2	875.9	1731.8	2157.2	1417.9	1800.2	1160.6	641.9	674.1	1472.7	1583.0	806.1	1201.7	1268.5	1013.5	1462.8	1158.2	1135.2	1774.8	1520.9	2176.6	1558.1	815.1	919.1	819.2	66.8	243.4	14.0	166.7	325.5	235.6	338.9	211.9	183.3	439.5	259.2	153.5	170.0	13.8	251.6	282.5	478.1	211.2	298.2	308.0	319.0	328.0	379.9	313.7	338.6	326.6	320.7	321.3	326.8	333.3	333.4	9.7	28.9	67.2	0.0	146.8	14.5	8.3	10.8	918.0	0.9	41.6	35.9	0.0	22.8	85.7	5.5	0.0	10.0	10.1	7.1	37.2	47.4	0.6	16.4	34.3	60.9	14.6	298.2	0.0	34.5	27.8	99.0	438.3	21.3	42.9	6.8	22.9	37.6	16.4	0.0	0.0	19.3	8.2	34.8	17.4	2.1	25.7	136.7	10.6	0.0	55.5	0.4	2.1	0.0	0.0	40.7	15.6	12.8	778.5	7.6	11.7	33.8	63.6	0.8	6.6	10.2	43.3	0.6	5.6	1490.1	14.9	8.8	87.0	6.8	25.0	11.0
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		12000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	34.0	84.4	21.3	8.0	22.7	3.9	34.2	21.0	36.3	41.9	16.8	47.7	15.9	36.7	3.4	27.2	44.3	2.1	36.0	20.2	23.1	44.6	36.3	29.1	5.4	23.7	22.2	43.7	37.2	4.5	71.9	5.2	19.6	59.4	3.1	1.8	35.9	13.0	17.1	31.1	33.8	3.2	22.5	39.4	38.6	16.0	22.0	1.0	40.3	3.1	1.9	38.5	33.5	24.9	1.6	26.9	0.6	21.8	6.1	3.2	2.5	15.7	4.5	2.7	2.1	0.0	31.8	0.4	42.6	2.2	2.8	23.0	1.3	8.8	0.3	32.1	70.9	0.0	12.0	13.0	11.3	5.5	9.8	14.0	7.9	2.7	1.5	5.1	5.6	0.2	11.2	4.4	2.7	40.4	0.4	10.8	28.0	5.4	21.5	15.3	0.3	43.5	4.5	1.2	30.6	23.6	47.1	35.2	4.2	1.2	33.7	13.1	19.9	5.8	21.4	18.5	10.8	11.1	3.7	2.5	8.1	0.9	13.3	10.0	50.7	34.6	33.3	49.6	32.9	36.8	46.3	31.4	45.1	31.9	39.6	31.3	10.8	44.8	55.4	70.3	45.4	41.3	21.3	22.7	21.0	36.3	20.2	23.1	23.7	22.2	19.6	22.5	22.0	24.9	128.8	35.3	62.7	69.9	64.6	72.5	141.3	97.7	179.8	116.3	147.3	165.6	28.0	90.1	76.6	126.9	60.5	86.6	77.9	76.2	60.7	62.9	22.1	66.5	102.9	84.1	135.5	25.7	34.6	37.6	46.3	100.9	76.0	77.6	50.8	71.6	99.9	63.0	74.8	65.6	30.2	109.4	50.8	60.3	91.0	20.3	149.5	71.1	81.8	29.0	136.5	126.9	77.2	40.7	63.7	37.0	104.7	127.5	93.1	98.4	157.2	150.2	70.9	126.7	118.3	75.9	100.8	2.0	40.4	100.9	65.6	46.1	87.3	183.8	107.6	100.6
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 250.5;Erythroid cells: 311.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	89.3	136.1	78.3	26.2	75.6	127.7	72.9	73.5	101.5	88.1	77.3	192.9	21.9	79.5	55.7	50.1	89.1	41.2	101.2	76.4	81.7	60.4	175.2	48.3	21.1	88.6	77.9	86.8	43.7	56.7	64.3	30.8	79.8	143.7	23.5	11.1	70.4	81.9	34.7	31.4	59.7	51.9	78.6	43.8	97.7	44.7	80.3	29.3	51.6	27.2	15.8	145.6	64.3	73.6	1.0	305.4	265.6	366.7	104.0	181.0	59.5	143.6	170.4	211.8	180.6	205.4	176.2	3.0	105.8	230.2	76.9	3.9	145.0	153.9	62.0	126.5	218.7	151.9	40.2	279.9	195.7	111.0	53.1	234.7	79.8	130.5	12.8	152.2	137.6	210.7	159.6	25.8	160.4	255.4	98.5	139.2	271.8	76.1	67.8	485.8	59.3	79.0	150.6	1.2	77.7	419.2	36.8	2.7	139.9	97.2	178.3	257.5	174.0	149.7	216.8	101.8	36.8	2.7	2.0	83.1	65.8	19.8	177.2	12.9	13.3	39.8	14.9	11.9	12.7	27.6	14.4	16.3	17.6	29.9	26.0	13.4	4.2	2.5	10.6	58.3	0.9	10.7	78.3	75.6	73.5	101.5	76.4	81.7	88.6	77.9	79.8	78.6	80.3	73.6	52.2	0.0	13.9	18.6	40.6	32.2	56.3	49.0	40.9	15.2	116.6	135.8	44.5	52.9	25.1	58.8	2.1	71.7	45.7	19.3	250.5	116.5	5.0	30.8	113.3	55.3	45.1	311.8	16.8	40.3	26.1	87.3	29.6	59.8	29.9	199.9	55.6	132.2	131.2	8.4	21.1	38.6	26.4	46.5	68.6	21.6	89.2	35.4	62.2	10.3	46.5	45.9	19.6	10.1	3.6	58.3	23.8	94.8	34.5	121.8	9.0	75.5	7.9	5.6	52.6	40.1	105.8	1.7	32.7	38.6	24.6	21.8	26.2	89.4	54.9	60.9
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115175-138139443	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.2;testis: 53.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.4	6.5	9.7	0.5	10.5	0.0	4.5	9.2	11.7	8.6	18.6	2.1	0.2	4.9	23.1	1.0	37.2	8.7	3.6	10.5	9.2	20.5	0.5	4.5	0.4	10.5	12.3	5.3	4.4	24.3	8.9	0.1	12.1	5.0	1.1	12.9	3.7	4.5	0.4	0.3	0.6	3.1	9.6	0.2	2.8	53.3	11.0	0.7	12.4	0.6	0.2	2.1	0.6	8.9	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.7	0.4	0.7	0.3	0.1	1.8	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.1	0.0	0.9	0.0	3.8	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	29.9	0.0	6.7	2.5	0.0	0.8	4.9	1.7	0.5	1.6	0.0	0.7	0.0	0.0	0.9	0.4	0.8	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.5	9.2	11.7	10.5	9.2	10.5	12.3	12.1	9.6	11.0	8.9	1.0	6.4	7.5	26.8	0.3	0.6	8.5	41.1	0.0	11.7	9.0	7.9	4.3	8.6	38.1	33.1	14.6	0.5	0.1	0.3	86.1	23.8	704.9	205.8	9.2	3.5	5.4	0.0	57.9	4.0	0.0	4.2	2.6	12.7	0.0	7.7	3.6	0.6	0.1	6.7	42.2	3.3	44.7	0.0	0.3	256.5	9.0	1.4	10.6	3.7	0.6	19.1	0.0	11.1	8.1	4.2	0.3	13.9	0.0	4.8	0.2	92.3	431.9	25.8	0.0	0.5	12.6	326.8	24.7	0.0	0.3	0.0	0.8	10.9	1.7	5.9
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017909	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	8.7	7.7	6.3	10.4	6.4	8.1	12.1	9.2	6.3	10.2	8.7	11.6	13.2	9.3	8.5	12.1	14.8	8.9	13.5	7.1	6.5	11.1	10.3	10.2	12.2	5.9	6.3	12.4	11.6	12.4	6.0	14.2	5.7	9.5	11.5	7.6	10.9	8.7	17.7	10.0	10.4	12.4	4.9	9.6	11.5	6.2	6.4	9.4	12.2	17.2	13.7	9.6	9.0	6.3	30.0	19.1	24.3	18.3	18.2	23.4	22.1	27.2	18.3	37.5	27.3	30.5	26.5	30.1	14.0	20.5	36.5	10.1	21.9	27.2	24.1	36.1	21.3	17.9	24.1	26.6	25.7	24.3	20.7	19.7	33.8	34.4	42.9	19.3	19.8	21.1	33.9	23.6	14.0	13.9	21.4	11.3	22.3	19.5	23.3	12.7	22.9	25.3	21.2	23.6	7.7	12.7	19.8	21.0	26.1	17.8	23.9	22.5	22.1	8.3	33.0	21.2	39.4	27.0	40.9	26.1	16.3	31.9	18.4	47.3	33.4	76.4	40.9	36.0	36.6	43.5	37.4	35.2	39.9	38.0	28.1	27.2	37.3	40.4	42.1	34.5	33.5	25.1	6.3	6.4	9.2	6.3	7.1	6.5	5.9	6.3	5.7	4.9	6.4	6.3	13.1	28.9	20.7	2.3	16.4	5.0	8.5	18.2	9.6	11.9	14.1	13.6	10.4	15.7	19.4	9.2	14.6	49.5	18.4	8.2	39.2	24.8	2.6	16.1	17.5	12.8	4.2	8.0	2.5	30.1	41.6	12.4	11.7	11.8	10.1	22.8	7.9	7.9	34.4	10.1	3.2	10.8	12.2	9.3	9.7	1.7	11.8	13.7	16.0	1.9	23.4	17.6	18.6	2.5	2.7	31.3	8.3	7.2	10.8	12.8	16.6	16.4	30.6	11.5	13.1	7.7	12.2	9.3	15.0	12.4	4.1	19.7	14.7	15.1	12.8	7.1
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367948	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 274.9;Inhibitory neurons: 307.2;Oligodendrocytes: 277.7;Respiratory ciliated cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028334, HPA038014, HPA054289"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028334: , HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	6.7	10.6	9.4	5.5	9.9	3.5	11.1	8.4	12.2	13.0	11.8	9.8	3.9	12.9	13.3	7.5	27.7	10.0	6.2	10.8	10.8	12.5	7.9	7.6	5.6	10.2	10.0	13.6	7.2	18.3	14.2	4.8	9.9	8.0	5.6	20.7	4.3	11.5	4.1	4.0	4.6	14.9	9.3	4.4	5.8	16.0	9.9	11.1	13.6	4.9	6.4	8.8	6.2	9.6	24.3	23.6	26.4	20.9	25.1	26.1	9.4	16.6	24.2	28.5	35.8	13.8	33.7	7.1	29.4	14.5	38.8	16.2	15.6	35.3	46.1	25.5	12.3	12.5	21.3	14.1	18.5	23.8	8.3	18.8	20.1	29.5	38.3	39.2	40.8	21.1	12.6	9.5	28.8	7.1	22.7	16.8	26.5	27.4	25.2	16.1	29.4	15.3	46.0	7.3	27.5	40.6	23.0	7.6	18.4	28.3	24.4	16.4	25.4	17.4	59.5	16.5	40.2	11.7	21.3	14.8	19.8	8.2	17.8	1.6	3.9	2.1	9.6	6.3	11.6	9.9	12.0	9.9	6.3	9.3	10.1	11.7	1.1	11.4	9.8	5.1	14.9	5.3	9.4	9.9	8.4	12.2	10.8	10.8	10.2	10.0	9.9	9.3	9.9	9.6	12.3	6.4	10.9	97.6	9.0	14.4	34.5	61.9	15.4	18.9	13.7	14.7	5.1	20.0	29.3	27.6	25.0	7.6	9.2	2.1	23.5	26.6	43.2	75.7	20.4	12.8	17.5	13.7	274.9	8.9	7.4	21.1	12.8	22.2	21.5	21.8	13.9	11.2	14.6	28.6	307.2	4.1	36.7	4.1	11.9	13.8	18.0	6.5	8.8	64.6	3.3	23.8	10.3	106.1	277.7	16.9	6.0	20.7	7.2	8.6	4.9	40.9	142.9	64.9	19.7	21.2	24.7	67.7	21.9	9.2	10.2	2.7	18.7	26.4	6.0	16.5
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"bone marrow: 12.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.1	0.4	0.6	0.9	12.3	0.1	0.5	0.7	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.3	0.7	0.0	0.1	0.4	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.7	1.0	0.2	10.4	0.9	0.3	0.0	0.0	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.1	0.9	0.3	0.2	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	2.1	0.1	0.0	4.6	0.0	0.4	0.4	0.9	0.5	0.7	0.3	0.7	1.1	0.6	0.9	0.7	0.9	1.0	0.1	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	22.8	0.0	0.0	0.0	46.3	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.9	5.1	23.4	0.0	3.3	0.0	0.0	2.6	0.0	17.5	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.5	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 14.6;fallopian tube: 17.6"	"Group enriched"	"Detected in some"	6	"Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	0.7	0.7	4.1	0.4	4.0	2.9	0.7	8.8	5.5	1.1	14.6	0.6	0.2	0.6	0.7	0.4	17.6	0.4	0.5	3.4	4.1	1.0	0.4	2.2	0.3	6.9	7.0	0.7	1.3	0.9	3.7	0.2	4.2	0.8	0.0	7.4	1.6	0.7	2.7	0.8	0.8	0.2	5.2	0.5	0.6	4.3	5.0	0.5	1.1	0.0	0.2	0.5	0.5	4.4	0.3	0.2	0.4	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.7	0.8	0.1	0.0	1.0	1.7	0.3	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.4	0.0	0.1	0.1	1.0	0.2	0.1	0.3	0.3	0.0	0.3	0.5	0.9	0.9	0.2	0.6	0.1	0.1	0.3	0.3	0.0	1.1	0.3	0.2	0.3	0.1	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.0	4.1	4.0	8.8	5.5	3.4	4.1	6.9	7.0	4.2	5.2	5.0	4.4	0.2	0.0	0.5	27.4	0.0	0.0	0.2	1.1	0.0	1.5	0.1	0.0	1.5	2.8	2.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	3.1	20.0	0.2	0.3	0.0	0.0	26.6	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.4	0.0	0.0	3.3	17.9	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.0	1.0	0.0	2.7	0.0	67.8	36.6	0.0	0.0	0.0	0.3	0.2	0.0	0.5	48.4	2.3	0.0	0.5	0.7	5.0	0.7	0.0	0.0	0.3	0.2	0.4	0.0	0.1
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	5.2	7.4	5.4	4.4	6.0	2.5	5.7	4.8	7.7	5.4	9.2	9.0	6.0	3.8	5.8	5.2	4.8	3.4	10.7	5.1	5.2	8.2	7.8	3.2	4.3	5.6	5.4	2.9	4.9	8.2	3.8	3.7	5.5	4.5	9.0	5.3	5.2	5.4	23.3	5.7	6.1	5.0	4.7	5.0	4.4	4.3	5.9	4.2	7.3	16.9	4.6	4.0	3.6	7.2	4.6	5.4	7.5	7.1	13.4	12.2	1.8	9.1	7.2	10.3	6.7	2.4	7.7	4.8	5.7	12.9	4.5	4.6	9.4	12.4	11.0	10.4	4.8	7.6	3.0	7.6	11.4	6.7	7.7	13.3	14.2	12.1	17.4	9.5	10.2	10.4	9.7	3.1	10.9	8.0	3.8	4.4	0.9	10.2	10.2	4.2	4.7	2.7	11.9	2.5	5.4	2.8	11.8	9.7	10.4	3.8	3.5	7.2	10.2	4.1	3.3	8.7	4.2	4.5	4.3	4.5	7.1	13.8	8.6	7.5	3.7	3.2	1.6	2.6	0.8	4.9	1.6	1.9	3.3	2.3	1.4	1.8	9.1	2.5	3.9	3.2	1.5	1.8	5.4	6.0	4.8	7.7	5.1	5.2	5.6	5.4	5.5	4.7	5.9	7.2	5.6	3.2	4.4	10.1	3.7	2.3	5.6	14.3	2.2	7.7	6.1	5.1	14.4	4.3	7.3	7.3	6.2	10.1	3.7	18.8	23.5	9.1	7.8	5.5	8.1	7.9	3.0	2.1	13.0	6.9	4.7	5.7	4.1	6.1	4.5	9.2	7.5	9.0	12.9	10.1	14.3	7.6	12.2	10.3	2.7	3.7	6.5	7.2	5.4	4.7	13.5	9.6	12.3	6.0	13.2	6.0	6.2	6.4	0.9	5.9	19.0	14.3	8.6	7.1	6.6	5.9	5.1	17.3	8.3	3.6	1.8	9.0	3.6	13.1	14.5	4.8
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418380	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.5;heart muscle: 18.3;pituitary gland: 18.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 195.5;Inhibitory neurons: 265.4;Oligodendrocyte precursor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 26.2;SCLC-21H: 80.6;SuSa: 25.1;U-2197: 45.8;U-87 MG: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	8.5	5.9	13.1	0.8	14.8	0.0	5.1	17.2	45.5	2.1	0.0	2.3	0.4	1.2	1.4	0.8	2.3	2.8	18.3	15.6	21.4	0.4	0.0	0.7	0.6	0.7	0.8	0.4	1.7	0.2	18.4	0.9	6.7	0.2	0.9	6.5	0.5	2.5	0.5	0.9	0.9	1.5	0.0	0.1	1.1	8.9	0.8	0.5	6.0	1.4	0.6	0.7	0.8	10.0	1.4	0.5	5.5	0.0	3.1	12.5	4.6	3.4	8.9	1.8	0.6	2.7	5.4	0.0	14.2	0.8	1.5	2.2	0.2	0.1	3.3	0.0	0.1	0.0	2.2	0.0	0.5	0.0	0.1	26.2	1.1	2.1	0.5	11.1	0.5	0.0	0.0	0.1	2.1	0.1	0.0	0.5	9.7	0.1	5.4	0.0	0.2	0.0	5.9	4.5	80.6	6.2	0.7	0.3	0.0	25.1	0.7	1.5	3.0	2.5	0.9	45.8	3.3	0.6	0.0	0.0	35.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.8	17.2	45.5	15.6	21.4	0.7	0.8	6.7	0.0	0.8	10.0	21.4	0.0	1.5	3.9	0.0	0.8	0.2	0.6	0.6	12.1	0.2	0.1	35.2	0.0	2.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	54.3	2.7	0.3	5.2	0.0	0.0	195.5	0.0	12.9	5.7	0.0	7.4	0.0	0.2	0.0	0.0	0.7	20.2	265.4	0.0	4.1	1.0	0.0	42.3	0.0	0.5	1.8	11.2	0.0	0.3	0.0	98.5	6.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	3.4	2.9	19.7	0.3	12.0	0.4	0.2	0.1	0.3	1.4	0.2	0.0	0.0	0.0
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 567.3;Alveolar cells type 2: 566.9;Club cells: 217.6;granulocytes: 278.8;Late spermatids: 223.3;Respiratory ciliated cells: 250.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	7.5	7.4	17.7	4.9	26.7	19.3	8.3	46.5	45.4	6.7	8.2	6.9	9.2	9.4	8.1	5.4	13.6	5.4	11.6	21.5	10.9	9.2	6.6	4.3	4.8	8.6	5.3	20.1	12.0	8.9	5.5	2.2	15.1	6.5	7.5	30.6	9.3	5.5	29.6	19.0	7.8	5.6	2.5	5.4	5.6	11.3	14.6	3.0	7.6	20.3	5.3	5.5	6.8	50.1	9.2	3.6	4.0	4.6	0.9	0.9	5.0	3.7	0.4	0.6	0.5	5.1	6.4	5.9	10.8	0.7	4.3	4.5	3.0	1.2	0.7	5.8	5.3	31.4	9.1	6.9	2.4	5.6	5.5	1.4	7.8	1.0	1.7	9.3	0.5	3.6	5.0	13.1	0.6	6.2	5.3	4.6	9.0	16.5	3.7	4.4	4.5	4.3	1.2	6.3	9.2	5.4	9.2	4.8	3.3	7.3	12.6	15.6	5.6	5.7	12.6	7.2	5.5	23.1	11.0	4.2	3.8	9.0	5.4	11.4	3.6	2.2	2.8	3.4	1.9	2.7	2.4	2.4	2.8	4.5	3.4	3.6	7.0	4.0	3.4	2.9	1.6	1.7	17.7	26.7	46.5	45.4	21.5	10.9	8.6	5.3	15.1	2.5	14.6	50.1	5.5	567.3	566.9	34.9	1.9	4.1	6.3	6.6	6.2	2.7	8.2	7.1	9.7	8.6	217.6	9.2	4.2	0.4	0.8	2.3	11.7	3.3	128.2	2.1	2.4	38.8	6.7	27.1	37.2	3.1	0.2	38.3	3.1	1.7	278.8	9.7	2.5	2.7	2.0	1.7	26.0	6.5	8.2	4.1	2.9	223.3	7.8	31.8	7.2	12.2	1.8	12.3	0.0	46.8	16.9	0.8	2.9	6.4	0.7	6.1	3.5	16.1	250.6	18.5	6.6	13.2	3.8	67.1	3.5	4.4	9.7	0.1	21.5	5.9	10.6	4.8
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 68.6;Karpas-707: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	22.1	11.5	14.6	14.3	15.0	12.6	20.2	17.0	18.9	21.8	15.4	15.3	17.8	11.2	18.5	39.5	16.4	14.1	15.5	15.2	15.4	32.5	53.7	21.7	17.5	14.9	14.8	22.7	45.1	64.1	19.8	14.8	15.2	23.7	13.0	8.8	31.2	13.6	27.2	23.2	22.4	8.8	14.8	31.1	26.0	9.7	14.4	17.3	25.6	13.4	20.0	18.8	25.6	15.2	11.7	2.7	3.2	7.9	21.4	28.0	18.1	17.0	22.4	3.5	5.8	0.1	29.8	6.8	10.0	13.8	7.2	18.5	3.8	9.4	10.0	68.6	3.5	5.1	5.6	5.7	20.3	4.8	0.8	22.5	23.5	6.3	11.8	20.8	25.1	10.8	0.5	79.0	24.6	8.4	4.3	4.3	3.9	40.2	10.0	1.6	29.7	42.1	28.9	19.5	2.2	0.5	7.3	6.4	9.0	19.2	18.4	4.5	20.6	13.5	2.9	12.9	4.6	37.5	31.4	4.1	23.1	4.9	13.8	16.4	5.4	9.3	25.1	5.1	30.5	13.4	43.7	29.2	6.1	9.1	39.4	30.2	9.8	17.2	14.5	17.2	31.6	18.1	14.6	15.0	17.0	18.9	15.2	15.4	14.9	14.8	15.2	14.8	14.4	15.2	42.2	38.5	21.7	11.8	22.6	21.0	36.4	38.2	38.7	8.4	33.4	37.5	15.5	21.5	27.9	23.9	8.4	53.3	43.7	32.8	52.8	30.5	17.8	42.4	16.8	33.4	4.2	10.3	26.2	35.5	75.7	22.7	49.5	37.4	1.3	8.3	55.3	45.2	62.4	11.8	20.6	34.8	22.4	32.5	9.6	30.8	23.6	22.9	26.6	14.0	67.6	15.2	43.3	13.6	23.9	21.5	26.1	12.4	68.8	23.4	83.8	92.1	30.5	8.3	13.1	24.5	15.0	10.7	8.3	50.9	27.0	45.6	48.8	22.2	25.0	32.6
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	116	"heart muscle: 1438.4;skeletal muscle: 634.8;tongue: 722.1"	"Cell type enriched"	"Detected in some"	36	"Cardiomyocytes: 995.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8;testis cancer: 13.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 29.2;NTERA-2: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.7	1.7	0.2	0.0	0.2	0.0	0.8	0.2	0.8	0.2	0.2	0.5	0.0	0.4	0.1	5.7	0.6	0.0	1438.4	0.2	0.4	1.9	0.3	2.1	0.0	0.3	0.4	0.5	0.6	0.0	1.7	0.1	0.1	2.6	0.1	0.0	8.0	0.8	634.8	0.7	0.5	0.0	0.2	0.1	0.6	0.5	0.2	0.0	0.6	722.1	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.2	0.4	0.3	0.4	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	995.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	0.0	0.0	0.2	0.0	0.6	26.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	24.6	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 93.6;Hepatocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 102.6;TIME: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	25.9	4.4	7.3	6.1	8.7	3.7	17.5	12.2	10.0	9.8	4.0	8.8	6.6	12.7	3.5	7.0	8.3	7.0	8.7	7.0	4.9	9.4	16.8	6.3	8.9	5.0	7.6	15.4	5.6	16.5	5.5	4.4	5.1	9.0	9.2	7.0	5.2	7.7	8.3	10.1	10.9	10.5	4.3	9.4	7.9	13.4	9.1	27.0	5.9	8.5	8.0	8.6	7.9	7.3	8.8	11.3	12.7	9.3	33.7	35.9	2.3	18.8	15.3	17.0	23.0	10.9	38.7	0.4	12.7	102.6	46.6	10.6	11.4	10.7	28.3	11.7	13.9	23.4	5.4	15.2	22.4	1.7	84.0	31.9	10.8	23.8	7.2	62.2	65.8	16.3	11.2	1.5	63.7	10.9	18.3	4.4	9.3	10.0	10.5	13.6	18.5	1.8	12.6	1.8	3.9	14.4	22.8	3.7	6.3	10.5	11.7	7.3	147.1	16.7	24.4	75.0	13.7	13.0	14.3	1.0	20.7	6.3	12.4	14.5	0.5	13.6	11.0	0.7	19.8	2.2	17.5	12.9	0.5	2.5	21.8	14.5	1.9	20.8	0.8	0.5	29.5	6.5	7.3	8.7	12.2	10.0	7.0	4.9	5.0	7.6	5.1	4.3	9.1	7.3	52.5	9.6	8.8	25.1	16.0	16.6	23.4	8.3	7.4	20.6	14.7	13.1	13.5	57.2	10.9	27.6	4.2	1.3	16.9	32.8	9.8	33.9	6.6	4.7	20.5	21.7	18.0	15.1	39.6	19.5	3.0	16.3	9.2	10.3	93.6	13.2	25.4	141.9	2.8	20.2	30.1	11.4	4.1	7.9	7.1	14.5	21.8	5.8	12.4	17.8	10.1	12.9	40.2	12.5	15.3	27.1	15.9	20.7	10.0	17.9	38.4	63.2	5.3	17.2	0.0	13.4	21.0	8.1	46.8	6.8	14.8	2.6	33.9	11.0	18.1	16.7
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.2;skin 1: 38.5;vagina: 30.7"	"Group enriched"	"Detected in many"	4	"Squamous epithelial cells: 212.4;Suprabasal keratinocytes: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 90.2;HaCaT: 382.6;K-562: 311.3;Karpas-707: 135.7"	"Group enriched"	"Detected in some"	8	"hypothalamus: 1.1;pons and medulla: 4.5"	"Low region specificity"	"Detected in some"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.4	0.7	0.5	9.7	1.5	0.6	1.1	12.3	0.0	1.4	0.8	0.1	0.0	100.2	0.2	0.0	0.2	0.3	2.8	0.2	0.0	0.8	0.5	1.1	2.6	0.1	0.1	0.0	2.3	0.8	0.8	0.2	0.8	0.1	14.3	0.2	0.1	38.5	1.4	0.2	3.0	0.1	4.0	2.2	6.8	1.7	2.5	0.0	7.7	0.1	30.7	0.4	41.3	0.3	22.1	5.6	0.0	0.0	0.0	0.0	0.0	2.9	7.8	0.3	61.5	90.2	8.6	0.0	8.5	382.6	46.1	3.3	2.3	5.6	25.1	0.6	36.0	0.0	0.0	0.0	0.3	0.0	4.2	0.0	3.0	10.0	0.4	6.4	311.3	135.7	0.3	9.9	1.2	0.2	11.7	7.5	11.4	0.2	0.0	0.5	1.9	0.4	19.5	49.0	30.9	0.8	0.1	4.2	20.9	0.1	2.7	0.2	27.5	0.3	54.5	39.1	0.3	0.0	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.1	0.3	2.8	1.1	2.6	0.8	3.0	6.8	0.4	0.0	0.0	2.3	0.0	0.6	16.3	0.6	16.2	4.0	0.2	0.9	1.3	0.1	0.0	8.0	0.0	0.0	2.0	0.0	0.6	0.0	0.1	0.4	3.9	0.3	0.7	0.0	14.5	0.2	0.2	0.1	4.4	29.6	5.8	1.3	0.9	0.0	0.1	0.3	0.0	17.2	0.8	20.3	0.0	1.6	0.3	0.0	0.2	3.6	0.0	0.1	2.0	0.0	1.0	0.2	2.4	0.2	0.0	1.2	0.4	0.0	0.0	7.0	0.0	0.0	0.0	1.2	5.8	10.0	212.4	73.6	0.1	0.7	0.2	2.6	12.0
NMUR1	"FM-3, GPC-R, GPR66, NMU1R"	ENSG00000171596	"Neuromedin U receptor 1"	Q9HB89	2	231523187-231530445	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 13.7;Hepatic stellate cells: 7.9;NK-cells: 47.4;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Group enriched"	"Detected in many"	7	"gdT-cell: 18.1;MAIT T-cell: 4.6;memory CD8 T-cell: 8.8;naive CD8 T-cell: 5.2;NK-cell: 10.9"	"Group enriched"	"Detected in many"	19	"NK-cells: 10.9;T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA027895	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027895: AB_10602713"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.74e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-4)"	"unprognostic (3.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.61e-1)"	"unprognostic (5.25e-2)"	5.2	1.3	0.1	0.5	0.1	2.6	1.5	1.1	0.3	0.7	0.0	1.1	2.8	0.9	2.3	1.6	1.4	0.7	0.7	0.1	0.0	1.0	0.8	3.1	0.5	0.0	0.0	0.3	4.2	0.3	0.2	1.3	0.0	1.3	0.8	8.2	1.2	2.1	0.2	0.4	3.7	0.9	0.0	3.6	0.8	1.5	0.0	0.1	0.8	0.0	0.2	1.3	0.6	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.0	18.1	0.0	4.6	0.1	1.3	8.8	0.1	0.0	0.1	5.2	0.7	10.9	0.1	0.4	0.6	4.9	0.1	0.1	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.3	0.0	0.1	2.5	0.0	0.0	0.0	2.1	0.5	13.7	0.0	0.0	0.0	1.2	0.4	0.2	0.6	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.1	1.3	0.0	7.9	0.0	0.2	1.7	0.7	0.1	0.0	0.9	1.4	0.5	2.1	0.3	0.0	0.0	0.2	2.6	47.4	0.5	0.1	0.1	0.0	7.5	2.4	0.1	0.0	0.1	0.0	17.2	0.0	0.2	0.9	2.2	4.7	0.0	0.4	0.7	6.9	5.2	0.0	0.1
NMUR2	NMU2R	ENSG00000132911	"Neuromedin U receptor 2"	Q9GZQ4	5	152391546-152433368	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 6.2"	"Group enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 5.1;Oligodendrocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;stomach cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 9.6"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Low region specificity"	"Detected in all"			"HPA027800, HPA045836"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA027800: , HPA045836: AB_10968856"	"unprognostic (1.82e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.44e-3)"		"unprognostic (3.13e-1)"		"unprognostic (6.47e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.90e-5)"	"unprognostic (1.48e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.29e-1)"	0.0	0.1	1.0	0.0	3.5	0.0	0.0	1.4	1.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	3.0	0.4	0.0	0.3	0.0	4.5	2.1	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.8	0.0	1.0	1.5	3.0	0.6	0.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.5	1.4	1.8	0.7	3.0	4.5	2.1	4.1	3.8	3.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 239.1;tongue: 384.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 344.3;Hepatocytes: 314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	26.0	16.5	12.8	11.8	16.0	15.0	13.7	11.2	21.7	16.4	34.9	25.9	17.2	11.0	16.7	16.8	10.7	15.0	137.7	16.1	11.5	57.0	116.4	13.2	16.5	10.3	12.0	10.1	17.8	55.6	9.6	12.7	9.5	18.3	27.8	12.9	26.6	18.2	239.1	10.4	16.1	20.6	9.3	11.5	31.2	6.2	15.8	26.8	31.1	384.0	17.2	17.3	9.3	15.1	15.4	12.6	30.5	59.6	44.0	50.3	9.9	17.5	39.8	24.8	20.8	19.0	30.4	18.5	21.5	43.9	22.3	16.6	120.5	5.4	27.4	31.1	33.6	24.0	70.7	23.8	27.5	50.2	43.1	37.9	17.5	16.3	18.6	42.6	56.3	22.7	21.4	81.3	60.0	15.1	55.8	35.8	6.4	0.1	15.2	54.7	73.8	70.8	58.0	15.5	44.2	37.7	62.9	1.4	46.7	6.9	47.7	58.3	23.2	29.5	28.3	12.0	8.3	36.1	45.1	26.5	7.1	68.8	22.1	12.5	18.2	16.0	16.7	23.0	17.1	12.0	17.1	15.5	32.0	12.0	15.5	14.7	2.9	23.2	24.7	9.1	22.2	19.3	12.8	16.0	11.2	21.7	16.1	11.5	10.3	12.0	9.5	9.3	15.8	15.1	12.0	54.5	37.8	60.7	19.6	11.5	9.5	19.0	13.1	17.9	9.6	6.3	344.3	38.6	27.0	27.6	35.5	8.7	20.4	34.4	27.4	14.4	16.7	18.5	16.6	19.2	19.9	34.9	124.8	10.7	2.3	27.2	23.9	25.1	25.2	26.8	21.0	314.3	25.0	6.7	110.6	22.6	20.3	40.6	11.9	4.6	14.9	19.8	14.2	45.9	25.9	12.5	35.0	77.9	63.4	9.5	16.7	19.2	20.0	11.7	23.6	21.7	18.1	12.8	0.0	14.0	20.1	4.0	1.4	17.6	8.1	2.1	20.9	18.8	28.9	9.9
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963350-56977606	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	10.4	8.8	6.9	10.3	7.9	17.5	15.5	8.2	7.6	12.3	7.8	15.8	19.5	11.1	11.3	11.3	16.8	9.6	10.9	7.2	6.8	11.0	8.6	9.1	16.7	7.5	6.8	15.1	22.9	10.9	4.1	8.3	7.8	11.3	14.2	6.9	16.0	10.7	21.8	17.8	14.7	10.2	7.4	11.6	13.3	6.7	6.9	17.6	12.0	16.1	17.5	11.4	8.5	8.7	18.9	17.2	12.3	21.9	22.7	40.5	33.9	14.6	26.5	16.7	16.8	30.3	34.4	67.8	24.5	12.5	13.1	19.7	24.2	26.2	15.8	12.4	30.8	16.8	14.2	33.0	17.7	30.8	17.4	37.7	31.4	15.4	26.7	34.9	28.5	28.6	28.9	22.0	22.8	27.9	44.3	41.2	16.2	36.0	26.4	30.5	13.2	25.4	24.1	28.1	28.5	24.3	15.1	60.2	22.5	15.8	26.9	21.6	18.4	13.0	31.2	15.8	27.3	29.5	13.2	34.5	13.2	19.4	17.1	14.2	33.1	16.7	26.2	31.3	40.8	45.6	40.1	33.8	39.4	35.7	48.3	40.6	8.0	48.1	28.3	30.3	52.0	35.8	6.9	7.9	8.2	7.6	7.2	6.8	7.5	6.8	7.8	7.4	6.9	8.7	10.3	3.2	5.8	5.2	21.3	25.4	20.9	31.4	35.9	6.6	24.7	20.6	16.2	17.2	18.4	7.3	4.2	31.5	19.8	10.6	19.6	19.0	27.0	30.9	14.3	13.2	17.5	27.3	6.8	22.8	32.7	15.6	15.3	15.2	8.2	19.1	10.4	5.1	17.8	1.7	6.8	20.6	16.2	20.3	16.2	12.5	16.1	14.2	12.4	1.9	26.9	10.0	25.7	5.0	8.0	16.9	20.3	23.3	14.7	16.7	31.4	14.8	25.0	9.4	13.1	15.5	19.8	13.0	8.9	24.4	24.7	27.9	18.2	30.8	34.5	20.6
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1 (RPN12) binding protein 1 homolog"	Q9ULX3	16	69741871-69754926	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: AB_2680764, HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.21e-5)"	"prognostic unfavorable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	33.3	51.8	13.5	23.2	18.6	31.1	32.2	14.7	17.3	29.2	18.1	25.1	31.5	28.4	14.0	41.8	43.4	24.3	18.5	13.9	13.4	23.7	24.5	20.6	37.0	15.2	13.9	54.5	90.1	17.7	15.3	20.5	15.2	24.9	19.1	7.0	31.1	19.2	36.6	42.5	23.2	20.1	13.9	27.3	37.1	12.8	15.3	26.5	30.8	20.2	30.1	31.5	31.7	14.9	58.7	125.9	29.0	82.7	63.2	98.6	57.5	46.1	63.6	84.0	75.9	143.5	93.5	129.9	69.9	51.2	44.2	84.9	80.3	102.6	49.4	33.0	93.6	50.8	57.5	186.6	111.3	95.0	40.9	125.5	85.8	96.9	122.6	78.0	71.7	77.0	117.2	39.2	42.5	152.8	119.6	187.9	89.2	64.9	73.8	130.5	30.1	164.6	62.5	56.5	75.0	37.1	144.8	50.1	73.8	25.5	54.4	84.0	55.3	56.8	51.8	52.6	76.0	63.9	52.7	230.1	57.0	85.3	64.2	0.3	37.9	5.7	41.5	32.5	58.1	47.0	50.3	38.5	51.3	53.9	53.3	49.0	1.9	65.7	26.5	26.8	68.2	46.7	13.5	18.6	14.7	17.3	13.9	13.4	15.2	13.9	15.2	13.9	15.3	14.9	31.3	3.2	18.8	4.6	36.2	60.0	75.1	84.7	87.6	10.2	52.3	69.7	5.7	24.3	47.2	20.2	0.0	71.9	22.5	14.2	41.1	47.9	10.7	22.0	42.5	39.9	10.2	37.6	6.9	85.9	82.6	35.8	23.4	26.5	16.5	68.5	32.5	14.8	36.2	5.0	6.7	36.9	36.7	30.7	24.1	7.1	36.7	19.6	21.4	2.8	35.7	11.6	35.0	6.0	5.7	46.9	25.1	42.5	24.8	72.0	35.3	37.4	17.1	5.4	26.3	47.2	30.5	18.1	33.4	64.0	59.7	47.5	30.7	77.4	63.2	67.8
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
NODAL		ENSG00000156574	"Nodal growth differentiation factor"	Q96S42	10	70431936-70447951	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3;skeletal muscle: 2.3"	"Group enriched"	"Detected in some"	26	"Early spermatids: 15.4;Late spermatids: 38.5"	"Cancer enriched"	"Detected in some"	10	"testis cancer: 20.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;SH-SY5Y: 1.4;SuSa: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA045201	Uncertain				"Secreted to blood"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA045201: AB_2679252"	"unprognostic (3.07e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-5)"	"unprognostic (4.37e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	0.0	0.6	0.6	0.5	2.3	0.6	0.6	0.0	0.4	0.2	0.3	0.0	0.3	0.3	0.2	0.3	0.5	0.6	0.1	0.1	0.4	0.2	0.7	0.6	0.3	0.1	0.0	0.1	0.2	0.7	0.2	0.0	1.3	0.2	0.0	2.3	1.0	0.2	0.0	0.5	0.2	0.2	1.9	0.6	0.2	0.1	0.0	0.0	0.4	0.4	0.6	0.3	0.2	0.8	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.2	0.0	0.2	0.2	0.5	0.0	0.1	0.1	1.4	0.4	0.1	0.0	3.5	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.5	1.1	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.3	0.6	0.5	0.6	0.7	0.6	0.7	0.5	0.6	0.6	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	38.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595611	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2;placenta: 10.6"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 72.8;naive CD8 T-cell: 34.9"	"Lineage enriched"	"Detected in single"	78	"T-cells: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 123.3;LHCN-M2: 38.1;NB-4: 28.8;PC-3: 37.9;U-2 OS: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 32: Non-specific - Translation"			"HPA061318: AB_2684478"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favorable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.7	0.1	6.1	0.6	4.8	0.2	0.3	1.7	4.2	4.7	0.3	0.3	0.1	0.3	0.1	0.2	0.5	0.0	0.5	4.0	3.6	0.4	0.1	0.7	1.8	2.1	5.0	0.0	0.1	0.0	0.7	10.6	1.8	0.8	0.0	0.0	0.3	1.4	3.5	0.3	0.5	0.1	2.4	0.7	0.9	0.7	8.2	0.6	0.4	0.8	0.4	0.8	2.7	2.0	6.3	0.2	0.2	0.0	0.2	0.0	0.0	3.2	3.5	1.2	1.3	0.4	1.2	0.0	123.3	1.5	4.8	0.5	2.2	0.3	3.4	0.1	2.2	0.0	5.2	0.0	0.0	0.9	0.0	0.5	0.7	0.0	0.5	0.4	0.1	0.1	0.0	0.0	38.1	0.2	1.1	28.8	2.6	0.0	37.9	17.0	11.6	0.0	2.9	0.0	0.2	0.0	6.5	0.1	0.0	9.9	0.1	0.5	0.7	2.3	38.5	0.2	2.7	0.0	0.1	0.4	0.0	3.2	0.0	0.9	0.1	0.2	0.6	0.2	0.2	0.1	4.3	0.5	0.1	0.1	72.8	34.9	0.8	0.4	0.3	0.3	3.4	3.1	6.1	4.8	1.7	4.2	4.0	3.6	2.1	5.0	1.8	2.4	8.2	2.0	0.4	0.0	0.0	2.0	0.3	0.0	0.4	0.0	0.6	0.0	0.1	0.9	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.1	0.6	1.5	0.3	0.0	2.5	0.2	0.0	12.2	1.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.0	1.5	0.1	0.6	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	2.3	0.4	0.0	1.7	0.4	0.1	0.8	2.0	0.0	0.0	0.1
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570754-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.3;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	12.6	14.8	6.6	10.1	8.0	16.2	11.3	10.2	8.2	9.6	5.1	10.8	8.1	9.3	11.0	13.7	7.8	6.6	11.2	7.5	7.1	13.7	14.4	9.0	10.3	6.2	6.6	9.1	16.0	12.1	8.3	10.9	6.1	10.0	10.6	6.2	12.9	8.6	19.4	13.1	9.0	8.8	6.3	9.6	11.7	13.1	7.3	9.9	10.2	11.9	11.7	12.3	10.7	8.8	19.7	33.2	18.6	32.6	22.1	24.2	34.9	33.1	25.8	36.9	27.5	37.5	24.0	45.4	19.5	32.1	30.8	24.5	43.8	38.7	43.6	32.2	33.8	43.8	20.3	46.6	28.0	52.8	23.9	22.6	28.7	40.7	39.1	16.7	25.5	25.0	59.4	28.5	33.9	38.2	36.4	37.4	49.7	51.8	28.8	32.0	49.2	41.4	26.1	30.6	31.6	34.3	24.2	39.4	29.1	20.2	20.8	20.4	24.2	33.8	41.1	33.6	53.9	37.9	63.7	52.4	28.1	49.7	41.5	1.5	3.9	2.2	4.0	5.2	5.9	4.8	4.2	4.2	4.9	3.7	3.2	4.8	0.5	4.8	5.9	3.1	6.0	2.8	6.6	8.0	10.2	8.2	7.5	7.1	6.2	6.6	6.1	6.3	7.3	8.8	22.2	16.0	16.7	31.6	17.1	33.0	29.9	17.2	17.1	13.0	16.3	12.8	19.2	11.5	16.1	12.9	12.5	32.7	16.4	9.9	15.6	27.5	189.3	8.9	19.5	22.9	11.4	19.8	72.9	24.1	33.7	20.2	13.3	17.8	14.0	20.2	12.5	12.2	15.4	16.8	57.6	12.4	18.3	9.8	13.0	163.0	17.1	12.2	8.8	36.5	23.8	13.9	20.6	54.3	54.2	19.0	7.0	16.6	22.1	30.3	10.6	17.0	7.3	16.7	13.1	36.4	22.5	26.4	42.1	17.8	34.2	29.6	17.7	30.4	18.3	22.3
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717931-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	12.4	8.2	5.0	14.4	5.5	20.8	16.3	9.6	13.0	14.8	6.1	14.8	12.2	15.0	12.7	14.9	14.5	12.7	12.3	5.0	5.3	15.5	18.9	9.8	22.9	5.8	5.4	14.8	14.4	15.6	3.3	17.8	5.9	11.9	15.5	10.3	9.4	11.3	15.5	11.9	10.9	15.6	5.8	12.6	10.2	11.5	5.8	19.7	15.2	17.0	24.5	18.4	6.0	8.9	54.3	63.4	45.7	29.6	21.1	25.3	52.2	37.1	28.6	71.0	58.5	53.5	36.2	86.5	26.8	36.4	47.1	38.4	112.9	54.0	105.7	26.8	92.7	57.9	36.3	48.3	24.7	74.8	34.0	19.8	34.2	52.7	36.9	20.7	67.8	39.1	96.6	25.8	58.8	49.2	89.1	29.6	50.6	61.0	74.4	63.6	101.4	59.8	31.0	57.6	39.4	37.8	32.8	84.7	40.3	63.3	60.5	44.0	26.5	64.3	44.7	21.7	75.7	16.2	45.5	93.7	26.4	54.8	37.6	12.8	6.3	4.6	9.7	7.6	10.4	10.6	10.2	11.9	8.9	13.0	16.4	11.9	0.8	13.1	7.7	6.5	11.8	9.4	5.0	5.5	9.6	13.0	5.0	5.3	5.8	5.4	5.9	5.8	5.8	8.9	25.5	28.9	18.6	10.4	33.7	33.4	38.9	30.5	27.9	21.9	15.8	11.8	18.6	21.5	27.8	9.2	14.6	45.4	33.8	13.1	11.7	23.5	1.7	17.1	28.9	26.0	27.5	24.2	11.3	17.8	37.1	25.0	20.4	18.7	24.1	31.9	16.8	25.3	20.3	25.2	11.4	16.8	26.4	11.8	11.8	4.3	20.8	15.7	17.8	8.4	19.5	15.8	21.6	13.0	16.3	16.6	9.2	19.2	17.4	24.9	12.2	28.6	24.8	32.7	6.6	25.9	21.8	30.2	35.0	26.8	33.2	33.0	32.0	27.0	21.9	25.4
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693476	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	17.1	29.2	11.3	15.1	12.7	28.7	17.5	12.1	18.0	20.5	9.6	21.3	14.9	15.5	7.9	35.1	16.2	9.0	18.6	11.8	12.3	22.0	16.2	14.3	20.9	12.3	11.8	18.5	17.5	11.5	16.5	8.1	12.1	19.8	9.5	4.9	20.5	4.4	12.6	22.7	19.5	6.6	11.2	26.5	18.8	10.4	11.8	16.1	23.1	8.2	12.6	17.1	23.3	12.9	38.3	33.5	24.4	29.5	8.1	7.8	32.2	17.1	7.7	7.4	8.4	20.0	15.7	30.2	9.8	6.2	8.1	41.4	11.6	50.0	2.2	34.4	51.9	26.3	28.9	43.6	21.3	59.3	38.2	9.6	12.4	31.2	11.7	10.0	15.3	16.7	19.8	26.9	6.8	32.3	36.4	48.0	29.5	16.6	46.7	48.5	16.7	24.7	18.2	10.1	19.2	40.3	22.1	19.5	30.8	2.7	26.9	31.0	22.9	34.2	32.5	24.8	34.5	24.0	29.9	41.0	33.3	46.2	40.0	57.3	24.4	26.9	15.1	28.4	11.7	14.1	14.8	13.6	17.6	15.8	14.8	12.6	53.1	16.7	33.8	13.6	22.3	11.9	11.3	12.7	12.1	18.0	11.8	12.3	12.3	11.8	12.1	11.2	11.8	12.9	10.9	3.2	15.3	4.9	15.3	39.0	13.7	33.0	25.0	11.0	10.2	7.7	3.5	7.2	20.3	14.7	6.2	19.4	11.0	35.6	3.9	25.7	105.7	5.4	5.0	12.9	12.6	8.8	11.4	29.1	16.2	10.2	15.8	4.7	15.2	9.7	10.8	6.2	13.9	28.6	10.9	24.8	20.3	10.7	21.8	48.3	9.9	12.7	21.4	2.8	17.7	13.8	18.6	5.5	8.2	22.4	39.9	11.3	14.0	8.6	27.4	7.8	15.9	8.3	13.1	10.0	10.6	14.5	25.9	45.4	39.8	19.8	14.3	9.7	24.1	14.5
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	34.4	77.5	36.1	3.8	37.1	0.7	35.4	36.7	36.2	37.1	30.7	32.5	6.7	27.8	11.4	48.6	35.4	10.2	99.3	32.9	35.0	33.0	52.0	28.9	3.1	43.9	36.2	29.3	50.6	37.7	60.2	11.6	39.6	70.1	7.6	28.6	51.1	13.8	142.2	79.2	18.1	8.0	35.4	15.9	28.2	7.6	36.9	2.8	35.6	97.5	4.1	38.7	39.8	38.1	14.9	23.9	3.9	22.1	19.2	14.5	22.0	11.8	12.5	12.6	7.4	5.2	38.2	0.3	38.0	13.8	3.3	24.3	5.4	18.3	3.0	13.4	8.3	0.6	19.8	7.8	12.0	1.3	2.9	8.9	33.1	9.9	7.0	35.9	5.3	5.2	5.5	15.3	24.0	38.7	0.3	1.9	3.7	13.5	58.1	13.3	8.3	29.8	21.5	4.5	31.1	16.6	49.5	35.3	5.7	5.1	75.5	4.0	12.4	16.5	14.1	16.3	10.3	22.1	7.5	4.2	46.4	3.7	5.7	0.0	3.5	0.0	0.1	0.3	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.2	0.8	0.4	0.1	1.1	0.0	1.3	36.1	37.1	36.7	36.2	32.9	35.0	43.9	36.2	39.6	35.4	36.9	38.1	5.1	28.9	33.6	19.2	2.7	13.8	27.6	70.6	21.6	18.5	29.3	32.6	51.2	35.8	28.8	3.7	16.7	8.1	0.8	18.2	15.6	61.3	1.2	8.6	14.0	10.1	22.3	0.0	5.0	34.7	11.3	13.8	11.2	16.4	2.5	7.6	13.2	30.9	11.4	55.5	7.6	23.7	38.7	4.1	4.5	0.7	25.1	3.4	21.4	4.7	14.6	36.3	1.0	4.0	11.3	44.2	11.4	30.1	10.4	28.5	15.5	26.2	21.3	47.9	13.1	38.7	32.3	0.3	1.2	16.4	19.7	11.1	3.2	3.6	16.4	31.6
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 49.3;testis: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 107.4;Late spermatids: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 73.4;HEL: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (2.63e-4)"	10.4	9.1	12.8	8.7	17.5	20.8	10.2	20.8	19.9	8.7	3.1	17.2	18.7	6.6	12.0	2.5	8.6	8.6	5.6	13.2	14.7	14.5	7.0	13.4	8.0	14.5	13.5	4.0	11.1	4.3	22.3	11.1	14.8	8.7	13.6	49.3	9.7	8.2	1.6	3.5	19.8	6.5	10.3	12.9	13.2	50.0	13.1	15.1	9.7	1.7	5.8	9.7	5.2	19.5	9.1	27.4	16.9	11.6	3.6	5.4	2.3	5.7	4.6	7.1	4.9	73.4	20.8	0.6	16.6	7.5	11.0	2.5	5.4	15.9	3.2	2.1	4.3	58.2	14.5	53.2	9.3	0.9	3.3	13.6	2.2	5.2	3.4	16.1	43.1	12.5	17.7	7.6	3.4	5.1	19.3	17.8	9.9	27.7	25.3	8.2	2.1	3.0	12.0	1.6	22.3	18.1	17.9	0.4	9.8	17.4	3.7	17.8	45.5	6.6	22.6	6.1	5.9	5.6	2.1	4.0	7.2	31.4	20.3	2.9	2.0	1.2	5.8	4.5	5.1	1.6	3.8	3.4	2.1	1.1	7.6	6.4	6.5	8.3	12.1	0.2	6.9	4.9	12.8	17.5	20.8	19.9	13.2	14.7	14.5	13.5	14.8	10.3	13.1	19.5	23.1	6.4	3.3	7.2	4.1	0.0	10.8	0.0	2.2	49.9	20.8	18.3	8.8	11.5	1.3	12.9	66.7	0.3	29.5	57.9	9.8	8.0	107.4	9.4	2.9	25.3	17.5	4.6	29.7	7.8	2.1	5.8	20.4	8.7	12.0	11.1	21.8	4.7	9.8	8.4	22.0	36.6	0.0	3.3	0.0	171.5	5.6	8.6	0.0	33.7	6.1	17.2	24.7	14.1	51.2	14.0	36.6	4.9	9.0	15.2	59.4	24.0	2.2	57.3	19.7	1.7	5.0	75.3	3.8	0.8	0.0	0.4	16.5	16.9	29.5	28.7
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461353-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	19.0	22.0	15.6	13.5	15.5	19.9	17.8	14.3	17.6	19.8	14.5	15.3	8.7	19.5	9.3	29.7	17.1	8.0	20.5	16.5	14.4	21.4	27.0	18.1	14.3	15.2	14.6	19.3	28.4	13.6	24.3	12.1	15.1	23.5	11.8	6.8	17.3	10.1	31.0	27.9	16.2	13.7	13.9	23.5	18.0	28.8	15.8	13.8	17.3	12.0	16.0	22.9	20.6	15.6	37.5	52.3	20.0	45.6	30.5	20.6	33.6	41.2	30.8	46.7	39.3	57.8	13.5	65.3	18.3	46.4	20.7	25.7	58.8	59.1	49.5	41.5	23.9	33.8	62.9	33.1	29.8	78.2	47.0	23.7	48.0	62.9	60.9	19.7	31.6	23.5	54.8	24.5	38.1	33.1	43.3	77.1	71.4	42.0	47.6	36.9	19.9	33.5	36.7	44.1	23.3	31.8	34.0	43.9	14.9	21.3	17.7	44.1	34.7	28.2	38.5	36.6	72.7	22.9	34.4	54.5	25.3	40.6	33.4	0.0	3.0	0.2	3.6	5.9	4.1	2.8	2.7	3.6	5.0	2.2	3.3	3.2	0.1	2.8	6.3	2.7	3.0	2.7	15.6	15.5	14.3	17.6	16.5	14.4	15.2	14.6	15.1	13.9	15.8	15.6	4.8	3.2	12.9	5.2	5.7	20.0	6.6	3.7	4.0	6.5	6.7	6.5	6.6	4.3	8.6	3.7	6.2	4.2	5.4	3.8	3.9	6.3	30.4	7.1	7.7	6.5	10.2	5.7	11.6	4.0	6.1	4.8	9.2	13.6	3.8	7.3	4.2	8.8	5.0	3.3	7.3	5.6	2.0	1.6	4.0	22.0	5.9	3.4	5.4	4.7	3.8	4.2	4.1	6.0	5.9	5.7	2.1	6.0	4.8	10.6	2.4	3.0	6.0	3.8	0.0	6.9	4.5	2.7	5.6	9.5	25.9	3.0	4.9	7.0	7.2	9.5
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	8.6	5.8	4.2	8.0	5.8	6.8	10.0	5.0	5.3	8.2	5.2	8.6	6.0	9.8	7.4	8.7	7.4	6.5	6.8	4.1	5.3	7.2	5.5	6.9	12.0	5.6	5.4	11.2	7.1	12.6	3.2	7.6	5.6	7.4	8.3	5.8	7.8	8.5	6.3	7.2	5.9	9.9	4.6	9.8	6.2	6.1	6.0	12.6	10.5	6.2	12.6	8.6	5.1	7.1	18.9	27.1	13.4	24.2	28.5	24.3	19.8	19.7	14.9	20.9	18.7	11.2	18.5	54.2	16.3	20.1	33.8	39.9	43.5	25.8	22.3	36.3	21.4	37.1	25.9	22.4	20.3	63.2	30.5	24.0	23.5	22.0	31.6	16.7	23.7	16.3	60.7	17.1	22.5	29.7	42.7	24.8	21.4	28.4	26.8	29.8	37.9	23.0	10.6	13.4	23.0	12.3	25.3	25.1	18.0	17.3	9.5	21.2	24.9	18.3	14.0	26.7	25.0	17.7	37.5	26.7	18.5	37.4	26.6	18.9	8.3	11.3	11.4	10.8	15.8	13.0	11.3	11.8	12.1	12.9	13.3	11.7	3.1	13.2	15.7	10.2	13.8	7.1	4.2	5.8	5.0	5.3	4.1	5.3	5.6	5.4	5.6	4.6	6.0	7.1	25.4	19.2	33.4	15.7	33.8	13.0	18.4	15.3	21.1	17.9	14.7	20.6	28.4	14.3	19.8	11.0	10.4	19.5	37.7	10.1	15.6	23.5	13.9	17.9	46.2	23.9	9.0	37.6	12.1	12.9	20.1	25.8	23.9	20.8	52.4	30.6	16.1	11.5	26.5	28.6	12.5	16.9	6.1	17.7	12.1	9.4	32.0	23.9	10.6	18.7	34.5	12.4	43.3	15.6	25.9	16.1	11.2	23.7	36.5	23.3	10.3	15.8	21.2	17.7	6.6	29.3	21.5	73.3	50.2	25.4	15.9	14.6	30.1	33.4	20.3	12.2
NOLC1	"KIAA0035, NOPP130, NOPP140, P130, Srp40"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	36.5	23.9	10.7	41.9	12.3	37.2	32.3	14.6	20.5	27.1	4.5	31.8	21.8	30.3	18.7	33.3	34.4	29.0	24.0	12.6	18.2	21.4	37.5	24.9	43.1	10.9	14.4	34.4	38.4	42.9	14.6	38.3	11.9	31.5	39.1	38.0	26.3	26.6	45.3	21.9	22.8	33.8	10.8	27.6	27.4	19.3	12.2	54.2	37.6	46.4	55.7	64.2	19.6	18.3	202.1	175.1	98.2	209.0	84.7	66.0	166.6	108.5	87.8	150.1	130.5	302.1	132.4	401.5	118.1	69.5	73.9	225.1	285.0	236.1	173.3	127.0	194.8	267.9	143.6	200.3	112.0	389.8	122.8	86.3	169.8	158.3	328.7	94.5	96.5	194.3	286.6	172.6	102.6	170.3	373.7	95.0	196.5	150.7	137.1	277.3	261.6	233.3	100.2	123.5	148.3	141.9	103.5	124.1	144.5	95.6	207.5	99.3	79.3	67.7	93.5	81.3	256.9	165.5	254.4	442.4	110.5	422.7	60.7	2.4	12.5	11.6	20.4	14.4	24.9	16.6	16.1	19.2	16.2	12.1	18.5	22.6	1.3	17.3	17.2	12.4	13.0	17.9	10.7	12.3	14.6	20.5	12.6	18.2	10.9	14.4	11.9	10.8	12.2	18.3	47.8	60.9	74.7	6.2	47.6	120.4	112.6	37.7	101.9	20.8	52.6	48.0	35.3	20.0	68.2	16.5	14.6	49.2	29.1	28.3	25.4	42.2	29.0	38.5	56.3	47.3	27.6	56.8	8.8	23.1	62.7	63.9	43.3	73.1	44.2	28.6	16.8	23.4	27.1	10.1	7.9	38.3	18.3	11.2	46.0	9.7	23.0	26.8	26.6	4.7	22.9	15.1	32.0	2.5	6.8	48.8	21.0	21.1	62.3	89.5	10.2	19.9	56.6	20.0	6.6	85.8	58.9	32.1	53.5	103.3	117.5	48.6	44.5	40.1	49.1	100.5
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949712-156973176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	5.0	4.4	2.5	4.7	2.6	6.8	4.4	2.7	3.3	4.7	2.5	5.1	3.4	4.8	3.3	5.2	4.6	2.7	3.7	2.5	2.4	3.7	5.0	3.9	5.7	3.2	2.3	5.2	5.9	4.3	3.1	4.0	3.1	3.8	3.7	3.2	4.2	3.0	7.5	6.1	4.4	4.6	1.8	4.7	4.3	4.1	2.8	4.2	3.8	4.3	5.0	4.8	4.7	3.1	13.5	11.4	8.2	12.3	8.1	8.4	11.3	13.2	6.5	10.5	8.5	12.4	11.1	23.4	12.9	10.8	10.7	10.7	14.9	15.9	12.8	10.7	12.9	19.6	9.9	11.5	6.5	34.7	11.6	6.0	7.7	9.4	12.1	6.1	8.9	12.9	30.3	12.2	9.6	17.7	22.1	28.9	19.9	11.9	12.2	15.7	12.4	18.1	6.8	15.8	10.0	12.3	12.0	9.4	9.2	9.2	4.6	18.5	14.5	11.2	3.7	21.1	17.2	15.7	12.1	21.1	14.4	24.4	10.8	0.8	0.8	0.4	0.6	0.5	0.3	1.3	0.7	0.8	0.8	1.8	0.9	0.5	0.2	0.7	0.7	0.8	0.3	0.3	2.5	2.6	2.7	3.3	2.5	2.4	3.2	2.3	3.1	1.8	2.8	3.1	15.3	9.6	18.3	7.2	16.1	39.4	46.9	10.5	12.0	16.8	9.5	7.9	11.7	8.6	15.5	5.5	20.9	16.2	19.3	20.0	3.9	19.2	9.6	17.9	20.7	16.0	7.8	19.1	9.6	13.6	20.5	16.9	13.3	18.6	21.5	21.2	6.8	13.6	14.3	11.8	10.8	16.2	6.1	10.4	26.0	4.4	17.4	13.3	24.9	13.1	18.3	7.5	21.6	7.1	10.2	15.9	14.1	13.2	15.3	36.3	8.7	6.3	15.3	29.8	0.0	28.9	18.0	33.5	37.6	20.0	42.5	7.3	21.0	26.6	21.8	37.3
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833721-14896157	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.3;Hep G2: 126.5;LHCN-M2: 65.8;RPMI-8226: 90.4;SiHa: 144.9"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	24.1	27.6	4.4	10.3	4.4	0.0	23.6	4.4	16.0	22.0	4.4	32.3	0.7	25.6	0.0	24.9	20.4	0.4	92.3	4.5	9.6	32.0	28.3	26.9	2.7	4.8	4.3	21.3	133.9	0.0	29.2	6.8	4.5	21.6	8.2	4.2	31.1	4.5	101.7	28.1	26.1	8.2	4.3	19.9	36.4	31.0	4.5	0.0	21.5	1.4	0.2	28.8	22.2	5.1	1.2	56.8	51.4	76.3	0.0	4.6	42.2	3.4	9.1	11.5	11.0	0.8	2.8	4.3	2.8	8.8	1.0	0.7	8.8	0.7	11.3	6.2	0.0	3.7	57.8	126.5	48.7	5.8	2.7	0.6	0.5	6.2	6.3	1.2	9.0	0.0	29.7	2.6	65.8	0.0	1.6	0.0	0.0	0.0	0.0	1.9	4.3	90.4	0.0	2.6	1.1	45.8	144.9	0.0	0.1	1.7	63.1	0.6	2.1	1.9	0.1	2.6	58.1	0.3	2.1	4.7	2.3	2.3	1.3	3.7	0.2	0.2	0.0	0.4	0.3	0.0	0.1	0.3	0.1	0.5	0.2	0.3	0.6	1.9	2.0	1.6	0.3	0.6	4.4	4.4	4.4	16.0	4.5	9.6	4.8	4.3	4.5	4.3	4.5	5.1	5.6	3.2	10.5	9.1	5.3	6.4	1.4	10.6	3.4	8.7	7.8	5.8	58.4	7.2	8.6	11.0	6.2	6.8	4.2	14.4	0.0	15.6	32.9	3.3	3.1	7.3	7.7	5.5	12.7	29.4	12.4	7.9	11.7	4.2	23.6	13.0	7.9	7.6	6.3	35.3	16.2	11.7	2.0	12.7	2.8	12.0	2.8	10.3	5.4	7.5	11.2	5.4	16.5	13.6	32.1	27.4	10.8	6.4	16.2	2.1	16.1	7.9	7.4	8.5	6.6	5.7	7.5	16.1	13.1	6.7	5.8	9.6	4.2	9.5	13.0	1.6
NOMO2	"NOMO, PM5"	ENSG00000185164	"NODAL modulator 2"	Q5JPE7	16	18417325-18562211	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 300.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046697, HPA061174"	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (2.58e-3)"	"unprognostic (4.11e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.54e-2)"	55.9	66.1	119.0	27.6	128.5	31.1	54.7	106.5	141.4	54.0	108.0	65.4	34.8	59.8	53.5	57.2	48.2	22.4	191.7	133.8	124.9	76.7	96.6	73.8	23.9	112.0	108.8	48.4	300.4	76.8	104.2	49.1	112.6	59.5	35.6	42.3	63.3	31.7	126.2	60.5	56.7	41.5	100.3	61.8	88.5	50.4	112.7	23.1	55.9	52.2	29.6	61.3	50.5	116.5	71.1	101.3	37.5	104.5	141.0	85.9	110.3	122.1	144.6	101.5	125.4	87.7	108.6	83.0	433.3	213.4	71.0	80.5	81.2	84.8	88.1	67.7	64.5	37.0	98.2	313.5	195.5	88.7	252.1	91.2	112.6	117.2	106.8	107.9	113.1	70.3	52.3	185.4	120.6	213.9	33.2	197.2	72.9	107.0	42.3	71.1	50.8	230.1	150.9	63.6	52.6	44.2	94.4	128.5	82.4	75.2	99.6	185.8	106.1	60.7	47.0	127.4	86.8	95.6	112.0	44.6	135.3	92.9	85.1	21.8	12.6	11.8	14.3	11.9	11.6	10.8	14.0	14.5	14.1	9.8	9.3	11.8	13.8	8.3	15.4	22.8	22.4	17.5	119.0	128.5	106.5	141.4	133.8	124.9	112.0	108.8	112.6	100.3	112.7	116.5	0.5	6.4	2.8	2.0	3.8	0.4	0.4	0.6	2.8	0.9	0.5	0.3	124.4	0.0	1.4	0.0	4.2	0.4	1.3	0.4	1.9	0.2	0.2	0.3	0.8	3.2	0.0	2.5	6.4	0.7	0.3	9.1	4.1	0.6	0.0	0.7	0.7	0.8	0.1	0.0	5.1	0.2	0.0	0.8	0.2	0.4	0.0	1.2	0.0	5.6	0.2	0.3	2.1	8.5	7.6	0.4	0.1	0.4	22.7	0.4	0.6	0.1	1.9	0.6	6.6	0.6	4.8	1.2	1.3	3.3	0.6	0.4	3.2	1.1	0.4	0.1
NOMO3		ENSG00000103226	"NODAL modulator 3"	P69849	16	16232506-16300806	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 30.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.3"									"HPA046697, HPA061174"	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	5.7	5.8	3.1	0.7	3.2	2.7	5.2	4.4	4.6	5.2	1.6	6.5	0.7	7.7	0.8	4.8	5.5	0.3	20.3	3.4	3.0	4.3	4.4	6.7	0.4	3.0	2.8	5.4	30.0	0.5	4.3	0.8	3.3	3.8	1.0	3.1	5.5	0.4	22.1	5.1	5.1	0.4	2.4	4.0	8.7	3.5	3.5	0.5	4.9	0.1	0.7	6.6	4.5	4.3	1.3	2.9	0.8	2.8	0.6	2.6	1.2	1.9	1.8	2.4	1.3	1.1	1.5	1.3	9.3	1.0	0.4	1.0	2.7	1.7	1.9	1.3	1.9	1.3	3.5	6.6	0.9	1.6	7.0	1.0	6.1	3.4	0.8	1.5	0.8	2.0	1.1	2.1	1.0	5.9	0.5	3.0	0.8	0.4	1.9	2.2	2.6	4.7	0.7	1.1	1.1	1.8	1.3	2.0	1.3	1.5	1.8	1.3	1.5	1.1	1.8	1.9	1.1	2.4	1.9	1.7	2.4	3.0	1.7	0.0	0.2	0.3	0.2	0.3	0.1	0.4	0.3	0.4	0.4	0.1	0.1	0.3	0.2	0.3	0.1	0.2	0.3	0.3	3.1	3.2	4.4	4.6	3.4	3.0	3.0	2.8	3.3	2.4	3.5	4.3	1.3	3.2	4.1	2.9	3.3	10.5	3.7	3.0	2.2	5.7	2.8	1.8	8.2	8.6	4.3	3.7	12.5	2.0	5.2	2.0	0.0	1.2	1.8	2.2	2.2	3.6	3.5	4.0	4.4	1.5	1.4	3.1	5.1	2.2	4.5	8.7	5.3	2.9	1.6	6.7	5.4	1.5	2.0	4.9	4.4	2.2	2.1	2.7	1.8	2.8	3.3	1.1	7.2	5.0	7.2	1.8	1.6	1.2	3.2	2.9	2.1	1.0	6.1	5.2	6.6	4.3	2.3	8.2	6.6	1.5	11.2	2.5	3.5	5.2	1.9	3.2
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP10	"MGC70651, NOLA3, NOP10P"	ENSG00000182117	"NOP10 ribonucleoprotein"	Q9NPE3	15	34341719-34343136	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 878.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059198	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA059198: AB_2683945"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.48e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.39e-3)"	"unprognostic (8.11e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-3)"	154.9	145.7	119.9	104.8	122.2	208.3	151.7	124.3	149.6	118.6	120.1	164.3	109.3	91.9	285.5	175.0	120.0	90.2	179.4	120.7	129.1	167.7	241.1	148.0	146.2	125.3	123.2	63.3	90.4	142.5	90.5	126.8	125.6	98.2	202.1	48.4	93.6	102.2	184.4	114.4	110.2	163.6	125.1	167.5	119.0	41.7	132.7	213.2	112.8	227.4	218.6	213.6	121.2	132.8	212.2	471.9	325.1	205.3	520.4	443.7	172.4	281.3	471.8	555.4	703.6	358.5	200.3	146.7	328.6	457.7	627.3	292.8	599.1	502.8	526.0	216.0	341.7	461.6	396.5	523.7	724.2	303.2	228.6	513.8	471.0	508.3	588.1	305.0	795.6	399.9	417.0	206.4	695.3	295.8	234.0	486.1	319.8	628.7	453.3	252.2	223.4	241.8	754.0	475.5	210.4	279.5	202.1	211.7	221.4	442.9	235.4	619.4	331.2	295.3	219.6	418.2	242.7	198.9	427.1	406.8	377.5	495.8	214.5	1080.4	852.4	889.6	368.7	867.8	394.9	723.0	476.7	442.7	636.3	639.5	503.6	441.2	2797.7	534.1	696.7	824.6	700.1	1065.2	119.9	122.2	124.3	149.6	120.7	129.1	125.3	123.2	125.6	125.1	132.7	132.8	202.7	109.0	153.3	7.2	175.1	239.5	179.8	470.8	130.3	30.9	158.6	195.2	299.7	143.0	273.9	149.0	12.5	210.7	158.0	286.1	446.1	365.6	15.0	230.7	148.1	257.5	195.7	169.5	6.7	351.9	402.1	154.2	122.9	234.0	164.0	81.3	240.9	359.7	878.9	13.5	7.1	283.9	315.3	504.5	321.5	16.8	103.8	309.2	190.3	12.2	322.1	70.0	250.3	5.0	10.0	600.6	362.9	100.1	209.5	251.2	304.2	668.9	298.6	33.7	105.2	91.7	336.0	19.0	101.8	224.8	302.8	214.0	154.2	128.7	241.0	451.3
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.1;Suprabasal keratinocytes: 205.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	32.9	24.3	17.6	23.7	17.4	24.8	21.6	17.4	18.1	15.2	15.0	22.1	18.0	14.0	10.7	43.6	15.5	12.5	29.0	17.9	17.2	25.1	31.7	14.1	26.8	17.1	16.9	15.6	21.5	15.3	10.6	15.7	17.4	14.1	18.8	4.8	14.8	12.0	70.9	29.8	16.3	14.5	16.3	17.3	19.9	15.1	17.6	16.6	11.6	30.6	29.9	44.6	21.1	18.2	85.2	135.1	30.3	134.2	49.6	53.3	122.1	70.2	42.4	103.1	89.4	190.7	85.6	145.6	91.6	53.4	101.0	76.5	162.7	242.7	74.5	184.5	115.8	77.7	103.5	159.5	98.7	156.5	80.4	51.8	113.5	98.3	126.1	31.5	79.2	64.4	155.5	69.6	78.9	261.2	121.8	208.7	111.9	127.9	170.3	95.5	44.7	152.1	101.2	75.9	96.0	76.5	41.1	165.1	94.3	28.8	71.9	110.8	68.4	76.9	75.9	68.8	177.1	85.7	122.4	165.1	58.0	218.7	67.2	7.6	51.9	9.5	52.9	86.5	69.4	81.9	58.5	56.7	78.9	85.4	62.6	65.2	4.4	80.0	45.9	97.1	44.1	44.7	17.6	17.4	17.4	18.1	17.9	17.2	17.1	16.9	17.4	16.3	17.6	18.2	21.8	6.4	19.6	2.3	34.4	202.1	145.6	66.4	114.4	3.7	37.2	35.3	35.6	25.8	48.8	1.8	4.2	46.2	17.3	31.8	37.2	53.6	11.0	13.8	30.6	37.6	20.9	20.8	3.1	53.6	60.3	43.3	53.0	20.2	26.6	15.1	12.1	36.9	38.1	0.0	2.9	32.3	32.6	8.3	46.4	5.5	19.6	17.1	56.9	1.9	20.8	4.9	4.1	3.0	1.7	56.4	18.0	14.7	23.8	134.2	20.1	72.6	16.5	3.0	6.6	90.5	46.1	38.4	32.1	112.9	205.3	38.3	22.2	35.9	57.7	116.6
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745546-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1"	"Cell line enhanced"	"Detected in all"		"NB-4: 1305.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	400.7	245.3	101.7	175.2	105.0	242.1	420.4	97.4	125.9	589.9	106.6	440.5	185.0	405.7	77.3	320.0	424.5	39.4	273.8	93.6	99.7	259.3	224.7	219.1	213.6	114.7	103.5	790.1	1016.5	123.0	201.7	78.4	105.4	386.3	64.1	70.2	397.0	104.5	308.6	635.8	333.6	60.1	108.4	358.9	445.3	116.5	107.3	225.3	302.8	110.0	128.3	411.8	422.5	105.6	99.7	103.0	90.7	214.6	110.6	184.2	176.8	60.6	110.5	57.8	85.3	95.5	194.8	440.3	87.0	71.2	44.2	139.8	52.9	88.8	30.2	133.0	177.8	142.6	85.1	113.5	163.0	207.4	271.6	162.5	198.9	50.8	136.1	188.0	92.3	183.1	176.8	206.5	52.3	86.9	577.2	1305.4	209.4	173.4	60.0	380.4	160.8	209.8	112.6	151.9	96.8	340.9	50.6	330.7	330.0	65.8	156.2	493.7	114.4	56.4	150.2	49.2	125.8	306.3	290.6	120.9	71.2	145.4	92.4	21.5	23.3	26.3	55.3	35.3	74.5	311.8	108.2	96.0	33.1	238.5	244.1	108.6	3.3	96.7	25.1	41.6	120.0	15.8	101.7	105.0	97.4	125.9	93.6	99.7	114.7	103.5	105.4	108.4	107.3	105.6	229.4	41.7	120.7	0.0	210.4	0.0	0.0	0.0	0.0	0.0	605.5	415.5	0.0	0.0	69.3	104.8	0.0	454.3	224.1	0.0	266.1	266.5	0.0	100.6	156.9	94.5	0.0	0.0	0.0	989.2	570.3	107.2	0.0	115.5	68.1	268.3	0.0	0.0	259.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.1	0.0	0.0	269.8	0.0	0.0	0.0	0.0	348.1	0.0	0.0	61.8	0.0	0.0	369.7	18.2	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	506.8	131.3	226.3	0.0	0.0
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652593-2658393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB075757: AB_2665763, HPA049918: AB_2680952"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	41.4	31.3	39.9	42.6	39.7	60.4	37.1	38.8	59.7	30.9	35.3	33.8	28.8	39.9	34.7	37.1	50.7	26.3	30.9	41.1	45.8	29.8	30.5	25.9	53.5	40.4	40.6	49.7	38.6	27.1	31.5	37.4	43.4	31.1	39.9	21.0	27.1	35.6	43.2	38.4	28.1	52.0	39.9	37.7	25.9	28.3	45.4	51.9	33.4	29.2	62.2	52.4	28.4	44.4	152.8	147.3	108.4	108.0	122.8	89.8	184.2	150.4	97.3	198.3	134.9	204.3	122.2	330.5	82.7	104.2	117.7	253.3	287.5	221.4	196.6	93.5	171.4	195.0	76.0	225.3	125.9	179.4	91.3	123.6	137.2	254.8	260.4	78.2	117.4	153.1	215.7	151.2	138.1	103.1	317.8	214.1	233.8	270.9	180.9	257.2	156.2	188.5	120.8	146.7	115.5	101.1	171.0	193.4	302.8	115.7	167.6	152.7	91.6	170.2	115.9	132.6	227.2	91.9	186.0	274.0	45.9	209.4	128.5	5.1	23.2	18.9	33.0	26.4	41.1	35.8	35.9	36.6	23.6	32.4	34.0	34.0	1.8	33.6	19.8	41.1	33.4	24.8	39.9	39.7	38.8	59.7	41.1	45.8	40.4	40.6	43.4	39.9	45.4	44.4	75.0	44.8	59.8	14.0	89.3	96.4	103.6	76.4	88.2	39.5	62.9	78.6	39.0	42.9	100.1	23.9	62.6	117.5	132.2	71.8	25.4	78.2	8.0	64.6	100.6	73.3	72.3	93.2	24.6	86.5	124.2	87.5	44.4	48.5	79.1	97.5	52.5	40.9	86.9	50.5	24.1	81.2	54.9	46.8	45.9	14.0	57.2	57.5	30.2	12.2	64.9	32.8	80.3	18.1	21.5	75.6	34.6	54.9	79.6	92.0	38.7	53.8	81.2	37.6	26.3	110.0	141.5	50.3	185.9	89.1	81.7	56.5	102.6	99.4	110.0	58.0
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069691-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 22.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 142.3;Horizontal cells: 67.3;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;HaCaT: 3.1;HEL: 4.6"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	0.4	2.8	16.3	0.1	20.1	1.8	1.2	8.0	16.2	0.6	0.0	1.3	0.6	0.5	0.2	0.7	0.6	0.6	0.8	22.2	2.4	0.9	3.1	0.4	0.0	3.0	2.1	0.2	0.9	0.5	0.8	0.4	0.4	0.7	1.1	3.6	1.5	1.4	0.2	1.1	0.7	0.4	0.0	0.0	1.4	1.8	5.5	0.1	0.1	0.2	0.2	0.6	0.4	21.5	3.9	0.0	1.8	1.1	0.0	0.0	0.2	0.3	0.4	0.5	0.4	0.9	1.0	0.0	2.2	0.1	0.6	3.1	0.6	0.1	0.1	0.1	1.7	4.6	0.6	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	1.0	0.6	0.4	0.0	0.1	2.1	0.3	0.0	1.3	0.6	1.5	0.0	0.7	0.1	0.9	1.4	1.4	0.9	0.8	0.1	0.6	0.5	1.1	0.2	0.4	0.0	0.4	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	20.1	8.0	16.2	22.2	2.4	3.0	2.1	0.4	0.0	5.5	21.5	4.4	0.0	0.5	5.9	0.4	2.9	6.1	0.7	0.6	11.6	14.1	21.5	2.3	2.8	1.5	22.0	204.3	0.2	0.4	7.9	9.8	1.0	36.8	4.5	3.5	3.6	6.7	2.7	142.3	1.2	0.3	1.3	9.7	7.9	0.0	8.0	3.3	21.2	0.1	67.3	107.6	10.2	0.0	0.8	0.4	12.4	4.4	0.2	0.0	43.1	0.0	13.4	1.0	79.9	82.9	0.7	5.3	7.2	0.1	6.8	3.9	0.6	1.7	3.8	6.6	0.9	1.1	2.0	2.2	2.3	2.0	0.5	0.5	1.9	5.3	7.8
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800529	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.1;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 40.3;Extravillous trophoblasts: 27.7;Granulosa cells: 57.3;Proximal enterocytes: 10.7;Undifferentiated cells: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 16.5;SCLC-21H: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002014	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	0.9	0.5	0.2	14.4	0.5	0.0	0.3	0.1	2.1	0.3	0.0	6.8	12.1	0.2	0.0	0.7	0.4	0.4	0.4	0.7	0.2	1.6	0.1	1.8	0.8	0.3	0.1	0.6	0.3	0.1	1.3	0.6	0.5	0.6	8.9	0.2	0.1	0.2	0.8	0.2	21.1	1.8	0.1	0.1	0.1	0.3	1.0	0.1	0.4	0.7	0.1	3.6	0.2	0.9	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.9	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.1	0.7	0.2	0.3	0.1	0.5	0.1	1.0	0.9	1.2	0.0	0.0	1.3	0.6	0.0	0.2	3.6	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.2	0.0	0.0	0.7	2.4	0.0	4.1	0.0	27.7	0.2	0.0	0.1	0.0	57.3	0.0	0.0	0.7	0.0	2.2	3.8	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.9	0.4	0.0	1.4	10.7	0.1	0.5	0.1	0.0	0.3	1.2	0.0	1.5	0.0	0.0	0.5	0.3	0.1	10.2	1.0
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150991017-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 62.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Early spermatids: 81.9;Endothelial cells: 32.6;Hepatic stellate cells: 29.3;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.1;HUVEC TERT2: 44.7;K-562: 16.6;TIME: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	19.3	6.3	8.4	5.8	6.8	0.8	13.2	5.7	6.7	7.3	3.4	5.9	2.6	9.7	0.4	5.8	8.1	4.7	20.6	5.7	6.1	24.2	4.3	11.2	2.7	9.2	7.7	3.2	2.9	1.2	7.2	4.8	8.6	7.6	1.2	0.8	4.4	1.7	3.9	4.2	6.7	3.7	7.5	62.4	5.4	7.2	11.0	0.6	9.1	3.5	1.2	9.7	7.4	6.0	0.4	0.1	1.3	4.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	2.2	0.4	2.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.4	2.2	0.3	6.4	0.6	0.5	10.4	0.1	0.2	0.0	0.0	0.1	44.7	5.1	16.6	3.6	0.0	0.0	0.2	0.5	1.7	0.7	0.1	3.0	0.0	1.8	0.0	0.3	0.5	0.4	0.2	1.4	0.0	0.4	0.1	1.4	82.5	0.2	0.7	0.4	0.1	2.4	8.9	2.2	0.0	7.5	0.0	0.2	0.1	0.1	1.1	0.2	0.7	0.3	1.7	0.9	0.2	0.5	2.3	0.9	0.3	0.2	0.2	0.2	2.1	0.5	8.4	6.8	5.7	6.7	5.7	6.1	9.2	7.7	8.6	7.5	11.0	6.0	20.4	9.6	2.2	0.3	0.7	0.9	0.1	0.1	0.0	0.2	0.2	0.3	3.1	0.0	0.7	0.0	0.0	0.2	0.7	0.1	0.0	1.0	81.9	4.9	0.7	32.6	0.0	0.0	0.2	0.0	0.1	2.9	0.5	3.2	5.7	0.7	29.3	0.7	0.4	0.0	0.2	0.4	0.0	0.6	0.5	29.3	0.9	0.4	0.0	7.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	1.2	1.5	0.4	0.1	0.2	2.2	0.3	0.0	0.6	2.6	6.9	5.3	0.2	0.6	3.6	1.6	0.9	0.1	0.9
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555468-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.8;Late spermatids: 844.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	42.4	48.0	33.2	27.1	37.0	31.7	42.8	37.2	45.1	50.0	29.4	49.0	29.1	49.3	10.0	47.8	45.1	15.4	60.9	31.9	35.0	48.1	48.6	39.5	51.8	36.2	34.9	44.5	125.1	24.0	40.8	21.6	36.9	44.0	14.6	10.1	38.3	20.6	134.7	46.7	50.8	16.2	34.7	63.2	44.8	143.5	36.0	40.0	40.9	65.2	26.5	41.3	41.7	38.0	239.7	114.5	49.6	113.1	43.5	32.7	44.5	54.8	50.0	90.9	85.3	84.9	43.1	63.4	93.5	48.2	37.0	51.0	47.8	98.4	40.3	74.1	126.0	81.3	67.9	96.6	66.6	67.8	64.6	43.4	66.5	71.4	37.7	38.0	54.4	101.8	90.7	46.0	50.3	59.7	66.2	127.0	65.9	89.3	100.4	89.3	74.0	58.3	43.5	70.6	57.4	71.2	74.9	59.1	50.2	21.8	53.9	72.6	83.5	83.6	64.4	27.0	99.3	87.8	186.7	86.6	31.2	90.7	65.2	261.9	129.1	192.3	257.3	126.1	328.8	161.8	519.8	294.6	127.8	157.2	841.3	466.7	244.1	244.5	117.6	168.8	303.6	579.4	33.2	37.0	37.2	45.1	31.9	35.0	36.2	34.9	36.9	34.7	36.0	38.0	78.3	19.2	34.9	13.1	67.3	72.8	54.8	109.8	40.9	25.4	45.5	49.5	38.4	62.9	59.3	51.5	22.9	94.2	74.7	171.6	86.1	84.5	364.8	56.3	44.9	73.0	58.7	58.5	9.2	283.6	85.0	51.7	57.6	68.6	68.4	57.0	93.9	49.5	72.2	11.8	9.1	108.9	91.6	63.8	67.0	844.8	71.7	55.5	62.2	13.1	100.5	45.5	120.5	9.0	12.3	219.2	138.2	72.2	55.4	43.2	129.6	133.8	58.4	37.2	59.2	85.1	66.1	268.7	50.9	39.6	76.3	136.3	154.2	73.1	108.5	54.4
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	32.6	20.4	6.1	4.6	5.8	0.3	31.4	5.0	7.6	17.5	4.2	15.3	14.0	14.9	4.3	5.1	16.4	14.0	16.1	4.9	5.6	32.6	7.3	30.8	4.6	6.6	6.0	10.6	22.6	3.8	3.8	25.4	6.5	13.3	16.4	0.8	48.9	6.8	5.1	7.3	14.3	12.8	5.5	5.5	23.0	14.4	6.6	1.9	13.5	3.6	3.0	8.1	11.3	5.0	0.0	3.6	1.1	0.0	0.0	0.0	10.1	0.4	0.0	0.0	0.0	6.3	6.5	0.1	4.3	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	41.9	1.8	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	31.8	0.0	0.0	0.1	0.1	0.1	0.1	20.5	0.3	0.4	1.9	0.0	3.4	1.6	0.0	0.1	0.2	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.2	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	5.0	7.6	4.9	5.6	6.6	6.0	6.5	5.5	6.6	5.0	167.0	9.6	10.3	2.0	1.6	1.0	0.6	0.3	0.6	0.1	20.0	11.0	7.1	15.7	3.3	3.7	0.0	18.9	0.4	57.3	13.7	8.0	26.6	16.3	3.3	129.6	11.4	2.7	0.4	21.8	7.0	6.1	41.3	23.2	0.0	72.4	172.5	1.0	1.6	0.0	0.5	35.9	0.0	6.3	0.9	60.9	8.7	1.2	24.9	55.3	0.7	1.6	0.0	2.0	0.0	17.7	53.4	5.7	0.2	3.3	43.1	59.0	1.5	0.3	72.3	1.3	11.3	13.7	1.8	0.4	0.4	26.3	0.9	71.9	20.7	1.2
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOTCH2		ENSG00000134250	"Notch receptor 2"	Q04721	1	119911553-120100779	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		160000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	27.1	12.9	16.4	20.4	13.6	13.7	24.8	11.9	16.4	31.0	20.3	16.0	5.4	21.2	20.8	24.9	25.7	18.5	14.2	15.9	13.7	10.9	19.6	20.2	16.7	20.6	18.6	33.9	20.1	12.1	5.5	24.9	13.9	20.4	13.6	19.3	17.1	22.2	6.4	32.3	11.9	26.6	15.7	25.3	10.5	25.4	19.3	15.3	21.2	8.9	17.9	19.0	24.1	14.8	54.2	17.7	27.0	20.7	108.5	92.7	26.6	39.7	54.8	51.8	55.8	16.3	14.2	1.4	32.6	75.3	46.2	20.1	42.8	35.3	82.5	64.0	27.2	32.1	45.7	1.6	40.5	32.7	8.0	75.5	22.5	155.2	103.7	78.4	26.9	14.5	0.8	65.3	63.7	59.2	13.9	9.2	34.6	5.0	19.6	9.1	94.2	36.1	27.3	33.4	1.1	13.4	54.5	50.0	27.9	53.4	28.0	11.7	97.0	67.0	45.8	102.7	63.1	27.9	16.8	16.5	98.7	29.5	65.2	15.0	14.9	22.9	1.4	7.3	1.4	39.0	1.6	0.9	23.7	33.3	3.1	2.0	8.9	2.4	10.5	12.3	3.8	4.4	16.4	13.6	11.9	16.4	15.9	13.7	20.6	18.6	13.9	15.7	19.3	14.8	4.6	35.3	19.5	125.4	36.6	46.3	56.6	14.8	31.3	3.3	38.1	25.3	16.0	24.3	28.5	18.4	6.2	1.6	26.0	6.2	0.0	46.8	17.7	33.8	21.9	5.4	6.1	18.3	4.2	12.9	8.9	67.8	5.1	61.1	15.8	78.3	3.9	41.5	32.7	3.3	22.6	7.9	20.3	74.7	78.2	12.6	55.0	76.6	39.2	43.1	79.3	46.2	15.5	75.4	0.6	26.8	105.5	85.4	14.2	37.2	3.2	4.9	16.4	10.5	19.7	83.6	34.0	10.0	4.3	75.1	88.9	1.6	18.5	22.0	15.8	66.9
NOTCH2NLA	"N2N, NOTCH2NL"	ENSG00000264343	"Notch 2 N-terminal like A"	Q7Z3S9	1	146146203-146229026	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.6;dendritic cells: 2.8;Extravillous trophoblasts: 2.0;Fibroblasts: 1.2;Hofbauer cells: 2.1;Macrophages: 2.2;Plasma cells: 3.0;Smooth muscle cells: 1.4;Syncytiotrophoblasts: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB004669	Uncertain				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004669: AB_426149"	"unprognostic (1.54e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-2)"	14.5	5.9	6.3	6.8	4.2	5.3	13.4	2.1	9.7	18.9	17.1	7.8	5.1	9.0	13.6	22.0	9.8	6.9	10.6	8.9	6.1	8.6	15.5	13.1	5.9	6.9	4.9	11.6	10.9	8.8	3.7	9.6	4.9	14.5	6.4	8.6	14.9	7.8	9.1	29.0	7.1	8.5	2.4	11.4	7.4	34.0	7.7	5.4	10.6	3.8	6.8	9.1	21.0	6.5	22.8	7.8	12.2	4.4	11.4	31.4	4.8	12.3	20.7	14.1	16.0	4.3	10.5	5.0	5.1	9.7	7.6	10.1	6.9	15.7	22.1	13.5	5.8	17.1	15.8	2.0	12.9	7.6	6.1	28.5	4.9	15.5	33.2	17.4	10.2	7.4	5.4	26.6	20.1	15.9	4.2	5.2	3.6	1.7	14.9	4.1	11.9	16.2	7.4	12.0	1.9	1.2	21.0	12.2	4.9	7.9	20.5	7.7	42.2	9.5	8.2	19.9	16.1	51.0	14.2	12.5	15.6	6.1	8.4	16.8	13.4	27.9	4.3	13.4	4.1	14.3	4.0	4.0	10.5	11.4	5.8	4.2	19.5	4.5	18.1	17.3	4.2	3.0	6.3	4.2	2.1	9.7	8.9	6.1	6.9	4.9	4.9	2.4	7.7	6.5	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch receptor 3"	Q9UM47	19	15159038-15200995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		46000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: AB_2678926"	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	85.7	5.3	14.8	10.4	12.4	0.2	50.5	11.0	21.3	49.4	7.1	14.8	5.5	39.9	16.9	74.3	35.8	23.5	43.6	9.5	11.3	26.0	3.2	38.3	9.2	12.0	15.2	18.9	10.7	12.6	10.3	59.8	14.3	22.0	4.2	0.5	24.4	16.5	29.7	82.1	14.3	16.9	8.2	15.0	11.6	3.8	15.8	34.1	32.3	25.1	10.4	26.3	55.1	10.0	13.0	8.1	66.3	30.3	9.2	7.3	29.8	10.2	0.4	0.4	0.3	15.6	13.4	0.4	7.7	18.9	0.1	15.1	12.1	0.2	0.6	0.1	3.1	0.4	12.4	3.5	4.5	0.0	1.2	8.4	7.3	15.5	1.6	0.6	0.8	4.6	0.5	0.6	1.2	66.9	15.9	0.1	38.8	11.2	0.0	0.1	3.7	0.3	0.0	41.2	1.9	21.4	0.1	37.8	0.0	19.6	40.3	0.1	0.0	1.9	21.0	0.3	0.1	0.1	0.7	0.0	45.7	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	14.8	12.4	11.0	21.3	9.5	11.3	12.0	15.2	14.3	8.2	15.8	10.0	39.6	9.6	1.5	5.9	0.4	24.1	7.8	17.8	4.6	0.4	41.5	30.7	60.7	0.0	28.5	16.5	0.0	20.2	1.0	0.0	5.9	14.8	0.5	4.8	13.5	32.0	0.0	0.0	0.6	0.0	3.9	24.2	2.0	11.8	0.0	5.9	4.2	0.0	2.8	0.0	0.3	0.3	6.1	10.4	12.3	0.1	9.0	4.1	17.8	13.1	0.7	0.8	0.0	0.0	0.2	0.9	0.1	11.7	0.0	13.0	0.1	0.0	4.2	0.8	414.2	131.6	317.0	0.9	1.2	72.1	72.2	31.5	2.0	1.2	0.2	36.0
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202574-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034660, HPA063906"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"			"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034660: AB_10601974, HPA063906: "						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.0	0.1	0.3	0.1	0.2	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.6	0.3	0.2	0.2	0.5	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOVA1	NOVA-1	ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443090-26598033	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.3;ASC diff: 25.6;HAP1: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	23.4	5.4	44.0	2.4	39.7	0.1	28.9	85.4	56.3	12.1	18.9	11.6	1.4	8.5	4.9	2.9	6.7	4.8	3.3	38.8	65.3	6.1	0.9	1.4	3.4	50.3	51.2	5.0	1.2	2.4	19.3	0.1	48.5	5.6	5.1	13.4	2.7	15.9	4.3	4.7	3.6	9.5	49.2	0.9	3.3	8.8	71.1	1.2	3.4	8.7	4.5	5.9	8.4	45.5	0.0	11.6	53.3	0.0	25.6	14.6	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.7	0.7	7.1	0.1	23.7	0.2	0.0	0.0	1.8	0.0	0.1	0.3	8.5	0.0	2.1	16.8	0.0	3.6	2.9	17.8	10.3	8.7	0.0	0.1	8.4	0.0	9.8	0.1	13.5	0.0	10.9	1.3	14.8	0.2	6.8	9.1	15.5	9.4	0.0	0.0	0.0	4.2	1.1	0.0	0.0	6.5	7.7	5.2	1.4	0.0	0.0	0.0	8.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	44.0	39.7	85.4	56.3	38.8	65.3	50.3	51.2	48.5	49.2	71.1	45.5	24.8	0.0	1.5	141.0	0.2	5.2	5.9	0.0	4.6	222.9	51.5	29.6	1.1	5.7	0.0	14.7	4.2	0.1	1.4	6.6	9.8	0.4	20.1	0.6	15.0	9.4	65.9	0.0	414.9	0.4	0.0	188.8	0.5	0.2	0.0	18.2	38.6	0.5	0.2	136.3	203.5	7.1	0.0	0.6	10.5	16.5	150.4	2.1	3.6	93.7	0.0	32.3	0.0	1269.7	319.5	2.0	11.7	65.8	1.9	6.7	0.3	30.3	4.4	12.0	6.6	28.6	17.7	163.1	64.3	0.7	3.1	0.0	1.5	30.0	8.4	0.6
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NOXA1	"FLJ25475, NY-CO-31, SDCCAG31"	ENSG00000188747	"NADPH oxidase activator 1"	Q86UR1	9	137423350-137434406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 37.5;Gastric mucus-secreting cells: 54.6;Paneth cells: 34.7;Proximal enterocytes: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.6;EFO-21: 11.3;MCF7: 19.8;T-47d: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044781	Uncertain		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA044781: AB_10960532"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.97e-3)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.97e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-2)"	3.7	6.6	11.4	3.5	11.9	3.0	6.9	7.4	24.4	7.5	5.1	12.6	19.3	6.1	1.2	9.6	9.3	6.9	3.9	11.2	10.8	14.7	12.5	4.6	2.5	13.0	11.7	10.1	17.2	6.1	15.4	1.2	9.6	10.4	3.8	2.6	19.9	7.1	10.3	18.4	13.2	1.3	7.7	7.1	17.6	3.9	11.5	2.7	12.9	1.4	1.4	5.6	8.7	8.5	2.0	5.0	0.1	3.8	0.4	0.0	2.6	0.4	0.6	0.2	0.3	0.8	12.6	0.0	11.3	0.1	0.8	8.6	0.2	0.2	0.0	5.5	4.2	0.0	3.6	1.9	1.2	0.1	2.4	0.4	2.7	0.0	0.1	2.2	0.3	0.0	0.7	0.8	0.0	19.8	0.0	1.1	0.2	5.2	1.7	0.1	0.0	7.8	3.3	4.3	1.0	0.3	0.3	2.0	2.0	0.2	18.8	1.6	1.3	0.2	2.6	2.9	0.4	0.8	0.0	0.1	0.3	0.7	0.6	0.0	0.4	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.6	2.5	0.0	0.0	0.2	11.4	11.9	7.4	24.4	11.2	10.8	13.0	11.7	9.6	7.7	11.5	8.5	4.0	0.0	5.4	6.5	4.0	3.4	6.1	2.8	3.4	9.8	16.2	11.2	1.3	14.3	7.2	12.9	8.4	0.4	2.3	37.5	7.9	7.4	0.3	11.2	2.1	2.4	6.7	2.7	22.4	11.0	0.4	1.7	54.6	20.0	2.5	3.8	0.7	6.5	5.4	3.3	17.0	20.5	4.1	3.8	9.0	0.5	1.2	6.1	8.8	6.5	3.8	10.7	4.1	8.0	3.8	7.0	34.7	0.7	2.1	4.4	39.5	19.9	5.9	8.2	6.6	3.2	3.8	5.1	5.0	12.8	4.1	0.3	3.5	1.0	24.6	7.4
NOXO1	"P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28"	ENSG00000196408	"NADPH oxidase organizer 1"	Q8NFA2	16	1978917-1984192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.6;lymphoid tissue: 4.7;testis: 4.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.1;Intestinal goblet cells: 34.7;Paneth cells: 20.5;Undifferentiated cells: 42.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;HaCaT: 1.6;OE19: 4.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA071540	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA071540: AB_2686415"			"unprognostic (3.74e-1)"							"unprognostic (1.10e-1)"				"unprognostic (1.73e-2)"				0.1	0.2	0.6	4.7	0.8	0.3	0.4	0.5	1.6	0.6	1.0	8.6	3.1	0.3	1.1	0.9	0.2	0.3	0.1	0.6	0.4	0.6	2.3	0.3	0.4	1.1	0.2	0.3	0.4	0.1	0.9	0.0	1.3	0.6	5.9	0.3	2.4	0.2	0.5	0.5	3.4	0.5	0.1	0.3	0.3	4.8	0.5	1.0	0.2	0.0	1.6	0.4	0.3	0.8	0.1	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	2.7	0.2	0.1	0.0	0.0	1.6	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.4	0.1	0.4	0.1	0.4	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.0	4.3	0.0	0.2	0.4	0.0	0.3	0.0	1.4	0.0	0.6	0.5	0.1	0.1	1.0	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.3	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.5	1.6	0.6	0.4	1.1	0.2	1.3	0.1	0.5	0.8	0.1	0.0	0.0	0.3	0.4	0.3	1.3	9.0	2.8	0.1	7.1	1.8	0.0	1.5	10.6	5.5	0.0	0.8	0.1	52.1	0.0	1.0	6.2	2.9	0.3	0.1	6.6	0.0	1.1	1.9	2.9	0.1	4.6	2.0	0.0	0.2	0.4	0.4	0.3	0.0	0.9	34.7	6.1	0.3	0.3	1.5	0.6	0.1	0.0	0.0	0.6	0.6	0.0	0.0	0.2	1.0	20.5	0.4	0.0	3.3	14.4	1.0	10.6	0.0	0.0	0.0	0.6	3.2	3.3	1.5	0.4	1.5	0.2	0.2	42.4	5.7
NOXRED1	"C14orf148, FLJ32809"	ENSG00000165555	"NADP dependent oxidoreductase domain containing 1"	Q6NXP6	14	77394021-77423517	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 5.9;testis: 6.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 137.8;Late spermatids: 125.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055658, HPA060408"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 34: Spermatids - Unknown function"	Vesicles	"Plasma membrane"	"HPA055658: AB_2682878, HPA060408: "	"unprognostic (1.92e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.07e-3)"	0.2	0.6	0.5	0.1	0.6	0.2	0.5	0.2	0.5	0.2	1.7	0.5	0.5	0.5	0.5	0.3	0.5	0.6	0.1	0.5	0.6	0.5	0.3	0.3	0.6	0.8	1.0	0.3	0.4	0.2	0.7	0.3	0.7	0.3	0.5	5.9	0.2	0.4	0.1	1.1	0.3	0.4	0.9	0.5	0.2	6.9	0.5	0.5	0.9	0.0	0.4	0.2	0.2	0.7	0.3	0.7	0.3	0.4	0.1	0.7	0.5	0.3	0.5	0.3	0.2	0.4	0.3	0.7	0.1	0.6	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.4	0.0	0.7	0.2	0.1	0.6	0.4	0.9	0.3	0.5	0.4	0.2	0.8	0.1	0.5	0.1	0.8	0.2	0.2	0.0	0.2	0.6	0.2	0.1	0.0	0.3	0.1	0.7	0.5	0.4	0.1	0.1	0.7	0.7	0.4	0.9	0.2	0.2	0.4	0.1	0.7	0.7	0.4	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.2	0.5	0.5	0.6	0.8	1.0	0.7	0.9	0.5	0.7	0.2	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	4.2	0.0	0.0	0.3	0.0	0.0	137.8	0.6	0.1	0.2	1.8	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	3.0	0.0	0.0	0.3	0.2	125.8	0.9	0.3	0.0	0.0	0.0	0.4	0.0	3.0	4.4	0.1	0.0	1.2	0.1	0.1	0.3	0.1	0.2	1.5	0.0	0.0	0.1	4.1	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.9	0.0	1.8	0.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.7	0.9	0.0	0.0	0.1	0.9	0.7	0.5	0.4	0.0	0.5	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.1	2.9	1.5	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	1.8	0.1	1.1	0.5	1.7	0.9	0.7	0.5	0.5	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPAS2	"bHLHe9, MOP4, PASD4"	ENSG00000170485	"Neuronal PAS domain protein 2"	Q99743	2	100820139-100996829	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 112.6;Early spermatids: 65.1;Excitatory neurons: 150.5;Inhibitory neurons: 58.5;Microglial cells: 69.3;Oligodendrocyte precursor cells: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 142.8;PC-3: 110.3;RT4: 90.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019674	Uncertain	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 50: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA019674: AB_10601275"	"unprognostic (2.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (5.47e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (3.55e-7)"	"unprognostic (7.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-3)"	9.6	12.5	17.9	6.0	19.5	0.1	9.5	1.9	17.6	14.5	3.2	15.6	20.9	13.5	2.9	50.3	10.9	9.9	29.2	16.5	8.4	23.0	23.6	7.9	2.3	6.7	10.6	3.9	39.5	1.2	14.9	5.3	5.2	17.3	11.1	6.2	18.2	4.4	22.0	28.1	17.3	9.1	6.0	5.9	24.0	11.1	18.0	1.2	9.6	7.7	5.0	28.3	22.2	11.3	13.4	74.1	0.1	0.9	69.9	30.1	10.6	24.4	72.2	9.8	21.1	1.3	6.0	0.0	28.5	4.0	142.8	0.6	10.8	18.1	10.2	0.9	4.2	0.0	13.7	34.6	33.1	0.0	3.0	25.6	28.7	23.9	38.3	39.8	41.0	7.8	0.3	0.2	8.0	27.1	5.1	0.6	1.3	21.8	110.3	0.3	1.6	0.8	51.0	90.4	0.2	1.4	0.1	4.4	54.8	0.8	0.7	0.8	15.8	7.3	9.6	14.6	10.7	0.0	0.0	0.1	77.3	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	17.9	19.5	1.9	17.6	16.5	8.4	6.7	10.6	5.2	6.0	18.0	11.3	1.2	0.0	11.4	112.6	0.4	3.8	8.6	12.0	3.4	6.4	9.0	10.2	16.0	21.5	8.8	12.9	0.0	0.8	0.2	32.6	0.0	12.9	65.1	10.1	5.7	7.1	9.1	0.0	150.5	15.6	1.0	5.7	24.5	22.0	0.0	3.7	21.4	14.4	0.1	28.6	58.5	8.9	6.1	0.3	1.0	14.0	7.2	0.7	3.6	69.3	0.8	3.2	0.0	58.3	4.2	14.3	15.5	5.3	0.1	27.3	30.5	11.3	6.0	0.6	0.0	4.8	3.9	0.6	3.5	9.6	6.5	0.3	1.3	5.5	12.4	39.1
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.8	0.8	17.3	0.1	19.9	0.0	0.9	14.6	12.9	6.0	0.0	1.4	0.3	3.9	0.8	0.3	3.9	0.7	0.4	14.0	15.0	0.9	0.1	0.2	0.1	22.8	18.0	2.7	0.4	0.5	1.0	0.5	15.8	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.6	18.0	1.1	1.0	1.3	15.9	0.4	1.8	0.2	0.2	0.5	0.5	18.3	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	19.9	14.6	12.9	14.0	15.0	22.8	18.0	15.8	18.0	15.9	18.3	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
NPAS4	"bHLHe79, Le-PAS, NXF, PASD10"	ENSG00000174576	"Neuronal PAS domain protein 4"	Q8IUM7	11	66421004-66426707	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 170.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 10.2;Horizontal cells: 11.8;Rod photoreceptor cells: 5.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	13	"cerebellum: 170.4;cerebral cortex: 55.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.9;cerebellum: 5.0;cerebral cortex: 7.5;hippocampal formation: 4.6;olfactory bulb: 3.8"	HPA039255	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA039255: AB_10674282"	"unprognostic (7.81e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-3)"		"unprognostic (4.97e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.21e-2)"	0.2	0.2	0.8	0.4	2.9	0.0	0.1	170.4	55.3	0.8	0.5	2.7	0.1	3.3	0.1	0.3	1.3	0.1	0.2	4.2	8.6	0.1	0.1	0.1	0.0	2.2	1.6	0.3	0.3	0.0	19.3	0.0	3.6	1.2	0.1	0.1	0.1	0.7	0.0	0.1	0.5	1.3	0.1	0.0	1.1	0.1	1.2	0.0	0.1	0.2	0.0	1.1	0.5	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	170.4	55.3	4.2	8.6	2.2	1.6	3.6	0.1	1.2	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.2	0.1	0.4	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.8	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.2;liver: 48.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.6	0.1	0.4	0.0	0.7	0.0	0.4	0.9	1.1	0.6	0.3	1.6	54.2	0.4	0.0	0.4	0.5	5.8	0.1	0.7	0.2	0.9	48.1	0.2	0.0	0.3	0.4	0.6	0.6	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.1	0.1	0.1	0.3	50.5	0.1	0.3	0.0	1.5	1.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.9	1.1	0.7	0.2	0.3	0.4	0.4	0.3	0.3	0.6	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16783.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	260.1	297.0	127.1	261.3	145.4	305.3	221.3	152.2	190.6	284.5	434.0	259.7	201.7	196.7	16783.1	185.0	170.0	356.0	215.1	118.1	156.9	322.4	202.4	786.0	360.3	185.7	145.6	283.1	219.9	241.3	197.5	263.1	179.2	164.2	220.8	48.6	221.9	261.3	58.7	181.6	193.3	180.5	151.1	305.6	206.8	156.8	172.1	134.4	444.7	114.7	241.9	347.4	187.9	195.5	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	127.1	145.4	152.2	190.6	118.1	156.9	185.7	145.6	179.2	151.1	172.1	195.5	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039463-137046179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 146.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	129.5	45.7	140.8	12.2	128.1	3.4	133.0	110.6	181.3	130.5	55.0	93.1	23.4	121.6	4.3	53.7	148.6	24.9	149.1	143.3	143.1	75.9	23.7	115.4	13.0	138.9	142.3	68.2	81.2	23.0	266.0	21.1	131.3	260.5	13.4	9.2	137.4	35.1	34.0	56.4	72.1	16.9	120.7	145.2	126.2	35.3	142.9	2.9	68.4	12.4	3.9	97.9	90.5	114.7	33.6	41.9	10.1	67.1	23.7	23.8	2.8	68.7	23.0	16.9	6.7	17.1	18.5	30.3	50.7	28.6	4.6	122.4	8.6	20.5	1.6	25.0	40.4	13.6	123.7	12.9	33.3	11.9	0.3	16.5	31.9	8.7	17.9	43.1	43.6	13.2	0.7	0.8	3.5	138.4	1.0	1.1	21.1	111.0	68.1	19.9	0.0	132.8	28.6	22.7	77.2	50.0	18.4	65.3	46.5	3.6	140.1	17.9	73.9	12.4	21.6	84.1	21.0	0.1	0.4	1.4	17.7	1.2	10.5	0.0	0.6	0.9	12.3	0.1	14.7	0.1	19.0	18.9	1.1	0.0	0.5	3.1	0.0	0.2	0.1	3.4	15.9	3.3	140.8	128.1	110.6	181.3	143.3	143.1	138.9	142.3	131.3	120.7	142.9	114.7	397.0	0.0	7.7	64.3	3.4	23.6	77.6	15.0	31.3	97.5	174.0	139.7	18.3	71.4	19.8	29.5	16.7	1.1	5.5	122.2	0.0	52.5	1.8	39.0	27.7	307.2	281.6	19.3	71.7	66.0	1.3	61.2	153.9	101.3	0.0	9.2	406.2	1.9	22.2	62.2	64.7	589.1	18.3	21.0	20.0	6.9	161.2	6.6	30.2	37.5	3.0	38.5	1.0	38.2	39.0	33.0	106.0	145.6	1.4	234.9	37.5	0.7	7.5	62.0	39.5	23.9	38.9	2.8	19.0	15.9	23.7	1.8	12.3	9.1	98.1	103.1
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	31.9	24.8	20.6	9.4	21.5	19.9	28.1	20.2	28.9	20.4	22.5	40.8	15.9	24.8	3.9	26.9	23.2	15.8	30.7	20.7	19.0	40.6	20.6	26.6	13.6	22.6	20.3	23.6	24.1	16.7	27.0	10.0	20.9	29.3	4.4	2.5	29.7	15.2	66.3	23.7	25.4	8.6	19.7	40.1	27.1	23.1	22.1	7.7	39.2	28.8	6.1	39.2	22.1	21.0	22.5	31.2	5.5	4.5	11.8	21.7	1.7	8.5	0.7	26.6	14.9	18.0	16.6	1.0	44.6	15.7	0.3	24.0	7.5	10.4	2.6	20.0	7.5	8.0	26.0	8.3	29.6	8.1	13.0	21.3	31.7	9.3	0.0	9.8	22.6	6.1	1.1	3.5	10.6	106.6	3.3	21.2	8.3	13.1	33.8	6.6	2.6	12.6	11.1	14.8	10.1	3.2	22.4	6.1	41.8	3.0	23.4	15.3	25.3	6.7	5.4	14.0	4.4	11.7	4.3	0.7	9.8	15.2	2.7	23.9	18.5	7.2	2.5	13.0	3.1	1.4	1.5	1.7	11.4	0.9	0.9	1.8	13.7	3.2	18.8	0.5	3.7	6.3	20.6	21.5	20.2	28.9	20.7	19.0	22.6	20.3	20.9	19.7	22.1	21.0	23.6	9.6	15.6	0.0	3.5	9.2	8.2	17.1	10.8	19.0	17.2	16.0	16.7	10.0	16.4	27.6	25.0	15.0	11.8	7.6	13.7	14.8	2.3	11.9	8.1	13.6	12.0	3.0	0.0	9.2	7.8	16.1	18.8	6.4	2.5	32.3	15.0	9.1	11.2	8.4	0.0	10.2	20.3	16.7	12.0	8.5	22.1	15.1	7.2	0.0	16.3	20.1	6.2	0.0	0.0	10.8	14.3	14.7	8.4	4.4	17.6	19.9	19.0	8.5	19.7	14.9	15.2	6.7	3.0	16.9	11.2	8.9	9.0	9.7	13.1	7.7
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47624665	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		3000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	32.2	50.0	30.6	19.4	34.8	7.3	30.1	30.7	41.1	41.5	26.1	38.6	20.3	32.0	11.1	92.2	32.6	22.2	30.6	32.9	30.3	30.9	23.8	30.5	18.4	35.7	34.2	39.9	34.2	30.1	26.7	27.3	35.7	27.9	27.4	21.0	44.4	20.6	114.5	47.3	37.1	33.7	26.1	31.9	33.4	19.2	34.2	26.4	26.8	86.6	27.5	34.8	58.2	30.5	105.7	81.7	67.3	49.4	92.1	81.9	147.5	47.5	63.9	70.4	66.5	55.7	100.6	68.4	76.1	69.2	70.1	62.0	83.7	44.8	108.7	31.5	73.2	76.5	62.3	59.2	48.3	48.8	46.6	61.5	41.1	52.7	26.8	99.2	77.5	20.1	72.5	30.7	109.9	37.2	66.0	34.7	47.8	74.4	68.0	50.5	107.2	60.1	82.6	81.0	59.7	46.0	59.1	34.9	44.7	122.0	256.3	35.5	88.6	44.1	35.2	72.5	34.9	63.7	81.1	39.9	64.8	25.3	33.5	14.2	9.9	12.4	8.8	7.9	9.6	7.7	7.2	9.2	9.7	6.9	6.3	7.8	28.4	8.8	9.1	10.1	8.8	6.3	30.6	34.8	30.7	41.1	32.9	30.3	35.7	34.2	35.7	26.1	34.2	30.5	32.0	83.3	59.1	68.6	44.7	77.9	68.9	40.2	109.8	144.6	76.6	33.8	60.3	55.8	53.6	42.3	268.9	81.2	35.6	87.0	27.4	69.3	34.2	95.2	80.9	45.4	44.3	44.6	98.0	54.4	74.4	66.0	58.1	158.1	41.7	62.7	45.7	32.5	40.5	112.7	95.3	44.1	38.7	51.0	62.1	50.8	52.8	45.4	58.7	37.5	51.5	38.7	38.1	69.4	74.9	103.4	61.6	50.0	52.5	106.2	58.7	46.5	63.8	153.3	78.9	53.8	53.5	52.0	28.6	101.6	102.6	104.7	40.4	45.9	51.5	195.2
NPFFR1	"GPR147, NPFF1R1, OT7T022"	ENSG00000148734	"Neuropeptide FF receptor 1"	Q9GZQ6	10	70247329-70284004	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.5;retina: 3.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.5;Muller glia cells: 10.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 15.7;hypothalamus: 6.3"	"Low region specificity"	"Detected in single"			HPA037521	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 5: Muller glia cells - Visual perception"			"HPA037521: AB_2675520"	"unprognostic (1.73e-3)"	"unprognostic (7.29e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (9.62e-2)"	"unprognostic (6.78e-2)"	"unprognostic (5.84e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	0.2	0.0	1.6	0.4	2.5	0.3	0.1	9.5	1.8	0.1	0.9	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.0	1.6	2.8	0.0	0.0	0.2	0.6	2.5	2.8	0.1	0.0	0.0	0.1	0.0	2.7	0.1	0.1	3.1	0.0	0.2	0.2	0.1	0.1	0.0	1.8	0.2	0.2	1.0	3.2	0.0	0.0	0.1	0.3	0.1	0.2	2.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.7	1.6	2.5	9.5	1.8	1.6	2.8	2.5	2.8	2.7	1.8	3.2	2.9	0.2	0.0	2.0	6.5	0.2	1.7	1.8	0.3	0.0	0.7	0.1	0.3	1.0	1.5	0.0	1.8	0.0	0.2	1.5	0.4	0.0	0.0	0.3	0.6	0.2	0.5	0.0	0.0	0.2	0.2	0.2	0.8	0.0	0.8	2.5	0.1	0.4	0.2	0.1	0.0	1.4	0.1	0.0	0.3	2.8	1.6	0.6	0.8	0.0	0.0	0.4	10.4	1.0	1.0	1.0	0.1	0.1	0.4	0.0	1.1	0.0	0.1	0.1	1.6	0.0	1.7	0.6	0.6	1.2	0.0	2.0	1.1	0.3	0.0	0.2	0.9
NPHP1	"JBTS4, NPH1, SLSN1"	ENSG00000144061	"Nephrocystin 1"	O15259	2	110122311-110205066	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"		"Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.5;Endometrial ciliated cells: 136.3;Respiratory ciliated cells: 167.4;Spermatocytes: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046093, HPA074071"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA046093: AB_2679535, HPA074071: "	"unprognostic (2.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.64e-2)"	3.1	3.7	4.5	1.0	4.7	0.1	4.0	4.0	8.6	4.7	11.1	5.3	1.0	5.4	9.0	1.3	17.1	3.3	4.8	4.6	5.2	8.0	0.8	4.3	0.9	5.4	5.8	4.5	3.2	17.0	11.7	1.3	5.0	4.4	1.7	10.8	2.5	4.7	36.2	1.7	1.9	4.6	4.6	1.9	3.6	24.9	5.5	1.1	7.4	10.8	0.6	4.1	2.7	4.6	9.8	3.1	5.9	4.3	3.3	7.9	1.3	2.4	7.9	8.5	8.4	3.1	7.1	0.5	6.0	5.8	7.8	4.7	2.8	7.5	10.0	1.7	3.9	0.2	1.9	2.1	4.5	1.4	0.0	5.2	4.4	12.7	3.6	12.0	4.7	1.9	0.1	0.8	4.9	2.0	1.0	2.1	2.8	0.2	4.9	0.2	6.5	0.3	14.5	0.8	3.0	3.1	3.2	4.2	9.2	2.8	5.1	1.0	3.2	4.9	4.2	5.0	7.7	2.4	2.9	0.7	13.9	0.2	3.3	0.3	0.0	0.0	0.3	0.1	0.5	0.8	0.2	0.1	0.3	1.5	0.5	0.3	0.2	1.1	0.0	0.0	0.0	0.1	4.5	4.7	4.0	8.6	4.6	5.2	5.4	5.8	5.0	4.6	5.5	4.6	8.3	6.4	8.9	31.6	1.6	5.2	8.7	18.1	2.8	11.8	5.3	6.6	14.3	8.6	23.3	9.2	47.9	1.9	0.3	0.8	19.6	15.6	148.5	136.3	15.8	7.0	0.0	0.0	29.1	4.9	0.5	8.1	0.0	17.0	0.0	13.4	9.3	2.7	1.4	21.9	15.0	0.9	18.3	0.8	3.1	65.2	7.5	1.4	7.2	4.7	0.0	12.3	0.0	12.1	11.5	6.4	1.3	9.8	0.1	3.1	0.2	35.9	167.4	69.1	13.1	14.3	10.3	146.3	24.9	1.0	4.0	0.3	1.3	9.6	1.7	5.8
NPHP3	"CFAP31, FLJ30691, FLJ36696, KIAA2000, MKS7, NPH3, SLSN3"	ENSG00000113971	"Nephrocystin 3"	Q7Z494	3	132680609-132722414	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Ciliopathy, Disease variant, Meckel syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009150	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"HPA009150: AB_1078086"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.36e-5)"	"unprognostic (8.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (8.28e-9)"	"unprognostic (2.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	7.0	6.0	3.7	4.1	5.6	2.8	7.6	4.0	4.5	9.2	4.4	5.5	3.3	12.9	10.8	4.0	8.1	7.3	5.6	3.5	5.6	4.4	2.9	7.2	5.0	5.6	5.0	15.9	4.5	3.6	3.6	7.4	5.4	6.8	4.1	3.1	5.3	6.0	3.7	8.0	4.1	7.8	4.2	6.2	4.0	3.4	5.2	3.7	6.4	5.2	2.8	5.3	5.4	7.9	4.7	2.5	12.2	8.3	9.0	15.1	5.6	13.9	11.3	6.3	7.6	3.6	2.1	0.6	6.0	13.9	5.4	4.2	5.1	6.3	7.2	2.6	3.5	3.8	2.9	4.0	9.1	0.7	4.1	12.2	3.8	7.2	10.2	13.5	9.5	2.9	1.8	3.8	18.0	4.4	0.6	4.6	5.9	3.0	3.8	1.5	11.3	5.2	7.9	3.2	0.3	9.3	9.1	2.5	10.5	10.5	3.9	2.2	11.5	9.6	6.2	11.7	5.8	3.1	1.2	1.2	10.7	1.1	9.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.5	0.3	0.1	0.5	0.0	0.7	0.2	0.3	0.0	3.7	5.6	4.0	4.5	3.5	5.6	5.6	5.0	5.4	4.2	5.2	7.9	25.5	28.9	18.6	0.0	12.4	19.1	15.9	10.5	7.4	20.8	21.5	27.6	20.9	12.8	8.9	16.5	56.3	18.7	13.5	9.4	0.0	6.8	2.4	14.0	20.1	24.7	12.7	7.4	0.0	4.9	11.7	25.2	4.1	11.0	7.6	25.6	52.1	14.6	9.7	26.9	0.0	11.6	4.1	18.5	17.2	4.3	60.0	9.8	14.2	0.0	13.2	13.2	10.3	0.0	0.0	8.1	5.4	40.3	5.6	15.8	14.8	5.2	14.3	34.1	32.9	26.6	20.6	14.1	5.5	6.9	18.8	9.2	14.0	15.1	13.4	9.1
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.7;hippocampal formation: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	2.7	2.2	1.0	2.3	0.8	3.7	2.7	0.0	2.7	2.9	2.5	2.2	2.1	2.8	2.3	2.0	7.9	2.1	1.9	3.1	0.0	2.2	1.3	3.0	2.3	0.0	0.0	2.9	2.4	2.7	7.8	1.6	0.0	2.2	1.2	2.4	2.2	2.3	2.2	4.9	2.1	2.2	0.0	2.2	2.0	5.3	0.0	2.5	6.7	1.9	1.1	2.1	2.5	0.0	7.8	4.8	5.4	4.3	4.7	6.8	4.1	3.9	3.9	5.3	4.2	4.1	6.5	4.0	9.6	4.6	3.6	7.4	2.7	6.6	2.7	5.1	7.3	3.4	8.1	4.1	3.7	6.5	5.1	5.6	3.2	6.3	3.9	3.4	3.8	9.4	6.2	4.1	2.4	5.9	8.3	7.1	1.0	4.0	5.5	7.1	3.4	6.5	2.6	1.0	17.0	5.5	6.1	4.5	6.5	2.3	6.0	7.2	3.7	7.6	3.2	13.0	4.8	5.0	7.0	4.2	3.4	8.3	2.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	1.0	0.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	24.2	1.3	4.0	1.2	1.8	3.4	7.3	3.0	3.6	3.1	4.3	3.9	3.7	33.3	0.6	2.2	2.1	1.9	1.6	2.0	10.2	3.3	2.9	3.6	3.2	47.1	1.8	0.5	3.5	4.1	3.0	0.0	4.0	1.8	1.5	2.0	5.0	30.8	2.2	2.0	3.5	3.7	1.4	4.1	2.4	10.6	14.0	1.8	6.3	2.1	10.6	17.3	2.1	2.2	2.2	2.6	1.8	1.1	1.9	10.9	18.2	6.6	1.6	2.7	11.6	6.5	1.9	5.3	1.1	1.7	4.0	1.7	1.1
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 938.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.4;Excitatory neurons: 37.7;Respiratory ciliated cells: 37.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebral cortex: 938.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	55.4	49.4	43.3	10.7	42.1	12.7	54.6	60.6	938.3	69.6	30.2	88.8	5.7	57.1	0.0	47.1	74.6	7.7	60.4	43.7	39.7	43.0	44.6	51.5	14.6	43.1	36.3	102.2	49.3	13.9	157.0	8.3	44.1	70.5	9.1	38.4	41.1	26.6	69.7	63.6	49.2	30.0	34.9	55.8	50.0	96.8	37.8	17.0	57.3	23.6	12.0	67.6	56.9	39.3	0.4	12.5	56.7	22.0	0.1	0.9	9.9	22.0	15.3	19.9	17.5	8.6	13.6	3.6	30.4	30.5	23.5	9.9	26.4	3.0	20.1	11.3	10.0	0.0	20.9	47.0	76.6	28.3	6.4	42.8	42.6	16.6	29.6	11.6	9.7	19.0	3.2	15.2	22.7	26.9	0.0	14.5	0.6	0.0	0.6	10.8	0.3	5.2	32.1	26.7	2.4	21.0	11.6	1.4	29.1	6.7	4.4	24.2	2.0	26.4	1.2	0.4	7.2	8.3	6.7	7.5	0.9	1.8	14.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	43.3	42.1	60.6	938.3	43.7	39.7	43.1	36.3	44.1	34.9	37.8	39.3	6.8	6.4	20.0	22.2	4.4	9.3	1.0	3.7	12.5	9.0	8.1	7.4	2.0	7.2	17.6	9.2	6.2	2.6	6.5	5.1	0.0	5.3	64.4	5.2	7.3	6.2	4.9	9.1	37.7	2.0	1.8	9.9	3.6	4.0	22.1	5.3	6.8	3.3	2.3	6.7	27.2	5.3	4.1	4.7	4.1	22.3	21.5	3.9	0.0	5.6	6.1	3.2	4.1	24.1	17.5	4.4	4.3	19.2	14.7	1.5	4.1	1.0	37.4	6.3	19.7	6.8	5.5	14.9	10.8	9.6	4.0	1.2	5.1	2.3	6.1	1.0
NPIPA2		ENSG00000254852	"Nuclear pore complex interacting protein family member A2"	E9PIF3	16	14748066-14765413	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.8;Astrocytes: 2.9;granulocytes: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;NB-4: 2.4"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"																		5.2	2.8	1.0	0.3	0.9	0.3	4.7	1.2	2.9	5.7	0.9	8.9	0.2	4.4	0.8	3.9	3.6	0.2	4.1	1.1	0.9	6.6	2.8	4.0	0.3	1.2	1.0	6.8	4.4	0.3	9.6	0.3	1.1	5.0	0.8	1.5	3.1	0.3	7.0	5.6	4.0	0.2	0.9	3.6	4.2	14.6	1.0	0.5	4.1	0.3	0.2	5.4	4.7	1.3	0.2	0.2	0.1	0.0	0.2	0.1	6.8	0.5	0.3	0.0	0.1	0.2	0.9	0.0	0.6	0.5	0.1	0.8	0.2	0.0	0.0	0.5	0.4	0.4	0.6	0.1	0.2	0.1	1.6	0.0	0.9	0.9	0.6	0.0	0.1	0.8	0.5	0.4	0.1	1.4	0.8	2.4	0.4	0.0	0.2	0.7	0.4	0.1	0.3	0.3	0.6	0.3	0.2	0.4	1.1	0.9	0.0	0.6	0.5	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.2	2.9	1.1	0.9	1.2	1.0	1.1	0.9	1.0	1.3	0.8	3.2	4.8	2.9	0.1	2.3	0.0	0.2	0.0	0.0	0.8	0.5	1.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.0	2.2	0.8	0.0	1.1	0.0	0.1	10.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0
NPIPA3		ENSG00000224712	"Nuclear pore complex interacting protein family member A3"	F8WFD2	16	14708944-14726338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 4.2;Respiratory ciliated cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;hTERT-RPE1: 6.4;NB-4: 10.6;SK-MEL-30: 15.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.44e-1)"	"unprognostic (7.83e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.58e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.71e-2)"	5.1	3.6	2.0	0.8	2.0	0.7	4.7	2.8	9.4	6.6	1.5	9.3	0.2	6.8	0.8	4.4	5.8	2.5	4.4	2.2	1.7	5.5	3.8	4.7	0.4	2.0	2.0	7.7	4.0	2.5	10.7	0.5	2.1	5.8	0.9	2.0	3.1	1.0	7.4	5.8	4.1	0.4	1.7	4.0	4.7	6.5	2.0	0.1	4.7	0.3	0.4	7.2	5.4	2.1	0.0	0.6	0.1	0.3	0.0	0.1	1.4	0.5	0.0	0.4	0.4	0.0	1.9	3.3	0.2	1.2	0.7	0.1	0.1	2.1	0.2	0.1	0.0	0.3	0.7	0.4	0.2	0.1	0.5	4.4	0.7	1.2	0.1	6.4	0.1	0.6	0.1	0.2	0.2	1.2	0.0	10.6	0.8	0.0	0.0	0.1	0.0	0.0	2.9	1.0	0.4	0.4	0.0	0.2	15.9	0.6	0.2	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.7	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	2.8	9.4	2.2	1.7	2.0	2.0	2.1	1.7	2.0	2.1	0.2	3.2	0.5	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.1	4.2	0.0	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	1.1	0.1	0.1	0.8	1.2	0.0	0.1	0.2	0.1	1.2	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.6	0.0	0.7	0.6	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.3	1.0	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.7	0.1
NPIPA5		ENSG00000183793	"Nuclear pore complex interacting protein family member A5"	E9PKD4	16	15363628-15381047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.4;granulocytes: 11.4;Respiratory ciliated cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 17.7"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.19e-4)"	"unprognostic (5.85e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.58e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.02e-2)"	26.3	24.4	21.7	1.2	22.1	4.1	22.9	27.7	26.3	29.9	16.7	43.1	2.8	32.8	8.3	21.3	18.1	5.1	23.5	22.3	22.7	36.8	22.0	21.9	3.1	23.1	21.7	43.0	28.1	4.8	78.3	1.4	22.9	32.4	2.7	10.8	18.7	2.9	33.9	26.8	24.6	2.7	18.7	28.8	26.0	42.8	21.0	5.4	28.8	4.1	1.5	25.8	23.7	21.5	1.1	1.5	5.4	0.8	9.9	10.3	0.8	2.1	5.0	6.9	7.0	2.3	1.0	2.3	0.6	5.5	2.1	2.3	1.8	5.5	3.5	4.5	2.1	3.0	7.8	11.3	1.5	0.8	4.1	2.1	9.1	2.7	3.6	3.1	3.7	8.5	3.2	1.7	6.7	1.2	2.4	3.6	7.7	4.5	0.9	0.8	0.8	0.7	5.9	2.1	0.0	0.8	6.0	2.7	6.7	0.7	2.6	17.7	8.9	0.0	2.8	8.5	0.4	4.8	7.1	8.2	1.0	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.7	22.1	27.7	26.3	22.3	22.7	23.1	21.7	22.9	18.7	21.0	21.5	2.0	0.0	3.7	8.8	1.6	4.8	0.4	2.3	8.6	2.0	1.5	2.9	4.1	4.3	2.5	1.8	0.0	0.6	0.7	0.6	0.0	0.1	20.4	2.4	2.1	1.8	0.0	6.9	10.2	0.2	0.3	4.8	1.5	0.9	11.4	2.9	2.2	1.8	0.3	1.7	8.1	0.5	2.0	1.0	2.3	4.1	1.5	1.2	0.0	1.9	0.1	0.8	0.0	7.1	6.9	0.0	0.0	0.7	0.8	0.4	0.4	0.2	11.1	2.5	0.0	2.2	2.9	5.8	1.0	6.2	4.5	0.3	1.8	0.1	0.6	0.2
NPIPA7		ENSG00000214967	"Nuclear pore complex interacting protein family member A7"	E9PJI5	16	16379055-16393954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 16.2;Endothelial cells: 3.8;Fibroblasts: 4.8;granulocytes: 5.7;Respiratory ciliated cells: 2.9;Smooth muscle cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 91.3;THP-1: 81.3"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.17e-2)"													16.5	24.2	32.7	9.7	32.2	12.9	10.9	38.4	44.1	16.7	30.8	20.1	9.7	11.1	24.7	23.2	14.6	16.7	9.9	32.4	32.8	28.5	28.9	14.8	16.0	31.8	31.2	17.6	36.5	26.8	84.7	9.9	32.0	23.4	22.6	28.8	16.9	9.1	9.5	35.5	18.6	11.0	30.5	28.1	18.7	26.3	32.1	14.3	28.2	4.1	12.9	13.7	13.6	32.5	7.6	16.6	19.6	7.6	11.5	9.2	12.8	15.7	6.1	17.6	9.2	17.3	11.9	19.0	12.2	16.5	10.6	22.8	13.9	16.1	13.0	5.6	4.2	19.2	59.5	26.0	10.9	6.8	91.3	16.5	61.1	9.7	20.6	21.7	9.2	31.3	11.6	23.8	19.4	32.5	15.4	39.5	13.6	27.8	5.5	22.5	13.2	11.1	29.1	32.3	25.3	13.5	12.4	28.3	12.8	23.9	20.4	81.3	7.9	16.8	7.9	7.7	13.5	4.9	19.7	15.4	9.6	21.2	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	32.2	38.4	44.1	32.4	32.8	31.8	31.2	32.0	30.5	32.1	32.5	0.0	3.2	2.6	0.3	0.2	1.7	0.0	0.5	0.0	0.0	0.0	0.0	16.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	4.8	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.0
NPIPA8	LCR16a9	ENSG00000214940	"Nuclear pore complex interacting protein family member A8"	P0DM63	16	18317942-18336736	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;granulocytes: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 28.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.3;EFO-21: 58.1;HMC-1: 217.0;SCLC-21H: 53.1;THP-1: 60.6"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.68e-1)"					"unprognostic (3.60e-2)"				"unprognostic (2.81e-1)"				14.3	9.6	3.7	2.5	3.9	6.9	13.3	6.5	28.6	13.1	2.4	28.7	0.2	12.6	0.5	10.1	28.7	0.1	11.3	4.0	3.4	18.4	9.6	12.4	2.5	4.0	3.2	20.7	11.0	6.3	36.4	6.3	4.6	16.9	2.1	5.0	9.8	7.5	18.9	14.6	12.9	0.4	2.7	13.1	13.9	20.8	4.3	3.1	13.7	0.1	0.1	15.8	10.8	3.6	0.0	2.3	0.3	0.5	1.5	0.7	0.7	0.0	0.0	0.1	0.2	0.4	10.5	61.3	58.1	0.5	0.0	0.1	23.6	7.1	0.1	0.1	0.1	0.1	1.9	2.0	9.7	0.1	217.0	0.3	0.0	0.0	0.0	0.1	4.3	14.4	24.4	0.2	0.0	0.1	0.0	0.2	16.4	24.8	0.0	2.5	36.2	1.7	0.3	0.2	53.1	16.8	0.0	0.4	0.6	11.2	0.0	60.6	0.0	1.1	0.1	0.2	13.8	0.0	0.1	0.2	18.6	16.5	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	3.9	6.5	28.6	4.0	3.4	4.0	3.2	4.6	2.7	4.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0
NPIPA9		ENSG00000233024	"Nuclear pore complex interacting protein family, member A9"		16	18358086-18379331	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (9.10e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.87e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.25e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.90e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.45e-3)"	67.7	62.8	166.9	26.7	164.4	29.4	66.5	232.7	283.1	82.8	136.2	119.7	25.7	74.7	58.4	63.5	78.1	30.6	77.6	168.1	177.5	79.6	64.1	67.1	32.4	165.7	150.8	135.0	75.1	44.7	224.4	22.8	169.8	89.4	40.2	72.4	55.9	43.0	115.1	73.9	69.2	47.7	132.7	74.7	64.7	84.8	152.5	30.7	81.4	29.1	27.3	70.2	66.3	162.9	23.6	15.1	82.7	67.9	69.4	64.4	19.3	88.5	32.1	42.6	63.0	15.2	13.6	32.6	33.2	78.4	25.2	41.7	26.0	24.0	51.9	27.8	24.8	87.0	85.7	75.4	70.3	41.7	190.6	66.6	105.3	53.5	71.4	89.2	21.1	39.3	20.4	62.7	43.1	35.8	68.2	89.3	34.8	23.2	19.0	97.1	20.6	32.5	42.4	43.9	23.4	36.2	55.5	34.5	49.3	31.6	31.9	48.4	40.4	56.9	24.9	48.4	27.5	46.9	40.3	49.2	25.5	56.2	30.1	0.0	0.1	0.1	0.5	0.0	0.2	1.4	0.4	0.3	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	166.9	164.4	232.7	283.1	168.1	177.5	165.7	150.8	169.8	132.7	152.5	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB11		ENSG00000254206	"Nuclear pore complex interacting protein family member B11"	E5RHQ5	16	29381354-29404029	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 17.5;Intestinal goblet cells: 9.4;Undifferentiated cells: 9.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (6.82e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-4)"	"unprognostic (7.41e-2)"	"unprognostic (2.94e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.79e-5)"	2.8	1.6	6.0	2.8	5.4	4.7	2.5	7.2	8.4	2.9	6.3	2.7	2.0	2.1	3.2	2.1	3.1	1.8	2.3	5.6	6.7	3.3	4.2	2.5	6.0	5.5	4.6	3.3	2.0	0.9	2.6	1.2	5.4	2.8	1.7	5.8	2.2	0.6	4.4	6.7	3.7	0.9	3.4	4.4	2.7	4.9	5.8	2.0	3.2	0.9	1.1	2.3	2.5	6.6	1.5	1.2	2.2	3.2	1.6	1.2	2.9	1.4	0.6	1.2	0.5	1.7	2.9	9.0	2.1	0.7	0.5	2.6	1.8	2.1	1.2	2.2	2.4	2.1	4.4	2.8	0.8	2.6	4.9	0.7	1.6	1.3	1.8	2.5	0.6	2.4	2.7	2.6	1.1	3.5	2.2	8.3	3.8	0.9	2.7	3.3	0.9	3.0	1.3	1.1	2.9	1.4	0.4	2.0	1.1	6.8	1.1	3.3	3.0	3.0	1.3	2.1	1.9	2.5	1.7	7.3	1.7	3.3	2.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.5	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	6.0	5.4	7.2	8.4	5.6	6.7	5.5	4.6	5.4	3.4	5.8	6.6	1.4	9.6	5.6	3.6	4.2	0.0	0.1	0.3	0.6	0.2	1.5	0.9	2.5	1.5	2.6	0.0	0.0	0.3	3.7	8.8	0.0	1.2	17.5	0.6	0.5	2.6	7.2	1.3	4.6	0.8	0.2	1.8	3.6	0.6	5.1	0.4	0.4	0.2	0.3	5.0	5.4	9.4	0.0	0.0	0.0	5.9	0.3	1.6	0.0	1.0	1.5	0.1	5.2	2.5	4.2	1.9	5.9	0.7	2.7	0.1	3.7	0.3	2.3	0.3	0.0	0.5	1.0	0.8	0.1	0.5	0.0	0.4	4.4	0.3	9.8	0.0
NPIPB12		ENSG00000169203	"Nuclear pore complex interacting protein family member B12"	F8W0I5	16	29483642-29505999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"brain: 198.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.3"	"Group enriched"	"Detected in all"	4	"B-cells: 8.4;granulocytes: 29.3;NK-cells: 14.2"	"Cell line enhanced"	"Detected in all"		"NB-4: 166.4"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.28e-7)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.14e-4)"	25.4	21.7	135.6	40.5	135.5	63.7	21.9	136.7	198.1	30.8	109.8	27.5	24.0	24.0	38.5	24.8	27.5	24.8	29.2	127.2	143.6	31.8	58.2	27.5	57.0	128.7	140.4	26.9	24.2	15.1	26.3	20.4	128.8	33.3	25.6	32.2	34.5	20.0	44.3	108.9	33.6	19.7	105.7	51.2	23.5	29.1	137.3	28.1	28.8	15.5	29.8	26.7	24.2	131.2	26.2	26.7	20.6	52.8	24.7	14.7	40.0	15.7	4.4	7.8	6.7	23.1	52.5	43.8	27.4	13.1	15.4	34.5	35.2	25.3	10.7	28.1	25.6	33.3	36.0	46.5	22.2	36.1	61.5	23.0	19.5	17.6	18.5	19.9	9.0	24.3	34.5	37.2	12.7	42.6	26.6	166.4	31.5	17.6	19.3	61.6	9.1	42.7	19.1	18.6	21.9	15.4	8.9	36.5	22.5	9.2	18.7	43.4	22.4	49.9	19.2	34.9	30.2	19.5	21.3	42.7	20.3	63.9	23.9	29.3	3.5	1.4	3.9	1.2	1.0	3.7	2.3	2.7	2.4	8.4	3.1	2.1	9.5	14.2	3.0	2.6	1.8	1.3	135.6	135.5	136.7	198.1	127.2	143.6	128.7	140.4	128.8	105.7	137.3	131.2	0.0	3.2	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
NPIPB13		ENSG00000198064	"Nuclear pore complex interacting protein family, member B13"	A6NJU9	16	30222937-30254510	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 10.6;Club cells: 7.4;granulocytes: 12.6;Respiratory ciliated cells: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.11e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.58e-2)"	3.2	2.2	4.0	2.1	2.2	6.1	3.0	4.3	4.7	4.4	0.0	3.8	1.6	2.2	4.5	2.5	3.8	1.6	3.2	3.6	3.3	3.0	4.1	4.1	3.6	2.0	1.1	3.9	2.5	1.8	4.1	1.5	1.4	4.0	2.0	3.9	2.8	1.5	3.8	7.2	4.8	0.5	0.1	5.1	2.9	2.8	3.1	1.1	4.1	0.6	2.1	3.2	3.4	2.8	2.2	5.4	1.3	4.4	0.6	1.4	2.6	0.4	0.0	0.2	0.2	0.6	2.9	3.3	2.1	0.8	0.5	2.5	2.4	1.2	0.7	1.9	1.1	3.5	6.3	2.8	0.2	4.4	2.7	2.0	1.7	1.9	1.1	0.6	0.9	1.4	1.5	4.5	1.0	4.5	2.0	4.3	1.8	0.5	1.3	4.1	0.7	1.8	1.2	3.6	1.5	1.6	0.6	1.6	0.8	1.7	1.3	1.1	2.1	2.5	2.6	2.4	1.3	1.8	2.3	4.1	2.4	2.0	1.3	0.0	0.3	0.0	0.6	0.1	0.3	0.0	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.4	0.4	0.1	0.0	0.1	4.0	2.2	4.3	4.7	3.6	3.3	2.0	1.1	1.4	0.1	3.1	2.8	0.8	16.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	7.4	1.8	0.0	0.5	0.8	0.0	0.0	0.6	0.0	0.3	0.4	1.7	0.0	0.0	0.0	1.5	0.1	1.3	0.0	0.7	12.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.3	10.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.2	0.0	0.0
NPIPB15	"LOC440348, NPIPL2"	ENSG00000196436	"Nuclear pore complex interacting protein family member B15"	A6NHN6	16	74377878-74392080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 394.8;Late spermatids: 241.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 11.7"									"HPA011188, HPA053611"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (2.23e-2)"	"unprognostic (3.48e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.14e-3)"	9.6	7.9	0.6	0.8	1.0	4.1	10.5	1.3	5.6	10.0	0.4	19.6	4.6	4.6	0.1	13.5	9.2	2.5	7.0	0.6	1.5	16.2	35.3	11.1	3.4	0.6	0.6	8.5	19.9	1.6	19.6	3.2	0.7	26.5	11.9	3.1	26.3	1.5	4.4	11.5	20.2	1.8	0.4	13.3	19.1	55.9	0.9	2.0	17.1	0.0	2.7	11.3	9.5	0.7	2.5	0.0	2.3	1.3	2.7	1.9	0.4	1.5	2.3	1.9	5.1	1.3	0.1	4.2	0.0	3.3	0.0	4.5	0.0	2.0	1.4	0.0	2.6	0.1	6.6	2.5	1.3	1.7	8.1	2.7	3.9	3.7	2.7	2.7	0.0	0.1	0.3	1.6	1.6	3.9	0.9	0.0	0.5	1.2	0.0	0.8	2.1	2.8	0.0	1.6	3.2	0.0	6.2	0.0	4.4	0.0	11.7	2.0	0.1	1.7	4.6	0.0	0.9	5.4	1.7	1.0	2.3	1.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.6	1.0	1.3	5.6	0.6	1.5	0.6	0.6	0.7	0.4	0.9	0.7	5.7	3.2	5.9	6.2	3.8	2.0	1.8	2.5	4.0	3.5	8.0	5.0	1.3	7.2	6.1	7.3	8.4	1.9	5.3	17.4	0.0	1.7	394.8	6.0	3.1	4.1	17.5	0.4	3.6	3.8	1.0	4.5	29.6	11.3	0.0	11.7	2.9	3.3	1.3	0.0	4.2	32.8	6.1	1.5	1.3	241.9	11.5	3.1	3.6	2.8	2.8	0.8	1.0	4.5	7.9	2.6	20.4	7.5	5.8	9.6	27.4	1.4	4.6	2.6	0.0	4.3	2.7	28.4	5.3	3.1	2.7	2.5	3.5	4.7	16.2	9.7
NPIPB2		ENSG00000234719	"Nuclear pore complex interacting protein family member B2"	A6NJ64	16	11927259-11976643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"testis: 15.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;granulocytes: 2.5;Granulosa cells: 3.1;Proximal tubular cells: 4.4;Respiratory ciliated cells: 2.2;Theca cells: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.5;U-266/70: 26.9"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (8.80e-2)"	"unprognostic (4.83e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.58e-2)"	2.6	2.0	5.4	0.4	5.4	0.9	2.1	6.0	6.3	2.9	5.2	2.1	1.6	2.3	4.0	1.1	2.5	1.3	1.5	5.2	5.7	3.5	1.6	1.5	1.3	5.5	5.1	3.0	2.1	2.8	2.7	1.1	5.4	2.1	1.4	4.1	1.6	1.8	1.5	3.4	2.0	2.2	4.7	1.9	1.7	15.1	5.6	7.8	2.9	0.4	0.7	1.8	2.0	5.9	0.1	1.6	2.0	1.1	4.6	7.4	3.0	2.2	3.9	1.0	0.6	1.2	1.8	1.0	0.7	2.1	0.3	0.4	1.3	1.7	2.0	1.2	1.7	0.5	2.1	1.8	7.4	1.1	0.4	0.3	3.5	2.3	4.9	0.3	0.3	0.2	0.2	5.5	0.7	2.3	0.3	0.8	0.6	1.4	1.6	2.2	0.1	15.5	0.7	1.0	2.9	0.0	5.0	0.3	0.0	2.0	0.3	3.6	0.5	0.3	0.3	0.4	0.2	26.9	8.8	1.2	3.1	0.4	1.2	0.0	1.0	0.2	0.3	0.0	0.0	0.8	0.5	0.4	0.8	0.4	0.9	0.2	0.2	1.5	0.1	0.7	0.0	0.4	5.4	5.4	6.0	6.3	5.2	5.7	5.5	5.1	5.4	4.7	5.6	5.9	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.0	1.8	0.0	0.7	0.5	0.0	5.9	0.5	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.5	2.5	3.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	4.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	2.6	0.0	0.0
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 2.8;Gastric mucus-secreting cells: 2.0;Skeletal myocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 161.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	53.3	47.1	141.3	37.2	137.3	149.4	47.7	127.7	184.3	71.8	111.9	72.4	28.5	38.3	51.8	44.4	58.6	28.5	60.8	118.8	134.1	71.1	65.1	66.3	77.0	133.3	147.3	49.6	47.2	13.1	70.5	21.9	127.9	74.9	34.9	51.7	43.5	22.6	87.9	140.9	76.7	28.1	90.1	99.7	51.3	46.6	134.8	53.6	75.6	24.1	34.8	48.0	52.5	122.8	37.9	37.2	24.5	40.1	30.0	18.1	73.5	25.7	9.6	13.3	14.1	57.5	44.0	56.4	24.1	38.9	17.7	47.0	13.6	41.4	12.5	30.8	20.6	26.6	58.7	161.9	25.6	48.8	46.0	8.8	16.8	35.3	44.3	20.4	19.4	52.5	49.7	77.3	20.4	69.7	51.8	114.0	41.0	22.5	42.5	75.7	25.4	35.0	28.8	23.2	27.8	21.1	15.7	32.5	25.9	47.2	35.7	20.7	29.5	62.9	36.4	6.4	40.4	37.8	30.8	49.2	25.0	38.3	34.9	3.5	2.3	1.5	2.6	1.4	1.2	2.2	1.5	1.6	1.2	2.4	2.0	1.3	2.1	2.0	1.1	4.8	0.9	0.1	141.3	137.3	127.7	184.3	118.8	134.1	133.3	147.3	127.9	90.1	134.8	122.8	0.1	0.0	0.0	1.6	0.5	2.8	0.4	0.2	0.6	0.0	0.1	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	1.7	0.0	0.0	1.0	2.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.8	1.9	0.0	0.0	1.0	1.5	1.3	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.7	0.0	0.0	3.1	0.8	0.0	0.0	1.3	1.7	0.0	0.8	0.2	0.0	0.2
NPIPB4		ENSG00000185864	"Nuclear pore complex interacting protein family member B4"	C9JG80	16	21834569-21880827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Astrocytes: 149.5;Early spermatids: 150.6;Excitatory neurons: 255.3;Inhibitory neurons: 182.5;Microglial cells: 391.6;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 217.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.09e-3)"	"unprognostic (3.51e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.04e-8)"	"unprognostic (3.37e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.46e-3)"	25.3	18.6	29.4	26.3	11.2	88.8	24.9	45.3	24.1	28.1	0.0	27.0	17.3	20.5	71.0	19.4	27.8	17.6	21.3	12.1	5.1	25.0	30.4	27.6	38.8	8.3	4.6	24.4	22.4	6.6	23.6	14.8	8.9	28.8	27.8	31.2	23.3	11.8	28.5	104.5	36.7	13.0	0.0	41.1	26.5	20.8	14.8	17.3	31.9	7.5	27.1	20.6	24.8	9.0	14.0	18.6	17.3	13.7	12.2	17.3	29.3	16.7	5.1	5.5	8.9	38.6	19.2	27.2	12.4	14.5	5.1	15.5	9.4	14.0	10.9	10.9	8.7	10.5	56.2	53.0	8.0	44.2	26.9	13.0	16.8	14.6	24.3	11.3	12.1	21.2	23.3	22.8	8.4	40.0	16.9	27.7	20.8	4.5	9.9	25.4	10.3	15.3	6.2	13.6	17.2	10.5	11.1	12.8	8.2	16.3	16.9	12.9	26.9	29.1	14.7	14.0	14.7	11.6	11.9	27.8	9.2	20.4	14.0	3.1	0.9	0.3	0.7	0.5	0.6	1.0	1.0	0.5	0.2	2.7	0.8	0.9	1.4	2.2	0.6	2.0	0.2	0.2	29.4	11.2	45.3	24.1	12.1	5.1	8.3	4.6	8.9	0.0	14.8	9.0	7.1	3.2	16.8	149.5	4.3	7.6	1.2	0.9	3.4	5.1	1.3	0.9	2.1	0.0	6.1	0.0	4.2	0.5	7.6	1.7	0.0	1.0	150.6	5.1	5.4	3.6	1.2	4.4	255.3	0.6	0.3	3.6	6.1	8.8	10.8	3.0	1.4	0.8	0.7	1.7	182.5	2.1	2.0	1.2	5.2	25.3	0.3	4.3	0.0	391.6	2.8	1.2	3.1	207.6	217.1	1.4	3.0	0.4	5.9	0.7	1.0	0.1	3.9	6.4	0.0	3.1	3.1	1.5	0.5	2.3	8.4	0.8	7.0	1.8	2.2	0.7
NPIPB5		ENSG00000243716	"Nuclear pore complex interacting protein family member B5"	A8MRT5	16	22479121-22536521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 57.1;Club cells: 50.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.52e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-10)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.76e-5)"	58.6	36.5	63.2	66.8	37.2	136.4	58.0	69.0	90.4	67.1	6.8	61.8	36.5	41.8	124.9	41.2	54.9	27.7	50.9	24.8	27.4	49.0	38.4	77.0	82.6	22.1	37.3	57.1	49.4	14.7	50.4	29.3	22.9	58.9	47.3	115.7	56.7	22.8	78.4	212.1	90.9	25.3	2.6	84.6	50.9	41.0	57.1	43.1	75.5	17.7	61.0	45.9	58.8	33.2	31.3	25.7	16.3	23.3	27.8	24.9	35.4	18.9	6.3	11.5	13.9	35.4	53.3	43.9	34.7	17.4	11.3	24.5	41.2	21.3	19.0	53.8	17.2	16.1	85.6	66.1	27.5	83.5	29.1	30.1	20.9	23.0	41.1	20.6	18.3	45.0	43.5	52.8	10.3	57.6	26.6	101.3	46.4	4.9	11.7	44.7	12.1	51.1	18.2	18.9	21.0	14.9	23.3	36.6	19.7	32.9	19.9	30.8	71.4	39.4	17.4	31.2	30.6	35.7	18.9	54.4	15.7	63.6	14.3	6.2	2.7	2.1	3.9	1.2	1.6	6.8	3.8	2.6	1.4	7.7	4.0	3.5	6.0	2.8	2.5	5.2	2.0	1.3	63.2	37.2	69.0	90.4	24.8	27.4	22.1	37.3	22.9	2.6	57.1	33.2	30.0	28.9	57.1	1.0	20.3	14.4	11.2	3.0	17.1	16.5	10.5	7.1	34.8	4.3	50.6	5.5	10.4	5.1	22.8	3.3	0.0	3.8	7.1	19.3	20.5	23.6	1.2	17.2	0.3	1.4	2.8	20.4	22.4	32.7	10.1	21.0	8.2	2.0	4.4	6.7	0.2	3.8	0.0	8.1	16.7	2.8	10.2	25.5	5.4	1.0	14.2	5.5	12.3	0.5	0.3	5.0	4.0	6.4	21.7	13.0	4.3	1.6	31.6	23.8	0.0	32.7	22.7	3.6	2.3	14.0	11.5	5.9	29.7	9.3	3.3	10.3
NPIPB6		ENSG00000198156	"Nuclear pore complex interacting protein family member B6"	E9PJ23	16	28342555-28363508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 39.7"	"Group enriched"	"Detected in some"	19	"Early spermatids: 300.0;Late spermatids: 151.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.1;hTCEpi: 3.0;NB-4: 3.1;RPMI-8226: 3.4"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-3)"	1.2	0.6	4.9	0.3	5.0	0.7	1.3	5.2	8.7	2.5	4.2	2.1	0.3	1.3	1.0	0.9	2.9	0.2	0.9	4.8	5.2	1.1	1.2	1.4	0.5	4.7	4.5	3.2	1.5	0.2	2.5	0.2	5.2	2.3	0.6	1.3	1.1	0.6	1.4	2.1	2.1	0.4	4.3	1.9	1.2	39.7	4.8	0.4	2.4	0.1	0.3	1.5	1.7	6.2	0.1	3.1	1.4	0.3	0.7	0.0	2.7	0.2	0.3	0.0	0.2	0.1	1.3	1.1	0.2	0.1	0.3	0.4	0.3	0.3	0.1	0.7	0.2	0.8	0.7	0.0	0.0	1.0	0.2	0.4	3.0	0.2	0.6	0.5	0.0	1.7	0.1	2.4	0.0	0.7	0.3	3.1	0.7	0.3	0.1	1.6	1.1	3.4	0.0	0.0	0.4	0.6	0.1	0.1	0.3	1.5	0.6	0.3	0.2	0.4	1.0	0.2	0.2	1.0	1.1	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	5.0	5.2	8.7	4.8	5.2	4.7	4.5	5.2	4.3	4.8	6.2	0.2	0.0	1.1	0.0	0.1	0.5	0.4	0.0	0.0	0.5	1.6	1.7	0.5	0.0	0.8	0.0	0.0	0.5	0.1	0.4	0.0	0.0	300.0	0.7	0.4	0.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	1.5	0.0	1.4	1.1	0.2	0.2	0.0	0.0	0.1	0.0	0.3	0.3	151.0	1.2	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	1.4	1.9	0.0	0.6	0.3	0.2	6.0	0.2	0.0	1.7	0.4	11.7	3.1	0.0	1.3	1.4	0.4	0.3	0.5	0.7
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 22.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 152.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	1.4	0.9	4.0	1.4	4.0	2.6	1.0	6.1	8.2	0.5	0.1	1.4	1.0	1.3	2.1	0.2	0.7	0.3	0.4	4.0	3.0	0.6	1.2	0.8	1.5	3.1	0.7	1.6	1.7	0.4	0.3	0.7	1.9	1.0	1.4	4.5	0.8	1.1	5.0	3.2	1.3	0.7	0.0	1.3	2.4	22.2	2.7	1.0	0.6	1.0	0.6	0.5	0.1	1.7	0.6	4.1	3.0	2.0	1.3	1.3	6.3	1.5	0.1	0.3	0.5	1.5	1.8	3.2	0.9	1.0	0.3	2.0	0.9	0.6	0.2	1.1	1.5	1.2	4.5	3.1	0.6	2.8	6.3	1.4	3.1	1.0	0.9	1.6	0.1	1.9	1.0	2.2	0.7	5.4	0.7	2.9	1.9	0.2	0.2	2.6	1.8	1.6	0.2	1.5	1.6	0.8	1.3	0.5	0.6	2.8	2.2	1.2	2.2	1.1	2.8	1.5	1.0	4.4	2.2	3.1	0.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.0	6.1	8.2	4.0	3.0	3.1	0.7	1.9	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	152.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NPIPB8		ENSG00000255524	"Nuclear pore complex interacting protein family member B8"	E9PQR5	16	28637654-28658682	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	7	"testis: 13.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 19.9;Late spermatids: 35.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"hTCEpi: 20.6"									"HPA011188, HPA053611"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (8.28e-2)"				"unprognostic (1.88e-1)"			"unprognostic (1.10e-1)"		"unprognostic (5.78e-2)"			"unprognostic (1.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"			0.9	0.6	0.4	0.2	0.6	0.2	1.1	0.5	0.8	1.7	0.2	1.8	0.9	0.9	0.2	1.0	0.9	0.0	0.8	0.5	0.5	0.9	1.8	1.2	0.1	0.5	0.4	1.6	1.6	0.0	1.8	0.0	0.6	1.6	0.1	0.6	2.0	0.0	0.7	1.4	1.8	0.0	0.4	1.1	1.4	13.9	0.4	0.0	1.5	0.0	0.1	1.0	1.2	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.5	0.2	20.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8	0.5	0.5	0.5	0.4	0.6	0.4	0.4	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	35.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB9		ENSG00000196993	"Nuclear pore complex interacting protein family member B9"	F8W1W9	16	28751787-28772807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.4;Oligodendrocytes: 1.0;Plasma cells: 1.5;Respiratory ciliated cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.4;U-266/70: 2.8"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (7.38e-2)"	"unprognostic (6.63e-4)"		"unprognostic (6.63e-2)"	"unprognostic (5.05e-2)"			"unprognostic (5.53e-2)"		"unprognostic (4.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.36e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.71e-2)"	1.1	0.6	1.8	0.4	1.5	1.0	1.2	1.7	3.1	1.7	0.8	1.5	0.0	1.2	1.1	0.7	2.1	0.3	0.9	1.7	1.6	1.0	1.2	1.4	0.8	1.4	1.6	2.9	1.1	0.1	1.5	0.2	1.8	1.8	0.4	1.7	0.9	0.4	1.0	3.1	1.7	0.3	1.1	1.7	1.0	14.9	2.1	0.1	1.9	0.0	0.6	1.3	1.4	2.4	0.2	1.8	0.5	0.3	0.2	0.7	1.5	0.0	0.1	0.0	0.0	0.2	1.0	0.7	0.5	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.9	0.3	0.0	0.4	0.0	1.3	1.2	0.1	4.4	0.3	0.8	0.2	0.0	1.4	0.2	1.2	0.1	1.2	0.4	1.7	0.7	0.1	0.4	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.0	1.1	0.5	0.0	0.0	1.3	0.9	0.3	2.8	1.4	1.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.8	1.5	1.7	3.1	1.7	1.6	1.4	1.6	1.8	1.1	2.1	2.4	0.0	0.0	0.5	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.1
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 52.3;placenta: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 423.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 423.2;monocytes: 128.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	12.7	5.8	16.7	19.2	20.8	18.9	5.5	19.3	22.9	4.3	11.1	6.9	2.8	1.7	29.9	10.0	3.3	13.0	2.6	12.7	15.6	52.3	20.8	14.5	32.5	19.6	20.1	1.4	2.8	3.3	1.7	45.2	18.9	2.3	9.1	1.9	4.2	6.2	1.7	8.4	4.4	7.5	15.8	28.7	5.0	5.1	27.0	6.2	2.6	2.8	14.7	15.5	5.1	22.0	3.4	0.6	1.0	0.0	2.8	2.8	0.9	1.1	2.1	1.2	0.6	0.0	1.4	9.0	1.5	0.0	0.0	1.3	1.9	2.4	0.3	0.0	1.5	14.2	0.4	0.1	1.5	5.4	8.1	2.2	9.1	0.2	0.0	0.1	0.1	10.1	10.9	13.8	2.1	1.1	0.3	3.5	11.0	7.0	1.1	1.4	0.7	11.0	0.2	7.4	3.1	4.6	5.0	0.3	4.7	1.1	2.9	8.7	0.2	1.1	2.4	0.7	0.1	9.8	12.7	9.0	2.4	9.5	3.6	25.5	128.4	104.1	5.5	118.2	4.8	1.8	4.5	4.9	7.6	6.3	3.5	4.9	423.2	0.3	96.6	1.5	8.1	65.4	16.7	20.8	19.3	22.9	12.7	15.6	19.6	20.1	18.9	15.8	27.0	22.0	2.9	0.0	5.5	170.1	4.9	6.1	4.0	8.6	1.8	7.6	1.5	4.4	2.9	2.8	4.8	7.3	2.1	123.1	2.2	2.3	19.6	1.2	19.1	0.4	0.6	3.5	1.8	45.5	7.5	2.4	6.1	2.5	3.1	0.2	5.7	0.5	72.8	3.9	481.5	6.7	13.5	1.4	6.1	148.8	11.5	27.0	0.9	91.7	10.6	125.5	40.1	2.8	5.2	22.1	21.0	1.3	0.3	0.4	0.7	1.6	0.9	141.0	1.7	2.8	0.0	1.7	1.7	16.5	8.9	16.5	7.1	107.4	3.1	3.4	1.6	4.3
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 20.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		30000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	37.3	46.6	27.2	32.4	27.6	41.7	32.0	22.2	28.3	30.4	27.1	35.2	24.5	35.3	23.5	51.5	28.8	23.3	58.4	26.6	31.2	42.2	54.8	37.9	33.2	31.8	27.2	25.9	36.7	29.7	33.2	27.1	28.5	33.3	21.3	20.1	32.4	22.7	164.3	42.1	34.4	29.3	24.1	42.8	36.8	42.8	28.7	33.4	28.4	55.5	28.8	33.2	31.7	32.8	91.9	118.6	46.2	72.1	56.0	46.0	57.2	74.2	82.3	120.4	110.6	90.7	80.2	67.2	57.9	87.7	87.8	72.5	46.0	62.6	104.5	43.0	60.8	77.5	95.5	81.5	53.4	83.4	95.4	45.8	59.1	113.2	40.1	57.7	124.8	62.0	84.1	99.1	73.6	59.5	113.0	45.2	54.3	45.5	74.0	73.6	73.8	54.4	43.6	86.8	61.6	70.6	92.6	127.4	85.7	87.1	100.1	60.9	89.6	156.1	108.1	86.1	121.4	74.8	57.9	84.0	124.6	55.2	102.9	4.1	20.0	4.4	4.6	4.9	2.8	4.7	3.1	3.7	6.3	3.3	2.8	3.7	5.6	2.8	3.1	4.8	3.2	10.0	27.2	27.6	22.2	28.3	26.6	31.2	31.8	27.2	28.5	24.1	28.7	32.8	19.2	12.8	18.1	24.8	15.3	17.6	16.2	12.7	7.4	24.3	19.5	16.1	44.5	11.5	18.5	20.2	29.2	19.5	22.2	38.9	1.9	19.0	96.2	32.8	19.6	22.2	30.5	20.6	38.0	37.4	21.3	15.9	26.0	38.8	3.8	29.2	27.1	54.3	19.1	20.2	36.4	17.2	8.2	27.3	18.7	79.6	17.7	22.8	12.4	19.7	28.7	19.6	14.4	23.1	38.6	47.2	22.8	12.8	16.5	28.4	22.2	27.9	21.5	33.5	19.7	22.3	18.5	29.7	23.9	15.7	24.2	37.1	16.9	19.3	18.9	28.7
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411810	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		NA	Yes		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	515.1	370.6	180.7	468.4	190.3	789.2	597.1	188.6	233.5	759.2	195.9	486.6	347.1	656.6	421.5	623.0	596.1	355.4	336.7	169.0	210.7	375.3	370.3	364.5	777.0	196.2	188.6	1384.6	810.6	278.0	314.4	423.7	207.5	386.2	421.2	161.3	385.2	318.5	450.9	386.6	374.1	436.0	213.9	358.1	467.8	284.7	202.6	683.3	510.1	282.4	761.7	524.9	565.4	204.5	2476.2	1522.7	1864.0	2663.1	1073.3	1915.6	2736.9	2111.3	1826.0	2678.1	2387.2	3640.2	1622.2	6243.9	1683.2	1194.5	1927.6	1386.6	2552.2	4639.2	3423.4	2027.9	2027.3	2149.1	1361.9	2740.2	1593.2	4556.3	1790.7	1732.2	1559.7	1845.8	3572.3	2184.3	2019.4	1460.9	2712.8	1406.5	1945.5	2826.5	3071.1	3087.4	2400.7	1280.7	1857.2	2695.2	2051.7	3241.9	2306.9	1583.1	1433.8	1167.4	1210.6	2084.4	4091.0	1288.7	2513.8	2000.7	1289.5	916.7	2114.4	1082.5	3705.3	1161.5	2139.6	3702.2	1403.3	3561.5	1897.0	153.6	287.1	92.3	443.1	311.4	834.2	847.9	832.8	654.3	564.2	634.9	1189.9	973.4	38.0	656.2	264.4	516.8	782.6	1076.1	180.7	190.3	188.6	233.5	169.0	210.7	196.2	188.6	207.5	213.9	202.6	204.5	462.2	346.1	461.1	12.4	911.0	1400.1	1224.1	1692.5	993.1	177.2	779.0	1045.4	243.5	514.8	764.5	323.7	43.8	1647.8	615.9	175.3	743.4	1073.6	135.8	466.3	707.3	568.2	362.1	865.5	15.6	919.2	2021.0	685.9	489.8	544.6	443.8	688.8	383.8	254.1	1071.0	127.9	20.3	656.0	679.5	629.2	817.6	98.6	974.9	557.2	610.1	19.7	862.8	339.2	476.8	14.6	21.2	922.5	370.1	649.9	671.6	1051.5	404.2	911.0	357.4	144.1	433.9	617.8	1074.1	855.7	578.6	907.2	1019.1	1538.8	865.1	1019.5	866.2	967.3
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	12.7	19.5	9.9	18.5	10.2	27.2	19.0	7.8	10.4	19.6	9.6	15.5	8.3	17.2	10.1	26.6	15.3	9.8	8.4	9.6	11.6	16.4	12.3	10.2	23.3	8.4	8.5	20.6	30.3	16.4	12.4	16.3	8.6	13.4	19.3	1.1	15.1	8.2	13.3	16.7	10.7	19.9	8.5	14.8	13.1	17.1	11.6	20.3	11.1	10.1	25.9	20.9	16.7	9.3	94.8	117.2	34.2	226.2	76.5	80.0	36.1	50.0	75.7	75.8	64.4	126.5	117.1	154.8	91.0	56.0	41.6	99.2	192.6	211.8	59.3	66.1	199.8	124.5	50.5	206.0	86.1	286.6	87.4	69.6	100.8	105.2	417.0	39.0	100.6	187.1	156.9	83.7	63.3	173.8	121.0	371.8	60.7	131.1	89.1	93.3	179.2	158.0	75.0	45.8	70.0	45.1	31.2	72.5	144.7	41.8	94.4	59.0	40.1	30.0	95.8	44.8	94.1	36.0	39.9	179.7	41.9	263.4	31.8	0.0	2.8	0.0	3.6	4.0	6.5	4.0	5.9	6.9	6.4	4.8	9.5	9.8	0.1	8.1	0.8	8.3	2.6	5.1	9.9	10.2	7.8	10.4	9.6	11.6	8.4	8.5	8.6	8.5	11.6	9.3	5.1	3.2	5.0	1.0	15.3	62.7	79.6	121.4	28.5	1.4	55.5	54.4	2.9	28.6	32.0	36.8	0.0	91.4	15.6	16.3	78.2	54.0	8.9	7.3	22.1	21.6	24.2	17.9	2.7	41.2	90.6	29.7	13.7	10.5	16.5	19.6	15.0	19.0	68.6	0.0	2.0	33.1	46.8	21.1	69.9	10.9	28.0	18.0	30.2	1.9	14.7	2.5	18.6	1.5	1.0	34.2	12.7	23.7	19.1	118.5	3.1	61.6	16.4	2.0	6.6	47.9	21.6	46.5	91.3	21.3	49.9	60.7	18.5	29.0	46.9	62.8
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	873	"heart muscle: 60060.6"	"Cell type enriched"	"Detected in some"	23	"Cardiomyocytes: 62235.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.6;SH-SY5Y: 9.5"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 22.8"	"Low region specificity"	"Detected in all"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		1200000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	8.3	3.0	1.7	0.7	2.1	0.6	18.0	1.8	2.4	1.2	2.3	5.0	0.2	3.3	12.9	2.8	1.3	0.9	60060.6	2.2	1.5	2.6	5.0	58.1	1.2	1.7	1.5	12.1	68.7	0.9	3.9	5.9	1.4	5.1	0.0	0.4	28.5	0.0	8.9	5.8	6.1	0.7	1.3	3.1	3.6	3.9	1.7	0.5	7.1	0.0	0.0	1.2	3.9	2.0	0.5	0.2	0.3	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.6	0.8	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.4	1.0	0.3	1.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.3	0.3	1.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.6	9.6	9.5	0.0	0.0	0.5	0.3	0.3	0.1	0.0	0.4	0.7	0.6	0.1	0.4	0.8	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.1	1.8	2.4	2.2	1.5	1.7	1.5	1.4	1.3	1.7	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62235.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	339.1	0.0	0.0	0.3	0.0	0.0	2684.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	636.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921809-231926396	"Predicted secreted proteins, Transporters"	Osteogenesis	"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 33.5"	"Group enriched"	"Detected in many"	8	"Basal squamous epithelial cells: 190.1;Skeletal myocytes: 264.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 33.5;spinal cord: 30.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;NTERA-2: 3.9;SCLC-21H: 5.5;SK-MEL-30: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"medulla oblongata: 15.5;spinal cord: 12.5"	HPA035362	Uncertain				"Secreted to blood"	NA	NA	6140			"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	0.3	0.1	0.8	2.1	0.9	1.3	0.7	2.8	3.4	1.3	0.0	4.1	0.1	0.6	0.0	3.2	2.6	0.0	5.3	2.0	3.9	0.2	0.0	0.0	1.4	33.5	4.4	1.3	0.1	0.0	2.7	0.2	4.8	4.3	0.2	2.4	1.1	0.4	0.7	0.6	0.9	0.5	30.9	0.4	2.4	0.2	4.6	2.9	0.5	0.1	2.0	0.2	0.4	6.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.0	0.0	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.5	0.3	0.2	0.2	26.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	2.8	3.4	2.0	3.9	33.5	4.4	4.8	30.9	4.6	6.5	2.1	0.0	0.0	0.7	1.3	3.4	27.1	5.9	190.1	1.1	6.5	18.3	1.9	0.0	0.1	11.0	10.4	0.2	0.6	4.2	0.0	1.1	0.3	3.6	1.3	1.6	3.5	0.0	0.0	0.0	0.0	10.9	5.6	4.8	0.0	0.3	0.0	0.0	0.1	0.0	1.5	3.2	0.0	0.0	1.7	0.0	0.3	1.6	1.8	0.0	2.5	15.2	0.0	0.0	1.3	0.8	3.1	0.0	5.8	11.5	0.0	0.0	0.0	4.1	0.0	264.2	2.0	1.2	7.0	13.2	1.1	0.3	1.7	0.0	2.9	3.1
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 107.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8;Granulosa cells: 97.9;Proximal tubular cells: 143.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.3;fHDF/TERT166: 22.8;HeLa: 81.4;HSkMC: 50.0;U-138 MG: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052702	Supported		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA052702: AB_2681922"	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favorable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	21.3	3.4	1.4	0.8	1.2	4.5	3.8	0.9	1.7	8.0	5.6	5.3	0.7	4.1	2.0	5.3	4.7	4.3	27.3	1.3	2.0	107.8	4.8	11.1	0.9	1.5	1.4	1.7	1.3	1.3	0.6	9.5	1.3	6.3	1.1	2.6	1.1	8.9	5.8	5.0	1.4	3.0	1.1	9.6	1.0	1.7	1.3	4.9	13.0	9.5	2.0	1.8	4.5	2.0	0.3	4.3	0.2	0.4	2.4	35.3	0.1	10.0	1.9	0.6	0.6	0.0	0.2	0.0	0.2	22.8	0.7	0.0	4.9	0.1	1.2	0.1	0.0	0.4	81.4	0.0	7.1	0.1	0.2	50.0	0.6	2.6	6.9	2.3	0.3	0.1	0.1	0.6	3.3	0.6	0.0	0.5	0.1	0.0	11.9	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.5	13.3	0.1	0.3	0.2	0.0	0.3	21.5	0.3	1.8	0.3	0.2	0.1	0.0	3.5	0.1	0.3	0.1	0.3	0.2	0.3	0.1	0.2	0.4	0.3	0.2	0.0	0.5	0.4	0.5	3.3	0.4	0.0	0.4	0.1	0.1	1.4	1.2	0.9	1.7	1.3	2.0	1.5	1.4	1.3	1.1	1.3	2.0	3.9	16.0	4.9	1.0	0.8	5.4	0.1	1.6	24.5	11.6	0.2	1.1	27.3	0.0	1.7	9.2	0.0	0.0	0.2	0.1	52.8	0.1	1.4	4.5	8.5	11.9	0.0	13.9	0.4	0.0	0.1	2.6	0.0	16.5	3.8	97.9	15.7	1.6	0.1	3.3	11.4	0.0	0.0	0.3	0.0	3.2	11.1	1.3	0.0	0.0	0.2	1.7	0.0	1.0	0.3	0.0	0.1	12.8	1.4	1.9	0.0	143.4	3.7	1.5	6.6	0.3	6.6	0.1	1.2	23.0	1.3	0.1	1.3	16.5	0.0	0.3
NPRL2	"NPR2, NPR2L, TUSC4"	ENSG00000114388	"NPR2 like, GATOR1 complex subunit"	Q8WTW4	3	50347330-50350826	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038196, HPA038197"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA038196: AB_10675631, HPA038197: AB_10671523"	"unprognostic (7.25e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.06e-2)"	4.9	9.2	9.4	5.0	9.7	5.1	7.4	10.0	11.0	9.0	9.4	8.3	5.3	5.3	11.1	6.8	8.8	6.2	10.3	10.0	11.1	9.3	12.9	5.1	8.0	9.7	10.7	7.8	16.4	12.1	9.0	5.7	10.1	7.7	8.5	5.7	12.1	8.1	14.7	7.5	5.6	6.9	10.0	6.8	7.2	7.8	9.9	9.6	8.3	18.0	9.2	5.8	5.3	10.3	12.2	11.9	7.9	14.5	22.5	11.8	8.2	6.4	16.5	17.1	16.8	9.3	11.0	13.9	9.5	11.9	8.6	6.7	18.1	18.5	12.3	10.0	12.9	16.6	10.0	18.2	20.2	20.7	21.9	14.3	19.3	21.8	15.0	11.5	16.8	20.2	9.5	13.6	14.7	2.4	19.3	14.8	8.7	37.2	33.4	7.1	5.0	34.5	19.7	12.1	6.0	14.1	7.3	11.1	12.5	8.2	17.5	10.4	6.0	7.2	9.2	13.8	11.7	16.8	22.0	11.8	14.6	25.5	7.3	40.6	17.4	46.7	72.7	18.1	63.4	23.2	36.4	62.7	20.6	21.1	30.8	48.5	22.9	64.1	20.8	16.6	49.8	50.7	9.4	9.7	10.0	11.0	10.0	11.1	9.7	10.7	10.1	10.0	9.9	10.3	13.4	9.6	11.9	7.8	19.0	12.0	9.8	26.7	14.8	18.4	18.2	19.9	13.2	15.7	16.3	14.7	20.9	27.4	31.4	15.8	37.2	15.9	94.6	8.1	9.4	11.3	11.9	30.3	7.2	15.0	21.5	12.9	18.3	7.1	19.0	12.6	11.7	14.8	14.7	25.2	7.9	20.9	38.7	13.2	10.3	66.6	19.3	7.4	12.4	2.8	15.0	15.0	68.0	5.0	6.5	12.2	12.8	15.1	19.4	7.7	30.7	30.0	15.6	26.4	6.6	11.1	22.1	16.8	14.9	15.4	12.5	9.0	29.3	16.0	18.8	7.7
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	9.6	10.4	17.5	7.2	18.2	19.1	8.5	16.7	22.2	10.1	15.7	6.5	7.3	10.5	5.2	9.3	12.1	6.3	8.9	17.7	18.0	8.0	10.0	7.8	9.4	17.1	18.1	12.9	10.9	12.7	11.7	6.6	16.9	8.8	4.8	7.1	11.0	7.1	15.5	9.9	5.6	7.2	15.5	8.3	6.8	9.4	18.2	7.0	11.0	10.3	6.6	6.5	8.2	18.2	14.5	29.0	12.6	32.2	33.7	16.9	19.8	17.2	16.8	21.3	16.6	46.6	25.6	26.5	22.5	25.5	13.8	17.0	20.5	29.7	12.3	29.2	16.0	38.8	17.3	34.2	31.1	15.9	25.6	20.7	22.2	28.4	24.9	16.0	20.3	21.1	38.6	24.6	19.1	51.2	17.6	12.3	11.9	10.0	20.8	30.1	10.8	37.9	21.6	12.2	26.9	17.1	22.8	30.1	14.3	6.5	22.2	11.1	19.2	32.9	18.2	20.0	13.3	25.9	14.7	37.7	1.1	19.2	18.3	0.0	2.4	0.3	3.0	2.2	3.2	2.0	2.6	2.5	3.5	2.0	2.5	2.9	0.2	2.0	3.1	2.6	2.9	2.2	17.5	18.2	16.7	22.2	17.7	18.0	17.1	18.1	16.9	15.5	18.2	18.2	10.4	12.8	11.7	30.0	22.2	9.4	17.6	15.7	14.8	58.1	16.6	16.8	9.0	12.8	9.2	11.0	66.7	24.6	20.4	6.8	23.5	16.4	31.0	11.8	18.1	13.0	9.6	134.5	29.7	8.9	35.2	17.3	15.8	9.4	3.8	49.2	15.7	10.2	19.7	55.5	30.8	11.7	10.2	14.2	6.4	73.8	22.7	12.8	12.4	15.9	16.4	29.5	79.3	21.1	40.4	11.4	6.6	19.5	14.0	23.3	8.0	23.9	11.0	57.2	6.6	15.6	14.9	62.2	43.0	16.0	5.5	15.3	18.8	28.2	14.4	10.4
NPS		ENSG00000214285	"Neuropeptide S"	P0C0P6	10	127549309-127553540	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"head and neck cancer: 4.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"midbrain: 5.4;pons and medulla: 5.1"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 4.8;white matter: 2.2"	CAB020139	Uncertain				"Secreted in brain"	NA	NA									"CAB020139: AB_776718"					"unprognostic (2.83e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80466834-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 107.8;intestine: 31.6"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 175.2;Excitatory neurons: 88.6;Late spermatids: 44.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 32.0;HeLa: 26.0;SiHa: 40.7;U-138 MG: 85.2;WM-115: 120.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 55.3;cerebellum: 128.1;cerebral cortex: 102.2;hippocampal formation: 131.3"	HPA077062	Enhanced	Approved			"Secreted in brain"	NA	NA		1100000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA077062: AB_2732329"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	0.4	5.1	95.2	1.0	88.8	0.1	0.4	77.7	94.5	0.2	0.0	31.6	0.7	0.8	2.2	0.8	0.8	1.2	0.0	107.8	0.7	0.2	0.0	1.3	0.9	20.1	1.0	0.6	0.2	0.0	2.4	1.2	1.7	0.7	2.1	13.0	0.0	2.5	2.7	3.2	4.2	0.8	3.5	2.1	3.9	1.2	1.3	11.9	0.1	0.6	0.1	0.6	0.1	81.3	0.0	2.0	0.5	0.2	0.4	0.5	0.0	2.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.2	3.5	0.1	32.0	0.0	0.0	0.0	20.2	0.0	26.0	0.1	0.1	0.0	1.4	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	6.5	0.0	0.0	8.3	0.0	0.0	21.4	0.0	40.7	0.1	0.0	0.3	0.1	0.6	0.3	85.2	0.0	4.2	0.2	0.0	0.0	0.0	0.2	0.0	120.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	95.2	88.8	77.7	94.5	107.8	0.7	20.1	1.0	1.7	3.5	1.3	81.3	1.3	0.0	0.0	8.1	0.3	1.5	0.1	0.0	0.0	12.8	0.7	2.2	3.0	0.0	0.6	0.0	175.2	0.1	0.6	0.3	0.0	0.0	8.2	0.3	0.4	1.2	0.0	0.0	88.6	0.0	0.2	0.9	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	11.0	0.7	0.0	0.0	0.0	44.8	0.9	0.6	0.0	6.5	0.0	0.8	0.0	5.0	5.8	0.6	0.0	2.2	0.1	0.5	0.0	0.0	0.0	4.1	0.0	1.6	1.1	1.6	0.4	0.1	3.0	0.1	0.1	0.5	0.1	0.0
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617285-98629869	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 135.8;pituitary gland: 210.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 93.5;Peritubular cells: 326.1;Sertoli cells: 151.2;Spermatocytes: 85.2;Spermatogonia: 94.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 41.7"	"Region enhanced"	"Detected in all"		"cerebral cortex: 135.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 717.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	NA	NA	2490000	360000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	7.0	39.2	11.2	1.9	13.6	0.5	3.8	10.1	135.8	9.9	2.5	15.3	0.5	5.7	3.5	3.0	2.8	1.1	9.8	39.2	47.3	1.1	2.6	0.9	0.1	13.8	14.5	3.7	21.4	0.6	210.8	0.1	16.2	7.2	0.8	4.7	3.7	1.6	8.9	8.2	5.4	2.5	6.4	13.0	6.7	34.3	45.6	0.5	3.1	6.7	0.3	5.5	6.9	16.8	0.0	0.0	6.5	0.2	0.0	0.5	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	21.1	2.8	1.5	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	717.9	0.0	5.7	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	33.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	13.6	10.1	135.8	39.2	47.3	13.8	14.5	16.2	6.4	45.6	16.8	8.6	0.0	0.6	2.9	0.3	3.8	0.5	0.0	0.0	19.9	0.2	1.4	3.4	5.7	1.3	0.0	4.2	0.0	1.0	4.5	0.0	5.4	12.0	8.5	1.8	16.9	16.0	0.0	22.1	12.8	0.2	11.1	1.5	10.5	0.0	93.5	3.9	0.7	0.5	0.0	5.3	1.2	0.0	0.0	5.4	24.2	14.0	1.3	12.4	5.6	0.0	1.6	0.0	1.0	1.8	2.9	1.1	326.1	1.0	5.2	0.5	0.1	0.0	2.8	151.2	57.2	27.1	85.2	94.8	0.1	3.0	0.1	0.8	12.7	2.3	1.2
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38844028	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 280.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 280.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		420000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.7	5.0	91.6	1.9	75.4	0.3	2.8	0.3	145.7	8.7	0.0	9.5	1.3	10.9	3.8	3.0	7.9	2.0	15.7	280.2	17.0	1.6	1.9	1.9	1.6	4.1	15.2	8.1	5.2	7.0	6.8	0.4	0.7	8.1	1.5	5.3	4.8	7.0	0.6	1.1	3.3	7.6	3.1	2.5	5.0	1.8	58.0	0.7	2.7	2.5	1.5	7.3	4.8	46.0	1.0	6.2	0.2	1.8	12.2	1.2	0.0	4.1	0.9	7.9	2.7	6.2	1.3	0.0	7.2	1.1	23.3	0.8	1.7	0.2	2.6	0.6	2.0	0.0	0.2	9.6	1.2	0.1	0.3	3.9	0.4	7.2	0.1	11.4	0.3	0.1	7.7	0.3	0.3	9.7	0.0	0.5	7.3	3.0	2.2	1.6	0.0	15.3	2.0	17.1	30.8	2.0	23.6	0.1	0.7	1.7	9.9	2.5	0.4	14.1	8.4	0.0	0.7	2.1	0.0	0.0	87.9	18.5	7.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	91.6	75.4	0.3	145.7	280.2	17.0	4.1	15.2	0.7	3.1	58.0	46.0	4.7	0.0	0.0	9.4	0.3	1.1	2.7	0.9	0.0	6.6	3.3	1.5	18.0	4.3	3.0	3.7	2.1	0.0	2.3	0.0	0.0	7.3	1.7	1.7	3.2	4.2	1.8	0.0	41.7	3.8	0.0	1.5	0.5	3.0	0.0	1.5	5.0	0.4	0.2	0.0	50.4	0.2	6.1	0.3	0.9	0.8	1.8	0.3	1.8	1.9	0.0	4.8	6.2	19.1	10.5	2.0	0.0	2.2	0.9	3.8	0.1	0.5	2.2	3.3	0.0	2.4	2.8	0.2	1.3	0.1	1.0	0.0	1.7	0.3	0.0	3.4
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"retina: 220.5"	"Cell type enriched"	"Detected in some"	40	"Muller glia cells: 526.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"hypothalamus: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hypothalamus: 6.1"	"Region enriched"	"Detected in single"	8	"hypothalamus: 3.0"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 5: Muller glia cells - Visual perception"			"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	526.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 10.6"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 188.1;Enteroendocrine cells: 158.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"NB-4: 43.5;PC-3: 35.6;RPMI-8226: 74.7;SCLC-21H: 118.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	HPA064874	Approved				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.4	0.1	1.0	0.4	0.7	1.2	0.1	0.6	3.6	1.1	1.1	0.5	0.6	1.1	1.3	0.4	0.6	0.0	0.1	0.7	1.9	0.4	10.6	0.1	0.2	0.7	0.9	0.4	0.4	0.0	2.7	0.1	0.7	0.3	0.1	0.0	0.1	0.2	0.0	1.7	0.2	0.2	0.5	0.7	2.4	1.2	2.5	0.0	0.2	0.0	0.4	0.2	0.6	1.0	0.4	1.7	0.2	2.5	0.4	0.0	0.7	0.9	0.2	0.5	1.0	3.8	1.5	0.4	0.1	0.8	0.6	0.8	1.1	0.3	0.5	1.8	2.9	0.1	3.0	1.7	2.3	0.4	0.1	1.0	1.3	0.9	1.9	0.1	0.0	2.5	10.8	1.7	0.1	0.9	0.4	43.5	1.9	1.5	35.6	10.5	0.0	74.7	0.4	0.0	118.8	9.9	1.3	2.2	0.3	0.6	5.6	4.4	1.7	0.3	0.6	0.5	0.1	3.6	1.1	1.1	0.6	0.9	0.4	1.2	0.7	0.7	0.2	0.4	0.6	0.4	0.1	0.0	0.7	0.4	0.2	0.1	1.5	0.6	0.2	0.4	0.4	0.2	1.0	0.7	0.6	3.6	0.7	1.9	0.7	0.9	0.7	0.5	2.5	1.0	2.5	0.0	0.0	0.0	2.9	2.0	3.2	1.9	4.0	1.5	2.7	7.1	0.3	0.0	2.0	0.0	0.0	1.2	0.1	6.0	0.0	0.5	0.9	9.9	188.1	4.4	158.5	12.2	0.4	0.2	0.9	14.0	15.8	8.5	8.9	0.5	0.7	35.9	2.3	0.0	0.7	35.8	0.0	0.3	0.3	2.1	2.1	1.6	3.6	0.0	0.1	0.0	0.0	0.0	0.1	2.1	12.4	2.2	1.5	11.9	3.2	0.8	0.3	0.3	0.0	0.5	2.7	8.8	35.4	4.1	2.3	1.6	2.3	1.6	3.9	4.6
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284188-24291862	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Neuropeptide	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 122.6;brain: 423.9;prostate: 332.8"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Region enriched"	"Detected in all"	7	"hypothalamus: 423.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"SH-SY5Y: 700.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000	21000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.8	122.6	32.8	12.8	59.0	5.6	2.2	11.0	39.1	1.3	11.3	2.9	9.7	0.3	0.3	2.3	0.5	1.1	0.8	31.7	423.9	0.5	0.2	0.3	0.0	24.2	25.1	0.5	8.8	0.1	4.7	0.0	15.2	332.8	1.9	4.4	0.3	3.9	0.2	0.2	13.1	1.2	18.8	0.0	8.8	1.1	29.2	0.2	0.9	0.2	0.0	1.4	23.8	33.1	0.0	0.0	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	2.0	0.0	0.2	20.5	0.0	0.6	0.0	0.0	0.8	700.2	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	59.0	11.0	39.1	31.7	423.9	24.2	25.1	15.2	18.8	29.2	33.1	0.0	0.0	0.0	2.0	0.5	0.1	1.3	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	56.7	0.0	0.0	0.0	0.0	16.1	0.3	0.7	1.8	1.0	0.0	0.8	0.0	2.0	1.9	0.3	0.0	0.4	0.0	100.6	0.0	0.0	0.0	0.7	0.0	15.6	0.3	2.4	2.8	0.0	0.0	5.1	0.3	0.0	0.0	2.0
NPY4R	"PP1, PPYR1, Y4"	ENSG00000204174	"Neuropeptide Y receptor Y4"	P50391	10	46461099-46465958	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3;intestine: 6.0;skin 1: 3.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Region enhanced"	"Detected in single"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"A549: 28.6"									HPA027863	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"				"HPA027863: AB_10602819"		"unprognostic (2.26e-6)"	"unprognostic (2.94e-1)"			"unprognostic (8.17e-2)"		"unprognostic (1.20e-1)"		"unprognostic (1.30e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-3)"	"unprognostic (6.58e-2)"			"unprognostic (9.79e-2)"	0.5	0.0	0.3	0.7	0.1	0.0	0.2	0.6	0.2	0.1	0.0	4.9	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.7	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.6	1.3	6.0	0.0	0.0	0.0	0.0	3.0	1.2	1.0	0.3	0.0	1.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	28.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	5.9	0.0	0.4	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.2	0.2	0.4	0.5	0.5	0.6	0.3	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPY4R2	CH17-360D5.1	ENSG00000264717	"Neuropeptide Y receptor Y4-2"	P0DQD5	10	47918739-47923524	"Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"A549: 10.2"									HPA027863	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"				"HPA027863: AB_10602819"		"unprognostic (1.74e-2)"	"unprognostic (1.24e-2)"			"unprognostic (1.59e-1)"		"unprognostic (7.78e-2)"			"unprognostic (6.72e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.46e-2)"			"unprognostic (3.25e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.1	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	10.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
NR1D1	"ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092793-40100589	"Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 325.5"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.5"	"Group enriched"	"Detected in many"	6	"monocytes: 5.5;T-cells: 18.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	72.3	53.7	23.5	6.3	27.0	5.4	63.1	52.9	49.7	109.6	10.6	53.3	14.3	35.8	4.5	42.5	27.7	7.1	60.8	24.9	17.2	38.0	43.2	49.2	9.3	18.1	20.9	71.3	24.3	9.0	32.0	6.0	15.9	40.5	4.0	50.4	52.9	16.3	99.0	325.5	23.0	7.5	12.9	11.6	31.5	12.5	34.0	6.3	32.1	38.1	5.4	42.5	96.5	25.2	5.5	7.8	1.6	6.2	9.0	6.2	2.2	11.9	19.5	3.9	4.9	5.1	19.5	6.7	6.9	13.8	12.9	15.4	4.1	18.0	2.9	5.6	4.1	4.8	7.9	13.5	14.6	7.2	6.9	13.5	12.8	13.3	28.2	12.6	4.9	7.7	7.2	60.6	3.8	3.8	10.7	6.1	3.0	10.8	12.3	7.5	2.2	20.7	5.4	4.9	5.1	2.9	7.6	9.7	12.4	2.7	4.6	5.8	4.7	17.2	16.7	14.1	9.5	21.5	35.7	2.6	23.4	4.0	13.6	0.0	0.5	0.0	4.4	2.0	18.5	1.7	5.5	6.4	1.1	2.1	4.8	3.5	0.2	1.0	5.5	1.4	8.0	1.8	23.5	27.0	52.9	49.7	24.9	17.2	18.1	20.9	15.9	12.9	34.0	25.2	16.4	3.2	2.0	17.3	5.7	64.5	47.5	20.5	67.2	71.4	9.4	15.1	5.7	8.6	11.9	1.8	4.2	2.6	4.9	26.0	7.9	16.1	2.3	25.4	30.6	18.6	8.3	3.6	7.1	11.8	1.2	26.5	31.1	64.2	2.5	2.7	6.8	31.8	2.5	42.1	6.2	7.2	8.2	3.4	19.4	1.5	21.8	7.7	19.6	8.4	1.2	39.0	5.2	5.0	1.2	26.0	14.7	38.7	10.5	35.4	58.8	7.9	5.0	29.7	6.6	9.6	19.4	2.0	11.1	95.5	81.1	2.3	11.9	13.7	6.0	28.7
NR1D2	"BD73, EAR-1r, Hs.37288, HZF2, REVERBB, REVERBbeta, RVR"	ENSG00000174738	"Nuclear receptor subfamily 1 group D member 2"	Q14995	3	23945286-23980617	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053868, HPA054798"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA053868: AB_2682284, HPA054798: AB_2616453"	"unprognostic (8.64e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.47e-7)"	"unprognostic (2.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	15.4	16.0	14.1	10.9	13.7	15.3	20.9	26.8	21.5	13.7	8.7	13.7	13.6	24.9	13.8	15.8	16.8	14.5	31.7	14.2	14.8	21.8	29.5	14.1	14.7	13.1	15.2	31.2	17.0	52.8	11.9	8.7	13.7	17.5	11.3	34.4	32.4	24.7	54.5	14.0	13.9	13.3	13.7	18.7	14.8	7.4	17.3	12.2	54.2	50.4	14.2	10.6	12.4	18.8	22.5	5.0	11.5	10.9	11.8	12.6	7.1	32.7	42.7	17.8	19.7	3.7	21.6	16.0	10.7	46.0	27.8	14.7	14.6	21.4	36.9	5.8	16.9	2.6	11.3	4.5	24.6	8.6	2.3	16.9	22.1	21.7	55.4	32.9	12.3	9.3	5.8	56.3	14.2	12.9	4.7	2.7	12.5	18.2	24.8	4.1	18.6	11.1	9.9	30.6	11.8	26.2	23.9	13.6	29.2	18.5	11.9	7.4	24.5	46.2	47.0	30.2	37.6	27.4	39.4	7.4	26.3	12.6	27.5	0.0	0.3	0.0	1.4	1.1	2.6	1.0	1.6	1.3	0.4	0.7	1.1	1.1	0.1	0.5	0.6	0.4	1.0	0.4	14.1	13.7	26.8	21.5	14.2	14.8	13.1	15.2	13.7	13.7	17.3	18.8	51.8	12.8	7.5	51.6	39.6	33.3	34.7	14.5	59.2	82.5	29.7	23.9	39.5	17.2	17.5	20.2	39.6	11.1	43.0	17.1	7.9	11.3	10.0	77.5	49.8	38.9	28.5	3.8	58.6	15.1	2.5	47.7	35.7	135.2	8.2	33.2	15.4	33.1	9.6	95.9	62.0	18.2	26.4	12.8	32.0	11.3	34.2	26.8	28.4	32.8	12.6	62.8	11.3	44.2	57.5	19.8	10.3	42.5	28.5	41.4	17.9	11.9	16.0	53.6	32.9	46.8	45.5	7.6	10.9	42.0	33.5	6.8	44.4	37.0	12.1	31.1
NR1H2	"LXR-b, LXRb, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50383388	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	59.6	61.4	43.2	37.1	45.6	143.4	57.9	43.1	53.3	61.1	41.3	78.7	43.1	67.3	10.8	56.0	63.6	28.4	89.6	40.7	45.0	63.9	61.0	66.4	33.9	55.8	47.3	56.9	49.8	32.1	40.6	26.3	48.5	63.7	11.9	9.4	46.9	37.9	132.1	60.7	55.1	20.3	44.4	56.7	60.2	31.8	48.4	21.4	56.5	36.7	16.7	77.1	58.3	47.8	56.2	124.1	12.1	32.4	34.5	36.4	42.0	75.8	53.4	38.4	41.7	25.8	48.9	34.8	67.1	39.4	31.7	46.8	7.8	34.1	9.5	89.9	57.6	32.5	41.8	26.4	63.7	58.2	84.0	34.8	45.2	39.3	27.3	37.7	33.4	24.7	51.7	65.4	20.8	53.2	39.3	40.5	25.5	32.2	94.4	22.8	35.8	57.2	30.4	54.3	14.9	50.6	50.9	54.0	46.7	6.6	37.9	42.5	53.9	54.3	45.3	58.4	66.8	82.5	79.3	26.4	108.6	36.5	53.8	159.1	123.9	232.4	90.4	125.4	89.3	112.3	89.9	86.2	121.3	117.7	90.8	81.4	194.8	85.9	146.4	103.9	89.0	129.3	43.2	45.6	43.1	53.3	40.7	45.0	55.8	47.3	48.5	44.4	48.4	47.8	50.7	28.9	30.7	3.6	70.7	43.0	89.3	53.2	32.5	37.9	33.4	27.3	29.6	37.1	31.1	31.3	14.6	64.5	57.0	82.1	64.6	63.6	15.5	31.9	19.5	50.0	20.8	58.9	5.9	72.6	53.3	40.2	37.2	33.8	50.2	25.1	36.8	20.7	51.3	37.0	5.5	45.5	46.8	37.0	48.3	9.5	45.4	54.5	60.5	4.7	65.2	46.8	65.9	0.5	6.9	74.3	89.6	53.4	47.5	91.0	93.5	61.8	21.7	25.4	39.5	45.5	50.2	34.6	25.9	27.9	45.7	140.0	54.8	27.7	35.7	109.0
NR1H3	"LXR-a, LXRa, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269033	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 13.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 45.3;HSkMC: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	60.7	19.9	11.3	19.4	11.8	3.3	51.1	11.2	14.3	25.3	10.2	24.6	48.4	13.6	17.6	7.6	20.3	19.6	18.5	10.3	11.1	23.4	83.8	24.1	46.7	11.0	12.1	15.2	16.7	6.8	7.2	25.4	11.7	19.4	12.0	2.2	14.8	11.5	9.1	11.7	41.0	7.9	10.5	53.2	16.3	21.8	13.8	11.0	20.3	6.3	13.6	22.4	17.5	11.5	3.5	13.8	6.4	6.1	41.0	45.3	31.1	3.5	17.9	5.7	8.8	17.0	43.2	6.1	6.5	2.8	2.1	9.2	7.6	6.1	3.8	5.8	6.1	8.3	18.7	26.1	17.5	2.9	1.0	61.2	3.7	8.7	5.5	9.7	5.0	9.4	10.2	2.5	4.5	14.8	5.8	17.0	7.1	18.7	4.5	8.4	8.3	4.1	5.0	31.9	6.1	2.3	12.2	7.9	10.4	6.1	19.5	8.8	1.3	4.5	6.1	9.1	2.0	11.9	18.3	7.6	8.2	3.9	2.2	7.8	2.7	2.5	1.4	13.3	1.9	1.0	1.5	1.3	4.3	0.7	1.7	1.4	1.6	5.8	4.2	0.7	3.8	1.9	11.3	11.8	11.2	14.3	10.3	11.1	11.0	12.1	11.7	10.5	13.8	11.5	27.2	0.0	11.3	8.1	3.0	3.3	8.6	4.6	2.2	2.4	12.7	12.1	6.6	15.7	4.9	5.5	2.1	11.0	1.5	24.4	11.7	5.8	31.0	2.4	15.3	12.5	1.8	7.0	9.2	8.7	13.3	14.1	17.9	2.8	13.3	7.1	24.7	66.6	54.4	1.7	10.9	14.6	2.0	100.9	3.3	49.0	9.0	24.7	3.6	1.0	5.4	4.4	2.1	3.0	5.6	4.2	10.7	6.0	2.4	4.1	69.5	26.1	2.5	0.8	19.7	7.4	16.3	32.4	16.8	3.0	2.4	6.6	2.1	5.4	19.0	6.3
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	14.1	12.4	11.4	18.0	12.0	19.1	13.6	21.6	13.3	15.7	2.5	16.9	18.4	17.1	9.8	12.4	15.3	11.3	15.7	12.4	9.0	13.9	13.0	16.8	18.0	7.6	6.1	18.6	14.2	14.2	19.2	9.7	4.6	13.7	11.7	36.2	13.5	11.5	20.1	19.5	18.8	12.8	4.7	19.9	14.8	20.7	8.7	22.4	24.3	17.9	15.7	14.4	13.7	13.5	18.3	20.2	22.8	17.7	15.8	18.8	52.0	25.8	20.7	20.5	21.0	13.0	17.4	28.0	13.2	23.3	17.9	17.9	21.2	13.3	21.2	37.1	30.0	36.8	45.8	12.0	13.4	27.3	27.3	15.0	17.2	25.9	13.4	17.1	23.5	27.2	26.6	18.7	18.3	16.2	41.9	21.3	15.1	8.6	20.7	33.4	27.1	18.8	9.9	27.1	14.5	36.1	23.5	19.4	23.2	17.9	19.5	26.7	30.5	31.6	37.2	29.1	35.6	28.4	40.0	30.4	22.7	25.6	28.2	2.7	0.9	0.7	1.6	1.2	1.5	0.8	0.9	1.0	0.9	1.8	1.2	1.1	1.2	1.0	1.1	1.5	0.9	0.6	11.4	12.0	21.6	13.3	12.4	9.0	7.6	6.1	4.6	4.7	8.7	13.5	14.0	22.4	12.2	35.9	15.7	3.7	11.1	1.0	17.1	17.4	15.1	9.7	6.2	11.5	4.7	7.3	14.6	7.8	15.2	16.5	5.9	6.6	58.8	8.0	10.3	13.4	25.1	20.4	35.5	7.2	7.3	11.5	14.3	9.1	9.5	17.2	18.9	8.2	7.8	13.5	39.9	10.2	0.0	20.1	2.3	65.4	19.3	14.2	5.4	52.5	13.6	13.9	9.2	50.8	92.2	12.3	12.4	20.7	14.2	19.6	13.0	6.8	13.7	17.2	0.0	18.8	10.3	33.9	22.2	13.3	3.1	14.9	15.3	17.0	10.4	18.4
NR2C2AP	TRA16	ENSG00000184162	"Nuclear receptor 2C2 associated protein"	Q86WQ0	19	19201409-19203414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042054, HPA055653"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA042054: AB_10965022, HPA055653: AB_2682877"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.81e-2)"	"unprognostic (6.26e-3)"	"prognostic unfavorable (5.63e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.65e-3)"	"unprognostic (5.89e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (2.10e-2)"	14.5	10.0	13.8	12.5	14.2	7.6	15.6	14.3	14.2	14.6	12.6	15.0	8.2	14.8	13.7	17.0	14.9	6.7	10.7	14.2	13.8	16.2	10.6	9.5	13.6	14.4	14.1	16.4	15.3	7.8	8.2	7.6	14.4	14.8	11.0	3.5	13.3	10.6	12.6	21.0	12.4	11.4	14.5	13.4	13.4	5.5	14.1	10.2	11.1	7.8	13.6	17.8	14.6	15.6	50.7	29.2	13.6	28.9	11.1	11.1	52.7	28.3	16.0	37.9	35.8	19.7	60.4	27.3	77.2	15.0	26.5	44.2	36.0	37.3	23.1	24.3	39.0	15.6	18.0	21.9	12.9	30.5	23.2	11.3	45.1	26.3	35.4	10.7	15.2	31.0	28.4	35.0	22.8	130.0	51.2	27.6	24.4	72.9	58.8	36.3	22.0	53.3	23.5	26.4	45.2	20.7	24.3	47.1	37.0	16.5	25.6	18.9	12.2	24.5	23.3	61.7	54.7	20.7	32.4	36.3	28.5	51.3	33.2	2.6	14.9	1.5	31.4	21.5	41.2	43.6	40.7	30.4	12.6	42.8	42.3	39.7	2.7	27.4	17.4	24.7	37.7	26.3	13.8	14.2	14.3	14.2	14.2	13.8	14.4	14.1	14.4	14.5	14.1	15.6	14.7	0.0	9.4	2.3	19.2	31.7	41.3	19.8	38.1	3.8	26.8	31.8	2.5	5.7	12.3	7.3	0.0	24.8	17.2	10.3	7.9	20.8	0.7	8.9	7.8	13.5	4.8	8.8	2.9	16.2	34.3	12.1	6.6	11.4	14.0	14.0	5.3	4.5	18.5	8.4	1.7	12.8	10.2	5.0	11.0	1.2	16.4	9.3	10.6	1.0	15.2	5.5	11.3	2.0	2.4	19.0	5.4	13.5	8.0	67.8	7.6	10.9	9.2	3.9	0.0	11.7	10.9	4.6	16.7	26.3	25.1	12.6	16.3	8.7	17.9	36.0
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166022-108188805	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"brain: 19.7;choroid plexus: 14.3;retina: 30.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.0	0.3	16.9	0.0	19.7	0.0	0.0	7.3	18.6	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	14.3	0.1	0.0	0.0	0.0	7.4	13.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	30.6	0.1	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.7	7.3	18.6	16.6	14.3	7.4	13.0	7.8	7.2	16.4	12.9	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.6	4.5	4.5	3.7	5.6	1.0	4.8	9.2	11.7	5.6	4.0	21.8	8.7	6.2	3.8	3.1	5.9	5.8	9.4	13.7	3.5	12.1	8.5	7.3	3.1	3.0	5.9	14.7	7.6	12.5	5.5	1.8	3.0	3.7	26.2	8.5	10.7	4.3	12.1	3.0	15.3	4.9	3.2	5.2	8.3	4.3	6.1	2.9	19.7	14.1	2.1	5.9	3.3	4.8	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.6	1.0	0.2	0.0	1.3	0.7	0.1	0.2	2.3	0.2	0.6	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	9.7	6.0	0.9	0.0	6.9	2.0	0.0	0.0	0.0	0.1	1.2	6.1	0.5	0.0	0.1	7.8	0.1	0.1	0.0	0.0	1.4	0.6	0.1	0.7	0.0	8.7	4.3	2.5	0.1	0.8	0.0	0.0	0.1	1.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.8	0.1	0.7	0.4	0.0	0.2	1.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	4.5	5.6	9.2	11.7	13.7	3.5	3.0	5.9	3.0	3.2	6.1	4.8	11.9	28.9	13.9	265.8	5.1	2.0	2.2	0.4	6.2	10.3	6.2	5.8	20.3	7.2	6.7	11.0	18.8	0.9	1.0	76.1	9.8	3.0	68.2	2.1	1.1	8.2	18.0	0.0	275.7	5.8	0.5	5.9	13.7	2.6	5.7	6.4	8.6	7.0	0.6	13.5	269.9	44.6	6.1	2.9	2.4	41.8	4.4	1.7	7.2	176.1	1.2	8.1	1.0	230.2	95.7	3.2	26.8	3.8	0.8	1.8	26.4	2.3	4.7	9.6	0.0	14.7	5.1	1.8	5.6	2.6	1.7	0.1	4.9	1.8	21.5	2.1
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 879.9;Basal squamous epithelial cells: 729.1;Glandular and luminal cells: 739.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 36.7;non-classical monocyte: 54.2"	"Lineage enriched"	"Detected in many"	15	"monocytes: 54.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 78.4;MCF7: 86.9;SK-BR-3: 80.5;SK-MEL-30: 150.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: AB_2732149"	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	709.0	562.0	21.7	96.9	19.6	34.5	227.6	141.0	79.9	151.6	44.4	227.1	29.7	124.6	7.2	133.6	495.8	377.4	671.5	21.5	28.5	203.5	95.5	290.9	45.9	21.8	17.4	876.0	88.4	86.9	442.4	41.9	21.0	303.2	71.4	28.3	146.5	85.9	294.1	225.7	111.9	144.2	13.0	36.0	264.6	32.4	21.5	59.1	301.7	71.9	3.8	296.5	186.0	22.6	5.7	28.2	5.6	10.2	4.0	1.3	21.3	5.4	10.8	4.3	6.0	28.2	5.4	5.9	2.3	9.7	4.2	3.2	16.9	2.6	2.5	0.3	6.0	8.1	78.4	8.3	4.1	3.1	26.5	0.8	3.3	4.2	0.3	2.9	1.3	6.6	7.9	1.4	0.3	86.9	2.2	8.5	15.3	9.2	3.1	2.7	0.9	14.6	0.2	2.2	4.6	14.0	17.4	80.5	150.9	3.8	5.1	9.1	0.0	4.2	13.3	2.8	4.7	46.8	25.2	13.0	2.8	2.3	23.7	0.3	1.3	0.0	0.2	36.7	0.3	0.9	0.1	0.1	3.7	0.8	0.5	0.1	0.4	0.2	54.2	0.3	0.2	2.0	21.7	19.6	141.0	79.9	21.5	28.5	21.8	17.4	21.0	13.0	21.5	22.6	328.9	240.4	879.9	4.2	259.5	445.7	289.5	211.3	729.1	34.8	353.8	384.9	9.8	65.8	178.4	86.5	125.1	64.5	102.1	195.7	5.9	19.9	19.7	346.9	183.5	209.6	345.3	16.0	17.4	12.3	34.7	378.8	380.7	739.1	674.8	45.3	227.0	10.1	54.1	16.8	5.9	492.5	105.8	64.4	527.4	7.3	30.4	283.0	371.8	8.4	6.3	85.4	0.0	6.6	1.3	5.1	277.2	23.7	244.1	160.6	74.6	0.9	92.6	94.6	124.9	268.0	379.3	2.5	13.4	200.2	472.8	110.5	135.1	85.1	259.0	86.8
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324437-156342348	"Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 129.3;bone marrow: 130.8;ovary: 129.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	40.0	129.3	4.3	24.5	44.1	130.8	15.6	36.2	8.8	18.3	5.9	9.5	2.9	15.0	1.7	11.4	28.2	32.7	36.6	15.1	3.6	19.2	20.2	18.8	6.3	3.2	9.2	129.2	9.2	8.8	54.0	5.2	2.8	25.6	18.7	5.3	19.2	15.5	11.6	12.8	7.8	14.5	0.9	4.6	19.9	5.6	2.5	9.7	15.2	7.8	1.4	50.9	14.0	6.4	0.9	1.3	0.5	1.8	3.2	0.7	0.9	1.1	5.5	0.4	1.3	0.0	3.3	0.0	1.2	0.4	0.4	1.6	2.6	0.7	0.4	1.3	1.4	1.0	16.0	0.0	0.6	0.7	10.9	0.6	1.2	0.4	0.4	2.1	0.3	0.0	1.6	1.0	1.1	1.9	0.0	0.8	2.1	1.5	0.8	0.2	0.7	3.3	0.6	0.8	2.7	0.1	2.6	4.1	8.1	0.3	0.2	1.0	0.7	2.9	0.8	0.7	0.4	14.2	1.8	0.0	5.3	1.0	7.0	1.9	1.7	2.4	1.0	0.3	0.5	0.4	0.3	0.5	1.9	0.3	0.5	0.2	6.5	0.0	0.7	0.0	0.4	0.5	4.3	44.1	36.2	8.8	15.1	3.6	3.2	9.2	2.8	0.9	2.5	6.4	70.7	25.6	124.7	7.8	511.7	218.6	25.8	87.5	298.7	11.8	120.8	160.1	11.9	17.2	58.3	71.7	50.1	4.7	410.4	35.0	0.0	13.1	36.7	209.6	33.9	111.9	206.4	12.0	5.8	9.1	6.5	164.9	103.9	349.7	349.3	4.3	45.0	6.8	125.1	0.0	0.8	95.4	42.7	161.1	782.3	37.2	4.1	577.5	241.9	5.6	7.9	1.6	3.1	4.0	2.3	11.7	41.9	0.7	203.5	49.1	25.9	0.4	54.6	33.4	13.1	63.0	169.8	1.8	3.3	230.2	213.7	9.9	465.1	34.4	57.5	29.5
NR4A3	"CHN, CSMF, MINOR, NOR1"	ENSG00000119508	"Nuclear receptor subfamily 4 group A member 3"	Q92570	9	99821855-99866891	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 305.7;Langerhans cells: 417.5;Macrophages: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BJ hTERT+: 24.1;HeLa: 8.0;SK-MEL-30: 18.5;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043360	Uncertain					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"			"HPA043360: AB_10961186"	"prognostic favorable (5.97e-4)"	"unprognostic (6.92e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.69e-1)"	43.2	61.2	3.4	14.9	6.3	32.7	7.4	14.1	5.5	11.4	4.2	9.8	0.7	15.7	0.7	4.0	24.8	23.5	67.2	10.2	7.4	7.8	9.0	19.6	1.3	6.3	3.9	46.8	5.2	3.0	21.2	6.5	5.9	15.6	4.0	8.7	2.4	3.3	62.8	2.4	5.8	13.4	1.1	3.5	13.7	1.0	2.9	6.5	7.2	6.2	0.9	32.8	5.1	2.3	0.1	0.1	0.7	0.1	1.3	0.4	1.1	1.5	24.1	0.2	0.2	0.2	0.1	0.2	0.3	0.7	0.5	0.1	0.5	0.0	0.1	1.8	0.3	0.1	8.0	0.0	0.2	0.1	2.3	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.7	0.0	0.2	0.0	0.2	0.6	0.0	1.1	0.0	0.0	0.1	0.4	0.4	2.7	2.0	18.5	0.2	0.0	0.0	0.1	1.4	0.4	1.8	0.1	9.2	0.1	0.0	0.9	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	6.3	14.1	5.5	10.2	7.4	6.3	3.9	5.9	1.1	2.9	2.3	9.6	12.8	19.7	3.9	101.5	79.5	14.0	3.5	97.9	0.9	44.2	58.5	305.7	4.3	10.0	16.5	10.4	2.3	91.3	2.0	0.0	0.1	1.4	93.1	12.8	16.2	27.3	0.4	13.1	1.7	2.2	60.3	32.6	124.3	120.7	1.2	7.5	0.5	10.5	0.0	6.2	3.8	2.0	12.3	417.5	2.4	1.5	172.8	88.9	2.8	43.0	3.6	1.0	1.5	0.9	0.2	2.3	1.2	37.9	4.7	0.6	0.1	11.4	1.7	0.0	35.7	75.0	1.1	1.6	15.9	59.5	5.6	69.6	1.0	1.7	3.4
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 17.8;liver: 38.6;pancreas: 61.1"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.5	2.6	0.2	0.9	3.7	0.5	0.3	3.4	0.2	11.9	17.4	3.3	1.4	0.9	2.2	8.0	1.0	0.3	2.8	0.7	38.6	2.7	2.1	0.7	0.6	1.0	61.1	0.4	0.1	0.4	0.8	1.6	13.1	0.2	0.5	0.8	1.1	1.1	17.8	4.3	0.4	0.2	1.3	0.8	0.8	0.5	0.9	0.7	1.4	1.8	1.2	0.7	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.5	0.2	0.5	0.3	0.3	2.8	0.7	0.6	0.8	0.4	0.8	0.7	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 2363.9;tongue: 1144.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	24.8	0.0	0.2	428.6	0.2	0.0	0.1	0.5	0.4	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	20.4	1.0	0.0	22.1	0.0	2363.9	0.8	0.1	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.4	1144.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137299631-137302271	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	8.9	1.7	7.8	7.6	7.9	1.5	6.9	8.8	7.8	6.5	4.2	47.9	22.0	4.4	1.2	22.6	3.6	12.0	12.5	7.3	10.8	6.1	2.7	7.1	1.6	11.5	12.6	2.0	16.8	2.7	7.6	10.3	10.5	9.5	30.5	1.5	3.0	2.1	2.9	26.3	17.8	3.4	9.8	4.2	8.7	10.2	14.8	2.7	4.9	6.5	4.1	10.4	13.5	6.6	4.8	1.0	8.0	8.8	0.0	0.0	2.6	0.1	0.2	0.0	0.1	6.8	3.0	0.0	10.2	0.0	0.4	45.1	13.9	0.4	0.1	0.3	20.6	1.4	2.1	7.6	0.8	2.8	4.3	0.0	2.3	0.0	0.6	0.2	11.8	0.1	11.8	0.3	0.0	23.3	0.2	6.4	31.9	30.8	6.7	8.4	1.5	17.7	1.2	0.6	4.9	8.1	1.4	2.4	0.1	1.7	23.1	5.8	31.9	0.0	0.1	0.1	1.9	0.3	0.2	3.0	0.1	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.9	8.8	7.8	7.3	10.8	11.5	12.6	10.5	9.8	14.8	6.6	75.3	0.0	0.0	33.3	17.6	97.0	5.9	20.1	15.9	0.6	24.4	39.2	4.4	5.7	14.3	0.0	0.0	0.1	9.7	22.4	0.0	0.5	17.3	35.2	4.4	21.9	10.2	0.0	2.5	1.1	0.0	2.1	19.4	43.0	0.0	0.3	8.9	0.1	0.4	0.0	0.4	20.5	8.2	0.6	97.9	5.2	0.0	18.6	17.8	9.4	0.0	6.8	0.0	2.0	0.6	0.6	28.3	0.4	3.9	6.2	5.0	0.1	3.2	2.8	6.6	4.0	32.1	0.1	0.6	101.8	381.0	0.0	6.7	3.7	23.4	6.0
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716771	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	19.0	9.1	10.3	25.7	11.2	58.5	18.0	11.5	12.3	12.5	8.6	27.8	21.5	12.4	7.8	20.7	10.3	17.2	8.3	10.2	12.2	20.9	24.9	18.5	30.4	12.3	12.1	9.6	11.4	9.0	4.3	28.3	12.3	11.4	26.6	6.6	10.9	7.1	7.7	19.8	22.5	14.1	11.7	18.6	21.8	9.6	11.4	39.0	16.1	7.8	29.7	22.2	8.6	13.4	93.7	24.9	65.2	24.9	26.4	56.3	46.5	43.5	48.4	79.5	89.0	50.4	33.9	70.4	56.3	58.9	55.4	26.0	88.2	70.6	113.4	96.5	34.2	47.8	34.5	60.2	52.3	120.0	71.0	51.1	56.1	91.5	66.2	25.0	102.8	54.6	77.3	78.5	71.0	248.9	83.5	46.4	111.0	30.2	17.9	62.9	116.0	44.1	70.6	49.5	39.4	59.0	44.7	36.4	107.1	75.4	31.9	96.2	79.2	43.3	82.2	81.5	90.3	137.7	101.6	81.6	86.4	64.6	159.0	38.7	12.8	12.6	11.7	19.2	10.5	12.8	9.3	11.6	12.6	10.5	9.9	12.9	3.4	15.5	17.6	9.6	13.4	13.1	10.3	11.2	11.5	12.3	10.2	12.2	12.3	12.1	12.3	11.7	11.4	13.4	22.7	16.0	16.5	8.1	25.9	30.7	31.2	23.1	15.4	5.2	18.5	13.6	5.6	18.6	19.3	22.0	8.4	22.4	27.7	49.2	13.7	34.1	3.9	22.9	24.7	29.2	24.6	31.6	5.8	31.5	50.4	16.1	29.0	38.0	31.1	22.2	33.2	29.7	49.2	5.0	5.2	28.1	30.5	44.9	30.7	5.9	8.1	30.4	23.2	9.4	41.6	7.8	22.6	5.0	8.1	51.4	32.9	6.4	39.6	30.6	28.1	39.4	23.1	3.3	6.6	12.8	15.3	7.3	15.4	24.6	36.2	31.2	21.9	13.8	28.8	40.2
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 687.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 687.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	18.8	12.6	8.7	20.9	9.2	33.8	17.8	10.5	12.1	15.0	8.6	16.6	16.8	13.1	11.1	14.9	9.5	17.2	12.6	9.5	10.2	14.1	45.1	16.4	21.2	11.0	13.0	11.4	10.4	10.8	9.7	22.0	13.1	10.3	16.7	7.2	14.5	8.6	24.7	15.3	15.7	14.2	10.3	22.6	13.4	11.9	10.5	22.5	18.5	26.3	20.2	19.8	10.7	10.7	23.9	20.8	20.7	19.3	48.5	74.5	20.7	33.2	56.4	26.0	36.7	44.5	24.9	30.8	15.8	37.6	26.1	18.3	20.3	28.0	35.7	27.7	19.6	22.9	10.3	36.0	61.4	30.6	25.5	69.1	59.0	42.5	103.4	48.8	27.1	19.7	23.4	34.8	33.6	17.4	25.9	54.1	24.3	19.4	84.8	25.0	18.8	18.2	30.2	13.4	11.9	20.3	19.9	38.4	61.7	33.8	23.8	30.0	28.2	18.1	26.7	28.3	36.2	43.5	35.6	37.2	50.6	48.2	14.8	124.6	79.5	162.1	28.8	92.3	30.4	47.9	29.4	32.2	68.7	42.5	35.9	33.1	687.6	32.6	93.4	34.1	36.6	55.2	8.7	9.2	10.5	12.1	9.5	10.2	11.0	13.0	13.1	10.3	10.5	10.7	29.7	3.2	30.6	3.9	45.7	28.8	41.8	42.8	20.5	12.2	30.1	40.0	8.9	14.3	30.6	12.9	4.2	53.1	44.0	31.5	23.5	31.6	10.3	30.6	49.9	26.0	15.6	13.2	9.4	35.0	76.8	34.8	16.8	37.7	14.0	15.2	17.9	53.2	48.9	20.2	8.4	41.1	32.6	49.7	34.9	6.3	23.3	56.0	46.2	10.3	56.6	15.4	35.0	5.5	9.3	40.0	32.0	21.4	43.1	40.0	31.9	31.4	24.7	9.0	19.7	26.0	30.6	55.4	71.1	29.4	31.8	285.3	43.3	25.2	29.6	68.6
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	"Nuclear receptor binding protein 1"	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 234.3;Extravillous trophoblasts: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029527, CAB033078"	Supported		Supported	Cytosol		NA	NA		39000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	"unprognostic (4.95e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (7.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.48e-3)"	59.7	49.6	38.1	49.4	38.9	109.1	55.2	39.3	42.1	76.1	44.3	72.0	52.2	69.7	43.1	99.9	55.1	53.5	57.6	37.7	44.5	44.7	55.2	50.3	54.0	43.1	44.2	63.7	51.0	44.5	46.9	83.0	45.6	51.6	46.5	47.6	57.2	60.7	126.2	70.7	52.4	75.6	36.8	51.2	51.8	71.1	42.1	51.9	42.4	90.3	67.2	67.3	70.8	37.5	123.7	121.0	98.1	130.9	148.2	146.6	119.0	114.8	143.1	159.8	123.5	123.5	49.1	35.5	83.7	182.9	158.6	82.9	98.4	102.9	102.3	70.0	61.4	70.8	47.0	163.5	124.1	40.0	91.1	120.8	127.3	163.7	108.6	103.9	178.5	38.8	40.5	54.8	142.3	185.6	53.0	96.1	124.0	108.5	75.7	40.5	209.5	40.0	113.8	84.1	26.3	74.1	135.6	96.5	72.4	108.8	53.3	43.9	143.0	140.6	138.5	85.1	94.2	114.3	122.7	42.4	109.8	68.6	71.9	203.6	88.6	187.0	96.7	118.0	85.6	59.3	82.3	87.9	90.2	55.1	73.9	77.1	117.9	91.0	111.5	57.4	107.8	117.4	38.1	38.9	39.3	42.1	37.7	44.5	43.1	44.2	45.6	36.8	42.1	37.5	47.3	6.4	21.4	15.7	46.4	57.2	57.8	73.9	56.9	37.8	34.3	31.5	25.9	28.6	47.2	35.0	35.5	155.7	72.6	67.4	31.3	88.7	234.3	47.5	66.8	54.9	28.1	42.7	14.8	95.9	231.5	61.8	30.1	64.1	20.8	39.3	47.2	38.8	77.3	28.6	15.9	42.7	38.7	35.2	44.7	38.6	46.0	46.6	30.2	8.4	67.2	46.8	51.5	13.0	17.0	100.0	45.6	60.5	72.2	49.7	67.4	52.6	36.5	56.3	32.9	37.4	77.6	92.8	106.8	50.3	52.4	203.2	67.2	36.9	30.8	58.8
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833583-143840973	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.2;Oligodendrocytes: 120.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.8	9.6	21.4	6.4	35.9	1.6	18.4	35.6	28.7	15.1	12.6	28.2	7.6	17.3	7.4	9.5	17.6	10.3	15.1	24.9	25.8	18.1	32.3	16.6	4.5	49.6	35.7	13.4	10.7	8.9	14.5	5.7	47.1	19.6	5.6	7.4	19.7	12.6	6.9	17.7	11.1	11.7	30.6	7.1	14.0	6.9	36.4	3.9	15.8	7.1	3.4	14.2	14.0	48.5	10.2	12.9	11.4	14.0	16.5	25.6	2.6	18.7	9.0	7.2	10.3	3.1	8.8	1.1	5.3	24.1	5.2	15.5	7.0	6.6	3.2	12.4	4.7	2.0	36.0	5.3	18.1	0.0	4.1	30.3	15.5	3.1	3.5	22.4	10.5	3.4	6.7	12.7	15.2	3.5	0.8	0.4	3.7	10.1	5.5	3.4	10.0	4.5	8.9	3.1	3.9	7.2	25.3	13.3	10.1	5.9	18.7	0.8	22.5	4.6	12.5	20.4	6.8	6.3	0.5	0.3	22.8	4.1	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.9	35.6	28.7	24.9	25.8	49.6	35.7	47.1	30.6	36.4	48.5	15.1	44.8	13.7	134.2	2.0	9.2	6.2	5.2	5.7	15.4	16.3	23.2	9.9	41.5	10.4	11.0	14.6	0.9	3.2	9.2	0.0	4.3	0.5	8.1	15.2	10.4	9.0	0.0	41.8	4.0	1.0	11.2	15.3	14.1	0.0	8.5	7.5	41.7	2.8	16.8	32.7	8.4	16.2	5.7	4.6	1.2	28.9	4.5	10.6	22.5	3.9	17.7	3.1	30.2	120.7	5.4	3.6	21.4	2.3	7.1	3.9	4.4	7.0	11.4	13.1	14.2	18.3	1.2	3.3	4.7	9.1	0.8	4.4	7.2	6.2	5.0
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 37.3;brain: 38.3;epididymis: 34.4;retina: 38.0"	"Group enriched"	"Detected in many"	7	"Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in brain"	NA	NA		110000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	3.1	37.3	19.8	1.8	31.9	0.3	1.5	2.4	34.6	5.0	0.0	0.8	0.7	2.1	34.4	0.7	3.6	7.3	0.4	33.1	9.4	6.2	0.4	2.3	0.8	2.3	22.7	1.5	29.4	7.3	11.4	7.8	2.0	0.8	0.7	38.0	1.9	14.2	0.2	0.8	0.6	0.7	1.5	4.8	1.8	1.7	38.3	2.8	4.1	0.4	2.7	0.5	0.4	2.6	0.1	99.6	94.8	0.0	11.4	2.2	1.8	0.7	0.4	1.0	1.7	40.7	0.0	0.0	175.4	0.7	1.5	0.4	2.2	1.6	1.0	0.1	12.7	0.0	0.7	1.0	0.2	0.9	187.9	15.5	0.0	0.2	0.6	0.2	61.7	0.2	0.2	0.8	1.5	38.2	0.4	0.3	13.1	60.1	0.0	0.0	27.8	33.3	21.4	0.1	18.6	115.9	1.3	0.0	1.9	3.3	0.2	0.1	66.2	4.2	1.0	0.1	16.4	0.2	0.5	0.9	0.7	0.1	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.2	19.8	31.9	2.4	34.6	33.1	9.4	2.3	22.7	2.0	1.5	38.3	2.6	0.2	0.0	0.0	612.5	0.8	0.4	0.1	0.8	1.2	66.2	1.5	0.9	0.7	7.2	0.1	5.5	102.2	3.6	0.0	0.2	3.9	1.6	37.3	10.4	2.4	1.3	0.0	0.0	764.5	12.1	0.2	2.0	3.6	25.0	23.4	4.4	1.4	0.4	0.8	13.5	392.4	0.3	0.0	0.8	0.4	8.3	0.9	0.2	3.6	51.5	0.6	45.1	0.0	1259.2	21.9	3.7	0.0	0.4	2.6	1.2	0.0	3.3	0.1	8.8	0.0	1.0	2.6	1.1	2.7	0.2	0.1	4.4	1.1	34.2	0.0	0.0
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267860-90331969	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.3"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	1.0	1.0	2.1	1.4	3.0	3.5	1.2	7.3	2.9	1.3	2.3	1.3	2.5	1.6	1.3	1.1	1.2	0.9	1.2	2.1	2.8	1.1	1.7	1.2	1.2	2.5	2.1	1.5	1.2	1.4	1.8	1.1	2.4	1.3	1.0	3.1	1.4	0.9	1.6	2.0	1.5	1.1	1.8	1.6	1.3	0.9	2.8	1.7	1.7	1.0	1.1	1.1	1.2	3.6	0.7	1.4	2.0	1.2	0.3	1.0	1.4	1.4	0.9	1.0	1.1	1.8	1.3	1.3	0.7	1.4	1.3	1.9	1.1	1.9	1.9	2.5	1.7	1.7	5.0	1.3	0.5	4.6	2.2	1.8	1.3	1.0	0.6	2.1	0.9	3.3	0.8	2.0	0.9	1.4	2.1	1.9	0.7	0.6	1.1	1.8	2.9	0.5	0.6	2.9	1.8	2.1	0.6	3.8	1.0	0.7	1.7	1.9	1.2	1.5	0.7	0.9	0.6	1.6	1.9	1.3	1.4	0.8	1.8	1.6	0.8	1.0	0.8	0.5	0.6	0.8	0.5	0.6	0.4	1.0	0.5	0.6	1.3	0.7	0.4	1.1	0.5	0.2	2.1	3.0	7.3	2.9	2.1	2.8	2.5	2.1	2.4	1.8	2.8	3.6	18.2	35.3	29.7	11.4	21.6	5.9	7.0	13.3	17.1	79.4	19.7	14.9	13.2	37.1	18.8	18.4	87.6	19.1	26.4	23.3	7.9	16.6	8.6	15.2	23.8	20.8	24.7	13.7	10.0	14.6	13.0	16.7	18.8	18.0	38.6	24.7	28.2	42.1	11.8	53.8	12.2	24.2	14.2	17.6	6.7	9.7	23.6	12.8	8.8	4.7	25.1	30.4	30.9	15.1	18.8	14.0	17.7	33.1	9.4	8.0	36.5	18.6	11.4	111.3	0.0	26.6	16.5	24.3	39.4	9.3	6.3	25.2	18.6	18.3	23.7	5.5
NREP	"C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17"	ENSG00000134986	"Neuronal regeneration related protein"	Q16612	5	111662621-111997464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 118.3;Excitatory neurons: 116.1;Theca cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 24.6;NK-cell: 6.9;plasmacytoid DC: 25.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 425.3;SH-SY5Y: 461.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 1766.0"	"Region enhanced"	"Detected in all"		"cerebellum: 219.5"	HPA000545	Approved		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA000545: AB_1845721"	"unprognostic (2.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.76e-3)"	18.9	56.5	50.1	19.4	52.6	36.7	29.3	141.8	71.6	32.3	56.9	28.6	16.9	84.8	17.9	23.0	18.2	65.4	70.9	52.5	44.0	49.5	50.7	27.7	17.3	47.8	52.1	41.8	9.8	8.4	13.3	119.8	50.8	52.7	25.2	107.4	36.1	72.2	179.9	22.1	16.7	54.6	44.6	36.9	25.7	12.7	46.4	168.1	18.6	118.2	18.4	27.5	16.8	54.7	0.6	7.1	425.3	91.5	20.2	46.6	20.3	140.9	83.9	135.7	221.0	0.8	2.8	73.1	44.6	71.3	18.9	0.3	91.0	5.2	69.4	29.5	13.0	57.5	35.2	77.6	28.1	77.0	0.8	45.6	22.5	129.5	44.5	318.6	154.2	81.4	0.6	7.4	143.4	1.6	308.3	53.7	244.1	0.2	33.3	326.3	173.4	19.9	52.2	1.6	96.9	461.8	31.6	2.2	2.9	224.2	17.7	210.6	31.1	163.7	54.1	80.8	15.8	34.6	29.3	92.3	35.6	159.8	32.8	0.0	4.0	0.0	0.0	2.2	0.0	1.6	0.1	0.2	24.6	1.1	1.2	1.6	0.1	6.9	1.0	25.1	0.0	2.2	50.1	52.6	141.8	71.6	52.5	44.0	47.8	52.1	50.8	44.6	46.4	54.7	20.8	6.4	30.8	43.1	3.6	18.1	1.6	4.5	14.2	66.9	12.4	22.6	33.4	8.6	5.7	12.9	87.6	118.3	12.9	2.5	33.2	14.4	2.5	5.4	69.1	38.9	21.6	52.2	116.1	5.5	18.6	31.7	31.1	7.4	5.1	69.9	27.5	10.1	35.5	20.2	51.4	9.3	42.7	10.0	19.0	1.0	8.4	14.9	14.2	17.8	11.5	14.9	5.2	37.2	4.6	8.2	2.0	23.3	0.9	0.7	1.2	61.0	0.5	29.0	13.1	25.4	51.8	0.8	12.6	11.9	12.6	31.5	3.2	150.8	11.3	0.2
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611720-129757082	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	8.3	5.6	9.2	7.9	9.9	16.7	7.9	13.3	11.1	10.8	11.5	8.8	6.4	9.9	6.4	7.2	12.8	5.5	9.4	9.3	10.7	9.0	6.1	8.0	12.3	11.1	10.6	16.6	7.3	8.5	7.7	7.0	10.1	8.0	6.8	12.7	7.5	6.2	15.6	9.3	8.3	7.7	9.1	10.3	6.7	5.6	10.2	18.0	9.7	8.8	11.1	8.7	8.0	13.0	15.9	12.8	18.1	15.9	10.7	8.5	14.4	10.9	11.2	16.3	12.6	15.6	10.4	18.3	7.8	12.3	10.2	11.9	19.7	11.0	16.5	17.5	14.1	15.1	11.0	10.3	7.8	18.7	14.5	7.3	10.2	16.1	15.5	9.4	12.1	17.4	18.6	13.7	10.1	14.5	36.9	17.6	16.9	14.5	11.3	23.2	14.6	16.2	9.2	11.5	15.6	17.1	16.4	16.8	11.0	14.7	10.5	17.4	9.4	9.2	12.6	10.8	20.3	14.7	15.7	32.0	9.7	17.0	18.1	5.6	4.2	10.6	8.2	5.2	9.8	5.5	6.3	7.7	5.5	5.9	6.8	6.0	8.8	5.0	5.8	3.6	7.2	5.8	9.2	9.9	13.3	11.1	9.3	10.7	11.1	10.6	10.1	9.1	10.2	13.0	6.8	3.2	6.5	127.0	15.8	6.6	3.2	3.4	4.6	10.8	5.4	5.1	6.2	2.8	4.8	3.7	10.4	2.8	11.3	5.5	0.0	2.3	0.4	8.9	6.4	7.1	6.7	3.0	115.4	3.6	4.1	6.0	7.1	5.7	5.1	6.9	7.1	4.1	3.1	10.1	109.4	5.3	4.1	7.7	9.5	1.9	5.3	5.4	5.4	75.9	4.0	6.4	12.3	143.2	122.3	3.0	10.2	4.5	14.2	6.8	3.7	2.3	13.1	11.2	6.6	10.0	6.4	9.0	6.6	6.2	7.7	3.4	13.8	2.3	4.2	5.4
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639222-32855666	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 1466.4;Inhibitory neurons: 411.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"classical monocyte: 55.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 55.3"	"Cell line enhanced"	"Detected in many"		"A549: 132.5;BJ: 91.3;fHDF/TERT166: 98.1;GAMG: 95.4;U-2197: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.5	1.2	3.5	6.1	3.2	1.4	5.7	8.7	13.2	8.0	3.2	3.2	2.9	1.2	0.6	2.8	1.1	2.3	1.9	0.4	12.7	8.6	17.0	3.7	0.4	35.4	8.0	1.9	0.7	0.6	3.8	0.2	35.3	2.6	3.2	11.6	2.6	1.0	0.1	4.9	2.5	1.0	2.7	1.6	2.5	5.3	2.6	0.8	9.9	0.0	2.1	9.4	3.4	8.2	0.4	132.5	1.8	0.0	0.9	2.5	0.2	91.3	60.0	65.3	55.8	0.0	2.9	0.0	16.4	98.1	95.4	76.7	0.3	34.5	69.4	0.2	0.7	1.3	1.8	2.0	0.4	0.1	0.2	1.3	3.4	81.1	74.6	5.7	41.2	0.1	0.0	0.7	24.4	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.9	0.0	52.9	3.6	3.4	4.0	7.5	0.0	0.1	5.0	0.0	0.3	34.7	50.7	15.8	84.4	53.6	0.1	0.0	0.9	28.2	0.1	6.6	0.2	55.3	0.9	0.2	4.7	0.2	0.1	0.1	0.0	12.1	0.1	0.0	0.0	2.0	0.2	0.2	0.2	0.0	14.2	3.5	3.2	8.7	13.2	0.4	12.7	35.4	8.0	35.3	2.7	2.6	8.2	0.1	38.5	2.7	29.7	0.8	26.0	48.0	5.1	21.1	11.0	4.3	18.2	2.0	8.6	7.9	3.7	8.4	0.0	1.3	0.0	9.8	1.8	41.5	0.1	1.9	5.7	0.0	0.0	1466.4	0.2	0.0	10.5	0.0	0.2	1.3	3.2	7.1	5.3	0.5	28.6	411.8	0.0	2.0	10.2	1.9	23.5	0.3	22.1	1.8	36.5	49.2	5.0	0.0	54.3	19.2	0.9	0.0	0.4	0.0	42.9	0.0	18.7	2.4	3.1	0.0	0.1	9.3	11.3	5.0	3.2	6.1	0.0	0.6	0.0	0.0	6.5
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted in other tissues"	No	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	2.3	3.4	2.9	0.5	2.8	0.0	3.3	8.5	3.1	5.8	0.0	2.1	0.2	1.2	1.1	1.6	3.3	1.2	1.2	2.0	2.4	0.8	0.1	0.4	0.8	3.2	2.6	7.5	2.7	8.1	3.5	0.3	3.0	3.1	0.1	1.3	6.5	1.9	5.0	3.6	0.7	0.3	1.5	1.7	0.8	2.1	2.6	0.5	0.7	0.1	0.4	3.1	1.8	2.3	0.0	1.6	0.1	6.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.8	2.1	0.3	0.1	0.1	4.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.1	0.1	0.0	4.4	0.0	0.2	0.0	0.0	0.1	0.0	11.1	0.1	0.0	0.0	5.8	1.5	4.2	2.5	0.0	2.7	2.6	0.0	0.0	0.0	0.1	1.9	0.3	0.0	1.3	0.8	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.8	8.5	3.1	2.0	2.4	3.2	2.6	3.0	1.5	2.6	2.3	15.9	0.0	0.0	71.5	1.6	2.8	9.7	0.9	29.0	16.6	4.0	16.0	2.2	0.0	0.5	1.8	0.0	0.1	3.2	0.1	1.9	0.4	0.6	2.6	8.2	2.6	0.0	0.0	89.9	2.2	0.0	2.7	0.5	0.4	0.0	1.3	1.8	0.0	0.1	6.7	136.6	0.1	0.0	0.3	1.3	0.6	9.6	0.6	3.6	8.4	0.3	11.2	5.2	142.2	50.8	0.5	0.0	10.1	2.7	2.6	0.0	1.7	1.0	1.0	6.6	10.9	2.2	2.7	9.4	1.0	0.3	0.0	2.8	4.0	0.1	6.2
NRG4	HRG4	ENSG00000169752	"Neuregulin 4"	Q8WWG1	15	75935969-76059795	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;retina: 4.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 16.1;Exocrine glandular cells: 23.3;Gastric mucus-secreting cells: 31.1;Rod photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.8;HL-60: 2.1;U-937: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010957	Uncertain				"Secreted to digestive system"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA010957: AB_1079504"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-5)"	"unprognostic (8.28e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.06e-1)"	0.0	0.1	0.3	0.1	0.2	1.0	0.2	3.8	0.7	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.4	0.1	0.4	0.2	0.2	0.5	0.5	0.1	0.9	0.0	0.0	0.4	0.4	0.2	0.1	4.3	0.5	0.1	0.8	0.7	0.1	0.0	0.5	0.1	0.9	0.7	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.6	0.6	0.3	0.0	0.0	0.9	0.6	0.1	0.0	0.1	0.4	0.1	6.8	0.0	0.0	2.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.2	0.2	0.0	0.0	0.1	0.4	1.6	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.8	0.7	0.4	0.4	0.5	0.5	0.4	0.5	0.6	0.3	0.7	0.0	0.0	3.9	0.9	7.5	1.2	3.9	0.6	3.7	0.5	0.0	0.2	0.0	3.9	1.8	14.6	2.2	0.5	1.1	1.9	0.3	16.1	6.1	1.2	0.7	1.2	0.0	13.3	23.3	2.5	2.6	31.1	1.4	2.5	0.9	0.7	3.4	0.3	6.7	9.7	0.1	2.0	0.0	0.8	8.9	0.6	0.3	1.8	0.0	0.2	1.9	1.0	3.5	0.8	9.6	3.2	0.0	0.3	2.3	0.1	0.1	10.7	22.9	0.0	0.5	1.1	7.6	1.3	3.4	1.3	0.8	0.4	0.6	0.5	4.5
NRGN	RC3	ENSG00000154146	Neurogranin	Q92686	11	124739942-124747210	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"brain: 1158.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 245.6;Macrophages: 214.7;Smooth muscle cells: 60.5"	"Cancer enhanced"	"Detected in all"		"glioma: 39.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 1158.0"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.8;granulocytes: 2.5;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"HEL: 154.7;PC-3: 122.8"	"Group enriched"	"Detected in all"	9	"amygdala: 785.5;basal ganglia: 687.3;cerebral cortex: 1219.9;hippocampal formation: 641.9;white matter: 422.3"	"Group enriched"	"Detected in all"	6	"basal ganglia: 2940.0;cerebral cortex: 4703.6;hippocampal formation: 2490.2"	"CAB006908, HPA038171"	Enhanced					NA	NA		5300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB006908: , HPA038171: AB_2675878"	"unprognostic (1.37e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.14e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.03e-2)"	13.8	4.4	119.9	7.8	563.0	36.3	9.1	0.0	1158.0	9.6	0.0	6.1	1.9	10.5	2.7	4.4	12.4	5.2	19.7	282.2	0.0	29.6	6.5	55.2	3.5	0.0	0.0	9.5	2.7	0.4	11.6	5.8	0.0	6.3	1.5	1.1	3.4	2.5	3.7	4.1	6.3	4.9	0.0	55.8	4.8	7.0	0.0	1.5	11.8	4.3	1.6	8.0	7.8	627.0	13.5	11.2	44.8	51.2	0.6	0.2	1.5	6.4	3.8	5.7	3.5	7.7	20.3	38.1	22.4	1.4	14.5	4.2	8.8	15.4	2.4	6.4	24.9	154.7	4.9	4.5	0.2	3.8	47.4	0.3	0.0	4.7	1.1	4.4	29.4	13.2	8.7	15.0	4.7	51.3	0.2	2.1	16.1	7.7	122.8	21.6	21.5	3.6	3.2	9.0	8.2	16.3	8.6	27.8	1.8	8.7	25.7	41.3	31.2	21.8	16.0	9.1	16.8	3.6	0.6	0.3	15.2	39.9	27.5	1.7	3.6	0.9	0.1	2.1	0.2	0.2	0.2	0.0	1.8	0.4	0.2	0.2	2.5	0.1	1.3	0.5	0.0	6.8	119.9	563.0	0.0	1158.0	282.2	0.0	0.0	0.0	0.0	0.0	0.0	627.0	12.5	0.0	41.9	35.9	4.3	3.6	0.9	0.6	0.6	5.3	2.1	2.7	2.3	1.5	0.1	0.0	0.0	1.6	4.7	2.2	3.9	0.9	3.1	1.7	1.4	20.8	6.0	5.5	245.6	0.2	2.7	3.8	1.5	1.5	1.3	0.9	15.7	1.0	13.0	0.0	14.4	1.7	0.0	43.4	15.2	7.2	0.6	214.7	5.4	42.2	45.4	0.1	25.7	29.7	33.4	0.3	0.3	0.7	3.4	0.6	0.3	0.1	0.2	1.8	19.7	1.6	60.5	3.6	6.5	1.3	1.4	0.1	4.6	0.8	2.2	1.6
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	30.4	10.2	5.8	10.2	5.2	26.4	14.2	14.9	6.9	24.7	6.5	18.2	16.8	18.2	13.4	9.4	21.4	10.3	5.4	6.4	8.1	15.9	26.9	8.9	8.7	4.8	4.5	13.3	14.4	7.4	3.2	14.6	5.3	10.3	18.1	31.8	6.1	8.4	22.3	4.1	18.3	20.1	6.4	13.1	8.9	8.1	6.7	17.0	5.6	23.8	7.2	14.1	8.4	8.3	22.1	43.5	34.6	0.0	17.4	11.3	12.6	26.1	11.7	16.0	12.5	8.7	17.3	0.1	14.5	23.3	7.9	11.0	2.2	15.6	33.9	0.0	10.0	33.4	15.3	27.2	10.5	16.7	6.7	14.1	21.3	17.6	20.5	17.8	12.6	4.8	24.1	17.4	11.4	11.8	7.8	0.1	14.5	8.8	13.9	92.4	28.0	0.8	9.8	35.8	3.2	0.1	21.7	11.3	8.8	27.7	27.2	12.9	22.0	13.7	9.1	21.4	10.8	8.5	0.2	0.1	29.0	0.0	6.8	0.0	0.4	0.2	0.3	0.2	1.8	0.3	0.3	0.4	0.6	1.0	0.5	0.2	0.1	0.5	0.5	0.6	0.2	0.2	5.8	5.2	14.9	6.9	6.4	8.1	4.8	4.5	5.3	6.4	6.7	8.3	33.2	48.1	37.6	60.7	27.4	18.6	122.6	16.2	22.8	33.9	52.9	26.8	18.3	21.5	40.9	29.5	50.1	16.4	20.7	50.1	9.8	23.0	15.8	60.9	99.1	43.0	37.7	24.2	123.7	27.6	120.8	42.3	26.5	130.9	31.5	94.0	27.1	44.7	45.7	21.9	95.0	41.6	18.3	50.4	21.9	19.3	37.6	57.9	8.8	219.2	40.4	56.2	27.8	102.1	78.2	31.4	42.6	27.1	10.1	49.5	43.0	36.5	15.9	63.1	32.9	112.1	38.6	12.1	6.3	23.1	18.8	14.1	19.9	71.0	47.7	99.8
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.9;retina: 24.5;testis: 43.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 13.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	1.1	10.2	16.7	1.6	13.4	13.8	3.9	23.2	42.1	3.4	0.0	1.5	0.5	3.2	3.1	0.8	2.2	1.6	1.2	72.9	20.8	1.4	0.2	0.8	0.8	20.5	18.4	0.5	0.4	5.4	1.5	0.8	23.6	0.7	0.6	24.5	0.6	0.9	0.3	0.6	0.6	2.3	25.1	0.5	2.5	43.5	31.6	0.9	0.9	0.2	0.6	1.3	0.7	17.2	0.0	0.9	1.9	0.3	0.7	2.7	0.1	20.3	8.0	16.2	16.9	3.1	1.8	0.1	3.0	5.9	9.6	0.2	5.5	0.5	28.0	1.7	8.5	2.2	1.2	0.2	1.4	26.5	51.4	3.7	0.3	16.7	0.1	17.1	13.3	4.4	4.2	0.2	15.0	0.0	1.3	8.6	6.6	0.1	0.0	0.0	2.8	0.0	0.3	1.2	5.4	1.7	34.3	0.9	5.3	1.4	3.5	2.5	16.6	24.7	11.8	1.4	0.1	0.1	0.0	0.0	47.9	3.1	12.3	13.1	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.3	16.7	13.4	23.2	42.1	72.9	20.8	20.5	18.4	23.6	25.1	31.6	17.2	4.0	0.0	1.3	1.0	1.7	2.2	5.7	0.5	0.0	19.6	12.1	8.9	1.6	0.0	0.4	0.0	10.4	0.4	7.4	0.6	5.9	0.4	545.3	3.7	4.1	2.5	5.3	2.7	11.5	1.1	0.5	2.5	7.1	6.6	15.8	2.4	0.0	0.0	12.1	242.3	96.3	0.5	8.2	3.1	17.2	478.6	6.8	12.8	3.6	0.0	0.6	4.4	0.0	4.5	1.6	8.2	0.1	5.7	1.2	3.5	0.1	0.0	0.1	10.6	0.0	6.0	3.6	189.8	44.0	0.9	1.0	1.0	5.5	5.6	0.2	4.2
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24078662-24115010	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	75	"retina: 317.3"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3720.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 4.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	0.8	2.5	1.7	0.5	1.5	0.5	1.0	2.3	2.2	1.1	0.6	0.9	1.1	1.1	0.7	1.1	1.0	0.9	2.2	1.5	1.5	3.1	3.6	1.0	1.0	2.3	1.8	1.2	1.7	1.9	2.4	0.3	1.7	1.5	0.3	317.3	1.0	0.7	2.5	0.7	1.3	0.3	1.7	2.1	1.2	4.2	1.6	1.2	2.7	1.4	0.7	1.1	0.8	1.7	0.3	1.2	1.6	1.6	0.3	0.2	0.4	0.3	0.3	0.5	0.3	0.7	0.5	1.2	0.4	0.5	1.0	0.5	0.6	0.3	0.2	0.6	0.5	0.7	0.6	2.2	0.6	1.4	1.6	0.4	0.5	0.2	0.7	0.7	0.5	2.2	0.7	1.2	0.3	0.9	1.2	0.6	1.8	1.8	0.9	1.2	1.5	0.0	0.4	1.3	1.7	1.2	0.8	0.7	0.8	4.8	0.9	1.5	0.4	1.1	0.5	0.1	0.7	3.6	1.9	1.5	0.3	0.9	1.1	0.2	0.3	1.3	0.2	0.4	0.1	1.0	0.2	0.4	0.3	0.7	0.8	0.6	0.1	0.5	0.3	0.4	0.2	0.3	1.7	1.5	2.3	2.2	1.5	1.5	2.3	1.8	1.7	1.7	1.6	1.7	1.4	0.0	0.5	5.5	6.2	0.8	1.6	0.1	1.2	434.4	2.0	1.9	2.1	0.0	0.7	7.3	431.6	1.4	3.2	1.5	13.7	0.6	2.7	1.3	0.7	24.1	1.8	3.2	1.8	1.1	0.9	0.7	2.6	1.0	0.0	0.7	0.7	3.3	2.0	250.7	2.6	1.7	0.0	1.3	0.4	4.2	1.2	1.4	1.8	0.0	1.1	636.4	5.2	2.0	4.4	0.3	5.3	1.9	1.7	2.0	5.6	6.7	0.1	3720.7	0.0	1.2	0.7	9.7	4.3	2.2	0.4	2.5	2.6	2.3	1.0	2.1
NRN1L	"MRCC2446, UNQ2446"	ENSG00000188038	"Neuritin 1 like"	Q496H8	16	67884885-67888855	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 12.0;Astrocytes: 2.9;Bipolar cells: 2.0;Oligodendrocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"BEWO: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041761	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041761: AB_10961155"										"unprognostic (2.79e-2)"				"unprognostic (3.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.85e-1)"	1.8	1.4	5.0	0.9	6.6	3.7	1.7	7.2	8.2	2.6	9.6	1.3	1.0	1.3	0.4	1.1	2.9	0.7	2.5	4.8	6.0	1.8	2.4	1.9	2.1	5.6	4.9	4.7	1.3	0.7	6.2	0.6	5.6	2.7	0.5	5.5	1.7	0.8	2.1	3.2	1.7	0.5	4.4	2.5	1.2	1.8	5.4	1.1	2.5	0.7	0.6	2.0	2.1	6.6	0.1	0.5	0.7	0.9	0.3	1.1	38.1	0.4	0.1	0.4	0.3	0.0	0.6	0.5	0.7	0.1	0.0	0.4	0.1	0.3	0.3	0.3	0.9	0.4	1.5	2.0	0.6	0.2	1.4	0.5	1.2	0.1	0.0	0.4	0.1	1.4	0.9	0.7	0.1	1.6	0.5	4.3	7.1	0.0	0.5	1.5	0.0	0.7	0.3	0.4	1.1	0.4	0.5	0.5	0.5	6.8	1.0	1.4	0.6	0.3	0.3	0.0	0.1	0.1	0.4	0.9	0.1	0.4	0.2	0.0	0.5	0.0	1.0	0.3	0.6	0.5	0.6	0.3	0.1	0.2	0.5	0.3	0.6	0.3	0.4	0.1	0.4	0.3	5.0	6.6	7.2	8.2	4.8	6.0	5.6	4.9	5.6	4.4	5.4	6.6	0.1	3.2	12.0	2.9	0.1	0.3	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 48.6"	"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.3"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		780000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	125.2	42.3	9.3	43.3	9.4	3.7	62.2	0.0	26.0	36.9	13.3	26.6	21.3	51.6	35.7	19.7	34.5	54.1	80.8	48.6	9.1	52.7	53.1	63.7	23.7	4.0	3.9	43.0	33.0	24.4	9.0	133.7	2.1	21.3	23.6	11.6	19.3	38.4	55.9	22.1	21.0	55.9	5.7	66.7	18.6	12.9	13.4	18.2	49.7	46.6	12.4	35.3	20.0	10.7	57.4	217.8	11.1	1.1	204.8	224.7	1.3	224.4	216.2	109.6	118.2	28.9	132.4	1.1	26.6	444.6	116.8	15.8	13.8	65.2	89.3	0.7	11.2	0.6	24.5	48.7	74.3	20.8	1.6	277.3	11.2	261.7	116.8	371.6	304.0	1.4	0.7	1.4	221.3	96.8	1.4	3.9	5.5	11.9	204.2	9.6	24.8	1.2	109.7	1.3	5.1	2.7	23.0	17.5	0.9	9.2	1.0	3.3	369.5	156.4	36.9	193.0	153.8	0.7	1.1	0.7	425.2	26.4	143.5	0.4	2.5	0.5	0.6	0.4	1.0	0.7	0.7	0.6	2.3	0.6	0.6	0.6	0.4	1.2	0.3	39.3	0.6	0.9	9.3	9.4	0.0	26.0	48.6	9.1	4.0	3.9	2.1	5.7	13.4	10.7	366.0	0.0	20.2	80.3	4.3	15.7	10.6	5.5	7.4	10.5	4.2	5.5	67.6	28.6	13.0	18.4	4.2	61.5	29.4	0.6	1.9	57.9	1.3	11.3	116.9	174.4	4.2	3.2	105.4	18.9	13.4	58.5	6.6	11.0	7.6	62.3	184.6	12.5	135.4	0.0	14.4	1.8	16.2	62.7	33.3	5.5	42.3	46.0	12.4	78.7	5.8	3.4	0.0	11.6	2.3	15.4	0.0	21.1	1.6	4.1	3.0	59.8	5.4	0.9	282.7	13.1	117.9	0.2	1.3	2.7	10.5	67.2	3.8	61.1	1.5	3.3
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639694-196662004	"Disease related genes, Predicted membrane proteins"		"Growth factor binding"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	7.8	2.6	1.9	8.6	1.5	32.7	5.1	1.5	1.6	2.5	1.6	2.7	2.4	2.9	0.5	2.0	2.8	4.2	2.9	1.8	3.0	2.8	2.5	7.7	10.5	2.7	1.9	1.2	1.1	0.9	1.2	9.9	2.7	2.0	1.6	0.3	2.4	1.6	1.3	2.0	5.1	4.1	2.7	15.7	2.3	1.3	3.4	7.7	2.2	2.5	3.6	4.5	2.1	4.4	0.1	0.0	0.3	0.0	0.4	1.0	0.1	0.4	2.1	0.4	0.3	0.1	0.2	0.0	6.7	0.4	0.3	0.1	1.1	0.0	0.1	4.0	0.1	53.1	0.0	0.0	0.5	43.7	106.4	0.4	0.0	1.7	0.7	2.1	4.3	48.6	5.5	66.7	1.2	0.1	59.8	138.5	4.4	0.0	0.1	15.7	0.1	68.9	0.1	0.4	0.3	0.0	0.1	0.1	28.0	0.9	0.1	60.5	0.5	0.5	0.2	1.9	0.1	26.5	43.1	12.1	3.4	76.1	0.7	4.2	1.0	1.8	0.3	1.0	0.1	0.3	0.2	0.2	1.3	0.2	0.1	0.2	0.0	0.3	1.1	0.2	0.3	0.7	1.9	1.5	1.5	1.6	1.8	3.0	2.7	1.9	2.7	2.7	3.4	4.4	5.6	0.0	0.5	0.0	40.2	1.5	0.1	0.0	2.2	0.4	0.4	0.3	0.3	0.0	0.6	0.0	4.2	0.3	15.5	0.0	0.0	0.0	1.4	0.0	0.4	10.1	0.0	27.5	1.8	0.0	0.7	0.7	0.5	0.1	14.5	0.1	15.4	0.2	76.9	0.0	2.7	0.0	0.0	35.5	59.9	0.4	0.6	33.3	8.8	31.9	24.1	0.1	33.0	1.0	0.3	0.0	0.0	0.7	25.7	0.0	0.0	0.1	0.0	0.4	6.6	0.3	0.3	2.7	0.4	0.2	0.9	0.5	10.8	0.5	0.0	0.0
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 154.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	19.9	57.0	105.7	10.5	114.4	1.7	17.4	87.8	154.7	30.1	71.3	28.3	6.0	32.5	25.9	9.7	27.9	15.4	30.9	114.3	100.6	33.0	4.8	22.4	7.5	94.4	92.0	36.0	20.3	42.6	60.4	16.9	93.9	28.3	9.7	56.9	21.1	25.5	3.4	11.4	13.1	27.5	80.5	16.8	20.2	30.6	96.6	5.5	28.1	5.7	7.2	23.5	18.2	102.9	56.5	68.3	40.2	37.7	53.0	58.4	15.2	37.4	72.3	66.3	66.8	38.2	1.2	0.0	12.6	70.7	48.9	24.1	33.5	5.8	42.4	0.3	33.0	20.8	32.5	70.7	53.5	0.6	3.3	67.4	4.5	48.2	8.1	54.1	46.4	0.3	40.3	35.1	59.2	10.0	0.9	17.9	31.3	0.7	34.9	32.4	22.1	2.7	67.4	0.3	80.8	58.0	44.9	13.0	64.9	26.5	53.2	19.7	31.0	70.6	36.4	2.6	45.6	6.5	1.4	14.7	9.5	0.6	36.7	0.0	0.7	1.2	2.4	0.3	0.7	5.6	0.8	2.6	1.5	6.9	1.0	1.8	0.0	2.8	0.3	3.5	0.6	1.1	105.7	114.4	87.8	154.7	114.3	100.6	94.4	92.0	93.9	80.5	96.6	102.9	3.8	0.0	3.1	16.0	2.2	3.2	3.6	8.5	7.4	26.5	5.8	5.0	5.5	1.5	6.1	12.9	2.1	7.3	0.5	2.6	1.9	14.7	9.6	4.7	12.0	6.9	29.4	1.3	21.0	1.6	6.8	10.4	3.1	3.9	5.1	7.6	5.7	0.3	3.2	16.8	27.1	2.6	4.1	0.9	2.2	14.4	13.1	0.7	3.6	2.8	2.1	17.3	2.1	12.1	5.9	2.9	1.8	10.5	2.6	3.3	0.2	7.8	3.6	15.4	19.7	4.9	9.2	21.3	12.8	1.4	2.3	4.4	1.4	12.9	2.2	2.9
NRXN3	"C14orf60, KIAA0743"	ENSG00000021645	"Neurexin 3"	"Q9HDB5, Q9Y4C0"	14	78170373-79868291	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.8;retina: 42.9"	"Group enriched"	"Detected in many"	10	"Excitatory neurons: 3526.5;Inhibitory neurons: 5083.8;Oligodendrocytes: 2145.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 106.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 9.7;RT4: 24.7;SK-BR-3: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002727	Approved					NA	NA		710000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002727: AB_1079468"	"unprognostic (7.96e-2)"	"unprognostic (5.70e-4)"	"unprognostic (8.18e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.31e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.83e-7)"	"unprognostic (4.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	0.8	5.9	13.4	2.8	17.0	0.1	1.6	106.8	48.3	3.9	0.0	23.0	2.3	5.4	1.7	4.7	5.0	2.5	3.0	23.6	21.3	1.7	0.4	2.6	0.4	8.6	24.2	0.7	3.1	8.8	4.9	1.3	7.2	6.7	4.1	42.9	2.8	11.3	0.3	1.8	8.4	21.1	0.0	5.8	9.3	7.5	4.2	1.0	0.5	0.5	0.4	4.4	2.7	21.5	0.0	0.0	7.6	0.0	0.2	0.3	0.0	3.0	2.2	9.7	7.3	2.6	0.0	0.1	0.0	0.3	0.0	2.8	0.1	0.3	6.8	3.0	6.0	0.0	0.2	0.0	0.7	0.0	0.0	1.8	0.3	4.3	1.4	4.6	2.5	0.0	0.0	0.2	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.2	0.0	0.0	5.2	24.7	1.3	0.0	0.0	9.3	0.5	3.1	0.0	0.0	0.0	0.1	6.2	0.0	3.2	0.0	0.0	0.0	1.8	0.3	5.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.4	17.0	106.8	48.3	23.6	21.3	8.6	24.2	7.2	0.0	4.2	21.5	0.2	12.8	5.5	100.2	0.0	4.6	7.0	0.4	0.6	180.7	3.2	3.0	3.9	1.5	3.4	3.7	12.5	9.2	0.0	1.1	0.0	2.2	15.9	36.3	2.2	0.8	6.0	0.0	3526.5	3.1	0.5	1.8	0.0	31.5	0.0	0.8	1.4	0.1	0.7	116.1	5083.8	0.6	4.1	0.0	0.3	18.9	7.5	0.3	17.8	88.1	0.0	54.3	0.0	328.2	2145.0	0.7	0.2	6.4	1.2	7.5	0.0	0.1	9.3	10.7	0.0	0.4	2.2	2.1	0.8	0.1	0.9	37.9	0.6	0.0	1.0	3.0
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300213	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	8.7	7.2	8.9	12.0	13.4	21.2	10.9	26.2	10.4	11.1	9.8	10.1	8.4	11.5	10.3	11.4	10.1	8.0	9.1	7.7	10.0	10.6	6.6	9.2	13.7	9.7	10.8	12.3	11.3	12.8	9.0	10.7	12.2	9.3	10.8	11.9	10.4	9.6	13.6	12.0	9.4	12.0	6.6	11.3	8.9	23.2	12.0	20.2	15.5	11.5	14.7	9.3	7.9	17.5	20.5	25.9	26.0	22.8	12.5	16.1	0.9	18.2	17.9	24.6	22.8	5.7	16.6	41.7	19.9	24.8	22.7	17.0	41.9	40.0	29.7	72.9	25.9	18.6	29.5	0.2	20.7	40.4	21.2	15.2	23.6	29.4	27.3	17.5	36.4	26.0	25.9	14.3	25.2	42.3	28.3	13.1	28.5	13.7	22.5	31.0	3.4	12.9	15.9	24.4	31.6	21.9	46.7	20.1	13.8	24.1	20.2	33.0	27.4	17.1	25.0	11.0	22.6	16.7	15.7	29.5	9.9	19.3	18.7	14.7	9.0	10.5	7.2	6.1	6.0	8.5	6.1	5.0	7.2	10.3	7.5	6.0	18.6	11.3	12.2	9.4	6.4	3.4	8.9	13.4	26.2	10.4	7.7	10.0	9.7	10.8	12.2	6.6	12.0	17.5	37.4	22.4	31.4	84.9	71.7	17.0	32.8	27.2	34.1	94.4	29.8	25.7	44.5	34.3	35.0	55.2	150.1	43.6	66.1	19.7	17.6	27.8	31.9	27.1	65.7	36.4	41.9	48.3	107.0	21.2	23.7	32.7	41.8	41.9	41.7	64.0	33.5	19.9	27.7	89.2	110.3	25.6	12.2	36.8	25.7	50.3	51.0	47.1	16.0	115.2	75.0	29.2	95.8	140.8	157.5	23.7	31.0	33.1	55.8	29.4	33.6	19.2	17.3	112.3	52.6	42.9	36.1	83.7	62.1	41.8	20.6	35.4	62.0	55.9	28.2	30.0
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269704-38382272	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	22.4	14.4	10.0	24.8	13.7	60.2	23.4	28.4	20.5	24.0	0.7	22.4	24.1	22.9	17.4	22.9	23.5	24.5	13.7	12.8	22.3	20.0	16.6	20.6	35.3	3.1	4.8	36.4	20.1	24.8	17.3	33.5	5.3	20.9	26.6	23.3	19.9	24.3	14.4	19.8	26.7	19.8	0.1	26.9	29.0	14.4	10.4	38.3	27.6	16.0	31.0	23.3	23.1	18.7	62.1	34.9	58.7	39.9	40.3	46.0	43.4	50.8	55.9	43.1	49.7	18.8	33.6	73.5	45.5	35.0	41.7	36.4	47.0	40.6	61.0	29.4	27.6	93.6	28.6	22.1	41.2	41.7	32.5	24.9	40.4	39.0	78.6	40.3	50.1	79.8	67.9	47.4	41.5	22.3	122.8	35.4	40.0	48.0	16.4	55.5	64.1	23.4	30.3	47.3	33.0	44.6	41.4	35.8	35.3	37.5	45.1	31.4	48.3	44.5	46.0	67.0	30.3	41.9	53.8	69.2	37.6	41.3	33.0	37.4	11.8	21.9	17.2	5.6	11.0	43.1	25.5	15.5	9.3	60.7	31.9	13.7	57.9	19.6	3.6	12.6	43.4	7.3	10.0	13.7	28.4	20.5	12.8	22.3	3.1	4.8	5.3	0.1	10.4	18.7	75.1	67.3	57.3	0.0	57.8	0.0	0.0	0.0	0.0	0.0	73.4	69.1	0.0	0.0	30.3	51.5	0.0	101.6	101.9	0.0	23.5	73.0	0.0	109.1	81.3	28.0	0.0	0.0	0.0	61.0	173.8	33.1	0.0	97.5	8.8	99.7	0.0	0.0	44.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	49.7	0.0	0.0	0.0	0.0	64.7	0.0	0.0	48.9	0.0	0.0	31.7	34.2	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	130.8	55.6	81.7	0.0	0.0
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.0;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	24.0	38.8	13.2	10.2	12.6	8.9	20.2	14.2	13.3	20.3	13.7	13.9	17.6	13.6	44.5	51.7	14.9	7.9	22.4	13.7	14.3	14.9	50.4	12.9	9.1	16.8	15.4	10.3	10.6	12.9	8.8	10.3	18.5	14.8	13.5	10.4	16.7	21.3	10.1	22.6	24.2	12.5	13.4	9.5	13.8	8.9	15.2	9.9	13.3	10.9	18.1	12.1	24.1	15.1	135.6	48.9	65.5	33.8	54.9	41.5	36.2	26.3	35.2	46.9	59.3	68.5	71.7	67.0	86.0	35.9	174.2	67.6	85.5	122.1	41.3	22.0	49.5	27.9	44.7	70.3	39.8	27.6	21.1	51.1	46.3	92.2	23.0	20.2	44.2	28.7	46.4	29.1	36.1	60.1	27.3	35.8	26.0	67.4	58.1	19.9	47.4	54.6	98.9	55.7	23.4	26.5	23.4	34.6	28.4	44.9	23.1	35.0	38.7	21.6	35.4	52.3	51.0	40.9	29.4	114.9	40.0	42.4	20.8	21.0	19.6	18.7	16.3	18.7	16.4	19.1	16.1	14.1	19.4	15.1	11.6	12.7	2.2	19.7	14.2	17.4	20.4	15.2	13.2	12.6	14.2	13.3	13.7	14.3	16.8	15.4	18.5	13.4	15.2	15.1	7.1	12.8	16.7	5.9	6.3	10.8	12.8	53.0	10.8	4.3	11.7	6.1	25.0	15.7	29.0	12.9	0.0	21.5	6.1	9.6	9.8	20.1	13.3	15.5	6.6	9.2	6.0	13.0	2.2	20.3	22.0	9.0	8.2	15.5	8.2	14.0	7.5	55.0	18.6	1.7	2.2	10.2	26.4	8.7	9.6	8.0	8.4	7.9	5.4	1.0	11.0	10.6	7.2	2.5	5.7	21.4	11.9	9.1	11.3	10.4	25.2	16.5	25.4	6.2	0.0	5.9	12.5	3.7	7.8	19.4	12.1	18.6	5.3	25.1	11.2	16.4
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1 component of MIS12 kinetochore complex"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA045761: AB_2679444, HPA053721: AB_2682240"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	16.7	14.5	13.8	19.4	16.9	19.1	11.2	17.1	17.5	12.8	15.0	13.3	17.5	14.5	8.0	15.3	13.9	15.0	24.9	13.4	14.9	16.0	19.3	12.5	27.0	18.0	14.9	16.8	12.5	13.9	11.0	17.6	17.5	12.8	10.1	12.6	13.9	10.0	22.5	8.8	17.5	13.1	17.3	19.4	11.7	13.5	14.8	22.7	15.0	15.6	16.7	13.6	10.1	21.3	39.7	44.3	45.0	43.3	18.9	19.5	59.4	32.5	22.1	38.7	33.2	37.3	42.2	55.6	29.4	18.7	21.6	28.4	35.6	29.9	20.1	102.9	33.6	37.0	31.2	61.8	21.7	62.5	34.9	20.2	14.6	39.6	19.8	17.8	28.8	62.9	83.0	45.7	24.6	23.1	80.6	24.6	82.9	20.6	32.8	69.2	68.1	61.5	31.3	19.8	41.1	57.0	46.0	22.3	55.7	33.3	65.6	44.9	33.3	39.4	34.1	36.4	54.5	26.4	76.3	73.8	33.7	42.2	50.7	21.8	49.3	63.1	35.9	62.3	43.0	59.0	38.8	39.2	55.6	47.4	46.7	41.9	49.6	45.3	64.3	53.8	51.2	60.7	13.8	16.9	17.1	17.5	13.4	14.9	18.0	14.9	17.5	17.3	14.8	21.3	39.4	16.0	20.7	25.5	43.5	14.8	21.2	51.4	31.3	34.1	22.8	26.8	22.4	31.5	28.1	18.4	14.6	64.0	40.9	14.7	43.0	32.2	29.2	19.9	29.0	32.0	21.7	50.7	50.2	21.1	62.2	28.9	13.3	15.1	15.2	31.6	29.6	27.9	61.6	33.7	50.1	14.1	30.5	68.2	28.5	15.2	34.8	44.6	19.6	33.7	56.0	37.1	35.0	36.2	68.9	22.7	15.9	32.7	26.7	10.5	32.5	58.5	25.6	32.7	59.2	30.2	32.6	48.7	65.5	22.7	16.2	20.9	36.6	27.0	18.5	10.3
NSMAF	"FAN, GRAMD5"	ENSG00000035681	"Neutral sphingomyelinase activation associated factor"	Q92636	8	58583508-58659853	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 89.7;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023067, HPA023148, HPA023151"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoli		"HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.86e-3)"	"unprognostic (2.69e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (4.61e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.69e-1)"	16.8	14.9	8.5	16.1	9.5	7.9	13.5	9.0	9.8	14.2	9.7	15.7	9.3	13.9	9.1	13.1	10.8	10.7	11.9	8.4	9.1	9.4	5.7	12.0	21.6	9.3	9.0	12.1	17.1	17.5	10.4	13.4	9.2	12.1	14.5	4.8	11.3	12.5	18.5	19.2	14.8	14.1	8.7	16.8	14.0	5.5	10.5	35.8	13.5	15.4	22.2	16.2	13.3	10.0	33.7	32.7	14.3	20.1	53.8	43.3	24.8	26.8	58.5	36.3	33.9	17.8	20.6	40.5	21.6	41.6	37.6	26.6	24.7	21.2	41.3	46.0	13.7	75.7	19.8	20.5	67.8	33.7	51.1	29.2	33.7	26.2	99.5	29.6	36.5	36.9	32.9	29.1	41.6	25.7	71.5	26.6	25.7	27.0	12.6	26.7	21.2	11.6	19.8	26.4	13.1	16.5	22.4	8.3	24.8	18.6	20.1	41.8	34.4	35.7	21.7	48.2	27.3	5.5	2.6	31.6	52.3	25.6	23.1	8.3	7.1	4.7	6.0	5.0	6.2	4.2	6.4	6.5	14.0	4.0	4.4	4.3	14.6	6.4	3.6	4.7	8.6	4.7	8.5	9.5	9.0	9.8	8.4	9.1	9.3	9.0	9.2	8.7	10.5	10.0	9.6	9.6	5.9	68.9	28.4	18.4	10.4	7.2	26.2	9.7	7.8	6.9	15.8	1.5	9.6	9.2	4.2	12.1	17.4	8.9	3.9	7.7	0.3	5.9	14.5	12.1	14.4	12.2	89.7	8.8	8.3	13.8	14.8	7.8	28.5	15.8	5.3	4.0	17.8	32.0	94.9	10.4	2.0	31.0	35.3	2.1	16.4	33.9	10.6	54.4	22.6	6.3	13.4	102.1	51.2	7.4	9.1	12.8	18.3	13.0	8.0	4.9	3.8	6.3	6.6	18.0	10.8	2.0	3.5	16.1	17.8	9.3	22.7	10.6	10.7	11.0
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224994-27268772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 275.5;Late spermatids: 420.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	43.8	68.3	58.8	32.2	61.7	35.1	52.5	65.2	71.7	43.3	66.0	53.1	25.3	42.3	55.0	45.5	62.2	35.8	47.6	57.4	63.3	58.3	55.9	42.4	54.5	65.5	61.4	45.0	59.3	86.1	37.3	37.3	64.6	57.4	36.8	24.9	46.2	51.7	45.2	40.7	37.0	45.2	64.0	33.5	51.3	79.8	61.3	56.4	53.0	44.9	54.7	51.4	39.1	67.0	56.5	80.6	53.8	58.6	85.8	114.2	43.1	58.9	60.4	44.5	46.1	62.7	134.1	110.0	137.7	91.1	45.7	59.5	101.9	178.6	57.3	136.3	70.6	51.0	68.6	122.1	149.1	59.9	37.4	112.6	122.3	111.7	211.5	127.8	60.3	104.3	69.6	33.8	82.9	96.7	80.0	67.5	46.8	94.0	54.7	69.1	65.8	174.7	129.9	36.3	56.4	51.0	40.2	55.9	104.3	65.1	92.3	71.9	37.8	53.3	33.2	61.1	57.8	101.0	78.1	85.9	114.0	59.4	23.3	125.3	91.2	86.2	78.9	81.6	86.3	84.2	111.1	95.7	128.4	133.1	126.7	99.7	29.6	213.8	81.5	124.6	113.0	120.3	58.8	61.7	65.2	71.7	57.4	63.3	65.5	61.4	64.6	64.0	61.3	67.0	34.8	35.3	36.4	8.5	38.1	28.3	57.6	110.7	33.0	14.9	60.7	83.8	49.6	62.9	58.5	44.1	2.1	126.2	41.2	45.6	129.1	79.2	209.9	40.3	32.9	33.9	58.7	24.0	5.4	73.0	63.3	44.5	17.3	29.6	275.5	37.4	52.8	64.0	83.2	13.5	6.7	65.8	44.7	53.3	45.6	420.8	24.2	39.5	46.2	12.2	98.1	64.7	43.3	12.5	14.8	40.1	45.7	39.9	28.1	49.0	83.9	173.8	94.6	18.8	26.3	58.1	50.1	119.0	39.4	43.5	32.7	64.3	55.3	39.9	46.7	48.3
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA051614: AB_2681551, HPA065734: AB_2685549"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	19.9	18.1	11.0	14.1	12.8	30.3	23.7	12.4	12.9	17.0	13.4	18.6	12.5	15.8	18.6	17.0	13.4	15.9	23.8	11.2	12.4	18.9	17.8	14.2	21.7	12.2	11.9	19.0	12.8	17.8	11.2	19.6	12.6	13.2	17.5	16.7	16.0	13.9	33.6	15.8	12.3	16.1	11.8	14.5	16.6	15.5	12.7	26.0	18.1	27.2	26.1	20.7	14.7	16.1	43.0	36.3	42.3	26.9	32.7	48.9	20.5	33.5	62.5	58.2	67.0	23.4	39.9	53.2	38.5	32.0	42.9	31.1	33.4	28.2	58.8	60.0	32.4	75.4	20.0	34.1	47.7	22.8	22.1	36.5	38.4	33.6	43.6	38.8	53.2	27.5	44.1	34.2	51.4	74.3	58.9	20.9	9.3	48.4	48.0	33.3	29.4	48.6	35.5	32.1	28.0	29.7	40.1	119.2	56.3	24.9	50.9	25.9	33.3	22.3	62.9	27.8	48.3	45.1	86.6	67.6	35.4	43.4	35.3	12.9	23.9	69.4	22.0	21.7	24.3	25.0	23.1	24.8	24.4	25.5	23.7	25.9	11.3	22.0	23.3	14.2	37.6	24.5	11.0	12.8	12.4	12.9	11.2	12.4	12.2	11.9	12.6	11.8	12.7	16.1	21.8	9.6	13.1	136.1	22.0	23.8	36.3	39.1	21.1	23.8	23.3	24.8	20.1	21.5	26.0	11.0	16.7	34.2	20.3	16.2	27.4	33.1	28.0	26.4	19.7	23.0	13.8	36.2	150.1	42.5	27.8	21.4	13.7	20.7	25.4	24.1	23.2	13.7	44.3	15.2	156.8	17.7	18.3	26.5	24.3	9.9	23.3	24.4	17.8	157.4	29.4	18.4	20.6	139.2	386.0	34.2	19.5	24.5	20.2	28.1	20.6	35.2	23.4	26.4	6.6	20.7	23.4	44.4	31.7	16.0	18.9	46.7	24.6	20.9	19.8	37.6
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957091-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124"	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	27.3	20.6	9.3	14.6	11.8	20.2	27.4	10.8	13.3	23.0	9.3	37.0	24.7	23.4	12.4	19.2	22.8	14.4	21.2	9.5	10.0	15.6	25.2	16.9	23.8	10.9	10.8	22.7	30.0	15.1	11.2	14.1	10.9	24.8	21.0	10.7	24.4	16.5	20.6	19.4	26.8	17.7	10.4	23.3	29.5	4.9	10.6	21.5	21.1	8.4	19.7	30.0	20.8	13.2	43.4	51.9	55.0	49.0	18.9	24.7	40.3	23.7	42.3	40.0	55.2	40.5	32.8	57.2	17.9	18.9	22.0	36.7	32.5	26.0	31.5	69.0	76.3	37.5	17.0	76.5	16.0	43.2	25.5	16.9	19.4	23.5	37.9	22.4	42.8	51.5	35.1	40.3	22.6	35.1	78.2	62.8	28.7	30.7	40.4	66.9	42.4	61.2	27.7	35.4	14.9	29.1	27.0	18.1	38.2	22.0	20.0	40.3	35.3	15.8	28.0	26.8	49.6	53.0	60.6	88.0	19.7	57.5	17.3	0.3	31.5	19.5	29.6	38.3	34.4	50.6	39.5	38.7	33.1	46.6	41.4	33.6	2.9	41.7	38.5	51.5	48.3	36.5	9.3	11.8	10.8	13.3	9.5	10.0	10.9	10.8	10.9	10.4	10.6	13.2	49.3	22.4	33.1	9.4	35.5	17.0	45.0	47.0	23.9	20.3	30.4	34.3	23.1	30.0	31.8	12.9	33.3	56.4	40.0	35.8	35.2	28.0	0.7	16.8	15.4	33.9	21.6	26.1	5.3	61.2	38.0	25.9	28.5	17.0	11.4	34.6	18.5	33.3	35.6	26.9	5.4	35.1	46.8	20.0	19.2	1.6	35.4	22.4	21.4	7.5	48.6	33.3	40.2	7.5	17.4	30.4	37.0	33.4	36.3	41.9	36.8	39.2	21.6	37.4	26.3	27.1	31.3	6.7	16.6	35.5	21.6	66.2	29.3	39.6	44.8	47.9
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447570-137459334	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 361.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Peritubular cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favorable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	23.1	14.5	167.1	12.6	154.3	12.2	20.3	66.6	361.3	24.2	73.4	22.7	29.9	32.8	10.7	16.3	28.7	9.7	16.1	360.8	115.1	30.8	23.5	19.8	13.0	99.7	153.1	22.5	31.6	17.9	70.6	7.1	75.1	31.2	10.4	12.1	20.2	13.8	8.9	20.6	24.9	13.9	109.9	17.0	23.5	18.9	210.5	8.4	23.9	3.9	10.3	22.2	17.5	105.4	24.4	19.3	33.7	50.4	77.1	36.4	28.9	23.0	30.2	21.5	16.5	51.7	14.3	30.2	30.3	34.0	48.1	72.7	50.0	30.9	12.9	39.7	53.8	23.5	46.7	69.5	41.7	16.2	51.5	41.7	57.9	25.1	58.3	48.5	23.1	0.8	55.0	4.9	29.2	56.4	0.7	69.8	42.9	97.6	51.4	14.6	53.3	68.0	14.9	12.1	135.7	112.8	55.0	30.3	35.7	13.9	21.5	33.0	58.6	37.9	30.9	92.9	39.6	10.3	17.0	45.8	21.6	21.2	35.6	1.6	2.1	3.5	1.5	13.8	0.3	0.2	0.5	0.9	6.3	0.1	0.5	0.7	0.3	0.0	12.1	0.2	0.8	1.8	167.1	154.3	66.6	361.3	360.8	115.1	99.7	153.1	75.1	109.9	210.5	105.4	9.9	0.0	3.9	71.5	5.9	13.6	9.4	3.6	7.4	9.6	14.3	12.4	6.1	11.5	2.3	11.0	8.4	0.4	17.7	40.7	5.9	8.2	7.1	7.6	18.3	9.5	19.2	1.7	24.2	21.4	1.3	11.0	10.2	11.1	2.5	12.0	9.7	26.3	6.7	28.6	14.9	21.3	8.2	8.6	21.2	15.3	23.9	10.5	16.0	15.9	9.8	10.3	6.2	16.1	5.3	21.4	34.3	71.5	8.5	32.6	43.4	29.7	2.9	12.9	13.1	8.3	10.9	3.0	5.9	6.3	14.6	1.5	8.0	11.0	20.5	16.7
NSRP1	"CCDC55, DKFZP434K1421, NSrp70"	ENSG00000126653	"Nuclear speckle splicing regulatory protein 1"	Q9H0G5	17	30115521-30186475	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015593, HPA015603"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA015593: AB_2072217, HPA015603: AB_1846157"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.43e-1)"	23.1	18.8	25.0	18.8	28.4	25.0	21.9	34.0	34.4	18.6	32.5	25.0	16.8	22.9	22.5	19.5	19.6	19.6	25.8	21.7	28.5	21.4	20.2	18.8	22.3	29.8	25.5	22.8	20.3	24.2	17.9	22.0	27.9	20.5	18.3	19.5	18.0	17.9	25.2	25.0	17.9	21.1	25.0	19.4	19.1	19.3	26.9	17.6	25.5	20.8	19.9	21.1	18.0	34.7	30.9	27.3	26.3	21.0	35.0	33.0	18.6	41.8	42.6	31.4	33.5	28.3	19.6	56.1	32.6	39.8	38.5	44.4	41.1	32.2	50.8	13.5	55.7	25.6	43.8	21.1	56.5	40.0	29.8	38.3	41.5	50.1	64.6	36.5	29.7	20.3	41.0	35.6	43.8	22.1	26.9	39.0	17.4	33.8	22.0	30.8	43.3	37.8	32.5	32.9	24.8	21.6	32.1	84.2	38.6	26.4	44.1	44.3	32.4	37.7	26.7	40.0	67.1	25.8	36.9	44.1	46.5	35.5	44.1	66.1	39.7	33.1	32.2	38.2	36.0	62.1	35.8	32.1	21.5	57.9	34.6	31.5	59.5	32.8	44.4	62.4	35.6	14.5	25.0	28.4	34.0	34.4	21.7	28.5	29.8	25.5	27.9	25.0	26.9	34.7	97.5	76.9	91.0	49.0	59.2	67.6	95.9	124.0	88.8	62.6	51.4	64.1	147.3	72.9	80.6	84.6	35.5	58.3	54.0	57.5	97.8	71.7	259.2	79.2	89.6	91.9	31.3	68.0	30.6	75.2	69.5	76.3	37.8	76.6	83.4	43.6	94.9	143.7	53.6	74.0	41.9	65.1	59.0	63.1	46.5	137.0	77.0	52.3	49.8	69.3	70.6	78.7	63.8	52.8	88.5	71.1	54.1	71.5	48.2	75.8	57.9	90.6	84.9	56.8	72.3	113.1	97.1	186.9	105.8	40.7	52.0	110.8	52.5	56.1	54.3	63.2
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	21.6	16.0	10.4	29.1	10.9	28.2	38.6	11.3	13.4	16.2	12.0	24.7	20.8	18.2	19.5	24.1	17.7	17.8	23.0	10.8	11.3	16.4	36.7	19.5	34.3	11.2	10.6	18.0	20.0	24.9	11.5	19.8	11.2	20.7	27.7	10.9	17.9	17.0	39.0	22.7	20.4	22.4	10.4	23.0	21.4	18.9	11.8	26.5	18.0	30.2	36.8	29.3	15.0	13.2	97.6	85.8	49.9	45.4	31.7	36.1	112.9	72.5	48.6	84.4	71.5	113.0	75.6	170.6	74.0	63.8	101.6	70.7	102.1	90.6	114.6	115.1	73.4	100.8	199.0	67.0	44.8	176.8	77.4	40.2	67.5	91.8	80.5	33.6	60.6	70.3	132.3	66.3	79.9	71.1	93.2	89.3	80.0	69.3	101.3	121.1	50.5	54.7	61.7	112.1	45.8	65.4	184.4	101.2	79.1	65.0	85.0	84.2	66.6	66.8	82.0	68.4	111.1	51.2	100.1	159.9	52.9	143.9	77.6	16.2	18.6	21.2	21.1	22.4	27.9	22.4	22.1	25.0	21.5	20.6	23.2	23.5	3.9	24.4	21.2	20.2	17.0	17.0	10.4	10.9	11.3	13.4	10.8	11.3	11.2	10.6	11.2	10.4	11.8	13.2	13.2	19.2	17.6	27.7	26.3	37.7	16.4	15.7	21.6	6.2	15.5	14.2	18.7	17.2	30.3	18.4	14.6	20.1	17.1	16.2	9.8	19.6	3.1	11.2	12.9	16.2	14.9	22.3	37.2	15.3	21.2	14.5	17.9	14.1	20.8	17.8	10.0	33.9	14.4	3.3	30.2	16.5	16.2	18.5	21.1	2.9	13.1	16.4	16.0	20.6	21.9	7.2	21.6	24.1	45.4	24.8	14.8	14.3	23.0	18.9	10.2	9.8	17.4	7.3	6.6	20.2	15.4	14.9	17.7	30.1	30.5	23.1	20.7	17.2	19.8	17.0
NSUN3	FLJ22609	ENSG00000178694	"NOP2/Sun RNA methyltransferase 3"	Q9H649	3	94062980-94131832	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036181	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036181: AB_10602715"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-1)"	"unprognostic (7.35e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.63e-3)"	"unprognostic (6.94e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.33e-2)"	2.5	2.8	2.0	2.7	2.6	3.7	2.9	2.7	2.9	2.7	1.1	3.5	3.1	2.8	3.2	2.3	2.6	2.3	2.4	1.8	1.8	2.4	3.1	2.7	3.2	1.5	1.5	3.2	3.1	2.3	2.3	2.2	1.7	2.7	3.9	3.4	2.7	2.0	1.1	3.3	3.0	2.5	1.3	3.5	3.2	3.3	1.8	3.3	3.0	1.4	2.8	2.6	2.5	2.5	2.5	2.9	3.5	2.9	2.1	3.0	1.5	3.5	2.7	3.9	4.3	1.7	2.3	3.9	4.1	2.4	2.7	3.3	3.9	2.8	5.4	6.1	2.7	6.1	4.0	2.8	2.4	6.5	5.2	2.8	3.1	3.1	3.1	3.5	3.2	4.0	2.5	5.3	3.5	2.5	5.8	3.4	3.2	2.9	3.6	4.8	6.0	3.8	3.4	2.3	6.5	4.8	3.6	2.6	3.8	2.4	4.3	4.0	3.5	3.1	3.1	1.8	4.2	4.3	5.2	6.6	4.1	5.7	4.6	5.5	1.9	2.0	2.2	1.9	2.3	2.0	2.0	2.1	1.6	1.8	2.1	2.5	3.3	2.9	2.9	2.3	2.3	1.3	2.0	2.6	2.7	2.9	1.8	1.8	1.5	1.5	1.7	1.3	1.8	2.5	8.5	6.4	3.2	34.3	13.9	3.1	7.3	11.3	9.6	8.3	5.2	3.6	4.5	4.3	12.4	7.3	10.4	6.4	11.6	11.9	5.9	8.1	79.3	9.9	9.8	8.0	2.4	32.2	27.1	7.8	3.8	7.4	13.3	7.1	2.5	10.2	7.1	6.3	6.4	11.8	29.6	9.4	12.2	10.7	4.6	26.2	4.4	9.9	3.6	30.0	10.4	13.2	10.3	38.2	42.9	8.1	9.9	4.1	7.1	5.0	12.6	9.5	12.7	7.2	6.6	5.4	7.2	8.7	8.4	6.1	3.4	4.0	10.8	9.3	6.9	7.9
NSUN4	"MGC22960, SHTAP"	ENSG00000117481	"NOP2/Sun RNA methyltransferase 4"	Q96CB9	1	46340177-46365152	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	15	"testis: 89.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 144.5;Late spermatids: 513.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA028489	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA028489: AB_10601444"	"unprognostic (3.28e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.28e-1)"	3.6	5.2	0.7	2.8	0.9	5.9	3.0	1.8	1.5	2.7	1.6	2.6	2.8	2.7	1.2	3.9	2.6	3.6	3.8	0.7	1.2	3.6	4.4	3.0	2.7	1.4	1.7	3.6	3.0	3.3	3.6	3.5	1.5	3.6	3.0	2.3	3.5	2.3	3.7	3.3	2.7	3.0	0.3	3.4	2.7	89.0	1.2	3.1	3.3	3.6	4.0	4.4	3.1	1.2	4.1	8.5	6.4	7.6	7.6	5.6	9.2	4.2	5.3	8.5	9.2	10.2	3.6	10.4	11.4	6.3	11.9	6.1	5.7	9.3	6.4	12.4	9.8	10.2	9.4	13.9	8.9	7.9	7.5	7.5	9.4	11.8	13.1	3.4	9.5	8.1	15.9	10.7	8.8	12.8	6.8	4.3	7.6	6.0	3.9	9.3	4.2	14.0	14.7	13.4	9.7	3.4	6.7	8.3	8.6	6.4	5.4	9.9	7.2	5.7	6.2	4.2	5.1	5.9	5.5	9.1	3.2	9.9	6.6	2.3	7.6	8.3	3.4	5.1	4.7	7.8	3.6	4.4	7.1	5.9	4.2	3.0	20.5	4.4	4.0	8.7	2.0	3.7	0.7	0.9	1.8	1.5	0.7	1.2	1.4	1.7	1.5	0.3	1.2	1.2	8.1	19.2	17.5	10.4	13.7	5.6	13.0	8.1	13.6	9.1	9.5	8.1	14.6	17.2	12.4	9.2	8.4	11.1	11.5	5.4	1.9	9.1	144.5	10.4	9.4	13.3	7.8	17.7	13.8	6.9	11.3	9.4	14.8	12.4	29.8	9.4	8.9	12.6	9.3	5.0	14.7	9.0	4.1	13.1	8.6	513.8	12.5	14.1	3.6	8.4	9.2	5.7	4.1	11.1	12.5	9.0	5.8	10.9	12.5	16.0	5.7	11.8	8.4	11.5	0.0	11.0	9.2	7.6	11.4	13.1	5.8	15.2	8.8	11.3	9.0	15.2
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase 5"	Q96P11	7	73302516-73308826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	13.9	11.6	9.8	9.7	11.3	33.4	14.1	11.7	12.9	15.3	9.1	18.6	8.9	18.7	3.2	17.7	15.5	4.2	17.7	9.8	10.9	17.4	16.2	12.1	14.2	12.8	10.8	13.0	24.0	6.6	12.8	6.1	11.7	15.5	4.3	3.2	14.6	6.3	37.9	19.7	17.7	6.2	11.6	24.4	16.3	20.7	11.0	13.0	13.6	8.1	9.4	18.6	14.7	13.3	34.7	46.4	12.3	29.3	4.8	6.3	48.4	15.3	9.1	23.6	25.3	63.0	24.3	55.3	10.6	7.7	34.6	28.9	23.7	15.2	8.1	36.6	57.0	20.7	35.8	36.4	20.0	45.9	26.0	8.3	25.7	20.0	17.3	5.2	3.1	40.4	71.0	12.7	10.8	83.2	39.3	91.6	52.1	24.9	34.9	48.9	9.5	79.8	10.1	17.1	33.2	54.6	27.9	72.5	36.4	12.8	47.9	37.1	5.3	0.2	34.8	34.7	11.1	49.6	73.8	80.8	0.5	65.6	2.5	23.7	21.5	24.0	19.6	19.6	15.7	32.2	22.3	20.4	25.0	46.2	31.0	26.5	27.4	26.8	14.8	31.5	26.9	23.2	9.8	11.3	11.7	12.9	9.8	10.9	12.8	10.8	11.7	11.6	11.0	13.3	11.1	6.4	7.4	14.4	38.2	17.0	20.0	32.8	14.8	27.5	23.0	25.0	20.4	27.1	21.3	36.8	12.5	37.7	27.3	18.3	37.2	35.8	17.4	18.1	12.7	8.9	3.6	19.1	9.2	33.0	48.9	17.2	21.4	15.5	26.6	50.5	5.3	21.0	36.6	32.0	9.3	18.3	26.4	21.0	10.8	21.6	29.2	20.2	21.4	3.7	39.9	13.2	36.0	10.1	12.1	29.1	20.5	20.7	24.9	12.6	28.4	25.1	21.8	23.1	6.6	20.8	16.8	64.2	56.7	15.1	21.3	21.8	24.9	16.2	23.1	14.3
NSUN6	"ARL5B-AS1, FLJ23743, NOPD1"	ENSG00000241058	"NOP2/Sun RNA methyltransferase 6"	Q8TEA1	10	18545561-18659285	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 61.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045902	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA045902: AB_10962354"	"unprognostic (7.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-3)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (2.23e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.00e-3)"	6.4	12.2	13.6	7.5	14.3	12.4	9.3	16.0	15.9	9.0	13.5	6.1	8.6	9.6	12.2	5.7	8.7	6.0	8.6	14.0	14.1	10.6	61.1	6.5	11.3	13.8	14.8	12.7	12.0	7.8	17.2	6.5	14.7	10.5	8.4	12.9	8.4	5.6	4.5	9.1	8.7	6.1	13.9	9.8	8.5	17.5	13.8	11.8	12.0	4.8	10.9	9.1	7.6	17.6	7.5	6.3	16.6	12.3	8.1	11.1	7.2	10.3	2.5	8.4	11.3	12.0	11.2	17.0	4.3	4.0	5.9	11.0	17.1	10.8	10.8	16.6	13.9	17.8	8.8	14.5	8.3	8.1	11.6	8.6	10.3	8.0	5.5	8.3	3.9	20.0	25.1	16.1	8.2	4.2	18.6	9.3	8.5	14.8	4.8	13.1	8.6	17.4	6.3	9.1	8.9	11.0	8.7	9.0	7.3	11.3	5.8	6.4	6.7	7.0	8.1	12.8	7.6	9.9	11.0	18.8	5.0	14.5	4.3	1.5	3.5	2.8	4.4	4.7	7.0	8.0	6.3	5.6	2.9	6.1	7.8	6.7	1.6	5.3	8.2	4.0	10.5	2.5	13.6	14.3	16.0	15.9	14.0	14.1	13.8	14.8	14.7	13.9	13.8	17.6	75.4	9.6	15.1	57.8	34.9	28.7	17.1	11.0	30.1	33.2	32.4	34.7	8.1	18.6	13.6	9.2	22.9	10.1	39.6	19.5	5.9	10.0	19.7	23.6	38.9	37.5	14.5	20.8	43.5	12.7	8.0	19.2	40.2	49.0	17.7	32.0	26.7	86.6	7.4	25.2	45.0	24.5	18.3	24.2	52.4	12.7	25.7	28.5	12.4	23.4	15.3	15.3	17.5	43.7	57.6	11.1	20.0	17.0	31.0	10.1	40.2	10.9	14.5	28.9	13.1	20.1	19.1	49.5	21.8	21.3	26.7	6.7	31.0	26.7	18.7	14.2
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749925-40811184	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.6	0.9	0.6	1.0	0.6	0.6	3.8	0.4	0.4	2.5	7.2	2.8	1.7	2.2	2.7	1.8	6.8	1.2	2.1	0.5	1.5	4.7	0.4	3.3	0.3	1.8	2.4	2.3	7.2	3.3	3.6	1.3	1.5	4.5	2.4	0.7	4.8	1.5	0.0	1.5	2.1	1.2	1.2	2.7	3.2	16.5	2.0	0.3	4.7	0.2	0.3	1.3	1.2	0.8	2.6	0.1	1.2	0.0	0.0	0.0	1.7	0.0	0.2	0.1	0.1	1.0	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.6	0.1	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.4	0.7	0.6	1.5	0.3	1.7	0.0	3.0	3.9	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.4	0.5	1.5	1.8	2.4	1.5	1.2	2.0	0.8	0.1	9.6	7.8	3.6	4.3	1.1	3.1	1.5	2.2	0.1	8.6	7.1	3.5	0.0	10.5	9.2	0.0	9.2	0.1	2.7	9.8	5.8	47.5	20.7	0.9	0.6	8.3	0.4	0.7	5.4	3.6	1.2	4.6	5.4	0.0	8.5	0.7	0.2	3.8	0.0	0.9	7.1	4.1	0.8	0.4	75.6	1.5	2.2	0.0	8.4	1.0	2.1	0.0	18.1	1.3	4.7	2.7	0.0	0.3	4.5	2.2	5.5	36.4	0.1	0.0	0.4	0.8	38.9	11.4	8.2	1.0	4.5	0.7	3.4	7.7	5.7
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131757	"Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		760000	"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	31.6	31.4	14.5	17.9	15.9	16.3	31.8	16.5	17.4	37.0	14.8	43.0	24.5	34.7	5.2	45.9	32.1	8.4	32.6	14.1	16.7	47.8	29.1	29.2	18.3	17.1	15.5	37.5	33.7	11.7	18.9	10.2	15.6	35.7	13.1	8.7	25.8	15.3	41.1	33.8	43.7	7.6	16.6	40.7	36.8	15.2	15.5	16.0	37.7	16.1	15.2	37.9	35.9	18.4	52.5	77.7	25.3	26.5	7.5	15.4	33.7	29.5	26.2	29.7	18.8	29.5	58.3	35.5	21.5	21.0	5.2	33.7	18.1	37.7	16.5	16.1	51.3	40.5	68.7	50.0	38.0	38.8	17.2	23.1	17.4	21.3	57.0	11.9	33.0	27.6	38.4	16.8	30.2	51.2	28.0	39.0	26.5	43.6	50.6	24.9	32.9	50.9	39.3	26.7	30.0	60.1	28.3	34.8	43.9	14.0	49.8	27.2	20.4	25.0	62.1	9.8	40.3	33.3	5.6	41.1	23.8	23.3	40.4	183.7	29.7	48.9	39.2	49.6	27.7	94.9	25.5	33.6	37.9	87.4	21.6	33.5	14.4	72.6	50.7	50.4	45.2	30.2	14.5	15.9	16.5	17.4	14.1	16.7	17.1	15.5	15.6	16.6	15.5	18.4	23.0	32.1	19.5	22.2	132.9	47.4	86.1	108.8	90.5	66.0	58.8	101.9	16.4	77.2	35.2	58.8	20.9	64.9	85.8	272.8	78.2	102.2	2.1	53.2	53.5	26.6	64.1	59.5	7.7	121.4	100.4	59.8	181.5	43.2	46.3	59.0	11.7	41.9	74.5	42.1	8.0	133.4	52.9	55.7	64.4	6.8	59.4	56.2	58.7	18.7	108.4	55.9	98.9	19.6	19.2	127.5	221.6	47.4	51.2	115.8	231.6	144.2	31.1	65.5	32.9	39.0	107.6	19.0	49.6	89.4	44.3	31.2	67.4	98.4	152.8	85.9
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 72.4;tongue: 28.6"	"Cell type enhanced"	"Detected in single"		"Inhibitory neurons: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050283, HPA054158"	Supported					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.2	2.6	1.4	0.1	0.8	0.0	0.0	4.8	5.4	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.2	0.0	11.4	0.7	1.6	0.4	0.0	0.0	0.0	3.0	3.1	0.1	3.9	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.1	0.1	72.4	0.0	0.1	0.1	1.4	0.0	0.1	0.2	2.2	0.1	0.0	28.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	17.8	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	4.8	5.4	0.7	1.6	3.0	3.1	2.0	1.4	2.2	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 35.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 159.5;Late spermatids: 300.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.5	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.1	2.6	0.1	0.7	0.1	0.0	1.0	0.1	0.7	0.6	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.0	0.1	0.2	0.8	35.5	0.4	0.0	0.7	0.0	0.0	0.3	0.1	0.2	1.2	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.4	0.1	0.0	1.0	0.0	0.1	0.2	0.2	0.6	0.1	0.2	0.3	0.0	1.1	0.8	0.4	0.9	0.1	0.5	0.1	0.2	0.2	0.6	0.5	0.3	1.0	0.1	0.3	0.2	0.7	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.4	0.4	0.1	0.3	0.8	0.7	0.0	0.2	0.0	1.2	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	159.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	300.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	126	"testis: 16.6"	"Group enriched"	"Detected in some"	97	"Early spermatids: 52.3;Late spermatids: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG45, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103087185-103277605	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	24.6	27.0	25.0	19.0	27.2	29.7	23.0	27.3	28.5	37.6	36.8	27.3	9.9	18.8	17.3	67.1	26.5	16.4	28.5	25.2	28.8	32.5	27.8	30.8	18.3	26.9	29.5	32.4	22.0	21.7	34.0	17.9	27.2	32.4	16.7	47.3	46.4	18.4	51.6	19.9	20.4	13.4	26.4	32.8	22.3	30.8	27.2	28.6	55.4	18.1	24.5	33.3	42.7	28.6	148.4	52.5	32.6	67.5	27.2	33.2	18.2	66.0	64.7	29.9	32.4	34.6	91.7	49.2	47.7	45.6	27.6	62.8	23.4	33.8	38.3	40.3	21.6	38.7	21.1	39.6	48.5	64.2	21.0	50.4	34.1	28.0	24.8	57.5	25.6	19.4	29.4	36.4	54.5	73.8	53.7	64.6	34.6	43.2	68.6	102.6	30.0	19.6	43.3	72.5	10.0	24.9	35.8	25.9	50.3	33.7	39.2	38.1	30.5	20.5	24.8	39.7	51.7	32.9	71.6	85.5	23.9	64.6	7.8	29.5	16.5	31.3	10.0	18.8	10.3	8.9	8.4	8.7	14.7	5.2	6.7	8.0	27.4	14.4	23.0	9.6	9.3	10.5	25.0	27.2	27.3	28.5	25.2	28.8	26.9	29.5	27.2	26.4	27.2	28.6	16.2	83.3	34.9	141.7	17.2	7.4	29.0	26.9	5.7	24.4	13.9	13.6	2.6	18.6	60.4	27.6	45.9	19.4	23.3	48.7	11.7	28.5	103.7	29.5	17.1	19.8	11.5	12.4	79.8	26.0	11.7	17.5	25.5	46.2	8.8	18.2	13.9	17.4	19.9	47.1	83.6	17.6	18.3	29.8	14.2	61.9	24.8	27.1	26.6	78.7	25.9	85.5	16.5	70.4	107.5	57.9	23.1	13.5	21.0	35.7	11.7	15.3	44.1	59.1	32.9	22.9	21.7	25.3	20.5	22.9	7.5	35.0	16.6	15.8	18.0	80.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825057-41836260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	7.9	7.6	12.4	1.5	12.8	1.2	7.6	15.5	13.4	7.6	10.8	12.9	1.9	7.0	3.3	6.3	7.0	3.2	7.1	13.0	12.3	11.1	8.7	6.5	2.8	10.9	11.3	7.4	11.5	2.8	9.9	3.0	10.6	9.0	1.1	3.6	7.8	4.2	6.0	4.7	6.5	4.8	10.0	5.7	8.9	9.5	11.8	0.9	13.0	5.6	1.9	8.9	6.8	12.7	8.1	39.5	7.8	12.7	8.6	6.0	3.2	9.5	8.5	12.9	14.3	34.0	2.1	9.3	5.6	6.3	8.6	8.3	8.2	9.9	4.6	5.9	19.7	4.1	21.8	17.8	10.1	0.1	4.7	5.3	5.4	17.4	6.5	4.7	7.5	13.8	3.6	2.4	8.6	18.0	8.2	5.1	5.0	7.9	4.2	6.2	13.2	7.8	3.7	10.0	6.0	3.5	13.4	13.8	4.9	6.7	6.7	6.3	7.1	5.3	5.4	9.3	9.5	2.7	5.6	4.2	4.2	0.1	8.1	1.1	2.3	0.3	1.8	0.5	2.5	1.8	2.4	1.8	2.4	2.5	1.9	2.1	1.3	0.7	0.4	1.3	0.4	2.0	12.4	12.8	15.5	13.4	13.0	12.3	10.9	11.3	10.6	10.0	11.8	12.7	24.8	9.6	17.2	15.0	16.9	18.1	58.7	47.3	33.6	33.8	45.1	61.1	13.6	22.8	16.6	29.5	18.8	39.0	8.7	5.1	101.8	51.6	99.8	10.9	26.8	29.1	39.4	2.5	14.2	41.6	56.2	35.2	14.3	12.1	11.4	40.1	26.7	24.0	13.4	116.1	15.5	13.2	32.6	13.2	18.5	121.6	32.3	11.7	35.6	6.5	5.8	42.4	6.2	13.0	7.2	39.1	9.8	30.5	15.5	78.7	1.4	65.1	12.7	36.5	39.5	31.1	49.3	131.8	30.0	19.8	17.2	31.2	13.8	23.7	15.2	44.6
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 117.6"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.5	24.0	11.4	12.7	24.6	10.0	19.2	22.7	15.0	10.4	117.6	19.8	29.5	9.1	22.4	16.5	20.6	15.7	25.9	11.0	16.3	28.2	42.6	16.7	21.4	24.1	20.9	13.2	22.2	23.8	9.6	8.3	24.1	28.3	19.9	11.2	22.7	16.6	21.5	10.7	26.8	11.3	21.0	13.5	21.6	10.6	19.3	14.5	28.3	23.2	22.4	15.8	9.4	40.9	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	11.4	24.6	22.7	15.0	11.0	16.3	24.1	20.9	24.1	21.0	19.3	40.9	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
NT5DC2	FLJ12442	ENSG00000168268	"5'-nucleotidase domain containing 2"	Q9H857	3	52524385-52535054	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 69.2;Peritubular cells: 135.4;Sertoli cells: 111.7;Smooth muscle cells: 83.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050683	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA050683: AB_2681215"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	30.3	73.2	26.0	18.6	25.2	15.5	27.9	38.6	29.8	48.0	43.2	18.3	13.7	36.3	27.5	69.4	29.5	12.1	117.5	26.0	30.2	30.6	7.8	33.6	16.3	41.8	46.6	45.3	15.6	16.5	50.8	32.7	64.0	74.9	12.7	8.5	43.5	39.3	10.3	49.0	16.2	20.8	26.8	18.6	16.4	49.7	27.6	9.9	26.3	10.9	22.9	40.7	38.7	25.9	138.8	73.7	238.9	128.4	186.2	252.3	188.3	139.6	121.2	95.4	78.0	216.5	66.8	174.4	15.1	177.9	76.0	47.3	194.9	179.8	90.0	71.0	123.8	104.1	122.1	337.4	274.9	0.1	88.8	333.0	40.9	162.9	49.4	175.4	203.0	125.2	194.9	57.5	112.0	145.5	72.7	179.2	318.1	125.6	234.6	104.6	100.3	168.8	52.7	35.5	111.1	323.3	54.7	101.2	71.8	178.6	96.0	98.5	95.1	123.7	153.8	123.8	298.9	25.9	47.3	129.4	369.4	0.7	152.1	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	26.0	25.2	38.6	29.8	26.0	30.2	41.8	46.6	64.0	26.8	27.6	25.9	20.9	9.6	11.5	2.6	12.9	7.8	26.6	15.2	30.1	18.4	54.6	69.2	14.0	5.7	13.0	12.9	0.0	3.4	3.3	3.1	17.6	10.1	6.9	5.3	20.0	12.6	12.6	8.0	0.9	2.3	24.8	24.8	8.6	10.8	18.4	36.4	11.0	1.2	10.4	1.7	1.2	6.0	10.2	10.1	8.8	19.7	49.7	7.8	16.0	1.9	2.8	36.6	1.0	5.0	1.5	7.0	0.6	135.4	21.4	23.4	0.6	9.3	2.7	4.7	111.7	18.6	83.4	6.2	37.9	23.5	13.8	2.3	2.8	15.8	7.2	12.7
NT5DC4		ENSG00000144130	"5'-nucleotidase domain containing 4"	Q86YG4	2	112721486-112742879	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.2"	"Group enriched"	"Detected in some"	11	"Early spermatids: 20.0;Late spermatids: 6.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"K-562: 16.1"					"Not detected"	"Not detected"			HPA046856	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA046856: AB_2679841"	"unprognostic (2.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.20e-4)"	"unprognostic (2.26e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.60e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-4)"	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.1	2.2	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	20.0	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Erythroid cells: 31.2;Horizontal cells: 16.8;Inhibitory neurons: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.5;RPMI-8226: 6.3;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	1.1	0.6	6.3	0.2	5.9	4.7	0.9	6.4	7.9	2.2	4.6	2.8	0.4	2.1	0.4	0.9	1.6	0.4	7.1	5.6	5.8	2.2	1.0	0.8	0.3	6.2	6.1	1.9	1.1	1.8	4.5	0.2	6.4	1.8	0.1	0.5	0.8	0.7	13.3	0.8	0.8	0.4	5.7	0.9	1.1	6.8	7.3	1.1	0.8	4.6	0.2	2.0	1.1	6.4	0.3	0.7	0.3	2.9	1.7	1.9	1.2	0.6	0.2	0.2	0.4	0.0	0.2	3.3	1.8	0.0	0.5	0.0	0.1	0.1	0.0	2.9	1.8	2.3	0.1	0.3	1.7	0.6	4.3	1.4	1.5	0.3	1.1	0.6	0.0	8.5	2.0	0.0	0.0	0.8	2.8	2.6	1.8	1.0	2.5	2.1	0.2	6.3	1.0	0.0	3.6	5.9	1.0	0.1	2.6	2.1	1.0	0.9	0.0	0.9	1.0	0.2	0.8	9.3	1.3	0.5	0.5	0.4	2.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.3	5.9	6.4	7.9	5.6	5.8	6.2	6.1	6.4	5.7	7.3	6.4	1.1	0.0	0.5	11.1	0.5	1.7	2.1	0.1	2.2	5.5	3.4	6.1	7.9	1.5	0.6	9.2	2.1	1.0	2.6	0.4	17.6	0.3	0.9	0.3	3.3	1.7	1.2	31.2	7.6	0.6	1.2	2.5	1.1	0.9	0.0	5.2	0.7	1.3	1.5	16.8	13.2	0.8	0.0	0.8	0.6	4.4	0.6	3.4	0.0	3.7	0.3	4.7	2.1	4.0	5.4	0.0	0.1	1.2	2.3	3.2	0.1	2.9	0.0	1.8	0.0	7.4	1.8	1.5	6.0	1.8	0.4	0.5	2.3	3.2	0.5	1.3
NTAQ1	"C8orf32, FLJ10204, WDYHV1"	ENSG00000156795	"N-terminal glutamine amidase 1"	Q96HA8	8	123416726-123470028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	7.1	10.9	16.2	5.1	16.7	5.9	13.5	16.3	24.0	12.8	15.5	7.5	4.3	8.1	8.9	6.9	7.5	6.7	20.1	14.8	17.8	13.0	6.8	6.8	7.4	17.0	17.9	18.2	9.6	11.0	10.5	6.8	17.4	10.2	7.9	14.9	6.9	8.8	16.0	7.7	4.4	9.5	15.8	5.2	8.5	12.7	20.0	7.1	12.8	17.6	10.1	8.8	7.2	17.7	26.6	26.9	39.2	18.1	15.3	40.9	14.5	19.1	21.3	23.4	26.1	15.8	17.8	19.7	19.8	23.8	32.7	12.8	25.8	29.7	31.4	53.1	15.8	25.6	13.2	22.4	21.2	12.7	10.9	24.1	16.0	29.3	32.8	27.1	22.6	41.2	18.8	29.0	33.5	84.3	30.2	14.4	12.3	65.6	20.5	13.5	20.0	20.4	31.1	22.6	18.6	34.1	20.7	109.0	35.8	44.5	17.6	12.2	9.8	26.5	46.2	19.7	26.4	17.4	38.1	24.1	18.8	14.1	19.1	16.3	5.7	2.1	6.2	8.7	7.4	5.0	7.3	7.7	9.0	4.1	6.2	6.9	1.5	16.0	3.8	5.2	10.6	4.6	16.2	16.7	16.3	24.0	14.8	17.8	17.0	17.9	17.4	15.8	20.0	17.7	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	13.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.0	0.3	0.0	0.0	0.0
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432108-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.5;Basal prostatic cells: 36.6;Basal squamous epithelial cells: 89.4;Prostatic glandular cells: 20.5;Sertoli cells: 32.9;Smooth muscle cells: 24.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.4;cerebral cortex: 1.3;hippocampal formation: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.4;BJ hTERT+ SV40 Large T+: 14.8;BJ hTERT+ SV40 Large T+ RasG12V: 19.7;HBF TERT88: 18.0;RT4: 8.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.7;cerebral cortex: 2.0;hippocampal formation: 2.2"	HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	4.2	1.8	0.2	0.7	0.4	0.0	2.7	3.4	1.3	6.6	0.2	1.8	1.9	1.9	2.0	3.4	2.9	1.8	3.1	1.2	0.3	2.6	7.7	1.6	0.3	0.4	0.2	11.1	0.2	0.1	1.0	1.9	0.3	3.6	1.0	0.1	3.1	2.4	1.8	3.2	2.5	0.9	0.3	4.5	2.5	0.8	0.1	0.4	0.9	1.0	0.4	4.6	7.0	0.2	1.9	0.0	6.7	0.0	0.0	0.0	0.0	4.5	11.4	14.8	19.7	0.1	0.2	0.0	6.7	7.3	0.0	2.4	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	4.5	4.7	8.5	0.3	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.2	0.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	1.3	1.2	0.3	0.4	0.2	0.3	0.3	0.1	0.2	1.0	0.0	0.0	0.0	0.0	18.5	36.6	0.7	89.4	0.0	0.2	10.3	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.1	0.0	0.0	5.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	2.1	0.1	8.4	0.3	7.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.9	0.0	20.5	0.2	0.0	0.8	0.0	32.9	6.8	24.0	0.5	0.8	5.0	3.3	0.1	0.5	0.5	0.2	6.9
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	11.7	9.3	13.8	6.2	14.7	4.7	11.0	14.8	19.7	15.5	11.1	16.8	6.6	15.4	3.1	11.3	13.8	6.0	15.8	13.5	14.2	9.8	21.9	10.7	8.4	15.4	13.9	16.1	9.9	4.8	11.5	5.6	15.6	11.2	5.6	1.8	16.0	11.5	9.7	9.3	11.1	5.3	13.6	16.7	13.2	8.7	15.2	7.6	9.6	6.8	5.9	11.8	12.5	14.2	29.8	74.2	20.8	32.2	8.5	15.9	22.8	12.1	13.2	23.1	14.6	53.0	28.8	63.0	25.2	10.7	15.1	26.2	26.1	29.0	4.0	28.9	63.3	19.5	47.7	60.9	11.5	22.4	22.3	13.2	14.9	12.3	13.2	15.4	33.4	37.0	22.2	22.6	9.0	34.9	33.9	88.3	46.2	37.3	47.3	80.8	22.0	103.5	17.2	10.7	43.9	43.5	13.2	41.0	25.4	7.6	29.6	23.5	12.9	19.9	21.5	17.5	23.1	30.3	38.0	26.9	8.8	31.7	24.9	4.2	15.0	3.4	14.4	26.0	16.2	37.5	17.3	16.7	25.7	32.8	12.8	15.4	0.7	19.1	22.5	26.3	34.0	14.4	13.8	14.7	14.8	19.7	13.5	14.2	15.4	13.9	15.6	13.6	15.2	14.2	47.2	28.9	27.5	2.9	12.9	8.7	16.4	21.6	8.0	8.8	18.9	23.4	14.1	44.3	28.3	3.7	0.0	10.5	8.1	75.6	17.6	16.3	8.1	20.4	19.5	36.5	67.4	26.7	3.0	9.1	18.3	17.6	16.3	23.3	5.7	20.5	51.0	866.4	13.4	6.7	3.6	85.3	54.9	25.5	17.6	23.8	33.8	9.3	21.4	2.8	9.7	10.7	18.6	3.0	4.9	12.1	81.6	25.2	16.0	6.4	12.8	28.8	23.5	8.1	13.1	8.1	23.6	5.4	32.0	11.7	10.1	2.7	12.2	20.6	56.8	21.0
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 321.8;choroid plexus: 89.2;retina: 74.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	175	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	175	"dendritic cells: 17.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"	NA	NA		58000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	17.9	4.7	137.2	2.3	138.8	0.0	2.9	165.1	321.8	1.6	89.2	12.0	2.5	1.3	0.6	9.4	0.9	9.6	30.5	136.9	131.5	2.3	0.3	25.8	0.4	144.0	135.4	0.3	0.9	22.1	0.9	0.7	143.6	1.9	3.8	74.8	2.7	2.8	0.9	6.1	4.6	4.5	135.0	0.5	2.0	0.6	154.2	0.5	1.1	5.0	0.4	3.5	1.8	158.4	0.1	0.0	7.5	0.1	0.9	22.2	0.0	36.7	19.5	11.7	6.8	0.1	0.0	0.0	0.0	20.3	0.0	0.3	0.0	43.6	12.6	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.2	2.0	0.0	38.0	45.0	29.0	7.5	0.0	0.0	0.3	122.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	3.9	20.8	0.0	2.4	3.8	0.0	0.0	0.2	1.3	0.0	0.1	8.1	47.7	81.8	2.2	31.6	0.0	0.0	0.2	0.1	0.0	166.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	137.2	138.8	165.1	321.8	136.9	131.5	144.0	135.4	143.6	135.0	154.2	158.4	1.2	608.9	27.6	2164.2	0.0	1.8	0.0	1.5	2.2	225.3	0.9	4.4	13.7	0.0	29.7	20.2	950.8	0.0	5.4	0.4	0.0	0.6	10.9	0.0	0.5	2.9	0.0	2.7	651.0	0.0	0.0	22.2	0.5	0.0	53.0	0.1	0.7	0.0	0.1	40.4	1056.6	0.1	0.0	0.0	3.8	2.2	0.3	0.7	3.6	139.6	0.0	30.5	0.0	1930.7	1257.6	0.1	0.2	0.4	0.1	0.1	0.0	0.1	1.5	1415.0	0.0	20.6	7.5	0.4	0.9	0.5	4.8	0.0	0.8	0.0	0.8	0.1
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636135	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 761.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	26.4	68.6	20.6	19.3	21.7	24.5	22.1	23.6	27.0	22.5	22.4	23.2	18.3	19.6	15.9	20.2	18.9	19.9	67.9	21.0	23.1	31.5	41.6	22.8	20.2	22.5	23.8	19.8	31.1	22.4	23.4	19.6	22.5	22.7	11.2	6.3	22.4	16.7	98.9	25.1	19.5	13.7	21.3	29.7	24.9	93.3	22.9	16.1	17.9	84.3	16.0	23.9	20.0	24.1	57.8	117.2	47.9	82.2	30.0	44.6	50.2	107.6	63.5	108.1	92.8	96.6	74.0	74.8	53.7	78.5	76.7	110.1	101.8	96.4	66.8	56.3	50.9	31.2	106.3	100.4	96.3	63.3	45.0	47.0	48.6	113.5	56.0	34.2	60.1	64.1	116.5	54.2	57.5	194.1	72.0	85.6	62.6	105.4	96.6	66.8	55.8	150.4	43.7	32.4	96.5	48.5	53.1	97.3	74.7	30.2	81.4	32.4	41.8	129.1	64.5	118.7	115.3	41.2	53.7	115.2	59.0	64.4	75.0	32.9	49.7	39.2	43.7	55.1	43.7	43.2	43.5	46.5	49.2	50.4	43.9	36.3	13.6	30.6	70.9	52.8	44.5	36.4	20.6	21.7	23.6	27.0	21.0	23.1	22.5	23.8	22.5	21.3	22.9	24.1	35.6	3.2	13.9	5.9	45.9	99.8	85.7	50.3	16.5	18.3	33.4	33.8	4.1	20.0	35.7	22.0	22.9	72.6	23.1	49.7	97.8	60.5	391.4	21.4	29.8	38.3	20.3	23.4	6.4	55.9	86.8	41.1	21.9	23.2	30.4	20.5	20.0	52.7	67.0	42.1	6.5	44.0	42.7	27.6	80.3	761.6	35.1	34.3	55.2	3.7	33.1	23.3	25.7	4.5	9.2	69.2	29.9	24.8	41.0	105.7	84.5	89.6	22.5	23.6	26.3	34.1	58.8	129.2	43.2	19.2	99.3	135.6	38.3	39.2	48.4	70.7
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021510-9244000	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;heart muscle: 59.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 137.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056419	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	6.4	0.5	4.5	3.6	6.4	0.1	5.3	10.1	4.9	9.3	2.8	14.7	6.7	9.6	3.5	18.9	10.3	7.3	59.4	3.8	7.0	2.0	6.9	4.3	0.2	12.7	37.1	0.9	2.3	4.3	3.0	0.9	14.4	3.9	3.9	0.4	10.9	2.0	2.1	8.1	10.5	6.0	13.8	0.1	17.5	3.1	10.1	2.9	2.0	2.6	2.1	10.2	5.4	8.8	0.1	0.0	1.3	4.6	4.2	0.1	27.5	0.3	0.4	0.3	0.5	0.1	5.7	0.0	6.2	0.0	9.0	0.1	1.2	0.9	0.0	6.4	10.4	1.4	0.0	0.0	0.1	0.5	0.1	0.1	2.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	5.6	0.1	0.6	1.8	0.0	0.0	3.4	4.8	0.0	0.0	0.3	0.0	0.0	0.1	4.7	1.1	4.5	16.6	0.3	0.0	6.7	14.4	0.0	22.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	6.4	10.1	4.9	3.8	7.0	12.7	37.1	14.4	13.8	10.1	8.8	0.7	0.0	0.0	10.7	0.3	3.3	6.6	21.8	9.6	2.9	4.7	4.4	28.1	0.0	23.9	1.8	0.0	0.3	0.2	0.5	0.0	3.1	9.3	5.8	2.0	3.1	0.0	0.0	4.8	1.7	1.2	9.7	1.1	7.9	0.0	0.0	2.2	12.4	0.1	0.0	7.1	1.4	24.4	0.6	5.9	4.6	0.3	0.1	1.8	9.4	0.6	0.3	0.0	137.2	1.0	1.4	0.1	0.0	0.0	4.0	0.7	0.2	11.1	0.2	0.0	3.9	6.8	1.6	2.0	12.7	2.8	0.5	0.5	0.0	0.6	3.5
NTN3	NTN2L	ENSG00000162068	"Netrin 3"	O00634	16	2471297-2474145	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 1.7;REH: 5.0;SCLC-21H: 5.8;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050817	Uncertain				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA050817: AB_2681247"	"unprognostic (2.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.61e-2)"	0.1	0.0	2.2	0.0	1.2	0.0	0.0	0.5	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	2.3	0.0	0.2	0.0	0.0	2.1	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.7	0.1	0.0	0.0	5.0	0.1	0.1	0.0	0.0	5.8	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.2	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	0.5	1.6	1.1	2.3	2.1	2.0	0.8	1.5	2.7	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NTN4		ENSG00000074527	"Netrin 4"	Q9HB63	12	95657807-95791189	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 181.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 198.6;Hepatic stellate cells: 369.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 513.8;hTERT-HME1: 205.8;PC-3: 189.6;TIME: 289.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049832	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA049832: AB_2680905"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (2.85e-1)"	"prognostic favorable (8.12e-9)"	"unprognostic (3.52e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (6.67e-5)"	24.4	17.3	6.4	5.7	7.5	0.1	72.9	4.4	10.5	26.5	12.0	16.5	12.0	12.7	15.3	15.6	34.4	22.4	66.8	8.9	5.7	107.6	26.7	70.2	2.9	5.9	8.7	86.1	62.5	13.3	7.6	11.9	5.7	42.4	18.1	0.6	32.6	59.1	12.6	8.8	17.5	15.0	6.1	181.5	48.7	12.1	6.2	6.2	14.4	19.9	6.5	49.5	14.4	8.7	26.7	71.3	2.0	0.1	28.5	45.0	3.0	49.7	513.8	67.1	78.2	56.1	48.8	0.0	3.5	105.3	88.1	42.2	0.6	15.3	34.0	0.0	4.3	2.3	12.7	11.1	1.7	0.0	0.1	1.1	43.5	75.0	205.8	72.9	133.3	0.4	0.0	0.1	25.4	20.0	0.2	0.3	1.1	7.9	189.6	0.2	0.6	0.1	64.8	133.4	0.3	0.6	60.5	77.1	1.3	2.3	22.2	0.1	289.3	25.9	9.5	101.3	5.2	0.1	0.1	0.0	5.9	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	7.5	4.4	10.5	8.9	5.7	5.9	8.7	5.7	6.1	6.2	8.7	31.9	41.7	123.2	6.2	3.8	4.7	120.5	15.2	39.3	1.8	77.6	55.4	44.8	44.3	30.8	198.6	0.0	6.2	1.3	4.4	5.9	36.7	10.3	36.4	3.2	35.5	0.0	2.7	28.1	28.0	3.6	33.7	23.0	28.1	1.3	25.9	369.5	10.2	0.4	0.0	70.6	37.2	4.1	26.3	3.7	3.8	2.1	2.6	7.2	20.6	0.6	0.3	0.0	112.6	1.8	36.7	4.0	3.4	0.9	108.9	1.5	84.3	38.0	0.2	26.3	119.0	73.9	1.9	0.6	5.9	2.3	1.6	3.3	1.4	6.4	127.0
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244526	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 40.4;brain: 74.6;retina: 26.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.9;Bipolar cells: 69.6;Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 108.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"basal ganglia: 74.6"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.8;HMC-1: 16.2;NB-4: 39.0;U-937: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071290	Approved				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA071290: AB_2686381"	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	0.6	1.9	18.6	1.1	74.6	40.4	0.2	13.3	25.6	0.8	0.0	0.5	1.2	0.5	0.3	0.3	0.5	0.8	5.5	17.6	6.5	0.7	0.3	2.9	1.4	11.5	5.4	0.2	1.0	4.4	1.7	0.5	14.7	6.2	0.2	26.7	0.8	1.1	0.4	0.4	0.8	0.3	5.0	3.9	0.6	2.1	11.4	0.5	0.4	1.4	0.4	0.8	0.6	11.5	0.0	0.5	0.2	0.6	0.6	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	0.2	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.9	6.8	16.2	0.1	0.0	0.2	0.1	1.4	0.0	1.3	0.0	0.0	0.5	0.2	0.3	39.0	1.4	0.0	0.2	0.4	0.4	0.2	0.0	0.0	4.6	4.2	0.2	0.0	0.1	0.0	0.0	0.6	0.1	0.9	2.8	3.6	0.1	0.1	0.0	0.0	1.3	10.0	1.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.6	74.6	13.3	25.6	17.6	6.5	11.5	5.4	14.7	5.0	11.4	11.5	0.8	0.0	0.6	34.9	0.5	0.3	0.6	0.0	0.6	69.6	0.1	1.0	3.0	0.0	0.6	0.0	171.0	0.1	5.0	0.0	0.0	0.3	1.4	0.6	2.4	1.3	0.0	0.4	8.1	0.0	0.0	1.9	0.0	1.1	1.3	0.9	0.7	0.1	0.7	1.7	3.6	0.2	0.0	0.3	0.3	1.3	0.6	1.2	1.8	8.4	0.9	20.3	3.1	11.1	21.5	0.1	0.0	1.2	2.0	2.3	0.0	0.1	0.0	108.3	6.6	2.4	1.8	0.5	0.2	0.2	0.3	0.1	1.2	4.3	0.1	0.3
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027054	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 230.0;thyroid gland: 116.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Supported	"Plasma membrane"		NA	NA		20000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	40.5	2.7	201.9	1.7	177.8	0.1	62.2	133.3	190.6	9.8	69.8	5.9	0.4	3.9	3.9	8.2	5.6	33.3	15.2	173.3	230.0	20.4	1.8	10.0	3.1	119.4	218.9	9.7	34.3	2.5	10.1	1.8	151.7	4.7	3.6	41.2	14.4	19.1	2.9	11.6	1.6	3.3	116.6	10.9	1.9	2.4	222.1	4.0	116.9	13.8	4.3	4.9	12.0	117.7	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	9.7	0.7	0.7	11.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	201.9	177.8	133.3	190.6	173.3	230.0	119.4	218.9	151.7	116.6	222.1	117.7	17.4	0.0	0.5	1144.3	0.7	56.6	1.0	1.8	93.9	30.3	144.1	116.8	11.4	0.0	0.2	9.2	6.2	0.0	1.0	8.7	27.4	36.1	1.8	1.2	0.4	8.0	0.0	0.0	750.1	0.7	0.1	76.6	0.0	2.3	0.0	0.1	5.0	0.0	0.2	242.3	877.7	0.7	0.0	0.0	14.2	3.6	104.1	1.4	17.8	65.6	0.6	241.0	0.0	557.9	109.5	0.5	7.0	48.2	0.3	0.9	0.0	7.1	1.7	12.2	124.9	9.9	114.4	0.8	2.3	5.2	24.6	0.0	3.3	0.2	7.2	0.9
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 100.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		19000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	12.8	3.7	31.3	0.8	33.2	0.1	7.8	30.7	34.3	12.8	0.0	3.4	0.5	10.4	3.2	1.3	15.0	1.6	5.8	38.8	25.8	5.1	1.0	5.3	1.2	21.5	19.6	7.2	1.0	0.1	12.2	1.0	22.1	9.0	2.0	5.2	6.8	4.3	1.8	4.8	2.2	3.7	10.9	2.5	3.2	9.8	33.4	1.2	3.0	1.9	2.0	8.7	7.4	21.5	0.0	13.1	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	2.6	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	100.6	1.8	0.0	1.3	0.0	0.0	0.0	3.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.3	33.2	30.7	34.3	38.8	25.8	21.5	19.6	22.1	10.9	33.4	21.5	0.5	0.0	0.0	239.3	0.0	0.5	6.4	0.0	0.0	53.8	3.7	6.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	119.6	0.4	25.0	1.2	0.0	0.0	360.0	0.0	0.0	5.7	0.0	0.5	0.0	0.0	2.2	0.0	1.0	1.7	277.8	0.0	0.0	0.0	0.6	148.9	3.4	0.6	0.0	177.1	0.0	8.6	0.0	499.6	7.4	0.0	0.0	27.4	0.0	1.3	0.0	0.1	0.0	3.7	52.6	20.3	40.9	11.0	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.7
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 165.8"	"Cell type enriched"	"Detected in some"	13	"Intestinal goblet cells: 1683.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 205.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 154.3"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		1600000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	6.2	1.2	3.3	3.6	0.6	0.0	5.2	0.9	8.4	0.7	0.5	1.8	6.6	0.3	0.7	5.6	0.9	1.3	0.9	2.5	18.1	1.7	1.4	1.2	11.7	11.7	10.2	0.6	0.4	0.1	32.3	0.5	6.2	0.3	1.5	0.0	0.1	0.6	0.0	0.2	165.8	1.1	3.2	0.1	36.4	0.3	26.8	0.5	0.8	0.2	1.0	3.1	0.3	3.6	0.0	5.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	50.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	10.7	0.0	4.1	0.0	1.7	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	205.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.6	0.9	8.4	2.5	18.1	11.7	10.2	6.2	3.2	26.8	3.6	3.6	0.0	0.5	0.0	0.0	1.3	0.7	22.6	0.0	0.0	10.1	0.0	0.3	0.0	27.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	2.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	44.3	0.0	0.2	0.0	1.2	1683.2	2.0	0.3	2.6	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	15.0	0.0	0.0	2.5	120.8	0.0	3.5	0.0	0.0	0.0	0.9	0.8	0.1	1.2	2.3	0.1	1.3	0.0	8.1	60.4
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302063-205321745	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.7;vagina: 45.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 120.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	2.1	3.7	1.3	7.7	1.9	11.4	0.9	4.6	1.7	31.0	3.2	8.0	16.5	1.6	1.3	56.7	4.0	1.7	1.2	1.2	1.3	28.2	5.1	10.3	11.5	2.1	1.8	1.3	16.0	0.8	3.0	4.4	2.0	1.9	8.8	0.5	15.1	1.6	0.7	22.4	12.5	1.2	1.4	13.1	2.5	3.7	2.2	3.9	16.1	1.1	8.0	3.1	45.3	4.1	4.3	23.1	13.7	0.6	0.3	0.6	44.1	5.5	5.7	14.7	5.9	24.4	0.8	7.0	3.2	1.5	24.1	8.3	3.2	8.3	6.3	0.0	0.4	0.0	1.4	4.2	9.3	0.0	0.1	2.6	6.1	8.6	5.0	3.3	0.7	0.0	0.9	1.7	2.8	1.0	0.0	0.1	8.9	3.1	0.7	0.0	1.0	36.1	40.9	0.1	2.1	0.2	1.6	6.5	0.7	45.6	6.6	0.1	1.7	5.3	2.5	0.6	8.7	12.1	2.0	4.4	0.8	0.0	2.1	11.2	16.5	40.1	10.3	11.8	7.6	37.9	12.7	12.3	10.4	39.3	27.9	21.9	120.4	17.5	13.1	4.1	8.1	17.4	1.3	1.9	4.6	1.7	1.2	1.3	2.1	1.8	2.0	1.4	2.2	4.1	2.0	6.4	6.8	0.3	28.0	1.1	3.2	3.7	13.1	1.1	1.9	2.2	2.7	20.0	2.9	33.1	0.0	9.2	7.1	34.9	5.9	46.9	2.0	45.3	7.5	5.9	10.8	2.7	0.1	1.8	29.1	3.7	7.7	52.4	0.0	2.4	0.7	2.6	4.7	0.0	0.4	43.0	18.3	12.3	11.1	2.1	0.0	8.9	7.2	3.7	38.5	1.3	18.6	0.5	3.5	6.9	7.8	0.0	18.5	2.5	18.3	17.2	7.7	0.5	6.6	2.4	5.5	0.9	1.1	21.5	5.4	4.1	5.7	0.5	22.0	0.5
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341772-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.4;monocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	36.7	33.2	23.5	47.0	24.3	30.7	31.3	24.5	23.0	32.5	23.2	36.0	62.1	32.7	18.1	27.7	31.6	33.8	33.6	21.1	24.1	28.9	35.5	36.4	62.8	25.9	24.8	35.2	40.1	40.7	25.8	30.7	25.3	31.4	30.2	31.7	41.8	28.5	52.8	29.3	56.9	21.1	24.2	54.7	36.6	52.0	24.5	46.2	47.3	32.4	40.6	30.2	28.0	26.7	78.0	34.8	45.9	26.9	47.0	56.6	38.7	61.2	55.8	45.5	52.2	34.2	67.3	84.5	78.5	38.8	58.3	38.0	27.9	40.0	29.2	74.2	46.4	30.8	32.1	21.9	65.2	72.0	38.0	36.4	46.4	32.9	31.3	56.4	30.6	41.4	81.5	2.5	37.3	42.0	126.9	55.0	73.0	79.4	45.6	69.4	47.9	12.8	33.3	37.9	42.9	71.8	116.3	48.7	60.4	31.7	33.9	40.6	62.7	38.2	13.7	51.8	58.9	78.5	64.0	73.7	77.9	60.6	64.4	18.2	20.5	28.5	25.9	27.1	30.8	26.9	22.6	26.6	18.1	26.0	24.5	23.5	37.6	33.6	34.9	25.2	19.8	23.8	23.5	24.3	24.5	23.0	21.1	24.1	25.9	24.8	25.3	24.2	24.5	26.7	61.0	73.7	66.4	14.0	52.7	24.9	33.8	36.4	39.9	38.4	31.0	32.3	57.4	34.3	51.4	25.8	12.5	49.3	91.8	53.4	60.7	52.1	249.4	59.5	46.5	45.8	29.3	17.1	13.6	69.8	43.0	42.3	29.0	47.9	72.2	45.1	33.2	40.5	30.0	48.8	19.4	40.9	18.3	37.1	45.8	34.2	44.1	46.7	16.0	18.7	559.4	57.7	74.2	11.1	23.0	52.3	20.5	41.0	22.3	48.7	56.5	37.8	55.7	41.4	26.3	39.5	43.3	160.4	12.5	25.8	29.0	50.1	60.0	40.2	26.0	33.1
NUBP1	"CIAO5, NBP1, NBP35"	ENSG00000103274	"Nucleotide binding protein 1"	P53384	16	10743786-10769351	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041656, HPA041799"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA041656: AB_10960278, HPA041799: AB_10960692"	"unprognostic (2.51e-2)"	"prognostic favorable (2.81e-5)"	"unprognostic (4.01e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.30e-3)"	"unprognostic (8.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.61e-8)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.69e-2)"	22.7	39.3	12.6	25.9	12.7	31.0	22.0	13.6	16.5	19.9	15.2	27.4	21.6	21.3	24.8	19.7	25.6	19.6	46.7	12.5	13.1	27.8	31.1	21.2	31.1	13.2	12.7	22.9	31.9	30.3	17.0	19.6	13.1	21.1	20.0	12.0	21.7	21.0	37.7	15.7	22.1	22.7	13.5	28.5	28.7	17.3	12.9	21.4	23.5	34.7	36.9	24.4	16.8	13.8	31.3	55.9	37.2	23.1	16.8	31.0	35.5	29.9	27.9	51.4	42.6	49.0	33.2	53.7	60.5	36.7	40.0	33.5	34.9	30.7	38.2	84.8	43.9	30.3	39.3	80.4	33.7	27.7	34.3	29.2	23.0	35.2	19.2	28.6	34.2	20.6	43.3	31.7	38.3	72.0	18.2	40.2	46.1	25.5	29.9	72.5	48.2	58.6	37.0	37.7	22.9	33.5	51.8	38.6	29.2	23.7	39.3	30.2	30.5	40.0	40.8	49.9	38.2	56.0	52.0	42.4	36.7	55.3	48.0	3.8	82.7	41.3	39.2	88.2	35.9	75.6	34.7	39.1	89.7	69.3	29.9	31.1	9.7	35.2	66.7	44.0	46.5	52.9	12.6	12.7	13.6	16.5	12.5	13.1	13.2	12.7	13.1	13.5	12.9	13.8	20.3	6.4	23.1	3.9	33.7	14.3	26.6	39.8	10.8	17.0	14.9	17.3	6.0	34.3	32.2	23.9	6.2	49.6	19.0	12.3	66.5	54.2	2.4	17.3	12.2	21.3	16.8	12.0	8.4	79.1	29.2	16.7	15.8	17.2	24.1	17.3	14.6	29.6	56.4	6.7	8.1	19.2	40.7	38.4	91.2	3.6	25.7	38.0	16.0	3.7	72.7	30.1	20.6	3.0	5.2	48.7	18.4	19.5	17.6	17.9	27.2	65.0	31.6	18.5	6.6	20.0	15.9	33.1	29.4	12.3	11.9	60.7	17.8	25.3	18.0	29.2
NUBP2	"CFD1, CIAO6"	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782932-1789186	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	19.4	34.3	18.2	10.6	19.7	16.6	17.6	19.5	25.5	21.6	26.5	21.9	14.5	18.7	3.8	30.8	17.1	5.9	20.8	17.6	17.1	26.4	53.2	18.0	16.0	21.3	18.4	17.7	34.2	8.3	18.7	10.9	18.9	25.6	4.2	3.4	22.4	10.4	27.9	25.8	20.5	6.7	18.9	26.8	27.2	10.1	19.7	14.0	18.9	8.2	6.4	20.8	20.1	19.8	28.6	91.4	16.2	49.6	12.1	9.2	50.9	32.2	14.8	20.7	23.3	56.1	41.5	45.0	38.1	7.4	15.2	32.6	10.8	31.6	3.8	39.6	85.7	19.6	67.2	83.0	23.6	30.2	38.2	13.1	26.6	16.9	12.1	13.0	26.2	54.9	49.4	29.6	8.7	109.1	58.8	53.7	44.2	26.4	52.6	80.0	33.4	106.1	16.7	21.1	58.4	70.4	31.9	50.4	38.1	4.2	75.5	35.9	29.8	33.8	42.6	31.9	34.1	65.1	44.9	54.4	20.4	36.0	44.2	72.3	58.1	59.8	64.9	61.6	59.2	48.5	56.5	57.7	62.3	47.6	47.1	45.0	29.7	57.9	60.7	87.5	84.2	67.9	18.2	19.7	19.5	25.5	17.6	17.1	21.3	18.4	18.9	18.9	19.7	19.8	41.0	16.0	30.9	9.4	38.4	35.8	39.4	75.8	24.5	36.0	52.2	65.9	24.9	42.9	43.7	31.3	20.9	103.9	55.5	40.2	66.5	64.7	33.1	23.1	32.7	35.1	38.2	36.4	6.2	74.3	83.0	38.0	32.6	24.5	20.3	48.6	31.8	65.0	62.2	23.5	7.4	51.7	54.9	39.3	28.8	90.9	36.7	27.9	58.7	7.5	55.1	54.4	68.0	6.0	11.0	63.7	30.4	30.9	38.0	45.0	65.4	67.1	22.2	42.5	46.0	28.2	43.3	34.0	30.6	44.7	41.5	41.3	42.0	49.6	58.2	32.2
NUBPL	"C14orf127, FLJ12660, huInd1, IND1"	ENSG00000151413	"Nucleotide binding protein like"	Q8TB37	14	31489956-31861224	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 68.2;Inhibitory neurons: 74.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029203	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA029203: AB_10602810"	"unprognostic (1.49e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.64e-8)"	"unprognostic (2.82e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.56e-2)"	9.7	6.4	4.2	3.9	4.6	1.8	8.9	4.5	4.8	4.9	4.2	7.6	4.9	5.8	7.6	4.6	6.4	5.3	17.0	4.0	5.0	12.2	12.3	4.1	5.7	4.9	4.7	6.8	5.5	7.9	3.8	5.5	4.5	6.3	7.8	5.2	11.9	6.1	11.9	4.7	5.8	5.4	4.3	6.6	4.7	3.5	5.0	5.5	8.0	17.4	5.4	4.2	3.2	5.8	13.6	8.5	6.4	3.3	8.9	16.4	11.5	7.3	8.2	8.9	10.2	5.9	15.3	9.8	9.2	9.1	7.5	11.7	8.6	15.5	15.3	7.1	11.1	3.5	6.3	30.4	8.8	10.4	3.0	10.7	17.0	6.0	12.8	7.3	5.0	7.0	6.4	4.9	9.8	7.4	7.7	7.1	5.4	10.8	13.1	8.6	13.4	5.3	10.2	10.0	6.0	6.2	12.2	10.8	14.5	7.2	21.1	5.4	4.9	8.6	5.9	5.6	6.8	8.1	9.7	9.3	5.5	7.3	7.9	0.0	1.1	0.4	2.1	1.2	1.7	2.6	2.7	2.3	4.4	1.7	3.0	2.4	0.4	2.5	0.7	2.2	1.8	0.9	4.2	4.6	4.5	4.8	4.0	5.0	4.9	4.7	4.5	4.3	5.0	5.8	6.9	12.8	9.8	68.2	10.1	9.6	8.6	5.4	9.1	15.3	10.2	7.1	36.9	15.7	10.6	9.2	20.9	11.2	7.5	6.3	7.9	6.8	24.1	12.6	10.8	6.3	7.2	6.7	48.2	5.7	10.2	12.0	7.1	5.4	14.5	16.4	4.6	15.3	4.9	10.1	74.8	12.0	2.0	4.1	16.1	7.4	6.5	6.1	12.4	54.4	2.8	16.2	5.2	87.9	99.6	5.2	5.8	11.7	8.0	4.4	5.1	19.1	18.7	28.4	13.1	11.8	9.8	15.7	5.2	7.3	11.6	5.7	6.4	23.1	18.2	5.9
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900312-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		27000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	181.3	103.5	55.8	106.8	60.4	82.3	141.6	65.5	68.1	115.0	79.4	122.1	179.9	127.6	61.3	111.2	116.9	108.3	204.0	58.2	63.0	154.6	264.5	157.1	82.1	65.9	62.9	125.6	130.1	173.5	69.5	114.8	67.5	109.2	54.8	30.2	117.8	103.0	180.1	96.6	163.6	106.0	57.7	111.1	118.8	34.7	73.1	49.5	122.2	110.7	53.1	130.1	108.9	61.6	54.8	182.1	84.2	188.5	304.6	249.2	97.6	208.1	189.9	103.3	144.2	92.9	203.1	54.7	151.8	250.6	98.9	132.0	48.6	107.0	43.3	194.6	90.3	141.6	119.0	131.6	156.6	85.1	183.6	288.0	52.1	96.8	62.9	275.2	167.2	60.7	173.1	278.8	107.0	71.6	42.3	68.6	42.2	132.1	93.5	78.7	125.3	114.9	90.2	134.6	61.2	123.2	247.1	152.2	88.1	79.7	78.8	112.1	234.6	172.3	114.3	107.0	99.3	210.8	501.1	37.1	132.5	54.3	207.3	102.9	108.5	105.7	100.6	128.5	75.3	46.8	67.5	77.2	79.0	37.3	55.3	56.7	104.7	69.2	114.2	113.9	74.6	129.5	55.8	60.4	65.5	68.1	58.2	63.0	65.9	62.9	67.5	57.7	73.1	61.6	154.5	41.7	72.1	17.6	51.0	48.3	67.2	81.3	66.0	21.7	57.6	57.5	58.0	78.6	51.5	69.9	14.6	101.5	69.6	153.0	41.1	148.0	10.8	27.4	65.5	116.0	74.4	54.5	14.5	118.3	150.9	126.7	76.0	50.2	95.2	64.1	122.0	149.2	213.7	20.2	18.9	109.9	69.2	138.3	74.6	9.3	110.3	101.9	101.4	17.8	120.3	52.6	74.2	8.5	11.8	100.0	149.2	124.1	126.3	63.8	453.3	135.4	24.4	20.5	92.1	51.0	79.0	21.9	37.6	65.6	49.9	102.1	73.0	103.9	123.3	68.1
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"	P80303	11	17208153-17349980	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 758.3;salivary gland: 771.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 1867.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000	690000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	56.2	75.7	23.9	62.1	27.8	619.9	141.1	28.8	32.1	137.2	58.0	68.3	57.3	60.8	458.2	146.3	107.2	60.8	95.7	22.8	34.7	43.2	102.2	49.8	60.2	25.7	28.2	56.0	758.3	479.1	113.0	90.9	26.8	70.9	68.4	64.5	771.4	190.9	38.5	21.1	40.7	78.5	26.2	42.2	92.9	119.2	28.4	334.2	153.9	30.4	78.5	61.8	44.9	26.6	119.9	49.0	53.7	163.4	118.9	162.3	65.0	260.5	381.0	115.1	203.0	48.7	26.8	182.9	63.5	250.7	107.1	50.1	34.4	66.8	178.7	126.7	76.3	135.8	57.8	85.2	340.5	1867.0	238.6	71.1	86.8	82.9	200.9	284.9	143.3	672.1	120.1	361.1	114.9	105.9	656.2	670.3	12.9	194.0	50.5	239.8	130.4	15.1	51.9	37.5	63.5	35.4	114.6	114.2	61.4	78.0	93.5	498.1	128.1	120.9	110.9	369.1	112.1	70.3	41.3	101.1	140.5	646.1	106.4	210.5	43.5	168.2	94.1	30.5	122.9	22.7	88.5	173.7	40.6	14.5	246.7	271.2	39.3	277.9	25.6	426.0	42.7	119.8	23.9	27.8	28.8	32.1	22.8	34.7	25.7	28.2	26.8	26.2	28.4	26.6	118.7	44.8	70.4	16.3	54.8	27.5	60.2	156.3	14.8	71.0	152.8	87.0	193.8	55.8	176.5	42.3	54.2	127.1	136.5	17.6	27.4	91.1	690.6	112.4	92.9	94.7	42.4	137.8	21.9	132.6	319.1	148.8	40.2	97.0	67.6	80.0	108.5	141.8	70.7	35.3	23.5	189.0	189.2	29.4	40.0	508.5	149.8	37.6	69.4	18.7	24.1	111.2	95.8	13.6	10.8	75.2	13.2	114.3	256.5	108.7	3.9	28.5	618.8	99.3	46.0	50.8	75.4	174.9	61.3	87.7	30.1	1158.2	92.3	88.3	45.3	61.2
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDC		ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946871	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 642.2;Respiratory ciliated cells: 635.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	62.6	140.1	108.3	37.7	111.2	51.7	64.2	113.6	124.2	69.3	118.7	97.8	35.8	70.1	70.0	59.7	93.9	28.4	106.7	110.1	115.8	79.8	116.0	63.7	42.3	109.5	110.5	74.5	81.4	53.1	75.4	40.8	110.7	72.1	31.5	48.6	54.5	57.0	126.1	67.1	52.7	41.8	108.6	63.3	85.3	86.7	110.5	47.5	63.2	60.6	42.3	80.0	61.7	120.2	204.2	208.1	106.9	149.2	83.5	74.6	121.2	159.2	97.3	209.4	153.5	192.3	137.8	169.5	137.1	109.6	154.2	156.2	229.5	209.8	160.7	132.1	238.0	210.9	207.7	333.7	147.2	224.9	149.2	80.6	134.5	252.7	161.8	90.9	156.4	194.9	306.1	92.3	143.5	175.9	227.3	289.9	281.2	264.8	266.4	234.7	135.5	172.4	180.1	79.2	177.4	133.1	173.3	109.0	149.1	99.8	106.5	137.0	155.5	148.7	178.1	188.3	207.4	184.0	311.9	202.0	160.4	312.7	170.9	184.4	138.8	141.1	152.7	150.2	154.5	176.7	154.1	145.4	140.7	185.9	150.7	154.9	95.4	147.4	155.1	163.2	163.5	168.0	108.3	111.2	113.6	124.2	110.1	115.8	109.5	110.5	110.7	108.6	110.5	120.2	111.8	134.6	116.1	12.4	93.6	154.1	329.0	187.2	82.0	93.3	85.1	85.9	166.5	137.2	169.8	110.3	52.1	203.3	89.2	91.3	262.2	285.0	85.6	473.8	105.4	120.6	131.4	99.3	16.1	317.4	206.7	128.9	105.5	113.4	147.6	104.5	95.3	642.2	147.5	111.0	16.5	123.1	128.1	70.2	132.1	132.7	135.8	83.7	151.2	11.2	115.3	181.1	86.5	10.1	19.2	309.7	79.7	153.1	77.5	277.7	76.3	200.1	635.8	105.7	111.7	129.1	174.6	246.4	249.7	70.9	148.5	162.7	128.9	91.1	129.1	200.1
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334121	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		7300	"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	11.1	5.0	3.3	6.0	3.5	1.3	9.5	3.7	4.2	7.7	3.1	5.5	2.8	7.2	5.2	5.7	6.9	4.8	6.6	3.3	3.5	7.8	6.4	7.0	9.3	3.7	3.6	6.3	6.9	5.8	4.2	15.1	3.4	5.9	6.7	4.7	6.1	6.8	6.1	4.3	5.1	7.9	4.1	7.3	5.8	13.0	3.4	10.1	9.0	9.3	8.5	11.4	6.8	3.8	28.9	16.7	24.7	13.7	13.1	18.0	13.1	20.6	24.8	57.8	54.4	17.6	21.8	18.5	13.1	22.5	16.3	17.1	36.3	34.3	79.8	23.6	12.6	28.8	9.9	19.6	27.2	13.7	10.6	12.7	18.4	28.1	40.3	18.3	53.0	22.7	32.2	9.5	49.5	23.3	33.3	15.1	17.3	59.7	22.7	21.4	20.4	18.3	35.6	14.8	20.5	18.1	9.4	26.1	21.6	25.6	19.2	9.9	14.2	28.2	17.2	12.1	17.6	6.9	9.4	22.3	10.4	22.2	24.1	0.0	0.4	0.5	0.8	1.3	1.4	1.2	1.0	1.6	1.4	1.1	1.1	1.6	0.0	1.7	1.7	0.9	1.5	0.7	3.3	3.5	3.7	4.2	3.3	3.5	3.7	3.6	3.4	4.1	3.4	3.8	25.4	3.2	10.0	6.2	11.3	17.7	24.4	19.4	10.2	5.0	7.4	6.3	11.3	2.8	23.2	3.7	6.2	23.4	9.7	2.5	7.9	17.1	122.3	11.2	19.2	26.5	9.0	14.5	22.9	11.0	21.2	16.2	5.6	10.2	17.7	11.8	8.9	6.2	9.8	5.0	23.5	5.7	14.2	4.7	11.5	22.5	13.1	8.7	7.2	13.1	16.9	4.4	5.2	15.1	15.3	14.1	4.7	6.8	12.1	29.6	3.4	13.0	15.4	9.0	0.0	13.7	15.8	53.3	36.4	8.9	16.8	8.2	9.5	12.5	9.9	22.7
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	13.9	11.8	11.1	13.2	13.2	11.7	11.2	13.2	14.0	8.1	10.2	11.2	14.5	10.2	6.4	12.8	9.7	5.7	8.3	11.0	11.4	11.7	15.3	8.7	15.1	12.8	12.6	8.9	15.4	6.8	9.3	10.3	13.7	8.9	6.1	7.3	14.0	3.6	20.9	10.7	13.3	6.3	12.8	12.8	11.8	10.4	12.5	8.1	9.4	5.0	9.8	9.2	10.3	17.7	62.3	32.3	23.5	37.1	14.1	10.4	31.3	24.6	7.0	8.7	13.9	28.6	46.3	35.5	57.5	4.0	39.8	30.6	12.6	13.9	10.7	70.6	36.6	32.4	42.0	26.4	15.3	37.3	35.3	3.8	7.7	8.4	12.1	12.3	9.8	39.1	35.1	42.6	8.9	25.2	55.1	80.9	25.8	18.4	35.2	45.7	39.2	63.0	8.0	14.3	59.6	33.6	38.7	24.7	66.3	13.8	47.2	37.8	21.9	29.4	43.8	32.6	56.7	35.0	63.8	61.5	34.2	63.2	31.4	49.9	48.3	32.5	60.2	59.8	76.5	91.7	84.0	71.8	68.0	68.0	88.7	79.0	6.2	83.8	51.5	81.1	83.5	69.1	11.1	13.2	13.2	14.0	11.0	11.4	12.8	12.6	13.7	12.8	12.5	17.7	58.0	28.9	23.8	9.1	47.5	59.4	54.9	92.6	42.7	30.7	70.4	88.6	43.1	35.8	53.1	38.6	22.9	118.7	43.8	25.4	148.7	63.6	95.1	57.6	44.1	47.4	43.8	78.4	18.8	64.0	55.8	48.6	32.1	38.3	31.6	35.7	36.0	55.1	69.8	10.1	14.0	45.3	87.5	41.8	42.7	24.5	51.6	35.7	49.8	11.2	46.4	51.4	52.5	11.1	36.0	59.9	33.6	51.1	55.5	95.2	31.5	112.5	65.1	38.2	39.5	51.3	46.5	87.6	44.2	56.0	67.6	56.8	48.3	64.8	68.6	59.3
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379119-44490658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	2.9	2.8	6.8	1.3	9.0	2.8	2.8	3.2	7.2	2.5	0.0	2.4	1.2	2.2	2.4	2.7	3.5	2.2	7.5	6.6	5.1	2.2	1.8	2.4	2.2	4.4	5.5	3.1	3.3	3.7	1.8	1.7	5.6	2.8	1.8	4.8	2.4	3.3	8.2	3.1	2.0	3.0	3.9	1.9	2.7	3.9	5.6	2.1	2.7	5.7	2.2	2.3	1.8	6.3	2.6	4.9	3.4	6.3	4.2	3.4	1.3	4.1	4.0	4.8	4.9	3.3	1.8	8.1	3.0	5.5	6.6	3.0	4.8	5.6	2.8	4.8	4.9	2.2	2.9	2.3	3.8	3.9	1.3	3.1	3.7	3.6	4.1	2.8	5.9	2.4	6.1	2.6	3.6	2.3	1.6	3.7	4.3	2.5	6.3	2.3	3.7	3.0	2.7	4.0	3.6	10.6	2.4	4.5	1.8	3.4	3.4	5.7	5.7	3.3	3.4	2.2	3.3	7.3	8.1	4.0	3.6	4.5	5.9	0.6	0.8	0.9	1.0	0.8	1.1	1.0	0.9	0.9	0.7	1.0	0.9	0.9	0.5	0.8	1.0	0.6	1.0	0.9	6.8	9.0	3.2	7.2	6.6	5.1	4.4	5.5	5.6	3.9	5.6	6.3	30.5	12.8	19.2	35.9	26.4	11.3	13.0	16.5	20.5	40.9	29.3	25.3	44.5	17.2	16.0	38.6	54.2	19.6	21.9	22.7	23.5	29.6	87.7	27.4	34.4	25.3	17.4	22.3	59.6	21.6	18.1	23.9	23.9	30.9	9.5	35.8	22.5	32.8	18.3	48.8	58.8	25.1	26.4	17.9	9.5	98.3	30.4	13.9	16.0	46.9	21.2	24.8	34.0	36.2	61.2	27.4	18.8	28.2	14.3	15.9	27.2	26.8	21.9	40.2	32.9	17.8	25.2	106.6	21.1	25.5	16.2	14.4	26.2	18.9	27.8	13.3
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242226-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No		21000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	19.1	8.0	13.7	23.8	16.6	77.6	15.0	14.6	18.0	16.9	10.9	19.1	16.2	12.4	5.4	29.1	12.0	10.5	18.7	15.4	13.6	8.9	6.3	12.4	37.1	16.1	14.1	9.3	9.1	3.2	4.4	10.5	15.6	11.3	11.0	4.3	12.4	7.0	21.3	33.8	16.8	9.2	15.0	23.6	12.2	65.5	14.5	59.4	7.6	13.5	31.5	14.6	18.5	17.9	98.4	155.2	83.3	111.0	30.0	41.3	61.0	42.3	36.5	57.0	65.8	84.2	72.1	102.8	33.7	47.0	115.5	117.1	63.8	64.3	33.1	46.2	109.4	80.6	136.3	72.7	7.2	63.2	78.0	27.4	16.7	82.3	29.0	18.6	31.0	147.1	65.0	111.6	64.5	250.2	119.1	245.3	179.5	48.5	94.7	163.5	123.4	86.4	31.7	54.9	83.5	115.6	43.7	126.9	20.8	59.8	83.9	165.8	29.1	54.2	205.1	126.8	102.3	85.2	70.6	108.9	54.6	155.1	199.8	31.5	60.2	44.4	42.8	78.6	34.3	71.0	49.6	45.6	94.3	65.1	48.9	42.3	16.2	39.4	66.8	211.5	75.5	45.7	13.7	16.6	14.6	18.0	15.4	13.6	16.1	14.1	15.6	15.0	14.5	17.9	13.0	6.4	7.5	1.0	34.2	40.1	26.5	22.6	14.8	11.2	25.3	39.0	16.8	10.0	13.7	11.0	4.2	38.5	46.1	39.6	19.6	24.3	54.7	14.9	24.3	12.8	7.8	111.7	0.5	37.4	80.0	29.6	13.7	10.7	61.0	32.4	7.9	5.2	89.4	0.0	0.5	35.7	32.6	46.2	86.7	121.2	22.1	52.6	46.2	0.0	47.1	27.4	47.4	1.0	4.3	20.4	18.4	18.8	33.1	21.5	17.3	14.1	13.0	7.9	32.9	27.5	32.4	70.2	54.8	41.0	37.1	23.7	37.3	13.7	45.1	27.3
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.3"	"Group enriched"	"Detected in many"	5	"Hepatic stellate cells: 60.3;Peritubular cells: 29.0"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	0.6	1.6	11.2	0.8	9.8	1.5	0.8	3.8	9.8	6.2	2.3	3.1	0.5	5.3	16.1	1.0	3.6	1.4	1.0	9.2	10.0	3.9	1.3	0.3	0.3	5.0	7.1	16.9	0.3	0.0	2.1	0.0	7.1	14.9	0.7	1.5	0.5	14.6	0.1	0.4	1.0	4.1	4.1	3.4	1.2	26.3	11.9	0.4	0.6	0.2	0.3	3.9	3.6	9.3	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	14.2	0.6	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.2	9.8	3.8	9.8	9.2	10.0	5.0	7.1	7.1	4.1	11.9	9.3	0.2	0.0	1.3	0.7	0.2	1.0	4.9	0.6	1.8	0.5	0.1	1.5	0.2	0.0	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.7	3.5	2.5	0.0	0.8	5.0	0.0	1.0	3.1	0.0	0.1	0.0	5.0	60.3	0.3	0.2	0.0	1.9	0.0	0.0	1.9	0.4	6.2	5.9	0.1	1.8	1.0	0.0	1.7	0.0	3.5	0.6	0.0	0.0	29.0	1.4	2.8	0.0	0.1	0.0	0.5	0.0	1.5	1.9	3.8	7.8	0.4	0.1	0.4	0.2	0.9	0.0	0.2
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;testis: 36.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 15.3;Late spermatids: 17.1;Peritubular cells: 20.7;Spermatocytes: 14.6;Spermatogonia: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 12.1;prostate cancer: 10.6;testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 69.3;NTERA-2: 42.9"					"Low region specificity"	"Detected in many"			"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.0	4.6	11.9	0.9	13.7	1.4	2.1	4.5	14.7	4.0	2.1	2.9	1.1	5.1	3.5	1.3	2.0	1.6	0.5	13.4	20.0	0.5	0.1	0.5	0.6	5.6	7.2	8.9	4.9	0.2	4.3	0.0	8.4	9.1	0.8	2.2	0.7	10.4	0.1	1.2	1.0	4.4	5.6	0.3	1.1	36.2	23.3	2.6	0.6	0.5	0.6	1.9	2.4	7.7	0.0	1.0	20.6	0.0	17.5	22.0	0.1	9.8	2.7	0.5	0.5	0.0	0.0	0.0	0.5	11.9	11.4	1.5	69.3	23.9	0.3	0.0	4.7	0.0	0.0	0.0	8.2	0.0	4.6	13.5	9.3	6.2	22.4	3.9	16.4	21.6	0.1	0.0	19.6	0.5	27.6	0.1	42.9	0.0	17.5	0.0	14.4	0.0	4.3	0.0	0.0	13.4	4.2	0.0	4.0	10.2	0.0	0.1	9.6	4.8	22.4	1.4	0.0	9.0	4.5	15.2	3.1	0.0	1.9	0.0	0.0	0.0	1.2	0.0	0.5	0.1	0.3	0.6	0.1	0.1	0.0	0.9	0.0	0.7	0.1	0.0	0.0	0.3	11.9	13.7	4.5	14.7	13.4	20.0	5.6	7.2	8.4	5.6	23.3	7.7	0.4	0.0	0.0	0.3	0.3	15.3	6.4	12.8	12.0	1.6	0.5	3.9	0.6	0.0	1.6	0.0	0.0	0.3	3.5	0.0	0.0	0.2	11.3	0.5	9.0	0.9	0.0	1.3	6.3	1.5	1.0	7.7	0.0	0.3	0.0	3.4	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.3	3.8	17.1	8.7	0.6	5.4	2.8	0.0	1.4	3.1	4.0	0.6	1.4	0.0	20.7	0.3	10.4	0.0	0.2	0.2	0.2	0.0	3.0	5.3	14.6	20.3	1.6	9.1	0.3	0.8	7.5	0.0	1.3
NUDT12	DKFZP761I172	ENSG00000112874	"Nudix hydrolase 12"	Q9BQG2	5	103548855-103562790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045449	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045449: AB_2679327"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.79e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.92e-2)"	5.7	12.1	5.2	3.6	7.3	0.9	11.9	7.1	7.1	9.2	6.9	13.3	16.9	6.4	12.0	7.7	8.5	7.4	10.4	4.6	6.4	26.6	28.4	6.5	2.7	6.2	6.2	6.7	12.3	24.4	4.0	5.0	7.1	14.6	14.4	12.5	12.9	7.8	13.4	7.4	14.3	6.0	7.0	4.4	14.2	5.0	6.3	4.7	16.0	8.9	3.5	6.0	4.0	9.2	6.2	2.7	14.6	5.5	9.8	20.3	0.0	10.7	10.1	9.5	12.2	5.3	22.0	0.0	6.9	6.2	10.6	9.9	13.8	22.3	13.2	0.0	8.3	6.4	10.1	2.8	10.1	0.0	0.0	9.7	19.1	6.3	16.3	11.2	6.6	0.0	10.5	0.0	16.8	11.5	0.5	0.3	7.5	0.0	8.4	0.0	12.9	5.0	15.9	10.7	11.0	11.4	6.9	10.3	16.5	11.5	22.6	6.4	8.0	12.0	4.3	10.5	8.7	7.2	11.6	0.0	12.3	0.0	8.9	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.9	0.4	0.6	0.3	0.0	0.5	0.3	1.1	0.1	0.2	5.2	7.3	7.1	7.1	4.6	6.4	6.2	6.2	7.1	7.0	6.3	9.2	5.8	9.6	9.0	10.4	1.6	3.3	6.3	13.8	12.5	10.4	9.2	5.1	11.9	15.7	9.0	12.9	2.1	5.9	2.3	15.4	58.7	11.2	7.1	9.5	7.9	4.6	4.2	4.2	8.3	14.2	4.6	7.0	13.3	5.8	1.3	9.4	3.3	14.7	6.1	11.8	9.0	17.5	14.2	4.6	1.9	4.9	13.4	4.6	8.8	2.8	3.0	13.1	1.0	14.6	23.7	10.6	15.7	10.5	1.2	7.6	21.1	34.0	15.8	17.7	6.6	8.5	6.2	11.0	7.6	10.9	3.1	3.0	1.1	11.7	14.1	7.7
NUDT13	DKFZp586P2219	ENSG00000166321	"Nudix hydrolase 13"	Q86X67	10	73110375-73131828	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040636	Approved					NA	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040636: AB_10960360"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.07e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.96e-2)"	1.9	3.2	1.4	1.9	1.7	2.4	2.0	3.4	2.0	1.7	1.3	2.6	2.9	1.7	3.9	1.6	1.9	1.8	4.3	1.6	1.3	4.3	6.2	1.5	2.4	1.4	1.4	1.8	3.1	3.0	1.7	1.5	1.8	2.0	1.8	2.9	2.1	1.0	4.2	3.0	2.5	1.1	1.0	2.5	2.9	2.4	1.8	1.5	1.9	2.1	1.5	2.4	1.7	2.2	4.7	3.3	5.3	6.6	3.2	2.7	1.1	4.1	3.6	2.1	2.3	8.7	9.6	2.3	2.0	2.5	3.4	5.4	0.5	3.8	2.1	1.7	9.3	6.4	5.9	4.9	0.3	3.5	2.5	2.0	4.1	2.7	1.5	5.6	1.6	4.1	5.5	3.5	2.1	2.2	2.1	5.0	2.0	3.0	10.5	4.7	0.9	0.1	2.9	2.1	2.3	3.4	2.0	5.4	1.9	2.2	3.0	2.3	3.1	1.8	7.1	0.7	1.6	2.5	3.1	3.1	5.0	6.5	1.7	0.0	1.1	1.1	0.7	1.1	0.8	1.3	0.5	0.6	0.8	3.7	0.9	1.0	0.4	2.2	1.6	0.3	1.7	0.4	1.4	1.7	3.4	2.0	1.6	1.3	1.4	1.4	1.8	1.0	1.8	2.2	1.9	6.4	2.0	2.6	1.9	0.9	1.9	2.8	0.6	1.1	1.6	1.7	6.2	1.5	2.2	3.7	4.2	3.6	0.4	1.1	3.9	1.8	5.5	2.9	1.3	1.8	1.2	1.3	4.7	0.7	0.9	1.1	1.5	2.7	0.0	1.8	0.4	3.7	1.7	0.0	5.1	1.7	2.0	2.9	1.0	5.0	0.9	1.8	0.0	5.6	2.8	0.9	2.1	4.5	8.1	1.6	3.3	0.7	0.7	1.2	2.5	6.2	5.3	1.9	0.0	2.3	1.4	2.9	0.9	1.4	1.4	1.1	0.8	2.3	1.3	1.1
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 176.1;Proximal enterocytes: 206.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	16.5	23.9	17.4	3.5	20.1	2.1	19.3	19.9	28.4	9.0	27.5	14.5	12.5	6.4	3.5	17.5	8.9	6.4	27.5	19.9	21.5	28.8	19.5	20.1	5.9	19.0	17.4	6.4	40.4	16.0	61.1	3.2	19.1	18.6	2.9	4.7	17.2	2.9	31.6	14.1	16.3	1.8	17.9	12.5	17.6	13.9	17.2	3.6	22.1	12.7	2.1	8.4	11.3	21.1	18.1	24.2	2.1	9.4	2.8	3.3	38.1	5.0	6.5	8.0	11.5	17.5	18.7	1.3	24.4	2.6	17.8	22.7	1.1	13.6	0.7	9.5	17.7	4.0	10.4	12.2	19.9	4.8	46.7	4.7	16.7	1.9	1.4	3.4	15.9	8.8	6.4	2.9	2.8	52.5	0.6	0.0	12.6	42.7	33.5	9.4	21.9	10.8	8.8	51.2	32.8	4.8	9.0	0.2	21.7	3.9	18.8	23.1	38.3	13.2	5.8	9.5	5.1	1.4	1.0	2.2	19.4	5.5	4.9	6.2	40.5	1.2	12.6	40.8	7.5	12.8	9.6	8.0	33.5	10.2	9.4	10.8	1.3	15.2	68.6	17.0	6.0	19.2	17.4	20.1	19.9	28.4	19.9	21.5	19.0	17.4	19.1	17.9	17.2	21.1	66.1	12.8	28.5	5.2	12.4	38.9	101.7	123.4	52.9	12.1	46.8	78.5	54.5	40.0	41.2	35.0	18.8	44.7	16.1	88.2	176.1	94.1	3.1	59.3	8.0	61.6	37.3	10.1	5.9	30.8	18.2	14.7	30.5	31.0	38.8	11.9	27.1	28.0	137.0	35.3	3.0	62.6	73.2	27.4	27.1	9.8	11.5	33.9	46.2	12.2	35.6	38.3	22.6	0.5	5.8	51.2	132.4	3.8	7.7	51.9	206.9	169.1	65.7	19.1	0.0	39.0	11.4	12.4	48.5	30.4	19.0	38.2	26.8	5.2	75.4	82.2
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 179.8;Proximal enterocytes: 334.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	30.6	19.0	39.3	15.2	40.1	10.4	22.9	35.9	49.3	17.1	28.6	25.6	22.2	19.4	11.0	11.1	22.7	9.8	32.9	34.1	38.3	27.7	33.8	26.2	12.3	40.7	39.6	25.2	14.7	48.6	15.8	8.1	40.9	17.8	19.5	18.8	16.1	13.6	24.7	11.6	57.6	12.6	41.7	36.0	21.3	12.2	41.2	6.7	24.4	24.5	10.1	20.9	14.0	40.8	20.8	10.8	17.5	9.2	34.3	31.0	8.1	16.5	15.1	10.9	11.3	16.8	9.0	3.4	14.1	15.4	21.5	14.8	15.7	10.4	17.3	10.4	11.5	8.7	15.3	16.4	22.0	14.9	15.4	27.8	9.0	7.2	19.5	9.7	17.2	0.0	10.2	17.4	10.7	21.5	0.0	4.0	13.6	20.6	16.0	11.6	12.6	26.1	10.8	16.6	8.6	15.0	9.9	9.9	15.6	14.7	21.6	11.7	17.1	17.7	7.6	32.8	13.0	17.1	18.1	0.5	11.5	11.2	10.0	7.2	41.7	47.0	6.0	54.6	6.2	11.2	6.0	5.5	32.4	10.5	5.3	5.4	34.0	9.8	63.4	4.3	10.7	17.4	39.3	40.1	35.9	49.3	34.1	38.3	40.7	39.6	40.9	41.7	41.2	40.8	56.1	16.0	41.1	4.6	13.0	8.4	12.3	21.1	10.8	22.8	22.2	20.2	85.2	44.3	23.9	20.2	8.4	21.0	11.5	58.8	68.4	24.7	77.8	27.2	25.5	33.0	25.3	17.9	5.6	36.9	26.1	27.8	36.2	33.1	19.6	23.0	78.1	107.5	65.1	43.7	3.0	74.7	18.3	179.8	25.3	37.5	26.4	73.6	17.8	3.7	64.6	14.2	17.5	3.0	4.6	31.1	66.7	39.5	14.3	19.5	334.3	109.4	19.8	19.2	26.3	22.1	30.7	28.2	6.3	15.4	5.4	7.3	15.1	68.2	48.5	16.0
NUDT16L1	"SDOS, TIRR"	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	19.7	46.4	43.1	12.0	44.8	22.2	21.5	43.6	52.5	23.1	45.6	28.5	21.7	21.4	15.3	28.9	23.4	8.4	58.2	44.1	42.0	43.4	64.1	17.2	17.9	45.3	43.2	22.7	24.6	20.4	39.9	8.0	41.9	34.8	11.9	14.5	26.6	14.7	25.0	25.2	29.2	8.5	43.3	33.7	30.1	22.8	44.3	18.2	30.8	16.9	13.1	22.7	21.8	45.7	14.7	23.8	21.2	28.7	15.7	12.1	19.4	17.2	12.9	20.4	12.8	26.9	11.6	15.2	24.4	20.7	10.3	16.8	23.1	23.4	9.5	22.6	38.9	16.8	21.1	32.8	17.0	24.4	19.2	18.7	21.3	17.2	10.7	13.9	15.1	22.6	31.2	18.5	20.1	57.3	36.8	36.0	33.6	24.4	27.0	50.9	22.4	24.2	24.8	18.0	41.8	31.5	25.1	25.9	11.7	16.5	38.4	56.4	20.0	16.7	25.3	39.8	15.9	32.1	20.5	26.1	10.4	32.3	34.8	56.6	54.3	96.2	52.6	48.2	63.1	60.7	63.4	62.8	50.2	65.3	74.0	63.5	68.2	63.9	53.5	83.6	78.3	98.1	43.1	44.8	43.6	52.5	44.1	42.0	45.3	43.2	41.9	43.3	44.3	45.7	23.3	16.0	22.4	14.4	32.6	14.0	19.7	37.4	27.9	52.1	36.0	36.2	52.6	24.3	28.0	42.3	10.4	53.8	43.6	47.7	109.5	28.7	5.2	28.7	33.6	21.4	43.1	23.1	10.2	30.9	31.8	24.0	30.5	29.0	27.9	31.7	17.9	41.8	40.9	47.1	11.8	51.7	89.5	18.3	18.7	8.7	31.4	20.8	30.2	3.7	43.3	83.5	34.0	9.5	15.0	30.0	48.5	50.0	33.0	17.9	77.8	98.2	20.1	58.3	46.0	14.2	22.8	14.8	34.7	24.9	16.6	49.1	43.6	58.0	51.4	17.6
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845630-145848954	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.1;Muller glia cells: 9.1;Spermatogonia: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 8.3;eosinophil: 17.5;plasmacytoid DC: 26.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 26.6;granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	1.7	2.3	5.8	1.7	6.0	3.3	2.0	6.3	7.1	2.8	5.1	2.6	0.5	2.0	1.2	2.1	2.8	1.8	3.4	5.8	6.2	4.0	2.0	1.8	4.2	5.9	5.7	2.6	2.8	2.3	3.1	0.8	5.5	2.7	1.1	2.6	1.9	2.2	3.1	2.1	2.4	1.2	5.6	4.1	2.1	4.0	6.6	2.0	2.5	2.2	3.3	2.8	2.3	5.6	3.7	2.6	2.4	1.3	1.2	2.0	2.4	1.7	2.8	1.8	2.4	1.6	2.6	5.3	1.8	2.9	0.4	0.7	1.8	1.0	1.2	0.6	3.0	2.1	2.5	2.5	3.8	1.6	6.7	2.0	1.6	1.2	2.0	2.2	3.6	8.6	4.6	4.8	3.3	5.8	1.8	3.1	2.0	2.2	0.3	4.8	0.9	1.7	3.0	0.9	1.1	2.7	1.1	2.2	3.0	2.5	12.2	7.5	2.1	2.1	1.3	1.0	0.7	4.2	2.1	1.4	1.9	2.3	1.6	8.3	0.9	17.5	0.8	2.5	0.5	1.4	0.7	0.5	0.9	0.8	1.5	1.1	0.1	0.3	1.7	26.6	0.8	1.1	5.8	6.0	6.3	7.1	5.8	6.2	5.9	5.7	5.5	5.6	6.6	5.6	3.1	3.2	5.5	0.7	1.8	1.8	0.8	1.4	2.2	1.9	2.6	4.6	0.8	2.8	3.4	0.0	0.0	0.6	15.1	0.8	1.9	1.0	3.3	3.5	1.7	1.8	1.2	0.4	0.6	0.7	0.7	2.3	2.6	4.1	2.5	1.7	1.8	0.5	3.0	0.0	0.7	0.5	2.0	0.6	1.6	2.1	1.5	2.3	1.8	1.9	0.5	9.1	3.1	2.0	0.9	1.4	1.4	0.4	3.8	1.0	0.7	0.6	1.7	3.8	0.0	3.7	1.2	6.8	14.8	1.6	1.3	0.5	2.2	1.8	1.2	0.8
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106874-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	7.4	6.4	5.1	4.8	5.2	4.4	6.7	5.4	5.5	4.9	4.3	5.7	6.5	5.4	12.9	8.0	5.3	4.2	4.8	5.4	4.8	6.8	5.6	6.1	8.8	5.3	4.8	2.3	17.0	2.7	9.1	2.7	5.7	7.8	4.7	1.2	8.5	4.6	2.3	7.1	7.6	3.6	4.4	10.4	8.9	7.7	5.4	6.8	8.2	1.2	6.3	5.7	5.5	4.6	8.1	16.8	0.5	3.6	12.4	4.6	9.0	4.8	12.6	6.1	7.0	4.0	6.3	6.0	7.5	5.7	15.5	13.8	2.3	7.7	2.0	7.5	2.3	5.1	4.9	3.9	8.3	1.7	15.2	8.5	7.2	2.4	6.4	7.9	7.7	13.0	3.8	9.9	6.0	8.6	6.9	4.6	0.9	4.8	4.1	3.0	1.5	6.5	9.0	7.1	1.8	2.8	3.3	4.0	4.2	3.7	9.4	8.3	6.4	4.0	2.2	5.4	2.5	4.4	0.5	1.9	7.0	4.5	9.8	0.0	1.5	3.0	2.2	1.6	2.1	1.4	1.8	1.3	1.0	2.0	2.0	1.1	0.3	4.0	1.3	1.9	0.7	0.9	5.1	5.2	5.4	5.5	5.4	4.8	5.3	4.8	5.7	4.4	5.4	4.6	5.6	3.2	2.2	1.0	7.3	2.0	3.4	5.2	1.2	3.3	5.9	4.6	1.9	8.6	3.0	5.5	0.0	6.7	6.8	12.5	5.9	9.5	14.6	5.9	2.4	4.7	3.0	5.2	1.6	13.6	9.6	5.9	6.1	4.1	0.0	6.3	5.7	4.0	14.5	3.3	1.7	10.9	2.0	16.8	1.3	15.1	3.1	9.0	5.4	2.8	15.3	4.1	19.6	0.5	1.6	10.1	14.6	3.4	6.2	4.6	41.2	13.6	7.0	1.2	0.0	3.1	3.7	3.5	2.7	6.3	1.8	3.1	7.9	5.3	7.0	2.3
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	21.7	32.0	36.6	10.6	37.9	14.9	26.0	37.4	47.3	26.4	33.6	29.0	16.3	22.3	35.8	26.0	25.2	13.9	28.2	35.8	37.5	23.9	27.0	13.6	17.3	37.5	37.0	34.8	34.5	19.4	30.8	18.1	37.1	26.8	19.0	20.8	21.1	15.6	44.0	25.7	18.6	18.4	38.1	20.2	25.5	16.2	37.4	23.7	7.1	15.0	18.0	28.4	22.6	40.4	59.3	24.2	30.8	10.9	20.7	37.7	22.0	28.1	62.7	31.8	33.0	16.5	27.4	16.7	22.8	35.0	12.2	25.4	28.1	68.7	32.1	61.7	24.8	35.2	44.6	31.4	61.1	28.1	13.9	38.5	45.1	41.4	77.0	43.3	66.2	55.9	10.3	64.7	46.9	36.8	29.1	26.1	19.4	26.8	67.7	36.7	19.2	41.7	31.3	19.2	6.3	24.9	45.1	16.9	27.3	27.4	14.0	29.5	43.2	27.1	24.4	18.0	29.8	14.9	25.7	28.8	33.9	26.0	35.4	20.8	16.2	13.0	14.7	14.6	20.6	22.6	23.9	19.0	20.7	22.2	27.2	23.8	5.8	19.9	15.1	19.1	27.1	15.7	36.6	37.9	37.4	47.3	35.8	37.5	37.5	37.0	37.1	38.1	37.4	40.4	26.3	3.2	4.1	9.1	17.0	28.2	20.5	44.6	14.2	13.6	39.1	53.1	24.9	37.1	20.6	16.5	6.2	39.0	16.7	20.2	88.0	26.7	11.4	20.2	18.5	24.7	22.2	21.0	6.9	40.0	37.8	21.5	13.7	11.5	13.3	21.6	28.5	36.2	36.9	8.4	7.7	34.7	14.2	31.1	23.0	26.8	27.4	20.3	23.2	11.2	25.8	25.9	18.6	12.5	19.0	32.6	26.5	19.2	31.8	18.5	28.7	65.4	25.4	16.5	26.3	21.0	23.9	39.7	19.2	25.0	31.5	18.9	17.8	35.0	30.0	23.6
NUDT21	"CFIM25, CPSF5"	ENSG00000167005	"Nudix hydrolase 21"	O43809	16	56429133-56452199	"Predicted intracellular proteins"	"Differentiation, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 445.9;Late spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019863, HPA074228"	Uncertain		Supported	"Nuclear bodies,Centriolar satellite"		NA	NA		12000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"	"Centriolar satellite"	"HPA019863: AB_2670299, HPA074228: AB_2686675"	"unprognostic (4.95e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	29.5	32.0	23.4	37.7	27.1	64.4	39.4	27.0	28.7	39.7	19.9	39.3	49.3	39.2	27.4	39.9	35.9	28.4	31.4	28.9	32.2	42.6	37.0	27.7	56.7	20.7	22.5	55.8	32.3	40.2	22.0	38.5	25.3	29.6	40.1	36.0	30.5	32.1	28.0	25.0	34.7	34.7	22.6	34.5	34.0	71.0	22.6	58.3	37.7	37.9	65.7	39.7	26.0	26.9	143.8	79.3	144.3	116.8	78.0	110.0	131.1	96.2	112.2	135.9	94.7	167.7	146.6	193.5	98.5	90.5	84.8	129.8	190.2	116.8	206.0	67.2	78.5	126.6	73.0	146.2	63.6	183.0	124.8	65.5	83.4	113.7	80.3	78.2	127.5	145.8	137.5	69.1	111.2	88.1	195.5	130.1	178.9	106.6	133.0	286.2	196.3	165.4	94.5	121.9	161.1	107.2	184.0	88.0	77.6	99.2	107.6	106.5	74.8	107.4	153.3	93.1	104.1	103.1	120.0	364.7	71.4	117.9	100.1	32.0	24.9	32.9	28.0	26.1	27.7	22.8	29.4	26.1	25.8	20.9	27.1	27.4	27.2	25.5	29.2	19.9	49.6	22.2	23.4	27.1	27.0	28.7	28.9	32.2	20.7	22.5	25.3	22.6	22.6	26.9	30.7	28.9	37.8	23.8	45.5	60.9	52.9	78.4	47.8	19.5	46.3	34.3	39.3	27.1	54.4	42.3	18.8	63.8	29.1	29.2	66.5	63.4	445.9	32.9	40.2	45.2	31.1	69.9	26.5	86.5	90.6	45.8	25.0	38.7	35.5	35.9	48.9	39.1	67.2	35.3	27.9	57.7	20.3	58.8	50.5	230.2	44.7	42.7	37.4	13.1	61.1	25.6	18.6	18.1	34.6	62.5	36.0	41.0	70.0	60.3	49.2	78.3	47.7	24.2	39.5	33.9	59.6	217.4	96.9	67.4	60.0	68.3	49.7	39.5	64.0	70.1
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	21.0	34.7	12.2	12.6	13.2	16.2	21.7	14.0	18.1	19.1	15.4	39.2	30.2	18.5	4.6	34.2	18.5	9.0	52.0	12.2	14.0	43.8	48.8	22.0	17.3	14.1	13.3	15.7	45.4	14.1	24.9	10.3	13.0	26.1	8.3	1.1	30.6	14.8	42.4	27.2	36.3	6.0	13.4	41.9	38.1	10.8	14.8	12.9	31.6	19.7	10.4	26.0	21.5	12.7	35.5	22.7	5.4	22.6	8.1	9.7	20.1	15.0	15.1	10.3	9.5	14.8	29.1	16.6	38.4	14.6	15.5	36.1	3.2	23.0	1.3	21.6	9.2	22.6	15.6	15.4	24.2	14.9	35.5	15.2	16.9	10.8	11.7	7.9	16.9	19.5	11.1	17.7	12.2	53.1	20.4	27.1	8.5	21.5	47.0	25.1	9.2	62.4	17.9	19.4	12.6	19.9	12.8	47.8	58.8	2.1	48.9	16.3	15.9	17.0	16.2	54.5	12.6	66.2	28.5	10.6	58.7	17.0	20.4	40.6	69.1	52.5	53.4	88.7	48.1	63.4	47.0	52.8	72.7	77.3	40.8	44.7	42.7	52.1	86.2	121.4	64.9	52.1	12.2	13.2	14.0	18.1	12.2	14.0	14.1	13.3	13.0	13.4	14.8	12.7	18.8	3.2	14.6	5.5	42.6	12.0	28.9	78.8	19.4	14.7	34.6	30.1	3.7	48.6	36.6	40.5	12.5	107.9	51.5	94.1	164.4	61.8	15.5	19.0	27.2	20.3	37.2	14.5	4.8	87.4	50.9	20.1	47.4	27.8	15.2	15.5	23.2	54.3	57.7	30.3	5.6	98.1	61.1	50.1	21.8	9.6	20.2	40.0	33.8	4.7	70.8	26.5	49.4	1.5	3.5	68.0	93.0	19.5	65.8	33.6	133.5	144.8	13.6	18.0	13.1	20.2	45.0	6.6	8.2	34.3	17.5	67.5	37.5	43.6	73.6	33.0
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 361.9;Erythroid cells: 520.6;Muller glia cells: 485.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	61.2	71.8	52.1	31.9	60.4	169.2	48.7	37.3	75.5	52.1	48.5	57.4	26.6	30.9	62.5	34.8	44.5	89.8	161.6	61.4	53.1	130.5	45.1	29.0	34.3	48.2	54.5	150.2	62.9	41.7	26.5	60.1	47.5	78.7	62.9	102.0	129.8	38.2	87.2	19.8	35.4	37.9	42.5	25.7	34.6	32.3	48.8	34.8	57.5	115.6	36.3	78.6	26.0	52.7	24.1	20.4	36.4	41.1	132.5	54.3	45.5	66.0	52.4	37.0	27.2	188.4	58.6	33.7	14.0	53.1	24.3	29.5	102.4	33.2	56.5	51.9	21.6	126.9	17.1	99.3	126.8	66.8	29.3	118.5	109.2	38.3	85.0	186.1	212.9	59.7	130.7	46.0	42.9	24.6	61.9	63.7	57.2	59.4	47.7	50.7	32.5	36.5	45.0	171.7	29.1	37.5	53.6	103.3	153.2	58.2	75.2	85.6	81.6	31.6	18.0	47.9	42.5	25.6	34.2	49.4	16.6	51.8	98.3	9.5	2.2	11.3	2.8	2.8	5.1	4.5	4.2	2.9	2.0	3.8	4.4	4.4	1.9	6.0	2.5	3.2	4.2	1.9	52.1	60.4	37.3	75.5	61.4	53.1	48.2	54.5	47.5	42.5	48.8	52.7	44.0	19.2	42.8	8.1	74.8	116.8	123.1	22.5	178.7	66.9	58.3	39.1	243.9	114.4	31.8	62.5	62.6	188.7	49.8	226.9	361.9	21.8	125.6	45.7	38.2	66.4	152.2	520.6	16.6	16.5	32.9	99.2	36.2	60.6	25.4	54.2	41.7	53.4	43.7	42.1	7.5	89.3	12.2	35.1	81.0	26.2	39.1	47.2	106.7	5.6	34.3	485.7	34.0	10.6	1.3	55.1	92.8	46.6	113.9	137.8	68.2	52.8	86.1	44.5	72.3	184.4	204.4	115.7	17.3	119.2	96.7	163.8	80.2	37.3	90.4	178.4
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"	A0A024RBG1	1	148748894-148750099	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 42.1;RT4: 34.5"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				4.9	6.8	0.2	3.6	0.4	23.6	1.8	0.0	0.9	4.4	0.3	5.7	5.3	3.7	2.6	8.1	7.0	17.7	20.8	0.5	0.6	9.8	3.9	2.6	6.8	1.3	0.5	16.1	11.9	4.6	0.3	7.7	0.4	7.5	6.1	0.6	23.6	3.1	5.3	1.3	5.2	3.6	0.3	3.0	4.1	7.7	0.3	3.2	7.9	8.1	3.7	11.1	0.6	0.6	3.5	3.8	1.5	4.7	6.3	5.1	9.3	4.1	6.2	4.4	4.2	42.1	14.8	3.5	1.7	3.7	4.2	5.7	6.8	3.0	2.2	11.0	3.3	8.5	2.3	5.4	8.4	5.8	2.6	10.6	9.7	5.5	5.1	5.3	16.5	4.3	17.6	13.8	4.2	3.0	7.9	1.1	8.3	3.4	6.2	9.7	2.2	10.0	3.2	34.5	3.0	4.4	3.5	8.6	23.7	1.0	11.7	11.0	9.1	5.8	4.5	9.6	6.3	3.2	5.2	4.5	2.7	8.7	17.4	0.0	0.1	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.4	0.0	0.9	0.5	0.6	1.3	0.5	0.4	0.3	0.3	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165330-12196144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	35.1	32.4	23.0	30.6	26.4	24.1	26.7	27.5	30.5	24.6	29.5	32.0	27.5	14.3	23.7	40.7	24.6	18.4	14.9	23.4	26.0	36.3	88.8	26.0	39.3	27.3	24.9	18.0	25.9	33.1	35.5	31.1	27.4	21.0	36.0	27.4	25.1	14.0	6.2	33.2	25.4	17.6	25.0	34.2	22.6	13.1	25.4	53.5	27.8	7.6	47.4	28.9	27.8	31.8	136.4	98.0	114.6	107.1	107.5	105.6	100.8	96.9	61.5	111.9	119.1	142.5	125.9	134.2	82.4	79.2	70.0	133.1	162.0	150.6	102.1	110.8	160.8	111.9	114.3	209.3	112.0	77.1	75.2	111.7	88.4	122.3	61.7	86.3	144.9	209.4	153.5	88.9	103.2	123.8	143.5	87.0	100.4	215.0	60.1	128.0	42.4	157.2	106.0	46.1	56.6	82.3	117.4	90.8	142.2	132.0	155.9	77.9	91.6	47.0	90.6	134.3	121.9	74.3	141.6	179.3	99.7	97.3	36.0	29.6	60.8	115.2	69.9	65.7	80.4	72.7	73.9	82.6	87.6	64.6	50.4	68.4	163.8	57.4	52.2	149.2	123.4	71.6	23.0	26.4	27.5	30.5	23.4	26.0	27.3	24.9	27.4	25.0	25.4	31.8	42.1	25.6	55.1	23.2	43.8	43.0	57.8	121.2	28.5	21.1	28.6	30.7	4.5	32.9	72.3	23.9	16.7	82.6	49.8	35.0	74.3	82.2	35.3	61.1	44.4	42.6	38.3	43.5	34.6	82.9	150.6	40.3	33.1	31.9	31.7	41.4	41.7	131.8	128.7	21.9	38.2	41.2	79.3	41.8	32.2	11.7	39.4	39.7	30.2	12.2	85.0	37.4	62.8	34.2	41.2	73.8	35.2	29.0	66.1	33.7	52.6	130.6	103.9	25.5	32.9	21.2	40.1	20.2	33.6	52.4	60.5	58.1	49.7	54.4	57.4	46.9
NUDT6	"FGF-AS, FGF2AS, gfg, gfg-1"	ENSG00000170917	"Nudix hydrolase 6"	P53370	4	122888697-122922968	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 37.2;Early spermatids: 36.7;Proximal tubular cells: 46.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039202, HPA066115"	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039202: AB_10795032, HPA066115: AB_2685620"	"unprognostic (7.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.91e-6)"	"unprognostic (1.13e-5)"	"unprognostic (2.32e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-1)"	4.9	10.7	8.2	2.8	9.4	2.2	5.3	5.8	10.6	4.2	6.6	7.7	4.4	4.1	7.1	3.3	6.7	3.6	13.0	8.4	8.2	19.4	27.3	3.2	3.9	6.0	7.3	4.2	4.0	7.4	6.4	3.2	6.1	3.7	6.2	8.3	5.2	4.3	10.0	4.2	3.7	3.5	5.9	4.5	3.3	7.1	9.0	4.8	7.3	10.9	2.3	3.2	3.2	7.8	5.4	7.9	11.5	10.3	10.3	10.7	4.1	6.1	8.1	5.3	7.3	3.4	12.1	5.6	4.5	3.3	11.7	2.7	5.1	4.8	5.4	13.5	3.4	5.0	7.6	9.2	3.8	10.4	3.0	6.6	2.1	4.6	4.0	9.8	7.0	9.7	12.8	13.8	9.0	6.3	14.5	11.2	4.3	20.8	9.9	4.9	14.6	6.4	12.7	3.2	6.1	7.6	6.3	8.5	12.5	13.3	5.6	8.3	4.4	12.8	6.7	11.2	5.6	15.4	12.9	10.7	7.7	15.4	5.8	0.0	2.0	0.0	1.5	2.8	1.9	4.0	2.0	2.6	4.4	1.2	1.5	1.7	0.3	1.3	2.5	1.7	2.3	1.8	8.2	9.4	5.8	10.6	8.4	8.2	6.0	7.3	6.1	5.9	9.0	7.8	7.0	16.0	7.8	10.7	2.0	0.9	3.1	9.3	4.6	12.5	4.7	6.9	5.3	4.3	5.4	5.5	0.0	16.4	1.3	4.1	37.2	6.2	36.7	8.9	7.4	5.4	7.2	3.0	8.9	5.6	3.7	5.3	5.6	3.4	1.3	12.8	4.6	21.3	8.7	15.2	9.6	6.0	6.1	4.6	2.0	6.1	6.2	5.0	5.4	4.7	1.5	14.0	0.0	13.6	10.8	4.7	5.2	9.1	3.8	1.2	2.5	46.2	10.4	11.9	0.0	6.3	5.0	28.5	3.7	3.9	1.8	4.0	3.3	20.8	10.1	2.1
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Proximal tubular cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 49.7;U-698: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	Nucleoplasm	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	14.4	23.6	5.9	5.2	6.0	2.2	9.2	6.4	7.4	5.8	15.6	12.0	10.8	7.8	17.5	6.6	10.2	6.8	37.6	5.6	7.8	22.1	70.1	6.1	8.9	5.5	5.4	7.3	9.5	16.3	6.0	4.5	6.0	6.6	12.3	9.7	9.0	7.2	8.1	9.0	8.7	7.4	5.3	7.0	7.5	8.7	6.8	6.4	11.8	12.1	9.1	8.2	5.8	6.1	2.1	7.0	6.2	3.5	28.4	7.2	5.8	1.8	9.1	2.7	3.5	2.0	8.8	10.3	6.6	6.9	6.5	6.9	4.7	7.6	1.6	3.3	6.4	0.1	0.4	9.6	3.1	7.1	1.4	12.2	9.4	1.5	5.3	1.2	4.8	14.7	7.6	4.4	1.1	19.1	3.7	16.8	6.6	12.4	1.7	7.8	0.8	3.1	14.1	0.0	5.1	5.0	6.5	2.6	5.7	10.6	18.6	49.7	3.7	3.1	0.4	1.4	0.3	0.0	0.0	40.6	12.1	8.8	0.0	3.8	12.4	1.7	12.6	17.5	14.4	14.2	14.8	15.1	10.2	19.8	19.5	13.5	2.0	3.5	17.5	11.7	31.5	8.8	5.9	6.0	6.4	7.4	5.6	7.8	5.5	5.4	6.0	5.3	6.8	6.1	8.3	16.0	8.7	12.7	4.1	9.7	6.5	14.6	14.2	2.5	10.9	14.5	17.9	18.6	7.9	14.7	0.0	20.3	7.9	12.1	58.7	8.0	11.6	19.5	4.7	8.2	6.7	3.6	4.3	9.5	9.1	8.5	3.6	6.6	1.3	7.0	5.3	41.2	5.9	6.7	5.6	6.6	10.2	9.2	4.4	4.6	5.6	4.1	8.8	1.9	2.1	25.0	10.3	3.5	2.7	4.0	10.4	4.9	1.1	2.0	22.6	42.2	21.0	7.3	6.6	7.1	8.9	14.2	20.0	12.2	13.9	6.7	6.9	10.7	14.8	4.5
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629937	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 78.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 218.9"									"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	10.3	5.3	6.9	1.9	8.7	3.2	9.9	10.3	10.4	10.1	6.9	12.4	14.2	4.3	2.2	57.6	5.0	1.6	78.9	6.2	8.6	25.5	58.7	6.1	1.8	9.2	8.7	4.6	13.1	12.0	3.0	1.7	8.6	9.3	5.4	0.8	24.1	4.3	58.8	31.7	11.6	1.5	8.4	4.5	9.1	4.4	9.2	2.5	20.4	41.8	3.7	3.7	12.6	9.1	33.5	13.3	5.1	8.4	4.7	5.9	8.1	6.9	3.2	2.7	2.8	11.0	8.5	35.1	10.6	5.4	3.9	16.1	5.9	4.1	0.3	34.3	14.7	2.0	6.1	34.2	1.4	11.2	16.0	3.6	8.1	3.4	1.1	0.7	6.0	42.6	9.9	30.1	2.2	55.9	18.6	16.0	3.1	58.7	28.0	11.4	2.7	218.9	8.4	5.8	2.6	3.7	1.8	18.7	7.1	1.8	10.2	4.6	1.6	7.1	10.1	45.7	1.3	21.6	15.3	7.1	5.0	14.8	4.1	0.0	1.1	1.1	2.9	4.7	2.5	3.2	1.7	3.5	4.6	6.4	1.5	1.8	0.0	9.5	13.7	12.4	1.3	2.1	6.9	8.7	10.3	10.4	6.2	8.6	9.2	8.7	8.6	8.4	9.2	9.1	8.7	0.0	6.5	6.2	12.0	12.1	12.7	9.4	17.6	4.5	42.3	39.9	79.5	15.7	12.1	29.5	0.0	29.7	7.2	76.5	84.1	14.3	3.3	8.2	11.0	9.2	2.4	34.5	0.6	23.9	21.4	12.5	23.4	13.8	8.9	3.7	8.6	222.8	9.4	5.0	0.7	102.5	12.2	5.3	10.8	8.0	5.0	5.0	28.4	0.0	2.5	7.9	4.1	1.0	2.9	9.9	26.4	5.3	15.7	18.5	139.4	237.1	4.5	7.8	6.6	7.8	17.7	13.9	8.8	129.6	25.6	17.4	7.6	6.6	69.8	25.0
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUMB	C14orf41	ENSG00000133961	"NUMB endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 290.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	35.6	25.9	17.3	37.7	19.2	35.5	33.0	20.4	23.4	34.3	22.0	46.3	46.6	35.6	25.9	40.0	39.0	41.7	28.8	20.9	17.6	41.3	52.1	52.8	24.7	20.3	19.5	33.9	37.3	40.5	20.2	44.4	19.7	29.5	42.2	20.4	36.8	31.6	21.1	32.6	47.4	37.6	18.1	40.4	36.8	20.3	19.4	27.6	39.0	24.1	30.9	40.5	34.0	18.2	70.2	46.9	33.3	30.2	65.8	99.6	45.3	64.9	87.2	51.2	54.1	57.0	86.0	31.9	39.7	80.7	37.8	45.2	39.8	66.6	77.2	48.9	22.2	25.5	28.2	37.3	69.7	23.7	57.5	56.0	70.3	126.2	74.8	56.2	112.3	49.2	47.0	37.1	65.6	62.9	43.3	32.8	15.4	78.9	50.1	27.6	46.7	21.6	71.2	105.3	13.6	35.3	81.0	54.2	33.4	55.9	81.3	34.5	108.8	76.2	42.7	49.3	28.2	30.9	38.9	29.2	153.1	27.4	34.3	91.9	93.3	96.8	12.6	76.4	13.2	22.6	12.7	14.0	68.7	21.4	12.9	11.8	290.3	12.8	102.8	12.8	17.9	64.5	17.3	19.2	20.4	23.4	20.9	17.6	20.3	19.5	19.7	18.1	19.4	18.2	54.4	64.1	49.0	108.4	53.6	42.8	27.7	38.6	42.1	30.7	38.4	26.0	22.0	44.3	50.0	55.2	81.3	26.0	29.9	59.3	25.4	27.9	11.9	68.2	35.0	59.2	40.7	22.9	151.1	26.4	31.0	37.5	43.8	56.6	24.1	26.3	52.1	51.0	42.6	15.2	78.8	39.4	36.7	91.5	109.7	8.1	45.1	94.1	46.2	141.5	117.3	42.6	39.1	62.4	81.8	46.9	39.3	36.9	40.9	37.1	64.7	43.2	56.9	46.4	26.3	22.8	29.7	59.2	32.7	35.6	46.5	34.3	25.6	16.7	37.5	44.6
NUMBL	"CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23"	ENSG00000105245	"NUMB like endocytic adaptor protein"	Q9Y6R0	19	40665905-40690972	"Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 42.6;Peritubular cells: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058251, HPA058380"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058251: AB_2683653, HPA058380: AB_2683698"	"unprognostic (2.78e-2)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.55e-15)"	"unprognostic (1.91e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.69e-3)"	31.3	16.2	25.0	8.1	27.7	3.0	22.2	19.1	31.2	49.3	0.1	35.2	8.4	45.2	6.2	17.6	46.6	11.4	25.9	31.3	18.5	12.4	15.4	25.6	3.9	6.3	11.9	38.8	10.1	2.4	72.4	5.7	10.6	35.2	3.8	5.2	14.7	13.9	11.4	17.9	18.2	12.5	3.9	12.6	22.2	25.3	17.4	2.3	28.4	6.1	2.6	36.2	38.0	13.9	17.0	46.4	9.7	25.7	22.8	22.4	5.4	20.2	17.5	11.7	14.1	17.5	12.4	6.2	19.7	29.4	8.8	16.4	7.1	8.8	6.2	16.8	11.8	6.8	47.0	2.4	24.2	3.4	7.7	21.5	5.9	19.2	8.1	18.2	16.7	5.4	20.0	7.1	8.2	15.5	10.8	3.3	11.3	9.9	10.7	9.1	26.5	12.7	3.4	4.7	19.3	34.1	22.2	12.9	19.7	6.1	13.1	5.7	31.9	21.2	24.1	33.7	25.6	9.3	11.9	3.9	34.1	10.8	12.3	0.0	0.1	0.0	1.1	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.4	0.2	0.0	0.8	0.2	0.0	0.2	25.0	27.7	19.1	31.2	31.3	18.5	6.3	11.9	10.6	3.9	17.4	13.9	6.9	0.0	3.4	13.4	2.7	13.6	14.6	2.4	4.6	14.2	4.9	6.1	4.0	4.3	3.4	0.0	0.0	2.8	4.1	1.8	0.0	2.5	24.7	10.4	24.7	6.0	7.2	1.7	12.9	1.8	5.4	24.2	6.6	7.9	0.0	5.5	5.7	2.2	1.6	11.8	7.4	3.5	0.0	1.9	6.8	10.1	42.6	2.3	3.6	3.7	0.5	3.0	0.0	9.0	4.9	1.7	3.3	51.6	1.4	18.7	2.5	0.6	9.2	4.6	0.0	20.6	10.4	1.4	3.3	5.6	21.0	2.2	2.3	6.9	3.3	8.8
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.7;U-266/84: 261.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	2.0	5.2	5.3	23.2	5.8	53.4	5.4	7.8	6.5	2.3	4.8	6.4	7.3	2.6	8.4	7.1	4.1	4.6	2.3	5.0	6.2	8.8	19.8	7.6	41.3	6.1	6.7	1.2	13.0	9.7	13.5	6.4	5.5	5.4	5.6	4.8	6.4	2.8	5.2	5.6	22.2	2.4	5.2	32.5	8.5	9.2	5.8	41.7	8.1	1.8	29.0	5.8	2.2	7.3	41.5	72.0	34.8	90.8	0.0	0.0	138.1	0.6	0.0	8.6	0.4	37.2	66.3	167.7	55.6	0.1	3.9	23.8	77.5	0.0	3.2	135.9	57.9	65.2	81.1	39.6	0.0	210.8	22.7	0.0	0.0	0.0	0.0	6.3	0.1	124.1	102.5	174.9	0.0	103.8	112.6	83.4	40.2	12.8	14.8	0.2	0.2	232.7	16.9	38.4	39.8	39.8	51.3	67.7	21.0	15.5	64.8	172.6	0.5	0.1	11.7	0.2	31.8	176.1	261.0	144.9	0.1	116.0	0.3	0.0	2.5	0.9	7.3	3.2	5.8	5.4	5.2	7.2	5.4	3.1	4.3	5.8	0.1	5.5	2.0	5.6	4.8	3.7	5.3	5.8	7.8	6.5	5.0	6.2	6.1	6.7	5.5	5.2	5.8	7.3	0.7	16.0	5.4	16.6	37.3	1.7	1.3	0.5	0.0	25.4	9.6	5.3	11.6	8.6	4.1	5.5	14.6	17.6	57.7	2.9	3.9	5.7	19.2	4.3	1.0	1.0	8.3	41.8	17.9	4.4	5.6	1.1	3.6	8.3	5.1	70.0	3.6	17.0	16.7	35.3	23.4	8.8	4.1	11.3	4.9	23.5	0.6	14.9	1.8	10.3	16.7	3.0	69.0	30.2	17.7	2.6	0.8	0.4	43.7	2.6	2.1	4.5	3.0	19.4	0.0	2.1	1.1	6.4	10.0	3.5	2.4	4.9	37.2	17.8	11.5	1.9
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.1	0.0	0.2	0.0	0.7	0.1	0.0	2.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.7	0.6	0.1	0.1	0.0	0.3	0.0	0.8	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	26.6	0.5	0.0	0.2	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.7	2.4	0.9	0.4	0.3	0.7	0.6	0.8	0.3	0.5	2.3	0.6	0.0	0.0	6.2	0.5	0.3	0.1	0.1	0.0	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	20.3	0.7	0.6	0.9	0.0	0.4	7.0	0.2	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	0.0	8.4	0.1	0.0	0.0	0.6	8.5	0.9	0.8	0.0	2.8	0.0	0.0	0.0	4.5	19.2	0.0	0.0	1.2	1.7	0.1	0.0	0.1	0.1	0.0	6.6	1.8	0.3	28.2	5.1	0.3	0.6	0.0	0.4	0.1	0.1	0.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120120	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.3	14.2	4.1	17.1	4.4	22.7	19.5	5.1	7.8	12.8	2.4	20.1	13.0	11.9	21.5	18.9	19.0	10.9	17.6	4.8	4.5	15.2	13.0	11.6	28.1	3.5	2.8	12.1	8.7	17.4	5.9	16.9	3.4	13.7	23.8	10.9	11.7	13.8	17.5	13.4	14.9	17.7	2.4	12.0	12.9	15.1	4.3	25.7	16.4	15.5	33.5	17.7	9.6	6.3	105.5	74.5	64.2	29.6	51.7	68.4	144.6	64.8	61.0	99.8	68.0	97.4	55.5	70.1	45.4	50.9	68.9	76.2	113.5	101.2	124.4	98.5	65.2	75.6	37.2	86.4	66.0	107.5	22.8	53.4	43.5	78.3	57.3	66.7	83.3	91.2	135.5	25.8	93.9	71.6	79.9	87.9	63.4	96.8	117.2	51.9	92.0	52.8	79.0	76.1	33.6	24.0	49.8	52.7	50.3	72.1	90.7	61.7	27.2	35.7	39.4	51.0	91.1	38.5	78.9	119.4	41.9	86.1	61.8	67.8	24.0	28.3	21.4	29.3	23.2	31.2	25.7	21.9	30.2	28.2	23.0	26.1	7.0	23.9	24.9	25.3	45.4	22.5	4.1	4.4	5.1	7.8	4.8	4.5	3.5	2.8	3.4	2.4	4.3	6.3	12.3	6.4	14.3	8.8	22.6	11.3	20.9	63.8	17.1	8.0	10.5	11.7	9.5	14.3	28.2	16.5	8.4	68.1	17.7	9.1	25.4	24.0	2.9	21.6	17.6	17.2	6.0	38.7	5.8	20.0	92.3	19.9	12.2	11.8	7.6	21.2	13.6	10.0	35.6	3.3	7.3	16.0	22.4	15.2	8.4	6.3	19.6	13.5	7.2	5.6	20.5	18.9	13.4	11.1	12.6	17.2	10.6	18.8	34.1	10.7	11.5	24.6	39.3	20.1	19.7	8.6	18.3	49.0	42.4	25.5	9.5	40.2	18.8	31.9	26.5	16.8
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
NUP58	"KIAA0410, NUP45, NUPL1"	ENSG00000139496	"Nucleoporin 58"	Q9BVL2	13	25301556-25349800	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.5;Late spermatids: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039360	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039360: AB_2676463"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.06e-1)"	13.2	14.1	11.9	17.2	12.1	34.7	16.1	14.1	14.3	13.6	11.0	12.3	11.8	15.0	12.0	13.7	13.2	13.8	14.1	12.9	13.4	15.5	16.0	19.5	21.5	11.8	13.3	18.4	12.3	10.7	20.9	20.6	11.1	15.4	14.6	27.3	10.7	11.2	20.4	14.2	11.5	14.6	11.1	12.2	13.2	47.6	12.4	26.9	19.5	24.3	18.9	18.7	12.8	14.9	38.5	22.6	53.8	40.6	17.9	25.4	40.9	55.8	41.6	57.9	47.3	37.8	40.5	65.0	26.4	31.6	49.7	41.8	61.6	45.6	92.4	60.5	30.0	90.8	20.8	26.7	33.0	66.5	103.9	17.4	61.8	47.8	106.4	28.6	36.3	55.5	49.4	27.6	66.4	15.2	86.1	47.0	32.4	61.4	19.5	59.1	70.5	29.8	32.1	29.4	63.5	32.0	36.0	27.2	44.6	43.3	18.4	60.6	29.6	37.4	37.2	36.3	66.5	33.9	29.9	87.4	27.6	38.9	65.2	1.4	6.3	1.8	2.4	5.3	3.2	2.4	3.1	2.9	3.8	1.9	3.5	3.1	8.9	2.3	6.3	1.9	4.3	3.4	11.9	12.1	14.1	14.3	12.9	13.4	11.8	13.3	11.1	11.1	12.4	14.9	25.9	41.7	105.2	0.0	53.6	0.0	24.1	0.0	52.3	34.6	27.4	20.7	0.0	20.0	13.6	25.8	54.2	27.2	30.2	8.5	11.7	13.4	122.5	30.6	51.4	23.9	9.7	41.2	0.0	10.9	39.8	27.4	26.0	47.7	24.0	32.9	19.2	27.1	23.0	25.2	0.0	13.7	0.0	40.5	0.0	238.7	19.3	56.6	0.0	0.0	31.7	22.7	19.6	0.0	0.0	19.3	6.8	24.8	41.6	39.7	11.7	37.0	5.8	49.5	19.7	35.8	22.3	86.7	78.8	33.8	0.0	39.5	38.1	21.6	14.0	28.7
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
NUP62CL	FLJ20130	ENSG00000198088	"Nucleoporin 62 C-terminal like"	Q9H1M0	X	107123427-107206433	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 17.3;fallopian tube: 17.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 21.5;Endometrial ciliated cells: 26.6;Respiratory ciliated cells: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 21.9;CAPAN-2: 23.5;HeLa: 30.7;K-562: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001884	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA001884: AB_1079512"	"unprognostic (1.62e-2)"	"prognostic favorable (5.66e-5)"	"unprognostic (8.80e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.52e-3)"	0.2	13.9	0.9	1.6	1.0	2.2	3.1	0.7	0.6	1.3	7.6	2.7	3.0	1.8	17.3	1.3	17.2	1.5	1.8	0.8	1.2	6.0	1.9	1.6	1.3	3.6	3.8	1.4	4.3	4.2	2.5	0.4	2.1	0.9	3.3	1.0	2.1	2.9	0.1	1.5	3.0	0.3	2.5	0.2	1.7	12.0	1.2	2.0	10.0	0.5	2.3	0.9	0.9	1.3	13.5	21.9	1.9	0.0	0.0	0.1	9.4	0.0	0.8	0.5	0.5	2.1	23.5	7.7	2.5	0.0	11.9	11.9	13.9	4.8	0.1	0.0	17.8	0.8	30.7	3.9	0.0	0.0	0.0	0.2	6.3	0.1	3.3	0.0	0.0	11.8	23.0	1.9	0.0	6.6	3.0	0.0	2.8	19.1	7.9	0.0	0.0	0.7	7.1	3.6	5.5	6.4	7.8	2.4	0.0	7.8	0.0	0.4	0.0	0.0	7.0	0.1	0.0	2.5	9.4	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	2.0	0.9	0.0	0.0	1.0	0.4	0.5	0.0	0.7	0.2	0.0	0.4	0.2	0.9	1.0	0.7	0.6	0.8	1.2	3.6	3.8	2.1	2.5	1.2	1.3	0.3	3.2	0.0	0.3	1.7	1.9	3.9	6.3	1.8	0.5	2.8	1.7	1.0	2.8	3.5	9.2	0.0	2.0	0.8	1.7	21.5	2.1	8.8	26.6	0.3	0.4	0.0	3.8	0.4	3.4	1.0	0.2	1.5	4.2	0.0	1.7	0.0	2.2	0.9	1.7	0.5	3.5	6.1	0.0	1.1	3.3	0.3	0.3	5.4	2.8	0.2	1.2	0.0	0.0	0.3	1.4	0.7	0.7	2.4	1.1	1.1	5.7	21.6	0.2	6.6	0.4	0.9	9.6	9.7	1.6	2.8	1.0	1.1	0.0	2.4	2.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730118-56850286	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA		38000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	17.9	13.9	13.2	21.3	17.4	52.7	15.5	6.8	23.9	15.3	0.2	17.7	9.9	16.9	12.4	22.3	15.3	12.4	14.2	30.6	10.7	12.8	9.3	15.3	27.7	10.7	9.3	14.9	14.2	14.8	10.8	19.1	9.9	17.7	18.1	31.7	12.2	12.7	20.0	21.6	14.5	19.5	8.3	24.2	15.2	39.8	11.4	34.1	34.3	14.2	30.3	17.1	16.1	11.5	71.3	84.5	71.6	81.0	25.9	34.8	81.0	58.7	48.2	156.2	100.1	119.4	66.1	107.7	60.4	54.9	54.2	120.6	143.3	90.1	149.8	34.0	81.3	72.6	64.7	97.3	35.0	96.7	82.8	29.3	35.7	104.2	64.7	31.6	90.8	95.3	87.8	22.3	72.3	52.4	136.2	81.1	92.1	44.2	95.4	163.9	129.4	108.9	53.1	47.8	66.6	44.1	159.1	54.6	47.3	77.4	43.0	57.9	55.3	68.1	74.0	57.8	67.5	35.0	60.7	190.2	47.4	88.5	67.5	19.3	49.9	195.7	38.9	77.2	45.2	45.4	28.3	40.9	60.9	45.4	28.7	41.0	11.8	51.8	77.5	28.7	39.7	47.4	13.2	17.4	6.8	23.9	30.6	10.7	10.7	9.3	9.9	8.3	11.4	11.5	11.3	6.4	12.3	17.6	13.4	12.0	13.6	20.7	6.2	68.6	9.0	7.6	11.8	1.5	20.2	9.2	10.4	21.1	9.4	8.6	11.7	24.6	11.7	10.9	8.8	16.5	4.9	33.2	51.1	25.5	31.7	12.8	13.7	10.6	17.2	22.3	10.8	7.2	26.6	38.7	49.4	11.2	24.4	17.8	23.8	7.7	23.3	17.3	16.0	33.7	30.3	11.7	8.2	18.1	22.1	21.4	7.2	13.5	8.1	16.5	3.6	11.0	13.0	20.8	13.1	11.4	27.9	54.6	62.2	14.3	16.1	10.3	13.5	22.3	15.3	18.0
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675469-117710727	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	17.8	20.0	12.1	22.2	13.0	19.4	22.2	11.4	15.5	60.3	16.1	19.8	16.5	20.6	28.4	15.7	18.4	16.1	11.7	12.9	13.8	28.4	31.6	18.2	21.4	10.8	12.5	16.5	20.4	29.8	11.9	21.6	11.9	20.6	20.3	12.5	30.5	17.6	10.0	11.1	17.6	18.7	11.7	17.8	24.2	12.6	13.5	18.5	35.4	12.6	20.6	23.5	11.7	12.4	27.1	19.5	41.3	46.4	40.7	52.9	101.0	48.3	50.1	39.5	45.1	44.6	29.5	63.4	51.1	44.7	50.0	24.0	62.1	47.2	73.0	47.9	57.0	72.8	31.5	80.2	62.6	92.8	41.2	46.6	52.5	43.3	87.7	40.3	41.3	46.5	88.4	54.9	59.7	30.5	43.9	58.8	48.0	36.9	35.3	41.7	29.7	45.7	79.0	26.6	48.7	38.5	29.1	37.4	36.9	45.6	23.8	95.9	36.4	24.3	30.1	39.2	70.5	75.6	60.8	66.8	57.6	70.0	49.7	1.9	1.3	0.8	1.3	1.4	1.9	1.1	1.6	1.8	1.5	1.0	1.3	1.7	0.1	1.9	2.5	3.8	1.7	1.0	12.1	13.0	11.4	15.5	12.9	13.8	10.8	12.5	11.9	11.7	13.5	12.4	18.7	0.0	22.3	30.3	28.5	60.5	41.9	32.6	19.4	15.3	26.6	13.7	6.3	15.7	24.0	25.8	10.4	26.8	38.1	26.4	27.4	23.4	16.0	15.7	28.9	24.3	13.1	19.1	33.4	30.2	63.6	22.8	38.2	21.4	31.1	15.8	28.2	39.7	35.3	15.2	37.1	29.3	20.3	37.0	42.2	14.0	18.0	30.2	32.0	20.6	28.4	8.3	24.7	35.7	36.5	37.4	22.7	20.3	57.5	73.1	18.6	33.6	23.1	9.6	6.6	21.3	25.9	24.9	25.4	25.7	56.1	57.9	26.2	14.5	26.1	77.5
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
NUTF2	"NTF2, PP15"	ENSG00000102898	"Nuclear transport factor 2"	P61970	16	67846923-67872567	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040915, HPA040956"	Supported					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA040915: AB_10794073, HPA040956: AB_10796233"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.17e-3)"	"unprognostic (9.80e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	57.1	53.7	86.4	36.5	86.6	42.0	49.8	88.8	93.4	47.4	75.3	57.9	27.4	60.7	49.4	53.7	47.9	26.6	74.7	88.4	96.6	50.8	51.5	49.9	47.8	96.2	99.6	42.4	56.9	41.6	43.0	49.8	99.2	44.6	42.6	17.2	40.5	32.5	93.4	58.7	42.8	58.0	90.7	41.4	45.9	56.6	88.3	57.4	39.3	79.2	53.3	57.9	45.2	91.7	149.0	174.8	186.9	212.2	92.8	94.1	249.9	118.8	102.8	165.4	134.1	222.3	152.5	169.2	107.7	161.3	95.9	130.3	235.4	176.2	179.3	65.9	225.5	114.2	73.6	357.5	124.0	161.6	83.1	123.4	114.1	152.9	190.7	91.0	175.5	127.7	164.2	59.1	173.6	301.8	257.3	311.1	318.9	152.4	117.6	228.2	121.5	254.2	218.9	128.5	169.6	164.4	266.4	109.5	93.6	174.5	161.0	137.3	147.4	140.3	168.3	104.2	144.0	94.8	131.0	367.5	92.9	113.0	147.8	47.8	64.0	27.4	61.0	95.7	70.1	52.7	64.9	60.3	81.5	51.8	48.8	55.9	17.9	71.9	88.3	78.7	72.8	101.8	86.4	86.6	88.8	93.4	88.4	96.6	96.2	99.6	99.2	90.7	88.3	91.7	67.6	57.7	20.2	4.9	58.6	68.2	79.5	136.5	64.9	15.9	62.8	53.7	38.7	27.1	58.5	49.7	2.1	208.2	62.4	66.2	137.0	196.5	9.9	71.4	66.1	71.9	98.3	126.4	6.9	105.1	336.1	57.6	60.6	52.7	39.3	65.1	28.2	22.5	149.4	20.2	7.4	69.1	89.5	32.4	83.6	20.8	33.2	75.2	58.7	4.7	130.2	26.5	69.0	4.0	8.3	198.8	93.3	42.9	86.2	166.0	96.5	124.1	53.7	7.6	13.1	48.5	187.5	54.6	82.0	88.7	87.7	183.5	62.9	62.1	95.6	114.5
NUTM1	"C15orf55, DKFZp434O192, FAM22H, NUT"	ENSG00000184507	"NUT midline carcinoma family member 1"	Q86Y26	15	34343315-34357737	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 19.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 89.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA040421	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA040421: AB_10793965"	"unprognostic (4.14e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.37e-2)"		"unprognostic (8.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.79e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	89.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NVL	NVL2	ENSG00000143748	"Nuclear VCP like"	O15381	1	224227334-224330189	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	7.0	7.7	5.5	8.7	5.7	9.8	10.7	7.8	7.5	9.5	6.5	9.1	6.3	9.0	7.7	7.2	8.8	5.6	5.9	5.3	6.4	8.7	6.1	8.0	12.5	5.4	5.3	10.6	8.8	9.5	10.3	13.0	5.6	9.0	10.6	12.8	7.4	7.9	6.5	15.7	8.2	8.1	4.7	10.4	7.2	6.6	5.6	13.0	10.2	5.2	12.1	8.8	8.9	7.5	28.8	15.8	31.2	25.2	11.5	16.6	31.6	22.0	16.5	30.6	27.0	23.4	23.4	39.6	22.5	14.7	11.7	26.1	37.3	22.2	31.5	30.5	47.0	16.4	25.5	11.3	20.3	39.1	28.8	13.5	16.9	26.8	28.5	14.3	19.2	23.0	48.9	23.8	19.1	21.3	30.6	18.3	47.5	20.0	26.1	34.2	37.3	24.8	17.8	19.2	27.5	22.9	34.2	53.1	31.9	25.6	24.3	32.1	19.8	23.2	14.9	27.1	42.9	15.6	33.3	39.3	15.1	30.2	24.8	13.9	7.8	8.4	11.5	11.8	11.7	13.5	11.8	9.1	8.7	9.0	9.9	10.0	0.8	11.9	16.4	9.0	9.3	7.8	5.5	5.7	7.8	7.5	5.3	6.4	5.4	5.3	5.6	4.7	5.6	7.5	10.2	22.4	23.1	21.2	14.3	5.2	4.6	7.8	4.0	14.5	7.9	8.3	10.5	7.2	12.2	1.8	10.4	21.5	12.6	26.9	13.7	9.5	10.1	10.0	11.6	9.3	4.2	7.2	32.1	8.4	14.0	9.3	5.6	7.3	16.4	13.4	4.6	4.5	10.7	10.1	31.0	12.6	10.2	6.5	5.7	3.1	9.6	8.1	5.4	26.2	8.7	9.7	15.5	24.6	43.0	7.0	23.4	10.9	12.3	3.7	7.0	8.1	16.7	20.4	0.0	8.5	10.1	17.5	11.3	7.3	4.5	18.3	12.9	11.4	14.7	3.7
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244743-37449463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;brain: 5.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 91.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046911: AB_2679861"	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	2.4	0.0	1.0	0.0	5.9	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	2.7	1.6	1.1	0.2	4.7	2.5	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	4.5	1.9	0.1	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
NXF2	"CT39, TAPL-2"	ENSG00000269405	"Nuclear RNA export factor 2"	Q9GZY0	X	102247167-102326722	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.3;testis: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"U-266/84: 35.6"									HPA002079	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"				"HPA002079: AB_1079515"																		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	15.3	0.0	0.9	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.6	0.4	0.3	0.3	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXF2B	bA353J17.1	ENSG00000269437	"Nuclear RNA export factor 2B"	Q9GZY0	X	102360396-102439932	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 15.3;testis: 7.1"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 1.8;Respiratory ciliated cells: 1.2;Spermatocytes: 2.1;Spermatogonia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"U-266/84: 35.6"									HPA002079	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA002079: AB_1079515"																		0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	15.3	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.0	2.4	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.3	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093143	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 25.0;testis: 57.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	0.6	0.8	0.0	0.1	0.0	3.9	0.2	0.0	0.1	1.4	0.1	0.3	0.6	0.1	10.9	0.1	25.0	7.2	0.4	0.0	0.0	1.1	1.1	4.9	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.9	0.0	1.1	0.1	0.0	0.1	3.0	0.0	0.0	0.6	0.1	57.8	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.2	0.0	0.0	0.1	0.5	0.2	0.0	48.6	0.5	0.0	0.0	46.6	0.0	0.0	0.0	1.9	0.0	0.6	0.0	2.2	0.0	8.6	1.0	0.0	0.2	43.0	0.0	0.4	0.2	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.0	0.0	0.0	0.1	135.9	0.1	0.1	0.0	0.0	0.7	101.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.4	8.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.9	0.0	0.5	0.0	0.1	0.9	0.0	2.6	0.0	4.2	0.3	1.4	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799310-979776	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.5;Microglial cells: 87.1;Urothelial cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 100.7;HHSteC: 106.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023566	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	16.9	7.5	14.5	8.7	13.1	1.1	19.0	12.1	15.0	41.3	21.9	70.0	5.4	47.2	11.6	27.2	29.1	13.7	16.0	13.5	13.2	14.4	9.5	24.6	5.0	13.6	14.9	14.8	33.6	2.6	6.8	14.5	14.0	39.7	4.6	8.9	20.7	25.0	99.2	24.9	19.8	23.1	12.8	6.4	28.3	9.6	17.1	13.1	12.9	35.7	13.8	43.4	42.5	12.3	14.3	21.2	81.5	52.8	5.3	1.1	4.5	44.6	29.3	46.1	73.3	50.4	14.8	0.6	83.6	57.5	10.8	100.7	52.9	83.2	36.3	0.6	30.9	0.2	12.7	44.8	106.1	0.3	2.3	32.2	75.6	6.0	36.0	9.3	41.9	11.3	7.4	0.0	12.3	5.8	2.9	1.0	39.2	42.3	1.4	6.2	2.1	0.3	32.9	20.6	20.9	13.6	21.1	0.1	1.1	50.3	14.9	13.0	0.0	1.0	19.1	0.4	12.5	7.5	5.2	0.4	0.4	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	14.5	13.1	12.1	15.0	13.5	13.2	13.6	14.9	14.0	12.8	17.1	12.3	36.5	32.1	11.7	13.4	0.9	17.5	53.6	18.8	12.0	2.6	7.6	12.4	8.6	2.8	13.2	3.7	33.3	0.4	0.4	0.1	0.0	3.5	25.1	20.2	52.1	34.7	1.8	2.7	6.9	24.6	0.7	23.0	1.1	12.6	1.3	1.0	14.6	8.2	6.3	5.0	10.7	0.0	0.0	0.3	8.8	91.5	15.5	1.9	7.2	87.1	0.6	11.4	0.0	23.1	3.3	5.9	0.0	7.2	0.4	36.0	0.0	0.5	15.5	18.0	13.1	14.5	19.2	13.1	10.1	13.1	12.4	0.4	1.5	27.2	0.0	59.0
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 79.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 27.0;Early spermatids: 73.6;Intestinal goblet cells: 35.1;Late spermatids: 53.5;Paneth cells: 18.1;Undifferentiated cells: 36.2"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049133	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.0	0.0	0.0	4.9	0.1	0.0	0.1	0.0	0.2	0.0	0.0	64.9	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.3	79.7	0.0	1.2	0.0	0.0	0.0	3.5	2.3	0.1	0.0	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.4	0.1	0.2	0.3	0.0	0.0	0.0	2.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	73.6	0.0	0.0	0.0	3.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	35.1	0.0	0.0	0.0	53.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	18.1	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	36.2	0.1
NXPE2	"FAM55B, FLJ25224"	ENSG00000204361	"Neurexophilin and PC-esterase domain family member 2"	Q96DL1	11	114678527-114707069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"epididymis: 25.3;intestine: 9.9;salivary gland: 21.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Distal enterocytes: 3.2;Early spermatids: 1.4;Enteroendocrine cells: 1.8;Intestinal goblet cells: 3.2;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.7;Paneth cells: 1.4;Prostatic glandular cells: 1.4;Undifferentiated cells: 1.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039744, HPA039876"	Enhanced					NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA039744: AB_2676660, HPA039876: AB_2676721"	"unprognostic (2.85e-1)"		"prognostic favorable (9.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.46e-2)"		"unprognostic (9.35e-2)"		"unprognostic (1.27e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-4)"	"unprognostic (9.00e-2)"		"unprognostic (9.22e-2)"		0.1	0.0	0.1	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	9.9	0.6	0.2	25.3	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.3	0.1	9.1	0.0	21.2	0.2	0.0	0.1	2.6	0.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.2	0.3	0.3	0.1	0.1	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.1	0.1	1.8	0.0	1.3	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.7	0.0	1.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.5
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101828231	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2;tongue: 50.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 177.7;Plasma cells: 59.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	7.8	6.4	13.6	11.7	23.2	12.5	6.0	20.1	18.7	7.6	1.3	5.3	3.5	8.1	3.3	6.1	7.4	6.5	18.4	12.4	21.0	3.3	3.5	9.4	16.7	21.6	21.3	7.1	2.5	20.7	6.8	6.7	24.2	8.3	4.6	11.3	3.5	9.8	73.2	2.0	5.0	10.6	16.5	12.5	5.0	7.4	23.7	13.1	5.9	50.5	14.2	7.2	4.5	34.8	19.8	29.9	25.1	9.2	26.6	26.9	5.7	21.7	27.2	25.4	36.6	7.0	2.0	29.3	62.6	24.4	30.4	4.1	28.3	23.2	31.2	36.7	8.9	22.7	19.0	19.3	35.0	19.4	19.9	15.6	3.9	21.1	7.8	33.1	27.8	27.3	4.7	92.0	42.5	10.6	26.2	4.6	14.6	1.0	18.6	11.5	30.7	12.7	18.8	5.1	19.6	23.4	9.3	2.2	16.7	14.9	4.3	27.2	24.5	28.0	33.7	3.3	23.0	43.0	47.5	34.0	23.9	83.7	5.4	8.0	16.5	20.1	14.6	13.0	10.0	10.8	16.0	15.2	14.2	6.4	21.6	17.6	8.6	8.9	12.7	8.8	20.8	14.1	13.6	23.2	20.1	18.7	12.4	21.0	21.6	21.3	24.2	16.5	23.7	34.8	24.1	25.6	5.1	11.4	19.2	3.7	2.2	2.3	6.2	26.1	9.8	9.0	49.4	4.3	2.3	0.0	8.4	0.7	12.8	1.0	0.0	2.6	1.4	2.9	11.8	17.2	7.2	0.0	34.1	2.6	1.6	10.0	1.5	1.9	13.3	46.0	40.4	1.8	6.8	48.8	35.2	0.6	4.1	19.1	10.0	1.8	9.3	11.0	7.2	9.4	26.3	22.7	23.7	44.2	177.7	2.9	0.1	7.5	59.6	1.0	0.8	0.8	3.1	17.1	19.7	14.9	8.3	11.8	15.1	3.8	3.0	0.7	16.2	20.0	0.9	1.1
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595786	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 119.6;salivary gland: 77.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 95.5;Intestinal goblet cells: 88.1;Paneth cells: 41.8;Undifferentiated cells: 115.8"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA042801	Approved				"Secreted to digestive system"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.1	0.0	0.1	7.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	114.2	0.6	0.2	6.8	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	5.3	119.6	0.0	77.2	0.2	0.0	0.0	0.7	5.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.5	0.0	0.0	0.0	17.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	41.8	0.0	0.1	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	115.8	0.2
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138669157-138780390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.1;kidney: 4.1;ovary: 8.1"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 156.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	6	"medulla oblongata: 11.7;midbrain: 7.6;pons: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;SiHa: 3.0;SuSa: 2.1;U-2 OS: 4.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.2	0.0	1.8	0.1	1.7	0.0	0.1	1.0	1.8	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	0.4	4.1	0.0	0.0	0.0	11.7	7.6	8.1	0.0	0.0	0.1	0.1	13.1	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.6	3.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.0	1.8	1.0	0.4	11.7	7.6	13.1	1.9	1.1	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544698	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 157.3;U-937: 166.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: AB_2686483"	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	7.6	4.8	5.3	8.0	5.6	17.5	15.2	6.0	6.8	9.2	4.0	7.8	9.2	5.6	7.2	8.9	7.0	6.1	2.7	4.8	5.8	9.3	11.9	8.0	12.3	6.0	5.8	6.5	4.3	7.3	1.2	8.4	6.4	6.4	8.5	2.2	7.7	4.3	1.9	12.2	7.5	4.5	6.8	7.5	8.7	27.6	5.4	14.8	7.9	3.4	14.1	8.8	4.4	6.9	14.2	12.2	11.6	20.3	17.1	13.5	25.6	8.8	14.9	11.1	14.4	9.6	19.5	18.1	27.1	11.1	30.0	10.5	15.4	13.8	16.9	23.5	9.5	15.1	10.6	15.8	7.0	157.3	60.9	9.9	11.8	10.6	6.6	8.3	10.0	18.7	16.1	72.2	11.0	14.6	23.9	16.6	18.6	19.8	18.0	9.4	16.4	21.6	10.4	13.9	4.6	14.6	37.7	21.2	12.0	10.1	9.0	52.1	7.5	15.9	9.0	21.2	9.3	14.8	19.5	27.7	13.9	166.9	16.6	4.7	7.2	3.6	9.2	9.8	6.0	6.3	6.7	7.5	9.7	6.2	6.6	6.5	1.4	10.8	8.1	5.9	8.4	8.0	5.3	5.6	6.0	6.8	4.8	5.8	6.0	5.8	6.4	6.8	5.4	6.9	4.8	3.2	6.5	2.0	10.1	19.2	21.0	10.4	9.6	1.4	18.0	11.3	30.0	2.8	12.8	3.7	0.0	15.1	12.9	7.9	21.5	12.5	21.5	9.3	6.0	5.4	1.2	12.4	0.5	14.0	24.8	7.5	7.1	15.0	5.7	6.0	4.6	5.4	11.4	0.0	0.4	4.4	10.2	10.1	20.0	5.9	4.7	9.9	1.8	1.0	31.9	9.2	26.8	1.5	2.5	9.0	7.6	4.5	12.3	20.3	7.6	16.6	10.5	1.4	13.1	5.3	5.2	31.7	33.7	17.0	23.3	29.1	9.4	6.6	6.4	21.3
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;pituitary gland: 22.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Golgi apparatus"	"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	2.1	2.5	6.4	0.3	8.4	0.1	1.6	0.0	22.5	2.9	0.0	1.3	0.2	4.6	0.0	1.1	2.2	0.2	0.7	11.4	2.9	1.9	0.4	0.3	0.1	6.6	0.6	5.3	0.9	0.0	22.0	0.3	6.8	2.0	0.1	1.9	0.9	0.9	0.1	1.4	0.8	0.5	0.0	0.8	0.8	9.1	2.0	0.1	0.7	0.1	0.0	0.6	2.0	8.2	0.0	1.1	3.0	1.4	2.0	1.2	0.2	0.1	1.0	0.1	0.4	0.4	0.2	0.0	1.0	0.3	7.8	0.1	0.6	0.1	0.0	1.4	0.2	0.1	0.3	0.2	1.4	0.0	0.8	1.3	0.0	0.4	0.5	0.3	3.9	0.2	0.5	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	9.4	0.3	0.2	1.0	1.1	0.1	0.0	1.4	0.0	1.9	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.4	0.0	22.5	11.4	2.9	6.6	0.6	6.8	0.0	2.0	8.2	3.2	0.0	0.0	9.4	0.0	0.1	0.2	0.1	0.6	6.2	0.3	1.9	1.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.2	0.4	1.4	0.0	0.8	11.1	0.0	0.0	0.9	0.0	0.4	0.0	5.6	0.7	0.0	0.1	13.5	10.3	0.1	0.0	0.0	0.7	0.7	2.5	0.1	0.0	2.8	0.0	3.3	0.0	2.5	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.5	0.7	1.3	2.6	0.2	0.1	0.0	0.1	0.8	0.0	0.0
NYAP2	KIAA1486	ENSG00000144460	"Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2"	Q9P242	2	225399710-225654018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"brain: 8.7"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 136.8;Inhibitory neurons: 238.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045531, HPA056945"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Cytosol	"HPA045531: AB_10960749, HPA056945: "	"unprognostic (2.49e-1)"	"unprognostic (3.34e-1)"		"unprognostic (1.24e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"		"unprognostic (6.13e-3)"		"unprognostic (3.33e-1)"	"unprognostic (2.08e-1)"		"unprognostic (1.32e-8)"	"unprognostic (9.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.27e-1)"	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.2	0.0	0.1	8.7	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.7	2.7	1.7	1.9	0.1	8.7	2.0	2.9	2.4	0.0	0.1	0.0	2.3	4.9	0.1	1.3	1.7	0.0	0.0	21.8	0.2	0.0	0.5	0.0	0.6	0.0	2.1	0.2	0.2	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.0	0.0	136.8	1.2	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	238.3	0.0	0.0	0.8	1.8	0.8	0.0	0.6	0.0	1.0	0.2	0.5	0.0	1.5	2.5	1.2	0.0	0.0	0.1	1.1	0.0	0.1	0.0	1.5	0.0	3.6	0.5	0.2	0.1	0.0	1.0	0.1	0.5	0.0	0.0	0.8
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24399003-24419283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.7	3.7	4.3	3.1	3.9	0.4	6.3	16.3	4.6	16.8	5.4	7.6	4.0	11.5	28.0	11.6	16.9	8.6	7.5	3.2	6.6	6.3	4.5	8.1	1.9	5.8	5.4	35.1	3.8	5.8	5.8	12.8	6.3	7.5	5.5	1.8	7.4	14.9	3.8	13.3	5.3	10.5	3.2	4.4	6.0	5.1	7.8	4.5	7.8	4.2	2.9	9.5	14.0	2.8	0.2	0.1	4.6	0.0	6.3	13.0	0.3	2.2	2.3	1.5	1.6	3.3	14.4	0.4	0.6	8.6	0.2	0.0	7.5	0.2	1.5	0.0	0.8	14.7	2.0	0.3	4.7	0.0	0.0	13.3	0.6	1.0	0.0	2.6	35.6	0.1	2.4	0.0	0.2	0.6	0.0	0.8	2.7	1.0	0.0	1.9	0.0	0.0	0.0	29.8	0.6	10.0	0.0	1.3	0.2	11.2	2.5	2.1	17.4	0.1	8.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.3	3.9	16.3	4.6	3.2	6.6	5.8	5.4	6.3	3.2	7.8	2.8	15.2	3.2	1.7	4.9	0.1	4.6	3.9	9.5	15.4	0.5	1.8	3.6	3.1	8.6	15.6	9.2	0.0	1.1	1.6	2.7	0.0	4.1	0.8	1.4	10.8	15.0	5.4	3.6	1.0	3.0	1.0	10.1	10.7	1.7	0.0	12.0	18.2	2.7	10.7	0.0	3.9	9.0	4.1	9.0	1.4	0.2	2.5	1.4	3.6	3.7	0.7	5.4	0.0	0.5	0.1	4.8	5.1	0.4	1.2	1.2	1.0	0.3	10.8	0.2	0.0	1.2	7.3	0.3	1.2	18.0	3.8	1.1	0.3	1.5	8.8	4.5
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120211032-120230334	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 396.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 2.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	66.0	91.5	47.7	18.0	56.8	10.8	42.6	35.8	57.1	66.7	40.5	61.9	47.7	54.2	16.0	22.8	54.6	34.5	55.1	48.1	36.5	51.4	396.6	19.2	5.8	39.0	37.8	61.0	74.1	6.7	27.4	8.1	37.1	33.5	36.5	30.7	53.9	13.7	13.2	12.0	57.3	29.1	35.9	54.4	33.5	3.7	45.0	4.6	25.9	12.2	3.7	42.6	40.4	44.6	24.9	7.5	30.9	14.4	47.8	53.4	1.7	47.7	53.8	20.5	30.0	7.5	37.3	0.0	115.5	35.6	33.7	25.7	8.9	13.2	8.2	18.7	21.1	21.1	4.7	190.1	42.4	46.7	7.9	66.8	7.9	19.8	54.8	39.9	59.7	12.7	14.0	22.7	5.0	9.4	0.3	139.9	11.6	7.3	40.8	11.8	0.9	23.7	31.8	13.4	1.5	10.0	14.0	15.2	40.2	8.6	4.8	74.7	32.7	39.3	14.7	40.8	4.6	0.8	0.7	0.4	30.3	76.2	14.1	0.0	3.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.1	0.8	47.7	56.8	35.8	57.1	48.1	36.5	39.0	37.8	37.1	35.9	45.0	44.6	19.4	0.0	0.6	102.2	3.7	9.4	33.6	7.3	12.5	3.2	6.0	7.0	5.5	34.3	3.5	71.7	2.1	2.1	1.1	135.9	27.4	14.8	0.2	4.7	70.9	40.0	22.8	12.8	0.6	28.7	5.5	135.9	11.7	12.2	1.3	2.6	12.5	218.8	6.0	0.0	2.3	56.5	4.1	11.5	20.9	1.1	16.8	11.0	16.0	23.4	10.2	279.4	0.0	5.5	11.0	28.2	56.5	4.5	14.5	31.3	111.1	79.3	0.4	10.6	52.6	8.6	40.8	0.7	6.9	11.3	10.2	6.2	3.1	149.0	45.8	192.5
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 294.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	20.9	25.5	26.4	20.3	30.5	26.3	30.1	28.5	32.3	19.5	26.5	28.8	31.4	17.6	38.3	23.3	30.1	19.3	22.0	26.0	28.4	44.3	59.2	17.3	28.5	29.7	28.3	35.7	40.6	34.9	22.6	20.0	30.4	25.0	31.1	43.8	25.6	22.0	25.5	21.6	30.2	15.0	28.8	23.0	39.5	58.6	28.2	39.7	30.9	37.1	33.4	20.0	20.1	35.6	44.2	25.0	55.8	40.6	32.1	37.6	36.9	28.0	36.5	29.1	31.4	39.7	33.1	61.7	29.3	15.4	32.1	33.4	38.1	33.1	41.0	53.2	18.6	73.8	28.0	75.4	29.1	50.1	47.6	28.7	45.6	28.1	102.2	26.5	20.3	77.4	95.4	48.8	32.2	59.0	88.1	55.1	51.4	294.4	17.3	36.8	52.4	54.7	58.0	21.4	60.5	38.7	25.5	25.2	88.6	43.2	41.9	42.3	21.9	32.0	39.3	20.0	43.6	65.8	72.7	140.1	25.2	48.5	27.1	49.1	21.8	42.4	26.2	23.3	34.3	45.7	30.6	26.6	26.8	43.2	37.2	36.9	20.8	45.0	28.2	26.0	37.2	22.7	26.4	30.5	28.5	32.3	26.0	28.4	29.7	28.3	30.4	28.8	28.2	35.6	30.5	16.0	40.9	7.8	49.8	28.6	40.3	51.8	38.7	63.2	47.5	41.1	43.4	52.9	40.6	60.7	45.9	89.5	44.1	28.5	86.1	42.9	164.2	43.3	19.6	34.2	22.1	56.4	2.9	48.0	60.2	23.5	37.8	29.8	48.2	21.7	35.0	69.5	45.6	42.1	3.9	52.2	50.8	53.4	37.0	153.8	28.3	33.4	35.6	3.7	42.1	75.9	59.8	4.0	13.1	34.6	44.0	25.9	29.3	37.1	63.0	112.9	56.6	70.5	26.3	23.9	26.7	193.0	148.0	43.4	29.3	45.6	47.5	34.2	61.7	32.4
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112905856-112933219	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 91.0;urinary bladder: 111.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 151.0;Hofbauer cells: 105.6;Paneth cells: 127.9;Urothelial cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 572.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 247.1;BJ hTERT+ SV40 Large T+ RasG12V: 336.6;OE19: 307.6;U-266/70: 272.9;U-266/84: 210.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	17.0	11.5	6.8	27.3	7.3	14.3	13.1	6.5	9.7	29.6	6.1	49.0	51.7	8.0	8.1	57.1	10.0	22.5	9.5	6.6	6.9	22.3	38.6	23.1	27.2	15.4	8.0	8.1	4.4	9.0	8.3	20.4	11.5	9.1	45.1	1.5	91.0	7.3	2.4	10.3	39.8	14.6	21.2	50.5	43.6	4.8	8.4	28.1	7.7	7.4	25.6	111.1	22.7	9.9	4.7	24.4	0.0	0.1	9.4	6.6	1.5	0.1	38.8	247.1	336.6	18.5	34.1	42.3	12.2	0.3	121.8	10.8	0.2	4.2	2.2	21.0	0.0	0.7	35.2	4.6	2.9	0.6	1.4	0.5	7.2	8.0	0.0	3.1	13.5	0.7	0.0	17.4	0.2	0.4	0.6	17.0	0.7	307.6	22.5	5.8	0.2	20.5	11.6	89.4	0.2	0.9	3.7	4.2	85.2	0.4	0.9	5.1	50.4	0.0	0.5	3.2	0.4	272.9	210.3	23.9	2.9	6.6	1.4	6.3	253.6	3.2	26.5	403.9	25.3	108.8	36.3	34.3	153.9	93.1	14.3	18.8	24.4	24.9	572.0	144.5	108.7	217.8	6.8	7.3	6.5	9.7	6.6	6.9	15.4	8.0	11.5	21.2	8.4	9.9	23.0	3.2	2.2	0.0	21.1	3.4	16.6	24.0	10.8	0.2	6.0	8.1	3.1	14.3	35.4	5.5	0.0	12.6	31.5	151.0	5.9	19.5	0.4	1.9	3.6	17.2	4.2	3.6	0.6	12.0	36.4	11.1	28.5	4.1	5.1	15.4	14.3	11.9	105.6	0.0	1.0	59.3	26.4	36.9	11.4	1.2	7.2	52.9	5.4	13.1	36.2	15.0	18.6	3.5	0.1	19.5	127.9	10.5	24.1	7.4	50.9	25.4	17.5	0.4	6.6	3.0	7.5	0.0	0.5	18.3	2.3	5.7	9.1	12.7	14.6	171.9
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 67.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.8;Endothelial cells: 21.4;Macrophages: 27.6;monocytes: 26.1;NK-cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 364.3;BJ hTERT+ SV40 Large T+ RasG12V: 297.5;Daudi: 88.7;SK-MEL-30: 135.0;U-266/70: 118.4;U-266/84: 115.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	11.9	4.3	5.1	25.7	5.5	15.1	7.2	5.6	7.9	9.8	4.6	8.6	9.3	6.2	2.9	13.4	6.2	17.8	8.7	5.1	5.0	5.8	19.6	26.3	38.0	10.6	6.4	2.1	1.6	2.8	2.3	23.4	8.0	7.2	9.0	1.0	67.2	3.6	2.5	2.7	9.1	12.9	12.0	43.5	18.5	3.8	6.0	36.7	5.2	6.9	33.1	22.8	5.6	6.5	3.0	0.5	0.2	0.2	1.7	12.3	0.2	0.5	41.9	364.3	297.5	0.6	5.9	88.7	8.4	6.9	71.3	3.4	0.8	0.9	12.1	22.8	0.2	0.2	0.8	0.5	2.5	0.1	0.2	0.8	6.0	19.7	0.0	0.3	5.2	4.2	0.1	42.2	0.2	1.2	2.4	4.2	0.1	0.4	12.4	20.5	0.1	13.5	0.1	31.2	0.1	0.1	3.3	0.6	135.0	0.2	2.6	5.4	8.1	0.6	0.1	1.1	0.3	118.4	115.4	13.6	2.6	4.5	2.7	3.9	35.5	2.7	25.6	55.6	33.5	24.3	30.0	29.6	26.9	15.5	28.9	21.7	3.6	32.1	60.2	11.5	35.4	30.9	5.1	5.5	5.6	7.9	5.1	5.0	10.6	6.4	8.0	12.0	6.0	6.5	22.8	3.2	6.0	0.3	16.6	2.0	1.6	4.0	2.8	0.1	2.1	1.3	1.6	0.0	5.1	1.8	0.0	0.2	15.1	1.2	0.0	1.0	0.7	3.5	3.4	21.4	0.0	4.0	0.2	1.2	2.4	4.8	6.1	1.7	1.3	2.5	12.1	2.6	16.1	0.0	0.5	3.8	0.0	19.7	4.7	1.2	0.6	27.6	5.4	10.3	26.1	0.4	26.8	2.0	0.1	3.8	1.2	3.4	15.5	2.6	0.4	0.3	12.2	0.2	0.0	1.0	2.7	0.1	0.1	7.6	1.1	0.1	15.5	6.0	0.4	10.4
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121017763-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;stomach 1: 22.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.1;Distal enterocytes: 82.3;Gastric mucus-secreting cells: 97.9;Paneth cells: 71.4;T-cells: 43.9;Urothelial cells: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 132.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 126.9;BJ hTERT+ SV40 Large T+ RasG12V: 66.2;GAMG: 35.3;hTEC/SVTERT24-B: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	2.3	0.8	0.7	4.2	0.8	35.7	2.4	0.7	0.8	3.3	0.6	7.5	2.7	0.5	0.5	4.0	0.7	3.6	1.1	0.6	0.5	2.3	11.8	11.9	3.6	1.4	0.7	0.4	0.7	0.1	0.6	1.4	1.4	0.5	3.4	0.2	4.1	0.4	0.4	0.9	2.0	1.3	3.3	5.3	22.3	2.1	1.1	3.3	1.1	0.6	1.7	7.8	1.4	0.9	2.6	0.6	0.2	0.9	1.0	1.6	0.1	0.2	0.9	126.9	66.2	0.3	13.0	0.6	4.0	0.1	35.3	6.4	0.1	0.9	7.2	25.2	0.1	0.1	13.8	0.0	0.7	0.2	1.8	0.8	0.6	50.7	0.1	0.3	0.3	1.0	0.1	5.3	1.1	1.7	0.1	3.1	0.1	4.5	3.7	0.1	0.2	1.4	0.1	13.7	0.1	0.2	1.1	0.6	18.5	0.1	0.4	1.7	0.1	0.7	1.2	2.1	0.2	4.9	10.1	0.3	19.9	1.3	0.4	12.3	29.6	65.8	53.1	32.5	14.3	2.5	36.2	62.1	8.9	0.8	9.9	38.5	132.8	20.3	23.5	0.5	27.8	33.2	0.7	0.8	0.7	0.8	0.6	0.5	1.4	0.7	1.4	3.3	1.1	0.9	28.6	0.0	4.2	0.7	4.6	2.2	5.0	2.7	1.8	0.0	3.3	4.7	0.6	1.5	3.9	0.0	0.0	0.2	54.1	82.3	0.0	2.5	6.6	2.0	0.6	4.5	1.8	0.8	0.2	3.8	1.3	2.4	97.9	2.8	11.4	1.0	2.2	4.5	12.6	0.0	0.2	30.7	4.1	3.1	7.2	3.4	0.3	16.7	0.0	1.0	6.0	0.0	9.2	0.0	0.0	12.7	71.4	0.0	14.3	2.2	2.4	0.3	3.8	0.0	0.0	0.7	2.8	2.4	0.1	14.6	1.0	0.1	43.9	0.2	5.1	96.3
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 781.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	60.0	119.6	69.4	40.8	71.2	106.4	150.1	74.6	97.4	99.7	75.4	75.6	750.0	82.5	63.7	105.0	56.0	68.7	52.3	71.2	78.7	114.6	162.5	42.7	38.1	76.5	72.0	77.0	36.1	46.1	53.5	65.0	85.2	74.3	67.2	51.1	225.4	94.6	58.2	71.6	781.8	97.8	73.6	34.1	70.1	56.2	73.3	30.2	67.7	60.0	69.1	58.9	63.8	81.7	241.5	42.8	27.5	98.7	272.4	260.8	93.4	142.2	288.0	124.2	135.2	110.5	30.8	0.5	101.0	241.8	118.0	249.4	126.5	265.7	134.0	42.4	174.9	268.1	28.1	82.7	139.9	0.4	169.3	172.1	134.5	111.9	129.5	204.9	147.1	48.4	470.8	50.0	175.5	62.6	72.1	15.3	55.1	73.2	59.6	66.3	104.5	65.3	119.8	3.9	57.3	60.9	89.7	235.1	209.5	156.6	78.6	65.8	114.3	70.5	65.3	117.9	90.2	42.4	47.6	64.6	97.4	72.0	34.4	38.0	39.6	36.0	28.8	35.3	31.2	15.2	24.0	30.5	44.3	16.2	29.5	29.8	40.0	16.9	37.2	9.4	24.6	29.6	69.4	71.2	74.6	97.4	71.2	78.7	76.5	72.0	85.2	73.6	73.3	81.7	49.0	19.2	49.7	37.9	44.7	151.3	144.0	362.8	185.5	35.2	154.2	163.7	21.8	18.6	182.7	35.0	27.1	120.8	80.3	38.2	90.1	34.6	30.4	37.0	90.4	37.7	43.1	317.0	31.8	13.4	90.5	124.2	55.5	40.6	43.8	32.2	37.5	152.2	66.2	43.7	33.4	104.1	197.4	31.8	68.1	15.2	104.1	56.7	85.4	17.8	34.8	37.4	18.6	22.1	41.9	12.6	74.6	120.0	32.9	82.6	1222.6	196.4	76.4	24.4	78.9	106.1	115.1	46.3	33.2	161.8	126.0	48.2	65.0	92.4	214.5	82.2
OAZ1	"AZ1, AZI, MGC138338, OAZ"	ENSG00000104904	"Ornithine decarboxylase antizyme 1"	P54368	19	2269509-2273490	"Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009291	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles	"Centriolar satellite"	"HPA009291: AB_1079519"	"unprognostic (2.37e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (4.10e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.01e-2)"	201.8	252.4	114.7	170.0	125.3	330.3	177.6	107.3	189.7	143.2	111.9	204.3	161.5	134.3	91.4	167.2	151.5	109.0	289.8	132.7	121.1	203.4	172.7	194.2	244.7	119.7	122.1	139.9	209.8	46.5	173.4	134.2	117.0	150.9	77.8	36.4	226.8	89.2	525.6	177.4	197.7	85.1	116.0	294.9	188.3	67.5	120.1	68.0	144.6	123.4	138.3	170.7	152.7	113.9	577.1	117.7	88.3	152.7	181.1	287.5	228.9	400.4	275.4	197.9	269.7	169.5	181.2	389.7	210.6	187.6	78.3	163.1	87.7	120.8	129.6	523.1	303.3	301.2	108.7	267.3	184.6	425.7	456.4	192.6	207.3	74.8	112.7	177.8	227.4	141.3	297.8	439.1	226.1	210.8	357.1	442.7	291.5	83.5	210.7	291.3	176.1	519.0	184.3	164.0	207.9	220.2	264.0	236.7	464.8	70.6	198.4	890.0	293.1	140.2	173.9	610.5	427.8	423.8	188.0	468.9	636.6	660.5	217.3	1887.3	1649.6	1940.9	466.4	1685.5	469.7	962.1	506.3	502.1	1155.4	941.6	464.3	466.0	2063.4	366.1	2039.6	778.3	779.9	2803.0	114.7	125.3	107.3	189.7	132.7	121.1	119.7	122.1	117.0	116.0	120.1	113.9	492.6	365.4	510.0	54.5	1096.3	1476.0	1102.4	828.6	715.9	325.4	748.2	626.1	746.8	579.0	543.0	294.3	106.3	1065.2	1149.3	1018.3	1230.6	1043.4	95.1	452.9	335.6	591.2	613.7	1446.6	85.6	1018.2	1605.0	711.4	305.3	325.4	713.5	385.8	529.0	773.2	2248.7	222.1	78.6	816.9	547.3	2400.4	2984.5	286.7	558.6	2391.4	1136.6	60.0	2929.3	362.0	1001.1	46.3	62.2	1071.2	1388.3	477.3	1143.0	1314.8	1700.6	1540.0	553.2	285.5	460.2	487.9	821.8	251.8	256.5	751.8	1283.3	1683.5	911.1	666.9	733.6	1692.6
OAZ2		ENSG00000180304	"Ornithine decarboxylase antizyme 2"	O95190	15	64687573-64703281	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 324.9;Sertoli cells: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 418.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047694	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA047694: AB_2680121"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (2.09e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-1)"	65.1	68.5	110.1	49.5	111.8	32.9	55.1	112.2	112.5	61.1	108.0	72.4	28.4	64.7	57.2	44.4	59.8	46.9	79.3	110.1	114.5	68.4	89.3	55.8	50.7	112.6	114.6	56.5	35.9	96.8	75.0	75.1	112.4	53.3	35.8	123.4	45.3	49.1	207.9	45.9	40.9	72.3	114.3	89.8	47.7	80.8	114.4	41.7	65.8	152.5	45.4	56.3	48.3	116.4	71.2	63.5	130.6	43.5	91.8	79.4	24.6	80.5	120.6	113.4	98.5	43.5	62.2	61.6	72.7	113.4	84.5	37.5	126.7	71.6	99.2	82.4	48.3	40.3	48.3	32.5	52.2	35.7	125.7	104.4	49.6	57.0	40.1	147.4	109.2	42.9	30.1	29.6	123.4	45.3	24.5	43.8	223.1	39.1	50.7	57.5	74.5	54.0	102.0	55.7	68.4	125.1	30.4	45.0	80.3	161.6	75.6	52.7	66.0	76.4	102.2	38.0	87.0	65.1	104.6	58.2	87.4	75.2	69.8	22.1	145.3	268.4	29.3	247.8	24.2	30.2	24.6	24.0	91.1	29.1	27.9	25.3	418.0	39.5	209.6	49.4	30.7	115.5	110.1	111.8	112.2	112.5	110.1	114.5	112.6	114.6	112.4	114.3	114.4	116.4	67.5	25.6	43.5	15.3	36.1	121.7	99.5	67.7	47.8	93.8	57.9	40.4	61.9	44.3	41.0	42.3	104.3	114.1	33.4	19.2	168.3	109.5	324.9	35.2	30.0	109.3	81.9	33.3	14.6	66.0	70.9	61.3	14.3	20.5	103.3	36.9	134.6	83.6	133.9	74.0	13.6	26.0	91.6	115.4	238.1	80.9	114.3	86.6	103.2	20.6	114.2	268.2	49.4	12.1	26.9	81.8	25.7	68.1	19.1	88.9	29.2	94.2	51.1	180.8	374.7	68.1	160.9	166.2	83.9	28.0	121.2	68.5	31.7	44.3	27.4	72.4
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546126-135549969	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 24.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 2.4;Breast myoepithelial cells: 3.4;Late spermatids: 1.8;Leydig cells: 1.5;Melanocytes: 1.8"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-266/70: 1.6;U-266/84: 6.4"									HPA055955	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"			"HPA055955: AB_2682985"	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.9	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 481.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	3.5	2.5	2.4	1.4	18.4	1.6	3.7	10.4	4.4	8.1	18.1	5.2	0.7	3.7	1.8	4.6	5.1	1.1	78.5	0.9	2.7	6.6	1.3	8.9	2.1	4.3	2.7	8.6	5.4	1.1	13.6	0.9	2.4	9.9	0.5	0.8	9.4	1.7	481.3	4.7	5.4	0.5	1.0	9.3	5.2	1.9	6.3	4.9	7.5	112.8	1.3	3.2	7.4	0.1	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	2.4	18.4	10.4	4.4	0.9	2.7	4.3	2.7	2.4	1.0	6.3	0.1	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
OBSL1	KIAA0657	ENSG00000124006	"Obscurin like cytoskeletal adaptor 1"	O75147	2	219550728-219571859	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 337.3"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1140.1;Late spermatids: 1994.5;Spermatocytes: 572.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.4;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.3;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 155.2;SK-BR-3: 150.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036404, HPA036405"	Approved		Approved	Centrosome		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome		"HPA036404: AB_10670437, HPA036405: AB_2675104"	"unprognostic (2.36e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.27e-3)"	"unprognostic (2.89e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.16e-1)"	52.3	117.5	25.0	9.7	24.3	3.1	53.5	24.4	32.2	74.6	34.4	44.6	9.4	78.0	22.5	17.7	84.6	28.8	90.8	26.1	27.9	110.1	43.9	38.6	9.6	30.3	29.1	337.3	120.6	49.5	74.9	45.8	24.8	63.1	5.4	14.9	62.9	44.2	64.1	38.3	22.5	20.9	25.2	31.7	48.0	40.5	29.7	6.9	148.9	30.2	4.6	41.2	36.7	22.3	34.2	22.7	40.9	85.8	27.7	20.4	155.2	25.3	36.8	31.5	29.0	20.0	52.2	0.2	51.6	34.7	30.5	34.4	31.9	19.0	6.5	0.3	56.2	74.3	23.0	102.1	20.9	1.9	0.3	55.3	15.4	7.3	12.1	56.1	3.4	0.1	31.3	0.7	22.7	84.6	0.1	21.3	97.8	9.7	23.1	37.5	36.3	0.2	57.4	31.9	18.1	61.3	28.6	150.9	59.2	102.8	14.0	63.9	8.6	33.3	35.6	10.6	10.0	0.2	0.2	0.3	19.5	0.2	33.7	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	1.3	0.0	0.0	25.0	24.3	24.4	32.2	26.1	27.9	30.3	29.1	24.8	25.2	29.7	22.3	10.4	9.6	20.4	45.7	1.1	8.4	22.8	11.7	19.9	35.8	27.0	38.7	52.4	27.1	10.0	53.3	2.1	64.7	2.5	1.5	52.8	15.9	1140.1	19.5	33.0	11.4	20.4	0.0	21.1	12.5	69.7	30.1	6.6	21.7	4.5	152.8	11.4	15.4	7.7	42.1	43.3	3.7	6.1	1.0	3.9	1994.5	77.0	3.4	14.2	9.4	0.7	87.0	0.0	23.1	3.1	7.6	2.0	74.1	0.1	8.8	7.1	20.3	7.8	11.6	13.1	29.9	27.0	572.7	57.0	4.3	6.7	86.5	1.4	114.0	3.3	10.2
OCEL1	FLJ22709	ENSG00000099330	"Occludin/ELL domain containing 1"	Q9H607	19	17226213-17229219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"liver: 75.5"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 137.0;Proximal tubular cells: 150.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042070, HPA043223"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042070: AB_2677830, HPA043223: "	"unprognostic (6.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.18e-3)"	18.3	21.6	14.9	4.7	15.8	5.6	16.4	15.9	24.9	14.8	15.5	20.9	19.0	13.5	18.9	9.4	18.1	5.8	17.4	14.6	15.6	37.4	75.5	14.6	7.3	17.4	16.0	11.2	22.7	7.2	9.2	6.7	17.0	21.1	12.3	8.9	14.9	9.0	14.0	8.8	20.0	7.2	16.4	17.3	22.1	6.7	16.5	6.7	20.5	13.5	9.5	13.9	12.3	15.8	8.2	6.4	3.3	2.9	34.9	13.8	8.5	5.3	14.5	4.1	7.2	4.6	9.8	7.2	19.5	7.8	3.6	3.9	4.5	5.4	3.8	6.0	5.3	6.7	6.8	22.6	11.7	1.4	10.5	11.1	5.6	4.8	8.1	14.2	5.9	8.9	5.8	6.8	7.5	6.7	3.7	4.0	5.6	12.3	11.3	2.7	2.8	18.2	17.7	11.2	1.1	5.6	3.3	10.8	9.4	6.9	16.4	6.8	3.9	2.6	3.0	5.1	2.6	18.5	15.3	5.8	7.7	6.3	1.2	27.7	30.8	15.2	9.9	20.9	9.5	15.7	15.1	11.4	23.3	17.0	16.5	10.8	9.7	16.0	17.1	10.0	19.1	13.4	14.9	15.8	15.9	24.9	14.6	15.6	17.4	16.0	17.0	16.4	16.5	15.8	14.6	12.8	8.2	3.9	16.4	6.4	26.7	18.8	17.1	11.4	21.4	23.7	7.3	27.1	21.9	20.2	2.1	38.6	23.9	66.8	60.7	21.4	6.3	59.3	12.5	15.6	17.4	9.7	4.7	27.1	46.0	17.2	25.5	20.4	15.9	8.0	25.0	93.5	25.8	25.2	5.2	40.5	10.2	26.1	7.5	14.6	28.3	22.3	16.0	3.7	19.2	29.6	24.7	1.0	4.6	21.0	67.4	23.3	23.2	20.7	137.0	150.5	71.8	9.7	32.9	12.5	25.8	7.8	13.8	8.8	6.7	103.2	16.4	19.9	28.1	21.9
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044803	Approved		Approved	Mitochondria		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	129.5	184.0	161.1	99.4	170.6	107.7	153.9	154.6	212.9	150.3	173.5	161.1	155.8	138.0	192.2	118.1	167.2	124.6	219.3	177.3	177.0	238.1	326.5	124.1	127.3	161.1	153.1	159.1	156.1	248.7	109.9	118.4	157.6	145.9	159.9	143.7	161.9	148.1	255.0	107.1	134.6	133.3	163.1	105.1	141.3	91.0	165.8	133.6	239.4	255.9	133.9	136.3	72.3	172.6	165.2	118.2	231.7	162.8	230.8	283.0	178.6	253.1	393.8	261.1	311.3	110.6	473.2	190.4	241.5	238.0	311.4	141.7	229.4	250.4	296.2	149.4	152.7	293.4	105.7	88.1	336.5	309.1	300.9	292.0	353.5	208.3	258.4	315.4	270.0	173.9	339.8	104.1	300.0	107.7	261.4	287.6	195.2	211.7	110.4	169.6	216.9	203.1	502.9	154.5	139.8	261.0	120.4	101.1	306.5	179.8	212.8	271.5	196.9	176.1	200.7	120.7	333.1	256.3	380.4	283.1	223.2	251.0	220.2	47.8	60.2	76.5	62.6	68.0	90.8	74.1	73.1	79.2	75.4	64.9	90.2	80.5	48.3	95.4	86.5	85.2	68.5	73.5	161.1	170.6	154.6	212.9	177.3	177.0	161.1	153.1	157.6	163.1	165.8	172.6	176.7	160.3	124.5	85.8	107.1	79.7	111.3	243.3	102.4	126.6	96.7	119.6	152.3	102.9	169.4	121.4	66.7	170.5	103.1	140.0	137.0	140.0	34.3	147.3	120.5	120.2	130.1	89.8	125.1	128.3	168.8	124.4	84.1	110.5	141.8	102.6	118.9	167.3	152.7	89.2	137.2	131.3	124.1	94.0	77.2	35.5	132.3	106.1	87.2	76.8	107.2	206.1	121.5	106.1	158.1	130.7	122.5	139.2	115.3	104.2	164.1	178.9	151.2	111.6	124.9	121.3	112.7	188.3	88.3	94.1	75.9	164.7	109.8	197.2	142.7	100.4
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 31.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.7	6.2	1.6	6.5	1.8	7.8	7.2	6.7	6.8	22.2	11.0	10.3	2.1	4.0	11.6	7.5	8.5	1.5	5.9	5.4	11.0	18.8	15.1	0.6	9.3	7.7	2.3	20.2	8.3	3.4	3.9	8.3	3.5	11.2	2.3	6.7	4.6	0.6	11.3	10.0	0.6	5.4	2.1	15.2	2.4	6.5	0.9	31.4	0.6	2.8	5.0	7.9	7.4	23.3	4.5	0.6	0.9	0.6	0.9	15.1	0.3	1.6	2.5	3.3	20.7	39.8	0.5	5.9	1.1	8.3	33.4	7.2	4.3	7.8	0.3	12.2	2.4	1.1	9.8	0.3	1.2	2.5	0.1	6.4	4.1	1.0	1.6	1.4	3.1	0.1	0.4	0.1	22.4	1.5	1.2	3.1	8.0	2.1	0.2	6.0	1.1	25.7	22.2	2.7	2.8	0.3	27.2	0.9	5.0	14.7	4.0	1.2	0.4	7.7	1.8	2.7	0.5	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.5	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	2.7	0.5	0.1	0.4	0.1	0.1	6.2	6.5	7.2	6.7	5.9	5.4	9.3	7.7	8.3	5.4	6.5	7.4	4.8	109.0	67.3	1.6	3.2	3.7	60.8	7.6	1.8	5.7	49.7	16.9	1.4	64.3	51.0	25.8	14.6	30.3	3.6	94.1	9.8	65.6	1.9	78.5	12.1	10.7	26.3	2.5	1.3	61.6	2.5	5.8	46.4	119.7	2.5	6.5	18.2	48.3	3.0	6.7	1.1	45.1	16.2	12.9	1.2	1.6	3.1	2.4	1.8	16.9	3.9	2.8	1.0	0.5	1.5	64.6	61.8	1.5	1.1	101.5	42.3	10.5	63.0	6.3	13.1	3.3	4.4	4.7	8.2	29.5	15.5	16.4	4.3	0.7	47.9	224.0
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 2.3;Excitatory neurons: 8.6;Inhibitory neurons: 7.0;Late spermatids: 2.4;Microglial cells: 4.7;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.2	0.2	2.9	0.3	2.1	0.7	0.5	2.3	3.2	0.4	1.6	0.2	0.0	0.1	0.9	0.2	0.3	0.2	0.1	2.1	2.4	0.3	0.3	0.2	2.1	1.9	2.0	0.3	0.2	0.0	0.3	0.0	2.0	0.3	0.2	0.6	0.3	0.3	0.1	0.7	0.7	0.1	1.8	1.2	0.2	2.1	2.4	0.8	0.3	0.0	0.8	0.1	0.3	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.8	0.4	0.2	0.1	0.4	1.1	0.3	0.0	1.4	1.5	0.4	0.6	0.0	0.2	0.0	2.7	0.4	2.9	2.1	2.3	3.2	2.1	2.4	1.9	2.0	2.0	1.8	2.4	2.2	0.1	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.0	0.0	0.0	0.6	0.0	2.4	0.0	0.1	0.0	4.7	0.3	0.5	1.0	1.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
OCM2		ENSG00000135175	"Oncomodulin 2"	P0CE71	7	97984684-97991169	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA							"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OCRL	"Dent-2, OCRL1"	ENSG00000122126	"OCRL inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	13.9	23.8	12.4	4.7	13.2	5.0	12.7	5.3	13.6	14.9	27.2	16.4	8.0	19.4	16.1	11.6	16.7	8.3	10.7	13.1	20.3	9.5	15.7	10.0	2.8	9.6	14.0	28.4	13.0	34.6	25.6	11.2	17.4	18.5	12.4	9.9	11.0	21.3	14.8	12.4	12.2	15.0	7.6	7.9	14.5	24.6	18.6	4.4	16.8	6.7	3.0	22.8	12.3	8.6	19.3	20.5	17.0	18.7	29.3	24.1	17.1	28.5	22.3	28.2	26.3	14.2	13.3	1.5	46.7	24.1	33.0	11.6	30.5	20.9	29.2	0.1	21.5	5.8	18.5	14.1	21.1	5.7	0.6	20.7	27.3	28.3	27.3	27.7	21.2	8.4	7.9	13.6	28.7	24.2	4.3	8.2	6.2	24.4	30.9	4.2	17.6	11.5	16.1	19.1	20.5	26.1	13.5	18.0	14.6	21.5	13.2	10.0	19.3	23.0	10.6	24.6	29.1	3.8	3.3	3.7	16.2	21.4	18.8	0.0	1.0	0.0	0.1	1.1	0.3	0.1	0.0	0.0	1.2	0.1	0.2	0.1	0.1	0.0	3.6	0.4	0.0	0.4	12.4	13.2	5.3	13.6	13.1	20.3	9.6	14.0	17.4	7.6	18.6	8.6	6.7	3.2	7.8	14.4	2.6	4.7	3.4	5.4	3.4	9.9	9.3	5.6	10.3	4.3	8.8	18.4	6.2	6.4	0.3	14.4	3.9	5.3	31.2	4.9	6.9	6.4	17.5	3.8	20.0	3.6	5.4	7.8	11.7	6.1	0.0	17.0	8.2	11.5	5.0	13.5	23.1	11.8	6.1	11.8	4.0	8.9	23.0	5.8	8.8	21.5	4.3	9.6	0.0	17.6	21.0	8.5	8.3	34.3	1.4	5.9	15.7	5.2	5.4	7.2	0.0	4.5	6.0	6.8	14.6	8.3	7.4	5.7	1.0	7.6	12.2	8.4
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550654	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.9;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HMC-1: 2.2;Karpas-707: 1.3;NB-4: 2.5;RPMI-8226: 1.2;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031116	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
ODF1	"CT133, HSPB10, ODF27, ODFPG, RT7"	ENSG00000155087	"Outer dense fiber of sperm tails 1"	Q14990	8	102551589-102561018	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	590	"testis: 397.0"	"Group enriched"	"Detected in some"	19	"Early spermatids: 208.2;Late spermatids: 322.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064295	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA064295: AB_2685235"					"unprognostic (3.79e-3)"													0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.3	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	397.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	322.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.0	0.0	6.6	0.0	0.0	13.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 317.6"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 8228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Vesicles,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Vesicles	"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	14.3	11.8	9.6	22.1	9.8	31.1	14.2	17.9	13.5	20.4	40.1	15.7	10.3	21.9	11.0	12.4	22.6	13.2	14.4	11.1	10.7	14.1	16.4	14.4	25.6	13.4	16.1	15.1	13.2	15.3	30.8	15.9	11.6	16.1	15.1	14.9	12.9	14.7	8.9	19.3	13.7	20.5	9.7	20.5	13.7	317.6	11.7	34.8	13.2	5.3	26.6	17.0	14.4	9.9	44.2	52.2	85.3	97.7	33.3	39.6	68.6	72.3	33.7	58.9	30.8	51.8	31.6	78.6	26.7	59.2	45.7	112.7	62.9	43.1	59.4	52.2	29.3	69.8	84.9	43.8	19.3	76.2	84.5	32.8	26.9	62.6	43.9	36.5	52.0	58.8	83.9	42.9	56.3	134.9	81.5	92.7	33.4	89.7	37.2	73.6	82.0	60.9	30.7	33.6	51.2	43.6	67.8	64.0	22.9	38.3	59.8	54.8	49.9	73.1	44.6	84.9	71.7	79.6	123.9	55.9	33.4	68.4	64.8	21.6	9.2	10.3	11.4	13.4	13.6	8.2	10.2	12.2	8.8	7.0	7.2	9.3	3.0	12.0	17.8	8.3	8.1	10.1	9.6	9.8	17.9	13.5	11.1	10.7	13.4	16.1	11.6	9.7	11.7	9.9	14.2	6.4	6.8	9.8	14.4	16.7	16.7	7.4	19.9	9.8	11.2	9.5	10.6	11.5	8.5	7.3	10.4	13.1	13.7	4.6	11.7	10.6	1914.4	39.4	16.3	18.3	3.6	29.8	18.5	9.0	16.8	14.0	10.2	13.4	19.6	10.1	8.2	9.6	12.4	8.4	16.6	10.9	12.2	10.2	14.9	8228.0	42.6	12.9	10.6	12.2	11.1	8.6	9.2	14.1	9.8	7.4	3.2	33.8	16.1	16.1	3.0	6.9	46.6	8.9	13.1	11.1	16.7	268.1	58.3	13.8	13.2	33.2	16.8	11.4	7.6	12.9
ODF2L	KIAA1229	ENSG00000122417	"Outer dense fiber of sperm tails 2 like"	Q9ULJ1	1	86346824-86396342	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 335.7;Respiratory ciliated cells: 361.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028020, HPA028095, HPA028333"	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007"	"unprognostic (4.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (4.69e-7)"	"unprognostic (2.40e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.04e-3)"	22.6	20.2	14.0	14.0	15.8	17.1	23.0	16.8	20.0	21.7	14.3	18.4	8.3	18.1	23.3	17.6	23.7	15.2	13.4	14.2	12.7	24.5	7.1	22.9	16.6	13.2	14.8	18.8	11.4	7.2	28.1	10.1	8.1	20.0	14.8	41.2	15.5	10.5	5.2	11.9	22.8	9.7	9.0	36.5	8.7	13.3	15.2	21.9	22.1	3.7	13.2	15.3	17.6	16.8	30.0	7.9	19.7	15.1	21.0	35.8	20.6	28.6	17.4	27.6	32.0	6.2	16.3	0.7	26.3	15.3	35.2	15.3	8.1	16.7	23.6	14.1	12.8	7.3	24.5	0.6	15.9	13.1	9.3	16.5	20.2	41.7	11.4	19.9	45.3	19.8	10.2	6.8	16.4	4.0	15.7	13.8	24.1	6.5	14.5	21.0	14.8	3.2	27.7	40.0	19.5	14.1	25.8	26.2	54.9	30.7	8.5	12.6	41.7	23.0	21.4	31.8	29.4	1.9	1.0	12.3	5.4	6.7	26.5	5.6	2.2	13.6	26.1	3.4	51.5	20.9	30.2	21.0	2.4	21.2	19.3	18.8	6.3	14.8	4.1	12.7	31.8	4.9	14.0	15.8	16.8	20.0	14.2	12.7	13.2	14.8	8.1	9.0	15.2	16.8	72.9	93.0	76.2	22.5	54.0	25.0	54.6	49.0	15.4	139.3	67.0	49.3	12.0	21.5	133.2	80.9	141.8	7.3	73.9	23.1	23.5	61.9	48.5	335.7	57.3	78.7	41.3	16.6	119.1	27.1	35.1	52.5	13.3	70.6	36.7	55.9	72.8	3.9	15.5	57.2	107.2	68.5	42.7	21.2	19.7	10.3	24.8	18.6	56.9	38.4	21.8	28.8	80.3	29.1	49.9	55.9	28.1	28.6	38.9	16.5	9.3	23.1	361.9	120.3	19.7	24.3	32.1	64.0	27.4	19.2	17.3	2.9	106.4	60.6	28.2	67.3
ODF3	"CT135, hSHIPPO, SHIPPO1"	ENSG00000177947	"Outer dense fiber of sperm tails 3"	Q96PU9	11	196761-200261	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 9.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 95.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038919, HPA039241"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA038919: AB_2676270, HPA039241: AB_10673417"					"unprognostic (4.17e-1)"					"unprognostic (2.41e-1)"				"unprognostic (1.24e-2)"	"unprognostic (1.99e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODF3B	FAP123	ENSG00000177989	"Outer dense fiber of sperm tails 3B"	A8MYP8	22	50529710-50532580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 88.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 455.4;Late spermatids: 807.7;Respiratory ciliated cells: 417.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 92.0;intermediate monocyte: 75.6;myeloid DC: 55.5;neutrophil: 56.2;non-classical monocyte: 53.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 55.5;granulocytes: 56.2;monocytes: 92.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.5;Karpas-707: 40.8;U-266/70: 57.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062837	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA062837: AB_2684877"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (2.84e-4)"	"unprognostic (2.60e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.61e-2)"	21.9	6.0	6.3	26.8	4.0	13.3	24.3	6.6	4.4	13.8	22.3	8.4	6.9	6.1	0.9	14.4	88.8	9.8	18.6	8.4	11.8	16.4	32.4	36.4	14.0	32.7	35.3	2.1	9.0	3.9	7.9	6.8	16.0	19.9	1.6	0.0	46.5	5.5	5.4	13.5	12.3	2.1	17.0	24.1	12.2	16.3	11.9	5.9	21.9	1.7	4.2	6.8	11.3	6.4	2.9	1.8	0.3	0.7	0.0	3.6	1.7	0.1	0.6	0.1	1.8	3.2	13.5	1.0	3.4	0.1	0.5	8.1	0.0	0.0	0.0	1.4	0.9	0.6	2.5	2.4	10.0	0.0	6.5	2.1	1.7	0.0	0.0	1.0	0.2	1.0	0.8	40.8	0.0	0.0	0.0	1.5	0.2	0.8	1.9	1.5	0.2	7.2	0.0	0.0	0.2	11.6	1.3	1.6	0.2	0.2	1.2	2.0	1.0	0.3	1.1	0.8	0.2	57.9	5.9	0.9	1.3	0.2	1.0	10.1	92.0	11.3	0.6	75.6	0.9	4.2	1.6	1.1	55.5	2.2	1.0	0.6	56.2	0.1	53.6	5.3	2.3	28.6	6.3	4.0	6.6	4.4	8.4	11.8	32.7	35.3	16.0	17.0	11.9	6.4	73.3	19.2	52.9	0.0	32.3	24.1	21.9	70.0	61.5	0.2	63.8	61.8	5.3	24.3	66.5	3.7	0.0	3.4	8.9	8.6	0.0	76.7	144.5	455.4	8.9	33.0	20.4	0.4	0.0	74.8	39.6	29.1	27.5	22.0	6.3	0.0	21.0	30.2	36.2	0.0	0.1	23.6	46.8	66.0	33.2	807.7	5.3	82.5	17.8	1.0	113.8	0.0	7.2	0.0	0.0	35.0	29.4	3.4	73.3	30.4	53.0	16.9	417.1	0.1	0.0	36.0	27.6	10.0	3.7	46.4	36.1	5.5	11.4	0.0	9.2	33.7
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 8.2;testis: 23.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1184.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA067065, HPA067973"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA067065: , HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.3	0.3	0.7	0.0	0.7	0.0	0.3	0.4	0.9	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.5	0.5	0.2	0.3	0.2	0.0	0.7	0.6	0.1	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.1	0.0	0.0	8.2	0.1	0.2	0.0	0.5	0.7	0.1	23.4	0.8	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.4	0.9	0.5	0.5	0.7	0.6	0.7	0.5	0.8	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1184.9	8.4	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	7.6	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ODF4	"CT136, OPPO1"	ENSG00000184650	"Outer dense fiber of sperm tails 4"	Q2M2E3	17	8339840-8346048	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	131	"testis: 13.0"	"Group enriched"	"Detected in some"	48	"Early spermatids: 32.1;Late spermatids: 36.0;Spermatocytes: 47.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072129	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA072129: "	"unprognostic (5.16e-2)"				"unprognostic (5.13e-1)"	"unprognostic (3.54e-4)"						"unprognostic (3.64e-1)"					"unprognostic (5.40e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	36.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	14.4	7.5	7.2	9.2	15.0	14.0	10.4	10.1	13.3	8.4	10.8	13.4	9.4	17.2	7.8	8.8	10.6	10.0	7.6	8.2	16.7	21.8	9.5	6.7	8.9	8.6	10.3	29.1	32.4	12.4	14.2	9.2	16.6	12.7	15.2	21.7	12.2	9.0	10.3	13.6	8.8	8.7	8.5	13.1	8.3	8.2	6.4	19.9	9.5	7.1	11.5	8.2	11.9	12.6	13.9	15.1	12.1	17.5	16.3	28.8	19.9	12.2	12.7	12.8	28.2	29.7	8.7	23.5	9.9	11.6	32.3	11.4	10.9	12.5	7.1	10.9	8.2	17.7	15.9	16.4	13.8	9.6	12.5	21.3	15.4	24.1	13.2	13.8	9.0	32.1	17.3	15.3	13.5	9.7	14.3	21.6	46.0	5.0	11.2	10.5	25.0	26.1	12.9	11.0	17.2	15.1	33.0	24.5	26.9	29.1	12.4	13.2	18.1	11.5	12.2	18.9	20.2	13.3	13.3	9.8	7.4	16.7	1.4	9.0	2.5	3.0	8.9	4.5	3.6	3.8	4.2	7.6	2.3	4.7	3.6	3.9	10.0	11.4	4.8	5.7	3.9	7.5	9.2	10.4	10.1	7.6	8.2	8.9	8.6	9.2	8.7	8.2	11.9	28.1	28.9	37.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	18.8	16.5	0.0	0.0	29.7	25.8	0.0	22.0	12.6	0.0	9.8	22.8	0.0	26.8	27.0	9.8	0.0	0.0	0.0	25.4	25.7	12.3	0.0	38.6	12.6	26.4	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	24.7	0.0	0.0	4.0	0.0	0.0	10.7	15.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	28.0	6.9	29.0	0.0	0.0
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1 centriole and centriolar satellite protein"	O75665	X	13734745-13769357	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 64.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 64.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (2.76e-7)"	5.8	5.9	8.3	11.7	8.7	15.6	14.6	10.8	9.8	11.2	10.1	9.4	10.2	10.5	11.5	9.9	9.6	7.3	5.9	8.2	9.4	9.6	7.2	9.2	19.1	9.7	8.3	11.2	11.2	15.3	10.9	5.3	8.9	11.7	8.2	11.2	15.6	6.5	5.2	11.8	12.8	7.6	8.2	13.9	12.2	9.9	8.4	10.1	12.9	4.1	16.8	8.5	10.4	10.0	16.0	7.1	10.3	18.4	8.4	13.0	7.7	4.9	11.3	5.7	7.3	12.8	17.7	23.2	12.5	5.9	10.6	15.3	7.5	13.7	9.2	11.6	18.9	10.8	22.3	10.8	6.4	14.4	19.1	10.4	9.1	12.9	12.7	10.6	6.4	4.2	16.5	20.4	6.4	12.6	9.9	17.3	10.8	5.8	10.2	24.9	11.9	46.6	8.9	13.5	10.5	16.6	23.2	18.5	11.6	22.7	17.5	13.0	5.8	10.0	5.2	12.1	6.3	15.1	15.1	26.9	8.3	6.4	8.3	4.3	1.7	6.2	11.6	2.2	13.4	13.7	10.1	14.2	3.8	15.4	8.3	12.5	4.7	14.1	3.1	64.2	8.6	4.4	8.3	8.7	10.8	9.8	8.2	9.4	9.7	8.3	8.9	8.2	8.4	10.0	40.2	70.5	64.1	60.4	90.8	22.4	89.3	51.8	38.1	47.9	65.9	64.1	17.8	35.8	66.7	31.3	89.6	34.5	219.8	82.3	7.9	60.2	178.6	232.2	33.0	39.5	48.6	30.1	43.3	59.3	23.4	31.2	58.1	180.8	27.3	41.1	24.7	13.3	25.2	37.0	50.2	60.3	42.7	19.8	43.0	187.4	52.2	35.1	17.8	32.8	38.2	41.3	145.2	76.9	64.5	60.7	72.9	33.8	50.5	84.4	83.8	15.3	81.3	107.2	39.5	42.4	25.2	72.7	59.9	32.6	27.3	87.0	102.2	30.7	52.2	82.8
OGA	"MEA5, MGEA5, NCOAT"	ENSG00000198408	O-GlcNAcase	O60502	10	101784443-101818465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA036141: AB_10672079, HPA076501: AB_2686802"	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	65.3	34.1	77.3	46.7	80.3	89.0	59.2	99.3	82.8	62.2	54.3	64.8	28.1	50.0	55.5	57.4	52.9	29.8	60.7	82.2	74.0	45.6	46.0	52.9	69.8	66.8	70.3	66.8	42.9	60.6	44.9	41.0	67.7	52.7	40.7	99.8	50.5	38.9	56.6	72.7	62.8	35.4	68.6	74.4	46.4	38.6	84.3	67.6	51.7	29.5	64.8	57.0	58.6	77.6	89.8	44.7	63.7	124.6	40.0	96.6	44.4	61.7	61.8	28.1	48.0	33.1	56.0	59.6	43.7	73.7	48.2	62.9	60.3	77.5	59.2	87.9	41.2	59.6	65.0	26.0	43.1	44.4	32.3	93.9	85.1	48.1	113.7	80.0	53.0	53.1	42.8	107.3	48.3	45.6	47.2	46.1	35.4	19.4	44.8	64.8	70.5	44.0	47.2	80.0	27.7	48.8	55.2	29.4	78.2	58.0	77.9	47.7	80.9	43.0	41.6	63.0	71.6	53.1	91.0	47.2	54.0	74.6	24.0	14.4	2.1	7.2	6.4	2.0	5.1	6.6	4.5	5.8	1.3	7.5	6.1	5.2	14.1	6.6	6.3	3.3	4.6	1.5	77.3	80.3	99.3	82.8	82.2	74.0	66.8	70.3	67.7	68.6	84.3	77.6	66.3	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	66.5	47.0	0.0	0.0	0.0	86.5	0.0	41.9	89.3	0.0	13.7	38.0	0.0	61.6	68.3	18.1	0.0	0.0	0.0	40.9	34.3	20.3	0.0	83.7	0.0	69.4	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	48.6	0.0	0.0	0.0	0.0	82.4	0.0	0.0	44.3	0.0	0.0	34.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	50.9	34.6	44.8	0.0	0.0
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase L"	Q9ULD0	10	49734641-49762379	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 98.5;kidney: 121.8;liver: 80.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.7;renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.2	11.6	23.1	0.3	23.4	0.0	0.0	23.7	41.1	0.7	98.5	1.4	1.0	2.2	0.5	0.1	1.0	0.4	5.8	24.4	36.9	121.8	80.0	0.0	0.2	38.4	25.6	1.6	4.3	50.5	29.3	0.1	38.9	1.6	0.3	18.7	17.1	6.3	0.1	0.1	1.1	0.7	15.4	0.3	1.0	2.3	33.8	0.5	23.0	0.8	0.6	0.5	0.5	24.3	0.0	0.0	4.7	21.3	0.0	0.0	2.7	0.1	0.1	1.1	0.2	10.5	2.3	0.0	11.4	0.0	3.4	0.4	7.4	0.2	0.4	0.0	0.4	0.0	0.2	5.3	0.2	0.0	1.6	0.3	0.0	0.0	0.0	0.6	0.0	5.4	0.5	0.0	0.0	3.2	8.2	7.3	2.0	0.8	1.0	0.0	0.0	0.0	43.4	0.7	12.0	16.3	0.1	16.2	1.1	6.1	4.5	2.9	0.0	0.0	10.6	0.0	0.7	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	23.4	23.7	41.1	24.4	36.9	38.4	25.6	38.9	15.4	33.8	24.3	0.0	0.0	0.0	20.2	0.8	0.0	0.9	0.4	0.0	30.4	0.1	0.1	4.4	2.8	0.1	29.5	31.3	0.0	0.0	0.4	92.0	1.1	0.2	0.9	0.2	0.3	4.8	0.0	16.8	0.0	0.1	0.3	0.0	1.6	0.0	0.7	1.4	55.3	0.1	30.3	21.4	0.5	2.0	1.3	0.0	0.5	0.0	0.5	0.0	1.0	0.0	5.4	0.0	3.5	1.8	0.1	1.1	0.0	0.0	0.3	0.0	84.7	0.0	18.1	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.1	0.6	0.4	0.3	0.3
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451521-56479104	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	9.6	12.3	5.2	8.8	6.5	3.9	9.5	5.5	7.3	10.4	4.1	7.7	8.8	9.8	7.6	19.4	10.6	6.7	14.5	5.3	7.2	9.3	9.1	8.0	8.9	6.5	6.3	8.1	5.7	12.0	6.1	9.2	6.5	8.4	9.6	9.6	6.4	9.5	31.5	6.3	5.1	16.7	5.1	7.5	6.1	9.5	6.3	10.5	10.2	23.5	14.5	9.1	5.7	9.0	25.4	27.4	25.7	32.5	28.6	34.5	26.0	39.1	29.9	52.4	38.5	34.5	16.5	44.7	19.0	29.3	21.7	34.9	57.2	25.5	57.3	14.1	29.6	32.4	21.6	32.8	21.4	34.9	36.2	23.2	29.0	38.7	31.2	23.1	45.3	29.3	44.3	8.2	46.2	15.6	27.4	19.2	45.0	19.8	47.2	51.2	41.0	51.9	22.9	16.7	20.4	24.1	46.3	29.0	25.2	26.9	26.4	30.1	28.9	28.1	23.2	22.9	36.7	18.0	37.1	67.5	22.9	26.5	22.7	13.4	4.6	4.5	7.7	6.4	10.1	7.1	9.5	9.4	6.4	5.6	10.7	8.4	1.5	8.5	8.6	6.8	9.0	5.9	5.2	6.5	5.5	7.3	5.3	7.2	6.5	6.3	6.5	5.1	6.3	9.0	8.9	3.2	16.0	9.8	14.1	17.7	13.8	11.2	17.6	11.3	13.1	10.7	21.4	20.0	15.0	9.2	10.4	18.3	11.7	5.8	25.4	13.7	22.2	11.6	20.0	12.2	2.4	19.6	14.4	14.1	20.5	22.3	12.2	19.1	45.7	13.0	9.7	17.6	12.0	13.5	16.6	7.9	4.1	6.9	10.2	15.6	12.2	10.9	10.6	4.7	16.1	13.6	10.3	9.0	14.5	17.4	5.5	15.8	16.1	11.0	4.6	13.8	8.0	15.2	13.1	16.7	19.0	26.0	29.6	21.2	18.9	11.6	18.4	19.1	10.6	9.0
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.5	15.0	10.8	7.7	11.1	8.4	7.5	10.9	14.0	9.1	12.4	9.9	13.8	6.8	5.9	10.7	10.2	4.8	10.3	10.6	10.9	14.1	21.2	7.7	11.0	12.3	11.4	9.4	20.9	6.5	13.2	5.6	11.5	12.0	5.5	4.9	14.7	7.8	10.9	11.9	12.7	3.3	10.8	14.4	13.0	29.1	11.6	9.3	11.8	4.5	6.6	7.8	8.3	13.5	11.7	18.6	7.6	12.4	5.2	5.5	20.4	6.9	7.1	9.5	8.6	17.6	10.2	13.0	14.1	6.0	5.6	16.5	5.5	9.5	3.6	9.1	12.0	20.6	17.8	18.3	11.1	20.7	15.5	8.1	14.0	8.8	7.8	13.7	10.1	24.7	24.4	9.3	4.8	22.4	17.6	39.0	4.6	8.0	23.5	19.2	7.3	23.2	7.2	10.4	9.7	8.8	9.4	13.4	13.8	5.0	34.0	17.6	6.5	13.0	13.2	15.5	7.3	23.4	15.1	12.4	17.9	10.7	12.8	18.7	11.7	18.9	9.1	12.9	7.8	15.9	7.5	9.0	13.1	11.3	8.1	7.7	9.6	9.7	18.2	7.8	16.0	9.0	10.8	11.1	10.9	14.0	10.6	10.9	12.3	11.4	11.5	10.8	11.6	13.5	4.1	0.0	7.0	4.6	10.0	2.9	6.5	10.3	8.0	3.6	9.2	8.6	0.4	10.0	8.6	12.9	2.1	25.9	5.6	9.2	9.8	11.8	97.3	13.0	5.2	5.9	2.4	17.2	3.2	15.0	14.0	5.4	8.6	5.3	0.0	8.6	7.9	21.1	12.5	11.8	3.6	8.0	16.2	11.9	3.4	431.0	8.7	6.4	7.2	1.0	7.7	7.8	10.3	3.0	2.6	12.7	7.8	4.5	18.4	4.6	32.4	34.1	30.5	6.4	13.1	4.1	5.7	36.8	16.2	7.3	4.5	16.4	7.2	11.5	10.1	4.3
OGFOD3	"C17orf101, FLJ22222"	ENSG00000181396	"2-oxoglutarate and iron dependent oxygenase domain containing 3"	Q6PK18	17	82389210-82418637	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052099	Uncertain		Approved	Nucleoplasm		NA	NA		9700	"Cluster 26: Non-specific - Mitochondria"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA052099: AB_2681725"	"unprognostic (1.12e-2)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.95e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.02e-1)"	14.6	19.6	4.3	9.0	4.7	10.1	14.0	6.1	6.9	14.2	9.7	13.5	9.9	16.0	6.4	12.5	13.3	8.1	24.0	3.8	4.3	15.4	20.5	13.7	8.4	5.3	4.5	14.6	25.7	15.3	22.0	8.9	4.6	15.5	5.4	2.7	18.9	10.2	24.3	13.0	11.1	5.7	3.7	11.4	15.8	8.5	4.1	5.4	19.0	9.0	5.4	14.4	11.5	5.1	23.0	28.6	9.4	31.5	17.8	22.4	16.1	22.9	21.4	23.5	24.0	30.8	30.9	15.7	17.8	18.0	23.9	16.9	8.1	19.4	9.7	12.5	24.5	23.6	22.6	39.7	15.9	27.8	27.0	18.1	14.0	10.9	9.3	17.1	24.8	17.2	30.4	12.0	6.9	21.7	19.1	29.1	8.9	24.3	33.5	12.4	18.0	24.4	13.5	21.3	20.2	40.1	39.4	36.1	18.8	7.9	21.4	36.2	19.4	44.0	27.3	17.5	30.0	20.9	2.0	14.6	27.5	15.9	23.2	0.2	13.8	4.5	6.5	12.9	7.4	13.6	9.4	13.0	23.6	11.9	11.1	9.3	1.6	7.0	8.5	12.3	3.9	8.0	4.3	4.7	6.1	6.9	3.8	4.3	5.3	4.5	4.6	3.7	4.1	5.1	13.9	25.6	16.5	3.3	21.6	11.3	23.8	27.1	13.1	23.1	26.0	29.7	18.6	18.6	19.1	22.0	10.4	37.9	12.7	19.8	9.8	27.3	28.2	23.1	17.0	18.4	28.8	21.8	6.3	31.4	59.2	25.3	19.4	16.8	9.5	20.8	8.9	28.0	37.1	30.3	7.7	24.0	12.2	22.4	16.4	45.7	20.8	19.9	14.2	3.7	27.1	12.4	34.0	8.5	6.9	20.1	32.4	18.8	53.1	35.1	42.3	27.8	18.2	16.1	6.6	30.2	23.1	16.1	10.3	19.9	12.8	31.7	15.9	27.0	28.6	28.1
OGFR	7-60	ENSG00000060491	"Opioid growth factor receptor"	Q9NZT2	20	62804835-62814000	"Predicted intracellular proteins"	"Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 12.5;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017899	Supported		Approved	Nucleoplasm		NA	NA		20000	"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA017899: AB_1854774"	"unprognostic (1.33e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (5.19e-4)"	33.4	25.7	25.9	26.8	28.1	34.5	31.7	21.0	45.4	37.1	21.7	38.4	28.5	30.7	5.3	27.3	34.6	11.5	29.1	28.4	22.8	38.5	79.4	54.5	26.6	25.4	22.7	41.4	33.4	13.1	36.8	13.4	22.9	42.3	8.6	17.2	30.9	14.1	29.5	32.5	42.9	10.5	21.8	68.3	34.3	21.1	23.9	15.2	39.3	9.9	15.2	35.1	34.1	27.7	51.5	34.2	19.8	26.5	16.4	16.5	56.1	30.9	25.3	91.3	41.0	77.3	36.9	58.6	57.2	21.5	56.8	58.8	20.2	32.8	25.9	19.3	37.5	29.4	42.9	71.1	28.7	36.9	69.6	23.4	23.6	24.9	10.4	30.9	20.4	37.9	29.0	30.6	13.5	76.4	78.9	69.8	13.3	24.5	65.1	62.1	34.5	27.5	14.2	25.5	19.8	30.2	42.5	59.5	49.6	17.9	29.7	56.5	34.8	61.1	54.1	48.1	45.6	38.8	11.5	30.9	47.9	39.6	24.5	1.8	1.5	12.5	0.7	1.4	0.4	1.0	0.9	0.8	1.0	1.5	0.9	0.5	3.1	0.6	1.4	0.7	0.6	0.4	25.9	28.1	21.0	45.4	28.4	22.8	25.4	22.7	22.9	21.8	23.9	27.7	25.2	9.6	15.0	19.6	52.8	27.0	35.7	20.2	35.3	59.5	18.6	16.8	5.9	40.0	12.6	16.5	93.8	27.8	47.0	35.5	11.7	35.7	1.9	19.9	24.4	25.1	18.0	26.1	29.1	32.9	52.1	25.3	28.5	20.2	0.0	24.5	28.9	49.2	57.5	43.7	23.5	30.4	12.2	79.5	37.6	3.5	32.6	51.7	16.0	11.2	70.3	35.7	74.2	19.1	10.2	31.4	39.7	18.8	44.2	36.5	60.4	27.4	19.4	42.3	19.7	18.2	22.1	5.7	8.9	19.2	23.3	27.9	44.7	20.5	24.2	32.3
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	12.6	13.8	18.6	13.2	18.3	12.2	12.8	20.5	19.6	18.2	12.5	14.8	18.9	17.1	10.3	9.6	16.9	8.4	11.8	19.6	15.8	30.3	20.7	10.7	26.2	18.8	16.7	22.5	10.6	6.6	10.8	8.6	17.9	15.7	8.1	12.1	12.2	10.1	7.2	9.6	17.2	9.8	16.2	15.2	12.4	8.6	17.5	13.5	13.1	8.0	21.2	15.3	14.3	17.4	11.3	20.7	20.3	13.1	19.9	22.3	38.4	14.5	14.8	21.6	25.6	19.9	10.8	68.5	9.5	18.3	34.1	10.8	12.1	15.9	9.0	25.1	17.6	33.9	32.5	29.3	20.7	13.3	20.9	22.3	20.0	37.4	16.0	17.4	27.3	9.6	11.0	10.9	20.9	21.3	10.7	13.2	11.0	10.3	29.3	7.8	13.7	22.4	12.4	5.7	9.0	15.9	18.4	15.2	11.5	10.4	23.7	22.9	17.5	21.9	22.7	17.2	24.0	10.7	16.9	35.9	17.4	37.9	13.7	15.1	10.9	20.7	18.7	9.0	18.4	13.9	15.8	15.3	9.8	16.5	12.1	11.5	2.9	27.0	7.3	15.9	21.0	10.9	18.6	18.3	20.5	19.6	19.6	15.8	18.8	16.7	17.9	16.2	17.5	17.4	9.5	0.0	3.4	15.3	16.7	5.5	8.9	8.3	9.1	20.9	6.7	7.4	2.3	10.0	4.9	9.2	35.5	6.4	16.5	9.0	11.7	7.7	0.9	5.0	12.2	10.4	18.0	22.3	11.2	6.7	10.1	11.7	6.1	4.4	2.5	10.0	10.0	11.8	18.0	8.4	9.2	8.8	6.1	9.0	5.8	1.8	14.3	9.3	7.2	10.3	15.8	11.3	27.8	13.0	9.9	8.8	11.0	13.5	10.0	5.2	47.1	86.3	4.1	34.7	26.3	11.1	10.3	10.2	21.5	5.0	4.5	4.0	12.9	12.0	14.0	5.4
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383268-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.0"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		170000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	100.1	22.5	1.4	6.0	3.0	0.2	53.8	4.7	6.8	216.0	11.0	43.0	10.6	130.5	44.9	30.8	67.1	164.7	79.8	1.7	2.3	6.4	4.1	18.6	2.1	1.8	1.8	91.8	11.1	117.3	19.1	22.7	2.0	57.9	32.2	0.0	3.2	19.3	2.6	3.8	23.6	118.0	2.3	2.4	22.0	13.3	2.2	4.5	14.7	22.0	5.6	54.0	23.3	2.1	0.0	0.0	0.0	0.0	4.4	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	32.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	1.4	3.0	4.7	6.8	1.7	2.3	1.8	1.8	2.0	2.3	2.2	2.1	10.3	6.4	1.5	1.0	0.4	4.2	0.1	0.0	1.2	0.6	0.7	0.4	2.6	10.0	7.4	3.7	0.0	2.0	0.6	0.1	0.0	0.0	1.2	2.9	104.1	5.2	0.0	0.0	1.9	0.0	1.7	326.2	7.7	1.7	1.3	0.0	20.0	0.1	4.6	0.0	1.8	0.0	0.0	0.3	11.1	4.2	166.2	2.3	1.8	16.9	0.2	0.1	0.0	2.0	1.6	0.0	0.0	212.1	0.7	0.4	0.0	0.0	2.9	0.2	6.6	4.7	22.7	0.6	0.6	0.7	4.5	5.7	2.1	1.6	0.0	0.2
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309273-41332591	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	0.6	1.7	0.1	3.3	0.2	10.3	1.2	1.2	0.4	0.9	0.2	4.1	3.5	0.8	0.3	3.8	0.4	0.6	1.5	0.2	0.2	0.3	1.2	0.5	5.8	0.2	0.4	1.5	0.3	0.1	0.1	2.3	0.4	0.5	3.9	0.7	0.8	0.6	10.3	3.3	3.9	1.1	0.1	1.7	1.5	20.9	0.2	9.1	0.4	0.8	5.2	0.7	1.3	0.5	33.7	17.8	34.3	24.9	1.7	2.1	32.4	20.0	9.3	24.5	26.1	31.8	16.2	19.8	17.0	7.7	37.8	51.0	35.7	16.1	19.2	42.4	40.1	42.4	49.8	33.6	0.4	46.5	22.1	0.7	3.2	13.8	14.5	5.2	21.1	40.8	59.4	37.3	16.5	16.3	27.1	34.8	30.9	50.4	37.9	32.9	28.4	30.5	11.1	15.4	53.7	17.5	33.7	34.3	9.6	13.7	33.7	26.3	10.0	24.5	37.3	24.6	36.6	17.0	83.2	71.1	7.1	56.5	35.9	0.0	0.4	0.5	0.2	0.7	0.8	1.0	0.7	0.8	0.7	1.2	1.3	0.8	0.0	1.2	0.4	4.1	3.1	0.8	0.1	0.2	1.2	0.4	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.5	0.2	0.0	0.5	1.0	2.7	4.1	0.9	3.6	1.2	0.0	1.1	2.2	0.2	0.0	1.8	0.0	0.0	15.0	1.7	2.3	0.0	0.4	12.0	1.9	0.6	0.9	0.0	45.9	2.2	0.4	24.0	1.7	5.1	1.1	1.3	5.2	0.0	0.8	7.5	0.0	2.1	3.0	8.2	2.2	1.8	10.8	0.9	1.2	0.0	0.0	0.6	1.1	2.1	1.5	2.5	0.2	0.5	1.2	10.9	0.4	0.9	0.3	0.0	0.3	6.6	1.0	1.1	110.6	56.8	8.3	2.4	3.8	1.2	2.1	7.6	0.9
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248599	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol		NA	NA		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	42.2	44.3	39.7	38.2	42.7	53.7	57.3	42.5	48.9	34.3	30.0	48.0	50.1	34.7	38.8	58.1	38.0	35.1	57.4	44.5	43.8	56.4	43.0	23.5	47.9	38.0	36.6	31.1	56.3	44.1	27.4	42.0	40.1	41.1	52.7	42.5	36.3	33.6	105.6	52.0	45.7	37.0	38.0	24.6	35.2	48.8	40.7	58.3	59.7	93.1	53.3	48.3	31.0	39.1	181.4	84.1	134.9	225.5	70.1	152.2	243.0	142.1	142.8	194.2	147.1	200.9	104.4	246.5	138.9	114.5	143.9	139.9	165.3	164.6	227.3	113.7	142.5	231.3	76.4	209.9	135.3	264.3	90.2	134.8	200.6	206.3	217.4	177.4	174.5	88.0	256.8	82.3	170.3	116.6	241.4	272.9	159.1	193.9	273.0	180.4	217.8	170.7	245.1	192.0	218.3	124.7	96.8	141.6	206.2	142.2	101.2	220.6	127.5	127.1	161.4	128.5	210.8	76.2	207.3	190.5	124.6	180.0	115.4	18.1	24.9	7.4	16.2	24.2	23.4	17.9	18.6	20.8	37.1	16.4	21.5	21.2	2.1	26.1	20.0	22.5	25.3	22.7	39.7	42.7	42.5	48.9	44.5	43.8	38.0	36.6	40.1	38.0	40.7	39.1	43.2	35.3	33.0	57.5	49.0	62.7	73.5	92.4	76.8	47.3	86.0	83.8	68.3	47.1	57.0	31.3	35.5	153.7	47.7	44.6	103.7	145.1	267.8	37.1	55.2	47.8	70.7	92.5	132.6	105.3	112.8	53.0	60.1	43.1	41.2	73.3	29.3	25.8	97.3	33.7	129.8	79.6	65.1	59.6	54.4	99.5	40.4	55.9	32.0	65.6	83.1	60.3	52.5	101.6	101.8	112.8	51.8	51.1	56.3	84.2	78.4	141.7	36.1	35.9	26.3	69.7	92.3	104.8	35.9	113.7	64.1	105.9	55.9	94.6	107.6	79.3
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073853	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.0;testis: 27.0"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 537.8"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037947, HPA037948"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.5	0.9	1.1	0.2	0.8	1.1	5.5	0.6	1.5	0.8	0.8	0.2	0.1	0.4	0.4	3.0	1.7	1.0	0.2	1.1	0.3	1.1	0.3	1.7	0.3	0.5	0.3	0.2	0.1	0.3	1.0	3.2	0.3	0.3	0.0	0.7	2.7	0.1	0.2	0.7	0.5	0.2	0.2	9.0	0.3	27.0	0.7	0.1	0.4	0.3	0.0	0.2	0.8	1.2	0.0	0.0	0.1	0.2	0.2	0.7	1.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.4	3.6	4.8	0.5	0.0	0.0	0.4	0.1	0.2	0.1	3.6	0.0	0.3	0.2	0.2	0.0	0.3	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.1	5.3	0.0	2.6	0.1	0.1	0.2	0.0	1.8	0.1	0.1	3.1	0.7	0.2	1.1	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	2.6	0.4	0.0	0.5	0.2	0.0	1.1	0.8	0.6	1.5	1.1	0.3	0.5	0.3	0.3	0.2	0.7	1.2	0.7	3.2	0.6	0.3	0.1	0.3	0.5	0.0	0.0	0.1	131.3	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	2.7	537.8	0.1	0.2	0.3	0.0	0.0	0.1	0.0	1.7	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.2	0.3	66.1	4.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	8.2	0.0	0.4	0.0	0.0	0.8	0.7	6.6	0.5	1.0	2.8	1.9	0.0	0.3	11.4	0.9	0.1	0.0	0.1
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 202.6;skin 1: 94.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.7"	"Group enriched"	"Detected in many"	26	"granulocytes: 49.7;T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	36.8	30.7	130.8	3.4	134.5	0.2	25.0	118.5	202.6	17.2	80.7	4.8	2.1	16.7	4.5	5.6	11.1	6.7	10.1	134.0	127.3	9.2	41.9	10.1	7.9	152.5	168.8	9.7	11.2	9.6	19.1	7.1	162.0	10.1	1.1	24.6	10.0	13.4	1.8	94.8	3.8	6.7	130.0	2.5	2.2	10.7	123.2	16.5	13.2	1.0	4.8	3.0	14.1	120.7	0.0	3.7	3.0	25.6	23.4	14.3	1.7	5.6	18.5	1.2	1.5	0.3	2.4	0.1	2.3	4.2	2.1	1.5	9.8	1.7	0.1	0.1	2.1	0.0	0.2	0.3	0.1	0.0	4.3	7.5	1.5	0.1	0.2	0.7	0.1	4.8	0.3	0.3	0.0	8.2	0.3	0.2	15.8	2.5	0.0	0.1	0.0	0.0	0.0	0.9	0.1	24.3	0.9	0.1	5.2	9.7	0.9	0.0	0.3	10.5	28.7	0.1	0.1	0.0	0.0	0.0	0.3	0.0	25.6	21.2	0.0	49.7	6.2	0.0	6.6	0.0	7.0	5.5	0.0	0.0	13.5	8.9	0.5	1.2	0.0	0.1	17.0	2.9	130.8	134.5	118.5	202.6	134.0	127.3	152.5	168.8	162.0	130.0	123.2	120.7	12.9	0.0	0.0	108.4	0.3	125.0	4.7	5.9	8.6	4.9	6.9	13.8	0.8	7.2	0.4	7.3	0.0	0.1	1.0	0.1	1.9	0.9	8.6	0.9	2.2	4.3	1.2	0.4	27.3	2.4	0.0	17.2	0.0	1.0	4.5	6.5	1.4	24.7	0.3	1.7	51.0	0.2	2.0	0.3	32.6	52.8	13.7	0.6	17.8	15.0	0.4	91.1	7.2	124.7	3.5	4.1	0.0	9.8	0.5	7.9	0.0	0.2	0.2	3.7	0.0	7.4	24.3	3.0	10.4	1.4	118.1	0.1	7.7	0.6	0.1	2.9
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 31.2;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058824	Approved				"Secreted - unknown location"	NA	NA		260000	"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058824: "	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	21.6	6.2	1.4	5.2	1.8	0.3	12.5	2.2	1.9	27.2	7.5	8.4	5.0	19.0	21.3	8.2	17.5	23.8	14.8	1.8	1.9	6.4	10.8	18.9	9.3	2.0	1.5	48.6	2.8	2.3	3.1	7.3	1.7	14.1	10.2	0.2	5.6	18.3	5.2	8.3	7.2	18.0	1.2	14.7	5.4	4.1	2.1	3.2	8.2	12.1	5.6	14.9	17.7	2.0	0.0	0.0	0.4	0.0	1.9	1.9	31.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.2	0.1	20.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.8	0.1	0.0	0.0	1.4	1.8	2.2	1.9	1.8	1.9	2.0	1.5	1.7	1.2	2.1	2.0	6.1	0.0	0.0	1.0	0.4	5.2	0.0	0.0	1.2	0.1	0.2	0.3	1.0	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	13.3	2.9	0.0	0.0	0.1	0.0	2.0	52.3	0.0	0.4	0.0	0.0	5.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	6.1	0.7	39.7	0.4	7.2	2.8	0.0	0.0	0.0	0.5	1.4	0.1	0.0	39.5	0.2	0.1	0.0	0.3	0.0	0.0	26.3	9.4	16.3	0.3	0.1	0.2	3.7	0.3	0.7	5.0	0.0	0.1
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777133-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		240000		"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	15.4	2.9	2.6	2.7	3.1	0.3	11.1	2.2	4.6	25.0	3.3	29.9	3.3	25.3	2.8	8.2	6.4	4.8	16.4	2.2	2.4	4.3	0.7	10.5	2.4	2.8	2.1	12.0	4.8	4.6	2.8	7.0	2.8	7.4	6.2	2.2	7.0	12.2	10.8	16.0	6.9	16.0	2.1	32.8	5.5	1.1	2.6	3.1	19.1	10.0	3.7	17.6	14.6	2.1	0.8	14.6	1.2	0.4	16.8	160.0	0.1	1.8	8.2	3.5	3.5	0.2	2.2	0.0	3.4	0.1	34.0	25.5	0.4	0.8	4.0	0.0	0.1	0.0	39.8	0.1	0.9	0.0	0.1	11.3	2.7	10.2	1.4	38.0	0.0	0.0	0.0	0.2	1.8	0.4	0.0	0.3	3.4	0.0	0.9	0.0	9.5	0.0	0.0	1.2	0.0	0.1	2.9	0.2	4.3	28.6	3.9	0.5	0.1	5.2	4.6	5.5	0.7	1.9	0.0	0.1	15.2	0.8	64.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	2.6	3.1	2.2	4.6	2.2	2.4	2.8	2.1	2.8	2.1	2.6	2.1	40.1	0.0	1.3	0.7	0.4	12.0	5.9	17.5	6.2	0.6	2.9	8.3	13.8	1.5	5.5	0.0	2.1	0.3	0.5	0.0	0.0	0.1	0.7	0.2	1.5	21.2	0.0	0.0	0.4	0.6	0.3	29.0	0.5	0.2	0.0	0.9	3.6	0.1	0.1	0.0	0.6	0.0	4.1	1.5	7.9	1.4	2.8	0.9	10.6	8.4	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.1	4.0	0.0	0.1	11.5	4.0	13.1	63.0	36.4	0.4	0.7	4.5	8.4	0.0	0.6	4.2	0.0	3.5
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023869	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.5;Hofbauer cells: 38.4;Skeletal myocytes: 175.5;Smooth muscle cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 6.7;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	11	"monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.7;HSkMC: 113.3;RH-30: 88.5"	"Group enriched"	"Detected in all"	4	"hippocampal formation: 41.0;white matter: 11.9"	"Low region specificity"	"Detected in all"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	23.4	6.9	4.2	19.2	7.5	0.4	14.7	2.4	5.6	16.8	6.0	18.3	2.1	16.2	5.0	3.9	11.4	48.3	6.6	5.7	3.4	3.1	0.8	15.3	14.0	3.7	4.0	4.2	1.4	3.5	2.8	40.6	4.7	5.3	2.9	0.2	10.4	6.9	10.2	10.1	5.5	22.0	3.0	10.2	3.3	15.9	9.8	3.7	20.8	6.5	11.2	16.8	7.3	4.2	0.1	0.4	6.6	2.2	21.0	39.7	0.0	2.3	10.6	4.3	11.8	0.0	0.2	0.0	0.3	25.7	4.3	0.0	0.6	0.1	2.5	0.0	0.8	0.5	0.2	0.0	0.3	0.1	0.8	113.3	0.0	5.3	0.0	2.1	0.7	0.0	0.0	1.0	19.3	0.1	0.1	0.2	2.1	0.0	1.0	0.2	88.5	8.9	1.6	0.1	0.8	0.3	9.1	0.0	0.6	19.6	0.0	0.1	0.1	2.7	0.7	4.0	3.6	0.0	0.1	0.0	25.1	2.7	1.3	0.0	0.4	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.2	4.2	7.5	2.4	5.6	5.7	3.4	3.7	4.0	4.7	3.0	9.8	4.2	4.1	0.0	0.6	0.0	0.2	3.3	0.1	0.1	0.0	0.1	0.4	1.0	3.0	1.5	0.7	1.8	0.0	0.3	0.1	0.0	0.0	0.0	122.5	1.2	24.9	1.7	0.0	0.4	2.8	0.0	0.3	21.9	0.0	0.7	1.3	1.1	1.1	0.2	38.4	0.0	0.9	0.1	0.0	31.1	9.0	12.9	20.8	16.6	1.8	8.4	0.9	0.8	0.0	0.0	2.9	0.0	0.0	29.3	0.1	0.1	0.0	0.1	0.1	0.1	6.6	175.5	57.2	8.8	1.7	0.1	2.3	0.3	0.6	16.4	0.0	0.0
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025935-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 87.2"	"Group enriched"	"Detected in some"	22	"Oligodendrocyte precursor cells: 124.1;Oligodendrocytes: 39.9"	"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"eosinophil: 19.0"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 56.2;NB-4: 41.8;THP-1: 35.9;WM-115: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			0.0	0.0	46.4	0.0	58.3	0.0	0.0	52.7	54.4	0.0	21.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	48.1	49.8	0.0	0.0	0.0	0.0	58.0	54.6	0.0	0.0	0.0	0.1	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	48.0	0.0	0.1	0.0	50.9	0.0	0.0	0.2	0.0	0.0	0.0	87.2	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.5	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.0	1.7	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	41.8	3.6	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	35.9	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.4	0.0	11.7	2.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	58.3	52.7	54.4	48.1	49.8	58.0	54.6	51.4	48.0	50.9	87.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	124.1	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492199-137494394	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018303, CAB024865"	Uncertain					NA	NA					"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	11.4	18.7	15.1	14.0	22.8	12.8	19.7	23.1	14.9	16.7	14.9	20.8	14.9	13.5	17.8	13.3	19.4	15.1	19.8	13.0	19.5	28.4	31.1	11.9	23.4	18.8	17.9	13.5	17.9	18.1	10.4	11.5	21.1	20.8	20.0	20.5	19.5	16.7	28.2	12.8	14.2	12.4	15.6	20.2	17.3	8.2	18.3	20.2	20.1	29.9	21.5	14.8	10.5	27.3	31.2	13.0	8.3	7.9	41.7	39.0	24.6	12.7	13.9	10.9	13.7	4.0	18.7	69.8	26.3	13.1	37.8	31.2	31.1	31.3	13.3	55.1	17.9	22.0	10.4	16.1	20.3	54.3	14.7	37.3	33.6	10.4	22.4	24.1	9.3	34.3	42.7	20.1	29.2	19.5	18.0	19.4	12.4	47.4	28.5	22.1	27.7	29.1	23.6	20.5	8.7	4.3	26.0	41.9	37.6	38.4	19.5	20.1	5.4	5.6	10.8	27.8	13.5	16.3	23.4	46.2	16.8	42.2	14.1	20.1	14.4	32.1	19.4	24.1	25.6	35.6	23.7	23.1	15.4	35.0	33.9	31.5	17.2	30.9	35.1	8.2	23.6	15.9	15.1	22.8	23.1	14.9	13.0	19.5	18.8	17.9	21.1	15.6	18.3	27.3	8.4	19.2	11.5	37.9	25.7	6.0	18.2	35.6	13.6	7.8	15.0	12.3	27.2	8.6	33.0	25.8	12.5	22.9	14.4	8.4	25.4	11.2	5.8	31.6	10.8	6.3	6.0	15.6	18.3	5.5	10.0	12.0	5.6	18.4	6.3	10.9	6.4	18.7	15.8	1.7	31.7	17.7	36.7	10.1	9.7	12.7	9.9	12.9	7.2	29.0	11.3	10.9	15.5	52.8	106.5	3.8	10.9	8.6	16.8	12.3	8.5	32.4	63.1	20.5	6.6	12.0	8.6	14.3	13.6	17.3	6.8	18.3	20.7	17.1	14.6	17.1
OMG	OMGP	ENSG00000126861	"Oligodendrocyte myelin glycoprotein"	P23515	17	31272013-31297539	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 116.5;choroid plexus: 44.1"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 458.9;Respiratory ciliated cells: 708.8"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.5;glioma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008206, HPA012693"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA008206: AB_1854240, HPA012693: AB_1854239"	"unprognostic (8.05e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.96e-13)"	"unprognostic (7.80e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.42e-2)"	0.0	0.1	69.7	0.0	78.1	0.7	0.0	70.7	116.5	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.9	71.6	0.0	0.0	0.1	0.0	68.6	66.5	0.0	0.0	0.0	0.3	0.0	71.5	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.1	0.0	69.6	0.3	0.1	0.0	70.5	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	78.1	70.7	116.5	71.9	71.6	68.6	66.5	71.5	69.6	70.5	88.4	0.5	0.0	3.7	18.3	0.3	0.4	0.0	72.8	0.0	4.2	0.1	0.1	0.7	0.0	44.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	458.9	3.8	1.6	0.0	0.0	28.0	0.0	0.6	1.5	0.0	7.0	0.0	0.0	0.7	0.1	0.5	0.0	18.7	0.0	61.1	20.1	0.7	0.0	0.0	1.1	0.0	3.7	0.2	78.2	1.0	78.4	101.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	708.8	2.4	0.0	0.7	19.1	0.0	0.0	0.2	0.1	11.8	1.4	0.0	0.0	0.0
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52755053-52791078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 6.0;liver: 12.9;pancreas: 13.6;retina: 4.6"	"Cell type enriched"	"Detected in some"	16	"Horizontal cells: 647.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Low region specificity"	"Detected in many"			HPA003457	Enhanced					NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.0	0.0	0.7	0.0	0.7	0.5	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.4	2.0	0.0	12.9	0.0	0.0	1.8	2.1	0.0	13.6	0.0	0.0	0.0	1.7	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	1.8	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.0	1.8	0.1	0.1	0.3	0.0	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	1.9	0.3	0.0	0.0	0.6	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.4	0.3	0.4	2.0	1.8	2.1	1.7	0.6	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	40.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	21.1	1.4	0.1	0.0	0.3	0.0	0.0	0.4	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	647.8	0.2	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	15.6	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;gallbladder: 10.1;intestine: 10.1;liver: 8.5;retina: 5.4"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;cerebral cortex: 2.3;hypothalamus: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.4	0.0	9.1	0.0	0.0	0.8	2.3	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	10.1	0.0	0.3	4.2	0.1	8.5	0.0	0.0	0.6	0.3	0.0	2.3	0.8	0.8	0.0	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.1	0.8	2.3	0.3	4.2	0.6	0.3	0.8	0.0	1.0	0.2	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 14.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 29.4;Spermatocytes: 74.1;Spermatogonia: 56.8"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CAPAN-2: 8.3;MCF7: 2.9;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055165	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.1	0.2	0.1	0.2	0.9	0.0	0.1	1.4	0.2	0.2	0.0	0.0	1.8	0.4	0.0	0.9	0.1	0.0	0.1	0.2	0.5	14.2	0.1	0.0	0.4	0.2	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.2	0.0	8.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.3	1.1	0.3	3.8	0.0	0.0	0.4	0.6	0.0	1.5	0.5	0.0	0.0	8.6	0.2	0.2	0.0	0.1	29.4	1.8	0.1	0.7	0.0	2.7	0.0	0.6	2.4	0.5	0.0	0.8	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.5	2.0	0.3	0.7	7.2	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	1.2	0.4	0.3	0.2	1.2	0.5	0.6	0.0	0.5	0.2	74.1	56.8	0.0	1.0	4.5	0.4	0.0	0.0	0.3
OOSP2	"FLJ36198, OOSP2A, PLAC1L, TMEM122"	ENSG00000149507	"Oocyte secreted protein 2"	Q86WS3	11	60040409-60048044	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	180	"testis: 18.0"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050914	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA050914: AB_2681271"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"Outer mitochondrial membrane lipid metabolism regulator OPA3"	Q9H6K4	19	45527427-45602212	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	4.8	7.2	3.3	4.7	3.4	4.0	3.5	4.4	5.2	3.0	3.7	4.6	4.0	4.9	3.0	5.8	3.4	3.3	10.5	3.2	3.1	7.4	7.8	4.4	4.7	4.9	4.0	3.4	4.4	12.0	6.0	4.4	5.0	3.8	3.9	6.4	4.0	4.1	11.1	5.8	5.0	4.7	2.5	5.8	4.9	8.9	5.5	4.6	4.6	12.9	4.7	4.1	3.5	3.2	15.2	18.9	7.4	7.3	4.8	5.9	11.3	9.7	8.9	10.1	10.7	8.8	10.5	13.0	6.9	9.8	11.5	12.0	12.5	13.3	8.9	24.0	12.6	20.1	10.8	9.1	8.8	14.1	25.0	8.9	10.1	11.2	12.2	5.8	7.3	7.6	17.5	14.2	6.9	9.3	11.3	5.8	6.5	12.6	12.9	10.9	6.7	7.1	8.0	26.9	5.5	6.6	12.4	11.3	5.2	6.6	6.3	8.0	15.9	8.5	9.7	7.1	16.7	9.5	19.1	10.6	8.2	10.1	13.1	5.6	5.3	2.9	3.6	7.8	3.6	4.4	3.2	3.1	5.6	3.9	3.9	4.0	4.7	7.8	10.5	5.1	4.8	3.6	3.3	3.4	4.4	5.2	3.2	3.1	4.9	4.0	5.0	2.5	5.5	3.2	11.0	12.8	11.7	8.5	23.0	18.7	22.4	14.6	13.1	22.8	9.2	7.9	25.4	17.2	11.6	11.0	52.1	25.6	15.7	18.8	25.4	18.4	18.5	12.8	13.8	15.2	13.8	5.7	9.5	21.1	29.8	10.6	14.3	20.1	15.9	8.9	11.4	21.9	16.3	20.2	10.2	14.5	16.2	11.4	28.3	20.2	6.2	17.4	14.2	4.7	19.0	15.1	11.3	3.0	8.1	18.2	19.2	6.4	11.9	15.8	21.2	16.8	10.7	36.0	0.0	23.3	23.6	23.9	13.1	11.2	19.6	36.3	14.4	19.5	16.6	16.7
OPALIN	"HTMP10, TMEM10, TMP10"	ENSG00000197430	"Oligodendrocytic myelin paranodal and inner loop protein"	Q96PE5	10	96343221-96359365	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	654	"brain: 166.5;choroid plexus: 47.8"	"Cell type enriched"	"Detected in some"	304	"Oligodendrocytes: 304.5"	"Cancer enriched"	"Detected in single"	36	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Region enhanced"	"Detected in all"		"white matter: 240.1"	"Low region specificity"	"Detected in all"			HPA014372	Supported					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA014372: AB_2158172"					"unprognostic (1.18e-1)"													0.0	0.0	112.6	0.0	135.3	0.0	0.0	58.9	166.5	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.9	86.6	0.0	0.0	0.0	0.0	101.3	106.0	0.0	0.0	0.0	0.1	0.0	83.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	149.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.6	135.3	58.9	166.5	104.9	86.6	101.3	106.0	83.4	72.4	94.9	149.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	304.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	67949349-68433913	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	4.1	5.1	20.8	1.8	18.6	3.9	4.5	14.2	19.5	6.0	1.0	3.4	2.5	5.6	3.7	3.8	3.2	2.7	3.1	18.0	14.6	4.3	1.3	4.4	1.9	9.5	11.9	4.5	3.1	3.6	2.7	5.6	5.8	10.1	3.4	11.5	5.4	5.0	6.5	6.4	2.9	4.0	6.1	2.3	3.8	2.6	16.3	1.2	4.7	4.8	1.4	2.3	3.8	11.5	23.6	5.1	3.2	7.3	7.1	6.8	5.0	4.2	5.6	8.3	10.1	3.3	4.5	1.5	13.7	4.9	3.4	5.7	3.1	2.9	12.6	0.9	2.1	5.2	6.9	3.7	2.4	2.1	5.2	4.6	4.8	6.9	6.4	10.6	5.6	1.1	3.2	3.1	4.3	10.1	0.8	1.8	7.5	10.0	4.8	0.9	7.3	1.3	8.5	7.6	1.7	2.8	7.2	9.1	13.7	7.1	6.2	1.6	6.0	5.0	7.3	18.1	4.5	2.9	3.4	1.0	4.0	2.8	3.5	1.0	1.0	0.4	0.5	0.4	0.4	0.5	0.4	0.3	0.4	0.8	0.4	0.5	4.6	0.5	0.6	1.6	0.3	0.2	20.8	18.6	14.2	19.5	18.0	14.6	9.5	11.9	5.8	6.1	16.3	11.5	13.8	16.0	19.3	383.9	0.0	3.2	5.4	2.0	10.2	5.4	6.7	5.0	3.3	2.8	6.4	18.4	6.2	23.0	2.3	3.9	0.0	1.2	2.0	7.2	4.3	8.1	4.2	1.3	84.6	0.8	11.7	18.0	14.8	12.9	8.8	36.3	5.0	0.2	4.6	0.0	78.8	3.0	2.0	2.1	9.5	1.7	21.1	5.9	8.8	54.4	1.2	16.0	3.1	600.2	41.7	1.3	2.4	12.0	0.1	8.5	3.8	1.8	10.9	5.1	0.0	24.1	5.4	0.3	1.9	8.9	5.1	66.9	1.4	4.2	4.1	4.2
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 66.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 115.7;Late spermatids: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.9;BEWO: 21.0;Hep G2: 18.8;PC-3: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA		34000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	9.2	14.8	3.3	1.9	5.6	2.7	8.6	8.1	3.7	6.4	5.7	15.0	13.8	4.8	0.6	15.6	4.2	2.5	35.1	2.9	2.7	15.8	34.3	6.4	0.8	12.2	5.6	5.7	10.0	6.7	3.2	1.3	12.5	8.9	2.2	0.3	11.2	5.7	34.2	13.3	12.2	1.1	3.9	9.1	19.7	66.5	5.3	0.3	5.9	15.4	0.5	4.8	9.5	6.5	4.2	4.2	0.4	33.9	1.5	3.1	21.0	2.1	1.3	1.2	0.7	8.1	7.8	0.0	6.8	3.8	0.0	5.5	1.0	3.1	0.1	1.1	0.0	1.4	7.0	18.8	10.5	0.1	0.0	4.4	13.8	1.4	0.0	0.0	0.2	5.8	5.1	0.0	0.0	4.8	0.3	3.3	2.8	6.5	26.2	0.4	0.0	5.6	3.6	5.1	1.2	0.1	0.0	1.4	0.1	0.4	8.8	4.6	0.2	0.0	5.5	0.0	1.4	1.1	1.5	1.1	0.5	1.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	3.3	5.6	8.1	3.7	2.9	2.7	12.2	5.6	12.5	3.9	5.3	6.5	1.1	3.2	3.2	9.1	0.8	2.0	2.8	4.4	3.4	1.1	6.1	6.1	2.9	7.2	4.7	9.2	0.0	1.7	0.2	37.6	11.7	3.8	115.7	2.6	2.7	1.1	1.2	0.0	0.2	2.7	2.7	2.7	18.3	5.5	0.0	6.0	2.2	25.1	2.4	0.0	0.3	10.0	4.1	6.0	0.5	231.7	2.5	3.4	0.0	1.0	2.1	4.3	0.0	0.5	2.6	3.6	13.1	3.8	0.6	1.9	23.8	13.3	2.2	0.1	0.0	3.6	2.2	3.1	2.3	7.2	1.8	2.5	0.6	10.2	18.2	3.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN3	"ECPN, encephalopsin, ERO, NMO-1, PPP1R116"	ENSG00000054277	"Opsin 3"	Q9H1Y3	1	241590102-241677376	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 133.9;Extravillous trophoblasts: 252.9;Langerhans cells: 206.8;Syncytiotrophoblasts: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 10.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 72.4"	"Low region specificity"	"Detected in all"							"CAB013682, HPA064443"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013682: , HPA064443: AB_2685267"	"unprognostic (2.41e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.96e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.13e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.44e-3)"	2.6	2.2	5.0	3.4	5.5	1.1	3.1	4.1	9.6	2.7	3.2	6.4	1.6	3.8	4.4	4.2	4.5	3.1	2.1	5.8	4.3	4.2	11.0	8.4	4.4	3.5	6.4	2.1	1.9	1.4	2.7	18.7	3.4	1.0	5.5	0.5	2.3	1.3	1.8	2.2	2.9	1.8	3.5	4.5	3.3	2.5	7.1	4.9	3.2	4.0	5.1	4.2	2.9	5.3	4.5	15.0	10.7	0.8	38.3	72.4	8.2	8.0	6.0	5.6	5.6	1.1	12.5	0.6	0.4	9.7	6.3	25.9	3.4	5.7	5.6	16.7	0.8	0.0	3.2	9.5	19.4	3.9	8.3	37.0	15.5	3.5	8.4	37.7	11.5	13.4	7.6	2.3	9.1	2.4	1.4	5.0	29.1	19.3	8.0	6.3	0.6	14.6	38.5	6.7	2.8	10.9	5.0	15.6	4.6	21.5	0.8	14.9	13.9	1.3	1.0	2.2	8.6	5.3	8.7	0.7	4.3	12.4	16.7	0.0	0.8	0.7	0.0	1.1	0.0	1.8	0.1	0.1	2.2	1.7	0.2	0.3	0.3	0.5	1.1	10.0	0.2	0.5	5.0	5.5	4.1	9.6	5.8	4.3	3.5	6.4	3.4	3.5	7.1	5.3	3.7	6.4	5.4	4.9	35.5	14.7	13.5	12.7	18.8	3.3	12.4	10.5	0.8	15.7	7.0	12.9	0.0	80.6	60.1	41.4	13.7	16.8	133.9	10.5	5.8	5.9	4.2	15.1	56.7	10.5	252.9	7.7	12.8	22.2	2.5	22.4	8.6	26.3	26.6	0.0	15.7	8.8	20.3	31.9	206.8	89.7	11.1	56.9	28.4	9.4	30.2	4.3	5.2	10.1	7.2	19.3	10.8	16.6	18.4	20.1	7.6	21.5	2.7	2.1	0.0	5.4	13.3	7.8	8.3	29.7	12.4	171.6	6.4	6.6	7.1	15.2
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654547-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Biological rhythms, Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.9;skeletal muscle: 2.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 4.6;Excitatory neurons: 2.8;Inhibitory neurons: 1.9;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved					NA	NA				"Cluster 47: Non-specific - Unknown function"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	2.0	0.1	1.5	0.0	7.9	0.0	0.7	0.0	3.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.1	1.1	0.6	0.0	2.5	0.7	0.4	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.8	0.4	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.9	0.0	3.0	1.6	0.0	0.1	0.1	0.2	0.1	1.4	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN5	"dJ402H5.1, neuropsin, TMEM13"	ENSG00000124818	"Opsin 5"	Q6U736	6	47781982-47832780	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 27.1;Late spermatids: 25.6;Spermatocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026084	Supported					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA026084: AB_2671807"					"unprognostic (1.95e-1)"								"unprognostic (6.18e-2)"		"unprognostic (4.84e-1)"	"unprognostic (1.07e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	13.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.1	0.5	1.4	0.1	1.6	0.4	0.0	0.0	3.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.1	4.4	0.1	0.1	0.3	0.0	0.1	0.1	4.7	0.1	0.1	0.5	0.2	0.0	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	16.4	0.1	0.0	0.1	6.4	6.5	0.0	0.1	1.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.4	22.0	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	1.4	1.6	0.0	3.2	1.9	0.0	4.4	0.1	4.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	3.7	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	11.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	2.6	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	1.2
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.6;testis: 2.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 29.2;Excitatory neurons: 41.1;Inhibitory neurons: 23.5;Late spermatids: 29.7;Microglial cells: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	11	"SH-SY5Y: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.1	0.8	2.9	0.3	2.5	0.7	0.4	8.8	3.5	0.2	0.0	0.2	0.2	0.3	0.6	1.1	0.2	0.3	0.1	1.5	2.6	0.2	0.2	0.2	0.4	2.2	5.2	0.4	0.2	0.2	0.0	0.2	1.0	0.3	0.2	0.9	0.3	0.2	0.4	0.6	0.2	0.2	1.7	0.4	0.4	2.8	10.6	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.2	0.5	0.4	0.2	0.1	0.4	0.2	0.4	0.4	0.2	0.3	0.2	0.3	0.5	0.2	0.3	0.4	0.3	0.2	0.6	0.2	0.5	0.2	0.2	0.3	0.3	0.6	0.4	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.2	0.2	0.3	0.4	0.4	6.8	0.1	0.2	0.4	0.4	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.5	0.2	0.3	0.3	0.3	0.2	1.1	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.7	0.4	0.2	0.4	0.2	0.1	2.9	2.5	8.8	3.5	1.5	2.6	2.2	5.2	1.0	1.7	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	29.7	0.0	0.2	0.0	10.3	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.2
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397931-70410195	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 146.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.5;Breast myoepithelial cells: 3.3;Glandular and luminal cells: 2.1"	"Group enriched"	"Detected in some"	5	"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	NA	NA		63000		"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 35: Glandular cells - Unknown function"			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494153-203508949	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1.5;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"	NA	NA						"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.4	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.3	0.2	0.5	0.8	0.7	0.8	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 879.4;tongue: 394.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 933.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA		370000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	92.7	90.4	45.7	35.8	53.5	50.1	64.0	45.9	55.9	52.3	36.8	55.4	63.2	39.7	21.9	61.8	37.7	41.6	105.7	54.9	49.2	72.3	73.8	58.9	45.7	48.0	53.9	92.1	35.4	33.1	33.8	57.5	52.9	34.1	57.2	48.8	46.3	41.4	879.4	77.9	69.6	43.4	44.3	57.3	56.1	72.8	45.4	30.1	27.1	394.5	37.6	43.8	56.3	49.0	83.3	23.1	12.8	17.8	171.4	175.6	15.2	97.6	110.7	72.1	119.0	41.1	108.1	0.7	37.6	134.3	113.2	75.6	17.3	93.5	54.8	192.9	9.2	17.2	32.1	22.0	175.4	0.6	59.5	94.6	72.6	69.2	71.8	177.9	62.4	23.8	21.5	123.7	98.7	17.6	8.3	2.3	5.2	22.4	10.3	1.4	25.5	8.5	87.9	57.6	2.8	13.6	84.9	25.0	64.3	49.9	54.6	11.4	171.6	58.8	28.9	81.0	27.5	63.3	23.5	0.6	88.3	14.3	11.4	47.9	2.5	0.3	56.1	1.5	43.3	18.0	71.2	65.8	0.5	11.7	28.0	34.5	1.7	51.2	3.8	5.2	109.6	30.2	45.7	53.5	45.9	55.9	54.9	49.2	48.0	53.9	52.9	44.3	45.4	49.0	68.2	67.3	29.4	18.6	25.9	74.4	46.6	104.5	67.2	38.7	30.5	32.9	237.7	68.6	81.3	31.3	18.8	112.8	89.8	199.8	33.2	135.5	281.9	36.0	38.6	82.4	42.6	126.5	48.9	114.0	39.8	91.6	88.7	37.4	70.8	92.8	47.8	30.9	31.6	90.9	26.6	106.4	65.1	15.1	26.0	933.6	95.7	14.5	90.7	25.3	36.6	36.4	119.4	13.6	28.1	166.3	186.9	103.4	86.3	92.3	209.9	162.4	73.7	103.4	111.7	63.1	106.6	102.0	13.7	58.1	77.9	75.4	107.5	166.3	44.1	75.0
OR10A7		ENSG00000179919	"Olfactory receptor family 10 subfamily A member 7"	Q8NGE5	12	55221025-55221975	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055111	Uncertain					NA	NA									"HPA055111: AB_2682698"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10AD1	OR10AD1P	ENSG00000172640	"Olfactory receptor family 10 subfamily AD member 1"	Q8NGE0	12	48202083-48203387	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049913	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA049913: AB_2680950"	"unprognostic (2.90e-1)"	"unprognostic (2.79e-1)"			"unprognostic (2.67e-2)"			"unprognostic (1.70e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.74e-1)"		0.0	0.4	0.2	0.3	0.2	0.0	0.0	1.3	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.1	0.3	0.3	0.4	0.3	0.1	0.0	0.9	0.1	0.2	0.3	0.0	2.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.9	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.1	0.1	0.3	0.3	0.4	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10C1	"hs6M1-17, OR10C1P, OR10C2"	ENSG00000206474	"Olfactory receptor family 10 subfamily C member 1"	Q96KK4	6	29439306-29440977	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049336	Uncertain					NA	NA									"HPA049336: AB_2680718"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10G3		ENSG00000169208	"Olfactory receptor family 10 subfamily G member 3"	Q8NGC4	14	21568520-21580076	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 11.7;Club cells: 2.5;granulocytes: 2.5;T-cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019766	Uncertain					NA	NA						"Cluster 11: Alveolar cells - Smell perception"			"HPA019766: AB_1854780"																		0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.3	0.3	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.3	0.1	6.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
OR10K1		ENSG00000173285	"Olfactory receptor family 10 subfamily K member 1"	Q8NGX5	1	158461574-158470857	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 14.2;Club cells: 5.0;granulocytes: 8.8;Respiratory ciliated cells: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA059125	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 11: Alveolar cells - Smell perception"			"HPA059125: AB_2683913"																		0.1	0.2	1.7	0.3	2.2	0.6	0.1	4.3	4.2	0.0	0.2	0.1	0.1	0.1	0.3	0.8	0.0	0.1	0.0	1.9	0.4	0.1	0.2	0.1	0.1	1.2	0.9	0.1	0.1	0.0	0.0	0.1	1.8	0.1	0.1	0.8	0.1	0.0	0.6	0.1	0.1	0.1	0.6	0.2	0.1	0.3	2.6	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.2	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.8	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	0.2	0.0	0.2	0.4	0.3	0.2	0.4	0.3	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.7	2.2	4.3	4.2	1.9	0.4	1.2	0.9	1.8	0.6	2.6	5.6	0.0	22.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0
OR10K2		ENSG00000180708	"Olfactory receptor family 10 subfamily K member 2"	Q6IF99	1	158418210-158426237	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA059125	Uncertain					NA	NA						"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059125: AB_2683913"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10Q1		ENSG00000180475	"Olfactory receptor family 10 subfamily Q member 1"	Q8NGQ4	11	58227882-58228918	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046968	Uncertain					NA	NA									"HPA046968: AB_2679881"											"unprognostic (4.82e-1)"		"unprognostic (6.34e-2)"	"unprognostic (4.37e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10R2	OR10R2Q	ENSG00000198965	"Olfactory receptor family 10 subfamily R member 2"	Q8NGX6	1	158472220-158480936	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MOLT-4: 32.1"					"Not detected"	"Not detected"			"HPA059775, HPA060399"	Uncertain					NA	NA					"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"				"HPA059775: AB_2684124, HPA060399: AB_2684276"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10S1		ENSG00000196248	"Olfactory receptor family 10 subfamily S member 1"	Q8NGN2	11	123976661-123977781	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019038	Uncertain					NA	NA									"HPA019038: AB_1854785"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10V1		ENSG00000172289	"Olfactory receptor family 10 subfamily V member 1"	Q8NGI7	11	59712916-59713845	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060076	Uncertain					NA	NA									"HPA060076: AB_2684198"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11H12		ENSG00000257115	"Olfactory receptor family 11 subfamily H member 12"	B2RN74	14	18601045-18602129	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047370	Uncertain					NA	NA									"HPA047370: AB_2680016"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11H2	"C14orf15, OR11H2P, OR11H8P"	ENSG00000258453	"Olfactory receptor family 11 subfamily H member 2"	Q8NH07	14	19712904-19714332	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047370	Uncertain					NA	NA									"HPA047370: AB_2680016"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11H4		ENSG00000176198	"Olfactory receptor family 11 subfamily H member 4"	Q8NGC9	14	20239286-20244349	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA052790	Uncertain					NA	NA									"HPA052790: AB_2681950"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13A1		ENSG00000256574	"Olfactory receptor family 13 subfamily A member 1"	Q8NGR1	10	45302298-45315608	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Daudi: 10.4;U-698: 9.3"	"Not detected"	"Not detected"							HPA057237	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA057237: AB_2683378"	"unprognostic (7.88e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.33e-5)"	"unprognostic (6.43e-3)"	"unprognostic (6.04e-2)"		"unprognostic (8.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-15)"	"unprognostic (6.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.09e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.7	0.0	0.0	0.3	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1
OR13C3		ENSG00000204246	"Olfactory receptor family 13 subfamily C member 3"	Q8NGS6	9	104535749-104536856	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053978	Uncertain					NA	NA									"HPA053978: AB_2682330"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13D1		ENSG00000179055	"Olfactory receptor family 13 subfamily D member 1"	Q8NGV5	9	104694379-104695485	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055921	Uncertain					NA	NA									"HPA055921: AB_2682970"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14A2	"OR5AX1, OR5AX1P"	ENSG00000241128	"Olfactory receptor family 14 subfamily A member 2"	Q96R54	1	247722957-247724043	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	8	"testis: 2.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	51	"GAMG: 5.0"									HPA052685	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA052685: AB_2681914"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14K1	OR5AY1	ENSG00000153230	"Olfactory receptor family 14 subfamily K member 1"	Q8NGZ2	1	247738615-247739559	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"GAMG: 5.2"					"Not detected"	"Not detected"			HPA016643	Uncertain					NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"				"HPA016643: AB_1854788"										"unprognostic (1.62e-1)"		"unprognostic (1.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1L3	OR9-D	ENSG00000171481	"Olfactory receptor family 1 subfamily L member 3"	Q8NH93	9	122675036-122676153	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA058878	Uncertain					NA	NA									"HPA058878: AB_2683843"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"retina: 1.1"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044828	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1S1	OST034	ENSG00000280204	"Olfactory receptor family 1 subfamily S member 1"	Q8NH92	11	58212720-58216084	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049304	Uncertain					NA	NA									"HPA049304: AB_2680704"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1S2		ENSG00000197887	"Olfactory receptor family 1 subfamily S member 2"	Q8NGQ3	11	58203202-58204181	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049304	Uncertain					NA	NA									"HPA049304: AB_2680704"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A1		ENSG00000221970	"Olfactory receptor family 2 subfamily A member 1"	Q8NGT9	7	144312419-144322737	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058272	Uncertain					NA	NA				"Cluster 72: Non-specific - Transcription"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"	"unprognostic (3.98e-1)"							"unprognostic (6.53e-2)"					"unprognostic (1.13e-2)"		"unprognostic (9.14e-2)"	"unprognostic (2.22e-1)"		0.7	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.2	0.8	0.4	0.4	0.0	0.4	0.0	0.2	0.4	0.1	0.4	0.1	0.3	0.4	0.2	0.8	0.1	0.4	0.5	1.1	0.3	0.0	0.3	0.0	0.3	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.6	0.0	0.2	0.7	0.2	0.2	0.4	0.0	2.4	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A25	"OR2A25P, OR2A27"	ENSG00000221933	"Olfactory receptor family 2 subfamily A member 25"	A4D2G3	7	144069811-144075870	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.2;Club cells: 1.8;granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA058272	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 60: Granulocytes - Receptor signaling"			"HPA058272: AB_2683662"																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	6.4	5.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
OR2A4	OR2A10	ENSG00000180658	"Olfactory receptor family 2 subfamily A member 4"	O95047	6	131699644-131701401	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Endothelial cells: 1.6"	"Cancer enriched"	"Detected in single"	17	"renal cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"basophil: 12.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.0"	"Not detected"	"Not detected"											HPA058272	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"			"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"													"unprognostic (1.22e-5)"	"unprognostic (3.60e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A42		ENSG00000212807	"Olfactory receptor family 2 subfamily A member 42"	Q8NGT9	7	144228244-144239605	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058272	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"													"unprognostic (1.41e-1)"			"unprognostic (3.14e-1)"		0.1	0.1	0.4	0.0	0.3	0.4	0.2	0.2	0.3	0.2	1.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	0.4	0.3	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.3	0.1	0.2	0.3	0.4	0.4	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A7	HSDJ0798C17	ENSG00000243896	"Olfactory receptor family 2 subfamily A member 7"	Q96R45	7	144257663-144264792	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	6	"basophil: 12.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 12.3"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;hTCEpi: 6.2;RT4: 5.0;SK-BR-3: 5.3"									HPA058272	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.33e-1)"	"unprognostic (9.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.22e-1)"	1.9	0.7	0.6	1.1	0.7	3.1	5.9	0.4	0.4	4.5	2.2	5.8	10.5	1.7	3.8	5.2	3.4	3.0	1.4	0.1	0.5	6.1	3.2	3.1	1.4	0.8	1.1	3.3	6.1	3.1	2.0	1.7	0.8	4.7	5.4	1.8	5.4	1.4	0.2	11.5	7.5	1.1	0.6	1.8	6.4	0.9	0.8	0.9	10.0	0.3	1.4	2.3	4.4	0.6	12.7	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.6	3.4	0.0	0.0	0.0	0.0	2.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	6.2	0.4	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	3.2	5.0	0.0	0.0	3.1	5.3	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	12.3	0.1	0.0	0.7	0.0	0.2	0.6	1.0	0.5	0.0	2.0	0.6	0.5	0.0	1.5	0.0	0.0	0.7	0.0	0.6	0.7	0.4	0.4	0.1	0.5	0.8	1.1	0.8	0.6	0.8	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2AE1	OR2AE2	ENSG00000244623	"Olfactory receptor family 2 subfamily AE member 1"	Q8NHA4	7	99875987-99877057	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042957	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"						"HPA042957: AB_10794539"	"unprognostic (6.75e-2)"				"unprognostic (6.22e-2)"				"unprognostic (5.21e-2)"				"unprognostic (1.58e-1)"	"unprognostic (3.16e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OR2B11		ENSG00000177535	"Olfactory receptor family 2 subfamily B member 11"	Q5JQS5	1	247449118-247458105	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"Alveolar cells type 2: 2.2;Club cells: 5.0;granulocytes: 3.8;Macrophages: 2.2;Respiratory ciliated cells: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"THP-1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047459	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA047459: AB_10963692"					"unprognostic (1.83e-1)"													0.1	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
OR2D3		ENSG00000178358	"Olfactory receptor family 2 subfamily D member 3"	Q8NGH3	11	6920974-6922043	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052551	Uncertain					NA	NA						"Cluster 55: Plasma cells - Humoral immune response"			"HPA052551: AB_2681867"														"unprognostic (4.52e-1)"				0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2K2	"HSHTPCRH06, HTPCRH06, OR2AR1P"	ENSG00000171133	"Olfactory receptor family 2 subfamily K member 2"	Q8NGT1	9	111327483-111330183	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024261	Uncertain					NA	NA									"HPA024261: AB_1854786"					"unprognostic (1.03e-1)"													0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.6	0.2	0.2	0.4	0.3	0.4	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M4	"HSHTPCRX18, HTPCRX18, OST710, TPCR100"	ENSG00000171180	"Olfactory receptor family 2 subfamily M member 4"	Q96R27	1	248231417-248244679	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA051308	Uncertain					NA	NA									"HPA051308: AB_2681435"																		0.1	0.1	0.5	0.1	0.5	0.7	0.2	0.9	0.8	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.5	0.9	0.8	0.4	0.0	0.2	0.2	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"kidney: 5.0"	"Cell type enriched"	"Detected in single"	8	"Proximal tubular cells: 4.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052019	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052019: AB_2681696"													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2V1	"OR2V1P, OST265"	ENSG00000185372	"Olfactory receptor family 2 subfamily V member 1"	Q8NHB1	5	181123122-181131169	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"liver: 1.6;retina: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA049953	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"					"HPA049953: AB_2680971"																		0.1	0.0	0.4	0.1	0.4	0.3	0.4	0.8	0.8	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.7	0.6	0.1	1.6	0.1	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.8	0.8	0.7	0.6	0.4	0.2	0.3	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2V2	"OR2V3, OST713"	ENSG00000182613	"Olfactory receptor family 2 subfamily V member 2"	Q96R30	5	181147586-181159285	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049953	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"						"HPA049953: AB_2680971"																		0.1	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.0;brain: 6.1;thyroid gland: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.5;K-562: 4.1;PC-3: 13.2;U-2 OS: 8.4;U-937: 6.3;WM-115: 9.4"					"Not detected"	"Not detected"			HPA045594	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"				"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.3	0.6	1.1	0.4	1.1	13.0	0.2	0.0	1.5	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.8	0.1	0.1	1.2	4.3	0.1	0.1	0.5	0.1	3.0	3.1	0.0	0.3	0.0	0.2	1.3	3.9	0.5	0.6	0.3	0.1	0.2	0.0	0.4	0.2	0.5	0.8	1.0	0.2	1.2	6.1	0.1	6.3	0.9	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.3	13.5	0.0	0.0	0.0	1.7	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	13.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.3	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.1	1.1	0.0	1.5	1.2	4.3	3.0	3.1	3.9	0.8	6.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2Z1	OR2Z2	ENSG00000181733	"Olfactory receptor family 2 subfamily Z member 1"	Q8NG97	19	8721634-8732160	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048760	Uncertain					NA	NA									"HPA048760: AB_2680513"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4A47		ENSG00000237388	"Olfactory receptor family 4 subfamily A member 47"	Q6IF82	11	48488717-48489780	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059763	Uncertain					NA	NA									"HPA059763: AB_2684122"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4B1	OST208	ENSG00000175619	"Olfactory receptor family 4 subfamily B member 1"	Q8NGF8	11	48216810-48217739	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059443	Uncertain					NA	NA									"HPA059443: AB_2684019"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4C15		ENSG00000181939	"Olfactory receptor family 4 subfamily C member 15"	Q8NGM1	11	55554307-55555419	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA061939	Uncertain					NA	NA									"HPA061939: AB_2684643"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4C5	"OR4C5P, OR4C5Q"	ENSG00000176540	"Olfactory receptor family 4 subfamily C member 5"	Q8NGB2	11	48365485-48366465	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049516	Uncertain					NA	NA									"HPA049516: AB_2680800"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4D5		ENSG00000171014	"Olfactory receptor family 4 subfamily D member 5"	Q8NGN0	11	123939543-123940637	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045005	Uncertain					NA	NA									"HPA045005: AB_10959302"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F16		ENSG00000284662	"Olfactory receptor family 4 subfamily F member 16"	Q6IEY1	1	685679-686673	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain					NA	NA									"HPA047705: AB_2680125"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F21	OR4F21P	ENSG00000176269	"Olfactory receptor family 4 subfamily F member 21"	O95013	8	166086-167024	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"BEWO: 1.0"									HPA047705	Uncertain					NA	NA					"Cluster 28: BEWO - Transcription regulation"				"HPA047705: AB_2680125"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F29		ENSG00000284733	"Olfactory receptor family 4 subfamily F member 29"	Q6IEY1	1	450740-451678	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain					NA	NA									"HPA047705: AB_2680125"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F3		ENSG00000230178	"Olfactory receptor family 4 subfamily F member 3"	Q6IEY1	5	181367268-181368262	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain					NA	NA									"HPA047705: AB_2680125"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4K1		ENSG00000155249	"Olfactory receptor family 4 subfamily K member 1"	Q8NGD4	14	19930917-19936757	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028877	Uncertain					NA	NA									"HPA028877: AB_10600923"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4K15	OR4K15Q	ENSG00000169488	"Olfactory receptor family 4 subfamily K member 15"	Q8NH41	14	19975444-19976659	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055732	Uncertain					NA	NA									"HPA055732: AB_2682900"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4M1		ENSG00000176299	"Olfactory receptor family 4 subfamily M member 1"	Q8NGD0	14	19773504-19783696	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 48.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058889	Uncertain					NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4M2		ENSG00000274102	"Olfactory receptor family 4 subfamily M member 2"	Q8NGB6	15	22070241-22083221	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain					NA	NA						"Cluster 48: Smooth muscle cells - ECM organization"			"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4M2B		ENSG00000182974	"Olfactory receptor family 4 subfamily M member 2B"		15	21637909-21638992	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain					NA	NA									"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4N4		ENSG00000183706	"Olfactory receptor family 4 subfamily N member 4"	Q8N0Y3	15	22094522-22095472	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	81	"testis: 8.0"	"Group enriched"	"Detected in some"	113	"Early spermatids: 29.9;Late spermatids: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA057442: AB_2683442"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4N4C		ENSG00000279408	"Olfactory receptor family 4 subfamily N member 4C"		15	21651844-21652968	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Centrosome		"HPA057442: AB_2683442"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4P4	OR4P3P	ENSG00000181927	"Olfactory receptor family 4 subfamily P member 4"	Q8NGL7	11	55635113-55640309	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA059458	Uncertain					NA	NA									"HPA059458: AB_2684027"																		0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4Q3	"C14orf13, OR4Q4"	ENSG00000182652	"Olfactory receptor family 4 subfamily Q member 3"		14	19743571-19749469	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049924	Uncertain					NA	NA									"HPA049924: AB_2680955"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51A7		ENSG00000176895	"Olfactory receptor family 51 subfamily A member 7"	Q8NH64	11	4903783-4909462	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061356	Uncertain					NA	NA									"HPA061356: AB_2684488"												"unprognostic (4.57e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51B5		ENSG00000167355	"Olfactory receptor family 51 subfamily B member 5"	Q9H339	11	5303444-5505652	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Astrocytes: 10.1;Excitatory neurons: 5.7;Microglial cells: 21.5;Oligodendrocyte precursor cells: 6.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 4.1;U-2197: 1.1"					"Low region specificity"	"Detected in many"			HPA063124	Uncertain					NA	NA					"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA063124: AB_2684943"	"unprognostic (9.22e-3)"				"unprognostic (1.80e-1)"		"unprognostic (2.01e-1)"	"unprognostic (3.76e-2)"		"unprognostic (4.75e-1)"		"unprognostic (1.36e-1)"	"unprognostic (7.37e-5)"	"unprognostic (2.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.71e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.5	0.0	0.0	0.0	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0
OR51D1	OR51D1Q	ENSG00000197428	"Olfactory receptor family 51 subfamily D member 1"	Q8NGF3	11	4637477-4643060	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061240	Uncertain					NA	NA						"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061240: AB_2684457"												"unprognostic (1.90e-1)"						0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.3	0.5	0.4	0.5	0.4	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51E1	"GPR136, GPR164, OR51E1P, OR52A3P"	ENSG00000180785	"Olfactory receptor family 51 subfamily E member 1"	Q8TCB6	11	4643420-4655488	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.7;placenta: 7.4;prostate: 6.6"	"Group enriched"	"Detected in some"	7	"Adipocytes: 44.1;Enteroendocrine cells: 21.3;Sertoli cells: 26.3;Smooth muscle cells: 31.8"	"Cancer enriched"	"Detected in many"	21	"prostate cancer: 34.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	107	"SCLC-21H: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB019995, HPA051439"	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB019995: AB_10283600, HPA051439: AB_2681487"	"unprognostic (6.67e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.71e-2)"	"unprognostic (4.87e-5)"	"unprognostic (3.55e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.36e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.23e-6)"	"unprognostic (2.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	5.7	0.0	0.2	0.7	0.2	0.0	2.4	0.2	0.4	0.5	0.2	1.7	0.4	0.9	0.3	0.1	0.6	0.5	4.6	0.2	0.2	0.7	0.0	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.5	7.4	0.2	6.6	0.8	0.0	0.2	0.5	2.1	0.2	1.3	1.0	0.2	0.1	0.7	0.2	0.2	0.0	0.5	3.9	0.2	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	44.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.3	4.1	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	3.4	0.1	0.0	0.0	0.0	26.3	0.7	31.8	0.0	0.2	0.1	0.3	0.0	0.1	0.8	0.1	0.2
OR51M1		ENSG00000184698	"Olfactory receptor family 51 subfamily M member 1"	Q9H341	11	5383812-5393263	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056773	Uncertain					NA	NA						"Cluster 11: Alveolar cells - Smell perception"			"HPA056773: AB_2683233"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.3	3.2	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51Q1		ENSG00000167360	"Olfactory receptor family 51 subfamily Q member 1"	Q8NH59	11	5422111-5423206	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"RT4: 2.8"	"Not detected"	"Not detected"							HPA044998	Uncertain					NA	NA					"Cluster 15: RT4 - Unknown function"				"HPA044998: AB_10794780"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51T1		ENSG00000176900	"Olfactory receptor family 51 subfamily T member 1"	Q8NGJ9	11	4881819-4882883	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046877	Uncertain					NA	NA									"HPA046877: AB_2679853"												"unprognostic (2.59e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52D1		ENSG00000181609	"Olfactory receptor family 52 subfamily D member 1"	Q9H346	11	5488685-5489749	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.1"	HPA046965	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"HPA046965: AB_2679878"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52E2		ENSG00000176787	"Olfactory receptor family 52 subfamily E member 2"	Q8NGJ4	11	5058650-5059627	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045748	Uncertain					NA	NA									"HPA045748: AB_10959665"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52I2		ENSG00000226288	"Olfactory receptor family 52 subfamily I member 2"	Q8NH67	11	4581743-4593340	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049343	Uncertain					NA	NA									"HPA049343: AB_2680721"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52N1		ENSG00000181001	"Olfactory receptor family 52 subfamily N member 1"	Q8NH53	11	5786471-5791265	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA054028	Uncertain					NA	NA						"Cluster 60: Granulocytes - Receptor signaling"			"HPA054028: AB_2682348"																		0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.4	0.2	0.1	0.4	0.1	0.2	0.4	0.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OR56B1	OR56B1P	ENSG00000181023	"Olfactory receptor family 56 subfamily B member 1"	Q8NGI3	11	5736448-5738523	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045043	Uncertain					NA	NA						"Cluster 32: Non-specific - Translation"			"HPA045043: AB_10794296"																		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
OR5A2		ENSG00000172324	"Olfactory receptor family 5 subfamily A member 2"	Q8NGI9	11	59416969-59426413	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047135, HPA049575"	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"				"HPA047135: AB_2679948, HPA049575: AB_2680820"																		0.2	0.2	0.8	0.3	0.6	0.8	0.2	1.7	1.1	0.1	0.0	0.2	0.3	0.4	0.4	0.1	0.2	0.2	0.2	0.7	1.2	0.2	0.3	0.2	0.4	0.6	0.2	0.2	0.3	0.1	0.0	0.1	0.7	0.2	0.2	1.1	0.3	0.2	0.4	0.5	0.4	0.1	0.1	0.5	0.2	0.5	0.7	0.2	0.3	0.1	0.2	0.1	0.0	1.2	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.3	0.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	0.0	0.2	0.6	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.3	0.7	0.0	0.2	0.2	0.3	0.5	0.1	0.1	0.5	0.3	0.2	0.1	0.3	0.3	0.1	0.2	0.1	0.4	0.4	0.2	0.2	0.3	0.1	0.3	0.4	0.1	0.6	0.4	0.2	0.2	0.6	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.8	0.6	1.7	1.1	0.7	1.2	0.6	0.2	0.7	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5D16		ENSG00000205029	"Olfactory receptor family 5 subfamily D member 16"	Q8NGK9	11	55838752-55839738	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA046711	Uncertain					NA	NA									"HPA046711: AB_2679766"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5F1	OR11-10	ENSG00000149133	"Olfactory receptor family 5 subfamily F member 1"	O95221	11	55993681-55994625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA059360	Uncertain					NA	NA									"HPA059360: AB_2683990"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5J2		ENSG00000174957	"Olfactory receptor family 5 subfamily J member 2"	Q8NH18	11	56176618-56177556	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA059466	Uncertain					NA	NA									"HPA059466: AB_2684029"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5L1	OST262	ENSG00000279395	"Olfactory receptor family 5 subfamily L member 1"	Q8NGL2	11	55811367-55812476	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047524	Uncertain					NA	NA									"HPA047524: AB_2680076"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5L2	"HSHTPCRX16, HTPCRX16"	ENSG00000205030	"Olfactory receptor family 5 subfamily L member 2"	Q8NGL0	11	55827219-55828154	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047524	Uncertain					NA	NA									"HPA047524: AB_2680076"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5P3	JCG1	ENSG00000182334	"Olfactory receptor family 5 subfamily P member 3"	Q8WZ94	11	7824818-7830840	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060787	Uncertain					NA	NA						"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA060787: AB_2684364"																	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
OR5T1	OR5T1P	ENSG00000181698	"Olfactory receptor family 5 subfamily T member 1"	Q8NG75	11	56274154-56276819	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050952	Uncertain					NA	NA									"HPA050952: AB_2681287"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5V1	hs6M1-21	ENSG00000243729	"Olfactory receptor family 5 subfamily V member 1"	Q9UGF6	6	29353749-29431967	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"Early spermatids: 17.3;Late spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.3"	"Not detected"	"Not detected"			HPA046707	Uncertain					NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA046707: AB_2679763"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B1	OR7-3	ENSG00000221813	"Olfactory receptor family 6 subfamily B member 1"	O95007	7	144000320-144008793	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.5"	"Not detected"	"Not detected"							HPA053164	Uncertain					NA	NA					"Cluster 2: Karpas-707 - Immune response"				"HPA053164: AB_2682065"																		0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B2	OR6B2P	ENSG00000182083	"Olfactory receptor family 6 subfamily B member 2"	Q6IFH4	2	240028965-240030456	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA							"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B3	"OR6B3P, OR6B3Q"	ENSG00000178586	"Olfactory receptor family 6 subfamily B member 3"	Q8NGW1	2	240045077-240047027	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"retina: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6C6		ENSG00000188324	"Olfactory receptor family 6 subfamily C member 6"	A6NF89	12	55293988-55296569	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA051090	Uncertain		Approved	"Lipid droplets,Plasma membrane"		NA	NA						"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Lipid droplets, Plasma membrane"		"HPA051090: AB_2681341"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6K3		ENSG00000203757	"Olfactory receptor family 6 subfamily K member 3"	Q8NGY3	1	158716327-158720720	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"bone marrow: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	21	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055949	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"					"HPA055949: AB_2682982"																		0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6M1		ENSG00000196099	"Olfactory receptor family 6 subfamily M member 1"	Q8NGM8	11	123805335-123806387	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048674	Uncertain					NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"			"HPA048674: AB_2680489"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6N2		ENSG00000188340	"Olfactory receptor family 6 subfamily N member 2"	Q8NGY6	1	158774222-158781204	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"bone marrow: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056637	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"					"HPA056637: AB_2683198"																		0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6P1		ENSG00000186440	"Olfactory receptor family 6 subfamily P member 1"	Q8NGX9	1	158560606-158570580	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047466	Uncertain					NA	NA									"HPA047466: AB_10963091"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6T1		ENSG00000181499	"Olfactory receptor family 6 subfamily T member 1"	Q8NGN1	11	123942785-123943873	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060893	Uncertain					NA	NA									"HPA060893: AB_2684380"	"unprognostic (9.30e-4)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR7A5	HTPCR2	ENSG00000188269	"Olfactory receptor family 7 subfamily A member 5"	Q15622	19	14826241-14835185	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;epididymis: 4.5;parathyroid gland: 7.0"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.3"	"Cancer enriched"	"Detected in single"	8	"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053823	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA053823: AB_2682274"	"unprognostic (3.26e-4)"	"unprognostic (1.44e-1)"		"unprognostic (7.46e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.89e-2)"		"unprognostic (1.49e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.01e-7)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.47e-3)"	0.0	0.1	0.8	0.0	2.7	0.0	0.7	2.7	2.0	0.1	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	3.0	1.8	0.0	0.0	7.0	1.3	0.0	3.3	0.5	0.0	0.0	0.2	0.6	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	2.7	2.0	0.9	1.5	3.0	1.8	3.3	0.9	2.5	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2
OR7C1	"OR19-5, OR7C4"	ENSG00000127530	"Olfactory receptor family 7 subfamily C member 1"	O76099	19	14789260-14835376	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 6.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.2;Club cells: 2.5;Glandular and luminal cells: 1.4;granulocytes: 1.3;Melanocytes: 1.8;Respiratory ciliated cells: 1.5"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA047127	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 11: Alveolar cells - Smell perception"			"HPA047127: AB_2679944"	"unprognostic (7.68e-4)"	"unprognostic (1.31e-1)"			"unprognostic (2.13e-1)"	"unprognostic (1.71e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.39e-1)"			"unprognostic (4.30e-2)"	"unprognostic (6.11e-4)"		"unprognostic (1.90e-1)"	"unprognostic (6.80e-2)"	"unprognostic (6.91e-2)"	0.1	0.7	0.3	0.2	0.3	0.6	0.4	0.7	0.6	0.1	0.2	0.0	0.2	0.1	1.8	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	6.0	1.7	0.1	0.5	0.8	0.0	0.5	0.2	0.8	1.3	0.8	0.1	0.0	0.0	0.2	0.1	1.9	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.9	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.3	0.3	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.6	0.1	0.5	0.1	0.0	0.1	0.3	0.3	0.7	0.6	0.3	0.2	0.3	0.2	0.5	0.0	0.3	0.9	0.1	0.0	3.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1
OR7C2	"OR19-18, OR7C3"	ENSG00000127529	"Olfactory receptor family 7 subfamily C member 2"	O60412	19	14941489-14942448	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047295	Uncertain					NA	NA									"HPA047295: AB_2680013"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8D1	"OR8D3, OST004"	ENSG00000196341	"Olfactory receptor family 8 subfamily D member 1"	Q8WZ84	11	124302831-124315099	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA059510	Uncertain					NA	NA									"HPA059510: AB_2684045"																		0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8K1		ENSG00000150261	"Olfactory receptor family 8 subfamily K member 1"	Q8NGG5	11	56345945-56347031	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055233	Uncertain					NA	NA									"HPA055233: AB_2682749"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Spermatocytes: 4.0;Spermatogonia: 1.8"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"		NA	NA						"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"		"HPA045595: AB_10964447"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR9K2		ENSG00000170605	"Olfactory receptor family 9 subfamily K member 2"	Q8NGE7	12	55126406-55132750	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA015808	Uncertain					NA	NA									"HPA015808: AB_2669306"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.3;NK-cells: 88.6;Theca cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016583	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016583: AB_1848720"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	10.8	5.4	4.4	9.6	4.6	8.8	10.9	5.2	6.8	7.3	22.1	10.6	20.8	7.6	0.0	8.7	7.7	3.3	9.3	3.8	4.9	11.2	12.3	15.5	12.0	5.5	4.9	6.7	8.1	8.7	2.6	4.5	5.5	6.4	0.3	0.0	15.6	2.6	60.1	46.6	13.8	2.2	5.4	23.1	12.5	11.5	5.1	6.1	10.4	14.0	2.8	11.1	7.8	5.1	18.3	42.0	3.4	16.9	4.0	4.9	18.4	20.5	2.9	8.8	4.7	33.1	16.2	13.3	31.4	3.1	11.8	30.2	3.4	13.7	0.0	41.9	7.8	23.9	6.8	16.6	10.1	18.5	43.7	2.0	5.1	14.4	0.9	4.9	12.9	30.0	16.8	6.9	2.3	41.4	46.1	81.7	19.6	10.3	35.7	16.8	7.9	20.5	5.0	13.4	16.4	3.3	10.7	11.7	17.5	0.2	29.3	11.6	23.5	21.0	8.4	28.6	15.9	9.4	8.7	5.6	15.7	25.9	19.1	9.4	6.3	8.2	18.6	5.4	13.9	6.3	15.4	18.8	7.5	9.0	14.3	12.5	6.9	7.5	5.2	1.9	13.7	7.6	4.4	4.6	5.2	6.8	3.8	4.9	5.5	4.9	5.5	5.4	5.1	5.1	32.0	28.9	16.4	1.0	41.0	22.6	10.1	3.4	6.8	2.1	48.4	22.9	4.2	18.6	10.3	1.8	4.2	3.7	92.3	8.4	1.9	13.3	3.4	14.1	11.1	40.6	2.4	23.8	0.3	19.5	15.2	9.5	8.6	17.4	7.0	24.0	43.2	17.9	38.6	0.0	0.5	9.3	2.0	28.2	65.0	11.8	13.4	42.8	21.4	4.7	27.2	5.8	88.6	3.0	1.5	29.5	6.3	9.4	30.5	14.8	17.2	12.1	6.3	6.9	0.0	6.3	10.8	1.7	6.0	6.9	37.4	7.8	70.3	86.0	20.1	10.7
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 140.4;Endometrial ciliated cells: 77.2;Glandular and luminal cells: 76.9;Plasma cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 149.0;RPMI-8226: 160.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"	8.8	10.7	18.7	30.9	13.7	39.4	7.2	16.5	21.2	8.0	25.3	7.1	7.9	11.9	6.9	3.3	10.6	9.4	4.4	24.4	26.2	13.5	2.1	9.9	31.0	21.0	20.0	6.0	7.1	39.6	38.9	5.5	24.5	6.8	3.9	3.3	7.3	9.4	1.4	2.5	17.8	6.4	13.7	27.7	11.3	3.0	27.5	12.0	16.0	1.6	22.1	10.7	3.8	12.2	22.1	52.2	20.0	38.3	17.2	17.2	1.3	21.4	24.3	24.6	20.7	28.9	24.1	149.0	59.7	38.9	47.9	8.8	7.6	6.2	8.6	17.1	11.7	23.0	24.2	9.1	26.1	56.6	29.2	16.2	3.6	39.4	5.8	24.4	39.6	21.3	27.8	130.7	18.1	44.9	77.4	25.1	23.8	8.1	18.6	33.0	15.3	160.8	14.4	18.0	32.1	78.5	20.5	9.4	11.8	10.2	13.3	22.7	36.3	57.0	55.5	39.3	29.9	115.9	94.8	116.4	40.6	30.8	28.5	13.2	6.8	75.9	4.9	5.8	5.1	29.2	4.1	3.6	3.9	29.4	2.6	3.2	58.9	18.3	3.3	6.4	2.4	7.0	18.7	13.7	16.5	21.2	24.4	26.2	21.0	20.0	24.5	13.7	27.5	12.2	29.0	3.2	9.6	5.2	140.4	4.0	9.7	5.3	5.2	33.5	10.0	6.7	4.2	8.6	11.1	16.5	66.7	1.3	55.4	1.0	5.9	20.9	3.6	77.2	39.8	27.0	17.3	27.1	13.2	11.6	1.6	13.9	1.5	76.9	26.0	14.9	23.9	0.7	14.9	43.7	14.7	2.4	2.0	19.1	12.5	7.4	8.1	33.0	10.6	7.5	37.6	12.1	39.1	7.1	1.2	10.7	0.3	10.1	76.3	10.3	0.2	8.9	31.2	19.1	0.0	17.9	15.2	5.3	9.1	1.2	3.1	3.0	28.8	12.8	2.0	7.0
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949068-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.3;Hofbauer cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 94.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	17.3	34.1	18.0	8.2	16.5	17.6	15.2	16.9	17.1	24.4	26.0	22.7	9.2	18.3	16.3	15.4	19.2	9.9	16.7	15.3	16.3	19.3	70.2	14.2	11.9	18.6	18.5	18.9	17.7	18.9	18.0	14.9	17.1	26.3	8.6	4.0	14.6	17.0	7.9	14.3	16.1	9.8	17.4	22.5	17.1	15.6	20.5	11.2	16.4	8.1	10.6	27.2	20.2	17.7	2.8	15.8	8.1	10.7	68.1	60.7	0.6	9.3	62.3	6.8	17.2	1.5	26.1	3.9	20.7	17.9	27.5	12.7	1.4	17.6	4.6	12.3	5.2	10.2	4.9	16.1	94.9	11.2	30.5	65.5	45.9	13.1	25.5	63.8	11.7	2.2	11.7	20.6	22.1	10.8	0.7	42.6	6.6	9.1	4.3	8.6	6.3	30.8	26.2	6.8	2.0	13.5	8.4	2.6	14.9	19.5	19.7	45.5	8.5	5.1	3.5	11.4	2.2	50.4	4.0	3.1	25.3	26.4	7.9	23.2	8.7	26.6	3.4	9.2	3.6	7.1	1.8	2.7	8.5	6.7	2.2	2.9	15.3	11.7	12.6	9.5	2.7	3.3	18.0	16.5	16.9	17.1	15.3	16.3	18.6	18.5	17.1	17.4	20.5	17.7	12.1	6.4	10.8	0.0	23.9	7.9	24.5	25.6	32.5	1.5	11.1	19.6	6.9	5.7	11.6	16.5	2.1	28.1	25.9	11.1	13.7	21.4	61.1	16.5	21.8	16.5	15.0	16.2	0.0	11.4	2.7	25.9	4.1	10.5	7.0	17.9	23.6	77.3	93.8	35.3	0.0	11.3	10.2	43.7	11.5	36.7	53.1	31.4	21.4	0.0	39.1	24.4	17.5	0.0	0.0	9.5	18.4	43.2	18.1	14.0	9.5	48.2	14.7	3.6	26.3	11.0	14.0	26.5	2.5	17.0	4.5	4.4	9.7	61.0	5.8	20.4
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404423	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 29.0;lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.4	0.6	0.2	3.5	0.1	29.0	1.1	0.6	0.2	0.6	0.0	3.4	1.7	0.6	0.1	2.7	0.3	0.4	0.2	0.1	0.2	0.5	0.6	0.6	6.7	0.3	0.0	0.5	0.3	0.3	0.3	1.9	0.2	0.4	4.0	1.0	0.6	0.1	0.5	2.0	2.3	0.9	0.0	2.0	1.0	5.2	0.2	11.6	0.3	0.1	7.7	0.9	1.0	0.3	19.3	20.8	33.0	21.7	0.8	2.7	31.8	13.5	12.2	38.9	40.0	25.8	10.7	44.2	11.6	8.5	17.8	25.9	48.9	16.9	33.8	19.0	28.1	53.2	30.2	25.8	0.2	71.9	29.2	1.4	0.8	38.1	4.3	2.7	11.7	27.6	63.0	20.9	12.8	14.4	56.9	34.0	73.1	11.7	29.5	60.2	51.3	43.1	6.8	25.0	18.5	15.6	31.0	18.8	10.3	30.5	10.2	28.7	5.4	15.8	22.5	24.9	34.0	10.9	31.1	54.4	15.6	52.6	19.5	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.4	0.4	0.6	0.8	0.1	0.3	0.4	3.4	0.2	0.0	1.2	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.3	0.0	0.2	0.0	0.2	0.3	0.6	0.0	0.0	0.3	1.7	0.9	0.3	0.4	1.2	0.7	0.7	1.1	0.5	0.0	0.1	0.0	0.0	5.5	0.7	1.2	0.0	0.3	5.6	0.5	0.6	0.5	0.0	14.1	0.7	0.2	9.9	0.7	0.5	0.6	0.0	2.8	0.0	0.2	2.9	0.0	0.7	1.3	0.0	0.3	0.4	3.8	0.6	0.6	0.0	1.0	0.3	0.2	0.0	0.5	0.5	0.2	0.8	0.4	6.3	0.2	0.2	3.9	0.1	0.9	0.0	0.6	0.7	4.1	6.5	2.5	1.1	1.8	1.1	0.9	3.7	0.4
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.9	4.9	2.8	6.7	3.1	5.7	8.0	7.6	4.6	5.8	4.6	7.2	9.1	6.0	6.0	5.8	5.1	4.3	8.8	2.7	3.3	5.6	5.2	4.9	8.5	2.4	2.6	6.8	6.9	7.2	5.1	5.6	2.6	6.4	6.8	7.8	7.1	5.8	6.7	8.4	7.7	4.8	1.4	6.5	7.0	20.8	2.6	9.4	8.3	6.0	8.4	5.4	5.8	5.0	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.8	3.1	7.6	4.6	2.7	3.3	2.4	2.6	2.6	1.4	2.6	5.0	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039553: AB_2676566, HPA053748: AB_2682247"	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	11.8	17.9	13.5	9.8	14.0	8.8	15.8	18.3	17.9	11.1	11.1	10.0	6.8	13.6	16.3	9.0	15.3	9.5	20.3	14.0	13.6	14.5	15.8	10.8	13.8	14.2	12.7	20.1	9.6	19.4	13.2	12.7	13.9	12.3	10.6	33.8	9.0	11.5	21.7	10.6	8.8	10.9	14.3	10.8	8.4	25.8	13.5	20.5	16.1	20.5	13.2	10.8	9.5	17.0	16.5	22.9	39.1	30.6	31.0	32.2	29.4	32.9	30.4	38.5	53.0	31.6	20.0	32.3	44.6	22.9	33.0	28.5	45.1	27.3	52.4	40.6	31.3	30.8	30.5	33.3	16.9	34.6	9.7	29.6	20.1	43.5	38.6	21.4	23.7	34.2	71.5	33.8	37.5	22.2	13.7	18.4	28.5	24.3	24.3	33.5	53.5	20.4	30.8	24.6	27.8	20.4	25.9	15.7	26.2	41.4	20.9	29.9	19.6	19.1	18.5	39.1	39.7	16.1	38.0	22.4	25.3	34.7	29.9	22.5	10.1	11.5	12.6	17.1	18.7	17.7	17.7	15.7	8.6	15.2	21.9	18.5	7.0	19.4	22.4	11.0	18.8	12.7	13.5	14.0	18.3	17.9	14.0	13.6	14.2	12.7	13.9	14.3	13.5	17.0	17.8	12.8	13.4	36.2	21.6	5.0	11.0	16.0	5.7	18.7	9.2	11.0	36.3	11.5	15.7	7.3	12.5	23.4	13.6	14.2	21.5	10.8	61.2	21.2	19.8	10.9	10.3	12.0	56.2	10.3	24.5	17.5	11.7	15.1	12.0	23.7	12.1	9.5	20.0	6.7	68.0	12.5	10.2	8.8	3.9	26.7	18.6	13.1	8.8	37.5	12.4	20.2	10.3	41.7	44.8	10.5	12.1	15.4	23.9	10.0	58.3	31.4	21.4	28.1	13.1	21.6	17.1	67.8	34.6	8.7	4.4	14.6	17.0	20.0	14.2	8.3
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930396-148021604	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	9.7	11.2	11.5	10.1	13.1	19.3	14.6	21.6	16.3	9.0	8.7	12.6	12.0	12.0	11.0	10.6	14.2	9.7	11.6	12.8	10.8	20.5	12.8	9.3	10.9	9.6	7.9	16.7	8.2	16.2	7.6	10.1	10.0	12.1	13.8	19.7	13.4	10.3	15.0	9.3	11.4	11.5	7.6	8.9	9.4	15.5	10.9	15.7	15.6	10.9	11.9	10.2	6.6	14.4	22.8	19.3	37.2	20.4	14.2	13.9	39.9	25.2	21.3	31.3	31.0	47.9	22.6	29.3	26.8	15.1	27.7	22.4	43.4	25.2	32.4	20.6	36.1	40.2	19.0	32.8	18.8	25.9	14.5	11.9	29.4	34.0	13.9	23.3	21.4	27.5	38.8	14.9	21.2	23.8	20.1	20.9	42.3	18.9	28.0	21.6	24.9	26.5	34.5	46.3	35.0	27.4	22.6	24.7	30.1	33.6	18.9	12.2	15.5	23.5	23.2	17.3	23.4	14.7	37.9	27.5	19.1	20.0	14.6	24.1	13.1	18.3	13.6	17.5	13.9	14.1	12.9	13.9	16.4	14.5	13.4	13.5	18.8	19.3	14.0	8.3	15.1	11.7	11.5	13.1	21.6	16.3	12.8	10.8	9.6	7.9	10.0	7.6	10.9	14.4	21.5	83.3	62.5	53.5	26.0	26.0	21.8	47.1	27.3	48.7	20.3	24.0	25.9	11.5	66.1	12.9	39.6	40.3	27.3	21.7	45.0	31.6	34.0	47.9	17.6	23.8	22.9	46.5	88.4	17.2	48.2	27.7	14.3	26.1	45.5	28.3	19.2	17.1	23.8	53.8	91.4	18.9	28.5	18.8	20.7	15.7	22.4	19.7	21.4	34.7	22.0	33.8	24.7	69.9	71.3	18.3	15.4	21.4	12.8	24.4	23.2	55.4	85.8	37.5	32.9	23.2	31.5	61.2	26.8	22.6	24.9	32.7	25.6	16.9	21.8	20.6
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;lymphoid tissue: 7.4;testis: 9.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.3	0.7	2.0	2.2	1.6	10.3	0.6	1.5	1.9	0.7	1.0	1.7	1.5	0.8	1.1	4.1	0.4	0.6	1.5	1.9	1.8	0.4	0.9	0.6	7.4	1.5	1.9	0.4	0.3	0.7	0.6	3.3	1.7	0.3	1.9	0.3	0.7	0.2	0.1	1.1	1.5	1.0	1.6	2.4	0.8	9.6	1.8	6.2	0.5	0.3	7.3	1.2	1.3	1.8	28.6	27.4	43.7	33.9	5.4	6.8	31.6	54.2	20.2	59.3	30.9	39.3	18.0	35.6	27.1	10.5	29.1	29.9	57.9	15.1	50.4	17.2	46.4	27.9	13.2	40.1	6.6	46.5	23.7	1.8	2.6	32.4	17.1	9.3	20.0	30.1	36.0	17.4	35.9	26.9	65.6	60.7	48.1	20.7	76.0	78.6	80.6	35.8	14.9	9.8	52.2	30.4	24.5	29.8	18.1	34.9	15.6	37.9	11.6	53.7	34.6	33.6	51.8	12.5	18.9	123.2	22.2	29.5	40.1	0.0	0.3	0.3	0.9	0.7	0.4	0.7	0.5	0.5	0.6	1.4	0.8	0.3	0.0	0.8	0.8	1.0	1.2	0.7	2.0	1.6	1.5	1.9	1.9	1.8	1.5	1.9	1.7	1.6	1.8	1.8	1.6	3.2	14.5	1.0	8.8	6.6	2.2	3.6	8.6	6.6	4.1	5.8	3.7	1.5	6.3	5.5	4.2	39.3	6.0	9.5	1.9	2.5	13.2	6.5	7.5	4.3	1.8	45.4	6.3	0.7	40.9	8.0	7.1	9.4	1.3	56.7	0.7	9.9	15.7	11.8	2.7	12.4	6.1	3.8	11.9	8.9	2.8	7.7	33.8	2.8	1.2	2.5	2.1	0.0	2.0	2.1	1.4	3.4	18.5	2.6	2.3	1.0	10.7	10.2	0.0	5.1	7.3	102.6	108.9	16.9	6.0	10.9	7.5	47.5	14.4	2.7
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	193	"liver: 42973.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	13.4	10.3	0.1	12.7	0.3	223.1	6.6	0.0	0.4	2.7	0.2	1.5	0.1	2.7	0.3	1.9	1.9	1.0	3.4	0.2	0.2	4.9	42973.6	24.4	0.7	0.4	0.2	1.6	8.1	0.0	1.4	1.3	0.1	57.6	0.0	1.1	1.4	0.0	2.0	1.7	2.3	0.3	0.2	51.3	19.2	2.7	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.1	0.3	0.0	0.4	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8873.2"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	4.0	4.0	0.2	3.2	0.4	27.1	3.0	0.0	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.8	0.1	0.1	1.7	8873.2	5.8	1.1	0.2	0.3	0.3	2.1	0.0	0.2	0.2	0.1	23.6	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.2	7.3	21.9	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9 endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 3551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		10000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	151.0	93.0	61.1	118.6	59.3	149.0	113.4	60.7	60.8	135.6	94.3	158.1	149.9	101.2	141.4	105.2	109.6	106.2	111.0	58.4	71.5	114.8	264.5	130.0	89.7	64.5	62.8	124.6	270.0	171.6	71.5	141.3	63.5	116.4	132.6	75.5	189.0	102.1	59.6	119.8	143.2	110.2	60.8	106.0	137.2	38.9	66.7	72.6	129.4	65.5	94.2	119.7	103.5	63.7	86.8	170.8	86.2	214.4	440.4	295.6	190.5	211.9	268.4	153.4	154.6	180.2	274.5	110.0	345.3	255.2	118.5	152.9	81.3	137.5	121.2	142.0	97.6	124.0	115.3	164.8	287.1	196.9	307.3	273.7	217.6	150.7	152.6	529.4	258.6	71.7	96.0	427.9	162.2	149.5	53.7	239.7	97.7	172.0	121.2	69.8	3551.9	281.5	116.5	210.6	88.4	116.4	300.3	205.5	176.6	158.1	245.4	381.0	238.9	206.0	122.3	140.4	136.4	253.4	234.6	112.9	173.8	141.6	290.4	175.7	241.2	274.6	72.9	213.0	68.5	50.5	61.1	65.0	172.6	54.3	46.8	54.1	246.4	58.8	182.4	149.0	74.4	218.9	61.1	59.3	60.7	60.8	58.4	71.5	64.5	62.8	63.5	60.8	66.7	63.7	83.3	86.6	116.7	22.2	65.8	57.7	85.4	103.3	43.9	44.1	61.2	46.6	14.1	80.1	111.8	73.5	77.2	142.4	64.5	153.0	9.8	144.8	6.7	34.0	73.3	90.2	103.6	53.4	19.5	110.1	124.6	113.6	65.7	60.0	91.1	61.6	81.4	161.1	144.8	50.5	27.0	167.3	107.8	121.1	99.1	10.7	113.4	106.1	119.2	29.0	125.0	87.2	53.5	23.6	24.4	94.7	155.4	79.0	141.1	56.5	154.0	53.9	74.0	50.9	92.1	68.3	66.9	38.1	46.4	51.3	51.6	197.7	59.5	64.9	102.4	65.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59615774	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		70000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	19.6	41.7	14.1	15.5	15.2	27.2	27.4	15.3	18.9	24.7	18.4	26.8	29.4	20.0	31.6	19.6	22.4	19.5	25.5	15.0	15.6	42.8	57.6	18.5	17.8	15.4	16.7	22.4	37.3	44.9	16.1	22.9	16.7	25.9	28.3	15.9	30.1	27.0	57.7	26.6	25.5	21.2	14.0	15.6	27.8	18.0	15.7	24.0	32.3	43.8	23.7	19.6	17.1	15.1	40.9	33.6	24.7	33.2	56.5	52.4	26.8	32.9	42.3	38.4	34.4	38.1	40.2	41.1	42.7	37.9	47.2	41.4	45.4	43.5	43.0	40.0	20.9	28.1	25.1	25.8	60.2	36.2	52.9	40.4	52.8	36.2	94.4	40.0	41.7	38.3	48.6	37.3	34.5	19.0	34.0	26.2	28.0	59.5	32.7	32.5	39.8	28.6	45.6	47.0	28.5	20.3	38.6	47.7	46.0	33.6	66.9	22.7	45.8	32.7	22.8	49.5	22.3	51.9	45.2	41.4	37.0	25.6	26.8	1.7	1.6	1.5	2.8	1.4	2.6	2.2	2.9	2.3	1.6	1.6	2.6	2.1	1.5	2.2	1.3	4.0	1.3	1.1	14.1	15.2	15.3	18.9	15.0	15.6	15.4	16.7	16.7	14.0	15.7	15.1	29.2	25.6	9.0	14.7	18.9	39.6	16.4	13.7	29.6	23.8	38.0	27.1	34.1	32.9	19.0	27.6	22.9	14.2	31.1	34.0	7.9	14.0	8.8	37.9	52.7	21.8	30.0	10.5	25.6	18.6	14.7	21.1	22.4	43.8	27.9	21.8	15.4	67.1	16.0	26.9	22.9	40.0	8.2	12.9	16.9	14.5	15.8	17.9	14.2	12.2	9.6	15.7	18.6	18.1	23.3	20.2	20.5	19.9	32.2	31.2	34.6	21.0	27.8	21.7	6.6	28.4	19.3	25.1	14.5	27.0	47.3	30.8	20.0	43.5	28.4	26.4
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.7;retina: 160.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.4;Excitatory neurons: 132.8;Inhibitory neurons: 156.3;Late spermatids: 304.4;Oligodendrocytes: 182.8;Rod photoreceptor cells: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.9;HeLa: 146.4;hTERT-HME1: 38.2;SiHa: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.4	11.8	6.2	2.8	14.4	52.7	1.5	17.0	20.5	1.6	2.1	1.7	7.5	2.0	14.6	3.7	2.0	3.0	12.2	8.5	4.4	2.6	1.0	1.6	2.3	9.6	9.8	1.6	5.0	9.3	20.9	4.6	10.0	2.3	1.7	160.8	2.9	2.4	2.8	5.4	5.6	1.2	1.8	4.8	3.5	28.7	21.3	0.6	3.2	3.2	1.3	4.4	2.1	15.1	7.1	15.4	1.5	6.7	1.0	5.8	1.6	1.3	3.1	4.8	4.8	14.0	3.9	12.5	5.7	1.9	1.5	4.1	6.2	0.6	3.5	6.7	1.8	41.9	146.4	2.7	0.9	0.2	2.5	0.3	16.8	11.8	38.2	1.6	12.1	4.8	26.7	0.5	11.0	7.8	1.3	4.5	3.8	3.3	13.8	3.5	0.5	0.7	0.6	2.7	16.7	6.8	39.2	4.1	0.4	2.9	4.9	2.2	8.8	3.4	18.1	3.2	6.8	3.2	4.8	2.3	13.3	0.0	2.7	0.0	0.7	0.4	0.5	1.1	1.0	0.5	1.0	0.4	0.6	0.6	1.0	1.1	0.7	1.0	0.9	0.2	0.7	2.0	6.2	14.4	17.0	20.5	8.5	4.4	9.6	9.8	10.0	1.8	21.3	15.1	1.2	0.0	3.1	37.9	0.2	5.2	0.9	0.4	0.6	93.2	1.3	0.8	11.2	2.8	1.0	1.8	81.3	0.2	0.3	1.3	1.9	1.8	135.4	1.6	0.5	2.8	7.2	91.3	132.8	1.5	0.2	1.6	2.0	1.6	0.0	3.2	0.4	0.1	0.2	18.5	156.3	2.8	0.0	0.3	1.8	304.4	2.5	1.7	1.8	8.4	0.4	31.4	0.0	35.7	182.8	0.8	5.2	1.9	1.4	1.2	0.7	0.8	1.3	619.5	0.0	1.1	2.3	48.6	4.4	1.4	9.5	0.3	0.5	1.2	1.2	1.3
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162045-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 214.3;Oligodendrocytes: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	22	"basophil: 93.4"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	72.0	27.8	77.1	9.4	105.6	15.4	47.9	99.6	136.0	52.4	114.0	34.9	20.7	48.0	17.2	30.8	29.6	21.1	52.0	77.3	90.6	43.5	13.3	24.2	10.4	89.7	95.0	27.3	16.5	62.8	18.7	8.3	94.5	23.0	22.7	82.2	51.5	26.2	170.9	17.5	20.2	41.1	79.2	9.9	21.3	14.3	91.3	9.6	29.0	123.1	7.9	25.4	20.0	136.8	38.2	11.4	26.3	49.1	60.0	48.7	24.5	14.0	40.4	12.4	10.2	7.1	38.9	0.1	16.0	25.1	19.7	37.9	10.4	24.4	11.4	0.2	19.6	12.1	7.8	0.2	29.9	30.4	6.0	63.4	34.4	9.5	38.4	54.0	15.9	10.4	0.0	0.3	15.5	16.1	7.0	9.1	21.7	19.5	36.8	0.0	21.0	3.2	3.3	27.7	16.9	16.6	32.6	37.5	46.1	24.5	13.7	21.7	3.4	45.9	9.4	14.9	13.6	0.4	5.3	1.0	22.3	8.7	26.8	93.4	4.2	1.1	0.2	2.2	0.1	0.0	0.8	0.6	4.1	0.4	0.6	0.5	1.6	0.2	0.7	4.1	0.8	1.5	77.1	105.6	99.6	136.0	77.3	90.6	89.7	95.0	94.5	79.2	91.3	136.8	214.3	16.0	21.6	142.0	5.4	20.1	43.4	16.6	29.6	66.6	73.6	64.3	78.0	41.5	20.0	20.2	22.9	12.1	11.1	23.6	64.6	13.3	67.7	27.6	55.3	89.9	4.8	18.7	180.3	7.4	8.1	59.9	16.3	17.0	17.2	137.9	37.5	12.4	26.6	25.2	166.4	40.0	40.7	27.4	17.9	76.4	42.9	34.3	58.7	67.5	11.0	124.8	0.0	75.9	433.0	10.7	19.1	54.9	2.5	27.1	29.8	71.7	21.7	112.3	32.9	44.7	65.8	6.7	9.9	27.2	10.2	6.4	3.8	103.7	16.2	26.4
OSBPL2	"DFNA67, KIAA0772, ORP-2"	ENSG00000130703	"Oxysterol binding protein like 2"	Q9H1P3	20	62231922-62296213	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 94.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 94.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041127, HPA042659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041127: AB_10962008, HPA042659: AB_10960683"	"unprognostic (1.00e-3)"	"unprognostic (7.20e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.20e-5)"	"unprognostic (3.86e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.32e-2)"	14.6	15.2	21.1	13.4	21.2	32.9	18.9	38.9	21.4	21.9	20.0	24.3	22.8	14.0	15.8	40.7	15.6	20.0	25.4	16.6	20.3	20.8	18.0	16.2	14.3	23.7	24.0	15.8	39.7	26.4	26.4	13.7	22.3	19.8	22.7	14.5	24.9	18.8	18.0	43.5	21.6	17.4	19.4	24.9	27.9	14.9	29.8	17.2	21.9	11.9	20.4	23.1	29.8	19.4	23.9	17.0	19.6	18.3	19.4	19.1	18.5	14.2	27.9	46.6	32.1	61.0	24.1	11.5	37.1	28.4	41.8	40.7	18.9	42.4	25.7	13.7	17.7	30.6	21.5	31.2	19.0	11.8	26.6	17.7	61.0	20.8	23.3	22.1	19.1	29.4	20.3	21.2	13.5	19.4	17.2	19.8	6.4	43.5	15.0	15.9	23.5	15.3	23.6	48.2	25.6	16.7	25.7	48.2	24.3	25.9	32.1	21.0	13.2	23.2	17.0	24.7	17.3	24.5	37.4	17.5	25.7	8.4	14.9	16.1	9.2	34.5	13.0	11.7	11.4	13.7	10.5	13.7	9.9	10.9	9.5	11.4	94.6	16.8	9.9	7.1	17.5	10.9	21.1	21.2	38.9	21.4	16.6	20.3	23.7	24.0	22.3	19.4	29.8	19.4	27.1	16.0	18.3	17.3	16.5	20.1	24.8	24.4	14.2	18.9	24.7	16.6	61.2	15.7	28.2	11.0	6.2	13.4	21.6	44.5	31.3	22.7	33.0	22.6	12.0	18.1	16.3	24.2	13.9	20.1	14.8	17.8	42.8	34.2	10.8	19.2	12.8	14.1	12.3	18.5	21.7	29.6	22.4	11.1	8.0	17.4	17.4	14.3	8.8	10.3	16.8	18.2	27.8	9.0	15.5	39.8	37.0	13.2	21.9	38.8	30.2	14.1	34.3	15.9	13.1	14.8	13.1	22.8	11.1	25.2	27.8	37.1	18.5	12.0	25.7	58.7
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OSBPL5	"KIAA1534, OBPH1, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087107-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	22.0	8.0	7.1	7.2	7.7	13.6	19.2	7.8	11.5	42.2	2.1	28.2	5.9	26.6	2.9	12.5	22.3	5.0	14.9	5.2	6.4	13.5	3.1	17.5	2.4	50.3	13.3	14.5	10.4	2.3	10.3	5.0	56.0	25.6	3.2	1.8	16.4	9.9	9.9	25.9	16.6	7.6	5.4	24.9	15.5	3.3	19.8	22.0	14.9	5.9	1.4	24.6	28.3	10.5	3.7	5.6	6.6	7.6	18.9	8.8	0.1	17.9	8.8	7.1	5.0	0.0	10.4	0.0	5.3	10.1	4.9	13.3	1.3	5.0	1.1	3.5	6.0	15.1	19.2	0.0	15.9	13.6	2.3	13.9	5.7	2.5	2.6	5.2	4.8	26.7	5.5	0.0	3.5	10.3	30.7	75.5	4.8	2.4	11.5	15.9	9.0	2.2	3.0	3.3	10.8	1.3	7.6	26.1	7.0	3.7	10.8	35.9	16.4	8.8	12.1	21.2	3.1	3.8	0.0	0.5	9.5	25.3	11.5	0.2	3.6	1.2	9.0	4.7	1.2	0.0	0.9	3.3	3.0	0.0	0.6	3.4	0.4	11.0	11.5	1.3	0.1	5.2	7.1	7.7	7.8	11.5	5.2	6.4	50.3	13.3	56.0	5.4	19.8	10.5	19.5	0.0	5.5	8.1	0.5	4.8	2.6	4.2	5.2	11.5	7.7	5.2	6.9	2.8	4.8	3.7	8.4	0.4	34.6	8.3	1.9	3.0	0.1	2.2	22.1	12.1	0.0	5.7	25.6	2.0	0.6	12.3	5.1	2.5	1.3	3.5	3.9	0.5	1.7	62.2	20.6	8.0	2.0	8.7	3.1	1.2	9.0	3.9	3.6	17.8	2.3	4.1	56.7	20.1	28.2	2.2	8.5	17.0	4.9	3.2	6.1	3.2	5.5	1.2	13.1	7.4	11.4	0.1	0.6	3.8	6.8	0.0	9.1	2.5	8.2	2.5
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.5;Gastric mucus-secreting cells: 118.7;Paneth cells: 29.9;Proximal enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083, HPA073967"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (1.19e-5)"	5.0	3.7	10.6	4.9	10.4	7.2	5.4	9.5	14.0	11.1	7.3	22.7	22.3	8.6	1.6	3.4	7.6	5.3	6.5	10.3	9.9	9.9	2.2	8.5	7.5	10.6	10.2	9.6	17.3	2.6	10.1	2.3	10.7	14.3	8.7	3.1	9.0	6.1	20.2	1.7	22.7	3.5	9.2	17.2	34.0	1.4	10.5	4.9	11.3	3.5	3.8	9.1	7.0	10.9	6.0	6.9	3.0	3.4	3.3	4.6	2.5	2.2	3.2	3.7	4.2	7.1	17.8	6.0	8.7	3.2	1.3	43.2	1.7	4.8	1.2	20.8	2.4	4.4	15.0	4.8	3.0	9.4	0.1	7.4	0.9	2.4	1.7	11.5	7.7	10.5	4.4	8.1	5.8	7.8	9.5	10.0	1.8	23.8	8.9	8.6	4.7	8.3	5.0	4.5	3.1	7.0	3.7	1.2	3.3	3.7	6.4	5.9	8.9	5.6	4.9	0.0	1.8	14.6	5.8	5.8	6.1	7.9	2.2	0.0	0.6	0.6	1.8	0.4	0.8	1.0	0.7	1.1	0.6	0.4	0.5	0.8	0.3	0.4	0.0	1.0	0.9	0.9	10.6	10.4	9.5	14.0	10.3	9.9	10.6	10.2	10.7	9.2	10.5	10.9	5.5	0.0	3.9	10.4	4.5	0.1	1.1	2.5	1.2	6.1	2.9	2.5	2.7	1.5	7.4	3.7	6.2	0.2	15.4	29.5	0.0	2.7	0.1	2.1	2.7	4.3	6.0	3.2	7.3	14.7	0.1	2.0	118.7	1.7	2.5	7.1	5.3	0.5	2.7	11.8	6.3	25.8	4.1	3.4	0.8	0.3	2.8	2.3	1.8	1.0	2.7	7.1	8.2	3.5	9.3	9.3	29.9	2.6	11.4	1.7	34.5	1.2	3.4	8.2	0.0	2.5	1.9	0.0	0.3	1.3	0.1	0.5	10.0	3.3	17.6	1.3
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	24.2	13.5	18.1	24.3	43.3	32.5	21.1	9.7	22.5	22.6	12.3	11.2	9.3	22.3	7.7	24.4	10.5	18.4	14.0	15.3	13.7	36.4	19.2	19.6	30.9	11.7	13.4	17.4	14.0	13.0	5.6	18.2	14.0	14.9	11.7	14.2	13.5	12.7	10.7	28.7	13.0	18.9	9.1	26.7	16.0	16.6	13.1	33.7	14.3	11.5	32.0	19.1	10.2	16.6	36.5	22.8	49.7	35.5	67.5	94.8	31.6	54.7	76.3	34.2	31.1	33.2	14.6	50.8	30.4	65.3	21.5	14.9	37.2	31.6	51.3	43.6	33.3	136.0	21.0	19.8	41.7	87.2	53.1	50.4	58.7	51.2	63.3	61.8	30.0	29.1	95.0	22.7	57.3	25.0	58.8	41.4	24.3	13.2	22.6	30.4	67.7	29.3	26.4	30.3	27.2	28.4	46.7	16.6	34.0	38.9	13.0	52.4	70.6	55.0	27.5	57.5	29.7	22.7	38.4	54.6	21.0	47.9	32.8	134.8	50.8	74.1	29.2	37.4	27.9	45.3	31.2	24.6	46.9	40.8	27.9	23.2	195.7	36.0	44.5	54.9	41.1	31.8	18.1	43.3	9.7	22.5	15.3	13.7	11.7	13.4	14.0	9.1	13.1	16.6	63.5	57.7	58.3	54.5	87.8	116.2	65.7	39.6	114.9	49.7	68.4	55.5	42.5	25.8	36.1	51.5	89.6	34.8	111.3	13.6	60.7	53.9	47.4	29.0	102.6	68.7	9.5	63.5	246.3	55.2	28.7	98.0	28.5	44.1	254.8	36.3	52.1	45.9	77.1	42.1	248.6	25.8	40.7	98.0	127.0	22.1	65.9	142.0	35.6	79.6	149.3	50.2	125.7	113.6	92.9	104.0	28.3	82.8	56.8	54.6	23.9	180.2	37.4	37.3	46.0	79.3	83.1	66.2	129.9	89.9	124.5	48.2	105.3	58.4	20.0	62.4
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.0;testis: 76.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	6.8	8.2	9.7	2.4	10.4	2.0	9.4	7.4	10.5	9.5	31.3	7.3	2.9	10.0	22.0	5.0	58.0	8.8	7.9	11.1	13.0	19.1	2.8	11.0	1.9	11.3	14.7	9.1	8.2	30.2	23.1	5.6	10.9	9.9	3.9	23.1	8.7	8.9	4.9	6.8	2.7	7.9	9.9	1.4	6.3	76.1	13.5	3.6	17.9	5.2	1.5	5.9	4.8	8.3	6.7	6.3	7.6	8.9	8.9	8.6	1.4	4.0	9.7	9.7	6.6	0.1	5.8	1.5	7.3	7.3	7.1	5.1	0.2	7.5	6.2	1.1	5.9	0.1	3.9	0.7	10.9	0.8	1.2	9.8	12.0	13.7	5.9	14.1	6.7	6.3	0.1	1.7	7.7	4.8	3.6	2.5	7.8	2.6	2.6	3.8	3.1	1.2	16.0	2.3	20.4	9.0	7.5	3.5	5.4	7.2	7.6	1.1	5.8	7.0	2.6	12.7	6.9	2.8	3.1	0.8	13.4	0.2	4.7	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	0.2	0.6	0.2	0.6	1.0	0.1	0.1	0.0	1.2	0.7	0.2	9.7	10.4	7.4	10.5	11.1	13.0	11.3	14.7	10.9	9.9	13.5	8.3	3.0	9.6	10.9	4.6	0.4	1.5	5.5	21.3	3.4	5.4	7.9	7.5	5.5	5.7	21.3	12.9	16.7	12.2	0.0	2.0	23.5	15.1	453.5	88.6	5.8	3.3	4.9	1.7	8.1	9.3	3.4	6.4	6.1	7.7	0.0	4.8	2.2	2.3	4.2	5.0	6.9	2.3	32.6	0.8	1.2	66.8	12.5	1.4	3.6	1.0	0.1	12.9	0.0	5.0	2.6	7.2	4.0	9.1	0.4	3.5	0.5	26.1	199.1	21.3	0.0	4.7	7.7	163.7	20.6	3.6	3.1	20.1	0.7	13.9	2.3	5.2
OSER1	"C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1"	ENSG00000132823	"Oxidative stress responsive serine rich 1"	Q9NX31	20	44195939-44210771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 842.5;Late spermatids: 2257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045125	Approved		Approved	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim, Nuclear speckles"		"HPA045125: AB_10961629"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.18e-1)"	"unprognostic (6.07e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.01e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.06e-1)"	43.4	26.6	22.0	22.3	23.2	128.5	42.3	24.7	26.8	37.2	21.9	39.2	27.2	35.1	30.7	46.2	34.9	23.6	37.5	21.9	24.1	35.7	38.1	36.0	27.7	25.0	23.7	42.5	23.5	29.4	24.3	25.2	24.4	36.7	24.7	25.1	36.9	21.5	110.1	51.8	37.3	25.7	24.1	40.1	32.9	116.3	23.8	25.3	37.7	61.1	32.5	44.6	39.2	27.8	50.6	37.1	28.9	22.6	75.2	54.6	32.7	45.0	69.6	71.0	64.1	93.9	54.7	49.1	44.3	43.3	96.1	73.9	31.8	42.7	59.3	16.2	20.1	16.1	99.8	66.8	41.6	27.6	26.8	64.5	72.3	47.1	86.1	38.7	32.8	30.6	24.9	64.9	40.2	75.8	22.5	35.9	25.7	46.5	39.3	32.8	46.4	35.0	37.3	34.7	28.2	27.5	64.2	90.5	62.2	33.9	45.1	25.6	27.8	60.6	45.3	35.8	39.7	44.3	49.1	48.4	42.6	20.6	31.1	264.8	68.4	119.5	50.0	68.3	54.1	120.1	57.1	49.7	60.7	115.2	67.7	61.8	306.7	67.7	100.2	39.7	73.8	91.5	22.0	23.2	24.7	26.8	21.9	24.1	25.0	23.7	24.4	24.1	23.8	27.8	51.2	19.2	21.0	14.4	70.0	259.4	137.6	95.4	101.3	10.3	69.1	75.2	38.7	18.6	61.3	12.9	4.2	40.4	48.6	58.6	37.2	45.1	842.5	94.7	48.0	36.8	49.5	25.0	9.0	36.4	38.2	48.6	37.2	175.1	33.0	22.9	18.5	27.9	43.4	11.8	9.0	34.6	65.1	30.6	111.1	2257.1	40.7	55.2	76.5	5.6	84.2	31.0	30.9	5.0	12.5	49.3	87.7	35.3	40.6	91.4	68.1	33.5	36.9	14.8	19.7	47.0	45.6	194.8	71.7	50.4	198.5	173.6	55.2	22.3	47.5	119.4
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446401-20455089	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	5.7	6.3	6.1	3.8	6.2	6.1	7.0	6.4	7.3	6.8	6.8	7.6	3.8	6.4	8.5	6.0	6.1	6.6	8.1	6.0	6.3	5.8	11.1	6.2	9.3	6.4	6.1	5.3	5.6	7.4	5.2	6.7	6.4	4.9	7.0	4.1	5.3	8.3	10.5	4.7	6.2	5.6	6.5	8.4	6.4	2.4	6.3	9.9	7.6	9.9	10.1	8.2	4.9	6.9	10.3	17.2	5.6	16.2	9.9	6.6	17.6	8.0	11.3	21.1	20.1	21.5	12.3	21.1	10.3	11.0	9.0	8.6	17.9	17.6	14.1	16.8	19.1	14.8	12.2	32.1	7.4	24.3	19.7	5.3	5.2	26.1	14.0	4.6	14.3	18.8	14.0	12.1	17.6	21.0	25.0	11.8	9.1	31.5	31.8	35.3	10.3	12.4	12.8	11.7	21.3	4.2	15.4	16.0	11.9	3.3	9.7	23.7	6.1	8.7	21.2	11.3	10.7	3.4	18.0	31.7	5.0	36.1	11.0	9.3	29.2	38.5	18.8	27.9	17.4	28.7	19.7	17.2	44.5	38.1	15.9	17.4	13.8	20.9	23.3	16.9	19.2	24.6	6.1	6.2	6.4	7.3	6.0	6.3	6.4	6.1	6.4	6.5	6.3	6.9	27.1	35.3	34.9	16.3	46.0	11.5	20.9	26.2	14.2	37.8	24.0	25.1	17.2	15.7	29.1	23.9	37.5	66.3	31.8	22.5	35.2	24.7	3.1	19.2	18.3	24.1	26.9	19.6	23.0	29.8	47.0	23.4	28.1	16.3	25.9	24.6	25.7	19.3	65.8	10.1	24.1	24.2	22.4	30.7	32.8	3.0	19.3	34.2	21.4	7.5	28.4	31.0	32.0	16.6	17.0	20.0	30.6	21.4	26.2	10.9	42.2	39.7	25.5	51.5	13.1	24.6	23.9	7.8	16.9	22.0	11.5	46.1	26.8	37.3	31.6	17.4
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	3.9	8.2	3.6	3.5	5.0	1.9	7.2	6.1	5.0	4.5	3.0	3.5	3.3	5.7	5.6	4.0	5.2	3.2	8.9	3.4	4.0	8.4	7.9	3.9	6.5	4.3	4.5	8.7	3.1	4.7	2.7	4.0	4.5	4.1	3.9	9.8	4.7	3.7	12.3	6.1	3.5	5.0	4.3	5.4	3.1	6.4	3.9	5.6	5.2	11.0	6.3	3.6	3.0	6.1	7.1	3.8	16.7	12.7	12.9	7.1	9.8	10.8	7.5	14.9	15.9	4.5	7.1	4.7	11.7	4.5	8.2	10.1	15.0	12.7	16.9	12.3	11.5	15.3	9.0	5.9	6.7	8.8	7.6	7.8	10.6	11.5	5.5	10.2	11.3	11.8	5.6	7.2	9.8	3.9	6.8	9.9	8.1	9.5	17.4	7.5	13.4	8.1	9.7	3.8	10.1	11.2	7.3	12.8	23.9	20.6	10.1	9.9	4.7	9.6	8.5	14.3	6.8	7.3	6.6	7.4	12.7	11.0	10.7	0.5	2.7	2.3	7.5	2.7	10.6	7.7	7.7	8.6	3.8	9.8	11.3	10.5	0.4	7.6	2.4	6.6	6.6	3.1	3.6	5.0	6.1	5.0	3.4	4.0	4.3	4.5	4.5	4.3	3.9	6.1	3.6	6.4	3.6	6.8	8.4	1.9	2.8	5.9	5.2	8.9	4.0	4.8	8.6	8.6	2.8	0.0	12.5	10.6	7.3	0.4	7.9	3.0	1.4	3.5	5.5	4.1	0.0	5.2	6.6	2.3	7.3	4.5	1.5	2.3	3.8	6.8	3.6	2.9	4.4	10.1	10.0	1.1	2.0	2.4	1.7	0.8	11.1	4.1	1.8	5.6	1.8	12.0	13.4	10.1	17.0	2.0	1.0	8.2	1.9	1.1	1.7	10.2	6.0	11.8	26.3	5.8	8.4	9.6	13.7	4.4	2.0	2.2	6.0	11.8	2.2	1.0
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901849-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 246.6;Granulosa cells: 144.4;Late spermatids: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 22.2"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA028515: AB_10602014, HPA050595: AB_2681186"	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (3.91e-6)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	19.2	7.6	9.6	8.6	9.3	51.9	12.1	10.9	12.1	8.6	7.0	10.5	7.9	18.4	5.7	8.3	5.9	16.3	14.8	10.6	17.9	17.1	18.5	16.4	10.8	12.4	11.4	17.8	7.9	33.2	9.8	7.0	12.5	10.0	8.9	12.9	7.4	7.8	15.2	5.2	7.1	21.1	14.9	9.3	6.0	23.1	10.2	8.9	14.1	18.8	10.0	11.0	4.7	18.3	32.1	30.6	7.9	16.2	17.5	14.0	9.9	23.5	49.9	21.7	22.2	14.3	29.6	21.9	45.7	13.0	26.1	11.6	16.0	18.8	34.6	33.3	11.7	34.2	11.7	8.0	31.9	17.0	20.4	16.1	23.2	24.5	22.6	20.9	28.6	28.7	19.7	38.3	16.2	24.8	29.7	11.7	4.4	33.6	16.7	13.1	11.5	18.6	33.2	24.2	7.1	18.1	17.3	149.6	29.5	12.9	30.1	27.9	20.2	23.2	20.2	20.1	22.2	35.0	32.2	24.2	38.6	21.9	17.5	22.2	1.6	7.5	1.9	1.2	2.7	3.5	2.8	1.7	1.8	2.0	2.3	2.6	12.4	2.5	1.5	1.3	3.1	1.6	9.6	9.3	10.9	12.1	10.6	17.9	12.4	11.4	12.5	14.9	10.2	18.3	9.8	64.1	14.8	49.3	10.4	6.0	6.9	9.2	2.8	9.0	13.3	6.7	13.9	17.2	12.5	7.3	2.1	6.8	10.6	4.2	9.8	13.6	246.6	11.6	10.8	7.4	9.6	8.6	14.9	16.0	8.4	13.7	2.0	14.1	17.1	144.4	13.6	17.6	16.5	3.3	14.9	3.8	20.3	19.1	9.4	216.8	12.5	15.7	7.2	9.4	13.3	25.3	5.2	7.5	7.8	14.0	3.4	12.4	6.1	7.2	3.0	14.8	15.2	6.0	13.1	18.9	9.0	28.9	8.8	4.5	4.3	1.6	8.3	3.0	5.1	7.6
OSMR	"OSMRB, OSMRbeta"	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 74.9;Pancreatic endocrine cells: 72.4;Prostatic glandular cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 154.3;GAMG: 162.7;HSkMC: 192.7;U-2197: 158.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA		51000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	59.3	29.8	7.8	25.3	7.6	0.1	37.3	7.4	8.4	26.0	9.7	25.2	5.5	22.9	7.6	17.1	27.8	28.8	27.6	6.5	10.5	29.9	19.2	46.2	16.0	13.4	10.8	24.6	16.4	6.5	10.4	35.3	10.2	24.6	10.5	4.3	27.4	13.5	11.8	21.9	15.1	39.0	9.3	17.9	18.4	5.6	11.5	13.9	23.9	8.5	15.1	40.9	22.3	8.1	32.6	41.2	6.9	17.7	72.6	154.3	23.4	51.7	81.7	49.8	66.4	0.1	85.9	0.0	23.9	55.3	162.7	43.9	8.9	63.6	79.8	0.1	5.1	2.2	31.2	31.6	82.4	0.0	0.6	192.7	37.3	111.9	94.9	92.3	7.7	0.0	0.0	0.2	31.8	8.8	0.1	0.1	1.1	6.8	13.3	0.0	2.3	0.0	99.8	9.5	0.1	0.3	116.8	0.2	0.2	9.5	35.4	0.3	12.2	120.6	45.1	158.1	28.0	0.0	0.1	0.1	96.8	0.1	26.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.6	7.4	8.4	6.5	10.5	13.4	10.8	10.2	9.3	11.5	8.1	41.5	44.8	56.8	13.4	0.6	30.3	74.9	55.0	27.3	0.2	21.7	10.8	5.0	15.7	51.4	12.9	0.0	6.9	0.2	0.2	0.0	48.7	0.6	6.6	38.9	47.0	0.0	0.4	2.0	48.6	6.8	37.2	6.6	9.2	1.3	2.6	55.0	16.6	1.6	0.0	1.8	0.0	8.2	6.1	7.6	1.4	41.7	1.1	7.2	46.9	1.6	0.7	0.0	13.6	3.6	72.4	0.0	7.5	0.6	73.8	0.0	5.9	19.3	0.6	19.7	32.4	33.6	0.3	1.6	10.5	24.0	17.1	1.7	4.7	0.0	57.7
OSR1	ODD	ENSG00000143867	"Odd-skipped related transcription factor 1"	Q8TAX0	2	19351485-19358623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 81.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 35.8;Leydig cells: 133.6;Peritubular cells: 45.9;Smooth muscle cells: 21.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.9"	"Region enhanced"	"Detected in some"		"thalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	11	"U-2197: 101.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015525	Uncertain					NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"			"HPA015525: AB_1854822"	"unprognostic (1.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.85e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.47e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.62e-1)"	38.6	2.4	0.4	3.5	0.8	0.0	22.4	0.3	1.7	16.7	1.8	23.1	1.4	10.3	0.3	3.6	8.1	5.9	13.4	1.6	0.0	1.5	0.5	17.0	0.5	0.3	0.1	6.1	2.8	0.2	2.7	3.3	0.2	13.9	2.0	0.0	31.5	3.7	3.0	10.8	11.1	11.3	0.2	0.1	9.7	5.4	3.4	0.6	10.2	3.5	0.1	81.4	12.3	0.0	0.0	2.4	0.1	4.7	3.2	9.2	0.0	6.0	2.8	5.6	2.8	0.0	0.1	0.0	0.0	8.5	2.7	0.0	3.0	1.4	1.4	0.0	0.2	0.0	0.1	3.5	4.0	0.0	0.2	4.6	0.0	5.2	6.9	4.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	3.6	5.0	0.0	0.2	0.0	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	1.3	0.4	101.8	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.3	1.7	1.6	0.0	0.3	0.1	0.2	0.2	3.4	0.0	1.2	0.0	0.5	0.0	0.0	4.7	1.0	1.7	0.6	0.0	1.0	6.1	7.2	0.0	1.1	3.7	0.0	0.5	0.1	0.1	0.0	1.3	0.7	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.4	35.8	0.0	0.1	1.3	1.2	0.0	0.0	0.9	0.0	0.0	0.3	4.1	0.0	4.9	3.8	133.6	0.3	3.6	2.8	0.0	0.0	0.0	0.0	0.1	0.4	0.1	45.9	0.0	0.4	0.0	2.9	0.3	0.0	0.0	1.3	21.4	0.4	0.1	0.3	4.1	0.4	0.7	0.8	0.2	1.1
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	16	"ASC diff: 542.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	45.0	9.9	0.0	2.4	0.0	0.6	26.0	0.2	0.2	166.1	0.0	9.2	0.6	155.1	53.7	15.1	155.3	12.9	4.2	0.0	0.0	1.3	0.3	3.6	2.4	0.0	0.0	93.2	4.2	3.0	2.7	8.2	0.0	40.2	3.8	0.0	6.8	72.2	5.6	27.9	24.9	47.1	0.0	0.2	5.1	35.6	0.0	0.8	5.6	5.1	1.1	27.2	83.8	0.0	32.3	4.5	0.0	4.4	542.4	17.2	4.3	17.6	33.1	13.7	13.6	3.4	3.9	0.0	2.9	26.7	0.8	12.4	2.7	4.7	6.7	1.5	13.0	0.6	3.3	1.6	8.9	0.9	0.6	17.0	9.8	2.3	1.6	0.8	0.0	4.8	4.0	0.4	0.6	14.6	2.9	5.7	0.0	2.6	2.8	13.8	1.6	1.1	1.1	2.7	1.4	0.1	1.9	7.5	0.4	0.3	4.3	7.5	0.2	2.1	0.1	13.9	1.0	0.7	0.5	0.3	0.9	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	14.1	6.6	3.4	1.2	0.0	7.9	5.3	0.7	0.0	3.3	0.0	0.0	17.2	0.9	0.7	0.0	0.0	5.8	7.8	243.1	3.7	0.0	0.0	0.0	0.0	138.4	71.7	0.5	5.9	0.0	0.2	0.0	0.0	9.3	0.0	0.0	18.4	10.2	1.9	21.9	24.1	784.1	2.7	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	758.3	4.6	3.6	103.9	0.1	1.7	0.0	32.9	8.8	21.3	5.1	4.5	0.3	9.1	24.2	2.3	95.6	22.3	2.2
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088514-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 302.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA020514: AB_2670461"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	44.3	36.9	27.8	65.7	35.0	56.3	34.9	32.0	37.2	34.1	25.4	42.5	38.2	22.7	38.2	104.8	20.0	42.8	32.0	28.3	33.2	34.6	57.7	56.4	74.9	31.0	32.5	16.0	19.4	72.1	19.1	69.9	33.1	22.7	45.8	12.3	38.5	19.6	9.5	63.1	47.8	28.8	30.8	87.0	40.6	18.0	31.0	47.8	29.0	16.0	85.0	55.3	53.9	35.1	69.1	16.0	7.7	11.2	45.4	41.7	81.3	71.9	46.9	26.9	24.4	8.2	50.8	70.9	35.3	59.2	34.6	111.8	12.9	51.9	77.0	302.0	16.0	39.3	24.8	42.5	36.7	71.5	141.6	29.1	49.2	31.6	21.8	23.7	91.2	59.4	13.4	158.4	65.4	35.9	107.5	44.8	14.5	161.5	30.8	20.1	52.3	63.0	57.0	97.1	6.5	0.6	53.1	74.1	36.2	58.2	97.4	79.9	86.4	55.8	19.4	108.3	30.8	30.1	52.5	26.7	67.1	81.9	46.4	359.5	177.7	464.8	158.6	199.3	169.6	101.2	110.5	131.5	148.7	87.4	62.1	109.8	495.2	168.4	256.8	110.6	163.0	283.0	27.8	35.0	32.0	37.2	28.3	33.2	31.0	32.5	33.1	30.8	31.0	35.1	113.4	22.4	24.4	8.1	90.8	82.2	61.2	78.2	61.5	2.9	38.6	23.2	7.8	28.6	51.2	33.1	6.2	125.5	162.1	64.8	76.3	49.7	11.9	42.8	59.4	60.5	27.2	23.3	32.0	52.3	252.9	42.1	31.1	51.1	137.6	4.2	71.7	32.2	233.1	10.1	12.6	31.9	69.2	167.4	181.5	6.0	23.9	155.7	76.5	43.1	329.9	6.0	268.8	30.2	67.3	60.5	97.7	15.4	83.2	34.1	64.1	63.0	27.3	8.6	19.7	15.9	45.0	6.7	17.8	141.4	114.5	133.9	163.8	37.6	38.2	91.6
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.2;Excitatory neurons: 1.0;Inhibitory neurons: 5.9;Late spermatids: 1.4;Oligodendrocyte precursor cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.0;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	9	"B-cells: 4.0"	"Cell line enriched"	"Detected in some"	24	"U-2197: 39.1"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in single"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.3	0.1	0.6	0.7	0.9	0.0	0.1	0.1	1.2	1.2	0.2	0.1	0.0	0.1	1.6	0.0	0.7	0.8	0.4	0.8	0.8	0.1	0.6	0.2	0.6	0.5	0.2	0.2	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.1	0.2	0.1	0.8	1.2	0.1	0.0	0.4	0.2	0.3	0.4	0.3	0.1	0.1	1.0	0.0	1.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	1.6	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.9	0.1	1.2	0.8	0.8	0.5	0.2	0.5	0.4	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
OTOA	"CT108, DFNB22"	ENSG00000155719	Otoancorin	Q7RTW8	16	21663968-21761935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 1.8;testis: 4.0"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 111.8;Kupffer cells: 60.5;Late spermatids: 18.7;Macrophages: 34.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041405	Enhanced				"Secreted in other tissues"	NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 4: Macrophages - Innate immune response"			"HPA041405: AB_10796344"	"unprognostic (7.96e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.18e-2)"	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	4.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	8.4	0.0	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.0	1.8	0.0	0.4	0.1	0.3	0.0	0.2	11.6	0.3	0.2	1.0	1.2	0.0	2.6	0.4	0.8	0.3	0.0	0.5	5.7	0.1	0.7	0.4	111.8	0.0	1.8	0.1	0.0	60.5	3.7	18.7	0.3	34.4	1.8	0.0	1.9	0.0	0.0	0.5	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.7	0.0	0.0	6.6	0.2	0.7	9.4	7.4	0.0	0.1	0.5	0.2	0.1	0.2	0.2
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558756	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 23.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 4.0;Skeletal myocytes: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HDLM-2: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.2	0.5	23.1	0.3	16.3	6.4	0.2	0.2	13.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.3	0.1	4.1	3.3	0.0	0.0	0.2	0.1	5.2	2.8	0.0	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.1	4.2	0.5	0.2	1.1	3.0	0.9	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.1	16.3	0.2	13.1	4.1	3.3	5.2	2.8	4.0	4.2	3.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.8	0.3	0.0	0.0	0.1	0.5	0.4	0.0	0.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041030	Uncertain				"Secreted in other tissues"	NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041030: AB_10795000"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188726-4226929	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035599	Uncertain					NA	NA						"Cluster 25: Spermatids - Spermatogenesis"			"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.1"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	1.4	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
OTOR	"FDP, MIAL, MIAL1"	ENSG00000125879	Otoraplin	Q9NRC9	20	16748358-16770062	"Predicted secreted proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024335	Uncertain				"Secreted in other tissues"	NA	NA					"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA024335: AB_1854838"	"unprognostic (8.50e-3)"				"unprognostic (9.56e-2)"						"unprognostic (2.34e-1)"				"unprognostic (1.81e-1)"	"unprognostic (1.72e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	12.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77638713	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"brain: 28.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"hypothalamus: 20.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 15.5"	HPA059342	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies"	"HPA059342: AB_2732635"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.1	0.0	9.2	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	28.7	9.2	1.7	6.6	0.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	44.8	57.0	69.9	43.0	78.0	63.5	47.3	53.0	93.4	54.1	39.7	51.9	42.0	49.0	37.4	85.4	55.8	35.9	62.4	79.3	62.5	61.3	47.0	47.1	59.8	65.0	58.0	44.5	43.9	47.1	48.6	49.3	66.1	53.5	39.3	25.6	54.3	42.6	70.2	78.1	51.9	38.0	51.2	58.6	54.0	57.1	65.0	56.0	51.9	48.4	57.1	52.5	56.7	67.7	113.4	198.9	107.2	95.7	70.7	77.8	83.0	66.0	97.1	143.6	105.1	138.1	104.5	59.3	122.0	106.6	124.4	138.1	140.4	165.4	88.1	69.9	111.7	99.3	114.1	172.9	98.8	99.2	104.3	83.4	106.4	110.2	69.8	74.4	137.2	54.6	71.2	65.3	97.9	237.2	109.2	133.0	126.5	95.4	94.1	88.3	41.8	102.5	151.1	162.1	81.5	117.5	74.6	114.1	123.3	72.9	178.2	86.3	100.1	75.8	74.2	103.3	88.4	76.2	51.7	86.4	98.4	64.0	74.5	228.8	186.8	189.9	165.5	244.2	131.2	149.6	152.1	153.6	203.1	139.3	117.1	130.4	184.6	161.8	218.9	140.7	224.7	313.4	69.9	78.0	53.0	93.4	79.3	62.5	65.0	58.0	66.1	51.2	65.0	67.7	37.0	19.2	56.5	15.0	67.2	48.3	70.9	137.8	83.6	44.4	42.5	48.8	31.9	37.1	82.5	46.0	39.6	146.2	56.5	104.7	74.3	80.7	72.6	55.4	36.2	43.4	87.8	35.5	17.8	85.5	109.2	50.0	71.9	44.3	48.7	54.6	35.7	33.2	90.4	30.3	16.9	70.8	101.7	57.4	65.9	87.1	34.2	61.0	51.6	8.4	98.0	43.2	78.2	12.5	18.8	90.1	92.0	25.6	80.8	51.8	90.8	85.2	89.2	55.7	26.3	28.1	62.0	48.0	71.4	77.7	52.6	194.8	73.7	51.7	62.7	71.6
OTUB2	"C14orf137, FLJ21916, MGC3102"	ENSG00000089723	"OTU deubiquitinase, ubiquitin aldehyde binding 2"	Q96DC9	14	94026340-94048930	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 7.3;testis: 14.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 641.1;Late spermatids: 1415.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.5;Karpas-707: 18.0;OE19: 18.1;RPTEC TERT1: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002329, HPA075090"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA002329: AB_1079537, HPA075090: AB_2686734"	"unprognostic (6.80e-3)"	"unprognostic (1.39e-3)"	"unprognostic (3.68e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.02e-4)"	"unprognostic (3.16e-1)"	0.3	0.6	1.2	0.2	1.1	0.2	0.8	1.3	1.3	1.3	0.1	0.5	0.3	0.8	0.3	3.8	0.6	0.4	0.1	1.0	0.8	0.6	0.8	0.4	0.3	0.1	1.3	0.7	0.7	1.9	0.2	1.8	0.1	0.6	0.8	0.6	0.7	0.2	0.1	7.3	0.3	0.3	0.1	0.2	0.5	14.4	2.5	0.1	0.2	0.0	0.8	0.9	1.5	0.5	1.3	3.7	2.4	2.3	0.9	0.7	2.6	0.5	0.3	1.4	2.1	0.8	5.9	0.3	2.2	0.6	16.5	0.3	3.2	1.7	1.1	0.9	1.5	0.1	0.4	3.9	1.3	0.0	0.6	0.6	2.1	0.5	0.9	1.8	1.6	3.3	0.1	18.0	0.7	1.3	0.1	0.4	0.7	18.1	3.1	0.1	0.2	1.0	11.2	1.7	1.8	1.3	0.7	0.8	1.9	1.6	6.3	0.8	1.7	0.9	2.8	0.7	1.0	3.0	2.2	0.0	1.7	0.9	1.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	1.2	1.1	1.3	1.3	1.0	0.8	0.1	1.3	0.1	0.1	2.5	0.5	0.5	0.0	0.5	0.7	0.2	0.1	0.7	4.0	0.6	1.5	1.1	1.1	0.5	0.0	2.4	0.0	0.0	4.2	0.1	1.9	1.9	4.3	641.1	6.4	2.8	0.9	0.0	2.7	1.9	1.6	1.5	0.6	4.6	24.8	0.0	2.2	0.4	0.9	1.4	0.0	1.3	1.4	2.0	1.2	1.3	1415.3	6.8	2.4	0.0	0.0	0.4	0.5	0.0	0.5	0.6	5.2	1.3	3.4	0.1	0.3	0.5	1.5	1.8	1.4	6.6	0.6	0.6	9.2	4.3	2.0	2.3	117.5	1.0	2.2	1.0	2.4
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439075-23442377	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	13.0	11.7	8.0	10.2	8.4	60.4	10.3	9.5	10.2	8.4	8.4	8.7	6.8	10.2	6.8	7.8	11.2	9.7	43.4	8.7	9.0	19.7	7.6	19.7	14.4	8.3	8.0	13.6	6.9	19.4	8.0	12.1	7.6	8.8	7.6	5.9	6.7	7.6	29.4	20.9	8.2	9.4	8.4	13.7	22.9	7.5	9.2	6.8	13.3	22.6	12.5	11.9	7.6	9.2	4.8	2.3	2.4	1.1	9.3	4.6	3.2	1.9	4.2	4.4	4.0	0.9	38.1	2.2	4.1	2.4	1.5	36.5	2.5	4.5	2.9	17.4	7.1	0.1	5.7	1.5	8.0	0.4	3.2	4.8	19.4	1.3	6.1	3.9	1.5	2.2	0.5	15.1	2.5	2.3	1.5	1.4	1.9	2.7	1.3	2.4	10.8	2.2	5.8	4.0	1.1	2.6	23.4	4.1	11.3	6.3	1.7	3.3	2.7	2.5	3.7	7.0	0.8	7.6	15.0	1.1	3.8	1.5	1.0	2.5	0.5	1.0	0.3	0.6	0.3	0.7	0.5	0.3	0.3	1.2	0.4	0.6	1.3	0.0	1.9	0.2	1.3	0.2	8.0	8.4	9.5	10.2	8.7	9.0	8.3	8.0	7.6	8.4	9.2	9.2	17.3	67.3	11.5	3.3	55.9	32.0	7.1	5.0	13.6	20.1	12.3	9.1	149.0	7.2	4.9	5.5	2.1	3.3	9.6	47.2	11.7	6.0	8.0	35.0	44.5	25.6	6.0	13.5	4.3	7.1	3.2	20.8	47.4	33.8	5.7	10.4	16.4	10.1	51.0	53.8	4.8	77.9	10.2	68.2	219.1	7.6	6.5	105.7	33.8	8.4	9.3	33.8	10.3	4.0	6.5	10.1	16.3	13.2	50.0	7.7	8.0	25.1	9.8	26.2	6.6	82.2	19.4	7.2	4.7	15.1	30.5	7.9	16.5	7.5	24.3	10.9
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882395-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	3.3	5.7	4.8	3.3	5.0	6.4	4.7	5.2	5.9	6.2	2.2	6.4	5.0	7.7	6.0	3.8	5.6	3.3	3.4	4.9	3.2	4.6	3.1	4.9	3.6	2.8	3.1	6.7	4.6	4.1	5.5	2.4	2.8	5.9	3.8	9.3	3.9	4.1	4.9	6.4	5.8	5.6	2.2	4.8	4.8	10.7	3.6	3.7	3.9	4.3	3.0	4.5	4.9	5.2	5.8	2.2	9.5	11.4	4.0	3.5	9.3	6.1	3.5	3.0	3.0	10.2	5.4	9.2	4.8	13.5	2.2	5.6	8.9	3.5	5.9	6.0	11.9	8.8	13.4	7.2	2.2	6.5	7.8	2.9	3.4	4.8	6.2	6.4	4.1	9.2	6.3	3.8	5.3	3.2	5.0	6.5	4.5	4.6	5.6	11.5	24.2	3.4	5.1	6.3	8.4	5.9	4.4	3.5	4.6	9.2	5.2	4.8	5.0	7.3	9.3	8.2	5.3	4.4	4.0	5.6	5.1	8.6	3.4	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.0	4.8	5.0	5.2	5.9	4.9	3.2	2.8	3.1	2.8	2.2	3.6	5.2	5.0	16.0	7.5	11.4	5.6	14.1	5.9	2.4	4.6	14.9	10.2	9.1	4.7	4.3	2.0	9.2	16.7	2.7	6.5	4.7	0.0	5.1	16.0	11.7	7.8	5.1	12.0	6.1	32.6	4.5	5.4	7.0	5.1	8.3	1.3	16.4	7.9	2.2	1.9	26.9	28.5	7.0	4.1	2.6	8.9	16.4	5.6	5.2	5.4	6.5	4.1	8.9	5.2	21.1	16.6	5.0	6.7	6.0	8.6	9.8	4.7	4.2	9.7	15.5	6.6	7.8	6.1	23.5	21.4	5.7	8.8	2.5	7.0	4.7	7.0	4.8
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180589	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.0	12.8	9.6	13.8	12.3	32.0	12.6	13.0	12.5	12.2	11.0	11.6	11.5	13.6	14.2	13.4	16.1	12.3	11.8	9.9	8.7	11.9	20.2	15.3	16.2	9.1	9.1	14.5	12.2	17.1	9.7	15.1	9.5	10.2	12.1	17.0	11.0	11.4	40.4	15.4	11.2	13.7	8.7	16.2	10.8	31.9	9.4	16.4	13.6	40.4	14.3	18.7	12.1	14.9	28.2	15.7	18.3	17.1	21.3	25.8	24.5	24.0	26.9	30.2	23.9	16.9	33.8	51.2	10.6	33.8	18.5	16.6	31.9	33.6	39.3	22.0	15.0	24.7	20.1	15.8	24.9	52.3	17.7	20.3	33.5	36.9	48.3	25.4	27.1	22.0	41.5	37.3	30.1	16.8	32.4	22.7	20.5	27.0	17.7	26.3	20.0	12.1	29.4	20.1	17.7	14.6	22.2	33.0	24.3	24.1	11.0	21.2	33.1	33.8	21.5	17.7	32.2	27.2	28.7	33.0	23.4	36.5	33.4	0.0	0.4	0.8	0.9	0.6	0.6	0.8	0.6	0.7	0.4	0.6	0.6	0.6	0.1	0.5	0.8	0.7	0.5	0.3	9.6	12.3	13.0	12.5	9.9	8.7	9.1	9.1	9.5	8.7	9.4	14.9	24.8	64.1	23.5	27.7	19.6	63.2	55.3	13.9	18.2	16.1	20.3	11.8	20.2	22.8	20.5	27.6	25.0	21.5	28.2	16.3	9.8	12.7	185.2	52.8	29.1	44.7	15.1	21.4	36.4	14.7	21.4	30.3	14.8	45.7	20.3	19.6	21.0	24.0	12.7	6.7	30.8	15.2	20.3	20.8	42.4	82.4	20.2	23.6	32.0	30.0	17.7	8.3	11.3	40.2	53.7	23.9	11.7	30.1	20.1	64.7	13.1	7.7	45.3	20.9	0.0	39.4	24.2	27.9	48.5	27.4	54.4	16.0	22.9	20.7	15.6	60.4
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922024-48958386	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"U-266/70: 1503.3;U-266/84: 407.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	37.7	44.8	42.9	36.9	44.9	56.7	36.6	39.2	45.5	40.6	33.6	45.8	39.6	43.0	29.9	37.5	41.4	24.7	29.9	44.8	46.1	41.1	39.5	39.6	43.4	44.2	42.8	46.8	37.7	35.6	46.1	26.4	46.0	43.1	21.7	30.2	36.3	32.0	39.7	44.6	47.3	27.0	38.3	60.7	37.5	24.2	44.9	47.0	42.3	25.2	35.8	39.9	36.7	43.9	53.0	77.8	36.0	88.9	59.2	52.3	41.4	45.7	52.9	55.9	59.8	39.7	57.3	58.9	29.2	56.8	49.1	63.3	54.2	45.7	51.7	69.1	65.0	44.5	79.4	45.0	49.3	43.4	48.7	58.1	41.2	58.2	39.5	61.4	44.7	47.8	56.9	90.7	40.0	52.3	67.7	89.2	64.9	19.5	60.4	53.0	52.5	77.4	38.9	46.4	34.7	60.7	60.2	38.7	61.7	82.7	51.6	39.2	64.2	36.5	46.2	97.2	38.1	1503.3	407.1	56.5	56.3	58.9	25.7	5.5	3.3	7.6	6.6	5.2	5.6	8.6	5.1	5.7	4.8	5.3	4.8	7.1	8.5	20.3	5.1	6.2	7.3	3.6	42.9	44.9	39.2	45.5	44.8	46.1	44.2	42.8	46.0	38.3	44.9	43.9	21.3	9.6	22.3	17.3	33.3	22.2	21.2	13.7	13.1	35.5	23.7	19.7	11.5	15.7	16.3	27.6	27.1	13.3	38.2	28.4	9.8	13.6	1.9	24.5	23.2	19.6	48.2	32.6	15.5	18.3	16.3	18.4	21.4	33.1	7.0	28.5	22.1	24.3	16.7	28.6	15.7	28.5	10.2	22.9	33.9	2.9	20.8	25.7	26.6	15.9	22.6	18.0	30.9	14.1	14.1	21.5	19.0	23.7	38.1	27.5	28.1	21.7	21.6	27.9	13.1	19.9	20.1	10.4	12.6	15.9	25.6	30.8	33.3	28.6	20.1	27.4
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062457-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 4.8"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 64.1;Spermatogonia: 25.1"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.1	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.3	1.3	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.9	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.3	0.0	0.3	0.0	1.8	0.0	0.4	0.4	64.1	25.1	0.0	0.6	0.3	1.0	0.2	0.0	0.2
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010726	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	11.7	7.7	21.0	3.8	39.2	1.1	7.8	28.7	18.5	9.9	6.8	7.6	6.2	10.5	3.8	7.7	9.3	4.8	7.1	15.3	22.1	5.6	10.7	7.3	1.9	41.4	37.2	10.9	6.1	10.9	3.4	7.1	35.5	6.6	7.1	10.1	7.8	7.5	18.6	5.8	6.2	10.8	27.9	3.6	6.7	12.7	31.7	2.1	6.7	16.2	3.2	6.3	5.2	43.0	17.2	13.5	9.3	15.6	12.0	11.1	8.8	11.8	17.3	14.0	9.6	10.0	13.6	0.2	7.5	21.7	6.3	13.4	13.2	13.1	14.6	16.5	6.7	6.6	18.9	6.8	12.8	7.6	6.9	12.4	9.9	23.7	20.6	10.9	11.5	2.0	18.4	18.1	10.1	17.5	1.3	2.1	11.9	12.8	13.1	1.8	12.9	4.4	5.4	23.2	6.0	11.4	20.8	15.2	18.5	12.1	12.6	4.0	13.9	14.4	13.2	9.8	14.0	19.1	20.0	2.0	12.8	2.2	24.1	2.0	0.0	0.4	0.7	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.2	0.3	0.3	0.4	0.0	0.1	0.1	0.0	21.0	39.2	28.7	18.5	15.3	22.1	41.4	37.2	35.5	27.9	31.7	43.0	10.2	35.3	11.7	56.8	3.0	15.9	22.7	8.7	13.1	28.0	18.3	9.3	22.2	12.8	15.3	11.0	106.3	23.5	5.1	41.1	7.9	14.5	63.4	21.8	17.8	16.7	17.4	14.9	20.6	11.1	11.6	14.8	21.4	40.2	0.0	22.0	20.3	33.0	3.1	23.5	24.6	15.8	8.2	0.8	5.9	79.4	14.6	2.4	37.4	22.5	4.3	23.6	15.5	33.2	176.8	20.6	21.3	23.0	4.7	20.2	17.1	11.5	17.4	66.9	0.0	19.8	17.9	11.1	7.2	11.8	16.6	21.2	7.5	11.1	11.1	34.0
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699850	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	5.0	3.9	4.8	9.6	6.3	26.8	4.6	5.9	4.9	5.5	6.2	4.7	7.6	3.6	2.6	8.0	3.5	4.7	6.7	4.9	5.0	4.4	12.3	6.4	12.5	6.6	5.6	4.8	6.8	3.8	3.6	6.5	6.4	6.3	4.6	4.6	5.7	3.3	5.2	11.8	5.8	4.8	5.6	7.1	4.3	7.1	5.8	11.2	4.1	5.5	13.5	5.7	6.9	7.1	10.0	11.5	11.2	12.8	10.0	10.3	12.3	9.8	6.9	13.8	10.2	15.4	7.2	18.0	18.9	6.4	19.9	11.1	14.1	12.9	9.2	31.1	11.6	12.9	36.3	8.3	8.8	12.4	21.2	6.0	15.2	11.3	9.4	7.6	11.8	14.9	13.0	27.8	10.0	6.1	12.4	10.6	6.9	10.5	12.0	18.8	10.0	7.1	8.9	10.1	5.1	8.3	35.1	7.8	7.6	13.5	8.5	14.1	11.1	17.8	20.0	13.4	13.2	12.4	20.6	20.3	10.1	23.2	9.3	0.2	0.6	1.1	0.3	0.7	1.0	0.3	0.8	1.1	1.0	1.6	0.5	1.3	0.7	0.3	1.1	0.8	1.7	0.3	4.8	6.3	5.9	4.9	4.9	5.0	6.6	5.6	6.4	5.6	5.8	7.1	20.3	3.2	11.5	23.5	24.6	0.0	23.2	0.0	26.2	11.9	12.8	11.7	15.0	10.0	4.3	5.5	14.6	15.1	70.6	21.1	7.9	5.5	9.4	20.6	28.1	13.3	9.5	13.7	18.5	5.8	10.3	10.1	16.8	24.0	10.2	14.0	6.4	36.9	13.9	8.4	19.5	15.7	0.0	18.9	0.0	4.2	10.5	25.0	0.0	38.4	17.1	10.4	26.8	16.6	31.7	8.0	13.3	6.4	38.5	25.9	14.1	15.1	5.1	31.4	0.0	11.5	10.2	29.7	28.8	23.7	0.0	14.2	35.8	7.6	15.6	23.1
OTULINL	"FAM105A, FLJ11127, NET20"	ENSG00000145569	"OTU deubiquitinase with linear linkage specificity like"	Q9NUU6	5	14581792-14616180	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	3.1	2.7	1.2	6.8	1.1	30.3	4.1	1.3	1.6	3.8	4.8	12.3	6.6	1.5	1.4	1.7	1.4	2.7	0.9	1.1	1.8	3.6	1.4	13.1	5.4	2.3	1.5	2.0	7.6	1.2	2.5	4.2	2.1	8.3	13.3	0.5	1.4	10.0	0.4	1.7	9.4	2.5	2.4	7.9	3.3	2.5	1.9	3.4	2.8	0.8	3.6	5.2	3.1	3.6	0.0	0.8	1.6	0.0	0.3	0.0	6.9	2.0	1.8	0.5	1.0	2.8	1.7	0.1	1.1	0.9	2.8	0.1	3.7	1.6	0.7	1.1	4.9	4.6	17.7	0.4	1.7	0.1	55.6	0.1	0.3	0.2	0.0	0.0	0.1	2.9	0.0	7.1	0.2	1.4	0.0	1.7	2.5	16.1	11.9	0.5	0.7	2.0	0.0	13.9	6.0	7.0	0.9	0.6	0.0	1.7	0.6	16.9	0.0	0.9	4.4	0.4	1.6	0.0	0.0	0.1	1.0	27.2	0.4	0.2	33.4	0.3	5.5	16.2	7.3	0.1	6.7	7.2	33.8	0.1	9.0	9.1	8.6	19.2	12.7	25.0	12.8	24.6	1.2	1.1	1.3	1.6	1.1	1.8	2.3	1.5	2.1	2.4	1.9	3.6	10.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.4	7.9	0.0	0.0	0.0	29.5	0.0	0.9	36.7	0.0	1.9	0.4	0.0	0.9	16.6	1.1	0.0	0.0	0.0	6.2	2.2	1.4	0.0	1.2	0.0	0.5	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	8.8	0.2	0.0	0.0
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 18.0;skin 1: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.8;Basal respiratory cells: 6.3;Club cells: 4.1;Ionocytes: 6.1;Respiratory ciliated cells: 6.8;Suprabasal keratinocytes: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	95	"neutrophil: 9.4"	"Lineage enriched"	"Detected in single"	95	"granulocytes: 9.4"	"Cell line enriched"	"Detected in many"	9	"THP-1: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052122	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.1	0.0	2.1	0.0	1.7	0.0	0.2	0.1	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.1	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.0	18.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.2	0.3	2.8	0.0	0.0	0.0	0.5	0.0	0.1	1.8	2.3	1.3	4.2	2.5	0.0	0.1	5.9	0.0	0.3	0.3	0.4	4.4	2.2	0.1	0.8	0.0	1.1	3.0	2.7	1.9	0.5	1.1	2.5	2.7	2.2	5.0	0.0	1.9	2.0	0.0	0.7	0.0	0.7	0.8	0.0	2.6	2.4	0.0	0.2	2.1	2.6	4.6	0.0	2.2	1.6	2.3	3.6	0.7	1.2	0.8	0.4	0.5	1.8	0.2	1.5	0.0	1.0	54.1	0.1	0.9	1.7	0.0	0.9	1.5	1.1	4.0	0.3	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.1	2.5	1.9	1.4	0.2	2.5	0.7	0.0	2.8	1.8	0.2	0.0	0.0	9.8	0.1	1.7	0.0	6.3	0.6	0.0	0.8	1.0	0.8	0.0	4.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.6	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.7	0.3	0.3	0.5	1.1	2.6	0.1	0.0	0.1	0.2	0.1
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56816693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"choroid plexus: 108.8;retina: 279.9"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.0	0.0	4.1	0.0	1.3	0.0	0.0	8.5	0.5	0.0	108.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	2.6	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	2.5	0.0	2.0	0.0	0.0	279.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.8	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	249.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.3	8.5	0.5	5.9	2.6	0.2	8.7	2.0	0.1	12.8	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.6	0.0	0.0	0.3	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2071.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	4.1	1.6	7.6	1.1	7.8	1.9	3.5	8.0	10.6	3.8	5.8	3.4	1.1	15.4	5.1	3.0	2071.7	1.1	2.3	7.7	7.0	5.0	8.0	3.9	2.2	7.3	6.9	6.7	1.5	6.8	2.4	2.0	7.2	5.5	2.2	4.3	4.2	1.5	2.6	7.6	5.2	1.4	6.5	4.6	2.8	9.2	6.9	1.2	2.4	1.0	2.0	4.6	3.8	8.2	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	7.8	8.0	10.6	7.7	7.0	7.3	6.9	7.2	6.5	6.9	8.2	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 7.1;stomach 1: 7.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 24.4;Spermatocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.9;hippocampal formation: 3.3"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.1	1.5	0.0	3.5	2.9	0.3	0.5	5.3	1.0	0.3	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	4.5	0.4	1.2	0.1	0.0	4.1	1.3	0.0	7.1	0.7	0.0	6.7	2.3	0.0	0.0	0.0	7.9	1.4	0.0	0.1	3.3	0.0	0.2	1.2	3.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.1	7.3	0.0	1.0	0.0	0.3	5.4	1.0	1.3	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.0	0.1	0.0	0.0	2.1	0.1	2.6	8.3	0.0	0.0	5.4	0.0	0.1	2.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.4	8.4	0.3	0.1	8.3	11.4	4.8	4.0	0.0	14.6	11.7	1.4	8.6	8.8	1.8	0.0	1.7	0.2	17.1	0.0	8.4	18.6	24.4	1.3	0.3	3.6	0.0	3.3	10.9	3.2	0.2	17.9	18.4	0.0	0.0	0.0	0.0	0.1	1.7	1.7	15.5	10.2	0.0	0.7	7.4	0.3	0.5	0.0	0.0	0.0	0.7	0.0	1.0	0.3	16.9	10.5	0.4	0.0	12.9	12.0	1.6	6.4	0.0	0.0	0.0	0.7	37.9	0.7	4.9	9.8	0.1	0.4	0.0	12.3	15.1
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L mitochondrial inner membrane protein"	Q15070	14	22766522-22773042	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	77.7	90.7	27.6	40.8	28.5	71.9	67.6	31.4	28.8	59.4	47.1	72.9	66.3	55.0	48.1	76.6	55.8	49.6	147.2	27.5	29.6	70.8	108.6	54.8	70.0	31.3	29.1	71.2	98.0	105.3	27.5	38.0	31.1	45.0	57.7	41.9	64.2	44.8	234.9	69.3	58.9	46.1	29.1	62.3	83.9	25.0	31.6	63.6	54.9	272.5	75.5	61.3	60.4	31.1	89.3	121.3	48.8	82.1	146.7	217.4	94.4	64.0	138.1	94.3	107.9	91.1	96.4	167.0	86.4	75.0	73.0	121.0	103.0	126.3	90.0	67.6	65.4	79.1	73.2	329.7	165.5	150.9	88.4	211.0	137.6	75.4	114.9	114.7	273.3	93.8	62.2	124.0	103.4	130.0	91.8	51.3	53.2	118.5	150.0	92.9	87.2	128.3	117.9	103.4	35.1	67.0	94.6	205.7	129.7	58.4	89.2	122.7	86.2	52.7	62.2	98.5	75.4	94.0	84.7	78.1	41.6	83.6	60.0	11.9	68.1	18.5	29.5	71.6	36.0	51.0	42.5	37.4	95.1	54.4	47.4	35.6	15.1	41.7	58.5	26.9	55.8	53.7	27.6	28.5	31.4	28.8	27.5	29.6	31.3	29.1	31.1	29.1	31.6	31.1	30.6	48.1	44.0	7.8	83.7	69.5	61.1	89.0	92.8	31.0	52.1	46.5	118.0	72.9	62.1	29.5	10.4	72.8	32.5	48.9	74.3	85.2	10.2	20.4	40.3	58.6	40.7	64.3	6.8	161.3	113.0	47.6	66.8	23.1	80.4	56.5	64.2	102.9	143.4	18.5	7.5	75.3	38.7	148.1	76.8	13.3	57.2	85.6	51.6	3.7	133.4	22.9	74.2	4.5	8.0	86.3	69.7	36.9	84.2	45.6	101.4	116.0	42.6	38.3	39.5	39.4	43.0	31.8	28.4	112.9	67.3	57.2	57.9	70.6	112.1	74.9
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
OXCT2	"FKSG25, FLJ00030, SCOT-T"	ENSG00000198754	"3-oxoacid CoA-transferase 2"	Q9BYC2	1	39769523-39771348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 73.0"	"Group enriched"	"Detected in some"	80	"Early spermatids: 420.5;Late spermatids: 1019.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.6;THP-1: 8.4;U-266/70: 6.2"	"Not detected"	"Not detected"							HPA075423	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA075423: AB_2732292"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.16e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.39e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.85e-1)"	0.3	0.8	1.1	0.4	1.3	0.5	0.3	1.5	2.0	0.5	0.0	1.0	0.7	1.1	0.9	0.7	0.8	0.7	6.6	1.0	0.5	0.4	0.6	0.5	0.6	1.8	1.1	2.3	1.2	0.1	1.1	0.2	1.8	1.3	0.4	0.0	0.3	1.3	0.4	3.2	1.1	0.6	1.3	1.1	0.7	73.0	1.0	3.9	1.8	0.0	0.2	0.4	0.5	4.5	0.4	0.2	0.0	0.9	0.3	1.1	0.0	1.1	0.0	1.0	0.5	3.9	0.4	0.0	0.7	1.6	0.1	0.4	1.2	0.1	0.5	0.0	2.5	0.7	3.0	0.2	1.8	0.0	0.4	0.5	0.3	0.1	0.1	0.0	0.8	0.3	0.2	7.6	0.1	1.1	0.0	1.2	0.1	0.0	1.0	1.1	1.2	1.2	0.3	0.8	1.3	0.6	3.3	0.2	1.1	0.0	0.4	8.4	0.9	0.0	0.2	3.7	0.0	6.2	3.6	0.4	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	1.3	1.5	2.0	1.0	0.5	1.8	1.1	1.8	1.3	1.0	4.5	0.3	0.0	0.6	0.0	2.3	0.3	0.3	0.1	0.0	0.2	0.3	0.5	3.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.7	420.5	0.2	2.1	0.8	0.0	0.0	0.0	0.7	0.1	1.5	0.0	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.3	8.3	1019.0	4.1	3.0	1.8	0.0	0.7	0.2	0.0	0.0	0.0	0.4	0.1	6.4	8.9	0.5	0.6	0.0	0.1	0.1	0.0	1.1	2.7	3.4	2.7	0.1	0.4	0.0	0.8	0.6	0.5	0.2
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 56.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.3;Proximal enterocytes: 16.1;Skeletal myocytes: 12.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 67.0;eosinophil: 144.5"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 144.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;Hep G2: 7.6;HMC-1: 6.1;REH: 3.2;THP-1: 2.8"									HPA051433	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	2.1	1.8	1.2	1.5	1.2	2.4	1.9	0.3	1.8	6.9	1.1	3.9	5.0	3.1	2.3	2.4	3.6	1.4	2.4	1.3	0.6	8.4	56.3	1.9	1.2	0.9	0.9	9.1	7.2	0.3	3.8	1.7	0.7	6.6	1.8	0.3	1.5	1.7	0.9	3.1	8.5	0.8	0.4	4.9	2.3	1.2	1.0	1.0	2.2	0.4	1.1	6.0	4.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	6.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.3	2.2	0.0	7.6	0.0	0.1	6.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.0	3.2	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	67.0	1.8	144.5	0.1	0.6	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.8	1.2	1.2	0.3	1.8	1.3	0.6	0.9	0.9	0.7	0.4	1.0	0.6	0.1	0.0	0.5	0.7	0.1	0.5	0.6	0.2	0.6	1.6	0.4	0.6	0.4	2.8	0.2	1.8	0.0	0.1	0.0	1.9	1.9	0.6	0.0	0.1	2.0	0.1	1.2	0.0	0.0	2.0	0.1	2.0	0.0	0.1	2.5	0.4	0.4	8.3	1.0	0.0	0.0	3.4	0.0	1.3	1.2	0.3	3.4	1.5	3.6	1.0	3.0	0.9	0.0	0.0	0.0	0.6	5.3	1.9	0.0	0.5	16.1	4.9	0.2	0.0	0.0	12.9	1.1	0.3	0.2	0.3	0.1	0.3	1.1	0.3	5.1	0.3
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA056878: AB_2683265, HPA057019: AB_2683310"	"unprognostic (1.08e-1)"	"prognostic favorable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	11.4	16.7	8.4	3.2	8.3	6.3	12.6	8.5	15.2	7.7	7.9	10.0	4.5	7.9	0.0	11.0	8.4	1.2	15.4	8.1	8.9	14.2	18.0	7.4	3.9	8.9	8.7	5.5	14.8	1.5	6.6	1.7	8.6	11.1	0.2	0.1	10.6	1.9	16.4	14.3	9.8	1.3	9.0	11.7	15.4	29.7	8.9	0.6	8.9	0.0	0.7	10.0	7.5	9.3	15.2	56.0	0.5	12.6	3.2	0.3	9.5	7.3	0.2	0.1	1.4	14.9	14.1	4.7	12.6	0.0	7.8	13.1	0.0	10.0	0.0	7.7	29.4	4.2	26.1	37.2	22.9	3.0	11.1	4.8	6.8	2.9	3.1	0.7	5.3	22.3	7.3	7.2	1.1	38.3	10.7	12.4	6.9	7.9	24.9	9.7	0.4	20.5	2.9	8.2	2.4	11.2	3.1	19.0	27.6	0.2	27.4	17.1	4.5	10.8	7.2	12.2	8.4	19.8	7.9	6.5	14.6	11.3	11.0	18.6	23.6	18.4	23.5	20.8	25.1	26.4	31.9	27.0	22.9	28.6	33.5	26.0	17.1	35.5	22.6	31.2	30.6	23.8	8.4	8.3	8.5	15.2	8.1	8.9	8.9	8.7	8.6	9.0	8.9	9.3	17.9	32.1	17.1	7.5	26.1	8.5	21.5	48.6	21.6	19.9	40.3	40.0	16.2	30.0	26.1	23.9	6.2	37.1	24.8	43.4	72.4	38.1	85.7	29.9	25.6	19.2	21.7	38.1	8.3	47.9	28.8	20.6	28.1	26.9	14.0	26.1	23.6	55.0	44.2	23.5	7.7	35.5	50.8	34.2	11.1	34.6	33.2	21.0	16.0	5.6	41.2	41.3	47.4	7.5	12.6	43.9	41.5	23.7	19.7	40.4	63.4	89.3	36.0	30.9	26.3	11.9	18.5	95.7	20.4	35.8	8.5	27.9	29.5	56.5	31.6	26.6
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.0;Inhibitory neurons: 62.8;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 81.0"	"Lineage enriched"	"Detected in all"	4	"T-cells: 81.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favorable (7.63e-4)"	5.8	4.0	2.0	11.4	3.3	8.9	4.8	2.4	3.7	2.7	3.7	8.5	12.2	3.0	2.5	5.4	3.4	5.0	9.0	1.8	2.4	8.7	16.9	4.2	17.0	2.3	2.4	3.0	3.7	7.3	2.4	3.6	2.5	2.9	7.2	4.6	4.4	2.6	14.9	4.1	14.1	2.8	1.3	7.1	7.3	4.4	2.8	18.1	5.6	10.1	12.1	5.4	3.3	3.4	8.3	12.0	7.6	12.0	8.8	7.8	29.7	8.8	6.5	11.8	9.5	17.2	8.2	11.8	5.4	5.5	6.5	5.9	15.9	14.3	11.2	21.6	10.5	17.4	9.6	9.3	9.1	28.3	10.2	5.8	10.5	19.2	9.2	3.7	9.3	12.0	24.1	27.3	5.2	14.7	16.6	14.8	16.3	12.4	13.8	14.6	9.3	20.7	8.0	9.9	5.4	7.5	9.8	16.3	14.0	8.2	10.4	16.1	4.2	7.7	9.8	8.5	14.4	9.9	19.0	19.0	9.1	24.3	10.5	0.1	3.8	3.1	22.6	5.4	30.3	5.5	34.6	24.5	6.0	4.3	81.0	61.8	3.4	19.3	5.4	4.6	20.4	19.3	2.0	3.3	2.4	3.7	1.8	2.4	2.3	2.4	2.5	1.3	2.8	3.4	4.9	0.0	8.6	35.6	8.9	2.4	5.4	7.9	6.2	5.8	5.7	3.4	12.8	7.2	4.7	7.3	6.2	10.2	29.4	8.9	31.3	9.8	40.2	3.9	5.5	4.4	3.0	16.2	67.0	6.2	8.1	5.1	11.2	3.9	20.8	5.8	3.9	23.3	8.5	3.3	62.8	7.6	6.1	5.2	3.6	31.7	3.1	6.3	5.4	17.8	10.2	5.8	41.2	36.2	42.1	7.5	2.9	1.9	20.8	5.0	21.2	15.7	7.2	11.7	6.6	6.1	6.8	9.0	11.7	7.5	3.4	5.1	90.0	7.8	11.5	6.5
OXR1	TLDC3	ENSG00000164830	"Oxidation resistance 1"	Q8N573	8	106270144-106752694	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 1458.0;Inhibitory neurons: 1366.9;Late spermatids: 405.5;Microglial cells: 496.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027375, HPA027380, HPA027395"	Enhanced		Approved	Vesicles		NA	NA		12000	"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554"	"unprognostic (8.16e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (6.59e-2)"	"prognostic favorable (5.82e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-1)"	28.7	57.7	19.2	11.1	27.8	18.6	29.0	14.0	50.3	30.6	0.0	20.1	14.2	27.7	54.5	28.7	22.4	22.1	30.5	25.7	4.3	29.7	38.3	20.0	14.4	19.2	6.4	27.0	17.1	23.9	12.2	17.0	21.3	21.1	21.7	79.5	48.6	47.6	52.1	27.4	12.2	21.7	1.8	19.5	27.3	56.1	10.7	22.2	21.3	59.6	16.4	23.7	17.9	22.2	29.5	11.0	32.3	6.5	41.2	51.4	15.0	23.7	28.3	21.6	27.5	9.7	35.6	29.6	26.8	25.6	13.2	20.4	18.5	21.2	37.3	24.9	20.0	39.8	15.3	18.0	25.5	12.8	22.8	30.3	32.1	23.7	34.9	30.0	24.7	24.2	20.3	106.5	24.6	26.2	38.3	17.3	4.2	43.5	19.4	9.9	25.7	55.7	24.0	36.8	19.4	6.0	10.5	7.3	25.8	14.1	34.1	21.2	18.4	24.6	17.1	22.6	15.6	19.7	13.3	12.1	29.2	3.7	30.9	38.1	9.3	17.8	3.9	17.6	6.5	11.4	6.7	6.2	11.2	7.9	16.0	7.1	4.7	11.0	19.4	7.9	5.2	7.8	19.2	27.8	14.0	50.3	25.7	4.3	19.2	6.4	21.3	1.8	10.7	22.2	54.9	67.3	25.5	125.0	47.1	67.6	57.2	42.6	60.9	89.8	36.7	33.5	58.2	15.7	37.3	35.0	58.4	32.6	44.1	44.3	33.2	16.6	231.2	75.3	32.1	41.8	27.5	19.5	1458.0	17.0	20.0	41.3	39.8	65.3	30.4	29.1	44.6	34.5	19.5	26.9	1366.9	28.2	34.6	33.0	41.4	405.5	34.2	36.3	24.9	496.5	41.1	55.6	22.6	294.0	142.6	23.6	24.9	48.9	73.7	60.4	16.5	16.4	53.5	125.8	19.7	46.4	41.6	140.4	51.6	56.7	75.6	71.1	26.5	33.5	26.4	86.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.5;Spermatocytes: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.1	11.0	3.1	5.5	3.4	4.0	9.3	3.5	4.6	4.9	5.3	11.1	9.4	4.6	13.9	8.5	6.8	3.9	12.9	3.3	3.6	13.7	22.0	4.9	7.9	3.3	3.3	4.9	10.5	10.0	5.8	5.9	3.4	5.9	12.3	10.2	10.1	5.9	14.6	7.7	7.8	5.2	3.5	7.9	8.2	11.7	3.5	7.1	8.6	15.6	8.8	5.5	5.3	3.4	11.0	18.1	3.8	10.5	10.7	11.6	10.9	8.6	12.4	15.8	11.2	13.8	12.9	20.4	11.5	8.0	9.2	11.3	15.7	16.6	14.9	12.3	16.0	22.5	15.2	16.9	13.1	18.4	13.7	11.0	20.4	12.7	13.3	10.3	13.8	18.9	23.5	16.0	13.7	16.6	13.6	14.4	0.7	8.8	20.6	17.8	9.9	33.7	23.3	6.8	5.4	9.7	13.8	23.6	18.3	6.0	25.5	16.9	8.5	10.0	11.9	13.1	12.7	15.1	18.8	6.6	13.9	16.0	10.4	2.1	5.1	3.7	8.6	6.0	10.1	7.9	8.8	10.8	8.4	8.9	10.2	10.7	0.8	11.4	6.8	8.8	6.0	6.3	3.1	3.4	3.5	4.6	3.3	3.6	3.3	3.3	3.4	3.5	3.5	3.4	5.9	0.0	9.4	3.9	9.3	3.1	5.9	23.0	4.0	6.5	8.7	13.2	13.3	10.0	12.0	11.0	4.2	19.5	7.1	5.4	11.7	13.5	59.5	7.8	7.2	4.9	2.4	2.1	4.5	6.8	16.9	5.9	4.6	6.4	10.1	13.0	7.5	17.4	8.5	5.0	5.1	9.8	14.2	3.8	3.2	15.1	7.2	6.8	5.4	1.0	5.2	9.1	6.2	3.5	3.8	7.5	8.9	4.1	7.8	6.5	10.6	18.4	9.2	7.4	0.0	5.3	5.8	48.0	12.6	7.2	4.4	14.1	5.9	19.2	8.8	3.6
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive kinase 1"	O95747	3	38165089-38255484	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		300000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	18.4	17.2	9.7	15.7	10.0	33.8	15.6	13.6	12.5	17.8	13.0	18.3	15.2	14.8	15.6	34.1	12.8	15.1	16.9	9.9	10.8	21.5	18.6	15.5	18.5	11.0	11.0	16.1	12.1	26.3	11.5	16.5	11.1	16.5	19.7	13.0	15.2	16.3	36.7	19.5	15.7	17.6	10.2	15.0	16.8	14.1	11.0	25.1	14.8	35.4	23.4	26.7	21.1	11.2	48.5	21.9	42.5	29.8	29.0	33.3	48.2	41.9	57.1	59.2	63.8	28.3	30.8	53.4	20.8	50.5	25.4	29.4	57.8	43.1	77.5	57.6	24.5	58.6	46.1	31.1	34.6	36.6	34.2	26.6	49.6	54.8	87.8	55.7	37.5	67.7	45.2	29.9	102.7	13.7	71.1	26.4	44.8	31.2	26.1	24.2	35.7	41.4	36.4	36.4	22.0	34.0	45.9	114.2	29.0	46.3	37.7	23.7	34.4	37.0	36.6	56.8	63.0	22.7	29.0	38.7	50.7	44.6	75.3	6.8	1.6	3.9	1.8	2.8	1.9	1.0	2.2	1.7	2.6	1.2	1.7	2.1	3.2	3.1	2.5	1.4	2.8	0.9	9.7	10.0	13.6	12.5	9.9	10.8	11.0	11.0	11.1	10.2	11.0	11.2	19.0	12.8	25.8	46.7	27.3	44.1	35.5	25.3	26.7	13.3	19.4	16.5	32.6	4.3	27.6	27.6	20.9	12.1	27.4	44.0	19.6	28.4	3.9	39.9	32.1	19.0	24.1	29.7	59.6	14.5	21.0	18.4	90.7	91.2	15.8	24.9	14.6	20.5	14.9	21.9	51.9	24.5	10.2	29.8	79.0	2.3	9.6	58.0	7.2	29.0	35.2	8.0	18.6	44.7	42.8	46.5	29.4	12.8	19.5	56.5	27.0	22.5	16.1	7.0	13.1	23.7	22.6	15.1	18.5	41.9	51.9	33.0	29.6	19.6	21.6	115.3
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"brain: 1167.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.0;Hepatocytes: 41.2;Late spermatids: 66.3;Proximal enterocytes: 15.7;Proximal tubular cells: 36.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in many"	141	"hypothalamus: 1167.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;HMC-1: 1.1"	"Region enriched"	"Detected in many"	6	"hypothalamus: 179.3"	"Group enriched"	"Detected in some"	903	"basal ganglia: 794.6;hypothalamus: 1854.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	3.2	1.7	8.3	0.0	0.8	0.1	1.7	0.5	0.9	0.9	0.7	0.4	1.0	0.4	0.0	0.2	0.3	0.0	0.5	0.2	1167.9	4.1	19.3	0.2	0.1	0.2	0.7	0.3	0.1	0.0	15.9	0.0	0.2	0.7	0.0	0.0	0.5	0.1	0.2	2.3	1.0	0.0	1.3	0.2	0.2	2.6	7.8	0.0	0.6	0.0	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.4	0.2	0.5	2.1	0.8	0.5	0.4	1.6	1.4	1.7	0.5	0.2	0.0	0.7	1.3	0.3	8.3	0.8	0.5	0.9	0.2	1167.9	0.2	0.7	0.2	1.3	7.8	0.2	0.6	0.0	1.8	0.3	3.5	0.8	0.7	0.1	1.2	0.0	1.2	1.7	0.2	0.0	1.3	5.5	0.0	0.0	2.3	0.1	1.9	0.1	30.0	0.2	2.4	0.3	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.0	41.2	0.2	0.0	0.1	1.8	0.0	0.3	1.6	66.3	0.9	0.6	3.6	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.7	1.2	1.2	0.4	15.7	36.5	0.9	0.0	0.0	1.8	0.7	1.1	7.8	0.3	1.0	0.0	1.1	0.0	2.0	0.3
P2RX3	P2X3	ENSG00000109991	"Purinergic receptor P2X 3"	P56373	11	57338352-57372396	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;liver: 1.7;testis: 5.2"	"Group enriched"	"Detected in some"	28	"Early spermatids: 34.5;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057776	Uncertain					NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA057776: AB_2683526"	"unprognostic (5.44e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-3)"		"unprognostic (2.24e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-7)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.29e-1)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RX4	P2X4	ENSG00000135124	"Purinergic receptor P2X 4"	Q99571	12	121209861-121234106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.3;Distal enterocytes: 133.7;Hofbauer cells: 129.5;Syncytiotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039494	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039494: AB_10969132"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (6.30e-10)"	"unprognostic (2.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.76e-3)"	10.1	9.9	4.8	15.1	5.0	14.1	12.7	8.3	5.6	18.8	4.6	33.5	28.9	8.5	3.7	5.0	15.3	16.8	7.2	5.1	5.3	13.0	11.5	20.4	15.9	6.7	5.4	18.1	37.4	33.1	5.1	32.7	6.0	12.1	30.2	2.0	30.1	12.0	1.0	4.5	32.8	10.7	6.3	12.6	20.2	6.0	6.3	7.8	12.9	2.3	8.9	12.1	4.1	7.6	6.6	15.4	1.1	21.7	10.3	8.3	40.6	4.9	26.1	6.7	13.3	10.9	23.1	6.4	18.5	17.4	48.2	2.3	4.7	3.2	4.1	17.5	11.8	3.1	0.9	12.5	25.3	7.6	42.5	11.9	6.8	11.0	14.5	20.4	24.2	7.7	6.1	16.2	5.0	31.8	4.7	10.7	5.5	31.8	10.5	6.6	29.5	34.6	3.1	18.0	6.1	9.0	16.0	8.8	55.0	5.7	38.5	21.2	2.1	10.0	11.2	1.2	5.2	28.0	26.1	3.7	19.6	10.2	9.1	72.3	59.1	10.7	13.6	63.1	15.1	11.3	21.9	13.3	32.5	7.1	16.4	9.6	0.8	29.6	54.6	4.4	17.1	32.6	4.8	5.0	8.3	5.6	5.1	5.3	6.7	5.4	6.0	6.3	6.3	7.6	8.4	6.4	19.2	6.5	14.0	3.8	8.9	11.9	6.8	11.1	17.7	11.9	3.8	21.5	11.2	20.2	2.1	135.3	13.7	133.7	0.0	69.7	15.2	9.8	8.9	9.2	21.5	2.1	6.4	35.4	73.8	14.3	19.4	15.1	13.9	14.3	23.6	9.4	129.5	15.2	5.3	90.3	20.3	43.7	20.8	25.1	8.7	53.7	10.6	18.7	57.9	6.5	19.6	4.5	8.0	33.1	80.6	9.8	21.9	10.2	98.7	23.2	6.4	8.6	19.7	7.4	12.0	8.1	6.6	3.4	4.0	155.7	17.8	15.4	24.7	9.7
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 94.6;Plasma cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.2;Karpas-707: 32.7;RPMI-8226: 59.5;U-698: 47.1"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.8	0.3	1.8	30.4	2.2	9.4	0.8	0.2	2.7	0.3	0.0	2.4	1.5	0.1	0.0	0.7	0.3	1.3	8.0	2.1	0.9	0.7	0.5	1.4	78.2	0.6	0.5	0.0	0.2	0.2	1.2	0.2	0.7	0.5	1.9	0.4	1.8	0.0	17.5	0.0	24.7	0.5	0.1	54.4	3.4	0.7	1.1	12.1	0.9	4.0	53.9	2.7	0.3	1.4	8.3	6.7	0.0	0.0	0.2	1.3	0.0	8.4	3.9	0.9	2.6	5.5	9.8	53.2	4.9	4.2	2.9	4.3	18.8	0.0	1.7	0.9	3.2	2.7	17.5	6.3	1.2	3.6	4.2	2.1	1.8	0.2	12.4	6.5	0.0	12.2	0.5	32.7	18.2	0.0	23.4	8.1	4.9	4.4	20.5	0.8	0.0	59.5	0.2	6.3	4.3	0.0	7.5	2.5	3.9	0.0	2.0	3.3	0.1	0.0	4.5	0.2	1.5	11.0	25.2	47.1	0.0	5.1	0.5	0.0	0.1	2.0	3.1	0.0	4.2	76.4	2.8	2.2	0.4	84.8	0.3	0.3	0.0	0.0	0.0	0.1	1.9	4.5	1.8	2.2	0.2	2.7	2.1	0.9	0.6	0.5	0.7	0.1	1.1	1.4	0.1	0.0	0.6	0.0	94.6	0.4	0.1	0.0	0.0	0.8	0.1	0.1	2.7	0.0	0.0	1.8	0.0	0.0	13.4	0.0	0.0	0.2	4.8	0.2	0.2	0.7	0.0	11.1	0.0	0.2	0.0	0.3	0.5	0.3	4.5	0.0	1.4	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	3.1	1.5	1.6	3.6	0.0	1.1	0.0	2.1	0.0	0.0	1.5	0.0	0.0	29.7	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	1.0	0.8	0.0	0.0	0.0	11.0	0.0	0.1	0.1
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.4;skeletal muscle: 12.4;tongue: 7.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.3	1.1	0.0	0.3	0.2	0.0	0.1	1.0	2.6	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.3	0.8	1.3	1.0	1.5	0.2	0.1	0.3	0.2	3.4	0.4	0.3	0.1	0.0	1.3	0.8	3.4	0.3	0.0	0.3	0.2	0.7	12.4	0.1	0.1	0.1	0.1	1.6	0.2	1.1	0.6	0.0	0.0	7.7	0.0	0.2	0.1	1.2	0.0	0.4	0.7	0.2	0.1	0.0	0.8	0.1	1.7	0.7	1.2	0.0	0.0	0.0	1.1	0.4	2.9	1.3	0.0	0.1	0.1	0.2	0.0	1.9	0.9	0.0	2.8	0.0	2.4	0.3	0.0	1.2	0.0	9.7	0.0	0.0	2.1	0.6	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.2	3.1	1.2	0.1	0.5	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.2	0.0	0.0	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	2.6	1.0	1.5	3.4	0.4	3.4	0.1	0.6	1.2	0.2	0.0	0.6	0.3	0.1	0.1	0.8	0.8	0.6	7.6	0.0	0.4	2.4	0.0	0.2	1.8	0.0	0.5	0.0	0.1	0.0	0.0	2.2	1.8	0.5	0.2	3.5	2.7	8.9	0.0	0.4	1.4	0.0	0.7	2.5	0.1	1.8	0.1	0.1	1.7	7.9	0.7	8.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	5.0	3.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	3.2	1.1	0.0	20.8	0.4	1.6	0.4	0.3	0.1	0.4	0.5	0.1	0.1	0.2
P2RX7	"MGC20089, P2X7"	ENSG00000089041	"Purinergic receptor P2X 7"	Q99572	12	121132819-121188032	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 156.7"	"Group enriched"	"Detected in all"	5	"glioma: 7.2;melanoma: 19.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.9;gdT-cell: 1.3;intermediate monocyte: 4.5;myeloid DC: 2.6;non-classical monocyte: 3.3;T-reg: 1.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 4.5;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 40.0;RPMI-8226: 24.8;SK-MEL-30: 41.0;U-266/70: 21.7;U-266/84: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034968, HPA042013, HPA044141"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830"	"unprognostic (1.05e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.54e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-1)"	2.8	2.5	20.2	5.1	28.5	2.9	2.0	23.1	30.7	6.1	11.3	3.6	1.5	4.1	1.5	1.4	2.3	3.5	1.3	21.8	20.7	0.7	4.6	6.5	5.9	26.3	24.7	8.3	1.4	1.7	1.8	2.9	28.3	1.8	2.3	0.5	2.5	1.8	0.6	13.1	1.8	4.2	21.3	5.9	1.6	1.3	26.2	1.7	1.0	1.0	3.6	2.3	4.4	47.3	0.1	0.0	0.0	1.0	1.1	0.4	0.8	0.1	1.9	0.7	1.7	0.0	0.0	0.1	0.1	0.7	4.3	0.2	0.0	0.0	0.5	1.8	0.1	0.7	0.0	0.1	0.8	1.6	11.6	1.0	0.0	2.0	0.0	0.0	1.9	0.4	0.0	40.0	0.0	0.0	0.2	4.4	0.1	0.0	0.4	3.8	8.9	24.8	0.0	0.0	0.5	2.3	0.2	0.0	41.0	0.0	0.6	7.8	0.0	0.6	0.1	0.1	0.2	21.7	20.2	0.1	2.4	11.8	6.1	0.4	2.9	0.0	1.3	4.5	0.5	0.3	0.6	0.6	2.6	0.2	0.5	0.6	0.3	0.6	3.3	0.4	1.4	0.9	20.2	28.5	23.1	30.7	21.8	20.7	26.3	24.7	28.3	21.3	26.2	47.3	2.0	3.2	4.8	12.1	3.9	6.9	3.0	0.0	1.8	3.9	1.8	2.2	2.4	5.7	3.7	0.0	2.1	3.5	9.0	1.2	0.0	1.2	0.6	0.7	1.6	3.9	0.0	1.7	52.8	0.0	0.9	3.7	0.0	0.3	6.3	2.6	5.3	3.9	23.4	1.7	18.4	0.2	0.0	21.5	35.0	1.5	11.1	34.2	16.0	34.7	21.2	1.3	7.2	87.9	156.7	0.2	0.0	10.5	1.3	1.2	0.1	0.0	3.6	1.0	6.6	3.2	1.9	1.2	0.9	1.0	3.7	4.0	6.6	4.1	0.1	1.0
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152835131-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 25.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Cholangiocytes: 21.5;Distal enterocytes: 25.4;Kupffer cells: 21.1;Squamous epithelial cells: 45.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.0;non-classical monocyte: 2.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.0;monocytes: 2.6"	"Cell line enriched"	"Detected in many"	5	"HEL: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	1.6	1.4	6.2	2.3	14.2	5.7	1.4	3.1	6.4	4.5	1.0	9.1	3.2	6.5	0.5	19.2	2.1	2.0	2.9	5.9	6.7	0.8	1.5	7.0	0.8	3.3	4.2	8.8	3.3	0.3	1.6	25.4	8.4	7.7	6.7	9.0	3.2	2.2	7.7	8.9	6.1	4.5	4.9	2.2	0.9	1.1	8.2	1.6	1.3	3.4	2.7	2.4	8.0	4.1	0.0	0.7	7.0	0.0	1.1	0.1	0.0	0.0	0.1	0.2	0.6	9.0	0.1	0.0	0.7	0.0	1.1	1.5	3.9	1.3	0.3	0.0	3.4	45.9	0.1	0.0	0.0	5.4	4.0	0.5	8.7	0.0	0.4	3.5	0.0	1.5	1.4	0.0	0.0	0.1	0.8	0.1	6.4	0.0	5.5	0.0	0.2	1.3	0.0	3.1	1.1	0.0	0.0	0.0	0.9	1.6	0.0	2.4	0.0	0.7	1.8	0.0	3.9	0.0	0.0	0.0	4.5	0.0	5.2	6.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.1	6.2	14.2	3.1	6.4	5.9	6.7	3.3	4.2	8.4	4.9	8.2	4.1	1.0	0.0	0.5	12.7	0.8	1.9	6.7	3.3	15.9	23.3	0.5	0.1	7.1	21.5	1.0	0.0	0.0	0.2	1.6	25.4	0.0	1.3	0.2	1.9	12.0	7.1	0.0	10.8	0.0	0.0	0.3	5.6	0.0	2.7	10.1	0.1	11.7	0.3	7.4	0.0	0.2	8.9	0.0	21.1	0.3	0.8	14.9	15.9	0.0	1.0	1.8	19.1	0.0	0.0	0.6	0.9	12.3	6.0	0.0	6.3	13.4	0.2	0.2	1.5	0.0	1.2	1.0	0.4	2.2	45.4	2.0	0.1	0.5	3.5	8.3	4.9
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78963727	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 256.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 121.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036757, HPA065766"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	0.8	0.5	0.4	14.6	0.5	8.2	0.9	1.4	1.1	1.0	0.0	2.7	3.1	0.8	0.3	1.1	0.4	3.2	0.4	0.4	0.1	0.4	1.6	2.4	27.4	0.2	0.0	0.4	1.5	0.0	0.1	0.3	0.2	1.3	3.6	0.6	1.2	0.2	0.2	0.6	6.4	0.7	0.0	16.6	3.9	0.3	0.2	10.3	0.6	0.1	25.8	5.4	0.4	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	121.8	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	9.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.1	0.0	26.5	0.1	1.4	0.2	0.3	0.1	256.1	0.2	158.1	12.6	0.9	11.4	73.1	28.0	25.5	4.0	74.1	25.7	19.5	27.9	18.1	10.9	2.8	41.7	13.2	0.4	0.5	1.4	1.1	0.4	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.7	0.0	1.7	0.0	79.3	1.8	0.0	0.0	0.0	0.0	0.3	0.3	1.2	0.0	0.6	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.5	0.1	29.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.6	38.5	0.0	0.0	3.6	8.8	0.0	32.5	0.0	9.2	0.0	0.0	0.0	0.0	0.0	32.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.0	0.0	55.1	0.0	0.0	0.3
P2RY11	P2Y11	ENSG00000244165	"Purinergic receptor P2Y11"	Q96G91	19	10111693-10115372	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.8;NK-cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 13.9;T-cells: 18.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 29.7;NB-4: 33.7"					"Low region specificity"	"Detected in many"			HPA014232	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA014232: AB_1854883"	"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.77e-4)"	7.1	4.5	8.0	3.8	9.2	5.6	7.0	8.4	12.4	8.9	4.7	9.4	4.1	6.2	0.7	8.2	10.6	1.1	6.1	8.5	7.5	12.1	10.1	7.4	6.8	9.0	7.7	9.2	7.6	0.6	9.5	1.1	8.3	11.7	0.8	1.6	7.3	1.2	9.0	16.9	10.9	0.7	7.1	15.0	7.3	10.9	10.0	1.4	11.3	0.3	2.0	9.8	8.4	8.2	5.2	4.8	1.7	6.5	2.5	2.0	10.6	1.9	1.0	1.1	2.1	5.7	3.0	9.8	2.6	0.5	0.8	8.2	1.7	5.0	0.2	4.3	29.7	7.7	8.4	3.3	3.7	3.5	14.8	3.7	4.1	1.6	2.7	2.0	0.7	6.2	3.5	13.8	1.1	7.5	6.8	33.7	11.7	4.9	3.9	10.5	3.3	5.6	2.1	6.5	7.3	12.1	1.2	4.1	14.7	0.7	3.6	14.2	2.0	7.1	2.8	11.6	3.8	25.6	20.0	3.1	4.8	20.8	6.3	3.5	1.7	0.1	7.3	2.0	18.9	1.2	1.0	6.9	0.8	0.6	0.7	5.5	0.5	13.9	1.2	0.2	1.5	4.9	8.0	9.2	8.4	12.4	8.5	7.5	9.0	7.7	8.3	7.1	10.0	8.2	2.3	6.4	3.7	0.0	3.3	4.8	2.6	2.6	0.6	7.6	3.8	3.2	1.7	5.7	2.6	1.8	2.1	1.8	7.3	4.4	1.9	1.2	0.3	3.8	3.6	2.8	3.6	3.2	0.0	1.1	1.4	1.9	4.6	5.0	3.8	4.2	2.2	3.6	37.8	6.7	0.0	5.2	4.1	2.4	3.3	0.4	3.4	8.7	1.8	0.0	0.8	1.9	22.6	0.0	0.0	1.5	1.6	1.2	2.9	4.1	1.2	1.5	3.5	6.0	0.0	6.8	2.7	1.8	3.6	1.3	4.0	1.4	9.3	5.1	5.6	1.7
P2RY12	"HORK3, P2Y12, SP1999"	ENSG00000169313	"Purinergic receptor P2Y12"	Q9H244	3	151336843-151384753	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.8;lymphoid tissue: 9.8"	"Cell type enriched"	"Detected in some"	27	"Microglial cells: 421.6"	"Cancer enriched"	"Detected in many"	14	"glioma: 17.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 8.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;monocytes: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013796, HPA014518"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA013796: AB_1854884, HPA014518: AB_2669027"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.64e-4)"	"unprognostic (4.84e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.04e-1)"	8.6	4.0	4.8	1.9	5.1	0.5	3.7	5.1	6.1	1.3	2.4	1.6	1.2	0.7	0.6	1.2	2.5	2.2	1.3	5.7	6.9	0.6	2.5	2.5	9.8	10.2	8.1	1.6	0.8	1.6	0.3	2.3	11.8	0.9	1.4	0.3	2.9	2.0	0.1	0.4	2.8	1.6	11.5	5.5	1.1	0.2	8.5	0.9	0.5	0.6	8.7	1.1	0.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.3	0.0	0.0	3.2	0.5	0.0	0.0	0.3	0.0	2.2	0.3	0.0	1.3	4.8	5.1	5.1	6.1	5.7	6.9	10.2	8.1	11.8	11.5	8.5	13.8	0.2	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	421.6	0.7	0.4	0.0	15.6	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329549	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.1;lymphoid tissue: 36.9"	"Group enriched"	"Detected in some"	9	"Kupffer cells: 124.4;Macrophages: 53.2;Microglial cells: 66.5;monocytes: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 581.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 581.5;monocytes: 185.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA049047: AB_2680611"	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.8	3.8	1.6	20.6	1.6	25.1	4.2	1.6	2.2	2.6	2.7	4.5	4.6	1.9	0.8	3.2	3.1	3.9	1.4	1.9	2.0	1.6	8.2	7.6	18.2	3.1	2.4	1.6	1.2	1.6	0.5	3.3	2.8	1.4	6.2	0.1	2.9	3.2	0.7	2.1	11.0	5.3	3.7	36.9	3.1	0.7	4.2	4.5	1.3	3.8	8.4	4.1	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	152.5	137.2	0.3	155.4	0.3	1.5	0.2	0.2	66.4	0.6	0.2	0.3	581.5	0.1	185.6	1.1	0.2	77.6	1.6	1.6	1.6	2.2	1.9	2.0	3.1	2.4	2.8	3.7	4.2	4.0	0.9	0.0	6.1	0.0	1.3	0.0	0.1	0.0	0.0	0.8	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	3.6	0.3	0.0	0.2	0.6	0.5	0.0	2.5	0.0	0.7	0.4	7.7	1.7	0.2	0.0	0.0	124.4	4.5	0.0	0.0	53.2	0.0	66.5	63.3	1.1	2.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.0
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278542	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.6;placenta: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"eosinophil: 230.1;plasmacytoid DC: 98.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 98.0;granulocytes: 230.1"	"Cell line enriched"	"Detected in single"	68	"HMC-1: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	7.9	0.8	2.6	10.8	3.8	0.7	7.0	3.4	7.1	5.9	24.6	11.7	6.9	8.0	0.6	20.2	1.1	5.2	5.3	3.2	1.8	2.0	1.0	7.2	9.6	1.3	2.2	1.5	0.6	2.4	0.9	31.7	1.1	0.7	9.7	0.4	1.2	1.3	2.5	1.9	12.0	4.1	1.0	5.7	11.2	0.5	3.8	4.8	2.5	6.4	6.7	9.2	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	10.3	0.4	230.1	1.1	0.3	19.0	3.7	0.6	2.2	13.8	17.0	0.1	0.0	8.9	11.7	0.1	98.0	1.1	2.0	2.6	3.8	3.4	7.1	3.2	1.8	1.3	2.2	1.1	1.0	3.8	3.3	5.8	3.2	0.5	31.0	13.9	2.3	0.0	0.0	0.0	2.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.1	54.4	0.0	0.0	0.0	0.4	1.0	35.5	5.9	0.0	0.4	41.2	0.0	0.2	3.9	0.0	0.7	45.7	0.0	0.0	0.0	0.6	0.0	16.4	0.0	0.0	0.8	61.3	0.5	0.0	22.7	3.6	5.6	1.2	0.4	1.0	29.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.7	0.4	26.3	1.6	29.3	0.0	0.1	0.2	1.7	0.3	4.8	1.5	0.1	0.1
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218281-73242427	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.7;skeletal muscle: 50.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 57.6"	"Group enriched"	"Detected in many"	12	"granulocytes: 57.6;monocytes: 20.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.8	3.8	1.4	1.8	1.6	15.8	1.7	1.3	1.0	6.9	1.1	3.3	2.7	0.5	0.3	29.7	1.4	0.7	10.0	1.3	1.8	2.7	3.9	3.5	0.1	2.1	1.9	0.4	0.7	4.8	1.6	2.0	1.6	2.1	2.8	1.2	6.2	1.2	50.2	6.0	5.9	0.5	1.3	3.9	1.1	1.2	2.6	0.2	8.8	31.3	2.8	2.2	19.0	1.4	7.2	6.7	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	17.2	5.4	0.0	10.4	0.4	0.0	32.8	0.9	15.2	0.0	0.0	0.6	2.3	0.6	3.2	0.1	30.8	0.0	0.0	6.8	2.3	0.5	0.0	1.4	0.0	1.4	0.0	0.0	25.1	0.1	26.1	0.4	6.8	24.5	0.0	0.0	1.1	2.4	17.9	0.0	0.0	0.5	29.6	0.0	0.2	12.9	76.5	10.2	0.0	0.3	0.0	0.0	1.0	0.4	0.0	0.0	5.6	0.0	0.5	6.6	57.6	0.0	20.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	13.5	0.0	0.0	2.5	1.4	1.6	1.3	1.0	1.3	1.8	2.1	1.9	1.6	1.3	2.6	1.4	0.7	3.2	0.5	0.0	0.2	3.7	8.6	13.2	1.2	0.7	2.8	0.5	6.1	5.7	10.3	0.0	0.0	16.5	0.0	18.0	1.9	5.8	6.0	1.4	0.1	1.5	0.0	0.8	0.0	6.3	1.3	0.7	0.5	0.8	0.0	1.2	0.0	5.2	2.6	0.0	0.0	5.1	0.0	3.7	0.7	8.8	0.0	4.5	0.0	0.0	2.8	6.0	0.0	0.0	0.1	18.9	10.9	0.0	0.2	5.3	14.2	0.3	2.8	0.4	0.0	0.8	1.4	0.1	0.1	12.6	7.2	10.9	0.1	0.1	3.0	11.7
P2RY4	"NRU, P2P, P2Y4, UNR"	ENSG00000186912	"Pyrimidinergic receptor P2Y4"	P51582	X	70258170-70259764	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB022644	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB022644: "	"unprognostic (4.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.69e-1)"	"unprognostic (9.53e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.89e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.2	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RY6	P2Y6	ENSG00000171631	"Pyrimidinergic receptor P2Y6"	Q15077	11	73264498-73305103	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.5"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 124.3;Syncytiotrophoblasts: 272.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"myeloid DC: 27.2;plasmacytoid DC: 87.5"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 87.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 59.2;EFO-21: 18.1;MCF7: 30.4;SK-BR-3: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074751	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA074751: "	"unprognostic (2.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.93e-3)"	"unprognostic (4.00e-3)"	"unprognostic (1.86e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (1.48e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.05e-1)"	2.9	1.5	0.9	7.0	1.1	0.8	1.2	0.6	1.8	1.7	0.8	2.2	2.4	0.8	0.5	2.5	1.1	1.5	2.8	1.4	0.7	7.5	0.9	2.9	3.1	1.2	0.8	0.3	1.4	0.2	2.3	10.7	1.0	2.0	1.7	0.8	1.4	0.6	2.7	0.7	4.0	2.7	0.5	32.5	1.8	0.5	1.3	1.4	4.9	0.3	1.3	3.1	1.4	1.4	1.3	12.9	0.1	59.2	0.0	0.1	13.7	0.2	0.0	0.2	0.1	11.6	0.2	0.1	18.1	0.4	0.1	3.0	0.1	0.1	0.1	0.3	0.1	0.1	1.2	8.1	0.0	0.2	0.3	0.2	0.0	0.7	0.0	1.0	0.1	0.1	0.1	0.4	0.2	30.4	0.1	2.8	0.2	0.4	0.2	0.1	0.1	1.4	11.0	0.2	0.2	0.7	1.7	53.4	0.1	1.2	13.4	2.7	0.3	2.0	0.1	1.8	0.1	0.5	0.2	0.1	2.7	4.0	0.1	2.3	2.7	0.2	0.1	4.6	0.3	0.1	0.1	0.1	27.2	0.2	0.1	0.1	0.6	3.4	1.5	87.5	0.1	2.2	0.9	1.1	0.6	1.8	1.4	0.7	1.2	0.8	1.0	0.5	1.3	1.4	0.3	0.0	0.6	0.3	1.5	0.1	0.4	0.4	0.6	0.0	0.6	1.0	0.8	0.0	0.7	9.2	0.0	124.3	16.9	0.1	3.9	2.7	0.4	0.3	0.1	8.9	0.0	2.7	0.7	14.4	11.6	1.8	0.0	0.4	0.0	0.2	1.1	0.1	19.8	0.0	0.1	0.3	0.0	9.2	9.8	2.3	0.0	12.9	0.0	13.1	13.4	1.1	0.0	0.5	0.0	14.9	0.0	0.0	12.6	0.3	2.9	12.0	0.9	0.1	0.0	2.4	0.8	0.0	0.1	0.2	0.4	272.5	0.6	0.5	0.2	0.5
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462581-1537185	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 31.2;lymphoid tissue: 40.1"	"Group enriched"	"Detected in some"	4	"B-cells: 42.0;dendritic cells: 56.2;monocytes: 26.1;NK-cells: 56.7;Plasma cells: 49.3;T-cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 119.2;MOLT-4: 60.6;NB-4: 59.6;RPMI-8226: 74.3;THP-1: 73.7;U-266/70: 96.8;U-698: 192.8;U-937: 60.6"					"Low region specificity"	"Detected in single"			HPA003631	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.80e-5)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favorable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	3.5	4.6	0.4	19.2	0.5	31.2	2.4	0.8	1.1	0.7	0.8	3.4	3.4	0.8	0.9	1.3	0.7	3.8	4.9	0.2	0.7	3.6	1.9	3.0	40.1	1.5	0.5	1.1	2.1	2.1	2.1	1.2	0.9	1.5	3.2	0.7	3.4	1.1	2.6	1.8	7.5	1.4	0.5	20.0	5.1	0.4	1.4	16.4	7.9	1.4	33.4	4.4	0.5	1.8	0.6	0.5	0.5	1.5	0.0	0.0	1.3	0.2	0.1	0.0	0.1	0.4	0.7	119.2	0.6	0.0	0.5	0.5	0.0	0.1	0.0	4.7	0.4	1.0	1.3	6.1	0.1	53.2	12.3	0.1	0.1	0.1	0.0	1.1	0.0	35.1	1.1	48.9	0.1	0.1	60.6	59.6	0.7	0.1	1.3	54.1	0.6	74.3	0.1	0.9	0.2	0.8	0.4	1.1	0.3	1.1	0.6	73.7	0.3	1.0	1.1	0.5	0.3	96.8	19.6	192.8	0.2	60.6	0.2	49.9	18.9	31.1	58.6	12.7	53.6	34.2	44.5	55.8	13.6	38.3	34.7	36.4	11.3	37.5	5.2	3.6	37.6	53.3	0.4	0.5	0.8	1.1	0.2	0.7	1.5	0.5	0.9	0.5	1.4	1.8	5.9	0.0	1.8	0.3	42.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.2	0.0	0.6	1.8	0.0	0.0	56.2	0.1	0.0	0.0	0.0	0.1	0.1	5.2	0.0	9.9	0.7	0.2	0.0	0.4	2.6	0.1	1.3	0.3	3.9	0.3	1.9	0.0	0.7	0.0	0.0	11.2	1.8	0.0	0.0	8.7	1.8	1.9	26.1	0.0	56.7	1.0	0.4	0.0	0.0	0.0	49.3	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.0	40.7	0.9	0.2	0.0
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 193.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	12.4	11.1	3.6	8.7	3.5	6.1	10.2	3.6	4.4	13.4	7.3	8.3	2.4	13.8	6.1	4.4	9.8	12.0	9.1	3.8	3.8	7.2	13.3	11.6	5.1	5.2	3.5	12.8	6.8	5.9	15.5	37.4	3.8	7.5	5.4	1.3	6.7	5.9	3.0	7.6	7.4	20.3	3.4	11.5	6.7	15.2	3.8	7.6	7.6	3.9	5.1	12.3	8.5	3.6	8.7	22.3	48.7	115.0	112.8	85.4	20.1	101.8	131.9	71.9	121.7	11.3	18.8	13.0	79.7	193.0	29.2	7.8	20.9	25.9	49.2	19.5	26.3	30.5	32.2	32.6	65.2	30.9	34.0	73.8	17.4	72.6	30.9	102.4	102.9	18.3	17.5	16.1	49.0	4.7	20.6	17.8	53.1	4.7	16.0	19.9	71.9	17.7	38.2	4.9	10.2	17.3	62.5	1.7	45.8	85.2	3.7	127.0	85.1	53.8	47.2	43.4	41.2	14.5	17.5	11.9	61.5	41.5	77.0	5.0	18.9	16.8	8.3	20.4	8.8	4.1	6.3	7.0	23.6	3.3	5.1	5.3	1.8	17.8	26.3	10.9	12.4	9.3	3.6	3.5	3.6	4.4	3.8	3.8	5.2	3.5	3.8	3.4	3.8	3.6	13.7	3.2	2.3	5.9	10.5	0.0	6.4	0.0	6.2	10.2	4.5	6.5	5.0	7.2	0.6	11.0	25.0	47.9	11.1	0.4	0.0	11.5	17.1	3.2	30.1	16.4	6.1	11.3	12.9	7.6	56.6	34.4	3.6	4.4	1.3	28.8	16.8	11.3	17.6	15.2	10.8	2.5	0.0	8.7	0.0	10.8	19.3	11.7	0.0	9.4	10.5	3.5	6.2	9.5	6.9	7.4	2.0	16.1	11.2	3.4	1.7	1.9	0.7	22.1	0.0	17.2	22.3	30.6	18.8	3.5	0.0	17.5	9.6	27.0	1.9	4.5
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828407-6839847	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.2;Cone photoreceptor cells: 100.1;Horizontal cells: 43.7;Leydig cells: 49.7;Peritubular cells: 38.4;Rod photoreceptor cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 39.6;hTERT-RPE1: 27.3;NTERA-2: 27.5;U-251 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		740000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.5	2.6	1.2	1.5	0.7	0.3	3.9	3.7	2.7	11.9	5.6	5.4	0.8	19.2	0.5	1.6	9.9	1.7	4.5	1.1	1.2	2.0	0.6	3.7	0.3	1.3	0.2	12.4	2.9	4.5	15.4	1.3	0.3	6.0	0.3	4.1	6.5	3.7	0.8	3.0	2.8	3.8	0.2	1.3	3.8	1.2	0.9	0.1	4.3	0.3	0.3	7.8	6.4	0.5	0.0	1.6	7.1	14.0	8.4	10.2	0.3	39.6	22.4	12.2	13.5	0.6	0.0	0.0	0.5	14.9	0.5	0.0	4.4	0.4	2.7	0.1	18.8	1.0	4.2	1.9	5.9	1.0	0.0	11.1	0.4	6.0	3.3	27.3	13.1	1.2	3.7	0.0	5.7	0.0	0.1	0.4	27.5	0.0	1.1	0.0	6.9	0.2	0.6	0.0	2.8	10.5	0.1	0.0	4.8	3.4	0.2	0.2	23.2	12.0	17.5	18.6	27.7	0.1	0.3	0.3	10.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.7	2.7	1.1	1.2	1.3	0.2	0.3	0.2	0.9	0.5	2.3	0.0	0.0	3.3	0.5	0.0	4.9	0.0	2.2	47.2	5.3	5.5	11.1	1.5	1.8	5.5	100.1	0.5	0.1	0.1	1.9	1.4	0.9	0.9	19.6	3.9	1.2	0.0	13.1	2.7	0.5	24.1	2.0	0.4	0.0	0.8	7.9	0.0	1.4	43.7	13.7	2.7	0.0	0.0	0.0	2.2	49.7	0.5	0.0	2.8	1.1	5.3	0.0	5.5	1.3	1.3	0.1	38.4	3.1	5.1	0.4	0.4	1.5	28.8	6.6	7.8	11.9	0.7	0.8	0.8	0.0	1.0	0.9	3.2	0.6	1.5
P3R3URF-PIK3R3		ENSG00000278139	"P3R3URF-PIK3R3 readthrough"		1	46043661-46176488	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	8	"testis: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 3.1;RT4: 10.7"									HPA005751	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"				"HPA005751: AB_1855350"																		0.4	0.0	0.0	0.4	0.1	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	21.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.0	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	1.4	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.8	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 494.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No		60000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	28.1	26.0	25.7	20.8	26.4	15.5	26.3	29.6	58.5	31.9	34.7	16.3	11.0	27.0	18.9	10.1	41.1	26.3	38.7	26.5	27.1	35.8	72.8	27.8	16.2	32.9	30.0	34.9	17.5	17.0	11.6	65.3	33.0	20.0	17.4	33.3	13.0	18.4	110.9	17.4	14.4	28.5	30.2	19.6	19.8	19.3	30.1	12.9	13.9	54.0	14.6	29.6	18.2	39.0	84.0	21.2	60.1	117.6	181.2	138.3	50.1	239.9	215.8	90.8	215.8	35.6	63.6	28.4	89.7	239.0	55.1	92.5	38.3	87.7	197.1	36.5	14.5	24.4	18.6	42.5	75.3	45.1	16.4	84.5	50.3	77.7	101.6	494.2	43.5	23.8	38.3	14.7	79.3	22.4	17.9	42.9	21.6	38.9	92.3	16.4	40.2	52.4	51.0	35.6	5.5	33.7	49.2	143.2	58.3	135.0	21.9	41.9	41.9	110.5	44.8	31.3	56.9	81.8	31.3	13.7	198.1	64.5	54.9	1.1	18.8	14.9	6.7	23.5	8.7	8.2	8.1	7.9	20.7	9.2	5.9	6.1	10.4	5.2	25.7	16.6	10.7	9.1	25.7	26.4	29.6	58.5	26.5	27.1	32.9	30.0	33.0	30.2	30.1	39.0	29.0	6.4	28.4	87.1	31.7	36.3	33.0	138.0	22.2	13.5	23.8	15.7	42.0	7.2	69.2	23.9	27.1	31.5	24.9	25.1	0.0	33.1	16.8	85.6	89.2	25.9	10.3	7.2	48.8	19.5	116.4	67.7	14.3	131.4	40.5	16.9	20.0	29.8	43.9	11.8	41.6	9.5	46.8	54.1	75.7	8.1	51.9	51.5	44.4	62.8	39.0	34.0	6.2	86.5	44.8	36.6	27.1	47.0	32.9	24.9	13.5	25.1	94.6	17.2	39.5	37.0	44.7	61.7	34.0	9.8	23.9	33.2	27.7	31.1	7.0	17.6
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
P4HA3	C-P4Halpha(III)	ENSG00000149380	"Prolyl 4-hydroxylase subunit alpha 3"	Q7Z4N8	11	74235801-74311640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 10.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 25.6;Erythroid cells: 13.5;Horizontal cells: 18.5;Rod photoreceptor cells: 12.8;Spermatocytes: 13.1;Spermatogonia: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 19.5;fHDF/TERT166: 9.5;HSkMC: 9.1;HUVEC TERT2: 38.2;TIME: 27.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA007897	Approved				"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA007897: AB_2156427"	"unprognostic (2.74e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.31e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.54e-4)"	"unprognostic (9.65e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.34e-9)"	"unprognostic (1.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.83e-4)"	1.6	0.7	0.1	3.9	0.0	0.0	0.9	0.1	0.3	1.3	0.3	1.6	0.3	4.5	0.5	0.3	1.2	5.6	0.3	0.0	0.1	1.0	1.3	1.4	0.9	0.1	0.1	1.0	0.2	0.0	3.7	3.9	0.1	6.3	0.7	0.0	0.5	4.3	0.1	0.3	0.4	10.5	0.0	0.1	0.4	1.5	0.1	0.1	2.6	0.1	0.3	5.4	1.7	0.1	0.0	1.4	1.7	0.0	6.2	0.7	0.0	19.5	1.4	1.0	2.1	0.0	0.0	0.0	1.8	9.5	0.7	0.0	0.0	0.3	0.2	0.0	0.1	0.0	1.2	0.0	8.0	0.0	0.0	9.1	0.0	6.5	0.7	1.1	38.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	27.4	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.2	0.4	0.7	0.9	0.0	9.1	0.5	0.1	0.4	0.0	0.2	0.0	14.6	0.2	3.1	0.2	0.0	0.2	25.6	3.8	2.5	3.2	0.0	13.5	2.4	0.0	0.4	5.2	0.0	1.0	0.0	4.3	6.1	0.0	0.4	18.5	3.3	0.2	0.0	0.9	1.1	3.2	0.0	0.3	0.0	6.5	1.6	1.9	3.1	1.5	0.9	0.8	0.2	0.4	0.0	1.1	0.2	0.0	0.7	12.8	0.0	2.1	5.4	13.1	12.2	0.1	0.3	0.1	0.4	1.3	0.2	0.6
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989889-49007153	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.3;Respiratory ciliated cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favorable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	13.3	37.1	50.6	4.9	53.3	5.9	12.4	44.3	67.9	18.4	89.7	14.7	12.1	17.6	18.7	8.2	39.8	11.2	26.2	53.5	57.3	29.8	11.9	15.7	6.5	52.2	49.6	20.0	38.5	39.4	75.9	11.0	51.5	18.5	7.4	16.4	19.6	16.8	15.2	10.1	13.0	7.4	45.8	10.7	25.1	23.6	53.3	5.5	26.5	11.3	3.8	12.8	13.1	49.6	8.6	27.9	4.8	0.1	15.5	17.6	0.4	16.8	24.6	13.2	14.8	6.3	55.6	8.1	15.8	21.6	10.5	4.8	12.5	6.6	4.1	30.4	19.5	0.0	42.1	0.0	38.6	8.3	0.2	11.0	6.3	13.4	1.1	51.4	15.0	0.1	0.0	37.9	6.5	48.1	1.2	1.0	6.8	52.6	31.2	0.0	0.0	53.5	24.4	15.9	20.9	0.2	17.7	25.0	0.1	1.1	20.1	13.1	9.9	8.0	6.1	19.9	14.5	50.0	28.6	0.1	54.9	0.7	7.1	8.0	9.0	5.9	6.7	3.5	9.6	8.4	12.3	11.7	9.4	15.9	13.0	8.3	0.8	5.9	4.5	1.6	17.0	6.0	50.6	53.3	44.3	67.9	53.5	57.3	52.2	49.6	51.5	45.8	53.3	49.6	15.1	22.4	17.3	36.2	16.1	9.2	34.6	41.1	12.5	72.9	28.7	23.0	12.0	41.5	44.0	46.0	87.6	31.4	13.4	27.4	19.6	38.3	138.4	106.4	23.7	12.6	80.9	12.4	55.7	39.1	9.9	28.1	48.9	31.2	22.9	31.6	15.4	8.5	16.8	117.8	48.6	40.4	65.1	6.3	12.8	155.3	30.4	13.0	12.4	20.6	11.3	58.4	14.4	17.1	32.3	23.6	51.8	25.9	28.9	24.4	56.2	30.4	169.4	72.5	19.7	32.9	24.7	32.5	7.0	12.9	10.4	26.1	25.0	23.9	40.9	31.2
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104537-56113910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		2300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	78.4	59.6	46.7	89.3	50.4	132.9	76.2	50.7	58.0	64.8	43.0	78.7	74.1	64.7	48.2	132.5	64.7	43.7	76.9	48.6	51.8	62.1	72.8	62.5	96.6	49.4	48.3	71.2	75.1	83.7	36.3	69.2	51.0	53.2	90.5	38.3	63.9	55.4	144.0	106.1	69.7	68.4	49.8	61.2	65.5	63.1	48.9	123.4	61.4	92.5	120.7	105.3	76.9	57.2	429.6	374.8	248.9	275.5	112.5	169.8	499.6	441.3	209.7	530.9	293.8	464.7	307.5	850.8	291.2	209.6	155.9	343.5	574.2	493.1	510.9	243.9	517.6	659.1	242.5	400.4	219.7	898.8	232.4	172.5	247.2	460.2	410.8	218.1	327.3	292.0	812.8	380.7	294.7	383.5	700.8	496.2	410.9	264.5	460.9	569.3	449.8	577.2	272.0	315.7	372.8	225.6	290.5	451.6	275.0	183.1	488.7	343.5	264.8	256.3	364.7	300.3	495.5	234.4	345.1	822.1	232.3	532.6	340.9	34.3	87.0	54.6	129.9	96.0	174.7	98.0	136.8	141.3	102.1	81.3	129.7	131.2	13.8	151.5	82.0	98.6	170.9	155.9	46.7	50.4	50.7	58.0	48.6	51.8	49.4	48.3	51.0	49.8	48.9	57.2	135.7	54.5	91.2	9.8	136.3	368.5	244.7	187.4	224.8	56.2	151.9	165.7	37.3	118.7	161.3	130.6	18.8	232.0	163.1	123.4	193.7	235.8	530.6	127.1	218.4	154.2	93.3	552.1	12.8	249.1	321.7	139.5	112.7	142.2	170.9	103.7	107.8	197.5	208.6	33.7	13.0	159.0	99.7	124.2	127.8	238.9	132.0	126.2	129.9	6.5	155.4	117.1	178.2	10.6	14.8	269.3	100.8	126.7	163.5	360.7	118.6	264.7	103.6	48.8	144.7	188.1	191.7	344.6	110.9	295.2	362.7	193.5	176.2	132.2	254.1	242.7
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931114	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 130.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	17.3	29.0	85.2	11.3	92.6	9.0	17.6	82.3	130.1	19.4	68.8	25.0	11.8	16.6	23.8	14.4	19.6	12.0	25.2	80.3	85.9	23.9	21.9	12.6	12.6	88.0	88.6	24.6	22.2	19.1	25.8	11.7	87.3	22.0	16.3	46.4	15.4	19.8	19.8	19.2	14.3	15.5	85.4	16.3	18.5	30.3	85.7	15.9	18.8	7.5	17.2	21.7	16.3	101.2	13.5	30.6	27.2	21.3	28.9	29.6	15.5	22.6	25.9	35.3	25.0	60.2	10.4	40.4	34.4	23.2	32.8	30.2	33.5	27.2	52.2	30.4	20.8	41.4	28.0	50.3	34.6	39.1	15.3	30.5	41.7	38.8	47.2	28.4	27.0	32.1	50.7	33.7	33.2	26.3	34.5	40.5	12.7	71.0	23.7	31.6	72.6	66.5	26.5	22.9	28.8	33.8	26.8	17.7	70.6	25.4	53.1	21.8	19.7	24.8	15.7	35.3	22.3	41.3	50.3	82.2	17.4	25.0	26.5	53.4	26.2	32.3	26.8	17.2	29.5	40.8	28.7	27.3	34.4	36.1	37.0	31.7	2.2	32.4	6.3	24.8	36.8	27.9	85.2	92.6	82.3	130.1	80.3	85.9	88.0	88.6	87.3	85.4	85.7	101.2	9.0	3.2	12.5	40.1	11.5	4.7	11.6	27.3	6.8	50.4	6.8	9.1	19.6	8.6	15.6	16.5	112.6	33.5	9.5	5.5	13.7	15.9	38.4	10.7	12.2	9.8	3.6	20.2	17.4	13.8	4.8	11.5	6.6	9.4	19.6	30.1	11.7	13.6	18.8	47.1	23.7	7.7	20.3	9.5	6.6	22.6	16.8	9.5	14.2	14.0	16.3	37.6	18.6	24.6	55.5	7.3	5.7	18.0	15.3	9.6	12.0	53.5	14.1	51.7	6.6	18.2	12.5	48.9	28.6	9.6	8.1	18.3	9.8	29.9	10.3	8.0
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol		NA	NA		3900000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	627.6	341.5	48.8	490.8	73.4	364.0	575.7	54.9	58.6	700.3	86.2	524.3	450.2	453.5	68.3	1353.3	437.0	227.1	233.8	35.3	80.2	296.4	347.7	490.3	542.4	104.1	58.7	724.0	728.0	126.7	167.7	214.5	92.2	473.9	270.3	80.2	1287.6	172.7	197.7	732.4	502.0	226.5	64.1	483.1	524.7	507.9	92.7	421.0	303.4	75.8	532.3	630.5	853.3	81.6	2069.1	644.4	372.2	842.0	585.0	1050.0	793.4	504.4	593.5	451.8	468.7	791.5	1107.8	3230.4	1609.1	809.5	291.3	792.4	554.6	1092.3	459.5	758.2	555.4	1713.1	302.2	562.6	835.7	673.3	891.0	1338.6	1050.2	554.8	2126.1	950.7	690.8	1071.8	1339.4	1120.1	477.5	857.3	2617.8	949.5	882.3	1487.3	929.6	967.5	541.7	1074.2	301.8	953.1	629.2	650.1	415.8	548.6	1200.7	513.2	1031.7	949.5	1005.1	512.4	809.4	723.9	897.9	753.6	606.1	1523.2	609.7	1378.1	538.8	122.8	401.3	131.2	159.3	405.2	348.9	297.4	333.0	264.3	421.4	263.0	437.4	370.4	112.5	306.9	468.5	277.2	301.5	568.0	48.8	73.4	54.9	58.6	35.3	80.2	104.1	58.7	92.2	64.1	92.7	81.6	348.4	371.8	939.1	28.7	1089.1	787.4	1075.3	735.0	1067.7	66.5	1036.1	641.2	139.7	459.0	1020.8	110.3	50.1	454.2	872.8	457.0	264.1	467.0	1727.8	352.1	628.4	523.0	477.1	999.1	42.4	769.0	860.8	458.8	530.1	436.1	1054.1	357.3	570.8	308.3	615.5	72.3	34.1	853.8	360.1	1520.8	1162.9	306.0	498.9	1144.3	370.0	53.4	1583.7	167.7	679.7	29.7	41.1	626.9	698.0	424.3	674.4	655.3	446.1	388.4	473.5	88.4	499.6	530.4	876.7	1433.1	476.0	929.6	765.3	777.9	1041.1	408.3	1061.2	1296.9
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;prostate: 2.5"	"Group enriched"	"Detected in some"	10	"Early spermatids: 14.3;Late spermatids: 48.5"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.5"									HPA041573	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041573: AB_2677556"					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.0	1.0	4.6	0.0	3.9	0.0	0.0	2.3	6.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.7	6.1	0.0	0.0	0.0	0.0	2.6	2.7	0.0	0.0	0.1	2.0	0.0	2.5	2.5	0.0	1.1	1.8	0.2	0.0	0.0	0.1	0.0	0.8	0.2	0.0	1.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.9	2.3	6.3	3.7	6.1	2.6	2.7	2.5	0.8	4.3	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	48.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PABPC1L2B	RBM32B	ENSG00000184388	"Poly(A) binding protein cytoplasmic 1 like 2B"	Q5JQF8	X	73002939-73006106	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.2;pituitary gland: 2.1;prostate: 2.7;salivary gland: 2.1;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.7;Excitatory neurons: 2.2;Inhibitory neurons: 2.7;Oligodendrocytes: 1.7"	"Cancer enriched"	"Detected in single"	23	"prostate cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"									HPA041573	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041573: AB_2677556"					"unprognostic (1.73e-1)"							"unprognostic (2.26e-1)"			"unprognostic (3.31e-1)"			0.0	0.6	2.6	0.0	1.7	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.3	3.4	0.0	0.0	0.0	0.0	1.6	1.0	0.0	0.0	0.0	2.1	0.0	0.8	2.7	0.0	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	0.2	5.2	1.3	3.4	1.6	1.0	0.8	0.1	2.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25096136-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 36.8"	"Group enriched"	"Detected in many"	14	"Early spermatids: 217.6;Late spermatids: 135.4;Spermatocytes: 190.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"U-266/84: 6.8"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.4	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.2	0.1	0.2	0.4	0.0	0.2	0.2	0.5	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.6	0.0	0.1	0.5	0.3	0.0	0.2	0.2	0.3	36.8	0.3	0.0	0.2	0.0	0.0	0.3	0.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	6.8	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.1	0.3	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	1.3	11.7	9.9	2.8	0.0	0.1	0.4	0.0	5.3	0.0	1.3	0.0	0.0	2.0	4.0	0.9	0.0	0.3	217.6	0.2	0.4	2.5	4.2	2.7	0.0	0.4	1.8	2.0	0.0	0.1	4.5	0.1	2.5	1.0	1.6	1.7	0.0	1.6	2.0	5.7	12.7	135.4	3.1	1.9	5.4	0.0	2.1	1.3	0.0	0.0	0.0	0.1	3.0	4.9	0.0	4.5	0.5	2.0	1.0	0.0	6.6	4.8	10.5	190.8	5.1	0.0	12.9	2.9	2.5	0.2	2.7	5.0
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560709-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 469.7;skeletal muscle: 557.5"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 460.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Supported		Enhanced	Cytosol		NA	NA		850000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	98.4	95.9	26.1	51.2	27.5	76.8	76.1	24.7	28.6	68.8	31.5	83.6	36.8	87.2	41.1	72.1	67.8	39.8	151.9	25.8	24.4	57.0	82.0	72.9	65.1	33.6	25.6	124.8	469.7	27.9	37.4	49.6	30.4	59.3	32.7	22.7	75.5	36.9	557.5	65.0	66.7	46.2	30.4	71.2	153.1	99.4	32.7	32.7	55.0	244.6	65.1	91.9	69.2	36.1	280.8	90.3	75.7	143.3	223.0	441.9	250.7	161.6	135.2	143.5	103.6	175.0	142.2	239.7	150.3	238.5	58.0	131.5	161.2	197.8	175.8	120.6	128.7	200.2	94.1	194.7	234.5	146.5	122.5	392.7	234.3	164.0	252.6	180.0	179.4	174.9	211.3	126.6	231.5	131.5	135.3	132.8	268.9	95.4	98.0	105.4	274.6	194.9	138.4	343.0	63.9	106.9	118.3	106.1	266.1	137.3	115.8	388.9	146.2	118.6	161.8	308.1	201.3	315.1	423.3	202.5	181.7	130.8	78.6	9.8	18.2	4.8	14.2	22.9	13.3	16.0	20.6	13.0	19.0	19.9	25.3	17.6	1.9	11.8	33.0	18.2	14.9	7.9	26.1	27.5	24.7	28.6	25.8	24.4	33.6	25.6	30.4	30.4	32.7	36.1	55.0	19.2	48.9	8.8	120.6	55.8	80.7	36.5	45.5	25.9	104.4	77.5	145.3	90.1	47.7	47.8	81.3	85.2	82.0	115.5	41.1	44.4	70.7	49.0	95.7	50.5	59.3	75.3	9.4	92.3	154.1	69.1	88.7	78.9	53.2	83.0	69.9	152.7	100.5	33.7	10.3	87.5	26.4	460.9	104.6	25.6	69.0	162.4	56.9	13.1	78.6	29.1	30.9	6.0	13.7	57.0	83.2	46.3	212.5	103.5	96.4	46.5	17.5	110.5	6.6	85.3	75.2	37.4	186.3	77.5	41.8	107.1	66.7	86.2	81.7	114.9
PABPC5	PABP5	ENSG00000174740	"Poly(A) binding protein cytoplasmic 5"	Q96DU9	X	91434595-91438584	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.4;ovary: 11.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.8;Endometrial stromal cells: 8.3;Horizontal cells: 8.4;Oligodendrocyte precursor cells: 7.5;Peritubular cells: 11.7;Sertoli cells: 13.1;Skeletal myocytes: 11.2;Theca cells: 12.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HSkMC: 2.8;LHCN-M2: 1.9;RH-30: 8.4;U-2 OS: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000164, HPA000165"	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA000164: AB_1079551, HPA000165: AB_1079552"	"unprognostic (1.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.55e-2)"	"unprognostic (8.07e-2)"	2.1	7.4	1.1	0.7	1.3	0.0	0.9	1.1	1.5	2.3	0.5	1.5	0.4	3.1	2.5	1.2	1.8	1.3	1.6	1.0	1.4	0.8	0.3	0.9	0.8	1.5	1.3	11.1	0.4	1.2	1.3	0.7	1.4	2.3	0.7	1.2	0.8	2.0	0.5	0.4	0.7	2.9	1.4	1.8	0.7	1.6	1.4	0.2	2.0	0.9	0.5	1.3	1.0	1.7	0.0	0.0	7.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.1	1.5	1.0	1.4	1.5	1.3	1.4	1.4	1.4	1.7	1.3	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	12.8	0.1	1.1	0.7	0.0	0.0	1.8	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	8.3	1.3	0.0	0.0	1.7	0.0	0.0	5.0	0.0	0.1	0.0	6.6	1.1	0.0	0.1	8.4	1.8	0.0	0.0	0.0	0.4	0.7	5.9	0.1	3.6	1.0	0.0	4.1	0.0	7.5	3.6	0.0	0.0	11.7	0.0	0.3	0.0	0.1	0.0	3.4	13.1	11.2	4.4	0.2	0.3	0.1	0.3	0.0	0.1	12.0	0.0	0.0
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	133.2	178.7	187.0	86.4	183.9	136.9	127.7	193.4	249.3	165.6	184.5	184.1	107.6	176.0	130.3	151.0	175.6	63.4	138.1	185.8	196.6	187.7	194.8	130.0	103.9	186.0	182.2	176.3	138.8	101.0	199.0	79.7	181.6	179.4	101.5	126.6	130.4	85.8	131.5	136.9	167.8	97.4	175.6	174.3	159.3	230.1	186.3	147.6	189.8	94.1	116.5	146.3	144.0	190.4	127.2	133.9	298.3	216.6	125.5	143.1	191.4	120.4	121.6	168.4	157.4	168.0	223.0	229.7	67.0	157.0	180.6	186.4	337.7	169.7	230.7	195.2	116.7	173.5	208.1	435.5	145.2	273.5	220.2	157.1	164.7	125.0	149.1	240.9	188.1	196.0	164.5	174.6	159.8	239.6	296.1	334.5	328.6	151.2	149.3	289.1	114.8	136.2	196.1	256.2	205.6	159.9	161.4	143.2	129.6	196.9	114.2	196.3	153.2	112.1	153.8	110.4	161.8	207.3	153.0	276.5	51.4	221.4	138.7	15.7	7.6	8.5	6.0	5.8	4.9	7.4	6.1	5.5	6.1	9.3	7.5	7.0	10.0	10.1	7.2	13.8	7.6	2.5	187.0	183.9	193.4	249.3	185.8	196.6	186.0	182.2	181.6	175.6	186.3	190.4	66.3	35.3	49.4	0.0	83.3	157.8	84.4	74.0	158.2	120.1	110.2	89.5	14.3	77.2	51.2	126.9	146.0	70.0	102.5	85.5	13.7	52.6	55.6	71.8	80.8	75.0	161.4	94.2	0.0	57.2	67.4	72.4	68.8	78.6	24.1	169.3	66.0	121.6	63.2	77.4	0.0	107.2	54.9	84.7	119.0	45.9	81.1	85.5	53.4	0.0	104.4	55.8	65.9	0.0	0.0	59.2	91.6	59.8	102.2	88.7	88.9	40.3	49.8	80.2	72.3	57.5	85.0	41.8	33.3	187.4	179.9	62.8	67.3	107.6	108.1	114.6
PABPN1L	ePABP2	ENSG00000205022	"PABPN1 like, cytoplasmic"	A6NDY0	16	88863333-88866660	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"adrenal gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;NB-4: 1.8;SCLC-21H: 4.7;T-47d: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.6"	HPA043415	Uncertain					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"				"HPA043415: AB_10981610"	"unprognostic (2.19e-1)"							"unprognostic (1.50e-2)"			"unprognostic (1.40e-3)"	"unprognostic (8.96e-3)"		"unprognostic (1.57e-1)"	"unprognostic (3.19e-1)"			0.1	2.4	0.1	0.0	0.3	0.8	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	2.6	0.3	1.8	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.4	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PACC1	"C1orf75, FLJ10874, PAC, TMEM206"	ENSG00000065600	"Proton activated chloride channel 1"	Q9H813	1	212363928-212414901	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 13.1;Extravillous trophoblasts: 7.0;Hofbauer cells: 28.2;Syncytiotrophoblasts: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008540	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008540: AB_10794083"	"unprognostic (2.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.10e-2)"	"unprognostic (6.98e-2)"	2.9	2.5	15.0	4.0	24.5	5.8	2.6	24.4	22.9	3.0	10.1	2.0	2.0	2.7	1.9	3.9	1.7	2.8	2.4	15.5	18.8	10.2	1.5	3.8	8.0	26.1	22.3	1.7	3.3	3.6	3.4	4.2	25.3	2.9	2.1	6.0	2.7	1.5	2.1	2.3	3.0	2.9	23.0	5.4	1.8	5.6	20.9	8.6	2.0	1.4	5.2	4.4	3.0	35.1	11.6	8.8	13.0	21.6	7.5	4.0	12.9	6.6	5.2	10.8	9.5	7.4	8.4	13.6	5.3	3.3	10.5	10.1	12.5	6.0	10.7	10.3	13.5	12.8	5.8	9.2	10.7	20.8	19.5	3.6	6.2	9.9	7.2	10.8	12.3	19.7	11.8	7.8	7.5	4.6	23.2	21.4	17.3	5.4	11.5	18.9	14.5	13.1	5.5	5.7	20.1	31.2	7.7	11.3	30.2	12.8	16.8	25.2	10.9	7.0	8.0	16.8	17.3	10.2	17.3	19.1	9.4	18.9	19.9	21.3	8.7	5.3	5.3	11.8	7.0	8.5	4.1	6.2	14.4	8.2	5.8	6.4	0.7	7.0	11.0	20.4	6.4	6.2	15.0	24.5	24.4	22.9	15.5	18.8	26.1	22.3	25.3	23.0	20.9	35.1	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	13.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.7;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.8	2.5	13.6	1.1	15.2	5.7	2.0	5.9	14.2	2.3	13.2	1.2	1.4	5.3	9.7	3.0	35.7	5.1	13.0	11.9	12.5	10.2	4.8	3.8	1.4	15.1	15.7	4.2	4.3	2.0	23.7	0.4	10.9	3.4	2.4	7.5	2.2	3.6	2.1	4.6	0.8	2.1	9.4	1.8	2.3	29.5	13.5	0.7	4.0	1.3	1.0	4.4	0.9	24.2	0.5	1.7	0.7	1.0	0.0	0.6	1.2	0.4	1.6	0.0	0.3	3.5	0.4	3.2	0.4	0.0	0.3	1.4	0.8	0.0	1.7	0.0	1.1	0.0	1.9	0.0	0.0	0.4	0.5	1.0	0.0	0.5	0.0	0.6	0.0	1.1	0.5	0.7	0.3	0.1	0.2	1.2	0.0	2.8	2.9	0.6	0.0	0.0	3.6	3.6	6.9	3.1	0.0	0.0	0.0	0.2	0.0	1.1	1.2	0.7	0.3	0.0	0.2	1.3	0.5	1.2	0.3	0.8	1.3	2.3	0.7	0.7	0.7	0.2	0.5	0.3	1.1	0.4	0.1	0.6	1.4	0.6	2.5	0.0	0.1	0.5	0.5	0.2	13.6	15.2	5.9	14.2	11.9	12.5	15.1	15.7	10.9	9.4	13.5	24.2	0.3	0.0	1.7	61.0	0.1	0.3	4.2	8.7	2.8	1.3	1.3	3.0	41.0	0.0	8.9	5.5	8.4	0.1	0.0	0.1	54.8	3.4	310.9	67.0	3.1	1.2	6.6	0.0	124.3	7.1	0.1	1.2	0.0	1.9	0.0	0.7	0.7	3.9	0.1	0.0	174.9	0.3	10.2	0.6	0.3	369.8	3.7	0.4	0.0	11.2	0.0	6.0	0.0	59.3	20.0	1.6	1.2	2.6	0.1	3.2	0.0	6.3	118.4	8.1	0.0	1.1	2.2	53.4	6.1	1.1	0.3	0.3	0.3	2.9	0.4	2.7
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070272-66244744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol		NA	NA		17000	"Cluster 46: Basophils - DNA binding"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	30.6	24.0	26.4	33.7	28.4	26.0	26.4	28.4	29.0	30.4	11.0	29.7	13.3	26.7	17.7	32.1	22.2	23.6	45.4	27.2	18.5	28.0	11.4	30.2	49.8	18.2	20.4	32.4	26.8	18.7	21.6	18.9	17.1	34.6	10.2	35.1	92.8	22.2	22.4	27.6	25.6	30.3	13.0	34.9	24.9	42.2	20.7	35.1	34.0	17.2	46.2	33.9	29.6	18.8	44.1	45.6	21.1	13.3	38.5	46.1	23.7	59.3	41.9	40.6	25.2	28.4	34.3	27.6	38.2	102.5	37.7	27.9	15.6	42.7	54.4	43.7	18.3	45.0	41.7	41.2	45.8	6.5	34.6	46.8	19.8	37.0	47.2	78.1	39.8	18.2	16.7	52.2	44.7	83.3	48.1	16.8	9.8	12.0	21.2	31.6	21.5	47.9	28.9	43.4	29.8	33.6	61.5	34.5	29.1	33.9	39.7	8.3	54.4	52.2	23.1	71.9	25.6	26.2	19.1	7.4	45.0	10.4	26.0	3.7	1.3	2.8	3.4	1.0	2.2	2.9	3.1	2.9	1.3	4.8	3.5	3.1	7.4	2.0	2.9	0.8	4.0	3.0	26.4	28.4	28.4	29.0	27.2	18.5	18.2	20.4	17.1	13.0	20.7	18.8	19.9	3.2	3.0	93.7	41.3	10.1	17.6	8.8	16.5	31.4	16.5	16.3	16.9	8.6	12.1	12.9	50.1	8.1	31.9	2.8	5.9	20.5	17.0	11.1	17.3	18.2	6.1	14.1	113.5	62.7	10.9	15.8	13.7	16.3	23.5	80.3	26.0	4.6	13.1	92.5	90.0	2.2	6.1	14.5	14.7	27.6	18.6	22.7	10.6	96.5	33.4	13.9	38.1	87.4	49.2	54.7	1.2	18.0	13.5	23.3	1.0	13.1	11.8	41.2	13.1	12.3	16.5	20.6	21.8	16.5	9.9	5.7	36.3	16.5	3.6	17.0
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015149	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 95.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		2400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	40.8	74.3	25.7	37.1	29.1	29.3	40.7	34.2	27.3	37.5	32.3	61.7	40.8	39.1	21.2	34.1	35.3	45.3	55.7	27.7	39.2	47.1	41.1	50.9	34.2	40.5	36.8	31.4	162.4	29.4	39.9	34.2	40.8	47.0	41.6	28.2	43.5	27.4	49.8	39.5	38.1	30.4	30.7	35.9	51.5	19.5	32.5	28.7	43.9	42.4	26.4	36.5	34.5	31.1	76.3	78.3	64.6	41.5	32.6	34.6	52.9	67.8	40.7	59.9	49.7	82.1	43.8	35.2	56.1	50.6	40.8	52.8	42.5	72.1	39.3	36.1	42.4	56.8	39.4	117.8	46.1	40.5	118.1	33.4	69.8	79.1	34.3	48.7	49.9	32.1	49.9	24.9	52.2	49.7	43.1	63.3	35.6	110.4	32.7	52.3	96.5	23.8	68.9	44.4	41.9	18.7	81.1	55.2	155.8	41.5	40.1	53.1	74.3	44.5	56.4	50.0	40.5	18.4	27.2	38.4	42.7	35.4	99.1	26.1	18.5	47.4	6.8	32.2	7.3	11.3	7.8	5.8	21.5	11.6	7.6	5.8	95.7	16.8	33.9	7.9	12.1	14.1	25.7	29.1	34.2	27.3	27.7	39.2	40.5	36.8	40.8	30.7	32.5	31.1	31.7	70.5	60.6	20.2	20.6	23.2	43.4	23.9	21.1	15.7	37.4	31.1	26.3	24.3	37.2	46.0	39.6	34.4	19.9	142.6	45.0	80.2	3.6	51.6	31.3	28.6	24.7	12.6	22.7	65.4	29.6	20.9	36.7	57.4	71.0	14.7	16.1	22.3	42.7	6.7	41.0	49.5	30.5	38.5	50.0	6.2	21.8	44.9	83.6	54.4	51.3	8.4	7.2	29.1	19.5	70.9	62.3	23.3	13.1	50.6	32.0	55.0	30.7	24.9	92.1	23.5	82.9	22.6	27.6	22.5	16.9	48.2	19.1	13.8	42.2	30.3
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177522-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 161.8;skeletal muscle: 480.9;tongue: 279.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	14.4	66.5	19.6	4.5	28.2	0.4	18.4	24.5	20.9	33.3	18.8	50.2	4.7	33.5	11.4	52.6	29.1	7.2	161.8	18.0	19.4	14.8	43.6	15.9	2.0	33.8	27.5	23.2	33.1	11.0	6.2	16.1	32.1	35.2	2.7	4.5	40.8	20.6	480.9	41.4	11.3	21.2	25.0	4.5	33.5	4.5	25.4	2.0	24.5	279.4	5.2	21.5	31.8	39.0	56.4	27.1	12.5	51.5	10.3	10.2	59.8	19.4	24.6	33.9	19.1	40.8	7.3	0.3	5.9	9.2	23.0	90.0	23.7	40.2	13.0	8.7	44.8	8.4	105.5	91.7	19.9	2.0	8.4	28.2	52.3	17.9	28.3	27.2	15.3	15.2	18.4	0.7	13.9	106.7	0.7	40.8	15.5	43.7	58.7	33.1	48.0	9.0	14.3	49.3	0.3	42.6	28.2	17.9	24.6	24.6	127.3	6.9	6.9	57.6	62.5	7.5	47.1	10.1	4.4	5.3	18.6	19.2	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.6	28.2	24.5	20.9	18.0	19.4	33.8	27.5	32.1	25.0	25.4	39.0	6.1	0.0	8.1	4.9	0.3	35.9	29.1	25.1	30.7	0.7	32.2	24.3	112.0	38.6	18.1	5.5	0.0	31.0	0.6	0.2	9.8	37.7	0.0	3.1	8.4	7.8	0.0	2.7	0.8	15.5	60.6	12.6	9.7	6.2	0.0	3.0	8.6	33.1	6.0	0.0	1.1	0.2	14.2	1.6	4.6	0.4	16.1	1.0	17.8	2.8	0.0	63.6	0.0	0.0	9.5	41.0	0.0	12.4	2.6	56.8	1.5	24.3	5.0	3.2	32.9	18.5	25.4	0.2	7.5	39.7	29.8	18.3	0.7	4.8	1.4	29.8
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205128-17246007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"esophagus: 109.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Extravillous trophoblasts: 14.0;Squamous epithelial cells: 5.6;Urothelial cells: 22.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;EFO-21: 2.1;HaCaT: 1.5;RPTEC TERT1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	109.5	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.4	1.4	18.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.1	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.6	0.9	0.0	0.0	14.8	0.0	3.9	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	14.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.8	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.2	0.1	5.6	0.0	0.7	0.0	0.1	0.6	22.5
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 17.0;urinary bladder: 25.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 14.0;RT4: 17.4;T-47d: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	17.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	3.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	3.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.0	0.0	1.4	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.5	0.1	0.1	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	7.9
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 105.1;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 183.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017007, HPA042825"	Enhanced					NA	NA		29000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.8	0.1	0.2	0.7	0.4	105.1	0.3	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.4	1.0	0.4	1.1	0.3	0.2	0.5	1.7	7.9	0.3	0.3	0.1	0.1	0.3	0.0	0.2	0.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.0	29.9	0.4	0.1	0.1	1.6	0.3	0.3	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	79.9	71.3	97.5	0.4	5.7	0.2	1.1	0.5	0.7	13.9	1.8	2.6	4.5	183.0	4.5	1.8	6.2	0.4	35.8	0.2	0.4	0.2	0.8	0.3	0.2	0.3	0.1	0.3	0.0	0.1	0.4	0.0	0.0	3.7	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.6	0.6	0.0	0.0	12.6	0.1	0.0	0.4	0.2	0.0	0.4	0.0	0.0	3.3	0.4	0.2	0.0	14.6	0.0	0.0	22.3	0.0	20.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 94.1;endometrium 1: 256.0"	"Cell type enriched"	"Detected in some"	10	"Glandular and luminal cells: 10785.5"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.1;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"	NA	NA		120000	"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"			"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavorable (0.00e+0)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.1	0.2	0.2	1.1	0.4	1.6	0.5	0.7	0.7	94.1	2.0	0.1	1.0	256.0	0.9	0.2	4.8	0.3	0.1	0.4	0.4	0.1	0.1	0.5	0.6	0.3	0.2	0.7	0.0	0.0	0.0	27.2	0.2	2.7	0.1	0.4	0.4	44.8	0.6	2.1	0.8	0.1	0.1	0.3	6.0	0.7	0.4	0.0	0.3	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	1.6	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.2	2.9	0.2	0.0	0.3	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.3	0.0	0.2	0.4	0.2	0.1	0.2	21.0	0.6	0.3	0.2	0.0	0.0	1.0	0.2	0.1	0.8	2.2	0.1	0.2	0.2	0.2	3.1	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.3	0.3	0.5	0.1	0.1	0.2	0.4	0.7	0.7	0.4	0.4	0.3	0.2	0.2	0.1	0.4	1.0	0.0	0.0	0.5	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.9	0.6	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	613.5	1008.8	67.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	10785.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	144.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0
PAF1	"F23149_1, FLJ11123, PD2"	ENSG00000006712	"PAF1 homolog, Paf1/RNA polymerase II complex component"	Q8N7H5	19	39385629-39391154	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041875, HPA043637"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041875: AB_2677720, HPA043637: AB_2678592"	"unprognostic (5.33e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.73e-1)"	36.9	45.4	32.3	26.1	36.4	36.9	37.5	35.1	36.3	40.7	32.4	41.4	22.9	36.9	28.0	44.8	38.9	23.6	45.2	32.8	38.8	35.4	49.5	33.5	29.3	36.4	34.9	50.1	31.9	38.3	48.5	21.0	35.6	40.6	20.2	26.5	38.2	27.7	62.3	34.3	37.3	23.2	33.0	46.9	39.4	68.5	35.7	31.0	41.4	30.9	31.5	37.9	37.4	40.0	92.1	114.9	74.9	40.3	46.7	39.5	30.5	75.0	69.4	86.1	82.7	95.3	48.3	72.6	51.0	61.6	51.3	31.4	81.3	62.1	70.2	82.4	95.2	71.6	77.0	62.6	50.4	61.5	65.6	39.9	42.0	72.0	46.4	54.3	63.8	63.0	56.7	59.0	71.5	103.3	70.7	40.5	26.5	76.2	38.7	70.8	73.4	51.7	64.7	102.3	63.2	42.6	80.5	52.8	41.6	37.1	50.4	52.5	60.8	51.6	68.1	54.5	84.0	63.2	61.2	61.9	51.6	53.0	49.0	32.3	20.0	33.7	29.4	28.0	30.9	40.1	24.4	29.4	21.8	36.6	27.3	25.3	31.3	30.5	26.6	20.4	26.0	21.6	32.3	36.4	35.1	36.3	32.8	38.8	36.4	34.9	35.6	33.0	35.7	40.0	26.6	22.4	46.2	9.4	49.9	53.5	63.0	29.9	63.2	14.1	28.9	27.1	37.5	21.5	35.9	22.0	8.4	38.4	33.2	26.0	13.7	27.3	40.4	48.4	25.3	24.4	26.4	16.4	3.8	27.3	30.0	33.0	43.3	62.8	50.7	19.0	18.2	24.1	24.8	8.4	4.8	22.4	26.4	12.9	62.4	30.6	35.1	28.1	23.2	1.9	20.4	23.4	12.3	6.6	8.8	23.3	22.1	27.8	54.2	24.5	22.9	25.9	64.0	16.8	13.1	22.5	29.8	96.0	26.8	41.0	49.2	64.0	48.7	24.6	21.9	34.8
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 640.0;Late spermatids: 1864.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome		NA	NA		860000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	34.8	32.2	35.5	27.2	43.1	4.0	32.6	31.5	46.5	38.3	6.7	46.4	30.5	43.9	26.9	38.0	36.7	31.8	51.1	46.2	47.4	41.4	30.0	37.3	30.9	41.3	38.4	35.4	26.3	56.4	38.4	32.4	48.1	32.6	32.8	47.2	32.4	38.6	87.7	42.1	36.5	44.4	30.2	31.0	34.6	55.7	36.7	41.5	43.9	73.2	38.8	35.7	37.8	38.0	51.3	53.3	81.8	28.4	66.9	74.1	27.3	76.5	67.1	56.3	53.0	69.7	18.7	64.5	63.5	100.3	27.4	53.5	74.4	59.8	80.6	50.9	48.4	56.4	48.8	27.3	69.3	37.5	66.4	68.8	73.5	58.8	58.1	71.7	58.1	51.8	38.8	32.7	84.8	21.1	58.3	28.6	36.7	30.5	27.0	39.5	67.6	30.0	62.5	30.5	37.4	62.0	63.0	34.5	65.5	51.8	36.5	30.1	84.9	71.5	17.1	57.1	61.0	24.7	32.1	28.8	60.4	33.7	66.2	2.6	1.7	3.4	4.7	2.5	5.2	2.9	4.1	3.3	2.5	2.4	4.9	3.8	2.6	3.6	3.8	1.5	5.1	2.4	35.5	43.1	31.5	46.5	46.2	47.4	41.3	38.4	48.1	30.2	36.7	38.0	73.7	121.8	92.2	90.8	82.7	118.7	114.8	74.3	63.2	102.4	52.1	42.9	136.3	30.0	101.6	35.0	50.1	56.4	117.2	77.4	35.2	77.2	640.0	82.2	95.5	77.2	34.1	45.9	178.1	56.3	76.7	74.7	87.7	100.9	93.7	45.1	43.2	32.3	60.2	102.6	161.8	43.7	57.0	46.3	77.0	1864.4	64.0	77.6	56.9	104.9	90.3	60.7	97.9	115.1	193.5	100.8	61.5	56.8	91.7	91.6	76.9	55.0	80.7	65.8	46.0	84.5	133.0	256.8	78.1	69.7	132.6	129.6	92.7	54.7	39.2	122.4
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144284-117176894	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	23.1	34.3	35.1	21.2	42.2	41.2	20.6	43.9	45.0	20.8	28.4	21.7	22.4	23.8	22.7	23.9	20.9	19.9	28.2	33.9	45.4	25.3	23.8	21.7	20.7	47.6	45.0	23.3	20.3	21.9	24.5	25.4	51.0	22.3	20.0	23.2	17.4	16.1	15.7	22.0	19.4	20.4	48.7	20.4	23.0	30.0	43.6	21.5	31.9	20.3	22.2	26.9	20.9	51.6	43.4	48.5	54.9	79.7	60.1	41.7	42.6	71.0	61.7	38.8	35.2	89.2	92.9	46.6	99.4	85.8	38.7	67.7	80.6	92.0	50.9	41.8	31.1	120.0	41.3	57.9	53.8	42.1	44.0	46.6	71.7	77.4	96.7	42.4	64.8	25.6	65.0	34.6	60.3	27.7	40.8	61.7	50.4	60.0	37.8	44.9	62.2	51.2	59.8	66.7	60.9	80.5	82.2	61.6	28.1	46.6	68.4	35.6	103.8	70.4	46.3	34.8	51.4	10.8	17.9	61.5	28.3	78.8	60.4	63.4	51.4	48.6	39.0	58.7	46.4	43.8	44.7	41.0	37.4	41.2	45.8	49.2	63.7	33.1	66.3	27.4	35.1	53.1	35.1	42.2	43.9	45.0	33.9	45.4	47.6	45.0	51.0	48.7	43.6	51.6	48.5	28.9	34.8	17.9	41.4	122.4	44.5	45.9	54.7	38.6	55.4	32.1	37.6	58.6	32.8	66.2	47.9	40.4	44.4	48.0	46.9	61.3	13.1	63.6	54.8	64.8	82.6	39.4	29.2	39.5	86.7	40.8	33.6	78.4	19.0	36.8	79.6	47.0	43.0	47.1	32.5	41.8	36.7	65.4	175.9	13.7	45.4	52.1	49.8	20.6	59.3	36.2	21.6	13.0	61.2	99.0	50.5	34.3	28.9	67.0	33.7	54.8	32.9	38.3	13.1	42.8	40.0	54.7	84.7	53.2	115.9	54.6	41.6	35.2	45.4	50.6
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		290000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	8.3	23.5	34.7	12.4	35.4	27.9	13.7	36.5	44.1	18.9	31.3	16.8	12.4	13.8	12.9	28.1	14.8	10.8	4.6	35.1	39.9	21.8	7.9	9.2	17.0	32.2	33.1	18.3	18.1	13.8	21.2	5.9	34.4	15.2	12.1	13.0	17.0	6.3	13.5	13.6	14.7	7.5	32.0	16.0	15.9	23.7	42.9	37.6	9.3	5.2	18.3	14.1	16.6	32.5	111.9	200.2	127.5	135.8	2.6	6.7	38.1	27.9	39.2	91.9	94.4	67.7	94.7	70.0	34.8	35.0	63.7	37.1	58.9	75.2	38.3	105.7	77.0	85.8	52.7	91.8	19.3	54.4	90.3	19.9	33.9	56.5	26.3	50.7	41.3	152.5	58.5	81.9	67.9	162.5	124.2	42.4	70.3	138.3	0.2	90.0	47.9	62.0	76.4	117.7	144.8	109.9	44.6	89.4	47.0	40.4	111.4	62.1	22.3	74.8	98.5	6.7	77.3	38.0	84.9	60.6	41.3	87.4	65.8	23.2	27.5	15.7	23.4	22.3	31.2	38.3	32.8	26.7	51.1	48.2	43.3	30.6	3.4	18.2	12.0	27.8	58.1	21.0	34.7	35.4	36.5	44.1	35.1	39.9	32.2	33.1	34.4	32.0	42.9	32.5	18.8	16.0	11.2	3.6	26.1	28.2	45.7	82.7	46.1	26.5	67.9	83.2	2.3	30.0	41.6	33.1	14.6	38.6	13.2	39.1	80.3	112.9	16.7	30.4	12.4	24.4	58.9	53.0	3.0	55.3	44.9	21.7	38.7	33.1	27.9	71.4	17.9	10.3	62.7	11.8	5.4	54.0	87.5	28.2	33.5	27.0	13.7	21.8	46.2	1.0	18.2	33.7	11.3	3.0	3.6	81.5	36.1	9.1	37.3	31.0	30.9	63.7	35.0	19.8	0.0	3.6	52.6	5.6	188.8	59.0	17.8	13.5	24.6	46.2	74.3	58.9
PAFAH2	HSD-PLA2	ENSG00000158006	"Platelet activating factor acetylhydrolase 2"	Q99487	1	25959767-25998117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018157	Approved					NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA018157: AB_1854928"	"unprognostic (9.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.27e-2)"	4.6	7.3	4.7	6.5	6.5	6.8	9.2	6.3	6.0	8.8	6.7	16.3	17.4	4.9	9.9	7.8	8.3	10.4	9.7	4.5	5.8	19.3	18.3	8.6	8.4	6.4	6.5	4.7	31.2	22.9	5.9	9.2	6.5	8.8	16.6	14.1	10.0	6.3	18.0	11.4	19.0	6.9	5.5	7.6	15.6	7.7	6.5	48.7	16.4	10.7	7.4	7.0	5.5	8.2	8.6	10.7	6.7	7.6	13.9	10.9	13.7	9.6	5.0	8.6	5.7	4.4	18.1	3.8	11.7	5.7	8.1	7.5	10.1	9.3	11.0	7.8	6.1	6.3	4.6	8.8	8.4	3.3	52.5	7.2	21.2	13.2	8.7	4.7	8.3	8.9	8.9	7.1	11.7	3.8	10.3	3.3	13.4	29.9	5.9	8.4	6.3	8.7	13.9	3.0	8.0	6.8	5.7	7.7	18.2	11.0	12.7	6.0	7.8	5.9	7.4	12.5	7.7	13.0	18.1	4.8	12.5	13.2	20.0	36.2	6.7	60.2	23.7	6.4	15.3	3.5	8.3	15.4	5.0	4.4	10.6	14.9	5.8	17.4	2.4	39.0	9.0	8.7	4.7	6.5	6.3	6.0	4.5	5.8	6.4	6.5	6.5	5.5	6.5	8.2	4.6	16.0	12.8	9.8	3.2	1.5	2.1	5.3	1.8	9.5	9.4	4.8	6.8	11.5	11.9	18.4	27.1	11.2	37.7	34.9	3.9	11.1	1.1	8.6	4.5	5.6	7.8	3.2	4.0	7.3	9.5	3.5	12.2	13.2	27.8	7.3	5.7	21.4	11.2	5.0	3.6	18.2	4.1	11.6	1.6	1.0	2.5	7.1	8.8	5.6	7.3	6.3	23.7	4.0	10.0	10.6	15.8	2.6	6.5	4.2	43.1	18.3	8.9	8.8	6.6	5.3	4.1	19.9	8.9	4.5	3.8	10.0	9.0	4.4	19.4	4.9
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	3.9	3.1	3.4	9.0	3.5	12.3	2.0	14.8	4.0	1.8	4.3	9.2	7.6	1.9	2.2	1.6	1.8	7.1	4.7	2.8	3.7	1.7	4.7	14.9	14.5	4.5	4.5	1.2	14.9	0.9	2.0	16.0	4.9	2.6	8.7	5.0	3.7	2.1	1.3	4.3	9.0	3.0	4.9	9.1	4.4	0.7	5.2	10.4	1.8	2.1	14.0	4.8	2.6	5.6	0.1	0.1	4.8	0.2	8.9	8.5	0.1	2.0	15.5	1.0	1.9	0.3	0.1	35.4	0.2	0.5	7.6	1.5	0.1	1.8	0.9	0.9	4.5	20.8	0.3	0.0	9.1	3.4	45.5	4.1	1.2	8.9	8.2	0.9	0.0	6.2	0.2	0.1	14.8	0.3	12.6	0.3	0.4	8.1	1.4	9.5	2.4	0.1	1.6	7.6	1.0	1.7	0.0	0.3	36.1	0.8	1.2	3.5	0.3	1.1	0.6	0.0	1.2	5.7	1.6	12.3	9.7	11.7	8.5	13.1	1.4	2.0	2.5	6.4	6.1	2.0	6.2	4.4	1.9	1.6	4.9	3.8	2.3	1.7	14.6	4.1	7.2	2.7	3.4	3.5	14.8	4.0	2.8	3.7	4.5	4.5	4.9	4.9	5.2	5.6	6.2	0.0	12.4	40.8	37.0	31.5	3.9	5.2	0.6	39.7	2.2	2.2	15.4	10.0	14.0	3.7	0.0	0.8	39.0	169.6	0.0	4.0	3.5	0.6	4.4	10.9	3.6	3.8	57.5	6.5	26.2	24.3	8.2	1.1	124.5	97.0	12.5	10.3	27.1	63.9	60.0	23.2	6.1	73.6	26.2	2.1	2.5	79.1	140.5	166.8	40.8	34.9	19.6	82.4	75.3	2.0	62.1	7.9	38.4	7.7	109.3	0.4	0.8	3.2	124.9	32.3	37.1	0.2	3.0	3.8	22.6	2.3	78.1	11.8	27.4	13.7
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687447-49695984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	151	"testis: 17.2"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 166.9;Spermatogonia: 206.5"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.5;melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 188.0;Karpas-707: 139.8;U-266/84: 230.7"									HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	139.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	0.3	0.2	0.3	1.6	0.6	2.8	230.7	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	166.9	206.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE2	"CT16.4, GAGEC2, MGC62094, PAGE-2"	ENSG00000234068	"PAGE family member 2"	Q7Z2X7	X	55089018-55092842	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 27.9"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 107.5;Spermatogonia: 234.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"U-266/70: 1058.4;U-266/84: 1493.9"									HPA052619	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052619: AB_2681887"										"unprognostic (3.49e-2)"					"unprognostic (7.73e-2)"			0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.1	27.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.3	0.0	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.3	0.0	0.0	255.7	0.9	1.9	1058.4	1493.9	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.3	9.7	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.8	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	107.5	234.6	0.0	0.0	4.0	0.0	0.0	0.0	0.0
PAGE2B	CT16.5	ENSG00000238269	"PAGE family member 2B"	Q5JRK9	X	55075030-55078909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 56.5"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 240.8;Spermatogonia: 322.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-266/70: 1390.8;U-266/84: 2279.6"									HPA052619	Supported					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052619: AB_2681887"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"		"prognostic unfavorable (3.02e-4)"	"unprognostic (1.40e-1)"		"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.81e-2)"		"unprognostic (2.05e-8)"		"unprognostic (1.41e-1)"		"unprognostic (8.84e-2)"	0.1	0.0	0.2	0.0	0.2	4.0	0.3	0.2	0.7	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.3	0.3	0.1	0.0	0.2	0.3	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.7	0.4	0.1	0.2	0.7	0.1	56.5	0.3	0.2	0.1	0.7	0.4	0.2	0.2	0.3	3.8	0.0	0.0	0.8	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.0	1.3	0.4	2.9	0.5	0.2	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.3	0.1	0.5	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.9	0.0	0.0	216.2	0.2	2.6	1390.8	2279.6	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.7	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	36.1	0.0	0.0	0.3	0.0	26.5	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.3	13.0	4.4	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.8	4.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	19.7	0.0	0.0	240.8	322.4	0.0	0.0	0.3	0.1	0.4	0.0	0.0
PAGE3	"CT16.6, GAGED1, PAGE-3"	ENSG00000204279	"PAGE family member 3"	Q5JUK9	X	55258412-55264846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 7.6"	"Group enriched"	"Detected in some"	63	"Early spermatids: 107.9;Late spermatids: 312.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA045032, HPA062248"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Nucleoplasm	"HPA045032: , HPA062248: AB_2684725"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	312.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49834264	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 871.9;placenta: 1023.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1"					"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.3	5.7	0.1	0.3	0.2	0.0	0.0	0.1	0.5	7.0	0.1	0.2	0.4	51.2	871.9	0.0	21.4	0.0	0.4	0.1	0.2	3.1	0.3	0.2	0.0	0.1	0.1	3.7	2.5	0.0	1.3	1023.1	0.1	171.8	0.0	0.0	0.6	77.2	2.3	0.0	0.3	24.2	0.0	0.3	0.2	5.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	11.7	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13314.7	0.0	0.0	0.0	0.0	4.4	1.9	72.5	25.9	0.0	0.0	0.0	0.0	905.4	72.5	0.0	1.9	0.0	0.0	0.0	0.0	1052.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	48.8	20.7	0.0	0.0	8524.1	0.3	0.0	0.0	0.1
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220346-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 26.5"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 131.0;Spermatogonia: 158.8"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.9"	"Group enriched"	"Detected in some"	170	"Karpas-707: 437.8;U-266/84: 992.7"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA052619: AB_2681887, HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	26.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	437.8	0.0	0.0	1.2	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.5	1.3	1.6	4.2	992.7	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.9	0.1	1.6	0.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	19.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	11.9	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.1	0.0	6.6	0.0	0.1	131.0	158.8	0.0	0.1	0.0	1.4	0.0	0.0	0.1
PAGR1	"C16orf53, GAS, MGC4606, PA1"	ENSG00000280789	"PAXIP1 associated glutamate rich protein 1"	Q9BTK6	16	29816152-29822489	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 166.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Plasma cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041440, HPA043608"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"			"HPA041440: AB_10795541, HPA043608: AB_10797144"	"unprognostic (2.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.09e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-2)"	23.5	27.8	10.2	5.5	10.8	6.5	23.2	18.4	12.3	120.8	8.9	48.9	8.7	55.3	7.1	25.7	68.4	6.1	32.0	10.1	9.9	30.4	28.1	23.0	8.7	10.9	10.7	166.5	26.3	7.4	128.9	3.7	10.8	69.3	5.7	6.8	21.4	8.8	24.6	18.0	30.8	4.7	10.5	23.6	26.4	31.2	10.6	9.3	30.2	9.0	6.8	50.7	73.8	12.5	16.7	24.1	13.9	8.7	7.0	6.7	11.8	12.7	11.5	14.5	12.7	17.1	16.9	33.4	12.7	9.1	7.2	15.4	15.2	19.1	9.2	14.8	31.1	14.8	16.4	16.1	7.3	23.6	26.9	7.5	15.1	10.2	10.0	13.4	12.1	31.0	20.1	10.4	9.9	45.2	18.6	27.6	19.3	14.2	20.4	35.4	24.5	24.9	10.8	7.8	34.9	13.2	9.6	22.4	9.7	10.5	20.9	15.0	9.2	12.0	10.9	15.2	12.9	19.4	21.3	13.1	15.8	24.2	15.0	22.5	16.9	33.0	19.7	17.0	22.1	19.7	16.8	20.0	21.3	19.5	21.7	20.1	11.0	13.9	19.6	21.5	12.7	15.2	10.2	10.8	18.4	12.3	10.1	9.9	10.9	10.7	10.8	10.5	10.6	12.5	1.3	0.0	9.8	66.6	15.2	0.0	0.3	0.1	18.2	3.5	4.7	2.9	0.6	14.3	6.9	1.8	0.0	5.6	5.3	5.9	0.0	27.9	0.5	1.0	1.3	3.8	14.6	10.7	16.2	21.7	8.2	4.4	13.3	0.8	7.6	0.3	6.1	2.0	7.5	5.0	16.5	11.1	0.0	5.6	0.0	0.6	0.9	7.7	0.0	9.4	22.5	1.9	4.1	11.6	8.6	13.5	15.8	3.4	34.5	0.7	20.7	2.1	3.0	3.3	0.0	0.9	5.0	3.1	1.6	16.7	0.4	6.7	10.9	0.2	13.2	0.2
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 496.6;liver: 1408.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA		40000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.2	6.4	2.1	0.0	1.9	0.0	0.2	1.8	3.4	0.1	1.1	0.3	0.1	0.1	0.5	0.0	0.1	79.4	0.0	2.2	2.3	496.6	1408.4	0.0	0.1	2.8	2.3	0.1	9.2	0.8	3.0	0.0	2.3	1.5	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.6	0.3	0.4	3.3	2.5	0.7	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	238.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.9	1.8	3.4	2.2	2.3	2.8	2.3	2.3	2.6	2.5	2.8	0.0	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.5	250.2	0.0	5.5	0.0	0.0	0.0	0.0	21.5	2.4	66.8	0.0	0.1	1.1	1.8	21.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	807.7	0.0	3.3	2.3	0.0	0.0	22.2	0.0	15.7	0.6	1.8	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.4	0.0	344.4	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.1
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		60000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	69.5	54.3	47.8	36.6	50.8	56.6	67.4	52.0	64.2	65.1	52.0	57.1	43.3	61.6	57.3	52.0	51.2	53.3	92.5	51.2	52.0	78.0	90.9	50.3	39.4	49.5	49.5	53.7	54.8	74.3	29.3	68.1	50.8	69.1	54.8	95.2	51.3	68.5	155.3	31.1	40.2	65.3	54.3	34.2	46.9	83.6	49.0	47.6	73.6	122.9	45.3	70.1	39.9	56.5	94.5	82.2	158.0	153.7	161.8	127.1	129.1	81.2	180.0	151.5	130.9	77.2	112.8	62.5	136.9	115.5	227.3	60.4	249.3	98.0	153.5	52.2	96.7	49.2	157.1	122.6	142.3	74.2	74.3	135.8	186.1	102.5	191.7	153.1	146.8	45.9	115.9	82.1	153.0	101.7	82.4	101.8	78.5	89.4	104.8	63.8	119.2	88.1	188.8	114.3	89.4	135.3	260.3	99.2	190.0	144.0	141.4	106.3	82.4	136.6	112.5	68.8	103.7	61.7	112.6	94.3	79.7	113.1	120.4	40.4	24.1	46.2	18.9	20.7	25.2	26.4	23.2	26.2	23.7	26.7	28.9	23.2	8.6	24.9	22.5	66.8	23.0	22.1	47.8	50.8	52.0	64.2	51.2	52.0	49.5	49.5	50.8	54.3	49.0	56.5	66.4	32.1	52.2	15.0	39.4	73.3	74.0	78.5	52.3	48.8	78.8	53.1	122.4	78.6	52.7	44.1	20.9	76.3	66.0	33.1	158.5	120.3	182.6	73.8	56.4	71.2	44.9	54.9	30.0	91.6	89.2	64.2	39.3	55.9	24.6	47.4	50.0	49.2	59.4	35.3	25.3	52.1	103.7	40.9	39.7	58.0	76.4	42.0	83.6	20.6	53.8	86.6	24.7	26.7	35.1	116.4	43.8	66.5	43.3	106.4	45.1	148.8	40.9	67.7	26.3	70.2	71.4	171.2	76.6	56.0	66.3	68.1	35.1	49.7	47.7	84.3
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 834.4;Late spermatids: 2779.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles		NA	NA		21000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231"	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	103.3	148.6	107.9	77.2	107.9	115.7	90.3	120.0	149.6	77.3	119.9	79.1	44.2	94.1	85.6	68.8	91.6	66.5	173.1	107.8	118.9	104.7	114.2	73.1	109.0	119.5	114.0	112.3	64.2	88.9	96.2	93.7	123.8	84.3	53.9	168.9	92.1	82.4	169.6	48.2	50.0	83.1	119.1	92.1	58.1	169.0	110.0	147.4	74.6	161.9	107.7	81.4	54.3	138.9	91.9	102.7	196.2	118.5	144.0	81.3	95.6	81.9	113.6	104.7	163.6	138.5	86.7	160.7	170.8	62.3	120.1	88.9	173.5	112.5	137.4	155.7	136.4	148.5	145.7	125.8	93.0	92.8	105.4	93.2	92.4	78.5	88.8	112.9	108.7	173.3	143.7	138.6	95.8	121.1	254.3	227.3	118.9	130.5	74.6	140.0	248.1	177.2	84.0	163.2	90.9	165.2	121.2	110.7	251.2	245.4	214.4	192.6	66.9	55.9	67.9	61.3	67.3	200.0	262.6	167.8	98.2	161.6	58.9	569.5	292.2	735.8	286.2	329.3	317.0	378.7	314.7	330.4	292.0	337.7	364.4	356.5	800.5	347.5	380.6	298.7	449.5	577.2	107.9	107.9	120.0	149.6	107.8	118.9	119.5	114.0	123.8	119.1	110.0	138.9	154.8	73.7	87.5	26.4	173.8	159.8	164.3	168.2	79.1	102.4	108.2	98.0	59.7	97.2	100.9	99.3	58.4	198.6	253.1	74.0	170.2	126.4	834.4	228.6	109.2	126.9	97.0	190.0	40.6	115.1	134.1	129.5	38.7	109.0	109.0	108.2	123.1	103.8	142.3	97.6	46.6	57.7	120.1	142.2	196.1	2779.9	160.9	170.6	135.2	29.0	239.2	158.5	247.2	29.7	59.9	122.5	64.7	155.3	146.8	232.8	62.1	256.2	149.4	93.6	170.9	87.7	180.3	432.3	238.1	57.0	208.3	479.7	191.3	145.8	59.5	178.3
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182738-71227103	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 181.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 86.0;Early spermatids: 95.1;Hepatocytes: 67.1;Proximal tubular cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.8;SCLC-21H: 23.1"	"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.4	1.6	131.5	1.8	159.1	1.3	4.5	108.3	176.8	3.1	66.3	3.8	3.7	2.9	1.8	6.1	7.2	1.1	23.0	94.7	116.5	10.3	18.1	2.7	2.1	134.9	136.6	11.5	54.2	6.0	2.2	0.6	143.0	4.8	3.7	27.7	37.9	3.5	48.5	16.4	2.7	1.7	132.8	2.2	10.5	2.2	130.3	2.4	11.6	26.7	4.6	2.8	4.0	181.5	2.5	0.6	1.0	3.6	0.4	0.5	4.4	0.3	0.1	0.3	0.2	0.9	1.0	3.2	0.6	0.0	2.4	2.0	6.1	3.7	1.2	1.7	5.0	3.1	0.4	0.1	1.6	0.8	0.2	0.6	3.3	0.2	3.6	0.9	0.6	7.2	5.5	3.0	0.2	3.2	1.0	1.7	2.6	5.8	2.3	0.0	10.5	15.8	1.9	1.7	23.1	1.3	2.6	1.7	1.1	5.5	7.5	0.2	0.1	0.3	1.9	1.9	1.0	6.1	5.5	3.9	0.2	1.1	0.5	0.5	0.3	0.5	1.0	0.4	1.2	2.5	1.3	1.0	0.4	2.6	2.1	1.9	0.2	0.8	0.4	2.3	0.6	0.6	131.5	159.1	108.3	176.8	94.7	116.5	134.9	136.6	143.0	132.8	130.3	181.5	3.3	3.2	4.5	5.2	9.9	7.8	7.0	4.0	5.7	11.3	14.8	8.8	86.0	12.8	2.7	7.3	6.2	3.2	13.2	2.7	21.5	4.9	95.1	18.4	3.9	3.9	41.5	15.6	4.2	41.3	9.2	4.7	11.2	17.5	1.3	7.5	7.1	67.1	1.9	6.7	4.6	6.3	14.2	3.2	1.6	30.0	5.3	2.6	14.2	2.8	2.4	12.3	4.1	2.5	31.9	10.4	4.0	5.3	29.9	9.4	1.3	56.9	15.5	43.3	0.0	9.3	4.0	32.9	7.7	17.3	20.0	6.3	4.7	4.3	8.1	6.0
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77322017-77474635	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		560000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	12.7	13.4	32.4	33.9	44.5	59.0	18.2	13.9	57.7	21.1	0.0	43.2	43.1	20.9	29.8	21.4	21.9	30.9	9.4	58.3	8.0	26.1	14.5	16.8	20.4	19.2	12.2	21.1	17.5	20.5	20.7	14.7	19.4	19.1	46.5	25.1	19.9	19.7	87.0	16.2	45.7	27.0	0.9	29.3	41.2	25.7	17.1	29.1	40.6	18.8	23.1	27.7	20.7	30.0	39.9	26.7	56.7	25.5	22.8	37.6	45.9	44.6	32.1	42.0	48.7	38.7	52.8	36.3	16.0	39.4	54.4	20.2	40.2	47.8	65.5	41.4	32.6	38.2	17.6	2.3	15.3	64.3	53.5	28.2	28.8	49.2	73.1	36.6	10.1	41.3	25.5	61.2	77.6	2.9	42.3	30.2	84.5	166.2	22.5	62.6	72.3	1.4	10.6	32.9	24.6	23.9	23.6	9.7	19.5	55.0	45.4	29.0	0.9	27.3	47.5	148.9	37.9	165.7	92.4	23.4	23.0	42.5	30.6	2.5	182.2	292.7	11.2	177.7	9.4	16.8	8.4	10.7	264.3	12.9	7.4	14.5	431.8	28.4	202.6	22.9	7.3	92.3	32.4	44.5	13.9	57.7	58.3	8.0	19.2	12.2	19.4	0.9	17.1	30.0	3.1	3.2	20.5	24.2	23.9	11.9	33.3	28.2	23.9	51.6	25.1	19.7	6.2	35.8	30.8	25.8	8.4	25.4	10.2	78.6	45.0	32.4	38.8	37.3	13.5	3.2	37.8	30.5	219.1	56.3	53.5	24.0	45.9	39.7	132.2	35.2	3.6	11.4	49.8	1.7	118.5	50.8	28.5	59.6	152.9	28.3	14.3	80.0	30.2	54.4	121.7	14.9	10.3	53.3	70.7	50.9	57.9	13.2	28.6	28.7	47.9	55.7	39.0	6.4	13.1	13.8	25.2	50.4	53.8	23.6	10.4	95.0	19.3	10.3	52.8	33.2
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1700000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	31.8	18.1	21.2	34.6	24.9	28.1	19.5	25.0	21.7	21.1	19.8	25.6	23.0	21.9	16.0	26.5	20.5	23.8	24.0	19.5	24.6	22.1	33.8	26.3	40.9	26.7	23.4	19.8	18.5	32.6	8.4	33.3	27.7	20.1	26.6	17.4	14.5	18.9	28.3	16.6	22.5	27.0	24.8	43.5	20.9	15.1	23.0	45.1	19.7	25.9	39.4	34.1	16.0	34.1	140.7	49.1	67.6	49.8	47.1	61.9	100.0	69.1	57.0	73.7	66.8	117.5	70.1	89.4	192.7	70.8	75.1	70.2	72.5	66.2	113.6	39.9	35.2	132.2	52.1	92.5	95.0	130.2	122.0	49.6	53.1	66.2	139.2	78.1	74.3	97.3	65.0	107.5	72.9	146.7	124.8	67.2	40.5	74.7	73.4	112.4	38.6	80.9	64.8	96.7	39.6	44.7	92.8	64.7	52.7	51.9	227.0	92.6	76.9	60.9	33.6	64.3	103.1	72.5	138.9	216.4	50.4	127.6	59.1	37.3	20.0	48.0	10.9	23.2	14.7	11.2	12.7	12.6	25.4	11.3	9.1	10.9	47.6	12.2	21.2	9.3	20.7	14.9	21.2	24.9	25.0	21.7	19.5	24.6	26.7	23.4	27.7	24.8	23.0	34.1	164.9	80.1	40.2	37.9	142.8	97.4	89.2	41.8	96.2	42.6	59.7	47.5	59.3	62.9	45.1	82.8	52.1	50.3	135.1	69.6	33.2	71.5	57.1	107.9	112.6	104.0	44.9	72.3	32.2	59.0	101.4	68.9	58.1	96.1	148.8	70.9	66.0	138.6	104.3	55.5	38.9	46.4	57.0	160.5	115.9	75.5	60.9	169.6	33.8	46.9	183.2	63.7	140.1	37.2	61.3	100.4	52.1	45.5	100.0	149.4	58.2	85.2	76.4	45.0	39.5	86.0	75.9	24.5	43.0	103.2	86.2	34.9	139.1	96.3	51.0	124.1
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.9;pancreas: 42.7;pituitary gland: 13.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 104.1;Excitatory neurons: 364.0;Inhibitory neurons: 323.5;Oligodendrocyte precursor cells: 165.9;Peritubular cells: 81.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.8;HAP1: 9.9;HDLM-2: 12.4;NTERA-2: 9.7;SCLC-21H: 12.4;SH-SY5Y: 7.7;U-2197: 7.6;U-251 MG: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	1.0	5.2	16.9	1.6	16.2	0.1	5.2	0.0	17.6	2.3	0.0	0.7	0.2	5.4	5.8	0.7	2.5	1.6	0.3	17.8	31.9	0.7	0.2	0.9	1.7	1.6	0.0	6.2	42.7	0.1	13.7	0.6	6.0	3.4	0.7	7.0	2.2	4.8	1.6	1.3	0.5	4.7	0.4	2.0	2.0	2.6	13.2	0.6	6.2	0.4	0.8	0.9	0.7	2.8	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.3	0.4	1.1	0.0	0.0	0.0	0.0	10.8	1.2	1.6	0.0	9.9	0.6	1.3	12.4	0.4	0.0	1.3	0.0	0.0	0.0	0.4	0.3	0.0	0.1	2.2	5.7	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	9.7	0.0	2.2	0.1	4.3	0.0	0.8	0.0	12.4	7.7	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.7	4.7	7.6	13.6	0.1	0.1	0.1	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	16.2	0.0	17.6	17.8	31.9	1.6	0.0	6.0	0.4	13.2	2.8	0.9	3.2	1.1	16.0	0.6	0.3	13.3	0.2	0.0	104.1	6.9	10.4	1.0	20.0	0.7	0.0	0.0	0.3	0.2	0.2	0.0	4.7	4.4	1.0	10.8	2.3	3.6	0.0	364.0	13.1	0.4	10.3	10.2	1.7	1.3	21.9	1.4	0.2	0.2	6.7	323.5	0.3	0.0	0.3	5.7	7.0	34.2	1.1	0.0	17.8	0.7	27.5	1.0	165.9	12.0	5.3	0.0	81.3	1.0	1.7	0.0	0.6	0.0	6.0	0.0	1.6	7.8	1.4	1.4	0.3	1.1	6.7	2.4	29.2	0.3	0.9
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 154.7;MCF7: 172.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	11.6	20.0	16.7	8.1	18.2	5.3	22.1	14.2	18.4	27.2	14.0	30.2	27.4	20.6	9.4	43.9	23.4	7.5	15.5	13.9	13.4	37.2	26.2	39.6	4.5	17.1	17.2	24.2	31.8	16.2	30.5	16.3	15.8	40.7	8.0	5.8	42.4	11.0	14.0	40.4	25.1	5.7	12.0	13.8	25.3	35.0	15.7	5.4	29.3	4.3	5.4	20.2	30.4	17.0	62.8	154.7	22.7	34.8	7.1	7.5	68.1	29.3	11.7	19.3	19.4	102.1	51.9	14.3	43.3	18.7	25.2	22.7	12.6	23.2	7.2	38.0	35.4	16.9	27.5	50.4	11.3	17.5	23.6	9.0	10.2	18.1	12.9	12.6	25.5	21.4	34.3	11.0	11.8	172.7	18.6	18.9	41.4	55.2	36.7	18.5	17.9	10.9	19.0	67.9	72.2	49.9	29.8	130.6	33.6	11.7	58.1	28.4	42.8	32.6	55.6	37.8	53.0	12.3	12.9	11.9	39.9	10.3	39.9	0.3	0.7	1.2	0.6	0.3	0.8	0.5	0.7	1.1	0.9	0.6	0.5	0.5	0.5	0.9	0.6	0.8	0.9	0.7	16.7	18.2	14.2	18.4	13.9	13.4	17.1	17.2	15.8	12.0	15.7	17.0	5.1	0.0	1.5	9.4	3.9	14.4	15.9	13.8	9.6	18.8	34.2	21.7	2.0	20.0	9.1	18.4	25.0	42.6	4.4	47.5	31.3	20.5	4.1	19.5	8.5	15.0	44.9	5.0	3.9	19.7	67.4	8.8	23.9	23.3	5.7	21.6	10.0	13.3	9.6	21.9	4.2	33.8	28.5	5.3	4.1	6.4	11.8	3.6	7.2	8.4	11.2	13.6	8.2	9.5	13.5	21.8	44.2	10.5	5.8	21.7	39.5	14.4	13.7	13.4	0.0	8.5	7.5	10.4	24.0	20.1	18.8	65.4	6.0	22.3	33.9	24.3
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB014895: , HPA057000: AB_2683307"	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favorable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	5.8	5.6	6.2	4.4	6.5	3.5	6.4	9.8	10.7	7.1	6.2	6.1	6.5	5.6	5.6	10.1	5.4	3.3	4.7	6.2	6.1	7.9	9.9	4.8	6.3	6.0	6.2	6.2	6.0	5.8	5.1	3.8	6.2	5.3	5.3	8.6	6.0	4.0	5.4	9.0	7.0	4.0	5.7	7.8	5.7	9.8	6.6	6.4	5.3	4.8	6.9	6.6	7.2	7.0	17.3	13.1	15.4	10.8	12.6	9.4	13.9	12.0	18.4	19.7	23.6	11.2	17.3	18.2	8.7	8.6	15.0	15.2	13.9	19.8	23.4	10.8	8.1	11.2	18.2	31.8	11.7	20.5	17.3	11.2	20.3	18.7	20.7	10.9	10.6	17.1	23.4	9.4	17.2	17.4	21.2	21.3	34.3	12.5	7.6	24.2	18.9	24.7	15.2	15.2	11.2	11.3	12.5	13.5	16.7	13.4	12.9	13.9	7.7	23.1	8.7	11.2	13.2	11.2	19.0	18.3	15.4	14.8	14.3	6.4	1.8	1.8	2.1	2.3	2.6	1.8	2.4	2.7	2.0	1.4	2.6	2.1	0.1	2.1	4.5	1.5	1.7	1.1	6.2	6.5	9.8	10.7	6.2	6.1	6.0	6.2	6.2	5.7	6.6	7.0	4.7	12.8	4.2	8.5	5.1	0.9	3.5	5.4	2.2	4.8	4.0	3.7	4.8	2.8	8.2	3.7	4.2	2.9	3.8	2.4	3.9	5.8	6.8	2.3	5.1	4.8	1.2	4.6	7.4	5.0	2.0	4.4	4.1	2.6	5.1	7.7	3.3	4.7	3.7	1.7	8.0	3.4	2.0	5.0	1.5	3.6	4.7	5.1	1.8	5.6	8.4	4.8	5.2	7.1	5.9	8.6	2.5	6.4	4.2	5.3	4.6	5.4	8.3	7.5	6.6	4.7	3.0	30.0	17.7	5.4	2.7	1.2	3.7	6.9	4.8	4.1
PALD1	"KIAA1274, PALD"	ENSG00000107719	"Phosphatase domain containing paladin 1"	Q9ULE6	10	70478767-70568450	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Microglial cells: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 5.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;Daudi: 26.7;NB-4: 25.7;RPMI-8226: 32.8;U-698: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015696, HPA017343"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA015696: AB_1852399, HPA017343: AB_1852397"	"unprognostic (1.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.52e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.81e-3)"	6.9	4.5	16.3	5.1	15.0	2.5	5.3	16.1	18.1	5.5	10.6	14.3	2.7	4.8	1.2	4.7	5.8	4.6	7.4	15.4	16.4	5.3	1.6	19.9	9.2	23.6	17.5	5.5	7.2	1.6	5.4	7.6	20.7	6.0	2.2	1.0	4.0	2.1	5.6	5.5	8.1	4.8	22.1	14.7	7.5	3.6	21.4	4.6	8.2	3.0	8.0	5.2	3.7	19.9	0.0	6.4	7.2	21.5	0.0	0.0	0.0	0.0	0.0	1.8	0.4	2.7	0.2	26.7	5.5	0.0	0.3	0.1	11.9	0.0	0.5	0.1	13.6	0.0	0.9	0.5	2.2	9.0	0.0	0.0	0.0	0.7	0.0	1.9	3.1	8.2	1.4	3.6	0.2	2.2	4.6	25.7	7.6	0.0	0.0	13.5	0.1	32.8	1.9	0.0	7.1	5.3	0.3	0.1	0.6	0.9	0.0	1.9	0.6	0.0	9.7	0.0	0.8	0.3	0.0	26.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	16.3	15.0	16.1	18.1	15.4	16.4	23.6	17.5	20.7	22.1	21.4	19.9	15.0	0.0	1.1	4.6	3.2	1.3	0.1	0.1	4.0	0.5	1.3	2.2	3.6	1.5	0.0	1.8	0.0	0.0	11.4	0.0	0.0	1.7	0.9	1.1	0.6	20.3	0.0	0.0	4.9	0.2	0.1	3.5	0.0	1.8	1.3	0.7	12.5	0.2	7.4	0.0	2.2	0.0	0.0	10.8	3.3	0.5	1.8	12.2	1.8	129.3	0.3	3.0	0.0	6.6	0.9	0.1	0.0	0.7	5.1	0.3	0.0	0.1	0.0	0.4	0.0	3.0	5.1	0.2	2.7	0.5	1.3	0.0	0.6	1.2	0.0	0.0
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497052-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 304.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Mitochondria,Cytosol"		No	No		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	"Plasma membrane, Mitochondria, Cytosol"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	65.0	35.5	31.7	49.7	27.3	0.9	43.6	11.1	19.9	146.1	0.0	303.3	29.0	301.5	21.9	122.6	118.4	71.0	180.4	27.9	36.2	42.1	12.4	71.7	16.9	29.8	25.9	62.1	13.2	55.6	11.3	62.1	25.1	137.0	74.9	12.8	40.8	205.7	127.7	34.7	64.1	303.1	21.4	60.5	94.8	35.1	24.7	23.3	38.7	47.3	16.6	280.2	85.3	22.7	82.1	39.6	87.9	53.4	77.2	83.9	123.6	53.7	137.6	47.2	66.7	1.1	4.6	36.6	14.4	23.7	29.0	17.0	54.1	138.8	60.5	73.9	16.6	0.8	112.5	10.4	135.5	0.4	1.0	132.8	84.4	85.5	125.4	115.0	20.8	19.7	0.1	0.5	304.5	3.8	23.8	1.4	24.9	20.8	24.1	8.3	81.4	0.8	5.3	16.4	9.0	46.4	102.8	8.1	7.3	151.2	48.6	0.5	64.4	50.3	192.1	20.7	90.1	47.8	0.7	1.7	41.6	1.0	14.2	13.7	3.1	0.0	4.6	1.8	0.2	0.1	0.5	2.4	2.1	0.1	0.6	1.6	0.7	0.6	1.2	0.2	0.8	1.8	31.7	27.3	11.1	19.9	27.9	36.2	29.8	25.9	25.1	21.4	24.7	22.7	22.7	32.1	9.4	167.8	1.5	93.6	527.9	56.8	76.8	6.0	46.0	107.9	591.7	20.0	58.7	44.1	18.8	52.1	8.1	20.9	1.9	27.6	133.1	52.8	181.2	27.7	44.8	0.8	27.8	51.3	115.6	130.5	59.7	51.0	52.6	21.0	47.8	11.2	24.5	26.9	108.4	30.7	18.3	28.9	23.8	146.4	130.1	36.7	23.2	16.9	52.9	55.1	17.5	182.4	6.5	83.0	18.6	399.4	2.6	167.6	9.8	23.4	85.2	4.0	177.5	115.4	227.8	81.0	7.6	34.1	49.3	22.3	9.2	13.4	29.3	113.0
PALM	"KIAA0270, PALM1"	ENSG00000099864	Paralemmin	O75781	19	708935-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 257.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.2;Distal tubular cells: 52.8;Hepatic stellate cells: 63.1;Leydig cells: 48.4;Muller glia cells: 92.8;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;EFO-21: 20.7;REH: 34.3;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	89.0	23.1	158.4	2.0	140.7	0.7	66.0	86.1	257.8	60.3	54.5	54.4	7.4	43.3	3.3	14.4	47.0	2.8	41.1	165.1	97.0	52.7	7.3	30.0	0.6	106.4	103.6	65.7	5.8	1.2	62.5	6.6	96.9	42.6	0.6	4.6	12.9	8.3	9.6	33.4	20.8	2.4	95.0	23.4	18.0	19.6	112.1	0.6	21.0	1.7	0.2	29.4	41.8	110.5	0.0	7.6	14.6	16.6	0.6	0.2	2.2	0.9	0.0	1.0	0.2	1.9	0.1	0.0	20.7	0.0	0.0	2.7	8.0	0.0	0.4	0.0	14.1	0.0	4.3	9.3	9.4	0.0	0.3	3.0	0.0	0.9	0.0	0.4	0.4	1.6	4.6	0.1	1.1	15.9	1.1	9.4	5.9	1.0	3.2	34.3	0.0	0.2	0.6	0.0	1.7	28.0	7.5	0.1	0.2	4.6	1.8	4.5	0.0	0.0	13.4	16.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	158.4	140.7	86.1	257.8	165.1	97.0	106.4	103.6	96.9	95.0	112.1	110.5	27.2	0.0	1.7	85.2	2.7	7.1	7.2	6.3	1.8	11.4	5.7	5.3	5.8	1.5	4.9	5.5	12.5	0.9	0.2	1.3	52.8	1.4	1.4	3.8	27.0	25.6	0.0	1.3	26.9	0.2	7.2	37.6	1.1	5.9	0.0	1.4	63.1	0.4	1.0	25.2	15.1	0.1	12.2	2.4	5.4	6.6	48.4	1.1	17.8	10.3	0.1	92.8	0.0	16.6	9.8	0.2	1.4	45.1	0.1	10.1	7.2	57.9	0.5	5.7	0.0	2.3	14.1	0.8	7.3	1.1	7.0	1.9	1.1	0.1	0.4	7.2
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053363-14062076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.9;liver: 55.7;stomach 1: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.1	0.2	1.3	0.1	1.4	0.0	0.6	1.3	1.5	2.0	1.0	0.8	1.6	1.0	6.7	0.3	1.8	1.0	0.4	1.3	1.8	46.9	55.7	4.3	0.0	2.9	1.7	0.2	24.5	6.5	0.4	0.4	2.6	4.0	0.2	0.5	3.7	4.5	0.1	0.5	1.1	0.0	1.7	0.1	30.5	15.2	1.8	0.0	12.7	0.0	0.0	4.7	1.6	1.7	1.4	1.3	2.9	17.6	0.3	0.0	3.3	0.3	0.0	0.7	0.5	20.2	0.3	0.0	0.2	0.4	5.5	0.0	15.8	0.0	0.3	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.5	0.0	0.0	3.4	0.0	0.0	3.2	0.2	0.0	10.3	1.6	0.8	0.0	0.0	0.0	0.0	1.7	1.9	2.3	0.1	0.0	0.0	3.2	1.3	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	1.3	1.5	1.3	1.8	2.9	1.7	2.6	1.7	1.8	1.7	0.1	57.7	40.9	0.3	0.5	0.0	0.6	0.1	0.0	0.7	1.0	1.4	0.3	22.8	10.1	38.6	0.0	0.3	0.0	0.7	1.9	9.4	0.0	3.2	1.0	0.2	1.2	0.0	0.3	27.9	3.1	1.7	7.1	6.3	1.3	0.1	1.8	40.5	0.1	0.0	0.5	3.0	0.0	1.3	0.3	0.5	0.9	0.2	1.8	0.0	1.0	0.8	0.0	0.0	0.1	5.5	1.3	2.6	0.0	1.0	3.2	9.5	2.1	0.6	0.0	0.1	0.2	0.0	18.8	0.0	0.0	2.2	0.3	0.0	1.0	1.0
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99646113-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 130.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 537.2;Cardiomyocytes: 157.6;Endothelial cells: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 155.2;LHCN-M2: 49.5;TIME: 220.5;U-87 MG: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	130.8	43.0	14.6	7.1	11.7	0.0	77.6	10.5	15.3	27.4	45.8	9.5	3.4	33.0	6.1	38.2	22.8	14.6	91.2	13.7	12.7	11.0	57.1	28.4	3.9	12.0	11.8	18.8	4.9	9.2	10.5	43.2	11.5	18.0	6.5	7.5	71.0	7.9	112.6	48.9	8.6	31.4	11.1	6.3	6.1	11.0	14.1	8.0	7.2	66.2	8.6	14.5	15.9	10.4	0.0	0.3	0.4	0.2	7.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	39.2	2.5	0.6	10.8	0.0	0.5	0.1	0.1	0.1	0.0	18.6	26.4	0.0	0.0	0.1	3.9	2.0	0.0	0.0	4.3	155.2	0.0	22.7	0.0	49.5	0.6	0.0	0.0	0.0	1.6	6.8	0.0	38.2	0.1	0.0	8.0	0.9	0.5	0.0	9.9	0.0	1.0	2.3	0.0	220.5	0.0	0.4	16.8	0.0	0.0	0.0	0.1	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	11.7	10.5	15.3	13.7	12.7	12.0	11.8	11.5	11.1	14.1	10.4	537.2	6.4	5.6	0.3	0.5	38.5	11.4	49.6	22.2	2.0	20.0	31.8	157.6	32.9	35.9	3.7	0.0	0.4	1.6	0.1	5.9	8.1	74.9	78.7	71.9	219.4	1.8	2.7	1.4	0.2	0.3	19.2	2.0	17.7	1.3	0.0	96.0	57.3	0.6	3.3	1.8	0.0	14.2	2.2	5.5	12.2	9.3	1.7	24.9	73.1	0.0	55.0	0.0	0.5	0.2	4.1	0.0	24.0	0.0	5.9	0.0	0.4	111.5	3.3	0.0	91.3	12.7	0.5	0.6	27.5	46.5	0.3	1.4	110.1	0.1	3.3
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1560.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		98000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	119.3	202.5	71.6	34.6	81.4	10.1	99.0	50.7	82.5	595.0	96.2	125.1	52.6	140.9	678.2	69.4	87.6	97.3	1560.4	75.2	179.9	116.0	20.1	88.3	27.7	86.5	99.8	136.4	104.4	257.8	137.0	60.0	170.9	91.6	80.4	37.6	205.4	236.5	155.3	66.9	52.1	157.9	55.7	52.5	131.6	22.4	106.0	17.9	95.1	159.4	30.5	103.3	116.1	50.0	111.3	16.3	195.9	87.2	529.9	314.8	78.0	307.6	457.0	89.1	268.9	53.5	143.2	0.1	65.0	714.5	125.7	36.8	11.0	135.3	244.0	13.5	44.7	22.9	60.0	17.7	80.3	7.4	23.9	173.4	57.3	65.6	49.2	562.6	186.8	8.9	0.9	15.0	255.6	22.9	0.1	3.2	35.3	19.7	59.3	8.5	108.9	62.4	346.1	13.0	92.3	63.9	131.2	8.3	83.3	114.0	34.0	7.3	144.9	280.8	72.4	133.3	93.4	33.1	8.6	0.4	322.3	30.8	247.6	4.2	8.0	0.2	20.7	1.5	14.9	0.8	12.3	15.6	3.1	0.4	4.1	6.8	16.6	26.3	3.4	1.6	19.9	10.8	71.6	81.4	50.7	82.5	75.2	179.9	86.5	99.8	170.9	55.7	106.0	50.0	45.7	54.5	39.3	47.0	3.9	28.2	12.0	26.1	12.0	19.1	27.5	12.1	1406.5	0.0	30.4	60.7	2.1	1.6	12.6	13.7	7.9	12.6	8.8	47.6	48.6	63.5	321.4	3.4	229.2	21.5	40.6	220.4	26.0	83.0	9.5	68.3	74.6	3.5	5.9	8.4	487.7	13.8	18.3	10.3	48.3	8.1	60.3	9.3	37.4	192.0	9.5	11.6	22.6	154.8	9.3	30.6	6.3	58.6	12.1	26.4	4.8	43.8	19.2	3.8	19.7	36.4	44.9	2.6	5.6	8.0	23.7	6.7	16.6	19.3	6.3	18.2
PAN3		ENSG00000152520	"Poly(A) specific ribonuclease subunit PAN3"	Q58A45	13	28138506-28295335	"Enzymes, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 154.6;Microglial cells: 209.9;Oligodendrocyte precursor cells: 171.4;Oligodendrocytes: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028817	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA028817: AB_10602016"	"unprognostic (3.25e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.42e-2)"	17.1	9.8	7.8	14.2	8.9	31.3	18.1	16.4	10.8	16.1	12.2	13.9	9.6	15.3	20.6	12.5	16.1	11.0	8.5	7.9	8.1	13.4	11.0	14.6	21.5	8.5	8.4	16.3	17.0	10.1	12.5	11.8	8.9	14.1	12.6	15.8	14.8	12.1	6.8	20.1	18.7	10.8	8.6	25.8	13.0	14.2	7.9	21.5	17.4	5.7	19.4	13.1	15.3	11.8	9.9	6.2	16.8	17.9	8.2	11.6	13.9	10.1	16.1	10.5	10.0	10.3	21.2	34.9	7.1	14.9	11.8	14.4	15.1	11.9	17.8	19.8	7.9	28.3	8.7	8.9	10.9	21.6	17.0	11.5	11.9	8.9	18.1	13.5	14.2	16.2	14.1	10.4	11.6	13.6	23.6	52.2	18.0	13.6	5.9	54.5	17.9	12.8	16.7	13.2	15.8	12.5	11.9	17.3	13.9	10.3	9.2	40.6	13.8	10.5	8.9	10.3	9.8	7.9	6.1	35.6	6.2	16.2	13.1	22.8	10.1	13.4	9.0	9.6	9.6	12.3	10.2	9.2	9.8	11.4	11.5	11.1	22.5	11.9	14.4	15.6	8.7	11.2	7.8	8.9	16.4	10.8	7.9	8.1	8.5	8.4	8.9	8.6	7.9	11.8	32.3	16.0	19.5	97.9	42.9	66.3	16.2	10.2	18.8	27.3	36.1	16.9	7.8	17.2	14.8	16.5	29.2	18.1	51.1	13.6	1.9	13.6	21.3	33.2	25.7	26.8	27.1	61.0	131.4	12.5	15.9	23.7	19.4	38.5	16.5	26.3	28.9	10.7	13.7	26.9	154.6	18.0	16.2	41.4	88.0	12.4	26.4	34.7	56.9	209.9	35.4	13.7	35.0	171.4	222.3	13.6	21.5	21.8	28.9	35.0	13.2	14.3	16.6	37.8	13.1	31.6	26.2	26.5	23.0	22.5	80.7	24.1	36.1	17.1	17.0	31.2
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.0	12.3	14.5	16.8	13.7	20.9	12.2	15.3	15.9	11.9	14.1	11.4	8.4	11.0	11.3	20.0	16.3	12.1	8.7	15.5	13.5	15.7	18.3	14.1	18.5	12.7	14.1	12.9	10.3	10.9	8.9	15.3	13.3	12.0	14.2	10.3	11.9	10.7	9.6	11.7	11.6	13.7	12.7	14.9	9.1	25.9	13.9	16.8	15.4	11.2	22.0	15.6	9.9	12.4	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	14.5	13.7	15.3	15.9	15.5	13.5	12.7	14.1	13.3	12.7	13.9	12.4	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PANK3	FLJ12899	ENSG00000120137	"Pantothenate kinase 3"	Q9H999	5	168548495-168579368	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078669	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA078669: "	"unprognostic (1.24e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-3)"	"unprognostic (2.01e-1)"	12.5	20.1	6.8	13.5	8.3	17.9	25.5	20.4	10.0	10.5	2.6	27.0	41.5	13.2	9.3	13.1	7.9	10.0	10.3	8.5	7.9	15.0	43.2	10.3	13.1	8.8	8.7	11.3	10.5	21.8	6.3	14.1	8.5	12.8	25.7	18.0	10.5	7.8	7.7	14.9	30.5	11.7	7.6	12.7	16.1	12.5	9.4	14.2	15.2	12.1	12.5	11.5	11.2	10.4	29.0	16.1	65.2	34.9	23.8	27.5	27.5	17.1	18.0	22.3	32.5	26.9	26.1	44.9	27.3	24.3	35.6	20.3	44.2	34.2	40.1	42.1	21.6	23.4	15.2	20.1	27.7	31.1	29.4	22.1	45.4	28.1	31.4	15.8	26.5	33.1	21.5	43.4	31.0	16.0	31.3	14.1	27.7	22.2	12.1	22.3	44.8	18.2	28.1	42.2	30.2	64.4	19.6	31.5	48.9	32.6	41.2	38.8	27.8	29.9	41.3	17.9	36.8	30.0	45.1	32.5	17.8	31.3	23.8	1.1	1.0	0.5	0.5	1.2	0.7	1.4	0.6	0.6	0.6	0.5	0.4	0.7	0.4	0.3	1.7	0.9	0.7	0.3	6.8	8.3	20.4	10.0	8.5	7.9	8.8	8.7	8.5	7.6	9.4	10.4	26.3	25.6	19.3	6.2	18.3	34.3	23.6	27.4	4.6	28.7	59.1	29.0	16.4	17.2	26.4	25.8	27.1	17.6	29.9	114.8	9.8	17.9	12.8	20.4	28.7	24.8	34.2	36.4	23.3	20.1	14.2	22.0	36.7	32.4	15.2	31.4	14.3	94.2	23.0	28.6	22.6	37.5	26.4	33.6	30.5	17.0	16.8	25.0	23.2	10.3	23.1	12.6	14.4	12.5	17.5	23.0	40.4	17.7	17.0	40.1	98.3	27.2	22.7	26.4	26.3	30.7	28.0	42.1	25.1	26.7	56.1	41.9	18.0	42.4	50.6	52.3
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4 (inactive)"	Q9NVE7	1	2508537-2526597	"Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	10.1	11.0	1.0	2.7	1.7	4.7	9.7	1.0	5.1	10.9	2.1	13.9	4.1	11.4	0.0	9.1	10.0	0.0	21.8	1.3	1.0	11.0	12.7	11.9	2.7	1.1	1.4	9.4	8.7	1.2	13.6	2.5	1.2	10.3	2.7	5.6	10.0	1.7	32.8	12.6	11.6	1.8	1.2	13.7	11.5	8.9	1.3	2.8	11.5	20.5	2.6	12.5	10.4	1.2	2.2	6.3	4.9	13.8	9.4	5.2	4.5	0.0	1.7	0.1	2.2	12.6	18.5	2.2	0.7	4.3	8.1	4.6	0.2	7.8	5.5	0.0	12.3	7.4	1.6	5.7	0.7	5.7	0.1	8.0	7.0	11.6	2.3	0.6	5.6	2.7	0.1	14.9	0.7	5.5	11.8	7.7	0.0	3.1	12.5	13.4	0.7	5.3	0.0	3.8	10.8	6.1	0.5	10.7	11.9	3.2	5.4	0.0	1.1	15.1	2.3	5.0	5.7	4.6	0.3	4.7	6.9	7.3	3.6	0.5	0.0	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	1.0	1.7	1.0	5.1	1.3	1.0	1.1	1.4	1.2	1.2	1.3	1.2	4.7	6.4	5.1	7.5	6.1	4.1	5.6	7.4	6.2	7.2	3.7	2.4	23.3	2.8	6.4	3.7	10.4	7.8	5.9	7.9	7.9	5.7	1.4	3.8	4.2	5.4	3.0	11.6	6.1	6.9	5.0	6.4	4.6	5.0	1.3	5.3	3.6	7.9	5.3	3.3	6.4	4.5	6.1	5.0	3.0	0.6	5.9	5.0	5.4	1.9	7.4	4.6	11.3	5.5	3.5	5.3	8.8	9.1	7.1	4.0	4.7	4.8	3.1	13.9	19.7	2.6	6.3	6.3	6.1	3.9	4.4	9.7	8.9	3.2	5.9	4.2
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128841-94181968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	11.4	7.2	5.1	12.1	5.2	4.1	6.4	1.2	5.5	7.9	2.7	8.4	5.4	8.5	5.2	7.9	5.2	11.5	9.9	5.0	7.1	6.9	16.8	10.2	6.4	2.1	2.9	7.1	7.4	4.4	4.7	9.7	3.3	7.7	7.2	3.1	6.0	7.0	20.8	8.3	5.8	12.8	2.8	5.8	7.4	9.9	4.9	8.1	8.7	10.8	7.0	21.9	6.5	2.7	24.6	10.2	26.2	16.0	23.9	32.3	17.1	29.8	63.0	25.1	30.7	26.2	37.6	7.8	27.3	30.5	46.1	50.5	20.9	49.2	25.2	33.6	10.9	36.0	10.2	13.5	23.1	18.7	31.0	25.7	33.9	32.8	29.2	16.1	21.2	20.1	23.8	27.5	28.3	7.8	31.3	4.4	21.0	19.7	18.2	36.7	35.0	9.7	16.3	24.0	11.0	31.9	20.9	11.9	14.4	13.3	25.2	9.5	15.4	49.5	25.5	16.4	29.9	4.5	18.2	12.6	20.6	19.0	32.2	3.2	4.0	0.3	2.1	2.2	2.4	1.3	1.7	2.3	2.7	1.2	1.6	1.7	0.2	2.6	1.4	0.4	2.9	3.2	5.1	5.2	1.2	5.5	5.0	7.1	2.1	2.9	3.3	2.8	4.9	2.7	3.8	0.0	8.7	4.6	6.6	102.0	12.3	14.9	13.6	1.3	4.5	2.0	4.7	4.3	4.7	1.8	0.0	12.8	5.3	4.7	0.0	15.7	5.3	9.1	13.0	6.8	2.4	5.2	8.9	18.2	32.4	17.5	7.1	13.9	9.5	4.0	2.2	8.1	20.5	0.0	15.4	4.1	0.0	3.1	21.6	3.9	4.4	11.5	17.8	8.4	3.7	1.1	1.0	9.5	5.8	26.1	3.4	3.8	7.4	10.2	2.6	2.1	6.2	1.1	0.0	16.9	10.6	1.7	8.2	8.3	72.2	23.8	6.6	10.1	4.2	12.7
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180295	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Excitatory neurons: 13.3;Hepatocytes: 10.7;Inhibitory neurons: 15.8;Muller glia cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.3;HDLM-2: 16.7;Hep G2: 19.6;MCF7: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.0	0.8	4.4	0.5	4.4	1.6	1.0	8.4	40.1	1.7	0.0	0.3	0.0	1.2	0.5	5.2	2.2	0.4	0.7	8.0	13.1	3.0	9.6	2.1	0.0	51.0	8.8	3.4	1.4	0.3	7.9	0.1	48.4	3.9	0.0	1.6	5.0	1.4	0.7	1.1	0.2	0.0	7.9	1.9	0.4	1.7	14.1	0.0	7.3	0.1	0.1	1.4	1.9	16.4	0.9	2.1	0.4	2.3	0.0	0.2	4.9	2.6	2.5	0.5	0.4	0.5	8.0	0.0	10.3	0.3	1.4	0.5	1.3	1.0	0.1	16.7	1.4	0.4	3.5	19.6	0.7	0.1	1.2	0.2	1.0	0.7	0.0	1.1	0.6	0.0	1.4	0.0	0.2	10.8	0.0	1.0	3.9	0.0	4.2	1.0	0.0	4.0	0.0	1.6	9.8	0.9	1.6	0.2	6.5	0.5	0.7	0.8	4.5	0.5	4.1	6.7	4.9	1.8	0.1	0.6	0.3	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	4.4	4.4	8.4	40.1	8.0	13.1	51.0	8.8	48.4	7.9	14.1	16.4	0.0	0.0	1.1	7.2	0.3	0.5	3.1	0.6	0.0	11.4	2.5	2.4	0.8	1.5	2.6	0.0	0.0	0.0	1.5	0.0	5.9	2.3	0.3	5.9	1.5	0.7	0.0	0.4	13.3	2.8	0.2	0.8	0.0	7.0	0.0	2.1	0.0	10.7	0.1	0.0	15.8	0.0	0.0	0.9	1.5	0.2	0.0	1.1	0.0	1.9	1.8	29.7	0.0	6.6	1.2	1.8	0.0	1.2	0.5	6.0	0.0	3.0	3.0	3.6	0.0	0.1	0.9	0.0	1.8	0.3	0.3	0.0	0.2	0.1	0.0	4.5
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.4;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		76000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	16.1	6.6	15.7	8.4	17.0	2.3	10.7	12.1	23.5	30.3	15.7	13.4	3.0	20.4	14.9	7.1	23.0	5.6	8.0	14.4	13.3	42.6	3.2	13.4	15.2	14.1	14.6	16.8	4.0	0.4	16.4	4.0	13.1	13.6	4.5	9.5	7.5	7.5	2.1	15.7	17.8	6.3	12.3	29.1	11.3	6.4	14.4	5.1	24.8	1.8	13.6	5.1	9.1	12.3	2.7	2.6	1.0	0.4	1.9	2.3	5.8	0.5	0.0	0.1	0.2	3.4	0.8	0.5	2.7	0.0	0.1	4.3	2.7	2.0	0.3	3.0	3.9	1.2	4.7	0.3	16.1	0.4	2.1	30.6	11.4	0.5	1.7	0.2	0.6	2.5	0.8	0.3	0.0	1.4	0.3	3.0	0.6	0.3	0.8	0.4	0.3	2.8	2.3	0.6	0.3	0.5	6.2	7.0	1.3	7.9	0.2	4.8	0.5	0.7	2.3	0.2	0.3	1.3	0.1	0.3	1.4	1.4	0.6	0.8	0.5	0.3	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.5	0.2	0.2	2.5	0.3	0.2	5.4	0.3	0.1	15.7	17.0	12.1	23.5	14.4	13.3	14.1	14.6	13.1	12.3	14.4	12.3	0.4	0.0	2.6	119.8	0.3	2.0	0.7	5.1	0.6	1.2	1.8	1.4	1.9	7.2	4.8	5.5	8.4	0.5	5.7	0.4	0.0	4.0	0.3	11.8	37.9	3.4	0.0	0.0	0.3	0.0	1.1	8.3	0.5	16.1	0.0	0.2	3.3	0.1	1.2	0.0	0.9	0.4	2.0	0.3	1.6	1.7	34.5	1.8	1.8	10.3	1.6	15.7	0.0	3.0	0.3	0.4	0.0	44.0	0.2	1.4	0.2	10.2	3.7	3.0	6.6	1.4	1.8	0.6	0.1	0.8	3.0	0.4	0.7	0.1	1.0	0.4
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1036.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001788	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	52.6	60.5	62.7	66.6	65.1	96.9	62.7	71.7	87.4	61.7	70.1	70.5	57.1	68.5	72.5	59.6	57.9	56.1	61.0	59.9	64.4	60.7	81.6	50.0	77.8	63.0	61.7	76.1	71.6	73.2	53.0	85.3	64.3	54.2	71.8	92.4	63.8	54.0	46.7	57.9	67.6	61.6	62.8	69.3	65.9	75.8	62.1	93.0	68.9	56.4	82.8	66.4	53.5	80.7	126.6	119.4	150.5	152.6	107.2	119.4	331.6	112.9	120.4	132.1	125.8	132.9	125.6	170.9	125.3	134.1	115.2	104.4	50.1	156.9	235.0	141.1	81.1	131.9	88.9	138.5	110.6	166.2	133.4	110.6	134.1	148.0	131.1	127.8	150.5	79.5	128.2	146.5	128.9	184.6	140.5	91.1	102.9	205.0	135.3	146.7	183.5	98.7	132.0	192.7	154.0	102.0	151.4	115.8	111.6	167.9	165.3	158.3	119.0	91.3	72.6	104.1	140.7	114.3	186.7	138.6	144.5	137.5	158.9	73.5	32.0	56.1	23.8	39.3	29.0	38.9	30.2	34.2	38.8	42.7	35.3	33.9	41.3	41.3	37.7	25.1	32.7	36.6	62.7	65.1	71.7	87.4	59.9	64.4	63.0	61.7	64.3	62.8	62.1	80.7	126.3	80.1	122.4	64.6	171.4	229.7	406.3	196.6	126.9	78.2	140.0	101.6	157.2	88.6	160.1	84.6	95.9	346.2	139.6	124.1	183.9	121.4	634.7	326.1	145.4	150.7	117.2	126.8	87.9	137.0	440.7	129.9	95.3	371.7	136.4	113.8	85.6	112.3	155.6	63.9	111.5	154.9	168.9	141.3	239.4	275.3	96.3	153.2	168.9	104.9	171.8	93.4	135.9	105.1	115.2	129.6	118.9	80.5	197.4	373.0	122.5	136.5	253.1	107.2	105.2	131.6	185.0	256.8	203.0	146.0	247.6	1036.0	167.8	131.2	166.1	540.3
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756253-60802086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	3.7	3.0	2.2	2.2	2.3	1.4	3.4	3.2	3.1	4.2	1.7	3.2	1.3	4.1	1.2	3.5	3.2	1.4	3.1	2.3	2.3	2.5	2.3	3.2	3.0	2.5	2.1	4.9	3.5	1.7	3.1	2.0	2.5	2.6	1.5	4.0	3.8	1.2	4.2	3.7	3.6	1.5	1.9	4.1	3.4	3.5	2.6	3.7	6.2	1.7	2.5	3.2	4.1	3.0	1.8	1.5	3.4	2.0	3.1	3.7	2.4	1.5	1.9	1.4	1.2	2.4	1.3	2.6	1.7	1.3	1.4	2.8	3.7	1.8	2.3	4.0	2.1	4.0	1.7	1.7	1.9	4.4	2.4	2.2	2.5	1.7	3.7	2.9	2.6	2.6	3.2	1.9	1.4	1.4	5.0	3.6	5.3	2.9	1.1	3.4	4.9	2.7	1.9	1.4	1.6	2.4	2.2	2.7	1.9	3.2	1.3	2.7	2.4	1.8	1.8	1.3	1.7	2.4	1.5	5.4	2.2	4.8	1.4	3.7	0.8	1.5	1.3	1.0	1.7	1.1	1.2	1.2	0.7	1.4	1.7	1.5	2.2	1.4	1.2	0.8	2.2	0.8	2.2	2.3	3.2	3.1	2.3	2.3	2.5	2.1	2.5	1.9	2.6	3.0	11.5	12.8	12.2	13.1	13.9	12.5	13.5	4.6	12.0	6.8	8.4	8.6	7.9	7.2	8.8	9.2	25.0	6.0	21.0	6.9	3.9	4.8	4.7	6.1	13.2	10.9	2.4	13.3	29.5	4.3	4.6	11.0	6.6	6.6	13.3	14.6	11.7	5.0	7.4	5.0	24.8	5.7	10.2	10.4	22.7	4.3	7.5	17.8	12.4	25.3	12.0	5.1	8.2	19.1	22.1	4.9	6.0	8.6	12.7	15.4	4.3	3.5	7.1	10.3	26.3	9.3	11.3	30.3	17.3	13.2	15.9	8.8	20.8	10.6	4.0	16.2
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153791-116402321	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 72.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		78000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.1	1.5	0.7	1.8	0.2	0.0	0.8	0.5	0.9	4.2	2.2	2.0	0.3	3.9	0.6	2.5	3.1	2.0	2.6	0.3	1.6	3.8	0.3	1.9	1.2	2.5	2.5	2.5	0.8	9.1	0.4	72.3	2.0	1.1	1.5	1.0	0.4	2.1	0.3	0.9	0.9	4.2	0.4	0.3	1.1	0.8	1.6	0.8	1.0	1.4	1.0	4.5	2.4	1.3	0.0	14.9	22.3	0.0	50.0	37.8	0.0	12.2	21.4	3.3	5.6	0.0	0.0	0.0	0.0	8.6	1.1	1.7	0.0	0.0	15.6	0.0	0.0	2.6	12.8	0.1	24.3	0.0	0.0	137.4	0.0	16.4	1.9	26.9	0.1	0.0	0.5	0.0	3.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.1	1.2	1.8	0.0	0.0	6.8	0.0	0.0	28.9	36.3	1.8	1.0	1.4	0.0	0.0	0.0	25.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.9	0.3	1.6	2.5	2.5	2.0	0.4	1.6	1.3	0.2	0.0	1.5	3.9	1.0	2.9	0.2	4.0	92.2	17.6	0.8	0.4	3.4	0.0	1.6	165.5	12.5	0.5	0.1	0.1	9.8	5.9	20.1	4.7	101.3	1.4	0.0	0.0	10.0	0.9	19.5	31.8	0.5	2.6	1.3	10.4	4.6	0.1	0.4	0.0	19.6	0.0	0.0	0.0	5.8	17.9	14.3	1.0	1.8	7.5	0.0	2.5	1.0	15.1	2.9	0.3	0.0	8.6	1.2	1.2	0.2	51.5	1.6	2.9	0.0	3.3	10.9	2.2	0.6	19.7	1.1	14.0	1.3	0.2	0.1	0.3
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845601	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 56.8"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 140.7;Extravillous trophoblasts: 71.9;Muller glia cells: 41.4;Oligodendrocytes: 37.6;Syncytiotrophoblasts: 74.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 19.8"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.6"	"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA		2000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.5	0.3	0.3	0.0	2.5	0.3	0.4	6.6	0.0	0.6	0.0	0.6	0.3	0.0	0.2	1.8	0.3	0.5	0.2	6.3	0.6	0.1	0.0	0.5	0.5	0.0	2.5	0.0	1.1	56.8	0.6	0.2	0.5	3.7	0.1	0.6	0.0	0.1	0.2	0.5	0.4	0.0	1.6	0.4	0.3	0.0	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	4.3	2.1	3.5	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.5	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.3	1.6	1.3	0.1	0.6	0.3	0.4	0.0	19.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.4	0.5	0.2	0.5	0.5	0.6	0.4	0.3	0.4	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.8	0.0	0.0	5.5	0.0	1.5	0.0	0.1	11.7	0.0	2.6	0.2	0.1	0.3	140.7	0.0	16.3	0.2	71.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	10.8	0.2	0.0	0.0	0.0	1.9	11.5	0.0	0.0	2.8	0.0	41.4	0.0	5.0	37.6	0.8	0.0	10.9	0.0	0.0	0.0	0.5	0.0	2.4	6.6	0.0	1.2	1.3	2.2	0.0	0.0	74.0	0.0	0.0	0.2	0.1
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	33.3	135.2	6.3	26.6	7.0	2.0	20.9	6.2	9.5	17.8	6.2	79.9	29.5	8.5	3.1	10.2	12.4	20.7	11.6	5.8	6.2	23.8	77.0	70.4	11.0	6.9	6.6	27.5	26.1	2.1	3.0	58.5	7.5	6.7	64.3	2.3	16.4	3.4	4.7	3.5	61.8	16.7	6.8	8.5	9.2	11.7	8.0	3.0	21.3	8.7	14.8	16.6	11.5	7.2	19.9	20.0	6.4	0.3	129.4	164.8	0.3	189.8	157.7	110.4	79.9	1.0	4.1	0.1	9.8	473.2	3.5	8.5	13.9	13.3	125.2	0.2	10.0	8.8	13.4	0.1	196.5	0.2	3.8	58.7	0.3	63.7	5.2	135.6	94.2	1.4	0.0	89.4	79.2	74.1	0.1	0.7	7.4	4.8	24.1	0.4	0.1	0.4	117.5	8.7	0.9	1.6	92.5	3.3	1.1	12.6	13.5	5.3	120.0	38.2	22.5	131.5	13.9	0.3	1.0	0.3	18.3	0.2	0.2	0.0	1.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	7.7	0.0	0.0	0.8	6.3	7.0	6.2	9.5	5.8	6.2	6.9	6.6	7.5	6.8	8.0	7.2	49.5	240.4	38.2	3.6	2.6	2.3	0.9	18.0	1.8	0.2	11.5	4.7	4.4	8.6	13.8	9.2	0.0	0.5	0.8	202.4	13.7	6.4	1.2	2.6	18.7	23.2	12.6	5.2	22.2	30.2	0.8	36.1	15.3	11.6	0.0	20.3	36.0	111.5	11.5	0.0	27.6	26.5	4.1	29.8	50.7	0.8	17.4	51.0	1.8	30.0	5.2	1.3	0.0	21.6	1.0	19.4	46.1	5.3	3.1	2.1	181.3	9.8	3.4	0.0	13.1	1.0	20.4	1.2	0.7	1.1	1.3	1.4	1.7	96.4	74.3	1.1
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861484-25875708	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1939.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.5;HaCaT: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	5.5	23.9	8.5	4.4	8.4	5.1	5.2	7.5	8.6	11.9	10.0	6.4	20.9	11.1	28.2	17.7	20.0	7.8	3.3	7.9	10.1	35.3	7.4	5.6	4.3	9.6	10.2	35.3	6.6	13.7	6.7	21.4	9.4	7.9	2.9	1.5	5.3	24.3	3.0	31.4	18.9	9.5	9.2	10.2	8.1	46.2	10.6	3.5	5.1	1.9	4.9	13.6	13.5	9.4	30.7	6.0	5.8	18.9	7.1	14.8	20.4	19.9	17.5	19.2	17.0	9.8	75.5	0.3	13.6	19.2	6.3	62.6	3.2	33.0	11.4	12.1	3.4	25.6	8.4	12.1	12.0	0.4	3.1	14.9	43.3	13.7	10.2	16.9	7.5	2.8	2.8	2.1	14.4	7.0	0.2	1.9	9.3	3.1	10.3	2.1	0.6	3.8	39.3	22.9	3.1	11.5	32.1	40.7	14.8	7.9	11.6	4.6	8.1	3.1	9.7	10.2	5.4	0.4	0.4	1.3	14.5	0.7	6.6	5.4	7.3	15.7	1.4	13.9	1.4	4.0	0.8	1.0	7.6	1.7	1.3	1.9	3.7	3.4	17.5	0.8	0.2	1.4	8.5	8.4	7.5	8.6	7.9	10.1	9.6	10.2	9.4	9.2	10.6	9.4	4.9	0.0	3.1	11.4	2.2	18.1	4.3	4.6	4.6	2.1	9.4	9.5	1.9	17.2	5.1	77.3	0.0	52.8	1.3	0.7	21.5	5.6	350.9	23.4	11.5	5.9	4.8	0.0	11.9	13.9	12.3	7.8	0.5	9.0	7.0	4.6	10.4	5.5	11.0	3.3	11.2	2.2	0.0	10.3	14.9	1939.3	19.9	7.8	21.4	7.5	7.6	1.6	0.0	8.5	4.0	6.4	3.0	15.1	0.7	3.1	27.9	70.2	8.6	0.6	13.1	4.3	4.7	11.6	10.0	4.7	13.1	35.7	1.6	5.8	3.7	3.1
PAQR9	FLJ41938	ENSG00000188582	"Progestin and adipoQ receptor family member 9"	Q6ZVX9	3	142949164-142963674	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.5;retina: 9.6;testis: 20.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 42.1;Erythroid cells: 28.2;Hepatocytes: 18.4;Late spermatids: 98.3;Syncytiotrophoblasts: 36.5"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;AF22: 1.0;U-266/70: 3.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052798	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA052798: AB_2681955"		"unprognostic (4.13e-2)"		"unprognostic (2.54e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.12e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.91e-2)"	0.0	0.0	1.9	0.0	1.7	5.2	0.0	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	2.3	1.5	0.0	13.5	0.0	0.0	1.1	1.9	0.0	0.0	0.2	0.9	0.2	1.1	0.0	0.0	9.6	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	20.4	3.3	0.1	0.0	1.4	0.0	0.1	0.0	2.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	0.9	5.5	2.3	1.5	1.1	1.9	1.1	0.2	3.3	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	6.7	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.1	0.7	0.0	0.2	0.0	28.2	0.8	0.0	0.1	0.3	0.0	0.2	0.0	1.0	0.0	18.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	98.3	1.2	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.1	2.6	5.4	0.0	0.1	36.5	0.0	0.1	0.0	0.0
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 9.6"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		21000	"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	13.1	15.9	19.6	4.8	17.0	0.5	21.5	10.9	12.4	25.9	16.0	30.4	10.6	20.7	12.2	47.8	20.6	14.9	14.6	17.8	20.6	25.1	22.1	15.2	2.6	15.7	22.1	38.5	34.2	20.7	7.3	21.7	15.9	17.0	21.7	13.6	20.1	23.9	40.5	52.1	13.4	21.8	16.0	4.2	17.7	14.0	24.0	13.5	15.2	30.9	12.4	21.3	30.8	13.9	50.6	121.1	40.1	28.6	28.5	24.2	59.1	22.2	25.4	37.3	40.0	44.3	43.3	0.3	31.4	44.6	30.4	35.8	34.7	56.7	46.1	0.4	26.8	0.0	14.9	44.1	36.2	5.7	0.1	28.7	54.9	50.9	38.1	35.9	23.3	32.4	34.7	14.9	44.8	35.4	59.3	4.2	18.0	32.7	41.4	44.9	39.0	21.9	80.9	38.4	20.1	20.9	26.8	37.3	42.9	49.6	21.1	6.7	28.4	18.7	56.1	35.5	24.2	13.2	17.1	0.1	21.0	0.2	22.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	19.6	17.0	10.9	12.4	17.8	20.6	15.7	22.1	15.9	16.0	24.0	13.9	6.4	35.3	35.3	455.4	0.2	34.0	42.3	19.8	19.9	8.7	17.1	24.9	39.0	21.5	24.3	14.7	29.2	24.9	0.2	25.6	0.0	34.1	19.9	22.3	29.9	9.4	24.0	2.7	5.4	36.4	25.0	22.3	13.3	33.4	1.3	33.1	8.9	24.8	3.4	11.8	147.0	30.1	14.2	0.6	4.7	20.3	30.4	7.7	5.4	193.0	0.8	28.8	1.0	367.9	13.9	38.8	23.8	38.4	1.4	31.4	13.7	25.6	29.3	19.7	26.3	23.4	26.1	6.2	27.6	40.4	61.5	40.1	1.5	32.1	22.0	47.2
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731580-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Glandular and luminal cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.0;MCF7: 51.7;T-47d: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	1.9	1.1	1.6	0.8	2.0	2.3	3.5	3.7	1.8	1.7	8.4	2.5	3.6	1.4	8.2	3.1	3.8	2.5	0.8	2.7	1.8	16.1	4.4	5.4	1.0	1.8	2.1	1.1	4.6	4.3	1.4	3.9	1.6	1.2	2.3	8.9	1.8	1.7	3.9	2.9	3.2	0.8	1.8	1.1	5.7	2.7	2.0	0.9	3.7	0.9	2.1	1.7	1.5	2.4	5.4	6.2	1.7	3.7	1.1	0.4	8.0	0.4	0.6	0.9	0.7	29.0	12.7	2.4	5.4	0.1	3.8	4.3	2.6	3.9	1.5	1.2	1.5	1.3	2.1	11.5	1.2	0.9	1.3	0.1	1.9	0.5	1.6	1.7	0.1	2.3	3.1	1.6	0.1	51.7	2.5	2.3	3.0	9.0	2.3	1.4	1.7	2.3	12.9	5.9	1.1	1.6	4.1	9.6	3.0	7.2	48.8	1.3	0.2	0.5	3.2	0.5	1.0	1.9	1.3	2.0	1.3	0.9	1.1	1.6	0.2	1.5	1.4	0.3	1.5	1.1	1.4	1.4	0.3	1.3	2.2	1.4	1.1	1.6	0.6	1.3	0.9	0.4	1.6	2.0	3.7	1.8	2.7	1.8	1.8	2.1	1.6	1.8	2.0	2.4	0.4	189.1	50.4	2.9	4.5	63.0	58.9	17.0	30.7	14.4	60.3	15.0	4.3	37.1	31.1	90.1	54.2	35.5	4.0	68.6	41.1	26.2	4.0	110.1	14.4	1.7	14.9	0.4	11.5	24.4	15.0	4.7	55.5	179.2	1.3	1.8	1.8	20.1	3.7	5.0	10.6	26.7	22.4	0.8	4.2	2.5	1.8	3.5	16.0	1.9	1.2	12.3	2.1	1.5	4.6	57.5	39.7	0.7	6.3	43.6	29.3	102.0	30.0	62.7	6.6	1.2	4.8	16.6	9.4	34.7	68.3	48.4	6.3	1.5	27.3	102.7
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247514	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	3.4	1.7	5.8	1.4	5.7	0.6	5.3	3.8	7.9	9.6	6.8	6.0	1.8	6.5	2.7	18.0	6.2	3.3	2.9	9.3	7.8	7.0	3.5	2.9	2.5	6.3	5.8	6.2	2.1	2.1	3.8	5.5	5.5	5.7	2.0	1.8	4.5	5.9	1.9	38.1	3.0	5.4	4.6	2.0	2.7	2.1	8.3	5.3	18.0	1.0	4.3	5.6	12.0	5.9	3.0	4.3	17.7	13.4	0.6	0.7	12.9	3.3	0.7	2.9	0.4	1.2	1.2	0.0	1.4	1.5	5.1	13.4	6.4	19.2	2.8	0.5	5.7	0.2	3.5	10.4	0.8	4.0	36.4	5.7	34.0	0.3	1.8	2.2	1.4	4.2	1.4	0.8	4.3	5.0	3.6	0.4	5.3	1.4	5.2	0.1	11.7	1.5	0.5	27.9	7.4	7.7	4.1	2.2	20.0	8.6	2.6	3.4	1.1	5.9	28.8	2.2	1.6	0.9	1.2	0.3	1.9	0.9	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	5.7	3.8	7.9	9.3	7.8	6.3	5.8	5.5	4.6	8.3	5.9	3.3	3.2	0.6	7.5	0.7	39.6	13.7	11.0	18.8	1.3	4.1	10.3	2.8	1.5	2.3	3.7	0.0	0.6	9.7	0.4	0.0	0.4	0.5	9.8	10.1	8.2	0.0	0.0	6.5	0.2	9.5	4.1	0.5	3.3	0.0	3.1	10.8	1.5	0.8	0.0	8.5	0.7	8.2	0.9	6.5	0.7	1.8	0.8	12.4	15.9	0.0	2.0	0.0	25.6	4.8	0.8	0.0	1.9	3.6	6.6	0.0	7.6	2.6	2.5	19.7	1.9	13.6	1.5	6.0	25.3	63.9	0.4	8.0	2.0	0.6	13.4
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	38.4	35.8	46.5	26.6	48.2	33.8	40.3	47.4	66.2	33.8	50.7	47.7	29.2	31.9	57.7	36.7	30.2	19.7	54.1	46.6	48.2	39.6	45.0	28.4	32.0	47.7	48.7	31.7	49.9	39.7	32.0	25.5	47.4	37.1	41.9	32.7	40.5	30.3	54.9	37.1	34.7	29.7	47.2	36.2	42.6	26.7	47.6	34.5	31.4	51.6	33.8	38.9	31.5	48.4	115.1	55.6	39.7	33.0	38.8	42.1	80.2	39.2	59.4	80.5	65.0	172.0	59.0	47.8	90.0	56.7	73.5	49.2	64.1	68.0	90.0	71.6	76.1	73.9	35.5	96.9	57.3	73.9	61.6	60.0	85.4	58.0	70.7	38.5	59.0	82.4	42.6	45.0	69.2	131.0	148.3	194.3	105.5	100.6	53.3	64.7	72.8	92.0	79.0	97.6	37.9	52.0	47.6	162.9	107.8	48.1	159.2	143.5	31.8	29.3	63.0	60.9	108.2	89.2	65.7	116.0	56.6	75.1	35.5	97.5	143.1	133.4	51.3	107.8	60.9	62.4	57.3	59.9	132.4	59.1	68.7	54.2	41.3	67.1	83.3	79.7	73.7	116.1	46.5	48.2	47.4	66.2	46.6	48.2	47.7	48.7	47.4	47.2	47.6	48.4	30.3	22.4	19.7	17.9	37.6	30.3	54.9	93.5	26.7	35.9	31.8	31.5	41.2	35.8	44.5	31.3	31.3	58.9	38.4	24.4	117.4	63.9	24.0	15.2	18.3	30.2	33.7	23.3	23.4	84.7	49.0	35.1	28.1	13.7	69.8	33.1	33.2	30.4	77.7	33.7	24.1	42.0	77.3	56.2	55.7	9.7	28.9	57.5	42.7	33.7	79.3	55.9	50.4	17.1	28.0	60.3	35.1	27.1	42.3	55.4	47.3	86.0	30.5	51.1	6.6	44.8	96.6	47.8	47.4	40.2	30.0	42.1	40.9	49.0	49.2	58.8
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PARP10	"ARTD10, FLJ14464"	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	25.2	34.9	10.0	36.3	10.6	23.7	24.6	9.8	13.2	31.8	10.4	33.2	28.4	29.1	3.7	21.5	35.7	9.9	13.8	9.0	10.4	38.4	39.7	34.7	35.8	16.0	11.0	40.6	21.7	6.2	26.0	10.2	12.5	35.7	4.9	6.4	38.3	16.6	18.3	23.1	35.4	7.3	13.3	61.2	25.6	35.4	12.3	34.2	29.4	4.5	10.6	17.8	25.1	11.9	17.8	1.8	1.2	3.3	8.4	7.3	9.3	3.0	3.7	18.7	21.0	0.9	29.6	21.9	39.8	9.2	21.4	6.7	0.4	10.1	0.8	49.5	0.1	24.1	10.8	11.0	7.8	9.5	27.7	4.7	9.9	9.3	3.8	2.1	2.9	30.6	0.4	16.9	3.7	21.4	33.4	16.5	1.0	0.2	13.9	30.8	3.5	29.4	7.7	21.6	1.0	1.1	19.8	2.0	38.8	0.4	22.0	13.9	13.1	9.6	14.2	16.4	10.9	28.4	18.3	5.1	13.9	31.6	5.3	0.0	2.4	3.6	4.4	2.8	2.7	1.1	2.1	3.6	2.3	2.0	1.5	2.4	1.0	1.8	2.8	16.5	1.5	3.5	10.0	10.6	9.8	13.2	9.0	10.4	16.0	11.0	12.5	13.3	12.3	11.9	22.3	3.2	5.2	10.4	19.1	7.6	8.2	10.7	17.6	5.7	12.3	16.0	3.2	7.2	6.3	9.2	14.6	2.2	42.2	20.5	1.9	9.2	6.2	12.0	12.7	10.7	19.2	5.7	0.4	5.6	4.0	12.7	23.9	13.3	19.1	25.9	9.3	21.1	12.0	0.0	0.6	17.3	6.1	16.6	6.8	7.9	15.8	21.4	7.2	12.2	25.8	13.4	34.0	4.5	1.0	6.5	13.8	11.3	15.2	4.5	22.0	25.1	6.7	20.4	6.6	11.7	13.4	19.6	9.1	10.4	4.7	1.4	27.0	17.7	16.4	4.0
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PARP12	"ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023749-140062951	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	6.4	4.7	4.1	12.3	4.3	15.8	6.6	3.6	5.3	4.0	5.2	12.1	18.3	7.6	9.6	4.8	8.1	9.3	5.9	3.6	4.2	5.0	7.8	15.4	13.4	8.3	4.4	6.3	9.2	10.2	2.3	9.9	5.4	7.0	11.6	1.8	17.2	4.8	2.9	15.0	18.1	7.9	6.3	17.1	13.1	10.4	4.9	10.7	5.8	2.5	9.5	8.7	2.4	5.0	20.8	7.6	0.6	0.8	2.4	5.7	15.1	4.7	10.4	36.3	42.5	4.9	12.6	8.6	11.5	3.9	28.0	9.3	5.4	17.6	6.0	33.4	8.7	9.2	4.9	6.8	15.2	2.4	6.2	5.7	6.7	12.7	15.5	9.9	28.2	10.4	19.0	6.0	2.7	8.4	25.7	14.3	1.3	10.7	18.0	15.2	0.0	2.7	7.1	7.9	4.6	0.0	14.2	7.7	11.2	0.7	9.2	5.6	31.0	4.3	10.2	0.3	14.5	0.5	1.5	2.0	7.9	12.2	5.2	1.2	3.0	4.3	1.5	5.5	1.3	1.7	2.1	1.6	2.1	2.4	0.9	0.7	1.0	2.5	6.4	0.2	5.8	1.2	4.1	4.3	3.6	5.3	3.6	4.2	8.3	4.4	5.4	6.3	4.9	5.0	24.1	6.4	10.6	2.6	17.9	6.5	7.2	4.4	8.0	2.9	6.2	5.5	5.4	7.2	5.8	11.0	2.1	6.0	13.0	48.9	1.9	13.9	0.7	7.0	6.4	18.1	24.0	4.8	1.2	26.0	19.1	6.9	18.3	6.3	19.7	38.2	7.9	10.9	24.2	0.0	2.6	19.4	4.1	13.6	9.7	0.9	7.2	20.5	7.2	26.2	17.5	2.9	11.3	9.5	3.1	35.2	37.0	7.2	8.3	12.4	44.2	6.9	9.0	2.5	0.0	7.3	7.9	35.0	15.6	8.7	9.9	2.1	15.6	8.4	11.6	10.6
PARP14	"ARTD8, KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680839-122730840	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	14.0	12.6	4.3	24.3	5.1	20.1	11.3	3.6	2.7	11.4	5.5	11.5	15.3	8.2	2.4	9.0	10.7	15.2	11.1	2.8	5.1	14.9	24.5	33.5	24.0	15.1	5.9	9.2	7.8	7.3	7.6	17.8	8.6	13.0	8.7	1.1	11.7	7.2	5.0	5.3	17.5	10.2	10.9	37.4	11.7	2.2	8.9	15.4	14.7	8.3	26.8	13.7	9.4	7.8	15.6	13.0	8.0	8.3	9.1	26.2	0.0	6.1	40.1	74.7	113.1	6.9	28.7	0.0	24.2	13.4	41.8	11.5	11.9	11.6	15.0	24.0	1.5	14.6	5.8	8.7	20.4	6.4	6.8	14.7	4.7	13.0	4.8	16.4	32.2	12.3	7.0	22.7	2.1	7.9	24.8	1.5	1.1	2.1	11.1	34.2	8.3	4.3	9.5	16.2	0.6	0.0	15.3	3.1	14.1	0.8	5.7	9.3	22.0	4.0	9.4	2.3	5.5	8.7	1.6	2.7	12.0	13.8	7.2	13.1	10.8	5.8	8.6	13.7	7.2	12.8	4.5	5.6	5.6	20.3	3.6	4.1	29.5	9.5	14.7	0.7	9.9	4.3	4.3	5.1	3.6	2.7	2.8	5.1	15.1	5.9	8.6	10.9	8.9	7.8	111.5	246.8	98.4	17.3	115.3	16.8	17.0	35.9	13.1	2.1	19.6	15.6	14.6	24.3	65.9	25.8	4.2	14.1	64.9	43.0	3.9	36.0	0.3	118.8	59.8	94.7	10.7	18.5	0.5	41.2	28.4	37.2	24.5	149.8	32.2	69.6	67.1	32.5	36.5	0.0	3.0	18.2	26.4	61.6	39.9	2.1	28.0	83.9	16.0	124.6	132.2	15.1	58.7	47.3	1.1	44.0	20.2	17.3	50.9	31.8	29.5	11.5	73.0	1.0	13.1	32.7	30.3	1.9	1.1	13.7	10.5	4.8	51.4	42.8	16.0	25.9
PARP16	"ARTD15, C15orf30, FLJ20509, FLJ25281, pART15"	ENSG00000138617	"Poly(ADP-ribose) polymerase family member 16"	Q8N5Y8	15	65234460-65300618	"Metabolic proteins, Predicted membrane proteins"	"Unfolded protein response"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 33.0;Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017081	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA017081: AB_10963218"	"unprognostic (1.17e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.61e-2)"	6.6	9.8	5.0	4.7	4.8	6.0	8.8	7.0	5.6	12.6	4.4	10.2	6.2	8.7	5.1	7.5	9.7	4.3	4.9	4.9	4.9	6.2	13.2	5.1	7.0	4.8	4.8	11.9	7.5	8.2	5.5	6.0	4.9	8.4	6.4	5.1	7.2	6.2	3.8	8.1	7.1	6.8	4.7	6.5	7.9	4.8	4.9	10.0	6.4	3.9	8.2	10.0	9.1	5.1	6.0	6.3	6.5	10.4	5.3	4.9	2.8	2.8	7.1	7.0	7.3	4.5	5.4	18.9	7.3	3.5	15.3	9.4	30.3	3.7	5.0	7.3	11.3	3.1	6.5	6.3	9.1	8.7	5.6	6.1	6.0	2.0	7.2	10.6	6.4	17.9	7.6	7.1	5.9	6.8	19.0	8.8	2.8	29.7	8.2	33.5	11.8	14.3	5.0	5.3	10.8	7.2	8.3	7.5	6.8	5.1	8.7	7.5	2.7	8.5	6.5	4.7	3.9	13.3	16.5	24.2	7.0	12.5	4.2	19.9	3.9	12.2	12.6	6.0	14.0	8.5	11.9	12.8	5.2	11.1	14.7	10.9	15.0	12.5	6.5	4.4	10.8	6.9	5.0	4.8	7.0	5.6	4.9	4.9	4.8	4.8	4.9	4.7	4.9	5.1	3.7	3.2	3.1	10.1	9.6	5.2	6.0	3.9	9.6	12.1	5.0	4.7	4.1	7.2	3.4	3.7	0.0	12.5	9.1	3.4	0.0	5.8	0.8	1.5	4.7	4.5	1.8	3.0	14.0	9.1	5.7	7.0	11.7	2.7	0.0	6.5	2.9	6.0	3.8	3.3	18.3	4.9	4.1	2.5	1.7	1.9	9.9	4.3	3.6	11.2	4.3	7.3	9.2	10.6	13.4	5.3	2.5	7.9	9.8	3.2	7.1	4.0	2.6	33.0	6.6	4.3	4.5	1.6	28.6	4.6	4.3	5.5	9.0	6.3	5.4	3.0
PARP2	"ADPRTL2, ARTD2"	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343615-20357904	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	17.7	21.1	21.1	10.7	22.0	26.8	17.5	21.4	31.4	18.1	16.4	19.3	12.8	20.9	17.8	14.6	17.5	10.0	17.1	22.5	21.0	15.5	17.2	13.5	14.5	19.5	18.9	22.9	17.9	11.1	21.0	12.9	19.8	13.9	14.0	26.4	14.2	13.4	32.4	19.2	14.2	15.8	19.0	16.5	16.3	23.8	19.8	11.9	16.7	27.1	17.9	13.8	15.3	22.1	55.5	39.5	59.7	45.3	19.4	18.4	43.4	60.2	32.5	74.8	91.8	36.8	51.3	40.4	26.5	19.0	64.8	50.1	78.3	27.5	87.8	32.4	38.3	37.2	46.6	63.3	17.3	77.9	20.4	12.5	23.0	45.5	51.1	20.5	38.5	48.0	39.2	53.4	52.3	33.5	40.1	33.0	33.0	62.8	60.0	49.7	79.7	26.5	30.0	28.2	41.3	28.3	65.3	36.8	17.9	37.4	34.2	25.8	26.6	45.3	68.1	31.5	48.1	49.3	67.7	53.4	19.0	33.3	51.4	1.9	5.0	0.5	8.9	4.8	11.7	6.8	8.4	7.9	5.5	4.1	9.0	8.6	0.1	7.6	2.6	5.6	5.3	4.8	21.1	22.0	21.4	31.4	22.5	21.0	19.5	18.9	19.8	19.0	19.8	22.1	12.1	25.6	6.5	7.2	9.5	6.5	10.5	16.1	18.8	29.2	7.4	10.0	14.0	5.7	19.9	7.3	12.5	25.8	10.2	4.5	7.9	12.8	9.3	9.9	13.3	11.0	4.8	30.3	17.6	8.7	22.2	11.6	7.7	11.3	8.2	18.4	6.8	10.1	11.9	30.3	15.5	5.0	14.2	4.6	5.1	9.8	11.5	6.6	8.8	9.4	4.2	20.7	6.2	6.0	9.3	10.1	4.5	17.0	19.1	4.5	5.3	7.4	28.0	23.2	6.6	9.8	18.5	20.9	41.5	11.3	4.8	14.9	6.2	16.7	7.4	7.0
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PARP4	"ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420931-24512778	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	18.6	22.8	8.4	24.2	11.9	22.1	16.7	11.2	8.2	24.3	12.1	38.7	38.9	17.9	18.0	22.0	21.1	29.5	12.7	7.5	10.4	26.9	24.9	28.7	23.6	15.6	11.3	18.6	14.8	18.5	5.8	15.9	15.2	13.1	39.5	8.3	16.8	18.6	6.4	11.0	39.1	19.5	11.3	26.3	34.4	9.0	11.8	21.6	21.2	11.3	25.2	28.3	14.0	15.6	42.9	37.7	18.1	32.7	48.7	68.8	15.3	48.7	63.5	41.8	37.1	15.5	108.5	32.0	47.3	44.5	46.3	48.5	27.2	49.4	34.1	73.7	19.0	45.9	33.0	35.9	27.8	59.3	43.3	39.9	16.3	34.6	18.3	81.4	69.7	24.5	13.2	13.8	50.2	19.9	37.6	28.5	20.5	100.6	45.9	35.0	33.8	45.0	77.6	86.7	16.4	20.9	35.7	14.2	33.5	23.4	7.1	48.2	99.7	18.9	19.8	24.4	50.4	15.6	19.3	41.4	34.3	30.6	42.1	50.0	21.1	45.9	20.4	25.7	20.4	14.2	16.8	20.5	27.9	8.0	12.2	14.8	24.0	21.1	34.6	10.4	21.9	20.1	8.4	11.9	11.2	8.2	7.5	10.4	15.6	11.3	15.2	11.3	11.8	15.6	20.5	51.3	51.8	21.2	20.5	2.8	6.9	29.2	6.2	6.3	10.2	5.8	17.6	17.2	52.6	25.8	2.1	5.0	33.8	74.2	5.9	26.1	5.4	35.9	19.4	19.8	4.9	13.9	1.5	22.5	8.9	18.3	42.8	50.9	99.2	30.7	31.1	16.0	17.7	1.7	2.1	27.0	18.3	23.4	6.9	4.7	11.8	35.3	8.8	36.5	37.1	6.7	36.0	21.1	40.8	30.9	53.8	8.2	27.0	10.6	59.7	18.2	69.7	7.4	6.6	12.2	10.4	2.5	8.9	13.5	3.8	1.9	28.9	24.1	30.8	20.5
PARP6	"ARTD17, pART17"	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	20.0	20.9	63.2	14.6	64.8	30.5	20.0	62.2	84.6	22.2	61.2	28.7	15.3	24.5	24.0	17.7	22.6	21.3	19.6	64.5	57.7	23.8	15.5	19.7	19.4	55.7	55.9	29.2	32.5	12.6	49.7	18.3	55.3	25.1	14.8	52.9	23.2	17.3	34.8	23.0	21.7	20.2	51.0	20.6	24.2	34.5	57.1	21.0	30.2	21.2	17.4	22.7	19.1	64.9	15.9	27.6	29.0	37.8	30.5	25.2	23.7	13.8	19.9	21.8	31.1	18.5	28.2	22.3	8.4	20.3	31.4	20.9	32.4	18.1	12.4	26.5	30.6	31.7	55.0	0.2	25.4	16.7	30.1	32.6	43.5	20.1	55.2	33.7	14.6	35.6	16.6	24.3	17.5	28.4	14.4	28.7	14.2	13.2	0.0	26.7	20.8	17.2	19.9	30.4	81.4	43.1	22.6	17.8	37.0	38.2	22.8	18.8	14.0	26.7	24.7	35.7	20.7	27.9	27.7	23.2	19.1	31.4	19.1	1.1	3.6	8.2	2.3	3.1	1.6	2.4	1.7	2.5	2.6	2.3	2.6	2.0	3.6	3.0	3.5	2.2	2.9	2.1	63.2	64.8	62.2	84.6	64.5	57.7	55.7	55.9	55.3	51.0	57.1	64.9	11.5	22.4	21.2	54.9	15.3	14.4	9.6	6.9	31.3	16.4	13.0	13.7	20.9	2.8	12.9	9.2	20.9	7.3	12.0	8.0	7.9	9.7	61.4	8.0	10.3	11.1	17.4	4.6	19.7	12.7	5.3	13.9	21.4	10.0	15.8	17.3	6.4	6.1	8.9	18.5	20.5	6.5	6.1	14.8	11.1	178.1	12.5	14.0	16.0	20.6	9.3	8.8	6.2	27.2	54.6	9.2	9.0	9.8	12.3	9.0	17.7	12.3	5.8	15.5	6.6	13.7	12.5	44.3	12.6	19.3	15.8	6.4	13.3	8.6	7.5	9.3
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120183-102197520	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.3;lymphoid tissue: 7.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 20.0;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039677	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	0.8	0.6	0.2	3.1	0.2	9.3	1.8	0.3	0.4	1.2	0.1	3.0	2.3	1.2	0.5	3.6	0.6	1.1	0.4	0.3	0.4	0.8	0.6	0.6	4.2	0.3	0.4	0.7	0.2	0.3	0.2	2.3	0.3	1.0	3.8	0.2	0.9	0.9	0.4	1.9	2.7	1.7	0.3	1.2	1.8	3.9	0.3	7.5	0.5	0.3	5.1	1.9	1.1	0.3	13.5	27.2	23.6	13.7	3.8	3.4	16.7	19.9	11.0	32.0	27.9	14.8	10.4	25.4	11.4	7.8	16.2	14.5	38.5	11.7	34.2	25.7	22.6	31.9	15.7	13.9	1.1	33.5	9.1	3.3	2.8	22.3	14.4	8.3	21.6	18.9	31.0	15.3	21.1	10.7	30.5	31.1	31.7	17.8	26.6	20.4	38.9	16.7	10.3	21.1	15.9	14.7	13.8	16.6	11.8	24.0	27.1	12.1	8.5	16.5	15.7	20.2	25.3	11.3	24.8	22.8	11.4	33.7	22.4	2.6	0.4	1.0	0.5	0.6	0.1	1.1	0.9	0.8	0.7	0.7	0.5	0.6	0.0	0.5	0.4	0.7	1.8	0.7	0.2	0.2	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3	1.1	0.0	0.0	2.9	4.3	3.7	1.5	3.6	0.6	1.9	2.4	2.4	0.7	1.5	2.5	1.8	0.0	11.3	2.3	1.5	5.9	1.6	2.5	3.0	11.6	2.5	1.8	20.0	4.1	1.3	13.9	4.8	6.1	3.0	5.7	15.0	2.2	0.1	6.5	3.3	5.3	3.1	10.2	5.7	4.3	2.6	1.2	3.1	0.0	3.7	1.7	0.2	2.1	3.5	4.1	1.2	0.8	0.4	14.2	0.7	1.3	1.8	1.4	0.9	0.0	1.1	2.8	16.0	17.7	9.8	1.6	3.6	4.1	9.3	7.8	1.6
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"	Q9NVD7	11	12377563-12535356	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 229.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		7300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	61.8	17.6	9.3	22.7	9.0	0.1	40.9	7.2	10.1	53.9	16.5	92.4	17.5	71.8	16.7	42.8	38.8	31.9	34.3	9.8	11.6	23.0	16.9	28.8	6.4	11.0	7.3	31.9	36.0	16.9	11.7	35.9	8.4	50.6	38.4	8.9	20.9	68.9	8.1	14.0	26.1	95.5	11.3	11.3	42.5	6.8	8.6	4.6	17.9	11.7	9.1	55.0	28.2	11.0	34.0	33.1	30.2	39.4	147.8	110.6	69.1	126.5	130.1	87.7	81.6	24.7	51.8	0.0	41.1	229.5	9.9	20.7	0.4	66.4	104.0	0.6	14.9	0.1	42.4	18.7	114.7	0.1	0.9	91.3	22.3	37.1	57.4	107.5	110.9	0.0	0.1	0.3	131.8	20.4	0.0	0.2	14.2	20.2	26.4	0.0	75.2	0.2	44.9	32.8	4.8	0.1	97.6	39.1	65.5	66.9	18.4	0.9	138.2	105.1	43.8	57.2	35.4	0.1	0.1	0.2	58.5	0.1	118.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	9.0	7.2	10.1	9.8	11.6	11.0	7.3	8.4	11.3	8.6	11.0	37.0	99.3	33.0	47.3	1.1	13.8	25.0	29.3	20.5	4.3	24.4	24.8	45.1	18.6	27.0	27.6	0.0	39.9	0.7	39.6	39.2	56.1	0.9	26.9	62.5	33.3	27.1	0.0	31.4	67.1	92.2	59.1	24.5	35.9	5.1	34.8	39.7	19.1	6.5	0.0	34.9	26.2	18.3	1.8	8.8	2.5	41.0	2.0	46.2	36.5	1.0	25.3	0.0	30.7	1.0	51.7	25.4	51.9	0.2	33.5	23.1	38.1	54.8	2.5	52.6	32.6	60.6	1.1	3.4	20.2	8.9	19.0	2.3	25.1	32.4	25.1
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172939	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.9;tongue: 170.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 113.2;Hofbauer cells: 90.6;Macrophages: 78.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 158.0;RPMI-8226: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		NA	NA		24000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	42.6	30.7	26.7	21.3	19.4	43.4	33.0	18.7	24.3	21.8	22.6	21.8	7.4	22.2	13.5	11.9	19.2	10.7	86.9	34.1	24.7	23.0	14.4	29.7	19.2	23.3	25.7	27.1	11.9	18.5	24.3	21.4	26.9	17.0	8.6	10.5	11.4	13.7	195.9	14.2	18.6	22.9	20.8	35.3	15.0	6.6	28.3	9.4	12.8	170.6	16.1	23.9	16.7	19.7	23.5	27.7	0.4	19.1	28.1	35.5	0.1	32.4	20.1	20.9	15.6	28.9	13.8	0.2	17.5	87.2	16.4	0.9	45.9	2.1	11.5	33.1	28.5	100.4	45.8	0.2	46.5	76.5	86.7	55.4	24.0	15.2	0.2	15.0	158.0	0.4	36.6	67.0	22.9	15.9	0.4	50.4	9.8	20.4	18.7	0.2	0.8	159.5	0.5	0.6	24.6	17.1	8.6	1.6	84.9	3.3	15.9	30.7	99.2	19.0	20.0	29.4	3.4	16.2	15.3	0.7	82.8	22.1	106.0	6.9	6.8	1.6	1.0	7.1	1.6	6.2	1.7	1.5	7.2	6.4	0.4	0.9	4.7	0.8	2.9	14.9	2.4	9.5	26.7	19.4	18.7	24.3	34.1	24.7	23.3	25.7	26.9	20.8	28.3	19.7	70.3	0.0	10.6	5.2	48.2	5.2	3.4	1.3	4.0	11.2	8.3	9.4	55.0	4.3	0.9	1.8	16.7	1.0	29.0	0.3	27.4	1.5	6.6	8.0	12.6	63.7	1.2	113.2	15.1	3.1	10.8	18.4	4.1	11.7	64.7	20.2	53.2	12.5	90.6	6.7	12.5	0.7	6.1	49.7	39.5	21.6	19.9	78.7	19.6	28.1	44.7	8.9	9.2	2.5	5.9	4.7	0.0	10.9	58.1	5.1	0.0	30.0	3.8	15.2	6.6	18.2	14.2	1.9	5.8	0.7	4.4	1.8	16.7	2.3	0.6	1.5
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.7;lymphoid tissue: 30.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	3.5	2.9	3.7	26.7	3.5	49.7	1.8	4.4	7.1	2.6	4.0	3.1	3.6	2.4	0.6	2.5	2.2	6.2	1.3	3.8	4.7	1.8	3.1	10.4	30.1	8.2	4.9	0.8	1.4	0.5	1.3	3.0	6.9	2.1	3.4	0.2	2.6	1.1	1.2	1.7	12.7	2.9	5.9	28.9	4.4	1.7	7.9	18.4	1.9	0.4	26.8	4.7	1.5	9.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	116.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	16.8	44.9	0.1	0.0	0.0	9.2	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	64.7	0.0	0.0	11.5	0.2	0.0	0.3	0.0	0.3	0.0	53.9	1.9	12.5	62.0	71.3	13.9	57.6	13.9	21.4	8.0	15.2	49.2	20.4	8.9	10.3	72.2	13.1	65.9	33.3	12.1	44.6	3.7	3.5	4.4	7.1	3.8	4.7	8.2	4.9	6.9	5.9	7.9	9.4	1.3	6.4	14.0	1.0	56.9	2.4	0.1	0.0	0.6	0.2	0.7	1.5	1.1	0.0	3.1	0.0	0.0	0.6	51.7	0.1	0.0	0.0	4.2	3.7	0.4	2.9	0.0	10.1	3.9	0.2	0.7	2.3	3.6	2.5	60.1	0.0	3.9	1.3	66.7	0.0	2.9	0.0	0.0	87.3	53.4	2.7	0.0	91.9	5.4	10.3	62.0	0.0	26.8	0.0	1.4	0.0	0.0	0.0	15.9	0.0	0.0	0.5	1.5	0.2	0.0	0.5	0.4	1.1	0.8	0.4	1.8	1.0	48.3	0.0	0.1	0.1
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 16.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 24.5;Theca cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.6	1.1	3.7	7.1	19.8	8.8	2.1	1.0	5.3	2.5	3.1	2.4	3.4	2.1	3.9	3.3	6.1	2.0	1.1	2.7	1.7	3.7	1.4	3.2	13.7	1.9	1.9	1.9	3.6	2.4	4.6	1.0	1.8	10.0	2.3	11.9	2.9	1.4	0.8	4.1	4.5	1.2	0.3	4.1	3.0	16.1	3.2	22.9	5.1	0.2	7.8	2.1	2.2	5.2	7.4	9.9	12.9	16.7	1.1	1.9	17.4	7.0	2.2	6.3	8.8	8.1	7.4	3.8	1.4	1.5	13.8	17.9	15.1	6.1	4.6	15.6	13.8	10.6	19.1	14.4	0.8	14.7	16.0	0.9	4.7	6.5	1.9	2.6	4.6	16.2	14.0	5.2	4.5	8.0	17.5	15.4	14.6	8.8	5.9	27.5	13.3	4.7	2.5	16.0	23.1	7.0	3.9	8.0	3.2	6.8	6.7	10.5	6.1	8.8	7.7	11.1	9.6	6.8	7.4	18.1	5.4	10.9	8.2	4.4	0.6	0.5	1.0	0.4	0.9	4.5	3.9	3.5	0.8	3.9	2.3	2.6	0.8	1.9	0.7	0.4	4.1	2.2	3.7	19.8	1.0	5.3	2.7	1.7	1.9	1.9	1.8	0.3	3.2	5.2	2.3	3.2	7.9	2.6	8.5	2.7	1.2	1.6	2.2	2.6	3.5	4.3	3.1	2.8	1.9	3.7	4.2	0.9	2.2	3.1	0.0	1.5	14.9	13.9	1.6	8.5	0.0	13.3	12.5	2.0	1.7	2.7	3.6	4.4	3.8	11.7	17.5	1.5	2.0	1.7	6.1	3.5	0.0	4.7	2.0	3.5	5.9	2.1	12.4	3.7	2.7	2.1	7.2	0.5	2.6	0.9	1.0	24.5	4.7	1.7	1.9	1.4	12.3	18.7	0.0	2.1	2.1	16.1	12.7	2.6	1.4	0.3	19.1	26.5	3.9	0.9
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746279-125749867	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"epididymis: 1868.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;NB-4: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA076587: AB_2732316"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1868.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840072	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"seminal vesicle: 106.8"	"Group enriched"	"Detected in some"	70	"Early spermatids: 22.9;Late spermatids: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045632	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 34: Spermatids - Unknown function"			"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.2	0.7	0.1	0.6	0.4	0.1	1.8	1.3	0.1	0.0	0.0	0.1	0.1	14.9	0.1	0.1	0.1	0.1	0.5	0.2	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	2.9	0.1	0.7	0.1	106.8	0.2	0.4	0.1	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.4	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.3	0.5	0.2	0.3	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.6	1.8	1.3	0.5	0.2	0.0	0.0	0.1	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ crumbs cell polarity complex component"	Q8NI35	1	61742477-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 75.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 72.3"	"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	3.4	7.2	6.8	3.6	5.4	3.5	18.1	75.0	5.3	8.4	25.3	12.2	8.9	5.8	26.5	19.3	8.3	7.1	45.2	3.8	9.2	27.5	12.4	10.0	2.9	12.8	9.0	6.8	12.4	20.0	10.9	3.5	14.2	12.3	11.1	15.8	20.0	7.9	45.4	22.4	9.3	3.5	11.5	3.1	10.2	5.1	9.1	4.0	13.1	16.1	6.2	7.9	13.2	9.5	36.3	7.0	2.3	3.2	1.3	3.3	29.5	2.1	2.8	2.2	3.0	12.5	13.2	0.2	9.1	4.4	18.7	21.1	5.1	18.9	3.8	3.5	8.8	0.2	10.4	11.3	2.9	0.1	0.2	1.2	19.7	3.7	8.0	5.3	1.2	0.0	0.0	0.0	1.9	12.6	0.1	0.1	12.0	16.4	1.9	0.1	2.8	5.2	30.3	33.4	6.1	2.0	8.8	29.4	7.7	23.7	23.7	0.3	0.3	1.8	4.3	0.2	4.2	1.4	2.7	4.8	1.7	0.0	0.5	0.4	0.0	7.2	1.2	0.1	2.3	1.2	2.0	1.7	0.0	1.1	2.6	1.7	0.6	2.6	0.1	0.2	1.9	0.6	6.8	5.4	75.0	5.3	3.8	9.2	12.8	9.0	14.2	11.5	9.1	9.5	6.4	86.6	60.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	35.0	29.8	0.0	0.0	39.0	57.0	0.0	4.3	3.8	0.0	5.9	37.6	0.0	55.7	8.6	1.6	0.0	0.0	0.0	26.4	0.7	5.5	0.0	98.3	1.3	14.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	2.7	0.0	0.0	35.7	27.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	26.4	10.3	1.7	0.0	0.0
PATL1	"FLJ36874, Pat1b"	ENSG00000166889	"PAT1 homolog 1, processing body mRNA decay factor"	Q86TB9	11	59636716-59669037	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039030, HPA074680"	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"		"HPA039030: AB_10673232, HPA074680: "	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (3.93e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.37e-3)"	"unprognostic (6.74e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.34e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.86e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.18e-1)"	18.6	17.3	10.1	18.9	11.7	56.6	16.5	11.9	11.8	19.0	12.4	17.5	22.4	18.7	11.6	19.1	14.5	14.6	15.7	9.5	11.3	16.5	33.1	21.4	20.3	12.0	11.1	19.2	11.1	14.2	8.6	21.9	12.4	12.0	20.8	23.5	15.8	12.1	40.8	19.0	19.1	18.5	10.7	18.8	16.8	12.5	11.9	20.3	14.6	32.9	23.7	20.0	18.1	14.0	57.7	44.2	31.9	31.4	30.7	34.3	27.6	37.4	63.8	66.1	66.1	28.7	49.4	56.3	35.6	40.4	64.0	42.1	46.6	45.0	70.4	49.4	21.4	32.4	21.3	28.6	110.1	43.0	69.2	38.9	33.9	56.7	77.3	31.8	32.1	34.2	40.5	44.5	37.9	26.7	41.7	39.1	32.5	41.8	28.9	33.6	53.2	24.2	41.1	52.9	22.8	22.0	52.7	39.1	64.9	26.7	55.6	31.5	31.3	43.0	39.4	75.5	33.5	45.4	53.8	47.6	51.8	35.5	36.1	1.9	2.4	3.4	2.7	2.8	2.2	2.0	2.1	2.4	2.3	1.4	2.0	2.0	3.4	1.6	2.9	1.4	1.9	1.5	10.1	11.7	11.9	11.8	9.5	11.3	12.0	11.1	12.4	10.7	11.9	14.0	13.8	3.2	15.9	10.4	24.1	27.0	18.9	15.8	27.3	10.5	12.7	9.8	13.0	18.6	17.6	11.0	0.0	11.1	16.2	21.7	13.7	14.0	11.8	16.9	21.8	17.6	13.7	12.6	10.7	18.2	14.0	13.2	13.7	28.6	23.4	10.8	10.4	34.5	24.0	6.7	11.2	16.3	2.0	30.8	36.3	4.2	10.8	24.6	10.6	13.1	29.6	7.9	15.5	16.1	18.1	22.8	13.7	9.4	17.4	21.3	16.4	9.4	13.8	10.8	6.6	13.4	12.1	12.0	9.1	25.0	34.1	12.7	18.8	10.1	16.1	19.3
PATZ1	"dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG"	ENSG00000100105	"POZ/BTB and AT hook containing zinc finger 1"	Q9HBE1	22	31325804-31346346	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047893, HPA048315"	Approved		Supported	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA047893: AB_2680201, HPA048315: AB_2680353"	"unprognostic (3.25e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-3)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (9.22e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.79e-6)"	10.2	10.5	16.0	11.4	18.1	15.8	12.1	16.4	16.1	14.5	11.1	14.8	9.9	18.7	14.2	6.1	22.2	9.3	10.8	14.7	16.0	11.6	11.8	11.2	20.3	18.4	16.7	27.3	13.5	21.0	10.5	9.3	17.6	13.1	6.9	14.9	18.7	17.0	10.5	7.9	12.7	12.2	17.1	15.7	11.1	8.1	16.4	24.0	19.3	8.5	14.8	15.7	9.7	20.4	19.0	23.3	46.7	27.7	12.1	11.1	24.5	5.7	14.2	22.6	20.6	16.5	17.7	40.1	20.1	10.6	7.9	14.5	32.0	17.3	11.5	23.7	29.5	16.9	16.7	33.8	19.7	57.4	21.9	17.4	20.5	14.4	16.0	17.8	18.0	19.4	7.3	15.7	14.6	57.7	37.1	39.3	31.4	34.4	27.1	61.9	19.9	13.3	15.3	39.4	60.8	48.7	14.2	17.1	31.4	15.4	33.8	36.2	12.8	15.1	28.3	9.5	19.5	20.3	14.4	36.5	6.3	7.5	26.3	0.0	1.0	2.8	1.8	0.6	1.8	2.5	1.3	2.3	1.4	1.8	2.9	2.2	0.4	2.1	0.3	4.0	2.2	1.2	16.0	18.1	16.4	16.1	14.7	16.0	18.4	16.7	17.6	17.1	16.4	20.4	6.6	3.2	14.9	11.4	12.8	1.7	7.1	7.6	8.0	16.8	22.0	16.0	13.7	17.2	11.7	20.2	8.4	5.2	17.0	3.3	19.6	14.3	0.6	14.9	8.8	7.6	20.4	8.0	2.4	6.2	2.0	6.4	5.6	16.7	6.3	19.3	7.1	16.2	9.4	21.9	5.0	9.7	20.3	8.1	2.6	1.7	9.6	6.6	3.6	7.5	7.7	14.4	12.3	11.1	8.8	6.4	6.0	8.6	5.5	7.4	5.0	7.1	10.5	14.3	6.6	7.1	8.5	0.7	8.1	2.3	1.6	0.8	10.4	8.4	11.8	7.3
PAWR	"par-4, PAR4"	ENSG00000177425	"Pro-apoptotic WT1 regulator"	Q96IZ0	12	79574979-79690964	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.7;naive B-cell: 2.8;NK-cell: 1.4"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;NK-cells: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012640, CAB020779"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"CAB020779: , HPA012640: AB_1855748"	"unprognostic (2.42e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.77e-3)"	"unprognostic (5.39e-2)"	"unprognostic (9.44e-3)"	"unprognostic (4.21e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.97e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.23e-2)"	11.0	6.1	6.8	9.0	8.0	3.1	13.4	4.8	3.6	20.9	21.6	16.7	11.7	28.0	15.9	14.3	24.7	8.5	5.2	4.7	7.6	12.6	13.3	11.6	6.9	7.7	13.4	20.4	11.6	13.3	8.7	6.2	5.5	14.9	15.3	0.7	14.3	21.8	1.7	16.5	12.1	16.7	5.5	6.2	13.6	10.9	12.4	4.3	16.2	1.8	6.6	16.1	16.4	5.5	54.5	49.1	8.8	0.3	4.4	1.9	58.6	34.1	9.9	17.0	10.3	61.5	20.2	36.2	61.2	19.0	12.2	59.2	31.0	25.7	24.3	14.7	42.2	0.0	28.7	27.1	23.6	0.5	1.0	4.1	53.4	13.4	76.0	63.0	28.7	14.8	2.1	4.9	18.8	41.0	8.8	0.2	42.6	15.7	27.7	0.0	20.2	23.5	32.4	40.4	25.4	0.1	60.8	31.8	5.7	29.4	28.5	0.3	43.2	25.4	22.8	0.9	23.1	15.3	21.6	26.8	4.2	0.1	11.2	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.2	2.8	0.2	0.2	0.2	1.4	0.0	0.1	0.0	0.0	6.8	8.0	4.8	3.6	4.7	7.6	7.7	13.4	5.5	5.5	12.4	5.5	51.3	80.1	40.7	16.6	33.1	200.1	170.3	42.0	63.2	6.4	93.6	77.3	21.0	60.1	59.2	66.2	0.0	57.1	4.6	103.9	17.6	57.3	62.6	75.7	50.9	31.0	68.8	4.6	1.5	38.5	81.4	41.7	32.1	157.5	1.3	87.4	13.6	54.5	6.5	16.8	50.9	120.9	32.6	1.6	19.2	96.3	84.8	5.3	17.8	23.4	0.4	2.5	4.1	30.7	0.9	83.2	72.0	91.0	11.4	273.4	44.3	47.2	49.9	1.4	85.5	18.3	109.7	98.4	62.1	76.6	179.6	76.9	6.7	62.9	92.7	169.5
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.6;kidney: 85.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.4	5.4	0.2	0.0	0.0	1.8	29.6	0.0	8.4	0.0	0.0	0.5	0.4	85.3	0.1	0.0	0.0	6.8	1.6	0.2	0.4	5.9	0.8	0.0	3.3	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.4	0.5	0.4	6.8	1.6	3.3	6.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.4	14.9	0.3	9.4	0.1	0.5	0.5	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.6	0.1	0.2	0.3	39.7	1.1	6.5	0.0	0.0	0.0	0.2	0.1	4.1	0.3	0.8	0.5	1.0	0.0	3.1	0.0	6.6	0.0	0.8	18.7	1.6	0.6	1.9	2.8	0.2	0.0	36.2	1.1	0.0	0.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.5	0.5	0.3	0.6	1.1	6.5	4.1	0.8	1.9	0.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PAX6	"AN, AN1, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31817961	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 61.6;retina: 68.9"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 264.2;Muller glia cells: 462.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;AN3-CA: 20.1;HEK 293: 18.0;HeLa: 14.9;hTERT-RPE1: 50.6;U-251 MG: 16.5"	"Region enhanced"	"Detected in all"		"cerebellum: 54.3"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.0	0.6	21.7	0.0	22.9	0.2	0.1	61.6	34.1	0.0	16.5	0.2	1.7	0.0	0.6	0.0	0.0	0.0	0.0	23.6	20.7	0.8	0.1	0.0	0.0	22.0	18.1	0.0	9.2	0.0	4.3	0.0	21.7	0.0	0.3	68.9	0.1	0.0	0.8	0.5	0.9	0.0	21.4	0.0	9.4	1.6	19.6	0.4	0.0	0.0	0.1	0.1	0.1	25.8	0.0	0.2	15.1	20.1	4.6	6.6	5.9	0.0	0.0	0.2	0.0	1.3	3.7	0.1	6.3	2.3	9.0	0.4	1.8	0.0	0.3	0.0	18.0	8.9	14.9	8.4	0.0	0.5	0.0	0.1	0.7	0.1	0.5	50.6	0.0	5.2	7.6	0.0	0.2	0.0	3.7	0.6	0.3	0.0	10.1	0.0	7.3	0.1	0.8	0.6	0.7	0.0	0.4	0.1	0.0	0.0	4.7	0.0	0.0	5.3	0.4	0.0	16.5	0.1	0.2	0.1	8.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.7	22.9	61.6	34.1	23.6	20.7	22.0	18.1	21.7	21.4	19.6	25.8	0.2	0.0	0.0	76.7	0.1	0.5	0.0	0.0	0.0	78.8	0.5	0.0	3.8	0.0	0.0	0.0	12.5	0.1	0.1	0.2	0.0	0.0	0.7	0.2	0.5	1.0	74.6	0.0	3.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	264.2	1.6	3.1	0.0	0.0	0.4	0.6	0.0	0.2	0.0	3.7	0.6	462.6	0.0	3.5	0.6	2.5	1.3	0.0	0.0	0.0	0.1	0.2	0.0	30.6	0.0	0.9	0.5	21.4	7.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 267.9;thyroid gland: 565.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.0	1.4	0.6	0.9	0.5	1.7	0.1	1.1	14.5	1.7	1.8	0.6	8.8	32.9	2.2	37.5	3.6	2.1	1.0	1.9	267.9	1.2	1.6	1.7	5.2	1.3	1.7	1.0	1.4	1.4	1.9	3.0	1.1	0.9	1.5	1.9	26.1	0.5	1.8	2.4	0.8	3.7	0.8	1.4	2.4	2.3	0.5	565.5	0.3	1.0	2.1	1.0	1.9	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.4	0.9	0.1	1.1	1.0	1.9	5.2	1.3	3.0	3.7	2.3	1.9	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001572, CAB016239"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"CAB016239: AB_2159984, HPA001572: "	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	7.3	0.1	0.7	0.0	0.2	0.3	81.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.1	43.0	2.2	0.0	0.0	3.7	0.1	0.0	51.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	20.5	0.7	0.0	8.5	0.7	7.1	0.0	5.3	2.3	0.0	2.5	2.1	3.8	2.0	0.0	0.3	0.0	0.0	1.6	1.8	1.6	0.8	0.0	0.5	11.4	2.1	12.3	0.0	58.3	7.3	0.9	1.2	0.0	0.0	0.0	4.2	0.7	6.0	0.0	1.9	0.0	0.0	5.3	2.3	0.3	0.2	7.3	0.9	0.0	0.1	1.9	18.9	0.0	0.0	0.0	0.0	6.9	3.4	0.0	1.3	7.0	1.4	0.9	5.1	0.0	0.0	0.0	0.6	2.2	1.0	0.0	0.1	4.4	0.7	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.4	45.3	174.8	0.0	1.6	1.3	0.4	0.0	25.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.7	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	20.9	0.0	0.0	26.8	0.0	0.0	0.1	2.0	2.4	0.9	172.0	0.3	0.1	0.1	0.0	0.6	12.1
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771792	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	5.8	6.2	7.3	6.4	8.4	28.6	7.2	10.1	9.8	7.4	8.5	6.8	10.2	8.3	7.2	5.8	7.4	4.9	4.6	7.0	9.2	6.7	6.6	6.3	9.4	8.5	8.1	10.9	6.9	4.7	5.8	6.3	8.5	5.8	7.6	13.0	5.7	5.2	9.3	8.0	7.9	5.3	7.7	7.4	5.5	8.3	8.0	10.1	6.2	6.7	8.0	6.3	6.0	10.5	14.5	11.5	24.4	19.7	9.2	7.4	32.0	10.4	7.0	13.7	10.0	24.3	12.8	16.9	7.9	6.2	10.9	14.1	23.7	9.8	14.5	14.0	18.2	29.6	19.7	17.9	4.5	33.6	17.1	3.9	14.5	16.0	7.5	9.7	9.5	18.4	34.3	15.9	10.3	12.6	23.1	19.8	64.5	16.4	11.0	21.1	22.0	25.0	11.0	13.1	19.3	11.2	15.2	17.3	12.1	15.1	11.3	18.7	8.2	10.5	13.7	11.8	16.5	15.5	19.8	31.0	7.8	30.0	10.7	0.0	0.3	0.1	0.6	0.1	0.8	0.5	0.7	0.5	0.4	0.6	0.7	0.7	0.0	0.2	0.2	0.3	0.4	0.1	7.3	8.4	10.1	9.8	7.0	9.2	8.5	8.1	8.5	7.7	8.0	10.5	28.9	12.8	21.6	62.3	22.0	25.5	21.5	5.6	31.3	50.6	26.0	20.2	12.3	21.5	15.3	20.2	62.6	16.7	39.2	19.4	5.9	7.4	36.8	47.8	51.6	22.3	22.1	17.9	61.6	8.0	12.1	27.1	30.1	45.6	12.0	42.4	15.4	12.7	10.2	21.9	66.1	23.7	6.1	13.9	19.3	32.8	14.6	24.3	21.4	55.3	14.1	28.6	24.7	117.6	155.4	6.8	12.8	17.0	29.1	25.1	17.4	7.9	24.5	81.6	32.9	51.5	23.5	32.2	18.2	26.5	25.4	17.8	29.4	26.3	21.7	32.4
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003124	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 12.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	4.3	3.9	2.3	5.8	2.5	9.8	5.4	12.0	2.6	4.8	2.7	4.9	4.8	4.6	4.8	5.4	4.2	4.4	3.9	2.3	2.4	4.6	5.7	4.2	8.8	2.8	2.6	5.7	4.4	6.2	3.8	6.1	2.9	4.4	4.9	3.9	5.7	3.6	5.9	6.5	5.7	3.7	2.5	5.6	5.2	8.7	2.6	26.6	5.5	4.6	6.0	5.3	4.7	2.8	17.7	14.2	18.4	31.2	7.8	6.5	16.4	7.6	8.0	10.3	11.9	15.7	13.6	22.9	9.4	9.1	21.3	13.6	23.7	12.1	12.7	23.0	18.4	17.4	10.7	13.6	5.5	23.9	22.3	6.3	9.0	10.3	4.2	5.8	9.9	22.8	24.3	15.1	10.4	24.3	51.1	19.9	29.8	17.1	9.5	28.8	18.7	24.8	10.7	14.6	14.6	9.4	20.3	14.9	9.5	16.6	11.4	20.1	5.1	8.6	1.5	12.3	18.6	15.2	9.5	31.0	21.1	27.7	23.6	0.2	0.9	0.5	0.9	1.1	1.4	0.5	1.5	1.1	1.0	0.9	2.4	0.7	0.5	1.3	1.3	1.2	1.2	0.9	2.3	2.5	12.0	2.6	2.3	2.4	2.8	2.6	2.9	2.5	2.6	2.8	5.2	6.4	6.3	18.9	5.8	6.4	5.1	4.7	4.0	18.9	8.9	6.6	6.9	7.2	7.1	9.2	10.4	9.0	3.8	6.8	5.9	3.9	2.3	5.5	6.9	5.2	2.4	10.3	21.4	3.3	8.0	6.9	5.6	6.5	2.5	8.8	5.0	9.2	4.4	3.3	24.2	8.4	2.0	6.1	7.1	2.8	8.7	4.8	3.6	15.9	6.3	8.0	7.2	27.2	27.4	4.4	4.3	9.4	4.9	8.0	5.2	4.2	4.3	12.3	0.0	11.1	5.1	22.6	18.7	8.9	7.0	6.2	4.9	6.3	9.8	4.5
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX non-homologous end joining factor"	Q9BUH6	9	136992422-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.1;dendritic cells: 198.4;Distal tubular cells: 131.0;Extravillous trophoblasts: 216.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm		NA	NA		95000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	24.1	24.9	15.9	8.1	16.3	17.6	23.6	18.0	27.3	27.9	9.6	25.5	11.8	23.5	1.7	29.5	24.7	4.3	29.3	13.9	15.0	37.3	44.7	28.4	11.8	21.9	18.8	21.5	37.7	5.5	37.4	7.5	19.1	34.5	2.0	1.2	20.2	7.4	14.9	34.7	28.8	1.9	19.4	48.3	31.2	14.8	17.1	10.1	32.4	2.1	4.0	25.7	25.5	21.8	27.6	30.3	4.8	18.4	8.5	7.6	70.5	20.7	12.3	13.7	7.4	13.5	19.8	24.6	35.3	5.4	5.4	43.5	1.7	15.6	1.1	63.3	42.7	19.3	16.2	11.4	12.7	27.6	41.2	5.6	14.6	4.7	6.3	2.4	12.5	44.1	29.4	7.1	3.1	61.2	29.0	45.6	28.7	32.6	91.5	37.7	9.8	70.4	9.5	14.2	22.6	28.2	17.8	44.0	24.9	0.8	52.5	23.4	16.6	6.5	19.9	31.2	25.1	13.1	12.5	16.9	11.6	31.6	24.8	25.9	44.3	18.7	142.3	54.9	122.5	33.8	78.3	123.9	46.2	30.5	42.4	99.1	14.9	87.7	29.0	238.2	66.0	62.2	15.9	16.3	18.0	27.3	13.9	15.0	21.9	18.8	19.1	19.4	17.1	21.8	65.5	16.0	27.6	0.0	20.2	0.0	0.0	0.0	0.0	0.0	76.8	95.0	0.0	0.0	7.4	40.5	0.0	147.1	198.4	0.0	131.0	54.3	0.0	45.3	34.0	22.6	0.0	0.0	0.0	43.4	216.7	25.0	0.0	44.4	12.6	66.5	0.0	0.0	77.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	35.2	0.0	0.0	0.0	0.0	40.0	0.0	0.0	21.5	0.0	0.0	82.4	11.7	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	88.7	72.3	59.1	0.0	0.0
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76173040-76178314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (1.62e-1)"	24.2	31.0	12.4	22.6	11.8	46.6	23.1	12.7	19.9	22.6	12.9	27.2	40.3	24.0	23.6	33.3	19.3	19.2	21.1	12.1	13.5	29.4	31.8	22.4	26.3	13.3	14.0	20.2	19.5	20.8	19.8	22.8	13.1	25.2	28.2	20.1	21.4	18.9	24.3	26.4	33.2	26.1	12.6	25.6	23.8	6.5	13.7	20.6	19.0	19.3	26.7	33.1	21.9	12.5	35.3	50.9	41.5	28.2	53.5	52.3	36.0	62.5	51.2	53.9	46.3	48.9	46.8	47.1	40.3	62.3	68.6	49.7	70.3	68.1	69.5	36.1	45.2	36.0	30.1	72.4	82.0	104.6	49.2	42.2	55.4	74.9	63.2	33.3	69.6	17.0	50.7	22.9	67.8	41.6	49.1	75.3	116.1	87.0	78.9	41.3	43.7	6.0	79.8	64.9	24.3	30.9	27.6	44.0	0.2	53.0	26.8	39.1	60.8	39.9	40.8	48.6	56.7	40.6	77.3	27.8	44.7	35.7	32.3	17.6	41.1	42.6	68.3	62.8	50.6	70.7	61.0	67.8	53.5	57.3	61.9	59.4	7.7	69.6	71.8	56.0	57.0	44.0	12.4	11.8	12.7	19.9	12.1	13.5	13.3	14.0	13.1	12.6	13.7	12.5	32.8	35.3	29.1	2.6	32.9	52.9	84.4	119.6	50.7	21.0	29.3	35.3	38.5	31.5	64.3	40.5	14.6	55.5	57.5	46.9	49.0	71.0	0.9	51.9	49.1	34.4	27.6	17.5	2.3	62.5	60.4	42.9	28.1	45.7	51.4	33.5	25.7	47.9	69.8	8.4	2.4	50.3	77.3	30.5	31.5	3.8	47.8	38.1	46.2	1.9	68.0	26.4	45.3	2.5	2.8	58.7	44.7	38.7	25.7	58.3	105.5	84.1	49.1	25.0	52.6	35.9	47.0	4.4	18.9	59.4	70.5	55.0	49.2	82.0	51.9	82.1
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 171.5;kidney: 270.0;liver: 335.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 16.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		NA	NA		1100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	8.9	11.2	2.9	8.4	5.5	9.3	4.5	5.3	5.3	3.9	4.2	33.2	171.5	5.9	3.8	3.4	7.2	9.4	6.2	3.0	4.6	270.0	335.2	3.9	5.5	4.9	4.1	3.6	63.0	5.6	2.3	4.2	4.2	5.6	27.6	8.7	4.5	5.1	5.6	5.6	146.4	5.0	3.0	4.6	54.8	3.8	4.4	2.1	5.5	3.1	2.2	5.4	2.1	8.9	3.8	7.5	7.1	4.9	6.4	3.6	3.3	15.1	9.5	5.6	5.8	6.9	9.5	4.2	5.6	10.6	2.3	5.8	3.3	3.9	4.8	2.0	5.4	3.3	9.3	6.4	3.0	5.0	3.3	6.4	4.0	3.4	4.2	10.1	3.5	4.0	3.1	9.2	8.9	5.9	4.7	8.7	2.1	3.0	3.2	8.0	9.4	7.1	11.3	5.4	4.1	5.5	10.1	5.8	7.0	2.0	20.0	5.9	10.9	5.5	3.9	2.7	2.5	5.5	4.3	6.3	6.6	2.7	1.4	2.6	2.8	1.5	0.4	1.4	0.8	0.8	0.6	0.4	2.8	0.6	1.1	0.7	3.3	1.8	0.9	1.2	1.1	1.2	2.9	5.5	5.3	5.3	3.0	4.6	4.9	4.1	4.2	3.0	4.4	8.9	1.6	3.2	4.2	3.6	4.5	1.9	1.7	2.2	1.2	5.0	6.2	2.8	3.5	24.3	4.3	55.2	10.4	3.9	3.7	97.5	109.5	8.8	1.2	17.9	5.7	3.4	7.2	6.6	1.8	31.8	2.0	3.2	33.1	6.5	1.3	8.2	6.4	216.9	3.1	10.1	2.8	42.6	2.0	10.4	4.4	0.4	4.1	5.5	1.8	3.7	5.0	5.5	3.1	3.0	7.5	12.5	46.4	3.0	1.5	2.0	380.2	426.5	12.9	17.2	0.0	2.0	6.6	1.6	1.4	1.8	0.6	3.1	2.8	9.6	57.3	3.0
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"brain: 3.1"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063021, HPA069649"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA063021: AB_2684923, HPA069649: "	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.7	0.0	1.1	0.2	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	1.1	2.7	0.9	1.2	0.7	0.9	0.6	0.7	0.3	0.8	3.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015629: AB_1855012, HPA059373: AB_2683994"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	21.4	12.9	6.4	20.8	11.0	24.6	16.6	18.5	8.9	21.1	13.2	17.9	15.4	22.1	16.4	22.5	19.4	16.9	18.5	6.0	11.9	11.2	18.2	17.6	22.1	10.7	9.9	29.4	12.0	14.3	8.7	20.9	11.8	18.6	18.5	20.2	13.1	17.4	15.5	17.3	14.2	25.4	8.6	18.9	16.0	14.1	10.3	42.0	26.7	22.8	22.0	20.0	12.0	19.8	32.5	20.5	71.9	35.4	34.7	35.0	50.4	44.5	29.9	49.5	43.0	23.3	21.5	78.7	6.2	51.8	40.8	21.8	63.1	33.1	59.6	85.5	34.6	74.6	38.1	18.1	49.6	62.7	54.6	33.2	37.3	55.4	35.4	38.9	48.4	60.6	43.7	41.7	50.3	11.0	103.9	18.8	43.8	22.0	34.4	53.8	45.1	40.1	20.4	62.5	48.7	53.8	52.7	12.4	41.6	43.4	23.4	35.7	56.5	46.1	34.8	40.1	54.4	30.0	51.3	73.6	28.5	49.8	46.9	9.0	4.0	9.9	3.6	2.6	3.8	2.9	3.6	4.0	4.0	5.3	5.7	3.6	2.3	3.6	8.0	8.7	3.9	1.6	6.4	11.0	18.5	8.9	6.0	11.9	10.7	9.9	11.8	8.6	10.3	19.8	49.1	41.7	61.3	95.3	44.0	40.5	35.8	28.3	43.9	45.6	40.7	30.4	61.7	30.0	39.8	23.9	47.9	36.0	67.7	36.8	19.6	37.7	39.1	61.4	54.5	47.7	35.2	82.9	76.4	46.2	36.9	39.8	42.8	46.8	29.1	61.9	33.5	47.9	53.0	30.3	84.5	35.3	28.5	61.7	47.7	17.1	34.2	65.6	48.0	80.6	67.6	29.1	49.4	87.9	135.5	49.7	29.2	58.3	76.9	37.5	18.7	18.4	58.2	44.3	26.3	54.3	69.2	48.6	35.8	43.7	51.6	50.9	50.4	45.8	39.8	37.0
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184733-32190202	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	30.3	39.6	4.9	14.2	4.5	9.0	27.6	3.9	5.5	47.4	5.0	51.2	10.6	47.8	30.4	33.5	47.1	4.9	32.1	4.5	4.7	37.9	31.0	43.9	16.7	5.1	4.6	52.3	28.2	4.5	52.0	25.2	4.8	39.3	12.2	8.5	27.6	12.3	29.8	34.1	39.8	13.0	4.3	64.5	36.7	23.9	5.0	23.9	55.2	2.3	17.8	42.4	39.2	4.6	4.8	7.9	32.3	17.7	23.5	29.4	13.9	3.7	8.9	9.7	10.0	6.5	7.8	21.9	23.5	13.7	3.8	13.4	8.1	26.8	10.6	19.5	30.3	20.5	7.1	3.8	20.7	13.2	18.7	43.2	14.9	7.4	24.8	16.6	19.1	38.8	26.5	11.1	3.7	18.1	13.6	29.7	0.6	2.9	2.2	18.8	5.0	26.1	21.2	7.7	9.4	12.6	3.0	6.8	26.5	18.3	16.9	25.0	6.5	8.5	19.8	3.4	4.2	54.1	36.9	27.2	17.3	9.9	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	4.5	3.9	5.5	4.5	4.7	5.1	4.6	4.8	4.3	5.0	4.6	27.7	6.4	11.0	14.4	18.5	18.2	18.5	11.8	15.4	19.2	17.0	12.2	3.7	31.5	10.1	16.5	8.4	32.2	29.4	9.6	3.9	17.1	1.0	12.3	24.5	24.8	30.5	19.1	7.8	14.0	25.6	16.0	12.2	16.6	15.2	21.8	28.9	23.0	19.0	26.9	7.0	15.5	10.2	34.5	55.5	4.2	20.2	25.3	8.8	9.4	23.9	21.0	35.0	6.0	9.1	13.9	12.5	19.5	17.7	19.4	12.5	10.2	9.6	4.9	6.6	19.7	19.8	1.6	6.1	19.7	19.5	47.2	16.7	22.8	13.2	18.1
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PBX4		ENSG00000105717	"PBX homeobox 4"	Q9BYU1	19	19561707-19618693	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.1;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.5;Gastric mucus-secreting cells: 17.3;Plasma cells: 18.8;Spermatocytes: 26.6;T-cells: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.0;T-reg: 3.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;RT4: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049859, HPA056469"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA049859: AB_2680918, HPA056469: AB_2797256"	"unprognostic (5.36e-3)"	"prognostic favorable (8.69e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.44e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-2)"	"prognostic favorable (5.94e-7)"	0.2	0.0	0.6	0.4	0.6	0.4	0.2	0.3	0.8	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.6	0.1	0.0	0.3	1.2	0.5	0.5	0.2	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.4	0.0	0.4	0.3	0.4	2.1	1.0	1.0	2.3	0.0	0.6	0.1	0.1	0.5	2.5	0.1	1.0	0.0	0.2	0.0	1.7	0.0	0.8	1.1	0.8	0.0	1.1	0.3	0.4	0.6	0.9	1.1	1.4	0.0	0.3	0.1	0.5	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.5	1.0	0.7	0.2	1.8	1.9	0.5	0.0	0.0	0.8	3.2	0.8	1.1	1.1	0.1	0.8	0.1	0.4	0.1	0.0	0.0	0.5	1.5	0.3	0.2	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.2	1.2	1.9	0.0	0.0	1.2	1.0	0.2	0.0	0.0	0.0	3.1	0.5	0.6	0.6	0.3	0.8	0.6	0.6	0.5	0.5	0.5	0.4	1.0	0.5	0.7	0.0	4.1	9.8	8.7	4.8	2.6	1.3	1.8	0.6	1.1	1.8	0.4	1.5	1.6	0.0	0.0	0.0	14.5	1.1	1.9	0.7	3.1	8.3	1.1	0.4	0.0	0.8	5.0	0.0	1.1	3.4	17.3	3.5	0.0	1.2	0.4	0.0	0.4	0.0	7.3	2.9	0.0	0.3	3.8	1.5	0.3	1.6	1.8	1.0	1.5	1.4	6.2	1.5	1.4	2.4	0.1	0.7	18.8	2.6	0.2	0.0	5.4	0.1	6.6	1.4	1.4	26.6	10.7	0.7	2.6	0.0	50.4	0.5	0.7	3.1
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 176.0;Muller glia cells: 221.4;Theca cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 183.9;NK-cells: 56.9;T-cells: 197.4"	"Cell line enriched"	"Detected in all"	7	"Karpas-707: 1100.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol		NA	NA		26000	"Cluster 13: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	57.7	122.5	169.3	58.4	180.3	35.1	45.9	159.8	158.8	74.5	296.1	124.5	55.4	81.7	39.0	46.0	68.8	52.8	67.7	144.4	173.6	56.9	29.7	49.0	69.4	208.2	189.7	115.3	34.0	102.4	168.9	33.3	168.5	63.6	29.7	38.9	53.0	95.3	139.7	37.2	90.7	52.4	171.7	82.2	82.7	58.1	210.4	80.8	85.9	100.5	59.1	79.2	50.5	161.2	7.3	19.1	29.9	20.0	101.3	31.5	22.0	25.1	55.3	11.9	23.5	5.6	24.9	31.3	79.1	30.5	17.0	26.8	7.3	16.1	8.3	16.9	11.7	7.1	26.2	20.1	46.9	8.6	83.6	48.0	26.2	15.1	3.0	137.7	45.4	23.6	4.2	1100.7	29.8	11.1	17.6	27.5	11.4	19.3	14.4	20.2	43.1	69.7	32.9	14.1	4.9	37.6	32.5	10.2	26.7	56.1	31.0	36.6	42.9	11.8	8.6	7.6	7.8	149.4	133.9	7.7	42.2	12.4	9.6	129.4	10.3	183.9	41.9	14.8	116.3	36.0	112.4	66.9	9.1	23.6	72.9	46.2	95.2	56.9	29.7	16.2	197.4	61.5	169.3	180.3	159.8	158.8	144.4	173.6	208.2	189.7	168.5	171.7	210.4	161.2	24.5	67.3	77.9	56.8	43.0	10.1	24.0	22.4	13.1	23.8	17.6	19.7	38.5	38.6	31.1	42.3	16.7	19.5	48.2	21.0	0.0	46.0	142.1	12.9	25.9	23.8	83.7	22.3	1.5	18.5	24.0	35.9	19.9	10.5	51.9	30.3	28.9	19.4	14.7	1.7	1.2	20.9	69.2	20.2	13.8	176.0	64.3	16.8	26.6	7.5	25.5	221.4	39.1	3.5	1.6	22.4	29.3	129.1	49.0	10.5	56.0	9.9	23.9	8.8	52.6	83.9	50.6	8.8	13.9	6.3	11.5	27.1	116.2	153.3	15.9	13.9
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134905120-135007959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.4;tongue: 42.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036428	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	5.3	7.7	7.3	4.8	8.5	7.6	6.0	7.8	7.6	4.3	11.0	6.1	9.5	4.2	4.1	8.3	5.7	4.6	17.1	6.4	7.5	10.2	11.9	4.9	5.9	8.7	7.7	5.1	8.0	13.0	3.8	3.5	8.0	5.4	7.0	9.9	9.6	3.8	49.4	9.2	8.1	3.6	6.8	5.8	8.2	3.2	8.1	5.5	9.6	42.7	6.1	4.5	4.9	10.8	7.5	7.2	9.4	6.9	5.7	5.2	5.2	6.0	5.2	3.8	3.8	12.0	17.5	8.7	8.8	4.4	6.1	6.5	5.6	5.9	3.4	12.3	3.1	6.0	9.5	7.1	5.4	7.1	3.6	3.4	7.1	3.6	7.6	5.1	4.3	7.7	7.7	12.2	6.9	13.0	7.5	12.3	5.1	11.5	6.9	10.9	8.4	9.7	8.1	7.4	7.2	9.2	10.4	6.0	9.1	7.1	13.0	9.4	5.9	6.4	4.3	7.1	8.1	10.6	15.7	5.5	7.8	8.8	4.8	5.7	5.1	5.4	3.6	4.5	2.9	4.5	4.0	3.4	4.4	4.2	3.8	4.3	2.8	4.0	4.6	7.7	3.9	2.7	7.3	8.5	7.8	7.6	6.4	7.5	8.7	7.7	8.0	6.8	8.1	10.8	4.2	9.6	10.3	28.7	8.8	3.6	6.4	15.8	7.4	13.5	11.7	8.4	32.5	20.0	12.5	16.5	12.5	13.6	10.1	13.6	21.5	17.1	8.4	7.9	6.1	6.9	4.2	31.5	10.6	18.2	24.4	5.8	13.3	8.7	6.3	22.4	7.1	23.1	24.6	23.5	12.9	9.5	20.3	10.0	9.6	3.5	7.2	10.2	5.4	17.8	26.9	14.8	7.2	13.0	20.6	17.8	6.2	2.2	13.1	7.1	26.5	26.3	11.9	45.9	0.0	9.0	7.4	5.2	11.5	13.8	6.0	10.1	7.8	9.5	15.9	8.7
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087477-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		1600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	278.3	276.3	145.5	199.8	155.0	390.0	240.4	168.5	203.5	209.3	159.1	259.9	172.8	253.9	142.6	278.4	193.8	134.9	223.2	142.1	155.6	218.1	304.3	233.6	227.1	163.7	146.9	186.0	249.9	174.6	140.2	194.8	159.2	143.9	125.8	90.5	185.0	139.5	782.3	216.6	203.1	172.4	163.8	241.3	214.5	95.2	150.4	301.0	170.8	308.3	209.6	233.8	206.0	190.9	384.9	387.5	327.1	257.5	345.1	262.4	525.9	280.5	257.2	272.0	227.0	453.0	250.6	522.9	140.9	320.7	293.7	334.7	388.4	408.6	276.5	376.2	299.9	419.2	219.5	701.3	388.0	350.8	385.8	230.3	261.6	224.5	310.5	203.4	350.7	138.9	437.2	375.6	346.2	475.7	454.7	524.7	331.5	361.1	253.2	362.9	358.0	527.1	375.5	389.6	309.7	249.1	230.3	465.8	342.1	229.8	277.6	314.2	325.1	253.5	317.6	217.6	359.4	495.7	551.2	531.7	268.6	480.4	319.5	42.6	89.7	141.5	80.3	92.5	73.8	41.1	62.1	69.3	82.9	36.4	62.8	71.2	138.2	95.4	80.5	58.9	81.7	100.5	145.5	155.0	168.5	203.5	142.1	155.6	163.7	146.9	159.2	163.8	150.4	190.9	241.0	153.8	132.7	27.4	312.7	484.0	296.0	192.1	196.9	64.9	270.8	212.6	0.6	208.8	134.5	196.8	22.9	372.4	208.7	401.7	272.0	196.0	34.4	187.6	220.8	242.8	178.6	485.3	19.1	199.2	470.1	196.9	227.9	284.8	114.2	129.6	227.0	392.7	385.7	58.9	18.0	239.8	138.4	509.2	795.9	34.4	186.1	382.4	300.6	30.0	422.9	122.3	347.1	14.1	49.1	211.7	311.7	186.5	357.1	278.5	338.4	481.0	128.6	56.1	170.9	222.9	241.9	131.0	65.5	267.0	545.8	703.4	291.2	148.4	232.9	366.6
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		970000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	467.6	429.4	213.6	263.0	232.5	863.1	396.1	260.1	240.3	385.9	238.8	318.2	334.8	345.0	366.4	314.4	407.8	301.5	340.3	197.9	232.9	534.9	509.0	350.9	380.4	228.2	223.5	507.3	501.5	437.3	220.7	299.7	232.8	265.5	325.5	665.2	322.1	264.5	481.1	416.6	324.5	333.8	227.4	323.8	390.4	363.6	228.8	543.6	414.9	401.7	455.6	313.3	323.5	263.2	527.6	809.2	755.8	614.7	1068.5	809.3	582.3	547.0	722.3	844.6	605.4	951.9	760.5	916.9	518.6	796.7	398.6	501.2	830.1	720.1	830.0	579.1	617.4	917.3	597.0	946.0	1071.1	922.5	592.1	937.8	593.9	719.6	1147.1	1451.3	819.3	583.5	810.8	1621.9	762.9	1444.3	856.8	1030.1	975.1	447.8	559.7	690.0	686.4	1098.4	667.5	814.6	742.4	655.6	736.2	656.2	553.9	767.2	918.2	791.8	615.9	443.9	614.0	412.7	561.7	908.2	666.0	840.7	523.9	572.6	494.4	19.1	34.5	25.9	27.7	34.0	44.6	38.1	42.3	35.7	41.6	34.3	48.1	41.8	30.8	23.9	33.3	57.2	52.3	30.1	213.6	232.5	260.1	240.3	197.9	232.9	228.2	223.5	232.8	227.4	228.8	263.2	306.1	115.4	179.2	64.9	433.6	390.7	302.9	352.6	569.1	88.0	361.5	389.9	73.7	253.1	193.0	296.1	110.5	329.2	313.6	242.9	493.1	233.0	68.3	264.2	289.3	285.1	206.5	525.1	54.6	240.0	365.1	285.8	326.2	298.1	155.0	360.3	283.4	302.2	368.2	102.6	58.1	279.1	223.8	437.6	473.8	65.6	309.1	376.0	233.1	74.0	476.5	152.9	292.5	58.8	101.4	250.8	266.5	229.0	483.8	256.3	446.8	714.4	159.5	188.3	190.7	346.6	435.1	292.8	183.4	511.3	382.3	443.3	341.6	240.4	325.7	345.0
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6;retina: 81.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 229.1"					"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	7.3	7.1	8.9	7.5	6.8	8.9	4.5	34.6	11.9	8.2	2.8	13.7	1.7	8.7	7.5	1.4	5.3	2.6	3.4	13.5	8.1	4.8	1.3	2.8	3.3	32.3	12.0	3.9	2.7	0.1	22.6	1.2	31.3	2.3	1.6	81.5	1.8	0.8	0.4	2.1	8.7	7.8	8.9	10.0	4.7	14.8	17.9	18.9	1.0	1.7	2.9	4.1	2.8	9.5	0.0	0.0	0.5	0.0	13.7	29.0	0.2	1.8	0.4	3.1	1.4	0.0	0.0	0.0	0.7	8.2	3.9	0.1	1.7	0.0	0.5	56.9	0.2	0.0	0.0	0.0	13.7	0.0	0.0	40.8	0.2	0.5	0.8	0.0	0.0	2.0	0.0	0.2	1.8	0.7	16.5	3.3	0.8	0.1	2.8	0.0	0.1	2.4	0.0	0.0	4.9	46.9	1.2	0.0	0.0	1.3	0.0	8.7	0.0	0.0	0.1	12.3	0.0	0.7	3.1	0.0	25.0	31.3	1.1	2.1	0.2	3.0	0.7	0.1	0.1	1.3	0.4	0.0	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.0	0.4	0.2	8.9	6.8	34.6	11.9	13.5	8.1	32.3	12.0	31.3	8.9	17.9	9.5	0.6	0.0	0.0	2.3	6.2	0.3	0.1	0.3	0.0	159.4	0.1	0.5	3.6	0.0	0.7	1.8	50.1	0.1	0.3	0.0	0.0	0.1	36.5	0.2	8.9	2.2	3.0	0.0	3.8	0.2	0.1	2.3	0.5	0.3	0.0	0.2	2.2	0.0	0.4	116.1	4.6	0.1	0.0	0.0	0.7	79.8	8.4	0.9	3.6	1.0	0.0	49.3	0.0	0.5	5.5	0.9	0.1	12.8	4.1	1.3	0.0	0.4	0.0	83.1	0.0	1.1	3.9	34.1	21.2	0.0	0.0	0.0	2.5	0.2	0.2	0.5
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase subunit beta"	P05166	3	136250340-136337896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 202.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7;Late spermatids: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		120000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	34.4	75.1	23.3	15.2	33.6	37.9	27.5	31.4	29.3	17.5	35.5	43.6	38.1	13.8	13.9	26.3	19.2	17.0	94.6	23.6	28.5	88.9	202.1	14.8	16.2	31.1	29.4	12.1	32.0	57.0	15.6	19.6	30.4	23.7	41.9	17.2	23.6	21.7	83.8	15.1	27.5	22.6	27.1	12.7	26.1	38.8	29.8	21.1	37.9	91.4	20.7	20.5	11.4	47.8	64.8	45.8	42.4	64.4	30.2	34.5	75.4	33.0	35.5	49.1	69.6	67.9	44.7	80.3	89.4	46.6	44.0	35.1	50.3	44.0	69.4	47.8	43.0	140.8	49.5	101.4	66.4	107.3	60.2	40.8	41.4	31.0	69.4	30.5	56.1	131.6	104.5	41.0	38.0	123.1	109.3	63.1	36.0	96.8	40.9	29.3	34.6	116.6	89.9	69.4	84.0	62.9	84.4	48.9	77.5	35.2	98.3	62.9	42.0	24.5	26.0	69.2	29.6	78.3	70.0	66.9	34.9	41.7	29.9	7.3	29.5	7.5	22.6	30.8	25.4	21.7	14.7	23.2	44.6	19.8	15.1	18.7	2.7	25.9	28.7	38.5	14.8	22.6	23.3	33.6	31.4	29.3	23.6	28.5	31.1	29.4	30.4	27.1	29.8	47.8	5.6	9.6	14.0	16.0	9.2	4.1	9.4	37.9	3.4	16.0	12.5	5.3	51.1	8.6	28.4	20.2	10.4	57.1	8.0	15.1	39.2	24.6	316.7	14.1	9.5	8.1	9.1	53.2	16.5	14.0	27.1	13.6	14.8	14.1	29.2	18.1	9.3	76.3	35.1	11.8	22.7	15.1	24.4	11.7	5.2	159.0	13.7	11.4	19.6	16.9	16.5	11.8	10.3	22.1	50.9	14.4	16.7	10.9	22.6	10.4	19.2	97.3	23.6	13.2	13.1	13.6	13.1	11.3	29.0	16.2	3.3	50.9	9.9	52.8	25.1	12.2
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149294-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA		88000		"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	0.5	5.1	20.5	0.2	35.4	0.0	0.1	0.9	23.9	1.5	0.0	0.5	0.1	1.6	0.5	0.3	1.2	0.5	1.2	19.6	15.2	2.1	0.1	0.7	0.0	7.7	24.9	2.3	0.2	0.0	1.4	25.9	11.3	10.6	0.2	3.0	0.5	17.3	0.0	0.0	0.4	0.7	3.7	0.0	0.4	1.4	16.8	0.1	0.5	0.0	0.0	1.8	2.8	19.1	0.0	0.7	8.7	0.0	0.3	0.0	0.0	8.6	4.6	0.7	0.4	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.9	0.0	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	11.5	27.4	0.0	0.3	0.0	4.2	0.0	24.1	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	55.4	14.5	0.0	0.1	12.9	0.0	0.0	0.0	1.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	35.4	0.9	23.9	19.6	15.2	7.7	24.9	11.3	3.7	16.8	19.1	1.4	0.0	0.6	58.1	0.0	0.1	0.5	0.1	1.2	15.0	1.2	2.7	2.3	0.0	0.7	0.0	0.0	0.8	0.0	0.9	1.9	0.0	5.6	26.5	4.6	4.0	0.0	0.0	64.9	0.0	0.9	15.5	0.0	29.1	0.0	5.0	0.0	0.0	1.8	0.0	57.7	0.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	6.5	0.0	8.6	0.0	46.8	59.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.1	2.7	0.0	4.3	11.5	17.4	0.9	0.0	0.3	2.9	0.2	3.9	0.1	0.4
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 10.7;ovary: 7.4"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 120.4;Inhibitory neurons: 349.7;Oligodendrocyte precursor cells: 173.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;AN3-CA: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077495	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.2	10.7	0.2	7.7	0.0	0.2	0.0	3.7	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.2	0.0	0.0	0.0	0.2	1.6	4.8	7.4	0.0	1.0	0.2	0.8	2.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	7.8	0.0	0.1	0.2	0.2	0.0	0.0	1.2	0.0	0.0	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	7.7	0.0	3.7	2.4	6.2	1.6	4.8	2.0	0.0	7.8	1.2	0.5	9.6	7.4	2.3	0.2	1.5	0.5	0.2	1.2	4.2	1.0	1.8	0.7	0.0	3.2	0.0	0.0	20.8	0.1	0.1	0.0	0.0	0.6	0.2	0.1	2.1	0.0	0.0	120.4	0.0	0.3	1.0	0.0	0.2	1.3	0.1	4.6	0.3	1.0	33.7	349.7	0.0	0.0	0.0	2.0	0.6	9.6	1.0	10.6	12.2	0.0	0.2	0.0	173.9	5.3	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.8	1.4	6.6	0.6	0.8	0.3	1.0	0.1	0.9	15.7	0.6	0.1	0.1	0.4
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943581-141969741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 38.5;Endothelial cells: 40.0;Hepatic stellate cells: 41.0;Hofbauer cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"non-classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	41	"monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 25.9;Karpas-707: 66.5;U-937: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"	NA	NA		14000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA051242: AB_2681402"	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	13.4	5.0	0.8	2.5	0.9	0.5	4.9	2.5	1.7	2.7	1.2	2.0	2.0	2.8	0.4	2.1	2.1	4.0	10.8	0.6	0.8	6.0	4.0	15.5	2.6	0.5	0.3	1.7	1.4	2.9	3.6	30.2	0.6	1.9	1.3	1.6	1.4	2.3	4.0	1.7	2.1	5.2	0.3	18.6	2.0	1.1	1.4	0.8	6.5	5.1	1.0	3.2	1.9	0.3	0.1	0.1	1.9	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	5.0	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.6	1.4	0.2	0.1	0.2	0.5	0.2	0.0	0.0	0.4	0.0	0.4	25.9	0.3	0.0	66.5	0.0	0.4	0.1	0.3	0.5	0.0	0.3	0.5	0.2	3.0	0.0	0.1	0.3	0.7	0.1	0.1	0.3	0.2	0.0	1.8	1.8	0.6	0.1	0.9	0.1	0.4	0.4	0.1	0.4	11.7	2.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.8	0.9	2.5	1.7	0.6	0.8	0.5	0.3	0.6	0.3	1.4	0.3	38.5	0.0	1.1	0.0	0.5	0.6	0.0	0.0	1.2	1.3	0.1	0.1	4.0	0.0	0.0	0.0	2.1	0.3	0.3	0.0	3.9	0.1	1.7	0.1	0.1	40.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	1.3	0.0	41.0	0.5	34.6	0.0	0.2	0.0	0.0	8.5	0.3	2.5	0.0	1.5	1.8	6.5	0.3	0.5	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.4	0.0	0.7	1.0	0.0	0.2	0.2	0.3	0.5	0.2	1.4	0.0	0.2
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631744-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;lymphoid tissue: 25.1"	"Group enriched"	"Detected in many"	4	"Adipocytes: 57.6;Astrocytes: 77.1;Early spermatids: 60.7;Endothelial cells: 126.7;Excitatory neurons: 125.2;Hepatic stellate cells: 79.6;Inhibitory neurons: 67.9;Oligodendrocyte precursor cells: 193.0;Oligodendrocytes: 101.1;Spermatocytes: 68.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;HEK 293: 9.3;U-87 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA		690000		"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	1.6	1.8	15.8	1.8	20.6	0.0	0.8	7.9	13.9	2.2	0.1	1.2	0.8	2.1	0.8	0.6	2.0	3.2	2.2	11.7	25.5	1.9	1.0	14.0	0.6	9.3	15.8	0.5	6.0	1.6	0.9	4.4	11.4	1.0	0.8	1.0	0.7	0.7	1.7	0.3	0.8	2.1	7.6	25.1	1.5	8.8	27.9	0.2	2.9	1.3	0.5	2.7	0.8	10.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	9.3	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	1.2	0.0	1.0	0.0	0.0	0.0	5.3	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	20.6	7.9	13.9	11.7	25.5	9.3	15.8	11.4	7.6	27.9	10.5	57.6	0.0	4.3	77.1	0.1	2.7	0.1	0.0	1.2	7.1	0.4	0.6	6.0	1.5	8.6	1.8	0.0	0.2	0.5	0.1	0.0	11.1	60.7	2.6	2.0	126.7	0.0	0.0	125.2	8.3	0.1	11.7	0.0	19.8	0.0	20.5	79.6	0.3	0.6	0.0	67.9	0.0	0.0	1.9	2.5	19.0	1.8	0.5	10.6	12.2	1.6	2.3	0.0	193.0	101.1	1.3	0.0	1.2	1.2	0.3	0.0	0.0	5.1	0.0	6.6	1.9	10.7	68.3	10.6	0.4	1.0	0.0	1.1	1.6	0.0	0.4
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 21.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6;ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA		83000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	1.8	0.1	6.8	0.2	7.6	0.0	1.7	0.0	10.7	1.6	0.0	1.3	0.2	1.1	0.2	0.8	0.6	0.4	0.3	10.7	12.0	0.2	0.0	0.1	0.2	0.6	1.3	1.0	0.1	0.1	0.7	0.1	4.1	0.2	1.7	1.8	0.6	0.3	0.4	0.9	0.4	0.9	0.0	0.0	0.5	0.6	21.5	0.8	0.2	0.9	0.0	0.8	0.6	0.0	0.0	0.0	18.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.6	0.0	10.7	10.7	12.0	0.6	1.3	4.1	0.0	21.5	0.0	29.9	0.0	0.5	13.4	0.0	3.1	0.1	0.9	4.6	12.9	0.5	0.8	1.8	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	6.2	11.3	1.8	0.0	24.5	0.0	0.1	2.9	0.0	1.4	0.0	2.5	1.1	0.0	0.1	0.0	51.8	0.1	0.0	0.3	3.4	2.2	3.4	0.1	0.0	7.5	0.0	1.9	0.0	40.7	2.2	0.1	0.1	0.4	0.0	0.4	0.0	0.2	1.3	1.9	0.0	5.9	7.8	0.1	1.5	1.0	1.6	0.0	0.2	0.7	0.0	0.1
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Group enriched"	"Detected in many"	8	"Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4;RH-30: 120.4;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		340000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	1.8	3.2	10.5	5.2	14.6	0.0	3.0	0.0	33.7	23.9	0.0	19.2	3.2	16.9	25.1	14.3	9.7	8.1	19.1	23.7	50.1	2.0	1.0	2.9	1.4	13.0	14.3	4.7	0.9	1.1	0.2	0.2	14.3	10.6	7.8	3.4	0.8	18.2	0.6	11.6	5.0	22.1	3.9	18.6	11.4	1.0	46.3	1.4	4.1	0.4	1.2	16.3	5.9	11.8	0.0	1.1	14.4	20.1	29.5	28.5	0.0	3.8	0.0	1.9	0.9	1.9	26.5	0.0	0.1	0.2	0.0	15.3	1.3	38.5	3.4	0.0	43.4	0.1	26.8	0.0	30.4	0.6	0.0	17.2	8.8	1.0	10.7	17.5	7.5	0.0	0.0	0.0	9.0	0.1	0.0	0.1	8.8	9.3	4.0	0.0	120.4	0.0	0.9	65.2	0.9	0.2	0.4	1.2	1.3	8.2	1.8	6.9	0.0	24.1	6.2	6.7	0.0	0.0	0.0	0.0	18.8	0.1	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	14.6	0.0	33.7	23.7	50.1	13.0	14.3	14.3	3.9	46.3	11.8	1.1	0.0	0.0	311.8	0.3	85.0	92.4	25.7	46.7	46.8	0.7	9.0	83.2	0.0	13.7	64.4	0.0	0.1	0.0	0.3	0.0	0.6	16.9	66.8	8.4	7.6	0.0	0.0	1152.0	0.7	0.1	24.0	20.9	60.4	1.3	0.8	19.2	0.1	0.3	10.1	882.3	0.5	4.1	1.0	3.5	10.4	0.3	1.3	21.4	43.1	0.0	1.3	0.0	917.3	26.4	26.5	0.0	28.6	1.3	26.1	0.0	0.2	27.0	3.4	0.0	51.3	11.0	1.1	2.7	18.5	38.6	0.1	1.8	1.7	0.3	50.3
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 28.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.0	0.0	5.8	0.0	12.1	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	4.5	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	1.4	0.0	1.3	1.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	5.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	12.1	0.0	19.7	28.4	4.5	1.1	1.2	1.3	5.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.1	2.1	0.0	0.0	18.2	0.4	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	24.8	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	3.7	0.0	25.8	0.0	2.5	2.2	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.4	0.1	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.1
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;pituitary gland: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Hepatic stellate cells: 1.4;Sertoli cells: 6.6;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 9.1"	"Low region specificity"	"Detected in many"							HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.0	0.2	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.0	1.5	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	1.1	0.1	9.1	0.3	0.0	1.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.5	1.0	0.7	0.4	1.5	0.7	1.1	0.9	0.5	1.9	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 5.1;Bipolar cells: 11.4;Cone photoreceptor cells: 6.2;Horizontal cells: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.9;cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.1;hTCEpi: 3.4;PC-3: 5.1;RT4: 5.2;SH-SY5Y: 2.1"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No				"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	0.3	0.3	0.4	0.0	0.5	0.0	0.2	3.9	1.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.7	0.0	0.3	0.1	0.6	0.1	1.5	0.0	0.3	0.1	0.0	0.7	0.0	0.8	0.0	0.4	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	7.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.6	1.7	5.1	0.0	0.0	0.0	0.1	5.2	0.2	2.1	0.0	0.6	0.0	0.3	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.9	1.1	0.3	0.1	0.3	0.1	0.4	0.1	0.0	0.5	0.2	28.9	5.1	0.0	0.0	0.0	0.0	0.8	0.0	11.4	0.8	1.3	0.4	4.3	1.9	1.8	6.2	0.0	0.0	0.1	0.0	0.7	1.3	0.8	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.8	0.0	0.1	1.4	0.1	0.0	5.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	0.0	0.2	1.3	3.6	0.0	0.2	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PCDHA2		ENSG00000204969	"Protocadherin alpha 2"	Q9Y5H9	5	140794852-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;pituitary gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.9;SH-SY5Y: 1.2;T-47d: 1.2;WM-115: 1.0"	"Low region specificity"	"Detected in all"							HPA035653	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"			"HPA035653: AB_10670969"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.39e-3)"	"unprognostic (4.61e-2)"			"unprognostic (4.16e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.35e-3)"	"unprognostic (5.64e-6)"	"unprognostic (2.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.42e-1)"	0.1	0.1	0.4	0.0	0.5	0.0	0.2	1.8	0.4	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.8	0.6	0.4	0.4	0.0	1.8	0.0	0.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.1	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.2	0.1	0.2	1.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.8	0.4	0.3	0.2	0.8	0.6	0.5	0.4	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4"	"Not detected"	"Not detected"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.2	0.2	0.9	0.2	1.2	0.9	0.4	2.9	1.1	0.5	0.0	0.3	0.3	0.6	0.4	0.1	0.3	1.3	0.1	0.9	0.5	0.4	0.1	0.4	0.3	0.6	0.5	0.2	1.2	0.1	0.4	0.1	0.6	0.4	0.2	0.9	0.2	0.3	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.4	0.4	0.1	0.3	0.1	0.2	0.2	0.1	1.5	0.1	6.6	5.6	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	1.1	0.1	5.1	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.1	0.2	0.3	0.3	1.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.1	0.1	0.1	0.2	1.7	1.2	0.9	0.1	0.1	0.2	0.1	0.2	0.2	2.3	0.0	1.4	0.5	0.8	5.4	0.1	0.6	1.2	0.8	0.5	0.1	0.3	0.1	0.1	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.9	1.2	2.9	1.1	0.9	0.5	0.6	0.5	0.6	0.3	0.4	1.5	0.1	3.2	2.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.3	0.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	2.9	1.1	0.0	0.4	0.5	1.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.4
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 3.3"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;EFO-21: 3.4;T-47d: 3.7;WM-115: 1.3"	"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.1	0.1	0.6	0.0	1.0	0.0	0.1	3.3	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.0	3.3	1.1	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA6	"CNR2, CNRS2, CRNR2, PCDH-ALPHA6"	ENSG00000081842	"Protocadherin alpha 6"	Q9UN73	5	140827958-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;EFO-21: 8.4;hTERT-RPE1: 2.2;U-2 OS: 3.4;WM-115: 5.2"	"Low region specificity"	"Detected in many"							"HPA059326, HPA078110"	Enhanced		Approved	Vesicles	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA059326: AB_2683980, HPA078110: AB_2732371"	"unprognostic (1.15e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-4)"	"unprognostic (4.23e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.56e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.55e-2)"	0.2	0.3	0.8	0.1	0.9	0.0	0.3	4.1	1.1	0.4	0.0	0.1	0.2	0.6	0.3	0.0	0.3	0.3	0.1	1.0	0.7	0.4	0.0	0.2	0.1	0.4	0.3	0.4	1.0	1.5	1.5	0.0	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.1	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.5	1.0	0.1	0.4	0.0	1.3	0.0	3.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	4.1	1.1	1.0	0.7	0.4	0.3	0.5	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA8		ENSG00000204962	"Protocadherin alpha 8"	Q9Y5H6	5	140841187-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 12.6;SCLC-21H: 3.6"									HPA044585	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA044585: AB_10793953"	"unprognostic (1.11e-2)"			"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"			"unprognostic (1.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.87e-4)"	"unprognostic (5.62e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.20e-2)"		0.0	0.1	0.4	0.0	0.5	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.6	0.6	0.3	0.2	0.6	0.2	0.4	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051374-141059346	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.9	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.1	0.4	0.2	0.3	0.1	0.1	0.2	0.4	0.3	0.1	0.4	0.3	0.5	0.1	0.4	0.1	0.0	0.5	0.2	0.0	1.4	0.3	0.2	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.9	0.5	0.4	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.0	0.0	1.1	0.0	0.4	0.0	0.9	0.0	0.0	0.3	0.1	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.2	0.4	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7
PCDHB10		ENSG00000120324	"Protocadherin beta 10"	Q9UN67	5	141192353-141195647	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.9;Endometrial stromal cells: 3.4;Endothelial cells: 3.2;Enteroendocrine cells: 4.2;granulocytes: 4.5;Peritubular cells: 4.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.6;ASC TERT1: 6.4;EFO-21: 14.1;U-2197: 7.0"									HPA013445	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"			"HPA013445: AB_1855054"	"unprognostic (1.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.40e-3)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-3)"	1.4	1.8	2.1	0.5	1.9	0.0	1.7	1.1	2.7	2.3	0.0	2.6	0.5	3.4	1.6	0.8	1.8	1.5	1.6	2.4	0.9	0.7	0.2	1.4	0.3	1.6	2.5	2.5	0.7	1.3	3.6	0.7	1.5	1.6	0.7	1.5	1.1	1.5	0.5	0.9	0.8	3.1	1.2	0.6	0.9	0.7	2.6	0.2	0.9	0.7	0.1	1.6	1.4	2.1	0.0	0.0	3.9	3.7	6.6	6.4	0.2	0.4	3.6	0.1	0.3	0.0	0.3	0.1	14.1	1.0	2.9	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.7	2.5	0.0	0.0	3.5	0.3	0.0	0.0	4.3	1.3	0.1	0.1	0.1	0.1	0.0	0.2	0.8	2.4	0.0	0.5	0.0	2.6	5.4	4.4	0.1	0.6	0.4	2.9	0.2	1.4	3.6	2.0	7.0	1.0	0.0	0.0	0.0	4.4	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.9	1.1	2.7	2.4	0.9	1.6	2.5	1.5	1.2	2.6	2.1	2.6	0.0	0.5	0.0	0.0	0.0	0.1	1.5	0.0	8.9	0.5	0.9	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	3.4	3.2	4.2	0.0	0.0	0.9	0.0	2.1	0.0	0.2	4.5	0.2	1.4	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	2.9	1.6	1.9	0.6	0.2	0.4	0.1	0.1	0.3	0.0	0.3
PCDHB11	"ME2, PCDH-BETA11"	ENSG00000197479	"Protocadherin beta 11"	Q9Y5F2	5	141199610-141203779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 4.9;Endometrial stromal cells: 3.5;Fibroblasts: 4.8;Peritubular cells: 3.4;Sertoli cells: 6.6;Skeletal myocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.6;EFO-21: 8.9;U-2 OS: 3.0"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.32e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.47e-3)"	1.3	0.6	0.2	0.5	0.5	0.2	0.9	0.9	1.2	1.2	0.0	1.0	0.2	1.5	0.5	0.7	0.9	0.9	0.8	0.5	0.0	0.7	0.2	0.8	0.1	0.3	0.3	1.6	2.6	2.6	0.7	0.6	0.1	0.9	0.3	0.6	0.8	1.0	0.4	0.8	0.4	1.2	0.4	0.6	0.6	0.4	0.0	0.3	0.6	0.6	0.1	0.9	0.6	0.4	0.0	0.1	1.8	5.6	0.1	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.9	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.8	0.0	0.1	0.0	1.4	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.0	2.2	0.0	0.0	0.2	2.2	0.3	1.3	0.1	0.7	0.3	1.3	0.0	0.3	0.1	3.0	2.4	0.0	0.1	0.0	0.0	1.4	0.1	1.5	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.9	1.2	0.5	0.0	0.3	0.3	0.1	0.4	0.0	0.4	1.9	3.2	0.5	0.0	0.0	0.0	0.7	0.0	0.0	4.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	3.5	1.9	2.4	0.0	0.0	1.8	0.0	4.8	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	3.4	0.1	0.9	0.0	0.9	0.0	0.2	6.6	4.1	1.7	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.7
PCDHB12	PCDH-BETA12	ENSG00000120328	"Protocadherin beta 12"	Q9Y5F1	5	141208697-141212571	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.0;Endometrial stromal cells: 2.8;Fibroblasts: 2.8;Melanocytes: 3.6;Peritubular cells: 2.6;Skeletal myocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;ASC diff: 2.5;EFO-21: 3.0;RH-30: 3.2;U-2 OS: 2.3;U-2197: 2.4"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.43e-2)"	"unprognostic (3.22e-3)"	"unprognostic (4.18e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.22e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.41e-3)"	1.3	0.6	0.1	0.4	0.7	0.0	1.2	0.9	1.1	1.9	0.0	1.3	0.2	2.7	0.8	0.4	1.9	1.0	1.4	0.8	0.1	0.6	0.3	1.4	0.1	0.3	0.3	2.2	1.3	1.0	2.0	0.4	0.0	0.9	0.4	0.8	0.6	0.9	0.7	0.5	0.6	1.8	0.1	0.7	0.6	1.1	0.1	0.1	0.6	0.9	0.1	1.2	1.1	0.7	0.0	0.0	0.7	2.7	2.5	1.4	0.4	0.0	1.9	0.1	0.2	0.0	0.0	0.0	3.0	0.3	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.7	0.1	0.0	0.0	0.1	0.0	0.5	0.5	3.2	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.6	0.2	2.1	0.4	0.2	0.4	2.3	2.4	0.0	0.0	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.9	1.1	0.8	0.1	0.3	0.3	0.0	0.1	0.1	0.7	1.9	0.0	1.1	0.0	0.0	0.4	0.0	0.2	0.0	4.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.8	0.1	2.8	1.3	1.8	0.0	0.0	0.9	0.0	2.8	0.5	0.1	0.0	0.1	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	2.2	1.6	1.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0
PCDHB14	PCDH-BETA14	ENSG00000120327	"Protocadherin beta 14"	Q9Y5E9	5	141223343-141227759	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.1;Early spermatids: 8.1;Horizontal cells: 13.5;Peritubular cells: 8.6;Spermatocytes: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.4;SiHa: 12.0;U-2197: 8.5"	"Low region specificity"	"Detected in all"							"HPA007692, HPA045248"	Uncertain		Approved	Vesicles		NA	NA		39000		"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007692: AB_2667896, HPA045248: AB_10959599"	"unprognostic (2.57e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.90e-2)"	3.1	2.8	2.3	0.8	3.2	0.1	3.5	2.1	4.0	6.0	0.0	4.6	0.3	7.0	2.4	2.0	4.3	1.9	4.4	2.6	1.3	2.1	1.2	3.0	0.4	1.5	2.3	4.7	4.0	3.6	6.2	1.1	0.7	3.1	0.9	2.3	3.6	1.9	1.6	4.4	1.6	2.6	1.6	2.0	1.9	2.5	3.1	0.4	2.2	1.5	0.3	3.5	3.5	3.3	0.0	0.0	3.3	6.3	5.4	6.4	0.4	0.5	5.5	0.5	1.7	0.1	1.0	0.3	4.5	1.5	2.9	0.3	0.7	1.0	0.5	0.0	0.1	0.0	1.3	0.1	0.2	0.3	0.2	1.2	4.7	0.1	0.2	4.8	0.6	0.2	0.0	5.8	2.3	0.5	0.4	0.0	0.4	0.0	1.1	3.8	4.1	0.0	0.1	0.2	7.6	14.4	12.0	0.3	1.3	0.5	6.1	0.5	1.7	2.2	1.9	8.5	2.2	0.0	0.1	0.1	4.5	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.2	2.1	4.0	2.6	1.3	1.5	2.3	0.7	1.6	3.1	3.3	4.1	0.0	4.8	0.0	0.0	0.4	1.1	3.1	0.0	15.1	1.6	2.4	3.3	0.0	3.1	1.8	0.0	0.0	0.2	0.3	0.0	0.9	8.1	0.8	6.3	3.9	3.5	0.0	0.0	2.4	0.0	5.0	0.0	0.9	0.0	1.3	3.3	1.3	0.1	13.5	0.0	0.6	4.1	0.0	0.7	2.1	3.4	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.5	8.6	0.0	0.5	0.0	0.8	0.6	1.3	0.0	6.3	3.9	8.0	0.1	0.7	2.8	0.0	0.2	2.5	0.3	0.7
PCDHB15	PCDH-BETA15	ENSG00000113248	"Protocadherin beta 15"	Q9Y5E8	5	141245395-141249365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.3;Bipolar cells: 4.4;Early spermatids: 7.5;Endometrial stromal cells: 4.4;Fibroblasts: 3.7;Horizontal cells: 5.0;Skeletal myocytes: 4.2;Smooth muscle cells: 4.1;Spermatocytes: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;LHCN-M2: 4.9;WM-115: 4.9"	"Low region specificity"	"Detected in all"							"HPA007172, CAB026471, HPA074676"	Uncertain		Approved	Mitochondria		NA	NA		250000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	3.8	1.4	1.9	2.5	2.1	0.0	2.6	4.2	2.4	6.4	0.0	3.8	0.5	6.8	2.5	1.4	5.0	2.1	4.4	1.8	1.6	2.1	1.1	3.7	0.7	3.0	2.5	7.4	3.3	0.8	3.5	1.5	2.0	2.4	0.9	2.0	1.7	2.0	1.3	1.3	1.8	4.1	2.5	2.5	2.1	5.4	2.3	0.3	2.7	1.4	0.5	3.6	3.2	2.4	0.2	0.0	6.2	0.7	1.5	1.6	0.1	0.4	1.2	0.1	0.3	0.0	0.3	0.0	1.2	0.9	1.6	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.7	1.3	0.0	0.2	1.6	0.3	0.0	0.0	1.0	4.9	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.7	0.0	0.4	0.1	0.3	0.8	0.3	0.3	1.6	0.8	0.3	0.0	0.0	0.6	0.6	2.2	0.0	0.1	0.8	0.0	0.8	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	4.2	2.4	1.8	1.6	3.0	2.5	2.0	2.5	2.3	2.4	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	4.4	0.2	0.3	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	7.5	0.2	4.4	2.4	0.0	0.0	0.0	1.5	0.0	3.7	0.5	0.2	0.0	0.6	1.4	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.9	0.1	3.4	0.0	0.1	0.0	0.7	0.1	0.8	0.0	4.2	4.1	4.8	0.7	0.2	0.6	0.0	0.1	0.5	0.1	0.3
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094606-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Endometrial stromal cells: 7.2;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 51.0;EFO-21: 28.7;U-138 MG: 22.2"	"Low region specificity"	"Detected in many"							HPA007548	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA007548: AB_2667859"	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.84e-4)"	2.7	0.9	0.7	0.4	1.2	0.1	2.6	0.9	2.6	1.8	0.0	2.3	0.6	2.3	0.6	0.9	1.3	1.4	1.9	2.4	1.0	1.0	0.2	2.2	0.2	0.9	0.9	1.7	1.0	0.1	1.8	0.7	0.7	1.5	0.9	1.4	1.7	0.4	1.0	2.0	0.9	1.4	0.9	0.6	0.8	5.5	0.8	0.2	1.3	1.3	0.1	1.2	1.3	1.8	0.4	3.4	23.7	51.0	6.7	3.1	10.8	0.9	3.7	0.0	0.0	0.6	0.2	0.9	28.7	1.7	5.6	0.0	1.2	0.3	0.0	0.3	0.8	0.0	0.1	6.9	0.0	0.0	2.4	1.6	0.0	0.0	0.4	1.0	0.5	2.9	0.8	0.7	7.1	0.2	6.9	0.0	10.5	0.3	6.7	0.0	17.6	0.2	2.6	0.0	13.1	3.6	0.0	3.4	7.6	13.2	14.6	4.3	2.8	22.2	6.6	10.5	3.4	0.3	0.1	0.2	4.8	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	2.6	2.4	1.0	0.9	0.9	0.7	0.9	0.8	1.8	5.1	0.0	0.5	0.0	0.0	0.8	1.1	0.6	4.0	3.1	1.8	1.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.6	2.1	7.2	2.5	1.2	0.0	0.0	0.4	0.0	3.7	0.5	1.3	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.3	1.0	1.2	0.1	3.6	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	1.5	0.0	0.8	0.0	0.3	0.8	1.4	0.0	3.0	1.9	9.9	4.0	0.7	0.4	0.0	0.1	0.1	0.1	0.7
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.8;Cone photoreceptor cells: 2.1;Endometrial stromal cells: 2.6;Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;HAP1: 3.5;SH-SY5Y: 15.2;U-138 MG: 5.3"	"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050296: AB_2681078"	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	1.8	1.2	0.4	0.7	1.1	0.0	1.7	0.6	1.5	1.2	0.0	0.9	0.3	1.5	0.7	0.3	0.9	0.8	1.1	1.0	0.2	1.1	0.1	1.1	0.1	0.3	0.5	1.6	1.2	1.7	1.8	0.4	0.1	1.4	0.5	1.0	0.7	0.5	0.7	0.7	0.5	1.0	0.2	0.4	0.5	3.6	0.6	0.0	0.7	0.9	0.1	0.8	0.9	0.8	0.0	0.0	1.1	3.1	1.9	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.2	1.7	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.6	15.2	0.0	0.1	0.0	0.5	1.9	0.1	0.0	5.3	0.7	0.5	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.6	1.5	1.0	0.2	0.3	0.5	0.1	0.2	0.6	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.9	0.8	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.3	0.8	0.4	2.6	1.1	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	1.8	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.1	0.0	0.3	0.0	1.7	1.1	1.8	0.7	0.1	0.3	0.0	0.0	0.4	0.0	0.3
PCDHB4	PCDH-BETA4	ENSG00000081818	"Protocadherin beta 4"	Q9Y5E5	5	141121818-141125623	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.7;SH-SY5Y: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014466	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA014466: AB_1855058"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.03e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-4)"	"unprognostic (5.18e-3)"	3.2	2.1	2.7	0.7	3.0	0.0	3.4	3.3	3.7	3.6	0.3	2.0	0.6	5.4	3.8	1.5	4.0	2.4	2.3	3.2	4.2	1.5	0.3	2.1	0.4	5.0	3.7	4.2	8.5	1.4	2.7	0.1	5.7	2.4	0.9	1.6	2.1	1.9	1.6	1.3	0.9	3.3	5.0	0.7	1.3	0.5	2.7	0.4	1.5	2.1	0.2	2.1	2.1	6.7	0.0	0.0	0.3	1.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.7	5.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	3.0	3.3	3.7	3.2	4.2	5.0	3.7	5.7	5.0	2.7	6.7	9.7	0.0	0.5	0.0	0.0	1.1	0.4	0.2	0.6	4.9	2.6	3.8	1.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	8.2	4.3	0.0	0.0	0.0	1.7	0.0	9.5	0.0	0.3	0.0	0.1	3.6	0.0	0.1	8.4	0.0	0.0	2.0	0.0	1.1	0.0	1.5	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.0	6.4	0.0	0.7	0.0	0.0	2.5	0.6	0.0	8.7	4.0	1.4	0.5	0.0	2.0	0.0	0.0	0.5	0.0	0.4
PCDHB5	"DKFZp586B0217, PCDH-BETA5"	ENSG00000113209	"Protocadherin beta 5"	Q9Y5E4	5	141135206-141138615	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7"	"Low region specificity"	"Detected in many"							"HPA013191, HPA067473"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Vesicles	"HPA013191: AB_1855059, HPA067473: "	"unprognostic (2.21e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-3)"	1.4	1.6	2.2	0.4	1.7	0.0	1.6	1.1	3.2	3.4	0.0	1.4	0.2	4.2	3.5	0.7	2.8	1.8	1.9	2.8	0.6	2.4	0.7	1.7	0.2	2.5	1.6	5.9	4.7	2.7	3.2	0.4	1.3	2.9	0.3	2.4	2.2	2.1	1.1	0.6	0.6	2.1	1.7	0.7	1.0	3.1	1.8	0.4	2.5	0.6	0.1	1.6	1.3	2.3	0.0	1.0	18.7	0.3	1.3	0.8	0.2	0.4	0.1	0.3	0.3	0.0	0.0	0.0	9.6	0.0	13.9	0.0	9.8	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	3.8	0.9	0.0	0.7	0.1	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	14.0	0.0	0.0	0.0	16.4	0.5	0.0	0.2	6.1	21.7	17.6	4.3	0.0	32.4	14.1	5.3	0.0	0.0	0.0	0.0	1.7	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	1.1	3.2	2.8	0.6	2.5	1.6	1.3	1.7	1.8	2.3	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.6	5.2	0.9	2.2	1.1	1.5	1.8	1.8	0.0	0.0	0.0	0.0	0.0	2.5	8.2	0.5	4.3	1.1	0.0	0.0	0.0	3.6	0.0	1.5	0.0	0.2	0.0	0.5	0.4	0.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.8	3.1	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	2.2	0.0	4.5	0.0	1.1	0.0	0.5	0.1	0.7	0.0	2.1	2.7	13.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.6
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150057-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5"	"Low region specificity"	"Detected in many"							"HPA029566, HPA075308"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA029566: AB_10601385, HPA075308: "	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	0.8	0.7	0.9	0.2	0.9	0.0	1.1	0.4	1.6	1.2	0.0	0.7	0.0	1.9	1.1	0.2	1.0	0.3	0.7	1.4	0.3	0.6	0.1	0.7	0.1	0.8	0.7	1.2	0.5	1.8	1.0	0.4	0.8	0.5	0.1	0.9	0.7	0.3	0.4	0.7	0.3	0.9	0.6	0.2	0.4	1.9	0.8	0.1	0.4	0.3	0.1	0.7	0.7	1.3	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.1	0.0	0.1	3.7	0.4	5.4	2.3	0.0	0.6	1.2	7.6	0.0	0.0	0.0	0.0	3.8	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	1.6	1.4	0.3	0.8	0.7	0.8	0.6	0.8	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.7	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.5	0.8	7.6	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172644-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 38.4;Late spermatids: 27.3;Spermatocytes: 24.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.9;EFO-21: 4.8;U-138 MG: 3.2;U-2197: 9.6;U-87 MG: 3.3;WM-115: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059271	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA059271: AB_2683962"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	1.7	0.7	0.5	0.9	0.6	0.0	2.0	0.6	1.6	2.9	0.0	1.5	0.4	4.5	1.6	0.3	2.6	1.5	1.6	1.0	0.7	1.0	0.3	2.0	0.2	1.7	1.2	2.3	0.4	0.3	2.4	0.2	1.2	1.1	0.4	1.4	0.6	1.0	0.4	0.7	0.8	3.1	0.9	0.7	0.7	2.0	0.6	0.2	1.0	0.6	0.2	1.3	1.5	1.0	0.0	0.0	0.4	0.4	3.9	1.9	0.0	0.2	0.5	0.1	0.1	0.0	0.1	0.0	4.8	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	1.4	1.0	0.3	0.0	0.8	0.0	2.1	0.0	0.7	3.2	0.6	9.6	0.1	0.0	0.0	0.0	3.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.6	1.0	0.7	1.7	1.2	1.2	0.9	0.6	1.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	4.9	0.2	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	38.4	0.3	2.4	1.1	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.0	6.1	0.0	0.0	27.3	0.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.3	6.6	3.4	2.1	24.5	0.7	0.0	0.9	0.1	0.0	0.3	0.0	0.0
PCDHB8	"PCDH-BETA8, PCDH3I"	ENSG00000120322	"Protocadherin beta 8"	Q9UN66	5	141177790-141180539	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Early spermatids: 5.0;Spermatocytes: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;T-47d: 31.4;U-138 MG: 12.1;U-2197: 34.2"									HPA057773	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA057773: AB_2683525"	"unprognostic (1.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.82e-4)"	"unprognostic (3.54e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.30e-4)"	0.8	0.5	0.2	0.2	0.5	0.0	0.5	0.1	1.8	0.6	0.0	0.4	0.1	1.3	0.7	0.3	0.5	0.6	0.6	1.0	0.0	0.4	0.1	0.6	0.0	0.6	0.5	0.9	0.5	1.0	0.8	0.2	0.4	0.4	0.2	0.8	0.3	0.3	0.1	0.4	0.1	0.7	0.2	0.2	0.2	1.1	0.7	0.0	0.2	0.3	0.0	0.3	0.3	1.0	0.0	0.0	0.1	1.3	3.8	2.4	0.2	0.2	7.7	0.0	0.1	0.0	0.0	0.0	20.9	0.1	7.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.2	0.4	0.0	0.0	1.3	0.0	0.3	0.1	1.7	6.2	0.2	0.0	0.0	0.0	0.0	0.5	0.1	8.4	0.0	0.1	0.0	6.0	1.6	0.1	0.0	1.1	0.0	31.4	0.0	0.9	12.1	6.0	34.2	0.0	0.0	0.0	0.0	3.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	1.8	1.0	0.0	0.6	0.5	0.4	0.2	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1
PCDHB9	"PCDH-BETA9, PCDH3H"	ENSG00000177839	"Protocadherin beta 9"	Q9Y5E1	5	141187127-141191541	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Bipolar cells: 20.2;Horizontal cells: 10.1;Skeletal myocytes: 6.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 10.3;ASC TERT1: 9.4;SH-SY5Y: 14.3"									HPA013445	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA013445: AB_1855054"	"unprognostic (1.85e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.01e-2)"	1.0	0.8	0.6	0.1	1.0	0.1	1.2	1.1	1.9	1.5	0.0	1.1	0.1	2.0	1.8	0.3	1.3	0.7	1.1	1.4	0.2	0.5	0.2	1.1	0.1	0.3	0.6	2.0	0.7	1.1	2.4	0.5	0.4	0.6	0.2	1.2	1.0	0.3	0.4	0.8	0.4	1.2	0.3	0.3	0.5	0.8	0.9	0.2	0.6	1.0	0.1	0.8	0.9	0.9	0.0	0.0	0.9	6.0	10.3	9.4	0.2	0.1	3.5	0.4	0.5	0.0	1.0	0.4	3.9	0.2	2.8	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.9	0.0	0.0	1.8	0.0	0.1	0.0	2.7	3.1	0.9	0.6	0.7	0.3	0.0	0.4	2.8	5.4	0.0	0.6	0.1	2.1	14.3	0.6	0.1	1.0	0.4	2.6	0.2	0.9	5.2	0.5	4.7	1.2	0.0	0.0	0.0	3.1	0.2	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	1.0	1.1	1.9	1.4	0.2	0.3	0.6	0.4	0.3	0.9	0.9	1.8	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.5	1.4	0.2	1.5	1.3	1.8	0.0	0.0	0.0	0.2	0.0	0.4	1.0	0.2	2.8	1.3	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.1	0.0	0.0	1.8	0.2	0.1	10.1	0.0	0.1	0.0	0.3	0.0	0.4	1.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.0	1.9	0.0	0.2	0.0	0.3	0.0	0.7	0.0	6.3	1.8	1.0	0.2	0.3	0.0	0.0	0.1	0.3	0.0	0.1
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	0.3	0.2	1.1	0.2	2.3	0.2	0.2	3.2	2.0	0.5	0.0	0.5	0.2	0.6	0.9	0.2	0.4	0.1	1.2	2.2	0.9	0.2	0.1	0.3	0.1	1.5	1.4	0.6	0.5	0.5	0.9	0.5	0.9	0.3	0.2	1.0	0.2	0.2	0.7	0.3	0.1	0.4	1.7	0.2	0.1	0.7	1.4	0.1	0.2	0.4	0.1	0.4	0.3	1.3	0.0	0.2	0.3	1.1	0.7	1.3	0.1	1.1	0.7	0.3	0.6	0.3	0.1	0.2	1.8	0.7	0.5	0.1	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	1.1	0.3	0.0	0.4	2.1	0.0	0.1	0.1	0.5	4.5	0.0	0.1	0.5	0.1	0.0	0.2	2.0	1.6	0.2	0.2	0.2	1.0	1.3	0.1	0.6	1.1	0.3	7.3	0.2	0.5	2.0	0.3	1.0	0.2	0.1	0.6	0.1	2.4	0.1	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	2.3	3.2	2.0	2.2	0.9	1.5	1.4	0.9	1.7	1.4	1.3	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	1.6	1.6	3.5	0.4	3.2	0.1	1.1	4.1	2.4	1.3	0.8	1.0	0.8	1.3	0.7	1.7	1.3	1.4	1.0	2.7	3.8	0.5	1.5	1.3	0.4	3.3	3.1	1.3	0.6	2.1	0.8	3.6	3.4	1.4	0.9	2.5	1.8	1.8	1.1	2.0	1.0	1.1	4.2	0.9	2.0	0.5	3.9	0.4	2.1	0.3	0.5	0.8	1.3	3.8	0.0	0.0	14.6	7.5	6.3	2.7	6.9	2.6	0.1	3.6	5.6	0.3	0.9	0.8	9.6	3.7	0.2	0.4	3.5	2.4	2.8	0.9	0.1	0.0	0.3	0.0	2.5	1.5	0.3	16.1	0.4	2.4	1.0	0.4	1.4	0.3	0.0	0.1	9.0	0.1	0.1	0.4	1.4	0.0	0.1	0.2	1.2	0.0	2.4	0.1	2.0	0.7	0.4	0.1	0.4	3.5	19.7	1.9	3.3	6.7	0.4	11.6	0.1	0.2	1.2	0.1	3.4	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	3.2	4.1	2.4	2.7	3.8	3.3	3.1	3.4	4.2	3.9	3.8	5.8	0.0	2.0	0.0	0.9	0.1	2.3	0.6	1.2	27.7	2.2	2.2	3.4	1.5	1.6	1.8	16.7	2.1	1.3	0.7	0.0	1.0	0.0	1.3	7.7	4.8	1.2	0.4	0.0	1.4	1.3	4.8	1.5	2.0	1.3	1.0	4.6	1.7	1.0	23.5	0.0	1.6	0.0	0.0	0.0	0.2	3.4	0.7	1.8	0.0	0.0	5.7	0.0	0.0	0.0	3.1	0.4	2.2	0.5	2.8	0.4	0.5	0.0	6.7	6.6	14.9	3.7	0.4	0.7	1.2	0.4	0.4	0.5	3.0	1.3	1.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512975	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	0.8	0.7	1.4	0.7	1.8	0.0	0.6	5.1	1.3	0.8	0.7	1.0	0.2	0.7	0.3	0.7	0.9	0.5	1.6	2.1	2.3	0.5	0.4	0.6	0.4	1.8	1.2	1.1	0.5	0.3	0.6	2.2	2.1	0.5	0.3	3.1	0.7	0.7	1.1	1.7	0.4	0.8	2.4	0.3	0.4	0.8	1.9	0.3	0.8	0.5	0.3	0.6	0.8	2.9	0.0	0.0	0.7	2.4	24.3	25.9	0.9	5.5	10.6	4.2	6.6	0.1	0.2	0.6	9.1	5.6	47.4	3.7	0.1	0.6	6.6	0.2	2.4	0.1	0.1	0.0	4.0	0.4	0.0	19.0	0.3	7.4	0.1	69.8	6.5	1.2	0.0	0.1	0.1	0.0	0.0	0.3	2.9	0.0	0.1	17.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	9.9	0.5	3.2	7.9	0.8	0.1	0.6	0.1	0.0	0.4	0.0	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	1.8	5.1	1.3	2.1	2.3	1.8	1.2	2.1	2.4	1.9	2.9	0.5	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.1	0.5	0.8	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.2	1.1	0.0	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430507-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0"	"Group enriched"	"Detected in many"	5	"glioma: 1.7;melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	3.0	4.3	5.3	0.8	6.8	0.0	1.5	5.5	3.7	2.0	0.8	1.3	0.2	2.6	0.4	1.0	1.9	3.9	4.2	5.1	8.4	1.0	0.7	3.1	0.4	10.0	4.2	1.9	1.1	0.3	1.4	2.2	4.5	1.0	0.3	1.4	0.9	1.5	1.3	1.7	0.8	1.7	5.5	1.2	1.0	0.3	5.2	0.9	1.6	1.1	0.4	1.2	2.0	4.6	0.0	0.0	0.1	1.9	0.8	1.4	0.1	9.3	15.4	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	4.5	0.0	0.0	5.4	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.6	7.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	6.8	5.5	3.7	5.1	8.4	10.0	4.2	4.5	5.5	5.2	4.6	2.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.8	0.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	2.2	0.0	0.0	0.0	0.2	0.0	3.2	1.1	0.1	0.0	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.7	0.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	2.2	1.6	1.8	0.7	1.4	0.0	1.9	2.7	2.5	3.0	0.7	1.5	0.1	2.9	1.9	0.8	3.1	1.4	4.9	2.9	1.5	1.1	0.7	2.0	0.2	3.8	3.2	6.3	1.8	3.8	2.6	0.7	2.6	1.9	0.3	2.3	1.2	2.2	1.0	1.0	0.6	2.1	3.5	0.6	0.9	2.3	2.6	0.8	1.6	1.1	0.2	1.4	1.7	2.2	0.0	0.7	0.3	0.2	2.8	6.4	0.0	3.9	1.3	0.3	0.5	0.0	0.0	0.1	0.4	4.4	0.5	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.4	0.1	0.0	0.2	3.9	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.5	0.0	0.2	0.5	0.0	2.3	0.1	0.3	0.4	0.0	2.3	0.6	0.3	0.2	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.4	2.7	2.5	2.9	1.5	3.8	3.2	2.6	3.5	2.6	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.3	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.1	0.9	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.1;BJ: 2.3;EFO-21: 5.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	1.2	1.2	2.6	0.2	1.7	0.0	0.9	2.2	2.6	1.6	0.1	0.7	0.0	1.4	0.9	0.2	1.2	0.9	3.7	2.5	1.8	0.5	0.6	0.9	0.0	3.8	2.9	2.5	0.9	0.6	1.2	1.7	2.2	0.7	0.2	1.8	0.7	0.8	0.8	0.5	0.2	0.9	3.4	0.2	0.4	1.5	2.9	0.2	0.8	0.9	0.1	0.8	0.9	2.5	0.0	0.0	7.1	0.0	0.0	0.9	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	2.2	2.6	2.5	1.8	3.8	2.9	2.2	3.4	2.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355021-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Skeletal myocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	1.7	1.3	1.6	0.4	1.8	0.0	0.9	3.7	1.7	1.3	0.0	0.9	0.2	1.6	0.8	0.4	0.9	0.8	1.5	2.9	1.5	0.4	0.3	1.0	0.1	2.1	2.4	1.6	2.1	2.3	1.0	0.8	1.7	1.1	0.3	1.5	0.8	1.1	0.7	0.5	0.3	1.5	2.0	0.3	0.4	0.7	2.1	0.2	0.7	1.0	0.1	0.7	0.8	2.5	0.0	0.1	0.8	0.4	3.3	7.4	0.0	4.3	3.4	0.2	0.8	0.0	0.1	0.7	1.4	3.7	1.3	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.3	4.3	0.1	0.0	0.0	2.6	4.3	0.0	0.1	0.2	1.8	0.6	0.2	0.2	0.1	0.0	0.2	0.3	1.2	0.1	0.2	0.0	0.6	1.3	0.2	0.2	0.9	0.3	1.6	0.0	2.8	1.8	0.5	2.4	0.3	0.1	0.2	0.1	6.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	3.7	1.7	2.9	1.5	2.1	2.4	1.7	2.0	2.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373891-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	1.4	1.1	1.6	0.7	1.8	0.1	1.3	7.2	1.6	2.7	0.0	2.0	0.2	3.2	1.4	0.8	2.0	1.1	2.7	1.7	1.8	0.8	0.5	1.5	0.4	1.8	1.7	3.5	1.2	1.1	1.8	2.3	0.9	1.2	0.4	2.0	1.5	1.6	0.9	1.5	0.8	2.0	0.8	0.9	0.7	0.8	2.0	0.5	1.2	1.0	0.4	1.6	1.5	1.9	0.0	0.3	2.7	0.4	1.3	4.7	0.1	2.1	0.7	1.1	1.1	0.0	0.1	2.0	2.6	3.3	1.0	0.4	0.1	0.4	0.7	0.0	0.2	0.0	0.3	0.2	0.7	0.1	0.1	4.9	0.3	0.2	0.1	1.0	1.6	0.1	0.2	1.1	0.3	0.4	0.7	1.7	0.3	0.0	0.1	1.4	0.4	0.0	0.3	0.1	9.6	0.7	0.1	0.3	0.6	0.6	5.6	0.1	4.8	0.7	0.3	0.7	0.7	0.4	1.7	0.4	0.8	0.7	12.2	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.6	1.8	7.2	1.6	1.7	1.8	1.8	1.7	0.9	0.8	2.0	1.9	2.8	0.0	2.2	0.0	0.4	0.0	0.8	0.0	0.0	10.6	0.3	1.0	5.0	1.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.5	0.4	4.6	1.8	0.0	0.4	0.0	1.5	0.1	2.2	0.0	0.4	0.0	0.6	3.6	0.7	0.1	1.7	0.0	0.2	0.0	0.3	0.0	0.3	1.2	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.1	2.2	1.6	0.4	0.0	0.3	0.7	0.9	0.0	5.2	1.9	0.3	0.3	0.5	0.0	0.3	0.2	0.5	0.2	0.2
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	0.5	0.4	1.0	0.2	0.9	0.0	0.6	5.9	1.0	1.2	0.0	1.1	0.1	1.3	1.1	0.5	1.0	0.4	1.5	1.1	0.6	0.6	0.4	0.7	0.1	1.5	1.2	1.5	0.7	2.2	0.8	1.3	0.9	0.9	0.3	1.6	0.8	0.8	0.7	1.0	0.4	0.8	1.0	0.4	0.3	0.5	1.3	0.2	1.9	0.5	0.1	0.9	0.7	1.5	0.0	1.6	2.3	0.0	6.6	11.3	0.0	3.3	20.8	4.2	6.1	0.0	0.0	0.5	5.2	0.7	0.2	0.2	0.0	0.1	3.4	0.0	0.3	0.0	0.4	0.2	1.1	0.0	0.0	5.0	0.1	0.0	0.7	10.9	1.7	0.0	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.4	18.6	0.0	0.1	0.1	3.7	8.1	0.0	6.7	0.1	0.1	3.1	0.1	0.1	1.9	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.9	1.0	1.1	0.6	1.5	1.2	0.9	1.0	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.3	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	2.8	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.1	0.1	0.6	0.1	0.6	0.4	0.1	3.9	0.8	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.8	0.5	0.0	0.1	0.1	0.1	1.1	0.7	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.3	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.9	0.1	0.4	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.2	0.6	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.6	0.2	0.4	0.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.6	3.9	0.8	0.8	0.5	1.1	0.7	0.7	0.3	0.9	1.2	1.2	0.0	0.6	0.0	0.1	0.0	0.9	0.0	0.0	11.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	2.1	1.2	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.3	0.4	0.7	0.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.2	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	0.1	1.5	0.0	0.7	0.0	0.2	0.0	1.7	0.0	5.2	0.9	0.7	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	1.8	1.6	3.3	0.7	3.5	0.1	1.3	6.6	3.2	2.0	0.4	1.2	0.5	2.5	1.1	1.4	1.9	2.0	1.1	3.7	2.6	0.8	0.4	1.5	0.5	3.6	3.4	2.8	0.8	1.1	0.9	1.0	3.8	1.5	0.7	4.4	1.1	2.2	0.8	1.7	0.6	1.8	3.7	1.1	0.8	0.4	3.6	0.5	1.4	1.2	0.7	1.2	1.4	5.7	0.0	0.1	0.6	1.6	0.1	0.2	0.2	0.7	0.0	0.6	0.6	0.2	0.4	1.3	3.6	2.0	0.3	0.1	0.1	0.2	0.7	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.2	4.0	0.1	0.4	0.3	16.9	1.0	0.0	0.1	0.2	0.3	0.3	0.1	0.5	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.4	0.9	0.4	4.6	0.3	0.3	0.1	2.5	0.2	0.0	0.0	5.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.5	6.6	3.2	3.7	2.6	3.6	3.4	3.8	3.7	3.6	5.7	0.6	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.6	4.5	0.2	0.3	1.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.3	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	0.6	0.7	1.8	0.1	1.2	0.0	0.5	2.1	1.6	0.6	0.0	0.3	0.0	1.2	0.4	0.3	0.4	0.5	0.5	2.9	1.6	0.4	0.1	0.6	0.0	1.9	3.3	1.4	0.8	2.3	1.0	0.2	2.4	0.6	0.1	1.6	0.3	0.9	0.2	0.2	0.1	0.9	2.4	0.1	0.1	0.4	1.8	0.0	0.6	0.3	0.0	0.3	0.3	3.5	0.1	1.9	1.6	0.0	12.9	6.6	0.1	1.2	3.2	0.5	0.7	0.2	0.5	0.5	4.2	0.5	3.1	0.6	0.3	0.2	0.4	0.0	0.8	0.0	0.2	1.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	7.1	0.1	0.0	0.2	0.2	3.0	1.7	0.4	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	1.0	0.7	0.0	0.8	0.1	1.2	8.6	0.0	1.0	0.2	1.3	1.1	0.0	0.0	2.4	0.3	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	2.1	1.6	2.9	1.6	1.9	3.3	2.4	2.4	1.8	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.2;Cardiomyocytes: 1.4;Endometrial stromal cells: 1.0;Fibroblasts: 1.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;ASC TERT1: 9.8;LHCN-M2: 8.2;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	1.5	1.0	2.6	0.6	3.6	0.1	1.1	6.3	2.8	2.1	0.0	1.1	0.2	3.0	0.9	0.9	1.6	1.9	1.8	3.1	3.2	0.7	0.7	1.7	0.3	3.7	3.3	2.8	0.8	1.2	0.9	1.1	3.6	1.3	0.8	1.6	0.8	1.2	0.8	0.8	0.5	1.5	3.0	0.6	0.6	0.5	2.2	0.4	0.7	0.9	0.3	0.9	1.1	5.5	0.1	0.3	2.0	0.2	13.5	9.8	0.1	2.1	2.9	0.6	3.2	0.0	0.3	3.7	1.0	1.7	7.1	0.5	0.4	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.2	2.5	0.5	0.2	0.1	4.7	1.7	0.1	0.2	1.2	8.2	0.5	2.9	0.7	0.1	0.9	0.9	7.8	2.6	0.2	0.2	0.3	1.5	1.6	0.2	0.4	0.4	1.5	3.0	0.2	5.9	2.9	0.6	4.4	3.9	0.2	2.2	0.6	3.1	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.6	6.3	2.8	3.1	3.2	3.7	3.3	3.6	3.0	2.2	5.5	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	2.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370242-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	0.7	0.3	0.4	0.2	0.8	0.0	0.5	3.8	0.8	0.8	0.0	0.8	0.0	1.0	0.6	0.3	0.7	0.4	1.2	0.9	0.5	0.3	0.2	0.5	0.2	1.3	1.4	1.2	0.7	1.1	0.7	0.4	0.6	0.4	0.3	0.8	0.8	0.4	0.5	0.6	0.3	0.7	0.6	0.4	0.4	0.4	0.8	0.3	0.6	0.5	0.2	0.6	0.6	1.4	0.0	0.6	0.4	0.3	10.4	8.4	0.2	1.2	2.0	0.7	0.8	0.0	0.0	1.8	0.3	3.5	0.6	0.5	0.0	0.2	0.5	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	2.1	0.4	0.2	0.1	0.2	1.0	0.0	0.2	0.8	0.2	0.4	0.6	0.9	0.1	0.0	0.1	1.5	0.6	0.0	0.2	0.1	2.4	0.5	0.0	0.0	0.2	0.3	0.6	0.0	5.5	0.5	0.1	0.5	0.6	0.2	1.8	0.2	0.4	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	3.8	0.8	0.9	0.5	1.3	1.4	0.6	0.6	0.8	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	1.3	1.1	1.3	0.4	1.5	0.0	0.9	4.4	1.4	1.5	1.8	1.1	0.2	1.6	1.5	0.7	1.3	0.5	1.5	2.0	3.2	1.4	1.6	1.1	0.1	2.0	2.0	2.4	1.0	1.9	1.2	3.0	1.5	1.2	0.4	1.4	1.6	1.4	1.0	1.7	0.5	1.0	1.4	0.4	0.4	0.5	2.5	0.7	1.7	0.8	0.2	1.0	1.1	1.5	0.0	1.1	11.1	0.1	6.9	8.5	1.3	10.8	43.3	4.4	3.0	0.0	0.0	0.4	8.3	0.3	0.2	3.3	0.0	0.0	4.6	0.0	0.0	0.0	0.2	2.4	2.8	0.0	0.0	8.4	0.1	4.1	0.0	0.1	6.7	0.0	0.4	0.1	0.0	0.0	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	15.5	5.6	4.2	22.7	6.0	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	1.5	4.4	1.4	2.0	3.2	2.0	2.0	1.5	1.4	2.5	1.5	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.8	2.7	3.6	1.1	3.6	0.0	1.8	5.8	3.1	2.0	3.3	1.7	0.7	3.1	2.0	1.9	2.8	1.6	2.9	3.9	6.4	2.2	2.1	2.7	0.4	5.1	4.7	5.7	3.8	20.3	1.7	4.8	5.4	3.0	0.9	3.1	4.7	3.9	2.1	3.8	0.8	2.8	5.3	1.3	1.5	1.9	4.9	1.3	4.5	1.9	0.8	1.9	2.1	6.1	0.0	2.4	0.3	0.0	66.3	49.6	1.3	18.3	0.0	29.2	32.5	2.9	10.0	10.6	23.4	20.5	0.0	13.9	0.0	7.6	16.4	0.0	3.1	0.0	0.0	0.1	6.9	0.0	6.5	17.6	1.5	1.7	9.4	12.6	9.0	0.0	0.2	0.0	1.0	8.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.1	0.0	0.1	0.0	2.0	19.1	0.1	9.2	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.6	5.8	3.1	3.9	6.4	5.1	4.7	5.4	5.3	4.9	6.1	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.2	1.5	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.8	0.5	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	3.1	3.1	3.0	0.9	3.6	0.4	2.2	5.0	2.4	2.9	2.9	2.4	0.5	3.2	2.0	1.2	2.9	1.7	2.4	2.5	3.5	1.1	1.3	2.0	0.7	3.6	3.5	6.0	1.2	2.8	1.8	3.1	3.2	1.4	0.7	2.8	2.2	2.4	2.9	2.1	1.0	1.9	3.3	1.5	1.1	0.6	3.7	0.6	2.6	1.5	0.6	1.8	2.3	3.9	0.0	0.1	16.0	0.1	0.5	0.6	0.8	1.4	0.0	0.4	0.9	0.2	0.2	1.4	5.4	0.9	0.2	0.3	0.0	0.3	1.0	0.0	0.3	0.0	0.2	0.1	1.3	0.1	0.1	3.6	1.8	0.8	0.1	0.1	0.5	0.3	0.1	0.2	0.1	0.3	0.1	1.1	0.6	0.0	0.0	0.2	0.0	0.1	2.5	0.2	0.2	0.3	0.0	0.1	0.1	0.4	1.2	0.3	2.6	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	3.0	3.6	5.0	2.4	2.5	3.5	3.6	3.5	3.2	3.3	3.7	3.9	3.6	3.2	0.5	0.0	1.0	0.0	1.5	0.0	0.0	6.9	0.6	0.4	3.9	0.0	1.3	0.0	6.2	0.2	0.6	0.4	0.0	0.7	0.0	0.6	3.8	2.6	0.0	0.0	0.0	1.2	0.1	3.3	1.1	0.5	0.0	0.4	1.4	0.7	0.3	10.1	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.2	0.0	0.0	0.1	2.7	0.0	0.0	0.0	2.0	0.1	1.2	1.5	0.8	0.1	0.3	0.7	2.5	0.0	5.2	3.2	0.2	0.5	0.3	0.1	0.1	0.7	0.8	0.4	0.8
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	5.2	4.6	4.6	1.8	4.7	0.1	4.2	10.8	3.5	4.9	5.0	5.0	0.9	5.7	2.2	3.0	4.4	4.4	4.3	4.5	7.0	2.4	1.5	5.8	1.2	6.0	6.0	8.1	1.7	4.3	2.2	5.5	5.3	3.8	1.7	5.8	3.7	5.5	3.0	3.3	2.1	5.1	7.7	2.7	2.4	1.9	5.0	1.5	4.0	4.1	0.9	3.3	3.8	7.3	0.0	0.0	2.9	86.7	1.9	0.3	0.9	5.7	0.7	2.1	4.3	0.1	5.3	0.7	4.6	11.7	0.8	1.4	0.2	1.0	2.0	0.1	0.6	0.0	0.2	0.0	6.4	0.5	0.1	26.7	0.7	1.7	0.9	72.4	4.6	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.0	0.6	10.1	1.9	0.0	0.2	0.0	9.3	12.8	0.2	0.0	0.0	1.0	1.0	0.9	11.5	10.3	0.2	0.9	0.1	0.1	0.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	4.7	10.8	3.5	4.5	7.0	6.0	6.0	5.3	7.7	5.0	7.3	2.2	3.2	1.3	0.0	0.3	0.4	0.8	0.0	0.0	7.9	0.3	0.5	1.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	0.2	0.1	0.4	2.1	2.2	0.0	0.0	0.0	0.5	0.1	3.4	0.0	0.3	1.3	0.5	0.4	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	1.9	0.1	0.4	0.0	0.3	0.0	0.7	0.0	5.9	2.2	0.0	0.1	0.5	0.4	0.0	0.0	1.2	0.1	0.2
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512977	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 308.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Bipolar cells: 8.4;Endometrial stromal cells: 5.5;Fibroblasts: 10.2;Horizontal cells: 11.8;Skeletal myocytes: 6.6"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"plasmacytoid DC: 15.3"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 15.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 200.7;HSkMC: 186.2;U-138 MG: 244.1;WM-115: 382.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832"	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (6.00e-4)"	63.3	64.3	248.0	15.4	241.0	0.2	59.9	221.6	308.1	107.8	165.1	60.4	7.4	81.3	60.8	54.5	62.6	30.2	77.8	232.3	227.5	36.6	29.5	101.9	9.5	236.9	241.0	65.1	34.7	36.8	79.0	37.1	216.6	66.0	20.4	36.3	46.4	40.7	27.6	64.7	32.0	39.5	216.5	22.2	38.7	22.0	263.5	15.7	45.7	26.3	14.8	60.6	80.0	220.8	12.8	7.7	48.1	14.0	200.7	178.3	0.6	58.6	162.6	30.9	32.5	0.0	12.7	43.5	39.7	108.0	111.7	46.2	6.1	20.7	28.2	0.2	20.0	0.1	1.2	1.2	62.6	0.5	1.5	186.2	31.6	46.9	37.2	104.2	19.7	0.0	0.2	1.6	79.2	24.8	1.0	5.4	2.3	0.8	0.1	30.0	97.1	0.4	17.9	13.7	16.6	69.8	17.3	0.6	115.9	16.8	40.0	66.9	22.1	244.1	12.2	46.7	72.2	0.1	0.6	0.7	60.3	0.1	382.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.3	0.0	0.1	248.0	241.0	221.6	308.1	232.3	227.5	236.9	241.0	216.6	216.5	263.5	220.8	2.5	0.0	0.0	0.0	0.3	0.3	0.5	0.3	8.0	8.4	0.2	1.1	0.8	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.2	1.4	0.3	5.5	1.9	0.0	0.0	0.0	0.2	0.2	10.2	0.0	0.5	0.0	0.2	1.1	0.0	0.3	11.8	0.0	0.2	0.0	0.3	0.3	0.7	1.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.6	0.0	0.1	0.0	1.0	0.0	6.6	1.7	1.6	0.0	3.9	0.1	0.7	0.1	3.5	0.0	0.5
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 3.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.2	1.1	17.3	0.1	12.2	0.0	0.2	19.3	14.6	0.3	0.1	0.6	0.0	0.4	0.2	0.2	0.3	0.2	2.2	12.7	13.9	0.1	0.1	0.4	0.1	12.9	21.9	0.3	0.3	0.0	1.1	0.1	10.3	0.2	0.1	6.6	0.3	0.1	0.7	0.5	0.1	0.2	22.4	0.1	0.2	0.9	14.3	0.0	0.1	0.3	0.2	0.2	0.3	31.4	0.0	0.0	0.9	0.2	0.2	0.7	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.8	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	1.3	0.0	0.0	9.1	0.5	0.0	0.0	0.1	7.3	14.2	0.1	0.0	0.1	10.0	0.1	0.3	0.1	0.8	0.1	0.2	0.6	0.2	0.0	0.2	0.6	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	12.2	19.3	14.6	12.7	13.9	12.9	21.9	10.3	22.4	14.3	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	0.3	0.5	5.6	0.1	8.6	0.0	0.3	0.0	11.7	0.8	0.0	1.3	0.0	1.2	0.2	0.3	0.7	0.2	5.3	28.4	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	1.2	0.1	0.0	0.5	0.0	1.2	0.4	0.5	1.2	0.5	0.2	0.7	0.0	0.1	0.3	0.6	0.3	0.1	0.2	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.3	0.3	1.5	0.1	0.8	0.5	0.4	0.5	0.0	0.0	0.4	1.4	2.2	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	4.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	7.4	0.1	0.2	0.1	14.4	0.2	0.2	6.5	0.0	0.0	0.0	8.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.6	0.0	11.7	28.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	45.4	44.2	64.8	30.8	66.1	22.2	35.5	60.6	74.1	62.1	72.0	34.7	24.6	40.0	27.2	31.8	53.4	26.0	27.5	61.7	63.0	70.9	57.8	42.6	36.8	67.4	63.7	63.4	41.2	40.2	63.3	23.3	62.9	65.9	12.6	18.2	35.0	19.8	13.5	21.4	47.7	21.0	61.4	81.9	41.2	25.9	66.6	23.5	86.3	9.0	24.2	40.5	42.5	72.8	31.2	39.1	39.4	21.6	39.8	54.5	29.1	29.2	32.5	29.7	32.2	27.3	54.5	9.1	20.0	19.5	49.5	50.3	9.3	27.1	13.7	45.4	31.0	36.0	49.9	38.7	32.2	6.8	11.6	73.0	56.0	36.3	48.4	42.7	21.7	45.3	28.9	40.1	22.2	20.9	4.9	45.5	44.3	23.3	25.4	24.7	13.3	18.9	33.7	24.7	37.2	57.4	29.8	37.1	51.7	24.9	48.0	23.2	21.6	29.1	20.4	30.4	14.0	69.0	36.5	2.6	7.1	24.8	35.1	3.6	8.2	3.5	11.0	7.3	10.9	9.8	6.7	9.8	9.2	9.8	12.1	11.0	0.6	16.1	7.7	8.0	4.8	8.3	64.8	66.1	60.6	74.1	61.7	63.0	67.4	63.7	62.9	61.4	66.6	72.8	9.9	16.0	19.8	16.0	13.8	4.0	10.6	8.6	30.1	11.9	12.7	13.2	4.9	8.6	10.5	9.2	10.4	5.1	12.8	6.0	13.7	5.0	0.7	12.4	32.3	11.7	8.4	7.2	4.8	2.1	2.5	15.4	22.4	10.1	0.0	18.1	11.0	14.0	6.9	11.8	6.9	9.1	6.1	9.5	6.8	3.0	9.0	12.8	1.8	8.4	5.1	9.6	5.2	8.0	11.6	4.0	8.5	2.2	11.4	6.6	8.6	12.4	8.5	12.4	6.6	7.1	12.3	13.2	7.4	15.1	3.7	3.4	12.2	17.6	7.5	8.3
PCED1B	"FAM113B, MGC16044"	ENSG00000179715	"PC-esterase domain containing 1B"	Q96HM7	12	47079603-47236662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1;lymphoid tissue: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 63.3;K-562: 48.9;SK-BR-3: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043901	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	Vesicles	"HPA043901: AB_10959888"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (4.55e-6)"	"unprognostic (4.79e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.74e-2)"	"prognostic favorable (5.36e-5)"	6.5	40.1	3.4	17.9	3.2	10.6	6.1	2.7	3.3	6.7	2.3	10.1	2.2	8.7	2.0	3.1	9.3	5.9	3.3	2.4	3.7	6.0	3.9	9.1	36.0	4.8	5.3	23.4	2.7	1.2	2.3	3.6	4.4	5.8	2.7	0.8	3.3	2.3	1.3	2.7	12.2	4.5	3.6	29.5	3.8	13.7	4.8	7.1	3.4	1.2	24.1	9.6	5.4	5.0	3.4	63.3	1.5	0.0	0.5	0.0	3.0	2.0	3.5	0.7	0.3	3.2	12.3	11.5	3.4	6.5	1.2	9.2	0.0	9.4	0.0	13.5	0.0	0.4	0.6	1.3	1.3	2.7	0.5	0.2	4.1	1.1	7.1	8.8	2.7	0.8	48.9	10.6	4.4	1.5	0.7	2.3	10.6	7.9	0.9	0.2	1.6	8.2	9.7	5.2	0.4	0.0	5.7	31.0	0.0	3.2	5.7	4.0	0.8	0.2	0.9	0.1	2.2	11.4	8.6	20.3	3.0	8.7	0.3	1.7	1.1	2.8	42.5	2.3	48.3	50.1	50.7	54.1	6.4	35.6	88.8	83.5	4.5	30.1	2.6	38.1	59.1	35.4	3.4	3.2	2.7	3.3	2.4	3.7	4.8	5.3	4.4	3.6	4.8	5.0	3.4	3.2	5.6	30.3	23.6	1.1	0.9	4.2	9.1	2.5	4.4	6.2	0.5	0.0	1.5	1.8	0.0	0.5	21.1	0.2	0.0	3.2	0.9	5.1	1.4	3.4	10.2	0.4	32.4	12.8	9.1	3.1	1.5	10.3	1.3	47.8	9.7	0.3	37.6	0.0	2.2	1.4	0.0	4.3	1.8	2.5	3.7	10.7	1.8	60.0	5.3	0.9	23.7	17.6	0.6	11.7	0.8	0.7	28.1	1.4	0.1	0.4	0.8	0.1	0.0	1.3	4.4	0.7	0.2	2.8	0.6	2.1	36.2	22.4	0.3	4.2
PCGF1	"MGC10882, NSPC1, RNF68"	ENSG00000115289	"Polycomb group ring finger 1"	Q9BSM1	2	74505043-74507695	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011356, HPA069156"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA011356: AB_1855063, HPA069156: AB_2686095"	"unprognostic (2.41e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.13e-1)"	9.9	10.4	13.7	8.6	14.5	17.8	15.2	14.6	17.3	12.8	13.0	11.5	11.2	12.5	14.4	9.7	14.4	10.0	12.3	14.1	13.9	10.9	13.0	12.3	14.1	13.9	13.8	14.8	11.0	17.6	2.3	11.4	14.7	9.3	12.3	18.1	11.0	8.8	12.1	14.8	10.8	11.2	13.7	8.5	11.7	11.0	14.5	14.4	14.2	17.6	14.7	10.7	2.1	15.1	18.9	11.6	12.3	19.0	15.4	19.0	19.0	17.8	23.8	16.2	10.9	25.5	12.8	16.9	7.6	16.5	38.0	11.4	20.7	23.5	14.6	16.3	24.7	12.0	15.7	25.6	24.9	31.7	16.5	25.5	33.3	10.5	57.4	26.0	12.8	21.8	25.0	23.0	17.8	27.8	22.6	42.0	16.3	23.5	12.3	18.0	27.3	14.1	24.8	21.0	14.0	27.8	13.8	27.1	30.1	12.1	10.1	21.4	11.7	26.2	17.5	14.5	24.1	12.5	9.7	18.3	22.1	22.6	16.3	11.1	24.2	10.4	15.5	20.1	18.3	18.1	20.7	19.8	26.9	17.9	16.3	16.8	8.7	14.4	23.3	13.1	24.2	14.2	13.7	14.5	14.6	17.3	14.1	13.9	13.9	13.8	14.7	13.7	14.5	15.1	7.0	3.2	1.8	2.3	8.7	12.5	9.0	23.8	31.3	5.0	10.5	10.9	3.5	12.8	10.6	3.7	4.2	12.2	6.5	9.5	31.3	11.0	19.0	11.3	11.5	8.5	1.2	10.3	1.7	10.4	19.5	13.1	6.1	10.4	10.2	2.9	7.1	6.2	13.6	5.0	1.6	12.8	18.3	9.9	14.0	4.9	7.8	10.8	7.2	0.0	15.0	6.7	19.6	0.5	2.3	11.3	15.9	4.9	11.4	9.4	14.2	17.5	9.5	9.5	6.6	10.4	14.0	19.3	8.0	24.3	18.9	18.3	9.6	5.0	9.4	8.5
PCGF2	"MEL-18, RNF110, ZNF144"	ENSG00000277258	"Polycomb group ring finger 2"	P35227	17	38733898-38749817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047732, HPA063531"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047732: AB_2680138, HPA063531: AB_2685031"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.10e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	33.6	38.3	3.3	4.6	3.2	0.0	33.0	7.7	5.5	44.7	4.3	24.4	3.7	40.6	2.4	21.4	35.9	6.1	37.3	3.2	5.2	56.5	12.9	33.4	2.1	2.6	3.0	40.5	22.9	2.9	55.6	6.8	2.9	37.5	1.6	7.2	22.6	2.7	9.3	21.6	22.7	2.1	1.2	28.3	25.3	13.3	4.1	0.2	41.7	0.9	0.8	27.3	30.8	3.1	16.9	38.2	9.2	34.5	7.2	2.3	11.7	13.1	6.2	6.2	7.4	21.1	17.6	1.3	14.3	4.2	16.3	26.2	3.4	6.1	2.5	10.4	20.1	7.9	20.7	52.4	2.3	1.2	9.4	2.5	2.8	9.0	6.1	9.6	7.5	7.9	14.9	21.2	3.9	37.8	1.5	0.2	11.7	7.4	15.3	12.6	14.7	3.3	3.2	22.5	16.4	26.8	12.6	9.0	20.8	9.0	35.4	1.6	22.0	24.8	27.1	24.8	23.2	12.5	4.1	4.3	13.3	2.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	7.7	5.5	3.2	5.2	2.6	3.0	2.9	1.2	4.1	3.1	49.6	3.2	16.0	2.0	1.1	14.1	11.2	19.7	23.9	59.9	20.6	17.0	2.1	15.7	10.1	20.2	10.4	13.3	0.8	23.7	52.8	24.9	15.1	8.0	22.1	46.4	13.2	0.0	6.5	13.7	26.7	21.9	12.8	12.8	1.3	14.0	51.0	2.9	4.8	35.3	7.0	12.5	22.4	2.9	5.5	5.0	37.0	2.9	14.2	6.5	3.2	26.4	2.1	9.5	2.4	18.9	10.3	29.3	3.8	15.4	22.3	59.6	5.0	16.5	0.0	16.8	16.7	6.1	15.7	9.6	16.9	22.2	0.9	13.3	13.2	11.1
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	32.7	45.1	17.9	15.5	18.5	30.1	34.7	30.6	19.5	41.9	16.7	31.7	22.6	35.3	8.7	35.5	33.6	14.0	27.2	18.9	17.0	31.7	29.7	34.7	18.3	18.1	17.2	50.4	27.8	7.8	31.4	19.8	17.5	38.3	10.3	13.3	37.4	9.7	18.4	53.3	36.2	10.7	16.2	51.0	32.1	23.3	17.9	18.6	34.6	11.4	11.8	27.2	39.4	24.1	22.1	19.6	35.3	40.4	15.8	16.2	43.3	29.2	15.9	23.5	23.7	21.5	23.8	15.7	19.1	28.3	23.8	14.9	16.5	23.7	17.8	20.8	17.9	22.6	24.2	38.4	19.3	15.5	28.9	20.5	31.0	20.5	9.3	15.4	30.5	28.2	31.5	12.6	23.3	24.6	41.8	54.6	23.4	14.9	35.0	41.0	22.4	10.1	14.1	35.6	50.2	37.9	15.2	16.1	16.1	22.7	31.5	21.8	36.9	22.8	18.4	19.2	38.1	30.1	27.6	24.6	18.0	24.5	43.0	3.4	7.1	3.1	3.3	5.1	2.8	4.2	2.0	2.1	3.2	5.0	2.5	1.7	4.5	4.7	2.2	4.6	3.3	2.3	17.9	18.5	30.6	19.5	18.9	17.0	18.1	17.2	17.5	16.2	17.9	24.1	29.5	12.8	28.8	19.6	12.5	25.4	17.3	17.2	25.0	12.3	28.3	21.3	21.7	17.2	21.8	9.2	12.5	13.4	13.5	21.4	3.9	20.6	52.0	17.7	28.7	27.8	19.2	9.1	18.1	19.8	30.0	17.8	35.2	21.2	16.5	22.4	25.4	15.3	12.2	6.7	18.6	21.7	20.3	15.1	21.0	54.4	16.4	20.1	23.2	23.4	14.3	9.1	16.5	27.2	22.8	32.7	19.3	15.4	22.9	24.0	19.1	9.4	14.0	8.5	6.6	18.8	18.8	19.0	25.6	22.5	28.7	23.7	13.3	20.8	20.2	38.2
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284337	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 345.7;Oligodendrocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038349, HPA059071"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038349: AB_10669523, HPA059071: "	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.90e-4)"	13.7	21.8	17.8	13.1	18.9	5.8	11.9	17.4	20.0	12.0	10.9	15.3	17.6	12.5	10.7	12.8	12.1	12.7	28.3	14.2	25.2	23.4	26.2	13.1	16.9	21.8	21.2	14.9	16.2	19.9	7.2	15.9	17.7	13.7	14.1	16.3	17.6	14.0	15.2	11.2	21.0	11.9	17.6	17.8	14.7	11.4	21.1	19.4	24.2	16.7	15.7	12.2	8.5	23.0	32.9	14.2	11.6	5.0	16.5	25.7	8.3	18.2	37.3	16.2	22.5	2.2	18.7	43.2	8.3	22.9	13.3	6.3	12.6	12.5	28.4	50.1	9.5	20.4	9.0	22.2	21.8	16.0	31.0	11.7	22.6	12.1	16.8	33.2	13.7	19.0	11.1	23.5	25.4	6.1	36.2	4.1	1.7	7.5	8.1	17.8	21.5	11.7	29.6	5.1	5.5	7.8	8.9	9.4	15.6	4.1	7.6	7.1	35.9	19.0	13.4	11.8	21.8	40.8	26.9	38.2	26.7	11.4	6.0	6.4	1.6	2.7	2.6	4.0	4.7	4.0	3.9	2.7	2.1	3.9	3.9	3.9	2.1	5.1	7.7	0.5	2.4	2.6	17.8	18.9	17.4	20.0	14.2	25.2	21.8	21.2	17.7	17.6	21.1	23.0	35.8	6.4	24.0	135.8	60.1	34.4	48.7	34.8	38.7	20.2	26.8	30.6	81.2	28.6	28.3	29.5	16.7	16.5	49.7	82.8	49.0	33.9	127.8	25.2	38.7	33.8	21.6	124.8	99.0	63.9	5.0	32.7	33.1	29.0	23.4	14.0	35.3	58.6	50.5	50.5	159.5	65.4	20.3	73.1	64.9	345.7	19.6	65.9	42.7	56.2	74.0	79.9	40.2	107.1	252.6	54.3	55.1	29.7	72.3	61.2	83.7	59.0	27.9	19.3	13.1	59.1	39.4	78.2	14.4	34.4	31.3	5.6	55.9	10.9	49.0	67.2
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177536-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	22.2	29.0	16.6	15.8	17.4	15.5	22.9	19.0	18.8	27.0	18.3	25.2	12.1	23.0	23.0	19.3	25.9	17.1	37.7	16.8	17.3	20.1	23.8	18.6	25.8	16.4	16.6	33.7	23.9	19.1	22.6	15.5	16.4	24.7	18.5	10.7	23.8	19.2	29.1	18.9	20.2	21.8	16.5	24.7	24.4	45.3	17.6	24.4	20.8	24.4	23.0	23.9	22.4	18.8	62.9	26.3	39.1	34.7	70.2	52.3	27.4	47.2	70.7	64.4	59.1	51.9	57.7	50.2	30.7	64.5	81.6	38.8	62.9	42.8	71.2	44.3	62.1	64.8	68.1	45.9	70.0	110.4	25.5	43.3	46.6	40.4	71.1	51.4	51.3	68.5	50.4	19.9	73.6	30.3	59.4	77.9	38.9	115.1	33.2	53.4	43.4	48.0	58.8	31.3	52.0	31.9	29.5	72.2	55.9	39.3	39.9	133.4	33.5	19.0	68.7	27.9	36.2	30.4	30.4	70.4	65.3	74.1	44.2	28.2	25.5	20.0	68.9	34.4	81.6	39.7	58.0	72.5	26.0	39.5	52.2	54.6	3.9	22.6	33.2	24.8	64.7	54.7	16.6	17.4	19.0	18.8	16.8	17.3	16.4	16.6	16.4	16.5	17.6	18.8	26.5	19.2	16.7	16.3	28.4	21.5	29.1	37.8	17.6	23.6	25.5	32.3	27.8	21.5	23.7	14.7	16.7	30.2	38.5	7.8	27.4	22.8	52.8	26.8	35.7	26.2	7.8	32.8	43.6	13.8	24.7	33.8	18.8	21.7	10.8	39.0	18.9	18.4	20.2	37.0	33.7	15.6	16.2	18.2	14.0	18.1	41.3	17.2	16.0	26.2	24.0	19.0	38.1	25.1	40.4	18.1	15.8	40.6	16.8	46.3	13.6	23.6	30.4	23.8	19.7	37.4	30.9	204.4	72.7	17.6	24.7	31.1	43.7	33.0	20.1	25.3
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 432.1;liver: 681.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.2	1.1	0.8	1.7	0.8	0.0	29.8	0.7	1.6	0.0	0.6	57.8	110.4	1.2	0.2	0.4	0.9	5.0	1.0	0.7	1.4	432.1	681.4	0.2	0.3	0.7	0.9	1.6	0.4	0.0	21.1	0.3	0.8	0.2	79.8	0.5	1.1	0.2	0.4	0.9	143.9	2.9	0.6	0.3	0.9	0.0	1.3	0.1	0.8	6.5	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.6	0.7	1.4	0.7	0.9	0.8	0.6	1.3	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754012-83162930	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 25.6;pituitary gland: 11.1;retina: 21.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 655.4;Inhibitory neurons: 746.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 25.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	28	"REH: 263.3;U-2 OS: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA		6000000		"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	1.8	4.2	4.0	0.2	5.5	0.0	2.4	25.6	22.4	1.5	0.0	2.1	1.5	0.3	3.8	2.3	1.0	0.9	1.4	7.8	1.7	4.4	0.1	0.8	0.1	0.0	0.0	0.8	3.9	4.4	11.1	0.3	0.0	2.5	1.7	21.7	2.5	2.5	0.1	2.0	1.7	0.1	0.0	0.5	1.5	3.7	1.3	1.2	4.6	0.1	0.2	0.6	2.6	4.2	1.2	1.6	1.9	0.0	0.8	0.1	0.0	0.7	0.7	0.5	1.0	0.3	0.7	0.0	0.0	0.8	7.7	0.6	5.7	2.4	2.4	0.3	0.8	0.0	1.2	0.1	0.0	0.8	0.2	0.4	1.8	0.0	9.6	0.5	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.0	2.0	1.0	4.7	263.3	4.2	0.0	1.9	0.9	4.9	3.4	0.2	2.7	0.6	1.2	3.4	0.6	0.0	0.0	284.5	1.2	0.6	0.2	0.0	0.5	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.5	25.6	22.4	7.8	1.7	0.0	0.0	0.0	0.0	1.3	4.2	0.6	9.6	17.9	40.5	0.0	2.5	9.0	3.2	13.6	121.9	11.0	9.7	31.2	22.8	12.6	1.8	131.3	1.9	0.0	22.9	7.9	6.4	13.0	7.4	6.7	2.5	60.1	0.0	655.4	4.9	0.4	2.4	20.4	13.5	0.0	24.2	0.0	0.2	1.7	85.8	746.4	15.0	2.0	0.0	0.0	7.9	2.8	0.4	0.0	50.6	0.0	16.2	0.0	73.9	73.7	2.5	21.9	6.4	0.0	3.9	13.5	23.0	7.7	86.9	0.0	0.3	3.2	5.0	19.5	19.3	3.4	0.7	0.3	37.5	9.3	6.0
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18027975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 528.5;Spermatocytes: 569.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite"	Cytosol	"CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	29.5	31.3	32.9	28.1	39.7	52.2	43.1	42.7	37.0	39.3	39.9	37.3	21.8	39.3	41.6	28.1	44.1	30.7	38.6	31.7	35.0	33.0	39.2	33.6	41.5	35.5	34.2	47.0	39.9	52.6	31.0	35.2	37.2	33.5	27.4	76.6	35.1	32.2	105.3	30.4	29.5	30.6	32.8	33.4	27.9	154.2	35.8	56.9	49.0	84.9	37.3	31.0	26.2	47.0	64.0	66.8	100.5	133.4	55.2	57.0	51.7	52.6	64.4	54.9	61.3	45.4	37.0	83.0	35.3	52.8	47.2	45.0	64.8	48.3	93.0	27.6	25.1	142.7	46.2	93.1	61.6	63.7	35.1	50.3	50.6	63.9	70.3	47.9	64.1	84.9	98.4	62.6	67.9	32.0	136.8	103.3	82.7	52.8	19.1	81.0	90.1	30.0	45.3	87.1	76.6	57.6	56.5	30.5	82.1	42.8	48.2	91.0	57.8	49.6	40.5	61.3	45.0	26.6	62.9	72.5	41.8	68.3	52.0	31.5	7.2	18.7	13.0	4.6	13.5	13.0	11.6	15.1	7.3	13.1	12.9	13.2	7.6	13.9	10.0	17.8	13.1	5.6	32.9	39.7	42.7	37.0	31.7	35.0	35.5	34.2	37.2	32.8	35.8	47.0	91.6	128.2	154.9	187.7	109.3	33.8	66.3	44.4	75.7	196.1	74.1	72.0	249.4	62.9	117.2	86.5	350.3	50.9	145.9	33.6	29.4	73.0	528.5	275.2	130.4	86.5	71.2	115.5	219.9	59.0	33.6	100.4	55.0	132.5	142.1	103.9	64.6	50.8	43.3	129.5	211.8	45.7	61.1	61.3	39.7	301.3	92.2	83.6	55.2	162.1	82.8	145.8	132.8	208.6	243.1	58.9	36.0	97.8	84.7	45.8	45.6	25.9	282.1	234.9	124.9	173.8	92.7	569.3	177.1	65.4	38.2	60.5	122.5	92.1	50.6	47.2
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1022.2;Late spermatids: 428.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		4100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	48.7	43.2	77.5	32.8	85.1	75.9	46.2	70.2	107.1	46.4	56.4	45.5	36.6	38.8	48.5	45.3	39.2	28.4	121.7	87.5	84.8	51.1	73.8	37.9	41.4	80.3	73.0	39.3	38.1	46.3	43.3	42.9	86.2	52.1	43.1	55.8	39.8	50.1	211.9	44.6	34.6	48.9	71.1	34.5	37.8	76.7	72.3	57.4	49.0	163.3	46.7	40.7	38.0	79.2	87.3	68.4	70.4	88.6	152.1	125.9	77.6	140.7	82.9	114.7	143.4	200.1	65.4	117.9	113.0	127.5	126.5	106.6	123.9	143.6	159.9	79.2	180.0	175.5	122.2	192.1	99.2	203.7	197.7	62.8	105.2	128.5	138.5	80.7	107.6	89.8	256.5	107.7	142.3	258.9	98.5	150.4	56.5	84.7	78.6	83.4	89.7	82.6	108.9	62.4	137.5	52.4	111.2	173.9	97.7	82.5	107.8	146.1	83.3	67.2	80.7	124.7	151.2	64.1	109.9	115.4	103.6	135.8	137.7	162.9	193.2	178.0	93.0	182.4	94.7	105.0	93.7	102.8	176.0	81.5	86.5	98.0	101.6	108.5	185.7	79.9	129.2	204.1	77.5	85.1	70.2	107.1	87.5	84.8	80.3	73.0	86.2	71.1	72.3	79.2	57.0	54.5	41.4	21.2	62.6	175.1	74.4	204.4	56.3	72.6	48.0	40.6	154.1	60.1	96.4	79.1	37.5	169.3	66.8	56.6	78.2	113.5	1022.2	51.9	58.4	69.8	55.2	170.1	77.0	110.7	214.0	79.2	26.0	48.8	107.7	38.8	53.9	115.6	119.1	65.6	52.8	72.9	187.2	78.7	127.5	428.1	71.7	78.2	138.7	31.9	143.7	121.2	74.2	30.7	72.2	106.6	57.9	73.7	71.8	67.8	65.1	89.3	106.2	66.3	111.7	64.0	110.4	224.9	96.3	60.7	157.6	148.3	83.0	55.0	58.7	59.1
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: AB_2684519"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	36.5	35.2	18.2	23.3	20.2	16.8	38.2	25.2	21.9	33.8	23.2	38.8	25.9	35.3	47.5	28.0	30.8	29.0	35.5	16.4	19.9	38.3	30.4	28.3	28.8	19.1	19.2	42.6	73.9	77.9	25.5	26.3	19.9	36.1	25.8	25.4	57.6	32.0	83.4	33.5	26.8	28.3	18.9	46.3	29.5	14.9	18.9	35.1	53.3	67.1	27.3	32.6	31.0	21.6	11.7	5.7	24.3	5.4	34.1	28.4	14.0	13.4	22.8	5.5	9.0	3.1	23.6	12.0	18.0	17.3	8.4	27.2	4.7	15.8	9.3	11.9	8.5	12.6	11.7	8.3	43.9	5.2	12.4	30.4	31.7	6.9	17.4	35.8	24.4	16.0	9.5	36.0	12.0	4.2	24.5	13.7	8.9	16.7	3.0	8.0	4.5	13.8	24.7	21.7	16.2	15.0	10.9	14.8	17.1	18.5	14.2	7.6	22.2	6.8	5.9	8.8	5.2	21.6	15.6	3.9	16.4	11.4	7.0	18.7	8.4	23.2	8.6	11.0	10.4	13.1	11.5	9.4	8.1	13.0	13.5	12.4	29.4	21.6	12.7	14.7	13.2	9.1	18.2	20.2	25.2	21.9	16.4	19.9	19.1	19.2	19.9	18.9	18.9	21.6	98.4	115.4	68.1	78.7	78.1	54.0	66.0	49.7	58.6	80.7	66.7	61.0	92.7	48.6	52.0	84.6	10.4	38.1	80.7	28.7	64.6	32.9	4.7	66.6	63.9	79.3	46.7	51.4	144.7	39.8	37.2	79.2	45.9	92.2	53.0	107.2	76.4	37.1	25.1	58.9	159.7	39.0	61.1	51.8	56.8	10.4	104.1	62.7	71.2	144.3	52.5	120.8	55.6	106.1	122.3	43.8	32.2	120.0	101.8	98.0	45.5	92.8	56.7	24.0	39.5	73.2	68.2	16.4	24.2	38.3	59.2	68.5	62.1	87.6	30.9	94.6
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 180.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 138.2;Rod photoreceptor cells: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	31.4	33.6	27.2	22.9	31.0	17.8	37.5	40.2	40.7	36.7	28.3	25.3	23.3	39.2	49.2	22.8	29.0	32.5	42.5	27.1	30.5	34.2	32.1	24.0	41.6	27.1	25.9	57.0	27.0	27.7	31.8	41.2	25.3	29.5	20.3	180.5	32.3	18.3	44.6	66.0	25.0	19.0	24.9	36.3	21.7	24.7	28.4	39.5	27.1	32.9	29.6	20.6	28.1	38.9	22.9	8.5	32.0	25.0	30.1	37.1	30.1	13.6	15.1	19.7	12.0	19.4	35.9	33.8	23.5	16.6	15.6	27.6	17.6	22.4	26.5	7.4	23.0	16.4	42.1	32.9	25.3	16.9	24.0	52.7	30.5	10.4	17.9	35.1	29.1	34.0	30.4	29.8	16.3	14.8	39.8	56.7	23.5	31.6	31.7	32.6	12.6	41.1	30.0	26.1	50.0	58.9	26.1	30.1	37.2	49.4	32.2	34.1	21.2	29.4	10.3	18.9	11.3	35.8	31.3	32.9	19.5	17.9	16.1	10.1	7.9	9.4	9.4	5.4	11.2	10.2	14.0	10.7	9.0	10.7	19.2	14.2	10.2	17.4	5.3	5.4	22.6	9.8	27.2	31.0	40.2	40.7	27.1	30.5	27.1	25.9	25.3	24.9	28.4	38.9	40.8	22.4	26.9	25.8	21.0	20.4	15.6	10.2	31.3	118.5	27.5	18.0	67.4	28.6	17.5	29.5	93.8	33.7	21.9	6.7	23.5	8.4	13.2	21.3	23.2	36.6	22.8	35.3	34.8	9.1	7.0	34.8	17.9	26.4	12.7	33.5	45.0	36.7	14.4	37.0	29.5	15.9	14.2	28.8	10.7	9.5	42.9	17.3	48.0	21.5	19.2	61.3	20.6	138.2	64.6	9.9	15.7	30.9	20.2	14.6	12.0	23.3	24.3	181.9	26.3	25.0	27.7	51.7	37.7	24.9	21.3	21.9	21.6	63.1	15.2	11.3
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324141-46445769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 239.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016820, HPA019887, HPA032101"	Uncertain		Supported	"Centriolar satellite,Centrosome,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 37: Myocytes - Muscle contraction"	Centrosome	"Centriolar satellite, Cytosol"	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	9.7	11.1	7.6	5.9	10.5	17.7	8.9	4.2	11.9	8.6	5.3	10.7	4.1	8.2	4.3	11.7	8.5	3.6	28.3	6.0	5.4	7.7	10.9	8.2	8.2	9.0	3.9	9.6	7.8	4.3	20.3	3.5	9.5	8.2	4.3	4.6	9.7	4.2	239.2	12.3	10.1	4.4	2.6	11.5	9.5	25.6	4.7	12.5	8.4	52.0	5.5	9.6	9.2	7.4	15.4	11.6	18.0	11.1	8.9	8.8	11.3	11.6	8.0	11.3	10.0	14.2	9.7	15.2	7.3	13.4	15.3	10.8	14.6	9.9	7.8	44.9	20.4	40.2	24.1	11.3	3.1	20.6	16.1	4.8	7.5	15.2	7.6	5.5	8.8	15.8	20.9	22.4	15.8	25.4	20.6	21.3	18.0	13.9	8.0	25.3	7.2	13.5	8.7	16.3	22.1	9.8	25.4	15.7	8.0	4.4	14.8	16.0	12.1	20.4	10.2	11.7	18.9	19.3	17.2	16.4	12.6	19.9	11.1	6.0	0.6	1.2	1.5	0.5	4.6	0.3	0.7	4.8	2.0	0.1	0.5	8.8	0.4	0.4	1.0	4.6	0.8	2.0	7.6	10.5	4.2	11.9	6.0	5.4	9.0	3.9	9.5	2.6	4.7	7.4	10.5	28.9	32.0	19.9	8.6	8.3	5.7	7.0	13.6	15.0	8.9	8.6	35.7	10.0	15.3	0.0	6.2	6.4	36.7	14.0	0.0	7.1	20.4	17.0	19.9	10.1	15.6	36.2	38.1	7.6	7.4	13.1	25.0	17.8	16.4	25.4	7.1	9.0	23.3	23.5	39.0	11.2	4.1	6.9	5.5	25.6	12.8	12.7	0.0	17.8	14.7	6.8	25.7	10.6	21.9	5.7	5.7	12.0	31.4	4.2	5.7	4.1	13.0	11.1	26.3	61.3	14.2	40.5	39.8	25.0	7.1	6.4	18.8	15.1	10.4	5.1
PCNX1	"KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex"	ENSG00000100731	"Pecanex 1"	Q96RV3	14	70907405-71115382	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.5;Alveolar cells type 2: 27.9;dendritic cells: 31.6;Endometrial stromal cells: 35.3;Granulosa cells: 57.2;Theca cells: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048970, HPA053532"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA048970: , HPA053532: AB_2682180"	"unprognostic (1.96e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (9.01e-3)"	"unprognostic (2.90e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.37e-2)"	14.1	20.0	8.1	15.3	10.4	17.5	10.7	8.2	9.9	9.6	11.1	11.5	7.9	11.0	5.1	7.8	10.5	10.0	11.5	9.5	8.3	11.8	11.5	12.8	14.4	5.7	6.3	20.0	7.0	15.8	8.2	9.0	7.1	9.1	7.6	16.6	6.7	8.8	15.2	7.3	11.8	13.2	6.2	13.4	8.2	20.7	9.0	16.9	12.3	21.8	12.5	15.5	7.4	8.8	22.3	15.5	17.4	10.9	28.7	19.3	9.6	23.3	23.2	17.9	24.9	15.4	9.8	15.8	7.8	24.0	14.0	21.9	18.8	18.8	26.8	49.0	7.3	3.0	9.7	17.0	17.4	24.5	8.0	20.0	16.4	17.8	31.9	22.0	18.0	16.1	1.3	22.5	20.9	18.0	11.6	22.0	8.8	9.9	8.4	10.5	20.0	4.7	12.2	16.3	7.2	11.3	17.6	10.5	13.0	17.7	9.5	22.7	21.5	32.7	36.5	10.7	17.1	13.5	7.4	13.4	20.2	19.7	11.6	3.3	1.8	1.7	3.4	1.0	4.6	1.3	5.9	3.6	0.4	2.8	2.5	4.0	9.8	1.9	0.7	3.7	10.3	1.7	8.1	10.4	8.2	9.9	9.5	8.3	5.7	6.3	7.1	6.2	9.0	8.8	31.5	16.0	27.9	0.0	8.3	0.0	0.0	0.0	0.0	0.0	11.4	19.7	0.0	0.0	6.2	9.2	0.0	5.9	31.6	0.0	1.9	8.2	0.0	14.1	35.3	9.2	0.0	0.0	0.0	5.3	6.9	9.6	0.0	14.1	15.2	57.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	8.4	0.0	0.0	24.3	0.0	0.0	7.5	9.5	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	5.1	24.0	50.0	0.0	0.0
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex 2"	A6NKB5	1	232983435-233295725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 9.3;Endometrial stromal cells: 8.8;Glandular and luminal cells: 11.1;Granulosa cells: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.2	2.1	8.4	2.5	8.9	2.2	3.8	6.2	18.3	4.0	0.0	2.3	1.5	3.1	6.6	3.6	4.2	3.9	1.7	15.7	1.8	4.8	0.6	2.5	5.0	1.9	4.7	7.1	4.5	3.6	14.8	1.0	2.5	4.7	2.1	11.5	4.7	3.6	3.1	4.7	5.2	2.4	0.3	3.9	3.4	2.8	8.2	3.3	5.6	0.6	3.7	4.7	5.1	6.8	5.1	12.0	6.4	0.1	10.3	11.1	1.9	3.0	8.6	3.1	5.3	3.9	6.0	10.5	6.8	8.1	11.1	8.2	2.9	8.5	7.1	8.9	8.7	0.1	6.6	0.0	4.6	3.5	2.0	8.5	7.4	6.0	23.6	10.3	5.8	7.7	0.0	5.5	3.0	3.0	9.8	0.2	20.7	4.2	7.2	0.1	1.7	1.5	5.5	7.7	11.0	9.2	4.4	1.8	1.8	3.6	4.3	0.9	2.2	8.4	5.4	9.6	9.9	6.5	7.3	0.1	7.7	3.8	9.9	0.3	0.2	0.1	0.7	0.1	0.5	0.3	0.6	0.7	0.5	0.3	0.2	0.5	0.1	0.2	0.1	0.1	0.7	0.3	8.4	8.9	6.2	18.3	15.7	1.8	1.9	4.7	2.5	0.3	8.2	6.8	7.0	9.6	5.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	6.9	7.4	0.0	0.0	6.8	12.9	0.0	0.4	5.8	0.0	7.9	6.4	0.0	9.3	8.8	1.1	0.0	0.0	0.0	3.3	1.6	3.6	0.0	11.1	1.3	8.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.7	0.0	0.0	1.7	4.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	6.5	4.3	0.0	0.0
PCNX3	"FLJ22427, PCNXL3"	ENSG00000197136	"Pecanex 3"	Q9H6A9	11	65615773-65637439	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018084	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA018084: AB_1855083"	"unprognostic (9.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.69e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.82e-1)"	5.2	6.5	3.9	8.0	3.3	10.4	5.5	2.5	4.7	5.9	2.0	7.3	8.2	7.8	1.6	7.7	6.4	4.5	4.5	3.2	1.1	5.4	5.1	6.7	7.3	4.4	3.2	6.0	8.1	4.6	6.6	5.0	2.9	6.2	3.2	2.6	7.9	4.9	4.2	7.7	9.0	4.0	1.8	8.6	7.1	8.9	4.2	7.2	7.4	2.1	4.3	6.3	5.6	4.7	19.5	28.6	10.3	25.6	7.9	6.1	23.3	13.5	11.5	12.9	9.4	13.8	21.5	14.2	25.4	12.0	17.5	31.2	11.0	15.6	3.8	12.1	19.4	18.6	28.6	11.4	8.8	18.3	21.9	11.6	7.7	12.7	10.0	5.8	12.7	14.7	21.7	11.7	7.6	28.8	15.6	14.1	20.9	8.4	18.2	21.6	9.2	18.6	5.6	30.9	12.7	19.0	14.3	18.6	15.7	4.5	32.8	12.4	18.3	22.3	20.7	18.6	13.6	19.1	12.2	12.7	17.8	8.8	19.9	3.5	0.9	0.6	1.2	0.4	1.0	0.5	0.7	0.7	0.5	0.8	0.5	0.7	1.3	0.6	0.7	1.2	0.2	0.6	3.9	3.3	2.5	4.7	3.2	1.1	4.4	3.2	2.9	1.8	4.2	4.7	10.8	6.4	6.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	11.3	8.4	0.0	0.0	0.6	12.9	0.0	6.8	10.7	0.0	0.0	9.1	0.0	13.5	9.1	5.1	0.0	0.0	0.0	8.9	5.6	3.2	0.0	20.4	5.1	17.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	5.9	0.0	0.0	4.3	0.7	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	8.3	3.0	10.2	0.0	0.0
PCNX4	"C14orf135, PCNXL4"	ENSG00000126773	"Pecanex 4"	Q63HM2	14	60091911-60169133	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.8;Endometrial ciliated cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002076, HPA003390"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA002076: AB_1078322, HPA003390: AB_2066703"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (6.84e-5)"	"unprognostic (2.13e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.59e-2)"	7.8	9.2	4.1	6.3	4.8	7.4	8.1	7.0	4.4	10.1	12.1	6.3	5.0	12.5	7.1	5.6	13.1	8.3	11.1	3.9	6.1	12.3	6.7	7.2	7.1	5.0	6.0	16.3	6.5	11.4	11.9	8.5	4.7	11.7	6.7	18.2	7.1	8.5	12.3	7.4	6.1	10.2	4.9	7.4	6.2	11.0	5.7	11.6	9.7	5.7	7.0	6.6	7.8	6.2	85.2	14.3	25.2	17.3	19.2	22.2	11.1	28.5	44.1	31.2	38.3	15.0	26.1	14.8	11.6	23.7	26.0	11.1	16.6	16.2	51.7	20.8	7.9	25.0	10.1	9.7	39.7	25.0	17.7	18.5	10.2	23.0	38.3	24.3	14.9	34.8	12.5	21.2	48.2	11.5	35.9	8.0	12.7	9.7	17.4	20.9	31.8	6.4	15.8	11.7	17.9	21.8	25.5	9.2	18.2	13.4	22.7	11.1	30.7	66.4	52.8	16.7	20.5	7.1	7.4	19.6	26.1	8.5	33.2	3.4	4.1	3.3	4.8	4.3	6.5	4.1	3.4	4.2	4.4	2.8	3.7	4.4	2.1	8.4	5.2	4.4	3.8	3.4	4.1	4.8	7.0	4.4	3.9	6.1	5.0	6.0	4.7	4.9	5.7	6.2	22.3	16.0	29.9	0.0	18.2	0.0	0.0	0.0	0.0	0.0	19.9	17.5	0.0	0.0	19.2	25.8	0.0	18.3	42.8	0.0	17.6	18.4	0.0	82.0	37.4	14.0	0.0	0.0	0.0	13.1	8.3	13.6	0.0	27.0	15.2	33.9	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	20.4	0.0	0.0	18.5	0.0	0.0	14.4	34.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	19.4	14.5	33.8	0.0	0.0
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867438-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 647.3;seminal vesicle: 1280.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 600.9;Distal tubular cells: 645.6;Horizontal cells: 1398.2;Proximal tubular cells: 941.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 41.7;thyroid cancer: 48.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 215.9;T-47d: 64.7"					"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	5.2	52.9	197.6	2.0	647.3	0.0	8.4	166.2	202.0	180.9	509.6	135.5	5.1	126.9	365.6	228.2	10.2	4.2	4.6	121.8	175.9	52.1	0.5	0.6	0.2	75.6	299.1	3.5	6.2	19.7	8.8	2.0	70.2	323.4	32.4	385.3	21.3	1280.1	0.6	14.8	6.0	54.6	64.1	2.6	7.1	0.9	491.1	7.9	227.7	0.0	1.0	468.0	128.6	85.5	0.0	0.0	3.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	2.3	1.9	0.0	0.0	0.0	0.0	215.9	0.5	0.0	0.3	0.3	0.0	34.8	0.0	0.2	64.7	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.6	647.3	166.2	202.0	121.8	175.9	75.6	299.1	70.2	64.1	491.1	85.5	0.0	0.0	1.5	15.3	2.9	3.1	0.4	0.0	0.0	600.9	0.4	0.4	8.8	2.8	0.0	77.3	62.6	0.3	0.0	0.1	645.6	0.4	1.3	0.0	0.2	5.0	1.2	0.0	71.3	0.2	0.3	1.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1398.2	21.5	0.2	0.0	0.0	7.5	0.4	9.6	7.0	21.4	8.4	0.0	68.4	0.0	7.5	11.9	0.8	0.2	0.4	0.0	4.4	0.0	941.2	0.0	200.0	0.0	0.0	77.4	3.4	9.5	0.0	6.0	2.9	2.2	0.5	0.5	1.0
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258745-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.7;pituitary gland: 84.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 35.8;Bipolar cells: 82.8;Inhibitory neurons: 34.0;Sertoli cells: 19.7;Squamous epithelial cells: 23.5;Urothelial cells: 39.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RT4: 13.8;T-47d: 8.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 206.6"	HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	2.7	0.4	14.1	0.8	71.7	0.1	1.8	19.6	33.2	4.0	0.9	5.6	1.7	1.8	2.6	18.8	2.1	2.0	0.8	6.8	14.7	0.9	4.0	4.6	0.2	39.7	23.3	2.2	0.5	0.4	84.3	0.3	39.8	11.0	2.5	39.2	1.9	16.4	0.4	5.6	2.8	6.6	28.1	0.3	2.0	1.8	15.2	2.0	0.7	1.5	2.6	35.6	17.1	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	13.8	1.9	0.0	0.0	0.2	0.0	0.2	8.9	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	14.1	71.7	19.6	33.2	6.8	14.7	39.7	23.3	39.8	28.1	15.2	13.9	0.0	3.2	6.4	2.0	0.0	0.0	35.8	8.3	12.5	82.8	3.2	1.0	0.2	0.0	7.6	0.0	6.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.1	1.3	1.9	0.2	4.6	0.3	1.3	0.0	0.0	0.9	0.1	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	3.5	0.0	5.0	1.4	0.2	0.0	1.9	0.0	2.5	0.0	0.6	0.9	5.9	19.7	0.0	10.0	1.3	1.5	23.5	0.3	1.8	0.0	0.0	0.0	39.9
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 68.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 19.1;hypothalamus: 68.3;pons: 30.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.7	6.3	5.5	4.7	3.7	0.1	1.4	1.0	19.1	0.9	0.0	2.4	5.2	0.1	0.0	0.1	0.2	0.2	0.8	3.0	68.3	0.4	0.0	0.3	0.1	6.6	7.7	0.4	7.6	0.0	12.1	0.0	30.0	0.4	2.3	8.7	2.7	0.1	0.3	1.1	3.6	0.6	4.0	0.1	5.7	0.1	6.6	0.2	1.9	0.0	0.0	2.0	0.5	5.3	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.7	1.0	19.1	3.0	68.3	6.6	7.7	30.0	4.0	6.6	5.3	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831096-48835610	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 642.6;pituitary gland: 1243.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 3045.7;Horizontal cells: 437.4;Paneth cells: 628.8;Proximal tubular cells: 1601.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 2.4;memory CD4 T-cell: 5.0;memory CD8 T-cell: 4.9;naive CD4 T-cell: 2.0;naive CD8 T-cell: 6.4;T-reg: 1.8"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 58.9;PC-3: 148.5;SCLC-21H: 58.2;SH-SY5Y: 53.8;SiHa: 52.1;U-266/84: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		3300000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	2.2	29.5	177.1	0.5	135.6	0.0	2.0	21.6	212.8	18.2	118.8	19.2	9.6	34.1	2.9	0.9	6.9	0.2	16.0	105.6	642.6	152.1	1.3	2.9	0.1	290.3	257.1	2.3	54.0	11.1	1243.7	0.2	193.0	14.4	0.5	2.5	6.7	0.8	0.8	8.8	13.7	0.6	95.5	1.1	21.9	19.7	264.9	0.0	3.3	0.0	0.0	1.2	6.5	51.8	0.1	5.4	0.2	14.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	5.3	0.1	0.0	10.4	0.0	4.2	0.8	0.0	1.1	0.0	0.0	58.9	0.0	0.0	9.3	0.0	0.0	3.7	0.0	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.5	7.9	0.0	148.5	0.0	0.0	0.4	1.4	0.2	58.2	53.8	52.1	0.2	4.9	0.7	0.2	0.1	0.1	0.1	22.7	0.2	5.0	13.3	73.6	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.8	0.0	2.4	0.0	5.0	4.9	0.0	0.0	2.0	6.4	0.0	0.0	0.0	0.0	1.8	0.7	177.1	135.6	21.6	212.8	105.6	642.6	290.3	257.1	193.0	95.5	264.9	51.8	0.8	0.0	0.0	29.0	12.5	15.8	1.3	4.3	0.6	139.6	11.4	14.9	1.4	2.8	4.3	389.9	52.1	1.0	1.0	18.2	277.8	8.6	12.8	44.3	8.7	3.6	3045.7	2.7	64.8	0.7	69.0	17.2	112.1	35.2	0.0	2.5	0.0	0.5	1.7	437.4	118.8	218.9	54.9	0.3	17.2	52.9	3.4	10.5	56.9	22.5	0.4	96.2	1.0	72.9	26.0	23.1	628.8	7.2	4.5	30.4	21.6	1601.1	24.8	148.2	0.0	0.3	12.6	32.5	82.2	0.2	11.5	1.9	20.1	0.2	15.6	3.7
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 28.5;brain: 30.2;retina: 35.8;thyroid gland: 56.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.3;Excitatory neurons: 322.8;Horizontal cells: 132.9;Inhibitory neurons: 148.8;Melanocytes: 209.9;Muller glia cells: 452.7"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 65.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 60.0;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		18000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	0.7	28.5	8.6	0.8	14.9	0.5	0.4	0.1	30.2	1.6	0.0	6.9	4.8	0.2	0.3	1.1	1.0	0.5	4.7	15.8	11.1	0.2	0.2	2.5	0.0	2.2	1.3	9.0	19.8	0.8	2.0	0.6	2.6	1.4	1.7	35.8	1.7	1.2	0.1	14.1	2.1	0.4	1.4	0.1	8.1	4.8	13.2	0.0	56.9	0.1	0.1	3.0	2.4	11.9	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.1	30.2	15.8	11.1	2.2	1.3	2.6	1.4	13.2	11.9	0.1	0.0	7.3	7.8	0.0	8.2	0.0	0.0	1.2	28.1	0.0	0.0	1.2	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	1.3	0.0	0.0	322.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	132.9	148.8	0.6	0.0	0.0	1.3	6.3	2.8	0.2	209.9	8.4	0.0	452.7	0.0	44.7	6.4	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.5	1.2	1.0	0.3	0.2	1.4	0.0	0.1	0.6	0.0	0.1
PCSK4	"DKFZp434B217, MGC34749, PC4, SPC5"	ENSG00000115257	"Proprotein convertase subtilisin/kexin type 4"	Q6UW60	19	1481428-1490752	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 66.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 277.1;Late spermatids: 679.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.7;HMC-1: 3.7;JURKAT: 5.3;U-266/70: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005572	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA005572: AB_1855087"	"unprognostic (1.00e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-3)"	"prognostic favorable (9.45e-5)"	"unprognostic (5.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.94e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.93e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.03e-2)"	0.8	1.4	1.1	0.3	1.1	0.6	1.2	0.9	2.5	1.7	1.3	1.3	1.7	1.1	0.1	1.1	3.2	0.6	0.5	1.4	1.6	3.7	4.0	1.1	0.3	1.9	2.8	1.1	2.8	0.9	7.1	0.2	1.5	1.8	0.1	0.6	1.1	1.2	0.3	0.6	1.1	0.1	1.8	0.7	1.4	66.0	1.6	0.4	3.4	0.0	0.1	1.0	1.2	0.9	0.6	0.3	1.2	6.7	0.1	0.2	1.8	0.5	0.1	0.0	0.2	0.6	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.1	0.3	1.1	1.0	0.4	0.0	3.7	0.6	0.0	0.0	0.1	0.3	0.2	5.3	1.2	1.8	0.0	0.0	0.1	0.3	0.1	0.3	0.4	1.2	0.1	0.1	0.4	0.0	0.0	1.4	0.1	0.3	0.1	0.4	2.5	0.4	0.0	0.5	0.0	0.1	0.0	7.7	1.5	0.3	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	1.1	0.9	2.5	1.4	1.6	1.9	2.8	1.5	1.8	1.6	0.9	0.2	0.0	1.1	12.1	0.1	0.6	0.9	1.8	0.6	1.5	3.1	2.2	2.3	1.5	3.6	0.0	8.4	0.5	1.7	1.6	5.9	1.8	277.1	5.2	1.0	0.5	0.0	1.7	3.2	1.0	0.5	0.8	3.1	1.1	0.0	3.3	0.0	3.2	0.8	3.3	3.7	1.4	0.0	0.3	0.0	679.2	6.2	1.1	3.6	3.7	0.0	2.4	0.0	1.0	1.6	0.9	1.1	5.3	1.4	0.5	2.8	1.9	8.3	9.1	0.0	0.2	0.5	98.0	9.6	1.2	0.0	0.3	0.7	2.4	2.1	0.7
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362975	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 2447.1;neutrophil: 626.3"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 2447.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		290000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	17.6	4.2	6.6	5.9	6.6	2.3	6.9	22.2	23.8	9.0	0.0	10.2	25.0	7.1	9.6	8.5	6.9	8.6	5.3	7.4	7.8	3.8	1.7	6.1	2.7	21.7	17.3	13.5	3.0	5.9	2.3	9.4	20.0	3.3	8.4	6.0	3.5	3.0	3.0	3.6	26.4	6.6	23.0	3.3	3.3	6.3	5.3	9.1	4.8	5.4	2.5	5.3	8.8	2.4	2.5	1.8	5.1	3.4	3.2	1.0	32.6	4.7	0.4	0.3	0.0	18.7	2.0	0.8	1.3	0.6	0.1	46.9	2.4	1.4	0.3	0.6	4.1	6.3	4.5	1.6	0.8	1.9	2.8	6.0	0.4	1.0	0.5	0.3	9.6	3.1	7.5	2.4	3.3	11.5	7.4	11.1	22.8	4.3	1.9	1.3	30.4	1.9	42.5	2.9	0.7	0.5	7.1	1.5	0.5	9.5	2.6	8.0	7.6	1.5	66.5	3.8	2.0	0.7	0.3	1.0	5.1	2.7	25.7	2447.1	43.1	192.4	100.0	25.9	85.2	92.3	100.8	93.7	21.8	116.5	98.2	125.2	626.3	135.5	51.6	135.0	96.9	10.1	6.6	6.6	22.2	23.8	7.4	7.8	21.7	17.3	20.0	23.0	5.3	2.4	41.1	6.4	7.2	189.7	0.1	6.5	3.5	8.6	13.6	4.8	0.7	2.0	5.8	11.5	14.3	5.5	0.0	2.1	9.6	47.3	0.0	8.2	19.0	6.0	35.1	19.5	1.2	0.0	33.5	6.1	34.3	26.6	9.7	10.6	0.0	32.1	15.0	0.9	2.9	55.5	81.9	10.2	6.1	4.1	3.9	39.4	20.5	7.5	1.8	70.3	11.4	30.3	82.4	149.3	5.8	10.1	18.5	25.2	0.4	2.9	99.2	4.2	23.4	1.4	19.7	9.1	11.4	1.0	1.9	6.2	3.0	2.5	6.2	5.6	23.9	0.9
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101289784-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 153.6;liver: 160.0;lymphoid tissue: 81.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		480000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	5.3	2.2	17.5	3.0	67.3	1.1	11.2	57.8	37.0	2.2	4.2	16.5	6.8	2.0	3.3	9.0	2.8	3.1	20.0	19.3	34.1	3.2	160.0	3.6	2.5	113.0	64.5	6.1	2.6	0.6	5.1	32.0	95.6	3.1	14.8	7.6	2.8	0.6	11.4	10.1	10.1	3.6	42.9	81.4	9.8	13.0	54.0	20.9	2.2	16.3	1.8	3.7	2.6	153.6	19.7	14.6	2.6	0.9	0.2	0.4	47.2	0.7	2.5	0.0	0.1	35.7	8.3	0.4	2.4	0.6	1.1	11.4	12.5	1.5	0.0	2.8	60.3	33.5	8.4	53.8	1.6	4.5	0.4	0.3	7.5	0.2	0.2	0.2	0.1	4.3	24.5	0.2	0.0	8.8	0.1	4.7	9.3	65.9	6.5	0.2	0.4	4.4	4.4	25.4	7.3	8.6	26.2	1.5	9.1	6.6	2.2	21.9	0.2	0.3	1.2	0.3	0.2	0.5	0.6	0.7	0.2	0.6	7.3	0.8	0.2	0.9	0.2	0.4	0.3	0.5	0.4	0.2	0.1	1.0	0.6	0.5	0.4	3.3	1.3	0.4	0.1	1.2	17.5	67.3	57.8	37.0	19.3	34.1	113.0	64.5	95.6	42.9	54.0	153.6	1.7	3.2	0.6	2.9	1.3	0.4	0.3	0.9	0.6	1.7	15.4	6.6	2.0	8.6	1.4	1.8	20.9	6.7	0.6	22.6	0.0	0.6	1.6	4.7	21.6	4.9	0.0	3.2	19.4	0.8	24.3	15.5	1.5	6.9	0.0	4.2	12.5	231.6	1.4	196.9	30.8	3.7	0.0	5.2	1.1	2.4	10.5	1.7	0.0	5.6	1.0	1.7	3.1	25.6	561.9	7.3	8.2	0.0	0.0	1.7	2.3	0.1	1.2	1.6	0.0	2.0	1.0	4.7	2.4	0.9	0.1	3.3	1.0	106.5	8.5	0.2
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55751051-55842830	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.0"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 68.5;Hepatocytes: 72.8;Syncytiotrophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 241.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 94.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	15.3	8.5	8.0	10.4	8.0	11.4	12.4	8.1	8.9	10.7	8.3	23.1	18.1	7.4	28.3	10.7	9.0	9.7	19.0	7.7	9.2	29.7	98.0	18.8	9.9	8.7	9.5	8.3	11.8	13.4	7.9	28.7	8.7	9.6	23.8	4.2	10.8	23.1	18.9	6.4	16.5	10.7	8.1	15.5	19.0	13.3	9.9	5.9	8.5	19.3	8.9	13.4	7.9	8.0	21.2	19.3	13.9	5.1	18.4	17.7	36.6	8.1	10.3	12.5	12.1	22.0	26.7	5.9	61.0	12.7	11.8	11.5	8.2	13.7	11.2	94.8	19.5	51.9	5.7	40.2	16.3	20.0	39.5	14.7	17.3	7.6	13.5	15.2	24.8	17.7	38.4	20.2	13.7	18.7	16.0	16.1	15.4	0.0	16.9	8.1	20.5	4.9	13.4	15.6	7.1	16.1	4.2	8.7	34.6	30.4	23.6	33.8	18.2	14.7	10.4	16.2	10.9	57.9	19.4	3.6	13.2	32.7	25.5	77.3	60.9	241.1	9.4	52.6	5.6	8.6	6.1	9.7	49.0	5.3	3.6	8.2	63.3	27.5	58.9	3.9	11.8	29.3	8.0	8.0	8.1	8.9	7.7	9.2	8.7	9.5	8.7	8.1	9.9	8.0	13.1	3.2	8.1	25.5	4.2	1.0	2.4	6.6	2.8	4.0	5.4	4.8	15.7	15.7	3.2	9.2	2.1	51.6	5.2	17.8	11.7	13.0	18.3	6.4	6.0	10.3	13.1	12.2	16.5	13.7	68.5	8.2	7.7	6.3	15.2	7.1	10.4	72.8	22.1	1.7	26.4	17.1	8.2	25.2	5.1	20.0	16.4	20.1	12.4	9.4	15.1	4.0	11.3	19.6	4.2	9.5	10.1	25.9	5.3	1.7	13.9	40.6	3.8	2.3	13.1	4.3	8.9	17.9	7.7	6.6	1.4	67.2	5.6	8.2	16.2	2.6
PCYOX1	"KIAA0908, PCL1"	ENSG00000116005	"Prenylcysteine oxidase 1"	Q9UHG3	2	70257386-70281185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 599.4;Hepatocytes: 187.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 313.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035193	Approved				"Intracellular and membrane"	NA	NA		510000000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA035193: AB_10602017"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	78.5	33.5	15.4	12.7	15.7	3.7	34.4	12.1	18.4	56.5	29.3	26.9	24.9	39.9	33.6	38.8	35.6	31.7	37.7	14.7	27.8	92.6	103.5	56.2	14.6	16.5	22.0	39.6	20.6	66.0	17.9	29.0	24.9	44.3	23.6	30.7	70.1	46.6	92.1	33.0	24.5	40.8	14.6	15.6	22.1	14.2	28.4	11.1	60.0	50.4	14.2	25.7	25.2	13.2	38.8	54.9	43.2	48.6	313.2	160.0	37.9	64.8	59.4	35.4	26.5	86.5	33.6	4.0	27.3	89.2	58.2	62.2	31.7	50.2	40.5	22.1	26.9	14.9	41.0	75.7	31.4	14.1	12.7	154.9	54.1	47.4	13.3	93.9	42.6	14.2	27.0	27.8	50.7	23.6	10.7	22.8	26.1	55.9	23.1	19.6	90.2	34.5	50.1	42.8	11.3	24.1	97.8	47.7	45.5	61.0	39.1	18.2	53.4	59.2	32.7	52.9	34.2	22.9	55.1	5.1	71.3	19.3	22.1	16.3	6.5	6.8	8.3	5.4	10.4	3.7	8.0	6.7	5.9	2.8	10.8	9.2	4.1	6.1	6.0	7.4	7.8	6.5	15.4	15.7	12.1	18.4	14.7	27.8	16.5	22.0	24.9	14.6	28.4	13.2	37.3	599.4	77.5	16.0	12.2	21.3	23.1	43.9	29.6	48.7	46.0	31.8	81.1	40.0	49.9	53.3	43.8	43.4	12.1	30.7	7.9	26.7	1.7	18.4	65.9	33.4	8.5	12.0	24.7	10.2	36.0	81.9	22.4	36.2	10.1	20.9	39.7	187.8	22.1	57.2	36.8	21.0	36.7	17.4	9.2	3.9	89.2	14.3	24.9	23.4	8.6	90.3	11.3	21.6	18.0	13.9	21.0	120.7	26.2	27.0	47.7	69.0	25.0	36.9	72.3	65.5	63.7	14.7	32.2	40.8	28.3	22.0	14.5	56.2	26.5	18.4
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358037-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 17.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.2;RPMI-8226: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	3.2	4.6	2.3	5.3	2.4	3.9	3.3	2.4	4.5	5.1	0.2	3.2	1.8	4.9	0.6	3.5	5.3	4.7	3.9	2.9	4.4	2.0	0.5	3.4	6.6	3.7	2.5	5.7	3.1	17.5	4.9	4.2	5.0	3.9	0.7	7.6	2.9	4.5	0.8	5.4	4.8	5.2	1.0	4.0	3.7	6.4	2.3	4.6	2.7	1.8	3.2	3.8	3.8	2.3	4.3	2.7	9.2	20.3	7.8	7.9	4.9	9.0	4.0	7.8	13.2	0.8	7.6	17.9	27.1	6.7	36.1	7.7	8.8	20.3	0.7	8.4	8.2	8.4	0.0	0.7	17.3	7.3	9.1	14.9	3.0	10.7	12.6	9.4	17.3	16.6	4.9	50.2	0.4	17.9	8.1	11.2	4.7	15.8	16.3	10.7	6.7	50.8	4.9	2.0	13.3	13.6	17.9	11.9	14.6	10.0	20.0	12.4	8.2	6.8	5.5	14.7	4.2	20.1	29.2	10.6	11.2	38.3	14.6	3.0	7.1	4.0	2.8	9.6	3.7	1.6	5.3	2.1	13.2	1.0	6.3	4.4	1.2	4.8	9.6	0.9	7.3	4.7	2.3	2.4	2.4	4.5	2.9	4.4	3.7	2.5	5.0	1.0	2.3	2.3	4.5	9.6	1.7	2.9	2.3	1.0	1.0	3.2	2.8	5.2	2.4	1.8	5.3	4.3	3.6	1.8	0.0	6.0	1.9	0.6	0.0	3.0	3.3	3.2	2.4	4.6	0.0	2.5	10.5	2.3	6.6	5.0	2.0	2.3	2.5	9.6	2.5	0.4	7.6	11.8	12.4	1.8	6.1	8.2	1.4	1.5	3.4	6.9	1.8	4.7	7.0	7.8	1.0	5.5	4.9	2.1	1.7	2.6	1.3	0.8	2.6	0.6	2.8	14.2	0.0	2.5	2.7	1.2	3.5	1.9	1.6	1.2	5.6	9.7	2.3	0.9
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.2;retina: 12.1;testis: 13.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 23.5;Early spermatids: 29.1;Late spermatids: 90.1;Muller glia cells: 30.1;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 41.9"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 22.2;HEL: 25.7;Hep G2: 10.2;NTERA-2: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.1	0.8	12.1	0.2	12.2	0.8	0.1	10.6	12.8	0.7	7.5	1.2	0.3	1.6	0.6	0.8	2.2	0.4	2.9	13.2	9.8	0.2	0.0	0.7	0.0	9.5	10.2	1.4	1.5	0.0	1.3	1.3	9.8	0.8	0.2	12.1	0.1	2.4	0.0	0.1	0.6	2.5	8.6	0.2	0.2	13.4	11.4	0.5	0.0	0.0	0.0	0.3	0.3	12.9	0.0	0.0	10.3	0.1	0.0	0.0	0.1	0.0	0.9	0.3	0.1	22.2	0.0	0.0	5.2	0.0	0.0	1.0	4.2	0.0	0.0	0.0	0.1	25.7	0.0	10.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.5	11.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	7.2	5.8	0.0	0.0	0.5	7.1	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.4	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	12.1	12.2	10.6	12.8	13.2	9.8	9.5	10.2	9.8	8.6	11.4	12.9	0.0	0.0	0.0	23.5	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.5	1.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	29.1	10.7	0.2	0.1	1.8	1.3	5.6	0.0	0.0	0.4	0.0	0.2	4.5	5.8	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	90.1	0.3	0.9	0.0	3.7	0.3	30.1	0.0	23.6	41.9	0.2	0.0	2.6	0.1	0.1	0.0	0.5	6.4	1.6	0.0	0.0	1.0	1.8	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408597	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		410000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	25.7	29.6	35.8	22.6	36.2	23.2	24.4	36.5	39.3	26.2	34.1	32.4	17.9	26.9	17.5	37.2	22.6	11.9	40.2	34.4	36.1	28.5	31.3	24.0	18.9	37.3	37.9	25.7	26.6	22.5	21.9	19.2	37.4	26.0	18.0	22.9	26.2	20.9	105.0	27.9	23.3	21.1	37.6	23.8	26.3	19.7	37.0	25.5	24.3	59.7	22.4	29.3	26.4	36.6	96.9	82.4	54.6	71.0	41.5	43.2	34.7	76.7	44.9	61.6	51.8	83.9	47.4	41.3	67.2	74.7	78.4	50.2	66.3	78.4	60.5	59.8	74.4	43.6	80.8	74.1	60.8	80.1	40.5	45.6	58.5	68.1	110.3	56.3	62.7	67.5	103.0	75.6	61.4	200.3	110.4	111.2	68.7	98.1	88.3	50.5	54.3	73.6	63.6	73.0	54.8	110.6	58.0	92.4	43.4	61.3	41.1	42.5	57.6	83.6	91.4	100.8	123.6	71.4	87.5	91.0	67.7	72.2	89.1	13.4	12.1	12.5	15.4	16.6	13.9	15.7	14.2	11.2	10.2	14.9	9.8	13.2	31.6	28.0	15.6	21.1	20.9	6.6	35.8	36.2	36.5	39.3	34.4	36.1	37.3	37.9	37.4	37.6	37.0	36.6	82.9	86.6	94.7	6.2	73.6	62.2	110.6	104.6	57.5	97.4	84.3	76.6	63.6	72.9	86.7	42.3	33.3	213.1	84.7	101.6	168.3	176.1	60.3	91.3	118.6	99.1	117.9	151.7	10.1	171.0	223.0	87.4	59.7	88.3	72.2	83.4	61.8	80.8	114.9	77.4	11.6	116.5	75.3	38.3	63.3	78.3	83.6	66.1	103.2	5.6	102.1	166.4	119.4	8.0	17.4	177.4	92.2	92.2	102.5	184.3	100.0	134.5	96.8	101.0	52.6	85.6	127.2	132.5	123.0	131.9	65.6	184.4	79.5	115.2	114.0	122.5
PDC	MEKA	ENSG00000116703	Phosducin	P20941	1	186443566-186461114	"Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	478	"retina: 668.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 99.1;Cone photoreceptor cells: 362.8;Muller glia cells: 179.8;Rod photoreceptor cells: 999.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.0"	"Low region specificity"	"Detected in all"			HPA062235	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA062235: AB_2684720"	"unprognostic (2.06e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.53e-2)"		"unprognostic (2.43e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.07e-7)"	"unprognostic (3.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	668.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	99.1	0.0	0.0	0.1	0.0	0.0	0.0	362.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.2	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	57.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	179.8	0.0	2.5	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	999.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.7;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"Plasma cells: 9.5;T-cells: 34.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;MOLT-4: 2.4;RPMI-8226: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favorable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"	1.2	0.3	0.0	3.2	0.2	0.9	0.4	0.0	0.1	0.6	0.2	0.8	0.3	0.4	0.0	0.8	0.6	0.3	6.7	0.1	0.1	0.7	0.4	1.8	16.1	0.1	1.4	0.2	0.3	0.0	1.5	0.0	0.2	0.7	0.1	0.0	1.0	0.2	0.1	0.3	3.8	0.2	0.1	7.0	1.8	0.3	0.4	3.1	1.5	0.0	4.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.8	0.2	8.7	12.4	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	4.3	2.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	1.4	0.2	0.1	0.4	0.2	0.4	0.0	0.6	0.0	3.6	0.4	0.3	0.0	0.0	0.0	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.6	0.0	34.7	0.0	0.0	0.1
PDCD10	"CCM3, TFAR15"	ENSG00000114209	"Programmed cell death 10"	Q9BUL8	3	167683298-167734939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027095	Approved					NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA027095: AB_1855101"	"unprognostic (3.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.98e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.95e-3)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.58e-2)"	34.4	30.4	24.0	39.2	27.1	61.7	41.3	28.4	34.3	24.9	22.6	50.9	48.7	27.3	29.1	50.4	24.4	29.5	35.9	25.6	28.0	43.5	36.4	31.4	53.0	26.9	25.6	25.6	25.7	41.5	21.9	44.4	27.3	31.0	48.7	20.3	31.4	24.7	21.8	27.6	43.4	30.3	27.9	33.1	41.3	44.1	25.9	50.9	37.9	29.6	52.6	50.2	32.3	32.2	133.1	49.3	61.6	39.6	56.7	62.1	67.7	78.5	82.7	89.8	89.9	92.3	153.3	107.5	150.0	73.2	156.5	86.0	73.1	91.1	108.0	172.2	52.9	164.8	59.3	61.1	80.3	109.8	93.0	47.9	92.7	56.9	92.6	64.3	73.3	89.1	129.6	105.2	82.1	117.2	88.4	67.7	79.3	119.3	67.9	51.3	46.9	157.9	112.7	53.5	58.9	52.1	75.2	80.8	148.5	76.8	149.0	92.4	70.5	63.5	41.2	68.9	113.5	113.4	170.9	187.6	75.3	114.6	53.2	224.8	81.7	196.5	82.4	107.0	100.1	136.2	111.2	100.2	79.4	136.4	92.0	95.3	175.0	107.1	138.9	73.2	181.9	133.8	24.0	27.1	28.4	34.3	25.6	28.0	26.9	25.6	27.3	27.9	25.9	32.2	103.3	44.8	42.6	18.6	74.8	108.1	91.0	227.1	69.4	20.2	49.1	57.4	71.1	32.9	120.9	33.1	6.2	106.2	76.9	100.1	105.7	101.4	76.0	58.8	48.3	69.8	34.6	123.3	48.0	122.0	112.3	52.9	62.7	61.4	62.7	34.8	45.3	41.5	91.2	20.2	33.8	75.4	120.1	53.8	73.6	33.5	49.7	89.0	49.8	27.2	100.5	52.9	88.6	19.1	49.7	121.7	103.0	39.5	51.2	97.2	72.0	123.5	92.8	24.1	32.9	37.9	128.4	119.5	103.7	66.6	129.0	103.0	77.9	38.9	55.9	122.7
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510531-5571282	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		31000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	4.4	0.8	0.4	6.9	0.6	0.3	4.3	0.5	0.5	2.5	0.3	1.7	0.7	2.2	1.2	2.0	2.4	3.4	2.7	0.4	0.8	1.2	4.2	7.1	10.4	1.1	0.6	1.6	0.6	0.4	0.2	4.8	1.1	1.0	2.1	0.0	1.3	1.4	1.5	1.4	1.5	3.1	0.9	15.1	1.4	0.6	0.7	5.0	1.0	2.2	6.2	4.2	2.2	1.3	6.0	0.0	0.0	0.0	4.7	5.4	0.1	71.4	111.6	33.7	40.4	0.0	0.3	0.0	0.2	29.2	4.8	0.5	0.1	9.7	33.3	88.1	0.0	0.0	0.0	0.0	26.5	0.0	0.0	5.0	0.1	15.8	18.5	9.7	22.4	0.0	0.0	8.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.0	0.1	49.7	24.0	1.4	11.8	20.1	1.2	0.1	0.1	13.6	0.0	3.0	1.5	0.3	0.0	0.5	1.4	0.6	0.2	0.7	0.3	0.3	0.1	0.0	0.3	0.7	0.0	0.1	0.0	1.1	0.3	0.4	0.6	0.5	0.5	0.4	0.8	1.1	0.6	1.1	0.9	0.7	1.3	6.1	6.4	0.5	1.6	0.4	1.0	0.1	0.7	1.8	0.0	0.2	1.5	0.1	0.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.0	1.6	0.2	17.9	6.7	0.5	0.0	3.8	0.2	6.8	0.0	2.9	0.0	1.4	0.0	0.0	5.3	13.1	0.0	5.9	2.5	1.8	12.2	26.4	0.0	0.0	1.0	2.4	3.7	0.0	2.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.0	0.3	1.0	0.8	1.1	0.1	0.0	0.1
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	26.3	25.6	18.9	30.0	19.1	35.4	43.0	20.2	23.7	27.1	18.4	31.1	32.4	25.9	39.9	32.6	33.7	23.4	22.8	19.3	20.2	33.2	32.7	23.4	43.2	19.2	20.0	29.8	45.4	29.6	16.9	28.4	19.3	25.9	38.4	17.7	31.7	30.3	36.4	25.8	25.9	28.7	19.0	27.5	30.6	19.9	19.5	42.3	34.6	27.0	50.6	32.8	21.6	19.3	50.5	36.2	53.8	126.7	75.8	82.6	59.3	58.6	66.7	67.9	75.3	65.2	43.1	90.6	46.6	64.8	90.8	70.5	116.5	97.1	98.9	74.7	127.2	128.6	46.2	119.3	91.9	161.6	83.3	75.6	93.4	86.2	138.7	71.2	95.8	123.9	260.3	57.7	84.1	109.5	113.0	116.6	77.5	161.6	54.9	79.4	41.5	117.8	103.7	29.3	98.4	102.4	66.7	107.8	71.6	58.1	54.8	162.8	73.0	33.3	71.4	80.1	105.1	76.5	96.4	97.9	62.1	154.9	87.0	4.1	12.4	11.5	14.1	12.0	16.5	14.2	15.9	14.9	17.3	13.8	15.5	14.8	5.3	18.8	15.2	15.9	20.3	12.0	18.9	19.1	20.2	23.7	19.3	20.2	19.2	20.0	19.3	19.0	19.5	19.3	47.2	12.8	15.3	9.4	54.1	49.5	76.4	14.6	40.5	36.9	58.0	59.7	27.4	52.9	14.0	29.5	12.5	63.9	82.2	29.2	78.2	55.3	17.0	36.1	38.5	38.8	47.2	64.1	13.2	74.1	71.6	32.2	32.1	33.5	15.9	59.8	44.6	28.2	49.2	16.8	12.7	44.0	22.4	41.9	33.2	15.0	49.0	40.9	35.6	8.4	62.8	34.7	84.5	8.0	12.4	58.6	36.4	40.6	58.0	103.9	47.8	83.6	16.0	35.3	19.7	43.8	55.5	33.0	85.8	58.7	46.0	46.7	60.7	60.8	68.0	84.1
PDCD2L	MGC13096	ENSG00000126249	"Programmed cell death 2 like"	Q9BRP1	19	34404399-34426168	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 35.7;Spermatogonia: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052181	Approved		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA052181: AB_2681751"	"unprognostic (5.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.98e-2)"	4.2	5.6	5.0	2.7	5.3	3.1	4.1	4.8	5.8	4.3	4.2	5.3	2.6	5.0	2.9	5.3	5.0	2.1	7.5	5.0	5.6	3.5	5.5	2.9	4.7	4.5	4.7	4.4	8.3	2.2	5.8	2.5	4.9	3.4	3.4	1.1	5.5	3.8	24.7	4.7	4.0	3.1	4.7	4.8	6.5	14.4	5.4	2.9	3.1	9.1	4.8	4.8	3.9	5.7	21.6	35.9	4.4	8.7	2.0	4.2	13.8	6.8	4.9	11.1	11.1	33.6	15.1	17.7	28.8	3.9	11.6	7.4	17.4	14.9	11.7	26.1	36.6	17.4	5.7	26.8	14.5	34.0	9.8	5.1	12.9	6.5	21.2	4.6	11.3	28.0	35.1	9.0	9.6	27.3	13.4	12.4	16.0	47.3	34.4	19.2	8.2	25.1	14.1	12.1	25.8	9.2	0.7	21.4	12.5	7.3	9.3	13.9	6.0	7.3	9.0	8.6	23.4	20.1	32.8	31.4	9.1	29.8	6.3	0.0	3.3	0.0	9.1	5.3	12.9	12.7	8.9	9.0	6.8	10.1	13.1	9.9	0.7	12.5	3.4	23.6	11.7	5.7	5.0	5.3	4.8	5.8	5.0	5.6	4.5	4.7	4.9	4.7	5.4	5.7	5.5	3.2	4.8	3.6	7.6	8.2	15.0	7.6	10.2	4.3	4.8	7.4	5.1	5.7	4.8	3.7	2.1	8.1	12.0	1.7	7.9	13.3	27.4	6.3	4.3	4.9	12.1	4.6	4.2	15.3	7.0	5.1	9.2	2.7	4.5	5.6	5.0	5.1	7.5	1.7	4.3	5.0	2.0	3.3	3.7	3.9	5.3	4.1	3.6	2.8	7.1	4.8	9.2	4.0	3.4	13.1	5.0	6.8	8.2	27.6	1.1	10.2	6.1	2.4	0.0	6.1	12.6	35.7	42.9	7.5	10.7	1.8	5.4	8.2	7.7	9.6
PDCD4	H731	ENSG00000150593	"Programmed cell death 4"	Q53EL6	10	110871795-110900006	"Predicted intracellular proteins"	Apoptosis	RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 505.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 786.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 295.6;U-266/70: 320.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001032, HPA027214, CAB037024"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107"	"unprognostic (4.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.25e-1)"	45.7	30.7	15.0	53.2	15.7	74.0	146.6	18.1	16.9	49.3	24.7	157.6	90.7	67.0	36.2	151.3	57.7	43.4	22.4	13.7	17.2	26.2	36.2	32.8	60.7	15.7	18.5	133.6	505.4	283.9	40.3	97.0	15.4	55.3	130.4	50.4	255.0	60.4	11.8	104.2	100.2	51.3	15.5	67.6	102.3	29.9	16.6	73.9	154.5	18.7	95.4	42.2	61.8	17.3	26.5	25.4	40.6	43.7	61.6	110.7	23.8	29.9	89.7	14.7	25.7	16.0	65.0	252.3	81.7	43.5	11.4	118.8	26.1	79.4	32.4	219.7	50.6	127.5	146.9	27.9	26.9	65.2	135.8	88.0	247.4	15.7	84.0	67.6	28.2	40.1	35.3	119.6	37.6	69.7	24.2	76.4	10.6	19.0	46.3	10.4	71.6	138.7	24.8	36.8	17.8	73.6	58.7	31.6	109.1	44.6	295.6	121.3	71.8	22.6	16.8	17.1	11.0	320.1	163.8	143.6	22.2	87.4	24.5	186.1	19.5	52.4	54.0	27.0	96.0	54.1	49.7	59.8	23.0	39.5	43.0	53.2	38.3	84.7	29.6	38.5	29.0	40.4	15.0	15.7	18.1	16.9	13.7	17.2	15.7	18.5	15.4	15.5	16.6	17.3	85.3	19.2	50.0	16.3	132.0	133.1	88.1	104.6	113.3	61.8	148.1	113.9	16.8	42.9	90.3	25.8	31.3	229.5	246.1	348.0	35.2	70.8	20.2	66.7	132.5	79.1	33.6	94.2	26.2	101.4	78.4	72.1	82.0	59.4	132.9	111.7	97.1	23.6	56.5	21.9	44.4	150.6	81.4	84.1	49.7	11.0	145.1	66.1	291.7	46.9	57.4	40.9	75.2	36.7	70.6	45.0	244.3	222.7	134.7	51.3	292.1	28.1	47.8	206.1	39.5	69.4	48.6	63.3	72.2	200.8	165.2	786.0	229.2	176.8	190.3	73.3
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581190-32587453	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		47000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	95.7	96.1	86.2	73.8	87.0	46.8	82.0	85.4	110.2	73.2	80.8	100.1	65.8	68.8	50.8	109.3	70.9	34.8	170.9	86.7	91.1	97.8	101.2	68.0	58.6	87.1	87.7	71.8	102.4	52.6	95.1	61.2	88.4	64.3	55.7	39.2	70.1	41.9	224.2	60.5	62.0	65.8	85.8	56.8	78.9	144.4	94.6	41.8	60.6	132.2	59.5	91.1	80.3	89.9	499.0	630.0	168.8	163.7	223.8	334.0	190.0	353.2	225.6	295.2	252.2	525.0	188.3	272.6	498.7	177.1	286.3	133.2	213.6	281.7	254.4	493.1	333.6	412.4	303.9	382.8	284.0	587.0	157.3	219.7	253.8	195.9	315.0	145.1	198.8	214.9	381.0	298.8	247.2	332.0	243.6	298.6	164.9	410.5	211.6	238.9	248.8	323.6	231.9	167.6	326.0	178.4	338.1	351.8	283.4	125.2	152.6	294.6	299.4	272.6	291.7	274.2	602.7	270.6	413.0	504.4	302.3	459.8	244.2	40.7	93.4	50.9	106.4	149.0	134.3	147.3	167.4	132.1	120.6	116.3	115.3	114.3	13.7	116.9	197.6	123.6	217.8	122.7	86.2	87.0	85.4	110.2	86.7	91.1	87.1	87.7	88.4	85.8	94.6	89.9	115.4	73.7	62.7	16.6	70.4	121.6	174.0	292.0	97.3	43.2	129.1	216.4	336.1	94.4	119.4	75.4	27.1	194.7	69.0	94.6	189.8	245.3	469.7	94.0	166.4	121.3	71.3	44.8	24.0	247.3	216.5	150.4	64.2	115.0	46.9	84.9	83.6	151.1	146.7	50.5	29.3	113.6	140.4	48.3	93.1	481.2	142.6	67.4	124.5	11.2	113.8	104.0	66.9	17.6	16.8	292.2	100.4	123.0	124.4	392.4	125.1	216.8	107.9	45.3	72.3	126.8	218.4	487.0	413.1	170.9	119.9	143.0	78.4	164.9	157.8	140.4
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798571-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 299.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011905, CAB016212, HPA051604"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		4100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Centrosome	"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favorable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	33.1	27.6	16.3	24.5	17.9	21.2	32.9	18.4	23.3	35.0	23.0	46.4	36.2	35.1	26.4	46.0	30.9	25.9	30.5	17.6	19.7	35.0	33.2	35.2	26.1	25.2	18.1	34.3	25.0	40.6	22.8	31.2	26.4	30.0	41.5	30.5	29.7	23.7	33.9	39.8	38.8	31.8	18.6	27.5	37.2	23.8	18.8	24.4	34.2	22.1	30.1	26.9	35.9	21.4	47.2	46.4	30.2	25.1	78.5	80.6	34.3	67.2	56.2	50.9	52.2	33.3	43.8	75.9	33.8	77.7	32.2	45.5	47.8	61.4	57.8	27.4	39.5	56.7	37.4	28.2	50.8	56.5	57.6	62.2	69.5	57.6	67.8	60.5	77.1	32.4	50.3	26.2	74.4	27.0	36.3	31.8	29.9	43.5	57.8	32.8	36.5	43.8	64.6	39.2	14.7	26.8	61.6	67.8	30.7	48.9	62.0	51.4	101.1	59.5	28.2	50.1	46.9	26.6	37.6	55.6	56.7	62.6	28.8	6.8	13.5	11.0	8.0	18.1	8.7	12.0	8.9	8.1	12.4	10.8	7.7	7.5	6.8	12.1	18.0	5.0	9.4	10.0	16.3	17.9	18.4	23.3	17.6	19.7	25.2	18.1	26.4	18.6	18.8	21.4	78.5	86.6	84.8	85.8	76.1	41.7	62.6	62.7	51.8	28.6	42.5	34.0	53.4	62.9	80.6	64.4	52.1	53.0	58.5	299.9	37.2	67.2	85.3	121.6	84.0	68.8	36.1	40.6	83.5	78.3	52.8	54.3	96.8	77.8	53.7	53.0	54.3	57.3	60.6	25.2	69.2	97.1	63.1	93.0	44.7	50.4	74.0	85.0	28.4	75.9	71.0	23.1	42.2	96.0	161.7	122.5	127.1	80.5	46.9	56.5	130.2	61.0	130.9	49.9	46.0	42.3	50.4	93.0	48.4	61.5	43.2	96.6	55.2	47.7	86.7	70.3
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133808	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 176.1;Cone photoreceptor cells: 221.0;Rod photoreceptor cells: 176.3;Spermatocytes: 164.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoli	"HPA049388: AB_2680741"	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	12.0	12.4	13.8	11.9	14.3	10.0	11.9	18.0	18.2	16.2	12.2	15.8	9.9	16.5	12.7	17.8	13.6	8.4	11.4	14.2	13.3	10.3	12.5	10.2	14.5	14.2	13.5	16.8	11.2	11.6	10.9	11.9	14.6	13.0	9.3	10.8	10.0	11.9	13.1	11.1	11.3	13.3	12.0	13.4	11.0	18.9	14.2	15.7	12.5	8.7	15.1	14.8	14.0	16.7	18.2	14.9	24.8	25.7	24.4	34.2	15.0	20.4	22.6	24.7	18.8	18.2	19.7	34.9	21.7	16.5	18.5	33.5	63.9	14.7	17.7	21.3	17.0	33.9	12.8	15.9	22.5	46.6	21.8	20.0	22.0	13.6	25.4	23.7	19.8	25.6	44.0	27.6	21.7	13.9	48.7	33.2	30.1	21.1	13.3	42.7	31.8	39.0	15.2	28.5	20.4	24.3	22.8	19.1	31.3	27.0	15.4	37.7	20.0	25.2	24.6	14.8	31.9	49.1	60.4	24.9	22.7	50.5	13.2	2.1	1.4	0.9	2.0	1.2	1.7	2.3	1.9	1.8	1.3	2.4	2.0	1.9	0.3	3.3	1.2	1.8	1.5	0.7	13.8	14.3	18.0	18.2	14.2	13.3	14.2	13.5	14.6	12.0	14.2	16.7	33.6	0.0	14.3	10.1	46.3	38.0	67.8	6.0	89.4	176.1	33.1	40.9	17.7	21.5	11.1	29.5	221.0	55.3	55.8	17.2	29.4	9.0	5.9	26.8	51.8	36.5	14.4	27.5	31.0	8.2	32.6	38.4	20.4	28.2	19.7	49.0	31.1	19.4	23.6	75.7	32.9	26.9	6.1	23.2	22.8	8.9	58.1	24.7	12.4	9.4	14.5	47.2	45.3	15.1	28.9	7.3	11.6	48.2	37.9	56.8	14.2	22.7	8.5	176.3	46.0	45.5	38.8	164.6	107.3	48.8	39.9	71.4	49.5	60.3	26.1	51.5
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828588	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	11.0	8.7	6.8	10.4	9.5	19.4	13.0	8.5	8.7	12.1	7.3	10.2	9.3	13.4	7.7	9.8	10.3	9.5	8.8	6.5	9.2	8.8	6.4	13.1	13.1	8.8	8.4	9.9	6.8	11.0	5.0	14.1	9.2	11.1	10.5	12.4	12.8	9.2	5.9	10.6	9.1	11.3	7.4	12.7	10.7	6.7	8.5	13.1	11.6	6.9	12.3	9.2	7.5	10.6	16.9	23.2	38.4	14.4	34.1	22.5	21.4	23.1	23.8	20.9	21.2	15.2	21.9	28.1	18.7	27.5	23.0	32.3	24.1	22.6	22.7	28.0	12.1	29.2	30.1	25.3	17.4	24.6	55.3	19.7	15.8	20.7	10.3	19.3	43.3	17.6	29.7	16.1	23.1	25.8	27.1	22.2	28.4	28.8	17.6	27.8	36.5	20.9	25.6	0.0	30.8	27.4	31.3	17.3	13.8	25.1	26.5	16.8	48.4	19.4	23.0	28.4	22.8	12.0	26.7	30.5	16.6	19.6	19.0	30.4	13.8	23.9	15.2	12.5	16.2	12.7	18.2	14.1	14.5	16.0	18.5	16.4	11.4	19.8	21.8	17.0	31.3	13.4	6.8	9.5	8.5	8.7	6.5	9.2	8.8	8.4	9.2	7.4	8.5	10.6	43.0	9.6	9.2	5.2	16.7	24.2	14.7	25.4	25.6	42.6	19.9	16.0	5.7	14.3	13.4	20.2	22.9	27.6	29.1	12.9	9.8	20.7	5.5	29.9	22.3	37.5	12.6	50.5	5.8	18.0	27.3	26.7	9.7	36.3	57.1	14.4	31.8	7.6	24.9	40.4	8.2	19.0	24.4	22.6	15.7	4.1	23.0	19.3	19.6	10.3	30.4	36.1	20.6	6.6	15.4	16.5	13.2	17.0	18.2	15.8	9.1	15.3	21.9	38.2	19.7	15.8	21.6	14.5	21.9	25.8	23.2	31.9	25.9	19.9	13.5	16.5
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556519-55592245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 65.1"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1285.9;Late spermatids: 634.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HaCaT: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048260, HPA072384"	Enhanced		Approved	Microtubules,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules	Centrosome	"HPA048260: AB_2680333, HPA072384: "		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	65.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1285.9	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	634.7	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	13.1	0.0	0.1	40.4	50.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165988078	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 67.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 204.7;Inhibitory neurons: 209.6;Microglial cells: 89.0;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 67.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 9.0;LHCN-M2: 12.5;RT4: 6.9;SH-SY5Y: 8.1;TIME: 11.3;U-2 OS: 7.0"	"Region enriched"	"Detected in all"	11	"basal ganglia: 350.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 194.1"	"CAB045998, HPA047200"	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	2.6	1.3	3.1	0.8	67.2	0.0	2.3	5.5	10.7	1.3	0.0	1.0	0.2	2.0	2.4	0.4	2.4	1.5	3.6	2.1	2.5	3.8	0.3	1.0	0.5	1.6	2.3	2.3	0.5	0.5	2.7	2.5	0.9	1.7	0.2	1.9	0.4	1.7	0.4	0.3	0.7	2.1	0.5	1.4	1.1	3.4	9.6	0.3	6.0	0.5	0.4	3.2	0.9	0.1	0.0	2.4	5.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	3.8	0.1	2.2	0.0	0.0	0.1	3.9	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	12.5	0.3	0.9	0.0	1.1	0.0	4.7	1.5	5.8	0.0	5.9	6.9	1.8	8.1	0.0	0.0	0.4	0.7	0.0	0.0	11.3	0.1	7.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	67.2	5.5	10.7	2.1	2.5	1.6	2.3	0.9	0.5	9.6	0.1	13.8	0.0	0.0	10.4	0.1	0.4	3.3	0.4	0.0	7.2	0.3	0.3	7.3	0.0	1.2	5.5	2.1	7.8	0.0	0.0	3.9	2.0	14.3	0.2	1.7	13.4	0.0	0.0	204.7	0.0	6.1	6.6	1.1	0.4	1.3	0.1	7.9	0.0	0.8	16.8	209.6	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.8	89.0	0.0	12.6	0.0	48.7	51.8	0.1	0.0	0.4	0.0	17.9	0.0	7.2	0.9	1.1	0.0	12.4	5.0	8.8	2.1	0.1	0.3	2.9	0.1	1.6	0.1	6.9
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623244-178072777	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 6.3;parathyroid gland: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0;Hepatocytes: 11.1;Late spermatids: 46.4;Oligodendrocytes: 14.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;fHDF/TERT166: 2.4;HAP1: 1.4;Hep G2: 2.8"									HPA034560	Approved				"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.3	0.3	0.8	0.1	2.0	0.2	1.7	1.9	1.2	0.6	0.6	0.5	0.8	1.2	0.4	0.0	0.3	0.4	0.3	0.6	2.1	0.5	6.3	0.0	0.0	2.5	2.1	0.4	1.1	9.8	0.9	0.0	2.7	5.2	0.4	1.4	1.4	0.8	4.4	0.1	0.5	1.1	3.7	0.1	0.4	2.8	1.9	0.1	1.3	1.3	0.0	0.0	0.1	3.2	0.0	0.4	0.2	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.2	1.6	0.0	0.6	2.4	0.3	0.1	1.4	0.0	0.0	0.0	0.9	1.1	0.1	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.2	0.4	0.1	0.6	0.0	0.3	0.2	0.0	0.2	0.0	0.5	0.0	0.3	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.8	2.0	1.9	1.2	0.6	2.1	2.5	2.1	2.7	3.7	1.9	3.2	0.1	0.0	0.0	2.3	0.2	0.6	1.4	0.1	0.0	1.7	4.2	0.8	0.0	1.5	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.8	37.0	0.3	0.2	0.6	6.7	2.7	1.6	6.7	0.0	0.6	0.0	0.2	0.0	0.0	1.4	11.1	0.1	0.0	8.2	0.9	6.1	1.2	2.1	46.4	1.5	0.3	0.0	0.0	0.0	4.7	0.0	6.0	14.9	2.3	0.0	0.7	0.0	5.4	0.6	1.3	0.1	1.0	0.0	2.0	0.6	6.8	6.9	0.0	1.3	0.3	0.3	0.3	1.3	1.0
PDE11A		ENSG00000284741	"Phosphodiesterase 11A"		2	177628069-178108339	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Cardiomyocytes: 1.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034560	Uncertain					NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA034560: AB_10602140"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556274-57566848	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043171	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	7.6	8.6	4.1	8.3	4.6	13.9	6.0	5.1	4.4	5.2	4.7	7.2	9.1	5.7	3.9	9.0	4.2	7.1	5.7	4.3	5.2	8.0	10.6	5.5	8.9	3.9	3.9	4.7	9.8	9.2	4.4	7.3	3.5	6.3	6.7	7.3	5.9	6.4	8.4	4.9	7.2	6.9	4.2	7.1	7.2	4.2	3.9	7.0	7.2	7.9	8.1	8.6	4.9	6.2	19.5	18.8	11.5	21.3	14.6	10.3	20.8	16.1	15.3	17.8	15.8	24.9	12.9	31.6	5.9	14.6	23.7	12.5	24.8	16.8	14.5	14.7	12.7	23.5	15.4	19.3	16.6	31.1	23.5	14.2	11.3	21.5	19.0	9.3	15.6	16.1	19.4	22.3	16.3	15.0	28.0	10.2	17.8	15.1	32.0	10.5	9.4	23.0	14.4	22.3	10.2	16.0	17.3	20.2	17.4	9.1	15.0	17.6	19.3	14.7	13.7	28.1	26.4	21.9	34.2	27.4	17.3	24.1	22.2	20.6	9.3	8.7	10.9	12.7	12.3	6.7	10.2	11.3	10.2	11.4	12.4	12.4	2.3	14.9	13.8	5.3	13.5	10.2	4.1	4.6	5.1	4.4	4.3	5.2	3.9	3.9	3.5	4.2	3.9	6.2	15.9	25.6	21.9	32.0	20.0	36.8	18.5	13.2	14.8	21.0	17.9	10.0	10.8	22.8	14.8	31.3	12.5	19.0	23.9	17.9	5.9	10.0	1.3	15.5	19.3	14.6	12.5	20.4	50.8	9.8	11.3	14.6	12.8	21.7	19.7	12.8	13.6	27.8	15.0	26.9	49.0	10.8	10.2	18.5	16.8	1.3	10.5	16.1	12.4	26.2	15.8	18.3	17.5	47.7	56.6	9.0	9.8	12.4	20.4	18.6	14.8	16.5	8.9	31.1	6.6	32.7	15.1	18.6	10.3	21.7	39.6	20.5	19.2	19.7	19.5	19.1
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.6;thyroid gland: 45.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 396.3;Excitatory neurons: 764.9;Late spermatids: 592.1;Oligodendrocytes: 1178.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 37.2;HHSteC: 22.0;HSkMC: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	10.5	4.4	16.9	4.6	20.4	0.0	5.0	35.5	23.4	17.2	2.4	11.8	3.0	8.7	8.0	5.6	10.3	23.7	15.6	30.3	8.4	46.6	3.9	3.6	2.1	2.6	4.2	10.9	2.1	2.2	2.7	1.2	5.4	3.6	6.7	1.4	2.0	5.4	2.8	2.2	5.7	12.9	3.7	3.1	5.6	35.6	16.5	8.4	45.8	5.0	0.9	9.7	9.8	18.2	0.0	0.2	3.9	0.0	37.2	3.1	0.1	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	4.7	0.0	5.1	0.0	22.0	0.0	0.0	47.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.7	0.0	5.4	0.1	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	20.4	35.5	23.4	30.3	8.4	2.6	4.2	5.4	3.7	16.5	18.2	6.7	0.0	2.6	15.3	0.0	1.3	2.0	0.1	8.0	20.0	0.3	0.3	5.9	1.5	1.4	27.6	0.0	0.1	0.0	0.1	185.9	0.5	396.3	0.3	0.4	8.9	0.0	0.0	764.9	0.4	0.0	18.6	0.0	0.8	0.0	0.1	5.0	0.0	0.1	0.0	185.8	1.0	0.0	0.0	1.8	592.1	14.9	0.4	0.0	30.0	0.0	0.3	0.0	18.1	1178.0	0.2	0.1	8.2	0.2	2.6	0.1	1.5	0.0	1.2	52.6	21.0	45.1	9.1	4.9	1.0	1.3	0.0	0.2	7.6	0.1	0.7
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 197.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 75.1;basal ganglia: 84.7;cerebral cortex: 102.1;hippocampal formation: 84.4;white matter: 48.3"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.8;T-cells: 7.3"	"Cell line enriched"	"Detected in some"	8	"HeLa: 513.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	89.2	44.1	75.1	5.1	84.7	4.7	83.6	0.0	102.1	38.1	0.0	34.6	6.0	27.2	8.3	18.6	39.3	22.7	41.1	84.4	7.0	32.5	19.4	12.6	6.7	6.4	5.1	11.6	6.9	5.5	11.8	12.0	10.1	20.7	8.9	3.0	9.2	10.7	16.8	18.1	18.7	18.5	0.0	197.0	17.1	7.4	17.9	3.8	24.1	28.9	3.5	28.8	27.1	48.3	0.3	0.2	0.7	0.2	0.2	0.1	0.3	0.1	0.2	0.2	0.4	0.4	2.5	0.8	12.2	0.2	1.9	0.2	0.9	0.1	0.1	0.1	0.1	0.0	513.6	0.8	0.9	0.0	7.8	0.1	1.1	2.7	20.5	1.1	11.3	0.5	0.8	0.9	0.1	0.0	0.2	0.2	7.4	0.2	14.0	0.0	0.2	1.4	0.1	0.3	44.5	2.4	0.4	0.2	2.2	0.7	0.3	0.1	65.2	0.1	9.4	3.5	0.4	0.4	0.2	0.1	3.9	0.1	0.6	0.0	0.6	0.0	7.3	0.8	4.2	2.8	4.3	4.3	1.0	1.8	2.7	2.3	0.1	0.0	0.4	0.0	1.8	1.5	75.1	84.7	0.0	102.1	84.4	7.0	6.4	5.1	10.1	0.0	17.9	48.3	114.9	0.0	0.5	2.0	0.7	2.5	0.1	0.0	0.0	4.9	0.6	1.0	7.8	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.6	0.0	0.1	58.5	34.4	5.3	70.1	0.0	0.3	2.1	0.0	0.1	1.3	0.1	118.2	2.1	0.5	1.7	35.6	1.2	0.0	9.4	8.2	2.5	0.3	4.9	1.8	11.2	0.0	0.0	0.0	9.0	5.7	0.1	0.0	0.4	1.5	0.1	0.0	0.1	0.0	0.4	0.0	1.8	6.6	4.8	2.5	0.5	2.8	0.0	0.6	0.2	0.1	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 74.9;skeletal muscle: 70.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 619.3;Excitatory neurons: 2969.7;Inhibitory neurons: 1116.9;Oligodendrocyte precursor cells: 848.0;Oligodendrocytes: 443.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 57.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in many"		"A549: 62.2;AN3-CA: 70.4;HeLa: 104.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.9	1.3	3.3	9.8	9.9	74.9	4.6	0.0	11.3	5.3	0.0	21.0	5.5	7.4	18.4	13.7	7.3	9.1	15.7	4.4	4.2	17.2	2.8	13.3	5.3	7.0	2.0	3.0	3.7	5.5	6.7	16.6	1.2	19.9	15.0	21.4	7.4	21.2	70.4	4.5	7.0	15.3	0.8	4.0	10.3	3.4	3.8	8.6	7.4	34.4	5.6	22.0	8.2	5.7	0.1	62.2	12.8	70.4	2.3	4.4	10.1	1.6	1.8	3.4	4.9	24.5	2.0	4.8	0.2	0.5	10.3	10.6	0.0	2.8	5.9	2.9	7.0	9.2	104.6	5.3	9.1	4.4	0.7	9.3	2.3	9.6	1.7	1.1	7.3	0.3	0.0	1.6	5.9	4.5	3.6	10.3	2.4	1.8	3.2	1.2	16.0	10.5	15.9	23.5	2.3	8.0	16.4	27.1	14.2	11.4	1.9	9.3	8.5	0.9	0.2	12.0	3.3	3.5	0.1	0.5	10.3	17.3	2.7	4.2	2.0	57.9	1.5	0.1	1.5	11.0	1.4	0.7	1.4	11.3	0.9	0.7	3.1	0.4	0.2	0.0	0.8	1.1	3.3	9.9	0.0	11.3	4.4	4.2	7.0	2.0	1.2	0.8	3.8	5.7	22.5	32.1	110.0	619.3	32.3	10.6	30.1	6.6	35.3	20.2	5.1	2.7	35.7	8.6	30.2	42.3	73.0	11.3	118.6	28.1	11.7	0.6	21.4	19.0	8.6	16.9	33.4	2.1	2969.7	1.8	25.7	27.5	40.2	21.9	22.2	0.3	17.2	0.8	5.2	1.7	1116.9	18.2	6.1	4.8	11.1	36.6	1.5	29.5	10.6	407.5	6.0	12.0	29.9	848.0	443.3	8.2	11.9	4.9	44.4	43.3	8.9	27.5	19.4	52.8	0.0	64.0	6.3	1.1	7.7	40.6	8.8	3.1	94.3	1.1	11.7	26.5
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857953-149944793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"retina: 1119.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 2946.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.1	0.7	0.5	0.2	0.5	0.9	0.2	1.4	0.7	0.1	0.2	1.2	0.2	0.1	16.3	0.9	0.2	0.2	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.2	1.7	0.1	0.5	0.3	0.9	1119.5	0.4	0.2	0.3	0.6	0.1	0.1	0.2	0.2	0.2	1.5	0.6	0.0	0.4	0.0	0.2	0.0	0.1	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.2	0.3	0.4	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.1	0.4	0.4	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.5	0.5	1.4	0.7	0.5	0.5	0.3	0.3	0.5	0.2	0.6	1.2	0.9	0.0	5.8	0.0	0.4	1.1	0.6	0.8	0.0	150.5	0.5	0.4	6.7	0.0	2.8	0.0	244.0	1.1	1.6	14.3	0.0	0.1	18.4	1.5	0.5	11.6	0.0	0.0	1.2	0.2	2.2	1.2	0.0	2.5	3.8	1.9	2.2	0.6	0.3	75.7	0.6	0.4	2.0	1.9	0.4	5.5	1.2	1.5	0.0	0.0	1.4	263.1	5.2	0.5	0.2	0.1	2.8	0.4	0.3	0.4	0.4	0.1	3.2	2946.4	0.0	1.0	1.2	2.3	0.8	5.4	0.6	2.9	1.5	2.2	2.7	0.2
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 385.0"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	13.5	5.5	25.7	8.4	4.1	8.2	22.3	2.5	1.9	1.7	1.2	2.7	4.0	1.7	10.2	3.7	5.9	11.2	22.6	4.9	1.0	4.6	14.3	22.8	19.9	2.8	1.8	8.2	4.1	3.1	25.5	2.8	1.3	385.0	3.8	3.0	1.1	2.1	3.0	2.5	9.3	10.1	2.9	4.4	24.1	12.2	12.0	0.1	9.3	3.8	1.4	39.3	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	13.5	25.7	8.2	22.3	11.2	22.6	22.8	19.9	25.5	9.3	24.1	39.3	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
PDE6D	JBTS22	ENSG00000156973	"Phosphodiesterase 6D"	O43924	2	231732433-231786272	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 211.9;Late spermatids: 147.9;Spermatocytes: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037433, HPA037434"	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA037433: AB_2675475, HPA037434: AB_10672490"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (7.07e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (4.97e-4)"	16.8	28.1	43.4	16.2	47.3	14.6	16.3	47.4	50.7	19.2	38.0	19.6	13.4	17.6	14.9	16.3	15.5	14.2	19.3	44.4	45.7	19.5	15.4	15.2	23.3	45.6	46.0	13.4	13.2	23.5	25.0	23.0	45.7	13.7	17.6	69.6	14.2	17.6	13.7	16.4	15.7	22.0	46.5	18.8	16.2	27.8	45.8	32.4	14.0	16.7	24.0	17.9	16.4	49.6	26.3	20.3	37.0	28.2	43.7	36.1	15.7	27.0	44.6	40.8	56.9	8.1	24.5	21.4	22.7	23.2	74.9	20.4	22.3	30.2	52.6	63.5	26.4	31.2	12.4	13.0	20.2	20.6	17.2	25.5	26.4	39.8	30.4	27.5	44.1	68.3	9.1	23.5	27.5	52.0	67.7	64.4	28.6	39.6	28.1	45.7	17.0	32.9	42.8	19.5	36.4	32.6	23.0	19.4	46.3	36.1	17.5	43.0	19.5	26.5	7.3	57.9	21.4	57.9	26.3	52.6	27.4	38.6	42.5	84.4	48.2	68.4	46.3	48.7	36.3	50.4	46.0	47.3	49.3	55.5	31.7	44.3	42.0	34.4	64.9	55.8	84.4	43.1	43.4	47.3	47.4	50.7	44.4	45.7	45.6	46.0	45.7	46.5	45.8	49.6	20.8	0.0	8.7	18.3	19.5	13.8	12.4	23.6	21.1	14.7	13.3	17.7	13.1	12.8	15.8	12.9	16.7	16.4	18.2	10.2	25.4	23.1	211.9	6.8	9.2	19.6	17.4	15.8	13.4	23.9	21.9	14.7	13.3	6.5	14.5	7.3	19.2	5.0	18.9	11.8	18.1	10.0	14.2	14.4	15.1	147.9	13.1	17.5	23.2	16.9	24.6	22.0	17.5	48.7	34.0	26.0	14.9	12.4	17.0	10.5	11.2	18.4	11.8	29.0	19.7	10.7	24.9	236.8	65.1	20.3	14.2	13.5	18.5	11.5	10.5	11.0
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973042-14981865	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"retina: 911.3"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 831.9;Rod photoreceptor cells: 218.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"	"Low region specificity"	"Detected in single"							HPA045118	Supported		Uncertain	Vesicles		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.0	0.4	0.3	0.0	0.4	4.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	911.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	1.0	0.3	2.3	0.3	0.4	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.1	0.0	0.0	0.0	831.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	0.0	21.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	23.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.6	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65714334-65842322	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 108.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.4;Inhibitory neurons: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 94.9;MOLT-4: 167.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	8.5	3.1	5.2	28.5	8.0	26.6	19.8	8.5	7.2	13.4	7.7	7.6	11.4	6.3	14.0	6.6	7.9	11.5	49.3	5.1	5.3	18.8	5.5	19.1	58.8	6.6	5.2	6.0	14.3	3.1	13.4	8.3	5.2	13.7	9.8	14.0	20.8	8.6	63.6	8.2	26.4	5.5	3.9	29.4	13.0	10.3	8.2	108.3	22.9	75.9	43.0	9.9	8.9	11.1	12.5	10.8	47.2	22.2	6.7	5.8	20.0	9.3	7.9	11.5	11.0	12.8	8.1	35.0	2.2	5.8	10.2	13.8	17.5	19.7	12.0	41.3	8.9	25.6	18.5	9.6	3.4	20.3	9.8	8.3	32.0	7.4	22.3	9.9	11.4	84.0	19.1	94.9	7.9	6.8	167.6	23.0	50.3	10.1	4.8	61.8	7.2	9.2	7.8	24.6	22.9	26.5	9.8	4.9	4.8	32.2	26.1	52.2	7.4	15.9	19.6	11.3	7.6	45.6	21.3	60.3	16.1	42.1	8.9	2.5	0.7	5.5	3.4	0.6	5.5	6.5	5.2	3.4	1.5	7.5	11.9	9.2	2.5	2.3	0.2	2.1	4.7	1.8	5.2	8.0	8.5	7.2	5.1	5.3	6.6	5.2	5.2	3.9	8.2	11.1	8.6	19.2	22.7	41.4	95.1	18.1	13.6	8.8	7.4	27.3	23.1	21.8	46.6	20.0	17.3	3.7	56.3	14.1	93.4	3.7	0.0	8.2	32.1	11.8	12.6	7.9	9.6	31.6	102.4	5.3	8.4	17.2	8.2	13.5	9.5	14.2	6.8	4.3	10.4	18.5	111.3	6.5	12.2	17.3	34.9	15.0	7.5	26.2	16.0	48.7	19.7	10.1	47.4	89.0	86.2	6.1	5.6	7.5	56.3	19.4	5.9	21.3	20.3	66.1	0.0	18.4	11.1	10.3	10.9	6.0	18.8	8.6	81.3	6.8	6.5	10.8
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	16.7	16.6	20.9	8.5	32.3	3.3	10.5	21.9	22.4	11.6	15.2	24.0	15.3	9.1	7.3	6.4	9.0	15.8	8.0	17.3	20.1	24.3	30.0	10.8	5.6	23.8	28.5	12.7	14.5	16.9	6.7	11.4	23.6	6.9	21.9	14.5	6.4	9.6	5.8	6.3	13.6	10.6	19.5	6.3	11.0	11.0	26.9	4.6	12.3	6.5	5.1	17.7	7.0	45.2	29.0	48.4	7.9	5.4	32.7	17.2	9.6	19.4	21.1	16.6	18.9	10.9	16.9	5.8	14.6	25.9	19.7	20.2	33.8	14.9	22.0	10.8	20.2	7.7	30.3	15.6	23.5	4.5	11.3	17.4	9.1	19.6	18.6	14.3	21.6	6.4	15.6	18.3	15.2	24.5	2.6	4.5	3.8	9.5	8.6	3.6	6.5	8.1	13.2	89.0	18.3	14.1	18.9	20.3	55.5	8.7	6.7	8.7	17.1	38.4	13.6	13.9	31.6	8.9	16.7	6.2	26.1	18.1	11.0	0.0	0.9	0.6	0.3	0.7	0.6	0.2	0.5	0.6	0.5	0.3	0.7	0.3	0.0	0.2	1.6	0.0	1.1	0.2	20.9	32.3	21.9	22.4	17.3	20.1	23.8	28.5	23.6	19.5	26.9	45.2	30.7	6.4	26.5	83.9	14.8	11.3	11.1	13.9	18.2	13.0	6.6	5.2	6.8	41.5	15.4	7.3	12.5	8.0	5.5	58.7	7.9	11.3	6.4	12.5	21.6	24.3	14.5	0.8	60.8	9.6	7.1	16.2	26.5	20.6	22.1	17.9	14.3	23.3	10.8	10.1	126.2	19.0	4.1	12.3	18.9	5.6	10.8	19.2	10.6	85.3	9.0	2.6	10.3	119.1	968.6	11.5	31.8	11.3	7.2	25.4	22.1	21.1	10.5	31.2	39.5	17.8	24.5	25.6	17.3	7.5	10.4	4.5	10.8	25.3	28.5	26.4
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653621-42775509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	9.4	11.1	12.3	3.9	15.1	0.5	10.8	14.0	12.9	7.2	8.6	74.7	2.9	5.1	19.4	3.7	10.6	6.8	4.3	10.6	12.6	29.8	4.2	4.9	4.8	12.4	14.4	3.5	4.1	6.5	9.9	10.3	12.7	38.5	16.4	10.7	12.7	15.8	2.4	7.0	47.3	8.8	11.0	18.3	13.4	1.9	15.0	7.8	6.5	4.8	3.1	18.9	6.2	12.0	0.0	2.8	29.7	3.7	0.0	0.8	0.5	0.0	0.0	0.0	0.0	3.2	18.2	0.0	30.0	0.0	2.2	0.0	2.7	9.8	0.0	0.0	10.4	0.0	0.0	6.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	23.2	1.5	34.7	41.2	14.6	0.0	0.0	0.0	1.2	20.4	7.6	22.5	13.5	5.2	0.0	0.5	7.0	0.2	19.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.2	3.1	0.6	0.4	0.9	0.0	0.4	1.0	0.3	12.3	15.1	14.0	12.9	10.6	12.6	12.4	14.4	12.7	11.0	15.0	12.0	18.6	3.2	5.0	43.4	1.6	1.0	10.9	4.2	6.2	26.4	13.4	12.6	1.6	5.7	2.4	18.4	0.0	0.0	1.0	90.8	29.4	7.3	0.6	18.1	8.5	11.9	13.1	3.2	5.6	2.4	0.1	5.9	1.5	26.8	1.3	6.1	5.7	0.9	7.5	35.3	10.8	25.8	8.2	1.3	0.8	2.2	11.8	1.6	28.4	31.9	1.1	11.0	0.0	29.1	16.6	5.3	105.3	6.0	0.2	28.1	233.5	8.9	1.3	2.8	13.1	0.5	6.4	0.4	2.3	0.5	0.6	0.4	3.8	16.9	24.4	15.0
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		580000	"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	15.4	8.5	29.3	7.9	36.8	1.7	17.0	36.6	32.4	18.1	20.5	29.2	20.2	26.1	11.2	9.6	21.2	11.4	21.1	27.0	27.5	22.2	8.5	24.9	3.5	46.4	37.5	7.7	71.6	6.6	10.2	26.8	40.7	23.3	14.8	5.2	20.3	11.2	95.2	12.5	25.9	10.2	35.8	16.3	32.1	4.5	36.5	6.6	10.0	15.1	2.4	17.8	15.9	58.8	22.9	15.3	1.5	21.6	4.1	0.7	50.7	5.0	2.9	6.4	4.4	23.8	25.3	0.6	8.7	4.3	2.9	56.6	1.5	69.0	3.4	12.9	2.3	0.3	13.3	8.7	26.9	2.4	2.2	3.0	26.8	3.3	21.3	8.5	12.5	1.3	2.3	3.1	15.8	28.7	3.5	5.0	40.1	8.9	3.3	11.6	1.5	2.5	9.0	5.3	2.1	1.8	76.5	4.2	13.3	47.5	10.7	2.6	37.3	13.6	37.8	8.0	31.0	0.9	1.4	0.8	12.3	7.1	311.4	11.3	1.6	2.4	1.6	1.9	2.2	1.9	1.6	1.5	1.5	1.8	1.9	2.0	4.9	3.4	3.3	2.1	1.8	2.1	29.3	36.8	36.6	32.4	27.0	27.5	46.4	37.5	40.7	35.8	36.5	58.8	15.2	89.8	11.9	11.1	1.5	28.0	20.2	12.1	59.7	15.7	12.7	154.9	29.9	15.7	11.0	14.7	8.4	8.8	1.7	76.9	5.9	15.8	0.3	49.0	4.2	19.4	13.1	0.0	7.7	53.3	5.4	12.3	41.8	35.7	10.8	18.1	21.0	1.0	2.0	32.0	5.9	40.5	2.0	1.3	10.4	0.1	2.1	14.8	14.2	6.5	1.5	0.7	1.0	5.0	27.5	72.6	97.0	6.4	4.4	29.4	47.2	8.5	4.5	2.1	39.5	48.9	110.3	0.5	1.8	9.4	9.8	2.9	3.9	0.2	32.1	18.2
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244982	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	950000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	32.6	6.4	14.7	7.1	10.7	0.4	24.0	10.3	22.2	7.5	4.8	20.6	4.9	8.9	5.2	6.2	7.2	11.7	31.2	12.0	9.8	17.0	3.7	28.1	7.4	13.6	12.4	3.8	8.8	8.9	4.0	40.2	12.0	7.6	3.5	0.8	10.6	5.2	18.7	10.3	9.1	9.2	10.6	6.6	7.9	3.4	16.0	2.1	16.1	11.0	1.6	8.5	6.6	9.4	33.8	2.6	8.4	0.0	0.0	0.0	9.9	0.1	0.4	0.2	0.0	13.0	10.3	0.0	69.2	0.0	3.1	12.4	0.5	2.8	0.0	0.1	0.2	0.7	1.1	4.8	4.3	0.0	18.1	0.0	0.3	0.0	0.4	0.9	52.6	0.0	1.3	6.1	1.9	13.7	0.1	0.1	3.2	8.1	3.4	0.0	0.3	22.8	27.7	0.1	0.2	0.0	0.6	53.5	0.2	6.0	24.3	0.1	68.1	0.1	6.4	0.1	7.5	0.1	0.4	0.3	0.1	1.5	31.3	0.0	0.0	0.0	7.3	0.1	10.0	0.0	4.3	5.6	0.0	0.0	3.6	1.9	0.1	0.0	0.4	1.3	2.3	2.1	14.7	10.7	10.3	22.2	12.0	9.8	13.6	12.4	12.0	10.6	16.0	9.4	75.0	0.0	1.1	0.0	0.6	2.8	1.2	3.8	1.2	0.7	5.1	7.1	3.1	0.0	1.3	7.3	0.0	7.3	4.0	0.1	0.0	20.0	1.3	4.0	0.7	60.6	1.8	0.0	2.8	3.6	6.5	1.6	0.0	5.6	0.0	13.1	16.8	1.4	7.7	0.0	0.9	0.7	4.1	2.6	44.3	0.1	0.6	25.5	1.8	14.0	1.1	0.3	0.0	0.0	0.2	54.7	0.0	0.0	0.0	2.7	0.1	1.9	0.9	0.1	6.6	4.7	9.6	0.3	1.6	1.1	1.4	4.5	2.0	1.2	0.1	0.6
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971799	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		37000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	4.8	4.0	0.9	1.3	1.0	0.6	7.5	0.4	1.0	9.2	0.7	2.3	2.0	9.9	2.1	3.3	6.7	4.8	2.6	1.0	0.8	5.5	5.1	3.1	1.1	0.8	0.7	7.7	4.3	20.3	0.4	4.5	0.7	8.7	2.0	0.7	8.4	7.0	1.2	1.6	2.8	9.4	0.9	1.3	2.8	0.9	1.1	2.0	6.5	1.2	1.0	3.2	1.2	1.0	2.5	3.7	38.6	25.4	7.0	13.4	1.0	21.5	21.5	12.0	16.1	2.2	9.4	0.0	3.8	60.0	9.2	2.6	10.8	13.4	16.5	0.0	5.0	25.5	3.2	2.4	18.3	3.9	0.3	14.2	6.6	30.6	21.7	56.8	6.0	0.1	0.1	0.1	30.2	0.1	0.0	0.0	0.4	0.0	1.7	0.0	8.1	0.0	22.5	0.9	0.0	0.0	0.0	0.2	0.4	6.0	3.1	1.3	28.3	41.7	0.4	10.9	17.3	0.0	0.0	0.0	16.1	0.0	1.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	1.0	0.4	1.0	1.0	0.8	0.8	0.7	0.7	0.9	1.1	1.0	2.4	6.4	14.2	98.6	0.7	49.6	22.7	12.4	25.0	2.0	14.7	13.6	16.8	58.6	7.8	12.9	0.0	0.6	3.4	0.5	0.0	15.4	30.5	6.9	15.0	7.3	0.0	5.5	64.4	7.1	0.3	18.6	8.2	11.4	1.3	124.1	10.0	15.9	13.0	0.0	32.1	2.1	4.1	34.4	21.6	23.8	5.3	32.1	10.6	85.3	14.2	6.3	0.0	233.2	3.0	18.0	0.5	23.0	1.4	8.7	2.4	18.6	3.5	0.5	6.6	34.8	18.2	0.7	2.9	3.4	13.5	0.5	0.9	13.8	2.1	4.8
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907189-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 106.5;ovary: 78.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1"	"Group enriched"	"Detected in many"	29	"granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4"	"Group enriched"	"Detected in many"	6	"ASC diff: 139.8;HHSteC: 42.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 39.4"	"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		95000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA046183: AB_2679573, HPA066271: AB_2685645"	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	20.4	106.5	0.5	3.4	0.8	0.9	21.7	0.7	1.3	25.1	9.0	8.8	4.1	11.8	7.1	1.9	9.3	34.0	23.2	0.8	2.2	7.7	2.3	3.1	7.4	5.1	6.6	78.0	25.7	17.1	13.4	7.0	9.4	10.0	9.8	1.5	8.6	37.4	2.2	7.9	4.8	9.7	1.8	2.8	23.4	3.3	2.0	3.7	18.3	8.8	5.4	15.8	15.4	2.3	0.0	7.8	4.0	0.0	139.8	4.2	0.1	0.9	0.8	0.7	0.8	0.0	1.3	7.4	1.4	7.3	5.2	0.4	0.0	0.2	0.3	0.0	3.2	0.2	1.6	0.3	42.6	0.0	0.1	14.7	0.0	0.1	0.0	0.2	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	1.4	0.0	2.1	0.0	6.7	0.0	0.1	9.6	0.0	13.8	3.2	1.8	0.0	2.0	1.0	0.1	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	9.5	16.4	0.0	1.4	0.4	1.7	7.2	0.0	0.0	0.2	6.0	0.2	17.1	0.1	0.0	0.1	4.2	0.5	0.8	0.7	1.3	0.8	2.2	5.1	6.6	9.4	1.8	2.0	2.3	15.6	0.0	0.0	1.0	1.6	3.1	7.7	0.2	1.8	2.3	1.7	9.4	4.5	32.9	0.6	5.5	0.0	0.2	30.0	0.2	0.0	30.6	8.2	0.8	1.8	10.3	1.8	1.3	13.9	4.4	0.2	44.3	0.0	1.4	0.0	8.1	2.9	0.0	0.3	26.9	95.0	1.0	0.0	1.3	3.7	13.3	0.3	0.8	0.0	28.1	0.9	1.5	46.4	2.0	2.8	3.0	0.5	2.2	8.4	1.6	0.0	0.3	0.0	0.5	6.6	1.9	3.7	0.4	4.3	0.3	2.0	0.0	10.2	5.2	0.6	3.2
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 subunit alpha 1"	P08559	X	19343893-19361718	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 508.8;tongue: 770.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 479.9;Distal tubular cells: 354.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	93.0	69.0	62.1	37.9	66.9	88.1	63.1	66.2	91.5	55.9	84.4	112.6	87.0	53.1	78.9	76.8	49.1	29.3	508.8	68.2	67.0	174.1	118.3	47.2	36.6	64.5	62.7	50.6	83.4	161.0	48.7	43.1	65.0	48.4	104.4	90.1	109.7	63.4	459.0	60.9	82.1	51.8	59.6	49.3	121.8	24.0	67.4	52.3	64.5	770.2	59.1	61.7	56.1	71.1	124.9	151.4	107.9	114.2	102.3	77.7	131.6	83.8	74.6	170.2	130.7	216.6	78.2	212.2	60.6	102.0	226.7	159.0	334.2	145.8	178.1	70.1	186.1	104.8	264.0	194.2	107.8	170.3	82.8	100.9	132.8	157.3	154.4	85.6	105.3	129.8	94.2	87.2	120.7	164.5	142.7	173.5	110.0	227.4	261.7	145.2	180.9	260.3	298.0	125.1	59.7	62.6	134.1	167.8	158.1	229.8	177.1	118.1	65.4	87.6	78.6	240.9	108.6	73.3	82.0	140.5	82.4	117.2	77.4	99.9	87.4	65.3	72.3	119.9	88.9	103.4	69.4	79.5	115.7	82.1	67.7	72.0	15.5	98.1	109.1	76.9	84.4	89.6	62.1	66.9	66.2	91.5	68.2	67.0	64.5	62.7	65.0	59.6	67.4	71.1	34.1	44.8	44.4	18.6	30.7	29.8	59.7	135.4	25.0	59.0	37.0	29.3	479.9	87.2	74.8	152.6	33.3	105.0	32.5	73.0	354.1	88.8	2.5	41.2	33.7	36.8	41.9	55.8	21.2	59.8	120.7	49.2	49.5	36.9	42.6	39.7	18.2	76.3	73.2	25.2	24.6	64.4	71.2	26.8	30.5	4.1	35.4	32.5	56.9	9.4	40.8	49.0	26.8	13.0	11.5	47.4	52.5	40.6	43.3	47.1	88.6	213.7	33.1	69.1	32.9	37.5	51.7	51.1	25.3	45.2	33.4	133.4	31.6	25.4	130.3	55.8
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	602	"testis: 60.2"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283164-287215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 2509.7"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 294.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	2.8	0.6	64.4	0.4	70.1	0.6	0.8	80.5	96.0	0.6	61.2	2.7	23.9	0.3	0.9	0.9	0.7	0.1	4.4	64.2	66.7	0.6	0.6	0.7	0.2	76.6	67.1	1.5	2509.7	0.0	7.6	2.5	73.2	1.0	0.3	2.4	1.0	0.1	0.6	0.4	7.1	0.0	69.9	0.3	191.7	1.0	68.7	0.0	0.4	0.0	0.5	0.5	0.6	88.5	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.5	0.0	7.9	0.0	0.3	6.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.3	2.9	0.1	4.6	0.1	0.4	0.2	1.6	0.0	0.1	0.0	0.9	0.0	0.0	1.6	3.7	0.0	0.1	0.0	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	70.1	80.5	96.0	64.2	66.7	76.6	67.1	73.2	69.9	68.7	88.5	0.0	0.0	0.5	1.6	1.9	0.5	0.0	0.0	0.0	4.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.1	0.3	0.1	0.0	0.0	12.4	294.9	1.3	5.5	65.7	0.1	0.0	0.1	0.0	0.0	0.4	0.0	14.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.6	0.6	0.0	2.0	22.2	25.5	1.4	0.4	0.2	0.0	3.9	1.1	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.4	0.0
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746410-43773278	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1048.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		200000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	17.0	16.6	7.5	16.5	8.0	27.1	15.6	9.2	7.6	24.7	13.9	20.6	23.6	16.4	44.7	18.9	15.4	13.5	17.3	7.7	9.8	15.3	34.5	16.8	18.7	9.3	8.2	16.5	36.0	22.6	16.2	23.8	9.1	25.2	22.5	8.4	21.6	19.1	7.6	17.3	21.4	17.0	9.0	12.5	20.4	10.8	9.3	9.6	56.0	4.1	12.3	15.6	15.2	9.8	29.4	11.9	24.6	55.1	48.9	51.9	70.8	58.6	62.1	46.0	56.7	33.6	32.1	33.8	37.4	72.9	30.8	47.8	31.8	61.5	39.7	24.3	44.7	47.2	17.6	30.9	80.1	26.0	33.8	33.6	49.8	35.0	58.5	54.0	81.3	11.1	27.7	17.4	45.5	11.1	9.1	30.4	24.4	48.5	44.0	17.9	36.7	26.2	39.3	26.0	22.9	25.4	48.7	49.0	19.4	25.0	33.1	28.1	50.9	37.7	18.9	29.7	29.1	7.1	8.6	33.9	48.1	41.2	28.8	11.6	8.8	13.3	12.1	9.2	12.8	5.4	6.8	9.5	8.3	6.1	6.0	7.1	2.4	12.7	9.9	17.6	5.8	15.8	7.5	8.0	9.2	7.6	7.7	9.8	9.3	8.2	9.1	9.0	9.3	9.8	224.9	192.3	183.9	31.6	177.8	192.2	313.7	665.2	114.4	56.5	137.9	95.5	58.3	124.4	427.7	167.3	41.7	655.2	319.6	228.7	70.5	401.2	24.3	178.8	300.3	223.7	186.1	95.3	29.2	390.4	807.8	350.7	261.0	328.5	261.6	255.1	233.1	342.2	426.0	70.7	38.3	523.1	231.9	157.3	292.2	26.7	253.5	246.5	243.7	36.5	258.0	128.3	279.1	29.7	38.8	279.9	196.8	276.8	341.1	286.5	234.3	129.1	245.6	61.9	124.9	138.4	389.7	186.4	147.6	138.9	148.5	1048.8	237.8	390.8	335.4	291.7
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028662	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 386.7;Hepatocytes: 595.4;Plasma cells: 556.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	50.3	30.0	22.8	91.5	27.5	35.7	38.2	31.1	24.1	92.8	33.6	84.8	74.1	58.6	163.5	38.9	81.6	53.5	40.4	22.1	31.2	49.5	241.7	48.5	59.0	35.3	29.3	47.3	112.6	26.4	44.6	92.0	34.2	69.3	85.5	8.4	56.1	47.4	9.3	30.0	66.3	71.9	29.6	63.6	95.6	30.8	33.8	46.7	234.1	10.1	72.4	65.6	33.3	49.8	251.3	236.0	249.8	703.3	223.2	158.2	358.2	343.5	230.5	194.8	314.5	196.6	661.5	179.4	748.2	287.0	532.2	160.1	170.6	329.1	168.9	129.0	99.0	86.6	62.7	436.6	298.4	198.5	233.9	156.4	145.1	213.6	169.8	251.7	401.0	90.6	143.6	476.1	173.4	276.4	190.9	226.0	371.1	510.9	134.0	123.6	192.5	440.5	228.2	194.9	79.1	207.6	313.0	223.7	124.1	295.7	127.4	151.9	220.6	152.1	84.5	372.0	247.5	357.5	173.7	125.5	354.2	231.1	528.9	74.4	80.5	51.0	130.4	85.6	135.4	99.1	83.7	100.8	77.6	58.2	77.4	82.7	11.0	91.9	91.4	251.8	68.7	160.6	22.8	27.5	31.1	24.1	22.1	31.2	35.3	29.3	34.2	29.6	33.8	49.8	43.3	28.9	36.2	6.8	87.9	34.7	88.0	142.5	29.0	4.2	50.8	31.5	31.0	95.8	92.4	42.3	4.2	177.8	86.9	135.4	15.6	129.0	3.1	91.1	93.1	57.0	61.6	41.2	3.2	91.0	386.7	102.8	119.8	107.1	57.8	72.0	81.4	595.4	147.9	0.0	5.7	282.9	61.1	84.7	49.6	5.5	59.0	55.3	87.2	9.4	51.8	15.6	68.0	4.5	11.9	94.5	88.6	42.9	556.7	108.1	71.3	66.3	114.8	6.7	32.9	35.2	66.0	47.6	86.1	29.2	28.6	230.4	46.7	52.4	155.6	72.4
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067025-123225227	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	17.9	23.6	0.3	15.2	0.3	17.9	13.8	0.2	1.4	14.5	2.7	20.1	13.9	12.4	30.2	6.1	14.0	19.6	9.9	0.6	0.8	14.5	80.2	17.7	11.1	0.5	0.6	11.5	26.6	10.7	12.7	47.4	0.4	32.3	25.0	4.2	13.7	7.9	4.2	8.8	12.8	17.0	0.3	10.1	33.4	15.3	0.9	4.5	30.8	4.3	12.0	17.9	9.5	0.7	24.0	14.6	17.7	21.5	80.3	71.9	95.0	44.9	74.5	24.5	66.9	47.8	21.6	0.0	57.6	69.9	15.7	12.5	7.8	27.4	25.7	1.1	8.8	10.4	3.9	56.7	33.2	26.5	1.4	62.3	40.2	16.6	34.5	26.1	84.0	10.1	13.6	60.4	16.9	29.6	7.2	31.3	13.1	54.5	15.6	6.7	13.0	67.5	20.7	13.9	19.3	11.4	22.0	24.0	40.4	28.7	21.4	32.3	47.2	6.2	19.5	29.4	12.3	18.1	5.0	10.8	20.2	21.0	21.5	0.0	9.3	0.3	1.4	2.4	2.3	3.5	1.0	0.8	5.5	1.1	0.6	0.6	0.2	0.5	0.5	12.8	0.0	2.3	0.3	0.3	0.2	1.4	0.6	0.8	0.5	0.6	0.4	0.3	0.9	0.7	17.2	19.2	30.7	2.6	5.6	5.0	6.0	6.4	3.4	13.1	6.9	4.7	2.7	35.8	11.3	5.5	39.6	41.8	3.1	5.4	0.0	32.2	1.6	5.4	13.1	24.3	8.4	5.5	9.6	28.6	133.6	20.7	30.5	21.1	3.8	7.3	37.5	50.1	12.1	0.0	7.1	36.9	0.0	7.8	5.5	2.0	24.2	4.4	8.8	5.6	5.0	2.3	0.0	1.0	2.5	11.9	7.6	22.2	40.1	18.1	3.5	5.3	6.4	28.4	13.1	3.6	17.6	1.3	1.5	3.4	4.1	50.2	3.1	23.3	15.1	4.5
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1202.1;Plasma cells: 883.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	118.3	112.3	54.5	155.8	64.6	140.8	124.9	57.1	66.7	178.8	71.2	156.0	122.4	131.6	418.5	98.2	133.5	96.7	113.4	55.9	60.8	130.3	260.5	103.8	118.1	61.1	55.4	99.8	252.1	149.7	74.0	171.3	60.7	127.4	171.6	48.0	184.1	135.5	59.3	64.3	121.5	155.5	60.9	107.4	155.4	55.1	62.6	86.6	363.3	59.4	153.7	130.9	75.7	66.4	287.0	304.6	425.7	672.6	535.6	459.4	753.4	677.8	625.9	348.3	465.1	435.1	548.5	460.9	464.7	668.9	674.1	228.0	324.1	568.3	371.1	363.2	253.4	374.2	228.4	713.2	577.5	387.9	268.9	334.2	428.4	338.1	603.3	642.1	798.0	171.8	328.0	963.6	348.7	338.8	150.5	400.8	356.6	923.4	236.4	355.7	433.0	846.4	498.3	339.9	272.0	543.2	267.6	387.0	396.2	547.8	136.8	648.5	395.0	324.4	409.8	296.3	399.1	900.0	596.6	297.1	438.5	479.6	464.8	276.1	200.0	95.5	198.4	210.9	219.0	197.6	154.2	187.6	215.0	161.0	74.3	125.1	35.0	241.6	161.4	268.9	174.4	319.2	54.5	64.6	57.1	66.7	55.9	60.8	61.1	55.4	60.7	60.9	62.6	66.4	217.1	57.7	124.2	17.6	193.9	103.0	294.2	552.8	61.5	69.1	121.1	91.7	35.9	148.7	264.6	196.8	29.2	456.3	164.6	125.8	43.0	338.6	8.2	146.5	382.9	176.2	157.7	89.2	47.4	240.6	1202.1	228.2	138.1	255.0	131.3	210.6	211.3	355.6	413.1	42.1	30.5	276.3	170.9	155.7	149.8	16.2	121.2	145.9	199.3	15.0	132.1	106.5	142.2	32.6	25.3	175.4	131.2	135.1	883.2	385.4	99.9	149.6	145.8	60.1	85.5	96.9	225.3	98.5	117.9	95.4	102.6	554.1	125.7	254.3	248.3	265.3
PDILT	PDIA7	ENSG00000169340	"Protein disulfide isomerase like, testis expressed"	Q8N807	16	20359175-20404737	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Isomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"stomach 1: 122.7"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 136.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;HBEC3-KT: 3.0;hTCEpi: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041913	Approved				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA041913: AB_10795644"							"unprognostic (1.99e-1)"					"unprognostic (6.09e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.63e-1)"				0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	122.7	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	3.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.2	3.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.2	0.0	0.3	0.1	0.2	0.5	0.7	0.1	2.8	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	23.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.4;Plasma cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;granulocytes: 25.2;T-cells: 21.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 71.8;U-87 MG: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017554, HPA027376"	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB017554: AB_2161138, HPA027376: AB_1855139"	"unprognostic (2.14e-1)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	7.7	16.0	2.5	11.6	3.0	15.8	10.1	5.6	5.3	5.5	2.7	16.7	16.5	4.0	3.1	8.5	3.6	6.0	28.1	3.1	2.1	4.8	11.2	4.2	13.1	2.7	6.7	12.2	6.9	4.3	3.8	6.4	3.2	4.7	13.3	27.1	10.2	5.0	9.0	18.1	9.1	4.4	1.3	10.5	13.6	12.2	5.0	8.3	3.9	7.6	19.1	11.0	7.6	2.5	34.0	1.4	8.4	21.0	3.4	5.1	12.1	29.1	23.4	14.3	30.4	8.6	7.1	32.1	15.8	9.1	11.9	14.5	5.8	18.2	45.5	6.6	11.7	39.3	7.1	10.2	6.2	19.6	14.0	6.6	6.4	10.0	16.6	19.8	7.7	16.7	8.5	21.5	19.2	3.5	12.5	24.5	20.8	6.9	9.2	13.1	13.8	52.5	7.4	10.8	15.7	18.0	7.6	8.8	11.1	7.0	5.6	8.0	9.2	22.7	7.4	12.0	7.9	71.8	44.8	26.9	72.6	14.0	4.6	19.6	3.4	25.2	3.7	2.3	4.2	7.3	5.9	4.0	3.5	8.6	21.2	13.5	12.7	2.2	3.2	0.6	12.2	9.2	2.5	3.0	5.6	5.3	3.1	2.1	2.7	6.7	3.2	1.3	5.0	2.5	9.2	3.2	5.0	12.1	33.7	50.1	5.1	15.8	4.6	29.4	7.0	4.7	35.5	2.8	7.0	3.7	47.9	10.2	9.9	11.9	5.9	8.7	130.4	6.4	7.2	9.6	7.8	4.2	35.4	3.7	13.2	8.5	9.7	12.1	5.7	13.3	19.6	20.2	10.2	55.5	32.7	6.6	12.2	12.0	15.2	43.8	3.4	12.9	30.2	30.9	11.4	7.4	10.3	12.1	14.8	9.6	17.5	3.8	144.8	7.2	6.7	1.9	5.0	18.5	6.6	4.6	11.6	9.6	10.4	8.9	43.3	4.1	17.3	5.3	7.0	6.1
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.2;tongue: 285.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 123.0;Proximal tubular cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	40.8	63.8	49.9	8.7	51.2	5.0	26.4	65.7	58.2	30.5	37.1	42.7	28.1	29.4	124.4	21.8	24.3	18.0	116.6	50.6	41.8	62.7	50.8	15.3	10.1	40.8	44.0	48.2	44.3	40.7	17.0	14.7	41.8	23.5	21.5	14.7	25.7	27.4	216.2	26.0	32.5	25.7	40.8	18.4	33.7	13.7	44.6	12.6	27.3	285.0	9.2	30.9	22.2	44.6	12.4	17.5	20.6	18.5	21.2	16.5	2.2	13.2	19.3	19.3	18.5	1.7	13.2	15.5	21.7	37.0	13.0	6.4	13.7	5.3	18.8	30.6	19.3	14.0	17.1	13.2	11.3	0.0	15.0	33.6	19.6	12.5	0.9	33.7	17.2	20.0	5.7	15.0	11.0	15.8	11.8	0.0	4.5	37.2	17.1	17.5	45.8	21.1	10.4	10.4	13.8	20.7	18.7	5.9	9.0	25.0	35.0	13.7	8.8	22.5	18.4	16.0	10.1	29.4	29.9	8.2	33.3	4.9	15.4	14.3	16.2	8.9	16.2	12.9	12.8	12.9	14.8	18.0	18.4	13.8	17.2	18.0	2.6	22.9	14.1	25.8	22.4	17.4	49.9	51.2	65.7	58.2	50.6	41.8	40.8	44.0	41.8	40.8	44.6	44.6	17.9	9.6	10.3	18.3	12.1	15.2	12.3	12.4	17.6	19.0	16.0	26.8	5.4	12.8	11.7	20.2	6.2	19.6	16.7	38.6	58.7	11.7	8.8	6.5	12.1	11.8	13.8	10.8	18.6	9.1	3.6	17.7	13.7	7.8	1.3	19.0	18.2	52.0	19.9	43.7	15.6	50.2	16.2	13.6	9.1	18.9	24.2	12.0	24.9	8.4	14.5	37.3	7.2	6.0	11.3	6.2	55.2	52.6	25.9	6.7	123.0	131.9	6.5	11.0	19.7	15.0	20.5	3.3	11.7	14.6	18.8	7.9	12.9	29.0	36.9	11.3
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596516	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2300.1;tongue: 1216.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 681.3;Cardiomyocytes: 764.5;Kupffer cells: 464.0;Proximal enterocytes: 654.2;Smooth muscle cells: 489.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8;thyroid cancer: 89.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 32.5;eosinophil: 38.1;intermediate monocyte: 63.5;myeloid DC: 16.8;non-classical monocyte: 39.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 16.8;granulocytes: 38.1;monocytes: 63.5"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 482.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	451.2	216.3	32.4	33.4	48.0	2.5	388.7	32.9	43.0	76.3	222.0	278.9	72.3	89.0	10.4	151.5	153.5	80.6	480.4	40.0	35.3	127.8	223.4	120.4	24.0	44.5	41.8	240.8	549.3	18.2	39.9	104.8	45.3	91.2	42.6	2.0	60.2	529.5	2300.1	91.9	163.3	62.2	34.8	99.0	173.1	13.3	39.8	13.8	72.1	1216.5	13.5	187.5	95.2	59.4	0.0	37.7	1.5	9.5	482.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	12.8	0.0	5.3	1.7	1.6	0.0	0.1	0.0	0.0	0.0	1.3	0.2	66.8	0.0	4.5	0.0	0.0	5.3	0.0	0.0	0.0	0.2	2.4	0.0	1.7	0.0	0.2	0.9	0.0	0.4	0.1	0.0	2.1	0.0	0.0	0.3	23.5	2.6	0.5	2.7	0.0	3.0	8.6	2.4	1.3	1.1	0.0	0.0	0.8	2.1	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.3	32.5	38.1	0.0	63.5	0.1	0.4	0.0	0.0	16.8	1.5	0.0	0.0	2.5	3.3	39.8	0.5	0.0	14.2	32.4	48.0	32.9	43.0	40.0	35.3	44.5	41.8	45.3	34.8	39.8	59.4	681.3	32.1	16.0	154.4	6.0	10.5	279.2	9.2	19.9	0.1	95.9	40.6	764.5	30.0	36.1	378.9	0.0	5.9	3.9	67.7	13.7	7.2	14.9	151.0	52.1	108.0	55.4	9.3	0.4	5.5	0.7	326.9	158.5	347.5	5.1	19.9	199.2	130.5	49.8	0.0	1.2	96.0	6.1	464.0	21.5	6.7	134.2	204.8	90.7	19.7	19.8	8.4	1.0	7.1	26.2	6.2	46.3	44.8	6.4	110.0	654.2	74.2	66.3	0.4	164.3	293.2	489.7	1.8	1.0	12.3	9.2	10.9	5.3	18.7	60.5	157.4
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 675.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0"	"Group enriched"	"Detected in all"	7	"B-cells: 223.8;granulocytes: 189.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		93000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	301.7	32.4	10.7	91.5	10.8	25.0	236.0	10.2	18.5	133.1	30.2	220.0	179.4	115.0	91.8	182.3	155.3	114.9	393.2	11.7	10.9	82.8	160.3	337.2	104.5	20.4	12.7	35.6	98.3	65.9	29.5	141.1	14.1	116.9	218.5	36.9	166.1	114.7	675.1	136.8	249.0	146.0	14.0	148.3	148.3	13.7	13.8	105.9	194.7	290.0	123.7	276.3	165.3	11.2	274.4	181.8	12.4	0.4	64.1	43.3	277.1	82.6	266.4	218.8	356.5	387.0	429.8	0.3	21.9	233.8	110.4	766.3	91.5	498.1	220.6	0.2	132.0	277.9	50.1	635.3	731.0	0.1	13.2	125.5	257.0	111.9	400.6	233.2	396.8	24.2	60.0	70.3	52.7	51.4	0.8	4.9	24.6	137.7	137.2	234.1	10.0	98.4	114.4	268.9	48.3	18.9	91.2	84.6	0.9	293.8	68.2	125.7	345.1	84.5	19.7	0.7	0.7	31.2	0.1	91.6	92.5	0.2	41.0	0.4	2.4	189.7	11.9	0.8	0.1	223.8	2.3	14.1	31.0	213.0	0.5	8.1	7.5	8.9	1.5	3.2	2.2	44.5	10.7	10.8	10.2	18.5	11.7	10.9	20.4	12.7	14.1	14.0	13.8	11.2	435.0	76.9	123.5	0.0	145.6	366.3	805.9	763.8	244.7	10.1	100.6	131.4	266.2	223.1	250.2	51.5	29.2	538.2	20.5	657.0	15.6	420.1	8.4	218.6	319.3	359.3	101.3	41.6	0.9	172.5	116.7	149.2	100.9	113.0	12.6	47.2	459.7	100.4	50.0	1.7	0.4	488.9	152.5	19.4	105.2	8.0	5.0	88.8	40.9	2.8	8.8	11.6	32.0	0.0	0.0	227.0	769.2	0.7	103.5	256.5	1059.7	109.0	316.4	59.5	315.5	21.0	213.1	4.3	35.7	170.4	197.9	117.0	25.8	1.9	419.2	554.3
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 793.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"white matter: 429.2"	"Low region specificity"	"Detected in many"			HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	66.0	31.6	40.6	31.9	42.2	23.7	51.0	51.0	56.6	85.1	42.6	86.9	60.9	80.2	9.8	131.4	56.0	52.8	51.4	36.9	43.9	77.7	59.4	88.8	54.4	56.6	52.9	49.6	53.7	9.8	35.3	40.5	59.4	45.5	11.2	2.0	48.6	30.9	201.9	153.1	64.3	23.2	49.9	232.0	38.8	12.2	49.9	20.4	27.4	60.9	24.4	57.5	91.7	54.8	90.3	54.5	36.2	63.9	69.9	118.5	40.9	139.1	102.4	97.6	98.5	62.4	14.7	36.9	38.4	126.4	18.1	44.7	20.5	95.0	19.0	0.1	14.1	11.6	35.2	46.1	88.2	13.0	85.9	127.2	11.6	48.2	13.2	76.8	54.2	20.2	3.3	23.4	67.4	46.5	16.7	15.4	29.8	37.8	5.5	13.3	6.9	3.9	17.3	18.3	11.3	26.9	29.1	78.1	128.7	21.3	27.5	25.8	68.2	105.7	108.6	127.9	64.8	0.4	0.8	12.5	109.0	51.3	79.6	78.2	48.0	162.3	47.0	64.4	42.2	25.0	35.5	46.9	38.4	27.6	23.8	35.4	101.6	28.1	63.8	24.7	40.7	34.6	40.6	42.2	51.0	56.6	36.9	43.9	56.6	52.9	59.4	49.9	49.9	54.8	85.8	76.9	13.1	5.5	45.0	95.1	12.9	48.1	39.9	3.0	34.0	42.5	10.2	18.6	34.2	18.4	0.0	73.1	70.9	92.0	15.6	24.9	1.0	8.8	94.0	48.7	1.2	10.5	3.2	26.1	115.1	98.9	7.7	13.8	27.3	25.7	86.4	49.4	59.0	3.3	2.3	12.6	20.3	59.1	73.8	3.4	132.0	37.9	48.0	8.4	42.5	33.1	122.6	7.1	3.9	93.2	126.1	218.2	6.8	52.7	217.6	146.3	5.2	3.6	59.2	27.1	108.3	0.7	6.3	39.7	100.7	793.0	71.6	21.0	15.0	30.6
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 4781.7;tongue: 1519.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	36.3	11.5	12.7	25.7	13.3	0.0	34.5	16.8	14.8	22.7	10.9	201.2	20.8	235.3	59.1	216.2	97.5	40.1	314.0	12.0	15.7	13.9	7.7	55.2	10.7	19.9	14.2	38.1	18.7	0.8	20.7	18.8	13.8	87.0	32.5	11.2	56.3	148.1	4781.7	12.1	69.0	127.6	17.9	24.5	95.8	8.2	14.6	4.1	32.7	1519.6	26.2	141.1	40.8	14.2	0.0	0.0	0.9	0.0	0.3	0.0	0.8	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	0.0	15.1	0.0	0.8	4.7	13.5	0.0	0.0	8.7	0.0	2.6	0.0	12.3	9.1	0.0	0.0	0.0	115.6	0.0	0.0	0.1	2.4	0.0	1.0	0.0	26.9	0.3	0.0	0.0	17.6	13.3	0.0	0.0	7.3	2.8	0.6	0.0	7.9	0.0	7.6	0.1	7.1	111.2	34.8	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	13.3	16.8	14.8	12.0	15.7	19.9	14.2	13.8	17.9	14.6	14.2	22.4	9.6	6.0	37.2	2.6	8.9	11.4	0.7	12.5	12.1	72.8	105.7	228.9	5.7	2.2	0.0	12.5	2.5	0.6	0.2	0.0	332.7	0.4	1.4	0.8	39.0	3.5	0.0	2.5	16.7	2.7	82.9	1.1	1.1	0.0	1.3	67.5	0.9	1.6	5.0	0.5	0.5	2.0	1.8	11.7	2.6	19.6	2.3	124.5	1.0	3.2	36.4	0.0	6.6	2.6	31.2	0.0	196.0	7.3	12.2	0.0	0.2	3.2	44.3	105.2	428.3	131.4	4.0	12.6	2.4	7.1	12.2	2.5	2.4	0.3	3.9
PDLIM4	RIL	ENSG00000131435	"PDZ and LIM domain 4"	P50479	5	132257696-132273454	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 315.5;Prostatic glandular cells: 473.0;Skeletal myocytes: 225.2;Urothelial cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 91.8;HBEC3-KT: 109.2;HHSteC: 103.7;hTEC/SVTERT24-B: 117.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011912	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments, Cytosol"		"HPA011912: AB_1856277"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.40e-3)"	24.8	6.6	14.5	18.6	13.8	0.7	34.5	17.9	17.8	36.5	20.1	104.9	6.9	90.7	17.7	50.0	48.3	20.5	61.6	15.8	23.8	33.3	1.2	10.5	4.5	27.7	20.5	28.4	6.5	4.9	28.2	8.0	21.3	50.2	4.8	2.6	47.4	28.1	5.4	64.4	27.2	42.9	22.5	6.7	32.2	6.3	17.9	6.6	14.2	2.6	10.1	59.4	39.1	21.7	46.6	0.0	9.7	0.1	13.2	36.7	3.3	12.9	6.3	12.9	4.2	0.0	4.3	0.3	8.6	68.4	65.8	91.8	0.0	109.2	6.1	0.2	5.1	0.0	0.0	2.2	103.7	0.0	0.3	46.5	7.8	117.6	43.7	45.9	74.0	0.0	20.2	0.1	57.6	0.0	0.0	0.3	3.4	0.0	28.1	2.2	66.4	0.2	29.0	0.0	0.0	39.0	29.7	0.0	0.0	7.7	0.1	4.8	47.9	46.3	49.9	48.4	72.9	0.1	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.5	13.8	17.9	17.8	15.8	23.8	27.7	20.5	21.3	22.5	17.9	21.7	10.1	0.0	4.4	5.5	0.7	105.7	315.5	183.8	76.2	0.5	38.2	149.5	6.8	0.0	57.0	14.7	2.1	5.1	0.8	0.6	107.6	121.5	14.2	21.1	81.0	69.8	16.8	0.0	0.7	9.9	14.4	85.1	6.1	17.9	4.5	10.7	21.0	0.3	6.6	0.0	0.6	16.6	61.1	0.3	32.5	15.8	36.4	3.4	165.4	3.7	1.0	17.7	0.0	0.0	0.3	105.7	154.6	27.4	0.0	473.0	5.6	8.9	138.3	0.7	26.3	225.2	53.8	9.9	13.9	47.8	82.8	22.8	4.2	2.0	5.5	381.7
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 570.3;skeletal muscle: 661.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 438.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	74.3	26.7	23.0	74.5	27.2	50.3	58.2	18.8	39.8	183.7	30.2	570.3	31.5	489.5	28.8	64.5	236.0	45.0	79.9	22.3	27.6	52.8	16.0	84.7	15.1	23.9	23.4	94.2	15.1	9.6	66.3	33.2	24.9	245.3	24.9	5.7	42.3	200.7	661.5	38.0	111.7	177.6	20.8	84.5	156.1	37.6	28.5	11.5	37.1	70.5	7.6	315.4	125.0	20.5	115.8	25.8	120.7	89.4	32.5	59.9	118.9	232.4	132.8	128.9	89.0	50.9	109.6	20.4	220.4	156.4	69.5	59.5	19.7	160.6	30.3	27.5	27.6	73.6	92.2	52.6	83.6	38.8	237.3	132.0	29.1	115.6	51.5	191.9	85.4	18.3	52.4	15.3	102.5	103.9	7.0	88.6	75.7	23.2	108.8	144.4	101.3	14.0	89.1	29.6	17.5	35.8	91.5	16.9	44.6	39.9	24.3	31.3	292.9	153.8	168.1	60.5	211.7	4.0	4.7	24.1	73.3	44.2	35.7	177.1	46.7	121.2	5.3	22.9	6.3	9.6	3.1	7.2	26.7	5.3	3.0	4.0	438.7	2.3	29.3	1.9	7.0	23.9	23.0	27.2	18.8	39.8	22.3	27.6	23.9	23.4	24.9	20.8	28.5	20.5	36.6	0.0	0.6	11.1	7.5	14.5	47.1	106.8	6.2	6.3	7.6	65.3	21.0	4.3	20.9	25.8	14.6	12.5	4.4	5.5	25.4	164.8	27.0	7.5	44.8	51.0	3.5	9.4	13.9	242.1	53.3	65.0	9.7	7.3	17.2	18.6	51.0	1.6	64.0	8.4	7.4	2.1	36.7	16.6	18.3	49.3	44.7	44.9	10.6	5.6	31.0	16.2	1.0	2.0	1.7	320.1	33.6	223.0	3.2	30.4	1.0	15.7	13.2	22.6	164.3	24.6	157.7	11.6	38.7	12.2	15.8	14.1	10.8	18.2	3.1	25.3
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	6.0	2.6	3.6	1.8	4.6	1.5	3.6	6.9	5.2	2.0	7.7	3.8	5.4	2.6	3.4	3.7	3.4	2.0	1.8	3.6	4.3	9.2	8.6	3.4	2.6	6.2	4.6	7.4	4.5	6.1	3.0	4.0	6.8	3.8	4.1	5.0	3.6	2.6	2.5	2.1	3.2	2.1	3.5	2.0	3.0	3.8	5.7	2.5	9.3	4.1	3.0	2.1	2.2	4.3	9.8	11.7	7.1	14.1	18.7	9.6	8.9	5.0	19.2	11.3	17.0	23.9	6.7	13.5	6.9	6.9	10.8	12.1	20.8	11.3	10.9	3.2	10.5	6.8	5.9	15.9	10.1	8.8	11.5	7.4	8.3	16.1	16.6	12.3	4.9	14.9	13.3	9.5	10.3	6.3	17.1	6.2	8.4	6.5	14.7	16.7	9.9	21.4	6.0	10.3	14.3	8.0	15.9	6.5	6.0	5.5	8.7	4.3	4.6	7.0	9.2	4.2	7.5	16.6	16.9	13.4	9.5	6.9	7.0	1.1	0.2	1.2	3.8	0.1	3.1	1.0	1.8	3.2	0.8	2.1	2.6	3.0	0.7	4.2	0.1	0.5	0.6	1.3	3.6	4.6	6.9	5.2	3.6	4.3	6.2	4.6	6.8	3.5	5.7	4.3	2.5	9.6	22.9	8.1	3.1	5.2	6.4	1.3	6.2	9.6	5.8	4.2	5.1	8.6	3.1	9.2	14.6	12.8	3.3	13.3	7.9	3.4	0.2	3.5	3.2	3.3	3.6	0.8	8.8	2.9	2.2	4.1	3.1	4.3	6.3	14.4	7.1	20.5	2.4	5.0	7.6	4.2	2.0	1.3	0.4	2.4	3.1	1.2	3.6	3.7	0.4	8.1	7.2	4.5	4.3	3.4	6.6	4.5	4.5	8.9	7.4	9.9	1.2	6.7	0.0	5.9	2.7	12.6	5.7	8.0	2.4	3.6	3.4	4.0	5.5	6.5
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537979-2603188	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.6	13.5	15.1	12.4	25.2	16.1	11.1	10.2	20.6	10.9	1.5	15.8	17.3	11.8	13.2	13.3	14.7	9.5	15.1	19.2	5.2	17.0	12.4	13.6	15.0	10.8	6.1	14.0	19.4	27.1	11.2	12.1	11.3	13.0	14.9	15.5	17.8	12.2	18.9	14.2	19.6	12.3	3.7	13.9	13.6	14.7	7.7	16.8	15.8	19.2	14.1	11.1	10.4	12.5	13.1	16.5	20.1	13.5	20.3	16.9	21.5	21.7	13.6	18.7	15.6	16.6	15.2	21.4	14.5	20.7	15.9	20.2	24.3	15.3	17.6	39.6	17.1	11.4	23.0	27.7	17.7	19.2	29.0	15.4	27.5	20.1	13.3	17.9	17.3	19.1	22.2	17.0	22.1	27.7	19.2	13.3	12.8	24.3	15.1	39.0	20.2	19.5	18.0	11.5	31.7	16.3	27.9	31.3	11.5	12.8	29.0	23.5	21.6	20.2	20.2	20.0	18.8	22.6	23.4	33.3	9.7	13.1	17.9	5.4	7.1	8.4	4.1	8.3	3.9	4.2	3.8	5.0	5.8	3.4	4.3	4.0	12.5	5.2	8.9	8.0	1.9	4.7	15.1	25.2	10.2	20.6	19.2	5.2	10.8	6.1	11.3	3.7	7.7	12.5	17.6	16.0	19.1	45.1	32.9	26.6	20.8	25.7	26.7	60.2	30.0	22.0	33.8	40.0	23.0	11.0	54.2	47.0	35.2	41.1	13.7	23.1	14.4	35.6	23.8	19.1	21.6	28.0	46.7	23.6	27.9	23.2	23.0	45.3	7.6	18.1	22.5	46.1	26.0	74.0	41.7	29.9	10.2	55.7	51.1	30.4	31.7	37.1	21.4	31.9	43.3	42.3	25.7	37.7	44.2	31.6	24.0	44.4	27.1	30.3	50.2	44.8	41.1	44.9	46.0	30.5	30.0	46.8	36.8	38.5	34.1	104.7	25.7	24.2	31.4	27.1
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 135.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	61.5	3.3	8.9	55.9	9.3	0.0	20.9	13.7	8.1	43.1	23.5	16.6	3.8	25.9	11.3	15.8	33.4	42.1	20.3	8.0	14.6	3.4	0.6	32.4	9.8	24.9	15.6	29.4	6.4	1.1	3.3	135.6	19.1	14.0	10.6	22.7	9.1	14.1	30.0	20.0	15.9	34.5	16.4	0.3	24.7	4.5	22.5	10.3	6.2	11.3	18.5	96.1	25.2	21.2	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.3	13.7	8.1	8.0	14.6	24.9	15.6	19.1	16.4	22.5	21.2	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PDPR	PDP3	ENSG00000090857	"Pyruvate dehydrogenase phosphatase regulatory subunit"	Q8NCN5	16	70114332-70162537	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048092, HPA070386"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA048092: AB_2680261, HPA070386: AB_2686263"	"unprognostic (8.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.04e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.36e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.24e-2)"	11.5	12.6	10.7	8.1	13.3	15.9	11.3	14.7	11.4	13.1	9.8	14.5	9.1	14.1	11.9	8.1	12.8	6.7	14.7	10.7	11.4	16.3	8.6	9.6	11.1	11.8	12.4	13.5	12.3	10.2	10.4	9.0	11.8	10.9	11.8	12.1	10.3	9.6	23.2	12.2	13.7	15.1	10.6	15.4	12.0	19.1	12.5	15.8	13.0	13.6	12.5	13.8	9.8	13.9	6.9	19.4	17.9	33.0	32.6	20.9	12.1	11.1	19.4	17.4	13.1	25.1	13.4	14.4	19.1	35.8	16.1	26.7	26.4	24.1	20.3	3.5	9.1	35.8	12.7	17.6	9.3	39.9	27.9	28.0	22.6	25.1	23.0	25.2	18.7	26.6	24.6	6.6	15.3	20.8	25.3	23.3	27.8	4.9	10.0	49.0	18.5	14.9	13.8	16.3	8.3	12.3	30.2	6.2	8.2	24.2	24.4	12.4	10.9	20.4	27.3	17.6	17.9	15.4	17.9	50.9	9.1	13.8	13.5	1.6	1.5	1.4	1.4	1.5	2.0	0.9	1.1	1.3	1.6	1.5	1.3	1.5	1.1	0.9	1.5	1.5	1.3	1.0	10.7	13.3	14.7	11.4	10.7	11.4	11.8	12.4	11.8	10.6	12.5	13.9	12.6	22.4	18.2	18.6	13.0	2.8	4.9	3.5	18.2	21.6	14.2	12.1	19.2	17.2	9.1	1.8	31.3	7.7	16.0	12.1	5.9	5.3	54.4	13.7	16.0	17.4	4.9	17.4	18.0	6.7	7.8	16.1	11.7	17.1	18.3	23.9	17.2	11.2	16.4	32.0	20.3	10.0	4.1	17.8	3.5	20.8	10.8	15.7	7.2	10.3	12.2	11.2	15.5	9.5	13.9	6.8	6.1	16.6	11.7	10.3	11.6	4.4	12.7	20.8	19.7	22.7	11.5	10.8	15.4	11.1	1.8	4.9	11.9	12.7	14.5	4.6
PDRG1	"C20orf126, dJ310O13.3"	ENSG00000088356	"P53 and DNA damage regulated 1"	Q9NUG6	20	31944337-31952046	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 55.4"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8;Theca cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047084, HPA063542"	Approved		Approved	"Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Actin filaments"		"HPA047084: AB_2679925, HPA063542: AB_2685035"	"unprognostic (2.17e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.00e-2)"	9.0	12.7	17.7	7.7	18.1	17.0	11.0	20.6	19.2	10.1	19.0	11.1	8.3	8.9	12.8	13.8	10.0	5.7	11.8	18.2	18.2	15.7	14.3	8.2	11.8	19.9	18.3	9.5	9.8	55.4	11.3	11.1	19.9	11.6	6.9	9.6	8.7	15.1	15.2	11.5	8.9	7.6	18.8	13.2	9.7	38.0	18.3	12.3	10.4	15.9	12.5	10.0	10.1	20.0	36.6	29.2	17.8	19.7	10.0	7.4	32.9	28.8	16.1	42.3	23.8	107.7	17.9	36.4	21.6	13.6	31.1	23.2	37.8	28.9	34.1	13.4	25.2	50.8	21.7	37.8	25.3	29.3	20.2	9.1	20.9	29.8	30.5	17.9	17.8	37.9	51.7	18.2	17.8	44.3	38.3	34.3	36.7	37.6	61.0	29.6	53.6	19.2	27.8	19.5	42.1	20.2	87.2	27.8	53.6	18.3	48.5	35.5	16.3	34.2	40.3	31.7	36.8	13.3	14.9	40.0	22.9	103.4	22.9	13.4	10.4	16.7	19.0	14.9	18.4	35.4	20.2	20.8	15.8	36.2	27.0	23.6	4.3	28.7	21.6	29.9	21.2	18.2	17.7	18.1	20.6	19.2	18.2	18.2	19.9	18.3	19.9	18.8	18.3	20.0	22.9	19.2	9.7	4.2	23.4	25.5	16.1	14.0	23.9	21.2	26.7	22.7	17.6	14.3	9.1	11.0	14.6	45.8	29.4	9.6	33.2	24.8	11.8	16.7	20.2	22.9	22.0	13.9	6.3	21.2	26.7	22.3	6.6	18.8	33.0	27.7	12.5	7.9	26.2	16.8	5.9	12.6	10.2	9.1	17.8	17.4	16.1	12.4	12.4	5.6	37.4	23.2	13.4	4.0	5.9	23.8	15.0	17.0	14.8	17.8	13.9	19.3	10.0	21.2	26.3	17.2	22.7	86.8	38.1	18.0	28.6	20.4	18.4	170.9	13.4	14.7
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586452-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	11.8	8.1	3.8	9.4	6.2	23.3	12.6	7.6	14.3	18.5	0.0	13.5	6.1	19.0	13.2	7.1	12.8	7.8	7.4	7.5	8.3	9.8	9.6	10.9	13.3	0.7	0.4	15.9	7.5	9.3	9.8	10.1	0.0	12.8	8.2	11.1	8.5	9.8	11.4	10.4	10.6	11.7	0.3	13.4	9.8	12.1	0.9	20.9	10.4	8.0	10.7	10.2	11.4	10.5	12.4	7.3	32.7	17.6	15.3	11.0	9.2	20.5	13.7	17.1	17.1	10.1	20.2	45.0	7.2	10.1	17.2	16.1	23.9	12.9	20.2	36.1	9.0	40.7	13.1	14.2	9.0	37.6	24.0	8.6	6.4	14.3	12.8	11.2	13.1	17.8	14.4	29.6	15.8	15.9	45.3	28.2	24.2	25.9	8.9	45.7	45.2	15.5	11.0	10.2	8.5	20.4	23.6	23.0	9.2	19.7	22.2	24.8	26.0	16.3	15.7	11.8	12.4	9.0	10.7	37.4	7.0	25.1	24.1	3.0	2.7	4.0	3.0	2.4	3.5	3.4	3.5	3.2	3.5	4.5	3.4	3.3	3.3	2.8	3.3	2.3	2.8	1.6	3.8	6.2	7.6	14.3	7.5	8.3	0.7	0.4	0.0	0.3	0.9	10.5	50.3	16.0	30.2	86.8	33.9	28.9	23.8	14.6	34.1	42.3	24.3	17.0	26.7	21.5	24.6	27.6	25.0	24.9	35.9	17.4	5.9	14.8	14.5	24.2	79.7	42.2	31.8	22.9	185.5	16.0	18.5	46.4	19.4	19.9	23.5	55.3	23.9	28.0	18.5	47.1	222.6	21.8	16.2	39.0	38.1	13.7	67.1	31.3	35.6	131.2	39.4	15.8	34.0	154.8	155.1	14.7	17.9	62.4	43.8	23.4	15.9	12.9	31.3	20.8	72.3	46.9	51.4	49.5	60.6	17.0	29.3	6.2	37.1	41.8	21.1	17.0
PDSS1	"COQ1, COQ1A, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697701-26746798	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.1;lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	2.1	1.4	0.8	5.3	0.9	5.8	2.3	2.6	1.4	1.8	0.6	14.1	19.1	1.9	1.3	4.3	1.5	1.6	2.8	0.8	0.8	6.2	3.6	2.2	4.0	0.8	0.9	1.7	1.3	2.2	0.8	2.4	0.9	1.5	15.1	1.9	1.8	1.3	5.7	1.4	15.3	2.9	0.8	1.8	2.8	2.8	0.9	13.8	1.2	9.5	4.7	3.1	2.2	1.1	15.6	11.8	8.9	16.3	2.9	5.4	12.2	14.0	3.6	20.0	13.7	18.3	8.4	35.0	7.2	7.0	7.6	19.2	28.6	21.8	16.7	14.7	23.6	30.4	9.9	13.6	4.3	20.3	11.6	6.8	9.2	19.0	5.0	3.5	10.7	22.8	28.4	9.3	14.4	24.9	64.6	14.7	17.9	24.9	11.3	29.6	25.1	25.5	12.0	7.3	25.7	15.8	13.5	27.6	15.9	9.2	9.9	23.7	6.8	11.1	17.9	22.9	22.5	3.6	14.1	25.6	10.9	51.3	8.7	0.0	2.8	0.5	0.4	2.3	1.0	0.2	0.8	0.6	2.6	2.4	1.6	0.7	0.1	0.4	1.2	0.7	0.0	0.7	0.8	0.9	2.6	1.4	0.8	0.8	0.8	0.9	0.9	0.8	0.9	1.1	3.6	0.0	0.0	18.9	4.8	6.9	3.6	5.7	8.0	2.9	4.4	5.1	2.2	5.7	3.9	3.7	4.2	7.7	4.9	11.7	7.9	6.1	12.0	2.1	3.8	2.7	10.8	8.4	16.9	3.9	12.4	3.4	10.2	3.3	0.0	3.7	1.8	4.5	8.8	1.7	32.5	13.0	6.1	5.3	2.7	4.1	2.1	7.7	1.8	5.6	6.2	1.2	1.0	6.6	6.5	5.6	9.8	2.6	9.1	3.7	29.8	26.3	2.1	4.9	0.0	4.1	6.5	12.5	9.4	13.6	3.1	6.3	4.8	4.6	29.8	3.3
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.6;Late spermatids: 733.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		9600	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	33.3	37.9	4.9	20.9	5.0	12.9	33.1	14.7	6.5	35.7	7.9	61.3	52.5	31.9	17.0	43.4	29.2	20.8	39.1	6.0	4.1	47.6	104.5	34.6	13.4	6.2	4.7	31.1	70.4	27.1	63.2	23.5	7.5	55.8	47.8	13.4	80.5	25.2	52.0	27.8	61.1	18.5	1.2	31.8	56.7	113.2	7.2	11.7	42.9	16.5	15.0	39.1	34.7	5.7	21.4	30.9	31.1	26.1	16.9	20.4	51.4	19.6	17.4	14.3	19.7	38.0	45.3	40.7	42.0	26.5	20.5	34.0	22.1	20.1	20.5	25.0	30.2	24.7	51.8	100.2	44.3	19.7	56.4	21.5	20.4	25.0	20.9	28.0	15.3	21.6	18.5	26.0	34.1	52.2	12.9	10.4	15.3	20.8	11.7	19.9	12.9	48.6	22.7	33.9	31.9	22.8	52.6	30.0	50.9	19.7	121.0	30.3	23.8	11.0	10.0	12.3	25.7	24.2	25.1	39.3	22.7	16.4	35.8	2.9	7.8	11.6	9.4	7.7	10.8	8.3	6.8	7.7	11.7	9.0	8.2	8.1	1.0	7.5	6.2	5.4	6.6	8.2	4.9	5.0	14.7	6.5	6.0	4.1	6.2	4.7	7.5	1.2	7.2	5.7	29.6	38.5	64.6	32.7	33.0	38.2	42.2	21.6	18.8	32.1	57.9	27.8	45.7	58.6	52.9	29.5	31.3	51.7	30.6	149.8	27.4	38.2	483.6	48.1	41.7	35.1	161.2	33.2	80.7	58.3	56.5	36.0	71.9	75.3	39.3	42.1	27.5	123.6	30.5	40.4	68.3	216.7	24.4	33.1	16.8	733.8	49.0	30.9	26.6	31.9	27.5	19.7	39.1	55.8	45.0	46.5	114.4	45.5	45.4	58.1	115.6	53.4	48.3	47.4	46.0	24.0	28.0	142.3	72.7	24.6	42.6	80.7	33.9	21.2	127.2	76.5
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1717.4;Late spermatids: 4366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		830000	"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	25.6	21.8	79.4	7.6	62.2	12.9	18.4	23.9	87.0	14.3	17.5	17.1	14.1	12.3	10.2	19.7	14.0	7.0	15.5	62.5	51.7	50.4	21.5	20.9	7.0	48.8	59.7	19.1	21.3	17.8	37.3	7.8	54.7	17.2	9.4	10.0	22.7	10.6	6.7	13.9	19.7	6.9	34.4	12.5	16.6	23.9	70.5	10.2	19.1	5.4	9.3	10.9	12.6	57.6	43.4	51.9	8.1	15.5	19.4	27.3	9.9	15.2	23.8	14.5	12.1	42.5	65.7	14.4	15.7	21.9	20.0	31.9	15.8	43.4	9.5	16.2	13.4	14.7	60.9	31.7	38.1	14.0	20.6	38.9	40.7	15.3	16.9	23.6	6.9	6.3	26.2	31.9	13.8	29.1	2.0	24.9	22.3	41.9	19.7	16.7	4.8	40.4	62.9	51.9	7.8	9.3	63.3	57.7	23.2	3.3	19.0	19.4	12.5	10.5	20.3	14.2	14.4	19.3	9.8	8.4	43.2	39.9	10.3	0.6	2.4	0.1	0.8	2.2	1.5	0.6	0.8	0.9	1.3	1.7	0.8	0.6	0.6	0.9	4.3	0.6	0.7	1.4	79.4	62.2	23.9	87.0	62.5	51.7	48.8	59.7	54.7	34.4	70.5	57.6	15.8	80.1	66.6	44.1	37.7	28.4	142.4	72.2	27.3	46.3	74.8	53.5	48.0	34.3	73.2	101.2	22.9	42.9	23.6	97.6	180.0	146.4	1717.4	66.9	28.3	36.1	30.1	15.8	49.3	196.6	86.3	39.4	63.2	73.2	31.8	23.8	17.2	54.2	207.6	52.2	48.7	55.4	12.2	58.2	101.0	4366.5	50.1	118.7	42.7	61.8	38.4	14.9	20.6	16.6	13.5	223.4	36.4	54.2	146.4	184.7	108.4	95.7	71.1	43.3	6.6	17.0	35.0	678.1	30.4	60.7	28.4	124.1	27.3	22.1	57.5	239.8
PDXP	"CIN, dJ37E16.5, FLJ32703"	ENSG00000241360	"Pyridoxal phosphatase"	Q96GD0	22	37658723-37666932	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 209.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.4;Inhibitory neurons: 25.0;Microglial cells: 7.5;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 5.8;Plasma cells: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"plasmacytoid DC: 11.6"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000531	Approved					NA	NA		94000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000531: AB_2666018"	"unprognostic (6.29e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	5.8	23.7	144.7	0.8	158.7	5.8	5.3	106.1	209.2	6.7	83.0	20.6	26.5	8.5	5.6	3.8	8.0	3.9	26.3	165.0	129.2	15.9	74.5	5.7	7.5	117.5	130.0	8.5	13.5	9.5	39.6	1.1	119.8	7.3	11.6	29.6	12.0	6.0	15.8	3.4	32.2	7.2	109.2	14.3	11.9	27.0	137.8	13.5	5.9	14.1	9.5	7.8	3.8	148.0	8.6	19.6	39.4	34.4	12.0	3.7	5.3	18.9	9.7	34.0	26.7	9.9	1.2	54.0	18.8	9.8	28.5	4.4	52.8	0.6	28.5	16.9	105.2	11.0	26.6	41.2	8.3	39.2	47.0	1.8	4.7	17.6	23.7	14.0	15.6	61.1	33.3	31.1	29.9	12.3	74.3	61.3	20.6	15.2	46.4	58.5	28.5	39.7	14.6	1.1	89.5	57.8	17.8	15.4	36.1	17.2	5.0	31.8	9.8	28.7	36.6	30.2	37.6	33.0	44.1	57.4	27.2	14.3	38.5	0.0	0.3	0.5	0.9	0.5	0.1	1.3	0.4	0.5	0.6	1.2	0.3	0.1	0.3	0.9	0.4	11.6	0.5	0.2	144.7	158.7	106.1	209.2	165.0	129.2	117.5	130.0	119.8	109.2	137.8	148.0	0.1	0.0	0.6	3.3	2.8	0.0	0.0	0.0	2.8	1.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	2.1	19.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	25.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.5	0.1	0.2	0.0	8.0	5.8	0.1	0.1	0.0	9.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.9	0.2	0.4	0.1
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 47.0"	"Group enriched"	"Detected in some"	83	"Early spermatids: 47.8;Late spermatids: 119.0"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.0	0.0	43.2	0.1	31.1	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	17.6	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.0	0.0	8.3	9.2	0.2	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	31.1	0.0	43.1	47.0	17.6	1.8	4.1	0.2	21.0	9.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	119.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDZD11	PDZK11	ENSG00000120509	"PDZ domain containing 11"	Q5EBL8	X	70286595-70290514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003972	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA003972: AB_1855165"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.52e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-3)"	27.6	35.6	67.6	19.5	67.6	11.0	33.4	67.9	85.9	30.5	67.9	39.5	33.4	26.1	43.2	41.3	31.1	27.8	51.2	66.6	71.9	44.2	35.4	21.4	27.7	68.3	70.1	26.4	22.8	53.2	29.4	22.3	73.1	31.1	44.7	51.8	30.4	32.6	24.1	32.8	31.7	35.2	67.4	23.0	27.9	10.9	70.7	36.2	37.8	40.8	35.8	37.5	28.8	70.5	75.5	83.7	56.1	63.0	90.6	107.3	47.8	79.4	88.0	115.4	107.0	80.6	92.9	40.2	95.7	140.4	130.0	55.7	92.4	107.2	130.4	56.5	75.6	26.4	79.2	62.1	80.9	36.4	34.8	110.8	73.4	128.0	78.6	108.7	95.0	49.7	42.5	140.9	187.8	113.0	58.9	49.2	44.4	167.6	148.1	41.4	113.3	79.6	99.7	67.4	60.5	61.0	87.7	67.3	86.1	66.5	62.2	31.8	75.5	82.9	70.5	128.2	79.0	30.8	58.8	42.1	120.0	52.1	99.0	17.9	25.6	18.2	40.1	47.6	44.9	37.1	41.3	45.5	38.5	37.0	25.2	36.5	10.6	36.5	62.1	28.9	77.4	34.8	67.6	67.6	67.9	85.9	66.6	71.9	68.3	70.1	73.1	67.4	70.7	70.5	26.6	12.8	11.8	4.6	12.3	24.6	28.8	76.2	22.8	26.0	30.4	42.7	45.0	24.3	36.6	33.1	4.2	42.0	16.7	39.0	117.4	46.1	0.6	25.1	32.4	25.4	18.5	20.2	3.2	41.1	61.0	35.0	16.8	25.7	26.6	29.8	20.0	20.5	62.6	32.0	3.6	48.2	48.8	27.5	18.8	1.0	30.4	22.1	30.2	4.7	27.9	71.3	16.5	3.5	2.5	55.9	52.3	38.0	23.2	18.6	66.7	92.0	27.7	21.7	39.5	19.9	40.4	7.7	19.8	44.9	28.1	26.8	22.1	52.5	43.9	33.8
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639131-32110932	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.9;Excitatory neurons: 313.2;Oligodendrocyte precursor cells: 745.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 24.8;cerebral cortex: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;EFO-21: 4.5;SiHa: 11.6;SK-BR-3: 10.6;T-47d: 5.5"	"Low region specificity"	"Detected in all"							"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.5	0.9	4.5	0.7	24.8	0.1	5.0	0.7	15.7	2.2	10.6	1.4	0.5	2.5	1.9	5.3	2.2	0.9	18.8	4.7	0.3	8.2	0.1	9.0	0.3	4.5	4.3	14.4	1.2	0.6	1.8	10.9	1.0	1.5	0.7	14.8	1.6	1.9	2.5	10.1	0.6	2.4	0.3	0.2	1.7	5.6	4.1	2.6	1.0	4.8	1.7	0.6	2.1	0.0	0.1	0.0	3.1	0.1	0.0	0.0	8.1	0.0	0.0	0.6	0.5	0.0	0.0	0.0	4.5	0.0	1.2	4.3	1.7	0.9	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	2.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.1	0.7	11.6	10.6	0.0	2.6	5.5	0.0	0.0	0.0	2.2	0.0	0.5	0.0	0.0	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	24.8	0.7	15.7	4.7	0.3	4.5	4.3	1.0	0.3	4.1	0.0	26.2	44.8	38.6	39.2	0.2	16.8	4.4	14.0	13.6	7.0	10.6	6.9	53.9	0.0	9.3	5.5	98.0	25.5	1.9	0.1	0.0	0.2	232.9	9.7	16.9	14.7	0.0	1.3	313.2	0.2	3.4	8.6	7.7	33.2	1.3	18.7	5.7	0.2	2.2	15.2	113.2	0.0	4.1	0.3	3.1	55.2	7.5	1.0	7.2	87.1	0.2	6.4	0.0	745.0	104.7	3.5	0.0	10.5	0.1	3.5	0.0	8.2	2.8	62.1	46.0	7.3	13.4	12.3	3.8	15.1	18.5	21.1	1.3	46.8	0.0	1.8
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 19.3;kidney: 17.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.3;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077887	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	17.1	0.0	0.0	0.0	1.0	2.8	0.1	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.3	8.6	0.0	0.0	6.2	0.0	0.0	93.4	3.9	0.1	0.0	0.2	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.4	30.5	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	8.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	0.2	0.1	79.1	29.5	0.7	0.7	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	21.0	0.1
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 150.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Bipolar cells: 18.0;dendritic cells: 14.0;Excitatory neurons: 11.0;NK-cells: 26.8;Rod photoreceptor cells: 14.1"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;testis cancer: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.4;NTERA-2: 12.4;RH-30: 17.3;SCLC-21H: 29.5;SH-SY5Y: 28.7;U-2 OS: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.7	5.0	98.2	1.9	102.8	2.1	3.4	76.6	150.1	9.5	42.3	23.4	1.6	11.9	1.2	3.8	13.9	2.0	6.1	132.0	46.9	3.9	2.6	4.8	2.0	57.6	48.0	2.7	2.3	2.8	44.1	0.1	59.5	10.4	1.3	14.8	4.1	9.8	3.3	4.3	5.9	4.3	38.2	14.0	7.6	6.0	46.7	1.1	3.5	1.3	0.6	10.0	9.2	89.8	0.0	1.6	24.4	6.4	0.0	0.1	0.0	0.7	0.0	0.7	0.8	0.6	0.0	0.0	0.3	0.0	7.9	0.1	4.5	0.0	0.1	0.0	0.8	0.0	1.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.3	5.0	0.2	0.9	12.4	0.0	0.3	0.1	17.3	0.0	0.0	0.1	29.5	28.7	1.3	0.0	9.2	8.2	2.8	0.3	0.0	0.0	14.1	0.3	1.8	0.0	0.1	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	98.2	102.8	76.6	150.1	132.0	46.9	57.6	48.0	59.5	38.2	46.7	89.8	1.8	0.0	0.0	12.1	0.1	0.3	0.0	0.0	0.6	18.0	0.1	2.4	3.7	0.0	1.3	0.0	6.2	0.0	14.0	0.0	0.0	0.0	0.1	0.2	1.5	3.5	1.8	0.8	11.0	0.2	0.0	0.8	0.5	0.1	1.3	0.2	4.6	0.1	0.0	1.7	8.6	0.0	0.0	1.0	0.0	0.2	0.6	0.1	3.6	4.7	0.2	3.9	26.8	5.5	0.7	0.3	0.0	3.8	3.6	0.2	0.0	0.0	4.4	14.1	0.0	1.7	2.1	0.3	4.1	0.5	0.9	0.0	4.1	0.0	0.0	0.2
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375440	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Late spermatids: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	7.1	7.0	8.9	4.7	12.1	73.0	4.7	15.7	8.6	7.9	17.9	9.3	14.0	9.1	14.1	10.8	6.8	9.7	5.1	8.1	11.8	13.1	15.8	6.0	3.2	11.9	13.8	8.9	14.1	28.3	4.2	5.4	12.2	6.4	11.2	14.1	12.9	10.6	4.9	5.5	10.6	6.9	11.3	3.7	10.4	13.2	12.5	5.8	6.8	5.8	3.6	6.6	5.8	13.2	12.6	21.1	7.6	14.7	12.8	11.4	4.3	11.9	10.2	5.2	4.2	10.7	16.4	14.7	10.5	18.1	6.0	18.4	13.4	12.6	10.3	9.4	11.8	124.3	8.6	10.6	9.4	52.4	11.2	11.2	14.7	9.5	27.9	19.3	9.3	12.1	11.5	15.0	13.0	5.1	10.2	6.7	6.0	6.6	18.8	8.2	29.2	6.4	15.5	9.0	6.0	9.6	12.6	5.4	9.7	6.9	3.7	7.6	15.1	8.6	9.4	15.8	20.5	8.0	7.2	10.5	10.8	23.6	7.7	1.4	0.5	2.6	0.9	0.5	0.9	0.3	0.7	0.7	0.7	0.4	0.5	0.7	2.3	1.2	0.9	0.5	0.3	0.2	8.9	12.1	15.7	8.6	8.1	11.8	11.9	13.8	12.2	11.3	12.5	13.2	22.1	12.8	30.7	32.3	13.7	29.7	24.4	10.3	24.5	31.9	16.4	17.0	19.8	40.0	21.0	18.4	22.9	9.8	36.1	26.9	9.8	31.9	208.7	78.3	46.7	24.0	33.7	82.0	49.2	81.9	7.2	27.3	48.4	111.2	44.2	14.6	18.9	58.6	7.5	32.0	61.0	38.8	10.2	16.0	31.8	477.6	23.6	25.2	23.2	30.0	15.5	29.0	23.7	51.8	56.4	57.6	23.1	28.6	28.1	41.1	27.0	26.5	28.5	45.0	26.3	46.3	24.5	25.8	29.1	36.3	32.4	6.7	28.4	90.8	50.2	44.6
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PDZRN3	"KIAA1095, LNX3, SEMACAP3, SEMCAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382431-73624941	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	29.9	35.7	14.9	10.2	16.3	0.0	24.0	8.5	20.9	45.2	58.0	84.0	9.2	64.1	24.5	27.8	26.7	27.4	48.0	16.7	10.6	10.7	2.1	14.9	4.5	13.0	11.8	69.4	6.9	0.8	4.6	17.5	11.0	31.7	13.9	6.3	20.9	29.0	91.8	17.3	24.4	38.4	13.1	2.4	38.7	6.4	17.1	2.9	3.6	22.4	1.4	46.7	32.0	13.2	0.0	0.0	32.1	0.1	57.0	29.6	0.1	16.9	42.0	5.0	3.2	16.2	0.0	0.1	0.1	22.8	0.8	0.0	0.0	0.0	4.8	0.0	2.2	0.0	0.0	0.0	9.5	0.0	0.1	41.4	0.0	13.8	0.1	6.0	0.0	0.0	0.0	0.0	4.9	2.1	0.0	0.2	4.6	0.0	0.2	0.0	8.4	0.1	0.0	0.0	3.7	10.5	0.0	7.8	12.7	9.2	4.5	0.0	0.0	20.6	1.5	23.6	2.2	0.7	0.0	0.2	30.4	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	14.9	16.3	8.5	20.9	16.7	10.6	13.0	11.8	11.0	13.1	17.1	13.2	5.9	0.0	0.0	256.0	0.5	2.4	9.7	0.0	1.8	19.3	7.5	7.6	65.0	0.0	0.0	5.5	6.2	0.5	2.7	1.0	1.9	0.0	0.4	2.1	45.2	2.3	21.1	0.0	183.1	0.4	0.5	25.2	2.0	3.3	0.0	35.0	0.0	0.0	0.8	0.0	258.3	9.1	0.0	0.0	2.9	1.3	23.3	0.7	16.0	329.8	0.0	22.5	0.0	21.6	5.5	0.3	0.9	28.2	0.1	10.9	0.1	7.1	0.0	1.9	0.0	4.6	19.6	0.5	6.2	2.9	1.8	0.8	0.5	12.4	3.9	6.3
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188320-41574745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.9;seminal vesicle: 17.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 371.6;Inhibitory neurons: 125.6;Oligodendrocyte precursor cells: 561.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-266/70: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042101	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA042101: AB_2732496"	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.2	0.9	1.5	1.1	2.5	0.0	1.9	0.1	2.3	2.2	0.0	10.9	0.8	0.9	2.2	3.8	2.2	1.7	0.4	1.5	0.9	0.5	0.6	0.3	0.0	1.3	3.3	1.9	0.4	0.1	0.4	4.0	2.2	6.6	3.1	1.0	0.3	17.8	0.3	0.5	2.9	2.5	1.3	0.2	3.3	2.4	1.4	0.0	0.3	1.9	0.3	3.9	2.6	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	0.1	2.3	1.5	0.9	1.3	3.3	2.2	1.3	1.4	1.9	0.1	0.0	0.0	37.5	0.3	0.8	0.0	0.0	2.8	9.8	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.3	0.0	0.0	371.6	0.0	0.2	17.3	1.1	0.0	0.0	19.8	1.4	0.0	0.4	0.0	125.6	0.0	0.0	0.0	0.3	1.6	28.0	0.2	0.0	5.6	0.0	0.4	0.0	561.9	13.7	0.0	0.0	56.4	1.2	0.1	0.0	0.0	0.7	1.1	0.0	0.1	5.7	0.1	0.2	0.8	0.6	0.4	0.0	34.1	0.0	0.1
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PEAK1	"KIAA2002, sgk269"	ENSG00000173517	"Pseudopodium enriched atypical kinase 1"	Q9H792	15	77100656-77420144	"Enzymes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Excitatory neurons: 162.1;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 338.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.8"	"Cell line enhanced"	"Detected in all"		"TIME: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026313, HPA026517"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA026313: AB_1856801, HPA026517: AB_1856802"	"unprognostic (1.15e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.65e-3)"	13.8	4.4	8.9	5.8	13.3	9.1	9.5	5.5	8.8	11.3	1.0	7.8	5.9	7.4	6.4	5.2	5.7	10.0	16.2	8.2	8.4	5.0	3.8	18.0	6.8	6.4	7.8	7.5	4.8	5.4	2.9	16.7	5.8	6.0	8.1	13.7	5.5	7.3	6.7	6.7	7.3	9.9	4.9	29.4	4.9	9.9	11.8	4.7	6.3	8.5	4.7	9.0	7.5	11.7	5.4	7.8	18.1	4.3	33.4	35.7	6.3	28.6	19.7	14.9	14.9	6.3	4.7	4.1	5.0	41.4	5.7	2.6	14.6	4.5	16.9	4.2	7.6	7.7	12.2	3.8	12.2	4.6	3.9	27.6	4.3	28.8	4.8	16.3	42.3	6.6	10.0	4.0	16.1	2.2	2.6	4.9	8.4	3.7	2.1	5.3	10.8	3.0	4.4	9.6	4.0	4.9	11.2	2.3	18.6	19.7	1.7	3.2	52.1	31.5	15.2	13.2	12.2	6.3	9.5	5.9	5.5	10.5	17.3	0.1	0.2	0.4	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.1	1.8	0.1	0.2	0.0	0.2	8.9	13.3	5.5	8.8	8.2	8.4	6.4	7.8	5.8	4.9	11.8	11.7	48.3	147.4	46.8	101.9	12.6	21.9	7.5	5.6	2.2	18.4	6.1	5.8	46.9	10.0	29.2	1.8	12.5	3.1	12.3	23.9	0.0	6.9	15.1	22.9	19.5	41.2	3.0	10.8	162.1	5.4	2.0	35.6	15.8	10.1	17.7	6.3	31.8	6.0	18.9	20.2	84.4	11.9	2.0	21.3	34.7	13.6	19.9	20.2	12.4	124.6	8.5	28.1	10.3	513.2	338.1	9.8	10.7	16.1	7.0	8.3	15.7	3.7	41.6	20.1	13.1	23.0	37.7	13.6	13.7	5.8	18.0	6.3	8.2	22.6	12.3	7.2
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274631-2282175	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.3;lymphoid tissue: 4.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.5;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 12.2"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;cerebellum: 3.1"	HPA057806	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	0.5	0.4	0.5	1.3	0.9	2.3	0.3	0.5	1.6	0.2	0.1	0.4	0.2	0.2	0.0	0.2	0.5	0.2	0.7	0.4	0.5	0.3	0.2	1.1	0.4	1.4	1.0	0.1	0.2	0.0	0.2	0.1	1.0	0.3	0.2	0.0	0.2	0.0	0.3	0.3	0.8	0.1	0.9	4.1	0.3	0.1	0.8	0.1	0.2	0.0	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	10.5	4.4	11.7	1.6	5.7	0.2	0.2	0.1	0.2	1.8	0.4	0.1	0.3	41.0	4.5	1.9	0.2	0.0	1.1	0.5	0.9	0.5	1.6	0.4	0.5	1.4	1.0	1.0	0.9	0.8	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118136124-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2083.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		51000000	"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	217.9	1754.1	941.2	84.0	966.0	121.8	235.5	987.9	1049.0	258.0	958.4	208.9	601.4	186.6	383.7	219.5	218.4	154.8	463.8	932.6	951.5	1046.1	2083.1	176.4	122.7	959.0	965.9	335.9	357.5	1162.7	292.3	128.8	982.6	261.6	191.2	336.1	344.5	233.2	580.3	190.3	510.6	167.6	1006.6	121.2	201.7	152.2	1025.0	138.1	739.7	546.8	160.2	200.8	179.0	1081.7	289.2	241.6	340.0	348.8	493.5	250.2	500.0	214.5	262.3	347.7	177.1	151.6	96.4	439.6	221.3	336.2	139.9	194.4	495.0	202.8	257.7	115.1	454.2	220.0	274.7	1021.7	289.2	403.6	94.5	240.8	334.7	203.9	140.0	396.1	162.7	240.9	375.8	169.2	356.4	346.3	226.8	813.7	319.7	243.1	273.9	446.1	235.6	829.7	428.7	277.2	397.5	306.9	439.9	306.2	446.0	200.4	443.6	293.0	168.9	253.7	147.0	254.0	237.3	161.6	315.1	234.1	301.1	303.2	280.9	5.0	67.5	20.0	155.2	76.4	247.0	271.7	258.9	193.1	205.1	210.0	244.6	201.2	8.0	138.1	68.6	231.6	259.7	258.4	941.2	966.0	987.9	1049.0	932.6	951.5	959.0	965.9	982.6	1006.6	1025.0	1081.7	193.7	403.8	433.3	101.5	230.9	318.1	449.3	367.6	288.5	539.4	538.4	590.7	697.3	713.4	243.2	783.5	95.9	999.6	144.6	207.1	3705.6	507.9	44.3	499.3	319.0	186.5	320.6	218.1	93.7	244.6	862.3	347.9	169.2	369.8	371.8	419.7	213.8	2242.4	591.6	721.8	99.6	378.8	335.7	201.4	239.0	84.4	543.1	195.3	743.5	53.4	296.8	1792.2	101.0	39.2	199.8	184.2	313.3	731.6	279.3	517.4	2177.7	4542.6	291.6	411.6	368.1	337.5	347.8	330.6	145.7	367.7	325.2	615.5	216.7	921.6	631.3	399.5
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 382.5;skeletal muscle: 670.8;tongue: 581.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA025064	Uncertain				"Secreted in other tissues"	NA	NA		190000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	1.1	3.4	12.3	0.3	16.7	0.0	3.3	21.2	9.2	0.6	19.2	0.6	0.0	0.5	382.5	6.8	2.2	1.1	200.7	8.5	15.8	2.6	0.9	115.1	0.7	15.6	20.3	1.7	34.5	82.6	13.2	0.3	20.2	45.8	0.2	12.9	21.1	2.8	670.8	1.4	0.6	0.4	8.7	0.8	9.2	6.6	28.7	1.2	56.7	581.4	1.6	0.3	0.5	15.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	12.3	16.7	21.2	9.2	8.5	15.8	15.6	20.3	20.2	8.7	28.7	15.5	1.5	109.0	177.3	15.3	2.2	1.9	1.0	0.1	0.0	10.2	5.7	4.7	144.7	0.0	7.4	1.8	2.1	0.8	1.4	0.3	3.9	0.0	34.8	1.7	2.0	2.4	0.0	0.0	10.0	9.3	0.2	10.1	2.0	7.0	7.6	0.4	3.9	0.7	1.2	10.1	9.6	0.3	2.0	0.0	0.8	28.4	3.4	1.4	1.8	6.5	0.1	198.7	5.2	6.6	0.9	0.3	0.1	10.9	1.5	23.8	0.5	5.9	2.9	8.6	0.0	25.2	2.1	14.8	1.2	0.0	0.9	0.0	1.6	1.1	0.3	1.0
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 160.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 91.0;Proximal enterocytes: 49.5;Proximal tubular cells: 79.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.3;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	25.4	5.4	2.7	2.9	3.1	7.1	10.2	3.8	2.9	4.5	6.0	8.7	26.0	3.3	4.1	3.1	8.1	9.7	2.4	2.7	2.8	33.9	160.2	6.4	3.9	3.2	3.1	4.1	4.8	7.2	3.2	1.0	3.3	5.0	7.5	2.2	5.6	3.4	6.8	4.2	20.1	3.2	2.6	3.0	3.9	0.5	3.0	3.4	16.1	5.2	3.8	2.3	2.3	3.7	6.0	6.6	2.6	0.1	15.7	5.7	3.1	1.4	3.3	3.7	6.3	7.6	17.1	0.1	11.9	3.5	9.2	1.4	7.5	8.7	6.5	9.5	7.7	7.8	3.6	38.3	15.7	2.0	5.1	5.0	6.1	3.9	5.5	5.6	3.8	4.6	3.3	8.6	8.2	4.4	2.4	2.2	4.8	0.1	4.9	5.3	5.0	0.9	35.9	1.0	3.6	5.2	3.6	7.4	15.6	6.2	8.6	6.5	0.0	2.4	2.5	6.0	4.3	9.8	8.9	3.1	5.3	2.8	5.6	1.2	4.2	1.5	6.5	1.6	7.7	4.3	8.8	7.5	1.5	5.7	9.2	6.1	4.5	9.9	2.3	0.2	16.6	4.1	2.7	3.1	3.8	2.9	2.7	2.8	3.2	3.1	3.3	2.6	3.0	3.7	4.3	6.4	13.6	6.5	7.0	3.7	4.7	4.0	3.4	10.8	2.4	2.9	3.7	35.8	3.4	29.5	14.6	3.9	5.9	11.5	13.7	13.2	0.1	10.1	2.7	3.9	7.2	9.4	15.4	3.8	7.3	5.0	7.7	6.3	1.3	2.0	6.8	91.0	9.6	3.3	18.4	8.0	6.1	4.7	3.7	0.3	5.6	5.5	10.6	8.4	27.4	10.1	9.2	8.5	10.6	5.0	17.7	8.2	5.9	2.0	49.5	79.1	13.1	6.4	0.0	6.6	4.4	0.1	1.6	4.9	2.8	1.6	11.4	1.9	14.6	2.7
PEDS1	"CarF, Kua, TMEM189"	ENSG00000240849	"Plasmanylethanolamine desaturase 1"	A5PLL7	20	50118254-50153734	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 86.8;Extravillous trophoblasts: 167.6;Hofbauer cells: 38.6;Syncytiotrophoblasts: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA059549: AB_2684059"	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	13.2	14.0	19.6	7.3	24.0	5.7	10.4	25.3	24.3	12.7	15.8	18.4	8.7	13.8	10.7	26.0	9.1	7.2	20.8	19.6	20.8	9.3	17.8	13.7	6.0	25.8	24.4	5.5	9.3	12.8	5.8	17.6	24.1	11.6	7.1	2.2	12.4	13.5	16.9	22.9	9.8	21.8	21.0	10.0	15.1	6.3	23.3	7.8	7.7	16.3	7.4	15.4	15.1	29.1	19.6	17.7	20.7	16.3	30.7	23.0	34.6	13.6	12.6	27.8	15.6	48.6	30.5	7.2	21.2	12.8	39.7	52.8	10.4	27.4	10.0	3.8	8.0	9.3	24.5	41.6	17.3	15.1	24.2	19.7	62.7	15.6	16.4	13.4	33.6	12.2	9.8	10.2	9.5	17.3	12.0	38.1	10.1	50.1	18.3	9.7	15.9	7.8	53.7	28.4	10.8	7.1	15.4	52.2	32.4	20.3	8.3	21.2	26.8	23.1	12.1	15.1	13.5	7.5	13.6	2.9	19.9	11.1	19.1	4.9	5.3	6.2	3.1	10.2	2.6	1.8	3.5	2.6	5.6	1.5	2.9	3.4	2.0	4.0	14.0	3.6	5.6	3.8	19.6	24.0	25.3	24.3	19.6	20.8	25.8	24.4	24.1	21.0	23.3	29.1	8.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	86.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	167.6	6.3	0.0	0.0	0.0	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	50.1	1.2	0.0	0.0	0.0
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810077-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 76.9;brain: 218.4;choroid plexus: 177.0;ovary: 260.1;placenta: 135.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026070	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.4	76.9	76.5	1.5	56.5	0.1	10.9	4.4	41.2	8.7	177.0	5.1	0.6	22.8	5.8	2.2	12.9	1.9	3.5	28.7	218.4	3.4	4.5	1.8	0.5	51.9	105.8	260.1	2.5	9.9	28.8	135.1	95.6	3.0	1.7	17.9	5.4	4.9	0.7	1.5	1.4	9.2	27.4	0.8	2.1	33.6	130.4	1.0	5.7	1.8	6.2	3.5	3.3	42.8	0.0	0.0	4.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	218.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.6	0.0	71.7	0.1	0.1	0.1	0.2	6.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.5	56.5	4.4	41.2	28.7	218.4	51.9	105.8	95.6	27.4	130.4	42.8	4.1	0.0	4.6	0.0	0.2	4.8	1.9	0.0	4.0	31.0	10.9	17.8	17.2	1.5	1.8	1.8	8.4	345.8	1.6	0.0	1.9	0.9	32.0	1.3	35.0	3.5	0.0	0.0	0.0	0.0	45.4	56.9	0.0	1.6	0.0	224.1	4.6	4.3	34.3	148.0	0.0	0.0	0.0	0.6	1.7	19.4	58.7	1.2	14.2	0.0	0.0	17.0	0.0	0.0	0.0	0.3	0.0	109.9	0.0	2.0	0.0	1.1	2.2	13.7	13.1	29.5	17.0	53.0	36.2	2.0	2.6	477.1	0.2	395.9	0.0	0.7
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144420	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 228.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 76.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 76.9;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 58.8;U-698: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	27.6	7.9	10.2	28.1	14.4	228.5	25.7	11.9	13.5	17.9	9.2	18.6	17.6	17.3	8.6	42.9	12.7	26.1	11.8	13.8	11.2	10.6	13.5	31.0	24.7	12.2	11.2	5.5	9.3	37.9	15.8	15.6	12.2	8.9	20.1	5.1	18.9	7.7	7.1	29.7	23.2	13.9	12.6	21.8	18.1	10.7	10.9	28.3	9.7	10.0	29.0	22.4	23.7	15.6	3.6	2.8	36.5	24.6	4.2	3.2	8.3	4.8	5.4	4.3	6.8	58.8	4.1	48.3	11.3	1.7	1.6	5.8	11.1	10.5	8.6	12.2	8.9	4.4	1.7	9.5	12.4	4.8	8.3	4.2	8.1	6.4	21.6	4.5	24.3	18.2	2.7	11.7	3.7	0.3	10.6	6.9	23.8	11.1	1.7	13.2	12.6	28.1	17.7	10.8	16.7	23.3	3.6	5.5	12.9	11.3	3.0	3.3	17.5	4.0	5.7	4.0	7.1	27.0	2.8	146.7	2.1	4.3	10.9	15.0	15.6	15.0	0.9	14.1	1.7	8.5	4.8	1.9	5.4	6.6	5.6	2.5	76.9	3.0	23.2	0.5	11.6	6.6	10.2	14.4	11.9	13.5	13.8	11.2	12.2	11.2	12.2	12.6	10.9	15.6	94.5	28.9	49.2	4.6	84.4	224.1	74.6	48.2	105.9	1.7	60.9	50.3	5.7	15.7	52.0	5.5	0.0	1.7	16.9	57.9	1.9	5.3	10.6	34.6	26.4	52.1	25.7	3.4	23.4	26.7	8.6	24.5	75.4	58.7	15.2	6.3	37.5	7.5	22.8	3.3	19.1	23.4	30.5	67.6	103.7	11.2	1.5	107.0	112.1	119.9	30.6	5.5	3.1	82.9	67.9	20.9	45.9	1.9	318.8	44.7	32.7	9.6	43.6	2.0	0.0	10.1	51.9	8.4	9.6	208.0	217.5	4.0	49.4	3.2	32.4	145.8
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301524	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	11.6	3.0	8.1	4.3	7.8	18.6	7.7	27.9	5.9	6.7	5.4	7.0	11.0	6.7	2.5	4.4	6.3	10.0	2.9	5.6	6.6	9.2	2.8	6.7	4.0	8.8	10.9	15.0	28.6	1.9	2.7	3.1	9.3	4.7	3.9	15.1	7.7	3.5	2.4	5.9	9.2	3.3	8.0	6.8	14.4	10.0	10.4	19.1	4.1	3.8	2.0	10.6	5.7	9.2	0.1	3.1	8.8	0.0	4.8	7.2	0.2	1.2	4.2	0.9	0.1	0.2	0.7	0.2	4.2	2.5	0.0	0.9	6.9	0.0	0.4	2.3	2.4	7.9	13.0	0.0	4.1	1.1	33.3	4.5	0.4	0.0	0.0	4.8	1.6	43.8	6.0	0.1	0.9	0.0	39.5	0.4	14.5	0.1	1.2	19.2	0.5	1.8	3.6	15.4	17.5	0.0	0.8	0.1	10.2	5.5	0.0	6.3	0.5	2.6	4.4	0.8	4.4	0.7	0.1	1.0	4.6	5.4	2.6	0.9	1.9	2.4	0.3	1.0	0.5	0.1	0.3	0.2	1.3	0.4	0.2	0.1	5.6	0.3	0.8	0.3	0.0	0.7	8.1	7.8	27.9	5.9	5.6	6.6	8.8	10.9	9.3	8.0	10.4	9.2	13.9	0.0	10.0	114.3	7.7	14.3	10.4	1.7	9.6	30.7	7.1	7.7	2.7	8.6	6.7	12.9	29.2	0.1	11.8	15.0	3.9	5.9	3.7	23.7	14.5	18.0	7.2	5.5	13.5	14.1	0.1	13.5	34.1	21.2	5.7	5.7	17.5	1.0	1.2	21.9	22.1	7.9	2.0	19.7	14.0	5.7	17.1	20.3	17.8	100.2	22.9	9.7	10.3	150.8	77.5	9.1	6.0	18.0	5.6	7.8	12.4	10.1	8.8	19.7	13.1	5.4	22.0	2.0	24.0	4.7	18.3	0.1	6.2	5.6	3.1	12.6
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 26.5;Horizontal cells: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	7.5	10.2	19.1	2.6	18.7	1.2	7.7	21.1	33.2	12.4	4.4	15.3	3.2	13.9	5.6	6.9	11.2	6.8	8.8	20.5	15.0	6.2	4.2	5.5	3.2	22.7	17.2	13.5	8.2	11.7	13.4	2.4	23.6	14.6	1.7	5.5	8.7	14.8	18.3	7.7	6.3	5.6	13.9	5.1	9.4	7.6	19.5	1.0	6.3	4.6	1.5	14.7	9.1	19.8	20.2	8.1	6.5	5.0	10.2	4.0	5.6	6.2	8.0	5.7	4.9	11.8	4.3	5.0	6.1	6.9	10.3	10.2	4.0	7.8	2.4	9.6	4.1	1.3	7.2	3.5	6.4	1.0	9.2	3.8	8.6	5.8	2.1	8.3	1.2	6.4	2.3	7.2	2.5	11.5	4.2	3.0	3.9	10.2	8.4	13.6	4.7	5.2	3.2	6.3	7.9	4.4	3.2	8.8	21.6	2.8	10.3	5.3	3.4	5.0	7.6	21.7	5.4	6.9	4.2	2.7	10.6	3.1	4.1	0.5	1.0	0.2	1.0	0.8	0.8	1.2	0.8	1.2	1.4	1.5	0.9	0.7	0.0	0.5	3.4	0.4	1.0	0.6	19.1	18.7	21.1	33.2	20.5	15.0	22.7	17.2	23.6	13.9	19.5	19.8	5.0	6.4	2.0	2.0	0.7	1.7	3.8	0.9	4.0	13.3	3.0	4.4	8.1	4.3	0.6	0.0	10.4	2.5	0.4	0.6	1.9	3.2	5.0	0.4	2.6	2.7	26.5	0.0	7.1	2.5	2.1	4.2	2.0	1.1	0.0	2.9	3.3	2.8	3.3	21.9	7.7	1.4	2.0	1.9	1.4	10.4	7.5	2.9	0.0	1.9	2.8	7.5	0.0	2.0	2.5	1.8	1.4	9.8	1.0	2.5	0.9	2.9	0.2	9.7	6.6	3.1	4.9	3.0	3.5	1.8	0.3	0.3	1.3	1.5	0.8	1.5
PELO		ENSG00000152684	"Pelota mRNA surveillance and ribosome rescue factor"	Q9BRX2	5	52787916-52804044	"Predicted intracellular proteins"	"Cell cycle, Cell division, Translation regulation"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 90.7;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031458	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli fibrillar center"		"HPA031458: AB_10602141"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.40e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.21e-2)"	9.4	17.6	5.3	5.2	5.9	8.2	7.3	5.7	5.2	6.9	4.9	11.3	4.6	9.8	7.5	6.7	7.9	6.3	10.3	5.7	6.1	9.9	10.7	11.7	6.3	5.4	6.3	5.1	5.3	7.4	6.0	11.6	5.7	6.7	3.7	4.4	4.9	6.7	12.2	8.4	6.2	9.9	5.9	12.6	7.5	4.4	6.7	4.8	7.2	8.8	3.6	8.4	6.7	5.2	18.1	18.3	8.1	14.5	14.0	10.3	7.1	20.4	22.4	19.6	23.9	18.4	13.8	5.9	36.0	22.1	29.4	14.8	11.9	17.3	16.9	6.3	16.8	6.6	15.2	15.5	42.6	12.5	7.6	13.0	17.5	22.7	18.6	16.9	11.8	8.8	8.4	18.5	17.3	14.1	13.1	7.7	6.1	3.3	19.3	4.5	10.4	17.6	14.3	8.5	13.3	10.3	10.8	13.3	11.9	13.7	12.2	4.5	11.7	11.8	11.4	12.5	26.0	7.9	10.4	7.8	22.5	11.6	10.4	22.3	5.9	7.6	4.8	3.9	5.9	4.8	6.2	5.4	6.1	3.6	5.0	4.7	19.0	4.7	2.2	2.3	4.8	4.4	5.3	5.9	5.7	5.2	5.7	6.1	5.4	6.3	5.7	5.9	6.7	5.2	49.9	9.6	7.4	0.0	9.8	46.9	53.0	24.4	14.2	16.5	12.7	18.7	12.7	17.2	20.2	9.2	2.1	35.9	10.5	8.7	35.2	31.5	65.1	18.7	23.1	50.5	10.2	8.0	0.0	25.5	90.7	36.7	9.2	27.6	1.3	11.4	40.4	18.7	20.1	8.4	0.1	16.0	14.2	6.6	23.3	9.2	17.7	15.8	7.2	0.0	7.7	15.5	6.2	0.0	0.0	24.5	6.0	12.0	14.3	36.5	12.3	29.0	16.9	11.0	85.5	13.7	56.5	22.1	13.9	14.9	35.8	53.9	23.0	18.8	11.5	38.3
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.2	17.8	34.9	13.4	34.1	10.9	14.9	29.9	33.1	19.9	21.2	18.3	11.8	21.5	6.2	19.5	19.8	8.8	23.1	33.4	30.7	16.8	17.7	13.1	16.3	34.2	33.3	21.9	17.5	15.5	23.5	11.4	33.8	20.5	7.5	8.7	15.3	12.2	46.8	18.7	17.4	10.8	31.8	20.5	17.5	32.8	33.6	12.5	17.2	18.1	12.0	19.5	17.0	33.9	41.8	89.8	34.8	55.3	26.5	19.5	77.9	29.6	20.5	40.1	42.7	88.1	30.0	100.0	44.4	23.4	28.5	62.6	65.1	46.3	22.6	52.1	93.2	44.6	45.1	72.0	34.2	36.4	57.5	23.9	28.2	49.5	41.3	20.7	30.2	52.9	54.7	42.6	22.4	57.2	68.9	42.7	57.3	40.2	29.7	71.7	30.8	49.3	28.2	31.2	34.8	46.5	50.8	36.9	39.4	33.1	44.6	24.3	30.7	30.9	43.5	47.3	57.9	22.7	42.5	41.6	34.9	37.1	40.6	0.2	0.7	2.0	0.9	1.0	0.9	0.8	0.9	0.7	0.8	1.3	0.9	1.3	0.2	1.3	1.2	1.1	0.6	0.7	34.9	34.1	29.9	33.1	33.4	30.7	34.2	33.3	33.8	31.8	33.6	33.9	10.4	22.4	30.1	11.1	18.5	14.8	14.8	15.7	21.1	24.0	13.5	12.4	22.6	8.6	20.9	9.2	16.7	30.9	15.3	11.8	1.9	15.9	64.7	16.6	17.3	13.7	12.6	14.1	10.6	14.6	28.3	16.6	16.8	17.6	30.9	21.1	5.0	10.6	16.9	35.3	13.0	18.6	12.2	6.0	20.4	27.0	9.3	10.4	10.6	5.6	65.1	10.7	5.2	5.0	11.5	11.4	11.7	19.2	23.6	19.3	8.3	4.7	22.3	17.8	6.6	16.8	14.8	31.3	67.5	20.0	16.3	21.2	17.4	16.6	21.9	13.0
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 166.2;liver: 267.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 122.9;Hepatocytes: 220.1;Peritubular cells: 346.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	71.6	33.9	13.2	5.2	13.6	9.2	92.7	16.3	20.0	47.4	12.7	13.6	15.0	36.9	166.2	26.8	26.5	5.4	24.5	13.0	15.2	30.2	267.4	25.8	5.2	14.9	15.3	27.9	32.2	13.3	24.7	7.3	16.8	30.8	3.4	2.8	27.1	24.0	29.5	34.3	13.7	6.8	15.1	12.8	19.5	40.8	14.2	5.6	33.5	10.7	4.5	21.1	24.2	17.2	34.3	64.7	16.5	43.4	34.6	23.8	25.1	21.6	19.0	28.5	22.4	38.2	22.6	29.8	38.1	21.9	21.6	39.9	24.6	12.8	7.2	22.2	86.9	14.8	33.2	55.4	38.4	13.5	21.4	24.9	26.7	19.2	29.1	9.7	15.7	41.3	14.6	12.3	12.9	66.0	23.9	24.2	23.2	65.5	52.4	22.2	26.7	27.5	24.1	12.5	16.7	39.5	15.3	10.1	39.2	31.5	15.6	5.1	13.9	28.1	28.2	47.4	18.9	17.0	12.1	5.5	25.9	18.5	23.6	1.9	41.1	2.1	16.9	39.0	24.8	23.5	22.2	21.5	30.5	28.3	17.2	19.4	3.1	29.3	28.0	27.7	22.4	21.3	13.2	13.6	16.3	20.0	13.0	15.2	14.9	15.3	16.8	15.1	14.2	17.2	38.1	16.0	17.5	4.9	12.4	18.2	21.0	27.9	39.3	4.5	33.0	45.1	15.5	11.5	24.9	27.6	0.0	19.5	5.9	9.3	17.6	33.3	2.9	21.8	122.9	18.5	68.8	17.1	5.4	38.5	21.6	30.4	8.2	23.8	12.7	52.4	10.4	220.1	23.5	5.0	6.8	30.9	24.4	13.7	12.2	14.9	94.8	11.2	21.4	3.7	5.7	34.7	2.1	9.5	4.0	25.7	10.8	346.8	15.3	35.1	21.7	32.3	14.2	6.1	6.6	20.0	23.6	21.0	24.9	39.5	18.2	14.6	12.5	49.3	24.1	23.8
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446671	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 376.2;brain: 164.1;testis: 129.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3626.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 923.2"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	8.6	376.2	29.9	4.4	164.1	0.0	4.9	45.2	45.6	9.2	0.5	23.1	1.1	8.1	0.0	1.4	7.6	12.5	25.6	2.7	74.0	0.2	0.2	3.7	0.1	81.4	15.9	29.7	1.1	0.0	17.1	2.9	51.3	22.4	2.0	0.6	2.7	23.4	3.0	0.8	4.2	4.6	54.0	0.1	10.0	129.0	38.0	0.2	1.0	5.3	0.1	0.6	6.2	10.1	0.0	0.0	0.1	0.0	14.3	8.6	0.0	7.7	2.5	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	164.1	45.2	45.6	2.7	74.0	81.4	15.9	51.3	54.0	38.0	10.1	0.2	0.0	1.5	0.3	0.5	0.1	0.2	758.4	0.0	0.3	0.1	0.6	0.8	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	85.7	0.1	3.1	0.9	0.0	0.0	0.4	0.0	0.1	16.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	2.0	0.0	0.7	60.8	1137.9	1.2	0.0	1.9	0.0	0.0	0.0	0.5	0.4	0.0	0.0	225.7	0.0	0.2	0.0	0.0	3.6	0.0	6.6	1.7	1.2	274.1	19.1	0.1	0.4	0.0	0.2	3.1	0.0	0.0
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PER3		ENSG00000049246	"Period circadian regulator 3"	P56645	1	7784320-7845177	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 137.8;Bipolar cells: 241.0;Horizontal cells: 124.5;Rod photoreceptor cells: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 36.0"	"Low region specificity"	"Detected in all"							HPA019530	Approved		Supported	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA019530: AB_1855201"	"unprognostic (5.11e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.87e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.62e-1)"	13.9	11.1	10.1	4.6	14.1	0.7	12.6	46.1	15.9	12.4	3.1	18.4	6.4	19.0	10.6	17.0	12.6	12.2	22.3	9.6	9.9	12.5	25.6	12.0	4.7	12.7	13.9	18.5	17.0	19.8	16.9	2.7	14.4	15.6	6.6	55.9	25.4	20.5	28.7	13.4	9.4	10.7	11.8	9.0	17.4	8.8	14.4	4.6	23.3	24.3	7.2	10.3	10.4	26.0	7.2	2.1	6.1	1.8	1.1	0.6	1.8	3.0	5.5	5.5	7.6	8.6	27.7	3.2	1.6	12.4	9.4	3.3	22.1	1.4	8.3	0.2	1.2	22.7	8.3	1.3	6.8	0.7	7.6	3.0	2.4	6.0	6.1	11.4	2.0	1.6	18.7	5.8	2.4	5.7	12.7	10.2	3.3	16.0	5.9	11.0	2.2	0.2	3.1	1.3	7.9	8.5	26.3	0.1	11.0	6.1	6.6	1.0	4.2	14.9	21.4	4.6	4.0	0.8	0.5	2.7	10.5	36.0	21.2	0.3	0.6	0.4	1.5	0.7	1.8	0.6	0.7	1.4	0.7	0.2	0.6	0.7	0.0	0.3	1.3	0.5	1.3	0.6	10.1	14.1	46.1	15.9	9.6	9.9	12.7	13.9	14.4	11.8	14.4	26.0	45.0	19.2	12.1	137.8	3.9	30.1	13.1	4.3	40.5	241.0	14.3	17.3	17.0	8.6	9.9	9.2	81.3	1.7	3.0	5.0	9.8	3.2	16.5	4.4	19.6	17.5	6.6	0.0	42.8	4.8	0.5	33.6	20.4	4.3	26.0	6.9	10.8	28.1	9.4	124.5	64.1	4.0	12.2	8.5	14.8	5.8	12.5	11.2	12.4	40.3	3.4	91.2	2.1	62.4	91.6	5.7	1.6	27.4	3.3	9.7	5.0	5.2	9.7	138.5	6.6	39.2	25.4	22.2	23.2	32.9	25.6	0.5	5.9	11.5	1.7	8.6
PERM1	"C1orf170, MGC13275, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"heart muscle: 68.8;skeletal muscle: 194.5;tongue: 135.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Breast myoepithelial cells: 3.9;Cardiomyocytes: 21.5;Early spermatids: 6.0;Late spermatids: 5.8;Spermatocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031711, HPA031712"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	2.0	0.2	0.0	68.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.4	0.0	194.5	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	135.8	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.8	0.0	1.2	0.7	3.8	3.9	21.5	0.0	0.0	1.8	0.0	0.1	0.0	0.1	1.9	0.2	6.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	1.6	0.5	4.3	0.4	1.1	0.0	0.3	0.0	0.0	0.1	2.3
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"P53 apoptosis effector related to PMP22"	Q96FX8	6	138088505-138107419	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 782.9;skin 1: 1115.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3312.8;Squamous epithelial cells: 3451.4;Suprabasal keratinocytes: 5828.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 555.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 39.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1024.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022269	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA022269: AB_1855219"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	27.1	9.3	7.0	9.9	7.1	1.5	131.0	7.8	8.6	201.6	13.7	40.9	50.2	23.2	47.9	782.9	61.2	37.9	53.9	6.8	8.1	21.9	93.7	27.0	3.3	9.2	7.8	6.4	33.1	40.6	13.1	38.7	8.6	60.7	38.4	8.7	295.9	46.8	5.7	1115.1	52.0	19.8	7.8	1.4	65.1	3.1	9.3	23.3	24.6	16.3	149.4	60.2	426.4	6.3	81.5	80.3	3.7	11.3	60.0	63.1	172.7	115.5	129.8	17.6	12.9	64.8	143.1	1.5	45.5	37.5	144.0	268.4	15.6	207.6	4.5	126.9	64.6	1.5	70.7	69.8	42.6	1.7	1.0	44.3	1024.8	2.2	111.8	91.7	71.3	5.8	2.4	31.3	3.0	53.4	1.5	4.6	34.4	174.6	47.1	1.5	28.6	0.9	108.2	94.0	29.3	3.7	141.2	68.7	59.6	90.7	36.4	18.4	82.6	29.4	12.1	31.7	2.1	11.1	17.4	1.3	23.0	1.5	65.5	39.8	0.0	0.0	4.3	0.0	7.6	2.0	5.3	3.8	0.0	1.0	0.6	2.3	0.3	0.1	0.0	0.0	8.9	1.3	7.0	7.1	7.8	8.6	6.8	8.1	9.2	7.8	8.6	7.8	9.3	6.3	13.9	211.5	84.2	0.7	8.1	3312.8	1415.8	1383.2	1110.4	3.3	371.4	305.0	137.7	260.2	728.5	154.5	16.7	994.5	17.6	374.8	62.6	588.0	2.1	1013.4	78.1	71.8	147.2	13.9	1.2	305.1	990.1	83.8	197.2	777.1	10.8	0.5	21.4	171.3	82.0	3.3	2.1	185.0	736.5	3.8	259.2	2.7	10.5	12.8	350.4	12.2	10.3	29.1	3.1	2.0	0.5	655.0	316.7	2.6	43.2	789.2	355.0	10.6	743.5	28.3	6.6	15.4	82.6	2.4	1.4	3451.4	5828.3	824.0	67.2	73.5	218.6	1546.6
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PET117	CSRP2BP	ENSG00000232838	"PET117 cytochrome c oxidase chaperone"	Q6UWS5	20	18137863-18143169	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA047716	Approved				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA047716: AB_2680128"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (7.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.15e-4)"	"unprognostic (3.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	8.7	16.8	12.5	5.5	13.0	8.0	8.5	12.8	17.8	8.4	13.5	12.2	15.6	9.9	10.4	8.0	8.5	5.1	12.9	12.6	12.9	14.1	12.5	8.0	6.0	12.7	12.4	10.0	11.4	9.7	11.8	7.4	13.0	9.3	9.4	9.7	10.4	6.5	22.9	10.8	10.9	5.8	12.8	8.6	16.5	7.2	12.8	4.5	8.9	9.6	5.3	9.5	7.6	13.8	33.0	28.7	10.4	10.6	14.9	11.3	29.8	16.8	16.5	19.6	18.2	26.5	26.7	19.5	27.0	16.1	34.9	17.6	19.0	31.5	20.5	4.4	20.9	21.9	19.2	63.8	24.6	29.2	23.2	17.8	17.1	19.3	20.1	15.7	15.7	23.3	18.6	17.1	14.3	26.8	17.1	33.5	15.4	35.2	31.8	15.3	33.4	35.0	21.2	19.4	18.9	18.6	23.1	43.0	46.9	27.1	26.2	21.3	15.0	17.7	13.7	19.0	29.4	24.4	41.8	31.5	8.8	9.5	16.3	3.4	24.9	11.4	18.3	23.3	20.7	26.2	22.7	23.0	22.0	23.2	31.6	24.2	1.5	21.0	29.7	41.0	20.4	15.8	12.5	13.0	12.8	17.8	12.6	12.9	12.7	12.4	13.0	12.8	12.8	13.8	10.3	19.2	10.6	0.3	11.4	3.8	16.7	17.2	8.0	16.9	13.5	14.6	13.7	35.8	16.3	16.5	4.2	29.8	12.4	15.4	33.2	21.8	1.0	12.3	8.8	9.1	15.7	16.8	2.6	26.7	34.5	10.1	24.5	11.9	8.8	6.9	8.9	25.8	14.9	23.5	2.5	18.4	16.2	13.9	4.0	3.2	16.1	7.7	7.2	1.9	15.1	19.7	16.5	3.5	1.4	34.0	12.3	6.8	9.4	26.8	44.0	53.1	9.4	13.7	6.6	9.6	10.8	16.3	31.3	13.4	6.3	13.0	11.9	9.7	23.6	14.5
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	5.8	6.9	2.6	6.0	4.7	4.1	8.7	4.6	4.3	6.4	2.5	8.6	6.6	6.7	11.2	6.1	5.6	4.7	8.9	2.4	3.1	14.2	13.0	5.3	6.9	3.5	3.5	6.8	8.8	11.7	6.3	4.2	4.1	7.8	9.5	13.2	9.1	7.0	9.1	7.9	8.1	5.4	2.8	6.0	8.2	6.7	3.0	7.9	8.6	9.9	6.7	5.6	5.8	6.3	8.3	8.9	14.4	24.6	8.9	7.6	13.0	5.4	7.1	6.3	9.1	5.5	8.7	12.2	12.0	6.3	9.6	8.4	11.0	9.9	10.0	12.7	9.7	5.8	9.5	7.0	6.2	10.6	6.4	8.2	8.6	9.4	12.7	8.0	9.9	12.6	21.9	17.2	10.1	15.5	21.3	10.4	10.0	12.3	8.3	15.0	16.0	15.3	8.8	12.0	10.6	17.1	12.4	34.3	10.8	20.2	7.1	4.4	8.1	6.0	8.1	23.0	5.7	18.9	15.9	16.7	5.7	6.2	9.8	0.8	1.1	1.8	2.5	1.8	2.5	3.0	2.6	2.8	1.2	2.8	2.9	3.3	0.9	4.7	2.2	0.7	2.8	1.1	2.6	4.7	4.6	4.3	2.4	3.1	3.5	3.5	4.1	2.8	3.0	6.3	14.2	28.9	18.4	26.1	14.1	5.9	8.4	8.1	10.8	43.5	11.7	12.6	29.7	5.7	13.1	5.5	35.5	9.0	13.6	17.2	9.8	6.6	7.3	22.6	14.7	11.6	13.9	12.4	30.0	7.5	3.9	11.6	21.9	14.2	8.8	20.5	8.2	14.2	5.4	40.4	45.7	12.0	8.2	7.6	3.1	4.8	14.3	8.4	7.2	13.1	12.7	14.2	14.4	23.6	55.2	6.0	11.3	15.1	11.6	9.6	16.5	19.2	32.4	42.9	6.6	15.5	12.6	36.6	14.4	11.2	7.7	8.3	12.0	11.8	15.2	7.7
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918717	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017150, HPA050104"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	17.5	25.1	34.7	19.0	35.8	13.3	31.2	32.5	42.5	24.6	33.3	24.9	24.6	23.4	33.1	34.3	25.7	17.0	28.0	36.3	38.1	32.4	27.1	20.1	27.4	33.3	33.0	24.6	27.2	33.5	24.5	23.1	35.1	24.3	27.6	20.2	28.7	25.6	39.8	28.1	25.9	21.0	31.6	27.7	28.3	30.8	34.1	30.2	26.4	34.9	34.7	23.2	22.2	34.2	27.1	24.4	21.0	21.1	48.6	37.9	21.9	26.8	35.3	34.4	26.5	11.3	30.7	25.2	28.1	38.3	16.6	31.9	18.6	40.0	24.0	28.4	14.1	15.6	14.8	29.2	68.3	46.9	27.5	49.9	49.3	23.3	22.8	43.9	44.5	34.8	28.7	40.5	54.7	43.1	35.8	43.5	7.5	57.4	29.5	33.0	31.5	55.5	58.8	19.1	14.7	24.0	20.2	38.4	24.7	20.5	53.2	72.0	39.7	23.1	18.2	30.3	19.8	43.1	54.0	35.1	38.5	26.3	16.0	89.6	64.7	47.3	58.5	60.9	64.8	93.2	67.5	65.4	70.8	84.1	74.7	67.9	32.4	71.1	60.5	94.9	79.6	82.7	34.7	35.8	32.5	42.5	36.3	38.1	33.3	33.0	35.1	31.6	34.1	34.2	5.0	16.0	10.3	9.8	17.0	19.4	9.2	41.3	26.7	8.0	16.8	17.0	12.8	17.2	20.7	40.5	0.0	37.9	19.6	20.2	45.0	13.7	12.2	8.2	7.0	12.3	12.7	14.1	13.0	13.8	13.9	11.1	19.4	7.4	3.8	9.3	18.2	32.9	23.0	5.0	13.5	16.0	20.3	18.3	10.7	21.1	14.0	12.9	21.4	4.7	27.1	12.6	25.7	9.5	12.9	16.0	11.4	19.9	17.4	10.1	20.1	34.5	22.9	5.1	6.6	5.8	10.3	41.1	24.3	34.0	22.0	20.0	13.8	11.6	15.8	9.4
PEX11G		ENSG00000104883	"Peroxisomal biogenesis factor 11 gamma"	Q96HA9	19	7476875-7497449	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.4;testis: 29.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 85.3;Late spermatids: 69.6;Proximal enterocytes: 37.0;Proximal tubular cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 24.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA069817	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA069817: AB_2686207"	"unprognostic (2.26e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.60e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (3.27e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.83e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.19e-2)"	4.6	12.1	2.9	1.4	4.7	1.2	5.3	3.3	3.5	3.7	2.4	5.1	6.5	2.9	2.3	4.9	3.6	1.6	2.5	2.9	3.2	8.5	26.4	3.4	1.0	3.7	3.9	3.3	5.4	4.0	4.3	0.9	3.5	6.4	1.5	1.1	4.8	1.9	2.1	5.9	5.7	0.7	3.4	5.0	5.0	29.0	3.5	1.0	6.4	0.9	0.4	4.3	3.6	4.9	1.9	3.6	0.8	3.2	2.5	1.4	4.7	1.0	0.7	0.8	0.8	1.3	6.3	1.1	5.9	0.5	1.4	3.3	0.6	1.1	0.3	0.5	1.3	0.7	1.0	0.3	2.2	0.1	3.7	2.9	1.3	0.8	1.1	0.6	0.5	3.1	1.7	0.1	1.0	1.0	0.6	0.7	0.2	3.0	2.1	0.1	0.2	0.1	2.2	2.4	2.3	2.1	1.6	0.3	0.5	0.5	5.2	1.2	0.0	0.1	0.5	3.1	0.1	1.9	1.3	0.6	0.5	0.1	0.6	24.5	3.9	16.0	1.6	3.9	1.1	2.5	1.1	0.6	3.5	4.1	1.2	0.9	12.8	7.9	3.5	2.3	0.4	2.4	2.9	4.7	3.3	3.5	2.9	3.2	3.7	3.9	3.5	3.4	3.5	4.9	3.8	0.0	9.2	2.3	1.0	3.2	4.3	15.9	5.2	2.6	10.2	9.4	2.1	7.2	8.1	3.7	2.1	3.0	0.4	12.6	17.6	9.3	85.3	16.5	4.2	3.7	5.4	0.4	0.6	3.6	3.1	5.2	7.7	6.9	0.0	7.6	4.6	35.9	18.1	0.0	0.9	11.4	16.2	7.5	0.4	69.6	4.4	3.5	3.6	1.0	1.8	7.0	0.0	1.5	3.6	4.5	9.6	3.8	0.9	3.2	37.0	41.5	29.3	3.2	6.6	3.2	4.0	22.4	3.1	5.8	2.7	1.4	1.1	11.6	11.3	3.8
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.2;Spermatocytes: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA069386: AB_2686135"	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	3.9	6.8	6.7	3.6	7.2	1.5	5.5	7.9	9.1	5.3	6.7	3.4	3.6	4.3	10.7	3.4	5.6	3.2	9.1	6.8	7.1	8.2	9.0	3.4	4.8	6.8	6.9	8.2	4.0	7.8	4.7	4.7	6.8	5.7	2.9	4.6	5.5	6.9	10.3	4.2	3.5	3.5	7.3	3.9	3.9	6.8	7.0	3.2	7.7	10.8	4.5	3.7	2.7	8.4	2.8	3.7	5.4	4.4	11.0	9.9	3.9	7.3	8.3	6.0	6.3	3.2	3.0	6.4	11.6	4.1	4.9	7.3	6.6	4.8	5.2	2.3	8.7	4.7	3.8	5.9	12.8	6.7	1.2	9.2	9.2	3.7	10.9	7.7	4.6	5.2	7.5	6.6	7.2	2.9	7.9	3.8	2.2	6.3	5.8	3.8	9.3	6.4	7.1	4.2	4.0	4.0	4.6	3.0	9.6	6.5	7.4	3.7	3.7	5.6	3.5	6.3	4.9	13.3	9.9	7.5	6.0	5.1	5.2	2.2	1.5	3.0	1.8	1.1	3.2	2.3	3.0	1.8	1.7	2.6	4.1	3.5	1.0	2.0	1.2	1.7	2.4	1.4	6.7	7.2	7.9	9.1	6.8	7.1	6.8	6.9	6.8	7.3	7.0	8.4	2.7	3.2	0.5	6.5	3.3	0.6	1.9	1.3	1.8	2.1	2.4	2.2	6.3	0.0	2.7	3.7	0.0	6.7	1.4	1.3	3.9	3.5	17.2	1.9	2.3	3.9	1.2	0.8	1.3	1.1	4.1	2.6	2.6	1.5	2.5	2.0	3.3	5.4	2.9	1.7	1.9	1.7	2.0	2.6	0.6	3.0	3.1	1.5	1.8	1.0	0.9	8.3	1.0	4.5	2.8	2.2	1.0	1.5	0.5	2.4	2.7	3.3	1.8	2.2	0.0	2.6	3.7	21.0	10.2	1.4	1.3	5.2	2.8	3.0	2.2	1.3
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.8;Urothelial cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	9.5	8.0	6.6	6.7	7.1	7.4	11.1	9.7	9.2	10.2	10.2	10.2	10.2	9.2	7.5	10.2	6.6	8.8	11.9	6.8	7.4	13.6	25.0	9.3	6.8	6.7	7.1	11.0	11.8	9.6	7.4	9.3	6.8	14.6	10.7	8.8	8.7	5.8	14.6	7.9	9.8	8.1	6.6	6.7	10.1	14.9	7.1	7.3	13.7	13.6	6.7	13.8	9.1	7.7	15.5	11.3	15.7	20.3	14.8	11.5	24.2	15.9	12.3	10.6	10.8	16.9	22.9	10.0	16.7	15.6	19.9	22.8	14.1	19.2	20.0	9.9	9.7	9.2	15.1	28.0	17.5	13.9	10.8	14.2	28.9	14.5	22.3	16.2	19.4	11.3	22.8	8.7	16.3	14.1	10.4	16.6	17.2	28.6	11.2	11.1	17.4	12.7	20.3	38.2	17.7	12.2	17.7	23.7	14.9	18.5	15.8	7.1	15.3	20.2	27.0	11.8	13.6	14.2	11.6	25.0	12.7	14.0	14.5	12.4	3.9	5.9	5.0	3.9	4.7	5.4	5.8	5.5	5.1	4.1	6.1	4.6	3.7	5.5	5.0	4.5	5.4	3.9	6.6	7.1	9.7	9.2	6.8	7.4	6.7	7.1	6.8	6.6	7.1	7.7	12.9	19.2	19.1	14.0	13.8	51.2	35.1	61.9	25.6	11.9	23.0	13.2	21.9	28.6	53.0	22.0	8.4	36.9	13.4	27.6	25.4	28.8	125.8	24.5	16.1	15.1	2.4	9.9	18.8	28.5	43.1	14.5	12.8	28.8	8.2	15.6	13.6	49.3	20.9	16.8	16.8	14.5	36.7	14.6	25.9	28.7	9.6	14.8	16.0	25.3	19.3	12.6	18.6	14.1	19.4	23.2	13.2	11.7	9.9	43.9	28.8	33.2	38.7	15.0	6.6	11.6	18.8	66.8	26.4	21.8	50.3	68.7	15.0	11.4	18.1	112.0
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.3;Syncytiotrophoblasts: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	15.9	13.9	15.5	9.5	15.3	7.8	16.2	11.7	21.8	15.5	10.7	16.8	15.1	17.1	6.4	20.9	13.7	9.3	19.6	15.8	13.6	15.8	33.0	14.3	10.5	14.1	13.1	14.9	11.2	11.8	14.1	11.8	13.8	26.4	8.2	28.1	16.8	23.8	22.6	18.6	16.2	8.5	12.2	12.6	13.8	14.0	14.3	9.7	14.0	11.3	8.6	48.8	17.6	16.0	22.5	21.1	17.2	19.2	12.3	11.6	11.2	25.2	20.8	27.4	26.1	22.4	40.1	16.4	24.9	19.4	16.3	26.3	17.9	24.6	12.9	23.1	30.3	20.4	22.6	31.2	18.8	23.0	27.3	14.2	19.2	20.7	19.0	16.3	17.9	21.2	32.2	16.3	12.4	18.7	21.9	30.4	17.7	17.2	24.6	23.5	14.5	23.3	21.7	14.8	20.5	23.5	24.4	20.2	23.9	13.2	18.4	16.2	17.7	19.9	21.5	19.6	22.0	23.3	20.4	32.3	21.8	31.2	21.7	1.4	2.2	4.6	4.5	1.6	2.8	2.2	2.3	3.4	2.7	2.0	2.9	2.8	0.3	2.6	1.5	2.8	3.0	2.4	15.5	15.3	11.7	21.8	15.8	13.6	14.1	13.1	13.8	12.2	14.3	16.0	5.9	9.6	2.0	32.0	9.2	7.1	13.9	29.2	4.0	15.1	8.3	6.9	8.4	4.3	12.3	9.2	27.1	49.7	11.3	14.1	7.9	17.2	5.9	10.6	4.9	7.8	9.0	4.6	42.0	14.7	18.7	8.1	4.1	7.4	6.3	7.8	8.2	51.1	22.7	18.5	48.4	9.7	14.2	9.0	3.1	3.1	8.1	8.0	12.4	28.1	19.9	21.2	10.3	29.7	29.9	18.2	12.3	5.7	14.7	10.8	29.7	18.5	23.5	67.3	6.6	4.5	11.0	7.1	12.8	7.1	8.1	64.7	9.8	8.3	12.0	13.5
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909663-45918812	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.06e-4)"	23.4	27.1	22.3	10.9	23.8	20.3	22.2	23.4	24.4	18.2	16.6	20.6	21.3	18.7	6.3	21.3	18.9	10.1	17.0	23.0	22.7	26.7	50.2	16.2	16.6	26.2	23.6	18.3	40.0	10.1	32.0	6.7	23.2	21.7	5.1	4.4	21.6	9.7	18.1	27.2	25.3	6.0	21.9	24.5	27.6	25.8	23.6	11.8	21.8	7.5	8.6	20.1	18.0	26.0	15.0	19.9	6.7	16.8	11.0	13.2	19.4	11.6	15.2	15.5	12.0	22.6	10.7	25.6	15.0	10.9	14.7	27.2	6.9	23.0	3.7	22.4	23.6	16.7	28.8	20.1	34.8	24.9	33.8	21.3	20.1	9.4	15.1	9.1	17.0	21.9	13.4	29.6	10.7	42.0	21.3	32.5	15.1	28.7	20.0	18.4	16.8	29.4	10.0	26.5	17.0	22.7	13.3	27.1	24.5	4.2	40.4	21.1	13.6	14.8	19.0	36.9	21.5	47.1	33.1	16.2	16.2	14.7	16.2	35.3	44.1	36.8	47.9	51.0	44.9	57.0	48.9	49.6	47.8	50.5	44.4	46.7	32.2	44.9	38.6	44.7	61.1	46.1	22.3	23.8	23.4	24.4	23.0	22.7	26.2	23.6	23.2	21.9	23.6	26.0	25.1	3.2	5.4	3.9	35.7	16.6	24.4	47.6	19.4	15.7	25.9	22.4	3.8	22.8	25.1	14.7	10.4	39.9	31.9	45.8	50.9	37.3	25.9	19.7	13.8	21.5	28.1	25.9	4.8	88.7	22.2	15.7	17.9	20.3	21.0	16.2	21.8	68.6	34.2	15.2	5.1	26.5	30.5	37.7	19.7	32.6	19.3	20.0	21.4	3.7	46.6	28.8	26.8	5.0	10.6	55.9	49.2	14.3	27.1	26.1	90.5	68.1	26.4	18.0	32.9	16.8	24.4	27.2	15.4	21.6	21.0	64.0	33.0	19.9	29.6	28.2
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276807-160286348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA		7900	"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	79.3	25.7	21.1	14.5	22.5	12.3	36.5	22.2	23.5	20.3	15.6	22.6	19.4	18.2	25.0	24.9	22.9	19.6	39.4	21.5	22.7	33.1	109.1	21.6	16.6	22.3	23.5	23.6	17.2	40.4	15.0	21.9	23.5	28.0	23.2	30.9	21.3	26.6	66.2	18.2	18.8	16.7	22.1	16.7	20.0	16.8	22.7	21.0	34.3	84.8	20.5	23.9	15.2	24.5	31.2	18.9	69.8	22.4	59.8	57.8	53.0	25.3	51.3	44.6	35.3	35.1	37.2	37.8	40.9	37.3	26.3	29.7	34.2	44.0	35.3	32.3	17.3	26.6	26.5	36.3	46.9	48.6	32.6	84.7	51.0	60.0	38.6	35.8	32.2	51.4	40.8	27.9	50.0	17.8	37.0	15.8	50.3	38.6	48.2	45.7	34.4	45.5	45.8	61.8	23.2	38.3	98.3	49.5	37.4	71.3	48.1	48.2	24.8	26.5	31.1	29.9	30.1	42.5	57.9	68.6	43.1	20.9	38.9	9.1	5.5	5.0	5.8	8.9	4.2	5.0	2.8	3.5	5.5	1.9	4.0	3.7	2.2	4.7	6.6	3.4	4.2	2.3	21.1	22.5	22.2	23.5	21.5	22.7	22.3	23.5	23.5	22.1	22.7	24.5	16.4	9.6	20.6	9.1	12.7	9.9	21.0	15.4	13.1	18.8	18.9	16.4	45.6	20.0	11.3	16.5	10.4	30.0	6.9	25.4	49.0	22.6	6.6	12.0	13.7	13.6	11.4	15.6	8.6	14.8	51.2	18.4	13.3	12.0	16.5	15.6	20.0	60.1	30.1	25.2	9.0	11.5	0.0	15.7	7.0	3.1	21.8	15.0	21.4	6.5	24.9	39.0	12.3	6.0	11.5	20.2	17.2	29.3	9.5	18.5	29.8	40.7	11.8	12.7	32.9	14.6	16.2	17.8	25.3	15.0	9.9	38.7	12.5	18.2	15.7	25.2
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	39.8	45.9	33.1	33.5	36.6	35.8	53.9	34.2	45.6	40.7	38.6	43.1	39.8	33.3	42.4	32.9	41.8	31.9	39.7	32.1	35.1	53.6	43.7	36.5	39.4	37.3	34.5	33.3	39.0	57.7	27.2	24.7	37.6	44.2	39.6	66.5	50.9	83.4	61.8	24.5	41.0	35.3	37.3	36.5	48.3	22.1	34.5	48.8	53.2	44.6	35.7	35.7	31.3	43.3	88.2	29.3	46.9	47.9	50.7	63.2	24.5	64.4	75.3	49.9	55.2	18.4	76.9	50.2	93.6	59.9	39.7	33.3	33.1	50.1	61.2	93.3	28.5	61.1	26.0	28.3	33.9	51.5	46.5	70.9	43.5	37.8	45.6	77.0	55.3	79.3	34.4	46.7	53.9	26.4	90.4	30.1	27.2	126.4	26.3	16.5	37.4	42.1	59.9	61.6	16.7	43.0	41.9	192.0	36.9	39.8	58.7	36.1	54.7	44.4	58.1	57.7	32.4	86.0	53.8	87.9	56.5	26.7	50.2	179.9	55.6	102.6	57.2	58.0	51.2	46.1	39.6	46.5	46.3	50.5	51.6	49.3	38.6	83.1	67.8	46.8	48.6	71.7	33.1	36.6	34.2	45.6	32.1	35.1	37.3	34.5	37.6	37.3	34.5	43.3	28.0	48.1	25.2	32.3	29.7	18.1	31.0	57.8	28.5	28.9	38.9	33.1	27.2	28.6	38.4	27.6	12.5	42.8	38.3	30.2	133.1	52.3	5.6	36.5	19.9	20.7	28.9	25.6	11.9	49.1	24.8	29.8	20.4	22.2	18.3	20.2	25.7	36.7	26.6	13.5	15.2	37.5	48.8	39.1	22.4	7.3	29.5	26.8	28.4	16.9	36.3	68.4	53.5	31.7	45.9	42.0	28.2	35.7	41.7	36.3	43.3	61.4	36.6	34.4	6.6	34.9	24.6	13.7	20.8	28.6	21.0	34.8	37.6	27.7	30.0	43.0
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077923-18105396	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 198.7;Proximal enterocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB070429	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB070429: AB_11154363"	"unprognostic (2.25e-1)"	"unprognostic (5.75e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.77e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (3.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	7.5	5.8	7.3	7.8	6.2	12.1	6.7	3.7	6.8	4.9	5.8	16.9	19.2	5.5	5.3	7.5	6.0	5.3	5.8	7.9	5.3	7.5	7.3	5.0	7.3	8.4	7.8	5.4	8.0	9.2	4.2	5.0	7.0	5.3	13.1	3.1	6.4	5.6	6.3	5.6	19.9	5.4	6.3	8.1	9.3	3.1	8.3	7.3	6.9	4.1	6.7	6.0	3.9	5.5	18.3	8.7	10.2	9.2	10.5	6.6	18.8	11.8	12.2	12.8	10.5	15.2	15.1	11.3	10.8	17.5	11.2	18.7	15.9	16.5	10.9	19.0	12.4	19.4	12.3	12.8	10.0	26.0	23.6	8.2	12.7	17.3	16.2	6.1	15.2	11.1	21.2	8.1	12.7	22.0	22.8	8.8	13.2	24.9	15.7	17.6	8.6	4.1	14.8	20.6	17.7	15.5	17.1	12.0	16.3	8.2	19.3	9.7	20.4	23.6	10.2	12.8	12.4	21.4	15.8	16.6	10.9	12.3	17.1	1.2	1.7	1.4	2.0	1.1	1.9	1.4	1.8	2.6	1.5	2.0	2.0	1.3	1.2	2.7	2.6	3.1	0.8	1.0	7.3	6.2	3.7	6.8	7.9	5.3	8.4	7.8	7.0	6.3	8.3	5.5	10.5	6.4	10.3	1.3	14.7	13.5	14.8	9.3	8.6	24.5	12.4	7.2	29.3	25.8	13.8	7.3	43.8	11.9	18.0	198.7	5.9	24.7	1.0	16.3	16.2	17.6	24.5	11.1	4.9	23.6	9.8	13.0	20.9	18.6	12.0	19.8	18.9	33.0	15.2	30.3	5.6	22.9	6.1	20.4	10.7	2.8	12.5	11.0	0.0	2.8	20.4	9.2	22.6	4.5	4.3	31.6	51.8	11.7	11.8	20.4	91.7	21.7	11.5	25.5	13.1	18.8	9.6	9.4	10.1	13.7	17.6	9.3	13.9	21.4	29.4	18.7
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Early spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 156.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	33.1	27.8	43.7	13.2	42.8	8.8	34.2	38.0	43.3	25.0	33.5	25.3	12.1	26.0	10.9	18.8	23.2	13.6	22.0	39.1	38.5	24.5	37.8	22.1	18.6	40.9	41.2	29.2	30.4	18.9	44.1	10.0	41.2	19.7	11.8	13.6	22.2	13.6	74.1	26.2	20.3	15.2	43.1	16.0	22.2	50.9	45.4	39.3	20.0	28.4	20.8	21.7	21.2	40.9	14.7	24.7	13.0	34.2	29.1	19.9	24.3	14.0	16.6	16.2	17.2	36.9	21.8	156.1	8.3	16.2	23.6	18.2	22.1	19.5	16.8	20.8	18.2	13.8	19.0	25.7	15.4	21.3	13.6	22.2	35.2	11.1	34.5	22.0	14.2	75.0	28.2	5.3	14.7	20.0	49.7	18.5	38.6	28.0	13.1	23.7	28.1	21.4	13.0	21.4	10.9	22.6	20.9	45.4	20.1	26.2	10.2	12.5	12.7	18.2	29.9	15.8	17.2	9.5	11.6	53.4	18.0	22.8	12.2	0.0	1.6	2.1	2.9	1.4	3.6	1.9	2.0	2.9	2.6	1.4	2.6	2.6	1.2	2.8	4.1	4.6	0.9	2.2	43.7	42.8	38.0	43.3	39.1	38.5	40.9	41.2	41.2	43.1	45.4	40.9	8.6	12.8	20.1	11.4	5.6	14.5	7.2	5.2	8.0	7.8	9.2	8.5	13.7	14.3	5.6	7.3	8.4	11.3	5.1	9.9	9.8	10.1	277.8	7.0	13.6	10.3	7.2	4.6	31.5	14.9	6.4	7.8	4.1	5.2	3.8	7.2	5.7	17.6	4.7	13.5	22.1	7.2	4.1	5.4	5.0	43.7	14.3	5.2	5.4	1.0	4.6	12.7	5.2	16.1	13.3	10.2	14.2	13.9	2.9	14.1	9.9	19.3	9.8	7.0	19.7	12.0	10.2	32.2	16.6	7.4	15.3	7.7	5.8	9.6	10.4	5.7
PEX5L	"PEX5R, PXR2, TRIP8b"	ENSG00000114757	"Peroxisomal biogenesis factor 5 like"	Q8IYB4	3	179794958-180037053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 185.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 252.3;Excitatory neurons: 848.2;Inhibitory neurons: 475.2;Oligodendrocyte precursor cells: 215.1;Oligodendrocytes: 2006.1"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 7.8;MOLT-4: 27.9;RPMI-8226: 21.8;SCLC-21H: 12.8;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058026	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA058026: AB_2683582"	"unprognostic (5.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.67e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.66e-10)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.03e-3)"	0.7	0.3	26.2	0.1	85.5	0.0	0.1	60.1	53.9	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.2	34.1	26.5	0.1	0.0	0.2	0.0	72.2	64.0	1.8	10.2	30.1	5.3	0.0	71.6	0.2	0.0	15.3	0.2	0.0	1.3	0.1	0.1	0.0	42.1	0.0	0.1	4.8	56.5	2.7	0.2	0.4	0.0	0.0	0.0	185.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	7.8	0.1	0.0	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	1.3	0.7	0.0	0.7	0.0	3.8	0.0	0.0	27.9	0.0	1.6	0.0	0.3	0.2	0.0	21.8	0.0	0.0	12.8	0.7	0.0	0.0	0.0	0.0	0.1	2.1	0.0	2.7	0.1	0.0	0.7	16.7	0.5	0.1	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	85.5	60.1	53.9	34.1	26.5	72.2	64.0	71.6	42.1	56.5	185.5	0.0	0.0	0.0	65.6	0.0	0.0	0.2	0.0	0.0	11.3	0.1	0.1	3.2	0.0	0.0	0.0	252.3	0.1	0.0	0.0	0.0	0.0	29.6	0.2	0.6	0.4	0.0	0.0	848.2	0.6	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	10.1	475.2	0.2	0.0	0.0	0.4	18.0	0.3	0.1	0.0	35.6	0.7	2.3	0.0	215.1	2006.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	9.5	0.0	2.4	0.2	0.7	1.1	0.0	0.3	0.0	0.1	1.9	0.0	0.1
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.5;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.2"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000		"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.8	0.2	0.1	0.7	0.3	66.5	0.3	0.1	2.2	0.1	0.7	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.9	0.1	0.1	0.6	2.2	10.5	0.3	0.3	0.2	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.5	0.9	0.1	0.2	0.0	0.6	2.5	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.3	0.1	2.2	0.1	0.1	0.3	0.2	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853296-73854483	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 2.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 10.0;Club cells: 2.6;Enteroendocrine cells: 5.3;Macrophages: 6.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"basophil: 14.2;neutrophil: 9.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in single"		"EFO-21: 1.7"									HPA052485	Supported				"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.3	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.7	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.9	0.0	0.0	2.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.1	0.3	0.0	11.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.1	0.0	10.0	2.6	1.8	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.7	2.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	1.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.5
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles		NA	NA		670000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	8.4	9.9	4.7	7.8	5.1	9.8	8.2	6.2	5.8	7.8	2.8	6.7	4.8	9.0	2.6	8.4	8.0	2.8	6.3	5.1	3.3	11.0	10.1	5.8	9.8	3.9	3.9	9.7	10.3	5.6	5.5	5.2	4.6	6.9	5.6	5.8	6.4	4.7	6.4	6.8	7.7	6.8	3.3	11.0	7.8	7.8	3.9	7.5	7.8	3.2	8.2	7.6	6.2	6.0	15.6	67.0	33.8	50.2	12.1	10.0	38.7	19.4	7.4	35.1	26.4	32.9	13.7	69.8	30.8	11.4	12.4	35.1	78.5	25.6	25.8	30.6	64.0	40.0	63.2	41.9	10.4	32.9	28.3	9.5	6.2	40.5	25.5	9.9	29.5	36.6	54.8	10.1	13.7	23.0	58.1	28.4	55.7	8.5	29.9	86.0	35.2	32.6	16.1	25.5	20.4	31.7	24.1	15.3	22.2	17.9	15.3	14.9	20.9	19.2	25.0	35.7	49.0	11.8	23.5	33.7	21.0	45.4	32.9	20.2	5.1	12.7	6.8	4.5	8.7	14.8	8.8	7.9	4.4	16.7	10.9	8.6	49.1	5.2	3.7	12.9	5.0	2.3	4.7	5.1	6.2	5.8	5.1	3.3	3.9	3.9	4.6	3.3	3.9	6.0	2.9	0.0	7.9	3.9	6.0	2.4	1.7	1.9	1.8	8.1	4.5	3.7	4.3	1.5	4.1	3.7	6.2	5.2	3.2	2.1	0.0	3.7	2.1	2.4	5.9	3.6	0.0	9.2	5.8	3.0	4.3	4.0	5.6	3.7	1.3	9.7	2.5	4.2	4.6	1.7	5.4	3.5	2.0	2.5	1.4	1.1	5.3	3.4	3.6	4.7	4.5	1.6	4.1	6.6	3.9	1.9	4.9	1.5	5.3	2.9	0.8	2.7	5.1	7.3	0.0	5.1	3.2	5.6	8.8	3.9	2.0	3.1	3.3	7.7	6.2	1.4
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245035-140303113	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	74.1	50.9	73.9	37.7	75.6	60.2	50.0	82.2	88.4	41.4	70.8	59.2	40.2	50.8	54.3	52.3	41.9	35.7	93.3	77.2	79.7	61.6	38.5	46.9	46.1	82.9	77.2	37.2	34.7	52.8	39.4	50.8	80.5	44.8	42.9	35.1	45.4	43.7	149.0	46.2	39.8	61.4	79.1	36.6	40.7	29.9	79.3	51.5	42.4	86.4	51.6	45.9	40.9	81.2	172.4	79.6	137.7	80.9	89.7	91.8	133.8	229.6	114.9	174.6	192.6	172.1	107.9	114.9	224.1	124.3	180.0	62.6	102.0	228.7	204.2	122.6	102.9	102.4	76.5	113.0	105.1	213.5	76.4	98.2	119.8	148.5	156.3	112.6	196.0	132.8	93.7	73.1	149.8	78.5	146.0	147.6	92.0	70.3	119.2	101.3	195.9	86.3	197.1	77.9	78.2	81.8	172.1	148.6	136.8	128.5	102.1	122.3	249.1	121.8	119.6	71.9	208.0	70.3	198.6	299.2	122.5	138.5	144.1	149.5	84.7	130.3	86.2	131.1	91.8	106.0	98.6	100.4	100.5	97.9	97.3	88.4	14.0	114.7	130.3	93.0	129.3	115.5	73.9	75.6	82.2	88.4	77.2	79.7	82.9	77.2	80.5	79.1	79.3	81.2	87.9	67.3	33.0	16.3	57.4	38.0	65.9	96.2	30.7	42.5	50.1	57.3	81.3	52.9	62.1	66.2	45.9	116.1	53.1	56.6	123.3	121.9	3.9	58.0	56.6	73.8	46.6	62.9	31.2	101.7	86.6	55.4	35.2	70.9	54.4	53.6	72.1	56.9	85.4	25.2	29.3	43.6	48.8	61.1	37.7	12.9	52.2	63.4	74.7	37.5	90.4	84.9	71.1	24.1	39.3	128.9	55.1	52.3	35.5	45.4	80.9	147.3	45.3	42.9	65.7	39.6	63.7	23.7	61.8	40.8	34.9	85.6	45.2	42.9	47.3	63.6
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118055	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 641.9;Suprabasal keratinocytes: 642.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol		NA	NA		85000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028700: AB_10603983, HPA058304: AB_2683673"	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	99.3	80.2	157.9	55.4	167.4	110.5	71.6	168.7	195.3	59.5	144.7	65.7	43.9	59.2	67.2	73.9	57.7	39.7	103.1	159.4	180.9	95.5	103.2	71.0	64.0	171.8	173.3	60.0	49.8	53.5	100.5	57.0	171.8	54.3	41.9	53.6	50.9	45.6	183.3	54.0	46.8	46.3	165.8	54.5	52.8	58.6	169.4	67.1	48.5	114.5	61.3	82.6	59.9	176.0	305.9	205.3	154.0	201.1	141.3	134.1	167.2	218.4	205.1	190.9	150.6	274.2	228.4	204.6	252.4	148.1	185.6	220.0	241.6	279.1	235.2	224.6	236.3	226.1	322.4	394.9	405.9	314.5	217.1	149.0	362.8	305.6	877.0	144.1	222.4	208.9	343.6	142.6	177.8	316.4	237.2	372.6	300.1	359.7	495.8	200.4	154.9	249.8	212.1	186.7	202.5	334.1	168.3	224.3	367.6	200.5	184.9	394.3	188.9	195.4	283.8	245.1	472.2	211.6	226.3	403.5	236.7	214.2	273.1	112.6	104.8	115.5	58.5	107.5	66.9	116.6	72.5	72.1	129.2	120.0	74.7	72.1	54.1	66.1	135.1	201.5	98.8	73.5	157.9	167.4	168.7	195.3	159.4	180.9	171.8	173.3	171.8	165.8	169.4	176.0	178.2	32.1	39.7	13.1	94.6	641.9	320.5	407.2	124.7	76.3	105.5	140.2	125.2	62.9	163.9	115.8	16.7	183.1	114.3	83.6	342.4	168.0	36.1	152.7	140.4	162.3	101.3	93.0	21.5	150.6	242.9	157.2	55.5	176.1	99.5	116.8	97.5	143.5	175.0	21.9	21.8	97.3	248.2	64.2	399.6	26.9	126.5	120.0	184.9	7.5	123.8	94.8	80.3	11.6	62.4	230.3	78.9	110.2	79.1	426.2	86.2	281.2	135.0	77.6	78.9	135.7	298.2	142.7	269.8	153.3	642.6	179.6	113.8	137.3	95.9	355.6
PFDN4	"C-1, C1, PFD4"	ENSG00000101132	"Prefoldin subunit 4"	Q9NQP4	20	54208087-54228052	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024055	Approved					NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA024055: AB_1855236"	"unprognostic (2.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (9.40e-4)"	"prognostic unfavorable (7.66e-5)"	"unprognostic (7.87e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.44e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.47e-10)"	"unprognostic (9.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	5.5	6.2	12.6	4.8	12.9	5.3	6.0	12.5	19.0	5.8	10.7	3.7	2.0	8.0	5.8	5.3	4.7	5.8	14.2	13.1	14.4	6.4	4.0	3.9	6.8	13.3	13.9	7.9	3.7	5.8	2.6	6.6	13.8	5.4	4.2	3.4	4.1	5.2	8.8	4.4	2.7	6.3	12.7	3.2	2.3	7.6	13.2	4.8	6.9	8.2	4.9	5.8	2.7	13.1	9.9	3.4	11.6	3.8	8.1	19.4	11.5	9.2	7.1	21.8	9.6	12.6	9.9	7.2	30.1	10.4	12.6	8.4	13.3	11.9	36.7	7.2	10.0	6.1	13.1	42.6	10.5	12.5	6.8	10.3	16.8	9.4	17.3	11.3	13.8	8.9	11.6	8.2	20.0	38.8	12.8	29.5	14.1	6.2	16.5	9.9	4.1	13.2	18.7	12.7	13.6	14.4	11.2	30.3	31.9	10.5	9.4	25.4	6.9	15.5	18.8	21.8	20.8	5.1	8.1	11.0	15.4	11.0	13.7	3.6	5.4	2.6	4.4	5.8	6.2	6.0	5.9	5.3	7.8	5.2	6.1	5.7	0.8	7.6	5.5	8.6	12.5	5.0	12.6	12.9	12.5	19.0	13.1	14.4	13.3	13.9	13.8	12.7	13.2	13.1	46.7	28.9	32.9	6.2	47.3	91.1	86.4	190.5	59.7	16.5	67.6	82.2	73.6	52.9	68.7	40.5	0.0	124.4	53.2	45.5	107.6	147.5	196.9	67.6	53.5	65.3	71.2	77.2	14.7	137.9	147.1	66.6	19.9	82.1	43.1	52.1	84.6	71.6	95.3	13.5	14.6	56.7	85.5	104.3	104.8	35.7	78.9	46.8	62.2	8.4	172.5	41.7	52.5	12.1	11.9	145.8	68.5	68.1	35.1	69.0	42.7	135.4	66.6	15.7	105.2	55.5	64.6	181.4	92.8	57.3	88.5	93.4	53.6	48.5	66.5	76.7
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299452	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 3559.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	719.5	656.4	903.9	307.4	919.3	863.9	819.2	894.2	1279.0	907.5	890.8	684.3	238.6	555.3	867.4	520.1	654.0	366.1	633.1	880.3	907.3	677.4	505.6	539.2	610.5	907.4	899.1	1007.6	724.5	606.1	688.1	399.6	910.7	671.6	371.8	371.8	557.5	394.2	723.2	684.8	514.0	357.2	935.9	712.7	591.9	388.0	927.2	547.7	634.5	615.5	625.9	614.7	651.4	928.1	333.3	492.3	472.8	426.6	889.1	1220.7	347.2	814.5	1081.9	730.8	489.3	456.0	496.9	449.2	479.3	871.1	285.7	299.0	416.7	575.0	702.6	425.4	575.7	410.6	639.1	634.6	574.3	676.8	425.6	1174.9	823.4	522.7	398.6	1269.3	658.4	539.4	485.7	589.1	735.3	1150.9	478.1	993.0	447.7	359.1	757.4	381.1	514.6	530.8	842.9	477.8	396.5	454.1	525.6	450.1	612.1	481.8	588.1	843.6	585.6	408.2	319.1	198.7	372.6	444.5	500.8	670.7	450.3	528.5	386.0	1641.6	2761.6	989.6	1636.2	2095.6	2283.3	3705.2	2468.1	2003.4	2060.9	3368.6	3147.1	2533.0	740.8	1645.0	2221.2	1921.0	2149.1	8653.7	903.9	919.3	894.2	1279.0	880.3	907.3	907.4	899.1	910.7	935.9	927.2	928.1	711.6	262.8	501.5	27.7	1274.1	1505.2	1217.7	1648.8	900.3	184.0	1219.6	1850.4	598.0	684.9	778.6	566.4	102.2	899.8	862.2	593.0	1412.6	561.2	902.9	629.9	703.6	734.7	659.9	587.9	25.3	961.0	973.4	708.4	362.9	440.2	655.9	647.4	782.8	584.8	1830.1	72.3	25.0	892.0	734.5	1977.7	2549.4	3559.9	948.7	1235.9	1538.5	15.9	1663.4	619.2	905.3	21.6	27.6	705.6	990.6	655.2	582.9	971.9	1053.0	2024.3	862.7	321.5	552.2	713.6	902.4	469.7	234.3	762.4	1526.5	876.0	1147.0	658.2	849.4	1114.8
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 220.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		89000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	45.3	78.2	23.7	13.7	24.4	12.9	45.4	24.2	27.3	49.2	22.6	55.9	9.3	54.8	14.2	70.2	46.2	6.7	85.1	24.4	24.4	78.8	98.1	41.7	15.9	24.6	24.6	45.3	51.7	14.4	62.7	13.6	24.7	51.0	11.6	8.6	47.6	8.0	129.3	49.6	45.3	9.9	23.7	49.9	58.4	91.4	24.0	17.1	45.6	14.7	17.0	55.6	46.7	25.2	49.4	36.0	34.9	56.7	22.7	17.3	43.4	37.2	20.6	48.0	48.7	42.6	24.0	102.8	43.1	20.5	83.5	42.2	69.5	47.6	58.3	49.3	52.9	89.8	39.4	78.3	33.2	56.3	49.3	20.7	50.9	64.8	41.6	28.5	40.2	61.2	107.2	29.6	36.7	36.0	73.9	58.7	47.7	33.0	37.6	71.9	38.0	65.2	58.9	23.4	61.3	83.9	32.1	83.3	61.3	35.0	44.4	65.0	22.5	24.7	36.0	26.0	68.7	71.2	220.3	89.4	20.5	71.9	38.1	1.8	2.6	1.8	1.9	3.2	2.1	3.3	2.3	3.1	2.4	3.2	1.8	2.5	1.1	2.1	3.5	3.5	3.5	1.9	23.7	24.4	24.2	27.3	24.4	24.4	24.6	24.6	24.7	23.7	24.0	25.2	17.4	25.6	8.7	5.2	49.1	55.7	45.2	92.6	43.9	24.5	30.2	17.1	20.7	60.1	51.6	55.2	10.4	127.5	37.6	90.0	121.3	87.6	94.2	106.5	64.7	30.6	50.4	48.4	4.3	103.8	126.1	32.6	44.4	66.9	61.6	32.9	19.2	74.0	79.2	18.5	4.1	75.7	87.5	35.4	45.2	42.7	61.8	37.2	71.2	2.8	66.3	51.0	50.4	1.5	7.1	88.0	71.3	49.2	55.3	53.9	76.4	210.0	53.0	29.0	39.5	43.6	96.3	208.2	60.4	64.3	63.9	110.8	36.9	47.4	82.7	46.7
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 20.8;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 23.8;granulocytes: 20.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	4.3	6.8	13.2	8.3	14.5	23.5	6.4	8.6	15.2	9.1	42.5	22.2	32.2	5.0	11.6	9.6	5.7	5.8	36.0	13.9	11.4	29.7	4.0	13.3	7.0	13.3	13.8	5.2	16.0	15.3	23.1	3.9	12.2	4.8	24.1	83.3	7.6	4.1	49.5	8.1	22.2	5.0	9.7	15.0	15.5	7.0	19.3	20.2	51.7	42.7	6.7	4.2	4.2	18.4	15.0	6.5	4.2	7.3	8.4	4.1	6.9	2.1	2.5	3.6	2.0	16.0	21.1	2.7	3.3	3.3	10.8	20.8	3.1	7.9	2.1	0.6	3.2	21.1	17.4	5.9	7.0	0.0	14.2	5.9	11.7	3.5	19.1	4.3	0.8	8.7	14.6	0.1	2.0	4.5	3.6	0.6	5.8	7.2	9.7	0.0	0.0	0.4	4.9	15.3	6.6	4.0	13.7	22.8	17.4	4.5	15.6	1.8	0.4	0.0	7.6	11.0	1.9	6.6	7.0	1.4	8.8	0.0	3.9	1.6	1.2	20.8	0.3	2.6	0.4	1.9	0.2	0.4	1.1	2.3	0.5	0.6	3.5	1.6	1.9	23.8	0.0	0.7	13.2	14.5	8.6	15.2	13.9	11.4	13.3	13.8	12.2	9.7	19.3	18.4	1.0	6.4	54.8	105.1	5.0	15.2	3.8	5.0	10.2	7.0	3.7	4.2	79.0	4.3	8.7	16.5	0.0	0.7	24.6	53.8	25.4	5.0	51.0	18.0	3.7	4.2	6.0	0.8	14.5	7.6	0.4	4.6	14.8	21.3	9.5	2.3	2.5	5.8	5.6	3.3	13.0	20.1	8.2	13.6	4.9	158.2	2.8	8.5	21.4	11.2	5.4	9.8	5.2	4.5	10.6	16.6	26.2	3.0	3.8	13.5	45.4	32.8	15.3	110.5	0.0	3.3	3.1	5.1	3.2	9.9	11.6	1.5	1.6	7.5	36.9	11.5
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 40.4;monocytes: 25.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	1.8	2.5	5.1	4.0	5.5	14.8	1.9	6.1	6.3	3.3	3.4	3.3	18.4	2.0	18.0	7.3	1.6	1.6	1.5	5.1	6.5	3.5	1.7	4.2	1.5	6.8	6.4	3.3	11.2	3.2	5.2	10.2	6.9	3.6	3.4	16.1	2.7	1.3	5.4	3.8	20.8	2.4	5.9	10.3	1.3	24.0	7.7	1.3	1.6	3.4	1.1	2.0	5.8	6.7	12.0	3.9	8.3	8.1	2.8	4.0	16.6	6.1	10.4	11.9	29.3	6.0	4.2	5.5	5.8	4.6	28.4	3.5	3.6	10.6	10.6	3.5	2.9	12.3	9.3	6.7	2.5	2.3	5.1	4.2	15.6	19.4	1.9	52.5	2.9	6.7	4.4	4.5	9.7	2.8	0.8	17.3	5.0	2.3	8.0	0.9	4.1	5.9	4.5	11.4	2.5	5.4	6.6	3.0	23.6	8.2	6.3	5.3	0.9	12.0	4.7	1.6	36.7	21.6	4.4	3.2	83.9	4.3	74.8	0.0	12.5	21.9	0.4	13.8	0.1	0.3	0.6	0.1	5.1	0.2	1.0	0.3	40.4	0.5	25.1	0.6	0.0	4.9	5.1	5.5	6.1	6.3	5.1	6.5	6.8	6.4	6.9	5.9	7.7	6.7	0.1	0.0	1.3	13.1	0.3	3.2	0.3	7.0	1.8	6.3	1.6	1.3	1.0	2.8	2.1	0.0	2.1	13.8	0.2	1.3	0.0	2.9	2.8	1.9	2.4	0.8	4.2	0.4	4.5	1.5	40.3	1.2	0.5	3.3	1.3	2.0	1.1	1.0	6.0	6.7	7.3	13.0	2.0	7.8	0.5	2.6	0.9	7.3	1.8	3.7	3.5	3.3	1.0	6.0	13.9	2.9	1.4	0.7	1.8	0.4	43.6	0.2	2.7	4.4	0.0	0.1	1.5	0.5	0.8	2.5	1.7	5.5	0.9	1.3	3.7	0.1
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 273.7;Proximal enterocytes: 331.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	62.7	36.1	36.5	41.6	40.3	45.2	57.3	43.8	40.7	60.0	36.0	79.5	99.9	47.9	12.9	79.7	42.9	40.9	41.5	35.6	29.7	95.4	60.6	51.0	42.1	54.0	45.6	42.6	40.0	21.1	38.8	41.7	50.3	47.6	24.9	23.8	58.5	38.1	18.8	68.7	92.2	18.6	48.4	59.6	64.6	44.7	54.3	26.0	47.7	17.8	23.1	57.5	58.2	57.7	127.9	54.8	38.4	111.2	58.0	43.2	167.6	93.9	60.2	53.3	51.9	74.5	27.5	74.9	108.8	62.5	50.3	67.6	30.3	84.4	12.3	62.9	67.7	152.5	47.2	123.4	45.1	116.1	93.1	57.0	51.0	54.5	27.0	80.6	79.2	53.9	95.9	83.7	36.9	161.3	50.8	89.9	60.2	114.0	60.2	122.1	35.7	206.6	23.9	139.0	67.0	49.7	137.3	114.9	60.7	15.4	90.9	101.6	116.7	80.4	50.9	53.0	37.1	159.7	45.6	31.1	132.9	89.7	65.4	17.7	71.5	17.2	37.8	119.0	31.2	41.0	48.9	34.4	83.4	54.5	28.3	22.9	14.0	26.1	126.8	52.4	78.5	84.2	36.5	40.3	43.8	40.7	35.6	29.7	54.0	45.6	50.3	48.4	54.3	57.7	56.2	22.4	27.9	53.2	45.3	35.7	40.3	95.2	37.0	74.6	41.3	36.6	14.4	27.1	51.6	92.0	66.7	119.6	38.7	273.7	99.7	85.5	2.3	40.7	29.6	49.0	46.3	45.6	15.7	51.4	174.8	44.6	126.4	83.1	41.9	61.2	40.7	70.0	108.6	30.3	9.3	131.4	57.0	64.7	44.5	8.2	39.1	60.0	69.4	29.0	129.4	67.6	33.0	10.1	41.7	52.7	174.2	55.7	39.2	54.9	331.6	142.4	33.7	53.6	26.3	21.3	47.8	1.8	12.2	42.3	36.1	160.8	31.8	31.2	178.6	54.2
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 1570.1;tongue: 1393.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		410000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	18.7	54.2	50.4	11.0	50.9	8.0	15.0	58.1	59.3	28.2	50.1	34.2	10.4	36.1	14.3	38.6	29.2	15.9	298.6	49.4	63.3	46.0	8.4	14.9	8.0	54.5	51.1	45.1	10.9	136.2	36.5	12.0	58.7	29.0	16.1	85.5	29.2	39.0	1570.1	14.4	16.0	35.1	46.1	11.8	23.0	50.7	62.1	9.3	21.5	1393.9	10.2	27.7	19.2	43.4	32.9	30.6	98.4	87.5	97.2	72.5	20.2	85.4	80.2	77.1	54.4	76.3	40.5	192.9	69.6	44.1	44.9	36.0	90.1	91.2	70.9	5.5	43.9	54.7	64.7	1.9	54.3	2.9	30.9	102.1	50.4	69.2	107.3	125.1	85.9	3.7	64.6	91.7	71.5	25.8	69.5	5.1	67.7	36.0	93.9	115.7	55.7	141.3	48.4	32.5	111.5	82.6	51.0	75.9	86.5	78.7	80.3	11.2	75.8	34.0	46.5	49.5	72.1	52.8	145.3	106.4	62.4	6.8	28.5	0.3	2.9	7.8	2.1	2.5	0.9	8.8	3.5	2.1	5.6	8.3	4.3	2.4	0.7	2.1	2.1	0.9	3.5	3.1	50.4	50.9	58.1	59.3	49.4	63.3	54.5	51.1	58.7	46.1	62.1	43.4	8.6	16.0	8.4	30.3	6.9	7.4	21.7	22.1	15.9	43.3	5.6	9.1	345.9	12.8	10.8	22.0	43.8	2.8	0.9	3.4	66.5	10.6	43.1	5.5	18.0	17.3	9.1	8.6	23.2	2.5	3.8	27.1	6.6	2.4	1.3	17.3	13.9	2.7	4.1	121.1	30.0	9.1	34.6	3.8	3.7	27.0	30.7	4.3	55.2	3.7	11.3	125.7	4.1	15.6	3.4	3.5	1.9	47.8	4.6	7.9	2.7	30.6	11.2	51.1	26.3	37.6	24.5	52.1	14.4	9.2	5.3	2.5	3.3	24.0	10.1	9.7
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137718	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 277.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 459.8;Late spermatids: 516.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		1900000	"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	35.0	11.5	41.6	41.5	39.3	14.4	23.5	13.8	49.9	26.3	61.7	43.8	48.8	55.5	5.6	67.1	34.9	34.1	128.6	60.4	65.0	44.6	4.7	19.1	32.5	30.7	50.9	19.1	15.9	15.2	29.9	15.5	58.0	35.6	30.7	277.0	39.8	62.0	70.4	40.3	59.6	44.1	8.3	19.1	36.8	141.1	47.0	29.7	38.5	21.0	21.2	64.7	42.8	31.7	314.8	420.2	25.9	0.6	26.8	56.9	336.9	187.2	66.6	186.2	222.8	444.5	320.4	37.0	147.8	134.9	174.9	243.0	141.7	292.3	173.1	102.1	111.0	132.0	189.1	24.2	65.2	53.7	203.4	27.0	61.2	190.0	96.0	273.7	367.8	153.7	37.0	1.3	195.7	239.8	182.5	44.4	42.9	133.9	149.3	138.8	46.9	150.1	185.7	115.9	69.5	64.7	133.7	111.0	172.0	307.8	93.7	80.3	449.2	124.6	65.3	380.5	199.3	195.4	200.1	135.7	331.0	98.0	78.5	30.8	8.5	2.9	26.8	4.2	21.2	13.7	26.2	25.0	14.5	15.3	9.6	15.4	1.3	26.7	1.6	22.5	37.6	16.5	41.6	39.3	13.8	49.9	60.4	65.0	30.7	50.9	58.0	8.3	47.0	31.7	30.5	3.2	7.0	128.6	14.8	28.7	58.5	96.8	14.8	40.4	10.3	7.7	147.4	8.6	57.9	64.4	54.2	7.8	16.3	72.6	43.0	115.7	459.8	41.2	9.0	36.0	37.2	10.3	49.4	10.8	205.8	25.9	35.7	63.8	55.9	25.8	14.6	0.7	33.9	42.1	25.9	23.1	124.1	7.6	31.4	516.3	7.5	14.3	19.6	15.0	15.4	113.1	16.5	16.1	6.7	116.8	57.2	6.8	14.2	80.9	53.2	5.9	62.6	133.4	13.1	43.2	34.6	149.4	3.5	25.1	22.6	26.5	28.8	11.2	28.9	64.2
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PFN2		ENSG00000070087	"Profilin 2"	P35080	3	149964904-150050788	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 461.8;Ionocytes: 231.9;Muller glia cells: 289.3;Proximal tubular cells: 198.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035611, CAB037073"	Enhanced					NA	NA		19000	"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB037073: AB_1079600, HPA035611: AB_10672870"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.42e-4)"	"prognostic unfavorable (2.19e-7)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.99e-1)"	27.3	39.1	188.0	19.8	205.1	3.1	35.9	147.7	261.5	42.4	165.3	44.3	25.2	60.9	151.8	25.0	97.1	35.8	45.7	268.1	182.4	116.0	25.0	20.2	7.2	162.1	154.4	60.5	37.8	79.3	61.7	21.4	164.3	66.2	27.4	154.9	49.0	64.7	255.3	14.1	34.4	58.8	165.3	16.3	38.4	27.4	166.3	28.4	99.5	89.9	10.2	52.1	32.5	192.3	556.7	189.8	446.3	184.0	97.5	330.3	119.1	174.0	262.9	268.3	310.1	71.2	435.7	0.1	357.8	383.1	457.2	5.7	187.0	247.5	386.7	17.8	111.3	6.5	94.7	206.0	130.1	31.3	8.8	209.1	205.4	263.9	341.5	285.9	159.3	87.9	1.6	21.3	282.9	206.0	27.3	1.5	195.0	3.7	248.1	31.1	321.7	2.6	200.8	278.6	241.6	248.8	86.4	41.1	239.6	306.6	65.3	4.5	116.1	127.2	177.3	214.1	228.4	28.5	2.3	14.7	275.3	1.8	159.2	1.7	0.2	0.4	2.2	0.1	4.7	2.0	4.8	4.1	0.1	1.0	7.3	4.4	1.2	1.4	0.0	0.2	1.4	2.1	188.0	205.1	147.7	261.5	268.1	182.4	162.1	154.4	164.3	165.3	166.3	192.3	16.2	6.4	6.9	26.4	4.5	9.8	52.4	106.0	100.2	52.1	54.3	37.0	48.3	32.9	47.3	136.1	18.8	11.9	1.9	12.8	461.8	42.1	57.6	75.5	28.3	22.6	121.2	0.0	65.0	27.3	11.5	54.7	7.7	10.6	8.2	39.5	25.4	12.3	3.2	26.9	33.8	27.9	231.9	1.2	9.3	27.2	74.0	2.9	35.6	15.9	4.8	289.3	1.0	21.6	30.3	14.9	19.4	96.7	3.4	57.9	103.2	198.2	116.4	42.2	13.1	52.7	71.8	28.5	19.2	51.5	7.5	10.3	5.0	55.8	30.5	37.7
PGA3		ENSG00000229859	"Pepsinogen A3"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	613	"stomach 1: 89073.4"	"Cell type enriched"	"Detected in some"	526	"Gastric mucus-secreting cells: 3263.5"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.9"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;THP-1: 1.1"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				80.5	10.0	0.5	0.2	0.2	0.2	18.2	0.7	0.9	11.1	0.0	145.3	1.3	3.8	0.0	96.4	4.5	0.1	11.4	2.9	0.0	5.4	16.2	6.2	0.0	0.0	0.0	5.4	13.0	0.0	13.4	0.5	0.1	5.5	0.1	0.9	6.8	0.7	4.4	6.0	5.7	0.4	0.0	6.3	89073.4	7.3	0.0	0.1	5.0	0.5	0.1	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.7	1.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.6	0.4	0.2	0.3	0.0	0.0	1.3	0.5	0.2	0.7	0.9	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	6.2	0.0	0.3	3263.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.1
PGA4		ENSG00000229183	"Pepsinogen A4"	P0DJD7	11	61222349-61231694	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1281	"stomach 1: 66596.4"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 109.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	26	"monocytes: 10.9"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								9.6	8.3	0.1	2.1	0.1	0.0	9.0	0.1	0.2	7.5	0.1	52.0	2.5	4.6	0.0	9.1	19.1	0.3	6.2	0.1	0.1	30.3	11.7	37.9	0.0	0.1	0.1	4.1	18.8	0.0	3.5	3.8	0.1	16.2	0.4	0.3	4.5	0.7	2.5	4.1	2.9	0.8	0.1	5.2	66596.4	4.3	0.1	0.1	3.1	0.0	0.2	5.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.0	1.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	109.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2014	"stomach 1: 39870.8"	"Cell type enriched"	"Detected in some"	77	"Exocrine glandular cells: 4383.1"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Cell line enriched"	"Detected in some"	19	"BJ hTERT+: 28.8"									HPA046875	Supported				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		19.7	4.4	0.3	1.1	0.3	0.0	4.5	0.1	0.6	4.0	0.0	6.2	0.6	1.9	0.0	7.0	5.1	0.1	3.5	0.7	0.0	2.4	7.0	5.4	0.0	0.1	0.0	2.6	8.2	0.0	3.8	0.5	0.1	1.8	0.1	1.5	2.5	0.5	1.9	2.1	2.1	0.9	0.0	3.9	39870.8	2.3	0.0	0.2	3.1	0.2	0.1	2.3	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.3	0.3	0.1	0.6	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4383.1	0.0	0.1	56.6	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	5.1	0.0	1.6	0.9	1.3	0.0	0.0	1.0	25.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77967949-77969638	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 2.3;Basal respiratory cells: 1.6;Langerhans cells: 1.5;Melanocytes: 3.6;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.3"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.3	0.4	0.1	0.4	0.0	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.8	1.0	0.3	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.4	1.0	0.5	0.4	0.3	1.0	0.7	0.1	0.5	1.0	1.5	0.5	1.0	0.4	0.3	0.5	0.5	0.8	0.3	0.3	0.5	0.6	0.4	1.1	0.2	0.9	1.7	0.1	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	10.5	17.7	13.0	17.0	12.7	16.3	9.7	12.7	17.0	9.8	10.1	16.1	15.2	10.9	6.6	23.9	12.4	8.7	20.0	19.0	12.5	14.3	28.9	9.3	21.2	9.3	9.7	7.2	25.8	10.7	9.9	10.7	10.1	9.4	11.3	6.0	15.5	11.5	33.2	17.1	13.2	11.3	7.9	12.8	13.3	16.5	10.8	14.8	11.6	19.0	16.1	15.6	11.8	11.3	72.2	134.3	28.2	79.5	19.4	15.6	66.1	37.4	22.0	59.1	33.0	168.6	40.2	92.3	67.2	31.2	30.4	61.2	132.9	67.5	24.1	47.3	106.7	110.7	61.6	89.2	44.0	105.8	61.8	19.4	48.8	69.0	73.6	19.3	43.6	73.4	143.3	36.9	23.5	128.5	144.5	105.7	108.0	61.8	94.4	109.4	31.2	73.3	38.4	97.4	102.8	58.0	62.2	86.1	38.9	22.2	108.9	57.5	38.2	29.9	65.5	60.6	89.9	77.2	124.8	133.5	38.8	85.3	51.1	4.9	1.1	0.3	1.1	1.2	1.8	1.7	1.3	1.3	1.0	1.7	1.3	1.7	0.9	1.6	1.7	3.3	1.1	0.8	13.0	12.7	12.7	17.0	19.0	12.5	9.3	9.7	10.1	7.9	10.8	11.3	6.6	3.2	6.1	3.9	8.9	11.5	16.7	2.6	2.2	9.5	7.8	5.5	15.1	15.7	1.5	5.5	14.6	7.6	11.9	11.7	5.9	5.8	14.5	6.3	6.3	7.0	13.1	5.0	5.1	7.9	14.4	4.9	4.1	9.3	0.0	7.1	5.7	22.4	7.3	6.7	3.9	8.9	2.0	6.9	5.8	20.6	5.9	4.7	3.6	1.9	5.3	4.4	3.1	2.0	2.3	7.5	6.9	6.8	9.7	19.5	5.2	11.5	4.5	12.9	6.6	8.0	6.4	15.1	10.1	10.8	17.3	6.2	7.4	9.2	15.7	16.1
PGAP2	"CWH43-N, FRAG1, MRT17, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 216.2"	"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	8.9	14.9	16.4	6.4	17.5	9.5	11.5	15.9	18.2	13.7	17.0	13.9	18.4	8.3	216.2	34.9	19.2	7.6	21.7	16.6	16.3	13.9	30.9	16.2	10.4	17.8	16.6	11.2	28.9	17.6	15.1	14.2	17.2	16.7	13.3	9.2	18.4	33.4	11.4	48.0	16.0	7.6	16.3	11.3	14.1	28.5	17.3	13.1	19.4	9.5	13.5	10.9	18.8	20.9	27.1	36.3	17.2	15.8	15.2	28.9	27.3	10.9	9.4	15.6	14.2	31.1	46.6	29.0	12.3	8.0	9.4	44.1	27.6	30.2	15.5	35.5	30.9	17.7	14.7	38.4	10.7	23.0	22.0	22.8	41.9	11.6	39.3	10.2	18.0	38.4	38.4	41.8	16.6	39.9	28.0	19.3	32.4	56.7	21.5	44.0	2.0	27.8	30.0	31.6	22.7	22.5	19.7	52.0	12.3	20.1	43.2	9.6	16.5	9.9	9.2	23.8	6.8	26.2	31.3	21.6	12.9	15.3	19.1	3.0	6.4	5.9	9.1	9.2	11.0	11.4	13.2	11.3	9.7	12.7	17.3	11.8	18.2	10.7	9.2	6.6	13.3	8.8	16.4	17.5	15.9	18.2	16.6	16.3	17.8	16.6	17.2	16.3	17.3	20.9	8.4	12.8	10.6	7.5	10.6	31.7	15.1	23.3	33.6	14.1	19.2	18.0	13.7	11.5	13.0	12.9	22.9	74.9	5.2	11.4	1.9	15.6	147.6	11.7	6.6	9.0	3.0	13.2	15.4	21.3	18.4	7.6	10.2	14.7	8.8	13.4	3.6	14.6	16.0	3.3	19.1	10.5	10.2	5.0	8.0	296.8	8.7	5.5	5.4	4.7	8.9	9.3	8.2	10.6	23.0	14.2	9.3	6.8	12.2	9.1	39.8	10.2	15.2	9.5	6.6	11.0	7.2	17.7	21.6	31.1	28.6	29.3	9.4	11.8	20.1	13.0
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins phospholipase 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 800.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	10.5	11.9	17.0	5.6	17.2	5.0	12.9	14.0	19.6	14.6	16.2	18.6	14.9	11.3	18.3	25.8	15.9	13.4	14.8	17.5	16.7	20.6	35.6	12.1	7.4	14.9	15.4	13.5	27.1	22.7	14.9	11.8	14.6	18.5	13.7	7.1	25.1	11.7	8.3	21.0	17.1	6.1	14.7	12.3	16.6	9.1	16.5	4.8	27.1	4.5	7.5	12.2	13.7	15.5	3.7	9.6	7.7	7.0	7.9	8.1	7.9	4.3	10.1	6.7	6.1	5.4	23.8	4.2	19.7	8.3	2.2	12.6	2.4	2.9	3.1	8.6	7.7	5.2	6.0	9.3	10.6	12.9	12.8	14.9	15.0	3.1	6.8	7.6	2.2	1.9	4.9	9.6	6.1	8.7	2.9	11.7	7.6	800.4	2.1	3.2	4.7	12.1	10.7	12.0	7.1	4.7	11.9	134.0	6.9	0.8	11.4	12.4	3.4	7.2	7.6	3.5	3.3	8.5	2.0	1.4	8.1	4.9	8.1	2.6	7.2	4.6	15.2	11.6	8.3	8.1	10.6	12.5	5.7	7.7	10.1	10.1	2.0	10.4	4.3	3.9	5.4	7.3	17.0	17.2	14.0	19.6	17.5	16.7	14.9	15.4	14.6	14.7	16.5	15.5	6.5	3.2	14.9	7.8	3.7	3.8	3.3	5.6	3.4	12.6	9.1	7.0	7.7	14.3	10.1	14.7	8.4	8.1	5.3	20.3	1.9	7.6	0.1	3.5	4.5	5.0	8.4	3.0	9.0	11.1	6.5	5.1	9.2	5.7	8.9	6.8	4.6	9.0	4.4	13.5	6.3	15.3	8.2	5.1	2.8	0.1	3.1	3.7	1.8	2.8	1.9	7.5	4.1	9.0	6.1	6.3	13.9	1.5	2.8	3.7	22.9	3.4	4.9	22.1	0.0	5.0	3.3	0.7	2.4	8.1	2.8	10.4	4.9	5.8	13.3	3.1
PGAP4	"C9orf125, MGC12992, TMEM246"	ENSG00000165152	"Post-GPI attachment to proteins GalNAc transferase 4"	Q9BRR3	9	101473170-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;hTERT-RPE1: 28.8;OE19: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	Yes				"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.9	10.3	21.5	2.2	21.3	0.5	2.4	18.9	26.2	16.6	4.5	13.4	8.4	7.1	3.7	14.4	13.7	6.8	30.4	24.9	26.1	4.7	2.4	5.4	0.4	17.9	13.4	19.5	11.1	16.6	12.3	0.6	26.1	6.9	11.2	9.9	6.1	9.4	4.8	12.0	7.6	6.7	9.6	1.6	16.0	2.8	19.2	0.9	4.2	6.1	2.4	6.4	11.9	20.3	0.0	14.6	11.3	0.0	0.3	0.2	0.0	9.8	14.1	7.0	13.8	0.7	7.8	0.0	3.2	17.9	0.8	23.1	0.0	16.1	4.2	0.0	5.8	8.1	10.3	0.0	0.5	0.0	0.0	6.2	25.5	0.0	3.8	28.8	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	14.0	48.1	0.0	0.0	5.7	0.0	10.5	2.7	18.9	17.8	5.5	0.0	0.0	2.7	0.0	13.8	0.0	10.7	6.6	0.0	0.0	1.0	0.0	0.0	15.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	21.3	18.9	26.2	24.9	26.1	17.9	13.4	26.1	9.6	19.2	20.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 33.4;Inhibitory neurons: 26.7;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.7;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	2.9	2.9	5.8	1.9	6.2	1.6	2.9	5.9	7.3	3.8	2.9	5.9	1.4	4.4	2.6	2.1	3.4	1.9	3.2	6.8	4.5	3.2	2.6	2.5	1.6	4.1	4.2	3.1	2.1	2.4	3.1	2.0	4.5	3.5	2.1	6.2	2.1	3.2	2.1	1.4	2.7	5.4	4.0	3.2	3.2	3.1	4.4	2.3	2.5	1.6	1.6	3.3	2.8	6.7	6.4	3.5	10.9	15.5	8.6	6.1	3.6	8.2	5.6	10.2	11.5	3.9	2.6	4.2	5.1	5.7	11.6	2.8	11.9	6.7	13.2	4.7	6.8	7.8	6.9	4.9	4.0	9.7	0.9	5.0	3.1	10.1	3.5	5.8	12.7	8.1	10.2	0.5	11.5	2.0	8.2	12.1	4.1	0.1	6.9	14.0	13.9	0.1	5.1	3.4	7.5	14.3	5.6	1.0	6.5	10.8	3.1	5.9	9.1	15.2	10.2	1.0	13.2	4.0	4.3	5.5	3.4	5.5	7.3	1.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	1.5	0.1	0.1	5.8	6.2	5.9	7.3	6.8	4.5	4.1	4.2	4.5	4.0	4.4	6.7	6.1	6.4	1.1	12.7	1.4	0.3	3.0	0.7	1.8	6.2	2.3	2.9	7.5	0.0	0.2	0.0	2.1	0.8	3.6	0.5	0.0	1.1	1.4	1.1	4.4	4.6	1.2	5.2	33.4	2.5	3.7	4.1	0.5	1.0	3.8	4.7	3.6	0.2	1.7	5.0	26.7	0.7	2.0	4.0	1.4	1.0	1.8	1.2	3.6	7.5	2.1	4.4	0.0	20.6	22.3	1.1	0.3	3.4	1.5	0.8	0.6	3.9	4.2	4.4	0.0	6.2	4.3	5.0	9.7	1.8	0.3	0.4	1.3	3.1	1.1	0.5
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA029888, HPA029889, HPA029890"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.05e-4)"	3.2	3.6	3.5	5.4	3.7	4.3	5.8	5.4	3.9	4.9	2.8	4.6	5.9	4.8	5.1	6.0	3.8	4.7	2.8	2.9	4.3	3.7	7.2	3.6	7.5	3.5	3.0	5.6	6.7	3.3	2.7	5.8	3.6	5.1	6.1	4.4	5.4	3.3	1.4	8.1	7.1	3.6	2.1	9.4	5.2	6.0	4.1	5.6	6.5	2.4	7.1	4.4	4.7	6.3	4.4	5.7	8.5	5.2	7.7	5.0	10.7	4.1	3.4	6.9	6.3	4.2	5.6	11.2	5.0	3.9	3.8	6.9	4.7	5.2	7.6	6.7	2.1	10.7	10.0	6.4	4.4	5.9	10.3	4.5	5.5	8.2	4.5	5.5	3.9	3.8	17.5	9.5	5.0	7.3	2.0	6.5	8.4	14.6	6.6	13.1	2.8	3.5	4.0	5.5	3.0	5.6	6.0	8.5	7.0	5.9	3.6	11.2	5.0	4.7	4.5	4.3	4.6	8.8	9.2	4.1	5.0	12.7	4.4	11.0	6.0	9.4	6.1	4.4	6.1	8.3	5.5	5.9	5.5	8.4	5.5	6.8	4.6	5.9	6.8	2.7	4.1	4.1	3.5	3.7	5.4	3.9	2.9	4.3	3.5	3.0	3.6	2.1	4.1	6.3	5.3	0.0	8.9	2.6	11.2	5.2	2.9	7.6	14.8	3.6	7.3	5.6	2.2	2.8	9.1	5.5	2.1	11.5	7.9	6.9	1.9	5.1	3.5	6.0	4.9	5.9	1.2	17.9	2.3	3.0	4.4	3.5	6.1	6.9	2.5	7.8	3.3	3.4	2.9	1.7	2.7	4.3	6.1	3.3	4.4	2.7	3.1	3.7	7.2	2.8	4.6	3.2	6.2	6.0	4.3	2.2	6.0	1.9	5.7	2.8	9.0	3.0	4.6	2.7	0.0	4.0	5.6	14.5	10.2	7.9	6.5	27.8	7.8	4.8	5.1	2.1
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102083-34108686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.9"	"Low cell line specificity"	"Detected in many"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	0.8	0.8	2.5	1.6	2.4	2.8	1.1	3.1	3.2	0.6	2.2	0.9	1.1	0.7	1.3	0.8	1.1	0.7	1.5	2.4	2.6	1.1	1.3	0.7	2.0	3.5	2.4	0.9	1.0	1.5	0.6	0.6	3.5	0.9	1.1	2.4	0.7	0.8	5.3	1.6	1.1	0.6	1.9	1.4	1.4	1.8	2.4	1.3	1.1	1.3	1.5	0.6	0.6	3.1	1.0	1.9	1.3	2.2	3.9	2.5	0.8	1.7	1.6	1.0	1.3	1.3	1.4	2.2	1.3	1.3	2.1	3.0	0.8	1.9	1.3	2.4	2.0	3.7	4.2	1.0	1.6	1.2	3.2	1.9	2.2	1.4	2.5	1.8	1.1	4.1	2.6	2.6	2.2	0.8	2.1	2.9	0.5	2.2	1.4	3.1	1.8	1.1	1.4	2.3	1.9	1.7	0.8	1.9	0.6	1.6	1.8	1.9	1.3	3.2	1.8	1.7	1.1	3.1	2.1	1.2	2.8	2.9	1.9	3.9	0.5	0.6	0.4	0.4	0.3	0.5	0.6	0.4	0.3	0.9	0.9	0.8	1.1	0.6	0.3	0.6	0.5	0.2	2.5	2.4	3.1	3.2	2.4	2.6	3.5	2.4	3.5	1.9	2.4	3.1	1.4	0.0	3.2	2.0	4.1	0.8	2.5	1.8	3.4	5.6	1.9	1.3	5.8	2.8	2.9	0.0	6.2	2.0	5.6	3.1	9.8	1.2	11.6	2.0	3.8	2.1	0.0	2.5	2.7	0.7	0.6	1.8	3.6	2.3	1.3	1.8	3.6	2.2	1.3	10.1	3.1	2.5	4.1	2.8	0.4	11.5	1.2	2.2	0.0	1.0	2.1	2.1	3.1	2.0	3.9	2.1	2.5	0.4	1.6	2.0	3.6	1.4	3.9	6.9	13.1	3.9	1.9	7.6	1.6	2.3	0.3	3.3	4.6	2.7	2.9	1.5
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420511	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 400.2;esophagus: 572.4"	"Cell type enhanced"	"Detected in all"		"monocytes: 214.9;Squamous epithelial cells: 496.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1074.7;monocytes: 321.0"	"Cell line enhanced"	"Detected in all"		"A549: 1445.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		41000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	115.8	51.0	49.5	59.8	49.2	400.2	89.0	52.9	49.3	75.9	52.5	52.9	91.6	23.1	41.9	572.4	30.0	94.2	34.3	47.4	54.3	53.2	81.3	88.5	38.1	57.0	54.6	35.7	32.0	52.7	43.8	47.4	55.4	30.4	46.3	49.1	133.7	22.9	34.7	50.0	70.7	35.0	49.7	110.4	61.4	68.3	59.2	53.6	71.8	28.2	73.8	61.8	126.9	52.0	191.5	1445.2	319.3	340.6	445.4	274.0	71.8	124.8	185.9	144.4	195.3	219.2	190.4	163.5	151.0	109.2	202.4	148.0	225.6	192.1	96.4	127.5	199.9	227.8	264.3	452.1	136.3	390.9	249.7	196.5	92.2	229.4	55.5	186.9	344.0	223.0	305.3	145.7	183.5	202.5	321.4	179.4	194.7	221.0	109.1	252.7	298.1	312.2	199.6	105.5	178.0	154.1	99.1	153.5	137.5	196.7	173.3	308.5	369.3	81.1	149.6	98.3	134.5	111.6	256.0	323.5	175.1	393.9	73.6	1060.2	321.0	1074.7	23.2	137.7	26.5	33.1	21.4	20.8	144.6	23.3	21.1	22.3	332.6	19.7	105.6	98.7	23.1	225.0	49.5	49.2	52.9	49.3	47.4	54.3	57.0	54.6	55.4	49.7	59.2	52.0	7.4	19.2	35.0	11.8	24.9	13.0	30.8	78.0	70.6	7.8	30.4	18.5	11.0	50.1	73.2	20.2	18.8	134.6	29.8	24.3	52.8	52.1	10.9	17.8	18.6	22.6	23.4	55.7	8.6	40.3	40.7	37.5	41.8	24.5	25.9	53.9	16.1	66.2	134.6	1.7	12.6	30.2	59.0	163.8	30.9	13.4	17.1	150.9	17.8	4.7	214.9	16.5	10.3	13.6	9.0	38.7	26.7	10.5	41.9	43.5	66.6	55.1	46.2	20.2	19.7	23.4	21.5	41.5	38.4	496.0	16.6	81.3	19.4	27.3	51.7	76.1
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289126-296107	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 657.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 132.8;U-266/70: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	25.3	5.6	5.8	41.6	5.8	16.3	41.9	5.5	25.6	56.0	6.8	25.2	50.5	21.6	32.7	14.1	34.6	18.9	18.8	5.4	5.8	116.4	77.8	67.0	63.5	6.9	6.4	8.7	657.7	2.9	12.5	7.3	8.2	34.6	6.3	0.6	36.2	46.1	4.5	8.6	103.0	3.0	5.7	101.9	18.5	6.3	7.1	37.4	74.4	3.2	17.6	21.5	22.6	6.3	5.4	5.8	10.5	11.7	4.2	3.7	8.2	4.2	3.4	2.4	2.1	5.0	15.0	0.0	5.3	5.1	5.1	3.3	0.9	1.9	0.3	13.3	4.0	2.5	4.2	6.8	5.3	0.3	22.8	13.8	1.5	0.9	0.7	8.9	8.1	132.8	10.5	15.9	1.3	7.7	24.0	12.1	8.3	1.8	1.0	21.5	2.1	7.8	5.6	1.8	0.1	2.4	1.5	7.8	7.2	4.6	5.7	2.9	7.5	4.9	7.0	1.5	0.5	34.8	1.0	6.0	0.8	4.3	5.8	1.2	0.7	1.0	6.1	3.2	5.1	1.5	1.0	3.3	0.5	1.5	2.1	4.5	3.7	5.6	2.5	2.0	0.1	2.2	5.8	5.8	5.5	25.6	5.4	5.8	6.9	6.4	8.2	5.7	7.1	6.3	17.8	160.3	81.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	35.1	26.8	0.0	0.0	31.6	33.1	0.0	0.3	29.8	0.0	0.0	4.9	0.0	12.5	12.0	4.5	0.0	0.0	0.0	8.3	3.3	4.2	0.0	17.6	6.3	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	16.1	0.0	0.0	2.9	10.2	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	14.4	0.9	0.0	0.0
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262877	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	9.4	8.1	4.6	11.1	6.1	12.8	9.6	6.1	4.2	7.6	5.6	14.6	13.0	8.0	3.6	9.6	7.5	7.4	6.7	4.2	5.9	8.1	12.8	7.4	9.8	5.3	5.9	7.3	9.6	12.6	3.2	8.3	6.4	8.4	15.1	12.0	6.6	5.9	7.8	4.9	11.1	9.8	5.8	10.3	11.7	5.6	5.6	9.4	8.6	9.1	11.0	11.3	5.4	6.8	14.7	15.6	17.5	22.7	10.0	8.3	8.6	17.7	10.4	14.5	14.8	17.1	15.3	29.6	23.4	12.4	14.9	11.2	23.3	23.3	21.5	32.9	12.9	17.1	21.0	13.9	13.3	23.7	24.2	12.5	14.0	14.3	14.8	9.2	14.7	17.2	14.1	12.3	16.7	22.8	20.9	7.9	13.0	16.4	12.0	22.6	23.3	30.3	15.2	27.3	17.0	13.0	21.0	15.8	17.6	10.4	21.2	17.4	17.0	14.8	14.0	10.3	20.9	20.4	24.5	15.5	10.7	24.1	20.9	13.7	19.0	34.1	7.0	25.3	8.0	9.7	7.8	8.9	17.2	11.3	7.4	6.8	19.5	10.5	27.0	15.5	7.6	10.3	4.6	6.1	6.1	4.2	4.2	5.9	5.3	5.9	6.4	5.8	5.6	6.8	21.8	12.8	20.8	24.8	26.2	9.9	11.8	12.2	9.1	23.3	18.3	10.4	17.1	5.7	18.3	16.5	47.9	15.3	27.2	29.0	27.4	19.3	49.2	15.8	21.3	20.3	30.1	9.5	30.5	21.6	14.9	15.5	19.9	13.5	23.5	17.2	20.7	25.7	22.6	23.5	27.6	22.4	10.2	21.9	13.2	10.2	13.4	24.8	10.6	33.7	26.8	27.8	24.7	38.2	38.0	24.0	27.2	15.4	12.0	15.6	20.7	22.8	20.3	111.2	13.1	20.5	16.7	14.7	13.9	10.7	12.4	13.5	16.1	19.6	23.9	20.3
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129295	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 1126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	120.7	141.8	87.3	149.0	94.1	252.8	89.1	103.2	119.0	100.2	117.2	127.4	123.4	72.3	73.0	154.1	79.3	110.1	247.4	92.7	109.2	233.5	143.8	117.1	139.0	104.8	95.1	61.9	61.1	188.8	30.0	138.6	109.5	92.8	143.1	298.8	93.2	101.8	452.0	92.6	119.1	116.7	102.4	97.2	86.1	29.2	111.1	158.3	105.6	266.7	189.6	148.4	49.4	101.3	943.0	426.7	139.7	283.8	236.1	190.0	331.3	469.2	324.0	402.9	670.0	390.2	287.7	373.9	473.7	326.5	479.5	397.6	624.8	729.3	800.7	229.8	246.6	290.3	657.8	341.8	258.0	671.8	309.2	238.5	302.2	366.7	192.7	646.1	418.8	361.9	308.5	553.4	557.4	371.2	593.5	506.0	433.3	628.5	800.7	421.8	374.4	1157.0	423.8	385.4	208.0	286.6	486.3	409.0	422.9	352.6	214.8	347.9	340.2	428.1	294.3	433.4	329.0	609.5	1221.7	391.5	1207.0	750.5	286.6	170.6	360.2	321.1	121.9	382.0	135.9	128.4	144.3	132.9	333.7	101.2	130.9	140.7	281.9	140.3	527.0	130.2	168.4	606.0	87.3	94.1	103.2	119.0	92.7	109.2	104.8	95.1	109.5	102.4	111.1	101.3	166.3	150.6	168.6	20.2	174.8	144.3	272.2	1126.6	122.3	211.3	72.4	67.2	480.4	140.2	436.9	174.7	77.2	298.4	200.6	196.5	471.6	715.8	19.3	123.7	112.4	182.3	102.4	95.9	32.5	236.4	746.4	131.3	95.3	145.1	195.5	98.1	139.6	200.2	499.0	309.6	37.0	164.3	518.8	298.4	188.8	12.1	94.8	310.4	167.2	25.3	499.3	245.7	131.8	20.1	21.9	510.2	149.9	127.2	214.8	118.3	221.5	566.0	235.6	188.8	124.9	84.0	191.8	8.8	57.4	138.4	119.1	349.6	251.9	278.7	203.5	225.8
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785660-49787285	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	531	"testis: 199.9"	"Group enriched"	"Detected in some"	9	"Early spermatids: 1143.9;Late spermatids: 2784.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1143.9	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2784.5	14.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	204.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511636-17521288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	65.0	85.9	31.6	20.0	33.8	40.6	60.9	33.8	41.8	53.2	33.9	53.9	26.2	42.6	13.2	107.4	44.6	16.9	32.1	30.1	33.3	64.7	75.6	46.5	27.2	36.5	32.4	59.7	88.2	28.5	43.0	17.1	35.2	57.3	16.1	3.7	66.1	19.0	18.0	83.6	49.0	15.9	34.5	73.6	54.7	23.2	34.6	26.2	58.3	11.6	20.6	50.1	62.6	38.5	68.7	62.2	38.7	26.3	57.6	94.8	70.6	45.4	76.5	46.4	59.5	29.7	104.0	74.4	50.0	74.9	33.1	46.6	21.9	73.6	14.5	37.3	80.9	35.3	28.0	54.1	97.8	38.7	38.6	111.8	100.5	27.9	83.9	48.3	63.3	29.4	40.7	18.7	58.5	77.2	84.6	108.6	50.6	72.9	244.0	57.3	23.3	49.9	64.3	56.3	47.3	56.0	28.3	33.2	70.3	21.1	47.9	69.7	57.2	47.9	12.9	96.0	26.6	31.4	23.9	32.2	68.2	97.5	48.0	73.0	163.5	194.6	55.3	185.4	44.9	61.5	49.5	50.1	185.0	71.4	45.4	46.1	158.8	72.5	180.2	137.2	57.3	102.7	31.6	33.8	33.8	41.8	30.1	33.3	36.5	32.4	35.2	34.5	34.6	38.5	93.7	28.9	38.3	7.2	84.8	64.5	94.5	132.5	100.2	22.2	128.9	177.8	8.9	110.1	89.4	47.8	16.7	122.4	98.8	194.0	111.6	177.5	35.5	89.4	99.7	72.0	133.0	48.4	3.5	208.8	169.6	94.2	82.0	90.9	25.4	163.7	99.2	94.0	263.4	26.9	4.9	147.0	75.3	306.5	142.4	70.8	90.7	208.2	74.7	8.4	325.3	79.4	139.0	8.0	11.8	175.7	211.6	69.2	40.4	107.6	263.1	211.1	66.7	28.1	52.6	51.4	103.9	28.7	25.8	210.7	96.2	105.2	85.2	178.3	173.4	143.5
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023053	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 629.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Group enriched"	"Detected in some"	202	"eosinophil: 443.7;neutrophil: 494.6"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 494.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;HEK 293: 1.8;HeLa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		35000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	1.5	0.3	0.3	1.8	1.1	629.4	0.3	3.4	1.5	0.1	0.0	0.3	0.6	0.2	0.0	0.5	0.6	0.2	1.7	0.6	0.0	0.8	2.5	8.7	0.5	0.0	0.1	0.1	0.5	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.5	0.0	0.3	1.0	0.7	0.1	0.0	42.5	0.4	1.0	0.0	3.3	0.5	2.3	0.0	0.4	0.2	0.0	0.3	3.1	0.5	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.2	0.8	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.8	1.8	0.3	1.7	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.3	0.0	0.2	0.2	0.9	0.2	0.0	1.2	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.7	0.6	0.3	0.4	0.7	0.0	0.2	0.4	443.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	494.6	0.0	2.3	0.0	0.1	3.9	0.3	1.1	3.4	1.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 258.8"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	258.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Metabolic proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.9;skin 1: 73.7;vagina: 21.4"	"Cell type enriched"	"Detected in single"	12	"Squamous epithelial cells: 4.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.9;head and neck cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HaCaT: 3.8;HDLM-2: 1.6;hTCEpi: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	73.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	7.6	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593411-63660245	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 1559.1;tongue: 788.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Supported	Cytosol		NA	NA		21000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	113.7	70.8	31.6	20.7	34.7	21.5	57.4	34.3	38.4	33.9	53.1	58.9	60.8	22.9	19.2	49.3	17.0	30.3	178.9	31.4	34.0	52.2	279.8	42.6	14.7	44.7	34.1	51.0	112.2	65.3	31.8	26.9	32.7	46.6	49.9	22.6	41.8	49.7	1559.1	30.6	55.1	41.4	31.9	14.7	30.6	11.1	36.5	14.3	27.5	788.0	19.4	38.4	22.1	30.2	113.4	47.0	17.3	57.0	111.0	81.4	138.6	45.7	61.8	48.9	79.0	38.8	51.3	35.8	93.2	71.2	107.4	26.5	24.0	96.3	55.9	44.0	32.1	75.3	72.6	40.3	91.6	66.8	4.3	103.4	60.7	57.1	88.5	129.8	29.6	36.3	0.1	46.3	78.8	6.9	19.6	36.7	78.3	3.4	73.9	26.8	80.0	11.8	70.0	35.3	10.4	66.7	100.0	103.0	157.4	78.6	32.4	25.2	3.1	71.6	36.0	64.0	39.4	29.1	45.5	57.8	117.0	58.0	31.5	46.0	33.2	49.2	40.5	22.4	32.7	22.4	23.5	31.0	48.4	11.8	21.0	24.7	38.7	43.9	21.2	13.9	20.4	35.4	31.6	34.7	34.3	38.4	31.4	34.0	44.7	34.1	32.7	31.9	36.5	30.2	8.4	93.0	29.4	48.3	16.9	17.8	29.0	58.8	47.8	9.2	33.8	21.8	139.2	48.6	24.2	16.5	10.4	76.6	14.2	81.8	88.0	55.9	32.0	8.2	12.1	12.7	13.1	5.7	17.9	238.4	185.9	37.0	27.0	13.5	5.1	134.3	15.0	214.4	24.6	0.0	26.3	47.5	20.3	17.0	10.8	8.5	22.1	13.5	26.6	4.7	32.8	75.8	29.9	32.2	9.8	70.5	31.6	38.0	40.4	29.2	90.2	74.8	17.0	11.4	13.1	53.4	25.5	5.6	10.1	57.3	18.2	58.8	19.0	20.2	81.5	19.0
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826660-37862937	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 334.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1700000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	8.2	11.2	3.2	9.5	3.2	10.1	8.8	4.6	4.5	10.9	4.5	9.8	7.6	10.1	4.9	36.6	7.9	11.3	5.6	4.9	3.1	8.0	14.8	6.9	10.0	3.4	3.0	6.9	4.4	8.4	3.0	11.7	3.6	7.8	9.0	18.2	7.7	5.2	1.2	17.5	7.8	13.7	3.5	8.3	6.1	5.3	3.1	10.2	9.7	1.9	22.7	18.9	16.4	3.7	27.4	9.5	14.6	16.6	10.2	12.4	19.8	32.6	18.9	27.8	26.4	18.0	19.2	38.0	15.5	17.8	34.9	13.8	36.0	32.0	65.1	23.0	21.0	40.1	15.2	12.3	23.2	44.2	26.5	17.0	36.0	22.0	18.6	16.2	41.6	31.2	53.6	6.2	24.3	15.6	49.8	49.6	17.3	19.2	15.5	35.8	23.1	14.8	15.7	52.3	31.8	10.8	17.5	23.3	12.0	19.5	21.5	45.4	37.0	19.7	24.9	27.3	67.1	14.0	38.4	40.3	10.9	56.2	32.9	19.8	27.5	67.2	9.8	22.4	11.5	9.4	8.0	11.1	31.9	5.5	7.7	9.8	33.6	28.1	18.2	7.1	14.9	17.0	3.2	3.2	4.6	4.5	4.9	3.1	3.4	3.0	3.6	3.5	3.1	3.7	16.9	0.0	8.2	5.2	13.8	14.7	14.3	32.9	17.6	7.8	12.6	6.9	4.5	14.3	23.1	3.7	0.0	31.9	11.9	10.6	5.9	16.0	0.9	9.0	12.7	22.9	7.2	8.0	8.3	11.8	37.8	10.3	5.6	14.7	12.7	56.4	42.5	9.7	37.9	6.7	5.6	9.2	4.1	24.4	15.2	2.0	8.4	24.5	5.4	4.7	46.1	334.1	13.4	8.0	0.9	14.5	6.7	9.8	10.5	17.7	6.9	10.4	9.8	16.0	13.1	5.8	23.8	0.6	2.1	42.5	32.1	79.8	14.7	19.8	12.9	20.4
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330316-74398433	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.1;Exocrine glandular cells: 124.5;Pancreatic endocrine cells: 140.1;Respiratory ciliated cells: 95.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 16.6;LHCN-M2: 19.9;RH-30: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	1.9	2.6	17.6	3.7	22.1	3.2	1.9	0.0	21.5	4.9	0.0	3.2	1.3	4.4	0.8	1.0	3.2	3.3	1.1	23.1	16.2	1.6	1.0	1.8	3.0	1.9	4.5	0.9	3.1	0.7	3.9	1.1	2.2	2.9	3.5	2.6	2.6	1.3	5.9	0.7	1.5	4.0	0.3	1.5	2.1	1.3	5.7	8.1	2.7	11.1	2.7	6.4	1.9	7.8	2.7	3.8	14.5	2.7	4.3	1.9	0.4	3.5	2.6	3.0	3.3	1.4	6.8	0.3	8.5	2.3	5.3	1.3	2.9	0.7	2.8	1.1	1.5	2.1	2.0	1.1	0.5	2.4	3.2	1.0	0.7	6.8	1.2	3.2	16.6	5.0	2.8	1.8	19.9	0.3	9.9	2.1	2.9	2.0	3.3	3.1	18.9	0.1	7.8	0.5	0.7	2.9	5.7	1.3	2.6	3.9	0.2	0.4	14.0	6.6	6.0	2.7	3.7	2.4	3.8	0.3	0.6	3.4	1.6	1.2	0.3	0.5	0.9	0.3	1.3	1.1	1.6	1.1	0.2	0.8	1.5	0.8	0.3	1.4	0.2	0.8	3.9	0.5	17.6	22.1	0.0	21.5	23.1	16.2	1.9	4.5	2.2	0.3	5.7	7.8	19.6	6.4	6.4	8.5	20.9	7.6	41.2	14.3	10.8	23.9	26.5	19.4	7.3	17.2	30.2	9.2	16.7	0.6	17.6	13.8	5.9	37.4	14.1	28.1	23.5	32.1	11.9	47.5	90.1	124.5	5.3	21.0	7.1	25.5	8.2	16.1	29.3	1.0	5.4	8.4	64.8	16.2	18.3	23.0	21.6	3.6	2.5	9.9	16.0	20.6	4.6	4.4	12.3	14.6	7.1	140.1	9.3	3.8	13.4	50.4	4.2	5.3	95.4	11.0	26.3	21.3	16.7	34.2	21.2	9.0	5.3	0.1	25.0	8.8	20.9	55.6
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	23.6	21.0	12.0	18.1	12.9	9.3	18.0	20.2	15.2	24.4	19.6	18.0	15.8	17.1	34.5	12.3	13.4	24.6	14.3	9.7	10.5	13.6	38.3	16.8	11.2	10.9	10.2	22.7	46.1	13.3	28.2	47.5	13.1	51.0	23.4	26.8	35.8	20.3	6.7	10.9	18.2	18.5	6.6	11.5	24.9	32.3	11.1	8.2	25.6	8.6	15.2	19.0	12.3	15.9	35.1	23.4	41.8	51.0	68.9	72.9	48.9	118.1	82.9	55.2	83.3	60.1	16.1	18.3	24.7	112.3	53.0	20.1	38.4	49.5	104.6	14.6	37.8	22.7	41.9	105.0	77.6	22.6	11.2	46.2	40.1	96.6	120.0	55.5	64.6	12.1	74.9	19.6	61.0	39.1	3.7	14.7	18.8	31.8	31.6	16.2	92.5	11.3	42.0	36.0	16.9	26.3	34.8	28.5	20.9	61.8	27.0	25.5	94.2	38.3	21.2	74.9	60.5	36.5	16.1	13.0	29.7	17.7	58.4	10.8	4.1	2.7	2.6	3.5	3.9	4.6	2.8	3.4	3.6	2.5	4.5	4.7	1.8	3.5	4.5	4.2	2.1	2.3	12.0	12.9	20.2	15.2	9.7	10.5	10.9	10.2	13.1	6.6	11.1	15.9	14.3	28.9	27.7	14.4	13.0	15.8	29.2	28.5	5.7	16.4	19.9	15.0	6.8	15.7	36.1	11.0	10.4	32.4	12.7	15.9	7.9	31.7	67.7	17.0	35.1	13.8	16.1	6.9	25.1	49.6	71.1	46.1	23.9	36.4	5.1	25.4	14.3	32.6	17.6	8.4	29.4	35.5	18.3	6.0	8.7	20.9	33.5	8.6	10.6	15.9	10.1	25.9	2.1	41.2	36.8	37.9	19.7	18.4	44.1	56.5	16.1	23.2	22.2	21.1	6.6	22.1	26.6	75.5	34.2	11.6	15.6	64.4	10.1	12.2	17.6	25.6
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 269.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.8"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		450000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	28.9	61.0	3.7	12.6	4.1	0.0	21.0	5.8	3.8	51.7	3.3	269.4	15.4	154.0	40.8	98.6	96.5	19.6	126.1	3.1	4.1	11.5	5.1	14.6	5.8	4.6	4.0	19.8	2.7	5.0	4.3	5.8	4.3	159.0	34.2	8.0	6.7	214.0	37.5	11.1	72.0	132.5	4.7	10.8	65.2	3.0	4.6	2.9	13.1	30.5	2.9	216.7	40.6	4.6	0.2	0.2	0.0	0.0	0.7	0.0	0.3	8.2	6.3	3.8	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	9.2	0.0	9.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.7	0.0	0.0	56.5	0.0	38.8	1.8	1.5	0.0	0.0	0.2	0.1	47.8	2.8	1.2	0.0	0.0	0.1	0.0	5.7	0.3	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	3.7	4.1	5.8	3.8	3.1	4.1	4.6	4.0	4.3	4.7	4.6	4.6	21.6	0.0	1.7	0.7	0.2	2.3	5.6	0.0	0.6	25.3	0.2	1.5	107.2	2.8	1.8	12.9	4.2	0.0	0.1	0.1	1.9	0.1	1.8	3.7	2.8	36.6	0.0	4.0	1.4	0.0	0.2	12.4	0.0	1.1	0.0	18.7	39.3	0.1	0.1	0.0	1.7	2.7	0.0	4.0	2.8	0.5	8.1	2.1	3.6	124.6	1.0	8.3	0.0	1.0	2.3	0.1	0.1	4.9	0.0	2.1	0.8	1.2	0.8	1.9	52.6	1.7	35.9	0.1	0.2	0.4	2.4	0.0	0.6	30.0	1.6	1.5
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211593-2214840	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.2"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 404.5;Early spermatids: 480.5;Late spermatids: 1591.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.42e-4)"	7.5	11.8	17.3	6.1	17.6	8.3	7.6	19.5	26.9	6.4	10.6	11.2	6.0	8.7	4.7	6.9	7.2	3.2	33.0	16.3	13.3	14.0	11.5	10.0	6.4	26.8	15.2	4.7	7.8	5.6	11.9	5.3	27.6	8.3	3.8	7.8	7.3	4.8	41.1	7.8	11.5	3.4	12.6	13.7	10.3	52.2	15.7	5.5	16.1	18.0	3.8	8.6	5.4	17.8	16.2	26.0	18.9	17.5	7.3	6.1	35.4	18.5	8.6	16.5	17.0	40.3	20.0	12.3	17.7	8.5	13.5	26.7	12.7	15.7	7.4	17.0	35.3	12.4	44.3	18.4	4.9	21.8	19.6	6.8	7.0	15.6	5.7	6.3	10.9	20.0	22.4	12.7	9.3	44.1	25.1	35.7	24.1	9.8	23.9	40.9	16.3	27.5	13.9	10.1	24.1	14.8	16.8	29.8	13.1	13.4	22.9	25.3	10.9	17.6	22.5	15.9	18.7	30.1	13.9	17.8	5.8	19.2	13.7	0.0	0.8	2.5	0.7	1.2	0.1	0.2	0.4	0.5	0.5	0.8	0.2	0.4	0.6	0.1	1.2	0.7	0.5	0.2	17.3	17.6	19.5	26.9	16.3	13.3	26.8	15.2	27.6	12.6	15.7	17.8	35.0	6.4	7.8	17.6	20.9	23.3	7.8	2.6	4.0	196.1	31.1	33.8	40.7	17.2	5.7	40.5	404.5	121.1	44.8	63.6	58.7	10.4	480.5	28.5	22.5	24.7	29.8	38.3	38.0	14.0	107.1	20.3	28.5	27.7	10.2	54.1	20.3	39.2	58.0	144.7	30.9	37.3	2.0	33.1	64.8	1591.0	25.7	37.9	35.6	7.5	20.2	63.4	42.2	11.6	21.9	14.4	32.5	28.2	36.9	21.9	34.8	39.4	3.4	220.6	39.5	19.3	94.3	162.9	64.8	12.7	31.8	54.5	30.0	70.8	50.5	15.2
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340598-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	10.1	27.8	30.1	6.9	30.2	13.1	10.3	27.0	36.7	14.9	38.3	23.5	22.4	11.1	12.8	5.5	12.7	7.9	25.1	31.0	30.6	40.8	48.4	14.3	6.5	35.6	28.9	16.5	34.2	13.9	24.4	5.2	36.2	20.3	15.6	4.2	20.4	12.9	27.1	4.9	30.3	6.4	36.2	23.5	23.6	3.8	30.2	8.2	14.6	14.4	6.3	15.9	8.3	35.5	8.7	13.6	11.1	11.2	13.7	10.8	13.5	10.2	15.9	6.9	10.2	9.7	18.4	13.4	16.7	16.8	12.3	2.3	4.4	2.3	3.8	15.9	4.8	14.7	15.0	27.9	19.4	8.7	58.5	10.9	4.9	5.3	1.0	24.6	10.4	22.8	27.5	19.7	5.8	13.9	8.9	7.0	11.3	6.0	4.2	0.1	4.1	12.1	7.5	13.5	3.9	6.1	1.9	1.1	18.4	7.2	5.1	17.3	16.1	7.9	5.3	10.4	4.4	24.3	12.6	8.2	21.0	24.0	7.4	28.4	5.5	8.1	4.8	5.8	2.9	1.9	3.4	4.5	3.5	5.5	4.2	3.8	3.1	4.8	6.8	2.3	4.2	3.9	30.1	30.2	27.0	36.7	31.0	30.6	35.6	28.9	36.2	36.2	30.2	35.5	7.5	9.6	15.0	10.4	12.2	2.3	10.2	9.5	8.6	4.7	14.3	9.8	20.9	37.1	13.2	31.3	10.4	18.6	21.2	73.9	7.9	20.7	0.8	15.2	8.6	10.0	38.9	10.7	11.3	45.4	26.6	9.6	27.5	14.7	35.4	7.9	13.6	72.5	24.1	5.0	7.9	21.0	8.2	29.0	5.4	1.7	7.8	19.3	16.0	8.4	13.1	8.9	24.7	3.5	4.3	44.4	36.5	20.3	25.8	9.2	88.2	85.7	12.3	7.0	6.6	10.3	9.0	2.9	4.7	1.8	1.1	18.7	15.2	9.4	33.4	16.9
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I like"	A6NFU8	15	98968229-99007792	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 30.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.1;Distal tubular cells: 1.9;Early spermatids: 3.8;Excitatory neurons: 3.8;Inhibitory neurons: 3.3;Late spermatids: 1.7;Skeletal myocytes: 2.1;Spermatocytes: 2.7;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041781	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.7	0.2	0.9	0.1	0.4	0.0	1.1	0.2	0.0	0.5	0.2	0.2	0.0	0.8	0.1	0.5	3.8	0.5	0.4	0.4	0.0	0.2	0.3	0.2	0.3	0.1	0.5	0.0	0.1	0.2	0.1	0.5	0.0	0.1	0.6	0.5	30.9	0.1	0.1	0.1	0.0	0.0	0.2	2.0	0.4	0.1	0.1	7.5	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	1.1	0.5	0.4	0.2	0.3	0.1	0.0	0.4	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	3.8	0.1	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.9	2.7	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101129813	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 63.9;endometrium 1: 103.4;fallopian tube: 34.3;smooth muscle: 78.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Group enriched"	"Detected in many"	5	"hypothalamus: 7.7;thalamus: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	338	"T-47d: 170.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favorable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	1.4	1.7	1.3	0.3	1.0	0.0	7.0	0.8	0.9	63.9	0.6	2.4	0.5	103.4	0.8	0.7	34.3	0.9	3.7	0.8	7.7	1.1	0.3	1.4	0.2	1.7	1.7	16.3	0.6	0.3	1.0	1.7	1.7	3.7	0.7	0.1	3.8	9.0	0.6	0.5	0.7	78.4	1.5	1.7	0.6	3.5	9.2	0.2	1.3	1.8	0.2	1.6	10.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	170.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.8	0.9	0.8	7.7	1.7	1.7	1.7	1.5	9.2	1.2	1.3	3.2	0.0	0.3	0.7	0.1	1.1	0.0	0.0	1.3	35.9	19.8	18.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	64.0	90.1	177.1	3.5	0.0	0.0	0.1	0.0	0.1	12.5	0.0	76.3	0.0	34.7	2.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	40.9	14.6	1.9	0.0	22.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	10.5	0.0	0.3	0.0	0.0	0.0	0.2	6.6	1.4	14.9	3.9	2.3	0.0	0.6	0.0	2.3	15.1	0.0	1.0
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 677.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 520.4;Theca cells: 907.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		1200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	108.0	171.3	97.9	37.5	102.5	25.1	106.0	83.8	115.5	135.4	96.3	98.2	109.3	154.5	273.3	57.0	149.0	56.9	38.6	102.3	127.0	235.4	677.4	62.1	27.6	97.2	109.3	93.3	40.2	113.9	59.1	44.9	126.1	127.6	87.3	80.5	71.4	200.4	15.7	53.2	131.9	85.2	106.1	41.4	77.1	46.5	112.8	33.4	89.0	27.0	29.3	77.3	65.0	116.9	165.6	102.4	196.3	227.7	414.2	196.9	127.1	243.0	281.0	126.1	155.7	124.5	196.6	47.3	259.5	253.8	147.3	128.3	216.5	102.1	168.8	50.8	248.7	53.7	88.5	141.0	69.0	88.4	27.5	204.7	56.5	153.8	79.2	93.5	82.6	55.7	57.2	28.8	150.3	176.5	66.9	64.7	515.8	179.4	170.3	78.5	123.1	68.5	168.7	123.9	182.9	81.7	178.1	291.7	98.9	188.2	67.4	56.2	64.2	87.6	127.7	312.6	233.6	29.9	59.2	51.0	238.8	138.6	170.6	21.0	20.1	20.4	8.7	19.9	11.8	5.8	12.0	12.9	17.0	5.5	12.0	10.1	9.1	8.8	18.4	12.0	13.4	50.2	97.9	102.5	83.8	115.5	102.3	127.0	97.2	109.3	126.1	106.1	112.8	116.9	109.1	125.0	91.4	16.0	19.0	94.1	131.3	67.4	81.4	199.1	110.8	95.1	17.1	120.1	76.7	73.5	68.8	88.2	25.8	170.5	68.4	93.0	4.2	119.7	264.2	81.9	57.7	37.6	36.5	73.0	138.6	153.1	50.4	122.4	40.5	197.0	66.4	520.4	51.8	65.6	58.5	85.0	81.4	35.0	51.2	9.0	172.1	111.1	103.2	15.0	26.5	109.8	18.6	108.6	91.3	68.9	144.7	181.7	22.6	118.8	375.5	295.1	105.4	92.4	105.2	99.2	111.1	68.2	77.2	69.3	87.7	62.1	32.1	907.9	137.6	127.9
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378649-78425114	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.1	10.0	12.6	17.9	14.9	39.6	15.4	13.3	25.3	14.2	15.8	13.0	11.7	14.9	6.0	10.8	14.0	13.2	11.1	13.0	16.6	13.8	7.0	23.5	16.9	18.0	15.4	13.9	10.9	11.5	11.5	19.7	15.6	12.4	7.8	6.6	11.9	10.8	13.5	11.5	14.7	10.3	12.9	19.8	11.4	8.9	18.8	14.0	16.4	7.6	11.6	14.5	12.0	18.1	19.9	16.7	17.8	13.5	14.6	23.0	18.8	18.3	17.2	19.3	21.2	17.8	15.8	20.2	10.8	10.8	19.4	15.5	19.8	12.5	15.1	30.3	24.1	22.2	25.0	17.5	15.2	17.7	16.9	23.6	16.1	14.6	12.6	19.1	37.8	15.9	26.0	14.2	13.2	10.8	39.5	19.5	17.4	8.5	15.9	19.4	29.6	16.8	21.0	19.5	21.4	33.2	15.4	16.4	18.5	17.8	17.4	23.8	22.8	24.9	16.6	13.5	15.4	16.0	9.5	15.2	19.1	19.0	18.7	2.1	17.7	19.3	11.0	15.0	13.6	10.3	11.6	11.7	20.6	11.9	14.5	10.6	33.9	11.2	7.2	9.4	15.1	12.0	12.6	14.9	13.3	25.3	13.0	16.6	18.0	15.4	15.6	12.9	18.8	18.1	25.9	12.8	16.8	10.1	11.6	4.5	12.0	16.3	7.4	13.0	6.4	8.8	5.8	4.3	12.0	12.9	2.1	20.2	11.2	7.7	3.9	5.8	20.0	9.0	8.7	21.5	4.2	5.5	14.8	7.0	8.1	9.7	12.2	6.7	7.6	13.3	15.0	3.9	15.4	20.2	15.0	6.1	6.1	13.9	8.3	10.8	10.5	19.2	5.4	17.8	12.1	11.0	10.3	11.6	20.4	7.2	15.6	8.6	9.4	9.2	8.0	5.2	14.4	11.4	32.9	6.8	10.8	17.9	18.4	5.8	3.8	19.3	10.8	14.7	8.5	10.9
PHACTR1	"dJ257A7.2, KIAA1733, RPEL1"	ENSG00000112137	"Phosphatase and actin regulator 1"	Q9C0D0	6	12716554-13287843	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Protein phosphatase inhibitor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;brain: 52.1"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1954.8;Inhibitory neurons: 523.7"	"Cancer enriched"	"Detected in many"	5	"melanoma: 10.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 52.1;cerebral cortex: 27.3;hippocampal formation: 14.8"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 37.8"	"Group enriched"	"Detected in many"	18	"B-cells: 13.6;dendritic cells: 37.8;granulocytes: 18.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 74.6;SK-MEL-30: 79.5;U-266/70: 176.1;U-266/84: 133.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029755, HPA029756, HPA029757"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870"	"unprognostic (7.86e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-4)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.16e-1)"	5.1	2.0	4.3	12.6	52.1	38.0	1.5	0.0	27.3	1.1	0.0	2.0	2.8	1.1	2.5	1.7	2.4	6.0	18.1	14.8	0.0	7.5	2.6	13.9	14.9	0.0	0.0	1.6	6.0	0.4	4.0	2.6	0.0	1.1	2.0	7.8	1.0	0.7	0.4	3.3	3.0	2.5	0.0	11.2	3.7	1.9	0.0	3.5	1.1	0.7	23.9	4.1	1.0	5.4	0.2	0.3	4.5	0.3	0.0	0.1	14.7	1.5	5.0	4.1	7.7	0.3	0.3	0.9	1.2	0.6	6.4	0.3	0.0	0.2	5.3	17.3	0.6	39.5	0.6	0.2	0.5	38.1	74.6	1.7	0.1	0.0	0.7	0.3	6.2	2.1	18.6	31.1	4.1	0.0	0.4	22.4	5.1	0.0	0.0	17.7	10.2	2.9	2.9	0.5	18.3	5.8	0.1	9.9	79.5	6.1	21.2	8.6	6.8	0.6	1.1	0.0	0.4	176.1	133.7	33.5	2.3	9.8	26.0	0.2	1.3	1.5	0.1	1.1	0.1	9.9	0.1	0.0	6.7	13.6	0.0	0.1	18.7	0.1	0.9	37.8	0.0	0.9	4.3	52.1	0.0	27.3	14.8	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.6	67.3	48.5	265.1	131.6	3.7	1.4	0.8	1.2	43.5	2.1	3.9	10.4	4.3	8.3	62.5	4.2	1.4	79.4	0.7	31.3	0.7	59.9	5.5	2.8	12.9	1.8	13.7	1954.8	2.9	2.3	8.6	0.5	15.0	81.2	2.7	13.6	1.1	83.1	180.0	523.7	0.2	0.0	138.2	91.5	79.8	4.7	188.5	48.0	114.3	20.5	28.4	6.2	186.5	247.8	0.8	0.2	6.4	59.6	1.0	0.3	1.0	5.1	14.0	0.0	4.0	4.3	2.0	4.8	2.1	3.1	1.9	8.6	6.6	1.0	0.8
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 164.2;placenta: 83.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	11.6	25.4	7.0	7.8	9.0	7.6	5.5	4.3	5.7	8.1	164.2	8.5	7.5	9.9	3.6	22.0	5.7	8.4	12.4	10.0	4.9	5.9	7.9	15.7	7.8	12.3	10.3	6.5	4.9	13.1	4.0	83.8	15.1	10.3	8.5	2.7	6.0	6.9	4.5	2.7	6.1	9.8	3.5	13.5	12.0	6.5	16.5	2.7	15.5	7.3	6.7	7.6	6.4	4.5	21.9	13.5	3.6	26.6	3.7	8.0	15.3	18.0	27.2	7.7	9.6	23.9	9.5	1.2	47.5	51.7	5.4	6.5	2.0	17.9	9.1	18.1	8.5	35.5	14.7	14.0	6.1	9.1	10.5	11.2	9.8	7.7	24.9	11.8	47.0	6.7	10.2	0.1	12.4	24.0	1.3	2.1	26.8	7.7	3.8	3.3	26.3	0.2	9.3	19.2	5.2	5.2	20.0	26.1	0.3	13.4	9.8	13.1	82.2	34.9	18.2	15.2	11.8	0.2	0.1	0.3	8.6	9.5	3.2	6.0	3.5	6.7	3.3	2.5	12.3	0.4	4.0	4.4	3.3	0.2	2.4	1.6	1.8	3.5	2.7	3.2	5.5	1.9	7.0	9.0	4.3	5.7	10.0	4.9	12.3	10.3	15.1	3.5	16.5	4.5	160.9	214.7	94.5	41.4	11.7	24.2	16.0	19.5	47.3	37.0	14.2	13.8	71.8	32.9	73.2	22.0	2.1	84.7	27.5	58.9	13.7	30.5	10.1	49.6	43.7	158.6	21.6	32.8	55.2	22.5	49.8	144.8	54.6	64.7	38.7	34.9	157.1	27.6	35.4	101.0	133.8	19.2	24.4	121.1	40.2	23.2	103.2	52.5	24.9	77.8	71.7	10.3	15.5	5.5	20.9	49.4	22.3	120.0	10.6	63.3	20.2	24.8	51.1	3.0	98.6	95.9	83.5	3.1	2.3	33.0	17.2	52.5	51.3	127.9	26.3	30.9
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500364	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 212.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	7.2	6.5	6.3	8.6	8.1	11.8	10.1	8.2	6.8	13.6	10.2	12.9	9.1	13.7	7.1	33.0	13.2	8.9	8.9	5.8	8.5	14.1	16.3	12.4	7.8	9.1	6.8	13.1	11.7	15.1	4.0	10.4	7.2	11.8	14.1	5.1	11.3	8.2	11.9	16.2	10.3	13.8	5.5	12.0	10.7	8.6	8.0	11.9	12.4	18.3	12.2	9.4	14.8	9.3	26.0	17.2	37.8	27.5	9.6	10.2	5.8	18.1	18.3	38.5	40.0	16.4	28.1	24.5	15.9	21.6	24.3	17.7	26.3	17.4	33.9	18.1	14.9	51.6	28.2	26.5	14.3	31.2	56.7	9.9	16.4	24.7	42.7	14.0	52.0	19.5	26.0	16.9	24.5	8.0	22.3	7.8	28.3	14.0	11.8	23.2	35.7	18.5	20.2	22.8	20.1	26.0	41.0	16.9	20.9	14.9	22.5	11.1	33.3	18.8	34.6	13.4	35.8	12.4	19.7	20.1	18.4	26.2	20.3	1.9	2.0	2.0	3.3	2.0	2.9	1.4	2.6	3.3	2.2	2.2	1.8	2.6	1.4	2.4	3.3	2.6	1.2	1.5	6.3	8.1	8.2	6.8	5.8	8.5	9.1	6.8	7.2	5.5	8.0	9.3	65.9	70.5	49.8	60.7	38.9	38.6	23.6	24.1	46.7	34.6	37.0	35.8	38.5	40.0	53.7	23.9	20.9	17.6	36.7	59.9	17.6	32.4	6.1	125.6	58.6	56.2	49.3	32.2	65.8	36.5	17.3	29.1	35.2	212.6	48.0	38.8	42.5	63.3	22.8	23.5	82.6	57.0	24.4	33.6	32.3	8.5	19.3	40.3	17.8	92.8	33.7	19.8	51.5	117.1	148.1	48.2	33.5	29.7	30.8	24.4	40.0	45.5	63.3	39.8	39.5	45.6	31.0	47.1	39.4	62.1	54.1	15.2	35.7	15.3	50.6	30.9
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600925-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	8.2	8.9	9.5	7.1	9.5	4.4	8.1	11.8	10.3	6.9	7.9	6.3	5.0	9.1	7.5	9.0	7.9	7.1	9.7	9.8	8.9	7.6	8.2	6.4	10.9	8.8	9.0	11.4	7.1	8.8	5.1	7.3	9.1	8.4	6.2	8.4	7.3	6.2	12.1	10.6	5.4	8.3	9.0	7.1	6.3	5.6	9.8	7.2	8.7	10.0	10.4	7.7	5.5	10.9	15.5	15.9	13.5	25.6	19.0	18.3	14.9	21.4	16.0	17.6	16.4	21.8	15.1	15.2	19.0	27.7	21.2	12.2	19.1	29.7	25.7	24.7	20.4	13.0	18.5	8.8	11.3	10.8	13.5	18.6	16.4	17.2	15.6	16.5	15.0	8.7	10.4	17.2	27.4	13.3	15.2	13.4	16.9	10.3	12.4	12.1	19.1	12.4	16.4	18.1	17.3	19.9	19.3	16.4	22.7	13.0	22.0	14.7	23.2	29.0	16.1	16.3	32.7	13.3	13.6	17.0	20.8	17.4	21.3	8.7	4.8	6.6	7.1	5.7	8.1	8.2	7.1	7.4	4.8	7.1	7.9	8.3	3.8	10.7	6.1	6.4	6.5	5.5	9.5	9.5	11.8	10.3	9.8	8.9	8.8	9.0	9.1	9.0	9.8	10.9	34.6	25.6	40.2	10.7	36.1	28.6	31.6	72.1	26.7	60.0	27.7	42.2	56.6	20.0	47.3	35.0	39.6	51.5	42.4	29.5	74.3	53.6	37.2	32.8	44.6	36.8	27.5	26.9	14.2	33.3	50.3	41.8	16.3	28.3	46.9	35.0	28.2	28.5	30.1	75.7	14.8	26.9	65.1	17.2	17.6	9.7	42.0	21.9	21.4	5.6	43.4	86.9	37.0	8.0	11.8	40.3	23.1	41.3	29.7	31.9	16.5	56.1	63.3	72.3	46.0	50.3	51.7	64.5	86.4	32.3	25.9	51.4	34.2	43.2	27.7	27.8
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404052-49414901	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis, Host-virus interaction"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 473.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 749.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		360000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.58e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	81.6	88.4	39.2	23.3	42.2	19.8	77.4	44.2	49.8	55.3	54.0	104.5	52.6	68.0	34.1	88.6	55.7	26.9	147.0	40.6	44.4	143.4	120.4	59.0	27.0	43.9	42.5	59.7	62.5	70.1	51.1	33.1	44.1	67.2	60.0	12.1	135.9	44.7	138.1	67.5	68.0	35.7	40.9	61.1	79.7	33.5	41.9	26.2	61.5	98.5	26.8	75.2	59.4	46.0	86.0	339.1	46.4	96.9	81.9	48.3	111.8	69.8	72.3	175.1	122.4	749.5	80.2	119.2	88.1	60.0	67.3	63.4	151.7	135.3	128.4	72.9	327.1	77.7	122.8	361.8	53.0	109.6	58.1	54.9	125.9	130.9	41.6	45.7	87.6	68.6	112.7	27.6	77.5	224.0	106.0	118.5	99.9	135.9	311.1	74.9	144.0	103.8	144.0	116.1	122.1	75.9	35.4	59.1	113.7	71.7	112.2	33.4	58.9	96.3	124.7	78.4	98.4	35.3	65.7	59.1	58.0	125.6	110.7	11.7	45.9	13.4	61.6	53.4	80.5	61.2	56.6	56.3	62.3	46.7	59.4	59.7	8.9	69.0	59.5	155.1	61.4	79.8	39.2	42.2	44.2	49.8	40.6	44.4	43.9	42.5	44.1	40.9	41.9	46.0	88.5	48.1	46.8	8.8	78.3	117.5	147.5	182.6	70.0	44.8	135.7	180.0	8.4	100.1	101.9	84.6	37.5	230.2	144.4	220.8	406.9	233.1	14.0	93.4	85.5	92.6	131.9	77.2	7.8	158.6	278.7	87.8	74.9	131.0	73.0	124.6	61.4	101.8	228.1	21.9	10.0	281.7	223.8	51.9	87.9	24.7	89.5	70.9	158.3	1.9	120.3	83.1	88.6	11.1	15.3	162.8	139.8	115.1	93.0	242.8	151.4	473.6	68.0	42.1	52.6	72.8	306.5	18.0	47.3	107.6	124.0	152.4	75.9	159.9	337.2	161.9
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970780	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		77000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	134.3	166.6	75.6	95.2	75.6	149.4	138.7	76.7	81.3	152.2	78.8	162.3	149.8	134.0	122.6	168.7	137.0	80.3	157.0	72.9	75.1	112.7	233.4	88.0	141.9	74.8	75.2	244.3	199.5	130.9	76.3	84.9	75.8	114.0	145.4	48.2	138.1	97.8	303.5	150.6	127.4	102.3	75.5	113.6	141.8	36.1	77.5	144.5	103.4	231.1	162.8	135.8	125.4	75.9	270.5	261.1	214.1	295.8	170.6	295.0	469.2	183.6	245.6	329.7	259.8	420.5	283.0	567.8	78.8	187.4	200.6	225.0	395.9	337.5	267.2	306.9	316.1	296.4	146.3	409.2	284.1	488.8	212.4	307.2	229.2	208.0	452.5	331.8	331.4	157.0	270.1	127.1	238.5	277.2	449.0	452.9	813.3	236.8	224.7	307.4	338.3	356.7	270.0	312.8	111.7	372.9	152.2	434.9	503.8	440.1	67.6	379.3	191.8	141.5	227.4	115.2	402.2	128.1	166.3	586.7	186.7	251.0	207.6	78.5	88.3	43.8	84.2	107.2	103.8	102.8	96.2	98.1	138.5	98.1	85.0	85.1	35.4	117.8	94.8	129.0	123.6	114.2	75.6	75.6	76.7	81.3	72.9	75.1	74.8	75.2	75.8	75.5	77.5	75.9	114.1	48.1	54.8	14.7	155.0	74.4	106.8	110.1	191.8	42.9	155.1	230.8	45.1	91.5	62.1	35.0	39.6	212.9	99.8	104.6	115.4	134.1	2.8	68.2	124.8	86.0	100.6	143.7	10.0	162.3	282.2	97.7	100.4	88.0	63.5	177.2	92.1	172.5	163.0	18.5	11.4	142.7	77.3	125.0	70.4	7.2	97.3	105.0	72.9	8.4	131.0	87.3	102.0	12.5	12.9	119.8	90.3	68.8	145.9	99.4	197.3	142.4	40.1	46.8	72.3	109.1	128.7	33.3	57.0	245.3	76.3	170.1	102.9	218.5	268.5	113.4
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	20.1	18.1	22.9	17.7	21.1	7.5	23.1	26.1	21.8	46.8	31.3	32.1	6.9	42.0	13.3	20.7	44.6	15.7	20.4	21.7	21.4	24.9	6.9	21.4	16.1	20.5	22.9	47.2	25.5	26.4	75.7	14.1	19.3	31.7	9.4	40.0	23.6	20.2	16.1	10.7	21.0	22.4	19.2	22.2	22.3	43.3	20.8	28.1	44.3	10.3	14.6	28.0	26.9	19.8	6.6	11.1	46.5	43.0	13.8	14.5	141.8	6.6	13.7	11.3	14.7	7.4	10.5	17.4	5.7	11.3	17.4	5.8	12.9	15.4	15.2	60.8	7.5	22.8	14.5	7.5	15.0	12.4	38.5	18.0	8.0	18.1	18.1	36.2	13.7	19.8	4.6	6.4	11.5	8.2	15.8	22.1	492.6	2.5	3.7	25.1	31.3	0.9	12.3	29.0	9.0	32.1	10.4	23.4	17.4	178.3	3.4	12.4	7.8	20.8	34.5	13.2	9.6	12.8	8.9	24.9	9.3	6.7	14.4	0.6	0.2	0.0	0.8	1.1	0.5	1.1	1.2	1.5	0.1	0.9	1.2	0.9	0.0	0.8	2.8	1.2	0.8	0.8	22.9	21.1	26.1	21.8	21.7	21.4	20.5	22.9	19.3	19.2	20.8	19.8	11.9	16.0	19.8	48.3	7.7	2.4	5.5	4.6	9.1	24.2	10.8	11.2	0.5	11.5	13.1	9.2	27.1	5.9	10.1	0.8	1.9	5.4	26.4	20.0	17.4	11.0	11.4	9.5	36.4	5.2	11.5	11.8	5.1	10.6	19.0	15.5	8.6	2.0	4.4	16.8	44.0	2.7	4.1	5.4	3.9	17.6	14.3	6.0	7.2	12.2	3.2	17.7	7.2	23.1	13.0	4.6	1.9	12.0	3.0	4.5	0.7	5.3	19.2	36.8	0.0	15.8	12.2	17.7	25.1	10.2	2.4	5.1	11.2	8.7	2.0	4.9
PHC2	"EDR2, HPH2"	ENSG00000134686	"Polyhomeotic homolog 2"	Q8IXK0	1	33323623-33431052	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047403	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047403: AB_10964220"	"unprognostic (8.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	114.4	87.1	57.1	52.1	66.9	50.6	103.8	62.5	64.3	87.1	73.5	104.3	26.0	86.3	27.9	50.7	86.2	49.2	113.1	56.0	63.6	141.7	124.9	135.0	31.3	79.7	67.7	66.9	54.8	33.4	70.5	46.2	68.9	79.9	27.9	51.1	68.8	44.6	260.0	68.2	64.2	60.2	64.5	118.9	92.7	62.2	67.1	40.4	81.7	74.7	23.9	97.2	63.5	72.5	53.0	34.0	145.3	56.0	149.3	169.9	43.2	51.4	111.1	70.0	76.5	21.5	115.2	47.2	42.4	81.3	56.7	27.4	29.2	88.0	67.2	22.9	26.6	31.5	15.7	54.9	229.2	38.8	29.1	279.3	53.4	126.3	99.0	133.2	93.9	44.9	28.3	35.1	185.1	21.8	84.8	39.7	33.1	89.4	97.8	95.0	60.4	26.3	128.4	39.5	88.3	81.0	40.2	39.9	204.7	60.7	19.9	49.5	93.8	69.5	35.0	59.9	98.1	24.3	18.0	35.6	165.5	40.7	195.3	10.5	6.6	3.4	2.0	6.7	1.6	1.4	2.2	1.8	3.4	1.2	2.6	1.4	93.4	2.1	8.3	3.9	1.6	2.2	57.1	66.9	62.5	64.3	56.0	63.6	79.7	67.7	68.9	64.5	67.1	72.5	89.3	16.0	13.9	24.2	5.6	14.1	28.9	16.2	4.6	75.9	24.1	30.9	31.8	25.8	13.2	35.0	68.8	11.3	17.4	19.5	17.6	34.4	58.2	18.7	40.2	43.0	37.7	17.4	60.7	44.4	9.2	32.9	14.8	28.5	6.3	39.4	47.8	55.6	21.4	62.2	82.0	21.9	18.3	75.7	14.1	72.9	29.2	55.3	21.4	61.8	18.4	58.5	8.2	91.0	117.2	85.8	11.0	29.7	2.5	23.8	11.2	31.7	14.8	78.5	13.1	24.2	48.7	14.2	8.6	7.9	10.9	11.5	11.4	30.0	20.0	30.9
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039162: AB_10671038, HPA062031: AB_2684666"	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	9.1	7.4	3.7	12.7	9.1	50.8	10.5	29.3	8.9	9.0	6.3	10.5	11.2	12.2	8.1	12.4	10.2	12.9	8.1	2.0	14.3	9.7	8.7	9.7	18.1	6.5	2.9	14.9	11.3	15.1	5.4	8.4	7.8	11.6	11.3	42.0	8.9	8.6	8.7	8.5	12.3	13.5	0.0	13.9	11.8	11.5	5.5	16.8	16.6	14.0	14.1	11.8	7.4	14.0	35.0	32.3	6.9	11.6	19.2	19.4	12.8	14.6	16.5	14.8	18.2	21.6	17.0	16.5	34.8	20.5	19.7	17.1	15.3	14.1	26.6	38.3	14.2	28.5	30.2	10.0	11.3	35.4	14.8	14.0	8.1	22.1	31.0	10.9	11.1	12.7	6.9	45.0	14.6	32.3	16.2	7.4	7.2	11.3	11.9	12.0	29.5	24.0	7.4	38.7	7.5	4.6	48.1	29.8	9.8	4.5	34.6	27.0	22.3	20.5	12.1	17.1	25.4	43.0	37.6	48.1	12.8	13.1	12.6	9.5	7.0	25.7	16.2	11.2	13.8	16.8	15.2	14.1	7.8	21.6	15.6	13.8	10.2	13.3	7.3	26.0	20.2	7.5	3.7	9.1	29.3	8.9	2.0	14.3	6.5	2.9	7.8	0.0	5.5	14.0	26.8	22.4	31.9	77.4	46.2	14.1	16.9	16.1	19.9	36.3	16.4	12.1	22.7	18.6	18.7	27.6	60.5	15.5	45.9	11.1	0.0	8.9	5.5	18.7	34.5	21.3	7.8	28.8	108.2	7.5	9.6	25.1	25.0	19.0	12.7	35.9	19.6	17.8	11.1	53.8	103.2	14.1	16.2	21.6	22.6	3.8	29.5	22.5	19.6	105.9	25.5	21.9	32.0	103.0	156.5	10.4	16.7	27.8	45.6	22.8	16.4	10.7	24.1	126.2	6.6	29.8	26.4	21.0	19.3	17.8	15.9	18.3	40.4	25.7	14.4	19.6
PHETA2	"DKFZp686J07229, FAM109B, IPIP27B, SES2"	ENSG00000177096	"PH domain containing endocytic trafficking adaptor 2"	Q6ICB4	22	42074248-42079438	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 14.1;Endometrial stromal cells: 10.3;Extravillous trophoblasts: 27.4;Syncytiotrophoblasts: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 20.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;fHDF/TERT166: 33.7;HSkMC: 32.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA000647	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA000647: AB_1078800"	"unprognostic (4.96e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	11.1	4.3	2.8	6.6	2.7	4.6	9.7	2.5	2.8	12.2	4.3	11.4	6.0	15.4	2.8	9.6	9.8	8.2	8.5	2.5	2.8	7.1	1.9	9.7	4.1	3.1	2.7	5.2	18.2	4.8	5.8	15.6	2.8	9.9	8.5	0.4	12.7	7.6	2.5	8.3	9.4	12.9	3.1	7.8	13.4	2.5	2.8	2.4	5.8	3.1	4.2	11.3	9.1	2.8	0.1	0.0	0.0	0.2	30.9	36.8	0.2	21.4	17.5	13.0	12.9	22.6	20.5	0.1	13.1	33.7	0.0	3.7	0.1	0.2	6.9	0.0	0.0	0.0	29.1	0.2	17.6	0.0	17.1	32.3	9.5	20.1	2.5	0.0	29.3	0.3	0.2	0.0	14.1	0.4	0.1	0.2	2.4	1.1	0.0	0.2	0.1	0.3	5.9	0.0	0.2	0.2	9.2	0.1	0.1	0.2	14.1	0.0	30.0	0.2	13.8	31.5	0.1	0.5	0.5	0.3	0.0	0.4	24.0	20.0	4.3	1.7	1.3	4.9	0.2	0.5	0.8	1.0	8.4	0.2	0.6	1.2	0.3	0.7	2.8	3.9	0.6	3.2	2.8	2.7	2.5	2.8	2.5	2.8	3.1	2.7	2.8	3.1	2.8	2.8	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.4	0.0	0.0	0.0	0.0	0.0	14.1	0.2	0.0	3.9	5.7	0.0	1.1	10.3	3.0	0.0	0.0	0.0	7.0	27.4	6.6	0.0	2.8	0.0	3.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	22.2	0.2	3.6	0.0	0.0
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	35.0	31.9	0.3	4.6	0.2	11.2	37.6	0.2	1.1	65.8	0.4	49.6	5.9	51.8	18.1	19.4	57.8	4.2	41.6	0.3	0.2	38.2	22.8	41.1	6.3	0.6	0.2	89.6	41.5	2.1	76.6	1.8	0.3	49.9	2.3	6.1	32.8	4.2	42.2	25.5	38.6	2.6	0.3	47.3	39.7	70.2	0.3	5.5	58.4	13.1	10.3	49.1	40.6	0.6	1.4	2.0	4.5	2.8	1.9	1.1	10.3	3.1	4.8	2.5	2.6	2.8	1.3	0.5	2.0	7.4	25.9	0.4	0.9	1.6	0.6	1.8	0.9	4.3	3.6	1.2	0.3	2.5	20.0	2.2	2.0	4.6	4.0	3.3	1.5	1.4	1.7	3.6	1.9	1.1	0.8	1.5	1.9	0.4	1.4	1.8	0.6	1.5	0.3	1.9	2.9	3.3	1.6	1.6	2.6	1.0	1.2	3.0	3.0	4.5	1.2	2.7	3.4	2.9	4.5	8.3	3.3	2.6	2.7	0.2	0.2	1.0	0.7	0.2	2.1	0.6	1.6	1.9	0.3	0.9	1.6	0.9	1.5	0.7	0.2	0.1	0.6	0.7	0.3	0.2	0.2	1.1	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.6	32.9	19.2	24.8	19.2	70.5	33.9	89.0	26.8	34.1	74.4	36.0	37.1	19.6	15.7	20.5	23.9	37.5	16.9	53.3	16.7	35.2	13.1	153.8	14.9	15.3	29.9	12.0	3.8	19.1	17.9	16.3	32.6	15.3	20.3	69.2	21.4	33.2	7.6	11.8	45.4	30.3	16.0	34.6	14.1	43.1	88.6	43.2	20.9	37.4	13.1	11.4	34.7	27.8	26.2	18.0	17.9	14.5	41.0	54.8	59.0	29.6	22.9	22.1	73.6	78.9	28.9	42.3	80.9	51.2	15.9	24.0	37.5	71.4	19.1	10.1	75.1
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703902-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	41.9	78.5	49.1	39.0	55.4	53.4	40.9	52.2	53.9	43.1	46.3	49.2	32.3	40.0	39.2	46.7	39.7	34.6	46.5	43.0	54.2	38.4	52.4	40.4	61.7	52.5	56.2	80.7	41.0	47.7	36.3	43.7	54.8	48.4	34.6	59.1	44.5	44.7	81.3	50.9	40.7	33.4	56.6	49.8	42.7	41.7	55.0	53.2	48.6	63.7	61.3	42.3	41.9	57.4	31.2	30.7	119.2	125.5	40.7	24.5	49.0	41.2	37.3	49.8	54.3	88.9	31.4	91.1	24.4	29.2	31.7	38.4	92.5	45.3	72.0	73.3	82.1	91.1	54.8	116.9	41.5	134.2	5.4	18.5	46.7	32.1	29.4	82.3	80.2	64.4	102.7	57.5	36.0	53.4	25.6	115.0	37.6	68.3	18.9	121.0	84.4	73.7	62.1	32.5	56.7	75.9	56.4	18.4	41.5	49.7	36.3	158.6	54.0	28.1	46.6	36.3	53.2	50.7	46.1	112.3	36.7	88.6	45.6	1.6	1.4	3.2	1.5	1.5	1.4	2.6	2.7	2.1	1.4	1.7	2.6	2.8	0.2	1.2	1.6	1.2	1.8	0.8	49.1	55.4	52.2	53.9	43.0	54.2	52.5	56.2	54.8	56.6	55.0	57.4	42.5	25.6	30.1	17.9	24.5	29.8	22.7	13.3	13.1	12.1	38.1	31.8	59.3	35.8	23.7	11.0	41.7	14.8	25.9	11.0	13.7	12.5	15.3	32.1	27.4	28.2	25.9	7.4	14.9	12.6	8.9	27.6	12.8	42.1	6.3	38.1	29.3	27.5	11.6	11.8	19.0	22.8	18.3	13.9	28.7	9.7	22.4	21.5	19.6	28.1	11.8	33.4	10.3	17.6	33.6	17.1	19.4	21.1	16.4	27.6	18.6	12.4	22.7	26.8	19.7	27.9	53.1	18.9	22.0	21.2	23.4	17.4	21.2	33.2	20.0	27.4
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 40.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021410: AB_1855287, HPA021452: AB_2670708"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	13.7	11.0	11.6	15.6	12.6	39.9	14.4	14.1	12.1	17.9	7.2	18.2	11.5	18.7	14.0	10.6	17.2	11.0	11.0	10.7	11.9	12.3	14.7	16.7	18.2	11.5	11.1	17.9	19.1	13.8	16.9	10.9	9.1	21.8	11.4	14.9	15.7	17.0	15.7	15.2	17.7	14.6	7.2	22.9	14.8	9.9	11.3	25.3	17.0	14.2	17.2	16.8	13.8	14.0	15.0	24.4	33.1	19.8	18.6	13.8	15.0	14.6	22.0	23.0	21.2	16.9	14.3	17.3	17.9	17.4	19.0	15.9	21.5	13.0	21.8	27.9	22.5	18.8	27.2	13.2	16.8	20.5	22.7	15.8	13.8	20.9	19.0	21.3	16.7	23.0	16.0	18.6	14.2	16.6	38.3	26.7	19.0	33.6	10.4	38.2	26.8	17.6	15.2	19.3	22.8	18.7	22.6	35.7	17.6	17.5	19.6	26.6	9.9	18.9	16.8	18.2	18.4	21.9	19.9	20.2	14.7	15.2	19.5	25.2	4.4	7.2	6.3	3.6	6.1	4.4	4.9	6.6	2.5	6.5	4.4	5.2	40.1	6.3	4.3	8.2	3.1	2.9	11.6	12.6	14.1	12.1	10.7	11.9	11.5	11.1	9.1	7.2	11.3	14.0	13.1	16.0	8.6	27.1	24.7	15.3	8.5	7.5	26.7	22.7	17.6	15.1	6.9	8.6	12.2	3.7	14.6	7.9	24.5	12.0	1.9	9.1	9.5	17.5	16.4	14.4	10.7	27.0	16.3	10.4	7.6	11.9	12.8	23.8	14.5	14.4	14.3	11.7	9.2	25.2	18.6	16.5	12.2	15.7	18.9	7.4	17.1	16.5	12.4	27.2	20.0	12.9	17.5	30.2	31.3	9.7	6.5	16.6	31.4	27.1	8.9	5.9	8.1	21.3	26.3	11.2	17.2	13.5	12.6	22.2	16.3	6.0	35.3	11.4	10.8	14.0
PHF13	MGC43399	ENSG00000116273	"PHD finger protein 13"	Q86YI8	1	6613731-6624030	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026830	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA026830: AB_1855288"	"unprognostic (6.59e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.05e-1)"	11.5	8.9	7.9	4.7	7.6	9.5	11.4	7.0	8.5	18.5	7.2	16.5	5.2	17.1	10.1	15.1	15.2	10.5	8.3	8.0	8.6	7.7	12.3	10.0	6.2	8.4	8.0	14.1	10.0	9.8	9.9	7.9	7.4	11.4	3.4	6.2	9.6	10.5	10.0	14.4	7.7	8.0	7.4	7.0	9.6	34.0	9.4	8.7	8.8	6.9	5.8	12.3	14.4	8.8	19.2	8.9	25.8	31.8	13.0	17.7	15.1	29.0	21.2	22.5	20.4	17.7	18.2	17.2	11.1	22.2	13.9	15.9	17.1	18.6	22.1	22.9	22.3	26.3	14.3	15.1	13.6	7.0	16.9	19.8	7.9	21.6	10.1	24.9	14.0	16.0	31.7	12.1	19.4	21.3	16.4	19.8	19.1	10.1	15.3	27.7	20.3	9.3	12.2	9.8	18.3	22.7	12.4	21.5	19.1	17.7	17.2	13.4	14.9	39.1	19.1	16.3	14.3	25.2	26.1	29.0	21.6	18.0	8.5	2.3	1.3	4.6	2.4	1.2	3.6	1.5	3.0	2.3	1.3	1.4	2.0	2.4	4.1	2.8	2.0	1.2	2.5	2.3	7.9	7.6	7.0	8.5	8.0	8.6	8.4	8.0	7.4	7.4	9.4	8.8	11.8	3.2	5.0	8.5	8.9	37.5	18.0	7.8	62.0	7.2	23.9	14.7	5.6	5.7	4.5	3.7	0.0	11.4	8.1	4.3	9.8	6.2	7.9	11.5	17.6	10.2	7.8	12.0	3.0	3.7	12.2	15.1	4.6	14.3	5.1	9.6	8.2	9.5	4.3	18.5	3.9	4.2	2.0	4.1	19.1	7.4	10.5	5.0	16.0	1.9	4.5	10.6	1.0	3.0	5.0	5.8	2.2	7.9	8.0	17.5	3.6	4.6	5.4	6.0	26.3	12.1	15.1	14.7	33.2	41.1	40.2	21.2	9.5	8.4	2.8	12.0
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169623	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: AB_2732420"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	9.9	8.0	17.2	8.6	15.6	5.5	13.7	17.5	26.9	9.1	12.7	9.8	8.2	13.1	7.8	8.4	8.8	9.3	5.3	17.0	16.1	10.0	11.4	8.6	9.9	16.5	16.7	14.5	7.1	9.5	7.9	8.4	17.3	10.0	10.4	6.7	7.9	8.1	6.0	8.5	8.2	11.0	14.2	10.3	10.3	9.3	16.0	17.8	9.2	7.8	10.2	9.2	7.6	16.9	16.4	32.8	46.4	49.2	16.2	15.6	23.1	12.6	10.0	14.5	15.9	29.5	28.9	62.4	22.7	11.7	32.7	22.8	42.4	14.6	16.0	23.1	17.3	31.1	28.1	38.0	14.8	70.2	28.8	14.2	15.0	17.3	30.9	20.4	21.2	24.2	42.4	21.6	17.6	21.6	28.0	30.4	39.3	68.1	24.4	45.9	30.3	19.8	15.0	30.6	42.2	58.3	19.5	64.6	21.1	33.6	34.6	50.1	20.6	20.3	27.1	13.6	25.0	27.7	51.1	43.2	14.4	57.8	48.6	1.0	0.9	0.6	1.3	0.8	1.0	1.8	1.4	1.6	0.5	1.4	1.9	1.7	0.0	1.4	0.8	2.7	1.9	0.4	17.2	15.6	17.5	26.9	17.0	16.1	16.5	16.7	17.3	14.2	16.0	16.9	80.6	41.7	41.6	141.0	66.9	57.5	68.6	27.5	68.9	92.7	80.3	91.3	22.7	37.1	44.2	33.1	58.4	68.8	58.4	54.6	27.4	92.0	23.9	40.9	82.7	77.4	92.2	46.9	223.8	84.3	80.9	65.9	55.5	48.1	56.5	103.7	64.2	43.6	42.1	79.1	260.6	72.3	42.7	39.6	24.7	16.2	102.9	39.1	37.4	116.2	58.0	36.5	87.6	263.4	200.8	90.4	45.9	116.9	34.3	82.0	46.0	35.9	28.0	63.3	52.6	71.0	67.6	142.3	133.7	56.5	52.4	39.8	58.6	73.7	72.0	54.2
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576584-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 155.2;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	22.6	15.8	27.6	11.6	30.7	17.3	23.5	32.1	28.1	31.1	23.2	28.8	10.1	29.6	13.2	19.4	27.4	11.9	28.1	25.9	28.2	16.5	14.3	24.0	13.5	30.4	30.0	34.2	21.7	17.2	29.7	15.9	29.2	24.9	9.3	13.8	21.1	17.8	28.7	23.2	18.7	14.6	27.5	23.9	22.9	15.1	28.6	18.6	25.7	21.2	10.0	24.5	26.3	34.4	16.1	13.6	27.9	22.6	17.4	13.5	14.0	12.8	17.0	18.2	12.9	6.4	9.3	11.7	9.0	16.7	16.3	30.6	17.7	12.3	9.6	31.8	11.5	9.6	15.9	9.7	15.0	18.8	31.3	13.7	20.2	8.6	14.4	17.7	14.6	17.7	14.2	19.6	12.5	36.1	35.9	20.3	7.2	28.3	11.5	40.4	21.4	4.6	11.4	20.5	36.4	17.6	13.4	21.1	11.7	8.0	14.4	31.9	17.2	16.9	14.3	18.6	18.3	15.3	2.7	8.6	9.3	11.3	19.6	0.4	0.8	0.8	0.9	0.4	0.9	0.5	1.0	0.6	0.8	0.8	1.0	1.2	1.6	0.3	0.6	1.2	0.6	0.7	27.6	30.7	32.1	28.1	25.9	28.2	30.4	30.0	29.2	27.5	28.6	34.4	18.4	16.0	13.7	13.7	7.5	7.6	6.6	7.1	4.6	14.4	13.3	11.0	15.5	4.3	16.0	5.5	8.4	7.3	9.8	7.5	0.0	5.6	155.2	13.2	14.0	15.0	16.3	9.9	11.9	5.6	3.5	13.3	10.2	13.3	17.1	8.4	13.2	7.6	5.8	10.1	16.0	7.3	8.2	12.4	10.0	575.3	19.9	10.2	3.6	12.2	9.0	9.6	5.2	20.1	28.8	6.1	3.8	20.3	3.9	8.7	4.1	3.2	16.4	7.9	19.7	15.0	13.4	1.8	3.4	7.8	8.0	6.0	9.6	4.9	7.6	8.2
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	12.1	14.0	8.0	13.5	9.6	24.9	10.9	10.4	11.3	11.6	9.9	9.2	9.4	11.4	10.0	11.6	7.9	10.7	17.5	8.0	6.4	10.7	13.4	10.3	11.8	6.5	6.7	11.3	8.9	15.7	8.7	12.4	6.7	9.9	10.1	12.5	9.6	8.0	16.7	7.7	9.9	11.5	5.7	11.5	9.3	13.5	7.2	25.6	22.7	18.5	12.4	12.8	8.9	9.8	20.9	20.6	33.1	19.1	25.3	29.9	11.9	30.1	23.4	20.2	19.7	11.5	14.0	23.8	25.6	30.3	17.4	12.0	22.5	16.0	24.9	40.4	16.1	25.5	24.3	8.2	26.6	20.7	17.6	22.5	19.4	21.1	31.1	19.5	22.6	37.2	32.1	36.4	30.4	21.0	67.6	9.2	14.7	23.8	27.1	32.6	22.1	20.6	16.5	17.8	81.4	23.8	19.1	13.5	24.5	13.8	26.5	23.0	29.6	32.6	25.9	21.5	29.1	21.5	29.9	30.3	28.8	35.8	29.6	3.5	3.8	7.0	2.1	2.4	2.1	2.1	1.9	2.5	3.6	2.2	2.8	2.2	12.6	3.0	3.6	2.9	2.5	1.5	8.0	9.6	10.4	11.3	8.0	6.4	6.5	6.7	6.7	5.7	7.2	9.8	65.9	25.6	51.6	74.4	51.1	33.6	52.6	48.2	40.9	55.7	40.5	38.0	88.5	25.8	57.2	36.8	43.8	29.7	92.9	35.1	23.5	37.3	81.2	39.8	73.4	55.2	43.7	37.9	133.9	31.3	32.0	51.6	41.8	48.9	60.2	60.1	36.0	33.4	36.6	53.8	192.2	29.0	44.7	39.6	49.3	49.5	40.0	84.2	23.2	83.4	67.5	50.9	78.2	104.5	117.5	40.6	26.4	42.9	66.6	40.4	41.5	25.7	30.8	54.1	46.0	68.1	58.9	115.1	45.9	44.9	36.2	45.0	65.8	61.4	30.9	66.7
PHF21A	"BHC80, BM-006, KIAA1696"	ENSG00000135365	"PHD finger protein 21A"	Q96BD5	11	45929319-46121454	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 172.4;Excitatory neurons: 171.0;Inhibitory neurons: 140.0;Microglial cells: 138.7;Oligodendrocyte precursor cells: 250.3;Oligodendrocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 34.9;neutrophil: 31.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 34.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023253, HPA023580"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023253: , HPA023580: AB_10962727"	"unprognostic (5.30e-3)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (2.59e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.21e-1)"	13.1	17.4	18.5	20.5	25.1	28.8	11.0	39.1	23.8	12.9	5.4	18.5	7.0	17.2	10.7	11.4	12.9	12.6	17.4	13.2	20.7	7.9	8.0	17.3	16.8	17.0	17.9	24.1	8.6	16.5	12.8	13.1	15.8	12.1	9.5	16.7	9.9	11.3	15.3	13.5	10.4	16.7	12.0	17.4	10.0	23.7	26.8	17.8	12.8	12.8	14.8	14.0	11.6	27.3	7.3	19.1	36.8	35.6	14.8	22.5	4.9	14.6	25.4	12.3	20.5	3.7	11.2	30.4	10.3	14.2	19.3	8.2	22.0	9.4	12.4	34.0	15.3	17.2	19.9	7.7	17.6	12.5	25.9	20.6	21.3	7.1	20.2	30.2	18.4	21.1	21.0	48.2	14.5	6.9	13.6	20.6	31.9	9.3	11.3	22.8	18.2	10.4	12.6	12.2	24.1	31.7	21.6	10.9	16.0	23.6	19.7	23.5	18.8	20.2	16.3	16.9	12.0	52.5	46.2	20.8	16.1	13.6	16.3	34.9	7.8	4.1	6.1	3.9	5.1	5.0	4.7	5.4	4.3	4.2	2.8	4.8	31.3	5.6	7.2	2.9	6.0	4.1	18.5	25.1	39.1	23.8	13.2	20.7	17.0	17.9	15.8	12.0	26.8	27.3	13.9	12.8	17.7	172.4	25.2	10.3	8.8	11.2	22.2	25.5	11.8	12.1	25.7	10.0	10.5	3.7	27.1	4.3	26.1	4.8	1.9	10.0	9.0	10.3	26.8	15.0	23.4	18.7	171.0	6.3	3.4	18.3	12.8	11.1	16.5	30.1	12.5	5.5	10.0	15.2	140.0	6.8	4.1	25.4	12.4	8.2	26.1	23.9	10.6	138.7	35.6	7.9	37.0	250.3	231.3	5.5	6.5	14.7	21.8	7.6	5.6	3.9	15.4	23.3	13.1	18.6	18.8	16.9	16.9	19.0	8.8	4.2	19.5	19.2	6.2	5.7
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45010005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.2	1.2	6.7	0.1	7.9	0.0	0.4	4.8	6.1	9.0	1.5	0.2	0.1	3.2	0.4	0.4	2.5	0.1	0.9	5.1	5.1	2.6	0.0	0.1	0.0	8.5	8.3	4.0	0.5	0.9	18.9	0.0	5.2	5.2	0.0	6.1	0.3	0.5	0.2	0.1	0.2	0.7	4.4	0.1	0.6	5.4	6.8	0.2	2.0	0.3	0.0	0.2	3.2	4.7	0.0	0.0	11.2	10.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.1	2.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.6	0.0	0.0	8.8	0.0	0.0	0.1	0.9	1.3	0.0	6.7	0.0	0.4	0.0	2.6	0.2	0.0	0.1	8.7	37.5	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.5	8.5	0.0	0.2	0.4	0.0	5.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	4.8	6.1	5.1	5.1	8.5	8.3	5.2	4.4	6.8	4.7	0.0	0.0	0.0	96.6	0.0	0.1	0.6	0.0	0.0	14.1	0.0	0.3	2.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	1.9	0.0	16.2	0.1	3.2	0.4	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.0	0.0	0.1	28.6	9.1	0.0	0.0	0.0	0.0	41.9	0.6	0.1	0.0	5.6	0.0	5.0	0.0	29.1	9.3	0.1	0.0	1.9	0.0	1.7	0.0	0.0	0.7	23.3	0.0	1.1	0.5	1.2	2.9	0.0	0.0	0.0	0.3	1.9	0.0	0.1
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235029-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA052410: AB_2681822"	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	22.0	39.6	21.3	24.5	21.0	10.1	19.1	21.6	25.1	22.3	20.7	24.2	22.8	23.6	23.3	35.3	20.2	20.2	18.0	22.7	23.1	22.5	26.3	18.3	30.4	25.4	30.3	19.0	17.9	24.3	20.8	23.0	25.1	24.0	17.7	15.2	19.1	22.8	22.6	19.3	21.4	22.9	21.8	28.4	19.7	24.8	23.1	36.7	24.3	21.9	34.2	29.1	23.3	22.9	49.6	78.1	85.2	56.0	54.4	54.7	33.4	65.8	72.2	78.5	66.7	42.5	34.2	72.5	39.7	71.2	55.4	46.6	81.1	54.1	64.6	73.7	67.4	54.6	51.5	47.8	87.5	26.4	82.7	75.9	51.5	68.4	45.6	82.3	75.6	34.8	61.1	17.4	92.7	37.9	45.7	53.5	80.7	35.7	34.3	61.5	41.5	35.4	83.9	27.4	28.0	89.0	47.0	37.9	75.2	50.9	46.0	30.7	69.5	69.0	47.9	41.2	82.8	32.0	35.2	37.6	62.0	42.9	60.6	23.1	8.2	15.5	16.2	6.6	13.9	12.0	12.3	17.9	9.3	15.6	10.0	12.5	15.9	10.7	9.5	16.7	11.2	7.9	21.3	21.0	21.6	25.1	22.7	23.1	25.4	30.3	25.1	21.8	23.1	22.9	22.3	6.4	9.2	2.0	21.9	84.1	22.7	21.6	56.9	13.6	36.5	17.7	18.7	15.7	17.2	22.0	6.2	32.1	31.2	24.0	39.2	39.2	19.8	20.2	25.7	26.0	18.6	33.6	3.7	21.5	21.0	20.0	8.6	22.1	17.7	15.2	17.5	13.8	37.0	16.8	2.8	18.5	26.4	20.9	40.3	24.8	24.8	20.8	33.8	4.7	37.3	14.5	35.0	3.5	2.5	35.1	26.0	17.3	23.7	28.9	16.6	30.1	11.4	11.0	39.5	14.8	29.1	30.9	22.4	39.2	83.3	76.8	21.3	30.5	16.5	27.1
PHF24	KIAA1045	ENSG00000122733	"PHD finger protein 24"	Q9UPV7	9	34957608-34982544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 44.8;testis: 16.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Cone photoreceptor cells: 8.4;Early spermatids: 3.9;Late spermatids: 7.9;Muller glia cells: 14.2;Spermatocytes: 4.9;Spermatogonia: 4.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020974	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA020974: AB_1852364"	"unprognostic (5.54e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.30e-1)"	0.7	0.2	20.6	0.4	27.8	0.0	0.6	0.0	44.8	0.3	0.0	0.5	0.1	0.5	0.2	0.2	0.4	0.2	0.2	25.5	1.6	0.2	0.1	0.2	1.0	10.5	7.3	0.1	0.0	0.0	0.4	0.0	10.0	0.1	0.2	6.7	0.1	0.0	0.1	0.9	0.5	0.4	0.6	0.2	0.3	16.1	9.4	0.7	0.4	0.0	0.8	0.1	0.3	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	20.6	27.8	0.0	44.8	25.5	1.6	10.5	7.3	10.0	0.6	9.4	21.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	1.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.2	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.1	0.4	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PHF3		ENSG00000118482	"PHD finger protein 3"	Q92576	6	63635802-63779336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024676, HPA025763"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024676: AB_10599736, HPA025763: AB_10600987"	"unprognostic (4.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.37e-1)"	19.6	18.2	12.5	16.9	18.9	39.5	21.4	32.2	15.3	20.6	11.7	16.7	16.0	22.8	17.5	12.8	16.7	16.1	13.7	11.0	15.4	19.7	28.0	16.0	21.6	17.4	13.7	32.2	18.4	23.8	12.2	24.3	19.4	18.2	17.6	27.7	15.2	15.9	20.3	16.5	16.1	15.5	14.5	21.3	18.3	14.3	14.7	30.6	26.1	22.9	18.1	15.4	16.8	30.5	35.8	17.5	28.1	17.0	27.3	29.6	28.6	23.0	32.5	16.9	22.3	24.0	16.6	44.0	19.3	20.7	24.4	15.3	27.7	23.9	27.8	35.2	23.3	52.5	21.7	38.2	24.7	45.3	20.7	21.4	21.2	24.0	34.1	29.1	19.8	23.0	58.4	39.9	17.4	21.2	19.5	23.9	16.3	22.9	10.4	33.7	25.6	21.2	20.5	21.0	30.8	22.7	27.7	12.5	20.1	30.7	21.3	41.2	28.2	25.9	30.4	20.0	27.6	33.9	37.6	41.0	11.9	35.6	20.3	15.5	6.2	7.1	7.6	8.0	7.4	7.3	7.1	6.1	5.5	8.9	10.0	7.6	14.4	5.0	11.5	6.7	5.5	4.4	12.5	18.9	32.2	15.3	11.0	15.4	17.4	13.7	19.4	14.5	14.7	30.5	87.9	157.0	133.2	76.0	108.0	54.9	62.1	42.2	71.7	67.9	49.4	56.8	95.2	34.3	88.6	46.0	47.9	47.6	91.2	50.1	15.6	48.4	40.5	68.8	93.7	61.1	43.1	63.1	71.1	37.6	31.5	77.2	60.6	84.3	103.0	85.5	41.7	47.1	28.8	50.5	80.5	46.1	28.5	46.2	33.2	26.5	81.1	65.3	23.2	70.3	69.6	47.4	74.2	76.9	129.8	29.8	40.5	56.8	92.4	64.1	55.5	36.4	72.9	66.8	59.2	103.7	58.5	103.0	69.3	48.4	42.9	31.2	97.1	114.2	49.4	51.0
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468692	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	26.0	21.1	26.5	23.0	29.7	58.2	27.7	30.0	30.6	23.3	28.9	25.1	22.7	22.9	26.0	29.0	22.8	19.6	20.9	26.7	28.5	25.5	30.9	20.1	35.5	28.9	28.5	20.7	26.2	25.1	21.5	25.6	29.7	19.7	28.8	24.5	21.0	19.1	35.8	27.7	22.4	22.6	28.8	26.4	26.0	18.8	28.2	52.2	19.7	29.0	41.9	30.6	23.7	33.9	80.5	56.8	95.0	62.8	68.7	51.7	65.9	80.1	65.5	102.9	86.4	78.4	46.5	115.4	45.7	60.1	72.1	60.7	130.2	95.3	115.6	71.7	136.5	71.8	86.9	92.2	71.9	190.3	54.9	50.4	72.9	81.3	100.5	41.7	73.8	80.6	97.5	71.8	74.9	107.5	154.8	124.3	96.1	220.8	82.2	115.4	84.9	81.5	68.6	63.1	46.6	38.9	87.9	57.4	90.0	66.6	45.9	96.8	50.7	54.0	95.6	44.1	97.9	58.9	112.3	194.9	52.2	82.6	59.0	32.8	47.0	57.9	36.0	45.2	47.2	47.6	41.1	45.6	49.2	42.6	40.2	39.5	55.6	47.6	44.1	41.7	47.8	59.3	26.5	29.7	30.0	30.6	26.7	28.5	28.9	28.5	29.7	28.8	28.2	33.9	36.4	22.4	13.9	2.3	52.3	77.2	78.1	81.1	58.1	24.6	35.1	35.4	10.6	41.5	33.5	11.0	4.2	93.0	42.3	27.2	46.9	58.5	14.7	26.6	20.7	43.7	15.0	56.1	3.5	56.2	115.0	36.2	20.4	25.5	33.7	20.9	37.5	24.7	58.7	13.5	3.7	32.1	63.1	38.8	55.9	9.1	42.3	37.3	33.8	2.8	67.5	47.3	59.8	5.5	8.2	64.5	32.5	41.8	41.6	84.4	41.1	42.1	24.3	28.2	98.6	32.3	38.6	63.5	88.1	59.0	91.6	109.2	42.3	20.2	41.9	95.7
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373312-134428791	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	6.7	18.0	6.6	14.2	7.9	8.4	10.8	10.3	9.3	8.3	6.2	9.1	8.9	9.7	32.7	8.2	7.9	6.6	6.7	7.1	8.4	10.2	7.7	6.8	25.3	8.3	7.8	33.3	9.5	16.3	6.2	9.3	8.4	9.2	10.3	12.0	13.2	11.0	5.0	8.3	8.8	8.1	8.6	13.3	9.3	9.2	7.7	20.8	13.2	6.8	29.8	8.6	7.1	11.5	28.2	22.9	98.7	40.8	17.9	22.9	18.7	27.6	22.1	29.1	35.6	13.9	28.5	45.1	61.8	16.9	28.3	24.6	69.4	31.3	48.6	37.2	32.1	44.3	37.7	16.1	19.2	44.2	23.3	15.3	23.2	31.7	39.2	29.1	41.1	43.1	32.6	21.8	35.8	18.7	71.3	21.8	30.1	38.3	31.0	69.6	36.0	34.5	30.7	33.8	34.1	39.9	21.2	19.3	29.5	29.0	18.0	24.0	31.5	26.8	19.2	34.0	42.9	11.1	27.3	60.5	17.7	51.4	34.3	5.9	6.3	4.1	8.0	6.6	8.7	18.7	8.2	7.3	9.5	12.4	9.6	8.2	2.6	11.0	8.4	11.7	9.1	5.5	6.6	7.9	10.3	9.3	7.1	8.4	8.3	7.8	8.4	8.6	7.7	11.5	25.5	22.4	18.4	13.1	42.7	13.0	14.3	28.7	22.2	22.4	17.5	20.3	16.3	11.5	17.8	16.5	18.8	11.8	27.1	9.9	23.5	14.2	3.7	13.0	29.1	18.7	11.4	31.3	27.8	13.8	7.6	17.2	14.8	18.7	24.6	149.5	20.0	15.2	15.1	18.5	23.4	12.5	10.2	15.5	10.2	3.1	20.8	20.2	7.2	29.0	25.3	27.9	21.6	33.2	46.7	14.4	18.7	15.4	23.1	12.3	9.5	19.8	16.5	19.7	26.3	21.0	21.9	10.3	22.0	25.7	11.5	4.7	22.6	69.3	17.7	11.5
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410660-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	212	"testis: 1216.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.8;U-266/70: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	4.8	2.8	0.6	1.3	0.6	4.1	5.0	0.9	1.3	2.1	0.6	4.3	2.7	1.6	3.3	2.6	2.0	1.1	1.9	0.6	0.7	2.9	4.7	2.4	2.1	0.8	0.8	1.4	4.4	5.7	1.7	2.0	0.8	4.3	4.6	0.6	3.5	1.7	2.3	5.0	4.2	1.4	0.7	3.2	2.5	1216.7	0.7	2.8	2.2	0.9	2.2	2.4	2.3	0.8	2.2	0.6	1.6	6.8	1.1	1.6	2.8	2.1	2.2	1.7	2.1	1.1	0.9	3.6	0.2	1.6	1.0	1.2	1.2	3.4	2.9	4.5	1.6	4.1	0.6	2.5	1.1	4.6	7.5	1.0	3.7	1.6	3.5	0.5	2.5	8.3	2.5	14.8	1.3	1.0	5.4	1.7	0.7	0.7	4.6	2.4	1.5	4.5	1.8	0.9	1.1	1.3	2.0	0.1	1.6	2.0	1.0	2.3	1.8	2.8	1.9	3.0	4.5	17.4	9.0	2.1	1.2	10.4	1.7	0.3	1.1	1.8	0.9	1.2	1.1	3.4	1.0	1.6	0.5	1.8	0.7	1.5	0.2	1.1	0.6	1.1	2.5	0.9	0.6	0.6	0.9	1.3	0.6	0.7	0.8	0.8	0.8	0.7	0.7	0.8	4.3	3.2	4.6	15.7	7.8	4.6	4.8	3.5	13.6	11.2	6.2	5.0	9.7	4.3	1.3	7.3	8.4	3.5	5.8	7.7	13.7	3.6	2630.6	5.3	3.1	6.7	11.5	14.7	10.9	2.8	2.0	5.7	6.1	2.1	7.0	3.7	3.3	4.5	4.2	13.5	12.4	4.2	2.0	4.1	2.3	8698.5	77.0	7.9	8.8	1.9	4.4	8.1	7.2	5.5	16.3	3.7	2.4	63.2	7.6	1.7	12.7	7.3	6.0	15.3	52.6	6.0	4.5	1456.7	71.6	7.6	3.0	0.5	5.5	7.2	10.2	2.2
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 70.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 57.9;Spermatogonia: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	11.6	8.1	8.3	13.3	11.1	16.2	13.8	9.5	10.3	13.9	20.0	11.6	10.3	14.1	70.6	13.4	14.1	9.2	9.8	7.8	11.2	9.7	28.7	13.5	16.3	10.1	9.4	19.3	17.8	10.8	13.9	13.2	11.2	16.0	9.6	14.6	12.8	18.3	11.0	13.1	14.2	9.4	8.1	13.9	12.7	40.1	10.2	18.6	13.2	7.8	15.8	14.1	13.5	13.3	16.1	14.0	20.4	19.9	12.2	9.6	33.3	12.0	10.4	12.9	11.4	15.7	12.8	23.4	6.9	10.8	13.9	16.5	51.1	10.3	13.7	36.4	23.8	14.2	18.1	15.8	9.6	22.4	25.6	10.9	14.0	15.0	20.2	9.7	12.0	24.3	18.7	33.2	7.6	16.1	30.6	16.9	37.2	11.0	19.6	29.7	22.5	22.9	8.9	19.2	29.2	14.5	31.6	20.5	10.5	31.2	20.5	15.5	14.3	10.3	14.5	19.2	10.0	25.1	25.4	28.3	12.2	27.9	11.3	6.1	2.7	4.4	3.2	4.8	5.1	2.3	3.3	3.9	2.9	3.1	2.5	2.8	4.4	3.5	3.2	2.3	5.3	3.4	8.3	11.1	9.5	10.3	7.8	11.2	10.1	9.4	11.2	8.1	10.2	13.3	9.5	9.6	10.3	17.3	11.2	8.9	9.4	4.5	15.4	13.7	13.9	8.1	7.8	5.7	5.4	9.2	12.5	13.9	14.1	8.3	0.0	5.1	54.9	34.5	11.3	11.3	5.4	5.2	19.7	4.6	4.7	6.9	10.7	40.2	14.0	15.0	7.9	39.4	6.8	8.4	22.0	8.8	10.2	11.8	6.4	31.4	9.3	11.6	3.6	20.6	9.2	6.1	9.2	27.2	30.0	4.4	9.4	6.4	14.4	10.9	9.2	3.7	16.5	15.3	6.6	11.6	9.2	57.9	58.7	15.2	9.8	12.2	13.5	6.3	8.3	14.7
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 2541.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"OE19: 833.5"									HPA068787	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA068787: AB_2686035"	"prognostic favorable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	3.7	0.4	0.1	88.8	0.2	0.2	11.1	0.3	0.1	0.8	0.0	2541.0	881.0	1.2	0.0	2.0	3.5	0.3	0.3	0.1	0.1	1.9	1.0	0.2	1.2	0.1	0.1	0.5	1.9	0.0	0.5	0.0	0.1	2.5	370.7	0.0	0.3	3.0	0.4	3.7	2320.2	17.3	0.1	0.4	177.1	0.3	0.1	0.0	0.4	0.0	0.0	5.6	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.0	0.1	833.5	0.3	0.1	0.0	10.8	0.0	1.5	61.5	7.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	46.0	0.0	0.2	0.3	0.0	0.0	40.2	38.0	0.0	117.2	0.0	0.0	0.0	0.0	0.1	19911.4	0.0	2.5	0.1	0.0	0.0	0.2	1938.2	0.0	0.0	0.2	0.0	0.5	884.8	0.1	213.9	0.0	0.0	0.6	0.0	0.0	0.0	8220.0	20.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	9497.7	0.0	2.1	1.1	51149.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	4881.6	1.0
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78934419-79078254	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019140: AB_2670073, HPA019838: AB_2670287"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	8.5	5.7	7.6	8.4	9.9	29.4	12.0	18.8	9.3	11.0	6.0	8.5	5.8	11.1	8.4	6.2	9.8	6.3	6.6	6.6	9.0	6.1	4.8	8.8	11.0	8.8	8.7	11.7	8.4	8.5	9.4	7.9	9.2	8.7	7.7	20.5	8.5	7.0	9.7	8.9	7.9	7.1	8.3	9.9	8.1	6.4	8.5	13.1	7.8	8.4	9.1	8.4	9.2	14.0	13.6	10.8	25.2	24.6	9.6	13.7	14.6	14.3	11.3	12.0	15.1	13.4	8.2	22.3	11.1	9.0	10.1	12.2	19.1	9.1	20.1	32.2	13.9	25.0	20.7	10.0	4.4	28.2	15.4	8.4	7.9	14.4	14.3	10.1	12.9	14.0	25.5	20.8	11.7	9.1	11.0	21.0	15.9	7.0	11.8	18.9	32.3	9.7	12.9	18.0	24.7	15.8	19.0	14.4	9.2	16.0	11.2	37.6	15.2	13.9	9.8	6.8	23.8	14.2	14.9	12.3	5.9	17.9	21.2	10.0	4.2	7.7	4.4	3.0	4.7	6.1	5.3	5.0	2.9	6.6	5.8	4.6	14.4	4.6	5.7	5.3	4.8	2.1	7.6	9.9	18.8	9.3	6.6	9.0	8.8	8.7	9.2	8.3	8.5	14.0	64.4	70.5	109.9	181.8	92.5	63.2	88.9	56.7	48.9	183.4	53.7	52.2	58.6	54.3	95.9	55.2	152.2	85.4	95.3	52.1	1.9	71.6	33.8	94.6	75.1	74.5	72.7	80.4	168.9	47.2	91.0	77.3	59.7	58.4	115.2	76.6	71.0	21.3	51.0	181.7	196.4	58.2	71.2	83.8	75.6	17.2	101.2	83.3	49.8	154.6	134.7	84.4	83.4	154.3	346.1	58.1	49.1	87.6	124.8	81.5	46.7	19.0	148.4	174.1	52.6	97.9	87.4	127.3	53.6	50.1	56.4	102.1	92.9	50.5	62.1	104.5
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.7	6.9	1.0	11.4	0.7	4.8	8.9	5.7	2.6	17.0	4.0	1.1	3.3	6.5	5.6	3.8	3.2	7.5	6.0	8.7	2.7	2.3	2.1	1.1	8.8	11.9	8.3	7.6	32.0	9.8	1.8	9.1	6.0	3.3	3.9	7.1	6.4	102.6	3.4	2.1	3.4	7.9	3.4	6.9	2.1	10.4	4.0	6.9	89.2	1.4	4.8	3.5	6.7	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	11.4	8.9	5.7	6.0	8.7	8.8	11.9	9.1	7.9	10.4	6.7	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892298-18984114	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 42.7;Hepatocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	12.7	9.6	4.6	6.8	6.3	15.0	7.6	6.6	5.5	9.0	6.9	6.8	12.5	10.5	6.5	6.3	9.9	8.1	12.6	5.6	5.4	6.7	34.3	6.4	7.7	6.9	5.6	16.8	15.2	8.1	12.8	10.5	6.7	9.7	6.5	10.6	9.5	7.1	7.8	8.8	10.1	6.2	5.5	9.3	8.6	9.7	6.0	12.6	10.1	14.3	7.4	6.2	8.1	7.3	11.3	10.6	6.1	10.2	8.2	7.5	16.6	4.9	4.1	7.1	7.7	11.3	7.3	13.3	3.6	6.4	11.2	10.3	11.0	12.8	7.6	6.5	11.2	15.9	17.6	13.8	5.8	15.2	19.7	12.6	8.3	8.7	12.5	11.8	7.4	13.8	5.3	8.0	5.0	12.0	16.0	25.2	7.5	5.2	11.2	12.4	12.5	14.9	4.6	5.0	5.2	8.0	14.8	15.3	6.8	20.3	18.9	8.8	13.2	9.6	5.3	10.3	7.6	7.6	6.7	10.1	5.4	8.1	5.2	4.3	3.2	7.2	2.0	3.8	2.1	1.6	1.7	1.5	2.1	1.7	1.9	1.9	5.4	3.0	2.5	1.1	2.3	1.9	4.6	6.3	6.6	5.5	5.6	5.4	6.9	5.6	6.7	5.5	6.0	7.3	6.1	9.6	12.9	27.7	5.7	6.5	5.4	6.0	8.6	11.1	8.0	7.4	20.1	12.8	5.1	9.2	10.4	16.8	3.4	9.6	0.0	7.5	7.2	6.4	11.8	7.3	4.2	14.5	15.2	5.1	17.5	5.3	4.1	7.2	1.3	42.7	20.3	57.4	8.0	5.0	19.9	7.4	4.1	18.9	3.8	5.3	7.5	10.5	5.4	13.1	8.3	17.0	7.2	16.6	16.9	6.3	12.6	7.9	7.4	6.9	12.4	4.8	4.1	13.3	0.0	7.4	5.9	7.9	7.9	8.6	4.7	10.5	7.4	12.1	10.7	3.6
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 264.6;tongue: 172.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Hepatocytes: 46.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	4.0	4.1	11.4	0.7	15.0	1.7	2.8	14.8	11.6	1.8	8.8	8.5	1.1	1.3	0.7	5.2	1.9	1.6	18.7	11.8	15.6	1.1	1.6	1.7	0.8	17.6	17.5	1.8	1.2	0.9	2.4	0.3	15.3	2.3	0.7	0.9	5.2	0.5	264.6	3.3	2.5	1.1	16.6	1.5	1.6	1.0	16.9	0.7	2.0	172.3	0.9	4.1	1.2	15.4	1.1	0.8	0.2	0.7	1.1	2.0	0.6	0.1	0.2	0.4	0.3	0.3	0.5	0.3	0.2	0.3	0.5	0.6	0.5	0.1	0.3	0.3	0.9	0.3	1.5	0.3	0.2	0.6	1.2	1.2	0.8	0.5	0.2	0.3	0.0	0.8	0.9	1.5	0.0	0.5	0.9	2.4	0.3	0.3	0.5	0.5	0.0	0.3	0.2	0.8	0.6	0.6	0.1	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.6	1.7	0.5	0.6	0.3	0.9	0.4	0.6	0.4	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.0	11.4	15.0	14.8	11.6	11.8	15.6	17.6	17.5	15.3	16.6	16.9	15.4	12.6	12.8	4.2	16.0	10.4	1.3	7.7	0.2	0.6	3.9	25.6	6.7	1.7	48.6	3.7	27.6	0.0	7.5	17.7	9.0	1.9	14.6	2.7	20.8	11.3	8.2	16.7	6.6	3.1	12.3	14.5	10.4	2.6	16.4	8.2	4.6	23.6	46.5	12.1	11.8	3.8	12.6	0.0	36.8	1.2	5.9	18.0	8.9	1.8	3.7	10.7	5.0	8.2	3.5	5.2	11.0	10.1	16.1	5.2	11.6	17.8	16.8	2.2	5.4	13.1	34.0	7.2	11.1	9.1	1.2	1.0	7.3	8.2	3.7	24.1	8.4
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76031776	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 159.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1438.7;Basal squamous epithelial cells: 582.8;Urothelial cells: 760.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"monocytes: 1.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 296.3;RPTEC TERT1: 233.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	21.3	31.0	9.9	17.3	10.1	21.8	28.1	8.9	11.0	23.1	6.2	8.9	6.5	13.4	4.4	59.8	7.8	39.3	20.6	10.3	11.3	14.8	67.6	27.1	5.9	10.8	16.9	19.2	17.9	5.3	8.2	14.3	11.3	8.9	10.2	13.8	159.1	8.2	5.8	11.5	8.6	14.8	9.6	19.5	22.5	3.1	11.5	7.4	27.2	1.5	7.5	60.9	33.7	11.3	60.9	71.5	54.9	30.4	25.0	51.6	3.9	50.5	134.7	22.4	30.8	39.7	72.2	0.3	14.8	21.2	73.8	30.7	1.5	84.2	47.9	9.3	1.2	1.5	3.8	68.2	36.3	1.4	15.1	16.2	60.6	93.2	182.6	296.3	54.4	0.1	5.0	1.7	115.8	7.8	0.2	7.9	20.1	36.3	108.7	0.2	14.3	1.8	233.7	135.1	4.0	10.4	8.8	0.8	169.5	67.8	35.5	0.7	50.8	75.8	7.2	89.3	50.4	0.8	0.3	0.2	127.9	0.8	96.7	0.2	0.0	0.0	0.9	0.1	1.5	0.0	0.9	1.0	0.0	0.0	0.1	0.2	0.2	0.0	1.1	0.0	1.6	0.2	9.9	10.1	8.9	11.0	10.3	11.3	10.8	16.9	11.3	9.6	11.5	11.3	98.5	12.8	12.4	7.2	13.0	195.3	1438.7	249.6	582.8	5.2	136.2	140.3	34.8	11.5	44.4	31.3	2.1	4.7	42.9	11.6	84.1	74.8	2.2	11.5	111.2	162.5	117.7	0.0	7.8	43.1	11.5	203.2	55.0	20.4	79.5	7.1	21.4	127.8	94.7	1.7	14.6	41.0	384.5	14.0	123.4	2.1	9.3	110.8	286.4	8.4	24.0	97.8	0.0	142.2	2.7	208.4	27.7	15.4	19.0	116.1	0.2	39.3	12.4	5.2	269.5	59.8	276.3	0.7	3.2	66.3	75.6	7.4	132.8	20.7	18.0	760.3
PHLDA3	TIH1	ENSG00000174307	"Pleckstrin homology like domain family A member 3"	Q9Y5J5	1	201464278-201469237	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 269.3;Prostatic glandular cells: 188.7;Urothelial cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 284.8;WM-115: 164.3"	"Low region specificity"	"Detected in all"							HPA027601	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA027601: AB_10601389"	"unprognostic (1.51e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (8.55e-3)"	"unprognostic (4.34e-3)"	"unprognostic (5.55e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (9.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.45e-2)"	155.6	30.0	34.9	8.4	50.6	0.3	119.3	51.2	41.9	56.8	21.3	139.4	4.1	52.9	11.6	89.4	40.8	15.3	40.9	31.7	39.4	18.2	8.1	41.6	2.5	73.4	50.3	23.5	23.4	10.7	28.4	8.9	51.3	64.8	5.5	3.0	39.3	26.8	75.9	68.3	29.0	17.8	45.2	10.4	35.1	8.9	52.1	10.1	31.5	11.6	4.9	75.5	68.4	69.2	52.4	60.8	11.1	33.5	50.6	47.7	284.8	75.6	57.3	18.2	21.0	4.0	39.5	0.1	3.1	37.6	15.7	90.0	1.0	61.0	3.6	0.0	22.4	0.0	26.2	47.6	57.4	0.0	1.0	66.7	90.6	29.4	25.8	53.5	26.3	4.5	0.0	0.1	36.7	37.5	8.0	0.8	19.1	0.0	3.8	2.5	51.9	0.0	16.9	115.1	0.7	11.7	26.5	0.8	62.7	42.5	25.0	3.6	39.4	42.2	69.6	36.1	16.2	1.4	0.2	0.1	102.4	0.1	164.3	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.6	0.0	34.9	50.6	51.2	41.9	31.7	39.4	73.4	50.3	51.3	45.2	52.1	69.2	83.3	9.6	9.1	8.8	0.9	78.1	269.3	48.8	93.9	5.2	29.8	42.4	6.2	2.8	30.7	49.7	0.0	84.9	1.8	2.2	11.7	42.0	36.8	42.7	15.2	22.2	5.3	2.7	5.7	18.9	24.4	43.3	7.1	31.8	0.0	11.2	10.4	1.4	18.1	0.0	8.3	2.1	10.2	0.6	28.5	136.5	26.8	7.9	32.0	1.0	18.2	105.4	1.0	4.5	37.1	71.4	2.9	41.8	2.1	188.7	1.2	8.5	22.3	5.2	0.0	38.0	55.8	0.8	4.0	92.1	102.0	37.5	5.7	46.5	3.6	556.5
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 87.2;Late spermatids: 87.7;Oligodendrocytes: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.2;ASC TERT1: 105.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037959: AB_10673651, HPA038448: AB_10697390"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	52.6	8.1	39.2	11.5	79.7	0.5	38.9	42.5	66.0	39.1	3.8	23.8	9.2	38.4	2.6	9.1	30.2	21.6	33.0	42.3	49.2	15.8	3.2	26.8	4.6	64.3	64.6	31.9	22.2	4.5	8.8	24.6	56.0	16.7	6.4	1.6	11.1	15.8	13.3	15.1	15.3	18.6	33.4	12.5	14.3	12.0	75.3	3.1	20.3	13.6	2.3	21.9	22.9	133.7	4.8	7.5	28.9	14.2	105.2	105.9	10.1	21.9	26.6	12.7	7.4	11.2	31.8	0.0	40.2	44.3	17.2	18.6	6.6	44.8	2.0	0.7	4.2	8.6	5.7	5.5	27.2	0.0	15.8	55.8	9.6	17.8	12.5	28.3	36.6	0.7	7.5	0.3	16.7	3.4	0.1	0.5	10.2	0.4	3.8	1.1	7.5	0.7	12.5	6.8	6.5	14.5	55.8	4.7	15.6	11.3	20.1	2.7	45.4	25.9	22.9	13.2	18.3	0.2	0.0	0.1	7.5	1.5	29.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	39.2	79.7	42.5	66.0	42.3	49.2	64.3	64.6	56.0	33.4	75.3	133.7	34.4	6.4	13.7	53.2	1.6	18.4	9.2	13.7	14.2	4.0	7.2	19.6	5.6	1.5	6.3	31.3	0.0	1.0	2.5	34.2	0.0	9.4	78.3	11.6	87.2	32.1	8.4	0.0	4.1	4.4	1.5	54.9	11.7	8.6	1.3	25.6	26.4	0.9	5.9	3.3	8.3	20.4	0.0	2.5	34.4	87.7	67.1	8.2	12.4	23.4	2.2	7.6	0.0	67.3	244.5	24.3	29.8	44.4	0.7	4.2	10.7	7.8	0.5	2.3	39.5	42.9	53.8	21.9	10.1	1.9	9.1	1.5	5.4	11.0	16.8	2.4
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 249.9;Basal prostatic cells: 189.9;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 103.8;HaCaT: 105.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: AB_2674492"	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	25.6	7.2	2.2	15.7	2.3	1.5	11.3	0.9	4.0	10.6	10.3	29.0	6.0	20.4	7.4	11.1	13.3	15.3	42.7	0.9	0.5	31.5	35.6	17.6	5.1	1.2	1.8	8.9	10.0	1.8	5.7	40.8	1.6	16.4	8.6	0.5	10.6	25.7	4.8	7.0	7.7	24.3	1.6	16.5	11.7	2.8	3.9	5.0	6.2	8.7	3.2	26.5	10.5	2.0	103.8	11.2	62.2	0.1	19.8	32.3	25.5	58.3	28.5	37.8	44.5	32.1	7.5	0.0	59.6	22.6	38.2	105.2	0.9	37.5	68.6	1.6	1.5	0.0	26.1	10.6	21.3	0.2	0.3	38.1	21.9	26.1	48.1	42.5	61.8	1.0	0.1	0.4	11.5	0.2	4.2	0.1	25.3	1.0	19.3	9.0	80.1	0.0	22.2	24.5	1.6	4.7	57.6	1.1	5.9	34.1	2.1	0.3	54.4	10.2	85.2	27.4	14.3	5.4	0.2	0.2	10.4	0.1	19.9	0.1	0.0	0.0	2.6	0.0	1.8	0.2	1.8	2.9	0.0	0.4	0.0	1.1	0.2	1.0	0.0	0.5	0.4	0.8	2.2	2.3	0.9	4.0	0.9	0.5	1.2	1.8	1.6	1.6	3.9	2.0	30.9	80.1	7.5	2.6	1.6	249.9	189.9	33.3	33.0	0.2	11.6	9.8	95.8	25.8	16.8	33.1	2.1	27.0	13.0	0.6	23.5	62.6	12.9	3.7	15.3	44.8	10.8	2.7	51.7	20.5	51.5	40.3	14.3	26.2	7.0	1.2	35.3	35.2	3.5	0.0	9.5	3.4	8.2	2.5	20.6	5.3	14.3	2.9	23.2	39.4	1.0	0.1	23.7	4.5	1.8	45.4	0.5	22.6	2.8	60.1	0.0	30.9	6.8	0.3	13.1	21.0	95.9	0.5	3.3	17.7	114.7	66.8	6.7	2.7	1.9	84.0
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.0;skin 1: 43.5"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 58.0;Urothelial cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	3.7	9.2	6.3	5.6	5.5	3.5	6.4	3.9	6.4	14.4	8.9	6.1	5.0	5.3	1.1	42.0	8.0	6.1	5.7	5.1	7.8	8.1	13.9	5.6	7.7	4.5	3.8	12.7	8.0	4.2	10.5	3.1	5.8	14.8	1.7	0.8	15.6	3.7	3.7	43.5	6.6	1.9	2.8	6.6	6.3	30.1	4.5	6.2	5.0	1.0	6.8	8.2	22.4	11.3	6.9	7.2	3.0	7.4	2.6	5.3	19.1	4.9	4.3	4.8	3.3	7.3	7.2	4.1	15.2	3.0	3.8	8.0	2.1	8.6	0.9	9.9	6.8	4.6	7.4	8.8	6.5	1.8	8.5	4.5	10.7	5.1	3.1	3.7	4.3	10.2	8.3	6.1	2.4	11.0	7.2	0.4	1.8	16.6	5.8	8.3	3.9	2.8	2.3	23.3	0.1	6.4	6.3	13.5	6.2	1.8	9.7	5.8	5.4	3.1	8.2	3.8	4.7	15.8	18.8	4.7	2.9	3.4	5.3	0.2	2.3	0.3	2.4	1.4	1.8	2.2	2.2	1.8	4.4	2.4	3.2	3.0	0.5	1.8	0.1	5.1	2.3	1.7	6.3	5.5	3.9	6.4	5.1	7.8	4.5	3.8	5.8	2.8	4.5	11.3	2.7	0.0	1.7	2.6	17.1	29.1	27.2	11.6	31.9	1.0	10.0	8.0	1.9	8.6	7.6	9.2	0.0	18.5	7.6	7.1	1.9	5.5	11.3	12.9	9.6	4.6	3.0	1.7	5.1	2.4	4.5	7.3	4.6	9.8	5.7	3.2	4.6	12.6	3.6	0.0	7.0	4.3	8.2	2.8	34.7	8.9	3.7	11.2	5.4	11.2	6.7	4.1	7.2	4.0	2.0	2.1	4.7	3.4	11.6	22.0	10.5	8.5	12.7	1.9	6.6	8.6	10.9	28.2	4.8	37.7	38.4	58.0	14.3	4.6	3.7	45.1
PHLPP1	"KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP"	ENSG00000081913	"PH domain and leucine rich repeat protein phosphatase 1"	O60346	18	62715541-62980433	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 107.2"	"Group enriched"	"Detected in many"	10	"Astrocytes: 423.7;Oligodendrocyte precursor cells: 538.3;Oligodendrocytes: 1663.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 4.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in all"		"REH: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020200	Approved				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA020200: AB_2670383"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (5.35e-8)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.25e-2)"	5.5	14.6	46.4	1.9	74.3	7.3	6.4	49.5	59.8	4.4	17.1	5.2	5.4	4.6	1.9	7.6	3.4	4.1	3.4	45.6	46.4	3.2	16.6	3.4	2.7	61.8	58.4	4.4	7.0	5.7	7.5	5.5	53.8	4.0	5.6	16.1	10.8	3.5	4.2	12.5	4.9	3.3	47.0	1.8	4.9	10.8	58.7	4.4	4.6	3.7	3.6	5.5	4.8	107.2	13.7	5.0	20.2	6.8	3.4	2.9	15.8	4.0	3.6	7.8	8.0	11.1	8.0	9.1	2.4	6.1	3.1	16.3	10.5	6.4	10.0	28.4	8.8	3.1	5.4	20.6	4.8	4.7	1.5	3.0	4.1	8.4	7.6	6.4	5.6	4.9	8.0	17.9	7.6	3.0	3.5	4.1	8.2	2.7	4.9	32.7	11.5	11.1	4.5	17.5	9.3	3.7	4.4	9.9	8.2	11.8	4.4	13.3	7.2	6.4	3.0	3.9	9.4	2.0	1.1	10.6	3.8	5.4	5.0	0.0	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.0	4.0	0.3	0.1	0.2	1.3	0.1	46.4	74.3	49.5	59.8	45.6	46.4	61.8	58.4	53.8	47.0	58.7	107.2	10.1	3.2	1.5	423.7	1.9	16.8	5.0	2.9	8.0	21.2	12.1	11.3	4.1	11.5	6.3	0.0	29.2	12.9	3.3	8.4	1.9	3.8	33.5	13.7	6.0	8.1	12.1	3.8	80.1	4.1	5.8	7.0	10.2	26.6	2.5	9.6	5.3	21.5	2.4	26.9	64.7	8.5	2.0	2.5	9.8	36.4	5.9	5.8	24.9	79.6	2.6	83.6	2.1	538.3	1663.2	4.5	8.0	3.8	1.0	7.5	7.4	1.9	10.0	17.4	0.0	13.5	5.3	8.0	15.4	13.2	18.6	26.1	2.7	8.3	11.1	11.0
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 158.7;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	5.0	2.8	1.9	2.4	1.9	2.9	10.6	4.1	1.6	4.7	3.7	5.8	6.4	5.3	4.2	3.2	6.0	4.0	2.7	1.6	2.8	5.6	3.6	3.3	3.0	1.4	1.8	6.0	5.1	7.2	4.6	3.0	1.5	13.0	5.8	7.2	8.5	4.7	3.4	3.5	6.4	3.1	1.7	2.5	4.7	13.7	2.4	3.0	9.8	1.6	3.0	3.8	2.8	1.9	6.6	1.8	4.6	6.2	8.5	2.7	17.8	2.8	1.9	4.3	4.7	6.3	4.9	6.4	6.1	2.1	8.9	5.0	6.2	3.4	3.5	9.5	7.0	6.4	6.1	11.0	5.6	5.3	5.6	4.9	6.3	4.9	6.5	3.6	3.9	8.9	10.8	6.4	2.7	6.0	3.7	6.8	6.0	4.2	2.3	3.6	2.8	5.1	6.8	19.6	19.1	6.5	5.8	3.1	6.8	5.5	8.4	3.2	2.3	4.7	4.3	4.2	3.1	6.2	6.0	5.7	5.5	3.2	5.1	0.1	0.7	1.0	3.3	0.9	4.6	6.5	3.6	3.2	0.9	8.8	4.7	4.6	1.3	9.8	0.9	4.2	4.4	1.4	1.9	1.9	4.1	1.6	1.6	2.8	1.4	1.8	1.5	1.7	2.4	1.9	6.1	3.2	3.6	0.0	6.8	2.5	10.3	5.4	2.8	8.7	15.2	11.0	4.1	5.7	4.7	3.7	6.2	8.8	2.5	7.0	9.8	7.6	158.7	10.6	5.0	4.3	15.0	6.9	0.0	11.1	9.3	6.9	15.3	3.3	0.0	5.7	2.5	3.7	2.8	6.7	0.0	6.6	12.2	0.6	1.6	35.9	4.7	2.0	3.6	0.0	1.0	6.4	1.0	0.0	0.0	6.4	6.8	4.9	3.8	6.5	12.7	12.2	13.4	10.2	0.0	6.7	9.3	68.9	13.9	4.5	4.3	5.5	5.7	8.8	7.5	5.5
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 19.9;brain: 18.3"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in some"	9	"pons: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.3	19.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.2	0.0	0.5	0.0	18.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	18.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PHRF1	"KIAA1542, PPP1R125, RNF221"	ENSG00000070047	"PHD and ring finger domains 1"	Q9P1Y6	11	576470-612222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.2;MOLT-4: 39.0;U-138 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019867, HPA062933"	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA019867: AB_1852416, HPA062933: AB_2684907"	"unprognostic (5.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.28e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	14.3	17.5	1.2	1.0	2.6	3.1	13.9	1.4	3.6	14.4	0.9	14.2	0.0	13.2	1.3	18.7	13.5	1.1	14.0	1.1	1.1	12.5	26.5	14.5	0.0	1.5	1.1	14.6	14.4	0.0	13.9	0.0	1.5	14.5	0.0	0.2	13.8	1.2	18.7	22.2	16.3	1.0	0.5	17.6	14.3	17.9	1.7	0.1	13.5	0.0	2.1	12.6	14.4	1.7	2.6	1.6	0.4	7.9	0.0	0.4	1.5	6.2	0.5	0.6	0.0	0.0	0.2	14.8	14.7	0.3	0.3	3.1	0.2	0.0	0.0	4.6	10.5	0.9	0.0	24.2	0.0	1.7	1.6	3.6	0.0	0.0	3.9	0.0	0.3	13.1	3.5	0.0	0.0	0.8	39.0	0.5	1.9	0.2	7.2	1.4	1.5	0.0	0.0	0.3	11.4	1.8	4.3	12.9	0.1	8.9	0.4	5.1	1.2	21.2	7.4	0.5	1.5	2.7	3.7	1.5	0.5	1.2	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.4	0.5	0.3	0.4	0.4	0.2	0.5	0.3	0.1	0.4	0.3	0.2	1.2	2.6	1.4	3.6	1.1	1.1	1.5	1.1	1.5	0.5	1.7	1.7	11.5	6.4	11.1	10.1	14.9	17.6	10.1	7.4	18.2	12.2	11.6	7.9	7.8	11.5	8.2	14.7	8.4	8.0	17.1	24.1	0.0	11.6	2.1	14.0	12.9	11.9	11.4	16.0	5.9	10.6	8.0	11.3	23.4	17.7	5.1	14.7	4.6	17.5	9.5	20.2	6.6	14.2	2.0	10.6	11.7	2.8	11.8	13.1	3.6	10.3	11.3	8.2	23.7	4.5	8.4	18.0	12.2	10.5	17.5	12.4	21.8	7.0	12.5	16.0	13.1	14.1	12.2	26.4	28.0	17.4	17.8	8.9	17.2	13.0	14.9	13.6
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.7;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 25.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.9	4.8	3.7	13.1	4.6	12.3	7.1	5.0	6.3	8.7	2.7	6.0	4.0	8.7	5.2	8.6	5.4	10.7	13.0	4.6	3.8	5.7	6.3	7.6	18.1	4.1	3.2	8.2	4.5	26.3	4.6	11.0	3.7	6.7	6.6	7.2	5.0	8.0	112.7	6.8	8.0	11.9	3.9	12.8	4.4	10.0	3.9	9.1	6.5	57.7	17.6	11.7	5.8	7.2	34.6	15.5	20.9	42.6	17.8	19.5	17.3	59.6	54.1	34.9	39.3	26.6	27.3	31.0	4.8	46.4	37.8	27.9	30.1	15.5	49.3	20.9	24.0	12.7	16.7	7.8	19.3	16.9	33.5	11.6	14.5	20.4	30.4	22.4	12.6	17.1	21.0	53.1	37.7	21.7	14.0	10.9	18.9	9.6	18.2	13.8	42.3	25.4	9.6	45.9	20.0	27.9	33.4	37.5	21.9	30.5	39.7	13.0	12.9	59.7	31.9	34.0	35.5	24.9	31.1	38.3	18.9	26.7	52.5	14.1	2.7	4.6	1.8	11.7	3.7	8.2	5.6	1.7	2.8	5.3	1.7	1.8	1.6	5.1	25.4	1.2	8.2	2.7	3.7	4.6	5.0	6.3	4.6	3.8	4.1	3.2	3.7	3.9	3.9	7.2	12.8	6.4	15.2	31.6	54.0	15.9	20.9	9.0	21.1	8.7	13.2	10.0	23.8	14.3	10.8	7.3	12.5	13.7	18.4	8.9	0.0	4.4	27.4	8.1	20.9	9.6	5.4	8.4	109.1	6.7	8.6	18.3	7.7	12.5	39.2	26.7	18.9	5.7	11.7	3.3	94.6	6.6	22.4	32.7	32.6	4.5	12.2	39.7	10.6	47.8	11.1	4.7	10.3	91.5	144.4	5.7	5.6	13.5	34.8	9.0	2.3	2.2	9.7	9.0	13.1	15.1	15.3	47.6	39.2	14.4	17.8	14.8	54.2	14.7	4.8	21.5
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 667.8;skeletal muscle: 483.6;tongue: 412.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 258.6;Proximal tubular cells: 414.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	57.9	66.5	22.9	9.5	23.7	8.2	32.2	23.5	28.3	28.8	31.7	46.5	58.7	22.1	16.7	22.9	16.7	28.2	126.5	21.7	24.1	191.4	667.8	17.3	7.5	21.6	24.4	36.8	48.2	56.7	20.9	19.3	22.8	22.5	37.2	28.2	33.7	25.4	483.6	17.5	55.8	23.2	22.7	12.8	44.2	15.1	26.0	5.6	56.0	412.7	5.4	27.0	14.8	23.6	17.2	35.2	15.6	22.5	110.7	69.9	12.4	17.2	23.9	19.4	19.1	9.1	30.3	0.9	12.9	29.0	47.0	7.8	20.5	20.2	11.8	41.4	10.7	14.9	9.3	36.6	54.8	2.5	26.8	50.3	28.9	21.0	8.4	22.7	18.7	16.8	8.4	32.2	45.5	16.3	9.2	12.1	14.4	49.4	12.6	15.7	24.1	5.8	40.6	21.9	5.3	16.8	64.8	1.4	32.9	12.5	64.8	44.2	6.4	29.5	10.6	36.4	11.8	36.6	26.3	3.3	38.3	18.9	11.6	16.3	18.7	8.2	8.0	14.2	17.6	11.0	9.9	10.4	15.8	5.6	12.5	12.7	0.8	4.4	11.2	14.4	10.5	12.3	22.9	23.7	23.5	28.3	21.7	24.1	21.6	24.4	22.8	22.7	26.0	23.6	53.6	12.8	19.2	8.5	14.5	11.9	27.6	19.1	6.2	47.0	22.6	24.5	258.6	77.2	19.7	35.0	22.9	137.8	20.5	72.9	144.8	40.6	33.1	18.5	29.0	29.7	31.8	15.2	7.1	19.6	34.3	41.3	41.8	26.8	30.4	28.3	25.0	145.5	55.4	21.9	5.6	57.4	46.8	21.0	22.0	45.4	25.4	25.3	17.8	4.7	10.3	69.3	7.2	2.5	2.4	16.7	46.0	37.6	15.1	11.9	141.9	414.6	19.6	41.8	19.7	30.2	37.5	12.5	1.6	7.3	13.4	83.9	25.2	103.3	46.9	18.1
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PHYHIPL	"Em:AC025038.1, KIAA1796"	ENSG00000165443	"Phytanoyl-CoA 2-hydroxylase interacting protein like"	Q96FC7	10	59176643-59247774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.4;brain: 45.5;retina: 30.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.6;Early spermatids: 208.4;Horizontal cells: 144.7;Inhibitory neurons: 170.2;Late spermatids: 241.4;Muller glia cells: 246.1;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 357.1"	"Group enriched"	"Detected in many"	5	"glioma: 21.1;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;Hep G2: 34.3;SCLC-21H: 6.1;SH-SY5Y: 19.4;SK-BR-3: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038746	Uncertain		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA038746: AB_10673293"	"unprognostic (6.34e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.60e-7)"	"unprognostic (1.29e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	0.3	18.4	22.5	0.4	30.1	0.0	0.4	31.6	36.9	1.6	0.3	2.1	8.5	0.7	1.8	0.3	1.1	0.1	0.3	21.2	36.1	11.0	1.1	0.2	0.0	41.3	32.1	0.8	5.4	0.0	6.7	1.8	32.8	2.8	0.3	30.5	0.7	2.6	0.6	0.3	8.9	0.1	42.4	0.1	0.6	6.5	26.2	0.0	0.2	0.0	0.0	0.1	1.2	45.5	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	19.4	0.0	8.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	30.1	31.6	36.9	21.2	36.1	41.3	32.1	32.8	42.4	26.2	45.5	3.1	0.0	0.0	210.6	0.0	0.0	14.0	0.0	0.0	135.2	0.2	1.0	0.5	2.8	0.0	3.7	12.5	1.0	0.0	0.1	13.7	0.6	208.4	24.1	8.0	1.6	0.0	2.7	97.3	6.5	0.3	1.2	0.0	71.9	0.0	0.8	0.7	1.8	0.5	144.7	170.2	3.0	0.0	0.0	0.0	241.4	13.1	1.3	1.8	11.2	0.0	246.1	0.0	264.9	357.1	1.7	6.3	0.4	0.0	4.0	24.0	80.3	0.0	53.9	0.0	3.0	2.4	137.1	27.2	0.1	0.0	49.0	0.6	0.3	9.6	2.8
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208471-178232802	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	23.2	10.6	7.4	16.4	8.2	14.9	14.0	6.8	8.6	12.3	8.3	23.9	20.7	14.3	15.8	11.1	13.9	14.4	15.5	6.7	8.3	17.5	42.2	15.8	24.5	11.4	8.3	12.5	15.6	13.7	5.2	16.3	10.0	13.7	30.8	3.4	13.8	12.0	19.6	10.7	24.8	18.5	7.6	17.2	15.5	5.9	9.5	25.1	19.7	18.7	23.6	13.7	9.6	11.7	9.6	3.8	9.0	3.6	21.6	17.4	13.9	5.6	6.2	7.6	11.8	9.7	11.7	13.0	18.4	17.6	9.7	6.2	7.7	14.3	8.5	24.0	8.7	15.6	18.0	7.1	35.1	9.2	11.4	19.6	15.0	9.3	22.4	14.9	24.9	18.6	11.8	26.7	11.3	13.1	13.1	5.5	1.9	11.5	12.4	9.1	4.3	25.0	13.4	8.3	5.7	5.4	9.2	5.2	9.4	10.2	5.5	7.4	9.9	7.8	7.0	5.1	6.2	18.8	5.5	7.2	2.2	9.2	5.2	16.7	41.7	36.9	20.3	46.8	20.4	28.4	22.2	22.9	53.4	26.3	27.3	22.2	9.2	23.7	47.2	70.9	28.6	33.2	7.4	8.2	6.8	8.6	6.7	8.3	11.4	8.3	10.0	7.6	9.5	11.7	23.1	19.2	14.3	31.6	63.0	10.7	43.1	16.1	25.0	21.9	17.2	14.5	17.4	37.1	13.0	23.9	25.0	18.4	72.5	96.1	19.6	24.6	21.7	13.2	27.7	26.2	19.2	30.7	20.7	18.6	20.2	33.4	76.9	13.8	12.7	38.4	31.1	30.1	31.7	15.2	17.9	40.8	6.1	37.1	22.9	55.3	42.6	43.3	24.9	36.5	61.1	25.0	70.0	29.1	45.2	15.1	64.5	25.2	51.4	30.3	119.2	43.1	13.6	26.4	13.1	34.5	23.6	37.2	25.9	14.6	10.4	22.0	58.9	36.3	39.2	36.6
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824534-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.4;prostate: 31.0;smooth muscle: 49.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 6.3"	"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	5.8	1.1	0.6	54.4	0.8	0.0	22.1	0.1	1.6	11.0	0.0	7.8	0.2	19.8	2.1	2.5	20.9	1.5	1.8	0.9	0.9	0.9	0.2	2.2	0.6	0.7	0.8	6.3	0.3	0.0	0.5	0.3	0.4	31.0	4.6	0.6	2.0	6.8	0.4	0.4	4.6	49.9	1.1	1.3	0.7	0.5	2.4	0.4	0.6	0.2	0.2	8.3	6.5	0.6	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	21.3	0.0	0.1	30.0	0.4	0.5	0.5	0.0	0.0	0.5	0.0	0.1	7.9	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	1.6	0.9	0.9	0.7	0.8	0.4	1.1	2.4	0.6	0.2	0.0	0.0	2.3	0.1	0.1	36.8	0.0	0.6	0.2	73.2	13.6	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.6	0.2	9.1	2.5	0.0	0.0	4.3	0.0	0.4	3.9	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.6	1.9	0.9	0.2	3.6	1.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.1	19.3	0.0	0.1	0.0	0.5	0.0	1.7	36.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	15.7
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174902-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2267.8;lymphoid tissue: 2103.1;vagina: 1595.8"	"Group enriched"	"Detected in many"	10	"Basal respiratory cells: 5354.5;Club cells: 2170.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Group enriched"	"Detected in some"	22	"cerebral cortex: 12.0;pons: 7.3;thalamus: 19.0"	"Immune cell enriched"	"Detected in some"	1021	"neutrophil: 1763.3"	"Lineage enriched"	"Detected in single"	4377	"granulocytes: 1763.3"	"Group enriched"	"Detected in many"	5	"EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		1400000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	6.1	0.7	0.2	101.9	0.5	1.8	8.8	0.2	12.0	180.1	1.2	124.3	1.9	2.3	1.1	2267.8	4.8	56.6	1.7	0.2	0.4	1.5	3.3	32.5	0.4	0.3	0.3	0.7	1.6	0.2	2.8	1.1	7.3	11.7	43.3	0.0	460.8	3.5	0.6	78.6	42.3	7.5	0.3	20.0	9.0	0.5	19.0	90.6	0.8	1.9	2103.1	44.7	1595.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.4	0.0	3.1	2.1	1.4	89.3	0.0	1.1	109.8	0.0	23.2	0.1	1.2	0.0	0.5	6.3	0.9	0.0	0.7	0.0	0.0	21.7	17.8	1.9	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.1	0.2	103.7	189.9	0.0	1.0	0.0	21.9	0.4	0.0	0.0	15.7	2.1	0.1	0.0	0.0	0.0	0.8	1.0	10.9	0.3	0.9	0.3	1.8	0.4	14.3	0.7	0.1	0.3	0.4	1.7	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1763.3	0.0	0.1	0.1	0.1	0.6	0.2	0.5	0.2	12.0	0.2	0.4	0.3	0.3	7.3	0.3	19.0	0.3	0.1	0.0	8.6	0.0	7.4	0.1	4.7	5354.5	0.0	0.0	39.4	8.4	0.2	8.6	2170.2	18.4	0.0	0.2	0.5	375.4	0.0	46.6	0.1	3.7	0.7	3.0	16.6	0.0	0.0	317.3	0.0	0.8	2.6	6.9	4.5	0.0	0.0	0.0	0.1	0.0	0.0	31.8	197.4	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.8	219.6	0.0	0.2	29.1	33.9	0.2	152.9	0.0	0.0	0.0	50.5	0.0	0.0	36.2	3.8	0.0	2.5	0.1	154.1	150.4
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	12.0	25.7	15.5	10.0	15.1	24.1	9.3	15.1	18.9	12.6	13.4	10.7	9.8	12.7	13.0	20.7	9.6	14.0	14.2	15.5	17.8	12.6	15.0	14.2	11.2	20.2	18.8	10.0	8.4	16.6	15.8	18.0	22.0	10.9	8.7	12.9	10.5	10.4	12.7	17.4	10.8	13.0	15.8	14.6	9.4	10.8	17.3	9.8	9.5	13.0	10.6	14.5	12.7	15.2	28.7	21.3	17.2	30.7	36.0	25.8	13.8	28.0	61.5	43.3	45.7	19.4	27.7	10.4	16.2	35.8	31.8	27.1	19.3	55.9	35.8	12.6	16.4	9.3	14.6	17.7	34.5	8.4	12.7	27.3	46.9	45.4	80.1	47.4	22.4	19.9	14.7	16.5	30.4	14.6	18.4	6.4	11.1	14.7	19.8	8.6	17.8	10.3	29.7	26.6	5.8	18.9	23.9	5.9	35.5	24.0	16.4	13.2	25.0	20.6	15.2	24.6	22.1	14.6	18.4	16.9	38.1	5.0	6.8	0.0	1.2	0.0	1.3	0.8	1.0	1.4	0.5	1.1	1.3	0.6	0.4	0.9	0.4	0.7	0.6	0.6	1.2	0.6	15.5	15.1	15.1	18.9	15.5	17.8	20.2	18.8	22.0	15.8	17.3	15.2	4.9	3.2	5.4	9.8	12.0	13.4	4.5	6.5	8.0	14.7	10.7	8.9	10.4	10.0	4.3	5.5	12.5	14.0	12.5	8.6	3.9	4.9	2.4	6.8	15.4	6.9	3.0	8.2	10.9	4.9	6.4	12.0	7.1	7.6	1.3	5.7	3.6	9.9	38.1	11.8	10.9	4.0	6.1	15.0	24.7	2.2	4.4	19.0	10.6	12.2	15.0	8.0	18.6	5.5	6.0	7.2	0.8	9.1	9.4	5.8	9.0	7.3	4.8	15.1	6.6	11.9	8.0	11.0	6.1	6.3	14.3	27.1	9.7	12.4	3.6	7.8
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25160663-25279204	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004099	Enhanced		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	7.9	8.9	3.4	14.0	3.9	14.1	16.5	3.6	4.5	11.4	5.8	18.7	39.0	8.0	5.8	16.7	8.7	8.3	4.5	3.2	4.1	12.9	57.9	16.5	18.1	4.3	3.6	5.2	9.5	7.7	3.4	12.0	4.5	11.4	20.4	4.9	23.5	7.9	2.4	13.1	31.6	9.1	4.5	13.5	22.7	12.1	3.7	19.7	24.1	4.8	18.9	14.3	8.1	5.3	33.8	9.9	16.7	14.6	18.2	33.9	31.3	50.8	48.6	48.4	58.1	14.0	37.7	86.3	11.5	45.3	37.5	14.7	37.3	24.6	41.7	28.9	12.2	30.4	23.3	26.1	14.2	61.9	21.0	21.6	17.9	18.6	19.2	12.9	28.0	27.0	20.7	76.2	37.0	18.8	58.3	39.7	23.6	40.5	13.6	34.4	58.1	47.5	32.2	32.2	28.9	6.2	24.5	17.1	12.0	17.0	25.7	27.3	33.8	31.8	8.4	18.3	32.5	76.3	49.5	77.4	34.5	45.4	30.6	5.3	1.1	3.4	1.5	1.2	1.0	1.4	1.5	1.5	0.8	1.2	1.2	1.4	1.7	0.9	0.9	1.5	3.5	0.6	3.4	3.9	3.6	4.5	3.2	4.1	4.3	3.6	4.5	4.5	3.7	5.3	5.6	6.4	18.5	21.5	14.9	15.0	15.8	9.9	8.0	2.1	8.4	5.3	0.0	5.7	12.2	9.2	0.0	21.6	6.7	20.2	5.9	5.5	1.0	10.0	3.4	7.1	8.4	25.7	8.7	7.1	12.6	6.1	16.3	8.5	0.0	3.5	6.8	40.4	10.3	1.7	13.7	13.7	8.2	15.4	13.9	1.0	4.4	8.6	5.4	11.2	10.3	0.7	4.1	30.2	20.1	5.8	8.2	4.5	27.4	14.1	16.8	20.3	10.4	3.4	0.0	5.3	7.2	9.6	10.3	18.3	15.6	13.5	10.3	4.4	13.9	18.2
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 209.1;Inhibitory neurons: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	18.8	21.6	45.2	19.2	61.0	24.1	16.8	2.1	74.4	20.4	9.6	23.7	15.8	24.2	9.9	14.3	19.5	13.5	21.5	65.3	9.0	21.3	25.2	19.1	20.5	14.6	4.8	21.4	18.7	34.5	25.2	17.9	14.5	19.5	14.9	27.7	16.5	16.9	23.6	15.1	22.9	21.9	0.0	21.0	26.0	25.7	8.6	34.3	18.0	15.9	18.0	22.2	16.9	43.3	24.5	20.2	17.4	26.3	48.7	29.1	24.9	21.6	32.6	31.3	30.4	15.9	10.2	45.6	12.6	43.9	30.7	21.1	33.4	20.9	19.0	38.9	50.9	47.1	27.1	18.3	24.3	47.0	36.1	26.2	12.9	26.7	14.7	20.4	25.8	13.8	130.2	37.6	24.6	33.8	41.6	16.0	13.8	43.4	20.6	41.1	38.1	8.5	17.3	38.3	42.6	31.0	28.4	32.6	22.6	24.3	27.6	21.3	26.2	56.4	29.1	21.1	18.5	28.6	31.3	35.8	37.4	33.2	24.1	2.1	3.7	5.3	3.2	3.8	3.1	3.4	3.6	3.9	2.5	3.4	3.6	5.0	5.1	7.0	3.3	8.5	4.3	2.2	45.2	61.0	2.1	74.4	65.3	9.0	14.6	4.8	14.5	0.0	8.6	43.3	13.0	12.8	30.4	65.6	14.7	10.1	6.5	7.6	9.6	35.8	17.2	14.4	30.2	20.0	10.5	7.3	47.9	17.8	21.5	19.7	1.9	9.7	36.5	10.3	17.9	15.5	19.2	12.4	209.1	6.3	19.6	15.6	38.7	15.8	12.0	13.8	11.4	19.7	20.1	37.0	127.4	16.7	10.2	21.0	12.6	25.3	19.9	20.2	10.6	39.4	10.9	23.1	16.5	50.3	88.4	8.9	9.7	24.0	15.5	10.1	23.8	10.3	9.6	25.4	26.3	14.5	19.3	35.3	29.6	14.1	9.8	20.0	15.3	26.1	14.3	8.9
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	45.6	45.0	57.3	33.1	61.4	78.0	47.6	64.4	63.2	62.6	53.2	50.9	35.8	58.8	54.8	48.0	58.6	40.2	45.8	59.2	62.3	50.4	40.5	47.2	46.8	57.9	60.7	60.2	46.1	56.0	56.5	39.6	60.4	57.6	44.0	46.4	45.8	42.6	68.5	60.5	47.0	62.2	54.4	59.8	48.0	46.0	61.0	45.7	67.8	58.6	47.5	48.9	51.3	68.2	49.2	40.1	34.2	53.9	92.8	68.1	28.9	50.9	88.3	65.3	53.8	51.7	43.4	46.1	57.1	78.5	41.1	44.9	57.3	52.5	50.1	63.0	50.9	33.0	48.8	26.6	64.8	38.5	60.9	71.7	62.4	72.3	51.3	56.3	63.7	46.3	57.5	67.9	56.0	91.2	41.0	30.9	27.6	69.5	60.3	36.2	28.8	54.4	45.2	61.2	41.3	35.4	35.5	71.1	46.7	53.9	60.1	71.9	50.3	46.5	36.3	37.3	55.1	71.6	50.4	89.8	52.9	39.7	82.3	41.3	22.7	36.0	17.8	24.7	19.9	20.4	18.5	23.6	24.3	16.7	15.1	14.3	21.0	19.3	26.3	13.9	20.0	23.9	57.3	61.4	64.4	63.2	59.2	62.3	57.9	60.7	60.4	54.4	61.0	68.2	16.8	16.0	24.3	19.2	26.4	22.3	18.2	17.7	28.5	33.5	24.3	24.6	7.0	21.5	17.7	12.9	20.9	30.1	16.0	28.7	19.6	20.9	12.2	21.5	19.9	19.3	18.5	26.9	17.8	24.9	20.5	25.9	23.0	24.6	19.0	30.0	15.4	12.4	29.2	35.3	19.0	16.4	10.2	20.1	20.5	15.5	23.3	21.3	14.2	15.9	29.3	23.1	21.6	18.1	25.8	23.5	17.3	24.8	24.4	17.7	25.7	15.2	17.1	28.4	13.1	24.2	23.2	28.9	25.1	24.8	31.1	48.7	23.8	44.7	20.2	28.1
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693791-6700815	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 90.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.1;Excitatory neurons: 24.4;Horizontal cells: 18.5;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 16.1;Peritubular cells: 13.9;Spermatogonia: 6.7"	"Group enriched"	"Detected in many"	4	"glioma: 14.7;testis cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.9;HAP1: 9.8;hTERT-RPE1: 16.2;NTERA-2: 20.8;SH-SY5Y: 19.4;U-2 OS: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	0.4	5.4	66.0	0.9	54.9	0.0	0.8	14.6	90.4	17.8	0.0	4.8	0.6	21.1	2.2	0.8	7.5	1.7	1.0	59.8	56.9	0.9	0.2	1.0	1.1	12.1	36.1	3.3	0.7	5.4	15.6	0.3	23.1	5.5	0.6	7.9	0.8	5.5	0.2	0.5	3.0	5.1	7.3	0.6	2.3	4.0	40.6	0.0	0.9	0.4	0.4	3.7	10.1	52.9	0.0	0.5	7.4	1.4	0.2	0.4	0.2	2.0	9.9	5.1	4.6	0.1	0.2	0.2	0.0	3.5	0.8	0.2	9.8	0.3	2.4	0.3	1.3	0.4	0.3	0.0	0.3	0.4	0.3	1.2	0.0	2.0	0.0	16.2	0.0	3.0	0.0	0.3	0.5	0.2	0.3	0.3	20.8	0.0	0.1	1.4	0.1	0.2	0.1	0.1	2.6	19.4	0.1	0.1	0.0	1.3	0.1	0.0	0.0	5.2	10.5	5.5	1.4	0.2	0.0	0.3	7.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.0	54.9	14.6	90.4	59.8	56.9	12.1	36.1	23.1	7.3	40.6	52.9	0.2	0.0	0.0	3.6	0.1	0.3	0.0	0.0	0.0	16.1	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.8	0.3	3.5	0.2	0.0	0.0	24.4	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	18.5	23.9	0.0	0.0	0.0	0.2	1.1	2.1	0.0	0.0	3.7	0.0	3.9	0.0	16.1	3.1	0.0	0.0	13.9	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	1.6	0.1	6.7	0.0	0.1	0.1	0.3	0.0	0.0	0.1
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054309-68198603	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	10.2	10.2	5.6	14.1	7.0	23.2	11.7	11.9	9.4	15.3	5.7	12.0	12.0	14.7	13.9	15.1	14.0	12.7	11.5	7.6	8.3	10.8	9.7	14.9	18.2	4.8	4.9	22.7	11.3	12.5	6.5	12.9	4.9	15.5	11.1	21.3	10.4	17.7	12.4	12.6	12.3	13.6	4.7	15.3	12.7	20.6	6.9	24.9	18.8	16.3	17.6	14.1	10.8	7.0	13.1	17.6	27.9	13.6	16.4	16.8	8.4	19.6	19.8	21.1	23.6	14.7	19.2	24.6	13.1	16.5	13.5	35.5	41.5	10.7	22.7	14.2	15.5	29.6	17.3	16.3	10.7	29.0	23.0	15.2	30.5	13.7	12.4	16.2	15.1	14.1	20.7	18.3	16.3	10.7	24.1	15.0	15.8	14.4	9.9	21.2	26.8	24.1	13.8	16.4	23.3	9.8	13.1	12.1	13.4	25.4	10.7	26.9	13.5	18.3	19.3	10.6	14.6	13.6	19.2	26.2	11.4	30.2	13.7	33.8	31.4	41.9	18.7	23.9	19.3	20.8	18.7	19.8	30.7	19.5	22.3	19.6	70.8	19.2	25.7	16.7	21.5	27.3	5.6	7.0	11.9	9.4	7.6	8.3	4.8	4.9	4.9	4.7	6.9	7.0	38.7	109.0	58.4	106.7	91.5	38.0	58.2	29.4	132.1	72.2	30.3	25.1	28.3	45.8	35.9	12.9	106.3	35.5	61.3	35.2	21.5	32.5	67.1	23.5	48.2	42.0	27.6	41.0	165.7	22.6	20.4	37.5	43.8	27.2	56.3	30.6	40.0	34.9	45.8	48.8	136.6	30.2	14.2	102.4	38.8	33.4	123.6	62.6	21.4	248.3	104.9	57.8	56.7	120.1	126.2	25.5	25.0	113.6	59.3	48.3	38.1	20.0	25.0	64.8	32.9	47.7	31.6	66.7	45.4	51.1	33.0	36.0	67.6	22.6	22.4	64.5
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.8	5.4	7.3	4.1	8.1	7.4	5.1	16.9	9.8	4.9	6.4	4.9	2.8	5.0	7.5	3.7	4.5	4.6	6.8	8.7	6.2	6.4	5.9	4.3	6.2	4.7	6.9	5.0	4.2	11.8	5.6	3.9	5.4	6.5	7.0	10.9	5.5	4.4	16.1	7.7	4.2	4.7	3.7	6.0	4.5	67.2	7.9	4.6	8.2	10.2	5.2	4.1	4.4	8.0	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	7.3	8.1	16.9	9.8	8.7	6.2	4.7	6.9	5.4	3.7	7.9	8.0	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	21.9	11.5	11.3	12.8	10.8	4.9	23.3	10.2	12.2	35.2	13.5	24.5	7.6	32.0	7.9	37.3	37.2	12.1	18.1	10.9	12.8	13.7	7.2	17.9	9.1	11.7	12.2	23.4	13.1	14.4	15.4	10.7	11.7	21.6	8.0	9.8	29.2	21.1	25.8	34.4	14.6	23.6	11.3	13.3	21.7	11.1	13.9	13.5	14.9	14.5	17.9	29.1	34.9	10.7	34.6	23.5	23.8	21.1	35.9	67.3	14.5	31.8	43.6	35.5	39.3	19.3	22.2	17.8	33.6	54.8	15.0	35.0	12.4	50.4	29.9	19.4	18.3	8.2	15.9	10.4	35.8	14.7	38.8	55.2	32.3	32.9	18.6	45.6	52.0	15.8	13.2	24.0	74.7	57.6	15.8	7.8	37.0	97.3	37.7	24.6	16.2	11.7	28.2	20.5	8.1	37.9	30.7	16.9	15.5	27.0	78.0	22.1	80.7	47.2	34.8	31.7	20.9	32.6	15.7	11.5	45.8	10.9	23.9	8.9	9.1	10.7	10.6	8.7	11.4	5.4	6.7	11.6	6.8	3.6	6.2	6.0	2.2	15.2	12.5	8.4	8.1	7.0	11.3	10.8	10.2	12.2	10.9	12.8	11.7	12.2	11.7	11.3	13.9	10.7	14.7	22.4	11.5	8.5	8.6	10.7	7.9	15.4	19.4	10.2	16.2	16.5	0.9	4.3	22.8	16.5	12.5	3.7	10.0	2.1	1.9	7.9	2.3	29.4	14.8	12.3	4.2	2.1	4.2	7.7	7.3	11.9	13.3	19.1	10.8	4.9	13.2	3.8	5.2	10.1	3.9	6.2	12.2	4.4	7.0	3.9	14.3	4.1	5.4	7.5	13.1	4.2	8.2	6.6	7.4	12.7	2.0	13.2	4.8	9.2	2.1	1.8	37.6	11.8	26.3	7.0	13.6	4.0	11.4	19.9	16.3	4.0	8.6	6.0	2.8	10.4
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007736-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.7;Late spermatids: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	8.0	10.7	9.2	6.0	11.8	4.7	9.0	11.6	11.4	11.0	3.8	15.4	6.6	10.5	2.3	11.1	8.8	2.9	10.1	8.5	7.4	8.7	15.5	7.9	5.6	12.2	11.5	10.6	13.9	3.5	10.4	5.3	10.3	11.4	2.4	3.7	9.8	3.9	10.6	12.7	9.9	3.8	8.5	11.6	12.1	37.2	10.4	5.9	7.5	4.8	4.0	10.4	9.7	17.4	15.1	10.6	9.7	9.3	4.7	4.2	15.4	9.0	4.9	9.2	8.4	16.7	6.8	11.4	7.9	4.8	10.1	15.5	10.0	7.1	4.0	18.5	15.8	8.2	7.8	13.1	9.6	12.0	13.8	4.9	7.8	8.3	5.1	5.1	11.1	11.6	15.5	15.2	4.5	15.5	21.9	13.9	21.6	7.3	9.7	19.3	9.9	15.0	6.1	8.3	17.8	19.8	12.8	12.4	10.3	7.3	11.5	11.0	8.2	9.2	13.2	19.4	14.2	28.3	22.8	14.4	7.7	14.6	11.5	10.5	13.2	19.8	15.2	15.3	10.8	16.1	10.8	14.0	11.0	14.6	9.3	10.6	15.8	17.1	19.5	11.0	13.0	10.3	9.2	11.8	11.6	11.4	8.5	7.4	12.2	11.5	10.3	8.5	10.4	17.4	12.8	3.2	15.0	15.0	10.1	18.4	8.4	15.8	7.4	18.8	14.5	11.2	3.6	11.5	11.5	9.2	12.5	24.3	12.3	13.2	7.9	17.1	103.7	13.9	10.7	12.3	22.1	9.9	7.3	17.6	16.9	9.1	11.7	12.4	7.0	15.2	11.4	12.3	14.6	26.9	5.7	15.6	20.3	8.3	9.2	264.3	14.0	10.6	7.2	2.8	12.8	11.3	10.3	6.6	18.0	13.5	7.8	18.4	12.0	11.9	14.0	12.5	15.6	23.1	6.6	8.1	9.3	69.1	42.1	7.4	15.5	36.4	10.1	13.3	12.4	9.0
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782133-73016461	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 334.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite"		"HPA052269: AB_2681779, HPA066120: AB_2685621"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	7.6	9.1	5.2	6.7	5.5	10.2	12.2	7.4	7.3	11.5	9.8	7.4	7.0	11.5	10.7	7.1	11.0	8.4	7.5	4.6	4.8	8.3	9.8	8.7	9.9	5.1	5.0	12.6	5.5	8.5	7.5	9.7	4.7	9.8	8.8	10.2	7.4	8.2	6.6	8.5	6.9	8.5	4.7	8.4	8.7	14.3	5.0	13.0	15.5	7.4	8.4	10.1	8.0	6.0	13.1	4.2	16.8	9.8	14.4	25.3	6.5	11.9	15.9	11.8	14.4	5.8	22.1	12.0	13.7	13.2	6.2	11.1	9.1	12.0	18.9	12.2	8.7	8.2	10.9	6.7	18.4	31.0	7.5	16.4	9.4	12.7	30.7	15.1	15.5	8.2	11.7	6.1	15.9	3.7	15.2	18.6	8.9	23.3	3.9	12.0	12.4	12.4	24.5	7.0	9.6	15.4	9.2	6.3	16.3	13.5	10.6	21.8	11.8	6.0	6.3	9.5	7.2	9.7	7.5	6.0	18.0	17.3	13.3	8.4	3.4	6.1	6.0	3.7	6.4	5.9	6.4	6.5	3.0	5.6	8.7	7.3	3.3	8.6	3.6	5.1	5.3	2.5	5.2	5.5	7.4	7.3	4.6	4.8	5.1	5.0	4.7	4.7	5.0	6.0	33.8	32.1	30.8	101.2	21.6	10.3	16.3	10.5	16.5	17.1	15.5	17.8	28.1	14.3	27.7	5.5	16.7	9.4	19.3	6.6	13.7	11.6	334.5	41.5	33.6	20.0	7.2	15.2	115.1	11.1	10.2	20.4	21.4	18.5	24.1	21.8	9.7	5.6	7.1	18.5	119.3	9.7	12.2	8.6	3.5	50.4	19.3	10.3	8.8	92.8	9.8	11.9	17.5	143.7	138.6	12.0	8.5	15.4	11.6	11.8	7.1	6.5	46.3	31.3	13.1	28.9	17.9	59.4	39.2	11.8	8.9	6.0	23.1	25.6	10.0	13.7
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957175-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 500.3;Oligodendrocytes: 709.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles		NA	NA		40000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favorable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	183.5	62.5	97.1	120.4	162.1	111.4	111.5	119.3	118.7	86.4	43.8	86.3	106.3	79.3	52.4	109.1	66.1	127.0	87.9	91.7	110.8	168.5	147.0	99.4	82.7	125.2	130.7	94.4	80.6	120.6	36.5	157.2	131.6	73.1	83.1	71.5	62.3	93.6	75.8	74.2	115.5	135.3	106.0	126.5	73.0	64.9	120.7	93.1	75.7	101.9	96.7	139.5	73.5	194.7	167.0	78.4	121.1	85.9	185.5	188.8	228.5	211.7	274.7	164.4	143.0	310.7	222.4	126.0	210.8	342.6	171.1	134.6	129.4	154.2	232.8	38.6	45.0	364.9	101.5	98.9	185.6	87.2	158.3	166.6	161.7	308.7	253.3	275.1	178.7	85.9	239.1	103.0	305.2	98.2	103.9	76.8	66.9	269.0	42.7	69.8	182.2	91.1	312.5	139.2	72.9	58.7	258.4	85.4	68.7	156.5	115.6	67.0	196.9	298.6	104.1	355.0	170.2	36.7	107.1	118.4	70.8	64.6	206.6	6.4	13.5	7.5	5.7	11.7	4.9	3.1	4.2	8.0	11.4	2.1	4.2	4.0	40.6	7.1	12.5	3.9	6.4	5.3	97.1	162.1	119.3	118.7	91.7	110.8	125.2	130.7	131.6	106.0	120.7	194.7	147.1	35.3	58.9	134.5	33.3	116.0	44.4	33.0	30.1	20.8	34.8	28.6	46.4	42.9	34.3	71.7	12.5	42.9	43.9	64.2	31.3	57.7	59.3	32.3	32.8	98.7	25.1	88.8	144.7	37.6	127.1	44.6	34.1	50.9	48.2	23.2	71.4	52.3	85.0	40.4	140.7	30.1	30.5	142.8	229.2	95.4	35.8	127.4	60.5	500.3	92.1	22.6	32.0	188.0	709.3	90.2	55.3	43.6	39.1	49.5	71.4	84.0	41.0	16.3	78.9	36.4	92.7	17.3	14.1	34.4	96.5	41.3	38.9	23.6	30.6	77.7
PICK1	"dJ1039K5, MGC15204, PRKCABP"	ENSG00000100151	"Protein interacting with PRKCA 1"	Q9NRD5	22	38056311-38075701	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.1;Late spermatids: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000819, HPA072674"	Approved		Supported	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA000819: , HPA072674: AB_2686547"	"unprognostic (1.97e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.56e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.61e-3)"	8.8	14.9	12.4	4.8	15.2	5.4	13.5	12.8	20.3	9.9	12.9	11.9	10.1	11.7	13.8	15.9	16.3	8.9	18.2	14.5	13.5	15.1	17.5	10.8	5.4	14.5	13.6	15.4	18.5	29.3	28.8	6.7	16.7	25.6	12.2	5.9	18.6	12.6	26.3	16.9	11.3	11.3	11.6	10.1	16.2	27.4	15.6	5.9	14.6	16.2	8.2	9.3	12.0	23.0	19.5	13.7	7.6	10.0	5.3	4.1	11.3	10.7	12.8	22.5	22.7	14.6	12.0	8.6	11.6	13.0	17.0	20.8	21.0	43.2	19.3	5.3	33.6	3.1	16.8	17.1	19.3	10.1	20.4	13.3	24.9	14.8	21.9	22.8	8.8	11.1	6.4	6.2	4.7	12.4	6.0	0.9	12.1	44.3	14.9	5.1	0.3	7.8	25.8	31.1	31.5	16.0	12.0	28.8	11.1	11.1	16.8	7.3	2.4	6.4	12.0	8.6	6.4	13.9	3.4	2.7	13.8	3.4	9.4	0.0	0.9	0.0	0.5	0.4	0.2	0.3	0.5	1.0	1.6	1.1	1.0	0.5	0.6	0.4	0.5	0.3	0.7	0.6	12.4	15.2	12.8	20.3	14.5	13.5	14.5	13.6	16.7	11.6	15.6	23.0	8.1	9.6	10.6	11.1	8.1	8.0	14.2	15.6	12.0	12.7	18.7	16.1	10.2	11.5	12.1	7.3	8.4	26.1	6.0	25.4	11.7	18.8	116.1	15.4	3.6	7.8	10.3	1.7	26.8	15.7	14.8	6.8	29.6	17.3	8.9	36.3	5.7	9.7	15.1	20.2	19.4	20.1	18.3	31.5	13.3	85.5	11.1	16.3	7.2	6.5	16.0	13.6	8.2	8.5	29.0	21.4	18.5	17.0	5.8	22.1	18.3	16.0	12.8	12.5	13.1	6.0	9.5	17.2	6.7	12.0	9.7	38.4	6.8	15.5	18.5	14.7
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Inhibitory neurons: 142.2;Langerhans cells: 210.4;Microglial cells: 179.9;Oligodendrocyte precursor cells: 543.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 71.1;intermediate monocyte: 79.4;myeloid DC: 83.6"	"Group enriched"	"Detected in many"	53	"dendritic cells: 83.6;monocytes: 79.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;hTEC/SVTERT24-B: 86.1;LHCN-M2: 57.3;REH: 62.3;RH-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	31.2	29.5	18.8	13.9	20.8	2.9	25.8	9.0	21.2	30.2	9.0	37.6	5.5	22.9	8.9	12.0	33.9	12.7	17.0	20.6	15.5	5.6	62.2	24.4	4.4	14.8	30.5	31.0	13.8	1.5	8.8	26.1	13.6	19.2	21.5	3.8	10.2	14.8	13.1	20.0	25.1	16.7	11.8	20.3	25.5	5.5	21.4	3.4	16.6	20.8	3.6	30.9	27.0	13.8	0.0	1.9	0.0	0.0	54.5	10.5	0.1	9.2	34.7	5.8	7.1	0.7	0.0	0.0	0.2	13.0	18.0	1.7	0.0	1.7	7.8	0.0	0.0	0.0	4.0	0.1	22.3	0.0	0.1	19.8	15.5	86.1	14.0	16.1	0.0	0.0	0.0	0.1	57.3	0.1	0.1	0.0	0.9	7.6	5.2	62.3	90.7	0.1	1.1	0.0	1.8	2.3	19.4	1.8	0.1	0.7	0.2	0.0	0.0	22.3	8.3	21.1	8.8	0.1	0.0	0.0	29.3	0.1	3.7	0.0	71.1	0.0	0.0	79.4	0.4	0.2	0.0	0.2	83.6	0.0	0.0	0.0	1.5	0.0	16.7	0.4	0.3	28.4	18.8	20.8	9.0	21.2	20.6	15.5	14.8	30.5	13.6	11.8	21.4	13.8	4.0	6.4	70.9	53.8	1.6	15.6	6.1	13.5	6.8	5.7	0.9	1.7	2.6	8.6	11.1	0.0	0.0	1.9	0.2	75.7	0.0	2.5	0.1	1.4	37.8	4.1	4.9	0.4	121.0	4.0	31.5	107.3	1.1	4.4	6.3	7.8	4.2	135.0	3.3	0.0	142.2	11.9	4.1	42.5	210.4	1.9	88.0	50.1	21.4	179.9	35.2	14.0	1.0	543.4	3.5	1.6	24.2	75.2	0.5	21.9	39.5	0.3	2.5	1.3	0.0	4.8	8.7	0.4	2.1	1.4	14.5	4.8	2.4	41.0	36.0	1.4
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.3	3.1	2.3	2.3	2.8	7.4	3.3	2.5	4.1	3.6	2.8	3.9	3.0	3.0	0.1	4.0	3.3	1.1	2.9	2.1	2.2	3.1	5.5	2.7	3.2	3.6	2.6	2.8	3.7	0.9	2.8	1.9	3.5	4.3	0.6	0.2	3.2	1.0	6.5	5.5	4.5	0.7	2.5	5.0	4.0	2.4	3.0	3.2	3.8	0.8	1.0	3.2	3.1	4.6	5.4	6.2	2.9	6.2	0.6	2.2	26.6	7.5	2.0	2.7	3.6	5.7	10.2	4.4	2.3	1.1	2.5	7.9	2.1	3.0	0.5	9.0	12.3	3.8	5.0	12.0	6.8	4.3	9.4	8.4	5.3	1.4	0.3	0.5	5.0	10.3	4.5	3.3	1.1	2.6	12.0	7.2	4.0	5.8	4.3	19.4	4.2	8.6	1.1	1.9	5.1	6.8	3.1	8.2	2.0	1.6	6.0	7.3	2.7	3.4	7.6	2.5	4.9	10.5	6.4	8.5	4.4	3.5	5.6	0.0	0.5	0.0	0.4	0.4	0.4	0.3	0.3	0.4	0.8	0.4	0.4	0.4	0.0	0.1	0.4	0.2	0.9	0.4	2.3	2.8	2.5	4.1	2.1	2.2	3.6	2.6	3.5	2.5	3.0	4.6	4.9	3.2	8.8	25.8	7.2	0.0	3.6	0.0	6.2	14.9	7.3	8.1	4.2	5.7	5.6	3.7	10.4	29.2	8.9	12.0	1.9	2.5	1.4	6.7	4.2	3.7	9.0	5.7	12.8	4.6	7.5	4.4	10.7	4.2	1.3	14.0	2.2	10.3	5.5	1.7	14.2	8.1	0.0	3.5	0.0	1.9	7.2	3.8	0.0	7.5	4.1	7.0	2.1	6.6	26.9	3.5	9.9	4.1	6.0	4.4	10.0	3.8	0.0	15.4	0.0	5.7	3.5	25.2	20.8	6.7	0.0	9.7	6.3	7.5	10.5	3.6
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 270.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047185	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA047185: AB_2679973"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	79.0	26.4	15.2	20.5	16.0	29.8	65.1	16.5	19.0	30.7	10.4	86.7	7.7	40.4	0.5	48.4	38.1	9.0	29.4	12.9	13.8	57.2	48.2	67.2	14.8	25.0	17.6	15.8	21.9	5.2	6.8	18.6	22.5	49.4	4.8	1.7	33.3	11.2	6.8	48.8	41.1	14.3	17.6	55.2	38.0	5.2	17.4	7.2	32.4	4.3	5.9	65.3	40.4	21.2	42.0	42.1	6.5	31.3	27.6	30.0	155.2	99.9	43.9	36.1	14.0	61.3	68.5	34.2	68.2	48.4	18.0	88.4	13.9	36.0	7.3	33.8	56.0	58.3	77.9	49.4	41.6	26.4	9.3	24.6	19.4	28.3	23.3	21.3	43.9	56.1	80.4	42.8	21.2	270.1	32.7	91.2	14.7	19.7	25.7	77.7	9.3	86.9	16.4	61.1	12.8	3.4	130.5	68.0	17.8	6.5	93.0	76.5	120.1	86.0	49.6	58.4	51.6	8.7	21.1	21.2	67.9	46.5	52.2	1.8	5.0	3.3	8.1	9.7	7.8	2.3	6.0	5.5	9.7	3.1	1.0	2.5	0.1	1.0	13.1	1.7	5.0	3.9	15.2	16.0	16.5	19.0	12.9	13.8	25.0	17.6	22.5	17.6	17.4	21.2	69.1	73.7	19.8	27.1	14.3	19.1	12.9	27.6	5.2	2.2	23.5	16.3	5.0	10.0	17.1	58.8	16.7	6.7	16.8	19.3	0.0	37.3	1.6	6.2	15.4	45.0	21.0	12.6	0.4	21.7	30.5	13.7	25.0	9.9	8.8	0.7	55.3	22.0	23.6	3.3	0.5	29.5	10.2	16.8	19.0	1.0	5.6	21.8	16.0	21.5	15.6	1.5	3.1	16.6	5.0	85.9	18.0	2.6	30.8	48.3	8.1	5.5	9.7	4.1	0.0	30.3	9.0	0.3	2.0	18.9	15.9	5.1	21.6	5.6	12.0	21.8
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319452-15335554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"			"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	2.1	2.9	2.2	2.9	2.7	9.2	3.1	2.0	3.6	2.8	0.8	3.7	1.9	3.0	3.5	5.1	2.8	3.7	2.0	1.6	1.8	3.8	4.5	6.7	3.5	2.8	2.7	2.4	4.0	3.3	0.6	3.6	2.2	2.7	3.7	4.5	4.6	1.7	1.3	1.4	2.4	2.5	2.2	2.0	2.8	2.6	2.3	4.0	4.4	1.3	4.7	10.3	1.9	5.8	14.5	8.3	9.1	5.0	2.6	2.8	7.0	3.7	5.7	7.4	7.3	9.2	6.5	6.6	2.9	2.9	9.0	5.8	14.3	11.4	12.6	6.1	9.5	5.5	11.0	5.8	4.5	8.8	2.9	3.3	8.1	10.0	16.0	2.4	5.0	5.2	6.4	7.0	5.1	9.2	9.0	3.4	4.7	5.5	8.2	3.0	12.4	10.7	5.6	9.4	6.2	9.4	6.9	6.8	14.4	8.7	6.6	7.4	4.2	6.2	2.4	14.0	7.3	5.4	7.2	9.9	9.4	5.6	7.9	22.9	3.8	4.3	2.6	6.3	3.7	3.0	4.1	2.6	3.9	2.1	3.8	2.9	5.2	1.8	8.6	2.6	4.1	2.7	2.2	2.7	2.0	3.6	1.6	1.8	2.8	2.7	2.2	2.2	2.3	5.8	6.4	19.2	83.5	6.8	7.2	29.6	41.9	10.6	13.6	3.5	13.2	10.5	6.9	5.7	20.1	3.7	0.0	6.3	7.4	8.4	11.7	7.6	5.4	30.8	9.8	7.9	10.7	9.3	2.2	5.8	10.2	12.7	17.9	45.6	33.6	3.0	3.6	4.4	8.8	3.3	2.0	5.0	2.0	8.4	43.4	4.4	3.1	18.1	28.4	2.8	3.6	4.2	4.1	1.0	7.7	8.3	5.1	3.0	5.5	32.0	2.1	6.6	19.8	3.0	13.1	10.6	16.3	2.7	3.7	35.5	55.0	28.0	11.7	2.9	6.0	62.2
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	6.4	4.8	2.3	5.8	2.6	9.1	9.0	2.8	2.6	5.5	3.1	7.0	7.5	6.4	11.0	5.7	7.8	6.3	2.8	2.5	3.3	10.3	9.4	6.3	8.2	2.8	2.7	4.7	5.7	10.6	3.9	4.8	2.6	7.7	7.8	7.9	4.3	6.8	1.5	6.1	5.8	5.6	2.7	6.1	7.6	6.5	2.7	6.3	13.3	1.8	8.6	7.5	3.7	3.1	10.5	12.2	5.8	4.1	6.6	13.2	7.8	9.0	19.9	10.4	17.8	5.1	10.3	10.9	10.4	12.9	15.6	18.3	3.3	9.5	8.6	10.4	6.4	10.9	13.6	6.7	11.9	30.8	8.7	12.5	11.4	7.9	10.7	13.8	13.6	9.2	12.2	6.9	15.0	9.1	3.4	12.8	3.1	7.9	4.8	4.9	5.6	24.1	18.4	12.4	2.5	6.2	8.1	12.2	17.3	5.4	11.7	22.2	9.5	13.6	4.3	3.7	18.6	8.1	15.9	8.6	12.4	34.5	10.2	13.6	7.7	3.3	6.2	9.7	7.0	6.0	6.1	6.9	7.0	3.9	4.8	5.5	14.5	5.3	11.4	5.4	6.5	5.5	2.3	2.6	2.8	2.6	2.5	3.3	2.8	2.7	2.6	2.7	2.7	3.1	3.5	9.6	9.5	17.6	27.5	4.6	9.5	14.9	4.6	3.3	5.6	4.2	3.4	1.5	14.9	0.0	12.5	12.4	11.2	4.8	1.9	7.4	26.8	4.3	3.2	4.7	6.6	8.2	18.3	10.9	12.0	6.0	6.1	6.4	8.2	4.6	6.8	4.4	8.6	1.7	17.7	4.1	4.1	7.5	6.7	5.1	1.5	8.8	3.6	12.2	8.4	2.7	11.3	17.1	14.6	6.9	4.0	1.5	3.8	3.4	6.4	9.7	7.9	9.4	6.6	4.8	4.2	5.9	3.8	5.7	4.0	6.6	12.5	4.2	4.0	7.4
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	18.2	20.8	12.8	13.0	13.2	27.2	21.8	13.8	16.2	21.4	13.8	20.7	15.4	24.3	38.9	16.6	23.5	18.1	14.9	13.3	14.4	20.0	16.0	15.0	19.7	14.1	13.8	22.4	25.9	19.6	18.1	20.2	14.4	16.4	19.3	17.7	20.7	17.5	13.6	40.7	21.6	18.9	13.6	20.3	19.6	18.3	13.7	27.6	15.3	11.1	20.9	18.8	18.8	14.5	33.3	28.1	37.2	25.5	27.8	25.0	27.8	21.1	23.5	35.6	30.9	25.6	47.6	17.7	30.4	25.4	28.3	35.0	24.6	30.8	28.6	39.5	28.4	21.8	25.5	31.9	30.6	44.9	27.4	37.4	36.0	25.6	27.9	27.7	23.0	33.5	33.5	32.9	29.2	17.3	34.4	40.1	38.5	67.4	38.7	27.9	30.3	31.9	55.5	24.1	19.5	37.1	30.5	35.6	50.3	52.4	31.9	31.6	21.0	22.6	37.8	28.0	22.8	21.8	33.1	27.6	16.2	29.0	43.9	71.5	28.1	55.6	35.4	26.9	29.8	37.2	40.6	37.4	24.3	33.8	60.1	43.4	18.2	51.6	29.5	24.1	40.0	40.9	12.8	13.2	13.8	16.2	13.3	14.4	14.1	13.8	14.4	13.6	13.7	14.5	19.4	9.6	10.3	0.0	24.2	13.5	19.7	31.2	18.2	15.7	20.9	29.5	20.7	17.2	17.7	29.5	8.4	61.6	23.9	20.6	33.2	31.9	78.2	15.2	19.3	20.0	7.8	58.9	0.0	41.1	50.9	31.0	15.8	18.6	7.6	21.6	22.9	15.4	35.3	20.2	0.0	19.6	32.6	23.7	16.9	80.8	47.2	20.0	26.6	0.0	27.6	30.1	42.2	0.0	0.0	34.8	27.6	40.6	12.4	14.2	25.2	20.9	20.1	17.9	32.9	22.2	18.7	30.0	18.8	17.7	19.0	23.7	29.1	21.5	18.9	15.5
PIGF		ENSG00000151665	"Phosphatidylinositol glycan anchor biosynthesis class F"	Q07326	2	46580937-46617055	"Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051389	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051389: AB_2681464"	"unprognostic (3.85e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.97e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.71e-2)"	16.7	29.0	16.8	18.3	19.3	10.3	17.0	20.3	21.0	12.7	19.8	18.4	17.3	11.1	27.8	15.7	14.9	18.2	17.0	17.1	20.9	20.1	16.6	12.6	15.7	19.8	19.2	13.7	23.0	20.1	15.5	17.4	20.2	15.4	19.1	25.3	21.9	9.9	25.8	12.2	17.9	7.6	21.5	13.3	16.4	26.2	18.4	8.4	22.8	14.4	12.4	18.5	11.6	22.5	31.0	18.9	39.7	22.9	47.2	48.8	22.1	37.5	22.8	15.1	15.1	9.4	22.2	18.2	68.8	25.3	39.9	25.1	35.9	27.1	30.4	52.1	36.7	36.2	13.9	49.9	27.5	23.1	25.6	33.4	40.7	23.1	34.7	50.5	41.8	16.6	33.8	51.5	56.7	8.7	18.1	22.5	31.3	64.9	29.7	18.7	36.4	38.2	44.0	32.9	27.6	35.1	17.1	24.4	57.0	35.1	14.4	27.7	27.1	25.2	29.0	35.8	36.7	25.8	31.2	32.2	27.6	43.8	45.0	3.6	12.5	11.5	9.3	18.4	10.2	11.8	11.2	9.4	14.4	14.0	8.2	10.7	6.2	10.9	17.7	19.1	14.7	6.6	16.8	19.3	20.3	21.0	17.1	20.9	19.8	19.2	20.2	21.5	18.4	22.5	35.0	9.6	18.5	32.0	23.8	25.5	38.0	93.5	30.1	32.9	35.9	34.0	3.7	30.0	54.3	20.2	29.2	39.2	24.6	18.3	35.2	29.6	65.0	31.9	26.3	26.4	17.4	17.9	21.9	29.7	53.4	24.7	18.8	25.8	19.0	34.5	26.7	22.4	37.6	37.0	24.4	26.3	81.4	22.5	21.5	29.5	14.9	24.8	30.2	30.0	27.9	71.1	23.7	41.2	70.7	21.1	23.8	16.1	38.6	45.6	26.0	31.7	38.1	27.4	6.6	20.9	31.3	96.4	41.8	37.9	34.1	32.3	19.7	39.1	36.8	44.9
PIGG	"FLJ20265, GPI7, LAS21"	ENSG00000174227	"Phosphatidylinositol glycan anchor biosynthesis class G"	Q5H8A4	4	499210-540200	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015997	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA015997: AB_2164679"	"unprognostic (3.87e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.61e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.97e-2)"	12.7	13.7	6.0	11.4	6.7	9.4	12.8	6.0	6.9	10.6	7.8	12.9	14.2	11.5	20.5	11.4	11.6	12.9	8.1	7.5	5.5	9.5	8.9	11.6	13.4	6.7	6.1	15.4	14.1	17.5	15.2	12.6	7.0	12.1	12.0	10.7	14.7	11.2	8.1	20.3	13.5	9.8	6.0	13.1	13.2	8.8	6.8	10.8	14.9	4.1	11.3	12.9	11.5	10.3	18.7	20.2	18.2	15.2	33.0	23.1	28.7	24.0	28.8	25.1	29.7	21.5	42.4	7.8	17.4	30.8	46.0	25.0	17.2	23.5	23.1	7.3	19.1	19.4	24.7	17.0	22.6	27.3	27.6	26.2	38.9	23.2	12.7	27.4	19.4	14.9	21.4	16.5	22.6	11.6	15.3	23.9	29.6	20.2	28.2	16.9	11.2	11.5	24.2	25.4	18.2	23.2	17.7	18.3	17.6	17.3	29.2	24.1	30.0	25.6	12.0	13.3	37.7	13.5	19.4	12.3	21.7	19.9	32.7	20.5	5.1	4.2	5.9	6.5	6.7	3.5	4.5	5.7	8.1	2.8	4.8	3.9	3.8	7.8	4.9	7.2	8.3	3.9	6.0	6.7	6.0	6.9	7.5	5.5	6.7	6.1	7.0	6.0	6.8	10.3	14.4	16.0	12.6	21.9	12.6	8.9	10.9	17.7	12.5	10.8	11.4	9.3	8.6	7.2	23.0	9.2	4.2	16.7	14.8	14.9	0.0	15.8	2.4	16.4	15.4	13.1	10.8	11.2	23.2	17.8	14.8	10.2	22.4	20.2	12.7	19.8	8.9	10.1	9.1	8.4	15.1	8.5	16.2	11.5	6.5	0.7	13.7	9.5	8.8	24.4	13.6	11.6	17.5	16.6	26.0	18.4	12.8	12.8	14.9	13.7	13.1	5.6	19.9	10.5	19.7	10.4	11.5	9.9	8.2	10.1	6.3	23.1	14.2	13.0	9.7	14.2
PIGH	GPI-H	ENSG00000100564	"Phosphatidylinositol glycan anchor biosynthesis class H"	Q14442	14	67581955-67600286	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Autism spectrum disorder, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031624	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA031624: AB_10601046"	"unprognostic (1.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.69e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.68e-7)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.73e-1)"	15.4	34.2	19.9	8.2	23.6	27.2	19.2	23.4	26.4	25.9	22.5	14.2	12.6	14.0	36.6	14.0	15.5	13.6	15.1	19.4	23.4	34.7	23.9	13.7	11.9	23.9	22.4	23.8	29.2	66.7	13.6	12.5	23.9	28.9	11.6	47.6	26.2	16.0	32.2	19.9	16.1	10.9	22.6	16.5	19.6	20.7	22.7	11.8	28.8	24.7	13.3	16.4	14.4	27.4	24.5	15.6	14.7	30.3	32.1	12.3	12.4	13.3	16.1	18.2	17.7	25.4	8.3	16.5	12.9	9.1	30.4	17.5	26.3	18.9	20.1	25.4	34.8	17.3	12.4	26.1	25.2	12.8	19.9	17.9	23.8	13.7	21.0	5.6	11.8	28.5	39.7	11.5	13.3	21.4	18.8	21.4	2.7	33.8	41.9	6.3	14.8	9.9	19.6	20.0	18.3	22.1	10.1	19.4	33.8	10.8	22.0	12.5	6.1	18.1	23.2	23.8	15.8	21.9	15.2	11.2	13.9	27.1	25.7	42.0	24.8	52.5	44.9	35.1	58.5	61.8	46.5	41.8	25.4	72.0	48.3	45.0	12.1	51.5	45.7	29.6	48.2	35.0	19.9	23.6	23.4	26.4	19.4	23.4	23.9	22.4	23.9	22.6	22.7	27.4	14.8	3.2	14.1	5.5	23.6	20.6	20.4	37.1	19.4	35.5	22.8	25.9	4.9	22.8	17.8	22.0	35.5	29.8	28.7	9.5	29.4	22.3	12.1	20.3	10.5	16.1	7.2	13.2	8.0	37.1	28.7	20.8	9.2	10.9	7.0	13.4	13.9	14.6	22.7	26.9	10.4	14.9	26.4	7.6	12.9	9.4	21.5	12.3	35.6	7.5	7.0	96.6	23.7	8.5	10.3	24.3	10.6	21.1	31.2	26.8	29.4	31.3	12.2	45.5	0.0	22.7	18.7	78.8	59.5	17.7	20.9	56.4	20.7	34.6	14.1	18.2
PIGK	"GPI8, hGPI8"	ENSG00000142892	"Phosphatidylinositol glycan anchor biosynthesis class K"	Q92643	1	77088989-77219430	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056383, HPA057040"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA056383: AB_2683109, HPA057040: AB_2683319"	"unprognostic (2.43e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.12e-3)"	9.8	12.4	5.2	6.3	6.6	8.8	12.4	6.1	9.4	9.7	5.7	8.5	6.9	9.5	9.7	6.5	9.3	10.0	14.1	6.0	6.4	17.7	13.2	9.2	8.8	5.9	5.5	9.6	9.6	16.3	6.5	6.4	6.2	11.2	9.3	9.8	9.5	8.8	7.0	4.8	7.3	10.7	6.8	9.8	8.9	6.0	5.5	8.5	16.3	9.8	7.5	9.3	4.2	9.8	12.3	14.2	11.5	14.7	64.1	48.1	18.6	24.4	33.1	25.0	35.6	11.8	12.2	10.7	24.4	43.1	29.7	10.8	14.8	20.8	45.2	22.1	15.1	14.6	13.8	11.1	14.4	32.5	12.4	29.2	11.1	26.7	22.9	29.9	37.4	13.2	18.0	35.6	39.0	8.3	10.3	13.2	10.4	13.7	23.4	12.0	33.7	13.3	31.9	8.9	9.7	9.1	23.2	20.8	27.1	18.9	10.0	18.5	21.5	40.1	15.6	21.9	25.0	16.1	23.7	10.7	29.8	40.5	16.2	7.2	3.0	5.8	5.8	3.4	6.0	3.7	6.0	5.0	5.7	3.2	7.5	6.8	1.5	7.4	3.5	3.9	9.8	4.7	5.2	6.6	6.1	9.4	6.0	6.4	5.9	5.5	6.2	6.8	5.5	9.8	17.7	9.6	9.1	16.3	14.4	9.6	15.2	23.7	5.2	14.2	21.0	14.2	23.0	18.6	18.3	40.5	2.1	16.0	14.1	9.7	3.9	20.8	2.1	15.6	15.5	18.1	10.8	16.4	51.4	21.1	35.7	29.3	6.6	14.1	17.7	14.7	20.3	29.3	20.3	8.4	40.2	12.4	24.4	14.5	13.9	3.7	19.6	11.9	19.6	26.2	9.2	17.6	18.6	40.7	78.2	11.9	8.5	27.4	41.7	10.1	9.3	23.3	25.3	12.4	52.6	16.3	24.1	75.8	30.2	9.4	11.9	15.2	15.5	12.7	12.7	11.5
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031990	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA047418	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	3.2	4.2	3.0	4.0	4.8	1.8	5.2	4.6	3.7	4.1	3.3	3.8	4.4	3.6	6.0	3.4	3.9	3.3	2.6	3.2	4.0	4.0	5.2	3.6	4.3	5.7	4.3	4.0	7.8	6.7	3.6	3.4	5.3	6.1	4.3	8.1	6.3	4.1	1.4	5.5	4.8	3.2	4.7	4.2	4.6	3.5	4.4	4.9	6.1	1.7	4.0	3.0	2.6	8.6	5.8	5.2	6.1	9.1	8.0	6.5	2.0	8.6	5.4	5.6	5.1	2.8	10.3	4.1	6.9	5.6	4.8	11.5	6.9	6.9	7.0	8.7	7.2	9.3	6.8	4.2	4.9	12.1	7.0	6.0	4.5	6.6	5.0	4.8	4.7	8.9	5.1	7.5	6.5	9.8	7.9	6.4	6.5	10.9	7.4	2.3	6.4	18.0	6.1	7.9	8.7	13.5	9.4	11.0	6.9	5.8	20.7	14.4	6.7	7.3	6.4	11.1	5.3	13.5	16.0	0.2	6.7	6.1	8.3	8.9	12.4	5.3	6.7	10.4	6.9	5.1	6.7	5.3	7.7	4.8	8.4	6.7	2.2	8.9	13.8	9.1	7.8	7.3	3.0	4.8	4.6	3.7	3.2	4.0	5.7	4.3	5.3	4.7	4.4	8.6	10.0	12.8	19.8	7.5	7.7	4.2	4.7	6.4	17.1	16.1	14.1	9.0	5.3	17.2	13.2	16.5	10.4	7.6	5.0	7.3	1.9	13.3	6.7	5.5	12.5	10.0	12.6	14.1	5.7	18.5	3.2	11.9	7.1	8.1	5.1	9.6	15.4	22.2	7.3	16.8	5.5	12.8	2.0	14.5	5.0	3.9	8.4	9.2	8.8	4.7	12.3	27.9	9.2	12.5	23.1	12.0	5.3	9.1	11.2	8.1	10.1	6.6	10.2	13.6	19.7	10.7	8.6	29.3	8.1	17.0	4.5	1.8	7.3	11.0	12.1	3.7
PIGN	"MCD4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 323.7;Alveolar cells type 2: 372.2;Club cells: 138.4;granulocytes: 159.0;Oligodendrocytes: 123.2;Respiratory ciliated cells: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	10.0	10.3	9.8	10.9	14.3	16.9	15.9	49.4	47.1	11.8	3.2	16.2	14.0	11.1	11.9	22.7	8.9	12.6	13.5	13.1	9.6	11.9	18.1	9.9	10.5	4.1	0.1	12.1	15.8	16.0	4.3	17.5	9.6	17.3	18.4	38.9	14.8	7.5	13.4	20.1	13.3	8.9	0.0	10.0	21.1	19.8	11.4	12.3	16.9	10.8	12.8	14.9	7.7	49.7	31.6	19.0	18.4	23.0	23.1	31.4	24.3	32.3	25.7	21.2	24.9	24.4	31.9	36.0	44.0	25.0	18.3	44.6	26.0	27.8	32.9	30.3	16.9	21.6	29.6	19.7	16.8	46.0	24.6	18.5	18.1	21.0	24.5	22.3	27.0	25.3	26.1	50.8	23.3	28.2	22.8	13.5	29.9	25.3	17.3	24.1	35.1	35.7	25.5	48.5	20.8	21.4	42.5	29.0	13.6	50.9	46.1	28.6	29.8	41.0	28.2	15.4	23.5	54.3	53.8	17.4	22.5	25.7	40.9	10.1	7.5	6.1	6.9	6.6	7.2	7.9	7.1	6.9	8.9	8.8	8.0	8.4	9.6	12.1	7.8	10.2	6.5	3.7	9.8	14.3	49.4	47.1	13.1	9.6	4.1	0.1	9.6	0.0	11.4	49.7	8.9	323.7	372.2	52.5	9.7	8.0	8.9	8.4	10.2	7.2	16.3	9.4	10.4	12.8	138.4	11.0	4.2	9.6	14.1	11.6	1.9	11.0	6.4	9.1	16.2	24.7	6.7	16.6	54.5	9.5	11.5	26.6	10.2	11.5	159.0	19.3	10.0	12.0	10.1	6.7	41.3	11.6	10.2	9.2	4.0	6.5	7.2	26.9	3.6	44.0	7.9	7.3	3.1	57.8	123.2	10.9	9.4	3.8	8.2	11.7	5.6	5.0	145.5	6.6	6.6	6.8	6.7	20.7	7.3	17.4	17.0	10.4	18.5	10.5	12.3	12.1
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37062846-37073170	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	33.9	41.3	18.7	12.5	20.2	9.1	35.4	22.4	24.7	22.9	24.8	24.2	19.0	18.3	107.2	16.8	25.7	22.5	40.1	18.1	22.8	35.9	54.7	21.6	16.6	22.8	21.6	27.9	41.4	51.9	38.0	20.9	22.6	33.7	27.4	28.6	32.2	26.7	44.0	12.4	15.5	17.1	22.1	14.9	22.8	36.5	20.0	22.0	36.3	42.8	19.7	26.2	13.2	25.4	25.9	11.5	23.7	14.8	41.5	28.6	16.9	21.9	38.7	18.6	21.1	15.4	53.7	37.1	45.7	32.0	81.4	19.4	22.7	25.5	18.5	37.4	36.1	86.2	13.8	21.3	26.3	26.9	16.6	26.5	47.2	33.4	43.0	42.2	35.1	80.5	50.7	61.8	38.5	16.5	32.9	25.5	19.6	76.8	27.9	31.0	12.1	37.0	48.2	13.3	49.2	29.8	61.4	43.0	81.8	33.6	35.2	53.2	18.3	12.9	6.6	14.8	19.3	81.1	96.5	42.0	38.1	30.5	43.4	0.4	13.5	3.7	19.6	20.3	24.8	34.2	25.1	21.6	20.9	28.1	33.3	29.0	1.9	16.8	22.6	30.9	20.6	15.6	18.7	20.2	22.4	24.7	18.1	22.8	22.8	21.6	22.6	22.1	20.0	25.4	37.4	28.9	41.8	9.8	37.0	33.0	58.9	88.9	35.3	21.2	74.1	86.4	82.4	42.9	65.1	44.1	10.4	60.7	29.4	21.6	90.1	61.8	79.3	67.0	35.9	31.3	44.9	25.7	6.9	71.3	52.4	48.9	30.1	49.3	15.9	32.2	35.3	79.8	66.7	16.8	8.7	63.9	65.1	57.6	39.9	75.6	69.0	44.1	37.4	2.8	50.2	37.0	23.7	7.5	18.2	57.7	50.3	35.0	54.3	45.6	52.3	97.1	86.9	33.6	65.7	32.7	44.6	350.8	177.5	44.2	26.3	52.3	31.7	62.6	53.1	63.7
PIGQ	"GPI1, hGPI1"	ENSG00000007541	"Phosphatidylinositol glycan anchor biosynthesis class Q"	Q9BRB3	16	566995-584109	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 78.9;Late spermatids: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039105, HPA039828, HPA061414"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508"	"unprognostic (1.23e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (2.53e-6)"	"unprognostic (2.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	13.3	23.9	7.1	3.8	8.0	30.4	15.0	2.0	12.0	15.4	8.6	16.2	7.5	18.3	1.4	13.2	16.5	2.8	13.3	9.6	5.2	30.7	19.0	17.9	2.5	6.6	9.7	15.6	21.9	9.4	25.4	3.3	6.5	19.4	1.1	1.2	19.3	5.8	18.4	15.7	12.6	1.6	3.5	15.0	17.0	28.1	6.0	2.7	31.1	1.7	1.2	15.8	12.1	4.3	14.2	21.9	7.3	10.3	4.6	2.7	13.9	14.7	5.6	6.3	6.6	14.6	12.9	7.6	18.6	3.3	5.5	22.2	3.3	6.4	1.3	21.9	30.4	11.4	23.8	10.8	8.9	10.1	10.2	5.2	9.8	10.2	2.0	4.0	6.1	13.7	26.1	4.1	2.1	20.7	18.3	11.4	10.0	3.0	21.9	36.6	6.4	17.7	5.6	5.6	13.2	21.4	16.8	7.6	10.8	2.3	17.3	6.9	14.5	10.4	13.7	11.7	10.4	15.8	5.0	6.0	4.8	5.4	10.4	0.9	2.8	1.6	2.8	3.1	2.4	2.3	2.3	2.6	2.7	2.5	2.5	1.6	3.0	3.3	3.7	5.6	2.4	2.6	7.1	8.0	2.0	12.0	9.6	5.2	6.6	9.7	6.5	3.5	6.0	4.3	9.7	16.0	20.3	14.0	6.9	4.8	6.6	8.4	5.2	12.1	15.8	11.0	8.4	4.3	10.6	40.5	4.2	10.5	8.8	31.5	3.9	19.3	33.6	21.0	7.8	9.0	20.3	78.9	19.3	17.4	8.4	9.4	16.3	11.4	8.2	19.7	6.4	16.4	9.5	10.1	13.8	13.0	8.2	9.1	4.4	61.4	7.5	8.2	16.0	3.7	7.7	14.6	10.3	7.5	6.6	14.1	11.6	7.2	9.1	6.9	7.6	12.4	23.3	13.7	0.0	7.7	9.9	30.1	13.6	6.2	4.8	5.9	7.8	11.1	16.9	5.0
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928522-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2641.0;salivary gland: 1645.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7090.1;Intestinal goblet cells: 2361.1;Paneth cells: 3208.3;Proximal enterocytes: 1558.6;Undifferentiated cells: 4954.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Secreted to digestive system"	NA	NA		1300000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favorable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	2.4	0.5	0.4	187.3	0.2	0.3	131.0	0.5	0.4	547.0	0.2	1693.4	2641.0	20.5	0.2	12.4	3.6	455.0	0.5	0.4	0.2	108.9	34.5	101.6	1.7	0.2	0.2	0.6	13.3	0.1	1.3	0.3	0.4	13.6	1222.6	0.1	1645.1	5.3	0.3	0.6	809.8	39.1	0.1	0.8	414.6	0.3	0.6	0.4	0.2	0.0	0.6	80.3	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	36.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	1.9	0.3	0.0	0.0	0.2	0.0	6.9	0.2	1.7	0.8	2.5	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.3	0.6	0.3	0.4	1.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.8	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.5	0.4	0.4	0.2	0.2	0.2	0.4	0.1	0.6	0.6	2.1	93.0	604.3	0.0	22.1	0.3	4.0	106.6	0.0	0.0	392.4	192.0	1.4	876.4	638.4	108.5	0.0	0.1	2.5	7090.1	17.6	92.5	0.0	65.9	14.6	5.4	426.4	2.7	0.0	64.5	0.0	4.7	482.1	120.1	52.0	0.0	1.8	28.0	0.4	0.0	0.0	2361.1	59.0	2.2	1.1	0.0	0.0	5.7	1.8	0.0	0.6	0.0	0.0	0.0	0.0	221.5	3208.3	0.0	0.7	53.9	1558.6	328.4	415.4	0.0	0.0	0.0	21.0	0.0	0.0	6.9	0.0	0.0	15.6	0.1	4954.6	761.3
PIGS		ENSG00000087111	"Phosphatidylinositol glycan anchor biosynthesis class S"	Q96S52	17	28553383-28571794	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018149	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA018149: AB_1855373"	"unprognostic (2.29e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.65e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (5.31e-4)"	25.0	15.5	8.3	15.5	8.5	25.3	11.4	8.2	8.6	12.9	18.6	25.5	30.9	12.0	3.3	23.5	20.1	15.6	25.4	10.5	9.1	16.6	4.9	20.2	18.9	8.8	9.4	13.3	16.8	28.5	3.3	17.4	8.8	17.7	15.7	3.4	14.8	16.2	31.4	18.5	32.2	16.1	7.8	18.2	26.9	13.4	8.7	17.5	24.3	19.7	13.7	17.7	5.3	8.0	34.7	57.4	26.5	67.9	51.1	38.2	40.1	42.3	34.5	44.4	58.1	60.4	33.8	22.3	62.9	57.8	43.1	64.5	32.4	48.2	16.6	65.8	92.5	30.1	45.3	26.2	47.8	58.5	73.8	46.7	33.6	27.8	37.8	44.5	60.3	37.8	89.3	34.1	38.5	42.6	36.9	40.2	13.2	77.9	17.6	31.2	87.8	73.6	30.6	36.9	54.3	37.7	60.3	115.4	32.8	26.4	105.4	69.5	52.2	31.5	32.5	27.1	35.0	56.5	84.0	17.0	56.6	56.8	45.1	86.2	60.4	78.9	34.3	55.0	31.0	23.5	27.5	32.5	64.9	22.3	28.8	24.0	29.4	43.0	39.6	49.8	45.2	46.3	8.3	8.5	8.2	8.6	10.5	9.1	8.8	9.4	8.8	7.8	8.7	8.0	15.7	44.8	21.4	10.7	15.9	8.3	11.3	21.1	13.6	20.5	20.5	17.1	40.7	20.0	18.8	46.0	64.6	35.0	31.6	48.5	11.7	43.5	9.5	15.3	15.7	18.7	40.7	17.9	10.9	26.3	53.4	14.9	18.3	21.5	3.8	17.1	26.4	7.9	31.1	52.2	12.6	28.3	24.4	28.1	8.0	13.1	23.9	22.9	7.2	1.9	66.1	17.5	93.7	9.0	11.7	22.5	21.6	22.6	16.8	15.0	49.0	19.1	14.4	56.1	6.6	12.3	15.9	74.2	62.0	19.3	12.5	36.4	21.8	25.0	27.6	12.4
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	11.0	14.8	20.8	9.7	25.3	10.6	13.5	23.4	25.3	13.6	18.0	20.0	12.2	16.3	19.8	18.6	25.1	11.4	16.2	21.2	22.0	16.0	13.8	10.3	11.8	24.5	22.5	20.9	11.5	28.9	14.3	15.9	24.7	12.3	22.3	16.5	12.3	13.5	16.2	12.9	13.3	17.6	23.3	9.6	10.9	19.1	22.7	14.7	13.2	20.5	15.8	14.2	13.8	31.7	30.2	37.2	47.0	34.4	30.0	36.1	46.8	30.0	35.8	50.3	43.9	69.3	61.9	38.4	48.0	30.0	65.1	54.5	43.1	57.0	50.6	16.5	23.2	87.3	22.6	78.9	27.9	53.4	20.0	32.1	36.2	28.9	32.8	23.2	36.7	37.9	44.4	33.4	43.0	33.5	45.6	54.0	23.7	68.8	55.9	32.7	58.5	61.8	44.5	27.4	30.0	28.2	56.6	101.0	38.0	26.0	55.8	37.1	21.7	82.0	29.1	44.8	30.8	22.2	33.3	25.4	49.9	54.8	36.0	14.0	5.6	2.4	16.2	8.4	14.4	10.7	14.5	17.8	13.6	12.6	14.4	14.5	1.0	16.7	6.8	13.2	14.1	8.8	20.8	25.3	23.4	25.3	21.2	22.0	24.5	22.5	24.7	23.3	22.7	31.7	5.2	9.6	4.8	26.8	6.4	4.5	11.8	32.7	7.4	8.9	4.9	4.7	6.6	8.6	21.6	11.0	16.7	40.1	5.7	15.4	1.9	19.2	17.8	14.4	7.2	9.1	10.2	9.1	30.4	17.6	29.3	10.1	4.6	11.5	8.2	19.5	7.1	8.5	15.8	1.7	39.0	15.3	22.4	6.5	2.2	16.7	5.6	4.7	1.8	16.9	5.7	8.5	5.2	46.3	78.5	10.4	19.0	7.9	7.6	10.6	9.0	9.2	28.5	9.5	19.7	8.3	13.7	34.6	12.8	9.5	5.8	21.2	6.8	9.8	24.3	8.7
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 87.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 87.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	10.5	10.3	14.4	10.4	15.6	9.0	9.9	14.7	16.7	7.5	19.5	10.8	9.1	8.3	12.4	10.3	7.9	8.3	9.6	15.2	16.7	12.2	8.2	7.2	7.1	15.1	15.8	6.8	9.0	19.6	12.7	8.3	14.8	12.8	10.1	17.4	9.9	10.5	17.1	10.4	9.1	11.2	16.0	6.8	7.6	6.0	16.2	11.6	9.2	14.1	10.9	8.7	7.6	16.7	39.4	18.7	21.4	18.1	22.7	15.3	12.6	18.1	20.7	19.3	20.5	13.7	25.6	20.3	63.6	15.4	25.1	22.2	19.5	16.6	23.1	18.6	19.6	21.0	12.8	12.6	19.2	20.6	34.6	15.1	25.7	17.1	15.7	16.3	12.7	36.5	11.7	38.6	21.0	30.1	59.2	32.1	12.8	30.7	18.3	31.1	27.6	29.5	24.6	11.5	24.4	29.2	31.8	23.9	29.7	16.9	71.8	20.3	8.2	18.1	9.2	25.6	29.5	57.0	70.4	41.1	20.7	26.9	21.5	39.6	7.5	87.5	3.3	10.8	3.0	4.6	3.1	4.6	7.7	5.5	3.7	3.2	18.8	8.7	11.6	3.3	4.4	4.1	14.4	15.6	14.7	16.7	15.2	16.7	15.1	15.8	14.8	16.0	16.2	16.7	14.2	19.2	16.3	13.7	16.4	17.1	30.1	5.5	31.9	34.9	28.3	19.2	12.6	21.5	8.4	29.5	47.9	21.4	31.6	20.8	35.2	7.9	30.5	17.2	23.5	16.9	15.7	15.8	17.7	5.6	20.9	22.0	9.2	17.9	12.0	19.3	17.5	16.6	20.1	33.7	23.7	17.0	8.2	21.4	25.4	22.7	28.0	18.1	21.4	15.9	25.0	50.0	32.0	12.1	14.5	5.2	12.5	35.0	20.1	33.8	27.1	32.5	10.2	39.1	26.3	23.6	28.1	27.1	36.0	29.3	15.9	11.6	21.2	22.7	25.7	23.0
PIGY	MGC14156	ENSG00000255072	"Phosphatidylinositol glycan anchor biosynthesis class Y"	Q3MUY2	4	88520998-88523776	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059018	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"				"HPA059018: AB_2683884"																		35.7	39.6	35.1	23.1	37.0	44.5	48.2	38.7	43.4	32.1	33.8	30.7	30.7	34.0	45.6	28.4	33.8	22.5	32.3	34.0	37.3	41.2	52.0	26.3	27.8	36.7	35.6	34.3	41.3	41.9	3.3	28.5	36.5	32.3	31.2	22.9	43.1	33.9	48.6	27.1	28.3	36.2	39.2	26.1	24.6	22.4	36.2	27.3	32.0	42.3	29.4	28.7	3.7	39.3	60.1	19.8	39.1	46.4	76.7	78.3	26.2	43.2	60.6	53.1	44.6	15.5	46.3	0.2	47.3	61.7	36.4	25.2	35.6	54.4	66.6	73.4	61.8	66.2	24.8	59.9	58.0	110.7	40.9	54.4	80.8	34.5	69.5	50.4	88.5	20.4	75.9	64.9	77.8	45.5	68.5	67.6	32.7	70.5	37.5	68.0	36.3	69.8	44.4	33.4	46.7	45.7	54.9	49.4	119.9	38.4	23.0	54.8	60.6	56.1	51.9	55.3	40.6	45.6	40.1	7.5	49.3	55.7	63.1	82.4	92.1	79.0	90.4	94.9	102.2	98.9	103.2	98.3	111.0	80.5	105.4	101.6	18.1	108.9	95.3	68.3	116.8	186.1	35.1	37.0	38.7	43.4	34.0	37.3	36.7	35.6	36.5	39.2	36.2	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946356-196969060	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 205.1;Intestinal goblet cells: 61.3;Paneth cells: 129.7;Proximal enterocytes: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA058599, HPA059920"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.7	1.6	8.2	2.0	8.5	1.0	5.4	8.6	9.6	4.3	4.4	39.1	1.6	3.4	0.7	4.2	3.4	2.0	6.9	8.1	9.2	2.1	2.6	3.7	1.1	7.6	8.6	0.8	2.7	3.0	4.1	1.0	10.0	6.1	16.7	3.1	4.7	2.6	7.4	4.7	11.7	2.7	5.3	1.9	4.6	1.6	8.6	1.2	1.9	3.2	0.5	10.4	4.6	7.7	1.8	1.2	0.7	2.8	7.7	3.7	0.7	2.6	7.3	2.0	1.6	1.7	1.5	0.3	5.1	5.9	1.3	3.0	0.1	0.4	0.5	0.5	0.3	0.8	0.6	6.5	3.6	0.0	2.9	3.7	5.6	0.3	0.9	2.2	2.4	4.7	0.2	2.2	1.9	3.2	0.3	1.5	0.1	2.2	0.9	0.4	0.1	0.6	3.0	3.3	1.1	1.2	3.7	0.3	1.5	0.3	7.2	2.6	6.0	1.6	0.4	4.7	0.9	1.0	0.1	0.1	0.4	1.1	0.6	0.0	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	8.2	8.5	8.6	9.6	8.1	9.2	7.6	8.6	10.0	5.3	8.6	7.7	8.9	0.0	1.1	20.5	1.7	7.8	9.1	3.8	6.8	7.1	22.6	33.9	8.0	1.5	2.8	9.2	2.1	0.0	2.8	205.1	5.9	2.3	2.1	5.1	3.0	5.5	13.8	3.0	31.3	3.6	0.0	5.0	1.5	6.5	5.7	0.3	12.1	10.3	1.8	15.2	21.9	61.3	10.2	4.4	3.4	5.0	4.1	2.2	8.8	5.6	4.1	4.6	2.1	12.5	2.7	3.2	129.7	6.4	1.9	7.4	50.0	5.4	2.7	7.0	0.0	7.7	6.5	1.2	0.2	11.5	5.1	0.1	1.7	0.0	44.4	14.7
PIH1D1	"FLJ20643, MOT48, NOP17, Pih1"	ENSG00000104872	"PIH1 domain containing 1"	Q9NWS0	19	49446298-49453497	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047258	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA047258: AB_10964561"	"unprognostic (2.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	38.0	37.1	31.4	26.8	32.0	34.5	37.1	31.5	39.5	38.0	33.8	40.4	43.5	32.4	13.2	45.0	39.7	27.0	31.5	33.0	31.8	41.4	47.7	30.5	43.6	31.7	30.9	29.9	39.7	50.4	34.5	33.1	32.0	39.6	29.5	11.8	49.5	33.8	67.5	45.3	37.2	26.3	31.9	39.4	41.3	17.8	33.1	46.1	37.1	57.6	36.1	33.0	39.4	31.8	133.6	67.0	84.6	130.3	40.1	37.2	54.0	52.9	68.8	79.8	122.3	72.4	89.6	89.1	48.6	56.7	20.0	79.9	44.8	96.6	46.2	85.5	85.1	79.9	89.6	93.0	63.1	86.7	115.3	43.5	40.4	59.0	55.8	74.8	74.8	79.2	119.5	76.8	50.5	59.9	98.4	173.3	101.1	118.4	63.2	83.1	93.6	90.4	65.1	107.2	109.2	158.0	54.3	91.2	53.2	41.1	44.0	104.3	44.9	66.9	52.0	26.9	84.2	205.5	172.8	49.8	36.6	93.6	47.5	166.8	104.5	121.0	88.3	104.0	75.6	116.1	98.8	94.9	105.1	110.1	79.5	73.4	11.8	103.7	108.7	100.2	158.3	107.0	31.4	32.0	31.5	39.5	33.0	31.8	31.7	30.9	32.0	31.9	33.1	31.8	45.5	38.5	36.6	10.7	54.8	55.8	61.9	80.2	59.7	20.9	46.8	50.0	11.2	41.5	46.4	20.2	18.8	101.7	48.8	48.6	62.6	74.1	18.1	47.4	24.1	39.2	57.5	33.4	10.5	46.3	116.5	59.9	43.8	30.6	52.6	30.8	35.3	44.3	71.2	23.5	8.5	63.9	38.7	40.8	55.7	9.9	62.4	40.7	64.0	11.2	59.0	55.0	40.2	10.1	10.9	47.3	75.4	47.0	60.3	65.6	90.2	115.9	59.4	22.6	26.3	44.5	46.8	40.6	29.9	49.0	67.1	94.0	50.4	48.2	59.4	66.2
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 70.3;RT4: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.0	3.6	10.4	15.2	23.6	5.0	9.7	8.5	23.3	7.4	0.0	15.8	14.4	8.4	4.8	12.9	6.5	8.0	10.6	11.2	18.8	10.2	4.9	17.2	23.4	19.2	20.4	3.0	5.2	3.2	3.3	12.8	17.1	6.2	12.9	2.9	7.2	5.4	20.9	21.2	14.9	9.9	7.3	13.6	18.9	1.9	28.0	22.3	8.1	10.8	22.1	10.9	10.7	44.2	7.5	14.8	12.9	11.9	7.4	0.6	70.3	0.9	2.9	2.8	2.1	8.8	19.2	12.7	2.7	1.7	2.5	18.3	7.7	5.2	1.1	7.7	2.1	0.3	30.1	3.3	0.4	4.5	9.3	0.9	5.4	0.7	0.4	1.1	19.1	12.6	4.7	8.3	0.2	16.7	15.4	12.8	11.8	29.3	9.3	16.6	3.3	2.4	3.5	75.6	14.1	7.8	26.0	35.9	8.4	4.7	16.1	2.4	0.7	0.4	4.5	1.3	0.2	8.9	2.6	16.4	0.5	6.7	1.9	0.0	0.1	0.0	0.5	0.0	0.5	1.5	0.6	0.4	0.1	3.2	0.3	0.3	0.2	0.8	0.0	0.0	1.2	0.2	10.4	23.6	8.5	23.3	11.2	18.8	19.2	20.4	17.1	7.3	28.0	44.2	26.7	0.0	12.2	16.0	15.3	3.8	2.1	7.9	1.2	16.6	5.3	4.4	6.9	5.7	6.9	3.7	0.0	4.4	3.3	29.2	0.0	1.8	0.6	2.0	2.5	26.1	9.6	0.0	14.3	3.4	4.4	4.5	28.5	2.4	32.4	8.5	31.1	5.5	4.2	15.2	22.8	23.8	2.0	1.6	5.1	0.7	1.2	2.9	3.6	27.2	2.3	2.7	4.1	23.6	111.5	4.7	14.5	7.5	4.9	2.4	14.6	2.1	9.1	1.0	0.0	7.7	3.3	0.1	1.5	8.1	8.0	2.2	5.0	9.4	15.5	13.8
PIK3C3	Vps34	ENSG00000078142	"Phosphatidylinositol 3-kinase catalytic subunit type 3"	Q8NEB9	18	41955234-42087830	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 114.9;Inhibitory neurons: 104.1;Oligodendrocytes: 115.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040718	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA040718: AB_10793862"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.15e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-3)"	10.9	16.1	6.8	12.0	10.0	15.9	16.4	18.2	11.5	13.2	12.7	11.7	8.9	15.0	16.6	11.8	12.2	12.1	11.5	7.3	7.8	16.2	14.3	11.7	14.1	8.3	7.0	17.0	9.0	18.6	8.0	17.2	9.9	12.8	13.7	16.7	10.9	12.5	12.2	11.4	10.6	13.9	8.7	13.3	11.5	18.0	7.6	18.5	15.3	16.2	15.8	15.1	9.9	12.9	16.2	11.3	27.8	21.3	31.6	33.8	17.1	31.4	39.8	24.7	33.2	5.4	8.0	10.0	17.6	31.8	19.4	26.0	22.1	17.5	34.2	16.3	15.5	20.8	15.4	21.7	26.3	30.9	22.1	37.3	25.8	23.2	29.9	37.9	25.6	19.9	20.9	12.2	34.3	5.3	13.6	19.8	20.4	6.0	8.1	81.9	21.0	26.1	28.3	17.1	24.2	28.1	10.2	7.3	22.2	30.8	10.8	24.8	33.7	33.3	9.7	7.4	14.6	33.3	42.2	11.3	27.5	41.4	18.0	20.5	9.9	21.2	9.2	11.0	10.3	11.4	9.3	11.5	10.2	10.1	11.8	8.9	19.2	12.1	12.5	5.8	17.0	8.2	6.8	10.0	18.2	11.5	7.3	7.8	8.3	7.0	9.9	8.7	7.6	12.9	22.4	22.4	36.9	70.2	21.1	11.5	10.8	15.3	15.4	28.2	11.5	11.0	23.5	4.3	27.3	14.7	20.9	20.6	26.8	13.8	7.9	14.4	28.6	16.9	22.4	19.9	4.9	19.1	114.9	10.3	13.3	22.4	13.7	18.3	17.1	25.4	17.2	13.4	15.6	55.5	104.1	11.5	16.2	17.9	10.1	13.2	14.6	20.9	7.2	58.1	21.5	26.2	13.4	83.4	115.6	14.3	10.0	24.0	18.2	14.5	12.9	12.3	22.4	22.5	19.7	25.4	18.9	20.0	18.6	14.3	11.4	27.4	23.8	24.7	10.6	15.9
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Lipid metabolism, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	14.7	7.9	3.1	8.1	3.7	12.4	8.5	9.7	8.3	8.7	0.3	6.7	4.2	8.3	4.8	7.9	5.7	8.4	9.5	3.7	3.6	8.2	7.1	7.9	9.2	5.1	4.2	10.3	4.3	11.5	3.4	11.1	5.1	7.3	5.8	12.4	4.5	7.1	7.1	5.5	5.3	8.9	2.3	8.8	5.8	6.1	3.7	13.7	7.9	13.0	9.2	8.6	5.8	6.4	19.9	6.5	9.6	9.2	22.7	27.7	6.5	10.8	16.5	10.9	16.0	5.1	13.0	16.1	21.7	10.8	14.1	5.9	8.4	9.8	16.5	32.0	6.2	22.4	5.2	4.4	10.7	13.1	12.6	16.8	10.6	12.4	15.0	13.4	15.8	12.9	10.6	17.3	18.9	6.9	10.9	8.5	8.0	8.8	7.8	13.9	10.0	16.7	8.5	10.0	5.2	9.9	13.1	10.8	16.1	9.1	19.0	11.1	21.1	10.4	6.5	18.1	13.3	9.3	13.8	29.0	11.3	9.6	5.4	1.3	1.2	0.4	1.2	1.0	0.8	1.5	0.8	0.6	0.8	1.6	1.0	0.8	2.2	0.7	0.9	0.9	0.8	0.3	3.1	3.7	9.7	8.3	3.7	3.6	5.1	4.2	5.1	2.3	3.7	6.4	31.3	32.1	26.8	60.7	28.3	14.7	17.9	11.2	2.2	27.9	14.4	15.2	18.5	5.7	15.9	7.3	31.3	10.2	17.9	8.7	1.9	10.7	2.0	14.1	21.7	25.6	2.4	9.2	126.7	13.9	6.1	23.5	8.6	21.6	31.6	19.9	33.5	21.9	11.1	38.7	122.0	10.3	14.2	23.5	24.3	3.4	32.6	20.9	14.2	75.9	24.5	17.4	18.6	130.2	84.2	16.9	10.8	39.5	15.1	34.6	9.5	14.8	20.1	27.1	26.3	25.7	28.6	11.8	10.2	9.8	14.9	8.8	19.9	19.6	9.2	32.0
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651731-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.9;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	7.2	3.1	6.8	33.4	6.3	60.9	3.9	6.1	7.5	6.2	6.4	5.4	5.2	4.9	1.7	4.9	6.1	7.0	3.3	7.0	5.3	6.4	3.5	12.0	46.9	7.3	6.6	7.0	3.0	2.9	2.8	4.2	7.8	4.6	3.4	0.6	5.1	2.7	1.2	3.0	17.2	4.7	6.6	50.4	5.7	4.0	9.3	24.3	5.5	3.5	32.0	7.4	5.1	8.5	8.1	5.2	0.4	1.4	1.3	1.1	0.7	12.1	24.5	26.0	21.1	0.3	3.3	21.5	4.9	9.8	12.4	2.4	2.0	11.0	16.2	153.3	0.4	2.4	1.3	9.0	5.1	56.0	18.7	4.3	4.5	29.2	9.8	11.4	3.8	14.9	8.0	0.1	15.0	0.6	5.4	65.9	2.2	0.3	1.4	68.9	13.0	0.7	10.9	0.0	1.7	1.5	2.7	4.9	11.9	6.8	0.8	65.4	9.8	7.7	7.9	0.2	11.5	4.9	4.9	30.1	16.7	78.6	4.4	18.0	23.5	40.2	21.6	23.0	22.6	12.8	16.3	19.9	22.5	13.6	20.9	23.1	63.2	25.9	29.2	25.7	13.3	38.3	6.8	6.3	6.1	7.5	7.0	5.3	7.3	6.6	7.8	6.6	9.3	8.5	1.7	9.6	13.4	2.0	22.2	1.5	2.2	1.8	4.0	0.7	2.0	1.7	3.1	0.0	1.1	0.0	2.1	0.3	44.0	0.1	1.9	3.9	3.0	2.0	1.7	2.7	0.0	10.3	6.7	2.0	0.5	2.9	0.0	1.0	25.3	4.2	3.6	0.0	14.7	0.0	13.4	0.1	0.0	35.2	6.0	2.8	1.2	23.1	3.6	29.0	19.3	2.5	29.9	1.0	1.1	11.3	0.0	1.5	8.2	4.1	0.2	3.8	3.3	1.3	6.6	2.0	4.7	1.5	3.4	2.9	1.1	0.3	37.1	1.5	0.2	2.1
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106908980	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 43.6;lymphoid tissue: 19.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.9;dendritic cells: 26.5;Early spermatids: 28.9;granulocytes: 20.8;monocytes: 23.8;NK-cells: 25.7;Plasma cells: 88.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.4;HL-60: 28.8;HMC-1: 34.9;Karpas-707: 29.1;MOLT-4: 56.0;U-266/70: 71.4;U-937: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	3.1	1.8	0.5	11.5	0.6	43.6	1.9	0.8	1.3	1.9	1.3	4.2	4.1	1.3	0.5	1.7	1.4	3.2	1.6	0.5	1.0	1.0	2.0	4.9	19.0	2.5	1.3	1.6	0.3	0.7	0.2	2.9	2.7	1.0	3.8	0.1	1.3	0.9	0.3	0.8	4.3	2.7	1.8	11.0	4.0	5.2	2.0	16.4	1.1	1.0	19.7	4.3	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	17.9	0.0	0.0	0.0	28.8	34.9	0.0	0.0	0.0	0.0	0.0	11.0	16.9	20.6	29.1	0.0	0.0	56.0	17.6	0.0	0.0	0.0	14.6	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.6	2.9	0.1	0.2	0.1	0.0	71.4	0.0	27.3	0.1	52.1	6.7	10.8	6.0	24.3	8.8	17.8	8.1	7.3	4.1	6.7	9.4	10.2	4.2	5.9	22.7	9.8	43.7	8.6	4.4	6.8	0.5	0.6	0.8	1.3	0.5	1.0	2.5	1.3	2.7	1.8	2.0	3.9	1.5	0.0	1.8	0.3	24.9	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.6	0.0	0.0	0.0	26.5	0.2	0.0	0.0	28.9	0.1	0.2	1.7	0.0	7.8	5.5	0.0	0.0	0.1	3.6	0.1	20.8	0.4	2.5	0.5	6.8	0.0	0.3	0.0	0.0	11.9	8.3	18.8	0.6	18.9	7.2	15.0	23.8	0.0	25.7	0.0	0.2	0.0	0.0	0.0	88.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	6.6	3.7	0.2	0.3	0.1	18.1	0.6	0.6	0.1
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215756-68301821	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 410.2;Endometrial stromal cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 265.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	60.6	27.3	13.6	27.8	33.3	126.4	92.1	12.5	40.8	51.2	0.6	38.2	17.2	65.8	45.0	43.2	69.0	35.0	72.3	29.9	13.0	35.9	100.8	26.7	28.5	11.2	22.1	53.3	13.4	40.2	7.3	32.4	12.0	26.7	22.2	59.9	64.5	31.9	63.5	28.7	24.5	74.8	9.9	38.1	18.3	8.6	20.3	46.5	20.6	33.9	23.7	27.0	31.7	36.0	4.3	8.2	23.8	71.4	265.5	76.9	10.4	23.2	10.6	8.8	9.4	20.4	7.4	21.8	38.5	32.0	4.3	10.2	6.7	46.9	11.0	90.6	8.9	26.1	6.5	17.0	89.2	27.0	20.1	81.9	104.2	16.1	83.6	4.1	11.7	25.0	4.1	16.1	8.1	11.3	65.7	10.5	6.9	14.7	4.3	61.1	11.3	17.0	11.5	47.9	4.7	21.3	4.0	6.3	15.0	13.7	34.3	19.0	14.0	10.3	10.4	17.3	14.8	18.0	29.2	25.2	11.1	32.9	7.8	22.0	1.7	8.8	11.5	2.4	16.6	1.7	14.9	11.1	3.0	3.9	18.6	14.1	2.2	11.7	6.5	1.2	12.3	5.5	13.6	33.3	12.5	40.8	29.9	13.0	11.2	22.1	12.0	9.9	20.3	36.0	47.7	51.3	24.8	112.3	47.7	14.4	23.5	30.8	175.2	46.0	61.4	168.4	263.0	38.6	19.3	5.5	25.0	13.4	410.2	28.4	72.4	15.8	12.6	38.7	479.9	39.0	9.6	43.5	232.8	9.5	18.5	151.0	43.8	93.2	68.9	110.4	31.1	198.3	30.7	48.8	82.7	32.6	28.5	69.2	24.7	11.9	172.1	68.8	33.8	117.1	37.6	194.1	137.0	281.5	199.9	12.3	19.8	122.2	173.2	8.4	24.3	39.1	8.7	89.4	19.7	127.2	76.5	1.7	4.5	37.2	10.2	10.0	309.9	45.4	36.5	8.1
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153163-18170532	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 14.4;Undifferentiated cells: 16.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA069291	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA069291: AB_2686109"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	7.2	25.6	26.2	6.9	22.9	9.7	7.6	1.1	41.5	17.6	2.0	13.4	20.5	17.5	12.0	26.0	16.7	12.3	12.8	41.0	6.7	9.5	10.5	9.1	5.2	4.4	7.1	21.5	11.0	20.8	21.5	8.7	4.9	15.5	9.6	7.9	15.0	10.4	12.4	26.3	16.7	9.8	4.7	8.7	15.1	11.5	9.4	11.6	10.5	9.9	6.2	15.3	15.3	16.4	39.1	18.0	25.4	36.8	35.3	36.6	40.5	29.4	38.3	21.6	16.6	18.3	20.4	28.0	48.8	41.9	17.5	28.7	15.6	33.2	11.3	25.0	65.5	10.8	21.3	44.0	29.7	24.6	13.4	45.7	36.4	15.0	21.5	36.8	6.6	11.9	33.6	10.8	30.3	57.0	21.5	17.0	32.9	35.8	48.5	19.6	33.4	23.5	37.7	22.8	63.0	68.0	27.1	28.5	28.9	16.0	19.1	15.8	11.4	40.9	20.8	49.2	27.5	22.9	26.4	10.9	33.9	39.4	26.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.2	22.9	1.1	41.5	41.0	6.7	4.4	7.1	4.9	4.7	9.4	16.4	1.0	6.4	1.1	7.2	0.8	1.9	1.3	1.0	1.8	6.3	3.6	3.2	1.5	2.8	1.0	3.7	4.2	1.7	0.8	6.9	0.0	6.0	0.3	1.3	1.7	0.8	6.1	7.4	11.7	6.2	2.9	1.7	1.1	0.8	2.5	1.4	1.4	1.3	2.2	10.1	11.2	10.5	0.0	4.7	1.0	0.0	1.8	1.7	0.0	3.7	1.6	5.7	0.0	10.6	9.2	6.4	7.0	1.9	0.9	1.1	14.4	1.1	0.5	4.3	0.0	1.4	1.4	0.5	2.1	1.3	2.3	1.2	0.9	3.2	16.4	0.6
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 199.0;Endothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"RT4: 76.1"					"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	31.2	12.2	13.0	7.2	11.2	0.7	28.0	35.9	14.8	15.3	14.0	7.5	3.2	15.9	10.3	7.1	10.1	10.7	35.2	11.4	14.9	16.2	4.0	18.5	6.2	16.7	17.3	4.1	4.7	12.1	8.5	13.3	16.8	12.0	4.9	17.9	12.5	6.1	12.0	6.4	8.6	11.5	15.5	11.2	9.9	25.4	15.9	10.8	14.2	18.5	5.3	14.8	7.4	11.4	10.9	3.6	47.4	24.4	4.6	2.0	15.2	6.3	4.6	8.2	10.1	2.1	3.2	14.3	18.9	2.5	9.9	6.4	16.9	5.8	5.3	11.1	15.0	9.3	41.8	1.6	1.5	8.3	11.8	5.8	3.3	8.7	3.2	7.8	17.3	32.8	3.5	10.0	11.8	16.7	33.4	5.1	16.9	3.1	9.6	42.0	12.7	17.0	20.4	76.1	34.4	24.9	20.5	53.5	5.7	28.5	14.9	7.3	32.4	8.7	8.0	1.5	6.2	14.1	15.8	8.5	6.9	10.9	4.5	0.0	0.2	5.8	2.0	0.3	1.9	0.3	0.4	1.8	0.0	0.0	0.1	1.1	0.0	0.0	2.4	0.3	2.3	0.6	13.0	11.2	35.9	14.8	11.4	14.9	16.7	17.3	16.8	15.5	15.9	11.4	199.0	0.0	8.4	15.7	3.1	2.5	5.4	42.1	14.8	48.3	32.0	30.1	21.1	0.0	28.8	18.4	45.9	4.4	13.9	21.7	0.0	0.6	11.8	13.9	21.0	83.3	7.8	5.9	26.2	1.2	1.1	16.2	55.5	26.2	9.5	6.1	0.0	0.0	1.7	3.3	55.9	8.6	38.7	0.0	4.4	19.9	1.2	8.4	5.4	60.9	0.9	33.5	3.1	22.1	7.1	1.4	1.5	7.9	10.1	7.2	4.5	4.2	26.7	42.8	0.0	13.3	18.0	35.9	31.7	8.0	1.8	1.4	15.7	19.2	6.6	5.0
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678934-130746829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	8.8	8.5	3.7	7.8	4.2	8.9	10.0	5.2	4.9	9.4	5.6	8.2	7.5	10.1	7.9	8.0	9.1	7.2	7.6	4.1	4.5	10.5	21.2	9.6	9.4	3.2	3.6	12.4	6.9	17.6	6.1	9.7	3.8	9.8	8.1	16.5	7.6	9.6	7.3	7.8	8.0	10.4	3.8	10.0	7.5	11.4	3.2	11.4	13.1	8.6	10.4	9.0	6.5	7.1	20.7	12.9	18.5	13.4	26.6	21.1	12.8	15.0	17.9	20.2	23.3	16.7	17.1	24.2	18.4	15.2	16.1	28.7	30.7	23.3	31.6	14.7	11.3	19.7	13.8	11.7	12.2	30.3	9.5	14.7	16.4	21.7	13.6	12.6	19.0	13.8	23.3	11.9	18.1	18.1	24.9	9.2	23.3	18.6	12.4	17.2	21.4	21.9	13.2	16.7	17.0	12.4	21.6	13.4	15.3	21.5	18.6	13.1	15.2	15.5	13.3	17.6	12.2	13.8	13.5	31.2	17.0	11.3	14.7	9.7	5.3	7.0	6.3	6.0	9.3	5.6	5.7	4.7	6.9	3.5	6.6	6.0	4.4	8.5	6.6	2.4	6.8	5.3	3.7	4.2	5.2	4.9	4.1	4.5	3.2	3.6	3.8	3.8	3.2	7.1	8.3	6.4	8.7	18.6	8.8	3.8	3.9	5.7	10.8	8.1	5.7	4.7	7.7	8.6	9.6	11.0	14.6	5.6	7.2	5.5	1.9	5.0	4.4	8.9	7.5	8.9	3.0	9.2	28.5	5.8	3.4	6.9	13.3	9.9	9.5	9.5	7.5	18.2	5.9	5.0	30.3	6.8	8.2	6.4	2.6	3.1	9.6	7.3	5.4	20.6	7.1	9.0	6.2	22.1	32.9	6.6	4.3	11.7	6.9	4.8	6.2	4.2	12.6	12.6	6.6	8.9	6.2	17.0	13.9	9.5	4.4	4.2	7.5	9.6	6.1	3.4
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	6.5	3.6	1.4	19.7	1.3	87.4	2.7	1.3	7.5	2.1	1.6	3.3	3.3	1.4	0.8	2.5	3.0	6.6	1.8	1.3	1.7	1.4	2.9	14.1	13.7	4.0	2.7	0.8	1.3	0.8	0.8	3.1	3.6	1.5	2.6	0.0	2.1	1.0	0.7	1.5	9.5	3.9	2.8	22.4	3.6	2.2	6.8	12.3	1.7	0.9	8.9	6.5	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.4	1.5	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	1.5	2.5	0.6	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	9.5	16.1	5.7	18.1	14.3	11.8	4.3	10.1	15.6	11.5	5.7	7.5	12.0	34.4	8.6	19.0	9.0	13.2	16.2	1.4	1.3	1.3	7.5	1.3	1.7	4.0	2.7	3.6	2.8	6.8	5.4	0.2	0.0	6.1	0.7	11.7	1.0	0.0	0.0	0.0	0.0	0.2	0.3	2.1	1.5	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.1	4.5	0.1	0.1	0.7	0.0	4.0	0.3	0.0	0.3	0.5	1.5	0.1	5.1	0.0	1.4	0.4	18.3	0.0	0.5	0.0	0.0	35.7	40.5	12.2	0.3	36.8	1.8	79.6	19.8	0.0	32.0	1.0	0.3	0.0	0.0	0.0	24.7	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.4	0.6	0.4	0.1	0.9	0.4	25.7	0.0	0.0	0.0
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266255-208358746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042604	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	10.4	7.9	7.6	12.0	7.6	28.8	8.1	14.3	9.3	9.1	10.5	6.1	6.0	9.3	11.9	6.3	6.4	7.2	7.4	7.7	7.3	10.6	10.5	7.8	17.4	8.0	7.4	10.0	22.2	11.1	6.0	9.7	6.9	11.5	7.4	17.3	6.5	8.0	6.5	8.2	7.3	8.9	7.4	15.1	8.0	14.0	8.9	19.3	12.2	9.0	16.1	8.2	5.8	11.1	8.0	7.9	18.3	14.3	18.1	21.4	8.5	9.6	19.5	11.1	15.0	11.3	6.6	9.2	9.8	16.6	21.7	8.0	16.1	10.8	18.8	7.9	10.1	33.0	15.6	10.2	13.7	29.5	28.5	16.0	11.5	13.0	24.1	18.5	18.3	24.1	22.7	16.1	14.0	3.4	26.9	22.1	15.2	6.1	5.9	9.9	14.2	12.7	14.2	11.5	5.8	13.8	10.6	6.8	19.2	21.4	4.3	31.3	21.2	13.8	9.2	9.4	9.0	11.2	14.2	19.2	11.1	25.2	13.9	0.9	0.5	0.4	0.9	0.4	0.5	4.4	1.2	1.4	0.5	3.2	0.9	1.1	0.7	3.2	0.7	1.2	0.9	0.3	7.6	7.6	14.3	9.3	7.7	7.3	8.0	7.4	6.9	7.4	8.9	11.1	18.8	25.6	16.2	58.8	82.0	15.3	6.7	7.8	25.6	21.9	10.5	6.6	17.5	11.5	10.6	11.0	16.7	8.1	14.4	8.1	5.9	5.4	10.4	11.3	19.4	18.8	18.6	25.5	72.6	4.3	5.7	15.7	16.3	21.7	36.1	18.0	18.2	19.4	14.4	10.1	67.9	9.6	4.1	29.9	32.5	8.3	18.6	28.5	10.6	48.7	19.1	13.5	16.5	80.9	81.7	8.5	5.9	13.5	10.3	18.1	14.3	9.9	9.2	19.7	13.1	15.4	18.9	30.5	23.0	14.8	15.3	7.3	21.5	13.3	8.8	11.4
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400096	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 80.8;Kupffer cells: 100.7;Langerhans cells: 65.9;Leydig cells: 52.5;Macrophages: 144.7;monocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1659.8;non-classical monocyte: 1146.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 1659.8;monocytes: 1146.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.9;HMC-1: 25.5;NB-4: 20.4"									HPA056132	Approved				"Secreted to blood"	NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	14.6	9.3	7.2	38.5	7.5	26.0	8.9	13.7	9.6	10.7	7.7	7.6	4.1	8.2	4.7	3.7	14.2	9.3	5.7	6.9	9.3	12.6	9.7	30.4	9.2	12.1	9.4	9.5	5.3	3.6	15.5	11.3	11.7	11.3	5.3	3.8	5.7	4.0	5.3	5.3	8.0	9.8	9.0	31.1	5.9	10.8	9.3	5.0	9.4	2.9	3.5	17.7	6.7	15.5	0.3	0.4	0.6	0.7	27.9	1.8	0.2	0.2	1.4	0.1	0.5	0.0	0.5	0.6	1.7	0.4	0.3	0.8	0.2	0.1	0.0	1.4	1.0	0.6	1.3	0.1	0.3	1.1	25.5	2.0	0.4	0.2	0.6	0.1	0.3	2.5	0.2	1.8	0.2	0.9	2.0	20.4	0.6	0.4	0.3	0.5	0.0	0.4	1.1	0.6	0.8	0.3	0.0	6.9	0.7	0.1	0.1	6.0	0.6	1.2	1.2	0.8	0.2	2.5	2.0	0.6	0.3	2.3	0.4	316.9	584.3	18.5	2.5	863.0	2.1	2.3	0.9	1.0	288.0	1.1	1.0	1.8	1659.8	6.4	1146.1	5.4	2.2	354.1	7.2	7.5	13.7	9.6	6.9	9.3	12.1	9.4	11.7	9.0	9.3	15.5	1.0	3.2	12.4	8.8	2.7	1.8	0.3	0.9	0.0	3.6	2.1	3.0	0.6	2.8	3.9	1.8	4.2	0.6	2.1	0.6	27.4	0.2	0.7	3.9	13.1	4.1	0.0	2.7	15.9	0.4	0.6	2.8	0.5	5.8	10.1	0.8	1.8	1.8	80.8	1.7	14.8	1.3	0.0	100.7	65.9	1.9	52.5	144.7	1.8	28.1	72.3	1.4	3.1	2.0	10.3	0.3	0.1	21.4	0.4	0.5	0.1	0.7	3.1	2.4	0.0	1.0	0.7	1.6	2.6	0.2	0.9	0.8	2.0	0.4	0.9	0.3
PILRB	"FDFACT1, FDFACT2"	ENSG00000121716	"Paired immunoglobin like type 2 receptor beta"	Q9UKJ0	7	100352176-100367733	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 221.1;neutrophil: 141.8"	"Group enriched"	"Detected in all"	8	"granulocytes: 221.1;monocytes: 75.5"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 344.6"									HPA026750	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA026750: AB_10670828"	"unprognostic (8.33e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.35e-3)"	63.2	89.0	72.9	71.0	75.0	71.7	77.6	104.3	86.3	87.0	90.9	65.8	66.1	62.9	67.6	47.2	83.8	52.2	47.7	75.5	70.8	118.8	125.0	43.9	83.7	71.8	70.8	82.1	91.7	58.3	182.0	32.9	71.5	102.7	57.4	66.8	66.4	58.0	78.7	90.1	75.9	42.3	64.2	113.5	68.7	157.5	74.3	59.0	122.9	34.3	65.7	61.9	56.2	78.1	62.5	51.4	57.9	100.7	63.0	14.4	56.2	37.0	16.5	25.7	24.9	36.5	70.3	50.3	68.0	19.0	45.7	65.1	32.3	38.9	17.5	41.6	47.3	46.5	204.8	32.2	14.0	47.4	116.0	18.1	44.8	34.8	70.2	31.9	21.8	73.6	50.7	118.9	18.3	83.9	74.8	243.3	25.2	51.7	26.9	43.3	16.9	51.6	116.4	100.3	53.8	38.5	31.2	344.6	45.7	61.7	60.5	72.3	52.4	90.8	57.9	58.8	48.7	71.2	98.6	61.8	25.5	69.4	54.6	21.2	35.6	221.1	10.7	59.2	6.7	0.6	1.3	7.1	17.8	1.6	1.2	2.6	141.8	17.9	75.5	0.5	0.6	25.7	72.9	75.0	104.3	86.3	75.5	70.8	71.8	70.8	71.5	64.2	74.3	78.1	22.8	38.5	45.9	0.0	25.3	15.7	18.1	17.1	11.4	44.7	32.9	33.7	1.1	44.3	32.2	14.7	68.8	12.9	49.5	12.3	1.9	7.6	18.4	43.1	17.5	19.8	29.4	7.4	0.0	5.6	12.1	13.4	36.2	57.2	25.2	26.0	24.3	77.7	10.0	75.7	0.0	21.2	22.4	16.0	16.6	13.6	74.0	11.7	19.6	0.0	10.0	19.0	134.9	0.0	0.0	7.4	16.2	51.1	14.5	17.9	20.3	4.9	40.3	64.9	26.3	18.2	14.3	49.4	10.2	10.5	13.5	15.7	37.0	23.5	22.4	16.7
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849689	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 782.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	55.3	90.1	130.7	31.2	140.6	48.1	52.3	132.5	201.4	59.4	99.9	83.2	36.4	61.7	7.2	59.5	63.7	13.0	105.5	149.6	141.4	70.1	63.2	49.0	26.4	152.6	134.4	54.6	43.5	28.2	69.2	20.5	156.7	74.7	9.3	20.6	39.6	22.0	90.4	54.3	49.0	16.7	113.9	53.8	61.1	98.4	133.8	42.3	44.8	33.4	12.4	67.4	52.4	132.7	116.8	104.5	75.4	70.8	25.8	22.9	45.1	85.3	35.7	60.9	58.3	97.5	36.1	72.0	132.0	31.7	63.8	58.4	52.2	49.6	19.3	153.9	223.5	187.0	137.2	85.5	41.9	88.0	105.0	31.5	33.5	39.5	18.7	45.7	49.9	124.1	86.1	105.4	37.3	81.0	133.7	338.6	72.8	47.8	156.8	120.6	79.4	121.2	44.5	56.4	95.1	112.4	82.0	40.5	96.6	30.8	51.9	104.3	87.3	85.6	68.3	133.6	139.1	135.0	137.0	97.1	90.9	111.3	107.2	280.9	181.0	397.6	170.1	202.0	159.8	165.5	165.5	171.8	171.4	176.5	130.5	146.0	114.0	192.2	195.8	316.9	245.5	214.7	130.7	140.6	132.5	201.4	149.6	141.4	152.6	134.4	156.7	113.9	133.8	132.7	73.8	28.9	20.5	11.1	48.8	48.3	65.7	153.9	23.3	77.3	56.1	62.0	79.6	44.3	67.4	62.5	12.5	119.4	81.3	82.3	164.4	101.5	270.5	75.9	57.6	65.6	99.9	78.9	41.3	108.6	98.1	66.5	38.7	40.6	63.5	83.6	56.4	45.8	140.7	60.6	39.2	70.6	160.7	54.7	75.2	782.4	90.1	60.6	124.5	20.6	131.6	87.9	138.0	11.6	24.3	113.7	81.2	129.8	74.3	68.9	97.0	143.8	104.5	76.0	65.7	52.3	98.6	186.7	94.7	54.0	65.9	55.0	77.8	81.8	69.2	58.5
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PINK1	"BRPK, PARK6"	ENSG00000158828	"PTEN induced kinase 1"	Q9BXM7	1	20633458-20651511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 384.4;tongue: 392.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	50.7	127.2	119.3	13.7	103.4	13.0	41.9	104.6	110.9	37.9	73.0	62.3	32.3	43.9	18.8	48.8	34.4	23.5	153.4	106.6	107.0	56.8	76.8	30.1	10.8	118.5	127.8	30.1	52.7	66.5	33.4	21.3	118.3	37.1	15.0	29.4	55.0	29.7	384.4	55.3	35.2	20.0	124.9	27.9	46.7	94.8	132.1	12.3	41.6	392.3	8.3	47.4	42.7	95.0	49.9	22.2	10.3	29.6	34.6	32.8	10.7	68.2	67.9	32.4	56.1	7.7	39.3	11.7	52.6	69.9	75.4	22.5	15.0	36.2	16.0	14.0	56.8	5.9	60.3	12.1	26.8	6.3	17.7	30.8	38.5	40.6	13.9	36.2	21.3	10.7	14.5	14.5	23.6	21.2	9.2	14.1	4.6	12.9	72.2	7.9	18.0	9.4	20.1	11.5	37.8	14.8	74.4	24.2	20.8	12.3	8.0	21.6	32.6	29.1	14.9	49.2	9.7	16.7	3.6	5.4	63.1	17.9	14.0	3.6	1.6	3.7	0.8	1.1	1.0	0.2	0.7	1.1	0.5	1.4	0.5	0.8	8.1	0.6	3.9	1.0	1.5	0.6	119.3	103.4	104.6	110.9	106.6	107.0	118.5	127.8	118.3	124.9	132.1	95.0	38.7	22.4	19.2	16.3	9.1	15.7	36.0	7.9	10.8	50.1	31.5	24.4	1.1	37.1	9.2	44.1	37.5	26.3	9.2	107.4	80.3	24.0	77.7	22.3	16.1	48.5	20.0	56.0	27.2	28.0	31.8	27.4	12.2	26.4	0.0	36.7	84.3	110.5	23.7	28.6	24.4	30.2	12.2	27.1	16.3	151.4	35.4	22.7	21.4	25.3	10.1	69.7	12.3	8.5	14.3	56.6	67.9	56.8	27.0	67.5	66.9	109.2	7.6	69.0	85.5	30.9	32.2	120.8	24.6	19.3	24.0	34.2	10.6	34.2	24.4	47.9
PINLYP		ENSG00000234465	"Phospholipase A2 inhibitor and LY6/PLAUR domain containing"	A6NC86	19	43575801-43583964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 23.5;Proximal tubular cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 73.1;HMC-1: 46.6;JURKAT: 37.1;REH: 29.8;THP-1: 36.6"	"Not detected"	"Not detected"							HPA061218	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA061218: AB_2684453"	"unprognostic (6.72e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.60e-2)"	9.9	3.5	16.3	3.3	16.7	2.7	8.5	18.1	22.1	17.3	16.1	13.3	1.4	14.7	9.4	10.5	17.1	9.3	9.8	16.1	16.8	22.9	2.1	7.7	5.0	17.2	17.0	19.6	2.4	0.7	14.9	2.8	16.0	13.5	3.0	2.6	5.8	10.4	1.7	7.6	6.4	11.1	16.4	8.4	7.3	5.4	17.4	10.6	11.8	3.3	5.2	10.3	13.0	15.7	0.7	0.3	1.9	0.3	3.4	4.5	0.4	0.8	1.2	1.6	4.3	0.0	0.1	0.0	0.2	19.0	1.8	4.0	0.0	0.2	1.5	0.1	0.2	73.1	0.8	0.1	10.3	0.0	46.6	10.2	0.4	10.3	0.2	4.3	2.7	37.1	0.9	1.0	0.7	0.4	8.9	1.1	1.8	0.1	0.7	29.8	0.2	0.0	0.8	0.4	0.3	0.0	0.0	0.4	0.1	0.3	0.1	36.6	1.2	4.7	0.9	0.1	3.1	0.0	0.0	4.4	16.0	0.0	0.4	10.4	1.5	0.7	3.0	1.2	3.6	1.7	0.9	2.5	2.3	4.7	0.3	3.6	0.5	1.4	0.2	21.0	2.0	1.7	16.3	16.7	18.1	22.1	16.1	16.8	17.2	17.0	16.0	16.4	17.4	15.7	1.8	12.8	3.2	2.3	1.1	3.6	10.0	5.6	8.6	6.1	2.4	5.6	2.8	8.6	5.7	9.2	6.2	0.4	1.8	0.1	23.5	1.3	6.4	2.1	9.9	4.3	0.0	4.4	0.5	0.4	0.4	9.1	2.0	2.0	0.0	7.6	5.7	0.0	5.1	6.7	1.1	0.8	2.0	1.0	3.9	7.3	11.5	2.7	5.4	1.9	3.3	5.6	0.0	5.0	0.5	0.4	0.1	9.8	1.7	5.2	0.7	19.0	15.0	3.3	0.0	2.1	5.9	2.3	1.2	6.7	3.1	0.1	1.2	13.6	1.7	6.6
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000254093	"PIN2 (TERF1) interacting telomerase inhibitor 1"	Q96BK5	8	10764961-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	9.9	7.7	7.2	8.9	8.4	9.1	9.9	8.9	8.9	9.7	6.1	9.9	6.2	9.3	4.5	12.1	8.8	4.0	8.2	7.4	7.1	11.6	11.7	8.0	11.5	7.2	7.1	9.8	9.0	6.1	6.4	7.2	7.4	8.1	6.1	12.0	7.3	4.2	13.5	14.4	7.7	8.5	7.0	9.3	8.2	9.7	7.4	13.0	8.2	9.3	11.1	10.2	10.5	7.7	14.5	18.9	20.1	19.2	16.6	13.5	23.1	21.5	9.7	23.2	15.6	20.0	12.4	38.5	7.4	11.7	28.3	28.6	51.4	39.9	29.8	15.7	15.3	16.2	13.3	22.0	18.8	17.4	9.7	11.3	24.9	18.3	34.0	8.2	32.7	25.8	52.3	23.1	22.9	17.1	57.7	21.8	46.3	62.6	21.0	46.5	24.5	35.2	17.5	17.5	16.6	17.3	14.5	17.0	48.3	24.3	18.1	21.7	20.0	13.9	30.3	18.0	28.1	10.3	29.0	71.2	14.4	32.6	32.1	1.9	8.4	6.1	14.6	10.7	18.9	12.9	12.8	15.6	11.1	10.8	17.1	13.5	0.5	12.5	9.9	8.6	16.1	10.4	7.2	8.4	8.9	8.9	7.4	7.1	7.2	7.1	7.4	7.0	7.4	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	13.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	48.2	0.0	0.0	0.0	0.0
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000258724	"PIN2 (TERF1) interacting telomerase inhibitor 1"		8	10725399-10839847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"cervix: 2.9;vagina: 5.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"									HPA009065	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"									"unprognostic (2.57e-1)"					"unprognostic (6.34e-2)"				0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.9	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.2	6.7	12.4	10.4	26.6	20.7	12.0	14.2	5.6	0.0	0.0	0.0	8.6	8.2	3.7	12.5	0.0	4.0	6.9	11.7	0.0	37.0	0.0	0.0	7.3	8.4	6.9	25.0	0.0	0.0	5.3	7.7	0.0	14.0	0.0	12.5	7.0	0.0	3.3	22.4	5.0	8.2	5.4	10.3	32.7	9.3	3.9	7.2	13.1	3.3	9.0	7.2	17.6	15.3	0.0	5.3	6.4	14.0	20.2	6.5	13.3	7.0	22.1	0.0	12.5	5.5	21.5	22.7	12.0	28.6	0.0	8.3	0.0	9.6	8.9
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139739	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"salivary gland: 16791.8"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 1117.6;Breast myoepithelial cells: 324.2;Melanocytes: 403.8"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	333	"T-47d: 703.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	NA	NA		66000000	"Cluster 37: B-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	9.1	3.6	0.7	0.2	4.8	0.1	3458.7	2.7	2.7	5.6	0.0	0.5	0.0	0.1	2.7	1.3	4.2	0.1	4.8	0.9	4.6	0.5	2.0	6.4	0.8	8.5	4.4	3.8	21.1	0.4	1.9	2.3	6.8	33.3	0.0	0.0	16791.8	3140.5	1.7	189.7	0.6	0.0	3.5	0.6	0.6	0.7	4.6	0.3	0.7	0.0	1.8	0.6	1.5	11.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	703.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.8	2.7	2.7	0.9	4.6	8.5	4.4	6.8	3.5	4.6	11.5	6.9	0.0	2.0	0.0	3.6	10.8	6.6	18.8	0.0	0.0	1117.6	324.2	0.1	0.0	48.2	1.8	0.0	0.0	7.0	0.0	0.0	9.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.5	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.4	0.0	1.6	0.0	0.0	1.5	403.8	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	0.0	13.1	0.0	0.1	147.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.7	0.0	2.5	0.0	0.0	13.7
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534854-22714578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 498.1"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1585.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		4900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	28.4	15.5	162.5	47.8	329.4	44.8	15.0	239.0	239.9	26.5	49.8	17.8	13.2	21.1	11.8	19.8	15.2	32.9	13.5	169.7	193.6	16.5	18.6	25.9	81.2	260.6	273.4	8.8	10.9	24.8	8.5	23.7	271.7	9.3	19.1	15.3	7.8	13.0	5.1	8.3	20.6	31.5	171.8	62.6	19.3	12.5	233.3	60.4	12.8	10.9	88.5	24.1	10.5	498.1	30.2	29.2	33.4	10.8	52.3	70.6	25.3	55.0	58.1	29.1	35.7	27.6	47.2	63.2	19.4	111.0	63.7	10.4	29.2	15.4	29.2	140.5	30.4	118.7	21.6	60.9	92.5	23.1	89.1	35.6	13.7	39.7	38.2	44.6	43.7	83.5	67.4	119.1	54.5	12.5	92.3	20.5	13.7	14.5	20.7	36.9	47.8	86.3	43.0	5.8	6.1	13.9	17.7	9.0	86.4	37.6	7.6	39.1	53.0	22.3	32.8	41.7	33.9	75.1	46.3	45.0	60.5	68.3	17.6	72.6	32.6	104.0	119.5	57.9	164.0	52.1	94.2	139.9	43.7	33.1	62.8	118.2	40.5	144.2	67.3	44.8	75.9	183.4	162.5	329.4	239.0	239.9	169.7	193.6	260.6	273.4	271.7	171.8	233.3	498.1	22.5	3.2	6.7	84.9	43.2	17.6	4.0	2.0	3.4	5.7	12.9	5.5	8.1	14.3	5.6	18.4	2.1	8.6	196.9	3.4	11.7	9.7	22.9	7.4	15.7	29.2	4.9	236.9	65.6	10.7	5.4	19.6	6.6	24.8	22.8	13.4	62.4	8.7	31.8	13.5	62.0	2.9	0.0	98.6	80.0	34.5	16.8	82.8	104.9	142.4	81.3	5.0	159.6	167.9	1585.0	22.1	3.7	10.1	36.4	7.1	1.0	15.6	2.2	9.1	19.7	14.1	30.6	6.1	7.9	3.3	16.9	12.4	130.7	8.5	2.8	6.6
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	13.6	17.2	18.4	11.6	24.0	26.5	20.0	13.4	32.8	18.4	20.7	24.1	16.0	18.5	81.6	28.2	26.6	16.1	15.0	22.3	11.5	36.0	14.8	19.7	13.5	14.9	13.0	16.0	21.0	39.1	18.7	12.1	16.0	21.6	26.3	29.1	25.6	18.4	14.0	27.1	19.2	15.9	11.9	14.6	39.8	28.1	15.7	11.4	22.4	10.5	18.8	18.2	20.5	20.9	52.0	36.4	14.8	17.6	0.0	0.1	47.0	21.4	40.6	38.7	35.1	46.7	73.4	11.3	44.1	25.6	47.4	46.1	24.2	42.2	30.3	15.9	26.1	20.0	17.5	33.7	32.8	19.3	35.0	12.9	70.0	14.7	26.9	46.4	19.6	12.1	26.8	33.3	20.0	52.6	16.5	16.7	28.1	32.1	31.2	0.5	130.9	17.2	39.6	91.1	23.7	30.0	45.8	30.4	29.7	49.3	83.2	17.8	4.2	18.5	26.1	27.7	22.8	25.1	31.5	25.6	36.0	16.0	32.1	58.8	8.2	25.8	24.3	10.5	16.1	8.7	14.8	18.4	8.6	11.0	13.8	16.7	16.3	16.2	14.6	3.8	19.9	11.0	18.4	24.0	13.4	32.8	22.3	11.5	14.9	13.0	16.0	11.9	15.7	20.9	4.1	9.6	8.6	4.9	6.9	12.4	6.2	11.7	10.8	14.3	13.2	8.0	121.7	12.8	11.9	35.0	18.8	11.3	7.4	33.7	21.5	17.7	25.7	14.2	4.2	8.8	22.2	5.2	28.0	19.7	15.2	5.4	26.0	20.3	3.8	4.0	9.3	12.6	8.9	8.4	11.8	18.4	10.2	6.0	2.2	47.9	6.8	5.7	12.4	2.8	5.9	7.5	5.2	5.0	11.5	40.5	12.8	5.3	9.4	10.1	14.2	13.3	15.3	8.1	19.7	3.8	13.1	12.0	9.0	14.3	12.8	17.4	11.9	5.5	10.4	9.2
PIP4P1	"C14orf9, MGC26684, TMEM55B"	ENSG00000165782	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1"	Q86T03	14	20457681-20461465	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.4;Hofbauer cells: 54.9;Syncytiotrophoblasts: 167.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048528	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA048528: AB_2680427"	"unprognostic (1.84e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.96e-1)"	23.6	27.3	37.2	13.6	38.3	49.0	22.4	36.5	38.6	22.2	32.1	25.4	17.8	21.6	27.0	25.5	21.6	13.4	22.9	38.2	38.8	27.4	25.1	23.9	18.8	38.3	37.8	20.9	24.4	30.6	28.3	16.6	40.4	23.6	15.6	26.1	23.5	15.4	35.1	33.6	28.7	15.9	36.0	31.3	27.8	21.2	38.2	16.9	22.5	22.6	21.1	24.2	21.3	36.5	21.1	32.4	21.3	25.1	32.7	20.2	39.5	19.6	38.1	26.2	31.5	19.3	33.2	18.8	16.5	24.6	75.9	21.6	26.3	21.5	22.9	24.9	19.7	13.5	15.5	28.6	44.6	25.2	26.7	26.3	28.9	30.2	30.5	23.8	24.5	28.7	11.5	37.1	21.9	24.2	34.3	22.1	14.3	32.9	44.5	25.1	20.7	12.6	24.6	46.6	30.7	23.0	20.1	32.6	25.8	18.3	16.4	23.6	17.2	23.8	30.1	36.0	17.6	42.0	58.0	27.6	16.5	19.2	26.5	1.3	3.2	7.3	4.2	2.3	3.5	12.4	5.2	4.8	4.1	10.3	5.8	6.1	4.1	4.4	2.0	10.4	4.5	2.5	37.2	38.3	36.5	38.6	38.2	38.8	38.3	37.8	40.4	36.0	38.2	36.5	23.5	9.6	12.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	29.8	22.7	0.0	0.0	3.1	22.0	0.0	78.4	23.8	0.0	19.6	36.8	0.0	19.1	13.5	9.1	0.0	0.0	0.0	40.0	35.0	8.2	0.0	24.3	3.8	15.6	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	12.9	0.0	0.0	0.0	0.0	36.9	0.0	0.0	7.6	0.0	0.0	20.4	5.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	167.2	9.9	18.4	0.0	0.0
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993802-91040872	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.2;Cytotrophoblasts: 32.6;Distal tubular cells: 49.0;Extravillous trophoblasts: 31.1;Hofbauer cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.54e-4)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	11.9	13.9	13.2	6.6	15.7	30.0	7.4	16.5	20.1	9.2	20.2	14.6	2.8	10.5	4.2	5.9	7.2	11.0	20.7	13.3	20.4	10.0	3.8	5.5	6.9	16.5	16.4	10.6	3.3	10.9	7.9	8.8	18.2	8.7	4.8	11.0	7.3	12.2	13.5	6.5	5.3	13.5	16.4	8.3	6.5	6.9	17.5	9.5	6.6	14.8	5.4	9.9	6.6	21.0	4.8	2.9	16.8	10.2	27.2	30.6	3.5	19.3	24.2	10.2	15.1	1.9	8.1	9.4	2.6	19.9	10.3	1.1	4.2	7.0	13.6	8.1	7.3	13.9	2.9	1.5	23.6	3.3	12.2	17.2	4.4	12.8	9.6	27.4	9.8	2.7	7.4	31.0	35.6	3.3	10.4	9.5	8.6	0.0	9.8	3.9	6.9	11.2	14.9	3.0	2.0	9.7	1.5	6.6	28.4	11.4	0.2	6.3	15.1	18.5	7.1	11.2	9.0	12.0	7.0	6.0	31.6	6.4	25.2	0.9	11.6	10.8	1.3	5.9	2.3	2.7	3.1	1.7	10.8	1.9	4.8	1.9	76.9	2.4	2.2	6.0	2.8	6.1	13.2	15.7	16.5	20.1	13.3	20.4	16.5	16.4	18.2	16.4	17.5	21.0	26.2	0.0	2.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.5	11.2	0.0	0.0	3.1	9.2	0.0	32.6	7.7	0.0	49.0	18.0	0.0	0.8	11.7	5.2	0.0	0.0	0.0	8.9	31.1	18.7	0.0	1.0	8.8	4.1	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.1	0.0	0.0	13.1	1.5	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	10.9	3.7	14.3	0.0	0.0
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	20.1	19.1	16.0	16.1	17.3	9.7	19.5	17.8	19.2	18.9	20.8	17.2	16.2	18.8	21.1	20.4	18.9	19.7	19.8	16.8	17.3	21.9	18.6	21.8	18.7	15.1	15.7	18.7	13.6	23.0	21.5	25.9	14.7	16.7	15.1	30.1	16.9	14.1	29.2	21.0	16.9	20.3	14.2	19.0	16.6	35.1	16.9	24.7	18.4	25.4	20.1	20.5	17.4	18.4	49.3	37.4	57.7	67.6	37.5	38.8	56.7	63.5	89.3	116.6	103.7	68.7	46.8	43.9	66.8	67.9	52.7	42.0	75.7	42.6	101.2	68.8	54.0	36.0	48.4	33.9	70.1	64.9	43.8	51.1	40.3	72.7	90.7	52.1	48.8	69.4	35.6	36.7	60.4	69.9	63.6	32.4	86.0	38.2	58.3	60.5	50.7	34.1	61.2	27.1	38.6	49.4	87.1	66.6	57.4	96.4	69.2	59.4	47.4	46.6	64.7	42.6	77.0	50.5	93.6	99.3	44.7	18.6	56.6	0.1	3.9	5.7	3.7	4.7	2.8	6.6	3.3	4.1	6.4	3.0	3.7	2.9	8.9	3.9	3.8	6.7	3.1	4.7	16.0	17.3	17.8	19.2	16.8	17.3	15.1	15.7	14.7	14.2	16.9	18.4	11.6	32.1	12.2	43.8	21.3	66.2	23.2	17.0	39.9	34.1	31.3	22.0	18.4	17.2	15.3	31.3	98.0	25.9	18.3	12.7	9.8	13.5	4.9	64.0	26.2	15.6	6.0	12.4	59.6	8.7	29.3	19.8	19.4	71.0	12.0	19.9	14.3	14.3	12.8	26.9	51.2	9.7	18.3	10.7	29.5	4.8	13.4	14.9	12.4	44.0	12.2	12.5	9.2	54.8	64.0	19.4	8.9	10.9	16.8	20.9	21.0	10.1	18.4	43.0	13.1	17.4	20.9	52.1	24.6	38.4	50.0	63.5	15.9	18.4	10.7	39.4
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705240-69009176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 97.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"eosinophil: 34.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 34.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.2	11.9	5.6	6.0	5.3	16.1	4.9	18.4	8.1	6.3	97.3	31.2	34.8	7.5	1.7	1.2	6.0	4.0	32.2	12.3	10.7	7.8	0.3	12.9	2.6	7.9	11.2	1.0	8.6	13.7	6.6	6.5	6.3	3.1	29.1	38.0	16.4	9.6	2.9	2.3	30.8	2.9	4.0	2.6	26.1	24.7	11.4	1.0	1.2	5.1	3.6	3.3	2.5	3.7	0.0	0.0	43.8	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	4.6	0.0	3.6	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	17.0	0.3	13.4	0.0	0.9	4.4	0.0	2.0	0.0	0.0	0.0	0.1	0.5	0.9	9.3	0.3	1.1	0.1	0.2	2.3	73.1	1.4	1.4	0.1	0.3	0.3	3.4	0.9	0.1	0.0	0.1	0.5	1.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	17.0	3.5	2.3	0.0	3.1	0.0	5.6	0.5	34.5	0.0	0.0	0.0	4.7	0.3	0.1	0.1	5.4	0.7	0.1	1.7	0.0	0.2	1.4	1.6	0.3	5.6	5.3	18.4	8.1	12.3	10.7	7.9	11.2	6.3	4.0	11.4	3.7	3.6	35.3	34.4	28.7	19.2	0.6	3.2	0.5	0.6	5.1	4.7	3.3	61.6	2.8	2.8	5.5	2.1	21.3	0.0	127.4	27.4	1.6	100.0	12.8	13.6	3.3	37.0	53.6	84.7	14.0	1.3	3.1	40.2	27.5	5.7	3.8	1.4	0.0	3.9	0.0	270.1	32.6	14.2	1.0	1.3	47.6	2.5	5.6	5.4	60.0	2.6	120.2	0.0	80.9	6.4	5.2	46.6	1.5	43.2	2.5	39.2	1.4	6.5	3.3	26.3	2.5	32.2	39.0	4.5	0.7	0.3	8.8	2.1	0.9	29.7	9.8
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700468	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	22.1	15.6	30.7	11.5	36.6	3.4	19.2	19.4	66.4	24.0	0.0	62.2	8.6	44.9	7.6	20.3	29.8	8.2	32.2	40.2	5.0	15.8	8.7	22.6	6.5	13.3	7.7	22.2	18.0	10.7	20.6	11.2	12.9	33.9	4.5	13.2	18.1	25.1	17.7	16.0	24.1	16.0	0.0	22.4	29.7	61.4	19.5	5.3	21.1	4.8	4.2	39.4	24.7	33.2	18.9	18.0	13.4	18.0	25.5	21.0	20.3	36.1	22.4	15.2	12.3	16.1	5.2	7.8	13.6	39.0	16.5	16.4	6.5	11.7	6.2	28.7	11.9	9.0	15.0	13.1	22.0	9.4	26.7	23.7	9.9	12.4	4.1	9.9	25.6	11.5	14.1	13.5	14.4	15.7	11.2	6.6	14.4	6.8	24.6	21.4	7.2	11.2	11.5	15.9	13.7	12.0	18.7	10.1	11.1	16.6	7.9	14.1	57.3	21.3	11.8	75.1	17.0	16.0	14.3	3.5	27.6	19.2	15.0	1.0	0.7	0.0	0.7	0.5	0.2	0.6	0.5	0.4	0.8	0.3	0.2	0.4	0.5	0.5	0.8	0.5	0.4	0.6	30.7	36.6	19.4	66.4	40.2	5.0	13.3	7.7	12.9	0.0	19.5	33.2	20.3	6.4	5.0	8.8	6.2	5.4	3.0	6.1	7.4	56.8	9.6	6.6	7.5	7.2	3.0	16.5	37.5	7.8	10.6	12.2	1.9	7.9	11.6	6.4	29.0	22.1	8.4	2.1	30.6	7.1	7.4	10.7	7.1	11.6	1.3	10.7	16.1	4.0	15.7	30.3	17.9	9.7	6.1	19.6	13.2	24.0	14.9	15.5	5.4	22.5	15.0	14.3	11.3	9.0	6.8	12.1	13.2	24.0	5.7	4.4	7.2	6.4	4.1	26.8	13.1	8.4	10.4	18.6	11.8	7.8	6.8	16.4	8.0	11.9	7.2	5.3
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920881-127930785	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.6;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Karpas-707: 45.5;RPMI-8226: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA056240	Uncertain		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA056240: AB_2683075"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.2	1.0	0.0	1.0	0.6	1.7	1.6	1.8	2.3	0.2	1.0	0.1	1.3	0.2	3.2	1.7	0.3	0.2	0.9	1.0	1.3	0.2	1.9	0.1	2.1	0.8	0.9	1.3	2.9	3.8	0.6	2.4	3.1	0.0	0.2	3.2	1.4	0.1	3.9	0.5	0.3	0.7	0.6	1.4	2.5	1.3	0.1	1.7	0.0	0.2	1.0	3.6	1.0	0.0	0.7	0.7	0.8	0.8	1.9	4.1	0.8	0.8	0.2	0.2	0.3	5.5	0.5	1.6	3.7	1.6	1.7	0.0	4.1	0.2	0.3	2.7	0.0	1.4	0.1	1.3	0.0	0.2	2.1	2.6	0.6	0.0	1.3	0.0	3.7	0.0	45.5	0.0	4.0	0.0	1.6	0.4	1.7	0.6	0.4	0.1	31.5	0.0	0.1	1.4	2.7	0.3	1.0	0.0	0.4	1.7	2.2	0.6	0.5	1.3	0.9	0.1	4.0	2.8	1.0	8.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.0	1.6	1.8	0.9	1.0	2.1	0.8	2.4	0.7	1.3	1.0	0.5	0.0	9.3	0.3	1.1	2.2	4.7	5.1	8.6	0.7	3.2	4.7	0.5	0.0	2.0	5.5	0.0	0.9	1.5	0.6	1.9	1.4	22.6	2.3	3.5	0.8	0.0	3.2	0.9	1.5	4.4	0.9	7.7	4.1	0.0	1.7	0.4	0.3	0.3	5.0	1.7	0.4	2.0	0.3	0.6	24.6	0.9	0.3	0.0	0.0	0.2	1.9	0.0	0.0	0.1	1.2	0.1	0.4	2.0	2.9	0.1	0.1	7.4	0.8	0.0	1.0	1.3	1.8	2.2	2.3	1.1	3.1	0.9	1.2	0.7	2.1
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 48.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA		35000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	19.1	19.9	20.2	5.2	23.7	5.7	15.4	23.5	24.3	12.4	21.2	10.0	6.5	11.7	15.3	29.6	13.3	11.4	17.3	18.7	22.9	11.4	21.0	15.4	2.7	23.0	22.6	13.1	3.3	4.9	11.3	10.5	22.8	10.1	6.7	7.9	10.3	14.2	14.7	11.9	8.6	10.4	22.5	20.1	11.9	6.2	22.5	6.2	15.7	6.4	7.1	30.4	17.4	25.7	14.3	76.6	45.0	66.3	26.1	29.0	14.4	4.2	26.5	11.0	24.5	21.5	118.9	0.0	147.2	12.3	292.4	96.7	52.8	21.3	4.0	0.0	11.6	8.4	80.7	63.9	33.4	4.4	29.8	8.3	72.3	41.9	14.4	19.2	683.9	0.0	6.4	19.2	9.4	29.8	3.3	4.1	48.4	62.1	47.7	0.0	8.9	37.9	22.2	136.0	17.2	47.5	36.7	20.5	267.9	76.8	42.4	26.7	43.2	5.9	11.0	28.5	8.7	9.1	39.6	0.3	28.6	15.8	59.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	20.2	23.7	23.5	24.3	18.7	22.9	23.0	22.6	22.8	22.5	22.5	25.7	24.5	0.0	4.1	0.0	1.1	8.7	24.3	48.4	10.8	2.8	4.2	4.8	5.8	10.0	19.4	1.8	0.0	96.1	0.0	4.8	9.8	5.9	0.6	59.6	3.8	40.3	11.3	11.6	0.2	2.5	12.8	15.6	15.8	20.0	0.0	21.7	22.9	24.0	22.0	20.2	0.2	3.4	38.7	6.4	3.4	4.0	37.6	4.1	40.9	0.0	11.9	30.8	0.0	0.0	0.0	3.4	1.7	28.6	3.6	18.1	5.9	12.0	38.0	4.8	13.1	8.4	11.3	0.6	3.5	34.5	12.6	85.6	0.6	56.2	4.3	50.9
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"	"Cataract, Deafness, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 80.7"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	34.1	13.7	6.7	12.2	6.3	18.7	16.0	14.3	9.8	7.4	7.5	8.9	8.8	10.1	4.8	7.3	10.8	7.1	7.3	6.1	7.5	18.9	6.3	14.7	8.4	7.0	6.0	7.6	9.2	5.0	12.6	19.9	6.8	9.0	2.0	3.5	7.5	5.3	5.3	7.8	7.8	3.2	3.8	18.0	8.2	20.3	7.2	3.8	11.5	3.2	4.3	7.3	7.1	5.1	21.7	19.7	5.8	5.8	17.3	6.6	13.2	17.4	13.6	11.9	12.9	28.6	6.6	12.9	18.0	8.8	15.8	24.0	7.9	15.5	1.9	14.4	16.9	13.5	12.8	23.7	35.9	28.7	34.2	12.4	8.5	21.2	9.1	4.9	10.6	9.0	40.3	7.6	6.9	80.7	12.5	12.4	5.7	14.2	8.1	17.4	6.5	13.0	7.6	18.9	14.2	8.4	10.1	31.8	11.0	4.7	26.5	15.5	21.0	14.9	17.7	9.6	16.3	8.9	13.3	16.2	14.2	19.0	12.1	24.1	21.7	16.1	10.6	15.8	10.3	11.9	7.7	9.0	18.3	11.9	10.3	8.6	47.0	10.4	8.7	8.9	8.2	13.8	6.7	6.3	14.3	9.8	6.1	7.5	7.0	6.0	6.8	3.8	7.2	5.1	11.1	16.0	15.6	17.3	12.4	25.6	34.7	31.5	38.7	26.0	18.6	12.6	55.5	12.8	31.1	42.3	20.9	223.5	12.9	12.0	11.7	33.2	60.0	36.2	17.9	19.6	20.9	32.4	40.3	16.8	25.9	13.6	17.3	87.3	18.3	13.2	8.9	7.5	36.4	18.5	35.5	12.9	22.4	36.4	12.7	81.9	9.6	19.8	3.6	9.4	27.1	11.8	24.7	16.1	19.9	15.9	8.4	7.2	11.4	52.1	12.3	13.9	10.9	25.8	19.7	4.9	11.1	25.0	17.9	27.7	21.3	245.0	11.8	8.3	14.2	43.5
PITHD1	"C1orf128, HT014, TXNL1CL"	ENSG00000057757	"PITH domain containing 1"	Q9GZP4	1	23778418-23788232	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016936	Uncertain					NA	NA		640000	"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA016936: AB_2067141"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.93e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.38e-1)"	42.2	49.8	102.6	28.3	105.5	100.6	42.6	94.4	120.5	49.3	75.9	43.1	28.1	36.8	55.1	70.0	38.6	24.5	44.6	107.8	125.0	39.7	52.9	35.4	45.9	105.8	110.0	43.3	43.2	124.3	48.3	37.8	131.4	49.0	40.8	47.5	42.8	38.1	78.5	70.3	37.2	37.7	97.5	44.5	46.3	53.1	106.1	142.5	36.5	54.9	52.6	40.3	57.9	112.6	49.9	27.6	44.6	84.4	66.9	48.2	33.5	70.5	51.2	61.1	47.2	43.9	55.4	132.8	58.7	64.7	25.1	55.8	89.4	55.4	61.5	67.6	68.8	124.1	83.9	61.2	40.3	128.8	45.7	39.1	69.8	47.9	67.2	55.0	53.3	79.8	185.9	68.1	72.2	38.1	82.3	71.1	57.9	79.5	67.0	89.3	49.3	87.4	56.7	34.6	105.0	42.3	50.2	74.8	90.7	47.0	45.7	56.8	47.8	41.9	54.4	86.3	60.4	58.8	64.6	153.1	73.3	140.7	65.9	20.4	22.0	49.4	36.6	29.5	40.7	53.3	42.2	42.8	22.7	48.2	51.2	49.1	22.5	43.0	35.6	35.3	39.2	33.7	102.6	105.5	94.4	120.5	107.8	125.0	105.8	110.0	131.4	97.5	106.1	112.6	59.6	9.6	19.6	15.3	66.3	129.1	48.0	30.6	68.9	65.2	58.9	66.9	39.9	35.8	21.4	22.0	22.9	97.6	116.7	31.8	52.8	38.4	12.3	46.8	30.7	46.6	32.9	162.9	24.6	33.9	63.1	50.5	42.3	35.8	24.1	34.6	33.2	37.5	78.0	104.3	24.4	42.6	42.7	37.4	64.3	16.3	42.9	51.5	120.9	9.4	63.5	118.3	61.8	9.5	21.7	36.4	28.8	57.6	46.3	61.9	28.7	48.9	11.9	41.0	78.9	52.3	47.1	139.3	116.4	86.5	134.7	116.4	80.1	66.9	44.1	34.6
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562792	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		190000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	42.5	36.8	41.7	61.0	45.4	93.6	41.7	46.6	56.2	50.7	51.0	47.2	56.7	55.3	58.8	76.6	65.9	45.4	39.1	43.8	50.5	40.0	39.0	46.9	40.4	62.4	45.4	32.1	33.9	60.8	33.1	50.2	58.4	54.2	55.6	47.6	84.1	61.7	24.7	93.2	88.9	54.3	41.9	42.4	40.5	44.8	52.2	33.2	64.7	22.7	57.1	51.9	41.8	43.0	64.9	70.5	70.5	61.0	72.1	78.8	110.7	68.9	75.8	70.6	50.9	78.7	25.7	81.8	62.4	94.0	45.4	79.5	64.2	68.4	97.0	68.3	69.2	44.7	61.4	37.0	70.6	31.1	51.6	58.9	90.6	70.5	73.1	74.4	118.4	67.1	63.3	44.9	74.8	36.5	80.1	28.5	49.3	103.4	34.1	63.8	27.2	46.9	70.5	73.5	25.2	55.2	83.2	59.1	51.4	70.5	52.2	24.7	113.8	44.8	39.5	126.4	95.5	27.2	49.8	28.8	77.4	47.9	58.4	3.7	2.4	3.2	2.1	2.7	4.0	4.3	3.1	2.8	3.5	3.1	2.9	2.6	8.0	3.7	1.9	2.7	5.2	1.7	41.7	45.4	46.6	56.2	43.8	50.5	62.4	45.4	58.4	41.9	52.2	43.0	29.3	35.3	35.0	28.7	14.1	31.0	17.5	12.0	12.0	36.4	30.0	30.2	23.9	17.2	17.1	25.8	8.4	43.4	26.9	41.2	13.7	16.0	12.0	50.5	48.4	31.4	22.1	15.6	42.4	18.5	47.3	19.1	13.3	36.5	19.0	16.8	34.6	30.2	40.5	40.4	46.3	27.7	10.2	29.9	49.7	16.8	12.5	36.4	19.6	36.5	36.6	40.2	13.4	12.1	16.0	26.0	22.9	21.8	15.7	33.0	78.0	16.3	21.7	18.4	6.6	18.8	45.1	35.8	34.7	37.8	41.8	120.0	14.9	24.7	25.3	27.0
PITPNB	VIB1B	ENSG00000180957	"Phosphatidylinositol transfer protein beta"	P48739	22	27851669-27920134	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		300000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (9.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.64e-1)"	42.2	27.1	27.9	33.3	30.4	21.6	33.0	30.9	34.1	31.7	22.6	53.1	21.9	31.5	28.6	52.5	29.3	35.4	35.8	32.2	31.6	25.2	56.9	32.1	34.6	29.5	31.8	30.0	28.3	24.0	22.5	49.2	30.5	27.5	30.1	18.1	24.7	37.0	21.3	30.3	28.1	44.2	29.1	27.7	35.3	19.4	31.9	33.4	24.8	21.7	41.1	54.2	36.6	30.5	94.1	39.8	71.5	53.8	62.3	74.7	54.5	88.8	77.4	95.5	91.7	63.4	43.1	64.7	46.0	86.0	70.5	96.6	103.0	88.7	133.2	111.1	97.4	66.1	62.0	58.5	66.9	152.5	102.6	67.2	85.0	115.7	119.6	62.9	94.4	44.8	95.3	130.5	88.5	50.0	64.9	74.7	54.4	97.8	52.1	81.6	112.9	95.6	79.1	87.6	83.6	104.7	60.8	72.7	75.7	75.9	39.4	53.7	93.2	94.9	138.9	72.9	94.2	53.0	66.7	125.2	81.6	74.1	82.2	36.0	18.6	18.6	30.9	21.7	34.0	35.2	29.7	32.3	24.9	30.9	28.4	28.0	16.7	27.4	21.2	22.2	40.8	26.0	27.9	30.4	30.9	34.1	32.2	31.6	29.5	31.8	30.5	29.1	31.9	30.5	97.0	28.9	32.4	57.8	44.3	96.0	128.9	40.8	65.4	24.1	37.4	33.4	57.8	35.8	48.4	31.3	14.6	39.7	45.9	26.1	37.2	49.0	21.4	55.4	72.5	62.4	25.2	15.8	51.8	50.2	52.3	65.9	32.6	79.8	21.5	37.0	30.7	45.8	27.3	32.0	45.7	26.7	24.4	23.6	42.2	6.9	32.0	35.1	26.6	68.4	55.6	17.4	48.4	60.8	67.0	66.7	21.1	48.2	54.2	97.5	17.2	29.6	22.8	16.1	26.3	57.9	76.7	44.0	35.4	60.9	82.1	48.6	42.3	46.9	24.0	112.9
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 91.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA060227: AB_2684226"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	10.6	24.5	19.6	24.3	12.6	26.8	6.4	6.1	23.2	10.7	13.9	14.4	18.7	9.3	2.4	19.5	23.1	9.0	22.3	13.3	23.8	37.8	11.0	16.3	27.6	14.2	31.0	4.0	9.8	10.3	26.7	8.0	13.5	10.4	7.5	40.7	8.7	10.3	6.9	5.0	21.1	5.9	2.3	21.6	16.0	8.8	51.5	17.4	15.7	18.4	17.2	16.2	9.3	5.5	12.7	31.2	18.8	13.9	20.3	12.1	30.5	12.2	21.5	14.8	8.4	28.5	22.6	12.5	28.7	17.5	28.4	32.4	14.5	27.0	4.8	91.0	6.0	17.0	55.8	10.8	16.0	19.4	35.3	15.0	17.0	22.4	14.7	27.4	17.9	18.7	13.2	11.0	12.5	19.1	33.2	45.6	19.3	35.9	13.5	23.7	6.0	17.3	24.4	25.1	18.1	11.5	27.3	37.6	29.6	9.0	7.4	16.9	17.7	26.5	20.1	16.9	8.9	16.0	8.3	11.2	37.1	22.7	10.6	0.0	1.4	0.9	1.1	3.3	1.0	0.7	0.8	1.0	1.0	0.5	0.3	0.8	1.4	0.1	2.7	0.4	0.7	1.1	19.6	12.6	6.1	23.2	13.3	23.8	14.2	31.0	13.5	2.3	51.5	5.5	7.5	3.2	5.8	2.0	10.8	8.2	6.3	9.3	13.6	45.7	5.4	5.2	8.4	5.7	9.7	20.2	64.6	4.6	10.6	69.9	3.9	11.3	6.1	63.3	16.5	4.9	11.4	0.4	5.1	9.3	8.9	4.2	34.7	24.6	2.5	7.1	3.3	3.4	8.4	38.7	6.6	16.8	10.2	13.2	14.0	17.0	2.1	15.2	3.6	10.3	13.5	20.7	3.1	0.5	0.5	15.9	32.7	1.2	7.5	9.8	39.0	18.9	37.8	53.7	0.0	6.3	9.8	1.4	5.5	11.2	3.3	15.2	14.9	1.4	24.0	19.4
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.6;Cone photoreceptor cells: 54.2;Excitatory neurons: 51.3;Horizontal cells: 40.4;Inhibitory neurons: 41.3;Late spermatids: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 29.5;JURKAT: 35.6;MOLT-4: 55.0;WM-115: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	4.6	9.0	11.4	4.6	12.3	5.2	3.7	6.7	15.6	6.1	18.7	5.7	4.7	4.6	3.7	4.7	3.7	2.6	4.9	13.1	1.8	8.7	11.0	6.8	3.2	4.9	3.6	15.3	3.5	6.6	8.4	3.6	1.6	3.5	2.5	15.2	2.4	3.8	5.0	4.1	4.9	5.7	0.4	4.4	4.6	7.3	4.9	87.3	3.7	3.3	1.9	7.0	4.9	3.8	4.6	8.7	2.8	4.1	1.9	3.7	16.8	0.7	1.1	2.3	1.2	3.8	3.7	0.0	3.7	1.5	4.8	12.8	2.3	2.2	0.8	0.3	2.8	29.5	5.7	10.5	1.3	1.1	6.0	1.8	3.8	3.0	2.3	10.8	4.5	35.6	6.8	0.3	2.9	2.9	55.0	6.1	3.2	1.4	3.9	15.7	0.2	11.4	4.1	4.7	2.5	0.9	6.3	5.2	4.1	1.6	1.1	3.1	13.3	3.3	3.7	5.4	5.1	0.8	1.0	20.4	8.2	2.2	25.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.6	0.0	0.2	0.5	0.4	0.0	1.9	0.0	0.0	0.3	0.7	11.4	12.3	6.7	15.6	13.1	1.8	4.9	3.6	1.6	0.4	4.9	3.8	16.2	0.0	5.0	33.6	2.8	3.6	0.7	0.7	2.2	19.6	1.5	1.5	7.3	2.8	1.6	9.2	54.2	1.3	6.3	6.3	1.9	3.3	33.0	3.7	3.6	9.3	0.0	1.7	51.3	4.5	6.5	3.8	2.0	5.2	1.3	0.8	6.4	16.3	0.5	40.4	41.3	3.7	0.0	0.6	1.1	87.7	1.8	3.6	1.8	10.3	1.3	3.7	10.3	22.1	1.8	3.9	0.3	4.9	2.2	1.1	6.1	2.6	0.1	15.8	0.0	2.1	2.5	8.2	4.7	3.6	1.6	3.7	4.8	0.4	2.6	0.6
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451263-6556555	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 20.5;Hepatic stellate cells: 27.8;Inhibitory neurons: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 17.7;HeLa: 14.8;hTCEpi: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.3	3.1	23.6	1.1	20.7	0.1	1.4	7.3	23.7	3.1	0.0	7.5	1.3	1.9	3.4	17.8	4.3	1.8	1.3	19.1	1.6	2.8	1.4	3.1	0.2	0.0	0.8	26.6	1.7	0.9	2.0	0.1	0.0	4.5	3.7	7.9	4.7	8.9	0.9	17.0	2.7	4.0	0.5	60.8	6.8	4.2	4.6	0.4	2.7	0.9	1.1	1.7	6.4	13.0	9.0	0.9	0.7	0.3	0.1	0.2	0.7	0.6	0.2	0.8	0.6	0.6	6.3	0.2	3.3	0.2	2.4	17.7	0.3	3.7	0.3	0.3	0.6	0.1	14.8	0.2	0.9	0.4	0.6	0.2	50.4	1.0	2.8	4.1	0.4	0.7	0.1	0.0	0.6	0.8	0.1	0.2	1.0	4.5	2.5	0.3	1.9	0.1	1.2	0.1	0.4	0.5	8.1	3.8	0.2	0.3	1.3	0.0	0.3	0.4	3.2	0.6	2.1	0.5	0.2	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	23.6	20.7	7.3	23.7	19.1	1.6	0.0	0.8	0.0	0.5	4.6	13.0	1.5	3.2	16.5	3.6	0.2	5.1	2.2	9.6	2.2	13.5	1.3	1.8	2.0	4.3	11.4	1.8	4.2	0.1	0.2	11.1	0.0	2.2	4.1	10.1	1.0	7.8	1.2	0.0	20.5	0.5	0.0	1.6	4.6	10.3	5.7	1.6	27.8	1.6	0.1	5.0	24.2	3.7	4.1	4.1	0.4	1.8	0.6	0.3	0.0	2.8	0.1	0.6	0.0	0.5	1.6	10.0	5.7	0.0	0.2	2.4	0.6	0.3	7.8	11.9	0.0	12.0	1.9	3.4	1.7	11.5	5.8	0.1	0.7	7.1	6.5	5.2
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 186.1;Late spermatids: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	40.8	64.9	22.7	19.1	24.9	26.0	36.9	23.8	34.2	40.9	22.9	40.9	19.6	40.5	23.8	38.4	38.0	18.3	60.2	25.2	24.5	50.5	44.9	40.4	21.0	25.3	26.0	54.4	41.1	33.3	42.3	17.0	26.0	42.6	22.1	49.6	41.3	22.1	94.9	39.2	32.7	25.8	21.0	30.4	37.0	43.6	26.1	42.4	41.7	59.6	21.7	43.6	38.4	28.5	81.8	67.2	21.7	31.7	62.1	67.6	22.3	125.9	51.0	92.5	49.1	55.5	45.5	38.5	39.5	70.7	33.2	55.8	37.8	82.4	74.3	72.3	55.0	61.1	42.9	39.2	36.2	21.8	62.3	50.4	57.0	103.5	55.8	55.4	81.2	56.3	60.1	44.5	115.7	67.1	59.6	14.0	15.0	97.9	71.0	27.5	34.1	54.0	67.9	54.8	29.4	16.4	95.9	57.5	46.6	35.8	67.2	23.9	114.5	63.7	17.2	160.5	47.8	36.1	48.6	41.7	108.8	38.2	31.5	3.1	6.9	1.5	10.3	8.8	10.5	10.4	9.5	10.9	13.3	5.3	9.7	11.1	0.3	13.7	11.9	5.3	12.6	8.5	22.7	24.9	23.8	34.2	25.2	24.5	25.3	26.0	26.0	21.0	26.1	28.5	12.2	28.9	29.0	13.4	9.3	6.8	17.6	11.1	6.2	13.1	10.7	12.2	44.9	8.6	23.5	3.7	20.9	13.4	7.9	12.4	7.9	18.2	186.1	14.5	14.6	14.0	18.0	10.7	18.4	29.2	20.0	14.7	16.8	23.1	14.5	18.0	7.1	16.3	14.8	6.7	17.9	12.7	20.3	10.1	6.3	98.7	17.1	10.0	19.6	6.5	9.9	7.1	4.1	11.1	14.7	34.8	10.0	14.7	13.7	23.9	10.6	8.5	19.1	19.7	6.6	16.9	15.3	28.1	21.6	17.0	5.7	13.5	10.1	30.4	12.9	17.7
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027734-135034813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 711.6;vagina: 199.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 121.0;Basal squamous epithelial cells: 409.2;Squamous epithelial cells: 1069.0;Urothelial cells: 257.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 141.4;HeLa: 108.9;K-562: 112.1;T-47d: 157.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008743	Approved		Approved	Nucleoli		Yes	No				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	1.5	1.9	0.7	7.7	0.6	0.3	0.6	0.9	0.7	83.5	4.7	11.4	12.1	0.8	0.0	711.6	0.5	1.1	0.2	0.9	1.1	0.1	0.3	0.4	0.1	0.8	0.9	0.6	0.4	0.0	164.7	2.7	0.7	20.1	2.0	0.1	137.5	0.0	14.1	2.0	7.9	0.4	0.5	0.2	41.9	2.2	0.7	0.0	0.2	20.1	12.6	85.0	199.0	0.8	57.5	36.9	0.0	44.7	1.4	0.9	13.4	9.6	14.6	5.1	2.3	141.4	32.5	59.9	17.6	0.9	12.6	17.6	6.4	25.5	0.3	0.7	48.2	13.4	108.9	38.4	15.6	5.8	0.1	1.4	18.4	0.0	4.9	0.3	0.1	10.1	112.1	0.2	1.9	18.4	0.6	12.3	0.1	4.8	31.8	18.5	1.1	1.2	0.6	17.9	20.2	0.1	48.4	24.1	0.0	0.5	157.5	4.2	1.5	6.1	13.4	3.5	17.0	0.1	0.2	40.7	8.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.7	0.9	1.1	0.8	0.9	0.7	0.5	0.7	0.8	0.1	0.0	0.0	0.0	0.2	1.3	121.0	12.8	409.2	1.0	2.5	2.7	2.3	1.5	8.6	0.0	0.0	0.8	0.0	4.2	0.0	0.2	4.2	0.3	0.6	1.2	0.0	50.8	0.0	0.4	2.1	28.8	0.5	0.2	0.0	2.7	0.0	0.0	0.9	0.0	0.0	2.4	6.1	0.0	0.3	5.7	0.3	1.0	0.0	0.0	0.0	0.4	1.0	0.0	0.1	16.9	3.4	0.0	3.1	101.6	0.3	0.2	6.1	1.8	0.0	2.1	4.5	2.2	5.6	1069.0	6.8	7.7	0.9	0.7	2.5	257.3
PIWIL1	"CT80.1, HIWI, PIWI"	ENSG00000125207	"Piwi like RNA-mediated gene silencing 1"	Q96J94	12	130337887-130372637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 42.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 48.6;Rod photoreceptor cells: 177.9;Spermatocytes: 125.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;OE19: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066880	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA066880: "	"unprognostic (1.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.22e-1)"		"unprognostic (1.48e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.36e-2)"	"unprognostic (9.85e-6)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	1.3	0.3	0.7	0.0	8.1	0.7	0.1	1.0	1.5	0.1	1.8	123.0	0.5	0.1	0.7	0.0	0.3	48.6	0.4	0.3	1.4	1.2	0.0	4.4	0.0	0.3	0.6	0.0	0.6	0.0	0.1	1.1	0.0	0.4	1.7	5.8	0.6	0.0	1.9	3.1	30.6	2.8	0.5	0.0	0.0	0.8	12.2	4.1	1.0	0.4	0.6	0.3	2.2	0.1	0.4	0.4	0.9	0.1	177.9	0.0	0.0	0.2	125.6	5.3	0.0	1.3	1.0	0.6	0.5	0.5	0.2
PIWIL3	HIWI3	ENSG00000184571	"Piwi like RNA-mediated gene silencing 3"	Q7Z3Z3	22	24719034-24774720	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"Early spermatids: 23.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA061955	Uncertain					NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"			"HPA061955: AB_2684647"					"unprognostic (9.05e-2)"				"unprognostic (2.20e-1)"				"unprognostic (3.12e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.33e-2)"		"unprognostic (1.72e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 8.7;Spermatogonia: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 93.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036587, HPA036588, HPA057508"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	3.3	1.1	5.5	2.8	5.3	24.3	3.6	4.9	5.0	4.4	3.4	5.8	5.8	3.7	2.3	1.6	3.6	4.6	2.8	5.6	4.7	3.2	1.3	2.7	3.9	4.5	4.4	3.4	11.3	0.4	2.2	2.0	4.5	2.5	6.0	6.7	8.8	2.6	1.0	1.7	6.3	2.0	4.5	3.7	5.1	13.3	4.9	3.0	2.0	1.0	2.7	3.3	3.0	5.4	0.2	0.1	0.4	0.0	6.6	4.3	0.5	0.5	0.3	0.2	0.9	0.7	0.6	0.0	0.4	2.8	0.2	0.0	0.9	0.0	0.2	2.7	0.3	0.2	0.6	0.0	2.5	6.5	0.1	1.5	0.0	0.5	0.0	0.1	0.1	0.5	0.3	0.0	1.1	0.4	0.3	93.2	0.1	9.2	0.6	0.4	0.0	0.0	2.1	0.0	0.4	0.3	0.4	0.9	0.4	0.3	0.0	20.7	1.2	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	9.9	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.5	5.3	4.9	5.0	5.6	4.7	4.5	4.4	4.5	4.5	4.9	5.4	1.1	0.0	0.5	3.3	0.2	1.3	0.2	0.4	0.0	0.6	1.3	1.3	3.5	7.2	1.4	0.0	0.0	4.0	0.2	4.1	1.9	6.2	4.7	0.7	0.7	0.6	0.0	0.4	5.4	2.0	0.5	1.6	7.7	1.3	0.0	0.9	0.7	0.0	1.7	0.0	4.9	8.7	0.0	3.0	1.7	2.1	0.3	1.7	0.0	3.7	2.0	0.7	1.0	5.0	6.0	3.0	4.9	1.2	0.1	0.5	4.4	0.6	1.7	3.3	0.0	2.2	1.3	1.2	12.0	0.6	0.1	1.0	0.3	0.3	5.3	0.1
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165521	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 160.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	22.9	14.5	46.8	8.7	50.5	3.6	19.4	37.2	78.0	19.9	33.0	15.4	6.4	16.4	160.0	12.3	16.0	11.1	15.0	47.1	48.9	19.2	9.4	13.8	10.0	38.9	41.7	25.8	14.5	38.7	28.1	17.3	40.6	15.3	7.6	17.6	10.6	32.4	7.9	14.6	11.1	16.0	40.1	13.3	14.0	26.4	49.0	10.0	22.7	8.8	12.1	17.4	15.1	43.5	27.3	19.6	62.9	43.7	21.3	22.5	18.7	17.8	22.0	16.7	22.3	17.1	25.8	4.4	26.7	28.1	39.2	24.0	99.0	34.9	21.2	20.2	33.0	8.1	16.0	10.9	25.7	4.9	14.4	23.1	23.6	28.6	17.0	15.8	19.0	13.2	7.8	3.0	16.9	14.1	2.1	8.4	43.4	23.1	32.0	20.0	28.2	6.9	23.4	22.6	46.4	30.7	28.6	4.9	22.2	50.1	7.7	7.0	17.8	13.9	22.6	41.7	8.3	0.0	0.2	9.1	15.3	13.1	19.4	6.6	6.8	2.1	29.6	9.2	34.3	16.4	26.1	27.5	7.3	22.8	26.5	31.3	2.3	30.0	6.5	8.9	17.5	19.4	46.8	50.5	37.2	78.0	47.1	48.9	38.9	41.7	40.6	40.1	49.0	43.5	4.7	16.0	4.8	2.9	9.7	41.0	19.4	30.8	23.9	16.8	5.0	6.2	7.1	4.3	14.8	3.7	8.4	35.6	5.9	1.0	15.6	24.9	74.7	3.9	10.4	6.6	5.4	10.8	8.1	11.7	15.3	18.2	7.1	5.8	4.5	27.9	6.8	1.7	7.0	5.0	8.3	3.6	6.1	2.9	9.9	32.7	27.1	5.7	5.4	2.8	2.9	30.6	14.4	5.0	3.7	18.0	1.7	19.5	7.7	17.0	0.5	6.5	4.4	6.1	6.6	9.4	16.3	1.4	1.5	11.2	29.5	20.8	11.2	27.0	2.6	22.5
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334713-109409974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	59.3	67.9	63.3	44.4	72.9	87.9	57.0	44.9	89.8	68.9	22.1	56.1	33.4	74.5	62.2	50.8	46.2	48.3	65.8	78.6	77.0	61.1	77.3	51.4	41.4	52.6	52.1	87.8	38.8	88.1	36.8	58.2	56.2	78.4	52.5	64.2	49.2	91.9	39.0	30.6	40.6	77.1	58.9	54.7	33.1	47.0	58.6	53.8	92.1	54.2	44.6	53.7	36.9	68.9	36.0	24.6	96.2	74.6	93.4	101.3	52.4	57.9	86.5	44.6	72.6	22.9	47.6	46.0	78.1	111.8	71.8	20.5	57.0	71.3	81.1	39.5	21.7	53.5	47.4	31.1	66.2	40.2	75.8	70.4	58.1	59.7	85.1	80.0	72.4	40.8	37.2	84.0	73.0	21.9	48.8	36.9	19.2	21.9	16.3	31.1	84.6	77.5	69.5	31.9	18.4	47.1	59.8	21.5	70.5	64.2	48.6	58.7	84.6	63.4	30.7	58.8	27.5	56.4	51.6	53.5	66.8	54.8	42.6	32.9	19.2	29.3	14.4	19.7	14.4	16.5	14.1	13.4	19.3	11.7	18.0	13.4	49.0	17.8	27.7	8.0	20.5	18.5	63.3	72.9	44.9	89.8	78.6	77.0	52.6	52.1	56.2	58.9	58.6	68.9	85.2	67.3	58.4	71.2	76.9	63.5	56.2	59.8	58.1	102.1	53.0	58.5	127.5	51.5	51.7	57.0	62.6	24.1	78.2	85.9	49.0	40.8	22.5	42.8	97.5	70.3	67.6	32.1	159.0	33.3	31.0	86.7	32.1	68.2	47.5	99.3	70.6	94.8	54.5	77.4	126.0	53.1	36.7	91.5	78.5	20.7	85.1	77.1	60.5	66.5	73.4	93.0	68.0	60.8	111.6	30.9	30.4	92.6	72.0	59.2	46.8	58.7	48.4	91.3	78.9	105.0	110.1	73.4	42.9	43.7	58.2	26.3	68.7	61.6	39.3	44.0
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088708-2135898	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 72.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.1;Horizontal cells: 119.5;Inhibitory neurons: 101.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		840000		"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	14.8	9.5	7.9	4.9	10.4	3.9	13.7	65.4	32.1	22.1	0.0	40.3	3.8	30.6	2.0	11.3	25.9	3.7	23.9	9.6	1.6	7.5	8.9	13.4	3.4	16.2	1.7	23.8	10.4	2.3	72.4	3.7	12.6	19.9	1.5	7.4	10.4	8.7	47.7	16.8	15.3	6.1	0.1	9.9	19.1	10.3	4.7	2.8	10.3	8.3	1.5	24.5	15.5	4.9	4.2	8.9	4.8	10.9	8.2	8.8	9.3	14.2	5.9	4.0	4.0	8.0	3.1	6.3	8.9	7.3	4.3	10.4	1.4	2.1	1.5	7.4	7.1	3.9	25.8	3.2	16.1	5.4	7.8	8.2	7.0	7.5	4.6	5.6	3.1	6.6	5.7	6.2	2.6	6.9	7.7	16.5	4.3	1.7	6.6	21.6	7.7	9.6	2.1	2.8	19.9	22.2	12.9	8.5	8.9	1.7	7.0	18.3	7.4	12.7	10.3	9.6	10.5	9.0	4.3	7.0	7.1	5.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	10.4	65.4	32.1	9.6	1.6	16.2	1.7	12.6	0.1	4.7	4.9	21.3	12.8	12.2	61.7	6.9	24.3	10.3	14.7	30.7	79.8	15.4	18.9	26.4	4.3	10.9	9.2	41.7	6.0	11.2	13.6	9.8	5.2	51.9	16.0	32.1	17.1	30.5	4.8	138.1	3.1	4.0	30.4	8.2	16.9	8.2	21.3	15.7	24.2	5.2	119.5	101.0	17.6	4.1	7.2	12.6	10.6	27.7	7.8	23.2	18.7	6.2	36.4	11.3	38.2	29.5	4.5	5.9	45.9	9.0	10.3	8.9	7.7	32.9	35.2	32.9	41.4	25.2	10.1	15.8	26.0	20.0	3.1	10.9	10.1	14.2	6.9
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47740202-47948466	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	1.7	0.1	1.1	0.4	0.9	1.1	0.5	2.1	1.9	0.2	0.0	0.4	0.9	0.3	0.6	0.4	0.3	0.4	2.6	0.4	1.3	0.3	0.8	0.4	0.9	0.5	0.7	0.3	0.3	0.1	0.4	0.6	0.7	0.3	0.5	1.7	0.4	0.1	2.8	0.5	0.4	0.4	0.1	0.3	0.4	1.5	0.8	1.5	0.4	3.3	0.6	0.6	0.1	1.1	0.4	0.7	0.6	0.8	0.1	0.0	1.2	0.3	0.2	0.2	0.4	0.8	0.4	0.3	0.3	0.4	0.4	0.8	0.5	0.6	0.6	0.2	0.4	0.3	0.3	0.8	0.0	0.5	0.3	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.4	1.1	0.5	0.2	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.3	0.1	0.7	0.5	0.4	0.5	0.3	0.4	0.5	5.9	0.1	0.1	0.5	1.1	0.2	0.3	14.7	5.7	0.5	0.2	0.2	0.3	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	1.1	0.9	2.1	1.9	0.4	1.3	0.5	0.7	0.7	0.1	0.8	1.1	9.1	0.0	0.0	13.4	0.3	0.1	0.0	0.0	0.0	3.1	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.5	0.1	3.7	0.0	0.0	25.7	0.2	0.2	1.7	0.0	0.3	0.0	0.2	2.2	0.1	1.4	1.7	37.9	0.7	0.0	0.3	0.0	5.3	0.3	0.2	0.0	15.0	0.0	0.5	0.0	11.6	17.1	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.2	1.4	0.6	0.0	0.0	0.0	0.1	0.3	0.8	0.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;lymphoid tissue: 7.9;retina: 13.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.2	0.1	5.4	0.4	5.6	0.9	0.7	4.8	10.8	0.1	4.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	4.9	0.3	1.6	2.3	1.5	4.9	5.2	0.1	0.1	0.0	0.1	0.5	5.1	0.3	1.2	13.3	0.1	0.0	0.1	0.0	0.6	0.0	5.0	7.9	0.0	2.3	5.0	0.9	0.0	0.0	1.7	0.2	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	5.4	5.6	4.8	10.8	5.4	4.9	4.9	5.2	5.1	5.0	5.0	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	13.6	60.6	0.4	0.0	0.0	14.4	0.0	20.1	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.7;Spermatocytes: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;Karpas-707: 2.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.4	0.9	1.5	0.5	1.7	1.5	0.2	3.2	1.1	0.2	0.3	0.1	0.3	0.3	0.7	0.4	0.3	0.4	1.1	0.8	1.2	0.2	0.1	0.2	0.9	0.7	0.5	0.3	0.8	0.1	0.3	0.2	0.8	0.4	0.2	1.1	0.5	0.0	2.3	0.5	0.2	0.1	0.1	0.7	0.4	8.2	1.1	0.1	0.7	0.8	0.2	0.1	0.2	3.1	0.7	0.5	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	1.4	1.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.6	2.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.2	1.4	0.7	2.6	0.0	0.2	0.5	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.4	0.6	0.1	0.4	0.3	0.2	0.2	0.2	0.4	0.7	0.2	0.5	2.0	1.6	0.1	1.0	0.2	0.8	5.3	0.9	1.8	1.0	0.6	0.5	1.5	0.8	0.7	0.5	1.9	1.0	0.9	4.1	1.0	0.6	2.0	0.6	0.6	1.5	1.7	3.2	1.1	0.8	1.2	0.7	0.5	0.8	0.1	1.1	3.1	0.6	3.2	2.2	4.6	4.7	2.2	1.8	0.6	7.4	2.4	0.5	0.4	1.7	0.0	0.9	0.0	0.0	0.4	1.6	0.6	0.0	0.1	42.7	1.5	1.3	1.3	0.0	0.8	5.0	0.0	0.2	1.5	0.5	1.8	1.3	0.5	1.4	0.4	0.3	3.3	5.6	0.0	2.0	0.6	1.9	8.2	0.6	1.3	3.6	1.9	0.1	0.9	1.0	3.5	6.1	0.1	0.0	0.4	1.7	1.5	0.1	0.3	0.0	4.1	0.0	3.2	1.1	52.3	3.1	2.6	1.1	0.1	3.1	0.8	0.2	0.8
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048021-42058517	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 71.9;Fibroblasts: 55.4;Leydig cells: 137.6;Peritubular cells: 112.1;Rod photoreceptor cells: 95.9;Theca cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 85.9;ASC diff: 61.7;CACO-2: 101.0;HHSteC: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"	NA	NA		80000		"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	25.7	11.3	3.1	4.9	3.8	0.8	16.1	0.8	6.2	31.8	6.4	20.3	10.7	25.7	2.1	2.2	24.2	3.3	37.6	4.8	1.0	10.7	6.9	16.5	2.1	1.5	1.6	50.1	7.0	1.1	6.8	3.6	1.3	12.2	5.7	5.3	20.7	5.8	85.5	3.8	13.7	9.8	1.4	9.6	9.6	14.8	2.1	6.4	5.1	27.7	1.4	32.5	17.4	4.7	0.0	5.5	14.0	85.9	61.7	0.7	5.3	0.2	0.0	1.2	1.5	101.0	0.2	0.0	0.3	1.7	1.8	0.0	1.3	0.0	0.0	8.1	3.5	0.2	3.3	27.0	53.7	0.0	1.2	5.7	0.3	0.2	0.0	0.6	0.7	0.0	1.2	0.0	0.3	0.3	0.0	0.3	23.8	6.8	1.7	0.0	27.3	0.0	0.0	0.0	2.8	5.1	1.3	0.0	0.2	16.3	0.1	0.7	0.0	0.6	2.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.8	0.8	6.2	4.8	1.0	1.5	1.6	1.3	1.4	2.1	4.7	28.8	19.2	0.5	4.2	0.3	3.2	0.2	0.0	0.0	4.7	1.3	2.0	9.2	1.5	0.0	1.8	16.7	0.5	0.6	22.8	0.0	2.1	1.1	6.0	31.4	3.1	71.9	0.0	22.8	1.3	1.3	55.4	2.6	26.3	0.0	4.5	2.9	2.7	0.6	0.0	3.3	18.6	0.0	0.6	3.1	5.4	137.6	0.6	1.8	3.7	0.0	21.3	0.0	10.1	1.8	1.9	16.0	112.1	0.0	0.8	15.2	3.9	0.0	95.9	13.1	14.2	15.1	0.7	1.7	0.0	1.8	0.3	0.8	135.4	35.9	0.1
PKDREJ		ENSG00000130943	"Polycystin family receptor for egg jelly"	Q9NTG1	22	46255663-46263343	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Cone photoreceptor cells: 4.2;Early spermatids: 2.5;Horizontal cells: 1.7;Late spermatids: 2.4;Spermatocytes: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA034587	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA034587: AB_10670570"	"unprognostic (9.48e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	3.4	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	1.8	4.2	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.4	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.4	0.8	0.3	0.6	0.0	0.0	0.0	0.3	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1 ciliary IPT domain containing fibrocystin/polyductin"	P08F94	6	51615299-52087613	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.7;kidney: 13.6;pancreas: 9.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.1	1.1	0.0	0.0	0.0	13.6	1.5	0.0	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.4	60.1	0.0	46.0	0.0	0.1	0.0	0.1	1.9	18.2	293.6	0.2	0.0	0.3	0.0	0.0	3.2	0.9	0.1	0.1	2.6	0.4	0.0	0.0	0.0	3.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	83.1	2.1	0.5	5.4	0.0	0.0	3.1	0.0	0.5	0.7	2.6	0.0	0.4	0.0	0.4	0.0	23.3	0.0	0.1	0.0	0.0	0.1	15.0	1.7	0.0	0.0	0.0	0.3	0.0	0.1	0.8
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362461-109537207	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.5;thyroid gland: 68.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"							HPA044458	Uncertain					NA	NA		13000000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	25.5	2.7	0.2	0.5	0.2	0.4	2.6	0.1	0.2	13.7	1.4	2.6	1.1	5.9	0.3	1.7	14.1	0.4	9.3	0.1	0.3	1.9	0.6	6.9	1.2	0.2	0.2	2.6	0.5	0.0	0.8	0.0	0.1	0.7	1.6	0.0	0.7	0.2	0.2	1.7	4.3	0.4	0.1	0.5	1.6	0.5	0.1	0.1	68.8	0.6	1.1	1.2	1.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.4	1.3	0.0	2.8	0.7	24.4	0.3	0.0	0.0	0.6	0.0	0.1	0.0	1.9	1.5	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	47.0	3.4	14.0	1.8	0.4	0.2	0.0	0.1	6.6	1.1	49.9	1.3	0.0	10.4	0.6	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.5	0.6	0.3	1.8	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.1	0.0
PKIA	PRKACN1	ENSG00000171033	"CAMP-dependent protein kinase inhibitor alpha"	P61925	8	78516340-78605267	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 1160.4;tongue: 953.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.8;Cardiomyocytes: 367.0;Excitatory neurons: 103.3;Inhibitory neurons: 78.2;Muller glia cells: 82.8;Oligodendrocyte precursor cells: 82.9"	"Cancer enhanced"	"Detected in many"		"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 21.4"	"Lineage enriched"	"Detected in many"	9	"T-cells: 21.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 63.9;HUVEC TERT2: 104.0;RT4: 100.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042791	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042791: AB_10795761"	"unprognostic (3.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.59e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.65e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.52e-3)"	2.5	9.5	44.4	5.6	49.3	2.7	4.1	41.4	49.2	2.2	11.9	3.5	1.2	3.1	3.0	21.5	5.3	8.2	185.9	49.8	44.0	4.7	0.2	8.6	7.6	25.4	34.3	5.8	1.4	108.1	8.0	1.6	36.0	20.3	2.8	33.7	6.2	5.3	1160.4	9.2	2.5	2.6	35.2	4.1	1.6	1.3	48.1	26.3	34.2	953.8	11.0	9.5	3.6	36.2	0.6	0.3	34.2	0.0	18.5	4.8	0.2	32.1	6.3	3.4	7.2	0.0	5.3	14.8	0.2	4.8	3.3	0.5	11.3	10.3	22.3	63.9	24.6	18.5	3.7	0.2	1.2	0.0	10.3	7.7	1.5	0.0	9.6	45.5	104.0	19.8	0.0	15.8	51.4	5.4	28.3	0.0	8.1	0.0	35.3	0.0	29.3	0.0	18.7	100.2	16.6	32.5	4.1	26.4	0.0	8.9	0.0	0.1	41.2	7.8	6.4	1.8	19.2	6.5	6.9	4.9	36.9	0.1	9.8	0.0	0.0	0.0	0.5	0.1	0.4	2.3	9.1	1.8	0.1	2.2	7.7	4.6	0.4	1.7	0.1	0.2	21.4	2.5	44.4	49.3	41.4	49.2	49.8	44.0	25.4	34.3	36.0	35.2	48.1	36.2	0.6	3.2	2.8	104.8	9.8	5.9	8.8	4.5	19.9	40.2	2.6	6.5	367.0	0.0	2.0	1.8	2.1	3.1	2.7	0.4	1.9	0.0	13.9	0.9	0.2	9.1	10.2	4.2	103.3	0.2	2.8	12.3	0.0	1.3	5.7	18.6	2.5	0.0	0.7	58.9	78.2	0.8	6.1	0.0	1.1	5.9	0.0	3.9	3.6	15.0	0.5	82.8	0.0	82.9	17.9	1.5	0.1	0.4	2.3	6.1	0.0	0.1	1.0	6.9	0.0	22.9	4.8	0.4	0.6	13.9	13.8	3.4	8.0	0.1	0.3	3.6
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.4;intestine: 90.8;parathyroid gland: 63.7;placenta: 60.4"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 70.4"	"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 34.8"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 34.8"	"Cell line enhanced"	"Detected in many"		"AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7"	"Region enhanced"	"Detected in all"		"cerebellum: 63.0"	"Region enhanced"	"Detected in all"		"cerebellum: 45.0"	HPA030156	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	2.2	5.8	4.4	9.0	3.9	0.2	23.3	70.4	5.2	4.9	3.4	90.8	15.5	3.4	3.4	5.2	5.5	5.7	0.5	5.9	6.9	2.8	8.2	4.1	2.2	13.9	7.4	0.8	6.3	63.7	22.1	60.4	14.6	6.2	62.4	56.1	8.5	2.4	0.7	9.1	28.3	3.9	3.9	3.2	34.4	4.2	6.8	3.7	1.1	0.6	4.1	5.4	1.2	5.0	0.1	2.8	71.8	0.3	0.6	0.3	62.4	0.0	0.8	0.3	1.2	0.4	3.0	0.0	0.4	0.0	3.8	0.3	0.0	1.5	0.8	0.4	3.7	1.2	3.9	1.7	0.2	0.0	12.3	0.3	1.2	1.2	15.3	34.0	0.3	0.5	22.3	0.4	0.2	84.9	0.3	0.4	29.6	91.2	112.5	0.6	10.8	0.4	187.1	10.6	157.7	0.2	0.0	17.1	2.0	39.4	12.0	1.8	5.7	0.2	47.3	0.2	6.2	0.2	0.3	0.2	46.7	1.5	0.4	0.0	0.6	0.0	0.0	3.2	0.7	0.0	0.0	0.0	34.8	0.1	0.4	0.1	0.1	1.9	0.3	0.5	0.4	0.7	4.4	3.9	70.4	5.2	5.9	6.9	13.9	7.4	14.6	3.9	6.8	5.0	3.0	3.2	3.9	17.0	4.6	19.8	2.3	2.5	2.8	23.6	94.8	53.3	0.3	2.8	10.2	1.8	4.2	542.7	0.9	750.2	19.6	22.6	106.0	5.3	1.6	3.9	98.0	4.0	5.5	35.8	420.5	6.9	52.0	5.5	38.7	0.3	1.1	3.8	53.1	6.7	15.5	94.9	14.2	75.5	251.9	251.1	1.2	51.2	44.4	9.4	25.5	15.2	0.0	6.0	8.5	50.4	355.4	0.4	1.2	13.8	255.0	26.9	58.3	54.8	6.6	0.3	2.7	3.3	5.8	12.4	17.0	959.8	3.5	0.2	92.9	8.3
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 370.6;naive B-cell: 377.4"	"Lineage enriched"	"Detected in all"	11	"B-cells: 377.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 540.5;HSkMC: 211.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	90.3	76.6	77.4	59.0	80.0	20.7	74.2	70.9	95.6	105.2	78.0	189.1	30.3	111.4	37.8	76.4	101.7	73.8	289.9	82.7	82.5	104.5	44.5	162.9	49.4	80.9	77.0	57.5	32.3	66.8	69.1	82.3	72.5	102.4	31.5	26.9	45.9	75.3	104.8	31.4	72.2	92.6	73.1	42.7	81.8	68.3	83.4	19.3	68.4	91.1	46.7	169.0	68.9	73.4	27.8	27.9	44.7	28.8	67.0	135.7	6.2	66.0	540.5	73.6	55.4	64.7	12.5	108.3	52.7	58.5	61.2	10.6	9.0	14.4	23.9	54.8	16.3	16.7	4.1	45.7	61.7	2.1	1.1	211.7	28.5	35.8	7.9	36.4	167.5	29.3	13.4	2.6	6.8	35.0	17.2	27.5	23.7	0.2	39.4	2.8	1.2	2.6	40.7	5.5	18.0	58.7	16.9	7.9	45.6	19.3	21.0	13.6	108.5	99.9	44.2	44.8	32.3	13.9	41.9	76.3	49.5	1.9	43.8	2.9	1.8	0.7	1.5	1.7	1.3	370.6	1.9	1.8	9.1	377.4	5.4	8.8	2.2	4.4	1.6	35.8	1.0	17.8	77.4	80.0	70.9	95.6	82.7	82.5	80.9	77.0	72.5	73.1	83.4	73.4	93.3	9.6	6.1	26.8	82.9	25.2	14.4	20.3	10.2	24.6	37.6	45.1	233.6	24.3	15.7	46.0	20.9	15.1	6.2	44.2	127.2	70.6	110.1	104.2	91.5	122.3	44.2	34.9	65.9	30.8	17.8	93.2	5.1	18.5	47.5	27.8	65.0	37.8	8.2	10.1	42.7	15.7	32.6	3.8	20.4	40.1	73.0	14.2	49.8	22.5	8.1	94.1	3.1	25.6	25.4	39.1	46.9	61.3	11.8	11.6	19.3	156.6	78.3	28.7	118.3	19.5	153.0	155.9	27.4	5.3	30.0	36.7	8.5	80.8	29.1	10.2
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 4207.6;tongue: 2900.8"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 2065.2;Late spermatids: 1763.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		310000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	190.5	600.9	539.0	341.4	552.3	439.0	190.5	586.8	629.9	406.8	755.0	225.0	170.8	202.8	205.7	658.3	240.0	212.0	779.6	549.1	561.6	549.5	32.2	236.9	284.1	640.0	559.1	169.4	112.6	269.6	224.1	168.6	636.2	252.6	206.2	1266.7	389.8	291.6	4207.6	350.5	218.0	298.9	522.3	239.2	228.6	235.1	677.1	203.5	174.6	2900.8	429.2	578.5	374.9	530.6	1584.6	3937.1	788.9	938.8	914.3	1009.4	638.7	1684.6	3878.2	2619.1	2623.6	1094.4	1931.2	1184.5	1627.3	3157.6	1937.8	2253.9	2480.9	3383.2	2051.7	2134.0	1126.5	727.7	1809.1	929.7	637.1	955.2	1525.1	926.4	1559.2	2025.1	810.9	3403.0	1558.6	587.3	182.8	933.3	4267.0	965.1	359.4	419.6	966.2	2438.6	1433.3	1046.5	2560.0	2301.7	3557.2	1973.8	804.4	871.5	2226.3	1344.7	1755.4	1291.4	932.0	675.7	1247.3	3003.7	1622.0	2928.7	3110.3	1170.0	1762.1	1037.2	3720.5	1534.4	3002.3	131.9	836.3	138.6	192.6	466.7	187.9	205.2	254.1	190.4	685.6	142.9	215.8	162.5	100.7	108.4	380.1	140.5	334.0	1261.7	539.0	552.3	586.8	629.9	549.1	561.6	640.0	559.1	636.2	522.3	677.1	530.6	95.9	118.6	88.1	107.7	169.6	565.5	708.9	2065.2	307.9	480.7	157.8	174.7	313.2	87.2	759.4	829.4	369.1	566.1	100.2	358.9	802.2	1395.6	315.0	169.2	77.3	207.7	282.2	44.8	90.2	597.0	1416.7	220.1	138.1	188.0	206.7	144.0	73.2	4.3	750.0	1065.0	97.6	166.8	925.7	297.7	532.9	1763.1	157.2	558.8	355.8	38.4	1255.0	784.1	78.2	53.3	33.4	1213.2	264.5	268.1	209.9	431.4	389.1	208.7	396.9	708.6	124.9	160.9	398.2	43.4	98.6	341.6	389.0	575.7	192.7	157.4	380.7	860.7
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	59.2	45.1	47.1	40.4	50.3	66.8	49.0	44.6	52.4	46.6	44.2	72.4	14.5	61.0	13.6	16.2	48.7	23.9	89.0	40.9	46.3	43.1	25.0	71.1	49.4	53.6	48.4	38.7	52.5	32.8	44.9	33.3	49.8	43.8	9.3	11.5	41.3	30.6	81.7	20.1	45.2	33.0	49.8	90.4	51.4	50.2	49.2	35.6	39.6	53.8	25.8	60.3	32.8	48.5	152.8	88.9	32.3	67.8	51.3	59.8	53.0	53.5	63.5	55.2	52.5	34.9	84.2	144.4	135.0	92.2	68.9	34.4	52.1	23.8	21.2	117.6	67.7	172.8	55.4	75.2	169.1	68.2	103.9	43.3	17.0	33.5	52.2	62.5	129.8	74.9	78.0	96.7	41.4	62.5	104.1	63.2	59.2	54.7	100.0	138.5	43.9	104.7	27.3	24.2	117.3	166.0	33.2	41.7	88.9	15.5	37.8	117.7	196.6	108.8	46.1	133.2	82.8	126.5	123.6	78.9	71.5	135.7	87.4	27.6	27.9	40.6	30.4	38.5	23.3	15.9	20.5	21.1	26.8	16.9	18.6	21.0	32.6	22.1	52.3	17.0	25.7	29.0	47.1	50.3	44.6	52.4	40.9	46.3	53.6	48.4	49.8	49.8	49.2	48.5	78.1	3.2	2.2	17.3	35.3	3.7	6.4	1.9	1.8	37.2	17.6	14.7	4.0	27.1	3.1	35.0	16.7	2.8	77.9	4.9	1.9	28.2	4.9	27.0	25.4	49.4	40.2	17.7	3.6	30.1	14.5	20.8	30.1	20.7	2.5	80.9	53.2	11.3	59.8	48.8	8.6	10.9	8.2	69.0	17.0	8.4	19.9	56.2	17.8	17.8	48.2	61.2	102.0	7.5	11.9	64.2	10.6	23.0	27.1	12.7	1.1	15.2	12.4	29.2	26.3	21.7	29.2	9.3	42.2	1.3	2.7	3.7	55.5	34.3	4.8	4.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702503-128720916	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 27.1;Breast glandular cells: 15.3;Endothelial cells: 17.9;Microglial cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 78.0;REH: 42.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	12.6	2.7	6.1	2.6	5.8	2.6	13.2	7.3	6.8	6.3	4.7	5.1	4.7	7.6	0.6	5.2	7.0	2.3	15.9	5.0	5.2	9.0	4.1	11.1	2.1	6.1	5.9	2.8	5.3	2.2	1.8	3.3	6.0	5.4	0.9	0.1	11.5	2.0	3.6	5.4	6.2	2.8	5.4	9.5	7.0	2.6	7.2	2.8	6.9	3.4	1.1	6.9	6.3	5.3	2.9	14.1	11.3	17.2	0.1	0.3	27.7	8.7	2.7	12.6	13.0	0.1	10.1	0.1	8.4	4.7	2.6	19.0	13.8	2.1	2.9	9.0	26.0	17.1	78.0	20.5	2.1	2.1	3.0	0.6	0.7	6.8	1.9	2.7	25.1	5.0	39.6	1.9	2.3	26.9	2.6	9.2	10.5	13.1	4.1	42.4	21.3	3.8	5.3	1.7	1.9	8.5	6.6	3.5	6.5	6.1	12.3	13.6	21.9	0.1	10.3	20.0	6.7	6.2	2.9	5.7	1.6	2.2	8.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	6.1	5.8	7.3	6.8	5.0	5.2	6.1	5.9	6.0	5.4	7.2	5.3	27.1	0.0	2.0	0.3	1.2	1.0	1.7	1.7	3.4	0.2	15.3	3.6	1.8	4.3	2.1	0.0	0.0	2.2	2.0	1.5	0.0	1.9	0.2	2.2	1.1	17.9	0.0	5.0	0.3	2.6	6.1	1.8	5.1	4.9	0.0	5.0	9.3	0.4	1.9	0.0	0.2	1.7	0.0	0.8	2.3	0.9	1.5	0.8	0.0	13.1	1.2	0.3	4.1	0.0	0.1	3.3	1.5	0.7	1.6	1.1	2.6	0.6	0.5	0.2	0.0	0.7	1.3	2.8	6.6	2.8	1.0	1.4	1.9	1.4	2.5	1.7
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 106.8;Early spermatids: 121.1;Spermatocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	4.8	4.2	6.6	4.0	6.6	2.5	3.9	9.6	6.9	8.1	5.5	6.5	2.8	8.3	5.4	4.1	6.5	4.7	3.5	6.7	6.7	6.7	4.4	4.5	5.0	6.9	6.6	8.6	3.9	3.4	4.6	5.3	6.6	5.0	3.8	4.7	4.2	6.6	7.6	5.4	4.3	6.0	7.5	4.7	4.4	8.2	7.3	5.2	11.5	5.9	4.5	7.0	4.6	7.6	8.8	3.0	3.9	3.8	7.3	11.0	4.8	11.0	7.6	6.5	5.6	5.2	6.6	12.2	8.9	9.7	5.1	4.6	9.1	7.0	8.6	8.4	7.3	7.2	5.7	4.9	7.5	6.6	5.4	8.3	11.3	8.1	6.6	6.8	6.3	4.1	5.8	8.8	15.1	5.2	6.2	7.3	6.1	12.4	6.5	9.8	17.7	6.7	13.0	6.9	12.6	7.5	7.8	5.6	7.6	4.5	4.7	8.4	7.5	10.2	5.0	5.7	7.1	5.1	6.1	6.2	12.9	11.6	5.5	0.3	2.1	1.7	3.9	2.9	4.1	2.8	2.8	3.2	1.9	2.2	3.3	3.0	5.7	2.3	1.9	1.7	3.3	2.4	6.6	6.6	9.6	6.9	6.7	6.7	6.9	6.6	6.6	7.5	7.3	7.6	18.4	6.4	15.7	28.1	12.5	17.5	106.8	13.7	17.1	23.7	12.4	11.7	7.4	12.8	18.2	16.5	4.2	14.9	11.1	12.3	9.8	17.1	121.1	15.1	37.7	16.0	14.9	11.0	30.3	12.6	28.8	22.3	3.6	23.8	6.3	17.3	10.0	8.4	12.6	13.5	27.2	11.8	14.2	8.4	22.5	40.8	18.6	15.3	14.2	16.9	20.8	9.5	11.3	27.6	40.8	14.5	7.0	29.3	8.6	32.2	8.5	7.5	16.3	11.5	32.9	27.3	20.8	99.7	26.4	17.1	13.8	29.0	17.1	24.2	10.8	45.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 416.7;skin 1: 699.9;vagina: 200.4"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2500000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	9.7	0.2	0.3	0.2	0.2	0.2	31.7	0.0	1.1	102.9	0.0	0.4	0.2	0.2	3.3	416.7	1.0	0.1	0.6	0.2	0.0	0.4	0.3	5.0	0.2	0.0	1.1	0.2	0.5	0.0	0.6	5.5	0.5	32.3	0.2	32.4	60.5	9.1	6.6	699.9	0.6	0.0	0.0	0.1	0.4	0.2	0.0	23.7	0.5	2.9	48.0	3.2	200.4	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	1.1	0.0	0.2	0.1	0.0	234.6	0.0	144.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	501.4	5.6	132.5	0.0	0.0	0.1	0.0	0.2	0.0	38.4	0.0	0.1	0.0	0.0	192.6	0.0	0.4	0.0	0.0	1.1	0.0	0.0	18.3	4.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.1	0.2	0.0	0.0	1.1	0.5	0.0	0.0	0.0	39.9	0.0	0.0	0.3	0.0	139.7	58.2	57.1	63.7	34.7	7.7	17.9	1.9	0.0	20.0	0.0	2.1	0.1	0.1	0.1	0.0	2.5	0.1	0.2	0.1	4.1	0.0	0.0	0.6	1.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.1	1.6	4.1	0.0	16.5	0.8	0.0	0.4	16.0	0.0	0.0	5.2	0.0	0.0	0.1	16.1	0.1	0.0	0.0	25.7	0.2	0.1	2.8	37.4	0.0	6.1	2.0	0.0	0.1	234.5	409.0	0.1	1.1	0.0	0.1	47.5
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456952-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 261.0;Inhibitory neurons: 260.9;Oligodendrocyte precursor cells: 235.3;Oligodendrocytes: 864.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	13.4	6.5	165.2	6.7	229.0	8.3	26.2	186.6	212.7	31.9	89.3	12.6	12.4	14.0	14.2	17.8	19.6	15.3	22.1	130.2	179.5	57.0	16.8	12.6	6.0	256.9	217.1	13.3	15.1	18.1	9.6	6.2	213.7	12.9	13.4	18.5	34.0	20.9	8.2	16.1	11.3	14.3	222.9	6.1	13.8	10.3	194.1	16.1	30.4	9.8	10.1	16.5	12.4	239.5	36.9	21.8	26.7	30.4	12.1	13.4	25.7	29.1	15.9	44.5	38.4	72.4	32.5	23.4	21.5	35.4	16.0	29.0	35.2	29.8	74.1	35.4	19.2	21.2	23.5	56.3	20.9	34.4	4.6	5.7	28.1	30.0	46.3	26.7	23.0	28.9	30.1	33.3	34.7	42.6	15.2	14.3	28.8	51.4	15.9	20.6	40.2	19.3	64.6	26.6	46.2	8.2	20.3	30.4	24.5	24.9	34.7	31.3	10.6	25.9	29.2	19.3	38.2	19.8	18.0	17.0	14.8	19.2	25.4	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.1	0.0	0.4	0.1	0.4	0.0	2.0	0.2	0.7	0.2	165.2	229.0	186.6	212.7	130.2	179.5	256.9	217.1	213.7	222.9	194.1	239.5	59.8	41.7	18.9	28.7	3.1	27.0	21.3	23.5	34.1	44.5	44.3	35.9	49.7	38.6	28.7	47.8	29.2	0.2	3.5	17.7	23.5	21.3	14.6	21.0	12.2	71.1	9.0	24.6	261.0	18.1	0.3	15.3	26.0	38.5	10.1	11.8	23.2	28.6	3.1	5.0	260.9	16.6	16.2	7.6	10.0	9.2	10.8	6.2	7.2	163.9	4.5	8.6	2.1	235.3	864.7	17.4	16.7	17.0	5.2	44.6	12.4	33.1	29.0	19.2	13.1	11.4	13.9	15.4	6.3	30.4	30.4	0.3	5.0	15.5	19.4	26.8
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 27.3;pancreas: 10.5;stomach 1: 41.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 280.1;Exocrine glandular cells: 116.3;Gastric mucus-secreting cells: 116.2;Intestinal goblet cells: 137.7;Paneth cells: 225.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 6.4;HaCaT: 2.2;MCF7: 2.3;OE19: 5.9;SK-BR-3: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.2	1.3	0.1	27.3	7.6	0.1	0.0	0.2	4.5	3.4	0.0	0.1	0.1	0.1	0.0	4.7	0.2	0.1	0.1	0.0	10.5	0.0	0.0	0.3	0.1	0.4	23.6	0.0	0.1	0.0	0.0	0.0	7.0	0.6	0.1	0.0	41.9	2.2	0.1	0.0	0.0	0.0	0.3	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.5	6.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	35.3	23.1	0.7	0.3	0.0	0.9	3.7	0.6	0.0	0.7	0.5	0.1	5.7	17.9	1.8	0.0	0.6	0.1	280.1	0.0	2.6	0.3	25.1	3.5	0.2	12.7	0.0	0.5	116.3	56.7	0.1	116.2	45.7	0.0	0.4	0.0	0.0	0.9	0.0	0.3	137.7	24.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	225.3	0.0	0.7	1.3	16.1	0.0	60.1	0.0	0.0	0.0	2.0	1.1	1.2	1.7	0.0	0.5	0.5	0.0	57.3	14.6
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730070	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	10.0	9.0	11.4	3.4	12.7	6.2	12.0	12.6	13.8	8.4	11.9	11.5	10.5	8.1	7.3	11.4	8.4	7.3	16.0	10.4	12.2	14.7	21.2	7.4	4.0	13.9	14.4	10.5	34.5	23.0	12.5	3.7	13.1	15.1	10.8	15.5	11.8	7.1	22.1	9.3	10.6	7.0	14.2	5.2	9.8	5.0	12.7	4.9	17.8	19.3	4.6	7.0	7.6	15.1	17.2	6.2	4.8	7.4	15.0	14.9	9.4	14.9	11.0	8.5	8.9	15.6	29.1	24.5	11.6	11.1	14.0	9.3	14.9	20.1	13.0	8.3	22.8	8.7	17.5	11.5	14.2	19.2	5.9	15.1	22.9	8.6	21.3	14.3	7.7	22.5	48.8	10.7	14.7	30.3	15.7	8.6	8.6	39.0	24.1	9.3	14.3	19.5	16.2	25.0	30.8	10.1	13.7	35.5	11.9	12.3	21.3	4.0	10.4	12.4	10.1	12.9	10.8	18.5	36.0	17.8	13.5	11.0	15.5	5.4	4.1	2.7	6.2	2.7	5.7	3.7	7.8	6.0	8.2	4.3	8.7	8.0	1.8	5.0	4.5	7.0	8.3	12.1	11.4	12.7	12.6	13.8	10.4	12.2	13.9	14.4	13.1	14.2	12.7	15.1	11.7	25.6	21.8	14.4	11.7	36.7	36.3	39.7	25.0	52.5	27.5	18.3	56.8	30.0	24.9	22.0	50.1	42.7	8.3	31.5	27.4	15.0	26.7	15.1	9.5	17.1	107.7	48.4	24.1	25.9	53.4	29.3	32.6	14.0	14.0	147.4	23.9	103.1	19.4	26.9	28.6	52.8	34.6	22.4	17.1	8.7	33.2	64.6	30.2	18.7	6.1	47.7	13.4	16.6	20.1	13.9	38.9	34.6	20.6	67.8	78.9	19.2	16.4	42.3	19.7	38.2	21.1	62.7	47.5	39.0	42.6	34.5	14.3	28.6	58.9	44.9
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72934762-72954806	"Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;kidney: 14.4;liver: 71.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 52.2;Proximal enterocytes: 70.0"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 9.1;Hep G2: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA		2300000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.2	27.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	14.4	71.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.3	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.8	52.2	0.0	0.0	0.3	2.4	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	70.0	13.4	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	6.3	0.0
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261058	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	15.1	11.5	12.9	7.6	12.5	7.0	9.8	12.8	18.1	6.6	9.2	8.0	6.9	6.2	8.7	6.2	7.4	9.3	35.5	13.1	14.2	33.4	17.3	17.5	13.6	13.1	14.1	7.7	7.4	11.4	11.4	27.3	14.6	8.1	5.9	4.4	9.1	5.7	58.3	13.9	6.5	8.8	12.4	20.3	8.4	10.8	15.9	11.7	13.2	22.4	5.1	8.8	6.4	16.1	10.0	10.0	7.9	25.5	36.7	26.8	19.0	24.6	31.6	35.7	30.2	26.1	18.6	17.4	31.2	34.1	28.5	15.2	8.5	10.4	15.9	6.0	16.4	5.0	10.4	19.0	19.6	4.6	25.0	19.0	11.2	35.2	5.5	44.6	22.5	8.9	7.9	9.8	23.0	21.3	7.2	14.5	5.1	9.4	12.1	9.9	11.3	55.3	17.7	8.7	3.0	5.1	31.2	9.6	19.2	6.6	25.2	23.7	18.8	31.5	15.0	41.1	16.5	34.6	33.5	22.1	28.6	13.8	12.0	19.6	24.1	16.0	4.7	27.5	4.8	5.0	5.2	7.0	14.1	5.3	6.5	5.5	1.0	2.3	32.4	12.2	5.1	14.6	12.9	12.5	12.8	18.1	13.1	14.2	13.1	14.1	14.6	12.4	15.9	16.1	4.4	6.4	3.3	3.6	3.0	4.8	2.4	6.8	2.8	12.1	7.0	6.0	22.5	1.5	5.1	9.2	8.4	20.9	4.9	8.1	5.9	10.1	1.9	4.3	4.8	5.9	0.0	1.7	7.0	7.2	7.6	8.2	8.6	9.0	15.2	6.6	9.3	13.7	116.0	38.7	6.7	8.5	2.0	37.1	6.8	6.1	2.1	21.4	12.4	10.3	7.7	4.4	3.1	5.5	3.9	6.3	5.0	1.5	2.6	2.6	3.0	19.5	2.7	6.1	0.0	5.5	6.7	3.4	2.8	4.1	3.4	50.8	3.9	3.1	4.1	2.0
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1519	"pancreas: 117705.6"	"Cell type enriched"	"Detected in many"	17	"Exocrine glandular cells: 20351.4"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	10.0	6.5	0.2	1.7	0.1	2.9	5.8	0.2	0.6	5.8	0.0	2.3	15.8	2.3	0.0	3.3	1.8	0.9	21.5	0.2	0.2	2.7	7.2	32.1	4.0	0.1	0.1	77.5	117705.6	0.0	4.4	6.0	0.2	4.4	0.3	0.7	21.3	0.0	1.9	3.4	7.7	0.1	0.1	3.0	8.7	4.3	0.1	0.3	1.5	0.0	0.0	1.3	1.9	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	12.8	91.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.8	1.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.2	1.9	24.3	10.6	0.4	0.1	1.1	1.2	0.0	0.1	20351.4	0.0	0.3	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.1	1.2	0.0	0.0	0.0	41.0	3.1	1.5	0.0	1.0	43.9	0.0	2.1	0.0	0.0	1142.1	1.7	3.4	0.1	0.2	4.1	7.6	1.0	0.0	0.0	0.0	3.4	0.5	0.2	0.0	0.1	0.0	0.3	12.5	1.2	0.1
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 1302.4;intestine: 1973.9;placenta: 756.7;urinary bladder: 813.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 645.0;OE19: 2384.4"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	680000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	1302.4	7.0	0.1	280.2	0.1	0.0	27.4	0.1	0.7	5.4	2.9	1474.0	786.8	4.3	3.3	29.3	14.8	57.7	137.4	0.0	0.2	6.6	238.6	16.8	5.4	0.6	0.7	44.1	7.8	0.9	2.5	756.7	0.2	203.9	1668.0	0.1	24.6	6.1	6.0	18.1	1973.9	164.4	0.1	0.4	11.6	36.8	1.3	1.7	11.1	114.2	15.0	813.6	12.1	0.1	0.0	0.0	1.6	0.0	248.3	0.0	8.5	0.0	0.1	0.1	0.0	11.2	0.0	0.0	1.1	0.0	0.8	18.7	0.0	0.0	0.0	0.1	0.3	0.0	0.3	645.0	0.0	0.1	1.1	2.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.4	2384.4	0.0	0.0	0.0	7.6	0.0	198.2	1.0	4.7	0.0	20.1	0.0	31.1	0.1	0.0	0.0	0.0	0.0	44.7	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.2	0.6	0.7	0.2	0.1	1.3	0.1	20.6	6.4	6.7	0.0	9.1	13.9	10.8	0.2	0.6	0.9	1.0	0.8	14.9	12.8	9.3	0.0	0.0	3.6	0.4	536.5	1.9	0.7	4.0	0.7	43.1	6.9	62.3	13.5	0.0	1031.5	4.6	656.0	6.1	0.6	4.5	0.0	30.0	310.9	9.5	0.0	0.0	393.6	2.0	18.8	31.1	11.6	171.2	3.5	14.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	574.1	1.2	2.6	921.1	328.2	0.2	1.9	0.0	0.0	2.4	37.8	0.9	1.5	4.9	16.8	6.8	6.2	0.1	861.9	32.2
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"lymphoid tissue: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 16: Immune cells - Immune response"					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134807-31140508	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 5.9;esophagus: 13.8;skin 1: 15.4;vagina: 7.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021016	Uncertain		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.8	0.2	5.9	0.7	0.1	0.3	0.0	0.0	13.8	0.0	0.0	0.0	0.4	0.1	0.5	0.0	2.5	0.0	1.6	0.1	0.0	0.0	1.0	0.1	0.0	1.7	0.3	0.0	0.0	1.8	0.3	0.2	15.4	0.2	0.0	0.1	0.0	0.6	0.5	0.1	0.1	0.6	0.0	1.7	0.0	7.1	0.2	0.0	0.0	15.1	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.1	1.6	0.1	1.7	0.1	0.1	0.2	0.0	0.0	3.6	1.6	0.0	1.3	0.2	0.2	0.0	0.0	7.5	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	17.8	0.0	0.0	0.0	0.0	0.4
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.8;skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.1;Cone photoreceptor cells: 66.7;Muller glia cells: 57.1;Oligodendrocytes: 137.1;Rod photoreceptor cells: 153.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.0;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;TIME: 19.4"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	5.1	17.3	13.8	5.5	23.8	0.3	4.3	20.8	20.5	4.6	4.5	6.5	6.3	8.6	3.0	4.3	5.1	5.8	25.1	14.1	18.2	6.1	4.7	8.0	10.2	24.8	23.5	1.7	4.9	12.8	6.6	5.1	26.7	6.8	3.3	78.8	4.1	8.0	66.7	6.4	8.5	10.3	14.3	11.2	3.3	2.8	21.1	4.7	4.9	41.2	5.6	5.1	2.6	41.5	0.7	1.3	0.0	0.3	5.7	3.0	0.1	1.3	8.5	1.4	3.4	0.0	2.1	0.0	1.8	3.7	2.7	0.3	0.0	0.2	2.2	0.9	0.2	0.0	0.5	1.3	13.1	0.0	1.9	0.6	0.3	0.7	5.7	2.6	4.9	0.1	0.0	8.0	2.2	2.2	0.1	0.2	0.1	1.0	0.1	0.1	2.0	0.8	2.7	0.6	0.9	0.1	1.5	2.9	7.1	4.3	0.8	2.2	19.4	2.2	0.8	2.8	1.0	0.5	1.8	0.2	1.9	0.0	4.8	0.0	2.1	0.0	0.1	5.7	0.4	4.0	0.5	0.0	1.2	0.9	0.0	0.0	0.0	1.1	1.4	0.8	0.1	1.4	13.8	23.8	20.8	20.5	14.1	18.2	24.8	23.5	26.7	14.3	21.1	41.5	7.2	3.2	1.7	30.7	2.4	2.8	1.0	1.5	1.2	77.1	2.4	2.9	35.3	5.7	0.5	0.0	66.7	0.2	0.6	1.2	1.9	13.0	0.3	0.5	4.6	14.3	0.0	0.0	31.6	2.9	0.2	7.4	1.1	0.7	0.0	0.1	4.6	2.0	5.6	33.7	34.7	1.6	18.3	1.2	11.1	0.2	0.6	4.9	7.2	15.0	3.1	57.1	1.0	25.1	137.1	2.7	1.4	7.9	0.7	2.5	5.7	5.2	0.2	153.8	13.1	18.0	9.9	0.9	1.0	0.2	3.0	0.1	1.1	1.6	0.3	0.4
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041105, HPA072562"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Cytosol"		"HPA041105: AB_2677300, HPA072562: "	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	18.1	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.1	0.5	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	44.9	0.0	0.1	0.0	0.2	0.7
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091911	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.7;ovary: 47.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053361	Approved				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	8.9	1.5	8.7	1.4	10.9	0.0	3.4	10.5	14.4	1.2	22.1	33.7	0.7	1.8	0.9	4.4	6.4	2.0	132.7	9.1	9.7	0.1	6.1	8.0	0.6	10.2	10.9	47.6	0.9	0.0	0.8	4.7	9.2	14.9	2.3	18.9	2.7	7.7	0.5	1.7	3.0	3.3	9.5	1.6	6.3	10.1	11.8	0.0	2.4	0.3	1.2	17.6	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	10.9	10.5	14.4	9.1	9.7	10.2	10.9	9.2	9.5	11.8	8.6	0.7	0.0	0.5	25.8	0.0	0.4	0.0	0.0	0.0	11.6	0.2	1.3	75.3	0.0	0.0	0.0	70.9	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.1	30.8	0.0	0.0	0.0	6.7	10.8	0.1	0.3	0.0	0.2	0.0	0.0	1.2	0.7	4.9	81.4	0.5	0.0	1.9	0.0	30.8	0.0	0.5	0.1	0.0	0.0	73.4	0.0	1.3	0.0	0.0	0.0	32.1	263.0	0.5	63.1	0.6	0.7	0.0	0.4	0.3	0.1	0.0	0.0	0.1
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062615	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 39.1;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Excitatory neurons: 34.6;Inhibitory neurons: 43.5;Muller glia cells: 33.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.5;ASC TERT1: 19.5;BJ hTERT+: 16.2;hTERT-RPE1: 26.3;TIME: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		960000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.7	2.9	0.7	1.4	0.8	0.0	14.9	9.7	2.2	6.9	1.7	3.1	3.9	8.8	2.9	4.7	5.4	9.3	2.5	0.5	1.5	20.8	1.4	2.6	1.9	2.0	2.7	10.8	0.6	19.7	2.2	3.8	2.1	3.1	3.2	5.6	39.1	2.9	0.5	10.9	6.1	6.9	1.4	5.1	1.6	1.0	2.5	0.6	41.9	1.3	2.7	3.9	6.0	1.0	0.2	1.6	0.6	0.0	14.5	19.5	0.1	6.8	16.2	1.3	1.8	0.0	3.4	0.0	0.4	7.2	1.4	3.3	0.1	5.0	1.4	0.0	0.0	0.0	11.8	0.0	1.2	0.0	0.0	7.9	5.4	1.9	2.1	26.3	9.3	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	1.4	0.7	0.0	0.0	11.8	2.2	0.0	1.7	2.6	0.2	47.3	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.8	9.7	2.2	0.5	1.5	2.0	2.7	2.1	1.4	2.5	1.0	11.1	6.4	2.8	20.9	0.1	9.4	2.7	18.1	21.6	2.7	22.1	14.5	4.1	5.7	11.3	33.1	0.0	7.3	0.5	1.7	0.0	0.6	0.1	5.6	22.0	4.0	1.2	0.0	34.6	2.0	1.3	14.8	0.0	9.4	1.3	9.6	8.6	0.0	0.6	16.8	43.5	7.2	4.1	0.0	2.1	1.4	16.1	0.5	7.2	25.3	0.0	33.5	0.0	5.5	1.8	5.1	11.3	16.6	0.1	2.6	15.6	2.3	8.1	1.4	6.6	3.4	4.8	0.1	1.0	9.3	5.4	1.5	0.6	6.3	7.5	3.0
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26903372-26947242	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	16.0	16.9	8.5	16.2	9.0	42.0	12.6	9.3	11.2	11.3	9.6	15.2	13.6	17.5	13.4	18.8	9.8	13.0	18.8	9.5	9.7	15.4	21.5	12.8	15.0	8.1	8.3	11.0	12.0	16.9	8.0	16.0	9.0	12.9	15.9	14.1	10.9	12.5	50.3	12.1	12.6	19.3	8.3	13.3	12.7	20.4	8.1	18.0	15.9	29.1	18.1	14.7	11.2	10.2	64.6	37.0	46.1	46.3	30.4	38.2	34.6	58.4	33.1	43.9	42.2	13.1	29.8	56.9	48.0	45.0	30.6	25.1	45.8	46.0	47.7	75.7	19.1	35.2	57.9	25.5	30.9	28.8	46.3	34.4	27.0	53.2	38.8	33.0	44.3	41.7	22.1	56.6	47.6	26.6	56.3	28.1	66.8	33.2	31.6	39.4	28.7	34.4	33.5	37.6	29.2	49.9	31.3	36.5	19.1	44.8	25.5	22.5	54.3	0.2	53.8	28.5	48.3	18.4	43.7	59.5	30.8	40.4	23.4	21.9	12.7	21.0	11.0	18.2	12.6	14.3	11.5	11.4	13.1	11.9	10.3	12.0	11.4	14.9	21.2	6.6	18.0	9.6	8.5	9.0	9.3	11.2	9.5	9.7	8.1	8.3	9.0	8.3	8.1	10.2	10.8	16.0	11.2	18.3	18.8	11.0	11.3	14.6	17.1	9.1	7.5	6.6	23.8	5.7	16.1	9.2	0.0	24.9	14.9	11.9	9.8	17.6	27.7	10.2	12.3	17.1	9.6	25.9	31.9	16.2	26.6	11.5	15.8	14.7	40.6	13.2	12.5	10.7	20.7	5.0	30.8	8.6	14.2	15.8	8.2	6.6	8.7	17.5	1.8	21.5	15.9	9.5	16.5	24.6	32.1	15.2	8.7	8.2	23.1	10.6	11.0	12.3	12.7	6.7	19.7	13.0	34.1	28.1	24.9	20.9	9.5	49.3	18.3	21.5	12.6	11.6
PLAAT1	"A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1"	ENSG00000127252	"Phospholipase A and acyltransferase 1"	Q9HDD0	3	193241128-193277738	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 90.1;testis: 73.6;tongue: 44.5"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.9	2.5	4.6	0.2	4.9	0.1	1.8	3.5	6.0	0.4	0.8	0.6	0.0	0.9	5.9	6.5	0.5	0.2	9.3	5.1	6.0	0.7	0.1	0.2	0.0	4.5	4.3	0.2	1.4	2.1	2.2	0.1	4.2	0.1	0.1	9.0	2.0	0.7	90.1	3.3	0.3	1.3	2.3	0.2	0.8	73.6	3.9	2.2	7.0	44.5	0.3	0.3	0.4	4.5	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.1	0.0	0.2	0.0	5.3	0.0	12.9	0.4	0.6	0.0	5.6	6.9	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.4	23.8	0.0	10.7	0.0	3.7	0.0	22.0	4.1	1.5	3.3	0.0	2.1	6.5	0.1	0.1	0.0	13.3	0.0	18.6	0.1	0.0	0.0	7.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	4.6	4.9	3.5	6.0	5.1	6.0	4.5	4.3	4.2	2.3	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PLAAT2	"FLJ20556, HRASLS2, PLAAT-2"	ENSG00000133328	"Phospholipase A and acyltransferase 2"	Q9NWW9	11	63552770-63563379	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 67.9"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.3;naive B-cell: 8.2"	"Lineage enriched"	"Detected in many"	10	"B-cells: 17.3"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 128.9"									HPA058997	Approved		Approved	Mitochondria		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.3	0.0	0.6	0.8	0.6	0.1	9.1	0.5	0.9	0.9	0.3	11.2	67.9	0.3	1.2	1.5	4.7	0.6	0.2	0.5	0.5	8.6	4.6	3.6	0.3	0.7	0.6	0.2	0.0	0.0	0.2	0.2	0.6	0.4	13.7	0.0	0.9	0.5	0.0	0.3	42.5	0.3	0.5	0.7	12.4	0.5	0.6	0.3	0.9	0.0	0.3	1.3	0.2	1.1	0.4	1.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.3	15.6	0.0	0.9	0.0	0.4	1.0	0.6	0.2	0.1	0.2	0.0	0.1	1.0	0.1	0.2	0.0	0.1	0.1	1.2	0.3	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.3	0.1	8.7	1.9	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.1	4.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	128.9	16.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.9	17.3	0.2	1.0	0.1	8.2	0.2	0.7	0.1	1.6	0.0	0.9	0.0	3.9	0.6	0.6	0.5	0.9	0.5	0.5	0.7	0.6	0.6	0.5	0.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
PLAAT3	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3"	ENSG00000176485	"Phospholipase A and acyltransferase 3"	P53816	11	63573195-63616883	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 318.7;brain: 394.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 187.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 187.8;T-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	318.7	36.2	208.5	10.2	287.0	3.1	166.8	234.7	261.6	13.3	142.8	32.8	8.7	17.6	26.6	13.2	33.0	29.1	103.0	197.7	215.3	65.0	76.5	37.6	11.6	283.0	250.7	73.4	32.4	28.6	33.4	40.3	279.8	16.4	7.6	26.6	28.9	29.9	108.9	10.7	21.8	15.8	241.2	15.9	31.9	54.7	237.1	7.1	41.2	118.7	4.4	26.7	9.6	394.8	87.7	135.1	3.7	0.2	148.2	25.1	24.1	3.2	26.9	22.3	11.2	30.8	247.1	0.0	55.3	6.9	72.4	4.4	127.4	6.8	16.9	108.0	5.0	1.3	33.3	5.4	87.8	0.0	1.3	15.2	0.7	55.4	2.2	88.1	35.4	0.0	1.6	9.6	24.0	15.3	0.2	0.6	10.8	55.0	43.0	0.0	0.0	8.7	71.2	12.3	1.7	9.7	18.0	51.5	28.7	54.6	111.6	4.5	52.2	10.0	0.7	34.0	7.7	39.6	28.0	0.3	40.1	0.0	1.0	0.1	21.1	0.1	55.0	9.1	30.3	7.4	12.1	40.5	6.4	1.2	3.9	30.0	1.3	21.0	0.6	187.8	9.3	27.2	208.5	287.0	234.7	261.6	197.7	215.3	283.0	250.7	279.8	241.2	237.1	394.8	80.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.0	0.0	0.0	137.4	18.6	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	365.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	290.6	2.0	0.0	0.0	0.0
PLAC1	"CT92, OOSP2B, OOSP2L"	ENSG00000170965	"Placenta enriched 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"placenta: 27.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 24.5;Leydig cells: 5.6;Peritubular cells: 7.9;Spermatocytes: 6.5;Spermatogonia: 11.0;Syncytiotrophoblasts: 10.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 20.1;hTCEpi: 15.6;hTERT-HME1: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000163, HPA063425"	Enhanced		Approved	Vesicles,Cytosol	"Secreted in female reproductive system"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA000163: , HPA063425: AB_2685012"	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.0	1.2	0.0	0.2	1.2	0.3	0.4	1.1	0.0	2.0	0.3	0.1	1.8	0.3	0.5	20.1	0.0	0.1	0.3	2.3	0.0	0.0	0.9	15.6	0.1	6.3	0.1	2.4	0.2	0.1	1.7	0.1	1.0	0.0	0.3	0.0	1.3	2.6	0.0	0.3	3.7	0.0	0.0	3.0	0.0	0.0	3.7	0.7	2.2	0.1	0.0	0.0	0.5	0.8	0.2	0.0	0.4	0.1	0.3	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.3	0.0	2.8	24.5	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.9	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	11.0	0.0	0.0	10.7	0.0	2.1	0.0	0.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.2	2.0	1.8	81.3	2.0	365.9	3.8	2.8	2.4	32.8	1.4	236.0	78.9	2.7	1.2	92.0	18.7	6.5	2.8	1.5	1.7	2.6	35.4	41.2	93.8	7.8	2.7	1.0	1.6	0.5	2.0	33.7	5.5	3.7	163.3	1.1	6.6	2.3	2.0	1.0	88.5	18.5	2.3	155.1	117.5	0.8	2.4	40.5	2.6	0.8	137.5	11.0	5.8	3.7	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	1.8	2.0	2.8	2.4	1.5	1.7	7.8	2.7	5.5	2.3	2.4	3.7	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
PLAC9		ENSG00000189129	"Placenta associated 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 124.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 37.9"	HPA043469	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	112.3	18.4	10.2	6.6	9.2	1.2	85.7	10.3	15.5	77.3	53.3	22.1	4.0	26.9	5.0	21.4	30.4	9.0	124.3	14.3	5.9	17.9	6.4	56.1	2.7	5.9	5.8	11.5	5.7	4.1	4.9	12.5	6.4	35.9	4.6	0.6	20.1	7.6	16.9	47.8	19.7	6.5	6.5	5.0	21.4	14.9	6.9	2.2	44.6	19.2	1.9	54.0	75.7	8.5	0.2	0.0	0.8	0.0	98.5	85.3	32.1	10.3	8.7	0.9	1.2	0.0	0.7	0.0	0.2	6.0	0.1	0.8	0.1	0.0	0.0	0.8	0.3	0.0	0.5	0.0	16.4	0.0	2.3	28.7	0.0	2.1	1.2	10.6	3.4	0.4	0.0	0.4	0.0	0.3	0.1	0.6	1.9	0.4	1.5	0.0	0.1	1.5	0.0	0.6	0.0	1.8	0.0	1.2	0.7	0.2	0.1	0.2	3.6	6.6	3.6	21.0	0.2	0.7	0.9	0.1	1.9	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	10.2	9.2	10.3	15.5	14.3	5.9	5.9	5.8	6.4	6.5	6.9	8.5	246.2	3.2	1.8	0.0	1.6	126.4	0.7	1.1	8.0	0.4	7.4	14.0	24.4	0.0	0.3	0.0	0.0	7.0	3.6	0.1	0.0	0.3	4.6	3.1	75.7	102.5	1.8	0.0	0.5	0.2	17.7	926.5	5.6	4.4	1.3	0.1	115.6	0.3	14.1	0.0	0.5	0.0	0.0	0.0	191.3	26.7	873.5	7.9	136.9	7.5	0.0	50.2	0.0	0.0	0.2	0.7	0.0	659.7	2.1	1.0	0.0	0.2	0.9	1.7	295.9	89.7	446.6	2.6	2.9	4.6	126.3	11.5	14.1	1.1	0.0	1.8
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192504-32207743	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.7;Glandular and luminal cells: 47.7;Late spermatids: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 18.3;non-classical monocyte: 34.8"	"Lineage enriched"	"Detected in many"	15	"monocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	4.4	3.2	4.4	6.6	5.2	32.2	4.6	5.0	5.0	4.8	7.4	7.8	10.4	6.0	5.2	12.8	9.4	4.1	5.2	5.1	4.0	4.9	4.3	6.6	7.7	4.3	4.1	7.7	6.0	8.5	5.5	3.9	3.6	5.3	8.0	13.0	6.8	5.4	10.2	7.5	12.9	7.2	3.7	6.2	7.2	16.4	4.2	8.9	4.8	8.3	10.7	5.6	6.1	4.2	19.4	10.9	28.5	10.4	10.4	8.0	17.8	7.5	11.9	16.0	14.5	82.3	9.5	19.8	10.1	7.8	22.4	18.6	35.7	17.3	21.0	11.9	16.1	80.3	9.4	39.8	12.7	35.5	17.0	9.7	15.1	12.9	9.1	7.5	11.7	20.7	28.7	17.5	8.5	10.8	39.2	24.4	13.4	14.8	12.4	25.0	36.8	12.6	6.9	14.6	12.9	14.2	18.5	9.9	16.1	16.5	14.9	42.8	8.8	19.3	20.5	14.0	15.5	47.5	28.5	25.1	11.2	73.5	12.1	2.2	3.6	0.9	0.7	18.3	1.4	1.4	1.0	1.5	2.2	1.0	1.2	0.7	0.9	0.5	34.8	0.6	0.8	2.5	4.4	5.2	5.0	5.0	5.1	4.0	4.3	4.1	3.6	3.7	4.2	4.2	4.3	12.8	21.1	2.0	6.0	7.5	13.5	6.2	10.8	7.4	8.6	6.5	4.2	2.8	12.2	1.8	31.3	3.2	8.1	13.1	3.9	3.8	56.7	26.1	9.1	5.2	10.7	10.3	4.5	5.2	3.1	5.7	8.2	47.7	2.5	6.4	7.1	3.8	6.0	3.3	3.8	12.4	2.0	8.9	7.8	159.8	2.5	11.9	0.0	4.7	11.1	6.3	0.0	1.5	4.9	6.2	8.9	7.2	7.9	15.0	29.3	3.4	6.8	21.3	6.6	7.1	4.1	11.8	10.8	21.2	11.6	4.1	7.4	6.2	16.7	21.7
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 688.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1172.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1172.3;monocytes: 550.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	52.1	10.4	7.5	81.7	9.8	688.4	14.5	11.2	32.4	30.9	10.3	26.7	10.0	30.2	4.8	11.6	22.8	78.1	23.0	8.1	10.4	18.2	19.8	69.5	10.6	12.2	9.8	14.9	13.6	5.4	9.1	35.9	13.3	11.5	20.1	2.8	21.7	5.8	3.6	7.8	10.6	26.2	9.7	20.4	28.4	3.1	24.8	10.2	9.5	4.7	8.6	109.7	15.8	13.8	83.9	31.0	26.1	1.9	23.4	83.3	16.2	180.7	189.6	114.6	141.4	2.4	95.1	2.4	43.0	116.9	66.8	35.2	7.0	46.4	127.9	5.3	5.3	15.8	44.7	3.9	30.6	18.8	195.2	87.4	9.0	311.7	46.5	160.6	129.0	19.1	16.4	2.2	107.7	6.1	21.0	55.3	8.7	156.1	64.7	24.0	17.4	5.6	35.9	3.8	1.3	22.2	82.0	17.4	25.0	12.6	3.2	59.4	129.7	230.0	121.1	109.8	413.1	3.0	9.0	0.6	346.9	36.0	346.5	87.7	476.5	745.5	6.8	427.9	8.3	2.7	8.9	5.7	213.6	1.4	3.2	4.0	1172.3	6.7	550.7	69.3	3.6	253.9	7.5	9.8	11.2	32.4	8.1	10.4	12.2	9.8	13.3	9.7	24.8	13.8	23.1	73.7	76.6	2.3	15.5	105.2	820.7	274.2	72.3	0.7	45.8	22.5	4.5	24.3	151.9	20.2	0.0	6.5	17.4	314.5	1.9	219.3	0.9	188.1	68.0	64.9	14.8	5.2	2.5	106.5	58.8	145.4	156.0	519.1	305.2	4.2	19.2	1.7	428.9	10.1	3.3	85.3	22.4	155.4	1833.9	2.0	6.8	864.3	72.9	5.6	52.1	1.2	4.1	1.5	0.9	558.8	435.5	4.1	14.5	479.4	12.7	2.7	52.7	0.7	6.6	38.5	90.0	1.2	4.7	202.6	63.1	13.1	33.2	3.1	29.3	2274.4
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14567883	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 285.9"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 187.7;Hofbauer cells: 105.6;Kupffer cells: 109.4;Macrophages: 116.3;monocytes: 192.8;Paneth cells: 105.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 113.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 662.9;intermediate monocyte: 204.4;myeloid DC: 357.3;neutrophil: 443.8"	"Group enriched"	"Detected in all"	135	"dendritic cells: 357.3;granulocytes: 443.8;monocytes: 662.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.6;BEWO: 98.4;CAPAN-2: 245.6;MCF7: 46.3"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"	NA	NA		3400000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	29.4	5.6	2.1	33.7	2.5	285.9	27.8	2.4	3.7	22.4	25.9	58.8	28.2	13.5	10.6	56.3	16.6	33.1	32.6	2.1	2.4	26.3	10.6	64.0	9.2	3.5	3.2	4.4	30.0	3.2	3.4	35.9	3.2	10.2	79.2	0.8	11.9	15.3	9.9	24.8	42.6	28.1	3.1	25.2	36.6	10.0	2.8	7.8	6.1	17.2	32.7	58.5	29.6	4.8	7.1	5.0	0.5	48.6	0.3	0.0	98.4	0.2	0.0	3.0	2.4	14.1	245.6	0.0	1.4	1.0	0.4	9.4	0.0	0.0	0.5	0.0	0.1	0.0	6.4	0.0	3.8	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.1	46.3	0.1	0.2	16.5	0.7	0.3	0.1	0.1	0.5	0.7	28.9	0.0	0.4	30.2	14.8	1.9	26.5	9.0	9.6	0.0	0.5	0.4	0.0	0.6	8.7	23.7	0.2	0.0	0.1	0.4	0.4	662.9	5.8	1.0	204.4	0.6	3.6	0.5	0.4	357.3	0.8	0.7	0.7	443.8	1.7	73.5	4.1	0.9	423.2	2.1	2.5	2.4	3.7	2.1	2.4	3.5	3.2	3.2	3.1	2.8	4.8	15.5	9.6	8.6	0.3	2.9	6.8	8.8	4.9	6.8	0.0	11.9	6.6	16.5	30.0	20.4	33.1	0.0	94.5	1.5	67.8	11.7	13.1	51.8	2.5	9.1	7.2	9.1	1.7	1.6	46.5	187.7	59.6	13.3	0.9	5.1	5.9	4.6	2.9	105.6	0.0	0.9	31.3	6.1	109.4	68.6	5.8	26.1	116.3	5.4	7.5	192.8	1.6	1.0	1.5	0.2	28.6	105.9	27.8	3.6	3.8	52.8	15.7	19.0	0.2	0.0	12.0	10.4	17.4	12.0	17.8	19.9	70.3	1.6	6.1	75.2	30.1
PLBD2	p76	ENSG00000151176	"Phospholipase B domain containing 2"	Q8NHP8	12	113358566-113391629	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 139.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 139.8;Late spermatids: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 246.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017163	Approved				"Intracellular and membrane"	NA	NA		820000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA017163: AB_1853029"	"unprognostic (8.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.36e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.92e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.58e-11)"	"unprognostic (7.55e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	26.7	139.0	23.6	16.7	21.3	9.0	16.4	31.0	30.3	20.5	5.7	12.9	8.1	19.7	25.9	12.6	13.9	20.2	31.7	23.2	33.4	11.8	23.3	20.9	10.8	47.4	35.2	48.6	26.1	17.5	27.2	12.8	44.7	17.9	12.8	13.0	17.9	15.9	23.8	19.1	11.4	27.1	26.9	13.5	13.2	50.7	40.9	5.8	18.0	14.3	10.8	20.5	15.4	24.5	20.1	36.2	15.4	58.6	246.3	136.9	20.9	41.6	82.0	28.8	35.7	30.9	11.8	9.3	34.0	113.1	46.9	21.3	14.9	24.6	32.0	19.0	10.9	16.4	21.5	37.3	76.9	19.8	49.3	115.8	32.0	34.6	20.5	87.4	45.4	8.3	49.9	22.1	44.9	34.1	3.7	21.2	17.1	16.2	16.6	15.8	16.2	25.0	33.8	27.7	15.5	15.3	57.3	44.6	25.5	26.5	29.4	18.8	73.5	67.9	26.3	68.9	24.4	11.8	21.9	11.4	112.3	16.5	40.6	0.0	3.5	0.2	1.2	2.1	1.0	0.4	1.4	1.5	3.5	0.4	1.0	1.4	0.3	0.9	1.5	1.3	0.9	2.0	23.6	21.3	31.0	30.3	23.2	33.4	47.4	35.2	44.7	26.9	40.9	24.5	6.5	9.6	6.4	11.8	5.3	5.4	4.6	2.1	5.7	9.8	5.4	4.3	10.0	5.7	1.4	1.8	6.2	4.6	6.4	3.6	0.0	20.5	139.8	2.6	13.5	7.0	5.3	13.9	12.4	13.8	11.1	29.5	6.6	5.8	10.2	13.3	8.2	16.1	32.5	20.2	14.2	2.9	0.0	25.8	8.4	398.5	40.4	27.0	21.4	3.7	39.4	3.1	4.1	9.0	11.8	11.5	3.4	48.2	5.9	6.4	6.4	5.0	2.2	5.2	6.6	10.7	11.3	11.1	8.1	6.2	1.8	4.4	5.3	33.6	4.0	3.7
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251530-64269150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 113.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		210000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	12.8	19.1	6.8	9.7	7.3	7.4	11.2	8.2	8.0	19.7	7.0	22.8	113.8	17.8	3.6	35.3	16.5	7.1	11.5	6.5	7.3	11.7	6.4	15.6	4.4	9.2	7.6	15.8	8.6	10.0	5.8	10.3	8.1	13.1	12.5	1.4	13.5	10.4	6.7	20.3	101.6	11.4	7.7	14.5	14.7	9.5	9.2	3.9	10.3	4.2	5.3	13.8	18.8	7.7	45.2	24.9	24.0	36.0	24.6	18.9	23.8	35.3	26.4	29.5	17.9	22.1	33.5	3.2	20.8	44.4	25.4	75.9	27.2	33.0	10.1	21.8	15.1	35.1	54.9	16.7	17.0	8.6	22.3	16.0	21.5	32.1	23.6	32.2	43.5	13.4	17.6	3.8	37.9	54.5	10.9	17.9	38.8	56.9	26.9	23.5	54.0	13.3	18.2	46.8	6.4	26.4	52.0	64.4	25.2	14.8	33.9	16.4	76.4	27.1	32.0	62.7	23.2	4.6	2.4	3.6	44.8	19.9	25.5	0.0	0.4	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.4	0.0	0.1	0.1	0.2	0.1	0.4	1.2	0.0	0.1	6.8	7.3	8.2	8.0	6.5	7.3	9.2	7.6	8.1	7.7	9.2	7.7	11.2	3.2	7.9	7.5	1.8	13.0	6.0	6.4	6.2	1.2	6.1	4.6	3.3	8.6	6.3	16.5	0.0	9.2	8.3	52.3	1.9	7.8	1.3	3.5	8.7	13.2	2.4	7.8	0.6	7.7	19.1	7.6	28.5	7.1	5.7	20.2	18.2	3.4	9.8	3.3	0.9	46.2	12.2	10.1	13.5	1.4	9.9	8.8	8.8	8.4	22.1	4.7	2.1	1.5	0.6	17.3	23.8	12.4	2.6	7.4	161.7	4.0	2.8	1.1	26.3	6.0	9.8	3.1	8.3	19.4	11.8	14.6	2.7	6.8	65.5	8.3
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029642	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 89.5;Theca cells: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	14.8	12.9	14.3	4.6	16.1	4.3	10.6	15.4	15.6	15.9	9.7	15.7	4.9	11.5	4.2	26.2	9.8	5.6	7.2	12.8	19.0	10.1	5.4	11.3	6.6	20.3	18.5	12.7	6.0	3.9	9.3	3.8	19.6	9.1	10.1	2.8	13.0	8.8	2.9	18.5	8.3	5.6	19.4	7.2	8.3	32.6	16.9	9.1	8.3	4.1	6.6	15.7	19.0	21.9	1.0	2.7	9.4	2.6	25.3	22.2	2.8	2.8	11.1	4.2	6.4	1.0	2.3	0.6	1.4	26.3	2.9	15.0	4.8	3.0	1.3	3.9	1.2	0.5	1.7	4.7	14.7	0.0	1.6	18.0	31.6	12.9	1.7	9.4	8.2	2.2	16.3	1.3	9.6	1.2	2.2	1.1	2.4	5.5	2.7	0.9	1.3	3.6	5.1	5.0	0.1	2.6	0.8	12.4	3.2	3.1	2.7	1.2	4.4	2.5	6.3	6.7	0.1	5.2	2.2	0.6	6.4	0.1	1.3	14.6	2.7	0.2	13.0	3.7	15.2	1.3	16.9	12.8	3.8	0.6	10.1	7.9	9.9	5.9	2.2	2.0	16.6	7.4	14.3	16.1	15.4	15.6	12.8	19.0	20.3	18.5	19.6	19.4	16.9	21.9	5.2	3.2	7.5	22.9	3.6	2.8	12.4	9.6	8.0	0.9	5.4	6.1	4.7	8.6	7.3	9.2	2.1	1.8	4.2	89.5	3.9	11.4	1.7	3.3	11.3	8.1	4.9	3.6	1.9	3.0	5.1	10.2	6.6	3.8	4.5	3.6	20.0	4.1	4.0	3.3	2.3	28.3	10.2	3.8	14.5	3.6	12.8	4.3	1.8	3.7	3.4	13.3	1.0	7.1	2.2	4.1	34.7	14.3	5.9	13.2	10.0	5.8	6.2	1.7	6.6	5.4	7.2	3.1	3.7	12.6	5.8	0.8	7.4	53.4	11.3	14.7
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607855-218637184	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 166.0;skeletal muscle: 114.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.5	2.7	4.5	0.2	4.4	0.0	1.3	4.5	7.2	1.4	3.5	15.6	0.6	0.6	0.3	4.8	0.6	0.4	1.1	4.5	4.6	10.7	0.6	0.6	0.1	5.6	5.1	0.7	0.5	1.7	9.6	0.2	4.9	4.4	1.7	166.0	2.3	0.3	114.0	1.0	3.3	1.3	4.2	0.3	6.9	9.8	5.0	0.1	1.6	30.4	0.1	20.5	2.0	4.7	0.0	0.9	1.2	0.0	0.3	1.2	1.1	0.0	2.5	0.4	1.3	0.0	0.1	0.0	1.5	0.4	0.4	0.1	0.0	1.5	0.3	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	2.8	0.1	1.9	0.5	4.2	2.8	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	4.3	0.0	1.8	20.2	0.3	0.1	0.1	0.2	2.1	0.0	4.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	4.4	4.5	7.2	4.5	4.6	5.6	5.1	4.9	4.2	5.0	4.7	0.3	0.0	1.1	7.8	0.1	0.5	0.3	0.9	3.4	139.9	1.5	0.9	1.0	0.0	0.1	0.0	246.0	0.1	0.1	0.0	0.0	0.1	21.4	0.6	0.4	1.5	0.0	0.0	6.7	0.0	13.5	0.7	0.0	1.0	0.0	0.1	0.7	0.0	0.6	8.4	4.9	0.1	0.0	0.0	0.4	33.8	0.3	0.2	0.0	0.0	0.1	9.1	0.0	2.0	2.3	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.2	176.9	0.0	6.1	1.8	3.6	1.2	0.6	0.1	0.8	0.1	0.0	0.1	0.2
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.4;T-cells: 6.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	33.3	22.4	36.2	21.7	37.3	10.0	31.8	43.8	41.3	42.5	27.8	25.2	17.8	36.1	13.7	18.9	31.9	19.9	31.9	35.6	32.9	23.2	9.7	32.4	36.4	34.8	36.2	42.6	11.4	13.3	21.6	23.8	34.2	30.2	13.7	10.9	20.2	20.5	18.5	31.5	28.8	22.9	32.0	30.0	19.4	26.3	39.5	60.5	45.0	20.3	24.0	30.4	32.0	38.6	16.6	20.8	97.2	71.6	38.0	26.5	30.9	26.7	34.1	52.4	44.3	50.1	5.4	37.0	31.9	29.1	55.0	30.2	42.7	47.8	30.4	10.5	22.7	2.6	36.4	59.6	28.9	14.7	9.7	34.1	26.3	38.8	30.0	47.2	59.4	77.3	28.0	23.6	48.0	123.8	90.7	11.5	36.2	21.3	37.6	71.1	70.8	18.2	28.7	30.1	34.4	65.7	47.8	22.1	48.4	54.1	25.8	17.0	64.6	124.4	40.3	40.2	32.9	26.1	12.4	30.3	29.7	15.6	52.9	0.0	0.0	0.0	4.7	0.0	6.4	0.2	4.1	3.9	0.0	0.5	4.3	4.3	0.0	3.4	0.0	0.0	3.8	3.0	36.2	37.3	43.8	41.3	35.6	32.9	34.8	36.2	34.2	32.0	39.5	38.6	33.4	16.0	7.0	69.2	5.1	5.6	1.8	5.3	14.8	4.3	4.7	5.8	9.6	1.5	3.8	3.7	10.4	1.9	7.4	9.4	0.0	3.3	7.0	5.4	16.9	24.2	1.8	2.1	9.7	1.6	2.0	11.5	10.2	10.3	1.3	19.8	11.7	3.1	4.0	3.3	9.1	9.5	4.1	2.9	4.3	7.2	15.2	1.7	3.6	16.9	1.2	6.7	2.1	13.0	16.4	3.3	4.8	18.4	6.3	2.3	7.8	3.0	1.8	5.1	13.1	8.5	10.2	15.9	13.0	6.1	7.0	0.8	17.0	5.7	6.4	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745071	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6;retina: 12.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.0	0.0	5.5	0.3	4.8	0.2	2.6	4.5	6.0	1.2	9.3	2.5	2.5	0.7	8.2	0.1	8.1	1.5	1.8	3.8	1.4	1.2	0.1	4.0	0.0	1.3	4.6	0.1	1.4	0.4	1.5	0.4	1.5	0.3	2.4	12.4	1.3	1.9	0.2	0.1	2.5	0.1	1.6	0.0	3.8	11.3	1.3	16.6	5.7	0.0	0.0	0.4	0.1	2.0	0.0	12.3	39.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.4	9.8	0.0	0.8	0.0	0.1	0.0	7.0	0.0	0.0	0.0	3.6	10.1	0.0	1.4	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.3	0.0	0.0	4.4	2.4	9.4	20.8	1.3	1.6	0.9	0.0	0.0	2.4	0.2	3.6	0.9	0.0	9.4	0.0	5.7	4.2	0.0	0.0	0.0	0.2	0.0	1.7	0.4	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	4.8	4.5	6.0	3.8	1.4	1.3	4.6	1.5	1.6	1.3	2.0	0.0	3.2	13.6	93.7	0.3	0.0	0.4	0.5	0.6	10.5	4.0	5.0	0.8	4.3	2.3	1.8	4.2	0.0	0.1	2.7	0.0	2.2	206.2	34.6	1.3	0.6	3.0	0.0	126.0	2.3	0.3	0.3	15.3	13.6	0.0	0.1	0.0	0.0	0.2	25.2	131.5	4.0	0.0	0.3	0.4	21.4	1.2	0.4	0.0	12.2	0.1	16.1	0.0	5.5	5.7	1.5	4.6	0.4	0.0	0.4	2.8	2.1	23.4	3.0	0.0	0.0	0.2	2.4	1.2	0.7	0.1	0.0	0.3	0.1	4.4	0.4
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505532	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.8;skin 1: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.5;Cone photoreceptor cells: 75.0;Oligodendrocytes: 37.4;Rod photoreceptor cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBEC3-KT: 130.9;hTCEpi: 58.9;hTERT-HME1: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.6	1.4	1.0	3.9	1.7	2.2	6.2	7.9	4.8	6.3	0.0	1.1	2.2	0.3	1.7	19.3	3.2	2.9	0.2	2.4	1.0	0.8	2.1	1.8	5.3	3.3	3.1	0.1	5.1	0.0	7.9	0.4	3.6	14.6	0.8	44.8	16.4	5.8	0.2	59.6	3.3	0.1	1.2	5.5	2.0	0.6	6.9	4.4	1.7	0.0	6.5	9.1	18.3	7.2	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.2	0.0	17.1	0.0	130.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	58.9	0.0	32.8	0.0	0.0	0.0	0.0	3.1	0.3	0.6	0.0	0.0	0.1	1.9	1.4	0.1	0.1	0.0	0.2	6.1	14.7	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.6	0.2	1.0	1.7	7.9	4.8	2.4	1.0	3.3	3.1	3.6	1.2	6.9	7.2	0.2	0.0	1.7	2.9	6.1	15.4	14.5	22.8	10.8	102.5	1.7	5.5	3.3	2.8	10.8	0.0	75.0	0.0	7.3	0.7	1.9	0.1	0.1	0.7	0.2	0.7	1.2	0.0	9.3	0.0	0.0	0.4	1.5	1.4	0.0	0.1	0.0	4.9	0.1	26.9	19.8	1.9	2.0	0.3	1.1	0.2	0.0	0.5	3.6	1.9	0.4	14.9	7.2	2.5	37.4	0.5	0.6	0.0	1.9	4.9	3.8	33.5	5.8	169.0	0.0	0.0	1.0	0.2	0.3	13.0	14.6	0.0	7.0	0.1	0.5	9.2
PLCL1	"PLC-L, PLCE, PLCL, PPP1R127, PRIP"	ENSG00000115896	"Phospholipase C like 1 (inactive)"	Q15111	2	197804593-198572581	"Metabolic proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.3;tongue: 40.8"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 2062.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.7;K-562: 15.6;Karpas-707: 10.7;MOLT-4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031849	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031849: AB_10602192"	"unprognostic (7.77e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (3.91e-7)"	"unprognostic (1.07e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.20e-2)"	4.0	4.1	15.6	2.7	40.5	1.6	2.4	32.5	21.4	4.5	9.5	4.0	0.6	14.8	3.1	3.6	3.3	3.0	32.4	13.8	30.8	31.5	0.5	3.2	3.4	42.6	37.4	7.0	1.6	14.8	2.1	7.9	39.2	10.5	1.3	4.0	2.3	7.1	30.8	0.9	1.8	6.0	22.6	1.9	2.2	1.7	27.7	17.2	3.3	40.8	2.6	4.1	1.9	65.3	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.5	0.0	0.2	0.0	1.8	4.2	0.0	0.0	0.0	0.0	8.7	2.9	15.6	10.7	0.1	0.4	11.4	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	1.6	0.9	1.8	0.0	2.5	0.8	0.2	0.0	0.7	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	1.4	0.0	15.6	40.5	32.5	21.4	13.8	30.8	42.6	37.4	39.2	22.6	27.7	65.3	7.0	19.2	4.4	44.4	0.9	1.3	0.8	0.0	0.6	14.8	2.0	1.8	159.0	1.5	1.9	14.7	0.0	0.1	0.8	1.8	58.7	0.9	15.5	2.0	102.7	5.4	1.8	0.0	201.0	0.4	0.0	6.0	1.1	1.9	6.3	3.8	0.4	0.0	3.1	15.2	160.9	0.0	2.0	4.1	2.0	3.8	1.8	4.6	0.0	49.6	2.9	2.7	0.0	181.5	2062.6	0.2	0.0	7.9	3.8	0.6	0.6	52.4	2.2	1.2	32.9	5.4	31.8	1.0	1.8	0.2	1.3	0.1	8.2	1.6	0.1	0.3
PLCL2	"KIAA1092, PLCE2"	ENSG00000154822	"Phospholipase C like 2"	Q9UPR0	3	16802651-17090604	"Metabolic proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 212.5;Extravillous trophoblasts: 73.0;Inhibitory neurons: 163.7;Microglial cells: 124.6;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.1;Daudi: 24.7;HAP1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047616, HPA061728"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047616: AB_2680105, HPA061728: "	"unprognostic (2.95e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.98e-10)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.97e-2)"	7.8	11.8	2.8	5.8	5.0	10.0	5.9	13.7	4.0	4.2	1.1	5.6	6.6	6.6	2.5	1.3	4.3	4.1	21.1	3.3	1.6	7.4	5.6	4.8	10.2	3.6	1.7	12.5	6.7	0.8	6.0	3.8	4.1	3.1	5.7	2.1	2.8	1.4	27.1	1.9	8.3	4.2	0.8	12.9	5.4	3.9	1.7	5.9	3.7	7.7	7.7	2.6	3.1	2.9	0.0	1.9	2.5	0.0	9.3	21.1	2.0	1.8	5.0	0.8	2.0	0.0	1.8	24.7	0.0	1.6	1.0	0.0	24.8	0.9	1.8	11.8	5.2	0.0	2.6	0.0	0.3	3.8	2.7	3.4	0.2	6.9	0.0	1.5	4.3	8.1	5.8	9.4	0.0	0.0	4.3	0.4	5.0	0.0	2.6	9.4	0.0	13.5	0.0	0.4	8.0	3.6	1.0	3.0	0.7	1.7	0.0	4.0	4.4	1.2	1.7	1.1	4.2	8.9	0.0	15.7	1.3	5.2	0.9	0.9	0.8	1.9	2.1	0.9	2.6	1.4	2.0	2.9	1.0	1.3	1.9	2.1	1.8	6.5	1.2	0.5	1.5	1.1	2.8	5.0	13.7	4.0	3.3	1.6	3.6	1.7	4.1	0.8	1.7	2.9	8.6	0.0	2.2	8.1	17.5	1.0	0.9	1.1	1.2	11.5	0.6	0.4	38.6	11.5	1.1	3.7	4.2	2.5	34.1	12.5	7.9	2.6	1.1	7.5	4.1	6.6	3.6	7.0	212.5	9.2	73.0	7.8	17.3	2.1	2.5	5.6	5.7	6.4	7.8	16.8	163.7	9.8	0.0	8.7	4.6	1.5	19.6	13.8	0.0	124.6	12.3	1.2	39.1	121.7	72.2	2.9	22.6	19.2	18.2	0.5	9.5	10.9	1.3	1.8	6.6	9.6	5.0	2.5	5.4	0.3	0.6	49.8	24.2	6.5	5.4	0.6
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 34.7;Distal enterocytes: 34.2;Gastric mucus-secreting cells: 33.1;Paneth cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 110.4;HEL: 172.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007721	Approved		Approved	Cytosol		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	14.7	4.1	4.6	9.4	8.8	32.9	9.7	13.0	19.2	10.0	0.0	8.2	8.6	5.6	1.4	17.5	9.1	8.8	5.6	4.4	0.0	5.7	10.1	7.4	17.3	3.4	1.5	12.8	7.5	3.2	7.7	7.8	4.4	7.5	5.7	6.0	11.4	3.7	8.4	18.7	12.5	2.7	0.5	17.5	26.9	6.7	4.0	8.9	10.4	2.7	9.0	6.1	9.7	13.4	28.4	110.4	25.7	38.8	5.0	3.9	20.4	24.4	2.9	12.8	12.4	40.6	29.1	34.8	17.9	10.7	19.0	8.5	6.3	15.9	6.7	21.2	46.2	172.6	36.1	59.7	15.6	17.4	63.1	20.1	1.9	47.0	4.9	8.6	9.7	57.2	44.0	18.7	9.2	8.2	52.3	24.2	57.8	7.1	19.2	29.1	13.3	53.9	3.9	12.9	25.9	15.0	24.6	14.4	21.1	17.5	27.6	22.0	7.2	17.1	28.2	18.5	26.9	6.3	17.9	86.4	11.0	44.4	18.2	3.7	2.7	5.4	1.9	6.0	2.7	1.6	1.4	2.4	2.0	5.6	1.8	1.9	3.3	1.2	9.0	2.1	3.2	2.3	4.6	8.8	13.0	19.2	4.4	0.0	3.4	1.5	4.4	0.5	4.0	13.4	15.8	9.6	34.7	5.5	4.1	6.9	13.6	3.9	2.2	7.4	4.7	3.6	6.5	10.0	2.8	0.0	2.1	10.1	4.9	34.2	0.0	6.3	0.9	1.6	3.4	6.1	3.0	9.9	5.3	1.8	11.3	6.1	33.1	3.2	3.8	32.1	4.6	6.9	5.5	8.4	6.1	11.2	0.0	7.3	9.8	0.9	2.5	11.9	0.0	5.6	3.7	2.3	9.2	0.5	5.7	18.8	40.9	3.8	2.7	5.3	3.0	1.7	1.3	7.1	13.1	6.5	7.9	8.4	15.9	4.2	8.7	27.0	3.8	2.8	9.4	8.0
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;retina: 14.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 7.1"	"Low region specificity"	"Detected in all"							HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"	0.3	0.3	2.6	1.6	2.9	4.6	0.2	0.7	7.3	0.3	0.0	1.2	2.8	0.3	0.2	0.5	0.2	0.7	0.3	3.9	1.6	0.6	1.0	0.6	2.9	4.1	4.5	0.2	0.6	0.1	1.4	1.0	4.1	0.3	1.5	14.8	0.9	0.2	0.2	0.6	2.7	0.3	2.2	1.6	0.9	1.0	3.5	2.7	1.3	0.1	2.2	0.5	0.3	1.9	2.3	2.1	2.0	0.9	0.0	0.1	0.6	4.0	1.9	3.7	3.2	1.4	1.1	1.7	2.0	0.2	1.2	5.6	0.8	3.7	7.1	0.5	1.0	0.4	4.1	1.3	0.3	0.5	2.0	0.0	0.7	1.2	2.2	3.4	2.0	2.1	0.0	4.0	0.4	0.2	1.2	0.4	0.7	1.5	5.1	1.1	2.8	1.6	1.7	2.3	0.4	3.4	0.8	0.5	0.8	2.2	0.3	0.1	2.0	0.8	5.0	0.4	0.8	4.8	0.7	0.3	0.4	0.3	0.2	0.3	0.0	0.0	1.8	0.0	1.8	0.3	0.9	1.8	0.1	0.4	0.4	0.9	0.1	1.1	0.0	3.8	0.9	0.3	2.6	2.9	0.7	7.3	3.9	1.6	4.1	4.5	4.1	2.2	3.5	1.9	0.4	19.2	2.2	3.3	2.3	0.1	9.9	17.1	7.4	0.8	2.9	1.8	3.7	22.8	3.5	60.7	4.2	0.0	8.4	1.6	160.4	44.2	11.9	0.9	0.2	0.7	25.1	0.0	11.7	50.1	0.0	0.4	7.1	1.5	0.0	5.4	0.4	168.6	0.0	6.7	6.0	7.8	2.0	1.6	0.0	12.0	0.3	1.8	0.0	3.7	0.0	0.0	2.1	7.5	0.9	50.1	0.2	0.4	3.9	7.9	1.0	196.6	1.0	3.5	0.0	0.0	1.7	0.5	0.5	2.2	0.1	0.0	5.3	0.5	1.5	14.1
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306952-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;heart muscle: 33.2;ovary: 22.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	3.9	12.7	4.5	0.5	4.1	0.0	2.4	17.8	4.2	2.9	1.1	0.9	0.5	1.1	0.9	0.6	3.4	2.4	33.2	3.4	9.5	5.9	1.6	1.8	1.6	8.2	10.4	22.5	3.6	0.3	5.3	0.1	16.0	1.0	0.6	0.7	0.4	1.0	0.5	0.7	1.2	1.2	7.7	0.2	5.0	0.4	12.1	0.5	1.5	0.7	0.2	1.4	4.0	6.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.4	34.3	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	4.1	17.8	4.2	3.4	9.5	8.2	10.4	16.0	7.7	12.1	6.3	8.7	0.0	0.0	7.5	0.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	138.2	5.7	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.3	0.9	1.7	58.7	13.6	42.4	5.3	27.8	0.0	2.0	10.3	0.0	1.1	0.0	33.4	33.2	0.4	0.1	1.7	163.5	2.2	0.0	0.6	0.3	4.4	7.8	0.2	0.0	52.5	0.0	0.4	0.0	7.5	1.3	0.9	0.0	0.4	0.0	0.3	0.1	10.4	0.0	0.2	6.6	0.2	2.9	0.2	0.0	0.2	0.0	0.1	0.3	9.7	0.1	0.1
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD2		ENSG00000129219	"Phospholipase D2"	O14939	17	4807152-4823434	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013397	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA013397: AB_1855328"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.48e-2)"	17.4	8.1	19.9	10.0	22.8	2.6	17.9	21.5	21.3	32.3	16.0	11.2	6.9	15.2	6.9	63.3	14.5	14.3	10.2	19.4	21.9	11.7	12.1	16.1	9.5	30.4	24.3	21.5	14.0	8.9	10.4	14.2	22.3	19.0	9.0	4.9	22.6	14.5	5.1	33.5	10.7	13.4	24.7	12.6	11.3	4.3	24.5	12.9	11.9	6.7	18.0	15.0	37.1	23.5	13.0	20.2	17.4	18.8	15.0	19.9	20.0	8.2	17.2	14.2	11.3	21.7	15.1	5.6	9.4	21.3	5.3	30.2	13.9	18.3	12.8	7.3	7.0	1.8	15.7	13.2	10.8	0.1	13.3	29.4	27.0	12.8	12.1	20.0	33.2	3.9	2.1	5.2	12.0	9.9	0.7	2.4	9.2	10.7	8.7	6.3	11.2	1.4	12.9	20.9	5.9	10.2	15.5	18.1	11.6	14.1	13.0	3.0	26.1	9.4	9.5	21.6	12.8	4.6	2.3	1.2	14.4	2.6	5.6	4.0	4.8	1.2	1.2	4.9	0.9	1.6	1.3	0.9	3.6	0.9	0.3	0.4	0.3	0.8	5.4	1.6	2.3	2.4	19.9	22.8	21.5	21.3	19.4	21.9	30.4	24.3	22.3	24.7	24.5	23.5	10.9	0.0	1.1	26.8	2.8	12.6	9.8	11.2	14.8	1.2	11.6	10.3	2.8	7.2	8.9	1.8	0.0	21.8	2.6	7.1	1.9	8.7	0.0	2.5	4.6	12.0	1.2	0.0	1.6	11.5	14.8	7.7	10.7	5.4	5.7	12.0	12.8	2.9	12.9	0.0	2.7	7.0	6.1	8.1	13.8	0.5	9.6	10.7	7.2	5.6	19.9	7.8	1.0	3.5	5.8	10.4	10.2	8.6	1.4	14.0	3.8	4.2	9.2	1.7	0.0	4.1	5.0	0.2	2.7	9.8	12.1	17.4	3.1	7.2	5.7	10.5
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924713-104937761	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 284.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 3621.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 3621.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2900000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.4	1.0	5.1	5.7	4.7	13.4	1.5	7.0	7.1	1.0	0.4	0.8	3.8	1.0	0.2	0.6	1.8	2.4	0.5	4.5	7.3	0.8	0.5	1.8	11.3	15.7	6.8	0.5	1.1	1.2	2.1	0.8	10.3	1.7	0.5	0.5	3.5	1.8	0.3	0.6	5.1	0.5	13.9	10.4	2.8	0.6	9.4	2.8	0.6	0.0	9.4	1.9	0.4	16.7	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	127.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	10.7	0.1	0.0	0.1	30.0	0.1	85.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	191.5	0.0	0.1	0.3	0.1	0.2	0.4	0.0	0.1	0.2	1.6	0.3	4.6	43.0	699.5	1.0	188.4	1.9	222.7	0.8	1.2	545.8	198.4	1.7	0.4	9.8	25.4	297.9	3621.6	1.0	72.9	5.1	4.7	7.0	7.1	4.5	7.3	15.7	6.8	10.3	13.9	9.4	16.7	0.8	0.0	0.0	0.3	34.7	0.4	0.1	0.0	0.0	2.7	0.6	2.8	1.4	0.0	0.0	0.0	0.0	0.2	284.8	0.0	0.0	0.0	0.7	0.1	0.3	2.7	0.0	5.5	0.1	0.0	0.4	1.1	1.1	0.4	3.8	0.0	0.0	0.0	30.6	1.7	0.1	0.0	0.0	1.3	32.0	4.7	0.0	38.0	5.4	22.5	11.3	0.1	2.1	0.5	0.1	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.0	1.1	6.6	1.6	0.3	1.6	1.6	0.0	0.4	0.3	2.2	0.0	0.1	0.0
PLD6		ENSG00000179598	"Phospholipase D family member 6"	Q8N2A8	17	17200995-17206333	"Metabolic proteins, Predicted membrane proteins"	"Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 32.4;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.8;NK-cells: 6.3;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.2;REH: 31.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA049345	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA049345: AB_2680722"	"unprognostic (1.71e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.83e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.24e-1)"	4.6	4.1	11.5	1.4	10.8	2.0	3.8	10.7	11.4	7.6	10.3	9.0	1.7	3.5	5.0	1.6	5.7	2.2	5.2	10.9	12.1	2.9	5.9	2.8	3.0	10.3	14.6	7.9	5.0	5.7	8.1	1.8	14.0	5.6	1.7	3.6	3.2	4.4	5.2	4.5	3.2	2.4	8.7	4.3	4.5	21.2	13.1	1.6	3.3	1.4	2.2	4.3	4.4	11.1	7.1	5.4	0.2	6.0	2.3	0.9	0.3	2.2	3.6	4.0	2.4	6.3	2.0	15.4	3.3	2.2	2.4	1.9	41.2	1.2	3.8	9.7	12.0	14.9	4.2	11.3	10.2	11.2	6.0	2.0	4.4	2.4	9.7	4.5	1.0	7.1	13.5	0.4	4.6	9.0	8.3	15.8	0.1	8.0	7.4	31.5	3.1	11.3	3.7	0.5	23.4	9.7	2.8	3.9	7.2	4.3	3.8	17.8	1.1	0.1	0.3	9.0	4.5	1.9	7.5	0.1	4.8	11.4	8.6	0.4	0.4	0.2	2.9	0.3	9.9	5.8	11.3	6.0	0.1	4.8	11.9	5.5	0.5	6.3	0.2	1.5	9.4	4.1	11.5	10.8	10.7	11.4	10.9	12.1	10.3	14.6	14.0	8.7	13.1	11.1	0.6	3.2	3.3	4.6	3.3	5.5	4.5	1.7	9.6	4.5	2.2	3.9	7.2	1.5	1.9	1.8	0.0	5.5	0.5	0.5	1.9	1.4	7.1	7.5	1.5	0.8	1.2	3.4	6.0	0.7	1.3	2.8	1.5	3.4	1.3	3.3	1.8	2.1	2.7	6.7	9.8	2.0	6.1	0.6	1.7	2.7	4.4	0.8	3.6	2.8	0.7	6.5	0.0	3.0	7.1	1.0	0.1	4.9	10.1	5.9	0.8	1.4	6.0	1.3	0.0	1.4	1.5	32.4	23.7	1.3	1.6	0.8	3.6	5.6	1.5	1.2
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 384.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	41.8	30.9	44.2	22.6	25.4	43.2	37.9	20.4	39.7	57.4	6.7	58.0	21.1	55.2	8.5	59.7	47.9	22.8	78.9	42.2	31.0	30.0	31.3	49.2	22.1	48.5	28.6	47.1	27.6	8.1	33.0	18.3	30.8	49.5	13.0	3.9	42.9	19.8	256.5	83.1	53.8	27.7	28.8	46.1	49.1	15.3	43.2	14.4	25.7	74.7	15.8	56.5	55.7	25.9	92.6	247.3	15.1	20.3	31.6	66.9	62.8	125.9	49.3	32.3	18.7	39.2	88.5	8.9	82.9	179.7	54.6	98.9	10.3	162.6	13.3	58.7	10.0	24.9	268.0	34.0	54.0	9.6	26.1	71.8	40.7	84.6	164.2	28.3	43.0	7.6	16.2	25.9	39.7	175.3	5.1	19.8	12.2	29.4	384.8	1.8	46.2	24.6	67.7	147.7	16.6	16.8	217.4	50.0	21.1	21.7	55.7	12.4	125.7	117.8	217.3	110.6	155.1	4.7	3.7	6.3	106.9	15.2	176.2	0.0	2.0	0.1	0.6	1.7	1.3	0.6	1.2	0.9	1.6	0.6	0.8	0.5	0.4	0.3	1.2	1.3	1.4	2.0	44.2	25.4	20.4	39.7	42.2	31.0	48.5	28.6	30.8	28.8	43.2	25.9	83.8	28.9	15.6	78.0	27.0	108.0	53.1	62.9	50.7	15.8	29.4	27.9	39.3	31.5	42.9	40.5	25.0	34.4	27.1	257.8	0.0	39.3	1.4	39.4	52.6	68.2	32.2	11.8	47.3	20.2	32.1	45.7	170.2	57.3	8.2	14.4	63.1	69.0	35.2	30.3	36.5	79.9	10.2	67.5	100.4	5.0	44.4	61.2	33.8	27.2	54.9	11.2	15.5	14.6	3.4	157.8	194.1	74.9	39.3	144.9	124.9	4.6	50.3	10.8	6.6	42.1	61.5	1.2	7.1	72.2	76.7	69.0	35.0	18.8	61.6	121.0
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	0.8	51.1	0.3	5.5	0.3	12.7	3.9	0.8	0.6	3.9	0.1	25.1	29.6	1.5	32.4	16.4	1.7	3.9	0.3	0.4	0.2	9.7	29.7	1.6	0.2	0.3	0.2	0.6	7.9	7.0	1.3	1.5	0.3	7.7	28.7	0.1	6.8	4.2	0.3	26.5	32.6	1.3	0.2	0.6	20.6	3.1	0.4	22.9	23.5	0.2	5.5	12.1	7.9	0.4	91.0	13.4	0.0	0.1	0.0	1.0	8.4	17.9	2.7	4.2	5.2	48.8	94.4	0.0	17.3	2.5	0.2	42.4	0.1	177.4	9.6	0.1	0.7	0.0	19.4	0.4	3.8	0.0	0.0	1.9	12.3	4.6	55.4	0.0	14.8	0.0	0.4	0.4	3.0	28.9	0.0	0.2	0.3	57.4	64.1	0.0	0.1	14.0	30.0	2.4	0.7	0.2	17.0	7.9	5.2	0.9	11.6	0.9	69.3	0.0	54.1	0.3	0.4	0.3	0.2	0.3	10.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.8	0.6	0.4	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.1	0.0	1.1	1.0	0.6	149.0	29.0	69.9	37.0	0.0	4.9	6.0	0.5	10.0	11.8	5.5	0.0	1.0	0.0	25.0	3.9	42.1	0.1	2.3	0.2	2.0	8.4	16.0	0.8	46.3	5.5	4.2	37.2	2.2	0.0	24.0	0.0	11.5	6.8	0.0	0.6	68.5	26.4	1.3	57.1	0.3	0.3	7.4	21.4	0.0	5.2	0.0	0.0	0.5	0.3	179.8	23.9	0.0	0.0	15.8	47.9	3.2	4.5	0.0	0.0	0.0	4.6	0.4	2.3	21.2	90.6	1.5	1.3	107.7	54.8	25.5
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
PLEKHA2	TAPP2	ENSG00000169499	"Pleckstrin homology domain containing A2"		8	38901235-38973912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.1;dendritic cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004706	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA004706: AB_1079633"	"unprognostic (2.78e-1)"	"unprognostic (8.80e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.60e-3)"	17.5	15.7	13.6	35.3	11.1	39.7	10.6	6.1	18.3	16.9	13.1	16.9	10.1	15.0	10.6	14.0	15.8	17.7	42.8	25.3	10.2	17.1	9.4	20.1	78.7	10.7	6.9	19.1	6.6	21.2	8.7	17.8	11.8	10.2	12.4	5.4	7.4	18.8	4.5	8.4	16.0	18.9	10.1	43.0	12.6	5.9	10.1	17.9	19.3	8.0	66.1	17.3	10.3	16.3	30.0	6.5	4.1	10.0	10.2	20.1	4.6	35.7	27.2	25.9	21.5	3.7	19.4	164.7	41.3	31.9	22.9	17.9	10.8	21.6	38.4	42.8	1.0	84.7	54.4	4.0	36.9	28.0	32.9	46.3	14.7	13.2	23.6	60.1	4.4	26.3	8.7	45.0	24.1	3.7	56.0	12.8	3.9	23.2	10.2	14.1	22.4	34.6	31.3	24.9	0.5	6.5	41.9	7.4	27.9	6.1	16.9	13.0	6.5	18.5	14.5	3.2	28.5	14.7	14.8	76.3	29.3	28.7	4.2	6.9	1.5	8.1	1.9	2.0	2.0	10.0	2.2	2.3	1.8	12.7	1.4	2.6	3.3	3.9	2.2	5.4	1.9	1.0	13.6	11.1	6.1	18.3	25.3	10.2	10.7	6.9	11.8	10.1	10.1	16.3	8.8	3.2	17.9	15.0	94.1	8.8	15.7	17.1	6.8	1.8	7.2	5.2	40.7	12.8	17.3	40.5	0.0	7.7	132.0	9.0	1.9	7.4	1.0	17.8	28.7	10.9	13.1	12.2	21.2	5.5	17.7	22.2	9.2	25.4	36.8	21.3	19.6	10.2	48.8	58.9	7.7	11.8	6.1	79.6	55.3	2.5	22.7	49.7	16.0	35.6	48.4	12.1	64.9	52.3	4.7	24.5	4.7	25.2	56.4	9.9	15.9	16.3	23.5	1.4	13.1	35.8	24.8	0.7	7.9	5.1	6.7	4.5	53.9	4.4	12.8	35.7
PLEKHA3	FAPP1	ENSG00000116095	"Pleckstrin homology domain containing A3"	Q9HB20	2	178480457-178516463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 196.2;Late spermatids: 413.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034496, HPA034497"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA034496: AB_2674189, HPA034497: AB_10603126"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.02e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.52e-2)"	3.6	6.6	4.1	3.9	4.7	5.4	3.0	7.1	5.9	3.4	5.9	4.0	4.6	3.5	6.2	3.2	3.5	3.0	6.3	4.2	4.2	4.7	4.1	3.2	3.6	3.8	4.2	3.8	2.7	4.6	4.2	2.7	4.1	3.6	2.6	8.0	2.7	4.3	2.7	1.7	3.4	3.4	4.0	3.4	3.9	10.0	4.3	1.3	3.7	3.2	2.8	3.7	2.5	5.1	4.1	2.7	3.1	4.0	6.0	3.2	5.9	6.6	5.0	3.2	3.5	1.1	2.7	3.5	8.3	4.7	9.0	2.8	2.9	1.7	6.0	10.8	2.8	5.5	2.7	3.2	4.2	3.5	6.0	2.9	5.6	5.9	3.7	5.7	2.9	3.1	2.6	5.4	4.3	1.3	4.7	5.1	5.2	2.9	3.9	2.5	4.6	6.1	4.1	2.4	3.2	4.5	3.3	2.4	10.4	4.3	2.8	6.1	3.3	6.3	6.1	8.0	7.4	6.7	14.2	3.5	8.2	2.9	3.7	0.5	0.2	0.3	0.4	0.2	0.4	0.5	0.7	0.5	0.2	1.5	0.4	0.5	0.6	0.8	0.4	0.6	0.3	0.1	4.1	4.7	7.1	5.9	4.2	4.2	3.8	4.2	4.1	4.0	4.3	5.1	56.7	16.0	14.6	9.8	32.7	43.2	48.4	12.6	50.7	90.3	39.6	35.2	56.1	32.9	13.4	27.6	41.7	29.2	53.6	15.3	78.2	36.9	196.2	44.9	39.5	44.9	25.8	35.3	15.8	47.3	18.6	43.0	21.4	38.0	10.8	23.7	39.3	42.8	15.8	132.9	20.4	23.3	12.2	28.3	44.9	413.6	34.8	33.1	30.2	18.7	28.6	56.7	40.2	11.6	18.5	45.0	11.3	52.3	39.9	91.7	20.0	67.9	17.9	64.0	78.9	54.2	54.4	66.0	41.5	28.6	30.4	30.5	44.0	44.8	19.0	79.7
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129733-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 555.7;Inhibitory neurons: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 22.6;MAIT T-cell: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.6;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 65.5;NTERA-2: 64.4;SuSa: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	10.5	61.3	7.2	5.2	15.7	3.7	15.3	3.9	15.8	30.7	1.3	12.1	13.0	29.8	32.3	20.7	20.0	18.5	35.2	12.6	7.7	42.7	16.2	12.8	3.1	13.6	16.1	32.7	14.9	21.9	12.6	12.7	11.5	17.3	13.6	35.1	15.5	28.0	2.4	17.7	13.3	15.3	11.8	3.4	18.6	20.5	10.4	8.6	14.6	5.1	4.9	23.5	25.0	14.7	25.8	12.5	45.2	0.4	14.9	20.1	15.8	10.8	23.7	6.5	10.2	19.1	22.8	0.5	3.5	12.1	13.2	10.9	30.8	20.3	13.5	65.5	10.8	15.4	28.1	9.1	14.0	0.3	2.0	11.8	20.4	18.6	35.2	35.5	7.1	12.9	6.7	0.7	7.0	8.0	10.2	1.8	64.4	21.1	6.5	0.2	21.0	0.2	45.6	30.5	4.1	9.1	10.6	5.9	40.3	61.0	7.4	3.5	10.8	4.0	17.3	0.9	0.4	0.6	0.5	0.3	9.8	0.2	8.3	22.6	0.3	0.3	2.4	0.4	5.7	0.2	2.2	2.1	1.8	0.3	0.3	1.6	0.8	1.6	0.2	2.5	2.1	0.4	7.2	15.7	3.9	15.8	12.6	7.7	13.6	16.1	11.5	11.8	10.4	14.7	19.9	25.6	28.2	145.9	3.2	20.5	46.6	42.2	25.0	86.2	27.8	49.7	157.9	57.2	49.5	46.0	137.6	26.8	9.0	25.6	35.2	33.7	25.8	84.2	187.3	17.2	32.4	7.8	555.7	33.1	38.7	79.8	37.8	98.8	3.8	11.3	20.3	38.9	6.6	126.2	506.4	17.9	22.4	10.5	94.1	15.3	40.4	11.4	117.4	178.0	168.2	97.5	0.0	158.8	82.0	52.6	30.9	28.2	4.9	33.4	30.4	115.3	60.6	139.7	32.9	24.7	38.1	45.5	48.8	39.4	25.7	26.4	12.0	75.3	36.9	47.2
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218853-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Distal enterocytes: 66.6;Excitatory neurons: 102.6;Inhibitory neurons: 62.5;Oligodendrocyte precursor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 60.3;BEWO: 94.6;CAPAN-2: 79.2;OE19: 80.9;RT4: 66.4;SK-BR-3: 58.4;T-47d: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157, HPA054311"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: , HPA054311: AB_2682446"	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	5.1	6.6	20.4	6.0	21.6	0.4	13.7	20.9	34.4	4.1	9.1	32.2	25.5	4.8	12.9	17.2	9.3	13.2	20.8	19.6	18.7	27.4	27.5	3.2	0.6	23.1	24.3	4.6	10.2	5.7	31.1	8.8	23.3	13.8	29.3	11.4	9.0	13.9	6.0	4.0	29.5	3.8	17.9	3.1	39.7	5.4	34.6	1.0	4.0	2.4	2.4	12.7	7.5	24.1	60.3	36.8	23.7	0.1	0.3	0.6	94.6	2.1	6.6	0.2	0.3	17.8	79.2	0.3	17.3	1.4	0.3	6.7	0.3	6.5	0.3	0.2	3.8	0.2	15.2	25.7	3.5	0.0	0.1	1.0	19.6	0.0	5.0	7.2	10.4	0.8	0.1	0.2	23.9	26.7	0.1	0.1	7.4	80.9	44.6	0.0	0.2	0.1	23.0	66.4	4.8	48.4	26.6	58.4	0.4	4.9	55.3	0.3	0.7	0.0	1.0	0.3	0.5	0.2	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.6	20.9	34.4	19.6	18.7	23.1	24.3	23.3	17.9	34.6	24.1	0.2	0.0	10.9	111.0	0.3	0.1	4.2	1.9	0.6	41.6	15.7	8.1	16.6	37.1	4.5	9.2	20.9	6.6	0.5	66.6	3.9	8.4	10.4	4.0	1.3	1.2	16.8	2.7	102.6	5.1	2.4	9.0	40.8	6.2	0.0	0.3	5.0	21.4	0.8	18.5	62.5	32.7	4.1	0.6	0.7	4.0	5.3	0.7	0.0	15.0	0.1	1.2	0.0	85.5	41.8	13.3	33.2	3.8	0.1	6.9	15.2	11.7	7.2	7.1	0.0	26.4	1.1	0.6	0.2	1.4	0.6	21.6	0.6	0.1	34.5	13.7
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PLEKHB2	"EVT2, FLJ20783"	ENSG00000115762	"Pleckstrin homology domain containing B2"	Q96CS7	2	131104847-131353709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075014	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA075014: AB_2732275"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.72e-8)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.65e-1)"	27.0	55.5	52.7	38.3	55.4	64.8	26.1	61.4	56.2	25.4	53.4	59.9	46.8	16.6	30.7	30.3	26.7	29.7	33.5	57.8	73.1	111.8	22.4	44.4	37.0	64.8	69.4	11.7	20.8	88.5	26.2	31.0	81.3	34.6	60.9	81.1	26.0	26.3	35.6	23.5	56.2	25.9	56.8	42.5	58.5	36.1	60.0	31.2	48.7	30.6	34.5	38.3	18.2	63.1	85.3	65.4	48.6	38.1	37.4	36.2	79.2	94.4	80.0	88.9	73.8	140.0	83.4	68.2	97.5	92.0	64.4	58.8	89.0	81.5	98.8	40.0	48.6	119.4	31.0	81.4	51.9	115.4	88.8	31.9	67.2	105.2	96.9	54.6	71.1	36.5	57.5	53.0	166.9	46.7	71.4	57.0	73.9	80.8	99.1	52.5	37.7	72.7	138.6	89.7	60.3	39.7	29.6	166.3	107.6	64.9	23.6	89.0	86.6	89.2	60.4	76.7	86.5	51.2	85.6	46.5	130.8	76.6	82.8	27.5	54.9	29.0	24.4	69.2	23.9	15.5	18.2	23.2	52.7	17.1	19.4	23.2	32.3	26.5	78.2	18.7	23.6	48.3	52.7	55.4	61.4	56.2	57.8	73.1	64.8	69.4	81.3	56.8	60.0	63.1	37.8	60.9	53.9	14.4	50.0	114.3	35.6	47.2	64.9	85.6	57.6	26.5	28.6	34.3	59.5	64.4	125.1	44.9	59.5	174.4	158.5	62.4	66.4	108.8	44.2	57.2	56.8	44.2	38.9	43.1	51.0	29.6	62.2	164.1	58.9	25.4	31.4	20.9	106.3	101.0	41.5	67.6	128.1	111.0	169.5	22.1	14.3	117.9	76.5	26.2	86.2	46.0	49.4	15.1	32.0	81.5	68.4	24.0	35.8	58.6	120.2	193.4	52.1	78.8	13.1	26.1	35.9	92.3	65.9	97.6	140.4	92.9	59.1	51.0	76.1	70.7
PLEKHD1	UPF0639	ENSG00000175985	"Pleckstrin homology and coiled-coil domain containing D1"	A6NEE1	14	69484692-69531551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;parathyroid gland: 6.0;retina: 8.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 60.9;Horizontal cells: 230.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 3.7"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.7"	"Cell line enhanced"	"Detected in some"		"OE19: 1.1;SK-BR-3: 2.4;T-47d: 2.3;U-266/70: 1.0"	"Region enhanced"	"Detected in many"		"cerebellum: 30.0"	"Low region specificity"	"Detected in many"			HPA051875	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"			"HPA051875: AB_2681648"	"unprognostic (8.73e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.42e-2)"	0.1	0.2	1.2	0.1	0.5	0.5	0.6	8.1	2.4	0.3	0.0	0.0	0.2	0.1	1.6	0.1	0.1	0.1	0.1	0.3	1.4	1.4	0.0	0.2	0.9	1.4	3.2	0.1	0.2	6.0	0.3	0.1	1.6	0.1	0.0	8.8	1.6	0.3	0.1	1.5	0.1	0.0	0.4	0.2	0.2	1.2	4.5	0.1	2.2	0.0	0.2	0.0	0.0	1.1	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.4	0.1	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.7	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.1	0.3	0.1	0.1	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	1.2	0.5	8.1	2.4	0.3	1.4	1.4	3.2	1.6	0.4	4.5	1.1	0.5	0.0	7.3	0.3	0.0	0.4	1.8	0.1	0.0	60.9	0.6	0.4	1.3	0.0	2.0	0.0	4.2	0.1	11.2	0.1	3.9	0.1	0.5	0.4	0.2	1.0	0.0	0.0	6.3	0.2	0.1	0.6	0.0	0.6	1.3	0.1	0.4	0.0	0.1	230.5	3.3	0.0	0.0	0.0	0.6	0.1	0.0	1.0	0.0	0.0	0.6	1.7	1.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.2	0.5	0.9	5.9	0.0	1.4	0.6	0.8	0.3	0.0	0.3	0.1	2.3	0.2	0.1	0.7
PLEKHF1	"APPD, MGC4090, PHAFIN1, ZFYVE15"	ENSG00000166289	"Pleckstrin homology and FYVE domain containing 1"	Q96S99	19	29665459-29675477	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 77.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 59.2;Leydig cells: 78.3;NK-cells: 166.9;Peritubular cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"NK-cells: 82.3;T-cells: 183.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 39.0;SK-BR-3: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA025925	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA025925: AB_1844958"	"unprognostic (5.01e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (4.54e-4)"	18.0	3.6	9.4	4.6	12.4	6.7	17.0	10.8	9.7	18.1	5.9	9.9	4.0	18.8	1.9	15.3	15.5	4.6	24.8	7.8	10.1	4.9	16.4	10.5	9.0	14.2	12.5	8.4	4.9	5.9	2.5	4.9	11.3	16.5	1.1	0.2	18.6	6.1	77.3	8.5	10.0	2.7	10.8	14.4	7.2	3.4	13.9	7.4	6.3	38.5	5.1	16.9	14.9	14.0	14.3	5.2	0.1	3.3	10.5	9.0	39.0	3.6	4.9	4.4	7.1	3.3	6.4	0.1	12.7	4.7	8.1	12.6	1.1	3.3	0.7	9.7	7.1	7.1	2.6	6.5	17.9	0.4	19.0	15.8	1.3	4.7	8.7	2.8	3.8	7.1	8.2	0.0	2.5	1.9	1.0	5.9	0.7	2.3	2.5	0.1	4.7	4.0	3.0	22.5	0.1	2.3	2.0	32.9	18.4	3.2	12.0	2.1	3.5	5.7	5.9	7.2	6.7	2.5	27.3	1.2	6.3	7.5	2.0	10.4	0.8	0.2	183.9	0.5	128.1	5.5	74.0	147.2	1.4	10.2	43.9	82.4	2.1	82.3	0.9	0.6	76.4	67.1	9.4	12.4	10.8	9.7	7.8	10.1	14.2	12.5	11.3	10.8	13.9	14.0	5.2	0.0	0.5	1.3	9.5	55.2	29.0	15.8	17.1	0.8	12.7	9.0	8.7	18.6	9.6	9.2	0.0	59.2	53.6	0.9	5.9	22.1	0.5	4.4	10.1	11.2	0.0	2.7	0.2	8.3	7.4	17.6	2.0	7.8	0.0	0.8	12.5	10.0	11.1	0.0	0.4	1.2	16.2	3.0	12.6	1.9	78.3	3.0	17.8	9.4	0.5	5.5	166.9	0.0	5.6	3.8	2.5	72.6	10.1	34.0	0.5	6.0	4.2	0.5	0.0	24.7	7.6	0.4	1.8	8.9	35.8	38.4	40.9	0.9	1.2	25.4
PLEKHF2	"FLJ13187, PHAFIN2, ZFYVE18"	ENSG00000175895	"Pleckstrin homology and FYVE domain containing 2"	Q9H8W4	8	95133785-95156685	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 102.6;U-698: 109.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024829	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA024829: AB_10603127"	"unprognostic (4.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.67e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.61e-3)"	12.4	6.1	5.5	21.3	5.5	84.8	21.6	6.1	6.7	9.2	6.9	16.0	12.6	7.4	14.6	15.4	8.9	11.2	8.9	5.2	5.7	22.2	14.7	17.5	53.1	6.3	5.8	7.3	11.8	6.9	3.6	15.1	6.2	9.3	13.9	14.8	11.8	7.4	10.7	19.5	13.7	7.1	6.6	22.6	21.9	12.3	5.4	23.8	9.7	9.3	56.1	12.7	7.5	8.3	27.5	4.5	7.0	4.2	10.0	11.1	37.6	14.9	20.0	12.7	13.6	11.3	29.7	102.6	12.6	10.5	6.6	33.1	10.9	18.1	18.3	19.2	7.4	49.4	10.0	8.8	9.9	9.9	68.7	7.1	25.0	10.0	18.8	14.9	14.1	32.9	32.6	13.0	13.6	16.8	29.0	12.8	4.2	50.1	20.6	11.5	7.1	14.0	10.4	24.2	9.3	5.4	11.3	13.5	27.8	9.7	36.2	16.0	9.0	9.8	6.7	8.6	8.7	17.2	14.9	109.4	7.5	22.8	14.1	107.2	21.6	43.0	9.0	18.6	10.8	69.7	11.2	13.9	24.3	78.6	12.9	12.7	29.8	12.4	16.0	10.1	13.7	19.4	5.5	5.5	6.1	6.7	5.2	5.7	6.3	5.8	6.2	6.6	5.4	8.3	29.3	12.8	14.1	7.2	88.8	61.4	73.4	29.7	56.3	17.0	49.0	22.7	7.0	31.5	26.1	5.5	14.6	51.6	17.8	46.7	29.4	13.6	59.5	47.1	12.0	18.5	33.6	34.5	5.0	22.0	36.1	11.9	31.1	59.5	60.4	14.4	25.0	11.0	29.6	6.7	2.4	14.6	57.0	22.6	54.0	19.8	8.7	34.7	21.4	14.0	31.9	19.1	13.4	10.6	4.7	14.6	39.0	3.8	21.3	42.4	20.7	95.9	26.2	31.7	13.1	10.8	14.5	55.2	16.0	47.2	57.7	50.9	27.4	6.0	17.7	75.4
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412669-39428415	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	32.6	10.7	4.6	22.8	3.8	22.1	20.3	4.6	7.5	28.2	11.3	24.5	8.1	31.2	4.4	10.1	24.9	17.4	25.6	4.3	3.7	27.7	8.0	42.2	20.7	7.1	4.4	20.1	7.1	5.2	12.2	23.0	5.1	21.0	5.2	4.6	8.4	15.1	6.3	9.0	18.9	18.5	4.7	33.4	15.6	15.7	9.3	21.1	19.1	4.9	18.3	20.9	17.4	5.2	8.5	40.8	73.0	39.9	6.9	9.0	10.6	21.9	17.3	14.9	12.8	26.5	14.9	14.7	15.8	28.8	12.4	2.8	11.1	19.4	7.9	49.3	10.2	19.3	23.5	12.4	11.9	2.2	23.1	20.7	3.3	17.9	8.7	25.8	19.3	41.7	13.2	16.9	24.1	17.0	24.2	7.5	17.3	7.8	3.9	86.1	8.9	4.6	12.7	15.4	2.0	23.6	4.9	1.8	7.0	25.2	21.9	21.8	24.8	38.8	30.0	14.5	14.4	12.6	4.1	21.4	21.6	8.7	22.0	1.3	0.5	0.1	1.4	0.2	0.9	1.2	0.7	0.8	0.3	1.1	1.0	1.2	0.8	0.4	0.7	1.4	1.3	1.1	4.6	3.8	4.6	7.5	4.3	3.7	7.1	4.4	5.1	4.7	9.3	5.2	30.4	6.4	27.4	1.6	9.7	4.0	5.5	2.9	6.8	0.6	4.6	11.7	6.4	2.8	6.4	0.0	0.0	0.8	8.7	5.0	0.0	5.6	14.2	11.9	20.1	17.7	1.2	1.7	0.5	4.9	2.9	16.9	13.3	30.4	2.5	6.9	8.2	0.8	9.9	0.0	0.8	3.7	0.0	12.8	21.1	19.8	7.2	25.6	5.4	2.8	5.4	1.1	4.1	2.5	0.3	4.2	2.1	8.2	9.1	3.0	2.6	0.2	2.2	2.4	6.6	64.5	26.8	2.5	4.1	6.5	2.8	1.1	12.2	2.4	3.1	1.9
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
PLEKHG4B	KIAA1909	ENSG00000153404	"Pleckstrin homology and RhoGEF domain containing G4B"	Q96PX9	5	92151-189972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.2"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 6.3;Club cells: 11.2;Collecting duct cells: 11.0;Glandular and luminal cells: 9.5;Respiratory ciliated cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.2;HAP1: 13.7;NTERA-2: 14.1;REH: 33.0;SCLC-21H: 14.0;SH-SY5Y: 12.6;SK-BR-3: 13.5;SuSa: 13.2;T-47d: 19.1"					"Low region specificity"	"Detected in all"			"HPA036274, HPA058157"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA036274: AB_10669668, HPA058157: AB_2683625"	"unprognostic (3.60e-2)"	"unprognostic (8.52e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.59e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (5.96e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.98e-7)"	"unprognostic (1.43e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-3)"	0.1	0.1	1.9	0.1	1.1	0.6	1.5	0.5	0.5	1.0	9.2	0.4	0.2	0.8	0.1	0.3	1.1	0.0	0.0	0.9	1.1	2.5	0.0	0.6	0.2	0.8	1.2	1.0	0.4	0.1	3.5	1.4	0.4	1.8	0.0	0.2	2.6	0.3	0.1	0.5	0.1	0.2	0.8	0.1	1.0	2.9	2.8	1.0	3.1	0.0	0.1	0.0	0.4	1.6	0.0	1.4	10.1	15.2	0.0	0.0	0.2	1.1	0.3	1.0	2.2	1.8	0.2	0.2	3.3	1.4	0.9	0.6	13.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	4.1	0.0	0.0	0.1	0.4	0.2	0.0	14.1	0.0	0.2	33.0	7.1	8.6	1.2	0.0	14.0	12.6	7.9	13.5	0.0	13.2	19.1	0.0	0.1	0.4	3.7	0.0	0.3	0.2	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.9	1.1	0.5	0.5	0.9	1.1	0.8	1.2	0.4	0.8	2.8	1.6	0.1	0.0	3.4	0.3	0.0	0.4	3.8	0.1	0.0	0.4	6.1	6.3	1.6	0.0	11.2	11.0	0.0	4.6	2.8	0.0	0.0	0.4	0.3	4.8	3.7	0.7	0.0	0.0	1.0	0.2	3.7	1.0	0.0	9.5	1.3	4.4	0.0	0.0	0.7	0.0	0.6	0.2	0.0	0.0	0.8	0.3	0.3	0.4	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.1	14.0	0.2	0.0	0.1	0.9	2.4	5.9	0.0	0.3	1.8	0.3	0.4	0.0	1.0
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6467122-6520074	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.4;skin 1: 102.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 57.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 32.1;TIME: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	18.7	15.0	4.4	2.9	2.6	0.6	12.0	57.4	16.6	14.0	0.0	7.3	6.4	7.5	1.9	21.6	8.6	7.3	16.4	13.0	0.0	6.5	1.8	6.0	5.0	0.0	0.0	7.5	5.1	4.4	43.3	12.4	1.8	9.9	3.5	3.4	9.3	7.2	6.8	102.5	8.4	3.9	0.0	50.9	4.4	5.4	0.0	2.0	7.2	3.0	3.3	5.9	14.3	0.0	7.1	2.7	11.9	9.4	1.5	4.2	3.1	8.4	7.0	3.2	2.1	6.9	18.8	0.3	22.6	2.8	4.9	22.6	2.2	23.7	1.3	16.5	3.0	0.0	15.1	2.9	1.9	0.0	1.3	5.5	10.2	8.1	12.5	17.4	24.9	1.7	0.0	1.5	0.6	5.0	0.5	32.1	4.9	2.3	23.8	0.1	2.7	2.3	6.3	3.1	10.5	25.2	1.1	8.2	1.5	5.3	8.2	0.5	30.3	8.1	5.0	0.0	6.6	0.1	0.0	2.4	9.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.6	57.4	16.6	13.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.6	0.0	1.5	1.0	0.2	7.4	2.3	4.7	8.0	1.4	1.4	2.2	4.1	1.5	3.6	3.7	2.1	2.6	0.1	4.2	0.0	1.3	8.6	2.5	5.9	9.8	3.5	0.4	17.4	1.3	4.0	1.9	3.1	3.2	0.0	4.0	7.5	0.3	5.3	1.7	9.6	6.4	6.1	0.8	1.3	5.7	1.8	2.4	0.0	7.5	0.0	9.7	0.0	2.0	1.2	5.1	5.6	8.6	0.4	3.8	4.1	0.4	2.7	1.5	13.1	2.1	1.7	2.1	5.1	10.8	14.5	1.9	0.7	2.5	2.8	5.8
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.9;intestine: 43.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 117.9;Extravillous trophoblasts: 56.2;Paneth cells: 67.5;Proximal enterocytes: 62.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 153.2;CACO-2: 50.1;CAPAN-2: 27.3;OE19: 48.0;RT4: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	15.1	0.3	1.3	4.3	1.2	2.7	12.8	1.5	2.0	7.5	2.1	31.0	36.5	0.5	0.5	33.9	1.0	5.0	0.3	1.0	0.9	2.7	4.5	1.3	0.6	1.4	1.4	0.2	5.6	7.9	5.2	8.5	1.0	3.0	17.9	0.2	13.3	1.3	0.4	12.1	43.4	1.1	0.7	0.5	11.0	0.8	1.3	0.7	3.9	0.2	2.5	15.7	15.0	1.5	0.7	6.0	0.8	0.1	2.9	0.2	153.2	0.3	0.0	0.4	0.3	50.1	27.3	0.3	0.4	0.0	0.2	13.0	0.0	0.4	0.2	0.1	0.1	0.2	1.5	10.2	0.5	0.5	0.4	0.0	0.7	0.2	0.0	0.5	0.1	0.2	0.4	0.3	0.0	7.9	0.0	0.7	12.7	48.0	1.0	0.2	0.2	0.3	0.1	53.2	0.3	0.2	1.2	23.1	0.3	10.9	7.5	0.0	1.2	0.2	0.5	0.6	0.2	0.0	0.1	0.1	0.8	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	1.3	1.2	1.5	2.0	1.0	0.9	1.4	1.4	1.0	0.7	1.3	1.5	0.6	0.0	0.0	0.0	0.2	5.0	7.0	2.8	20.5	0.0	4.6	2.9	0.4	8.6	2.5	1.8	0.0	17.6	0.4	117.9	0.0	12.1	1.4	2.9	1.1	0.8	8.4	0.0	0.2	1.8	56.2	1.5	16.3	4.2	0.0	0.5	0.4	2.3	2.7	0.0	0.2	19.3	0.0	0.0	0.7	2.0	2.5	0.3	0.0	0.0	0.2	0.8	2.1	0.0	0.1	2.2	67.5	0.7	0.2	8.4	62.6	0.8	3.0	0.1	0.0	4.7	3.1	0.2	0.5	14.2	7.0	23.9	0.3	0.0	27.9	21.6
PLEKHG7	"C12orf74, FLJ46688"	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q32Q52	12	92702843-92772455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 1.8;epididymis: 1.9;fallopian tube: 2.8"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 72.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 1.9;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SK-BR-3: 1.5"									HPA060632	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA060632: AB_2684333"	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.5	0.3	0.3	1.9	0.0	2.8	0.4	0.0	0.0	0.0	0.3	0.2	0.8	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.0	0.0	0.2	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.8	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.9	0.1	0.3	6.1	0.0	0.4	0.0	0.0	0.7	0.0	16.3	1.8	0.0	0.0	0.0	0.2	0.0	0.6	1.0	13.7	0.3	0.1	1.2	0.0	0.1	0.2	0.0	0.0	1.1	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	4.1	0.0	0.0	0.9	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.3	0.2	0.1	72.0	0.6	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.3
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533290-67589612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 158.0"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.2;BEWO: 9.7;RT4: 10.2;SK-MEL-30: 12.0;T-47d: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA047707: AB_2680126, HPA051964: AB_2681675"	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.26e-4)"	0.9	4.0	20.9	1.3	72.6	0.0	2.5	44.6	51.6	2.9	0.0	6.7	11.7	1.4	8.3	1.2	3.4	2.1	0.7	24.9	31.9	2.1	0.4	0.7	0.1	78.9	59.7	0.2	7.7	9.5	4.3	1.1	71.2	10.3	6.7	7.3	22.8	2.3	0.9	4.3	9.3	0.8	36.8	0.9	6.3	1.8	59.7	1.1	38.9	0.4	0.3	1.4	0.9	158.0	5.3	1.2	2.0	10.2	0.2	0.0	9.7	0.0	0.0	0.1	0.1	3.2	1.6	0.0	1.6	0.0	0.9	2.3	3.6	0.9	0.1	0.3	3.5	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.3	4.0	0.0	0.0	7.6	0.0	0.2	3.0	6.0	0.6	0.1	0.3	1.5	1.1	10.2	2.7	2.5	0.9	1.9	12.0	4.7	9.7	2.1	0.0	0.8	3.6	1.0	0.6	0.0	0.0	0.0	0.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	72.6	44.6	51.6	24.9	31.9	78.9	59.7	71.2	36.8	59.7	158.0	0.1	3.2	6.4	19.9	0.7	0.1	0.7	3.1	1.2	16.7	5.8	6.0	3.6	2.8	3.4	9.2	39.6	3.0	1.4	21.2	3.9	2.2	0.6	19.1	2.0	0.7	7.3	0.0	13.4	4.0	0.3	0.6	29.0	18.0	0.0	67.7	0.0	0.2	0.8	3.3	21.9	16.9	0.0	0.6	0.3	0.7	0.3	1.5	3.6	12.2	0.0	4.6	0.0	34.2	607.7	2.9	7.7	0.4	0.0	4.1	12.8	1.7	3.9	36.6	0.0	1.5	1.0	0.7	1.6	2.3	2.3	10.7	0.3	2.0	16.4	1.2
PLEKHH3	FLJ21019	ENSG00000068137	"Pleckstrin homology, MyTH4 and FERM domain containing H3"	Q7Z736	17	42667914-42676994	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 45.5;T-47d: 48.7;U-266/84: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046234	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA046234: AB_2679597"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.05e-3)"	"unprognostic (5.95e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.44e-3)"	10.3	11.1	1.3	1.9	1.6	5.2	10.6	3.7	2.4	16.9	0.3	10.6	3.8	15.3	1.6	17.7	16.8	2.8	9.5	0.6	1.3	5.5	7.8	10.1	1.2	2.2	2.4	15.1	41.3	5.2	9.3	3.5	2.0	11.2	1.1	1.3	9.8	6.5	25.8	11.9	4.8	3.6	1.1	4.4	15.6	7.3	2.5	2.5	8.5	4.9	1.2	12.0	14.4	1.2	13.7	12.2	5.7	9.3	7.0	2.9	10.3	5.2	4.7	3.9	3.7	5.7	7.4	2.0	6.1	5.9	6.6	25.1	4.1	6.7	1.2	12.8	9.0	0.9	26.6	4.9	7.6	0.2	8.7	4.8	11.0	5.1	0.8	3.9	2.7	0.8	15.5	30.1	1.7	24.6	0.7	11.0	2.1	6.9	10.8	2.1	5.6	45.5	1.4	15.1	20.4	22.1	8.1	11.1	12.0	1.3	48.7	11.2	4.0	12.2	11.3	14.2	9.3	36.0	42.9	10.5	8.9	3.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	3.7	2.4	0.6	1.3	2.2	2.4	2.0	1.1	2.5	1.2	13.4	12.8	13.1	16.3	1.7	15.6	22.9	10.3	41.5	63.2	32.4	29.7	11.3	12.8	9.4	9.2	22.9	11.3	2.1	7.6	0.0	2.7	9.8	15.5	18.4	11.2	7.7	24.4	7.0	7.6	4.4	17.0	30.5	18.3	2.5	2.9	12.8	11.8	2.2	33.7	11.3	5.8	12.2	3.5	11.3	2.7	17.7	2.4	16.0	4.7	1.0	18.0	0.0	6.6	3.9	5.6	1.7	22.6	10.5	12.4	0.7	3.2	7.0	23.1	26.3	16.0	38.0	5.1	16.6	49.4	18.6	6.2	1.8	7.7	6.4	20.0
PLEKHJ1	FLJ10297	ENSG00000104886	"Pleckstrin homology domain containing J1"	Q9NW61	19	2230084-2237704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.3;Proximal enterocytes: 372.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048989	Approved		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA048989: AB_2680590"	"unprognostic (5.11e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.03e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (1.10e-5)"	"prognostic favorable (6.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.26e-3)"	43.4	64.1	41.8	26.4	39.0	38.3	40.5	40.4	51.3	38.8	40.6	109.2	105.2	33.6	18.0	61.3	30.0	19.5	77.6	40.2	39.8	101.1	78.7	42.0	39.3	41.6	41.7	44.1	94.1	14.7	36.4	19.7	43.6	43.4	34.0	4.7	52.2	14.3	88.9	51.7	101.5	12.2	40.2	61.4	99.7	68.0	45.3	27.8	69.2	33.2	24.0	40.8	39.7	38.8	93.9	38.2	68.2	83.0	21.8	28.3	40.3	51.6	24.1	54.1	48.9	98.1	43.1	88.4	42.1	35.6	34.7	71.6	65.4	34.0	16.1	90.8	83.7	46.3	44.5	129.0	34.7	98.6	68.9	41.6	34.2	25.8	23.1	21.5	34.9	75.4	99.5	101.0	39.8	61.3	97.0	88.0	122.6	55.6	52.1	114.7	47.5	108.8	55.7	92.0	170.2	94.1	32.6	58.7	104.5	27.3	78.6	98.2	36.6	23.0	68.7	69.7	56.7	147.3	97.2	101.3	67.4	94.8	30.1	88.2	76.4	129.6	86.9	98.2	77.1	118.8	85.9	91.8	80.8	143.2	69.0	67.2	66.1	53.8	108.3	159.0	112.6	97.2	41.8	39.0	40.4	51.3	40.2	39.8	41.6	41.7	43.6	40.2	45.3	38.8	25.9	38.5	21.1	9.8	67.0	34.8	54.6	61.5	20.5	22.0	60.0	68.1	40.0	87.2	37.8	46.0	16.7	89.8	65.8	356.3	164.4	121.1	68.5	33.2	33.4	26.7	54.0	39.8	12.1	179.5	99.3	46.0	121.8	35.2	18.4	117.1	25.7	49.2	95.4	25.2	11.7	228.5	95.6	43.9	33.3	115.6	47.2	48.1	30.2	9.4	74.7	31.9	65.9	12.1	7.6	146.6	233.3	35.3	49.0	82.2	372.5	148.4	29.1	22.7	32.9	18.9	47.5	93.7	100.7	47.2	42.6	47.7	52.6	81.4	254.1	58.4
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"OE19: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	7.0	6.4	2.9	5.5	2.9	9.7	6.2	3.5	3.8	12.9	3.2	6.5	3.5	5.7	1.0	31.7	5.9	5.3	6.2	2.8	3.1	3.6	3.6	8.8	4.8	3.7	3.1	4.9	6.1	4.4	5.7	2.9	3.2	5.1	3.6	1.6	14.4	0.9	12.3	11.8	6.2	2.0	2.8	6.8	5.6	3.4	3.4	5.4	6.5	7.2	4.8	6.8	13.6	3.7	7.3	11.0	1.7	5.4	8.4	4.8	0.1	3.3	4.9	1.9	2.6	4.2	6.0	5.2	3.4	3.9	14.1	1.7	4.1	1.9	1.6	13.7	3.5	0.0	5.6	6.9	2.0	0.0	4.3	2.2	4.9	0.9	8.0	3.8	10.0	0.0	5.2	6.2	9.1	6.0	5.2	1.1	1.7	26.6	9.0	2.8	5.6	5.3	6.0	16.8	3.2	2.1	3.2	4.5	5.2	4.8	10.1	5.3	19.1	12.7	3.6	5.2	5.9	0.6	6.2	1.8	7.7	2.8	5.8	2.8	1.2	1.0	0.2	0.3	0.0	1.2	0.6	0.2	0.3	0.3	0.2	0.0	6.5	0.7	0.4	0.2	0.5	0.2	2.9	2.9	3.5	3.8	2.8	3.1	3.7	3.1	3.2	2.8	3.4	3.7	12.6	12.8	18.1	7.8	17.5	18.0	18.1	10.3	6.8	10.4	11.7	8.4	8.7	15.7	12.7	12.9	16.7	4.8	24.3	25.6	5.9	8.1	4.3	24.9	11.1	12.1	13.8	10.8	13.5	8.2	4.7	12.1	19.9	27.9	1.3	5.4	12.8	8.1	9.1	16.8	13.3	13.0	4.1	27.9	15.2	2.0	7.2	21.1	7.2	9.4	13.7	7.3	14.4	7.5	20.8	18.3	17.7	7.9	22.9	27.2	8.6	10.5	11.9	8.2	0.0	17.7	7.6	7.6	3.7	10.0	16.3	8.6	18.5	9.3	12.2	43.1
PLEKHM2	KIAA0842	ENSG00000116786	"Pleckstrin homology and RUN domain containing M2"	Q8IWE5	1	15684320-15734769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032304	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA032304: AB_10670964"	"unprognostic (3.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.36e-8)"	"unprognostic (4.01e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (5.50e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.89e-2)"	40.2	37.7	72.3	23.0	76.1	66.2	32.3	63.5	121.9	33.4	44.6	32.4	16.3	32.0	7.6	40.5	27.0	22.0	61.3	78.4	57.2	26.3	20.6	46.9	26.4	65.3	63.3	33.3	27.7	24.6	26.8	22.8	63.8	29.5	9.0	8.2	27.2	15.2	136.0	47.6	27.8	17.1	60.0	42.9	28.3	35.6	70.6	18.9	28.2	62.9	17.4	32.3	34.6	85.9	43.1	25.5	24.4	42.7	56.8	45.3	26.5	36.3	58.9	45.1	41.4	35.0	37.7	23.9	37.8	55.8	45.6	25.2	19.0	40.9	17.2	46.4	33.2	29.5	43.3	27.3	59.9	25.0	32.5	52.2	45.2	47.0	53.2	51.9	34.2	39.6	35.8	63.0	23.3	33.5	28.5	25.9	18.6	14.4	21.1	38.7	21.3	32.3	22.1	18.7	25.3	34.5	40.7	24.1	99.1	16.6	16.3	37.8	38.8	62.3	29.0	62.7	27.5	31.9	23.2	29.7	53.7	39.7	38.7	0.3	2.8	1.8	1.8	2.8	1.4	2.1	1.2	0.7	2.6	2.4	1.5	1.2	3.0	1.1	3.3	2.1	0.8	1.5	72.3	76.1	63.5	121.9	78.4	57.2	65.3	63.3	63.8	60.0	70.6	85.9	25.6	16.0	16.0	28.7	15.5	24.9	11.7	8.8	3.4	28.4	14.2	14.2	26.6	8.6	7.8	16.5	22.9	7.8	16.8	16.6	1.9	13.1	31.6	15.1	26.1	18.9	11.3	2.5	27.2	17.8	8.9	23.3	14.3	25.7	18.4	25.5	26.7	11.6	37.2	28.6	25.8	15.4	6.1	38.9	20.9	24.5	20.5	36.9	8.8	23.4	14.5	28.4	3.1	16.6	17.6	23.4	14.7	18.0	8.7	19.2	10.5	6.8	8.9	21.1	0.0	27.4	18.7	18.4	6.0	15.9	36.1	24.6	11.8	26.1	12.2	23.9
PLEKHM3	"DAPR, PLEKHM1L"	ENSG00000178385	"Pleckstrin homology domain containing M3"	Q6ZWE6	2	207821288-208025527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 99.1;Inhibitory neurons: 70.5;Microglial cells: 36.5;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035046	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"HPA035046: AB_10603128"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.86e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.33e-2)"	2.9	4.1	2.3	1.3	2.6	4.3	2.4	0.4	2.9	2.7	0.0	3.1	0.9	2.5	0.9	1.6	2.0	1.4	2.9	2.8	2.1	1.9	3.1	2.9	1.5	2.0	2.6	3.1	2.2	4.0	2.5	1.4	2.2	2.5	1.5	8.3	2.2	1.4	2.4	2.6	1.9	1.9	0.2	1.9	2.2	1.7	1.3	2.2	3.6	1.6	1.4	1.9	2.5	2.0	0.7	0.7	1.6	0.9	2.7	2.7	2.5	1.5	1.6	1.2	1.1	0.9	0.7	0.6	1.5	1.8	1.2	0.8	1.7	2.2	1.6	1.2	2.6	1.3	2.2	1.3	1.6	1.4	0.7	2.2	2.6	1.3	1.6	1.9	1.3	2.1	0.8	1.7	1.5	0.4	1.7	0.9	1.6	0.5	0.8	1.3	1.4	1.3	0.6	0.9	3.5	1.8	1.4	0.1	1.5	2.7	0.4	1.1	1.8	1.9	1.1	1.1	1.0	2.0	2.4	0.6	2.2	0.8	1.4	1.3	0.8	0.4	0.9	0.3	0.3	0.9	0.8	0.8	0.7	0.6	1.0	0.8	2.6	0.9	0.7	0.7	0.5	0.2	2.3	2.6	0.4	2.9	2.8	2.1	2.0	2.6	2.2	0.2	1.3	2.0	6.3	19.2	21.7	29.0	2.7	0.0	0.2	0.1	0.6	3.1	4.1	3.7	1.2	1.5	5.6	1.8	12.5	0.3	4.1	1.2	0.0	3.1	2.5	4.1	6.3	2.3	0.0	4.0	99.1	3.4	0.5	3.0	2.0	4.7	0.0	25.0	0.4	0.6	0.6	6.7	70.5	0.1	0.0	1.0	2.4	5.2	0.3	3.8	0.0	36.5	4.6	2.3	0.0	45.2	86.9	3.5	1.6	0.0	2.0	0.2	1.1	4.9	0.8	9.6	0.0	1.7	3.8	0.4	0.7	1.1	0.1	0.1	2.5	6.9	0.5	0.1
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966482-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.9;skin 1: 46.0;vagina: 24.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 29.6;Pancreatic endocrine cells: 38.5;Prostatic glandular cells: 37.9;Squamous epithelial cells: 19.2;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 15.1;HaCaT: 26.0;SK-BR-3: 16.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	1.6	0.0	0.7	0.1	0.4	1.7	0.0	0.1	11.5	0.0	0.6	0.9	0.4	0.3	54.9	0.9	0.7	0.2	0.0	0.0	2.1	0.9	1.1	0.3	0.0	0.0	0.1	1.1	0.5	0.3	0.4	0.0	3.6	0.1	0.0	10.2	1.2	2.1	46.0	0.8	0.1	0.0	1.2	2.0	0.4	0.1	0.1	0.7	0.0	1.6	7.5	24.2	0.0	15.1	1.4	0.0	1.0	0.1	0.7	2.5	6.8	1.7	4.1	1.1	2.0	11.3	0.0	3.2	3.0	5.7	26.0	0.2	4.5	0.7	5.0	1.0	0.0	5.6	3.3	0.6	0.3	0.2	0.2	3.8	2.9	1.6	3.7	0.5	0.0	0.3	4.0	0.2	8.3	0.0	0.3	0.5	2.4	11.0	0.1	0.0	5.6	4.3	4.2	0.1	0.1	7.5	16.6	1.0	0.4	3.2	0.0	3.2	5.3	2.3	0.5	4.6	3.2	0.1	0.1	6.8	2.5	3.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	1.1	0.0	1.9	4.6	29.6	5.0	1.8	0.5	3.8	1.8	0.9	0.0	6.4	0.0	0.0	7.1	1.0	1.9	0.0	13.8	0.0	3.0	1.1	0.7	0.0	0.0	0.0	14.0	2.0	0.9	3.1	8.2	0.0	0.0	0.7	0.3	1.1	3.3	0.0	0.0	8.2	0.3	1.4	0.0	0.0	0.9	1.8	0.0	1.9	0.2	0.0	0.0	0.0	38.5	3.3	0.0	2.5	37.9	0.0	0.1	5.2	0.2	0.0	0.2	1.0	0.0	0.7	19.2	17.3	9.9	2.8	0.0	0.1	52.9
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 103.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040055	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	37.9	31.8	23.1	30.5	26.9	52.0	22.7	25.0	25.0	17.0	16.7	23.6	10.0	19.8	5.7	13.9	22.4	26.0	16.5	21.7	24.4	14.2	11.8	42.2	34.3	31.8	26.2	14.9	8.2	7.4	10.3	25.4	26.6	17.4	7.8	14.4	9.9	13.9	5.8	10.6	17.8	22.9	27.6	103.2	16.3	8.3	28.0	16.0	29.9	8.2	21.1	25.8	16.7	25.5	6.5	4.2	7.9	7.8	68.0	38.8	18.4	18.5	27.4	19.2	19.6	5.1	4.0	17.1	9.5	37.7	19.5	2.2	9.0	7.4	11.2	26.6	2.7	17.2	1.9	6.0	52.2	19.4	24.7	28.3	6.5	24.0	7.8	16.6	27.0	3.5	5.2	59.5	25.9	1.9	4.1	20.9	15.0	3.2	3.7	14.9	19.0	12.2	3.1	4.4	0.6	6.7	7.7	2.6	25.4	12.9	2.7	26.1	35.3	14.8	13.4	14.1	7.8	22.0	37.1	5.8	16.0	24.8	8.8	22.2	43.2	25.6	13.2	52.3	11.9	9.8	7.4	12.2	27.1	6.8	3.1	6.5	77.3	7.0	73.0	3.1	10.7	36.0	23.1	26.9	25.0	25.0	21.7	24.4	31.8	26.2	26.6	27.6	28.0	25.5	24.9	0.0	5.6	17.3	9.1	5.6	2.3	2.3	0.6	0.6	6.4	8.3	3.6	2.8	2.4	9.2	0.0	4.2	15.9	0.5	3.9	2.4	5.0	1.4	5.9	26.1	0.0	2.1	0.2	1.5	5.9	8.6	0.5	2.3	18.4	2.5	34.2	2.1	63.2	0.0	0.2	0.3	4.1	52.3	24.3	2.9	18.3	46.5	14.2	8.4	18.9	56.8	16.5	2.5	2.7	2.0	0.0	25.6	2.7	3.5	0.0	2.2	2.1	3.8	13.1	10.2	5.9	0.9	2.3	1.9	4.4	6.0	10.5	4.6	0.4	3.4
PLET1	C11orf34	ENSG00000188771	"Placenta expressed transcript 1"	Q6UQ28	11	112248153-112260860	"Predicted membrane proteins"	Differentiation			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Excitatory neurons: 1.7;Inhibitory neurons: 2.0;Microglial cells: 1.0;Oligodendrocytes: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.8"	HPA040237	Uncertain					NA	NA						"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA040237: AB_10793960"								"unprognostic (8.70e-2)"		"unprognostic (1.75e-1)"			"unprognostic (8.51e-3)"	"unprognostic (5.19e-2)"				0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.2	0.1	0.6	0.3	0.3	0.4	0.1	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.1	0.2	0.3	240.9	2666.4	0.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
PLGRKT	"AD025, C9orf46, FLJ14688, MDS030, Plg-RKT"	ENSG00000107020	"Plasminogen receptor with a C-terminal lysine"	Q9HBL7	9	5357971-5437925	"Predicted intracellular proteins"	"Chemotaxis, Inflammatory response, Plasminogen activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 244.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 247.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008214, HPA011144"	Supported		Uncertain	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008214: AB_1078363, HPA011144: AB_1078364"	"prognostic favorable (5.56e-4)"	"unprognostic (5.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.09e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	18.9	17.9	9.6	20.2	10.5	13.6	25.4	10.3	13.8	18.1	15.3	41.2	44.1	12.3	27.7	20.3	19.8	15.6	33.6	9.5	10.1	33.4	21.6	14.6	23.9	10.3	9.8	10.0	12.5	19.9	10.4	15.0	10.7	17.4	46.8	15.8	16.7	13.5	58.6	16.4	36.3	17.3	10.6	14.5	20.0	4.8	9.8	35.3	24.8	37.1	22.7	17.6	12.8	11.1	54.8	15.4	31.8	23.0	20.0	27.7	0.1	26.2	29.0	22.1	25.5	0.2	24.2	12.4	13.7	19.8	32.7	12.6	21.9	72.0	46.1	247.5	14.0	97.6	12.5	17.4	43.3	29.8	22.4	30.6	25.8	20.6	42.0	18.9	32.2	41.0	5.5	86.2	54.3	12.0	32.1	33.6	20.6	44.5	8.9	20.1	15.6	39.6	50.6	11.4	25.1	32.7	26.0	40.6	50.6	22.5	32.8	41.4	23.1	28.0	34.8	24.7	51.7	16.4	25.3	25.6	48.6	18.6	16.1	244.3	18.8	38.3	43.0	25.5	54.0	48.9	53.7	56.7	27.6	42.9	51.1	51.2	22.8	52.7	17.9	44.3	74.9	44.0	9.6	10.5	10.3	13.8	9.5	10.1	10.3	9.8	10.7	10.6	9.8	11.1	27.8	12.8	25.5	25.5	22.0	26.4	23.4	144.2	27.3	11.8	56.9	58.7	58.7	22.8	49.7	22.0	0.0	88.6	23.1	139.2	109.5	82.5	0.8	39.6	28.1	21.2	26.5	25.2	18.8	51.1	108.7	25.3	20.9	22.0	90.7	14.6	15.0	27.5	82.8	10.1	26.7	124.2	83.4	21.7	35.6	1.9	16.4	33.0	33.8	21.5	84.3	24.4	24.7	20.1	40.5	82.7	157.2	19.9	23.0	27.3	191.3	76.8	52.6	15.1	0.0	26.0	33.2	21.2	13.7	41.1	30.3	65.8	33.0	23.1	106.1	24.0
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 956.3;breast: 463.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	956.3	11.3	12.0	3.5	14.8	0.3	463.0	7.4	10.6	1.4	5.3	9.3	0.5	0.7	0.4	1.3	1.4	6.6	10.4	10.0	10.3	2.7	40.8	0.7	1.7	6.9	11.5	2.1	6.1	0.2	1.3	0.2	7.8	2.6	3.7	0.6	20.8	0.6	9.5	16.0	13.9	1.5	6.6	1.0	5.5	13.2	10.6	2.3	5.3	17.3	0.1	7.9	3.1	8.2	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	14.8	7.4	10.6	10.0	10.3	6.9	11.5	7.8	6.6	10.6	8.2	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 621.3;liver: 905.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 743.3;Hepatocytes: 527.0;Syncytiotrophoblasts: 1815.2"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 776.5;eosinophil: 581.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 776.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 2345.1;HHSteC: 2025.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	621.3	127.5	15.4	44.8	18.1	119.3	460.1	15.9	47.2	96.4	17.4	51.5	186.1	56.1	13.6	20.5	60.0	71.2	215.5	15.8	16.2	169.4	905.1	126.3	38.4	18.9	17.9	44.2	29.6	18.8	34.4	155.9	20.2	30.5	23.2	13.1	47.3	27.9	435.5	103.1	164.3	35.4	15.6	43.9	44.3	24.3	54.5	33.8	32.4	127.4	32.4	107.6	61.9	21.5	0.5	35.0	39.3	28.9	2345.1	318.3	434.8	113.5	87.6	67.7	76.5	54.1	8.3	0.4	2.0	232.9	432.1	4.7	39.1	0.3	115.1	146.9	0.8	191.8	5.4	205.2	2025.0	23.3	336.2	338.2	39.7	165.7	0.4	54.4	84.8	0.1	35.3	40.6	266.2	10.0	53.5	79.4	52.6	1.1	69.5	127.0	18.4	1.3	0.2	133.2	3.0	64.7	52.8	13.2	113.6	49.6	27.0	50.8	134.1	0.1	20.6	105.6	0.5	24.4	26.7	76.2	0.6	39.0	10.9	776.5	111.0	581.9	80.7	149.5	69.9	23.6	69.8	57.9	63.8	25.8	67.3	57.6	6.7	17.2	169.0	7.9	74.7	106.5	15.4	18.1	15.9	47.2	15.8	16.2	18.9	17.9	20.2	15.6	54.5	21.5	280.4	19.2	51.4	7.5	43.9	206.2	507.2	69.5	42.1	2.4	213.3	24.1	62.3	91.5	62.1	12.9	0.0	173.6	77.5	43.3	27.4	105.6	3.6	83.5	188.1	91.2	14.9	78.5	0.6	16.0	743.3	182.0	24.5	232.5	422.1	8.1	94.9	527.0	410.7	11.8	0.8	26.1	26.4	214.1	81.1	12.3	39.7	277.1	87.2	10.3	50.2	44.4	30.9	3.5	2.6	37.4	45.7	69.2	45.3	109.0	382.5	267.9	16.9	4.8	13.1	36.1	68.8	8.0	25.9	12.3	108.5	1815.2	123.3	21.4	44.3	263.3
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867694	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Supported	"Lipid droplets"		NA	Yes		11000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	30.8	69.9	23.3	41.4	39.6	70.8	29.5	44.2	27.5	50.4	25.9	37.6	70.8	22.6	14.4	124.7	22.9	34.5	25.3	22.1	28.6	38.0	26.5	25.7	29.1	51.1	36.1	40.0	20.3	9.8	9.3	33.3	48.9	28.0	20.9	1.7	45.9	21.0	112.0	87.5	73.9	23.9	36.2	32.3	28.5	34.3	39.1	28.0	24.8	36.4	33.0	37.5	55.4	66.0	138.2	79.1	53.6	50.5	59.8	189.8	24.1	196.8	178.9	152.0	142.9	52.6	124.9	72.5	43.3	242.2	82.1	61.3	25.1	108.2	88.2	82.7	35.4	79.1	43.0	97.8	41.4	56.7	112.9	147.1	46.2	107.4	23.6	90.5	81.2	23.5	122.4	31.3	192.1	57.1	78.3	72.9	42.5	63.3	127.7	136.2	74.9	40.2	133.8	31.7	2.3	26.3	62.5	55.5	49.5	43.2	70.4	125.9	125.1	83.3	80.5	333.8	102.9	44.1	58.9	50.8	250.7	79.6	97.3	128.3	141.7	64.8	13.8	100.4	14.6	46.3	24.7	15.9	109.1	36.3	19.4	12.4	173.9	39.5	76.7	82.8	34.1	86.4	23.3	39.6	44.2	27.5	22.1	28.6	51.1	36.1	48.9	36.2	39.1	66.0	19.2	19.2	25.6	5.5	28.5	142.2	62.9	58.8	90.0	0.4	108.0	43.1	2.3	14.3	51.3	11.0	2.1	152.2	34.4	169.7	37.2	114.7	9.7	65.2	50.9	27.7	40.7	18.5	0.8	86.8	77.3	62.9	33.1	78.4	55.8	112.9	26.0	18.2	101.2	0.0	1.1	67.0	28.5	57.8	103.4	14.0	35.8	74.7	55.2	2.8	62.3	23.9	15.5	5.0	17.1	243.4	223.0	53.0	37.1	39.3	268.8	38.8	65.2	0.7	52.6	37.8	66.2	75.1	14.6	109.0	229.3	194.8	20.3	193.4	54.8	69.2
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 764.9;breast: 316.5;skeletal muscle: 249.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.3;Astrocytes: 12.1;Cardiomyocytes: 35.9;Hepatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"ASC diff: 249.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		55000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	764.9	3.9	8.5	6.4	9.4	2.7	316.5	8.0	5.1	8.8	2.5	70.7	2.3	28.7	2.0	9.6	18.5	8.5	112.8	5.0	6.7	7.6	87.1	3.4	0.8	9.8	9.7	21.8	24.7	0.1	4.4	0.1	7.3	13.4	3.9	0.2	22.6	15.1	249.9	16.3	18.9	20.4	8.5	4.9	25.1	2.7	11.1	0.9	4.1	163.4	0.2	34.3	7.2	7.1	0.1	0.4	0.1	0.7	249.6	1.6	8.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.4	0.0	1.2	0.1	0.0	1.8	0.0	0.6	0.3	0.0	0.1	1.4	3.6	0.1	0.1	8.1	4.7	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.2	0.3	0.1	5.7	0.3	0.0	0.2	0.0	29.7	0.1	0.4	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	9.4	8.0	5.1	5.0	6.7	9.8	9.7	7.3	8.5	11.1	7.1	12.3	0.0	7.2	12.1	0.2	0.3	1.2	0.4	0.6	0.3	0.9	3.9	35.9	7.2	2.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.3	1.6	0.4	1.0	0.0	0.0	0.3	1.5	0.3	1.7	3.6	0.6	0.0	1.0	7.5	30.6	0.1	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.5	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.9	0.9	0.0	6.6	5.9	1.8	0.5	0.4	0.3	0.3	0.4	0.1	0.3	0.3	1.9
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.0;lymphoid tissue: 43.9;testis: 33.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.3;Early spermatids: 123.7;Erythroid cells: 38.3;Extravillous trophoblasts: 55.9;Spermatocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 5.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051638, HPA053229"	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	1.4	1.5	2.3	13.4	2.3	32.0	1.5	2.5	3.2	2.3	2.0	9.6	10.4	1.2	0.4	13.9	1.0	1.4	1.0	2.3	2.1	1.4	1.9	1.9	27.8	2.3	2.3	1.3	1.1	0.2	1.2	6.4	2.2	1.2	10.1	1.2	2.4	0.3	1.0	5.7	9.2	4.0	2.0	9.1	6.2	33.1	2.5	43.9	0.9	0.4	30.0	2.8	4.0	2.8	199.9	207.5	166.2	90.9	5.2	11.7	92.8	111.0	74.5	172.5	127.0	184.3	131.0	99.1	56.3	76.5	90.1	112.8	229.5	93.5	206.1	139.5	128.0	125.2	163.4	257.1	1.7	147.5	133.7	4.8	5.2	124.7	125.2	21.6	127.9	127.5	200.7	133.9	134.8	187.8	139.8	151.4	189.5	82.1	103.5	217.2	111.7	160.0	49.3	43.9	94.3	65.3	126.8	88.9	55.8	94.4	114.4	92.1	65.1	82.7	102.7	79.9	194.1	93.2	156.8	173.6	69.3	127.7	137.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.3	0.0	0.0	0.0	0.4	0.9	0.0	0.0	5.6	1.4	2.3	2.3	2.5	3.2	2.3	2.1	2.3	2.3	2.2	2.0	2.5	2.8	0.6	3.2	0.0	3.3	7.6	1.3	1.2	6.5	0.0	1.4	1.7	2.3	0.6	0.0	1.4	0.0	4.2	32.3	0.4	5.5	0.0	0.8	123.7	3.4	1.3	2.5	0.0	38.3	3.1	0.8	55.9	4.7	10.2	1.8	1.3	19.9	3.3	1.1	20.8	0.0	2.3	7.3	4.1	6.9	3.2	13.9	1.2	7.2	0.0	2.8	0.4	1.1	0.0	1.5	2.3	1.2	0.3	0.7	23.0	2.0	1.5	0.1	1.3	1.3	0.0	2.3	6.1	79.5	13.5	12.2	1.8	3.8	2.5	1.2	17.9	2.0
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 9.1"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1060.6;T-47d: 396.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	24.3	8.4	25.6	7.4	35.7	9.3	40.6	6.4	31.2	37.9	16.4	11.8	9.3	29.0	9.3	35.5	21.0	32.1	54.7	44.4	10.4	15.7	31.1	32.3	7.2	8.1	12.3	19.3	23.4	5.9	6.3	47.6	8.4	17.7	14.6	2.1	42.9	10.5	7.4	47.3	12.9	26.6	7.3	83.6	10.4	38.1	11.8	7.2	18.0	13.6	7.6	29.8	32.1	16.8	131.1	115.6	38.3	3.1	19.9	31.9	15.1	27.1	44.8	86.3	49.8	8.6	112.1	0.0	176.3	95.2	208.3	159.8	1.7	61.5	75.6	0.3	3.5	0.0	50.8	9.7	106.1	0.6	3.6	18.7	82.0	33.3	90.9	1060.6	175.4	0.0	0.1	4.4	169.8	47.5	0.3	0.2	7.6	12.4	18.5	6.3	106.5	0.0	221.6	25.4	2.3	5.1	82.4	16.0	76.0	66.1	396.9	2.0	231.9	24.3	63.8	11.0	217.8	0.1	0.3	0.3	18.8	0.3	110.7	2.2	0.5	1.9	0.1	1.2	0.0	0.8	0.5	0.0	2.2	0.6	0.9	0.4	1.5	9.1	0.5	1.5	0.4	0.4	25.6	35.7	6.4	31.2	44.4	10.4	8.1	12.3	8.4	7.3	11.8	16.8	144.6	19.2	15.8	5.9	23.4	141.7	194.1	116.1	380.7	3.8	108.5	203.7	128.9	30.0	134.9	18.4	4.2	66.5	22.7	66.3	9.8	109.8	10.9	132.7	67.8	178.7	84.3	2.7	44.3	77.9	257.3	107.8	136.6	165.4	9.5	4.1	89.3	7.7	14.9	0.0	22.8	39.9	124.1	8.1	19.3	5.0	12.8	39.5	24.9	15.9	3.2	3.3	0.0	3.5	4.9	103.2	44.6	10.9	8.2	76.1	38.5	5.5	31.6	2.9	0.0	74.0	106.6	65.1	10.4	184.9	103.4	129.8	21.2	7.4	45.6	63.1
PLK3	"CNK, FNK, PRK"	ENSG00000173846	"Polo like kinase 3"	Q9H4B4	1	44800377-44805990	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060318	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA060318: AB_2684252"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.78e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	13.6	6.4	3.2	10.7	3.6	13.8	8.9	4.0	5.3	8.7	8.1	4.9	3.3	8.1	2.8	19.2	7.4	17.3	6.3	3.6	6.0	5.8	7.1	12.9	9.0	9.3	7.1	6.6	8.9	7.1	7.5	6.7	6.7	5.6	2.9	0.4	6.7	3.3	2.8	16.1	6.5	4.9	5.8	7.7	5.4	2.1	5.4	5.4	7.3	2.4	5.8	18.0	8.7	7.2	7.2	4.1	6.6	3.4	4.7	15.0	12.3	15.7	20.8	5.9	5.8	2.5	9.9	8.1	6.5	12.9	18.7	6.5	3.7	21.4	3.2	13.5	0.7	9.1	2.6	6.2	22.5	2.9	11.7	11.8	12.3	17.4	16.1	20.0	17.8	3.0	4.9	3.6	13.0	4.6	6.2	2.7	4.5	4.0	5.5	7.8	4.3	13.3	20.3	2.4	5.0	3.2	4.5	8.3	17.6	10.1	0.6	2.8	23.3	3.6	9.4	7.5	9.7	9.5	4.7	2.8	8.0	5.2	7.2	0.0	4.0	1.0	1.9	5.9	2.1	1.4	11.6	4.7	5.0	1.2	12.4	5.8	4.7	0.8	6.3	2.0	14.0	4.4	3.2	3.6	4.0	5.3	3.6	6.0	9.3	7.1	6.7	5.8	5.4	7.2	55.7	12.8	35.1	1.3	32.2	44.1	60.5	23.3	32.5	7.1	58.4	33.7	3.4	32.9	15.8	5.5	2.1	19.0	32.2	77.7	0.0	18.3	0.8	41.9	27.6	43.5	53.0	2.7	3.6	13.0	22.9	36.7	109.6	67.5	78.7	12.0	32.5	6.7	36.9	6.7	6.3	53.0	2.0	37.7	60.3	0.7	9.9	72.5	12.4	10.3	9.8	7.4	1.0	1.5	2.0	24.3	116.8	5.3	31.4	25.8	47.3	3.3	14.7	10.2	26.3	58.5	30.5	2.5	4.5	37.2	33.5	59.2	65.2	17.0	46.3	58.9
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	"Polo like kinase 5 (inactive)"	Q496M5	19	1508023-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.1;cervix: 9.6;testis: 7.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Leydig cells: 36.4;Muller glia cells: 9.4;Peritubular cells: 67.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enhanced"	"Detected in many"		"cerebellum: 16.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 42.0"	"Group enriched"	"Detected in many"	5	"cerebellum: 36.9;cerebral cortex: 10.6;hippocampal formation: 13.9"	HPA035024	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA035024: AB_2674418"	"unprognostic (4.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.69e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.01e-4)"	0.1	0.2	4.4	0.0	2.2	0.4	0.5	16.1	4.8	9.6	2.2	0.4	0.1	2.9	2.1	0.6	2.5	0.0	0.1	6.5	0.6	0.1	0.1	0.0	0.1	0.4	1.2	0.5	0.1	0.1	0.8	0.0	1.2	0.9	0.0	0.6	0.2	1.0	0.2	0.4	0.2	1.0	0.1	0.0	0.1	7.2	1.3	0.0	0.1	0.0	0.0	0.1	3.7	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.2	0.1	0.2	0.1	0.0	4.4	2.2	16.1	4.8	6.5	0.6	0.4	1.2	1.2	0.1	1.3	0.7	0.3	0.0	0.0	14.7	0.0	0.1	0.1	0.0	0.6	2.7	0.9	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.1	0.0	0.0	2.4	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.0	36.4	0.4	1.8	0.0	0.0	9.4	0.0	1.0	0.3	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.1	1.9	0.4	0.1	0.1	0.0	0.1	0.0	0.1
PLLP	"PMLP, TM4SF11"	ENSG00000102934	Plasmolipin	Q9Y342	16	57248547-57284672	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 844.1;choroid plexus: 1086.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 161.5;Glandular and luminal cells: 134.3;Oligodendrocyte precursor cells: 140.2;Oligodendrocytes: 193.4;Pancreatic endocrine cells: 119.0;Proximal enterocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"naive CD4 T-cell: 14.5;naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 14.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.8;Hep G2: 81.1;OE19: 79.6;RPTEC TERT1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041862	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA041862: AB_2677712"	"unprognostic (7.96e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (2.06e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.32e-2)"	14.5	2.8	549.6	2.3	673.5	2.3	12.1	352.7	646.8	24.6	1086.0	10.5	33.5	6.3	2.4	34.3	22.6	27.4	8.4	489.4	603.1	41.0	9.8	50.7	2.4	769.3	601.6	3.0	52.5	14.8	4.4	2.6	775.8	12.8	12.6	2.0	41.9	27.9	3.8	99.5	33.4	2.4	689.1	19.6	79.8	6.2	844.1	1.1	12.8	6.3	4.9	9.6	26.1	779.6	1.6	5.7	7.1	1.4	0.0	0.1	3.6	1.1	0.3	0.4	0.3	15.9	6.8	0.5	27.8	0.0	1.8	5.2	3.3	5.0	0.1	1.6	2.7	7.3	3.0	81.1	1.0	0.7	1.8	0.2	1.2	0.1	0.6	3.6	8.0	1.7	1.3	1.9	0.1	2.0	0.9	1.8	5.9	79.6	2.3	0.9	1.3	1.4	33.5	17.1	1.6	2.8	1.9	2.2	3.3	2.2	11.7	2.2	6.0	1.2	1.6	1.0	1.3	1.4	1.7	0.9	1.6	0.5	4.7	1.7	1.0	0.7	0.8	0.5	0.6	0.7	2.2	0.6	0.2	1.2	14.5	5.7	1.8	0.6	0.5	0.5	0.6	2.2	549.6	673.5	352.7	646.8	489.4	603.1	769.3	601.6	775.8	689.1	844.1	779.6	18.4	64.1	26.5	0.3	1.4	13.9	15.9	61.4	22.8	2.7	23.8	23.6	3.2	161.5	26.4	90.1	2.1	2.2	1.8	26.6	15.6	61.3	0.9	66.9	12.4	20.5	1.2	5.3	0.5	70.2	1.3	5.1	76.0	134.3	3.8	13.4	11.0	4.2	0.7	5.0	0.7	23.7	93.6	0.8	2.2	1.5	4.7	2.1	3.6	25.3	1.3	0.5	0.0	140.2	193.4	119.0	66.8	22.2	1.3	5.8	149.9	28.6	4.0	7.7	0.0	3.6	4.0	1.6	3.3	54.2	42.8	1.1	2.4	1.2	36.1	13.3
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 236.8;Sertoli cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	58.1	34.6	46.3	35.2	51.2	16.1	41.2	48.6	56.6	65.4	46.4	47.3	37.7	65.0	30.5	21.3	51.1	42.0	71.2	44.5	47.4	45.5	78.1	44.4	15.4	49.6	50.8	54.4	39.0	36.9	29.6	83.8	52.4	34.7	23.2	10.6	75.9	40.6	40.5	27.2	35.6	78.4	44.8	31.5	35.5	11.6	52.2	7.9	34.9	41.6	12.9	42.4	36.0	53.1	112.5	91.4	51.3	239.7	343.4	190.6	39.0	330.4	436.1	170.4	287.1	105.2	71.5	63.1	339.5	367.3	125.9	93.4	75.6	115.6	115.6	66.2	78.3	34.0	136.6	137.3	212.5	21.9	162.7	234.0	59.7	206.2	81.9	573.3	305.0	14.8	97.6	30.9	180.2	71.1	5.7	58.6	22.9	115.4	131.6	25.8	100.0	141.0	98.7	24.3	19.2	77.7	137.3	97.4	164.8	80.4	48.3	55.9	298.7	190.1	141.6	236.3	161.9	71.4	123.7	38.7	425.1	75.5	316.8	0.0	40.3	2.0	17.3	34.4	3.1	1.7	3.0	8.4	32.7	3.4	1.2	6.4	35.5	5.4	32.3	4.9	2.0	22.6	46.3	51.2	48.6	56.6	44.5	47.4	49.6	50.8	52.4	44.8	52.2	53.1	19.4	0.0	7.9	9.4	3.7	7.0	8.0	22.8	8.0	5.7	17.9	17.5	18.3	8.6	8.6	11.0	2.1	39.7	8.7	14.8	3.9	30.3	1.0	11.0	62.2	33.9	8.4	3.0	4.2	9.8	236.8	47.5	17.3	24.8	0.0	20.4	36.8	37.1	46.3	6.7	5.8	12.5	4.1	26.5	8.3	2.4	44.4	16.3	10.6	15.9	17.9	7.9	15.5	3.0	9.8	22.4	15.4	24.5	19.4	8.0	41.5	16.7	4.5	3.1	105.2	77.2	47.3	0.5	3.3	7.4	5.1	33.7	5.5	37.1	16.6	3.9
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		21000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	63.1	20.1	13.4	35.6	14.5	1.1	18.6	15.1	17.2	10.2	19.4	36.2	42.2	23.5	13.4	18.2	11.4	41.5	22.1	13.3	15.1	26.1	57.3	12.9	3.8	23.1	18.1	20.5	18.7	16.5	7.9	80.6	16.3	13.2	29.9	56.6	9.5	16.2	3.0	3.9	35.0	46.8	17.8	5.4	20.1	8.5	20.6	10.5	90.0	3.9	5.5	25.7	10.0	17.6	134.5	94.3	29.0	9.5	102.5	109.6	73.2	465.5	141.6	247.7	463.0	7.2	13.4	0.0	88.8	79.5	113.1	27.8	34.0	400.5	636.0	0.6	53.5	33.3	84.3	66.9	262.5	0.1	0.6	192.9	56.5	215.2	104.1	723.8	347.7	0.1	45.1	1.8	441.6	48.8	0.3	0.6	18.5	0.3	40.0	0.2	19.2	0.6	105.0	6.5	14.5	0.5	370.3	39.4	39.9	135.1	107.5	4.2	440.4	304.2	92.2	97.8	280.7	138.9	20.9	0.5	566.5	0.4	55.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	13.4	14.5	15.1	17.2	13.3	15.1	23.1	18.1	16.3	17.8	20.6	17.6	29.1	16.0	11.4	130.9	0.4	7.0	6.4	115.1	30.1	17.1	23.7	10.2	14.3	44.3	47.0	27.6	35.5	9.2	0.3	143.7	9.8	64.5	0.5	35.4	13.8	24.3	19.8	4.6	22.8	53.1	130.6	68.1	19.9	38.7	0.0	42.7	21.0	65.2	5.1	0.0	46.4	19.5	22.4	1.0	2.5	1.2	13.1	3.0	14.2	21.5	0.7	53.8	0.0	64.3	6.0	82.4	48.8	4.9	1.3	8.9	50.5	8.2	33.0	24.7	19.7	36.9	47.2	11.0	18.0	27.5	5.5	18.7	1.0	24.5	25.1	5.6
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"melanoma: 115.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 20.3;monocytes: 22.5;T-cells: 12.6"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 695.6;WM-115: 680.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted to extracellular matrix"	NA	NA		1600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	41.9	27.3	43.6	22.9	53.2	19.6	32.8	54.9	58.5	33.3	46.8	37.8	25.7	38.9	11.7	12.2	32.5	18.8	42.6	43.6	46.3	36.3	54.1	37.5	14.6	61.1	52.3	26.3	41.8	21.5	27.1	35.0	58.9	24.2	15.3	3.9	19.4	18.6	15.3	19.1	35.9	26.0	49.4	35.3	30.0	12.9	51.7	8.0	25.3	11.8	7.5	35.2	25.2	71.9	71.7	62.4	27.1	168.2	116.2	83.9	51.4	125.5	135.9	122.7	88.6	98.0	89.0	5.6	140.2	211.4	100.7	83.0	50.0	72.0	31.2	37.8	23.8	7.2	70.7	97.3	157.6	31.5	57.4	90.8	67.6	71.6	55.4	120.2	110.9	4.6	68.4	695.6	84.2	194.5	3.4	72.1	53.5	120.5	94.9	21.8	35.1	108.3	42.0	19.1	21.2	116.0	81.1	116.2	288.1	66.8	21.9	105.2	100.5	188.1	94.9	228.1	155.0	38.5	75.9	5.2	112.4	74.2	680.2	0.0	18.1	4.4	12.6	21.8	10.9	3.7	9.3	8.3	16.5	2.2	4.1	4.5	1.8	3.6	22.5	20.3	6.7	9.5	43.6	53.2	54.9	58.5	43.6	46.3	61.1	52.3	58.9	49.4	51.7	71.9	34.1	22.4	8.7	11.1	9.7	8.9	10.8	18.9	8.0	5.7	8.1	9.1	16.1	21.5	8.7	25.8	14.6	20.4	22.0	37.6	1.9	40.2	0.6	10.8	29.9	28.5	16.2	19.1	11.9	31.6	71.6	34.2	17.9	20.5	19.7	25.9	26.7	18.3	50.1	8.4	10.8	18.0	4.1	23.3	18.3	2.1	26.1	23.2	62.2	4.7	18.9	7.7	12.3	10.1	33.4	36.1	37.8	14.7	19.7	8.0	45.8	8.8	9.3	7.3	19.7	14.3	29.8	8.9	12.4	1.9	4.8	18.9	12.5	18.4	27.3	5.2
PLP1	"GPM6C, PLP, SPG2"	ENSG00000123560	"Proteolipid protein 1"	P60201	X	103773718-103792619	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 7004.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 4822.5"	"Group enriched"	"Detected in many"	22	"glioma: 160.5;melanoma: 75.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SK-MEL-30: 241.0;WM-115: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004128	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA004128: AB_1079635"	"unprognostic (5.72e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.95e-2)"		"unprognostic (2.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-5)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.16e-2)"	7.3	15.7	2252.5	4.2	4296.1	0.1	5.4	4251.8	3472.7	17.8	1056.0	73.9	6.3	6.8	6.7	9.9	7.3	9.6	30.1	2314.1	2859.4	2.9	2.0	1.2	0.4	5976.3	3571.3	5.7	2.5	83.1	6.4	0.0	5342.5	21.1	14.9	7.5	6.7	30.0	2.4	24.4	22.4	22.7	3919.9	0.5	15.4	33.5	3592.5	3.8	3.4	6.8	0.4	12.9	21.8	7004.9	0.2	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.8	1.9	0.0	0.0	0.2	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	4.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	241.0	6.3	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.3	0.2	4.0	0.0	139.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2252.5	4296.1	4251.8	3472.7	2314.1	2859.4	5976.3	3571.3	5342.5	3919.9	3592.5	7004.9	0.5	0.0	0.0	23.8	0.1	15.9	0.3	0.0	6.2	1.7	0.2	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	9.7	0.0	0.0	13.3	0.0	0.0	0.0	188.3	3.3	0.0	0.1	0.0	11.2	0.0	0.0	0.0	5.8	3.1	7.5	0.8	396.6	17.8	0.0	30.7	0.0	31.2	4822.5	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	3.1	2.4	0.6	0.3	0.8	2.6	0.0	0.2	5.6	0.0	0.1
PLP2	"A4, A4-LSB, MGC126187"	ENSG00000102007	"Proteolipid protein 2"	Q04941	X	49171898-49175235	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 496.5;Exocrine glandular cells: 496.6;Pancreatic endocrine cells: 550.1;Suprabasal keratinocytes: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042415	Approved					NA	NA		250000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA042415: AB_10796907"	"unprognostic (1.40e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.55e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	105.1	195.8	17.3	87.6	17.6	358.6	99.8	19.8	21.3	173.6	27.0	164.1	71.0	162.0	42.7	381.7	124.4	53.2	121.0	17.3	24.4	61.3	36.6	118.6	59.9	22.7	21.9	110.3	250.8	37.5	97.4	60.8	20.4	97.8	130.5	6.2	119.3	104.7	99.0	390.6	96.2	156.6	20.2	79.1	114.6	23.3	21.7	77.9	46.8	53.3	148.0	182.8	264.3	19.7	539.1	312.8	0.4	1.0	131.6	388.9	1.6	278.2	223.5	339.9	255.4	115.2	248.4	193.5	68.1	209.2	340.7	444.1	260.5	517.4	214.5	490.2	104.2	71.4	421.1	3.1	210.0	136.0	304.2	174.7	505.6	443.5	516.5	317.6	260.9	63.0	55.1	239.6	249.2	346.0	14.9	346.2	3.3	263.6	456.2	48.9	300.1	563.8	464.6	355.1	69.4	120.6	394.4	155.6	244.4	2.6	340.6	77.0	293.7	194.4	185.4	344.6	472.4	102.2	100.6	50.9	461.3	359.7	464.4	486.8	287.7	148.7	59.9	99.8	100.7	226.4	214.3	112.8	298.5	144.8	107.8	93.4	320.0	70.5	63.7	694.2	265.8	235.8	17.3	17.6	19.8	21.3	17.3	24.4	22.7	21.9	20.4	20.2	21.7	19.7	49.3	73.7	38.2	1.0	160.8	439.7	306.0	496.5	167.9	0.4	67.8	115.4	33.3	57.2	101.9	80.9	0.0	2.7	232.0	134.6	21.5	379.6	16.4	71.8	27.8	63.7	111.7	43.1	0.6	496.6	27.2	110.4	71.9	51.1	88.7	15.4	55.3	12.8	157.5	0.0	0.7	254.9	138.4	130.3	210.5	20.3	169.9	133.3	224.1	4.7	146.4	18.9	35.0	0.0	0.6	550.1	200.3	60.9	148.5	219.5	141.8	9.4	92.9	1.1	124.9	76.1	128.7	4.2	1.4	401.0	504.9	6.4	162.7	29.6	285.2	334.1
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762595-37779768	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 101.8;Exocrine glandular cells: 49.8;Hofbauer cells: 47.3;Proximal tubular cells: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol		NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	34.2	23.1	22.2	21.2	24.3	14.6	23.3	25.3	27.1	22.1	26.8	47.2	34.5	19.2	23.3	20.2	27.5	19.1	39.2	24.0	25.0	58.5	78.2	25.7	25.0	22.8	24.9	24.7	40.3	37.4	16.2	20.1	23.7	20.2	37.9	10.9	28.3	27.8	46.4	17.0	37.3	25.9	23.7	25.0	33.5	8.4	24.5	27.4	31.8	42.1	29.0	22.9	16.1	28.6	50.3	45.4	35.1	32.0	25.9	31.1	31.6	55.2	45.8	34.7	38.9	51.6	24.3	58.4	61.9	39.9	55.5	41.4	65.4	52.5	56.6	49.9	34.3	79.4	16.4	51.7	51.6	36.8	52.5	22.9	49.8	33.0	52.0	37.6	52.3	78.3	42.8	42.1	28.7	34.8	116.4	32.4	43.0	92.8	41.9	73.6	46.6	34.8	56.5	60.0	21.5	25.1	45.4	20.0	56.8	25.4	44.2	48.6	52.1	19.1	60.7	69.8	38.1	43.3	90.9	43.0	27.4	51.8	35.0	164.3	109.6	136.1	85.6	130.0	90.0	77.8	87.8	83.6	115.2	61.9	77.0	74.3	46.9	75.9	147.4	66.5	116.7	110.2	22.2	24.3	25.3	27.1	24.0	25.0	22.8	24.9	23.7	23.7	24.5	28.6	35.9	9.6	26.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	27.8	23.0	0.0	0.0	8.1	31.3	0.0	21.2	20.0	0.0	101.8	38.2	0.0	12.8	20.7	13.5	0.0	0.0	0.0	49.8	31.6	13.9	0.0	19.6	12.6	14.8	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	11.9	0.0	0.0	0.0	0.0	33.2	0.0	0.0	1.8	0.0	0.0	82.2	13.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	12.9	9.8	17.1	0.0	0.0
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55534969	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 359.1;Endometrial stromal cells: 206.7;Hepatic stellate cells: 267.0;Leydig cells: 219.3;Prostatic glandular cells: 182.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 445.7;fHDF/TERT166: 142.8;HMC-1: 235.8;HSkMC: 171.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	172.3	78.1	51.5	42.3	59.9	0.9	140.7	63.7	59.4	88.7	59.6	118.3	47.4	119.5	39.8	42.4	73.4	167.5	117.1	49.9	56.8	104.0	67.7	56.2	32.2	62.1	56.2	29.4	35.6	49.0	27.8	37.6	64.2	254.1	65.8	9.7	32.9	61.3	70.0	57.9	79.1	108.9	62.5	31.1	70.9	21.0	58.6	15.8	112.9	81.5	24.2	128.8	63.8	72.9	9.8	24.4	7.0	14.2	445.7	51.8	9.6	21.8	61.4	11.9	27.9	16.7	17.7	10.2	20.0	142.8	31.9	6.5	25.2	12.6	13.5	6.8	20.1	1.1	9.6	21.3	70.5	2.5	235.8	171.3	25.7	17.6	10.9	23.3	19.9	9.1	0.2	27.0	24.1	6.0	6.8	5.5	15.5	1.1	20.0	2.0	11.7	0.9	46.3	79.8	8.4	5.8	21.5	4.2	13.4	28.8	15.6	1.6	24.0	4.0	6.9	17.8	15.5	16.6	7.4	11.8	15.7	1.3	19.5	0.0	0.4	4.0	1.6	0.5	1.7	6.7	5.3	3.4	2.0	3.3	9.5	7.7	0.3	3.0	0.9	15.0	2.6	1.8	51.5	59.9	63.7	59.4	49.9	56.8	62.1	56.2	64.2	62.5	58.6	72.9	359.1	6.4	9.4	0.0	9.8	0.0	51.0	0.0	10.2	4.0	8.4	45.7	0.0	21.5	5.6	29.5	2.1	3.3	5.4	61.0	5.9	25.2	44.4	10.7	206.7	112.3	1.2	5.7	0.0	28.5	11.1	115.5	11.2	18.5	27.8	4.0	267.0	48.3	12.8	1.7	0.0	20.2	0.0	12.0	0.0	21.0	219.3	8.1	0.0	0.0	4.5	16.6	1.0	0.0	0.0	30.0	24.6	88.4	13.0	182.0	49.4	29.3	2.2	5.6	59.2	89.7	49.7	54.4	17.7	10.0	0.0	4.9	11.3	3.1	12.1	42.8
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120457227-120592065	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 12.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 14.2;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.0	0.0	2.9	0.1	3.5	0.4	0.1	6.4	2.8	0.2	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	5.3	8.9	0.8	0.1	0.0	0.0	11.0	5.3	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	4.3	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.2	0.0	0.3	0.1	0.0	1.7	1.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	14.2	1.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.9	0.2	0.0	2.8	1.7	1.2	0.1	10.4	0.0	0.0	0.0	2.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.9	3.5	6.4	2.8	5.3	8.9	11.0	5.3	12.2	4.3	3.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.3	10.9	0.1	2.5	0.0	0.0	9.7	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.2	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	7.9	0.0	0.5	0.0	9.0	0.0	0.0	0.0	0.0	4.9	1.5	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662294-4665258	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.2;Late spermatids: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HDLM-2: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	3.6	6.6	3.8	6.2	4.0	1.5	7.3	7.0	5.0	5.0	8.7	9.3	10.5	4.0	12.7	7.4	3.3	4.6	2.8	4.3	3.3	5.4	18.9	3.4	8.2	3.4	3.6	4.0	17.2	7.7	4.7	7.1	3.6	16.4	9.9	5.1	7.7	4.8	1.9	8.2	11.4	3.4	3.3	6.0	11.3	5.9	3.3	6.1	7.1	1.5	8.4	5.2	5.1	3.5	8.2	8.3	8.8	10.9	6.9	7.7	8.8	5.5	7.1	4.4	5.0	2.2	5.3	7.9	2.2	5.5	10.9	10.0	6.2	7.8	4.6	99.2	5.9	15.7	8.7	11.3	6.3	5.7	11.4	8.5	6.2	3.4	7.5	5.8	6.6	8.8	2.7	8.1	5.6	8.8	5.4	15.0	8.1	8.2	2.9	5.3	0.0	6.1	7.6	9.3	22.0	11.1	6.5	5.8	3.5	10.8	8.2	12.7	7.8	3.9	3.3	5.3	3.6	1.7	6.4	2.0	6.1	4.1	3.7	6.8	4.1	3.5	3.1	3.7	3.6	2.6	5.6	4.8	4.2	3.3	9.6	6.9	1.8	4.2	4.4	3.2	8.6	4.1	3.8	4.0	7.0	5.0	4.3	3.3	3.4	3.6	3.6	3.3	3.3	3.5	2.8	6.4	2.7	0.0	2.6	0.0	2.5	0.0	2.8	7.5	4.2	2.7	0.0	5.7	1.3	1.8	2.1	18.6	2.9	9.7	1.9	11.0	82.2	2.1	3.4	3.0	10.9	2.1	0.0	13.9	2.9	2.3	7.1	5.3	0.0	4.1	4.2	15.3	6.5	3.3	0.0	7.3	0.0	4.7	0.0	46.3	2.8	1.7	0.0	0.0	3.0	4.6	3.1	0.0	0.0	10.8	6.5	4.9	1.5	7.5	13.4	2.8	0.0	4.9	0.0	1.7	1.8	0.5	1.1	4.6	0.0	10.4	3.4	3.5	5.1	3.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	4.8	9.7	10.0	1.1	11.5	0.4	4.9	16.4	13.9	6.3	1.4	9.6	0.7	6.4	0.6	2.5	5.1	2.1	91.2	10.6	9.1	4.2	0.3	2.1	0.5	11.0	10.7	8.7	2.3	1.2	4.7	0.5	11.1	4.9	0.5	4.0	3.4	2.5	210.1	1.4	3.1	2.7	8.8	2.4	3.1	5.0	11.7	0.4	1.8	74.4	0.3	6.7	4.0	11.0	0.0	0.0	2.2	11.1	11.4	8.6	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.5	2.4	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.6	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.8	0.1	0.1	0.7	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.8	0.0	2.6	0.0	0.0	1.7	0.0	0.4	0.0	0.0	2.3	0.5	0.2	0.2	0.0	1.3	1.5	1.0	0.0	0.9	10.0	11.5	16.4	13.9	10.6	9.1	11.0	10.7	11.1	8.8	11.7	11.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	1.8	2.1	0.1	0.1	0.0	1.9	0.0	1.4	0.1	1.7	1.4	0.0	1.3	0.0	0.6	0.7	4.1	0.0	0.1	0.0	0.8	1.1	0.0	0.5	8.4	0.0	0.0	0.0	0.3	0.0	1.7	5.0	2.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	2.3	0.0	3.7	0.0	7.0	3.0	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;kidney: 15.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	9.7	0.0	12.8	0.0	0.7	7.1	12.7	0.1	5.2	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.3	15.6	3.6	1.4	0.0	10.2	9.1	0.0	0.3	0.0	0.1	0.0	9.8	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.1	0.6	10.9	0.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.8	7.1	12.7	10.4	9.3	10.2	9.1	9.8	9.6	10.9	11.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 72.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 72.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	21.9	35.8	80.2	10.6	62.7	15.8	21.1	28.5	80.9	39.4	22.3	41.9	5.6	32.9	7.5	16.0	35.4	13.3	32.5	111.3	70.5	18.9	25.9	29.9	5.2	39.4	44.0	40.4	17.0	13.0	73.5	11.1	44.6	40.8	4.4	10.6	22.3	13.6	33.0	24.7	17.4	16.5	32.0	28.9	26.5	17.4	75.3	3.0	26.0	5.4	2.8	32.3	27.5	41.2	23.6	14.3	7.8	32.2	31.8	30.3	2.1	40.8	37.7	24.7	25.2	2.8	4.3	4.5	23.6	52.5	5.2	4.2	4.4	12.3	13.3	12.3	8.4	1.4	9.5	2.8	16.5	1.4	45.3	27.3	21.7	21.4	4.2	35.8	17.0	7.2	22.9	36.0	21.1	34.6	0.8	6.4	8.5	7.9	78.6	0.5	1.1	12.9	11.7	11.0	8.3	27.6	17.1	14.6	9.0	2.4	20.9	29.6	19.8	55.7	11.8	95.2	21.8	22.4	14.7	1.6	54.1	21.2	22.4	2.0	17.7	9.1	0.6	15.3	0.1	0.1	0.2	0.0	6.7	0.0	0.3	0.1	72.3	0.0	10.8	0.2	0.6	6.7	80.2	62.7	28.5	80.9	111.3	70.5	39.4	44.0	44.6	32.0	75.3	41.2	9.5	6.4	8.3	0.0	1.5	0.0	6.9	0.0	11.4	7.0	9.9	10.7	0.0	8.6	1.3	3.7	12.5	0.6	1.5	0.1	1.9	6.2	11.7	2.0	11.0	10.1	17.0	0.4	0.0	8.7	2.3	12.7	3.1	3.4	2.5	3.6	11.4	8.3	4.2	8.4	0.0	2.0	0.0	11.1	0.0	13.5	14.3	7.9	0.0	0.0	12.1	16.0	6.2	0.0	0.0	9.6	0.4	16.6	1.3	11.6	0.6	1.5	1.5	6.9	6.6	5.7	13.0	2.3	7.4	2.6	0.0	2.9	1.5	11.2	0.7	5.3
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596393-142713664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 315.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 36.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055744, HPA061936"	Enhanced					NA	NA		56000000	"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	1.6	3.9	0.8	18.8	1.3	7.4	5.7	2.7	2.2	10.1	11.7	144.2	191.6	3.3	3.1	9.6	7.7	27.7	1.2	1.1	1.4	26.7	27.5	14.8	1.7	3.3	0.3	0.9	12.2	15.7	6.2	1.5	3.2	3.1	139.1	24.9	9.1	1.9	0.9	3.6	315.6	4.3	0.3	0.9	45.8	7.5	0.4	5.9	7.7	0.9	2.9	19.6	3.7	1.4	90.0	69.2	4.8	10.4	0.7	0.0	112.3	1.7	2.3	9.4	20.1	31.7	68.8	15.2	35.8	0.1	31.9	18.9	18.8	28.7	20.0	5.5	27.0	27.2	10.2	11.4	0.9	13.0	1.7	0.1	4.7	17.8	11.4	14.8	4.5	16.4	11.8	1.7	1.1	21.0	21.4	7.0	18.9	166.4	25.9	8.7	20.3	12.7	143.6	81.7	24.1	9.7	10.0	7.0	7.8	13.3	55.6	2.2	1.2	1.1	11.3	3.5	21.3	12.7	12.6	18.1	3.2	12.8	3.5	1.9	0.2	2.6	1.5	0.2	2.0	0.3	1.8	2.0	0.4	0.3	2.2	2.6	1.8	3.2	0.2	0.5	1.3	1.0	0.8	1.3	2.7	2.2	1.1	1.4	3.3	0.3	3.2	0.3	0.4	1.4	0.6	54.5	38.0	1.3	1.6	2.9	4.1	23.2	2.8	3.4	9.7	4.2	3.1	54.3	46.8	44.1	16.7	5.8	0.7	471.4	21.5	21.8	64.3	22.2	1.8	0.7	53.9	5.9	18.7	34.0	1.9	1.1	50.0	26.8	8.9	32.3	1.1	31.5	0.6	5.0	25.2	147.9	24.4	1.6	1.0	20.5	1.2	1.4	1.8	5.6	0.8	2.8	0.0	4.0	3.1	70.2	200.5	0.0	2.8	6.8	335.1	40.6	42.2	13.4	0.0	1.2	1.9	4.6	4.1	7.6	3.3	1.4	1.8	1.3	85.2	20.7
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394842	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.0;Ductal cells: 5.8;Exocrine glandular cells: 3.6;monocytes: 2.0;Pancreatic endocrine cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA048387: AB_2680381, HPA068609: AB_2686011"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	39.5	21.1	7.4	11.0	7.5	3.3	35.0	7.0	8.5	46.2	7.2	27.1	3.1	44.5	5.9	37.4	29.4	6.5	32.0	6.8	7.4	23.5	14.4	32.8	10.5	8.5	7.3	30.5	16.7	5.6	16.4	7.0	7.6	24.7	3.4	1.2	22.9	8.0	21.2	35.2	21.9	12.3	7.4	40.7	21.9	6.1	8.1	6.4	22.8	11.1	10.5	34.8	38.1	7.7	26.7	6.6	5.7	17.2	19.4	32.8	6.8	24.1	22.1	21.3	19.3	9.8	6.6	7.3	19.4	35.1	9.0	37.6	7.0	41.4	10.9	19.0	4.0	6.7	9.2	6.0	23.6	2.5	8.2	22.6	25.4	20.7	30.1	32.0	32.3	14.5	4.1	5.6	27.1	14.3	7.7	2.0	5.1	7.1	18.3	15.1	4.3	8.3	20.1	17.7	4.7	15.6	13.9	8.8	5.9	5.0	16.0	1.3	53.2	13.9	14.5	15.7	10.3	6.2	7.4	3.0	22.4	8.4	15.9	7.0	24.5	2.8	39.5	34.1	40.8	32.2	72.8	40.7	24.1	32.5	59.2	36.1	2.6	18.0	30.2	2.8	83.5	33.3	7.4	7.5	7.0	8.5	6.8	7.4	8.5	7.3	7.6	7.4	8.1	7.7	1.0	3.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.8	0.0	0.1	1.0	1.0	0.0	0.0	0.0	3.6	0.3	1.0	0.0	0.1	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192335-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	60.2	43.8	30.2	9.4	28.2	2.3	41.9	30.9	32.5	28.9	11.6	27.4	6.8	30.1	15.7	23.2	41.2	45.6	28.0	28.7	38.5	25.3	69.0	37.4	10.5	39.3	44.0	36.4	20.5	4.3	11.2	56.4	32.6	13.8	25.2	13.7	23.6	25.8	7.4	16.1	13.6	33.7	36.9	30.1	14.4	21.6	41.8	6.6	31.2	18.8	6.7	19.8	25.5	32.2	0.0	9.9	1.7	0.0	60.5	48.2	0.3	11.5	15.7	5.0	10.9	1.0	12.6	0.0	12.3	21.0	5.0	1.4	2.4	1.1	2.8	0.1	0.1	5.0	7.9	1.3	28.1	0.1	1.3	29.6	1.6	10.4	3.0	62.1	50.8	0.0	0.2	0.9	7.4	0.3	0.0	0.1	2.1	5.1	3.4	0.0	0.8	0.0	0.1	0.0	0.6	0.0	20.1	0.1	3.9	2.5	0.7	0.6	106.4	10.4	2.6	23.6	2.1	0.3	0.0	0.0	2.6	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	28.2	30.9	32.5	28.7	38.5	39.3	44.0	32.6	36.9	41.8	32.2	77.3	3.2	10.3	151.1	1.0	10.8	5.6	0.8	12.0	0.6	10.2	8.6	4.1	25.8	6.0	3.7	0.0	0.7	0.3	27.4	0.0	8.2	1.1	3.6	11.6	63.4	10.3	15.6	1.7	11.6	0.5	57.1	2.0	1.5	1.3	7.0	110.3	44.1	0.8	0.0	0.6	11.7	0.0	7.1	11.8	3.8	42.9	1.1	3.6	40.3	0.1	51.4	0.0	61.3	0.6	4.7	13.3	32.4	2.8	2.6	6.4	28.3	6.4	1.5	0.0	18.9	23.6	1.2	0.9	4.8	8.7	0.8	1.8	20.0	8.1	2.7
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146605346	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Cell type enriched"	"Detected in single"	6	"Inhibitory neurons: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.0"	"Low region specificity"	"Detected in some"			HPA047249	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA047249: AB_2679997"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.6	0.3	1.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXDC1	"TEM3, TEM7"	ENSG00000161381	"Plexin domain containing 1"	Q8IUK5	17	39063313-39154394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 299.3;Fibroblasts: 63.8;Sertoli cells: 46.0;Skeletal myocytes: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;MOLT-4: 3.0;U-87 MG: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012805	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"			"HPA012805: AB_1857893"	"unprognostic (4.28e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.07e-3)"	"unprognostic (6.07e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (9.15e-8)"	"unprognostic (9.37e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.33e-2)"	6.3	2.8	6.7	3.3	7.9	1.1	8.3	10.0	11.6	5.3	4.6	5.2	1.8	12.6	3.8	12.2	11.5	14.3	21.7	6.0	6.1	5.5	0.6	4.2	5.4	6.8	10.4	14.9	3.5	6.7	2.8	2.2	7.8	5.4	2.9	48.4	4.1	5.1	8.1	4.2	5.3	10.8	5.1	1.8	4.5	5.7	8.3	23.1	3.1	18.4	5.3	4.0	4.6	8.0	0.1	0.0	0.1	1.4	0.2	0.0	0.2	0.1	9.2	0.6	0.4	0.1	2.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	0.5	0.0	0.7	0.2	0.6	0.1	0.2	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.9	0.0	0.6	0.0	1.1	3.0	0.3	0.3	0.1	0.0	0.3	0.4	0.4	0.0	0.1	1.4	0.1	0.0	0.2	0.0	0.1	0.2	0.2	0.0	1.1	0.6	0.4	0.2	0.1	0.0	0.1	5.9	0.4	0.1	0.3	0.1	0.1	1.8	0.0	1.5	0.1	0.5	0.6	0.0	0.1	2.1	2.2	0.4	1.1	0.0	0.9	0.0	0.8	6.7	7.9	10.0	11.6	6.0	6.1	6.8	10.4	7.8	5.1	8.3	8.0	3.4	0.0	14.9	2.9	0.7	5.2	0.9	0.2	2.8	299.3	1.6	1.8	6.9	0.0	1.9	0.0	20.9	0.1	5.4	0.1	0.0	0.0	2.2	0.2	2.4	14.4	0.0	2.7	16.6	0.2	0.1	63.8	2.0	0.3	1.3	0.2	0.4	0.2	0.1	6.7	16.3	0.0	2.0	1.3	6.9	9.1	0.6	7.9	7.2	35.6	5.2	12.2	18.6	3.0	1.4	0.1	0.0	1.2	2.0	0.9	0.0	0.1	1.5	24.2	46.0	96.1	29.3	0.7	0.7	1.2	4.4	0.0	12.1	0.4	0.0	0.5
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		10000000		"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	11.2	7.6	13.9	7.0	13.0	1.0	9.6	0.6	16.4	11.6	0.5	9.1	3.4	10.9	2.3	11.3	10.2	4.8	15.8	14.0	7.9	8.6	3.2	14.7	6.3	5.5	5.6	13.8	9.3	24.0	5.5	8.2	5.6	9.3	1.9	1.7	12.9	6.3	10.9	15.1	7.9	5.2	1.3	13.2	7.9	9.0	14.8	6.3	9.6	6.1	4.2	9.8	10.0	5.5	45.3	21.1	22.8	18.1	29.3	32.7	36.3	26.3	22.2	14.8	14.7	70.2	20.6	5.0	38.6	28.4	20.0	68.2	11.7	51.6	6.1	7.2	18.6	0.7	13.4	18.3	19.2	5.4	3.6	32.8	35.4	27.4	21.2	14.9	7.5	14.7	26.3	9.1	16.1	26.3	10.6	9.9	22.0	14.2	18.5	14.0	58.0	14.1	12.9	89.4	20.2	22.1	19.1	17.9	24.7	14.7	28.8	33.9	28.0	23.6	30.0	43.4	28.1	5.5	3.9	9.8	33.9	10.2	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.9	13.0	0.6	16.4	14.0	7.9	5.5	5.6	5.6	1.3	14.8	5.5	1.9	48.1	4.1	8.8	1.8	15.8	5.6	23.4	6.2	6.7	6.6	7.4	13.0	1.5	18.6	12.9	4.2	21.8	0.8	3.6	0.0	8.9	4.4	5.0	10.0	3.8	9.6	0.4	22.1	6.9	2.5	13.8	7.1	5.6	0.0	20.8	2.2	0.9	13.1	20.2	11.3	4.0	0.0	7.4	12.8	1.0	7.8	7.4	8.8	5.6	1.0	2.5	1.0	13.6	3.6	17.0	2.3	6.4	3.1	21.3	7.4	1.5	11.2	3.3	6.6	6.4	9.9	5.3	9.5	6.7	16.1	7.3	2.2	4.7	5.1	9.5
PLXNA2	"FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2"	ENSG00000076356	"Plexin A2"	O75051	1	208022242-208244384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 35.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 100.6;Excitatory neurons: 134.7;Horizontal cells: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.8;HaCaT: 55.4;HUVEC TERT2: 70.3;TIME: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009763	Approved					NA	NA		1400000		"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB009763: AB_2166388"	"unprognostic (8.25e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.88e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.40e-1)"	7.9	1.4	6.6	2.1	9.1	0.4	4.9	10.5	11.2	3.9	19.0	9.0	6.8	6.0	2.0	15.4	5.2	4.0	8.8	10.0	1.6	3.4	2.4	14.3	1.0	2.2	7.8	13.8	35.1	1.3	3.0	8.5	3.2	4.1	7.2	3.7	4.1	3.1	9.6	9.5	7.7	5.9	4.5	1.3	9.0	0.6	2.7	4.3	6.8	9.4	2.4	9.4	6.3	7.7	6.4	3.7	6.9	1.0	7.6	14.7	52.8	5.0	3.1	3.0	0.5	0.2	0.1	0.0	9.8	3.9	1.3	55.4	0.1	31.4	0.9	1.9	1.1	0.0	6.9	3.7	3.2	0.0	0.2	3.9	10.0	2.4	14.2	2.0	70.3	0.0	0.0	0.0	30.7	0.7	0.1	0.1	1.1	11.2	9.4	0.0	7.0	4.7	5.7	4.0	2.0	12.5	5.9	4.5	5.5	13.3	0.5	0.0	162.9	1.1	1.7	5.9	10.4	0.3	0.0	0.0	6.5	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	9.1	10.5	11.2	10.0	1.6	2.2	7.8	3.2	4.5	2.7	7.7	50.7	28.9	28.6	100.6	1.7	4.8	16.2	12.9	30.1	12.7	2.9	2.2	5.8	7.2	25.6	0.0	2.1	5.3	0.8	64.6	1.9	4.2	0.9	13.8	0.9	48.1	9.1	0.0	134.7	15.3	2.5	9.6	44.4	9.5	6.3	1.1	36.8	5.9	3.3	249.0	62.9	29.0	8.2	5.5	6.0	0.6	9.9	4.4	5.4	54.4	1.4	0.4	1.0	44.7	3.1	23.3	52.2	6.8	1.7	8.2	33.6	2.2	8.5	2.7	6.6	26.3	8.1	1.9	1.0	41.1	10.5	1.9	1.1	1.4	26.5	22.7
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.8;brain: 29.1"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 235.3;Inhibitory neurons: 261.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 29.1;hippocampal formation: 26.0"	"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 25.2;HMC-1: 17.1;hTERT-RPE1: 22.1;RH-30: 18.5;TIME: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	13.8	2.4	4.2	1.6	5.6	0.3	7.6	0.1	29.1	8.4	0.0	1.5	0.4	1.5	0.2	3.8	2.0	1.9	3.9	26.0	1.3	0.7	0.3	1.2	1.0	2.3	0.1	3.6	0.4	0.1	1.0	3.5	1.8	0.5	0.7	4.8	0.4	0.9	0.7	2.2	0.8	2.6	0.9	1.5	1.6	1.1	1.6	0.2	1.5	3.1	0.3	1.0	0.7	4.4	0.0	0.1	0.2	0.0	25.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	17.1	0.2	0.0	0.1	0.0	22.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	18.5	2.0	0.0	0.0	0.4	9.6	0.0	0.0	0.0	0.2	0.0	0.0	57.6	5.7	0.2	1.3	0.5	0.0	0.0	0.0	5.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.0	4.2	5.6	0.1	29.1	26.0	1.3	2.3	0.1	1.8	0.9	1.6	4.4	2.5	0.0	0.0	5.2	0.6	0.6	0.2	0.0	0.0	22.4	2.2	0.1	10.9	0.0	0.0	12.9	16.7	0.1	17.4	0.0	0.0	0.0	14.0	2.1	3.0	2.7	1.2	0.0	235.3	0.0	0.1	7.4	1.1	5.0	1.3	1.6	5.0	0.2	0.1	0.0	261.3	0.1	0.0	0.0	1.1	9.8	14.0	0.7	7.2	10.3	0.0	11.3	2.1	51.8	3.7	0.8	0.0	7.2	0.7	0.1	0.0	0.5	0.0	1.5	0.0	0.7	1.1	0.2	0.3	0.1	1.3	0.0	1.7	0.4	0.1	0.4
PLXNB1	"KIAA0407, PLXN5, SEP"	ENSG00000164050	"Plexin B1"	O43157	3	48403854-48430086	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.1;Oligodendrocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040586	Enhanced				"Intracellular and membrane"	NA	NA		95000000		"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA040586: AB_10794034"	"unprognostic (1.31e-3)"	"unprognostic (7.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.60e-4)"	9.0	2.8	26.6	3.3	54.5	1.0	13.7	34.3	28.6	17.1	33.0	19.5	9.7	19.5	5.6	22.9	25.3	10.3	10.4	22.0	28.3	27.6	28.9	11.4	1.6	42.9	43.9	19.1	26.0	6.1	17.9	6.8	41.5	22.9	5.4	4.2	17.3	15.8	1.7	24.6	13.0	7.5	26.5	6.5	14.7	3.9	40.4	5.0	35.8	1.4	2.0	16.3	21.4	61.0	5.5	9.2	16.7	9.9	6.1	4.9	34.1	4.6	2.6	2.6	1.7	11.3	20.7	0.0	16.6	3.2	1.7	16.3	3.6	37.0	0.5	9.7	0.7	0.0	19.9	21.5	8.9	7.5	3.1	8.8	31.5	0.6	7.5	10.1	4.3	3.7	1.4	0.8	2.5	9.5	1.3	6.5	29.7	12.0	2.0	8.4	3.6	1.3	15.6	24.5	8.5	18.4	5.9	34.6	5.3	4.4	18.5	6.2	8.5	2.6	7.8	3.8	5.3	0.3	0.0	0.2	0.5	2.2	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	54.5	34.3	28.6	22.0	28.3	42.9	43.9	41.5	26.5	40.4	61.0	3.2	35.3	24.3	121.1	0.7	11.5	15.8	26.1	32.5	2.6	23.3	31.5	17.7	30.0	27.5	46.0	2.1	23.7	0.2	36.2	5.9	18.5	4.3	54.2	9.3	5.0	52.7	3.2	1.4	15.8	2.4	7.2	26.5	41.8	0.0	11.2	5.3	59.7	2.9	3.3	2.6	21.2	30.5	3.1	1.2	5.1	15.2	1.0	1.8	4.7	0.7	24.3	0.0	21.6	70.1	21.9	21.8	15.4	0.3	11.4	21.5	12.7	56.5	5.7	0.0	6.1	13.0	1.4	2.7	22.3	9.7	9.9	1.3	0.5	28.3	11.6
PLXNB2	"KIAA0315, MM1, PLEXB2"	ENSG00000196576	"Plexin B2"	O15031	22	50274979-50307646	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 296.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 11.1;intermediate monocyte: 16.4;myeloid DC: 8.3;non-classical monocyte: 21.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	25	"dendritic cells: 8.3;monocytes: 21.2"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 306.0"	"Low region specificity"	"Detected in all"							HPA003100	Uncertain					NA	NA		78000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003100: AB_1079638"	"unprognostic (4.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (8.47e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (1.61e-2)"	"unprognostic (9.41e-3)"	"unprognostic (6.05e-2)"	28.1	42.9	12.5	31.2	11.5	14.6	25.0	43.2	14.7	38.8	61.2	45.8	45.0	44.0	7.7	48.6	50.6	51.5	20.1	9.8	12.3	42.5	33.2	40.2	22.8	21.1	22.9	49.6	47.5	22.5	33.8	35.7	16.9	40.0	16.4	9.3	53.0	45.6	7.0	50.2	50.3	20.2	13.2	74.2	87.4	18.6	16.7	7.8	53.8	3.1	15.3	33.3	41.3	15.5	77.0	125.0	58.2	78.7	35.2	43.2	98.9	104.8	55.8	36.8	36.1	87.0	102.0	59.9	114.1	86.8	22.6	145.9	10.2	77.5	9.1	10.8	50.3	11.2	233.2	64.3	79.2	2.0	54.6	67.8	117.5	39.1	29.9	64.8	30.0	0.1	15.9	14.3	38.7	132.4	1.1	21.0	15.5	45.9	31.3	64.2	97.8	18.8	39.4	237.5	29.6	53.6	103.0	306.0	22.6	16.9	119.9	72.0	64.9	76.1	112.6	39.7	37.9	8.1	1.5	11.0	60.4	3.5	101.5	0.0	11.1	0.0	0.0	16.4	0.2	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.4	0.1	21.2	6.6	0.5	7.7	12.5	11.5	43.2	14.7	9.8	12.3	21.1	22.9	16.9	13.2	16.7	15.5	15.2	64.1	54.5	33.0	6.2	22.9	22.7	70.6	23.9	15.5	48.2	40.8	15.5	62.9	94.4	136.1	16.7	3.1	11.8	172.0	3.9	93.1	9.0	87.8	33.4	24.8	49.7	2.1	13.5	57.5	29.3	28.7	296.2	72.6	5.1	43.2	21.4	58.8	36.3	13.5	9.3	77.9	40.7	46.8	38.2	4.3	24.2	49.9	14.2	24.4	45.1	54.1	2.1	4.5	1.6	117.5	111.4	19.2	4.9	54.3	110.5	36.4	154.6	10.4	26.3	18.9	35.8	2.2	2.4	34.5	25.1	6.4	4.1	48.5	56.5	45.1
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 210.2;intestine: 57.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 43.8;Oligodendrocytes: 72.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048046	Enhanced					NA	NA		390000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048046: AB_2680239"	"prognostic unfavorable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	14.7	28.8	74.4	2.0	122.8	0.7	16.0	86.1	110.8	10.8	28.7	57.2	2.3	23.6	3.9	7.0	11.9	4.9	9.6	77.4	83.0	1.8	1.1	2.8	0.5	105.0	102.2	1.8	6.5	0.2	3.1	0.4	101.5	16.6	2.0	2.4	26.3	8.5	0.8	10.0	9.3	6.5	71.3	0.7	13.6	11.5	123.9	0.1	1.7	0.4	0.3	20.8	13.0	210.2	9.3	1.1	1.1	0.7	1.2	0.7	0.7	8.5	1.7	1.1	3.0	0.0	0.1	0.0	5.4	2.4	1.6	1.0	0.0	7.2	0.9	0.1	0.0	5.8	12.0	6.6	2.3	0.0	0.6	1.8	5.2	5.2	3.2	19.8	3.4	0.2	0.5	3.1	2.3	7.6	0.1	1.4	0.2	6.3	14.0	2.8	0.9	0.1	1.4	4.2	2.4	7.5	0.4	7.8	20.2	0.2	10.4	0.0	15.0	8.6	4.4	6.8	10.9	3.0	0.8	0.2	18.6	0.5	70.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	74.4	122.8	86.1	110.8	77.4	83.0	105.0	102.2	101.5	71.3	123.9	210.2	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	6.6	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0
PLXND1	KIAA0620	ENSG00000004399	"Plexin D1"	Q9Y4D7	3	129555214-129606676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.3;Endothelial cells: 102.1;Hepatic stellate cells: 132.1;Hofbauer cells: 81.5;Kupffer cells: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 392.3;HSkMC: 286.1;HUVEC TERT2: 346.1;TIME: 414.4"	"Group enriched"	"Detected in all"	4	"amygdala: 36.6;basal ganglia: 33.1;cerebral cortex: 27.4;hippocampal formation: 26.3"	"Low region specificity"	"Detected in all"			CAB020819	Approved					NA	NA		120000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB020819: "	"unprognostic (8.97e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.93e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.00e-2)"	72.6	22.1	32.0	37.4	38.1	26.5	47.4	36.2	35.6	58.4	26.1	19.5	6.0	33.5	17.6	21.5	35.0	39.4	39.8	29.3	34.2	24.7	18.3	67.5	34.7	48.7	43.5	16.3	13.9	18.0	11.1	112.4	43.8	19.0	16.9	3.5	13.3	27.0	12.9	19.5	20.9	52.6	38.8	33.6	15.8	10.8	49.0	62.7	29.5	39.8	23.2	37.1	26.8	43.2	10.0	57.7	47.4	16.3	392.3	167.9	98.4	42.8	123.1	25.5	29.5	13.4	8.1	2.1	179.9	152.9	13.2	0.6	25.9	0.6	7.5	1.9	3.2	40.7	30.2	61.4	44.8	13.5	11.0	286.1	1.7	26.4	2.8	36.6	346.1	2.1	14.5	1.5	34.8	31.0	2.4	44.2	11.8	2.4	8.0	47.4	32.0	51.8	10.2	2.3	27.6	1.1	11.0	3.5	15.9	107.6	15.5	59.7	414.4	21.5	28.5	0.6	32.4	1.9	2.2	19.9	7.5	29.2	19.0	0.0	10.7	0.0	1.7	5.1	6.8	0.0	1.2	1.4	2.9	0.0	0.0	0.1	0.2	3.1	5.2	3.6	0.0	1.7	32.0	38.1	36.2	35.6	29.3	34.2	48.7	43.5	43.8	38.8	49.0	43.2	107.3	3.2	27.2	12.4	3.6	8.0	0.4	2.1	0.6	0.1	7.6	3.4	10.6	5.7	3.1	0.0	0.0	7.1	16.9	0.2	0.0	1.4	1.4	3.7	52.5	102.1	13.1	12.6	10.4	3.5	16.4	19.5	5.6	6.2	22.2	1.3	132.1	7.7	81.5	0.0	0.6	3.2	6.1	75.6	31.8	1.8	38.8	41.7	8.8	27.2	29.4	6.5	10.3	0.5	27.7	2.7	0.1	13.9	12.9	0.5	0.0	0.3	1.2	0.3	32.9	14.4	37.1	0.6	4.0	1.5	4.4	5.3	14.4	49.5	0.5	0.6
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146055-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	5.4	6.0	4.5	8.6	4.8	9.2	9.4	7.3	5.2	9.4	10.1	13.6	8.8	11.8	8.2	8.9	12.9	6.5	8.2	4.5	6.1	9.2	4.8	4.9	11.2	4.6	4.0	22.3	10.7	9.2	8.2	4.8	3.3	25.4	10.1	14.1	7.8	8.5	29.1	12.6	8.9	10.4	3.4	6.1	8.5	3.0	5.9	13.6	12.5	16.3	10.8	10.9	8.1	3.9	30.7	13.4	11.8	18.3	3.8	2.3	0.8	15.1	15.0	22.1	28.2	15.7	14.6	88.3	18.0	3.3	18.8	11.5	24.3	12.1	49.9	27.8	30.8	18.0	8.0	14.9	4.2	52.4	13.9	3.8	8.8	8.4	17.7	18.0	5.4	26.2	7.0	46.3	6.9	4.7	33.3	41.3	4.8	26.4	13.2	54.5	58.5	65.1	24.8	5.7	33.1	23.0	9.1	14.5	15.1	15.3	0.1	45.5	8.8	0.4	13.3	4.6	32.0	24.5	38.3	19.0	6.1	44.3	2.1	0.8	0.3	1.2	0.7	0.2	1.2	1.5	0.9	1.3	0.6	1.0	1.4	1.2	1.0	1.9	0.2	0.9	0.1	0.6	4.5	4.8	7.3	5.2	4.5	6.1	4.6	4.0	3.3	3.4	5.9	3.9	7.3	9.6	10.3	21.5	14.3	30.2	23.8	7.4	17.1	28.5	21.6	16.5	23.4	27.1	11.5	16.5	31.3	2.8	7.1	6.8	5.9	11.9	5.5	15.1	13.6	8.8	10.8	18.3	29.5	10.4	2.4	12.0	15.3	20.6	6.3	17.3	8.9	9.2	3.4	8.4	38.9	21.4	6.1	6.7	17.9	9.0	24.5	6.8	17.8	26.2	14.6	11.1	4.1	32.2	27.3	18.1	7.9	19.2	15.5	44.4	5.2	15.6	12.2	24.3	6.6	26.9	20.3	5.3	6.6	24.4	31.7	1.2	10.5	5.3	28.4	17.4
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 207.5;U-138 MG: 202.1"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	2.0	0.7	2.8	8.0	2.7	88.1	3.9	2.6	5.1	6.5	3.0	2.5	3.7	5.4	0.2	13.7	2.9	8.0	0.9	2.6	2.8	2.3	2.1	3.8	14.7	2.8	2.7	0.7	1.2	14.8	16.7	13.4	3.0	3.6	3.4	2.0	3.6	1.3	1.5	24.1	3.9	1.9	2.7	4.6	2.5	3.1	3.7	12.1	2.1	1.5	14.2	17.3	7.9	2.4	26.6	17.4	5.2	1.6	8.8	69.0	19.8	125.4	84.1	71.5	70.7	1.7	32.5	104.6	17.0	23.5	207.5	38.4	21.0	11.8	70.4	33.7	154.5	19.4	26.0	4.6	87.6	67.1	28.2	28.7	30.8	93.8	48.5	26.1	24.0	46.7	26.7	17.5	24.1	2.6	53.8	20.1	151.7	2.7	32.7	54.1	28.8	39.1	41.9	24.2	39.7	32.7	6.1	3.2	71.5	56.1	5.3	54.6	90.6	202.1	54.0	10.3	141.4	2.8	0.3	92.1	16.8	37.6	48.5	169.8	16.7	103.6	10.9	26.2	9.6	33.8	5.0	6.8	12.1	25.0	4.1	5.9	53.5	6.3	32.1	10.2	25.2	15.1	2.8	2.7	2.6	5.1	2.6	2.8	2.8	2.7	3.0	2.7	3.7	2.4	29.2	32.1	25.7	0.7	175.3	803.1	316.2	236.4	415.4	0.2	111.8	82.0	4.7	12.8	129.6	3.7	2.1	120.3	125.3	141.1	0.0	54.7	0.8	463.6	48.8	48.5	133.4	5.5	0.0	67.0	14.7	32.9	168.2	529.8	31.8	11.8	7.9	0.5	89.5	0.0	0.0	146.8	181.0	37.2	363.3	1.1	0.9	140.6	74.7	7.5	142.4	0.3	34.0	0.0	0.2	100.1	123.6	1.2	63.1	265.7	94.7	0.5	101.5	0.7	0.0	10.8	32.0	0.3	19.8	474.5	691.2	315.2	117.0	19.8	122.2	569.2
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197833	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"brain: 92.8"	"Group enriched"	"Detected in some"	4	"B-cells: 2.7;Exocrine glandular cells: 2.0;monocytes: 1.0;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 92.8;thalamus: 60.2"	"Immune cell enriched"	"Detected in some"	10	"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	85	"T-cells: 9.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 44.9"	"Group enriched"	"Detected in many"	129	"hypothalamus: 624.3;thalamus: 339.8"	"Region enriched"	"Detected in some"	34	"hypothalamus: 83.0"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	NA	NA	274000		"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.0	0.0	0.2	0.5	2.7	0.6	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	92.8	0.0	0.0	0.1	1.0	0.3	22.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.4	0.5	0.0	60.2	1.0	0.0	0.1	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	44.9	0.0	0.7	0.8	0.4	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.9	0.0	0.0	0.0	0.8	1.5	0.6	0.7	1.3	0.4	0.6	1.8	0.0	0.3	0.5	0.5	0.6	0.8	0.1	0.3	0.3	0.1	0.6	0.6	0.5	0.2	0.7	0.1	0.8	0.6	0.5	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.2	2.7	0.1	0.3	0.0	92.8	0.3	22.2	0.3	0.0	60.2	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	3.3	0.8	0.2	0.8	0.2	1.8	8.3	0.7	0.5	80.5	0.3	1.3	1.6	32.2	1.5	0.7	1.2	1.6	0.6	0.3	0.0	2.1	5.0	0.9	5.6	0.0	0.4	4.3	2.3	1.7	0.7	2.8	0.1	0.9	1.2	0.4	3.5	0.8	0.3	115.2	2.1	3.5	0.0	0.5	1.1	4.8	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.5	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 115.6;Late spermatids: 259.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons: 13.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.0;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA056716, HPA075825"	Approved		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA056716: AB_2683215, HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.7	2.2	0.4	1.3	0.9	4.5	1.5	2.5	0.8	1.8	0.5	3.2	2.9	1.7	13.5	2.9	2.0	0.9	3.3	0.8	1.9	3.0	3.1	1.6	2.0	3.5	3.9	2.6	6.5	1.2	2.7	0.6	13.3	3.6	3.3	3.5	1.7	0.3	0.6	4.4	3.9	0.3	1.9	4.7	2.6	20.9	1.0	2.4	2.1	0.0	0.5	1.8	1.9	1.4	0.2	0.4	2.8	2.8	0.0	0.6	1.9	0.6	0.2	0.6	2.1	1.1	2.8	1.9	0.4	0.1	0.1	1.8	1.0	0.1	1.4	0.2	4.3	1.9	3.7	3.1	0.0	4.2	3.2	0.0	0.9	0.1	2.1	0.6	0.8	2.3	0.4	1.7	0.1	2.4	1.1	6.8	0.8	0.1	1.2	2.9	0.2	1.5	0.3	0.8	21.0	10.7	0.0	0.0	0.2	2.0	0.5	2.7	1.8	1.3	2.2	0.6	1.4	3.9	1.5	1.2	0.6	2.8	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.9	2.5	0.8	0.8	1.9	3.5	3.9	13.3	1.9	1.0	1.4	0.0	0.0	0.6	1.0	0.3	0.4	0.1	0.1	1.2	0.9	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.0	0.2	115.6	0.3	0.2	0.3	5.4	0.8	0.7	0.2	0.1	0.6	0.0	0.1	3.8	0.3	0.0	0.1	4.7	30.3	0.7	0.7	0.0	1.9	5.5	259.5	1.2	2.4	0.0	1.0	0.0	1.1	0.0	1.0	1.6	0.1	0.1	1.5	0.0	0.1	0.2	0.6	1.6	0.2	0.0	0.0	0.1	2.9	0.9	0.3	0.0	0.1	1.0	0.0	0.9	0.2
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"PML nuclear body scaffold"	P29590	15	73994673-74047827	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	84.4	29.4	14.4	25.6	13.8	38.1	77.0	11.8	16.4	53.7	11.6	46.7	18.4	47.1	7.5	38.3	44.6	21.6	39.3	13.8	13.1	35.4	25.4	75.2	25.6	18.2	13.8	37.5	20.3	8.3	26.8	23.7	14.8	41.5	8.5	3.9	44.2	17.2	22.5	47.4	39.0	19.5	14.6	48.6	35.3	11.3	15.2	17.0	48.1	7.9	15.2	42.7	44.5	13.1	37.2	13.8	11.8	11.4	30.2	43.2	40.6	18.5	31.6	55.9	63.3	14.6	64.2	16.4	63.7	31.6	53.3	66.6	16.3	37.1	7.6	58.0	25.1	35.8	21.3	16.3	36.9	33.9	31.1	83.7	24.8	37.5	19.2	39.3	38.3	26.1	30.6	28.3	32.7	17.3	28.3	52.6	12.8	7.7	25.0	21.6	13.4	30.8	60.3	59.5	10.1	11.1	29.7	16.3	44.8	10.3	12.8	28.7	66.1	56.6	15.5	28.5	38.1	29.4	20.0	8.0	38.9	42.2	18.2	7.4	14.7	23.4	13.0	20.2	9.8	12.4	10.4	14.1	14.5	10.2	8.2	8.5	12.0	14.5	22.6	9.2	14.3	10.1	14.4	13.8	11.8	16.4	13.8	13.1	18.2	13.8	14.8	14.6	15.2	13.1	127.8	16.0	12.2	8.8	24.9	22.9	14.3	30.4	37.5	8.1	13.5	12.8	10.0	5.7	16.7	5.5	2.1	9.4	18.8	13.1	7.9	25.8	3.4	16.0	16.7	48.0	14.3	29.3	4.7	19.1	15.0	20.7	58.1	26.0	12.0	11.5	32.2	11.3	30.8	8.4	4.8	14.3	14.2	20.1	18.5	4.0	27.7	19.6	7.2	7.5	24.6	8.5	20.6	4.5	6.0	62.8	15.5	24.0	21.6	26.2	22.8	10.4	18.3	5.4	39.5	7.7	20.4	1.1	4.0	27.1	19.6	4.9	20.4	16.8	12.1	26.0
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576900-41589871	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favorable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	47.0	51.7	49.0	12.0	50.4	26.2	39.0	47.0	65.0	34.4	41.2	33.6	37.7	26.9	19.2	73.7	34.7	18.8	26.5	49.5	52.1	59.4	64.2	33.8	17.5	46.9	47.2	48.1	45.0	15.4	19.5	14.2	51.2	26.5	20.3	13.6	23.3	20.2	16.2	33.2	33.8	19.9	47.8	13.7	65.7	32.6	49.8	14.3	13.8	11.4	16.8	31.7	28.0	49.7	16.0	29.0	19.6	42.5	54.3	84.0	23.0	61.7	69.8	56.0	61.0	23.0	15.3	14.9	20.3	74.4	40.0	23.4	25.8	40.0	31.1	31.2	38.6	3.8	34.8	49.2	85.8	22.6	23.8	70.4	38.2	58.3	24.2	61.9	9.3	23.8	16.9	51.9	76.5	42.0	17.1	32.5	6.2	75.1	38.2	13.1	20.7	30.7	24.0	17.1	5.8	11.2	50.5	18.1	75.2	15.2	20.3	24.4	7.5	63.2	34.3	59.4	32.8	33.2	34.0	24.3	70.3	18.8	38.7	21.0	22.0	44.8	27.7	18.5	22.3	17.8	27.6	22.8	23.2	20.5	29.4	21.1	28.8	13.4	22.9	9.2	49.4	18.8	49.0	50.4	47.0	65.0	49.5	52.1	46.9	47.2	51.2	47.8	49.8	49.7	7.8	35.3	106.4	16.3	15.0	14.8	10.2	22.5	20.5	16.7	22.8	29.3	12.4	82.9	25.8	35.0	6.2	57.1	10.0	104.8	107.6	31.8	17.1	77.7	34.2	6.9	48.7	19.3	14.9	11.0	91.1	33.3	36.2	51.4	3.8	60.9	8.9	83.5	34.5	28.6	10.9	58.1	14.2	14.4	13.5	15.3	28.0	16.3	44.4	3.7	21.9	67.1	16.5	4.0	7.1	10.8	117.0	30.5	17.7	8.5	176.1	138.5	34.8	22.6	39.5	18.9	36.9	72.6	10.9	23.1	14.1	65.3	21.0	37.9	55.3	8.2
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924740-154936719	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 266.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA		15000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	39.9	56.4	99.0	29.8	100.1	15.3	35.0	97.9	108.9	33.4	95.0	39.9	45.9	25.9	17.7	77.7	37.2	17.2	63.1	93.9	96.4	53.8	91.9	30.1	34.6	98.6	97.4	35.8	41.6	58.2	60.3	23.7	96.0	32.4	22.2	19.8	34.0	27.1	79.1	69.2	44.2	27.7	96.4	45.7	40.5	26.6	102.3	27.9	31.5	47.4	36.8	31.9	37.9	99.8	51.8	72.9	46.7	72.5	43.6	30.9	48.5	40.5	29.3	38.9	37.0	30.6	101.0	75.1	75.9	49.3	40.5	49.4	65.3	63.9	17.8	103.3	28.9	34.1	104.1	29.0	40.0	51.4	29.3	36.3	58.7	70.2	49.6	19.5	40.0	65.9	36.8	221.7	41.3	108.3	40.8	51.0	41.0	121.7	95.0	60.3	29.8	171.1	66.1	38.4	37.7	91.1	44.1	75.7	51.9	35.0	146.7	91.1	32.7	35.8	29.2	84.4	62.1	174.0	153.2	131.8	58.9	83.9	46.7	28.0	80.9	91.8	68.2	205.6	110.1	114.8	93.1	70.6	93.6	111.1	59.1	59.1	6.9	59.7	219.4	96.5	134.3	80.0	99.0	100.1	97.9	108.9	93.9	96.4	98.6	97.4	96.0	96.4	102.3	99.8	22.7	57.7	37.5	9.4	42.2	69.8	105.9	95.8	51.8	38.5	67.1	68.3	57.3	78.6	42.2	53.3	8.4	235.7	31.5	65.0	266.1	69.6	9.0	45.0	28.5	29.8	66.4	35.6	5.1	71.3	108.1	45.1	46.9	44.2	22.2	49.8	39.3	146.9	141.0	37.0	7.0	78.9	67.1	67.9	49.5	13.5	42.6	47.8	65.8	3.7	49.5	119.1	41.2	8.0	11.8	61.7	61.7	47.8	58.8	53.7	219.3	246.1	22.1	27.4	32.9	46.0	48.4	51.3	51.3	81.0	90.5	227.7	45.1	162.6	79.9	76.2
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669733-153689010	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1;intestine: 81.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AN3-CA: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.2	43.7	1.9	48.8	0.0	0.6	6.5	53.3	1.3	4.8	81.7	3.4	6.5	1.7	14.0	4.1	2.6	6.5	49.8	40.8	1.9	0.2	0.6	0.0	19.6	22.8	0.9	0.3	0.5	1.8	2.0	21.1	17.2	3.8	7.9	0.4	37.6	2.0	1.8	13.4	15.7	15.0	0.2	15.9	8.8	65.1	1.4	0.3	0.3	0.1	27.4	2.2	28.5	0.3	0.1	0.4	33.9	0.0	0.0	3.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.4	0.3	0.2	0.7	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.7	0.0	0.1	2.7	0.9	0.3	0.4	0.0	0.2	1.2	0.0	0.2	0.2	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	48.8	6.5	53.3	49.8	40.8	19.6	22.8	21.1	15.0	65.1	28.5	0.0	0.0	0.0	18.9	0.0	0.6	0.4	40.9	0.0	21.6	0.3	0.9	3.0	0.0	18.0	0.0	22.9	13.5	0.1	1.7	0.0	0.4	0.3	0.3	4.4	0.3	0.0	0.0	29.0	0.4	63.9	0.5	0.0	0.3	0.0	46.9	0.0	0.0	2.4	0.0	24.2	1.1	12.2	0.0	0.0	0.8	0.0	0.3	1.8	1.0	0.0	3.2	0.0	11.1	13.2	2.9	0.1	0.4	0.0	0.3	20.3	0.4	2.6	19.4	0.0	0.0	4.0	0.6	0.9	0.0	0.6	49.5	0.1	0.6	0.4	1.0
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99397629-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	68.2	68.8	56.9	52.0	55.4	106.8	75.3	78.4	89.8	103.1	67.5	114.5	51.4	79.7	93.6	51.8	93.2	38.2	84.6	54.3	56.4	67.1	62.2	74.4	78.7	56.7	54.7	123.0	66.0	38.4	112.0	36.4	52.9	91.2	49.4	102.1	76.6	48.1	89.4	64.1	94.1	49.4	49.3	90.6	77.1	39.4	56.9	51.4	114.5	31.2	54.9	81.6	80.3	60.1	26.7	19.5	98.8	72.0	35.3	46.8	45.8	44.1	22.8	25.6	29.9	33.3	49.2	85.8	26.6	25.3	28.7	41.9	49.3	33.3	45.2	75.0	48.8	52.6	105.0	30.6	22.2	73.0	67.9	51.8	50.0	27.4	37.5	95.7	34.2	44.8	59.3	52.5	31.3	25.2	31.8	71.2	55.2	24.5	15.3	62.1	29.6	32.4	47.1	47.1	43.4	51.9	21.7	23.6	35.3	75.4	32.8	58.6	45.0	25.2	28.9	25.7	37.2	35.9	24.3	70.5	37.5	68.3	27.0	12.3	10.8	11.9	12.5	6.4	13.0	19.3	12.0	10.4	5.0	25.8	17.9	16.6	30.0	23.5	7.7	19.6	12.4	3.7	56.9	55.4	78.4	89.8	54.3	56.4	56.7	54.7	52.9	49.3	56.9	60.1	175.8	185.9	237.6	356.2	375.8	195.3	357.3	250.5	165.6	546.2	143.9	192.5	121.2	137.2	215.7	178.4	446.2	158.3	336.4	152.4	74.3	130.8	17.0	132.2	185.7	210.7	247.8	194.4	241.5	104.5	102.1	240.1	100.9	140.5	190.5	344.5	135.7	109.4	99.7	498.0	257.4	129.6	199.4	128.0	236.8	47.9	593.3	152.1	167.2	193.9	261.6	223.6	375.9	270.4	252.6	133.1	176.2	441.2	209.8	293.6	205.8	58.6	179.6	419.9	249.8	288.7	236.3	342.6	181.3	115.5	173.6	180.9	283.8	363.3	151.3	352.4
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, TAHCCP2"	ENSG00000127838	"PNKD metallo-beta-lactamase domain containing"	Q8N490	2	218270392-218346793	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	50.9	88.9	127.6	33.3	134.7	35.4	49.7	131.2	168.4	62.8	129.3	74.7	40.6	45.6	77.3	40.5	60.6	41.6	98.4	127.8	137.5	106.5	191.5	55.5	40.9	133.9	130.9	47.1	46.1	93.4	49.5	46.9	134.1	87.4	54.7	26.7	60.6	55.3	85.1	44.9	51.1	36.4	128.7	58.7	81.6	45.6	137.8	45.8	90.0	93.6	37.6	64.2	45.4	134.7	53.2	68.3	49.1	77.0	72.2	60.6	90.0	32.7	70.3	76.1	85.0	112.9	51.2	61.7	63.7	55.0	83.5	53.6	95.4	61.4	52.9	128.0	119.4	90.0	119.5	169.4	78.7	58.9	38.6	83.0	59.8	51.9	15.0	51.0	83.2	48.0	67.8	78.3	68.4	152.2	77.6	139.5	49.0	121.3	69.3	75.1	49.5	51.8	88.3	79.2	47.4	39.9	23.6	156.9	94.6	52.0	52.4	56.4	51.5	31.4	53.7	37.5	45.5	32.4	35.7	69.0	79.9	95.8	38.8	142.4	111.4	151.9	97.7	114.3	94.2	223.1	105.7	117.7	106.4	187.2	116.4	111.2	31.3	136.2	109.4	99.0	150.0	132.2	127.6	134.7	131.2	168.4	127.8	137.5	133.9	130.9	134.1	128.7	137.8	134.7	84.5	70.5	91.2	30.0	58.2	55.2	91.5	179.2	82.6	54.5	130.1	162.4	154.5	128.7	127.8	196.8	6.2	172.9	48.2	292.0	508.7	70.6	13.5	125.9	116.5	66.9	121.3	56.3	44.9	49.8	105.3	88.5	99.9	114.1	57.1	97.0	83.2	250.4	136.7	35.3	47.4	186.3	187.2	85.3	59.6	16.5	103.2	66.2	136.9	20.6	79.6	168.8	51.5	19.6	32.8	37.7	143.6	124.1	74.6	93.4	162.7	326.7	148.5	41.6	92.1	60.0	128.6	42.5	50.6	113.9	62.4	77.3	52.5	97.2	228.1	117.5
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.2;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 13.6;Spermatocytes: 14.3;Spermatogonia: 13.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.2	0.2	2.1	0.1	3.7	0.1	0.5	2.5	10.2	0.1	1.6	0.3	0.0	0.1	0.0	0.2	1.9	0.0	0.2	2.2	2.0	0.2	0.5	0.2	0.4	1.9	1.9	0.4	1.7	0.0	0.3	0.0	3.0	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	1.8	0.4	0.2	8.1	2.3	0.2	0.2	0.0	0.2	0.2	0.2	2.7	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.7	2.5	10.2	2.2	2.0	1.9	1.9	3.0	1.8	2.3	2.7	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	4.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.8	19.9	2.1	0.1	0.1	0.0	0.0	1.5	0.9	0.0	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	13.6	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.5	1.3	1.3	0.0	0.0	0.0	0.1	0.0	0.9	2.7	0.0	0.0	0.5	0.2	14.3	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2058	"pancreas: 444687.5"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 4086.8"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		14000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						13.8	3.1	0.0	10.5	0.0	1.1	8.9	0.0	0.0	7.2	0.0	3.8	64.8	9.1	0.4	4.8	1.5	0.0	78.2	0.0	0.0	3.0	10.2	2.1	16.9	0.0	0.0	216.0	444687.5	0.0	2.5	24.4	0.0	4.5	0.0	0.0	71.7	0.0	2.9	4.6	34.0	0.0	0.0	3.8	28.2	2.3	0.0	0.0	2.0	0.0	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.5	0.0	0.0	0.3	0.0	0.0	0.1	4086.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	14.5	0.0	0.0	0.5	0.1	507.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427847-116477957	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.0;skin 1: 14.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.1;Early spermatids: 1.5;Late spermatids: 1.9;Melanocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 320.3"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									2.2	0.1	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	320.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	35.5	30.2	75.0	20.3	80.5	8.8	20.6	55.5	85.6	37.6	34.7	56.7	13.9	46.3	54.6	23.4	38.1	24.6	23.3	77.3	90.0	27.8	4.9	15.5	16.4	62.1	62.5	53.4	9.2	8.0	53.1	21.4	62.9	48.8	16.5	59.9	10.9	89.3	12.0	9.8	24.9	52.3	66.9	19.2	26.0	71.0	78.4	19.0	18.5	10.4	12.5	41.7	26.6	70.3	48.2	42.8	72.3	54.1	53.1	56.0	29.9	49.8	27.8	44.5	32.5	40.6	29.2	1.1	33.8	60.7	42.4	31.6	56.0	29.4	45.7	45.7	34.7	27.2	35.8	30.7	56.8	15.3	41.6	49.8	35.1	53.4	33.5	87.4	68.1	28.7	23.9	29.3	61.2	117.6	30.5	37.1	21.8	24.6	149.0	47.5	45.0	1.1	58.8	1.5	85.4	65.5	87.5	19.9	40.4	43.6	97.0	25.6	66.5	89.3	71.7	54.9	41.1	25.7	42.9	14.2	88.3	21.4	30.3	2.9	1.8	4.7	8.5	3.5	5.8	2.8	10.9	8.7	3.9	3.1	10.4	10.0	1.6	5.6	5.3	0.6	14.2	7.3	75.0	80.5	55.5	85.6	77.3	90.0	62.1	62.5	62.9	66.9	78.4	70.3	13.1	6.4	3.0	21.9	8.8	3.8	6.8	5.0	6.2	48.6	7.0	7.5	19.9	2.8	4.1	14.7	12.5	7.5	10.4	6.7	15.6	10.1	84.2	32.2	30.6	13.5	18.7	3.0	31.4	6.7	11.3	20.5	14.3	10.2	16.5	16.6	20.0	1.6	15.6	58.9	28.9	5.4	14.2	6.8	25.9	57.6	32.6	18.8	19.6	12.2	14.1	65.2	10.3	17.1	21.7	30.2	1.4	84.7	10.9	7.4	1.6	26.6	23.1	49.1	72.3	31.2	44.1	87.2	44.4	4.7	3.8	6.0	20.0	43.8	2.5	3.7
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504701-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;retina: 24.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.2;Horizontal cells: 30.3;Inhibitory neurons: 92.0;Muller glia cells: 26.9"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 78.4;JURKAT: 43.3;SH-SY5Y: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	10.8	52.2	1.2	55.1	0.4	1.9	1.3	73.4	3.5	0.0	1.4	0.8	0.8	1.0	0.5	2.5	3.9	4.9	55.1	88.4	3.2	0.9	6.8	0.4	29.0	25.7	0.8	3.9	2.7	15.4	0.5	28.7	0.8	0.9	24.5	0.3	0.9	0.5	0.6	1.1	1.9	16.5	0.5	2.8	1.7	67.0	0.2	2.7	0.2	0.3	2.2	0.8	29.2	0.0	11.7	63.0	0.6	12.2	2.6	0.1	3.2	17.2	7.8	2.6	0.5	8.4	0.0	2.3	1.2	19.3	0.2	39.5	0.0	6.0	0.0	7.0	0.0	8.7	0.1	0.9	0.0	0.4	4.2	0.0	33.4	0.2	78.4	37.7	43.3	0.0	0.1	4.9	0.3	19.3	0.1	34.7	0.7	0.1	0.1	12.8	0.0	18.7	4.3	30.7	44.9	0.0	0.1	2.1	4.5	0.2	1.2	18.6	0.8	12.7	16.1	2.6	5.9	4.6	0.1	36.1	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	52.2	55.1	1.3	73.4	55.1	88.4	29.0	25.7	28.7	16.5	67.0	29.2	0.4	3.2	13.0	20.5	0.6	0.0	0.1	0.2	0.0	6.5	0.9	1.1	0.5	0.0	3.7	0.0	2.1	0.0	0.0	0.1	0.0	0.3	5.4	1.0	4.5	1.0	10.8	0.0	71.2	0.0	0.1	3.6	0.0	1.5	1.3	0.0	0.4	0.1	0.1	30.3	92.0	0.5	0.0	1.6	0.8	1.5	11.1	0.1	1.8	12.2	0.0	26.9	0.0	19.1	11.5	2.7	0.0	12.0	0.0	0.0	0.0	5.4	2.9	6.2	0.0	0.2	4.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.2
PNMA3	"MA3, MA5, MGC132756, MGC132758"	ENSG00000183837	"PNMA family member 3"	Q9UL41	X	153056409-153060467	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 37.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 42.1;Inhibitory neurons: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.2;SCLC-21H: 1.0"	"Low region specificity"	"Detected in all"							HPA047920	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA047920: AB_2680210"	"unprognostic (1.66e-2)"	"unprognostic (8.97e-3)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (9.43e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.62e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (7.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.07e-2)"	0.2	1.3	4.3	0.8	5.2	0.3	0.2	1.5	9.4	0.3	0.3	0.4	0.2	0.3	37.3	0.3	1.6	0.2	1.4	5.0	5.4	1.4	0.4	0.4	1.5	5.5	3.6	0.5	0.3	0.6	9.3	0.1	5.4	0.5	0.1	2.1	0.3	0.4	0.1	0.4	2.2	0.1	2.0	2.5	0.4	8.9	5.9	0.5	1.2	0.2	1.3	0.2	0.3	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.2	1.5	9.4	5.0	5.4	5.5	3.6	5.4	2.0	5.9	5.5	0.1	0.0	0.0	9.4	0.3	0.3	0.0	0.0	0.0	7.5	0.2	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.0	0.0	42.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.4	0.0	0.1	6.7	38.6	0.0	0.0	0.9	0.3	1.4	1.2	0.4	0.0	3.7	0.1	3.4	1.0	9.5	2.7	0.0	0.0	0.4	0.2	0.2	0.0	3.8	0.0	2.9	0.0	0.0	0.3	0.1	2.1	0.0	0.0	0.0	1.0	0.7	0.0	0.1
PNMA5	KIAA1934	ENSG00000198883	"PNMA family member 5"	Q96PV4	X	152988824-152994116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 22.8;testis: 8.7"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 20.3;Spermatogonia: 71.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	578	"HMC-1: 356.2;U-266/70: 560.6;U-266/84: 355.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044690, HPA073946"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA044690: AB_2679049, HPA073946: "	"unprognostic (5.25e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.55e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.76e-9)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-2)"	0.0	0.0	8.8	0.1	11.2	0.0	0.0	0.3	9.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	22.8	0.0	0.0	0.0	0.1	3.0	5.2	0.0	0.0	0.0	0.9	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	2.0	0.5	0.1	8.7	20.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	356.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	560.6	355.8	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	11.2	0.3	9.4	8.9	22.8	3.0	5.2	3.5	2.0	20.1	2.4	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	1.7	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	2.6	0.4	1.3	0.3	1.2	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	71.9	0.0	0.0	0.3	0.9	0.1	0.0	0.0
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072454-153075019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 27.0;Distal tubular cells: 11.7;Horizontal cells: 23.5;Muller glia cells: 21.1;Proximal tubular cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HMC-1: 6.7;SK-MEL-30: 6.9;U-2 OS: 14.7;U-698: 8.5"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria	Nucleoli	"HPA045007: AB_2679181, HPA052115: AB_2681734"	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favorable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.9	1.8	17.3	0.2	16.8	0.4	1.1	8.8	26.5	3.1	3.4	1.7	0.6	2.4	5.9	0.4	3.0	1.0	2.1	16.5	16.7	8.2	10.2	0.6	0.4	16.4	13.1	5.1	0.9	2.2	11.9	0.2	16.1	0.5	0.2	3.5	1.0	0.6	0.5	1.1	0.9	0.7	8.9	0.9	1.2	1.7	17.3	0.2	3.1	0.7	0.3	0.4	0.7	16.7	0.0	5.3	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.8	0.4	0.9	0.0	2.8	0.0	0.0	0.0	0.6	0.0	0.3	0.2	7.5	3.3	6.7	1.1	0.0	0.1	0.0	0.2	0.2	5.6	1.4	0.0	0.1	0.4	1.1	0.0	3.3	5.9	0.0	0.0	0.0	0.0	0.3	0.0	3.2	1.9	0.4	0.0	6.9	0.3	0.0	4.2	0.0	0.0	14.7	0.0	0.0	5.7	4.6	8.5	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	16.8	8.8	26.5	16.5	16.7	16.4	13.1	16.1	8.9	17.3	16.7	0.2	0.0	0.0	4.6	0.5	0.0	0.3	0.0	0.0	27.0	0.3	0.5	2.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.5	0.0	0.4	3.4	0.4	0.0	0.0	8.1	0.2	0.0	2.4	0.0	0.8	0.0	6.5	0.7	2.9	4.0	23.5	9.6	0.0	0.0	0.8	0.4	0.7	2.8	0.8	0.0	1.9	0.0	21.1	0.0	4.5	1.4	0.3	0.0	3.0	0.7	0.1	0.0	27.0	0.0	8.7	0.0	0.8	1.9	1.0	2.8	0.0	0.0	0.0	0.7	0.9	0.0	0.1
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"							"HPA012956, HPA077702"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328, HPA077702: "	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.1	22.8	45.8	0.9	44.8	0.7	4.7	16.2	54.3	5.8	13.9	3.6	0.7	12.5	16.2	1.2	22.1	5.2	15.0	45.4	53.9	8.7	0.4	1.7	0.3	27.0	30.1	17.2	6.3	15.8	36.7	2.6	35.3	8.8	0.7	35.6	6.0	9.6	1.6	1.2	1.3	7.2	23.3	0.6	1.8	22.5	39.8	30.1	15.4	1.1	0.6	3.1	1.6	34.6	0.0	13.9	19.7	19.6	5.6	12.7	3.5	1.3	0.2	2.4	1.2	0.2	1.6	0.1	18.1	0.9	6.8	0.2	32.9	5.3	1.6	0.1	12.2	0.0	0.5	0.5	9.4	0.2	0.2	3.3	6.5	8.2	0.0	1.8	2.0	11.9	36.3	0.2	35.9	0.1	0.2	0.2	16.5	0.0	0.0	0.0	21.5	0.0	8.2	0.1	16.0	31.3	0.1	0.3	0.0	18.0	0.2	0.3	1.2	0.0	0.2	0.2	6.8	0.1	0.1	0.2	0.3	0.1	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.0	45.8	44.8	16.2	54.3	45.4	53.9	27.0	30.1	35.3	23.3	39.8	34.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.0	0.0	1.8	11.0	0.0	1.9	0.0	0.0	3.9	0.9	0.0	8.4	2.3	0.3	0.0	0.0	0.0	0.0	0.5	2.8	0.0	1.3	0.0	13.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	10.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0
PNMA8B	"KIAA1183, PNMAL2"	ENSG00000204851	"PNMA family member 8B"	Q9ULN7	19	46486906-46495879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 14.7;brain: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 8.3;Granulosa cells: 5.3;Theca cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;AN3-CA: 1.8;SH-SY5Y: 1.4"	"Low region specificity"	"Detected in all"							HPA054810	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA054810: AB_2682609"	"unprognostic (1.31e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (4.26e-4)"	"unprognostic (7.30e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.32e-2)"	2.7	14.7	32.8	0.3	31.1	0.0	2.4	0.0	41.6	1.9	0.0	1.5	0.3	1.7	0.5	0.5	1.6	1.0	1.9	20.1	25.3	0.7	0.4	0.7	0.4	22.5	15.0	3.9	0.9	0.2	7.3	0.3	27.3	1.6	0.1	2.1	1.5	1.0	0.5	2.3	0.9	0.6	2.1	1.9	0.9	0.8	18.5	3.5	0.8	0.4	0.1	1.1	1.6	19.0	0.0	0.0	1.4	1.8	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	31.1	0.0	41.6	20.1	25.3	22.5	15.0	27.3	2.1	18.5	19.0	8.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.3	0.0	0.5	0.9	0.8	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.1	0.0	5.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 158.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"CAB017029, HPA043412, HPA051005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	5.3	158.3	15.9	0.2	28.9	2.1	8.4	17.3	16.3	7.6	7.4	4.2	0.5	4.4	1.4	3.0	9.0	0.3	22.6	9.9	17.0	3.7	0.5	8.9	0.3	17.3	22.7	3.0	1.7	7.4	30.7	3.2	20.0	8.5	0.0	0.1	3.2	21.3	21.1	3.1	7.2	0.2	10.8	2.1	6.9	4.5	25.7	0.1	1.8	17.5	0.0	6.5	5.9	11.7	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	5.3	0.2	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	24.1	4.5	0.5	0.1	0.1	0.0	0.3	0.0	0.0	6.4	5.8	0.1	2.3	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.9	28.9	17.3	16.3	9.9	17.0	17.3	22.7	20.0	10.8	25.7	11.7	3.1	0.0	0.0	1.0	0.5	0.5	0.7	0.0	0.0	0.3	20.1	15.1	13.4	1.5	0.0	5.5	0.0	0.1	1.1	0.1	1.9	0.0	0.7	24.0	2.6	5.0	3.0	16.6	0.5	0.0	0.9	1.1	0.0	9.0	0.0	0.7	27.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	2.1	0.2	0.0	1.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.0	0.5	0.0	48.0	0.8	1.0	2.3	0.0	0.4	0.0	11.0	0.0	0.3	1.8
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183220	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	57.8	60.6	42.7	68.0	46.6	135.9	60.2	50.6	48.1	82.2	77.8	83.1	56.5	81.5	129.5	74.0	77.0	41.8	54.9	42.9	51.4	87.6	124.8	61.4	87.6	47.5	45.1	84.5	78.5	40.8	90.7	53.8	47.2	83.8	63.1	76.0	65.6	48.4	59.9	67.7	90.5	48.0	43.9	103.6	70.7	58.5	47.1	65.6	88.4	27.0	69.5	69.2	73.3	50.9	152.4	72.0	193.2	94.0	45.5	37.4	141.4	116.6	35.4	82.4	81.2	112.3	232.6	229.1	72.7	53.2	69.7	156.4	153.3	85.5	138.5	105.1	109.0	158.6	243.7	246.0	39.1	201.0	107.6	55.8	73.5	80.1	65.1	115.5	57.3	119.0	149.1	128.2	65.8	122.6	145.5	170.3	126.6	76.2	114.3	188.4	137.0	64.2	65.6	219.3	93.8	50.5	126.2	90.5	69.1	133.2	114.4	117.5	92.7	115.9	90.9	52.7	142.2	102.5	87.8	194.0	59.5	167.3	70.6	9.2	13.7	22.0	17.0	11.4	16.1	22.2	12.1	10.9	11.8	25.5	17.2	16.6	27.6	15.4	16.4	22.1	14.2	6.1	42.7	46.6	50.6	48.1	42.9	51.4	47.5	45.1	47.2	43.9	47.1	50.9	105.6	192.3	125.0	40.8	170.5	126.2	244.5	84.4	153.1	203.1	77.5	87.5	63.4	61.5	164.8	60.7	56.3	113.2	230.9	129.3	35.2	89.4	59.0	155.0	178.9	127.9	136.2	121.1	33.1	58.3	100.0	117.1	101.9	289.4	142.5	273.5	69.3	67.8	62.3	153.1	35.6	96.6	71.2	69.3	72.5	53.7	156.3	93.9	49.8	25.3	89.2	138.0	193.6	41.2	54.6	76.7	126.3	151.6	116.7	172.1	82.9	28.9	111.7	172.4	151.2	166.2	161.3	212.8	149.3	145.0	112.0	99.6	170.6	211.8	123.7	245.4
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;fallopian tube: 18.2;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0"	"Group enriched"	"Detected in many"	20	"B-cells: 260.3;dendritic cells: 194.0"	"Group enriched"	"Detected in some"	6	"Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300		"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.2	0.8	5.4	9.9	5.1	2.7	0.6	1.3	10.8	0.2	1.3	2.9	4.3	0.1	0.0	0.6	18.2	1.1	0.1	2.9	9.9	0.7	0.2	1.0	25.1	10.4	6.3	0.4	0.0	0.0	0.0	0.0	9.9	0.2	1.5	0.0	1.6	0.1	0.0	0.1	5.8	0.5	14.3	14.4	3.2	0.6	4.3	2.7	0.4	0.0	23.6	3.7	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.0	4.4	23.0	0.1	0.1	0.0	0.2	11.5	2.3	0.2	7.7	0.1	231.2	0.2	0.1	1.1	260.3	0.1	0.1	1.3	1.2	3.2	194.0	0.5	11.1	5.4	5.1	1.3	10.8	2.9	9.9	10.4	6.3	9.9	14.3	4.3	3.0	0.1	0.0	1.9	1.3	61.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.4	0.4	0.2	0.0	23.3	0.1	0.0	0.0	0.3	2.8	0.3	1.7	14.2	1.0	3.0	0.0	1.0	0.0	0.9	0.1	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	1.1	0.0	0.3	0.5
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477089	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 333.9;epididymis: 594.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 531.3;U-937: 593.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		58000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	78.6	24.8	16.1	46.8	16.6	333.9	34.6	22.6	22.7	25.3	18.9	52.2	120.3	14.2	594.8	87.4	18.2	56.8	29.0	17.7	19.6	206.8	98.0	48.6	46.7	20.3	18.1	5.0	23.2	32.0	19.8	132.6	20.1	15.0	61.8	27.1	22.6	27.4	7.3	29.6	60.3	38.7	23.1	44.5	50.6	7.4	21.1	33.5	17.8	10.0	64.4	100.4	41.5	20.1	86.1	113.4	24.0	53.9	26.0	21.0	71.8	85.2	40.3	68.2	67.0	66.1	76.5	227.1	96.8	45.5	81.5	89.9	125.2	159.8	89.5	75.0	109.6	189.1	89.9	109.3	24.2	531.3	94.7	14.4	57.4	206.0	91.0	37.8	295.9	141.0	95.4	137.4	86.7	79.1	157.6	311.3	67.5	215.7	186.1	130.2	35.9	88.3	243.7	79.6	101.9	22.6	163.4	205.0	13.2	32.6	75.5	92.5	240.0	46.1	62.6	105.1	148.4	63.1	113.3	258.9	39.3	593.0	4.6	12.0	30.6	10.3	39.8	27.3	73.6	25.7	44.2	45.0	48.1	28.8	27.6	35.9	3.7	38.5	26.6	27.3	16.7	31.1	16.1	16.6	22.6	22.7	17.7	19.6	20.3	18.1	20.1	23.1	21.1	20.1	149.6	0.0	23.5	5.9	50.3	84.6	67.4	12.6	112.7	4.7	56.3	62.6	3.5	27.1	13.4	82.8	14.6	360.6	45.2	61.1	39.2	43.2	1.3	36.0	12.7	139.4	46.4	227.3	0.6	51.5	41.8	32.4	106.5	65.3	57.7	5.0	24.3	30.6	70.9	16.8	1.1	51.3	18.3	18.1	58.4	0.8	0.3	83.3	30.2	3.7	13.2	78.8	29.9	3.0	0.9	130.8	83.9	0.7	88.6	27.5	41.2	118.9	10.5	18.1	0.0	23.9	41.3	0.4	0.7	114.7	63.9	646.2	62.3	3.1	51.4	77.1
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Proximal tubular cells: 126.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003656	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	20.8	27.6	11.9	9.7	12.6	8.7	22.6	12.0	11.8	13.9	16.9	15.4	18.9	14.0	18.1	21.0	24.7	9.4	42.1	11.1	14.2	41.2	40.1	9.8	10.8	12.1	13.5	22.4	28.8	25.2	13.5	8.0	12.4	12.8	12.3	16.8	26.9	10.8	77.9	15.0	11.4	12.1	12.5	9.4	19.5	7.8	15.6	16.3	29.9	66.0	10.2	8.9	13.3	11.9	44.7	18.1	2.8	44.4	0.9	0.5	11.9	13.7	1.5	23.0	14.1	18.1	16.1	13.9	0.1	4.5	0.3	25.7	0.0	45.6	39.2	0.4	32.0	10.0	32.8	38.6	28.6	17.8	14.1	29.5	45.7	11.7	27.3	5.5	16.2	0.3	39.9	0.5	0.3	11.8	0.3	17.2	46.9	30.7	38.0	0.3	0.2	15.6	30.6	20.3	25.3	12.7	41.2	16.8	23.7	49.7	26.1	13.0	9.4	0.2	11.4	35.5	0.2	20.3	0.3	27.0	0.2	0.1	3.7	7.4	11.4	9.7	6.1	13.5	7.0	14.7	8.7	6.7	22.2	16.7	11.3	10.8	0.7	11.9	12.5	16.3	6.0	9.3	11.9	12.6	12.0	11.8	11.1	14.2	12.1	13.5	12.4	12.5	15.6	11.9	10.7	9.6	12.5	3.3	8.2	11.9	16.7	46.0	17.6	11.3	38.2	33.5	55.0	20.0	24.3	20.2	0.0	28.7	7.8	31.2	95.9	34.2	3.1	35.9	20.6	10.6	19.8	15.6	2.8	48.7	21.3	14.6	13.7	15.5	8.2	17.3	13.2	62.1	28.7	10.1	3.6	30.6	38.7	9.2	10.2	3.7	16.4	12.1	17.8	1.0	13.3	36.1	6.2	2.5	1.0	39.8	25.1	20.3	14.2	15.3	47.6	126.4	31.0	15.0	6.6	6.6	14.6	22.2	21.4	24.0	16.8	14.0	6.4	49.0	32.3	16.0
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;epididymis: 1.7;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.2;Inhibitory neurons: 2.1;Late spermatids: 2.1"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA050409: AB_2681118, HPA054211: AB_2682418"				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.0	0.8	0.1	3.4	0.3	0.3	0.2	2.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.9	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.8	3.4	0.2	2.3	1.4	0.5	1.2	0.6	0.4	0.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	17.9	27.3	18.3	26.2	23.2	26.1	16.4	14.7	31.5	20.2	12.6	25.7	26.9	20.8	5.3	20.4	16.8	13.7	20.7	21.9	16.3	25.6	21.9	40.4	19.5	23.4	20.3	18.8	16.4	15.6	32.7	13.6	25.6	21.4	8.4	10.6	15.8	12.8	33.5	17.5	29.6	14.5	10.1	41.9	19.2	36.4	23.7	10.9	22.7	19.5	8.9	24.6	17.4	23.6	32.4	80.1	14.7	36.1	25.5	37.0	34.3	42.2	41.9	31.4	28.8	18.6	43.7	27.3	69.1	55.3	19.7	40.8	13.1	39.4	16.3	68.5	29.2	17.7	41.8	13.9	29.2	20.2	53.0	31.6	22.2	41.8	23.8	49.2	62.7	31.4	14.9	36.5	28.6	15.7	22.2	26.0	16.2	15.5	71.7	17.3	9.0	31.9	27.9	31.2	19.0	32.5	34.9	15.7	45.6	20.4	14.1	27.6	67.0	38.5	22.1	53.3	44.2	42.6	30.1	12.2	64.2	23.2	36.7	15.7	11.3	37.6	5.4	20.0	5.5	6.5	3.8	5.7	12.1	4.3	3.3	4.5	3.2	7.9	35.0	3.8	6.9	8.8	18.3	23.2	14.7	31.5	21.9	16.3	23.4	20.3	25.6	10.1	23.7	23.6	12.6	6.4	12.0	16.6	11.9	4.8	4.1	9.3	8.6	12.1	10.9	8.3	10.0	15.7	10.1	33.1	27.1	18.2	14.4	48.5	1.9	15.8	73.4	8.2	7.2	13.5	17.4	25.4	14.0	7.1	15.5	7.3	14.8	10.7	12.0	19.5	13.6	20.2	27.4	21.9	16.1	14.6	10.2	68.3	16.0	106.1	9.6	42.4	8.8	15.0	23.6	9.2	21.6	9.0	16.4	9.5	17.9	7.5	8.8	4.9	67.0	12.1	14.4	16.5	0.0	7.1	7.7	60.8	10.5	8.5	5.5	12.4	15.9	10.0	20.9	3.6
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459952-137550402	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.0;T-reg: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	22	"HMC-1: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.6	7.0	5.2	2.2	5.3	2.1	11.3	1.9	8.6	17.6	1.2	10.8	2.2	12.3	1.0	2.7	13.0	3.7	6.9	6.6	2.6	6.3	14.0	4.7	4.4	4.6	2.6	21.5	17.9	2.0	8.9	0.6	3.6	22.5	1.4	1.3	15.9	2.7	17.3	14.3	8.4	1.6	2.2	7.0	16.3	2.6	4.2	1.4	17.3	3.4	1.4	10.5	7.6	5.9	0.1	1.0	0.2	0.3	0.8	0.5	0.4	0.8	0.8	0.2	0.2	0.1	0.5	0.6	0.8	0.4	0.4	0.3	0.1	0.0	0.0	1.6	0.9	0.8	1.0	0.3	0.5	0.4	83.7	1.2	0.1	0.3	0.0	1.4	0.1	0.1	0.1	2.3	0.1	1.6	0.2	1.6	0.0	1.2	0.9	2.0	1.3	2.8	0.1	0.3	1.6	0.4	0.1	0.6	0.3	0.2	3.7	1.2	0.6	0.0	0.1	0.4	0.1	0.8	0.2	0.2	1.2	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	1.0	0.3	0.2	0.0	0.0	0.0	0.1	1.2	0.2	5.2	5.3	1.9	8.6	6.6	2.6	4.6	2.6	3.6	2.2	4.2	5.9	3.0	9.6	5.9	56.2	4.8	1.5	1.1	0.9	2.2	2.5	6.5	8.3	3.9	4.3	2.6	1.8	6.2	0.2	2.1	6.6	0.0	0.7	0.5	1.7	4.8	1.2	17.3	0.8	23.6	0.0	0.3	3.6	12.2	3.8	7.0	1.2	2.5	10.2	2.6	5.0	21.5	9.2	0.0	4.5	1.0	0.6	4.4	1.2	0.0	9.4	1.3	2.5	1.0	11.6	21.0	0.6	7.1	1.9	1.6	2.5	3.8	1.0	1.6	9.6	0.0	2.3	2.1	3.1	4.0	0.9	3.3	0.0	2.3	0.6	2.0	0.7
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1848.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 212.8;hTCEpi: 234.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	232.7	171.7	61.6	145.9	66.3	368.1	135.4	84.0	67.5	93.8	47.9	158.4	70.2	100.6	80.4	91.4	204.4	139.3	132.5	58.3	74.2	103.5	318.1	159.6	134.1	87.7	65.7	222.5	89.2	86.8	78.5	122.6	73.0	95.0	77.5	129.8	91.9	84.3	460.6	147.5	94.3	130.3	69.5	139.6	104.6	50.1	57.4	165.9	105.6	163.4	111.2	141.4	98.5	80.4	12.1	12.0	25.3	42.4	96.7	166.6	16.9	16.0	110.6	29.5	69.0	10.2	34.5	25.9	71.2	19.4	116.3	40.5	13.3	23.9	45.6	31.8	36.3	4.7	69.8	31.9	212.8	25.0	57.9	117.6	234.4	19.6	90.1	107.9	49.4	30.3	4.1	81.0	33.3	11.5	6.8	124.7	7.0	13.9	23.1	29.1	30.0	21.5	70.2	21.1	15.7	42.2	40.3	56.3	44.0	73.6	27.9	119.4	44.8	23.1	13.2	16.2	5.9	118.3	64.0	9.0	46.3	20.6	14.9	32.8	17.3	103.8	18.3	19.0	19.0	20.7	22.1	19.7	11.3	23.0	24.9	25.9	100.9	19.2	17.9	18.7	19.0	10.5	61.6	66.3	84.0	67.5	58.3	74.2	87.7	65.7	73.0	69.5	57.4	80.4	405.7	141.1	149.8	36.2	747.6	968.9	776.8	98.9	1286.2	130.6	412.5	381.5	188.6	230.2	65.2	90.1	50.1	235.8	662.8	158.1	234.8	203.5	103.4	528.4	655.3	356.1	248.0	284.1	10.0	238.2	78.6	720.1	225.8	955.1	164.6	153.2	238.5	207.6	229.4	72.3	15.5	200.7	34.6	452.6	1848.0	41.5	481.9	898.3	439.4	39.4	763.5	403.3	440.8	20.1	41.5	143.0	184.6	377.3	530.6	738.5	211.1	319.2	61.5	134.8	420.7	731.3	725.6	51.9	64.6	840.2	1250.8	274.5	735.8	214.3	136.9	472.8
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
POC1A	"DKFZP434C245, WDR51A"	ENSG00000164087	"POC1 centriolar protein A"	Q8NBT0	3	52075226-52154690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Dwarfism, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.8;testis: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Extravillous trophoblasts: 33.8;Late spermatids: 73.4;Spermatocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040600	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA040600: AB_10672837"	"unprognostic (2.68e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (5.08e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (9.43e-7)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.32e-2)"	1.4	4.1	1.5	4.0	1.5	11.1	2.2	1.4	1.8	1.5	1.1	5.9	4.8	1.0	1.0	4.7	1.7	1.1	1.4	1.7	1.6	2.1	5.2	1.9	5.4	1.9	1.6	0.7	0.9	1.1	0.7	4.1	1.8	1.3	6.0	0.4	1.3	1.0	1.5	2.6	4.0	2.9	1.5	2.8	2.8	17.6	1.6	12.8	1.0	1.0	7.0	2.0	1.8	1.8	30.1	25.2	25.0	33.5	5.1	6.5	33.9	30.0	28.7	62.8	48.7	22.1	31.0	31.3	8.8	23.9	48.6	18.3	38.0	33.9	45.3	26.0	16.0	21.4	26.3	23.9	1.4	24.5	13.0	3.6	7.3	49.6	25.9	8.7	29.0	46.2	18.8	32.9	37.5	23.8	45.6	44.2	19.1	33.7	41.0	19.6	19.7	30.0	14.2	21.0	11.6	16.7	24.0	23.7	18.3	26.0	29.2	45.7	9.7	28.6	27.6	46.3	49.3	27.8	49.1	26.6	19.2	42.6	29.1	0.0	1.6	0.0	1.2	2.2	0.1	0.9	0.8	0.4	1.9	0.5	0.7	0.4	0.5	1.4	1.6	1.9	2.6	1.1	1.5	1.5	1.4	1.8	1.7	1.6	1.9	1.6	1.8	1.5	1.6	1.8	0.9	0.0	1.3	0.3	2.5	1.7	1.6	4.7	0.0	0.7	2.1	2.2	0.7	0.0	1.4	1.8	0.0	21.8	0.9	4.4	0.0	1.8	47.9	4.5	1.0	2.9	1.8	15.6	2.3	3.0	33.8	3.4	2.0	1.5	0.0	11.3	1.8	4.2	12.9	1.7	1.4	5.4	0.0	2.6	3.4	73.4	1.2	2.6	1.8	1.9	2.7	0.8	1.0	0.0	2.7	2.1	2.2	0.4	12.9	1.3	3.0	3.2	4.2	0.0	0.0	1.1	3.4	40.1	21.2	4.9	1.8	7.5	1.6	4.4	8.4	2.1
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717448	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 102.7;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.09e-4)"	5.8	6.1	5.3	6.1	7.6	10.2	9.5	6.9	8.1	7.6	4.3	5.1	4.6	7.6	8.3	3.8	8.9	4.4	3.8	5.2	5.8	5.2	4.5	6.0	11.4	6.8	6.5	11.2	5.1	5.7	3.3	5.9	6.9	6.9	6.3	29.2	4.3	5.2	3.8	6.0	5.9	7.3	5.9	9.7	5.5	20.1	6.1	14.3	5.7	3.5	11.0	5.6	5.5	10.5	16.1	12.4	20.5	20.4	8.7	7.0	15.0	14.9	8.9	25.9	19.4	18.3	14.3	21.5	27.9	8.4	34.8	14.8	18.3	14.8	19.3	23.3	12.7	14.1	9.3	10.2	11.7	16.2	26.3	7.8	14.3	19.6	32.4	8.7	10.5	21.6	13.8	38.1	12.2	19.1	26.3	20.5	8.9	3.6	10.9	16.5	17.0	25.8	11.9	7.8	16.1	17.7	14.0	7.6	15.7	10.3	14.5	18.5	4.5	8.7	19.2	15.3	30.5	23.4	53.1	31.6	13.2	21.3	21.1	8.1	10.0	23.1	14.6	11.2	12.9	15.1	14.5	15.5	15.2	18.0	14.8	14.4	10.0	18.5	9.0	17.1	21.5	8.7	5.3	7.6	6.9	8.1	5.2	5.8	6.8	6.5	6.9	5.9	6.1	10.5	5.9	6.4	11.1	6.2	8.3	2.7	3.0	8.2	5.2	12.3	5.2	6.2	3.9	8.6	6.3	7.3	12.5	7.4	12.2	3.6	9.8	7.7	102.7	12.3	8.4	5.8	4.9	13.5	18.4	6.9	7.7	6.1	6.1	5.7	2.5	8.1	6.1	3.6	6.3	10.1	9.4	4.0	10.2	5.4	4.8	53.3	6.2	6.0	3.6	14.0	4.0	5.9	10.3	9.0	32.1	5.5	2.5	7.2	10.5	2.5	3.2	5.1	19.9	39.0	6.6	3.8	6.0	36.8	15.7	6.4	2.8	4.1	10.8	9.6	5.5	1.7
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 13.4;Bipolar cells: 38.7;Leydig cells: 18.3;Peritubular cells: 38.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.6;HSkMC: 11.6;hTERT-RPE1: 18.8;SiHa: 9.7;U-2 OS: 6.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	11	"spinal cord: 18.9"	HPA042807	Approved				"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"			"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.49e-4)"	1.8	0.7	1.9	0.9	1.7	0.5	4.9	2.3	1.8	5.6	0.8	2.8	0.4	1.5	0.2	8.2	2.1	1.3	4.7	1.2	3.6	1.7	0.5	5.1	0.2	4.3	4.4	3.3	1.5	0.1	5.1	3.7	3.0	7.9	0.3	2.0	5.3	0.9	1.6	11.4	2.3	0.5	3.1	1.0	1.7	7.2	3.7	0.0	3.1	1.3	0.2	2.7	12.0	2.0	0.3	0.4	0.4	0.2	0.6	1.5	0.1	4.1	2.4	0.8	1.6	0.3	0.4	0.2	0.3	6.6	0.2	1.6	0.1	0.1	0.4	1.5	0.6	0.8	0.4	0.0	5.1	0.2	0.5	11.6	0.7	1.1	0.1	18.8	0.0	0.1	0.4	0.3	1.6	2.7	0.2	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.3	0.0	0.7	0.4	9.7	0.1	0.3	0.4	0.1	0.5	0.7	2.0	6.7	0.5	0.2	0.3	0.0	0.1	0.8	0.9	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	1.7	2.3	1.8	1.2	3.6	4.3	4.4	3.0	3.1	3.7	2.0	1.4	0.0	0.5	2.3	0.0	1.3	0.9	13.4	0.0	38.7	2.1	8.0	1.6	0.0	1.4	0.0	2.1	0.4	0.2	1.8	0.0	0.2	1.7	0.5	6.1	0.9	0.0	2.7	0.5	0.0	0.2	4.7	0.0	0.4	0.0	0.5	0.7	0.1	9.8	1.7	0.7	1.1	0.0	1.2	1.7	2.1	18.3	0.9	1.8	1.9	0.0	1.8	0.0	1.5	0.3	0.6	9.0	38.0	0.0	0.5	0.6	0.1	1.4	4.6	0.0	0.6	1.0	1.0	0.7	2.6	4.3	0.8	0.2	0.1	1.4	1.6
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		33000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	20.8	6.8	27.7	8.9	26.5	0.3	21.9	25.2	34.4	26.0	19.0	8.4	5.1	27.5	5.6	8.1	49.0	14.5	29.1	25.2	25.3	96.2	3.0	31.8	5.6	29.2	28.1	6.1	26.0	18.9	1.1	29.3	29.5	8.7	8.6	67.8	16.1	18.9	15.3	4.8	6.2	28.9	22.0	5.6	5.6	2.4	42.0	3.7	28.5	26.1	6.1	9.6	1.0	22.0	50.9	18.9	42.6	16.3	0.5	0.0	2.6	5.4	4.2	16.9	6.1	121.4	83.1	0.3	109.7	295.8	57.1	34.9	34.3	0.7	15.3	5.4	17.3	0.2	115.0	2.7	1.1	4.2	4.0	0.2	0.4	50.5	0.8	9.4	146.3	1.5	10.5	1.8	16.9	18.0	0.5	1.3	509.7	10.0	43.6	16.2	73.1	15.8	1.6	16.6	34.3	8.9	34.7	7.0	0.2	640.8	4.1	2.2	474.0	6.8	26.6	72.5	226.1	2.5	4.5	1.2	27.1	20.1	48.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	26.5	25.2	34.4	25.2	25.3	29.2	28.1	29.5	22.0	42.0	22.0	165.8	6.4	9.9	3.6	2.4	5.2	0.9	14.0	0.6	9.7	33.3	20.7	22.9	4.3	25.4	27.6	87.6	0.8	1.0	1.0	0.0	4.6	0.8	44.8	13.0	181.1	2.4	2.7	9.4	18.3	0.4	9.2	1.1	121.3	2.5	2.2	65.0	1.0	0.4	5.0	3.3	12.9	4.1	0.9	9.6	1.3	4.7	2.6	5.4	92.8	0.7	10.6	0.0	7.1	3.1	42.7	0.8	0.4	4.3	3.6	0.7	0.8	10.3	188.4	0.0	6.3	8.4	0.3	1.1	1.3	3.1	0.7	3.3	1.9	2.7	5.8
PODXL2	"endoglycan, PODLX2"	ENSG00000114631	"Podocalyxin like 2"	Q9NZ53	3	127629185-127672802	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6;pituitary gland: 59.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 118.1;SCLC-21H: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024934, HPA042265"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"CAB024934: , HPA042265: AB_2677920"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-3)"	3.8	17.3	45.0	2.7	39.9	1.8	8.8	34.1	50.9	2.9	1.9	9.4	7.2	4.4	2.3	4.2	4.3	4.5	4.1	42.3	65.6	7.2	1.6	2.0	2.2	49.2	50.9	11.2	13.5	5.3	59.0	1.0	54.6	13.1	8.2	21.6	24.9	2.0	3.2	7.6	6.7	1.8	32.9	2.0	14.1	30.8	53.6	1.9	5.5	1.8	2.7	3.1	2.8	40.5	0.3	13.8	37.5	89.2	0.0	0.0	55.2	4.3	0.2	7.9	1.6	28.7	1.5	34.0	33.3	0.6	12.1	0.2	30.9	0.0	0.7	0.2	63.3	0.7	30.9	29.3	1.2	78.1	75.7	1.5	6.6	0.2	0.0	20.9	2.2	0.2	45.6	0.2	2.9	17.6	0.3	0.3	56.2	7.9	66.6	0.2	1.0	118.1	10.9	3.9	167.0	94.0	40.9	86.3	77.2	3.7	22.0	39.2	0.4	0.2	17.2	1.5	27.3	0.2	0.0	26.9	0.9	50.1	25.1	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.6	0.5	0.1	45.0	39.9	34.1	50.9	42.3	65.6	49.2	50.9	54.6	32.9	53.6	40.5	1.6	0.0	1.1	10.4	3.4	5.5	3.7	1.3	9.1	96.3	17.5	18.4	0.5	4.3	1.7	9.2	31.3	2.2	4.4	14.3	1.9	6.8	73.5	8.7	2.5	2.2	63.5	5.5	21.3	20.1	5.9	8.2	25.0	12.3	1.3	9.5	0.7	0.7	1.3	82.4	57.7	23.2	4.1	1.3	2.8	153.1	8.7	1.6	21.4	5.6	8.1	19.0	6.2	29.1	12.5	12.9	16.7	5.7	10.4	9.9	10.8	2.9	1.7	49.9	6.6	3.8	9.8	20.4	80.4	10.0	5.5	1.5	3.3	7.5	21.8	3.1
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238658	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 20.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		60000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA054519: AB_2682515, HPA059935: AB_2684171"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	17.6	10.8	7.9	11.7	8.4	10.5	16.5	7.2	7.7	15.2	9.1	20.0	20.4	14.9	14.4	12.4	20.4	11.4	17.5	7.7	7.3	16.1	30.9	12.2	9.1	9.3	8.3	20.0	13.8	23.8	9.1	16.4	8.0	14.5	19.1	5.9	13.0	18.1	12.8	13.7	24.0	18.1	8.0	9.4	11.1	9.5	8.1	10.5	18.9	14.0	10.0	14.0	10.9	8.2	47.1	37.2	31.5	34.7	52.9	51.4	58.8	47.8	56.2	78.8	51.3	111.9	62.1	31.7	69.8	53.5	87.2	51.2	30.5	59.0	68.0	16.5	19.2	47.1	32.1	51.2	41.2	41.0	28.9	45.4	45.7	59.7	38.8	33.5	44.6	30.0	36.3	17.6	55.6	23.1	28.4	31.4	16.2	45.2	59.4	23.3	83.6	29.5	24.2	30.7	20.6	26.5	109.5	30.0	41.0	24.0	44.7	48.5	38.8	113.4	42.2	71.8	82.4	21.4	29.3	28.7	68.5	139.9	73.0	4.3	5.4	2.6	3.2	15.1	3.6	3.2	2.8	3.0	4.6	2.6	3.6	2.5	1.0	2.0	20.9	3.4	3.3	4.2	7.9	8.4	7.2	7.7	7.7	7.3	9.3	8.3	8.0	8.0	8.1	8.2	7.8	9.6	9.5	11.1	5.2	2.9	4.7	8.6	5.2	3.1	7.2	7.1	13.4	8.6	7.9	7.3	2.1	15.2	5.7	17.5	1.9	10.0	0.9	7.1	10.8	9.3	12.0	9.2	9.0	10.4	28.2	12.0	9.2	13.6	5.1	13.1	13.9	39.8	10.7	8.4	9.0	13.4	2.0	8.1	3.8	1.7	10.5	6.5	5.4	6.5	9.3	5.2	3.1	11.1	9.6	9.6	11.9	14.3	8.2	6.7	31.7	5.3	7.2	4.3	13.1	11.1	9.4	2.9	7.3	9.7	1.7	7.7	5.0	26.0	19.0	4.1
POFUT2	"C21orf80, FUT13, KIAA0958"	ENSG00000186866	"Protein O-fucosyltransferase 2"	Q9Y2G5	21	45263928-45287898	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 95.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044297	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA044297: AB_10965176"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (1.49e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.16e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.66e-12)"	"unprognostic (1.56e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-2)"	15.7	20.7	9.4	8.5	9.6	14.0	14.1	9.5	10.9	20.2	21.2	17.3	9.7	16.1	8.9	8.6	20.4	10.3	16.6	9.6	13.8	19.6	20.5	16.1	7.7	11.9	12.1	27.7	19.0	8.2	31.4	16.8	11.8	19.1	6.3	8.6	14.5	10.3	7.8	8.6	15.0	12.0	9.6	16.9	15.3	17.6	13.7	5.3	22.2	5.1	6.5	15.9	13.9	9.6	10.4	11.2	22.1	24.5	39.3	36.1	10.3	57.1	45.4	25.9	38.7	24.0	17.2	7.2	41.9	95.1	58.5	10.4	13.1	22.9	27.9	12.1	15.2	14.4	17.4	18.8	45.4	10.7	18.4	25.6	14.7	32.4	17.7	84.5	25.6	9.5	13.5	11.6	27.4	10.7	5.3	17.7	27.6	17.3	15.7	10.8	6.6	9.1	14.4	9.4	9.6	14.0	33.6	20.3	21.1	24.6	14.8	15.4	28.5	19.5	19.0	30.2	25.8	27.7	15.4	5.5	39.9	13.2	30.8	0.3	0.3	0.8	0.3	0.3	0.5	0.2	0.3	0.2	0.1	0.2	0.4	0.4	0.5	0.3	0.3	0.4	0.3	0.3	9.4	9.6	9.5	10.9	9.6	13.8	11.9	12.1	11.8	9.6	13.7	9.6	12.4	6.4	9.6	19.6	10.7	6.6	7.0	6.8	6.2	6.9	11.8	9.5	8.7	11.5	7.0	12.9	10.4	9.0	14.7	7.4	3.9	7.6	34.9	29.4	17.5	8.7	10.1	7.4	6.8	6.2	13.5	19.8	13.3	15.9	7.0	20.4	10.0	8.6	6.9	5.0	9.9	14.7	4.1	4.8	8.8	51.2	14.6	8.1	8.8	7.5	8.0	10.2	3.1	11.1	7.6	8.0	7.5	13.9	12.4	7.3	6.6	3.9	30.6	14.5	0.0	14.5	17.5	20.1	5.2	4.5	4.0	13.5	12.3	12.2	7.8	7.9
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856359	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630, HPA075919"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: "	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	11.3	9.1	33.8	13.5	38.4	11.0	14.2	32.4	39.2	14.9	25.0	12.3	9.5	15.7	10.9	14.7	11.9	11.2	10.5	30.4	30.8	13.9	11.1	19.5	13.5	34.2	36.5	17.3	13.7	19.5	8.3	14.1	34.8	10.5	13.7	26.5	11.6	13.0	6.8	18.8	11.3	15.2	34.2	14.3	14.0	6.3	34.7	12.3	11.7	9.5	16.9	17.5	11.5	43.4	33.4	27.4	29.5	36.5	30.5	25.2	17.1	22.6	22.7	28.1	21.2	21.0	27.4	37.3	33.1	23.3	23.8	32.6	37.1	29.7	25.6	46.3	25.4	14.9	25.2	15.0	26.0	52.8	39.7	19.2	46.1	31.7	44.9	24.8	25.4	33.9	51.0	24.3	27.0	15.7	33.0	13.2	48.5	38.5	32.2	37.2	16.5	32.9	29.4	79.4	38.4	46.5	32.1	43.6	41.7	43.5	41.7	48.3	24.1	29.7	29.7	23.9	41.2	34.2	47.7	47.8	16.7	25.9	28.7	2.2	6.0	5.1	4.7	7.5	5.1	6.7	4.6	5.1	7.8	3.9	4.2	4.6	0.8	7.5	9.0	3.7	4.3	4.9	33.8	38.4	32.4	39.2	30.4	30.8	34.2	36.5	34.8	34.2	34.7	43.4	11.7	54.5	19.5	12.4	20.2	21.9	26.2	13.0	18.8	30.7	17.8	12.8	10.1	11.5	19.4	12.9	10.4	10.8	15.3	9.8	1.9	16.9	2.8	9.8	19.9	16.0	9.0	5.9	14.7	16.3	12.3	15.4	13.3	15.2	24.1	23.4	15.0	13.4	16.0	48.8	15.7	11.9	4.1	20.1	17.5	1.6	10.8	18.7	8.8	8.4	21.6	16.5	10.3	23.1	27.8	15.0	11.9	18.0	11.6	31.9	9.2	7.3	11.1	29.5	13.1	19.8	17.1	1.0	3.3	25.4	24.0	9.0	13.7	7.8	15.6	28.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468963-119494708	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 81.2;monocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	6.8	7.2	5.9	7.8	6.1	3.1	7.7	6.0	8.2	7.1	6.9	6.8	4.2	9.0	7.8	5.6	6.0	4.7	5.9	5.9	7.2	5.7	6.6	5.6	10.8	6.6	6.5	5.5	7.9	9.5	4.9	8.2	6.6	5.4	7.2	4.2	4.6	11.6	3.2	10.0	7.8	10.4	6.1	9.0	5.4	2.5	7.2	9.7	5.6	3.4	10.8	8.5	6.3	6.7	10.8	7.1	11.7	13.1	29.5	16.8	8.6	16.7	16.7	12.3	18.4	11.5	6.9	16.5	22.2	21.4	10.6	11.9	15.9	16.8	20.4	14.4	10.6	19.3	11.1	12.9	19.1	21.3	21.7	17.5	9.6	13.3	18.0	15.7	15.5	11.2	10.5	19.7	13.9	10.9	12.5	20.7	12.4	18.6	13.8	12.2	12.2	24.0	11.6	13.9	12.7	20.0	8.1	4.9	13.4	11.7	13.2	17.8	19.7	13.1	8.0	3.8	8.9	27.1	25.2	21.7	11.1	20.6	18.8	2.9	16.4	13.9	16.2	15.7	18.7	13.9	18.2	17.0	20.7	10.1	21.1	20.0	1.2	29.5	10.8	11.5	22.3	15.0	5.9	6.1	6.0	8.2	5.9	7.2	6.6	6.5	6.6	6.1	7.2	6.7	19.1	0.0	6.2	11.4	15.7	16.8	7.3	17.4	16.5	13.6	9.7	8.5	5.2	14.3	10.1	20.2	6.2	10.6	17.1	5.2	0.0	6.9	0.7	5.5	19.3	16.1	9.5	8.4	32.7	5.3	14.7	14.5	9.2	7.0	17.7	11.3	13.6	12.5	8.4	5.0	31.6	11.7	22.4	11.9	81.2	0.2	8.7	16.6	12.4	6.5	151.4	10.3	21.6	23.6	25.8	5.0	8.3	17.0	14.1	8.0	8.5	6.0	6.5	13.0	13.1	16.7	13.4	1.5	1.5	13.9	14.9	6.6	15.5	17.4	13.9	5.9
POGLUT2	"EP58, KDELC1, MGC5302"	ENSG00000134901	"Protein O-glucosyltransferase 2"	Q6UW63	13	102784281-102798976	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Extravillous trophoblasts: 23.3;Fibroblasts: 3.8;Hofbauer cells: 3.3;Syncytiotrophoblasts: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.9;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020780, HPA043946, HPA064398"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		44000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256"	"unprognostic (1.97e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (4.81e-4)"	"unprognostic (4.34e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.60e-3)"	4.6	2.3	1.5	3.1	2.2	1.6	3.3	2.2	2.4	5.6	1.6	3.5	1.3	11.1	4.3	2.6	4.3	8.1	4.8	1.5	1.5	4.6	7.7	3.4	2.4	1.8	1.7	6.5	1.6	2.8	2.1	12.2	1.9	2.7	2.7	3.4	1.8	4.2	0.8	2.3	2.1	12.5	1.7	3.6	2.4	1.5	1.9	1.9	2.9	2.5	1.9	6.0	3.2	2.7	8.1	6.0	36.8	35.5	37.0	28.5	9.0	21.4	16.4	19.5	33.5	17.1	11.5	0.0	16.7	17.6	10.0	13.3	26.6	10.9	19.5	3.4	22.1	9.8	16.3	18.8	32.1	25.4	34.5	27.0	12.3	14.8	14.2	29.1	43.0	12.3	16.3	0.0	10.5	9.0	11.4	20.8	23.5	11.5	17.9	0.0	26.3	9.5	53.7	0.7	5.5	33.7	21.0	5.6	12.3	30.5	16.1	10.9	13.3	12.8	9.3	14.7	21.6	7.4	14.4	0.0	25.2	0.0	22.6	0.0	0.0	0.0	1.4	0.0	2.4	0.2	0.7	1.1	0.6	0.0	0.2	0.7	0.0	3.9	0.0	0.0	0.9	0.2	1.5	2.2	2.2	2.4	1.5	1.5	1.8	1.7	1.9	1.7	1.9	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	23.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0
POGLUT3	"KDELC2, MGC33424"	ENSG00000178202	"Protein O-glucosyltransferase 3"	Q7Z4H8	11	108472112-108498384	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	24.6	13.2	5.0	17.3	5.0	7.6	16.2	4.6	5.4	33.6	7.0	16.8	9.4	35.0	27.3	21.0	23.0	21.7	15.2	4.2	5.9	15.6	13.2	16.0	10.4	5.5	6.1	36.5	8.3	25.2	5.4	32.7	5.4	28.4	16.9	5.8	13.9	28.4	5.5	13.7	11.2	37.1	5.3	12.4	11.3	5.8	5.5	16.4	12.1	13.9	9.5	22.5	18.8	6.0	10.9	12.4	46.5	47.8	76.5	88.5	44.8	47.0	43.7	66.0	71.1	58.9	78.1	0.1	28.6	61.6	73.1	7.9	35.6	1.2	69.3	19.4	27.4	18.1	12.1	27.2	30.8	47.7	0.2	51.1	14.6	35.0	1.0	40.1	56.6	0.3	41.5	0.3	101.0	7.9	30.9	27.2	20.3	11.5	34.8	1.5	72.5	0.2	12.3	30.3	9.7	29.5	89.1	6.2	13.3	21.4	42.3	18.0	56.8	127.0	24.9	10.8	49.7	0.4	0.1	0.3	32.6	48.9	103.1	0.1	0.1	0.0	2.0	0.7	1.7	0.2	1.0	1.7	0.5	0.3	1.0	1.5	0.1	1.9	0.4	1.0	0.9	0.5	5.0	5.0	4.6	5.4	4.2	5.9	5.5	6.1	5.4	5.3	5.5	6.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	27.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	21.2	0.5	0.0	0.0	0.0
POGZ	"KIAA0461, ZNF280E, ZNF635"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459494	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 347.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	27.0	32.4	29.4	15.6	42.8	40.2	29.0	51.0	42.9	42.7	20.9	45.4	15.2	36.5	56.2	22.5	45.5	23.7	26.9	27.3	27.9	36.3	29.1	26.4	21.1	44.5	29.0	66.5	29.2	34.5	61.6	16.0	36.2	40.4	21.4	55.3	27.3	25.0	26.1	36.7	29.1	28.2	23.6	32.5	29.8	33.6	34.9	27.3	46.9	20.1	21.7	35.8	32.5	79.1	22.1	28.0	68.4	38.8	29.8	28.7	23.3	18.9	17.3	21.1	21.9	31.3	22.2	45.4	31.5	23.6	16.7	18.6	40.9	20.0	27.5	38.4	22.4	27.8	41.1	18.4	21.8	38.5	26.9	25.7	16.0	23.4	27.8	39.3	34.2	33.4	26.3	42.2	21.5	55.7	42.7	24.4	48.4	22.8	16.5	41.2	33.1	22.8	22.9	34.8	36.6	37.8	31.5	26.3	31.2	56.0	34.3	49.9	28.3	25.2	29.8	21.0	27.2	30.6	27.6	86.1	18.0	20.3	21.7	3.3	1.0	2.5	1.8	0.9	1.5	2.1	1.7	2.4	1.0	2.0	1.8	1.8	2.1	1.3	1.2	1.8	1.4	0.8	29.4	42.8	51.0	42.9	27.3	27.9	44.5	29.0	36.2	23.6	34.9	79.1	42.7	60.9	41.6	167.8	60.6	45.2	26.8	25.2	54.1	83.7	48.4	34.9	18.8	37.1	30.0	64.4	83.4	17.1	34.4	31.8	3.9	22.3	17.0	31.5	40.9	45.0	58.2	29.3	147.8	14.7	11.3	40.2	34.7	43.6	27.8	87.6	47.2	44.4	21.3	79.1	142.4	32.4	20.3	30.0	49.2	12.2	53.7	32.8	51.6	112.4	30.7	37.8	26.8	155.8	347.4	23.7	26.3	73.7	58.9	31.4	29.3	13.7	29.7	60.1	65.7	55.8	41.3	32.3	49.9	40.3	34.1	11.5	39.9	44.0	36.4	28.8
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	3.7	2.0	1.9	4.8	2.5	7.3	5.1	2.2	1.8	4.3	0.8	4.1	2.4	4.2	1.4	3.9	3.7	2.1	3.5	1.3	1.9	2.9	2.0	3.1	6.8	2.3	2.3	5.8	2.8	3.4	1.8	5.6	2.4	3.1	5.2	3.7	3.0	3.5	4.9	4.0	3.5	4.8	2.2	3.5	3.7	2.6	2.1	11.9	3.1	3.1	7.7	3.7	3.8	2.6	32.7	24.6	30.3	24.1	5.2	6.5	6.9	23.6	12.7	25.0	28.3	20.4	17.0	41.1	7.7	9.6	23.4	26.0	59.7	18.7	33.6	21.1	24.8	31.0	42.8	13.5	2.4	41.6	15.5	4.1	3.6	31.2	8.4	5.8	13.0	20.8	28.7	20.0	16.8	22.4	45.2	7.2	30.7	20.3	19.1	39.0	81.5	30.7	7.1	21.1	27.9	16.7	28.1	11.2	11.6	33.0	25.7	11.5	10.1	21.3	14.9	42.4	22.6	11.6	18.1	32.7	12.4	18.3	24.9	0.0	0.2	0.2	0.6	1.4	0.8	1.0	0.8	1.0	0.7	0.4	0.4	0.5	0.0	0.8	0.2	0.2	0.9	0.5	1.9	2.5	2.2	1.8	1.3	1.9	2.3	2.3	2.4	2.2	2.1	2.6	5.8	9.6	6.5	38.5	5.2	2.8	4.6	1.8	5.7	3.9	4.7	4.3	11.8	0.0	7.2	1.8	2.1	6.1	3.2	2.5	3.9	3.2	0.2	3.2	4.7	6.3	4.2	24.2	42.3	3.0	4.9	4.6	4.6	3.8	9.5	8.3	3.3	3.4	4.4	1.7	65.7	4.2	4.1	4.4	1.5	1.7	6.2	4.5	0.0	57.1	3.7	4.8	5.2	59.3	97.7	1.4	1.2	3.4	8.6	2.0	2.3	1.6	6.1	7.4	6.6	9.2	6.0	6.4	4.5	5.5	2.3	2.3	4.9	5.0	4.2	2.4
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261920-65305589	"Metabolic proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.2;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	3.3	2.6	1.9	5.3	2.9	6.9	3.5	4.8	3.3	4.5	1.7	5.3	3.6	5.0	3.3	4.5	3.8	1.8	2.9	1.9	1.5	3.5	3.7	3.5	10.0	4.5	2.8	5.1	3.3	3.2	1.9	2.1	3.7	3.0	4.9	3.6	4.2	3.1	3.1	5.1	4.2	4.1	3.1	5.7	3.8	5.2	2.6	15.9	3.3	3.4	13.2	3.2	3.2	7.0	32.6	21.9	47.3	20.4	3.7	3.6	19.5	25.6	15.9	64.4	43.3	6.9	24.0	48.1	20.4	11.0	35.5	18.9	38.8	25.1	61.1	21.3	14.7	32.4	39.4	10.4	0.9	33.5	25.6	3.7	2.9	47.4	8.5	10.3	14.6	20.2	30.2	25.3	44.4	34.9	62.6	13.2	38.6	16.1	16.2	33.4	29.9	40.7	14.1	21.8	32.5	18.1	14.9	15.9	7.9	29.7	28.6	14.1	3.9	25.4	18.7	19.8	16.0	12.0	14.7	45.0	14.9	18.8	33.7	10.0	5.2	2.3	3.8	3.2	4.5	3.9	4.2	4.2	7.4	3.9	3.5	3.1	1.4	3.8	1.7	5.9	4.6	5.3	1.9	2.9	4.8	3.3	1.9	1.5	4.5	2.8	3.7	3.1	2.6	7.0	2.6	0.0	3.4	1.0	5.1	1.7	4.2	5.7	2.2	2.2	3.0	2.3	2.9	7.2	3.7	5.5	2.1	15.6	4.3	3.0	3.9	5.3	2.7	1.8	2.9	3.7	3.0	23.2	4.3	3.4	19.0	7.7	5.6	2.5	0.0	11.0	5.3	2.1	9.7	3.3	3.6	3.5	2.0	2.8	3.7	4.0	7.5	5.3	0.0	12.2	8.0	2.2	5.2	1.5	8.7	4.9	2.2	7.5	10.4	3.4	1.7	2.0	3.2	5.4	6.6	19.6	5.0	23.7	17.7	4.3	1.4	7.3	5.5	4.0	6.3	3.7
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 254.5;Late spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 280.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	12.4	17.5	26.6	13.5	27.4	51.3	27.4	82.3	35.5	18.9	24.3	12.3	10.8	12.9	19.7	26.5	13.2	17.4	26.1	28.1	29.0	18.0	33.9	14.2	20.2	27.1	27.8	20.4	16.9	18.8	26.7	11.1	28.9	24.8	13.2	18.0	30.3	11.3	85.3	23.1	10.8	10.6	27.6	17.2	14.0	53.1	30.2	24.8	14.2	70.0	22.2	30.8	18.9	28.9	40.2	23.5	40.6	80.4	21.8	20.7	33.8	25.2	29.3	41.5	37.7	33.1	46.0	36.4	31.1	16.5	43.4	20.0	34.1	29.5	50.3	23.8	36.7	26.5	18.2	45.3	34.1	18.6	280.6	18.8	34.4	30.1	35.4	51.8	32.1	77.2	58.4	22.4	40.3	23.6	78.0	52.6	54.4	48.4	26.7	44.2	40.8	31.4	78.4	32.1	22.7	41.8	29.9	19.9	79.0	41.4	52.5	31.5	17.8	19.1	27.0	48.8	24.6	32.5	58.4	52.2	19.3	39.4	52.2	47.6	15.1	48.1	12.0	18.8	13.3	12.2	12.5	13.0	15.7	11.1	14.1	13.3	63.6	22.2	26.3	84.9	19.3	11.5	26.6	27.4	82.3	35.5	28.1	29.0	27.1	27.8	28.9	27.6	30.2	28.9	13.9	3.2	13.6	6.8	20.2	16.8	30.1	14.2	31.3	2.9	14.3	15.1	21.6	7.2	20.7	7.3	8.4	7.5	51.9	3.1	5.9	11.7	254.5	13.8	7.7	12.5	6.0	7.6	15.8	9.6	7.0	9.7	10.2	9.9	23.4	12.7	8.6	12.7	7.4	6.7	20.3	5.4	4.1	5.7	9.9	133.9	7.2	18.2	7.2	19.7	11.2	8.3	13.4	12.5	16.7	33.6	5.8	3.8	21.9	41.6	4.3	6.8	16.4	4.4	0.0	6.6	12.3	19.4	15.4	27.3	20.0	11.1	16.2	7.8	6.6	31.6
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114680-44124358	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	48.4	58.8	48.9	35.0	46.7	44.6	44.4	46.4	53.8	53.4	52.0	39.0	32.4	47.3	14.0	86.6	75.8	18.5	86.8	46.5	47.6	51.6	113.5	36.2	36.9	49.0	49.3	59.3	73.4	62.0	53.0	27.1	49.3	46.8	28.9	22.6	46.6	30.1	118.8	59.9	32.9	32.4	46.9	35.9	48.0	48.7	56.7	46.2	40.6	77.5	33.4	48.2	54.3	45.6	162.2	209.3	114.1	240.5	99.5	105.5	112.9	97.2	97.5	130.6	97.4	178.0	151.4	371.1	121.2	141.1	261.0	218.3	188.9	265.6	84.4	105.9	222.1	82.2	216.3	152.3	112.8	253.4	96.1	96.8	159.6	202.4	195.1	136.3	110.7	245.8	305.4	173.2	146.3	262.7	310.5	476.0	180.0	231.0	203.0	206.4	153.4	528.9	114.0	102.7	225.0	176.2	121.5	430.6	83.7	73.5	249.7	321.6	88.0	171.7	215.8	213.3	310.5	269.3	430.3	359.1	154.1	252.7	248.6	1.7	41.2	10.4	51.6	38.9	77.3	82.2	61.7	52.5	70.8	80.2	81.4	60.5	3.3	44.9	38.8	112.7	54.1	69.7	48.9	46.7	46.4	53.8	46.5	47.6	49.0	49.3	49.3	46.9	56.7	45.6	25.6	6.4	31.8	11.8	35.3	49.3	83.0	111.8	42.7	41.6	57.1	62.7	58.2	44.3	54.1	29.5	31.3	69.9	24.3	31.0	103.7	71.9	108.9	53.5	52.4	33.6	41.9	52.2	5.0	59.5	84.1	49.3	40.2	24.9	26.6	65.6	19.2	95.6	46.8	53.8	5.1	53.6	30.5	14.4	26.6	288.0	41.7	15.0	49.8	4.7	13.0	58.1	18.6	5.0	7.8	44.5	25.0	53.4	38.0	127.6	10.0	95.2	69.7	52.0	19.7	55.4	78.6	48.2	52.4	70.5	60.5	35.4	25.7	103.9	81.5	71.3
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	7.9	6.2	6.1	14.6	6.0	10.1	11.1	6.0	7.3	10.6	7.6	17.2	15.7	16.5	12.0	12.9	16.3	14.9	8.9	5.9	6.1	44.5	7.1	11.5	14.5	4.9	5.6	16.0	11.4	7.8	4.6	11.5	5.6	8.3	17.9	14.9	6.8	10.1	7.7	11.6	14.4	15.3	5.1	11.4	15.4	19.6	5.5	15.7	15.0	12.5	15.2	12.7	7.5	7.4	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.1	6.0	6.0	7.3	5.9	6.1	4.9	5.6	5.6	5.1	5.5	7.4	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 129.3;Late spermatids: 469.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	25.9	36.5	51.7	26.3	56.0	68.2	33.3	52.5	54.9	43.2	45.5	36.7	25.8	40.5	34.7	42.6	53.2	24.0	34.4	50.2	51.1	40.6	33.2	36.3	36.2	59.2	54.1	91.1	35.9	34.4	35.6	32.6	53.3	41.3	29.3	30.1	37.7	33.4	34.9	39.1	31.8	35.4	50.6	38.6	44.4	30.8	54.1	48.6	37.6	34.5	46.4	34.8	34.3	58.1	43.7	43.7	96.3	45.4	42.7	48.7	61.7	49.0	41.1	73.6	54.6	51.6	29.5	73.3	30.8	58.2	34.9	49.5	101.0	55.8	57.1	35.6	74.9	58.4	50.8	53.6	39.5	91.9	57.5	33.8	62.5	54.1	56.0	61.4	52.5	54.1	63.7	47.0	58.8	48.5	76.3	65.3	53.5	56.4	40.5	96.5	87.7	49.5	61.4	27.9	31.5	27.2	59.6	51.1	53.0	56.2	47.4	67.4	48.3	46.7	56.0	31.8	50.1	45.3	59.5	67.1	37.8	56.0	67.4	23.3	36.9	29.8	30.9	34.8	32.0	26.9	27.3	26.3	41.9	26.2	29.7	27.1	21.2	28.6	30.9	21.5	31.0	38.7	51.7	56.0	52.5	54.9	50.2	51.1	59.2	54.1	53.3	50.6	54.1	58.1	15.8	19.2	15.1	10.4	28.6	19.6	23.7	13.1	22.2	30.1	23.0	20.6	13.3	17.2	16.0	20.2	20.9	36.5	23.1	22.9	21.5	29.1	129.3	22.9	20.7	18.9	19.2	25.6	7.1	24.9	39.7	23.2	21.4	23.4	24.1	18.8	16.1	19.0	22.2	25.2	8.8	15.8	16.2	25.7	17.9	469.0	21.8	19.9	19.6	18.7	40.3	23.6	22.6	11.6	17.4	26.4	21.2	24.8	24.5	37.2	19.2	20.3	19.5	17.1	46.0	19.3	18.5	33.0	34.5	22.9	17.6	52.1	23.0	22.6	19.0	28.6
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLE3	"CHARAC17, CHRAC17, CHRAC2, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410675	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	25.4	32.9	20.3	34.9	20.9	113.5	31.7	24.7	24.2	25.8	17.3	29.6	25.4	25.2	26.0	39.7	28.2	18.0	26.4	21.2	19.7	23.6	38.1	23.7	53.6	21.9	19.6	22.6	27.4	26.7	11.2	26.6	21.5	23.0	32.8	16.4	27.2	22.8	79.1	37.3	26.3	27.8	20.8	33.0	24.9	41.1	19.8	55.1	21.8	56.4	56.7	28.5	24.8	21.5	85.0	103.3	71.2	107.6	39.8	35.3	62.5	110.3	56.0	122.1	95.6	96.5	75.0	305.5	66.9	65.0	74.5	141.4	140.3	121.4	112.0	58.8	84.7	158.9	97.7	99.5	42.4	333.5	92.2	40.5	82.2	106.3	135.5	44.3	86.0	152.7	225.7	165.6	85.9	215.1	230.6	178.4	92.1	180.7	184.8	232.4	296.3	171.8	53.4	79.8	153.8	88.7	160.2	100.0	89.4	43.0	149.7	148.1	71.3	90.0	122.3	115.2	191.2	86.0	301.5	407.4	82.2	193.5	110.1	77.4	85.4	90.4	83.8	87.0	104.2	86.3	78.9	79.8	83.3	82.4	84.8	79.3	17.5	77.4	71.6	83.6	102.0	135.2	20.3	20.9	24.7	24.2	21.2	19.7	21.9	19.6	21.5	20.8	19.8	21.5	37.2	38.5	30.2	2.0	61.4	93.8	30.8	37.0	66.0	15.0	51.9	49.9	43.6	21.5	35.8	31.3	6.2	60.7	73.9	28.9	43.0	35.7	5.1	45.4	53.7	33.9	24.6	101.6	4.7	45.4	62.5	37.6	22.4	44.1	57.5	41.4	25.7	43.1	49.3	13.5	3.9	36.9	28.5	36.5	66.4	16.4	35.8	44.7	40.9	1.9	60.3	29.9	48.4	3.5	3.6	37.6	13.9	42.5	67.8	36.0	18.3	34.4	35.5	18.3	13.1	47.9	45.7	40.2	93.1	87.6	94.9	34.9	65.5	36.3	42.5	22.6
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958643-74970128	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.7	17.1	16.0	5.4	16.1	23.3	19.9	14.5	25.3	14.7	13.9	16.4	5.9	12.0	2.7	11.4	11.9	7.7	15.0	15.8	14.9	14.5	15.2	12.1	12.5	15.4	15.2	13.6	8.6	3.0	3.1	6.5	15.8	10.7	6.0	7.1	12.2	6.7	29.0	10.5	13.2	7.3	15.1	12.1	14.6	6.8	15.5	5.3	10.3	16.9	7.3	15.0	12.0	17.2	37.4	33.5	3.3	3.3	11.2	23.4	0.0	24.3	29.1	36.6	30.7	43.1	16.2	33.3	19.9	26.6	10.1	16.0	15.6	19.5	39.6	15.5	42.2	28.0	20.3	46.7	38.8	40.4	41.5	23.8	37.0	15.3	33.3	12.6	16.1	4.8	33.9	21.2	28.1	35.6	12.0	110.1	24.2	23.0	59.1	14.1	28.8	29.4	30.3	1.0	10.8	15.9	33.5	13.9	19.1	1.9	10.4	13.6	18.4	8.7	9.6	6.0	24.7	7.3	5.0	12.8	31.2	58.8	43.4	7.0	53.6	19.1	13.3	32.7	14.5	35.2	19.2	16.1	29.7	33.3	20.5	14.7	3.5	10.6	30.2	33.8	20.4	31.8	16.0	16.1	14.5	25.3	15.8	14.9	15.4	15.2	15.8	15.1	15.5	17.2	156.9	25.6	40.4	3.9	83.9	84.5	96.6	82.4	62.0	33.9	89.9	80.4	40.3	48.6	52.6	73.5	43.8	156.3	69.5	116.4	148.7	53.6	12.1	37.3	34.2	96.0	12.2	50.9	6.2	80.7	154.7	66.4	30.5	33.4	61.6	53.9	94.2	147.1	115.6	18.5	6.6	100.8	44.7	113.7	111.5	24.0	67.1	91.9	97.8	9.4	134.1	174.9	87.6	4.0	11.1	83.5	157.5	54.5	55.8	100.3	190.7	182.3	49.2	126.8	78.9	99.4	68.8	45.9	91.5	57.8	97.7	94.0	70.3	108.1	88.3	95.4
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	13.3	11.1	6.8	4.0	5.0	2.6	12.0	4.8	6.3	12.0	4.5	13.3	5.5	12.9	0.4	14.6	11.2	0.9	13.8	6.1	3.5	10.1	12.9	13.8	3.0	9.0	5.8	10.8	10.7	2.9	8.4	2.5	6.5	10.5	0.9	1.4	12.3	2.2	25.0	16.0	14.5	1.3	5.4	16.2	11.9	5.4	5.7	7.3	10.5	10.9	2.4	12.2	12.7	6.3	8.0	17.0	6.7	10.0	7.7	1.6	16.4	16.4	2.7	7.9	5.9	28.0	10.9	14.4	33.6	5.9	16.9	11.8	14.3	4.8	0.9	35.8	31.3	19.4	19.5	11.1	10.8	21.3	33.6	2.4	8.7	7.0	3.0	8.3	12.2	26.8	19.5	5.4	6.1	22.8	16.3	16.5	8.7	13.7	8.2	18.2	13.7	17.4	3.2	19.2	24.5	6.9	26.8	9.6	16.8	6.0	7.7	10.8	17.3	12.8	15.6	28.5	14.2	17.0	9.4	18.6	9.5	14.3	11.6	3.3	4.3	6.1	5.5	4.0	4.3	2.0	4.6	6.8	6.0	3.0	3.7	4.4	1.8	5.0	3.5	4.1	3.3	5.3	6.8	5.0	4.8	6.3	6.1	3.5	9.0	5.8	6.5	5.4	5.7	6.3	15.7	12.8	11.9	11.4	17.2	12.2	11.0	10.7	9.1	7.6	12.0	10.3	19.0	11.5	9.5	11.0	2.1	15.0	33.8	17.2	9.8	10.4	1.3	8.4	9.4	12.4	5.4	9.0	12.9	10.9	15.8	11.9	21.4	11.3	8.2	14.8	14.6	17.8	12.7	3.3	9.9	24.9	4.1	18.5	14.7	1.5	14.3	17.2	19.6	8.4	21.8	6.1	30.9	9.5	11.9	11.4	15.9	10.5	16.8	17.7	10.5	7.5	7.8	6.4	6.6	13.3	12.9	9.2	11.1	11.8	11.9	21.8	21.7	14.8	17.6	15.5
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497054	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017030, HPA023202, HPA078396"	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"CAB017030: , HPA023202: AB_1855523, HPA078396: "	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	4.5	5.8	2.7	4.4	3.0	3.6	4.5	3.9	4.5	6.8	3.0	4.7	3.5	4.7	2.0	4.0	5.6	2.4	5.0	2.8	3.6	5.7	5.3	3.9	5.4	3.2	3.0	7.9	4.7	2.4	4.0	2.9	3.1	5.1	1.9	2.6	3.9	2.9	6.8	4.2	5.6	2.0	2.9	7.5	4.0	12.8	3.1	6.3	5.8	4.2	4.0	4.8	5.3	3.9	8.1	10.4	6.7	7.6	7.2	4.7	8.4	4.6	4.6	7.0	5.9	10.1	6.2	15.7	5.4	2.8	6.5	5.3	9.3	3.9	8.8	4.6	11.0	9.9	12.2	10.5	7.0	14.2	10.6	4.5	4.7	5.3	7.2	8.4	4.7	7.6	18.3	4.7	6.5	10.0	15.3	15.4	7.3	8.6	11.2	13.3	23.8	14.2	6.4	2.4	9.3	10.0	4.4	7.1	8.0	8.7	7.4	12.0	6.1	7.0	9.9	5.8	12.3	8.4	7.2	11.3	5.9	13.4	4.8	7.2	5.2	6.0	6.5	3.2	6.6	10.7	7.5	6.2	9.7	11.9	9.7	9.7	0.9	5.8	8.4	4.4	8.1	4.0	2.7	3.0	3.9	4.5	2.8	3.6	3.2	3.0	3.1	2.9	3.1	3.9	24.6	12.8	21.2	7.8	19.6	8.2	13.7	7.8	16.5	5.0	30.1	37.5	18.4	12.8	13.3	3.7	0.0	13.0	22.7	31.7	0.0	5.4	14.7	16.5	26.7	16.0	10.9	20.4	9.1	3.8	14.4	19.2	14.8	29.2	13.3	9.9	14.6	4.7	9.2	6.7	7.4	13.9	6.1	6.9	7.1	7.3	6.5	17.7	7.2	11.2	8.0	4.5	18.6	13.0	14.1	2.9	21.8	3.0	6.3	9.8	8.9	5.2	7.1	9.2	6.6	92.0	18.4	49.7	9.2	10.8	8.7	4.0	16.2	15.2	19.8	5.2
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	5.0	3.8	2.3	6.9	2.7	4.2	4.8	5.1	2.9	5.9	5.3	7.0	4.6	4.2	3.6	5.5	5.5	4.3	3.7	2.2	2.2	4.7	5.6	5.7	12.9	2.7	2.2	4.7	5.4	3.7	3.2	4.0	2.7	4.7	7.2	7.4	4.0	3.8	8.5	8.5	4.4	6.3	1.8	5.6	4.6	10.6	2.5	12.9	6.8	4.7	14.2	4.8	4.3	3.6	46.7	9.7	13.5	19.9	17.6	29.1	33.0	48.6	13.9	26.2	29.2	12.0	7.9	48.9	12.0	17.6	7.6	11.4	13.1	28.6	31.5	25.9	10.0	15.3	31.6	35.5	13.4	26.8	19.2	19.5	33.4	21.5	11.3	10.6	24.3	14.5	24.0	29.6	33.0	15.0	23.9	6.4	4.2	33.2	7.2	25.1	14.3	11.8	9.9	34.6	15.1	5.4	14.5	12.9	7.3	15.4	17.9	10.8	36.2	23.6	24.4	12.2	25.2	28.0	21.3	91.1	11.8	14.5	27.3	4.1	1.7	2.7	4.2	1.6	3.8	5.0	3.5	3.1	1.3	4.9	2.8	3.0	1.7	4.2	1.6	2.6	4.6	2.0	2.3	2.7	5.1	2.9	2.2	2.2	2.7	2.2	2.7	1.8	2.5	3.6	3.1	12.8	8.2	12.1	15.1	4.7	3.2	4.8	19.4	6.3	3.4	3.3	2.3	5.7	6.5	3.7	10.4	2.4	5.2	6.3	5.9	2.1	11.4	10.2	4.8	2.8	5.4	5.7	14.8	0.9	2.8	5.3	8.2	9.0	0.0	6.1	1.4	2.4	1.7	0.0	15.3	2.2	4.1	2.2	2.2	7.3	3.4	3.0	1.8	6.5	3.2	2.6	2.1	10.1	13.4	1.9	4.5	3.0	12.7	2.2	3.1	2.3	5.4	9.4	0.0	7.0	5.0	25.9	6.7	13.0	3.0	1.9	8.8	5.6	3.0	2.3
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269517-54321266	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.4;Spermatocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	21.2	9.2	7.6	7.2	10.6	7.0	18.2	7.4	9.2	13.8	4.8	9.5	7.8	15.0	14.4	7.2	11.3	9.6	10.7	5.7	8.5	14.4	7.5	10.0	9.6	9.5	8.0	16.7	13.4	15.8	11.5	14.8	8.3	14.1	8.6	25.4	8.2	14.6	6.3	7.5	6.6	11.5	8.6	9.4	9.7	38.0	8.5	14.6	31.4	5.6	8.4	9.4	8.7	12.9	12.0	4.3	31.4	19.1	10.3	20.1	10.2	9.7	20.6	10.9	18.0	3.2	11.1	5.6	3.1	14.2	11.1	9.6	7.4	11.1	12.2	13.7	3.7	7.1	5.2	8.3	16.9	11.4	5.5	21.9	16.4	9.5	19.6	24.5	23.4	9.1	4.9	15.6	18.3	9.6	8.2	9.9	10.8	3.0	4.7	5.1	6.4	14.1	12.3	15.9	14.6	14.9	6.9	6.0	10.1	20.2	22.1	5.1	11.3	20.4	5.5	3.1	8.2	12.6	3.0	7.9	14.5	10.0	15.1	4.0	6.3	6.7	4.6	3.5	4.3	5.1	4.8	4.8	6.1	6.5	7.0	4.0	3.9	4.9	3.7	4.8	6.1	3.9	7.6	10.6	7.4	9.2	5.7	8.5	9.5	8.0	8.3	8.6	8.5	12.9	8.7	25.6	16.4	24.5	5.0	2.5	8.0	9.1	10.8	15.3	12.1	10.0	10.5	2.8	9.6	5.5	10.4	33.5	4.7	1.8	9.8	9.0	117.4	14.4	12.3	8.0	6.1	5.0	16.5	6.2	16.6	11.0	9.2	10.3	13.3	13.9	8.9	6.1	9.2	3.3	20.3	4.7	8.2	5.9	2.5	25.4	19.9	6.2	7.2	26.2	8.2	18.7	7.2	28.6	43.5	6.2	2.6	18.0	3.3	4.7	3.7	15.6	20.6	23.6	32.9	13.9	9.6	80.1	31.4	4.9	2.6	27.9	6.4	11.7	4.3	3.1
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1D	"AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I and III subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 819.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	72.1	124.8	56.0	57.4	58.5	150.8	90.6	77.5	75.5	102.5	67.2	98.7	86.2	67.5	78.1	142.3	75.7	55.8	90.7	58.4	57.3	84.4	81.2	76.5	90.8	53.4	54.7	118.7	267.3	54.2	69.3	62.3	54.9	88.6	87.4	58.5	112.5	65.7	119.9	143.4	86.6	66.4	52.7	75.6	132.9	76.0	55.3	117.5	62.2	85.0	87.3	91.7	111.7	56.3	103.2	94.8	106.8	110.5	121.6	213.4	143.4	99.2	171.2	129.2	127.7	155.0	203.9	331.3	73.2	113.9	215.7	155.4	200.4	319.8	152.3	102.5	119.0	236.0	97.4	262.9	181.4	215.7	178.0	195.5	330.2	106.0	194.6	143.9	180.9	187.9	132.3	56.6	126.8	106.7	213.2	257.7	259.1	320.2	100.4	144.0	182.6	151.1	204.7	157.2	182.2	142.3	67.3	132.0	381.4	133.9	81.3	198.6	124.9	56.5	90.1	97.9	110.3	92.2	113.1	188.4	49.5	152.3	112.9	80.0	115.9	56.3	71.0	124.4	94.5	83.9	114.9	91.8	130.9	83.8	121.8	98.4	42.0	88.8	113.5	95.9	179.0	83.8	56.0	58.5	77.5	75.5	58.4	57.3	53.4	54.7	54.9	52.7	55.3	56.3	122.5	89.8	108.8	13.7	147.4	336.6	303.0	247.7	385.3	56.6	171.4	241.4	73.5	118.7	123.8	29.5	16.7	155.0	133.9	104.5	74.3	137.2	464.1	100.9	98.4	111.8	124.4	182.4	30.0	309.2	273.2	100.5	126.4	106.3	95.7	125.8	112.5	81.2	165.7	45.4	22.2	203.5	65.1	205.2	148.2	819.5	116.5	142.5	80.0	19.7	260.9	56.5	151.4	13.6	22.3	232.1	124.6	79.0	105.9	256.2	210.1	152.1	58.5	44.0	78.9	105.2	164.4	268.0	81.9	307.8	317.0	145.8	148.5	179.8	197.2	345.7
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1, RPA49"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485948-37503697	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	20.8	15.3	9.4	14.6	9.7	13.1	24.0	9.7	9.0	22.7	7.0	17.9	8.5	24.3	14.8	13.9	20.0	12.6	18.4	8.8	10.6	8.4	29.7	11.9	19.3	9.0	9.5	42.4	27.9	11.5	9.4	8.3	9.4	14.0	10.9	8.9	18.0	17.4	19.1	15.7	10.9	22.5	10.2	10.9	15.0	9.1	9.6	17.0	13.7	10.5	21.6	17.9	17.0	10.4	58.5	53.7	29.0	46.2	53.2	67.8	18.9	50.6	19.5	51.2	45.0	46.4	18.9	84.1	23.8	58.5	34.9	23.8	71.5	60.0	64.2	81.9	33.6	40.4	68.0	33.3	39.7	78.2	27.5	72.7	20.9	100.4	85.7	32.2	26.5	46.0	107.5	36.0	45.6	28.0	54.5	26.8	51.7	39.7	43.5	47.8	26.7	40.5	26.7	21.4	41.3	33.9	33.7	26.7	43.8	23.8	26.0	51.4	18.3	60.3	91.9	52.3	102.2	19.5	29.6	87.7	20.8	48.8	51.2	0.0	3.5	2.2	14.2	6.0	22.7	10.1	13.5	14.5	5.6	11.5	16.6	14.7	1.1	13.1	5.2	3.9	8.0	7.5	9.4	9.7	9.7	9.0	8.8	10.6	9.0	9.5	9.4	10.2	9.6	10.4	7.2	0.0	8.4	1.6	20.4	28.3	23.7	10.9	21.1	7.0	13.2	15.2	8.6	14.3	7.4	0.0	4.2	15.6	20.0	4.3	7.9	13.8	5.6	5.4	20.1	7.1	1.8	15.4	1.8	21.6	21.4	16.1	8.6	6.7	8.8	14.0	3.9	18.7	7.4	3.3	2.4	7.7	6.1	10.3	8.0	10.7	14.9	8.1	5.4	3.7	9.2	9.2	12.3	1.5	2.1	14.1	3.0	15.1	28.3	23.6	3.1	5.9	4.1	6.9	0.0	22.1	15.9	20.6	23.5	14.0	17.8	8.3	23.7	31.9	11.9	12.7
POLR1F	"A43, RPA43, TWISTNB"	ENSG00000105849	"RNA polymerase I subunit F"	Q3B726	7	19695461-19709037	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	8.6	7.9	5.8	8.0	6.4	17.2	10.2	6.1	9.2	8.9	5.6	7.3	5.6	11.9	5.1	9.5	6.6	6.2	7.8	6.2	6.8	8.0	8.7	6.3	10.5	6.1	6.8	8.8	7.5	9.1	2.7	10.8	6.1	9.7	7.0	3.2	6.1	8.9	7.1	7.6	5.3	11.8	6.6	7.8	5.8	6.2	6.5	8.6	8.7	8.3	12.9	12.2	4.6	7.6	28.0	20.9	15.1	22.6	17.1	21.1	11.7	15.7	11.8	17.9	20.7	17.2	23.9	31.0	44.6	19.6	22.7	24.6	30.9	29.2	33.3	9.9	23.7	28.8	15.9	13.3	26.2	59.4	20.0	19.2	20.3	19.7	23.4	12.1	29.7	21.3	45.0	27.2	26.1	10.1	32.9	55.3	39.3	28.9	23.4	26.3	26.0	32.6	29.7	14.2	10.9	16.4	14.3	38.3	20.0	24.6	15.5	52.5	25.0	37.0	19.8	34.5	38.4	34.4	22.8	77.5	25.0	86.9	55.5	5.7	4.5	1.4	7.9	6.0	12.0	12.5	9.4	10.5	7.0	13.0	10.7	12.6	0.4	17.4	5.9	9.0	9.3	5.8	5.8	6.4	6.1	9.2	6.2	6.8	6.1	6.8	6.1	6.6	6.5	7.6	21.6	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	40.3	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	34.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	16.6	3.0	0.0	0.0	0.0
POLR1G	"A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34"	ENSG00000117877	"RNA polymerase I subunit G"	O15446	19	45406644-45410737	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 14.5"	"Cell line enhanced"	"Detected in all"		"U-251 MG: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	3.2	2.4	2.9	3.3	3.0	2.1	3.1	4.1	4.3	2.4	1.1	2.5	2.4	2.7	1.4	4.3	3.0	2.8	3.5	2.9	2.4	2.7	2.6	2.0	3.5	3.4	2.6	3.5	3.8	2.9	1.9	2.2	3.6	2.2	2.1	2.7	2.8	1.9	6.7	4.4	1.9	3.0	1.1	2.1	1.8	1.8	3.4	2.1	2.3	4.5	4.0	4.1	2.4	3.8	31.4	29.0	5.3	20.6	7.5	6.5	20.3	15.3	5.2	26.2	15.1	32.5	21.5	48.3	14.8	11.3	20.6	29.5	46.4	43.0	18.4	22.1	28.7	24.3	11.0	23.9	12.8	25.3	8.9	9.4	27.3	38.2	20.7	7.0	19.2	16.0	63.0	8.9	25.6	37.0	18.7	9.3	37.0	34.6	27.3	25.1	19.5	32.2	10.5	22.7	30.8	9.6	30.9	40.6	6.4	10.6	19.9	15.4	18.2	36.5	36.7	20.4	200.5	16.1	74.0	51.6	16.8	37.6	25.9	1.5	2.7	0.3	1.4	3.5	3.1	2.7	2.0	2.2	4.2	3.0	2.9	3.5	1.3	3.3	2.8	14.5	1.3	2.0	2.9	3.0	4.1	4.3	2.9	2.4	3.4	2.6	3.6	1.1	3.4	3.8	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	26.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0
POLR1H	"A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1"	ENSG00000066379	"RNA polymerase I subunit H"	Q9P1U0	6	30058899-30064909	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	26.0	26.2	5.0	4.3	5.0	2.6	22.4	4.7	9.6	24.4	5.1	22.4	16.8	22.7	4.7	29.3	21.7	1.1	23.7	5.2	6.2	32.3	24.4	19.7	2.9	5.5	5.6	25.4	30.0	2.4	18.0	5.8	5.4	21.1	14.2	4.3	16.8	2.7	25.4	23.0	24.7	4.0	5.4	33.2	26.3	30.5	5.3	13.1	17.5	7.7	3.3	23.0	22.1	5.2	17.9	5.4	20.5	40.9	5.7	5.9	6.9	7.2	19.4	19.9	18.7	23.0	9.3	16.2	7.3	8.1	10.4	10.8	37.4	27.7	25.4	2.0	43.1	24.6	13.7	31.0	36.4	33.8	8.1	22.5	13.1	20.4	49.0	6.4	32.3	25.1	60.8	8.3	15.5	29.9	22.9	67.5	0.0	29.9	28.1	18.1	26.5	30.2	11.5	23.7	12.5	20.0	10.0	19.5	10.4	9.8	19.1	30.4	7.3	19.5	8.0	0.0	23.1	9.7	10.7	20.4	3.4	33.1	25.4	22.1	5.3	4.4	6.5	3.9	6.7	4.9	6.0	6.1	6.3	4.3	6.6	5.1	4.0	5.1	3.9	4.9	7.8	4.0	5.0	5.0	4.7	9.6	5.2	6.2	5.5	5.6	5.4	5.4	5.3	5.2	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	28.2	20.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	43.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	17.6	4.4	0.0	0.0	0.0
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462660-57472009	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	35.1	41.6	49.9	30.4	51.2	43.9	39.6	52.3	60.3	36.8	49.4	36.0	33.1	39.2	67.1	31.2	47.0	31.3	52.1	51.0	52.0	59.8	62.3	47.7	38.7	50.5	51.0	54.3	45.1	55.1	46.9	39.5	51.8	40.4	40.0	59.3	39.0	45.9	74.2	34.5	31.8	40.6	52.4	30.8	36.4	25.4	50.4	47.7	40.8	61.4	44.9	39.1	31.2	54.5	59.3	94.0	81.2	72.7	72.7	62.9	67.6	75.4	84.9	126.0	82.3	121.7	74.7	65.8	86.4	89.3	75.6	60.5	111.9	83.5	134.2	30.2	77.0	51.1	53.5	142.0	81.8	95.0	94.4	57.8	66.4	96.7	88.7	66.6	74.8	90.0	90.2	37.3	81.6	78.6	106.9	98.6	118.4	72.1	138.0	151.4	94.4	120.5	99.7	56.7	102.5	117.4	122.9	69.8	81.4	74.0	51.6	85.2	54.4	76.3	76.3	56.8	89.0	82.2	76.2	135.0	75.3	79.5	102.5	79.8	38.3	70.3	44.6	37.8	49.2	52.4	50.6	42.8	38.1	48.4	60.4	57.4	96.9	64.6	49.5	31.2	54.9	60.5	49.9	51.2	52.3	60.3	51.0	52.0	50.5	51.0	51.8	52.4	50.4	54.5	49.5	25.6	43.0	11.1	49.2	31.0	46.0	51.3	30.1	81.6	39.4	52.5	11.0	41.5	31.9	27.6	56.3	78.8	49.8	38.2	92.0	62.9	5.6	25.0	25.4	39.0	38.2	35.6	13.3	65.8	80.8	40.5	15.8	22.3	61.0	46.1	23.2	25.1	41.2	52.2	13.9	34.5	48.8	22.9	30.3	8.4	51.6	22.7	40.9	8.4	49.1	102.7	58.7	8.0	9.6	59.5	44.6	51.9	40.0	43.9	63.8	120.4	29.4	93.9	46.0	30.0	49.1	50.4	66.4	30.0	30.0	92.9	52.9	49.0	38.4	43.5
POLR2D	RPB4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843553-127858155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 170.2;Spermatocytes: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	12.3	10.4	7.2	14.4	9.8	32.4	11.9	9.6	8.3	9.4	7.3	12.0	9.7	10.3	8.0	12.3	10.6	8.4	10.0	7.5	8.7	8.8	19.2	10.2	19.7	8.0	8.9	15.0	14.7	10.4	8.3	15.9	8.3	9.5	14.7	8.1	8.4	9.2	29.3	11.3	9.3	15.0	8.4	12.8	9.4	74.3	8.1	28.3	9.1	27.1	26.9	15.3	8.4	11.0	63.4	40.6	73.9	51.9	26.8	29.2	59.0	59.1	27.9	69.6	61.9	92.0	50.9	97.7	49.6	40.0	39.8	32.7	107.0	51.2	107.3	57.7	58.3	96.6	37.9	85.4	31.4	104.9	51.6	20.8	37.8	93.3	53.2	19.3	46.1	70.4	137.1	84.8	40.4	50.1	105.0	47.5	103.6	65.9	46.4	99.3	77.8	88.0	23.1	42.6	45.7	60.9	39.9	48.9	50.7	54.7	54.6	71.4	47.0	60.1	84.4	34.4	69.0	99.4	173.4	173.0	52.4	51.2	60.5	9.9	22.8	17.3	26.3	31.7	25.0	22.8	21.0	23.2	29.9	20.2	27.6	23.7	7.3	25.8	35.0	19.5	20.6	21.3	7.2	9.8	9.6	8.3	7.5	8.7	8.0	8.9	8.3	8.4	8.1	11.0	10.9	3.2	11.7	2.6	22.0	10.8	22.0	7.6	15.9	15.1	9.8	6.2	10.4	11.5	10.1	12.9	8.4	33.0	23.4	7.6	11.7	20.3	70.8	13.2	16.1	12.5	8.4	31.1	4.7	17.5	31.0	15.2	9.7	10.4	18.4	23.1	11.4	17.0	21.7	33.7	5.2	11.9	8.2	11.1	14.1	170.2	17.7	13.3	8.8	2.8	23.4	13.2	16.5	2.5	7.5	18.4	8.4	18.4	46.6	26.2	10.2	11.1	6.8	13.7	13.1	18.5	15.5	86.1	48.9	19.3	10.1	26.7	17.1	31.5	14.0	18.9
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II, I and III subunit E"	P19388	19	1086574-1095380	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	30.8	16.7	25.5	16.3	22.9	15.4	18.1	23.0	28.9	13.0	16.0	18.7	13.7	12.8	14.4	22.8	17.3	7.9	14.6	25.9	23.5	23.6	41.1	17.0	18.6	28.1	24.7	14.0	13.2	20.3	12.2	10.3	28.6	12.5	19.5	17.5	14.8	12.1	16.4	16.2	17.0	16.7	23.4	19.3	15.9	13.0	26.6	13.8	17.0	22.6	26.6	14.0	11.2	24.1	33.6	30.8	41.6	33.4	55.6	34.5	19.5	24.2	34.1	39.5	23.1	36.1	11.9	27.5	10.7	72.1	6.1	26.5	79.1	26.9	73.1	29.2	23.9	36.3	36.2	33.9	22.3	54.3	26.4	25.5	17.5	27.7	51.0	40.6	36.7	14.7	42.3	31.0	44.3	27.6	30.0	17.1	33.6	23.9	23.1	31.9	40.7	27.0	39.5	38.3	21.0	23.9	40.2	27.8	17.5	37.2	29.5	24.7	49.9	19.6	21.7	36.0	28.4	47.6	70.9	50.9	32.3	34.6	23.2	24.2	50.2	29.5	25.5	33.7	26.5	18.2	23.2	26.0	44.3	19.6	18.5	18.4	25.2	28.7	38.7	31.2	24.5	38.4	25.5	22.9	23.0	28.9	25.9	23.5	28.1	24.7	28.6	23.4	26.6	24.1	67.7	32.1	63.0	8.1	80.1	104.3	83.9	152.1	59.7	55.7	80.9	82.9	78.2	60.1	79.9	55.2	41.7	234.3	67.4	103.1	174.1	156.7	21.0	64.0	64.4	77.8	70.6	77.4	13.0	141.1	264.1	95.1	66.3	57.2	71.0	74.9	68.9	96.6	259.7	55.5	13.9	91.8	107.8	93.6	221.7	37.8	69.3	103.7	99.6	6.5	361.7	78.1	103.0	4.5	10.6	162.5	84.6	62.1	93.8	111.7	163.1	188.4	72.3	48.9	26.3	50.5	96.9	125.4	82.5	104.1	109.7	234.6	73.4	110.6	130.5	106.9
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II, I and III subunit F"	P61218	22	37952607-38041915	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	4	"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	52.5	61.1	73.4	34.6	92.3	38.9	50.8	77.5	90.2	59.5	56.9	64.9	37.7	53.2	24.8	58.7	50.2	19.5	91.8	74.2	91.2	58.2	118.6	41.6	31.0	87.9	83.9	60.9	47.5	76.5	62.7	30.2	82.6	47.7	28.7	16.8	56.1	39.6	111.0	45.8	42.3	28.8	75.3	36.4	57.6	48.8	86.8	36.7	54.7	68.4	26.3	53.1	52.7	123.7	150.7	176.2	120.6	128.7	141.1	81.7	109.4	138.0	81.0	141.4	130.5	210.0	51.8	117.4	99.1	120.3	138.3	106.4	166.9	135.7	67.1	143.0	303.7	107.3	181.3	289.1	125.9	213.6	67.0	112.4	99.8	186.3	72.1	71.2	118.7	130.4	208.9	93.7	101.9	220.2	168.4	258.2	174.3	175.4	134.7	162.3	110.4	134.5	77.4	94.8	180.6	67.2	129.5	88.9	215.3	69.6	62.9	144.3	110.5	119.8	173.9	150.4	158.1	106.0	178.0	247.9	122.4	107.9	138.4	118.9	92.9	140.8	83.8	90.4	78.5	95.8	71.9	81.8	86.3	71.3	63.1	63.7	122.8	113.7	78.5	123.3	103.4	85.3	73.4	92.3	77.5	90.2	74.2	91.2	87.9	83.9	82.6	75.3	86.8	123.7	82.6	38.5	85.9	9.4	73.2	204.3	113.9	205.4	63.7	26.7	133.8	168.7	0.3	101.5	122.5	121.4	25.0	243.5	70.5	148.7	193.7	160.0	117.0	96.0	117.2	94.8	117.2	109.6	9.9	159.5	303.4	97.4	58.1	82.4	90.0	90.0	98.6	304.4	178.5	28.6	10.7	143.1	116.0	94.2	102.9	42.0	159.7	65.9	225.9	2.8	102.3	99.4	111.2	9.5	99.0	182.4	152.9	151.2	65.7	137.3	196.6	306.5	114.3	33.3	157.8	90.1	197.1	237.0	241.0	106.0	224.3	211.9	82.4	82.7	145.7	121.2
POLR2G	"hRPB19, hsRPB7, RPB7"	ENSG00000168002	"RNA polymerase II subunit G"	P62487	11	62761565-62766710	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053000	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA053000: AB_2682010"	"unprognostic (7.58e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (6.02e-5)"	"unprognostic (8.50e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.21e-1)"	63.1	69.5	75.5	48.3	79.7	70.6	75.3	82.0	101.1	54.8	72.3	53.9	37.3	52.5	85.8	59.2	64.3	41.5	53.5	75.1	80.7	67.7	67.9	49.1	89.1	85.0	76.6	54.6	41.1	57.9	41.1	60.7	84.5	55.2	66.1	76.0	41.9	51.8	45.4	60.9	44.1	66.2	83.8	62.7	49.9	32.6	79.2	112.2	53.6	47.3	106.2	53.1	50.1	90.1	124.4	212.7	225.1	142.9	114.0	111.7	56.7	85.7	107.8	199.8	159.9	129.3	141.4	173.9	192.5	129.8	86.2	118.9	103.6	159.8	176.4	342.3	129.7	116.6	157.2	156.5	159.6	159.7	103.2	108.8	161.2	93.0	185.9	105.6	157.9	160.5	148.5	115.4	143.4	389.4	230.6	209.4	142.3	130.7	218.2	185.6	207.0	234.8	150.8	103.8	95.7	162.1	143.8	112.8	226.2	84.6	318.6	132.6	62.7	101.7	109.0	199.1	101.0	89.0	177.6	192.8	103.7	99.8	139.1	169.9	147.5	164.1	127.2	160.7	124.2	150.4	109.0	126.0	174.9	146.7	103.5	129.6	64.0	154.6	175.3	184.5	151.0	230.5	75.5	79.7	82.0	101.1	75.1	80.7	85.0	76.6	84.5	83.8	79.2	90.1	50.9	38.5	60.7	3.3	69.1	44.9	46.6	209.0	43.3	43.5	47.0	56.3	46.4	55.8	102.3	77.3	8.4	222.1	79.3	27.5	140.8	120.3	7.4	51.3	66.4	73.3	58.6	59.3	1.9	111.3	138.4	69.5	30.5	61.2	90.0	69.6	73.5	73.8	191.6	38.7	2.2	55.1	148.5	74.5	80.7	14.9	70.8	86.4	88.9	2.8	149.2	147.2	118.4	2.5	8.5	93.1	48.3	62.1	39.3	35.1	44.1	150.4	58.0	55.9	78.9	51.8	65.7	36.4	38.9	62.9	60.4	139.0	79.7	91.7	77.6	41.4
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II, I and III subunit H"	P52434	3	184361718-184368596	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	41.6	60.6	50.4	32.5	51.0	31.1	42.2	53.5	60.1	48.8	51.8	54.4	57.6	36.3	39.7	52.1	39.8	30.0	34.8	50.7	49.9	77.5	63.8	37.6	41.1	50.8	50.6	40.2	52.1	35.5	32.9	34.9	50.9	42.9	57.8	14.6	44.2	26.3	37.3	37.8	55.5	35.0	49.8	41.9	51.2	32.3	51.3	39.8	48.3	30.0	40.8	43.4	41.5	52.9	225.2	77.3	81.7	121.4	89.0	62.8	101.2	82.8	86.3	110.8	141.6	199.6	104.6	126.0	201.7	65.0	168.4	88.8	147.4	148.7	98.1	124.4	194.7	121.4	89.8	126.2	80.1	129.3	67.9	81.6	83.3	72.6	129.8	99.4	116.3	124.6	95.3	81.0	89.0	265.6	128.7	172.3	89.0	279.0	159.3	74.3	74.9	171.2	133.9	100.3	122.8	87.3	69.7	214.0	126.9	78.6	267.9	102.4	61.5	52.5	82.9	70.9	224.3	161.7	181.3	237.3	83.4	136.2	71.5	8.3	17.6	15.9	26.8	30.7	32.9	32.9	31.6	29.1	34.0	33.9	45.8	34.8	1.3	29.8	19.2	34.7	36.7	21.6	50.4	51.0	53.5	60.1	50.7	49.9	50.8	50.6	50.9	49.8	51.3	52.9	45.1	38.5	43.8	23.8	39.4	113.4	74.1	113.7	61.5	22.0	70.1	77.0	17.4	47.1	70.2	44.1	16.7	103.2	45.8	132.8	140.8	73.0	21.0	62.3	62.3	57.9	55.7	53.8	12.9	91.2	146.0	52.8	53.5	83.7	31.1	50.4	43.2	58.5	61.4	25.2	15.8	80.2	93.6	21.4	57.5	14.3	46.0	29.9	51.6	9.4	29.0	26.7	32.0	8.5	11.5	97.6	90.9	27.8	52.1	139.7	94.5	150.5	55.1	24.9	39.5	48.0	69.6	92.9	111.0	66.0	74.2	122.3	38.0	71.6	83.1	92.5
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113709-36115213	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1145.8;Late spermatids: 2796.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	32.6	41.0	97.6	23.3	104.3	44.4	34.8	104.2	118.6	30.6	85.8	35.0	28.9	28.4	39.7	40.2	55.7	27.2	78.9	94.6	100.8	32.9	40.2	25.5	31.5	98.5	98.6	50.0	83.9	61.3	26.1	21.8	101.0	30.2	20.2	25.9	66.9	35.9	195.2	41.5	29.9	21.7	98.5	29.7	31.5	66.8	97.4	30.4	37.2	119.7	24.2	28.3	15.7	120.6	96.7	364.7	61.9	103.8	38.5	44.6	67.7	35.5	47.5	80.5	67.5	179.0	62.0	61.6	80.4	38.2	46.8	49.6	60.4	82.5	42.1	107.8	115.5	59.1	88.8	180.9	70.0	88.7	53.1	47.5	71.4	51.7	75.1	51.1	52.8	112.2	66.6	117.1	48.5	292.1	124.6	111.0	74.5	201.6	151.7	130.4	51.6	114.0	94.0	121.3	145.0	74.0	60.1	172.5	59.5	53.7	81.3	92.7	35.7	88.6	91.6	60.3	128.2	83.2	88.4	99.6	102.3	88.0	94.7	130.7	109.5	128.4	113.9	115.2	130.6	168.7	148.3	134.1	90.2	134.8	150.4	117.2	72.5	111.0	113.0	223.8	176.5	114.0	97.6	104.3	104.2	118.6	94.6	100.8	98.5	98.6	101.0	98.5	97.4	120.6	108.2	83.3	66.3	2.9	62.9	79.0	94.9	156.4	75.1	63.1	203.5	279.4	253.5	133.0	124.7	163.7	25.0	144.5	76.3	141.5	352.1	178.2	1145.8	380.4	114.9	101.6	106.2	199.9	2.9	240.5	166.2	96.9	71.4	126.0	82.4	150.0	111.0	282.5	124.3	33.7	3.2	163.3	126.1	72.9	63.8	2796.6	139.1	68.7	168.9	0.0	122.5	183.2	77.2	1.5	7.9	196.8	196.8	154.2	88.5	127.9	221.4	528.2	386.6	73.6	111.7	111.1	125.1	378.2	183.1	155.9	109.0	103.8	68.1	133.7	167.7	90.1
POLR2J3		ENSG00000168255	"RNA polymerase II subunit J3"		7	102537918-102572653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 87.4;Extravillous trophoblasts: 65.6;Hofbauer cells: 42.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5"									"HPA011403, HPA046970"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA011403: AB_2668503, HPA046970: AB_2679882"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.55e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	2.4	2.3	1.0	1.7	1.1	2.1	1.7	1.5	3.1	3.9	0.9	2.2	2.9	3.2	0.4	1.9	3.6	0.6	1.4	1.0	1.3	2.0	2.5	1.9	1.2	1.2	1.1	3.2	1.6	1.5	2.0	1.5	1.2	2.3	1.8	0.7	3.3	0.5	1.0	3.8	3.0	1.6	1.1	3.2	2.2	0.9	1.3	1.4	3.1	2.7	2.9	2.3	1.8	1.2	10.3	4.8	1.9	0.1	0.2	0.8	0.9	6.0	1.7	3.8	4.3	3.8	2.8	1.4	0.4	0.0	5.5	4.8	3.1	2.4	4.1	25.5	5.5	2.9	3.8	1.2	1.1	3.7	2.5	0.4	2.1	1.9	1.9	7.4	6.0	2.4	3.2	2.0	0.6	8.0	8.9	0.5	0.0	3.6	6.0	0.4	3.3	2.4	0.9	1.3	2.0	0.4	10.9	1.0	5.5	2.3	0.0	1.7	4.9	3.4	9.1	0.0	1.5	0.3	0.8	4.6	5.9	2.9	3.9	9.6	4.1	6.5	2.2	1.7	1.3	3.5	2.2	3.2	4.6	3.9	2.7	2.7	9.4	3.9	3.1	3.1	3.3	3.0	1.0	1.1	1.5	3.1	1.0	1.3	1.2	1.1	1.2	1.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	65.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.0	0.0	0.0	0.0	0.0
POLR3A	"C160, hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029515	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	4.3	6.0	6.6	5.2	7.1	3.9	6.2	6.7	7.9	5.1	4.7	4.8	5.1	5.5	7.5	5.0	4.8	3.7	4.9	8.1	3.7	5.2	5.6	4.0	5.7	5.5	3.4	6.5	5.4	6.8	10.4	6.1	5.5	5.8	5.7	12.8	5.0	4.5	11.5	6.7	4.7	5.6	2.2	5.1	4.7	6.0	4.0	7.6	5.6	8.7	6.3	5.0	4.8	6.5	14.2	16.3	17.4	28.8	11.2	14.2	11.6	16.0	20.7	20.2	19.8	22.1	10.0	17.6	9.7	14.0	11.5	15.7	30.3	17.5	24.4	13.0	22.2	14.2	13.6	26.6	10.5	24.6	11.5	12.2	12.3	35.9	33.0	19.4	18.0	14.1	26.8	10.6	19.9	10.6	18.7	15.6	19.0	11.0	75.1	17.5	11.0	11.5	10.0	8.6	15.5	20.0	15.4	28.3	16.6	15.5	21.0	12.7	19.8	12.9	12.5	14.2	32.0	16.4	18.6	21.0	23.0	25.4	6.4	5.4	2.6	1.5	3.5	3.1	3.5	2.6	2.8	3.4	2.4	3.2	2.5	3.0	1.5	3.4	2.9	2.6	4.6	1.9	6.6	7.1	6.7	7.9	8.1	3.7	5.5	3.4	5.5	2.2	4.0	6.5	8.5	0.0	9.1	17.0	8.7	9.9	5.1	5.3	11.4	28.3	9.6	8.3	11.7	8.6	9.5	0.0	64.6	8.0	12.6	6.1	1.9	7.0	1.6	8.3	14.4	8.1	7.2	11.6	26.4	6.2	6.9	8.2	8.2	8.9	6.3	15.7	5.3	9.5	5.5	15.2	26.3	10.2	0.0	6.9	3.7	1.2	13.1	5.9	1.8	10.3	7.8	13.0	12.3	16.1	18.7	8.1	8.3	8.2	11.2	4.7	8.0	5.0	10.4	31.5	6.6	13.6	8.3	12.5	18.0	10.1	9.1	4.1	7.8	13.7	8.6	3.6
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POLR3C	"C82, RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145844402	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 288.2;Late spermatids: 574.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	16.9	8.5	5.0	10.5	5.3	14.7	15.1	8.7	6.5	14.1	4.6	12.0	8.0	13.4	9.3	11.1	12.3	10.9	10.1	5.5	4.9	10.3	10.7	9.7	14.1	4.6	4.6	16.0	14.6	11.9	6.3	10.4	5.1	9.6	11.2	7.9	12.4	8.3	14.7	15.9	11.8	13.1	4.7	12.6	11.3	24.8	5.3	15.3	11.4	10.3	15.6	13.0	12.2	6.5	29.9	23.7	19.0	17.6	23.0	29.3	19.8	30.6	31.5	36.2	34.9	32.6	16.4	51.6	28.9	37.2	19.5	31.6	30.6	30.5	34.9	22.7	24.9	27.9	26.5	17.6	42.1	58.4	35.2	29.3	18.9	42.4	61.7	20.8	21.8	22.0	36.3	30.9	35.6	37.2	27.7	22.1	29.0	29.3	29.7	30.1	23.6	34.1	19.7	20.6	18.2	26.4	26.0	37.5	36.7	28.5	29.5	49.6	26.7	34.0	27.4	19.6	41.9	42.9	48.1	58.8	12.4	28.4	28.3	63.0	31.7	31.9	22.5	36.9	29.5	30.4	24.2	23.3	33.9	33.8	25.1	22.7	2.7	34.0	27.0	35.6	23.3	26.1	5.0	5.3	8.7	6.5	5.5	4.9	4.6	4.6	5.1	4.7	5.3	6.5	12.6	6.4	10.8	12.1	15.6	5.0	8.3	8.8	13.1	3.6	5.5	5.2	23.8	2.8	10.1	3.7	4.2	11.7	18.5	3.5	11.7	14.8	288.2	7.8	7.3	11.2	4.2	19.1	13.0	21.3	12.5	11.0	9.2	7.5	8.2	6.9	9.3	5.2	14.3	1.7	12.4	7.5	8.2	12.6	6.2	574.5	10.2	9.4	1.8	10.3	13.3	5.1	10.3	14.1	12.9	16.5	6.8	14.7	12.2	8.4	8.9	12.8	8.1	3.8	19.7	11.0	9.9	26.1	22.5	10.9	4.3	9.6	13.4	11.1	8.5	9.5
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	15.0	11.9	3.4	4.4	3.3	6.5	10.6	3.0	3.9	14.1	3.8	11.3	2.5	10.4	3.3	15.2	11.3	4.1	14.1	3.0	3.6	11.7	10.0	11.1	4.7	3.7	3.6	14.9	17.5	4.0	13.7	6.6	3.6	12.8	4.5	4.0	10.6	3.8	32.8	11.2	8.6	5.8	3.5	11.4	10.6	19.3	3.9	3.4	10.6	8.3	4.3	15.1	14.4	4.3	5.1	10.7	11.0	7.8	10.0	16.6	11.3	18.9	9.1	10.7	8.7	10.5	3.6	27.8	10.2	12.5	8.9	9.1	16.9	9.2	11.0	6.9	9.4	20.7	10.5	11.2	13.6	5.0	9.5	13.8	12.9	13.4	21.8	13.1	8.9	14.9	28.9	9.5	8.7	7.2	22.2	10.4	18.9	13.0	9.0	14.7	12.2	18.0	6.1	6.0	7.8	24.2	8.5	5.9	17.7	11.9	5.4	8.0	13.0	9.4	9.1	18.8	11.4	17.0	22.7	18.9	9.2	10.1	14.0	0.1	1.4	0.3	1.8	1.1	2.5	2.4	2.3	2.6	1.6	2.2	3.0	1.9	0.1	2.9	1.6	3.5	1.8	1.3	3.4	3.3	3.0	3.9	3.0	3.6	3.7	3.6	3.6	3.5	3.9	4.3	15.0	9.6	6.5	4.6	15.8	19.5	43.6	21.2	13.6	12.8	15.2	14.5	10.9	4.3	13.3	11.0	16.7	16.2	18.5	6.9	11.7	20.2	42.7	11.6	37.7	15.6	21.5	10.3	2.4	11.8	33.2	21.3	12.8	14.8	18.4	18.7	11.7	3.8	13.7	3.3	2.8	19.1	12.2	8.8	8.2	40.5	15.8	8.6	8.8	1.0	13.4	4.5	14.4	2.5	3.5	22.5	6.7	12.8	20.5	52.3	6.7	12.6	11.2	12.2	19.7	22.1	21.3	44.2	52.0	12.1	19.2	27.0	15.0	25.1	12.3	41.8
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POLR3F	"C34, RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467389-18484646	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	6.6	6.5	10.1	6.4	10.9	9.8	9.5	13.1	12.6	6.1	9.7	5.2	5.0	8.0	9.5	7.0	6.8	5.7	9.8	11.1	10.5	8.5	6.4	6.2	7.3	10.1	10.0	8.2	6.0	7.6	3.2	7.5	10.5	7.0	6.1	21.2	5.7	6.6	10.9	7.4	4.4	7.2	9.9	6.3	5.5	9.1	9.9	6.9	11.0	9.5	7.2	6.9	3.0	10.9	12.9	12.6	14.9	15.9	9.5	11.7	22.7	19.0	13.2	23.8	19.3	14.0	12.1	12.0	10.0	14.2	21.3	20.0	20.8	21.2	27.2	8.1	11.0	8.5	7.1	18.6	12.4	22.8	11.9	10.6	14.0	32.2	18.0	13.1	12.9	9.4	19.4	11.7	19.0	15.8	17.3	21.1	17.2	14.3	29.1	11.8	29.4	12.7	13.0	9.1	27.3	17.2	13.9	24.2	32.2	14.0	13.6	15.5	10.1	26.0	13.4	16.2	27.8	11.2	38.0	11.7	10.7	11.0	19.5	0.4	3.0	1.3	2.7	3.7	4.5	3.1	3.6	2.7	3.7	1.7	3.5	3.6	0.8	3.7	3.0	2.7	3.7	2.7	10.1	10.9	13.1	12.6	11.1	10.5	10.1	10.0	10.5	9.9	9.9	10.9	7.3	9.6	4.8	9.8	8.0	8.9	3.7	5.7	10.2	18.3	6.6	5.8	8.3	2.8	5.1	1.8	10.4	10.7	8.5	3.5	9.8	8.8	42.7	8.5	6.7	9.0	6.7	8.2	21.7	6.8	12.1	7.0	4.6	4.8	5.7	8.8	7.1	4.6	7.6	11.8	19.4	4.4	4.1	9.2	6.7	7.7	6.2	5.9	5.4	10.3	10.4	17.5	12.3	15.1	13.0	7.7	1.9	10.1	9.0	4.3	2.9	12.2	11.3	19.3	13.1	8.3	8.3	28.1	22.9	8.4	11.4	7.3	8.0	11.3	4.3	3.2
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
POLR3GL	"flj32422, MGC3200"	ENSG00000121851	"RNA polymerase III subunit GL"	Q9BT43	1	145964690-145978848	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 196.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA027288	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027288: AB_10602119"	"prognostic favorable (2.96e-4)"	"unprognostic (3.58e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (6.52e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	50.3	42.0	33.4	26.5	33.9	28.7	41.9	32.7	42.9	29.8	33.9	41.2	19.8	30.2	27.7	20.1	31.4	21.0	67.7	32.6	35.9	31.7	55.2	31.7	40.5	34.9	33.8	36.2	21.1	31.4	33.3	19.8	33.6	28.7	25.0	28.3	26.2	24.6	139.8	26.9	36.7	24.4	33.1	46.6	33.6	19.8	34.4	41.1	33.7	66.1	41.6	32.7	25.1	33.9	28.5	12.6	28.6	26.4	70.3	78.8	6.9	28.3	43.9	19.0	28.6	3.9	31.0	60.9	41.4	39.6	15.4	8.6	14.1	27.7	28.8	66.8	15.5	40.6	10.6	19.8	43.2	41.1	55.3	60.1	18.1	31.2	36.0	55.5	50.5	64.2	68.9	51.5	73.1	30.5	33.6	51.4	5.9	42.9	27.8	27.8	35.3	92.8	30.6	6.5	15.5	28.8	40.0	2.6	58.3	23.2	24.8	65.5	52.7	17.7	11.7	35.0	19.3	83.9	27.4	47.4	32.1	48.5	16.4	225.8	53.8	266.1	124.2	73.3	119.0	118.4	125.3	123.2	56.0	110.0	126.7	130.6	41.2	116.2	79.0	44.1	179.5	103.5	33.4	33.9	32.7	42.9	32.6	35.9	34.9	33.8	33.6	33.1	34.4	33.9	69.8	28.9	52.8	12.1	63.0	27.9	27.5	52.4	15.9	32.3	34.8	37.8	83.7	52.9	35.7	20.2	8.4	19.9	76.0	35.1	123.3	35.2	38.8	21.9	24.7	51.4	21.1	46.7	6.5	38.6	26.5	40.1	21.9	15.5	85.4	35.6	60.7	84.3	70.2	57.2	7.9	31.1	63.1	70.0	46.6	11.2	45.1	54.9	58.7	10.3	73.1	84.9	196.7	4.0	9.3	38.6	33.8	47.0	48.2	20.1	31.6	41.2	42.7	20.9	26.3	32.6	40.5	22.9	29.4	25.2	30.0	9.4	94.6	50.0	33.1	24.6
POLR3H	"C25, KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525799-41544606	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.6	21.0	40.4	8.5	38.9	5.4	15.1	38.0	49.5	11.0	33.3	13.4	4.8	14.0	9.0	16.4	15.8	7.9	18.3	39.5	38.6	13.5	26.7	14.2	10.0	41.1	41.7	18.5	12.2	11.9	18.2	6.5	38.1	15.4	5.2	7.0	11.5	10.7	13.8	12.1	9.7	11.7	40.1	10.9	13.4	16.2	41.3	8.0	14.1	9.0	7.7	14.2	9.8	39.4	36.4	23.8	21.4	32.7	23.0	20.9	14.8	30.5	27.3	49.0	39.3	47.9	12.0	30.8	21.9	49.9	27.8	17.8	39.8	48.1	30.6	26.3	50.1	18.4	37.1	23.7	23.9	75.3	30.8	26.3	30.8	64.9	17.4	18.8	23.5	29.3	39.5	19.9	28.0	34.4	19.3	20.1	15.6	49.8	28.1	30.0	16.9	32.6	22.9	21.7	21.2	12.5	37.0	39.7	19.3	13.7	15.6	21.1	22.7	29.8	30.7	49.8	39.8	16.7	28.6	46.6	49.5	26.8	28.9	0.1	12.5	0.2	8.8	18.3	12.6	16.6	8.7	10.4	14.2	13.9	11.6	9.7	0.6	5.4	18.6	13.3	5.8	9.9	40.4	38.9	38.0	49.5	39.5	38.6	41.1	41.7	38.1	40.1	41.3	39.4	6.1	0.0	32.0	15.7	14.8	17.7	12.0	19.0	13.6	18.8	24.9	23.4	6.4	14.3	19.8	16.5	16.7	32.9	7.9	5.0	46.9	30.4	42.6	12.7	15.4	10.3	14.3	19.1	10.0	29.6	30.9	14.8	13.3	8.9	11.4	13.1	9.7	33.3	30.5	21.9	7.1	4.8	14.2	9.5	11.0	163.9	16.8	10.2	24.9	1.9	19.6	24.1	18.6	2.0	6.7	27.6	6.6	20.3	21.8	16.8	4.1	40.7	12.7	20.9	0.0	17.9	16.8	51.6	50.9	21.2	25.6	17.9	10.3	21.2	9.5	11.8
POLR3K	"C11, RPC11"	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53608	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	6.9	10.4	12.5	13.1	13.0	11.6	7.0	12.3	13.5	6.4	11.0	8.1	8.3	6.8	7.3	8.7	7.4	5.2	10.3	12.6	12.8	8.2	9.0	6.5	18.4	11.8	11.9	7.1	6.9	12.3	6.1	6.7	12.5	8.0	7.6	5.1	8.4	6.8	20.5	5.3	8.5	6.7	11.5	11.9	8.4	2.6	13.6	13.1	9.5	12.6	16.3	8.8	5.8	13.2	36.1	60.9	37.7	39.4	15.2	9.4	30.3	50.2	16.0	43.4	28.7	79.4	38.2	93.1	37.1	17.7	17.3	35.0	88.5	23.0	31.0	56.5	82.1	68.2	44.5	56.6	11.6	62.1	64.3	9.2	20.4	48.3	24.3	9.9	21.7	40.9	99.0	29.0	28.4	89.9	75.1	41.2	62.3	44.8	57.4	89.9	43.7	96.7	25.0	25.7	55.1	32.5	34.7	63.2	30.8	15.9	37.2	55.2	20.9	28.1	34.5	37.8	61.6	18.5	47.5	183.8	12.1	45.1	42.5	30.5	36.3	93.2	40.4	54.7	42.1	114.6	51.3	46.5	34.4	109.9	45.8	42.6	27.7	41.2	51.8	70.2	87.6	53.1	12.5	13.0	12.3	13.5	12.6	12.8	11.8	11.9	12.5	11.5	13.6	13.2	23.3	3.2	11.3	2.0	31.8	33.3	19.9	34.4	17.6	16.4	29.7	33.8	28.9	18.6	30.3	18.4	4.2	42.5	28.2	17.6	49.0	34.0	0.7	21.6	15.6	20.0	18.0	38.3	5.1	35.0	51.1	16.9	9.2	14.9	22.2	29.7	20.7	27.5	43.7	10.1	4.6	21.8	71.2	15.1	24.3	1.8	21.1	23.2	23.2	3.7	44.1	23.5	34.0	1.0	3.4	37.0	16.2	16.6	28.1	29.6	17.1	43.4	30.6	10.8	13.1	12.0	25.2	4.5	18.9	23.4	44.2	12.9	23.1	58.8	29.3	22.1
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617221-633537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 84.0;Spermatogonia: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	17.2	23.9	19.5	9.1	20.5	6.8	18.1	20.7	28.5	19.3	16.9	22.3	14.5	19.7	10.0	21.0	19.2	5.3	38.0	20.1	17.5	26.2	41.3	16.0	9.6	24.4	20.4	20.7	26.3	11.4	22.7	5.0	21.3	20.7	7.2	5.7	17.2	9.2	69.2	27.9	23.9	6.6	17.8	22.5	21.8	66.6	20.9	11.0	20.1	14.9	7.5	21.5	17.7	24.4	24.5	43.6	9.7	42.1	19.7	11.0	35.7	11.1	12.9	15.7	14.5	44.2	15.9	24.9	22.0	10.2	7.9	24.5	35.5	21.0	11.8	28.3	86.8	19.3	26.4	56.9	20.5	32.6	34.7	10.7	29.3	16.4	19.7	11.3	22.9	34.0	37.3	23.6	14.8	34.3	43.7	44.7	38.4	31.1	30.2	42.0	13.3	42.4	21.4	20.7	30.7	22.1	10.2	26.7	28.4	10.3	15.4	29.9	14.1	17.2	22.0	26.9	33.3	57.4	51.0	38.7	36.9	27.3	21.8	0.0	2.9	2.5	6.2	3.8	5.0	5.6	4.6	4.6	5.5	6.3	3.9	4.5	0.5	6.0	4.2	5.4	3.1	4.6	19.5	20.5	20.7	28.5	20.1	17.5	24.4	20.4	21.3	17.8	20.9	24.4	10.3	12.8	11.5	2.6	14.2	8.0	6.1	5.8	10.2	18.3	9.1	8.0	18.0	15.7	7.9	16.5	18.8	15.5	13.3	31.5	7.9	6.7	39.8	7.7	6.1	9.7	13.1	9.4	2.7	8.0	8.7	8.9	14.3	8.6	12.7	15.1	8.2	21.9	10.4	11.8	2.7	12.7	4.1	8.3	7.4	84.0	12.5	8.0	10.6	3.7	7.4	8.4	18.6	1.5	4.6	6.5	12.4	13.2	7.8	10.3	26.0	15.1	6.4	18.1	6.6	8.9	10.0	31.6	84.9	10.6	7.2	7.7	12.7	15.6	24.4	6.2
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"	A8CG34	7	75416786-75486299	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	14.9	14.0	3.5	15.5	3.8	28.9	14.2	8.0	9.3	13.8	2.4	14.2	12.0	16.6	9.0	15.9	14.1	12.0	13.9	7.0	4.9	13.1	13.2	12.9	18.2	2.2	3.1	18.7	18.1	16.8	13.4	16.4	2.0	13.0	12.9	26.3	14.3	11.5	19.6	17.7	14.0	15.1	0.3	15.5	14.0	12.5	5.2	17.6	16.7	10.7	19.9	14.3	14.3	5.5	41.8	34.1	46.3	89.0	17.1	19.0	30.4	29.7	27.3	23.7	22.8	41.2	26.5	73.4	12.0	32.6	37.2	36.7	39.6	36.7	38.9	49.9	55.1	36.4	39.6	27.8	22.5	97.0	49.5	16.2	22.8	36.3	26.8	34.5	24.6	29.9	103.8	39.8	38.9	41.8	59.5	49.3	36.9	32.0	38.4	53.0	30.7	37.6	13.1	56.0	51.4	67.4	34.3	54.0	23.8	41.5	47.1	34.2	27.4	57.4	30.6	42.2	62.3	42.4	54.4	88.2	37.3	49.1	53.9	0.2	0.4	0.5	1.1	0.5	1.0	0.8	0.9	0.3	0.3	1.0	0.5	0.6	1.2	0.9	0.3	1.1	0.2	0.6	3.5	3.8	8.0	9.3	7.0	4.9	2.2	3.1	2.0	0.3	5.2	5.5	23.1	35.3	26.2	29.4	27.8	18.0	11.8	13.4	33.6	30.7	21.3	23.4	12.6	21.5	21.4	12.9	68.8	13.4	27.2	12.3	5.9	11.8	2.1	14.2	21.3	20.7	28.7	33.9	59.2	17.1	10.2	21.0	31.6	18.3	7.6	28.6	16.8	15.1	12.0	25.2	60.2	17.4	14.2	16.4	15.8	3.8	18.0	21.7	7.2	35.6	17.1	21.3	37.0	28.1	45.6	18.8	8.0	15.4	37.8	24.6	10.0	9.6	18.7	29.4	13.1	26.1	17.4	19.2	12.4	32.9	18.5	17.0	34.0	22.0	17.0	19.7
POM121L12	DKFZp564N2472	ENSG00000221900	"POM121 transmembrane nucleoporin like 12"	Q8N7R1	7	53035633-53036925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	133	"testis: 13.3"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027836	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA027836: AB_10669592"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POM121L2	POM121-L	ENSG00000158553	"POM121 transmembrane nucleoporin like 2"	Q96KW2	6	27285903-27312170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 8.3"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046150	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA046150: AB_10960993"		"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"				"unprognostic (1.43e-2)"		"unprognostic (5.88e-3)"				"unprognostic (3.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.03e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	903	"pituitary gland: 34360.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.8;Late spermatids: 352.6;Spermatocytes: 83.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Group enriched"	"Detected in all"	6	"hypothalamus: 38.0;thalamus: 13.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;THP-1: 2.1"	"Region enriched"	"Detected in all"	7	"hypothalamus: 44.0"	"Region enriched"	"Detected in all"	5	"hypothalamus: 88.1"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	6.1	19.1	2.7	1.2	2.8	1.1	3.5	3.2	4.4	3.0	2.2	6.9	0.4	3.1	0.3	13.7	2.2	0.2	12.1	2.3	38.0	4.9	12.9	3.5	1.1	4.5	3.3	5.0	22.6	0.1	34360.0	1.2	3.7	5.0	0.0	0.2	5.8	0.3	5.7	35.7	4.8	0.1	4.0	11.1	15.5	25.7	13.1	1.2	8.4	5.2	0.4	2.5	3.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	12.6	8.6	11.5	13.2	9.1	16.8	8.8	11.3	15.9	17.4	11.6	12.6	3.8	18.2	8.0	27.9	10.5	9.7	2.7	2.8	3.2	4.4	2.3	38.0	4.5	3.3	3.7	4.0	13.1	3.5	22.3	0.0	2.2	1.0	16.1	4.5	2.2	6.9	2.2	2.6	6.1	6.7	2.5	2.8	2.5	0.0	0.0	0.5	24.4	0.2	15.6	7.8	119.8	0.6	4.9	11.6	0.0	28.8	0.3	17.3	6.0	5.2	4.6	0.6	7.0	9.7	15.4	2.0	34.5	6.7	0.6	0.0	6.1	10.9	7.9	352.6	4.7	17.2	17.8	1.9	8.5	11.5	15.5	0.0	0.3	10.1	1.1	13.2	17.8	4.1	0.1	3.9	0.7	7.5	13.1	4.6	3.8	83.0	27.3	1.6	5.5	0.4	14.9	12.9	0.6	3.8
POMGNT1	"FLJ20277, LGMD2O, MEB, MGAT1.2"	ENSG00000085998	"Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)"	Q8WZA1	1	46188682-46220305	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044518	Approved					NA	NA		17000000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044518: AB_10795985"	"unprognostic (4.59e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (5.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	22.5	40.4	45.8	14.9	51.9	5.5	23.7	52.7	50.4	26.3	44.5	23.9	21.5	24.1	31.1	18.7	26.2	17.8	83.3	45.9	49.8	36.5	40.7	24.0	13.6	55.0	53.3	21.9	29.5	87.5	47.3	20.8	53.8	37.9	17.9	21.8	24.8	27.5	73.9	23.2	19.6	27.8	51.2	24.6	30.3	37.2	50.9	18.8	37.9	48.1	16.2	27.8	21.0	61.0	37.7	39.6	47.3	46.0	51.0	55.3	60.9	49.3	82.7	65.9	51.5	22.6	30.5	34.6	79.7	82.3	112.3	21.1	34.2	70.5	39.3	45.4	38.6	27.3	34.2	34.3	44.6	21.3	25.8	56.2	90.5	73.7	68.2	118.0	68.0	46.6	32.9	21.9	108.9	26.2	37.8	15.3	39.2	21.5	54.7	27.2	48.4	32.7	58.2	45.9	17.9	64.1	45.7	52.1	70.7	67.4	34.8	29.8	50.0	49.2	43.5	56.4	96.4	54.7	65.3	16.1	75.1	20.8	53.5	0.0	1.1	1.2	3.3	2.1	2.2	1.4	2.2	2.6	1.6	2.6	4.1	3.2	0.0	6.2	4.1	4.6	2.5	1.4	45.8	51.9	52.7	50.4	45.9	49.8	55.0	53.3	53.8	51.2	50.9	61.0	12.0	12.8	40.4	15.0	11.7	8.4	40.4	31.0	13.6	38.9	18.5	14.9	44.5	21.5	30.1	35.0	50.1	25.2	17.5	13.9	13.7	39.3	47.6	15.3	13.7	17.5	27.0	9.0	19.4	39.9	27.4	14.8	7.1	27.1	27.1	25.2	14.6	20.5	15.6	26.9	20.6	12.6	16.2	14.6	6.4	15.6	20.2	10.6	24.9	8.4	18.0	21.9	19.6	19.6	33.7	38.7	14.5	13.2	16.9	44.4	19.0	22.8	21.2	36.4	13.1	16.4	16.4	11.2	12.9	12.7	7.5	23.4	13.6	19.0	17.4	33.0
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106079	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA034870: AB_10602701, HPA040989: AB_2677238"	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favorable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	11.0	13.5	22.1	4.2	21.0	20.7	9.9	22.6	23.1	19.4	19.8	14.9	3.6	50.7	11.3	7.5	30.9	9.0	19.1	22.6	20.8	12.8	9.2	10.2	3.1	21.7	21.0	30.4	15.3	17.7	19.1	5.5	24.9	15.2	2.9	9.0	13.8	14.5	31.5	11.7	7.1	19.7	18.1	6.0	13.8	14.8	26.7	5.5	11.8	18.6	2.3	15.2	13.6	17.8	20.0	14.9	8.5	26.0	32.0	8.2	13.5	5.6	10.0	19.5	22.7	18.2	13.7	0.0	20.6	10.2	23.6	0.4	14.0	16.3	8.5	0.1	39.2	14.0	11.1	17.4	12.1	9.9	15.9	9.5	11.9	13.2	7.7	7.7	7.6	29.7	11.6	0.1	7.6	11.8	18.1	2.6	18.7	12.4	27.7	7.0	6.0	12.3	11.6	14.4	13.4	12.2	11.8	9.4	10.9	5.7	17.8	8.6	3.6	15.7	21.9	23.3	23.3	14.5	23.2	0.1	20.2	19.6	17.0	0.0	0.5	0.5	3.0	0.4	2.7	1.9	1.9	1.9	0.6	0.9	2.3	1.9	0.0	1.0	0.4	0.6	1.7	1.0	22.1	21.0	22.6	23.1	22.6	20.8	21.7	21.0	24.9	18.1	26.7	17.8	4.1	3.2	2.0	11.8	2.6	8.0	2.8	3.8	6.8	15.3	8.2	7.5	17.0	10.0	3.4	14.7	8.4	3.4	3.2	2.4	5.9	9.9	10.4	6.9	6.6	3.9	6.0	28.4	13.2	10.7	5.3	14.3	4.6	2.5	0.0	12.6	5.0	6.6	6.2	10.1	14.1	1.9	4.1	4.2	4.8	24.5	19.9	3.7	5.4	3.7	1.1	10.1	5.2	15.6	7.4	5.5	2.0	29.3	3.1	4.4	1.4	5.2	9.2	5.2	13.1	8.5	8.3	10.0	19.0	6.0	11.6	1.8	3.6	3.2	2.7	2.2
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein O-mannose kinase"	Q9H5K3	8	43093498-43131180	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.9;Inhibitory neurons: 6.8;Microglial cells: 7.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013321	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	2.3	2.8	11.6	2.5	12.6	6.8	3.8	6.0	14.5	4.1	0.0	3.3	1.6	2.3	7.2	1.9	2.4	1.9	1.3	12.3	7.9	2.0	3.3	2.6	4.0	8.8	7.6	2.6	3.3	2.6	0.9	3.1	9.1	5.0	3.6	5.9	2.4	2.4	2.8	5.8	1.8	2.6	6.1	3.9	3.2	3.6	11.1	4.9	3.1	2.7	4.1	2.7	0.8	8.8	7.8	9.1	9.2	24.4	8.8	6.6	9.1	4.3	4.7	6.1	6.1	8.4	13.8	9.2	7.7	7.1	2.5	8.2	13.5	11.7	7.9	2.0	4.3	19.2	6.2	15.6	8.3	6.1	9.9	8.7	15.2	11.1	10.8	4.6	9.1	10.1	4.6	15.9	9.7	5.3	14.5	18.6	19.8	11.2	1.7	8.7	10.2	4.1	19.1	11.3	6.5	8.2	12.4	7.5	10.0	10.7	14.9	9.6	9.8	11.6	12.8	11.8	8.1	5.8	11.6	11.7	5.7	6.3	16.0	2.2	0.9	0.8	0.8	0.8	0.9	0.5	0.8	0.8	1.4	1.2	1.0	1.1	2.8	0.9	1.5	2.4	1.2	0.6	11.6	12.6	6.0	14.5	12.3	7.9	8.8	7.6	9.1	6.1	11.1	8.8	0.6	0.0	0.5	2.9	0.7	0.4	0.1	0.3	1.8	1.6	0.3	0.3	0.3	0.0	1.3	0.0	0.0	0.4	1.0	0.5	0.0	0.2	0.0	0.7	1.9	0.3	0.0	0.4	6.9	0.0	0.8	0.6	1.5	1.0	0.0	1.2	0.0	0.3	0.2	0.0	6.8	0.3	0.0	0.3	0.0	0.0	0.6	0.8	1.8	7.5	1.3	0.3	2.1	5.5	6.5	0.2	0.0	0.0	1.5	0.2	0.5	0.1	0.0	1.0	0.0	0.2	0.6	0.3	1.1	2.3	0.1	0.5	0.9	0.6	0.5	0.2
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678959	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	78.9	71.6	77.5	62.9	78.5	66.4	66.7	82.1	101.1	45.1	77.8	66.6	57.0	44.4	78.9	68.7	43.4	46.2	126.3	78.1	83.6	94.1	110.9	65.6	65.4	82.2	83.4	32.9	46.6	51.7	41.7	100.3	83.2	46.6	66.3	56.2	45.1	50.7	175.6	48.5	58.4	57.2	83.6	61.2	54.9	70.0	81.0	64.6	51.4	114.6	70.1	74.0	46.9	86.3	103.4	124.9	129.9	153.1	145.3	161.3	120.3	232.1	203.8	225.5	179.5	245.7	228.7	181.7	136.3	178.6	241.7	150.3	170.7	179.3	307.5	137.7	131.9	171.7	130.1	191.1	203.0	209.6	136.0	131.2	181.9	162.5	149.5	122.3	181.6	139.7	222.2	72.5	291.5	182.5	178.4	295.6	226.1	319.0	146.1	169.6	199.3	122.2	259.6	160.7	152.1	117.1	104.0	147.4	162.2	161.5	103.1	238.5	166.2	108.7	111.2	172.3	195.5	61.5	118.5	255.3	129.2	139.8	243.6	146.4	155.3	101.7	99.9	210.8	88.7	136.4	101.6	113.2	190.8	137.6	71.8	101.9	135.1	95.3	213.9	223.4	132.3	165.2	77.5	78.5	82.1	101.1	78.1	83.6	82.2	83.4	83.2	83.6	81.0	86.3	527.4	131.4	114.2	17.3	218.5	409.8	345.1	1106.2	124.1	110.1	194.3	229.9	806.2	204.5	523.9	239.1	54.2	660.4	255.5	410.0	600.7	566.3	1156.6	266.7	235.8	486.2	228.7	271.5	23.4	699.5	974.0	281.8	128.9	293.0	207.3	181.6	434.1	538.7	780.7	97.6	22.4	315.0	585.9	431.0	673.7	533.7	201.0	407.1	300.6	29.0	612.6	294.7	228.6	13.6	26.1	755.1	414.0	233.6	228.1	443.5	491.8	922.5	472.8	121.8	322.1	193.8	494.6	625.5	240.3	230.1	416.3	972.4	202.7	234.7	335.5	494.3
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320883	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	5.8	12.4	13.2	4.1	14.9	2.5	5.7	13.5	13.4	8.0	12.5	6.7	2.6	6.7	9.8	5.5	5.8	4.0	7.9	12.7	13.1	10.8	9.3	5.6	1.8	14.6	14.6	6.1	8.8	8.6	12.6	7.0	13.4	7.8	3.3	5.6	6.3	6.9	19.1	4.7	4.9	4.6	13.7	5.6	5.9	37.5	14.4	2.9	10.9	8.4	1.9	7.9	5.3	15.4	15.6	19.4	18.6	21.1	13.0	10.3	14.8	13.4	10.8	19.3	16.6	9.6	13.6	4.6	10.6	12.6	27.1	17.1	8.8	13.3	13.5	6.9	12.1	2.8	8.9	7.9	15.8	3.2	8.9	10.5	13.9	18.3	17.8	13.6	11.5	4.5	7.4	10.5	13.0	30.7	5.4	15.0	5.3	21.4	16.2	5.3	18.0	4.1	20.4	11.3	15.6	15.2	8.7	14.6	11.3	12.0	15.1	6.5	9.6	14.6	22.8	17.1	12.0	6.8	14.5	2.1	7.4	4.8	13.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.2	14.9	13.5	13.4	12.7	13.1	14.6	14.6	13.4	13.7	14.4	15.4	3.2	6.4	2.8	27.1	2.0	3.1	2.7	3.4	2.8	7.5	7.2	7.6	4.3	4.3	1.6	1.8	16.7	6.0	1.2	6.5	0.0	7.6	14.3	5.8	6.7	3.1	18.0	0.0	12.9	7.5	10.2	6.1	4.1	7.0	2.5	6.4	2.5	5.7	5.5	8.4	14.5	3.2	2.0	2.2	2.6	17.2	1.8	2.4	1.8	9.4	2.3	5.9	0.0	20.1	30.5	5.5	3.2	4.1	2.1	5.2	2.5	3.6	5.1	15.1	0.0	6.2	5.0	11.3	8.2	5.2	1.8	5.7	1.2	13.9	3.6	1.9
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.3;Late spermatids: 60.8;Spermatocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA049817, HPA071198"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896, HPA071198: "	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	13.7	10.6	5.8	3.6	5.6	6.8	13.2	8.2	9.7	15.3	4.7	15.9	2.4	16.2	4.6	10.7	12.3	2.2	14.7	5.8	6.1	11.3	5.5	10.4	3.3	6.1	5.6	16.6	12.9	2.5	10.1	1.8	5.8	14.4	3.5	6.2	9.4	4.4	19.8	12.2	9.4	6.2	3.9	9.0	12.6	29.5	5.7	4.7	11.3	0.9	3.6	13.9	12.3	6.4	2.8	11.1	17.7	22.7	11.4	4.4	2.6	3.9	6.2	2.7	3.7	6.5	5.0	1.7	1.0	3.6	6.2	1.5	4.1	1.9	2.7	7.0	6.4	7.6	6.2	4.0	2.6	3.4	4.8	3.8	7.3	9.8	3.2	1.4	1.7	2.8	4.2	12.8	12.8	3.5	6.2	14.2	7.9	4.1	5.6	2.4	12.9	2.9	2.1	4.2	9.1	16.7	3.6	16.2	6.1	18.6	6.1	4.5	7.0	8.9	1.2	22.2	9.5	3.2	3.0	12.3	1.7	13.7	12.7	0.6	1.2	2.3	0.8	0.5	1.2	0.8	1.4	1.4	1.2	1.6	1.7	0.9	1.3	1.0	0.6	1.2	1.4	0.4	5.8	5.6	8.2	9.7	5.8	6.1	6.1	5.6	5.8	3.9	5.7	6.4	5.5	3.2	4.1	4.2	8.1	7.0	7.3	11.5	21.1	5.0	8.0	8.4	6.7	2.8	3.5	5.5	12.5	6.9	7.7	8.1	0.0	1.4	45.3	5.8	5.7	4.3	13.1	9.4	8.2	2.2	3.2	8.1	25.5	7.0	5.7	4.7	2.5	1.7	3.2	3.3	8.6	4.8	2.0	4.9	3.3	60.8	6.2	6.5	10.6	2.8	0.8	5.0	2.1	6.6	8.1	1.8	9.3	7.9	15.2	4.7	4.3	5.9	4.1	5.3	13.1	2.9	5.6	33.0	8.0	18.3	7.0	10.4	9.1	2.0	6.3	11.1
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404862-95435329	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 258.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 341.5;Extravillous trophoblasts: 300.9;Skeletal myocytes: 284.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 33.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		160000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	50.6	129.9	196.0	22.7	206.2	10.9	62.6	184.9	258.9	43.3	150.1	69.0	81.6	45.9	61.2	28.6	41.3	53.3	45.5	192.1	209.8	56.5	183.7	105.4	14.3	183.6	197.1	31.6	26.8	28.4	49.8	98.3	186.0	39.5	86.0	30.2	29.9	45.6	15.4	56.6	51.0	51.5	182.0	22.3	27.6	28.3	197.9	13.9	37.7	17.5	33.0	37.6	30.3	205.7	51.1	313.4	250.6	137.2	34.2	74.5	69.6	101.5	118.7	77.3	83.7	72.1	113.8	0.0	138.4	100.9	148.2	33.3	46.2	78.3	87.4	0.8	59.8	25.9	186.3	238.1	53.9	0.1	34.1	108.6	88.7	41.7	56.5	157.8	162.7	0.0	16.9	1.0	231.1	46.6	0.1	29.2	49.2	135.4	71.4	0.0	117.5	12.5	239.4	39.4	17.2	53.5	144.7	159.8	102.9	142.7	47.3	17.0	178.3	115.7	83.7	39.6	100.2	26.2	32.5	0.4	108.1	23.9	154.3	0.0	7.8	0.8	5.0	4.3	4.5	1.6	1.9	4.5	33.8	0.5	2.5	3.5	0.0	8.9	2.3	8.1	1.1	4.4	196.0	206.2	184.9	258.9	192.1	209.8	183.6	197.1	186.0	182.0	197.9	205.7	65.7	128.2	104.3	341.5	4.6	16.8	42.8	201.4	25.6	5.6	51.0	37.6	39.4	67.2	178.5	84.6	0.0	75.6	13.9	121.4	9.8	149.9	5.5	29.9	32.0	86.5	12.6	26.1	0.7	50.6	300.9	36.3	20.4	57.0	14.5	55.2	44.3	151.7	40.5	38.7	1.8	36.3	173.0	20.8	63.7	2.6	16.1	27.4	112.1	72.1	17.4	185.0	10.3	126.2	149.2	75.7	102.2	21.8	4.9	25.7	85.7	55.8	64.6	8.2	19.7	284.5	49.2	2.6	7.5	25.4	16.1	50.3	8.1	44.5	81.0	23.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 616.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.4	3.8	2.1	0.5	2.0	0.0	31.2	1.7	1.9	5.3	1.4	2.0	7.9	0.9	3.6	0.5	1.3	4.4	1.0	1.8	2.1	2.7	616.7	14.2	0.1	2.3	2.2	12.4	14.3	0.2	24.9	0.8	2.9	0.9	2.8	0.1	26.3	3.9	0.3	7.4	3.1	0.2	2.1	0.3	2.3	9.0	2.1	1.6	7.1	0.3	5.9	1.4	0.9	1.9	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	1.7	1.9	1.8	2.1	2.3	2.2	2.9	2.1	2.1	1.9	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29606283-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042748, HPA064577"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA042748: AB_10964774, HPA064577: "	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	11.3	13.6	8.9	5.2	9.4	6.3	10.6	10.0	9.5	8.8	8.5	11.1	4.7	9.7	3.8	13.3	7.7	2.5	14.1	9.1	9.6	13.4	14.4	8.1	5.9	10.1	9.5	7.8	9.5	3.9	8.3	3.7	9.8	8.8	2.9	3.6	10.5	3.2	18.8	11.6	10.5	3.5	9.7	11.4	11.6	12.8	9.8	5.0	9.2	4.0	4.7	9.6	9.3	10.5	44.5	61.9	5.3	5.4	7.8	3.9	26.5	42.1	4.9	9.3	9.3	28.6	10.5	35.2	72.1	7.3	10.1	20.6	10.8	10.0	5.3	79.9	65.1	42.0	19.4	18.2	7.5	51.4	21.6	4.4	8.0	7.9	4.8	5.0	8.2	18.5	34.8	8.0	8.2	36.9	29.7	8.6	10.3	13.6	39.5	19.0	44.7	18.0	5.6	17.1	15.1	16.6	44.4	15.4	18.5	5.0	15.5	12.5	30.0	13.4	40.5	23.1	37.1	30.3	59.7	44.1	17.1	24.8	13.5	73.1	39.7	40.3	35.5	52.1	26.1	48.1	34.2	37.5	39.9	36.4	27.1	32.4	23.3	36.5	43.0	33.2	53.0	45.8	8.9	9.4	10.0	9.5	9.1	9.6	10.1	9.5	9.8	9.7	9.8	10.5	26.4	22.4	20.0	4.9	29.8	12.6	20.0	61.0	15.9	16.6	18.5	21.0	26.1	27.1	29.6	33.1	8.4	53.4	25.8	29.5	80.3	59.5	18.2	29.8	21.5	27.1	17.4	21.4	4.6	78.3	45.0	22.8	17.3	22.6	26.0	22.1	25.4	40.2	62.1	11.8	4.3	27.5	46.8	26.2	18.3	15.3	16.4	27.3	24.9	0.0	57.4	34.1	52.5	4.0	5.8	66.2	26.6	28.2	33.6	20.3	39.4	72.4	38.0	15.5	26.3	18.6	27.8	71.0	15.4	21.4	16.1	47.3	27.4	31.7	26.2	19.5
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581402	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	27.0	51.3	5.2	5.6	6.1	9.5	25.6	6.0	8.9	20.7	6.1	24.6	6.0	21.8	2.4	25.9	20.1	5.1	42.5	5.5	5.9	38.3	40.5	19.0	10.8	6.1	5.7	17.2	25.2	7.3	26.2	2.1	6.4	24.3	2.8	1.2	25.2	4.8	22.9	22.4	24.6	3.5	6.2	31.8	25.4	10.2	5.8	7.9	27.4	3.6	4.3	24.3	21.0	6.4	22.2	43.4	3.8	8.7	10.1	4.5	14.7	14.2	5.7	13.6	11.2	36.6	6.6	13.4	26.9	7.8	6.1	15.7	8.0	30.1	1.1	41.4	42.1	13.5	20.3	26.5	12.1	11.7	11.3	14.1	11.2	13.5	2.4	3.4	8.9	30.2	18.2	5.6	7.5	45.0	18.9	11.2	8.0	14.6	36.5	20.5	9.8	28.5	11.5	18.5	7.4	8.7	27.7	6.5	15.7	2.8	27.5	20.7	11.8	8.1	13.2	13.6	19.8	16.1	35.8	16.7	20.5	21.6	13.3	4.5	12.7	3.1	17.7	14.9	16.4	25.2	14.2	16.2	16.8	18.0	17.6	16.3	0.9	16.0	14.1	26.6	15.8	20.8	5.2	6.1	6.0	8.9	5.5	5.9	6.1	5.7	6.4	6.2	5.8	6.4	24.2	12.8	27.6	10.1	47.8	19.6	38.6	83.7	34.1	22.0	37.5	50.4	60.5	37.1	59.3	77.3	14.6	51.7	49.3	21.6	154.6	44.9	1.7	39.9	30.5	25.4	22.1	30.1	6.4	44.9	42.9	33.8	32.6	24.8	54.6	24.0	24.3	58.3	53.2	18.5	6.9	30.5	54.9	19.8	21.7	5.0	36.1	35.7	49.8	7.5	33.4	79.3	52.5	10.6	8.2	40.0	21.9	37.6	56.8	23.6	31.2	136.2	45.2	34.4	19.7	27.5	39.4	22.7	43.8	53.3	24.7	17.6	46.1	106.3	44.2	33.5
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706121-100707486	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	25.6	31.7	30.1	18.1	31.6	33.9	26.6	33.4	38.6	24.2	23.8	27.9	19.3	27.7	11.0	34.0	21.3	9.8	37.6	32.3	30.8	25.8	67.1	18.2	17.3	30.1	27.8	18.1	31.3	16.6	22.8	16.6	30.8	22.6	9.2	9.6	29.0	13.5	69.0	50.2	22.3	12.1	29.4	22.7	26.4	12.5	29.1	15.6	16.8	31.9	12.0	25.4	24.9	33.9	115.7	115.3	47.2	78.4	25.1	23.9	92.0	65.6	32.4	73.7	73.1	159.8	71.0	97.5	105.1	30.0	81.4	70.4	70.1	79.5	36.8	82.7	212.4	44.9	75.0	166.5	42.1	69.2	49.8	27.6	30.2	76.2	74.8	20.9	41.6	68.9	157.4	77.8	39.8	330.4	158.0	232.9	135.2	77.8	164.4	123.6	50.0	159.4	45.3	65.2	90.4	92.3	54.5	156.2	78.7	42.0	50.0	66.2	41.3	92.0	117.7	191.0	127.6	34.0	99.4	175.8	61.0	115.1	104.6	106.3	63.2	72.4	54.7	64.7	50.7	60.3	54.6	54.3	55.3	47.7	49.5	52.0	39.0	78.9	70.3	51.2	69.8	62.5	30.1	31.6	33.4	38.6	32.3	30.8	30.1	27.8	30.8	29.4	29.1	33.9	30.5	19.2	17.0	2.9	29.7	105.0	32.0	57.2	56.3	26.1	61.6	64.1	27.9	37.1	31.5	35.0	6.2	148.2	25.8	51.8	93.9	75.4	2.1	31.2	32.3	37.2	40.2	50.1	5.2	87.4	181.3	37.3	25.0	35.1	17.7	32.4	33.5	99.0	66.1	32.0	6.0	61.7	67.1	27.3	40.7	7.9	42.0	22.4	56.9	2.8	38.7	41.8	41.2	4.0	5.8	92.2	47.6	37.2	55.1	75.6	69.8	86.1	27.8	21.3	46.0	29.8	52.2	9.2	45.5	74.7	119.2	139.3	27.2	39.9	55.8	43.5
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 405.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 272.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024255	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	3.6	2.1	0.6	3.8	0.5	0.3	3.3	0.8	0.9	7.9	1.3	95.3	2.8	12.5	2.6	2.0	9.6	10.9	405.4	0.5	0.5	2.4	1.0	2.5	6.7	0.6	0.6	2.0	1.3	8.4	1.3	1.4	0.6	16.3	6.2	0.9	3.3	49.2	77.7	2.8	12.2	24.0	0.5	2.8	10.7	1.0	0.6	1.5	2.4	96.9	2.5	35.3	6.0	0.5	0.1	0.2	0.5	0.0	0.2	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.0	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	24.8	0.0	0.0	0.6	2.5	0.0	0.3	0.0	0.2	0.1	0.2	0.1	1.0	0.0	0.2	0.2	0.3	0.5	0.5	0.0	0.7	0.3	0.0	0.4	0.1	0.5	0.4	0.0	0.4	0.8	0.2	0.0	0.2	1.3	0.2	0.7	0.1	0.6	0.5	0.8	0.9	0.5	0.5	0.6	0.6	0.6	0.5	0.6	0.5	4.7	0.0	0.5	1.0	0.6	0.4	0.3	0.5	0.0	3.1	0.9	3.0	272.7	0.0	0.9	0.0	0.0	0.5	2.3	0.4	0.0	0.5	0.3	0.6	0.5	6.4	3.0	0.0	0.8	0.2	0.1	8.0	0.5	0.3	1.3	1.6	1.4	0.2	1.6	1.7	1.2	0.8	0.0	1.0	2.3	0.8	1.2	1.6	0.0	2.8	1.8	1.2	0.0	1.0	1.9	0.5	0.2	1.9	0.0	0.8	0.7	0.3	1.9	2.4	59.2	5.9	11.1	1.0	0.3	0.1	0.6	1.2	1.6	0.6	0.3	0.2
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 37.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 68.5;Club cells: 44.2;Pancreatic endocrine cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 176.9;LHCN-M2: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	5.2	37.3	8.7	3.3	8.3	2.9	4.7	7.0	10.6	9.1	4.5	6.3	2.3	7.1	2.1	10.8	5.8	4.6	11.5	11.2	7.0	3.7	1.5	4.6	3.6	7.1	6.6	4.3	3.5	9.8	4.7	2.4	7.2	4.5	1.6	7.4	4.9	11.6	7.6	5.9	3.7	4.6	6.2	4.5	5.2	5.1	7.7	2.3	6.3	3.5	3.3	6.2	7.1	7.8	13.1	15.6	3.8	26.6	15.9	9.4	1.6	3.7	7.7	5.8	3.9	1.8	19.7	1.1	15.9	8.3	6.5	17.3	5.5	176.9	1.8	8.3	1.8	2.2	9.0	3.8	23.4	2.0	22.5	12.2	20.6	16.8	36.0	13.5	5.3	6.4	1.0	12.1	60.8	3.7	2.0	2.8	4.9	4.0	10.4	4.0	4.6	20.5	9.8	5.1	4.2	6.5	30.8	5.9	5.9	2.5	6.7	1.0	3.3	15.0	7.8	36.4	6.8	10.4	6.3	1.5	43.0	4.9	8.7	16.9	5.5	6.8	10.8	4.9	8.5	3.2	7.1	9.0	6.8	3.5	4.7	7.1	1.1	8.4	4.3	3.6	4.9	4.7	8.7	8.3	7.0	10.6	11.2	7.0	7.1	6.6	7.2	6.2	7.7	7.8	5.4	6.4	2.8	5.2	3.8	4.0	5.3	68.5	8.0	15.4	2.9	4.6	3.4	4.3	44.2	16.5	18.8	0.3	7.3	0.8	1.9	6.9	0.2	13.4	3.5	5.7	6.0	1.3	7.8	9.9	1.3	5.0	3.6	17.8	5.7	3.9	5.0	0.7	3.5	8.4	7.6	2.9	12.2	2.7	4.5	0.1	5.6	2.5	3.6	2.8	3.1	10.1	10.3	6.0	2.8	36.4	1.8	4.1	6.3	2.5	0.2	0.7	8.7	15.5	6.6	4.0	4.8	2.9	4.9	4.2	3.8	8.2	6.9	7.5	1.5	6.6
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
POTEE	"A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma"	ENSG00000188219	"POTE ankyrin domain family member E"	Q6S8J3	2	131218067-131265278	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 1.9;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 6.0;Breast glandular cells: 2.5;Prostatic glandular cells: 2.8;Smooth muscle cells: 2.4;Spermatocytes: 4.9;Spermatogonia: 2.0;Urothelial cells: 2.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;K-562: 1.4;U-2 OS: 2.3"									"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-3)"		"unprognostic (3.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.61e-3)"	"unprognostic (5.77e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.2	1.1	0.5	0.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.0	0.2	0.0	0.0	2.5	1.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	2.4	4.9	2.0	0.0	0.1	0.4	0.1	0.2	0.0	2.2
POTEF	"A26C1B, POTE2alpha, POTEACTIN"	ENSG00000196604	"POTE ankyrin domain family member F"	A5A3E0	2	130073535-130129222	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.6;testis: 1.7"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 1.8;NK-cells: 1.0;Smooth muscle cells: 1.3;Spermatocytes: 2.2;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;BEWO: 2.0;CACO-2: 2.3;MCF7: 1.8;U-2 OS: 5.6;U-266/70: 2.7"									"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA		1900000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.35e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	2.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.1	2.7	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.6	0.1	0.2	0.0	0.0	0.2	1.6	0.9	0.5	0.5	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	2.2	1.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0
POTEI	POTE2beta	ENSG00000196834	"POTE ankyrin domain family member I"	P0CG38	2	130459455-130509707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 3.2;prostate: 2.5;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 2.3;Breast myoepithelial cells: 1.5;Cardiomyocytes: 1.9;Prostatic glandular cells: 1.9;Spermatocytes: 5.8;Spermatogonia: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.4;K-562: 2.0;MCF7: 1.2;RPMI-8226: 1.2;U-2 OS: 3.7;U-266/70: 1.2"									"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (2.52e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"		"unprognostic (3.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.1	0.0	0.1	0.1	0.6	2.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.2	3.3	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	1.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.3	0.5	0.0	0.0	0.0	3.7	0.1	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.2	1.0	1.7	0.8	0.6	3.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.3	1.5	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.1	0.7	0.0	0.0	0.0	0.2	5.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
POTEJ	POTE2beta	ENSG00000222038	"POTE ankyrin domain family member J"	P0CG39	2	130611440-130658037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA						"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (8.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.07e-2)"		"unprognostic (5.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.30e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU1F1	"GHF-1, PIT-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276584	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	137	"pituitary gland: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 homeobox associating factor 1"	Q16633	11	111352255-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 119.4;stomach 1: 40.1"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 566.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 33.5;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	9	"B-cells: 33.5"	"Group enriched"	"Detected in many"	4	"Daudi: 307.2;Karpas-707: 339.3;U-266/70: 326.6;U-266/84: 159.9;U-698: 610.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011193	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB011193: AB_532299"	"prognostic favorable (1.68e-4)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	1.9	1.2	6.4	49.0	4.9	8.1	5.6	4.2	7.0	1.7	20.3	15.7	22.2	1.5	1.3	2.9	1.3	4.7	1.4	5.4	3.6	1.4	1.4	3.3	99.3	6.2	6.1	1.1	0.6	0.3	0.1	2.8	7.2	1.8	13.4	6.5	12.9	1.9	1.8	1.1	38.6	1.2	2.7	79.5	40.1	1.6	5.4	9.6	2.8	0.3	119.4	9.3	1.9	7.3	0.9	0.9	0.3	0.4	5.6	5.2	1.0	0.2	0.1	0.1	0.1	1.1	0.3	307.2	0.7	0.3	0.2	0.8	0.9	0.4	0.1	0.9	0.2	0.5	1.0	1.1	0.1	0.6	1.7	0.2	0.3	0.3	0.6	0.5	0.3	3.4	11.8	339.3	0.3	0.8	1.5	1.6	0.4	0.5	0.5	65.3	0.7	83.0	0.2	0.8	0.6	6.1	0.7	0.3	0.2	2.4	1.3	0.9	2.7	0.5	3.1	0.6	0.5	326.6	159.9	610.8	0.4	0.7	0.5	3.8	0.2	0.6	0.3	0.2	0.2	33.5	0.5	0.2	0.1	24.0	0.4	0.2	1.6	0.5	0.4	0.3	1.2	1.2	6.4	4.9	4.2	7.0	5.4	3.6	6.2	6.1	7.2	2.7	5.4	7.3	0.0	0.0	3.6	0.3	131.3	0.3	7.1	12.3	0.0	0.0	0.0	0.9	1.9	10.0	20.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.4	24.9	0.6	0.2	3.0	6.6	0.1	5.7	0.0	0.8	4.6	0.5	0.0	0.1	0.7	2.4	0.1	0.0	0.1	0.7	2.0	0.6	0.4	10.9	0.3	0.8	8.8	1.0	0.3	0.0	1.0	0.0	4.6	0.4	1.2	0.4	566.8	1.2	0.0	0.4	65.0	0.0	0.0	0.1	1.0	6.3	1.8	0.8	0.0	0.0	4.2	0.0	0.8	8.4
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220876-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 270.6;Excitatory neurons: 187.6;Inhibitory neurons: 184.0;Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	4.0	2.5	5.0	2.2	5.8	3.9	3.4	7.3	5.2	3.6	2.9	3.7	1.3	4.0	2.6	2.7	3.4	1.4	2.6	4.8	3.8	2.9	2.3	3.5	3.0	4.1	4.2	4.1	2.4	3.4	3.6	2.4	3.9	3.2	2.1	12.9	3.0	2.0	4.1	3.5	3.6	1.4	3.8	4.2	2.6	4.3	5.0	3.8	3.3	2.6	3.4	3.4	3.2	4.4	7.4	4.0	14.8	4.5	1.7	1.7	6.1	0.9	1.6	1.7	1.7	8.1	4.2	8.3	3.8	1.5	1.7	5.6	8.8	2.7	2.6	3.3	3.5	5.9	3.9	7.1	1.1	6.5	3.8	1.2	1.6	2.0	3.6	2.1	2.3	5.7	6.4	4.3	2.3	3.7	6.0	4.3	17.4	4.0	2.3	8.7	5.4	3.7	3.1	4.0	9.0	6.9	5.6	4.1	3.7	7.4	4.6	7.9	3.8	3.4	5.3	2.0	3.5	4.4	2.1	18.3	1.6	3.9	4.4	4.6	0.3	0.3	0.2	0.3	0.3	2.0	0.2	0.0	0.4	0.7	0.3	0.2	0.4	0.2	0.3	0.9	0.2	0.4	5.0	5.8	7.3	5.2	4.8	3.8	4.1	4.2	3.9	3.8	5.0	4.4	19.9	12.8	17.2	270.6	25.2	13.4	11.3	9.7	9.6	58.7	12.5	11.8	15.8	14.3	11.6	20.2	102.2	17.8	20.2	12.3	5.9	10.5	26.2	17.7	18.7	19.8	24.1	14.5	187.6	11.6	18.5	17.5	10.2	18.9	19.7	18.7	15.0	13.3	13.3	47.1	184.0	14.3	8.2	52.5	12.4	44.1	25.7	19.9	7.2	114.3	21.7	43.8	14.4	186.0	202.1	16.5	8.0	20.7	33.5	16.1	5.3	8.3	11.5	101.7	26.3	28.4	16.4	17.6	35.7	12.7	11.1	51.7	14.1	11.0	14.5	21.0
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.5;Kupffer cells: 119.6;Langerhans cells: 104.4;Macrophages: 105.0;monocytes: 137.6;Plasma cells: 96.7;Spermatocytes: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 94.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.3;Daudi: 113.0;hTEC/SVTERT24-B: 42.7;U-266/70: 75.5;U-266/84: 80.2;U-698: 88.4;U-87 MG: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	2.6	2.8	6.1	28.0	5.9	8.4	1.7	15.5	10.6	1.1	3.8	4.3	3.1	1.2	1.5	2.0	1.6	3.4	0.8	5.8	15.4	1.4	2.0	3.8	52.1	8.0	9.1	0.8	1.7	0.3	2.0	3.8	9.4	3.0	3.0	1.9	2.6	3.1	1.1	1.4	14.0	2.9	5.8	27.5	5.0	9.2	14.0	6.5	1.5	0.5	48.3	7.1	1.2	6.7	0.9	1.5	1.8	0.1	0.0	2.9	0.5	8.2	52.3	5.1	10.0	0.5	1.4	113.0	2.8	2.9	0.9	1.0	0.6	8.6	23.2	0.3	0.5	2.7	0.3	0.1	0.6	1.1	2.2	2.2	1.6	42.7	2.8	0.4	3.2	2.4	1.3	25.4	1.1	0.8	0.3	6.1	0.4	0.2	0.6	1.3	0.2	0.4	0.2	0.5	1.8	0.8	0.4	0.7	0.8	0.7	0.1	14.1	3.9	22.0	2.3	0.2	1.1	75.5	80.2	88.4	41.3	2.8	3.1	2.6	28.3	0.5	3.1	51.5	2.7	29.3	4.4	4.0	20.9	33.0	2.3	3.3	4.3	1.7	94.9	3.4	7.2	14.4	6.1	5.9	15.5	10.6	5.8	15.4	8.0	9.1	9.4	5.8	14.0	6.7	2.7	0.0	7.0	0.7	225.5	7.8	8.3	14.1	4.6	63.5	7.2	7.6	3.7	2.8	3.2	0.0	6.2	0.9	29.3	2.8	0.0	1.4	15.2	4.0	1.1	7.3	9.5	10.7	19.7	2.8	0.8	2.7	1.5	8.5	6.3	0.5	4.2	1.1	49.5	1.7	10.0	1.6	4.1	119.6	104.4	9.8	0.9	105.0	8.8	32.8	137.6	1.9	37.0	4.5	1.0	3.5	0.1	0.4	96.7	3.8	2.8	0.4	2.4	6.6	0.0	1.7	5.0	75.1	28.8	13.3	8.8	3.7	31.7	0.6	1.0	5.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104853287-104858574	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 45.6;epididymis: 32.4;kidney: 58.8;seminal vesicle: 15.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			1.5	0.1	22.5	0.1	36.9	0.0	0.3	34.6	36.2	0.0	0.0	0.7	0.0	0.0	32.4	0.0	0.0	0.0	0.1	26.3	18.9	58.8	0.0	0.0	0.0	31.0	35.5	0.1	0.0	0.0	0.1	0.0	25.3	0.2	0.2	0.3	1.3	15.2	0.0	1.7	0.1	0.0	22.7	0.0	0.6	0.2	30.6	0.2	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	59.6	53.9	0.6	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	6.5	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	6.4	1.4	0.0	57.3	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	36.9	34.6	36.2	26.3	18.9	31.0	35.5	25.3	22.7	30.6	45.6	0.0	0.0	0.0	1.0	0.5	0.8	0.1	0.0	0.0	3.8	0.0	0.6	1.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
POU4F1	"BRN3A, RDC-1"	ENSG00000152192	"POU class 4 homeobox 1"	Q01851	13	78598362-78603552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.3;retina: 2.6"	"Cell type enriched"	"Detected in some"	10	"Skeletal myocytes: 28.6"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"medulla oblongata: 9.3;midbrain: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.1;HEL: 15.5;JURKAT: 12.2;REH: 10.9;RH-30: 17.9;SCLC-21H: 17.1;U-266/70: 16.1"	"Group enriched"	"Detected in some"	23	"midbrain: 2.5;pons and medulla: 2.1;thalamus: 2.2"	"Region enhanced"	"Detected in some"		"medulla oblongata: 4.1"	HPA068024	Enhanced	Approved				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA068024: AB_2685943"	"unprognostic (6.70e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.53e-1)"		"unprognostic (4.75e-3)"	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.5	9.3	5.2	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.9	0.8	0.7	0.0	0.1	0.8	0.0	0.0	0.8	0.0	0.7	2.7	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	5.1	0.0	0.0	0.0	14.1	15.5	0.0	2.0	0.0	7.7	4.4	0.0	0.1	0.0	0.0	0.0	0.0	12.2	3.1	0.0	0.7	0.0	1.2	1.4	0.0	2.1	0.0	10.9	17.9	0.0	0.0	0.0	17.1	0.2	0.0	0.0	0.7	0.2	0.0	1.5	0.2	0.0	0.0	0.3	0.0	16.1	5.1	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.2	0.4	0.6	9.3	5.2	1.6	1.7	0.8	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	2.0	0.0	28.6	0.1	2.5	2.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038215	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.1	0.3	1.2	1.0	1.0	1.5	1.2	1.5	1.2	6.3	0.4	4.9	4.3	2.3	2.4	1.8	7.1	2.1	3.3	1.0	0.7	16.5	8.0	3.7	1.0	1.3	0.8	0.5	13.0	0.0	0.3	0.2	1.1	7.6	1.1	0.7	0.8	2.4	1.0	2.2	8.0	0.3	0.2	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.2	2.0	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.2	1.0	1.5	1.2	1.0	0.7	1.3	0.8	1.1	0.2	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
POU5F2	"FLJ25680, SPRM-1"	ENSG00000248483	"POU domain class 5, transcription factor 2"	Q8N7G0	5	93733220-93741600	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;testis: 1.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Rod photoreceptor cells: 14.4;Spermatocytes: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA077615	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA077615: "	"unprognostic (1.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.03e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.16e-9)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-3)"	0.0	0.0	0.6	0.1	0.8	0.4	0.2	1.7	0.9	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.0	0.2	1.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.1	0.1	1.0	0.1	0.1	0.1	0.4	0.2	0.0	0.3	0.1	0.2	1.9	1.0	0.1	0.2	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.6	0.8	1.7	0.9	0.5	0.3	1.0	0.5	1.0	0.3	1.0	1.7	2.3	3.2	2.2	0.0	4.3	2.2	2.6	1.8	0.0	10.7	2.8	1.5	0.4	1.5	1.0	1.8	6.2	1.0	4.7	1.3	0.0	1.6	2.7	3.0	3.2	2.5	3.0	3.2	0.0	0.9	0.9	2.1	1.1	3.3	8.2	5.8	2.5	0.9	1.1	16.8	0.0	0.3	0.0	2.4	6.2	7.6	4.7	2.4	1.8	0.0	3.3	2.9	11.3	0.0	0.0	2.1	1.2	1.5	1.8	2.1	1.8	0.5	2.1	14.4	0.0	3.4	1.8	22.3	2.3	0.7	2.7	0.5	4.8	4.6	1.2	2.3
POU6F1	"BRN5, MPOU, TCFB1"	ENSG00000184271	"POU class 6 homeobox 1"		12	51186936-51217708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Excitatory neurons: 22.2;Inhibitory neurons: 29.4;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047021, HPA050411"	Enhanced		Supported	"Nuclear bodies,Actin filaments"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	"Actin filaments"	"HPA047021: AB_2679905, HPA050411: AB_2681119"	"unprognostic (4.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.58e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.11e-3)"	"unprognostic (4.45e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (2.48e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.33e-1)"	2.0	1.5	0.3	1.2	1.3	0.4	1.7	3.6	6.0	3.1	0.0	2.4	0.6	2.5	0.1	0.7	2.2	1.2	1.1	1.4	0.0	1.2	0.5	1.8	0.8	0.0	0.0	3.2	1.3	0.8	2.6	0.6	0.0	2.1	0.2	1.3	2.1	1.4	4.0	1.4	1.5	1.5	0.0	1.5	1.3	0.3	0.3	0.2	2.3	1.3	0.5	1.7	1.7	0.0	0.3	0.8	1.0	1.4	0.3	1.2	0.5	0.5	0.6	0.6	0.7	0.1	0.5	1.8	0.2	0.4	0.3	0.0	1.2	0.0	0.0	2.8	1.8	0.5	1.1	0.0	1.0	0.4	2.4	0.6	0.5	1.0	0.1	1.4	2.0	0.7	0.7	4.9	0.3	0.0	0.2	0.7	1.8	0.0	0.0	0.5	0.6	0.0	0.3	0.0	1.3	2.2	1.2	0.0	2.3	0.5	0.5	1.7	1.5	1.1	0.9	0.3	1.3	3.2	2.8	0.2	1.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	3.6	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.5	6.4	2.8	20.9	2.1	3.1	1.3	0.4	0.0	10.0	2.3	1.3	3.1	1.5	1.7	7.3	4.2	0.6	1.1	0.1	1.9	0.8	5.3	0.9	1.7	4.8	0.0	2.7	22.2	2.0	0.2	3.2	0.5	1.6	5.1	2.4	3.6	1.2	0.3	1.7	29.4	0.3	4.1	2.2	3.9	3.7	5.9	1.1	1.8	8.4	1.7	3.7	0.0	21.1	23.6	1.6	0.2	6.8	0.7	1.8	0.0	0.7	2.7	7.9	0.0	3.8	4.1	0.1	0.7	0.5	2.8	0.4	1.8	0.2	0.6	0.7
PP2D1	"C3orf48, FLJ25449"	ENSG00000183977	"Protein phosphatase 2C like domain containing 1"	A8MPX8	3	19979961-20012267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 2.0;testis: 7.4"	"Group enriched"	"Detected in some"	106	"Early spermatids: 420.0;Late spermatids: 301.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036870, HPA066083"	Enhanced		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA036870: AB_10671246, HPA066083: AB_2685611"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-1)"	0.2	0.1	0.0	0.1	0.0	2.0	0.1	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.1	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.4	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	420.0	0.2	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	301.8	2.5	0.2	0.0	0.0	0.0	0.1	0.0	2.0	0.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.1	3.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Inorganic pyrophosphatase 1"	Q15181	10	70202835-70233911	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 1239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		1000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	176.7	198.5	124.3	116.0	138.8	85.0	186.7	166.7	163.0	96.5	123.0	137.3	99.4	85.8	166.7	157.7	110.2	90.3	100.1	125.8	148.5	123.2	150.2	129.0	132.6	153.1	142.3	56.5	188.5	68.5	92.1	103.7	165.4	68.7	152.5	332.0	116.1	78.7	133.0	85.9	125.1	96.8	159.3	64.2	97.5	73.5	141.6	103.5	126.3	137.3	137.3	167.1	140.0	167.0	446.9	181.2	158.8	471.2	421.6	368.8	148.2	163.5	305.3	250.1	261.8	556.7	230.6	641.0	144.5	164.0	162.8	351.2	470.7	318.4	253.8	599.1	443.5	176.1	169.1	321.7	265.8	439.0	106.9	244.2	372.9	201.3	530.7	273.8	307.9	319.2	416.9	336.4	239.4	262.3	426.5	408.7	165.9	614.2	494.8	256.9	181.7	378.2	527.0	276.3	474.4	159.6	179.3	694.5	148.0	110.8	174.3	194.2	141.0	69.0	262.2	229.4	315.2	110.1	259.2	469.8	106.7	605.2	62.0	0.4	68.8	1.7	48.9	55.2	131.1	83.6	112.3	85.6	190.0	59.4	122.7	106.8	4.1	65.8	63.1	44.4	120.4	105.3	124.3	138.8	166.7	163.0	125.8	148.5	153.1	142.3	165.4	159.3	141.6	167.0	207.0	224.4	165.9	17.0	122.7	267.9	366.2	427.3	158.2	184.9	347.8	363.7	93.3	218.8	275.7	108.5	173.0	313.2	63.4	203.3	201.5	540.1	31.7	278.8	196.1	182.1	162.7	88.4	36.8	776.1	298.3	156.9	114.2	512.1	36.8	208.2	38.2	141.8	96.5	85.8	41.2	254.9	160.7	80.1	148.1	31.7	109.6	120.3	181.5	29.0	612.7	1239.0	65.9	21.6	98.4	532.9	213.5	117.4	161.2	512.4	444.5	551.2	92.1	278.4	65.7	97.2	136.8	173.7	170.7	245.8	257.1	245.7	120.9	203.0	347.6	613.9
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPAN	"BXDC3, SSF, SSF1, SSF2"	ENSG00000130810	"Peter pan homolog"	Q9NQ55	19	10106362-10112012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 243.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043265	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043265: AB_10793943"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (8.75e-3)"	"unprognostic (7.52e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.92e-3)"	23.3	20.5	4.9	15.8	5.3	12.3	20.2	6.6	7.7	18.3	2.5	18.8	12.3	19.3	4.0	27.8	18.9	6.9	17.6	5.1	4.0	18.9	24.5	14.8	18.1	4.1	4.2	19.6	23.2	8.4	13.8	7.5	4.3	19.5	5.8	4.8	16.6	6.8	32.8	28.2	20.0	6.9	1.9	26.5	18.4	18.9	5.5	10.0	16.0	11.1	12.0	20.4	20.5	8.8	51.0	42.0	16.0	35.9	10.8	11.4	34.2	26.7	12.8	33.7	26.3	56.0	19.5	59.0	48.0	17.2	24.4	42.6	42.0	47.7	14.5	31.8	104.6	104.1	47.6	55.2	27.5	66.4	62.5	17.9	36.0	37.0	46.0	22.0	17.2	45.6	76.1	54.9	17.7	72.2	82.5	243.5	75.1	26.8	103.2	60.2	20.5	80.4	19.0	44.8	33.7	41.7	23.9	42.9	40.8	10.6	23.8	37.2	21.1	45.8	24.3	50.6	70.9	111.0	59.3	61.2	31.8	60.2	41.4	2.4	7.1	4.0	6.7	5.0	8.6	17.0	9.2	10.7	6.6	20.6	12.9	5.9	4.7	5.6	3.7	5.0	9.7	3.2	4.9	5.3	6.6	7.7	5.1	4.0	4.1	4.2	4.3	1.9	5.5	8.8	12.2	3.2	6.4	0.0	20.2	57.4	50.3	15.4	4.0	11.3	12.8	14.1	3.9	10.0	12.1	5.5	6.2	26.4	24.0	20.0	3.9	33.2	9.0	4.6	10.5	13.0	6.7	10.3	0.0	30.6	32.0	14.1	6.1	5.1	7.0	13.8	10.4	11.4	32.4	18.5	0.0	17.7	16.2	7.6	17.0	9.1	18.6	10.5	12.4	0.0	15.7	5.0	18.6	0.0	0.0	31.7	12.6	10.5	9.9	33.2	10.3	18.9	5.8	9.9	0.0	18.8	16.7	22.7	42.1	6.8	52.8	17.8	18.9	19.9	24.9	27.9
PPAN-P2RY11		ENSG00000243207	"PPAN-P2RY11 readthrough"		19	10106223-10114780	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.6"									HPA014232	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"				"HPA014232: AB_1854883"	"unprognostic (4.81e-1)"	"unprognostic (5.85e-2)"		"unprognostic (3.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.54e-1)"		"unprognostic (1.61e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.34e-1)"	1.0	0.4	1.6	1.0	1.8	2.1	0.9	1.3	2.4	1.1	0.2	1.0	1.0	0.6	0.6	0.4	1.4	0.4	0.3	1.7	2.0	0.5	0.4	0.6	1.2	2.2	1.6	1.1	1.6	0.7	0.5	0.6	1.5	0.7	0.4	0.6	1.1	0.9	0.9	2.1	1.2	0.5	1.3	2.0	1.1	0.9	1.7	0.7	0.7	0.6	0.9	0.9	0.5	2.0	2.9	2.4	0.9	3.0	1.7	1.9	7.8	2.2	1.0	1.1	1.6	2.9	1.2	7.6	3.2	0.7	0.6	3.9	1.7	2.8	0.4	4.5	16.6	7.1	4.4	1.9	2.3	4.1	8.1	3.0	3.6	1.2	3.0	1.4	0.8	2.9	4.4	4.9	0.8	6.7	4.2	13.4	5.9	2.8	7.9	7.1	2.8	3.6	1.7	2.8	4.2	7.5	0.7	1.4	7.1	0.1	1.4	5.1	1.8	2.8	2.0	5.8	2.4	13.1	9.0	3.6	2.7	8.8	3.2	0.0	0.6	0.2	1.7	0.9	1.8	2.6	0.7	2.6	0.5	1.8	0.5	1.0	0.0	1.7	0.4	0.2	0.7	0.8	1.6	1.8	1.3	2.4	1.7	2.0	2.2	1.6	1.5	1.3	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 44.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 99.4;Hepatocytes: 144.5;Proximal enterocytes: 93.2;Rod photoreceptor cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 10.3;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 10.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	7.9	6.3	9.6	4.5	12.7	6.6	3.8	9.5	6.9	4.1	23.5	11.8	18.4	3.8	3.6	7.7	4.1	4.4	26.3	7.7	8.8	22.4	33.2	4.0	3.4	11.0	11.2	11.2	8.2	7.4	2.6	4.3	10.0	6.2	9.1	18.2	7.8	5.7	26.2	7.7	18.4	4.3	8.6	4.4	6.1	1.3	11.7	3.7	7.0	44.6	3.9	5.1	4.0	10.5	7.8	1.9	2.4	8.4	13.0	8.3	5.3	6.7	13.2	7.0	7.2	3.8	3.7	2.8	3.3	15.6	6.5	3.5	7.1	8.7	6.3	8.1	8.9	8.7	4.8	8.0	8.1	6.0	14.3	6.6	6.9	5.2	11.8	6.0	1.5	6.3	3.2	6.4	6.6	2.0	6.8	2.2	0.3	6.5	1.9	8.0	8.6	3.6	4.7	4.6	2.4	7.0	2.6	2.4	8.0	3.2	2.7	4.6	2.6	7.3	7.7	6.7	2.9	6.3	4.0	1.2	11.4	6.6	2.3	1.4	0.8	10.3	1.0	1.0	0.8	0.8	0.5	0.5	0.6	1.0	0.6	0.4	0.7	0.7	0.7	3.1	1.4	0.2	9.6	12.7	9.5	6.9	7.7	8.8	11.0	11.2	10.0	8.6	11.7	10.5	15.0	3.2	13.6	49.6	8.0	23.3	15.0	7.8	9.1	15.0	14.3	11.4	99.4	22.8	8.9	7.3	62.6	8.0	18.4	58.8	9.8	10.3	0.6	9.4	26.4	15.5	19.9	32.0	1.4	16.6	6.7	16.0	14.8	18.4	5.1	19.1	22.5	144.5	8.8	5.0	13.8	31.4	0.0	24.8	10.2	1.1	19.6	10.4	3.6	10.3	12.2	16.0	8.2	19.6	27.2	13.0	24.5	30.1	10.6	19.1	93.2	40.8	5.0	148.0	6.6	31.0	15.8	0.7	1.7	19.3	34.2	3.0	9.6	14.6	37.9	19.9
PPARD	"FAAR, NR1C2, NUC1, NUCII"	ENSG00000112033	"Peroxisome proliferator activated receptor delta"	Q03181	6	35342558-35428191	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 67.7;Pancreatic endocrine cells: 102.5;Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017635	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB017635: AB_1128605"	"unprognostic (3.70e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.59e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.00e-2)"	21.0	20.6	31.9	18.7	30.2	9.1	18.4	27.4	35.3	25.3	22.2	24.2	11.6	19.1	18.4	45.9	19.7	14.9	23.0	35.9	26.5	29.9	31.8	31.5	15.5	31.3	31.5	32.0	12.2	14.2	24.6	28.3	31.2	28.2	12.3	10.9	20.5	17.2	29.4	28.9	27.4	11.3	29.1	30.7	29.8	14.1	36.1	7.6	40.9	13.4	13.8	23.5	33.7	27.8	51.0	8.9	13.7	29.3	20.0	34.9	74.3	40.6	36.1	34.2	28.4	12.0	9.4	8.1	11.6	29.1	19.4	17.8	13.0	39.4	23.8	11.8	11.8	7.7	12.2	17.9	35.0	1.9	8.3	59.7	13.0	50.7	25.9	39.0	16.2	9.9	8.1	8.9	29.1	16.1	5.6	8.2	6.7	19.1	23.9	7.9	23.5	8.2	8.5	44.7	7.7	21.4	16.3	27.9	34.5	9.4	10.4	28.1	35.1	46.3	17.5	28.1	49.1	7.5	11.2	8.7	15.2	16.3	21.2	0.5	1.5	3.3	1.2	1.3	0.9	1.3	1.3	1.2	1.3	1.7	2.2	2.1	2.3	1.0	0.9	0.8	1.4	1.1	31.9	30.2	27.4	35.3	35.9	26.5	31.3	31.5	31.2	29.1	36.1	27.8	14.8	9.6	7.8	11.8	8.8	18.7	19.5	7.5	5.7	7.6	6.6	6.2	11.0	10.0	11.6	1.8	2.1	35.6	3.2	67.7	3.9	30.9	3.0	9.7	8.5	11.9	6.6	1.7	24.4	24.1	32.1	8.0	31.6	18.3	22.9	5.5	6.1	5.6	14.9	5.0	18.7	9.2	10.2	6.6	18.3	3.6	5.9	17.0	12.4	59.0	4.3	8.0	6.2	23.1	42.8	102.5	38.6	8.2	6.1	18.5	22.6	6.3	5.1	7.5	13.1	9.6	10.2	6.2	7.7	7.2	12.8	98.1	7.1	18.8	8.1	51.4
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 165.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	165.1	3.9	4.0	8.7	3.0	3.0	74.3	3.2	4.7	9.7	0.6	48.7	23.6	7.0	1.2	6.2	7.0	10.5	14.6	4.0	2.7	14.3	17.1	28.5	4.9	3.7	3.5	14.5	2.8	7.9	0.5	43.6	3.4	5.5	40.6	1.0	5.7	1.7	5.2	6.2	15.1	8.7	3.2	12.0	35.5	6.9	3.5	4.1	13.2	8.1	2.1	67.7	9.1	5.0	44.0	38.6	0.0	0.2	198.7	113.7	247.5	3.7	44.7	5.4	2.1	7.8	111.6	0.0	0.1	4.0	72.9	17.3	14.4	0.7	1.0	106.4	20.3	0.0	8.1	10.3	51.8	0.2	0.1	118.9	9.7	9.8	37.5	20.6	0.7	1.0	0.0	0.0	8.3	11.0	0.1	0.8	0.7	99.2	112.0	0.0	0.0	0.2	30.6	157.5	0.1	1.2	18.8	6.7	2.2	6.7	0.0	34.2	35.0	7.8	10.6	4.6	0.2	0.0	0.1	0.3	3.2	0.5	1.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	3.0	3.2	4.7	4.0	2.7	3.7	3.5	3.4	3.2	3.5	5.0	284.1	3.2	7.2	1.6	0.6	1.0	50.5	0.4	4.6	0.9	1.9	2.8	9.2	1.5	2.5	5.5	0.0	110.4	1.8	93.4	1.9	1.1	4.9	5.2	1.4	26.1	8.4	0.0	39.3	0.7	217.8	12.3	83.1	20.8	8.9	232.9	25.7	3.4	49.9	0.0	74.1	21.3	0.0	19.4	4.8	2.2	4.1	19.1	3.6	38.4	1.8	0.6	0.0	6.6	1.2	17.3	84.1	0.0	1.6	42.1	17.0	14.3	1.5	0.2	13.1	1.9	31.3	10.9	22.8	4.6	1.1	88.9	2.2	0.8	24.5	239.6
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 98.7;lymphoid tissue: 53.6"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.3	0.5	0.3	0.5	0.4	98.7	0.6	0.3	2.2	0.1	1.0	0.1	0.0	0.1	0.0	0.2	0.8	0.8	1.3	0.2	0.3	0.9	2.9	19.4	0.0	0.5	0.4	0.1	0.1	0.0	0.4	5.2	0.8	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.8	53.6	0.2	0.0	0.7	0.1	1.0	4.2	0.0	8.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.3	0.4	0.3	2.2	0.2	0.3	0.5	0.4	0.8	0.8	0.7	0.4	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
PPCDC	"FLJ14585, MDS018"	ENSG00000138621	"Phosphopantothenoylcysteine decarboxylase"	Q96CD2	15	75023586-75117462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 71.4;granulocytes: 153.5;monocytes: 71.6"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 133.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045667	Approved		Approved	Cytosol		NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA045667: AB_2679412"	"unprognostic (8.66e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-3)"	11.1	19.1	7.4	10.8	8.8	19.7	10.9	8.3	8.4	9.7	8.7	11.5	9.7	8.3	9.8	19.0	10.8	8.4	8.5	6.9	8.0	17.2	13.1	10.8	16.4	9.2	8.8	9.0	16.5	21.3	9.3	9.2	8.5	13.0	9.4	7.6	13.9	7.6	11.9	9.0	9.9	5.4	8.0	18.8	11.3	9.7	8.6	12.1	11.2	5.9	12.3	11.2	10.0	10.3	15.6	28.8	11.8	9.2	7.0	6.4	10.1	15.5	7.0	20.3	15.9	16.9	41.2	17.7	26.8	7.8	12.5	15.9	19.2	25.6	10.4	62.6	23.4	31.1	18.8	18.3	19.9	18.3	38.7	8.6	16.7	21.0	32.3	8.2	16.6	25.8	21.3	133.2	14.8	30.0	10.9	28.1	18.9	32.9	13.4	18.2	23.0	38.3	15.3	22.2	28.3	8.3	22.9	31.3	34.6	13.4	38.7	23.4	9.4	20.6	14.4	10.5	27.6	40.5	29.3	30.1	12.7	45.9	23.7	47.2	23.1	153.5	11.6	65.6	19.4	15.7	10.6	13.0	17.6	8.6	11.7	14.5	139.7	18.5	71.6	71.4	12.7	15.8	7.4	8.8	8.3	8.4	6.9	8.0	9.2	8.8	8.5	8.0	8.6	10.3	10.2	16.0	5.2	2.9	10.5	3.8	6.1	8.5	8.6	2.8	9.6	8.8	4.2	4.3	9.7	9.2	0.0	17.5	16.0	19.7	25.4	17.3	1.0	8.2	4.3	10.7	4.2	11.6	1.4	15.3	13.6	7.4	14.8	8.3	12.0	9.9	10.4	5.3	20.0	8.4	1.7	10.9	12.2	15.7	6.7	2.5	4.4	15.5	14.2	2.8	20.0	4.7	8.2	2.5	4.6	18.0	38.1	5.3	33.9	6.5	10.5	19.0	12.2	10.7	6.6	6.3	8.7	6.9	15.7	10.8	4.0	10.9	9.7	11.3	11.7	13.6
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 397.2;Proximal tubular cells: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	51.0	62.7	28.2	34.6	29.3	27.1	65.0	29.8	34.6	44.2	36.8	63.5	58.0	35.8	71.0	48.4	31.7	43.1	42.5	28.6	32.0	88.1	99.6	39.8	43.5	30.1	28.8	30.2	66.9	59.8	27.8	38.0	29.1	52.3	58.0	22.4	59.3	44.2	45.9	47.0	56.4	29.0	31.6	42.2	64.7	15.0	29.9	27.8	64.8	40.4	38.2	43.3	40.1	32.9	83.4	34.3	17.2	28.8	52.3	55.0	72.1	40.7	43.3	49.1	44.2	30.7	93.3	22.6	80.7	46.2	30.3	48.8	11.5	62.5	40.3	66.2	35.1	39.9	34.7	31.3	72.5	39.9	69.4	48.8	98.9	35.8	62.4	58.2	48.3	29.9	16.9	17.0	50.5	47.3	20.4	40.1	22.6	70.0	49.8	22.6	18.8	45.3	106.2	70.7	23.0	25.0	47.9	113.2	129.4	50.2	56.7	167.8	31.1	28.2	41.1	42.9	46.5	58.6	37.3	17.5	12.6	44.4	61.0	298.8	231.5	325.6	114.5	245.4	135.2	171.5	141.1	128.0	195.9	182.4	149.5	132.9	159.5	185.6	237.2	135.8	160.9	262.8	28.2	29.3	29.8	34.6	28.6	32.0	30.1	28.8	29.1	31.6	29.9	32.9	61.0	57.7	84.1	5.9	62.6	23.3	42.3	99.4	42.7	12.1	91.3	100.2	104.3	84.4	90.8	64.4	6.2	172.2	52.6	129.2	397.2	96.5	3.5	66.7	43.9	48.7	31.3	29.0	7.4	136.8	131.0	52.9	61.7	59.3	57.0	52.8	44.6	120.1	107.4	11.8	7.0	124.9	103.7	84.4	44.3	4.6	60.6	76.3	81.8	6.5	127.0	64.8	79.3	8.0	8.7	98.5	125.2	63.6	41.8	51.7	159.7	316.3	63.2	28.0	26.3	26.2	48.9	10.3	20.8	66.3	36.2	134.6	62.5	103.2	101.2	60.1
PPDPFL	C8orf22	ENSG00000168333	"Pancreatic progenitor cell differentiation and proliferation factor like"	Q8WWR9	8	49054311-49076093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 948.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"glioma: 0.7;renal cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HEL: 1.3"									HPA060329	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"			"HPA060329: AB_2684255"					"unprognostic (6.33e-2)"							"unprognostic (2.72e-1)"	"prognostic unfavorable (2.06e-10)"					2.6	0.1	0.2	0.0	0.6	0.0	1.1	0.6	0.5	0.0	0.2	0.2	0.0	0.0	0.0	2.4	0.1	0.0	1.6	0.3	1.4	0.0	0.1	0.1	0.0	1.0	0.2	0.1	0.1	0.0	0.3	0.0	1.1	2.3	0.0	0.3	9.8	0.2	948.1	1.7	0.2	0.0	0.5	0.0	0.1	0.2	0.4	0.0	0.3	112.8	0.0	0.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.6	0.5	0.3	1.4	1.0	0.2	1.1	0.5	0.4	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270690-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 261.2;SK-MEL-30: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	26.6	14.6	17.5	16.1	18.2	20.6	17.6	16.0	19.2	13.1	22.1	18.2	14.0	17.9	13.7	16.4	12.1	22.1	14.5	15.6	15.8	16.4	15.0	19.8	15.7	25.9	21.0	15.1	15.9	18.0	13.2	24.1	20.6	12.4	15.8	14.9	13.4	14.0	31.6	18.0	16.2	17.4	17.6	15.3	13.5	26.3	20.1	15.7	23.3	26.8	14.0	17.0	12.1	25.1	261.2	30.4	31.8	22.5	33.1	20.3	34.9	30.0	24.4	40.8	26.0	66.8	22.8	25.8	39.6	27.3	39.4	38.3	30.7	28.3	35.9	15.5	21.5	19.7	34.3	24.7	33.4	26.2	22.1	24.9	46.8	53.1	44.6	31.4	27.9	21.3	33.1	19.9	37.3	30.8	19.3	17.7	19.7	59.5	34.3	20.6	80.2	22.2	20.6	32.9	31.9	21.5	45.2	59.1	156.6	36.0	37.5	31.2	30.0	38.0	29.8	54.3	32.4	24.7	15.8	37.3	28.2	20.1	43.0	0.0	1.6	1.1	0.8	1.2	1.2	1.5	1.2	1.1	1.3	1.0	0.9	0.6	5.0	0.4	3.5	1.7	1.2	0.6	17.5	18.2	16.0	19.2	15.6	15.8	25.9	21.0	20.6	17.6	20.1	25.1	33.0	25.6	53.5	114.6	19.3	27.4	26.4	14.2	30.1	39.1	32.8	24.1	27.2	20.0	25.1	18.4	31.3	44.2	14.2	39.3	11.7	21.8	190.4	28.7	44.4	31.4	26.9	24.8	57.8	20.3	13.7	33.3	25.5	45.4	8.8	94.3	20.7	25.2	25.2	33.7	52.8	19.8	16.2	35.5	28.8	97.7	27.7	40.4	21.4	38.4	28.8	71.8	17.5	47.7	56.4	36.2	24.7	25.6	23.6	36.7	19.2	22.7	27.1	45.8	19.7	45.4	30.0	60.7	61.9	36.1	33.1	74.3	22.2	42.2	25.1	37.2
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119544-49151026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 45.0;skin 1: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 40.8;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center, Vesicles"		"HPA043567: AB_2678558, HPA050340: AB_2681096"	"prognostic unfavorable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favorable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (6.46e-7)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	2.0	4.5	16.4	0.8	18.8	0.2	2.7	11.7	28.6	4.6	0.0	6.6	3.0	2.2	0.3	14.1	1.9	0.6	3.1	18.2	11.4	3.1	2.7	2.9	0.8	10.1	8.7	1.3	4.7	2.1	45.0	0.4	9.9	5.6	1.0	3.7	5.3	0.6	1.4	42.3	3.7	0.4	3.5	2.2	2.4	4.2	11.7	2.4	2.8	0.2	1.1	1.4	8.1	16.6	3.3	3.3	3.3	8.0	0.1	0.0	6.0	0.4	0.4	1.5	2.2	2.2	1.3	7.3	4.3	0.4	2.4	1.7	5.0	0.7	0.4	7.9	10.8	4.6	3.5	1.7	0.4	1.9	11.4	0.4	1.8	1.0	0.5	0.7	0.0	12.1	9.0	11.2	0.1	14.2	2.3	3.2	1.4	23.1	36.1	7.6	6.5	3.6	0.5	1.6	7.2	9.5	1.3	29.7	3.3	0.0	16.5	4.4	0.7	1.7	6.1	1.1	0.2	21.0	18.2	5.4	1.7	7.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	18.8	11.7	28.6	18.2	11.4	10.1	8.7	9.9	3.5	11.7	16.6	15.7	0.0	0.6	8.5	0.8	7.1	8.0	3.5	11.4	40.8	10.4	6.1	4.2	8.6	3.0	5.5	14.6	0.5	3.6	19.3	19.6	2.7	1.2	1.3	3.6	15.2	26.5	2.7	19.9	4.4	2.1	3.4	3.6	2.4	0.0	2.7	23.2	8.6	2.5	43.7	21.5	26.3	8.2	2.2	2.4	1.7	5.6	2.7	16.0	2.8	0.0	16.2	0.0	10.6	2.7	1.9	13.7	3.8	1.2	18.2	15.0	4.6	0.9	17.9	0.0	0.6	5.5	2.5	5.9	8.7	11.8	0.5	0.7	13.2	20.4	6.3
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.8;heart muscle: 22.0;skeletal muscle: 18.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 12.7;Cardiomyocytes: 35.3;Excitatory neurons: 36.9;Inhibitory neurons: 31.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 58.8;cerebral cortex: 37.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 8.0;hTERT-RPE1: 13.1;RH-30: 13.6;U-266/70: 8.5;U-87 MG: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.5	0.6	9.5	0.4	4.2	1.0	0.6	58.8	37.4	3.5	0.0	1.4	0.5	2.3	2.4	1.1	1.0	1.7	22.0	7.6	0.0	5.3	0.3	0.8	0.2	2.2	0.0	0.9	0.1	0.4	1.6	2.8	1.5	1.0	0.2	7.2	1.4	0.6	18.9	2.0	0.8	1.2	0.0	1.6	0.8	3.2	2.5	0.4	0.5	12.0	0.2	0.6	2.0	3.1	8.0	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.2	0.4	0.3	0.4	1.6	1.8	0.2	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	13.1	0.0	1.6	0.1	0.3	6.5	1.1	0.6	1.0	0.9	0.0	0.3	1.4	13.6	2.3	0.0	0.0	2.6	3.3	0.8	0.2	1.1	1.2	0.2	0.6	0.0	4.8	2.8	0.1	0.1	8.5	0.2	0.1	12.4	0.7	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	4.2	58.8	37.4	7.6	0.0	2.2	0.0	1.5	0.0	2.5	3.1	0.1	0.0	0.0	12.7	0.1	0.0	0.1	3.7	0.6	5.1	0.5	0.3	35.3	0.0	0.9	0.0	6.2	0.1	0.1	0.0	0.0	0.9	2.7	0.4	0.3	0.6	0.0	0.0	36.9	0.0	0.4	1.7	0.0	0.7	0.0	1.8	0.7	0.0	0.3	6.7	31.9	0.1	0.0	0.0	0.0	3.6	0.3	0.7	0.0	4.7	1.9	1.5	1.0	5.5	1.9	0.4	0.1	1.9	0.0	0.1	0.0	0.1	1.0	1.5	0.0	1.1	0.8	0.6	1.4	0.3	0.0	0.3	0.1	0.1	0.0	0.0
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 201.3;Endothelial cells: 189.5;Excitatory neurons: 206.1;Oligodendrocytes: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001924, HPA071162"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001924: AB_1079665, HPA071162: "	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	32.4	27.0	22.5	13.7	33.6	3.3	37.9	0.3	29.5	24.0	18.3	25.0	11.9	27.7	11.4	28.6	26.6	20.1	77.0	29.0	10.0	36.3	26.7	39.6	9.3	7.0	14.9	85.2	21.3	17.1	19.6	60.2	11.2	24.7	18.2	5.1	21.6	29.3	25.9	30.4	15.0	31.3	5.9	29.9	25.5	11.9	31.6	18.5	39.0	44.3	10.5	24.4	29.5	22.9	18.8	37.1	29.7	25.5	48.4	133.3	52.9	67.0	75.2	38.6	55.4	98.0	55.9	14.2	75.6	135.7	51.5	46.0	16.3	61.0	69.1	32.3	9.0	31.3	28.3	14.6	21.0	9.8	16.9	104.8	41.3	112.1	114.0	75.2	134.0	18.9	16.7	13.9	138.5	14.4	9.1	2.8	53.4	26.8	28.5	14.6	74.0	5.5	56.6	41.0	2.4	12.1	33.4	17.6	91.3	206.5	22.7	14.3	131.3	107.7	36.0	59.8	68.8	0.2	0.4	1.2	119.7	13.7	173.7	0.9	0.2	0.1	0.3	0.0	0.6	0.3	0.5	0.3	0.3	2.7	0.5	0.5	0.6	0.1	0.1	0.9	0.8	0.2	22.5	33.6	0.3	29.5	29.0	10.0	7.0	14.9	11.2	5.9	31.6	22.9	201.3	99.3	19.8	7.5	9.4	41.0	76.5	42.8	68.3	15.5	19.6	40.3	164.0	10.0	18.3	80.9	4.2	37.2	2.5	8.0	11.7	42.2	3.5	40.2	12.7	189.5	18.6	8.6	206.1	24.8	23.2	74.6	46.9	73.3	3.8	132.8	157.8	14.0	8.9	45.4	68.4	15.9	10.2	16.7	30.9	5.4	21.1	6.2	62.2	174.3	3.1	6.3	0.0	116.6	202.9	33.9	19.7	42.2	4.6	45.0	8.6	48.7	9.0	1.8	19.7	71.7	78.9	2.4	8.6	48.2	27.6	91.9	5.9	25.4	12.5	84.5
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;OE19: 100.4;RT4: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	10.8	11.7	21.5	12.0	34.2	7.6	16.6	24.9	24.4	14.7	51.3	22.4	26.4	6.7	33.5	27.3	17.2	15.7	13.0	21.8	26.2	19.0	35.4	11.6	15.2	27.4	29.8	14.3	9.4	66.5	4.8	21.0	29.0	18.2	26.5	2.8	54.8	32.8	33.4	33.2	26.0	5.4	20.6	11.1	44.1	31.5	31.7	4.5	37.5	21.4	25.0	29.5	21.8	43.8	2.0	32.7	5.3	3.1	6.1	0.4	80.5	7.1	16.1	4.1	4.0	26.7	4.6	9.7	3.7	4.1	15.1	14.2	21.0	2.1	3.7	3.9	2.4	0.0	0.3	17.1	8.4	19.6	9.3	10.7	7.6	0.0	4.5	0.4	1.5	2.0	0.9	26.5	4.0	15.9	0.0	19.0	37.8	100.4	0.1	3.3	0.1	17.4	0.1	105.0	1.5	12.4	1.1	28.9	21.9	14.6	4.0	14.7	0.5	1.9	2.8	6.4	0.7	14.1	11.1	8.3	2.3	4.5	13.0	3.4	9.1	6.5	3.1	11.2	2.3	12.7	5.0	2.1	8.3	7.2	6.6	5.2	4.2	2.6	14.4	0.6	1.1	5.2	21.5	34.2	24.9	24.4	21.8	26.2	27.4	29.8	29.0	20.6	31.7	43.8	1.7	16.0	13.6	3.9	21.2	5.5	18.7	4.5	10.2	1.5	10.1	7.7	5.2	11.5	13.7	14.7	18.8	9.1	1.6	29.8	9.8	5.8	53.4	6.7	4.8	3.2	3.6	0.0	3.8	9.6	56.2	7.7	40.2	35.7	7.0	0.6	1.1	17.3	7.1	0.0	6.0	23.2	8.2	10.4	7.2	47.2	4.7	11.3	16.0	17.8	15.7	1.7	3.1	49.8	70.5	6.9	22.8	7.2	9.0	13.4	26.8	19.7	7.5	3.3	0.0	5.7	10.2	22.2	2.6	10.7	9.9	4.8	2.0	1.2	18.0	18.6
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 337.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	26.0	30.5	21.9	34.9	23.2	51.9	33.2	23.4	26.6	27.7	22.1	29.0	23.2	31.0	31.9	28.2	28.3	28.6	35.7	23.3	22.9	30.1	30.5	28.0	58.4	17.7	19.7	34.1	19.2	25.9	22.9	29.8	20.4	26.0	31.7	25.8	25.9	28.3	34.1	25.9	28.8	33.9	18.9	36.2	25.7	56.1	23.5	52.8	27.4	31.2	59.1	37.0	22.4	23.3	60.7	54.7	63.5	53.4	56.0	61.3	55.8	68.3	79.1	71.8	59.1	89.1	74.3	99.0	86.4	74.6	33.9	53.6	66.2	72.4	87.6	87.3	68.9	159.5	53.8	81.9	58.8	190.4	88.0	74.4	71.9	57.5	54.6	80.3	89.5	87.3	79.2	76.0	78.9	46.3	107.8	111.7	55.0	166.0	54.2	90.4	73.7	93.3	111.7	50.7	44.7	66.0	61.1	48.7	60.1	60.7	75.1	90.7	63.1	41.5	74.5	39.9	60.7	87.4	129.9	163.3	69.8	337.5	27.7	51.7	23.9	44.1	32.7	26.7	39.4	44.3	41.9	44.5	43.8	35.8	37.9	38.1	14.9	44.6	25.9	41.5	61.5	22.6	21.9	23.2	23.4	26.6	23.3	22.9	17.7	19.7	20.4	18.9	23.5	23.3	28.9	41.7	51.8	46.0	78.4	75.8	68.1	116.9	44.9	60.2	30.8	31.0	32.5	40.0	70.7	42.3	29.2	88.1	77.4	31.8	37.2	62.3	243.3	47.5	56.1	48.1	33.6	58.5	128.7	68.3	75.4	47.0	24.5	60.7	57.0	238.1	36.0	35.5	52.9	37.0	93.2	35.8	71.2	40.6	65.4	76.7	58.4	49.1	64.0	49.6	92.9	46.3	72.1	64.3	85.0	71.4	42.1	52.3	63.4	46.4	45.8	55.6	58.6	60.5	52.6	44.6	47.9	120.3	58.8	50.3	59.1	44.2	81.8	84.0	42.4	50.7
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		230000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	1148.4	1085.6	1707.2	714.4	1757.6	1052.9	1368.0	1733.9	2245.6	943.7	1718.8	1352.6	603.7	854.8	981.6	2149.0	771.3	548.8	781.6	1785.4	1791.4	1412.8	1318.6	1099.2	1067.1	1857.4	1728.1	799.5	967.7	1286.3	670.1	805.9	1860.7	766.1	1196.0	496.7	1020.3	782.9	566.1	1516.0	953.4	943.4	1767.2	1134.4	896.7	366.0	1742.4	2333.2	884.9	517.9	1647.3	1339.3	1208.7	1822.8	2141.8	3020.1	3731.1	2509.6	2798.6	4154.8	1115.0	3173.6	4588.0	5531.3	5393.2	3414.3	3127.1	4614.1	1893.1	3828.8	6554.2	3209.5	4495.7	5727.5	5062.6	2674.3	3204.3	1883.6	3911.6	4682.5	2255.3	3890.0	2246.2	3103.5	3820.5	3988.9	4295.5	2888.1	5717.2	3277.9	3933.2	3789.6	5790.6	3665.7	4667.5	7562.4	4612.9	7628.9	3689.2	3554.4	2050.1	5969.7	8018.9	4215.4	2548.3	2218.7	2500.5	7185.8	2493.3	4091.8	4303.8	5202.3	2587.0	2865.0	3656.5	2027.1	4050.5	3861.7	6522.3	9409.0	2614.0	4314.6	4455.2	475.6	1239.3	594.8	1421.6	1449.2	1534.2	2104.8	1500.3	1491.1	2196.1	1769.5	1217.2	1394.4	133.3	1349.0	1374.8	2618.5	2085.4	3631.4	1707.2	1757.6	1733.9	2245.6	1785.4	1791.4	1857.4	1728.1	1860.7	1767.2	1742.4	1822.8	713.8	794.9	759.9	37.2	1037.1	866.6	867.8	1097.5	1878.1	94.3	1226.2	1628.0	47.6	526.1	743.6	603.2	18.8	852.7	1067.7	658.4	1414.6	1172.4	78.2	539.3	770.8	719.7	529.6	1120.3	57.3	1218.7	1683.7	672.4	820.1	862.1	622.1	650.0	669.7	766.9	1582.1	111.0	50.4	1003.5	587.9	1110.0	786.1	81.4	582.2	988.1	691.9	41.2	1283.2	221.6	995.9	27.2	79.8	1222.6	715.0	613.1	1215.3	922.1	831.6	1636.8	481.4	101.5	394.4	588.7	942.7	366.7	246.1	2608.3	990.4	609.2	924.5	1157.5	1262.6	947.0
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.8;SK-BR-3: 1.9"									HPA058345	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"		"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.4	0.8	1.8	1.0	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.4	0.1	0.1	1.9	0.2	0.0	1.3	1.1	0.3	1.2	0.4	1.2	0.7	0.5	0.4	1.0	1.1	0.7	1.3	0.0	0.4	0.2	0.4	0.4	0.4	0.8	0.6	0.7	0.9	0.6	0.4	0.7	0.0	0.7	0.3	0.9	0.7	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 2.2"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.8;THP-1: 22.5"									HPA058345	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.3	1.9	0.5	2.2	0.5	0.2	0.4	0.7	0.9	0.4	0.4	0.8	3.4	0.9	0.0	0.1	0.1	0.1	0.0	0.5	0.5	0.7	0.3	1.0	2.1	0.5	0.5	0.2	0.0	0.2	0.2	0.8	0.5	0.4	0.2	0.0	0.0	0.1	0.5	0.3	1.8	0.1	0.4	1.7	0.8	0.0	0.5	0.0	0.1	0.0	0.8	0.1	0.1	0.5	4.1	0.0	0.5	3.2	0.2	0.5	2.8	0.5	0.2	1.2	0.9	0.0	6.4	1.9	2.4	0.0	3.1	4.5	0.0	0.3	0.8	4.8	0.0	0.4	0.0	0.0	0.1	1.1	1.7	0.2	1.0	0.8	0.4	0.0	0.0	0.2	0.9	6.1	0.9	0.7	7.4	18.8	7.6	0.8	0.1	7.2	0.1	12.2	0.0	0.0	5.0	6.8	0.8	13.1	7.9	0.0	6.1	22.5	0.0	4.4	6.1	3.2	10.5	4.4	6.9	11.9	5.0	5.8	9.8	1.6	3.8	1.6	4.1	5.2	4.8	7.0	4.6	4.5	8.0	6.2	3.8	5.0	0.3	3.3	3.6	8.3	6.1	12.0	0.5	0.5	0.7	0.9	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4D		ENSG00000256374	"Peptidylprolyl isomerase A like 4D"	F5H284	1	145241630-145242124	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Langerhans cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"			"Cluster 48: Smooth muscle cells - ECM organization"			"HPA058345: AB_2683685"					"unprognostic (9.32e-2)"					"unprognostic (1.33e-1)"				"unprognostic (3.05e-2)"				0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.8	0.1	0.6	1.9	0.6	2.4	1.2	0.8	1.7	1.6	1.1	1.5	0.0	1.2	1.3	1.7	2.2	3.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PPIAL4F		ENSG00000279782	"Peptidylprolyl isomerase A like 4F"	P0DN26	1	144592868-144593652	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA									"HPA058345: AB_2683685"					"unprognostic (1.08e-1)"					"unprognostic (2.22e-2)"				"unprognostic (2.02e-1)"				0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148482548-148483302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.8;Langerhans cells: 7.4;NK-cells: 9.2;Suprabasal keratinocytes: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;TIME: 1.9"									HPA058345	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA058345: AB_2683685"		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.1	0.5	0.7	0.5	0.4	1.0	0.1	1.5	0.7	0.0	0.1	0.2	0.7	0.1	0.4	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.1	0.3	0.7	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.3	0.3	0.1	1.1	0.4	0.0	0.9	0.7	0.7	0.0	0.1	0.4	0.4	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.9	0.1	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.4	1.1	0.0	0.3	0.0	0.9	0.4	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.8	1.4	0.2	0.6	0.9	0.0	1.9	0.2	1.1	1.2	0.3	1.1	0.8	0.9	0.0	0.5	0.4	0.2	0.2	0.5	1.2	0.4	0.7	1.2	0.8	0.7	0.4	0.8	0.6	0.7	0.0	2.2	1.7	0.3	1.1	0.6	0.7	0.4	1.5	0.7	0.4	0.3	0.2	0.3	0.3	0.1	0.5	0.6	0.1	0.0	0.6	0.0	1.0	6.8	0.4	0.8	0.0	1.8	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.1	1.4	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	1.3	0.1	0.4	0.5	0.2	1.7	0.0	0.0	0.0	1.2	7.4	0.3	0.0	0.2	1.8	0.0	0.4	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.1	0.0	0.5	2.6	0.0	0.1	0.0	12.5	0.1	3.2	0.1	0.0	0.2
PPIAL4H		ENSG00000270339	"Peptidylprolyl isomerase A like 4H"	A0A075B767	1	146344131-146344790	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"THP-1: 1.2"									HPA058345	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"				"HPA058345: AB_2683685"	"unprognostic (1.35e-1)"				"unprognostic (2.13e-3)"			"unprognostic (2.34e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.34e-1)"				"unprognostic (2.84e-2)"				0.0	0.0	1.1	0.0	1.0	0.0	0.1	2.4	1.6	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	2.4	1.6	1.1	1.0	0.8	0.8	0.8	0.8	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPIC	CYPC	ENSG00000168938	"Peptidylprolyl isomerase C"	P45877	5	123023250-123036725	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 251.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 229.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039163	Approved				"Intracellular and membrane"	NA	NA		3700000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA039163: AB_2676374"	"unprognostic (7.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.43e-2)"	37.0	20.6	5.3	16.4	5.6	0.2	30.4	6.8	7.0	42.3	12.2	41.4	37.3	31.0	36.5	46.8	14.8	33.5	44.4	5.2	5.8	24.9	28.9	27.0	7.6	6.4	6.3	16.2	30.3	20.9	6.2	48.3	6.2	23.4	49.9	4.9	31.7	24.0	41.2	20.2	32.3	45.2	6.1	7.7	22.4	9.0	6.7	5.8	47.2	33.3	14.2	45.8	28.8	5.8	19.6	16.8	6.4	136.2	229.7	104.6	26.9	54.4	42.3	27.8	56.7	28.1	128.6	0.0	94.2	147.1	83.3	21.9	18.9	68.6	22.1	0.1	33.1	27.8	60.7	32.8	58.9	0.0	14.7	65.8	51.5	32.5	34.0	49.9	58.1	0.0	7.9	0.0	20.1	116.5	0.1	0.3	11.6	120.9	29.0	0.0	14.5	0.0	87.7	67.0	8.5	14.9	106.7	51.1	12.1	77.8	72.0	61.8	64.8	52.9	32.7	18.5	23.9	0.2	0.1	0.4	45.9	0.2	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.6	6.8	7.0	5.2	5.8	6.4	6.3	6.2	6.1	6.7	5.8	214.1	32.1	16.5	6.2	1.6	47.4	52.3	251.7	30.7	16.9	63.9	47.5	46.4	61.5	149.0	73.5	4.2	60.1	0.6	134.0	29.4	201.5	1.7	52.4	94.8	106.5	12.7	0.0	0.8	126.4	65.2	198.2	55.0	50.8	1.3	54.2	80.7	57.8	43.2	0.0	2.2	177.1	207.5	4.2	40.3	4.2	112.5	6.9	32.0	5.6	3.2	2.8	0.0	1.0	0.3	90.3	181.0	100.1	0.6	48.2	189.0	81.7	110.5	4.4	39.5	22.7	87.5	41.6	37.8	118.6	49.3	25.0	3.4	61.2	117.0	81.5
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	26.0	27.9	22.3	16.1	22.9	18.5	26.8	22.7	26.5	31.4	20.2	41.1	18.3	33.8	24.9	31.8	35.0	18.1	33.3	22.3	22.8	33.0	33.7	23.3	27.2	22.6	22.0	36.7	40.2	23.8	27.7	20.7	22.9	32.3	22.5	20.9	26.2	23.6	43.1	29.5	29.2	25.4	23.7	32.7	31.7	41.8	22.3	20.6	29.1	30.3	28.2	36.4	29.5	24.6	24.5	34.4	37.2	25.7	40.9	36.9	14.3	40.8	42.7	58.7	56.4	32.8	64.8	68.4	52.2	47.9	34.5	32.8	57.1	52.3	68.8	41.1	38.4	75.6	37.4	9.7	50.9	68.4	36.3	32.8	47.2	53.9	21.0	42.0	54.5	52.8	74.8	39.5	46.6	24.7	34.2	42.1	39.9	49.7	31.5	41.4	28.4	38.4	37.8	37.2	47.7	42.3	43.8	31.5	28.4	49.7	40.9	155.8	35.8	36.3	35.3	48.4	57.1	55.8	66.4	52.5	27.0	86.4	52.3	38.3	62.8	32.6	83.9	64.8	82.8	107.5	89.4	83.8	74.1	109.2	103.5	82.4	6.0	123.2	70.0	63.8	101.3	122.5	22.3	22.9	22.7	26.5	22.3	22.8	22.6	22.0	22.9	23.7	22.3	24.6	28.2	32.1	36.7	10.7	37.0	24.9	43.1	69.8	23.9	25.9	30.3	47.5	31.8	21.5	62.1	33.1	14.6	62.5	39.3	22.8	66.5	57.5	29.2	34.6	27.7	28.7	28.8	38.3	7.7	48.4	59.3	34.0	16.3	23.4	55.2	44.1	37.9	31.1	56.1	23.5	8.8	32.9	40.7	33.4	26.9	76.3	29.8	30.0	39.2	8.4	46.8	34.0	58.7	8.0	13.6	40.0	24.1	45.1	31.7	32.0	39.3	69.8	63.4	29.7	59.2	23.3	40.1	76.1	51.4	24.5	26.3	34.8	36.6	36.3	35.9	32.9
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584342-169641406	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.0	23.2	23.1	28.4	22.1	54.2	27.5	28.8	58.6	27.6	22.9	26.3	26.6	28.8	31.5	27.5	23.6	22.0	25.6	21.5	29.9	29.2	47.1	24.7	36.9	24.6	25.6	26.5	21.2	32.6	25.8	28.0	24.3	27.9	26.0	29.3	26.5	22.9	27.6	25.4	29.7	21.7	22.9	32.3	27.4	20.1	23.7	36.1	29.9	26.2	35.4	26.3	26.5	25.9	56.4	25.5	70.8	35.9	35.4	42.5	63.7	58.9	42.3	45.0	45.9	66.3	58.9	94.8	52.5	44.1	55.5	50.5	56.6	48.4	65.6	68.0	45.7	129.9	36.7	88.3	34.4	136.8	58.9	36.6	54.0	58.5	64.6	40.6	50.4	53.5	142.7	76.2	49.5	43.5	101.0	81.9	100.8	45.3	25.1	90.7	71.7	90.5	53.9	81.2	60.5	41.2	63.4	47.2	68.9	52.9	44.2	78.7	52.7	53.9	43.7	38.4	52.6	41.1	65.3	126.8	38.5	68.1	54.1	31.9	22.5	36.7	22.8	25.1	26.7	32.9	30.9	29.2	18.2	38.4	33.4	27.6	40.4	21.1	31.4	30.0	26.8	17.0	23.1	22.1	28.8	58.6	21.5	29.9	24.6	25.6	24.3	22.9	23.7	25.9	159.7	221.2	175.1	53.5	188.8	151.4	191.4	185.9	101.3	204.6	120.8	156.1	148.4	107.2	169.5	93.8	54.2	170.0	160.1	91.6	80.3	103.1	11.0	104.6	142.3	141.1	104.8	163.5	82.4	103.3	177.0	142.4	66.8	126.3	179.1	115.8	121.7	181.2	151.7	220.4	81.8	135.8	116.0	130.3	126.5	15.6	142.0	129.6	110.3	46.9	152.4	137.6	133.9	53.8	69.7	93.9	118.0	146.7	130.1	161.8	121.1	113.8	132.2	109.1	164.3	150.2	193.9	276.4	183.8	108.3	172.8	205.5	166.7	147.1	149.9	167.7
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658335-42676758	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059019	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA059019: AB_2683885"	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	22.9	23.2	22.1	27.8	23.1	56.8	27.7	23.7	29.5	24.8	20.8	33.2	24.4	23.5	25.4	36.4	23.5	17.9	25.8	23.0	22.5	22.1	17.5	22.4	44.5	22.2	22.0	25.8	19.2	18.3	13.4	24.7	22.7	21.2	32.8	22.4	23.9	18.3	19.8	27.5	27.8	21.5	21.8	32.3	23.4	22.9	22.5	60.3	26.0	21.1	50.4	26.6	25.8	23.3	105.8	66.4	80.1	113.3	24.9	51.5	101.4	67.6	50.1	127.4	114.4	98.1	111.8	171.5	85.9	52.8	61.7	82.3	150.8	108.2	133.9	150.2	119.7	156.4	104.4	98.6	21.4	322.0	90.7	31.2	57.5	117.9	90.6	49.1	60.6	161.2	205.7	91.7	63.8	84.2	250.1	451.0	200.4	100.4	77.7	136.8	150.2	152.2	64.1	64.8	59.2	113.5	59.6	101.1	77.4	100.8	54.5	465.0	48.1	53.2	143.1	77.0	171.7	60.0	140.2	319.6	62.8	294.9	94.8	29.7	15.1	33.3	35.0	23.5	33.3	33.6	35.7	39.9	20.7	32.9	36.1	43.5	3.6	36.4	21.8	25.9	38.2	25.0	22.1	23.1	23.7	29.5	23.0	22.5	22.2	22.0	22.7	21.8	22.5	23.3	31.3	19.2	20.7	9.8	48.1	28.9	48.2	51.7	38.7	10.0	30.1	44.4	14.1	11.5	25.8	22.0	4.2	62.5	37.7	15.7	45.0	29.4	33.2	23.4	27.4	25.1	21.5	49.8	12.7	26.4	104.5	25.5	27.5	21.6	31.0	46.9	19.2	11.2	52.1	5.0	9.6	27.3	34.6	18.6	25.6	7.3	29.2	28.5	16.0	9.4	26.2	22.2	52.5	11.6	11.6	25.8	17.6	21.4	45.6	28.0	16.1	34.1	19.6	16.1	19.7	21.5	42.0	19.7	32.3	54.6	21.5	37.9	42.7	46.4	40.0	38.7
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666000-21700015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 190.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	8.9	14.2	4.7	12.8	5.7	6.3	9.5	4.0	7.0	11.6	2.1	12.1	8.1	12.0	9.3	16.4	10.7	9.5	13.9	5.8	4.8	12.6	15.0	10.1	16.4	3.5	2.9	10.7	19.2	16.4	14.3	9.1	3.9	12.4	10.6	9.0	14.7	9.5	18.8	12.3	13.3	9.9	3.6	14.0	13.9	10.1	3.1	15.8	18.8	13.0	16.4	11.7	12.1	4.8	20.4	17.1	18.1	20.1	19.2	17.6	15.8	19.3	17.9	28.0	24.5	21.3	10.3	34.0	12.7	27.2	13.9	22.9	28.6	23.6	16.2	19.2	28.2	26.7	14.2	32.4	14.7	42.5	21.5	17.4	21.2	19.4	14.0	15.1	25.1	18.5	190.3	17.9	19.6	28.6	20.5	13.7	20.2	35.7	14.9	23.7	31.1	5.7	14.2	14.1	30.8	18.4	21.2	32.7	9.7	11.3	27.1	20.3	27.5	15.8	25.1	17.5	12.7	19.2	17.5	24.7	21.6	22.6	24.9	1.5	9.7	5.1	9.6	15.3	12.2	7.2	11.5	12.6	13.7	8.3	10.5	9.4	2.3	14.1	22.6	11.9	15.6	12.1	4.7	5.7	4.0	7.0	5.8	4.8	3.5	2.9	3.9	3.6	3.1	4.8	9.8	9.6	29.5	15.0	21.5	3.2	7.9	10.9	10.8	26.3	13.4	10.2	5.7	27.1	16.6	14.7	33.3	15.8	39.4	23.9	13.7	12.8	66.8	15.4	14.8	8.0	11.4	17.7	19.9	16.7	13.3	10.3	39.3	19.5	17.1	16.6	10.4	18.9	15.3	18.5	24.2	20.6	14.2	21.0	5.3	90.9	12.2	15.5	1.8	8.4	16.6	11.5	52.5	12.5	17.4	18.5	17.4	13.5	23.8	10.9	14.2	9.1	11.9	31.4	0.0	11.2	9.4	23.6	17.3	12.3	5.7	22.2	24.5	14.8	20.8	12.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	13.0	16.4	15.2	19.8	14.9	35.1	25.4	17.0	22.3	15.7	13.9	19.0	14.6	20.2	28.4	18.6	22.5	13.0	18.2	14.6	16.8	18.4	21.9	15.0	32.2	15.7	15.5	35.4	12.1	14.0	14.9	17.7	16.8	15.1	19.5	25.8	17.1	18.2	18.0	18.0	18.1	12.4	15.4	17.5	19.0	21.1	15.5	30.1	20.8	11.1	32.5	16.2	12.5	18.2	19.9	18.3	53.0	23.5	42.5	90.8	17.5	32.0	35.3	37.1	37.2	13.0	37.5	19.5	32.0	35.4	41.9	24.6	19.3	38.1	33.2	41.4	43.8	84.0	48.3	90.6	21.3	79.7	39.8	32.7	37.7	30.3	47.1	62.0	25.3	38.4	67.4	46.3	46.3	32.4	61.7	67.2	32.9	19.8	28.9	23.3	30.5	29.1	49.6	30.4	22.2	21.1	31.3	29.9	51.7	62.3	24.6	36.9	34.2	51.4	28.8	31.2	26.2	45.5	51.0	94.2	39.6	36.2	33.7	36.2	17.5	19.7	17.5	16.4	25.5	35.2	20.9	17.7	30.9	26.7	25.3	27.6	4.5	31.8	23.1	25.6	30.3	14.6	15.2	14.9	17.0	22.3	14.6	16.8	15.7	15.5	16.8	15.4	15.5	18.2	12.5	0.0	11.5	16.0	33.6	31.7	43.1	71.5	37.5	12.0	23.7	28.2	18.5	15.7	30.4	16.5	10.4	50.3	24.8	9.7	56.7	26.0	44.1	16.1	21.4	16.2	9.5	25.5	19.3	16.1	51.6	22.1	16.3	13.4	26.0	17.2	13.6	19.4	47.0	3.3	18.1	25.3	48.8	32.1	59.1	9.5	36.7	26.8	28.4	9.4	30.2	23.1	37.0	15.1	19.7	18.2	18.1	28.2	24.5	15.9	25.4	59.7	28.7	11.9	19.7	18.2	39.6	45.7	22.6	34.5	46.3	30.8	31.1	8.9	29.4	35.6
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504495-149546043	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	19.6	19.2	12.3	15.6	15.0	36.4	20.3	19.8	18.3	18.1	9.6	15.4	14.2	20.1	25.7	13.7	16.5	18.9	15.9	13.1	18.0	17.9	22.9	16.1	17.2	10.6	12.8	27.3	14.8	18.8	18.8	22.7	10.9	19.2	16.0	13.1	15.8	15.2	10.7	14.4	14.6	14.7	11.1	17.4	16.4	16.3	17.0	18.5	25.7	11.5	17.1	20.9	16.9	15.8	22.7	12.0	41.0	34.7	23.8	30.9	38.1	43.8	41.1	46.4	49.2	25.1	22.8	23.8	29.4	33.9	27.9	20.1	31.5	16.5	73.1	34.7	29.7	26.4	27.0	43.9	37.3	49.2	21.6	24.3	27.8	47.6	39.7	26.2	25.7	17.1	58.1	14.0	36.5	24.2	28.1	41.8	32.6	22.6	18.5	37.2	37.7	11.9	35.6	17.0	24.1	18.4	52.0	22.4	31.7	28.2	26.5	35.1	31.0	30.8	24.3	55.1	42.3	18.4	9.9	37.0	26.3	38.7	45.5	34.1	17.1	20.4	15.1	19.9	21.0	23.7	19.5	17.5	18.2	17.9	24.5	18.8	14.5	32.0	19.3	17.9	23.7	16.5	12.3	15.0	19.8	18.3	13.1	18.0	10.6	12.8	10.9	11.1	17.0	15.8	54.8	67.3	70.7	25.1	49.7	48.8	56.4	49.0	30.7	46.2	29.5	34.9	45.6	18.6	59.7	46.0	8.4	50.4	48.4	16.9	43.0	42.0	24.4	57.6	55.7	43.2	23.3	25.4	37.3	26.3	46.2	76.2	20.9	48.2	77.1	30.9	33.5	21.3	37.3	28.6	34.7	22.9	48.8	25.2	43.8	12.0	61.8	38.3	40.9	21.5	45.5	42.0	28.8	27.2	41.1	32.2	21.9	56.1	29.4	33.8	19.7	37.6	71.9	37.1	52.6	66.1	70.5	75.9	59.3	22.5	45.3	65.3	53.4	47.7	22.3	43.0
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.6;testis: 18.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.1	0.9	4.7	0.6	5.2	0.2	3.0	5.7	5.3	3.8	12.2	1.3	1.4	3.0	9.0	1.4	35.6	1.1	2.1	4.8	5.2	4.3	0.6	4.7	0.6	7.5	8.2	5.3	2.3	5.2	2.7	1.1	5.5	1.2	1.0	7.4	2.3	2.7	4.3	1.3	0.7	2.0	7.2	0.8	1.7	18.9	5.1	0.8	11.1	1.7	0.6	1.5	1.2	7.6	1.4	1.2	1.1	6.0	9.2	11.5	0.6	0.0	2.2	0.5	0.1	0.1	1.6	0.0	0.4	0.6	0.8	0.9	1.0	0.0	0.3	0.4	0.4	0.5	0.1	0.0	4.6	0.5	0.2	2.4	5.6	0.2	3.5	8.6	0.7	1.3	0.6	0.4	0.4	0.6	0.1	0.7	0.2	4.0	0.8	0.6	0.0	0.5	4.7	0.1	1.3	2.1	0.1	0.3	3.9	0.3	0.4	0.9	0.3	0.1	0.2	1.0	0.2	0.2	0.1	0.1	1.9	0.1	0.4	0.8	0.1	0.2	0.1	0.1	0.1	1.5	0.2	0.1	0.3	0.5	0.1	0.1	0.4	0.4	0.1	0.4	0.1	0.2	4.7	5.2	5.7	5.3	4.8	5.2	7.5	8.2	5.5	7.2	5.1	7.6	2.6	6.4	6.9	11.8	1.8	2.2	3.7	18.2	2.8	2.4	5.7	7.0	3.7	2.8	22.1	3.7	2.1	0.8	0.4	0.9	25.4	1.9	374.4	226.5	7.3	1.8	3.0	0.4	15.0	1.2	0.8	3.9	2.6	5.8	0.0	4.1	1.1	0.2	0.4	1.7	6.1	2.0	22.4	0.0	0.3	75.1	5.3	1.1	3.6	3.7	0.6	7.8	0.0	8.5	6.2	0.7	0.8	5.3	0.8	3.8	1.5	13.0	228.6	13.4	0.0	5.2	5.6	101.4	21.5	1.9	3.0	0.7	1.2	3.0	2.0	1.5
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 41.7;Excitatory neurons: 46.6;Inhibitory neurons: 37.6;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 45.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	6.6	14.8	5.7	7.3	9.8	5.9	10.3	45.4	21.0	8.3	1.1	17.6	24.7	7.4	15.1	11.6	9.4	8.3	7.5	8.0	1.8	8.5	5.6	5.8	7.8	6.0	0.6	9.2	9.4	33.7	21.6	4.5	8.8	10.0	17.6	53.7	13.8	8.3	20.0	20.0	24.3	7.7	0.0	8.6	15.5	15.5	2.8	5.4	14.3	21.2	10.0	9.0	9.9	9.2	14.5	9.3	8.1	15.0	4.8	3.0	13.8	7.1	9.0	10.0	14.6	11.0	13.5	13.5	10.5	9.8	14.9	38.6	15.8	30.6	10.1	13.3	12.5	20.3	29.9	5.9	11.0	23.4	20.2	5.4	26.6	12.2	18.6	13.5	10.7	31.0	15.0	19.4	7.4	11.3	7.8	13.2	3.9	27.0	10.0	16.7	8.2	6.8	10.7	25.9	24.1	7.6	18.3	17.2	6.7	11.4	31.7	19.4	4.7	8.7	10.2	11.1	17.4	4.3	5.7	16.4	16.3	26.5	8.5	2.4	0.5	0.0	1.0	1.1	1.3	2.0	1.2	1.3	1.2	1.2	0.9	0.9	0.3	1.5	0.8	0.9	0.3	1.3	5.7	9.8	45.4	21.0	8.0	1.8	6.0	0.6	8.8	0.0	2.8	9.2	2.3	0.0	2.2	11.4	5.2	4.0	1.5	3.2	7.4	16.5	3.2	3.3	5.4	2.8	3.4	7.3	41.7	3.3	2.9	9.2	0.0	2.1	2.7	2.1	1.4	2.9	2.4	5.5	46.6	1.5	0.9	1.8	20.9	2.8	0.0	9.5	3.3	1.8	1.9	10.1	37.6	5.9	0.0	2.8	1.8	2.4	1.8	2.1	0.0	15.0	1.8	3.9	0.0	11.6	11.0	1.9	5.2	7.2	3.1	1.2	12.2	1.5	2.3	44.2	6.6	2.3	3.2	8.1	3.3	7.3	3.3	2.2	3.1	3.5	8.2	3.2
PPIP5K2	"CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	15.7	19.1	6.8	22.0	7.9	51.6	25.1	18.9	13.9	22.2	5.8	28.1	18.3	20.6	21.2	17.1	14.5	20.4	19.5	6.7	8.9	20.3	29.2	16.2	25.5	15.4	11.9	26.1	26.7	23.0	18.1	16.7	15.1	16.3	25.5	19.2	17.1	15.4	4.2	17.2	16.5	18.4	6.1	23.9	22.5	15.1	7.3	27.9	23.3	7.7	24.5	17.8	13.9	10.7	27.4	25.3	50.8	65.2	40.8	53.4	47.8	63.5	39.3	34.2	47.6	20.9	48.3	67.6	56.2	60.9	52.7	16.5	43.9	33.2	57.5	53.7	23.5	84.7	44.3	33.4	29.0	72.1	70.4	34.5	23.4	52.0	46.1	31.2	40.0	42.5	84.9	57.0	53.1	21.3	60.9	44.6	55.4	12.7	64.4	58.6	46.7	89.3	36.8	31.5	29.6	40.1	43.5	39.9	40.7	34.0	33.5	48.9	42.7	55.8	25.7	56.0	45.1	38.1	87.3	91.3	31.5	116.0	51.2	41.7	21.5	39.6	13.0	22.9	15.8	19.5	12.6	14.2	25.6	16.1	16.1	17.0	19.7	17.8	32.4	15.5	12.3	11.1	6.8	7.9	18.9	13.9	6.7	8.9	15.4	11.9	15.1	6.1	7.3	10.7	35.8	48.1	23.1	49.3	39.3	13.6	12.8	13.7	31.9	38.5	26.1	26.4	48.9	18.6	29.6	16.5	45.9	12.7	35.7	29.7	5.9	11.6	5.6	25.4	44.7	28.7	16.3	70.7	88.4	17.0	19.2	33.0	33.6	30.6	43.6	49.2	14.6	20.6	30.6	16.8	160.3	24.2	16.2	39.5	22.4	6.7	29.5	43.3	12.4	49.6	47.5	14.5	27.8	62.8	67.0	16.9	19.1	23.7	56.6	12.1	13.3	22.6	25.1	25.2	6.6	30.3	28.1	39.7	21.6	31.6	15.8	26.0	31.6	38.7	30.1	12.6
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 446.2;Late spermatids: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		380000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	22.7	19.2	14.0	22.2	16.5	142.9	23.5	27.0	22.4	22.4	3.3	36.6	36.8	28.0	19.3	25.7	17.3	20.1	36.8	16.7	24.4	42.5	51.2	20.3	24.4	18.2	16.3	16.2	25.5	36.8	14.3	22.1	20.0	29.9	36.0	51.0	31.5	23.0	78.9	21.9	37.3	26.5	15.3	20.4	23.2	54.5	16.4	31.1	24.3	76.6	26.2	21.4	17.8	23.1	129.7	28.6	24.4	20.9	36.5	33.6	31.1	34.8	40.7	25.3	23.8	16.3	37.2	77.1	32.4	39.6	18.7	28.1	25.5	35.9	44.0	70.1	14.4	47.6	19.5	25.7	30.6	54.7	32.6	28.6	42.1	29.7	40.4	29.5	25.1	38.7	26.9	59.6	31.3	56.5	71.5	12.8	23.0	25.8	23.9	25.3	56.5	25.0	30.4	61.2	41.2	31.0	36.1	41.7	30.1	22.2	42.0	23.5	35.1	52.4	52.0	23.3	25.0	46.1	28.1	89.9	24.0	21.2	27.1	5.4	1.0	3.0	1.8	1.0	1.9	0.9	1.4	1.6	1.5	3.0	1.1	1.0	4.4	2.9	1.2	0.9	2.6	0.9	14.0	16.5	27.0	22.4	16.7	24.4	18.2	16.3	20.0	15.3	16.4	23.1	25.9	16.0	22.6	43.8	34.2	77.4	41.3	17.6	34.7	42.2	41.6	22.7	95.0	44.3	20.0	38.6	64.6	31.9	49.1	111.2	33.2	24.6	446.2	31.3	34.6	31.5	60.9	93.5	77.8	24.4	24.0	36.6	25.5	38.8	26.6	20.7	22.9	73.3	28.2	58.9	71.6	60.2	22.4	33.5	51.0	565.6	42.3	58.6	60.5	25.3	26.8	40.1	45.3	66.4	53.4	34.6	87.8	52.3	45.4	86.5	128.5	90.0	17.8	66.8	39.5	36.2	35.9	69.8	25.3	32.9	82.3	73.5	40.8	19.4	42.1	69.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA		75000	"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	40.2	20.4	41.2	19.5	48.0	44.0	23.9	45.1	61.8	23.0	43.1	28.6	20.3	23.9	30.0	22.5	21.2	21.8	33.3	38.6	42.1	29.0	44.0	21.9	28.7	41.4	44.1	22.9	32.4	35.8	18.9	18.8	42.1	30.6	28.7	49.9	27.0	23.3	129.4	20.5	21.7	22.8	40.2	26.4	23.1	21.4	42.7	36.0	22.8	86.5	27.0	24.7	21.4	50.9	37.1	32.8	41.8	31.2	51.3	23.8	47.6	27.9	32.0	28.2	24.8	43.8	23.3	40.7	42.4	32.4	23.0	19.6	47.6	18.2	41.6	41.7	18.4	42.9	19.9	30.8	41.4	38.6	34.1	23.0	31.5	22.5	37.9	22.2	23.5	18.4	31.7	41.5	25.7	30.6	38.6	61.5	52.4	33.4	11.0	40.5	46.6	27.1	66.3	36.9	33.7	42.5	25.3	37.4	33.5	62.3	20.2	26.7	21.6	24.7	35.5	20.6	27.8	36.2	25.5	37.7	13.4	63.2	18.3	6.9	2.2	8.1	4.6	3.0	3.9	4.2	4.3	3.9	3.7	4.5	5.8	4.0	6.1	3.2	3.6	3.6	4.3	1.1	41.2	48.0	45.1	61.8	38.6	42.1	41.4	44.1	42.1	40.2	42.7	50.9	17.4	19.2	20.8	78.4	49.3	60.5	40.3	14.4	35.3	51.9	31.8	19.9	55.4	38.6	24.0	40.5	64.6	31.5	68.6	64.5	46.9	42.5	68.5	44.1	33.3	22.0	40.2	32.8	95.9	46.4	29.7	33.7	35.2	62.4	26.6	27.4	20.3	55.0	26.8	107.7	91.8	31.5	30.5	55.2	63.0	43.0	35.8	45.0	56.9	38.4	46.7	57.5	51.5	112.6	218.0	44.7	46.6	33.8	51.9	71.2	26.8	41.0	16.9	147.5	26.3	33.5	32.4	48.5	27.7	36.6	62.4	64.6	63.8	29.5	37.3	88.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 18.8;skeletal muscle: 68.4;skin 1: 18.1;testis: 63.8;tongue: 25.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 123.6;Late spermatids: 281.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 67.9"	"Lineage enriched"	"Detected in many"	15	"dendritic cells: 67.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 19.5"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 27.3"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	1.1	2.6	6.3	1.0	6.6	0.7	2.2	5.9	6.5	2.3	3.8	1.2	0.6	1.9	18.8	4.6	2.8	1.0	8.7	5.8	5.7	7.8	0.7	1.6	3.3	5.2	7.8	2.3	1.7	5.5	2.6	0.5	4.6	3.3	0.6	6.9	2.8	2.1	68.4	18.1	1.4	1.3	4.5	1.4	1.2	63.8	9.1	2.3	3.1	25.6	2.2	1.1	4.0	3.9	2.7	0.1	1.5	1.7	0.8	1.5	1.1	0.3	0.7	0.3	1.0	1.2	0.8	0.4	0.4	0.8	0.8	4.9	1.1	4.6	0.4	0.0	2.6	0.8	0.2	0.2	0.9	0.0	0.2	1.7	3.0	0.9	4.6	1.0	2.1	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.6	1.4	2.3	0.1	0.1	0.0	2.7	0.1	0.8	0.2	0.6	4.3	1.3	2.2	19.5	0.0	1.1	0.3	2.8	0.0	0.2	0.1	0.0	0.0	2.3	0.6	2.6	0.0	0.3	0.0	0.0	1.5	0.1	0.7	0.0	0.1	7.1	0.7	0.0	0.0	0.0	0.0	4.3	67.9	0.0	0.8	6.3	6.6	5.9	6.5	5.8	5.7	5.2	7.8	4.6	4.5	9.1	3.9	1.2	0.0	0.5	0.3	2.0	2.2	4.7	8.7	10.2	5.7	4.2	4.6	5.8	0.0	2.7	1.8	10.4	1.0	41.3	0.7	9.8	3.2	123.6	3.2	0.3	1.5	0.0	0.0	1.8	4.3	1.4	1.1	1.1	0.6	0.0	5.6	0.7	0.1	0.7	0.0	1.5	0.9	2.0	1.3	11.5	281.6	3.1	2.0	0.0	0.0	1.6	25.4	0.0	0.0	0.2	2.1	2.4	2.6	0.0	6.7	0.3	0.6	1.8	9.1	6.6	1.1	2.8	2.8	16.9	3.5	2.8	0.5	0.9	3.2	0.8	2.9
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078902	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 4.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 79.8;U-266/70: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	6.0	5.9	7.6	2.2	8.5	2.4	3.2	11.0	13.4	7.3	0.0	5.9	1.9	4.2	1.9	6.2	4.1	5.9	6.6	9.2	5.6	5.8	3.2	3.0	1.0	11.3	7.6	2.2	3.7	15.5	10.1	8.6	13.1	4.0	3.9	11.3	15.2	2.2	21.8	6.0	2.5	4.1	0.0	2.2	6.1	1.7	12.7	3.5	10.7	17.8	2.2	10.8	4.0	0.8	2.6	1.7	8.7	4.6	5.1	0.1	5.4	0.3	0.2	0.9	0.3	0.5	0.6	0.5	0.8	0.4	2.0	8.1	7.4	0.5	0.3	79.8	7.9	7.7	7.0	0.9	0.2	4.7	8.6	0.9	3.5	0.2	0.5	0.6	0.5	3.8	0.3	12.0	0.1	4.2	1.8	0.5	5.1	14.2	1.7	9.5	1.5	1.8	0.4	8.4	10.5	9.0	4.5	5.2	0.3	3.0	5.7	4.7	0.4	0.9	0.9	0.7	2.9	75.6	0.3	4.3	1.1	3.9	1.9	0.4	1.6	3.2	1.5	3.5	0.1	0.1	0.3	1.0	0.8	0.6	0.5	1.0	0.1	0.6	4.9	0.4	0.0	1.6	7.6	8.5	11.0	13.4	9.2	5.6	11.3	7.6	13.1	0.0	12.7	0.8	2.6	6.4	2.7	126.7	1.5	8.7	5.7	3.0	8.6	59.4	4.7	3.0	33.9	8.6	10.9	1.8	35.5	3.8	11.6	12.5	0.0	2.1	1.2	3.2	17.5	5.3	13.8	3.4	344.6	4.3	3.4	6.5	11.7	6.8	0.0	2.2	2.5	18.1	7.1	6.7	175.7	8.0	14.2	15.4	7.2	1.2	5.0	14.0	3.6	53.4	6.6	10.2	26.8	111.6	77.4	2.2	8.3	5.3	2.9	5.9	2.2	3.7	9.5	10.4	0.0	42.5	21.4	2.6	3.4	13.1	8.7	2.6	3.8	2.6	5.6	21.2
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245759-52250599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	19.5	9.4	12.7	20.3	13.7	24.6	15.5	9.9	13.6	25.9	12.2	18.7	6.0	18.3	9.9	12.3	18.1	14.1	11.4	13.6	14.2	10.9	5.6	23.5	29.6	12.8	11.4	18.6	8.0	11.2	9.1	11.6	12.2	16.7	8.7	2.2	11.6	15.2	3.7	10.7	13.1	18.0	12.0	30.1	11.4	8.8	15.5	27.6	13.8	7.8	28.2	17.5	18.2	12.9	0.9	5.4	3.2	7.6	46.1	45.7	5.2	12.2	26.2	17.0	13.1	3.2	4.2	9.0	3.6	32.0	9.5	1.5	10.9	2.3	6.9	11.0	2.7	20.5	14.6	3.3	33.6	3.1	18.7	37.8	5.2	18.9	11.9	27.3	22.2	40.5	3.6	14.5	20.2	2.2	13.7	0.9	4.1	4.0	14.7	3.0	1.6	20.0	7.3	2.6	2.3	9.3	9.0	2.2	11.1	6.8	7.6	7.9	15.5	6.5	10.7	3.8	1.6	54.3	11.2	9.9	12.7	5.4	8.0	1.8	24.1	13.3	20.6	19.3	15.9	6.8	16.1	19.2	14.4	7.4	15.2	19.0	28.9	11.7	29.6	8.5	20.5	17.5	12.7	13.7	9.9	13.6	13.6	14.2	12.8	11.4	12.2	12.0	15.5	12.9	6.8	0.0	5.4	1.3	15.4	5.1	6.5	0.7	8.0	1.6	5.9	7.2	1.8	5.7	2.0	1.8	0.0	3.3	25.9	0.7	3.9	1.8	9.7	4.7	8.9	7.0	1.2	3.0	1.5	1.1	5.8	11.9	3.1	11.0	5.7	7.3	12.5	3.7	42.2	1.7	0.6	0.4	2.0	39.0	17.0	18.0	12.8	31.1	5.4	4.7	29.1	5.1	30.9	1.5	0.7	1.3	3.2	9.8	11.4	2.3	0.9	3.0	0.9	0.7	19.7	5.2	7.3	0.7	4.2	11.9	3.8	1.9	25.1	3.1	1.0	3.5
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166056-161178013	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 65.9;Respiratory ciliated cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	9.3	17.1	24.2	3.5	24.5	25.2	10.3	25.2	38.2	14.5	24.7	12.7	3.9	10.9	8.3	8.9	22.0	4.7	13.1	24.4	24.7	15.5	11.5	8.6	5.7	25.0	25.0	13.8	10.8	7.2	13.7	6.5	24.6	13.4	3.9	12.6	8.7	7.7	7.6	11.2	8.5	6.6	25.0	13.6	10.9	6.9	24.0	5.0	11.9	5.6	5.2	11.6	9.6	25.4	10.0	8.0	12.7	8.5	10.4	9.3	3.5	5.9	5.7	7.5	10.3	10.4	9.3	7.4	14.3	5.3	4.1	6.3	9.8	8.8	7.1	4.6	20.3	9.0	18.9	23.9	8.6	3.0	4.6	7.6	11.0	6.3	9.4	9.4	14.7	7.0	22.8	11.2	5.6	9.2	12.0	8.6	8.2	11.2	18.8	13.6	8.2	16.7	15.1	4.2	9.8	14.7	6.6	10.3	12.0	14.6	19.9	9.5	5.7	6.5	7.1	6.5	7.5	19.4	15.3	10.5	6.8	6.0	4.9	6.3	7.2	5.3	10.4	7.6	7.2	9.0	7.8	7.6	10.4	8.2	6.8	6.9	2.9	12.0	5.2	6.6	16.1	7.8	24.2	24.5	25.2	38.2	24.4	24.7	25.0	25.0	24.6	25.0	24.0	25.4	10.9	3.2	13.7	10.4	9.8	12.0	8.3	16.6	9.1	18.0	12.1	14.1	10.1	4.3	15.6	7.3	22.9	21.4	10.6	3.6	21.5	9.5	9.8	39.1	5.9	8.3	6.0	65.9	5.9	5.6	9.4	9.1	5.1	4.6	6.3	12.3	8.9	6.1	9.3	15.2	7.5	7.3	26.4	4.7	8.4	12.1	10.2	8.0	1.8	5.6	8.1	10.4	8.2	9.0	8.9	6.3	3.8	6.8	16.9	3.2	6.6	17.2	84.4	20.9	6.6	9.6	15.6	12.8	9.3	7.2	14.9	10.4	10.6	11.1	7.5	6.2
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 639.3;Late spermatids: 923.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	63.3	64.9	58.8	76.8	61.7	103.6	72.5	67.1	69.7	59.4	53.2	110.5	193.2	66.7	57.5	92.0	59.2	57.2	91.5	56.1	66.5	60.4	64.4	53.6	139.0	60.0	62.7	90.3	74.0	68.4	41.5	53.2	60.5	58.5	108.4	125.0	71.6	55.2	157.7	60.7	147.7	76.8	59.8	73.4	73.5	142.3	62.7	107.7	54.9	175.8	131.4	86.3	53.6	65.7	221.0	130.2	217.5	160.0	128.9	176.6	166.0	124.1	183.1	201.0	159.6	223.8	109.0	341.7	91.2	133.8	125.8	122.5	295.3	162.7	278.9	200.2	198.9	221.7	93.0	230.4	105.1	285.5	184.4	112.4	130.5	152.8	135.2	213.2	236.4	190.3	225.1	90.0	186.6	91.7	232.8	318.3	343.6	144.0	190.8	224.9	150.2	216.9	129.6	164.2	174.7	140.3	137.2	162.4	246.7	190.5	254.6	219.9	106.1	102.2	168.8	139.1	158.0	140.4	157.4	291.2	96.2	203.8	159.2	38.3	33.3	54.7	13.2	26.3	12.8	31.7	23.8	18.8	32.8	27.4	19.8	16.4	27.8	14.9	35.0	12.8	25.4	24.3	58.8	61.7	67.1	69.7	56.1	66.5	60.0	62.7	60.5	59.8	62.7	65.7	71.3	35.3	32.2	27.7	163.4	209.2	124.0	89.6	150.8	203.2	77.6	63.6	138.5	78.6	52.4	36.8	68.8	136.5	61.3	103.9	93.9	75.7	639.3	43.9	72.1	88.8	85.0	131.3	17.9	125.9	204.6	129.6	74.5	47.9	58.4	87.8	62.2	43.4	132.7	102.6	29.9	109.8	93.6	161.3	111.8	923.3	89.8	88.9	128.1	30.0	96.0	91.8	57.7	34.7	34.3	88.3	144.0	138.8	234.3	159.7	305.2	94.6	28.9	110.5	111.7	75.9	133.8	314.6	51.7	161.1	210.0	132.2	106.5	121.8	164.8	156.3
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	8	"cerebral cortex: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 51.5;AN3-CA: 65.6;fHDF/TERT166: 48.6;GAMG: 47.4;HBEC3-KT: 53.6;JURKAT: 76.7;RPTEC TERT1: 47.4;U-266/84: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA		43000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	44.5	41.1	0.7	0.0	0.7	1.9	41.4	0.6	8.8	44.4	0.6	55.5	11.6	49.6	33.1	52.1	37.3	11.8	51.0	0.7	0.7	62.3	47.5	43.7	5.4	0.9	0.7	41.8	45.1	2.2	29.2	5.8	0.8	46.3	0.7	7.9	42.8	0.0	50.4	42.9	50.7	0.0	0.6	39.8	59.5	41.5	0.7	9.7	42.3	0.0	11.8	51.6	42.7	1.1	51.5	0.0	0.0	65.6	29.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	48.6	47.4	0.0	0.0	53.6	0.0	1.0	34.5	42.6	0.0	0.0	0.0	3.0	3.9	0.0	0.0	0.0	0.7	0.0	0.0	76.7	0.5	2.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	47.4	29.0	0.0	0.0	0.7	35.5	4.8	26.8	0.0	0.0	0.0	0.0	0.3	4.1	1.5	30.7	64.9	26.7	0.7	0.0	0.0	11.5	4.1	12.4	4.7	9.3	4.5	6.8	5.3	6.5	2.2	7.2	4.9	7.0	2.8	3.9	7.9	3.2	8.4	6.8	0.7	0.7	0.6	8.8	0.7	0.7	0.9	0.7	0.8	0.6	0.7	1.1	38.2	19.2	20.2	2.6	57.8	52.8	80.0	77.2	29.0	29.3	47.7	32.8	18.8	52.9	49.7	40.5	6.2	56.0	39.2	111.5	95.9	142.2	242.1	19.8	24.2	44.3	53.7	32.4	10.1	136.3	119.9	27.0	53.5	31.8	78.6	21.4	45.7	28.0	65.7	13.5	9.0	83.8	77.3	49.7	53.8	696.0	32.3	43.5	62.2	3.7	75.4	58.4	92.7	6.0	7.6	136.5	114.1	40.3	42.2	66.6	139.6	93.3	38.7	33.1	39.5	27.2	89.4	61.9	23.2	39.0	66.5	75.2	52.4	16.5	51.8	94.9
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 353.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"		NA	NA		270000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments, Cytosol"		"HPA041296: AB_2677394, HPA071956: AB_2732192"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	31.5	18.6	21.2	32.3	26.6	57.5	21.7	25.3	65.3	34.1	15.0	73.3	22.8	66.2	31.1	71.2	40.9	36.6	28.0	27.7	20.3	18.2	14.2	24.6	31.9	14.3	14.5	27.4	11.0	18.5	11.2	41.6	14.2	67.6	35.4	14.6	19.0	84.8	20.5	17.6	27.6	83.7	14.1	30.8	29.2	23.5	20.7	34.3	24.9	27.2	27.8	64.5	27.7	27.0	42.9	36.5	49.3	28.5	36.8	36.2	45.8	84.0	46.5	53.1	35.2	34.9	20.7	36.9	33.4	113.8	21.4	33.4	38.6	32.9	63.8	51.3	24.3	98.2	40.5	24.1	29.1	64.8	59.5	30.7	24.3	53.6	49.1	60.1	37.2	36.7	41.1	43.0	57.0	27.7	71.4	34.3	39.1	18.8	25.2	57.9	54.4	27.8	31.4	66.6	23.8	17.9	66.3	23.2	28.5	45.1	32.4	30.9	56.8	56.3	29.9	40.1	48.2	28.3	27.8	48.6	19.2	36.3	49.3	155.1	44.4	197.4	62.8	47.5	56.5	56.8	59.7	66.8	41.8	52.8	47.3	61.3	187.2	98.2	70.4	35.3	69.6	46.3	21.2	26.6	25.3	65.3	27.7	20.3	14.3	14.5	14.2	14.1	20.7	27.0	108.4	76.9	65.9	168.5	79.7	84.5	69.0	59.1	57.5	82.2	30.7	69.0	127.4	32.9	61.5	53.3	35.5	66.7	113.4	44.9	15.6	50.9	111.3	47.5	113.6	93.6	44.9	66.3	240.4	40.0	82.0	82.4	42.8	81.2	121.4	66.6	55.0	27.5	78.0	102.6	135.4	37.7	44.7	57.5	100.8	64.2	86.3	92.8	60.5	132.1	112.0	52.2	120.5	353.9	132.9	55.9	42.7	147.4	60.7	52.0	34.3	26.3	41.0	61.4	210.4	74.6	332.7	133.4	89.8	50.9	81.1	83.7	119.7	81.5	41.3	63.6
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 356.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	40.0	11.1	5.1	36.0	12.6	8.3	17.8	8.9	9.9	51.8	15.5	151.0	24.1	222.0	30.5	150.1	52.6	72.5	356.9	5.5	6.5	14.3	8.4	24.8	18.6	17.2	15.3	38.3	7.2	6.2	5.0	34.4	18.0	142.8	64.8	7.6	20.0	198.6	84.1	11.0	30.9	246.4	16.2	30.8	41.5	7.1	9.2	7.7	10.9	80.5	15.1	86.7	23.0	27.3	2.2	4.4	3.3	3.2	4.6	3.3	5.4	1.7	1.7	1.8	1.7	1.9	3.9	2.5	0.8	3.2	4.3	7.0	5.0	2.7	1.9	3.3	3.1	2.5	7.1	1.2	1.1	5.4	2.8	2.6	3.0	2.5	2.6	9.1	1.5	2.8	3.9	2.9	3.1	1.7	4.1	3.4	2.3	2.4	0.9	2.6	8.5	3.7	1.4	8.1	4.0	3.1	3.3	3.9	1.9	4.4	3.4	2.4	1.9	2.5	1.5	1.9	1.5	4.2	4.3	2.7	2.4	4.4	10.2	2.4	1.7	1.5	1.6	1.0	1.4	2.0	1.1	1.0	1.5	2.1	1.3	1.0	16.2	0.7	1.5	1.7	1.7	0.5	5.1	12.6	8.9	9.9	5.5	6.5	17.2	15.3	18.0	16.2	9.2	27.3	12.5	12.8	19.8	181.5	6.0	17.3	49.0	35.6	8.6	59.3	11.1	20.6	836.8	11.5	23.0	12.9	75.0	18.1	8.6	52.9	11.7	10.1	39.2	19.3	16.1	15.2	24.0	5.2	225.7	12.9	8.4	51.4	17.3	7.6	18.9	438.3	16.4	9.6	9.4	26.9	205.0	17.2	63.1	23.5	10.9	13.1	12.2	8.2	8.8	102.1	7.8	10.2	5.2	102.5	647.4	6.3	21.1	51.1	9.6	24.3	12.8	7.1	27.4	30.4	32.9	38.6	162.7	19.3	13.9	7.1	10.9	25.4	10.7	14.2	33.9	28.4
PPP1R12C	"AAVS1, DKFZP434D0412, LENG3, MBS85, p84, p85"	ENSG00000125503	"Protein phosphatase 1 regulatory subunit 12C"	Q9BZL4	19	55090914-55117637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043532	Approved					NA	NA		29000	"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043532: AB_10961273"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.52e-3)"	"unprognostic (7.92e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.68e-3)"	103.0	67.3	86.5	49.6	80.5	55.8	96.2	71.7	102.8	158.4	91.4	298.6	61.1	200.7	26.0	80.6	143.2	26.2	283.7	86.6	79.2	96.3	85.8	107.0	44.8	93.3	83.0	104.6	86.3	36.5	108.3	36.8	86.5	137.9	19.4	15.4	60.4	57.7	43.4	75.0	135.9	58.4	69.9	138.9	132.2	150.8	87.1	28.9	85.8	22.3	23.1	173.6	101.4	80.6	52.9	66.7	36.2	43.8	39.8	24.1	84.0	58.8	41.9	35.3	38.9	24.1	37.6	77.9	25.0	33.8	36.0	49.7	12.6	23.2	12.0	63.6	120.7	52.0	67.5	40.2	82.0	38.1	90.1	37.8	29.0	35.1	22.4	29.2	39.7	39.8	40.3	87.1	32.6	32.7	45.4	55.3	26.2	34.8	67.6	62.0	29.9	31.4	32.4	89.2	47.0	37.4	42.1	35.7	37.9	17.9	22.9	76.6	82.9	86.0	41.5	43.1	62.3	43.0	37.7	42.8	78.4	77.5	54.2	0.0	1.5	2.6	1.1	1.2	0.8	1.3	1.0	0.9	0.9	2.5	0.8	1.1	1.6	0.6	2.4	1.5	0.7	0.7	86.5	80.5	71.7	102.8	86.6	79.2	93.3	83.0	86.5	69.9	87.1	80.6	28.2	22.4	15.5	19.9	9.6	11.5	5.1	4.6	1.8	31.3	11.4	12.2	50.3	8.6	8.6	11.0	22.9	6.2	20.4	31.9	1.9	8.4	19.4	9.2	25.4	23.2	5.3	6.5	15.1	15.1	10.3	18.6	33.1	15.1	6.3	96.2	23.6	17.4	15.7	37.0	16.7	18.7	8.2	24.4	16.5	9.1	17.1	20.2	17.8	12.2	14.2	19.1	11.3	10.6	16.2	13.3	20.1	25.6	13.0	7.6	17.1	7.9	7.8	21.7	39.5	15.6	45.5	19.7	13.4	8.9	8.2	10.1	13.2	28.5	13.2	8.7
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733195-103847575	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favorable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.0	4.7	3.4	3.2	4.2	0.7	7.4	6.6	8.5	6.8	4.0	7.7	7.1	7.6	2.1	11.6	9.8	4.7	21.2	7.6	3.9	6.9	5.0	9.9	2.7	1.2	2.0	10.9	8.3	7.8	6.5	6.0	1.7	10.7	5.6	8.0	10.2	5.3	7.5	12.5	7.6	5.2	0.3	11.3	10.1	19.1	3.8	2.0	23.4	6.2	5.1	8.0	7.1	4.2	4.9	4.2	0.5	5.4	0.9	0.4	1.9	3.2	2.3	4.0	1.8	3.3	4.4	1.1	11.7	2.2	4.9	9.8	5.8	3.7	3.5	2.2	4.0	0.0	1.3	5.7	3.6	0.5	4.4	1.0	4.4	0.3	4.7	1.7	7.9	2.8	0.7	1.7	2.7	20.3	0.0	0.5	1.0	12.3	5.1	11.3	3.2	2.7	7.8	12.7	6.6	16.9	9.9	7.3	2.5	2.6	18.4	0.7	7.1	2.9	4.0	2.4	3.0	4.0	5.8	8.4	1.8	2.9	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	4.2	6.6	8.5	7.6	3.9	1.2	2.0	1.7	0.3	3.8	4.2	35.1	19.2	39.5	31.0	7.1	13.5	16.6	6.9	18.8	15.8	31.3	20.6	45.4	14.3	11.8	7.3	12.5	2.9	11.9	26.9	3.9	7.9	58.0	37.9	7.9	30.3	15.6	2.7	106.1	6.4	1.0	7.7	37.8	48.5	0.0	83.4	14.3	9.0	2.9	15.2	105.9	14.2	6.1	1.6	5.7	78.4	4.4	3.0	3.6	49.6	0.4	5.8	1.0	31.7	33.2	6.8	18.7	20.3	6.3	13.1	14.6	7.8	8.3	12.9	6.6	10.9	6.7	17.8	15.1	24.1	12.9	2.2	9.0	8.7	15.8	13.7
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379638-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.4;heart muscle: 139.4;skin 1: 219.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 85.6;Granulosa cells: 118.3;Syncytiotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 130.1;hTCEpi: 189.0;hTERT-HME1: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151"	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavorable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	20.4	20.1	11.7	2.9	11.7	0.6	29.6	11.5	14.0	44.9	9.5	11.1	5.0	8.2	15.2	179.4	9.6	6.0	139.4	10.8	14.3	24.8	12.6	20.3	2.6	11.9	11.1	8.8	31.5	12.2	11.8	26.6	11.7	30.8	6.8	13.6	55.6	13.3	5.8	219.8	9.1	5.4	10.0	6.4	12.0	3.1	12.7	4.0	17.7	4.4	18.8	23.6	84.9	12.4	72.3	10.7	4.6	3.8	4.7	2.9	61.5	14.5	2.5	17.5	24.3	23.1	70.6	9.5	5.9	11.9	36.5	97.2	4.0	130.1	16.0	24.0	5.9	1.4	36.3	8.7	10.0	1.0	3.4	4.0	189.0	27.9	131.9	79.2	33.2	7.9	8.1	3.6	1.2	64.7	1.8	1.9	5.3	36.9	18.3	7.4	5.6	1.7	22.9	95.0	2.4	7.6	64.5	68.4	1.6	30.0	58.2	1.9	46.3	23.1	60.9	1.8	76.2	35.1	42.1	6.5	3.3	2.9	5.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	11.7	11.7	11.5	14.0	10.8	14.3	11.9	11.1	11.7	10.0	12.7	12.4	14.3	35.3	13.0	9.4	2.0	68.7	85.6	38.4	67.2	1.7	21.9	28.6	38.8	20.0	27.8	20.2	10.4	83.2	2.5	17.8	5.9	34.9	0.7	8.7	3.0	13.4	7.2	10.1	0.8	15.8	37.7	5.6	8.6	17.1	4.5	118.3	11.7	2.5	7.6	0.0	0.9	6.9	14.2	1.6	5.0	0.5	5.9	2.2	12.4	9.4	1.9	2.4	2.1	2.5	1.6	50.4	17.2	12.4	6.1	44.2	22.6	3.9	16.3	26.8	6.6	8.4	14.1	2.7	2.1	81.2	71.0	128.5	2.5	2.8	9.0	63.4
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PPP1R14B	"PHI-1, PLCB3N, PNG, SOM172"	ENSG00000173457	"Protein phosphatase 1 regulatory inhibitor subunit 14B"	Q96C90	11	64244479-64246943	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 653.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	75	"plasmacytoid DC: 382.3"	"Lineage enriched"	"Detected in all"	75	"dendritic cells: 382.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053882	Approved					NA	NA		190000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA053882: AB_2682291"	"unprognostic (1.36e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (1.14e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (6.86e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-1)"	90.7	107.4	31.1	49.6	32.0	49.0	71.5	33.1	38.2	82.1	34.4	76.2	51.6	54.2	14.5	238.8	48.9	19.1	128.5	30.4	33.3	97.6	139.5	64.3	32.7	35.7	33.1	40.4	247.8	19.8	39.3	38.1	32.8	49.6	24.2	3.9	83.6	18.3	217.3	172.4	65.0	22.1	32.4	83.8	74.6	61.2	38.6	31.0	52.9	53.2	36.5	92.3	107.9	31.6	409.8	236.0	147.4	237.1	69.9	93.6	224.7	211.4	130.8	215.4	95.2	138.6	351.1	204.0	369.8	198.0	181.1	264.8	112.2	214.0	80.6	178.7	176.0	145.3	260.5	218.4	126.8	227.7	137.3	86.4	223.9	165.5	283.4	189.5	194.1	149.3	201.2	108.4	240.2	483.3	246.2	341.4	416.4	209.3	520.0	236.8	475.2	540.3	191.4	190.8	220.3	319.0	165.2	227.3	314.3	72.5	156.3	138.4	180.0	311.1	291.1	614.7	320.2	102.2	70.2	204.7	269.0	189.7	362.2	0.0	2.3	1.9	1.5	3.1	3.1	5.0	2.4	1.7	4.0	3.8	1.3	1.2	4.8	3.0	2.8	382.3	0.7	2.7	31.1	32.0	33.1	38.2	30.4	33.3	35.7	33.1	32.8	32.4	38.6	31.6	107.4	9.6	11.7	6.5	49.3	228.5	90.0	66.2	41.5	21.9	211.7	273.7	38.7	41.5	32.2	79.1	8.4	58.4	333.8	69.9	76.3	131.9	6.3	60.8	180.6	81.8	83.0	37.6	3.0	234.2	653.6	77.5	45.3	126.1	27.3	273.4	46.8	101.4	87.4	20.2	4.6	109.8	44.7	33.0	119.5	9.0	9.3	75.2	60.5	2.8	72.8	38.7	12.3	6.6	1.8	306.8	51.2	11.7	55.0	365.5	129.8	63.1	10.2	19.3	26.3	332.6	136.6	5.9	14.8	169.1	259.0	132.8	37.4	179.6	107.4	258.3
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143044-150250392	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.5;skeletal muscle: 66.5;skin 1: 97.2;thyroid gland: 58.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 53.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044667, HPA047907"	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB044667: , HPA047907: "	"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.4	0.2	5.1	1.4	6.6	0.2	6.0	5.9	8.0	10.2	6.0	12.5	10.4	1.4	0.9	18.4	16.0	0.1	75.5	7.8	5.0	9.5	0.0	12.3	0.3	5.6	5.4	0.1	0.7	5.1	1.7	3.4	5.6	1.3	8.6	0.6	3.2	0.2	66.5	97.2	2.7	0.9	4.4	0.1	0.8	6.7	5.0	0.5	58.7	8.5	5.8	0.5	22.0	5.0	27.9	0.1	11.7	0.1	0.1	0.6	0.0	3.7	0.0	0.0	0.1	1.3	3.8	0.7	8.0	5.3	1.8	40.7	6.1	86.1	0.0	0.0	36.2	0.3	0.0	0.0	0.0	0.0	1.1	0.0	103.0	0.2	41.1	0.0	0.0	0.5	23.6	0.0	0.0	3.8	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	35.5	1.5	6.2	0.0	0.6	37.7	2.2	0.7	0.2	1.9	0.0	0.1	20.4	32.5	9.5	0.0	0.0	0.0	14.2	16.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.6	5.9	8.0	7.8	5.0	5.6	5.4	5.6	4.4	5.0	5.0	0.3	19.2	41.1	1.3	0.5	280.2	17.9	19.6	12.0	1.1	6.5	4.3	79.5	0.0	17.1	14.7	0.0	0.1	0.4	24.5	1.9	3.8	0.2	37.9	0.6	3.0	28.2	0.0	28.0	0.2	0.1	6.7	0.0	5.1	1.3	4.1	0.0	0.0	3.0	1.7	13.3	3.1	14.2	0.0	19.7	1.6	0.0	0.6	30.2	2.8	1.1	0.0	0.0	37.2	2.5	12.8	41.5	0.4	0.0	16.6	5.0	38.6	61.5	0.5	0.0	80.9	4.3	0.5	1.8	14.7	336.6	1.9	1.4	0.5	8.7	1.9
PPP1R14D	"CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016"	ENSG00000166143	"Protein phosphatase 1 regulatory inhibitor subunit 14D"	Q9NXH3	15	40815451-40828709	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 111.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 334.5;Paneth cells: 338.1;Proximal enterocytes: 412.4;Undifferentiated cells: 108.9"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;RPMI-8226: 3.1;RT4: 1.9;SK-BR-3: 1.2;T-47d: 1.1;U-266/84: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041846	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041846: AB_10794307"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.11e-2)"	0.1	0.0	0.1	9.6	0.1	0.0	0.5	0.5	0.1	0.3	0.1	107.1	111.1	0.2	1.9	0.2	0.3	15.6	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.2	0.0	0.3	0.4	0.1	0.1	0.1	0.7	92.5	0.2	0.7	0.4	0.0	1.0	82.3	3.6	0.1	0.0	1.7	0.2	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.1	0.0	1.9	0.4	0.3	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.5	0.9	0.0	5.7	0.3	1.8	0.0	0.4	0.1	334.5	0.0	1.3	0.0	0.1	0.0	0.0	61.3	0.0	0.1	5.3	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.2	58.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	338.1	0.0	0.0	0.1	412.4	52.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.9	0.0	108.9	0.2
PPP1R15A	GADD34	ENSG00000087074	"Protein phosphatase 1 regulatory subunit 15A"	O75807	19	48872421-48876058	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 575.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 340.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 114.6;granulocytes: 340.1"	"Cell line enhanced"	"Detected in all"		"HHSteC: 282.8;hTERT-HME1: 493.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018395, HPA020240"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"CAB018395: AB_2237473, HPA020240: AB_1849404"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.43e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	199.1	84.7	33.3	49.5	37.4	575.6	97.7	45.9	54.1	99.5	66.9	78.9	36.0	70.1	11.3	98.3	147.4	82.0	185.6	34.8	36.2	95.0	85.1	226.7	33.1	44.8	32.7	101.2	33.4	23.1	65.0	74.8	42.9	60.5	45.5	10.9	41.6	38.6	88.5	191.5	58.8	101.8	29.4	69.0	90.7	23.3	38.7	52.0	69.4	60.6	20.2	110.6	108.4	46.9	55.8	23.7	24.9	20.5	71.2	40.4	39.3	95.1	148.0	106.5	95.9	36.5	27.6	19.1	25.0	69.0	145.5	39.4	9.3	49.7	79.8	10.7	14.4	86.4	14.4	18.1	282.8	20.2	119.2	55.1	135.5	147.0	493.7	48.0	56.3	21.5	118.2	155.6	69.5	6.1	11.1	27.9	6.2	100.3	42.3	12.6	23.1	6.5	22.3	63.8	14.2	24.3	49.2	33.2	230.2	26.0	11.9	36.1	60.6	126.3	31.8	89.3	58.5	82.8	72.1	17.9	46.2	13.7	154.8	161.8	49.4	91.3	22.5	31.1	19.6	36.7	22.2	18.7	35.9	29.7	12.3	11.0	340.1	13.8	37.6	114.6	31.5	36.9	33.3	37.4	45.9	54.1	34.8	36.2	44.8	32.7	42.9	29.4	38.7	46.9	499.1	288.4	225.1	2.3	387.2	482.2	989.5	232.0	730.1	25.0	294.3	220.7	173.3	127.2	204.3	12.9	35.5	104.8	290.3	435.6	3.9	224.0	4.6	619.6	427.4	370.4	170.9	213.5	4.1	94.5	219.0	466.3	430.7	1063.2	708.1	53.3	150.0	14.4	195.0	35.3	4.1	354.1	140.4	146.7	904.4	5.1	58.7	615.3	396.6	9.4	105.1	50.5	20.6	1.0	2.0	233.4	421.8	23.0	477.1	731.5	348.7	9.0	246.2	27.7	85.5	483.5	612.1	7.0	9.5	573.1	431.0	288.4	427.9	102.8	321.8	733.9
PPP1R16A	"MGC14333, MYPT3"	ENSG00000160972	"Protein phosphatase 1 regulatory subunit 16A"	Q96I34	8	144477969-144502121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.9"	"Low region specificity"	"Detected in all"							HPA023755	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA023755: AB_1854268"	"unprognostic (9.63e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.45e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.79e-2)"	6.1	15.0	10.2	4.7	8.6	3.8	8.2	4.3	15.0	10.5	16.7	25.1	27.1	10.5	1.6	9.8	18.9	3.1	9.6	12.9	8.9	26.7	23.5	10.8	2.9	10.2	10.4	7.9	17.7	7.4	36.9	1.7	7.1	15.5	2.4	2.9	11.6	5.6	6.3	9.0	24.6	1.6	8.1	8.0	14.1	33.3	10.3	2.4	27.0	1.0	1.0	9.1	6.7	5.1	30.4	24.3	3.9	15.1	1.6	2.7	19.3	8.2	5.1	6.3	5.1	6.4	21.2	5.0	21.1	3.0	5.6	19.8	2.0	6.7	1.0	10.3	11.9	6.0	26.4	6.8	4.7	4.3	7.9	2.7	8.9	7.3	2.1	4.1	4.5	8.2	24.0	6.1	2.3	49.9	15.3	19.9	7.4	15.6	30.3	15.9	1.9	10.1	5.7	10.0	12.5	23.9	14.9	13.7	13.0	1.0	32.3	9.1	7.7	7.1	33.2	19.8	15.8	4.0	4.3	1.8	22.8	8.3	6.5	0.0	0.8	0.0	1.0	1.2	0.9	0.8	0.8	1.0	1.2	0.1	0.5	1.1	0.2	0.2	1.7	0.7	0.6	0.8	10.2	8.6	4.3	15.0	12.9	8.9	10.2	10.4	7.1	8.1	10.3	5.1	7.9	3.2	15.4	28.1	6.2	43.2	36.2	47.6	54.1	25.0	78.3	82.0	85.8	157.3	24.6	40.5	14.6	7.2	6.0	135.9	121.3	33.7	12.6	43.8	15.6	13.3	51.6	6.1	7.8	41.6	24.3	13.3	70.3	24.2	3.8	16.4	12.8	208.9	6.1	30.3	7.6	98.1	26.4	7.0	27.1	14.4	22.7	9.8	8.8	5.6	3.8	102.8	5.2	6.6	2.8	29.3	109.8	15.4	5.9	40.0	440.8	404.2	59.8	50.9	6.6	17.2	17.3	52.9	28.7	77.8	61.8	6.7	7.1	69.2	116.0	28.3
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805697-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;lymphoid tissue: 41.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 119.4;Inhibitory neurons: 46.8;Oligodendrocyte precursor cells: 49.8;Oligodendrocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 57.3;HMC-1: 59.2;HUVEC TERT2: 35.6;U-266/70: 96.7;U-266/84: 41.8;U-698: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049571, HPA079512"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	"Nuclear speckles"	"HPA049571: , HPA079512: "	"unprognostic (2.62e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	13.2	2.9	36.5	19.3	71.6	17.7	8.2	26.1	61.1	3.2	5.1	4.6	3.6	3.4	1.5	3.1	5.8	5.3	5.2	49.3	22.3	27.7	2.4	7.9	37.7	27.8	34.7	1.1	1.5	0.8	2.2	3.7	27.1	1.6	5.1	3.7	2.0	1.9	3.6	1.5	18.0	7.2	24.3	18.1	5.6	0.7	35.7	18.2	3.4	5.7	41.9	6.0	1.6	52.1	0.1	0.7	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.3	0.8	0.0	0.9	0.1	1.0	0.1	0.0	1.4	0.2	4.4	0.0	0.0	0.0	0.2	59.2	0.0	0.1	0.0	0.0	0.0	35.6	7.6	1.0	11.9	0.0	0.0	7.4	9.7	7.9	0.1	0.0	5.0	0.0	0.0	0.0	0.0	17.7	19.7	0.0	0.0	0.0	0.7	0.0	3.1	5.5	0.0	0.9	0.0	0.0	96.7	41.8	38.3	0.0	0.0	0.1	0.0	0.2	2.5	3.4	0.5	1.8	5.3	2.3	3.3	0.7	3.3	1.3	1.8	0.0	2.9	0.9	3.3	2.6	1.1	36.5	71.6	26.1	61.1	49.3	22.3	27.8	34.7	27.1	24.3	35.7	52.1	29.3	3.2	3.0	1.3	33.6	1.0	0.0	0.8	0.6	2.3	0.5	0.5	23.5	1.5	4.0	0.0	0.0	0.0	34.0	0.3	0.0	0.0	1.9	0.2	0.2	18.7	0.0	2.7	119.4	0.0	0.0	1.6	4.1	0.3	3.8	0.0	38.6	0.3	0.1	37.0	46.8	0.1	0.0	3.1	3.6	1.5	0.0	3.8	8.8	23.4	20.5	0.3	11.3	49.8	238.0	0.0	0.1	0.0	29.3	0.0	0.0	17.4	3.6	0.3	0.0	0.3	1.0	0.0	0.3	0.3	1.3	0.0	37.4	0.0	0.2	0.3
PPP1R17	"C7orf16, GSBS"	ENSG00000106341	"Protein phosphatase 1 regulatory subunit 17"	O96001	7	31687215-31708455	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;brain: 18.1"	"Group enriched"	"Detected in some"	35	"Early spermatids: 42.9;Late spermatids: 112.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	6	"amygdala: 7.8;cerebellum: 18.1;hypothalamus: 7.8;midbrain: 9.6;thalamus: 15.1"	"Immune cell enriched"	"Detected in some"	4	"non-classical monocyte: 51.9"	"Lineage enriched"	"Detected in many"	21	"monocytes: 51.9"	"Group enriched"	"Detected in some"	180	"NTERA-2: 40.4;SCLC-21H: 124.1"	"Region enriched"	"Detected in many"	32	"cerebellum: 430.8"					"HPA047819, HPA073123"	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"			"HPA047819: AB_2680166, HPA073123: AB_2732219"					"unprognostic (1.50e-1)"			"unprognostic (1.33e-1)"					"unprognostic (6.56e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.33e-1)"			0.2	4.6	7.8	0.2	2.0	0.3	0.0	18.1	1.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.8	0.0	0.0	0.5	0.0	1.3	9.6	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.1	0.0	51.9	0.0	0.0	0.8	7.8	2.0	18.1	1.9	0.1	7.8	1.3	9.6	1.8	0.3	15.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	112.7	0.3	2.2	0.0	0.0	0.9	0.0	1.0	0.5	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 208.4;Kupffer cells: 164.4;Langerhans cells: 179.3;monocytes: 212.8;NK-cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 215.8;neutrophil: 169.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 215.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	35.4	16.7	9.5	42.5	9.1	56.0	25.9	9.9	12.8	30.2	7.0	38.0	8.8	36.8	3.5	18.1	28.6	25.6	23.2	9.4	12.1	14.2	16.8	51.5	75.5	17.8	12.6	26.8	10.1	2.7	7.0	21.4	15.5	19.7	7.7	2.6	15.4	11.5	10.8	21.6	33.7	17.3	13.7	80.4	19.5	5.9	15.6	53.5	17.6	9.0	38.2	36.1	24.4	13.9	63.2	9.4	34.4	37.3	28.0	80.4	1.7	48.4	63.6	43.3	29.9	6.6	11.2	64.7	25.0	77.3	73.7	35.8	21.6	44.7	29.6	74.8	2.2	79.3	20.7	6.6	59.1	28.6	116.3	44.0	44.0	97.9	89.8	64.5	60.0	53.3	27.2	58.2	57.8	6.9	40.8	43.5	3.2	1.6	13.8	162.8	28.8	33.9	18.0	3.4	3.8	19.2	30.1	10.9	65.9	18.8	9.4	26.8	90.8	139.4	29.2	29.4	103.3	11.6	57.3	77.3	40.7	131.9	155.9	43.0	16.4	215.8	43.4	21.8	31.8	20.9	23.1	42.5	9.5	22.0	16.7	32.5	169.6	37.8	25.2	14.9	39.7	22.6	9.5	9.1	9.9	12.8	9.4	12.1	17.8	12.6	15.5	13.7	15.6	13.9	39.1	3.2	15.7	1.6	89.7	109.0	29.6	15.7	79.6	2.3	14.2	14.6	3.1	8.6	4.6	9.2	0.0	3.1	116.5	0.8	0.0	25.1	24.2	4.4	24.4	67.8	1.8	35.4	0.8	8.2	20.4	34.1	7.1	6.7	53.2	5.9	32.9	8.2	208.4	3.3	1.3	0.8	8.2	164.4	179.3	19.9	27.7	123.3	39.2	19.7	212.8	1.0	332.7	11.1	0.1	20.8	0.0	23.3	52.9	23.8	0.4	2.5	4.4	3.1	26.3	28.6	53.5	1.2	1.3	38.3	59.7	4.0	141.6	6.8	0.7	22.5
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 259.7;skeletal muscle: 831.6;tongue: 271.1"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	241.3	2.6	37.1	1.1	73.6	0.3	169.8	26.1	45.7	1.6	20.4	29.6	3.0	2.2	0.7	10.3	3.8	1.5	110.9	38.9	36.9	259.7	138.1	1.0	0.5	29.0	32.0	7.7	14.2	20.8	1.8	0.0	26.0	7.9	1.8	14.6	9.7	3.2	831.6	7.6	13.2	3.3	25.5	0.5	27.8	2.2	31.6	0.2	2.6	271.1	0.5	5.4	1.5	34.1	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	73.6	26.1	45.7	38.9	36.9	29.0	32.0	26.0	25.5	31.6	34.1	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Metabolic proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 711.8;choroid plexus: 506.6;intestine: 211.4;salivary gland: 366.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Distal tubular cells: 121.3;Intestinal goblet cells: 305.7;Melanocytes: 135.2;Paneth cells: 132.3;Undifferentiated cells: 423.7;Urothelial cells: 171.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 94.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.6;CAPAN-2: 12.6;HSkMC: 31.7;OE19: 15.6;SCLC-21H: 27.4"	"Region enriched"	"Detected in all"	8	"basal ganglia: 1243.8"	"Region enriched"	"Detected in all"	26	"basal ganglia: 1534.8"	"CAB004026, HPA048630, HPA061142"	Approved	Approved				NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438"	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	93.8	30.2	280.9	19.8	711.8	0.4	74.0	262.7	312.7	20.0	506.6	211.4	83.4	4.4	5.5	4.8	28.4	2.0	3.5	251.7	244.0	29.1	0.5	15.3	0.1	319.6	275.5	11.3	75.7	0.5	15.0	0.0	232.4	62.7	203.4	6.2	366.9	89.7	0.9	56.3	68.7	10.8	243.3	0.1	39.9	15.8	317.9	0.2	0.6	0.0	0.3	18.9	11.4	249.6	0.0	0.0	0.0	0.0	7.6	4.4	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	15.6	0.9	0.0	0.0	0.6	0.0	0.0	27.4	0.6	0.0	1.5	0.0	2.4	0.6	1.1	0.0	0.0	1.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	711.8	262.7	312.7	251.7	244.0	319.6	275.5	232.4	243.3	317.9	249.6	1.0	0.0	34.7	33.3	1.3	1.3	117.1	0.4	0.6	0.6	93.5	84.3	1.1	0.0	0.2	1.8	0.0	0.0	2.4	144.6	121.3	28.7	0.8	46.6	0.9	1.6	96.7	0.0	5.3	3.3	0.0	2.8	13.3	3.2	4.5	0.0	4.2	0.0	0.2	0.0	1.6	305.7	2.0	0.0	0.8	3.2	34.5	1.2	135.2	0.0	0.0	29.8	0.0	1.0	0.5	0.8	132.3	5.7	0.0	84.3	40.4	0.7	0.1	1.3	0.0	1.2	1.7	0.9	3.7	1.2	0.4	0.0	1.9	0.0	423.7	171.5
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.6;Oligodendrocytes: 190.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.3	10.6	10.6	10.5	13.4	9.9	8.5	8.2	13.4	8.5	10.7	8.8	7.9	12.7	19.6	12.1	14.5	10.8	10.1	9.7	9.4	28.1	11.6	11.2	13.3	11.1	11.0	13.4	8.1	33.5	9.6	12.8	10.2	11.4	10.6	12.0	5.7	10.6	5.7	10.5	9.9	13.0	8.7	13.0	9.0	9.4	11.7	13.9	21.4	4.8	12.2	9.5	7.6	18.9	17.3	8.2	6.8	8.5	17.1	12.5	18.3	10.0	11.0	6.1	7.2	4.5	10.6	11.8	16.4	14.2	11.7	9.3	5.8	9.1	12.4	15.1	4.8	12.6	7.2	10.8	11.6	5.5	9.8	15.9	8.1	11.0	13.2	15.1	15.3	5.9	5.2	19.2	16.7	9.5	10.9	9.5	17.7	12.3	8.4	9.1	18.8	13.1	11.9	10.8	9.2	5.7	19.0	4.8	18.1	18.2	8.6	9.0	13.9	6.4	7.8	5.6	8.0	14.3	4.1	10.5	10.2	12.5	8.6	18.6	4.7	8.1	3.7	5.4	2.9	5.4	4.3	4.4	5.0	6.8	6.4	5.5	11.6	3.8	4.8	3.1	4.6	2.3	10.6	13.4	8.2	13.4	9.7	9.4	11.1	11.0	10.2	8.7	11.7	18.9	14.5	22.4	16.5	37.5	23.6	10.5	32.9	8.6	13.6	9.1	6.9	6.7	11.0	14.3	9.2	25.8	2.1	21.7	8.5	11.7	5.9	11.0	3.9	10.2	11.5	10.9	18.7	10.3	99.6	8.4	16.3	15.0	25.5	12.3	12.0	12.4	10.8	13.6	35.2	28.6	49.6	10.7	10.2	26.1	12.2	5.7	12.2	19.3	12.4	44.0	24.3	21.2	19.6	69.9	190.3	12.2	9.3	20.7	19.4	17.0	10.7	59.3	20.0	6.8	13.1	9.6	14.2	9.8	10.8	17.4	14.1	27.1	20.5	12.1	8.4	27.2
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.0	8.2	10.3	2.4	9.9	0.8	6.0	6.2	12.8	6.8	8.2	8.9	6.2	6.3	3.3	7.0	7.2	3.6	12.8	10.7	10.3	11.9	10.2	9.3	1.7	8.8	9.6	7.2	12.9	14.4	15.6	4.1	8.4	9.5	3.3	4.6	10.5	7.1	6.1	4.5	6.4	2.5	7.6	5.6	11.5	7.4	11.2	1.4	10.6	5.1	2.1	9.0	5.7	7.8	12.0	17.9	9.2	9.6	3.9	3.3	0.1	6.5	8.7	8.6	5.6	17.5	20.3	0.0	12.0	6.3	21.9	43.7	8.5	8.3	2.7	0.6	9.7	0.2	28.0	13.0	9.1	5.8	21.3	2.4	15.3	4.3	10.2	9.3	5.4	0.0	12.2	0.1	4.9	27.5	0.2	1.9	13.6	24.4	24.3	0.0	16.3	19.9	8.1	15.8	14.2	20.8	11.4	15.7	12.2	7.0	12.1	5.3	6.7	3.2	14.4	15.5	7.4	8.8	22.3	0.4	6.7	1.2	8.3	0.0	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	10.3	9.9	6.2	12.8	10.7	10.3	8.8	9.6	8.4	7.6	11.2	7.8	3.1	3.2	7.7	10.1	0.7	2.2	1.9	4.9	2.8	10.0	8.4	5.7	10.4	15.7	3.8	7.3	8.4	0.6	0.3	8.9	5.9	5.7	0.3	7.5	2.9	3.1	6.6	1.7	3.5	3.3	0.9	2.2	4.1	9.0	2.5	13.6	3.9	5.9	6.0	1.7	4.8	8.9	4.1	3.5	1.6	0.9	1.2	2.3	3.6	1.0	0.9	8.3	2.1	3.5	1.4	7.4	7.1	1.9	1.0	4.7	6.4	5.1	5.8	7.1	0.0	3.4	3.6	0.5	4.0	4.6	1.7	0.3	0.4	5.1	8.3	2.6
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skeletal muscle: 1205.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 56.5;Skeletal myocytes: 108.8"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"HL-60: 206.4;THP-1: 385.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042227, HPA048632"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA042227: , HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	0.3	0.9	0.0	0.0	0.1	1.3	0.4	0.2	0.3	0.4	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.2	0.4	0.0	11.8	0.0	0.1	1.8	0.0	0.0	5.8	0.0	1205.9	2.1	0.2	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.4	47.6	0.0	0.1	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	206.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	385.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	1.2	2.9	1.3	2.4	0.6	0.0	0.2	0.0	0.0	3.0	0.3	1.6	0.0	0.0	56.5	0.9	0.7	0.9	1.2	0.0	0.0	0.5	2.7	0.6	0.0	1.5	0.0	0.7	1.1	1.2	0.6	0.0	0.0	1.1	0.0	0.0	0.4	5.7	0.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.3	4.7	0.2	0.2	0.2	0.0	108.8	0.5	1.7	0.6	1.2	0.1	1.4	0.2	0.2	1.6	0.5
PPP1R32	"C11orf66, FLJ32771, IIIG9"	ENSG00000162148	"Protein phosphatase 1 regulatory subunit 32"	Q7Z5V6	11	61481120-61490931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 253.2;Late spermatids: 363.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039068	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039068: AB_10672840"	"unprognostic (1.70e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.48e-4)"	"prognostic favorable (4.13e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.44e-9)"	"unprognostic (2.64e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.75e-2)"	5.3	3.4	18.1	3.8	18.3	5.5	5.7	14.9	20.5	8.8	32.7	6.4	3.6	6.2	12.7	2.9	40.6	3.7	4.4	18.6	20.9	6.5	7.7	10.9	7.3	28.0	36.7	6.6	3.6	1.9	14.0	4.2	25.7	6.0	2.7	2.6	4.1	4.5	4.6	11.5	5.0	4.8	24.6	7.4	4.2	93.8	19.4	6.4	4.4	2.0	4.3	4.4	5.6	21.8	0.7	1.4	8.4	3.5	3.7	5.5	1.1	1.7	1.3	1.1	0.9	0.4	7.4	1.6	2.3	0.8	0.4	0.9	1.2	0.6	2.1	2.7	1.7	2.1	0.4	0.2	3.6	1.4	1.6	5.8	2.1	0.4	6.2	6.7	0.8	6.0	0.8	5.0	0.5	1.9	2.1	3.0	0.6	1.4	0.8	4.1	0.2	0.5	1.1	0.3	0.9	2.0	0.3	3.7	0.6	0.7	4.3	4.6	3.1	0.4	1.7	1.3	0.3	8.0	2.3	1.0	0.9	6.0	0.7	1.5	1.1	0.7	1.0	1.3	1.0	0.4	0.6	0.2	0.5	0.4	0.4	1.3	2.0	0.8	0.4	0.4	0.8	0.9	18.1	18.3	14.9	20.5	18.6	20.9	28.0	36.7	25.7	24.6	19.4	21.8	1.5	3.2	1.1	6.8	0.5	0.1	0.8	2.5	0.0	0.5	4.2	4.1	1.3	0.0	6.1	5.5	0.0	1.0	2.2	0.7	31.3	0.5	253.2	27.9	0.9	1.5	3.5	0.0	2.2	1.6	0.3	1.1	0.0	0.8	0.0	1.7	0.4	10.8	0.8	0.0	1.1	1.0	4.1	1.8	1.2	363.8	3.7	0.8	0.0	1.9	1.3	3.0	2.1	1.5	2.7	0.6	1.1	4.1	0.9	1.8	2.1	20.3	72.1	0.2	0.0	0.7	2.6	8.1	1.9	0.1	0.3	0.4	0.7	0.6	0.9	0.8
PPP1R35	"C7orf47, MGC22793"	ENSG00000160813	"Protein phosphatase 1 regulatory subunit 35"	Q8TAP8	7	100435282-100436497	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021604, HPA051607"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021604: AB_2670774, HPA051607: AB_2681548"	"unprognostic (2.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.77e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.97e-4)"	8.8	16.7	7.8	11.9	7.7	8.7	9.7	9.6	13.8	12.3	8.7	10.6	11.5	10.9	2.2	11.1	11.0	3.1	9.4	7.7	8.0	12.4	12.9	9.4	14.5	8.2	7.7	13.5	10.5	7.8	11.9	6.8	7.8	11.2	2.4	2.4	9.9	5.4	6.3	7.8	12.0	2.8	8.0	22.1	10.9	48.7	8.2	15.3	12.0	3.5	5.5	10.3	10.3	7.7	41.0	14.7	11.1	19.4	3.3	4.9	14.5	11.6	10.5	8.2	9.4	6.8	36.2	14.0	22.2	6.4	39.3	17.4	5.9	9.4	1.8	30.9	18.3	11.6	11.8	14.1	14.5	12.2	16.4	6.8	17.0	7.3	12.0	14.1	17.2	38.8	21.1	24.1	9.9	34.1	36.2	64.6	23.0	17.1	20.1	14.6	4.7	37.9	11.4	9.5	11.8	35.0	8.9	62.5	35.0	6.9	18.0	28.8	13.9	12.2	18.4	16.4	28.9	37.9	23.1	20.2	13.3	19.6	25.0	17.1	2.3	5.7	5.8	1.0	6.2	4.3	5.9	6.6	1.7	5.4	3.3	3.2	10.5	3.8	0.7	7.6	7.6	2.7	7.8	7.7	9.6	13.8	7.7	8.0	8.2	7.7	7.8	8.0	8.2	7.7	47.7	16.0	9.6	13.1	30.8	21.0	39.9	13.9	28.5	35.7	51.3	60.6	2.0	27.1	7.8	47.8	8.4	66.5	47.8	23.6	52.8	9.1	17.3	34.6	22.7	22.1	18.6	17.2	10.2	10.0	40.2	16.5	20.4	24.9	8.2	28.3	15.4	16.1	16.8	48.8	11.8	32.0	18.3	12.0	15.4	8.7	18.0	17.4	17.8	12.2	11.6	26.8	27.8	12.1	12.5	10.7	30.2	9.4	24.2	55.2	26.2	39.5	16.5	37.7	13.1	12.4	17.8	106.1	29.8	36.7	33.4	33.9	37.6	35.2	28.1	43.9
PPP1R36	C14orf50	ENSG00000165807	"Protein phosphatase 1 regulatory subunit 36"	Q96LQ0	14	64549920-64589381	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.5;testis: 37.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 350.6;Late spermatids: 791.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077492	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA077492: AB_2732348"	"unprognostic (3.43e-4)"	"unprognostic (5.75e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-3)"	"unprognostic (9.77e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.46e-2)"	1.9	0.5	1.2	0.4	1.6	0.0	1.4	1.2	2.0	1.0	1.6	6.5	6.6	0.9	3.0	0.6	12.5	2.0	0.5	1.2	1.4	2.4	0.1	1.2	0.2	1.8	1.6	0.1	10.8	0.4	1.9	0.9	2.1	0.2	5.6	0.1	3.8	0.3	0.2	1.0	4.7	0.5	1.8	0.1	7.2	37.1	1.5	0.2	0.2	0.6	0.3	0.9	0.3	2.2	0.2	0.1	0.3	0.1	1.4	0.7	1.0	0.8	0.4	0.5	1.2	0.2	13.9	0.0	0.1	0.7	0.5	0.4	0.0	0.0	0.6	0.1	0.1	0.4	0.8	0.1	0.8	0.0	0.1	0.9	0.7	0.2	0.5	0.9	0.3	0.1	0.0	0.0	0.7	0.8	0.1	0.4	0.0	0.4	0.0	0.1	0.1	0.1	0.5	0.6	3.0	0.1	1.4	0.1	0.0	0.2	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.0	1.2	1.6	1.2	2.0	1.2	1.4	1.8	1.6	2.1	1.8	1.5	2.2	1.5	0.0	0.6	2.3	0.5	0.5	0.5	1.6	1.8	0.0	2.7	4.6	0.7	4.3	6.3	3.7	0.0	0.4	1.5	5.0	1.9	0.9	350.6	44.3	1.6	3.2	4.2	0.0	1.7	8.2	2.5	0.8	6.6	6.4	0.0	0.1	2.9	0.0	0.4	0.0	1.4	7.3	0.0	0.6	0.7	791.2	3.4	1.4	0.0	3.7	0.1	0.8	2.1	0.0	5.8	6.8	3.4	3.8	0.3	0.2	8.1	0.1	36.2	0.2	0.0	3.2	1.4	124.8	8.0	1.8	0.4	0.5	0.5	0.2	6.6	0.9
PPP1R37	LRRC68	ENSG00000104866	"Protein phosphatase 1 regulatory subunit 37"	O75864	19	45091396-45148077	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RT4: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041500	Approved		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041500: AB_10795122"	"unprognostic (8.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.89e-3)"	"unprognostic (7.72e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (2.04e-4)"	10.4	26.9	11.3	5.8	12.8	4.8	13.0	7.9	16.7	17.9	1.2	14.3	12.1	15.7	3.2	19.8	13.1	5.3	14.8	12.3	4.7	18.2	14.0	11.7	5.2	6.6	4.9	13.5	16.4	7.2	39.3	5.3	6.6	20.0	3.6	8.0	18.4	8.8	20.9	21.3	14.6	4.1	1.8	14.0	28.3	16.5	6.7	5.7	20.4	5.4	3.1	21.7	16.9	10.8	26.2	25.4	9.2	13.4	11.6	7.8	18.4	18.8	10.6	12.8	14.6	11.5	14.2	7.1	13.4	10.0	11.8	20.1	6.3	14.4	3.6	9.3	15.7	6.1	13.6	14.3	14.4	6.4	10.1	10.0	11.1	12.1	7.7	13.7	10.4	9.6	10.8	5.5	7.1	34.2	13.5	8.9	8.7	18.7	15.1	16.3	10.9	5.3	8.4	69.5	28.2	13.0	16.0	33.2	29.3	4.7	21.3	9.4	16.4	15.2	18.2	9.1	17.0	9.3	6.3	5.3	19.7	6.4	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.8	7.9	16.7	12.3	4.7	6.6	4.9	6.6	1.8	6.7	10.8	9.4	6.4	3.4	8.5	8.1	7.6	11.1	6.8	13.1	48.6	16.9	11.7	6.2	15.7	5.6	3.7	39.6	21.1	9.7	21.9	7.9	17.9	8.8	9.8	12.1	10.3	30.6	4.8	18.9	9.8	19.0	9.8	30.5	10.9	0.0	12.1	11.0	7.4	17.9	77.4	15.2	27.7	10.2	6.4	6.3	7.0	12.2	6.2	12.4	5.6	4.4	22.7	9.2	11.6	14.3	12.0	23.4	12.4	13.1	10.6	25.6	18.2	5.9	44.1	19.7	10.3	10.1	21.6	23.9	14.3	9.5	18.3	10.4	16.0	22.3	11.4
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	64	"heart muscle: 40.8;skeletal muscle: 152.9;tongue: 104.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 157.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"THP-1: 14.6"	"Region enriched"	"Detected in single"	12	"thalamus: 1.1"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 144.9;skeletal muscle: 95.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 69.9;Hepatocytes: 184.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 53.6;eosinophil: 15.8;neutrophil: 50.4"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 53.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 47.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	24.1	7.5	1.9	8.2	2.8	12.3	15.9	3.4	3.8	19.6	5.9	16.1	4.6	19.8	4.4	17.2	12.9	9.0	29.9	1.7	3.1	7.6	144.9	9.2	4.3	4.8	3.0	10.4	5.1	50.1	3.3	10.4	4.1	21.7	9.5	7.1	13.9	18.6	95.4	12.3	7.2	12.0	3.1	7.7	12.0	7.1	3.9	4.5	11.7	17.7	3.6	26.4	15.0	4.5	6.7	2.5	7.3	2.5	17.9	15.1	26.3	2.4	7.9	2.9	3.5	10.0	3.1	2.3	3.9	5.0	16.1	1.2	1.3	1.9	3.1	7.2	1.1	4.0	1.0	0.0	8.0	2.0	17.1	12.4	5.9	2.5	14.6	22.0	47.3	11.6	3.1	5.6	1.1	4.1	11.2	3.8	10.6	15.2	2.2	4.5	9.2	4.0	28.6	26.9	0.0	13.6	4.4	0.1	18.6	11.6	3.4	4.1	32.9	8.5	2.9	1.7	3.1	3.1	7.5	0.0	14.8	6.2	2.6	53.6	1.6	15.8	2.2	1.1	1.8	1.6	2.0	1.2	0.9	1.2	2.7	1.5	50.4	2.2	0.7	1.8	1.5	1.6	1.9	2.8	3.4	3.8	1.7	3.1	4.8	3.0	4.1	3.1	3.9	4.5	16.7	12.8	34.5	0.7	5.5	10.7	18.8	7.2	3.4	3.7	19.4	12.7	69.9	24.3	21.8	9.2	6.2	12.9	7.6	26.7	3.9	8.8	20.3	29.5	21.9	21.0	0.0	0.8	0.8	12.7	38.3	12.7	9.7	51.7	33.6	10.4	31.1	184.7	6.9	6.7	0.4	11.5	8.2	9.8	27.9	5.2	9.6	15.6	5.4	3.7	3.1	3.9	4.1	3.5	1.4	18.4	7.5	18.0	4.5	8.0	7.4	6.8	30.8	13.0	13.1	10.9	17.9	1.7	5.7	0.6	12.1	18.3	10.8	9.4	5.5	2.2
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633071	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 908.0;tongue: 448.5"	"Group enriched"	"Detected in many"	8	"Astrocytes: 201.8;Cardiomyocytes: 232.0;Hepatocytes: 64.2;Muller glia cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 41.9;HHSteC: 51.7;hTERT-RPE1: 85.4;LHCN-M2: 102.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	14.1	12.2	39.3	3.4	51.5	0.0	9.9	39.8	44.6	97.1	21.4	16.2	4.0	10.3	12.0	106.8	10.2	14.4	170.5	40.1	42.9	11.6	164.2	12.3	1.4	44.1	55.1	10.2	18.7	4.5	5.7	15.6	43.9	29.1	4.1	83.2	28.4	35.7	908.0	17.0	5.8	15.4	39.6	3.0	17.5	2.5	42.4	0.5	2.7	448.5	6.2	19.8	136.7	38.0	0.0	6.6	1.8	26.8	11.9	5.6	0.0	29.8	23.2	12.0	12.8	0.0	2.2	0.0	1.2	28.0	4.8	1.6	0.7	3.2	22.0	0.0	0.1	0.4	41.9	4.8	51.7	0.0	0.0	19.1	5.2	7.6	0.4	85.4	3.0	0.0	14.4	0.0	102.5	1.0	0.0	0.0	1.7	0.0	0.0	0.0	6.4	0.0	1.1	26.2	0.9	1.8	0.0	0.0	0.0	0.0	0.2	4.5	20.3	5.3	5.2	7.0	4.3	0.2	0.6	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	51.5	39.8	44.6	40.1	42.9	44.1	55.1	43.9	39.6	42.4	38.0	2.4	0.0	0.0	201.8	0.4	4.6	9.3	0.8	0.6	9.7	4.8	2.5	232.0	1.5	0.2	3.7	0.0	0.2	0.0	0.3	7.9	3.1	0.1	0.3	0.7	3.5	10.1	0.0	1.7	11.4	0.5	11.9	0.0	0.6	0.0	0.4	2.5	64.2	1.4	18.5	3.0	0.5	2.0	1.6	1.5	0.1	2.8	0.6	12.4	5.6	0.0	133.1	0.0	3.5	0.5	4.0	0.1	7.5	0.0	2.5	0.0	1.8	0.4	12.8	0.0	9.4	18.6	0.7	1.7	5.4	4.0	0.3	0.7	0.1	0.1	0.7
PPP1R3D	PPP1R6	ENSG00000132825	"Protein phosphatase 1 regulatory subunit 3D"	O95685	20	59936663-59940305	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.0;monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041146	Approved		Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Mitochondria"	Nucleoli	"HPA041146: AB_10793870"	"unprognostic (2.50e-3)"	"unprognostic (3.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.48e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (5.71e-2)"	3.7	2.9	6.7	4.8	7.3	6.3	3.8	7.3	7.4	4.2	4.6	3.7	5.3	3.7	3.4	5.8	3.5	3.0	5.5	5.9	6.6	4.1	1.1	3.5	3.9	7.6	6.9	4.5	3.5	5.1	2.8	5.4	7.1	6.3	3.0	2.1	4.3	5.6	7.1	4.2	5.0	3.8	7.0	4.9	5.4	1.9	6.8	3.3	3.6	9.8	5.1	3.4	3.6	6.7	5.1	3.1	2.1	4.3	4.6	4.8	17.3	6.6	7.1	7.9	3.8	4.9	6.8	2.1	8.0	5.5	4.9	14.7	4.3	4.7	5.1	5.0	3.4	5.6	4.2	2.6	4.2	2.3	15.2	3.4	12.7	2.8	2.4	4.2	4.4	1.4	1.0	0.5	5.1	7.9	1.9	7.5	1.5	9.6	7.3	2.4	0.9	3.3	5.3	8.1	4.0	2.4	8.2	24.6	7.4	3.9	9.0	8.2	4.7	4.6	1.9	4.9	1.1	1.7	4.5	0.5	3.5	8.1	2.9	0.3	0.7	3.0	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.2	0.3	0.2	1.8	0.4	1.8	0.2	0.4	0.2	6.7	7.3	7.3	7.4	5.9	6.6	7.6	6.9	7.1	7.0	6.8	6.7	10.4	9.6	0.5	12.4	3.3	1.3	4.6	2.6	4.6	7.8	5.7	4.2	6.7	7.2	4.3	5.5	2.1	14.3	4.5	4.0	5.9	1.9	0.4	3.0	4.9	8.6	1.8	1.3	0.9	3.1	6.4	3.3	3.1	3.4	5.7	3.9	9.7	0.4	5.2	13.5	2.4	3.6	0.0	9.8	2.6	1.3	3.1	7.4	5.4	1.0	8.7	11.0	13.4	2.5	1.8	3.5	6.1	4.5	3.7	6.7	6.7	6.2	4.3	11.4	6.6	5.7	4.9	0.4	3.6	4.7	3.1	4.9	5.6	5.1	3.8	9.5
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295652-23302859	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 47.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 111.9;Late spermatids: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	5.8	8.0	15.2	5.7	17.9	3.9	6.4	17.9	23.8	10.2	9.7	7.4	6.3	6.4	10.1	6.0	9.5	3.3	6.2	15.0	15.3	11.6	11.2	5.7	9.5	18.5	16.5	12.5	10.6	5.7	19.3	2.7	19.4	12.1	5.9	47.0	8.5	6.2	14.9	10.9	13.3	3.4	13.8	15.1	9.0	14.7	17.7	8.2	14.9	5.4	8.2	7.9	8.5	23.3	1.1	3.0	3.6	2.5	6.9	2.9	1.7	1.2	2.2	2.0	1.7	1.7	5.8	11.2	0.8	1.6	2.2	7.6	2.1	1.2	2.5	4.0	2.1	2.0	6.9	4.0	1.8	2.3	4.4	2.5	4.5	1.2	6.1	3.3	0.9	6.0	1.9	9.8	1.7	2.6	2.1	3.6	0.9	3.6	2.8	3.4	2.5	7.2	1.1	2.5	4.5	1.2	1.8	1.6	1.2	1.8	1.9	0.8	1.7	2.4	1.3	4.1	0.9	41.1	4.6	5.1	1.9	4.0	1.5	0.2	0.4	0.2	0.5	1.4	0.6	1.0	0.1	0.2	0.3	0.6	0.5	0.3	0.4	0.2	1.8	0.3	0.4	0.3	15.2	17.9	17.9	23.8	15.0	15.3	18.5	16.5	19.4	13.8	17.7	23.3	5.8	3.2	4.8	30.0	25.4	5.6	9.0	5.3	11.4	59.4	7.8	11.6	8.8	7.2	5.0	20.2	37.5	8.2	12.8	8.0	5.9	2.1	111.9	3.7	6.6	7.2	8.4	7.2	25.0	3.3	2.0	6.1	20.4	4.3	3.8	9.4	7.5	7.2	7.4	32.0	33.0	7.7	4.1	9.5	9.6	62.9	27.4	9.2	10.6	15.9	8.1	20.4	26.8	16.1	56.1	2.4	11.6	25.9	11.9	6.7	19.5	9.5	4.8	38.1	13.1	3.5	5.4	36.5	13.9	8.4	9.1	5.2	15.7	7.2	9.6	8.6
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269793-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 38.6;Horizontal cells: 48.8;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 9.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 13.6;HDLM-2: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.1	4.0	13.9	2.4	14.9	1.5	3.2	14.0	18.3	5.7	8.1	7.4	1.3	5.8	5.8	4.2	7.1	1.5	18.1	15.2	14.1	4.1	3.4	3.3	2.7	14.7	13.5	8.2	2.6	1.1	15.5	1.0	17.2	5.6	0.6	9.7	3.1	1.4	27.5	3.3	3.5	1.3	12.5	4.0	3.4	4.2	14.1	1.3	5.3	12.8	1.4	6.7	4.6	19.1	2.1	4.7	2.9	3.6	2.4	1.8	2.3	2.8	1.8	1.3	2.2	3.0	1.8	2.2	0.6	0.6	13.6	3.6	0.9	0.5	0.9	13.2	4.4	0.2	4.0	0.3	1.5	0.6	1.5	1.4	1.4	1.5	0.5	2.2	0.1	2.8	0.6	0.9	0.9	6.2	1.2	2.5	9.8	0.1	5.8	6.1	3.2	1.1	1.4	1.1	3.8	3.7	0.9	0.1	6.2	4.5	3.3	2.3	2.5	4.1	1.0	3.0	2.0	3.6	4.4	1.5	1.6	5.2	4.8	0.0	0.2	0.0	0.2	0.3	0.6	0.3	1.8	0.6	0.2	0.0	1.5	0.6	0.0	0.3	0.7	0.2	9.4	0.3	13.9	14.9	14.0	18.3	15.2	14.1	14.7	13.5	17.2	12.5	14.1	19.1	2.1	0.0	0.5	14.0	2.8	1.9	2.4	1.0	4.0	38.6	2.5	3.4	16.8	0.0	0.7	3.7	8.4	1.1	1.7	0.3	7.9	0.3	0.1	3.6	2.8	2.2	3.0	0.8	9.6	0.2	0.1	3.8	0.0	2.0	0.0	4.3	3.3	1.1	0.7	48.8	10.7	0.1	0.0	0.6	1.8	0.7	4.7	1.5	0.0	3.7	0.2	11.9	0.0	12.5	34.3	0.4	0.1	3.0	2.0	2.2	0.0	7.6	2.6	17.8	0.0	4.0	3.9	2.0	8.5	7.3	1.3	1.2	5.6	2.4	0.2	2.3
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5085341-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.9;liver: 6.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	2.3	3.0	2.3	0.3	2.1	0.1	1.4	1.5	2.7	2.1	0.9	2.0	0.2	1.2	1.0	1.8	1.0	0.3	5.9	2.0	1.8	0.6	6.2	0.3	0.5	2.3	2.3	0.8	0.1	0.3	0.2	0.7	1.9	1.2	0.5	0.2	0.6	1.4	0.5	1.2	0.5	0.5	1.6	2.8	0.6	0.2	2.2	0.2	0.3	0.2	0.4	2.8	2.1	1.7	0.0	0.2	0.1	0.0	1.6	1.0	0.0	0.3	0.4	0.2	0.3	0.0	0.3	0.0	3.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.9	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.8	0.5	2.0	1.7	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.3	2.1	1.5	2.7	2.0	1.8	2.3	2.3	1.9	1.6	2.2	1.7	4.2	0.0	0.0	0.0	0.4	0.5	0.5	0.4	0.0	0.5	0.2	0.1	18.5	0.0	0.1	3.7	0.0	0.8	0.0	1.3	0.0	0.3	0.0	1.2	2.0	1.9	1.2	0.0	0.0	0.0	0.4	3.7	0.0	7.2	0.0	1.4	2.9	0.0	4.5	0.0	0.0	0.9	0.0	4.0	4.7	0.2	0.9	1.8	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	1.8	3.0	1.8	0.4	0.0	2.1	0.2	0.2	0.0	2.0	2.5	0.1	0.9	0.2	0.3	0.8	0.2	0.5	1.4	1.2
PPP1R42	"dtr, LRRC67, TLLR"	ENSG00000178125	"Protein phosphatase 1 regulatory subunit 42"	Q7Z4L9	8	66964099-67056604	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 4.9;testis: 8.7"	"Group enriched"	"Detected in many"	5	"Early spermatids: 68.1;Endometrial ciliated cells: 79.3;Respiratory ciliated cells: 127.2;Spermatocytes: 111.8"	"Cancer enhanced"	"Detected in some"		"glioma: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024313, HPA027983, HPA028628"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064"	"unprognostic (8.03e-3)"	"unprognostic (5.45e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (5.42e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.61e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-1)"	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.1	1.4	0.0	0.0	0.1	0.3	0.0	4.9	0.0	0.0	0.4	0.4	0.2	0.0	0.3	0.0	1.4	1.2	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.4	0.4	1.4	1.2	0.9	0.9	0.5	0.6	0.0	0.0	1.1	11.8	0.0	0.0	0.0	6.0	0.0	0.1	0.7	1.0	0.9	0.0	10.8	5.5	0.0	0.0	0.0	0.0	3.9	0.5	68.1	79.3	0.7	0.2	0.0	0.0	3.2	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.0	1.7	2.8	0.0	6.1	0.0	0.0	16.5	0.6	0.3	0.0	1.0	0.0	3.6	0.0	3.5	2.9	0.1	0.0	1.9	0.0	0.0	0.0	1.9	127.2	3.5	6.6	0.0	1.4	111.8	3.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 968.8;Late spermatids: 1709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034500, HPA034501"	Supported		Approved	Nucleoli		NA	NA		960000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	59.0	55.9	71.3	54.4	94.7	68.1	50.2	65.5	82.4	46.4	68.3	66.0	58.8	48.5	61.4	80.3	81.3	40.2	100.5	77.5	69.4	64.6	76.0	53.9	78.7	67.2	67.2	37.5	60.0	55.8	42.6	44.5	65.7	94.5	64.2	58.0	63.1	54.0	100.4	64.3	61.0	55.0	66.5	48.7	58.9	158.2	67.2	66.8	65.1	64.4	80.8	58.9	52.9	75.1	117.6	69.5	77.4	98.3	149.7	149.0	106.4	126.3	114.7	85.2	119.8	38.1	145.6	60.0	37.1	108.9	128.0	112.1	127.9	119.6	130.2	156.4	126.1	105.1	112.4	151.4	96.3	147.0	105.9	116.0	92.7	101.1	74.2	115.7	128.5	121.0	108.0	86.2	202.0	155.8	132.0	112.6	106.3	185.7	64.5	90.4	200.9	121.9	159.6	116.7	104.6	82.8	67.6	157.4	120.3	86.4	93.8	156.7	127.7	76.8	72.5	146.1	103.4	90.8	59.6	162.8	215.2	154.1	103.7	107.9	84.9	108.9	64.6	87.6	68.3	71.6	76.5	77.1	81.3	66.5	58.5	67.6	66.5	75.8	96.2	48.4	121.5	89.9	71.3	94.7	65.5	82.4	77.5	69.4	67.2	67.2	65.7	66.5	67.2	75.1	50.5	57.7	54.5	17.6	47.9	27.8	48.6	126.2	25.6	41.5	44.6	36.8	98.4	45.8	105.5	44.1	16.7	89.6	46.9	53.4	121.3	90.6	968.8	83.6	39.3	45.9	25.7	48.0	33.8	145.9	92.4	47.5	34.7	53.4	59.5	48.9	32.9	49.9	100.5	32.0	19.4	68.7	109.9	40.7	46.3	1709.4	51.0	49.4	87.2	13.1	63.7	78.6	80.3	18.1	21.9	94.5	71.3	67.4	54.5	52.1	81.7	120.8	112.2	58.9	72.3	35.1	65.6	315.5	122.5	45.9	38.1	71.6	57.9	117.2	55.3	56.0
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830782-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	24.0	17.1	23.7	23.8	26.3	38.8	27.2	26.0	27.8	25.1	20.8	23.3	19.6	28.4	21.3	26.1	26.7	20.8	23.8	22.9	25.1	19.6	21.5	21.1	35.5	25.0	25.0	33.0	20.7	25.2	15.8	25.2	25.7	21.0	25.1	28.0	18.9	25.7	25.3	23.2	21.4	30.6	26.0	25.9	19.7	24.0	24.2	41.0	25.2	37.0	36.4	29.5	20.5	30.5	57.8	40.0	85.3	55.8	52.6	54.7	48.9	60.5	63.3	101.5	81.6	45.2	64.5	81.9	41.6	69.3	39.5	50.9	101.3	56.6	73.2	69.3	61.7	107.2	53.3	67.2	52.9	99.9	73.0	48.0	60.7	92.4	81.8	45.4	61.3	68.9	92.4	54.3	61.2	37.6	109.6	58.6	105.9	50.7	46.2	88.4	70.5	78.2	54.9	52.2	59.5	54.0	74.5	57.5	73.4	43.5	50.5	61.7	50.9	49.6	45.3	78.9	57.2	50.0	82.2	102.8	48.5	127.6	65.0	17.2	9.1	8.5	12.4	9.5	14.3	9.8	9.7	13.7	8.8	9.9	10.5	10.2	5.4	14.3	11.4	6.7	10.8	13.2	23.7	26.3	26.0	27.8	22.9	25.1	25.0	25.0	25.7	26.0	24.2	30.5	11.3	16.0	10.0	2.9	21.3	17.3	21.4	33.4	7.4	22.0	12.0	9.8	13.4	8.6	24.2	5.5	2.1	47.6	19.6	15.4	31.3	30.6	33.7	9.8	15.2	17.8	11.5	20.6	8.4	25.9	41.2	17.1	12.2	11.1	26.0	16.8	19.6	20.2	26.3	8.4	8.6	15.0	28.5	18.0	11.5	30.0	23.9	14.1	10.6	4.7	35.6	21.5	25.7	10.6	16.0	31.9	14.7	17.0	14.3	24.6	14.3	25.7	18.1	16.9	26.3	16.2	20.0	35.4	43.2	16.5	14.1	43.9	17.4	28.8	16.2	21.2
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 294.1;Excitatory neurons: 262.8;Inhibitory neurons: 201.5;Oligodendrocyte precursor cells: 593.1;Oligodendrocytes: 308.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 6.8;NK-cell: 10.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.8;NK-cells: 10.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 12.2;RH-30: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	1.7	7.0	13.0	0.9	20.1	0.2	4.9	6.0	14.5	2.7	0.3	8.2	1.7	3.0	4.9	1.6	5.7	2.4	5.2	14.4	7.5	4.7	0.4	3.7	0.3	5.9	6.9	3.3	8.8	6.7	4.6	2.5	8.0	2.3	3.8	18.5	9.6	2.8	4.9	0.5	2.2	2.2	6.6	1.8	4.9	6.7	10.2	0.5	6.6	4.9	0.3	2.6	0.5	13.9	0.0	11.0	6.6	7.6	0.0	0.0	5.3	0.5	0.1	1.0	0.8	6.1	3.7	0.0	9.0	0.5	0.6	0.0	12.2	0.0	1.2	0.0	4.5	11.4	4.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.8	4.8	0.1	0.0	5.5	4.9	1.8	0.0	11.8	0.0	10.7	9.2	7.3	7.4	0.0	0.9	1.4	4.0	2.1	0.0	0.0	0.1	4.4	0.1	4.0	7.3	11.5	0.0	0.2	0.0	0.9	6.8	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	10.3	0.1	0.3	0.0	0.1	13.0	20.1	6.0	14.5	14.4	7.5	5.9	6.9	8.0	6.6	10.2	13.9	4.5	41.7	66.6	294.1	2.4	0.4	0.9	0.0	0.6	58.2	24.4	12.2	127.7	18.6	16.5	47.8	56.3	21.6	3.3	15.7	3.9	25.1	17.9	40.3	4.5	6.8	38.9	2.5	262.8	7.0	3.1	9.4	21.4	57.1	5.7	39.5	7.9	1.5	1.7	1.7	201.5	15.0	4.1	0.6	0.3	15.3	2.5	0.8	7.2	41.2	0.0	46.9	3.1	593.1	308.4	6.6	14.4	0.7	2.7	4.8	1.8	9.6	20.6	88.9	0.0	118.4	9.2	25.1	12.6	0.5	0.9	33.1	1.7	22.9	15.7	2.6
PPP1R9B	"PPP1R6, PPP1R9, SPINO, Spn"	ENSG00000108819	"Protein phosphatase 1 regulatory subunit 9B"	Q96SB3	17	50133737-50150677	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 96.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022461	Approved					NA	NA		420000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB022461: "	"unprognostic (4.71e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.29e-1)"	23.5	30.0	61.4	28.6	58.6	33.7	20.2	39.3	96.7	25.4	4.6	17.6	14.9	22.0	8.4	28.9	19.6	15.5	24.3	90.2	30.3	23.3	11.9	39.9	36.8	25.7	40.1	27.8	18.3	15.2	20.6	14.6	24.0	21.5	8.9	7.9	17.6	10.6	11.8	24.2	30.2	11.8	22.2	52.4	17.8	24.0	47.7	22.5	22.0	14.8	28.0	20.4	22.6	48.9	25.9	45.2	24.0	60.5	31.2	19.8	56.9	36.4	33.1	31.5	22.9	38.3	19.9	48.6	57.8	42.2	30.7	25.2	24.9	25.8	19.6	125.7	37.2	79.9	35.4	26.2	30.3	35.1	121.2	22.2	44.4	34.6	21.7	60.5	31.2	15.4	43.0	35.7	21.0	47.7	13.0	50.2	9.4	33.0	40.9	26.5	32.5	34.6	21.6	15.0	15.1	44.5	23.0	35.6	29.5	19.3	47.7	68.8	25.5	66.4	48.7	46.0	48.8	65.4	16.2	35.2	30.5	34.8	32.4	4.2	1.8	2.9	1.3	1.6	1.1	1.6	1.0	0.9	1.4	2.0	0.4	0.9	4.1	2.2	2.0	2.0	0.5	0.8	61.4	58.6	39.3	96.7	90.2	30.3	25.7	40.1	24.0	22.2	47.7	48.9	18.1	0.0	2.2	6.2	23.6	23.6	3.6	5.8	13.6	18.8	7.8	5.3	7.7	4.3	3.2	16.5	2.1	2.3	29.0	10.9	5.9	9.7	2.6	4.0	9.5	20.9	12.0	20.2	6.6	9.1	3.5	10.5	5.6	6.3	2.5	9.6	18.2	8.7	27.7	16.8	6.5	10.8	10.2	48.6	34.6	5.1	20.2	30.2	12.4	2.8	42.1	3.2	34.0	2.5	2.7	9.1	10.2	15.4	15.4	7.8	18.1	9.8	3.4	2.6	13.1	7.0	9.1	5.5	5.7	16.9	22.4	1.0	14.9	10.0	10.7	5.4
PPP2CA	"PP2AC, PP2Calpha"	ENSG00000113575	"Protein phosphatase 2 catalytic subunit alpha"	P67775	5	134194332-134226073	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Hydrolase, Protein phosphatase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003848, HPA043236"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003848: AB_562203, HPA043236: AB_2678379"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	47.9	53.1	52.1	42.9	55.1	124.8	46.6	60.6	66.3	38.9	44.9	51.4	46.1	46.6	36.1	71.5	39.0	44.6	90.1	57.8	53.5	57.3	62.1	39.4	58.6	48.6	51.4	30.0	44.3	87.1	26.1	52.2	53.7	37.8	47.1	58.6	36.5	40.4	75.3	54.1	44.5	57.8	54.7	40.0	41.3	34.7	53.6	92.4	48.1	73.1	76.7	75.4	41.0	59.5	157.0	128.8	180.8	97.9	92.1	98.2	126.2	144.1	123.3	214.8	215.4	249.1	119.6	136.5	131.7	134.4	242.9	79.7	175.6	208.6	250.2	123.9	100.1	96.9	142.4	156.5	136.3	97.1	84.2	91.7	141.5	169.0	166.6	107.0	153.5	135.1	97.2	99.1	165.1	112.5	154.9	95.0	98.9	123.6	77.3	136.5	179.6	132.6	130.0	173.4	142.9	99.6	148.9	55.1	166.9	179.7	112.2	112.3	109.2	123.3	69.1	99.6	206.5	88.5	171.6	217.0	83.2	125.9	130.3	43.0	64.7	75.6	46.8	63.1	59.2	53.1	53.2	62.5	77.3	54.7	60.6	57.2	71.3	75.5	67.0	41.5	72.4	95.8	52.1	55.1	60.6	66.3	57.8	53.5	48.6	51.4	53.7	54.7	53.6	59.5	58.7	51.3	47.6	27.1	103.3	239.0	187.4	90.1	121.8	43.9	93.6	53.0	111.2	55.8	63.1	57.0	22.9	152.1	89.0	68.7	107.6	109.7	34.6	85.8	83.2	81.1	87.1	89.0	36.6	87.6	171.3	78.0	77.5	106.1	62.2	44.6	51.8	65.9	111.4	50.5	35.7	62.0	69.2	88.2	194.6	29.8	38.5	95.8	104.9	24.4	115.6	62.9	51.5	36.7	48.9	101.7	56.6	45.5	120.9	143.3	64.9	114.8	53.0	31.4	19.7	76.8	97.6	91.4	85.8	112.4	234.4	309.8	110.6	53.3	69.7	176.7
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	89.9	66.6	190.2	42.2	196.1	10.5	68.4	189.1	220.1	84.0	147.9	79.3	72.9	112.1	117.1	95.1	87.8	74.2	94.7	191.6	190.7	131.9	118.6	90.6	32.5	199.7	184.1	147.4	75.7	93.3	52.5	91.0	190.4	74.9	76.2	77.9	68.6	87.1	105.7	63.7	87.0	122.3	195.1	52.9	71.2	64.7	204.4	41.4	126.7	122.7	47.4	76.8	70.0	200.1	96.5	82.7	136.4	54.4	134.6	120.0	78.0	124.0	114.0	123.1	129.5	86.6	68.3	45.6	118.7	165.4	117.9	56.5	84.4	142.1	167.3	28.5	44.2	61.8	52.7	86.9	157.3	28.1	34.2	108.6	157.4	105.2	115.9	124.2	152.5	73.6	97.7	47.6	212.4	48.4	77.1	34.9	102.6	139.3	47.0	53.9	55.7	34.5	168.5	73.6	134.3	55.0	57.8	61.1	127.0	150.5	34.1	47.8	164.0	109.1	81.7	36.1	105.5	24.0	33.6	53.7	93.4	26.0	141.4	3.4	2.5	1.7	1.8	3.1	2.3	2.9	1.7	1.9	1.7	1.1	1.7	2.1	2.3	3.8	1.5	3.8	1.3	0.8	190.2	196.1	189.1	220.1	191.6	190.7	199.7	184.1	190.4	195.1	204.4	200.1	81.0	70.5	60.7	68.6	13.0	104.1	115.9	44.4	44.9	36.6	64.9	51.8	80.2	45.8	54.3	86.5	31.3	41.1	23.6	186.1	46.9	40.6	21.8	98.5	109.8	60.9	32.3	16.6	41.0	48.9	52.8	79.0	34.7	89.2	17.7	95.4	87.8	95.5	58.4	47.1	59.1	65.3	28.5	55.4	60.4	20.3	73.3	36.0	40.9	52.5	27.4	127.2	17.5	37.7	60.4	81.1	78.9	264.0	15.8	125.4	115.6	95.9	68.2	26.5	46.0	93.1	73.0	37.2	40.4	50.3	95.6	70.6	17.4	75.3	41.2	149.9
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766389	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 170.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 173.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	58.5	10.5	11.3	14.1	18.0	16.2	21.5	20.0	13.9	13.0	17.3	14.7	13.9	8.7	8.1	12.6	8.0	13.4	6.3	11.7	13.8	14.6	170.7	8.8	12.1	14.7	13.7	13.3	33.2	12.9	10.7	9.2	14.2	7.7	14.7	8.5	9.6	6.1	9.6	10.7	15.2	7.8	10.6	6.3	22.3	54.0	13.8	15.9	10.6	8.9	14.1	12.2	7.4	20.7	38.4	25.1	35.6	24.2	34.9	18.7	35.8	37.2	25.9	27.0	24.6	86.0	39.3	48.3	27.1	24.1	25.6	35.4	53.4	30.5	34.3	33.7	16.6	47.2	14.5	37.8	17.3	55.7	36.1	21.5	18.1	30.6	22.2	19.1	33.8	49.7	58.3	62.3	30.1	12.4	60.8	22.6	43.8	41.4	27.3	45.9	23.6	58.6	40.2	41.9	11.6	31.4	33.1	30.2	6.1	38.3	35.0	20.6	36.7	31.3	37.8	15.6	23.9	6.6	17.4	173.8	11.1	63.9	40.7	6.1	10.1	10.4	13.0	11.7	12.7	10.0	12.9	12.1	14.9	12.5	11.2	12.0	2.6	15.3	11.4	6.4	15.0	12.2	11.3	18.0	20.0	13.9	11.7	13.8	14.7	13.7	14.2	10.6	13.8	20.7	21.2	19.2	10.5	63.3	11.0	14.3	11.0	12.0	18.2	5.4	14.1	8.5	3.2	15.7	13.4	12.9	8.4	13.5	11.0	23.8	13.7	18.7	306.1	29.6	13.4	20.2	15.6	32.4	23.8	22.9	20.3	12.3	15.3	46.1	8.2	34.3	9.3	89.4	9.5	1.7	14.5	11.5	22.4	5.8	9.2	160.7	6.5	7.5	8.8	17.8	8.9	9.9	7.2	26.2	49.1	23.6	9.0	7.5	9.0	10.9	16.2	17.6	16.8	11.0	13.1	14.5	14.4	135.9	20.8	12.0	14.6	17.6	11.0	9.7	13.9	15.0
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291508-26372680	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	32.1	16.1	8.9	12.7	13.1	4.7	30.4	9.1	14.3	33.1	6.4	19.1	21.7	22.3	8.5	59.6	24.6	14.1	26.7	9.5	10.2	18.0	28.3	25.8	16.0	9.4	9.7	24.7	14.7	14.0	13.5	38.2	9.2	19.5	15.2	10.5	27.0	15.9	53.4	38.9	19.4	18.3	10.2	17.9	17.7	18.1	8.8	16.0	19.4	23.6	25.7	24.2	37.0	13.6	42.1	33.5	52.5	32.2	28.3	43.6	54.2	74.5	49.4	63.1	65.2	48.9	24.2	54.5	19.1	28.9	31.5	51.2	56.9	50.1	78.0	23.8	24.4	43.8	36.6	23.0	42.0	25.2	19.1	29.3	62.4	39.4	52.0	31.7	96.1	27.5	64.1	37.1	51.7	26.0	54.4	17.6	62.5	73.6	20.5	36.1	35.1	41.8	31.0	74.8	21.0	27.7	30.3	27.9	41.0	37.2	26.9	13.7	45.8	28.5	46.0	31.4	47.0	18.6	32.4	80.9	35.1	39.7	52.2	0.6	0.4	1.6	0.4	0.9	0.7	1.3	1.1	1.0	1.1	1.1	0.6	0.9	1.0	0.9	0.9	0.7	1.8	0.7	8.9	13.1	9.1	14.3	9.5	10.2	9.4	9.7	9.2	10.2	8.8	13.6	63.4	73.7	67.8	42.1	59.2	136.6	215.9	81.6	72.8	53.0	65.6	52.5	36.9	27.1	98.8	14.7	47.9	76.6	70.2	57.5	49.0	45.5	47.9	100.5	51.6	82.3	76.9	53.5	95.1	32.2	65.3	65.5	57.6	98.4	55.2	61.0	55.3	34.6	36.6	37.0	49.9	51.2	61.1	32.0	66.1	128.8	46.9	47.6	60.5	72.1	48.1	51.6	35.0	122.6	250.6	61.0	50.1	73.4	53.5	140.0	44.4	43.9	111.2	40.8	52.6	56.1	76.7	44.6	57.2	102.3	142.9	66.9	66.5	59.9	50.6	232.8
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146580742-147084784	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.1;retina: 43.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1539.0;Excitatory neurons: 846.0;Inhibitory neurons: 788.8;Late spermatids: 876.4;Oligodendrocyte precursor cells: 1035.4;Oligodendrocytes: 4480.1"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 5.2;MAIT T-cell: 4.1;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.2;naive CD8 T-cell: 3.8;NK-cell: 2.9;T-reg: 3.4"	"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.2;HDLM-2: 24.2;RT4: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	1.3	7.8	53.9	0.9	71.4	1.9	0.8	44.7	77.1	1.2	6.0	6.5	1.0	0.4	0.5	1.3	3.6	1.8	2.5	57.8	53.9	3.7	0.7	0.8	1.7	50.7	56.3	0.4	1.9	2.8	14.8	0.7	50.4	1.9	1.9	43.0	1.0	1.0	0.3	3.4	2.2	1.3	50.7	1.8	1.1	18.9	71.6	0.8	3.1	0.3	0.8	7.5	2.0	73.9	0.2	0.0	1.3	2.0	0.2	0.0	0.4	0.7	0.3	0.7	0.2	2.3	1.9	0.2	0.2	0.1	0.0	7.2	0.5	0.4	1.8	24.2	0.4	0.4	4.8	0.6	0.4	0.1	0.4	0.2	1.2	0.0	0.4	0.8	0.3	0.7	0.7	0.5	0.9	0.3	0.2	0.1	2.3	0.0	0.9	1.6	0.2	0.0	1.9	12.5	1.3	0.2	0.3	0.0	0.3	1.4	0.7	0.0	0.4	0.1	0.3	1.7	0.6	0.1	0.4	0.2	0.9	1.9	2.0	0.5	0.0	0.0	5.2	0.0	4.1	0.1	2.4	6.2	0.0	0.0	0.6	3.8	0.1	2.9	0.1	0.0	3.4	1.4	53.9	71.4	44.7	77.1	57.8	53.9	50.7	56.3	50.4	50.7	71.6	73.9	0.5	3.2	1.8	1539.0	0.3	2.0	1.1	2.3	4.6	90.5	0.5	3.6	1.6	10.0	0.9	9.2	150.1	18.9	30.2	0.0	21.5	1.7	295.3	1.0	0.1	2.0	13.1	1.3	846.0	0.0	0.3	1.1	1.1	0.4	0.0	0.0	0.0	0.0	0.9	47.1	788.8	0.0	0.0	1.2	4.7	876.4	3.4	1.4	5.4	58.1	0.3	45.0	57.7	1035.4	4480.1	0.6	0.0	2.2	3.3	1.0	0.0	5.5	0.1	275.4	0.0	0.7	11.0	4.8	2.2	1.6	1.4	5.3	31.0	0.1	0.0	0.9
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	0.8	6.2	72.9	0.6	86.7	0.0	1.4	42.1	106.2	18.0	0.0	1.1	0.8	27.0	7.4	35.9	9.9	0.4	2.5	85.7	44.5	0.3	0.1	0.1	0.3	52.5	52.7	0.6	0.7	1.5	22.6	0.1	55.1	5.0	0.3	10.9	5.3	14.5	0.8	34.0	1.2	11.9	62.3	0.3	0.8	7.3	66.9	2.7	0.1	0.9	3.1	0.9	11.5	91.2	31.4	46.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	19.0	0.0	68.4	13.7	20.0	0.7	0.0	0.0	2.4	0.0	3.2	3.7	0.7	0.0	0.1	6.6	11.4	0.0	0.0	0.0	0.1	4.2	0.0	0.1	6.6	36.2	0.0	0.1	2.2	0.6	38.9	0.0	0.0	1.2	0.0	0.1	39.1	7.5	1.5	0.1	0.0	1.1	18.9	0.1	0.0	0.2	22.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	86.7	42.1	106.2	85.7	44.5	52.5	52.7	55.1	62.3	66.9	91.2	0.2	0.0	0.0	61.0	0.0	14.7	0.4	0.8	4.6	11.0	1.9	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	67.4	0.8	5.7	0.6	0.0	0.0	203.3	0.2	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	3.3	82.8	0.0	0.0	0.0	1.1	182.5	6.8	0.0	0.0	4.7	0.0	6.5	0.0	14.1	94.6	2.4	0.0	4.5	0.0	1.3	0.0	0.2	0.0	3.1	0.0	0.0	2.5	2.3	1.6	6.5	22.0	0.0	0.2	0.1	0.0	0.2
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131901008-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	1.5	3.0	4.5	1.2	5.4	0.0	1.4	7.0	5.8	2.1	3.8	2.8	2.1	1.6	2.0	1.6	1.6	1.6	3.3	4.9	4.1	1.8	1.6	2.3	2.4	4.1	4.1	3.6	15.9	3.2	2.3	1.9	4.1	1.8	1.9	2.8	3.3	1.9	2.8	2.7	2.4	1.3	3.6	1.8	2.1	1.3	4.6	1.7	2.2	2.9	1.5	2.3	1.9	4.9	4.4	3.8	2.4	1.8	3.3	2.6	3.4	1.5	3.1	2.9	3.1	3.1	3.6	1.8	1.0	1.8	1.8	7.9	3.2	0.7	3.1	4.5	4.2	3.0	3.7	1.8	1.1	3.2	3.4	0.9	6.7	3.2	4.5	4.6	2.0	2.6	3.9	0.8	3.2	2.1	1.5	7.3	1.5	1.5	3.4	2.0	1.6	0.5	2.3	0.6	1.9	2.6	1.9	1.6	1.8	2.5	1.4	2.4	2.8	1.6	0.7	2.3	8.1	2.8	1.6	2.3	1.4	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.4	7.0	5.8	4.9	4.1	4.1	4.1	4.1	3.6	4.6	4.9	26.8	19.2	14.3	22.2	20.0	37.3	37.4	6.4	20.5	55.0	25.8	23.6	36.3	14.3	10.2	9.2	10.4	10.6	36.1	27.6	19.6	9.8	12.7	21.5	24.8	19.0	10.7	18.7	43.0	17.7	13.6	21.8	19.9	32.3	6.3	33.1	13.2	23.2	14.1	52.2	37.5	18.2	8.2	12.0	17.6	6.4	17.4	23.3	12.4	26.2	10.5	28.3	18.6	29.7	38.1	16.8	18.0	20.7	20.3	39.1	20.0	29.6	5.7	32.6	26.3	29.2	23.2	14.3	20.1	18.8	34.0	11.8	24.4	39.5	19.1	39.6
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965728-136147894	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 51.2;skeletal muscle: 180.5;tongue: 117.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3;Oligodendrocytes: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	3.1	3.4	3.3	2.3	7.2	0.2	7.1	4.3	5.0	5.2	3.9	8.0	2.0	7.7	5.1	8.3	4.1	5.0	51.2	4.2	4.9	22.0	1.1	3.9	0.6	5.7	5.5	5.6	3.4	11.7	1.8	2.8	5.3	5.9	5.4	2.6	8.9	6.5	180.5	18.9	2.3	9.6	4.3	1.1	7.4	7.2	6.0	0.6	3.1	117.6	1.2	4.5	4.0	13.7	37.4	2.0	10.3	5.0	8.1	10.2	11.9	28.5	35.3	13.2	16.3	2.4	2.4	0.1	10.7	29.3	9.5	4.7	4.3	10.0	28.3	0.1	1.4	1.6	1.0	0.1	5.8	0.0	1.4	9.3	8.5	16.8	7.8	13.3	12.8	1.0	1.0	0.1	19.2	6.2	0.3	0.2	7.2	0.4	6.9	0.1	15.1	0.1	46.2	1.4	0.7	5.7	4.7	5.7	10.9	9.2	9.1	0.5	8.4	13.7	7.5	18.8	12.7	0.4	1.0	0.1	10.1	0.8	4.9	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	3.3	7.2	4.3	5.0	4.2	4.9	5.7	5.5	5.3	4.3	6.0	13.7	7.9	28.9	27.6	51.6	2.8	26.4	19.5	7.1	19.4	5.7	19.9	15.5	115.3	8.6	10.0	55.2	0.0	10.9	6.7	25.3	21.5	20.6	8.4	9.9	19.0	11.4	13.1	0.4	35.2	9.9	15.4	14.8	21.9	16.1	3.8	15.7	8.6	2.9	2.5	3.3	47.2	6.9	6.1	2.4	9.8	10.7	24.5	3.2	28.4	13.1	9.6	8.9	2.1	72.4	201.1	17.2	10.6	18.4	1.5	17.8	21.7	40.1	8.1	2.6	6.6	29.0	14.0	10.1	18.6	15.3	33.2	10.4	3.4	6.7	8.9	15.6
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285410-212361853	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 252.7;Late spermatids: 547.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059288, HPA078841"	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA059288: AB_2683966, HPA078841: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	60.2	12.0	35.5	20.0	40.6	86.5	38.3	34.4	34.9	24.7	27.4	34.2	25.7	20.1	18.4	51.3	19.2	27.7	50.4	31.0	35.6	35.6	51.6	57.7	31.0	36.3	40.8	15.3	36.9	23.5	13.2	35.9	36.1	22.6	37.0	23.9	36.3	22.2	36.7	30.8	33.4	22.2	35.0	49.5	44.5	17.4	42.6	36.3	41.8	56.6	31.3	34.7	30.2	39.6	45.4	19.1	9.5	19.1	102.5	62.2	76.1	19.6	38.3	21.9	20.6	57.1	45.7	31.9	14.5	31.5	22.9	32.0	18.3	27.9	22.8	27.5	23.1	20.7	19.9	20.8	33.1	43.3	30.7	25.7	36.4	20.1	29.0	27.7	53.3	28.0	29.6	33.4	12.1	19.7	17.1	28.5	16.0	40.6	39.5	22.0	15.2	40.6	38.5	20.9	13.6	9.1	27.3	84.7	65.0	40.0	52.7	38.0	11.4	15.3	15.6	24.2	21.2	50.9	42.7	42.1	18.4	32.6	11.5	18.0	2.0	10.1	4.4	2.3	3.0	1.4	3.4	4.0	1.4	2.2	2.0	4.0	9.8	3.3	3.3	1.5	5.2	1.4	35.5	40.6	34.4	34.9	31.0	35.6	36.3	40.8	36.1	35.0	42.6	39.6	66.7	99.3	104.4	71.5	34.2	68.6	22.1	9.0	40.9	24.6	30.1	18.5	65.8	47.1	17.4	14.7	2.1	10.9	56.2	51.2	97.8	25.9	252.7	25.5	17.7	53.3	16.2	22.9	21.3	34.8	26.9	18.7	43.8	53.5	40.0	6.6	38.6	52.2	22.1	52.2	13.8	33.9	8.2	34.8	20.6	547.2	19.3	34.1	17.8	45.0	35.1	37.4	53.5	32.6	115.2	27.8	32.5	14.3	29.6	31.0	30.8	20.9	21.3	11.1	32.9	14.8	36.5	18.4	10.9	66.2	81.3	8.2	54.1	58.3	30.8	45.7
PPP2R5B	"B56B, B56beta, FLJ35411, PR61B"	ENSG00000068971	"Protein phosphatase 2 regulatory subunit B'beta"	Q15173	11	64917553-64934475	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036607	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA036607: AB_10670235"	"unprognostic (2.20e-2)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.12e-2)"	16.7	14.4	39.0	9.1	43.2	14.6	14.5	42.8	48.2	13.4	13.8	26.2	7.6	16.9	11.3	11.2	14.4	16.5	25.2	42.2	37.0	21.3	13.7	21.8	9.6	45.7	38.8	11.6	18.0	12.4	26.0	10.1	43.3	17.7	8.5	22.7	13.3	14.8	20.1	17.0	16.6	14.4	28.1	24.9	16.8	5.7	41.1	6.9	19.1	12.8	8.4	16.6	14.3	44.6	12.2	5.9	7.7	18.0	15.8	11.6	1.2	13.4	12.2	18.7	15.0	4.4	9.1	3.0	9.2	15.9	20.7	8.1	7.4	11.6	10.5	17.7	5.2	3.5	12.0	2.9	15.1	1.4	15.2	7.4	19.5	20.3	22.8	21.3	15.1	10.3	6.9	7.5	14.1	4.8	2.1	5.5	2.4	3.7	16.9	3.6	2.1	7.0	14.0	5.4	20.0	18.7	8.2	6.0	12.6	6.6	6.8	2.9	15.2	23.9	7.9	25.9	5.1	9.0	7.9	2.4	29.8	2.2	11.1	0.9	0.6	8.9	0.6	1.0	0.5	0.7	0.3	0.6	0.4	0.9	0.3	0.4	0.3	0.7	1.3	0.3	0.8	0.2	39.0	43.2	42.8	48.2	42.2	37.0	45.7	38.8	43.3	28.1	41.1	44.6	17.1	0.0	3.0	17.6	5.9	8.5	6.4	19.2	9.1	35.6	6.4	3.0	3.3	5.7	6.2	1.8	27.1	1.8	7.2	16.4	13.7	9.9	0.9	3.2	4.9	12.4	15.6	44.8	19.3	6.6	4.0	5.7	7.1	6.2	4.5	2.7	15.0	3.3	6.8	28.6	22.5	8.4	10.2	5.5	4.0	1.5	5.9	6.3	7.2	11.2	3.7	15.4	6.2	13.0	20.9	17.0	7.6	8.2	6.1	11.1	6.1	14.4	3.8	19.3	13.1	6.3	8.9	0.7	2.7	3.6	9.7	2.9	5.6	3.9	3.7	18.3
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 525.3;T-cells: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	54.7	58.4	72.7	77.6	75.1	129.2	62.0	67.3	81.2	59.2	55.1	70.7	52.4	53.8	63.5	73.8	49.2	57.7	112.6	89.3	72.5	58.6	89.3	66.8	136.9	73.1	71.1	61.2	59.6	64.1	43.2	45.6	72.4	50.5	74.4	56.2	69.2	55.8	79.2	67.3	57.3	60.8	74.2	72.0	53.8	66.5	71.9	114.4	66.5	73.0	124.6	67.3	44.1	72.8	100.6	67.4	111.8	108.6	99.5	138.8	107.9	92.7	121.5	113.5	107.9	68.2	169.8	272.1	86.9	120.8	79.7	102.7	103.6	98.2	146.6	123.2	48.3	79.0	74.8	66.7	73.3	122.7	162.4	91.9	124.4	78.2	72.1	100.7	103.3	145.3	167.5	111.7	109.7	153.2	124.1	135.1	65.0	200.7	111.2	103.7	125.8	67.8	109.3	112.1	87.2	163.3	125.6	82.2	161.1	78.0	150.2	92.9	103.0	71.1	67.3	276.4	93.0	154.8	249.3	449.4	106.6	89.5	81.0	97.5	72.7	72.6	217.2	94.3	140.0	74.8	139.8	172.3	65.4	68.8	98.4	153.5	133.7	68.2	104.6	95.8	156.2	91.3	72.7	75.1	67.3	81.2	89.3	72.5	73.1	71.1	72.4	74.2	71.9	72.8	51.0	83.3	93.9	61.4	94.4	58.6	45.7	35.0	26.2	30.8	51.7	35.8	133.9	47.1	52.4	36.8	58.4	49.8	525.3	69.3	46.9	38.3	79.6	104.2	39.2	45.9	47.4	45.3	124.6	46.9	46.6	43.4	33.6	54.9	69.6	38.7	59.3	78.5	73.2	26.9	92.2	78.9	38.7	122.9	84.5	69.5	52.5	78.4	85.4	84.3	128.2	49.9	280.2	71.4	89.8	50.6	69.7	45.5	193.9	48.9	51.0	62.8	76.5	43.3	39.5	34.3	54.1	47.1	27.5	36.2	70.3	52.4	323.4	42.7	62.6	71.6
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PPP2R5E	"B56E, B56epsilon"	ENSG00000154001	"Protein phosphatase 2 regulatory subunit B'epsilon"	Q16537	14	63371364-63543377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 283.4;Horizontal cells: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006034, CAB072342"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB072342: , HPA006034: AB_1079670"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.62e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.22e-2)"	12.7	12.5	9.5	13.5	11.0	14.5	12.5	10.3	11.1	14.6	7.2	17.0	10.7	14.9	10.2	19.8	11.7	12.0	15.7	11.4	11.1	14.7	15.8	12.7	15.4	7.4	7.6	12.6	10.9	17.5	6.6	16.0	7.9	12.7	20.0	26.7	9.2	12.6	17.8	11.8	12.3	15.0	7.6	14.3	12.0	14.3	10.4	19.2	20.2	16.5	17.0	17.1	9.8	7.8	90.5	26.0	46.7	22.1	31.6	37.0	44.5	37.1	30.4	39.5	39.1	33.1	35.4	39.6	22.1	38.1	29.3	36.2	48.1	34.4	67.8	36.2	11.8	25.7	18.1	27.7	33.7	41.7	30.4	27.1	37.7	38.8	42.7	28.8	40.2	39.8	33.3	41.9	43.8	60.2	41.8	18.7	35.3	37.7	46.8	41.9	47.8	30.1	38.2	68.1	26.5	51.6	47.7	39.1	25.0	40.1	57.4	20.8	37.8	61.7	68.6	31.7	33.0	15.2	24.4	50.9	28.4	26.3	42.7	1.4	1.3	1.3	2.0	1.4	1.9	1.1	2.2	2.5	1.2	1.7	1.7	1.9	1.0	4.5	1.9	1.9	1.4	0.6	9.5	11.0	10.3	11.1	11.4	11.1	7.4	7.6	7.9	7.6	10.4	7.8	52.1	89.8	55.5	54.2	52.8	80.4	56.9	34.0	60.3	65.0	49.3	27.8	61.7	44.3	35.3	22.0	64.6	27.2	54.8	55.0	29.4	46.4	283.4	65.1	57.2	52.5	27.1	41.2	110.4	47.7	41.5	44.8	33.1	74.6	24.1	48.6	41.0	45.1	29.8	262.5	131.6	51.6	28.5	38.7	49.0	46.6	43.8	42.3	37.4	59.0	49.7	38.4	61.8	93.5	91.8	41.4	48.1	43.2	55.9	58.5	24.9	41.2	41.6	81.2	26.3	51.5	71.1	74.9	22.5	63.1	91.6	30.6	57.0	47.8	70.2	46.9
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436433-73496024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 379.3;tongue: 179.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 119.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	44.8	37.5	40.5	29.8	51.1	19.8	32.1	49.5	63.1	30.3	26.7	41.4	24.2	40.3	34.5	33.1	30.9	28.3	41.3	56.9	29.5	28.1	21.8	23.5	34.9	25.4	25.2	39.6	25.3	39.2	30.6	25.5	28.7	39.1	29.6	57.0	26.6	39.8	379.3	26.3	22.6	48.2	27.2	25.3	24.3	29.0	29.1	32.9	23.5	179.7	36.1	34.3	24.3	44.9	53.7	29.0	50.9	53.0	71.4	98.3	24.5	48.0	65.7	46.1	45.4	18.6	26.8	47.1	15.3	70.0	21.8	28.1	41.6	36.9	64.5	66.6	34.0	20.3	25.0	35.5	42.7	45.2	40.2	70.1	43.5	43.6	58.1	84.7	32.3	40.6	25.6	54.0	94.1	16.9	40.7	41.6	20.7	23.3	83.8	26.9	27.7	22.4	45.1	25.6	27.2	31.5	28.1	69.5	36.4	42.1	52.4	43.2	35.6	36.6	33.7	29.5	66.1	35.8	105.3	33.0	45.3	64.0	21.3	2.2	2.0	3.5	4.0	2.7	4.8	2.7	4.3	4.4	2.1	2.3	3.4	5.1	1.1	3.5	1.7	4.0	7.8	1.9	40.5	51.1	49.5	63.1	56.9	29.5	25.4	25.2	28.7	27.2	29.1	44.9	23.0	3.2	14.3	72.5	31.6	25.6	29.8	13.2	27.3	54.8	25.7	16.9	48.9	14.3	12.8	18.4	20.9	21.0	23.7	11.1	62.6	18.1	11.8	20.0	24.2	21.5	42.6	30.7	119.5	19.4	16.8	32.6	20.4	18.8	21.0	35.4	18.9	14.2	20.3	38.7	111.0	13.2	18.3	31.7	24.2	9.9	33.5	25.2	26.6	51.5	29.6	34.8	18.6	79.4	54.4	16.7	12.9	29.0	34.1	27.1	13.4	34.2	17.6	30.1	6.6	41.8	36.4	43.8	49.2	32.1	31.5	22.2	27.3	28.4	13.1	22.1
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	28.5	11.9	11.8	16.5	11.8	26.5	20.8	17.7	15.3	18.1	31.1	16.6	9.1	14.5	10.6	16.9	15.6	15.7	34.5	11.3	10.8	12.9	12.4	21.5	33.0	12.1	11.0	14.0	14.3	18.4	11.7	19.3	12.2	14.4	10.3	77.9	14.0	8.2	89.4	13.6	15.4	15.5	10.0	22.4	14.6	56.0	13.1	15.0	16.6	54.2	26.9	17.0	16.4	14.8	12.2	8.8	7.7	9.4	19.8	24.4	11.2	16.5	28.9	23.9	26.5	5.1	7.5	45.7	19.7	25.6	40.0	8.4	17.9	16.5	30.5	26.3	9.5	9.8	10.5	14.7	26.8	7.1	15.6	15.0	22.3	16.2	16.5	25.6	21.1	22.0	19.6	58.8	27.2	5.7	16.8	11.7	5.6	12.5	12.0	54.0	18.1	15.2	22.4	11.3	5.4	12.7	12.3	7.4	17.4	14.4	4.9	11.8	22.8	37.1	7.9	56.7	12.9	29.3	38.5	48.3	19.6	9.3	25.1	5.4	2.7	10.7	16.6	3.2	12.7	26.3	19.0	23.6	5.1	21.3	18.1	14.9	0.6	19.2	4.7	6.2	17.2	7.1	11.8	11.8	17.7	15.3	11.3	10.8	12.1	11.0	12.2	10.0	13.1	14.8	27.2	6.4	5.1	49.6	74.7	16.6	21.3	32.6	12.0	12.8	10.0	6.0	8.0	14.3	14.0	7.3	47.9	18.0	50.3	6.7	7.9	15.0	145.8	6.5	12.7	24.2	10.3	10.8	78.9	21.0	23.8	25.1	6.6	14.6	3.8	3.9	23.6	7.8	13.1	3.3	83.6	2.5	38.7	10.8	24.6	22.6	22.4	19.3	28.4	76.8	30.4	13.1	59.8	99.5	64.8	21.1	7.4	21.4	96.8	26.3	10.6	11.6	7.8	50.5	32.9	19.5	23.3	131.8	29.6	17.1	11.4	14.1	53.4	4.8	6.3	25.5
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 80.8"	"Group enriched"	"Detected in some"	38	"Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	80.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.1	0.0	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.3	10.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.2	600.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085376	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	44.3	57.9	34.8	43.2	34.7	63.2	42.5	35.9	38.7	42.8	41.0	49.8	47.0	39.6	47.1	88.3	35.9	32.5	45.6	34.0	35.7	49.9	83.2	46.2	58.6	35.5	34.9	29.4	41.0	46.4	33.5	49.6	35.3	37.8	35.2	18.1	44.0	28.5	60.8	60.8	49.0	32.8	35.6	62.5	49.2	65.4	38.4	61.2	35.4	30.2	63.7	56.3	48.9	36.4	132.7	145.9	95.5	134.0	88.4	73.8	148.5	115.8	127.7	148.7	163.8	129.5	167.9	102.7	145.2	137.0	95.5	105.9	119.3	143.2	87.0	130.1	213.0	70.5	86.0	290.4	133.5	100.1	126.8	107.9	124.7	135.9	85.5	88.4	174.9	130.5	139.6	91.0	115.1	382.2	174.4	180.7	182.2	104.7	77.1	190.9	99.4	180.4	142.5	134.5	91.9	136.8	57.1	169.1	101.8	79.4	156.0	166.0	113.3	86.4	90.4	70.6	90.8	155.4	183.8	122.4	123.1	126.9	107.0	100.6	103.5	236.1	66.5	113.2	47.7	68.5	69.6	74.2	115.8	88.3	62.0	54.1	215.2	51.7	100.1	90.6	95.1	48.3	34.8	34.7	35.9	38.7	34.0	35.7	35.5	34.9	35.3	35.6	38.4	36.4	87.8	51.3	33.4	10.7	85.8	147.2	121.7	206.9	71.2	23.3	94.2	82.8	11.1	82.9	133.5	77.3	29.2	313.7	106.0	217.0	158.5	226.9	156.9	80.5	55.5	91.7	125.6	89.2	8.0	193.3	335.3	66.7	106.0	85.2	69.2	66.7	74.6	94.2	239.3	35.3	8.6	159.3	193.3	105.4	138.4	143.8	62.7	124.4	80.0	9.4	221.1	61.1	118.4	8.0	12.9	345.5	220.8	52.3	97.6	161.3	191.0	198.6	119.7	29.5	72.3	43.4	85.9	228.5	157.8	113.2	172.5	421.0	93.0	61.7	175.9	227.2
PPP4R1	PP4R1	ENSG00000154845	"Protein phosphatase 4 regulatory subunit 1"	Q8TF05	18	9546791-9615240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040905, HPA041089"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA040905: AB_10794869, HPA041089: AB_10805836"	"unprognostic (1.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.13e-3)"	"unprognostic (4.15e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	20.7	16.2	16.7	16.8	19.1	32.0	18.8	18.7	17.8	27.2	19.1	24.7	23.2	20.8	17.1	70.7	21.1	20.7	20.7	15.6	17.4	19.6	15.3	34.6	13.0	17.7	17.2	17.0	19.9	23.5	11.7	29.0	17.7	16.6	19.7	13.3	23.3	16.9	16.2	26.1	26.1	23.3	16.9	18.4	24.4	35.7	17.0	19.9	18.7	17.4	24.9	40.7	35.7	20.6	70.3	48.5	115.0	31.6	22.3	33.7	58.3	66.9	44.7	64.9	62.3	44.1	39.6	34.0	47.6	66.1	55.0	29.4	54.0	99.4	87.0	39.8	21.8	32.2	35.0	32.0	34.7	83.0	46.7	30.3	62.8	56.1	52.9	48.5	75.3	22.6	47.5	29.8	70.9	34.5	58.1	31.7	46.1	97.5	30.3	71.5	69.2	21.4	54.6	96.5	33.6	39.5	79.3	35.3	26.4	73.3	19.3	31.5	81.3	113.6	70.2	59.3	83.5	26.5	39.7	60.7	42.5	34.0	52.5	14.6	6.1	10.9	3.9	4.7	5.0	3.8	4.3	3.9	7.0	1.8	1.4	3.2	36.1	4.1	4.7	2.9	4.6	3.5	16.7	19.1	18.7	17.8	15.6	17.4	17.7	17.2	17.7	16.9	17.0	20.6	26.4	99.3	76.1	35.9	11.9	40.4	26.5	30.8	42.7	19.6	20.7	14.7	21.4	7.2	55.4	22.0	10.4	27.0	12.0	31.2	5.9	23.8	77.3	48.1	26.7	29.5	17.4	15.6	43.0	34.9	15.9	19.3	45.3	54.0	3.8	27.0	26.0	12.2	16.8	33.7	54.9	16.4	8.2	19.6	16.7	57.2	17.4	20.7	14.2	34.7	20.5	10.6	13.4	61.9	66.5	49.8	16.2	11.7	10.8	21.0	23.7	10.0	58.9	19.3	13.1	16.5	22.1	20.4	12.3	52.0	42.5	23.0	12.9	9.2	13.6	68.4
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996803-73069198	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	27.2	23.2	16.9	26.8	22.9	101.2	22.7	22.6	25.3	27.9	21.7	26.9	24.7	24.7	19.0	23.0	27.7	23.3	25.8	17.3	17.7	23.6	53.6	18.0	26.3	19.7	19.1	22.9	23.0	25.4	11.0	28.6	21.5	18.3	23.8	24.4	20.7	15.7	25.8	16.7	22.3	18.8	18.9	21.6	21.4	27.1	20.1	36.2	24.8	24.8	25.8	24.0	15.3	38.7	33.6	38.5	80.9	48.2	41.7	35.9	48.8	66.2	46.7	59.0	61.3	56.1	39.8	63.3	37.3	39.7	56.0	23.6	63.6	36.8	76.0	96.6	23.8	71.1	43.6	67.8	45.8	105.7	70.6	40.9	53.6	71.3	58.3	40.9	41.4	62.9	63.6	70.6	49.5	49.3	88.3	45.8	74.8	50.0	31.8	82.0	45.9	58.9	50.0	89.4	18.1	47.7	77.3	49.9	62.1	57.9	45.9	58.7	47.0	52.4	62.4	61.3	57.3	43.1	97.4	125.5	36.9	79.9	60.4	7.9	5.9	14.8	12.5	3.4	13.8	6.9	12.9	13.1	5.1	7.8	11.1	10.0	21.3	11.3	5.7	18.0	17.6	4.3	16.9	22.9	22.6	25.3	17.3	17.7	19.7	19.1	21.5	18.9	20.1	38.7	56.8	57.7	32.4	19.2	58.5	117.1	110.1	115.8	69.4	50.1	53.2	55.5	54.7	47.1	74.0	27.6	14.6	74.8	62.8	72.4	19.6	63.4	58.1	86.3	76.0	61.9	53.8	61.0	45.6	53.1	72.0	61.6	38.2	142.7	30.9	49.1	40.4	76.4	43.1	50.5	34.8	55.5	77.3	39.2	78.1	12.7	53.4	61.6	56.9	41.2	52.6	53.9	54.6	42.3	101.8	71.4	58.3	48.5	69.7	115.7	44.3	45.8	64.0	39.0	39.5	73.9	60.4	100.6	77.1	54.6	109.1	138.3	69.4	59.1	54.5	128.1
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457508-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: AB_2685153"	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.3	13.5	14.4	18.2	14.5	50.0	19.6	16.6	15.2	19.1	16.2	21.2	17.2	20.0	15.9	21.4	20.4	12.3	16.2	12.6	13.3	18.3	23.7	20.2	28.3	13.6	14.2	22.0	19.8	16.8	14.8	17.5	13.7	18.4	18.5	10.9	20.8	13.1	24.5	25.4	24.4	15.0	12.7	24.1	20.6	22.3	14.5	27.4	17.7	16.7	25.4	19.5	19.4	16.9	24.5	41.4	34.1	27.1	22.5	20.9	60.9	23.2	21.4	24.5	24.6	35.2	32.1	63.1	30.2	19.2	15.0	27.8	36.6	28.9	39.8	52.0	19.7	32.5	25.7	24.5	26.3	59.1	33.1	15.1	50.4	19.7	31.1	20.1	26.7	29.4	33.5	36.2	33.1	52.1	42.8	38.0	31.2	46.5	29.8	54.0	40.6	26.5	30.3	41.5	41.6	25.4	35.3	77.0	32.5	33.6	39.4	37.8	28.0	19.2	20.6	21.1	26.8	36.0	67.0	69.3	25.2	31.8	34.7	6.2	1.9	2.9	4.9	2.6	6.6	4.6	4.5	4.4	2.1	7.4	5.6	4.8	2.5	9.0	3.7	5.0	6.9	2.6	14.4	14.5	16.6	15.2	12.6	13.3	13.6	14.2	13.7	12.7	14.5	16.9	44.1	32.1	48.3	0.0	83.0	0.0	46.7	0.0	58.1	27.9	35.9	23.5	0.0	32.9	30.3	46.0	20.9	33.9	91.8	21.1	29.4	21.2	13.0	86.9	46.5	33.3	13.3	47.5	0.0	25.1	29.0	27.3	45.3	70.7	20.2	39.8	28.9	51.8	25.8	32.0	0.0	28.2	0.0	48.7	0.0	8.5	37.6	70.7	0.0	0.0	41.8	21.0	44.3	0.0	0.0	27.8	25.7	42.5	75.8	56.6	37.3	23.5	16.8	27.3	26.3	45.9	27.1	91.0	59.9	58.0	0.0	44.3	80.1	33.0	25.8	75.2
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	29.0	27.4	14.8	28.2	15.1	25.8	29.1	20.9	16.9	26.8	20.0	28.1	31.6	23.7	19.3	31.7	32.3	24.7	14.3	13.8	16.9	33.4	48.0	23.4	38.1	15.0	16.3	25.7	32.1	27.4	12.5	24.5	16.2	24.9	27.7	35.3	28.1	23.2	14.7	29.6	32.1	21.8	15.9	28.7	30.8	23.7	15.1	42.2	33.0	20.3	38.7	26.7	16.9	18.7	42.8	33.0	35.6	30.0	37.2	38.9	49.1	34.0	35.9	28.2	24.0	39.5	40.9	57.7	67.5	32.7	44.8	36.4	39.9	27.5	41.4	84.6	16.7	56.7	30.0	52.9	60.3	66.0	45.6	29.8	64.9	34.1	60.1	36.9	45.0	31.6	55.2	57.4	37.7	50.9	42.8	43.7	35.1	55.9	25.3	40.1	53.6	44.6	39.3	43.8	43.4	26.9	36.8	49.9	54.8	23.5	31.6	52.0	36.3	43.3	56.8	21.6	47.2	59.1	47.3	22.3	40.8	61.3	47.2	25.6	16.5	26.9	20.4	20.9	23.2	18.1	21.2	21.6	18.4	18.6	24.5	21.5	19.6	22.5	23.0	9.9	24.0	23.9	14.8	15.1	20.9	16.9	13.8	16.9	15.0	16.3	16.2	15.9	15.1	18.7	46.8	44.8	41.3	0.0	61.8	0.0	48.9	0.0	44.3	44.1	42.7	27.9	0.0	31.5	29.1	16.5	33.3	30.6	51.4	25.3	39.2	32.4	9.5	85.1	43.2	32.9	18.2	46.7	0.0	41.0	28.5	33.9	43.8	39.6	30.3	39.0	26.0	52.5	26.2	53.8	0.0	29.4	0.0	37.7	0.0	7.6	28.0	44.9	0.0	0.0	47.9	53.1	49.4	0.0	0.0	35.4	24.1	36.1	57.2	57.4	46.1	52.9	62.7	38.5	6.6	54.9	28.4	39.1	25.7	53.3	0.0	47.7	56.3	44.6	29.0	57.2
PPP4R4	"CFAP14, KIAA1622, PP4R4"	ENSG00000119698	"Protein phosphatase 4 regulatory subunit 4"	Q6NUP7	14	94146128-94279734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Cone photoreceptor cells: 75.0;Excitatory neurons: 63.1;Inhibitory neurons: 63.0;Spermatocytes: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.7;RH-30: 19.4;T-47d: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041866, HPA050321"	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA041866: AB_10804120, HPA050321: AB_2681086"	"unprognostic (2.65e-3)"	"unprognostic (3.06e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.49e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.24e-2)"	0.2	0.4	2.7	0.3	3.0	0.1	0.5	2.2	4.0	4.3	1.0	0.1	0.0	0.8	0.0	0.3	1.6	0.3	0.2	3.3	3.6	0.3	3.0	1.5	0.2	2.8	2.7	5.1	0.4	0.9	2.6	0.5	2.4	0.4	0.1	5.4	0.3	0.6	0.1	0.6	0.1	0.3	1.8	0.0	0.7	7.9	3.4	0.1	0.2	0.0	0.6	0.2	1.2	4.2	0.8	0.1	3.5	0.9	0.8	0.0	0.9	0.4	3.1	1.0	0.9	0.2	0.9	0.0	0.0	0.0	2.5	0.1	4.5	4.7	0.6	0.3	0.7	0.0	0.0	1.9	0.3	0.0	0.6	0.0	0.9	0.1	6.7	0.0	0.0	2.1	0.0	0.3	0.6	1.0	0.0	0.1	1.8	0.0	0.1	0.2	19.4	0.1	0.2	0.9	0.4	0.1	0.1	0.1	0.1	1.3	23.6	0.0	0.0	3.0	2.9	0.2	0.3	0.9	0.1	0.6	1.8	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.0	2.2	4.0	3.3	3.6	2.8	2.7	2.4	1.8	3.4	4.2	0.1	3.2	9.5	44.4	0.1	4.8	4.9	4.9	5.7	1.4	3.6	0.8	0.4	0.0	2.9	0.0	75.0	0.0	0.0	0.0	0.0	2.4	17.9	3.5	0.2	0.6	0.0	0.0	63.1	0.4	0.2	0.5	2.0	3.1	0.0	19.5	6.4	1.0	0.1	1.7	63.0	0.0	2.0	1.3	0.7	18.0	5.9	0.2	0.0	1.9	0.0	6.0	0.0	17.6	3.7	0.2	0.0	5.7	0.1	17.8	0.0	0.2	14.5	0.8	0.0	0.6	1.6	33.7	9.2	1.6	2.6	0.0	0.4	1.2	0.0	7.2
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46347087-46392981	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	27.4	37.5	27.7	17.7	29.3	14.2	26.3	28.4	36.5	28.0	27.7	31.3	16.8	34.9	9.8	30.4	31.7	13.3	56.4	29.8	28.6	29.1	32.7	28.0	19.7	32.3	28.2	24.7	23.7	32.5	36.6	15.8	33.3	23.7	15.4	14.4	23.0	18.2	58.9	27.5	25.9	20.8	26.2	33.5	33.6	16.9	30.3	20.5	26.2	45.7	15.0	27.7	26.3	28.5	61.9	114.9	66.0	50.1	48.3	50.9	30.6	75.4	59.6	88.2	78.2	82.4	47.9	94.3	39.9	54.0	48.4	49.9	86.2	88.5	24.7	65.9	120.5	76.4	80.9	59.4	54.5	106.6	52.8	47.8	40.9	62.1	45.9	34.2	77.2	79.3	76.0	47.3	49.4	67.5	59.5	203.4	50.2	109.6	61.7	89.0	56.6	76.5	52.8	81.8	93.1	69.7	62.6	78.8	26.9	28.6	49.7	67.8	65.5	38.3	64.3	29.1	79.1	38.0	93.0	111.5	41.7	89.4	65.9	0.0	10.3	3.0	27.8	18.0	17.8	15.1	12.8	22.0	16.8	11.7	12.2	16.8	0.2	22.0	23.4	11.7	14.3	15.4	27.7	29.3	28.4	36.5	29.8	28.6	32.3	28.2	33.3	26.2	30.3	28.5	28.1	6.4	12.5	22.9	16.5	9.4	16.6	20.9	19.9	19.7	13.1	13.5	5.6	44.3	14.2	16.5	16.7	26.4	12.3	25.2	33.2	29.9	1.2	31.3	25.2	19.6	14.9	11.6	18.5	19.5	36.2	17.6	26.0	19.6	4.5	18.6	24.3	24.9	21.6	16.8	23.2	17.0	22.4	12.3	8.2	3.2	17.4	11.9	16.0	11.2	12.1	21.0	17.5	17.6	14.5	26.4	17.0	18.4	25.5	12.1	16.3	21.4	14.6	17.9	39.5	14.6	19.9	26.6	32.0	20.8	13.2	25.7	20.4	23.1	25.0	11.7
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050940	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"			"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	32.8	25.2	20.9	24.4	22.6	42.2	29.9	22.1	27.0	22.8	18.1	28.4	20.4	19.7	23.7	25.0	18.5	18.6	21.6	21.7	22.0	32.6	25.1	24.0	30.8	21.1	20.4	19.6	27.7	32.6	14.7	19.5	21.6	20.2	30.9	17.5	26.1	19.7	69.9	23.5	22.5	21.8	21.8	27.6	20.9	28.1	20.7	38.9	31.5	53.5	36.2	22.9	18.7	26.9	32.6	23.4	41.6	39.3	43.6	36.2	41.8	33.7	36.5	48.7	40.4	37.6	33.5	46.5	25.5	45.6	41.3	64.7	56.8	36.7	56.2	42.0	27.3	38.3	33.5	33.6	35.7	67.6	50.8	30.0	49.2	40.1	38.1	37.5	46.2	52.6	45.7	52.2	53.3	48.6	64.0	42.5	38.8	90.4	42.8	51.5	62.7	62.2	42.1	32.3	42.8	42.3	60.3	47.8	41.0	35.0	74.0	42.0	45.3	29.7	28.4	58.4	45.5	57.5	112.4	62.3	40.1	43.5	49.4	61.7	21.8	35.9	22.4	28.6	27.2	26.8	28.2	25.3	24.0	20.2	27.6	26.5	50.9	23.7	33.6	17.2	38.9	25.8	20.9	22.6	22.1	27.0	21.7	22.0	21.1	20.4	21.6	21.8	20.7	26.9	39.8	41.7	37.8	20.5	62.6	77.4	55.5	64.0	60.3	14.0	42.5	28.3	37.9	31.5	43.1	27.6	8.4	45.7	43.7	47.5	56.7	46.3	130.5	22.7	21.5	44.8	47.9	60.2	35.3	55.2	57.5	37.2	34.1	24.7	45.0	20.4	48.5	41.7	52.3	15.2	30.0	43.0	67.1	61.2	60.9	83.3	29.8	51.8	44.4	32.8	60.0	29.2	40.2	22.6	35.8	48.2	37.4	36.1	82.7	47.2	43.7	79.1	34.3	12.5	52.6	28.7	46.1	124.8	48.3	76.8	87.5	87.2	57.1	23.2	43.9	59.8
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229779-55259017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol		No	No		19000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA043989: AB_10987309, HPA063681: AB_2685087"	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	21.8	36.8	31.6	52.7	35.4	96.4	20.3	8.0	35.7	22.0	19.4	28.3	38.1	25.7	5.1	35.2	26.6	23.8	28.3	41.7	12.8	23.8	25.5	28.3	82.4	15.0	13.2	21.1	20.3	22.6	29.7	21.2	15.6	23.5	12.2	8.8	24.1	21.4	38.7	28.5	42.4	18.4	8.3	61.5	42.6	89.7	20.6	62.2	27.3	20.2	49.3	33.4	23.4	18.1	101.2	143.4	28.7	46.1	33.5	30.8	73.1	63.1	54.7	64.8	55.2	95.4	67.9	261.0	33.7	56.6	48.2	48.2	10.3	65.9	25.1	98.2	241.8	198.5	71.8	71.0	57.5	295.9	187.6	45.4	37.4	64.5	43.4	34.7	42.2	178.7	105.5	112.1	42.5	64.5	218.1	105.5	39.3	82.2	116.5	131.8	56.4	216.0	45.9	126.6	81.8	45.5	58.7	69.7	62.2	24.6	38.3	219.7	55.3	101.3	49.7	39.4	96.4	55.4	108.7	184.1	92.4	240.5	79.1	0.0	2.8	6.5	11.7	3.9	6.6	3.3	4.8	9.3	4.0	2.7	4.9	7.5	3.1	7.8	3.4	28.6	3.6	6.8	31.6	35.4	8.0	35.7	41.7	12.8	15.0	13.2	15.6	8.3	20.6	18.1	14.7	12.8	19.8	11.1	27.2	2.8	8.9	1.0	11.4	16.3	14.2	10.4	2.6	18.6	6.2	18.4	10.4	11.1	66.2	21.7	0.0	21.2	237.3	36.3	13.6	15.8	15.1	41.4	14.4	28.7	9.3	9.7	50.4	19.7	7.6	19.7	16.1	22.3	32.4	30.3	10.6	15.7	2.0	31.2	4.8	55.3	18.6	34.0	0.0	9.4	21.9	14.7	51.5	6.0	11.3	47.3	18.8	19.5	27.0	22.1	34.2	12.3	12.6	15.3	19.7	12.5	10.7	38.5	41.0	13.9	3.4	11.4	39.6	31.3	14.2	50.7
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	21.9	35.6	23.5	20.9	27.3	21.4	23.2	24.3	32.2	23.7	19.2	28.5	24.5	25.4	11.5	28.3	23.8	18.0	36.7	25.4	19.7	29.6	72.4	25.2	27.3	26.9	22.2	24.8	29.0	21.4	41.0	14.8	21.8	31.4	11.8	12.6	27.9	17.1	65.8	27.6	28.7	14.0	18.2	32.4	30.1	62.7	26.0	25.8	30.8	31.7	16.5	23.9	22.3	25.8	30.9	17.8	27.3	34.8	19.7	21.0	24.4	30.1	31.9	31.5	31.7	15.0	18.7	36.9	14.5	30.0	17.4	24.6	16.9	22.4	11.8	19.3	30.9	19.8	37.7	37.7	25.6	46.9	52.1	31.2	23.8	19.0	10.1	24.8	27.8	30.8	20.5	31.5	23.2	50.0	32.3	33.9	11.3	19.5	21.9	44.8	20.9	24.3	23.1	36.1	17.0	23.1	31.0	47.6	25.0	10.1	17.2	35.2	32.5	29.3	26.4	24.6	20.3	33.6	8.7	32.7	30.6	22.6	41.2	4.0	8.6	5.8	9.0	9.4	10.4	7.9	6.2	9.6	8.8	8.4	5.9	7.9	13.7	5.9	6.8	11.0	13.3	8.5	23.5	27.3	24.3	32.2	25.4	19.7	26.9	22.2	21.8	18.2	26.0	25.8	28.5	22.4	20.6	79.0	32.0	8.8	14.4	12.9	22.8	43.7	25.5	21.8	19.2	37.1	17.1	27.6	56.3	17.3	39.9	39.8	31.3	19.3	84.0	30.8	39.0	18.1	26.9	19.8	83.0	32.5	11.8	15.3	35.2	34.8	31.8	23.9	18.9	65.1	16.0	65.6	80.8	23.0	16.2	25.3	8.8	48.6	19.6	23.4	10.6	61.8	32.1	25.0	50.4	52.8	59.9	33.3	29.0	19.9	42.0	19.4	27.0	23.6	17.9	43.2	26.3	16.9	18.7	78.5	47.1	17.9	8.5	28.5	28.4	17.8	25.2	17.5
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		6600	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030"	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	28.7	28.0	20.4	31.1	26.7	53.0	31.1	35.0	23.1	27.2	29.4	33.4	27.3	30.9	23.3	32.6	26.2	30.7	32.9	20.0	21.9	29.2	31.9	28.1	37.0	24.2	23.4	38.4	22.7	42.9	24.1	34.7	24.8	32.4	33.5	33.8	28.3	26.1	48.8	29.9	31.0	34.5	21.8	32.9	30.0	36.9	23.1	44.4	43.9	49.0	36.6	32.7	26.4	34.6	72.8	83.6	85.0	59.6	44.5	44.9	66.3	62.0	59.7	70.7	64.2	148.3	71.3	83.4	59.4	58.1	74.3	66.6	94.6	70.2	92.3	81.4	40.6	96.1	83.0	49.8	42.6	92.3	82.5	44.8	46.1	72.6	78.0	39.6	65.3	65.4	83.1	59.7	51.1	96.5	92.8	70.8	42.9	142.1	49.5	86.1	116.0	80.9	46.9	103.8	47.8	57.4	88.5	68.8	128.7	70.4	102.4	48.5	65.3	69.1	65.0	74.4	53.4	47.1	71.2	107.0	50.1	40.1	75.1	14.5	9.9	13.2	11.8	13.3	11.4	11.3	12.6	11.7	6.4	12.8	13.7	12.8	14.1	10.1	15.8	13.2	13.2	6.8	20.4	26.7	35.0	23.1	20.0	21.9	24.2	23.4	24.8	21.8	23.1	34.6	41.5	44.8	37.6	134.8	39.6	33.1	25.4	17.6	25.6	49.8	32.1	24.9	42.3	25.8	33.1	27.6	56.3	19.4	36.6	40.9	15.6	15.4	65.8	33.3	33.1	31.0	30.5	35.6	133.3	16.7	17.0	29.8	36.7	43.1	27.8	31.6	29.6	25.3	17.5	26.9	155.0	29.6	16.2	24.9	27.6	24.8	31.1	29.4	21.4	163.9	22.1	28.6	17.5	186.0	213.6	23.9	36.2	31.6	35.9	37.9	29.4	16.1	25.9	50.2	19.7	29.0	30.2	33.8	31.0	29.2	35.5	32.8	38.6	28.6	26.5	42.2
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"PPARG related coactivator 1"	Q5VV67	10	102132994-102150333	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA038511: AB_10672521, HPA057571: AB_2683472"	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	31.0	19.2	10.3	13.1	10.9	19.0	19.3	9.8	10.7	20.3	12.0	23.2	8.1	21.8	8.1	25.2	21.7	11.9	19.2	10.2	12.0	21.2	19.4	26.3	13.7	11.7	11.4	25.0	24.9	9.4	17.9	13.4	11.2	19.2	8.2	5.1	16.3	8.0	28.8	29.2	16.1	14.2	10.3	19.8	20.4	14.2	11.2	11.0	16.0	12.1	13.7	21.0	20.2	11.5	30.7	44.3	27.0	54.5	23.6	24.2	34.7	26.7	35.9	37.9	31.2	51.1	34.1	66.4	21.8	40.5	23.8	56.7	55.4	52.8	32.6	27.5	43.4	63.5	33.9	48.7	31.4	50.6	26.3	31.9	46.9	44.3	82.8	24.9	23.9	26.5	48.0	38.4	29.9	52.4	40.5	70.0	46.6	29.0	26.7	55.9	38.6	28.2	32.7	30.1	18.6	26.9	23.3	25.2	32.7	25.9	40.8	26.4	26.1	30.1	38.0	30.9	61.2	31.8	24.3	59.6	33.8	61.7	15.4	0.0	1.2	0.1	1.8	1.3	2.3	1.5	1.4	2.3	2.6	1.8	1.7	2.1	0.0	4.1	1.3	1.0	0.9	1.3	10.3	10.9	9.8	10.7	10.2	12.0	11.7	11.4	11.2	10.3	11.2	11.5	16.4	28.9	13.2	6.5	13.4	44.4	33.1	6.1	48.9	4.7	17.5	12.4	9.1	8.6	9.5	5.5	4.2	7.6	9.2	7.9	1.9	8.0	1.1	16.3	16.1	15.6	8.4	10.7	6.8	9.6	12.9	13.7	32.1	31.3	10.8	9.5	6.8	7.2	8.7	1.7	6.2	11.2	6.1	5.3	15.9	2.4	6.2	9.7	8.8	2.8	3.9	2.2	9.2	5.5	5.3	14.0	5.8	6.4	21.4	26.0	2.8	2.4	3.8	4.1	6.6	35.6	18.2	6.3	14.8	36.0	43.5	5.1	10.8	7.8	11.4	30.0
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	15.0	12.1	12.3	18.2	14.6	27.6	17.2	16.5	16.4	17.3	13.4	14.7	13.4	19.0	17.8	13.5	16.1	15.7	13.5	12.4	13.2	13.0	15.5	14.9	30.0	13.6	12.8	22.9	14.0	15.5	14.7	19.6	13.4	15.0	19.2	14.7	12.7	13.7	13.2	22.2	17.1	13.2	12.9	22.6	14.4	18.1	13.0	32.9	16.3	15.6	26.0	13.7	15.2	18.5	36.5	23.6	35.1	35.2	30.6	36.9	38.8	34.5	25.3	36.5	45.5	37.8	35.4	41.5	28.5	24.3	49.1	32.3	38.4	35.5	49.8	35.7	32.3	26.0	40.0	31.1	25.9	23.9	26.4	29.2	15.3	35.5	25.5	27.0	32.3	31.6	35.3	28.8	28.8	35.8	40.0	31.6	24.7	15.2	13.3	35.4	46.7	35.1	21.2	29.5	18.1	14.8	34.8	14.5	33.1	26.8	21.5	30.8	24.9	20.2	29.2	22.4	52.9	17.1	26.3	45.5	22.3	35.8	21.4	35.0	15.1	31.6	26.1	19.3	32.0	25.8	29.1	29.9	21.2	19.1	36.1	31.0	14.3	26.5	24.0	11.8	38.1	23.4	12.3	14.6	16.5	16.4	12.4	13.2	13.6	12.8	13.4	12.9	13.0	18.5	25.1	28.9	22.4	28.1	36.0	12.4	14.9	15.4	18.2	14.2	9.1	12.8	19.8	7.2	22.1	11.0	8.4	27.7	27.0	6.9	9.8	8.7	76.8	16.4	28.7	20.7	9.6	21.5	37.2	7.7	14.4	21.1	15.8	13.8	11.4	32.6	18.9	6.0	11.8	6.7	46.8	14.9	8.2	16.4	11.9	41.7	20.2	15.2	14.2	23.4	22.6	11.8	23.7	42.3	67.1	8.9	14.7	18.8	29.4	6.6	10.0	7.9	17.8	20.9	6.6	19.9	17.8	32.5	33.7	13.2	11.8	25.2	35.4	15.8	11.4	9.0
PPY	PNP	ENSG00000108849	"Pancreatic polypeptide"	P01298	17	43940804-43942476	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"pancreas: 174.4"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 40.5;Langerhans cells: 10.0;Pancreatic endocrine cells: 33.3"	"Cancer enriched"	"Detected in some"	132	"pancreatic cancer: 630.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	7	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;EFO-21: 3.2;U-2 OS: 3.9"									"CAB016735, HPA032122"	Enhanced				"Secreted to blood"	NA	NA	70300	44000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB016735: , HPA032122: AB_2674164"		"unprognostic (5.12e-3)"			"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"			"unprognostic (1.65e-2)"		"unprognostic (7.56e-3)"			"unprognostic (8.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.42e-1)"	0.1	0.3	0.0	0.2	0.0	2.1	0.0	0.0	0.1	0.0	0.0	2.5	1.1	0.3	4.2	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	174.4	6.9	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.0	0.1	0.9	0.3	0.0	0.5	1.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.7	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.5	0.0	3.9	0.4	0.5	0.0	0.3	0.9	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.1	0.0	0.0	40.5	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	10.0	2.8	0.0	0.6	1.8	0.0	0.2	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48890197-48903143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	38.8	50.6	35.5	25.6	36.9	46.0	39.3	38.1	44.2	47.9	31.1	50.0	39.2	42.5	22.7	48.6	41.0	24.2	43.0	36.7	40.2	41.7	61.0	35.6	31.1	38.8	37.3	58.4	62.8	28.1	50.5	18.2	38.6	42.2	20.4	21.5	43.2	28.3	65.0	52.0	42.2	25.3	38.4	45.2	52.1	13.8	39.0	38.6	38.6	32.3	29.0	39.2	43.2	40.0	100.6	124.3	64.5	63.2	58.2	40.8	48.8	57.3	67.1	116.8	70.7	146.3	45.0	91.8	46.2	40.0	88.1	79.9	110.6	42.6	43.5	80.8	95.2	78.1	94.6	109.5	55.9	95.5	69.8	50.7	81.4	96.8	95.5	46.5	67.0	35.9	75.7	169.0	50.1	167.5	41.5	94.3	60.3	69.3	139.6	66.7	63.0	209.4	75.5	66.2	95.7	49.4	75.3	82.6	66.5	48.0	103.5	68.9	58.6	51.1	92.2	65.6	77.4	99.9	106.5	69.5	29.0	88.0	53.8	41.8	81.9	53.1	56.4	79.1	74.7	83.9	78.2	56.2	96.9	70.4	81.5	74.9	23.4	76.1	73.0	86.9	114.3	84.5	35.5	36.9	38.1	44.2	36.7	40.2	38.8	37.3	38.6	38.4	39.0	40.0	37.0	41.7	65.9	6.2	65.4	111.8	86.1	99.5	85.4	36.7	76.9	97.2	39.0	54.3	68.6	31.3	12.5	58.5	53.4	85.1	49.0	59.9	6.2	37.5	38.6	54.5	70.1	38.7	4.4	95.8	56.1	53.9	39.8	54.3	70.5	36.6	43.5	45.0	70.2	18.5	3.9	68.2	77.3	72.2	113.5	4.9	69.9	56.2	88.9	3.7	96.6	47.4	55.6	3.5	4.8	73.7	123.6	43.6	105.9	54.2	151.1	108.5	51.6	27.7	39.5	64.4	69.8	2.7	17.7	69.5	117.3	54.6	62.9	67.0	67.9	69.3
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"intestine: 206.4;prostate: 109.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"PC-3: 379.0"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.2	0.3	4.4	0.1	106.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	109.0	206.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	12.4	12.8	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	379.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.1	0.0	0.0	0.7	0.0	0.0	0.4	908.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.7	0.0	0.0	101.9	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	624.3	63.1
PRADC1	"C2orf7, hPAP21, MGC13004, PAP21"	ENSG00000135617	"Protease associated domain containing 1"	Q9BSG0	2	73228010-73233239	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 126.6"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051066	Approved				"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA051066: AB_2681333"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.23e-2)"	22.8	35.9	46.0	9.8	48.1	8.7	19.3	48.6	50.6	15.1	54.1	29.0	25.2	12.6	16.3	25.8	11.3	9.8	101.4	45.8	46.9	27.0	71.5	12.7	9.2	47.6	47.3	11.0	41.6	21.2	23.1	8.2	47.4	19.3	21.4	15.5	29.1	14.7	126.6	20.6	22.1	14.8	46.7	23.6	27.1	31.3	49.0	11.0	17.9	107.1	9.9	23.1	16.3	46.4	21.7	16.6	16.2	31.3	49.3	19.2	22.6	37.8	15.1	32.5	18.7	46.6	20.6	23.3	20.2	38.0	29.3	19.5	25.8	22.7	23.0	36.2	28.2	36.7	21.4	35.2	15.3	20.3	33.7	25.0	13.5	29.2	15.4	9.4	30.5	39.0	32.4	46.1	37.8	41.9	51.7	34.0	5.2	93.7	74.2	31.0	68.6	71.8	18.6	19.0	34.5	12.3	18.1	42.5	15.7	17.3	22.5	15.7	18.9	37.6	16.6	32.9	31.8	52.2	43.9	22.3	24.0	39.6	15.7	15.6	35.0	35.4	24.8	84.3	20.1	17.5	23.8	23.6	36.3	21.8	22.3	19.5	5.0	39.2	105.3	73.3	31.1	48.2	46.0	48.1	48.6	50.6	45.8	46.9	47.6	47.3	47.4	46.7	49.0	46.4	21.7	9.6	4.6	10.1	11.0	15.6	11.3	34.5	4.6	15.2	23.3	23.9	62.6	15.7	20.0	14.7	8.4	25.7	25.4	44.7	72.4	23.3	57.3	12.1	9.3	17.7	32.3	4.2	6.9	46.9	47.2	20.4	13.7	6.0	28.6	4.8	30.7	63.0	49.1	11.8	6.9	47.7	44.7	25.5	14.0	144.3	16.8	19.3	16.0	1.9	7.2	31.4	21.6	6.0	7.0	23.2	31.2	16.1	29.2	10.7	101.4	65.2	15.8	28.3	32.9	19.1	19.1	61.5	21.1	30.1	24.0	13.5	9.7	27.2	50.2	15.4
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071161-49074002	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 163.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	26.5	38.7	66.9	15.6	67.3	8.2	23.2	67.2	82.5	43.2	63.8	32.3	6.1	51.5	163.4	11.7	36.0	14.8	32.0	66.7	72.1	26.3	11.5	29.7	12.8	69.4	73.8	37.7	10.5	29.2	74.5	11.4	73.9	26.4	11.1	21.6	13.9	35.8	12.1	14.7	17.8	43.6	66.1	21.7	21.9	28.2	71.1	21.5	27.7	9.0	14.9	33.1	26.0	69.8	17.0	35.0	40.0	51.5	140.4	84.7	5.0	59.1	61.9	39.7	43.2	2.0	5.3	1.7	14.0	129.3	32.6	15.5	1.6	32.3	43.6	31.3	45.4	13.4	43.0	1.8	143.2	8.8	25.0	108.3	27.0	75.0	54.0	80.9	61.6	41.3	2.1	4.6	69.5	31.4	56.6	10.6	22.5	8.3	2.3	30.8	21.9	3.8	60.0	5.0	26.6	66.3	49.5	25.5	35.2	35.1	25.0	6.2	37.8	30.1	39.6	65.6	17.5	71.7	19.8	13.4	72.7	15.3	48.1	47.0	13.0	18.5	38.6	15.0	43.2	32.0	41.6	33.9	14.9	30.2	36.7	40.1	34.1	39.0	11.2	5.9	68.4	26.0	66.9	67.3	67.2	82.5	66.7	72.1	69.4	73.8	73.9	66.1	71.1	69.8	21.5	12.8	10.0	7.5	8.7	7.6	14.9	34.8	11.4	23.1	8.0	10.7	5.8	11.5	16.3	11.0	12.5	3.3	13.2	2.2	11.7	16.7	3.4	6.8	31.6	30.9	10.2	5.2	5.8	5.7	13.4	29.9	4.1	9.2	15.9	13.4	33.5	3.6	6.1	16.8	7.0	4.7	40.7	5.7	11.3	6.0	38.2	6.6	14.2	5.6	5.6	29.2	16.5	3.5	9.9	4.1	0.8	41.3	10.5	10.1	1.5	18.5	17.7	8.6	19.7	13.2	33.4	14.7	4.5	5.0	7.4	9.7	17.5	36.3	1.5	9.3
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386439	"Enzymes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.9;Breast glandular cells: 14.1;Breast myoepithelial cells: 11.0;Hofbauer cells: 18.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 35.0"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 50.2;NTERA-2: 32.1;SuSa: 32.1"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	8.7	1.0	9.2	5.2	12.0	0.6	9.4	35.0	5.8	2.8	0.0	5.3	11.3	1.7	0.2	5.5	5.6	2.3	6.1	5.3	1.4	3.7	2.7	5.2	8.1	1.2	3.0	3.8	3.3	2.2	1.5	5.7	1.8	2.5	4.1	0.2	5.0	1.5	7.4	7.5	11.6	1.4	0.1	8.4	4.8	2.2	4.6	3.0	23.2	3.4	6.1	2.3	2.8	1.8	6.2	50.2	5.6	0.7	0.0	0.3	14.1	12.8	2.7	4.9	2.0	25.0	14.4	10.2	8.6	6.1	13.5	21.9	1.0	15.3	1.0	0.5	1.6	0.0	6.2	14.2	5.3	1.5	15.4	1.2	9.8	0.8	2.2	2.9	10.2	1.5	0.0	0.1	3.8	8.5	1.4	4.8	32.1	19.5	12.9	6.6	6.0	2.5	7.2	17.5	2.8	1.9	4.9	13.9	5.0	32.1	10.8	6.3	13.7	0.5	12.9	0.0	3.2	0.8	1.1	13.9	3.1	3.4	7.4	0.0	0.2	0.9	0.4	0.0	0.3	1.2	0.6	0.2	0.3	0.9	1.6	1.3	0.0	0.5	0.8	1.9	0.0	0.2	9.2	12.0	35.0	5.8	5.3	1.4	1.2	3.0	1.8	0.1	4.6	1.8	45.9	9.6	6.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	14.1	11.0	0.0	0.0	0.0	0.0	0.0	7.5	5.3	0.0	0.0	9.0	0.0	3.0	1.4	5.6	0.0	0.0	0.0	3.1	7.2	2.5	0.0	1.7	2.5	1.7	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.9	0.0	0.0	2.7	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.8	2.3	7.4	0.0	0.0
PRAM1	PML-RAR	ENSG00000133246	"PML-RARA regulated adaptor molecule 1"	Q96QH2	19	8490056-8502640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 97.0"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045236, HPA050161"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"		"HPA045236: AB_2679267, HPA050161: AB_2681036"	"unprognostic (1.68e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.12e-3)"	1.8	1.4	2.8	10.9	3.5	97.0	1.2	3.5	3.9	2.2	1.3	0.9	2.7	1.4	0.2	0.8	2.0	2.0	0.8	2.7	7.2	1.0	2.6	9.8	1.3	11.1	5.8	1.4	1.2	0.3	1.6	1.0	7.4	3.3	0.5	0.8	1.4	0.4	0.6	1.5	2.9	2.2	4.8	12.8	1.1	1.0	7.0	1.0	1.7	0.3	0.4	1.2	1.2	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	23.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.1	19.4	0.2	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.4	0.3	0.0	0.1	0.1	0.1	0.7	0.8	0.3	0.0	127.6	0.0	2.8	95.4	3.3	0.2	101.3	0.3	0.1	0.1	0.2	58.6	0.0	0.0	0.4	54.0	11.5	121.4	3.0	0.1	41.9	2.8	3.5	3.5	3.9	2.7	7.2	11.1	5.8	7.4	4.8	7.0	6.3	0.3	6.4	5.0	1.3	0.9	0.4	1.1	0.3	0.0	3.2	0.4	1.0	0.8	4.3	3.2	0.0	0.0	0.3	3.1	0.1	0.0	0.0	0.0	0.3	0.4	1.3	0.0	3.8	0.9	0.0	0.4	0.5	0.0	0.3	2.5	0.6	2.9	0.2	30.0	1.7	1.1	0.2	2.0	71.5	2.0	0.4	0.6	49.0	0.0	12.2	70.1	0.4	3.1	0.0	1.6	0.0	0.0	1.5	0.3	0.3	0.0	0.2	0.2	1.3	0.0	0.5	0.2	0.2	1.8	0.4	0.1	0.3	1.9	1.1	0.0	0.8
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.2	3.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.2	0.0	3.4	10.0	0.0	0.5	0.0	0.3	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	4.7	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.1	105.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRAMEF12		ENSG00000116726	"PRAME family member 12"	O95522	1	12773738-12777906	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045286, HPA051704"	Uncertain		Uncertain	Nucleoplasm		NA	NA							Nucleoplasm		"HPA045286: AB_10794782, HPA051704: AB_2681581"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF18		ENSG00000279804	"PRAME family member 18"	Q5VWM3	1	13222705-13226106	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057423	Uncertain					NA	NA									"HPA057423: AB_2683435"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF19		ENSG00000204480	"PRAME family member 19"	Q5SWL8	1	13369067-13371900	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057423	Uncertain					NA	NA									"HPA057423: AB_2683435"															"unprognostic (2.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF7		ENSG00000204510	"PRAME family member 7"	Q5VXH5	1	12916610-12920482	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain					NA	NA									"HPA049887: AB_2680935, HPA051704: AB_2681581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF8		ENSG00000182330	"PRAME family member 8"	Q5VWM4	1	13281035-13285174	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain					NA	NA									"HPA049887: AB_2680935, HPA051704: AB_2681581"															"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1135.4;liver: 675.2"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	6.5	74.6	1053.8	0.8	0.1	0.4	0.7	2.6	0.3	0.6	0.4	145.4	675.2	0.2	1.5	1.2	0.7	0.4	0.1	0.1	0.8	0.1	1.1	0.3	35.7	0.0	1.7	0.3	0.2	1.3	1135.4	1.7	0.4	0.8	2.7	12.2	0.6	0.3	0.2	0.3	0.1	0.3	0.2	0.8	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.7	1.1	0.4	0.6	0.8	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82822936-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 348.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		42000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	74.8	87.3	81.1	57.8	82.1	37.7	70.0	84.3	109.1	91.9	95.0	49.3	28.6	62.9	81.4	62.1	57.0	64.3	70.0	76.6	85.6	144.7	151.9	58.1	92.1	84.4	82.1	53.5	37.9	78.4	34.5	152.8	80.9	52.5	46.6	21.9	85.6	55.5	15.9	54.1	31.8	80.8	89.0	54.0	32.0	41.8	86.0	33.7	63.7	28.5	85.0	100.2	57.5	86.7	34.9	41.8	49.6	121.0	463.5	146.7	67.1	67.5	131.9	70.9	97.0	103.5	70.7	55.9	100.7	117.9	72.6	53.2	53.7	45.2	72.0	43.9	38.3	37.7	56.5	76.7	86.2	31.0	124.7	122.0	39.3	72.7	68.6	166.5	224.0	26.3	39.1	69.8	72.7	19.5	4.9	171.7	33.9	90.3	31.1	27.1	97.0	65.1	118.0	71.2	24.0	51.9	101.9	60.2	41.5	80.6	66.6	49.6	65.0	78.8	77.4	71.1	33.5	64.2	113.6	46.3	32.9	41.7	44.5	53.5	76.9	50.9	13.7	79.0	16.1	31.7	14.0	15.9	140.2	34.2	12.0	17.4	89.0	34.7	64.8	27.9	14.8	49.6	81.1	82.1	84.3	109.1	76.6	85.6	84.4	82.1	80.9	89.0	86.0	86.7	86.9	19.2	12.9	58.8	45.5	31.4	41.5	53.4	25.0	11.7	26.2	25.1	26.6	37.1	25.2	62.5	2.1	65.1	29.0	9.8	29.4	32.9	44.9	17.4	37.7	180.4	19.7	13.7	42.2	12.0	120.1	73.6	23.9	29.9	12.7	18.2	348.7	65.4	80.7	16.8	38.5	19.1	14.2	152.9	118.9	47.6	44.1	88.0	71.2	33.7	79.5	53.5	28.8	34.7	10.5	8.2	10.2	46.3	62.2	23.3	3.9	83.8	9.1	5.3	65.7	25.5	25.6	60.8	6.3	54.3	34.9	52.9	22.3	27.7	20.9	39.2
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	105993463-106109939	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.5;T-cells: 34.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 3.6"	"Low region specificity"	"Detected in many"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	6.6	2.1	1.6	20.0	1.6	20.3	6.8	5.5	1.8	15.7	3.1	15.2	9.2	17.2	1.3	55.2	5.5	12.7	1.7	1.5	2.8	2.5	4.5	10.1	15.9	3.2	1.8	4.9	1.9	2.5	1.4	5.1	2.7	3.4	17.2	1.3	9.3	2.4	4.3	9.1	12.6	5.5	2.4	13.6	15.2	1.2	2.9	4.2	9.0	2.2	27.8	19.6	20.2	3.4	1.4	0.5	1.1	0.0	1.6	2.1	0.2	7.2	23.3	2.3	3.7	1.4	9.2	2.0	0.4	13.8	0.3	0.5	0.0	3.6	2.5	21.7	0.1	0.4	4.9	0.0	3.6	0.8	1.6	2.3	11.6	3.3	9.7	0.7	2.9	1.0	1.4	212.1	0.4	0.0	0.1	0.5	0.8	1.4	0.0	0.5	0.0	42.4	2.1	0.3	0.0	0.3	1.0	0.9	0.0	1.6	1.0	2.4	1.5	3.1	1.8	2.1	7.2	81.5	57.0	4.9	5.1	1.3	2.1	2.4	0.8	11.1	22.1	1.2	34.0	2.5	20.5	20.2	0.5	1.0	1.8	11.3	12.5	4.7	0.3	0.4	29.4	2.6	1.6	1.6	5.5	1.8	1.5	2.8	3.2	1.8	2.7	2.4	2.9	3.4	93.1	0.0	5.1	0.3	42.1	19.5	8.6	15.0	3.4	0.6	2.8	3.4	1.5	0.0	19.1	3.7	52.1	0.7	199.8	129.8	0.0	0.3	0.9	15.9	101.0	41.1	1.8	6.1	1.8	0.2	0.7	18.5	19.4	62.6	3.8	9.9	6.4	2.5	19.8	0.0	19.2	15.0	10.2	38.0	199.2	0.3	0.0	64.5	37.4	23.4	30.4	0.5	89.6	0.5	0.1	7.8	103.7	1.2	786.9	4.0	3.2	0.3	13.0	1.1	0.0	5.3	30.1	0.5	2.3	43.9	41.5	0.7	184.3	1.6	8.7	91.9
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRDM11	PFM8	ENSG00000019485	"PR/SET domain 11"	Q9NQV5	11	45095806-45235110	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 60.0;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057072	Approved					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA057072: AB_2683328"	"unprognostic (3.32e-4)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.10e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.57e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.93e-6)"	"unprognostic (9.25e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	5.5	4.3	8.8	2.6	8.2	2.5	4.5	7.1	10.6	11.0	5.1	11.2	2.1	13.0	3.0	6.6	10.1	3.3	10.8	8.2	8.2	5.3	2.6	5.5	2.5	6.8	7.6	10.3	5.2	2.8	8.6	4.1	6.6	8.9	2.3	2.5	4.2	7.8	6.8	3.8	5.5	9.2	5.7	5.4	6.5	1.9	8.5	2.4	9.0	8.2	2.6	8.7	9.0	7.7	4.6	12.7	3.1	1.6	5.1	4.3	0.7	2.3	5.1	7.7	5.0	11.7	1.7	5.1	5.2	3.3	9.9	5.5	6.2	2.8	2.5	1.6	4.8	3.8	18.3	2.2	8.1	4.5	4.9	5.5	10.2	0.4	8.1	5.4	7.7	0.9	1.7	0.0	3.8	2.3	0.0	6.0	3.7	4.1	8.3	5.8	11.6	0.1	4.2	4.2	4.0	4.9	5.3	0.8	5.8	1.9	19.3	2.4	4.1	16.5	7.8	4.0	5.2	3.9	4.7	4.7	0.7	1.0	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	8.8	8.2	7.1	10.6	8.2	8.2	6.8	7.6	6.6	5.7	8.5	7.7	3.1	6.4	6.2	11.4	2.9	2.2	5.4	0.9	2.8	5.7	3.1	3.7	8.2	0.0	6.0	5.5	2.1	0.8	2.8	1.1	0.0	1.4	1.3	4.8	4.3	4.3	0.0	2.1	11.4	1.1	0.3	4.4	3.6	2.7	0.0	3.2	6.8	1.4	0.8	10.1	10.3	1.9	2.0	0.8	0.3	7.8	5.3	1.3	0.0	60.0	1.6	3.6	1.0	9.5	8.2	0.5	0.6	7.2	0.6	3.5	0.5	1.4	3.0	1.6	19.7	6.5	5.5	0.4	0.7	1.8	0.9	0.3	2.9	3.9	2.9	2.4
PRDM12	PFM9	ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682986	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Excitatory neurons: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"RH-30: 19.1"	"Region enriched"	"Detected in some"	7	"basal ganglia: 10.9"	"Group enriched"	"Detected in some"	26	"basal ganglia: 3.8;hypothalamus: 1.3"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.0	19.1	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.2	0.4	0.2	1.9	0.2	0.2	0.2	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
PRDM13	PFM10	ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606774-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Bipolar cells: 4.8;Horizontal cells: 1.7;Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HMC-1: 1.1;JURKAT: 2.7;RPMI-8226: 2.0;SCLC-21H: 2.3;U-266/70: 2.7;U-266/84: 1.4;WM-115: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain					NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA070592: AB_2686283"		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	1.1	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"NTERA-2: 49.4;SuSa: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.6	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.6	0.4	0.1	0.0	0.3	0.1	0.3	0.0	0.2	0.8	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.5;Plasma cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Daudi: 31.1;U-266/70: 32.2;U-698: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	2.0	1.8	1.8	4.5	1.7	1.7	2.1	1.3	1.9	2.2	1.2	2.3	2.8	2.2	1.6	2.5	2.4	1.4	1.7	1.7	1.4	1.5	2.1	1.9	8.3	1.4	1.4	2.4	2.3	1.8	2.1	1.2	1.4	2.4	1.8	1.6	2.3	1.5	4.5	3.9	2.9	1.4	1.0	3.7	2.2	2.0	1.3	3.2	2.2	1.7	7.4	1.9	2.2	1.6	2.8	6.0	4.4	5.8	1.9	2.4	4.4	2.2	1.8	2.2	1.6	4.1	3.0	31.1	2.5	2.7	2.1	4.1	3.9	2.9	2.1	3.3	5.5	6.5	15.1	5.0	1.3	5.6	3.9	1.1	3.9	2.7	1.8	2.4	3.3	3.4	5.6	2.0	3.0	6.4	5.5	3.7	5.1	3.1	3.1	8.5	3.5	2.5	2.3	4.8	7.5	4.3	10.1	5.1	1.5	1.7	3.8	2.7	3.3	3.8	2.1	2.9	4.3	32.2	3.5	76.0	3.6	6.5	5.3	0.0	0.4	0.5	0.2	0.8	0.2	0.6	0.1	0.3	0.4	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.2	0.4	1.8	1.7	1.3	1.9	1.7	1.4	1.4	1.4	1.4	1.0	1.3	1.6	2.4	3.2	12.5	6.2	5.1	2.9	1.8	1.6	2.2	3.4	2.8	2.4	4.4	1.5	7.8	1.8	6.2	1.4	2.0	2.3	0.0	1.3	2.2	2.6	2.5	2.5	0.0	2.5	9.0	2.6	0.9	2.6	3.1	2.0	3.8	3.3	1.1	2.2	1.9	3.3	6.4	1.3	2.0	2.8	2.2	4.3	1.2	3.3	1.8	6.5	2.9	1.1	4.1	3.5	8.0	1.7	0.8	0.4	15.9	2.3	1.1	0.8	5.3	3.1	0.0	3.1	2.3	2.3	2.9	3.2	3.4	0.7	2.7	1.3	2.2	1.8
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	21.7	15.2	19.4	19.3	21.2	79.4	21.9	27.5	38.7	27.8	7.6	27.1	13.0	24.2	16.4	21.9	20.9	17.0	19.9	21.5	18.2	14.2	13.1	21.4	27.3	18.5	16.6	34.3	14.9	14.7	16.3	16.7	18.7	24.3	13.8	18.1	21.2	17.6	43.8	27.2	23.6	15.0	12.9	20.2	19.2	18.7	16.9	22.6	24.3	30.0	25.0	27.0	26.8	34.7	15.3	8.5	30.3	11.8	23.5	18.0	14.6	19.5	11.8	13.0	14.5	13.5	16.9	46.4	16.7	18.9	11.0	18.5	22.8	11.4	14.4	28.9	16.3	31.2	10.6	6.4	12.9	10.5	25.8	19.1	19.7	13.8	11.4	12.4	13.0	18.0	28.2	52.0	16.5	7.7	16.9	16.6	9.0	12.1	11.4	23.3	16.4	13.9	7.4	17.0	26.3	17.0	15.7	9.8	21.4	18.0	13.9	16.8	23.2	16.7	18.1	15.3	10.9	75.8	55.4	65.5	14.8	24.1	21.9	4.7	4.9	7.5	5.5	3.2	3.5	18.5	4.4	5.2	3.0	13.4	4.9	4.4	9.9	6.2	6.0	5.6	4.4	2.8	19.4	21.2	27.5	38.7	21.5	18.2	18.5	16.6	18.7	12.9	16.9	34.7	41.3	38.5	39.7	34.3	182.9	62.1	54.8	17.1	61.5	49.5	43.8	33.8	41.3	27.1	33.0	23.9	45.9	25.6	77.7	26.9	17.6	17.3	21.7	84.5	62.5	35.1	37.8	21.7	114.5	13.8	16.2	47.6	25.5	121.2	40.5	50.0	26.0	18.8	16.6	70.7	97.0	24.1	14.2	45.6	39.9	15.6	44.1	42.1	30.2	75.9	41.5	21.2	59.8	70.4	122.5	15.5	25.7	45.1	71.7	54.5	34.2	9.0	43.8	39.7	26.3	86.3	34.4	52.7	49.4	65.4	52.1	18.3	74.4	25.8	19.6	64.5
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732871-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	12.8	8.6	12.8	11.9	13.3	16.9	11.7	14.5	13.5	12.0	13.1	15.0	13.2	15.2	13.4	15.6	11.8	11.2	8.9	12.3	12.8	21.0	7.0	12.9	12.4	13.2	12.8	15.0	10.2	44.5	8.1	12.5	13.5	11.5	16.4	20.9	11.5	12.1	12.5	12.3	13.8	13.9	11.1	12.3	12.7	11.6	14.7	11.4	12.6	12.8	14.0	11.5	13.2	14.3	19.2	20.9	22.4	23.4	23.7	24.3	17.1	25.6	33.2	25.4	19.2	14.7	8.1	24.6	10.6	27.2	23.7	13.4	23.5	18.7	27.4	18.1	24.1	19.5	15.5	15.8	30.5	28.1	19.3	29.8	35.3	28.7	49.1	27.6	33.5	22.7	24.0	29.0	30.6	20.1	15.9	24.9	11.7	12.4	28.2	12.8	22.4	24.2	26.2	29.0	27.6	25.8	19.3	13.5	23.5	15.2	16.5	14.1	34.1	19.4	14.0	26.1	21.7	20.3	21.5	17.2	14.2	13.1	14.7	1.1	0.8	1.4	1.9	3.0	1.3	2.6	1.0	1.7	2.3	2.1	1.6	2.0	0.3	1.2	4.2	1.2	2.2	0.8	12.8	13.3	14.5	13.5	12.3	12.8	13.2	12.8	13.5	11.1	14.7	14.3	10.6	9.6	6.4	4.9	38.3	14.5	9.0	4.2	8.0	13.6	7.6	6.7	7.3	4.3	6.3	12.9	14.6	6.3	9.8	13.3	9.8	14.8	23.4	12.3	19.8	11.2	12.6	6.9	12.0	11.4	7.5	9.7	10.2	21.8	3.8	11.0	11.0	4.6	11.4	33.7	12.2	10.3	2.0	10.3	7.2	28.4	6.2	9.0	8.8	15.0	12.1	7.5	12.3	9.5	12.9	16.6	8.1	4.9	8.2	12.4	14.6	9.7	7.2	11.7	6.6	12.4	10.6	6.3	12.5	12.5	16.9	4.8	11.1	6.4	12.0	10.2
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089241-123194266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.9;urinary bladder: 9.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Endometrial stromal cells: 6.5;Excitatory neurons: 7.9;Fibroblasts: 10.7;Late spermatids: 7.1;Oligodendrocytes: 11.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;HEK 293: 5.2;HEL: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	0.7	0.1	0.2	0.3	0.2	0.0	0.6	0.2	0.3	0.9	0.6	4.9	0.2	0.7	0.1	0.6	0.4	3.3	0.5	0.1	0.2	0.3	0.1	2.9	0.0	0.3	0.4	1.9	0.3	0.1	0.3	4.2	0.4	1.3	1.0	0.2	0.1	0.1	0.1	0.2	0.6	0.7	0.3	0.0	0.6	0.3	0.2	0.0	0.8	0.2	0.2	9.0	0.6	0.3	0.0	0.0	0.0	0.3	0.3	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.1	5.2	1.1	0.5	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.4	0.4	0.3	0.2	0.3	0.5	0.0	0.0	15.0	0.0	1.9	0.1	0.0	0.0	1.0	0.6	0.3	1.4	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.1	3.3	0.6	6.5	0.5	0.0	0.0	7.9	0.2	0.3	10.7	0.0	0.5	0.0	2.4	0.0	0.5	0.8	0.0	6.4	0.1	0.0	0.8	3.5	7.1	2.1	0.4	3.6	4.7	0.8	0.2	0.0	3.0	11.0	0.1	0.0	1.2	0.1	0.2	0.0	0.8	0.2	1.0	0.0	0.7	2.2	2.3	4.4	0.2	1.3	0.4	0.4	6.1	0.0	0.1
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.0"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 6.3;Spermatocytes: 14.3;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"REH: 3.8;SK-MEL-30: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	14.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRDM9	"KMT8B, MSBP3, PFM6, ZNF899"	ENSG00000164256	"PR/SET domain 9"	Q9NQV7	5	23443586-23528093	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Meiosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;epididymis: 1.6;testis: 4.0"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 44.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"U-266/70: 6.9"									HPA059555	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA059555: AB_2684061"							"unprognostic (1.23e-4)"			"unprognostic (8.64e-2)"				"unprognostic (2.18e-2)"	"unprognostic (8.34e-2)"		"unprognostic (4.11e-1)"	0.0	0.0	0.4	0.0	1.6	0.9	0.0	0.4	1.0	0.0	1.2	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	1.6	1.0	0.1	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	4.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	6.9	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	1.2	0.6	0.1	0.1	0.1	0.0	0.4	1.6	0.4	1.0	0.4	1.4	1.6	1.0	2.0	0.4	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45510914-45542732	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 2690.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	277.8	362.9	642.4	290.2	667.1	86.7	454.3	700.7	747.3	314.1	627.0	326.7	501.4	255.3	459.4	945.8	306.3	297.4	542.9	613.0	700.8	785.5	841.2	340.2	371.4	712.1	706.3	255.5	122.7	214.6	210.0	353.3	711.6	256.0	327.1	347.3	348.6	307.2	571.4	296.5	402.1	329.3	713.5	265.8	355.5	143.7	671.4	262.8	802.3	477.7	603.3	393.2	375.3	766.6	1028.1	1743.7	735.2	942.9	828.4	701.9	1459.3	1134.8	1144.1	1183.0	964.3	932.3	429.2	899.1	1125.9	1237.6	1448.6	967.6	1640.2	1101.3	1193.0	696.9	1266.4	678.6	2042.8	2484.7	361.0	793.6	848.9	610.4	813.6	1201.7	283.8	657.7	1409.7	1044.0	1271.8	292.7	1225.2	829.4	1053.7	772.5	2339.8	2241.0	1867.3	1863.6	934.0	1177.7	2211.5	872.4	987.5	495.1	1035.3	2524.2	73.3	2157.3	760.6	631.1	1208.1	474.8	1071.9	1034.4	1541.5	206.1	1220.5	1678.2	791.4	537.9	278.7	469.3	325.6	111.6	155.7	367.1	205.4	253.8	246.8	209.3	293.9	221.6	150.3	166.6	12.1	123.8	407.5	195.9	438.2	416.3	642.4	667.1	700.7	747.3	613.0	700.8	712.1	706.3	711.6	713.5	671.4	766.6	530.7	522.4	259.0	48.3	330.1	607.3	1115.3	1161.1	745.0	161.3	387.0	510.9	54.9	397.5	685.2	617.9	104.3	1258.6	151.5	339.3	946.9	1015.7	19.7	662.7	281.2	437.8	174.5	304.2	15.5	442.8	1773.2	462.0	500.0	435.5	325.3	463.2	326.3	875.2	1467.4	206.9	17.1	295.0	545.3	366.9	980.7	44.2	498.6	534.8	581.7	12.2	545.7	416.4	62.8	24.1	90.5	804.4	384.9	410.7	612.8	1100.9	995.0	2690.9	919.1	402.2	309.0	279.0	982.6	84.5	329.2	1346.9	528.6	1114.9	270.9	499.4	398.8	1462.7
PRDX2	"MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA"	ENSG00000167815	"Peroxiredoxin 2"	P32119	19	12796820-12801800	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1316.7;Erythroid cells: 3153.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008713	Approved					NA	NA		800000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB008713: AB_1620974"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.58e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"prognostic favorable (5.66e-11)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.41e-1)"	199.0	622.0	350.8	88.3	366.6	686.7	159.7	408.2	461.5	167.8	365.6	208.1	251.7	178.8	144.5	271.8	153.5	133.9	704.0	369.6	400.0	287.7	310.2	109.1	118.3	407.5	380.4	218.2	201.7	454.5	314.6	87.8	408.2	175.3	141.5	207.1	200.1	124.4	722.9	260.7	201.1	127.0	357.0	118.1	226.6	32.8	399.1	181.3	156.3	847.9	129.2	163.6	171.6	355.5	420.4	1.1	553.9	721.3	79.5	54.2	408.4	189.0	188.0	253.9	143.4	438.1	102.8	122.7	430.9	185.0	30.2	389.5	354.7	309.7	72.9	528.5	561.4	222.6	537.4	665.1	212.4	0.7	1.4	233.6	140.5	191.1	93.0	327.6	238.8	255.3	485.7	187.0	98.7	763.3	500.1	190.2	409.1	289.6	789.4	485.8	0.7	593.0	343.1	450.0	683.8	538.5	449.5	454.9	153.7	100.7	408.0	318.0	105.7	188.2	156.9	526.7	417.7	226.3	242.1	573.5	178.9	75.5	43.8	35.4	170.0	85.6	436.1	129.4	460.6	375.2	589.8	446.2	211.6	288.5	594.7	460.9	22.4	213.2	148.0	124.5	697.4	686.6	350.8	366.6	408.2	461.5	369.6	400.0	407.5	380.4	408.2	357.0	399.1	355.5	192.2	22.4	36.7	39.5	117.5	221.3	255.6	877.7	187.2	317.9	271.2	322.2	37.1	265.9	347.7	279.6	100.1	692.8	83.5	367.4	1316.7	329.5	3.1	138.6	218.5	130.3	333.7	3153.4	31.8	167.2	558.8	204.3	214.6	197.7	47.0	466.0	137.8	489.7	234.0	215.4	50.8	360.7	754.8	63.8	128.8	13.0	293.9	58.7	281.1	23.4	61.4	531.2	56.7	41.7	29.1	179.6	250.6	321.2	263.4	169.3	765.6	1097.9	152.7	373.2	157.8	142.4	273.2	4.8	7.7	368.5	229.4	508.4	144.4	816.6	475.7	243.1
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167720-119178812	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1060.4;Proximal tubular cells: 937.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	165.7	335.3	92.4	96.0	92.6	82.3	138.3	101.3	116.0	103.4	139.2	133.3	137.8	87.0	120.8	83.3	116.7	88.0	278.2	95.2	104.5	385.7	571.2	74.9	108.4	97.2	97.1	74.9	96.2	223.8	60.0	126.3	99.0	126.7	139.8	52.5	132.1	131.7	376.0	38.0	132.1	130.0	100.4	76.3	97.5	48.3	98.6	98.3	176.7	402.7	104.0	112.8	65.1	102.7	350.6	392.2	234.1	267.3	241.7	259.8	145.9	244.8	414.8	364.5	380.7	303.4	339.9	407.2	208.8	290.8	173.4	155.5	391.5	296.1	408.8	401.5	411.4	183.7	149.7	542.4	252.5	347.8	212.7	306.8	186.4	292.1	269.7	261.2	268.6	245.2	230.0	82.5	338.7	140.2	265.1	292.7	218.9	264.0	229.3	276.5	339.7	281.5	623.8	164.6	103.0	149.2	259.8	346.1	332.2	201.0	179.6	411.5	190.5	118.3	178.1	170.9	323.1	128.0	200.7	327.0	185.7	507.4	107.3	144.4	429.1	246.9	110.5	369.5	142.7	179.9	145.6	134.6	382.1	149.8	149.5	134.0	239.9	132.8	333.9	214.8	205.7	510.2	92.4	92.6	101.3	116.0	95.2	104.5	97.2	97.1	99.0	100.4	98.6	102.7	61.4	48.1	74.5	14.4	65.1	69.8	117.8	274.0	81.4	27.5	145.2	105.2	236.5	131.5	119.0	147.1	10.4	328.4	50.6	84.5	1060.4	124.5	5.0	105.1	76.0	78.3	110.9	132.8	15.4	75.1	212.0	100.8	116.7	77.3	52.6	131.0	73.2	390.0	247.6	40.4	15.4	132.5	221.8	164.2	96.0	10.5	77.3	127.9	133.4	10.3	158.4	76.9	39.1	12.5	18.8	63.8	99.3	101.2	153.7	95.1	176.1	937.8	163.4	24.8	72.3	63.1	105.3	11.2	23.2	146.4	52.6	155.0	56.1	440.0	207.0	119.6
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686397	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 1212.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1007.4;Plasma cells: 810.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362, HPA067039"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	85.7	84.6	25.2	53.9	27.4	34.3	74.9	28.7	36.6	82.3	40.2	72.7	64.0	68.1	19.5	62.5	66.1	64.7	108.6	24.7	28.7	41.8	277.2	47.1	58.7	30.6	26.8	81.2	1212.0	69.2	93.8	96.2	29.6	59.9	78.8	30.2	124.9	63.2	43.7	47.8	51.3	62.9	29.7	71.9	93.5	121.4	27.5	26.5	49.5	25.4	67.1	68.9	55.7	36.8	176.4	238.2	94.5	191.1	523.9	266.6	138.0	229.6	249.2	204.9	297.5	251.4	214.3	150.0	106.1	299.0	233.6	206.5	279.8	142.6	193.8	92.5	551.5	105.8	187.8	322.1	215.9	138.4	96.9	283.6	182.6	197.7	193.5	213.8	262.0	48.4	209.7	535.4	192.8	262.3	70.3	214.5	339.8	329.5	344.9	97.2	244.3	861.2	181.0	60.5	143.8	121.7	212.6	248.6	174.9	504.1	263.1	174.4	172.7	145.1	95.1	378.4	176.1	173.8	228.6	161.5	259.9	177.0	211.9	5.9	65.6	6.9	53.8	107.8	67.4	89.9	68.1	57.1	101.6	56.0	48.4	49.7	4.8	83.8	137.8	71.3	74.6	69.8	25.2	27.4	28.7	36.6	24.7	28.7	30.6	26.8	29.6	29.7	27.5	36.8	143.8	57.7	68.2	5.5	132.8	59.8	88.6	277.2	62.0	16.7	98.8	119.0	50.7	107.2	124.0	49.7	8.4	328.7	17.9	34.0	9.8	270.4	402.0	66.5	117.4	96.2	58.7	60.6	2.4	358.8	531.6	162.1	65.2	117.6	43.1	206.7	92.1	539.5	173.4	11.8	3.3	151.6	187.2	54.2	55.1	1007.4	252.5	47.1	199.3	1.9	75.2	55.0	27.8	8.5	7.3	241.4	44.1	144.0	810.1	174.6	61.2	54.2	89.9	21.7	144.7	79.2	185.3	258.2	251.7	83.3	52.1	258.6	42.0	311.8	115.7	73.1
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318121-64321811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 2430.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		6900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	181.8	400.3	346.0	112.7	342.6	285.7	170.1	375.9	429.4	227.2	480.2	346.6	213.3	153.7	176.6	448.5	400.3	120.7	467.4	340.4	384.6	377.1	280.3	217.2	110.1	382.8	373.3	246.0	224.9	254.5	313.3	164.1	387.0	165.5	299.6	109.0	286.2	164.4	504.0	181.1	226.1	97.1	365.2	162.9	313.9	150.1	377.8	167.7	354.5	439.6	137.8	192.5	244.8	346.4	225.3	453.4	267.9	444.5	284.3	424.4	308.5	274.9	442.3	199.8	247.4	332.9	451.8	329.2	467.0	447.4	712.6	503.5	253.3	589.4	125.8	456.6	200.8	333.3	728.8	386.3	581.0	127.8	271.3	432.4	757.2	334.9	337.8	387.6	308.4	380.6	191.5	755.6	285.5	572.0	220.9	547.8	402.6	356.5	573.9	210.9	274.5	1178.8	760.1	442.9	224.7	424.9	230.8	506.8	818.8	254.3	370.5	283.3	298.3	281.8	258.6	326.7	123.1	383.1	490.8	392.4	340.7	253.7	223.6	703.9	465.4	630.7	251.0	432.9	218.3	393.5	229.0	205.1	369.8	409.0	224.5	225.9	802.3	368.5	399.0	487.9	297.1	639.6	346.0	342.6	375.9	429.4	340.4	384.6	382.8	373.3	387.0	365.2	377.8	346.4	213.7	266.0	463.4	17.6	182.1	326.5	760.2	1591.9	405.2	159.0	266.2	435.9	617.6	371.8	931.2	450.6	70.9	1122.2	185.8	846.1	1612.1	788.4	79.6	865.2	221.3	204.7	801.9	200.6	12.4	1039.2	1144.0	296.1	365.4	285.9	104.7	299.8	205.6	405.2	476.9	92.5	14.0	1041.6	1072.1	206.5	261.0	294.9	279.0	210.8	435.8	8.4	339.7	309.6	278.1	14.1	15.3	1487.3	641.3	226.8	288.9	401.3	922.4	1468.5	2430.7	150.3	197.2	176.2	433.1	150.2	333.9	482.8	257.7	978.9	165.2	713.3	1231.7	1077.1
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477330-173488815	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	340.7	157.5	169.5	68.3	181.3	100.1	211.2	197.6	210.1	112.3	164.8	189.1	46.4	108.8	206.3	127.9	149.8	71.9	261.8	184.1	196.6	184.4	482.5	116.7	72.2	181.0	198.3	115.5	114.4	217.5	67.4	70.7	187.5	152.1	221.6	53.9	85.6	99.0	563.5	106.6	59.8	160.2	175.8	70.7	135.2	119.1	176.7	70.7	106.0	382.4	79.0	99.5	109.8	185.5	420.3	127.7	204.7	230.9	778.5	372.7	169.5	843.9	284.3	342.7	241.8	243.9	276.4	272.4	256.4	694.2	120.4	239.8	272.0	259.9	279.0	234.0	243.6	179.5	200.0	277.7	425.7	191.3	56.1	301.0	262.6	181.3	256.6	210.8	339.5	106.7	405.4	52.8	392.9	86.3	131.7	249.1	456.2	219.8	760.5	154.5	236.6	277.0	518.1	95.4	94.9	173.4	285.0	334.0	199.2	296.3	283.8	262.9	228.2	132.5	149.9	201.8	229.5	76.4	123.2	220.7	159.4	162.3	124.3	36.2	42.5	24.8	29.8	39.8	32.8	32.6	29.8	38.4	53.5	24.4	39.8	47.9	25.2	25.7	36.5	79.7	36.1	58.1	169.5	181.3	197.6	210.1	184.1	196.6	181.0	198.3	187.5	175.8	176.7	185.5	278.1	176.3	170.8	127.3	127.4	235.4	404.1	382.8	209.5	31.9	186.1	250.7	528.6	301.7	228.6	277.7	29.2	714.3	158.6	1315.9	860.8	178.6	237.5	206.9	226.8	191.8	142.1	449.5	13.8	202.3	939.1	307.0	111.6	200.0	348.6	216.6	214.2	1120.2	345.0	45.4	13.2	257.4	205.4	164.3	161.0	667.5	340.5	227.1	183.2	17.8	212.9	462.5	83.4	12.5	15.4	147.2	663.4	416.8	176.4	427.1	264.4	827.3	209.1	52.0	184.1	185.7	253.8	123.5	76.8	305.9	264.1	963.5	157.7	512.5	303.6	308.9
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134666	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 369.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	45.2	46.0	40.0	28.6	41.4	16.5	39.5	41.5	47.9	38.7	37.3	34.0	27.7	57.3	104.8	41.0	46.1	25.9	62.5	42.0	42.6	49.0	137.2	33.4	33.3	44.2	41.4	49.9	73.9	30.8	42.8	22.6	41.4	42.7	27.7	16.7	60.0	34.6	134.5	29.6	36.0	40.7	41.8	51.5	42.5	35.1	42.1	31.0	30.3	112.0	38.3	34.9	32.3	42.6	63.5	62.2	35.4	56.5	84.8	30.2	65.8	44.6	46.5	63.5	44.4	59.1	38.7	78.3	45.9	44.5	68.7	35.3	70.3	56.3	41.3	58.7	63.2	64.2	30.7	128.3	111.1	74.3	58.2	28.8	67.5	60.2	68.2	34.2	44.7	61.4	48.0	68.3	57.6	73.4	69.2	56.5	37.2	81.5	64.8	63.9	70.9	369.2	46.9	33.2	79.8	42.8	42.8	88.3	65.7	36.1	39.4	125.3	25.0	33.9	48.7	29.8	51.0	150.5	67.9	95.1	56.4	83.4	65.4	73.7	61.0	103.3	50.4	52.2	53.7	44.5	42.1	50.2	62.5	43.9	40.1	41.7	25.4	65.0	55.8	74.1	50.9	63.9	40.0	41.4	41.5	47.9	42.0	42.6	44.2	41.4	41.4	41.8	42.1	42.6	9.7	16.0	12.7	5.5	33.5	18.0	9.8	14.3	9.1	12.2	21.8	19.0	14.2	20.0	10.6	20.2	12.5	45.3	22.8	17.3	35.2	29.8	5.9	5.8	14.7	10.8	8.4	30.7	7.4	35.1	60.3	18.2	28.1	11.9	23.6	13.1	16.1	36.1	38.0	6.7	7.7	28.5	20.3	19.8	16.3	9.1	23.6	17.9	19.6	8.4	16.6	25.3	24.7	9.5	9.1	30.9	20.4	44.8	101.5	18.4	30.0	29.2	3.8	10.9	32.9	10.2	21.0	32.1	44.8	18.7	17.3	77.4	22.6	16.2	22.3	12.9
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303799-177306949	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	89.1	106.5	63.6	89.2	63.5	90.7	78.9	64.0	70.5	69.9	64.6	121.8	109.3	69.3	37.5	146.9	61.4	37.1	70.6	63.8	65.2	140.1	182.3	76.0	79.0	64.3	65.8	64.0	262.3	48.1	67.4	58.6	66.2	74.9	85.8	24.4	95.7	29.8	32.2	108.3	121.8	47.2	66.6	117.4	103.2	43.0	69.0	30.9	65.9	13.7	87.4	81.5	78.7	62.8	221.4	193.8	116.1	307.1	103.3	111.0	400.6	154.5	106.6	214.6	206.1	443.2	232.5	181.4	181.6	143.7	236.0	118.1	212.5	400.0	145.8	826.0	291.9	154.9	195.7	291.1	109.6	243.6	215.1	102.7	142.2	170.6	144.9	89.1	269.0	129.2	181.4	247.7	210.5	556.7	160.5	362.5	242.1	251.6	319.7	52.7	232.1	324.5	140.0	171.5	186.3	237.7	136.8	266.9	267.5	144.4	172.5	293.4	148.5	189.3	174.9	157.4	365.5	155.4	270.9	267.4	162.2	328.0	200.4	411.1	764.6	1198.6	248.0	988.0	238.5	276.0	202.6	245.4	775.1	238.7	175.7	195.7	553.7	327.4	989.8	281.9	246.6	614.3	63.6	63.5	64.0	70.5	63.8	65.2	64.3	65.8	66.2	66.6	69.0	62.8	174.4	22.4	23.4	8.1	198.3	348.3	297.0	331.8	152.5	60.8	339.3	415.4	0.4	168.7	159.0	104.8	22.9	756.9	231.4	572.7	303.3	382.9	6.6	114.1	111.2	171.5	157.5	128.9	9.7	563.3	552.7	134.0	110.6	129.9	108.1	145.9	120.3	247.5	352.2	60.6	10.0	311.3	219.7	271.0	337.1	24.6	114.0	293.8	256.1	7.5	410.1	117.1	325.4	4.0	12.2	752.9	664.0	109.1	393.9	612.4	853.7	567.0	60.5	68.9	46.0	126.6	177.3	81.5	218.6	246.7	420.8	883.6	169.7	221.0	433.6	480.2
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.6;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 400.3;Inhibitory neurons: 422.9;Proximal enterocytes: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"basophil: 24.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	3.4	1.4	0.4	3.4	1.3	5.0	3.8	0.0	2.5	2.9	0.0	18.2	11.7	2.0	2.4	1.8	2.8	5.6	4.4	1.2	0.1	1.6	2.4	2.1	1.5	0.7	0.2	4.2	6.2	1.2	1.2	0.7	1.1	1.8	17.4	15.4	2.1	1.9	0.8	2.3	25.6	3.6	0.7	2.0	8.8	1.8	1.2	1.6	4.4	1.4	1.9	2.9	2.6	2.7	16.7	5.4	4.9	8.0	1.1	2.8	0.0	5.5	9.5	10.0	13.9	17.8	26.6	0.0	9.1	6.6	23.0	4.9	3.9	12.3	14.7	4.8	6.3	19.3	5.9	9.3	3.0	2.3	19.3	1.6	5.1	11.5	10.2	13.9	11.4	0.1	10.6	7.3	4.9	2.8	0.0	2.9	2.6	19.4	3.7	0.1	0.0	2.8	4.8	2.5	2.2	4.4	6.9	0.9	10.9	2.3	8.0	3.8	10.7	8.3	4.6	15.4	12.4	0.4	0.1	0.0	15.4	0.0	3.5	24.5	1.3	0.4	0.8	2.2	0.3	1.7	1.5	1.2	5.6	1.6	0.2	1.1	0.3	2.1	1.5	0.6	2.3	1.0	0.4	1.3	0.0	2.5	1.2	0.1	0.7	0.2	1.1	0.7	1.2	2.7	12.3	0.0	2.7	47.7	2.7	4.1	12.3	15.1	11.4	43.7	8.5	8.0	10.3	14.3	8.1	0.0	400.3	0.4	1.5	87.1	0.0	13.6	8.8	1.5	2.4	7.3	9.6	19.1	65.3	12.9	2.8	8.2	29.0	2.5	17.7	10.8	8.2	1.9	2.7	5.0	422.9	27.0	2.0	2.5	7.4	2.1	3.4	4.3	0.0	67.5	2.9	7.9	0.0	36.7	90.7	17.4	50.9	4.5	4.1	4.3	113.1	2.8	3.5	48.9	0.0	6.5	6.0	2.4	2.9	4.4	3.3	0.3	3.6	9.9	39.3	8.7
PRELID3B	"C20orf45, dJ543J19.5, SLMO2"	ENSG00000101166	"PRELI domain containing 3B"	Q9Y3B1	20	59033145-59042809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047721	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA047721: AB_2680131"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.20e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.96e-2)"	30.0	33.4	17.7	30.8	19.5	37.4	32.3	20.2	24.1	19.0	16.1	68.8	92.5	20.9	18.4	43.1	19.6	22.6	28.4	16.8	21.0	34.2	33.6	23.2	34.5	19.4	19.9	14.9	26.2	43.3	27.3	28.2	20.5	19.9	64.8	17.7	28.3	13.3	18.7	25.0	83.4	24.8	19.4	25.1	44.4	25.5	19.3	34.4	37.0	38.9	40.1	49.4	19.9	21.9	118.6	54.2	53.5	71.6	36.8	51.0	75.6	87.4	70.2	147.1	77.3	152.4	98.4	187.1	138.2	61.2	115.3	123.5	106.2	127.5	154.3	106.9	68.2	132.1	87.3	33.0	77.7	174.5	114.9	46.4	162.1	85.6	196.3	49.9	47.3	143.0	51.6	77.1	61.6	145.3	186.9	71.0	26.3	187.8	149.6	101.5	125.9	107.8	72.7	98.8	97.2	92.7	139.5	218.5	208.1	37.3	116.2	125.6	64.0	54.8	54.5	101.2	45.4	51.2	77.7	149.5	61.9	81.7	65.1	52.1	22.1	23.3	32.7	30.2	40.6	41.1	40.1	37.7	28.9	30.1	35.4	38.1	19.5	45.6	37.7	24.6	46.5	36.9	17.7	19.5	20.2	24.1	16.8	21.0	19.4	19.9	20.5	19.4	19.3	21.9	25.5	22.4	36.0	0.0	43.2	0.0	67.0	0.0	52.9	9.8	53.0	32.1	0.0	17.2	15.5	22.0	6.2	64.2	47.1	62.6	68.4	60.8	68.5	43.6	20.6	26.8	27.9	55.2	0.0	56.8	113.2	21.6	45.9	64.7	16.4	26.1	18.5	27.8	54.5	11.8	0.0	46.8	0.0	38.9	0.0	24.7	14.9	37.6	0.0	0.0	49.5	16.6	35.0	0.0	0.0	77.8	45.9	15.8	51.5	113.0	137.5	51.3	22.6	10.6	26.3	31.9	21.5	79.3	39.5	69.5	0.0	124.1	47.0	43.3	59.9	229.4
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PREPL	KIAA0436	ENSG00000138078	"Prolyl endopeptidase like"	Q4J6C6	2	44316281-44361862	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 243.1;Inhibitory neurons: 219.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063238	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA063238: AB_2684967"	"unprognostic (5.60e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.98e-3)"	"unprognostic (4.38e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.75e-1)"	26.2	50.9	64.6	18.4	67.4	5.5	31.9	42.9	133.1	35.9	27.5	24.4	26.1	47.2	70.9	22.9	33.6	28.4	62.7	73.1	93.1	62.5	21.6	24.5	17.4	45.3	26.0	49.8	25.2	54.4	52.5	21.4	41.7	37.3	29.4	123.8	26.2	33.1	34.3	22.3	27.9	34.1	34.0	23.1	26.4	28.2	53.4	19.1	61.3	51.3	17.9	23.6	23.9	58.4	41.2	31.7	35.3	45.3	55.7	58.0	26.8	45.1	34.6	32.0	27.4	34.1	28.4	52.3	61.2	47.5	36.6	34.6	50.6	33.0	61.0	48.7	36.2	35.5	24.2	26.3	40.0	35.8	32.5	37.9	64.6	61.8	50.1	62.9	31.4	24.3	45.6	72.6	43.6	22.2	39.1	17.4	33.4	52.8	35.1	30.1	42.8	38.0	61.4	24.0	58.3	46.5	28.9	30.6	67.4	33.9	41.4	27.6	32.8	56.3	32.1	44.6	31.0	40.2	28.2	34.3	65.9	40.1	42.5	6.9	4.4	3.5	7.9	4.9	11.2	8.5	7.3	8.5	6.3	7.0	10.7	8.7	1.3	11.1	4.3	2.9	8.8	5.8	64.6	67.4	42.9	133.1	73.1	93.1	45.3	26.0	41.7	34.0	53.4	58.4	16.3	32.1	37.4	83.2	34.0	13.0	16.0	13.2	21.6	89.1	33.4	26.7	88.1	32.9	21.1	64.4	47.9	8.7	30.0	20.4	39.2	17.4	21.1	40.1	36.7	18.7	33.0	13.9	243.1	23.6	4.9	29.5	28.1	32.1	13.3	21.9	16.8	32.8	11.6	144.7	219.9	24.2	18.3	13.5	7.5	10.0	35.4	14.2	17.8	55.3	12.8	41.4	32.0	81.4	126.2	13.6	20.8	33.1	21.8	16.3	12.2	38.8	35.5	63.2	19.7	44.5	27.2	29.2	28.7	16.3	14.8	8.8	29.1	26.0	17.1	10.7
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827999	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.5;brain: 78.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	14.8	10.6	32.8	37.4	56.4	52.5	15.0	43.2	47.2	12.3	1.2	7.0	6.3	4.0	1.4	6.4	4.7	13.0	6.7	32.1	42.0	4.8	5.2	26.8	36.6	52.1	52.0	2.5	5.3	6.9	7.6	11.7	53.8	4.8	6.0	3.9	5.3	3.4	6.6	3.5	12.7	7.7	43.5	42.9	8.8	6.0	45.3	9.8	9.4	8.6	21.8	12.3	3.2	78.1	2.3	6.1	78.4	0.0	1.3	5.7	27.2	2.7	3.5	11.2	2.8	0.4	0.3	16.4	49.5	7.2	21.4	1.0	4.1	0.2	7.5	3.7	2.0	2.4	8.8	0.0	4.6	9.0	51.1	6.3	0.0	25.7	0.0	7.6	68.4	7.2	0.2	0.6	14.8	157.9	0.2	24.7	3.1	8.1	6.4	24.1	22.8	9.8	0.5	0.0	16.5	2.4	14.7	162.2	17.8	4.4	145.0	67.4	77.2	4.5	15.6	0.2	4.6	0.9	3.5	20.1	72.4	17.8	24.3	4.5	1.9	2.2	3.7	2.2	2.2	1.5	2.0	3.2	1.6	1.4	0.3	1.1	9.2	1.8	2.0	1.3	7.3	2.0	32.8	56.4	43.2	47.2	32.1	42.0	52.1	52.0	53.8	43.5	45.3	78.1	43.2	3.2	6.6	87.1	35.4	2.5	0.3	0.4	1.2	0.3	40.0	21.5	3.7	2.8	2.6	1.8	8.4	0.7	84.0	0.9	0.0	0.2	3.5	3.5	4.7	24.5	1.2	14.1	13.3	1.2	4.4	10.3	4.1	6.2	1.3	0.7	20.7	1.9	32.1	0.0	4.6	1.8	0.0	104.7	28.2	2.9	0.9	76.5	8.8	95.5	47.1	19.4	90.6	49.3	190.2	0.1	1.0	0.4	23.3	0.7	0.3	0.2	4.5	0.7	0.0	18.1	3.3	2.2	11.6	0.4	2.4	9.3	63.9	41.2	4.5	0.7
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952046-68237032	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 717.6;Microglial cells: 120.9;Oligodendrocyte precursor cells: 422.2;Oligodendrocytes: 222.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.0;HUVEC TERT2: 19.2;JURKAT: 8.3;NTERA-2: 12.1;RH-30: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	9.3	1.0	11.5	1.2	15.2	0.1	5.5	15.8	9.4	4.4	0.1	2.6	1.7	2.5	1.7	1.7	5.5	3.2	3.8	12.5	10.1	1.6	1.2	4.4	0.8	16.1	13.5	1.9	1.1	1.1	1.9	8.1	13.2	2.5	1.7	3.6	1.3	2.2	2.2	1.7	1.8	2.5	12.6	1.3	1.6	0.9	13.4	0.9	7.3	5.0	1.0	2.7	2.6	14.1	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	8.3	0.0	0.0	0.0	0.0	3.0	0.0	12.1	0.0	0.0	0.0	5.5	0.0	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	15.2	15.8	9.4	12.5	10.1	16.1	13.5	13.2	12.6	13.4	14.1	103.3	3.2	5.0	717.6	0.3	4.0	3.6	0.0	0.0	21.8	0.6	0.8	6.1	1.5	3.1	1.8	2.1	0.0	0.6	0.0	0.0	0.2	52.7	15.2	3.2	57.0	0.0	0.0	2.2	0.0	0.0	19.7	0.0	26.2	1.3	0.0	56.4	0.7	0.1	5.0	81.3	0.0	0.0	2.7	5.1	9.6	11.1	0.8	8.8	120.9	0.0	65.8	0.0	422.2	222.1	0.0	0.0	10.5	1.3	0.8	0.0	0.0	0.7	4.1	26.3	3.9	13.8	0.9	1.2	0.5	2.6	0.0	1.1	0.2	0.0	1.6
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386780-57390650	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 2616.3"	"Group enriched"	"Detected in some"	10	"Erythroid cells: 44.3;Extravillous trophoblasts: 107.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 7.2"	"Group enriched"	"Detected in some"	62	"HL-60: 3328.5;HMC-1: 5009.7;NB-4: 10560.9"	"Not detected"	"Not detected"							HPA038515	Supported				"Secreted in female reproductive system"	NA	NA		100000000	"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA038515: AB_10675800"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.39e-2)"		"unprognostic (3.49e-1)"	"unprognostic (8.62e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.40e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.32e-1)"	0.7	0.0	0.0	0.1	0.0	215.8	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	2.5	1.1	1.4	0.0	0.0	0.3	3.8	0.0	0.2	2616.3	0.0	0.0	0.4	0.0	0.9	0.0	0.2	2.1	0.4	0.5	0.0	3.0	0.3	0.0	0.0	8.7	0.2	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	101.3	0.0	0.0	0.2	3328.5	5009.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	9.0	0.6	0.0	0.0	0.8	10560.9	0.0	0.0	0.0	0.3	0.8	1.0	0.0	0.0	1.6	4.2	0.4	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.4	0.2	0.4	0.3	7.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	44.3	0.0	0.0	107.2	0.5	0.0	0.0	6.3	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"bone marrow: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"HMC-1: 198.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 3.5"	HPA064183	Enhanced				"Secreted in other tissues"	NA	NA		680000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"				"HPA064183: AB_2685205"																		0.0	0.0	0.0	0.0	0.0	48.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	198.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314567	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 93.2;liver: 185.7"	"Group enriched"	"Detected in some"	15	"Fibroblasts: 320.6;Hepatocytes: 364.7"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Region enriched"	"Detected in single"	33	"hypothalamus: 30.8"	"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 284.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB054258	Supported				"Secreted to extracellular matrix"	NA	NA		4300000000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB054258: "	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	93.2	2.3	0.0	2.3	0.0	0.3	15.1	0.4	0.9	0.6	3.9	1.2	0.0	0.6	0.9	0.3	20.0	0.4	31.7	0.0	30.8	0.2	185.7	26.4	0.4	0.0	0.0	2.1	1.5	0.0	2.1	0.0	0.1	0.6	0.1	0.1	3.9	0.1	9.5	7.7	0.4	0.3	0.2	0.7	1.4	0.2	0.2	0.3	1.7	8.1	0.3	2.6	0.5	0.0	0.0	0.1	0.0	0.0	284.6	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.1	0.2	0.2	0.0	26.2	0.0	44.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.7	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.9	0.0	30.8	0.0	0.0	0.1	0.2	0.2	0.0	5.1	22.4	16.2	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	2.7	10.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	3.7	4.1	0.0	2.7	0.0	0.0	0.0	320.6	0.0	0.8	16.4	0.0	6.4	364.7	0.1	0.0	0.1	0.0	0.0	9.4	1.9	0.8	0.0	2.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	0.1	0.0	0.0	10.9	0.0	0.0	3.5	1.5	0.0	0.3	0.0	1.1	0.0	2.3	0.1	0.0	0.1
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	6.3	3.0	3.7	5.2	5.0	1.7	5.0	0.0	7.2	12.5	0.0	4.2	2.6	12.1	1.6	2.4	6.4	10.0	13.8	4.2	0.0	5.0	1.7	9.5	4.6	0.1	1.3	12.5	2.0	1.4	2.0	5.3	0.0	5.1	2.2	4.2	7.8	5.6	3.9	4.7	2.4	12.7	0.0	14.8	2.9	6.0	3.9	1.6	7.9	4.6	3.4	5.5	6.3	1.0	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	3.7	5.0	0.0	7.2	4.2	0.0	0.1	1.3	0.0	0.0	3.9	1.0	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRICKLE3	LMO6	ENSG00000012211	"Prickle planar cell polarity protein 3"	O43900	X	49174802-49186528	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 60.8;Late spermatids: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA000998	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA000998: AB_1079258"	"unprognostic (9.83e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (2.28e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.84e-5)"	4.3	3.8	2.3	3.5	2.5	2.1	4.0	2.5	2.9	4.8	4.2	3.7	3.0	4.0	1.7	10.2	4.7	2.9	5.7	2.1	2.4	2.5	3.1	4.0	3.3	2.7	2.7	2.6	5.1	4.0	2.1	3.8	2.7	4.6	3.0	0.6	4.5	5.8	11.6	12.0	3.5	3.3	2.9	3.8	4.0	1.1	2.7	3.4	3.9	10.5	4.5	5.1	6.6	3.0	17.7	20.3	0.5	1.7	8.4	9.1	19.0	6.8	10.2	5.1	7.9	6.2	10.9	0.0	6.1	8.4	1.6	24.8	15.6	25.1	2.3	21.9	8.4	7.4	12.2	4.7	12.2	5.0	24.3	8.3	19.3	6.4	15.7	3.3	5.3	4.5	12.4	6.6	8.6	27.8	6.0	7.4	3.0	10.6	21.7	8.3	5.3	9.8	6.7	24.7	3.4	0.0	9.4	8.6	6.7	6.0	17.4	5.6	6.2	0.1	8.0	7.2	2.6	11.6	8.3	4.1	8.0	6.6	0.1	2.4	8.3	9.2	2.3	9.1	3.2	7.0	3.1	3.8	7.5	4.1	2.5	2.6	4.7	3.0	12.1	3.5	4.2	5.1	2.3	2.5	2.5	2.9	2.1	2.4	2.7	2.7	2.7	2.9	2.7	3.0	2.7	0.0	1.5	1.0	4.2	15.2	5.5	13.7	10.8	0.3	1.4	2.2	1.5	0.0	6.6	1.8	2.1	3.2	1.0	1.9	1.9	3.4	60.8	2.7	2.0	3.2	1.2	2.5	0.2	2.7	6.8	2.8	6.6	2.4	0.0	1.7	1.4	1.4	2.5	0.0	0.1	3.3	8.2	1.3	8.1	100.8	1.5	2.8	8.8	0.0	2.9	0.9	1.0	2.0	1.0	2.2	2.7	0.7	3.2	4.8	1.7	2.0	3.3	0.2	0.0	1.5	2.6	0.4	0.5	15.9	19.0	3.3	2.2	2.2	2.5	4.6
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780782-41787452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		Yes	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	1.8	1.2	1.3	0.3	1.2	0.1	1.9	1.3	1.2	2.2	0.0	1.6	1.1	2.4	0.0	3.8	2.3	1.0	1.9	0.7	1.0	1.3	2.0	2.1	0.1	1.1	0.7	1.3	1.2	0.4	1.0	0.6	1.0	2.3	0.5	0.6	1.7	0.4	1.6	0.8	1.2	1.5	0.3	4.5	2.6	0.8	1.0	0.0	2.5	1.5	0.3	2.6	2.9	1.3	0.2	0.6	1.3	1.2	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.7	0.9	0.4	1.5	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.3	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.5	1.2	0.2	0.0	0.6	0.0	0.7	0.2	1.8	0.2	1.3	0.3	0.0	0.2	1.4	0.1	0.4	0.0	2.4	0.2	1.2	0.6	0.7	0.6	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.3	1.2	0.7	1.0	1.1	0.7	1.0	0.3	1.0	1.3	0.0	0.0	0.0	1.6	15.0	1.5	1.4	2.4	30.7	2.3	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.7	2.6	0.0	0.0	0.3	0.0	0.0	2.8	3.5	17.7	0.2	0.0	0.0	4.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	1.5	0.6	1.2	8.4	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.5	2.6	36.8	1.7	2.2	0.0	0.7	4.1	0.0	1.9	3.7	1.9	1.4	49.4	2.0	0.0	10.9	0.0	3.0	1.4
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731296-56752374	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 56.4;Spermatocytes: 118.2;Spermatogonia: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain					NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	3.7	3.2	2.0	7.0	2.8	28.2	9.9	5.5	2.8	3.7	1.2	7.9	4.5	5.0	4.2	4.4	5.3	2.9	2.3	1.9	2.0	3.0	7.5	4.9	12.3	2.5	2.2	8.9	6.1	6.1	2.1	4.8	2.6	3.6	11.2	8.3	3.9	3.9	4.6	7.8	7.7	5.8	2.0	6.9	5.4	14.4	2.3	18.8	5.0	5.6	14.4	3.8	3.1	4.3	43.0	37.9	52.1	29.2	5.1	9.1	57.8	34.7	28.7	62.1	59.8	42.0	54.4	83.0	27.4	15.8	26.0	40.4	60.3	39.9	68.8	40.7	40.4	106.2	22.6	36.8	1.2	129.3	43.2	4.2	7.2	55.8	22.1	8.8	22.6	92.1	105.5	123.8	35.4	33.6	76.8	54.4	53.5	32.0	47.1	85.0	81.4	70.9	15.0	35.4	51.0	46.0	41.4	20.6	19.9	36.2	67.2	52.8	10.9	32.2	70.7	33.1	46.4	45.1	94.5	45.3	19.4	55.4	40.9	2.5	1.9	4.4	9.1	4.0	9.5	11.3	11.2	8.5	3.9	12.2	14.0	10.7	1.0	6.8	7.1	7.5	10.0	5.3	2.0	2.8	5.5	2.8	1.9	2.0	2.5	2.2	2.6	2.0	2.3	4.3	6.9	6.4	6.8	4.6	10.4	3.8	10.7	10.0	4.6	5.1	7.0	7.2	3.2	2.8	6.1	7.3	6.2	14.9	8.7	2.5	0.0	5.8	6.2	4.1	3.9	6.4	1.2	56.4	5.7	7.2	27.0	5.4	5.6	3.3	3.8	10.0	5.7	4.7	11.8	20.2	10.6	4.6	2.0	8.1	3.1	4.3	7.2	6.5	3.6	2.8	7.9	5.7	8.2	8.0	7.8	2.7	2.2	4.9	9.7	2.2	2.0	2.5	6.0	12.7	13.1	8.2	8.8	118.2	107.2	5.1	4.0	4.5	12.8	3.0	9.4	5.0
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788485	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.7"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 35.5;Oligodendrocytes: 54.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	5.8	3.0	6.1	2.9	11.3	0.0	3.8	10.8	12.3	17.5	2.5	53.7	2.1	13.9	2.1	8.0	18.3	1.6	8.8	5.2	7.9	2.5	0.8	1.0	0.1	17.1	11.3	5.4	1.3	0.0	0.7	1.0	14.7	15.6	3.7	5.7	5.0	5.0	0.9	3.4	21.6	8.1	12.7	0.2	20.0	1.7	9.1	0.2	1.7	1.4	2.3	11.0	14.4	18.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	8.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	11.3	10.8	12.3	5.2	7.9	17.1	11.3	14.7	12.7	9.1	18.4	0.2	0.0	0.0	1.3	0.0	0.5	1.0	0.3	0.6	2.6	0.4	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	3.4	2.6	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.2	2.8	0.1	0.0	0.0	0.0	35.5	0.0	2.0	54.7	0.1	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.3	0.0	4.9	0.3	0.7	1.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 292.5;Late spermatids: 478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	33.3	21.0	7.9	27.2	9.6	52.6	30.2	10.3	11.0	26.7	12.3	30.0	35.4	26.3	18.6	20.6	21.0	33.5	20.2	6.9	11.3	32.0	49.9	27.4	29.2	11.8	9.9	19.1	23.1	32.0	9.2	21.2	12.2	31.9	34.7	19.0	27.4	24.7	16.9	23.1	30.9	26.4	10.2	27.8	33.7	41.1	10.0	21.8	32.3	19.9	23.9	28.8	17.8	10.3	28.4	28.9	22.8	30.2	55.0	57.0	21.6	47.3	48.1	34.7	30.8	27.6	35.9	16.6	21.4	48.8	45.3	22.4	21.3	43.1	64.9	49.2	19.2	33.1	66.1	22.1	45.3	31.9	33.5	52.8	20.6	46.5	47.5	38.4	52.1	21.0	15.9	46.7	52.4	13.6	29.7	24.9	9.9	28.9	34.6	24.5	48.7	24.6	53.3	47.5	19.6	19.7	83.0	54.3	28.8	12.3	28.4	26.0	56.0	62.1	33.5	36.2	39.2	18.5	15.4	19.6	38.9	67.9	33.9	17.0	6.5	12.8	8.9	7.9	11.5	8.2	8.4	8.6	6.4	7.9	10.1	9.0	15.4	10.9	9.3	1.9	11.6	6.5	7.9	9.6	10.3	11.0	6.9	11.3	11.8	9.9	12.2	10.2	10.0	10.3	47.3	41.7	26.5	19.2	34.1	24.1	24.7	40.5	15.4	20.3	36.1	17.9	18.3	42.9	43.4	47.8	35.5	13.8	45.8	44.1	7.9	27.9	292.5	19.7	35.8	42.4	21.1	25.4	24.5	44.9	13.7	36.2	36.7	20.7	18.3	17.8	37.1	83.4	20.0	15.2	30.3	28.8	42.7	25.3	28.5	478.5	30.4	24.1	35.6	24.4	40.9	15.4	44.3	30.7	43.8	36.0	32.8	25.9	23.4	33.4	33.7	35.4	42.9	27.9	0.0	22.7	43.1	82.8	17.6	19.9	32.7	18.6	44.0	19.2	36.9	35.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667864-119681624	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.8	16.9	11.9	13.9	13.1	44.0	15.3	12.8	13.2	25.3	12.6	34.8	32.5	16.8	16.3	21.4	17.2	14.5	12.2	11.7	13.0	53.3	17.3	25.3	18.1	14.6	13.5	14.3	33.4	18.9	10.7	27.6	14.1	11.9	33.4	19.4	16.0	15.6	12.6	10.6	22.7	17.0	12.7	24.1	29.0	21.4	13.1	19.7	20.8	10.5	23.9	15.1	10.7	15.7	11.4	30.8	22.1	21.5	17.8	16.7	29.7	18.3	22.7	28.2	20.4	39.9	24.0	36.6	21.8	23.6	12.6	15.2	22.6	32.1	24.9	22.4	36.5	57.8	17.1	51.5	35.6	26.7	66.0	22.4	29.9	24.4	29.7	30.0	21.2	54.5	89.4	13.5	21.6	33.0	60.4	35.4	32.3	16.5	50.1	33.9	20.8	22.7	32.7	33.7	18.7	31.8	22.1	8.6	25.3	26.7	27.2	34.1	25.0	16.9	20.2	13.3	17.8	45.8	45.7	26.8	16.5	19.7	25.5	50.6	28.5	70.3	28.5	32.6	34.4	47.1	30.0	31.0	30.8	39.5	32.3	29.7	34.7	42.0	38.6	27.8	36.1	36.4	11.9	13.1	12.8	13.2	11.7	13.0	14.6	13.5	14.1	12.7	13.1	15.7	20.6	48.1	49.7	3.3	11.9	3.3	6.5	15.3	15.4	16.2	10.0	6.3	5.3	8.6	16.6	22.0	4.2	18.4	7.5	27.0	46.9	8.3	1.2	12.7	7.7	13.2	19.7	34.5	7.1	30.2	10.9	8.6	12.8	15.4	12.0	18.5	5.3	7.1	12.3	21.9	6.2	15.3	14.2	7.0	5.2	2.2	5.6	9.6	3.6	8.4	10.3	13.4	11.3	7.5	7.6	11.7	17.9	6.4	6.4	5.2	16.2	38.2	12.7	17.9	6.6	4.8	8.2	25.6	13.2	13.7	4.3	15.1	9.9	26.3	23.7	8.3
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.2;tongue: 103.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	12.4	10.8	9.4	7.8	10.1	9.0	11.8	12.5	13.1	14.8	6.0	23.4	32.0	18.7	8.5	10.3	12.9	7.1	25.8	10.1	9.5	9.5	56.3	10.0	6.5	10.8	10.1	11.7	34.8	64.7	6.7	12.3	11.0	12.7	10.7	14.7	8.2	19.4	97.2	15.4	20.8	19.8	10.8	8.5	18.1	6.7	10.6	5.9	6.3	103.8	5.6	18.6	14.0	11.2	7.8	4.2	11.1	8.6	25.7	22.1	39.7	14.3	7.9	9.5	10.3	17.1	15.1	13.9	7.1	11.6	5.5	20.2	13.1	16.1	9.2	5.5	9.0	6.2	15.2	27.8	17.7	7.4	2.6	17.4	31.7	9.9	46.0	14.1	9.4	10.6	8.9	5.6	8.2	7.8	5.5	4.1	23.3	13.4	18.4	8.5	14.8	6.9	6.8	6.1	7.1	13.2	10.8	12.1	52.8	39.6	11.4	9.1	10.8	10.6	23.3	9.9	23.6	8.9	10.1	7.1	11.0	6.4	14.1	0.9	0.3	0.6	0.4	0.4	0.7	0.3	0.4	0.3	0.5	0.3	0.5	0.3	0.1	1.5	0.5	0.2	0.2	0.2	9.4	10.1	12.5	13.1	10.1	9.5	10.8	10.1	11.0	10.8	10.6	11.2	10.4	3.2	2.0	14.0	10.6	16.6	11.8	11.4	18.2	14.5	6.7	8.1	66.2	20.0	5.3	18.4	14.6	21.9	10.3	22.7	1.9	6.1	0.8	5.4	15.1	8.2	11.4	3.4	23.2	7.0	42.1	13.6	13.7	10.4	1.3	11.8	6.8	44.9	5.7	11.8	18.8	12.6	10.2	8.9	12.5	1.8	9.6	7.3	16.0	10.3	12.2	6.4	11.3	25.1	21.3	9.9	12.0	16.1	9.0	7.2	55.1	5.4	7.0	19.5	19.7	11.3	20.4	13.9	11.2	13.1	14.1	20.5	9.7	43.4	10.1	4.8
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 116.8;Theca cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	62.7	126.5	46.6	27.6	47.6	18.9	53.9	39.9	64.2	53.2	29.5	59.0	20.9	56.9	28.5	41.8	53.7	14.2	204.8	49.2	53.3	35.4	78.4	46.1	15.9	56.8	54.5	94.1	34.0	21.6	71.2	17.3	55.3	41.2	13.0	25.2	42.3	20.8	310.9	42.3	36.3	21.8	40.7	71.6	40.2	57.2	50.3	18.2	39.6	122.1	13.4	50.6	44.2	46.6	37.5	16.3	40.3	74.4	36.2	30.8	9.9	30.5	23.6	32.7	27.5	21.6	15.0	13.8	26.2	49.2	22.9	25.4	26.7	26.6	32.3	23.1	17.7	27.7	20.6	24.4	36.8	21.9	33.5	33.8	18.1	30.0	11.1	26.6	29.7	19.0	29.1	47.3	36.7	48.1	46.3	31.9	21.5	38.7	45.0	38.0	47.8	36.7	41.7	13.5	36.5	24.2	34.2	31.3	23.8	18.1	37.2	26.5	37.7	71.7	20.3	100.7	39.6	31.9	24.9	23.6	49.6	28.0	32.7	0.1	1.5	0.2	0.8	2.7	0.3	0.8	0.3	0.5	1.1	0.5	0.5	0.7	3.2	0.4	2.5	0.6	0.3	0.6	46.6	47.6	39.9	64.2	49.2	53.3	56.8	54.5	55.3	40.7	50.3	46.6	39.5	6.4	3.4	9.4	7.0	8.8	6.8	6.4	2.2	42.2	19.2	19.0	116.8	22.8	4.7	14.7	27.1	6.9	9.0	24.6	7.9	12.4	32.4	11.7	22.9	26.7	17.5	2.5	16.9	19.1	5.7	22.6	8.6	12.9	0.0	15.9	26.4	39.7	34.5	3.3	21.6	11.8	2.0	49.4	50.8	15.7	49.0	37.1	14.2	9.4	37.8	26.1	9.2	10.1	10.7	15.6	11.6	51.9	3.3	6.4	20.7	11.8	7.0	23.9	19.7	23.3	23.5	26.4	6.9	10.1	11.2	8.1	10.0	100.6	14.4	6.6
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012504-69014113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	152	"testis: 24.6"	"Group enriched"	"Detected in some"	27	"Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol		NA	NA		1800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB019378: , HPA049979: AB_2680980"	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	125.9	158.2	72.0	124.1	83.2	57.1	118.4	76.7	119.1	151.2	97.3	70.0	51.7	145.5	122.3	98.5	141.3	125.2	430.0	89.0	102.1	164.3	150.8	163.7	111.4	85.6	91.8	202.8	63.1	300.2	88.0	164.3	105.0	114.5	79.1	132.2	169.7	137.6	250.6	63.8	58.7	132.1	71.7	121.7	86.9	130.8	91.8	109.4	173.6	147.4	103.6	136.4	67.6	93.5	95.5	180.0	225.9	136.1	294.6	331.7	33.9	125.7	257.9	192.2	168.6	70.5	125.5	96.3	84.3	276.7	196.8	77.2	168.8	204.2	273.8	65.8	60.4	149.1	154.0	233.0	213.0	115.8	160.2	239.1	207.4	222.3	185.9	215.0	324.6	80.8	68.5	147.2	236.4	181.0	128.2	60.9	83.9	97.7	121.4	88.1	373.6	106.7	292.4	204.3	81.8	110.3	115.4	207.6	496.8	208.5	162.8	161.1	232.2	269.4	127.6	123.3	119.0	121.6	93.5	142.4	163.0	107.8	171.8	149.6	108.3	189.4	48.6	101.0	48.8	42.8	35.9	43.6	105.9	32.3	32.1	35.9	208.2	76.1	120.9	34.7	50.9	113.5	72.0	83.2	76.7	119.1	89.0	102.1	85.6	91.8	105.0	71.7	91.8	93.5	134.1	147.4	263.4	38.5	126.0	142.8	100.1	136.8	116.7	99.6	106.8	65.4	606.2	81.5	156.4	252.0	66.7	77.4	127.4	58.1	178.1	80.7	407.9	142.9	116.4	131.8	136.9	52.5	76.1	52.0	86.8	163.2	78.5	110.3	185.0	78.2	158.1	120.7	146.1	139.7	78.4	53.3	136.3	176.2	171.1	93.7	133.6	151.1	192.1	46.9	142.3	125.1	78.2	57.3	76.3	74.6	51.5	190.7	95.6	85.3	27.1	210.1	307.7	59.9	85.5	123.2	210.9	219.8	54.2	122.4	131.7	82.5	117.3	184.0	43.9	112.8
PRKAR1B		ENSG00000188191	"Protein kinase cAMP-dependent type I regulatory subunit beta"	P31321	7	549197-727650	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 175.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.3;Excitatory neurons: 78.7;Inhibitory neurons: 61.1;Late spermatids: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 128.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026719	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA026719: AB_1855419"	"unprognostic (4.90e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.00e-1)"	12.0	11.0	79.6	7.5	99.4	8.8	12.4	0.0	175.7	17.6	0.0	19.4	12.3	23.5	3.7	12.0	15.8	7.6	17.1	105.2	76.3	15.9	12.9	12.4	9.7	62.9	15.9	28.1	6.5	8.9	35.7	5.5	53.3	12.6	6.5	19.3	7.3	8.3	7.3	8.0	13.4	8.7	4.2	22.8	11.3	15.4	52.5	10.2	8.2	3.8	5.3	10.2	13.5	88.9	83.0	54.2	8.0	19.7	5.1	4.6	22.8	15.9	7.3	10.0	5.7	97.9	17.5	63.2	11.3	7.2	33.1	60.3	27.0	30.6	4.2	12.8	20.1	4.3	33.3	65.4	9.7	39.7	9.5	12.8	9.2	6.8	18.7	11.1	10.8	15.7	61.6	11.8	9.2	77.8	47.5	26.5	128.0	22.1	23.0	30.9	1.6	27.4	25.0	20.8	106.0	81.5	41.2	39.2	32.0	3.2	20.1	14.6	13.0	4.4	9.9	6.0	32.3	7.7	23.4	41.0	8.2	29.8	59.5	1.8	2.4	0.0	5.0	3.0	7.7	7.4	8.9	7.7	2.8	10.0	13.8	13.3	0.9	4.6	1.2	6.6	6.6	10.5	79.6	99.4	0.0	175.7	105.2	76.3	62.9	15.9	53.3	4.2	52.5	88.9	18.3	3.2	4.4	12.4	7.3	3.8	7.4	6.0	6.2	11.1	9.0	12.8	13.1	4.3	5.0	5.5	4.2	4.0	7.0	10.1	25.4	4.1	62.3	4.5	6.5	15.2	4.2	13.5	78.7	3.4	5.8	8.2	10.7	4.4	7.0	55.0	16.4	8.5	8.9	53.8	61.1	10.9	2.0	6.2	8.6	130.0	11.8	8.7	7.2	15.0	1.6	7.3	5.2	24.1	7.5	7.7	14.1	15.4	8.2	5.6	20.7	24.5	1.4	6.3	0.0	12.8	9.0	15.6	11.1	10.7	4.7	3.4	9.1	12.0	15.5	5.0
PRKAR2A	PRKAR2	ENSG00000114302	"Protein kinase cAMP-dependent type II regulatory subunit alpha"	P13861	3	48744597-48847874	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.7;testis: 82.5"	"Group enriched"	"Detected in all"	8	"Early spermatids: 788.7;Late spermatids: 1370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005023, HPA038268"	Uncertain					NA	NA		210000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"			"CAB005023: AB_562330, HPA038268: AB_2675921"	"unprognostic (2.81e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.17e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (4.77e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-2)"	19.0	14.8	8.3	11.6	7.4	18.5	13.0	8.1	9.1	10.4	11.7	23.5	12.9	9.9	9.3	18.5	17.6	8.3	17.2	7.9	14.3	18.1	15.8	12.5	8.9	12.4	10.1	10.7	12.5	16.5	6.8	11.4	11.7	14.3	19.6	15.8	17.1	14.4	82.7	13.8	13.9	16.2	11.8	9.3	14.2	82.5	10.8	4.9	17.2	39.4	12.5	11.8	10.0	12.0	39.2	25.9	21.2	16.4	31.1	31.4	23.8	44.0	21.8	37.7	23.7	34.4	17.1	34.3	30.1	45.7	24.4	17.6	61.0	38.4	50.4	28.3	22.6	45.8	44.7	25.4	22.8	48.6	28.3	26.2	29.5	48.5	35.4	14.1	40.2	11.5	52.3	21.4	35.9	15.2	0.4	15.7	15.1	28.6	28.4	14.7	26.9	43.6	24.2	42.4	21.0	21.6	43.2	50.8	29.1	22.8	34.2	37.1	51.5	33.0	26.3	54.2	61.0	36.2	76.4	32.5	44.5	52.5	25.4	8.0	6.5	8.0	6.7	6.1	6.6	6.0	5.8	5.8	6.3	5.0	3.9	4.0	9.2	7.0	12.0	3.9	5.5	5.2	8.3	7.4	8.1	9.1	7.9	14.3	12.4	10.1	11.7	11.8	10.8	12.0	61.5	19.2	62.2	42.1	36.5	41.9	25.5	26.9	48.9	44.2	51.0	34.9	70.8	50.1	33.1	46.0	68.8	25.0	61.2	92.3	21.5	41.3	788.7	64.2	60.4	48.8	42.0	22.9	62.4	60.3	34.6	37.6	43.8	41.3	13.3	29.4	55.0	121.4	48.8	62.2	73.1	42.5	34.6	52.2	45.3	1370.7	55.0	48.0	30.2	38.4	48.3	24.8	39.1	42.7	90.9	66.4	46.9	55.7	48.6	34.0	45.2	41.2	50.3	46.2	52.6	51.8	46.6	82.1	61.0	79.0	62.8	23.5	54.1	32.8	87.9	26.6
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044705-107161811	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 135.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 110.2;Excitatory neurons: 146.3;Granulosa cells: 712.1;Theca cells: 271.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 70.7;Daudi: 99.8;K-562: 61.4;U-698: 254.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		570000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	135.8	44.9	10.7	4.8	12.1	14.2	51.3	5.7	17.5	8.0	5.3	11.1	3.6	6.9	4.4	11.2	7.0	4.9	15.5	13.2	9.5	8.8	2.5	7.6	3.8	6.2	10.2	26.4	8.7	6.5	11.4	15.1	8.3	9.2	6.9	7.5	9.9	4.4	1.5	3.7	11.5	5.1	6.9	16.7	9.1	13.6	7.8	2.6	3.5	6.1	4.0	20.3	6.2	10.1	0.1	1.5	9.1	70.7	36.8	0.0	0.1	3.6	11.5	3.0	2.7	0.0	0.2	99.8	0.8	2.3	8.6	0.1	7.1	0.0	5.5	2.8	7.9	33.3	0.1	0.0	10.3	0.6	4.5	0.5	0.0	0.3	0.0	3.1	42.9	5.4	61.4	2.9	0.1	7.5	14.0	0.4	17.3	0.0	2.8	4.0	0.2	0.0	0.1	0.1	11.6	16.7	5.4	1.2	3.9	22.9	2.1	7.0	24.4	3.5	9.2	0.0	7.1	2.1	0.1	254.8	2.5	17.5	33.9	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.6	10.7	12.1	5.7	17.5	13.2	9.5	6.2	10.2	8.3	6.9	7.8	10.1	39.6	3.2	1.5	9.8	1.9	2.4	1.6	2.1	0.6	33.5	27.9	10.5	35.9	12.8	5.1	7.3	10.4	0.1	3.7	1.7	0.0	2.5	7.9	1.8	16.2	17.4	0.0	110.2	146.3	0.0	0.6	17.5	3.6	0.9	4.5	712.1	19.2	0.0	1.6	5.0	71.9	1.9	4.1	19.6	26.4	8.5	29.8	64.1	17.8	15.9	17.0	6.4	3.1	60.8	10.9	0.1	2.1	53.0	2.0	3.5	0.0	0.8	5.4	11.9	19.7	5.4	57.7	2.5	6.5	0.7	2.4	0.0	3.7	271.7	2.7	4.6
PRKCA	"PKCA, PKCα"	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302613-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 564.8;Excitatory neurons: 247.6;Inhibitory neurons: 400.0;Microglial cells: 281.1;Oligodendrocyte precursor cells: 849.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 157.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	3.1	21.1	37.0	6.9	35.0	1.8	2.3	20.8	51.4	7.5	11.8	18.5	11.9	11.7	4.8	3.2	4.6	7.5	4.4	76.8	32.8	12.8	7.3	4.5	4.9	37.3	36.1	15.7	5.1	0.9	6.3	5.0	25.3	13.0	8.6	30.1	2.3	16.9	5.8	3.0	10.6	10.7	30.1	6.5	8.4	2.6	36.9	3.1	3.2	4.3	4.6	8.9	5.6	27.3	7.3	38.0	7.7	7.8	18.2	46.0	1.0	40.8	26.4	28.8	24.3	4.5	4.6	9.6	10.9	65.9	48.1	0.9	3.9	4.8	61.9	16.4	9.3	0.0	22.2	20.2	24.9	12.2	62.8	20.2	1.8	36.0	30.5	41.8	25.0	45.6	25.8	0.2	44.8	2.3	24.9	7.4	3.1	18.9	20.2	4.5	56.5	0.2	10.2	6.4	4.6	25.6	13.5	7.7	0.4	8.0	0.8	17.0	75.1	49.6	28.6	31.4	25.8	0.1	0.0	1.2	157.6	0.1	25.1	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.8	0.4	0.3	0.0	1.2	0.7	0.0	0.0	1.1	0.4	0.1	0.3	37.0	35.0	20.8	51.4	76.8	32.8	37.3	36.1	25.3	30.1	36.9	27.3	10.0	0.0	8.4	564.8	5.7	10.6	15.0	10.3	13.6	198.3	7.9	11.2	9.8	45.8	7.2	40.5	2.1	4.1	24.6	27.1	7.9	16.1	3.2	5.5	40.1	5.6	8.4	5.7	247.6	6.8	3.4	17.5	23.9	6.3	20.3	39.9	27.8	14.7	25.4	10.1	400.0	38.4	2.0	11.9	7.6	3.0	53.4	20.9	10.6	281.1	6.8	34.3	12.3	849.0	198.3	8.8	21.0	48.5	11.8	12.8	27.0	21.3	7.0	77.1	26.3	6.5	41.4	1.3	3.9	6.1	10.4	15.2	36.9	47.1	26.4	17.2
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 267.7;THP-1: 194.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 121.4;thalamus: 334.6"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		30000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	46.1	59.7	10.4	45.4	11.1	90.3	28.9	4.4	11.7	25.9	7.3	43.5	54.8	9.1	39.1	32.7	42.3	32.8	19.6	12.8	11.0	25.6	8.8	44.3	46.8	9.9	8.5	13.6	33.2	20.7	8.2	20.5	7.5	39.3	41.5	2.2	25.9	31.9	6.8	34.0	55.7	16.2	9.5	54.2	65.1	20.8	9.0	16.3	41.8	9.2	62.1	44.2	23.2	12.3	33.5	14.4	5.2	8.7	35.9	21.6	46.2	20.4	25.7	24.5	23.7	34.4	31.9	86.5	8.3	45.6	42.9	14.5	34.1	49.8	20.6	75.2	23.6	50.1	18.3	32.0	23.6	64.8	103.4	17.1	35.8	25.6	23.2	21.8	22.4	9.3	9.7	11.8	36.1	85.0	7.0	81.0	13.0	51.5	23.0	7.6	13.6	20.6	25.5	72.8	8.3	6.5	15.4	267.7	39.6	24.0	22.6	194.0	31.5	11.7	14.4	15.4	19.2	18.1	33.6	45.9	27.6	116.4	22.6	51.8	73.7	50.1	3.6	71.3	2.2	6.2	2.1	2.5	57.0	8.2	2.2	2.0	52.9	6.9	47.7	16.3	2.6	24.1	10.4	11.1	4.4	11.7	12.8	11.0	9.9	8.5	7.5	9.5	9.0	12.3	4.3	3.2	23.5	2.0	25.7	29.2	26.3	8.0	23.9	0.3	11.8	4.3	6.4	14.3	16.1	14.7	0.0	3.1	24.7	61.8	3.9	8.9	34.5	18.5	4.4	2.7	26.5	5.2	3.4	10.7	16.0	6.7	54.0	17.8	5.7	8.9	3.3	2.3	44.8	1.7	4.2	37.1	4.1	47.4	43.0	75.6	9.0	41.5	10.6	20.6	44.9	2.0	8.2	1.0	0.5	13.2	55.4	6.8	25.8	19.7	64.5	13.1	16.5	0.2	6.6	6.5	12.1	23.1	3.7	23.9	27.8	8.8	10.0	10.4	23.0	34.6
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 206.5;Excitatory neurons: 394.4;Inhibitory neurons: 531.9;Late spermatids: 456.4;Oligodendrocyte precursor cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 18.5;basal ganglia: 20.0;cerebral cortex: 34.5;hippocampal formation: 33.1;white matter: 17.1"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 27.0;TIME: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	4.4	5.6	18.5	3.7	20.0	8.0	4.2	5.5	34.5	4.6	0.0	5.7	2.6	4.4	2.3	4.1	5.7	3.0	6.2	33.1	0.0	10.0	12.5	20.1	5.7	6.0	0.2	2.8	3.3	9.4	5.2	8.3	4.4	2.9	3.3	15.4	2.7	3.0	7.6	2.7	3.5	4.1	0.0	3.9	4.1	7.6	1.1	3.1	4.9	5.3	4.2	4.9	3.4	17.1	7.7	2.7	3.8	3.8	5.8	6.7	3.1	4.9	9.5	4.3	4.5	0.7	7.0	11.3	4.8	5.5	6.1	1.8	2.5	2.8	6.1	6.9	4.4	0.1	1.8	1.5	6.5	0.9	3.8	5.8	3.0	6.5	4.7	3.6	16.0	2.4	1.6	2.6	5.0	3.8	3.8	0.5	1.3	4.2	1.4	27.0	18.3	12.4	3.9	5.1	2.6	5.7	2.4	7.6	17.1	1.4	6.1	2.6	26.8	8.2	8.5	6.1	5.1	0.0	0.0	9.3	6.7	6.3	8.4	0.0	0.5	0.7	0.3	0.1	0.4	1.5	0.2	0.2	0.8	1.8	0.5	0.1	0.1	0.4	0.6	0.3	0.0	0.3	18.5	20.0	5.5	34.5	33.1	0.0	6.0	0.2	4.4	0.0	1.1	17.1	12.6	6.4	9.2	90.4	20.7	5.0	8.4	5.0	9.1	55.3	6.4	5.7	11.9	8.6	17.2	11.0	14.6	0.5	9.3	6.1	3.9	3.7	206.5	6.8	7.0	13.8	7.7	0.4	394.4	3.8	7.2	8.7	11.2	6.9	7.0	2.9	13.2	12.5	2.8	11.8	531.9	5.8	0.0	19.0	10.7	456.4	5.3	11.5	14.2	70.3	9.4	6.5	1.0	147.8	96.0	3.6	2.9	6.0	4.2	5.3	4.1	30.2	19.3	7.6	13.1	2.9	6.4	2.8	2.3	9.0	4.8	2.9	6.8	1.2	6.2	8.8
PRKCG	"MGC57564, PKCγ, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 103.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 22.6;Glandular and luminal cells: 5.1;Horizontal cells: 5.0;Inhibitory neurons: 12.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 103.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.2;OE19: 4.0;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054560	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054560: AB_2682523"	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	0.1	0.0	47.5	0.2	44.8	0.9	0.0	5.8	64.8	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.5	0.1	0.0	103.3	4.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	1.8	3.9	1.4	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.5	0.1	0.6	0.0	0.6	5.2	12.6	3.4	0.0	0.2	0.0	0.0	0.0	18.3	0.1	2.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.6	0.1	0.6	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.3	4.0	0.1	0.4	0.2	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.7	0.7	0.0	0.4	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	44.8	5.8	64.8	103.3	4.0	0.0	3.5	0.0	0.6	12.6	18.3	1.1	0.0	0.0	1.0	0.7	0.1	0.1	0.0	0.0	0.0	2.3	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	4.2	1.2	2.0	0.5	0.0	0.0	22.6	0.0	0.2	0.6	2.0	5.1	0.0	0.0	0.0	0.0	0.1	5.0	12.8	1.5	0.0	0.0	0.0	1.8	0.0	0.6	0.0	2.8	0.0	0.0	0.0	3.0	2.0	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.2	0.0	4.0	0.4	2.9	0.9	0.1	0.0	0.0	0.2	0.0	0.4	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	6.7	5.0	2.0	6.9	2.4	2.6	10.4	2.0	3.2	12.7	0.3	12.4	11.6	11.0	8.2	15.1	15.9	11.4	6.9	3.4	1.1	13.5	7.3	16.6	4.6	0.4	0.2	13.6	7.0	13.0	3.1	10.9	0.5	17.3	13.1	6.2	17.5	12.7	6.2	6.9	10.8	11.0	0.2	5.2	34.5	12.5	0.9	10.9	24.5	9.8	10.4	16.1	6.2	1.1	81.6	20.2	20.0	21.6	17.3	23.9	32.2	20.4	29.9	26.4	28.3	29.7	38.6	24.7	65.3	28.8	36.4	37.3	37.9	40.0	44.8	18.2	23.5	22.9	24.3	16.6	27.9	20.9	10.0	21.8	27.5	22.6	35.1	42.8	20.9	13.3	25.8	19.8	27.4	28.0	30.5	8.5	42.3	86.4	22.1	21.8	30.7	41.2	42.3	24.4	31.5	25.8	44.1	57.7	20.0	29.5	63.0	14.5	22.4	27.5	21.1	26.0	34.3	33.9	34.9	35.2	19.8	16.4	11.0	0.0	0.6	0.4	1.1	0.6	1.7	0.9	1.5	2.0	0.8	1.2	1.6	0.9	0.3	2.6	0.5	0.8	1.1	0.7	2.0	2.4	2.0	3.2	3.4	1.1	0.4	0.2	0.5	0.2	0.9	1.1	17.6	73.7	82.1	23.2	5.8	57.1	49.5	39.8	30.7	16.4	29.0	19.7	16.2	24.3	45.3	49.7	14.6	30.2	15.0	29.0	25.4	16.5	8.4	42.0	29.7	20.5	29.3	10.5	77.2	22.0	26.6	32.2	59.7	72.3	8.8	20.4	17.5	17.7	10.0	15.2	55.2	28.3	50.8	18.6	26.8	6.8	23.3	11.6	17.8	22.5	12.7	8.8	6.2	33.2	33.5	55.2	18.6	28.6	29.4	99.4	18.7	20.4	31.9	9.4	19.7	23.7	18.7	15.8	20.6	38.5	63.6	20.7	14.8	14.3	28.5	80.1
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435284-11450968	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		55000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	115.3	107.6	76.4	81.2	86.7	169.6	117.6	85.1	97.6	144.0	91.4	119.7	120.0	123.0	113.0	106.5	126.2	92.0	90.4	76.4	82.0	108.8	159.9	105.5	93.3	89.9	83.9	196.9	186.2	116.3	118.3	108.8	85.9	108.5	98.9	46.6	145.9	97.8	74.8	129.3	121.7	78.5	79.6	111.2	124.9	88.5	83.3	83.9	135.5	44.9	86.2	109.9	122.6	88.8	274.8	216.7	211.6	391.5	351.2	426.4	241.5	305.5	387.6	331.5	302.7	328.3	327.5	204.4	478.1	409.2	165.4	283.4	226.3	309.6	292.1	193.3	173.5	178.0	269.4	268.8	258.0	263.0	236.4	404.5	228.6	312.5	261.4	425.6	232.8	210.1	204.8	422.4	289.0	470.1	187.9	322.1	485.0	129.7	283.3	201.8	215.3	505.6	223.2	260.1	146.9	291.5	282.3	280.4	280.5	200.8	292.5	296.7	263.6	437.1	198.2	416.0	361.0	471.9	575.3	132.3	330.1	276.8	306.5	38.8	47.2	45.1	37.9	36.2	42.6	35.9	31.8	36.4	36.1	38.7	30.2	33.1	56.3	32.8	41.2	75.7	37.5	39.5	76.4	86.7	85.1	97.6	76.4	82.0	89.9	83.9	85.9	79.6	83.3	88.8	45.2	12.8	16.9	15.3	65.1	41.8	72.2	90.0	39.9	18.2	56.9	47.5	10.5	71.4	44.9	64.4	33.3	174.9	54.6	152.0	33.2	88.7	18.1	47.4	65.0	52.0	58.8	40.6	12.3	127.5	189.1	62.6	70.3	67.2	41.9	104.5	60.3	86.4	93.4	10.1	12.5	123.2	65.1	80.0	43.4	55.9	78.6	59.3	53.4	14.0	81.4	59.8	61.8	6.0	39.0	89.0	132.8	72.6	91.4	45.9	187.8	62.7	32.7	30.2	39.5	39.8	52.0	36.8	55.2	49.5	37.8	143.5	55.5	84.2	128.2	66.6
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.6;fHDF/TERT166: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	8.0	9.6	5.6	2.2	8.0	0.0	7.7	6.5	6.7	6.4	3.7	9.5	1.0	7.9	3.5	2.1	6.5	4.4	6.1	7.5	7.5	17.5	1.6	7.5	0.3	8.6	8.6	11.2	5.4	10.6	5.6	1.9	8.7	14.7	1.3	4.7	2.9	9.3	1.6	2.8	3.6	6.3	8.9	2.3	4.6	11.7	8.1	2.4	5.9	2.6	0.5	13.1	4.6	10.3	0.0	4.4	4.8	3.1	21.6	16.5	0.1	14.1	10.4	16.7	7.3	0.0	0.3	0.0	1.9	19.4	4.0	0.1	7.9	2.1	6.8	0.0	6.2	0.0	0.0	0.5	8.8	0.0	0.1	18.4	0.3	1.4	1.5	6.1	2.6	0.0	1.4	0.4	17.4	1.8	0.0	0.0	2.6	0.0	9.6	0.0	6.3	5.2	9.7	6.6	4.3	13.0	2.6	0.0	4.5	4.6	0.0	0.1	5.6	13.6	6.7	1.0	3.7	0.0	0.0	0.0	3.5	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	6.5	6.7	7.5	7.5	8.6	8.6	8.7	8.9	8.1	10.3	4.6	0.0	7.4	362.1	0.2	0.5	4.8	0.4	0.6	1.4	1.4	1.5	1.2	10.0	0.0	12.9	6.2	0.0	0.0	0.1	29.4	2.4	39.5	2.8	9.2	6.1	3.0	2.7	147.4	4.2	0.1	6.4	0.5	8.4	0.0	18.7	10.8	2.5	0.2	1.7	171.1	0.2	0.0	1.6	0.9	16.9	7.5	0.7	7.2	89.0	0.0	16.7	0.0	390.6	76.6	2.0	0.1	12.8	0.4	12.4	0.2	4.5	0.1	2.9	0.0	13.3	4.5	3.2	7.8	0.0	0.9	0.3	0.6	29.6	0.1	1.3
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324833	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 152.1;U-266/84: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	15.1	19.9	6.1	18.1	6.8	8.7	14.4	7.8	7.3	19.3	3.9	16.4	8.2	18.9	13.8	10.7	9.9	13.3	9.8	6.0	7.5	12.0	10.1	14.7	29.1	7.2	7.1	18.0	9.1	11.7	6.5	14.9	7.8	11.7	11.0	41.6	10.5	12.5	14.9	12.2	10.3	16.2	7.6	23.4	12.4	23.3	8.1	20.7	13.4	12.1	28.9	15.5	9.5	7.1	38.8	14.3	44.4	36.1	33.2	55.1	31.5	25.0	48.8	29.1	28.7	23.4	14.0	58.5	20.1	39.6	43.2	15.0	31.1	31.9	39.0	72.3	38.7	39.2	24.4	17.8	13.8	26.2	21.5	26.0	16.2	46.2	29.7	26.6	52.6	19.9	32.3	70.9	33.8	6.1	11.6	21.6	45.4	0.4	14.2	40.8	67.9	51.8	18.9	42.1	32.5	81.0	24.6	13.9	152.1	22.8	15.1	25.1	47.7	80.0	40.5	31.5	28.5	78.1	159.7	68.2	27.8	11.2	48.7	6.9	7.7	6.1	9.5	6.7	8.1	10.6	8.5	8.1	7.7	14.6	9.6	10.8	1.4	6.9	3.6	8.1	4.4	3.6	6.1	6.8	7.8	7.3	6.0	7.5	7.2	7.1	7.8	7.6	8.1	7.1	41.4	41.7	17.8	21.9	60.2	37.9	32.1	24.1	14.8	47.6	14.7	15.5	9.1	27.1	16.6	18.4	68.8	11.2	37.7	7.3	3.9	13.1	57.1	8.3	38.5	48.0	18.8	12.0	24.8	10.6	37.0	33.0	20.4	14.1	76.9	26.8	44.3	12.2	12.8	43.7	18.7	6.9	22.4	31.2	91.2	100.6	33.5	24.4	49.8	68.4	32.7	15.9	27.8	37.7	12.6	16.1	4.3	30.9	60.2	34.3	6.6	8.6	10.3	118.8	26.3	27.5	24.0	54.7	39.9	10.6	23.9	9.7	33.5	29.1	12.3	34.1
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRKG2	"cGKII, PKG2, PRKGR2"	ENSG00000138669	"Protein kinase cGMP-dependent 2"	Q13237	4	81087370-81215117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.1;prostate: 9.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Excitatory neurons: 32.6;Inhibitory neurons: 66.1;Oligodendrocyte precursor cells: 106.6;Proximal enterocytes: 19.7;Smooth muscle cells: 29.8"	"Group enriched"	"Detected in some"	4	"melanoma: 4.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.0;ASC TERT1: 3.8;HEL: 21.2;hTCEpi: 4.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007386, CAB018739"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"			"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	1.0	0.2	2.1	0.2	1.5	0.5	1.5	0.5	1.7	1.0	0.0	2.4	9.6	0.4	0.3	2.8	0.3	0.2	4.3	1.5	1.6	0.5	0.0	3.3	0.2	3.5	2.7	0.0	1.4	0.0	2.2	0.0	3.8	9.6	2.8	0.3	0.3	3.4	0.0	1.2	13.1	0.5	2.2	0.0	0.9	0.9	6.0	1.0	0.9	0.0	0.4	0.5	0.6	1.0	0.1	0.3	0.1	0.0	5.0	3.8	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.5	0.0	0.4	0.0	21.2	0.6	0.1	0.0	0.0	0.0	0.5	4.0	0.0	0.0	1.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	1.5	0.5	1.7	1.5	1.6	3.5	2.7	3.8	2.2	6.0	1.0	0.3	35.3	2.6	1.0	0.3	0.0	0.9	0.1	1.2	0.0	0.3	0.1	4.9	0.0	2.0	0.0	0.0	0.0	0.1	5.5	0.0	0.2	10.3	0.3	0.6	0.1	0.0	8.0	32.6	0.0	0.1	2.5	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	66.1	1.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	12.2	0.1	0.0	0.0	106.6	1.1	0.9	9.2	0.0	0.5	0.8	19.7	0.2	0.8	0.0	0.0	0.1	29.8	0.0	1.3	0.8	0.1	0.0	0.4	0.0	0.7	0.3
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347417-162727775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.3;tongue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	3.4	3.3	4.1	0.1	3.6	0.3	1.9	0.4	5.7	1.3	0.6	2.7	1.2	1.6	1.2	3.2	1.2	1.5	9.1	4.6	1.8	5.2	1.2	1.0	0.5	1.0	1.9	2.8	1.2	2.3	1.8	0.4	1.6	1.2	0.6	1.5	1.3	1.4	28.3	2.0	1.0	1.2	1.0	1.0	1.9	5.3	1.9	0.5	1.3	15.9	0.3	2.5	1.0	2.4	0.0	0.0	0.3	2.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	4.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.0	0.2	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.7	0.0	0.0	0.5	1.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	1.7	0.3	2.2	0.8	0.1	1.3	0.6	0.8	0.9	0.7	1.6	1.8	1.8	0.5	0.6	0.4	0.0	0.1	0.8	4.1	3.6	0.4	5.7	4.6	1.8	1.0	1.9	1.6	1.0	1.9	2.4	2.3	9.6	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.0	0.0	1.8	1.8	0.0	0.5	0.4	0.0	19.6	1.1	0.0	3.4	1.8	0.7	0.0	0.0	0.0	2.2	0.1	1.8	0.0	3.2	2.5	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.8	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.4	3.7	0.0	0.0
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431292-178451512	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	28.7	21.9	22.1	13.8	22.6	18.2	26.4	24.6	31.3	23.6	25.3	36.4	13.7	28.7	25.7	22.8	23.4	17.5	37.2	22.8	24.9	29.7	20.2	21.2	16.9	25.0	22.5	23.4	25.4	26.2	22.5	11.5	24.2	23.4	20.1	30.9	22.6	24.3	100.7	31.2	19.7	29.4	25.2	15.9	26.0	24.3	23.1	20.4	22.1	72.7	20.4	32.1	22.0	27.1	24.6	18.4	48.2	20.8	49.2	56.7	39.6	35.4	37.7	46.4	50.8	50.9	33.8	51.0	39.8	43.6	30.9	21.0	42.0	28.5	50.9	43.9	25.0	29.2	17.0	46.7	58.6	21.2	16.1	32.2	69.3	44.0	49.7	46.0	46.8	32.8	26.7	34.9	62.9	25.3	46.3	52.2	46.7	42.3	33.5	38.5	89.0	46.6	52.4	25.5	30.2	39.4	21.9	20.2	48.3	36.3	30.6	27.4	20.8	32.0	42.6	33.8	29.9	52.5	33.7	62.6	40.8	35.1	20.7	5.4	24.7	25.9	18.1	25.5	26.2	34.3	28.4	22.7	37.2	26.4	31.4	25.8	5.1	25.2	26.3	49.7	38.3	30.9	22.1	22.6	24.6	31.3	22.8	24.9	25.0	22.5	24.2	25.2	23.1	27.1	35.1	16.0	33.4	23.2	37.7	63.1	90.0	89.3	30.1	53.6	48.1	40.3	43.5	20.0	39.9	25.8	43.8	37.7	49.3	16.9	125.2	51.4	149.5	43.6	36.2	34.5	47.9	19.1	39.5	41.6	53.2	42.7	19.4	27.0	28.5	40.5	21.8	18.5	30.4	10.1	46.4	35.5	93.6	19.8	69.4	307.9	39.4	26.4	69.4	21.5	38.6	49.2	9.2	30.7	47.1	36.0	25.1	37.2	42.5	94.7	30.8	89.0	30.6	86.2	46.0	45.6	66.7	78.7	57.6	43.7	78.4	43.4	33.6	47.0	39.6	73.0
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	Cytosol	"HPA051146: AB_2681361"	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favorable (1.94e-4)"	12.6	16.2	15.1	7.2	15.2	16.5	12.8	18.4	17.9	15.4	14.3	14.1	8.6	13.7	3.5	11.7	14.2	5.7	10.1	15.1	17.0	16.1	12.1	9.7	12.5	16.0	15.4	14.7	11.6	11.6	15.4	7.0	15.5	15.5	3.7	4.2	12.1	6.8	12.2	18.6	12.4	5.0	14.8	18.3	13.5	19.0	15.4	12.1	14.5	7.4	7.7	13.6	13.1	16.0	17.0	12.4	11.8	17.3	5.4	7.7	17.6	13.1	9.0	21.1	17.8	20.3	14.7	17.6	20.3	11.2	15.0	19.2	9.0	12.9	10.7	20.1	19.1	7.3	12.3	11.9	13.3	10.3	10.3	5.5	12.4	16.2	10.9	11.3	10.7	19.9	21.1	26.3	13.1	33.7	34.4	46.7	18.3	15.1	14.7	24.8	11.5	27.5	11.3	7.2	13.5	25.9	19.5	29.2	20.1	11.8	15.1	20.0	12.7	21.6	26.0	23.3	20.5	36.0	26.7	31.6	18.3	18.4	29.4	3.8	10.1	18.3	11.5	10.0	10.7	14.0	11.5	12.9	7.8	13.0	14.2	12.4	20.7	12.9	13.6	14.1	9.6	10.0	15.1	15.2	18.4	17.9	15.1	17.0	16.0	15.4	15.5	14.8	15.4	16.0	23.4	32.1	21.8	0.0	31.4	13.4	19.0	14.8	20.5	23.1	21.1	19.3	23.8	14.3	23.0	16.5	31.3	27.5	31.7	13.7	31.3	24.8	77.8	29.6	26.0	21.4	16.3	21.8	0.0	25.1	26.7	21.3	16.3	32.0	22.8	27.1	15.0	14.1	27.6	23.5	0.0	13.8	8.2	13.8	16.9	92.5	17.1	19.2	12.4	0.0	22.1	25.3	20.6	0.0	0.0	29.5	9.8	16.6	28.6	22.4	14.6	26.6	27.1	21.5	32.9	29.2	27.0	88.4	47.6	20.8	17.6	41.9	30.4	24.2	12.0	19.4
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22302826	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1022	"pituitary gland: 37505.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.8;Late spermatids: 28.4;Rod photoreceptor cells: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.0;SCLC-21H: 8.9;U-937: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	7200000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			3.2	11.2	0.3	1.4	0.0	0.0	1.2	0.6	0.1	0.8	0.1	2.7	0.1	11.5	0.0	11.7	1.6	0.1	4.6	0.0	0.2	2.4	9.6	2.1	0.0	0.9	0.7	4.0	5.5	0.0	37505.3	36.6	1.1	2.3	0.0	33.7	3.6	0.0	2.4	7.7	2.5	2.2	0.0	4.0	19.3	4.0	1.0	4.0	14.2	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1	0.4	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.2	0.9	0.7	1.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	13.8	0.1	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.5	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 22.8"	"Cell type enhanced"	"Detected in single"		"Endometrial ciliated cells: 1.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"medulla oblongata: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.3;MCF7: 1.8;RPMI-8226: 1.4"	"Group enriched"	"Detected in some"	58	"hypothalamus: 11.3;pons and medulla: 21.5"	"Region enriched"	"Detected in single"	14	"medulla oblongata: 5.5"	HPA014976	Uncertain				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	1.2	0.0	0.0	0.1	0.0	22.8	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	22.8	0.1	0.5	5.0	0.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRLHR	"GPR10, PrRPR"	ENSG00000119973	"Prolactin releasing hormone receptor"	P49683	10	118589997-118595648	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.2;brain: 12.7;pituitary gland: 6.9"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 7.7;Horizontal cells: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Low region specificity"	"Detected in many"			HPA039361	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039361: AB_10673527"					"unprognostic (1.83e-1)"						"unprognostic (2.62e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"		0.0	5.2	1.0	0.0	3.3	0.0	0.0	1.2	3.3	1.9	0.0	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.3	6.3	0.0	0.0	0.0	0.0	2.8	6.7	0.0	0.3	0.0	6.9	0.0	12.7	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	3.4	0.2	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.1	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	3.3	1.2	3.3	0.3	6.3	2.8	6.7	12.7	0.2	5.7	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1099	"testis: 14115.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.3	2.2	0.0	0.5	0.0	0.0	9.9	0.0	0.0	2.1	0.0	2.1	1.5	1.0	0.0	1.9	1.2	0.0	2.2	0.0	0.2	2.7	4.4	1.3	0.4	0.1	0.0	1.6	3.0	0.0	1.9	0.0	0.1	12.8	0.0	0.0	2.1	1.3	5.8	3.7	4.0	0.0	0.0	1.4	2.4	14115.0	0.0	0.0	4.3	0.0	0.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRM2	CT94.2	ENSG00000122304	"Protamine 2"	P04554	16	11275639-11276480	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1083	"testis: 11696.6"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 506606.3"	"Cancer enriched"	"Detected in single"	187	"testis cancer: 11.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 1.1;NB-4: 1.3;U-2197: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032738, HPA056386"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB032738: AB_2171312, HPA056386: AB_2683111"															"unprognostic (3.88e-2)"			1.9	1.9	0.0	0.3	0.0	0.0	8.5	0.0	0.0	1.7	0.0	1.7	0.6	1.0	0.0	1.6	1.1	0.0	1.9	0.0	0.0	2.2	3.6	1.1	0.5	0.0	0.0	1.4	2.6	0.0	1.6	0.0	0.0	10.7	0.0	0.0	1.7	0.8	4.6	3.1	3.2	0.0	0.0	1.1	2.0	11696.6	0.0	0.2	3.6	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70432.4	0.2	0.0	77.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506606.3	1538.1	115.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1673.0	0.0	0.0	0.0	0.0	0.0	0.0	913.8	0.0	0.0	1879.2	957.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 444.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA		8500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	79.7	102.2	62.5	76.2	63.2	65.0	76.7	68.1	74.7	107.0	59.4	87.2	55.1	115.4	44.5	90.7	109.7	49.8	149.2	65.7	71.1	77.9	61.8	76.5	94.0	66.5	65.2	106.7	66.3	65.6	101.1	65.3	68.8	77.1	45.5	71.3	67.6	73.9	242.6	74.8	71.8	74.0	66.3	91.6	69.4	78.4	71.3	79.6	70.9	163.2	84.5	92.6	81.6	68.7	262.5	584.9	396.5	481.7	105.4	118.7	208.4	163.7	283.1	461.8	394.0	439.5	202.2	425.9	119.0	193.4	181.1	188.0	337.3	345.8	200.1	333.7	580.5	311.5	156.4	484.6	256.8	378.7	214.2	166.7	169.3	259.2	369.0	154.8	277.1	338.3	334.0	293.2	182.5	394.1	493.2	467.0	420.5	324.9	375.6	344.8	319.9	388.8	264.0	540.9	440.0	342.4	188.9	193.2	103.4	126.9	146.8	220.6	173.9	269.9	262.5	125.4	398.6	280.0	457.4	429.3	165.7	271.0	289.8	25.0	76.8	37.5	104.0	93.8	129.6	198.9	95.4	111.0	131.5	171.6	105.2	103.3	14.8	162.3	71.9	158.9	97.7	132.5	62.5	63.2	68.1	74.7	65.7	71.1	66.5	65.2	68.8	66.3	71.3	68.7	169.7	3.2	10.3	15.7	112.4	207.0	228.7	444.9	123.5	228.9	71.3	96.8	17.2	40.0	117.3	44.1	106.3	195.6	74.4	45.1	127.2	204.0	5.4	88.9	124.5	167.8	115.2	38.3	9.8	135.2	177.5	101.7	51.5	87.5	54.7	154.2	109.6	22.1	104.1	129.5	15.8	74.5	227.9	27.0	125.7	19.4	104.1	52.9	112.1	15.9	149.4	119.3	57.7	14.6	20.2	125.6	45.6	89.1	117.8	263.0	35.2	87.5	62.8	168.7	92.1	89.7	236.3	66.8	121.8	94.9	158.8	235.2	76.8	200.7	105.0	183.2
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635595-46665124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 451.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	37.4	25.4	84.3	42.3	88.4	37.3	39.0	90.1	84.0	43.5	79.6	50.2	27.0	43.2	26.8	55.2	47.0	42.5	56.3	81.4	105.6	36.8	14.4	40.7	57.1	100.7	123.9	82.6	27.4	29.9	27.9	49.3	104.7	38.1	30.4	23.1	38.6	48.3	20.4	51.1	36.7	50.4	91.8	49.8	32.1	16.4	100.0	45.2	36.0	21.8	52.7	44.4	38.2	106.5	75.7	63.4	130.2	48.1	94.0	90.1	31.1	70.6	79.0	77.4	70.2	88.8	60.4	44.5	85.6	126.9	104.3	22.0	59.3	87.4	44.7	110.1	57.2	115.8	55.0	67.4	43.3	34.9	51.7	56.1	85.0	93.4	66.6	87.6	114.5	61.2	74.5	80.4	121.0	84.1	50.3	63.9	69.3	47.5	73.6	63.2	33.2	29.6	61.1	63.3	89.4	56.6	73.8	33.0	135.0	18.5	44.1	35.2	104.8	75.2	50.5	40.4	47.4	21.2	21.0	28.6	70.4	92.4	115.3	256.5	91.9	314.2	261.8	128.4	192.0	93.6	176.3	227.2	131.5	82.7	215.9	248.8	122.3	262.0	135.3	112.7	142.3	223.2	84.3	88.4	90.1	84.0	81.4	105.6	100.7	123.9	104.7	91.8	100.0	106.5	71.5	93.0	36.2	54.5	74.4	46.1	69.8	79.1	66.6	47.7	93.2	103.5	69.5	67.2	61.8	75.4	29.2	64.3	192.9	49.4	90.1	79.1	3.5	51.9	60.2	82.9	35.8	27.3	39.2	52.9	43.5	68.0	48.9	46.1	117.0	132.0	142.8	42.1	107.2	37.0	42.6	32.6	52.9	133.7	102.1	9.0	55.6	109.3	87.2	74.0	182.9	61.1	451.1	69.4	160.6	74.9	40.0	62.1	64.6	94.0	44.0	113.5	71.4	57.7	65.7	53.2	77.2	22.0	39.0	75.0	45.0	69.2	167.1	55.0	38.3	72.9
PRMT3	HRMT1L3	ENSG00000185238	"Protein arginine methyltransferase 3"	O60678	11	20387558-20509338	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Excitatory neurons: 55.5;Inhibitory neurons: 66.9;Oligodendrocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007832, CAB022083"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022083: , HPA007832: AB_1855721"	"unprognostic (2.08e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.01e-1)"	"unprognostic (9.92e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	5.0	7.4	4.5	8.1	5.4	8.6	9.6	5.0	8.3	5.1	3.7	6.5	7.6	7.7	3.8	8.2	8.5	5.4	9.7	5.2	5.3	6.9	5.4	4.7	7.8	5.4	5.0	8.1	6.7	11.1	2.6	6.9	5.5	6.1	7.7	7.7	6.5	5.7	10.2	6.2	5.9	7.3	5.0	5.5	6.6	4.3	4.8	9.9	19.8	7.7	8.8	8.0	4.6	7.9	26.5	31.4	18.9	17.4	11.8	19.5	36.1	17.9	15.5	24.5	18.5	25.9	7.2	55.8	12.8	14.1	22.4	34.0	27.2	25.6	37.7	26.1	26.4	26.9	25.5	23.3	24.0	48.8	11.4	16.3	26.3	16.1	54.6	10.3	19.7	19.8	61.1	15.3	15.6	26.7	38.6	16.6	26.7	45.1	27.8	27.9	42.3	46.3	23.8	20.2	18.9	24.8	31.0	28.5	23.2	20.3	30.1	14.1	13.3	19.8	17.3	32.7	34.2	9.1	9.7	58.3	15.7	34.1	39.0	3.8	5.1	4.4	4.4	6.1	7.7	5.3	5.5	4.9	9.8	4.9	6.0	5.2	1.3	10.7	5.2	2.0	3.6	3.9	4.5	5.4	5.0	8.3	5.2	5.3	5.4	5.0	5.5	5.0	4.8	7.9	5.5	9.6	5.1	54.2	11.8	6.0	7.7	6.7	15.9	3.8	6.5	4.2	11.8	4.3	5.7	0.0	2.1	11.4	5.0	3.2	9.8	6.9	3.1	6.0	8.2	5.5	7.8	29.2	55.5	5.1	11.0	8.9	11.2	5.5	5.7	8.0	2.9	4.3	6.5	6.7	66.9	7.3	14.2	5.3	3.6	1.0	6.5	10.9	3.6	35.6	6.7	5.6	2.1	41.7	63.2	5.1	2.2	6.4	8.9	9.5	3.5	5.9	5.8	6.6	0.0	7.8	6.7	13.7	9.6	18.7	5.8	7.3	7.0	12.5	7.6	5.7
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920525-22929408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	27.6	31.0	19.9	27.9	21.6	21.7	34.9	21.0	25.9	33.3	24.4	38.4	24.0	36.9	30.6	49.0	44.6	19.4	35.1	20.9	21.8	37.0	28.3	23.2	26.6	20.2	22.2	45.3	32.9	47.3	24.5	30.6	22.0	27.9	35.6	30.8	27.7	33.3	65.8	34.4	23.3	35.5	20.4	26.3	29.2	30.3	21.6	33.1	37.9	42.1	34.3	31.4	33.5	22.8	161.7	169.2	114.2	112.9	62.3	67.7	125.6	104.1	91.6	192.7	156.6	159.2	160.1	171.3	83.2	88.5	108.3	135.8	246.4	212.8	213.9	98.5	119.3	104.5	108.3	256.3	111.4	221.7	85.7	69.3	113.2	143.1	264.8	72.7	91.0	128.5	160.0	91.7	108.5	171.4	151.3	102.9	103.1	160.8	221.8	176.0	140.3	122.7	98.8	110.7	126.0	79.8	125.7	132.3	65.5	94.3	91.3	82.6	70.9	75.1	103.1	103.0	145.9	116.6	246.0	207.2	46.1	109.2	116.0	3.0	31.3	0.4	14.2	31.7	22.9	30.6	19.0	23.0	42.8	27.9	24.4	20.4	7.7	19.8	25.1	25.9	17.6	29.1	19.9	21.6	21.0	25.9	20.9	21.8	20.2	22.2	22.0	20.4	21.6	22.8	8.5	19.2	15.1	5.5	11.4	26.5	26.5	33.8	15.4	10.8	13.9	15.4	1.1	28.6	19.4	7.3	8.4	41.7	8.6	11.1	23.5	32.0	2.3	18.5	21.4	12.3	6.1	24.4	6.1	27.0	33.4	16.7	12.8	12.6	7.0	21.9	10.4	15.1	19.6	16.8	5.8	17.5	20.3	4.4	11.7	3.7	16.4	8.0	26.6	0.0	11.8	18.2	3.1	5.5	4.0	92.8	12.7	21.1	12.4	23.6	7.4	24.6	31.1	11.2	6.6	25.9	19.5	43.1	47.3	20.3	27.8	33.4	8.2	27.5	21.1	17.9
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056674-107067636	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 308.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	4.9	10.0	5.7	7.2	5.6	4.2	8.0	5.6	5.7	6.1	13.8	7.9	6.1	7.0	8.0	6.8	8.8	6.0	3.9	5.2	6.9	12.0	7.1	4.6	9.6	6.1	6.5	8.6	10.9	9.6	8.4	7.3	5.3	8.5	7.2	6.4	6.5	7.8	1.8	5.6	7.2	5.9	5.5	8.3	7.4	6.6	8.2	10.3	7.0	3.1	8.7	7.9	5.0	6.0	13.6	0.2	25.7	11.3	16.6	18.4	7.0	17.8	13.2	16.9	17.2	17.2	9.2	33.1	24.1	16.5	9.2	18.9	23.9	26.2	13.3	0.0	25.4	20.0	35.6	25.0	16.5	41.6	11.9	17.4	14.2	15.2	15.5	11.4	14.8	18.5	27.1	5.0	15.4	308.1	24.5	14.6	11.1	10.6	24.6	30.8	56.0	12.6	41.3	27.1	47.8	58.3	24.2	34.5	12.1	15.5	24.0	30.7	17.2	12.5	25.5	26.3	26.8	5.4	4.0	5.7	18.4	19.3	10.2	2.1	10.4	1.9	7.9	11.9	9.5	7.4	8.3	7.6	14.1	10.3	11.5	11.9	0.6	17.4	12.0	17.2	9.2	9.3	5.7	5.6	5.6	5.7	5.2	6.9	6.1	6.5	5.3	5.5	8.2	6.0	3.0	0.0	4.4	1.3	6.2	4.5	6.9	9.7	8.6	14.2	8.9	5.0	2.6	5.7	5.8	14.7	0.0	18.3	8.5	3.3	27.4	10.3	1.2	5.2	6.2	4.7	17.5	15.8	1.5	7.4	14.6	6.7	4.6	4.9	1.3	9.4	7.5	2.4	10.0	15.2	2.2	7.4	8.2	7.0	1.6	3.0	8.7	3.8	1.8	3.7	3.9	6.9	3.1	2.0	2.2	4.7	8.5	9.1	2.0	5.1	4.1	18.4	7.4	5.1	13.1	5.9	6.3	9.1	8.1	8.9	6.1	7.1	5.0	13.7	10.3	5.4
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PRMT8	"HRMT1L3, HRMT1L4"	ENSG00000111218	"Protein arginine methyltransferase 8"	Q9NR22	12	3381349-3593973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;retina: 3.9;testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.7;Cone photoreceptor cells: 16.7;Early spermatids: 22.8;Excitatory neurons: 60.5;Inhibitory neurons: 63.8;Late spermatids: 15.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"hTERT-HME1: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039747, HPA069769"	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039747: AB_2732482, HPA069769: AB_2686193"	"unprognostic (3.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.80e-3)"	"unprognostic (9.41e-2)"		"unprognostic (3.41e-5)"	"unprognostic (5.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.49e-2)"	0.0	0.0	3.2	0.0	7.8	0.0	0.0	3.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	5.4	1.5	0.6	0.0	0.8	0.0	2.1	3.0	0.0	0.6	0.0	0.1	0.0	0.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	4.0	1.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.8	3.8	7.2	5.4	1.5	2.1	3.0	0.7	0.3	4.0	3.6	0.0	6.4	1.7	1.6	0.1	0.0	0.0	0.0	0.0	21.7	0.1	0.0	1.3	0.0	5.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	22.8	2.2	0.1	0.3	0.0	0.0	60.5	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.0	63.8	0.0	4.1	0.0	4.2	15.4	0.6	0.4	0.0	1.0	0.0	0.7	0.0	3.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	7.5	1.6	0.0	0.0	0.2	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	3.2	9.9	1.4	2.8	1.8	8.5	4.1	3.1	2.4	2.8	1.8	2.3	1.4	4.6	3.1	2.9	3.3	3.0	2.8	2.0	1.8	4.3	3.4	3.2	3.5	1.4	1.6	11.3	3.3	6.1	3.6	3.0	1.5	3.4	2.6	5.2	2.7	3.3	3.3	2.8	1.8	2.7	1.6	2.8	3.1	7.1	1.7	4.5	5.7	2.5	3.0	2.5	2.3	1.6	2.8	1.8	4.3	3.3	3.3	5.6	3.8	3.1	4.9	4.6	4.8	1.4	3.1	9.8	1.3	2.7	2.3	1.9	5.1	2.6	6.3	3.5	3.0	5.4	3.6	2.3	2.5	8.0	2.8	3.9	2.7	2.8	2.5	3.7	3.9	4.8	5.4	5.5	3.9	1.6	6.8	3.1	2.2	2.7	3.2	4.5	3.7	3.6	3.7	2.2	2.7	4.1	4.9	3.8	2.5	2.8	1.6	1.7	3.3	2.9	2.4	3.3	3.4	6.2	5.3	6.1	3.3	4.8	2.2	6.1	4.2	8.6	4.7	4.7	4.6	7.4	5.7	5.8	3.0	7.2	7.1	6.2	2.8	4.3	3.5	4.4	5.5	2.1	1.4	1.8	3.1	2.4	2.0	1.8	1.4	1.6	1.5	1.6	1.7	1.6	8.7	0.0	5.3	9.8	40.4	0.0	4.2	0.0	26.7	56.5	11.7	21.8	5.9	7.2	0.6	35.0	112.6	14.5	51.6	6.2	5.9	7.0	73.1	9.2	9.5	8.4	17.4	10.3	29.8	6.5	14.8	12.9	11.2	13.0	33.7	15.6	12.8	6.9	17.2	50.5	29.8	7.2	0.0	36.5	0.0	13.4	18.0	63.7	0.0	17.8	10.9	48.1	16.5	20.6	16.3	7.4	6.2	17.0	18.4	4.1	7.4	5.5	1.5	81.1	13.1	6.2	18.5	36.5	19.6	4.3	0.0	15.2	61.2	18.5	6.3	2.0
PRND	"dJ1068H6.4, DOPPEL, DPL, PrPLP"	ENSG00000171864	"Prion like protein doppel"	Q9UKY0	20	4721909-4728460	"Predicted membrane proteins, Transporters"	Fertilization	Prion		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"choroid plexus: 31.3;testis: 70.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.3;Endothelial cells: 17.7;Late spermatids: 11.2;Spermatocytes: 4.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043373	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA043373: AB_2678450"	"unprognostic (1.69e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.63e-3)"	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.7	0.2	0.1	31.3	1.9	0.1	4.1	0.0	0.1	0.0	1.2	0.2	1.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.1	0.2	0.0	1.2	0.0	0.1	0.1	70.9	0.6	0.1	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.0	0.0	0.3	0.0	0.2	0.0	0.6	0.1	5.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.1	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	11.2	2.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	4.7	1.9	0.0	0.0	0.0	0.1	1.3	0.0	0.2
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.3;skeletal muscle: 81.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	1.4	4.8	4.2	0.9	3.3	0.4	1.5	3.5	2.5	1.4	2.2	1.9	1.2	1.7	0.4	1.0	2.1	0.4	23.3	3.3	4.5	1.7	0.6	0.9	1.0	6.4	7.8	0.6	0.4	2.3	2.9	0.6	4.9	3.3	0.1	0.3	2.4	1.3	81.0	0.7	1.6	0.5	6.1	1.6	1.2	0.8	5.0	0.7	1.0	18.4	0.6	1.6	1.0	2.9	1.5	0.6	0.3	0.3	0.1	0.3	0.5	1.2	0.3	1.3	1.1	4.3	2.6	5.7	1.1	3.9	0.1	0.7	0.5	0.1	0.3	104.7	1.4	1.4	2.7	0.5	3.0	0.0	3.2	0.9	0.7	2.8	0.6	0.7	0.1	3.7	0.5	5.7	4.1	1.2	4.9	2.6	1.4	0.6	2.7	15.4	0.4	12.5	0.2	0.1	1.3	0.7	6.0	4.5	0.2	1.3	2.1	3.0	0.4	0.1	0.4	0.2	0.4	1.0	1.8	9.2	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	3.3	3.5	2.5	3.3	4.5	6.4	7.8	4.9	6.1	5.0	2.9	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.2	0.0	0.4	0.1	29.7	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.2	2.4	1.5	2.5	0.0	0.4	0.0	0.0	0.3	1.2	1.1	0.9	0.0	0.7	2.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.1	1.2	3.0	0.3	0.0	2.4	0.0	0.2	6.6	5.6	2.9	0.4	0.8	0.3	0.0	2.6	0.4	2.4	0.6	0.3
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 598.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.2	0.0	0.6	0.1	1.1	1.1	0.1	0.6	1.0	0.4	0.0	1.0	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	1.0	14.8	598.5	0.2	0.6	1.6	0.8	0.2	0.3	0.0	0.3	0.1	1.5	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.4	0.4	2.6	0.1	0.8	0.6	0.2	0.0	0.3	0.4	0.2	1.1	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.6	1.1	0.6	1.0	0.6	1.0	1.6	0.8	1.5	0.4	0.8	1.1	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 177.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 6882.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.6;NB-4: 6.0;REH: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023648, HPA030218"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Golgi apparatus"	"HPA023648: AB_1855726, HPA030218: AB_10601152"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	2.4	1.7	3.3	1.4	3.2	1.5	1.9	3.8	4.9	3.9	2.9	2.0	1.1	2.9	0.4	1.5	4.3	0.7	2.3	3.1	3.4	8.2	1.2	2.6	2.2	3.7	3.5	6.1	0.9	0.3	2.9	0.6	3.4	3.5	0.4	1.2	1.7	0.5	0.9	1.5	4.0	0.7	3.3	9.8	2.0	177.5	3.2	1.4	1.8	0.5	0.8	2.2	2.7	3.4	0.6	0.9	1.6	5.6	1.0	1.6	1.6	0.9	0.6	0.7	0.6	0.9	2.0	0.0	0.3	0.8	0.1	0.8	1.7	0.2	0.3	1.1	0.4	2.7	1.7	0.4	0.4	4.5	0.1	0.7	0.3	1.2	0.0	0.7	0.1	0.7	2.6	1.6	0.6	0.2	3.3	6.0	4.4	0.3	0.5	7.1	2.4	0.1	0.6	0.2	0.4	0.7	0.4	0.1	0.5	1.0	2.5	3.9	0.5	0.2	1.0	0.6	0.3	0.7	1.0	1.2	0.4	4.1	0.8	4.9	1.1	3.5	0.5	1.6	0.2	1.9	1.1	0.3	0.6	0.5	0.4	0.8	0.7	0.6	1.2	2.5	0.6	0.5	3.3	3.2	3.8	4.9	3.1	3.4	3.7	3.5	3.4	3.3	3.2	3.4	2.3	0.0	1.1	4.6	2.8	1.0	1.2	1.0	0.6	3.7	1.5	1.9	6.6	1.5	1.9	0.0	4.2	0.8	3.9	0.8	0.0	0.6	1682.9	5.3	2.4	2.7	2.4	3.0	0.8	0.2	1.9	2.7	1.1	2.4	15.2	4.2	4.2	0.2	2.8	3.3	1.1	1.5	2.0	5.3	2.9	6882.6	25.4	6.8	0.0	3.7	2.5	7.9	1.0	2.0	0.9	0.6	0.3	19.5	1.2	0.8	2.0	1.2	3.9	4.4	19.7	1.5	2.4	79.2	21.7	1.1	0.3	0.7	2.6	7.5	1.7	0.7
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172072-35216240	"Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 126.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 114.2;Fibroblasts: 83.4;granulocytes: 63.1;Hepatic stellate cells: 74.6;Sertoli cells: 170.9;Syncytiotrophoblasts: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 385.0;HUVEC TERT2: 611.1;TIME: 365.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 8.9"	HPA039461	Enhanced					NA	NA		980000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA039461: AB_10673359"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.62e-6)"	"unprognostic (3.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.19e-2)"	126.8	23.1	6.8	19.6	7.3	8.6	53.9	12.0	7.7	31.2	14.6	25.2	16.3	36.2	13.4	12.0	42.9	21.2	43.5	7.0	6.8	15.6	6.8	19.8	10.0	8.9	7.3	18.0	12.6	6.1	8.6	31.3	8.8	19.5	21.4	1.8	8.7	17.3	10.1	25.2	21.4	28.4	7.5	27.5	23.2	5.0	8.9	3.0	26.0	10.3	4.0	34.2	28.4	10.1	15.2	88.9	0.2	9.2	93.6	76.1	20.2	20.8	90.4	33.7	65.2	115.2	76.7	2.9	63.3	21.0	93.6	48.5	20.2	131.8	27.8	0.7	27.5	33.2	19.8	4.7	22.8	1.3	385.0	65.1	48.8	159.0	131.1	49.2	611.1	1.1	11.8	4.2	35.3	5.0	1.1	1.6	12.2	18.8	90.4	0.6	16.7	0.4	58.3	5.8	2.7	1.2	11.3	23.9	18.8	11.0	8.1	5.0	365.5	86.0	43.2	32.8	35.4	0.3	1.1	0.9	99.1	33.5	18.6	5.0	1.5	0.8	8.2	1.8	14.8	0.9	2.5	5.2	7.8	1.3	0.6	5.9	4.0	3.3	1.3	1.3	2.2	2.2	6.8	7.3	12.0	7.7	7.0	6.8	8.9	7.3	8.8	7.5	8.9	10.1	19.9	0.0	12.6	2.3	0.5	13.9	18.5	10.1	10.2	0.5	1.1	4.4	2.4	5.7	4.9	5.5	0.0	12.1	2.0	0.5	1.9	32.2	1.6	1.0	24.0	58.8	6.0	2.7	3.6	16.4	114.2	83.4	1.5	0.9	63.1	15.9	74.6	1.9	21.9	1.7	2.5	0.7	0.0	1.6	8.8	1.0	15.5	13.5	3.6	9.4	2.2	0.3	7.2	0.5	5.6	15.6	0.5	2.6	0.6	9.7	9.8	6.3	1.8	0.6	170.9	4.3	45.9	20.4	19.7	2.8	8.4	69.0	4.4	4.2	2.0	11.9
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.1;liver: 173.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1	173.6	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771655-71785206	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 64.5;lymphoid tissue: 22.5"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 5.9;Kupffer cells: 8.0;Macrophages: 11.3;monocytes: 6.9;Spermatocytes: 23.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Region enriched"	"Detected in many"	7	"cerebral cortex: 13.3"	"Immune cell enriched"	"Detected in many"	50	"neutrophil: 414.4"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 414.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.2;NB-4: 8.9;NTERA-2: 5.5;U-266/70: 12.0;U-266/84: 20.8;U-937: 8.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.1;olfactory bulb: 3.5"	"Low region specificity"	"Detected in all"			HPA041408	Approved				"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	7.2	0.3	0.7	17.7	0.5	64.5	0.3	0.1	13.3	0.4	0.7	0.4	0.3	0.2	0.0	0.4	2.7	1.2	1.0	0.2	0.5	0.6	2.5	13.1	0.2	0.5	1.0	0.2	1.1	0.0	0.4	3.1	1.2	0.2	0.2	0.1	0.3	0.0	0.5	0.1	0.5	1.5	0.2	22.5	0.6	11.4	1.9	1.1	0.5	4.2	0.5	6.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	0.0	0.3	8.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	20.8	0.0	0.0	8.3	0.0	0.0	8.2	3.5	3.4	0.7	0.0	0.0	2.7	2.9	0.7	0.0	0.9	5.0	414.4	0.0	0.2	0.3	1.7	3.1	0.7	0.5	0.1	13.3	0.2	0.5	0.5	1.0	1.2	0.2	1.9	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	1.8	0.0	0.0	2.5	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	8.0	0.3	2.8	0.3	11.3	1.8	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	23.8	2.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0
PROKR1	"GPR73, GPR73a, PKR1, ZAQ"	ENSG00000169618	"Prokineticin receptor 1"	Q8TCW9	2	68643579-68658251	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.6;epididymis: 3.5"	"Cell type enhanced"	"Detected in single"		"Adipocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"					"Low region specificity"	"Detected in all"			HPA029396	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA029396: AB_10610285"	"unprognostic (5.46e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.72e-2)"	"unprognostic (8.96e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.19e-1)"	"unprognostic (7.22e-2)"	1.6	1.1	0.0	0.2	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.6	0.4	0.5	0.4	0.1	0.1	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5299218-5316954	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 1.7"	"Region enhanced"	"Detected in many"		"olfactory bulb: 17.0"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	1.3	0.1	1.4	0.8	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.5	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.0	0.1	0.1	0.4	0.2	0.0	1.3	1.4	0.2	0.9	1.2	0.2	0.1	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 272.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.3	0.3	4.1	6.2	3.0	4.0	27.7	2.7	3.5	44.9	2.0	30.7	12.4	6.0	4.3	5.1	5.4	30.9	6.7	3.3	2.8	20.9	1.8	3.1	0.0	3.8	4.3	0.1	14.4	0.0	0.1	30.1	3.6	2.8	16.7	272.9	57.9	7.1	1.0	0.9	22.9	3.5	2.8	0.2	24.8	8.0	5.0	0.1	4.8	0.0	0.1	4.2	0.2	3.1	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	70.6	28.9	0.6	62.2	0.0	0.0	0.1	7.3	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	97.4	0.0	0.0	1.4	0.1	0.0	91.1	0.1	12.0	3.6	0.0	2.4	1.9	3.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.0	2.7	3.5	3.3	2.8	3.8	4.3	3.6	2.8	5.0	3.1	0.2	3.2	4.8	1.3	0.3	0.0	0.1	7.2	0.0	14.8	38.2	30.0	8.6	31.5	29.9	82.8	581.7	0.6	1.0	39.3	0.0	64.1	31.4	71.1	1.7	5.1	44.4	2.1	0.9	15.5	0.1	4.4	31.6	14.8	0.0	3.8	0.7	0.1	0.1	10.1	5.4	15.0	34.6	0.0	0.0	44.3	3.1	0.7	0.0	27.2	0.6	47.5	0.0	45.8	1.2	38.2	28.3	6.4	0.4	1.5	18.8	3.6	144.8	311.3	0.0	0.8	3.1	2.1	1.0	0.7	0.0	0.1	0.7	0.3	26.0	4.1
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PROP1		ENSG00000175325	"PROP paired-like homeobox 1"	O75360	5	177992235-177996242	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"pituitary gland: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049839	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA049839: AB_2732557"										"unprognostic (2.90e-1)"		"unprognostic (4.90e-1)"		"unprognostic (2.13e-2)"				0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRORP	"KIAA0391, MRPP3"	ENSG00000100890	"Protein only RNase P catalytic subunit"	O15091	14	35121846-35277622	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	11.3	17.0	11.0	17.0	12.2	12.2	13.9	12.4	16.1	13.6	16.6	19.9	15.3	8.4	16.7	19.2	11.8	10.4	13.7	11.4	12.1	25.0	24.9	12.5	21.2	13.2	12.5	7.0	10.6	19.3	9.7	11.0	12.8	10.6	20.8	6.2	13.1	9.6	15.1	17.3	14.5	11.9	11.6	13.6	13.6	12.1	13.1	31.1	15.6	17.1	22.5	15.4	11.9	14.4	47.5	34.9	23.6	33.1	25.1	21.0	22.7	31.1	25.3	35.9	26.1	35.8	26.3	53.0	39.0	27.2	9.9	33.9	43.8	47.3	36.5	39.2	12.9	22.6	24.9	77.9	25.2	27.2	23.0	28.3	37.7	33.9	31.6	30.2	50.0	41.3	38.4	13.6	42.5	54.9	46.0	33.3	26.8	30.4	33.4	42.9	40.4	28.1	52.6	44.6	24.0	25.0	40.0	43.3	26.8	29.0	55.4	23.9	44.5	30.7	25.7	22.1	25.8	15.5	40.4	53.9	14.5	32.0	32.5	30.9	10.3	7.2	30.3	9.6	43.9	20.1	47.3	32.8	13.8	14.4	41.6	30.1	14.4	24.7	8.2	20.4	56.1	24.3	11.0	12.2	12.4	16.1	11.4	12.1	13.2	12.5	12.8	11.6	13.1	14.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 107.5;heart muscle: 116.6;liver: 283.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 83.1;Hepatocytes: 307.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 64.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	5000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	33.6	8.7	1.7	8.1	1.3	0.3	24.7	1.6	2.7	14.9	107.5	17.3	13.5	16.4	2.0	16.6	19.4	33.7	116.6	3.2	2.2	37.7	283.1	39.2	4.7	2.1	2.4	32.6	5.6	13.5	8.5	32.0	2.2	8.4	21.6	4.6	12.3	10.3	4.9	20.5	20.6	19.2	1.6	11.2	10.5	5.0	2.3	1.5	17.0	16.9	3.7	18.5	15.1	1.7	0.4	2.7	3.0	27.1	112.3	100.1	1.6	4.6	9.4	1.0	6.6	12.7	1.4	0.0	30.0	3.0	18.8	0.0	1.4	0.9	1.8	0.1	7.3	51.4	1.4	29.8	8.7	1.5	1.2	78.2	0.4	4.0	0.6	63.0	7.2	3.7	32.8	0.1	49.2	0.0	0.1	0.0	3.1	2.7	6.5	0.3	1.2	0.0	27.7	0.0	7.6	19.8	5.0	0.0	157.0	0.6	0.0	19.9	9.4	14.8	2.8	8.2	1.7	0.0	0.0	0.0	60.4	30.4	27.8	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	3.2	1.7	1.3	1.6	2.7	3.2	2.2	2.1	2.4	2.2	1.6	2.3	1.7	55.9	64.1	33.8	17.9	1.9	14.8	3.6	2.1	4.0	0.5	1.7	14.0	44.6	14.3	7.5	1.8	10.4	0.6	0.5	7.5	3.9	9.8	3.2	2.1	30.7	47.1	15.7	16.4	28.4	4.4	0.7	83.1	2.0	1.1	30.9	5.0	65.7	307.1	12.8	1.7	19.7	11.6	0.0	31.5	20.6	6.3	28.6	14.6	19.6	27.2	1.3	22.8	0.0	10.6	4.6	5.6	19.3	36.9	0.3	4.5	1.9	42.2	56.6	8.1	13.1	32.4	28.4	0.4	0.7	11.8	33.2	1.6	2.1	10.8	12.6	2.3
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009865-39038089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	9.0	7.7	4.7	11.1	5.1	25.5	9.1	7.0	6.2	7.6	4.4	12.8	10.6	9.0	9.0	11.6	7.2	6.0	8.9	4.8	4.3	9.0	9.5	12.2	13.4	6.7	5.2	6.9	15.5	5.7	7.7	21.0	5.9	10.6	13.7	9.9	13.6	6.2	10.1	15.8	12.4	7.8	5.1	12.8	10.9	12.7	5.0	14.0	10.0	7.2	14.6	8.5	9.4	6.9	16.0	12.2	37.3	25.9	12.5	10.0	59.1	14.8	13.0	14.6	15.5	39.0	24.3	37.1	11.7	14.5	19.7	26.9	40.5	26.6	23.8	56.6	33.1	54.7	13.4	27.1	28.5	57.7	32.4	13.3	31.4	23.2	52.3	9.0	24.2	41.9	27.6	21.8	15.7	27.8	35.2	30.6	55.8	31.4	13.0	36.6	39.6	23.3	14.6	24.6	21.0	24.2	10.4	26.8	21.7	28.9	28.8	32.9	22.2	8.4	13.5	16.7	18.9	20.2	22.6	39.7	13.6	31.5	16.8	4.6	1.9	0.4	2.8	1.6	3.1	2.0	2.8	3.0	2.2	1.4	2.4	2.6	0.5	4.2	2.5	2.5	1.7	2.7	4.7	5.1	7.0	6.2	4.8	4.3	6.7	5.2	5.9	5.1	5.0	6.9	9.5	3.2	15.3	13.7	11.7	7.0	5.2	4.6	8.0	11.7	8.4	7.6	6.2	5.7	5.6	0.0	8.4	19.3	19.4	12.7	1.9	7.3	16.8	9.0	9.4	10.0	11.4	6.3	16.8	13.5	18.5	6.4	11.2	12.1	12.0	12.5	8.6	6.0	10.4	16.8	12.7	16.3	0.0	16.3	8.0	5.6	6.5	9.9	5.4	12.2	9.9	4.5	13.4	14.1	27.3	15.0	19.2	4.9	16.9	11.2	6.5	3.6	6.0	9.5	0.0	7.8	7.2	14.0	11.6	10.5	7.2	26.8	11.5	5.2	14.8	8.1
PROSER2	"C10orf47, MGC35403"	ENSG00000148426	"Proline and serine rich 2"	Q86WR7	10	11823339-11872277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 41.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 28.4;Glandular and luminal cells: 28.4;Hepatocytes: 31.2;Prostatic glandular cells: 34.6;Urothelial cells: 69.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CAPAN-2: 99.5;HBEC3-KT: 64.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 14.4"	HPA041337	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA		220000		"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA041337: AB_10794663"	"unprognostic (2.36e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.60e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.69e-2)"	4.5	1.6	1.9	1.0	2.0	10.4	4.1	1.4	1.6	3.6	4.8	3.1	1.2	3.4	0.5	9.9	3.8	1.7	1.8	1.7	1.8	14.0	41.0	9.8	0.3	1.9	2.3	2.4	7.5	0.5	1.9	7.2	2.0	9.1	1.8	0.1	6.9	2.2	2.0	5.1	1.7	1.0	1.7	7.3	6.6	6.1	3.1	1.9	6.7	0.4	2.8	4.0	6.0	1.3	86.5	12.1	0.7	0.3	2.5	3.1	4.9	3.8	1.8	3.0	1.5	28.1	99.5	0.0	15.1	0.3	1.3	22.1	8.4	64.2	1.5	0.1	20.3	9.8	4.8	18.4	14.2	0.0	5.9	3.6	13.6	17.8	19.9	0.3	9.2	1.6	15.0	0.1	4.3	11.7	0.0	3.2	5.3	11.3	6.9	13.9	11.3	0.0	6.6	4.2	0.1	1.1	6.5	24.9	11.1	4.1	13.1	5.3	6.8	0.1	19.7	33.2	0.4	0.0	0.2	0.1	0.1	3.4	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.9	2.0	1.4	1.6	1.7	1.8	1.9	2.3	2.0	1.7	3.1	1.3	3.0	9.6	5.9	1.3	0.0	5.7	28.4	8.2	8.6	0.0	5.5	5.2	1.1	18.6	6.5	5.5	0.0	5.5	0.2	3.2	5.9	11.6	3.0	18.6	2.8	3.7	1.8	2.5	0.7	3.8	18.3	3.6	6.1	28.4	0.0	1.9	1.1	31.2	0.8	0.0	0.7	1.3	2.0	0.3	0.7	3.0	1.8	3.7	3.6	6.5	0.1	0.1	0.0	0.5	0.4	20.0	1.5	4.5	0.0	34.6	0.2	0.8	6.8	0.1	0.0	0.6	1.3	3.7	5.6	4.6	4.7	0.7	0.5	0.7	2.6	69.4
PROSER3	"C19orf55, FLJ30657"	ENSG00000167595	"Proline and serine rich 3"	Q2NL68	19	35758143-35771028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 89.6;Rod photoreceptor cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA058492	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA058492: AB_2683733"	"unprognostic (1.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.25e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (3.74e-7)"	"unprognostic (8.60e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (9.54e-2)"	2.3	2.4	3.4	4.3	3.7	5.2	2.3	2.3	5.2	3.4	6.7	2.9	1.8	3.8	2.8	2.5	4.3	3.3	2.5	2.8	0.6	1.9	1.3	2.7	3.0	3.6	2.7	4.1	5.1	3.1	3.8	2.8	1.6	2.4	1.9	3.6	2.6	3.1	1.7	5.8	2.6	3.3	0.0	2.9	4.0	8.8	2.6	4.6	3.8	1.4	2.6	3.1	2.9	2.5	9.3	26.7	9.4	9.3	3.7	3.8	3.1	6.7	7.6	7.3	7.7	8.2	6.3	5.2	7.3	6.4	3.5	5.5	4.0	11.8	4.9	12.5	6.8	7.5	12.2	3.4	3.2	6.0	15.6	4.6	6.5	10.2	9.0	5.7	3.2	6.7	6.6	9.3	6.4	4.6	10.7	2.5	2.6	5.4	3.9	8.2	2.3	3.9	4.7	9.8	9.2	8.1	7.4	5.4	1.0	3.5	8.7	5.1	8.2	7.7	8.1	8.0	7.2	11.9	8.6	4.2	8.0	3.8	6.1	5.7	1.7	4.0	1.1	1.0	1.9	2.4	1.7	1.0	0.4	2.6	1.4	0.5	10.3	0.8	1.0	1.5	1.6	0.2	3.4	3.7	2.3	5.2	2.8	0.6	3.6	2.7	1.6	0.0	2.6	2.5	2.6	9.6	1.5	1.6	7.4	0.0	12.8	0.0	6.2	10.8	3.1	2.9	1.4	8.6	1.8	11.0	89.6	8.2	9.4	5.3	0.0	5.9	30.0	8.9	6.3	3.4	9.5	9.5	3.7	1.9	5.4	5.6	10.2	3.6	2.5	4.4	7.5	2.6	2.8	6.7	2.1	3.9	0.0	2.8	0.0	21.2	14.3	3.3	0.0	1.0	7.0	6.0	13.4	1.0	2.1	5.3	3.4	4.1	3.4	9.2	5.3	1.8	14.6	39.5	6.6	7.9	5.0	27.2	6.5	4.0	0.0	7.3	6.6	15.4	4.7	5.7
PROX2	FLJ36749	ENSG00000119608	"Prospero homeobox 2"	Q3B8N5	14	74852871-74876154	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.9;Excitatory neurons: 1.6;granulocytes: 1.3;Inhibitory neurons: 1.1;Late spermatids: 1.0;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;CACO-2: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045057	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA045057: AB_10960259"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.73e-4)"	0.3	0.2	0.5	0.4	0.4	1.2	0.3	1.5	0.6	0.8	1.3	0.3	0.2	0.4	0.6	0.2	0.5	0.1	0.3	0.4	0.3	0.3	0.2	0.3	0.6	0.3	0.9	0.9	0.3	0.1	0.5	0.2	0.4	0.5	0.3	1.2	0.4	0.3	0.2	1.1	0.5	0.1	0.1	0.5	0.2	0.3	0.3	0.2	0.6	0.0	0.3	0.3	0.5	0.6	0.0	0.1	1.6	0.6	0.5	0.2	0.4	0.1	0.0	0.0	0.1	1.4	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.9	0.0	0.2	0.0	0.0	0.2	1.1	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	1.4	1.1	0.1	0.3	0.0	0.0	0.5	0.4	1.5	0.6	0.4	0.3	0.3	0.9	0.4	0.1	0.3	0.6	0.0	0.0	1.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 109.2"	"Group enriched"	"Detected in some"	52	"Hepatocytes: 63.5;Proximal tubular cells: 20.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;Hep G2: 3.6"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	14.4	109.2	0.1	0.3	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.4	1.1	0.4	1.6	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	0.5	0.3	0.4	0.8	1.4	0.1	0.6	0.1	0.1	0.0	0.5	1.3	0.0	0.0	0.1	0.6	0.7	0.0	0.4	0.3	0.3	0.0	0.3	0.1	0.7	0.4	0.3	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.5	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	20.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586939-13630859	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	14.6	15.9	8.4	14.4	9.7	43.0	19.6	12.2	10.4	12.8	8.9	16.0	16.9	14.0	28.1	15.8	11.7	15.5	14.3	8.5	10.8	20.7	21.9	14.9	18.2	8.7	8.7	12.9	17.0	18.7	10.7	17.4	8.7	14.3	18.1	10.1	14.3	13.0	23.2	14.3	16.5	15.1	8.6	13.6	15.0	18.8	9.1	25.0	23.6	22.2	19.7	16.4	12.3	10.1	29.5	21.7	18.9	16.4	25.9	24.7	23.5	33.6	16.6	35.9	34.2	20.8	43.8	24.4	18.3	31.1	16.3	23.8	25.1	27.8	41.3	36.3	24.9	28.4	18.5	16.3	30.7	22.6	32.9	19.4	44.3	31.3	15.4	21.9	35.3	35.0	29.9	32.1	33.1	30.5	42.2	15.6	17.8	29.0	10.7	29.8	22.8	30.6	23.9	12.6	13.2	32.7	26.6	18.8	29.1	23.0	29.0	36.6	30.2	22.2	26.1	36.5	25.5	31.2	35.8	34.8	32.8	27.9	15.4	27.2	27.3	36.5	27.7	25.1	24.0	26.9	24.8	23.9	27.4	25.8	26.4	32.6	40.3	39.7	37.4	23.3	33.5	16.8	8.4	9.7	12.2	10.4	8.5	10.8	8.7	8.7	8.7	8.6	9.1	10.1	24.5	19.2	22.4	14.7	32.8	45.6	24.0	35.7	25.0	13.5	22.6	15.0	9.4	30.0	32.9	22.0	10.4	30.5	28.7	21.1	41.1	30.9	29.8	27.5	22.8	21.1	12.6	25.9	27.0	29.1	40.4	18.9	19.4	22.0	27.1	10.5	16.4	28.4	26.0	21.9	25.3	21.8	46.8	20.7	18.0	16.5	17.7	19.4	24.9	18.7	29.7	20.2	36.0	28.1	29.3	33.7	28.9	13.2	27.1	16.2	30.2	50.6	31.8	21.7	19.7	20.8	18.3	105.8	41.1	17.1	46.9	41.7	33.2	11.6	19.0	25.8
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890547-60906585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA		71000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	46.1	70.6	89.8	49.8	87.9	67.0	48.8	73.7	100.2	57.4	60.2	54.5	42.9	55.4	34.2	81.7	57.3	29.4	47.9	91.3	94.1	50.4	77.2	34.6	64.1	92.0	80.7	66.6	69.4	79.8	79.3	42.9	92.9	62.1	51.8	46.1	56.5	48.2	75.2	80.3	49.5	47.9	75.6	54.3	54.3	30.5	81.1	78.5	43.4	38.9	73.7	58.7	55.9	84.5	197.5	147.0	161.8	116.2	92.7	80.8	155.6	102.4	137.5	200.2	149.0	162.7	141.1	280.5	145.2	98.2	120.2	179.0	229.2	184.6	153.4	207.0	153.4	232.4	111.3	184.9	134.2	308.6	161.1	86.3	137.0	154.4	171.9	58.7	158.7	167.4	248.2	155.3	99.5	270.6	328.9	249.5	292.6	150.5	197.7	285.8	165.5	227.5	101.7	127.5	142.3	172.9	126.6	208.3	178.0	73.1	225.8	170.2	101.9	89.6	147.2	161.8	171.2	147.2	223.3	287.9	111.6	208.6	138.6	4.2	7.8	2.0	2.4	3.8	1.7	0.9	1.8	1.7	3.6	2.4	2.2	2.0	0.5	1.8	2.3	3.9	1.7	1.0	89.8	87.9	73.7	100.2	91.3	94.1	92.0	80.7	92.9	75.6	81.1	84.5	15.8	19.2	23.7	10.1	26.7	42.1	35.2	40.2	33.0	32.0	24.6	19.4	17.6	20.0	28.6	27.6	10.4	94.7	16.2	20.4	27.4	48.5	21.6	21.4	19.7	27.3	39.0	45.2	19.8	51.6	90.2	24.9	23.4	28.4	22.8	25.4	20.0	46.1	46.3	62.2	22.2	40.0	32.6	23.0	21.6	3.6	37.0	19.3	26.6	11.2	41.2	25.4	21.6	10.1	11.8	33.4	27.7	38.7	31.9	40.4	27.8	27.9	17.8	25.3	46.0	22.4	22.6	25.2	38.0	37.4	41.6	40.6	24.8	24.8	55.1	26.3
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321479-150353233	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	26.0	24.7	18.1	22.3	20.2	44.8	27.0	23.2	23.1	27.5	22.8	25.2	16.9	25.0	26.7	22.2	25.7	13.8	19.5	17.8	21.4	29.0	30.4	24.3	28.6	19.7	18.9	34.1	23.8	17.6	27.0	20.9	19.3	27.5	19.6	43.5	21.7	19.5	22.2	23.8	24.6	18.7	17.3	33.8	19.1	20.1	19.7	30.9	32.0	14.9	28.5	24.3	24.3	21.6	44.8	47.5	47.1	30.3	31.0	33.5	63.8	45.6	31.9	69.1	47.5	36.6	40.8	58.7	29.7	37.6	64.4	51.5	86.1	32.2	61.7	29.7	38.3	50.7	72.1	35.2	30.7	62.5	31.6	24.6	43.7	59.0	50.5	32.9	42.7	39.0	61.3	34.8	50.0	66.5	52.3	55.0	67.6	114.3	41.9	75.1	38.5	38.8	28.5	26.7	40.3	35.7	37.9	44.2	34.9	63.3	52.9	150.5	34.3	43.2	33.3	36.7	75.8	33.1	62.8	64.7	28.8	56.2	45.9	9.3	9.0	13.3	14.9	11.8	14.6	13.0	10.8	9.8	9.5	10.0	11.0	11.4	5.3	11.5	21.8	7.6	9.1	8.3	18.1	20.2	23.2	23.1	17.8	21.4	19.7	18.9	19.3	17.3	19.7	21.6	26.1	35.3	23.4	31.6	26.1	11.7	13.1	13.0	10.8	30.4	10.8	10.8	13.2	11.5	19.7	11.0	18.8	16.1	22.9	15.8	13.7	15.6	11.5	13.2	20.0	22.5	2.4	19.0	19.5	11.9	16.0	16.3	17.9	17.8	22.8	25.5	14.6	11.0	12.1	32.0	17.5	17.5	4.1	8.6	11.8	5.3	20.2	14.5	10.6	15.0	14.2	27.8	17.5	18.1	28.4	13.4	9.5	18.4	12.4	12.6	12.6	5.0	20.6	42.6	13.1	19.1	21.2	44.3	23.5	11.6	10.1	20.0	24.0	11.3	11.6	10.0
PRPF31	"hPrp31, NY-BR-99, PRP31, RP11, SNRNP61"	ENSG00000105618	"Pre-mRNA processing factor 31"	Q8WWY3	19	54115410-54131719	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041939, HPA061873"	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA041939: AB_10793938, HPA061873: AB_2684630"	"unprognostic (1.32e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (9.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.04e-2)"	35.1	36.0	26.1	24.3	27.5	33.2	35.1	26.6	31.3	39.6	26.9	42.3	23.1	39.7	12.5	37.8	35.3	18.9	38.8	26.7	26.1	34.2	44.5	29.7	33.2	27.0	26.3	39.0	29.3	28.6	33.7	23.1	26.7	37.6	13.9	8.1	33.9	23.6	48.2	40.2	34.6	19.0	25.5	39.7	35.7	33.0	27.2	26.3	36.5	23.7	23.4	38.3	35.6	28.5	83.7	169.4	55.0	89.8	34.6	33.0	59.4	68.3	53.1	74.6	72.5	82.4	63.8	89.1	54.2	49.9	36.0	49.8	64.6	78.6	46.4	82.4	298.4	66.6	108.3	97.0	51.7	120.9	59.7	54.2	36.0	62.3	43.1	39.4	79.4	74.4	96.8	46.2	49.9	82.8	103.3	64.1	53.4	78.5	187.1	89.2	71.7	81.5	51.8	120.8	61.6	72.8	88.0	83.2	44.7	24.5	52.3	62.5	81.2	100.4	84.7	43.6	109.0	58.6	97.7	98.5	75.7	81.9	71.0	25.0	44.3	30.1	47.9	53.1	51.8	43.5	47.2	51.4	52.9	44.5	39.7	40.5	9.1	54.4	48.6	45.6	61.0	51.1	26.1	27.5	26.6	31.3	26.7	26.1	27.0	26.3	26.7	25.5	27.2	28.5	38.7	35.3	26.7	17.0	35.0	42.7	38.9	96.1	46.7	31.4	31.3	37.6	35.9	32.9	54.2	25.8	14.6	95.0	40.2	29.3	60.7	74.6	5.9	34.9	34.9	47.3	34.8	32.4	13.4	62.9	90.8	42.0	33.6	31.0	31.7	53.5	27.8	27.3	66.4	30.3	12.4	38.9	57.0	22.2	43.2	7.4	38.2	33.7	40.9	9.4	61.2	51.1	48.4	13.6	14.9	63.2	30.1	48.9	34.0	37.6	46.9	62.0	43.6	32.2	39.5	36.1	53.4	125.2	77.9	33.9	42.1	76.2	41.5	54.3	46.3	32.8
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404602-52420836	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	9.0	8.1	11.8	10.7	12.2	19.3	13.3	16.2	14.2	12.1	10.5	11.2	8.4	14.1	9.8	9.5	11.4	7.1	7.4	11.3	12.3	10.4	7.9	9.7	15.7	12.2	12.5	17.3	7.9	8.9	9.6	9.9	12.1	10.1	12.1	17.6	8.4	9.0	6.7	11.4	10.7	9.0	11.6	11.2	8.2	8.9	11.8	21.1	12.2	8.1	15.0	8.7	10.3	13.5	17.6	8.5	29.8	14.3	11.5	11.3	17.6	11.8	8.0	19.1	18.3	15.5	8.5	36.2	12.0	8.1	14.8	12.8	42.6	12.8	24.7	19.8	32.4	48.7	31.1	16.3	14.2	54.8	17.2	8.7	11.2	20.9	20.0	14.5	16.3	25.9	45.4	9.2	11.5	9.9	42.5	32.8	36.6	18.6	19.7	41.3	44.8	30.3	16.9	10.4	19.7	24.0	23.8	19.3	23.8	20.0	13.6	43.8	12.9	10.8	16.2	16.3	23.5	17.4	26.6	35.7	15.9	47.0	14.0	12.3	6.2	8.9	7.4	7.1	10.2	7.2	8.3	9.1	7.9	6.5	11.3	8.8	4.8	11.1	7.5	4.3	8.9	5.7	11.8	12.2	16.2	14.2	11.3	12.3	12.2	12.5	12.1	11.6	11.8	13.5	37.5	41.7	32.1	8.5	49.1	53.0	92.7	48.8	33.6	35.9	34.4	32.1	29.9	22.8	41.1	16.5	93.8	60.5	52.6	69.9	35.2	36.9	84.6	36.8	34.3	47.6	35.8	44.6	6.7	29.4	77.9	33.8	20.4	31.6	60.1	43.1	34.6	19.3	40.0	25.2	7.2	42.7	32.6	35.8	40.0	18.6	25.7	34.4	30.2	1.9	40.4	49.4	70.0	7.1	7.4	27.0	49.1	33.4	47.3	47.0	61.2	34.9	28.3	47.8	52.6	53.8	33.2	109.8	55.1	38.1	56.0	103.4	57.6	44.7	62.2	67.9
PRPF38B	"FLJ10330, NET1"	ENSG00000134186	"Pre-mRNA processing factor 38B"	Q5VTL8	1	108692310-108702928	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053255	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053255: AB_2682093"	"unprognostic (2.13e-3)"	"unprognostic (9.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.28e-3)"	"unprognostic (3.77e-3)"	"unprognostic (9.49e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-1)"	24.4	21.5	19.6	35.3	20.9	63.0	24.1	31.8	23.2	23.0	18.5	25.6	24.3	23.2	15.7	24.4	22.3	18.8	18.6	19.2	22.8	24.5	25.0	26.1	45.5	22.9	20.4	23.7	31.0	16.5	22.4	24.0	22.2	23.3	21.4	24.9	25.9	14.8	25.6	23.2	34.6	15.3	19.5	43.1	24.5	14.7	21.4	37.5	25.9	16.0	31.1	23.1	22.7	23.1	57.5	22.5	52.0	33.8	29.2	23.3	47.8	59.3	22.7	27.7	29.6	43.4	26.7	77.4	31.4	18.8	19.1	52.2	48.5	30.9	40.7	45.2	51.0	60.4	83.7	41.0	28.7	83.4	49.5	16.1	42.5	28.6	56.2	37.3	23.2	35.9	75.0	56.6	29.4	42.7	61.6	67.4	56.8	26.1	40.4	61.6	99.3	32.8	26.7	47.0	49.4	35.5	40.8	47.3	58.1	32.2	24.1	53.6	38.8	54.0	41.0	43.9	51.2	52.6	35.4	71.0	47.5	61.9	57.7	24.3	19.8	27.1	23.9	19.5	24.8	19.6	21.8	19.3	23.3	23.9	19.9	20.2	30.0	31.9	17.7	27.5	24.6	13.5	19.6	20.9	31.8	23.2	19.2	22.8	22.9	20.4	22.2	19.5	21.4	23.1	81.7	105.8	143.8	38.5	166.5	246.8	199.4	79.9	90.0	96.1	87.6	69.0	60.7	105.8	120.5	60.7	135.5	86.3	227.0	88.7	13.7	79.5	34.3	62.1	117.2	101.4	95.0	88.1	27.7	66.2	104.1	85.5	61.2	96.4	103.1	72.5	88.5	59.8	78.3	37.0	30.1	110.7	61.1	127.8	203.1	19.3	99.1	131.0	104.9	63.7	138.1	50.7	242.0	39.7	65.0	75.7	81.2	85.0	139.3	172.6	81.3	17.3	73.9	74.3	46.0	89.5	108.1	96.1	62.3	102.6	265.0	87.7	222.3	98.4	131.7	234.7
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084107-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001176, HPA078403"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA001176: AB_2171026, HPA078403: "	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	4.8	4.0	1.4	0.7	1.6	2.7	4.8	1.3	2.0	5.5	0.2	5.1	1.5	5.2	1.7	3.9	6.3	1.3	3.7	1.1	1.0	5.6	3.4	3.2	1.5	1.3	0.7	5.5	4.4	1.7	4.1	1.7	1.5	3.5	1.0	2.0	4.4	1.5	7.6	4.8	4.3	1.5	0.2	3.8	5.1	3.0	1.0	1.8	3.6	1.7	1.2	5.3	4.3	2.2	7.8	8.5	7.0	3.4	2.7	2.4	7.0	6.2	3.4	4.9	4.3	5.1	5.2	4.9	6.2	4.5	3.6	5.1	9.0	4.1	7.3	8.9	6.2	6.8	11.5	4.8	3.2	6.5	1.9	1.5	2.5	2.7	3.2	2.6	3.5	6.2	9.8	5.2	5.4	7.0	7.2	3.1	6.5	5.2	8.9	9.5	6.0	6.3	2.8	10.4	6.8	1.8	2.9	3.9	4.9	3.5	3.7	5.2	7.8	4.3	4.0	3.1	8.3	5.1	12.9	11.2	1.8	6.6	2.4	5.2	2.7	4.7	4.5	4.9	6.4	5.6	4.0	4.7	4.9	5.0	5.2	6.1	2.1	4.3	5.2	2.0	5.4	3.2	1.4	1.6	1.3	2.0	1.1	1.0	1.3	0.7	1.5	0.2	1.0	2.2	14.3	25.6	22.5	21.2	18.2	27.3	15.6	6.5	18.8	19.5	10.6	7.4	14.9	7.2	13.5	7.3	14.6	12.1	21.5	7.0	9.8	8.5	1.3	9.2	19.5	12.8	9.6	15.8	36.6	9.3	10.6	15.5	12.2	11.2	16.4	16.7	10.8	7.5	7.5	16.8	37.1	9.1	6.1	5.1	14.6	4.9	14.9	9.5	14.2	25.3	8.4	10.8	5.2	31.2	55.5	8.0	6.6	14.7	19.1	14.2	14.2	5.4	6.1	24.2	6.6	13.5	16.7	11.6	11.8	18.3	25.3	12.0	19.7	13.4	9.2	10.0
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275642-113294009	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	11.6	14.7	9.2	15.2	9.5	15.1	13.4	10.3	10.9	11.2	8.6	11.1	9.9	13.5	19.4	14.9	12.3	10.3	11.0	9.4	9.5	15.4	16.2	9.4	15.6	8.9	8.9	14.8	14.4	25.4	12.2	12.5	9.2	13.3	12.3	13.1	11.2	11.1	18.1	14.6	9.8	13.2	9.0	11.6	10.3	11.6	9.1	16.9	10.2	15.2	17.6	16.7	11.3	9.6	36.6	61.3	40.3	44.4	27.8	28.6	40.4	56.1	28.1	60.2	44.2	60.4	33.4	76.5	32.5	30.3	62.2	81.8	84.9	48.8	66.2	54.2	32.1	39.1	50.4	43.7	25.2	68.0	34.2	20.7	32.7	63.1	59.9	22.6	28.9	41.8	67.5	40.9	51.2	57.3	65.1	47.9	63.9	94.2	66.5	59.4	95.9	51.4	26.0	28.9	52.7	35.5	82.9	44.0	26.0	32.0	68.3	35.0	29.8	49.1	37.3	63.0	72.4	52.1	153.1	73.3	37.6	42.9	63.8	27.4	16.2	16.1	14.7	19.4	17.1	17.1	14.4	13.3	20.4	17.4	14.5	14.6	5.2	18.4	24.6	13.4	14.6	14.8	9.2	9.5	10.3	10.9	9.4	9.5	8.9	8.9	9.2	9.0	9.1	9.6	15.7	9.6	18.4	6.8	23.7	15.7	17.6	10.4	18.8	22.9	12.7	14.6	12.9	12.8	15.2	18.4	18.8	27.7	26.6	5.8	25.4	18.6	17.2	17.5	24.7	12.6	17.5	20.0	8.6	16.9	34.5	16.4	10.2	21.9	19.0	21.5	6.4	9.9	18.4	28.6	8.3	13.0	10.2	13.5	17.8	13.0	11.5	20.5	5.4	2.8	27.3	22.7	18.6	4.0	5.7	15.5	9.6	10.9	15.7	20.6	8.1	16.9	14.3	24.1	0.0	16.9	17.5	28.6	21.0	21.4	18.8	21.5	20.0	24.7	14.0	16.9
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA038272: AB_2675923, HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	16.7	16.7	9.0	24.7	9.8	45.0	21.5	14.3	10.4	16.8	9.4	24.2	23.0	18.6	15.7	27.6	18.0	17.4	15.3	8.7	10.3	18.9	21.7	17.4	30.4	10.4	8.7	18.9	19.7	24.0	10.5	22.2	10.9	18.4	20.9	16.7	16.6	15.0	22.8	21.0	23.0	17.4	9.9	20.7	22.2	25.5	8.7	31.5	24.6	20.0	28.1	27.1	15.1	12.3	63.4	62.9	68.9	70.8	39.1	51.8	95.5	61.8	55.2	86.0	78.9	120.0	57.8	130.9	88.0	62.7	49.2	63.8	90.8	74.3	91.6	72.4	78.6	121.8	55.7	79.9	50.7	135.4	81.6	41.7	61.9	113.8	127.3	52.4	67.5	60.8	133.2	60.6	52.9	38.4	57.2	63.4	102.9	41.2	75.8	110.4	73.3	86.9	43.7	99.8	82.2	56.0	73.9	53.5	67.6	50.6	46.8	85.4	79.1	90.3	56.6	51.9	81.4	38.8	67.7	130.6	57.9	78.2	56.1	87.6	70.1	91.7	66.7	86.5	62.3	65.5	62.1	60.7	79.4	70.3	65.5	58.8	61.1	70.4	101.1	84.8	58.8	80.1	9.0	9.8	14.3	10.4	8.7	10.3	10.4	8.7	10.9	9.9	8.7	12.3	98.5	112.2	118.5	48.3	120.3	141.0	120.0	117.9	101.3	65.0	73.6	70.6	64.4	55.8	122.1	53.3	73.0	123.1	123.7	67.2	49.0	110.0	150.3	101.0	126.6	97.4	78.3	105.6	56.4	111.5	155.9	96.4	74.9	121.0	123.4	111.0	53.9	72.5	109.2	60.6	53.3	81.5	87.5	95.7	114.5	36.4	69.3	125.5	55.2	44.0	184.1	62.7	107.1	44.7	71.3	128.3	86.8	79.7	112.1	131.7	69.5	75.7	152.6	75.2	98.6	104.8	132.1	239.0	121.4	141.6	151.7	132.2	119.9	164.9	103.7	148.4
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 61.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	8.3	16.3	16.3	3.2	15.6	0.7	11.5	13.3	18.8	23.9	13.7	15.6	4.0	17.9	10.4	10.4	19.1	6.4	15.6	16.6	16.5	23.9	9.2	7.4	3.1	16.4	14.5	25.4	16.0	20.3	26.2	6.5	15.9	17.5	3.4	12.3	13.3	11.7	25.2	11.4	7.6	7.8	13.3	9.5	14.5	33.7	14.7	3.5	29.2	13.5	3.4	14.6	14.6	15.3	7.2	10.5	10.3	10.0	8.4	5.4	9.5	5.8	8.1	6.1	3.0	12.2	15.8	5.8	12.0	7.7	8.6	4.2	6.3	20.1	3.1	4.4	2.5	6.1	4.2	4.4	10.6	2.0	7.8	7.7	16.8	6.1	22.0	13.2	4.9	11.7	3.0	3.0	7.3	6.7	1.4	4.2	4.4	8.2	3.9	5.1	1.6	4.8	13.0	6.6	10.9	13.1	4.7	12.8	7.2	9.4	24.5	5.7	2.0	3.7	14.9	4.9	2.5	7.1	4.3	2.4	11.2	1.5	3.5	0.0	0.1	0.0	0.8	0.1	1.1	0.3	0.8	0.3	0.2	0.6	0.8	0.9	0.0	1.3	0.0	0.5	0.3	0.3	16.3	15.6	13.3	18.8	16.6	16.5	16.4	14.5	15.9	13.3	14.7	15.3	5.3	12.8	20.3	15.7	4.1	3.6	8.7	10.2	11.4	19.1	6.6	9.7	1.2	5.7	17.5	18.4	10.4	21.9	1.2	1.5	7.9	13.8	28.9	8.6	7.5	5.2	7.7	3.0	19.3	11.1	7.4	7.2	4.1	5.6	2.5	15.6	8.2	3.1	5.4	11.8	22.9	3.2	12.2	1.6	2.1	23.1	11.8	1.5	3.6	6.5	4.9	8.3	2.1	20.6	17.2	6.8	1.1	12.0	1.1	6.7	1.4	5.6	24.5	19.8	13.1	9.8	9.7	61.3	26.6	8.0	6.0	26.4	3.1	9.2	5.2	5.0
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	9.1	7.2	4.8	11.3	5.4	27.3	8.1	7.5	6.7	5.8	5.2	8.6	10.2	9.9	10.1	8.4	4.4	6.1	5.0	4.7	5.1	4.2	4.3	6.8	14.2	5.4	5.5	8.4	6.8	4.2	3.3	7.6	5.3	6.3	8.6	15.9	8.4	5.5	16.3	13.3	9.0	5.6	4.9	11.2	8.1	3.8	5.5	8.8	6.5	4.5	10.0	6.7	7.0	6.9	6.0	3.9	14.4	12.1	8.3	7.3	12.3	7.7	3.4	4.7	5.2	6.9	7.1	8.1	5.7	5.1	4.8	12.8	10.1	6.8	7.1	4.4	11.1	6.7	19.1	11.5	3.6	11.2	10.6	5.7	6.9	5.4	6.6	11.0	5.1	6.5	11.6	3.1	7.4	2.7	7.2	26.3	6.0	3.8	4.3	9.9	6.1	11.2	8.4	10.2	7.9	7.3	4.7	3.9	5.5	16.9	9.6	7.9	7.3	11.2	6.5	4.3	8.2	7.5	7.9	6.9	3.2	7.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.4	7.5	6.7	4.7	5.1	5.4	5.5	5.3	4.9	5.5	6.9	122.4	109.0	103.2	35.6	110.5	83.5	64.0	43.1	69.4	88.6	80.4	49.5	79.1	61.5	75.1	97.5	89.6	61.8	151.3	94.9	72.4	64.4	15.6	115.9	143.5	85.8	75.3	79.1	42.8	56.8	49.9	78.7	88.2	113.4	90.5	96.2	61.1	85.8	41.1	106.0	49.8	88.8	50.8	71.6	49.4	20.6	98.8	71.4	35.6	49.6	97.4	81.2	118.4	50.8	68.1	62.8	61.5	89.1	101.9	62.8	55.5	89.5	71.7	184.0	59.2	105.3	85.8	66.1	76.5	66.7	91.4	63.6	106.2	93.1	87.7	65.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981132-64033100	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	44.0	32.2	33.6	30.8	37.4	33.3	40.1	44.9	37.1	38.5	34.5	39.9	30.0	43.5	27.9	38.9	49.3	27.2	39.0	32.9	34.7	35.3	29.8	32.1	40.9	37.7	35.5	50.6	44.2	37.2	36.7	30.9	37.1	34.5	25.9	36.4	38.3	36.4	64.6	58.3	38.1	29.7	34.6	40.9	37.3	41.0	35.5	44.4	36.2	37.1	40.5	40.5	36.2	46.8	72.8	86.5	62.3	66.3	69.5	48.6	81.5	56.1	62.8	167.9	74.6	233.6	86.2	90.9	133.4	74.5	107.1	110.0	101.2	116.1	88.7	44.0	59.0	76.8	112.7	213.3	76.7	105.3	102.3	55.2	81.4	77.5	89.2	59.9	63.3	83.7	76.2	76.6	56.8	89.2	106.8	131.0	55.4	114.4	106.7	116.0	53.0	87.3	64.4	71.9	61.8	72.4	108.6	110.0	74.1	43.2	108.0	135.5	90.1	96.2	55.1	77.4	104.6	63.7	66.5	94.6	70.3	62.5	76.3	90.8	59.7	73.7	67.0	62.7	93.3	67.1	82.3	72.5	58.6	58.4	95.8	80.9	50.3	130.5	77.8	54.5	79.7	92.3	33.6	37.4	44.9	37.1	32.9	34.7	37.7	35.5	37.1	34.6	35.5	46.8	60.7	60.9	62.6	19.2	69.3	38.4	45.3	50.7	63.2	81.6	54.2	59.8	70.5	34.3	71.6	62.5	37.5	72.5	53.2	43.8	82.2	59.3	49.1	70.3	66.8	55.7	52.7	43.5	12.5	56.7	47.6	51.2	38.7	62.0	91.2	49.0	63.9	55.2	46.3	42.1	14.8	60.6	57.0	44.8	34.1	28.7	58.1	49.9	48.0	5.6	79.7	86.5	57.7	12.5	17.8	65.9	43.9	52.6	67.8	33.5	58.0	65.8	87.7	112.7	59.2	68.2	61.9	120.6	118.9	59.8	46.3	94.5	60.0	32.6	47.7	34.3
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684867	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Rod photoreceptor cells: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm		NA	NA		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	78.5	128.7	82.6	45.7	85.0	70.5	78.6	93.2	121.3	98.5	98.7	93.5	33.0	94.5	44.1	85.3	94.2	30.8	100.9	84.4	84.0	78.2	91.2	84.2	52.8	83.6	82.1	131.6	78.3	82.7	130.4	44.7	86.2	89.7	44.5	115.6	78.1	49.1	146.7	92.6	84.2	51.7	80.9	98.2	80.5	100.1	81.5	83.9	89.0	80.1	61.6	96.9	84.3	88.0	104.0	240.7	149.0	116.1	120.8	90.4	107.9	78.2	109.5	160.3	122.4	208.2	50.0	150.0	73.2	150.5	113.4	152.9	356.3	139.5	181.6	99.4	170.0	124.3	187.1	161.0	73.5	145.4	138.9	86.0	91.2	194.8	146.7	84.5	146.1	106.2	121.1	126.6	117.9	112.7	114.4	117.4	97.0	97.7	74.4	218.4	82.3	80.7	63.1	121.1	71.0	103.8	145.0	61.5	69.3	121.6	87.4	91.3	122.1	91.7	78.3	130.2	176.1	46.6	46.7	101.9	81.6	108.1	121.6	23.1	8.9	10.1	19.1	14.4	23.6	17.5	17.7	20.9	15.7	18.3	16.7	20.0	9.0	14.2	21.7	25.2	23.2	11.2	82.6	85.0	93.2	121.3	84.4	84.0	83.6	82.1	86.2	80.9	81.5	88.0	45.7	60.9	84.3	24.5	72.8	30.1	30.0	42.5	56.9	128.0	31.8	34.4	39.4	42.9	53.9	47.8	252.3	43.3	66.6	42.9	7.9	35.5	11.8	45.4	38.8	46.3	36.5	73.0	23.6	40.9	26.7	48.3	56.1	40.3	52.6	55.9	37.9	38.7	39.8	72.3	29.3	40.2	32.6	40.1	26.5	11.2	73.3	42.6	19.6	19.7	48.3	55.9	46.4	21.6	19.0	42.7	36.5	52.3	70.0	31.4	48.7	18.3	51.3	293.2	72.3	65.4	44.8	100.4	99.1	57.3	27.8	39.5	62.8	50.2	50.3	31.5
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.6;intestine: 21.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Group enriched"	"Detected in many"	5	"medulla oblongata: 51.9;pons: 53.6;white matter: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.1	14.5	0.9	7.5	1.1	0.0	1.8	0.3	1.8	3.3	0.4	21.0	4.7	0.8	0.1	0.5	3.1	0.6	1.2	0.9	2.2	0.9	0.1	0.9	0.2	51.9	8.0	0.7	1.3	0.1	2.9	0.3	53.6	2.3	2.1	1.5	0.5	1.5	0.4	1.1	8.9	2.0	7.8	1.2	5.2	13.2	0.9	0.1	0.5	0.2	0.1	1.5	8.3	15.7	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	1.8	0.9	2.2	51.9	8.0	53.6	7.8	0.9	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628428-107651993	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		320000	"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	22.9	28.0	33.7	30.2	35.0	58.0	21.0	32.4	36.4	20.0	59.3	19.0	11.0	23.7	14.8	13.7	25.9	13.9	22.2	33.7	39.6	27.6	51.5	21.5	42.7	35.4	39.1	30.2	21.7	27.2	23.2	14.6	37.6	21.3	17.9	30.2	16.3	17.4	49.1	12.3	16.7	29.5	34.2	26.2	15.5	13.4	35.2	52.0	44.1	37.9	45.7	23.6	15.2	34.4	93.5	128.9	56.4	69.9	32.7	26.5	18.6	253.2	55.8	146.0	122.6	55.5	36.6	156.9	111.7	94.9	104.1	36.6	176.0	53.8	148.3	79.9	150.9	84.2	140.0	100.3	28.8	153.1	55.6	28.2	30.6	90.2	56.2	96.7	52.3	108.2	137.4	183.5	69.0	51.0	101.2	113.6	213.5	77.2	141.4	117.6	96.3	125.4	60.7	54.2	96.2	52.5	131.5	77.6	57.3	106.4	36.0	61.7	31.2	93.2	45.0	108.3	109.1	61.8	115.1	172.7	50.1	163.6	61.6	8.8	8.9	22.6	26.0	14.3	30.8	29.3	31.7	32.2	11.4	31.0	36.1	30.7	4.7	28.5	15.7	16.3	35.5	21.1	33.7	35.0	32.4	36.4	33.7	39.6	35.4	39.1	37.6	34.2	35.2	34.4	21.0	6.4	10.0	4.6	44.2	31.1	18.4	13.2	12.0	28.4	8.3	9.4	12.1	15.7	12.6	16.5	4.2	8.8	29.3	3.0	25.4	18.3	1.2	11.5	13.3	18.1	16.2	52.2	4.8	20.2	11.5	22.2	10.2	5.7	26.6	13.2	14.6	57.5	35.3	15.2	10.0	6.5	6.1	18.6	34.8	3.9	14.0	16.8	26.6	6.5	24.9	20.0	27.8	3.5	4.8	19.1	3.7	17.0	35.7	16.2	1.5	29.4	27.1	14.1	0.0	18.1	30.7	3.6	10.9	10.8	22.3	1.8	45.0	19.7	8.0	9.7
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 147.8;parathyroid gland: 182.0"	"Group enriched"	"Detected in many"	7	"Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	11.0	46.0	6.3	24.5	7.3	24.2	19.7	1.9	12.0	54.5	2.5	30.3	14.0	32.8	26.5	16.1	29.7	28.1	5.4	6.9	2.9	28.0	26.1	13.1	36.8	3.0	6.5	147.8	62.8	182.0	3.4	6.1	2.2	21.9	31.3	1.3	27.9	84.0	2.1	21.9	15.8	24.3	4.4	15.6	32.5	131.1	8.8	44.6	18.1	4.2	31.5	22.5	21.2	6.4	114.2	63.7	22.1	40.3	26.7	31.8	14.6	54.4	26.8	53.1	51.1	46.3	78.7	34.9	24.2	23.5	45.3	79.9	43.1	53.7	61.5	89.7	108.0	41.7	49.6	43.3	24.7	77.3	38.9	30.5	35.0	39.1	51.7	26.9	22.1	86.8	30.4	39.8	45.2	68.5	117.6	34.7	49.9	81.0	107.3	61.5	102.7	79.5	33.0	81.7	46.1	33.6	64.9	2.1	38.9	30.2	58.8	32.4	24.9	41.8	32.0	162.5	55.5	103.6	41.3	76.8	44.4	39.4	67.4	25.9	20.1	9.4	17.2	19.4	19.9	27.8	25.0	16.4	28.2	30.6	31.7	23.0	8.0	24.3	12.3	19.9	22.6	28.2	6.3	7.3	1.9	12.0	6.9	2.9	3.0	6.5	2.2	4.4	8.8	6.4	12.2	3.2	8.7	0.7	25.4	64.0	48.5	16.2	41.5	0.6	53.1	15.9	2.0	11.5	12.4	55.2	0.0	1.1	18.5	21.1	72.4	19.3	12.1	24.7	62.5	14.5	21.8	28.4	14.8	39.2	7.3	25.8	31.1	26.4	27.9	16.2	10.4	13.7	24.4	0.0	6.3	27.9	8.2	21.4	44.3	65.8	1431.5	20.7	40.9	3.7	18.2	1.2	18.6	3.5	5.1	24.6	17.4	1995.0	30.7	52.2	6.0	10.4	20.3	0.2	624.5	9.4	19.2	10.3	8.1	29.2	43.8	0.4	27.2	179.2	50.2	36.9
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 274.7"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	10.4	17.8	21.5	21.4	25.7	23.6	16.1	39.6	25.3	16.0	18.9	20.6	26.3	21.2	17.8	16.7	21.0	21.4	19.0	25.3	25.2	29.9	21.5	18.4	51.3	27.3	23.5	25.8	16.0	21.0	22.0	13.9	27.7	16.5	24.5	46.3	14.5	14.5	10.3	20.7	20.7	17.4	26.5	19.5	23.1	31.7	25.2	30.5	26.6	10.8	57.3	14.8	14.4	38.7	40.6	44.2	63.1	46.1	26.8	16.2	64.4	30.4	23.7	38.8	35.7	56.2	19.3	104.3	30.7	26.4	38.4	49.2	75.0	38.4	42.2	47.4	60.1	32.8	37.0	46.8	37.5	21.0	29.1	19.5	24.7	49.2	36.6	39.2	36.5	57.0	49.4	17.0	34.5	45.5	45.4	23.9	45.8	80.3	29.0	63.0	103.4	46.4	24.4	25.7	37.7	47.7	45.4	18.5	48.5	274.7	49.7	31.0	24.8	15.8	31.5	53.8	38.7	26.9	34.8	43.5	33.3	30.0	33.1	23.2	23.2	28.5	25.9	23.5	29.4	43.7	32.9	27.2	31.9	40.4	46.0	34.5	9.5	36.9	26.1	21.4	36.3	30.0	21.5	25.7	39.6	25.3	25.3	25.2	27.3	23.5	27.7	26.5	25.2	38.7	16.6	16.0	31.7	21.5	31.7	15.8	19.7	26.9	16.5	38.5	14.2	18.2	10.2	25.8	18.6	11.0	29.2	12.4	22.6	12.3	27.4	23.4	54.3	14.6	13.0	18.3	26.5	23.5	17.6	22.1	37.9	14.8	16.3	13.1	46.3	18.4	18.9	17.6	24.5	16.8	21.5	17.6	16.2	14.0	11.0	67.9	14.0	19.5	12.4	14.0	24.6	26.3	19.6	27.2	37.8	21.1	14.8	13.5	48.0	20.3	21.5	32.2	25.3	34.4	19.7	13.7	14.3	69.8	54.0	19.5	20.9	14.0	23.8	24.7	21.3	15.6
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155732-59206709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.1;lymphoid tissue: 20.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 26.3;Extravillous trophoblasts: 22.3;Granulosa cells: 14.4;Kupffer cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	1.3	0.7	1.8	6.5	2.0	18.1	1.8	4.3	2.7	1.2	1.1	4.6	6.5	1.7	0.5	3.8	1.4	1.4	1.0	2.0	1.3	0.6	1.4	2.3	10.3	2.3	1.5	1.4	0.5	0.3	0.0	4.3	2.2	0.8	5.6	1.7	0.6	0.7	1.2	3.1	5.0	3.6	1.1	3.3	2.4	1.8	2.3	20.6	1.3	0.4	12.0	2.0	0.6	3.7	105.3	56.9	84.5	24.8	2.4	16.0	31.7	66.7	41.9	69.1	54.2	68.4	78.7	80.2	65.9	52.7	56.2	40.7	67.0	73.9	145.0	99.3	39.1	86.4	58.8	50.3	0.6	88.7	32.5	4.0	5.3	81.9	109.0	17.1	77.2	57.9	48.6	76.7	72.8	95.2	80.7	26.1	31.9	52.0	82.5	67.3	135.7	45.9	20.0	32.4	34.5	45.4	61.7	18.4	29.2	38.0	54.4	34.1	57.8	146.4	157.3	73.5	117.8	48.8	108.2	73.6	34.5	47.4	150.1	1.7	2.1	2.3	0.6	4.0	0.2	1.1	0.5	0.7	2.6	0.6	0.3	0.5	2.1	0.5	9.5	1.1	1.4	0.8	1.8	2.0	4.3	2.7	2.0	1.3	2.3	1.5	2.2	1.1	2.3	3.7	4.5	0.0	1.7	3.3	3.1	1.9	2.0	1.5	0.0	2.0	0.8	1.5	2.0	1.5	1.6	0.0	0.0	6.2	1.4	2.0	0.0	0.4	0.9	1.4	1.9	3.6	4.9	26.3	1.6	0.5	22.3	2.9	2.6	2.2	2.5	14.4	4.2	0.3	7.8	1.7	1.8	5.0	0.0	18.6	6.3	0.4	0.9	7.8	1.8	2.8	8.4	0.9	4.1	2.0	3.4	0.9	0.7	2.2	9.7	1.1	0.5	0.5	0.6	3.2	0.0	2.9	3.3	2.6	5.1	5.5	1.3	2.1	3.3	1.3	8.4	1.7
PRR12	KIAA1205	ENSG00000126464	"Proline rich 12"	Q9ULL5	19	49591182-49626439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011959	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA011959: AB_10610286"	"unprognostic (8.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.20e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.52e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.32e-2)"	"unprognostic (9.65e-3)"	11.6	12.6	8.8	7.2	6.5	5.4	11.8	7.6	11.3	15.1	0.0	14.2	6.2	16.7	2.0	12.3	14.3	3.1	11.0	7.6	4.0	10.1	6.9	10.2	7.8	4.4	3.0	16.3	11.3	4.7	22.9	4.6	1.7	13.0	2.2	4.5	13.0	7.4	14.8	21.3	12.7	3.5	0.9	14.8	12.8	7.5	2.8	7.5	15.7	3.4	4.2	14.0	13.1	2.6	15.4	23.4	12.6	14.0	5.6	5.0	10.0	9.5	4.6	5.2	4.1	9.0	8.9	15.5	7.9	6.8	4.9	14.0	5.8	8.3	1.7	13.2	17.3	16.0	12.4	9.0	4.0	15.1	23.0	6.4	8.2	5.9	3.9	6.3	5.8	9.2	11.1	8.9	4.6	11.6	17.1	18.2	17.9	7.8	21.5	22.2	9.8	5.8	4.7	19.0	10.0	18.6	13.8	12.8	6.7	5.0	9.0	11.0	13.9	18.0	17.2	6.8	15.7	11.4	14.4	10.4	11.2	8.6	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.8	6.5	7.6	11.3	7.6	4.0	4.4	3.0	1.7	0.9	2.8	2.6	8.8	6.4	2.6	9.8	8.1	4.0	1.3	8.2	8.6	7.7	8.1	6.5	2.9	7.2	3.6	12.9	4.2	5.5	8.7	5.8	1.9	4.1	1.1	5.1	8.8	5.5	10.2	2.5	9.3	7.5	3.3	5.6	8.6	7.1	10.2	9.6	6.8	2.9	6.4	5.0	11.9	6.6	4.1	7.5	2.8	2.1	14.0	5.8	3.6	8.4	3.3	3.6	5.2	10.6	8.8	13.4	5.7	14.7	6.0	1.9	6.6	2.5	6.5	3.6	13.1	7.3	5.5	2.7	6.8	6.9	7.7	1.1	7.5	6.9	6.9	1.5
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441678-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	143.8	207.8	110.8	159.2	110.1	279.1	139.2	112.6	147.7	118.9	109.7	316.1	451.6	104.6	110.8	143.4	139.2	147.1	110.6	105.8	147.8	457.9	192.8	164.3	185.3	126.6	132.1	118.8	133.3	76.0	114.6	95.2	126.3	139.6	265.7	44.0	115.5	86.6	131.6	108.7	432.6	91.4	114.3	230.2	247.8	46.4	118.4	139.0	131.8	59.6	190.4	143.7	111.7	117.1	171.7	339.6	82.6	89.4	135.3	185.3	178.4	142.5	213.0	185.6	179.4	623.1	373.6	265.1	453.5	206.8	225.4	146.6	167.8	225.0	217.9	263.1	124.6	382.4	166.4	294.6	340.7	573.2	489.5	232.6	221.2	326.5	223.6	192.6	195.3	166.1	340.1	254.6	285.1	472.5	325.8	563.8	127.5	229.2	230.7	287.6	67.8	273.9	406.2	283.8	72.3	56.5	202.5	276.7	237.2	169.5	394.0	436.2	196.3	117.2	114.0	201.3	138.0	190.7	241.6	386.4	153.3	345.1	220.2	851.3	824.0	1620.1	511.1	941.9	503.0	888.2	563.7	545.8	649.3	855.6	520.6	557.7	2095.7	584.5	1014.6	539.0	824.8	1573.1	110.8	110.1	112.6	147.7	105.8	147.8	126.6	132.1	126.3	114.3	118.4	117.1	66.8	83.3	110.4	6.8	219.1	47.5	147.8	204.8	82.6	11.1	114.3	95.2	26.4	198.8	145.1	187.6	29.2	225.3	159.1	884.9	1365.6	228.0	12.6	182.7	67.1	80.3	169.8	99.2	6.3	253.9	337.7	76.6	263.0	127.4	186.7	53.4	78.1	152.8	355.2	18.5	7.1	346.9	193.3	345.0	174.4	8.7	58.1	266.8	108.5	9.4	384.7	85.3	297.6	4.5	12.9	332.3	858.1	45.9	120.9	174.7	1642.7	1097.6	215.9	20.9	78.9	33.6	67.1	29.7	22.8	107.1	56.0	291.0	212.7	88.4	340.0	193.1
PRR14	MGC3121	ENSG00000156858	"Proline rich 14"	Q9BWN1	16	30650717-30656413	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052022, HPA060265, HPA075914"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: "	"unprognostic (1.57e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (3.74e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.54e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.31e-3)"	20.5	20.2	17.1	13.9	16.8	23.6	20.3	19.0	21.7	26.6	12.8	30.8	13.8	29.8	7.1	22.4	26.1	6.6	16.4	16.0	15.3	22.1	21.3	24.1	14.1	18.5	16.6	25.1	24.9	13.0	21.2	8.3	16.1	26.2	7.8	9.4	19.1	13.7	15.1	26.2	25.6	10.9	15.0	32.5	26.0	12.6	18.3	18.7	23.4	9.6	10.6	24.5	22.7	17.9	18.2	20.3	17.1	18.2	15.2	11.7	11.9	17.6	11.8	18.1	17.2	9.3	17.3	30.5	15.3	12.9	8.4	17.7	14.4	20.4	9.8	41.5	36.0	17.9	19.6	21.4	23.6	16.1	43.3	9.8	23.1	13.0	13.7	18.9	23.1	8.2	22.8	24.3	10.0	42.2	36.7	28.4	6.2	12.4	10.3	29.4	8.4	44.2	13.7	7.3	14.5	32.4	7.1	26.8	18.2	5.3	29.9	13.1	18.1	16.3	17.7	17.0	18.4	44.1	29.4	21.3	11.0	33.0	14.7	11.4	6.0	23.7	9.6	6.5	7.4	7.0	8.0	9.7	5.7	10.5	7.3	7.2	22.5	8.6	10.9	7.6	10.3	5.5	17.1	16.8	19.0	21.7	16.0	15.3	18.5	16.6	16.1	15.0	18.3	17.9	18.1	9.6	10.4	13.7	23.2	22.8	26.1	28.8	33.6	13.9	19.1	18.7	6.6	25.8	13.2	12.9	14.6	15.8	31.9	24.1	15.6	22.3	6.7	8.8	13.0	20.9	12.6	15.4	7.5	22.2	15.3	15.3	27.5	15.1	12.0	15.4	18.9	10.1	18.2	1.7	7.7	18.3	20.3	16.0	34.1	2.5	19.3	20.2	8.8	8.4	30.2	13.1	33.0	5.5	8.7	20.4	14.6	21.1	17.3	23.6	23.6	15.1	10.0	14.2	19.7	12.8	19.9	17.2	27.2	28.5	23.0	14.1	26.5	11.7	19.8	17.3
PRR14L	"C22orf30, MGC50372"	ENSG00000183530	"Proline rich 14 like"	Q5THK1	22	31676256-31750140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062645	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062645: AB_2684817"	"unprognostic (2.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.14e-3)"	3.8	3.6	3.1	5.4	4.1	8.6	5.6	5.8	3.8	4.5	8.5	6.3	4.3	4.3	4.2	5.7	5.1	3.3	3.2	3.5	2.4	4.3	4.2	4.5	6.9	2.0	2.1	6.9	4.1	6.6	4.7	5.3	1.9	4.0	7.0	4.9	4.2	3.7	2.8	6.9	4.7	5.0	0.6	5.6	5.9	5.5	3.7	7.6	5.3	4.6	7.2	4.8	4.0	6.5	11.4	10.8	11.6	11.5	10.4	9.7	12.0	6.1	7.2	9.4	8.7	9.9	4.1	12.9	5.8	12.0	7.0	11.0	22.9	9.1	9.7	17.3	9.7	7.8	9.7	8.0	8.8	24.3	16.2	8.7	9.0	13.0	11.2	8.1	13.3	10.1	12.0	8.3	9.9	10.8	8.6	7.7	13.4	16.3	4.1	12.8	18.5	7.4	7.8	12.8	16.0	9.4	14.2	8.5	7.8	13.6	7.5	9.6	12.7	5.7	11.4	7.7	8.4	12.8	16.4	9.5	8.9	11.7	8.9	9.1	4.3	5.4	2.9	5.1	2.6	3.5	1.8	2.4	3.3	3.1	2.6	2.8	8.1	2.9	11.8	3.7	2.7	1.8	3.1	4.1	5.8	3.8	3.5	2.4	2.0	2.1	1.9	0.6	3.7	6.5	18.1	22.4	20.3	31.0	18.1	7.5	13.4	18.5	16.5	11.9	16.0	12.3	22.2	10.0	28.7	11.0	20.9	19.0	21.1	29.5	9.8	19.3	7.4	25.9	27.3	16.2	10.2	14.3	48.0	17.1	14.2	15.6	25.0	24.4	26.6	56.6	11.7	18.4	14.6	15.2	38.8	19.4	10.2	21.3	9.2	5.9	14.9	21.2	1.8	35.6	24.7	12.1	20.6	21.6	46.7	24.6	13.9	8.2	12.4	19.3	20.3	11.9	23.2	11.7	13.1	21.9	15.6	14.0	18.4	19.9	9.7	22.2	14.4	27.9	18.5	20.3
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563835-29567293	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 62.6;intestine: 81.4;stomach 1: 49.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	6.5	0.7	0.6	4.8	0.4	1.1	9.2	0.1	0.7	62.6	0.0	81.4	72.3	18.1	21.6	1.0	9.0	7.8	1.3	0.4	1.0	16.9	0.3	2.3	0.4	0.6	0.4	5.9	3.0	1.4	3.0	4.8	0.5	2.5	52.6	0.0	7.5	3.1	0.2	0.3	72.4	2.3	0.6	0.2	49.3	0.9	1.3	0.1	1.1	0.0	0.7	16.6	0.5	0.6	16.8	23.3	0.0	0.0	8.7	10.7	29.3	0.7	1.1	0.4	0.2	20.5	38.7	0.0	4.1	5.5	0.6	45.1	4.9	0.0	0.0	0.0	3.3	1.3	4.5	22.7	2.8	0.0	0.1	0.1	7.3	0.0	1.7	0.0	0.1	1.5	0.0	0.0	0.0	3.9	0.6	3.2	3.5	97.7	18.5	0.1	0.0	21.4	26.5	34.5	0.5	0.3	2.3	74.9	0.0	12.8	5.4	0.0	19.9	0.5	0.0	0.1	0.9	1.8	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.7	0.4	1.0	0.6	0.4	0.5	0.6	1.3	0.6	1.8	0.0	0.5	0.0	0.4	0.1	1.2	11.0	0.0	0.0	10.0	7.1	0.5	12.8	16.4	38.6	0.0	14.2	0.2	263.0	29.4	6.9	0.8	31.3	2.3	1.2	8.4	0.0	0.1	21.8	9.9	1.3	16.8	34.7	0.0	194.2	0.4	0.2	2.7	0.0	0.0	45.3	26.4	0.0	0.3	0.1	1.5	2.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.4	58.5	2.2	0.1	3.0	122.4	14.4	63.1	0.0	0.0	0.0	7.8	0.0	0.4	1.2	0.0	6.3	0.6	0.4	56.9	23.3
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 127.0"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocytes: 27.3"	"Group enriched"	"Detected in some"	5	"glioma: 3.1;liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"							HPA077250	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA077250: AB_2732336"	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	0.3	0.0	36.1	0.0	90.6	0.0	0.1	38.8	63.8	0.1	10.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	34.3	37.2	0.2	3.3	0.2	0.0	54.5	61.1	0.0	0.2	1.2	0.9	0.0	42.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	32.8	0.0	0.1	0.0	60.2	0.0	0.1	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	90.6	38.8	63.8	34.3	37.2	54.5	61.1	42.6	32.8	60.2	127.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.6	2.8	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	27.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR20A	"FLJ40296, PRR20"	ENSG00000204919	"Proline rich 20A"	P86496	13	57140918-57143939	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain					NA	NA									"HPA059485: AB_2684035"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR20B		ENSG00000204918	"Proline rich 20B"	P86481	13	57147488-57150509	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain					NA	NA									"HPA059485: AB_2684035"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR20C		ENSG00000229665	"Proline rich 20C"	P86479	13	57140918-57157082	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain					NA	NA									"HPA059485: AB_2684035"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR20D		ENSG00000227151	"Proline rich 20D"	P86480	13	57160632-57163653	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain					NA	NA									"HPA059485: AB_2684035"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR20E		ENSG00000234278	"Proline rich 20E"	P86478	13	57167197-57170218	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain					NA	NA									"HPA059485: AB_2684035"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784746	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 50.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 194.8;Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3"	"Not detected"	"Not detected"							HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.9	2.7	1.6	1.5	1.9	1.9	3.0	1.6	2.8	3.4	0.9	3.9	2.5	2.2	0.6	4.9	5.5	0.6	2.5	1.6	1.4	7.1	11.8	2.3	1.4	2.0	1.5	3.3	6.3	0.5	3.8	0.9	1.6	7.1	0.3	0.8	5.0	0.4	1.4	5.9	5.9	0.3	1.3	6.4	4.0	50.1	2.0	0.9	6.1	0.1	0.5	2.4	3.0	2.2	2.1	3.5	1.5	7.3	0.0	0.2	7.2	1.5	0.6	1.1	1.7	3.6	2.0	3.3	4.0	0.3	0.8	2.6	1.1	1.5	0.2	5.1	11.3	1.5	1.8	1.3	0.6	3.4	17.3	0.8	1.2	1.6	0.5	0.1	0.3	3.9	8.4	0.0	0.9	7.9	4.1	4.3	8.9	0.3	3.6	4.0	1.4	5.2	0.3	2.4	1.9	3.6	0.3	2.6	4.4	0.3	3.0	2.8	1.1	2.6	7.2	9.5	1.8	10.0	8.6	6.4	0.2	7.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.6	2.8	1.6	1.4	2.0	1.5	1.6	1.3	2.0	2.2	0.7	3.2	0.5	1.6	0.8	0.3	0.5	1.3	0.0	5.9	1.8	2.2	0.3	1.5	2.5	3.7	0.0	2.2	1.8	2.3	0.0	1.0	194.8	1.5	1.1	0.9	2.4	0.0	1.6	0.7	1.0	0.9	1.5	2.0	0.0	2.9	1.1	2.6	1.1	5.0	2.1	2.5	0.0	1.3	0.2	87.6	2.1	0.6	0.0	2.8	0.0	2.4	1.0	1.5	2.0	0.8	1.8	0.4	0.1	1.2	4.3	1.5	1.2	6.3	6.6	0.8	0.5	20.4	7.4	1.2	1.1	1.8	0.5	1.6	3.3	0.5
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 6.4;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	959	"salivary gland: 1106.3"	"Group enriched"	"Detected in some"	25	"Early spermatids: 25.5;Late spermatids: 9.8"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1106.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819729-126821786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 22.4"	"Cell type enriched"	"Detected in single"	13	"Cardiomyocytes: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 10.7;pons and medulla: 13.5;thalamus: 8.2"	"Not detected"	"Not detected"			HPA048386	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centrosome"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear speckles, Centrosome"	"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	4.1	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560394-565529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 46.5;kidney: 17.2"	"Cell type enriched"	"Detected in some"	9	"Collecting duct cells: 36.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	20	"cerebellum: 46.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.5"	"Not detected"	"Not detected"			HPA069297	Uncertain		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Cytokinetic bridge, Cytosol"	"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	46.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	17.2	0.0	0.0	0.0	0.2	1.5	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	46.5	1.8	0.3	0.1	0.2	1.5	2.3	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 29.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Golgi apparatus"		Yes	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Nuclear speckles"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.1	0.9	3.5	0.1	4.0	0.0	2.5	3.0	21.0	0.8	0.0	0.3	0.2	0.6	0.3	0.3	1.2	0.1	0.2	7.5	0.0	3.3	0.2	0.9	0.0	0.0	0.0	0.7	2.8	2.0	29.6	0.0	0.0	2.5	0.0	5.0	4.1	0.3	0.0	0.7	0.2	0.0	0.0	0.1	0.8	0.8	0.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.1	0.9	6.6	5.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	2.9	0.0	1.9	0.0	0.6	0.1	5.1	0.0	0.0	0.0	6.4	0.0	0.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.1	0.1	0.0	3.0	0.3	0.3	2.5	0.4	0.6	28.7	0.0	0.3	3.7	5.4	8.0	17.9	0.0	0.3	0.0	0.5	9.1	0.0	0.0	0.0	3.2	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.0	3.0	21.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.8	0.0	2.2	13.4	9.2	7.7	1.3	2.8	0.0	5.5	12.5	0.2	0.2	0.2	5.9	3.0	5.4	4.5	0.7	0.2	3.6	0.0	6.9	0.9	0.4	0.3	2.6	6.7	0.0	1.1	0.0	0.5	0.1	10.1	5.8	0.7	0.0	0.0	0.0	0.7	0.6	0.4	0.0	3.7	0.0	5.4	0.0	4.5	0.8	0.9	0.1	0.0	0.6	1.3	0.1	1.5	0.0	4.5	0.0	0.3	1.1	0.3	3.7	3.1	0.0	0.3	0.3	0.5	0.3	1.0
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"salivary gland: 6616.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.8;Cone photoreceptor cells: 139.7;Horizontal cells: 85.8;Rod photoreceptor cells: 119.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"OE19: 2.8"									HPA042133	Supported				"Secreted to digestive system"	NA	NA		14000000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	1.9	2.0	0.6	0.0	0.6	0.1	9.7	0.6	1.8	0.1	0.6	0.2	7.6	0.0	0.0	148.1	0.0	0.0	0.4	0.6	0.6	0.2	0.2	74.4	0.0	0.8	0.6	0.1	2.7	0.0	2.0	0.1	0.6	4.0	0.0	0.0	6616.8	0.1	0.8	73.4	0.2	0.0	0.6	0.1	66.0	0.5	0.6	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	1.8	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	0.3	3.2	0.0	0.0	22.0	3.1	6.8	19.9	9.6	92.8	7.5	2.8	1.8	7.2	8.2	1.8	139.7	16.4	20.1	6.3	1.9	0.1	10.2	0.1	0.2	9.6	16.2	14.1	0.0	0.4	2.5	9.3	10.7	0.1	8.9	0.4	14.6	5.9	7.7	85.8	0.0	6.4	24.4	8.7	6.0	13.9	21.8	6.1	28.4	0.0	7.9	18.2	56.7	0.0	0.0	3.4	14.4	24.5	17.1	9.3	7.9	0.2	6.8	119.2	13.1	23.0	7.1	13.5	5.7	8.1	2.3	4.0	20.1	0.5	9.6	4.0
PRR5	"FLJ20185k, PP610, Protor-1"	ENSG00000186654	"Proline rich 5"	P85299	22	44668547-44737681	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 91.3;NK-cells: 77.2;Proximal tubular cells: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 19.1;T-cells: 28.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 99.2;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054072	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054072: AB_2682369"	"unprognostic (2.63e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.83e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	16.2	2.4	7.2	3.2	7.7	7.2	12.2	5.9	11.3	8.4	11.9	6.0	8.6	3.8	2.1	7.6	4.3	2.9	3.5	7.9	9.7	11.5	18.5	3.5	3.9	8.1	8.2	4.0	6.2	2.3	16.1	4.5	8.5	7.9	2.4	0.4	5.7	3.8	0.8	7.4	9.4	1.1	5.9	20.5	5.2	5.1	10.5	2.3	4.5	1.2	2.5	6.9	7.1	5.8	8.1	9.6	2.0	6.8	0.2	0.3	25.0	7.0	6.2	4.2	3.4	24.4	3.4	0.0	5.2	8.2	4.9	7.2	2.1	7.1	0.7	0.2	19.9	15.9	1.3	28.5	5.8	2.9	5.8	2.9	7.9	0.4	2.2	1.0	0.2	3.7	10.1	0.5	0.9	21.4	1.1	4.6	1.3	11.4	1.4	0.7	4.5	14.5	1.4	3.8	7.0	1.0	1.9	11.4	9.5	5.5	5.3	2.8	0.0	0.1	11.0	1.0	0.1	99.2	31.3	0.2	0.0	6.4	0.8	0.5	0.3	0.1	24.8	3.4	28.6	1.6	8.3	18.8	0.7	0.9	3.5	13.0	0.6	5.6	19.1	0.4	14.8	6.8	7.2	7.7	5.9	11.3	7.9	9.7	8.1	8.2	8.5	5.9	10.5	5.8	6.0	0.0	3.9	11.4	9.2	8.3	12.0	2.1	4.0	0.7	13.6	13.2	2.0	10.0	2.3	5.5	0.0	32.1	50.3	20.5	5.9	5.2	0.5	4.4	5.4	12.5	9.6	91.3	2.0	7.9	3.3	23.2	8.2	4.7	7.6	5.4	21.4	19.9	32.1	0.0	1.8	22.8	2.0	13.5	8.2	0.5	5.3	7.7	8.8	3.7	3.0	6.0	77.2	1.0	0.2	8.4	7.6	3.8	29.0	24.2	50.9	55.2	1.4	1.5	0.0	11.4	5.3	0.3	20.4	8.0	8.5	44.1	37.1	51.8	25.5	13.5
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.7;SK-MEL-30: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046636	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: AB_2679730"	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.3	4.0	10.7	0.8	11.9	5.8	1.6	1.2	18.7	1.8	6.3	1.3	0.7	2.5	0.0	3.7	4.8	0.1	1.8	17.9	6.7	2.3	2.3	2.0	1.0	2.7	2.1	0.7	2.9	0.4	10.4	0.1	0.7	1.8	0.1	0.3	2.7	0.2	1.2	6.0	1.8	0.1	1.9	3.1	1.3	4.4	7.4	0.5	1.2	0.0	0.5	1.0	2.0	2.8	10.7	4.1	1.1	8.1	0.0	0.6	3.5	4.9	0.9	1.3	1.8	0.9	5.6	10.2	12.6	0.7	4.1	8.8	0.7	4.5	0.5	9.0	12.8	3.1	4.3	3.1	0.9	6.2	7.2	0.9	1.8	0.6	0.3	1.2	0.6	3.9	1.6	7.1	1.3	14.3	5.2	15.8	1.9	1.6	24.7	14.5	3.6	10.5	1.7	0.8	19.8	14.1	1.9	4.8	26.2	0.0	4.3	1.0	3.8	8.0	13.5	7.1	12.0	3.9	2.3	5.1	7.7	9.8	5.9	1.9	0.1	9.7	2.3	0.4	5.5	1.5	2.5	3.9	0.1	2.8	2.4	3.1	3.7	1.7	0.5	2.4	2.0	1.2	10.7	11.9	1.2	18.7	17.9	6.7	2.7	2.1	0.7	1.9	7.4	2.8	11.8	3.2	0.0	4.9	27.9	43.3	28.0	6.8	46.7	13.6	17.2	20.3	1.6	17.2	3.7	7.3	0.0	0.8	55.9	7.4	9.8	10.6	10.6	50.2	12.3	9.2	43.0	3.4	8.6	10.8	0.9	4.8	14.3	22.3	26.7	1.0	4.6	3.1	1.5	6.7	7.0	12.3	16.2	1.9	36.5	13.8	0.9	16.7	28.4	1.0	2.3	19.7	22.6	4.0	5.7	8.6	9.8	2.2	27.3	26.7	11.6	14.2	7.0	16.6	0.0	7.8	8.1	3.3	10.7	33.2	66.9	1.4	37.0	1.5	12.3	17.3
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 59.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
PRRC1	FLJ32875	ENSG00000164244	"Proline rich coiled-coil 1"	Q96M27	5	127517640-127555085	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039212	Supported		Approved	Vesicles		NA	NA		170000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA039212: AB_10794634"	"prognostic unfavorable (9.35e-5)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.19e-1)"	17.3	18.7	7.0	18.1	8.1	21.2	24.2	8.3	9.3	27.5	12.4	23.5	25.3	22.0	23.4	20.2	15.9	17.1	14.5	6.5	7.6	21.4	26.7	18.2	17.9	7.9	8.0	22.3	32.1	30.4	19.1	27.0	8.6	21.1	27.2	11.5	25.6	18.0	12.9	19.2	24.4	22.4	7.8	16.2	24.0	13.2	7.5	19.5	26.6	10.2	20.9	19.4	17.3	9.9	30.3	30.5	44.5	34.0	58.8	75.1	51.9	52.3	58.4	45.7	71.8	52.4	34.6	33.6	53.2	83.6	34.4	26.9	35.0	64.8	70.6	46.7	24.4	29.3	29.1	45.6	33.8	27.4	36.9	51.5	46.7	48.5	56.3	41.9	49.4	31.6	25.5	40.2	53.4	34.2	53.9	29.4	25.5	43.5	39.5	20.5	58.9	43.8	36.4	37.6	32.4	25.0	41.0	44.1	40.1	40.6	47.2	35.3	58.9	41.8	31.2	49.3	37.2	33.5	26.8	43.6	49.3	42.9	42.0	18.7	11.7	9.4	18.6	13.5	22.6	15.4	15.1	16.0	15.6	11.2	16.5	14.9	3.6	12.7	13.5	10.4	13.0	12.3	7.0	8.1	8.3	9.3	6.5	7.6	7.9	8.0	8.6	7.8	7.5	9.9	16.3	35.3	25.5	9.8	17.8	14.7	14.0	37.2	22.8	12.8	24.1	15.0	12.5	27.1	40.6	27.6	14.6	25.5	14.0	38.2	13.7	30.5	3.8	16.2	33.6	22.8	15.6	12.4	13.5	30.9	42.2	30.8	28.5	23.2	15.8	28.7	26.0	37.3	21.7	8.4	13.5	50.2	28.5	20.2	7.6	4.8	34.5	14.7	19.6	15.9	17.8	10.7	22.6	18.6	25.1	31.8	25.1	30.1	38.0	26.6	34.1	28.0	30.0	12.7	13.1	18.8	26.4	13.6	21.2	18.2	18.6	31.6	19.3	21.7	33.6	26.0
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	30.9	21.0	26.8	33.3	25.8	72.5	32.7	32.1	35.0	34.0	19.0	27.0	21.6	30.2	37.5	36.7	29.7	26.2	22.7	22.9	34.2	28.8	31.1	35.8	44.8	27.5	27.1	34.3	28.9	33.8	25.7	34.2	27.6	28.2	31.9	34.5	30.3	27.1	25.7	39.7	34.0	25.4	20.3	36.0	28.9	29.3	26.4	49.6	27.8	23.7	43.4	38.5	34.4	30.7	84.9	64.3	88.1	58.4	61.0	70.5	65.2	47.8	67.7	54.8	49.7	99.1	59.0	123.9	73.1	70.4	44.3	73.8	96.5	76.1	83.8	70.1	51.4	94.2	51.2	69.5	63.3	154.4	73.8	68.6	57.1	92.7	137.3	49.3	80.9	66.6	126.8	66.6	63.0	40.3	92.8	65.2	116.8	67.5	110.5	69.3	65.5	60.7	77.8	93.3	56.7	58.3	72.6	85.4	56.0	115.8	58.2	107.0	101.6	61.9	57.0	60.7	100.4	55.5	63.4	175.3	39.4	74.7	56.7	2.2	1.3	0.7	1.3	1.2	1.3	1.7	1.2	1.2	0.6	2.0	1.1	1.3	3.4	2.5	1.4	2.0	1.0	0.6	26.8	25.8	32.1	35.0	22.9	34.2	27.5	27.1	27.6	20.3	26.4	30.7	233.8	298.1	224.7	81.0	272.5	167.0	270.8	107.5	198.6	164.6	105.4	104.6	115.7	133.0	198.3	86.5	139.7	204.0	325.0	190.0	25.4	174.0	63.9	228.0	246.7	214.5	165.1	139.0	101.5	151.3	210.1	189.1	157.0	378.3	263.2	132.8	130.3	119.0	128.9	138.0	108.6	162.3	57.0	142.8	183.0	36.5	139.1	211.0	96.0	91.8	227.9	120.4	269.8	87.9	143.2	223.1	145.2	96.3	281.8	294.3	99.6	40.1	132.1	170.4	78.9	218.1	184.2	247.7	160.8	178.0	145.9	476.8	317.3	178.5	168.5	335.5
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591004	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.2;Proximal enterocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	1.2	0.4	0.9	1.2	0.9	0.1	7.0	1.3	2.6	4.9	0.6	8.4	12.0	1.5	12.9	13.5	4.9	4.3	1.2	0.9	1.0	11.8	6.4	3.9	0.9	1.2	0.9	0.3	13.1	28.4	15.6	2.1	1.1	6.2	7.7	0.1	11.3	9.0	0.9	12.9	11.0	1.1	0.9	1.0	9.8	0.9	1.1	2.3	13.4	0.1	3.9	6.7	5.5	1.0	11.1	0.4	0.3	0.9	1.3	0.0	4.6	0.2	0.0	0.4	0.4	2.2	14.9	0.7	1.6	0.1	0.3	8.5	0.3	8.5	0.4	1.1	1.2	0.5	0.8	0.7	0.9	0.4	1.1	0.9	7.4	0.3	0.3	0.7	3.4	0.9	0.2	0.8	0.0	2.4	0.2	0.7	0.6	18.0	1.4	0.2	0.3	8.7	6.5	11.7	2.4	0.3	1.3	13.3	0.1	1.0	14.4	0.2	0.6	0.8	0.7	0.4	0.1	5.1	18.7	0.5	0.2	0.3	0.4	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.2	1.2	0.2	0.1	0.9	0.9	1.3	2.6	0.9	1.0	1.2	0.9	1.1	0.9	1.1	1.0	6.4	6.4	13.4	0.7	3.4	4.1	11.6	20.2	29.6	2.2	21.5	22.6	0.9	8.6	14.2	12.9	2.1	13.0	4.1	47.2	3.9	31.9	0.7	10.8	4.1	6.4	16.2	1.3	0.5	33.2	6.5	1.6	16.8	16.1	2.5	2.3	1.1	6.8	2.3	5.0	0.4	18.0	8.2	1.9	1.2	0.4	0.3	3.3	1.8	1.9	8.2	0.9	2.1	2.0	0.4	27.4	29.4	0.0	4.4	14.5	46.3	15.5	8.8	4.1	0.0	0.8	3.9	1.9	2.1	23.3	4.7	12.7	4.1	4.6	20.7	14.6
PRRG3	TMG3	ENSG00000130032	"Proline rich and Gla domain 3"	Q9BZD7	X	151694607-151705924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;epididymis: 7.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.4;Excitatory neurons: 12.7;Fibroblasts: 15.2;Inhibitory neurons: 8.9;Langerhans cells: 22.4;Suprabasal keratinocytes: 22.6"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060566	Uncertain					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA060566: AB_2684321"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.84e-2)"	1.9	0.2	9.5	0.2	9.1	0.2	1.8	0.0	11.4	5.3	0.2	1.2	0.1	1.7	7.4	2.3	0.9	2.0	2.0	7.8	7.1	0.5	0.0	1.2	0.1	1.6	2.1	2.1	0.1	0.2	1.5	0.8	4.0	0.6	0.6	0.7	1.7	0.2	2.3	1.5	0.4	1.4	0.2	1.7	0.6	0.3	8.6	1.2	0.9	1.9	0.2	1.1	2.7	7.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.2	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.6	0.5	0.4	0.3	0.2	0.2	9.5	9.1	0.0	11.4	7.8	7.1	1.6	2.1	4.0	0.2	8.6	7.2	7.4	0.0	0.0	0.7	0.1	18.4	0.4	0.0	2.8	0.1	0.6	1.7	4.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.9	0.0	0.0	0.2	0.7	5.7	0.0	0.0	12.7	0.0	0.0	15.2	0.0	0.5	0.0	0.5	1.4	0.2	0.1	0.0	8.9	0.0	0.0	0.0	22.4	0.0	0.3	0.3	7.2	1.0	0.0	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.3	0.0	3.1	2.1	0.0	0.1	0.2	22.6	0.0	1.3	0.3	0.0	0.3
PRRG4	TMG4	ENSG00000135378	"Proline rich and Gla domain 4"	Q9BZD6	11	32829927-32858120	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 124.3;Basal squamous epithelial cells: 145.1;Prostatic glandular cells: 153.9;Squamous epithelial cells: 141.8;Suprabasal keratinocytes: 141.5;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 11.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 52.7;hTCEpi: 28.0;SK-BR-3: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA009040, HPA024566"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA009040: AB_1079694, HPA024566: AB_2237712"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.26e-2)"	1.1	1.6	0.7	2.0	0.9	4.6	7.2	0.7	0.8	7.5	2.1	6.9	7.5	1.4	6.1	23.4	5.4	3.4	1.3	0.7	1.5	13.3	22.6	6.4	1.1	1.1	0.9	0.3	3.9	2.9	2.8	5.8	1.1	6.3	6.3	0.2	10.0	6.0	1.1	20.8	7.4	0.9	0.7	3.0	5.4	0.5	1.0	3.6	5.5	1.4	6.6	6.8	13.7	1.3	13.2	0.4	0.1	0.1	0.3	0.0	5.4	0.1	6.5	1.5	2.6	6.2	12.7	0.1	0.4	0.0	3.3	52.7	1.3	3.2	0.4	0.4	8.7	2.7	1.8	0.4	0.0	0.9	2.4	0.4	28.0	0.5	0.1	2.2	0.0	0.0	0.0	0.7	0.5	5.9	1.1	6.0	0.6	10.7	1.5	0.1	0.0	1.6	9.6	16.5	1.8	0.1	8.8	22.0	2.8	1.6	16.0	12.8	0.1	0.6	0.8	2.9	1.3	5.8	4.3	0.1	1.6	7.5	2.5	0.8	2.3	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	11.9	0.2	0.8	0.2	0.1	0.5	0.7	0.9	0.7	0.8	0.7	1.5	1.1	0.9	1.1	0.7	1.0	1.3	4.2	28.9	23.0	1.0	2.8	124.3	92.5	53.6	145.1	0.1	43.0	21.1	1.0	95.8	33.9	47.8	0.0	24.4	1.7	46.8	7.9	31.5	0.7	75.5	7.4	10.2	13.8	2.5	0.3	36.3	16.8	3.6	25.0	81.9	0.0	6.0	8.9	57.1	8.1	1.7	0.3	34.7	24.4	50.0	15.4	0.3	0.3	12.6	12.4	4.7	40.2	0.1	0.0	1.0	0.1	26.4	19.5	1.5	6.9	153.9	48.3	21.4	51.1	0.2	6.6	2.5	8.8	2.4	4.1	141.8	141.5	82.0	2.6	0.2	47.0	167.4
PRRT1	"C6orf31, DSPD1, IFITMD7, NG5"	ENSG00000204314	"Proline rich transmembrane protein 1"	Q99946	6	32148359-32153083	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 40.1;ovary: 11.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.5;Cardiomyocytes: 125.5;Granulosa cells: 181.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 38.4;cerebral cortex: 40.1;hippocampal formation: 37.0;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.0;SK-MEL-30: 1.6;U-2 OS: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055149, HPA059099"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA055149: AB_2682717, HPA059099: AB_2732632"	"unprognostic (1.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.08e-5)"	"unprognostic (2.99e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	1.6	2.2	38.4	0.3	6.4	0.0	2.0	0.0	40.1	2.7	0.0	2.9	0.6	2.3	0.0	1.5	3.6	0.1	1.6	37.0	4.8	3.1	0.9	1.3	0.1	3.4	2.1	11.9	0.6	0.3	5.6	0.2	2.2	3.1	0.0	1.3	0.9	0.6	0.4	2.0	1.8	0.0	0.0	0.9	2.0	1.3	6.5	0.0	1.9	0.0	0.0	2.4	2.4	17.5	0.0	0.1	0.0	0.5	0.2	0.1	0.2	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.8	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	6.4	0.0	40.1	37.0	4.8	3.4	2.1	2.2	0.0	6.5	17.5	3.2	0.0	0.0	4.9	0.5	4.0	8.0	3.4	14.8	67.5	1.8	3.0	125.5	10.0	1.2	1.8	10.4	6.7	1.7	2.2	1.9	0.1	1.3	1.3	2.3	6.7	9.0	4.2	12.6	0.0	1.0	7.8	4.6	0.5	0.0	181.6	5.0	3.5	1.0	32.0	10.9	5.5	0.0	0.8	2.1	1.2	6.2	1.9	3.6	6.5	0.2	16.0	1.0	3.5	5.0	0.2	3.4	6.4	0.8	3.6	5.5	0.1	3.7	8.7	0.0	3.6	8.0	0.8	1.6	3.8	2.7	3.6	2.2	8.1	4.1	4.8
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		83000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	0.9	1.8	3.9	1.1	5.0	1.5	1.2	10.1	11.6	1.3	0.3	1.3	0.4	1.2	1.2	1.2	7.6	1.1	1.1	4.4	1.1	1.3	0.4	0.9	1.2	5.1	1.9	1.3	1.8	15.3	11.0	0.3	5.3	2.5	0.3	2.2	2.3	1.7	1.4	2.3	0.9	0.9	0.0	0.9	1.1	2.1	3.6	1.3	2.2	0.2	1.3	1.8	1.1	4.8	0.4	1.0	3.6	4.7	17.2	2.3	1.2	1.8	3.4	2.0	4.5	0.3	3.4	2.0	0.4	4.2	2.1	0.3	1.3	4.5	0.9	9.8	2.0	0.7	1.9	0.2	1.7	0.4	1.7	4.4	0.3	1.7	0.7	9.7	0.8	6.0	1.0	4.7	2.5	23.1	4.4	0.4	8.5	0.1	2.1	2.8	0.4	1.9	1.0	0.4	6.6	4.4	1.8	33.6	0.7	1.4	9.1	0.4	0.7	0.4	4.6	0.9	1.3	6.1	6.6	0.6	10.9	0.3	1.3	0.5	0.2	0.2	1.2	0.1	1.4	0.5	1.3	1.2	0.0	0.6	1.4	1.3	0.3	0.7	0.1	0.6	0.2	0.4	3.9	5.0	10.1	11.6	4.4	1.1	5.1	1.9	5.3	0.0	3.6	4.8	3.3	0.0	2.0	3.9	2.9	2.7	3.8	3.7	3.4	22.8	7.4	6.2	3.0	7.2	3.4	11.0	14.6	0.7	4.4	4.5	3.9	2.9	4.3	5.0	5.4	3.3	11.3	2.1	14.7	5.0	0.5	5.2	5.6	4.9	1.3	7.9	2.2	2.9	3.8	15.2	10.8	5.4	2.0	2.5	2.6	3.5	5.6	2.2	1.8	2.8	11.3	8.6	11.3	5.5	3.7	3.1	1.0	2.6	2.2	4.2	6.4	8.0	12.4	21.6	0.0	7.2	5.3	10.4	6.4	3.4	2.3	0.4	5.6	7.8	4.7	3.0
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.3;bone marrow: 57.7"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 4.8;Horizontal cells: 10.1;Inhibitory neurons: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 225.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	16.3	1.3	3.2	0.4	2.7	57.7	8.5	3.2	2.9	2.5	0.7	1.3	0.1	0.5	0.0	2.7	1.1	0.7	1.5	2.0	6.3	0.1	0.4	0.9	0.1	4.7	4.8	1.1	0.3	0.3	0.2	0.0	4.0	0.4	0.2	1.0	1.1	0.8	4.5	2.3	1.2	0.4	3.6	2.1	2.1	0.4	5.1	0.6	0.5	4.5	0.0	0.5	3.0	2.1	0.0	0.1	0.3	0.5	1.3	0.1	3.8	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.2	8.8	0.1	1.3	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.0	2.6	46.6	1.2	0.0	0.1	12.9	0.6	1.0	0.0	0.1	0.5	225.3	0.4	0.2	0.3	1.5	0.1	6.1	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.7	3.2	2.9	2.0	6.3	4.7	4.8	4.0	3.6	5.1	2.1	0.4	0.0	0.0	1.0	0.0	0.6	0.1	0.2	0.6	4.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.2	10.1	12.6	0.0	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.8	1.2	0.3	0.3	0.1	0.0	0.0	0.1
PRRX1	"PHOX1, PMX1"	ENSG00000116132	"Paired related homeobox 1"	P54821	1	170662728-170739421	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 351.7;Endometrial stromal cells: 158.6;Fibroblasts: 180.2;Late spermatids: 390.0;Leydig cells: 256.3;Oligodendrocyte precursor cells: 288.5;Smooth muscle cells: 206.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 367.0;ASC TERT1: 290.5;BJ: 109.7;BJ hTERT+: 213.2;HSkMC: 150.6;U-138 MG: 146.0;U-2197: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051084, HPA063566"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051084: AB_2681338, HPA063566: AB_2732702"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.60e-10)"	"unprognostic (4.23e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.69e-3)"	96.3	10.2	14.5	17.7	15.2	0.0	42.9	15.4	13.4	92.0	5.4	5.6	1.1	68.6	20.3	20.1	42.3	34.1	44.2	12.6	26.2	2.3	0.4	21.7	34.6	17.4	18.5	28.2	3.8	7.5	4.9	6.3	16.8	33.5	5.7	0.1	38.5	75.6	51.7	24.1	3.6	52.4	7.9	1.9	3.4	14.2	16.5	18.7	41.6	73.9	36.3	33.0	58.8	15.0	0.0	0.0	2.1	0.0	367.0	290.5	0.1	109.7	213.2	15.0	14.8	0.0	0.1	0.1	0.0	90.2	0.0	0.0	18.5	0.0	4.7	0.0	0.2	0.0	1.6	0.0	1.2	0.0	0.0	150.6	0.0	73.4	0.4	25.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.1	146.0	2.6	140.4	16.9	0.0	0.0	0.0	77.3	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	15.2	15.4	13.4	12.6	26.2	17.4	18.5	16.8	7.9	16.5	15.0	49.8	0.0	0.5	114.3	0.3	16.3	0.6	0.1	4.0	0.0	1.3	10.2	29.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.2	351.7	4.9	158.6	11.4	0.0	0.0	17.4	0.2	0.1	180.2	0.5	3.5	0.0	0.6	0.0	0.0	0.8	0.0	5.5	0.0	0.0	0.0	27.9	390.0	256.3	2.8	14.2	124.6	0.0	0.5	0.0	288.5	0.9	0.7	0.0	104.6	0.4	1.7	0.0	0.1	0.0	0.2	52.6	59.1	206.5	15.4	1.9	1.2	11.8	0.1	2.3	0.6	0.0	1.2
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665647-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.3;skin 1: 25.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.4;Early spermatids: 78.7;Fibroblasts: 44.2;Langerhans cells: 28.0;Smooth muscle cells: 21.2;Suprabasal keratinocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.9;BJ: 28.7;BJ hTERT+: 20.3;fHDF/TERT166: 41.6;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	14.2	2.4	0.5	1.2	0.5	0.0	11.7	0.4	0.7	23.3	1.0	2.2	0.2	3.9	0.2	5.4	3.4	1.3	9.5	0.6	1.2	1.2	0.1	4.6	1.1	0.5	0.5	1.3	0.9	0.5	4.5	1.4	0.6	14.1	0.3	0.0	7.5	2.7	1.6	25.5	1.6	0.6	0.4	0.1	2.8	10.7	0.5	0.3	9.5	0.6	0.8	10.7	18.3	0.5	0.0	0.7	0.0	1.1	3.3	12.9	0.1	28.7	20.3	3.6	4.0	0.0	0.0	0.0	10.2	41.6	1.5	0.3	0.8	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.0	0.0	4.4	2.1	6.4	0.0	0.0	0.0	0.9	0.0	0.0	2.7	1.3	0.1	0.0	1.4	2.7	0.5	0.0	0.0	8.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.7	0.6	1.2	0.5	0.5	0.6	0.4	0.5	0.5	3.9	0.0	0.0	0.7	0.1	27.4	1.1	16.0	0.6	0.0	6.0	6.0	0.3	0.0	10.1	0.0	0.0	0.2	0.1	0.0	1.9	0.1	78.7	1.0	6.3	3.0	0.0	0.0	0.4	0.0	0.4	44.2	0.5	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	2.0	0.0	28.0	10.2	2.8	0.3	8.8	0.0	0.0	0.0	0.0	5.0	0.1	0.9	0.0	3.4	0.0	4.0	0.0	0.1	7.9	0.0	0.0	0.4	21.2	3.6	6.8	0.5	29.7	0.4	0.8	0.0	0.0	6.2
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1923	"pancreas: 341429.7"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	45.2	9.9	0.0	4.7	0.0	0.0	25.7	0.0	0.0	19.9	0.0	11.2	54.5	8.9	0.8	15.2	5.6	0.0	51.0	0.0	0.0	9.6	29.7	6.4	6.5	0.0	0.0	177.5	341429.7	0.1	10.3	13.9	0.0	15.2	0.0	0.0	44.2	4.2	8.9	12.1	12.7	0.0	0.0	13.4	77.1	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	452	"pancreas: 239420.0"	"Cell type enriched"	"Detected in some"	11	"Exocrine glandular cells: 108258.7"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 4.1;T-reg: 2.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		890000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	65.1	12.5	0.1	0.2	0.1	3.2	25.4	0.0	0.1	27.6	0.0	12.6	358.5	11.4	0.0	18.2	9.6	0.1	25.0	0.0	0.0	9.4	32.2	8.2	1.3	0.0	0.0	64.9	239420.0	0.0	13.4	8.1	0.0	17.2	0.0	0.0	25.4	0.9	10.1	11.3	529.2	0.1	0.0	16.9	54.7	8.6	0.0	0.9	8.3	0.0	0.0	7.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.4	4.4	0.5	0.0	0.0	0.0	1.9	0.0	21.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.9	3.8	0.0	2.9	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	378.7	0.0	0.4	0.1	11.4	0.0	0.0	0.0	108258.7	0.0	0.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	348.9	0.0	0.0	0.0	0.0	9565.7	8.9	0.0	0.1	0.0	60.0	0.1	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	85.4	0.2
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 84.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 16.1;eosinophil: 33.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 33.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	38	"basal ganglia: 8.9"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.1	0.0	0.1	0.5	0.1	7.8	1.3	0.0	0.1	1.6	0.0	0.7	0.5	0.2	0.0	1.5	2.7	1.8	0.0	0.0	0.1	0.1	0.1	2.5	1.2	0.1	0.0	0.1	2.0	1.5	0.1	0.0	0.1	3.8	0.5	0.0	20.5	0.3	0.0	0.9	0.8	0.1	0.0	1.7	0.8	84.6	0.1	1.1	0.0	0.0	1.2	0.4	1.4	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	28.5	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	13.8	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	16.1	3.5	33.0	3.1	2.6	4.8	1.2	1.5	2.6	0.9	0.8	2.2	3.2	0.3	1.8	0.5	2.2	1.0	2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	4.6	1.1	37.9	9.4	13.1	0.0	6.1	8.4	84.1	0.0	2.7	0.0	0.0	0.3	2.1	1.4	0.0	1.1	111.0	0.3	2.6	1.6	0.0	9.7	0.0	0.4	9.0	0.7	0.0	0.4	0.0	0.4	0.0	0.0	11.1	0.0	0.0	1.5	4.1	0.6	0.7	349.7	6.5	5.7	0.0	0.0	1.1	0.0	4.1	0.0	0.1	0.7	0.6	3.8	20.4	32.7	0.1	0.1	0.5	0.0	46.0	0.0	1.0	453.2	270.2	2.8	0.6	0.1	3.4	0.0	2.4	14.5
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852730-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.6;salivary gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	23.4	0.0	0.5	0.3	0.7	0.4	79.6	1.3	0.8	0.0	0.0	0.0	16.7	0.5	2.9	0.0	0.0	0.0	0.0	5.8	1.5	2.4	1.1	0.0	6.0	0.5	0.0	26.9	0.3	0.0	3.2	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.3	0.0	2.2	2.5	23.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	17.3	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	22.9	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.2	0.0	0.2	23.2	221.0	128.8	28.5	0.0	42.8	23.7	0.3	38.6	343.9	16.5	0.0	36.7	1.9	18.5	1.9	113.1	0.0	28.4	4.6	1.8	3.6	0.0	0.0	98.3	37.1	1.3	52.5	56.6	0.0	0.0	0.0	0.1	2.3	0.0	0.0	7.5	207.5	0.0	1.4	0.0	0.0	0.9	7.2	0.0	1.0	0.0	0.0	0.0	0.0	380.6	32.3	0.0	0.3	75.4	0.6	0.2	108.0	0.0	0.0	0.0	13.7	0.1	0.2	22.7	27.6	10.5	2.7	0.0	6.9	479.5
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 249.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 104.6"	"Group enriched"	"Detected in many"	25	"NK-cells: 34.2;T-cells: 104.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		440000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	55.0	21.4	7.8	35.3	7.8	2.1	43.2	7.1	8.7	249.1	12.9	103.6	19.2	103.4	13.4	22.1	24.9	83.8	28.3	7.9	8.0	42.4	15.0	63.3	21.8	14.0	13.9	26.8	29.8	36.0	16.4	61.7	8.8	61.3	50.3	2.7	52.4	128.2	79.6	19.4	29.0	115.5	7.1	18.0	54.2	31.8	14.1	17.5	40.9	18.7	10.2	99.6	79.1	7.4	62.7	153.3	161.1	1.0	70.4	172.3	0.7	269.0	244.4	293.2	232.6	368.1	484.7	0.2	208.2	414.7	1093.7	126.2	2.6	205.0	70.9	0.7	13.0	21.1	74.7	1.4	36.3	0.1	0.9	137.4	26.8	143.2	162.1	1296.9	604.8	0.9	1.3	0.3	223.4	87.7	0.2	0.3	9.8	211.7	16.8	0.0	0.0	0.7	111.5	82.3	1.5	1.0	59.9	4.5	18.7	397.6	6.0	0.6	1138.2	174.0	2.3	351.7	154.5	1.3	1.3	0.8	124.2	0.5	176.3	0.2	0.2	0.1	104.6	0.1	0.2	0.2	17.8	60.0	0.2	0.0	4.7	50.4	1.6	34.2	2.7	0.2	0.0	39.9	7.8	7.8	7.1	8.7	7.9	8.0	14.0	13.9	8.8	7.1	14.1	7.4	95.8	28.9	14.5	14.0	3.2	15.4	96.2	367.1	2.8	1.6	44.7	78.0	4.3	37.1	231.3	53.3	2.1	18.4	53.4	154.8	7.9	162.6	3.1	10.3	130.3	502.1	13.8	20.4	26.3	83.5	15.7	117.1	22.4	7.0	2.5	347.3	591.8	5.2	5.0	0.0	16.5	30.6	85.5	36.6	18.2	6.6	14.3	5.4	72.9	39.4	1.5	0.8	180.2	11.6	2.3	257.7	80.1	7.5	5.8	100.1	5.2	5.7	90.1	0.9	39.5	14.4	105.9	3.0	7.3	1.7	9.8	4.5	24.0	445.1	11.1	60.2
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712419-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.5;esophagus: 388.6;vagina: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Horizontal cells: 11.8;Squamous epithelial cells: 9.6;Urothelial cells: 11.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;SK-BR-3: 24.4;T-47d: 14.6;U-266/70: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"	NA	NA		8700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	1.0	0.4	0.9	0.2	0.9	0.3	1.3	1.0	2.0	83.5	0.6	1.0	0.0	1.0	0.0	388.6	0.7	0.2	0.4	0.8	1.4	1.1	0.6	0.6	0.3	1.2	1.5	0.5	0.8	0.7	1.5	0.1	1.0	1.0	0.0	0.2	52.5	0.4	0.3	3.3	0.6	0.0	1.0	0.6	0.8	2.6	1.2	0.6	0.8	0.0	29.9	0.8	134.2	0.9	0.1	0.3	0.4	2.1	0.3	0.7	6.1	0.0	0.2	0.2	0.2	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.1	0.1	0.0	1.0	0.0	0.3	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	2.0	0.0	1.1	1.4	0.2	0.0	1.0	0.2	0.1	0.2	0.3	0.7	2.8	0.0	24.4	0.6	0.1	14.6	1.8	0.0	0.4	0.0	0.1	0.0	5.2	3.7	0.5	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.9	1.0	2.0	0.8	1.4	1.2	1.5	1.0	1.0	1.2	0.9	1.5	9.6	5.8	0.0	0.5	1.8	2.5	1.3	0.6	5.2	5.1	6.2	1.2	1.5	5.6	1.8	4.2	0.7	0.5	1.2	0.0	1.5	3.3	0.6	1.4	1.8	0.0	0.0	0.4	1.4	0.6	1.4	1.1	1.6	3.8	1.1	0.4	0.7	0.3	11.8	0.8	0.5	0.0	0.3	3.1	1.0	0.3	0.8	1.8	1.9	0.9	2.6	0.0	0.0	0.3	1.1	1.2	0.0	0.2	1.7	0.1	0.7	3.4	6.6	0.0	2.7	1.5	3.0	3.9	9.6	2.4	3.3	1.3	0.6	1.4	11.1
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750679-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	268	"pancreas: 31113.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	104	"basophil: 158.7"	"Lineage enriched"	"Detected in many"	104	"granulocytes: 158.7"	"Group enriched"	"Detected in many"	5	"OE19: 316.6;PC-3: 852.5"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		700000000	"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	3.8	4.6	23.5	7.2	29.3	0.6	1.7	25.8	35.4	30.8	16.9	87.0	92.6	0.4	0.0	116.2	0.3	22.8	6.3	28.2	25.6	3.7	12.4	0.6	0.7	25.0	24.5	12.9	31113.6	0.0	0.7	1.7	25.7	1.1	77.8	0.3	20.9	0.3	0.5	79.7	105.4	3.1	19.4	0.7	22.8	5.1	25.6	0.8	0.4	0.0	15.2	4.2	56.9	24.7	12.0	13.7	0.7	0.0	0.2	5.9	0.1	33.6	7.7	4.1	1.6	34.3	3.0	0.0	0.2	14.9	0.2	15.0	0.0	31.7	10.1	0.4	0.2	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	10.8	110.2	0.3	68.8	0.2	0.0	0.0	0.0	0.2	0.7	0.4	0.2	316.6	852.5	0.0	0.0	0.0	0.0	1.7	0.3	81.2	0.2	0.0	0.0	0.5	0.0	0.0	78.3	0.0	0.0	12.8	0.0	0.0	0.0	0.1	18.1	0.0	0.1	158.7	0.0	0.0	0.2	1.5	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.3	23.5	29.3	25.8	35.4	28.2	25.6	25.0	24.5	25.7	19.4	25.6	24.7	0.1	0.0	0.0	0.7	1.9	57.1	0.6	1.3	0.0	0.2	0.1	2.8	1.0	47.1	1.2	1.8	0.0	0.0	0.1	1022.9	3.9	43.2	31.4	0.0	0.0	3.2	192.6	0.0	32.8	2040.4	0.0	0.8	39.3	0.0	8.9	0.0	0.7	4.2	0.0	0.0	4.7	146.4	0.0	0.3	12.1	79.7	1.5	1.2	7.2	3.7	5.7	0.0	0.0	3.5	1.2	478.8	969.9	0.7	0.3	12.1	1127.1	14.7	0.1	0.2	0.0	0.0	1.7	0.5	0.9	1.1	134.1	0.1	2.1	0.0	329.0	56.2
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.5"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	2.9	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.5	0.1	0.3	1.3	1.1	0.3	1.4	4.2	4.4	3.2	2.1	3.1	0.4	1.3	0.7	1.8	1.9	10.2	0.3	0.3	1.1	3.6	1.8	1.1	0.3	50.5	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.6	0.1	0.4	0.1	0.1	1.3	0.5	2.2	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.8	1.7	6.8	3.2	2.1	1.8	1.9	1.8	1.8	2.6	2.2	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138926-31150083	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.6"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.7;Distal enterocytes: 13.2;Hofbauer cells: 18.7;Paneth cells: 15.4;Proximal enterocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA036079	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	1.4	0.8	0.4	0.3	0.6	0.4	0.5	0.4	0.8	0.2	0.3	0.7	1.0	0.1	0.0	0.3	0.3	0.1	0.3	0.5	0.5	0.2	0.3	0.7	0.1	0.5	0.4	0.1	0.2	0.1	2.6	0.7	0.5	0.1	0.2	0.0	0.5	0.1	0.2	1.0	0.7	0.3	0.4	0.1	0.3	0.4	0.6	0.8	0.3	0.0	0.2	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.4	0.6	0.4	0.8	0.5	0.5	0.5	0.4	0.5	0.4	0.6	0.5	0.3	0.0	1.1	0.7	0.2	1.9	2.6	8.9	1.8	0.5	5.9	11.7	1.1	2.8	3.5	0.0	0.0	0.8	1.2	13.2	0.0	1.7	1.7	0.9	0.6	0.6	0.0	0.4	0.6	2.8	1.2	1.3	1.1	0.9	0.0	0.5	3.3	3.3	18.7	0.0	0.8	4.1	2.0	3.2	3.8	0.9	2.8	4.2	0.0	0.0	5.4	0.6	4.1	0.0	0.1	1.8	15.4	2.6	0.0	1.7	46.9	1.9	1.2	0.0	0.0	0.4	0.4	0.6	4.4	1.5	2.6	0.5	0.5	1.1	3.9	1.9
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836300-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 41.3"	"Group enriched"	"Detected in some"	138	"Early spermatids: 612.8;Late spermatids: 325.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020541	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	41.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.7	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	612.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	325.7	2.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS45P	"PRSS45, TESPL, TESSP5"	ENSG00000188086	"Serine protease 45, pseudogene"	Q7RTY3	3	46742092-46750891	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"epididymis: 6.4;skeletal muscle: 10.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA060284	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"					"HPA060284: AB_2684242"	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.3	0.2	0.3	0.0	0.3	0.0	1.1	0.5	0.4	1.6	1.0	0.5	0.1	0.3	6.4	0.2	0.9	0.0	3.5	0.2	0.7	1.7	1.3	0.6	0.1	0.6	0.7	0.4	2.1	2.8	1.9	0.1	0.7	1.4	0.0	0.2	0.9	1.0	10.4	0.3	0.3	0.1	0.5	0.3	0.3	2.2	0.6	0.2	4.9	0.9	0.0	0.7	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.2	0.7	0.6	0.7	0.7	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 18.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 2.2;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 3.7;Sertoli cells: 6.6;Spermatocytes: 3.1;Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	1.6	0.0	2.2	0.0	0.0	2.8	1.6	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	2.8	1.6	1.0	2.8	2.9	1.0	3.4	0.8	1.9	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.1	0.0	3.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS50	"CT20, TSP50"	ENSG00000283706	"Serine protease 50"	Q9UI38	3	46712117-46717869	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pituitary gland: 17.2;testis: 52.0;thyroid gland: 16.5"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 359.2;Spermatogonia: 303.6"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"									HPA040768	Supported				"Intracellular and membrane"	NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040768: AB_2677126"																		0.5	1.2	0.9	0.0	0.9	0.1	1.9	2.3	1.5	4.5	0.7	1.6	0.0	1.5	2.9	0.4	2.3	0.1	4.1	1.1	1.2	5.4	2.7	0.7	0.0	1.2	0.9	2.2	4.6	1.4	17.2	0.1	1.0	4.5	0.0	0.2	1.9	2.1	1.2	0.4	0.5	0.2	1.2	0.3	1.0	52.0	1.1	0.2	16.5	0.0	0.0	1.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	2.3	1.5	1.1	1.2	1.2	0.9	1.0	1.2	1.1	0.9	0.0	0.0	0.0	1.6	0.0	0.1	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	3.1	0.2	0.0	1.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.1	39.5	0.2	0.0	359.2	303.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;liver: 9.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.3;Inhibitory neurons: 4.3;Oligodendrocytes: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 4.8;U-87 MG: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034955, HPA034956"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034955: AB_2674380, HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.2	0.1	1.7	0.4	1.9	0.0	0.2	1.9	3.2	0.5	1.5	0.4	0.3	0.3	0.1	0.3	0.1	0.3	0.2	1.8	1.9	0.6	9.9	0.4	0.4	1.8	1.8	0.3	0.6	0.0	0.8	0.1	1.8	0.9	0.1	0.1	0.4	0.2	0.1	2.8	0.4	0.4	1.7	0.5	0.5	0.0	1.8	0.1	0.4	0.0	0.0	0.4	0.5	2.2	0.3	0.4	0.1	0.3	0.0	0.5	0.8	0.4	0.8	0.5	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.8	0.0	0.4	0.3	1.0	0.0	0.4	0.1	0.9	0.2	1.1	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.0	0.4	0.0	0.5	0.2	0.3	0.8	0.5	1.6	0.1	0.7	0.2	0.1	2.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.9	3.2	1.8	1.9	1.8	1.8	1.8	1.7	1.8	2.2	0.2	0.0	0.0	1.6	0.2	0.4	0.2	0.2	0.0	0.4	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.4	6.3	0.2	0.2	0.2	1.1	0.3	0.0	0.3	0.4	0.7	0.1	0.0	4.3	0.1	0.0	0.0	0.4	0.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.5	4.4	0.4	0.0	1.2	0.2	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.2	0.1	0.1	0.5	1.4	0.0	1.0	0.1	0.1	0.3
PRSS54	"CT67, FLJ25339, KLKBL4"	ENSG00000103023	"Serine protease 54"	Q6PEW0	16	58279997-58295047	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	110	"testis: 41.4"	"Group enriched"	"Detected in some"	34	"Early spermatids: 526.0;Late spermatids: 208.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041549	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA041549: AB_10795640"	"unprognostic (1.13e-1)"			"unprognostic (3.24e-2)"	"unprognostic (3.09e-2)"				"unprognostic (3.08e-1)"	"unprognostic (4.88e-2)"			"unprognostic (1.23e-1)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	526.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	208.3	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135727	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 245.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3"	"Region enriched"	"Detected in single"	8	"hippocampal formation: 1.4"	"Low region specificity"	"Detected in single"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		4400000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.8	0.4	0.3	15.0	0.4	0.2	25.5	2.1	0.6	31.1	6.7	129.4	155.7	9.9	113.0	136.2	15.4	47.7	0.4	0.6	0.2	90.6	28.0	54.1	0.3	0.3	0.2	0.6	139.4	56.0	8.4	51.0	0.4	49.0	72.6	0.0	245.4	8.5	0.3	115.3	151.8	3.5	0.1	0.2	156.2	0.5	0.2	15.4	50.8	0.0	11.8	4.9	56.0	0.2	63.4	0.2	0.1	0.2	0.0	0.0	243.7	0.0	0.0	0.0	0.0	165.9	111.9	0.0	1.3	0.0	0.0	73.5	0.1	69.7	0.0	0.3	0.4	0.1	0.3	6.5	0.0	0.0	0.3	0.0	157.8	0.0	2.4	0.0	0.0	0.1	1.9	0.1	0.0	68.1	0.6	1.4	20.5	79.6	0.1	0.5	0.0	1.2	7.5	13.1	0.9	0.7	0.0	186.3	0.1	18.8	42.8	0.8	0.0	0.1	1.9	0.6	0.4	0.3	0.5	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.1	0.6	0.6	0.2	0.3	0.2	0.4	0.1	0.2	0.2	0.4	99.3	60.1	0.0	1.0	37.9	82.7	108.9	76.2	0.5	74.4	39.2	0.3	62.9	107.4	42.3	0.0	168.8	0.8	403.5	29.4	192.4	0.0	35.2	11.4	2.6	9.6	2.7	0.1	224.4	648.4	3.5	82.6	109.5	7.0	0.0	0.0	18.2	22.8	0.0	0.2	132.1	87.5	0.3	2.7	0.0	0.6	1.9	3.6	0.0	4.2	0.3	0.0	0.0	0.0	240.7	262.6	0.0	0.1	66.0	358.0	28.6	21.2	0.1	0.0	0.1	4.7	0.0	0.2	81.9	54.0	450.7	2.2	0.0	150.8	91.0
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848614-24952606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2"					"Low region specificity"	"Detected in all"			HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	5.4	22.2	21.7	4.5	28.7	0.9	7.6	24.9	27.2	12.9	16.1	9.9	17.7	15.8	7.4	5.5	9.8	14.8	10.9	22.4	24.6	4.8	2.8	4.3	4.2	26.7	24.0	20.2	4.6	13.4	11.4	2.9	28.0	7.8	11.3	16.5	9.7	8.2	1.3	1.8	17.1	9.8	25.8	3.2	17.5	2.2	23.7	6.8	5.3	2.8	3.2	7.4	6.3	37.1	19.5	41.3	30.2	12.4	4.9	24.4	0.0	20.2	15.1	14.2	19.3	75.9	94.3	0.0	3.1	23.7	1.2	10.7	34.7	0.0	22.0	0.0	1.4	56.2	7.6	0.1	14.6	0.0	0.0	7.1	0.2	7.7	0.0	13.3	22.6	2.2	18.6	10.5	6.8	0.5	8.8	0.1	20.9	3.3	0.7	9.7	0.1	0.2	12.7	0.5	21.5	0.9	19.3	0.1	0.0	0.6	1.1	4.3	12.2	6.3	15.5	23.1	12.2	0.9	0.0	0.0	16.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	4.4	0.0	0.1	0.0	0.9	21.7	28.7	24.9	27.2	22.4	24.6	26.7	24.0	28.0	25.8	23.7	37.1	3.5	0.0	0.5	136.1	0.7	2.7	4.6	5.4	2.8	10.2	1.1	5.8	8.6	7.2	3.9	3.7	2.1	1.0	0.8	3.8	5.9	5.8	1.4	1.5	27.3	2.8	5.4	3.0	38.2	0.5	4.9	20.6	12.2	2.2	0.0	25.1	7.5	0.1	7.2	6.7	43.0	7.3	0.0	0.9	3.1	1.0	12.2	7.8	3.6	24.4	1.5	45.8	0.0	111.6	148.2	2.3	2.1	9.8	1.3	1.1	12.2	0.1	1.1	15.9	0.0	16.4	10.4	3.4	6.3	0.4	2.8	0.8	1.0	22.7	11.6	1.5
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2098.1"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.8	0.2	0.6	0.0	0.7	2098.1	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.6	0.4	0.3	2.8	11.7	0.4	0.3	0.4	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.2	0.1	0.2	0.6	7.1	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.6	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.4	0.2	0.6	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 169.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		41000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	10.1	9.5	12.2	7.7	12.1	4.4	14.9	16.1	15.1	15.0	12.4	14.8	12.5	14.8	15.6	12.4	16.0	9.2	33.4	12.4	12.6	18.8	14.3	10.8	10.8	12.0	12.5	17.2	10.7	20.9	12.6	7.1	11.9	12.2	14.5	10.8	13.2	14.4	29.4	11.5	12.0	14.1	11.9	11.2	11.2	18.3	12.8	16.2	32.5	21.4	12.6	13.7	11.9	13.5	11.0	11.6	20.2	19.3	24.3	6.6	10.9	5.1	11.2	18.7	16.4	14.1	13.0	22.2	21.7	6.9	5.5	15.5	19.9	13.4	14.6	24.5	22.6	26.6	11.8	20.4	13.5	17.5	13.0	8.4	24.7	10.2	9.5	15.4	9.2	29.4	21.1	18.3	8.9	26.2	27.2	14.1	18.7	39.7	15.0	24.2	12.8	21.5	13.4	14.9	28.7	23.5	17.5	23.5	16.1	28.3	32.6	25.7	6.3	6.6	7.8	7.5	8.1	44.1	40.0	169.1	6.5	13.0	16.9	19.1	8.1	17.8	16.4	7.8	19.8	14.4	18.1	18.6	11.9	15.4	21.7	17.5	18.6	18.8	12.2	6.4	18.5	22.3	12.2	12.1	16.1	15.1	12.4	12.6	12.0	12.5	11.9	11.9	12.8	13.5	4.5	6.4	13.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	9.8	8.9	0.0	0.0	3.1	11.0	0.0	4.1	3.2	0.0	0.0	6.0	0.0	4.3	7.8	2.1	0.0	0.0	0.0	5.7	4.8	2.5	0.0	6.4	0.0	8.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.0	0.0	0.0	8.9	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.1	2.8	4.8	0.0	0.0
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2 with BCH domain"	Q8WUY3	9	76611376-76906114	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 120.6;intestine: 110.9"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 918.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1"	"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	11.3	23.2	26.9	11.9	82.9	2.9	5.2	49.5	54.7	16.6	0.0	110.9	7.1	50.6	18.5	34.0	29.4	16.4	8.9	26.9	48.4	15.4	1.9	5.1	2.8	90.0	52.8	4.7	4.3	4.0	30.9	4.0	76.4	47.6	18.5	39.0	14.6	64.8	16.7	5.4	27.7	55.3	31.7	4.4	37.1	4.9	53.1	0.9	2.6	56.8	2.5	69.2	14.4	120.6	0.0	0.0	1.5	0.0	51.1	25.8	0.2	1.8	3.6	6.6	14.7	0.4	0.0	0.3	3.9	4.5	13.6	0.0	0.1	0.0	18.0	0.4	2.9	6.3	3.7	0.0	8.5	0.1	0.3	28.7	0.1	26.7	0.7	15.1	14.4	0.4	0.0	20.8	83.2	0.1	4.6	1.8	4.0	0.0	0.0	0.5	71.5	0.3	40.1	0.0	17.4	0.0	0.0	0.3	4.9	2.8	0.1	0.7	11.9	14.2	0.7	34.9	1.2	22.2	3.2	0.0	11.5	0.3	0.0	0.3	0.5	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.2	0.1	0.0	0.2	26.9	82.9	49.5	54.7	26.9	48.4	90.0	52.8	76.4	31.7	53.1	120.6	0.4	0.0	1.1	27.7	0.0	2.3	0.4	0.5	0.0	47.5	1.2	3.4	11.1	0.0	1.0	11.0	0.0	0.0	1.6	3.5	1.9	0.0	12.6	37.7	4.7	3.7	54.3	0.0	152.4	0.5	0.2	2.9	3.1	34.7	0.0	0.1	21.8	0.2	3.2	15.2	65.4	36.4	4.1	3.1	3.1	30.0	0.9	2.3	5.4	13.1	1.7	9.9	2.1	134.7	918.7	0.4	8.8	1.5	0.1	5.1	9.9	20.3	17.0	6.5	0.0	27.2	9.6	4.3	4.2	0.0	1.4	0.0	0.7	0.5	5.2	0.6
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393766-40414793	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 34.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"spinal cord: 114.2"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	4.5	4.7	6.2	1.3	6.8	1.6	3.9	5.2	6.5	4.8	2.9	3.6	1.1	4.4	1.0	2.0	4.2	1.8	3.1	4.7	4.4	6.7	1.0	34.6	1.3	5.4	4.9	6.2	3.8	5.9	1.5	5.1	6.7	4.6	0.7	0.8	3.8	3.5	4.9	3.2	2.2	2.0	4.9	2.0	3.7	1.6	5.7	0.7	9.6	5.5	0.8	4.3	3.1	4.1	1.6	2.6	2.1	2.7	1.3	4.4	2.6	1.4	1.5	1.9	1.4	1.0	1.7	0.5	1.6	1.3	1.2	0.9	1.0	0.6	0.7	0.8	0.9	0.3	0.3	0.5	2.1	0.1	2.3	3.3	3.2	1.2	1.1	1.7	1.6	2.9	2.0	0.5	1.0	2.2	1.0	0.6	0.6	3.8	1.7	3.2	1.8	1.5	0.4	1.8	0.2	1.0	2.7	2.3	2.0	0.9	3.2	1.2	1.4	3.8	2.9	1.6	0.8	5.3	5.0	0.7	1.1	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.2	6.8	5.2	6.5	4.7	4.4	5.4	4.9	6.7	4.9	5.7	4.1	17.8	3.2	5.9	0.7	1.4	6.2	2.3	0.3	5.7	0.1	8.1	23.2	15.4	2.8	0.9	1.8	0.0	1.1	1.7	1.0	0.0	0.3	0.1	1.3	1.7	9.2	0.0	0.4	0.6	0.6	0.7	7.0	0.0	3.0	0.0	2.0	6.8	1.3	1.1	0.0	0.5	0.7	2.0	1.6	2.5	0.1	3.4	2.5	3.6	7.5	0.3	3.3	0.0	0.0	0.5	0.5	1.4	4.5	0.9	1.7	1.2	1.9	0.2	0.1	0.0	30.3	6.1	0.3	0.7	5.0	4.1	2.7	1.1	1.3	1.5	1.0
PRXL2A	"Adrx, C10orf58, FAM213A, MGC4248, PAMM"	ENSG00000122378	"Peroxiredoxin like 2A"	Q9BRX8	10	80407829-80437115	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Antioxidant		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 405.6"	"Group enriched"	"Detected in some"	7	"Adipocytes: 161.4;Cardiomyocytes: 161.5;Hofbauer cells: 75.1;Smooth muscle cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"plasmacytoid DC: 166.0"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 166.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 947.9;HaCaT: 276.4;HUVEC TERT2: 436.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009025, HPA024565"	Enhanced				"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA009025: AB_1078312, HPA024565: AB_1845519"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.32e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (6.11e-4)"	405.6	25.1	112.4	15.9	110.4	3.6	210.2	97.4	119.8	92.0	122.6	51.8	84.0	52.5	212.8	83.9	30.9	30.8	76.3	121.8	104.3	110.9	197.3	20.9	18.0	108.2	111.3	30.7	66.0	69.0	59.1	45.2	108.5	70.4	43.2	42.9	50.6	44.3	49.7	81.1	59.8	19.9	103.1	12.3	24.8	51.5	131.1	34.7	55.1	75.8	26.9	71.4	51.9	101.5	26.0	62.9	105.3	0.4	947.9	0.1	7.2	4.0	22.0	2.0	0.5	60.1	76.3	16.6	82.1	0.3	47.1	276.4	9.5	10.9	0.5	1.1	17.6	32.5	23.8	89.0	91.9	0.3	9.0	71.1	20.2	6.7	0.3	250.1	436.7	95.1	26.9	0.6	0.0	89.6	41.9	4.7	51.2	39.1	0.3	117.5	48.5	0.8	223.1	106.2	107.6	76.6	11.0	147.7	168.4	78.9	66.2	46.2	119.1	0.6	1.0	0.5	0.6	9.3	22.0	0.4	66.0	0.6	7.6	1.3	3.5	11.6	6.6	0.8	5.1	15.8	3.7	5.5	3.3	11.1	13.4	13.9	2.2	6.2	0.2	166.0	0.2	4.8	112.4	110.4	97.4	119.8	121.8	104.3	108.2	111.3	108.5	103.1	131.1	101.5	161.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.5	0.0	0.0	0.0	0.0	13.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	7.4	13.4	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0
PRXL2B	"C1orf93, FAM213B, MGC26818"	ENSG00000157870	"Peroxiredoxin like 2B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 5.0;Endothelial cells: 2.1;Hofbauer cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 51.8;U-2197: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	8.3	18.6	11.0	4.8	12.0	3.2	9.2	5.5	16.4	9.4	2.3	24.4	18.7	9.3	1.4	12.3	10.9	6.0	6.4	12.1	10.2	15.6	7.0	11.7	5.0	9.4	10.1	6.3	6.8	5.4	8.7	6.7	11.7	10.0	5.9	2.8	7.8	5.6	1.3	7.8	20.5	3.6	7.3	15.2	14.3	6.6	11.1	4.1	8.1	0.7	3.9	11.7	8.1	8.3	15.8	8.7	9.8	9.1	3.8	4.6	1.2	5.4	6.2	13.6	5.6	6.7	18.0	4.2	13.9	9.5	5.4	12.6	8.2	9.5	4.5	11.8	3.8	9.9	6.1	11.3	10.3	5.3	3.0	6.4	5.2	9.8	3.2	6.7	19.0	6.8	13.3	6.4	13.9	7.7	12.2	2.5	10.4	19.8	31.6	14.2	12.8	10.1	14.2	8.3	11.7	18.0	12.2	51.8	16.8	2.2	9.3	2.2	28.1	11.2	12.7	46.3	5.4	5.2	8.1	3.0	11.0	19.9	2.8	1.9	1.5	0.8	2.5	1.5	4.2	1.2	2.8	2.9	1.6	0.9	2.5	3.7	1.1	4.8	1.4	0.7	4.4	2.4	11.0	12.0	5.5	16.4	12.1	10.2	9.4	10.1	11.7	7.3	11.1	8.3	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
PRXL2C	"AAED1, C9orf21"	ENSG00000158122	"Peroxiredoxin like 2C"	Q7RTV5	9	96639577-96655317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.8;Cardiomyocytes: 18.3;Cytotrophoblasts: 15.7;dendritic cells: 22.5;Extravillous trophoblasts: 69.9;Hofbauer cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 45.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021294	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA021294: AB_1845818"	"unprognostic (4.17e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.70e-2)"	13.3	5.6	3.5	6.1	3.8	11.5	10.1	3.6	4.3	6.5	3.9	7.6	3.7	8.0	2.9	5.5	8.0	8.4	13.8	3.7	3.7	5.5	6.9	9.7	4.9	5.2	4.0	5.0	6.0	3.2	3.1	6.4	5.0	5.3	4.2	1.2	3.9	3.7	11.3	4.9	5.6	10.9	4.4	7.1	5.5	5.2	4.4	3.4	8.2	7.9	5.3	8.5	5.2	5.0	11.0	5.6	2.7	9.6	22.5	38.4	10.7	12.1	18.1	10.0	9.6	12.7	12.2	0.3	9.8	19.8	19.4	10.4	9.5	5.8	6.0	11.3	5.9	6.3	4.9	10.5	17.2	5.1	17.3	18.3	10.0	7.0	8.8	9.9	8.8	4.4	12.6	4.6	10.4	7.8	0.2	9.0	3.7	4.5	10.5	0.2	8.0	0.2	14.2	2.5	4.3	5.4	8.8	7.4	6.5	8.0	2.9	9.0	16.1	16.8	7.0	16.4	8.0	12.2	5.8	4.2	7.2	4.7	15.7	45.7	9.6	23.2	10.1	11.4	10.6	10.1	9.4	10.1	8.7	7.6	4.9	8.2	2.0	5.8	11.1	5.6	10.6	3.5	3.5	3.8	3.6	4.3	3.7	3.7	5.2	4.0	5.0	4.4	4.4	5.0	23.8	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	15.7	22.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	69.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	6.3	8.9	0.0	0.0	0.0
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"skin 1: 98.5;stomach 1: 38.6"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000		"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.3	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	98.5	0.0	0.0	0.0	0.0	38.6	3.4	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682725	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 3019.3"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 5332.3"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"spinal cord: 38.2"	"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA		18000		"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	4.8	0.4	0.5	0.5	0.6	0.2	1.9	0.3	0.9	67.8	0.2	7.8	4.0	0.4	0.6	334.0	7.9	10.0	0.4	0.6	0.2	5.8	0.7	6.3	0.1	0.5	0.3	0.6	3.2	0.0	0.6	2.4	0.4	230.6	4.8	0.0	23.5	1.9	0.3	11.1	2.5	0.1	0.2	0.4	3019.3	1.4	0.5	0.4	0.4	0.0	15.0	629.0	167.7	0.5	10.7	0.7	0.0	0.0	2.1	6.8	10.6	4.9	1.1	2.1	1.8	0.1	22.4	0.0	0.4	0.4	8.1	2.1	0.0	0.4	1.3	0.6	0.0	0.0	45.7	0.0	0.1	0.0	1.5	6.0	7.8	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.7	5.8	1.7	0.6	1.2	17.6	1.2	0.7	0.0	0.9	1.0	61.7	0.2	0.5	5.1	15.6	3.5	0.3	0.2	0.2	1.0	1.5	1.7	2.7	0.0	1.9	0.1	0.0	2.9	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	0.9	0.6	0.2	0.5	0.3	0.4	0.2	0.5	0.5	0.2	3.2	1.5	1.6	7.7	0.9	26.0	120.0	0.0	0.0	3.9	2.7	1.2	71.4	894.2	1.8	0.0	2.3	0.0	1.9	7.9	3.2	0.3	1.3	0.1	1.1	275.1	0.0	0.3	1.2	5.0	3.3	5332.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	12.9	179.0	0.6	1.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	57.1	0.2	0.0	13.4	238.7	0.3	0.4	994.9	0.0	0.0	0.0	48.9	0.0	0.5	13.1	1.3	28.5	4.6	0.0	0.9	1241.5
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 233.9;intestine: 261.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.1	159.5	3.8	151.7	0.7	1.5	7.8	233.9	53.8	0.0	261.8	6.1	78.3	1.4	1.6	46.2	8.9	4.4	220.9	63.9	2.8	2.4	1.2	0.9	23.8	25.4	15.3	5.0	1.5	99.4	0.8	27.3	4.3	3.5	36.8	1.0	1.2	0.4	1.6	41.4	17.7	14.9	1.5	44.2	12.4	70.2	1.4	1.1	0.0	0.4	105.7	14.7	87.6	0.2	0.0	3.0	2.7	1.1	0.6	0.3	0.2	0.0	0.1	0.0	2.1	0.3	0.2	1.8	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.1	1.6	0.0	0.1	7.7	0.2	0.5	0.1	1.2	0.0	1.0	0.4	0.7	0.0	1.7	4.4	0.2	0.4	0.3	0.0	1.2	0.0	0.1	0.0	0.1	7.4	6.4	0.1	0.1	0.2	0.2	0.5	0.4	0.0	2.2	3.5	0.2	0.0	1.9	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	159.5	151.7	7.8	233.9	220.9	63.9	23.8	25.4	27.3	14.9	70.2	87.6	0.7	3.2	0.5	6.8	1.0	0.6	0.3	0.3	0.0	50.7	1.1	0.5	1.5	2.8	1.5	0.0	95.9	0.2	0.6	0.8	1.9	0.2	6.6	4.8	47.7	1.0	18.0	0.0	41.1	1.9	0.2	4.0	2.6	1.8	0.0	0.4	0.0	1.3	0.7	13.5	29.9	0.9	0.0	0.6	0.7	2.7	3.7	0.5	0.0	3.7	0.1	13.2	0.0	9.0	2.4	0.7	1.4	4.1	0.1	0.4	1.3	1.2	0.5	70.8	0.0	2.0	1.1	4.0	3.7	0.7	0.1	0.7	1.9	8.8	1.3	0.1
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527303-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.4	17.8	24.8	3.1	46.2	1.2	5.9	62.4	46.1	11.9	0.0	6.7	4.8	8.8	3.8	5.3	2.5	7.4	27.5	51.9	4.0	1.9	18.9	4.6	2.5	3.3	10.0	18.0	9.9	18.4	7.3	6.6	1.8	3.9	7.3	19.9	4.1	5.8	1.3	4.4	5.0	5.8	0.0	10.4	9.8	16.4	7.8	2.2	6.1	2.3	3.4	5.8	4.3	17.2	11.0	5.7	25.0	0.1	8.8	53.8	1.3	5.7	8.9	5.1	10.5	3.3	4.3	6.5	3.6	23.8	22.3	0.9	7.3	10.1	9.7	0.0	6.6	0.6	4.6	0.5	15.9	0.2	0.4	14.2	6.2	28.2	4.9	48.0	6.8	1.6	0.8	4.9	47.3	3.7	0.0	1.2	4.9	9.6	14.7	5.2	21.4	3.0	12.7	14.0	10.7	11.8	2.5	1.1	3.8	5.4	0.3	2.6	28.0	15.7	10.8	37.5	5.1	0.4	0.7	14.8	49.5	2.7	5.4	0.7	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.4	0.1	24.8	46.2	62.4	46.1	51.9	4.0	3.3	10.0	1.8	0.0	7.8	17.2	8.1	3.2	2.7	558.3	3.3	21.9	13.7	26.4	13.6	191.9	14.4	10.7	119.2	7.2	23.9	9.2	118.9	3.2	0.1	48.5	1.9	13.5	686.7	12.5	69.9	8.2	6.1	0.0	284.7	8.7	1.7	44.3	43.8	6.6	0.0	87.2	4.2	42.9	13.1	18.5	121.6	20.0	44.7	16.0	25.9	217.9	33.2	9.0	1.8	148.9	59.7	78.0	0.0	488.1	584.6	27.0	13.5	53.8	0.1	11.2	20.3	0.3	41.0	52.0	13.1	29.3	17.7	16.5	17.7	32.4	9.9	1.1	1.1	114.9	17.2	23.7
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 51.2;Proximal enterocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.8;NB-4: 9.3"	"Low region specificity"	"Detected in single"							"HPA034722, HPA077847"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA034722: AB_10669730, HPA077847: "	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	1.7	13.7	1.4	3.1	1.3	3.7	3.9	0.5	1.2	2.3	0.7	7.0	2.0	0.7	4.0	10.8	1.7	1.3	0.8	1.0	1.0	5.2	21.2	5.8	3.9	1.0	0.8	0.5	11.6	3.0	3.4	0.9	1.1	8.7	1.9	0.5	11.3	1.2	0.6	9.0	17.7	0.4	0.9	23.3	12.4	1.5	1.5	5.9	10.1	0.3	4.0	3.7	4.2	0.9	5.7	1.0	0.3	0.1	0.0	0.0	6.1	0.4	2.2	0.4	0.5	1.5	8.1	9.8	1.2	0.2	1.7	7.4	0.0	2.0	0.1	8.3	0.1	4.1	0.8	2.2	0.1	6.9	6.9	0.1	1.9	0.2	0.5	0.9	0.0	3.8	3.9	4.1	0.0	3.2	7.1	9.3	0.1	1.8	1.1	0.1	0.1	4.3	0.4	1.4	0.5	0.0	0.7	5.1	0.0	0.2	1.6	5.6	0.1	0.3	0.2	0.2	1.6	5.0	4.0	3.0	0.9	3.3	0.1	1.7	0.9	1.7	2.0	0.6	1.7	1.0	1.5	1.8	0.6	1.2	1.7	1.9	3.9	2.4	0.7	1.5	1.1	1.4	1.4	1.3	0.5	1.2	1.0	1.0	1.0	0.8	1.1	0.9	1.5	0.9	0.9	19.2	12.0	7.5	28.6	12.7	10.4	7.6	13.1	0.3	22.5	11.2	1.8	11.5	5.8	33.1	0.0	20.7	41.6	39.1	0.0	21.3	0.3	9.0	1.6	2.1	7.2	13.0	0.9	23.6	11.2	3.0	31.1	20.4	3.8	2.9	2.9	51.2	12.1	3.3	1.7	10.7	4.1	13.8	17.0	0.9	0.9	14.3	1.8	2.8	13.8	10.1	47.4	2.5	0.2	23.1	17.8	0.0	18.3	15.8	50.3	7.1	4.6	0.4	0.0	3.0	1.7	0.2	1.1	17.4	15.8	7.5	28.2	1.7	18.6	11.1
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSENEN	PEN2	ENSG00000205155	"Presenilin enhancer, gamma-secretase subunit"	Q9NZ42	19	35745600-35747519	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 573.3;Respiratory ciliated cells: 954.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047435	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047435: AB_2680047"	"unprognostic (1.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.41e-3)"	50.4	65.7	87.8	39.0	86.9	35.6	54.2	91.0	89.6	59.4	127.3	57.3	42.0	46.5	134.6	69.5	228.0	37.8	55.2	88.5	96.1	76.5	78.4	54.9	41.2	95.5	103.8	37.5	63.0	75.1	60.0	36.4	100.2	46.7	63.4	38.5	55.6	53.3	51.9	45.4	43.1	47.7	96.0	57.6	52.2	148.9	89.3	54.0	58.4	46.7	61.7	59.3	44.6	97.5	94.2	187.8	75.1	87.2	136.5	85.3	43.2	49.8	108.9	111.0	117.7	52.3	173.7	48.9	116.0	99.4	76.2	54.6	65.3	86.1	105.0	81.8	55.1	34.5	44.1	50.6	118.9	53.7	60.5	88.8	153.4	129.7	106.2	95.8	112.2	94.1	53.7	116.5	127.8	108.5	62.8	63.7	55.9	214.9	49.7	58.8	30.2	89.9	226.4	46.7	62.1	94.5	65.6	144.3	45.6	98.8	92.0	119.7	46.4	88.4	52.9	60.3	81.1	88.0	107.6	62.1	152.0	50.3	72.1	140.8	208.3	202.0	131.3	232.9	123.9	109.3	95.8	114.0	154.8	100.4	73.1	92.9	539.2	91.4	191.1	337.1	107.4	245.3	87.8	86.9	91.0	89.6	88.5	96.1	95.5	103.8	100.2	96.0	89.3	97.5	58.4	38.5	38.2	4.2	53.5	38.7	59.3	192.5	39.3	13.2	55.6	36.7	29.7	51.5	137.6	128.8	14.6	92.5	73.2	132.8	60.7	146.8	199.1	573.3	42.7	52.4	70.2	36.6	1.9	151.0	135.9	50.5	34.1	75.6	57.7	22.5	42.1	49.7	164.4	6.7	2.1	66.1	185.1	51.2	90.9	126.5	54.7	69.8	71.2	1.9	85.9	58.6	86.5	2.0	6.3	171.4	152.5	40.6	83.1	44.2	122.4	194.4	954.0	19.7	52.6	33.9	147.7	344.8	35.8	48.4	48.4	104.1	53.3	56.3	67.3	74.0
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	161	"placenta: 259.7"	"Cell type enriched"	"Detected in some"	98	"Syncytiotrophoblasts: 207.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-2197: 412.3"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		75000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"					"unprognostic (2.02e-1)"	"unprognostic (3.54e-1)"							"unprognostic (2.44e-7)"			"unprognostic (2.28e-2)"		0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	259.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	18.1	6.0	1.5	2.3	0.0	0.4	0.0	0.0	21.1	4.3	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	21.9	0.2	0.0	0.7	0.0	0.0	412.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.6	0.9	0.5	0.0	0.2	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	207.0	0.0	0.0	0.0	0.0
PSG11	"MGC22484, PSG13, PSG14"	ENSG00000243130	"Pregnancy specific beta-1-glycoprotein 11"	Q9UQ72	19	43007656-43026474	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"placenta: 52.9"	"Cell type enriched"	"Detected in some"	57	"Syncytiotrophoblasts: 161.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-2197: 16.4"									"HPA042240, HPA046327"	Enhanced				"Secreted in female reproductive system"	NA	NA		40000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA042240: AB_10797384, HPA046327: AB_2679624"					"unprognostic (2.58e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.9	0.0	0.1	0.0	0.0
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740481	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	199	"placenta: 141.5"	"Cell type enriched"	"Detected in some"	88	"Syncytiotrophoblasts: 1579.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.4"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		67000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	3.9	11.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	17.9	0.9	0.0	0.8	0.0	0.1	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1579.6	0.0	0.0	0.0	0.0
PSG4		ENSG00000243137	"Pregnancy specific beta-1-glycoprotein 4"	Q00888	19	43192702-43207299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"parathyroid gland: 55.6;placenta: 143.4"	"Cell type enriched"	"Detected in some"	38	"Syncytiotrophoblasts: 553.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 552.6;U-2197: 147.3"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		58000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"	"unprognostic (4.29e-2)"	"unprognostic (5.18e-2)"		"unprognostic (9.49e-2)"		"unprognostic (2.52e-2)"		"unprognostic (3.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.57e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	1.1	0.9	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	55.6	0.1	143.4	0.0	0.2	0.0	0.0	1.2	0.2	0.0	3.3	0.0	1.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.8	0.0	1.8	0.1	0.7	0.3	0.0	2.7	0.0	1.9	552.6	4.6	0.0	0.2	0.4	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	8.2	53.6	3.6	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.4	0.0	0.0	0.0	7.1	0.9	14.5	0.0	0.0	4.4	2.1	5.5	147.3	0.1	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	1.5	0.4	0.5	0.3	0.0	0.3	0.0	0.0	4.7	0.0	0.0	0.0	14.3	0.1	0.1	0.2	0.1	0.0	0.0	1.0	0.0	11.9	0.4	0.0	2.7	0.0	0.1	0.0	0.0	2.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	553.7	0.0	0.0	0.0	0.3
PSG5	"FL-NCA-3, PSG"	ENSG00000204941	"Pregnancy specific beta-1-glycoprotein 5"	Q15238	19	43166256-43186536	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"placenta: 111.8"	"Cell type enriched"	"Detected in some"	44	"Syncytiotrophoblasts: 724.4"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 427.9;fHDF/TERT166: 1485.4"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		22000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-2)"				"unprognostic (4.69e-2)"		"unprognostic (1.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (7.92e-2)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	111.8	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.6	0.0	0.9	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.3	0.0	0.0	0.2	0.6	0.1	427.9	122.3	7.0	57.8	0.0	0.3	0.0	0.0	1485.4	1.8	16.4	0.1	0.0	65.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.8	0.0	1.1	7.8	2.3	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	10.2	0.0	0.0	0.1	0.5	1.6	54.9	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.7	0.4	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.3	0.0	1.2	0.0	0.1	0.1	0.0	0.5	1.8	0.0	14.2	0.0	0.1	0.0	6.0	0.8	0.0	0.0	0.2	0.0	0.0	3.3	0.0	16.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	3.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.5	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	724.4	0.0	0.1	0.0	0.1
PSG6		ENSG00000170848	"Pregnancy specific beta-1-glycoprotein 6"	Q00889	19	42902086-42919563	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 49.4"	"Cell type enriched"	"Detected in some"	125	"Syncytiotrophoblasts: 363.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-2197: 144.6"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		65000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"						"unprognostic (4.23e-1)"												0.0	0.0	0.4	0.1	0.2	1.4	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.5	0.6	1.1	0.0	0.3	0.0	0.0	1.9	0.1	0.2	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.3	144.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	363.5	0.0	0.0	0.0	0.0
PSG7		ENSG00000221878	"Pregnancy specific beta-1-glycoprotein 7"	Q13046	19	42924132-42937207	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"placenta: 4.1;skin 1: 1.2"	"Cell type enriched"	"Detected in some"	95	"Syncytiotrophoblasts: 162.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.6;fHDF/TERT166: 1.1;HBF TERT88: 2.3;U-2197: 1.8"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"																		0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	162.0	0.0	0.0	0.0	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"placenta: 6.5"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 34.3"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		55000000		"Cluster 28: Placenta - Pregnancy"		"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.3	0.0	0.0	0.0	0.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	135	"placenta: 106.3"	"Cell type enriched"	"Detected in some"	60	"Syncytiotrophoblasts: 277.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.2;GAMG: 16.3;HBF TERT88: 9.3;SuSa: 10.7;U-2197: 9.7"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		43000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	106.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	5.2	2.9	4.5	2.3	0.1	0.1	0.0	0.2	1.4	16.3	0.3	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	10.7	4.3	0.0	0.2	0.1	2.1	9.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	1.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	277.3	0.0	0.0	0.0	0.0
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893254-67929676	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.6	12.8	9.6	14.5	5.2	14.0	12.2	13.5	13.5	19.5	18.2	13.7	19.3	10.0	16.9	18.7	10.1	17.6	11.2	11.5	20.5	16.5	12.7	10.6	15.0	14.9	19.4	26.3	32.9	13.2	7.6	13.4	15.1	10.8	4.0	18.1	12.7	15.3	13.8	15.7	15.7	13.2	12.8	21.4	21.8	13.6	12.0	15.0	13.5	8.5	16.5	9.5	14.9	13.0	22.7	25.2	28.1	38.4	19.3	16.3	15.2	23.0	15.8	14.0	17.2	18.2	12.2	22.7	25.7	12.7	19.2	14.7	15.6	5.3	4.8	16.4	13.9	16.8	22.0	26.3	13.4	8.0	35.7	26.7	18.8	19.6	21.3	23.3	22.5	21.6	5.1	16.7	28.7	18.3	8.6	24.2	14.0	13.9	27.7	9.7	25.3	18.6	16.0	21.8	26.0	47.3	12.8	15.8	9.9	23.5	23.9	20.8	17.7	6.2	15.0	7.7	15.3	8.7	26.2	21.4	8.8	19.9	0.0	2.0	1.9	2.0	2.2	1.4	1.5	1.5	2.0	2.1	1.2	1.2	1.7	1.0	2.1	1.5	1.5	0.8	1.7	12.8	14.5	12.2	13.5	11.2	11.5	15.0	14.9	13.4	13.2	13.6	14.9	5.5	0.0	3.6	4.6	2.9	1.1	3.1	5.2	2.2	11.1	5.3	4.6	2.3	7.2	3.8	5.5	6.2	6.2	3.0	11.5	11.7	6.0	14.4	5.8	6.5	5.2	10.8	3.0	4.6	7.4	4.8	5.4	5.1	4.8	6.3	13.0	5.3	10.3	4.8	6.7	6.1	6.2	10.2	6.3	1.6	22.1	4.7	2.9	5.4	3.7	4.8	11.0	3.1	5.5	9.2	7.6	4.5	7.9	3.0	3.6	10.0	8.1	4.9	6.9	13.1	6.3	6.1	6.7	6.1	5.4	1.6	5.9	3.8	10.7	7.4	2.2
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome 20S subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033765, HPA037646, HPA043891, CAB079995"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA		20000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies, Centrosome"	"CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	87.2	85.5	55.1	94.9	57.8	135.8	96.2	55.4	68.2	76.8	58.7	92.5	96.4	80.7	108.0	94.7	79.4	79.6	140.5	59.4	64.4	98.4	139.2	77.5	114.9	55.8	56.6	79.4	54.6	78.5	50.4	113.0	58.8	81.7	101.9	63.2	74.4	85.8	168.7	80.5	86.1	96.1	56.6	75.6	75.7	56.2	60.2	122.2	88.4	152.6	109.9	111.2	56.0	58.6	408.8	279.8	227.8	275.7	223.7	225.5	193.3	232.9	305.2	348.3	283.9	244.2	500.1	349.5	262.1	248.6	315.4	303.1	259.3	290.1	328.3	344.0	389.6	220.4	190.5	326.1	291.0	355.3	277.5	217.8	171.6	188.9	390.7	252.7	347.0	271.6	398.9	283.4	315.2	277.8	334.0	319.5	191.6	340.5	414.1	223.3	336.1	217.5	313.0	304.7	188.2	119.3	246.6	273.9	229.0	233.8	164.4	222.9	272.0	226.2	222.9	402.7	295.4	123.3	366.1	319.9	334.8	291.1	296.6	115.5	191.2	47.5	97.7	139.8	128.0	104.1	110.8	109.7	243.3	95.3	98.5	94.4	36.3	145.1	137.5	138.7	154.9	235.8	55.1	57.8	55.4	68.2	59.4	64.4	55.8	56.6	58.8	56.6	60.2	58.6	119.0	83.3	90.2	64.3	101.7	142.9	231.2	365.7	76.2	50.3	105.7	125.9	0.0	82.9	176.1	88.3	18.8	469.5	135.3	49.2	256.3	228.5	75.5	84.0	94.0	135.5	40.1	163.9	56.8	233.1	370.6	128.5	66.8	79.8	78.2	134.7	95.3	127.9	292.9	57.2	66.3	63.6	231.9	161.8	170.5	36.3	116.5	153.6	144.1	122.7	263.7	111.6	168.9	64.8	35.3	223.2	88.6	127.5	112.1	209.1	135.0	257.1	115.1	54.8	85.5	99.2	129.8	174.9	80.1	114.3	151.9	627.3	130.7	137.2	97.1	248.1
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome 20S subunit alpha 2"	P25787	7	42916828-42932185	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 439.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008188	Uncertain					NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	100.7	113.4	53.7	89.0	54.1	120.2	100.1	55.7	82.8	71.2	56.4	90.9	104.3	75.6	83.1	110.0	70.5	49.4	119.2	52.5	56.6	117.0	319.5	85.9	101.4	55.6	54.5	66.4	91.0	71.0	63.8	78.9	55.5	91.1	86.8	42.2	76.0	58.2	227.5	86.9	96.7	67.3	58.6	94.1	104.8	56.1	55.4	137.5	67.4	120.1	108.8	92.4	77.0	62.8	202.8	212.5	243.4	296.4	128.1	142.1	181.1	174.7	202.8	274.9	292.3	316.5	322.2	371.5	301.7	155.5	431.6	273.3	254.3	242.4	314.2	270.3	202.3	189.8	279.1	337.1	137.3	325.8	197.7	131.7	172.7	211.7	125.7	196.1	265.1	226.0	389.8	219.4	223.5	235.9	295.0	634.9	482.4	331.3	259.9	282.1	235.5	364.3	268.2	271.6	196.8	199.1	189.5	429.9	200.9	328.3	312.4	375.6	189.9	161.0	295.3	174.5	348.6	282.6	470.3	611.1	276.0	406.0	468.9	278.5	185.4	351.9	133.9	193.4	156.9	195.4	163.3	157.9	199.8	175.2	146.0	155.2	93.1	160.7	210.0	225.0	240.8	363.3	53.7	54.1	55.7	82.8	52.5	56.6	55.6	54.5	55.5	58.6	55.4	62.8	92.2	89.8	100.5	11.1	100.6	0.1	89.3	0.2	41.5	32.4	125.2	121.4	0.0	123.0	66.8	95.6	22.9	293.3	141.3	130.3	170.2	348.6	23.9	42.3	41.5	93.2	154.9	126.9	15.3	380.0	300.1	67.2	23.9	37.6	166.0	27.5	122.8	204.8	193.5	28.6	16.0	199.8	0.0	173.5	0.3	19.1	79.2	94.1	0.0	12.2	439.1	85.3	153.5	17.1	27.9	314.5	166.9	84.7	72.6	97.8	332.7	301.5	58.3	46.6	131.5	55.3	74.4	125.8	115.6	44.3	0.0	279.1	81.8	39.1	252.8	98.2
PSMA3	HC8	ENSG00000100567	"Proteasome 20S subunit alpha 3"	P25788	14	58244843-58272012	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000905	Approved					NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"			"HPA000905: AB_1079702"	"unprognostic (3.60e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.91e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (2.16e-1)"	74.1	88.6	50.0	84.8	52.6	82.8	82.1	54.9	61.8	59.6	54.2	76.7	81.3	55.4	127.6	75.8	57.9	60.7	99.9	51.2	55.2	94.3	162.2	69.0	104.1	53.2	52.3	40.4	55.4	72.9	46.6	90.8	53.3	60.9	82.9	48.3	54.7	76.3	170.6	53.1	74.3	78.6	55.8	66.6	61.0	41.3	51.9	108.6	74.9	130.4	96.9	102.5	48.6	56.6	359.2	214.3	215.1	179.2	166.4	154.3	277.8	187.2	209.3	257.4	256.8	317.8	294.2	304.1	330.9	171.3	202.4	243.9	249.2	200.9	299.7	262.3	148.9	208.5	150.9	360.8	314.2	340.4	170.0	132.8	142.2	179.2	169.1	151.7	307.2	242.0	201.3	174.6	209.3	400.4	299.7	314.4	144.9	286.8	328.3	249.3	279.6	222.7	377.5	339.7	202.9	100.3	167.5	261.8	189.5	201.6	273.3	244.9	198.3	148.4	287.1	167.6	249.4	68.4	137.3	314.1	215.7	260.2	184.1	95.3	78.9	52.0	71.2	98.9	92.2	85.8	87.1	86.0	91.8	61.9	69.5	80.8	48.2	94.1	85.6	122.4	112.6	95.5	50.0	52.6	54.9	61.8	51.2	55.2	53.2	52.3	53.3	55.8	51.9	56.6	132.9	118.6	119.2	21.9	93.7	118.7	169.6	418.7	71.2	43.5	69.2	77.6	117.0	71.4	195.7	88.3	35.5	387.5	104.5	83.3	166.3	241.3	24.7	127.6	95.6	137.7	64.4	60.6	27.6	231.1	269.2	108.5	59.1	109.1	95.7	412.6	66.4	145.4	184.0	42.1	29.1	103.8	250.3	59.2	77.5	27.4	109.3	89.4	108.5	26.2	206.0	87.3	84.5	32.6	33.6	192.9	89.0	106.1	118.4	167.5	108.9	297.5	157.4	68.6	98.6	83.7	279.6	109.3	66.9	89.8	106.0	403.5	99.3	104.9	108.4	171.6
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSMA5	ZETA	ENSG00000143106	"Proteasome 20S subunit alpha 5"	P28066	1	109399042-109426448	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol		NA	NA		20000000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	3.5	4.7	5.1	4.3	6.2	3.8	6.8	4.0	7.7	5.8	2.7	7.4	7.5	5.5	8.6	6.8	9.1	5.4	7.7	6.8	6.7	10.9	20.2	5.9	12.7	5.0	4.7	5.2	3.2	5.9	1.4	6.9	4.5	5.4	8.5	4.8	5.0	6.2	6.1	6.2	6.7	6.5	4.1	4.8	5.2	3.5	5.3	6.4	10.2	5.1	9.3	6.1	0.9	6.6	10.1	11.7	6.2	5.7	17.6	16.9	12.6	4.9	29.8	23.2	17.9	15.0	5.5	28.1	7.8	21.2	4.2	5.7	13.8	13.7	16.1	10.7	13.1	13.4	7.7	12.4	14.0	15.2	5.3	8.5	12.3	12.7	14.3	6.2	15.0	8.2	17.1	6.5	12.4	18.6	54.4	10.3	5.7	7.0	16.5	4.4	16.9	7.4	19.0	11.5	7.3	5.2	10.5	16.2	8.9	5.0	5.9	14.1	11.7	4.6	4.6	7.9	10.3	3.6	11.6	19.7	20.0	26.0	7.4	11.0	4.3	3.1	7.7	6.3	8.4	5.7	9.0	8.3	5.9	4.7	9.7	9.7	1.4	7.2	6.1	4.2	11.4	7.0	5.1	6.2	4.0	7.7	6.8	6.7	5.0	4.7	4.5	4.1	5.3	6.6	68.9	41.7	56.8	9.4	77.4	63.6	73.5	231.0	38.1	32.6	59.5	75.7	89.5	75.8	120.9	42.3	6.2	227.0	114.5	82.1	140.8	164.9	82.0	157.6	74.1	71.6	56.3	85.0	21.7	183.0	181.4	60.4	74.9	81.9	82.4	77.7	51.4	117.4	166.9	13.5	18.4	144.1	168.9	57.8	73.6	23.4	67.7	86.3	58.7	15.0	184.8	50.2	114.4	13.0	20.2	191.6	103.5	62.1	113.1	122.2	138.0	205.6	172.4	31.7	46.0	56.1	182.6	120.3	89.1	70.4	65.9	241.2	106.1	121.4	135.3	104.2
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome 20S subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 156.3;Late spermatids: 474.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003049	Approved		Supported	Nucleoplasm		NA	NA		18000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	118.4	141.3	88.3	117.3	92.4	155.5	131.1	88.9	140.7	81.3	86.6	128.6	115.1	82.4	98.7	126.0	84.0	69.7	169.1	92.2	97.6	98.0	172.8	123.6	137.6	92.6	90.5	71.3	91.9	82.8	83.2	120.7	96.0	74.7	130.0	63.9	87.8	81.1	350.1	107.5	114.8	94.4	92.8	114.4	95.9	247.9	94.7	290.1	82.3	203.9	139.7	132.6	85.7	92.4	502.2	367.2	257.6	264.9	209.8	214.5	523.1	252.2	300.3	368.2	329.0	338.8	341.7	322.9	492.1	244.4	220.4	337.5	306.6	280.0	434.5	337.9	170.1	257.6	233.6	1011.6	235.8	542.0	225.8	166.7	229.4	256.6	324.7	178.2	312.2	548.1	284.2	220.4	298.7	522.9	838.2	458.2	249.3	391.0	407.0	1249.4	261.3	256.9	312.8	634.9	275.1	230.8	285.5	402.2	274.7	211.9	473.8	351.4	267.1	235.8	231.8	245.7	283.6	234.0	576.3	605.9	192.4	335.7	272.0	232.1	364.6	242.2	241.0	344.8	243.0	212.8	230.9	248.9	373.6	171.5	182.5	217.5	131.9	300.6	343.7	385.3	317.0	711.5	88.3	92.4	88.9	140.7	92.2	97.6	92.6	90.5	96.0	92.8	94.7	92.4	20.8	44.8	40.7	20.2	37.7	33.3	14.9	37.2	69.4	13.7	16.5	15.0	1.4	22.8	45.7	14.7	25.0	32.2	24.8	22.4	21.5	34.2	156.3	21.2	14.9	30.5	18.0	56.8	32.7	36.7	26.0	28.4	46.4	28.2	54.5	10.1	29.6	20.0	22.6	25.2	31.2	18.3	22.4	36.7	89.5	474.9	22.7	62.2	24.9	22.5	34.1	8.6	34.0	20.6	29.4	32.8	19.5	17.3	114.6	15.9	43.1	25.4	59.5	19.4	13.1	17.8	31.3	35.1	20.0	89.8	33.1	41.3	53.7	9.2	22.2	17.1
PSMA7	"C6, HSPC, RC6-1, XAPC7"	ENSG00000101182	"Proteasome 20S subunit alpha 7"	O14818	20	62136733-62143440	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 753.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046007, CAB046008, HPA047266"	Approved					NA	NA		22000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: AB_2680006"	"unprognostic (1.49e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-1)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.98e-2)"	223.2	200.1	127.6	148.5	132.0	260.4	198.0	136.9	146.2	134.6	127.1	180.3	132.2	163.4	102.9	191.0	140.5	91.3	266.2	131.9	137.0	168.9	214.0	170.3	164.9	134.0	131.7	134.4	140.2	114.1	104.1	115.0	136.7	117.8	108.0	54.5	129.2	104.2	753.9	136.6	151.3	117.1	134.7	163.3	152.9	61.3	136.4	188.0	121.9	375.3	155.4	168.2	141.3	143.7	532.8	674.6	390.9	419.4	357.2	277.8	345.0	398.3	343.6	1024.7	428.8	1785.8	504.0	438.2	926.2	421.0	644.1	627.2	371.9	752.5	497.0	261.0	261.1	1009.7	641.9	913.2	454.0	434.3	570.4	297.9	602.0	525.1	454.5	248.8	509.2	436.1	439.2	419.2	441.8	568.6	696.1	673.6	332.5	595.0	859.8	476.9	753.5	482.6	385.3	515.4	526.2	321.6	625.9	777.1	701.9	252.7	468.3	643.3	416.1	898.9	725.4	473.3	631.1	286.9	483.9	531.2	626.7	327.7	536.1	754.4	682.6	801.5	536.5	692.6	458.2	579.3	533.3	531.4	632.2	522.7	415.1	427.3	582.2	421.7	720.3	676.3	723.4	1131.2	127.6	132.0	136.9	146.2	131.9	137.0	134.0	131.7	136.7	134.7	136.4	143.7	402.9	211.5	180.8	20.9	252.3	374.5	350.6	616.4	167.4	127.5	223.0	296.4	304.9	327.5	369.2	257.5	73.0	666.2	309.5	375.2	498.9	581.9	355.5	290.2	345.4	397.3	232.0	439.4	19.2	727.7	775.7	321.9	132.0	276.5	251.4	304.7	335.5	787.5	807.0	82.4	18.4	325.6	453.7	435.7	453.1	211.0	334.6	414.8	368.2	18.7	598.4	219.3	377.9	15.1	28.9	663.3	386.4	293.8	234.5	639.7	455.1	759.6	288.8	122.5	230.1	237.0	659.7	81.4	126.3	291.9	309.3	852.6	310.4	410.0	386.9	438.7
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome 20S subunit beta 10"	P40306	16	67934506-67936864	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	26.3	26.9	5.7	81.8	6.0	71.3	24.9	6.9	8.8	18.9	6.6	51.6	110.5	18.4	5.7	22.8	30.4	31.2	16.2	5.6	8.0	35.1	37.1	42.2	122.3	12.6	7.4	14.6	15.0	6.3	13.2	23.1	8.6	28.9	22.9	0.4	65.1	22.4	6.8	18.1	95.8	14.0	9.5	102.7	62.5	5.3	7.8	61.9	23.6	3.5	37.5	36.4	18.6	11.7	31.8	26.9	0.7	2.2	6.7	17.2	99.6	10.8	42.3	38.5	50.6	13.9	148.5	111.9	23.4	13.2	12.9	47.9	0.0	13.4	2.9	50.3	1.9	39.2	7.6	16.4	65.7	78.5	115.2	26.9	8.4	15.2	1.5	12.1	20.6	32.1	3.6	48.2	9.0	42.6	140.7	84.9	1.0	1.1	10.2	183.4	8.3	169.4	31.6	52.5	0.9	2.3	31.1	67.5	17.2	0.4	14.5	171.3	32.0	21.2	6.6	9.7	15.3	189.8	43.9	88.4	57.1	97.9	47.0	539.5	714.6	571.1	511.7	787.1	376.4	402.6	397.9	437.3	594.8	390.2	326.2	364.6	786.2	588.6	607.4	604.4	495.9	1155.7	5.7	6.0	6.9	8.8	5.6	8.0	12.6	7.4	8.6	9.5	7.8	11.7	24.7	22.4	26.8	4.6	72.9	17.2	14.3	101.2	26.2	1.0	15.8	13.8	1.6	28.6	43.9	18.4	0.0	29.5	66.2	80.8	23.5	58.5	14.0	17.6	20.1	22.8	16.3	32.6	3.4	104.3	30.0	23.4	110.6	12.3	51.9	7.2	37.1	10.2	87.4	0.0	5.0	74.6	52.9	81.9	66.4	35.9	30.1	88.5	48.0	9.4	123.3	3.0	112.3	2.5	7.3	51.2	139.7	21.1	110.5	12.1	173.5	69.4	83.9	1.1	19.7	10.3	26.6	16.4	7.5	24.1	9.9	22.6	93.9	16.9	79.5	24.8
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042212-23044060	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"lymphoid tissue: 30.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 2.4;Late spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced					NA	NA				"Cluster 63: T-cells - Adaptive immune response"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.4	29.3	10.0	13.9	10.3	21.7	25.0	9.7	11.6	23.6	9.4	24.3	12.9	26.9	11.5	31.8	21.9	9.1	27.3	10.6	10.4	22.6	45.9	25.6	15.8	9.9	9.7	21.0	25.2	11.3	19.6	15.2	11.0	20.0	12.7	12.1	22.3	10.8	63.1	30.9	23.2	13.4	9.9	25.4	24.2	15.6	9.5	20.5	18.7	14.8	16.7	22.9	23.9	11.8	68.8	42.4	45.5	32.2	23.3	27.9	55.5	31.8	36.6	63.2	51.1	51.6	79.3	68.8	71.3	37.6	38.6	41.2	59.3	53.4	54.5	54.5	54.1	63.4	44.5	50.1	41.4	66.1	34.7	30.4	33.4	77.0	36.8	25.9	50.8	54.1	76.6	37.7	41.9	30.7	85.5	50.1	59.3	29.7	44.0	52.3	47.5	48.7	45.3	35.9	39.8	30.1	36.0	34.5	52.1	50.3	24.9	29.3	35.2	32.0	37.5	30.9	76.5	31.8	55.0	66.9	49.9	70.4	55.6	20.5	23.6	18.2	19.6	30.3	19.9	22.3	19.3	20.6	26.4	18.5	14.0	17.3	8.8	23.6	35.4	27.4	26.3	26.1	10.0	10.3	9.7	11.6	10.6	10.4	9.9	9.7	11.0	9.9	9.5	11.8	110.8	64.1	68.9	6.2	80.4	111.1	145.2	298.5	50.7	48.0	65.8	95.1	59.8	67.2	145.0	66.2	16.7	406.6	83.6	72.4	144.8	286.2	118.0	95.4	78.8	115.9	98.3	78.7	20.8	227.3	341.0	101.3	61.2	75.9	35.4	109.6	85.6	158.1	222.6	58.9	20.9	96.9	187.2	92.7	70.3	22.8	100.6	94.1	76.5	15.9	184.1	68.4	87.6	17.1	23.4	252.0	76.6	91.4	141.7	186.0	108.5	221.7	126.8	50.4	92.1	66.8	291.4	224.4	144.0	80.4	111.5	442.1	81.4	123.9	111.7	178.9
PSMB3	"HC10-II, MGC4147"	ENSG00000277791	"Proteasome 20S subunit beta 3"	P49720	17	38752741-38764225	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042775, HPA048147"	Approved					NA	NA		25000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA042775: AB_2678158, HPA048147: AB_2680285"	"unprognostic (1.86e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (4.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.03e-2)"	95.7	139.3	65.9	95.7	70.8	138.7	92.9	68.2	76.1	83.0	67.4	105.6	82.5	90.6	101.8	110.9	81.4	73.0	154.2	74.4	80.3	120.7	187.3	101.8	137.0	70.0	73.2	59.3	78.1	86.2	81.4	90.9	70.6	85.6	106.1	42.4	84.1	66.6	201.7	99.0	90.3	92.7	69.4	122.0	93.8	53.2	76.1	106.3	87.6	119.5	132.5	102.8	83.0	80.1	246.1	457.3	168.8	277.2	180.9	158.6	237.1	167.6	265.8	563.8	489.1	486.3	324.1	279.5	276.3	228.8	371.1	401.6	279.3	294.3	301.1	373.6	500.2	184.2	226.6	562.5	96.5	289.3	278.1	151.0	184.6	393.5	131.1	132.9	289.3	283.1	301.2	320.4	246.2	319.6	461.1	457.0	250.6	278.8	328.3	261.1	383.3	446.2	312.1	253.4	216.8	145.7	191.8	157.3	201.3	243.8	360.1	356.6	173.1	138.0	269.5	308.9	421.1	202.1	367.2	397.7	285.2	294.8	242.0	227.2	323.7	150.4	176.6	271.4	118.1	148.5	145.2	154.4	274.5	114.6	93.0	94.9	569.6	142.8	209.6	352.6	176.1	372.0	65.9	70.8	68.2	76.1	74.4	80.3	70.0	73.2	70.6	69.4	76.1	80.1	146.2	76.9	124.5	8.8	142.0	199.6	203.6	517.8	79.1	66.7	100.9	105.8	328.0	104.4	281.6	176.6	25.0	434.0	141.4	215.0	406.9	362.1	51.5	140.6	123.8	185.5	133.4	156.4	8.6	497.7	428.3	160.8	100.9	117.7	154.0	110.0	118.9	247.6	416.7	30.3	7.8	207.1	368.2	161.5	266.5	48.2	149.5	231.8	200.9	7.5	309.8	167.5	179.2	3.0	12.6	401.0	242.9	145.9	205.1	189.9	219.9	642.6	274.9	72.2	124.9	110.2	507.6	152.2	76.7	114.0	201.5	504.2	154.0	186.7	224.7	239.9
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome 20S subunit beta 4"	P28070	1	151399560-151401937	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	189.5	242.7	200.2	156.7	202.1	172.9	174.2	210.6	212.4	167.0	201.9	194.3	150.0	195.5	225.6	170.4	178.3	139.1	241.8	201.7	212.9	196.6	269.5	143.2	214.0	206.8	203.9	179.5	164.0	218.6	168.0	187.1	211.7	162.4	166.4	94.3	169.6	190.6	299.1	186.6	152.8	191.7	210.5	173.8	171.8	69.0	205.8	233.5	156.1	237.5	235.4	196.7	151.3	218.4	428.3	451.9	373.0	447.8	412.9	392.3	507.8	247.6	549.2	719.3	503.1	608.6	569.5	384.1	730.7	424.3	379.1	419.7	383.2	472.7	407.6	535.6	391.1	268.6	320.8	463.3	444.4	377.0	355.7	431.7	444.8	672.5	276.2	364.8	506.1	419.1	434.3	740.0	512.7	1174.2	463.5	452.0	952.8	638.6	576.2	433.8	266.9	688.2	594.4	354.2	408.6	488.0	283.6	626.5	879.8	459.1	564.1	594.6	320.7	310.4	326.1	333.8	557.0	726.9	902.5	769.1	459.5	337.8	667.8	291.8	343.4	227.0	265.0	342.2	314.8	293.6	303.7	301.0	421.7	257.5	260.4	272.8	251.5	347.3	270.5	468.1	405.1	395.2	200.2	202.1	210.6	212.4	201.7	212.9	206.8	203.9	211.7	210.5	205.8	218.4	72.2	153.8	127.4	10.1	82.2	76.6	81.9	131.5	82.0	56.3	62.0	71.6	128.0	68.6	123.2	71.7	16.7	209.8	79.7	87.8	103.7	127.9	16.0	118.1	107.5	97.7	66.4	87.1	10.4	195.8	146.7	91.9	47.4	110.0	111.1	81.1	92.8	151.7	125.0	48.8	11.5	80.5	89.5	108.1	88.8	15.6	104.4	89.4	96.0	12.2	186.2	89.5	64.9	6.6	14.7	131.7	75.0	105.3	89.1	75.5	117.5	148.9	141.5	62.8	65.7	86.0	127.5	54.5	49.7	80.0	75.9	267.3	80.2	124.5	96.0	89.1
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256527-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 308.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000872, HPA016885"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705, HPA016885: "	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	76.7	61.3	47.6	48.0	50.3	86.3	64.9	50.8	63.3	51.7	47.6	72.4	35.7	67.3	71.6	71.5	53.4	37.5	114.9	49.5	53.6	62.2	83.3	55.0	49.5	50.5	51.3	45.6	52.7	69.3	37.0	69.6	53.0	49.7	60.4	40.1	55.3	57.5	308.0	74.1	54.5	61.5	49.4	57.5	61.1	82.2	50.3	62.5	48.1	142.5	72.2	64.7	54.1	50.8	141.6	131.1	147.5	154.8	126.6	115.4	154.9	133.5	185.7	287.9	215.4	122.3	154.7	119.4	198.4	162.3	132.2	142.8	182.2	155.8	334.2	143.9	80.0	93.8	84.6	105.9	109.1	143.7	120.4	104.3	120.7	187.9	137.1	120.2	176.2	130.3	134.8	69.9	200.6	267.9	108.0	186.7	130.6	180.7	160.4	127.5	190.8	97.6	163.0	144.6	154.6	103.2	109.0	279.6	118.0	121.8	175.9	125.2	134.9	110.1	98.8	119.6	196.3	120.0	204.3	178.3	159.8	129.1	172.1	95.1	101.4	160.1	67.1	93.7	66.4	57.7	68.5	69.0	101.1	56.8	62.5	60.7	109.9	82.0	110.7	70.8	101.2	116.5	47.6	50.3	50.8	63.3	49.5	53.6	50.5	51.3	53.0	49.4	50.3	50.8	63.1	102.5	80.4	11.4	51.4	65.0	90.3	175.3	30.1	51.3	48.6	45.7	39.2	88.6	136.0	55.2	52.1	304.2	48.2	91.2	119.3	180.8	593.2	68.9	56.1	90.1	57.0	80.6	21.0	197.7	178.9	71.4	30.1	70.1	98.2	82.4	75.7	196.6	150.2	79.1	21.2	68.7	111.9	91.8	82.2	549.5	76.4	74.7	67.6	14.0	146.0	88.1	72.1	10.6	22.3	210.3	71.5	82.0	50.7	75.5	104.2	160.4	123.9	65.8	85.5	67.5	139.5	198.1	48.7	44.1	50.2	469.4	55.4	82.5	74.4	92.7
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103328570-103370346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: AB_2680833"	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	34.1	33.6	19.6	31.7	21.6	32.0	25.6	23.7	29.5	26.2	24.3	26.2	25.2	23.5	27.8	27.2	23.1	22.0	35.9	20.5	22.9	39.9	54.2	23.5	29.6	22.5	21.0	21.2	16.5	41.4	16.1	30.9	22.3	27.1	22.8	22.3	23.8	26.4	87.2	27.6	24.5	29.6	24.3	22.4	29.5	25.8	21.7	42.4	29.2	77.1	33.5	34.3	17.7	24.8	133.5	78.3	84.4	98.2	93.0	69.7	58.5	102.5	97.9	123.7	122.7	92.7	97.3	100.1	199.2	94.7	168.1	71.0	109.2	76.6	128.7	153.3	68.0	90.5	57.9	57.8	65.2	149.0	84.9	55.3	50.2	122.5	38.9	60.9	89.8	70.4	190.1	98.2	104.2	135.8	165.0	74.2	98.7	109.6	95.2	73.8	108.4	93.8	80.6	64.2	65.3	64.9	97.6	123.9	89.6	92.9	56.6	73.3	91.5	80.9	106.6	174.6	153.8	98.9	274.8	191.3	118.1	143.7	138.5	140.0	53.4	52.7	44.7	81.6	51.5	47.5	51.1	47.9	75.3	40.6	46.3	47.3	7.3	58.4	98.2	42.3	93.3	74.2	19.6	21.6	23.7	29.5	20.5	22.9	22.5	21.0	22.3	24.3	21.7	24.8	36.2	48.1	29.5	18.3	33.8	39.8	41.4	131.8	24.5	36.0	23.5	27.2	61.8	40.0	73.9	27.6	14.6	172.2	34.4	22.5	66.5	113.9	118.9	32.3	33.9	48.5	8.4	64.6	27.9	96.4	110.6	49.7	27.5	24.9	56.4	35.5	34.2	48.5	134.6	26.9	25.1	36.9	93.6	48.5	40.4	33.2	58.4	46.1	32.0	15.9	62.4	69.5	40.2	21.1	32.8	87.3	38.5	64.3	45.0	34.7	36.9	88.8	52.5	49.1	59.2	43.7	105.2	96.3	47.2	23.6	42.9	231.8	39.5	49.1	32.0	42.9
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572310-42577831	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 113.3;Spermatogonia: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA044439	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	3.3	1.4	8.3	2.5	8.9	8.2	3.8	8.7	10.3	3.5	7.9	4.2	1.3	3.7	3.8	3.0	6.2	1.4	1.8	7.8	8.5	2.8	0.8	2.3	3.9	9.4	8.9	3.4	2.1	7.6	1.5	4.2	9.2	3.6	3.0	7.3	1.5	3.9	1.5	3.1	1.6	5.2	9.0	1.9	2.4	23.7	8.8	7.4	1.8	2.3	5.5	2.9	2.9	8.9	21.1	29.0	48.3	34.9	11.0	15.0	11.0	80.4	23.7	63.4	78.3	28.6	12.9	21.1	17.6	22.2	27.6	29.9	36.9	28.8	73.0	31.0	30.0	13.5	66.1	35.0	1.6	46.3	14.4	5.3	6.4	101.5	34.2	9.4	18.8	28.3	44.5	38.2	56.6	21.8	33.3	28.0	30.0	23.9	26.8	32.3	50.7	20.6	14.8	16.6	65.1	40.6	32.1	11.8	34.7	24.3	28.3	20.3	8.8	70.5	41.1	55.2	128.6	30.0	54.1	30.8	32.8	21.2	79.7	0.0	0.0	0.9	0.7	0.2	0.9	1.1	0.4	0.7	0.0	0.3	0.1	0.4	0.9	0.1	0.3	2.8	0.7	0.1	8.3	8.9	8.7	10.3	7.8	8.5	9.4	8.9	9.2	9.0	8.8	8.9	6.0	3.2	3.7	2.3	6.4	5.4	2.7	3.7	0.0	5.9	4.8	5.2	0.9	4.3	2.8	3.7	10.4	15.6	3.7	1.4	0.0	4.5	12.8	11.1	5.8	4.4	0.0	19.8	1.1	3.3	19.1	5.5	1.5	5.0	1.3	7.7	2.9	2.2	7.4	0.0	1.2	1.2	4.1	3.0	2.6	13.1	5.3	2.4	5.4	2.8	5.8	4.6	3.1	1.0	1.5	2.0	0.3	8.6	6.5	2.0	0.2	2.2	14.9	13.9	19.7	8.6	16.0	113.3	44.6	3.2	4.1	5.2	2.7	2.5	2.5	1.7
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971165-39981764	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	41.3	54.8	21.8	21.0	22.5	14.5	38.2	24.1	24.8	38.0	21.3	41.6	20.4	50.9	26.9	54.8	38.2	16.7	58.9	22.9	25.4	48.4	69.1	35.9	18.2	24.1	23.5	32.0	32.5	30.9	37.1	19.3	25.8	35.2	19.0	13.8	36.5	20.3	112.7	48.1	39.0	20.8	24.6	40.3	43.6	43.2	22.7	22.3	41.1	30.2	23.1	41.6	38.0	26.1	68.7	221.3	43.8	53.5	38.0	31.3	47.0	38.6	50.4	87.0	66.4	129.0	46.8	33.0	72.7	49.2	50.5	35.6	61.6	52.7	72.1	60.6	63.0	46.9	39.2	110.4	52.5	52.2	54.7	31.3	46.0	69.1	48.6	25.8	60.5	42.3	63.0	48.5	57.2	108.3	62.4	32.1	80.5	88.3	66.8	54.6	49.7	48.2	64.3	105.7	56.9	74.8	42.3	69.3	38.9	41.9	47.8	45.5	36.2	53.2	54.9	52.2	97.1	62.2	114.6	51.9	69.7	54.0	62.8	38.0	41.5	33.5	44.8	64.8	39.0	35.8	39.8	46.6	66.9	34.7	32.6	32.8	22.3	43.8	89.8	34.8	59.8	61.9	21.8	22.5	24.1	24.8	22.9	25.4	24.1	23.5	25.8	24.6	22.7	26.1	52.5	32.1	19.8	8.1	53.6	64.0	84.8	191.9	40.9	50.1	31.2	31.9	38.1	52.9	96.2	44.1	14.6	174.7	53.7	119.7	92.0	143.3	203.9	70.3	46.3	63.2	59.2	48.8	8.5	110.9	118.9	55.8	53.5	57.1	41.2	41.9	29.6	50.9	163.7	42.1	8.5	41.7	126.1	42.7	66.3	120.0	55.0	57.4	44.4	12.2	91.6	59.5	63.8	6.6	10.7	127.0	103.1	70.0	58.3	65.4	95.2	179.2	88.0	49.9	92.1	49.0	152.1	114.6	45.7	44.7	58.2	399.5	57.5	69.5	69.1	79.8
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 596.6;Late spermatids: 1350.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	90.4	99.0	134.8	80.9	137.5	82.4	80.6	141.3	159.0	79.6	130.2	106.1	68.0	80.1	112.3	104.9	83.2	59.4	107.5	136.2	139.3	120.9	112.7	68.1	93.0	140.5	140.2	63.3	71.0	161.1	82.5	75.5	141.2	81.4	84.4	85.3	73.4	86.7	236.2	121.5	70.6	90.3	137.7	82.4	84.5	73.3	139.6	93.3	86.4	168.7	108.0	93.4	79.6	138.9	240.1	369.1	233.9	172.9	171.4	174.7	202.8	225.3	197.0	327.1	243.8	390.3	154.7	158.7	154.7	241.6	246.0	182.8	239.1	228.5	383.5	136.8	289.7	330.3	288.9	362.4	180.1	336.0	230.4	177.5	171.4	291.9	266.6	139.1	263.7	180.9	258.4	210.2	284.9	450.7	279.4	237.4	215.6	266.3	330.0	248.9	445.5	244.3	249.0	270.9	203.2	274.1	158.6	313.9	152.3	254.4	306.8	197.8	238.8	360.3	329.9	161.5	482.6	220.5	335.2	250.4	225.8	255.7	241.5	105.1	120.4	149.4	164.1	176.3	222.8	142.7	191.6	179.3	140.0	122.0	161.3	183.1	37.7	167.4	206.3	108.6	272.1	216.1	134.8	137.5	141.3	159.0	136.2	139.3	140.5	140.2	141.2	137.7	139.6	138.9	97.9	51.3	78.6	8.5	82.7	94.6	145.0	206.3	71.7	84.9	71.1	79.1	156.0	110.1	139.6	68.0	18.8	250.4	85.1	98.8	246.5	195.2	596.6	75.4	69.4	104.7	90.9	107.7	7.9	214.5	187.2	101.4	69.3	68.1	90.2	53.3	86.4	130.9	162.9	72.3	7.9	92.7	197.4	89.8	85.0	1350.2	133.0	93.4	99.6	5.6	148.0	221.4	109.2	7.5	10.5	167.5	96.3	153.4	88.0	125.6	163.7	330.3	95.1	108.4	111.7	113.0	228.7	151.6	150.2	95.0	102.9	369.0	102.9	124.7	97.9	137.9
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056845-231173116	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.63e-12)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	37.3	38.2	21.9	31.7	26.1	20.1	29.0	21.9	33.7	26.3	20.9	34.8	35.5	37.4	25.6	41.5	24.3	20.3	51.3	27.5	28.5	34.1	42.1	27.0	28.8	26.9	24.9	19.2	17.3	72.7	32.9	36.8	28.3	29.7	36.8	25.4	25.8	33.4	136.3	34.9	29.3	44.9	24.5	25.2	27.9	29.0	24.5	36.6	27.4	81.6	38.3	37.3	27.8	24.4	103.9	113.1	120.6	93.8	122.2	88.7	115.4	135.3	139.4	133.4	134.0	136.5	97.6	80.0	123.3	150.5	138.0	95.0	169.4	125.0	174.3	124.3	93.3	148.7	81.6	155.5	62.9	133.3	119.4	76.5	57.8	142.4	73.9	73.4	159.6	70.3	212.1	56.8	158.7	100.3	103.0	68.3	157.8	100.1	89.3	86.0	190.4	77.7	96.5	104.0	78.8	74.1	108.7	94.1	65.7	120.6	75.3	74.7	152.3	101.4	110.8	126.0	129.8	48.6	80.2	140.4	162.7	100.0	123.4	34.6	27.8	18.8	25.1	39.0	27.3	21.0	25.8	23.8	30.9	17.2	19.2	22.9	12.5	35.9	42.5	18.9	32.3	25.7	21.9	26.1	21.9	33.7	27.5	28.5	26.9	24.9	28.3	24.5	24.5	24.4	51.9	51.3	48.5	77.7	32.9	33.1	37.7	57.0	19.9	46.4	23.0	25.8	125.4	31.5	53.0	33.1	41.7	119.2	27.0	63.6	17.6	83.9	6.2	51.2	67.5	51.7	39.4	61.6	100.0	102.2	101.4	54.6	42.3	60.9	103.9	67.8	30.0	86.9	72.3	90.9	96.0	30.0	57.0	44.2	23.5	9.9	34.8	49.8	17.8	54.4	62.6	46.6	29.9	67.3	93.1	98.6	26.2	45.9	49.4	46.5	46.9	32.1	66.9	53.2	72.3	54.6	128.2	247.9	158.8	39.2	33.1	167.5	36.6	65.5	42.9	38.8
PSMD10	p28	ENSG00000101843	"Proteasome 26S subunit, non-ATPase 10"	O75832	X	108084207-108091549	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002920, CAB010434"	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		250000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Intermediate filaments"	"CAB010434: AB_640866, HPA002920: AB_1079708"	"unprognostic (1.59e-3)"	"unprognostic (4.12e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.95e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	28.2	38.6	49.4	26.2	52.3	28.7	35.1	54.5	68.3	34.3	47.4	32.7	25.3	36.4	48.3	34.5	44.9	25.8	26.0	49.9	58.9	34.6	33.4	28.6	34.8	55.4	58.6	31.7	18.6	41.4	33.1	40.4	61.4	31.6	33.2	44.6	26.2	30.4	24.8	26.8	27.0	36.2	56.4	27.1	27.8	27.5	57.5	41.9	38.1	23.9	39.1	33.4	27.7	59.4	101.3	100.5	68.9	62.6	102.6	77.3	61.8	81.6	69.2	73.9	64.0	60.7	64.4	86.0	119.7	80.2	107.6	54.0	109.8	80.3	113.4	91.3	94.8	50.5	91.0	78.2	51.8	79.2	54.8	58.2	85.9	67.2	82.2	73.2	186.4	83.2	99.9	114.3	94.0	133.0	75.3	70.9	124.1	96.9	138.3	74.2	97.5	92.7	80.7	64.8	44.2	42.1	124.8	52.4	86.0	87.4	56.5	66.9	130.5	58.1	33.1	98.3	61.4	88.5	128.5	90.5	80.4	109.2	69.7	83.6	46.8	72.3	45.9	58.1	49.0	47.9	45.8	49.2	52.2	48.0	45.6	51.4	22.0	58.3	71.4	53.0	57.8	69.9	49.4	52.3	54.5	68.3	49.9	58.9	55.4	58.6	61.4	56.4	57.5	59.4	14.2	19.2	19.8	3.3	23.4	22.6	25.9	31.8	23.9	15.1	20.4	20.6	11.2	8.6	35.4	11.0	2.1	28.3	12.8	16.5	31.3	19.9	4.1	38.3	26.9	22.8	14.4	35.7	3.4	18.7	35.3	22.6	11.7	21.6	34.1	17.9	22.1	25.6	31.3	13.5	4.5	16.8	16.2	29.5	19.0	4.4	25.7	20.2	17.8	0.0	26.1	18.3	20.6	5.5	9.6	24.5	14.1	21.1	34.7	26.6	14.9	34.8	69.9	7.7	0.0	13.8	32.1	46.2	40.3	32.4	29.1	25.0	20.2	24.6	19.2	33.7
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444379-32483319	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 308.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		95000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.9	26.5	25.6	29.4	26.4	34.5	22.6	24.6	29.5	22.8	20.3	27.3	27.2	28.8	23.1	36.3	21.8	22.7	37.0	26.0	25.6	30.1	37.7	24.3	30.2	27.0	25.3	20.6	25.9	35.0	18.5	34.1	28.1	25.0	32.0	23.8	23.3	21.8	96.0	33.8	23.2	35.0	24.4	24.0	22.9	34.2	25.9	38.4	21.6	58.6	39.1	34.0	24.8	31.2	127.0	136.8	98.4	106.2	65.4	48.4	103.8	71.5	90.0	151.9	122.0	139.9	111.5	99.1	110.7	77.0	145.9	143.0	114.5	98.5	147.8	50.9	81.2	81.0	68.7	108.3	63.3	95.5	81.6	43.7	51.0	134.3	91.8	49.0	108.7	87.0	155.5	110.9	90.8	78.0	143.1	57.4	134.5	67.4	68.8	89.2	127.2	132.4	75.2	92.2	86.3	58.8	89.8	63.4	71.0	100.3	154.2	45.1	77.8	84.3	99.5	105.6	166.5	62.2	105.0	129.1	122.5	74.8	145.2	48.3	41.2	26.7	40.2	41.8	44.2	36.3	39.1	40.6	46.6	34.2	34.5	36.4	19.1	47.7	45.6	38.2	51.5	45.6	25.6	26.4	24.6	29.5	26.0	25.6	27.0	25.3	28.1	24.4	25.9	31.2	62.7	48.1	31.5	36.6	56.3	126.9	108.7	116.3	44.9	44.5	47.8	40.8	71.9	41.5	78.0	25.8	31.3	178.2	57.8	87.5	80.3	117.8	205.4	45.8	46.2	69.7	48.8	100.8	36.0	107.3	146.1	63.8	43.8	59.9	45.7	79.8	55.3	107.0	92.3	37.0	36.4	58.7	77.3	48.4	72.6	48.0	49.0	61.1	26.6	15.9	77.5	63.1	40.2	33.2	55.6	117.2	48.0	48.5	79.3	131.9	66.4	120.6	52.6	43.3	52.6	68.0	189.7	152.7	98.4	85.3	117.5	308.9	54.8	52.0	67.6	109.5
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366605	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		73000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	14.8	13.9	11.2	11.4	12.2	12.5	11.9	15.0	19.4	9.4	9.7	10.4	8.2	10.5	10.9	12.5	7.6	9.7	13.7	12.6	17.2	14.9	28.0	9.4	10.8	17.8	17.8	9.1	15.6	14.8	7.6	11.0	18.9	10.7	11.6	8.9	10.0	7.7	35.8	10.3	8.7	11.3	12.9	9.4	11.2	14.4	16.0	12.1	10.3	29.1	15.1	14.7	8.0	12.5	63.8	38.5	29.2	32.2	21.9	26.3	40.6	44.2	27.9	47.8	42.0	40.4	27.4	36.6	28.0	35.9	37.4	37.0	51.1	45.1	70.7	17.8	38.5	43.2	29.9	41.1	28.6	44.7	25.0	29.6	29.4	45.3	35.2	21.2	47.6	27.8	57.4	21.0	45.0	43.5	41.0	42.6	35.7	30.0	50.1	20.9	75.6	32.5	36.1	52.0	28.0	40.6	32.9	62.6	45.2	34.1	45.0	36.9	49.5	50.5	34.4	38.6	81.4	21.4	35.2	30.5	59.8	46.5	29.9	14.0	9.9	8.9	8.7	16.7	12.3	8.0	11.5	9.9	10.3	8.9	10.1	10.7	7.3	10.9	19.6	7.0	12.1	8.7	11.2	12.2	15.0	19.4	12.6	17.2	17.8	17.8	18.9	12.9	16.0	12.5	59.6	48.1	58.8	9.8	37.9	112.3	119.5	109.0	43.3	40.8	37.9	33.0	108.1	25.8	97.7	46.0	25.0	88.3	47.9	29.7	70.5	80.7	158.1	99.1	62.3	73.8	32.9	67.3	21.0	78.7	88.8	64.0	33.1	125.3	50.6	39.9	41.0	84.1	56.0	92.5	22.0	28.6	65.1	44.7	90.6	197.0	46.3	50.6	48.0	10.3	59.8	58.6	37.0	14.6	15.0	84.9	22.7	44.0	58.2	93.4	26.0	77.2	68.1	44.6	26.3	78.6	146.8	126.2	108.0	52.9	94.8	123.0	53.8	53.8	34.1	123.2
PSMD13	"p40.5, Rpn9"	ENSG00000185627	"Proteasome 26S subunit, non-ATPase 13"	Q9UNM6	11	236966-252984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038691, HPA038692"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		81000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"	Cytosol	"HPA038691: AB_2676153, HPA038692: AB_10671749"	"unprognostic (1.32e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (2.24e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.76e-5)"	"unprognostic (7.54e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.52e-13)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	56.6	41.3	48.2	65.2	49.1	69.4	74.9	50.0	51.5	57.8	49.5	64.1	57.0	50.7	62.6	63.6	51.8	42.9	76.1	50.3	52.6	53.6	71.8	56.2	79.5	50.3	50.2	40.0	48.9	45.6	18.0	64.9	54.0	67.1	66.7	30.8	46.3	52.0	122.4	62.4	55.7	68.1	51.1	54.3	45.9	44.2	49.5	91.6	48.3	124.3	86.9	65.5	20.1	52.3	240.7	163.7	155.2	163.7	135.3	114.0	102.3	151.8	186.1	277.7	210.6	156.1	352.4	193.0	178.2	172.7	145.5	179.4	154.6	200.2	251.0	202.7	148.7	109.9	52.4	131.7	160.9	203.8	207.7	116.3	149.7	138.4	121.2	114.0	241.7	186.3	249.1	158.1	189.9	126.3	197.4	185.0	243.1	195.0	184.0	168.6	145.3	156.3	190.2	59.2	141.7	111.5	106.5	166.7	111.0	103.6	97.7	123.7	192.6	115.2	96.8	60.3	160.6	161.2	192.4	271.8	185.2	193.0	176.3	198.6	171.3	133.6	145.8	173.0	143.0	125.0	133.1	141.1	176.1	128.6	121.3	130.3	127.8	168.7	194.7	122.1	169.2	286.0	48.2	49.1	50.0	51.5	50.3	52.6	50.3	50.2	54.0	51.1	49.5	52.3	80.8	48.1	41.4	17.0	64.7	35.8	54.1	124.8	26.2	43.2	43.8	41.7	45.7	52.9	68.8	31.3	31.3	162.3	79.9	76.5	82.2	114.8	39.2	41.6	47.1	75.1	48.0	35.7	16.8	130.8	138.6	55.9	34.1	45.2	67.2	59.9	54.7	59.0	100.5	37.0	15.5	75.2	71.2	47.5	43.5	57.8	68.6	64.4	46.2	11.2	91.9	65.0	71.1	8.5	17.2	123.4	65.5	59.8	73.9	58.7	80.8	76.2	61.3	44.2	85.5	40.8	66.9	94.0	86.4	34.4	38.8	205.8	71.6	73.8	74.2	51.4
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308425-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	35.2	38.3	38.6	39.7	40.0	38.8	36.4	42.5	47.5	26.2	36.7	35.2	29.1	24.7	30.1	40.7	27.3	23.7	44.6	40.7	43.3	44.4	48.4	26.9	37.8	42.1	41.7	14.5	25.6	51.1	21.4	42.0	43.7	31.0	41.0	37.9	20.8	29.9	98.0	33.2	26.4	39.6	43.8	22.9	27.2	38.7	41.1	49.7	34.7	76.0	52.0	42.5	19.6	46.6	170.3	145.8	158.8	140.8	113.9	97.0	194.2	173.6	168.2	246.1	198.6	216.2	140.2	200.2	258.0	128.7	144.3	126.5	176.8	185.6	244.6	210.3	133.1	200.8	110.8	245.9	139.7	196.7	113.8	74.4	138.8	277.4	256.8	94.0	185.5	117.1	222.1	139.6	207.7	164.1	145.0	148.0	220.5	124.3	218.2	123.6	154.4	196.0	218.6	145.0	138.4	101.3	117.8	131.7	167.5	131.4	90.2	124.3	147.2	162.7	152.4	111.6	193.8	82.5	242.7	186.7	174.1	129.6	182.2	47.4	48.2	25.2	65.3	69.6	68.7	64.2	69.4	71.0	75.4	57.4	55.4	66.5	4.9	70.2	56.2	74.5	83.7	73.3	38.6	40.0	42.5	47.5	40.7	43.3	42.1	41.7	43.7	43.8	41.1	46.6	40.1	51.3	38.2	35.3	49.4	49.5	48.1	146.8	25.0	43.7	40.2	36.2	89.8	52.9	80.3	23.9	18.8	159.5	60.4	47.7	90.1	124.3	82.5	52.4	51.8	49.9	52.5	56.2	64.0	118.3	154.6	48.1	29.6	58.4	51.2	59.0	31.8	125.3	104.7	47.1	56.1	53.5	118.0	41.1	40.0	36.0	27.7	46.1	48.0	25.3	61.1	87.7	44.3	50.3	64.6	155.0	48.0	34.3	60.2	57.0	36.5	106.1	55.4	60.6	32.9	36.6	64.5	137.0	77.7	34.3	56.0	220.3	47.8	63.6	64.5	50.8
PSMD2	"MGC14274, P97, Rpn1, S2, TRAP2"	ENSG00000175166	"Proteasome 26S subunit, non-ATPase 2"	Q13200	3	184299198-184309050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 332.9"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045192, HPA062363"	Enhanced					NA	NA		430000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"			"HPA045192: AB_10961324, HPA062363: "	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (9.98e-4)"	"prognostic unfavorable (6.63e-7)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.74e-3)"	64.1	102.6	65.0	61.9	67.6	77.8	53.3	68.3	71.7	58.4	65.1	73.2	49.4	69.1	45.5	84.3	53.5	41.3	116.3	67.6	73.7	62.7	68.8	59.3	57.9	74.8	81.1	50.3	48.0	82.9	58.8	58.4	84.6	52.2	63.2	46.9	60.6	59.8	332.9	79.7	55.8	76.7	68.9	59.1	63.4	101.9	73.2	73.4	55.3	183.3	77.1	64.5	58.8	65.2	800.0	248.6	194.3	328.7	226.2	129.6	238.8	478.3	363.6	580.3	327.6	349.1	163.4	251.5	643.4	393.8	467.1	254.3	290.3	516.4	725.0	383.6	234.1	268.4	229.6	211.9	123.7	191.9	211.8	147.3	156.8	549.5	339.0	219.1	353.6	188.9	201.1	226.9	476.0	310.7	199.4	110.1	279.4	290.8	438.1	217.6	287.8	262.9	240.4	248.7	174.5	134.7	376.2	321.3	174.7	208.4	446.5	145.1	463.6	361.2	383.9	293.3	1049.9	219.7	501.3	412.9	438.7	204.2	256.7	48.8	86.0	82.2	61.9	74.5	56.7	59.0	60.1	68.0	103.1	53.5	58.5	56.3	26.6	76.7	79.6	48.3	66.9	96.3	65.0	67.6	68.3	71.7	67.6	73.7	74.8	81.1	84.6	68.9	73.2	65.2	49.0	67.3	61.7	13.4	53.4	71.1	66.2	101.1	58.1	66.9	38.7	31.5	113.3	38.6	81.8	57.0	20.9	153.8	60.6	67.3	90.1	183.2	161.8	56.1	55.0	63.0	79.6	105.9	21.0	130.8	117.9	60.3	45.3	61.3	40.5	111.3	35.0	60.5	83.8	72.3	20.0	40.0	79.3	38.8	54.0	90.3	48.7	58.5	53.4	15.9	94.1	117.1	51.5	12.5	16.6	349.2	33.3	65.8	84.4	63.1	59.1	97.0	71.5	60.5	32.9	48.2	183.0	184.6	138.9	65.2	67.1	222.9	53.0	94.3	55.8	57.7
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980807-39997959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 252.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.0;Syncytiotrophoblasts: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 842.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	56.5	64.2	44.5	47.6	45.4	48.1	53.6	44.1	50.0	54.6	40.7	60.3	43.3	61.8	35.0	69.6	51.6	25.3	76.5	47.4	47.0	47.8	93.6	51.0	45.7	45.9	43.0	52.7	57.1	55.4	48.3	47.4	48.0	47.7	46.1	31.3	54.2	37.2	252.5	86.1	48.9	45.2	42.9	49.3	52.7	52.9	44.2	56.9	45.9	103.3	51.1	53.6	53.2	46.6	203.7	247.8	133.2	192.9	106.3	68.2	158.3	146.2	150.7	257.3	198.3	206.4	170.0	242.3	357.7	157.6	172.5	310.2	238.6	190.7	172.9	245.5	266.2	140.4	120.5	207.2	96.5	191.3	151.0	91.5	160.0	272.7	118.8	86.4	147.6	166.0	291.5	146.9	121.2	148.0	298.2	131.2	185.5	130.9	145.2	216.2	184.7	227.7	130.5	135.3	174.9	132.5	139.7	842.6	124.3	160.9	190.2	162.7	132.9	110.7	195.8	165.6	266.2	158.2	217.2	269.3	169.4	142.2	182.6	8.1	22.4	19.0	17.6	21.3	17.2	16.6	17.0	20.4	29.8	17.7	15.3	19.1	6.3	16.6	18.3	20.4	16.3	17.9	44.5	45.4	44.1	50.0	47.4	47.0	45.9	43.0	48.0	42.9	44.2	46.6	32.4	44.8	40.1	16.6	43.3	46.7	57.2	71.5	33.0	70.8	31.7	25.7	21.3	15.7	48.6	16.5	20.9	165.3	38.0	98.3	46.9	101.4	247.0	30.7	35.9	46.5	26.4	44.6	18.0	106.3	131.6	50.6	34.7	28.5	25.3	70.2	32.2	50.9	96.3	60.6	17.6	59.2	69.2	27.4	37.0	51.8	62.7	39.1	65.8	4.7	57.4	89.9	35.0	11.1	16.5	101.4	68.3	54.2	57.2	76.3	75.3	54.8	32.0	56.9	26.3	51.1	50.7	87.3	54.0	38.7	44.6	271.7	32.4	78.8	77.2	53.7
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254709-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	108.8	118.0	198.8	77.8	203.8	89.4	97.9	203.0	288.1	88.7	195.2	136.9	68.9	99.5	114.3	115.5	91.0	58.2	191.2	202.8	205.8	110.2	170.5	81.7	95.7	208.5	215.3	85.8	114.0	91.6	79.4	91.1	209.3	91.3	82.1	64.5	83.9	86.4	404.1	103.3	91.3	91.0	204.2	109.6	115.4	152.0	203.7	114.3	76.7	188.0	114.0	118.6	88.2	203.4	251.4	294.8	213.4	175.2	227.4	167.0	231.9	166.0	202.1	258.6	205.1	388.3	278.2	202.2	396.2	235.4	178.7	255.4	277.1	250.6	219.6	331.9	236.6	197.8	256.2	396.6	250.8	234.7	220.5	182.5	204.2	296.3	271.4	193.3	229.5	222.4	313.6	247.9	220.2	723.5	217.4	276.7	406.0	384.3	293.4	181.6	207.7	364.7	252.7	210.6	166.7	283.8	184.5	266.3	222.7	313.0	278.9	452.3	203.4	128.1	201.2	159.2	288.2	295.1	397.7	430.3	212.6	218.1	238.7	439.4	439.0	713.9	247.3	478.1	281.2	399.0	287.4	274.4	398.4	426.1	261.0	258.1	580.2	351.2	502.3	240.3	476.6	651.0	198.8	203.8	203.0	288.1	202.8	205.8	208.5	215.3	209.3	204.2	203.7	203.4	90.1	57.7	62.9	15.7	78.5	88.6	111.9	249.0	58.1	50.9	60.9	69.3	245.2	82.9	125.0	60.7	27.1	328.6	74.0	104.1	168.3	177.3	279.1	91.5	63.0	95.8	84.2	107.3	25.3	186.9	234.1	88.5	46.9	59.1	83.6	88.8	83.2	116.0	184.5	33.7	24.2	94.1	156.6	104.0	98.0	243.2	105.3	90.3	104.9	11.2	256.6	91.9	115.4	16.1	23.2	172.2	129.1	98.6	67.0	121.4	168.6	206.6	148.3	54.6	118.3	79.0	221.1	234.8	83.5	66.7	86.5	414.6	77.7	105.6	114.5	107.2
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010550-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 285.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 513.3;Late spermatids: 717.7;Spermatocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"MCF7: 1458.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain					NA	NA		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"			"HPA036921: AB_2675383, HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	47.2	67.9	43.9	43.3	45.2	115.0	49.5	47.5	63.2	37.1	44.7	46.2	34.0	43.1	60.1	61.4	35.2	28.2	74.9	46.2	47.5	62.9	74.9	37.9	50.2	47.5	47.5	32.8	285.7	72.9	30.8	54.2	49.2	42.1	43.4	48.4	43.7	45.6	160.8	54.6	34.8	49.5	49.2	38.8	46.1	120.2	45.2	54.8	40.3	90.9	63.9	52.3	40.4	49.0	98.4	102.5	141.1	99.5	97.6	87.0	125.9	136.3	128.8	221.5	162.4	193.0	79.8	136.9	57.6	132.4	154.7	66.1	166.4	144.7	207.3	141.1	104.6	183.6	76.3	128.2	142.9	204.9	112.2	93.7	100.8	184.2	80.3	107.4	141.5	117.7	187.3	86.1	157.8	1458.7	141.0	125.3	180.7	157.3	71.9	117.2	101.1	132.4	177.1	140.7	52.1	85.0	101.6	85.4	136.2	123.4	74.3	125.0	125.7	98.1	106.5	145.2	217.1	108.2	171.0	204.1	144.3	190.8	116.1	99.2	113.9	140.3	103.4	133.0	107.3	124.7	114.0	112.9	120.1	120.3	113.6	110.5	139.4	111.5	139.8	84.0	137.1	167.2	43.9	45.2	47.5	63.2	46.2	47.5	47.5	47.5	49.2	49.2	45.2	49.0	46.4	32.1	43.2	7.5	48.7	62.1	71.7	152.5	27.9	37.0	33.9	34.9	100.0	22.8	86.4	44.1	22.9	197.8	47.3	27.6	86.1	104.0	513.3	49.0	42.3	55.3	25.8	99.9	11.7	133.7	102.3	47.6	27.0	48.9	45.6	46.7	28.9	47.4	92.2	33.7	10.9	27.3	73.2	38.1	40.5	717.7	51.9	51.7	48.0	4.7	71.0	81.8	39.1	10.1	15.4	87.1	30.4	51.1	58.1	44.7	29.7	95.9	73.0	41.2	59.2	41.3	145.8	336.9	131.3	53.4	69.9	290.6	50.4	68.7	35.8	66.1
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296814-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 596.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	68.9	78.8	51.6	52.1	52.9	126.7	57.5	54.5	69.3	50.1	50.9	75.8	47.3	59.5	59.3	85.8	44.0	41.2	124.8	53.0	54.2	57.3	75.1	52.6	62.3	54.3	54.1	37.8	49.0	49.0	41.7	70.2	55.6	68.3	65.4	47.3	59.7	59.2	265.8	85.5	55.6	62.4	54.3	56.5	58.0	42.0	55.0	71.9	42.0	159.5	71.2	73.1	62.2	56.7	140.1	226.2	170.6	89.0	120.1	122.1	209.8	191.6	166.2	236.2	212.7	301.9	189.8	190.1	207.7	156.7	103.2	176.3	135.0	175.1	215.4	113.3	146.3	147.2	169.1	235.9	156.0	241.3	241.3	112.4	176.3	213.4	213.0	106.0	207.0	119.2	222.2	82.1	153.5	345.4	147.0	232.1	184.9	145.0	113.8	198.8	106.9	251.6	125.1	207.3	106.9	119.3	185.7	70.4	114.9	130.5	148.7	166.6	187.5	137.5	116.0	152.5	146.5	174.6	241.4	560.2	186.6	174.1	145.2	152.4	163.6	193.4	133.2	176.2	130.5	149.7	131.8	141.2	201.9	110.5	126.6	131.2	98.7	139.5	187.4	172.2	168.2	187.8	51.6	52.9	54.5	69.3	53.0	54.2	54.3	54.1	55.6	54.3	55.0	56.7	74.4	67.3	59.4	16.6	84.2	104.4	183.5	167.8	64.3	59.6	47.0	47.5	53.3	57.2	114.9	46.0	8.4	337.1	69.5	120.4	80.3	158.5	153.8	76.3	80.6	96.2	85.5	121.0	22.7	190.9	229.8	87.7	67.8	80.3	103.9	76.7	66.0	147.6	188.5	57.2	21.3	100.1	122.1	75.1	91.2	25.3	56.5	95.1	99.6	9.4	119.5	86.0	81.4	15.6	25.7	164.0	104.1	65.5	121.4	259.6	93.9	109.4	88.1	59.9	92.1	68.4	186.1	184.2	88.7	103.6	129.3	596.1	86.2	114.0	110.3	197.8
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374550-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 708.9"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	224.8	130.8	102.3	78.0	109.6	118.8	184.9	104.1	114.8	109.6	97.6	111.8	98.1	115.8	119.4	156.6	104.0	69.2	361.8	114.4	117.5	122.4	143.0	114.9	90.8	109.2	104.3	82.1	117.3	150.2	111.1	101.1	121.9	107.1	98.9	60.6	118.8	84.5	708.9	178.4	106.4	105.2	105.4	99.4	117.6	145.8	112.6	120.3	91.2	361.1	109.9	106.3	111.0	112.6	337.3	522.7	202.2	231.9	322.0	256.9	105.9	238.7	322.9	358.9	372.3	362.0	196.3	234.7	242.8	320.0	220.1	114.1	341.7	296.8	321.6	389.8	225.6	256.1	159.6	226.4	415.1	260.8	217.9	261.2	290.8	309.7	408.8	197.3	286.5	279.9	324.9	255.7	400.6	332.8	247.6	146.1	157.8	492.8	282.7	254.7	324.6	187.4	255.7	275.1	210.8	214.3	247.3	315.7	233.8	187.1	165.3	242.0	212.7	272.1	251.5	289.0	355.8	257.2	322.4	318.0	410.1	264.8	310.1	169.0	239.5	132.6	188.2	265.1	160.0	172.8	162.0	181.0	263.1	173.6	133.0	129.5	89.0	182.7	319.8	183.2	295.2	352.3	102.3	109.6	104.1	114.8	114.4	117.5	109.2	104.3	121.9	105.4	112.6	112.6	137.4	67.3	67.9	8.1	122.9	206.0	224.5	293.5	80.2	102.6	116.3	141.0	263.8	81.5	158.8	80.9	54.2	367.2	128.2	194.6	348.3	276.0	422.3	137.2	158.2	127.0	146.0	129.2	14.7	267.4	327.5	146.8	71.4	122.5	93.8	146.9	81.4	123.1	296.9	77.4	15.4	183.9	219.7	93.1	169.5	1164.7	118.4	126.9	199.3	10.3	224.0	179.8	143.2	8.0	19.8	296.8	181.2	117.8	178.9	255.0	305.7	332.4	128.5	120.4	151.2	106.6	221.1	305.1	135.4	120.3	212.3	570.3	133.0	201.0	182.5	218.7
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888732-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	16.5	4.6	7.5	2.3	8.1	19.2	4.8	8.0	10.0	5.8	11.8	13.8	11.5	7.1	2.2	6.2	6.4	3.8	5.5	7.9	8.1	10.8	4.6	6.0	5.7	9.0	8.9	5.9	10.6	4.8	3.5	3.9	8.3	4.6	2.2	3.6	8.8	6.7	18.5	5.9	6.2	3.3	8.3	8.9	14.9	5.1	8.7	6.6	5.1	6.0	3.2	4.1	5.5	9.4	54.8	81.8	6.7	12.2	11.2	11.6	13.9	54.5	17.8	27.3	15.5	60.0	6.3	40.5	45.0	28.6	9.2	22.1	20.0	29.1	16.3	78.5	41.6	33.3	40.9	30.5	27.5	23.3	22.7	20.4	14.0	30.4	11.7	9.9	16.6	24.7	30.1	5.3	17.6	63.2	47.1	17.8	14.0	7.1	63.4	35.6	18.3	24.9	13.4	53.9	14.1	19.3	54.4	7.7	29.3	5.8	23.3	11.3	43.3	25.4	29.0	50.1	38.4	30.4	73.0	62.1	45.5	30.1	23.8	41.8	43.6	53.0	33.9	46.2	27.3	47.6	32.6	31.0	38.5	38.5	25.0	21.2	41.3	29.3	41.7	63.7	48.1	51.6	7.5	8.1	8.0	10.0	7.9	8.1	9.0	8.9	8.3	8.3	8.7	9.4	22.8	48.1	33.7	10.1	32.6	60.5	11.4	64.1	67.2	7.3	40.9	34.8	8.0	34.3	40.0	35.0	18.8	30.3	45.8	66.6	52.8	116.9	34.9	32.6	28.7	29.7	46.6	121.4	12.9	121.4	30.7	30.5	42.8	27.4	44.4	11.0	33.9	26.8	39.8	15.2	10.7	66.5	54.9	37.9	55.3	11.4	37.9	43.6	55.2	7.5	93.9	17.2	35.0	7.1	18.7	138.2	64.2	38.7	73.2	9.5	146.8	100.7	36.6	14.8	39.5	19.5	46.8	33.9	37.5	69.4	71.6	37.8	44.9	12.9	67.7	12.8
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136163-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		7500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favorable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.62e-3)"	163.2	231.2	36.4	102.1	37.3	120.3	157.1	37.1	47.1	159.0	36.4	182.2	133.9	128.6	85.0	177.6	139.6	68.3	145.2	35.7	38.9	224.5	219.7	184.1	156.8	40.5	37.6	154.3	131.0	84.6	115.0	72.4	39.0	146.3	119.9	24.5	151.6	85.9	140.7	142.9	211.6	79.8	39.6	272.6	160.4	30.7	38.2	129.1	150.6	67.3	150.7	135.2	157.1	40.3	98.6	79.0	59.8	115.9	127.6	146.0	91.6	61.5	199.0	193.2	274.8	51.9	233.5	252.1	44.8	102.7	101.7	139.1	86.8	127.3	128.7	211.2	52.5	112.9	34.9	289.6	280.0	144.8	137.6	128.2	80.4	87.4	76.3	182.6	147.4	158.1	17.5	218.5	76.3	249.3	376.0	175.1	5.8	162.3	135.9	293.2	123.4	182.9	246.8	259.8	37.7	67.3	78.0	200.7	124.6	35.5	131.9	139.5	85.1	52.8	61.0	60.6	92.7	201.8	224.5	120.9	71.9	128.0	86.6	394.8	441.9	552.3	484.5	570.1	484.8	399.4	448.4	463.2	425.0	370.1	318.6	395.7	653.9	515.6	575.2	408.3	537.9	978.6	36.4	37.3	37.1	47.1	35.7	38.9	40.5	37.6	39.0	39.6	38.2	40.3	305.5	208.3	172.7	7.5	353.8	156.4	241.6	570.7	199.2	28.2	159.6	169.2	59.6	248.8	296.5	283.3	10.4	393.3	406.7	347.8	318.9	500.0	3.5	171.4	250.5	228.0	189.7	244.9	1.4	549.8	293.2	184.8	138.6	223.9	240.1	124.7	242.4	266.6	313.7	6.7	1.9	397.6	280.8	295.3	294.2	16.5	189.2	275.4	188.5	4.7	930.4	98.3	620.0	3.0	6.6	373.6	461.2	124.8	422.0	280.6	754.3	700.5	236.3	23.5	105.2	121.4	283.6	3.5	24.9	200.0	156.0	304.4	424.6	243.6	406.6	301.3
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843760	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.8;Late spermatids: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	46.9	45.2	27.9	43.4	29.1	51.7	40.3	27.9	32.1	32.6	27.0	43.6	38.0	39.8	28.1	67.3	33.8	29.3	52.0	30.2	29.7	49.7	41.8	36.2	49.2	28.2	35.0	25.4	43.8	49.9	25.2	36.2	29.2	31.2	45.3	34.6	42.1	35.7	80.8	50.7	39.6	41.6	27.9	37.5	46.7	46.4	30.6	43.1	39.5	50.1	57.8	61.9	39.0	26.7	153.1	211.4	124.3	125.3	97.6	101.7	158.6	199.6	134.3	238.7	168.6	180.7	116.5	224.8	137.0	155.3	134.9	142.1	186.2	180.9	268.2	114.6	159.0	131.1	114.8	151.1	111.0	306.1	139.6	97.4	116.1	187.5	175.8	66.3	140.4	123.8	220.7	75.3	154.4	75.8	268.0	101.1	166.0	227.8	114.1	171.4	228.0	173.8	115.4	217.8	140.4	139.5	113.5	92.2	140.6	174.1	193.2	111.0	131.2	187.0	132.9	156.0	259.8	119.7	217.5	316.3	133.6	156.9	181.9	52.0	78.1	73.6	55.2	86.6	59.6	51.4	44.2	54.4	75.7	49.4	41.5	47.6	101.5	66.3	74.9	41.6	59.4	87.5	27.9	29.1	27.9	32.1	30.2	29.7	28.2	35.0	29.2	27.9	30.6	26.7	15.1	19.2	19.3	5.9	29.2	30.2	38.1	34.6	35.3	13.2	26.9	18.4	35.1	22.8	28.2	29.5	14.6	43.6	21.2	31.1	27.4	58.7	253.8	24.4	24.5	21.1	24.7	30.3	10.5	52.9	71.4	21.6	31.6	31.1	22.2	19.2	18.9	28.0	49.5	13.5	10.6	25.2	44.7	30.8	21.3	143.8	15.5	29.6	16.0	4.7	42.6	17.0	24.7	11.1	7.3	63.6	26.8	19.9	38.5	58.8	28.5	43.3	23.9	18.5	19.7	17.7	35.9	43.8	41.5	49.0	47.2	76.2	22.6	25.3	30.7	52.7
PSME3IP1	"C16orf94, FAM192A, NIP30, PIP30"	ENSG00000172775	"Proteasome activator subunit 3 interacting protein 1"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	48.8	50.2	80.5	72.9	93.9	151.0	66.7	85.8	99.0	52.4	83.8	75.4	67.6	54.1	64.7	63.5	54.1	47.3	59.2	78.4	89.7	66.3	62.6	57.6	94.8	91.7	87.3	54.6	55.3	76.7	65.3	56.0	87.3	64.7	87.5	75.2	55.2	50.3	79.0	90.3	76.1	52.3	87.9	93.3	62.6	96.8	85.8	85.0	71.5	66.0	96.5	53.3	56.1	103.7	119.3	148.6	163.6	109.8	70.3	86.2	153.4	138.3	102.3	166.3	107.1	141.3	122.5	179.2	150.6	105.8	84.2	155.9	114.4	137.9	167.1	80.3	92.1	125.0	141.6	148.3	101.0	154.8	170.8	86.6	134.8	158.2	127.4	101.8	121.0	134.4	170.1	56.5	110.8	88.2	169.4	143.2	105.1	88.0	111.3	205.6	236.9	174.5	113.1	96.4	116.3	133.9	250.2	105.2	92.7	113.0	87.1	105.9	120.2	122.0	102.3	90.2	103.7	133.2	113.1	228.6	125.0	109.7	119.6	170.3	78.3	124.1	47.6	93.0	46.8	83.1	45.8	44.7	90.0	77.8	47.0	49.1	107.6	57.1	123.4	62.4	69.2	68.1	80.5	93.9	85.8	99.0	78.4	89.7	91.7	87.3	87.3	87.9	85.8	103.7	16.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.0	56.7	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	59.5	16.8	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	53.1	1.5	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
PSMF1	PI31	ENSG00000125818	"Proteasome inhibitor subunit 1"	Q92530	20	1113240-1189415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 1242.7;Late spermatids: 4603.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041122, HPA041300"	Approved		Enhanced	Cytosol		NA	NA		160000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041122: AB_10805838, HPA041300: AB_10794370"	"unprognostic (1.79e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.32e-2)"	49.7	37.8	32.8	41.8	33.8	53.7	43.4	33.5	35.7	44.3	33.2	46.0	44.2	42.5	27.8	47.7	37.8	26.8	52.0	31.5	33.0	42.4	72.6	43.4	40.9	35.7	33.2	43.8	56.8	43.1	35.2	26.3	34.2	33.3	31.7	32.9	38.8	32.5	128.3	47.2	42.9	36.9	32.8	38.3	44.0	107.6	36.7	41.2	37.7	83.6	39.9	42.3	39.1	35.5	141.5	126.4	29.7	70.3	63.8	66.5	50.8	83.8	64.9	76.1	67.2	118.2	96.4	71.2	56.1	90.3	79.3	123.8	78.9	143.3	95.1	42.3	47.0	99.1	20.8	217.0	83.7	120.6	33.2	67.9	82.3	85.3	132.7	45.9	83.2	55.3	101.5	138.8	62.9	75.4	156.3	107.9	42.6	81.4	79.2	74.5	62.2	118.6	67.7	117.9	75.4	52.4	92.3	159.1	77.3	28.5	108.8	43.3	96.8	95.3	63.8	111.3	115.6	85.9	185.5	77.5	41.8	81.3	74.7	123.8	65.2	123.3	49.8	80.2	57.8	73.2	66.2	54.4	66.3	69.0	59.7	52.8	71.7	58.5	83.0	37.8	81.6	69.4	32.8	33.8	33.5	35.7	31.5	33.0	35.7	33.2	34.2	32.8	36.7	35.5	48.7	35.3	44.2	34.0	58.3	41.2	59.1	81.0	33.0	32.7	40.5	41.5	55.4	31.5	44.8	40.5	4.2	68.0	48.8	51.9	82.2	102.5	1242.7	27.3	38.4	47.4	67.4	190.1	25.2	103.8	88.9	50.2	48.4	28.1	49.5	46.5	50.0	70.0	100.3	21.9	25.4	57.9	34.6	56.3	56.7	4603.4	77.3	58.2	51.6	34.7	76.1	64.3	55.6	22.1	38.1	99.4	75.3	88.8	66.8	69.0	103.3	80.7	32.4	33.1	118.3	36.7	65.0	97.4	90.7	52.1	48.6	74.0	55.0	73.0	62.6	68.8
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.5	9.8	4.0	9.1	4.0	17.3	6.8	2.7	5.5	7.3	2.5	10.5	8.9	7.8	4.8	11.8	6.4	5.4	8.3	4.6	3.8	9.7	15.9	5.7	8.9	2.2	2.4	7.2	10.8	5.1	8.0	7.7	3.2	5.5	9.9	4.9	7.3	3.2	13.8	7.1	8.2	5.1	2.1	6.3	7.1	40.3	3.7	6.3	10.8	5.6	6.2	7.8	7.4	4.0	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	4.0	4.0	2.7	5.5	4.6	3.8	2.2	2.4	3.2	2.1	3.7	4.0	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 537.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 436.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	65.6	50.3	43.5	44.8	43.4	91.9	65.2	47.0	54.8	53.0	43.2	56.3	48.3	49.0	67.5	63.5	47.7	53.2	47.3	43.5	44.9	57.2	65.6	44.3	65.1	44.7	42.8	60.6	55.9	31.1	31.8	52.9	44.4	42.5	60.5	25.1	46.6	47.9	50.9	56.0	47.8	53.0	46.9	43.8	53.7	89.7	42.9	67.6	49.6	39.5	63.7	63.8	52.0	49.2	82.6	51.3	58.2	74.0	100.1	142.5	75.0	81.3	115.7	131.1	147.8	89.1	84.6	90.6	64.6	86.2	108.3	49.8	93.7	99.9	112.2	48.6	52.4	50.1	43.0	101.8	100.7	170.7	78.7	116.8	76.0	80.7	107.6	81.3	92.5	78.7	77.4	112.9	102.4	83.0	109.9	226.1	46.2	436.4	67.8	78.8	87.5	130.2	121.0	106.3	69.6	52.5	77.5	88.1	78.1	56.3	75.8	136.2	63.5	148.9	203.3	131.3	89.4	101.1	142.9	111.1	90.1	88.5	63.3	84.9	89.3	87.6	65.3	95.1	77.6	70.3	84.0	74.8	80.5	62.5	74.6	72.2	30.9	73.9	111.6	65.7	108.2	91.7	43.5	43.4	47.0	54.8	43.5	44.9	44.7	42.8	44.4	46.9	42.9	49.2	96.1	51.3	50.1	42.7	76.4	91.0	98.8	145.2	80.8	25.1	81.4	99.2	36.0	82.9	80.9	82.8	22.9	183.0	80.9	70.8	154.6	110.5	537.7	59.8	75.8	83.9	68.6	97.2	50.1	110.8	140.3	99.3	59.1	53.3	60.9	74.9	101.7	53.1	147.6	25.2	50.3	87.8	54.9	133.0	88.7	140.8	134.2	100.2	72.9	26.2	130.7	63.8	50.4	34.7	38.5	103.2	84.2	97.0	67.1	126.1	120.6	193.8	68.7	21.4	85.5	78.4	89.8	344.9	216.8	119.5	90.1	186.3	78.8	122.3	103.6	130.7
PSMG3	"C7orf48, MGC10911, PAC3"	ENSG00000157778	"Proteasome assembly chaperone 3"	Q9BT73	7	1567332-1571005	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023876	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA023876: AB_1844356"	"unprognostic (3.08e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.12e-1)"	"unprognostic (4.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	26.2	27.6	41.0	15.4	40.6	46.1	25.7	40.4	45.3	26.0	40.1	29.7	22.8	22.6	16.4	52.9	28.9	15.0	24.4	41.5	40.3	37.5	33.1	22.5	25.7	40.4	40.8	19.2	27.8	14.8	29.9	15.8	41.0	28.2	17.4	13.4	30.8	18.4	27.6	57.6	31.3	12.2	38.5	38.3	30.9	18.3	41.5	25.9	23.8	13.8	20.7	25.7	33.3	41.2	130.1	81.6	58.7	57.1	44.8	51.8	57.7	29.2	51.8	72.8	61.7	75.8	82.7	41.1	34.0	49.4	102.3	99.5	75.0	77.2	33.1	39.1	131.1	44.0	176.9	66.5	70.4	58.2	39.6	44.2	93.1	55.2	62.5	31.9	29.7	98.6	121.0	61.4	54.3	220.5	38.0	189.4	117.3	89.3	150.3	63.1	31.4	91.8	59.7	64.6	87.6	75.1	35.8	127.3	80.8	14.6	90.1	108.2	20.6	67.1	97.9	83.9	86.8	69.2	69.4	110.8	39.7	183.3	143.0	54.9	47.6	51.3	40.0	50.2	47.7	41.2	40.5	36.4	47.6	33.4	38.8	38.8	12.3	36.3	54.6	71.1	35.5	38.4	41.0	40.6	40.4	45.3	41.5	40.3	40.4	40.8	41.0	38.5	41.5	41.2	28.5	19.2	15.1	2.3	23.9	53.3	26.4	46.1	48.9	17.5	36.8	40.9	11.4	34.3	30.4	35.0	4.2	49.2	28.7	42.9	84.1	49.5	7.1	62.3	30.0	29.3	28.8	65.0	9.7	51.4	88.2	30.8	30.1	38.5	15.2	25.1	24.3	36.0	56.3	6.7	8.6	64.0	38.7	26.8	31.6	5.8	36.1	24.0	39.2	4.7	37.5	28.0	36.0	7.5	8.2	61.8	40.4	25.9	31.2	41.0	44.1	85.3	50.0	18.6	26.3	22.4	29.7	24.8	36.3	56.9	58.4	39.4	26.4	31.9	48.2	29.0
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	20.3	18.3	12.8	8.2	15.7	13.8	20.0	19.8	13.7	16.9	5.0	24.1	14.1	18.9	18.6	19.9	18.4	6.9	15.1	11.5	14.6	20.1	26.9	13.7	10.2	17.6	16.0	16.6	33.4	12.0	22.2	7.0	18.1	19.3	6.9	9.9	20.2	13.4	37.1	20.8	16.8	9.5	13.5	14.4	21.4	16.2	15.9	9.3	21.1	11.1	7.7	19.8	16.8	23.8	61.8	29.0	17.5	42.8	15.3	23.1	29.5	27.2	20.0	25.9	41.4	25.1	20.6	21.0	73.1	16.4	20.2	28.9	15.0	18.9	16.9	34.7	65.2	16.9	33.4	66.6	19.2	48.7	16.9	19.8	20.1	18.8	27.8	14.8	32.4	39.9	65.0	15.1	14.0	58.2	27.6	88.9	21.4	31.3	57.7	36.5	9.5	116.2	21.1	24.0	74.3	21.3	12.9	16.7	61.4	16.5	22.0	21.0	31.7	21.4	20.4	24.6	26.6	48.7	76.4	39.4	15.2	34.1	29.3	16.2	35.5	24.4	25.3	36.9	29.4	50.2	42.1	30.8	28.4	52.1	40.9	35.7	8.9	32.3	36.3	33.9	39.4	23.9	12.8	15.7	19.8	13.7	11.5	14.6	17.6	16.0	18.1	13.5	15.9	23.8	45.2	22.4	21.2	18.6	25.3	27.9	29.1	44.2	38.7	32.0	53.1	88.4	21.9	37.1	26.9	44.1	8.4	39.3	15.2	23.6	84.1	43.9	31.4	23.6	25.9	35.2	22.8	18.5	9.6	87.5	37.8	30.4	15.8	17.1	22.2	38.8	28.2	64.5	35.1	25.2	17.8	31.1	28.5	19.2	21.1	13.3	37.0	18.4	30.2	5.6	35.7	22.0	32.0	21.6	15.7	57.8	25.8	23.0	18.9	47.0	47.3	67.2	22.6	29.4	46.0	45.5	54.0	29.6	78.2	39.6	38.2	12.0	23.7	30.0	35.4	27.1
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137534-31139066	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"skin 1: 188.2"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 3.3;Glandular and luminal cells: 9.0;Melanocytes: 8.8;Suprabasal keratinocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.6;urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061228	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 44: Endometrium - Transcription"			"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	1.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	188.2	0.4	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.3	0.0	0.2	0.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.5
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.9	13.0	11.5	13.2	11.5	53.7	16.2	12.8	13.9	12.5	9.9	14.9	12.4	14.8	21.7	14.0	16.2	12.1	11.1	11.8	10.6	12.2	8.9	9.9	20.8	12.1	9.0	13.7	9.5	9.5	10.3	13.8	10.6	11.0	15.5	17.4	10.0	8.3	20.9	14.4	12.4	12.6	8.7	11.1	12.0	25.0	10.5	23.1	12.2	12.7	21.9	20.4	10.0	15.8	50.5	20.4	46.6	23.3	18.9	19.8	60.3	26.1	34.0	48.3	43.6	68.4	27.8	67.8	27.7	27.9	25.4	24.6	54.7	32.2	50.0	28.9	27.3	76.4	14.1	83.1	37.4	55.3	46.7	31.6	6.5	29.8	32.9	19.2	41.7	65.9	42.8	26.1	43.2	54.1	65.5	52.8	65.5	27.3	28.0	43.7	46.8	34.6	50.8	74.6	42.7	22.0	35.8	59.1	23.1	44.9	34.5	56.6	25.1	28.9	27.7	28.0	25.4	22.5	14.5	115.1	13.2	32.7	35.2	14.8	21.3	14.5	11.8	22.7	12.0	23.3	15.1	11.0	19.1	22.5	15.4	11.2	16.9	11.9	18.1	20.9	21.8	15.7	11.5	11.5	12.8	13.9	11.8	10.6	12.1	9.0	10.6	8.7	10.5	15.8	21.0	19.2	29.5	79.3	36.4	33.3	24.9	16.4	23.3	43.2	24.6	21.0	28.6	21.5	18.9	16.5	58.4	70.0	41.0	16.4	21.5	31.3	17.4	40.0	33.9	24.0	25.2	23.1	173.4	34.1	104.7	25.1	25.5	39.4	9.5	28.0	23.9	11.1	27.2	30.3	164.7	20.0	12.2	25.7	25.3	21.4	31.4	27.7	19.6	92.8	45.2	25.5	27.8	115.6	156.4	26.8	22.2	26.7	31.8	16.5	16.1	23.8	25.9	69.1	32.9	27.2	27.4	171.5	75.4	24.0	34.1	80.4	38.9	48.1	27.2	26.2
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	"Predicted secreted proteins"		"Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.0;Late spermatids: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											CAB025366	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB025366: "	"unprognostic (3.21e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.54e-6)"	"unprognostic (5.39e-3)"	"unprognostic (1.01e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	0.6	0.8	2.4	0.4	2.6	0.6	0.5	4.9	2.8	1.1	2.0	1.0	0.5	0.9	1.1	1.0	1.1	0.5	0.8	2.6	2.2	1.7	1.5	0.8	0.5	2.2	2.2	1.2	1.1	0.8	1.5	0.4	2.0	1.2	0.5	1.1	0.7	0.5	0.6	0.7	1.1	0.5	1.9	1.2	1.2	1.2	2.3	0.7	1.5	0.4	0.6	0.8	0.8	2.5	0.7	1.6	0.9	2.3	2.1	1.4	0.5	0.8	0.8	0.9	0.9	1.6	0.5	0.8	1.2	1.0	0.8	1.0	1.5	0.6	1.0	1.2	1.2	0.8	0.9	1.2	1.5	0.7	1.2	1.6	1.8	0.7	1.1	2.4	0.6	1.3	1.0	1.0	1.0	1.2	1.6	1.4	0.9	1.6	1.8	1.3	1.1	0.5	1.5	0.9	1.2	1.9	1.3	1.2	1.1	1.1	1.4	0.8	0.7	1.1	1.0	2.0	0.5	1.8	3.1	0.4	2.0	1.4	1.1	1.3	0.5	0.4	0.4	0.4	0.6	0.4	0.3	0.6	0.2	0.5	0.5	0.5	0.8	0.4	0.7	0.6	0.4	0.4	2.4	2.6	4.9	2.8	2.6	2.2	2.2	2.2	2.0	1.9	2.3	2.5	0.8	0.0	1.7	0.0	0.3	0.6	1.0	1.4	0.0	2.5	2.3	1.5	1.8	0.0	0.5	1.8	0.0	1.1	1.0	4.5	0.0	1.2	8.0	2.4	1.7	1.4	3.0	0.8	0.1	0.2	0.7	1.3	0.0	1.9	1.3	2.2	2.2	2.6	2.2	1.7	0.1	2.0	0.0	1.3	0.6	28.7	0.9	0.7	1.8	1.0	1.5	1.8	1.0	0.0	0.0	0.9	4.2	2.2	1.9	1.5	6.2	3.3	2.2	2.2	0.0	1.2	1.3	1.3	0.9	0.9	1.0	1.4	0.7	1.3	2.9	1.1
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.3;Spermatocytes: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	0.9	2.2	1.3	0.6	1.5	6.1	2.9	1.5	2.2	1.9	0.3	1.6	1.9	1.9	3.5	1.5	1.9	0.7	1.7	1.5	1.6	2.0	4.1	1.0	0.9	1.6	1.5	1.3	2.1	1.1	2.6	1.3	2.5	2.0	1.5	0.5	1.9	1.1	3.5	1.6	1.0	1.9	1.3	1.1	1.3	3.2	1.4	1.8	2.4	0.9	1.2	1.3	1.3	2.8	4.1	3.4	1.7	0.8	1.6	3.2	2.1	2.0	3.5	3.0	3.7	4.6	3.4	4.4	3.9	2.5	2.0	2.3	0.7	3.1	3.4	2.4	8.7	2.7	1.2	4.0	4.3	6.7	3.6	3.3	5.2	2.9	5.2	2.7	2.3	3.9	4.3	6.0	4.3	6.6	2.0	3.9	3.3	1.6	4.3	4.5	3.0	4.4	4.3	2.6	1.6	2.1	3.9	3.8	5.3	1.4	1.8	0.4	3.1	2.8	2.6	1.2	4.5	2.6	1.6	5.8	2.4	4.3	0.9	0.0	5.0	6.0	7.4	3.1	8.8	6.2	5.7	7.0	6.7	5.9	7.5	7.7	0.6	6.8	3.6	6.7	3.8	5.3	1.3	1.5	1.5	2.2	1.5	1.6	1.6	1.5	2.5	1.3	1.4	2.8	3.0	9.6	7.3	14.4	4.6	4.5	5.0	11.0	5.2	8.3	7.1	11.7	5.9	10.0	7.5	5.5	8.4	7.7	8.0	1.6	9.8	4.6	31.3	5.7	5.2	3.2	4.2	3.4	18.8	6.3	3.1	6.0	1.5	11.6	2.5	8.1	3.6	6.3	4.8	5.0	20.3	2.6	14.2	2.1	4.3	5.4	5.3	3.0	5.4	4.7	6.1	8.8	5.2	12.5	29.4	3.7	3.8	5.7	3.3	3.5	3.0	7.7	8.3	11.4	0.0	5.6	8.6	37.5	20.6	5.5	4.7	9.6	6.9	10.8	4.3	3.5
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTAR1		ENSG00000188647	"Protein prenyltransferase alpha subunit repeat containing 1"	Q7Z6K3	9	69709522-69760011	"Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021248	Uncertain		Approved	"Centriolar satellite,Rods & Rings"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Rods & Rings"	"HPA021248: AB_1855872"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.16e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	9.7	6.6	11.8	9.7	9.8	33.8	12.8	9.5	10.9	10.9	11.3	10.6	6.9	11.2	7.4	8.3	9.7	8.0	8.9	10.3	8.6	14.1	13.3	11.3	11.6	12.5	12.0	12.6	11.0	15.4	6.7	9.8	9.2	7.2	12.8	21.4	10.4	5.7	14.4	10.0	10.6	8.4	8.5	11.3	7.6	9.6	16.1	20.1	10.0	11.7	8.9	9.2	10.8	13.5	11.8	11.9	18.7	9.1	16.4	21.2	10.4	27.2	17.5	8.1	8.9	3.8	7.7	12.2	12.5	20.9	8.1	18.0	39.4	10.2	19.3	11.1	10.7	18.8	24.3	10.8	18.0	16.7	16.2	14.1	9.4	14.4	22.7	16.9	14.6	19.9	11.7	24.7	23.3	3.2	14.5	6.5	24.9	12.2	9.9	13.1	29.6	9.2	23.4	10.3	13.7	17.2	16.6	8.0	15.5	17.4	5.5	8.3	27.3	22.3	20.4	18.5	22.3	17.2	18.2	7.4	15.0	16.1	41.6	5.6	2.3	4.2	2.8	3.3	2.6	1.9	2.5	2.2	2.0	1.6	2.8	2.9	7.3	2.9	2.0	1.1	4.3	1.4	11.8	9.8	9.5	10.9	10.3	8.6	12.5	12.0	9.2	8.5	16.1	13.5	26.0	35.3	21.6	104.8	26.3	16.7	19.4	17.7	21.6	29.1	21.1	18.5	19.1	40.0	17.9	33.1	81.3	20.1	28.5	29.2	15.6	13.3	19.2	17.0	24.8	24.5	11.4	23.8	21.7	7.7	14.6	21.6	12.2	16.8	17.7	28.7	20.0	32.6	12.7	33.7	33.0	28.6	36.7	31.1	18.3	22.1	31.1	22.9	32.0	51.5	28.6	31.8	26.8	82.0	62.2	12.5	21.3	23.0	22.1	23.2	14.7	41.4	18.8	56.2	26.3	26.1	21.1	57.0	10.3	19.5	15.3	9.6	26.0	21.6	22.2	25.5
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.2;Inhibitory neurons: 125.8;Oligodendrocyte precursor cells: 203.1;Oligodendrocytes: 625.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RH-30: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	14.8	8.0	19.2	6.0	20.6	15.7	13.5	19.1	25.8	20.8	11.2	33.4	4.2	18.0	5.2	7.9	15.4	5.8	7.8	20.5	21.0	10.7	7.5	8.6	6.0	18.6	21.6	13.1	7.1	2.4	11.4	4.1	19.4	12.4	6.5	14.7	8.2	9.6	11.3	8.6	12.9	13.1	20.4	11.5	12.2	23.7	22.0	10.5	11.9	9.0	4.8	17.5	14.3	25.2	6.6	3.5	27.2	15.4	6.3	6.8	15.1	5.7	6.5	9.7	9.1	4.3	5.7	22.4	6.6	3.4	22.1	3.9	17.8	4.0	14.1	4.1	5.1	12.6	8.4	5.9	3.8	5.9	6.1	4.6	2.7	12.2	4.6	7.5	4.9	10.9	9.3	5.2	13.0	2.1	21.0	18.0	17.2	2.7	7.9	11.3	72.0	3.2	9.6	3.2	16.7	16.8	7.4	4.4	9.5	13.4	4.5	13.4	4.8	5.8	12.6	5.0	7.5	4.5	4.0	25.7	2.9	9.5	2.8	0.3	0.5	0.3	0.8	0.6	0.7	1.2	1.1	0.8	0.3	1.3	1.3	0.9	0.5	1.4	0.7	0.6	1.1	0.2	19.2	20.6	19.1	25.8	20.5	21.0	18.6	21.6	19.4	20.4	22.0	25.2	26.1	9.6	13.9	116.2	16.9	13.9	9.6	4.1	14.2	27.4	14.4	13.8	10.9	10.0	6.0	20.2	14.6	5.6	13.9	3.8	13.7	6.8	4.8	11.5	27.9	16.7	24.5	16.2	126.2	5.1	4.2	20.5	10.7	18.3	7.6	21.4	8.2	8.4	3.3	30.3	125.8	6.2	6.1	13.0	13.9	7.1	9.0	8.5	14.2	102.1	7.1	47.6	10.3	203.1	625.1	4.9	3.9	7.9	14.4	7.3	4.5	9.1	8.1	22.6	6.6	15.0	33.1	79.0	35.4	12.1	7.1	2.1	13.7	11.0	5.5	6.3
PTCD1	KIAA0632	ENSG00000106246	"Pentatricopeptide repeat domain 1"	O75127	7	99416739-99466163	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 29.2"									"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (4.70e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.10e-3)"	3.4	3.6	3.5	2.6	3.5	5.6	3.4	4.2	4.0	3.3	2.8	3.8	2.7	3.7	0.8	4.4	3.8	2.7	4.1	3.2	3.1	3.2	4.7	2.8	3.4	4.1	3.6	3.4	3.6	1.6	2.9	1.8	3.6	4.2	1.3	1.7	3.4	2.1	6.7	4.3	4.0	1.0	3.1	4.9	3.9	4.3	3.6	1.3	3.2	2.6	1.5	3.6	3.4	4.2	4.8	9.8	3.3	9.3	3.1	2.5	9.2	6.6	2.4	4.6	3.3	29.2	5.7	9.6	7.4	1.8	7.7	5.1	4.0	5.9	1.6	7.7	11.2	4.9	8.1	7.2	4.8	5.1	9.0	2.0	3.7	3.8	3.8	3.1	1.4	6.0	10.0	6.4	2.3	13.8	9.0	12.9	6.1	4.8	8.0	5.4	4.3	11.9	2.5	5.1	6.1	6.5	7.4	24.2	6.3	4.7	5.2	5.3	2.7	6.9	8.1	13.7	7.1	9.5	9.1	10.2	7.1	6.7	9.7	1.8	2.0	0.9	3.3	2.3	2.2	1.8	2.1	2.2	1.4	2.5	2.4	3.0	1.9	2.0	1.7	2.1	1.5	1.5	3.5	3.5	4.2	4.0	3.2	3.1	4.1	3.6	3.6	3.1	3.6	4.2	3.5	0.0	5.8	0.0	6.6	6.2	4.0	5.2	4.6	7.9	4.9	4.7	5.8	4.3	4.0	5.5	10.4	9.9	4.1	4.2	1.9	5.3	2.1	4.7	8.6	5.3	7.3	2.5	0.0	6.7	5.6	4.2	3.6	5.2	12.7	12.9	4.6	6.1	6.6	8.4	0.0	6.2	6.1	3.2	6.1	1.8	3.7	3.7	3.6	0.0	3.8	5.6	1.0	0.0	0.0	5.0	2.5	3.0	4.1	3.6	4.5	3.2	5.8	9.3	0.0	8.6	6.7	8.7	7.6	5.1	4.1	5.6	5.7	6.2	6.3	2.6
PTCD2	FLJ12598	ENSG00000049883	"Pentatricopeptide repeat domain 2"	Q8WV60	5	72320367-72368395	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043686	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043686: AB_10962485"	"unprognostic (1.59e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.62e-2)"	"unprognostic (7.60e-4)"	"unprognostic (7.68e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.24e-4)"	"unprognostic (2.53e-1)"	4.0	4.7	3.9	1.7	4.0	1.3	3.1	4.1	4.7	2.5	6.2	2.5	1.0	2.3	3.6	2.9	2.7	2.0	7.4	3.9	3.9	3.8	4.6	1.5	2.3	4.0	4.2	3.1	1.8	4.8	3.1	3.2	4.5	2.4	2.5	4.6	2.1	2.6	8.7	2.9	1.8	2.8	3.6	2.0	2.2	2.1	4.1	2.7	4.0	13.8	2.6	3.1	2.6	4.8	5.1	7.7	4.9	6.0	9.9	8.7	6.2	7.5	4.9	7.4	6.2	6.1	6.0	7.9	10.3	5.0	14.2	3.8	9.5	14.6	7.9	3.6	5.1	5.5	9.7	3.5	14.7	2.7	1.5	9.7	7.6	9.7	20.3	8.4	5.4	11.2	6.5	4.9	11.2	4.7	6.6	6.3	4.6	2.3	6.5	4.6	5.7	17.6	8.6	3.5	5.2	3.5	6.6	4.2	6.8	5.6	11.7	5.5	4.0	3.8	4.3	5.6	7.6	6.3	8.2	5.0	7.3	8.1	7.6	0.0	0.9	0.2	1.1	1.2	1.3	1.1	1.2	1.0	1.9	1.6	1.5	1.9	0.3	3.1	1.4	1.6	2.1	0.6	3.9	4.0	4.1	4.7	3.9	3.9	4.0	4.2	4.5	3.6	4.1	4.8	2.9	3.2	4.8	16.0	5.5	0.8	3.1	3.1	3.4	5.2	3.5	2.7	13.5	4.3	1.8	3.7	25.0	14.9	7.8	1.2	11.7	4.2	0.3	3.0	7.4	4.6	1.2	3.8	10.7	2.3	7.3	5.4	1.5	2.8	1.3	8.6	3.3	8.4	4.6	5.0	10.2	2.1	6.1	4.4	1.3	1.4	4.1	3.3	0.0	8.4	4.8	8.3	7.2	12.1	19.2	2.7	1.1	4.9	1.5	1.5	3.2	5.5	3.1	14.8	0.0	5.3	4.9	4.9	8.6	4.2	0.1	7.1	4.4	9.9	3.6	1.7
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106223-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (6.86e-4)"	10.0	15.8	13.1	7.6	14.2	14.7	9.9	15.2	15.9	11.6	16.3	12.6	10.1	11.7	10.2	10.7	11.7	6.4	26.2	13.3	14.5	12.4	16.5	9.6	11.8	13.6	14.0	15.1	10.7	13.1	14.8	9.2	14.7	10.4	13.5	13.2	9.8	7.5	32.8	10.3	11.9	9.0	13.7	12.0	11.8	16.6	13.5	10.5	12.0	36.3	11.1	10.3	10.7	16.7	16.2	37.6	22.0	18.5	16.1	16.6	26.2	32.6	13.8	18.0	18.0	69.9	15.1	39.7	11.8	17.1	18.6	28.9	44.7	17.7	22.9	17.8	37.0	31.8	23.0	59.2	16.3	26.0	23.1	19.8	12.8	13.7	24.4	18.8	15.7	28.6	33.5	14.8	16.0	15.0	21.7	31.0	20.2	31.5	23.9	28.8	30.9	30.6	24.6	31.7	23.9	14.7	15.2	25.0	30.4	20.6	13.2	15.7	11.3	14.2	15.1	14.6	19.2	33.7	47.6	31.6	13.8	29.4	11.1	4.4	9.6	7.6	12.4	7.0	14.6	15.3	11.2	13.2	10.6	16.4	15.1	11.3	0.3	14.3	14.1	10.7	13.9	8.8	13.1	14.2	15.2	15.9	13.3	14.5	13.6	14.0	14.7	13.7	13.5	16.7	17.1	57.7	33.5	50.3	31.0	26.0	26.3	27.7	34.7	61.7	19.2	16.8	105.7	18.6	37.4	23.9	66.7	53.0	30.6	21.7	25.4	18.8	34.8	27.5	33.3	23.5	31.1	39.5	52.9	11.9	27.0	30.5	30.1	24.2	33.6	47.5	21.4	41.7	21.7	37.0	53.1	25.3	20.3	19.6	13.3	22.4	27.1	17.7	8.8	21.5	22.7	49.8	28.8	48.7	53.4	15.0	19.2	19.5	26.4	23.7	23.2	30.1	26.2	65.3	13.1	36.3	21.3	98.3	62.4	28.7	24.7	36.7	31.8	47.9	38.5	20.4
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 6.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 29.6;WM-115: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	3.0	3.5	9.5	4.0	11.6	0.7	2.8	24.6	5.6	26.7	2.7	11.3	8.1	15.6	2.7	2.9	7.1	8.1	2.9	4.7	17.8	4.6	2.2	5.5	2.2	16.0	12.7	5.0	6.4	2.5	2.1	3.8	8.0	6.8	12.3	8.3	7.5	4.0	3.0	3.2	11.6	2.4	7.0	3.3	12.5	14.5	24.0	2.1	4.7	4.8	3.0	7.2	2.9	4.5	10.1	4.7	20.3	12.9	3.0	5.0	11.4	1.9	1.7	2.2	1.4	4.9	4.8	8.0	3.3	3.8	4.4	22.3	11.7	1.6	1.4	7.9	7.8	0.0	4.8	2.3	2.7	0.2	4.2	4.7	2.4	2.2	1.4	4.3	4.2	3.5	7.3	9.1	1.0	1.9	0.1	3.2	29.6	7.2	1.8	0.0	15.5	4.2	1.6	1.5	13.8	7.0	7.1	6.8	2.9	18.8	1.8	2.1	1.1	2.6	12.9	13.6	1.5	18.0	16.8	5.3	3.8	3.9	71.0	0.0	0.0	0.0	6.1	0.0	3.3	0.7	1.1	2.5	0.0	0.2	1.9	2.2	0.0	0.3	0.0	0.0	1.2	1.7	9.5	11.6	24.6	5.6	4.7	17.8	16.0	12.7	8.0	7.0	24.0	4.5	6.0	0.0	6.4	49.0	3.0	4.0	2.7	3.0	4.6	20.3	3.5	4.6	5.9	25.8	2.7	0.0	41.7	3.0	11.8	2.0	5.9	3.5	88.4	12.2	89.8	5.4	21.7	0.4	15.2	4.2	1.9	27.2	1.1	11.0	1.3	2.6	6.4	2.9	0.8	20.2	10.7	11.0	4.1	0.9	1.2	237.5	191.0	1.4	12.4	4.7	0.8	55.6	54.6	39.7	20.5	2.4	3.1	444.5	3.1	4.9	3.1	1.6	5.5	13.4	39.5	4.8	9.4	4.4	35.5	3.0	4.4	1.4	6.5	71.7	4.7	1.4
PTCHD1	FLJ30296	ENSG00000165186	"Patched domain containing 1"	Q96NR3	X	23334849-23404374	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Autism, Autism spectrum disorder"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;intestine: 6.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.6;Breast glandular cells: 9.6;Excitatory neurons: 22.0;Sertoli cells: 13.1;Skeletal myocytes: 11.9"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;RT4: 1.6;WM-115: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046110	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046110: AB_2679541"	"unprognostic (1.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.68e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	0.4	0.6	3.2	0.1	3.2	0.1	2.1	15.2	3.1	2.2	0.0	6.2	0.3	2.8	0.5	1.3	0.3	0.1	0.1	3.0	4.1	0.1	0.0	0.2	0.0	4.0	4.4	0.1	0.0	0.0	0.8	0.0	4.4	1.3	0.8	0.4	0.9	4.0	0.2	0.1	0.9	1.7	1.6	0.3	1.7	0.2	4.4	0.0	0.4	0.1	0.0	1.8	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.2	15.2	3.1	3.0	4.1	4.0	4.4	4.4	1.6	4.4	1.4	0.3	0.0	2.0	34.6	0.5	0.3	2.3	0.0	0.0	3.7	9.6	4.2	1.9	0.0	1.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.1	1.0	0.4	1.8	0.0	22.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	1.1	0.8	6.5	0.3	0.0	1.9	0.1	1.7	0.0	2.5	0.4	0.0	0.0	0.4	0.0	7.7	0.0	0.2	1.5	0.4	13.1	11.9	1.5	0.5	1.7	0.0	0.0	2.2	0.1	0.2	0.0	0.7
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.5	0.1	0.6	0.0	0.6	0.0	0.3	0.0	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.2	0.5	0.8	0.5	0.4	0.3	0.5	0.0	0.2	1.0	0.2	0.2	0.0	0.9	0.3	0.0	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.2	0.3	0.0	0.8	0.1	0.0	0.3	0.3	0.4	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.5	0.8	0.5	0.2	1.0	0.0	0.5	0.3	0.4	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261902-96336995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	1.6	2.2	1.6	3.4	2.0	4.9	3.1	1.2	2.6	3.5	0.8	3.4	4.1	2.1	2.8	3.7	2.5	3.1	7.2	1.8	1.0	3.7	4.6	2.6	5.6	0.5	0.6	3.6	2.7	8.0	0.6	4.6	1.3	1.9	2.9	0.9	2.0	3.5	2.9	3.2	3.2	3.6	0.2	2.6	1.4	1.9	2.0	3.6	4.5	3.0	5.2	2.6	1.1	1.4	14.9	11.6	2.0	5.5	4.2	8.5	3.4	10.6	15.5	10.6	7.5	4.6	4.2	24.9	9.5	10.5	2.1	6.0	14.1	11.1	16.1	12.5	10.3	24.5	19.8	2.5	4.3	17.8	8.1	7.2	10.9	14.4	10.2	2.7	7.0	7.6	12.5	12.3	9.7	4.4	14.0	3.0	3.1	5.1	11.1	10.9	10.1	18.8	5.7	12.5	8.6	3.5	3.9	3.4	1.4	2.3	8.2	6.3	11.8	9.1	5.5	6.3	12.3	2.5	13.3	11.8	5.7	19.3	7.5	10.5	2.6	1.5	1.7	1.6	2.5	1.7	2.8	2.2	4.0	2.2	2.5	1.8	0.9	3.2	1.7	1.2	1.7	6.7	1.6	2.0	1.2	2.6	1.8	1.0	0.5	0.6	1.3	0.2	2.0	1.4	12.4	19.2	9.1	8.8	50.5	31.6	18.9	22.6	42.7	10.2	22.9	18.4	94.5	14.3	15.6	11.0	10.4	78.4	23.6	11.9	1.9	20.5	60.1	6.6	9.1	22.9	5.4	38.3	29.3	44.9	54.1	18.0	14.8	9.3	32.4	17.6	34.2	32.1	45.9	5.0	29.2	17.1	10.2	45.3	31.5	52.2	23.3	36.0	19.6	15.9	39.3	4.7	29.9	21.1	8.7	23.9	11.9	25.9	45.5	21.4	16.6	19.0	5.2	4.7	0.0	13.8	15.8	12.1	18.8	33.1	33.5	80.9	34.3	14.6	34.8	16.3
PTDSS2	PSS2	ENSG00000174915	"Phosphatidylserine synthase 2"	Q9BVG9	11	448268-491399	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 144.6;Late spermatids: 347.6;Spermatocytes: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEK 293: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038928, HPA038929"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038928: AB_10672832, HPA038929: AB_2676274"	"unprognostic (3.41e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.75e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (6.18e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	13.8	21.3	6.2	2.2	9.6	2.2	12.5	8.6	8.6	16.3	8.4	15.4	1.5	15.4	3.7	12.0	14.7	3.9	25.2	6.3	6.1	21.0	13.5	12.8	2.3	10.6	9.1	21.9	18.9	13.6	13.7	5.8	8.1	17.0	2.2	3.1	11.4	5.2	17.7	11.9	10.4	4.9	6.7	12.6	15.5	47.2	8.4	3.3	17.4	5.5	2.0	14.2	12.0	12.6	15.7	15.6	12.8	18.5	11.0	18.2	15.9	13.1	15.5	16.7	14.7	4.1	10.5	8.3	11.0	17.0	15.1	25.4	15.7	20.8	8.0	13.9	67.2	10.5	11.9	9.6	21.3	13.9	8.8	20.8	15.2	5.8	10.1	14.6	13.2	9.8	30.9	2.5	13.3	2.2	13.9	13.3	18.1	12.4	36.8	14.7	14.4	4.1	11.9	3.1	19.3	10.6	18.4	11.9	15.2	13.9	4.3	8.1	16.1	7.7	5.1	3.9	8.5	10.3	4.8	3.6	13.5	6.4	5.6	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	6.2	9.6	8.6	8.6	6.3	6.1	10.6	9.1	8.1	6.7	8.4	12.6	10.3	0.0	6.1	18.6	6.2	4.8	8.3	6.1	6.2	36.9	11.1	11.0	20.1	5.7	6.7	7.3	29.2	19.6	3.0	12.5	5.9	13.3	144.6	7.1	11.1	11.4	16.1	8.2	21.1	13.1	21.3	12.9	9.7	7.5	0.0	30.1	9.3	6.0	17.2	21.9	17.8	7.6	8.2	4.7	4.2	347.6	17.1	6.9	5.4	5.6	5.8	22.7	2.1	18.6	26.8	11.7	6.9	15.4	9.5	10.5	7.0	17.7	4.9	29.8	6.6	11.3	12.9	98.2	24.7	8.2	5.1	17.4	4.9	34.1	9.0	6.1
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	6.8	5.5	6.9	5.6	16.5	2.3	10.3	1.0	8.7	5.9	0.0	8.3	12.7	4.9	4.4	4.5	5.1	5.3	7.1	14.1	1.3	31.5	14.0	6.0	7.9	0.0	0.0	2.0	7.5	9.2	1.3	5.6	0.0	7.1	8.0	11.8	8.3	4.6	9.2	5.4	10.0	3.3	0.0	6.9	14.1	1.1	0.8	7.3	10.6	10.0	7.9	9.0	3.7	0.0	26.9	11.7	0.1	4.8	7.0	13.0	14.7	6.9	0.7	2.6	3.5	10.7	20.9	25.0	5.9	4.5	1.2	11.4	8.3	4.3	4.3	30.2	9.9	24.9	6.1	5.6	7.2	8.2	8.0	8.2	17.0	8.0	1.3	0.1	1.5	22.9	17.5	8.4	4.1	7.8	17.8	9.5	5.7	15.9	2.5	13.7	2.4	13.1	43.2	6.4	22.7	1.4	12.5	3.7	23.3	5.2	8.6	30.4	3.4	0.2	6.3	5.5	0.1	6.3	7.6	25.2	3.3	14.7	8.7	3.4	7.2	4.7	7.5	11.6	8.1	9.2	8.8	8.1	7.6	5.8	6.8	7.1	2.2	5.6	10.3	6.7	14.2	5.9	6.9	16.5	1.0	8.7	14.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	12.1	28.9	26.3	2.9	13.5	11.0	14.7	7.7	9.6	0.9	13.6	9.4	29.5	15.7	20.6	29.5	0.0	19.6	10.2	19.5	52.8	22.5	0.3	10.7	5.5	8.3	11.5	9.4	0.5	34.4	18.7	10.2	41.8	17.8	24.1	5.1	11.4	24.3	15.6	0.0	0.2	13.1	18.3	17.1	6.5	0.3	0.9	12.3	8.8	10.3	14.6	13.9	33.0	0.0	0.2	26.8	26.7	0.0	8.1	11.4	19.8	190.5	14.4	9.9	6.6	7.7	16.0	1.1	6.5	7.6	12.4	12.0	13.2	3.0	19.2	22.2
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 68.0;NK-cell: 90.3"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.3;T-cells: 68.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA049668	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	2.0	0.5	0.2	2.1	1.7	1.4	1.2	0.8	0.7	2.1	2.6	5.6	0.7	1.5	1.0	0.4	1.3	1.6	1.9	0.1	0.3	0.5	1.1	1.7	3.2	2.4	0.6	0.8	0.3	0.4	2.1	0.2	0.4	0.8	7.9	0.0	1.1	0.4	0.6	0.6	1.4	0.8	1.5	6.3	1.3	0.2	0.4	0.9	1.1	0.4	1.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	68.0	0.0	33.5	0.1	9.0	40.9	0.1	0.0	1.4	22.5	2.3	90.3	0.4	0.2	0.2	12.9	0.2	1.7	0.8	0.7	0.1	0.3	2.4	0.6	0.4	1.5	0.4	0.1	2.9	3.2	0.0	0.0	0.9	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	50.6	3.2	0.0	0.0	0.0	0.2	0.1	2.0	1.2	2.7	0.2	0.0	0.0	1.5	1.1	0.1	1.3	0.2	2.2	0.5	0.1	0.0	0.2	7.5	0.0	1.9	0.4	0.0	0.0	4.6	1.8	1.0	0.4	0.0	187.4	0.0	0.1	0.0	2.8	0.0	4.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.1	0.0	31.4	2.2	14.6	0.0
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850933-60855950	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2;intestine: 8.2;stomach 1: 9.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 178.1;eosinophil: 234.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 234.1"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014259: AB_1849304"	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	0.6	0.0	4.3	0.6	4.2	0.0	0.6	3.3	11.2	0.4	2.3	8.2	4.4	0.4	0.2	0.8	0.6	0.5	6.7	3.4	3.6	0.1	0.5	0.6	0.1	3.7	4.2	0.1	0.5	3.4	0.3	1.0	3.9	0.5	4.1	0.1	0.1	0.1	7.3	0.4	6.9	0.3	3.0	0.5	9.3	0.3	4.2	5.0	0.1	3.9	0.1	0.5	0.2	3.4	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	4.8	1.0	0.0	5.9	1.9	0.1	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	3.1	14.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	178.1	0.1	234.1	0.0	10.9	0.0	0.0	1.5	1.1	5.2	0.0	0.0	0.0	0.7	0.1	35.8	1.1	1.6	2.3	4.3	4.2	3.3	11.2	3.4	3.6	3.7	4.2	3.9	3.0	4.2	3.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	1.2	0.0	0.2	0.0	0.0	4.1	0.5	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	2.4	0.0	0.3	0.5	0.0	1.9	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	6.8	0.1	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 4898.3;testis: 3242.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 38051.3;Peritubular cells: 65156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	27	"plasmacytoid DC: 1386.8"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 1386.8"	"Group enriched"	"Detected in some"	6	"HHSteC: 518.7;HSkMC: 252.0"									"HPA004938, CAB009916, HPA067456"	Uncertain				"Secreted to blood"	NA	NA		2500000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"CAB009916: AB_2174617, HPA004938: AB_1855745, HPA067456: "	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	391.1	297.1	1849.2	247.1	2423.8	9.9	121.1	2440.1	2559.6	1675.5	1508.4	84.8	31.5	320.4	735.9	172.5	492.1	396.7	4898.3	1760.9	2034.8	466.5	80.2	607.8	824.1	2339.4	2228.2	66.8	113.2	9.1	398.4	227.8	2318.0	727.0	17.7	146.1	97.8	813.1	108.3	164.9	205.9	99.7	1999.6	317.5	93.0	3242.2	2264.9	127.4	55.1	60.0	306.0	230.3	1181.0	2580.3	0.1	0.0	0.1	0.0	5.4	16.7	8.8	0.3	0.0	0.0	0.0	0.0	0.2	0.6	4.0	24.0	0.0	0.8	0.6	0.2	0.0	0.0	0.0	0.0	1.4	0.3	518.7	0.3	1.3	252.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.0	0.2	0.0	0.0	6.6	0.9	8.2	0.0	0.1	0.2	1.6	0.0	0.0	1.6	2.0	0.0	0.6	0.0	0.1	0.6	68.3	0.7	0.2	0.2	2.1	0.1	0.3	0.0	0.1	3.9	0.0	0.9	0.0	0.3	0.4	50.5	1.0	3.4	0.3	4.3	6.3	1.8	0.2	0.9	9.9	2.3	3.8	0.2	1386.8	1.4	11.2	1849.2	2423.8	2440.1	2559.6	1760.9	2034.8	2339.4	2228.2	2318.0	1999.6	2264.9	2580.3	29.3	0.0	0.6	665.0	1.5	70.4	3.2	0.1	5.7	46.8	6.6	14.7	333.6	8.6	0.1	138.0	52.1	14.4	1863.6	0.2	68.4	0.3	215.9	29.7	1156.5	167.8	0.0	13.5	4.0	0.0	55.0	1584.0	1.1	20.1	1.3	0.3	46.1	1.6	57.3	21.9	12.8	0.0	0.0	3.4	161.8	1230.9	38051.3	57.0	209.9	176.1	4.6	4625.8	583.9	63.3	850.4	1.7	0.0	65156.8	6.0	20.7	0.0	1.1	0.0	130.3	164.3	787.4	124.8	130.7	111.1	12.0	80.1	35.4	61.3	0.1	0.0	14.5
PTGER3	"EP3, lnc003875"	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 95.2;kidney: 81.2;smooth muscle: 68.0"	"Group enriched"	"Detected in many"	7	"Distal tubular cells: 225.0;Langerhans cells: 79.8"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	59	"basophil: 43.3"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 43.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.6;HAP1: 20.9;HDLM-2: 32.8;HEL: 15.6;T-47d: 72.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	54.5	6.7	7.1	5.0	4.3	0.2	28.6	0.0	8.5	4.7	10.4	13.9	1.2	95.2	3.7	3.9	10.1	8.9	1.6	4.7	10.9	81.2	0.3	1.0	1.3	5.6	0.6	1.7	6.6	0.9	0.6	0.6	3.2	3.0	2.3	0.7	11.9	7.9	0.4	13.8	3.7	68.0	2.4	0.3	22.4	1.0	4.7	0.9	1.0	1.4	1.4	6.6	6.1	1.1	0.0	0.0	0.0	0.0	28.6	0.7	0.1	0.7	0.0	0.1	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	20.9	0.0	0.1	32.8	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.1	0.0	0.3	0.0	0.2	72.5	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	43.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	7.1	4.3	0.0	8.5	4.7	10.9	5.6	0.6	3.2	2.4	4.7	1.1	6.9	0.0	0.5	0.0	0.0	5.0	0.2	0.0	0.0	1.6	13.7	6.1	1.8	1.5	0.0	20.2	0.0	0.0	0.2	0.4	225.0	3.0	1.6	0.6	4.6	1.7	2.4	0.0	2.2	0.0	2.4	12.2	1.5	1.2	9.5	0.0	0.7	0.0	0.1	3.3	3.4	1.0	12.2	0.0	79.8	1.0	1.2	3.2	8.8	0.0	0.6	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	1.3	0.1	7.2	0.0	0.2	6.6	0.5	11.7	0.1	0.1	0.1	7.5	0.1	1.2	6.2	0.0	0.2
PTGER4	EP4	ENSG00000171522	"Prostaglandin E receptor 4"	P35408	5	40679915-40693735	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.7;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 134.8;Langerhans cells: 130.7;Macrophages: 90.2;T-cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.2;HUVEC TERT2: 28.7;LHCN-M2: 27.6;RT4: 43.1;THP-1: 27.4;TIME: 54.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011226, HPA012756"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA011226: AB_1855885, HPA012756: AB_1855884"	"unprognostic (1.79e-2)"	"unprognostic (6.53e-3)"	"unprognostic (9.43e-3)"	"unprognostic (6.77e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.48e-4)"	11.7	9.7	0.7	15.1	0.5	85.7	6.3	0.9	1.0	3.1	1.1	20.3	20.6	2.7	1.2	5.6	12.1	11.2	6.4	0.8	0.8	8.5	4.1	18.3	15.4	1.8	2.4	1.2	54.2	1.0	1.1	3.0	1.7	3.0	17.0	0.1	3.5	2.5	3.9	3.8	24.8	5.9	1.7	12.5	19.7	2.9	1.0	19.4	2.8	6.8	9.3	11.6	2.4	3.3	3.7	0.8	0.0	0.1	16.7	19.7	0.1	0.3	1.4	1.0	0.7	0.0	1.1	0.4	0.3	0.0	17.5	2.8	0.2	6.7	1.7	43.2	0.8	0.0	1.5	0.0	15.1	15.2	3.0	2.1	1.0	10.2	4.1	2.3	28.7	14.7	0.0	10.2	27.6	0.0	16.3	7.0	0.1	0.7	6.5	10.7	2.7	1.4	3.9	43.1	0.0	0.0	0.6	1.3	0.1	0.6	6.6	27.4	54.0	5.5	0.0	0.1	1.3	0.1	0.3	2.0	2.4	11.3	1.5	5.3	7.1	14.6	15.8	19.0	9.0	1.8	9.5	9.9	8.1	1.6	5.7	8.1	12.8	3.8	24.7	1.1	8.4	7.3	0.7	0.5	0.9	1.0	0.8	0.8	1.8	2.4	1.7	1.7	1.0	3.3	44.5	12.8	9.0	1.3	46.4	61.2	5.8	16.2	22.8	0.0	9.4	9.1	3.9	0.0	10.2	7.3	0.0	0.2	134.8	45.7	0.0	0.9	3.7	1.6	1.4	18.0	13.1	2.5	2.8	7.7	0.9	30.0	29.6	2.2	10.1	4.6	3.6	0.8	29.5	0.0	3.4	53.8	4.1	49.7	130.7	1.8	0.9	90.2	19.6	3.7	48.8	0.1	57.7	1.5	7.1	2.9	28.1	0.4	38.6	6.7	16.3	0.1	13.0	0.3	0.0	39.1	11.8	7.1	1.0	17.5	30.4	0.3	214.9	0.1	31.4	1.4
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753042	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 84.2;urinary bladder: 78.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.2;Cytotrophoblasts: 146.0;Extravillous trophoblasts: 293.1;Syncytiotrophoblasts: 276.2"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 69.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 28.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.7;BEWO: 162.7;GAMG: 292.8;HaCaT: 216.3;SK-BR-3: 157.6;U-2197: 404.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	36.7	1.4	4.1	13.9	3.6	7.8	25.5	3.9	4.5	26.1	3.5	9.2	2.8	3.7	19.0	17.8	5.4	9.0	8.5	4.5	5.1	8.1	0.7	7.8	7.6	6.1	5.8	2.2	1.6	42.1	1.9	58.4	7.1	13.7	4.2	0.0	30.8	84.2	1.3	42.3	9.1	4.1	4.1	2.5	7.1	16.9	4.7	4.2	3.7	1.1	30.7	78.6	20.0	3.5	1.5	94.9	0.1	46.6	147.7	51.9	162.7	7.4	64.2	1.1	1.7	5.6	71.7	0.1	2.7	18.0	292.8	216.3	0.7	7.2	0.6	0.3	0.5	0.0	62.5	0.4	3.5	0.0	0.0	30.9	49.0	0.9	0.3	1.4	0.0	0.9	0.0	0.1	0.7	1.7	0.2	0.0	1.2	46.7	8.2	0.2	0.0	0.3	5.3	102.2	0.8	3.6	87.1	157.6	0.8	6.3	83.3	0.0	0.5	0.1	0.4	404.8	0.0	0.0	0.0	0.0	78.8	0.1	0.7	28.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	4.0	0.0	0.0	0.3	4.1	3.6	3.9	4.5	4.5	5.1	6.1	5.8	7.1	4.1	4.7	3.5	3.4	0.0	0.0	0.3	0.3	17.8	8.9	101.2	10.8	0.0	29.7	19.7	0.1	0.0	53.2	3.7	0.0	146.0	0.6	0.0	1.9	13.4	0.6	1.6	2.3	4.0	7.3	0.0	1.0	1.1	293.1	70.7	0.0	5.0	1.3	61.5	0.0	0.0	17.5	0.0	2.8	6.6	30.5	0.0	21.6	0.4	0.3	13.2	14.2	7.5	7.2	0.0	0.0	0.0	0.2	8.1	0.2	0.0	0.3	8.2	0.3	0.5	6.7	0.0	0.0	0.8	13.5	0.3	0.0	5.5	43.0	276.2	0.8	0.2	0.4	49.2
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	18.1	49.8	31.6	15.6	33.9	6.5	16.0	29.1	45.8	18.1	32.4	30.6	27.5	21.6	4.0	35.3	17.6	11.4	95.0	35.6	33.0	36.4	37.7	14.8	17.6	31.5	31.5	16.1	37.6	35.2	41.4	9.7	32.1	24.6	9.2	10.0	26.1	16.8	117.9	20.9	23.8	7.5	27.3	21.1	29.6	14.5	31.5	11.9	23.5	78.7	9.7	22.3	22.0	31.7	46.1	114.0	15.5	54.4	13.5	12.8	47.9	30.7	20.6	48.6	24.9	86.9	75.6	43.5	45.7	15.9	36.9	108.8	22.5	47.1	6.5	28.3	62.3	21.0	92.7	79.5	41.0	42.1	39.5	18.6	32.3	39.5	26.9	14.2	31.6	47.8	50.2	26.4	16.7	130.0	56.9	75.6	42.7	58.7	113.9	39.6	26.5	111.6	32.8	33.1	69.1	45.6	47.3	86.3	34.2	6.7	78.7	23.5	34.0	46.3	50.2	62.8	63.1	48.9	25.5	38.3	39.1	33.2	44.5	1.4	3.3	0.7	3.1	3.7	3.8	3.8	2.2	3.5	4.3	2.7	2.4	3.0	0.6	2.7	1.8	5.8	3.1	1.9	31.6	33.9	29.1	45.8	35.6	33.0	31.5	31.5	32.1	27.3	31.5	31.7	18.8	16.0	6.4	10.4	32.0	22.9	38.1	32.7	25.0	37.8	34.2	36.3	700.2	51.5	25.9	23.9	20.9	82.1	30.8	86.1	146.8	74.6	2.1	12.7	20.9	29.4	45.1	13.2	15.5	51.8	62.1	32.7	46.4	17.3	14.7	31.9	13.9	37.8	57.6	37.0	15.8	62.2	46.8	25.3	43.6	4.8	30.7	30.8	56.9	3.7	105.7	21.9	38.1	12.1	7.2	57.6	60.4	21.8	45.4	68.0	93.4	99.3	9.3	44.8	19.7	17.8	37.2	3.6	45.6	48.3	24.6	66.6	25.6	84.1	105.5	52.9
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.3;tongue: 10.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;granulocytes: 3.8;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.9;THP-1: 10.8"									"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.4	0.2	0.1	0.8	1.0	0.7	0.4	0.0	0.8	0.7	0.2	4.3	0.8	3.2	0.4	1.1	1.0	0.8	3.0	0.3	0.3	0.3	0.2	0.4	0.2	0.1	0.1	0.3	0.3	0.3	1.2	0.2	0.0	1.3	1.8	0.6	0.6	1.7	17.3	0.3	1.2	5.6	0.0	0.2	1.5	3.3	0.0	0.2	0.3	10.6	0.2	1.9	0.6	0.3	0.6	0.0	1.7	1.8	0.1	0.0	0.4	1.2	1.5	0.8	0.7	1.2	0.1	0.1	1.2	0.2	0.5	0.0	0.3	0.8	1.2	0.7	0.2	4.1	1.7	2.5	0.0	0.5	2.7	0.0	0.5	1.3	0.0	0.5	0.3	1.1	1.3	0.3	1.6	0.0	1.4	0.4	0.4	2.5	0.4	0.7	4.9	0.5	0.2	0.3	0.8	2.4	1.0	0.3	1.1	2.3	0.5	10.8	0.0	0.5	0.9	0.0	0.4	2.9	0.8	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.0	0.0	0.8	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116909916-116990353	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.2;Cardiomyocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 146.8;WM-115: 111.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved					NA	NA		340000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA017074: AB_1855888"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-2)"	11.6	21.1	3.2	10.1	3.5	0.0	10.6	3.3	4.8	14.9	8.3	40.6	11.3	31.2	10.6	21.2	23.9	17.2	48.8	3.3	2.6	4.0	6.6	6.6	2.5	2.8	4.5	15.9	13.3	6.3	2.9	5.0	2.2	18.0	21.7	1.4	18.5	23.6	2.9	17.8	14.0	46.6	4.6	3.1	10.5	5.3	4.1	5.3	6.9	3.9	6.2	20.1	15.1	3.2	40.0	10.3	18.4	42.8	3.2	8.3	2.6	2.8	4.4	15.4	5.8	7.2	8.7	0.0	35.7	10.6	12.7	69.7	41.4	74.4	9.7	0.4	25.1	2.9	24.0	11.1	1.1	0.1	3.9	37.3	66.0	2.0	36.4	21.9	30.0	4.2	16.5	0.2	23.5	50.9	0.0	5.5	21.5	3.3	0.1	0.0	100.6	0.2	51.3	32.4	9.0	20.8	80.0	55.9	22.9	32.1	48.8	12.3	77.6	22.4	33.2	37.2	25.1	0.0	0.1	0.1	146.8	0.0	111.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.5	3.3	4.8	3.3	2.6	2.8	4.5	2.2	4.6	4.1	3.2	2.3	3.2	5.9	15.0	0.5	66.2	13.4	25.6	22.2	6.5	10.9	11.9	79.4	10.0	12.2	3.7	0.0	0.8	0.3	20.6	1.9	31.2	4.8	10.2	19.3	12.1	13.9	0.0	13.6	31.8	5.5	32.0	10.7	16.9	0.0	22.1	3.9	11.1	4.4	0.0	7.4	18.2	14.2	8.8	9.7	6.3	19.3	4.7	8.8	3.7	3.1	1.2	0.0	31.2	0.9	27.9	11.1	30.1	0.0	15.1	15.8	1.2	13.6	0.2	19.7	48.5	12.5	0.8	5.2	20.3	45.3	0.8	1.4	28.3	26.3	17.4
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 80.7;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	43.2	4.7	0.7	9.0	2.5	0.3	24.0	0.3	1.9	29.5	1.8	38.9	3.2	79.0	16.1	16.5	80.7	31.3	40.4	0.5	0.8	4.0	6.0	18.2	0.7	0.6	0.4	38.1	2.5	0.3	0.9	1.1	0.4	22.2	6.6	0.2	7.6	8.3	4.0	7.2	10.5	40.5	0.6	0.5	17.9	5.1	1.0	0.3	7.8	2.4	0.8	81.7	18.2	0.6	0.0	0.1	1.9	0.1	45.1	45.2	0.5	1.0	5.7	0.2	0.0	0.0	0.0	0.1	18.4	13.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	3.3	0.0	0.6	0.0	15.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.2	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.2	0.0	8.2	0.1	0.0	0.0	0.8	2.4	143.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.7	2.5	0.3	1.9	0.5	0.8	0.6	0.4	0.4	0.6	1.0	0.6	5.3	3.2	2.7	0.0	0.0	3.7	0.7	0.0	0.0	1.1	2.2	1.3	5.0	2.8	1.9	3.7	0.0	0.3	0.3	0.0	0.0	0.6	1.8	0.0	0.9	28.1	0.0	2.7	2.7	0.0	0.2	70.8	1.5	0.1	0.0	25.0	117.8	1.0	0.3	0.0	2.4	0.0	0.0	3.1	6.7	3.3	26.8	1.0	1.8	6.5	0.1	0.4	0.0	1.0	0.2	1.2	0.0	104.9	0.3	0.4	0.0	0.2	2.2	4.5	0.0	7.9	3.5	0.7	1.4	0.5	4.8	0.3	1.0	0.5	0.0	0.6
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599893	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 278.5;liver: 594.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 5.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.9"	"Cell line enhanced"	"Detected in many"		"OE19: 909.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		2400000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	44.9	87.7	14.6	11.5	16.3	3.0	37.2	15.4	21.6	35.9	16.7	37.4	232.9	32.4	39.1	112.0	71.5	75.3	29.2	22.6	16.0	234.3	594.1	22.1	7.3	13.0	14.4	25.1	16.7	43.9	23.3	15.3	13.4	60.4	33.9	22.6	47.5	31.1	13.0	31.0	278.5	38.1	11.8	7.9	86.0	8.3	16.4	6.4	27.9	29.0	31.6	88.8	44.4	14.4	49.1	207.1	60.6	0.1	220.1	220.4	45.1	79.4	121.8	74.4	81.2	52.9	67.4	0.1	22.9	78.0	153.9	60.7	47.5	83.4	90.3	0.1	15.4	12.5	129.3	279.0	50.4	7.4	25.6	157.3	127.3	99.8	51.1	88.2	201.0	0.0	8.7	0.1	148.5	16.1	0.4	2.0	22.8	909.3	49.8	0.2	17.1	1.4	82.8	152.8	68.4	3.4	98.9	30.0	31.7	59.6	94.6	34.8	161.8	15.4	29.3	169.7	15.0	0.1	0.5	0.3	72.0	0.1	18.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.3	14.6	16.3	15.4	21.6	22.6	16.0	13.0	14.4	13.4	11.8	16.4	14.4	28.9	19.2	28.3	16.6	4.3	38.6	57.6	135.5	66.6	18.7	43.7	41.4	37.4	271.7	78.4	141.6	25.0	47.0	6.4	34.4	150.6	73.4	4.2	100.3	36.2	26.1	26.5	18.7	38.4	178.3	32.5	48.6	174.3	89.3	1.3	35.0	49.6	791.5	53.4	0.0	31.2	76.1	59.0	26.8	16.7	3.6	33.2	15.9	35.6	12.2	22.6	47.0	0.0	17.1	16.1	139.6	86.3	39.5	0.5	63.8	1230.1	581.3	80.3	46.4	13.1	17.4	61.8	15.2	5.3	242.9	30.5	20.5	5.8	46.8	145.9	156.5
PTGR2	"FLJ39091, ZADH1"	ENSG00000140043	"Prostaglandin reductase 2"	Q8N8N7	14	73851844-73886827	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 41.9"									HPA001125	Approved		Approved	Vesicles		NA	NA		36000	"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA001125: AB_2666207"	"unprognostic (3.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.10e-3)"	"unprognostic (6.99e-3)"	"unprognostic (5.96e-1)"	"prognostic favorable (4.55e-12)"	"unprognostic (4.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	6.9	12.2	10.4	2.8	11.5	0.9	9.1	11.1	12.1	4.8	11.6	7.2	12.1	4.6	17.2	5.0	12.0	5.2	27.1	9.9	11.7	18.9	19.1	5.6	3.1	11.8	11.9	7.4	5.3	10.6	7.6	2.4	12.1	9.1	5.7	10.7	6.7	5.4	32.8	6.9	8.9	2.6	11.3	3.4	6.2	6.2	10.6	3.0	12.6	32.1	2.6	4.2	4.1	13.9	8.9	11.9	9.6	4.7	7.6	16.3	7.6	3.0	4.1	3.6	5.6	6.8	21.2	0.9	6.8	3.0	8.4	8.8	8.7	6.5	6.6	6.7	4.1	6.2	5.5	3.0	3.8	2.3	2.2	7.7	15.1	5.5	4.4	7.8	1.8	6.1	8.3	1.8	8.2	12.7	6.2	5.9	10.7	11.9	11.6	7.6	3.7	1.5	19.7	8.6	12.7	11.0	7.7	8.1	9.8	9.1	41.9	3.7	2.7	5.3	10.0	3.9	6.6	10.2	4.7	2.8	8.3	5.5	7.2	6.7	1.1	0.9	0.6	0.4	0.6	1.0	1.1	0.5	1.3	1.0	1.8	1.5	0.8	1.3	1.2	1.5	1.1	1.0	10.4	11.5	11.1	12.1	9.9	11.7	11.8	11.9	12.1	11.3	10.6	13.9	4.5	19.2	13.0	10.7	2.9	6.8	12.8	16.7	6.2	8.9	8.4	5.5	43.2	8.6	12.9	18.4	14.6	6.3	2.0	8.6	25.4	11.7	2.4	21.5	5.8	5.2	4.8	4.2	8.0	8.7	2.5	6.1	5.1	7.3	3.8	9.3	3.3	14.3	7.4	33.7	10.3	10.0	10.2	5.5	3.1	2.0	7.2	4.3	8.8	5.6	4.0	22.3	6.2	7.1	20.4	8.7	11.1	6.8	2.9	7.2	24.8	18.4	31.6	20.8	6.6	9.9	6.1	42.1	18.8	3.5	6.7	4.0	2.9	17.3	11.7	7.7
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	12.8	2.9	3.1	10.5	3.2	9.0	6.7	4.2	4.8	5.8	5.5	108.3	10.8	6.1	2.2	67.3	43.2	9.6	12.6	7.4	5.5	9.3	3.0	11.3	4.6	6.5	5.2	2.0	1.8	2.0	4.8	2.2	6.3	21.1	24.2	0.7	4.3	6.1	2.1	152.5	17.7	16.1	6.7	8.0	20.5	0.9	7.0	2.2	3.2	4.0	11.6	175.0	15.9	11.9	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	3.1	3.2	4.2	4.8	7.4	5.5	6.5	5.2	6.3	6.7	7.0	11.9	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.7"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 405.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	17.0	7.9	1.4	13.9	2.5	116.7	3.0	1.1	4.1	62.2	2.7	14.9	2.6	8.9	0.7	6.9	5.1	31.6	11.7	1.9	1.4	10.2	8.0	34.3	8.9	2.0	1.6	2.6	2.2	5.6	3.1	8.4	1.5	25.0	9.9	0.3	1.2	127.4	0.4	1.6	3.6	12.2	1.9	2.8	14.8	0.2	1.8	5.2	3.2	6.5	0.6	162.5	2.2	2.6	0.0	21.8	0.1	0.0	2.5	2.1	0.0	93.4	405.5	0.6	3.6	15.0	17.2	0.0	0.0	0.1	2.5	12.2	0.0	7.6	1.3	0.0	0.0	0.8	2.2	0.0	13.2	0.0	0.2	0.8	2.7	11.3	28.7	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	5.5	1.5	0.0	1.0	0.0	0.9	2.7	0.0	0.1	1.5	19.3	0.6	13.5	0.6	0.2	0.0	0.0	27.7	0.4	2.3	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	1.4	2.5	1.1	4.1	1.9	1.4	2.0	1.6	1.5	1.9	1.8	2.6	5.2	342.9	77.7	0.0	7.4	118.8	59.1	72.8	12.5	0.0	2.6	12.8	2.5	0.0	79.7	0.0	0.0	0.2	4.2	0.3	0.0	0.8	0.2	50.0	9.9	31.1	1.2	3.6	3.8	0.2	0.3	270.7	2.0	98.9	347.6	3.8	13.6	0.2	12.1	0.0	1.0	1.0	8.2	21.0	305.6	0.0	0.0	173.1	35.6	3.7	3.4	0.1	0.0	0.0	0.1	4.9	0.1	0.0	2.0	122.6	0.2	0.3	13.1	0.3	0.0	1.8	12.8	0.1	0.4	3.3	28.4	0.5	10.8	3.7	1.2	151.6
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492054-13496181	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	245	"parathyroid gland: 50184.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.0;Oligodendrocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"	NA	NA	28000			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	50184.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.2	205.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 586.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1"	"Group enriched"	"Detected in many"	4	"renal cancer: 18.8;testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	32.5	72.2	45.0	1.1	43.8	0.0	20.2	45.7	60.8	43.8	38.0	10.3	1.2	19.1	2.7	3.7	20.3	3.5	33.0	42.6	43.5	586.8	84.6	25.6	2.4	46.5	44.9	22.2	7.6	1.2	5.9	16.0	46.7	12.4	0.6	0.7	2.7	3.5	7.7	9.8	9.6	2.6	44.5	54.4	7.6	10.3	46.2	0.4	6.5	2.2	0.4	12.3	20.3	43.3	0.0	0.2	0.2	0.2	15.9	1.9	0.2	0.4	0.2	0.3	0.2	0.4	0.0	0.0	1.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	15.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.3	2.1	0.0	0.1	0.1	5.3	0.0	116.9	0.0	0.2	0.7	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	43.8	45.7	60.8	42.6	43.5	46.5	44.9	46.7	44.5	46.2	43.3	4.6	0.0	0.0	17.3	2.5	1.3	0.1	0.0	0.6	1.5	2.9	0.4	5.0	2.8	0.0	33.1	0.0	0.6	0.1	0.0	95.9	0.0	11.6	0.6	20.5	4.1	0.0	8.0	1.6	0.5	60.8	9.6	0.0	0.6	0.0	0.1	17.2	0.7	2.0	1.7	2.8	0.0	0.0	1.3	2.8	32.5	5.9	2.1	0.0	1.9	0.0	3.2	0.0	1.0	0.3	0.3	0.0	2.2	0.0	0.0	0.0	324.8	0.0	1.7	138.1	6.5	21.7	0.9	2.7	0.0	0.9	0.8	2.0	0.3	0.0	0.1
PTH2R	PTHR2	ENSG00000144407	"Parathyroid hormone 2 receptor"	P49190	2	208359714-208854503	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Distal tubular cells: 7.9;Excitatory neurons: 15.9;Proximal tubular cells: 16.1;Rod photoreceptor cells: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 10.7;HEL: 16.0;HL-60: 4.0;SH-SY5Y: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA010655	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA010655: AB_2668333"	"unprognostic (4.76e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.77e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.54e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.37e-2)"	1.2	0.3	2.2	0.1	1.1	4.2	0.9	0.0	3.1	0.0	0.1	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	2.4	2.0	0.2	0.6	0.1	0.1	0.3	0.6	0.0	0.6	0.0	0.3	1.2	0.2	0.5	0.0	16.5	3.6	0.5	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	4.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.2	1.1	0.0	3.1	2.4	2.0	0.3	0.6	0.2	0.1	4.5	1.5	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.1	0.0	1.1	1.8	3.2	0.2	0.0	0.1	5.5	12.5	0.5	0.9	0.0	7.9	0.1	0.6	0.2	0.5	0.1	1.8	4.2	15.9	0.0	0.1	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.1	2.5	2.1	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	26.5	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972733	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HaCaT: 291.3;HBEC3-KT: 359.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	3.1	0.8	1.8	1.2	2.3	0.0	20.1	0.6	3.2	13.6	10.2	3.3	2.3	10.7	1.1	16.2	1.5	7.5	4.2	4.1	3.2	0.4	0.2	1.2	1.1	4.0	8.1	1.8	1.7	22.8	2.9	3.0	0.4	5.2	1.6	0.2	8.5	2.4	0.7	2.0	1.6	3.0	0.2	3.6	1.8	1.3	8.6	0.4	1.8	1.7	1.0	9.2	15.2	0.8	1.7	9.9	0.0	0.0	2.9	2.8	0.1	0.3	1.0	0.5	1.3	0.3	7.9	0.0	0.5	2.6	9.1	291.3	1.3	359.8	0.1	7.4	1.7	0.5	1.8	0.1	0.8	0.1	0.4	0.2	19.7	9.1	34.4	0.9	11.2	0.1	0.0	0.4	0.2	0.1	0.1	0.0	1.4	0.4	16.7	0.1	1.5	0.6	34.3	0.3	0.2	0.1	16.4	0.1	2.1	11.5	0.5	0.1	5.6	1.6	8.9	5.1	77.8	4.7	0.1	12.1	7.5	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	2.3	0.6	3.2	4.1	3.2	4.0	8.1	0.4	0.2	8.6	0.8	1.4	0.0	0.0	0.7	0.4	4.6	1.9	254.0	93.9	0.3	105.4	56.3	0.4	0.0	77.5	0.0	0.0	0.0	0.5	0.0	0.0	3.5	5.9	0.9	4.7	4.5	0.0	0.0	0.6	8.9	0.0	13.6	0.0	0.8	0.0	2.6	0.4	0.2	0.0	0.0	11.2	0.0	4.1	0.3	1.3	2.7	0.9	0.6	23.2	1.0	0.6	1.8	0.0	0.0	0.2	8.6	0.0	0.0	6.2	0.5	0.0	0.3	14.8	0.5	6.6	8.0	6.7	3.6	0.2	7.9	1.4	0.0	0.5	0.2	0.0	0.2
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 295.2;Excitatory neurons: 584.9;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 791.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	Yes		25000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	51.0	40.4	83.8	19.5	115.1	6.7	42.1	62.4	99.9	40.3	51.0	37.2	25.8	37.3	49.7	25.6	34.0	32.1	36.9	84.5	77.3	42.6	30.1	39.4	25.3	79.1	87.6	33.7	32.1	53.1	21.3	74.2	81.0	34.0	35.3	35.5	39.9	41.6	38.7	29.6	29.5	37.6	67.6	22.8	32.8	38.9	86.7	11.9	38.7	39.4	25.8	43.9	34.0	154.5	52.6	81.9	111.0	40.3	45.8	48.8	71.6	50.8	70.0	46.3	45.3	35.9	42.1	31.7	111.7	65.3	65.0	60.3	66.1	116.0	69.6	0.3	30.8	70.1	44.3	50.0	62.5	0.1	31.8	33.4	55.8	58.0	81.0	121.5	139.0	44.0	72.0	0.8	62.9	91.0	0.9	0.7	43.2	113.2	90.3	46.8	60.9	1.5	97.7	117.3	43.9	54.8	79.0	25.0	52.0	97.2	59.2	1.2	84.9	45.2	85.5	54.0	58.1	0.0	0.6	3.4	58.7	0.6	62.9	1.6	3.3	0.0	0.2	1.4	0.0	5.3	0.6	0.0	4.5	6.3	4.4	1.6	1.3	4.7	0.8	6.1	0.2	3.9	83.8	115.1	62.4	99.9	84.5	77.3	79.1	87.6	81.0	67.6	86.7	154.5	71.3	32.1	33.1	295.2	20.6	33.3	70.1	36.3	64.9	55.2	29.3	23.5	29.6	32.9	32.1	55.2	60.5	37.0	8.0	23.1	23.5	27.2	68.4	29.3	43.3	54.3	25.8	8.4	584.9	23.3	53.7	37.2	37.8	46.5	9.5	84.7	37.5	15.7	8.1	67.3	263.6	23.0	30.5	15.2	15.9	38.8	23.9	19.4	24.9	159.3	3.9	40.9	0.0	353.9	791.4	43.1	23.5	21.8	1.7	82.4	29.3	25.6	33.7	55.0	98.6	32.7	128.4	88.9	65.5	42.8	25.9	33.2	3.4	67.0	24.1	87.3
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.3;brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 127.4;REH: 141.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	19.7	10.8	46.9	52.6	54.4	106.3	11.5	22.8	102.9	11.5	38.3	29.8	34.1	9.9	8.9	19.2	15.6	12.7	10.6	96.3	8.5	15.9	15.2	28.6	78.3	0.0	26.0	4.7	12.6	7.1	13.7	8.0	0.0	25.5	23.5	4.4	26.6	12.3	5.0	45.2	48.8	10.7	0.2	78.3	22.2	9.5	27.0	86.0	12.5	5.4	73.6	21.0	15.1	37.0	38.2	10.4	2.8	3.0	76.6	5.5	21.5	2.9	1.9	1.9	2.7	9.9	21.5	127.4	4.0	5.8	3.1	34.3	1.1	31.3	1.1	8.7	0.8	26.4	10.6	2.0	15.7	28.5	45.5	41.6	46.0	2.6	17.3	13.0	1.0	36.0	31.7	85.6	2.1	4.0	49.1	57.0	2.2	33.0	2.6	141.2	0.7	88.3	8.5	29.5	19.2	3.5	13.4	9.3	5.0	6.5	11.5	72.1	17.5	1.3	2.8	2.5	1.0	68.0	32.0	68.9	5.2	60.6	2.4	47.3	48.4	36.9	33.9	43.0	22.2	46.0	17.0	24.3	36.1	46.6	20.8	25.9	45.8	29.0	53.5	11.7	18.2	50.1	46.9	54.4	22.8	102.9	96.3	8.5	0.0	26.0	0.0	0.2	27.0	37.0	6.9	3.2	29.8	16.6	64.3	37.7	38.7	19.7	6.8	5.4	5.9	7.7	3.7	8.6	13.0	14.7	0.0	2.9	33.4	65.5	0.0	8.0	1.2	7.1	1.8	9.6	7.8	20.2	109.2	8.3	26.5	3.5	22.4	5.3	28.5	1.1	5.0	24.1	23.1	8.4	9.2	21.9	10.2	68.4	32.1	1.0	1.5	55.3	8.8	22.5	62.5	2.8	70.0	7.5	15.1	13.3	42.0	0.7	68.1	18.6	44.6	16.1	13.9	3.9	0.0	3.3	3.3	4.2	6.4	4.8	30.1	1.9	46.6	1.0	18.1	17.9
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076307-43161719	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 317.3;Endometrial stromal cells: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 13.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 13.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		12000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	15.0	5.0	9.6	6.7	8.4	2.8	17.5	8.5	8.9	69.5	36.0	9.4	6.5	87.4	87.1	30.1	38.2	24.7	8.8	8.7	10.8	29.3	1.6	33.9	3.9	10.2	11.4	85.3	16.4	13.0	21.1	48.8	8.7	37.9	8.5	6.0	36.7	25.4	0.6	34.6	9.5	38.7	9.0	27.8	12.2	41.7	11.2	30.4	23.0	1.5	6.4	22.3	43.6	8.2	9.1	2.5	83.6	141.6	88.0	89.9	119.4	94.2	145.5	77.0	99.4	77.0	31.0	0.2	74.0	107.3	56.4	99.5	38.0	87.5	49.3	0.7	52.0	8.5	17.1	105.2	132.5	0.3	0.4	129.1	77.4	103.2	32.6	135.8	10.1	35.0	6.2	0.2	36.4	7.0	32.5	12.6	39.1	0.8	7.0	33.3	119.0	0.3	61.0	42.4	48.3	91.6	14.8	1.5	50.0	87.8	51.9	19.5	6.8	84.1	53.1	0.4	51.0	0.5	0.9	3.2	19.1	0.3	14.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.4	0.2	0.7	0.0	13.5	0.0	0.8	9.6	8.4	8.5	8.9	8.7	10.8	10.2	11.4	8.7	9.0	11.2	8.2	3.0	16.0	13.1	10.7	0.8	17.3	19.9	40.4	27.9	4.3	23.5	32.5	1.6	5.7	14.6	12.9	56.3	19.1	6.3	1.7	1.9	21.0	317.3	23.5	84.7	8.7	21.6	4.0	8.7	6.9	2.2	30.0	8.6	25.2	1.3	25.3	2.2	0.0	3.5	0.0	5.3	3.9	42.7	0.0	9.8	48.9	18.3	4.1	16.0	1.0	1.0	20.1	0.0	3.5	1.4	10.5	4.1	18.4	1.4	11.8	0.6	0.6	15.4	2.2	13.1	8.7	27.9	2.8	21.2	13.7	10.4	8.2	3.0	17.7	6.3	11.8
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 565.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 25.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 672.8"									HPA038186	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes		300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	138.4	78.4	115.9	37.0	105.9	14.3	121.4	103.2	122.3	188.2	48.6	293.9	33.0	243.9	29.0	128.0	145.3	28.9	98.7	117.0	74.3	186.6	565.2	173.5	22.7	45.9	43.5	239.9	50.3	82.4	96.3	49.4	48.0	194.3	28.9	64.6	94.4	86.8	56.3	116.8	101.1	98.8	31.6	61.4	109.5	32.6	86.0	16.3	109.5	16.2	20.1	176.6	137.5	72.5	49.2	250.8	324.8	320.3	149.8	126.2	127.5	210.9	189.2	157.6	130.1	153.8	190.2	19.5	151.8	321.7	143.2	104.6	178.7	159.3	61.9	672.8	219.1	27.5	160.6	58.1	174.1	7.7	56.6	123.7	68.8	121.4	245.6	237.7	175.3	8.6	175.5	50.6	139.8	144.1	9.2	40.7	347.6	92.2	180.8	4.2	99.8	39.6	124.7	12.5	107.4	363.6	254.7	86.9	186.1	230.0	75.9	23.4	296.7	239.6	344.2	36.6	195.2	42.4	19.3	25.4	196.5	18.1	183.6	25.6	0.4	3.6	1.3	0.1	0.6	0.1	0.1	1.1	0.3	0.0	0.0	0.1	1.3	0.1	0.0	4.4	0.5	0.4	115.9	105.9	103.2	122.3	117.0	74.3	45.9	43.5	48.0	31.6	86.0	72.5	370.5	0.0	14.1	9.4	22.8	289.5	328.0	44.6	257.8	325.5	239.2	275.5	10.4	88.6	16.7	154.5	200.1	153.6	88.4	99.8	234.8	61.9	6.6	73.1	494.8	342.7	513.3	248.6	28.7	34.0	404.0	292.4	66.3	117.5	52.8	216.3	325.2	710.0	491.3	116.1	15.2	229.4	22.4	100.4	309.4	23.1	489.6	136.8	227.7	12.2	76.7	512.6	4.1	13.0	3.1	38.3	141.3	692.1	38.8	399.9	244.2	547.6	11.4	357.7	598.2	232.0	411.7	7.4	32.8	259.4	249.2	163.2	81.3	122.5	198.9	206.7
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
PTOV1		ENSG00000104960	"PTOV1 extended AT-hook containing adaptor protein"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 326.5;Late spermatids: 631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA051812: , HPA075125: AB_2732280"	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	46.1	107.3	123.8	24.1	122.9	29.8	46.8	122.4	161.5	76.3	129.3	65.8	23.7	65.8	15.0	43.7	62.1	17.8	65.6	124.4	132.6	69.5	67.8	40.0	23.6	133.8	126.5	91.0	61.5	27.5	106.0	23.1	125.7	73.5	5.8	19.0	55.0	23.2	106.6	51.2	43.0	11.5	131.5	47.6	58.7	66.4	126.0	18.7	62.4	16.6	8.7	53.9	52.2	136.4	43.5	88.0	87.5	94.4	12.1	19.7	53.7	52.3	45.7	47.8	50.1	48.1	73.1	46.7	49.0	26.4	32.8	47.1	32.5	40.6	11.5	122.5	218.8	30.3	72.2	76.1	31.0	25.1	59.2	37.6	25.7	20.2	8.2	32.2	40.2	64.9	71.9	54.9	22.5	53.2	113.3	113.1	56.6	31.2	79.6	135.8	35.5	65.8	42.2	75.1	113.1	123.4	44.8	51.6	23.9	21.9	50.5	27.3	58.6	56.6	93.5	34.1	43.3	57.5	37.4	63.7	58.5	35.2	73.7	8.8	2.6	4.3	2.7	2.4	3.6	7.1	3.0	2.4	1.9	6.3	3.8	3.5	7.4	4.7	1.4	7.7	1.3	1.1	123.8	122.9	122.4	161.5	124.4	132.6	133.8	126.5	125.7	131.5	126.0	136.4	42.9	38.5	25.7	18.3	43.3	36.6	82.3	21.5	55.2	50.5	56.2	60.1	32.6	65.8	26.4	44.1	18.8	110.6	29.9	69.8	90.1	28.9	326.5	87.4	68.5	37.4	99.8	46.3	14.7	26.8	91.4	62.7	56.6	78.9	15.2	92.7	38.2	57.2	52.1	35.3	17.1	72.7	20.3	28.9	39.1	631.4	64.3	28.8	44.4	10.3	18.6	75.0	18.6	17.1	23.7	35.8	61.2	80.5	72.0	74.8	68.4	141.0	38.4	44.1	59.2	44.2	56.2	30.3	93.3	40.1	36.2	153.6	34.0	88.0	55.3	70.2
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase 4A1"	Q93096	6	63521746-63583436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.7"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3071.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 533.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	39.4	140.5	24.1	37.4	29.5	227.4	31.5	30.9	35.9	41.5	28.3	107.9	55.1	43.8	15.3	53.5	34.6	58.9	31.7	24.7	37.5	50.5	493.7	54.8	24.4	32.5	28.0	54.7	69.5	16.1	41.1	72.5	32.1	44.2	110.1	22.5	68.2	21.0	300.0	66.0	50.8	56.6	34.9	19.4	55.2	62.5	27.9	26.2	39.2	113.0	24.6	51.6	33.6	44.8	71.5	122.9	106.2	128.3	85.8	77.2	239.1	113.9	97.6	58.4	79.2	103.5	45.4	65.1	50.6	88.7	95.7	41.8	97.0	197.9	94.3	61.0	51.6	43.8	320.2	533.9	175.7	118.6	57.7	91.3	383.6	124.7	320.5	63.5	80.3	65.0	106.1	148.7	151.5	140.9	52.4	69.1	50.6	91.0	53.7	70.9	53.4	60.5	132.4	120.6	44.7	62.5	278.5	71.8	140.1	156.9	59.8	122.0	77.5	132.9	130.6	89.5	122.3	90.7	94.9	121.7	60.9	72.5	154.1	45.4	20.4	15.1	12.8	21.3	20.1	12.9	14.5	14.3	17.2	10.7	12.8	12.9	48.4	16.3	16.6	9.1	18.8	15.4	24.1	29.5	30.9	35.9	24.7	37.5	32.5	28.0	32.1	34.9	27.9	44.8	33.3	22.4	90.3	4.6	105.4	681.3	268.7	94.1	261.8	22.3	98.4	55.4	78.5	207.3	83.0	75.4	16.7	248.7	99.8	336.5	80.3	186.9	716.1	189.8	68.8	47.0	129.6	30.9	11.7	193.9	215.1	90.8	178.4	279.5	63.0	41.2	41.4	528.8	98.6	11.8	9.9	253.4	63.1	71.6	236.5	3071.4	28.6	99.7	170.7	5.6	47.4	22.0	15.5	9.5	20.4	151.8	196.9	24.0	110.6	166.4	181.3	112.1	61.2	24.6	6.6	44.4	110.2	47.2	26.3	181.8	641.0	459.6	123.4	79.1	214.6	164.1
PTP4A2	"HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2"	ENSG00000184007	"Protein tyrosine phosphatase 4A2"	Q12974	1	31906421-31944856	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 917.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003281, CAB011204"	Uncertain					NA	NA		490000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB011204: AB_532271, HPA003281: AB_1855903"	"unprognostic (2.67e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (6.90e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.10e-11)"	"unprognostic (1.16e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.72e-5)"	158.2	71.0	269.3	147.2	322.8	295.9	126.6	221.3	399.7	85.5	146.1	125.6	114.2	73.1	70.5	66.9	81.5	100.8	169.8	209.1	255.7	91.6	117.1	105.9	166.0	262.5	286.3	85.3	99.8	72.3	66.3	91.1	270.0	88.3	127.1	52.3	104.1	88.9	306.4	53.1	103.1	99.7	264.3	116.1	113.9	98.9	264.1	489.2	163.7	186.3	172.4	186.7	72.9	400.2	297.7	166.6	163.1	305.9	321.5	321.2	109.1	290.3	387.9	218.5	224.3	144.1	409.3	532.0	214.0	393.2	245.2	118.3	172.2	161.9	398.1	479.8	94.6	371.6	282.7	155.6	340.4	304.7	353.1	319.6	127.6	305.6	297.9	224.8	220.7	425.1	482.4	195.4	283.3	138.5	930.8	149.2	221.7	220.3	238.7	165.8	275.2	222.3	153.8	519.7	160.1	115.3	296.9	199.1	328.8	265.9	560.5	167.4	243.5	257.0	224.7	403.8	319.8	215.3	336.0	259.2	263.5	246.7	261.6	204.3	50.9	87.4	74.8	105.3	58.4	44.2	63.4	85.1	46.0	39.6	40.8	69.4	53.5	60.7	148.0	33.6	57.4	60.7	269.3	322.8	221.3	399.7	209.1	255.7	262.5	286.3	270.0	264.3	264.1	400.2	206.8	121.8	126.5	25.5	199.0	194.1	502.4	87.8	136.1	60.5	287.0	125.5	187.0	153.0	117.0	202.3	60.5	50.0	360.2	247.3	191.7	154.9	48.1	132.4	135.8	131.2	128.3	209.3	41.6	185.4	128.7	158.2	141.2	218.2	87.5	118.0	94.6	169.3	125.0	99.3	33.9	204.0	65.1	219.8	405.2	51.2	176.7	336.0	115.6	38.4	488.3	145.8	568.5	30.7	176.4	185.6	191.3	175.3	270.0	623.3	126.9	170.3	74.7	56.3	131.5	134.1	135.2	130.6	107.5	148.7	196.5	160.1	281.1	67.0	199.7	917.5
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase 4A3"	O75365	8	141391995-141432454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 640.3;pituitary gland: 207.5;skeletal muscle: 738.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.9;Cardiomyocytes: 272.8;Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 226.5;Smooth muscle cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	6	"granulocytes: 55.0;monocytes: 54.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.7;Karpas-707: 45.9;RPMI-8226: 38.1;U-266/84: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	48.6	16.6	11.4	2.0	9.8	0.7	43.3	9.0	14.1	87.3	9.2	70.7	2.1	69.9	3.0	15.1	67.2	1.4	640.3	10.1	10.6	48.9	9.8	58.4	1.1	10.5	10.3	46.8	116.2	2.6	207.5	2.3	10.7	73.6	0.7	36.0	29.9	2.1	738.1	22.8	37.4	4.4	9.3	56.8	99.7	22.0	13.3	1.1	35.2	62.1	1.3	40.5	35.7	9.2	0.3	0.9	0.6	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	2.3	0.0	9.8	0.1	0.1	0.0	0.1	0.1	0.0	128.7	1.9	5.2	0.2	1.8	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.4	1.0	3.1	45.9	0.1	11.3	0.7	0.2	2.1	1.0	0.7	19.3	0.1	38.1	0.0	0.1	11.4	3.9	0.6	0.1	2.6	1.2	1.8	0.0	0.5	0.1	2.2	0.1	0.0	11.6	42.0	0.3	0.1	2.8	0.1	1.5	3.3	12.5	3.1	28.2	1.8	5.1	5.8	3.0	2.0	1.2	6.5	3.4	55.0	1.5	54.1	8.6	5.3	5.1	11.4	9.8	9.0	14.1	10.1	10.6	10.5	10.3	10.7	9.3	13.3	9.2	52.7	3.2	44.5	5.5	21.1	9.9	5.2	23.7	7.4	102.9	9.8	7.4	272.8	4.3	8.3	7.3	123.0	0.3	5.6	0.8	9.8	8.2	10.9	2.0	3.1	57.7	10.2	0.8	5.3	62.9	0.3	21.7	5.6	2.0	1.3	6.6	15.0	0.3	4.1	15.2	10.3	2.9	26.4	2.8	20.1	7.1	3.7	4.0	21.4	8.4	12.8	36.7	2.1	2.5	0.7	10.8	0.2	1.9	79.8	11.9	0.2	5.0	1.1	226.5	32.9	17.1	140.8	4.4	24.8	1.8	10.2	0.3	13.7	3.4	3.0	3.6
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	47.2	118.0	157.8	56.2	154.0	52.9	60.9	136.2	185.0	73.5	124.6	105.2	49.6	87.4	55.8	116.8	77.3	49.3	176.7	158.5	141.6	125.5	154.2	72.6	49.9	151.3	148.8	63.8	70.4	146.7	73.1	49.8	147.6	119.0	51.3	43.4	97.1	86.8	340.8	73.7	57.1	92.1	143.2	82.8	83.5	124.5	162.7	59.1	75.3	206.2	54.9	71.1	62.2	148.5	108.9	183.9	111.0	219.9	74.4	94.5	118.3	115.5	120.2	144.8	100.1	103.4	135.4	113.9	83.3	187.3	173.1	184.1	110.9	138.2	100.6	198.6	68.1	64.6	193.6	101.7	229.1	113.1	147.2	114.6	133.1	109.8	101.8	230.9	146.5	120.3	102.0	124.7	117.1	293.8	103.0	76.6	186.8	301.0	193.0	108.3	93.7	216.2	159.0	119.8	120.6	86.9	220.4	237.3	147.3	99.4	253.4	55.0	101.7	127.6	113.8	129.9	165.2	114.9	284.1	96.8	153.2	79.1	180.7	7.6	19.2	9.8	20.8	18.4	19.9	10.8	15.8	18.5	23.0	13.4	13.8	13.9	6.1	20.4	18.3	16.4	16.9	20.4	157.8	154.0	136.2	185.0	158.5	141.6	151.3	148.8	147.6	143.2	162.7	148.5	19.8	3.2	8.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	51.9	38.6	0.0	0.0	3.1	53.3	0.0	49.5	9.2	0.0	54.8	70.3	0.0	33.7	21.8	19.0	0.0	0.0	0.0	62.3	44.2	12.2	0.0	32.9	8.8	24.8	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.9	0.0	0.0	41.9	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	37.9	4.0	31.8	0.0	0.0
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.1;Oligodendrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	3.7	5.7	7.8	2.2	14.1	0.7	3.1	9.7	12.4	3.1	2.5	4.3	1.4	3.1	2.2	2.0	3.3	2.2	7.0	8.0	8.9	3.3	1.5	4.4	1.9	10.9	11.5	3.0	5.9	3.6	6.7	1.7	10.8	3.2	2.8	4.4	2.9	2.0	4.8	3.1	2.3	4.1	6.7	1.8	4.3	7.8	10.2	1.8	3.3	6.7	1.9	2.5	2.7	18.3	6.1	2.7	4.7	6.1	5.8	7.9	6.2	4.4	3.0	4.4	3.7	2.6	5.0	5.1	2.9	3.4	10.1	4.7	4.9	2.8	4.3	6.8	1.3	1.2	7.7	2.8	7.4	1.4	3.8	7.9	10.0	6.7	9.2	2.6	4.7	8.3	3.0	0.0	8.4	3.3	5.2	2.2	3.3	5.0	4.8	5.6	9.3	0.0	2.4	1.5	4.1	5.1	6.1	5.7	9.5	6.2	3.1	2.5	6.7	5.8	3.5	9.1	5.4	7.2	8.4	0.7	4.3	2.5	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	14.1	9.7	12.4	8.0	8.9	10.9	11.5	10.8	6.7	10.2	18.3	5.7	0.0	7.7	19.2	4.7	4.8	3.0	2.2	5.7	10.7	2.3	3.3	11.3	5.7	1.4	5.5	10.4	0.4	2.6	2.1	3.9	3.1	11.7	2.3	7.3	5.8	3.5	0.8	36.1	2.9	2.0	8.1	14.3	3.1	5.7	6.7	4.2	1.0	3.1	5.0	27.0	2.6	4.1	1.0	4.6	6.2	3.7	3.6	3.6	14.0	0.5	2.2	0.0	18.6	82.6	6.1	2.9	14.3	2.0	1.4	1.1	1.7	2.1	9.8	19.7	7.4	5.5	21.0	20.8	4.7	4.3	0.3	4.0	2.3	2.3	1.8
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 235.1;Late spermatids: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	38.8	56.5	15.0	5.3	16.1	9.0	37.4	15.8	17.4	31.1	16.6	31.0	7.6	32.8	7.8	34.8	29.5	4.2	27.7	14.4	16.5	37.6	40.6	36.5	6.1	15.6	16.3	28.0	44.7	9.6	41.9	6.7	15.8	32.7	3.9	4.2	37.1	5.9	41.0	28.1	23.4	4.7	16.0	28.9	39.2	105.4	17.0	4.3	30.6	5.8	4.9	27.5	28.1	16.0	34.5	19.4	2.3	17.8	17.5	11.4	7.0	20.1	17.1	19.4	16.8	27.9	17.6	27.9	22.1	14.7	16.8	30.6	16.9	20.4	16.6	31.4	57.3	12.9	43.8	43.4	25.7	25.2	17.1	12.7	21.9	8.8	24.0	11.2	13.7	26.2	32.6	19.5	14.2	65.4	21.4	41.0	18.8	3.9	37.7	38.6	16.7	22.3	22.5	23.3	15.5	21.4	33.8	11.1	23.2	7.2	53.1	32.7	16.6	13.6	23.3	28.6	33.1	27.1	22.6	18.6	13.6	23.3	10.0	11.2	38.0	38.2	24.8	36.8	23.0	33.7	22.7	26.2	44.9	30.3	22.3	21.0	3.1	26.1	34.6	64.6	28.5	28.8	15.0	16.1	15.8	17.4	14.4	16.5	15.6	16.3	15.8	16.0	17.0	16.0	26.8	22.4	35.0	14.4	31.8	17.8	15.8	58.5	34.1	14.4	64.9	78.4	5.8	45.8	38.6	40.5	4.2	72.2	34.7	19.9	72.4	95.3	235.1	48.0	23.9	24.6	31.3	30.1	8.2	85.8	66.3	23.9	28.1	25.6	17.1	16.5	29.6	39.8	62.4	5.0	10.8	45.7	48.8	32.6	21.2	640.8	46.6	45.6	46.2	6.5	56.2	74.9	41.2	9.5	14.6	106.2	38.8	46.6	61.0	26.0	37.9	72.8	57.2	15.7	19.7	17.3	28.1	179.8	28.6	55.0	17.3	76.8	25.9	21.3	62.7	22.0
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;monocytes: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	26.3	30.8	13.0	44.5	14.0	55.4	22.1	12.3	14.7	23.2	28.6	24.8	13.9	23.0	18.7	29.6	22.0	23.1	31.9	17.5	13.0	46.7	21.0	55.2	52.9	16.1	14.4	25.6	15.9	48.3	19.7	34.2	13.7	25.0	18.8	9.9	18.9	18.2	35.4	23.9	28.3	21.9	13.7	46.5	21.0	18.3	14.2	35.5	18.7	21.6	52.6	35.8	23.5	14.1	66.1	32.4	38.4	26.6	24.6	33.6	54.5	43.2	40.8	123.8	44.9	96.1	134.3	32.5	74.8	40.0	48.7	56.9	30.8	123.8	78.2	48.5	27.6	45.9	30.9	51.3	49.0	48.2	60.2	39.6	84.9	55.9	68.2	54.3	72.3	38.5	81.5	28.9	68.3	36.5	52.1	38.1	20.4	36.2	44.2	45.6	44.6	31.1	71.2	48.4	30.8	35.3	62.0	77.6	71.3	32.1	50.4	50.9	108.2	107.3	43.1	48.8	54.2	31.4	27.3	38.9	67.1	32.3	40.6	19.8	7.1	25.2	12.9	12.1	9.5	19.2	10.8	10.0	7.1	17.4	8.9	9.8	15.4	5.3	22.8	11.8	9.4	8.7	13.0	14.0	12.3	14.7	17.5	13.0	16.1	14.4	13.7	13.7	14.2	14.1	34.0	227.6	83.6	22.9	147.8	86.0	61.7	37.1	56.3	25.1	23.9	24.4	30.0	11.5	40.0	36.8	47.9	54.0	68.7	26.1	23.5	26.2	67.7	45.0	44.0	36.3	18.6	32.0	61.6	19.3	20.9	52.1	32.1	65.9	70.8	14.2	41.4	20.8	37.4	43.7	43.3	16.4	20.3	40.6	169.5	37.4	14.0	100.7	37.4	32.8	207.8	12.1	38.1	27.6	42.1	41.7	14.5	12.0	178.7	26.6	8.9	65.2	30.2	27.5	19.7	55.5	57.7	20.8	24.5	48.7	47.2	54.3	83.8	44.3	14.6	53.5
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase non-receptor type 18"	Q99952	2	130356045-130375405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 143.4;NK-cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	22.3	12.3	19.6	23.2	19.4	28.2	21.5	21.7	21.4	21.2	18.4	35.3	21.7	15.7	6.1	17.8	19.6	14.8	15.3	18.8	19.1	25.4	37.8	22.0	42.7	21.0	19.6	12.5	34.6	9.5	19.0	12.2	20.1	33.3	24.7	6.4	31.9	13.2	7.5	12.7	39.4	13.3	18.7	63.8	27.0	4.6	20.0	11.1	20.0	7.5	48.6	18.8	18.9	19.6	12.4	8.3	3.2	16.2	19.7	13.5	32.9	6.2	5.6	7.9	8.8	16.4	18.5	46.4	6.2	15.2	3.7	13.8	14.3	14.1	7.6	21.1	8.0	16.9	9.8	19.5	10.2	16.6	44.5	16.0	11.4	8.7	12.0	1.7	15.2	10.1	16.1	34.2	15.4	24.3	3.1	28.4	3.3	26.6	8.6	28.4	9.5	63.0	15.9	7.5	20.6	5.4	10.9	38.6	18.7	3.1	13.2	24.1	14.4	11.2	12.6	6.2	5.9	5.6	1.6	44.5	17.1	14.9	12.4	8.4	7.8	6.7	6.4	11.2	4.0	7.3	4.2	6.1	6.9	5.1	2.6	5.1	4.8	3.1	19.4	7.5	6.0	10.7	19.6	19.4	21.7	21.4	18.8	19.1	21.0	19.6	20.1	18.7	20.0	19.6	37.2	28.9	23.9	12.1	43.6	6.5	28.8	15.9	12.0	13.4	52.0	53.5	9.0	18.6	17.5	36.8	4.2	15.6	85.6	75.9	54.8	19.0	0.9	20.6	14.0	30.7	48.6	32.4	18.2	45.4	30.5	16.3	65.2	24.0	35.5	12.2	25.7	21.1	92.4	10.1	18.6	52.5	30.5	113.6	35.9	1.6	19.0	143.4	33.8	35.6	65.2	18.4	148.3	5.5	6.1	29.0	66.9	11.3	23.5	37.9	41.3	37.3	20.5	11.6	19.7	15.1	21.5	2.6	6.0	19.4	5.8	11.5	39.3	16.2	47.5	28.9
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 50.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Centriolar satellite"		"HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.6	9.1	3.4	0.2	4.4	0.2	3.5	9.2	5.1	0.8	8.9	0.9	1.3	0.9	0.3	3.4	1.4	0.7	9.1	3.9	5.2	4.4	0.8	0.8	0.4	18.5	9.0	1.9	4.1	0.0	3.1	0.2	19.6	1.2	1.6	2.9	2.4	1.4	12.3	5.7	0.6	0.8	4.6	1.2	1.1	14.0	5.3	0.3	2.0	14.7	0.6	0.9	1.1	4.8	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	3.7	0.0	0.0	0.0	50.2	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.2	1.3	9.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.3	0.1	0.6	0.9	0.0	0.8	0.0	0.7	0.4	0.2	3.4	4.4	9.2	5.1	3.9	5.2	18.5	9.0	19.6	4.6	5.3	4.8	0.5	0.0	1.5	0.0	0.7	0.0	2.0	0.0	5.7	6.0	5.9	3.7	16.3	0.0	2.5	9.2	6.2	0.1	0.3	0.7	21.5	1.8	44.2	5.0	0.1	0.5	1.2	1.7	0.0	0.9	0.2	1.9	3.1	0.2	0.0	4.9	1.4	0.9	0.4	11.8	0.0	0.4	0.0	0.0	0.0	34.9	0.0	0.4	0.0	0.0	0.7	7.3	0.0	0.0	0.0	2.2	0.2	7.2	1.5	0.9	0.2	17.7	3.6	3.1	0.0	2.7	0.8	24.8	12.2	5.2	0.0	0.1	0.4	8.4	0.8	0.9
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase non-receptor type 21"	Q16825	14	88465778-88555007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Golgi apparatus"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.0	5.4	6.7	4.1	7.2	0.0	9.2	6.4	6.6	11.5	10.1	11.9	6.0	12.0	5.9	10.3	10.1	8.7	21.3	6.2	8.0	7.8	7.7	17.9	2.1	9.7	7.8	17.5	9.4	8.3	4.5	10.3	7.2	9.3	7.6	9.1	7.4	9.5	11.8	29.0	8.2	10.4	7.9	4.0	9.0	20.2	7.4	1.1	18.7	9.8	1.9	10.1	9.8	7.4	5.8	4.6	11.8	4.6	12.3	10.6	12.1	15.2	11.6	8.8	12.2	8.1	10.2	0.0	3.6	19.6	7.9	5.4	1.7	5.4	12.9	0.3	2.7	0.0	5.6	3.4	13.6	0.1	0.2	7.1	10.4	7.4	8.8	11.4	7.2	0.0	1.8	0.2	22.9	4.7	0.0	0.3	3.5	6.2	8.7	0.1	35.3	0.1	7.7	4.1	0.8	13.6	8.7	21.6	5.2	10.0	10.7	2.3	14.5	16.3	12.8	6.7	10.6	0.5	1.9	0.0	6.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.2	6.4	6.6	6.2	8.0	9.7	7.8	7.2	7.9	7.4	7.4	7.2	57.7	6.0	14.4	0.0	10.5	6.3	4.0	4.0	7.2	7.1	5.8	34.9	5.7	7.1	7.3	35.5	10.3	0.1	18.1	0.0	5.0	19.1	10.2	11.4	6.0	4.8	8.0	12.8	8.4	5.4	12.0	7.1	7.1	2.5	9.2	6.1	9.7	1.9	1.7	14.4	15.0	8.2	1.3	3.9	5.3	17.1	0.4	0.0	13.1	0.0	4.7	1.0	28.1	20.3	10.7	6.1	27.1	0.0	8.8	6.7	3.5	10.3	9.4	0.0	12.7	10.5	20.2	6.6	3.5	11.9	101.9	0.6	7.4	6.2	4.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 63.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 48.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 26.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 29.4;RPTEC TERT1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	4.0	2.2	7.1	1.7	1.0	0.1	7.5	0.0	2.6	6.6	8.5	9.5	12.4	2.2	17.7	13.2	10.1	2.7	21.1	3.2	5.2	23.0	29.5	5.7	1.1	0.3	14.7	0.6	14.8	10.7	2.9	7.3	1.6	5.9	10.1	2.5	8.5	5.1	63.5	30.1	12.9	1.4	0.4	0.3	9.7	3.2	26.7	3.6	10.1	46.9	4.4	4.2	7.2	0.4	11.1	13.5	0.5	3.5	0.0	0.0	21.1	2.3	0.0	2.9	3.2	7.2	17.7	0.0	2.4	0.1	7.3	25.8	3.7	15.2	2.9	6.2	8.2	0.0	6.2	7.5	0.1	0.0	0.1	0.2	16.0	3.6	7.7	1.2	0.0	4.5	0.0	0.1	0.2	14.0	19.3	3.3	1.6	29.4	10.0	0.1	4.4	0.3	34.0	21.1	8.6	1.8	5.9	21.8	0.0	7.1	12.5	1.8	0.1	1.0	8.2	1.4	0.0	10.4	18.2	0.0	11.2	0.0	7.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	7.1	1.0	0.0	2.6	3.2	5.2	0.3	14.7	1.6	0.4	26.7	0.4	0.4	16.0	28.4	0.7	0.5	11.9	25.9	19.3	4.0	13.4	7.8	8.6	48.6	24.3	24.7	31.3	0.0	23.6	0.1	30.0	17.6	14.5	21.5	27.6	3.1	3.3	13.1	0.0	16.1	19.2	23.7	1.8	15.8	38.4	1.3	0.9	4.6	36.3	2.6	0.0	5.2	18.7	8.2	0.0	1.8	18.5	1.2	0.8	3.6	1.0	0.7	0.3	1.0	0.5	0.6	29.1	24.0	1.9	0.2	26.1	27.9	19.2	28.4	2.2	6.6	3.2	6.0	1.6	10.4	7.0	20.6	10.8	0.8	0.4	18.4	29.0
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 161.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 59.0;Inhibitory neurons: 51.9"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 161.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;NTERA-2: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	1.5	0.5	37.2	0.2	161.0	0.1	1.1	0.0	55.2	0.7	0.0	1.0	0.1	0.8	0.0	0.5	1.1	0.3	11.9	32.1	25.5	1.7	0.0	1.5	0.1	11.3	6.4	2.1	0.4	0.2	2.1	0.0	6.7	1.0	0.3	2.0	1.2	0.6	0.7	0.6	0.6	0.4	4.7	0.4	0.9	2.9	19.9	0.0	0.7	3.3	0.0	1.0	1.1	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	161.0	0.0	55.2	32.1	25.5	11.3	6.4	6.7	4.7	19.9	29.5	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.2	6.9	0.0	0.0	59.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase non-receptor type 9"	P43378	15	75463251-75579315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	15.9	12.0	14.8	13.0	16.3	10.8	15.1	11.9	18.8	16.6	11.7	18.0	17.9	16.5	13.3	9.9	16.2	12.1	11.0	16.9	18.4	18.2	14.7	15.8	14.5	18.6	14.4	14.0	10.2	17.9	9.7	19.9	15.1	16.6	19.7	8.9	13.0	21.2	6.4	11.0	20.0	18.0	13.6	13.4	13.5	7.2	17.0	16.1	32.8	13.1	15.0	18.1	13.8	14.5	20.3	24.1	36.7	24.6	26.8	29.3	12.0	29.8	46.2	36.9	33.4	14.5	30.0	32.6	23.3	51.1	29.5	30.0	79.9	34.3	37.0	40.5	19.8	18.4	16.2	15.7	40.2	28.2	27.1	38.4	35.2	29.6	45.9	37.7	31.4	21.3	12.4	11.5	42.1	13.5	20.0	26.3	33.6	18.2	12.1	38.9	18.2	9.1	46.6	32.5	14.4	29.9	42.4	23.3	46.3	34.9	12.1	47.8	36.5	35.2	11.3	23.3	32.2	16.9	18.9	30.0	20.5	41.9	35.3	3.2	2.2	2.3	3.4	3.0	2.8	1.7	2.4	3.0	3.0	1.3	1.0	1.8	0.3	3.9	2.9	2.0	1.6	1.7	14.8	16.3	11.9	18.8	16.9	18.4	18.6	14.4	15.1	13.6	17.0	14.5	12.7	6.4	13.4	63.0	9.2	3.3	8.2	6.6	5.7	12.1	8.0	7.1	3.7	10.0	8.1	11.0	8.4	20.0	7.3	25.0	15.6	10.8	3.0	7.9	19.4	10.0	7.2	13.7	66.1	9.9	4.2	20.6	10.7	11.4	15.2	23.6	17.5	12.6	18.8	3.3	63.2	11.5	6.1	18.9	18.1	4.7	12.5	16.5	7.2	46.9	24.2	5.6	19.6	48.7	19.6	18.2	12.6	27.4	9.7	12.1	24.9	14.0	8.1	17.1	13.1	11.7	20.8	10.6	9.4	6.6	3.3	10.1	13.4	11.6	13.2	13.1
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase receptor type A"	P18433	20	2864184-3039076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	48.8	36.6	83.9	31.9	89.3	39.6	47.4	84.2	96.1	56.4	59.5	41.6	31.0	53.0	36.7	46.1	52.7	43.7	29.5	87.7	83.5	44.2	28.6	45.4	38.9	74.7	81.9	55.8	31.2	81.9	44.8	60.8	78.3	46.3	40.6	61.5	36.3	41.9	16.9	45.8	32.7	52.4	76.3	39.4	34.5	43.4	92.6	59.6	65.5	30.7	44.3	46.6	38.9	81.1	74.0	44.2	124.7	38.4	134.4	243.3	26.5	54.1	105.1	65.5	79.6	53.1	99.5	48.1	41.6	73.1	66.1	77.2	51.0	77.4	73.4	74.7	32.7	68.5	18.3	68.0	48.1	69.5	31.1	109.8	78.2	54.4	56.8	80.3	92.0	67.7	69.9	59.7	65.8	30.4	80.8	78.3	48.3	66.0	35.0	61.0	60.5	60.3	55.1	56.2	68.7	65.7	52.3	87.8	81.4	54.0	55.2	58.7	66.5	58.1	28.6	65.6	48.5	43.4	64.7	62.7	26.9	64.5	55.7	5.7	2.8	4.8	6.1	2.9	4.9	5.3	4.0	4.4	2.1	2.6	4.0	4.8	3.3	4.0	4.3	3.2	4.9	2.3	83.9	89.3	84.2	96.1	87.7	83.5	74.7	81.9	78.3	76.3	92.6	81.1	87.0	22.4	19.2	128.6	46.7	15.8	34.0	15.0	34.7	88.9	49.0	43.9	10.1	54.3	24.5	46.0	31.3	35.3	111.7	39.8	27.4	14.8	17.0	62.0	109.0	39.7	44.3	42.3	138.2	15.8	40.5	67.5	25.0	55.3	22.9	60.3	43.5	33.6	39.4	70.7	136.4	27.9	24.4	37.6	20.4	17.2	60.3	40.1	37.4	52.5	29.9	88.3	110.2	102.5	147.5	16.6	30.2	48.9	58.6	32.9	27.1	23.6	26.6	60.5	39.5	53.3	61.8	68.7	84.1	32.9	17.2	32.7	59.7	41.4	30.4	31.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRCAP	"CD45-AP, LPAP"	ENSG00000213402	"Protein tyrosine phosphatase receptor type C associated protein"	Q14761	11	67435510-67437682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 79.7;lymphoid tissue: 174.1"	"Group enriched"	"Detected in some"	6	"B-cells: 203.3;Plasma cells: 283.5;T-cells: 233.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 351.1;HDLM-2: 242.3;HL-60: 140.6;MOLT-4: 206.8;NB-4: 996.9;U-698: 248.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"			HPA043734	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA043734: AB_10962214"																		7.1	2.9	3.0	73.0	2.9	27.0	5.3	2.6	4.9	7.0	3.1	14.3	14.0	4.6	0.0	7.9	7.9	3.0	3.5	2.5	2.5	9.9	8.9	14.4	126.5	3.9	2.8	5.0	3.8	0.3	4.2	0.6	3.4	10.6	2.4	0.0	10.2	0.6	2.2	4.2	79.7	0.9	3.4	174.1	24.7	1.5	3.0	109.2	13.0	0.2	51.3	7.5	7.0	3.5	0.4	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.2	351.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	242.3	0.5	0.2	0.9	0.0	0.0	140.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	95.5	1.1	33.3	0.1	3.7	206.8	996.9	0.0	0.0	0.3	65.8	0.2	0.6	0.0	1.1	0.2	0.4	0.2	0.0	1.1	0.0	0.6	0.3	1.4	0.0	1.5	0.0	0.3	0.3	0.3	248.9	0.0	0.3	0.1	23.6	6.7	75.0	1559.9	5.6	1322.2	1334.4	955.3	1380.5	12.7	1714.2	688.5	1083.9	33.4	826.7	8.0	848.7	1374.2	1237.9	3.0	2.9	2.6	4.9	2.5	2.5	3.9	2.8	3.4	3.4	3.0	3.5	0.0	0.0	0.0	7.2	203.3	12.7	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	15.1	0.2	0.0	0.0	4.4	17.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.3	20.6	0.0	0.0	5.0	39.2	7.5	0.5	0.0	1.0	0.5	3.1	0.0	0.0	0.0	283.5	0.0	0.0	0.1	1.4	0.0	0.0	0.0	3.5	0.0	0.0	1.6	9.7	0.0	233.3	0.0	0.0	0.0
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase receptor type E"	P23469	10	127907103-128085855	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 634.6;plasmacytoid DC: 475.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	13.6	16.7	13.9	25.3	8.9	46.9	6.7	5.7	13.9	3.9	7.7	9.2	9.5	3.5	2.6	7.9	4.9	10.3	10.6	14.2	11.1	4.3	4.4	16.0	16.4	11.6	9.0	1.6	2.7	2.7	5.0	7.8	10.7	3.4	9.3	1.0	5.8	2.4	1.3	4.7	12.9	7.4	10.8	20.6	7.4	2.6	10.7	8.6	5.5	3.1	9.8	12.7	4.4	14.2	4.3	0.9	0.5	0.0	2.5	0.4	7.5	0.1	0.0	1.6	3.6	1.7	25.1	3.3	2.6	2.1	5.2	2.3	2.1	12.2	0.7	4.0	1.9	0.4	1.4	0.0	4.1	16.2	11.6	0.8	6.9	6.1	12.1	38.6	41.6	10.3	0.0	1.9	2.6	4.0	4.9	32.5	0.2	4.6	1.5	19.1	2.6	6.4	6.8	18.0	0.0	2.5	7.4	1.3	0.3	1.8	0.6	20.1	79.5	1.7	1.8	7.8	8.9	0.9	1.3	4.6	11.3	12.5	0.0	174.3	175.4	147.2	36.6	64.5	22.3	7.7	16.5	25.1	97.9	8.3	11.5	19.6	634.6	31.6	54.9	475.9	26.7	43.3	13.9	8.9	5.7	13.9	14.2	11.1	11.6	9.0	10.7	10.8	10.7	14.2	25.0	83.3	57.2	22.5	26.2	59.5	54.3	42.4	15.9	5.2	14.2	23.6	20.3	8.6	23.7	3.7	0.0	43.2	256.6	15.7	0.0	3.7	2.1	3.6	10.6	78.0	6.7	10.3	112.7	4.4	67.4	17.5	10.7	7.7	31.6	3.7	47.5	2.3	57.5	0.0	191.6	15.8	18.3	166.7	307.9	2.5	0.6	276.3	24.9	165.8	139.5	0.0	150.4	247.3	93.4	49.2	13.3	0.4	38.5	21.3	13.9	2.2	7.8	0.9	0.0	86.0	12.8	0.5	1.9	20.4	64.6	17.0	59.3	9.2	11.7	40.3
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 314.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		160000000		"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	91.7	11.9	47.1	14.0	48.4	1.8	57.4	22.3	45.6	36.3	4.7	79.5	70.5	28.0	71.9	101.7	70.5	30.4	7.6	45.3	39.9	27.7	107.2	35.4	4.7	33.1	43.6	22.1	56.8	31.1	23.5	55.7	33.1	67.3	51.4	24.7	101.7	43.1	2.7	107.9	78.5	35.0	30.4	4.0	49.7	9.4	45.6	29.6	23.8	3.4	26.2	40.0	51.2	37.4	165.6	76.5	49.0	58.0	11.2	0.6	274.3	92.1	36.1	73.9	62.6	82.0	214.9	0.4	25.6	40.2	59.2	124.7	57.5	200.7	89.1	2.0	72.1	1.0	48.7	75.3	33.8	1.2	1.3	11.3	113.2	106.4	174.9	92.6	111.5	7.7	25.4	7.1	27.5	94.0	1.2	1.3	75.9	89.8	21.0	57.2	86.9	3.7	28.3	241.5	73.3	28.0	90.8	314.0	11.8	128.8	91.5	17.3	88.2	1.6	116.5	7.5	126.1	3.1	2.7	0.4	7.4	3.9	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	48.4	22.3	45.6	45.3	39.9	33.1	43.6	33.1	30.4	45.6	37.4	2.3	157.0	101.1	39.2	2.3	62.8	51.3	67.4	52.9	33.5	146.3	102.9	7.6	130.1	74.9	86.5	43.8	64.3	1.4	259.9	0.0	147.4	4.9	80.6	17.2	7.7	100.9	8.0	40.6	120.8	290.1	19.8	93.8	70.6	5.1	72.8	10.4	159.6	14.1	185.1	16.1	171.7	50.8	4.9	5.8	8.5	6.8	3.4	12.4	7.5	2.9	27.2	2.1	16.6	68.1	165.0	124.7	7.2	1.8	68.0	208.1	13.9	128.3	31.0	0.0	15.8	18.5	9.0	37.5	107.5	91.4	66.2	3.9	9.6	142.5	78.7
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase receptor type G"	P23470	3	61561569-62297609	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.7;HSkMC: 61.1"					"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	18.0	13.2	7.6	4.6	7.8	0.0	12.8	4.9	10.4	11.9	23.4	8.2	3.7	10.6	8.4	4.1	9.0	8.3	10.0	13.7	6.2	14.4	5.8	12.8	1.8	8.4	7.2	12.0	3.9	26.6	5.2	9.9	5.9	7.8	6.1	8.6	5.2	8.4	7.4	4.5	5.9	13.0	10.0	7.0	5.8	7.7	9.1	2.1	13.1	10.4	1.7	7.0	6.7	5.0	0.0	5.3	27.3	0.0	81.7	41.6	13.5	17.6	28.5	18.2	24.4	13.2	0.5	0.6	10.1	20.7	14.5	0.2	13.4	13.6	28.3	1.5	7.7	1.4	0.1	15.0	27.5	7.5	0.1	61.1	5.3	25.9	30.9	5.8	19.7	2.0	0.0	17.3	16.3	7.6	0.0	0.1	17.0	0.1	0.0	11.9	8.6	0.6	18.2	8.2	2.1	4.5	4.3	0.1	6.9	11.2	0.2	0.3	46.0	25.4	24.1	41.0	14.7	5.5	6.8	0.0	19.2	3.2	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	7.8	4.9	10.4	13.7	6.2	8.4	7.2	5.9	10.0	9.1	5.0	45.3	12.8	32.4	356.8	2.2	9.2	6.4	5.0	13.1	98.5	9.6	6.3	12.5	8.6	5.8	22.0	6.2	10.5	0.9	12.1	5.9	9.6	3.6	14.4	31.9	55.5	24.6	0.0	416.1	1.8	0.8	47.7	4.1	30.5	0.0	64.6	90.3	32.7	19.7	154.8	684.3	8.9	22.4	2.9	8.8	4.3	66.5	1.1	17.8	771.0	0.6	40.8	2.1	920.3	11.8	5.3	5.6	56.8	4.2	10.9	13.9	18.2	2.8	5.7	72.3	81.1	60.6	2.0	8.6	2.1	4.8	12.6	2.3	20.0	12.1	2.7
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		670000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	6.0	3.2	10.2	20.5	13.8	29.5	6.1	6.9	14.9	6.2	18.5	10.2	9.4	2.4	7.8	1.9	4.1	7.1	2.7	10.0	12.7	13.9	11.9	10.0	15.5	9.7	11.7	1.6	6.1	15.8	10.1	7.6	12.4	7.9	8.7	8.1	10.1	7.0	2.4	4.2	14.5	5.9	6.0	23.3	14.6	2.3	18.5	7.0	19.6	2.7	11.0	6.9	2.1	14.7	7.6	28.3	12.1	7.0	1.9	4.1	4.2	7.5	5.5	12.9	9.2	2.0	40.8	6.9	51.8	19.1	19.6	6.0	19.0	2.0	14.9	46.6	5.4	1.9	34.9	2.8	12.1	2.7	41.5	3.2	0.6	3.8	1.0	31.7	7.8	0.5	2.6	4.4	4.7	17.0	0.1	17.3	9.7	25.7	4.4	1.6	1.6	4.0	52.6	11.1	7.9	2.5	20.2	12.0	19.4	8.9	13.0	20.3	25.7	9.9	10.8	20.5	23.4	1.1	1.7	11.4	11.7	8.0	37.3	0.7	1.1	2.8	1.6	2.0	1.0	0.8	0.9	1.2	0.8	0.5	0.7	0.9	9.5	1.0	4.7	1.5	1.0	0.8	10.2	13.8	6.9	14.9	10.0	12.7	9.7	11.7	12.4	6.0	18.5	14.7	1.5	9.6	16.7	43.1	11.3	0.3	9.8	0.8	0.6	13.6	8.3	4.1	3.7	17.2	13.0	38.6	6.2	1.9	32.7	35.5	0.0	7.4	5.5	13.5	2.2	4.5	12.6	3.2	81.0	5.0	0.6	4.0	22.4	22.9	13.9	2.5	5.0	15.6	30.0	10.1	167.5	10.1	2.0	74.2	5.7	8.2	0.3	40.2	1.8	189.3	36.0	10.3	21.6	239.8	167.7	11.8	28.0	0.4	12.9	25.3	37.6	13.5	4.9	1.3	0.0	3.3	4.9	0.2	4.8	0.5	0.3	1.9	22.0	2.3	7.6	8.2
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase receptor type M"	P28827	18	7566782-8406861	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 142.0;Astrocytes: 188.1;Inhibitory neurons: 751.6;Microglial cells: 263.3;Oligodendrocyte precursor cells: 224.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 4.7"	"Group enriched"	"Detected in many"	33	"dendritic cells: 1.8;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	Yes		130000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	53.1	24.1	18.9	11.9	37.6	1.2	41.8	13.0	27.7	18.4	44.2	25.3	8.7	24.2	11.9	14.2	23.3	32.4	61.2	12.7	38.7	29.5	11.8	38.9	15.5	21.7	53.0	26.4	13.2	23.4	16.1	33.2	34.3	16.7	11.5	19.3	10.9	36.0	52.5	12.3	15.1	24.8	5.8	23.1	18.4	22.8	47.6	16.7	54.8	63.4	11.9	23.9	12.2	14.4	4.6	33.4	15.7	0.2	98.0	67.4	38.7	41.1	35.6	26.9	39.5	30.9	7.1	0.0	39.0	49.1	0.5	0.3	0.2	14.3	36.9	0.5	7.2	0.0	22.2	15.2	27.9	0.0	0.4	77.1	29.3	14.9	42.1	51.1	27.2	0.0	0.0	13.8	21.8	0.7	13.7	0.3	2.6	9.9	7.3	0.5	13.5	63.9	64.9	57.6	1.4	8.6	1.1	0.2	34.6	24.9	0.2	0.0	28.2	54.9	34.6	26.4	7.2	1.1	0.4	0.3	46.8	0.2	10.4	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.8	4.7	0.0	0.0	1.0	2.0	0.0	0.0	0.0	1.8	0.7	1.1	18.9	37.6	13.0	27.7	12.7	38.7	21.7	53.0	34.3	5.8	47.6	14.4	142.0	44.8	36.0	188.1	1.1	6.0	7.3	3.0	2.8	28.3	2.5	3.2	26.7	14.3	7.1	5.5	2.1	11.4	5.4	0.9	1.9	17.6	25.9	28.9	15.6	68.9	1.8	0.4	70.1	8.3	3.4	14.0	8.2	59.6	2.5	13.0	47.2	25.3	9.9	0.0	751.6	1.4	0.0	8.0	5.7	42.0	2.8	5.1	30.2	263.3	0.6	2.9	3.1	224.7	50.3	14.3	1.2	5.3	2.3	8.3	3.0	13.3	15.6	2.2	6.6	7.4	9.9	8.6	9.9	0.9	2.8	12.6	5.7	3.7	0.8	8.6
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 234.3;pituitary gland: 182.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 59.0;Cone photoreceptor cells: 60.5;Enteroendocrine cells: 47.1;Excitatory neurons: 44.6;Horizontal cells: 97.6;Inhibitory neurons: 48.1;Rod photoreceptor cells: 38.4"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 66.4;U-87 MG: 249.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		38000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	0.7	25.2	91.6	4.8	98.3	0.6	0.2	12.2	139.0	0.2	0.0	5.3	1.6	0.3	0.0	0.3	0.1	0.3	0.3	116.6	234.3	0.3	0.2	0.2	0.1	62.4	85.5	0.2	36.3	0.0	182.3	0.2	138.1	0.4	0.8	21.4	0.1	0.0	0.1	0.9	2.0	1.6	22.2	0.1	6.0	0.7	98.9	0.0	0.4	0.0	0.0	0.9	0.9	70.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	2.5	0.0	0.8	0.0	0.1	0.0	0.0	1.2	4.6	6.8	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.8	1.9	0.0	0.6	8.4	0.0	20.8	0.0	0.2	0.0	0.0	0.4	0.5	1.5	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	10.8	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.1	66.4	0.0	0.2	0.1	0.3	1.1	249.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	91.6	98.3	12.2	139.0	116.6	234.3	62.4	85.5	138.1	22.2	98.9	70.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.1	0.0	59.0	0.1	0.1	2.0	0.0	0.0	0.0	60.5	0.0	0.1	0.1	1.9	0.1	0.3	0.1	0.2	0.7	47.1	2.7	44.6	0.0	0.3	1.9	2.6	0.0	0.0	0.0	0.0	0.3	0.1	97.6	48.1	0.7	2.0	0.0	0.4	0.8	0.3	1.8	1.8	4.7	0.0	6.0	0.0	1.5	4.0	2.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	38.4	0.0	0.1	1.9	4.2	2.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase receptor type O"	Q16827	12	15322257-15602175	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.8;kidney: 36.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 175.9"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	1.8	0.8	8.7	3.0	9.4	0.2	0.8	0.0	10.3	1.3	0.1	10.4	1.7	4.8	1.4	0.4	1.0	1.2	0.5	9.8	8.9	36.3	1.3	6.8	3.1	2.2	3.3	0.4	0.4	0.3	2.4	4.4	5.3	0.5	26.8	7.5	0.5	0.8	0.3	0.4	2.0	6.6	0.9	3.4	0.8	0.5	9.5	1.2	0.3	0.5	3.2	1.5	0.4	2.9	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.8	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.5	6.1	0.9	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.0	0.1	1.2	0.0	6.0	0.0	0.0	12.3	0.0	8.9	1.7	0.4	8.5	8.6	2.8	1.2	0.1	0.1	12.7	10.9	1.4	3.2	8.7	9.4	0.0	10.3	9.8	8.9	2.2	3.3	5.3	0.9	9.5	2.9	0.2	0.0	0.5	7.5	7.0	0.3	1.3	0.5	0.0	25.2	0.0	0.1	0.7	0.0	1.8	16.5	0.0	0.2	4.0	3.9	0.0	0.4	0.0	0.8	0.2	1.1	3.6	0.0	193.6	0.0	0.2	0.9	0.0	0.6	0.0	0.0	1.1	0.2	26.1	25.2	231.1	8.3	0.0	21.1	10.6	0.6	0.6	10.5	0.0	17.8	13.8	0.6	1.0	126.7	6.3	0.1	9.8	0.4	1.0	0.1	0.1	0.2	0.0	4.8	0.0	2.1	0.7	0.6	1.1	0.1	0.4	0.3	1.0	0.1	22.4	0.8
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.9;fallopian tube: 10.8"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 500.7;Inhibitory neurons: 700.2;Oligodendrocyte precursor cells: 418.7"	"Group enriched"	"Detected in many"	5	"breast cancer: 5.1;prostate cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 23.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.1	0.2	10.1	0.1	10.7	0.0	2.7	0.0	23.9	0.6	0.0	0.1	0.5	0.0	0.2	0.0	10.8	0.1	0.2	7.4	0.0	0.1	0.2	1.0	0.4	0.1	0.0	0.0	0.4	0.0	3.0	2.8	0.0	0.2	0.0	3.6	1.0	2.6	0.0	0.4	0.3	0.0	0.0	0.1	0.8	1.6	0.0	6.3	0.0	0.1	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	10.7	0.0	23.9	7.4	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.4	0.0	1.1	13.1	0.0	0.9	0.0	0.0	0.0	36.2	2.6	6.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	3.2	0.1	0.2	0.0	0.0	500.7	0.0	0.0	1.2	0.0	0.2	0.0	3.3	6.4	0.2	0.2	5.0	700.2	0.0	0.0	0.3	0.3	12.6	0.0	0.1	0.0	8.4	0.0	10.3	0.0	418.7	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	18.5	2.1	0.0	0.5	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 22.1;Respiratory ciliated cells: 24.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	7.1	2.1	12.6	1.1	18.3	0.1	6.9	6.4	16.1	31.1	6.1	5.3	0.7	11.9	3.3	4.3	11.5	4.8	8.7	14.4	10.0	4.9	9.1	9.9	0.6	29.1	18.9	13.0	11.1	9.2	10.2	11.5	28.0	14.0	1.4	18.8	14.6	12.9	17.5	10.1	2.4	1.9	6.3	2.1	5.9	4.0	9.7	1.0	5.2	9.9	1.3	12.3	12.2	11.1	8.1	10.8	0.6	1.6	28.7	1.0	95.7	8.4	7.4	0.3	0.5	9.4	34.7	1.4	16.2	1.6	1.0	42.3	38.5	27.1	0.1	0.5	19.7	1.7	12.1	39.8	12.1	0.0	1.7	13.3	14.4	0.0	2.5	11.3	0.2	4.7	0.3	1.3	7.6	13.2	0.5	0.2	15.8	15.9	4.9	0.0	11.3	0.5	11.7	39.4	32.3	42.0	8.5	26.3	5.8	6.6	15.6	1.8	7.1	1.4	9.3	2.6	1.2	0.8	1.1	0.1	18.8	1.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	6.4	16.1	14.4	10.0	29.1	18.9	28.0	6.3	9.7	11.1	1.0	9.6	13.6	0.7	0.1	1.5	6.7	22.1	1.8	5.3	4.8	5.6	5.2	5.7	20.2	5.5	12.5	18.7	0.5	0.3	0.0	6.2	1.3	8.6	9.4	1.3	0.0	0.0	12.1	2.7	10.5	4.6	0.0	10.1	1.3	0.7	1.8	5.3	2.6	0.0	8.0	0.2	6.1	0.6	1.1	1.2	4.7	0.4	8.8	3.7	0.0	16.7	0.0	8.5	4.4	7.3	0.0	7.2	1.2	6.5	0.0	0.3	24.3	42.6	6.6	5.5	4.1	2.1	6.4	0.2	0.6	9.0	0.6	0.0	0.2	10.0
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PTRH1	"C9orf115, PTH1"	ENSG00000187024	"Peptidyl-tRNA hydrolase 1 homolog"	Q86Y79	9	127690348-127724873	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 125.4;Theca cells: 460.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021223	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA021223: AB_1845798"	"unprognostic (6.58e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.46e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.74e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-2)"	16.6	25.5	9.0	5.0	9.1	4.3	15.7	8.0	13.7	11.9	6.8	12.1	4.3	12.7	9.5	10.4	15.1	3.8	18.3	9.1	7.8	26.7	18.1	12.7	3.3	6.7	6.9	8.3	20.9	7.7	17.7	2.7	6.8	13.6	2.3	2.8	11.5	5.3	19.9	24.8	7.6	3.5	6.0	12.6	14.5	17.4	8.2	4.1	20.1	3.3	2.5	12.9	9.6	8.3	28.4	11.7	2.2	7.5	3.9	5.1	20.3	18.6	5.0	7.0	3.9	5.2	10.1	9.4	24.3	8.0	9.2	31.0	2.4	13.3	2.5	15.4	3.5	4.0	15.4	11.8	11.2	6.3	12.0	4.2	13.1	8.6	8.9	3.5	13.4	14.2	11.8	8.2	7.8	24.4	12.7	7.9	3.5	23.5	52.9	10.0	5.5	22.9	13.2	5.6	11.9	10.7	18.7	23.0	14.4	2.0	20.3	3.0	15.8	9.2	13.9	36.0	11.1	23.5	14.1	7.1	13.2	4.2	11.8	8.5	31.1	14.0	67.5	37.2	69.3	21.7	34.3	68.5	28.0	17.1	24.8	57.0	4.0	28.1	20.1	25.3	37.2	31.6	9.0	9.1	8.0	13.7	9.1	7.8	6.7	6.9	6.8	6.0	8.2	8.3	17.4	3.2	9.1	2.0	8.6	17.0	41.2	27.4	9.1	28.3	26.5	23.1	0.3	21.5	13.8	47.8	45.9	13.1	13.4	11.2	66.5	60.5	86.6	54.9	25.2	19.7	30.1	10.8	1.3	33.6	23.7	20.1	10.7	25.5	17.2	15.8	18.5	28.1	46.6	16.8	1.0	25.8	32.6	11.3	13.9	18.7	22.1	11.6	16.0	1.0	15.4	22.2	22.6	2.0	1.0	48.1	13.4	94.0	8.8	85.3	14.6	125.4	43.8	59.0	0.0	15.2	17.0	24.6	9.2	14.4	21.2	18.7	16.0	460.9	17.5	34.8
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	20.8	25.9	24.3	17.3	25.1	14.5	27.6	25.0	31.9	19.7	23.6	24.1	15.3	18.8	48.5	18.1	18.4	18.2	14.5	25.1	26.1	18.5	45.7	14.7	19.0	25.9	26.1	16.9	19.5	18.6	14.1	18.6	26.7	20.7	27.5	10.2	15.9	18.6	25.0	15.7	13.2	22.9	24.8	17.5	16.1	19.5	24.9	17.3	16.2	20.9	24.1	44.0	11.8	27.4	75.9	142.9	44.3	40.8	84.8	72.6	47.4	70.6	63.8	60.7	89.0	94.1	57.7	54.1	105.0	60.9	101.1	73.3	98.4	93.8	89.4	104.2	133.2	96.7	72.3	176.2	129.4	86.0	52.5	82.0	120.9	93.9	108.5	42.8	102.5	37.4	111.3	58.2	92.4	187.9	74.2	71.2	38.0	194.5	113.4	39.1	74.8	80.7	103.7	109.2	57.9	74.2	36.7	39.6	91.5	50.7	93.1	61.1	67.2	77.8	77.8	47.1	77.9	73.6	91.9	82.3	50.7	54.4	60.4	6.1	69.0	2.9	22.7	67.4	30.9	43.1	26.3	25.7	50.0	33.1	37.4	27.0	29.0	34.8	86.0	59.4	34.0	37.9	24.3	25.1	25.0	31.9	25.1	26.1	25.9	26.1	26.7	24.8	24.9	27.4	21.4	16.0	13.6	5.5	18.7	36.7	50.1	48.1	27.9	4.1	17.1	22.4	15.4	11.5	51.6	11.0	4.2	26.8	13.0	8.9	11.7	27.2	22.1	23.4	33.1	22.5	6.7	17.9	9.8	25.6	25.0	29.7	17.3	24.1	22.8	12.8	12.8	31.5	16.9	8.4	9.1	10.3	22.4	9.7	17.2	12.0	17.4	14.6	14.2	2.8	11.4	7.2	13.4	7.5	11.5	28.8	12.3	9.8	24.8	35.1	10.0	16.5	33.3	3.4	13.1	25.4	32.2	33.4	13.3	21.3	35.7	31.7	12.6	22.4	16.7	37.5
PTRHD1	"C2orf79, LOC391356"	ENSG00000184924	"Peptidyl-tRNA hydrolase domain containing 1"	Q6GMV3	2	24789728-24793391	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019951	Approved		Approved	Nucleoplasm		NA	NA		100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA019951: AB_1853109"	"unprognostic (1.28e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	10.6	26.0	11.7	4.3	11.8	16.1	11.0	12.2	17.5	8.7	13.7	12.8	10.6	7.2	3.5	17.6	6.4	4.2	16.4	12.5	12.6	14.9	14.9	10.2	8.4	12.4	11.9	10.2	13.7	3.6	10.8	6.4	12.6	10.6	5.8	3.0	15.1	4.0	23.9	14.8	11.9	3.3	12.5	11.2	12.3	9.1	12.8	7.1	14.5	8.5	6.2	9.4	10.3	13.0	18.2	40.2	12.7	5.5	6.9	15.2	22.1	12.2	11.3	15.4	9.9	39.7	15.9	14.2	5.2	12.7	10.3	11.7	10.4	11.1	5.1	20.1	70.0	25.7	18.2	43.2	14.2	21.8	23.5	14.6	8.9	7.1	7.9	12.3	14.4	12.8	26.4	11.2	11.4	36.6	17.7	39.0	26.8	10.6	23.7	14.9	38.9	23.9	18.1	31.2	19.9	30.9	13.6	18.1	16.4	5.9	17.7	15.9	24.2	13.6	21.4	6.7	11.2	8.7	28.1	15.4	12.4	13.3	9.3	34.8	90.6	20.7	52.6	66.9	26.8	96.4	51.4	46.2	144.5	81.2	46.6	54.8	10.4	52.8	50.1	149.0	84.4	97.0	11.7	11.8	12.2	17.5	12.5	12.6	12.4	11.9	12.6	12.5	12.8	13.0	27.8	51.3	61.5	1.0	65.0	119.8	79.4	123.3	72.3	10.5	171.4	239.4	81.0	60.1	83.8	66.2	6.2	200.0	87.9	127.0	115.4	91.0	130.9	53.5	37.5	46.9	88.1	68.1	1.9	142.0	153.7	57.4	50.4	48.8	41.2	121.1	62.4	101.5	134.5	1.7	2.2	158.2	79.3	112.5	154.3	157.1	47.2	79.9	67.6	3.7	154.6	78.7	65.9	1.0	2.3	124.2	128.8	39.9	46.6	74.3	120.9	199.2	107.1	12.2	72.3	34.5	56.0	135.6	78.6	133.6	141.8	167.7	52.5	110.4	162.2	125.3
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226367-112269955	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001481	Uncertain		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	11.7	63.0	17.6	10.2	18.7	22.7	20.5	20.2	27.6	17.5	20.2	18.9	15.0	13.6	29.7	29.0	11.7	20.6	8.8	16.5	25.1	44.7	68.9	7.8	10.5	23.1	26.1	9.9	15.0	29.0	32.8	18.0	24.6	21.1	21.5	19.0	17.5	16.4	18.5	17.0	16.1	13.0	19.7	7.7	27.4	10.3	20.5	4.4	23.2	10.9	12.4	21.7	19.2	21.6	24.5	24.2	33.4	12.9	23.9	26.8	35.4	78.3	38.8	45.5	48.5	57.0	26.1	28.5	53.5	51.6	60.8	38.0	47.5	54.8	50.6	19.7	28.8	7.5	44.6	55.8	70.9	18.4	4.0	47.8	77.1	43.9	53.0	36.5	35.2	24.6	24.9	16.8	30.1	29.8	14.8	23.8	23.1	54.2	48.3	9.4	6.3	37.6	101.2	38.8	32.2	32.5	41.1	43.8	26.0	109.0	32.3	15.2	40.2	42.5	43.0	49.7	60.7	9.9	20.8	69.4	29.3	19.4	44.1	1.1	0.4	0.4	1.2	0.7	1.3	1.5	1.7	1.8	0.7	1.6	1.1	1.5	0.2	1.5	2.0	2.0	1.9	0.7	17.6	18.7	20.2	27.6	16.5	25.1	23.1	26.1	24.6	19.7	20.5	21.6	43.7	19.2	26.5	13.1	28.6	122.6	80.4	146.2	59.2	17.4	69.4	69.0	95.0	47.1	85.7	55.2	0.0	56.7	41.4	80.0	211.3	91.9	5.5	66.4	37.0	42.8	80.0	23.2	16.8	78.9	120.7	47.9	37.8	72.6	20.8	45.1	34.6	123.6	36.9	10.1	25.4	73.1	150.5	21.4	38.1	7.6	14.6	28.4	26.6	15.0	26.1	48.5	22.6	17.6	36.1	114.4	74.4	25.9	33.0	91.9	58.3	151.0	80.8	18.3	26.3	22.7	70.8	23.3	92.6	65.4	131.1	70.3	28.5	59.6	44.4	114.9
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"PTTG1 regulator of sister chromatid separation, securin"	O95997	5	160421855-160428739	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.1;lymphoid tissue: 144.9;testis: 175.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 218.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 218.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	3.7	3.5	4.2	25.2	5.3	160.1	10.9	4.1	11.5	9.6	4.0	33.9	24.6	4.8	9.6	59.7	5.0	6.1	3.5	8.1	6.6	3.0	5.3	8.7	81.5	3.9	4.8	1.8	1.5	2.3	4.3	21.2	4.2	3.1	44.1	2.4	10.3	2.7	2.5	36.0	24.1	19.2	4.0	18.6	11.8	175.6	5.3	127.0	79.3	1.3	144.9	12.5	19.9	4.7	345.4	178.2	385.8	279.5	64.4	63.3	120.8	177.5	406.1	463.4	503.5	341.1	294.9	373.3	154.7	204.2	527.5	176.1	243.5	496.1	661.2	428.3	220.3	196.7	241.8	208.6	13.0	181.5	165.6	29.6	81.5	315.4	189.5	139.9	333.4	243.3	160.7	282.3	485.4	162.3	220.7	446.1	197.5	279.3	251.4	199.4	452.4	320.7	239.6	82.6	241.0	151.3	258.6	156.3	535.6	309.3	319.9	195.7	144.8	208.3	275.9	164.9	531.3	239.2	235.6	432.3	225.9	310.4	379.6	9.7	3.2	10.3	25.5	8.7	9.6	30.9	52.3	60.6	23.9	23.5	12.7	31.4	3.0	14.6	5.8	22.6	218.0	19.8	4.2	5.3	4.1	11.5	8.1	6.6	3.9	4.8	4.2	4.0	5.3	4.7	11.8	6.4	21.5	0.0	40.0	247.9	64.5	163.6	142.3	3.4	15.8	40.5	4.0	4.3	31.1	5.5	0.0	125.4	38.3	17.7	3.9	5.8	770.5	22.7	9.3	20.6	6.0	415.9	1.3	5.3	196.2	35.6	28.1	16.7	37.5	66.2	18.5	7.1	87.5	0.0	1.6	39.2	126.1	36.3	412.3	105.1	11.1	39.1	87.2	0.0	24.7	3.5	6.2	0.0	0.6	3.0	10.7	7.9	91.4	54.1	9.0	2.0	17.1	1.0	6.6	18.6	43.2	708.0	57.3	232.0	156.1	31.9	73.7	16.8	70.3	50.3
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm		NA	Yes		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: AB_2684620"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	127.8	131.8	147.6	98.4	158.9	92.0	114.0	150.8	146.8	131.1	131.1	132.7	123.2	132.4	118.5	89.1	109.4	141.8	164.3	138.1	168.7	157.6	130.5	160.5	75.3	178.8	152.9	110.7	85.6	84.1	68.8	180.1	169.9	108.5	111.5	29.7	118.3	151.4	70.7	88.9	127.3	145.0	152.0	97.7	169.9	66.9	175.3	57.9	127.4	63.2	62.0	139.6	93.3	157.5	245.3	134.6	155.3	148.2	300.6	174.8	127.0	212.9	309.8	174.1	166.6	290.0	323.9	32.9	789.8	344.4	417.0	109.8	73.0	140.2	161.1	56.3	81.0	254.3	80.0	260.1	293.8	97.6	83.5	269.9	225.1	189.1	130.8	346.3	376.6	88.6	131.7	83.1	539.5	106.0	71.0	99.5	166.8	352.9	169.8	70.4	158.4	162.0	735.6	82.7	117.2	182.0	240.0	262.5	482.0	188.7	203.7	163.7	511.8	216.9	126.5	170.6	340.0	78.5	79.4	42.2	146.7	220.6	199.8	336.2	181.2	109.1	48.4	146.7	79.5	25.5	62.7	51.3	203.3	23.6	59.7	41.0	248.8	67.3	167.0	92.5	87.3	223.7	147.6	158.9	150.8	146.8	138.1	168.7	178.8	152.9	169.9	152.0	175.3	157.5	140.9	394.2	169.6	39.8	28.0	50.7	84.1	181.3	61.5	14.6	102.0	96.8	173.0	75.8	248.9	145.3	6.2	218.6	56.8	321.4	49.0	323.0	51.5	115.0	115.0	191.6	79.3	37.8	8.5	120.6	72.7	117.1	140.6	187.7	81.5	181.3	124.2	102.2	109.3	11.8	10.7	89.1	130.2	88.0	69.6	98.7	72.1	136.3	87.2	22.5	91.1	78.8	51.5	20.1	31.9	294.3	255.2	98.9	36.4	112.8	268.1	71.2	192.3	15.2	65.7	61.1	127.9	73.7	43.4	92.4	42.9	366.7	45.6	54.6	100.3	169.9
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960398-37961128	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.7;Early spermatids: 5.2;Langerhans cells: 12.9;Smooth muscle cells: 3.7;Spermatocytes: 4.3;Suprabasal keratinocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"		"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	0.2	0.0	0.5	0.2	0.7	1.1	0.1	0.6	1.0	0.4	0.2	1.4	0.0	0.5	0.3	0.1	0.5	0.2	1.0	1.0	0.0	0.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.4	0.3	0.1	0.0	0.1	0.2	0.7	0.1	0.4	0.3	0.1	0.9	0.3	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.3	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.6	1.0	1.0	0.0	0.3	0.1	0.4	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.8	4.7	0.7	0.7	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.6	1.5	0.0	0.0	0.0	5.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.6	12.9	0.5	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.6	3.7	4.3	0.2	0.0	2.8	0.0	0.6	0.0	0.2	0.4
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436850-157443633	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 231.5;urinary bladder: 191.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 16.2;Fibroblasts: 44.7;Glandular and luminal cells: 24.0;Langerhans cells: 23.6;Macrophages: 27.0;Melanocytes: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;thalamus: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1219.3;ASC TERT1: 1751.7;BJ hTERT+: 1201.8;HHSteC: 2261.1;HSkMC: 2364.2;hTEC/SVTERT24-B: 1276.5;TIME: 1761.1;U-2197: 1605.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	970000	"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	231.5	11.1	0.4	38.8	0.4	89.0	57.9	0.6	1.9	2.8	1.1	13.0	0.8	2.5	0.5	2.9	21.4	7.7	46.8	0.6	0.5	6.8	2.6	83.2	0.9	0.7	0.6	1.4	41.6	1.1	4.4	11.4	0.6	6.9	2.3	0.4	5.4	0.5	5.2	25.4	9.7	5.7	0.3	23.6	24.8	0.7	4.0	1.6	5.8	0.5	0.3	191.7	3.1	0.4	1.2	0.0	752.4	0.2	1219.3	1751.7	0.3	132.3	1201.8	56.2	60.9	0.7	7.9	0.2	460.6	157.4	87.6	0.0	0.3	1.1	110.5	0.8	0.3	2.0	0.1	0.0	2261.1	2.5	0.0	2364.2	0.8	1276.5	429.8	110.2	266.4	0.1	0.3	0.0	380.1	0.0	0.3	2.9	11.2	0.0	4.6	0.2	0.0	0.2	5.3	53.1	6.0	0.8	7.6	1.0	0.9	0.1	0.6	2.4	1761.1	252.2	12.2	1605.1	23.0	0.2	0.5	0.9	52.8	6.4	74.2	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	1.9	0.6	0.5	0.7	0.6	0.6	0.3	4.0	0.4	2.3	0.0	1.7	0.0	0.1	1.7	1.7	0.3	0.0	1.8	3.6	0.6	0.6	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	7.2	2.4	16.2	10.3	5.1	0.0	0.0	0.5	0.0	0.1	44.7	0.0	24.0	0.0	0.7	3.3	0.0	2.6	0.0	1.0	0.0	0.0	10.0	23.6	1.2	0.3	27.0	14.2	0.0	2.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.8	0.0	4.0	7.2	0.0	0.4	0.4	1.0	0.3	0.4	0.0	0.0	0.4
PTX4	C16orf38	ENSG00000251692	"Pentraxin 4"	Q96A99	16	1485886-1488981	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"brain: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HL-60: 21.2;NB-4: 15.7"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA073694	Supported				"Secreted - unknown location"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"				"HPA073694: AB_2732237"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-4)"	"unprognostic (3.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.23e-3)"	"unprognostic (4.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.03e-1)"	0.1	0.2	0.6	0.0	0.2	0.7	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.5	3.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	15.7	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.2	0.3	0.4	0.8	1.5	3.1	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829352	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 332.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	71.6	73.5	7.9	11.0	7.6	39.6	75.5	8.1	22.9	71.4	5.3	84.8	22.3	84.9	5.9	84.9	76.3	7.3	88.5	7.8	15.4	82.8	124.3	64.0	17.7	12.2	11.6	57.2	62.9	11.7	71.0	19.2	14.1	67.2	5.8	1.3	63.3	17.8	125.5	108.7	69.5	10.5	7.3	72.3	73.2	70.8	14.5	15.9	59.8	9.0	9.7	74.5	68.6	12.4	95.7	211.5	36.7	31.3	16.6	15.6	62.7	74.4	27.4	70.3	75.1	95.4	103.9	89.4	71.2	58.9	52.8	83.0	86.5	91.4	3.6	91.4	147.7	110.2	117.0	106.3	60.4	38.5	70.0	45.4	61.8	89.8	26.9	21.1	69.0	92.1	88.7	37.4	20.5	332.5	156.1	26.4	77.8	63.3	191.6	84.2	42.9	91.8	19.5	91.8	71.5	80.3	101.6	40.4	77.7	9.1	116.7	21.4	79.0	72.9	176.2	85.7	98.6	66.7	103.9	109.7	70.7	73.3	71.9	90.8	112.6	99.8	129.0	133.7	139.3	116.8	103.1	128.6	127.1	135.9	98.6	113.1	58.8	132.6	137.6	76.8	139.0	193.9	7.9	7.6	8.1	22.9	7.8	15.4	12.2	11.6	14.1	7.3	14.5	12.4	70.2	38.5	46.4	21.5	64.7	107.7	102.1	197.4	65.4	62.8	51.3	67.9	63.7	51.5	103.0	29.5	29.2	146.6	56.4	98.0	92.0	110.7	20.5	65.6	55.3	67.3	66.9	65.0	8.2	89.8	134.3	68.4	74.9	60.3	55.8	75.0	41.7	76.8	101.1	43.7	8.3	75.9	118.0	44.0	62.3	47.8	64.0	52.3	90.7	6.5	105.2	182.6	81.4	9.5	23.7	98.2	91.4	59.0	52.7	83.0	91.9	118.1	85.4	64.8	65.7	57.1	122.9	104.2	128.5	63.1	107.1	173.3	74.2	99.3	97.7	81.2
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	27.8	26.0	33.4	22.5	34.3	52.0	31.9	37.5	37.8	28.0	28.5	26.7	22.5	32.2	29.3	25.7	35.0	22.7	28.6	33.7	42.5	28.7	25.9	25.6	26.2	27.0	30.0	40.3	27.5	39.3	19.2	32.4	28.0	27.3	29.4	38.4	30.3	28.0	46.1	32.7	22.6	31.6	27.8	25.7	26.3	18.4	45.5	35.1	34.9	38.3	26.1	27.1	26.0	31.5	33.7	43.7	70.4	44.7	54.1	46.5	48.2	39.3	47.9	40.3	45.5	46.0	56.6	39.3	40.2	53.8	25.2	48.2	58.3	43.4	51.4	33.2	50.8	42.8	50.7	56.0	37.9	52.6	39.2	50.0	53.3	53.5	56.1	52.8	55.6	36.9	60.0	36.1	46.5	28.1	51.6	37.8	72.2	42.0	30.2	53.1	48.0	42.3	58.7	50.0	58.0	44.0	54.5	41.7	47.6	77.6	42.1	39.3	58.5	33.2	29.8	44.7	39.7	28.8	28.3	42.5	29.7	38.3	43.0	44.1	31.3	24.8	31.0	30.3	31.7	23.9	27.5	30.3	32.0	21.1	31.0	32.0	19.6	37.9	34.5	18.5	35.9	31.0	33.4	34.3	37.5	37.8	33.7	42.5	27.0	30.0	28.0	27.8	45.5	31.5	66.6	73.7	58.8	85.2	56.9	90.2	53.8	41.2	56.3	54.6	63.2	58.7	80.7	61.5	46.3	36.8	79.2	52.6	66.4	56.4	23.5	44.0	32.2	139.8	98.0	61.5	104.7	34.3	87.0	36.4	42.4	56.8	55.0	154.6	18.3	105.1	43.2	61.0	34.0	33.7	87.5	65.6	24.4	78.3	49.8	21.5	72.1	50.4	17.8	102.1	56.6	41.6	69.0	111.6	101.7	58.1	45.0	80.5	41.7	84.6	28.8	49.2	42.7	59.2	32.9	81.6	65.5	36.4	24.4	62.9	93.6	78.0	50.5	63.6	75.8	95.5
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	27.6	29.8	29.7	33.4	31.7	33.4	41.7	42.5	32.7	36.2	32.4	36.5	34.4	36.3	32.8	39.2	29.7	27.1	33.1	31.1	30.9	36.8	43.1	33.2	48.6	26.0	29.3	44.6	27.4	41.4	8.3	40.3	26.1	37.3	37.0	66.8	33.0	33.1	21.5	47.2	35.6	32.3	29.1	42.6	35.8	24.9	31.6	70.5	57.6	32.6	47.6	38.0	18.3	37.6	72.4	50.0	65.3	46.1	40.2	40.5	65.9	49.2	53.6	48.4	42.2	43.5	33.0	96.3	11.0	44.9	58.2	38.9	61.4	35.6	71.2	87.0	38.2	105.0	35.3	62.2	43.4	107.2	93.3	29.7	79.7	42.1	77.4	45.5	53.1	57.1	75.0	82.9	57.3	35.5	93.6	65.9	55.8	68.3	31.5	80.6	110.9	73.8	45.0	68.1	55.9	76.6	42.2	58.3	48.1	43.4	33.0	61.5	52.5	58.6	58.5	38.3	64.6	93.3	123.0	181.8	35.3	75.8	51.4	11.5	4.0	5.8	6.0	5.2	7.1	4.8	6.7	7.5	4.2	5.3	7.3	6.0	11.6	7.7	7.3	3.7	5.8	3.7	29.7	31.7	42.5	32.7	31.1	30.9	26.0	29.3	26.1	29.1	31.6	37.6	43.6	35.3	51.6	89.5	57.6	79.7	32.2	26.4	74.0	94.6	46.9	30.5	46.5	32.9	33.8	47.8	62.6	36.3	43.6	44.0	11.7	16.6	10.1	33.9	35.6	45.0	34.6	41.0	134.7	15.5	16.9	36.5	43.8	45.9	20.3	53.0	41.4	56.3	29.1	58.9	153.5	43.2	38.7	70.7	44.2	5.8	34.2	44.9	32.0	144.3	42.7	26.8	43.3	155.3	186.0	22.6	28.1	26.4	54.7	57.8	33.9	29.7	39.5	72.3	32.9	40.5	47.6	16.8	16.6	75.2	106.3	52.0	50.1	31.2	40.2	56.6
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844095	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 338.4;HEL: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.5	16.7	6.2	22.3	5.9	19.0	24.7	8.1	5.6	13.8	4.9	15.8	12.8	14.7	9.8	24.8	13.5	11.7	12.0	5.5	5.7	21.8	15.2	15.4	23.2	5.0	4.7	18.3	14.8	12.2	10.1	18.0	5.3	12.5	18.7	7.4	16.8	10.6	11.1	16.6	11.7	13.6	4.2	14.7	13.2	15.4	5.2	17.1	11.9	9.4	22.0	30.7	16.0	6.7	78.9	56.7	47.0	48.2	38.6	40.8	53.5	71.7	37.6	72.3	67.3	43.6	36.0	86.4	16.1	49.5	43.2	38.8	85.8	62.0	93.5	338.4	30.7	327.8	59.3	52.9	51.0	146.2	58.7	33.3	26.8	58.8	83.5	33.0	54.3	55.6	35.0	38.1	63.8	36.0	74.6	119.9	120.4	59.9	25.1	86.7	36.8	37.3	48.8	52.7	48.4	46.4	43.2	39.8	40.3	52.0	25.2	78.4	52.1	48.6	40.2	46.8	97.1	17.7	31.0	120.5	36.8	52.4	36.1	7.7	13.7	4.1	18.8	19.9	26.3	23.4	19.3	18.9	18.5	22.4	21.2	20.7	1.9	25.2	17.1	20.8	15.7	11.8	6.2	5.9	8.1	5.6	5.5	5.7	5.0	4.7	5.3	4.2	5.2	6.7	27.7	48.1	41.4	0.0	35.8	0.0	59.6	0.0	62.6	28.0	27.5	26.7	0.0	14.3	41.5	23.9	10.4	34.7	25.5	1.9	46.9	41.2	4.8	36.7	79.1	28.3	8.5	23.8	0.0	26.5	45.4	30.9	35.2	54.9	17.7	39.8	20.0	22.1	21.6	26.9	0.0	9.2	0.0	15.8	0.0	4.9	47.2	20.6	0.0	0.0	29.4	14.2	25.7	0.0	0.0	29.1	8.0	23.0	29.2	57.7	7.6	108.3	32.1	24.0	0.0	50.2	26.8	43.7	45.3	54.3	0.0	35.0	26.5	44.5	12.7	38.2
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
PUS1		ENSG00000177192	"Pseudouridine synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.5	14.9	10.1	14.9	8.4	23.0	10.4	8.2	10.2	9.7	7.6	11.9	9.7	12.5	14.0	16.5	11.2	7.1	8.7	8.9	5.9	13.0	21.6	9.0	18.5	7.1	5.1	8.6	14.8	5.4	8.7	6.4	6.2	10.9	7.9	5.0	9.3	6.8	14.2	14.4	14.0	7.4	4.4	15.8	12.7	13.0	6.9	8.6	9.5	4.8	10.6	14.2	10.7	9.2	45.3	58.1	13.7	24.0	13.0	21.5	82.2	34.5	14.2	25.4	16.3	64.5	28.7	53.2	38.3	18.6	19.9	56.0	44.4	32.2	16.3	24.0	90.6	54.0	30.9	56.9	34.0	93.5	47.4	21.7	25.6	28.9	24.8	12.3	25.0	36.8	68.0	15.6	14.9	77.9	61.9	83.4	71.5	36.7	87.3	57.8	19.2	55.4	20.8	61.7	37.5	20.8	28.6	38.9	32.5	13.1	42.5	99.3	22.7	20.2	43.3	43.1	50.0	43.5	35.5	64.5	20.7	73.6	28.4	1.0	1.3	0.2	2.0	1.0	1.5	4.6	1.7	2.1	1.1	4.2	2.4	1.3	1.1	5.6	0.9	3.0	1.8	0.9	10.1	8.4	8.2	10.2	8.9	5.9	7.1	5.1	6.2	4.4	6.9	9.2	7.0	0.0	6.1	9.8	10.7	29.6	22.3	8.4	6.2	6.2	10.7	10.5	5.3	8.6	6.2	5.5	22.9	13.9	11.7	10.9	5.9	12.3	0.9	6.6	10.1	11.1	14.4	13.2	11.9	9.6	19.1	8.3	15.3	7.7	16.5	11.7	6.1	12.9	15.2	0.0	8.4	20.1	10.2	7.3	8.1	3.0	7.8	7.2	7.2	9.4	8.8	4.4	6.2	5.0	7.1	16.3	6.9	9.4	8.8	35.4	4.0	13.7	4.9	10.0	6.6	15.9	9.3	18.5	19.7	14.7	22.7	8.6	9.5	14.3	18.8	21.4
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridine synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	3.6	3.7	2.7	4.1	2.7	5.1	5.4	2.9	3.4	3.0	3.2	3.6	7.5	3.3	6.4	2.7	3.7	4.1	3.7	2.7	2.5	4.8	15.0	4.9	6.8	2.7	2.6	4.8	4.0	3.9	2.9	3.2	3.0	4.8	4.4	3.9	3.8	2.6	3.1	4.9	9.3	2.7	2.9	4.8	3.4	4.5	2.9	4.5	6.9	1.8	6.8	2.6	1.6	3.6	3.2	1.7	4.9	8.4	4.1	4.6	5.3	6.1	5.5	6.0	5.6	4.8	4.4	12.8	6.3	3.4	5.4	4.2	5.7	4.9	7.4	10.0	2.9	9.0	2.5	15.9	7.6	10.6	5.8	5.3	6.0	4.2	9.4	7.7	7.9	9.1	9.2	6.4	4.6	2.7	8.0	8.7	4.4	3.0	3.5	7.7	6.6	4.7	4.3	6.3	2.8	3.9	5.0	9.7	9.9	3.5	3.4	6.3	5.9	5.7	4.6	3.9	4.7	8.1	3.8	23.6	5.0	6.8	6.5	9.1	1.2	1.1	2.3	1.3	2.5	3.0	1.4	1.6	0.9	1.7	1.7	1.9	2.3	3.1	4.8	3.0	1.0	1.1	2.7	2.7	2.9	3.4	2.7	2.5	2.7	2.6	3.0	2.9	2.9	3.6	6.6	0.0	14.3	20.5	6.8	2.4	3.5	3.3	1.8	6.6	5.9	2.8	5.1	1.5	4.3	3.7	0.0	7.0	8.1	11.9	7.9	3.7	1.6	6.2	4.3	5.8	1.2	5.9	28.3	5.1	4.7	3.1	5.1	8.5	0.0	9.9	4.6	16.3	5.8	1.7	21.7	2.5	4.1	5.7	2.1	1.8	3.1	4.6	1.8	14.0	9.0	7.0	7.2	19.1	24.4	3.5	3.0	1.5	4.6	3.8	26.7	6.3	7.7	7.1	6.6	3.1	3.0	13.9	13.4	3.9	2.3	12.4	6.6	8.2	4.5	10.6
PUS3	FKSG32	ENSG00000110060	"Pseudouridine synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.3	8.4	7.1	8.2	7.8	3.3	9.4	8.4	11.6	7.7	6.7	8.5	10.9	7.8	9.7	9.0	7.4	6.5	7.1	7.1	8.7	9.0	33.2	6.1	9.2	7.8	7.8	7.3	17.8	7.0	8.5	6.7	7.3	8.7	7.9	8.4	7.7	5.4	15.0	9.5	6.8	9.7	7.0	7.6	10.1	7.2	8.5	11.0	9.3	15.2	10.5	10.1	6.3	7.6	6.5	7.9	23.2	24.9	24.3	29.7	11.0	21.1	17.0	11.6	13.2	24.0	23.2	31.4	33.3	9.2	17.1	22.5	37.6	19.7	11.5	28.2	18.2	31.2	9.5	18.6	24.6	20.5	9.2	23.1	23.4	13.7	29.8	16.2	21.0	23.5	34.0	16.1	13.0	4.0	23.7	23.6	19.8	47.0	15.8	4.8	20.5	18.4	20.3	9.5	27.1	25.7	13.1	21.4	11.7	16.5	43.2	13.8	15.3	24.0	10.1	11.9	17.3	12.4	20.1	33.6	6.7	31.9	17.1	14.2	10.5	9.9	13.4	10.8	15.3	13.3	13.1	12.8	9.2	14.8	17.0	16.0	4.2	14.9	14.0	8.0	15.0	8.3	7.1	7.8	8.4	11.6	7.1	8.7	7.8	7.8	7.3	7.0	8.5	7.6	8.5	9.6	11.5	3.6	9.5	12.9	12.2	10.6	8.0	9.3	7.3	9.4	5.4	11.5	13.6	5.5	29.2	9.7	7.4	3.6	5.9	17.8	7.7	4.4	8.9	10.5	4.8	14.5	2.9	27.2	12.7	6.1	9.2	4.4	12.7	6.1	10.4	33.0	8.2	5.0	3.4	4.6	10.2	5.0	2.9	6.3	7.8	5.5	1.8	1.9	9.9	9.8	6.2	2.5	3.8	15.0	3.9	7.9	6.7	9.1	10.2	16.9	6.2	10.9	6.6	9.9	10.1	7.8	7.2	6.7	11.8	14.0	7.9	12.8	6.5	10.9
PUS7	FLJ20485	ENSG00000091127	"Pseudouridine synthase 7"	Q96PZ0	7	105439661-105522271	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024116	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024116: AB_1848754"	"unprognostic (3.07e-1)"	"unprognostic (1.52e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (4.89e-6)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (7.58e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.03e-8)"	"unprognostic (2.76e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (4.90e-2)"	7.1	3.5	3.6	5.5	3.9	3.2	7.4	4.7	4.1	5.9	3.0	5.3	4.0	5.6	3.0	7.7	5.2	3.2	4.8	3.6	3.2	4.4	6.3	4.6	4.3	3.5	3.2	4.3	6.0	6.5	2.7	5.1	3.6	4.4	5.7	2.3	4.7	3.9	11.0	7.8	3.4	6.5	3.0	2.8	4.2	4.6	3.1	3.0	7.6	4.8	5.3	7.2	6.2	4.1	32.1	18.2	18.0	29.4	13.6	14.9	19.9	14.7	13.0	25.5	20.9	24.5	12.7	17.5	24.7	15.6	22.0	25.0	33.0	17.9	39.6	12.9	26.4	26.2	17.2	25.8	16.1	42.1	9.9	15.2	20.9	21.5	27.9	9.5	27.2	16.2	59.8	14.6	17.9	39.8	48.4	39.4	44.6	39.5	23.6	29.1	26.5	81.5	31.0	23.3	30.2	28.5	29.3	53.0	21.3	20.5	19.2	9.9	16.6	37.4	25.1	49.3	32.5	11.0	24.4	46.9	13.1	35.7	33.1	0.0	0.8	0.2	0.9	2.0	2.1	2.0	1.3	1.0	1.2	1.3	1.1	1.2	0.1	1.4	2.0	0.0	0.9	0.7	3.6	3.9	4.7	4.1	3.6	3.2	3.5	3.2	3.6	3.0	3.1	4.1	8.5	6.4	9.0	13.1	4.8	13.4	13.9	5.0	13.1	4.0	8.2	6.5	3.8	1.5	6.0	1.8	2.1	5.6	2.8	3.6	1.9	9.5	1.7	7.0	14.3	10.4	7.2	8.4	43.2	7.2	10.2	8.6	8.6	5.5	11.4	4.3	4.2	5.1	4.4	0.0	27.9	4.1	2.0	2.8	6.0	1.8	4.1	3.3	0.0	11.2	4.0	1.5	3.1	8.5	23.8	7.6	3.2	1.9	6.7	18.3	1.0	5.6	4.3	3.2	0.0	14.3	10.4	1.8	9.7	13.7	9.8	3.4	3.9	15.6	8.0	8.2
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridine synthase 7 like"	Q9H0K6	12	43718992-43758793	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Approved	"Nucleoli,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoli	"HPA056203: AB_2683064, HPA058750: AB_2683807"	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	2.7	3.1	3.3	4.9	3.6	3.5	5.4	6.8	5.2	4.1	0.3	3.8	3.8	3.6	3.7	4.8	2.9	3.8	2.7	2.9	2.6	3.1	3.2	2.4	5.7	2.6	2.0	4.7	4.3	4.4	4.1	4.0	2.7	4.0	4.5	11.7	4.0	3.5	1.7	3.7	3.6	3.1	1.1	3.4	3.9	3.0	3.2	5.1	5.7	1.7	5.9	3.4	2.7	3.7	11.2	8.3	7.2	4.1	4.9	17.4	12.8	9.6	8.1	12.6	9.6	29.9	7.9	25.7	11.9	11.9	7.3	9.9	10.5	9.7	21.5	7.9	6.5	18.8	9.2	11.2	6.1	30.3	11.7	7.2	7.1	13.1	13.5	11.6	9.2	14.9	33.3	10.9	29.7	4.5	15.8	7.8	13.3	0.0	8.8	14.7	16.9	15.4	5.6	8.5	12.1	3.9	11.9	12.8	5.1	8.5	15.1	8.4	6.7	12.8	8.4	15.0	15.2	9.6	17.7	25.5	11.8	49.1	4.3	6.4	1.9	2.2	2.1	1.7	2.7	2.1	2.3	2.3	2.1	2.8	2.0	2.9	1.3	2.5	1.6	2.3	1.0	1.5	3.3	3.6	6.8	5.2	2.9	2.6	2.6	2.0	2.7	1.1	3.2	3.7	30.5	9.6	17.2	29.0	41.1	11.6	19.0	30.8	22.8	68.9	24.2	16.0	12.3	14.3	21.2	25.8	68.8	34.3	34.4	13.5	41.1	20.4	2.5	14.9	28.5	23.3	19.3	25.2	49.5	23.2	23.3	26.5	28.5	18.9	17.1	43.7	16.8	20.8	20.4	43.7	79.5	25.2	18.3	25.0	10.5	4.2	20.2	20.3	12.4	15.0	24.6	33.1	35.0	41.7	51.2	18.2	17.0	26.7	48.7	16.9	19.6	22.7	9.2	106.1	19.7	28.1	18.1	25.2	35.3	19.9	11.1	24.2	32.7	36.3	30.0	13.9
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridine synthase like 1"	Q8N0Z8	1	1308597-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA032057: AB_10601251, HPA039999: AB_2676792"	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	8.1	14.0	6.9	3.3	6.5	4.5	8.7	6.3	9.1	12.7	8.2	9.1	4.5	11.0	4.0	21.0	10.6	2.6	9.8	6.7	6.1	9.4	14.4	8.3	3.9	7.9	6.2	9.1	14.9	3.3	14.9	3.2	6.7	11.7	2.0	2.0	13.7	4.3	7.9	18.1	8.9	2.6	6.2	10.2	10.8	10.9	6.2	4.2	7.5	2.3	3.5	10.4	12.3	7.6	21.9	9.8	9.7	16.6	4.6	7.4	13.1	19.4	10.7	18.8	12.6	33.9	14.1	13.3	15.4	9.6	8.0	17.8	10.8	17.8	3.3	15.1	71.0	18.5	17.7	20.5	17.4	22.2	17.1	7.2	9.2	10.4	7.9	5.1	8.6	18.3	24.1	6.0	8.8	18.2	21.1	28.9	13.2	18.4	42.6	19.2	7.3	32.0	14.8	8.3	44.3	16.2	15.3	45.1	16.1	4.5	12.7	14.6	10.2	12.1	12.5	19.9	18.8	23.4	8.1	57.4	15.0	20.0	7.4	3.7	12.5	6.2	10.2	17.5	10.3	8.5	11.1	8.6	11.7	9.2	7.2	7.3	4.9	9.0	15.9	7.3	14.4	8.4	6.9	6.5	6.3	9.1	6.7	6.1	7.9	6.2	6.7	6.2	6.2	7.6	5.7	0.0	5.3	1.0	8.9	22.0	12.0	19.9	11.4	8.1	16.3	14.0	2.5	8.6	13.5	7.3	6.2	27.0	8.4	15.0	11.7	20.9	11.5	7.7	9.3	6.6	5.3	3.4	2.4	23.1	41.9	9.3	12.2	5.2	7.0	6.3	4.6	10.5	20.9	3.3	2.4	12.5	16.2	8.8	17.4	18.2	8.7	7.4	7.2	0.0	7.7	5.9	10.3	1.5	2.2	26.1	9.9	11.3	14.2	16.8	13.4	18.9	12.0	7.9	0.0	5.2	9.3	17.1	18.5	13.4	19.2	34.5	9.7	18.3	13.2	25.6
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 2129.3"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 641.8;Horizontal cells: 1527.7"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 59.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	291	"RPMI-8226: 1561.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 2120.1"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.4	1.0	82.5	0.7	40.2	0.1	15.0	255.6	86.5	0.1	8.6	0.3	0.2	1.4	0.8	0.1	0.1	0.3	0.2	9.3	100.5	82.1	5.7	2.2	2.4	127.4	85.7	0.5	0.2	2129.3	1.2	2.4	105.7	0.3	0.3	373.5	2.7	0.7	13.6	0.1	0.3	0.5	50.9	3.2	0.8	1.5	275.5	0.3	5.0	0.4	3.1	3.8	0.2	51.8	0.0	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.1	0.4	1561.0	0.0	5.3	2.3	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	4.6	0.0	0.0	0.9	0.3	15.1	82.5	40.2	255.6	86.5	9.3	100.5	127.4	85.7	105.7	50.9	275.5	51.8	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	51.3	2.4	2.0	0.6	0.0	0.0	38.6	10.4	0.3	0.0	0.0	641.8	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	11.4	0.2	30.0	0.2	53.8	1527.7	29.7	0.0	0.0	2.9	0.0	0.1	0.6	15.7	0.0	2.8	0.1	37.4	0.0	3.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	150.5	0.0	1.0	0.0	0.0	3.6	0.0	0.0	0.4	0.9	0.0	0.0	0.1
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"PVR cell adhesion molecule"	P15151	19	44643798-44666162	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"TIME: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		720000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	13.9	17.5	10.2	7.1	9.1	5.1	9.6	9.0	10.0	8.7	9.3	10.3	12.5	13.9	5.2	8.4	11.8	6.2	28.5	9.0	16.6	13.6	30.7	19.4	2.7	9.7	11.0	12.5	14.0	10.3	17.3	12.5	12.4	9.7	8.8	5.4	9.9	6.4	19.0	7.1	11.1	10.5	7.4	4.6	12.3	5.8	14.9	2.5	10.6	6.2	2.8	9.1	8.5	7.9	58.8	52.1	5.6	25.0	8.6	9.7	7.4	96.7	38.8	40.7	45.8	31.9	28.2	0.1	50.6	43.7	60.2	44.4	24.3	51.1	31.7	7.8	27.1	8.8	40.3	23.3	43.7	4.1	22.2	10.6	28.0	40.9	82.5	49.7	50.7	6.6	4.3	0.5	23.4	7.8	4.2	5.8	12.5	30.1	31.7	0.1	23.2	5.0	111.8	25.5	21.2	22.9	66.3	54.3	14.7	7.2	22.8	12.5	175.3	39.0	52.8	33.7	78.2	0.3	6.3	0.2	35.3	23.4	24.6	0.2	4.5	0.0	0.1	4.5	0.0	0.0	0.0	0.2	3.8	0.0	0.2	0.1	1.1	0.7	5.5	0.5	0.0	1.7	10.2	9.1	9.0	10.0	9.0	16.6	9.7	11.0	12.4	7.4	14.9	7.9	11.1	16.0	25.2	2.3	1.6	3.6	16.0	6.9	4.0	5.7	4.7	3.4	14.4	14.3	12.2	1.8	2.1	2.9	0.2	18.5	3.9	37.9	10.5	5.4	6.3	20.4	13.1	2.1	11.4	35.3	34.8	7.7	13.7	11.6	1.3	6.5	7.9	41.1	8.4	1.7	13.7	11.3	2.0	8.9	7.5	14.3	5.6	6.8	1.8	5.6	17.2	1.8	2.1	6.0	4.6	69.6	18.0	15.8	0.2	14.4	10.8	5.7	2.8	3.4	0.0	23.8	10.4	10.4	1.5	5.8	5.5	1.0	0.9	10.8	12.7	7.4
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.7;lymphoid tissue: 38.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.4;granulocytes: 2.5;Horizontal cells: 3.3;NK-cells: 4.1;Plasma cells: 1.9;T-cells: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"gdT-cell: 233.3;MAIT T-cell: 277.1;memory B-cell: 139.3;memory CD4 T-cell: 153.0;memory CD8 T-cell: 231.4;naive B-cell: 124.3;naive CD4 T-cell: 169.5;naive CD8 T-cell: 167.1;NK-cell: 263.0;T-reg: 136.0"	"Group enriched"	"Detected in all"	39	"B-cells: 139.3;NK-cells: 263.0;T-cells: 277.1"	"Group enriched"	"Detected in some"	28	"Daudi: 96.5;JURKAT: 55.9;MOLT-4: 107.2;U-698: 32.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoli, Endoplasmic reticulum"		"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.7	0.3	0.7	6.4	3.2	1.7	0.3	3.7	3.1	0.3	0.0	1.0	0.8	0.4	0.0	0.5	0.4	0.8	0.2	0.5	1.2	0.5	1.3	1.2	18.8	4.7	1.9	0.8	0.7	0.0	0.2	0.1	2.4	0.4	0.1	0.6	1.1	0.0	2.5	0.3	10.7	0.0	0.1	24.2	1.9	0.8	2.8	38.1	0.7	0.0	4.5	1.0	0.5	6.7	0.3	2.0	1.0	0.3	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.1	0.2	96.5	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	55.9	0.2	0.4	0.0	0.2	107.2	0.0	0.3	0.1	0.2	0.4	0.1	1.2	0.0	0.2	2.1	0.5	0.0	0.1	0.0	0.7	0.1	0.2	0.2	0.1	0.8	0.1	0.0	0.2	0.1	32.0	0.0	0.1	0.0	0.9	0.7	0.3	233.3	1.1	277.1	139.3	153.0	231.4	0.7	124.3	169.5	167.1	5.7	263.0	1.0	1.1	136.0	104.4	0.7	3.2	3.7	3.1	0.5	1.2	4.7	1.9	2.4	0.1	2.8	6.7	0.0	0.0	0.6	0.3	3.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.2	2.5	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
PWWP2B	"bA432J24.1, FLJ46823, PWWP2"	ENSG00000171813	"PWWP domain containing 2B"	Q6NUJ5	10	132397168-132417859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038056, HPA038502, HPA078118"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: "	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	10.4	31.0	9.5	3.2	15.1	2.4	10.1	3.6	10.8	9.8	9.1	19.1	4.8	10.4	1.0	22.1	9.3	2.0	14.0	10.6	7.1	11.6	5.9	11.0	2.9	8.5	7.2	8.3	38.1	6.5	14.5	4.2	7.9	11.3	2.3	1.9	15.4	3.9	22.3	16.1	10.6	1.2	4.7	27.2	16.3	17.4	7.8	1.0	13.5	5.1	1.6	12.1	12.2	5.2	21.9	12.9	1.6	8.2	1.2	1.0	56.2	2.6	2.6	1.5	1.4	5.8	12.4	0.0	8.8	1.6	3.2	22.9	2.3	3.1	0.2	16.5	6.4	2.5	12.4	5.7	5.8	7.2	9.3	0.8	8.0	0.9	2.3	1.3	1.2	2.9	4.3	1.8	1.0	44.5	0.2	27.0	2.5	8.5	9.5	5.2	0.1	5.0	0.7	16.3	10.4	12.9	1.7	33.1	6.9	1.6	10.2	17.5	4.3	0.8	4.4	4.0	1.8	0.4	0.2	4.5	5.0	6.4	1.6	0.0	1.6	2.6	1.3	3.5	1.0	0.9	0.7	0.8	1.5	3.3	0.5	0.5	0.3	5.4	5.3	0.9	0.0	0.8	9.5	15.1	3.6	10.8	10.6	7.1	8.5	7.2	7.9	4.7	7.8	5.2	5.8	22.4	11.0	2.3	18.0	17.6	14.0	5.8	9.1	7.3	13.5	11.0	5.4	14.3	10.2	9.2	8.4	31.8	12.1	33.5	13.7	15.0	33.0	29.5	4.7	7.1	25.3	2.1	4.3	22.0	47.4	4.1	16.3	19.9	2.5	13.6	13.2	1.6	13.1	15.2	3.8	29.1	10.2	12.6	17.2	70.8	3.7	13.3	14.2	5.6	7.3	3.1	6.2	2.0	0.2	10.6	25.5	2.2	2.2	16.3	5.5	1.5	29.4	14.9	0.0	3.9	5.0	1.2	1.6	8.8	20.3	52.9	7.8	17.4	19.4	31.8
PWWP3A	"EXPAND1, MUM-1, MUM1"	ENSG00000160953	"PWWP domain containing 3A, DNA repair factor"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.7;Cardiomyocytes: 31.4;Cytotrophoblasts: 18.8;Extravillous trophoblasts: 24.5;Fibroblasts: 14.5;Hofbauer cells: 16.9;Smooth muscle cells: 13.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048063, HPA054491"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243, HPA054491: "	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	16.3	13.8	28.2	5.2	26.2	3.1	16.2	21.4	27.3	20.5	14.9	17.7	4.9	23.1	5.8	10.0	22.6	5.4	13.0	24.9	28.4	14.0	22.6	12.1	5.1	31.5	29.6	29.4	11.8	6.3	30.4	6.6	27.7	15.8	4.8	8.0	13.2	9.1	13.1	13.1	14.6	10.1	23.7	16.6	13.3	36.4	30.8	4.9	15.5	5.9	4.4	16.3	13.8	26.4	7.9	12.3	11.4	15.8	7.7	10.2	18.5	11.1	6.9	8.8	7.7	8.2	5.5	14.9	5.3	13.4	3.1	9.1	9.4	7.2	7.5	17.2	10.3	6.9	12.9	12.4	9.1	5.8	20.5	7.8	5.0	5.2	2.9	12.6	9.3	9.7	14.4	7.5	8.9	9.6	10.1	8.7	16.4	6.7	5.9	18.4	11.6	6.6	6.9	12.3	9.9	24.6	8.7	14.8	8.7	10.0	7.7	16.8	11.4	12.2	16.2	9.5	13.0	15.8	11.5	5.2	14.8	10.6	17.2	9.6	0.8	4.8	2.9	1.8	2.5	2.8	1.7	2.1	1.4	2.5	2.3	2.4	1.4	3.1	1.6	2.6	0.8	0.9	28.2	26.2	21.4	27.3	24.9	28.4	31.5	29.6	27.7	23.7	30.8	26.4	20.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	18.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	24.5	14.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	14.2	0.8	0.0	0.0	0.0
PWWP3B	"FLJ33516, MUM1L1"	ENSG00000157502	"PWWP domain containing 3B"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"ovary: 189.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.2;Cytotrophoblasts: 1.9;Endothelial cells: 1.7;Fibroblasts: 4.0;Syncytiotrophoblasts: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;HHSteC: 1.6;HSkMC: 2.9;LHCN-M2: 5.5;NTERA-2: 2.1;SuSa: 1.5;T-47d: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.53e-2)"	3.5	3.7	4.5	0.0	3.8	0.0	1.0	0.1	7.4	13.7	0.2	0.1	0.0	15.8	9.3	0.3	13.5	1.2	4.3	4.5	12.2	1.4	1.5	0.5	0.0	2.6	8.1	189.9	28.1	0.7	6.1	0.5	5.5	2.4	0.1	0.1	0.2	3.5	10.9	0.2	0.1	3.1	0.5	0.0	1.2	18.0	9.1	0.0	10.3	9.2	0.0	0.3	2.2	3.1	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	1.5	1.9	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.8	0.1	7.4	4.5	12.2	2.6	8.1	5.5	0.5	9.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.1;Endometrial stromal cells: 99.4;Endothelial cells: 95.1;Hepatic stellate cells: 71.4;Skeletal myocytes: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 323.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		9100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	59.5	5.5	4.1	24.3	3.5	0.9	33.7	1.9	4.1	18.2	27.5	36.1	7.9	32.8	4.0	4.9	18.0	22.7	22.7	3.1	7.7	9.0	12.4	27.6	5.0	4.2	6.2	32.7	3.8	3.0	11.7	33.4	4.7	17.5	8.7	5.2	13.6	11.1	7.7	6.9	16.3	61.8	2.6	10.0	13.2	6.4	5.2	2.1	8.4	11.5	2.1	33.8	13.5	3.4	39.9	13.9	72.0	0.1	198.3	180.9	54.6	231.4	182.3	99.0	107.9	0.1	0.5	0.0	323.8	230.3	4.5	8.3	0.3	142.3	125.5	0.6	2.4	0.0	139.3	0.0	196.4	0.6	0.0	200.7	41.0	112.2	83.8	299.5	247.0	35.9	0.1	0.0	142.6	23.6	6.8	8.0	58.3	0.0	52.3	13.2	250.8	0.6	115.9	0.1	0.2	131.9	0.2	73.6	0.4	142.9	27.0	0.9	242.4	162.8	79.7	6.2	180.7	0.2	205.4	1.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	3.5	1.9	4.1	3.1	7.7	4.2	6.2	4.7	2.6	5.2	3.4	79.1	6.4	2.3	2.6	0.4	2.9	2.8	12.8	0.6	2.5	17.5	14.1	5.8	17.2	7.0	1.8	0.0	0.6	0.2	0.3	0.0	10.4	33.4	4.2	99.4	95.1	1.8	0.0	6.6	0.0	11.3	45.2	0.0	3.4	1.3	43.7	71.4	1.8	1.9	0.0	7.3	1.3	20.3	5.7	4.4	40.7	26.8	0.7	7.2	8.4	0.6	10.0	1.0	55.8	0.7	0.5	0.1	15.1	0.0	14.0	0.0	0.2	6.7	0.8	46.0	120.1	51.1	22.0	16.0	0.5	2.8	1.4	1.0	33.3	0.5	1.4
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426127	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 320.5"	"Cell type enriched"	"Detected in all"	9	"Oligodendrocytes: 732.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 159.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Supported		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	19.9	16.7	71.6	31.5	161.3	73.1	15.8	112.3	109.2	46.7	20.4	23.3	10.6	23.5	8.4	11.3	17.5	15.5	17.8	84.1	115.0	18.2	11.6	20.6	43.0	158.2	131.3	18.3	15.7	21.2	13.4	29.7	154.1	12.8	10.5	35.6	14.8	11.7	18.8	14.3	19.3	18.7	82.1	25.2	16.3	12.4	119.0	13.7	63.1	14.3	44.9	19.5	30.2	320.5	13.7	6.9	6.8	12.0	79.7	70.0	17.8	22.6	42.5	19.7	27.3	4.0	3.1	74.7	5.1	33.6	28.4	4.2	18.7	13.2	21.8	18.5	12.5	13.1	11.3	5.8	87.5	112.8	22.5	57.4	31.6	24.6	42.0	72.5	17.8	49.1	15.7	26.1	35.7	5.3	26.2	122.2	7.8	4.1	19.7	40.7	9.4	13.4	12.6	8.0	6.0	4.0	14.2	11.0	19.0	10.7	34.8	122.9	17.9	24.9	11.0	48.5	23.9	19.4	21.6	73.7	36.2	159.3	10.7	39.5	44.6	69.1	23.8	37.2	20.7	62.6	17.1	20.3	41.8	69.6	15.3	17.5	73.5	21.6	57.1	32.1	21.1	32.0	71.6	161.3	112.3	109.2	84.1	115.0	158.2	131.3	154.1	82.1	119.0	320.5	20.1	9.6	6.3	28.4	59.8	14.1	5.8	5.6	7.4	31.0	5.9	7.1	13.1	7.2	6.0	23.9	20.9	19.7	31.7	8.3	33.2	7.1	69.7	9.1	33.0	14.2	7.8	19.3	33.8	5.7	6.8	41.5	6.1	16.0	19.7	15.2	16.4	7.5	13.6	20.2	53.7	5.0	2.0	24.5	31.1	38.3	30.7	25.2	17.8	30.0	28.6	32.7	30.9	79.4	732.6	3.0	5.5	25.2	17.6	6.0	8.7	12.2	6.4	22.2	19.7	18.7	18.2	16.8	21.9	10.1	13.1	35.2	16.9	18.3	5.0	3.9
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702758-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 73.6;Late spermatids: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: AB_2681006"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	4.1	11.2	5.1	3.0	5.2	3.2	11.9	3.8	5.6	5.6	4.3	6.2	8.2	4.1	5.1	6.3	6.0	3.3	6.4	5.0	4.0	4.9	8.9	13.9	3.6	4.6	4.5	6.8	6.8	14.7	3.5	3.2	4.1	8.7	5.7	4.4	15.2	6.4	8.0	11.1	7.4	5.1	4.2	4.6	6.8	2.5	5.3	3.5	11.5	6.9	3.9	5.4	5.8	6.5	2.8	12.1	3.3	11.9	5.7	8.3	8.5	8.7	4.7	6.6	2.9	42.3	13.2	0.1	16.2	7.3	16.1	12.5	9.0	10.1	4.7	3.7	3.4	14.0	9.7	0.1	5.3	0.7	10.3	6.4	10.8	9.0	3.0	3.3	4.3	4.4	7.9	8.6	4.7	26.4	12.9	9.8	0.3	21.7	0.0	6.8	16.3	1.7	4.2	9.0	10.7	5.4	24.2	75.8	7.9	1.9	64.0	4.7	8.2	4.7	5.4	11.9	8.2	5.5	13.2	0.2	9.0	4.6	8.1	2.2	11.1	17.5	10.8	22.2	11.3	7.6	10.9	10.9	8.8	9.9	8.3	11.2	2.9	9.1	34.2	5.3	8.5	8.6	5.1	5.2	3.8	5.6	5.0	4.0	4.6	4.5	4.1	4.2	5.3	6.5	5.2	19.2	73.6	7.2	5.5	1.7	4.3	9.4	4.0	11.1	16.8	12.3	12.6	7.2	17.8	18.4	14.6	12.9	3.5	14.2	9.8	8.2	28.7	6.3	6.1	7.6	4.2	9.9	6.4	9.9	24.3	8.5	6.6	5.7	3.8	6.7	8.9	36.0	15.1	5.0	5.7	10.8	6.1	7.5	1.6	44.0	10.5	6.2	3.6	6.5	7.5	13.6	9.2	9.0	10.8	8.5	10.3	11.3	7.0	4.5	23.0	11.2	7.8	11.4	6.6	8.8	7.8	4.6	9.8	9.5	2.4	4.4	5.8	16.9	13.0	4.0
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	83.1	60.9	28.7	49.1	30.8	81.4	74.4	27.6	30.5	64.5	33.7	69.0	55.7	56.3	18.7	30.9	72.3	38.2	84.2	28.0	28.5	70.2	29.5	84.6	29.3	37.1	30.8	28.5	34.5	27.8	29.5	73.3	30.3	58.9	49.9	61.8	49.4	40.6	119.2	45.6	61.1	44.5	31.8	72.5	47.5	26.5	36.6	25.9	58.1	46.1	18.4	75.8	53.2	29.2	182.4	87.5	31.3	30.1	60.4	158.1	206.1	151.8	128.6	118.9	61.5	102.5	108.9	12.2	94.6	154.9	115.1	126.0	21.7	272.0	93.0	9.9	18.6	2.3	63.8	37.9	86.8	2.7	3.6	76.5	176.2	125.3	143.9	139.7	211.6	32.2	32.4	19.5	239.3	119.6	11.1	4.1	43.5	77.1	300.8	26.2	51.0	10.8	121.4	171.9	48.7	14.5	133.2	40.3	81.7	72.1	96.1	14.8	289.9	78.9	86.7	103.6	183.9	20.4	12.3	4.6	228.9	27.0	159.2	40.8	44.2	49.2	84.5	15.7	45.3	1.7	38.4	56.0	26.2	1.1	29.5	40.3	169.6	51.8	0.8	4.1	31.4	60.6	28.7	30.8	27.6	30.5	28.0	28.5	37.1	30.8	30.3	31.8	36.6	29.2	93.6	57.7	27.9	11.8	3.0	42.3	40.6	32.8	15.4	7.8	20.3	22.9	14.7	22.8	33.3	42.3	33.3	40.8	61.6	83.1	19.6	31.6	2.1	26.0	16.7	71.0	54.6	6.1	5.1	40.2	152.4	29.7	37.2	28.8	18.3	6.2	62.2	17.2	34.2	11.8	7.7	52.7	24.4	42.3	23.7	2.8	24.2	23.5	26.6	19.7	36.8	9.1	99.9	13.0	9.2	84.8	51.6	18.8	14.5	41.7	56.6	14.6	40.0	33.6	6.6	16.7	12.1	3.5	9.1	8.1	19.5	25.0	34.4	11.3	35.8	42.6
PXYLP1	"ACPL2, FLJ23751"	ENSG00000155893	"2-phosphoxylose phosphatase 1"	Q8TE99	3	141228726-141367753	"Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 148.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 196.8;Late spermatids: 131.1;Spermatocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017243	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA017243: AB_1844509"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.05e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.07e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.17e-3)"	4.2	6.3	5.6	4.3	6.4	5.0	8.3	1.7	13.5	7.3	0.3	5.4	5.5	8.8	148.2	2.6	6.4	8.2	13.8	6.3	6.5	7.5	5.1	4.9	9.1	1.0	3.0	8.6	9.2	16.2	7.4	18.2	1.1	10.1	5.6	18.3	6.6	28.9	2.9	4.6	6.4	7.2	3.4	5.3	5.0	8.9	3.4	53.3	5.9	2.0	9.9	7.0	4.7	6.6	5.3	5.5	23.3	18.5	9.0	7.7	5.6	3.6	9.0	9.1	12.5	9.2	1.8	0.3	4.9	8.2	1.9	1.2	24.7	2.3	8.7	17.4	16.3	1.9	7.5	7.4	19.2	4.8	1.0	7.3	10.4	2.8	1.0	11.3	0.6	17.8	0.9	2.1	4.1	4.5	25.8	6.0	9.7	13.2	3.1	3.5	13.6	3.2	6.5	22.8	10.1	17.8	9.3	2.9	7.6	4.2	9.7	2.8	1.1	11.6	6.9	8.0	3.5	4.9	0.4	0.7	10.7	6.5	10.4	15.2	6.0	9.4	13.4	4.0	8.6	0.7	7.5	8.9	5.3	0.5	21.6	17.6	3.8	19.3	2.0	1.9	4.3	8.9	5.6	6.4	1.7	13.5	6.3	6.5	1.0	3.0	1.1	3.4	3.4	6.6	1.1	9.6	8.7	14.0	2.2	0.0	4.6	0.0	6.2	3.3	9.5	6.7	7.6	2.8	1.8	46.0	6.2	2.1	3.4	2.1	0.0	3.2	196.8	1.0	9.3	1.4	4.2	4.4	41.3	3.7	8.2	7.9	1.1	1.8	2.5	5.4	1.4	3.8	0.7	6.7	31.8	3.9	0.0	1.8	0.0	131.1	20.2	2.0	0.0	1.0	3.5	8.0	3.1	32.6	6.5	3.0	8.6	15.1	2.7	7.6	4.2	11.7	2.9	5.2	13.1	6.6	4.2	95.9	13.8	2.2	0.0	1.1	4.9	0.9	4.7	6.6
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201486-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 84.7;skin 1: 90.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		640000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	25.6	11.4	4.1	32.9	4.0	43.4	20.4	4.6	8.6	22.1	5.0	48.1	63.9	10.7	0.0	56.1	17.4	4.9	9.7	3.7	5.2	10.9	10.4	32.8	19.1	7.8	5.1	14.9	11.3	1.7	7.7	6.1	6.7	19.9	9.5	0.1	24.6	8.7	3.4	90.5	48.5	5.8	7.6	84.7	22.1	2.3	6.7	9.5	9.1	1.2	12.7	19.8	33.1	11.3	23.9	54.8	0.5	0.2	9.2	18.9	0.6	12.6	22.6	8.8	6.5	0.1	31.7	10.6	0.1	17.6	0.0	69.7	2.9	57.4	0.3	73.0	0.0	9.3	7.9	18.3	25.6	86.9	65.7	24.7	30.3	4.0	1.2	0.2	18.4	0.1	42.9	17.5	2.9	148.9	0.2	237.0	15.7	13.2	0.1	75.5	0.0	35.2	1.3	22.3	0.7	0.2	10.4	0.0	12.4	0.3	15.5	186.9	11.8	0.4	0.7	9.9	0.3	0.6	0.1	0.2	6.4	112.1	0.1	585.7	1098.3	948.1	178.4	1138.3	112.2	213.7	146.5	183.3	829.2	210.7	102.1	139.6	1638.4	219.2	1152.8	769.2	206.4	814.2	4.1	4.0	4.6	8.6	3.7	5.2	7.8	5.1	6.7	7.6	6.7	11.3	35.7	22.4	28.9	0.0	58.5	74.1	66.3	237.0	100.7	0.2	92.2	131.7	2.5	41.5	84.3	25.8	0.0	62.5	158.8	184.5	5.9	90.5	0.8	18.6	16.8	39.2	58.9	42.9	0.1	56.5	11.3	39.3	50.4	7.3	110.9	60.2	48.9	3.3	425.8	0.0	0.1	144.6	75.3	555.8	280.2	2.9	47.2	344.2	97.8	13.1	277.8	0.0	132.8	0.0	0.1	60.4	360.0	22.6	54.1	22.6	504.8	3.6	88.2	0.7	26.3	10.5	28.5	0.3	1.4	83.9	163.7	17.8	70.8	119.9	287.1	70.6
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis, Stress response"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 111.8;salivary gland: 121.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.8;Extravillous trophoblasts: 63.8;Intestinal goblet cells: 83.4;Prostatic glandular cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	8	"B-cells: 4.2;dendritic cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047660	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	7.5	4.1	13.8	13.8	14.1	12.5	17.4	13.2	15.2	24.2	9.6	23.8	14.3	10.6	2.5	18.7	9.7	8.9	10.0	12.5	14.4	6.3	8.7	13.6	6.9	16.1	13.9	7.5	111.8	1.9	21.6	11.7	14.8	25.5	14.4	0.9	121.1	7.8	11.5	6.3	12.5	12.2	12.7	8.0	42.4	15.1	15.8	2.6	8.5	2.0	6.7	12.0	10.3	14.2	107.4	111.9	62.7	228.3	36.7	69.0	117.2	176.0	85.4	54.7	73.7	129.3	116.9	163.2	38.0	188.9	33.3	45.8	148.2	67.1	32.7	42.4	18.6	96.5	56.5	350.8	213.8	64.8	70.6	58.5	129.8	68.2	178.7	64.8	95.5	129.4	314.0	147.2	35.1	376.4	68.1	49.5	52.8	291.9	170.1	0.9	105.6	205.5	49.9	38.7	237.7	167.2	36.9	203.6	219.5	46.3	210.0	117.1	70.1	53.7	201.8	91.4	66.3	183.4	141.3	156.2	57.2	0.8	178.1	0.0	0.1	0.0	0.2	0.2	0.4	4.2	0.7	0.2	1.3	1.8	1.6	1.2	0.0	0.3	0.0	1.9	0.3	1.1	13.8	14.1	13.2	15.2	12.5	14.4	16.1	13.9	14.8	12.7	15.8	14.2	2.3	0.0	3.9	2.3	9.1	7.0	11.4	12.2	4.6	0.3	50.6	29.5	0.6	1.5	7.2	3.7	0.0	2.0	2.3	17.2	0.0	13.3	13.8	3.4	14.6	4.7	10.8	27.8	0.9	63.8	63.8	24.9	35.7	13.8	4.5	13.9	2.5	1.8	5.0	3.3	1.4	83.4	8.2	0.0	5.4	32.4	7.5	0.8	8.8	0.0	0.7	0.5	0.0	3.5	0.7	48.0	19.5	3.8	34.1	59.6	1.2	1.9	1.3	0.2	0.0	3.3	17.8	28.2	16.9	8.0	6.0	3.8	1.9	15.5	43.1	8.6
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	38.0	71.7	53.2	35.8	62.4	47.3	35.8	68.1	54.2	46.4	51.8	39.6	22.3	48.5	26.4	32.3	44.7	22.4	62.3	50.4	61.3	40.2	40.3	38.2	47.2	69.0	61.2	47.9	47.2	42.0	57.0	28.5	66.0	39.6	18.3	34.0	39.6	40.9	66.8	28.3	34.4	25.7	68.6	49.5	38.9	34.4	59.2	43.9	30.0	49.1	33.9	50.3	33.3	72.5	72.6	59.6	35.0	59.1	38.8	40.0	73.2	74.8	46.3	49.7	44.1	77.2	58.3	126.1	156.6	55.0	39.1	81.6	50.5	58.6	28.3	154.6	107.5	120.6	60.2	81.5	59.8	107.9	189.1	38.8	72.3	56.1	64.1	44.1	47.8	103.7	178.4	81.6	50.9	60.5	135.8	120.9	196.0	112.8	80.4	120.2	79.0	263.6	65.2	58.3	44.0	56.7	62.4	48.7	161.0	27.9	62.3	202.0	40.3	38.4	46.5	82.9	104.4	129.9	156.2	127.4	60.7	80.6	109.3	38.4	19.6	39.6	45.5	29.2	47.8	34.4	43.8	42.4	31.3	41.9	74.9	62.4	13.3	67.9	26.3	59.2	44.0	45.1	53.2	62.4	68.1	54.2	50.4	61.3	69.0	61.2	66.0	68.6	59.2	72.5	28.0	19.2	22.8	11.4	31.6	14.8	64.6	53.4	8.0	15.6	24.3	21.2	47.6	20.0	24.8	35.0	14.6	90.6	39.1	12.9	49.0	50.0	8.2	92.8	25.6	26.7	26.5	58.7	4.6	34.0	46.3	23.7	10.2	31.8	38.7	74.9	21.0	16.6	40.0	13.5	5.8	17.8	57.0	20.4	19.8	8.8	38.2	31.5	33.8	8.4	46.4	46.9	46.4	5.5	29.3	29.1	15.8	37.6	23.1	42.1	18.3	35.8	55.4	42.7	26.3	19.8	24.4	40.1	46.2	9.4	12.8	41.7	34.9	44.9	16.1	40.4
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603210-143609773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	5.0	9.7	2.8	0.4	2.9	0.6	5.2	2.7	3.3	5.1	1.0	4.2	0.5	5.2	1.1	7.1	6.0	0.8	3.9	2.9	1.6	9.7	17.2	3.8	0.9	2.3	2.2	5.1	9.2	0.6	10.0	0.4	2.7	8.7	0.6	0.7	5.8	0.5	3.0	4.0	4.1	0.4	1.5	5.9	5.5	7.0	2.7	0.4	8.4	0.3	0.7	4.4	3.8	2.1	3.2	4.0	1.6	2.5	1.8	0.6	2.0	3.0	1.4	2.9	1.9	2.9	2.6	6.2	2.1	2.0	1.1	2.6	2.0	4.0	1.1	3.0	5.3	3.7	2.2	2.0	0.6	1.9	1.0	0.8	1.9	3.1	1.9	1.2	0.7	3.7	4.3	3.1	1.9	7.2	3.0	1.7	2.1	4.5	10.4	2.8	1.8	4.3	3.4	2.2	5.3	1.4	3.6	4.9	1.6	0.8	6.4	2.0	0.9	2.9	4.0	3.4	3.1	2.5	0.8	4.2	2.6	2.0	1.9	0.2	0.9	0.0	1.1	0.6	1.2	1.3	0.8	0.8	0.6	4.7	1.1	1.0	0.1	1.3	0.7	3.0	0.9	0.6	2.8	2.9	2.7	3.3	2.9	1.6	2.3	2.2	2.7	1.5	2.7	2.1	2.9	3.2	3.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	8.8	7.7	0.0	0.0	0.6	14.7	0.0	5.1	1.6	0.0	3.9	10.2	0.0	6.8	6.6	1.9	0.0	0.0	0.0	9.1	11.8	2.9	0.0	5.2	0.0	5.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.8	0.0	0.0	12.4	4.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.5	1.2	14.7	0.0	0.0
PYDC2	POP2	ENSG00000253548	"Pyrin domain containing 2"	Q56P42	3	191461163-191461456	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"brain: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"A549: 1.1"					"Not detected"	"Not detected"			HPA055895	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"				"HPA055895: AB_2682962"																		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
PYGL	GSD6	ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944483	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 145.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 141.1;neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 279.1;HMC-1: 304.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	110.1	21.0	5.9	24.1	6.6	108.9	36.4	5.0	8.4	33.6	10.4	19.0	3.7	20.7	6.4	55.8	19.1	13.0	14.9	5.2	6.2	10.2	145.6	26.1	6.3	10.7	17.6	18.2	5.7	21.1	7.5	49.3	8.7	13.0	24.0	78.2	26.8	29.7	5.1	37.0	8.4	26.7	8.6	49.4	9.6	5.2	9.0	4.8	10.2	5.8	6.8	41.7	38.1	10.3	145.7	40.8	10.1	64.3	47.0	56.2	114.5	28.6	24.1	77.4	117.3	107.4	18.3	0.1	54.4	171.7	91.2	279.1	107.0	144.8	132.0	0.5	46.8	28.0	60.5	82.4	83.8	106.9	304.4	119.4	56.8	104.1	43.6	75.4	69.3	0.8	11.6	0.5	55.4	144.7	0.4	141.7	39.3	12.8	152.0	2.7	36.2	6.1	104.7	95.1	4.5	4.4	131.0	43.3	1.7	38.6	20.6	200.4	3.2	29.7	49.6	56.0	92.9	1.2	0.3	0.5	27.3	107.7	15.9	50.2	55.9	141.1	0.0	24.2	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	153.7	0.6	15.7	1.2	0.2	24.8	5.9	6.6	5.0	8.4	5.2	6.2	10.7	17.6	8.7	8.6	9.0	10.3	6.7	22.4	6.3	1.3	1.8	30.7	10.5	40.5	6.8	4.6	7.0	3.8	3.4	5.7	35.4	7.3	0.0	28.9	0.2	11.2	3.9	10.9	1.0	35.4	18.9	7.8	1.2	9.0	1.8	2.1	151.2	18.8	6.6	62.6	6.3	9.3	8.2	65.4	177.6	1.7	2.2	7.1	14.2	56.7	7.9	1.5	14.3	54.6	19.6	15.9	52.4	265.1	2.1	14.1	0.6	7.4	5.2	21.8	1.8	9.7	0.0	6.4	24.5	11.9	6.6	15.4	8.8	0.7	1.4	22.4	22.3	21.1	2.3	4.0	14.0	9.2
PYGM	GSD5	ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64759974	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	65	"skeletal muscle: 8468.3;tongue: 3594.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.7;NB-4: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		10000000	"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	15.2	3.0	35.4	2.1	30.1	1.2	7.7	55.5	29.4	5.8	15.5	25.5	1.5	10.4	6.4	92.2	14.6	3.8	70.8	26.8	26.1	2.4	1.2	2.7	2.2	48.8	30.4	4.0	1.6	0.3	1.7	1.4	39.6	25.6	3.6	2.9	50.0	26.3	8468.3	4.2	7.0	14.7	44.9	3.3	6.9	6.7	47.3	1.3	5.2	3594.2	1.2	16.7	5.2	38.1	0.1	0.0	0.7	0.1	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.3	0.4	0.1	3.7	0.2	0.2	0.1	0.0	0.0	1.1	0.7	0.6	0.0	1.1	0.7	2.2	0.7	0.1	0.1	0.4	0.7	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.4	0.4	0.3	0.4	0.3	0.0	0.4	0.1	0.0	1.0	1.4	0.4	0.0	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.3	0.0	0.2	0.2	0.1	35.4	30.1	55.5	29.4	26.8	26.1	48.8	30.4	39.6	44.9	47.3	38.1	2.4	0.0	2.3	29.7	3.0	0.8	0.6	0.2	5.2	3.5	2.9	4.7	47.5	0.0	0.8	0.0	4.2	0.6	1.9	1.0	0.0	0.1	11.7	1.6	5.2	2.0	0.0	0.0	0.2	0.0	0.2	5.1	1.1	4.0	0.0	0.8	1.8	0.0	0.5	0.0	0.2	0.9	0.0	0.6	1.3	49.2	16.4	2.3	0.0	1.0	0.5	9.9	4.1	0.5	0.4	0.3	0.2	44.0	0.3	1.3	0.6	0.0	0.1	1.3	6.6	64.3	12.8	1.2	0.9	2.5	0.6	0.1	2.9	0.9	1.1	0.3
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538884-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	1.8	2.3	2.6	0.9	3.0	0.2	1.7	7.3	2.3	3.7	2.9	3.2	0.4	5.6	2.0	1.8	2.5	2.3	1.3	2.6	4.6	0.9	0.1	1.9	0.5	3.3	4.5	6.1	1.4	13.2	3.0	2.0	3.1	4.5	1.0	4.5	0.9	4.8	11.7	0.7	0.9	4.7	3.3	0.3	1.4	3.2	4.9	0.4	6.8	9.1	0.4	2.2	1.7	2.4	3.7	6.3	12.2	6.2	4.4	10.0	4.6	7.8	8.9	6.2	7.1	4.5	0.0	0.0	2.4	5.3	8.9	0.0	12.4	0.1	8.3	0.0	3.9	1.8	1.8	0.4	5.9	6.6	0.0	5.5	6.2	5.5	0.9	6.9	3.2	1.0	0.1	0.0	10.3	0.1	0.3	0.0	3.3	0.9	3.4	0.0	14.8	0.0	2.1	2.7	6.5	7.3	7.6	0.0	5.6	1.7	2.3	2.1	0.0	15.8	6.9	0.3	9.5	0.2	0.2	33.6	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	7.3	2.3	2.6	4.6	3.3	4.5	3.1	3.3	4.9	2.4	0.6	9.6	6.3	23.5	0.0	1.7	5.9	0.1	4.6	5.6	2.4	3.6	6.1	0.0	1.9	9.2	0.0	1.5	0.1	0.0	0.0	0.5	2.9	1.6	18.2	1.1	0.0	0.0	1.8	0.0	0.2	9.3	0.0	1.9	0.0	7.1	1.1	0.0	0.5	0.0	30.4	0.0	0.0	0.6	1.4	2.6	9.9	0.3	7.2	4.7	0.0	7.0	0.0	59.8	1.9	0.5	0.0	12.0	0.0	5.7	0.0	0.2	1.8	4.5	0.0	12.7	6.1	11.6	2.8	1.4	0.9	0.3	0.6	2.0	0.0	0.7
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.6	30.6	30.0	16.7	30.3	6.5	15.3	29.3	29.8	21.4	21.1	23.5	19.0	19.1	23.5	24.2	20.3	12.7	15.5	29.9	34.0	24.7	20.1	15.7	26.5	30.5	30.8	27.2	18.1	27.5	32.4	16.3	29.1	23.5	15.3	12.7	23.2	23.3	18.9	22.4	24.4	15.7	29.8	28.2	21.6	16.1	35.3	22.5	26.2	15.9	27.8	21.2	20.0	32.3	28.1	19.4	40.4	36.0	39.8	19.5	37.0	17.1	23.0	26.5	22.7	26.1	34.2	34.9	26.4	19.9	28.7	37.2	35.6	23.7	17.4	34.7	25.1	27.9	32.7	23.6	18.5	25.8	23.9	16.2	33.8	23.9	20.0	30.0	16.5	52.5	37.1	57.6	25.2	42.8	36.0	30.0	43.3	55.7	34.2	40.2	25.7	55.6	27.1	26.1	48.4	71.8	27.0	48.5	34.9	39.1	59.7	45.9	14.1	23.5	35.1	25.6	25.1	56.8	54.3	37.1	19.6	32.4	31.8	2.3	3.9	10.9	8.0	6.5	10.0	6.9	10.3	10.7	4.1	7.5	11.0	8.7	3.8	6.3	8.4	3.9	5.8	6.2	30.0	30.3	29.3	29.8	29.9	34.0	30.5	30.8	29.1	29.8	35.3	32.3	7.0	9.6	4.9	5.5	12.6	5.5	3.8	5.8	7.4	11.8	14.3	10.0	5.3	5.7	7.4	12.9	2.1	15.5	14.1	10.3	19.6	6.2	3.4	5.7	7.5	6.8	5.4	12.4	6.3	5.9	12.6	5.8	9.7	7.4	0.0	9.3	7.1	9.4	6.5	21.9	4.3	10.6	6.1	6.6	3.5	2.2	9.0	5.6	5.4	6.5	6.4	10.6	8.2	5.5	4.7	9.7	9.1	9.1	11.5	4.9	12.0	9.8	4.0	6.0	6.6	5.4	6.9	5.9	12.2	9.8	5.3	11.6	11.7	9.3	8.4	3.7
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	24.5	30.8	19.8	24.0	20.2	22.5	27.9	21.5	24.8	26.1	22.9	31.1	31.6	22.1	41.5	72.3	22.7	19.8	21.8	19.5	20.7	26.3	43.0	20.8	35.4	20.5	20.6	17.1	28.0	26.3	22.3	22.8	20.5	31.2	30.0	17.4	34.0	15.9	29.8	41.9	29.5	19.8	20.1	31.1	24.1	25.9	20.1	33.2	27.0	29.0	42.1	24.8	31.4	20.2	50.3	39.1	56.1	31.4	33.4	43.2	92.6	36.1	43.1	33.3	28.0	57.7	57.9	62.9	53.6	35.1	15.4	38.6	43.6	77.1	26.7	48.6	32.7	51.0	35.1	71.8	40.7	59.7	44.7	39.2	48.8	37.7	56.0	42.2	35.9	27.3	44.5	67.4	39.7	75.3	38.6	105.7	98.3	56.7	20.2	34.3	22.3	72.5	69.5	69.8	37.7	43.4	46.2	61.1	33.1	51.8	74.5	124.0	28.2	20.0	28.3	31.5	26.6	35.5	58.2	97.2	34.2	40.9	31.9	17.5	79.8	75.8	58.5	92.2	72.3	98.1	105.4	82.2	120.2	88.2	68.7	69.5	19.1	53.1	66.5	65.6	186.0	87.2	19.8	20.2	21.5	24.8	19.5	20.7	20.5	20.6	20.5	20.1	20.1	20.2	16.2	19.2	17.3	0.0	28.6	0.0	29.4	0.0	21.1	12.7	41.7	38.4	0.0	25.8	14.2	23.9	8.4	84.3	21.1	29.8	78.2	40.6	15.2	21.1	17.0	16.3	7.3	32.2	0.0	50.6	76.3	17.6	22.4	21.1	18.9	14.5	22.9	44.3	55.2	6.7	0.0	32.1	0.0	47.7	0.0	11.7	23.3	42.8	0.0	0.0	110.4	55.7	48.4	0.0	0.0	54.1	33.7	23.7	21.9	34.7	66.8	61.3	16.8	13.6	13.1	18.0	15.7	23.8	25.6	63.1	0.0	62.0	29.6	16.5	29.3	34.3
PYROXD1	"DKFZp762G094, FLJ22028"	ENSG00000121350	"Pyridine nucleotide-disulphide oxidoreductase domain 1"	Q8WU10	12	21437615-21471250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038319, HPA038320"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA038319: AB_10669522, HPA038320: AB_2675956"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.70e-4)"	7.9	10.0	3.8	9.2	4.3	9.3	10.4	5.1	5.4	7.1	5.3	11.9	13.9	7.1	8.6	8.3	7.1	8.7	10.7	3.7	5.2	16.8	12.3	8.6	10.6	5.4	5.2	6.6	13.4	10.4	5.2	5.9	5.3	9.9	11.2	14.0	11.9	5.9	12.4	10.0	16.0	6.4	4.7	7.9	12.8	5.8	4.2	7.5	15.6	9.6	8.5	7.6	6.1	5.4	9.3	3.5	5.2	5.8	3.7	6.8	11.8	14.5	6.7	5.2	4.0	4.5	8.6	10.2	6.0	11.0	4.4	11.3	5.8	11.4	5.8	12.1	5.1	11.8	9.2	5.7	17.2	17.7	12.0	11.3	13.5	3.3	14.3	6.7	7.8	11.0	5.8	4.2	10.7	5.9	8.3	24.3	8.6	8.2	6.5	1.4	11.2	11.2	16.3	9.2	1.7	13.1	6.7	12.2	27.0	7.1	14.5	20.8	11.2	6.2	5.9	13.5	13.4	6.4	4.8	12.7	25.4	13.1	7.5	1.2	0.8	0.6	1.7	1.5	1.9	1.2	2.0	2.1	0.8	0.9	1.6	1.7	0.3	1.6	2.7	1.1	1.6	0.9	3.8	4.3	5.1	5.4	3.7	5.2	5.4	5.2	5.3	4.7	4.2	5.4	12.5	12.8	28.4	12.7	18.3	6.6	10.2	10.7	8.0	21.8	15.1	10.8	11.7	27.1	13.6	27.6	25.0	15.4	22.9	40.0	23.5	24.7	179.8	26.0	13.0	9.4	20.4	13.3	14.0	33.4	14.2	10.4	19.9	21.1	25.3	8.6	8.9	21.2	16.2	8.4	17.0	21.3	12.2	21.8	5.8	32.6	10.5	18.1	5.4	17.8	15.6	14.5	17.5	13.0	34.2	41.2	25.1	6.4	19.5	12.0	39.4	43.8	28.6	28.2	13.1	15.0	13.8	49.7	18.8	14.5	7.7	19.4	20.1	10.6	20.6	14.1
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415182	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 189.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 189.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 46.1;U-937: 31.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Approved		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favorable (3.37e-4)"	10.2	14.5	6.4	2.2	6.9	2.6	8.4	6.7	7.8	9.1	9.6	7.2	2.0	5.5	8.3	2.5	9.4	4.2	10.7	6.3	6.4	6.3	12.2	4.3	2.6	7.3	7.1	9.2	3.5	2.8	4.7	4.2	7.4	10.5	4.7	0.7	22.4	4.1	9.3	2.9	3.7	5.7	7.0	5.1	5.3	3.7	7.1	2.3	8.6	10.4	1.4	9.7	6.3	8.0	3.6	8.9	4.9	0.2	7.6	15.1	1.9	5.8	18.0	3.2	6.1	0.0	12.3	0.0	10.2	6.2	0.9	1.8	1.5	2.0	3.3	0.3	1.4	7.3	16.1	0.8	9.7	0.1	16.2	8.9	2.6	2.6	3.1	46.1	2.5	3.4	0.2	0.2	4.9	11.1	0.2	17.2	1.4	7.0	3.0	2.3	1.9	0.1	4.7	5.5	0.3	0.1	6.4	0.8	4.6	6.7	5.1	8.1	3.3	0.0	3.6	1.1	5.9	1.2	0.8	0.0	5.7	31.5	0.5	5.4	0.3	189.8	6.1	0.0	1.3	0.0	2.1	5.2	1.9	0.2	1.2	3.6	0.3	44.5	0.0	0.3	0.6	1.8	6.4	6.9	6.7	7.8	6.3	6.4	7.3	7.1	7.4	7.0	7.1	8.0	3.8	9.6	5.1	19.9	1.3	0.5	6.1	9.7	4.0	0.4	15.0	18.4	11.2	5.7	9.5	1.8	0.0	5.6	6.5	3.5	7.9	3.8	0.2	4.1	4.9	4.6	1.2	1.7	3.4	2.4	3.8	7.2	11.2	3.2	2.5	11.2	4.6	2.9	9.8	0.0	4.3	4.9	8.2	3.2	6.6	0.9	3.4	2.0	1.8	5.6	1.8	2.3	19.6	1.5	9.5	1.7	1.6	3.8	0.5	2.7	2.2	12.1	12.2	0.8	6.6	9.7	5.9	2.9	1.5	0.8	0.6	1.8	5.4	17.8	6.3	10.0
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520998-88523776	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	71.2	72.2	35.1	23.1	37.0	44.5	70.4	38.7	43.4	69.0	33.8	72.0	30.7	74.8	45.6	64.1	65.5	22.5	58.6	34.0	37.3	84.9	81.7	56.4	27.8	36.7	35.6	65.2	59.0	41.9	66.2	28.5	36.5	61.9	31.2	22.9	55.4	33.9	66.9	67.0	53.9	36.2	39.2	54.4	56.8	42.3	36.2	27.3	54.5	42.3	29.4	61.7	62.5	39.3	60.1	19.8	39.1	46.4	76.7	78.3	26.2	43.2	60.6	53.1	44.6	15.5	46.3	0.2	47.3	61.7	36.4	25.2	35.6	54.4	66.6	73.4	61.8	66.2	24.8	59.9	58.0	110.7	40.9	54.4	80.8	34.5	69.5	50.4	88.5	20.4	75.9	64.9	77.8	45.5	68.5	67.6	32.7	70.5	37.5	68.0	36.3	69.8	44.4	33.4	46.7	45.7	54.9	49.4	119.9	38.4	23.0	54.8	60.6	56.1	51.9	55.3	40.6	45.6	40.1	7.5	49.3	55.7	63.1	82.4	92.1	79.0	90.4	94.9	102.2	98.9	103.2	98.3	111.0	80.5	105.4	101.6	18.1	108.9	95.3	68.3	116.8	186.1	35.1	37.0	38.7	43.4	34.0	37.3	36.7	35.6	36.5	39.2	36.2	39.3	136.2	51.3	71.3	0.0	92.0	230.4	176.0	167.2	158.8	28.7	207.2	205.2	5.8	84.4	98.8	86.5	10.4	232.3	106.8	65.5	287.6	118.0	44.0	69.7	103.9	127.0	114.6	98.2	0.0	129.5	120.6	119.6	53.5	51.2	105.8	97.7	114.2	147.3	139.4	26.9	0.0	99.4	101.7	115.9	124.7	98.3	125.9	100.0	348.6	0.0	129.2	113.3	176.1	0.0	0.0	103.4	102.7	120.0	84.6	208.7	128.0	236.9	79.1	33.0	59.2	107.3	109.2	108.1	62.3	189.9	289.0	163.9	119.6	136.5	132.8	142.3
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 52.5"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100			"Cluster 9: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.2	1.4	0.3	0.1	0.4	0.2	0.7	0.3	0.1	52.5	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.4	0.2	0.2	0.3	0.3	0.3	0.0	0.6	0.2	0.0	0.0	0.4	0.3	36.6	0.8	0.1	0.8	0.1	0.1	41.6	0.1	0.1	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.7	0.3	0.3	0.3	0.3	0.4	0.1	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
PZP	CPAMD6	ENSG00000126838	"PZP alpha-2-macroglobulin like"	P20742	12	9148840-9208395	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 81.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0;liver cancer: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Group enriched"	"Detected in some"	9	"HeLa: 5.7;SiHa: 2.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	NA	NA		15000000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.2	0.0	0.4	0.0	1.3	0.1	0.2	0.9	0.6	0.2	0.6	0.0	0.0	1.3	0.1	0.0	1.2	0.0	0.7	0.9	0.6	0.2	81.6	0.8	0.0	2.3	6.7	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.6	0.0	2.3	1.0	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.9	0.6	0.9	0.6	2.3	6.7	3.9	0.9	1.0	1.3	1.9	3.2	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.6	0.0	2.7	0.0	2.1	0.0	1.4	0.0	0.0	0.0	26.2	4.7	0.2	2.1	0.0	0.0	3.7	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.8	26.4	0.0	0.0	2.9	0.0	0.0	0.3	0.0	11.0	0.0	0.2	0.0	2.8	0.0	0.0	2.1	8.5	4.6	0.0	0.0	0.4	0.7	0.0	0.0	0.0	24.7	0.6	0.0	0.3	0.4	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0
QARS1	QARS	ENSG00000172053	"Glutaminyl-tRNA synthetase 1"	P47897	3	49095932-49105130	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		58000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	61.1	58.8	20.0	57.2	21.3	96.6	89.5	23.5	18.5	58.3	34.2	104.8	101.6	45.5	58.5	102.5	71.0	48.3	72.0	18.4	21.1	57.1	51.1	52.3	75.8	23.8	21.0	69.0	73.9	78.1	33.0	76.7	23.0	60.4	121.0	21.4	103.2	61.1	156.1	105.0	84.6	60.2	22.7	60.1	75.0	30.0	23.0	92.3	53.2	146.2	118.8	72.8	58.1	24.6	95.9	97.8	128.0	197.4	146.4	180.8	159.2	90.5	188.2	160.5	152.9	123.0	113.5	257.1	61.4	136.7	95.3	119.9	166.3	137.8	111.4	78.2	148.0	206.4	156.0	216.1	91.2	187.2	130.9	184.8	123.1	127.4	108.1	175.3	184.7	144.6	95.3	112.4	118.0	89.2	130.7	154.9	116.1	159.0	122.9	76.0	123.7	200.6	108.5	163.9	48.7	161.6	85.4	211.0	147.8	122.7	184.4	205.5	137.6	82.8	127.3	131.7	117.9	111.9	176.5	142.9	88.4	156.3	60.3	30.7	84.3	25.8	44.5	104.1	57.4	62.2	54.1	47.0	127.0	49.9	46.6	49.0	8.0	71.8	94.5	57.4	82.1	81.2	20.0	21.3	23.5	18.5	18.4	21.1	23.8	21.0	23.0	22.7	23.0	24.6	15.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	193.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	156.7	14.7	0.0	0.0	0.0	0.0	0.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	187.0	2.0	0.0	0.0	0.0
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 752.2;choroid plexus: 301.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	66.6	74.3	515.1	10.2	720.1	15.1	26.4	696.9	571.9	15.8	301.8	21.2	25.6	16.5	40.1	15.6	17.3	17.7	43.4	457.6	578.5	110.1	197.2	23.3	11.9	663.0	752.2	18.3	28.8	49.9	32.7	11.8	688.6	28.7	17.0	40.1	36.3	19.5	108.6	16.2	23.9	17.9	524.9	14.3	23.7	12.4	602.6	13.6	22.1	61.2	13.3	14.5	15.1	663.7	33.1	62.5	30.2	35.8	66.1	32.3	41.5	43.2	22.3	47.5	41.6	52.2	46.4	12.2	28.0	30.3	50.8	18.4	40.3	58.4	33.7	35.3	7.3	34.8	33.4	128.3	37.3	46.2	2.9	40.8	35.6	31.6	40.3	25.9	24.5	33.2	37.0	29.0	50.6	19.2	65.0	77.8	44.8	36.7	45.4	27.0	21.0	52.2	48.2	17.5	47.1	64.3	31.9	6.7	156.6	35.0	15.7	19.0	37.7	23.6	41.1	26.5	38.2	43.1	67.7	85.3	52.0	43.1	41.7	0.3	38.9	3.0	31.3	61.3	29.8	18.6	33.1	32.3	48.3	18.3	37.4	32.6	1.1	29.8	48.4	115.1	20.3	34.4	515.1	720.1	696.9	571.9	457.6	578.5	663.0	752.2	688.6	524.9	602.6	663.7	20.3	28.9	31.5	10.7	14.8	20.0	21.3	32.2	18.8	36.2	37.6	28.3	74.4	50.1	19.5	38.6	8.4	69.6	22.8	13.7	109.5	41.1	1.0	11.8	19.1	17.2	174.3	30.1	23.1	23.4	34.2	27.1	27.5	17.8	25.4	42.3	20.7	337.6	80.3	82.4	21.9	31.1	34.6	38.1	23.9	4.8	22.7	32.2	152.9	12.2	23.4	387.2	16.5	15.1	481.3	16.9	11.6	38.0	23.6	23.2	41.4	527.2	6.2	31.4	26.3	27.5	25.4	3.3	58.9	29.7	16.1	18.3	18.5	90.0	35.7	17.3
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578592	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 628.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 250.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	76.3	24.2	208.2	36.8	437.7	69.7	27.8	355.8	207.9	29.2	2.5	22.2	7.9	28.4	8.7	34.4	25.3	33.8	149.3	211.1	301.1	22.7	41.1	55.9	27.4	431.2	367.9	38.2	16.0	15.0	6.9	53.0	451.4	15.3	16.7	26.9	15.3	22.3	157.0	18.6	11.9	46.3	304.5	39.8	12.1	47.3	365.7	28.5	22.1	222.1	25.3	38.2	16.4	628.6	17.8	72.0	250.8	83.7	74.3	81.9	58.4	46.8	109.0	74.5	89.4	49.3	15.8	21.3	38.6	117.2	50.8	25.9	134.4	48.4	120.2	43.7	43.3	83.4	38.4	55.3	90.4	44.8	24.9	96.8	19.5	80.0	125.8	72.4	104.4	30.9	124.3	48.2	48.6	32.8	30.1	9.5	32.4	17.3	36.0	45.9	156.5	42.3	40.5	54.4	5.2	28.7	49.9	26.7	19.2	101.2	10.5	71.8	107.2	51.3	42.7	55.9	86.1	30.9	40.9	26.3	44.2	38.7	122.8	3.6	7.1	3.4	1.8	4.7	3.0	1.2	1.3	1.6	3.7	1.2	1.1	2.0	9.2	6.3	5.1	6.2	1.0	1.1	208.2	437.7	355.8	207.9	211.1	301.1	431.2	367.9	451.4	304.5	365.7	628.6	180.6	150.6	51.5	1140.0	35.4	153.7	34.1	25.3	43.9	60.4	42.8	47.2	355.5	37.1	30.5	20.2	58.4	51.1	77.7	0.2	21.5	21.8	53.0	60.7	156.7	130.0	0.0	40.4	58.4	12.0	51.3	92.2	10.2	71.1	60.9	64.8	131.0	72.9	86.8	32.0	471.4	0.0	14.2	221.9	188.0	102.5	86.6	165.7	113.8	713.0	107.9	113.5	32.0	1421.0	4573.8	19.8	0.1	98.6	34.4	46.5	0.0	33.2	23.7	31.5	46.0	197.7	83.5	46.1	19.7	47.4	136.1	55.1	32.2	69.9	0.2	46.4
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37342827-37373322	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 170.3;epididymis: 104.0"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 1527.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 1527.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	5.6	170.3	8.4	14.2	7.5	47.3	15.8	5.1	11.5	21.2	4.2	25.3	5.6	9.8	104.0	3.4	2.2	10.8	5.1	8.9	27.4	6.1	2.6	5.6	8.1	9.7	11.6	1.0	13.7	14.8	27.0	9.2	14.7	7.2	10.2	11.9	25.5	6.7	4.1	36.3	4.5	8.3	7.8	13.9	7.6	2.0	20.3	5.1	3.8	2.8	12.5	15.2	4.6	6.7	1.0	40.7	0.1	0.0	6.0	13.3	0.1	6.6	86.5	6.4	10.1	2.9	7.1	0.2	3.0	32.6	72.9	0.1	2.7	0.6	10.3	0.6	76.0	18.7	0.3	7.7	0.6	3.0	0.1	8.5	0.0	47.3	0.2	0.4	26.2	0.0	0.0	0.0	0.2	4.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.8	42.6	10.9	117.1	0.2	6.4	1.4	426.8	8.0	0.7	2.9	19.4	0.0	0.2	0.1	0.6	15.3	341.7	0.3	25.8	0.3	0.0	9.8	344.8	3.2	0.4	38.7	1.0	2.6	0.6	0.5	124.7	1.2	0.5	0.3	1527.7	0.2	3.3	2.4	0.1	169.8	8.4	7.5	5.1	11.5	8.9	27.4	9.7	11.6	14.7	7.8	20.3	6.7	1.8	3.2	2.3	0.3	12.5	39.0	13.6	40.0	2.2	21.8	7.9	8.5	1.1	1.5	17.7	22.0	2.1	0.7	0.8	6.1	1.9	45.4	0.6	2.6	24.7	17.5	217.0	1.7	8.5	2.4	6.1	26.7	3.1	4.0	55.3	1.6	22.5	0.3	20.5	43.7	7.3	6.6	138.4	21.2	163.4	2.9	3.1	26.8	528.3	6.5	64.3	0.8	3.1	3.0	1.3	31.8	1.8	23.7	26.0	9.1	0.2	11.7	4.3	3.2	13.1	0.6	6.6	1.7	0.7	0.6	14.5	4.7	5.6	5.0	7.3	5.8
QPCTL	FLJ20084	ENSG00000011478	"Glutaminyl-peptide cyclotransferase like"	Q9NXS2	19	45692403-45703989	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040797	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA040797: AB_10794148"	"unprognostic (6.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.71e-2)"	4.1	7.8	3.9	3.1	3.9	4.1	4.9	3.6	4.8	4.9	4.1	5.9	4.7	4.8	3.7	4.7	4.8	2.5	3.4	4.2	4.0	5.3	9.2	6.2	4.7	4.5	3.8	6.6	7.5	4.4	7.0	3.7	4.5	6.5	3.9	2.1	6.7	3.4	1.5	5.2	5.5	2.5	3.2	8.5	6.1	4.4	4.2	2.4	6.7	0.8	3.5	4.6	4.4	3.9	16.7	10.8	8.5	36.9	8.6	4.1	6.4	10.3	15.7	15.0	24.7	11.2	12.3	19.7	11.1	11.5	15.4	9.5	10.0	11.9	8.9	5.0	12.7	6.7	10.9	24.6	14.6	7.5	12.0	7.6	14.9	12.6	17.3	10.7	13.6	10.8	9.7	32.1	9.5	13.0	7.0	7.7	5.5	14.2	5.4	7.8	6.4	16.5	16.2	8.0	7.6	4.7	10.6	8.8	18.2	3.7	6.4	10.6	8.4	7.4	12.4	7.3	10.4	28.6	20.2	18.2	26.0	17.2	5.8	1.4	0.3	0.2	1.4	0.5	0.9	0.9	0.6	0.3	0.8	0.6	0.5	0.7	1.3	1.4	0.3	1.0	0.3	0.2	3.9	3.9	3.6	4.8	4.2	4.0	4.5	3.8	4.5	3.2	4.2	3.9	0.5	0.0	1.5	2.3	3.3	1.3	1.2	1.1	0.6	1.1	0.7	0.6	0.8	1.5	1.2	0.0	0.0	0.8	2.1	1.2	0.0	0.6	5.4	0.9	1.4	0.7	0.0	1.3	5.5	0.4	1.4	0.7	1.5	1.4	5.7	0.7	0.0	1.3	0.9	1.7	6.5	0.4	0.0	0.6	1.8	1.3	0.0	1.6	1.8	0.0	0.7	0.3	1.0	3.5	1.6	0.6	0.1	0.0	9.8	1.2	0.7	0.1	2.2	2.4	0.0	0.6	1.1	1.0	0.3	1.4	1.1	0.8	2.4	1.5	1.0	0.5
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29663279-29698699	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 119.4;liver: 183.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.8;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 597.1;Hep G2: 258.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		780000	"Cluster 7: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	8.4	89.4	20.6	4.3	20.2	4.8	6.7	25.8	19.8	50.6	19.4	19.2	61.6	26.1	95.2	4.0	43.6	10.2	26.8	18.5	22.2	119.4	183.5	9.2	6.8	28.6	26.6	31.0	34.5	16.2	5.8	27.3	32.4	7.0	15.2	7.5	13.4	26.1	5.1	5.1	30.3	13.7	23.6	17.2	7.1	4.1	22.8	8.2	6.5	1.2	5.2	10.5	11.5	23.3	0.6	1.4	51.8	56.4	8.8	21.6	167.8	6.0	5.2	8.6	11.0	145.9	91.9	2.3	597.1	10.8	10.0	1.0	18.5	0.6	4.5	0.8	16.7	27.1	2.2	258.0	52.5	4.1	10.4	69.8	1.4	4.8	0.2	12.8	0.2	28.2	75.1	2.9	0.4	154.6	17.6	100.3	162.1	1.9	0.2	89.3	16.3	58.5	47.9	4.2	48.6	103.5	0.0	142.1	118.8	85.1	106.5	112.8	0.6	2.5	24.9	0.9	0.5	1.8	4.9	18.8	4.4	10.4	8.1	0.0	4.2	0.3	0.8	5.3	0.9	0.1	0.6	0.7	5.8	0.0	0.1	0.4	0.8	0.4	9.0	3.1	0.9	1.9	20.6	20.2	25.8	19.8	18.5	22.2	28.6	26.6	32.4	23.6	22.8	23.3	3.1	9.6	24.8	5.2	10.1	3.6	11.7	0.5	1.8	3.3	5.0	2.0	43.2	8.6	3.0	64.4	0.0	404.7	5.8	84.5	50.9	1.2	0.0	93.8	49.5	5.5	28.3	10.5	1.3	55.2	315.1	35.8	0.5	81.0	5.1	6.7	9.7	367.4	147.5	6.7	5.6	47.3	0.0	21.2	18.3	0.5	29.2	19.8	42.7	12.2	4.4	20.8	3.1	11.1	0.5	11.5	78.5	27.1	8.7	4.2	161.0	598.8	1.5	5.0	6.6	3.3	16.2	0.5	3.0	0.2	2.0	215.6	5.7	36.5	104.7	8.3
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892707-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;Bipolar cells: 1.0;Rod photoreceptor cells: 1.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.8	0.2	0.2	0.2	0.4	0.2	0.4	0.3	0.3	0.8	0.2	2.2	0.2	0.7	0.0	1.1	0.5	0.3	0.6	0.2	0.1	0.6	0.2	0.5	0.1	0.2	0.2	0.6	1.3	0.0	1.0	0.1	0.3	1.2	0.0	0.1	0.3	0.0	0.2	0.4	0.9	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.7	0.0	0.0	1.9	0.7	0.3	0.6	0.3	0.2	1.6	0.0	0.0	0.8	0.6	0.0	0.0	0.0	1.0	0.4	0.2	0.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	2.2	0.2	1.5	1.4	0.2	0.2	1.5	0.9	0.6	0.0	0.5	0.5	0.7	0.5	0.2	0.7	0.4	0.8	0.5	0.2	3.5	0.9	1.4	1.7	0.1	0.6	0.7	0.6	0.4	1.8	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.4	0.3	0.3	0.2	0.1	0.2	0.2	0.3	0.0	0.4	0.3	0.0	3.2	1.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5
QRFPR	GPR103	ENSG00000186867	"Pyroglutamylated RFamide peptide receptor"	Q96P65	4	121328642-121381059	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.2;Early spermatids: 2.1;Endothelial cells: 3.1;Excitatory neurons: 5.9;Inhibitory neurons: 10.9;Microglial cells: 2.8"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.6;hTERT-HME1: 4.7;RPTEC TERT1: 2.6;SCLC-21H: 1.7;U-2 OS: 3.7;WM-115: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA050236	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050236: "	"unprognostic (1.24e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.93e-2)"		"unprognostic (3.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"		0.1	0.2	0.9	0.1	0.7	0.2	0.1	0.2	1.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.6	5.9	1.2	0.0	0.0	0.0	2.7	0.9	0.1	0.0	0.1	0.3	0.0	3.2	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.2	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.5	1.5	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.1	0.4	0.1	0.2	0.1	0.1	0.9	0.7	0.2	1.1	0.6	5.9	2.7	0.9	3.2	0.3	3.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	3.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0
QRICH1	"AB-DIP, FLJ20259, VERBRAS"	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Unfolded protein response"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	29.8	27.9	15.4	30.5	17.0	61.0	27.8	25.3	20.2	25.8	16.0	25.9	26.3	28.6	25.9	30.0	27.6	25.2	26.0	16.9	14.8	21.3	23.5	27.8	40.1	14.7	13.2	34.0	26.0	33.2	24.8	27.0	14.6	25.8	25.2	30.4	28.3	26.3	34.8	35.4	31.0	28.9	13.2	35.8	25.9	44.5	13.3	51.9	25.7	32.4	41.9	26.8	23.7	16.9	41.4	39.6	78.6	35.6	48.2	45.8	48.2	48.4	60.3	75.6	70.7	44.3	50.8	65.6	29.1	58.9	62.8	33.5	69.0	63.0	64.8	57.8	45.1	65.5	52.9	37.8	43.1	57.9	75.0	53.3	47.4	74.8	46.6	46.2	60.3	62.7	45.0	58.6	51.6	31.8	84.9	41.4	62.3	43.7	48.9	43.3	40.3	55.4	47.6	63.2	29.9	58.9	54.9	47.7	39.7	59.3	42.4	65.5	52.5	49.0	55.1	43.7	69.8	54.2	66.6	82.2	44.0	55.2	57.2	21.3	15.6	19.1	18.1	18.9	21.5	16.6	17.3	20.6	18.5	16.6	18.3	22.0	11.7	18.1	33.0	13.5	19.8	14.3	15.4	17.0	25.3	20.2	16.9	14.8	14.7	13.2	14.6	13.2	13.3	16.9	21.8	9.6	18.9	19.6	30.5	22.2	13.7	16.0	17.1	13.6	20.6	17.7	21.1	14.3	17.9	20.2	22.9	25.7	28.2	16.6	1.9	15.9	15.8	19.8	20.7	19.6	25.9	22.5	37.9	14.0	27.8	20.3	23.9	27.5	16.5	20.0	18.9	20.4	19.7	11.8	39.1	20.6	10.2	25.3	18.3	10.9	22.4	19.5	12.4	14.0	22.3	12.5	15.5	24.6	25.5	18.6	10.5	30.9	39.7	18.0	14.4	10.1	15.2	17.6	6.6	21.9	25.3	52.4	27.8	24.5	22.6	36.8	28.5	17.0	16.8	15.5
QRICH2	DKFZP434P0316	ENSG00000129646	"Glutamine rich 2"	Q9H0J4	17	76274049-76307998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.8;Excitatory neurons: 9.8;Inhibitory neurons: 14.5;Late spermatids: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052219	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA052219: AB_2681766"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.82e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-3)"	1.0	0.7	3.9	0.7	3.7	1.7	1.1	6.3	7.0	1.8	2.5	1.6	0.3	1.1	0.7	2.1	1.6	0.3	1.6	3.6	3.6	2.0	2.3	1.7	0.6	6.3	3.8	1.3	1.9	0.6	1.8	1.0	6.4	2.1	0.6	2.7	3.6	0.5	1.2	1.3	1.1	0.4	3.2	1.1	1.2	18.3	4.5	0.5	4.4	0.5	0.5	1.0	1.7	4.4	0.8	1.6	2.9	3.3	1.5	1.4	1.4	1.4	0.3	1.0	0.3	0.5	0.3	4.2	0.5	0.9	0.8	0.3	4.0	0.7	1.3	1.1	2.2	0.4	1.2	3.7	0.8	0.6	1.9	1.3	0.6	1.2	0.1	2.0	1.3	1.2	2.3	0.8	0.3	2.5	2.3	0.5	1.2	1.0	3.2	4.9	2.5	0.1	0.5	1.5	2.7	2.7	0.7	0.4	1.7	2.9	1.2	1.7	1.2	0.8	3.1	4.1	1.7	1.1	1.1	0.4	0.9	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.7	6.3	7.0	3.6	3.6	6.3	3.8	6.4	3.2	4.5	4.4	0.8	0.0	0.0	6.5	0.8	0.1	0.4	0.2	0.0	0.7	1.5	1.8	1.7	5.7	0.3	1.8	0.0	0.7	0.1	0.7	0.0	0.9	33.8	1.4	0.9	0.9	0.0	0.4	9.8	0.0	1.1	0.3	2.0	1.6	0.0	3.7	0.0	0.5	0.2	1.7	14.5	0.5	0.0	0.6	0.4	9.1	0.9	0.3	1.8	5.6	0.6	1.9	1.0	5.5	5.4	0.4	0.2	0.7	0.9	0.3	0.2	0.8	1.1	2.3	0.0	0.9	1.0	5.0	1.5	0.6	0.3	0.4	0.4	0.1	0.6	0.3
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA amidotransferase subunit QRSL1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"memory B-cell: 86.4;naive B-cell: 71.0"	"Lineage enriched"	"Detected in all"	7	"B-cells: 86.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	5.0	5.7	4.0	8.6	5.2	6.4	7.4	4.7	5.0	4.8	5.8	8.2	7.8	6.3	6.1	5.7	5.4	4.8	10.1	4.1	4.5	9.3	7.8	4.6	15.9	4.6	4.5	5.6	6.0	9.4	4.3	5.7	5.0	5.3	9.1	8.4	6.1	5.6	19.4	5.9	8.9	5.8	4.1	10.5	6.7	6.6	4.5	8.2	9.2	21.3	15.5	5.7	4.9	7.4	9.0	9.1	12.3	17.8	7.8	9.7	17.3	10.0	10.2	13.1	13.0	10.7	7.1	29.7	8.9	11.2	13.5	15.5	18.6	12.1	16.4	14.2	14.1	14.5	9.7	11.1	12.2	33.2	12.5	9.6	18.6	14.0	20.6	9.9	9.5	18.4	26.8	9.4	11.0	10.1	10.7	16.1	12.9	15.6	10.5	28.9	15.8	7.5	14.3	10.2	10.7	11.0	8.0	18.4	15.3	10.7	12.1	25.3	9.3	9.2	7.6	10.0	15.7	5.4	8.3	17.2	12.6	22.1	14.0	5.0	6.4	1.0	6.4	9.6	6.3	86.4	7.1	5.6	10.7	71.0	6.6	6.4	1.6	7.0	13.0	8.5	8.5	5.7	4.0	5.2	4.7	5.0	4.1	4.5	4.6	4.5	5.0	4.1	4.5	7.4	9.0	19.2	12.5	20.2	64.6	4.0	8.4	12.8	6.2	14.9	10.3	6.1	24.8	7.2	9.3	11.0	16.7	21.5	12.3	11.0	17.6	15.4	15.5	28.2	12.0	10.8	17.4	13.7	14.6	18.4	23.0	9.9	15.3	14.8	18.9	15.3	8.2	14.6	12.9	3.3	18.9	11.2	14.2	12.4	6.1	8.4	8.4	10.0	8.8	12.2	18.3	9.9	19.6	22.6	26.5	14.2	8.3	9.1	13.2	9.3	12.2	19.5	19.9	19.1	0.0	10.0	10.0	25.6	14.2	12.2	5.4	12.3	14.3	21.1	18.7	8.9
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32892811-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	5.4	4.5	5.3	5.5	6.5	4.1	8.9	15.1	5.3	7.5	10.0	5.1	3.5	8.3	6.7	7.6	6.1	5.9	5.9	5.1	5.8	5.5	5.8	4.4	5.5	5.6	5.7	12.7	6.9	6.5	3.9	5.7	5.6	4.6	5.5	7.1	10.0	5.1	4.6	11.8	4.1	6.4	5.7	6.1	5.5	9.0	5.4	8.6	8.8	7.0	6.5	6.3	6.1	6.6	23.4	28.7	32.4	30.5	12.2	23.2	15.7	20.0	17.9	14.0	17.3	24.5	10.8	24.2	12.5	23.9	23.5	29.4	30.9	17.6	30.3	10.7	19.5	22.9	26.7	21.0	9.8	27.7	11.9	11.6	18.9	17.7	29.5	16.8	19.9	14.2	35.2	10.6	22.2	20.5	14.3	10.8	34.1	14.4	17.9	22.5	64.6	10.1	14.5	24.6	16.7	23.9	37.8	19.4	12.3	23.7	20.2	14.3	20.3	34.0	34.2	62.9	44.0	6.8	10.3	22.5	21.9	12.7	22.6	0.0	0.2	0.0	0.2	0.4	0.1	0.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.4	0.0	0.1	5.3	6.5	15.1	5.3	5.1	5.8	5.6	5.7	5.6	5.7	5.4	6.6	22.0	19.2	13.4	35.6	10.6	27.9	12.0	14.2	35.9	17.7	21.6	18.7	31.0	14.3	15.9	7.3	14.6	12.9	7.7	5.9	3.9	10.6	14.0	9.9	37.0	19.5	0.0	17.7	51.6	12.1	12.2	27.2	15.8	17.1	3.8	39.3	15.7	10.5	14.5	10.1	50.6	11.7	14.2	16.0	16.1	11.0	24.5	19.1	16.0	54.4	15.9	12.9	5.2	50.3	48.6	10.7	9.3	21.1	23.1	15.0	5.3	8.9	12.2	15.0	6.6	37.9	17.8	21.3	20.5	43.1	27.6	4.2	8.4	21.5	13.6	14.3
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 260.9;Paneth cells: 224.5;Proximal enterocytes: 261.8;Undifferentiated cells: 280.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	17.2	27.1	11.2	11.8	11.4	13.4	18.1	10.0	15.9	18.4	9.4	20.0	10.3	22.7	2.7	20.5	20.9	7.3	21.4	11.8	11.3	18.3	30.2	12.5	12.2	10.8	10.6	24.4	51.9	9.6	17.6	7.7	11.1	16.9	5.0	6.1	22.3	9.2	20.5	18.3	15.2	6.1	10.8	14.8	20.7	6.4	11.3	7.0	20.7	10.2	5.1	17.6	16.4	11.6	41.5	32.3	14.6	44.1	15.3	18.2	19.7	20.8	18.3	23.8	22.9	25.6	15.0	47.1	50.1	11.5	14.4	26.6	13.8	24.9	7.7	28.1	20.8	30.4	13.3	55.7	26.6	46.4	25.7	27.8	20.3	15.3	22.1	10.5	24.2	25.5	35.0	50.2	11.8	64.2	39.7	56.5	40.3	25.3	53.5	41.2	19.9	72.2	18.8	26.1	48.4	21.6	33.0	33.4	27.8	6.2	21.5	19.0	19.5	35.0	20.3	58.2	49.7	56.7	48.3	23.3	19.3	55.0	44.4	1.9	16.6	0.4	29.6	31.4	37.4	42.0	31.7	26.4	34.0	40.8	33.3	27.5	1.3	43.9	16.6	39.8	37.9	21.3	11.2	11.4	10.0	15.9	11.8	11.3	10.8	10.6	11.1	10.8	11.3	11.6	23.2	0.0	4.5	47.3	36.6	63.7	63.5	59.0	65.4	36.7	42.6	48.6	7.3	30.0	24.5	57.0	50.1	47.8	27.3	157.0	64.6	25.8	1.6	19.8	28.8	24.7	192.5	30.3	32.8	27.6	39.7	33.5	23.9	18.8	16.5	43.7	18.2	33.9	28.8	90.9	31.4	260.9	42.7	15.8	30.9	2.6	50.7	12.8	49.8	8.4	10.5	22.0	7.2	21.6	30.0	13.9	224.5	37.6	53.2	43.6	261.8	80.3	22.6	57.9	19.7	40.7	31.1	12.9	24.6	36.9	41.9	28.0	27.0	67.4	280.7	37.2
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	6.9	6.5	3.6	9.4	3.9	11.2	10.1	3.2	4.0	7.4	9.0	8.4	7.7	8.4	6.4	7.0	7.5	5.3	3.4	4.3	3.6	7.5	7.2	8.6	12.0	3.8	3.6	8.1	6.7	7.3	4.4	8.5	3.8	6.9	8.9	11.3	5.9	5.9	3.8	8.2	7.6	7.4	3.4	11.8	6.9	7.1	3.7	7.7	8.9	3.9	11.6	9.6	5.2	4.4	26.8	27.1	22.2	24.6	9.6	11.7	20.9	13.7	8.6	22.9	20.9	26.0	18.8	49.4	19.5	12.7	27.3	25.9	43.5	20.6	29.9	9.4	19.6	22.2	15.9	18.6	13.7	40.8	20.0	9.3	18.2	20.8	29.4	9.3	24.0	22.5	23.7	17.1	13.1	21.4	34.3	15.9	42.6	37.6	29.3	30.6	15.6	26.6	18.0	18.2	30.1	14.2	19.9	19.4	25.1	18.4	21.6	20.4	15.9	19.9	21.6	7.9	26.9	12.0	18.7	68.1	17.4	29.6	40.9	0.6	15.3	3.8	6.4	15.8	6.0	16.8	5.4	6.3	19.4	11.0	7.4	6.0	6.5	8.6	11.4	8.1	7.6	6.5	3.6	3.9	3.2	4.0	4.3	3.6	3.8	3.6	3.8	3.4	3.7	4.4	14.0	19.2	20.3	0.0	8.4	0.0	0.0	0.0	0.0	0.0	13.8	12.4	0.0	0.0	10.5	3.7	0.0	10.9	10.0	0.0	1.9	15.7	0.0	16.3	19.7	9.9	0.0	0.0	0.0	12.4	10.9	6.2	0.0	15.1	15.2	15.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	3.3	0.0	0.0	8.9	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	4.9	4.3	17.4	0.0	0.0
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2;Rod photoreceptor cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	20.5	21.9	41.2	15.2	52.7	29.0	19.6	53.7	43.8	23.4	36.4	33.6	19.7	23.9	14.8	16.1	22.5	16.2	33.1	39.9	42.3	20.1	28.2	16.7	22.5	60.9	49.8	27.2	42.8	29.0	22.6	13.7	63.6	22.7	15.3	62.7	35.7	19.9	54.5	22.5	20.4	22.2	49.3	20.2	28.4	30.8	48.6	20.3	17.6	31.5	18.8	22.2	17.8	73.7	38.2	48.7	36.7	35.9	15.2	20.6	25.2	24.7	23.4	41.0	29.7	35.0	17.6	38.1	25.6	30.2	28.0	28.3	38.9	45.8	27.5	24.7	41.6	35.7	33.4	29.2	36.0	24.7	25.6	24.8	35.5	35.0	16.4	30.1	31.7	42.9	41.8	31.0	24.3	33.1	55.6	43.8	29.8	40.4	35.8	37.9	44.8	22.8	20.3	41.9	47.2	41.1	28.1	32.8	41.8	25.0	30.3	29.2	27.4	37.9	31.8	32.2	51.1	23.8	22.2	39.3	29.5	34.3	48.5	38.4	50.5	82.5	64.8	44.1	56.5	56.5	52.7	55.0	56.7	42.1	40.5	47.0	31.3	59.5	50.3	52.9	61.5	51.4	41.2	52.7	53.7	43.8	39.9	42.3	60.9	49.8	63.6	49.3	48.6	73.7	25.2	25.6	14.7	4.9	15.5	14.9	16.5	35.9	10.2	28.0	22.8	32.9	24.1	24.3	20.5	5.5	27.1	18.8	19.8	17.9	56.7	32.3	36.4	15.2	17.0	21.1	19.2	17.9	5.1	50.9	21.3	25.4	20.9	10.2	22.8	24.7	20.0	21.6	30.2	18.5	5.0	21.5	22.4	18.2	12.3	113.2	17.7	16.2	21.4	5.6	18.8	59.3	42.2	4.5	9.5	37.0	22.1	21.8	34.7	11.4	41.7	38.5	22.0	115.7	13.1	19.9	31.1	49.8	32.4	13.6	16.2	7.7	18.3	30.7	22.8	13.6
R3HCC1L	"C10orf28, GIDRP86, PSORT"	ENSG00000166024	"R3H domain and coiled-coil containing 1 like"	Q7Z5L2	10	98134624-98244897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocytes: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037367	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037367: AB_10696930"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-2)"	12.8	8.5	8.8	7.8	10.0	17.4	11.6	10.9	11.1	14.2	9.1	12.1	6.4	8.9	9.7	13.1	9.2	5.9	8.3	8.5	8.9	11.8	13.5	10.9	12.2	9.7	9.3	8.7	11.0	10.5	8.6	8.3	9.7	12.7	10.1	10.0	11.8	6.6	9.9	15.1	12.3	6.5	9.4	15.3	9.5	31.1	9.5	13.7	10.1	8.0	13.0	12.4	13.1	10.9	14.6	9.4	13.9	12.4	11.7	12.4	11.5	16.1	22.4	15.4	17.0	12.8	10.0	20.4	8.5	9.6	8.7	16.0	14.2	9.7	17.4	15.4	9.6	12.1	7.3	14.4	14.4	16.7	14.1	11.4	10.9	13.6	20.0	13.6	10.1	12.6	10.6	12.4	12.2	14.0	13.2	17.3	10.1	6.9	12.1	13.4	15.9	8.2	11.2	8.5	4.8	10.2	8.3	6.0	32.9	17.7	10.8	10.4	11.2	10.3	11.0	11.6	12.2	12.5	14.1	34.4	14.8	17.1	7.7	12.2	6.3	17.8	8.6	8.8	7.8	9.2	8.9	8.9	5.0	8.6	7.7	7.7	7.6	10.4	13.4	5.5	13.4	5.5	8.8	10.0	10.9	11.1	8.5	8.9	9.7	9.3	9.7	9.4	9.5	10.9	11.8	16.0	15.1	30.0	13.2	3.3	4.8	3.9	6.8	6.7	5.9	5.0	8.9	10.0	6.5	7.3	6.2	9.8	15.6	13.5	5.9	7.8	28.4	10.8	10.5	9.5	6.0	11.8	39.9	6.9	9.8	8.3	14.3	10.1	17.1	9.7	6.1	4.5	6.9	5.0	35.8	12.2	2.0	8.7	5.1	13.1	5.3	13.5	12.4	51.5	9.5	6.5	13.4	34.2	59.8	10.5	5.4	5.7	11.9	5.4	9.6	3.4	13.0	14.2	0.0	7.6	7.1	36.6	23.9	6.3	3.8	13.0	12.8	8.7	9.5	7.5
R3HDM2	KIAA1002	ENSG00000179912	"R3H domain containing 2"	Q9Y2K5	12	57253762-57431005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 274.9;Inhibitory neurons: 204.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038327, HPA038328"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA038327: AB_10674681, HPA038328: AB_2675962"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.49e-2)"	19.8	18.4	11.2	20.0	14.5	24.2	18.4	12.9	26.7	20.1	0.8	18.7	22.4	23.7	11.0	20.4	23.5	20.2	34.3	14.5	7.2	17.3	22.0	18.0	23.2	4.5	6.9	32.4	20.2	24.2	19.4	17.9	2.2	28.2	16.9	34.9	15.8	15.9	42.8	24.0	20.9	17.9	2.3	24.5	20.2	19.4	8.8	28.6	20.6	29.3	18.4	16.6	17.7	19.8	20.4	28.0	22.7	28.4	36.5	51.2	15.2	20.9	25.3	14.4	13.2	9.2	23.4	22.5	25.3	29.6	16.1	26.1	13.7	24.8	16.7	31.4	17.7	27.6	11.1	12.0	27.0	18.4	33.9	35.0	38.7	23.8	52.5	62.1	20.5	38.3	19.5	28.6	24.8	25.1	25.9	13.6	5.8	12.4	20.3	15.7	16.8	14.8	12.8	21.9	23.0	25.0	19.8	26.1	21.3	13.0	23.0	33.5	24.3	15.0	11.4	34.4	21.3	17.1	9.0	9.1	31.4	19.0	27.4	4.6	2.2	1.8	1.6	2.1	2.0	4.7	2.9	1.5	1.3	1.9	3.0	1.8	4.9	3.1	5.7	2.0	0.9	0.8	11.2	14.5	12.9	26.7	14.5	7.2	4.5	6.9	2.2	2.3	8.8	19.8	53.2	32.1	27.7	82.6	60.0	43.5	28.1	13.3	46.1	112.2	50.1	43.2	33.8	32.9	12.7	38.6	79.2	22.9	60.9	28.5	50.9	13.3	18.2	44.9	83.9	28.5	24.7	22.7	274.9	11.1	19.2	39.7	41.3	51.5	25.9	53.2	31.8	79.6	19.3	109.4	204.6	31.3	10.2	63.1	34.7	33.6	59.7	46.7	26.6	65.6	26.5	40.0	57.7	114.1	130.7	11.7	42.2	48.2	27.6	25.1	38.2	68.3	19.4	77.5	32.9	71.5	43.9	42.3	47.1	40.2	51.4	24.4	55.7	56.0	29.8	27.9
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 586.7"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 586.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	37.7	26.3	34.5	50.1	31.2	98.0	37.0	33.7	38.5	42.0	29.3	39.4	23.9	34.1	13.4	81.8	36.9	28.4	32.4	32.1	28.0	58.8	47.8	55.7	54.3	31.3	29.4	23.7	50.8	19.2	33.1	25.1	28.9	42.2	17.5	22.0	48.1	15.8	55.8	58.8	45.5	18.7	25.6	93.9	39.1	9.1	29.7	39.6	32.4	23.8	36.5	43.2	49.4	37.0	44.2	25.4	26.1	36.5	16.6	28.9	43.7	29.3	23.2	28.8	25.4	27.6	36.7	31.5	23.9	33.4	6.1	39.6	15.4	34.7	12.9	49.2	33.0	43.7	19.7	48.3	49.3	24.6	73.0	38.7	65.9	18.7	39.1	26.3	33.4	35.7	82.2	62.8	27.1	79.0	34.7	46.5	34.5	53.3	41.2	33.9	12.5	60.8	48.2	45.7	46.6	45.4	25.8	56.2	48.9	20.0	49.1	57.8	34.3	52.3	29.1	62.0	30.0	69.1	39.1	47.6	33.5	34.9	45.9	117.4	13.1	111.0	14.9	10.1	23.1	38.5	30.3	20.5	14.3	21.5	28.1	20.1	586.7	8.6	14.0	6.0	49.3	26.5	34.5	31.2	33.7	38.5	32.1	28.0	31.3	29.4	28.9	25.6	29.7	37.0	23.2	19.2	21.5	0.7	59.6	35.1	49.0	24.9	25.0	17.5	30.7	20.6	6.8	20.0	26.3	18.4	8.4	38.1	29.0	34.7	7.9	57.7	1.3	20.1	20.1	22.8	32.8	106.5	4.0	55.4	46.7	20.0	30.5	33.5	23.5	10.3	12.1	13.3	26.2	28.6	3.0	31.3	34.6	27.5	37.0	2.6	11.1	59.0	24.9	1.9	51.4	8.0	29.9	1.5	3.1	68.4	31.9	11.7	37.3	48.9	13.1	16.0	19.9	12.4	26.3	13.6	20.6	0.8	4.0	34.3	31.7	69.0	48.1	15.2	22.6	70.9
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44337043-44351238	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.4"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"				"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAB10		ENSG00000084733	"RAB10, member RAS oncogene family"	P61026	2	26034084-26137454	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045611	Approved					NA	Yes		4300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"			"HPA045611: AB_10961124"	"unprognostic (7.73e-3)"	"unprognostic (2.45e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (9.22e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.06e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.99e-2)"	47.4	51.5	42.8	44.2	49.0	17.7	45.1	48.7	56.7	55.6	29.7	58.8	41.3	38.9	40.3	172.9	39.6	41.9	49.8	41.2	47.3	56.8	48.5	39.9	42.8	52.9	46.9	37.1	37.7	66.3	21.5	40.9	54.4	42.6	57.9	29.0	51.7	41.6	213.9	71.0	46.3	48.1	51.5	44.4	58.8	24.0	46.4	43.8	54.2	114.0	64.5	78.5	78.1	62.8	117.1	139.7	63.8	53.1	131.2	108.2	61.9	90.3	76.8	69.7	61.6	83.2	83.8	77.9	83.4	96.7	79.5	62.0	77.3	84.4	73.9	82.3	56.0	135.1	54.4	134.8	122.6	112.2	73.5	89.0	135.9	85.9	100.3	109.6	89.0	48.9	114.1	76.7	95.1	52.0	69.1	87.1	65.2	139.5	81.7	65.2	133.4	132.8	141.6	111.8	90.1	83.7	75.2	135.1	94.9	70.5	59.5	80.1	110.2	107.1	56.2	75.7	97.2	50.5	84.2	124.4	107.9	132.6	83.5	58.0	75.5	35.5	31.5	135.2	38.6	33.4	36.9	34.1	69.9	32.0	31.1	35.2	54.6	50.6	152.6	24.3	44.6	81.0	42.8	49.0	48.7	56.7	41.2	47.3	52.9	46.9	54.4	51.5	46.4	62.8	70.8	80.1	49.7	37.9	56.2	341.8	195.5	156.4	122.3	23.8	85.2	64.6	76.4	85.8	134.7	92.0	8.4	121.0	48.7	168.8	115.4	188.3	35.5	67.8	76.7	78.4	65.2	101.0	43.6	96.0	204.4	80.7	97.3	98.3	50.7	44.0	53.2	66.8	159.7	26.9	36.0	94.1	107.8	157.2	285.1	29.6	62.7	151.6	88.9	36.5	246.8	104.9	38.1	47.7	78.1	136.8	123.8	70.0	63.6	199.7	85.9	135.2	107.4	32.7	85.5	94.1	159.5	85.3	73.4	255.9	488.0	128.3	59.3	65.6	117.7	334.3
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891989	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 969.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	140.0	231.6	79.7	123.9	86.4	126.0	150.1	83.4	105.0	159.3	78.5	223.8	139.8	117.4	130.9	480.0	146.1	185.1	156.3	86.1	97.4	162.9	124.1	148.1	141.2	87.0	83.0	104.9	107.6	192.5	106.8	214.4	101.3	150.3	224.2	99.0	195.1	126.2	119.6	288.5	158.9	149.2	87.2	183.9	216.2	201.8	86.0	143.6	155.3	109.6	246.0	269.8	232.2	86.7	285.2	330.3	330.1	240.8	294.7	275.0	431.1	297.0	300.4	264.4	313.0	305.8	497.4	370.7	295.8	342.6	262.3	429.0	525.0	393.2	248.2	243.7	314.9	445.3	219.9	274.1	224.7	211.5	254.0	282.8	438.1	260.2	214.7	281.7	595.2	197.8	364.5	214.3	378.1	283.7	209.9	167.3	275.9	1057.4	185.9	176.3	250.5	346.3	716.1	734.7	237.4	251.9	214.0	335.6	286.5	387.8	445.0	243.0	453.7	208.4	296.4	203.1	267.8	112.2	289.5	288.8	193.7	353.5	228.8	183.5	154.8	235.2	56.7	133.9	58.8	78.8	85.3	68.6	137.1	64.1	78.9	63.6	232.8	71.3	154.6	87.6	109.5	340.2	79.7	86.4	83.4	105.0	86.1	97.4	87.0	83.0	101.3	87.2	86.0	86.7	155.7	57.7	57.8	15.3	90.2	192.2	180.2	375.2	134.3	42.3	107.5	69.6	89.5	105.8	245.4	187.6	33.3	326.4	76.0	313.4	346.3	360.6	413.1	119.3	72.7	260.7	206.2	91.1	31.3	337.0	340.4	96.9	149.9	194.5	74.9	75.9	235.2	88.4	239.2	57.2	27.7	227.4	244.1	114.8	214.2	80.9	97.3	148.1	186.7	42.2	217.8	137.9	65.9	25.6	21.9	391.1	277.0	86.5	72.1	187.6	205.8	271.5	240.0	36.1	46.0	45.2	161.5	407.5	95.3	225.5	284.4	969.3	96.6	97.6	209.2	360.8
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899497	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 798.0;Endometrial ciliated cells: 622.9;Glandular and luminal cells: 969.7;Urothelial cells: 613.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 101.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 101.9"	"Cell line enhanced"	"Detected in many"		"K-562: 73.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	7.5	5.7	3.8	17.7	2.7	58.5	21.8	3.8	3.8	14.5	39.3	40.7	41.3	5.9	14.8	47.1	16.9	21.7	12.0	4.4	4.3	13.7	7.2	74.0	17.2	3.4	2.7	4.6	42.5	12.0	8.6	25.8	2.1	8.7	47.0	6.1	23.8	13.5	4.6	18.9	53.5	7.1	2.3	12.0	45.5	6.4	4.0	15.4	13.0	2.7	31.1	23.6	14.9	2.2	41.8	18.1	1.9	8.0	0.4	0.1	54.1	4.2	6.6	7.5	9.6	40.6	23.2	17.0	12.7	5.1	0.4	31.6	14.5	9.4	11.3	44.2	13.5	3.3	9.0	11.9	20.9	7.3	36.3	4.8	12.2	2.8	7.9	11.1	0.1	22.2	73.1	8.2	3.8	9.9	12.4	10.7	12.0	40.9	5.3	3.9	9.7	13.2	39.4	42.2	7.4	8.5	10.6	52.3	13.0	36.8	35.2	14.0	0.6	0.2	23.1	0.6	0.7	16.5	20.7	4.5	0.3	9.8	5.7	24.0	20.5	38.1	4.4	9.4	9.9	6.0	3.2	3.1	18.3	3.8	2.0	2.2	101.9	10.9	20.2	11.0	7.7	10.7	3.8	2.7	3.8	3.8	4.4	4.3	3.4	2.7	2.1	2.3	4.0	2.2	7.6	798.0	112.9	1.0	128.5	15.9	113.5	49.5	24.5	5.4	113.6	58.5	15.8	84.4	228.0	64.4	16.7	44.9	123.6	385.5	15.6	170.2	0.9	622.9	71.4	25.3	243.7	3.8	7.9	248.9	8.1	28.7	272.7	969.7	30.4	2.8	32.2	15.3	32.1	6.7	8.6	312.3	95.6	59.1	174.7	1.8	1.8	121.1	16.0	2.8	95.2	18.6	120.5	0.0	1.0	364.6	299.1	1.5	48.2	192.7	331.9	16.5	348.8	21.0	6.6	9.0	23.3	2.4	5.2	124.2	30.5	96.0	83.8	2.8	256.6	613.9
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046941	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.6	6.6	5.2	6.6	7.0	13.8	6.9	4.8	8.5	10.2	2.4	8.2	3.6	18.8	28.5	6.3	11.8	8.3	6.1	7.1	3.4	12.2	5.4	7.6	6.9	2.8	4.6	9.9	5.6	6.3	4.3	8.2	2.2	10.8	4.9	10.3	4.8	24.7	5.0	5.9	5.5	19.5	3.7	6.6	17.2	7.8	5.3	6.2	11.4	7.5	5.5	7.6	6.2	6.1	7.1	8.8	7.3	9.3	11.9	15.0	7.8	13.8	15.8	8.3	8.6	7.4	7.4	14.5	10.8	14.0	6.1	4.8	10.1	6.1	12.8	3.8	10.9	5.1	9.1	5.1	17.2	9.7	5.5	14.8	11.3	11.6	25.4	11.0	5.1	9.3	3.9	12.1	10.9	2.5	7.5	7.3	6.2	3.1	6.2	6.4	26.0	4.9	12.4	5.6	1.7	13.5	9.8	3.9	17.3	8.7	3.0	8.9	7.7	11.2	8.9	13.3	13.8	8.9	7.8	9.4	11.5	16.4	7.0	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.4	0.4	0.2	0.3	0.1	0.1	0.5	0.1	0.0	5.2	7.0	4.8	8.5	7.1	3.4	2.8	4.6	2.2	3.7	5.3	6.1	16.7	57.7	31.5	79.7	17.7	10.3	8.8	4.4	12.5	28.1	10.1	10.7	25.8	24.3	6.0	42.3	29.2	11.6	15.1	5.5	7.9	12.6	16.5	13.1	31.0	14.1	14.5	17.4	63.8	18.7	7.9	29.1	14.8	15.7	3.8	28.0	11.4	8.6	11.4	38.7	57.9	6.6	4.1	23.0	12.2	6.6	33.5	16.2	23.2	34.7	19.4	26.0	15.5	53.8	82.9	16.6	4.7	28.6	17.0	11.1	5.4	18.1	7.3	31.4	26.3	34.0	25.8	14.9	21.2	9.2	9.5	5.2	12.9	19.2	6.5	6.4
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB11FIP4	"FLJ00131, KIAA1821, MGC11316, RAB11-FIP4"	ENSG00000131242	"RAB11 family interacting protein 4"	Q86YS3	17	31391675-31538211	"Predicted intracellular proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;testis: 48.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 334.6;Horizontal cells: 212.0;Late spermatids: 1251.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 78.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 64.3;Daudi: 36.8;Hep G2: 40.6;HMC-1: 41.5;RT4: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063203	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA063203: AB_2684962"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.70e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.29e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.74e-8)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.13e-3)"	0.9	1.1	68.9	8.1	72.0	15.0	4.1	48.9	71.4	2.7	22.0	9.3	12.9	1.2	11.2	6.7	7.5	3.2	2.7	66.2	47.6	6.8	2.9	5.7	11.8	55.3	66.0	2.4	17.6	6.1	3.5	10.5	51.7	2.5	7.3	7.7	7.4	3.8	0.5	8.1	14.7	0.9	54.3	7.4	13.4	48.8	70.7	4.6	4.6	0.4	10.7	5.1	2.1	78.4	12.4	1.4	1.3	3.2	0.5	0.0	64.3	0.2	0.0	0.8	0.8	20.7	1.9	36.8	4.6	0.2	13.3	10.3	12.2	5.9	0.5	7.5	11.0	0.0	0.5	40.6	0.3	2.7	41.5	0.3	5.9	0.8	2.6	0.4	0.0	10.9	2.7	0.9	0.0	9.8	2.7	0.7	10.5	22.9	0.4	1.0	0.1	7.1	2.3	37.8	19.1	13.9	2.8	17.4	14.6	8.7	25.7	1.2	0.0	0.7	6.3	0.1	0.6	6.6	5.6	3.4	0.2	3.7	2.5	5.5	8.4	78.7	13.9	11.9	8.7	5.8	7.2	10.3	5.4	8.6	7.6	9.1	40.5	6.4	15.8	1.1	9.6	8.7	68.9	72.0	48.9	71.4	66.2	47.6	55.3	66.0	51.7	54.3	70.7	78.4	0.6	6.4	8.3	15.7	12.1	3.1	11.4	5.7	1.8	9.6	9.1	5.2	7.3	15.7	9.6	11.0	10.4	73.1	19.8	32.6	13.7	17.5	334.6	39.0	3.9	1.5	14.9	2.7	68.6	28.2	10.9	2.3	17.3	48.8	12.0	7.3	1.1	4.4	6.0	212.0	71.0	16.0	12.2	1.9	5.7	1251.4	5.3	6.3	10.6	1.9	11.1	53.7	26.8	13.6	72.3	24.8	20.2	4.9	7.0	11.1	25.9	12.4	18.1	7.4	0.0	3.1	2.7	8.3	9.7	4.4	3.0	50.3	15.2	0.2	21.1	15.4
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Late spermatids: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Centriolar satellite"		"HPA036406: AB_2675105, HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.0	5.3	5.2	2.3	4.7	0.5	7.5	2.3	19.8	6.9	0.0	6.5	2.0	10.6	1.5	5.8	7.5	3.7	6.6	6.0	6.2	11.7	2.3	6.8	1.0	17.4	6.2	6.9	7.4	12.2	5.4	1.7	16.1	5.1	0.8	0.8	7.5	3.3	11.5	8.2	3.4	3.2	4.2	14.3	5.9	44.7	11.6	0.4	5.1	3.0	0.9	6.7	5.8	6.0	20.0	8.8	0.6	6.2	6.7	7.9	11.1	28.6	15.9	10.1	8.0	6.9	4.4	0.0	15.3	16.3	10.7	8.1	4.1	8.6	4.4	38.1	11.1	7.8	4.0	4.2	7.8	0.0	1.4	9.5	8.9	12.5	8.3	9.3	13.5	3.6	6.0	3.6	7.1	0.6	0.1	0.2	4.8	3.2	15.0	7.1	7.8	18.3	8.7	2.7	2.8	2.9	10.0	3.3	4.3	2.1	2.2	0.5	35.4	24.4	13.2	17.3	15.0	13.8	4.3	0.1	18.0	8.5	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	5.2	4.7	2.3	19.8	6.0	6.2	17.4	6.2	16.1	4.2	11.6	6.0	12.1	6.4	3.6	4.6	1.3	25.5	8.3	6.7	12.5	4.4	13.0	6.9	12.0	12.8	3.7	20.2	0.0	1.2	5.5	7.7	27.4	12.1	86.2	6.1	3.2	20.4	1.8	0.0	11.1	18.4	12.2	9.0	3.1	12.8	0.0	34.5	16.8	6.1	2.1	6.7	11.5	2.5	2.0	1.3	8.1	171.6	14.3	1.9	8.8	7.5	1.0	7.4	1.0	1.0	1.3	22.7	2.7	8.6	6.1	13.4	0.4	46.9	5.0	2.6	26.3	7.2	6.2	39.8	6.6	5.1	17.6	14.8	4.5	6.4	4.6	16.4
RAB12		ENSG00000206418	"RAB12, member RAS oncogene family"	Q6IQ22	18	8609437-8639382	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 96.4;Inhibitory neurons: 46.3;Microglial cells: 45.9;Oligodendrocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040727	Approved		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040727: AB_10794858"	"unprognostic (7.92e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.11e-2)"	36.8	26.2	27.0	17.8	29.8	13.6	27.9	31.6	33.9	28.3	21.6	34.9	11.8	29.7	19.6	28.8	26.7	18.5	85.4	30.0	31.3	31.4	36.5	30.3	20.9	25.3	27.3	31.0	13.4	21.7	21.3	30.0	25.8	22.7	16.9	22.6	18.0	29.7	193.8	31.5	20.2	34.3	28.3	28.0	19.2	12.0	32.7	15.2	19.8	106.6	20.8	29.0	25.3	27.2	33.1	19.4	22.1	23.2	64.3	54.2	12.2	44.0	60.2	49.1	57.4	26.3	29.7	11.3	41.7	53.1	36.8	20.6	25.7	47.1	59.3	4.5	20.8	9.7	20.7	27.7	59.5	12.8	9.8	53.9	65.2	36.3	45.9	50.6	60.2	10.0	15.0	15.8	48.2	35.9	14.8	12.9	14.3	113.8	18.0	10.2	53.6	10.9	48.5	43.8	36.5	25.8	33.6	45.1	57.6	31.0	13.2	19.5	50.6	56.6	33.0	57.2	67.7	10.6	6.6	9.8	42.4	11.8	37.0	4.5	0.9	1.0	0.8	1.5	1.1	1.3	0.9	0.9	0.7	1.1	1.1	1.1	1.6	1.5	2.4	1.7	1.0	0.5	27.0	29.8	31.6	33.9	30.0	31.3	25.3	27.3	25.8	28.3	32.7	27.2	34.1	12.8	19.3	31.6	3.8	6.5	1.7	1.9	2.8	15.1	11.6	12.2	96.4	1.5	8.3	3.7	6.2	1.8	7.1	1.6	3.9	2.3	0.0	8.1	14.1	16.1	5.4	3.2	41.6	1.3	1.4	14.5	4.6	7.6	6.3	9.4	16.4	16.0	1.7	11.8	46.3	2.5	2.0	16.6	12.3	0.4	3.4	9.3	3.6	45.9	4.5	14.1	2.1	23.6	43.3	3.2	1.7	4.5	2.4	6.3	2.2	5.9	7.0	7.7	0.0	13.2	13.6	1.0	1.5	4.5	8.4	1.1	4.5	12.3	3.1	4.5
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 7.0;myeloid DC: 10.5;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 12.9;monocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 846.1"									HPA003996	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	151.4	132.8	78.8	91.0	80.1	104.3	124.1	79.4	112.4	114.1	89.2	123.6	54.1	92.2	111.3	102.0	96.0	83.3	90.1	77.3	88.6	164.6	111.1	116.8	42.5	92.5	85.3	111.1	115.1	97.9	35.4	64.3	89.7	123.5	73.6	10.5	96.3	73.5	45.9	92.1	79.0	67.5	84.7	97.5	123.3	61.7	84.0	19.2	112.8	49.5	47.7	123.2	107.7	83.7	133.4	162.5	143.7	152.8	478.2	846.1	43.2	157.9	381.1	142.6	144.6	165.4	111.9	0.1	230.7	194.4	72.7	88.4	86.9	146.7	198.0	78.6	62.3	110.1	100.5	94.3	199.5	0.4	70.9	620.1	125.3	246.6	109.1	401.0	253.4	0.0	20.6	0.5	246.6	280.0	0.5	55.4	231.8	183.9	151.2	28.9	186.1	0.1	327.0	140.5	7.2	112.6	208.7	179.8	337.0	215.4	294.2	87.0	469.6	256.0	149.5	161.1	174.7	0.4	0.1	0.9	399.6	17.4	399.7	0.0	7.0	0.1	0.0	1.0	0.1	0.7	0.1	0.0	10.5	0.6	0.1	0.4	0.8	0.0	0.1	12.9	0.0	1.9	78.8	80.1	79.4	112.4	77.3	88.6	92.5	85.3	89.7	84.7	84.0	83.7	230.1	41.7	83.4	1.0	9.0	92.0	181.3	196.3	110.4	1.2	126.9	149.2	75.2	120.1	105.3	108.5	2.1	116.3	2.8	81.5	135.0	234.4	119.9	91.9	163.2	239.8	89.1	116.4	0.0	149.2	181.2	100.8	76.5	111.4	40.6	111.9	192.4	136.2	249.1	0.0	0.0	184.2	83.4	111.1	104.5	232.1	106.2	116.0	99.6	7.5	247.4	71.5	2.1	0.0	0.1	158.1	110.6	124.1	10.6	197.0	135.7	206.5	72.2	3.8	151.2	46.9	151.4	103.6	18.4	124.8	98.2	92.9	8.9	141.6	146.1	195.9
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178133-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		2700000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	39.0	38.7	37.5	35.6	39.7	66.5	42.1	40.3	47.7	37.8	32.6	42.8	39.9	35.6	34.2	63.2	34.0	30.7	32.4	38.4	40.9	50.0	82.8	49.2	41.1	39.6	39.9	35.9	27.6	45.8	28.9	43.1	40.5	38.8	42.4	45.5	34.6	38.1	39.4	56.4	38.9	33.4	40.8	38.3	44.3	33.8	40.2	35.2	43.8	38.9	49.5	43.9	40.8	46.8	53.8	53.7	66.9	56.3	76.2	82.5	52.6	74.8	59.6	56.6	44.7	42.6	57.0	51.2	42.5	72.0	49.2	100.1	48.1	55.8	63.6	44.4	31.7	55.7	69.0	43.9	52.6	60.1	63.8	53.0	98.5	58.2	63.4	62.5	81.2	47.1	42.8	45.6	85.6	50.8	58.5	48.1	39.7	104.8	59.9	45.8	72.3	60.4	62.3	76.0	58.9	34.4	89.0	78.0	53.8	47.1	82.1	46.8	76.0	60.1	43.9	75.3	53.0	40.8	82.6	52.3	56.6	51.9	80.7	34.4	29.4	33.5	22.4	41.5	22.4	24.6	20.9	24.7	31.4	23.4	24.6	25.0	31.8	26.5	43.7	19.0	29.3	24.0	37.5	39.7	40.3	47.7	38.4	40.9	39.6	39.9	40.5	40.8	40.2	46.8	102.6	160.3	103.9	23.5	64.4	157.9	78.2	84.8	97.3	93.8	70.7	58.8	39.2	62.9	96.2	62.5	37.5	85.2	79.6	95.1	86.1	81.3	41.9	80.7	89.8	84.5	60.3	44.4	42.5	64.4	83.0	68.7	64.7	94.4	77.2	58.1	61.1	113.6	91.0	94.2	38.0	59.8	95.6	89.9	105.4	36.2	51.9	80.7	110.3	44.0	84.8	100.5	49.4	38.2	59.0	80.7	52.9	56.4	50.2	81.0	63.2	103.3	86.8	62.0	59.2	64.0	105.6	112.9	113.6	120.0	202.4	116.2	74.3	82.5	64.0	106.0
RAB15		ENSG00000139998	"RAB15, member RAS oncogene family"	P59190	14	64945814-64973226	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 83.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041177	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centriolar satellite"		"HPA041177: AB_10794547"	"unprognostic (9.80e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.82e-2)"	2.8	4.9	30.0	6.2	35.0	0.8	8.4	28.2	43.2	7.3	13.4	13.5	12.7	4.2	5.6	4.3	4.7	6.2	33.4	38.9	22.6	19.3	21.2	9.9	3.8	21.2	20.7	2.2	12.6	39.4	9.6	16.1	28.6	10.9	20.2	5.8	36.5	4.6	10.0	7.2	13.1	11.8	17.2	2.8	10.9	1.7	25.5	7.7	6.7	1.2	3.0	17.9	5.0	31.5	10.9	57.0	20.3	20.3	4.5	6.4	57.6	6.7	9.3	13.5	11.8	26.8	28.4	0.6	3.9	16.5	6.2	10.9	128.1	1.3	9.5	3.6	6.2	12.3	1.1	23.5	0.6	0.6	7.5	4.4	2.5	5.9	1.2	3.5	42.6	29.2	0.4	2.0	23.9	61.8	15.2	11.3	45.8	65.6	8.2	18.5	151.2	1.0	15.8	116.1	65.4	12.7	3.4	116.7	15.0	23.6	33.2	11.8	11.2	11.5	49.0	5.5	8.7	0.6	0.4	5.8	2.4	0.3	8.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.9	0.1	0.0	30.0	35.0	28.2	43.2	38.9	22.6	21.2	20.7	28.6	17.2	25.5	31.5	1.7	6.4	3.9	5.9	0.8	2.5	3.2	1.3	0.6	2.9	12.4	7.4	22.2	4.3	4.2	16.5	0.0	24.7	5.0	5.5	3.9	7.9	0.5	6.6	2.8	3.7	1.2	0.0	51.3	12.2	16.0	2.0	2.6	13.6	1.3	4.1	4.6	8.7	2.7	11.8	28.0	35.2	0.0	0.3	1.3	1.1	0.3	0.9	0.0	4.7	1.0	2.0	1.0	10.6	4.9	13.0	5.5	1.5	0.2	5.6	2.9	5.9	1.3	2.9	0.0	2.4	5.2	0.9	0.4	1.6	1.1	17.9	1.5	1.5	12.0	14.1
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7;liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Distal tubular cells: 137.0;Hepatocytes: 121.7;Proximal enterocytes: 222.5;Proximal tubular cells: 170.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 42.4;Hep G2: 39.9;MCF7: 52.0;SK-BR-3: 48.1;SK-MEL-30: 86.7;T-47d: 34.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.51e-4)"	0.8	1.0	0.9	1.6	0.6	0.4	15.0	0.6	1.3	6.7	25.8	16.4	76.7	2.3	19.4	2.1	11.1	14.7	1.5	2.2	0.7	49.8	107.6	23.1	0.4	0.8	0.7	0.6	38.7	36.9	3.0	13.8	0.7	7.0	15.6	4.2	34.8	15.3	1.4	0.9	73.7	1.0	0.6	0.5	33.5	0.7	0.9	1.0	33.4	0.0	0.8	3.8	0.3	0.7	9.5	0.3	0.0	17.7	0.1	0.2	42.4	0.2	0.1	0.0	0.1	28.7	26.6	0.0	5.6	0.2	0.1	0.4	0.0	12.5	0.2	0.0	0.0	0.0	0.1	39.9	0.0	0.2	0.0	0.0	7.8	0.0	0.9	0.7	0.0	0.1	0.0	0.0	1.0	52.0	0.0	0.6	0.5	28.6	0.1	1.1	0.0	3.4	13.7	25.1	10.5	0.1	0.0	48.1	86.7	9.4	34.8	0.7	0.0	0.2	0.6	0.1	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.6	1.3	2.2	0.7	0.8	0.7	0.7	0.6	0.9	0.7	1.2	60.9	34.3	0.3	0.5	1.8	3.4	3.3	22.8	1.7	32.2	18.3	1.0	65.8	11.9	46.0	106.3	16.0	0.1	49.6	137.0	40.0	0.0	18.2	1.6	1.8	30.3	0.0	0.8	28.0	3.8	0.7	29.0	22.1	0.0	0.4	2.5	121.7	1.9	0.0	1.5	23.9	24.4	2.2	0.6	0.7	8.7	1.3	5.4	0.0	0.6	0.2	0.0	1.0	0.1	27.9	50.1	3.8	0.1	5.3	222.5	170.2	13.7	0.6	0.0	0.3	0.7	0.0	0.2	6.6	0.6	12.3	1.3	0.7	21.9	6.5
RAB18		ENSG00000099246	"RAB18, member RAS oncogene family"	Q9NP72	10	27504174-27542239	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025928	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA025928: AB_1855997"	"unprognostic (9.45e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	40.8	55.5	26.3	29.0	26.8	88.9	50.7	28.9	32.1	32.3	26.5	34.3	33.5	30.5	41.0	44.5	25.4	26.7	48.0	26.4	33.4	47.5	52.3	30.0	26.2	28.5	30.2	30.8	31.5	53.2	20.4	36.7	31.8	41.2	35.2	70.6	28.0	34.1	51.2	35.7	30.9	37.4	30.9	30.0	32.0	34.3	30.1	34.9	41.1	50.5	32.9	39.7	31.0	33.5	68.1	47.5	56.8	41.0	94.1	53.3	37.9	102.6	47.0	87.6	83.4	46.2	44.6	27.7	42.7	88.8	44.2	44.9	37.4	65.6	72.0	42.3	34.1	39.2	44.2	59.3	68.0	16.9	45.4	70.5	122.2	55.0	31.4	62.3	68.5	25.7	22.6	55.2	75.0	44.1	37.8	11.6	24.8	38.7	22.1	27.3	93.8	33.7	83.5	37.6	30.5	36.9	50.6	57.1	67.5	59.6	115.6	35.0	68.5	40.0	49.9	76.8	60.1	24.0	47.5	34.7	68.6	97.6	22.6	212.9	54.4	137.4	41.7	50.7	91.5	25.6	35.7	45.1	40.6	26.5	30.1	35.9	193.2	45.2	60.9	26.7	42.7	49.8	26.3	26.8	28.9	32.1	26.4	33.4	28.5	30.2	31.8	30.9	30.1	33.5	50.3	73.7	44.5	37.5	51.4	186.0	105.3	145.9	68.9	74.1	131.7	51.2	131.4	48.6	92.9	90.1	41.7	90.5	64.9	82.3	213.2	105.0	46.7	46.7	55.4	62.1	65.4	41.2	53.9	90.4	114.9	78.7	31.6	51.8	34.9	63.6	62.8	85.1	84.5	48.8	51.2	47.5	152.5	81.0	83.4	33.8	63.0	62.4	99.6	42.2	115.6	117.6	53.5	43.7	54.8	120.5	57.8	69.2	51.3	127.6	73.1	208.6	72.8	91.0	26.3	45.9	76.9	138.7	81.0	80.7	199.0	149.1	60.9	79.1	40.9	132.6
RAB19	RAB19B	ENSG00000146955	"RAB19, member RAS oncogene family"	A4D1S5	7	140404058-140427974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9"	"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HDLM-2: 5.4;MCF7: 3.3;RT4: 4.8;SK-BR-3: 4.6;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA051077	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA051077: AB_2681336"	"unprognostic (3.40e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (1.73e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (6.09e-3)"	0.1	0.2	1.0	1.1	0.7	3.9	0.5	1.7	1.1	0.2	0.5	2.2	2.2	0.3	0.9	0.2	0.7	0.7	0.2	0.6	0.6	1.6	0.3	0.7	1.1	0.7	0.5	0.1	1.7	3.1	0.9	0.3	0.9	0.6	2.7	0.3	0.6	0.2	0.6	0.6	2.0	0.2	0.1	0.5	1.5	0.2	1.1	1.0	2.1	0.0	0.8	0.7	0.0	1.9	0.7	0.2	0.1	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	3.8	0.2	0.4	0.0	0.1	0.8	0.0	0.6	0.0	5.4	0.3	0.1	0.6	0.2	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.4	0.0	3.3	0.5	0.3	0.1	0.4	0.3	0.1	0.1	0.1	1.8	4.8	0.8	0.1	0.1	4.6	0.0	0.3	4.8	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.8	0.3	0.4	0.9	0.2	1.6	0.5	1.0	1.5	0.1	0.6	1.1	1.3	1.3	0.9	0.2	0.4	2.1	0.3	1.0	0.7	1.7	1.1	0.6	0.6	0.7	0.5	0.9	0.1	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070696-65130331	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 911.4;Syncytiotrophoblasts: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		3000000	"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: AB_2683051"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	142.5	142.9	84.2	90.6	86.8	232.4	119.1	85.2	105.2	122.6	103.7	128.1	133.6	109.7	179.9	155.0	103.5	100.1	127.3	89.0	91.9	194.1	194.9	141.9	70.5	86.0	88.4	94.4	133.9	113.1	117.2	148.3	91.3	96.6	126.8	89.4	131.8	93.8	100.3	101.3	127.6	117.4	87.7	88.6	135.9	86.2	90.4	59.0	129.6	80.4	91.1	119.2	120.5	91.3	211.3	150.7	186.2	110.5	445.5	261.2	287.5	299.9	212.3	134.8	142.8	270.1	137.5	85.8	167.9	311.2	221.4	130.6	173.7	277.6	214.1	96.3	100.6	108.3	119.2	403.8	281.9	115.4	93.7	232.0	279.6	176.9	158.5	213.3	271.2	67.7	157.2	96.6	271.1	190.6	67.3	138.6	148.6	329.1	134.6	68.3	177.3	137.3	266.1	236.0	133.9	118.5	139.2	230.6	282.4	218.7	143.3	106.9	253.4	172.5	214.6	183.2	171.8	147.6	95.3	205.6	230.2	173.9	170.4	96.8	84.6	78.7	41.9	86.3	46.7	42.6	45.4	45.8	76.0	29.3	43.2	45.1	102.1	56.4	80.9	63.1	59.0	54.3	84.2	86.8	85.2	105.2	89.0	91.9	86.0	88.4	91.3	87.7	90.4	91.3	84.8	83.3	89.1	51.2	64.6	297.2	322.0	384.6	74.0	48.5	117.1	71.8	120.7	87.2	218.6	125.0	6.2	309.5	70.3	182.0	328.7	216.5	350.3	102.8	110.9	133.0	133.4	45.0	50.7	219.5	366.9	171.6	105.0	162.8	50.7	67.1	102.4	183.7	375.3	58.9	53.4	200.4	262.4	122.9	221.6	911.4	145.7	153.3	197.5	83.4	110.5	144.7	41.2	50.3	71.7	234.0	148.2	212.9	107.1	323.2	168.4	441.7	162.4	45.6	72.3	103.8	210.9	193.8	106.7	90.7	293.8	703.8	70.5	76.5	168.4	477.9
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268590-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	127.1	129.7	121.7	84.0	117.4	91.1	120.9	117.7	137.7	113.7	106.2	129.3	112.5	111.2	82.3	180.9	105.7	83.0	146.7	117.5	116.8	127.2	126.4	116.5	90.3	122.7	121.0	103.5	96.1	132.9	112.6	88.4	119.3	140.6	90.3	46.5	128.0	105.1	233.2	147.6	112.9	86.9	119.3	125.3	125.5	79.9	124.2	105.5	111.5	152.8	86.1	113.6	119.2	118.9	226.5	248.0	126.2	166.1	205.6	150.9	113.8	182.7	212.8	232.2	163.4	141.4	223.7	91.7	235.7	263.1	172.1	209.0	140.7	253.9	125.9	190.3	128.0	144.7	156.0	124.2	135.0	124.3	258.2	158.7	212.4	199.6	102.4	163.2	221.1	144.9	153.1	158.8	223.6	434.5	219.1	197.1	131.5	196.1	230.8	133.0	101.8	237.2	234.7	204.5	122.9	137.1	132.7	319.2	133.7	91.4	487.5	141.6	228.1	221.4	152.9	267.9	164.9	89.9	77.9	121.5	251.2	104.3	207.8	173.1	199.8	329.3	227.5	211.9	171.7	109.8	135.5	188.1	163.0	130.2	115.3	140.6	420.5	203.5	243.9	188.3	165.5	375.6	121.7	117.4	117.7	137.7	117.5	116.8	122.7	121.0	119.3	119.3	124.2	118.9	56.3	38.5	59.6	7.8	41.7	33.6	31.4	42.4	53.5	22.0	55.0	53.1	1.1	40.0	47.9	36.8	29.2	56.2	50.8	137.1	50.9	49.3	13.4	41.3	38.6	50.6	54.0	27.1	7.2	71.3	84.2	36.5	58.1	44.9	53.8	24.6	48.9	47.8	54.2	16.8	8.0	85.0	36.7	55.2	26.4	27.2	35.8	51.4	24.9	5.6	47.7	37.8	43.3	5.5	13.1	71.6	80.6	42.2	61.0	41.4	79.6	49.5	36.0	18.2	39.5	36.2	39.7	23.8	17.4	64.5	42.1	80.2	57.4	28.1	64.9	43.5
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561722	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	31.1	55.4	5.7	21.7	5.5	25.3	23.4	5.6	7.9	11.7	9.6	20.7	27.6	6.9	4.8	4.6	11.5	18.0	21.4	5.2	7.0	26.1	51.4	30.7	16.4	7.0	6.0	20.5	24.2	6.2	9.7	22.8	6.8	12.1	14.3	2.6	10.7	5.0	5.8	4.6	25.3	7.6	6.6	44.5	28.6	10.6	7.4	3.9	22.0	2.3	5.1	20.6	6.7	8.4	20.1	2.9	1.9	3.8	12.4	3.3	31.3	1.7	6.2	8.1	12.5	47.9	39.9	0.0	13.9	1.7	10.8	7.5	3.8	12.3	4.2	22.5	3.0	19.8	3.6	22.6	7.8	2.8	5.7	6.9	2.0	4.2	1.2	6.3	3.1	3.3	3.8	0.0	1.8	24.0	0.1	29.0	4.0	60.9	8.5	1.9	0.1	9.0	14.2	26.3	0.5	2.1	3.8	85.7	27.4	6.2	54.4	30.5	2.3	2.0	4.2	0.2	2.7	0.1	0.0	0.2	27.7	38.9	4.2	7.8	35.5	7.1	1.0	33.3	1.3	3.5	2.8	0.9	15.8	2.8	6.5	2.3	26.3	0.0	26.6	0.8	0.9	11.2	5.7	5.5	5.6	7.9	5.2	7.0	7.0	6.0	6.8	6.6	7.4	8.4	18.6	19.2	20.4	4.2	10.6	4.5	10.9	14.1	10.8	0.2	12.8	13.0	5.0	48.6	16.2	25.8	0.0	34.6	1.8	31.1	31.3	60.3	1.6	20.7	2.6	10.3	18.0	0.0	0.4	67.9	91.3	11.5	15.3	23.2	21.0	41.1	53.6	34.5	105.0	0.0	0.4	23.9	28.5	92.1	19.9	1.6	3.7	100.5	7.2	8.4	16.2	7.4	0.0	4.5	0.1	36.4	17.2	6.4	0.4	8.0	48.1	68.9	20.4	2.0	13.1	6.2	26.2	1.0	13.2	1.9	3.0	20.0	3.6	7.2	24.0	11.1
RAB21	KIAA0118	ENSG00000080371	"RAB21, member RAS oncogene family"	Q9UL25	12	71754863-71800286	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 497.9;Late spermatids: 807.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016988, CAB037048"	Approved					NA	NA		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"CAB037048: AB_1841130, HPA016988: AB_1855998"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.68e-2)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.31e-2)"	6.1	7.4	6.1	3.8	7.3	8.0	5.0	6.4	7.5	5.2	4.7	5.3	3.7	4.9	3.9	5.8	4.4	4.5	11.5	5.5	6.5	8.3	6.1	6.5	4.5	7.4	7.2	5.1	3.9	6.5	5.4	5.3	6.9	5.0	3.5	3.5	4.2	4.4	14.2	6.5	4.0	4.3	7.2	4.6	4.3	2.5	6.6	4.6	5.9	7.6	4.2	5.3	5.4	8.2	6.0	4.6	4.7	3.8	7.5	4.8	8.1	8.3	4.9	5.6	3.8	5.6	2.8	9.3	9.5	7.4	3.3	5.1	8.5	5.8	8.8	7.5	3.9	8.6	3.3	6.2	7.7	9.5	5.0	5.6	8.9	6.2	9.6	8.6	3.9	5.1	6.0	5.3	8.6	5.5	7.7	6.3	7.0	3.4	6.9	7.4	5.2	6.7	8.4	8.3	4.7	3.8	10.4	9.8	6.2	5.8	7.7	6.1	6.1	7.3	2.9	11.7	6.2	6.8	7.0	7.1	3.8	5.4	5.3	0.8	0.3	0.5	0.4	0.3	0.4	0.4	0.4	0.3	0.2	0.4	0.4	0.4	1.2	0.4	0.3	0.5	0.3	0.1	6.1	7.3	6.4	7.5	5.5	6.5	7.4	7.2	6.9	7.2	6.6	8.2	93.7	28.9	56.5	17.9	60.7	119.6	78.4	29.6	32.5	45.4	66.1	45.1	179.9	48.6	31.6	47.8	79.2	39.4	96.5	60.4	13.7	22.5	497.9	48.0	56.6	73.1	49.6	21.0	24.9	20.8	38.0	66.6	30.1	109.0	24.1	22.1	48.5	62.3	42.7	52.2	31.9	35.8	20.3	55.7	168.9	807.6	36.1	88.9	55.2	17.8	41.5	41.9	36.0	33.7	47.5	34.2	40.7	41.8	47.8	97.7	44.4	62.5	20.0	37.3	26.3	90.9	81.2	19.2	16.6	56.1	160.1	83.5	59.8	35.5	41.2	117.7
RAB22A		ENSG00000124209	"RAB22A, member RAS oncogene family"	Q9UL26	20	58309715-58367507	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066920	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA066920: AB_2685749"	"unprognostic (4.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.20e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.01e-3)"	6.4	10.2	8.7	5.3	10.4	4.7	6.4	5.9	11.0	6.9	0.7	6.9	7.1	6.2	7.8	11.6	4.7	5.6	4.2	11.3	9.9	7.5	7.4	6.0	5.8	8.4	8.3	5.6	5.5	11.6	6.1	4.8	9.7	5.2	6.8	5.4	6.4	5.6	4.5	7.5	6.9	5.8	8.0	6.1	7.0	5.4	10.1	6.3	8.5	5.0	7.2	7.0	7.7	8.7	17.5	7.1	8.8	5.7	17.9	16.7	5.2	12.9	14.9	17.4	10.4	11.9	11.8	9.6	15.7	18.2	19.5	13.7	4.5	20.4	19.7	6.5	4.4	6.8	10.0	9.5	13.8	8.5	11.5	11.4	24.4	12.4	12.7	12.3	11.0	7.5	6.0	13.4	18.4	25.1	10.0	8.0	2.2	15.3	17.4	5.2	8.6	8.3	10.9	11.1	6.7	9.1	18.2	34.0	15.6	4.6	12.6	11.5	17.6	28.7	11.9	18.0	15.6	11.5	17.0	6.3	29.5	8.0	10.0	1.5	1.0	0.8	2.2	1.3	2.1	1.5	1.7	1.9	1.4	1.4	1.5	1.8	2.0	2.2	2.1	1.1	1.5	0.8	8.7	10.4	5.9	11.0	11.3	9.9	8.4	8.3	9.7	8.0	10.1	8.7	34.2	22.4	16.2	25.1	34.2	56.0	68.9	21.3	32.5	14.6	32.7	22.5	18.6	32.9	20.9	20.2	8.4	16.6	39.7	39.9	50.9	37.0	6.4	30.1	32.8	29.9	19.2	22.3	27.8	36.0	24.7	39.3	31.1	33.7	11.4	19.9	26.0	25.3	28.0	11.8	26.5	23.5	22.4	23.0	69.7	9.2	31.4	33.6	24.9	35.6	23.0	27.9	34.0	24.6	32.1	75.2	26.2	20.7	29.3	75.4	24.5	44.1	22.4	12.6	13.1	42.4	39.7	22.2	39.7	47.6	68.9	35.4	40.6	30.1	22.5	124.3
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 22.3;Peritubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 97.2;U-2197: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	9.6	6.1	8.6	13.2	9.0	0.8	7.8	10.9	9.6	45.9	6.1	59.7	7.0	52.6	14.1	19.9	14.5	26.9	12.3	8.5	15.2	7.3	4.1	10.6	4.5	8.7	8.7	10.8	2.9	5.7	3.4	27.6	9.5	38.7	15.9	3.9	3.9	55.7	6.1	4.8	10.8	75.0	9.2	2.2	11.6	5.1	9.7	3.2	32.6	10.4	4.1	46.7	14.7	11.5	15.6	6.1	21.6	15.3	32.3	97.2	19.8	44.9	77.4	38.6	39.7	13.4	7.3	3.1	13.6	72.3	19.3	5.5	22.7	16.4	45.6	11.6	10.5	11.3	9.4	10.6	19.8	5.9	1.6	36.5	18.6	48.1	44.7	18.7	20.3	6.6	17.6	9.3	43.4	13.2	5.2	6.3	8.1	10.3	8.2	5.7	31.7	4.7	26.8	10.7	11.2	7.6	22.5	10.6	11.6	26.8	9.7	6.8	27.4	59.6	18.5	177.4	26.6	8.0	9.3	7.6	33.5	12.5	30.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.0	8.6	9.0	10.9	9.6	8.5	15.2	8.7	8.7	9.5	9.2	9.7	11.5	2.9	12.8	5.0	6.8	0.7	4.1	1.6	2.0	5.7	2.5	4.0	3.0	3.4	1.5	1.6	0.0	2.1	11.5	1.7	2.4	0.0	3.4	2.4	6.5	15.5	2.6	1.2	4.8	13.0	2.9	10.7	22.3	1.1	6.2	0.0	3.7	4.6	3.4	4.2	1.7	12.3	1.4	2.0	0.8	3.1	2.5	19.9	1.4	5.4	11.2	7.7	4.4	0.0	8.0	5.3	2.6	0.1	30.5	0.5	3.5	0.6	6.1	5.3	0.9	0.0	17.2	14.5	6.6	7.8	4.1	5.1	13.7	0.8	4.0	1.6	1.8
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070504	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 423.3;skin 1: 210.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 249.6;Squamous epithelial cells: 300.6;Undifferentiated cells: 244.6;Urothelial cells: 232.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 120.9;CAPAN-2: 119.9;MCF7: 171.5;OE19: 392.3;RT4: 153.4;SK-BR-3: 243.3;T-47d: 227.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.6	0.1	0.1	10.2	0.1	0.1	52.0	0.3	0.3	76.2	0.0	86.2	72.9	7.3	37.5	423.3	47.5	26.4	0.1	0.0	0.0	41.6	1.7	39.2	0.4	0.1	0.1	0.4	57.1	68.9	27.5	12.4	0.1	36.3	78.1	0.0	105.3	28.4	0.9	210.0	65.6	3.7	0.2	0.2	80.9	0.3	0.1	10.1	50.6	0.0	44.0	69.9	148.2	0.3	93.3	0.0	0.0	0.0	0.0	0.0	120.9	0.0	0.0	0.0	0.0	90.4	119.9	0.0	0.1	0.0	0.0	109.5	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	105.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	171.5	0.0	0.4	4.8	392.3	0.0	0.1	0.0	0.3	0.0	153.4	13.3	0.0	0.0	243.3	0.3	21.1	227.9	0.4	0.0	0.2	0.2	0.0	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	1.2	28.9	41.0	0.0	1.5	55.1	102.9	113.9	74.0	0.0	121.4	137.7	0.1	94.4	98.7	86.5	0.0	102.1	2.3	197.8	166.3	170.4	0.0	58.6	6.4	2.6	85.4	0.0	0.1	150.3	30.0	2.3	96.4	66.2	5.7	0.0	0.0	0.4	7.3	0.0	0.1	208.5	89.5	0.0	5.8	0.0	0.3	2.1	21.4	0.0	3.6	0.0	0.0	0.0	0.1	197.3	249.6	0.0	0.3	114.0	195.9	35.5	66.3	0.0	0.0	0.0	6.8	0.2	1.1	300.6	154.7	80.3	2.7	0.0	244.6	232.3
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 119.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 261.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB034046: AB_2176724, HPA001333: AB_1079730"	"prognostic favorable (2.56e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.32e-1)"	17.5	27.8	3.5	40.2	3.9	100.2	13.9	4.4	4.4	12.9	5.6	53.0	30.0	12.8	5.0	20.6	12.3	17.6	7.7	3.4	6.7	19.2	43.6	42.4	46.0	5.8	5.0	8.0	29.2	11.4	31.4	17.6	5.9	61.2	66.1	4.2	18.3	11.8	3.2	12.8	40.9	25.8	5.0	30.8	119.9	10.0	5.9	19.3	30.5	7.0	46.2	37.5	13.9	5.7	23.0	10.0	9.7	11.3	8.3	38.8	9.5	29.4	32.5	19.2	26.4	7.0	15.6	0.9	22.3	16.0	38.9	16.0	15.7	27.0	18.3	84.9	9.7	5.4	37.6	18.1	56.0	208.7	26.5	34.3	44.2	29.0	71.6	80.7	46.9	26.4	238.0	179.4	20.7	27.7	1.5	57.6	3.6	38.9	14.7	32.4	27.3	50.3	28.7	17.7	14.9	7.1	31.4	15.2	188.3	24.3	13.3	162.2	25.3	52.5	20.3	33.1	33.6	72.0	88.2	6.0	70.2	185.1	19.0	261.3	72.4	99.8	59.2	30.1	58.2	8.0	28.6	61.9	39.0	13.4	13.9	37.4	114.9	34.1	24.0	2.1	36.2	48.9	3.5	3.9	4.4	4.4	3.4	6.7	5.8	5.0	5.9	5.0	5.9	5.7	27.5	76.9	147.1	12.7	18.6	14.1	25.7	19.2	6.2	3.0	16.3	18.3	7.4	15.7	50.1	11.0	2.1	6.3	81.0	18.5	13.7	24.6	2.8	10.1	15.6	32.1	74.3	12.8	12.5	87.6	18.7	16.9	93.3	16.7	31.7	8.8	41.7	41.7	15.6	0.0	12.2	252.0	12.2	33.3	15.2	2.2	7.5	31.1	71.2	10.3	71.9	2.4	104.0	10.1	7.1	62.9	15.9	13.9	38.6	32.3	14.6	6.7	31.3	4.4	19.7	9.4	15.8	9.3	4.6	7.1	15.5	7.5	81.4	4.6	18.4	23.4
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB28		ENSG00000157869	"RAB28, member RAS oncogene family"	P51157	4	13361354-13484365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 119.9;Inhibitory neurons: 140.4;Spermatocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044575	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044575: AB_10959460"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.31e-3)"	"prognostic favorable (1.61e-4)"	17.1	18.9	22.9	12.8	25.2	19.3	20.3	39.5	29.2	15.3	24.9	16.2	11.0	22.5	18.8	12.0	21.9	15.5	30.4	23.7	29.5	16.4	11.9	16.1	18.3	22.3	26.7	22.4	10.0	23.9	19.3	19.5	24.7	16.2	18.1	55.4	12.1	16.0	7.2	19.9	11.3	17.3	24.3	17.2	14.5	37.7	29.6	18.4	19.5	13.3	16.7	13.2	13.3	28.9	22.0	11.4	36.3	18.6	18.7	34.8	19.0	19.7	22.7	21.7	28.9	11.3	22.7	26.0	12.5	19.3	46.0	11.1	31.4	17.6	39.3	16.7	15.7	18.6	20.1	10.8	18.3	21.2	10.9	16.0	23.3	19.8	18.7	26.5	23.9	32.9	37.0	97.1	30.4	8.8	45.3	52.7	50.7	16.4	19.9	28.6	22.8	21.5	18.7	11.9	28.7	17.3	17.0	12.2	28.1	28.2	13.7	23.8	16.5	28.8	12.6	23.8	30.7	24.0	18.0	34.6	25.7	38.3	38.6	21.0	16.2	26.1	16.5	15.6	17.0	18.4	15.3	16.2	16.8	17.9	20.3	16.5	15.1	20.6	14.4	12.9	17.2	10.6	22.9	25.2	39.5	29.2	23.7	29.5	22.3	26.7	24.7	24.3	29.6	28.9	17.8	6.4	6.4	81.0	22.3	27.4	26.7	38.7	22.2	31.0	15.6	14.0	18.2	2.8	16.7	7.3	33.3	23.3	15.1	7.9	19.6	12.9	19.1	19.6	17.7	18.4	10.3	9.9	119.9	14.2	22.7	27.5	11.7	8.2	5.1	12.4	12.8	6.8	17.0	32.0	140.4	11.0	32.6	15.1	18.2	20.6	18.6	14.2	30.2	49.6	16.7	44.5	19.6	97.0	79.8	11.2	7.8	24.0	19.2	21.4	6.3	18.8	36.5	44.1	19.7	24.1	20.1	123.9	63.7	20.6	30.0	27.9	21.3	10.6	11.6	19.0
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775482	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	13.5	14.4	12.5	20.4	14.1	7.1	14.1	14.3	12.1	8.7	10.5	12.6	10.6	8.3	23.8	7.8	6.2	16.9	13.1	12.3	14.3	73.1	19.4	13.5	35.1	15.9	12.9	7.9	9.2	25.5	5.9	7.2	15.8	13.8	10.1	6.8	19.8	13.9	6.4	5.5	12.4	14.8	14.3	24.3	10.4	4.6	15.3	12.1	33.4	6.0	28.0	15.7	5.7	17.0	20.4	18.6	2.8	13.1	52.5	29.8	9.7	14.1	43.2	28.9	34.4	5.6	28.7	21.6	13.6	24.3	34.6	11.2	32.8	37.3	26.4	88.3	15.3	16.4	7.3	9.5	25.4	16.1	23.2	29.0	24.6	23.3	32.8	24.0	37.2	19.8	16.2	24.2	41.2	7.6	17.7	8.3	13.1	25.4	14.0	3.7	43.1	17.5	33.6	27.7	4.4	12.5	10.0	45.0	37.8	10.3	22.0	13.2	38.7	29.7	15.0	43.5	20.6	39.4	87.0	11.5	30.1	26.3	22.5	92.4	22.6	62.3	92.2	43.8	86.9	50.8	51.0	79.5	33.4	45.8	37.2	63.5	8.8	94.1	53.9	10.4	53.3	51.3	12.5	14.1	14.3	12.1	12.3	14.3	15.9	12.9	15.8	14.3	15.3	17.0	16.3	19.2	17.7	11.1	61.2	0.0	6.3	0.0	13.6	2.1	19.5	16.0	19.3	21.5	6.2	31.3	0.0	12.0	82.3	1.9	29.4	18.7	5.1	2.0	6.3	18.6	4.9	10.8	7.8	10.1	6.4	11.2	10.7	3.5	13.3	9.2	14.6	33.7	32.8	0.0	10.2	3.7	0.0	30.1	0.0	4.1	14.3	34.0	0.0	10.3	76.4	26.5	129.8	10.6	9.8	8.3	4.8	20.7	34.8	10.7	9.5	187.7	2.9	2.0	6.6	10.0	6.7	3.8	11.8	9.3	0.0	2.9	51.7	19.7	5.5	6.9
RAB2A	RAB2	ENSG00000104388	"RAB2A, member RAS oncogene family"	P61019	8	60516936-60623644	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018781	Approved					NA	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB018781: AB_654960"	"prognostic unfavorable (8.22e-4)"	"unprognostic (1.84e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.10e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	67.0	52.0	42.6	36.5	49.0	48.7	49.1	38.4	63.0	48.5	30.2	54.4	49.1	45.5	48.9	83.2	32.1	37.7	70.2	48.5	52.3	63.3	70.3	40.9	26.4	41.4	41.7	35.0	43.2	68.6	39.0	51.2	44.4	55.0	48.3	41.2	54.5	37.7	115.8	42.1	53.0	40.0	42.2	33.5	60.6	27.4	44.9	31.2	62.4	69.1	27.8	48.4	59.9	42.2	121.6	68.6	46.2	40.4	152.8	105.9	65.7	101.5	72.5	50.3	58.5	29.5	92.0	39.0	40.2	129.4	83.7	70.8	55.4	64.9	69.2	59.8	45.9	56.3	30.1	40.8	112.9	17.3	48.8	113.9	86.6	57.0	68.6	101.1	62.9	32.6	36.0	51.0	80.1	40.4	75.1	29.3	42.6	176.5	30.6	45.6	20.2	33.9	94.2	55.0	31.6	63.2	43.8	84.2	92.0	60.3	84.1	40.3	104.2	66.9	64.3	100.4	63.0	64.7	49.4	43.6	97.3	37.7	82.7	230.0	164.4	241.2	88.0	149.3	81.5	112.3	90.0	101.2	147.7	108.9	92.2	100.1	310.9	130.2	152.0	97.1	117.7	129.3	42.6	49.0	38.4	63.0	48.5	52.3	41.4	41.7	44.4	42.2	44.9	42.2	167.5	157.0	129.0	67.3	99.3	214.4	197.0	267.0	135.5	102.2	152.6	148.2	182.0	117.2	190.7	165.5	16.7	214.4	112.2	198.6	426.5	266.4	404.2	133.2	200.4	163.8	178.6	56.0	103.7	278.1	365.2	194.9	107.6	197.1	92.5	103.6	121.3	261.9	204.2	124.5	89.6	332.0	266.5	100.2	146.1	111.6	175.2	129.4	279.3	89.0	159.3	153.6	129.8	133.7	124.9	324.4	168.6	165.5	143.8	315.2	200.2	366.4	142.1	60.8	170.9	149.3	236.2	219.7	106.2	210.6	241.5	467.8	102.8	162.7	169.9	335.6
RAB2B	FLJ14824	ENSG00000129472	"RAB2B, member RAS oncogene family"	Q8WUD1	14	21459020-21476960	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050292	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA050292: AB_2681076"	"unprognostic (7.56e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.69e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.63e-1)"	11.7	11.6	15.8	7.5	17.2	18.8	12.1	17.9	20.0	11.9	14.5	12.4	7.8	10.7	14.8	8.8	11.3	8.4	10.4	15.7	19.1	10.4	13.0	11.0	9.4	18.4	18.8	13.8	11.5	10.5	14.2	9.7	19.4	13.7	8.3	17.9	10.0	9.9	6.9	11.6	11.2	10.4	16.7	12.3	10.1	10.2	18.6	10.6	14.5	8.2	10.2	10.7	10.5	20.4	6.1	9.5	20.2	14.2	15.1	16.5	10.8	12.5	15.2	12.1	16.5	5.1	11.7	8.8	9.1	13.4	13.5	8.4	12.9	7.8	17.0	22.2	6.3	10.4	6.3	17.0	18.7	14.8	18.8	17.0	11.7	14.9	12.8	17.5	17.8	15.6	6.7	12.4	18.3	4.6	11.3	11.3	11.0	8.9	11.4	14.2	19.8	5.1	12.8	6.9	14.6	17.6	17.9	6.7	14.2	18.9	5.5	6.0	19.9	12.0	10.8	9.4	7.4	15.6	17.4	12.6	5.3	5.1	16.7	12.1	2.9	7.8	6.0	3.8	6.8	5.4	6.5	6.5	3.6	4.8	5.0	6.7	3.2	6.1	5.4	10.6	7.1	3.5	15.8	17.2	17.9	20.0	15.7	19.1	18.4	18.8	19.4	16.7	18.6	20.4	16.5	9.6	15.0	12.1	15.7	19.8	14.4	11.2	22.2	11.8	16.9	11.4	8.3	7.2	8.3	12.9	25.0	10.0	22.5	11.6	1.9	6.6	32.1	10.6	11.1	14.6	21.4	17.0	13.1	5.1	8.8	12.5	10.7	13.6	19.0	13.5	15.4	24.1	11.4	20.2	13.0	8.5	12.2	22.7	16.6	54.5	10.2	12.5	26.6	12.2	13.1	8.2	12.3	16.1	19.6	6.4	5.7	10.9	27.1	14.8	9.9	9.9	9.2	15.0	0.0	13.3	12.0	16.7	14.9	14.9	18.2	15.7	17.6	9.4	7.3	12.6
RAB30		ENSG00000137502	"RAB30, member RAS oncogene family"	Q15771	11	82973133-83071923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.8;Oligodendrocytes: 243.1;Plasma cells: 260.9"	"Cancer enhanced"	"Detected in all"		"breast cancer: 6.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 54.4;naive B-cell: 55.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.7;HDLM-2: 57.6;U-698: 164.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054514, HPA060565"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA054514: AB_2682512, HPA060565: AB_2684320"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.85e-1)"	11.2	11.0	12.3	13.9	28.0	14.5	12.4	20.5	12.9	8.3	0.0	13.1	17.8	8.4	5.8	6.9	5.5	5.7	9.3	10.5	24.2	3.7	7.7	6.5	19.8	28.0	19.1	14.0	4.3	2.9	4.4	8.5	28.6	7.2	13.8	11.2	6.1	5.2	12.9	7.4	21.3	10.2	20.3	10.1	11.6	4.0	21.8	10.4	5.8	11.8	28.4	8.9	4.4	39.7	4.1	5.6	5.8	2.9	11.1	16.7	6.8	9.8	9.1	19.0	7.9	8.7	1.8	55.7	10.0	14.9	4.9	4.8	8.3	6.4	11.3	57.6	1.6	12.6	16.4	5.1	2.6	2.0	2.5	9.5	4.4	8.5	6.5	7.2	14.0	5.0	1.9	15.0	9.8	7.9	2.1	0.6	7.7	5.5	10.0	4.8	15.2	23.7	9.5	3.4	6.7	4.6	22.6	5.3	2.7	8.6	12.4	0.2	17.9	8.1	19.1	8.0	2.7	24.0	14.3	164.6	3.1	1.4	5.7	1.4	0.7	1.0	4.9	0.3	3.6	54.4	4.8	4.8	2.0	55.0	11.2	10.0	0.9	2.3	0.8	5.8	9.5	6.2	12.3	28.0	20.5	12.9	10.5	24.2	28.0	19.1	28.6	20.3	21.8	39.7	15.2	9.6	3.3	87.8	80.5	24.9	10.7	9.9	73.4	8.3	11.7	13.0	14.5	0.0	2.7	3.7	16.7	7.0	6.8	5.4	1.9	2.4	0.7	3.3	6.1	10.5	10.1	3.2	60.7	4.0	30.8	23.5	5.1	4.2	0.0	0.9	18.2	6.4	1.9	11.8	78.2	1.5	8.2	1.6	15.2	1.3	14.3	6.4	42.7	67.5	24.8	13.9	3.1	80.4	243.1	4.3	3.5	18.0	260.9	8.9	9.3	4.6	2.3	10.5	6.6	20.3	13.5	0.7	2.2	11.0	11.5	2.9	12.9	24.0	1.8	2.0
RAB31	Rab22B	ENSG00000168461	"RAB31, member RAS oncogene family"	Q13636	18	9708275-9862551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 180.9;Kupffer cells: 283.8;Langerhans cells: 208.9;Macrophages: 221.6;monocytes: 193.2;Oligodendrocyte precursor cells: 184.0;Syncytiotrophoblasts: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 137.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 44.9;granulocytes: 137.9;monocytes: 51.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019717	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"HPA019717: AB_10601493"	"unprognostic (4.61e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.07e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (8.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.34e-2)"	35.0	104.8	83.1	42.2	90.5	59.7	22.2	89.1	92.6	85.2	67.7	45.8	11.1	56.2	9.4	31.8	28.8	45.6	20.9	75.9	93.1	16.3	10.5	58.9	22.4	96.6	95.1	44.2	7.0	8.6	10.0	56.5	96.8	21.3	17.7	12.6	13.7	48.7	5.4	12.9	23.7	85.8	91.5	31.3	31.7	42.6	99.3	9.8	25.9	10.5	22.6	54.5	35.2	92.1	2.7	14.4	105.0	0.2	136.7	70.5	74.6	25.4	71.0	18.2	15.8	4.1	14.4	0.1	16.6	99.7	175.3	9.9	25.9	32.6	21.1	6.5	14.6	89.3	104.4	1.8	158.0	7.4	94.2	76.5	6.6	42.1	32.5	78.0	47.4	0.0	22.2	0.4	42.6	11.9	0.1	11.5	22.2	1.2	6.3	0.1	11.5	3.7	13.9	0.3	2.0	6.8	96.4	60.7	34.7	87.5	6.9	48.4	51.9	112.9	56.4	78.3	37.5	19.4	5.7	0.1	153.7	0.1	47.1	137.9	51.6	21.3	0.1	47.2	0.1	9.8	0.2	0.1	44.9	6.7	0.1	0.1	74.4	4.3	50.2	5.2	0.2	19.5	83.1	90.5	89.1	92.6	75.9	93.1	96.6	95.1	96.8	91.5	99.3	92.1	10.0	176.3	33.3	91.4	32.4	15.8	17.7	30.8	23.3	3.2	13.2	12.6	10.6	12.8	51.2	11.0	0.0	180.9	11.0	8.7	7.9	7.9	5.4	10.2	86.0	33.1	0.0	2.5	8.1	19.6	19.0	55.5	5.6	6.2	7.6	72.9	30.0	1.9	157.0	151.4	19.6	0.6	8.2	283.8	208.9	10.9	17.7	221.6	7.2	75.9	193.2	21.5	4.1	184.0	7.0	19.4	1.4	117.4	12.0	27.3	0.0	4.0	47.0	3.9	39.5	14.0	87.3	1.7	4.2	14.5	16.1	186.6	5.1	36.3	0.3	38.8
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543833-146554953	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 175.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 232.6;Kupffer cells: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 86.5"	"Group enriched"	"Detected in many"	42	"dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8"	"Low cell line specificity"	"Detected in many"											HPA025731	Approved		Approved	Cytosol		NA	NA		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	35.0	16.5	7.5	29.7	7.8	175.1	27.0	8.6	11.0	19.0	9.2	38.3	17.4	26.5	14.6	11.6	20.8	24.1	17.9	7.1	8.2	21.3	50.2	32.1	22.3	9.9	8.2	13.0	12.2	8.3	5.0	14.8	8.9	14.5	37.7	2.2	18.1	16.9	4.6	20.2	18.4	46.5	9.2	54.1	19.4	33.3	8.8	22.5	11.0	8.3	15.2	28.6	15.4	11.7	65.5	34.5	38.7	65.3	58.0	98.5	0.1	123.3	138.4	167.7	276.7	21.2	31.6	0.1	43.9	132.2	183.5	84.2	2.4	80.4	225.2	0.4	29.1	82.4	78.3	77.3	252.1	114.2	115.9	87.6	133.1	95.8	135.3	86.7	110.5	0.0	15.8	0.4	92.8	15.8	52.0	61.8	5.0	0.0	65.2	0.0	41.5	0.9	65.6	45.2	0.1	50.6	144.7	17.6	219.3	34.3	33.7	91.7	88.0	50.2	67.7	133.1	152.6	0.2	9.4	0.4	115.1	86.0	69.3	86.5	46.8	8.2	0.0	21.2	0.0	0.0	0.0	0.1	42.5	0.0	0.1	0.0	16.5	1.3	15.4	2.2	0.0	14.4	7.5	7.8	8.6	11.0	7.1	8.2	9.9	8.2	8.9	9.2	8.8	11.7	30.8	48.1	9.4	2.9	4.1	53.5	95.3	92.6	17.6	1.4	29.0	38.9	2.0	52.9	36.8	11.0	4.2	2.2	3.4	64.1	25.4	164.4	96.9	8.5	40.3	34.3	60.1	14.9	2.3	105.7	6.9	51.5	18.3	12.4	57.8	27.7	27.5	75.4	232.6	0.0	1.3	31.3	22.4	254.6	101.7	156.7	24.5	146.7	168.9	24.4	147.2	9.0	2.1	4.0	4.6	154.3	46.3	25.6	0.5	99.6	33.3	83.2	9.5	1.4	19.7	46.1	46.3	70.9	14.2	2.5	19.0	3.1	7.0	33.1	62.5	65.6
RAB33A	RabS10	ENSG00000134594	"RAB33A, member RAS oncogene family"	Q14088	X	130171962-130184870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.5;choroid plexus: 16.4;heart muscle: 15.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 22.9;Melanocytes: 12.4;NK-cells: 22.6;Oligodendrocytes: 23.5;T-cells: 12.9"	"Group enriched"	"Detected in many"	6	"glioma: 10.7;melanoma: 2.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 111.4;Karpas-707: 126.8;U-266/70: 88.5;U-937: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059737	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA059737: AB_2684115"	"unprognostic (5.40e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.00e-6)"	"unprognostic (2.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.61e-1)"	2.3	1.3	23.6	4.0	28.2	6.3	1.3	27.9	31.6	2.3	16.4	0.9	0.7	1.7	0.5	0.5	1.6	2.6	15.2	24.4	24.4	1.7	0.9	1.7	11.6	29.0	24.7	1.4	0.2	2.0	2.2	1.4	29.7	0.4	1.0	7.6	0.5	0.1	0.1	1.1	2.2	0.7	27.8	2.5	1.4	0.6	25.7	4.8	0.6	0.2	12.3	1.7	0.8	41.5	0.3	0.2	7.5	0.0	3.2	1.0	0.1	1.0	2.2	1.9	3.2	0.1	0.8	5.8	0.1	0.6	0.5	0.2	9.4	0.2	2.0	30.2	0.1	35.0	0.1	0.0	31.3	28.4	111.4	1.0	0.2	0.6	1.3	1.0	0.8	34.7	0.1	126.8	0.3	0.3	13.1	9.7	1.1	0.1	1.3	0.0	0.0	1.6	0.2	0.0	24.3	19.4	0.2	0.3	0.5	0.4	0.0	15.2	0.2	0.1	0.1	0.4	0.2	88.5	29.7	0.0	3.9	55.1	0.0	39.9	1.3	87.4	32.0	0.8	20.0	20.2	29.0	32.5	10.0	8.8	27.8	40.0	4.1	19.5	5.4	1.0	72.8	18.1	23.6	28.2	27.9	31.6	24.4	24.4	29.0	24.7	29.7	27.8	25.7	41.5	1.7	0.0	1.1	1.6	3.2	1.9	0.6	0.5	1.2	10.9	0.3	1.0	8.4	2.8	0.2	0.0	2.1	0.9	8.9	0.0	0.0	0.0	1.2	0.4	0.8	2.0	0.0	6.6	4.0	0.2	1.3	4.5	0.0	0.8	22.9	2.9	2.5	0.1	1.9	5.0	3.2	0.4	2.0	0.3	12.0	1.2	1.8	6.3	12.4	1.9	2.5	1.6	22.6	4.5	23.5	0.8	0.0	0.4	3.3	0.4	0.0	0.2	0.3	9.3	0.0	0.0	2.2	0.1	1.2	0.2	1.1	1.4	12.9	0.2	0.3	0.6
RAB33B	DKFZP434G099	ENSG00000172007	"RAB33B, member RAS oncogene family"	Q9H082	4	139453232-139476609	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 22.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048367	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048367: AB_2680372"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.06e-3)"	"prognostic favorable (9.19e-4)"	8.4	5.2	3.7	5.2	4.4	12.8	7.1	7.0	5.3	8.1	2.2	4.1	3.8	9.5	4.2	6.6	5.6	6.0	6.5	3.3	4.4	5.0	16.7	6.8	6.5	5.5	4.5	9.9	10.0	4.1	2.8	9.0	5.8	6.8	4.1	4.1	4.2	5.6	4.2	4.9	4.2	8.4	4.6	7.5	5.4	3.6	4.8	5.4	6.3	5.2	5.8	5.6	3.1	7.4	5.1	1.9	5.6	7.7	12.6	12.3	9.4	6.1	8.5	5.2	6.4	5.5	8.0	10.7	3.0	7.0	2.6	4.8	6.1	5.4	6.2	10.1	4.0	3.7	4.5	6.4	12.6	6.8	8.4	9.5	5.9	6.6	6.2	9.4	15.3	6.7	4.1	20.6	3.9	3.5	5.8	6.0	3.9	8.5	3.2	7.3	8.4	4.7	7.3	3.4	7.4	7.6	4.3	8.5	10.1	6.2	3.9	4.7	10.7	6.2	4.5	10.6	3.4	10.9	13.3	6.9	6.2	7.3	5.6	4.3	3.4	8.7	3.6	3.5	5.8	4.3	4.5	4.0	2.3	3.6	5.6	5.1	22.6	4.3	3.4	2.8	5.2	3.5	3.7	4.4	7.0	5.3	3.3	4.4	5.5	4.5	5.8	4.6	4.8	7.4	13.9	6.4	7.7	5.2	15.1	9.9	7.2	3.4	18.2	5.0	10.0	6.3	10.1	5.7	4.1	3.7	0.0	6.3	9.1	5.3	1.9	5.3	34.1	13.7	11.3	12.0	8.4	3.8	5.9	4.7	5.7	10.7	7.1	10.6	6.3	3.3	11.4	19.7	6.6	3.3	7.5	8.2	2.0	9.4	8.9	72.1	10.5	7.1	1.8	10.3	8.6	5.9	3.1	10.1	8.9	6.2	5.2	12.8	10.9	6.8	6.3	4.5	6.4	8.5	6.6	12.8	9.9	4.6	4.3	12.9	11.6	16.8	13.2	3.4	6.5	5.9
RAB34	"NARR, RAB39, RAH"	ENSG00000109113	"RAB34, member RAS oncogene family"	"P0DI83, Q9BZG1"	17	28714281-28718429	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 169.7;Theca cells: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 51.0;intermediate monocyte: 47.2;myeloid DC: 76.3;non-classical monocyte: 23.4;plasmacytoid DC: 46.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 76.3;monocytes: 51.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021366	Approved					NA	NA		1100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"HPA021366: AB_1856003"	"unprognostic (1.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.31e-3)"	"unprognostic (7.72e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (5.05e-2)"	50.4	86.3	24.7	25.0	24.5	21.3	45.4	23.9	26.6	96.1	31.8	76.8	13.4	80.5	60.2	32.1	74.6	54.2	52.3	22.8	23.7	77.1	7.2	43.6	26.2	26.9	24.6	104.6	7.1	66.2	30.8	32.7	24.7	70.6	21.4	3.8	28.4	78.2	11.0	37.9	31.1	75.0	24.6	30.2	37.6	11.0	25.9	25.9	52.9	17.8	23.5	78.6	60.5	23.4	143.2	203.2	109.4	314.4	129.9	206.3	38.2	184.1	299.0	200.3	166.9	1.7	51.1	0.4	171.5	310.1	69.6	87.7	1.9	104.6	159.7	10.8	94.7	99.2	141.0	11.3	152.0	1.0	0.7	187.7	63.3	151.8	127.9	237.7	138.8	0.4	0.5	1.2	201.6	0.0	0.6	0.2	108.9	0.1	53.7	20.2	261.9	0.7	189.6	73.5	26.8	0.2	134.2	0.6	227.2	93.1	79.0	55.2	31.5	144.0	192.4	132.1	181.9	0.2	0.9	1.5	158.3	0.6	144.8	7.0	51.0	3.1	3.0	47.2	0.7	11.4	5.4	4.2	76.3	11.8	11.7	10.5	1.7	1.1	23.4	46.6	5.8	21.7	24.7	24.5	23.9	26.6	22.8	23.7	26.9	24.6	24.7	24.6	25.9	23.4	37.0	35.3	44.7	42.1	9.7	52.9	105.1	145.0	33.0	2.6	31.2	65.9	8.7	10.0	56.2	57.0	0.0	49.8	12.8	0.2	95.9	3.9	1.1	49.8	79.5	29.3	0.0	12.6	0.1	3.8	102.3	124.2	2.0	34.1	71.5	84.1	25.4	0.3	41.7	1.7	1.2	0.5	59.0	60.5	82.9	5.6	148.8	43.5	65.8	5.6	40.5	25.3	1.0	6.0	0.1	2.0	0.0	169.7	4.6	82.1	0.1	44.6	45.3	2.5	32.9	81.1	98.3	1.9	4.6	20.6	35.4	58.8	10.8	182.1	0.4	59.0
RAB35	H-ray	ENSG00000111737	"RAB35, member RAS oncogene family"	Q15286	12	120095099-120117502	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054146	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA054146: AB_2682399"	"unprognostic (3.15e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.46e-6)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	27.6	18.4	16.7	27.8	17.6	36.2	23.8	15.3	19.8	26.1	10.8	24.6	21.1	27.0	8.5	39.7	23.9	17.7	22.1	18.2	16.7	19.4	19.1	21.9	28.3	16.3	16.9	20.3	16.1	13.6	16.9	21.5	16.7	19.5	14.8	9.6	21.7	14.5	22.0	36.0	22.9	20.1	14.7	31.3	22.4	10.9	18.0	26.7	15.0	17.6	25.1	25.5	28.4	16.0	52.8	58.8	33.8	34.1	33.6	34.7	44.3	47.0	33.8	46.1	29.7	64.7	26.2	40.2	58.6	60.9	35.2	46.0	45.9	50.0	29.6	66.0	50.7	74.2	33.4	44.2	34.2	52.3	67.3	38.2	38.7	61.7	42.7	42.4	50.3	23.8	62.5	25.4	33.0	54.8	54.6	68.3	38.0	31.4	56.9	42.4	28.3	52.5	28.3	61.2	35.8	41.4	55.9	28.3	34.1	33.0	63.0	45.3	62.2	44.7	47.3	45.5	61.9	51.1	62.7	70.3	45.4	45.6	40.2	3.0	7.3	14.6	6.9	8.2	5.8	3.9	4.6	7.2	6.7	3.9	2.5	3.8	14.1	6.5	11.8	3.8	6.9	6.6	16.7	17.6	15.3	19.8	18.2	16.7	16.3	16.9	16.7	14.7	18.0	16.0	22.1	19.2	17.1	5.9	15.1	29.7	18.9	11.4	8.0	9.3	13.0	8.4	6.6	14.3	10.5	9.2	0.0	28.1	28.6	23.7	37.2	21.6	8.6	11.3	14.9	22.7	12.6	10.5	6.5	18.3	25.7	15.6	22.4	17.2	19.6	9.1	22.5	8.7	36.6	15.2	6.0	19.3	2.0	21.8	28.1	3.4	11.5	21.5	12.4	5.6	24.8	10.8	27.8	1.0	5.9	27.9	20.6	15.4	12.6	20.0	17.1	12.9	10.3	7.1	6.6	9.5	15.3	7.3	8.0	16.0	34.7	48.2	23.5	13.4	15.7	20.2
RAB39A	RAB39	ENSG00000179331	"RAB39A, member RAS oncogene family"	Q14964	11	107928448-107963482	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;lymphoid tissue: 3.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 5.2;Inhibitory neurons: 8.8;Microglial cells: 20.6;Spermatocytes: 6.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;NTERA-2: 8.6;RPMI-8226: 15.5;SCLC-21H: 27.8;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042505	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042505: AB_2678030"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.99e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.43e-1)"	0.7	0.9	1.7	2.9	1.4	0.6	0.3	3.1	3.2	0.2	0.2	0.5	0.5	0.2	0.0	0.3	0.2	0.8	0.2	3.2	3.9	0.6	0.6	0.9	2.1	3.1	2.6	0.2	0.3	0.2	0.4	1.2	3.5	0.2	0.8	1.1	0.2	0.1	0.0	0.3	0.7	0.7	2.6	3.0	0.6	0.8	2.2	2.6	0.3	0.1	1.4	0.9	0.0	2.3	0.0	1.8	7.3	0.1	0.0	0.0	0.9	0.1	0.0	0.8	0.6	0.0	0.0	0.4	0.1	0.0	11.6	0.0	7.4	0.0	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.5	6.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.2	0.0	4.0	15.5	0.1	0.0	27.8	17.1	0.0	0.0	0.4	1.6	0.4	3.0	0.0	0.1	1.9	0.0	1.3	0.1	4.3	0.0	0.4	1.7	4.1	0.1	1.4	0.0	0.0	2.2	0.0	0.8	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.4	1.7	1.4	3.1	3.2	3.2	3.9	3.1	2.6	3.5	2.6	2.2	2.3	0.0	0.0	1.1	0.7	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	1.8	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	8.8	0.0	0.0	4.1	3.7	0.8	0.0	4.1	0.0	20.6	1.8	0.0	0.0	4.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	6.4	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RAB39B	"MRX72, WSN"	ENSG00000155961	"RAB39B, member RAS oncogene family"	Q96DA2	X	155258235-155264491	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Autism spectrum disorder, Disease variant, Mental retardation, Parkinson disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;retina: 9.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.8;Horizontal cells: 10.1;Inhibitory neurons: 9.8;Muller glia cells: 11.6;Oligodendrocytes: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.8;Karpas-707: 35.6;U-266/70: 35.5;U-266/84: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001114, HPA042505"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA001114: AB_1079732, HPA042505: AB_2678030"	"prognostic favorable (8.95e-4)"	"unprognostic (1.20e-3)"	"unprognostic (3.52e-2)"	"unprognostic (7.10e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.00e-4)"	"unprognostic (1.78e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	0.2	1.9	6.5	2.8	6.7	0.9	0.7	6.8	10.7	0.4	3.0	0.7	0.6	0.3	6.4	0.3	0.5	0.6	0.3	7.0	7.0	0.7	0.3	0.6	5.3	6.4	6.1	0.4	2.5	3.8	6.5	0.2	6.9	1.9	0.6	9.9	0.4	1.3	0.0	0.0	1.2	0.2	6.1	3.1	1.3	0.9	7.0	5.3	2.4	0.0	5.9	0.8	0.1	8.2	0.0	0.4	5.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	27.8	1.2	0.1	14.9	0.0	0.0	0.2	0.1	11.8	0.5	2.3	0.0	0.0	1.7	0.0	4.8	0.1	0.0	0.4	7.8	0.9	0.0	10.3	0.0	35.6	0.1	2.1	10.3	0.0	6.9	0.0	0.6	0.0	0.0	2.3	0.0	0.0	13.4	10.3	0.0	0.0	6.4	1.8	0.4	0.2	0.0	0.7	2.2	0.0	1.1	35.5	26.7	6.2	6.2	0.0	0.0	0.8	0.3	2.2	4.6	0.2	4.7	4.2	6.0	6.0	4.6	2.8	6.1	6.9	2.7	3.3	0.4	1.1	4.8	3.2	6.5	6.7	6.8	10.7	7.0	7.0	6.4	6.1	6.9	6.1	7.0	8.2	0.9	0.0	0.0	2.6	7.9	0.5	0.5	0.0	0.0	11.8	0.6	0.9	2.4	0.0	0.0	1.8	8.4	0.0	7.6	0.0	0.0	0.2	0.2	0.0	0.7	0.8	1.8	3.0	7.7	0.9	0.0	0.7	1.1	0.1	0.0	2.6	1.8	0.0	0.1	10.1	9.8	0.0	0.0	0.3	3.1	0.0	0.0	1.5	3.6	1.0	2.2	11.6	6.2	8.0	10.3	0.4	0.0	1.9	9.2	0.6	0.0	0.9	0.0	8.0	0.0	0.1	2.4	0.4	0.8	0.0	0.1	0.0	9.1	8.2	0.0	0.0
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204042	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 290.7;retina: 77.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.4;Distal tubular cells: 39.2;Excitatory neurons: 34.0;Horizontal cells: 92.5;Inhibitory neurons: 41.0;Rod photoreceptor cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 290.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.8;SCLC-21H: 37.5;SH-SY5Y: 18.0;U-2197: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.6	15.6	41.0	1.7	56.7	0.9	2.1	6.8	290.7	3.3	0.0	6.4	3.1	2.7	1.5	2.5	5.2	2.0	25.7	53.4	32.5	5.9	3.8	2.5	1.5	26.8	4.6	25.8	2.0	12.8	38.4	1.4	23.3	3.9	1.8	77.5	4.0	3.9	9.9	4.1	3.2	2.1	0.0	2.8	4.5	2.2	29.4	1.3	2.3	8.9	0.9	2.6	3.6	90.5	1.4	1.6	3.5	4.9	5.7	1.4	2.2	3.2	1.9	2.2	2.9	1.4	0.9	5.2	3.4	2.6	2.0	4.2	16.6	2.0	1.0	1.1	5.3	2.1	6.3	6.0	1.4	3.6	6.2	4.6	2.0	1.2	0.6	4.2	0.6	6.4	1.1	1.8	2.0	5.2	8.0	1.0	2.9	4.4	20.8	5.5	0.3	4.4	2.3	0.8	37.5	18.0	1.6	6.6	3.7	1.4	1.4	0.6	0.7	1.8	1.4	26.2	1.8	3.2	7.4	1.3	4.9	2.7	1.7	0.0	1.3	1.8	1.3	0.9	1.8	1.9	1.3	1.3	2.9	0.9	1.7	1.8	2.2	0.3	1.3	2.6	0.8	1.3	41.0	56.7	6.8	290.7	53.4	32.5	26.8	4.6	23.3	0.0	29.4	90.5	2.3	0.0	0.0	8.5	4.7	3.2	2.5	3.7	8.6	102.4	4.8	4.8	1.3	2.8	2.2	16.5	8.4	1.6	7.4	1.6	39.2	2.3	2.4	1.0	1.3	2.6	9.6	0.0	34.0	0.9	5.2	3.1	2.0	1.4	0.0	1.6	2.5	1.6	5.2	92.5	41.0	2.8	4.1	2.2	15.3	0.2	4.4	4.5	10.6	13.1	2.9	15.4	1.0	7.5	10.1	1.0	2.0	5.7	1.1	1.1	5.3	8.3	1.2	46.5	0.0	1.8	8.2	0.4	3.6	6.0	4.8	1.8	5.3	4.5	4.2	2.1
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990700	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 31.0;pituitary gland: 10.6;prostate: 11.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.0	3.0	11.3	0.6	8.6	0.2	0.7	2.9	14.9	0.0	0.0	1.6	0.7	0.1	0.2	0.0	0.2	1.3	0.0	10.9	23.0	0.5	0.7	0.0	0.1	11.4	17.5	1.5	1.0	0.0	10.6	1.6	31.0	11.0	2.3	1.7	0.2	0.1	0.5	1.9	0.9	0.3	2.3	0.1	1.2	0.3	19.5	0.2	0.0	0.0	0.1	0.1	0.1	3.4	1.8	8.5	1.2	1.3	0.2	2.3	0.2	125.8	48.4	24.8	12.0	10.4	3.7	0.6	2.0	45.8	3.6	0.1	15.4	13.0	41.7	0.0	1.1	0.1	0.6	3.4	2.1	0.0	0.1	1.1	0.4	41.1	9.4	15.4	7.8	1.1	0.4	0.4	27.9	0.3	0.1	0.1	19.9	2.4	1.2	0.3	0.2	0.2	4.0	0.8	4.3	1.1	0.1	0.3	0.1	24.6	0.2	0.3	97.9	24.0	8.8	0.5	41.5	0.2	0.6	0.4	21.9	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	11.3	8.6	2.9	14.9	10.9	23.0	11.4	17.5	31.0	2.3	19.5	3.4	1.4	147.4	103.2	0.3	1.1	2.4	6.2	0.3	0.0	5.0	2.2	3.4	0.7	12.8	27.9	0.0	2.1	0.5	0.4	2.0	3.9	4.0	2.4	1.5	1.3	8.2	293.8	0.0	6.6	18.4	0.3	13.9	3.6	1.4	7.6	27.9	0.7	2.7	0.3	0.0	48.1	14.7	14.2	1.3	1.2	1.3	0.6	3.7	1.8	1.0	1.0	31.2	1.0	1.5	1.5	92.8	1.4	1.2	2.3	18.8	1.4	0.2	29.5	3.7	0.0	4.1	4.8	10.4	4.3	0.0	1.4	4.0	3.3	1.1	1.6	2.7
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 62.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 140.6;Inhibitory neurons: 509.9;Oligodendrocyte precursor cells: 131.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0;pancreatic cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HEL: 2.5;NB-4: 1.6;SCLC-21H: 10.2;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, HPA048156"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA003160: AB_1079731, HPA048156: AB_2680291"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	1.1	9.0	19.1	1.2	20.6	0.0	0.7	0.9	32.7	0.1	0.0	0.6	1.6	0.7	0.0	0.2	0.2	0.7	0.1	10.2	62.5	0.0	0.1	0.1	0.2	7.4	12.3	0.3	1.7	0.1	6.8	0.1	31.6	0.0	0.8	6.0	0.1	0.0	0.1	0.0	1.8	0.7	3.9	0.0	0.9	0.1	19.2	0.1	0.1	0.0	0.2	0.6	0.2	3.8	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	20.6	0.9	32.7	10.2	62.5	7.4	12.3	31.6	3.9	19.2	3.8	8.6	0.0	0.6	10.1	0.4	0.1	0.0	0.0	0.0	28.3	0.3	0.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.1	20.0	0.0	0.1	12.1	57.6	1.3	140.6	9.6	0.8	0.2	0.0	0.0	2.5	0.0	5.7	1.2	0.1	3.3	509.9	5.5	0.0	0.9	1.1	11.8	0.9	0.1	1.8	6.5	0.0	1.6	0.0	131.2	8.4	3.9	1.2	0.7	0.0	0.0	0.3	0.1	0.0	6.7	13.1	0.5	0.2	2.4	4.1	0.0	0.1	0.0	1.3	0.1	0.3	0.0
RAB3D	"D2-2, GOV, RAB16, RAD3D"	ENSG00000105514	"RAB3D, member RAS oncogene family"	O95716	19	11322068-11346270	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.5;skin 1: 53.1"	"Cell type enhanced"	"Detected in many"		"monocytes: 53.1;Squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 47.3;Karpas-707: 45.6;MCF7: 54.6;SK-BR-3: 68.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 73.1"	"CAB018067, HPA063283"	Approved		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB018067: AB_606903, HPA063283: AB_2684976"	"unprognostic (4.71e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (4.17e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.34e-1)"	5.5	3.4	11.5	5.1	9.9	17.6	12.2	8.5	13.0	15.0	6.3	8.1	8.1	7.3	6.1	34.1	8.7	3.9	3.6	16.1	13.0	5.8	1.8	8.7	2.4	20.7	10.8	4.2	68.5	4.4	4.7	7.2	23.4	17.1	8.6	1.7	30.1	8.1	2.5	53.1	6.1	8.8	12.2	8.8	19.5	1.4	15.2	4.7	6.2	4.2	9.1	7.0	15.2	14.1	1.5	14.2	4.4	17.7	7.1	12.3	0.9	1.3	3.8	2.5	2.5	5.1	0.5	0.6	16.0	8.6	4.7	19.1	7.5	11.9	2.2	7.8	1.1	5.8	6.7	5.8	4.4	3.1	13.2	5.3	47.3	2.1	5.1	6.5	20.5	4.3	2.1	45.6	0.8	54.6	2.2	6.9	3.7	28.7	14.4	2.1	0.0	16.1	22.0	14.2	4.9	9.5	4.3	68.8	9.3	6.0	41.1	35.1	7.9	2.4	0.8	11.4	0.2	15.5	21.3	3.2	8.4	19.0	2.6	123.5	84.1	95.6	3.2	51.4	5.6	2.2	3.2	2.6	35.5	2.2	2.2	2.7	169.1	1.6	41.3	0.9	5.7	26.3	11.5	9.9	8.5	13.0	16.1	13.0	20.7	10.8	23.4	12.2	15.2	14.1	10.0	6.4	17.2	4.6	4.0	15.7	4.5	13.7	12.5	0.7	23.6	14.1	4.3	10.0	19.1	14.7	0.0	8.0	4.4	5.7	11.7	4.8	0.5	5.4	6.6	9.7	18.6	5.9	9.2	25.6	6.6	5.4	23.0	14.0	12.7	4.1	17.9	1.5	9.4	0.0	5.4	29.3	4.1	40.0	2.4	0.2	4.4	16.0	8.8	5.6	53.1	5.3	2.1	1.0	1.3	12.7	5.8	4.9	8.5	11.7	1.4	3.6	1.8	0.4	6.6	3.3	8.5	0.1	2.5	47.8	37.8	10.4	3.9	3.8	15.4	5.9
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052292-135176394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		6300	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	23.4	21.1	22.5	24.3	24.1	37.5	25.6	18.7	23.1	27.5	22.0	23.7	19.1	29.2	30.6	26.2	22.9	21.6	35.2	24.5	24.1	23.2	20.5	20.4	25.9	23.3	23.2	35.2	35.4	34.0	18.9	23.6	24.3	29.5	27.9	34.1	35.6	28.3	36.9	26.2	21.4	30.9	19.7	21.3	26.1	18.7	23.1	30.3	30.8	36.0	30.4	26.0	22.4	22.0	51.2	20.4	34.8	29.0	67.3	57.0	32.4	76.6	62.6	59.5	58.4	45.3	40.7	75.5	46.2	78.5	22.8	42.2	37.4	70.6	72.1	36.2	37.9	34.3	24.8	39.9	46.9	46.8	39.3	50.2	91.2	54.8	98.2	53.6	43.6	33.7	49.5	42.5	54.7	30.1	24.1	18.2	27.1	30.7	33.8	40.9	45.0	31.9	35.0	44.9	28.3	22.4	52.0	30.7	36.8	30.5	27.2	33.6	53.0	60.0	45.7	26.0	32.5	30.1	18.2	55.8	39.2	27.8	34.3	10.3	4.3	6.7	1.5	5.3	1.3	5.5	3.8	2.1	4.5	6.8	7.9	4.2	1.7	3.1	6.0	2.3	5.4	2.1	22.5	24.1	18.7	23.1	24.5	24.1	23.3	23.2	24.3	19.7	23.1	22.0	34.3	25.6	26.7	86.8	50.4	30.2	46.8	28.8	27.9	28.9	30.2	27.8	58.0	32.9	32.6	31.3	50.1	23.6	15.3	39.4	11.7	20.0	34.8	31.8	33.0	28.5	34.6	24.4	137.8	26.9	17.1	35.5	46.9	31.5	46.3	27.2	32.9	25.7	22.4	30.3	106.8	31.2	28.5	26.7	28.1	23.2	30.7	32.4	23.2	112.4	24.2	18.0	6.2	107.1	123.3	34.6	24.3	35.7	40.0	42.5	29.9	21.1	36.0	33.8	46.0	31.8	34.4	41.8	25.8	37.5	29.7	39.1	28.3	35.0	24.7	51.0
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272453	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	10.1	9.0	6.3	9.6	6.7	10.2	11.2	11.4	7.8	8.7	23.5	8.8	7.8	9.4	8.4	9.0	7.0	7.9	9.3	7.3	9.3	11.7	10.0	8.6	12.6	6.7	6.9	9.6	8.6	18.6	6.2	11.5	9.0	8.5	8.3	18.1	9.2	7.9	8.7	7.9	7.8	9.3	5.7	9.2	9.4	6.6	7.5	13.1	12.8	12.2	14.4	9.1	6.0	9.1	21.3	15.8	18.9	14.3	21.2	25.1	21.4	21.4	20.3	18.9	22.2	14.7	17.3	26.4	14.8	20.9	14.3	19.9	19.8	16.4	21.8	22.1	12.9	20.6	21.5	13.8	27.9	29.8	20.3	20.0	18.4	18.5	28.5	21.2	17.6	11.4	36.2	16.6	21.6	6.0	23.0	10.5	40.8	11.4	9.3	12.5	26.0	23.7	16.1	17.3	18.8	22.7	22.2	21.4	35.3	20.3	22.4	28.0	25.7	20.6	9.6	14.4	23.2	14.6	19.2	22.8	17.7	24.6	24.8	10.0	2.8	5.6	4.8	3.6	5.9	4.8	4.7	6.2	3.8	3.8	4.1	4.9	1.8	2.8	3.9	2.4	6.0	3.3	6.3	6.7	11.4	7.8	7.3	9.3	6.7	6.9	9.0	5.7	7.5	9.1	28.5	41.7	21.9	60.7	30.4	11.6	13.6	15.8	17.6	57.9	18.9	16.3	34.8	32.9	23.4	25.8	68.8	18.5	30.6	23.8	5.9	17.4	4.3	21.4	27.7	22.3	35.4	18.7	106.8	16.7	13.5	23.4	20.4	28.5	19.6	40.8	28.9	24.2	25.4	42.1	105.1	22.1	16.2	29.0	9.4	2.8	18.0	22.2	14.2	68.4	25.2	39.8	26.8	82.0	81.5	21.7	14.2	25.9	24.7	21.0	19.4	14.9	17.2	50.5	6.6	24.1	20.4	17.7	13.6	17.5	9.8	23.1	27.1	23.6	19.3	13.2
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.59e-3)"	29.8	9.5	10.9	7.9	11.2	13.8	22.8	10.3	13.4	38.6	12.7	13.6	4.7	30.0	4.6	6.2	24.0	11.3	20.5	10.5	10.8	16.0	6.9	11.8	6.5	12.8	11.0	37.1	5.1	7.8	9.5	15.9	11.8	10.6	2.6	3.1	12.2	5.1	7.6	15.2	9.9	9.3	11.6	28.2	9.4	41.2	14.8	9.0	15.1	10.0	2.4	19.0	20.7	12.7	6.9	13.3	0.4	7.3	26.9	19.9	1.5	5.5	13.7	8.0	5.4	1.9	1.5	0.1	10.1	8.4	36.9	3.7	9.6	0.5	1.2	0.0	2.1	12.8	5.1	7.2	36.9	0.5	0.3	10.7	6.9	3.9	9.1	1.3	0.7	7.1	34.4	0.3	4.7	12.3	0.0	0.1	4.3	1.2	14.1	0.7	1.9	44.3	0.7	0.5	0.6	4.9	3.4	2.9	25.0	2.2	2.2	1.6	0.6	29.3	13.2	56.5	2.3	0.4	2.1	0.0	5.7	15.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.2	10.3	13.4	10.5	10.8	12.8	11.0	11.8	11.6	14.8	12.7	5.5	0.0	0.0	1.6	0.8	5.1	0.9	0.0	0.6	0.5	1.3	1.9	1.9	2.8	0.6	1.8	0.0	1.3	0.1	0.1	1.9	2.2	110.9	1.9	27.8	9.6	0.0	34.5	0.4	1.0	2.0	24.3	1.1	1.8	0.0	1.1	16.1	1.4	65.3	1.7	1.3	0.0	0.0	19.9	10.2	133.8	56.2	6.8	8.8	8.4	0.0	6.5	0.0	1.0	0.7	1.1	0.0	45.1	0.0	1.6	0.0	15.9	0.0	8.2	0.0	3.4	8.2	1.7	9.1	0.2	4.0	1.4	0.6	47.6	0.2	0.2
RAB3IP	"FLJ22548, RABIN3, RABIN8"	ENSG00000127328	"RAB3A interacting protein"	Q96QF0	12	69738860-69823204	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 210.4;Early spermatids: 287.3;Late spermatids: 453.9;Oligodendrocyte precursor cells: 261.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039794	Uncertain		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments"		"HPA039794: AB_10960557"	"unprognostic (4.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.68e-13)"	"unprognostic (6.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.37e-1)"	3.7	15.9	17.7	6.4	22.0	25.6	19.9	79.7	16.9	8.4	51.6	21.7	19.2	5.5	44.3	8.6	15.2	15.1	18.3	18.7	18.9	48.5	16.6	14.9	13.6	25.7	21.7	3.1	22.8	26.9	20.2	12.0	26.2	20.8	22.6	88.6	12.8	9.7	9.7	11.8	22.4	4.9	12.1	6.8	18.4	74.7	19.7	12.7	16.2	14.3	15.3	11.8	4.8	25.6	44.1	23.5	14.3	22.9	6.9	3.1	41.0	4.3	9.9	16.9	22.6	67.3	19.1	34.1	13.9	2.3	21.9	33.0	14.7	22.9	29.0	51.7	25.6	25.3	8.4	32.9	6.4	29.9	15.4	7.4	23.3	15.6	52.4	17.5	24.8	44.4	12.1	30.3	9.6	46.8	30.3	12.8	35.7	46.1	25.7	35.3	22.2	35.9	55.1	53.5	56.7	10.2	16.7	28.0	6.4	57.0	47.6	11.1	7.4	7.2	18.3	3.0	20.3	14.2	63.4	156.9	17.5	18.3	11.2	1.8	5.2	7.2	4.2	1.9	8.5	9.2	7.5	6.8	5.6	8.6	9.3	9.1	6.9	7.8	2.3	5.1	12.6	4.4	17.7	22.0	79.7	16.9	18.7	18.9	25.7	21.7	26.2	12.1	19.7	25.6	4.0	60.9	51.1	19.6	17.7	23.6	55.6	28.8	19.4	210.4	44.6	13.0	50.2	85.8	48.8	51.5	110.5	21.7	6.4	33.1	37.2	64.6	287.3	79.7	5.2	8.7	40.8	14.1	22.6	31.8	8.2	6.4	39.3	119.7	2.5	19.3	7.1	16.5	3.5	28.6	186.1	39.3	46.8	1.9	7.5	453.9	4.4	8.0	5.4	9.4	16.6	96.6	4.1	261.9	104.1	51.1	38.6	3.8	25.9	77.9	46.1	82.1	54.4	95.8	6.6	31.8	12.3	48.9	37.7	24.2	29.8	8.5	15.1	3.5	45.8	76.7
RAB41		ENSG00000147127	"RAB41, member RAS oncogene family"	Q5JT25	X	70282093-70285002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 65.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 533.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 3.7;U-87 MG: 4.6"									"HPA001510, HPA065289"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Vesicles, Plasma membrane"	"HPA001510: AB_1079733, HPA065289: "	"unprognostic (1.32e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.89e-2)"	0.2	0.8	0.5	0.5	0.6	0.4	0.1	0.3	0.9	0.1	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.5	0.6	0.3	0.4	0.3	0.1	0.3	0.5	0.5	0.5	0.8	0.1	0.0	0.2	0.2	0.4	0.2	0.0	65.5	1.0	0.0	0.5	1.3	0.7	0.0	0.4	0.5	0.2	4.0	1.0	0.0	0.8	0.0	0.0	0.3	0.1	0.5	0.5	0.5	1.3	0.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.6	0.5	0.6	1.1	0.0	1.1	0.6	0.0	0.0	0.0	0.8	1.3	0.1	1.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.5	1.2	0.0	0.3	0.8	0.5	0.8	1.7	1.7	0.3	0.9	0.9	0.0	0.4	0.8	1.5	0.5	0.3	1.5	0.6	0.3	1.4	1.6	0.6	0.7	3.7	0.8	0.7	1.1	0.8	4.6	1.1	1.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.3	0.9	0.3	0.4	0.5	0.5	0.4	0.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	533.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	28.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 46.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.0;Gastric mucus-secreting cells: 5.6;Plasma cells: 9.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 11.2;T-cells: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	7.6	8.3	9.5	10.4	9.7	22.3	7.1	11.6	8.1	7.3	9.3	7.9	8.0	6.6	2.9	5.9	7.3	9.4	4.2	7.9	5.8	10.4	46.9	14.8	17.4	10.0	7.5	9.9	10.3	5.2	6.7	3.9	8.4	9.9	2.6	0.7	10.2	5.0	1.8	4.0	6.9	2.7	7.3	10.9	8.1	7.5	7.1	12.9	22.7	1.4	4.6	7.3	4.0	6.7	22.4	6.0	1.4	5.7	2.7	1.2	8.3	7.6	5.1	4.4	3.5	9.4	9.4	0.6	17.1	5.7	5.9	9.2	0.5	8.8	1.0	11.2	5.6	1.5	1.1	12.5	25.9	5.1	12.7	7.1	5.4	2.2	0.5	1.9	8.7	13.0	2.5	10.8	6.1	9.7	5.0	9.8	7.0	5.2	10.5	10.8	3.2	6.6	14.1	18.7	0.4	2.7	3.3	7.0	14.4	2.2	3.0	5.3	12.5	9.3	6.4	7.6	2.9	16.9	9.8	3.6	8.5	1.0	10.3	0.4	1.2	2.3	1.5	1.5	0.7	0.5	1.5	1.2	0.6	1.0	2.8	2.4	11.2	1.4	0.7	0.9	2.4	1.0	9.5	9.7	11.6	8.1	7.9	5.8	10.0	7.5	8.4	7.3	7.1	6.7	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	12.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.1	0.5	5.6	0.5	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	9.2	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	2.5	0.1	0.1	1.2	0.2	0.3	0.1
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	50.9	54.4	95.4	39.4	102.3	35.0	68.2	106.2	96.8	76.8	76.5	72.2	52.4	73.8	92.4	99.8	75.7	55.8	87.2	93.1	99.5	70.1	68.8	72.9	44.5	103.5	105.6	85.4	47.9	112.1	31.4	63.4	106.0	74.6	80.6	72.9	61.7	94.6	100.6	92.4	50.4	79.9	103.6	48.1	67.0	57.1	99.9	64.0	64.6	127.6	76.0	65.6	69.6	112.9	62.3	39.1	80.2	59.4	128.5	115.9	72.1	56.1	102.3	68.3	57.5	67.5	76.7	34.7	65.5	107.6	50.3	44.8	51.4	77.8	63.3	44.1	39.5	39.3	53.1	38.6	94.5	33.2	61.6	94.9	142.7	64.2	54.2	153.0	87.0	42.2	36.2	99.3	87.3	42.3	42.6	51.9	35.8	51.5	35.2	36.5	49.9	45.1	128.2	100.7	40.0	35.6	73.1	72.4	89.0	88.3	104.6	102.5	72.3	44.5	32.5	32.8	22.2	56.4	46.9	21.8	71.5	30.7	38.4	18.5	10.1	32.6	11.1	9.3	10.3	8.9	9.0	9.9	8.0	6.9	10.2	8.0	27.4	7.6	10.6	8.0	7.6	8.9	95.4	102.3	106.2	96.8	93.1	99.5	103.5	105.6	106.0	103.6	99.9	112.9	24.4	57.7	37.1	13.1	26.7	51.7	26.5	34.0	35.3	33.3	54.4	38.2	53.2	55.8	34.0	42.3	52.1	44.0	29.1	88.1	35.2	49.4	11.1	24.1	22.8	30.8	38.9	29.8	21.4	37.1	42.8	33.1	37.2	33.9	19.7	34.1	42.1	86.0	31.1	16.8	23.4	51.1	16.2	46.4	52.3	27.7	53.4	25.4	35.6	11.2	64.7	41.6	32.0	11.1	26.3	71.3	44.4	59.5	27.1	57.0	44.7	35.9	23.9	31.6	59.2	31.9	33.2	36.8	25.6	64.7	89.2	88.0	25.0	23.4	42.7	65.8
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124978-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	133.5	118.1	91.7	113.7	99.2	203.5	119.4	97.4	107.9	90.9	77.1	106.9	135.7	103.1	67.3	92.3	87.3	88.6	69.7	89.0	101.9	145.9	99.7	120.1	94.6	98.5	98.1	82.4	76.4	102.6	48.7	106.8	98.5	70.6	86.3	40.5	84.5	84.3	46.7	91.5	124.1	97.6	96.7	116.4	118.0	41.7	104.3	87.1	109.7	54.6	79.2	115.1	83.0	100.6	169.5	311.3	96.2	140.1	210.7	144.8	184.7	201.6	212.5	273.9	238.1	223.5	163.5	81.5	172.9	254.4	194.8	231.8	179.1	197.9	175.7	104.9	232.6	124.8	120.6	326.1	206.4	165.8	195.6	187.3	204.7	208.1	144.6	143.1	292.6	110.2	145.8	123.6	189.7	154.7	170.3	148.6	95.2	294.7	0.9	110.0	165.2	139.4	209.0	246.1	53.6	136.2	103.7	651.5	220.6	149.5	288.7	159.9	276.6	279.8	155.0	237.9	218.5	113.0	157.1	104.1	185.1	127.6	290.4	56.9	119.7	129.5	45.7	103.4	40.6	42.8	44.5	46.2	83.4	43.6	36.5	37.2	194.5	56.8	110.0	55.1	56.0	99.2	91.7	99.2	97.4	107.9	89.0	101.9	98.5	98.1	98.5	96.7	104.3	100.6	185.1	6.4	9.7	23.5	83.7	111.3	89.6	139.6	62.0	51.0	86.8	80.0	5.4	77.2	66.3	106.7	12.5	189.6	95.3	198.8	252.4	207.0	63.7	43.5	51.3	146.6	78.6	64.6	12.0	173.8	210.6	81.8	78.0	51.1	44.4	59.1	165.2	63.9	443.6	38.7	12.6	115.2	142.4	204.1	213.8	100.4	108.7	171.2	158.3	24.4	207.5	105.7	133.9	18.6	21.2	247.2	189.9	155.7	64.3	105.0	243.3	408.8	33.7	43.1	131.5	57.5	137.3	28.9	60.8	74.8	130.8	274.9	83.0	65.0	99.9	145.1
RAB5IF	"C20orf24, PNAS-11, RCAF1, RIP5"	ENSG00000101084	"RAB5 interacting factor"	Q9BUV8	20	36605779-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 215.9;Exocrine glandular cells: 348.7;Hofbauer cells: 242.6;Pancreatic endocrine cells: 442.2;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA057387: AB_2683425"	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	45.2	49.0	33.0	46.4	33.4	69.0	33.4	36.0	40.4	45.4	35.8	71.6	49.3	29.1	40.9	152.2	27.3	38.6	53.0	32.8	34.9	53.1	115.7	41.9	38.6	35.0	33.7	22.6	42.8	55.2	20.8	33.4	34.4	29.8	59.9	28.6	56.3	27.6	216.9	39.8	43.2	34.7	35.4	57.0	48.5	37.5	36.1	41.6	27.8	78.2	56.4	50.3	58.1	37.0	224.8	164.4	59.9	75.2	127.2	74.8	142.5	135.8	79.4	132.7	119.5	455.9	279.5	96.6	327.4	122.2	244.8	163.2	123.3	219.3	130.5	73.5	119.1	230.0	233.3	516.7	149.1	247.4	109.3	92.6	225.0	187.7	110.1	70.4	124.5	104.0	158.9	226.4	125.2	156.9	148.6	318.2	98.5	227.1	344.6	114.8	137.2	245.9	119.3	163.5	99.3	76.0	195.3	513.2	187.6	89.3	111.5	206.5	135.1	192.6	132.5	195.3	211.7	138.8	236.0	162.2	204.4	281.3	104.7	22.0	76.9	97.3	17.7	38.9	17.8	35.7	21.2	27.4	47.9	33.6	26.1	19.4	120.6	18.4	46.4	32.8	39.8	28.1	33.0	33.4	36.0	40.4	32.8	34.9	35.0	33.7	34.4	35.4	36.1	37.0	47.5	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	87.1	64.5	0.0	0.0	0.0	42.3	0.0	83.1	111.1	0.0	76.3	215.9	0.0	43.0	34.8	24.4	0.0	0.0	0.0	348.7	126.8	14.5	0.0	61.6	0.0	24.3	0.0	0.0	242.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	93.0	0.0	0.0	0.0	0.0	442.2	0.0	0.0	11.9	0.0	0.0	147.8	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	135.6	27.0	29.9	0.0	0.0
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	71.2	69.8	87.7	53.0	96.5	38.4	50.6	85.4	112.8	64.4	79.3	66.2	71.6	66.9	53.0	100.2	54.0	55.6	99.5	101.8	100.9	75.1	85.3	68.5	45.7	106.0	90.1	64.5	49.0	67.5	36.4	91.4	112.9	64.0	70.6	56.1	47.8	64.9	107.5	55.0	83.4	79.8	80.0	56.9	54.9	36.1	97.4	54.2	98.7	101.7	60.8	78.9	62.4	93.4	86.2	66.3	105.8	68.5	135.9	154.3	141.7	130.4	124.6	111.1	100.8	131.5	146.4	73.2	136.6	174.0	94.9	94.6	68.4	135.3	142.5	84.6	25.6	118.2	68.6	110.9	114.2	78.1	113.1	114.7	246.8	113.5	165.0	124.4	135.9	75.7	71.3	111.5	133.3	99.6	85.7	54.7	42.2	192.0	62.3	64.8	193.9	132.5	135.2	146.6	83.0	70.5	136.1	136.7	290.9	104.7	107.2	71.0	165.0	113.3	56.9	193.5	56.6	71.9	89.5	149.5	46.3	63.2	104.6	227.9	81.8	133.2	84.2	87.6	76.2	56.1	70.3	75.5	62.9	50.7	52.0	61.8	61.9	78.6	88.6	33.7	86.3	111.1	87.7	96.5	85.4	112.8	101.8	100.9	106.0	90.1	112.9	80.0	97.4	93.4	66.3	32.1	51.0	79.7	59.2	83.5	49.4	57.2	88.2	53.9	45.8	30.4	64.2	35.8	42.7	68.0	87.6	109.9	55.3	85.2	43.0	66.0	8.8	51.5	41.3	78.7	52.0	47.5	133.6	49.5	162.3	60.5	52.5	51.2	48.8	83.7	72.5	63.7	65.7	40.4	119.0	61.8	75.3	58.4	85.7	9.5	52.8	58.3	72.9	49.6	74.2	47.7	52.5	130.7	109.4	79.0	61.7	61.7	86.3	57.8	102.7	54.1	47.2	54.2	26.3	47.4	65.5	74.2	53.4	106.5	112.7	173.6	63.8	45.0	50.8	69.8
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824235-133895882	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	47	"T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"HEL: 226.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		2200000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	6.8	11.1	45.7	2.8	72.6	12.0	4.4	0.4	138.0	2.9	0.0	6.8	2.4	3.0	2.1	4.2	16.2	3.2	20.8	71.8	31.3	7.1	0.9	3.1	3.3	74.6	43.1	2.1	4.4	24.9	12.0	1.7	55.7	2.7	2.1	29.4	10.1	5.9	2.7	1.5	2.9	8.4	3.7	5.9	5.5	4.0	21.5	1.4	5.2	2.8	2.0	1.6	2.2	63.1	0.1	3.0	5.8	14.9	10.1	10.3	0.5	3.0	6.3	7.2	0.8	1.6	1.5	0.2	6.3	2.4	21.2	0.4	13.8	0.4	3.6	0.2	8.6	226.6	3.5	0.5	1.2	1.4	8.5	3.1	2.9	1.1	0.2	0.1	2.9	8.3	53.4	0.6	1.1	5.5	0.7	21.3	18.0	10.8	2.2	0.2	0.4	2.3	4.0	1.3	47.2	10.1	4.4	4.2	26.7	22.5	16.8	9.7	3.7	6.5	15.5	3.2	5.4	5.6	1.5	0.5	0.7	0.5	5.6	0.0	0.0	0.0	0.6	0.0	7.3	0.1	0.1	1.7	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.8	45.7	72.6	0.4	138.0	71.8	31.3	74.6	43.1	55.7	3.7	21.5	63.1	2.0	0.0	0.0	25.8	0.2	1.3	2.2	0.5	0.6	10.5	2.0	2.3	30.8	1.5	2.8	1.8	2.1	0.3	0.6	2.2	3.9	3.6	0.1	2.3	0.9	3.5	0.0	79.2	60.5	1.3	0.7	3.7	2.0	1.3	0.0	12.4	7.9	0.1	0.2	67.3	54.1	0.2	0.0	0.6	1.1	0.2	1.8	0.4	1.8	16.9	0.1	10.2	0.0	17.1	9.6	2.5	1.1	6.8	0.1	2.0	0.0	1.5	9.3	21.3	0.0	4.1	13.8	0.9	12.7	0.8	1.4	0.3	1.1	2.2	0.0	0.6
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979666-129982738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;breast: 2.5;parathyroid gland: 3.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 10.3;Oligodendrocytes: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;prostate cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1"									HPA059131	Uncertain		Uncertain	"Golgi apparatus"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	0.1	0.6	1.4	0.1	2.2	0.0	2.5	0.7	1.9	1.9	0.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	1.3	1.6	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.0	3.6	0.2	0.3	1.3	1.7	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.7	0.5	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.5	3.2	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.7	1.9	1.3	1.6	1.2	1.2	1.3	0.7	1.6	3.6	0.1	0.0	0.0	0.3	0.1	0.8	0.3	0.3	0.0	0.0	0.9	0.1	10.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	1.7	1.0	0.0	0.0	0.7	0.0	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.3	0.4	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.6	1.4	1.4	1.3	0.0	1.1	0.5	0.1	0.1	0.1	0.3
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"	Q53S08	2	131361111-131364142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 7.4"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 2.2"									HPA059131	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.2	0.6	0.1	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.9	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	7.4	0.0	0.0	0.5	1.4	0.8	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.8	0.6	0.9	0.3	0.2	0.5	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689128-13710504	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 345.3;Syncytiotrophoblasts: 370.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	28.9	51.7	24.2	18.4	27.2	56.0	32.8	28.3	28.2	31.4	21.8	28.4	14.9	29.4	21.3	29.7	21.5	22.8	20.7	23.4	26.0	30.3	24.9	24.9	25.1	28.0	25.3	28.2	33.2	38.1	15.5	28.7	28.7	20.2	25.0	21.7	37.0	18.9	19.7	37.0	19.1	22.1	28.5	22.0	21.4	7.6	25.0	16.5	21.1	16.5	31.7	27.4	27.9	32.1	34.8	18.1	22.9	54.5	75.1	59.7	20.4	19.0	66.4	28.5	41.2	19.6	37.7	31.3	45.7	29.9	68.1	34.8	34.4	40.4	27.8	69.6	53.4	9.9	36.6	22.9	45.0	17.7	25.8	64.6	69.5	35.8	38.2	45.7	26.8	17.3	19.5	44.8	30.9	23.9	16.8	28.8	24.7	24.0	34.1	22.7	24.2	94.7	78.8	31.7	18.8	13.2	40.3	56.3	69.3	56.8	31.4	18.5	21.1	21.5	11.2	76.9	11.6	35.4	66.4	12.8	21.5	15.1	21.5	34.1	37.7	17.5	38.1	25.3	29.9	20.0	20.7	31.9	26.5	14.2	15.3	26.3	22.5	31.0	24.1	29.1	18.0	22.0	24.2	27.2	28.3	28.2	23.4	26.0	28.0	25.3	28.7	28.5	25.0	32.1	25.4	48.1	27.3	19.9	35.0	64.7	69.0	73.4	29.6	8.7	35.9	39.0	16.6	42.9	64.1	33.1	0.0	83.6	121.0	85.3	80.3	135.0	0.6	78.8	46.2	23.7	24.5	27.8	11.1	64.0	60.5	39.2	23.4	105.8	45.1	13.5	14.3	19.2	54.9	15.2	13.7	32.2	52.9	45.0	104.9	2.2	37.6	46.7	56.9	6.5	345.3	50.9	68.0	33.7	36.6	81.1	103.1	40.3	53.8	93.1	30.7	68.9	42.8	9.4	13.1	28.1	37.2	9.7	17.7	44.5	83.4	370.4	75.6	51.4	26.6	111.8
RAB9B	RAB9L	ENSG00000123570	"RAB9B, member RAS oncogene family"	Q9NP90	X	103822327-103832257	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 21.3;Cardiomyocytes: 79.0;Excitatory neurons: 28.4;Inhibitory neurons: 18.7;Muller glia cells: 32.2;Oligodendrocyte precursor cells: 37.7;Peritubular cells: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.5;MOLT-4: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061932	Approved				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA061932: AB_2684640"	"unprognostic (1.69e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.28e-5)"	"unprognostic (5.81e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.34e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.52e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.21e-4)"	"unprognostic (1.37e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	1.8	2.8	6.4	0.9	6.6	0.1	1.3	8.1	7.2	3.0	0.0	6.5	1.0	5.0	2.4	8.3	6.8	2.4	21.5	6.2	8.8	0.4	0.1	0.7	0.6	4.0	3.6	7.2	1.0	3.9	5.1	0.2	6.8	7.1	2.2	5.2	1.1	9.5	9.4	0.5	1.7	9.8	3.7	0.5	2.2	1.8	8.8	1.5	1.4	5.6	0.4	7.0	1.6	4.7	0.0	0.0	2.9	1.5	0.8	0.1	0.1	0.7	1.8	1.8	1.7	0.2	0.0	0.1	1.7	1.5	1.1	0.0	0.5	0.1	1.6	0.1	1.9	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.8	0.0	1.8	0.1	4.5	0.0	1.1	0.1	1.3	3.7	0.0	0.5	0.0	0.5	3.2	3.3	0.1	1.0	0.3	3.0	2.1	0.2	0.1	0.6	0.5	0.3	0.2	0.1	0.1	0.5	1.0	0.6	0.1	0.0	0.2	1.6	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	6.4	6.6	8.1	7.2	6.2	8.8	4.0	3.6	6.8	3.7	8.8	4.7	1.0	0.0	2.4	8.5	0.7	0.4	0.7	0.1	0.6	21.3	1.6	1.9	79.0	0.0	0.7	0.0	0.0	0.4	0.2	0.5	0.0	0.5	0.0	0.3	0.7	2.4	7.7	1.3	28.4	1.0	0.3	4.1	0.0	0.2	4.5	2.8	0.7	0.0	0.3	0.0	18.7	0.7	0.0	0.0	0.4	0.9	6.5	0.2	0.0	1.9	0.0	32.2	2.1	37.7	6.2	1.0	2.5	30.1	0.1	0.2	0.1	0.2	0.8	3.6	6.6	2.3	5.0	0.8	0.9	0.5	0.3	0.0	0.2	4.7	0.6	0.2
RABAC1	"PRA1, PRAF1, YIP3"	ENSG00000105404	"Rab acceptor 1"	Q9UI14	19	41956681-41959321	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019320, HPA029171"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB019320: , HPA029171: AB_10602121"	"unprognostic (7.70e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.45e-2)"	180.4	163.6	128.4	61.1	129.5	53.2	170.4	136.7	177.5	213.4	137.5	192.0	75.3	234.5	28.2	115.9	174.2	37.9	166.5	122.3	149.5	181.7	198.9	180.7	51.9	151.7	135.4	184.3	177.9	68.7	242.4	55.4	149.1	160.4	28.4	14.6	197.2	57.9	125.9	146.7	148.9	49.0	136.7	166.0	189.9	155.4	144.5	34.0	171.4	38.0	31.3	168.6	171.4	147.7	95.7	261.0	35.5	94.6	234.8	136.7	47.7	278.8	144.9	67.3	93.8	46.8	60.6	277.0	140.4	161.9	39.1	70.0	21.9	89.0	25.5	102.1	151.6	40.4	73.0	82.1	130.8	35.5	106.7	137.5	86.5	45.5	31.0	84.4	94.2	76.0	17.9	346.6	61.0	149.2	62.6	32.0	44.4	136.8	167.6	83.3	77.4	54.4	65.0	71.8	67.0	97.4	73.5	157.3	71.3	26.2	59.1	29.4	187.2	119.3	77.4	116.2	40.4	303.8	111.0	96.1	172.3	66.3	131.3	720.0	389.3	551.7	372.2	217.3	313.6	398.7	331.0	325.0	232.5	339.4	222.3	298.8	774.6	253.4	220.1	410.2	403.4	511.2	128.4	129.5	136.7	177.5	122.3	149.5	151.7	135.4	149.1	136.7	144.5	147.7	333.1	128.2	109.8	19.2	203.4	124.7	160.1	242.1	119.5	62.6	173.6	232.3	59.9	163.0	162.3	182.1	16.7	187.5	173.6	411.2	137.0	339.7	203.1	91.9	247.0	234.4	195.0	35.1	14.8	301.4	467.1	309.7	138.6	143.8	142.7	163.5	241.3	237.7	174.0	57.2	18.8	507.5	246.2	119.8	187.0	658.2	307.0	133.1	405.6	21.5	230.8	168.4	161.7	21.1	43.1	427.9	371.7	251.3	625.9	222.3	358.3	326.7	154.8	69.2	230.1	129.4	337.8	234.3	136.1	89.7	136.4	271.7	188.7	176.1	247.4	223.3
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5386340	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	30.1	23.6	39.1	23.2	45.8	17.1	43.9	41.0	49.3	22.2	32.0	21.1	16.5	26.8	25.1	18.5	16.7	21.7	32.4	37.9	46.7	23.5	32.8	19.5	33.5	43.1	44.8	21.7	18.0	48.0	19.7	30.8	44.2	31.0	20.7	58.2	22.7	21.8	68.5	16.3	18.9	27.5	43.5	28.3	24.0	18.8	43.7	37.3	25.8	52.4	40.3	23.1	15.2	50.7	45.5	57.5	59.6	33.3	60.9	60.5	31.2	58.3	44.5	61.8	58.5	51.4	19.7	98.3	46.0	61.2	35.0	35.9	87.8	50.0	86.4	60.7	75.0	60.9	73.1	39.4	56.4	41.3	37.9	47.2	33.3	59.6	76.5	37.7	54.4	49.9	52.3	48.3	54.2	32.7	66.1	30.4	26.8	25.8	24.9	61.2	70.8	32.4	30.6	43.1	25.3	39.4	52.4	52.8	49.5	52.3	95.9	17.2	46.9	53.1	24.2	52.6	69.6	26.9	31.0	52.4	41.2	62.3	37.5	14.9	21.1	22.4	25.0	22.7	21.9	80.4	19.5	24.0	22.6	96.7	24.6	21.5	30.4	22.6	50.9	35.0	20.0	16.6	39.1	45.8	41.0	49.3	37.9	46.7	43.1	44.8	44.2	43.5	43.7	50.7	36.4	35.3	45.1	57.5	53.8	24.0	30.1	17.0	25.6	51.5	87.3	46.0	91.1	14.3	32.9	18.4	39.6	39.7	47.2	18.6	41.1	30.4	7.6	19.8	55.5	37.9	16.3	58.3	123.7	23.8	35.0	38.5	23.4	25.3	12.6	47.0	34.2	31.7	89.8	35.3	115.9	17.1	30.5	32.1	38.2	6.0	33.8	36.5	30.2	90.9	32.8	89.7	63.8	78.4	114.1	28.3	65.5	28.2	28.2	52.8	16.5	38.1	19.0	52.5	26.3	34.3	47.7	82.2	75.7	25.5	20.3	25.9	34.4	61.2	18.9	33.6
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	7.3	21.5	7.3	25.1	8.8	11.5	9.3	8.2	9.2	11.0	10.7	15.0	16.8	8.4	2.7	18.7	7.0	6.6	16.8	6.5	7.9	19.2	10.6	10.1	46.7	10.7	8.5	6.3	17.9	11.5	16.4	5.3	8.4	28.6	4.6	3.5	17.5	7.0	6.5	23.6	28.3	3.4	7.9	47.9	14.4	6.2	8.2	5.3	13.9	3.2	9.4	12.5	12.3	8.5	13.5	21.1	5.6	10.5	3.3	4.7	10.1	15.5	9.2	10.9	10.7	15.9	12.0	27.7	23.7	6.5	4.4	17.8	2.2	9.9	2.1	9.5	9.9	10.5	17.0	21.7	6.5	7.7	32.1	7.9	8.0	13.5	2.4	6.3	15.5	7.4	4.9	9.7	8.5	31.9	9.5	17.8	7.3	5.4	11.4	33.6	5.1	17.4	7.5	17.5	8.6	11.1	7.6	34.8	7.0	1.2	27.6	15.9	27.5	16.4	8.4	12.1	15.6	15.3	5.0	20.7	17.3	18.2	12.6	0.9	2.8	2.4	3.5	2.9	2.4	12.1	2.5	3.2	3.7	15.0	2.2	2.1	0.7	5.5	3.3	2.2	2.2	2.8	7.3	8.8	8.2	9.2	6.5	7.9	10.7	8.5	8.4	7.9	8.2	8.5	11.5	3.2	10.0	4.9	42.4	5.1	14.7	14.6	17.6	11.1	13.3	11.0	1.9	11.5	12.9	20.2	35.5	26.1	21.0	35.0	17.6	16.0	0.7	9.2	8.2	14.2	17.3	6.5	4.8	20.9	7.1	9.0	23.0	10.0	18.4	12.1	7.9	4.2	12.4	15.2	6.5	33.7	18.3	8.4	11.3	1.3	4.1	10.5	10.6	9.4	11.6	8.6	22.6	5.0	8.4	20.0	44.1	6.4	21.4	15.4	32.3	11.6	8.0	43.4	13.1	7.9	9.6	4.3	6.0	16.6	8.4	22.0	14.5	22.6	26.7	19.0
RABEPK	"bA65N13.1, RAB9P40"	ENSG00000136933	"Rab9 effector protein with kelch motifs"	Q7Z6M1	9	125200542-125234161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023920, HPA067106"	Supported		Uncertain	"Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA023920: AB_1856023, HPA067106: "	"unprognostic (8.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.69e-1)"	17.4	15.0	27.9	14.6	30.0	11.6	16.4	27.3	32.5	16.4	25.5	17.7	11.5	15.1	16.9	16.1	15.4	10.6	14.5	27.2	28.9	14.7	58.7	12.2	13.9	28.5	28.6	13.1	14.3	14.9	19.7	11.9	28.6	14.0	14.8	15.7	10.7	13.0	15.0	16.6	11.4	16.4	27.9	12.8	13.5	16.1	29.7	14.8	11.7	13.6	13.8	17.3	15.3	29.2	24.6	57.2	21.3	39.2	34.0	41.0	39.4	33.3	32.5	38.7	30.6	68.6	24.0	73.5	29.1	45.5	38.2	64.8	54.2	41.3	38.0	42.6	45.1	32.6	52.7	105.2	30.4	62.3	21.7	30.0	49.0	55.3	59.1	23.5	41.8	45.3	71.8	20.6	37.5	66.8	44.5	42.2	43.0	96.7	51.2	62.0	41.2	81.5	31.4	18.8	50.3	25.5	34.3	23.8	39.2	21.1	48.3	26.5	36.1	26.7	26.3	61.8	58.8	27.4	65.5	51.2	34.3	40.1	40.7	27.8	19.6	23.2	24.0	16.6	22.1	23.8	34.4	23.6	21.6	20.6	38.2	28.2	27.9	23.0	17.3	20.6	38.8	23.8	27.9	30.0	27.3	32.5	27.2	28.9	28.5	28.6	28.6	27.9	29.7	29.2	9.9	0.0	11.3	13.1	9.9	14.5	17.2	23.4	28.5	12.1	9.1	11.2	9.5	10.0	8.5	5.5	8.4	36.1	7.8	8.7	25.4	13.9	85.2	8.6	11.9	13.1	2.4	13.5	25.2	13.3	32.2	17.4	10.2	8.5	5.1	10.4	10.0	54.8	20.9	13.5	24.0	11.9	10.2	7.7	10.8	19.2	16.1	7.4	8.8	6.5	31.6	12.0	14.4	9.0	17.2	10.0	4.9	18.8	16.8	24.9	9.2	23.2	8.0	17.1	0.0	13.5	13.5	7.0	11.2	20.0	12.9	12.7	13.0	13.1	15.9	15.6
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.1;Oligodendrocytes: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	22.5	15.5	27.3	16.9	28.8	7.3	21.6	23.8	31.6	21.9	19.4	39.7	12.2	28.8	25.4	31.7	21.9	19.0	26.3	28.0	27.8	19.9	11.7	19.3	19.5	27.3	29.8	23.8	16.3	31.3	16.8	21.4	28.0	29.4	22.7	24.9	24.3	30.2	34.5	23.6	17.2	31.7	26.1	18.4	21.6	21.8	27.1	19.6	39.2	30.7	19.4	26.0	21.8	30.2	19.5	25.7	39.6	33.0	44.8	36.2	24.5	20.0	35.8	30.3	28.2	29.9	18.6	26.6	15.6	31.3	40.4	64.7	25.6	25.0	32.4	25.1	15.4	20.8	40.4	22.9	38.3	17.2	17.5	35.2	37.6	26.1	29.3	43.5	34.8	26.2	18.3	19.9	36.9	43.3	22.5	13.5	14.6	55.7	19.6	36.7	72.3	23.0	25.2	21.3	22.3	17.2	35.7	31.9	18.6	29.5	60.7	9.4	26.9	25.6	15.1	28.3	20.3	19.3	33.9	27.7	24.0	8.7	22.9	3.4	1.3	1.8	0.9	2.1	0.7	1.1	0.9	0.9	1.1	1.4	1.6	1.1	2.1	0.8	1.0	1.5	1.2	0.5	27.3	28.8	23.8	31.6	28.0	27.8	27.3	29.8	28.0	26.1	27.1	30.2	47.2	25.6	50.8	115.2	26.6	18.0	23.0	20.8	40.5	44.9	26.7	26.4	46.9	11.5	31.9	11.0	50.1	25.5	26.0	24.9	3.9	11.8	15.4	31.5	30.3	33.1	16.9	17.0	179.1	14.5	8.7	22.9	18.3	47.7	14.0	34.2	27.1	15.4	15.9	57.2	129.7	16.7	24.4	28.6	14.4	17.5	40.7	25.1	14.2	78.7	35.9	33.6	33.0	101.0	147.7	13.0	18.6	51.6	11.9	39.7	11.7	10.1	30.6	34.6	85.5	31.0	51.4	73.8	37.4	27.6	17.3	41.6	16.4	22.5	21.6	27.8
RABGAP1L	"FLJ38519, HHL, KIAA0471, TBC1D18"	ENSG00000152061	"RAB GTPase activating protein 1 like"	"B7ZAP0, Q5R372"	1	174159410-174995308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 551.4;Inhibitory neurons: 444.0;Microglial cells: 267.0;Oligodendrocyte precursor cells: 362.4;Oligodendrocytes: 342.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 136.9;Karpas-707: 87.6;U-698: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054695	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054695: AB_2682577"	"unprognostic (2.57e-2)"	"unprognostic (7.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (6.96e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.66e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.14e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-1)"	12.1	8.6	16.1	22.8	19.1	31.1	15.7	46.1	20.6	15.0	51.2	20.4	22.0	13.1	16.3	18.6	19.0	22.1	121.0	19.4	17.2	16.8	16.3	26.4	41.9	9.6	13.2	28.8	19.9	10.5	20.5	18.3	11.2	10.4	21.2	16.2	23.6	10.5	6.5	16.5	24.3	13.4	10.0	26.3	22.6	31.1	15.9	20.1	10.0	7.4	50.1	19.9	10.3	19.5	15.6	8.0	6.0	6.2	16.4	23.9	13.3	18.1	16.0	7.9	10.6	7.5	56.0	136.9	12.5	14.0	9.3	19.6	5.2	12.1	11.0	37.7	8.5	34.2	11.0	11.5	10.1	15.1	13.2	18.9	8.2	5.7	8.5	13.3	17.7	12.6	20.2	87.6	12.8	5.3	11.9	14.4	37.2	20.9	4.8	41.0	12.0	45.7	15.5	70.9	17.5	10.4	17.2	28.8	12.1	18.4	14.0	18.1	24.5	9.9	8.9	11.0	10.7	75.6	26.3	85.7	10.9	10.1	7.5	16.7	50.0	110.2	25.7	86.5	22.7	34.7	31.5	31.5	40.3	26.4	15.2	23.5	89.6	80.3	180.8	53.6	42.3	32.9	16.1	19.1	46.1	20.6	19.4	17.2	9.6	13.2	11.2	10.0	15.9	19.5	23.1	73.7	106.1	143.7	63.8	12.4	11.4	19.9	39.3	38.7	20.7	13.2	263.0	47.1	38.6	33.1	31.3	39.1	101.2	43.3	13.7	28.8	117.2	59.0	18.6	17.6	49.1	33.8	551.4	36.9	9.5	35.3	46.9	46.8	24.6	8.9	23.9	16.3	38.5	21.9	444.0	37.8	18.3	57.0	16.2	121.3	15.5	63.1	16.0	267.0	100.4	17.3	68.0	362.4	342.8	24.5	36.0	18.8	81.8	11.5	39.8	13.3	100.3	23.8	6.6	15.0	25.1	91.8	18.5	36.9	13.1	28.2	74.6	26.1	27.0	27.5
RABGGTA	PTAR3	ENSG00000100949	"Rab geranylgeranyltransferase subunit alpha"	Q92696	14	24265538-24271611	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 59.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043488	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA043488: AB_10794887"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.01e-1)"	11.3	14.7	6.9	7.7	7.0	10.0	11.3	7.6	9.4	14.7	6.1	12.2	11.0	9.3	10.0	59.2	12.1	9.2	16.3	7.5	8.5	13.7	14.8	13.9	9.8	8.3	7.7	10.6	17.7	16.9	15.2	7.8	8.2	12.2	8.5	3.1	20.1	8.3	19.1	19.9	13.1	6.9	7.4	17.1	16.3	11.8	7.9	9.0	11.9	12.5	12.4	10.0	19.4	8.1	10.6	13.0	6.8	10.6	8.9	17.4	31.9	15.2	12.8	21.4	19.4	12.2	17.4	13.1	11.8	16.3	9.5	20.4	7.0	33.2	9.2	20.8	14.4	8.6	11.0	45.9	17.9	18.8	36.3	19.9	35.9	11.4	13.5	11.6	19.7	16.4	9.0	16.1	16.3	41.0	12.5	10.1	2.3	14.0	19.2	9.3	6.2	14.5	20.5	15.6	16.9	9.7	10.5	29.9	12.8	9.4	12.5	13.7	14.5	11.2	7.8	6.1	10.5	17.2	13.9	8.7	9.5	11.5	17.6	11.9	25.7	17.1	16.0	46.8	13.3	16.3	15.3	12.4	32.0	10.4	12.8	10.0	7.3	16.9	33.1	5.4	18.1	18.4	6.9	7.0	7.6	9.4	7.5	8.5	8.3	7.7	8.2	7.4	7.9	8.1	9.3	9.6	11.6	4.6	18.0	17.7	19.6	61.6	35.9	7.7	13.8	14.0	12.4	15.7	28.1	5.5	6.2	38.0	14.4	25.0	15.6	23.4	3.3	9.7	5.8	9.3	13.1	7.8	5.1	27.1	31.1	10.1	23.4	11.9	36.2	8.3	9.7	7.1	26.5	11.8	4.3	14.5	26.4	17.9	10.4	7.7	9.0	18.3	16.0	3.7	18.8	9.0	12.3	4.0	3.7	39.3	23.7	7.2	20.3	15.4	27.7	20.4	15.5	5.3	6.6	5.8	12.0	3.3	34.2	36.9	12.4	57.3	16.8	10.3	18.0	20.9
RABGGTB		ENSG00000137955	"Rab geranylgeranyltransferase subunit beta"	P53611	1	75786197-75795086	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026585, HPA027167, HPA030793"	Approved	Supported	Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: "	"unprognostic (4.83e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (9.80e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.05e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.89e-1)"	37.5	56.5	41.0	20.3	44.9	18.3	41.4	44.7	52.8	31.4	40.4	33.9	33.3	24.6	23.6	35.2	28.1	21.4	49.6	40.0	44.8	75.9	67.2	29.0	26.9	44.8	43.6	38.1	67.7	37.5	25.1	31.5	44.8	27.5	29.3	41.2	32.0	23.0	79.7	21.7	24.9	23.0	47.1	29.1	33.9	15.3	43.6	30.6	30.5	84.0	31.3	37.3	30.4	47.9	74.8	40.2	68.6	31.4	85.2	108.8	43.8	99.5	68.2	91.6	70.4	97.3	17.6	68.2	101.3	55.7	146.0	46.0	178.3	77.7	133.8	67.1	48.3	58.0	66.5	158.0	106.6	74.8	32.9	67.5	165.1	84.3	95.4	125.6	75.8	59.7	96.9	65.7	109.9	30.8	61.5	81.4	64.5	53.3	78.0	49.2	114.5	29.9	69.9	41.7	43.5	39.1	24.1	123.6	231.0	58.8	26.1	69.8	77.5	59.6	67.0	142.1	199.5	41.9	127.1	46.4	67.5	60.3	27.0	8.4	7.2	4.7	7.7	11.3	9.3	9.5	7.7	7.2	12.3	5.9	9.4	9.3	1.1	6.3	8.1	11.3	7.7	4.0	41.0	44.9	44.7	52.8	40.0	44.8	44.8	43.6	44.8	47.1	43.6	47.9	35.3	35.3	44.3	12.7	83.3	127.7	59.4	132.6	66.0	22.6	58.5	45.6	71.1	72.9	86.0	27.6	20.9	45.9	65.7	38.6	103.7	44.9	1.6	36.1	42.5	45.8	89.8	41.6	17.1	51.8	60.3	48.6	57.6	40.4	70.5	26.5	41.7	68.6	61.2	32.0	17.8	62.2	75.3	61.3	91.4	4.4	32.3	54.8	58.7	9.4	52.0	36.5	32.0	14.6	21.9	44.1	46.0	33.4	78.8	84.8	58.4	206.5	45.8	22.3	6.6	40.1	59.8	20.1	14.0	73.6	142.9	53.5	60.2	37.5	69.6	88.7
RABIF	"mss4, RASGRF3"	ENSG00000183155	"RAB interacting factor"	P47224	1	202878282-202889149	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 3764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027715	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA027715: AB_10602151"	"unprognostic (4.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.62e-3)"	"prognostic favorable (5.64e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.23e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.47e-1)"	4.0	3.9	6.3	5.7	6.6	8.4	3.9	5.8	8.4	4.1	4.2	5.5	5.6	3.4	3.9	8.9	3.0	4.1	4.5	7.0	6.5	5.6	5.3	4.7	6.7	6.2	6.3	2.0	3.3	3.2	3.9	4.9	6.3	4.2	6.0	6.8	4.8	3.2	4.8	5.5	5.3	4.7	5.9	6.2	3.8	18.0	6.3	5.7	3.1	4.3	8.6	5.1	4.8	6.6	11.7	12.2	8.8	10.6	13.4	9.9	9.5	12.9	7.1	12.8	11.8	8.9	9.9	9.6	6.0	10.0	8.8	10.9	6.9	8.0	9.7	11.8	12.7	7.9	9.8	9.1	10.8	11.1	13.4	8.5	11.2	16.0	4.1	6.3	16.9	12.4	12.7	10.3	12.5	19.5	12.5	12.0	7.2	9.1	15.1	8.7	12.3	13.2	13.2	12.2	12.3	11.0	11.0	19.1	10.4	10.6	12.6	8.1	13.3	8.9	8.2	4.3	11.2	5.4	13.0	10.1	8.8	10.3	8.5	32.4	21.1	31.6	18.4	23.2	13.5	17.8	17.3	17.4	19.0	17.8	15.6	16.5	33.3	17.9	22.0	18.1	21.1	18.3	6.3	6.6	5.8	8.4	7.0	6.5	6.2	6.3	6.3	5.9	6.3	6.6	11.8	0.0	15.9	4.6	26.2	54.3	37.8	53.3	17.6	5.4	18.9	12.3	11.2	17.2	33.8	12.9	2.1	52.5	39.1	42.4	15.6	37.3	696.1	17.9	8.5	20.6	23.4	21.2	9.0	53.4	50.5	16.6	13.7	14.5	12.7	8.0	20.3	34.9	42.1	1.7	7.0	14.7	40.7	37.4	36.0	3764.0	28.3	29.1	53.4	5.6	48.4	18.2	62.8	5.5	7.3	77.5	40.9	30.1	27.1	28.2	34.3	59.1	32.0	6.0	13.1	9.5	21.7	98.0	62.7	23.4	51.9	78.9	35.0	10.8	14.6	49.2
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.8"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.6"									"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.5	1.2	2.7	1.3	2.9	0.9	2.8	2.3	3.4	3.8	4.6	3.3	1.3	4.4	3.6	1.5	19.8	1.6	2.4	3.0	2.5	2.0	1.9	2.7	1.0	2.6	4.8	5.0	1.5	1.3	2.9	0.8	3.2	2.7	1.0	6.6	2.1	2.0	1.3	2.5	1.8	2.1	3.3	1.7	1.9	5.3	2.9	3.0	3.5	1.4	1.9	2.6	2.8	2.7	2.1	3.7	5.0	4.0	4.1	5.8	3.7	2.0	1.6	2.9	2.0	3.3	1.4	3.1	8.5	0.7	2.0	2.3	2.5	0.3	1.9	4.1	4.7	1.6	0.1	0.4	3.3	0.6	1.1	2.1	4.3	0.5	1.2	4.2	2.1	4.6	1.5	0.8	1.7	1.8	10.6	0.7	2.8	1.9	1.3	2.0	1.9	1.3	2.1	0.5	2.0	7.0	1.9	2.2	1.9	1.5	0.4	3.0	0.5	0.4	0.6	0.7	1.4	2.9	3.4	0.8	5.8	2.3	1.0	0.0	4.3	2.4	6.2	7.1	6.9	8.9	9.0	6.5	7.1	8.2	7.5	5.7	0.5	12.8	7.1	9.1	4.9	5.4	2.7	2.9	2.3	3.4	3.0	2.5	2.6	4.8	3.2	3.3	2.9	2.7	4.2	9.6	8.1	13.4	6.4	4.5	5.6	8.1	5.2	7.6	6.4	8.0	9.5	2.8	12.1	7.3	10.4	3.4	6.3	4.9	13.7	7.6	16.3	36.9	5.6	3.4	7.2	3.0	30.2	3.1	2.9	6.8	5.6	2.8	11.4	9.9	5.3	4.4	3.6	16.8	20.5	4.3	4.1	3.2	3.5	14.5	8.1	3.1	7.2	3.7	5.7	7.3	9.2	7.1	19.4	3.6	3.2	7.2	0.8	2.9	7.2	6.8	123.2	16.8	0.0	5.9	8.1	22.3	9.6	3.6	4.8	2.5	6.0	4.4	4.1	3.6
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783662	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	13.2	12.9	18.1	18.6	18.8	14.4	15.8	18.1	22.4	23.9	73.6	16.5	12.5	21.7	90.3	13.3	66.6	14.5	10.2	23.3	17.0	17.7	12.2	21.8	23.1	23.3	33.2	22.5	16.3	14.6	26.7	11.6	17.9	16.2	16.7	30.2	16.8	16.9	8.8	22.2	15.6	15.6	21.9	19.3	14.5	23.1	20.1	21.6	28.2	4.6	20.3	17.0	15.7	18.5	23.0	20.4	34.1	26.7	37.3	29.6	25.0	16.7	18.5	13.2	18.1	5.8	19.7	14.7	14.7	24.1	21.6	29.5	15.8	19.6	14.2	13.3	23.2	12.8	40.2	15.1	15.4	36.1	13.0	25.3	26.2	17.5	21.9	39.2	15.0	26.0	9.9	17.9	26.7	28.8	18.2	15.9	13.2	14.0	15.0	30.1	19.8	16.1	25.9	22.4	14.6	26.5	20.5	17.8	13.4	23.4	17.7	11.2	23.2	12.6	25.1	10.9	11.4	15.2	7.4	7.2	23.8	8.8	18.1	1.8	14.4	13.1	21.4	23.5	15.5	15.2	16.4	17.3	15.7	19.2	18.7	18.3	5.4	15.9	28.4	18.0	18.6	14.7	18.1	18.8	18.1	22.4	23.3	17.0	23.3	33.2	17.9	21.9	20.1	18.5	6.2	12.8	13.4	14.4	16.8	5.4	13.4	13.3	15.9	15.2	13.3	11.8	5.1	12.8	24.1	22.0	31.3	12.1	16.2	10.6	13.7	21.3	25.7	99.4	11.2	7.2	5.4	9.9	25.7	10.8	11.1	11.4	9.7	8.6	3.8	22.1	5.3	8.9	12.0	16.8	18.9	8.0	22.4	10.1	6.9	24.2	14.0	8.4	17.8	4.7	14.4	13.9	36.0	7.1	15.1	10.4	4.9	10.9	8.0	7.3	8.6	16.3	188.6	40.0	6.6	15.0	14.8	38.8	27.0	8.8	5.7	6.7	16.0	11.9	10.7	6.5
RABL3	MGC23920	ENSG00000144840	"RAB, member of RAS oncogene family like 3"	Q5HYI8	3	120684938-120742993	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035150, HPA035151, HPA069861"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA035150: AB_2674493, HPA035151: AB_10601154, HPA069861: "	"unprognostic (1.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.78e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (2.33e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.65e-1)"	10.8	16.1	2.3	5.6	2.5	5.3	8.8	2.6	4.1	7.0	2.6	8.1	5.5	7.0	2.7	7.9	5.9	5.7	7.3	2.1	3.1	9.8	9.7	5.6	5.9	3.0	2.8	9.2	6.4	11.8	6.3	6.9	2.9	6.9	8.6	5.8	6.9	6.5	13.8	6.3	6.0	6.2	2.7	5.6	7.1	4.2	2.4	6.4	12.3	11.9	7.3	7.3	7.9	3.7	20.6	17.8	12.6	3.9	11.7	17.0	11.4	18.8	13.8	10.0	8.3	12.6	6.5	17.3	8.5	15.4	17.6	7.1	14.0	9.2	18.3	14.8	5.9	16.0	12.9	15.7	8.1	31.2	9.1	8.4	11.2	8.9	10.7	11.6	15.1	9.4	14.2	9.7	12.8	20.8	18.2	3.0	6.4	19.9	8.6	7.7	17.4	6.6	9.6	10.0	5.8	4.5	9.2	5.5	5.4	4.8	10.5	9.8	22.1	6.5	7.5	4.8	17.1	5.4	7.9	13.6	16.7	25.4	8.4	3.7	3.6	2.6	4.6	5.6	3.6	3.2	4.5	5.1	6.5	2.6	3.8	4.4	3.7	5.6	3.1	3.4	5.3	3.4	2.3	2.5	2.6	4.1	2.1	3.1	3.0	2.8	2.9	2.7	2.4	3.7	17.6	9.6	11.7	14.7	11.6	6.4	17.2	17.3	11.4	39.8	13.7	10.0	14.3	12.8	16.7	9.2	116.7	13.3	7.7	13.1	7.9	15.2	25.5	22.3	11.9	12.8	5.4	10.7	11.7	16.2	18.0	13.8	9.7	14.2	8.2	10.4	8.2	18.1	14.7	8.4	10.2	12.7	16.2	10.6	7.2	9.8	5.9	12.0	10.6	2.8	11.4	19.2	9.2	7.5	17.1	14.6	15.8	6.0	11.3	12.2	9.6	26.4	15.7	20.0	0.0	16.5	10.4	26.9	8.5	10.5	11.1	22.0	10.0	16.6	12.1	15.4
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	37.5	45.5	49.9	29.8	67.2	51.9	35.9	43.7	69.2	33.5	30.2	59.9	39.8	38.5	10.7	57.4	36.4	15.3	86.3	47.6	35.6	55.3	24.3	41.7	26.9	47.8	41.0	39.5	101.5	22.7	69.9	21.0	41.8	67.4	21.2	15.3	42.8	20.1	154.5	45.7	51.6	16.2	35.6	50.3	61.7	50.0	47.2	28.2	42.1	60.9	18.2	43.7	35.0	45.9	75.2	97.9	68.4	80.3	27.5	30.7	178.5	65.8	42.2	63.1	45.9	109.7	77.2	104.7	40.5	52.0	66.4	159.9	76.8	58.6	21.5	110.1	97.5	64.5	127.2	129.9	49.4	120.6	79.4	34.2	59.6	39.0	42.8	38.3	66.4	88.8	142.0	50.0	43.9	149.5	130.2	82.9	128.0	91.3	82.4	167.4	81.6	103.1	41.5	65.7	223.5	92.5	117.2	135.6	83.5	36.1	116.8	120.1	81.1	80.9	69.8	86.5	109.1	42.3	51.8	85.5	68.2	57.8	77.5	0.5	1.8	1.2	1.4	2.4	1.5	2.2	1.5	1.4	1.3	2.0	1.2	1.5	0.9	2.3	0.8	1.7	2.3	0.6	49.9	67.2	43.7	69.2	47.6	35.6	47.8	41.0	41.8	35.6	47.2	45.9	36.2	28.9	41.2	24.5	25.5	18.0	17.7	12.6	38.7	39.5	38.7	33.4	35.3	0.0	13.8	25.8	20.9	25.2	35.3	172.7	31.3	34.9	13.4	42.6	40.6	25.7	52.0	25.6	37.7	58.2	33.2	28.1	43.3	43.8	15.2	85.2	0.0	0.0	31.0	38.7	34.3	78.5	20.3	0.0	26.5	18.5	19.6	37.0	40.9	8.4	27.5	22.2	24.7	18.1	26.9	62.5	80.9	26.7	67.7	36.6	59.4	55.8	18.3	38.3	0.0	19.0	33.3	18.1	28.0	55.3	19.5	28.3	29.6	41.0	94.9	26.5
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	24.7	8.4	3.6	207.2	3.8	411.9	11.4	3.9	8.0	12.2	4.4	34.8	35.3	10.1	4.7	15.9	11.7	37.1	6.5	3.8	4.7	10.9	19.3	63.4	387.9	6.5	5.3	5.5	5.3	2.1	3.4	12.4	7.1	10.9	33.9	0.4	21.5	8.3	4.9	7.6	96.9	19.6	5.2	299.9	42.7	3.5	6.1	323.9	9.5	7.2	309.1	54.0	9.9	7.2	136.6	0.2	0.0	0.0	14.3	130.5	0.6	17.9	41.1	14.2	28.8	0.3	44.8	167.4	19.8	52.9	0.8	33.3	1.0	231.6	15.6	522.5	0.6	209.6	3.6	0.6	35.8	734.5	1427.9	96.4	32.3	25.1	84.3	0.9	239.7	159.1	50.5	684.5	1.9	0.2	218.9	291.2	2.8	13.1	87.2	72.3	0.7	193.8	22.6	0.1	2.0	0.6	0.9	23.0	2.7	0.8	9.7	391.8	258.7	0.6	23.5	1.0	2.0	307.0	171.4	176.6	618.6	316.5	35.1	1319.9	519.8	1602.2	972.1	695.5	731.5	761.7	768.6	858.9	494.0	672.8	584.3	759.8	1336.4	972.2	879.5	728.7	1163.4	1566.2	3.6	3.8	3.9	8.0	3.8	4.7	6.5	5.3	7.1	5.2	6.1	7.2	4.4	16.0	47.7	0.0	329.0	5.4	2.2	26.0	16.5	0.0	8.6	9.5	1.1	2.8	12.6	1.8	0.0	0.8	381.4	3.4	0.0	13.6	0.2	1.1	0.8	5.6	4.2	109.7	0.4	2.2	1.5	9.2	33.6	1.0	520.5	0.3	13.6	3.4	150.8	0.0	0.1	6.3	0.0	129.9	63.9	0.9	0.3	147.9	30.2	3.7	125.9	0.0	717.9	0.5	0.0	18.2	18.1	0.0	287.8	0.5	0.6	1.5	4.4	0.0	13.1	2.4	4.5	0.0	1.0	5.1	4.0	2.9	419.6	3.7	11.2	3.6
RAC3		ENSG00000169750	"Rac family small GTPase 3"	P60763	17	82031678-82034204	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 45.0;Extravillous trophoblasts: 152.1;Spermatogonia: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 230.8;HEK 293: 274.7;NB-4: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047820	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA047820: AB_2680167"	"unprognostic (3.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (6.21e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.25e-3)"	12.3	5.0	22.8	1.8	20.8	7.7	13.7	26.3	29.5	5.3	9.3	4.8	3.4	2.8	7.3	10.9	3.8	3.0	3.0	19.7	24.5	9.4	20.7	4.0	1.7	23.3	22.3	4.8	4.7	9.3	22.8	5.6	27.0	11.1	1.4	2.8	18.1	4.2	0.8	12.4	3.7	1.3	15.3	1.9	11.8	28.1	26.5	2.2	9.8	0.2	1.5	3.1	7.6	20.6	11.1	15.1	45.6	63.1	9.7	18.2	50.5	7.8	7.2	26.1	22.3	230.8	21.4	5.8	11.5	4.8	1.7	15.6	43.0	17.8	4.1	3.6	274.7	64.6	20.2	16.7	47.0	28.0	12.2	27.5	13.0	3.5	12.0	19.5	60.3	33.8	103.1	30.2	10.8	35.6	7.3	156.4	61.4	39.2	27.6	47.6	4.5	27.7	20.0	5.4	109.8	111.5	4.1	57.2	55.7	16.1	58.6	40.7	21.6	10.8	9.8	5.5	12.1	14.6	9.9	4.4	6.6	17.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	22.8	20.8	26.3	29.5	19.7	24.5	23.3	22.3	27.0	15.3	26.5	20.6	1.6	0.0	0.0	2.3	0.9	8.7	16.3	12.2	19.9	5.3	36.9	45.0	0.2	4.3	3.6	5.5	0.0	30.0	1.8	3.3	21.5	9.8	19.1	5.9	5.4	2.3	3.0	6.9	5.2	3.3	152.1	10.7	8.2	12.6	4.5	17.8	1.4	11.3	9.7	6.7	8.3	5.1	22.4	0.0	2.6	16.6	5.6	0.9	14.2	0.0	2.0	6.0	0.0	3.5	2.0	5.5	2.4	1.9	2.6	16.4	4.2	26.0	2.4	7.3	0.0	0.8	5.3	2.2	58.0	15.8	7.5	14.1	3.1	8.6	5.2	8.4
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.6;Spermatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favorable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	9.6	11.5	6.3	8.5	6.8	8.0	11.7	7.3	8.8	9.7	7.2	10.8	4.8	10.1	8.1	9.5	9.1	5.4	12.5	7.1	7.9	16.1	13.4	8.2	19.4	6.8	7.3	10.3	16.5	12.9	16.2	8.2	6.9	9.6	9.3	16.5	10.7	8.5	13.3	9.9	11.7	5.6	6.5	13.3	11.8	41.2	7.2	14.8	11.1	8.3	13.0	9.5	8.9	7.9	16.2	7.0	21.7	25.7	0.0	0.2	26.5	15.7	19.8	21.0	29.5	16.9	17.3	70.7	16.6	9.1	41.9	7.4	21.8	9.1	32.3	0.0	11.8	17.3	17.0	16.9	25.3	0.5	21.7	15.1	14.9	15.6	15.2	0.0	18.4	18.3	16.9	21.0	26.7	0.0	32.2	11.8	13.4	6.7	8.8	27.7	19.8	15.9	25.1	14.5	22.7	15.8	14.4	4.5	0.6	22.8	21.2	21.1	5.6	0.0	19.1	9.8	10.3	26.9	44.6	24.4	21.3	33.7	14.2	1.4	2.3	4.0	4.3	2.9	4.2	7.5	3.9	4.6	3.4	5.5	5.4	4.7	0.9	6.5	1.4	1.7	5.8	2.5	6.3	6.8	7.3	8.8	7.1	7.9	6.8	7.3	6.9	6.5	7.2	7.9	17.5	32.1	17.9	20.2	20.2	5.5	6.5	10.3	12.0	17.9	13.6	15.1	33.5	8.6	19.9	5.5	20.9	18.0	20.5	9.5	25.4	12.8	121.6	19.4	23.7	13.9	15.1	24.4	16.5	12.9	17.3	11.5	12.8	16.0	30.9	20.2	10.8	12.6	10.1	6.7	17.8	11.1	14.2	10.4	4.3	72.3	14.3	11.9	5.4	11.2	15.6	20.8	16.5	23.1	28.1	12.2	7.5	10.9	31.7	9.3	11.1	24.3	29.3	45.4	6.6	20.1	16.5	172.7	70.1	12.5	5.8	14.1	17.2	16.7	10.8	6.4
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845934-116874776	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 424.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065, HPA073277"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB022065: , HPA020044: AB_1856035, HPA073277: "	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	75.4	80.5	62.9	74.0	74.5	206.0	71.9	74.7	75.7	50.5	56.7	73.1	57.3	67.6	54.6	71.2	50.6	49.4	89.8	58.1	74.3	68.2	64.7	67.9	122.8	70.0	69.3	67.8	41.9	82.3	33.8	90.1	75.2	57.5	82.5	114.2	56.9	65.0	76.6	54.0	60.4	60.2	71.9	75.5	56.4	88.7	67.2	177.2	80.9	95.5	119.5	59.7	44.5	97.1	301.6	143.9	277.3	156.7	136.5	117.0	124.2	202.1	191.4	220.8	202.4	119.8	275.2	438.6	109.4	146.0	117.4	162.4	238.5	132.1	257.6	589.1	153.1	447.6	167.2	153.7	85.5	145.7	253.1	100.2	106.0	129.4	156.0	146.1	176.4	625.8	183.6	595.6	193.1	181.1	665.4	86.2	163.6	385.4	179.2	241.8	201.5	223.4	133.5	173.3	348.2	179.1	212.2	569.4	140.6	144.5	238.3	178.5	128.5	154.6	223.5	164.4	217.1	313.3	383.9	391.9	132.8	206.7	189.7	35.3	7.9	28.0	17.4	8.7	17.5	14.4	20.3	20.6	9.0	12.8	20.8	20.6	29.7	14.3	12.7	7.6	43.7	11.4	62.9	74.5	74.7	75.7	58.1	74.3	70.0	69.3	75.2	71.9	67.2	97.1	115.7	256.4	157.1	24.5	111.2	95.6	77.5	62.5	78.0	75.4	65.8	53.0	155.2	51.5	101.0	55.2	31.3	142.4	118.1	90.4	43.0	54.0	258.0	67.0	86.7	97.0	84.4	249.8	39.3	44.9	157.0	89.4	57.1	88.2	153.5	112.9	75.0	72.1	67.9	67.3	48.1	72.7	69.2	93.1	100.0	424.9	116.5	93.4	69.4	45.9	110.8	112.5	77.2	41.2	58.3	63.5	66.3	106.5	124.0	100.0	35.7	59.4	70.5	67.9	72.3	88.6	85.3	33.2	88.6	103.7	100.4	113.7	134.1	85.5	94.1	95.5
RAD21L1	"dJ545L17.2, RAD21L"	ENSG00000244588	"RAD21 cohesin complex component like 1"	Q9H4I0	20	1226056-1296421	"Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 11.5"	"Group enriched"	"Detected in some"	14	"Early spermatids: 110.9;Late spermatids: 109.4;Spermatocytes: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;TIME: 1.5"	"Low region specificity"	"Detected in some"							HPA053282	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"			"HPA053282: AB_2682099"	"unprognostic (2.90e-1)"				"unprognostic (3.35e-1)"			"unprognostic (1.62e-4)"		"unprognostic (2.04e-1)"			"unprognostic (8.87e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	1.5	0.8	0.3	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	110.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	109.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.4	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 984.0;tongue: 447.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 901.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	79.2	63.4	77.8	49.4	79.8	85.8	71.0	78.1	95.7	59.2	71.0	91.6	48.4	65.0	31.2	70.0	64.1	38.2	132.4	80.5	79.8	54.1	70.4	66.4	55.9	80.5	76.7	56.2	76.7	66.1	47.7	55.5	80.1	57.5	35.8	24.5	68.0	52.5	984.0	72.6	52.8	54.8	77.0	54.5	66.4	48.7	79.4	53.0	54.9	447.9	44.0	78.5	57.1	82.0	138.0	52.6	55.7	57.4	91.5	104.1	94.7	66.1	130.2	152.6	137.2	59.8	95.3	117.3	150.0	99.4	104.4	102.7	78.0	137.7	55.9	170.0	109.8	47.2	57.3	58.3	181.7	102.1	130.7	107.9	199.6	110.1	208.9	89.7	105.4	188.0	124.1	102.1	138.2	139.8	126.6	124.2	76.5	124.6	135.6	65.4	59.4	189.6	118.9	53.8	104.3	81.8	75.4	129.1	145.8	40.2	100.4	173.7	82.5	214.9	57.4	263.3	203.9	148.2	133.8	86.0	177.9	193.3	183.2	31.3	76.3	64.9	81.1	102.4	87.3	77.5	66.8	69.1	68.3	73.5	63.3	73.4	9.2	79.1	105.3	86.0	82.0	69.1	77.8	79.8	78.1	95.7	80.5	79.8	80.5	76.7	80.1	77.0	79.4	82.0	120.2	86.6	56.2	11.8	127.6	120.4	176.8	165.2	122.3	51.7	110.3	121.3	59.5	108.7	108.4	55.2	20.9	212.0	99.6	95.7	166.3	179.5	193.1	74.3	76.9	120.4	87.3	901.4	22.0	191.0	240.1	101.4	101.9	74.1	111.5	77.7	86.4	96.2	175.3	52.2	22.9	138.5	136.3	88.3	170.3	44.1	118.4	119.6	142.3	12.2	182.5	73.9	94.7	15.6	25.8	184.1	119.0	114.0	159.0	351.3	139.9	163.3	91.1	56.1	111.7	138.3	129.3	263.6	179.6	153.3	146.5	244.8	113.0	117.8	154.8	211.1
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646349	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: AB_2681786"	"unprognostic (3.46e-3)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	6.3	8.0	5.8	2.8	6.9	5.9	6.6	7.6	8.6	6.9	4.0	8.7	2.5	8.1	10.3	7.6	7.3	3.5	7.1	6.8	4.9	6.1	6.2	5.0	2.5	5.0	4.4	9.2	9.2	8.8	8.1	3.6	5.7	6.2	4.6	8.5	7.1	4.2	11.3	10.4	8.0	3.8	3.4	5.4	8.6	5.5	5.4	4.0	6.0	4.7	3.5	7.9	6.9	8.6	9.1	22.8	2.1	12.1	13.3	20.0	9.8	6.3	11.2	11.0	12.8	20.4	14.8	20.6	3.7	10.3	19.7	8.8	17.6	14.2	16.5	11.7	13.4	9.5	13.3	12.5	10.8	10.2	7.6	10.8	24.1	13.4	36.7	7.2	5.4	6.5	17.9	3.2	10.1	8.6	7.7	13.9	11.7	9.0	6.8	7.2	3.7	10.1	8.8	16.9	11.5	14.9	11.7	4.7	2.8	5.6	11.5	7.0	9.5	4.7	5.5	14.5	8.3	5.7	7.7	24.2	8.4	12.5	6.7	7.0	3.3	1.1	4.1	3.8	5.6	7.0	5.4	5.4	3.6	5.8	4.9	4.5	0.3	9.3	4.8	2.5	4.0	2.7	5.8	6.9	7.6	8.6	6.8	4.9	5.0	4.4	5.7	3.4	5.4	8.6	3.5	38.5	27.1	65.6	34.6	26.0	37.3	33.7	31.9	56.8	6.6	4.8	130.0	44.3	31.6	7.3	89.6	69.6	22.9	31.0	1.9	6.3	26.4	8.2	15.8	16.6	37.1	38.5	65.9	6.0	49.2	37.6	37.2	7.6	30.4	8.5	22.1	38.5	37.4	37.0	79.7	44.1	18.3	27.2	12.2	12.6	60.6	16.5	16.0	49.6	22.4	38.0	48.4	65.9	92.4	4.8	35.6	53.4	33.0	32.1	53.7	4.4	40.8	60.8	32.9	50.9	39.9	108.4	87.2	39.2	26.7	33.1	25.2	11.5	52.3	25.1
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7;testis: 24.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.5	0.5	10.5	1.9	1.7	0.7	1.0	0.6	8.3	3.2	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.5	0.5	1.3	1.1	11.0	0.4	0.3	0.6	1.4	0.5	0.2	6.8	0.5	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.1	2.4	1.8	24.3	0.3	15.7	0.6	0.5	13.3	1.7	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.7	0.7	0.4	0.5	0.4	0.3	0.5	0.1	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RAD51B	"hREC2, R51H2, RAD51L1, REC2"	ENSG00000182185	"RAD51 paralog B"	O15315	14	67819779-68730218	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016191, HPA051869"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"CAB016191: AB_2238209, HPA051869: AB_2681644"	"unprognostic (9.10e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.13e-3)"	3.1	2.3	3.0	2.9	5.7	7.3	5.5	3.8	3.3	5.8	5.8	3.0	1.1	4.4	9.0	3.7	3.9	4.3	1.7	3.4	3.7	2.7	2.1	2.7	4.8	5.7	4.7	6.3	2.1	4.9	2.0	4.1	5.7	2.5	2.6	3.0	13.1	2.3	1.2	4.2	2.4	4.4	4.3	2.6	2.6	1.8	5.0	5.9	2.5	1.2	4.3	3.6	4.5	7.3	15.3	5.9	6.5	3.9	5.9	10.0	4.0	7.6	5.8	8.2	10.5	4.2	20.1	18.6	4.8	4.7	9.4	13.4	4.1	12.1	11.1	8.4	4.2	8.9	5.4	3.3	3.2	7.6	8.6	5.1	9.0	9.4	9.9	3.8	7.4	13.5	7.3	8.4	6.7	11.9	14.9	2.7	3.8	14.6	5.9	16.6	7.7	6.8	6.3	4.3	4.4	2.9	6.0	2.2	13.1	7.6	10.1	6.8	2.0	9.9	9.6	7.8	6.3	4.0	4.4	14.9	5.5	13.1	5.7	17.4	5.7	5.7	8.1	4.8	6.6	14.2	7.6	8.6	6.5	11.8	9.4	8.9	0.7	8.5	4.7	6.4	9.4	4.5	3.0	5.7	3.8	3.3	3.4	3.7	5.7	4.7	5.7	4.3	5.0	7.3	5.1	0.0	1.1	150.8	13.3	6.6	5.1	6.4	5.7	1.8	8.4	5.1	1.6	0.0	4.0	1.8	8.4	5.4	3.5	1.1	3.9	1.9	3.0	5.3	3.7	4.5	4.8	4.6	21.5	1.4	6.7	4.2	3.1	3.6	4.5	6.8	1.8	0.8	6.5	1.7	22.0	3.8	2.0	3.4	3.5	1.9	3.7	4.2	8.8	263.3	6.8	5.8	3.1	157.3	375.2	1.0	0.6	4.5	8.9	2.4	2.7	1.8	8.4	6.0	0.0	3.6	7.0	6.2	3.2	5.6	7.0	4.0	7.0	4.4	1.8	4.6
RAD54B	RDH54	ENSG00000197275	"RAD54 homolog B"	Q9Y620	8	94371960-94475115	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 7.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.0;Cone photoreceptor cells: 27.1;Excitatory neurons: 45.8;Inhibitory neurons: 19.0;Oligodendrocyte precursor cells: 39.7;Oligodendrocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.0;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA007087	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007087: AB_1856040"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.31e-2)"	"unprognostic (8.84e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.56e-8)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.04e-12)"	"unprognostic (5.86e-2)"	"unprognostic (5.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.68e-5)"	0.6	0.7	1.3	1.7	2.0	2.0	1.9	2.1	2.1	2.4	1.7	1.5	1.4	1.1	2.1	1.4	5.0	0.7	0.6	1.2	1.6	0.8	1.4	0.7	2.7	1.6	1.9	1.0	0.8	0.7	1.2	1.4	1.6	1.6	2.1	7.0	0.8	2.0	0.3	1.8	1.2	1.1	1.3	0.9	1.5	3.6	1.7	4.2	1.1	0.3	3.0	1.2	0.9	1.6	20.5	15.7	20.9	11.2	1.6	2.5	11.0	16.2	8.9	22.7	23.1	8.1	14.8	14.5	25.3	4.3	11.7	12.7	18.7	7.7	24.6	17.5	11.9	23.2	8.1	7.7	1.5	8.4	8.5	0.8	1.8	11.7	14.9	4.5	8.3	14.7	16.6	8.9	24.6	10.6	28.5	5.7	13.5	23.4	14.4	7.1	21.3	8.7	8.9	9.8	12.0	8.0	11.6	2.8	9.7	17.9	14.9	6.1	5.8	14.8	7.6	16.7	18.1	4.5	12.2	7.8	7.7	15.9	15.4	0.0	0.0	0.0	0.5	0.0	1.9	0.7	0.9	0.4	0.0	1.0	0.8	1.1	0.0	0.1	0.1	0.0	0.6	0.3	1.3	2.0	2.1	2.1	1.2	1.6	1.6	1.9	1.6	1.3	1.7	1.6	0.5	0.0	0.5	29.0	1.7	0.4	0.9	1.7	1.2	9.1	1.1	1.1	1.8	1.5	0.6	3.7	27.1	2.0	0.5	0.7	1.9	0.8	0.3	11.5	1.6	1.3	1.2	3.8	45.8	0.8	3.2	1.3	3.1	5.6	0.0	3.3	3.3	2.0	1.5	0.0	19.0	1.1	0.0	0.6	0.6	0.4	3.4	0.9	0.0	9.4	0.6	4.4	1.0	39.7	25.9	0.7	0.4	2.2	3.9	0.4	0.2	1.4	3.3	17.5	0.0	1.0	1.7	9.4	13.1	3.7	0.6	0.3	2.6	3.0	2.3	0.7
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.6	4.8	5.6	3.7	6.1	6.1	4.6	6.5	5.6	4.8	2.9	5.8	2.5	5.6	4.2	4.0	4.6	2.7	4.4	5.0	5.2	4.0	7.8	4.9	4.2	5.5	5.7	5.3	5.3	3.8	4.5	4.8	5.5	4.4	3.4	7.5	4.5	3.9	7.1	5.5	5.0	4.1	5.3	5.2	5.2	5.0	6.3	6.2	4.6	5.3	5.2	4.8	4.3	6.2	6.6	5.1	12.8	12.7	7.0	5.0	6.7	5.5	7.8	7.4	6.9	9.1	3.8	17.4	1.5	9.7	7.8	5.0	20.5	6.8	9.1	9.2	4.6	14.9	11.5	6.0	6.4	16.8	8.5	5.8	5.4	11.3	10.9	4.6	8.3	14.8	10.3	9.1	5.9	5.1	15.0	7.6	10.2	3.2	5.5	6.9	9.9	2.3	3.8	8.4	5.2	10.0	8.7	8.2	5.7	7.7	5.4	9.9	10.9	7.7	8.9	8.0	10.8	9.8	10.7	16.8	8.3	9.2	10.0	3.1	2.2	2.2	3.3	2.6	3.5	1.8	2.9	2.8	2.3	2.9	1.9	2.3	0.9	3.0	3.5	2.3	2.9	2.2	5.6	6.1	6.5	5.6	5.0	5.2	5.5	5.7	5.5	5.3	6.3	6.2	10.8	9.6	14.4	31.3	11.3	9.2	8.6	6.7	3.4	33.8	8.7	8.0	11.0	15.7	7.8	9.2	31.3	19.3	12.2	7.7	1.9	9.3	7.5	9.5	12.0	15.1	16.3	3.8	54.9	10.4	8.7	9.6	9.2	19.8	18.3	14.2	10.4	21.9	8.9	47.1	54.3	8.1	4.1	9.1	8.4	3.1	15.2	9.4	14.2	26.2	13.2	9.1	30.9	42.7	42.3	13.9	9.7	17.0	11.3	12.4	4.6	4.4	9.5	29.9	13.1	17.1	11.6	43.9	36.4	5.5	8.9	29.7	12.5	10.1	7.9	12.5
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RAD9B	FLJ40346	ENSG00000151164	"RAD9 checkpoint clamp component B"	Q6WBX8	12	110501655-110533556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 11.3"	"Group enriched"	"Detected in some"	21	"Spermatocytes: 91.5;Spermatogonia: 29.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"basophil: 4.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.7;SiHa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040643	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040643: AB_10805716"	"unprognostic (2.32e-1)"	"unprognostic (2.55e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.80e-2)"	0.3	0.1	0.3	0.2	0.4	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.0	0.4	0.4	0.3	0.3	0.1	0.8	0.3	0.3	0.2	0.3	0.3	0.5	0.4	0.3	0.7	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.1	0.4	0.8	0.2	0.2	0.5	0.3	0.3	0.2	11.3	0.4	0.4	0.2	0.5	0.3	0.3	0.2	0.7	1.6	0.1	0.1	0.4	0.1	0.3	0.1	0.7	0.2	0.7	0.6	1.6	0.1	1.2	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.4	1.5	0.2	0.0	0.2	1.9	0.3	0.2	0.2	0.6	0.5	0.2	0.1	2.7	0.3	0.9	0.9	0.2	0.4	0.5	0.1	0.5	0.5	0.1	0.4	0.3	0.3	0.2	0.3	0.1	2.9	0.3	0.4	0.0	0.6	1.0	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.7	0.3	1.0	1.0	4.7	0.5	0.2	0.2	0.4	0.2	0.4	0.3	0.1	0.9	0.3	0.2	0.1	0.5	0.2	0.9	0.5	0.1	0.3	0.3	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.7	0.2	0.0	0.0	1.6	0.7	0.5	0.4	0.5	0.0	0.3	0.3	0.3	1.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.9	0.3	2.8	0.2	0.1	0.4	0.0	0.4	0.7	0.0	0.1	0.7	0.0	0.3	0.0	0.9	0.4	0.3	1.3	0.0	0.7	0.0	0.0	1.2	0.3	2.0	1.5	0.5	0.0	1.9	1.9	0.6	1.0	0.5	2.8	0.4	0.0	0.0	0.5	0.2	0.0	0.1	2.4	0.8	0.0	0.5	0.2	91.5	29.0	0.0	0.4	0.1	0.3	0.1	0.1	0.2
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883716	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	3.4	0.5	2.2	0.2	1.9	0.0	3.3	11.0	3.6	4.1	0.4	3.4	0.2	3.2	0.2	0.8	3.7	0.7	4.8	1.8	4.0	0.4	0.1	4.5	0.1	3.3	3.7	1.5	3.3	0.3	2.9	2.6	3.4	2.0	0.2	0.3	1.1	1.2	2.8	1.2	1.3	1.0	2.8	0.5	1.3	8.2	2.7	0.2	2.5	2.0	0.1	2.3	2.9	1.7	0.0	2.1	4.4	7.8	0.2	1.9	0.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.5	0.0	3.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.2	0.0	0.4	1.9	0.0	0.0	7.3	0.1	1.6	5.0	0.5	0.0	0.0	0.0	8.9	19.0	0.0	0.0	0.0	1.8	3.2	0.6	0.0	0.0	0.0	6.1	1.9	0.2	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	11.0	3.6	1.8	4.0	3.3	3.7	3.4	2.8	2.7	1.7	1.8	3.2	1.5	10.1	0.0	0.8	0.0	0.0	0.6	2.1	3.4	1.8	2.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.2	1.1	2.6	2.2	0.0	0.0	2.6	1.7	0.0	3.9	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.5	3.6	0.3	0.0	0.6	1.2	5.1	3.4	1.0	7.2	14.0	0.0	4.7	0.0	7.1	3.5	0.3	0.1	3.8	0.0	0.4	0.0	0.0	1.5	0.9	6.6	4.7	4.1	17.0	11.7	0.0	0.6	0.1	2.1	0.3	0.0	0.0
RADX	"CXorf57, FLJ10178, FLJ14191"	ENSG00000147231	"RPA1 related single stranded DNA binding protein, X-linked"	Q6NSI4	X	106611930-106679439	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3;pituitary gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.3;Extravillous trophoblasts: 4.7;Syncytiotrophoblasts: 22.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.8;NK-cells: 1.0;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.2;RT4: 39.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000896, HPA001010, HPA001374"	Uncertain		Supported	"Nuclear speckles"		NA	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"		"HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-3)"	1.0	7.2	6.1	1.4	5.6	0.6	1.4	2.5	4.5	3.7	1.7	1.2	1.1	3.2	2.1	1.0	3.8	0.6	1.1	3.4	27.3	2.5	1.4	2.4	3.3	4.5	4.9	6.7	1.9	0.8	20.3	3.6	6.1	0.8	0.8	1.8	0.8	1.2	1.8	2.5	1.8	0.9	3.6	2.3	2.6	3.9	20.6	2.3	3.0	1.0	2.1	2.5	1.9	5.3	7.2	0.0	7.2	10.1	4.0	3.4	10.8	0.3	1.4	0.0	0.1	1.6	1.5	15.0	0.0	0.8	7.7	2.0	18.6	3.2	0.0	0.0	37.2	5.0	0.0	0.4	0.2	0.0	3.2	2.0	2.2	0.5	1.3	1.9	0.0	13.1	0.2	19.1	1.6	0.0	14.0	0.0	6.5	4.8	1.1	0.0	6.7	0.0	3.1	39.9	11.8	0.0	0.7	0.2	4.3	5.5	1.8	0.2	0.0	3.1	2.6	0.0	4.5	6.8	3.1	18.5	5.5	0.0	5.3	0.0	0.0	0.0	1.5	0.0	1.1	1.8	1.3	1.0	0.0	1.3	1.6	1.3	0.1	1.0	0.0	0.1	0.5	0.4	6.1	5.6	2.5	4.5	3.4	27.3	4.5	4.9	6.1	3.6	20.6	5.3	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.6	1.0	0.0	0.0	0.0
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664125	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 175.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002639, HPA002640, CAB019291"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB019291: , HPA002639: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	42.4	34.2	36.7	33.8	37.9	77.4	39.2	42.6	37.4	47.6	40.4	46.8	40.5	45.6	34.0	55.5	43.2	31.0	89.6	36.9	35.8	46.7	68.9	44.7	36.3	38.3	36.9	52.0	50.6	63.6	28.3	39.1	37.0	41.9	42.0	37.4	39.6	38.0	194.9	56.0	43.4	45.5	36.7	48.3	55.5	26.8	38.1	52.8	48.8	122.5	47.7	46.1	46.2	39.8	49.9	57.9	85.5	66.6	74.3	59.6	168.0	73.9	129.1	100.1	112.5	46.6	41.3	52.7	34.6	120.1	51.6	31.9	93.4	67.5	103.8	91.4	70.2	72.0	69.4	42.9	74.2	70.1	64.7	55.3	67.8	102.3	82.0	67.6	73.1	78.2	52.6	136.0	98.3	88.6	91.1	47.8	86.5	64.0	76.4	72.6	75.7	66.4	60.9	76.9	26.1	56.2	61.1	59.8	40.9	66.1	99.1	91.5	51.1	65.6	62.5	55.7	85.0	103.3	178.4	112.3	57.2	80.4	73.9	40.4	32.7	62.5	22.3	32.6	22.5	19.5	21.9	22.3	30.3	20.4	21.9	22.8	175.1	29.8	34.2	13.5	28.3	28.2	36.7	37.9	42.6	37.4	36.9	35.8	38.3	36.9	37.0	36.7	38.1	39.8	28.5	22.4	37.6	47.7	36.1	34.4	35.2	22.1	27.9	56.7	27.5	22.6	29.0	35.8	25.7	27.6	66.7	40.0	41.5	31.3	13.7	25.6	8.8	33.2	37.1	32.7	29.3	46.7	46.1	37.0	46.8	32.3	27.5	43.8	34.2	78.7	36.0	41.2	28.6	43.7	52.9	31.0	30.5	39.3	43.4	4.6	39.1	34.7	26.6	44.0	49.5	31.9	51.5	65.4	64.0	35.5	29.9	41.3	43.3	46.9	47.3	20.1	31.2	81.9	32.9	56.2	39.1	28.3	33.6	31.8	43.5	62.3	40.8	35.6	31.2	47.1
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681458-17811453	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	6.8	10.5	5.9	7.4	5.2	4.9	9.3	5.7	13.0	17.2	1.4	13.1	6.3	16.4	3.4	11.6	15.1	7.4	12.7	3.9	2.4	9.2	5.3	10.8	5.8	4.9	0.4	15.9	10.1	10.2	18.0	4.6	1.2	16.1	2.7	8.9	15.3	9.5	5.7	12.5	8.4	6.3	0.1	11.8	10.9	6.4	0.8	7.1	14.5	1.8	4.3	15.6	14.4	4.3	29.3	39.0	24.2	20.0	3.2	6.5	4.2	9.9	10.5	8.1	7.9	20.4	12.1	9.4	13.3	12.9	6.9	33.8	8.5	19.7	3.4	9.3	19.0	17.2	24.4	10.4	10.5	6.9	10.4	7.5	9.4	7.4	11.0	9.6	10.1	11.8	7.5	7.5	4.2	25.9	14.7	6.7	1.7	15.1	11.4	34.2	18.9	13.4	6.6	34.6	16.8	30.0	15.6	13.6	32.2	27.8	18.3	8.6	19.6	12.8	16.3	20.7	14.1	6.6	1.6	5.9	12.5	8.4	35.7	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.6	0.3	0.7	0.0	0.2	5.9	5.2	5.7	13.0	3.9	2.4	4.9	0.4	1.2	0.1	0.8	4.3	6.1	12.8	20.5	24.8	4.7	12.1	10.8	11.7	12.0	28.7	14.1	10.2	4.0	11.5	14.0	14.7	22.9	0.1	10.0	4.8	0.0	18.4	2.5	9.4	9.6	11.0	11.4	4.6	37.3	9.0	0.8	8.0	12.8	10.5	14.0	7.7	15.4	6.2	2.4	23.5	35.9	7.1	4.1	3.5	8.7	4.9	6.8	4.5	8.8	14.0	5.9	6.8	7.2	26.2	17.1	13.5	2.5	6.0	1.7	11.6	2.2	1.8	7.3	13.1	6.6	5.0	7.6	1.2	11.7	10.5	8.8	0.4	6.8	12.4	8.5	12.9
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656328-34832612	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 208.2;Early spermatids: 210.1;Late spermatids: 364.3;Syncytiotrophoblasts: 156.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 267.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 23.8"	"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (9.75e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	10.6	9.0	10.1	21.6	14.5	2.4	9.8	13.3	9.8	51.2	17.5	22.1	7.0	53.6	6.2	10.0	13.8	18.7	6.8	8.0	9.4	18.9	27.5	26.2	14.7	18.1	13.9	9.5	7.9	10.8	4.9	34.6	17.1	11.4	10.3	10.2	16.5	25.4	1.9	19.5	7.5	58.0	15.6	39.4	10.8	39.2	12.7	6.3	10.1	2.3	10.2	43.0	14.3	20.0	12.5	48.5	55.2	37.1	29.0	100.9	70.3	147.0	118.3	83.3	83.0	36.7	15.6	2.9	57.0	72.5	90.5	8.2	64.0	109.0	179.2	0.2	30.5	20.6	43.3	22.9	90.0	0.5	1.9	94.8	34.0	149.4	118.1	136.7	267.4	4.6	29.4	1.0	110.1	10.0	2.3	0.7	43.3	7.8	47.0	18.2	84.1	0.6	97.4	70.1	14.4	7.9	86.8	12.8	39.5	80.5	14.9	2.3	173.2	134.1	71.7	33.5	65.1	3.1	0.1	0.4	113.5	0.4	53.5	0.9	0.2	0.1	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.0	0.0	10.1	14.5	13.3	9.8	8.0	9.4	18.1	13.9	17.1	15.6	12.7	20.0	16.2	105.8	208.2	33.3	0.9	12.0	32.2	46.7	23.9	3.2	27.8	9.9	5.2	7.2	81.8	35.0	68.8	32.3	0.6	17.9	7.9	36.1	210.1	35.7	36.1	96.1	1.8	2.7	6.6	28.5	75.3	25.0	11.2	36.1	3.8	22.7	17.2	23.0	7.2	15.2	6.0	1.1	16.2	1.6	4.3	364.3	72.1	4.6	5.4	15.0	1.0	19.3	0.0	31.2	60.1	53.3	5.1	31.6	0.1	26.6	6.3	25.3	24.8	5.1	0.0	6.0	33.4	9.0	9.2	6.4	15.8	156.1	3.4	11.4	2.6	61.5
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 41.9;Leydig cells: 49.0;Peritubular cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA051054: AB_2681328"	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	48.0	17.3	9.4	8.3	10.4	0.2	47.2	8.8	11.9	55.3	7.4	33.0	6.7	66.8	9.9	15.5	71.8	24.7	32.9	9.9	9.3	14.4	3.9	28.6	9.6	9.4	8.5	50.9	14.3	10.8	19.3	7.8	9.6	31.8	8.1	8.9	13.8	31.8	12.5	20.3	23.0	30.1	8.6	4.5	28.2	6.0	10.4	5.0	21.6	17.1	9.6	38.9	43.7	8.7	0.0	0.0	0.2	0.0	104.3	10.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.7	0.2	0.6	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.1	1.9	0.0	0.6	0.0	0.0	0.0	5.8	0.0	1.1	1.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.8	0.0	0.1	0.0	0.0	0.0	0.1	9.4	10.4	8.8	11.9	9.9	9.3	9.4	8.5	9.6	8.6	10.4	8.7	25.0	12.8	4.5	2.0	0.0	4.1	9.3	0.0	0.6	14.0	13.4	10.4	13.0	12.8	0.6	22.0	0.0	0.1	0.3	0.3	5.9	8.2	0.3	25.0	16.5	15.2	27.6	0.0	10.5	9.8	0.1	24.8	7.7	41.9	0.0	9.7	10.8	0.1	0.5	26.9	17.9	0.7	0.0	0.0	4.2	3.3	49.0	0.9	5.4	14.0	0.6	20.5	0.0	5.0	0.4	4.9	17.5	70.7	0.1	7.9	1.3	1.9	4.4	3.0	0.0	21.0	8.7	0.4	2.7	0.5	2.8	0.0	1.3	0.2	1.6	5.1
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623565-39708120	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 292.4;Pancreatic endocrine cells: 411.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 302.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	27.8	32.1	32.4	20.7	35.5	7.4	23.8	35.8	37.3	23.0	30.2	30.9	32.6	20.4	20.1	54.0	19.6	26.8	17.6	33.7	34.3	20.6	21.4	41.8	21.4	37.0	35.7	22.2	16.0	22.6	10.5	32.5	36.4	15.4	31.6	13.0	19.8	15.8	25.8	26.9	30.9	21.1	37.7	18.8	33.8	12.7	34.9	25.5	17.4	19.1	35.2	23.5	22.0	39.8	81.0	18.3	44.1	38.6	81.7	67.6	30.0	69.7	99.7	61.8	67.9	46.1	39.0	41.5	25.5	54.1	58.1	81.5	62.5	45.0	105.5	40.2	29.6	32.4	28.1	34.1	132.1	56.9	43.8	53.7	54.0	110.0	155.4	76.7	302.4	39.7	65.9	27.0	63.2	26.3	40.3	66.7	123.0	88.0	35.9	49.4	40.2	36.3	63.1	37.3	78.0	75.6	42.8	67.7	49.4	78.7	63.5	60.9	98.0	36.4	32.4	46.3	50.7	47.6	39.1	50.3	40.5	58.0	67.2	38.3	13.5	15.7	12.5	15.6	15.7	15.8	20.1	16.2	22.6	18.0	25.6	22.9	6.1	23.2	12.6	14.5	28.1	15.9	32.4	35.5	35.8	37.3	33.7	34.3	37.0	35.7	36.4	37.7	34.9	39.8	66.5	83.3	38.1	25.5	40.5	90.1	37.3	75.1	41.5	14.6	41.3	63.5	37.3	40.0	50.3	23.9	6.2	52.1	28.4	80.1	21.5	165.4	98.2	56.5	64.8	121.5	47.8	35.1	47.6	122.0	92.5	52.4	42.3	99.9	31.7	41.8	75.0	27.8	101.9	11.8	48.4	53.1	144.5	33.0	292.4	17.4	47.8	73.0	30.2	44.0	97.0	37.3	23.7	39.2	37.0	411.0	73.8	69.6	48.6	61.0	70.8	38.6	36.6	16.6	32.9	26.5	131.9	59.1	71.6	113.4	109.4	62.0	37.0	53.9	58.7	64.5
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294710	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Cell division"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 335.7"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 378.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 378.4;monocytes: 176.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					NA	NA		440000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	53.8	35.9	30.6	57.2	30.8	60.0	39.9	32.8	38.7	44.3	33.1	59.2	50.5	37.5	15.8	73.3	45.7	44.8	51.0	32.3	37.7	56.5	34.2	50.7	35.8	30.8	33.6	28.7	25.6	335.7	16.6	63.1	30.6	51.0	51.8	25.8	36.2	31.7	30.1	25.7	44.8	46.5	31.3	54.2	39.3	29.9	37.9	27.5	30.8	43.9	35.0	51.0	49.1	32.8	179.8	47.7	46.8	29.5	71.2	115.5	66.7	121.4	105.8	93.3	70.5	99.4	118.0	7.1	63.9	131.6	88.2	64.1	22.5	93.1	85.7	293.3	25.8	84.4	36.3	71.3	46.0	45.1	144.9	60.3	99.0	97.2	74.0	77.1	272.9	6.3	66.5	28.1	108.2	91.9	5.9	100.0	31.7	71.6	101.9	1.2	59.3	38.1	97.5	45.6	13.3	32.1	50.4	137.9	85.1	39.3	43.3	66.3	168.4	91.1	69.8	93.9	48.8	16.2	9.1	12.8	72.7	57.5	95.6	101.8	80.9	230.5	19.0	117.7	18.5	45.0	18.0	19.0	65.4	59.6	11.9	13.7	378.4	25.5	176.1	6.9	24.6	59.5	30.6	30.8	32.8	38.7	32.3	37.7	30.8	33.6	30.6	31.3	37.9	32.8	69.3	9.6	27.0	6.5	23.8	19.4	30.1	22.4	7.4	4.1	23.2	7.9	55.8	18.6	21.9	11.0	12.5	6.0	11.8	95.3	66.5	84.9	18.8	28.4	22.8	77.8	18.6	8.4	12.9	55.0	128.5	32.7	17.9	26.7	106.1	90.6	78.5	9.8	53.6	13.5	9.7	19.1	18.3	54.3	59.4	23.0	19.9	66.7	35.6	16.9	62.6	26.3	21.6	10.1	5.4	138.1	62.1	31.2	6.7	28.5	44.6	104.4	46.3	7.5	19.7	18.3	33.4	13.1	16.2	16.4	18.9	36.7	19.5	12.9	31.3	32.2
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538114	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 195.6"	"Cell line enhanced"	"Detected in all"		"OE19: 239.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	29.7	20.4	42.7	23.4	44.1	30.7	27.8	45.8	82.2	26.8	38.6	34.1	18.7	22.1	23.5	50.3	24.8	20.3	28.5	40.7	45.1	42.7	19.9	22.6	24.0	44.1	48.0	26.3	15.4	47.9	16.8	31.4	44.4	32.6	25.4	13.5	25.0	48.2	38.5	75.9	20.4	21.1	43.6	26.5	25.7	13.0	45.3	29.3	22.9	32.5	25.4	33.8	33.3	45.1	58.9	37.6	34.2	39.0	38.3	60.7	43.3	67.7	38.1	35.6	38.0	42.6	57.5	70.5	47.0	64.8	50.2	32.8	48.1	52.7	44.2	71.4	38.5	38.5	34.6	32.7	31.2	114.8	43.0	42.0	52.2	49.6	48.7	47.7	60.6	64.6	53.7	67.7	56.2	46.3	70.7	50.9	25.4	239.5	31.9	93.6	59.4	54.2	48.4	80.7	44.7	34.8	58.2	52.8	30.9	52.3	32.9	53.8	67.4	105.0	76.9	72.3	81.9	38.7	42.9	77.9	45.6	53.4	40.5	13.0	9.6	15.7	10.3	10.6	8.7	9.9	8.7	8.8	8.7	7.5	7.3	9.4	195.6	14.8	17.8	19.8	6.4	4.5	42.7	44.1	45.8	82.2	40.7	45.1	44.1	48.0	44.4	43.6	45.3	45.1	101.8	57.7	35.7	15.3	48.0	156.4	80.9	59.9	112.7	42.6	96.0	102.2	64.8	88.6	64.6	480.1	29.2	104.2	70.9	122.6	123.3	119.4	16.1	99.1	82.6	86.9	74.2	175.7	25.4	90.7	518.6	71.6	56.1	179.4	40.5	85.8	78.9	88.3	70.1	52.2	26.7	87.7	109.9	92.8	69.7	9.5	72.7	78.4	58.7	20.6	99.6	47.6	83.4	17.1	25.3	166.3	78.2	87.3	63.2	174.4	61.0	115.0	38.6	37.3	65.7	76.8	105.6	66.7	80.0	149.6	242.5	44.6	62.6	128.4	90.1	216.4
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic subunit alpha 1"	Q6GYQ0	14	35538352-35809304	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 394.0;Inhibitory neurons: 233.9;Oligodendrocyte precursor cells: 239.3;Oligodendrocytes: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.5	18.5	24.0	9.0	28.1	7.1	16.0	36.0	29.0	21.6	18.3	17.6	7.7	16.5	13.8	15.8	17.9	9.4	12.8	24.2	26.3	14.4	13.0	14.1	9.6	26.6	25.5	23.9	16.3	25.5	23.4	7.4	26.2	17.5	14.5	39.4	13.0	10.5	18.4	20.1	14.7	12.6	25.9	12.0	15.8	10.6	26.4	9.7	16.3	10.9	9.0	15.9	18.3	33.6	7.4	8.7	11.0	9.6	16.4	11.4	7.0	5.2	5.4	6.7	6.0	5.2	6.4	7.2	7.2	7.1	8.8	12.0	13.4	10.2	6.2	16.1	5.1	6.7	11.0	26.3	8.4	11.4	10.4	8.6	18.3	5.8	14.1	11.0	9.5	14.2	6.7	17.9	5.9	11.8	8.5	5.4	5.0	18.2	12.9	6.9	6.7	4.6	13.8	11.9	10.2	16.7	11.0	18.9	9.6	10.6	18.0	5.3	8.7	6.5	5.0	7.6	6.5	14.6	14.4	9.3	3.0	7.3	7.2	0.0	0.2	0.0	0.7	0.3	0.9	0.5	0.7	0.9	0.3	0.3	0.4	0.7	0.0	0.7	0.3	0.4	0.8	0.1	24.0	28.1	36.0	29.0	24.2	26.3	26.6	25.5	26.2	25.9	26.4	33.6	40.2	16.0	30.9	162.6	63.9	38.1	28.3	13.9	62.0	86.1	27.7	21.5	19.4	15.7	25.2	23.9	394.0	10.9	105.8	31.0	0.0	12.8	19.5	47.0	38.5	31.4	31.1	14.9	215.3	15.8	5.5	34.6	54.0	50.8	53.4	41.6	18.5	14.8	9.2	52.2	233.9	23.3	16.2	10.0	39.9	8.7	34.2	35.4	19.6	173.3	16.8	30.5	16.5	239.3	412.8	15.9	25.9	29.0	86.3	36.0	26.6	10.4	25.2	119.1	39.5	59.0	37.8	47.0	38.0	55.9	46.2	15.2	80.7	24.0	28.7	27.1
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic subunit alpha 2"	Q2PPJ7	20	20389530-20712644	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 212.2;Microglial cells: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 91.5;SCLC-21H: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA042707: AB_2678124, HPA043622: AB_2678585"	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	16.7	6.5	4.6	6.1	6.2	20.6	15.0	10.8	7.6	9.6	5.7	12.2	10.3	8.7	3.7	8.8	10.8	11.3	7.9	4.3	4.8	10.2	27.3	25.2	6.4	6.9	8.0	7.4	17.0	13.1	14.5	17.6	7.5	13.1	12.6	13.4	15.1	5.5	34.4	16.9	10.5	7.0	2.8	7.5	18.3	10.1	13.1	8.0	21.1	21.0	5.4	12.6	8.4	9.5	7.0	4.4	9.2	4.7	5.1	3.6	10.1	1.8	2.0	2.1	3.0	3.8	9.5	3.2	6.1	3.0	10.6	7.1	9.4	8.6	4.0	16.1	4.6	11.1	2.5	6.7	1.8	14.0	6.4	3.1	6.4	3.5	1.7	3.9	13.1	14.9	2.2	6.0	3.8	4.9	5.6	18.5	3.8	22.8	3.9	7.6	6.2	4.5	7.4	91.5	51.4	4.5	6.9	5.2	6.1	8.9	3.6	13.7	3.3	3.7	3.6	2.7	2.6	3.5	2.6	1.8	3.1	9.1	5.4	4.4	1.1	3.6	0.8	0.4	1.2	1.1	0.5	0.8	0.5	0.8	1.0	1.1	4.4	2.7	1.0	1.2	1.0	0.3	4.6	6.2	10.8	7.6	4.3	4.8	6.9	8.0	7.5	2.8	13.1	9.5	90.7	6.4	42.5	212.2	9.7	10.6	10.1	25.9	6.8	47.8	13.5	7.7	9.1	41.5	27.0	14.7	27.1	10.6	14.6	24.7	1.9	23.9	28.9	61.0	16.4	80.1	24.6	10.7	87.3	24.9	4.9	7.6	51.5	123.0	8.2	97.3	67.1	47.4	12.8	52.2	122.0	20.7	40.7	18.3	10.3	7.3	1.8	13.0	8.8	145.2	18.2	8.8	10.3	122.2	111.1	19.5	21.0	6.8	4.8	20.5	20.6	12.5	43.1	13.5	13.1	16.4	9.7	12.3	11.1	15.3	16.6	11.2	14.3	19.7	30.6	25.0
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic subunit beta"	Q86X10	20	38472816-38578859	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051454: AB_2681490"	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	9.6	10.6	7.6	12.1	9.5	12.3	16.1	13.4	10.8	12.1	14.3	11.9	12.1	12.0	12.7	13.9	10.9	10.7	10.5	9.6	9.4	14.4	8.5	11.1	12.2	8.7	8.0	11.6	11.7	24.2	10.5	14.3	8.5	14.4	13.3	18.7	10.8	12.7	12.1	13.7	11.9	12.9	7.6	11.1	12.4	20.8	9.7	17.6	18.1	14.4	14.9	15.3	9.3	9.8	25.3	23.4	23.8	17.5	22.5	25.9	25.3	20.3	23.6	24.8	24.3	42.3	18.6	23.7	18.9	23.7	36.5	29.2	22.6	30.8	34.8	13.6	9.6	36.2	21.0	24.3	21.3	29.6	18.4	18.5	39.1	29.3	32.0	19.7	32.9	20.0	26.8	22.9	24.2	16.5	34.1	12.5	17.5	24.9	30.1	19.4	34.0	15.9	16.5	46.7	25.1	27.6	44.9	59.8	37.4	27.2	34.8	15.0	39.2	49.9	19.9	28.6	20.8	26.6	34.9	21.1	36.1	14.2	22.5	1.2	0.9	2.4	1.2	0.7	1.6	1.3	1.7	1.5	1.4	1.0	1.5	1.2	1.7	2.0	1.3	0.9	0.8	0.6	7.6	9.5	13.4	10.8	9.6	9.4	8.7	8.0	8.5	7.6	9.7	9.8	23.1	22.4	17.1	47.7	18.6	13.9	7.4	12.4	17.1	24.4	19.5	12.3	20.0	10.0	17.7	31.3	27.1	10.4	23.4	26.9	3.9	9.4	11.8	24.3	20.2	17.4	12.6	14.9	63.3	9.3	7.8	15.7	30.5	28.8	16.5	19.4	23.2	12.1	9.7	20.2	66.0	16.1	16.2	17.7	11.6	8.7	16.8	14.7	10.6	49.6	15.1	10.0	16.5	58.3	81.0	15.2	20.4	18.8	16.7	16.1	26.9	9.0	20.9	18.3	13.1	16.8	13.5	31.8	24.0	19.7	18.0	15.2	19.4	15.9	15.8	14.2
RALGDS	"RalGEF, RGDS, RGF"	ENSG00000160271	"Ral guanine nucleotide dissociation stimulator"	Q12967	9	133097720-133149334	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 24.0;MAIT T-cell: 9.7;memory CD4 T-cell: 10.9;memory CD8 T-cell: 17.6;naive CD8 T-cell: 9.1;NK-cell: 9.0;T-reg: 20.8"	"Group enriched"	"Detected in many"	7	"NK-cells: 9.0;T-cells: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 152.4;SH-SY5Y: 92.0"									"HPA025961, CAB032582"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB032582: AB_2238105, HPA025961: AB_2671795"	"unprognostic (1.01e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.35e-2)"	"unprognostic (7.92e-3)"	"unprognostic (8.20e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.91e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.03e-2)"	"unprognostic (9.54e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	36.8	29.7	68.3	20.2	88.1	41.8	35.5	76.3	75.8	22.2	34.7	28.2	17.3	19.0	12.8	40.5	23.9	31.3	26.8	66.8	66.5	14.8	13.4	35.7	27.6	91.3	87.5	33.0	22.9	16.6	68.5	10.9	84.4	25.0	10.1	7.3	31.8	20.3	32.5	62.3	25.2	13.6	73.5	22.2	21.4	6.1	86.1	15.8	23.5	16.3	16.9	38.8	29.6	117.9	7.5	10.9	22.2	27.8	8.3	12.1	18.7	8.8	13.0	8.8	5.7	9.5	16.1	11.3	8.0	15.1	13.4	33.8	22.7	16.1	2.9	152.4	16.3	9.6	22.0	13.8	10.8	15.6	16.9	14.2	22.1	4.7	9.7	23.7	18.2	21.7	19.3	68.4	8.3	24.6	22.2	15.0	15.3	33.3	27.6	22.2	5.4	18.9	10.8	13.0	70.1	92.0	10.5	15.4	14.0	8.6	16.0	15.9	9.5	9.8	10.3	7.4	6.1	3.2	9.2	14.0	8.6	17.4	11.2	2.3	0.6	0.9	24.0	0.3	9.7	1.7	10.9	17.6	0.8	0.5	2.4	9.1	0.4	9.0	0.3	0.8	20.8	6.1	68.3	88.1	76.3	75.8	66.8	66.5	91.3	87.5	84.4	73.5	86.1	117.9	83.9	32.1	11.3	43.4	17.2	55.4	46.3	19.5	40.5	16.6	55.5	40.5	7.2	12.8	21.4	9.2	12.5	5.5	45.7	40.6	3.9	11.4	0.6	100.2	11.7	54.1	37.0	14.3	34.1	6.7	4.5	21.8	26.0	93.1	15.8	26.9	36.4	3.8	12.5	62.2	29.8	14.4	22.4	9.8	51.1	1.8	13.4	33.6	23.2	12.2	4.9	16.3	46.4	32.2	86.4	11.5	31.5	9.1	26.5	43.9	26.7	2.5	34.5	9.3	0.0	43.7	15.4	2.5	5.1	47.6	101.4	5.9	41.6	19.6	17.6	116.6
RALGPS1	"KIAA0351, RALGEF2, RALGPS1A"	ENSG00000136828	"Ral GEF with PH domain and SH3 binding motif 1"	Q5JS13	9	126914774-127223166	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.8;Cone photoreceptor cells: 104.3;Excitatory neurons: 105.6;Inhibitory neurons: 164.4;Oligodendrocytes: 161.3;Rod photoreceptor cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014749	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA014749: "	"unprognostic (3.49e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.47e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.20e-11)"	"unprognostic (4.79e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.24e-3)"	3.7	3.4	15.3	3.7	13.8	3.2	6.6	18.8	16.3	5.4	5.9	12.5	30.6	4.7	9.3	7.7	8.5	6.4	13.0	13.4	14.7	14.6	2.7	6.5	4.4	18.7	13.8	4.1	11.3	15.9	18.8	3.9	20.2	7.9	13.0	30.7	13.1	8.2	9.4	10.0	29.1	4.5	13.6	5.2	18.2	10.6	16.4	4.8	13.8	6.0	6.4	8.5	5.9	22.0	3.5	3.1	8.1	8.0	1.5	1.1	8.8	1.1	1.1	1.7	2.4	8.6	5.8	5.8	0.8	1.4	10.3	12.0	2.5	1.4	1.0	2.3	4.9	0.4	4.3	1.5	1.2	1.0	6.3	0.7	4.9	0.8	1.0	1.4	2.8	13.3	0.8	5.8	0.4	6.5	1.1	0.9	2.2	33.6	2.7	3.9	1.9	11.2	3.4	8.6	7.4	11.1	3.4	10.5	2.5	5.6	9.5	0.5	1.3	0.7	2.4	1.6	1.3	10.5	10.8	3.0	3.2	1.0	1.2	0.0	0.1	0.7	0.1	0.0	0.2	2.3	0.3	0.2	0.0	0.7	0.1	0.1	0.9	0.8	0.1	0.7	0.1	0.1	15.3	13.8	18.8	16.3	13.4	14.7	18.7	13.8	20.2	13.6	16.4	22.0	6.2	6.4	4.1	87.8	11.2	2.7	4.4	3.6	2.2	36.8	8.5	5.1	10.2	17.2	10.2	11.0	104.3	9.6	3.6	18.8	5.9	6.1	27.6	11.8	2.6	2.3	7.8	0.0	105.6	6.4	1.0	3.2	34.7	7.2	0.0	6.5	3.3	2.1	2.6	45.4	164.4	16.8	12.2	2.5	2.8	41.4	1.5	2.7	1.8	31.9	3.5	12.4	8.2	68.3	161.3	8.9	14.7	3.8	5.5	6.2	56.9	3.9	13.4	119.0	6.6	5.8	3.2	31.3	12.3	11.6	4.7	4.0	4.7	4.4	17.8	9.1
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.2;testis: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 263.1;Cone photoreceptor cells: 206.4;Late spermatids: 185.9;Rod photoreceptor cells: 397.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 26.7;naive B-cell: 21.0"	"Lineage enriched"	"Detected in many"	11	"B-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 250.4;U-698: 194.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	8.5	3.5	24.0	5.0	13.2	8.1	4.9	4.6	6.5	3.3	13.4	11.5	9.4	5.4	16.3	8.0	8.1	4.6	7.1	5.8	6.7	32.0	2.8	52.4	3.0	2.4	18.3	5.7	7.8	2.9	9.2	2.6	7.3	12.1	52.5	5.4	5.5	1.4	19.6	16.4	11.8	3.4	28.3	13.7	77.0	5.5	15.2	6.8	4.8	56.2	12.6	7.6	2.1	39.9	12.7	38.7	0.4	42.3	61.6	15.2	34.0	74.8	27.1	24.3	15.1	38.3	83.7	11.2	100.8	13.5	32.2	17.2	8.6	35.4	0.1	10.3	0.0	8.7	14.6	7.1	11.1	0.4	27.5	7.5	35.1	24.6	18.8	23.7	15.3	20.6	3.1	17.8	6.3	17.0	3.5	26.5	15.3	13.4	23.5	39.9	0.7	9.3	24.9	6.0	17.2	22.2	24.5	48.4	26.3	29.3	5.6	17.9	12.4	11.8	45.4	16.4	91.8	250.4	194.3	7.2	5.7	14.2	0.8	0.1	2.4	0.3	0.1	0.3	26.7	0.2	0.1	0.4	21.0	0.7	0.2	1.3	0.4	0.1	0.8	0.0	1.1	3.5	5.0	4.9	4.6	7.1	5.8	3.0	2.4	2.6	3.4	5.5	2.1	5.4	12.8	6.9	29.4	263.1	14.8	16.3	5.4	14.8	97.4	27.9	15.1	17.5	15.7	8.7	14.7	206.4	7.5	11.6	39.5	21.5	15.2	123.0	23.3	25.6	4.9	35.9	22.7	84.0	12.0	10.1	18.7	48.9	33.0	8.8	60.3	2.9	55.2	6.3	13.5	92.3	22.5	0.0	8.5	4.8	185.9	50.1	7.3	8.8	41.2	5.1	27.8	10.3	107.5	4.0	31.0	52.4	46.6	105.2	26.0	22.7	9.7	23.9	397.3	19.7	41.5	18.6	146.6	34.8	29.1	34.1	3.3	10.3	20.7	15.6	72.0
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		9400	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	109.7	65.4	72.1	90.4	83.2	189.2	98.2	82.6	79.3	108.9	81.8	127.2	109.8	96.9	41.6	119.6	84.8	70.7	143.2	67.6	77.4	104.4	68.3	117.4	116.9	87.8	81.9	101.2	78.2	62.1	55.6	77.6	84.2	88.3	87.6	55.0	105.3	64.3	178.4	114.6	117.7	70.1	83.7	109.6	101.9	116.5	80.9	161.7	125.5	106.0	99.9	99.3	98.4	100.7	250.4	138.1	247.6	193.9	115.3	110.3	210.1	172.9	136.0	215.1	183.0	375.8	204.0	204.3	238.7	140.6	290.9	259.4	135.8	252.7	119.2	132.2	119.3	468.3	81.4	375.4	147.8	236.2	215.0	122.4	141.6	161.9	175.4	160.7	203.0	245.6	201.7	300.9	135.8	185.9	589.3	266.6	137.5	306.0	277.2	344.4	360.6	250.7	126.7	135.4	235.8	266.6	271.8	248.4	376.6	125.8	256.2	234.4	167.5	414.4	270.7	212.3	206.6	310.7	308.3	353.5	213.0	169.9	201.3	139.3	110.7	221.3	138.8	137.1	100.2	96.5	122.2	150.4	135.3	99.6	107.8	104.0	173.3	186.1	195.5	110.0	141.4	165.3	72.1	83.2	82.6	79.3	67.6	77.4	87.8	81.9	84.2	83.7	80.9	100.7	91.8	54.5	61.3	23.2	98.3	79.2	126.9	102.3	74.6	24.2	74.9	67.8	63.4	58.6	61.7	55.2	18.8	161.3	118.3	287.4	127.2	149.1	48.1	36.4	48.5	92.1	93.0	87.9	19.3	160.5	227.7	78.2	70.8	66.9	59.7	69.7	76.8	39.8	159.6	8.4	14.6	143.2	95.6	112.2	118.1	46.7	65.6	96.9	115.6	50.6	151.3	62.6	163.7	15.6	57.1	190.3	270.7	62.1	206.4	157.5	220.7	107.3	38.8	36.3	111.7	47.7	97.7	106.6	121.1	103.7	80.7	171.4	117.2	51.6	178.6	176.2
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAMAC	"C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET"	ENSG00000169612	"RNA guanine-7 methyltransferase activating subunit"	Q9BTL3	15	82986210-82991057	"Predicted intracellular proteins"	"mRNA capping, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041923, HPA041948"	Supported		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.45e-1)"	12.9	14.8	10.9	16.4	11.4	30.1	26.1	12.9	14.8	16.6	11.6	18.4	14.5	18.2	30.1	24.1	19.5	13.4	14.8	11.6	12.2	16.8	24.2	13.0	23.0	11.6	11.3	20.6	16.4	18.8	12.9	25.9	11.3	18.0	19.3	19.9	18.2	15.2	29.1	21.5	13.4	16.8	11.6	14.1	19.0	15.6	11.1	23.3	18.2	20.2	28.9	20.8	15.6	11.6	34.1	44.7	44.3	27.1	23.5	15.9	32.7	33.7	33.5	37.6	30.4	49.4	42.9	16.8	45.8	29.2	45.4	37.9	77.1	32.4	40.6	42.0	49.7	52.7	22.7	58.7	33.3	38.0	44.9	34.9	61.4	30.6	38.5	28.7	23.6	28.5	62.8	33.9	39.8	35.7	29.5	48.3	52.0	45.0	21.1	33.4	38.2	26.0	49.0	64.6	41.1	42.0	34.6	36.7	87.0	71.5	58.6	47.9	16.8	27.5	34.9	26.1	48.8	53.1	104.0	41.8	25.2	50.7	34.5	138.6	59.2	98.2	47.9	57.0	51.8	64.8	54.1	52.3	56.1	61.1	53.9	53.4	117.4	70.4	62.8	51.6	69.9	65.9	10.9	11.4	12.9	14.8	11.6	12.2	11.6	11.3	11.3	11.6	11.1	11.6	18.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	82.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	92.9	2.7	0.0	0.0	0.0
RAMACL	"C6orf119, dJ427A4.2, FAM103A2P, RAMMETL"	ENSG00000235272	"RNA guanine-7 methyltransferase activating subunit like (pseudogene)"		6	166585604-166587594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.5;ASC TERT1: 2.8;HEK 293: 5.9;HeLa: 2.2;HHSteC: 4.9;TIME: 1.8"									"HPA041923, HPA041948"	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 8: Neutrophils - Inflammatory response"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.33e-2)"	0.0	0.4	1.3	0.0	1.2	0.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0		0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.3	0.0	0.0	1.6	0.7	0.4	0.0	0.0	0.0		2.9	0.0	0.0	0.0	0.2	3.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	2.2	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	3.9	1.7	2.1	1.9	2.9	2.0	1.9	2.6	2.8	1.9	1.7	4.4	2.2	1.1	1.7	2.6	2.1	1.3	1.2	0.2	0.8	0.7	1.0	1.8	0.9	1.5	0.7	1.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127355	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 754.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 2431.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol		NA	NA		1400000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA065868: AB_2685572, HPA065931: AB_2685580"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	65.5	68.0	37.6	63.3	38.6	117.5	60.7	40.2	47.9	67.1	28.8	63.9	52.9	66.7	21.4	94.7	61.2	30.0	47.5	39.7	40.5	64.8	86.7	53.5	94.7	41.1	39.1	61.0	54.0	35.9	50.3	46.2	41.4	49.8	42.9	35.3	51.8	34.3	54.9	61.8	60.6	36.2	40.8	71.1	55.5	117.8	39.6	104.0	46.5	34.8	72.6	61.9	64.7	43.7	434.6	218.5	479.7	263.2	79.1	93.8	403.7	388.7	169.3	494.6	356.4	401.5	150.8	669.8	169.7	157.8	224.9	394.2	449.4	340.4	269.6	290.1	1071.3	562.6	218.5	426.6	120.3	913.7	294.4	103.9	158.7	393.0	139.2	114.3	227.1	300.2	2431.9	261.1	226.8	339.2	665.5	622.0	547.2	553.8	380.8	667.4	674.7	172.6	171.6	233.9	478.6	354.7	356.6	196.4	236.6	210.3	137.1	378.9	176.4	341.5	668.1	258.7	438.3	260.9	383.6	1066.0	186.9	405.9	292.7	21.1	94.7	75.8	71.3	101.6	78.8	123.1	101.6	91.1	111.5	119.1	101.8	77.0	9.5	90.8	93.6	103.6	115.4	102.5	37.6	38.6	40.2	47.9	39.7	40.5	41.1	39.1	41.4	40.8	39.6	43.7	133.1	35.3	37.1	14.7	135.0	274.4	195.0	260.6	109.3	44.4	142.3	175.6	47.1	104.4	104.8	90.1	6.2	409.2	103.8	106.4	277.8	188.5	394.2	104.6	131.1	143.5	117.6	259.2	22.2	112.3	754.9	156.7	72.4	86.7	64.7	187.2	93.5	169.5	268.7	37.0	21.4	194.0	209.5	85.5	223.3	236.1	145.1	95.3	177.9	6.5	140.6	103.5	87.6	7.5	23.9	150.0	109.3	136.9	179.6	338.0	107.3	213.7	93.8	39.0	98.6	110.9	289.5	505.1	435.2	220.1	294.9	194.7	119.2	176.5	273.6	218.2
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	25.1	40.3	30.0	24.0	30.6	21.5	24.7	30.4	33.7	30.5	25.0	43.1	22.2	35.1	10.6	26.6	29.0	17.8	35.3	30.0	30.3	24.6	24.4	25.2	26.5	33.0	34.9	28.2	29.6	20.7	32.0	16.7	31.7	32.2	12.1	19.3	25.6	22.9	36.6	29.2	27.6	19.0	30.5	30.1	32.0	44.7	31.5	26.2	25.8	21.3	17.9	36.6	27.9	31.1	73.8	50.4	42.3	47.6	31.2	31.3	30.0	45.9	43.1	52.7	56.7	64.9	25.4	69.0	50.4	35.8	33.1	44.8	38.2	44.8	32.0	71.0	62.3	37.1	38.8	77.6	33.7	54.9	52.2	30.9	30.4	33.0	37.3	24.5	38.9	37.0	68.4	63.6	30.3	30.7	91.8	26.6	77.6	31.8	64.3	67.0	40.6	63.3	34.3	56.3	46.4	52.1	41.1	42.9	41.1	24.7	32.7	41.0	40.6	44.2	32.2	78.2	68.4	65.4	72.1	59.2	55.9	68.0	55.6	14.5	23.1	29.2	23.2	23.2	24.1	17.6	22.7	23.5	23.4	24.5	19.5	25.8	26.0	17.9	24.3	22.3	32.1	24.5	30.0	30.6	30.4	33.7	30.0	30.3	33.0	34.9	31.7	30.5	31.5	31.1	14.0	25.6	26.6	9.8	18.4	12.2	20.5	27.1	9.6	16.7	12.0	10.2	16.4	18.6	19.9	7.3	25.0	29.2	18.6	16.9	43.0	28.8	59.5	14.3	12.6	19.2	13.2	8.6	9.4	20.8	29.5	17.1	17.3	15.4	17.7	14.1	9.3	10.8	25.0	23.5	11.7	20.2	32.6	14.9	16.8	73.3	16.8	16.5	21.4	8.4	31.5	21.9	25.7	13.6	17.5	22.7	11.4	24.8	21.7	18.8	20.2	21.0	21.4	20.8	19.7	13.5	15.8	86.8	40.8	10.4	11.8	35.4	20.6	19.1	15.1	23.0
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;kidney: 24.6"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	25.2	0.3	27.0	0.0	7.6	4.6	29.9	1.2	5.4	0.8	0.2	0.7	1.8	0.5	1.2	1.8	1.5	25.1	12.2	24.6	9.9	2.0	0.2	9.9	18.9	2.1	0.4	0.2	2.9	5.0	7.4	13.5	0.4	5.3	0.6	2.9	0.4	0.4	0.4	0.6	12.6	0.2	1.8	4.7	18.6	0.1	2.2	2.9	0.6	6.9	0.8	15.2	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	27.0	4.6	29.9	25.1	12.2	9.9	18.9	7.4	12.6	18.6	15.2	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011025-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA043748: AB_10796796, HPA052684: AB_2681913"	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	8.6	11.4	8.3	12.9	8.8	31.0	11.4	11.5	12.4	7.7	18.4	7.1	7.5	8.8	7.0	7.9	7.3	7.6	12.4	9.3	10.8	13.4	15.2	8.4	17.0	11.2	9.7	9.6	7.8	13.6	5.0	8.9	11.9	9.7	7.1	21.6	8.6	8.5	16.3	9.9	8.6	10.3	9.2	13.1	11.1	5.9	10.0	19.6	12.0	16.1	16.2	8.7	5.6	10.3	25.1	13.6	27.2	23.4	23.6	18.6	14.6	30.9	21.9	26.8	21.6	7.5	7.7	33.5	8.4	24.7	13.1	14.0	24.2	28.2	29.7	80.1	13.9	88.3	53.0	15.6	13.9	34.2	17.9	20.2	15.2	16.5	16.3	21.1	31.3	30.1	6.9	27.3	25.8	8.4	24.3	54.8	12.3	9.0	11.0	25.6	16.7	15.7	28.1	17.6	13.2	19.9	14.7	11.0	8.7	22.3	17.7	23.0	37.6	25.1	14.9	12.4	29.4	16.3	27.8	31.5	14.4	19.8	9.3	5.1	4.5	3.7	2.6	6.3	2.5	2.5	3.8	2.8	2.7	1.9	4.4	4.2	1.3	2.8	5.2	3.1	5.2	2.9	8.3	8.8	11.5	12.4	9.3	10.8	11.2	9.7	11.9	9.2	10.0	10.3	11.3	9.6	8.1	8.8	11.5	10.3	6.6	10.1	13.1	18.0	8.1	5.6	24.4	8.6	16.3	11.0	2.1	8.8	12.0	4.1	7.9	8.6	1.6	12.2	16.5	13.1	9.5	8.6	15.9	10.9	4.1	8.3	16.8	17.7	10.8	10.1	10.0	13.7	4.4	11.8	19.0	3.2	2.0	10.5	6.0	1.2	6.5	7.2	1.8	8.4	7.2	15.9	9.2	3.0	20.5	7.5	3.8	6.8	11.8	5.7	1.8	12.5	8.7	23.1	0.0	11.6	10.2	10.1	9.3	9.8	9.5	6.6	13.3	12.7	4.8	7.3
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037741	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.7;pancreas: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 132.8;Inhibitory neurons: 67.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"amygdala: 10.6;basal ganglia: 13.6;cerebral cortex: 11.0;hippocampal formation: 17.9;white matter: 11.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA		21000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.8	6.4	10.6	4.1	13.6	27.7	4.4	0.9	11.0	3.9	0.0	7.9	8.7	4.1	1.1	3.1	8.1	4.0	14.5	17.9	1.1	5.2	0.6	3.5	2.9	0.0	0.0	4.6	37.3	4.2	5.1	4.9	0.0	3.8	8.1	7.2	10.9	4.7	0.8	3.3	8.2	3.3	0.0	3.9	22.4	3.2	0.0	2.8	2.5	2.0	2.5	2.0	2.5	11.9	8.1	9.9	1.9	8.1	0.0	0.0	15.9	10.7	5.0	1.3	1.2	21.9	3.5	3.0	2.9	1.4	13.5	11.0	6.4	20.0	0.4	0.0	6.9	3.7	14.1	9.9	1.9	0.8	3.9	0.5	17.0	5.5	13.9	7.2	0.2	3.7	21.4	1.4	0.0	9.1	3.1	2.0	11.7	3.9	9.5	13.4	6.9	7.8	5.9	4.1	21.6	52.3	15.5	15.8	6.9	7.4	7.8	2.3	2.4	9.1	14.3	1.6	9.1	0.0	0.0	1.2	0.5	6.9	15.1	0.9	1.4	2.1	2.8	2.7	1.1	0.2	0.9	2.1	1.0	0.2	0.1	1.0	4.2	1.9	3.9	1.7	1.0	1.4	10.6	13.6	0.9	11.0	17.9	1.1	0.0	0.0	0.0	0.0	0.0	11.9	1.5	6.4	2.5	13.7	5.6	2.0	6.6	1.8	1.2	23.6	9.9	7.6	20.2	11.5	2.8	12.9	33.3	7.5	27.2	15.2	9.8	6.0	6.1	9.2	6.8	1.6	48.1	0.8	132.8	12.0	6.0	2.2	18.8	9.2	6.3	3.0	3.6	0.8	3.4	37.0	67.9	21.7	8.2	11.1	4.3	8.3	1.8	11.0	3.6	47.8	12.0	2.1	35.0	8.0	4.2	12.4	24.1	1.5	6.4	16.5	5.7	0.8	4.2	4.6	0.0	7.9	2.5	0.4	3.4	2.8	0.4	3.4	8.2	1.5	14.0	11.3
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443858	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 434.9;Inhibitory neurons: 176.3;Late spermatids: 245.3;Oligodendrocytes: 357.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol		NA	NA		62000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	15.6	12.6	49.3	18.8	54.9	14.3	17.4	56.3	56.7	11.7	25.2	16.5	10.0	12.2	11.2	18.5	9.6	11.6	9.6	48.3	54.1	16.5	21.1	14.0	23.4	59.5	62.6	10.8	19.1	10.3	16.1	13.2	67.6	10.3	18.6	65.7	12.5	15.1	5.8	14.4	14.3	22.1	51.9	18.0	11.2	22.6	64.4	32.4	17.6	5.7	24.4	19.0	12.9	72.4	50.8	30.4	37.8	32.8	47.6	56.4	14.2	86.7	48.6	51.1	40.0	22.7	66.5	61.0	26.3	65.9	24.3	27.8	47.0	80.5	68.7	60.4	17.1	37.0	35.6	29.6	93.8	64.1	25.2	65.7	47.8	45.3	69.5	42.3	67.9	61.9	25.7	51.6	128.3	27.7	104.9	31.3	13.9	43.0	19.0	41.5	22.4	20.8	51.7	40.8	55.0	32.5	36.2	81.2	48.9	20.6	18.5	41.5	67.2	52.7	36.8	23.9	51.7	16.5	30.1	51.1	43.9	47.3	69.7	32.8	17.4	10.4	23.3	24.9	24.2	23.9	24.4	23.5	27.9	17.1	12.3	19.5	2.5	37.0	28.5	60.6	41.2	14.8	49.3	54.9	56.3	56.7	48.3	54.1	59.5	62.6	67.6	51.9	64.4	72.4	17.6	16.0	12.2	88.8	34.7	13.9	10.8	11.7	22.8	48.2	17.1	12.2	11.1	14.3	14.7	16.5	50.1	6.8	45.7	9.7	23.5	17.7	434.9	7.4	16.2	15.7	20.9	19.8	146.4	20.9	16.5	11.5	16.8	11.2	15.2	19.8	13.9	18.5	23.8	15.2	176.3	13.0	12.2	33.4	27.6	245.3	9.3	24.7	17.8	89.0	32.6	16.9	34.0	110.6	357.6	23.4	14.6	10.9	30.4	16.3	14.5	20.4	7.6	77.5	0.0	12.7	17.2	16.7	36.5	26.8	16.8	4.5	34.3	19.8	18.4	15.1
RAP2A	"K-REV, RAP2"	ENSG00000125249	"RAP2A, member of RAS oncogene family"	P10114	13	97434169-97469128	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018552	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB018552: AB_2177305"	"unprognostic (2.40e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.53e-1)"	14.9	8.2	26.3	10.7	32.4	4.1	11.7	21.9	39.5	11.7	13.2	10.2	7.9	8.7	4.5	15.9	6.7	12.7	11.3	32.5	23.7	14.4	8.6	13.8	18.0	23.8	25.3	6.7	4.8	7.8	7.9	25.4	24.6	6.4	11.2	7.5	5.4	7.2	10.5	7.2	8.1	12.3	27.0	15.1	6.5	4.5	31.2	13.3	6.6	15.3	12.9	11.5	7.7	30.6	18.5	5.2	19.3	13.9	31.2	18.5	7.6	13.4	8.8	12.9	14.4	9.8	10.6	14.1	8.4	22.1	12.6	14.1	16.6	13.4	16.9	26.3	8.6	15.4	19.8	14.5	22.5	13.6	9.5	28.5	17.1	12.8	17.6	19.5	28.2	15.8	5.2	26.2	17.3	6.7	9.4	21.1	11.1	16.0	7.8	12.1	20.7	9.3	12.7	6.0	21.9	37.4	9.5	22.5	19.8	26.1	18.1	6.8	21.2	12.6	12.5	12.5	13.1	18.7	15.8	7.7	35.0	16.1	20.8	0.0	0.3	0.4	1.9	1.4	0.8	0.5	0.7	1.4	1.0	0.2	0.4	1.5	0.1	0.4	2.0	1.6	1.3	0.4	26.3	32.4	21.9	39.5	32.5	23.7	23.8	25.3	24.6	27.0	31.2	30.6	34.0	12.8	6.4	17.3	6.7	22.7	4.5	8.2	8.6	10.7	19.1	15.6	15.8	14.3	6.3	1.8	8.4	2.0	31.1	17.0	9.8	5.3	2.5	7.1	19.6	23.7	16.8	9.9	83.8	6.2	11.5	20.0	7.7	9.8	5.1	12.0	29.6	18.1	32.9	28.6	33.3	13.4	10.2	49.1	66.4	1.9	7.2	33.7	16.0	49.6	22.0	17.6	4.1	54.3	44.1	11.1	16.9	6.0	12.3	8.4	6.5	21.9	4.6	5.9	26.3	11.6	36.0	6.5	8.0	22.3	21.9	3.7	12.7	11.1	12.9	4.5
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 228.6"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	37.3	24.0	41.4	53.9	72.6	53.2	26.8	27.0	37.1	20.4	37.9	31.9	23.9	25.6	8.0	23.6	25.5	23.7	57.8	40.8	40.2	23.0	23.0	43.3	56.1	35.8	36.9	16.3	47.8	20.1	16.4	56.4	32.3	21.5	23.4	27.5	20.2	21.4	228.6	21.9	35.3	30.4	25.6	41.9	29.1	15.9	43.8	35.1	22.7	104.8	63.1	25.8	18.2	20.2	34.5	39.4	39.1	39.6	39.1	42.0	149.2	29.0	59.0	33.0	23.6	49.0	22.1	61.9	35.6	58.8	70.7	61.4	45.1	40.5	16.4	144.6	18.6	18.3	67.2	26.2	32.8	76.1	80.4	32.2	73.0	43.3	51.0	33.1	60.4	70.8	49.7	119.1	43.4	35.7	54.0	27.0	39.6	34.1	35.2	53.0	91.0	86.8	14.9	41.1	33.0	32.9	42.5	39.8	42.3	39.0	38.1	63.1	64.4	88.1	36.7	56.4	44.7	39.8	37.3	122.0	41.9	32.0	21.6	3.1	1.2	1.6	3.4	2.2	2.0	4.9	2.3	2.3	1.4	2.9	0.5	1.5	1.3	1.3	2.4	1.6	1.8	1.6	41.4	72.6	27.0	37.1	40.8	40.2	35.8	36.9	32.3	25.6	43.8	20.2	73.5	6.4	13.8	27.1	35.6	18.7	9.3	10.9	5.2	19.5	10.8	13.5	16.2	14.3	12.3	5.5	14.6	22.7	49.7	23.3	5.9	8.2	2.6	13.0	9.4	43.0	12.1	1.7	47.5	18.6	35.3	11.8	17.9	17.8	20.3	14.0	22.5	17.4	26.4	131.2	66.6	14.9	8.2	23.9	108.6	2.5	8.7	51.6	32.0	123.7	59.8	19.7	27.8	61.3	24.7	17.1	19.1	12.0	88.0	11.7	16.8	9.2	16.7	13.4	6.6	13.4	10.3	5.1	11.8	5.6	11.4	51.7	31.0	5.8	14.0	10.8
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734363-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Endoplasmic reticulum"	"CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524"	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	44.6	2.8	29.2	2.6	35.0	1.4	44.0	30.3	29.2	26.0	12.5	9.9	4.0	16.4	6.9	13.2	24.1	13.2	21.1	31.4	21.3	40.0	1.9	11.9	4.4	33.6	29.6	38.2	4.7	5.8	6.4	8.9	28.0	13.5	2.4	0.9	21.2	11.0	11.4	9.8	8.8	5.1	22.4	16.2	11.5	3.5	28.9	1.6	32.4	9.0	2.1	14.9	21.3	39.7	2.3	0.6	0.7	2.4	0.3	2.3	0.9	1.7	1.5	0.7	0.4	0.3	6.1	0.1	26.9	3.0	1.1	2.4	0.8	4.5	0.3	3.0	0.4	0.2	2.6	0.2	0.2	0.4	0.3	0.9	0.3	1.3	0.8	3.4	12.1	0.6	0.1	2.9	0.5	1.5	0.0	14.3	0.6	1.0	3.7	0.4	0.1	1.0	13.3	2.5	0.2	0.3	0.2	1.7	0.4	0.8	6.7	0.6	12.0	6.6	1.1	1.5	0.6	1.0	0.4	0.2	4.1	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	35.0	30.3	29.2	31.4	21.3	33.6	29.6	28.0	22.4	28.9	39.7	130.6	0.0	11.7	143.0	0.7	2.7	5.8	2.6	13.1	0.5	4.5	4.8	15.7	2.8	3.6	69.9	0.0	0.2	1.4	1.7	7.9	1.1	1.6	11.8	2.4	53.0	0.0	0.0	1.5	0.7	0.4	6.3	18.3	21.2	3.8	1.5	20.7	0.2	0.9	0.0	2.9	6.6	4.1	0.6	2.6	3.7	24.2	1.5	5.4	12.2	0.0	1.5	2.1	10.6	45.7	5.8	6.3	8.6	4.4	11.6	0.8	41.3	1.9	0.5	6.6	2.7	5.1	1.2	1.6	1.4	3.3	0.3	1.3	6.6	0.8	17.2
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 142.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	5.3	45.6	105.0	1.8	113.1	0.2	6.8	69.8	141.6	6.1	49.1	2.1	2.4	5.6	3.1	2.6	3.4	4.7	7.5	142.3	77.7	5.3	34.6	11.4	2.0	61.2	75.0	13.1	4.5	4.0	6.2	2.6	60.8	4.1	1.6	18.8	2.4	3.3	1.5	14.9	2.3	5.4	55.7	0.6	7.7	4.7	128.3	2.2	5.5	1.7	2.0	5.3	3.2	121.9	0.1	0.2	3.2	0.5	0.1	0.3	0.1	1.1	0.7	0.1	0.3	0.0	3.7	0.0	0.2	0.0	0.2	0.7	2.8	0.7	0.3	0.2	5.9	0.6	2.8	0.0	0.0	3.2	0.9	0.1	0.9	0.0	0.0	3.2	3.5	1.6	0.0	21.5	0.1	0.1	0.2	0.2	0.4	1.8	0.4	0.1	0.7	0.0	0.0	6.6	8.3	3.0	0.1	0.1	1.1	1.6	0.1	0.1	1.0	0.1	0.3	0.0	0.3	11.0	23.0	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	113.1	69.8	141.6	142.3	77.7	61.2	75.0	60.8	55.7	128.3	121.9	14.7	3.2	2.8	23.2	1.9	6.1	1.1	0.1	2.8	3.5	5.5	3.9	6.9	0.0	0.0	0.0	45.9	0.1	0.1	0.0	0.0	1.7	2.5	1.2	0.2	32.4	7.8	0.0	441.1	2.7	0.1	4.8	3.1	0.9	0.0	3.3	23.9	11.8	0.1	1.7	416.6	0.5	0.0	1.2	2.1	1.4	4.4	0.2	3.6	142.4	0.0	1.3	0.0	303.1	28.4	1.5	0.1	1.5	1.6	0.5	0.0	0.0	0.0	9.2	0.0	0.4	1.2	0.7	4.1	1.6	3.8	0.1	0.6	4.2	0.1	0.7
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635231	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.1;Excitatory neurons: 243.0;Inhibitory neurons: 253.7;Microglial cells: 182.7;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 479.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	3.9	5.0	8.4	12.7	8.3	12.6	7.4	35.5	12.3	4.7	0.4	5.0	3.8	4.7	4.8	4.0	3.9	5.7	3.1	10.1	11.4	4.2	6.5	6.9	21.2	17.4	8.4	6.0	4.2	6.7	2.9	5.9	19.3	4.9	5.6	8.1	4.0	3.4	3.5	4.6	4.1	4.1	4.3	8.8	4.7	12.1	12.7	15.0	4.9	3.4	18.1	5.6	3.5	17.4	9.6	6.6	9.8	9.4	5.1	5.6	9.4	10.5	8.4	8.6	13.1	13.0	6.6	22.2	6.7	7.4	14.1	8.5	13.1	11.9	17.8	11.1	7.6	13.8	9.6	7.6	4.3	9.9	14.3	4.3	6.4	12.8	12.9	6.2	7.9	12.6	8.0	13.2	8.0	5.1	10.3	9.2	4.6	5.5	5.2	15.0	13.5	12.2	6.8	7.5	34.5	7.5	11.3	5.3	13.4	10.9	6.8	8.7	7.8	11.6	8.1	9.5	11.9	7.7	9.7	23.9	6.7	13.2	10.0	2.3	2.1	7.8	6.8	2.4	11.6	5.0	9.2	7.5	1.6	5.8	15.4	11.2	9.9	6.4	1.9	1.9	11.7	7.1	8.4	8.3	35.5	12.3	10.1	11.4	17.4	8.4	19.3	4.3	12.7	17.4	5.8	12.8	15.5	119.1	29.1	15.8	5.2	3.7	14.8	11.7	7.2	5.5	4.1	1.5	6.6	7.3	20.9	6.1	7.7	6.0	1.9	4.7	36.4	5.8	5.1	7.0	13.8	13.3	243.0	2.8	3.2	7.0	8.2	9.9	2.5	9.7	7.9	6.0	7.8	1.7	253.7	7.9	0.0	11.4	23.1	16.4	4.4	12.0	14.2	182.7	10.2	3.0	13.4	189.0	479.5	4.1	5.8	5.3	19.1	7.1	3.4	2.3	7.8	8.5	0.0	6.2	6.1	12.7	9.7	10.9	17.5	7.0	28.4	4.0	6.2	6.2
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535335	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		69000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.1	6.5	1.5	5.2	4.6	3.1	13.3	1.3	7.9	9.4	0.3	7.0	7.8	5.6	4.6	8.8	5.1	8.9	5.9	5.0	8.5	7.2	61.6	14.3	3.7	2.4	7.0	2.0	6.4	5.6	3.6	13.0	4.1	6.6	7.3	7.3	8.6	4.3	6.6	8.9	7.9	7.8	0.1	16.9	8.8	9.4	2.7	2.6	30.0	6.2	4.9	7.7	6.6	2.2	11.1	7.5	15.6	9.0	12.0	15.4	14.7	15.1	11.0	15.3	19.1	35.0	11.4	0.0	3.7	23.1	11.2	5.8	8.2	12.9	31.7	2.2	4.6	0.0	17.9	6.2	30.0	0.1	0.2	21.5	10.7	28.1	29.4	16.8	24.2	1.7	0.8	8.2	31.0	6.2	0.1	0.0	9.2	5.7	10.0	0.2	22.0	6.9	11.2	34.9	5.5	7.5	10.3	9.8	12.5	20.4	5.5	0.5	29.0	37.5	12.5	18.2	16.1	3.8	7.7	0.1	30.9	0.2	8.4	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	1.5	4.6	1.3	7.9	5.0	8.5	2.4	7.0	4.1	0.1	2.7	2.2	36.3	16.0	8.4	12.7	1.2	49.1	20.7	10.3	16.5	11.3	21.6	9.4	1.1	15.7	9.7	14.7	14.6	8.9	0.8	32.9	7.9	6.3	14.4	24.4	17.7	29.0	2.4	3.2	84.0	9.3	7.6	23.4	47.9	65.7	1.3	6.2	103.5	79.6	18.1	10.1	56.7	8.6	4.1	17.8	51.1	4.9	4.7	28.8	12.4	92.8	3.3	18.6	0.0	41.2	9.1	20.5	21.3	4.9	0.1	19.0	22.4	2.8	5.2	4.4	19.7	26.8	33.4	29.3	19.6	26.9	40.9	10.9	2.8	0.9	13.3	28.4
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437764-47449143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 88.9;tongue: 33.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 63.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 238.7"	"Low region specificity"	"Detected in some"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	0.3	1.5	0.5	0.2	0.5	0.3	0.2	0.3	1.2	0.2	0.9	0.8	0.1	0.0	0.1	1.2	0.1	0.1	2.6	0.5	0.5	0.3	0.5	0.4	0.2	0.3	0.5	0.0	0.2	0.0	0.1	2.1	0.5	0.7	0.0	0.1	1.3	0.0	88.9	0.5	0.5	0.1	0.4	0.6	0.2	0.3	0.6	0.1	0.2	33.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.7	0.1	0.2	1.2	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	238.7	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.2	0.5	0.5	0.3	0.5	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	2.7	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.3	13.8	0.0	0.5	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	63.8	0.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.2	0.1
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5"	"Region enriched"	"Detected in all"	9	"basal ganglia: 109.2"					"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	4.1	7.0	3.5	2.6	15.0	0.0	6.9	2.2	6.6	9.3	7.2	6.0	1.7	7.4	6.7	7.9	6.0	5.3	14.0	3.5	1.4	15.1	6.5	5.3	6.7	3.4	1.7	11.5	1.3	6.0	7.5	14.4	0.9	12.5	2.2	13.6	13.1	11.2	2.4	1.1	2.0	5.9	1.4	4.9	3.9	0.6	2.4	1.2	9.1	5.3	4.2	7.2	6.1	3.7	0.0	1.9	1.2	6.4	13.7	3.6	0.0	1.6	0.8	0.0	0.6	0.3	0.1	0.1	0.2	2.5	0.3	0.4	0.0	0.3	0.0	0.1	16.0	0.1	0.1	1.1	0.3	0.2	0.1	7.1	0.0	0.0	0.0	82.3	13.4	0.1	0.1	5.6	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.6	8.3	0.0	0.2	0.1	9.1	0.0	0.1	0.0	1.1	0.1	2.1	7.0	0.2	0.0	0.1	5.6	0.2	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	15.0	2.2	6.6	3.5	1.4	3.4	1.7	0.9	1.4	2.4	3.7	2.4	0.0	0.5	41.4	0.3	0.1	18.0	6.4	1.8	4.5	1.7	7.5	12.0	12.8	14.9	11.0	25.0	0.2	0.8	0.0	0.0	1.6	1.5	8.3	4.2	10.5	0.0	0.0	66.8	0.9	0.1	6.8	7.7	3.0	0.0	0.1	22.1	2.1	0.4	5.0	92.6	0.0	2.0	1.9	0.4	1.2	0.0	0.3	0.0	29.0	0.0	24.8	0.0	19.6	2.9	1.4	0.0	0.0	0.2	10.2	0.6	0.6	9.2	6.3	0.0	2.9	9.7	0.2	1.0	6.6	0.1	0.3	0.5	0.2	0.2	9.7
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 221.9;fallopian tube: 206.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 93.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"CAPAN-2: 1319.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	221.9	21.3	1.0	65.1	1.5	0.6	44.6	1.5	1.7	74.6	11.3	31.7	5.1	25.9	27.0	11.3	206.4	19.7	81.5	1.5	0.8	25.1	4.2	52.7	18.9	0.6	0.4	60.5	10.0	0.2	27.7	3.5	0.4	78.6	36.2	0.9	165.3	37.2	5.6	8.3	38.5	51.2	0.4	2.7	23.7	4.5	1.0	1.8	20.4	2.8	6.2	92.1	32.2	1.4	19.2	6.9	0.2	1.0	4.0	12.6	0.3	1.8	5.7	1.0	1.4	1.4	1319.3	0.0	1.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.1	12.0	0.0	0.0	131.3	0.0	0.5	0.0	8.9	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.7	5.8	0.0	0.0	0.0	0.1	0.3	22.9	0.5	1.7	16.7	1.3	0.3	0.0	1.9	2.3	1.3	1.1	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	1.5	1.5	1.7	1.5	0.8	0.6	0.4	0.4	0.4	1.0	1.4	5.2	0.0	0.6	2.3	0.9	0.5	217.1	92.7	11.4	0.4	99.7	35.6	0.9	11.5	621.4	14.7	0.0	2.9	1.6	59.0	0.0	10.5	29.5	14.4	98.4	18.1	37.5	3.6	14.2	4.7	0.8	101.3	1.1	16.9	29.9	0.3	31.8	6.0	10.8	0.0	10.6	102.3	40.7	1.6	1.7	33.1	10.8	11.0	5.4	1.9	0.0	4.2	0.0	4.5	7.6	2.3	106.1	1.2	1.2	312.9	140.7	19.7	149.3	0.7	0.0	7.7	46.7	3.8	0.7	7.8	0.4	11.4	3.3	0.1	88.3	737.7
RARS1	"DALRD1, RARS"	ENSG00000113643	"Arginyl-tRNA synthetase 1"	P54136	5	168486451-168519301	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	27.5	25.6	12.7	31.5	12.3	12.8	36.3	19.6	15.6	22.9	9.4	37.6	54.8	26.7	33.5	38.2	25.8	23.4	29.5	12.8	11.2	33.2	43.5	22.0	31.0	9.0	10.7	23.0	34.4	32.7	16.6	36.5	9.8	27.9	43.0	17.2	32.9	23.5	31.1	41.8	48.7	32.8	5.4	21.8	32.8	23.2	12.1	23.5	30.2	34.6	40.6	41.1	25.2	21.4	100.2	115.6	82.5	94.2	113.4	128.9	143.9	143.4	122.3	145.7	168.7	198.4	105.6	104.3	114.2	137.2	149.3	93.9	111.0	192.7	188.5	110.1	76.5	71.2	103.1	126.5	96.8	169.2	72.6	99.7	100.8	159.0	76.0	89.3	118.5	56.4	107.7	51.9	158.1	92.4	70.7	68.7	138.1	86.7	77.8	30.3	122.0	99.7	129.7	110.8	79.6	97.7	109.1	124.7	152.7	101.1	113.4	69.9	118.7	104.7	96.3	81.9	169.4	51.8	100.3	105.7	114.3	118.0	101.9	5.2	21.5	8.2	17.4	27.3	20.2	15.5	17.2	18.8	32.1	9.5	21.2	22.6	5.8	26.6	26.7	14.7	19.3	18.2	12.7	12.3	19.6	15.6	12.8	11.2	9.0	10.7	9.8	5.4	12.1	21.4	10.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.0	0.0	0.0	104.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	96.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	84.3	1.4	0.0	0.0	0.0
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87513938-87589987	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	24.0	39.6	10.8	15.8	11.8	19.3	21.3	14.7	11.6	21.5	19.2	20.8	17.8	21.8	18.6	17.7	19.7	19.0	22.7	10.4	11.4	20.5	27.9	18.3	16.8	11.5	11.6	18.5	24.0	21.4	17.5	22.2	11.8	18.8	22.7	25.9	20.8	13.6	22.5	18.5	22.6	21.5	11.0	18.5	19.2	25.3	12.5	18.5	20.6	19.3	19.0	20.6	18.2	15.5	19.8	19.1	45.1	49.8	44.6	47.5	31.9	46.6	54.2	30.8	38.6	36.6	21.6	25.0	26.9	47.4	32.0	26.7	37.9	25.8	43.2	18.0	36.0	25.7	24.4	58.7	56.1	30.7	21.3	48.9	24.6	26.4	33.1	44.5	41.0	25.7	59.6	24.4	46.8	35.2	10.0	32.8	29.2	42.3	20.0	19.9	45.9	22.2	38.5	40.1	40.8	54.7	24.8	12.1	33.1	38.2	22.5	45.8	28.1	21.2	16.8	22.8	38.4	25.6	45.1	21.1	32.2	31.8	36.6	18.8	17.8	22.7	16.1	18.6	19.0	15.1	20.4	15.1	15.6	16.2	19.9	16.9	11.9	18.6	20.7	17.9	27.9	15.4	10.8	11.8	14.7	11.6	10.4	11.4	11.5	11.6	11.8	11.0	12.5	15.5	34.4	19.2	15.6	30.0	21.2	17.3	35.4	51.3	12.5	13.9	17.3	16.8	19.9	10.0	37.8	11.0	20.9	31.0	18.1	14.6	45.0	32.9	95.3	23.5	29.3	22.8	9.0	7.4	46.8	46.9	45.5	28.3	12.8	20.3	18.3	27.9	23.6	15.5	20.5	6.7	59.0	23.5	44.7	13.5	14.1	50.6	25.4	15.0	19.6	38.4	22.6	13.6	19.6	56.3	63.9	37.6	21.2	24.0	20.7	30.8	57.2	32.9	24.2	20.3	26.3	18.9	30.0	61.8	33.7	14.1	18.0	39.5	20.6	51.4	27.0	33.9
RASA1	"CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA"	ENSG00000145715	"RAS p21 protein activator 1"	P20936	5	87267883-87391931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 96.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 196.7;Excitatory neurons: 192.1;Inhibitory neurons: 234.7;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 220.1;Syncytiotrophoblasts: 487.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007789, HPA036393, HPA064556"	Enhanced					NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB007789: AB_598183, HPA036393: AB_2675097, HPA064556: AB_2685285"	"unprognostic (1.57e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-3)"	16.4	14.6	12.3	15.1	14.5	13.9	18.6	21.8	15.6	17.4	9.9	14.7	12.4	21.1	20.3	16.7	15.6	16.2	12.9	15.6	12.5	15.2	12.4	15.0	19.7	9.6	13.2	25.8	13.3	24.8	11.5	96.8	12.7	14.1	17.5	34.6	15.4	15.3	9.5	18.6	13.8	15.5	9.5	19.1	13.7	26.7	11.2	25.3	24.4	15.7	18.1	17.0	12.6	15.5	31.7	16.1	31.0	20.6	26.5	37.3	23.5	47.5	32.0	30.3	49.2	13.0	82.9	20.7	11.1	54.9	33.8	15.4	14.0	40.7	95.0	19.9	11.1	15.6	15.3	13.7	25.3	12.7	18.6	21.0	27.1	84.1	48.5	51.5	42.5	11.8	8.8	44.4	109.3	20.5	14.7	21.8	16.6	6.9	29.5	17.5	66.4	30.0	29.0	27.7	18.2	20.1	18.4	24.4	29.6	29.4	21.7	20.4	61.3	38.3	17.6	21.1	60.0	16.0	15.6	20.5	55.1	25.3	27.3	2.1	0.6	0.9	0.9	1.2	1.6	0.7	1.2	1.0	0.5	1.1	1.0	0.9	0.8	3.9	1.2	0.6	1.8	0.5	12.3	14.5	21.8	15.6	15.6	12.5	9.6	13.2	12.7	9.5	11.2	15.5	18.6	12.8	15.8	86.5	13.9	14.9	6.7	12.5	16.5	35.7	18.5	11.4	6.4	7.2	15.2	16.5	29.2	196.7	11.5	12.5	5.9	10.4	7.7	15.7	18.3	20.2	16.2	12.8	192.1	7.8	53.7	16.2	18.3	16.5	8.8	22.1	18.2	11.7	47.8	32.0	234.7	12.9	12.2	27.1	9.5	4.8	14.0	21.2	14.2	128.4	13.6	12.6	7.2	165.4	220.1	23.4	14.8	13.5	15.9	11.9	10.7	11.2	19.1	18.6	0.0	21.6	15.0	33.9	20.0	17.7	17.5	487.5	17.7	16.4	13.8	11.2
RASA2	GAP1M	ENSG00000155903	"RAS p21 protein activator 2"	Q15283	3	141487027-141615344	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035374, HPA035375"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA035374: AB_10602122, HPA035375: AB_2674596"	"unprognostic (1.85e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.36e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.23e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (7.62e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.34e-5)"	7.3	4.7	5.1	15.4	6.0	21.9	10.0	7.1	6.4	9.8	3.2	6.6	5.3	8.4	7.3	7.3	7.8	6.7	4.6	5.3	4.9	5.8	5.1	9.7	21.3	4.0	3.6	9.7	5.2	4.4	6.2	8.3	3.5	6.5	7.2	14.6	8.1	5.0	3.8	11.2	8.5	6.0	3.1	12.4	5.4	4.7	4.7	13.3	6.0	3.3	17.2	8.8	8.8	5.6	24.6	4.5	9.5	7.2	10.2	12.6	13.5	17.4	34.0	11.0	13.5	10.5	7.9	15.6	11.7	15.2	10.6	10.0	6.8	7.5	20.0	8.5	6.7	8.4	3.8	3.8	5.4	16.1	21.0	7.3	6.6	10.0	11.8	13.3	14.1	13.1	7.7	19.7	11.0	3.6	21.2	13.0	11.1	8.1	3.2	7.9	16.0	19.5	10.9	8.7	3.3	6.9	13.8	12.1	13.0	9.8	6.0	12.0	11.9	12.9	5.9	18.1	7.8	31.9	10.0	20.9	11.3	10.8	6.4	12.8	4.9	5.3	14.8	5.0	14.8	8.9	13.2	15.3	4.6	13.5	21.6	17.2	19.2	15.7	8.9	3.6	13.2	8.0	5.1	6.0	7.1	6.4	5.3	4.9	4.0	3.6	3.5	3.1	4.7	5.6	24.2	44.8	23.6	59.4	55.1	21.5	52.0	15.8	21.1	16.2	22.0	17.5	7.4	8.6	21.4	12.9	37.5	20.0	104.9	21.7	1.9	16.8	120.3	26.3	19.7	22.7	15.7	17.5	196.9	16.5	6.6	20.4	11.2	60.7	31.6	29.6	20.3	9.6	12.5	30.3	123.1	15.2	8.2	32.5	24.6	12.7	13.7	34.3	12.4	94.6	19.8	15.3	68.0	112.1	94.4	31.8	21.7	14.3	94.9	53.4	10.4	9.1	15.5	50.7	6.6	26.4	27.2	28.2	15.3	17.5	27.4	13.1	88.3	4.6	18.7	62.5
RASA3	"GAP1IP4BP, GAPIII"	ENSG00000185989	"RAS p21 protein activator 3"	Q14644	13	113977783-114132623	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.0;Horizontal cells: 60.6;NK-cells: 48.4;Plasma cells: 40.0;T-cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046759	Uncertain					NA	NA		1400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA046759: AB_10959887"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.99e-6)"	"unprognostic (8.98e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.08e-2)"	"unprognostic (4.11e-2)"	32.2	3.5	7.6	10.9	8.7	12.7	23.2	6.5	9.8	24.4	3.8	17.0	2.9	13.7	1.1	4.9	19.2	4.6	12.9	8.5	8.3	11.2	5.0	19.3	15.6	9.6	8.9	7.6	10.8	0.7	15.2	5.3	9.3	11.3	2.7	2.6	6.8	3.6	14.2	13.0	15.8	4.7	8.0	22.6	9.4	5.9	10.0	9.0	14.4	4.2	7.7	18.5	15.0	14.6	3.8	4.6	20.2	5.8	19.2	21.3	0.0	14.8	22.1	13.1	10.9	0.4	11.6	0.4	8.2	24.1	10.9	0.0	3.0	7.0	10.1	0.9	1.3	29.4	14.1	0.1	9.7	12.3	2.5	19.2	1.4	12.7	9.1	16.2	22.3	0.6	2.2	3.3	19.9	5.1	27.1	20.5	4.3	3.2	6.8	13.6	7.4	60.6	11.9	0.1	2.9	2.1	3.5	15.2	7.5	8.3	3.8	44.7	30.5	19.7	5.4	7.2	16.2	0.1	0.0	0.8	25.7	11.9	32.1	16.7	4.5	6.4	16.9	7.6	12.8	5.2	15.6	17.0	3.0	3.9	16.3	16.4	2.5	12.7	15.3	1.0	19.2	16.9	7.6	8.7	6.5	9.8	8.5	8.3	9.6	8.9	9.3	8.0	10.0	14.6	5.3	0.0	4.2	27.1	20.6	3.7	1.2	0.7	2.2	7.9	2.0	4.6	7.5	1.5	3.5	1.8	0.0	0.1	55.0	0.3	0.0	1.1	1.5	7.8	13.3	9.3	3.0	5.5	25.6	2.0	0.2	15.2	3.6	5.1	26.0	1.8	3.9	2.4	9.3	60.6	12.2	2.6	2.0	15.1	12.1	0.7	8.7	19.6	10.6	36.5	11.4	1.3	48.4	17.6	27.5	12.5	0.2	3.8	40.0	1.6	0.1	0.4	13.2	3.5	0.0	18.9	11.5	8.6	5.4	0.4	4.8	0.5	45.2	2.5	0.7	1.6
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616756	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 254.9;tongue: 88.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 73.9;Enteroendocrine cells: 71.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 48.9"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	38.9	17.5	22.9	10.8	18.8	6.0	31.2	22.7	23.0	37.4	3.6	29.8	10.9	37.7	4.7	10.8	28.4	6.3	14.5	22.5	22.8	29.2	2.6	22.1	13.8	21.5	25.9	25.2	12.3	12.8	24.2	13.0	17.3	23.4	4.0	13.3	12.9	18.0	254.9	17.3	21.6	7.5	17.2	16.8	16.1	5.4	22.7	4.8	17.3	88.6	7.1	26.0	29.0	16.3	1.1	1.5	14.1	2.6	1.8	5.8	0.6	16.3	7.6	4.3	4.9	6.1	3.1	9.9	11.9	24.0	0.3	12.7	0.6	0.1	1.7	1.7	2.4	3.2	4.1	1.0	2.1	2.0	4.4	6.4	1.4	1.4	0.4	18.7	2.7	6.5	5.9	17.0	1.4	4.0	8.6	7.1	1.0	6.6	7.3	17.5	2.9	16.5	0.4	5.0	12.7	25.3	2.3	2.3	1.9	7.5	1.1	5.7	3.0	48.9	22.3	4.9	4.1	28.9	18.5	7.7	4.3	4.5	5.9	0.4	7.9	0.2	1.3	8.6	3.0	3.2	2.4	1.8	10.9	2.9	2.5	1.5	1.8	1.4	1.1	9.2	3.3	3.8	22.9	18.8	22.7	23.0	22.5	22.8	21.5	25.9	17.3	17.2	22.7	16.3	26.8	12.8	10.9	15.0	8.3	3.8	4.5	1.3	0.6	73.9	2.0	3.0	1.1	2.8	5.2	3.7	16.7	0.2	7.2	5.9	13.7	1.1	0.4	3.3	13.0	24.9	71.8	5.7	5.6	0.7	0.2	5.0	3.1	2.9	1.3	13.6	3.3	1.4	6.0	28.6	6.6	11.8	0.0	11.6	22.8	0.3	8.4	13.3	1.8	4.7	14.2	9.4	6.2	5.5	1.4	1.7	2.8	7.9	4.0	2.9	19.9	8.4	6.2	11.7	13.1	21.3	10.0	3.4	3.3	1.3	3.4	0.4	6.4	5.6	2.9	4.1
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102479976-102517777	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 130.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Bipolar cells: 3.3;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.2;intermediate monocyte: 2.0;myeloid DC: 3.3;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.3;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.1;U-138 MG: 17.0;U-2 OS: 14.9"	"Low region specificity"	"Detected in all"							HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	14.0	5.8	6.5	4.2	6.1	2.2	10.8	6.3	7.9	13.3	3.0	11.9	6.4	16.5	1.3	2.8	9.7	3.7	4.7	6.2	8.0	6.4	0.8	6.0	4.7	7.8	8.3	9.6	2.4	5.2	5.8	4.9	6.7	8.1	1.8	5.3	4.5	7.6	130.9	5.5	7.8	3.8	6.6	5.9	4.9	2.1	7.6	1.9	3.8	19.2	2.8	9.5	9.5	7.5	0.2	1.4	3.7	0.5	1.3	2.9	0.2	6.8	4.4	2.2	3.6	0.5	1.1	3.4	7.3	8.6	0.7	9.1	0.0	0.0	1.1	0.5	1.6	0.5	2.7	0.8	1.2	0.3	0.5	2.9	0.8	0.1	0.2	10.4	0.9	1.7	0.9	9.8	0.7	3.0	2.9	1.9	0.3	1.7	1.9	2.8	1.5	4.6	0.1	0.9	3.1	15.1	1.0	0.5	0.5	3.0	1.0	2.0	2.0	17.0	14.9	1.8	0.6	3.5	2.9	2.4	2.3	0.9	2.8	0.0	2.2	0.0	0.3	2.0	0.2	0.1	0.3	0.1	3.3	0.2	0.3	0.4	0.3	0.0	0.4	2.1	0.3	1.2	6.5	6.1	6.3	7.9	6.2	8.0	7.8	8.3	6.7	6.6	7.6	7.5	0.6	0.0	0.6	2.9	1.1	0.4	0.2	0.0	1.2	3.3	0.1	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.9	0.1	0.0	0.1	0.3	1.8	2.4	0.4	0.5	0.2	0.0	0.3	5.6	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.6	0.9	0.0	0.3	1.0	0.0	1.0	0.6	0.6	0.0	1.5	0.0	0.1	0.0	0.0	2.5	0.2	1.3	0.3	0.1	0.6	0.0	0.5	0.8	0.3	0.0	0.3	1.1	0.1	1.6	0.3	0.0	0.2
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094104-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 505.8;Inhibitory neurons: 398.4;Microglial cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	Yes				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	10.3	3.6	1.7	2.8	3.2	0.6	8.0	0.0	7.4	7.3	0.1	4.2	2.7	6.1	3.6	17.0	5.5	7.5	13.6	4.3	0.8	5.8	3.0	9.4	1.8	0.0	1.0	3.6	4.6	4.6	5.9	9.4	0.0	5.0	4.4	28.9	6.6	4.4	4.6	7.0	3.4	6.6	0.0	3.2	3.7	8.9	5.1	1.8	5.3	10.0	2.9	5.0	10.5	2.4	30.9	8.9	12.1	4.2	8.6	11.6	17.3	13.2	13.6	11.7	8.5	14.8	15.6	0.0	23.0	13.2	19.7	25.2	10.2	23.0	10.7	0.0	5.0	0.0	9.8	7.1	10.0	4.7	0.5	35.1	5.2	13.4	54.1	13.7	10.3	0.0	1.0	0.0	16.5	3.2	0.0	4.2	10.1	6.4	1.8	0.1	5.2	0.0	7.2	3.6	8.8	4.4	10.9	9.5	9.0	10.8	10.4	5.5	18.9	15.1	15.7	17.2	21.0	6.5	0.1	0.1	13.3	2.4	11.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	3.2	0.0	7.4	4.3	0.8	0.0	1.0	0.0	0.0	5.1	2.4	99.8	76.9	12.9	47.3	1.0	15.9	10.0	15.7	8.0	50.7	17.8	11.7	37.4	17.2	18.2	16.5	152.2	15.0	1.0	9.0	5.9	21.8	17.4	33.6	43.0	66.2	34.1	0.0	505.8	12.5	16.4	18.4	17.9	27.6	7.6	19.0	35.3	6.7	16.8	84.1	398.4	15.7	6.1	4.5	21.6	7.3	19.6	16.5	3.6	271.7	8.5	24.7	0.0	154.3	101.3	33.6	5.2	23.0	2.9	32.6	4.9	6.6	34.7	175.5	65.7	22.7	56.9	40.5	34.5	17.8	24.2	41.9	2.3	8.3	12.6	38.2
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 371.9"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 425.1;Muller glia cells: 375.3;Peritubular cells: 469.8;Sertoli cells: 565.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	46	"plasmacytoid DC: 160.1"	"Lineage enriched"	"Detected in many"	46	"dendritic cells: 160.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 70.2;REH: 71.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 75.6;hippocampal formation: 54.9;thalamus: 53.2"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	244.7	53.5	48.7	5.9	63.7	9.3	153.3	31.1	83.6	69.2	13.4	16.1	5.4	22.8	11.9	11.7	32.7	12.6	91.0	60.8	61.9	181.7	271.3	25.4	3.0	71.6	49.8	53.7	30.1	4.2	371.9	1.3	39.4	32.7	6.5	47.7	97.8	55.7	183.1	44.1	12.2	3.4	45.7	18.6	42.2	47.7	40.4	13.1	88.4	103.0	1.2	16.6	26.3	53.6	0.0	0.3	0.3	0.0	70.2	3.8	0.3	0.9	1.4	0.1	0.2	3.0	0.0	0.0	8.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	0.9	0.3	0.3	8.3	0.5	0.1	0.3	17.1	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.2	7.5	13.8	1.3	1.4	1.3	4.5	71.0	0.1	0.1	1.5	0.0	12.9	0.4	1.1	0.9	16.3	2.1	0.1	0.1	4.1	0.1	0.7	0.5	0.2	14.5	0.6	0.2	0.4	0.0	0.5	0.0	0.4	0.0	0.4	3.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.8	160.1	0.1	1.0	48.7	63.7	31.1	83.6	60.8	61.9	71.6	49.8	39.4	45.7	40.4	53.6	172.2	28.9	36.8	21.2	11.0	17.2	96.2	46.6	27.3	51.4	106.9	147.2	71.2	20.0	33.5	149.0	4.2	3.3	45.8	42.9	13.7	93.5	2.7	150.9	264.2	31.1	222.4	0.4	15.0	1.3	2.2	191.1	86.6	425.1	8.8	40.3	9.7	21.6	3.6	6.7	5.2	262.7	260.4	3.1	22.2	8.1	109.6	27.3	30.2	1.9	2.2	375.3	0.0	17.1	1.6	9.0	21.8	469.8	56.1	73.3	16.8	13.8	7.2	23.8	565.4	228.1	191.7	1.7	3.0	54.8	13.2	6.7	27.0	73.7	32.9	20.0
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540831-35553999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 212.9"	"Group enriched"	"Detected in some"	4	"Intestinal goblet cells: 13.1;Sertoli cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 212.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;hTERT-RPE1: 9.8;SK-BR-3: 5.6;U-2 OS: 3.1;U-87 MG: 4.0"	"Region enriched"	"Detected in all"	8	"basal ganglia: 589.6"	"Region enriched"	"Detected in all"	8	"basal ganglia: 429.3"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.8	7.3	30.8	2.5	212.9	3.8	2.3	0.0	30.7	3.1	0.0	28.2	2.3	4.7	15.0	1.9	5.6	2.2	8.6	12.5	9.9	1.5	0.4	3.2	0.4	4.6	12.5	1.2	1.6	1.2	2.1	0.2	6.4	15.2	4.0	0.5	4.0	22.7	15.0	1.6	6.2	7.3	1.8	0.2	3.8	0.7	48.4	0.7	1.2	4.5	1.2	4.3	2.5	9.0	0.1	2.2	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.8	0.6	0.1	0.4	0.0	0.1	1.9	3.1	0.1	0.1	0.0	0.7	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.1	2.5	1.6	0.2	9.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.0	1.5	0.2	1.6	5.6	0.0	0.1	0.4	0.1	0.0	1.3	3.1	0.1	0.7	1.4	0.5	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	212.9	0.0	30.7	12.5	9.9	4.6	12.5	6.4	1.8	48.4	9.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	1.7	2.9	3.3	1.9	0.0	0.2	0.0	0.0	0.0	0.7	3.0	0.0	0.2	0.1	0.1	0.2	2.9	0.0	0.0	3.2	0.2	0.0	3.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.6	13.1	2.0	0.0	0.8	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.7	0.0	2.3	0.7	0.0	0.5	0.1	0.0	0.1	0.2	46.0	0.4	6.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.3
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
RASGEF1A	"CG4853, FLJ37817"	ENSG00000198915	"RasGEF domain family member 1A"	Q8N9B8	10	43194535-43267065	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;brain: 19.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035593	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA035593: AB_10602083"	"prognostic favorable (1.86e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.11e-7)"	"unprognostic (2.88e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	0.8	1.6	18.8	1.3	17.0	14.6	3.3	11.6	19.3	1.7	5.2	0.8	0.9	1.2	0.4	1.1	2.5	2.3	1.5	19.2	14.6	2.6	0.4	1.6	5.3	15.0	15.2	1.2	3.7	4.3	4.4	0.7	13.6	1.4	0.4	1.3	3.4	1.7	0.8	0.8	1.3	1.2	13.1	3.8	0.7	2.3	18.4	1.0	0.8	0.7	3.7	1.2	2.6	17.0	9.7	8.2	0.0	0.1	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.2	5.2	8.4	8.6	0.8	0.0	0.1	1.3	7.7	0.0	0.0	6.3	0.0	0.1	0.4	3.7	0.0	3.0	2.0	8.7	0.7	0.0	0.0	0.0	0.4	17.2	0.0	0.0	1.9	0.0	0.2	0.8	4.3	0.0	0.0	0.0	0.2	0.6	4.5	15.6	0.0	0.0	14.1	0.1	7.1	15.6	0.1	0.1	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	6.1	2.9	0.5	1.1	0.2	0.7	2.2	2.9	2.6	0.2	1.4	9.4	6.3	0.4	5.1	0.0	1.2	18.8	17.0	11.6	19.3	19.2	14.6	15.0	15.2	13.6	13.1	18.4	17.0	0.2	0.0	0.0	3.6	1.1	0.5	0.3	2.4	0.6	2.0	4.3	4.1	2.2	0.0	0.2	3.7	0.0	0.4	6.7	0.2	0.0	0.3	1.3	1.8	0.5	1.0	0.0	0.0	22.1	1.3	1.1	1.0	0.5	2.3	0.0	1.9	1.1	0.1	0.9	1.7	16.3	0.3	0.0	0.9	1.7	0.7	0.0	1.4	0.0	1.0	1.4	0.3	8.2	1.5	1.0	2.1	0.1	0.0	0.7	1.2	0.2	0.6	0.6	0.3	0.0	0.9	0.4	0.7	7.7	0.5	0.3	0.3	5.0	0.5	0.6	0.1
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0"	"Group enriched"	"Detected in all"	5	"B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	13.8	6.4	8.9	11.0	20.1	32.5	8.3	12.8	9.4	8.8	17.0	6.5	13.6	3.5	12.3	11.3	8.0	12.0	4.3	8.0	9.3	9.4	41.8	19.8	10.7	37.6	12.5	2.5	2.8	5.4	7.5	13.0	39.0	4.2	7.1	12.5	9.9	2.1	2.9	24.3	13.9	5.9	10.0	11.2	14.7	2.4	18.4	14.2	3.4	2.3	9.8	6.0	5.3	20.2	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	13.4	0.3	16.1	0.0	0.0	0.1	0.3	1.1	0.1	0.0	0.1	2.5	1.4	1.0	0.6	0.5	0.3	0.7	0.2	0.6	0.0	0.5	0.1	0.0	2.8	0.2	11.1	0.0	0.6	5.5	0.5	7.9	9.2	3.6	1.6	0.1	6.4	0.5	0.2	7.3	0.1	0.0	2.3	0.1	7.3	1.1	0.0	0.0	0.0	0.5	0.5	0.1	0.1	0.0	5.1	1.2	0.2	0.2	0.8	3.0	0.4	1.9	11.9	2.1	9.7	1.6	1.6	2.7	12.4	2.8	2.7	1.1	3.8	20.6	28.0	0.5	1.2	8.9	20.1	12.8	9.4	8.0	9.3	37.6	12.5	39.0	10.0	18.4	20.2	9.6	28.9	15.9	1.3	118.7	58.9	7.9	4.4	23.9	11.7	22.7	13.2	9.1	15.7	11.1	14.7	37.5	33.2	71.2	13.2	13.7	3.1	0.5	44.5	4.8	10.8	26.8	0.0	3.6	4.0	2.4	9.1	30.1	38.0	107.0	0.6	102.1	45.9	39.5	3.3	2.8	12.8	16.2	64.2	282.6	1.5	0.9	141.4	62.2	10.3	2.9	1.0	2.1	26.7	25.5	3.0	9.6	1.9	33.5	10.2	9.2	12.9	34.0	4.9	0.0	5.9	17.7	0.8	3.2	10.4	56.7	11.2	56.3	0.5	8.1	11.5
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100795-180209211	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.9;testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Microglial cells: 188.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HEK 293: 1.7;MCF7: 2.2;SCLC-21H: 7.6;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	0.3	0.2	6.2	0.2	16.4	0.0	0.4	21.9	8.5	1.3	0.0	3.4	0.1	0.0	0.1	0.3	0.5	0.3	1.3	7.1	3.2	0.2	0.0	0.0	0.0	7.3	4.4	0.1	0.1	0.0	0.1	0.1	7.5	0.9	0.2	0.3	1.1	0.9	0.0	0.5	0.8	0.1	5.2	0.0	0.7	5.8	4.1	0.0	1.1	0.0	0.0	0.7	1.1	7.6	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.4	21.9	8.5	7.1	3.2	7.3	4.4	7.5	5.2	4.1	7.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.8	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.5	0.0	0.0	20.2	0.0	0.6	0.1	0.0	0.5	0.0	1.5	0.0	0.0	0.1	0.0	12.5	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	188.3	0.0	0.2	0.0	15.1	19.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.7	1.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959906-79090780	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 26.5;lung: 7.5;retina: 7.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	0.1	0.1	4.2	1.0	4.1	0.0	0.1	24.4	24.4	0.6	0.0	0.2	0.2	0.4	0.1	0.1	0.4	0.1	0.0	12.2	6.4	0.7	0.0	7.5	1.3	13.9	10.2	0.8	2.3	0.6	1.1	0.2	16.4	0.5	0.2	7.4	0.1	0.2	0.0	0.0	1.4	0.1	8.7	0.6	0.2	0.3	14.9	0.5	0.0	0.0	1.4	0.3	0.1	26.5	8.5	0.1	0.1	0.0	0.0	0.0	7.7	0.0	0.4	0.5	1.2	0.0	1.5	0.4	0.2	0.0	0.6	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	10.4	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	13.0	0.1	0.3	0.8	0.0	0.0	0.1	1.6	0.7	0.0	1.7	0.0	0.0	15.1	0.0	0.3	0.0	3.8	2.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.1	24.4	24.4	12.2	6.4	13.9	10.2	16.4	8.7	14.9	26.5	0.2	3.2	80.6	8.5	4.5	0.6	0.6	0.2	0.0	13.7	0.2	0.1	1.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.6	0.4	0.5	0.0	0.0	80.9	0.0	2.7	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.0	25.2	91.2	0.0	0.0	0.3	16.1	0.0	0.0	1.8	3.6	5.6	0.6	1.1	0.0	1.5	121.5	0.3	0.0	0.4	2.1	0.2	0.0	6.8	2.0	2.5	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.8	0.1	1.6	0.0	0.4
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960363-81230162	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 220.6;Inhibitory neurons: 407.6;Microglial cells: 89.0;Oligodendrocytes: 395.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.9;MAIT T-cell: 5.2;memory CD4 T-cell: 2.6;memory CD8 T-cell: 1.5;naive CD4 T-cell: 4.2;naive CD8 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.8;CACO-2: 23.3;Hep G2: 31.8;HHSteC: 20.8;hTERT-RPE1: 15.3;SuSa: 16.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 24.5;cerebral cortex: 77.3;hippocampal formation: 46.6;olfactory bulb: 27.0"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	11.2	0.9	10.5	3.4	9.4	1.0	7.3	1.2	14.9	3.4	16.1	2.9	1.8	2.4	0.8	1.3	2.2	5.2	5.4	11.6	4.8	4.8	0.5	3.3	3.5	3.4	2.2	17.6	1.0	2.3	4.1	10.2	2.5	3.6	1.4	22.9	1.5	1.5	2.7	1.1	2.4	2.6	5.1	2.2	1.8	2.0	13.8	1.5	4.7	6.8	2.8	3.4	2.4	10.0	0.0	2.1	0.5	0.3	0.0	0.0	37.8	0.7	9.3	0.4	0.4	23.3	0.0	0.4	11.9	0.0	0.2	0.6	0.0	0.0	1.2	0.6	4.0	0.2	0.3	31.8	20.8	0.0	0.0	1.0	0.1	8.8	0.1	15.3	0.2	0.5	0.0	0.1	0.0	0.3	0.3	0.2	4.5	0.0	0.1	0.2	4.5	0.1	1.4	0.0	0.4	0.5	0.1	0.0	0.3	16.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.0	0.0	0.0	1.9	0.0	5.2	0.0	2.6	1.5	0.0	0.0	4.2	3.0	0.0	0.0	0.0	0.0	0.7	1.0	10.5	9.4	1.2	14.9	11.6	4.8	3.4	2.2	2.5	5.1	13.8	10.0	45.3	0.0	1.1	10.1	0.6	1.7	0.3	0.1	0.0	15.9	0.2	0.3	5.2	0.0	0.6	9.2	58.4	1.1	2.2	0.2	0.0	0.4	10.2	1.3	0.3	23.7	0.0	0.0	220.6	0.0	26.9	2.5	0.5	1.1	0.0	0.2	5.3	0.1	1.1	1.7	407.6	0.5	0.0	0.3	0.8	3.0	0.9	0.5	1.8	89.0	0.2	3.7	6.2	8.5	395.6	0.7	1.2	9.1	0.9	0.3	1.0	2.1	0.0	42.1	0.0	1.5	0.9	6.7	1.6	0.3	0.6	0.8	7.5	4.1	1.3	0.5
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 147.3;lymphoid tissue: 140.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	23.8	10.1	16.1	52.9	35.5	147.3	16.8	9.6	22.4	20.1	7.1	37.5	6.6	28.3	4.6	9.1	29.2	8.7	51.7	13.4	13.4	15.8	10.1	29.5	106.0	12.4	16.3	9.1	4.1	1.0	5.5	10.9	11.9	23.2	5.3	1.3	4.6	18.6	12.2	6.1	86.4	15.0	9.5	140.5	17.5	11.9	20.7	34.6	10.6	10.2	62.0	26.7	15.5	9.8	0.1	0.1	3.0	0.1	0.0	0.3	8.7	1.3	0.2	1.2	0.8	1.5	0.2	62.8	2.7	0.2	0.8	0.7	5.4	0.9	0.3	0.3	1.7	103.4	0.0	0.4	0.3	192.8	35.9	0.0	0.0	0.5	0.0	0.0	0.1	25.9	4.1	1.1	0.0	1.4	45.4	347.1	2.5	0.4	0.0	105.0	0.2	4.4	0.0	0.0	0.5	2.3	0.1	0.1	0.0	2.2	0.6	108.5	0.6	0.0	2.0	1.5	0.1	0.5	0.1	58.9	0.0	58.2	0.0	64.4	34.1	59.9	70.4	88.0	37.3	170.7	72.9	57.2	34.5	100.2	92.7	83.1	70.9	55.3	105.8	85.9	93.8	67.5	16.1	35.5	9.6	22.4	13.4	13.4	12.4	16.3	11.9	9.5	20.7	9.8	27.4	3.2	1.8	2.6	125.5	2.3	0.1	0.0	0.0	2.6	1.6	3.7	53.1	2.8	0.0	0.0	0.0	1.7	86.1	0.1	0.0	0.0	6.6	1.9	27.1	13.5	0.0	24.2	6.0	0.0	1.3	6.6	2.6	1.2	3.8	5.7	31.4	1.7	6.1	0.0	12.2	0.1	0.0	77.3	19.7	19.5	18.0	72.2	0.0	6.5	55.8	0.7	98.9	2.5	0.9	0.0	0.0	47.8	28.6	0.1	0.4	0.9	0.7	2.5	131.5	5.4	56.8	18.0	43.9	0.9	1.3	11.8	61.0	0.8	0.3	0.2
RASIP1	"FLJ20401, RAIN"	ENSG00000105538	"Ras interacting protein 1"	Q5U651	19	48720585-48740610	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 121.8;Endothelial cells: 83.9;Hepatic stellate cells: 94.2;Theca cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.7;HeLa: 13.9;HUVEC TERT2: 38.5;SiHa: 21.1;TIME: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077251	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA077251: AB_2732337"	"unprognostic (9.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (7.17e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.46e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	24.4	7.0	5.9	2.6	4.3	0.7	21.0	4.4	4.6	9.2	1.4	5.6	2.5	11.2	1.1	5.1	9.9	3.8	18.8	3.6	4.0	12.6	2.6	27.9	2.2	4.9	5.3	4.9	13.2	1.6	4.1	7.9	5.9	5.5	0.7	0.1	4.8	2.7	7.7	6.0	5.7	4.2	4.5	16.8	10.3	6.8	7.3	1.5	10.5	4.0	1.4	7.6	7.7	3.6	10.2	0.1	0.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.6	1.1	0.8	2.2	0.0	0.0	2.5	0.2	2.2	0.0	0.0	14.7	0.2	13.9	0.4	2.2	0.0	0.7	2.2	1.2	0.0	0.0	0.0	38.5	1.3	1.3	0.1	0.0	0.9	0.0	1.3	0.3	0.4	0.0	0.2	0.0	0.4	0.0	0.8	6.7	0.5	21.1	0.0	0.0	0.1	0.1	0.0	52.4	0.0	0.4	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	4.3	4.4	4.6	3.6	4.0	4.9	5.3	5.9	4.5	7.3	3.6	121.8	0.0	1.3	0.0	1.2	6.5	5.7	2.0	0.6	1.1	5.9	10.8	7.3	1.5	1.2	1.8	0.0	0.4	0.7	0.1	0.0	0.7	5.9	3.2	4.8	83.9	0.0	2.7	3.4	0.7	1.9	9.5	2.0	3.8	0.0	6.0	94.2	1.9	0.7	6.7	1.1	0.1	4.1	6.3	3.0	5.2	10.2	1.0	19.6	16.9	0.0	2.1	0.0	1.5	1.5	0.8	0.0	11.3	1.4	10.1	0.2	0.3	2.1	0.7	19.7	1.9	6.2	1.0	11.0	3.7	6.0	0.3	1.0	40.2	0.2	6.4
RASL10A	RRP22	ENSG00000100276	"RAS like family 10 member A"	Q92737	22	29312933-29319679	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Breast glandular cells: 35.9;Breast myoepithelial cells: 58.3;Excitatory neurons: 35.1;Rod photoreceptor cells: 19.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 3.4;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;NB-4: 2.5;U-2 OS: 1.1;U-266/70: 2.7;U-266/84: 1.0"	"Group enriched"	"Detected in many"	6	"amygdala: 33.7;basal ganglia: 16.7;cerebral cortex: 36.0;hippocampal formation: 26.3;white matter: 15.3"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 35.6;hippocampal formation: 27.8"	HPA056169	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA056169: AB_2683053"	"unprognostic (1.94e-1)"	"unprognostic (2.51e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.99e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.00e-4)"	"unprognostic (2.44e-1)"	"unprognostic (7.00e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.61e-3)"	0.9	1.4	26.6	0.3	23.2	0.1	2.0	6.3	28.7	0.4	5.3	0.7	0.3	0.6	0.1	0.4	0.6	0.1	3.8	24.5	13.4	1.2	0.9	1.2	0.1	9.3	11.6	0.2	0.4	0.1	5.0	0.2	10.4	2.0	0.0	2.6	1.0	0.1	0.7	0.7	1.1	0.0	9.0	1.2	0.5	1.8	13.3	0.1	1.1	0.1	0.1	0.5	0.3	16.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.4	0.0	2.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.1	0.0	1.1	0.0	0.1	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	23.2	6.3	28.7	24.5	13.4	9.3	11.6	10.4	9.0	13.3	16.2	3.9	0.0	0.0	17.9	0.4	0.4	0.6	0.0	0.0	6.8	35.9	58.3	1.1	1.5	0.0	0.0	6.2	0.2	1.0	0.7	0.0	0.0	1.3	0.8	0.3	3.1	0.0	0.0	35.1	0.0	4.7	0.5	1.5	1.4	0.0	0.5	7.9	0.5	1.1	0.0	4.4	1.1	0.0	2.6	5.8	0.5	0.3	2.7	0.0	4.7	0.2	3.3	0.0	3.0	3.9	0.1	0.1	0.0	0.3	1.7	0.2	0.1	0.2	19.6	0.0	13.4	0.5	1.5	3.9	0.3	0.6	0.5	0.5	0.6	0.4	0.2
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731639-35743521	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;skeletal muscle: 31.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 13.8;Early spermatids: 10.4;Late spermatids: 34.6;Muller glia cells: 29.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 24.3;HHSteC: 26.7;NTERA-2: 41.3;REH: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	15.4	1.7	25.9	0.1	32.3	0.0	11.3	8.7	25.6	3.9	7.6	1.9	0.7	2.8	0.6	0.4	3.9	0.7	19.3	26.5	18.1	3.0	2.1	1.2	0.1	16.5	19.2	3.7	4.9	5.2	6.7	2.8	18.0	2.9	0.1	9.0	9.1	14.7	31.5	0.8	1.2	0.7	13.2	0.3	1.8	3.0	17.5	0.4	1.7	0.9	0.1	1.4	2.3	12.9	0.0	0.3	6.3	0.0	1.1	0.6	1.8	1.2	0.8	4.3	3.6	8.1	0.0	0.0	0.7	0.2	0.0	0.0	24.3	0.0	1.5	0.0	8.0	0.0	4.1	9.3	26.7	0.0	0.0	19.5	1.5	1.5	0.0	3.4	0.0	13.2	5.5	0.0	0.3	0.5	11.6	0.0	41.3	0.0	0.0	20.8	11.1	18.5	0.0	0.0	18.3	17.8	1.2	0.4	1.7	17.8	2.3	1.2	0.0	2.0	14.5	0.1	0.5	0.0	0.0	5.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	32.3	8.7	25.6	26.5	18.1	16.5	19.2	18.0	13.2	17.5	12.9	0.3	0.0	0.5	0.3	0.0	0.1	0.5	0.0	0.0	3.9	2.7	1.4	13.8	4.3	0.0	1.8	2.1	0.0	0.0	0.0	0.0	1.3	10.4	1.0	0.7	0.7	0.0	0.0	2.6	0.0	0.0	1.9	0.0	1.4	0.0	2.8	0.0	6.7	0.2	6.7	4.9	0.2	0.0	0.6	0.0	34.6	2.1	0.1	0.0	1.0	0.0	29.0	0.0	0.5	0.5	0.3	0.0	3.0	0.0	0.6	0.4	0.1	0.0	1.2	0.0	1.5	2.3	4.8	0.9	0.0	0.0	0.3	0.1	7.0	0.4	0.2
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270830-27275192	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"ASC diff: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	32.9	4.1	1.9	3.1	3.2	2.3	21.8	3.1	3.1	21.4	2.1	20.4	7.7	21.6	3.9	9.8	22.0	3.8	11.3	3.2	1.7	30.4	12.9	13.0	10.8	1.8	2.2	9.5	4.9	1.4	10.6	2.9	2.0	20.3	12.5	0.1	5.3	5.6	3.5	10.1	20.9	5.5	2.2	14.8	13.4	2.9	3.3	1.2	12.1	1.7	10.0	19.1	15.9	2.4	0.3	1.3	0.3	0.6	42.4	4.3	0.2	1.9	1.8	0.1	0.1	8.1	0.8	0.3	0.5	1.4	0.9	0.1	2.5	0.8	0.1	1.7	8.8	1.8	0.2	0.5	6.8	0.6	0.6	5.0	0.7	0.1	0.1	1.7	0.6	0.7	0.3	0.1	0.0	0.8	0.0	2.4	1.5	8.0	10.2	0.5	0.0	0.2	1.4	6.2	0.7	0.3	0.7	3.3	0.2	1.0	0.2	0.8	0.3	0.1	0.3	2.9	0.4	0.1	0.0	0.0	0.4	1.9	0.1	0.4	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.1	0.2	0.1	1.3	0.1	0.0	0.1	1.9	3.2	3.1	3.1	3.2	1.7	1.8	2.2	2.0	2.2	3.3	2.4	29.6	16.0	11.2	0.3	6.0	4.6	3.2	0.9	17.6	0.0	6.2	11.9	1.4	0.0	8.6	7.3	0.0	0.7	4.5	9.3	3.9	1.8	0.0	5.1	9.8	5.9	0.0	4.0	0.6	2.4	0.2	30.1	42.3	6.1	0.0	2.1	2.5	0.2	1.4	0.0	0.6	5.6	4.1	0.8	6.5	0.0	0.3	6.1	1.8	1.9	1.7	0.3	0.0	0.5	1.8	0.5	12.7	1.5	17.1	1.1	11.4	1.7	10.3	0.2	32.9	11.6	112.0	0.0	0.0	13.5	4.4	0.8	4.5	1.2	6.7	1.1
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862317-52866835	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.6;ovary: 66.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	2.0	2.0	3.1	0.5	3.8	0.0	1.1	2.8	5.8	4.5	0.1	0.9	0.0	9.8	2.7	0.5	4.1	0.9	14.7	5.2	3.2	17.9	0.6	1.0	0.8	0.3	0.4	66.4	0.9	7.9	0.7	4.7	0.2	2.0	0.1	0.3	1.4	9.1	0.4	3.8	0.9	1.9	0.2	27.6	4.1	5.9	1.4	0.1	1.0	0.1	0.9	2.2	4.9	3.2	0.3	0.0	5.9	0.0	5.2	2.4	14.1	0.1	0.1	0.3	0.0	11.1	0.0	0.0	0.5	0.0	0.1	0.0	0.7	3.5	0.0	0.0	1.4	0.5	0.0	0.0	1.0	0.0	0.4	2.5	6.2	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	1.3	1.1	0.0	15.2	1.3	0.2	0.0	6.8	0.0	10.2	1.5	3.2	38.5	0.2	2.6	1.3	10.1	1.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	3.1	3.8	2.8	5.8	5.2	3.2	0.3	0.4	0.2	0.2	1.4	3.2	1.1	6.4	0.0	0.3	0.9	0.9	1.5	2.8	0.0	4.9	7.5	6.5	5.3	0.0	1.8	33.1	0.0	102.6	1.5	7.1	0.0	1.5	0.4	1.6	6.9	1.2	0.0	0.0	2.7	0.5	62.2	4.6	9.7	2.7	0.0	26.6	1.1	0.0	8.0	0.0	1.1	3.6	0.0	0.3	1.7	3.3	24.2	0.8	0.0	4.7	0.6	1.9	0.0	0.5	0.9	0.5	5.6	68.4	0.1	0.5	1.6	0.1	0.1	1.2	0.0	5.8	5.7	4.6	10.9	1.2	0.4	23.1	0.9	6.1	2.8	0.2
RASSF1	"123F2, NORE2A, RDA32, REH3P21"	ENSG00000068028	"Ras association domain family member 1"	Q9NS23	3	50329782-50340980	"Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 252.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040735	Approved					NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040735: AB_10671692"	"unprognostic (5.02e-2)"	"prognostic favorable (2.64e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-3)"	"prognostic favorable (2.60e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (3.80e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.71e-2)"	50.1	18.9	19.2	23.2	19.5	84.3	46.0	19.6	20.1	44.1	18.1	28.4	15.6	29.7	11.1	26.2	35.4	21.5	47.7	18.4	19.2	39.0	24.7	61.2	39.5	20.8	20.0	31.2	35.3	7.5	22.2	25.8	20.4	31.6	11.6	6.1	30.2	11.8	28.5	38.9	39.6	18.1	20.7	72.3	31.7	38.5	20.4	16.3	29.7	14.3	25.5	32.3	37.4	22.1	37.4	15.1	11.1	18.5	25.0	33.8	16.2	62.5	40.9	52.6	41.8	34.7	27.3	18.0	9.4	67.3	23.6	19.6	23.3	26.1	28.3	44.6	15.2	61.8	51.9	18.4	28.6	61.2	65.2	26.1	18.1	52.0	18.4	15.4	23.7	21.8	26.2	40.7	24.1	13.1	23.3	81.9	14.7	31.2	44.9	19.0	11.4	41.4	15.7	10.8	13.0	23.9	55.6	37.2	41.5	11.2	22.3	59.2	22.9	36.1	27.2	52.0	31.3	16.5	11.7	39.4	20.3	75.6	66.1	252.6	23.3	79.5	77.0	41.5	48.3	44.3	24.6	55.3	24.9	33.6	15.7	37.7	18.4	64.6	59.1	18.5	27.5	42.0	19.2	19.5	19.6	20.1	18.4	19.2	20.8	20.0	20.4	20.7	20.4	22.1	76.6	16.0	8.1	4.6	50.7	73.8	36.3	22.6	34.1	11.6	32.7	22.9	14.3	12.8	14.4	1.8	14.6	27.5	116.1	12.2	5.9	23.1	2.4	16.5	16.3	47.4	16.7	33.2	3.8	26.5	28.1	29.1	27.0	17.6	57.1	9.0	26.0	4.3	38.6	3.3	3.8	19.4	22.4	27.7	43.8	10.4	19.0	28.7	90.7	9.4	23.2	6.1	93.7	2.0	6.0	40.9	17.4	14.7	63.8	24.7	12.1	10.2	7.7	10.1	26.3	19.3	50.4	33.1	11.0	19.2	50.2	16.6	67.2	9.0	15.2	21.3
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507531-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 109.3;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070480	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	6.8	15.1	3.4	48.1	2.9	109.3	4.9	1.2	3.6	10.8	0.4	8.9	9.1	3.9	1.8	41.7	10.2	18.2	10.8	3.2	2.9	4.3	14.0	26.4	63.4	4.1	4.4	3.6	10.8	8.4	10.3	5.3	4.1	8.1	9.3	1.0	30.3	7.2	14.8	28.8	17.7	6.7	2.3	56.2	17.3	1.4	5.5	83.1	5.7	3.7	60.0	30.3	20.7	4.6	9.3	4.2	0.1	1.6	3.2	1.8	0.0	0.6	4.9	1.7	2.3	0.4	19.5	32.4	2.5	2.1	0.3	13.5	3.5	2.2	1.5	22.4	12.7	35.2	1.0	0.2	1.2	59.1	90.9	2.2	8.9	2.0	2.4	3.2	0.3	76.0	14.4	192.6	0.9	1.1	84.1	37.8	1.8	0.1	3.6	39.4	4.6	218.8	0.1	14.7	4.7	0.3	15.6	1.7	0.6	0.1	3.7	37.5	0.1	0.4	6.4	8.0	2.1	67.7	52.8	30.2	3.0	34.1	1.0	211.8	40.3	268.7	112.3	53.7	99.7	28.4	82.6	117.0	43.9	26.6	112.1	105.8	157.2	131.2	84.0	34.2	78.2	154.7	3.4	2.9	1.2	3.6	3.2	2.9	4.1	4.4	4.1	2.3	5.5	4.6	2.1	38.5	27.9	1.6	64.0	32.8	16.6	8.6	27.9	1.8	7.4	4.4	7.7	15.7	11.3	0.0	0.0	0.2	119.3	1.0	3.9	8.1	0.3	0.5	0.5	4.4	2.4	16.4	19.4	8.9	0.1	11.6	9.2	0.6	140.0	0.1	5.7	6.2	12.1	8.4	16.8	1.0	10.2	49.0	147.7	0.1	7.5	78.0	14.2	6.5	54.2	0.1	118.4	2.0	0.7	8.3	2.6	9.1	41.1	13.7	0.0	0.8	9.6	0.2	0.0	2.1	6.8	0.1	0.6	48.6	27.3	0.1	97.7	0.2	2.1	49.6
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.6;stomach 1: 34.9"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 2.7"	"Lineage enriched"	"Detected in single"	13	"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.2	0.1	0.0	4.9	0.0	0.1	8.4	0.0	0.2	2.3	5.0	11.9	9.8	0.5	2.8	1.9	2.7	4.4	0.0	0.1	0.2	6.0	2.2	1.3	5.7	0.0	0.8	1.3	16.6	0.7	0.4	7.4	0.0	5.7	12.7	1.6	3.5	3.7	0.0	5.3	12.3	0.3	0.0	0.2	34.9	0.1	0.7	30.6	5.7	0.4	6.9	9.2	1.8	0.1	0.3	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.2	12.0	76.0	1.1	0.0	0.3	3.8	0.0	6.0	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	5.8	0.0	21.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	11.1	0.2	0.0	0.1	0.5	23.5	70.2	2.8	0.0	0.2	1.8	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.1	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.0	0.7	0.1	0.3	12.8	5.1	0.0	25.0	9.8	38.5	70.5	18.8	0.1	25.1	42.2	1.2	21.5	37.7	7.3	0.0	55.7	0.1	81.1	17.6	18.2	0.3	45.4	2.0	0.8	120.3	0.4	0.3	80.9	23.0	1.7	171.8	22.8	1.3	2.2	0.4	4.0	4.4	0.0	0.1	57.9	103.7	0.3	1.0	0.0	0.0	1.2	1.8	0.0	0.6	18.7	0.0	0.0	0.3	67.1	65.8	0.0	21.3	24.6	30.1	37.8	29.8	0.5	0.0	0.0	1.6	0.0	0.2	11.9	1.4	47.2	3.5	0.7	23.2	60.5
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 606.9;Horizontal cells: 430.7;Late spermatids: 722.1;Microglial cells: 229.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Mitochondria, Cytosol"		"HPA038163: AB_2675874, HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	11.3	16.3	17.7	7.5	20.1	1.1	7.7	21.6	12.3	17.1	17.0	14.0	2.5	28.3	10.9	7.5	10.9	17.2	13.9	12.2	21.1	22.8	5.8	14.9	2.4	23.7	22.8	30.1	5.9	3.6	6.9	9.0	25.3	16.5	4.9	16.9	4.1	14.0	14.4	3.3	4.3	19.8	21.8	5.9	6.0	59.6	21.1	4.5	11.3	15.6	2.1	10.4	7.5	24.6	9.8	7.7	32.8	4.0	49.9	56.0	45.5	51.6	75.3	21.4	23.5	16.7	2.9	0.7	39.8	56.1	23.7	3.7	7.2	6.1	27.3	3.5	9.6	1.7	19.0	0.8	24.9	6.0	0.4	33.5	5.9	47.7	31.6	33.1	25.9	12.1	1.9	6.7	25.1	13.0	7.1	1.2	32.8	0.2	70.9	9.1	31.7	0.5	12.9	14.4	1.5	23.4	27.3	0.5	25.3	28.3	5.0	5.0	30.9	42.0	21.7	107.9	39.3	2.9	2.0	1.0	38.9	0.5	60.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.0	0.0	17.7	20.1	21.6	12.3	12.2	21.1	23.7	22.8	25.3	21.8	21.1	24.6	22.6	38.5	16.0	139.7	0.7	7.8	50.5	5.6	5.2	17.0	5.2	11.8	34.3	24.3	7.8	22.0	10.4	9.6	10.0	0.1	13.7	10.4	606.9	7.8	50.0	22.1	0.0	0.0	15.1	4.3	21.3	41.3	1.1	12.0	1.3	9.0	16.4	6.7	5.7	430.7	89.7	0.0	2.0	2.2	10.2	722.1	18.0	5.9	14.2	229.5	0.2	31.0	0.0	78.4	92.9	5.2	0.0	15.1	1.9	29.1	0.0	24.5	1.6	11.1	13.1	30.6	20.7	27.9	10.7	1.1	5.4	4.5	3.5	13.2	0.2	13.4
RASSF9	"P-CIP1, PAMCI"	ENSG00000198774	"Ras association domain family member 9"	O75901	12	85800703-85836409	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 22.8;Club cells: 47.8;Endothelial cells: 27.5;Hepatic stellate cells: 32.9;Respiratory ciliated cells: 27.2;Squamous epithelial cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;hTERT-RPE1: 12.7;RPTEC TERT1: 3.8;U-138 MG: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039428, HPA039678"	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA039428: AB_10795251, HPA039678: AB_10796332"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.90e-5)"	2.0	2.6	1.6	0.8	1.1	0.0	1.8	2.4	0.3	3.0	1.5	0.9	1.8	3.4	0.9	5.7	6.4	1.4	4.4	1.3	2.9	2.4	1.0	5.6	1.3	11.2	5.7	1.3	1.8	0.5	0.6	0.3	5.9	1.8	1.1	1.0	1.4	1.6	1.5	3.0	1.1	3.0	7.1	2.2	1.3	0.4	2.8	2.1	4.4	3.4	2.0	1.2	1.1	4.9	0.0	1.3	0.0	0.0	0.1	0.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.2	0.1	0.0	2.2	0.0	0.0	0.3	0.0	4.1	0.0	0.2	0.0	0.0	1.5	2.1	0.7	0.1	12.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.0	2.8	1.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	2.4	0.3	1.3	2.9	11.2	5.7	5.9	7.1	2.8	4.9	9.6	16.0	16.4	0.7	0.0	4.8	5.8	22.8	16.5	0.1	1.4	6.7	4.0	21.5	47.8	3.7	0.0	0.0	0.1	0.0	1.9	7.3	0.4	8.7	0.4	27.5	0.0	2.7	0.1	1.5	0.0	4.6	2.0	6.1	0.0	4.4	32.9	0.1	0.1	0.0	0.1	0.4	8.2	1.9	1.1	0.4	2.5	0.4	0.0	5.6	0.0	12.3	0.0	0.0	0.0	4.5	1.2	0.4	0.1	8.2	0.3	0.2	27.2	0.3	0.0	2.9	4.2	0.0	1.8	38.9	3.3	0.0	0.7	0.7	0.3	5.4
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333638	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5"					"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043575: AB_2678562, HPA049457: AB_2680774"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	12.4	12.9	4.1	11.8	4.9	19.0	12.6	3.9	5.5	17.9	6.2	20.4	17.7	22.8	0.7	15.1	19.8	3.3	9.7	3.7	4.4	12.0	8.3	13.1	11.1	6.9	5.0	19.3	11.7	4.4	17.5	6.0	4.4	15.2	3.2	1.1	13.1	7.5	8.5	11.8	22.6	4.0	3.8	21.7	13.9	11.5	5.0	11.4	14.3	2.2	5.2	16.8	14.0	4.5	62.0	38.9	14.1	21.6	5.6	7.0	31.0	31.9	14.0	24.7	21.8	42.7	17.3	65.0	43.7	10.4	19.9	31.5	15.8	21.1	4.9	55.2	93.5	100.3	25.7	48.6	12.6	63.5	62.4	8.2	7.2	16.6	6.2	8.2	16.2	48.6	80.9	56.2	7.6	57.8	85.6	255.5	55.1	13.1	73.9	78.3	20.5	57.2	6.9	24.4	40.3	46.7	34.7	22.3	18.3	4.8	32.0	30.5	22.5	63.7	32.4	56.7	54.5	122.1	109.0	54.9	42.1	44.2	42.5	0.2	1.3	1.8	3.3	1.5	1.7	1.4	2.8	4.6	2.1	2.0	1.9	1.7	1.2	1.9	3.3	0.9	1.1	2.2	4.1	4.9	3.9	5.5	3.7	4.4	6.9	5.0	4.4	3.8	5.0	4.5	1.2	0.0	1.1	6.5	7.8	0.8	0.3	0.5	10.2	0.8	2.0	1.1	0.7	0.0	0.4	0.0	0.0	2.0	2.3	15.2	0.0	4.5	0.4	1.6	2.2	1.1	16.3	12.0	4.8	4.3	1.9	1.6	6.1	1.2	4.5	0.6	0.4	0.3	1.3	0.0	4.5	9.3	0.0	0.0	0.8	0.0	0.0	2.0	0.0	6.5	6.8	0.3	0.0	4.0	4.2	5.4	10.2	0.7	15.3	0.3	14.0	0.6	1.1	1.0	0.0	0.8	2.4	0.7	0.3	6.1	0.1	1.5	5.5	0.6	14.3	0.2
RAVER2	"FLJ10770, KIAA1579"	ENSG00000162437	"Ribonucleoprotein, PTB binding 2"	Q9HCJ3	1	64745095-64833232	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Distal enterocytes: 60.1;Inhibitory neurons: 40.4;Oligodendrocyte precursor cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045785	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA045785: AB_10964058"	"unprognostic (8.02e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (1.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-2)"	4.7	8.2	12.8	4.2	12.1	9.5	8.2	15.0	12.4	7.7	12.6	23.6	24.2	7.8	5.7	9.4	7.5	11.3	12.6	13.3	10.9	7.7	1.6	8.3	2.0	9.7	12.2	6.4	7.3	16.2	12.3	7.3	10.3	12.0	26.8	15.1	15.5	10.3	22.2	6.7	26.1	9.3	10.4	4.3	12.5	2.7	13.3	8.3	6.1	17.7	4.1	6.5	7.4	9.3	16.7	5.1	15.2	16.7	2.7	2.3	4.1	3.6	6.5	7.3	8.2	13.6	7.3	0.1	8.2	3.8	16.6	12.4	15.7	10.9	8.9	0.1	17.3	20.2	13.7	12.2	5.1	27.5	0.2	6.8	9.8	0.5	7.5	16.9	12.2	16.6	4.5	16.3	0.6	6.2	9.2	5.6	18.8	13.1	13.3	31.1	23.9	6.7	8.0	12.3	11.5	25.6	16.4	0.0	16.0	14.3	12.6	4.3	4.6	6.8	10.9	6.8	13.1	12.3	14.9	7.0	4.1	0.1	6.4	6.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	12.8	12.1	15.0	12.4	13.3	10.9	9.7	12.2	10.3	10.4	13.3	9.3	9.2	6.4	13.5	72.8	0.6	8.0	7.0	3.9	8.0	7.1	7.2	6.0	24.4	11.5	8.3	1.8	14.6	0.2	1.1	60.1	0.0	3.4	9.8	5.7	2.5	10.6	18.0	4.2	29.0	5.2	0.3	6.3	11.2	6.5	1.3	7.1	6.8	0.3	0.6	0.0	40.4	30.7	4.1	4.8	3.3	16.8	6.5	2.0	3.6	22.5	0.3	26.1	0.0	40.2	1.8	2.7	20.5	8.2	2.3	6.6	26.9	2.1	6.1	3.7	0.0	6.2	5.5	3.1	3.2	8.5	5.8	0.3	1.5	1.7	27.8	7.3
RAX2	"ARMD6, CORD11, MGC15631, RAXL1"	ENSG00000173976	"Retina and anterior neural fold homeobox 2"	Q96IS3	19	3769089-3772228	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	DNA-binding	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"retina: 64.5"	"Group enriched"	"Detected in some"	9	"Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 217.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA052533	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA052533: AB_2681862"										"unprognostic (5.53e-2)"				"unprognostic (1.39e-2)"	"unprognostic (4.48e-1)"			0.0	0.0	0.2	0.1	0.4	0.4	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.0	64.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.6	0.4	0.3	0.3	0.3	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	14.3	0.0	0.1	0.6	0.0	0.0	0.0	123.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RB1CC1	"ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131"	ENSG00000023287	"RB1 inducible coiled-coil 1"	Q8TDY2	8	52622458-52745843	"Predicted intracellular proteins"	"Autophagy, Cell cycle, Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024391, HPA053049"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nuclear membrane"	"HPA024391: AB_2671554, HPA053049: AB_2682025"	"unprognostic (1.58e-2)"	"unprognostic (7.51e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.22e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.56e-3)"	"unprognostic (7.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.42e-1)"	17.6	15.0	37.2	11.8	30.4	52.3	17.0	26.5	40.2	15.2	16.4	13.7	12.9	17.4	13.0	16.9	12.1	13.8	24.1	27.2	23.9	17.1	21.5	14.9	13.3	29.9	25.6	20.1	16.8	22.2	8.0	15.5	24.1	15.5	11.3	20.3	16.2	12.2	38.9	15.0	14.2	15.0	23.0	14.3	14.5	34.7	33.1	22.2	17.7	32.1	12.9	14.3	11.1	43.5	23.8	20.8	25.2	22.1	27.4	31.0	14.4	17.7	36.1	18.4	22.8	14.6	26.3	17.4	29.0	26.2	46.4	31.0	31.4	16.5	34.5	13.1	27.4	29.7	20.8	20.2	33.7	10.7	16.0	29.1	33.4	18.3	49.6	38.2	25.2	26.8	35.8	27.4	22.6	15.6	27.2	15.7	24.9	22.4	10.3	13.7	12.1	17.7	16.9	18.5	24.0	25.0	18.4	20.9	39.8	29.3	23.8	19.3	29.9	17.5	24.2	27.8	15.7	26.8	24.8	17.0	27.6	18.2	20.0	47.9	12.9	24.6	11.6	12.2	11.8	12.3	9.7	11.9	12.6	9.5	11.9	11.0	40.3	14.2	17.1	6.3	14.1	11.9	37.2	30.4	26.5	40.2	27.2	23.9	29.9	25.6	24.1	23.0	33.1	43.5	83.8	195.5	121.7	73.8	66.3	88.3	60.2	32.0	51.2	82.0	45.5	39.5	163.8	20.0	57.4	18.4	68.8	27.0	74.2	45.4	9.8	52.4	61.9	103.6	112.7	66.0	44.2	117.7	104.0	49.3	26.3	78.2	36.2	143.5	25.9	78.1	36.8	44.5	23.6	87.5	123.2	31.9	30.5	44.5	41.4	49.8	77.3	60.5	42.7	76.8	67.6	33.0	64.9	106.1	104.2	63.5	43.3	73.4	86.1	99.0	47.2	27.0	115.3	57.3	46.0	132.2	76.9	238.8	132.7	59.4	91.9	60.5	66.2	68.6	27.7	88.2
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 143.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	27.1	25.0	22.9	21.1	23.8	143.6	25.9	33.1	29.9	27.8	21.7	31.5	15.0	33.6	26.3	23.2	32.4	25.5	23.9	22.8	23.5	24.3	26.8	27.9	29.7	24.2	22.8	38.8	22.2	21.8	28.1	31.7	24.4	26.0	20.4	51.1	21.4	19.9	29.7	34.6	26.0	24.1	23.9	29.4	25.6	45.5	24.4	26.6	27.2	25.7	23.5	25.3	24.7	27.7	35.4	18.4	42.5	44.4	31.9	32.9	45.9	28.1	26.1	25.1	27.3	20.5	28.3	49.6	20.3	24.4	28.7	33.3	46.2	24.8	41.9	26.9	35.7	41.9	57.1	58.6	24.7	57.5	23.7	28.8	33.7	33.2	38.9	28.6	36.9	42.2	54.5	43.8	29.7	36.5	45.5	51.2	48.7	24.0	17.3	62.8	42.5	43.3	24.7	31.7	33.4	28.5	39.7	35.1	52.3	47.0	27.4	49.7	32.3	31.0	22.8	27.0	30.8	37.7	40.9	60.9	25.1	36.5	26.1	7.1	1.2	2.0	2.0	2.0	2.2	2.0	2.1	1.5	0.9	1.7	1.8	2.0	2.5	3.5	1.1	3.7	1.7	0.6	22.9	23.8	33.1	29.9	22.8	23.5	24.2	22.8	24.4	23.9	24.4	27.7	139.1	86.6	115.3	47.3	125.7	100.7	103.5	40.8	223.1	67.1	145.6	160.8	147.0	44.3	56.5	27.6	100.1	46.3	88.9	71.5	25.4	48.8	307.5	109.8	123.7	93.7	82.0	83.1	52.5	47.6	57.6	127.1	121.8	203.1	51.3	127.8	64.2	59.5	38.4	62.2	53.4	76.0	28.5	53.5	70.2	41.9	72.4	101.5	62.2	54.4	54.0	53.1	52.5	61.3	58.7	56.4	32.8	58.6	173.7	99.9	54.5	23.9	52.0	61.4	52.6	247.0	112.9	100.3	45.8	161.0	101.7	101.5	110.2	105.3	69.3	111.9
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBBP9	Bog	ENSG00000089050	"RB binding protein 9, serine hydrolase"	O75884	20	18486540-18497225	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015830, HPA049005"	Approved		Supported	Nucleoplasm		NA	NA		40000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA015830: AB_1845410, HPA049005: AB_2680597"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.21e-2)"	7.2	10.3	5.3	6.6	5.8	3.3	9.5	6.2	5.9	13.4	8.2	6.3	6.7	7.6	6.6	7.7	5.8	9.5	5.4	4.5	5.8	17.7	25.7	8.5	7.1	5.7	5.9	6.9	5.4	15.9	5.4	5.5	5.7	8.6	7.5	8.1	8.8	8.8	3.5	11.0	6.5	7.9	5.6	5.6	7.2	3.8	6.6	7.3	24.3	3.9	9.1	8.3	4.6	6.6	12.2	14.1	12.8	18.2	8.9	14.6	13.0	13.7	13.3	17.4	17.7	10.2	10.8	15.2	5.5	9.6	12.1	13.5	10.2	22.5	20.7	4.6	12.5	8.0	4.3	31.4	5.6	11.8	4.7	7.6	8.7	14.3	8.4	8.7	22.2	12.5	5.1	11.6	15.2	6.9	12.2	8.1	8.5	16.9	26.4	11.9	38.0	9.6	15.7	13.2	10.9	18.7	18.2	21.8	9.7	8.7	17.6	3.2	12.8	29.0	9.5	18.5	12.3	13.1	34.5	10.4	11.4	5.5	9.5	9.3	2.0	0.6	1.9	2.5	2.9	2.2	2.3	1.4	2.1	1.7	2.0	1.6	0.3	1.8	2.0	0.4	3.0	2.0	5.3	5.8	6.2	5.9	4.5	5.8	5.7	5.9	5.7	5.6	6.6	6.6	6.7	22.4	18.3	3.9	5.5	7.4	3.4	7.7	10.2	4.3	7.8	4.6	8.1	4.3	9.3	11.0	0.0	3.3	5.8	5.1	15.6	5.9	5.1	4.9	6.5	6.6	5.4	2.5	3.4	2.8	4.0	5.5	6.6	6.2	0.0	6.2	6.1	17.9	5.7	3.3	4.9	3.6	4.1	6.8	5.2	1.6	5.3	4.4	5.4	1.0	5.9	8.6	3.1	5.0	4.7	4.7	2.5	7.2	4.3	3.3	9.2	21.3	10.5	6.8	0.0	5.7	5.7	1.3	4.1	8.5	6.1	2.5	6.1	7.3	6.4	3.8
RBFA	"C18orf22, FLJ21172, HsT169"	ENSG00000101546	"Ribosome binding factor A"	Q8N0V3	18	80034389-80050651	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040485, HPA041479"	Approved		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA040485: AB_10795368, HPA041479: AB_10795697"	"unprognostic (5.31e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.00e-3)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.82e-1)"	"unprognostic (5.00e-3)"	18.6	19.9	6.2	9.8	6.1	13.6	17.8	8.1	6.6	13.6	4.7	13.6	12.0	12.4	5.5	17.6	11.0	5.9	18.3	6.3	6.3	14.8	31.3	10.6	8.5	5.8	5.4	10.1	16.7	9.1	8.9	8.3	5.8	11.6	7.9	5.9	12.7	6.8	22.3	20.0	10.9	10.0	5.4	12.4	11.9	12.1	5.8	10.3	11.0	13.3	10.7	13.4	14.2	6.4	28.4	32.6	20.5	20.0	17.5	20.2	27.7	24.0	11.9	25.8	21.9	19.1	22.1	58.6	8.9	16.5	22.6	26.1	21.8	26.1	20.5	22.1	23.9	35.3	24.6	53.0	14.6	55.7	16.7	18.8	24.9	18.6	26.3	11.3	22.4	35.3	19.1	35.7	15.5	30.0	55.6	38.4	22.4	17.7	30.6	38.0	19.6	72.5	26.8	35.2	35.7	21.3	21.0	23.4	17.3	17.0	17.7	29.5	19.7	37.6	37.2	5.5	27.0	14.1	24.5	48.7	22.1	46.2	22.4	0.0	4.8	0.0	6.4	6.5	10.1	8.9	6.5	6.4	7.6	6.5	7.4	6.8	0.2	7.3	10.3	5.7	5.5	5.3	6.2	6.1	8.1	6.6	6.3	6.3	5.8	5.4	5.8	5.4	5.8	6.4	25.4	32.1	10.9	14.0	24.1	18.5	24.4	29.8	25.6	13.5	29.2	32.5	12.2	18.6	24.4	27.6	18.8	50.1	14.8	9.9	31.3	28.4	17.7	23.7	39.0	20.3	20.9	29.9	18.3	24.2	49.9	24.7	19.4	20.9	13.3	34.5	15.7	40.8	24.4	32.0	17.5	21.7	14.2	8.2	20.5	17.0	19.0	15.2	33.8	12.2	9.6	8.0	19.6	19.6	14.1	21.3	7.6	18.4	26.2	23.8	13.7	46.4	19.4	21.8	19.7	17.3	26.3	37.7	49.2	38.2	23.4	24.9	16.7	47.5	25.5	20.9
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028824	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA006455, HPA075862"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA006240: AB_1079750, HPA006455: , HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	28.4	21.9	16.4	12.3	21.7	0.2	27.0	38.8	41.9	49.0	0.0	59.2	11.7	67.5	21.6	34.7	40.4	25.2	37.0	24.3	11.7	18.7	25.8	25.6	5.9	6.9	3.3	63.0	18.7	26.2	27.5	32.6	5.2	31.4	21.4	15.5	23.7	29.7	77.1	23.7	23.4	52.7	1.1	9.9	28.9	25.7	7.3	10.0	28.5	44.3	8.5	43.1	36.5	17.8	46.2	27.4	110.3	64.8	62.4	111.2	36.8	89.9	123.6	67.1	72.0	60.1	21.3	28.2	41.2	108.9	41.9	46.5	40.2	41.7	95.9	19.2	36.6	16.7	26.5	22.3	18.8	4.4	11.6	77.3	53.1	59.6	73.3	64.8	86.8	7.0	13.7	3.9	80.3	14.0	4.5	2.7	40.5	19.7	42.0	7.6	92.0	7.9	50.1	47.5	34.1	106.0	110.3	15.5	31.0	57.0	16.9	6.8	105.5	96.4	54.4	54.7	41.2	2.8	9.4	38.3	42.7	6.8	51.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	21.7	38.8	41.9	24.3	11.7	6.9	3.3	5.2	1.1	7.3	17.8	34.3	67.3	38.5	189.4	1.0	37.1	50.6	57.3	57.5	20.8	31.4	34.5	62.2	31.5	40.4	27.6	0.0	69.9	0.9	17.9	35.2	53.0	24.8	17.8	60.8	45.9	57.0	0.8	378.7	32.1	89.1	67.8	15.8	25.0	2.5	30.6	40.7	26.0	10.5	117.8	418.1	24.7	18.3	1.3	14.7	9.4	79.6	1.8	16.0	183.6	2.6	16.9	0.0	237.2	130.0	77.4	10.7	93.3	1.4	57.4	22.5	18.7	20.9	6.7	52.6	74.5	93.3	42.2	25.6	31.0	33.8	29.0	2.5	48.2	23.8	61.1
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.2;intestine: 97.4;urinary bladder: 80.5"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 320.4;Inhibitory neurons: 163.9;Skeletal myocytes: 124.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 217.2;cerebral cortex: 118.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 16.1;NTERA-2: 14.2;SCLC-21H: 22.4;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, HPA075862, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB078782: , HPA030790: AB_10602305, HPA075862: "	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	0.9	11.8	0.4	29.7	0.6	0.3	217.2	118.3	3.0	0.0	97.4	1.5	39.9	3.1	9.6	3.6	0.0	0.3	23.6	0.0	0.3	0.2	0.6	0.1	12.3	1.1	1.3	0.5	0.9	7.5	0.0	13.4	22.3	2.4	3.4	0.2	24.4	0.5	0.5	9.1	9.5	0.0	0.5	4.2	7.5	0.0	0.0	0.3	0.0	0.0	80.5	8.2	40.2	0.0	16.1	0.2	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	14.2	0.0	0.2	0.3	0.7	0.1	0.0	0.0	22.4	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	11.1	0.6	0.0	0.9	0.0	0.4	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	29.7	217.2	118.3	23.6	0.0	12.3	1.1	13.4	0.0	0.0	40.2	0.5	0.0	0.0	5.9	0.2	2.0	8.1	0.0	0.0	11.5	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	5.7	0.3	0.4	7.5	0.0	0.0	320.4	0.0	0.1	11.8	0.0	0.7	0.0	0.1	0.0	0.2	0.1	5.0	163.9	0.0	0.0	0.6	5.5	10.1	0.3	7.6	5.4	10.3	0.0	1.2	2.1	11.1	4.8	0.0	0.0	10.5	0.0	15.2	0.0	0.1	0.0	3.1	0.0	124.4	7.5	2.4	26.4	0.0	1.4	0.1	2.3	0.1	0.0	2.8
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, S1-1, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47145221-47186813	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	23.7	31.1	28.5	19.9	28.8	32.5	23.9	32.6	36.4	33.3	26.6	28.8	18.1	29.5	12.4	34.2	31.5	12.1	30.8	28.5	28.4	30.0	32.2	23.9	25.1	28.2	27.9	40.6	32.2	15.9	38.0	17.3	28.3	33.8	11.3	14.8	23.6	15.6	26.5	27.1	27.8	12.5	26.6	33.9	26.4	12.8	29.3	23.6	33.1	12.4	15.9	28.3	29.9	31.9	50.1	52.5	48.9	58.8	25.7	21.0	57.3	36.8	21.4	37.2	35.8	46.4	39.8	60.1	22.0	25.6	47.5	47.7	64.9	46.1	20.4	61.6	59.0	45.1	65.1	48.8	37.5	46.0	52.1	27.7	22.0	61.2	49.8	26.5	40.4	56.5	38.3	47.0	23.0	74.9	84.8	78.2	81.9	37.1	58.0	74.0	41.0	62.2	27.7	42.9	58.6	44.5	56.0	41.6	35.6	29.3	50.9	45.7	35.8	43.7	54.9	47.8	39.5	48.4	42.9	49.5	38.8	32.8	62.3	13.5	8.1	11.4	12.7	10.7	12.0	11.2	10.2	10.8	9.2	11.1	10.0	9.7	7.5	9.9	15.8	10.7	12.7	9.3	28.5	28.8	32.6	36.4	28.5	28.4	28.2	27.9	28.3	26.6	29.3	31.9	17.4	41.7	36.9	22.5	21.6	11.1	22.4	15.0	22.8	26.7	16.5	16.8	36.6	21.5	28.8	9.2	14.6	34.2	21.3	32.2	11.7	20.5	1.3	23.6	20.1	19.6	35.8	14.9	14.8	17.7	28.5	20.2	31.6	31.5	24.1	29.1	16.8	23.3	19.7	21.9	15.4	31.5	10.2	14.2	10.0	2.7	18.0	15.4	16.0	8.4	19.9	14.7	20.6	15.1	18.1	19.8	20.8	25.6	22.5	18.7	23.1	14.3	28.8	27.0	0.0	21.4	21.8	10.7	8.7	23.4	10.5	46.1	23.8	19.7	34.2	18.1
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	24.5	20.2	2.6	28.7	3.5	30.2	22.6	23.2	8.0	18.2	7.6	24.5	20.3	28.6	12.4	23.4	26.6	23.7	18.4	2.9	9.6	17.7	18.5	22.9	39.9	4.1	4.1	39.0	19.9	25.2	13.9	30.2	3.7	23.4	24.1	27.4	19.3	19.3	19.2	17.6	20.2	28.5	0.9	27.0	22.2	23.0	6.2	50.6	23.0	17.2	44.8	36.4	17.0	10.4	87.9	57.6	121.3	74.5	29.1	57.0	74.5	47.7	56.1	65.5	64.0	80.4	60.3	157.5	51.8	96.0	68.3	60.7	144.8	121.9	83.3	74.8	52.2	132.0	56.6	54.2	50.0	145.1	67.9	82.0	61.7	75.2	49.7	41.8	73.9	84.0	128.1	73.9	58.0	64.3	172.8	40.8	88.4	56.7	59.2	104.2	149.0	77.0	47.0	142.2	63.9	82.9	85.1	66.0	64.3	99.2	85.1	52.4	104.9	54.8	81.0	54.3	71.7	79.7	93.4	165.3	48.3	55.3	72.9	6.7	10.5	8.9	11.7	11.6	13.6	12.2	10.4	13.7	12.7	11.5	10.7	9.8	7.5	9.9	9.8	8.1	10.1	11.5	2.6	3.5	23.2	8.0	2.9	9.6	4.1	4.1	3.7	0.9	6.2	10.4	22.6	25.6	24.1	0.0	28.7	29.6	23.8	17.4	19.4	15.8	19.4	19.3	22.5	17.2	19.2	3.7	27.1	21.5	35.8	17.1	1.9	14.9	4.8	20.7	24.0	18.7	24.6	25.2	0.0	17.8	18.5	22.6	11.2	24.9	26.6	31.5	20.0	14.0	18.5	8.4	0.0	20.4	20.3	24.6	20.6	4.8	14.6	25.7	16.0	0.0	23.7	13.5	21.6	0.0	0.0	21.0	14.6	16.6	22.9	18.5	15.0	9.8	25.3	14.4	6.6	28.0	22.6	15.1	17.4	21.8	29.5	17.5	29.7	18.7	19.8	27.8
RBM12B		ENSG00000183808	"RNA binding motif protein 12B"	Q8IXT5	8	93729356-93741017	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024398, HPA053050"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024398: AB_1856109, HPA053050: AB_2682026"	"unprognostic (4.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.15e-2)"	"unprognostic (4.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.62e-2)"	6.6	7.2	3.2	14.8	4.3	9.2	11.7	15.2	5.2	11.4	3.5	8.9	9.1	14.3	8.9	8.5	11.7	8.4	9.3	3.1	6.6	8.9	6.4	8.5	19.8	4.0	2.1	21.8	7.8	9.4	5.6	13.4	2.8	13.0	9.4	24.7	10.2	8.4	5.5	8.5	9.0	8.3	1.5	13.6	10.6	17.6	2.5	16.3	15.9	6.2	16.9	8.4	7.1	10.8	26.0	19.3	48.3	34.4	11.7	22.3	23.4	21.4	15.8	23.9	24.9	14.6	34.6	45.5	33.2	12.0	25.4	26.0	42.3	11.3	26.7	32.3	21.8	59.0	48.2	12.6	13.7	22.2	28.7	14.6	14.2	15.7	15.5	15.8	16.4	26.6	49.4	37.0	21.3	15.0	41.3	17.3	0.2	19.6	20.4	30.2	34.2	15.0	12.3	21.9	31.6	25.0	23.0	7.2	17.8	33.0	27.5	16.7	32.0	22.2	33.3	16.3	22.3	43.0	34.2	38.3	15.8	31.0	38.0	15.0	2.3	4.4	2.3	2.0	3.5	1.5	3.0	2.4	2.2	2.1	4.1	3.5	3.3	3.0	2.4	2.9	3.8	2.1	3.2	4.3	15.2	5.2	3.1	6.6	4.0	2.1	2.8	1.5	2.5	10.8	16.8	6.4	8.1	23.2	17.9	4.0	7.1	7.2	11.4	31.8	9.9	9.1	11.8	10.0	6.6	12.9	43.8	7.9	13.7	5.5	3.9	6.9	1.4	11.3	21.4	12.8	15.7	17.7	23.7	4.8	4.8	13.5	7.7	12.8	0.0	30.3	11.4	8.4	4.7	45.4	26.6	9.2	8.2	11.1	5.8	2.4	12.5	8.9	5.4	21.5	15.9	21.9	17.5	32.6	40.2	6.8	7.1	10.1	8.7	8.8	5.9	5.0	12.5	32.1	19.7	23.2	13.1	19.1	10.9	7.3	4.3	4.0	11.8	13.5	8.0	4.9
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616626-66629934	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"		NA	NA		31000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	26.9	32.0	39.9	25.0	40.2	32.6	24.1	52.6	48.0	37.2	48.5	29.4	15.7	30.8	19.1	33.9	37.6	10.7	33.2	40.1	38.9	50.6	40.4	27.3	28.3	39.4	40.6	45.1	34.1	17.5	34.5	19.6	39.4	36.3	18.2	35.8	25.3	14.6	29.7	28.4	29.1	15.6	37.1	40.4	30.1	44.0	39.6	25.7	28.4	11.6	29.2	30.4	28.6	48.6	83.0	77.9	55.9	43.2	25.3	16.8	97.0	45.0	16.4	40.8	24.0	79.2	60.6	130.9	49.2	21.9	45.0	69.0	63.4	36.5	43.3	63.9	68.7	81.7	67.1	71.2	14.1	71.5	70.0	11.8	13.3	41.9	23.3	24.1	31.0	38.2	98.6	83.9	40.2	70.3	122.4	79.4	107.2	69.0	85.7	125.3	65.4	67.3	34.2	71.5	67.0	61.9	78.0	55.9	33.9	45.9	77.3	63.5	50.5	49.4	97.9	40.5	72.6	49.8	75.2	109.0	41.8	68.9	120.1	19.7	24.3	27.3	27.9	26.1	27.2	21.3	24.1	26.8	33.6	21.8	24.3	28.2	9.0	21.7	27.2	21.3	23.1	34.0	39.9	40.2	52.6	48.0	40.1	38.9	39.4	40.6	39.4	37.1	39.6	48.6	12.6	9.6	17.0	0.0	27.4	38.1	45.7	20.7	15.4	24.8	19.1	16.3	16.3	18.6	17.2	14.7	29.2	56.3	32.7	17.7	17.6	26.5	37.3	18.1	16.5	21.3	21.6	23.1	0.0	18.4	54.4	20.1	9.7	17.5	19.7	20.4	22.5	24.5	29.0	11.8	0.0	20.9	24.4	16.0	30.2	27.0	17.1	20.1	12.4	0.0	25.4	18.1	34.0	0.0	0.0	19.3	21.7	16.1	20.7	26.9	19.0	12.2	23.2	49.4	6.6	15.1	21.5	53.9	40.1	20.9	31.1	69.2	29.0	13.7	25.2	32.6
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 10.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	0.6	0.8	3.5	0.4	2.5	3.0	0.5	3.4	3.4	0.6	2.9	1.3	0.1	0.8	0.8	1.0	0.7	0.6	2.7	2.6	3.6	1.0	3.0	0.7	0.6	2.9	1.9	0.6	1.1	0.3	1.0	0.4	1.8	1.1	0.4	0.7	0.9	0.5	1.0	0.6	1.0	0.5	1.3	1.1	1.0	0.5	2.6	0.8	1.0	0.4	0.4	1.1	0.7	3.4	1.6	0.9	0.7	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	2.6	0.5	0.9	1.3	0.7	1.2	2.5	1.8	0.6	0.6	0.8	0.7	2.7	1.8	2.0	0.5	1.7	1.5	0.4	0.5	0.8	0.2	0.6	0.0	1.4	3.8	1.4	1.0	3.2	2.5	10.0	1.7	1.9	4.4	2.8	3.4	1.5	0.7	1.8	2.2	1.0	0.7	2.3	5.9	0.5	1.4	1.2	0.7	2.1	1.5	1.7	1.1	1.1	1.0	1.7	1.8	1.2	1.8	4.8	4.3	5.9	4.6	4.8	2.7	5.9	2.9	3.1	4.3	5.9	1.9	2.5	2.8	3.5	5.0	8.4	2.1	3.6	3.5	2.5	3.4	3.4	2.6	3.6	2.9	1.9	1.8	1.3	2.6	3.4	0.5	0.0	1.1	5.5	1.1	0.0	0.5	0.1	1.2	1.1	0.4	0.4	0.0	1.5	5.0	0.0	4.2	0.5	2.0	0.3	0.0	0.5	1.7	1.4	0.9	0.6	0.0	0.4	8.7	0.2	0.4	0.8	1.1	1.1	0.0	0.7	0.0	0.5	0.2	0.0	8.7	0.5	0.0	0.3	0.3	0.9	0.0	1.2	0.0	5.6	0.0	0.1	0.0	4.0	10.3	0.4	0.1	0.0	1.0	0.5	0.0	0.4	3.6	0.8	0.0	0.8	0.4	1.0	0.9	1.0	0.1	1.1	1.0	0.5	0.2	0.8
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	4.7	4.0	3.3	7.0	4.0	44.7	4.2	10.9	4.1	3.2	4.5	4.3	5.3	3.4	3.4	3.2	3.8	4.2	4.6	4.5	2.5	3.2	7.2	4.2	11.3	3.1	3.0	5.9	4.3	3.7	1.6	5.0	3.3	3.6	3.8	4.9	4.6	2.6	7.0	2.9	4.8	3.6	2.7	7.2	5.4	8.6	3.4	8.6	4.6	6.6	9.6	4.5	2.2	5.6	11.8	12.7	11.2	11.6	7.0	7.2	17.6	6.2	8.1	9.5	12.4	15.7	10.6	22.4	9.7	7.0	7.8	16.4	17.6	15.5	13.9	23.4	16.3	18.1	21.0	11.4	9.6	19.9	18.4	6.6	10.5	13.2	12.3	5.0	10.2	16.6	26.1	38.0	9.6	12.1	18.0	15.4	24.0	10.4	7.1	21.1	17.0	15.3	7.8	11.8	13.4	6.8	13.5	16.7	13.1	11.9	11.6	23.5	7.2	9.1	16.2	9.9	11.4	28.8	15.9	48.0	13.6	19.7	11.4	6.3	3.9	5.6	3.7	3.4	5.3	6.1	4.2	3.3	2.8	5.1	3.5	4.3	5.4	3.1	3.9	2.7	4.5	3.3	3.3	4.0	10.9	4.1	4.5	2.5	3.1	3.0	3.3	2.7	3.4	5.6	9.1	6.4	3.7	21.5	18.3	33.1	9.3	7.3	6.2	5.7	10.8	5.0	12.3	5.7	4.8	3.7	14.6	8.7	12.8	9.1	0.0	4.1	9.6	15.9	14.5	8.4	9.6	10.7	30.0	3.5	7.9	8.1	10.2	18.8	28.6	10.6	11.0	18.5	6.5	0.0	26.2	8.4	0.0	6.8	11.4	6.7	4.1	7.7	8.8	39.4	6.1	3.9	7.2	29.1	31.2	4.3	3.9	5.3	15.5	9.6	8.8	4.5	10.6	7.3	0.0	11.2	12.4	30.6	13.9	9.4	33.8	4.7	14.3	6.5	9.9	8.6
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391285-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA036645: AB_10671965, HPA058136: AB_2683618"	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	13.0	10.3	10.2	10.6	9.5	11.1	12.3	8.8	10.5	12.0	7.4	14.4	10.4	16.9	10.6	17.0	12.0	9.3	10.4	9.9	9.5	9.7	9.9	11.5	11.2	9.9	10.1	14.6	17.8	13.8	10.7	8.0	8.9	10.9	11.9	8.2	12.3	11.0	6.1	16.5	13.0	12.2	9.3	11.4	14.6	11.4	9.7	19.7	10.8	7.0	12.2	13.0	10.5	9.6	19.2	16.7	38.2	40.1	33.7	26.2	23.3	17.4	32.2	27.2	22.3	20.8	13.6	27.5	14.1	31.5	30.0	17.3	22.0	31.3	13.1	22.2	17.3	23.9	26.2	17.9	19.7	31.4	13.0	28.6	38.2	25.0	29.5	29.6	28.5	44.3	18.1	18.2	23.6	20.4	54.8	19.8	30.5	17.6	25.9	19.4	16.8	23.5	24.5	45.5	24.7	35.5	22.4	29.5	20.6	25.2	23.4	36.7	26.0	27.7	24.1	23.6	33.3	26.6	25.9	30.3	22.6	24.8	30.2	0.0	1.9	0.7	1.8	2.7	1.9	1.0	2.2	1.9	2.1	2.4	2.2	1.3	0.4	1.7	2.7	2.3	1.1	1.6	10.2	9.5	8.8	10.5	9.9	9.5	9.9	10.1	8.9	9.3	9.7	9.6	16.7	3.2	5.4	4.2	15.2	25.4	38.9	12.6	16.5	18.2	24.9	20.2	17.3	20.0	12.5	14.7	10.4	15.2	19.8	19.9	11.7	19.4	22.4	17.6	17.2	19.1	12.6	19.0	4.4	23.2	20.7	16.7	21.4	19.6	5.1	31.0	17.9	20.5	18.4	15.2	5.1	21.0	12.2	33.1	20.9	10.6	15.8	15.1	7.2	2.8	16.3	14.2	22.6	3.5	5.0	28.2	13.4	15.1	16.4	32.8	15.2	16.5	11.2	15.5	26.3	26.0	21.1	14.9	7.9	28.0	28.1	19.7	16.3	21.0	24.4	36.7
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237622-122264840	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	9.0	9.5	7.4	6.4	7.9	11.7	16.4	8.0	10.1	8.9	7.3	7.5	7.0	8.8	10.3	7.7	7.4	7.6	13.5	7.8	8.8	11.4	8.4	7.2	8.1	8.2	7.9	9.5	6.9	11.9	5.7	10.4	8.6	11.1	8.1	11.5	7.9	8.3	20.7	6.8	6.1	8.7	8.0	8.0	8.5	3.6	8.0	9.5	10.0	23.1	7.6	8.7	5.4	8.4	8.1	8.3	11.2	12.4	16.1	19.8	9.7	18.0	14.7	12.1	11.2	9.6	7.8	14.1	7.7	11.8	13.3	18.5	17.6	18.7	15.1	14.5	8.0	10.5	12.6	8.2	18.1	21.1	14.0	17.0	20.8	12.7	25.8	12.1	17.6	11.3	14.6	10.7	18.3	8.8	11.1	13.0	8.7	27.2	13.7	9.7	23.2	19.3	16.9	9.0	23.3	12.3	13.6	18.9	21.3	8.8	11.0	11.8	9.8	11.3	6.4	18.3	18.0	15.5	30.7	11.7	18.6	12.9	13.8	4.5	6.2	11.4	6.3	7.2	6.1	5.8	5.5	6.2	6.5	4.0	5.7	6.0	6.5	5.4	9.7	4.6	6.4	5.8	7.4	7.9	8.0	10.1	7.8	8.8	8.2	7.9	8.6	8.0	8.0	8.4	19.7	32.1	12.8	2.0	18.3	21.7	11.7	28.5	19.9	12.4	27.2	20.7	51.6	10.0	23.1	25.8	2.1	32.8	23.3	17.2	27.4	23.2	75.0	14.7	19.9	21.6	19.7	28.4	9.1	16.2	44.7	15.9	13.3	16.4	17.7	14.1	13.6	13.7	27.7	3.3	12.9	16.5	34.6	21.0	17.2	76.9	13.4	18.4	19.6	4.7	20.6	16.9	27.8	6.0	10.7	23.0	18.7	17.0	16.4	20.8	14.8	26.6	19.8	14.7	19.7	15.2	25.4	19.7	22.1	16.5	25.9	56.9	23.5	16.7	14.2	20.7
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966325	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	11.5	14.1	7.4	12.5	8.5	16.4	13.5	5.7	8.8	13.8	7.9	13.8	8.7	13.1	8.3	12.5	12.9	6.4	11.6	6.5	7.1	13.4	12.3	12.2	14.0	8.7	7.9	18.9	14.2	10.1	12.7	9.9	8.8	15.1	8.9	7.7	12.6	8.4	16.7	12.5	13.5	9.0	5.1	13.3	13.3	11.9	10.3	10.4	20.8	9.3	12.9	14.4	12.4	11.1	13.0	25.6	15.0	29.3	14.7	11.7	22.7	22.9	17.9	25.3	18.5	34.4	17.7	23.1	13.9	19.5	18.5	18.1	35.4	22.1	19.8	42.0	20.8	49.6	28.0	33.4	11.1	37.9	22.7	14.6	14.3	31.0	11.2	16.2	18.6	17.8	54.3	9.3	15.9	19.4	21.4	28.6	32.8	12.9	21.6	28.2	14.4	20.1	17.3	24.9	17.9	14.4	20.5	29.3	14.2	12.4	32.3	10.9	21.3	16.6	20.3	14.4	14.3	16.7	13.5	22.7	22.3	26.7	21.5	0.1	4.4	1.3	7.7	7.7	6.0	7.3	5.5	6.4	6.1	5.9	4.4	6.0	0.2	7.6	12.4	4.2	5.4	4.8	7.4	8.5	5.7	8.8	6.5	7.1	8.7	7.9	8.8	5.1	10.3	11.1	8.1	16.0	9.6	18.9	15.6	13.8	14.6	5.1	10.8	11.8	10.3	8.3	20.4	7.2	9.2	11.0	8.4	10.6	13.2	6.5	1.9	11.7	7.2	9.1	11.7	11.2	9.0	12.4	13.8	13.3	9.2	13.6	10.2	9.8	15.2	15.5	4.6	6.9	12.3	6.7	13.1	8.4	6.1	7.6	8.7	9.5	10.8	9.8	3.6	24.4	16.8	5.4	8.2	11.1	15.5	14.5	5.6	7.2	15.1	15.3	6.4	9.8	12.8	13.5	0.0	14.1	12.9	16.6	15.1	11.8	11.5	11.4	15.1	10.4	7.8	11.4
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644336-110839468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;pancreas: 20.2"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2"	"Low region specificity"	"Detected in single"							"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"		Yes	No				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.5	0.1	0.8	0.2	2.6	0.1	2.5	0.4	0.8	1.5	1.8	4.1	0.1	2.9	0.6	5.6	2.6	0.4	40.8	0.8	0.4	0.7	0.1	0.9	0.1	0.8	0.9	2.7	20.2	1.2	1.7	1.6	0.6	1.3	0.4	1.2	7.3	0.7	15.6	1.2	0.8	2.2	0.5	0.1	1.0	0.8	0.8	0.5	1.0	3.8	0.6	1.0	5.5	0.7	0.0	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	2.5	6.0	5.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	16.2	0.0	0.0	0.0	0.1	15.0	0.1	0.0	0.6	4.9	9.2	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.4	0.8	0.8	0.4	0.8	0.9	0.6	0.5	0.8	0.7	0.3	0.0	0.0	0.7	0.2	0.1	0.2	0.4	1.2	1.4	0.8	0.5	151.5	0.0	0.1	0.0	2.1	1.6	0.0	0.7	1.9	0.0	0.8	0.5	1.2	1.5	0.0	0.0	14.8	0.2	0.2	3.3	0.0	0.1	0.0	14.6	1.4	0.0	0.1	0.0	15.4	0.7	2.0	0.0	0.0	0.8	4.4	0.0	0.0	17.8	0.0	0.1	0.0	1.5	0.6	0.0	0.1	13.5	1.0	0.0	2.0	1.5	12.4	2.7	6.6	3.7	5.4	0.5	0.8	3.7	0.0	3.1	0.2	1.7	0.2	0.3
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690792-150701077	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	20.3	15.8	18.8	19.3	21.1	64.5	22.2	21.8	28.5	21.3	17.4	22.5	19.7	23.5	19.8	16.8	25.4	22.7	20.9	18.9	19.7	21.8	21.3	22.7	29.2	21.0	18.9	30.7	18.1	23.9	10.9	22.6	20.6	17.7	23.4	23.6	16.4	19.6	27.3	18.8	19.0	21.3	20.3	26.7	19.1	11.6	19.6	41.6	22.2	34.3	32.3	26.1	16.0	26.0	34.9	37.3	56.0	66.2	37.2	34.3	79.4	35.0	39.1	68.4	75.7	61.3	50.7	51.7	54.5	33.6	65.1	36.1	73.0	63.3	71.0	57.6	55.6	41.4	35.1	26.3	35.4	74.4	47.0	29.1	50.1	56.5	37.0	30.2	48.9	41.7	44.3	50.7	43.2	41.3	68.4	50.6	33.8	42.2	37.6	69.8	46.4	45.9	34.0	35.6	52.4	39.1	39.3	64.4	65.2	33.4	67.2	64.9	33.0	55.5	43.7	24.3	64.4	46.8	56.0	74.2	44.0	66.3	42.6	27.0	30.6	51.8	33.9	36.7	38.2	37.9	31.4	32.5	36.5	35.9	33.2	31.8	52.8	43.8	46.9	19.7	37.4	33.4	18.8	21.1	21.8	28.5	18.9	19.7	21.0	18.9	20.6	20.3	19.6	26.0	69.4	28.9	28.2	8.5	51.3	26.0	52.9	33.9	42.1	33.3	29.3	25.9	28.2	27.1	35.9	16.5	25.0	54.9	56.6	34.2	25.4	36.3	8.4	48.4	44.1	50.5	25.9	34.9	7.4	34.3	43.6	39.3	24.5	101.6	63.4	37.3	27.8	16.6	44.3	30.3	7.6	33.2	44.7	31.1	30.3	3.6	43.2	45.8	23.2	6.5	48.5	35.9	58.7	7.5	13.7	29.1	37.1	45.5	32.1	25.6	29.4	22.5	23.1	19.0	32.9	40.2	37.6	32.0	28.5	22.8	21.7	72.7	56.9	34.4	33.4	39.4
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893204-22919182	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	31.8	37.9	35.8	34.1	38.5	53.2	40.7	55.0	42.0	46.0	48.4	38.3	30.7	53.4	39.3	39.6	59.4	39.1	33.6	35.8	42.9	44.2	40.7	42.0	44.8	38.6	38.5	57.9	39.2	83.2	40.6	46.7	37.0	39.0	41.7	52.2	38.0	40.1	29.1	36.3	37.3	45.9	37.7	45.4	39.2	31.3	43.4	57.9	54.5	40.7	50.6	43.5	37.7	45.0	55.9	86.3	86.6	45.4	46.5	39.6	36.1	59.9	81.3	114.0	88.8	39.6	66.6	93.0	45.8	55.8	54.8	77.3	98.3	50.3	92.2	73.1	81.2	43.7	65.8	2.8	72.9	84.6	68.9	51.0	68.3	65.8	43.4	63.4	64.4	45.5	56.5	58.3	56.6	71.1	93.8	38.0	38.7	84.8	80.3	80.1	71.8	56.6	44.0	78.0	59.5	66.3	89.8	68.8	38.6	56.6	50.8	49.6	59.8	19.3	33.3	47.5	56.1	55.1	77.0	87.6	32.4	48.2	71.7	40.1	47.7	50.7	37.1	37.0	25.1	29.3	26.3	32.2	49.5	34.7	31.5	28.2	136.6	59.7	49.7	24.6	30.0	32.0	35.8	38.5	55.0	42.0	35.8	42.9	38.6	38.5	37.0	37.7	43.4	45.0	36.8	44.8	48.3	12.1	82.3	18.4	44.7	28.4	27.9	66.4	38.7	35.9	24.3	68.6	42.7	33.1	116.7	53.0	53.8	48.8	45.0	36.3	9.5	55.1	36.8	39.5	65.4	54.1	13.5	33.5	48.0	32.0	36.7	41.4	70.9	27.2	53.2	37.2	31.5	50.5	16.1	39.3	20.3	54.9	33.6	11.9	35.4	40.4	16.0	19.7	70.8	52.4	102.0	18.6	15.3	39.7	55.1	28.2	42.2	29.1	57.3	33.1	64.0	164.2	32.9	47.8	32.1	52.0	64.3	22.0	21.0	101.4	64.0	28.1	42.3	27.8
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058532-73123899	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	31.4	23.2	14.7	36.0	16.2	72.6	30.7	21.5	20.9	28.7	17.2	28.9	23.4	31.4	22.7	28.9	29.5	21.2	22.2	14.5	19.3	20.8	21.2	30.3	40.0	14.9	13.7	31.1	33.2	22.7	25.3	26.7	16.1	22.5	24.0	41.9	31.4	19.8	41.1	33.3	29.9	23.2	12.5	29.7	27.7	28.5	15.9	36.4	29.3	21.9	33.4	28.1	29.8	20.7	97.8	55.6	86.9	66.6	38.1	44.6	76.5	78.4	54.6	59.5	65.2	74.5	61.2	116.7	40.5	54.0	45.1	72.3	100.9	47.2	101.6	73.8	53.3	98.2	43.2	57.7	24.1	87.5	60.0	32.4	33.3	69.7	56.7	51.1	60.0	42.4	102.7	47.6	65.2	73.3	114.4	51.1	73.8	59.6	60.1	97.4	94.8	57.1	49.0	67.4	58.5	55.8	98.5	64.4	35.0	52.2	92.7	37.9	77.2	87.5	85.5	47.3	79.7	50.2	96.0	141.5	39.1	61.3	61.2	17.4	17.2	16.6	19.9	19.2	18.7	22.3	15.8	16.9	18.2	23.7	16.6	17.6	20.3	27.2	17.5	28.7	19.2	11.7	14.7	16.2	21.5	20.9	14.5	19.3	14.9	13.7	16.1	12.5	15.9	20.7	177.8	230.8	319.9	94.7	226.2	227.4	194.3	109.8	198.6	253.8	136.2	139.2	131.5	77.2	191.8	92.0	268.9	151.8	268.4	137.5	17.6	111.0	71.1	160.4	295.6	170.2	155.2	149.3	115.4	122.6	183.5	185.1	146.8	223.2	247.8	183.3	95.3	98.3	113.1	180.0	99.3	146.3	54.9	110.8	180.8	29.2	157.8	169.9	81.8	71.2	176.9	131.2	155.5	84.9	134.1	132.9	111.0	137.7	233.2	236.5	86.3	32.9	137.0	263.0	72.3	234.2	213.4	213.8	212.9	196.7	236.7	185.4	242.9	161.0	162.5	235.1
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 251.4;Oligodendrocytes: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	21.7	26.0	17.1	28.5	21.8	37.2	25.6	32.0	30.1	24.9	13.7	21.0	18.6	28.2	28.1	20.9	24.2	17.5	18.8	19.5	18.3	20.3	21.1	21.5	40.4	14.2	14.4	32.8	27.9	19.2	30.2	24.2	15.0	21.2	21.9	40.9	23.7	18.6	26.0	32.4	28.5	20.3	13.8	33.7	25.0	30.0	16.7	29.9	25.4	19.4	34.2	20.8	21.5	22.2	55.3	29.1	70.1	35.9	30.7	32.2	38.1	37.0	30.9	37.5	38.7	39.1	45.9	82.1	29.5	27.3	24.7	51.4	53.0	36.3	54.2	49.6	56.3	63.4	68.0	35.8	23.9	119.9	48.6	21.9	29.6	38.6	53.3	34.4	39.8	50.5	49.0	26.8	41.9	18.7	73.3	63.3	43.6	49.3	16.9	72.9	57.5	43.8	34.9	31.4	53.2	35.6	31.8	38.2	23.4	42.4	34.4	99.0	38.0	31.8	31.7	25.9	38.0	38.5	36.0	100.0	51.6	66.0	38.6	3.8	1.4	2.8	2.9	2.0	3.0	3.7	2.8	2.7	0.8	5.5	4.2	3.7	2.0	2.3	1.5	2.6	3.3	1.0	17.1	21.8	32.0	30.1	19.5	18.3	14.2	14.4	15.0	13.8	16.7	22.2	50.2	57.7	83.5	148.9	80.9	34.7	35.1	25.0	47.8	63.7	36.5	31.0	42.1	35.8	35.6	25.8	73.0	34.3	72.4	34.8	9.8	25.4	49.2	29.0	59.9	43.3	49.1	41.9	251.4	26.0	31.5	41.6	32.1	36.6	55.8	75.9	60.0	40.3	32.9	57.2	170.8	39.2	32.6	53.7	23.0	27.3	65.0	41.6	16.0	137.7	58.0	37.9	56.7	217.6	253.0	27.0	31.5	47.4	65.8	51.1	28.4	19.6	37.7	72.0	52.6	71.3	43.1	102.3	78.1	47.3	35.5	23.0	54.8	57.7	37.5	33.7
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203605-146289223	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	7.3	5.4	4.1	8.4	4.2	19.5	9.4	7.0	4.9	8.3	4.0	7.8	7.5	9.3	8.0	7.3	7.4	5.9	7.0	3.9	4.8	8.0	10.6	6.7	11.7	3.5	4.5	10.9	6.0	8.9	3.6	9.2	4.0	7.6	8.3	9.4	6.3	6.4	7.2	7.2	7.3	7.6	4.3	9.4	8.6	10.1	4.6	12.6	10.9	9.2	11.3	9.3	5.9	4.9	15.0	12.1	15.3	24.8	13.1	12.5	17.7	10.9	12.3	15.7	17.2	21.3	18.9	31.7	8.4	12.5	21.5	15.3	23.1	25.2	27.7	24.3	10.2	21.7	12.9	14.9	14.4	34.3	24.1	11.7	13.0	16.9	29.9	12.1	14.2	14.9	24.3	18.7	15.0	13.5	25.0	17.4	21.2	16.5	13.6	22.2	23.7	21.9	16.0	16.6	19.1	13.1	22.5	21.7	17.8	15.6	25.3	18.7	13.5	16.6	17.6	12.5	17.8	17.7	18.1	36.6	12.5	24.7	15.7	1.7	0.8	1.6	1.4	1.3	1.6	1.2	1.4	1.6	1.1	1.4	1.8	1.5	1.2	1.8	1.5	1.3	1.5	0.7	4.1	4.2	7.0	4.9	3.9	4.8	3.5	4.5	4.0	4.3	4.6	4.9	12.7	16.0	17.6	20.5	13.1	66.2	9.5	52.6	6.2	11.2	13.0	8.6	17.3	5.7	32.3	14.7	10.4	9.2	17.6	10.1	1.9	7.8	32.4	15.1	11.8	15.7	10.8	11.8	32.2	6.8	8.3	17.0	11.2	13.9	22.1	12.2	11.4	12.1	11.2	15.2	31.4	13.8	30.5	20.4	40.6	6.6	11.5	14.1	19.6	28.1	16.9	8.4	12.3	28.6	43.8	11.5	8.7	14.7	7.3	17.4	9.9	7.9	36.8	8.7	0.0	16.5	24.1	31.4	13.2	12.0	62.1	9.7	15.7	9.8	12.5	19.7
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		NA	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	17.6	13.0	6.1	14.9	9.2	12.2	14.6	7.6	8.6	12.5	7.2	12.2	10.3	12.8	6.3	11.8	11.4	8.2	20.3	6.6	9.2	8.5	15.2	10.6	14.9	7.6	7.7	14.9	12.4	10.5	13.5	11.2	7.9	10.3	9.3	10.4	10.1	7.7	29.6	13.6	9.2	10.7	6.1	10.8	11.9	16.3	8.7	11.3	12.6	17.6	12.5	12.2	11.6	13.1	56.2	60.5	35.9	103.0	25.1	15.9	49.0	50.3	20.7	44.6	48.0	50.7	47.9	74.0	26.8	23.0	64.8	37.0	53.2	42.6	57.4	37.1	51.0	74.4	43.0	47.1	22.3	94.7	63.9	18.1	27.4	59.4	35.5	16.8	41.9	40.3	141.6	42.0	35.1	45.2	68.3	54.0	68.5	38.5	47.0	53.4	42.8	70.7	21.8	37.5	40.0	48.4	65.0	107.2	34.8	42.6	27.6	28.7	40.4	64.4	33.6	57.7	61.9	42.8	39.5	126.0	42.4	78.2	70.8	3.8	11.0	4.6	12.6	9.2	8.7	12.8	10.7	11.6	11.5	13.4	9.7	11.1	9.7	12.3	8.1	14.1	7.4	5.8	6.1	9.2	7.6	8.6	6.6	9.2	7.6	7.7	7.9	6.1	8.7	13.1	22.7	16.0	31.4	33.3	23.2	16.2	17.1	16.2	24.5	54.9	16.3	17.8	28.8	10.0	27.7	12.9	93.8	20.8	27.5	9.1	25.4	22.3	2.5	21.3	50.3	25.3	11.4	20.4	13.1	22.9	26.5	25.7	21.4	22.5	36.7	30.3	9.7	14.8	19.1	40.4	17.6	14.9	14.2	12.9	10.2	3.3	27.7	17.9	5.4	7.5	18.9	18.6	37.0	18.6	15.3	18.7	8.2	20.7	17.7	19.0	8.1	16.7	17.1	56.1	6.6	51.3	26.4	42.6	44.7	19.1	14.5	18.6	24.4	34.6	16.4	14.8
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48581162	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB062559: AB_2665621, HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	246.8	129.7	21.7	143.2	23.7	301.8	200.9	23.0	33.2	82.3	27.5	122.4	102.1	118.2	89.4	147.1	101.7	71.9	100.7	22.3	27.9	89.2	71.1	130.5	158.5	27.9	24.0	99.3	167.2	94.2	80.1	104.0	26.5	75.7	146.0	51.4	126.0	81.8	112.3	195.3	102.6	114.9	28.7	128.5	114.2	55.9	23.4	156.9	90.1	38.3	206.1	135.0	101.7	29.3	128.2	168.7	172.5	187.3	42.4	226.3	117.2	156.0	272.3	381.6	273.6	173.7	322.5	241.4	50.0	302.3	75.9	107.1	153.2	209.1	304.1	236.5	206.7	126.2	270.5	164.0	153.0	360.8	248.0	168.1	143.8	129.7	124.3	46.2	320.4	131.7	69.8	194.6	268.6	215.9	304.9	209.3	100.5	33.3	230.1	280.7	181.4	196.5	177.7	201.8	70.1	179.1	152.2	206.9	187.5	83.7	272.2	363.6	440.7	127.0	213.0	425.8	278.2	93.7	114.0	279.1	176.5	208.0	263.0	33.0	187.0	30.7	118.4	211.9	141.7	147.5	120.6	119.7	264.1	101.5	120.6	119.5	28.7	150.9	187.0	185.0	137.5	256.3	21.7	23.7	23.0	33.2	22.3	27.9	27.9	24.0	26.5	28.7	23.4	29.3	336.2	166.7	172.1	18.6	391.7	519.4	182.9	379.4	157.6	58.9	326.1	260.5	76.8	154.4	196.7	53.3	47.9	459.9	392.1	165.8	176.1	482.2	6.0	114.6	193.8	292.9	247.4	287.0	18.4	1442.0	726.9	274.2	164.1	234.3	265.2	144.9	195.9	74.6	433.2	42.1	17.7	360.2	136.3	439.5	783.6	17.1	245.7	339.3	522.9	18.7	571.7	181.8	358.4	15.1	18.0	915.3	235.9	147.4	317.7	119.0	143.3	164.3	84.6	87.0	131.5	378.4	299.4	43.6	200.8	285.2	507.8	489.3	352.5	178.2	368.0	202.6
RBM33	"DKFZp434D1319, DKFZp686F102, MGC20460, PRR8"	ENSG00000184863	"RNA binding motif protein 33"	Q96EV2	7	155644451-155781485	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019232, HPA021497, HPA021768"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (3.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.90e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.29e-4)"	25.4	19.3	14.4	15.2	14.4	62.2	23.3	39.8	18.9	26.8	6.7	24.8	14.0	22.3	17.1	24.3	20.5	8.8	20.1	11.9	20.3	22.7	32.1	30.1	18.8	16.6	11.6	26.1	30.1	8.1	28.3	10.6	14.7	23.0	12.7	33.7	23.0	9.4	30.9	30.5	31.1	9.5	3.7	30.2	26.9	16.9	16.7	31.5	24.5	10.1	15.6	19.4	28.2	23.8	31.9	37.0	22.7	21.1	12.0	15.6	22.9	19.8	14.0	12.0	17.3	34.2	30.0	35.1	25.9	14.7	32.5	22.5	20.8	16.7	15.9	33.3	29.0	33.5	41.7	22.7	13.2	47.7	32.5	15.3	19.3	19.2	27.3	17.4	21.4	38.8	43.6	28.3	17.2	31.1	49.4	40.8	24.4	21.4	23.3	39.2	25.4	29.4	17.4	34.1	23.0	23.5	33.2	21.7	18.0	17.0	16.6	24.8	24.8	20.2	11.9	36.6	26.6	48.8	40.7	52.4	32.7	30.5	26.4	33.5	10.4	23.1	6.6	10.5	5.4	9.5	6.6	8.2	9.1	7.7	6.1	7.8	37.2	9.1	8.3	9.0	9.3	4.2	14.4	14.4	39.8	18.9	11.9	20.3	16.6	11.6	14.7	3.7	16.7	23.8	36.3	32.1	36.4	68.2	52.3	19.6	20.4	19.7	33.6	57.6	22.2	19.8	30.2	14.3	17.0	3.7	83.4	18.1	60.3	32.4	7.9	20.1	25.6	25.9	43.7	27.6	26.3	37.2	86.8	18.0	17.4	26.0	45.3	43.0	39.2	38.9	17.5	30.0	15.9	132.9	85.5	28.1	16.2	28.3	24.4	42.0	26.1	39.3	12.4	87.1	42.9	23.0	42.2	97.0	115.0	23.5	28.5	17.7	93.1	33.3	37.1	18.2	19.2	91.5	13.1	37.5	31.5	29.5	24.4	26.3	23.4	26.1	53.0	33.9	24.0	36.5
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391396-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.4;skeletal muscle: 221.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 95.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 140.6;U-698: 150.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	11.7	10.7	6.7	26.6	9.4	136.4	12.8	13.3	10.3	18.8	15.1	96.6	8.7	38.4	0.9	16.8	28.9	5.1	72.6	5.9	6.4	16.3	16.4	21.0	43.4	8.6	11.5	27.8	10.8	1.9	12.2	5.5	8.0	27.0	4.1	0.6	19.7	11.9	221.7	9.1	39.8	8.7	6.6	65.8	23.0	38.1	9.4	26.6	9.4	32.7	12.2	42.9	13.6	7.9	20.1	20.4	9.7	25.1	0.0	1.6	56.3	6.5	1.6	13.5	3.5	84.2	20.6	140.6	54.1	1.9	13.2	18.3	8.0	8.0	2.1	29.0	34.5	118.0	7.6	52.6	6.0	57.8	54.2	1.9	3.8	5.7	1.1	1.9	9.2	52.5	100.9	24.6	1.6	87.8	42.7	58.5	36.9	10.7	25.5	82.0	23.6	114.2	10.1	9.2	40.9	26.3	15.2	50.5	24.7	8.7	28.3	79.4	17.0	4.4	42.6	6.0	27.6	60.1	86.8	150.7	1.1	40.3	4.2	0.0	0.5	2.2	3.1	1.8	1.9	3.2	2.5	2.1	1.0	3.3	3.0	2.8	0.7	3.5	1.7	1.3	4.7	2.1	6.7	9.4	13.3	10.3	5.9	6.4	8.6	11.5	8.0	6.6	9.4	7.9	13.9	3.2	5.2	10.1	110.9	9.1	28.3	7.9	13.6	1.0	15.8	21.0	42.5	8.6	6.6	1.8	0.0	1.9	156.9	41.6	9.8	6.2	4.2	54.2	5.2	11.9	62.8	280.4	2.5	5.0	5.8	8.8	12.2	21.5	8.8	31.5	10.4	6.0	9.6	0.0	1.3	56.4	12.2	8.1	18.9	4.0	4.4	27.6	1.8	2.8	5.8	12.8	54.6	4.5	4.6	5.9	35.4	6.0	52.8	18.8	2.8	16.4	22.5	1.4	6.6	20.6	7.6	2.4	13.2	9.1	8.4	2.3	81.0	13.3	34.0	18.5
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA		19000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	70.1	55.8	18.4	37.7	17.6	172.0	44.6	33.5	28.0	57.8	22.2	56.0	35.1	54.5	9.2	62.3	61.4	40.8	57.3	16.5	25.0	52.2	47.7	62.2	42.3	24.2	24.0	71.1	41.2	27.3	50.0	40.9	19.4	50.2	16.9	49.5	53.4	22.3	70.3	51.2	46.9	19.2	16.0	56.4	49.7	34.3	16.9	51.1	54.2	33.1	24.1	50.7	62.1	26.5	98.8	87.6	77.0	78.5	48.8	53.8	78.8	131.0	50.6	59.6	60.2	109.3	78.5	137.5	90.6	38.9	67.9	91.2	122.3	67.9	66.5	94.6	96.7	174.6	80.7	101.2	23.4	158.6	99.9	14.4	97.6	68.9	38.4	63.7	57.8	46.4	195.5	117.6	46.3	72.2	194.5	87.9	103.2	87.5	96.8	104.9	136.2	91.7	41.5	56.2	77.9	63.4	91.1	94.7	78.4	109.3	70.6	94.6	91.4	100.8	92.5	90.5	115.8	71.6	164.3	204.0	64.7	123.2	79.2	250.9	120.4	197.5	104.7	111.1	103.6	131.1	91.5	97.6	111.8	140.5	85.7	82.1	427.7	127.2	102.2	160.9	114.7	95.7	18.4	17.6	33.5	28.0	16.5	25.0	24.2	24.0	19.4	16.0	16.9	26.5	302.0	233.9	280.9	144.3	441.7	616.4	521.0	283.0	284.0	258.5	339.1	295.4	189.2	191.6	267.6	200.5	316.9	375.2	624.9	278.1	189.8	203.8	48.1	359.2	496.0	299.7	295.3	214.2	130.1	186.0	389.6	337.9	254.9	540.8	525.8	304.4	215.3	202.1	199.8	220.4	120.9	331.3	215.7	207.7	469.5	41.9	262.5	335.5	270.3	129.3	274.3	208.7	400.6	136.2	160.5	221.3	254.8	214.4	391.0	453.6	271.8	150.6	248.0	386.5	164.3	504.0	410.2	263.5	228.1	215.8	586.9	561.6	490.8	218.2	282.8	532.1
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638667-66668374	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	82.6	111.5	60.8	71.0	63.3	131.5	75.8	81.1	66.7	90.8	69.4	96.1	67.8	87.1	90.3	100.3	79.4	59.0	75.6	61.5	67.1	119.8	82.3	77.4	97.5	59.0	58.5	103.6	115.5	77.2	86.1	72.8	58.9	95.9	62.6	74.4	89.1	60.0	96.6	80.9	83.6	69.1	61.1	104.8	98.4	74.3	69.5	109.8	85.7	72.4	99.1	84.2	84.1	65.4	127.2	163.6	246.5	136.4	90.1	95.6	153.9	128.6	106.1	134.1	97.3	281.5	160.9	161.1	174.4	132.3	120.5	136.4	263.5	159.1	142.9	162.1	138.4	220.7	163.5	170.3	173.1	152.8	91.9	138.8	134.3	158.6	213.9	136.4	184.3	155.0	180.1	115.0	147.3	263.3	252.9	157.9	309.7	246.8	176.0	234.2	224.6	181.7	180.7	199.5	204.5	149.5	227.1	168.6	379.9	163.8	315.3	154.4	180.9	140.4	124.0	86.5	107.3	143.9	162.5	258.8	109.9	118.3	205.8	210.0	119.4	131.3	135.5	123.2	122.3	119.3	139.8	149.9	116.2	130.4	147.5	149.8	137.5	155.4	144.0	103.6	194.3	159.1	60.8	63.3	81.1	66.7	61.5	67.1	59.0	58.5	58.9	61.1	69.5	65.4	19.7	28.9	42.2	8.1	64.0	17.8	61.4	36.3	112.7	58.2	24.2	12.7	4.6	15.7	36.5	20.2	93.8	36.2	48.7	16.6	15.6	25.1	39.8	26.6	28.0	28.5	34.7	42.5	23.9	23.1	30.1	33.6	53.0	30.7	36.8	38.1	25.7	11.1	14.5	62.2	21.4	15.5	32.6	18.8	29.2	9.3	27.4	27.5	19.6	7.5	28.8	15.9	69.0	15.1	18.8	19.6	23.6	20.3	60.2	62.6	32.9	10.6	41.1	90.0	19.7	29.7	28.3	41.1	40.1	68.6	22.3	43.8	66.3	42.4	24.8	65.5
RBM41	FLJ11016	ENSG00000089682	"RNA binding motif protein 41"	Q96IZ5	X	107064420-107118823	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042881	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles, Cytosol"		"HPA042881: AB_10794536"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.92e-1)"	4.6	5.8	2.6	5.0	3.0	3.5	5.7	5.7	3.7	4.2	5.1	5.5	7.7	6.1	6.5	5.6	5.0	4.5	5.5	3.0	2.8	6.8	8.3	4.7	5.8	3.9	3.4	5.5	4.2	9.3	3.4	5.4	3.4	5.5	6.5	5.8	4.5	5.0	6.4	7.1	6.9	5.6	3.2	5.3	5.0	7.3	3.2	6.6	6.9	8.0	6.2	5.0	4.1	3.8	16.9	13.3	8.4	6.8	5.5	9.5	9.7	9.8	9.6	7.1	9.5	8.9	13.8	9.3	18.0	7.2	12.4	13.7	12.3	9.2	10.8	11.5	18.1	11.3	25.2	11.0	6.2	11.6	8.5	6.7	17.7	8.6	8.6	9.9	10.8	8.5	19.8	12.5	8.7	8.2	9.9	6.6	12.4	9.3	15.1	7.9	7.0	8.0	10.5	10.5	6.9	10.9	12.2	8.7	7.9	11.4	8.0	5.4	10.6	9.8	5.7	11.7	7.8	5.8	11.6	9.9	5.5	5.2	7.6	10.5	5.2	8.3	4.5	2.7	2.7	5.1	3.9	4.6	3.5	4.3	2.9	1.9	0.7	6.6	2.9	3.6	3.9	2.3	2.6	3.0	5.7	3.7	3.0	2.8	3.9	3.4	3.4	3.2	3.2	3.8	9.6	12.8	17.0	29.0	11.6	5.2	6.6	8.5	12.0	20.3	7.6	6.7	23.2	11.5	8.3	7.3	27.1	8.7	17.4	10.9	1.9	14.8	8.0	27.1	10.1	9.8	7.8	21.0	38.3	7.8	5.3	10.1	8.2	11.6	13.3	19.5	5.3	10.2	6.6	11.8	46.5	8.6	4.1	10.7	4.6	2.3	14.3	12.5	5.4	45.9	11.7	7.4	14.4	50.8	53.4	13.6	11.9	11.7	12.6	5.6	22.0	9.0	13.1	20.2	0.0	14.7	12.4	11.7	8.0	9.0	7.4	4.5	9.7	13.1	11.4	6.2
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 384.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	57.6	48.0	34.9	24.5	39.8	38.2	54.3	41.3	41.5	56.1	30.9	60.6	27.5	65.2	12.0	58.5	53.8	11.8	60.8	35.1	36.3	57.5	54.0	46.5	24.1	43.8	38.0	54.8	39.6	23.1	41.4	23.2	38.7	55.2	10.7	9.1	44.2	24.9	76.0	67.3	46.3	14.5	37.6	51.7	49.7	41.5	38.0	25.9	49.9	21.6	15.5	58.0	50.8	42.9	115.6	176.5	38.8	52.9	34.6	27.0	104.8	77.2	41.8	88.3	69.0	105.0	72.8	63.7	137.8	49.4	48.2	46.6	44.8	54.0	26.0	165.6	80.0	87.8	57.7	87.5	88.8	78.5	81.1	38.6	42.3	65.4	36.0	28.4	48.8	65.3	92.9	50.8	40.5	130.5	99.9	103.1	44.4	103.1	71.9	107.7	52.9	63.8	43.0	52.6	50.5	73.3	87.8	71.5	62.4	21.1	57.0	122.0	76.2	63.1	86.4	84.4	136.6	123.0	140.7	99.1	60.9	73.8	90.2	98.8	79.6	124.5	82.8	95.6	70.9	76.2	67.8	83.1	94.3	81.3	59.4	67.1	73.9	79.3	94.5	87.6	82.6	73.3	34.9	39.8	41.3	41.5	35.1	36.3	43.8	38.0	38.7	37.6	38.0	42.9	56.5	38.5	24.6	4.6	38.4	51.9	52.6	94.3	43.9	23.3	31.2	37.5	14.7	40.0	57.4	53.3	12.5	197.9	47.0	67.2	74.3	78.0	38.4	41.0	35.4	50.9	52.1	43.8	2.3	90.4	101.5	47.0	38.7	41.6	51.4	46.0	46.8	31.6	91.2	10.1	2.6	56.4	54.9	31.1	60.9	16.3	58.1	40.9	53.4	2.8	63.0	46.5	27.8	3.5	5.8	80.6	48.9	63.2	43.7	31.8	72.3	78.0	44.5	19.8	52.6	34.5	92.4	71.9	52.9	36.2	43.5	384.3	44.9	44.3	64.7	45.4
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261863	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;HSkMC: 18.5"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	5.2	8.7	2.4	4.2	2.3	6.7	6.9	1.6	2.3	7.5	3.5	4.2	3.0	7.6	9.4	3.2	12.3	6.8	3.2	2.1	2.7	7.0	6.7	6.1	6.9	2.9	2.9	15.4	4.0	5.1	2.9	5.7	2.3	6.5	4.4	1.8	5.2	7.7	3.4	4.7	3.9	5.7	2.8	7.9	4.6	3.6	2.9	7.0	12.3	2.5	4.7	3.8	3.1	3.0	3.5	2.2	3.5	4.7	9.4	20.4	2.3	4.0	9.2	5.0	7.2	0.1	5.7	2.7	1.5	7.3	2.7	1.7	1.1	4.6	2.5	4.2	2.5	6.6	1.0	0.2	9.1	8.2	2.2	18.5	5.0	4.0	3.0	7.4	10.7	2.9	2.7	3.0	6.8	3.5	4.7	3.9	1.3	0.1	4.2	3.2	4.1	1.6	8.4	3.0	1.3	4.2	3.8	2.8	7.8	0.6	4.1	5.2	6.1	3.7	3.3	3.2	1.7	1.1	0.8	0.0	9.7	3.3	2.3	1.0	0.7	3.0	1.2	0.9	2.0	1.2	1.6	1.5	0.5	1.3	2.0	1.5	0.8	2.7	2.4	0.2	0.8	0.6	2.4	2.3	1.6	2.3	2.1	2.7	2.9	2.9	2.3	2.8	2.9	3.0	26.5	3.2	8.9	2.9	9.6	3.3	3.2	5.8	5.7	6.7	8.6	14.9	2.6	11.5	5.7	18.4	0.0	6.8	8.4	1.7	27.4	6.8	3.0	30.9	17.2	16.9	6.1	8.8	1.0	5.9	4.7	21.8	5.6	9.4	3.8	13.4	20.7	9.1	5.1	6.7	1.3	6.9	4.1	10.4	4.3	2.4	28.0	8.2	3.6	2.8	12.3	22.1	13.4	4.0	0.9	4.6	5.6	29.0	5.5	2.8	5.5	18.2	26.3	1.3	0.0	18.4	13.0	0.5	3.6	7.3	3.1	1.4	13.5	30.4	3.7	2.2
RBM44	FLJ40411	ENSG00000177483	"RNA binding motif protein 44"	Q6ZP01	2	237798389-237842808	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 15.7"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 104.7;Spermatogonia: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003298	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 36: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA003298: AB_2284846"	"unprognostic (1.29e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.01e-5)"	"unprognostic (1.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.89e-3)"	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.1	15.7	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	1.6	0.4	0.8	0.7	0.3	0.6	0.0	0.8	0.3	0.7	1.5	1.5	1.8	0.0	0.1	2.2	0.0	0.0	0.1	16.8	2.0	0.5	2.4	0.0	0.0	2.4	0.2	0.3	1.0	0.0	4.6	0.0	0.3	0.0	0.2	0.3	0.0	3.3	0.0	0.0	0.8	2.3	16.1	2.8	1.5	1.8	1.9	1.4	0.0	1.0	3.0	0.4	0.6	0.0	1.5	1.0	2.0	0.1	0.1	1.8	0.0	6.6	2.6	0.7	104.7	59.8	0.2	0.6	0.0	0.8	0.7	0.0	1.6
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	4.8	6.5	12.5	5.5	12.9	4.1	8.5	12.4	18.4	5.6	12.7	8.3	5.9	6.3	9.2	6.1	7.3	4.7	6.4	12.6	12.9	6.5	8.1	5.4	8.1	12.9	12.5	5.7	7.9	8.8	6.4	3.3	12.8	5.8	9.3	9.8	6.2	5.2	4.8	8.2	6.7	5.7	12.6	7.8	6.5	6.6	12.6	8.9	7.0	3.2	9.9	5.6	5.1	13.3	9.5	10.1	15.7	6.5	13.6	15.7	9.8	12.8	14.5	12.9	14.2	10.7	7.7	15.8	8.4	15.3	12.9	8.4	13.1	16.7	15.7	12.7	11.2	12.2	6.3	16.1	14.3	14.9	11.6	12.7	13.7	13.2	11.0	12.5	13.7	8.7	11.5	12.6	16.2	15.1	15.5	10.0	11.1	14.2	12.8	12.4	11.1	15.7	19.0	21.8	9.7	10.1	9.0	8.8	11.8	17.7	12.9	13.9	11.7	9.1	8.6	10.7	12.7	11.7	14.4	20.3	8.9	11.9	12.8	3.8	5.3	1.9	6.2	8.6	7.1	12.5	6.5	6.8	7.2	8.6	5.9	7.3	1.0	11.3	10.2	7.7	10.9	5.3	12.5	12.9	12.4	18.4	12.6	12.9	12.9	12.5	12.8	12.6	12.6	13.3	5.2	3.2	4.2	8.5	6.3	2.5	3.5	11.3	5.2	7.1	4.3	3.6	4.2	8.6	6.6	1.8	10.4	5.6	8.1	5.0	7.9	7.3	3.8	4.8	5.4	5.9	6.0	8.6	10.2	6.6	10.3	5.7	7.7	3.5	8.2	8.2	3.3	5.1	8.2	10.1	13.1	7.6	4.1	8.1	3.3	4.3	4.4	5.3	1.8	6.5	8.1	7.6	6.2	15.1	13.7	5.2	6.5	5.7	8.0	1.7	6.1	7.0	9.6	9.1	6.6	6.1	6.1	11.4	5.6	6.2	3.4	1.8	6.2	9.1	4.9	2.7
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677887	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	8.1	16.2	25.9	11.1	26.2	4.9	10.7	36.5	31.5	21.9	23.2	15.2	10.0	19.8	20.4	13.7	18.7	10.4	10.9	25.7	27.7	15.2	14.3	9.4	16.1	25.2	24.9	30.0	13.6	13.1	23.6	13.1	25.3	18.6	12.0	34.5	15.3	14.9	16.3	18.8	14.5	14.5	24.7	15.6	12.6	16.2	26.2	13.3	16.1	15.3	17.3	14.0	15.5	29.9	21.3	21.0	45.1	37.7	21.7	22.3	15.3	19.9	20.0	21.9	22.3	29.5	21.9	23.8	27.9	25.5	21.5	27.2	30.1	27.7	23.2	23.0	20.4	25.7	26.6	31.9	15.9	26.4	24.4	23.3	18.6	22.5	19.1	25.1	21.5	19.0	20.0	23.1	29.8	34.3	16.5	20.4	26.7	47.8	27.9	33.4	35.8	24.4	20.2	21.1	27.7	25.2	23.9	12.1	47.3	28.8	32.3	24.7	20.1	24.1	24.6	23.7	18.3	11.2	20.5	24.2	22.2	18.4	21.7	26.4	15.1	43.9	16.1	22.6	15.7	34.6	14.9	15.8	18.2	28.9	18.1	13.5	9.8	22.6	25.9	15.1	12.2	13.8	25.9	26.2	36.5	31.5	25.7	27.7	25.2	24.9	25.3	24.7	26.2	29.9	7.5	12.8	5.9	15.3	25.9	8.0	14.7	29.8	24.5	36.3	14.4	13.6	6.9	12.8	15.9	18.4	33.3	36.5	11.5	8.1	11.7	11.9	26.5	13.4	12.8	9.5	19.2	12.0	20.0	5.8	16.5	14.9	11.2	11.7	8.9	17.0	12.8	9.0	13.0	25.2	25.8	11.7	26.4	9.8	6.1	53.9	18.3	9.8	16.0	11.2	10.5	23.3	13.4	29.1	31.1	4.7	12.4	13.5	13.4	7.0	21.2	13.4	22.6	60.4	6.6	12.0	14.2	50.8	42.8	13.6	7.1	22.2	14.6	12.2	10.9	5.7
RBM5	"H37, LUCA-15, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088919-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	70.6	53.9	42.2	44.2	45.4	63.5	69.8	48.4	49.6	96.2	47.9	74.8	37.4	74.6	64.0	57.5	85.8	40.1	58.0	41.1	52.5	66.2	58.1	61.8	66.8	46.5	42.5	120.2	73.1	45.2	84.7	60.1	46.2	85.2	47.7	90.5	63.9	47.2	63.6	81.6	72.1	53.7	40.9	95.2	64.8	62.9	44.1	62.5	80.8	36.4	69.5	66.6	73.2	62.5	31.1	37.3	132.6	58.2	54.3	78.1	31.3	91.9	54.8	67.0	46.9	37.6	34.7	72.4	31.0	60.3	65.6	26.8	90.4	44.5	71.5	67.5	33.2	91.0	136.5	34.2	66.7	84.1	71.0	70.1	49.8	72.7	71.3	114.5	71.9	72.5	63.3	47.4	63.7	27.3	85.6	56.9	47.9	52.3	42.3	46.3	57.9	37.6	48.7	152.1	19.0	43.8	75.6	32.8	46.2	89.5	30.2	79.9	82.0	44.3	45.9	61.7	53.7	64.8	103.2	76.4	32.9	50.8	52.3	54.3	21.4	29.2	24.8	22.2	23.3	20.5	22.2	25.9	18.4	19.6	27.9	22.3	39.0	22.9	22.6	13.9	28.5	17.0	42.2	45.4	48.4	49.6	41.1	52.5	46.5	42.5	46.2	40.9	44.1	62.5	70.1	70.5	103.3	108.7	69.9	32.0	39.8	31.1	27.3	94.4	43.9	44.2	44.5	25.8	68.2	38.6	183.5	52.5	77.0	51.3	11.7	27.3	128.2	52.4	67.9	67.9	73.5	40.2	100.8	20.9	26.2	54.4	74.5	47.8	68.9	85.1	60.3	40.0	32.4	94.2	107.1	53.7	50.8	42.2	48.4	246.2	64.3	56.4	44.4	96.5	66.9	43.2	75.2	117.6	136.0	30.8	45.8	57.9	64.5	49.5	42.4	11.3	84.0	126.1	32.9	62.4	57.1	57.8	33.0	31.1	34.0	81.7	68.1	52.2	44.7	55.5
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	65.2	75.5	51.4	43.7	50.5	45.8	58.3	56.9	96.4	108.2	53.0	81.5	43.4	70.0	34.5	51.7	81.7	27.6	74.3	51.0	54.8	74.3	78.1	64.7	59.8	53.6	51.0	96.2	89.7	36.7	72.8	30.3	50.0	98.2	39.5	64.3	50.3	36.0	44.0	54.3	78.0	42.2	48.1	103.5	69.3	66.1	53.1	48.6	74.9	25.7	50.1	67.2	68.5	51.7	28.6	18.0	73.0	48.1	70.8	38.4	25.9	47.8	41.0	40.8	42.7	31.0	31.4	147.2	27.0	47.0	41.1	23.6	61.2	40.9	51.3	57.3	23.2	68.6	46.1	41.3	40.0	71.3	69.4	36.0	50.5	45.7	50.9	76.4	52.2	37.0	57.0	36.0	39.3	26.9	66.8	106.0	57.9	34.7	32.0	26.1	31.0	38.0	40.4	57.0	28.8	51.6	43.7	31.0	30.9	62.9	25.3	55.7	48.8	41.2	48.0	33.3	48.6	49.7	123.7	84.9	23.7	58.6	40.6	16.4	8.5	5.2	13.3	4.6	11.2	12.3	9.3	8.2	8.8	11.5	9.3	10.2	5.6	7.2	8.8	9.6	7.0	6.1	51.4	50.5	56.9	96.4	51.0	54.8	53.6	51.0	50.0	48.1	53.1	51.7	76.0	57.7	75.2	172.4	87.4	54.0	43.0	34.2	67.7	120.1	43.5	33.8	35.7	40.0	45.9	62.5	102.2	38.2	91.9	46.4	11.7	33.4	31.9	51.2	69.5	57.2	47.3	51.9	195.6	28.0	33.0	53.9	64.7	46.3	43.0	93.0	45.7	36.0	27.8	92.5	216.8	44.5	36.7	56.1	82.2	25.2	65.6	50.1	60.5	161.1	66.1	43.4	62.8	154.3	177.9	34.3	32.4	60.5	106.9	51.2	60.9	17.7	49.1	145.7	46.0	55.6	63.7	135.3	56.7	46.7	45.3	36.3	66.4	66.3	39.5	35.2
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 196.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA013993: AB_1856137, HPA048003: AB_2680231"	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	18.5	9.1	3.4	6.5	5.3	39.8	15.3	7.6	7.8	12.9	3.6	13.1	6.2	13.9	4.9	13.3	13.9	10.5	9.9	4.0	5.1	12.7	18.0	13.7	6.8	6.3	5.0	16.4	10.0	9.6	7.2	11.3	5.0	10.1	11.2	6.8	12.7	8.7	12.2	10.8	11.3	10.9	5.2	10.1	12.1	11.5	4.0	15.2	10.4	14.6	9.3	12.6	13.2	6.6	13.1	13.4	17.0	11.5	21.9	27.6	11.3	31.1	43.5	34.6	37.8	30.7	28.1	24.2	34.5	28.0	26.0	11.0	19.7	23.6	40.4	15.3	8.4	27.5	14.5	27.3	36.7	18.9	15.3	32.2	25.0	31.2	41.7	32.6	30.1	17.1	19.8	2.9	20.8	6.4	23.0	9.5	13.9	13.1	19.7	14.5	29.5	18.2	26.1	22.2	13.1	12.5	18.8	10.4	8.9	27.5	6.8	5.0	26.6	9.1	17.2	10.2	22.8	10.8	12.4	18.8	7.3	22.7	14.9	53.0	15.3	17.8	11.5	13.7	15.2	11.9	11.6	10.5	15.2	9.7	14.8	11.6	14.0	17.3	16.5	14.0	14.7	10.6	3.4	5.3	7.6	7.8	4.0	5.1	6.3	5.0	5.0	5.2	4.0	6.6	49.4	16.0	25.7	2.0	44.0	67.4	78.4	48.4	41.5	11.5	47.4	31.9	15.1	30.0	34.2	29.5	12.5	51.0	52.4	30.8	66.5	49.8	196.4	37.6	38.8	45.0	47.4	26.1	5.4	35.1	78.0	51.7	26.0	51.3	40.0	20.1	37.9	27.5	29.8	8.4	5.6	30.9	40.7	27.4	55.3	29.5	31.4	30.8	42.7	7.5	32.2	24.5	28.8	8.5	10.2	39.0	37.6	17.0	18.0	71.2	38.1	46.5	27.8	13.0	0.0	49.1	47.6	35.3	16.9	32.8	68.6	92.5	46.6	18.7	38.4	82.6
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	19.4	7.1	12.5	5.7	11.5	3.6	17.4	9.3	13.1	14.7	15.1	12.9	4.7	13.7	9.3	8.2	13.7	9.5	15.6	9.2	10.0	14.7	3.4	37.3	3.2	14.5	11.7	12.6	7.0	8.6	6.1	23.5	13.4	11.2	8.8	6.0	10.1	8.7	8.4	8.3	9.0	12.1	9.8	10.5	8.5	4.3	15.2	3.5	18.3	10.8	3.9	10.3	13.9	11.7	28.8	24.3	10.5	14.9	23.7	22.7	9.3	34.8	37.0	26.9	23.9	18.7	50.2	0.2	42.1	36.6	11.1	20.4	7.8	57.8	30.1	8.3	6.7	3.7	19.0	4.8	15.4	3.8	6.5	20.9	13.9	28.1	33.5	31.4	51.1	6.1	1.8	6.5	47.0	3.7	4.1	4.9	6.2	0.0	7.5	2.4	11.5	0.3	34.1	6.4	0.8	6.9	39.6	14.9	5.1	22.2	16.0	6.3	78.2	16.7	35.8	9.5	8.4	6.1	2.5	1.7	6.1	0.9	23.6	0.6	4.7	1.6	0.8	1.3	0.9	0.3	0.3	1.2	2.7	0.5	0.9	0.6	1.6	1.0	0.3	0.6	0.5	0.8	12.5	11.5	9.3	13.1	9.2	10.0	14.5	11.7	13.4	9.8	15.2	11.7	74.4	41.7	20.5	34.6	1.5	3.7	9.7	6.8	11.4	4.2	11.4	9.4	7.9	12.8	14.2	12.9	10.4	19.8	7.0	19.7	1.9	23.6	12.6	16.4	16.9	47.9	5.4	3.2	7.2	16.9	38.5	16.9	6.1	21.8	8.2	10.4	52.1	1.0	10.5	8.4	10.0	5.9	4.1	22.7	5.5	24.2	17.4	11.2	0.0	53.4	6.2	5.4	4.1	30.7	9.6	37.8	11.5	24.8	0.8	13.4	1.6	13.4	6.8	1.7	26.3	11.2	15.5	0.9	1.8	5.4	2.0	23.7	2.5	8.7	7.0	17.3
RBMS3		ENSG00000144642	"RNA binding motif single stranded interacting protein 3"	Q6XE24	3	28574791-30010391	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 331.1;Inhibitory neurons: 655.9;Microglial cells: 1013.7;Oligodendrocyte precursor cells: 229.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.7;WM-115: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034719	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034719: AB_10670172"	"unprognostic (8.39e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.25e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.24e-4)"	15.8	8.6	6.5	2.1	7.2	0.1	12.2	9.5	5.8	9.9	12.0	8.1	1.4	6.2	6.7	3.1	9.8	6.7	14.3	2.1	21.4	5.1	3.7	12.6	2.7	12.6	15.7	11.6	2.0	4.9	3.2	10.4	9.0	6.4	2.6	0.4	4.7	8.7	6.4	3.8	4.0	4.5	6.3	6.6	4.3	2.2	11.1	5.5	15.3	10.8	1.7	8.1	7.3	2.6	2.2	0.2	10.2	0.1	19.6	12.5	0.0	5.7	3.6	5.9	6.8	0.0	0.4	0.0	6.1	20.7	1.8	0.2	0.5	3.8	10.9	0.0	1.1	5.9	8.7	0.0	19.9	0.1	0.0	11.8	2.6	10.5	12.3	8.4	7.9	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.3	0.0	0.4	0.4	7.5	0.0	2.2	0.0	0.0	19.4	13.7	0.0	0.7	4.6	0.0	0.0	17.1	11.1	11.6	13.5	11.7	0.0	0.0	0.8	1.5	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.9	0.3	0.0	6.5	7.2	9.5	5.8	2.1	21.4	12.6	15.7	9.0	6.3	11.1	2.6	100.9	118.6	18.8	331.1	0.6	8.3	25.5	23.0	2.2	0.4	2.7	19.8	16.2	31.5	21.3	9.2	0.0	16.4	5.9	0.0	0.0	5.3	35.1	2.8	7.0	54.4	0.0	0.0	20.7	1.2	3.0	96.8	2.0	4.6	5.1	19.8	129.9	1.9	2.8	0.0	655.9	0.0	6.1	30.3	14.1	18.8	159.7	2.7	7.2	1013.7	0.6	0.0	0.0	229.2	8.9	0.4	0.0	110.6	0.1	24.3	0.0	2.9	10.5	0.0	111.7	154.6	73.5	1.2	1.5	2.4	7.2	9.6	2.9	22.4	0.0	4.7
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA057707: AB_2683508"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	81.0	57.0	35.7	80.8	39.3	172.5	119.7	40.5	39.7	108.8	36.9	82.9	77.8	142.0	85.9	64.5	116.5	68.2	72.2	33.9	36.2	77.7	66.5	71.8	117.8	40.7	36.4	242.9	86.8	76.6	48.9	80.4	40.8	83.9	101.6	82.0	68.5	82.1	126.2	69.6	75.5	118.2	38.8	89.1	71.8	34.8	35.1	210.8	92.5	103.9	145.6	89.1	77.9	51.9	235.0	250.2	448.6	201.0	109.6	184.3	261.2	227.7	246.3	308.4	324.6	268.8	228.3	422.9	229.2	163.9	193.3	152.9	481.9	238.3	353.6	184.2	226.8	324.6	240.9	289.9	95.9	358.0	285.6	152.5	113.1	240.6	333.6	236.3	252.7	392.0	296.6	210.3	254.4	297.9	526.3	240.5	285.7	248.1	207.0	430.9	300.2	262.0	229.6	275.2	260.8	281.7	181.9	162.4	213.8	263.6	186.8	237.7	161.7	173.5	188.0	121.7	294.8	149.2	214.9	444.3	123.9	256.7	242.6	131.6	158.5	90.6	142.1	192.8	199.7	194.5	184.8	170.4	175.6	187.4	231.9	192.5	25.3	173.9	178.9	106.4	203.9	302.6	35.7	39.3	40.5	39.7	33.9	36.2	40.7	36.4	40.8	38.8	35.1	51.9	112.1	112.2	139.0	55.2	223.0	151.9	209.0	151.6	128.1	112.4	229.8	208.0	100.5	153.0	167.3	88.3	95.9	187.2	200.3	80.1	154.6	157.2	10.9	83.5	147.4	130.5	202.9	195.7	33.2	148.8	269.4	156.6	75.4	84.3	268.8	212.7	204.5	119.3	117.0	92.5	41.2	170.9	81.4	223.2	112.2	10.5	171.8	109.0	96.0	27.2	176.9	99.4	157.6	57.3	56.5	108.0	99.1	133.2	124.0	108.2	140.0	120.3	123.3	137.9	92.1	159.7	161.6	33.8	81.2	94.6	122.3	111.5	195.5	135.0	216.4	157.4
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein X-linked 2"	Q9Y388	X	130401987-130413656	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.04e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	15.6	12.2	26.3	10.1	26.1	11.8	14.6	26.1	48.8	21.7	23.6	17.3	10.4	16.8	16.4	13.8	16.3	9.9	13.9	26.3	27.4	14.4	13.0	11.6	14.1	25.8	26.3	18.0	16.5	10.5	11.9	10.5	26.1	15.0	11.6	11.2	11.9	12.3	12.4	17.4	12.8	13.2	25.3	15.1	14.5	7.0	26.2	17.2	12.6	10.0	16.6	16.6	15.6	27.9	22.7	23.3	23.4	24.3	23.1	41.3	23.2	21.0	21.1	23.2	25.4	17.5	27.6	21.8	48.9	16.1	31.1	24.4	37.2	19.2	33.4	20.2	32.5	19.8	22.6	18.6	20.2	30.6	22.8	30.2	27.1	25.9	36.1	33.8	26.1	27.2	17.2	18.8	26.4	39.2	36.4	37.9	17.4	40.0	37.2	27.4	22.7	29.5	23.7	18.0	26.8	32.0	13.2	28.0	39.1	18.8	18.2	22.2	17.5	19.0	15.5	44.8	43.6	24.6	27.9	30.5	22.9	49.5	23.9	9.3	6.8	8.6	7.7	7.7	8.2	10.9	10.0	10.7	5.9	9.0	10.6	9.7	6.0	7.3	7.2	7.7	16.5	4.1	26.3	26.1	26.1	48.8	26.3	27.4	25.8	26.3	26.1	25.3	26.2	27.9	30.5	19.2	19.0	5.5	32.9	32.1	29.0	42.8	22.8	22.0	27.5	33.0	22.6	22.8	40.1	11.0	10.4	33.1	28.4	14.1	15.6	34.2	3.8	21.0	43.5	31.9	40.7	19.4	7.4	35.6	40.8	27.3	13.7	18.3	35.5	27.8	45.0	24.5	34.5	16.8	8.2	23.6	36.7	47.6	24.4	5.8	32.3	27.6	28.4	2.8	41.5	23.3	41.2	7.1	9.4	29.8	18.1	44.0	17.9	26.4	17.9	39.5	27.9	12.5	32.9	30.8	29.8	30.2	53.3	22.4	29.7	25.9	32.0	31.9	29.2	22.9
RBMXL1	KAT3	ENSG00000213516	"RBMX like 1"	Q96E39	1	88979456-88992960	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA057707: AB_2683508"	"prognostic favorable (7.60e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	7.7	5.1	10.2	6.6	11.0	15.6	7.7	9.4	10.2	9.0	7.0	5.4	5.5	9.7	5.7	10.2	8.6	6.4	7.6	8.8	10.9	6.1	9.7	7.3	8.2	10.7	11.0	12.3	8.3	8.2	3.4	7.3	10.7	9.3	5.1	10.5	6.5	6.7	5.0	5.7	5.2	8.6	10.2	7.5	6.0	8.6	10.8	8.6	7.7	5.9	8.0	8.1	5.6	12.8	15.3	4.5	12.0	14.7	13.8	14.6	22.2	6.3	12.5	12.2	14.2	7.0	10.1	13.2	11.7	7.2	26.6	8.7	21.3	15.5	14.2	11.9	10.7	15.2	14.4	9.6	9.2	12.1	7.9	8.4	9.1	11.1	9.8	5.7	7.3	9.3	20.3	8.1	7.0	5.6	12.7	6.6	22.3	9.1	9.5	11.8	27.8	6.6	8.9	18.4	8.4	14.7	7.4	14.1	16.3	16.3	11.5	13.2	6.2	7.6	15.5	9.9	10.6	13.6	13.3	13.5	5.6	7.2	7.4	2.3	4.8	4.4	4.6	6.2	5.9	4.7	6.2	4.7	6.1	5.9	6.9	4.3	8.8	4.4	7.8	3.2	5.4	6.8	10.2	11.0	9.4	10.2	8.8	10.9	10.7	11.0	10.7	10.2	10.8	12.8	12.6	35.3	36.9	0.0	14.7	30.7	55.2	18.5	22.2	20.2	18.9	16.0	21.3	18.6	24.9	12.9	14.6	30.2	11.9	11.7	3.9	9.5	1.4	12.7	12.5	17.5	28.8	8.2	0.0	8.7	29.4	16.4	15.3	21.3	34.8	16.9	15.7	32.9	11.8	25.2	0.0	10.7	10.2	22.4	15.5	2.3	17.1	13.8	21.4	0.0	20.2	28.5	12.3	0.0	0.0	10.8	4.6	15.1	10.0	24.6	9.1	5.9	21.6	18.0	6.6	20.4	19.7	12.1	18.6	28.1	24.3	34.1	18.5	14.6	12.0	34.6
RBMXL2	"HNRNPG-T, HNRPGT"	ENSG00000170748	"RBMX like 2"	O75526	11	7088998-7091148	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	189	"testis: 35.9"	"Group enriched"	"Detected in some"	8	"Early spermatids: 157.6;Late spermatids: 160.6;Spermatocytes: 205.3"	"Cancer enriched"	"Detected in single"	133	"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA038912, HPA051842"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038912: AB_10670913, HPA051842: AB_2681634"		"unprognostic (3.73e-1)"			"unprognostic (2.24e-1)"							"unprognostic (5.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.77e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	205.3	20.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RBMXL3	"CXorf55, FLJ40249"	ENSG00000175718	"RBMX like 3"	Q8N7X1	X	115189410-115192868	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.7"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 17.9;Spermatogonia: 16.7"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051842	Supported					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA051842: AB_2681634"															"unprognostic (1.05e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1A1	"RBM1, RBM2, YRRM1, YRRM2"	ENSG00000234414	"RNA binding motif protein Y-linked family 1 member A1"	P0DJD3	Y	21511372-21549326	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"testis: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"U-266/84: 15.1"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1B		ENSG00000242875	"RNA binding motif protein Y-linked family 1 member B"	A6NDE4	Y	21511338-21549094	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1D		ENSG00000244395	"RNA binding motif protein Y-linked family 1 member D"	P0C7P1	Y	21880076-21894526	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1E		ENSG00000242389	"RNA binding motif protein Y-linked family 1 member E"	A6NEQ0	Y	21903618-21918067	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 2.6"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 1.7;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-266/84: 2.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1F	MGC33094	ENSG00000169800	"RNA binding motif protein Y-linked family 1 member F"	Q15415	Y	22168542-22182982	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"U-266/70: 29.7;U-266/84: 35.2"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		"Nucleoplasm, Nucleoli"		"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1J		ENSG00000226941	"RNA binding motif protein Y-linked family 1 member J"	Q15415	Y	22403461-22417881	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	193	"U-266/70: 25.2;U-266/84: 13.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	294	"intestine: 2713.5"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	4.6	1.1	3.2	0.7	0.5	0.3	3.2	0.2	0.0	4.0	2713.5	2.0	0.0	0.2	0.3	1.8	0.2	3.3	5.0	2.6	0.0	7.6	2.2	8.1	9.2	0.3	3.0	0.0	0.1	0.1	3.4	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1886.7	1.0	3.4	0.1	3.6	1.0	9.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.2	0.3	3.2	3.3	5.0	8.1	9.2	3.4	3.4	9.0	5.3	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348363-47357881	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	Transport		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	335	"retina: 542.3"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 2070.4;Rod photoreceptor cells: 1610.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	542.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.3	1.2	1.6	0.5	0.3	0.6	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.7	0.0	0.0	0.5	0.0	0.0	0.0	2070.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1610.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 11920.3"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	730.7	32.4	30.2	6.2	34.4	1.1	394.2	12.4	48.1	5.8	12.4	11.2	4.8	2.3	0.9	1.1	2.1	7.5	16.7	32.2	113.0	142.8	11920.3	24.5	0.6	21.5	19.3	4.1	82.4	0.1	519.9	12.4	21.3	8.6	6.7	3.0	13.7	4.6	6.2	16.4	19.2	0.8	14.9	5.5	11.9	4.7	46.2	1.5	7.9	5.3	0.1	19.0	8.8	18.0	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	34.4	12.4	48.1	32.2	113.0	21.5	19.3	21.3	14.9	46.2	18.0	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016021	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 401.0;breast: 394.6"	"Cell type enriched"	"Detected in many"	7	"Adipocytes: 3631.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 311.5;neutrophil: 344.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 344.7;monocytes: 311.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	401.0	15.0	20.7	8.9	27.0	28.6	394.6	23.8	38.3	22.6	23.4	15.0	2.6	20.4	4.2	34.4	14.7	51.6	86.6	20.4	22.4	72.9	9.6	8.8	8.3	23.7	24.0	12.7	11.9	68.9	16.7	15.9	23.7	18.6	4.4	5.0	22.3	8.1	16.0	35.4	11.5	14.9	23.5	112.1	17.2	9.2	22.4	12.6	36.2	24.9	5.6	23.6	27.9	36.4	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.9	2.5	3.2	0.0	13.0	1.3	0.0	0.0	0.1	1.0	4.4	0.0	2.8	0.0	0.1	1.3	1.6	0.0	0.0	0.0	2.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.2	0.5	2.6	0.2	9.8	3.5	34.8	2.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	311.5	2.8	0.4	138.4	0.2	0.1	0.0	0.1	10.6	0.2	0.2	0.1	344.7	0.0	68.3	2.0	0.7	96.8	20.7	27.0	23.8	38.3	20.4	22.4	23.7	24.0	23.7	23.5	22.4	36.4	3631.8	0.0	1.3	0.7	9.5	20.6	9.5	2.6	9.1	0.2	43.0	73.9	22.9	10.0	1.2	1.8	0.0	5.0	16.2	0.1	23.5	2.0	3.2	2.5	15.8	349.2	0.0	5.7	0.4	2.8	1.9	36.1	0.0	4.8	3.8	7.1	69.7	3.7	63.7	0.0	0.4	0.4	2.0	502.5	14.1	6.1	6.2	42.5	21.4	1.0	149.7	2.1	3.1	0.0	13.4	2.7	0.1	0.7	2.7	20.7	0.0	1.4	0.9	1.5	0.0	3.9	20.5	1.8	2.8	26.2	17.6	6.2	3.8	3.6	0.6	6.3
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 422.1;Oligodendrocytes: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	40.9	18.3	28.1	33.0	44.2	51.3	28.4	34.2	38.5	31.9	27.7	33.2	20.2	36.4	18.0	28.5	23.6	25.5	21.8	29.0	37.6	21.4	17.9	31.3	27.5	41.7	38.5	34.2	22.3	26.2	12.9	54.4	39.0	28.0	28.1	33.1	19.3	22.5	21.7	26.0	22.7	38.0	32.2	25.7	25.4	28.7	36.4	27.8	24.8	28.9	26.5	31.8	21.7	58.9	68.2	19.1	60.0	39.0	91.5	138.8	44.9	54.4	47.0	50.9	60.1	14.5	36.4	56.0	34.1	36.2	39.5	12.2	51.9	33.4	98.1	30.4	28.4	42.5	24.2	27.9	47.9	76.9	35.9	64.0	28.5	104.9	39.7	70.3	28.5	34.3	43.0	21.5	93.2	20.1	54.5	76.4	163.5	20.3	30.3	48.0	112.4	25.4	26.8	22.4	84.5	36.5	28.0	20.6	24.3	54.4	22.0	53.3	38.5	50.5	25.2	86.3	51.9	40.2	51.9	55.7	132.3	86.3	43.4	23.8	94.6	112.9	31.4	77.8	42.6	37.2	49.8	34.1	136.4	33.4	41.4	35.9	220.5	70.9	77.1	31.5	68.1	68.6	28.1	44.2	34.2	38.5	29.0	37.6	41.7	38.5	39.0	32.2	36.4	58.9	72.5	48.1	66.8	62.0	54.6	152.8	86.2	104.6	55.8	94.6	48.9	51.2	44.2	62.9	83.3	46.0	129.3	102.7	47.3	26.6	74.3	64.3	44.4	54.5	96.3	73.2	78.4	46.9	81.7	65.4	74.4	129.0	29.0	62.8	57.0	130.7	65.3	53.1	365.2	85.8	85.9	51.0	59.0	208.5	422.1	56.7	135.5	234.2	80.0	60.9	125.1	95.0	44.3	215.1	378.1	76.5	35.1	84.2	54.9	113.7	44.9	55.4	67.5	102.9	85.5	71.7	95.8	134.7	158.4	45.9	109.3	83.9	102.8	57.0	47.0	75.7
RBPJL	"RBP-L, RBPSUHL, SUH, SUHL"	ENSG00000124232	"Recombination signal binding protein for immunoglobulin kappa J region like"	Q9UBG7	20	45306840-45317824	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	270	"pancreas: 975.5"	"Cell type enhanced"	"Detected in some"		"Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.0;Spermatogonia: 1.4"	"Cancer enriched"	"Detected in some"	4	"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB006846	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB006846: "	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"		"unprognostic (1.34e-2)"	"unprognostic (6.09e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.92e-3)"	"unprognostic (2.48e-7)"	"unprognostic (5.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.49e-5)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	975.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384511-30572256	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 324.1;RPTEC TERT1: 232.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA056999: AB_2683306"	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	238.3	96.7	22.3	43.8	28.0	1.4	194.8	20.2	24.1	196.9	26.7	350.6	25.2	200.7	90.0	99.9	200.5	95.4	174.7	17.3	25.2	218.7	108.9	119.6	23.3	23.1	27.6	190.0	68.8	68.6	33.0	105.0	28.7	182.6	46.6	10.4	92.1	193.7	31.2	56.6	107.7	171.9	18.7	56.7	159.8	45.4	33.2	23.5	140.7	31.6	20.0	323.4	134.0	18.9	0.7	54.5	58.5	0.4	324.1	96.4	145.8	74.8	101.8	90.2	74.6	76.2	31.2	0.5	39.3	96.7	82.5	29.9	68.0	54.4	107.9	0.1	14.6	1.8	24.7	80.5	139.4	0.5	12.0	112.8	13.8	86.7	11.5	100.8	52.8	2.5	0.5	0.4	44.6	32.6	0.3	1.2	150.9	62.3	34.6	3.5	16.2	4.7	232.2	88.9	1.1	11.6	7.7	55.2	37.7	192.3	11.7	0.0	48.8	44.3	4.2	77.3	12.8	0.1	0.2	0.4	72.8	0.2	20.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	22.3	28.0	20.2	24.1	17.3	25.2	23.1	27.6	28.7	18.7	33.2	18.9	104.0	54.5	98.9	36.6	4.5	9.3	61.8	22.7	14.2	6.7	45.8	64.3	114.4	75.8	48.5	141.6	2.1	108.7	4.1	1.8	113.5	100.0	104.7	31.2	86.3	69.7	1.8	5.0	6.4	94.8	184.8	66.7	18.8	48.2	10.1	18.0	44.3	55.2	39.9	0.0	5.2	0.1	20.3	1.9	10.2	31.5	171.2	4.3	14.2	71.2	2.1	1.0	1.0	2.0	1.6	67.0	0.0	180.2	0.5	101.5	2.0	242.2	30.9	5.7	111.7	6.6	149.9	35.3	22.0	27.8	8.0	41.2	4.4	28.1	1.0	151.7
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044878	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	9.0	7.0	12.5	6.7	12.5	18.2	7.7	10.2	13.0	9.1	1.1	10.7	4.7	9.3	7.1	8.9	8.7	5.4	9.8	13.4	11.4	5.4	8.4	8.4	6.6	12.1	12.5	12.7	5.9	9.7	6.1	7.9	11.1	7.4	5.3	13.6	5.9	9.0	13.1	10.2	7.1	9.0	12.8	7.7	7.8	6.6	13.0	5.5	11.2	9.9	6.1	9.1	7.5	11.8	11.2	16.0	12.8	16.6	13.8	10.2	33.9	12.0	11.5	14.1	12.7	9.7	6.5	7.8	6.8	15.9	8.2	7.0	16.5	14.5	12.4	9.9	14.6	8.9	19.7	8.0	9.5	9.0	9.4	11.1	16.1	18.1	12.0	8.3	11.6	8.7	13.5	8.9	10.8	14.7	4.9	4.5	11.0	7.1	12.7	6.4	14.6	8.6	7.3	12.6	3.4	12.0	14.7	8.9	10.7	9.4	22.8	6.5	14.2	12.7	13.3	12.5	17.1	7.9	12.6	9.2	12.2	10.0	12.2	8.1	4.6	11.1	4.4	6.4	3.9	4.4	6.1	5.5	3.8	7.4	7.7	5.2	11.7	3.1	5.6	3.6	4.3	2.7	12.5	12.5	10.2	13.0	13.4	11.4	12.1	12.5	11.1	12.8	13.0	11.8	10.4	16.0	19.0	19.6	9.2	0.0	6.7	0.0	6.8	21.6	7.6	7.0	20.4	8.6	9.9	3.7	22.9	10.4	8.4	6.0	5.9	8.4	17.4	6.4	11.1	12.4	1.2	9.5	21.8	9.6	9.6	14.6	10.2	8.8	10.1	16.4	14.6	14.0	10.7	21.9	23.9	6.9	0.0	15.8	0.0	18.0	19.0	12.1	0.0	8.4	10.5	15.5	7.2	16.1	25.2	9.6	5.1	14.7	12.1	12.6	8.1	6.9	8.0	23.1	6.6	17.5	10.4	12.4	14.0	11.0	0.0	12.9	9.9	10.6	5.4	10.0
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931084-174022357	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	4.8	3.8	2.6	4.2	4.7	19.6	5.2	16.0	5.1	4.9	11.4	5.2	3.4	4.5	4.0	6.1	4.8	4.0	4.6	3.1	5.8	3.9	5.8	5.9	4.9	3.5	3.5	5.1	4.8	3.9	4.6	4.3	4.0	4.2	4.2	8.0	4.4	3.5	10.6	7.4	5.5	3.7	2.0	6.7	4.6	5.3	4.1	5.0	5.0	10.3	5.6	4.5	5.1	7.2	6.6	9.1	4.9	7.7	9.2	7.1	6.8	4.4	6.3	5.0	4.4	8.4	7.3	9.4	7.7	7.2	3.9	6.2	7.5	6.3	7.0	6.6	1.8	8.1	6.8	7.0	5.6	10.7	9.1	6.8	4.8	7.3	4.9	4.6	7.9	4.5	9.4	5.6	6.2	5.0	6.5	9.6	8.5	6.1	1.0	7.0	8.8	6.9	8.9	12.7	5.9	5.3	8.4	10.7	4.3	8.2	7.2	10.7	11.4	6.5	6.5	5.6	5.8	6.9	7.5	11.8	4.4	4.8	6.7	3.4	1.9	2.7	1.1	1.9	1.2	1.5	1.1	1.3	1.0	1.8	1.5	1.3	6.4	1.4	2.6	0.8	0.9	0.7	2.6	4.7	16.0	5.1	3.1	5.8	3.5	3.5	4.0	2.0	4.1	7.2	39.8	41.7	34.5	32.0	49.4	34.4	17.3	14.1	60.9	35.6	53.6	28.3	25.7	25.8	20.0	23.9	81.3	10.6	70.2	37.4	9.8	25.4	13.3	77.5	45.9	32.0	34.2	30.7	46.8	18.9	8.2	34.9	68.8	82.9	15.8	20.3	34.2	36.3	11.5	38.7	43.5	28.9	16.2	37.2	48.2	8.1	15.8	38.5	30.2	40.3	33.0	22.7	30.9	42.3	68.2	24.8	22.1	10.5	52.2	38.3	25.1	9.8	30.2	47.3	19.7	39.0	31.5	35.8	14.0	66.8	40.9	11.6	41.4	16.1	25.9	38.5
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905359	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	11.9	8.9	8.8	12.1	10.8	32.5	10.4	14.0	10.0	13.5	4.4	10.4	9.9	11.9	8.1	13.0	9.7	11.0	13.8	10.9	7.9	12.7	13.4	11.5	18.5	7.1	7.4	11.2	6.8	15.8	9.6	14.6	7.6	9.7	11.2	16.0	9.0	9.1	11.8	10.0	9.4	13.9	7.1	14.1	11.8	11.6	8.0	18.8	12.9	15.3	17.2	14.4	9.0	10.5	17.3	26.2	33.5	18.2	17.4	19.8	17.8	22.0	24.4	25.2	21.8	31.2	18.8	28.8	16.7	29.8	30.1	40.9	35.4	25.1	27.7	13.4	13.5	16.4	44.4	21.3	23.1	19.9	26.5	19.9	25.5	24.3	34.6	22.0	35.6	25.4	24.1	21.6	32.9	23.9	20.2	14.7	17.7	24.9	21.8	19.7	54.8	19.4	25.8	13.9	38.3	25.8	39.2	24.9	21.2	22.8	29.2	17.2	33.9	20.5	17.3	27.7	39.8	14.0	25.4	32.1	22.3	18.2	23.1	10.0	4.6	6.0	6.1	7.3	5.1	4.3	4.8	6.0	4.1	5.8	4.5	4.5	8.0	4.0	6.7	6.5	5.1	2.8	8.8	10.8	14.0	10.0	10.9	7.9	7.1	7.4	7.6	7.1	8.0	10.5	33.8	41.7	32.8	20.9	27.7	11.0	13.6	20.0	20.5	19.2	15.6	10.5	34.8	12.8	17.3	9.2	37.5	15.7	26.6	18.9	3.9	12.0	5.9	27.6	30.9	28.3	23.3	22.7	38.4	11.4	15.2	18.4	23.9	40.1	17.1	21.9	29.6	19.5	9.6	28.6	35.1	19.8	12.2	27.4	19.4	9.5	13.4	21.4	14.2	30.9	26.1	16.9	24.7	35.2	39.3	23.5	9.0	18.0	22.5	24.3	14.8	12.0	17.7	20.2	19.7	16.3	24.1	30.7	17.9	23.3	14.8	23.0	28.8	15.4	14.7	27.3
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615113	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 256.2;parathyroid gland: 453.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 245.5;Endometrial ciliated cells: 336.9;Glandular and luminal cells: 504.9"	"Cancer enhanced"	"Detected in all"		"glioma: 41.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"SK-MEL-30: 1323.8;WM-115: 815.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	58.5	22.0	59.0	50.3	68.2	6.3	65.0	64.6	79.8	86.4	69.9	39.0	31.6	28.7	8.9	24.5	12.4	57.4	61.6	57.5	65.7	89.8	256.2	38.6	12.9	68.1	65.3	8.7	64.1	453.5	30.7	95.6	68.3	24.1	39.5	13.1	20.4	15.1	34.4	29.1	27.6	48.7	67.4	14.6	34.9	10.5	72.7	82.2	61.0	31.8	9.7	101.3	20.9	75.0	47.7	9.5	47.9	29.6	25.7	15.9	29.1	175.8	181.3	71.1	70.5	54.1	44.7	0.8	8.1	103.4	139.5	4.1	34.4	35.6	94.5	26.8	21.2	9.5	16.5	25.8	98.1	15.3	28.9	41.4	31.9	84.4	58.7	17.9	23.8	32.5	18.1	45.7	47.7	23.1	145.4	12.2	27.4	48.0	23.5	53.9	37.5	22.2	22.8	81.1	23.0	10.1	128.4	82.2	1323.8	43.3	111.4	25.4	25.8	237.5	24.7	39.9	43.1	38.9	26.4	8.5	77.4	44.4	815.5	0.0	1.1	5.0	0.7	2.1	1.0	1.1	0.8	0.7	1.6	0.8	0.3	0.7	0.5	0.1	2.4	3.0	1.1	0.5	59.0	68.2	64.6	79.8	57.5	65.7	68.1	65.3	68.3	67.4	72.7	75.0	158.3	96.1	52.4	15.3	8.2	94.6	20.7	20.5	38.1	19.4	245.5	142.4	24.9	21.5	32.7	206.0	27.1	10.9	11.8	204.9	21.5	82.0	48.3	336.9	46.4	175.4	3.6	7.4	28.3	18.9	15.3	60.3	23.4	504.9	8.8	3.9	25.0	187.8	58.9	3.3	54.2	30.7	4.1	19.6	74.0	13.1	7.2	39.8	56.9	15.9	29.5	10.9	3.1	41.7	71.3	26.3	140.5	9.8	6.1	16.3	41.2	142.3	14.1	7.5	0.0	30.3	68.9	10.8	2.6	12.3	79.3	11.1	11.5	10.5	16.3	50.4
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 199.5;tongue: 180.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 255.4;Excitatory neurons: 261.4;Inhibitory neurons: 254.4;Muller glia cells: 183.1;Oligodendrocytes: 294.6;Smooth muscle cells: 138.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"gdT-cell: 1.8;memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 63.3;HDLM-2: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	38.1	12.6	35.7	7.7	41.2	0.0	17.1	31.7	106.3	20.3	0.0	20.1	9.8	17.5	51.5	25.9	17.0	35.1	199.5	34.0	65.0	32.4	4.9	16.3	4.1	69.6	76.0	24.0	11.1	85.5	17.5	0.6	68.8	25.3	22.6	61.6	9.6	27.0	73.3	17.2	19.1	14.0	20.6	7.1	36.5	5.7	65.5	4.7	20.1	180.1	7.0	44.0	21.4	62.3	0.0	0.0	1.6	0.0	0.7	0.2	0.1	1.1	15.1	1.1	0.1	0.0	0.0	0.0	0.8	63.3	0.0	0.1	0.0	0.0	0.3	129.7	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.1	5.1	0.0	0.0	0.2	2.7	0.4	0.4	0.4	13.6	0.1	0.2	0.3	4.9	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.8	0.1	0.2	6.8	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	2.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	35.7	41.2	31.7	106.3	34.0	65.0	69.6	76.0	68.8	20.6	65.5	62.3	7.6	6.4	5.8	13.7	0.6	6.2	4.6	0.0	0.0	24.8	1.8	1.4	255.4	8.6	0.0	3.7	4.2	0.1	0.8	1.0	70.5	5.5	40.2	0.8	0.4	17.1	25.1	0.0	261.4	2.5	0.0	22.2	1.5	0.8	0.0	0.3	0.4	1.2	0.1	30.3	254.4	1.5	34.6	0.3	8.0	14.2	29.2	0.9	32.0	46.9	0.0	183.1	0.0	76.9	294.6	2.9	0.3	50.4	0.4	3.3	0.0	1.9	0.0	9.7	98.6	16.4	138.4	1.5	1.4	0.5	7.4	0.0	4.0	0.8	0.3	1.4
RCAN3	DSCR1L2	ENSG00000117602	"RCAN family member 3"	Q9UKA8	1	24502351-24541040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 33.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 88.0;Enteroendocrine cells: 82.1;T-cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 38.2"	"Lineage enriched"	"Detected in all"	7	"T-cells: 38.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034533, HPA064289"	Enhanced		Approved	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA034533: AB_10601481, HPA064289: AB_2685232"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.41e-3)"	"unprognostic (3.66e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.52e-3)"	"unprognostic (9.83e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.71e-2)"	3.7	1.9	3.3	12.3	4.0	7.0	7.1	27.0	4.7	4.5	3.2	6.7	6.9	3.0	6.4	12.4	14.4	5.5	3.4	1.8	7.3	3.9	1.7	8.0	19.9	9.3	7.3	0.6	15.7	6.3	6.3	2.1	9.3	33.8	6.7	11.5	11.6	2.3	1.8	11.2	6.1	3.5	4.5	9.3	17.2	2.1	6.6	16.1	12.3	3.0	19.5	7.0	6.0	6.9	17.6	13.9	0.2	4.3	3.5	8.4	15.6	11.8	6.4	9.5	9.0	4.3	23.0	13.1	10.8	19.9	7.4	16.4	12.0	14.8	10.2	12.9	7.3	1.4	3.8	13.1	2.2	4.6	11.5	2.9	10.8	3.8	4.6	7.9	1.9	16.2	2.0	0.5	4.1	6.3	12.1	6.7	17.7	13.4	10.2	4.7	0.2	0.4	6.9	17.9	35.6	8.8	9.7	12.0	37.2	7.9	12.8	8.9	13.6	11.2	13.2	0.6	8.2	18.2	22.8	17.5	4.5	18.0	12.9	3.5	1.8	2.2	1.2	1.0	10.0	5.2	24.9	9.0	3.0	5.1	33.1	17.7	0.6	4.0	0.4	2.1	38.2	7.9	3.3	4.0	27.0	4.7	1.8	7.3	9.3	7.3	9.3	4.5	6.6	6.9	19.7	19.2	13.3	0.0	32.4	14.1	27.3	8.9	11.4	43.0	29.9	36.8	6.4	25.8	15.8	20.2	64.6	4.0	18.9	16.4	13.7	19.0	1.2	88.0	6.8	8.6	82.1	2.5	1.6	28.2	10.3	6.0	26.5	34.1	16.5	14.8	7.1	2.2	8.5	25.2	6.7	14.4	14.2	8.4	28.0	0.0	1.8	23.0	30.2	5.6	31.5	9.1	6.2	0.0	21.2	43.2	11.3	1.2	22.0	53.9	4.3	1.0	67.7	34.5	0.0	4.7	10.4	0.7	17.5	26.9	21.7	5.3	106.8	0.1	12.2	26.3
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488963-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 278.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	12.9	11.1	10.0	12.9	11.2	5.2	10.8	11.1	13.9	15.6	17.4	8.9	5.3	15.0	12.3	13.0	12.9	12.3	12.5	9.5	13.2	16.6	9.5	10.5	11.3	11.9	11.7	19.9	6.8	6.6	13.4	17.7	12.5	13.5	8.0	8.3	23.3	19.9	7.0	5.4	7.2	13.7	13.0	17.4	8.8	7.1	10.8	11.8	27.5	10.8	10.7	11.5	12.4	14.4	1.5	1.2	22.0	1.4	17.1	15.1	0.0	6.8	8.4	4.0	3.0	0.8	1.4	4.7	5.0	10.7	2.7	3.1	3.2	2.8	4.6	5.7	4.3	12.2	3.2	1.2	6.6	5.6	7.4	15.6	6.5	5.3	2.6	9.2	12.3	29.8	0.9	7.1	14.6	0.5	278.7	15.6	12.3	0.5	3.7	23.9	2.2	20.3	7.5	3.7	5.1	4.3	5.3	1.1	8.7	9.1	0.5	14.2	10.3	4.6	2.0	1.2	2.7	0.3	0.4	5.7	2.7	12.5	9.1	4.6	39.8	4.6	14.0	28.8	8.7	1.1	11.4	14.2	27.1	1.1	6.6	10.2	55.0	15.5	27.9	0.5	15.5	20.5	10.0	11.2	11.1	13.9	9.5	13.2	11.9	11.7	12.5	13.0	10.8	14.4	23.1	3.2	3.3	9.1	5.5	6.1	11.6	9.5	21.1	1.9	4.9	9.3	16.1	4.3	9.8	5.5	2.1	1.4	20.7	1.3	7.9	1.2	9.0	5.1	6.6	19.7	8.3	6.1	12.3	0.8	1.4	11.6	2.6	5.0	8.8	9.9	24.7	5.2	25.0	1.7	17.0	2.2	2.0	26.6	24.4	8.1	9.3	30.6	8.8	66.5	38.3	33.7	24.7	6.6	13.2	1.3	1.6	14.3	17.4	6.0	0.7	11.2	6.9	4.9	13.1	14.9	14.1	9.6	4.4	12.6	5.7	1.0	24.0	11.9	2.4	6.7
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	27.4	46.3	19.6	17.3	21.4	14.0	25.2	19.5	22.5	24.0	22.9	35.0	19.0	28.2	6.8	30.7	21.9	12.7	53.1	18.5	19.6	40.1	59.8	20.2	18.7	21.4	20.2	28.8	28.8	18.2	27.2	15.4	19.3	30.6	10.3	5.3	22.8	17.5	103.1	22.0	23.2	12.7	20.8	25.3	28.8	21.6	22.0	12.4	25.9	45.9	12.7	32.0	23.1	20.5	44.8	59.2	34.8	54.0	24.5	19.8	45.3	42.9	30.5	36.1	29.5	64.6	53.5	47.2	18.9	34.8	46.9	51.9	29.8	28.8	15.0	52.0	47.7	35.1	41.5	61.3	34.6	56.6	53.7	24.7	23.1	31.4	24.9	24.2	32.4	7.7	113.8	29.5	28.3	92.8	1.5	84.6	80.0	53.2	52.1	24.5	27.4	98.6	31.5	38.9	34.5	55.3	57.1	119.0	54.4	24.3	83.8	58.3	35.8	46.9	38.5	40.7	56.5	32.4	26.7	73.6	35.8	58.3	63.6	3.5	2.3	1.4	4.2	3.1	3.4	3.6	4.6	3.7	3.3	4.2	4.3	5.3	0.8	4.6	2.3	3.3	3.7	1.7	19.6	21.4	19.5	22.5	18.5	19.6	21.4	20.2	19.3	20.8	22.0	20.5	15.9	0.0	7.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	15.2	15.5	0.0	0.0	2.5	22.0	0.0	56.0	13.0	0.0	49.0	24.3	0.0	11.7	17.7	8.0	0.0	0.0	0.0	20.6	42.3	10.5	0.0	13.8	5.1	46.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	1.8	0.0	0.0	37.0	2.9	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	54.5	6.6	53.8	0.0	0.0
RCC2	TD-60	ENSG00000179051	"Regulator of chromosome condensation 2"	Q9P258	1	17406760-17439677	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072281	Approved					NA	NA		110000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA072281: AB_2686505"	"unprognostic (2.50e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.42e-8)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.03e-8)"	"unprognostic (6.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.41e-2)"	19.4	18.4	12.3	18.9	12.2	33.3	22.2	12.8	13.2	24.8	11.0	24.0	11.4	18.7	9.9	65.2	16.3	11.8	13.4	12.1	12.5	22.8	15.9	24.2	27.7	14.2	13.6	22.1	21.3	9.4	11.4	16.1	13.1	22.3	17.6	3.1	36.0	7.8	8.4	56.3	27.6	10.2	13.9	39.2	18.3	20.6	15.8	34.2	19.0	4.1	35.2	19.7	31.3	15.3	62.2	34.3	68.4	57.9	25.3	25.4	56.6	24.3	20.9	49.2	40.4	37.0	83.4	133.8	80.4	25.3	14.5	67.4	121.0	70.0	34.1	64.3	61.1	117.6	50.5	36.0	31.8	142.7	79.7	40.5	51.8	55.1	48.7	30.7	53.3	88.7	82.4	188.4	22.0	62.9	117.4	115.9	94.7	76.0	26.0	155.7	68.6	86.5	37.3	29.0	102.9	72.6	61.4	59.5	93.6	56.7	53.2	91.3	41.9	44.8	56.0	18.1	51.1	81.7	72.9	165.8	19.3	158.6	90.9	0.9	1.9	0.7	1.4	2.6	1.2	1.6	1.1	1.4	3.1	1.7	0.8	1.4	0.1	1.7	2.1	2.5	1.0	1.1	12.3	12.2	12.8	13.2	12.1	12.5	14.2	13.6	13.1	13.9	15.8	15.3	22.6	25.6	15.3	16.6	26.4	46.5	14.7	25.3	27.9	6.6	36.5	34.3	0.9	18.6	26.6	22.0	10.4	25.0	32.2	27.5	3.9	24.4	6.8	28.0	38.3	24.9	24.1	28.8	11.0	22.7	48.9	17.4	14.8	37.5	17.7	55.9	17.5	7.3	32.6	6.7	4.9	25.9	24.4	31.4	70.0	21.0	9.3	43.0	16.0	20.6	27.9	15.3	22.6	20.6	15.3	28.8	20.6	6.0	25.9	32.2	7.5	7.0	17.9	5.4	0.0	20.7	16.7	17.6	21.2	42.9	64.5	16.3	19.7	25.6	36.4	19.4
RCCD1	MGC14386	ENSG00000166965	"RCC1 domain containing 1"	A6NED2	15	90954870-90963125	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039683, HPA040776"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA039683: AB_10794752, HPA040776: AB_10795478"	"unprognostic (1.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.63e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	3.9	8.8	4.1	3.0	4.3	4.6	3.5	5.5	5.2	6.9	5.0	6.3	5.1	5.5	3.5	6.6	6.0	2.0	5.9	4.0	3.6	6.2	6.7	2.6	3.9	3.3	3.2	7.3	9.2	5.2	2.9	2.2	3.7	5.4	4.5	3.1	5.0	2.8	3.8	7.4	4.8	2.8	2.9	4.3	6.7	5.8	3.5	4.7	4.5	1.0	4.7	5.5	5.7	3.4	8.0	11.7	2.7	5.7	6.6	7.8	20.2	9.1	1.6	2.6	2.7	5.6	14.9	28.0	14.2	5.6	0.2	16.8	8.9	2.4	4.3	23.7	18.2	20.3	21.2	8.0	5.5	9.8	7.7	5.8	8.0	2.6	3.6	10.3	4.3	16.2	15.7	18.0	7.8	2.7	11.8	10.2	10.4	9.6	4.8	14.0	13.6	30.4	12.0	3.6	8.8	10.1	15.8	10.0	11.6	14.2	11.5	18.7	6.9	1.6	11.2	6.6	0.4	31.9	14.1	16.9	3.0	21.4	7.7	0.0	0.2	0.0	0.2	0.6	0.5	0.8	0.4	0.7	0.4	0.5	0.8	0.2	0.0	0.5	0.3	0.6	0.6	0.2	4.1	4.3	5.5	5.2	4.0	3.6	3.3	3.2	3.7	2.9	3.5	3.4	6.0	0.0	2.2	7.5	9.7	7.4	11.3	9.0	7.4	6.2	9.9	10.9	8.5	4.3	5.3	7.3	4.2	20.9	5.0	14.9	3.9	8.0	3.1	3.2	8.2	5.0	22.1	56.8	9.6	4.9	18.4	8.0	8.2	5.7	0.0	12.5	4.2	8.5	12.0	0.0	11.3	20.5	6.1	8.1	4.0	6.5	8.7	5.7	5.4	3.7	4.3	11.1	10.3	8.5	2.0	5.0	11.7	7.9	9.4	9.8	17.4	13.7	2.9	2.9	26.3	9.7	9.2	22.2	20.1	17.2	8.9	9.0	4.6	10.2	25.7	7.3
RCE1	"FACE-2, FACE2, hRCE1, RCE1A, RCE1B"	ENSG00000173653	"Ras converting CAAX endopeptidase 1"	Q9Y256	11	66842835-66846552	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074124	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"			"HPA074124: "	"unprognostic (1.11e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.14e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	10.1	10.9	14.9	7.2	15.1	20.9	9.3	17.9	18.2	10.7	13.7	13.3	10.1	8.4	5.9	19.9	8.9	8.6	7.3	14.7	14.9	25.7	7.9	8.9	9.9	14.0	14.1	10.8	15.5	9.5	13.9	11.8	14.2	12.0	8.2	10.0	12.6	6.1	4.4	19.9	12.4	5.9	13.5	12.0	12.0	13.5	15.5	9.5	7.0	4.2	6.1	11.9	12.9	14.6	22.7	24.5	14.7	13.8	9.0	7.8	32.3	11.6	11.2	17.7	15.8	46.6	47.2	17.2	21.8	11.1	29.3	39.6	17.1	17.4	10.2	20.7	19.3	15.5	17.0	18.0	31.7	20.3	22.0	12.6	32.7	19.9	17.6	13.7	14.6	23.5	21.7	26.0	9.0	42.8	28.2	38.3	43.5	43.1	24.0	22.9	11.0	34.1	19.5	12.0	18.3	16.5	16.8	22.3	74.1	14.3	26.2	16.3	9.7	24.2	18.7	26.4	18.5	14.6	15.2	19.6	16.4	20.8	18.4	23.1	21.1	14.6	17.1	24.0	15.6	15.3	14.7	22.1	18.9	12.0	11.8	17.8	7.2	14.3	21.5	29.1	6.7	17.8	14.9	15.1	17.9	18.2	14.7	14.9	14.0	14.1	14.2	13.5	15.5	14.6	12.5	0.0	4.8	4.2	16.9	31.2	26.6	46.2	14.2	9.2	16.4	20.6	1.8	10.0	20.3	16.5	29.2	54.6	24.9	12.4	3.9	24.3	10.1	11.3	12.5	12.2	10.7	10.7	7.7	27.4	65.0	12.0	11.7	17.1	8.2	13.3	8.2	3.0	22.8	3.3	6.2	16.0	26.4	8.9	15.1	20.2	6.8	13.3	14.2	3.7	12.9	6.4	9.2	6.0	4.0	30.0	18.0	6.4	14.5	19.6	23.2	7.4	8.9	18.0	13.1	5.6	32.1	9.7	25.7	17.1	24.9	58.6	19.1	10.3	16.2	23.9
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.6	7.0	9.5	7.9	10.2	17.0	16.8	12.6	13.0	9.0	7.7	12.1	8.7	9.6	6.9	7.2	11.9	6.8	16.8	9.4	10.6	16.2	12.3	10.0	9.5	8.9	10.4	14.5	8.3	12.6	5.8	10.0	9.9	10.9	13.2	14.8	12.9	10.1	16.5	5.6	8.6	11.6	9.9	11.5	8.9	13.6	10.7	12.7	18.9	23.6	12.6	7.6	4.7	10.7	9.8	5.0	14.6	13.8	15.1	13.1	8.4	6.5	15.1	13.2	15.4	13.8	11.9	16.2	12.0	9.4	13.1	5.8	37.6	11.5	19.9	13.4	12.3	21.2	9.2	17.9	13.0	28.9	11.2	12.2	14.1	15.2	14.2	15.9	27.0	20.8	19.9	16.2	30.9	15.8	26.7	11.5	24.5	26.9	8.7	14.2	34.4	13.9	20.4	16.7	22.6	12.4	10.7	24.8	28.2	15.9	14.0	12.9	10.8	8.6	8.5	7.8	11.1	17.0	13.0	22.8	10.5	20.2	14.0	27.5	9.2	9.7	4.3	5.7	7.6	4.6	5.4	5.2	8.0	2.1	3.9	5.5	4.0	5.5	5.6	4.1	5.7	4.7	9.5	10.2	12.6	13.0	9.4	10.6	8.9	10.4	9.9	9.9	10.7	10.7	22.2	19.2	10.3	28.4	25.4	40.7	32.3	47.1	39.3	35.0	38.5	25.9	56.8	24.3	23.5	23.9	20.9	31.6	31.2	21.9	68.4	30.3	37.3	11.9	17.1	22.3	13.8	21.8	31.2	22.5	23.2	24.6	21.9	17.3	5.1	23.8	25.4	23.0	19.0	23.5	32.3	23.4	38.7	37.5	26.8	59.8	22.4	27.4	28.4	22.5	23.9	32.0	24.7	31.7	41.0	26.5	22.6	25.2	19.7	36.6	24.6	69.4	13.5	21.7	32.9	20.9	27.3	72.8	41.7	28.1	31.0	33.8	32.9	35.2	27.6	26.3
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32091074-32105722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 660.2"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 288.2;Muller glia cells: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		9400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	81.8	54.4	26.7	58.3	39.6	8.1	64.6	24.0	28.2	73.9	37.2	54.7	43.4	79.7	660.2	25.7	69.5	50.1	46.0	26.4	37.2	39.2	100.7	50.6	29.2	29.9	27.6	83.6	21.9	62.2	67.3	129.0	29.0	85.6	53.7	48.7	89.9	82.5	32.7	26.8	41.5	79.5	31.8	35.9	40.7	22.5	36.7	19.0	63.4	28.8	23.1	113.1	41.1	31.3	130.0	143.7	335.9	217.4	720.2	548.1	340.4	425.5	501.5	286.6	515.6	123.6	157.2	0.4	293.3	718.4	380.4	157.6	118.0	135.2	450.2	63.9	231.9	28.2	104.7	58.4	519.7	21.7	42.0	780.1	154.8	197.1	215.4	333.7	647.7	60.6	17.4	25.8	342.1	116.0	61.4	50.2	137.2	2.7	143.9	45.1	393.5	39.2	270.1	355.8	82.1	42.6	117.1	26.2	333.1	227.2	171.0	77.5	350.8	417.0	215.8	338.5	364.6	1.0	0.9	1.7	514.2	28.3	224.9	0.3	13.6	0.5	14.9	16.2	11.8	6.2	6.9	12.3	15.2	4.8	5.1	9.5	0.6	10.9	10.3	8.2	2.7	9.3	26.7	39.6	24.0	28.2	26.4	37.2	29.9	27.6	29.0	31.8	36.7	31.3	131.3	54.5	34.8	9.8	11.8	41.6	80.8	78.2	34.1	40.4	47.9	37.5	9.0	42.9	55.1	47.8	12.5	172.6	10.5	14.3	7.9	143.4	210.4	60.7	154.9	112.1	53.2	16.4	8.0	45.7	288.2	152.1	23.0	110.2	12.7	100.3	85.3	61.7	44.2	15.2	5.9	80.9	38.7	17.8	33.9	173.8	80.5	19.9	32.0	8.4	50.3	327.4	19.6	16.6	1.3	39.7	30.8	73.0	38.6	184.9	6.7	14.1	30.4	17.0	26.3	80.8	91.7	17.0	7.2	33.2	28.3	217.0	13.6	55.8	75.3	99.8
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931738-76954393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 321.5"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 528.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		92000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	31.3	30.8	42.5	24.9	43.9	24.6	35.8	35.8	57.8	34.1	41.4	33.1	22.2	44.0	321.5	28.5	54.3	32.6	38.8	44.0	55.0	49.3	19.8	28.8	30.0	38.0	45.1	34.2	21.5	80.6	30.8	49.2	46.9	41.2	36.5	43.9	22.7	41.1	56.9	22.6	23.3	39.6	40.0	25.4	26.9	93.4	51.4	40.3	48.0	60.4	32.4	39.0	25.2	40.8	93.9	65.3	284.1	134.9	120.1	135.6	177.3	109.1	147.5	138.7	115.1	81.2	78.2	58.3	154.3	119.3	149.5	139.9	217.4	94.0	176.0	45.3	170.8	28.9	91.4	135.0	143.0	105.4	42.9	123.6	126.8	68.2	87.5	146.1	148.9	98.3	74.2	56.3	146.6	60.3	104.9	71.9	216.6	98.0	72.1	109.4	187.0	37.3	91.6	123.8	161.8	161.1	178.8	98.6	220.5	251.1	96.0	115.0	80.5	162.8	131.2	104.8	228.0	80.4	266.6	69.6	92.8	87.6	151.1	7.5	7.6	16.2	21.7	7.4	24.9	23.4	23.0	28.1	16.1	22.9	25.5	25.1	3.9	23.5	12.3	19.1	18.1	20.0	42.5	43.9	35.8	57.8	44.0	55.0	38.0	45.1	46.9	40.0	51.4	40.8	87.3	25.6	36.8	56.8	111.2	82.1	125.0	85.5	96.2	87.1	75.9	74.8	94.9	62.9	52.5	99.3	37.5	183.1	76.3	23.3	49.0	116.0	44.8	87.0	101.6	64.8	73.5	91.5	48.4	45.1	296.8	106.0	54.6	85.6	28.6	120.9	60.0	32.8	57.3	127.9	72.0	55.0	101.7	30.5	38.3	81.7	61.8	30.0	92.5	19.7	34.1	99.7	89.6	149.8	63.3	56.9	43.2	93.6	85.6	127.5	25.8	56.2	48.7	58.9	59.2	78.9	126.3	528.6	140.8	109.3	70.8	163.6	76.7	131.8	84.4	117.0
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592649-102730561	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.72e-4)"	11.2	5.8	3.3	11.2	3.1	46.1	9.0	4.6	4.1	14.2	3.3	11.0	12.0	9.5	13.3	33.2	9.5	8.7	6.7	5.0	3.6	6.7	9.4	12.9	11.9	3.4	3.5	9.0	7.9	10.4	5.2	20.8	3.6	8.8	11.1	6.3	10.2	5.8	11.8	16.6	12.6	8.8	3.5	8.6	13.4	13.7	4.3	14.5	6.3	10.6	14.7	10.2	19.1	4.2	21.3	19.5	17.2	19.0	13.5	18.6	36.1	21.5	15.2	19.7	18.7	18.0	25.2	23.8	17.1	18.7	9.9	32.6	26.2	15.4	29.4	10.1	9.6	44.2	17.4	17.6	18.4	44.3	38.2	13.1	23.6	17.4	26.5	21.1	21.8	22.1	35.7	17.5	20.1	34.6	27.8	29.9	8.5	23.2	33.1	70.4	17.4	10.6	24.1	25.9	22.2	13.8	48.1	21.9	13.9	21.5	30.0	34.6	23.8	13.6	10.2	43.8	14.2	12.9	16.6	25.0	16.3	32.0	14.6	3.1	1.4	2.2	0.2	1.5	0.3	0.3	0.3	0.6	1.5	0.3	0.3	0.3	3.7	0.7	1.8	0.6	0.5	0.5	3.3	3.1	4.6	4.1	5.0	3.6	3.4	3.5	3.6	3.5	4.3	4.2	15.8	48.1	40.0	32.3	27.3	57.6	27.7	12.0	30.7	8.4	25.6	20.7	16.7	10.0	19.7	3.7	2.1	31.1	39.1	31.5	5.9	6.7	5.1	55.7	36.1	15.9	21.0	32.2	39.3	7.4	20.4	20.2	32.6	58.3	24.1	18.0	11.0	11.7	15.1	10.1	33.8	16.8	10.2	38.8	65.6	4.9	24.2	43.6	24.9	52.5	33.1	9.5	12.3	22.1	23.5	16.7	15.2	21.1	14.8	25.4	18.2	8.0	16.3	5.4	0.0	18.9	19.6	22.5	18.6	46.9	117.6	43.1	26.2	20.3	22.8	72.3
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911230-63917164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.3	0.5	1.8	0.2	3.2	0.0	0.4	1.3	3.7	1.4	0.1	1.1	0.8	2.7	1.0	0.4	1.5	0.4	2.8	2.5	1.1	0.6	0.1	0.3	0.0	1.2	1.0	1.2	0.5	1.4	3.5	0.7	0.8	0.9	0.6	3.4	0.9	0.6	1.5	0.3	0.6	1.0	1.1	0.1	0.7	3.2	1.0	0.9	0.2	0.7	0.0	1.2	0.6	2.4	0.0	1.0	35.7	2.5	0.5	2.9	10.9	0.2	0.6	0.5	1.2	1.4	0.3	0.3	0.4	0.8	0.7	0.4	15.8	0.0	0.3	0.6	2.0	0.5	0.3	11.9	5.9	0.0	0.3	3.5	0.0	0.6	0.0	0.0	0.3	4.8	2.0	0.0	0.0	3.3	3.4	13.2	47.0	4.8	0.1	12.4	2.1	1.0	0.1	0.1	72.6	48.7	0.3	3.2	1.8	8.7	2.7	4.5	0.3	0.1	2.3	0.1	0.1	0.3	0.1	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	1.3	3.7	2.5	1.1	1.2	1.0	0.8	1.1	1.0	2.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	20.7	0.6	0.4	2.2	0.0	0.1	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.3	3.3	0.6	1.2	0.0	5.9	0.2	4.4	1.1	0.0	0.6	0.0	1.2	0.0	0.0	0.2	3.3	1.5	1.2	2.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1	1.0	1.0	1.5	0.2	0.2	0.4	0.0	0.0	0.3	0.1	0.2	2.2	0.0	0.3	0.7	0.7	2.9	0.0	0.3	0.8	0.1	1.2	0.8	0.1
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	16.9	15.6	11.3	10.7	16.1	31.7	19.7	21.8	16.6	20.3	9.2	19.6	12.1	19.1	21.4	14.5	18.2	12.4	22.7	11.1	14.3	15.7	15.9	14.5	15.2	13.4	12.0	26.7	19.7	20.8	16.9	14.9	14.6	23.9	13.8	30.5	19.5	24.5	65.2	19.2	18.7	14.0	11.5	18.6	16.2	33.7	12.6	19.2	31.9	51.7	14.6	18.8	18.0	22.3	15.5	13.9	25.1	14.4	21.3	20.2	26.4	18.3	18.3	20.0	20.2	12.0	20.9	22.8	11.6	23.7	13.9	23.4	20.6	18.2	15.4	21.5	10.9	21.4	22.6	17.0	23.4	34.2	19.8	22.0	16.6	21.9	27.3	22.4	11.8	23.2	21.0	29.2	29.9	11.2	16.8	18.8	27.2	11.3	14.4	17.8	49.6	27.3	17.2	28.5	16.0	32.5	46.7	24.3	33.6	24.1	29.9	23.3	17.1	17.5	19.7	23.2	20.4	23.5	18.4	30.1	15.2	19.6	15.9	27.2	12.4	45.9	8.8	12.5	11.8	15.4	9.4	9.7	13.7	11.4	16.0	11.6	20.8	19.8	14.3	14.5	12.7	8.8	11.3	16.1	21.8	16.6	11.1	14.3	13.4	12.0	14.6	11.5	12.6	22.3	23.1	38.5	44.4	67.6	23.0	14.5	10.7	16.4	29.6	43.7	29.0	25.9	73.4	24.3	24.9	14.7	35.5	26.7	30.2	16.6	21.5	10.4	70.4	22.0	37.4	17.7	34.2	29.8	121.9	15.4	14.8	24.0	28.1	26.6	19.6	21.7	21.8	20.8	20.5	23.5	101.1	17.3	16.2	22.3	14.2	122.6	22.4	24.6	23.2	49.6	22.2	24.1	14.4	87.9	131.6	10.4	15.8	27.1	28.1	12.5	24.1	22.8	22.2	47.7	0.0	33.2	24.8	65.4	35.1	33.1	16.9	25.4	22.6	22.7	17.5	9.0
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167708696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 115.5;skeletal muscle: 147.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 258.0;Kupffer cells: 137.5;Macrophages: 80.7;Microglial cells: 78.7;monocytes: 121.6;NK-cells: 142.2;Sertoli cells: 78.9;T-cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 195.2;HDLM-2: 91.0;REH: 224.0;RPMI-8226: 139.7;THP-1: 103.4;U-266/70: 132.0;U-698: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		200000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	14.2	5.8	5.5	42.9	6.1	55.7	11.6	5.8	6.3	5.6	5.9	12.0	8.8	4.6	2.5	8.6	4.0	11.7	25.6	5.2	6.3	5.2	8.0	16.8	88.7	9.9	7.3	2.8	1.5	2.4	2.0	17.5	8.4	3.7	11.9	0.6	4.7	3.9	147.9	2.8	29.3	8.6	6.8	52.4	12.4	3.7	7.7	115.5	6.1	50.6	73.7	14.0	3.4	10.0	0.3	0.0	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	195.2	0.6	0.2	0.0	0.2	0.0	0.0	0.0	91.0	0.3	1.6	0.1	0.1	0.2	34.4	3.7	0.5	0.3	0.4	0.0	0.0	0.0	76.0	67.8	56.7	25.4	0.0	69.3	49.8	1.7	0.0	0.0	224.0	0.8	139.7	0.0	0.1	0.1	0.1	0.2	0.6	0.1	2.7	0.1	103.4	0.5	0.2	0.6	0.2	0.4	132.0	42.5	132.0	0.1	64.6	0.0	249.3	170.3	271.3	63.5	119.8	76.9	216.4	81.7	80.0	103.4	201.7	68.1	64.7	165.7	130.0	122.7	54.3	129.4	148.9	5.5	6.1	5.8	6.3	5.2	6.3	9.9	7.3	8.4	6.8	7.7	10.0	18.7	3.2	6.7	0.3	258.0	1.1	1.2	0.0	3.4	0.7	6.2	10.7	46.8	0.0	3.1	1.8	0.0	0.5	73.9	0.1	0.0	0.2	0.8	0.4	2.1	18.8	0.0	30.1	4.2	0.0	0.5	12.4	4.1	0.3	13.9	0.2	19.2	1.5	44.2	0.0	0.7	0.0	0.0	137.5	26.9	1.7	0.9	80.7	5.4	78.7	121.6	0.2	142.2	2.0	0.6	0.1	0.0	0.4	55.1	0.8	0.0	0.5	0.0	0.8	78.9	5.8	39.7	0.0	0.3	1.0	1.7	1.2	97.2	0.6	0.1	0.3
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905271	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	434	"retina: 463.8"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"WM-115: 1.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA015783, CAB022363"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	0.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	463.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	230.5	0.0	0.0	0.5	0.0	0.0	0.0	475.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	11.5	0.0	0.0	1.5	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	107.7	0.7	0.0	0.0	0.0	0.9	0.7	2.5	0.5	1.8	0.0	0.1	393.9	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1926.6	0.0	1.7	0.3	0.1	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0
RD3	"C1orf36, LCA12"	ENSG00000198570	"Retinal degeneration 3, GUCY2D regulator"	Q7Z3Z2	1	211476522-211492162	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"retina: 47.2"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 82.7;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HMC-1: 14.4;SH-SY5Y: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029941, HPA029943"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA029941: AB_2732449, HPA029943: AB_2732450"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-2)"		"unprognostic (1.14e-2)"		"unprognostic (6.07e-2)"		"unprognostic (2.96e-2)"		"unprognostic (2.18e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.58e-2)"		"unprognostic (2.86e-2)"	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.5	0.3	0.2	0.8	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.1	0.7	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.5	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3 like"	P0DJH9	14	103940426-103942561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 23.3;retina: 13.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 10.4"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"		"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"HPA067971: AB_2685935"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	0.0	0.0	40.8	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11"	Q8TC12	14	67676800-67695793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 582.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7"	"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	NA	NA		340000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	23.6	59.5	39.3	24.5	43.2	13.9	28.7	50.2	54.4	32.6	35.9	29.2	34.1	33.2	86.0	34.6	23.5	42.7	17.6	40.4	47.2	106.0	153.1	34.9	20.4	49.2	47.7	28.9	42.6	79.8	23.4	21.9	49.3	582.0	31.4	73.9	44.2	34.4	8.3	31.4	23.9	43.6	49.8	22.2	31.9	28.4	46.1	30.7	61.7	13.5	26.2	34.3	30.3	58.4	183.7	81.9	71.3	82.0	111.5	100.4	59.3	68.0	134.2	83.7	150.9	68.6	216.7	31.7	51.2	64.6	104.8	142.5	104.0	150.8	113.7	63.0	42.6	65.1	40.7	69.0	106.9	24.3	46.0	94.4	98.0	109.3	92.0	63.9	97.4	87.0	52.1	101.1	77.2	97.5	72.2	38.8	40.4	49.7	92.8	53.6	87.4	45.8	194.1	93.0	73.8	62.0	71.2	89.7	99.1	58.2	100.7	38.3	74.2	89.5	101.1	38.9	49.5	47.5	40.0	40.7	115.8	66.0	74.3	282.4	71.1	104.0	62.3	57.7	68.2	39.0	67.7	61.5	51.3	45.5	67.3	64.8	11.0	56.3	65.4	59.1	65.1	115.8	39.3	43.2	50.2	54.4	40.4	47.2	49.2	47.7	49.3	49.8	46.1	58.4	27.0	25.6	66.0	38.2	29.2	11.5	40.0	77.9	16.5	53.5	45.4	24.5	20.4	68.6	59.9	47.8	50.1	24.9	32.4	26.8	7.9	92.5	2.5	21.9	50.9	39.3	43.3	29.2	33.3	84.0	38.1	37.5	19.9	38.2	29.2	46.3	47.8	241.8	35.8	79.1	37.6	28.9	89.5	42.4	15.4	6.1	43.2	35.9	35.6	17.8	39.8	299.7	37.0	70.4	43.4	61.2	36.7	56.1	27.3	285.7	17.5	56.0	23.9	97.0	46.0	29.7	38.7	25.8	24.0	20.2	19.2	63.5	29.8	66.7	25.3	46.1
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 209.7;Urothelial cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.5	4.8	2.5	3.4	2.6	2.2	4.5	3.9	3.6	9.4	3.9	8.6	6.7	4.2	0.7	19.8	4.8	3.0	13.0	2.4	3.5	9.2	8.2	4.4	3.5	3.5	4.2	3.7	8.6	12.4	6.4	10.1	3.7	6.3	3.8	2.1	9.6	3.7	9.7	21.0	6.1	2.0	1.6	6.2	10.5	5.3	3.8	2.2	7.5	4.8	2.7	5.1	12.2	2.3	10.9	12.3	2.9	10.3	1.5	3.0	17.9	3.4	2.1	3.7	6.4	23.3	15.7	9.4	5.3	1.2	2.7	14.1	7.8	7.2	1.7	7.3	60.0	12.2	9.8	14.6	2.9	12.4	8.0	2.6	6.3	3.0	2.9	3.7	3.0	5.2	27.2	2.9	2.3	13.4	6.1	9.6	2.5	17.7	25.7	15.7	6.7	27.6	8.2	37.3	8.8	6.2	8.9	31.3	7.0	2.7	12.0	9.3	3.0	0.3	3.7	0.1	8.2	7.8	11.0	9.6	9.1	10.6	6.6	3.8	4.1	4.1	8.2	6.3	7.7	5.4	6.3	7.6	4.2	5.8	8.4	6.1	1.9	7.8	5.0	6.4	5.5	3.0	2.5	2.6	3.9	3.6	2.4	3.5	3.5	4.2	3.7	1.6	3.8	2.3	8.9	16.0	13.1	3.9	6.6	10.7	31.7	11.1	7.4	21.0	12.2	9.9	27.5	20.0	19.3	14.7	41.7	41.3	9.4	47.2	11.7	13.5	24.3	18.3	8.8	9.1	12.0	4.2	9.4	6.5	29.0	7.1	46.4	31.8	8.2	24.4	18.5	7.3	11.5	25.2	10.0	27.5	12.2	4.9	5.0	13.2	3.7	4.2	7.2	4.7	5.0	9.0	6.2	5.0	2.9	14.5	35.7	3.4	8.7	30.6	20.3	4.8	12.8	25.3	6.6	5.1	6.5	3.2	8.9	11.1	17.5	209.7	9.2	11.1	28.1	110.1
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560679	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	14.4	14.5	10.6	8.3	10.8	5.4	12.6	11.0	12.4	10.1	15.7	14.6	11.6	14.2	12.2	9.8	11.9	9.4	29.8	10.5	10.8	14.0	18.5	11.8	12.5	10.8	10.5	10.0	14.1	18.7	11.3	13.0	11.3	13.3	10.4	8.3	10.7	11.0	28.1	9.6	11.4	12.0	11.1	11.5	14.6	11.5	10.7	12.5	11.1	27.1	9.5	15.5	10.2	11.7	28.6	8.9	7.3	6.0	21.8	22.9	24.7	16.8	17.7	15.2	15.0	6.9	14.6	28.2	9.7	10.3	19.7	15.3	10.8	19.9	17.6	15.6	28.8	10.8	10.6	21.4	18.6	13.7	14.1	17.5	19.9	14.8	22.9	21.2	14.2	11.2	19.9	9.2	25.2	9.2	11.8	23.7	19.9	21.9	24.1	16.5	20.1	12.1	29.9	18.4	11.2	19.3	9.3	20.4	25.8	15.4	10.1	7.2	14.4	21.5	13.1	16.6	20.6	26.0	23.1	20.8	15.1	9.0	17.1	1.4	1.4	6.5	3.3	1.7	5.5	7.3	3.9	4.9	1.9	11.6	5.5	4.5	0.5	3.1	1.7	6.1	5.1	1.3	10.6	10.8	11.0	12.4	10.5	10.8	10.8	10.5	11.3	11.1	10.7	11.7	21.7	16.0	12.8	0.0	36.1	24.5	31.0	27.9	31.3	23.5	20.1	24.5	55.6	32.9	20.9	16.5	6.2	44.6	34.8	20.6	31.3	37.8	27.4	27.4	19.7	19.4	13.2	18.7	0.0	35.3	50.3	38.5	20.4	19.7	12.7	16.4	20.3	30.0	24.2	15.2	0.0	27.1	20.3	17.2	14.6	13.6	66.8	15.4	23.2	0.0	23.2	31.3	29.9	0.0	0.0	27.0	36.3	44.8	15.6	45.1	23.3	38.1	18.8	22.4	32.9	28.5	29.6	79.5	30.6	18.9	18.6	45.7	27.1	30.9	29.2	27.3
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16"	O75452	12	56951431-56959374	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"liver: 793.0"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 365.1"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 4.3;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038518	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.3	0.3	0.9	0.0	0.9	0.0	0.3	0.9	1.1	1.2	0.9	0.3	0.0	0.4	0.1	1.4	0.5	0.0	0.4	0.9	0.8	0.5	793.0	0.4	0.1	0.8	0.8	0.5	0.6	0.0	0.3	0.0	0.9	5.2	0.0	0.4	0.5	2.4	0.2	2.9	0.5	0.0	0.8	2.5	0.3	1.3	0.8	0.2	0.3	0.0	1.3	0.3	1.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.9	1.1	0.9	0.8	0.8	0.8	0.9	0.8	0.8	0.9	0.1	0.0	0.0	2.0	1.9	0.0	1.2	0.3	0.0	2.2	0.2	0.0	2.0	5.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	8.5	0.1	0.1	0.6	0.0	13.5	0.2	0.4	0.0	0.3	0.0	0.1	0.0	0.3	3.6	365.1	0.2	1.7	0.2	0.0	0.0	6.3	0.3	5.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.3	5.7	0.0	0.1	0.2	1.0	0.0	0.0	0.1	1.4	0.9	0.8	0.3	0.0	0.6	0.1	0.0	0.3
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;JURKAT: 17.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.1	0.1	0.6	0.5	0.4	0.5	0.3	1.2	0.6	0.2	0.1	0.5	0.8	0.0	0.5	0.3	0.2	0.1	0.0	0.6	0.5	0.1	0.2	0.1	1.1	0.2	0.3	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.8	0.4	0.0	0.1	0.0	0.7	0.6	0.1	0.0	0.3	0.4	11.9	0.5	2.4	0.3	0.0	1.5	0.1	0.1	0.3	4.8	4.2	1.8	2.4	0.1	0.0	1.9	0.9	0.1	1.1	2.1	7.0	6.6	5.6	2.2	0.4	5.1	0.9	3.6	2.9	3.6	2.6	11.5	2.9	2.0	0.0	0.0	0.3	1.5	0.0	0.4	0.3	0.6	1.5	0.1	17.7	2.1	0.0	0.4	4.3	1.5	3.0	0.7	9.0	3.1	1.1	0.0	0.0	1.3	2.4	2.8	1.1	0.4	1.4	3.7	5.1	8.9	0.7	0.0	0.1	2.6	0.0	0.6	5.5	1.5	2.2	2.9	1.7	1.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.8	2.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.2	0.6	0.4	1.2	0.6	0.6	0.5	0.2	0.3	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	3.7	0.4	0.1	0.0	0.1	59.4	0.9	0.2	0.1	1.2	0.4	0.6	0.0	1.0	0.3	0.5	0.3	0.0	1.5	0.4	0.6	1.8	0.0	0.3	0.7	0.0	0.0	0.3	81.9	0.6	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.2	25.6	2.7	0.4	0.0	0.7	0.6	0.1	1.6	0.7
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 68.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	9.8	6.1	3.3	2.1	3.2	6.6	2.5	5.2	3.9	6.3	5.3	8.5	1.3	7.1	0.1	2.7	14.9	8.8	2.8	3.4	4.5	12.4	3.3	9.5	3.1	8.9	4.8	3.9	2.7	0.2	68.9	0.6	8.9	7.3	0.4	1.9	4.7	6.2	0.9	1.7	7.3	2.4	3.6	13.6	25.7	29.9	5.3	10.1	3.5	0.3	3.1	4.0	3.7	4.4	0.1	0.2	10.8	0.1	0.4	0.5	0.6	0.4	0.5	1.0	0.8	0.1	1.2	0.2	0.1	0.0	0.6	0.5	0.3	0.0	0.7	1.0	0.2	0.4	0.7	0.0	8.7	0.2	1.5	4.8	0.5	0.4	0.1	4.1	1.9	0.4	0.1	1.4	0.0	0.2	11.7	1.8	3.4	0.0	0.1	0.2	0.0	0.1	0.4	0.4	0.2	47.4	0.0	0.1	0.4	26.0	0.2	0.5	0.4	0.0	0.2	0.3	0.1	1.7	0.5	0.1	0.0	0.2	0.2	2.2	0.1	9.7	4.7	1.1	5.4	1.6	1.7	2.7	3.2	1.7	0.7	2.4	0.1	2.8	5.8	5.2	2.9	1.2	3.3	3.2	5.2	3.9	3.4	4.5	8.9	4.8	8.9	3.6	5.3	4.4	9.5	12.8	10.8	3.6	6.8	1.9	4.4	15.8	8.6	14.9	2.8	2.0	2.0	25.8	14.8	27.6	0.0	1.4	10.2	5.1	5.9	2.9	150.6	43.5	10.6	4.8	4.8	25.9	3.8	2.7	3.2	10.0	73.9	21.9	3.8	7.9	3.6	2.1	2.3	6.7	5.1	2.5	10.2	5.7	3.9	74.5	4.7	6.6	1.8	2.8	4.0	21.1	2.1	5.5	4.6	5.0	0.7	3.0	11.0	1.5	4.1	24.7	51.4	2.0	0.0	3.7	3.9	8.3	43.4	1.3	2.0	0.4	11.3	33.8	2.4	4.0
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468910-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA		25000	"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	28.9	17.1	5.8	33.9	7.4	18.7	18.6	6.9	7.1	19.1	7.5	14.9	11.4	22.3	13.7	19.8	14.9	20.6	26.9	5.7	7.1	14.9	15.7	22.9	40.9	8.9	7.3	14.8	9.9	10.8	5.3	22.2	8.5	15.9	18.2	9.9	10.1	17.8	12.5	18.5	13.5	30.4	7.7	31.6	14.5	10.5	8.0	34.3	16.6	19.7	38.4	26.1	10.3	9.1	61.6	61.1	46.5	34.7	94.3	116.1	52.3	119.9	101.6	76.2	88.7	68.5	49.9	73.6	43.5	83.7	94.0	44.3	51.2	60.4	108.5	122.1	31.9	89.8	65.6	30.0	35.9	62.3	66.1	64.8	30.1	109.0	79.1	67.6	87.2	50.6	33.0	36.1	102.3	31.2	70.0	73.6	77.1	18.3	41.6	56.8	184.7	57.2	29.6	42.5	12.8	35.7	86.9	23.6	62.0	159.0	58.3	37.4	115.6	105.9	67.4	93.9	111.6	14.3	46.3	161.3	88.9	35.9	80.2	21.4	18.6	18.0	31.2	32.3	31.5	30.3	29.3	30.9	24.0	26.6	19.1	26.7	8.7	36.9	31.0	17.8	44.8	24.0	5.8	7.4	6.9	7.1	5.7	7.1	8.9	7.3	8.5	7.7	8.0	9.1	56.1	22.4	18.8	6.2	45.0	23.6	15.4	23.3	22.2	11.8	14.7	14.7	8.7	10.0	22.1	14.7	14.6	13.0	59.0	5.8	9.8	20.3	1.4	15.9	41.0	45.7	9.7	30.3	15.1	24.8	27.5	45.6	7.7	17.6	52.6	23.1	30.7	15.9	27.9	15.2	9.4	6.5	12.2	35.3	26.1	2.2	22.1	50.8	30.2	12.2	50.6	16.9	64.9	10.1	19.1	31.8	4.2	37.6	33.5	7.3	4.3	12.4	25.1	10.8	13.1	33.1	34.9	7.6	12.7	20.8	42.9	3.6	53.6	31.8	8.0	10.5
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"	O94761	8	144511288-144517845	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.5;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	1.7	1.8	3.0	5.8	3.7	25.4	2.0	7.7	7.0	2.9	0.1	4.7	6.0	2.5	0.4	13.3	2.1	2.1	1.8	2.6	1.6	2.5	2.7	2.3	6.8	6.9	2.3	2.7	3.1	0.7	3.1	2.5	7.4	8.6	1.6	1.5	5.8	0.8	2.5	10.1	5.2	1.0	1.7	6.5	3.2	22.4	4.1	7.4	3.4	0.5	2.5	2.5	3.1	3.6	33.7	58.8	27.0	57.1	1.6	2.6	47.1	33.2	5.9	24.2	20.2	58.4	48.4	22.8	21.5	5.6	14.2	40.1	18.0	14.2	6.6	40.3	68.6	82.4	118.5	44.3	0.5	21.2	65.7	3.3	2.1	27.1	5.5	3.4	6.8	45.4	83.3	28.9	8.5	104.1	77.3	56.9	18.8	27.8	69.5	80.0	21.2	37.9	6.7	35.8	52.9	32.0	45.2	37.3	12.1	7.4	45.5	45.7	9.2	38.9	117.4	47.3	62.6	16.0	18.1	39.3	22.4	64.6	39.9	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.7	7.7	7.0	2.6	1.6	6.9	2.3	7.4	1.7	4.1	3.6	0.7	0.0	0.0	2.0	2.2	1.5	0.7	0.9	1.2	2.7	3.7	2.7	1.8	1.5	0.5	0.0	4.2	3.9	1.0	5.9	0.0	0.5	3.9	2.1	0.9	0.7	0.0	6.1	2.0	0.4	8.1	1.8	4.6	2.0	0.0	8.8	0.0	0.7	3.6	0.0	1.6	4.1	0.0	0.6	1.1	7.4	1.2	1.0	0.0	0.0	0.3	0.3	1.0	0.0	0.8	0.3	0.2	1.5	9.1	0.7	0.7	0.5	0.7	1.7	0.0	1.4	1.2	23.5	20.6	6.6	1.0	1.5	1.2	0.5	7.0	0.7
REEP1	"C2orf23, FLJ13110, SPG31, Yip2a"	ENSG00000068615	"Receptor accessory protein 1"	Q9H902	2	86213993-86338083	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 86.2;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 39.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 68.1;HAP1: 15.0;RPMI-8226: 16.0;SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058061	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA058061: AB_2683591"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-3)"	4.7	6.2	17.0	1.8	15.8	0.0	4.9	4.1	30.4	3.9	11.5	42.4	4.4	18.9	3.7	6.2	13.6	3.8	16.6	15.4	44.0	2.0	1.1	3.6	0.5	24.6	38.1	1.9	9.9	7.9	13.9	2.2	50.0	7.3	5.0	12.9	1.6	12.9	19.8	2.0	9.3	20.7	4.4	2.0	8.8	44.5	18.7	0.3	2.0	14.3	0.6	21.7	5.8	14.3	0.0	0.0	2.2	2.9	0.1	0.0	68.1	0.0	0.0	4.5	0.5	2.5	0.0	0.0	3.2	0.0	3.4	4.9	15.0	0.1	3.9	0.0	8.1	0.0	5.0	0.4	0.0	0.3	0.4	0.7	0.1	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	2.7	0.1	0.0	2.6	0.1	0.0	0.1	6.5	16.0	0.3	0.3	32.0	3.1	3.5	1.6	0.2	1.3	5.1	0.9	0.0	0.0	2.3	1.3	6.3	7.2	5.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	15.8	4.1	30.4	15.4	44.0	24.6	38.1	50.0	4.4	18.7	14.3	1.7	9.6	0.5	14.7	0.2	2.0	0.3	0.3	0.0	10.0	3.6	1.1	23.0	2.8	2.8	0.0	2.1	2.4	0.0	0.4	1.9	3.5	18.0	17.1	0.3	5.7	4.8	0.0	86.2	6.2	26.6	2.4	0.0	0.7	0.0	0.8	12.5	0.2	0.9	3.3	95.5	0.2	8.2	0.8	1.6	14.4	2.5	0.4	1.8	6.5	0.6	13.4	0.0	39.2	6.0	6.5	0.0	3.4	0.0	1.6	0.0	5.1	16.6	15.8	19.7	4.2	13.5	4.0	2.7	0.5	1.1	6.6	0.2	0.0	0.5	0.4
REEP2	"C5orf19, SGC32445, SPG72, Yip2d"	ENSG00000132563	"Receptor accessory protein 2"	Q9BRK0	5	138439057-138446969	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.7;choroid plexus: 77.8;retina: 61.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.3;Cone photoreceptor cells: 70.9;Excitatory neurons: 51.2;Horizontal cells: 48.8;Inhibitory neurons: 46.1;Muller glia cells: 29.8;Rod photoreceptor cells: 73.6"	"Cancer enriched"	"Detected in many"	9	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 97.3;SCLC-21H: 40.5;SH-SY5Y: 46.1;U-87 MG: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031813, HPA076571"	Enhanced	Supported	Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA031813: AB_2674054, HPA076571: "	"prognostic favorable (7.83e-5)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-6)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.13e-3)"	4.6	9.5	106.7	2.5	102.5	0.3	3.0	93.5	155.7	3.6	77.8	18.8	1.8	7.0	1.4	4.4	3.6	2.6	24.8	110.3	110.7	1.9	0.2	0.8	0.4	134.6	109.1	4.0	2.0	1.8	54.5	0.6	136.4	8.6	2.2	61.2	1.8	8.0	16.6	2.4	4.3	12.6	77.5	0.4	7.6	6.2	130.6	1.9	1.2	5.7	0.5	8.7	4.6	104.7	0.6	7.4	27.6	97.3	3.9	10.5	0.0	8.4	3.8	11.4	12.9	5.3	1.0	0.1	1.5	10.5	0.2	0.6	26.1	5.4	8.6	3.1	23.7	0.0	1.8	12.6	9.8	0.1	0.1	3.2	0.3	6.4	0.5	19.9	2.3	27.6	0.1	6.9	3.6	4.4	2.7	1.8	17.2	0.0	0.3	9.7	2.6	0.0	2.1	0.0	40.5	46.1	2.9	0.1	7.5	7.0	2.6	0.9	0.2	6.6	6.6	6.4	15.9	18.1	12.3	0.8	36.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	106.7	102.5	93.5	155.7	110.3	110.7	134.6	109.1	136.4	77.5	130.6	104.7	17.0	0.0	0.0	18.9	0.1	0.6	1.0	1.6	2.2	47.3	0.7	3.3	9.8	0.0	0.2	1.8	70.9	0.0	0.3	0.0	0.0	0.0	1.1	0.4	0.3	5.6	4.8	0.4	51.2	0.0	0.0	3.7	0.0	0.1	0.0	1.5	0.7	0.0	0.1	48.8	46.1	0.0	0.0	0.0	0.7	5.0	0.0	0.3	0.0	2.8	0.1	29.8	0.0	19.1	5.7	0.1	0.0	2.6	1.3	0.4	3.6	0.3	0.6	73.6	0.0	7.6	2.9	0.3	9.1	0.0	0.4	0.0	0.8	0.1	0.1	0.2
REEP4	"C8orf20, FLJ22246, FLJ22277, PP432, Yip2c"	ENSG00000168476	"Receptor accessory protein 4"	Q9H6H4	8	22138020-22141951	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 89.3;skin 1: 91.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042683	Approved		Supported	"Endoplasmic reticulum"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA042683: AB_2571730"	"unprognostic (2.38e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.65e-2)"	13.0	8.4	7.0	12.5	8.7	28.4	11.6	8.7	9.7	27.9	7.6	23.8	11.0	9.4	2.1	89.3	11.1	5.6	8.0	6.8	8.2	9.2	12.3	18.0	11.2	10.8	8.5	7.4	12.9	5.0	10.9	14.6	10.5	13.6	10.8	2.1	21.8	6.5	4.1	91.0	16.9	5.9	9.0	33.2	18.0	42.7	9.5	9.9	14.8	2.6	10.2	19.6	49.0	11.5	42.2	79.7	24.9	39.7	10.5	10.6	47.9	36.7	19.2	44.6	40.2	46.7	38.8	53.0	46.8	18.4	38.5	100.3	29.6	59.3	21.9	28.2	37.4	57.4	41.2	46.9	11.8	25.8	77.9	9.8	110.3	33.3	27.5	13.9	27.1	58.1	44.5	158.7	22.6	60.6	63.7	88.9	37.4	58.0	53.3	37.0	22.5	101.8	19.9	40.0	21.7	40.1	30.0	31.7	52.7	16.5	64.3	35.9	30.5	29.2	50.1	66.6	50.3	40.0	33.5	34.6	32.6	54.7	59.1	49.8	54.8	64.1	24.3	53.6	19.6	10.5	21.1	21.1	42.7	4.9	9.7	13.1	15.5	26.3	37.0	16.9	15.4	27.6	7.0	8.7	8.7	9.7	6.8	8.2	10.8	8.5	10.5	9.0	9.5	11.5	6.8	3.2	9.2	4.9	7.9	28.0	15.1	45.5	15.4	6.5	5.8	5.7	1.8	7.2	21.9	12.9	2.1	54.0	13.8	27.3	0.0	21.9	16.0	3.8	4.9	9.2	17.4	48.2	0.7	15.0	50.4	8.1	21.9	5.9	10.2	14.0	15.4	6.6	55.4	0.0	0.6	33.0	22.4	38.8	21.5	9.4	9.0	26.1	3.6	10.3	16.5	1.8	10.3	1.0	2.6	25.6	34.7	8.2	19.3	19.0	19.2	1.9	8.1	1.5	13.1	2.3	9.7	61.0	17.9	41.1	39.2	94.1	13.5	8.9	31.1	24.5
REEP5	"C5orf18, D5S346, DP1, POB16, TB2, Yip2e"	ENSG00000129625	"Receptor accessory protein 5"	Q00765	5	112876385-112922289	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003895, HPA069960"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA069960: AB_2686221"	"unprognostic (3.26e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (8.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-2)"	76.9	105.4	97.1	50.5	100.2	27.3	130.6	92.7	120.7	87.1	76.8	66.6	56.8	58.4	120.0	52.1	64.7	60.8	133.2	107.3	110.5	148.0	124.3	80.4	48.2	112.2	104.8	72.2	123.0	140.7	41.5	66.6	115.2	98.9	58.1	81.5	147.7	84.2	114.3	59.1	58.1	55.0	96.4	54.3	70.2	28.3	120.0	32.1	239.4	99.6	56.7	73.2	49.1	98.3	101.7	90.9	29.7	72.5	136.0	115.9	104.7	102.2	92.6	96.4	103.4	74.9	138.1	42.5	179.6	105.1	112.5	107.5	66.8	138.9	88.5	190.6	116.4	42.8	56.3	63.5	126.8	36.9	77.4	81.3	136.0	82.2	78.0	94.5	113.7	38.7	26.0	84.5	121.3	100.0	15.7	60.7	43.4	73.5	75.3	22.4	84.3	116.6	229.1	108.4	56.9	43.1	148.5	244.6	99.8	75.5	287.3	58.9	142.4	83.4	32.0	126.5	126.4	97.6	126.2	33.8	142.6	65.4	47.8	224.4	222.9	234.3	140.1	249.5	149.4	175.7	112.7	133.9	189.0	149.2	52.5	94.6	253.0	112.7	316.2	133.6	177.9	236.4	97.1	100.2	92.7	120.7	107.3	110.5	112.2	104.8	115.2	96.4	120.0	98.3	141.2	166.7	102.3	30.0	131.1	93.0	177.7	291.6	89.4	83.5	225.3	188.1	217.3	145.8	213.7	195.0	89.6	296.0	138.4	77.0	82.2	275.1	231.5	111.8	97.0	130.5	118.0	34.9	78.6	414.1	352.8	182.3	65.7	141.6	108.9	76.0	118.2	197.0	267.1	87.5	95.0	127.5	256.3	135.0	159.9	42.0	116.2	168.8	206.3	36.5	188.6	97.2	101.0	44.7	71.5	316.5	141.1	133.9	271.6	225.3	134.1	146.1	170.6	80.0	111.7	92.6	253.0	162.8	63.9	118.1	101.6	489.8	123.7	100.3	104.5	214.8
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1491166-1497927	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 217.5;liver: 398.0;testis: 283.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4"									"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	8.4	86.5	11.1	1.3	12.4	1.2	17.5	10.1	18.0	5.6	7.7	3.0	217.5	3.5	14.6	14.3	4.6	7.0	3.9	12.7	8.8	22.1	398.0	1.6	1.3	9.7	10.1	7.7	28.5	2.0	9.8	1.6	9.9	20.1	1.7	94.0	17.9	6.8	2.0	9.3	199.6	0.9	8.4	1.7	4.2	283.9	12.1	0.7	6.0	0.7	1.0	9.2	7.0	10.9	7.3	9.2	2.6	34.3	5.6	2.0	39.5	1.8	0.7	1.9	1.9	57.9	22.5	3.9	12.2	1.1	2.3	7.3	9.8	0.6	1.0	1.9	4.1	21.3	1.3	56.2	4.2	1.6	6.6	4.7	4.1	0.4	1.4	3.2	1.1	4.9	155.7	5.0	0.3	29.6	1.8	4.7	12.8	21.1	19.5	4.9	1.1	10.0	10.9	2.7	0.7	17.2	9.8	14.2	6.3	1.9	121.4	5.7	3.4	2.8	5.4	8.7	1.2	16.4	5.3	0.8	11.2	9.4	8.2	0.0	1.1	0.0	5.5	1.2	2.8	0.1	1.4	1.2	1.9	0.6	2.0	2.2	0.0	4.9	4.3	3.3	1.6	1.6	11.1	12.4	10.1	18.0	12.7	8.8	9.7	10.1	9.9	8.4	12.1	10.9	1.5	3.2	3.2	2.6	2.7	6.8	7.9	6.8	10.8	30.4	47.4	20.3	1.8	91.5	10.5	5.5	33.3	69.4	2.5	7.8	7.9	34.5	559.1	4.5	7.1	4.2	6.0	10.1	1.5	69.2	12.8	4.7	2.6	3.0	10.2	132.9	5.0	267.4	9.6	23.5	1.2	51.9	4.1	6.3	4.3	3135.0	34.2	4.1	30.2	0.0	1.7	44.2	2.1	0.0	1.5	25.0	53.6	16.6	1.9	13.1	898.7	52.0	8.3	292.8	19.7	0.8	3.3	29.9	36.5	17.5	6.7	36.0	4.3	50.1	70.7	14.7
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123409	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"pancreas: 103906.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 115721.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 1268.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.3;EFO-21: 18.3;HDLM-2: 15.2;NB-4: 11.0;OE19: 10.7;RPMI-8226: 32.5;SH-SY5Y: 12.5;U-2 OS: 31.1;U-251 MG: 10.8;U-266/84: 13.3"									"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	NA	NA		68000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			26.8	5.8	0.0	198.7	0.0	20.7	9.9	0.0	0.0	10.9	0.0	96.5	7597.3	5.3	0.0	9.3	6.4	96.6	10.2	0.0	0.0	93.0	15.9	4.5	7.5	0.0	0.0	25.6	103906.5	0.0	8.5	3.4	0.0	6.1	283.0	0.0	9.4	0.1	4.3	28.1	5638.4	178.1	0.0	8.5	945.9	3.9	0.0	0.0	4.0	0.0	0.4	3.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.5	10.7	0.0	0.0	0.0	32.5	0.0	0.0	1.4	12.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	31.1	2.0	10.8	0.0	13.3	5.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	25.5	1.9	1549.8	0.1	0.1	0.0	12.7	5.3	0.0	0.0	115721.8	0.0	0.9	692.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1813.1	0.0	0.0	0.0	0.1	0.0	17.0	0.0	0.0	507.5	0.0	0.0	0.0	0.0	22774.8	732.4	0.0	0.2	0.0	5100.1	20.8	0.0	0.0	0.0	0.0	51.7	0.0	0.4	0.0	0.0	0.0	0.6	0.0	5419.7	0.0
REG1B	"PSPS2, REGH, REGI-BETA, REGL"	ENSG00000172023	"Regenerating family member 1 beta"	P48304	2	79085023-79088019	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"pancreas: 39745.3"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 36125.0"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 201.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 4.1;RPMI-8226: 3.0;U-2 OS: 15.7;U-251 MG: 3.9;U-266/84: 3.8"									"HPA045549, HPA045579"	Supported				"Secreted to digestive system"	NA	NA		32000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (4.08e-1)"								"unprognostic (1.09e-1)"		"unprognostic (3.51e-3)"	"unprognostic (9.20e-2)"				14.6	2.1	0.0	35.8	0.0	9.8	3.3	0.0	0.1	3.9	0.0	17.3	738.0	2.0	0.0	3.5	2.1	0.4	3.3	0.0	0.0	2.6	5.5	1.7	1.7	0.0	0.0	2.1	39745.3	0.0	3.1	0.1	0.0	2.0	108.1	0.0	3.1	0.0	1.6	16.1	2754.3	112.1	0.0	3.2	5.0	1.5	0.0	0.0	1.7	0.0	0.0	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.1	3.9	0.0	3.8	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	86.7	0.0	0.0	0.0	3.3	1.8	0.0	0.0	36125.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	178.3	0.0	0.0	0.0	0.0	7978.5	174.7	0.0	0.0	0.0	3101.3	0.1	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	178.8	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"intestine: 6743.6;pancreas: 12212.2"	"Group enriched"	"Detected in some"	11	"Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		23000000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				18.5	10.0	0.0	13.3	0.0	0.2	0.6	0.0	0.0	0.3	0.0	19.2	5180.0	2.9	0.0	1.4	0.2	24.9	1.0	0.0	0.0	2.6	2.0	0.5	4.9	0.0	0.0	0.9	12212.2	0.0	2.1	0.1	0.0	0.5	0.0	0.0	2.1	0.0	0.6	0.4	6743.6	0.2	0.0	1.3	156.5	0.9	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.4	0.0	0.0	0.0	24.6	0.0	0.0	1.8	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	5.4	11.0	0.0	15.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	152.8	7.7	0.0	0.0	3.0	0.0	0.0	0.0	1988.6	0.0	0.0	189.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	55.8	0.0	0.0	0.0	0.0	5382.1	32.5	0.0	0.2	0.0	215.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	315.9	0.0
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pancreas: 3517.1"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 184.9;Pancreatic endocrine cells: 53.5;Proximal enterocytes: 39.4"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			1.0	46.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	2.4	0.1	165.7	0.3	0.3	0.0	0.2	0.0	0.0	6.0	0.4	0.1	0.0	0.0	0.0	0.2	3517.1	0.0	0.3	1.1	0.0	0.1	0.0	0.0	0.3	1.3	0.2	0.1	37.0	1.5	0.0	0.2	0.4	57.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.0	0.0	0.0	184.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.2	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	53.5	0.0	0.7	0.0	0.4	39.4	2.2	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.0	0.0	0.0	0.9	5.4	0.0
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794017-119811580	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 662.5"	"Cell type enriched"	"Detected in some"	7	"Intestinal goblet cells: 3458.1"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive CD8 T-cell: 24.6"	"Lineage enriched"	"Detected in single"	101	"T-cells: 24.6"	"Cell line enriched"	"Detected in some"	60	"OE19: 6164.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.7	0.0	0.0	34.4	0.1	0.3	0.0	0.1	0.2	0.4	0.1	236.2	264.5	0.5	0.0	1.5	0.0	0.5	0.0	0.1	0.1	0.7	0.3	0.0	1.6	0.1	0.1	0.0	133.7	0.0	0.0	0.0	0.2	2.6	314.0	0.0	2.3	0.2	0.0	0.0	662.5	8.5	0.0	0.2	19.0	2.4	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.3	0.1	6164.0	102.7	0.0	0.0	0.8	0.0	29.2	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.8	24.6	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	10.8	0.0	0.0	0.0	441.8	0.0	0.0	1.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3458.1	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	140.0	0.0	0.1	3.8	178.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.1	52.0	0.2
REL	"c-Rel, I-Rel"	ENSG00000162924	"REL proto-oncogene, NF-kB subunit"	Q04864	2	60881521-60931612	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2061.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 61.2;U-698: 109.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004404	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004404: AB_670194"	"unprognostic (2.77e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.66e-2)"	4.8	4.5	2.2	14.1	1.8	37.4	5.5	8.6	4.2	4.6	0.4	4.6	4.7	5.7	2.7	6.0	3.2	8.2	2.2	2.1	2.9	3.4	7.3	6.7	15.8	3.0	1.7	5.0	5.0	6.2	1.9	5.5	2.3	4.1	4.9	9.8	4.6	2.7	2.4	8.3	5.2	3.5	0.5	11.1	5.8	3.5	2.4	9.2	4.1	2.5	16.3	13.1	3.3	3.4	7.2	3.8	3.4	4.5	2.7	2.6	7.3	2.5	3.2	1.8	2.1	3.2	6.0	61.2	6.4	2.2	4.6	7.7	5.3	3.9	4.0	7.0	5.0	6.3	6.5	3.5	1.5	13.3	7.1	2.3	10.1	4.6	7.0	3.0	4.8	6.6	7.6	4.3	1.7	4.0	9.1	5.6	4.2	5.0	1.8	12.0	8.8	2.7	2.8	24.5	3.3	3.5	6.4	7.9	2.3	5.0	4.6	5.5	5.6	5.0	6.0	3.5	3.8	5.4	2.8	109.7	3.0	10.9	2.7	3.4	4.1	2.6	2.8	4.5	2.0	5.9	1.5	2.2	3.5	7.9	1.0	2.1	5.0	2.9	5.7	3.1	1.9	2.3	2.2	1.8	8.6	4.2	2.1	2.9	3.0	1.7	2.3	0.5	2.4	3.4	67.5	320.5	325.8	8.1	430.2	517.6	123.3	69.4	194.6	82.0	95.3	58.5	5.0	48.6	165.0	51.5	85.5	29.0	469.7	59.0	3.9	31.7	4.2	150.5	79.5	103.5	42.5	37.0	16.3	29.4	58.5	97.3	96.4	300.1	412.1	82.4	30.0	19.1	51.7	58.9	16.7	49.1	46.8	141.5	2061.4	3.4	15.5	463.9	135.2	42.2	451.1	21.3	145.2	8.5	9.2	35.1	46.6	23.7	119.5	99.7	34.3	7.7	153.1	56.2	13.1	65.9	73.9	51.5	38.4	158.0	463.1	77.6	303.7	21.3	50.1	260.6
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653597-65663090	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016"	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	67.3	42.8	27.4	38.5	29.9	79.7	63.1	28.7	35.0	61.7	26.9	63.3	31.3	61.0	23.0	60.8	62.3	34.7	49.4	27.3	29.6	50.0	66.6	70.3	39.7	35.5	30.0	65.3	49.0	25.9	32.3	27.8	31.8	55.6	23.8	9.8	54.4	35.4	74.9	66.1	49.1	39.8	29.1	59.7	56.8	24.1	31.4	30.3	45.0	26.9	36.7	60.3	59.4	33.4	66.9	68.4	31.4	45.2	49.1	49.6	32.2	52.9	65.6	62.3	49.9	33.0	71.1	53.0	85.5	75.4	72.0	63.9	36.8	66.6	35.5	62.1	53.2	57.5	50.1	47.5	56.7	43.8	78.8	55.4	65.3	70.4	79.2	58.9	76.6	43.7	56.6	61.4	48.5	90.3	74.1	38.5	20.9	43.6	64.6	61.5	29.6	80.6	50.7	60.9	26.6	59.5	47.1	72.7	72.4	22.2	82.3	29.4	100.3	65.8	55.3	103.3	50.9	86.0	80.5	53.6	71.7	30.8	65.4	12.5	14.0	18.6	22.7	17.1	25.5	17.3	19.8	22.4	15.4	14.0	18.4	20.0	21.2	25.2	15.4	15.3	21.4	16.5	27.4	29.9	28.7	35.0	27.3	29.6	35.5	30.0	31.8	29.1	31.4	33.4	43.2	32.1	25.5	9.1	33.9	47.3	54.4	41.3	33.0	9.4	31.6	27.9	23.1	17.2	30.9	11.0	8.4	24.0	40.7	30.9	29.4	41.4	5.1	32.8	25.7	43.9	19.7	19.0	5.5	45.1	24.8	30.1	33.1	50.0	44.3	26.2	32.9	20.3	24.3	15.2	5.9	25.0	32.6	24.9	40.4	7.7	28.9	28.0	32.0	10.3	35.2	14.5	28.8	7.5	13.8	65.4	20.8	26.4	30.7	66.8	22.2	17.4	23.4	9.5	13.1	30.5	34.7	14.3	20.3	29.2	43.2	43.6	37.9	21.0	21.6	75.1
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001449-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	17.2	13.1	3.5	18.7	2.9	40.1	12.6	2.9	4.4	9.1	3.1	13.3	10.8	14.1	0.8	8.7	9.2	7.4	12.7	3.1	3.4	21.3	13.0	23.0	19.2	4.9	3.5	6.4	16.5	2.1	4.0	4.8	4.1	15.3	3.9	0.2	12.1	5.2	14.0	16.5	17.7	4.9	3.6	29.1	12.0	4.3	4.6	9.2	10.0	1.4	15.6	13.8	8.1	4.1	22.2	13.0	1.3	5.7	2.8	9.1	4.5	3.9	27.5	5.9	9.6	4.5	23.6	61.9	11.0	6.4	20.8	9.8	0.5	9.0	5.1	79.5	2.0	2.2	0.8	2.5	23.8	4.9	35.3	15.0	3.7	12.3	14.4	5.4	3.9	1.7	0.5	39.2	2.1	5.3	1.1	14.9	2.0	6.3	2.4	4.8	3.2	7.7	10.0	33.7	0.1	2.0	4.1	11.4	11.6	1.4	4.0	11.8	12.6	14.4	7.1	5.3	14.4	49.0	31.2	67.0	15.6	1.7	8.1	0.0	5.1	2.5	1.4	3.4	2.0	9.2	2.2	1.9	3.8	8.0	1.7	0.8	15.2	2.1	2.8	4.1	1.1	2.0	3.5	2.9	2.9	4.4	3.1	3.4	4.9	3.5	4.1	3.6	4.6	4.1	16.4	6.4	12.4	2.3	64.4	37.9	108.5	20.3	40.9	0.0	17.6	11.3	1.8	24.3	15.7	3.7	0.0	4.2	35.0	53.0	9.8	33.1	5.2	15.1	15.2	30.8	22.8	22.5	3.0	31.5	7.3	35.4	65.2	29.1	50.9	3.8	5.0	3.5	18.4	3.3	1.7	33.3	8.2	15.1	74.9	3.4	4.7	44.7	24.9	3.7	112.5	0.8	7.2	1.5	2.5	37.4	90.3	2.6	108.8	145.3	48.0	19.4	7.4	0.3	6.6	28.9	27.3	1.1	1.7	27.7	31.8	9.9	53.8	4.1	16.8	89.7
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Microglial cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 59.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	13.5	2.4	10.6	4.9	15.5	25.6	7.8	20.1	14.9	5.1	9.3	8.3	6.2	5.5	2.7	6.4	5.1	6.1	6.0	8.0	13.3	3.9	4.8	6.6	4.7	29.7	19.3	3.5	2.3	1.5	1.4	6.1	27.7	3.0	6.6	3.1	3.5	3.8	15.8	12.4	5.5	6.0	24.4	7.3	12.3	1.6	20.1	3.7	12.5	4.3	4.8	7.8	4.1	39.7	4.8	5.1	12.9	11.1	10.8	6.2	10.8	8.0	6.9	5.5	7.2	16.8	5.7	1.3	5.7	6.9	9.8	4.3	4.1	7.2	9.6	0.2	2.1	1.8	4.7	18.2	8.1	6.0	4.5	10.6	10.2	7.5	8.2	3.4	24.9	3.3	3.1	5.0	6.4	4.4	7.5	8.3	3.2	6.9	1.5	2.5	45.0	2.2	13.2	5.9	2.9	8.5	6.1	6.6	10.6	3.2	18.0	3.2	29.6	13.8	8.7	10.1	9.5	2.5	2.6	7.3	11.7	12.8	11.4	0.8	15.2	27.4	5.1	5.7	6.3	0.7	6.2	4.9	8.5	0.2	5.3	7.0	59.3	7.7	5.5	9.8	5.5	5.1	10.6	15.5	20.1	14.9	8.0	13.3	29.7	19.3	27.7	24.4	20.1	39.7	30.5	9.6	3.1	16.3	2.9	3.3	2.5	1.7	10.8	0.4	8.1	9.5	2.1	5.7	3.9	0.0	0.0	1.4	9.8	8.4	0.0	3.1	6.5	5.5	9.9	14.4	1.2	3.4	3.3	8.6	3.6	10.7	22.4	2.4	2.5	0.5	6.4	0.9	2.6	3.3	2.4	1.6	0.0	3.2	2.7	8.1	3.7	9.2	1.8	36.5	4.1	4.0	0.0	22.6	12.5	10.3	2.9	6.0	15.5	2.7	6.7	0.2	3.3	1.4	13.1	18.8	16.4	0.8	0.3	5.5	4.7	5.2	10.6	5.1	1.1	3.8
REM1	"GES, REM"	ENSG00000088320	"RRAD and GEM like GTPase 1"	O75628	20	31475288-31484895	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Peritubular cells: 11.7;Sertoli cells: 59.2;Smooth muscle cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"WM-115: 22.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.6"	HPA049821	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049821: AB_2680898"	"unprognostic (6.16e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.39e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (7.79e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-2)"	13.9	2.2	1.2	1.7	1.1	0.0	7.5	0.9	2.1	20.1	1.3	6.5	1.3	10.5	7.2	2.0	10.0	2.2	6.2	1.0	1.0	3.2	0.8	4.6	3.0	1.0	1.1	3.9	1.1	1.1	2.7	2.1	1.1	5.5	1.0	0.0	1.6	4.9	3.3	3.2	3.7	3.2	0.9	2.5	2.4	1.4	1.3	0.7	4.8	2.4	1.5	4.8	9.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.9	2.1	1.0	1.0	1.0	1.1	1.1	0.9	1.3	1.0	7.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	7.1	2.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	5.6	0.3	3.6	1.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.8	0.0	59.2	0.6	28.1	0.0	0.2	0.1	0.9	0.0	0.1	1.5	0.0	0.0
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 162.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Late spermatids: 28.4;Paneth cells: 5.6;Smooth muscle cells: 10.7;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BJ: 2.0;HMC-1: 2.6;SK-BR-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000	10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	1.0	1.4	0.3	0.2	0.9	0.0	0.1	0.0	0.2	4.3	3.2	0.4	0.3	9.6	0.3	0.2	2.3	0.1	1.8	0.2	0.0	162.2	0.7	0.7	0.0	0.3	0.4	16.3	0.0	0.0	0.6	15.2	0.1	0.3	0.2	0.1	0.8	0.8	0.0	0.1	0.1	1.5	0.0	0.1	0.0	0.9	0.2	0.5	0.0	0.0	0.5	5.2	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.2	0.0	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.8	0.7	0.0	0.7	0.1	0.0	0.2	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	1.2	6.8	0.2	0.5	0.4	0.0	0.0	0.3	1.1	0.2	2.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	10.7	0.3	0.2	0.0	0.0	1.1	0.1	1.3	0.0	7.0
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935269-153944687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0;lymphoid tissue: 67.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 127.7;Hofbauer cells: 183.4;Kupffer cells: 70.7;Proximal tubular cells: 204.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.7;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.5;HMC-1: 121.4;SK-MEL-30: 86.4;U-266/84: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000428, HPA000522"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	22.2	19.2	14.6	13.5	18.2	10.9	11.1	16.0	20.6	5.0	12.3	13.8	8.4	3.9	2.5	2.9	5.6	6.2	11.5	14.6	18.8	43.0	5.3	24.6	16.5	18.4	19.8	1.7	1.8	2.1	6.0	10.3	18.0	3.8	4.2	2.2	5.8	2.0	2.2	9.7	13.9	4.7	15.2	67.0	5.9	1.2	19.4	6.2	5.4	0.1	6.3	6.2	4.5	19.6	0.0	0.0	3.3	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	35.5	0.0	0.1	0.0	7.1	0.0	0.0	0.0	1.5	28.2	0.0	2.3	20.4	0.0	121.4	0.8	0.0	0.0	0.0	0.0	0.0	1.0	8.2	10.3	0.0	0.6	7.5	0.3	0.4	0.3	0.0	13.6	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	86.4	3.0	0.3	9.9	1.3	0.0	0.8	0.0	0.1	12.5	74.8	5.0	2.5	13.3	9.8	1.7	0.9	2.7	0.1	0.7	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	2.0	0.1	1.6	0.3	0.0	0.5	14.6	18.2	16.0	20.6	14.6	18.8	18.4	19.8	18.0	15.2	19.4	19.6	1.9	0.0	2.2	7.2	8.0	4.7	1.3	0.3	0.6	2.4	0.4	0.6	1.0	2.8	0.4	9.2	0.0	1.3	2.6	0.4	37.2	1.4	0.1	0.1	0.5	10.7	1.8	3.0	0.2	0.4	6.0	4.5	0.0	0.3	127.7	1.3	52.1	0.8	183.4	15.2	1.7	1.0	0.0	70.7	13.3	0.4	0.3	49.2	28.4	6.5	40.7	10.7	8.2	0.5	6.2	0.5	5.3	0.4	4.0	1.4	12.3	204.2	0.2	0.8	13.1	2.2	4.9	0.1	1.4	0.4	2.0	2.9	7.5	0.7	0.7	0.6
REP15	RAB15EP	ENSG00000174236	"RAB15 effector protein"	Q6BDI9	12	27696447-27697596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"intestine: 59.4;stomach 1: 77.1"	"Group enriched"	"Detected in many"	20	"Gastric mucus-secreting cells: 132.5;Intestinal goblet cells: 440.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040448, HPA059868"	Approved					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA040448: AB_10964206, HPA059868: AB_2684148"	"unprognostic (4.13e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (9.43e-5)"	"unprognostic (7.29e-2)"	"unprognostic (7.42e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.13e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.77e-1)"	1.8	1.4	3.0	3.1	3.2	0.0	1.2	2.2	4.3	1.0	2.7	36.9	14.0	0.9	0.9	1.2	1.0	0.4	5.5	3.2	2.4	2.4	2.6	2.0	0.3	2.5	2.5	2.6	0.8	0.5	1.4	1.6	2.6	1.5	59.4	0.1	1.4	0.8	0.9	1.3	32.1	1.7	2.3	2.7	77.1	2.1	3.2	0.5	1.8	1.9	0.2	1.2	1.1	2.8	0.5	1.0	0.9	2.0	1.9	2.7	1.6	3.0	1.5	1.2	1.1	4.2	0.8	0.6	1.0	3.9	1.3	1.1	1.0	2.0	3.1	1.5	0.7	1.2	1.3	1.1	0.3	0.5	0.7	1.5	1.9	3.9	1.1	1.8	4.0	0.4	0.5	0.1	5.5	0.5	2.0	0.2	2.9	0.7	2.6	0.3	2.0	4.2	3.6	0.5	0.1	0.2	1.0	0.5	1.6	12.6	0.2	0.7	3.8	6.7	3.1	0.8	2.7	0.0	0.0	0.0	4.9	0.6	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.2	2.2	4.3	3.2	2.4	2.5	2.5	2.6	2.3	3.2	2.8	3.7	3.2	0.5	0.0	0.2	1.1	3.0	0.7	2.8	0.3	0.6	1.8	0.5	2.8	0.2	0.0	0.0	0.6	0.1	8.7	0.0	0.6	0.1	1.0	0.3	3.9	9.1	0.0	1.7	0.5	0.6	1.6	132.5	1.8	0.0	3.7	6.4	0.6	0.1	0.0	0.5	440.4	0.0	0.3	0.4	0.0	0.3	0.5	1.8	1.9	0.1	0.1	0.0	1.0	1.0	0.4	9.1	0.7	0.5	1.2	13.9	0.8	0.2	0.0	0.0	2.9	1.0	0.0	0.2	0.7	0.3	1.4	0.3	0.3	10.2	3.5
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 7.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 246.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (5.56e-4)"	"prognostic favorable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favorable (6.41e-4)"	28.7	77.2	45.1	25.2	43.6	44.1	35.1	43.1	46.4	31.7	54.6	68.4	42.2	37.5	31.8	37.4	40.9	14.6	65.3	37.9	40.0	51.5	86.6	31.7	35.7	52.3	46.7	37.3	67.7	35.5	69.7	12.1	45.5	49.2	28.3	23.7	41.7	23.9	134.5	31.8	56.5	15.4	41.1	56.2	53.1	18.2	49.5	41.0	45.0	66.2	24.8	42.5	25.0	42.1	59.4	71.3	66.1	81.5	15.8	11.3	40.2	28.7	35.2	27.6	23.8	55.5	37.6	65.5	70.9	20.6	48.0	43.4	36.4	11.4	13.9	72.0	54.8	38.4	40.3	70.4	52.3	68.4	60.1	14.7	34.1	15.2	3.5	26.1	39.4	39.1	93.5	39.9	23.1	76.7	95.1	77.4	69.5	39.7	69.9	51.8	76.4	246.3	29.4	103.7	96.9	123.7	43.3	107.5	75.8	27.2	52.8	54.2	42.1	21.2	17.4	23.6	58.7	115.4	46.1	59.8	37.1	59.9	53.3	0.0	1.4	2.7	0.8	0.7	1.3	2.5	1.8	1.5	2.2	2.4	2.3	1.1	1.4	1.8	0.3	7.8	0.8	0.9	45.1	43.6	43.1	46.4	37.9	40.0	52.3	46.7	45.5	41.1	49.5	42.1	21.1	35.3	18.6	17.9	26.9	9.4	18.3	11.5	14.8	57.9	39.3	33.1	46.5	45.8	15.0	14.7	41.7	28.0	49.5	53.7	62.6	37.3	7.8	53.4	14.3	24.3	68.1	14.5	13.0	50.3	12.9	16.1	23.4	35.8	24.7	56.3	26.0	69.7	32.0	80.8	15.8	68.6	32.6	14.8	23.9	9.8	22.1	21.8	16.0	9.4	88.4	101.3	40.2	17.6	16.6	34.3	37.1	19.9	26.4	31.6	47.0	32.8	36.2	55.8	6.6	28.0	20.1	10.2	3.1	17.6	17.8	25.6	16.0	33.5	109.7	19.9
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946658-17153272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 117.9;Inhibitory neurons: 142.7;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 204.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 13.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"basophil: 5.8;eosinophil: 4.5;neutrophil: 14.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.2;Karpas-707: 11.7;RH-30: 8.4;RPMI-8226: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favorable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.56e-4)"	2.4	11.1	7.6	1.2	9.4	3.0	3.3	2.4	29.1	15.9	1.6	4.3	2.1	4.2	12.6	1.3	2.1	2.1	1.6	11.2	9.2	11.0	7.6	4.6	0.5	2.4	4.4	4.0	10.3	9.4	6.0	2.6	3.4	8.2	4.6	9.3	5.1	7.8	0.9	0.9	2.0	4.2	0.9	1.2	6.3	2.1	9.3	0.7	2.0	1.3	0.6	1.8	0.9	12.5	1.4	0.6	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.1	0.2	0.1	5.2	0.0	0.6	0.0	3.9	0.2	1.1	2.8	0.5	30.2	0.6	0.0	0.7	0.0	0.7	0.0	0.1	5.3	0.9	0.0	4.7	4.9	1.6	0.0	0.0	11.7	0.3	1.4	0.0	0.4	0.2	4.3	0.9	0.0	8.4	9.4	0.3	2.8	4.2	0.3	2.2	2.1	1.7	1.7	3.9	0.2	0.2	0.0	0.2	0.1	0.4	0.5	0.0	0.4	0.0	0.4	0.2	5.8	0.3	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	14.3	0.0	0.2	0.3	0.0	0.1	7.6	9.4	2.4	29.1	11.2	9.2	2.4	4.4	3.4	0.9	9.3	12.5	11.7	32.1	13.5	6.5	0.9	0.6	9.6	4.4	1.2	49.5	7.9	5.5	6.6	4.3	8.8	14.7	0.0	0.2	1.5	10.4	1.9	3.0	0.2	7.1	4.0	2.3	9.5	4.4	117.9	14.6	9.1	4.1	9.7	9.6	0.0	7.9	4.2	15.1	4.2	38.7	142.7	7.8	0.0	5.7	6.4	0.9	9.3	6.6	1.8	21.5	4.9	0.9	0.0	84.9	204.0	7.9	5.1	12.8	1.3	10.6	2.3	11.6	2.7	2.6	0.0	0.8	2.0	0.7	2.6	0.9	1.3	0.7	0.5	16.3	10.2	6.5
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405442	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	100.4	154.2	60.0	89.3	67.6	81.6	97.1	67.0	62.8	93.6	78.3	137.4	114.8	74.4	122.7	176.4	86.1	86.9	75.7	61.1	64.1	106.3	224.8	79.6	94.6	67.0	65.1	92.9	122.3	100.9	82.9	99.0	66.9	94.3	151.4	73.8	101.1	104.2	105.2	101.7	120.0	104.6	65.6	102.2	118.6	107.1	68.5	94.5	85.9	85.1	143.5	101.0	106.5	76.1	203.1	111.0	131.1	146.8	233.7	275.7	100.9	297.1	261.1	254.3	253.2	157.6	299.3	143.9	242.7	297.7	205.1	213.3	152.2	176.7	322.2	180.8	156.1	163.9	247.2	153.0	252.5	181.3	188.6	225.0	176.1	264.3	233.1	175.4	235.8	160.3	197.8	232.6	299.8	141.5	127.2	127.3	87.5	314.1	279.0	146.0	131.9	183.7	227.5	94.3	109.9	126.2	167.9	376.9	242.9	143.7	149.6	127.4	171.8	197.3	114.1	355.9	219.5	223.0	270.2	255.3	209.6	254.8	102.8	239.1	235.5	284.5	195.9	268.2	180.0	169.0	169.8	210.0	221.2	151.7	127.0	155.9	351.3	164.8	275.9	256.1	244.5	309.0	60.0	67.6	67.0	62.8	61.1	64.1	67.0	65.1	66.9	65.6	68.5	76.1	88.7	64.1	50.0	23.5	73.1	53.2	84.4	214.2	50.1	33.6	111.9	123.6	41.6	118.7	131.4	104.8	33.3	233.8	97.5	218.9	66.5	213.4	475.6	89.5	93.5	68.2	36.5	57.2	16.7	258.4	321.8	94.3	71.9	118.8	44.3	76.5	82.1	233.5	217.9	37.0	16.8	158.6	122.1	104.3	73.2	464.0	82.6	99.9	62.2	15.9	126.1	97.0	114.4	19.1	25.8	256.4	195.4	76.0	145.1	142.5	238.7	119.6	136.3	62.6	111.7	60.9	141.6	291.4	145.2	103.4	67.1	467.9	74.3	159.0	162.0	141.0
RERE	"ARG, ARP, ATN1L, ATN2, DNB1, KIAA0458"	ENSG00000142599	"Arginine-glutamic acid dipeptide repeats"	Q9P2R6	1	8352397-8848921	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 373.9;Oligodendrocyte precursor cells: 392.0;Oligodendrocytes: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 22.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024093	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA024093: AB_1856177"	"unprognostic (4.73e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.94e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.46e-3)"	57.5	45.1	24.3	24.2	20.8	24.4	53.8	24.9	32.9	69.1	3.1	64.7	31.5	90.0	20.4	30.3	54.3	22.7	64.0	20.0	24.4	50.6	23.7	37.4	28.6	13.0	13.6	42.6	35.5	36.6	34.1	25.7	9.2	58.7	21.3	36.1	39.9	33.5	154.9	35.2	40.3	41.1	7.2	42.7	40.7	41.2	11.9	15.7	50.1	56.8	19.5	55.9	40.7	20.6	24.9	20.7	47.6	36.7	40.0	27.9	26.2	19.9	23.2	16.0	23.3	33.3	21.9	36.5	19.4	24.1	12.3	18.9	16.3	13.0	21.6	28.6	26.5	20.8	18.6	38.4	22.2	13.3	5.0	31.9	17.8	34.8	23.7	33.3	34.0	11.4	24.5	11.6	23.9	17.4	5.1	9.9	36.4	13.7	20.0	25.8	13.8	53.1	19.1	30.2	53.9	36.5	15.7	42.5	33.8	28.3	17.4	5.6	27.0	24.3	20.8	23.4	15.8	18.9	12.0	49.1	16.2	31.7	21.9	1.6	2.3	0.7	2.9	5.9	5.1	3.6	4.0	2.1	2.3	8.0	2.3	1.4	4.5	2.6	22.7	4.9	13.0	1.2	24.3	20.8	24.9	32.9	20.0	24.4	13.0	13.6	9.2	7.2	11.9	20.6	85.8	38.5	40.2	230.2	67.8	23.2	65.4	22.5	39.3	163.4	94.6	59.4	84.3	64.3	33.5	66.2	189.7	44.8	45.7	82.1	35.2	34.3	33.8	71.7	69.1	56.9	62.1	18.3	311.7	25.3	26.3	44.5	40.8	87.5	36.2	73.6	72.1	23.8	27.3	154.8	373.9	57.2	12.2	34.3	27.0	21.6	49.0	32.5	16.0	310.1	26.6	38.1	22.6	392.0	605.5	33.7	43.2	95.2	31.0	72.4	55.1	39.3	38.6	118.5	72.3	53.4	58.6	46.6	60.5	33.7	18.8	38.0	30.6	35.7	54.7	91.2
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
RESF1	"C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1"	ENSG00000174718	"Retroelement silencing factor 1"	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 73.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 212.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 212.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	14.3	7.1	2.5	50.7	3.1	21.8	13.9	7.5	10.9	28.9	2.2	14.0	23.8	23.2	9.1	10.6	38.1	19.3	8.1	1.8	3.3	9.1	24.9	17.1	70.2	4.1	2.8	73.9	6.7	9.8	4.0	37.9	5.0	9.2	13.8	7.0	8.2	11.2	4.1	9.1	27.3	16.0	2.0	45.3	20.5	13.2	3.6	60.7	12.6	11.9	62.5	17.7	8.6	5.1	7.6	13.3	22.5	8.6	10.1	12.0	33.6	9.1	9.0	6.0	6.9	50.6	48.9	36.4	21.9	7.6	21.5	9.6	31.3	6.0	8.4	27.1	4.4	51.1	6.7	6.7	19.7	37.0	79.2	6.5	9.0	7.1	11.6	25.4	50.3	24.0	29.5	56.1	6.8	3.7	52.6	15.6	48.3	28.4	5.5	24.1	21.4	16.0	6.3	14.0	9.0	8.1	11.7	6.0	6.0	112.9	20.8	40.5	32.0	6.7	10.4	11.5	9.6	33.9	38.1	44.8	3.6	20.6	7.4	55.5	14.7	15.4	42.2	16.1	40.3	33.6	38.0	40.7	12.3	26.8	44.1	43.8	212.8	30.6	18.1	7.7	38.9	20.4	2.5	3.1	7.5	10.9	1.8	3.3	4.1	2.8	5.0	2.0	3.6	5.1	35.8	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	15.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	5.1	21.5	0.0	0.0	0.0
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"intestine: 245.5"	"Cell type enriched"	"Detected in some"	38	"Intestinal goblet cells: 210.1"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000			"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	75.7	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	245.5	0.0	0.0	0.1	0.0	0.0	34.5	0.8	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.5	0.0
RETREG2	"C2orf17, FAM134A, MAG-2, MGC3035"	ENSG00000144567	"Reticulophagy regulator family member 2"	Q8NC44	2	219176225-219185475	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 42.1;Collecting duct cells: 46.0;Ductal cells: 43.8;Exocrine glandular cells: 48.3;Pancreatic endocrine cells: 40.4;Proximal tubular cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011170, HPA011844, HPA075910"	Approved		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA011170: AB_1845713, HPA011844: AB_2668544, HPA075910: "	"unprognostic (2.63e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (8.74e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.45e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.70e-2)"	34.4	47.6	73.6	26.5	74.1	47.4	34.1	73.2	90.1	42.7	66.1	41.3	31.7	35.1	45.9	38.5	38.4	32.1	24.6	74.9	76.6	51.8	57.2	29.7	34.3	77.4	77.3	51.9	52.4	76.6	43.7	28.3	77.2	36.9	38.5	50.6	39.8	29.7	24.9	45.0	36.7	33.9	76.5	38.2	42.9	104.0	78.8	34.3	44.6	27.7	34.6	37.7	35.9	78.0	34.6	36.2	30.5	46.5	113.2	47.7	32.5	41.4	71.3	49.4	42.7	36.3	58.1	28.1	40.4	78.5	101.4	43.3	37.1	37.1	54.1	39.5	31.0	37.5	51.2	61.1	64.7	41.1	49.6	52.0	95.5	55.5	53.3	84.7	45.2	29.9	26.3	62.8	69.3	50.9	24.8	44.4	22.6	44.0	41.5	31.4	33.8	22.7	41.1	40.3	43.6	44.9	26.7	50.8	98.4	47.4	42.4	44.9	36.0	55.0	29.4	78.6	31.5	63.4	39.3	31.5	57.5	40.3	31.0	12.5	6.3	6.3	9.3	8.3	8.3	8.3	7.4	9.5	4.3	5.7	6.6	8.8	23.5	5.2	8.1	6.6	9.6	3.6	73.6	74.1	73.2	90.1	74.9	76.6	77.4	77.3	77.2	76.5	78.8	78.0	22.4	16.0	13.7	0.0	7.9	0.0	0.0	0.0	0.0	0.0	42.1	32.0	0.0	0.0	6.2	46.0	0.0	31.1	21.1	0.0	21.5	43.8	0.0	21.4	19.3	8.6	0.0	0.0	0.0	48.3	37.2	11.9	0.0	30.5	5.1	29.2	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	11.4	0.0	0.0	0.0	0.0	40.4	0.0	0.0	5.7	0.0	0.0	42.3	2.2	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	30.1	8.2	24.2	0.0	0.0
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	16.2	21.7	17.3	13.2	16.6	6.9	16.9	16.4	18.9	23.0	18.7	19.0	14.2	18.5	21.3	29.2	16.8	10.9	16.2	17.0	17.4	19.5	33.4	17.4	19.5	16.9	18.0	19.6	39.9	18.9	20.4	20.9	17.7	25.5	16.8	31.4	23.2	14.0	22.4	33.9	20.7	15.1	16.8	30.1	22.8	38.7	19.1	20.6	16.3	16.4	21.6	19.4	23.1	15.0	12.0	36.6	15.8	25.8	39.6	21.9	22.5	16.9	22.7	19.6	22.9	17.5	25.3	26.3	23.1	27.5	20.1	45.9	20.5	25.3	18.9	28.2	19.3	10.7	22.2	31.0	27.2	18.6	26.5	33.6	34.2	21.5	21.8	21.7	21.3	19.0	22.3	25.4	15.7	20.7	27.5	26.9	10.0	22.5	9.0	14.7	24.2	27.2	22.5	38.2	28.2	19.3	18.1	14.6	26.1	28.9	41.5	14.2	27.2	21.0	12.8	21.1	16.2	43.4	55.3	22.7	19.3	11.6	16.2	54.9	16.2	36.4	44.5	19.2	39.1	23.7	36.5	42.9	15.1	24.8	35.1	40.4	13.8	28.2	24.1	15.0	57.0	36.4	17.3	16.6	16.4	18.9	17.0	17.4	16.9	18.0	17.7	16.8	19.1	15.0	16.7	25.6	29.8	0.0	8.8	0.0	0.0	0.0	0.0	0.0	21.7	18.3	0.0	0.0	6.2	31.3	0.0	22.4	24.7	0.0	7.9	16.4	0.0	14.5	16.7	7.4	0.0	0.0	0.0	25.4	16.0	7.4	0.0	20.0	7.6	26.8	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	8.8	0.0	0.0	13.4	5.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.4	8.1	17.3	0.0	0.0
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85341955-85354531	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 247.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 264.9;Proximal enterocytes: 249.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 197.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA007961: AB_1079802, HPA046513: AB_2679680"	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	247.0	52.3	16.5	17.6	20.9	3.8	63.9	19.8	15.8	18.9	27.3	89.6	167.0	16.0	38.4	36.9	15.7	32.0	20.3	14.9	20.0	54.9	115.9	24.6	11.7	21.0	20.0	17.0	37.5	36.9	7.2	11.6	20.0	32.5	73.5	9.5	27.8	23.6	68.3	48.8	142.4	22.0	19.2	11.7	60.9	14.6	19.9	12.2	47.4	55.1	19.9	19.0	23.7	23.7	52.7	30.1	16.8	40.0	197.8	37.0	22.1	37.8	46.5	22.5	31.5	20.9	36.2	18.5	30.3	29.6	17.9	42.6	22.9	65.6	21.6	22.8	15.9	9.0	23.5	50.6	47.6	17.9	19.3	48.6	87.2	28.7	38.1	51.4	37.6	15.4	9.7	43.1	42.0	11.0	12.5	9.0	5.6	52.6	36.2	8.1	33.7	23.9	39.1	30.1	8.3	13.8	31.4	59.9	101.8	11.2	28.2	2.9	30.0	25.3	13.8	23.5	19.9	23.0	22.9	7.2	30.9	20.5	17.6	0.0	3.8	1.8	4.8	4.0	6.2	2.6	3.5	6.0	4.0	1.5	2.5	2.5	3.7	5.1	8.7	2.7	4.2	3.4	16.5	20.9	19.8	15.8	14.9	20.0	21.0	20.0	20.0	19.2	19.9	23.7	7.3	28.9	29.6	5.9	4.5	11.3	10.8	18.6	12.5	3.7	13.0	7.9	21.7	21.5	15.5	12.9	18.8	10.9	4.3	264.9	0.0	23.7	27.6	9.7	6.8	9.7	10.8	2.5	5.7	36.1	6.5	9.0	56.1	16.6	10.8	5.5	7.5	54.7	9.9	11.8	4.5	45.0	8.2	10.4	8.6	60.0	14.6	7.4	30.2	7.5	8.3	8.3	10.3	6.6	12.1	32.7	79.2	12.4	10.3	11.8	249.9	17.8	11.9	4.9	0.0	7.7	8.8	2.9	3.1	24.9	14.9	8.5	7.7	9.9	56.6	9.8
REV1	REV1L	ENSG00000135945	"REV1 DNA directed polymerase"	Q9UBZ9	2	99400475-99490035	"Predicted intracellular proteins"	"DNA damage, DNA repair, DNA synthesis"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044534, HPA051036"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044534: AB_2678975, HPA051036: AB_2681319"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-3)"	9.8	11.6	7.0	6.1	7.6	7.0	11.2	13.1	9.6	11.9	9.4	9.3	6.1	14.2	17.3	10.5	11.4	7.9	12.4	7.2	8.7	9.0	10.0	11.2	10.0	7.0	7.4	12.1	6.9	8.8	10.4	7.3	6.8	11.2	9.2	12.2	9.4	12.0	15.7	10.3	9.0	10.1	6.9	9.4	8.2	9.6	8.5	9.7	10.3	23.7	10.0	10.5	11.5	8.5	7.9	2.0	12.4	4.7	9.5	9.3	13.0	8.6	10.8	9.9	11.3	4.6	7.5	15.9	6.7	9.2	10.4	10.9	9.3	11.5	15.3	7.0	5.8	8.1	7.7	10.5	10.6	10.6	16.5	9.1	13.7	8.9	13.0	11.1	12.9	8.1	9.4	5.3	11.1	5.2	11.2	19.0	8.9	5.1	5.2	17.4	8.8	7.0	12.3	13.4	8.0	8.5	7.6	6.4	11.2	13.3	6.6	15.2	9.1	11.7	9.7	4.9	5.7	7.2	7.8	12.8	4.8	13.4	9.2	0.0	0.2	0.0	0.3	0.2	0.2	0.1	0.5	0.4	0.3	0.4	0.9	0.7	0.1	0.3	0.1	0.1	0.3	0.1	7.0	7.6	13.1	9.6	7.2	8.7	7.0	7.4	6.8	6.9	8.5	8.5	45.3	70.5	61.9	59.4	27.7	48.3	57.5	37.8	58.6	84.2	21.7	20.4	52.5	20.0	38.6	22.0	39.6	32.9	17.5	24.1	5.9	18.4	29.2	41.6	32.8	31.6	17.5	35.7	71.3	18.1	20.0	33.8	31.6	30.0	25.3	32.4	23.6	18.0	19.1	82.4	78.2	16.3	26.4	17.6	28.3	21.6	27.1	20.6	19.6	53.4	27.3	36.7	14.4	60.3	77.0	16.4	25.6	46.3	23.3	51.0	30.0	12.5	33.7	57.2	26.3	51.2	28.8	52.1	53.8	36.3	35.5	35.2	26.8	39.7	19.3	63.5
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	6.1	3.6	11.2	6.4	9.2	7.2	3.1	28.8	11.9	16.6	11.3	4.8	4.3	10.3	2.3	4.6	6.2	4.9	4.4	7.2	10.0	4.1	3.5	4.4	5.6	3.6	7.9	7.6	4.2	3.2	0.9	6.8	4.4	4.8	3.5	26.2	3.2	5.0	5.0	4.7	3.6	8.0	1.8	4.6	4.5	7.5	8.4	6.0	6.6	12.2	2.5	4.8	1.0	10.7	9.2	6.3	11.4	13.3	35.2	35.0	11.9	13.6	16.7	6.4	9.6	8.1	5.0	17.0	9.3	15.9	12.0	9.4	17.6	5.7	10.7	13.9	10.0	13.9	13.9	13.3	9.1	13.5	6.9	21.0	3.2	12.0	15.4	10.3	10.2	10.0	18.3	13.9	10.8	7.2	16.7	3.6	3.2	3.8	10.2	11.6	12.7	6.6	2.5	7.9	15.7	11.8	17.5	3.2	12.4	8.5	7.1	14.2	13.7	9.6	9.6	47.0	15.4	14.0	17.1	17.6	9.1	10.5	12.4	0.6	0.6	1.2	1.0	0.5	1.6	1.0	0.8	1.0	0.6	1.6	0.5	1.0	1.9	0.4	0.9	0.9	0.7	0.3	11.2	9.2	28.8	11.9	7.2	10.0	3.6	7.9	4.4	1.8	8.4	10.7	133.4	48.1	82.4	290.6	65.7	30.5	19.5	12.8	45.5	117.5	20.2	17.9	34.5	11.5	29.1	20.2	56.3	27.2	35.3	11.8	3.9	17.3	40.0	151.1	610.1	57.4	59.8	27.5	161.7	11.5	11.9	82.7	41.3	107.5	46.9	61.5	21.8	16.0	11.8	35.3	360.2	18.6	10.2	19.9	87.4	16.3	50.4	57.2	21.4	105.9	23.7	59.6	33.0	594.7	190.3	8.5	12.3	39.1	41.3	21.3	18.4	15.9	43.5	57.6	39.5	122.3	62.3	68.5	70.4	26.1	26.9	33.0	46.4	30.3	21.5	8.2
REX1BD	"C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391"	ENSG00000006015	"Required for excision 1-B domain containing"	Q96EN9	19	18588685-18592337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 154.6;Extravillous trophoblasts: 147.6;Hofbauer cells: 258.2;Proximal tubular cells: 222.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 64.5;PC-3: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043414	Approved		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA043414: AB_10797141"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (8.47e-4)"	42.9	40.7	25.5	5.0	23.8	8.1	41.3	21.7	45.2	40.3	11.9	39.3	6.7	39.6	0.5	31.6	34.0	1.9	76.5	24.3	25.3	48.3	63.5	33.9	2.4	25.9	22.5	38.9	52.8	4.3	32.3	3.6	24.2	40.0	1.0	0.6	33.8	6.1	106.4	42.8	33.8	2.4	22.7	47.6	39.0	10.8	26.3	3.9	27.6	9.2	2.2	39.1	38.1	24.9	18.2	20.6	2.0	3.8	2.6	3.1	64.5	19.2	3.0	4.2	4.9	3.8	21.8	18.7	58.4	3.2	1.7	12.9	0.9	4.6	1.1	19.5	47.1	12.1	7.5	9.8	3.7	11.7	28.7	5.2	5.2	2.2	1.1	1.8	5.4	8.4	16.8	6.8	2.2	26.3	19.9	18.6	29.3	9.5	98.5	21.4	5.5	47.2	7.4	15.0	9.5	34.6	9.1	10.8	25.0	0.8	5.2	7.5	18.5	2.4	18.8	25.5	10.7	52.3	17.3	12.7	18.0	18.9	9.7	100.5	150.9	152.5	148.6	140.1	153.1	126.4	151.4	134.5	146.9	91.6	135.4	128.6	89.4	101.3	132.4	125.8	134.6	143.6	25.5	23.8	21.7	45.2	24.3	25.3	25.9	22.5	24.2	22.7	26.3	24.9	126.2	28.9	41.2	0.0	38.7	0.0	0.0	0.0	0.0	0.0	100.0	136.5	0.0	0.0	21.1	77.3	0.0	127.7	84.0	0.0	154.6	72.9	0.0	52.1	67.8	39.7	0.0	0.0	0.0	116.7	147.6	53.3	0.0	63.7	41.6	122.5	0.0	0.0	258.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	58.4	0.0	0.0	0.0	0.0	74.7	0.0	0.0	25.9	0.0	0.0	222.4	19.7	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	66.5	50.9	93.6	0.0	0.0
REXO1	"EloA-BP1, KIAA1138, TCEB3BP1"	ENSG00000079313	"RNA exonuclease 1 homolog"	Q8N1G1	19	1815248-1848483	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.2;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042155, HPA042552"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA042155: AB_10806233, HPA042552: AB_10794280"	"unprognostic (1.36e-1)"	"unprognostic (3.86e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-2)"	13.3	27.8	15.0	10.4	21.3	18.9	12.7	2.2	18.5	10.5	0.0	14.5	9.9	14.0	2.5	12.8	11.7	6.2	12.7	16.8	1.6	12.2	16.4	12.5	13.1	3.7	2.3	13.5	13.3	5.6	9.5	10.0	2.0	11.7	4.2	4.8	10.5	5.2	16.2	18.6	14.0	4.5	0.3	23.6	12.2	30.1	7.2	9.2	11.4	6.2	5.6	12.3	10.9	8.4	20.8	13.1	11.8	18.4	4.6	6.0	23.7	14.7	7.8	10.5	9.4	17.1	11.2	17.6	9.7	10.3	6.8	17.9	9.0	16.5	4.6	28.2	13.8	18.6	15.3	10.1	10.4	16.5	29.3	10.6	9.3	13.9	9.2	6.0	9.7	24.8	28.4	29.8	5.5	13.0	27.5	18.6	26.6	8.3	12.8	24.3	9.8	16.7	7.0	11.6	17.3	19.0	9.2	15.3	19.3	7.8	13.4	24.1	16.9	16.6	14.3	27.9	24.8	47.9	24.8	15.1	13.3	19.7	21.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	15.0	21.3	2.2	18.5	16.8	1.6	3.7	2.3	2.0	0.3	7.2	8.4	17.1	0.0	5.9	7.2	12.6	15.9	8.0	6.9	14.2	19.5	11.3	9.1	1.3	5.7	7.3	18.4	8.4	21.9	20.8	27.9	1.9	7.3	161.2	14.2	13.8	13.2	18.4	10.8	7.9	8.5	10.6	9.7	23.4	23.8	5.7	20.1	13.2	14.2	11.0	47.1	6.2	16.4	2.0	8.8	10.5	214.3	7.5	12.7	7.2	10.3	7.3	7.3	11.3	6.6	6.9	14.0	17.2	7.5	15.9	11.8	11.4	8.7	3.9	20.0	0.0	15.1	10.2	14.8	18.3	17.9	16.8	20.5	14.6	33.7	18.9	12.0
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439435-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"		NA	NA		340000	"Cluster 6: Non-specific - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (6.70e-4)"	51.1	57.2	23.5	40.3	25.9	55.0	57.1	26.3	31.5	73.4	28.6	80.4	24.3	71.5	46.5	65.8	38.1	47.8	140.3	24.0	29.5	102.5	50.2	42.0	32.5	30.3	28.1	69.0	45.5	154.5	32.5	56.9	29.7	72.5	47.2	9.2	115.3	58.0	40.8	50.5	33.1	106.7	26.6	44.8	65.4	53.5	25.7	30.4	36.5	40.5	37.1	68.3	64.4	29.9	159.3	92.7	32.1	88.4	254.6	268.7	81.9	266.3	192.9	122.6	155.4	244.9	261.2	88.8	258.2	220.8	185.4	97.4	74.1	219.5	201.5	86.9	61.3	98.1	136.0	144.7	339.2	72.3	29.5	190.8	206.0	157.4	163.7	214.1	223.1	84.7	183.9	48.6	278.5	38.7	49.4	84.0	102.3	119.1	160.3	45.7	112.1	317.1	177.0	126.9	59.8	38.5	122.7	86.7	110.8	134.8	184.9	35.6	231.4	162.5	194.2	124.0	161.6	39.7	52.4	146.3	111.3	165.2	89.7	64.3	14.0	21.3	32.2	19.2	37.2	37.6	47.9	41.1	18.8	29.2	43.0	35.1	3.5	45.2	20.6	70.1	75.3	29.1	23.5	25.9	26.3	31.5	24.0	29.5	30.3	28.1	29.7	26.6	25.7	29.9	82.9	105.8	56.4	20.9	42.3	138.9	146.5	189.1	88.2	14.9	99.2	100.6	370.0	47.1	126.5	95.6	2.1	171.6	55.3	27.2	277.8	126.6	83.6	75.3	110.8	98.4	80.9	315.2	20.0	70.7	188.5	176.8	48.4	85.2	31.8	40.1	89.6	80.0	98.2	5.0	17.4	82.9	89.5	21.0	56.7	48.1	210.6	33.9	241.9	15.9	41.9	36.5	29.9	25.1	33.5	110.0	33.7	176.8	103.8	199.6	26.7	371.4	126.5	8.3	52.6	90.6	177.0	237.3	82.1	119.9	162.7	269.1	47.5	120.6	72.4	130.4
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	12.6	15.7	8.6	6.7	8.9	5.1	12.3	9.0	9.4	16.0	8.1	14.8	5.7	12.7	3.8	18.2	12.2	4.5	16.3	8.7	8.6	15.6	22.6	10.5	8.7	8.7	8.7	18.0	21.4	5.1	13.0	5.8	8.9	15.7	3.9	3.5	13.1	4.7	35.4	17.0	14.3	3.9	8.7	18.8	14.1	18.2	8.8	8.3	12.8	9.7	6.6	16.2	15.1	9.2	9.8	22.2	10.3	15.1	10.5	10.7	18.2	16.4	9.3	17.0	11.2	26.8	12.3	31.5	11.0	9.0	13.9	26.0	21.5	17.2	9.7	20.5	19.8	17.2	23.7	21.1	13.0	39.4	16.1	10.1	14.4	17.9	24.4	13.0	12.6	16.8	38.3	13.5	11.0	28.1	27.9	23.7	20.8	35.0	32.2	19.7	16.7	31.5	10.8	9.1	29.1	15.9	17.4	20.2	19.4	10.1	24.7	15.7	11.1	30.9	16.1	14.7	20.3	8.8	11.5	21.6	11.5	22.5	18.7	0.4	1.3	2.0	1.9	1.3	2.2	2.4	2.0	2.0	1.1	2.8	2.5	2.7	0.1	3.9	1.1	1.8	2.0	1.0	8.6	8.9	9.0	9.4	8.7	8.6	8.7	8.7	8.9	8.7	8.8	9.2	16.8	22.4	15.0	4.9	29.7	25.0	22.3	12.9	10.2	26.6	27.0	23.5	9.9	21.5	8.5	25.8	22.9	37.5	27.8	24.2	19.6	29.2	38.2	36.6	34.5	17.4	13.2	7.6	4.4	28.7	36.2	14.7	7.1	32.7	17.7	24.2	19.6	26.8	21.3	16.8	4.6	22.2	4.1	22.4	11.5	83.3	28.9	13.2	7.2	1.9	37.9	17.6	51.5	1.5	5.0	30.6	21.7	24.0	18.4	25.3	30.8	28.2	10.4	34.1	19.7	13.1	16.9	51.6	65.9	10.7	27.6	31.5	24.9	16.4	35.8	13.7
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849665	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 343.8"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	15	"basophil: 86.7"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 86.7"	"Cell line enhanced"	"Detected in many"		"K-562: 44.7;U-266/70: 42.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040755, HPA040868, HPA066145"	Approved		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: "	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	2.3	1.8	1.4	1.8	1.4	11.6	3.6	1.6	2.0	1.7	0.4	2.1	2.9	2.2	1.2	2.3	4.2	1.6	3.4	1.4	2.3	1.2	1.8	1.0	2.9	1.7	1.1	1.9	1.7	40.0	0.9	1.5	1.6	5.3	3.0	4.2	1.7	1.3	1.0	2.2	2.1	2.7	0.8	1.0	5.0	343.8	2.2	7.4	0.9	1.3	2.6	2.0	1.6	2.1	11.3	6.5	10.1	4.5	4.2	7.5	3.4	7.6	8.4	8.2	8.9	4.7	10.0	7.0	11.5	6.7	5.7	5.7	7.7	3.4	8.5	6.5	4.9	11.7	10.2	6.7	0.8	17.2	16.4	3.8	1.5	9.7	12.4	3.5	2.8	0.0	44.7	29.8	20.5	15.1	2.8	13.5	5.5	4.6	6.6	14.0	18.8	12.6	2.5	4.0	8.6	9.7	7.3	9.6	2.4	2.9	16.2	14.8	1.4	6.1	5.4	8.2	9.3	42.5	31.1	2.7	12.6	22.3	5.6	86.7	0.4	5.7	0.3	0.1	0.4	0.0	0.4	0.4	0.7	0.0	0.1	0.3	0.4	2.2	0.2	0.2	1.8	0.4	1.4	1.4	1.6	2.0	1.4	2.3	1.7	1.1	1.6	0.8	2.2	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.0	1.3	0.0	0.0	3.2	0.8	0.0	0.0	1.6	0.0	2.8	1.6	0.6	0.0	0.0	0.0	1.5	2.4	1.5	0.0	1.7	1.3	26.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.5	4.7	0.0	0.0
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818069-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 285.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	5.3	13.8	2.6	12.9	2.4	19.5	12.8	8.7	2.6	5.7	1.7	9.0	8.5	10.6	4.3	6.7	8.3	4.6	6.1	2.7	2.5	5.1	7.4	5.4	24.3	2.7	2.2	7.8	4.8	5.1	2.6	10.8	2.8	6.3	11.6	5.9	5.5	4.1	3.5	7.5	7.9	7.6	3.7	6.6	6.5	12.8	2.6	24.1	6.5	4.4	23.4	5.7	4.6	2.5	49.0	51.1	86.4	69.5	6.5	10.0	47.5	66.6	29.2	85.5	73.7	63.0	72.2	179.8	26.8	25.3	53.2	72.5	111.6	45.9	112.0	71.5	68.9	105.0	54.4	68.0	7.5	127.2	48.3	9.8	5.8	74.5	49.9	14.1	28.9	63.7	75.1	44.2	51.4	56.1	108.8	58.1	104.2	101.2	42.1	40.3	103.4	41.1	25.4	42.7	45.1	79.2	49.4	65.3	33.4	45.7	52.2	66.8	15.5	45.1	49.7	57.1	70.9	24.9	36.7	285.3	32.4	73.7	86.6	1.5	4.4	7.2	3.2	6.1	3.7	5.8	3.9	3.3	6.1	5.5	5.0	4.5	0.9	2.5	5.3	2.5	6.3	3.1	2.6	2.4	8.7	2.6	2.7	2.5	2.7	2.2	2.8	3.7	2.6	2.5	9.3	9.6	6.2	5.9	11.2	12.2	6.9	6.9	7.4	16.5	8.9	10.5	7.5	1.5	8.6	3.7	8.4	29.6	5.1	3.0	3.9	7.3	8.4	7.0	7.9	9.4	6.1	43.8	30.2	8.9	39.3	7.5	3.1	7.7	1.3	17.8	8.9	7.2	11.9	8.4	20.3	4.3	4.1	6.7	4.0	7.9	6.2	6.5	8.8	34.7	6.4	5.4	1.0	33.7	18.0	5.4	1.5	4.5	21.0	2.7	1.1	5.4	3.8	12.2	6.6	7.9	29.8	52.6	43.2	9.2	7.0	16.4	6.6	9.2	10.1	3.3
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.0	6.0	7.3	19.3	7.6	41.5	13.8	8.9	11.9	8.8	7.4	15.4	10.9	14.1	6.6	11.8	10.8	7.7	9.1	7.5	7.5	7.3	10.7	7.2	31.5	7.3	7.4	15.0	11.0	8.0	5.7	14.5	7.6	7.7	20.4	11.2	8.6	7.0	8.3	11.7	11.7	17.6	7.5	14.3	10.4	22.7	8.1	35.7	7.3	6.7	34.5	7.8	8.2	8.3	167.3	56.2	130.8	83.6	18.8	20.1	103.0	78.9	49.9	123.6	135.8	84.8	77.9	119.5	177.4	38.0	118.0	86.1	116.5	77.5	151.1	180.5	102.5	123.3	86.3	86.3	14.6	131.8	79.5	17.3	27.5	84.9	66.1	27.6	42.0	183.8	97.9	165.4	85.3	79.7	167.2	122.8	116.0	148.1	76.0	129.9	112.5	164.3	44.9	60.7	126.3	63.3	97.3	107.6	90.3	97.6	183.0	123.7	19.6	74.4	93.3	125.8	239.9	91.9	216.9	398.9	65.3	142.8	100.0	0.0	2.8	9.7	11.5	4.2	11.1	13.1	11.4	12.0	5.0	15.1	11.2	10.2	0.6	9.8	14.7	9.6	21.8	7.7	7.3	7.6	8.9	11.9	7.5	7.5	7.3	7.4	7.6	7.5	8.1	8.3	5.1	0.0	2.2	3.3	14.0	6.0	15.3	18.1	5.2	16.1	4.1	8.1	7.5	5.7	9.3	11.0	0.0	43.0	9.7	4.4	5.9	15.3	27.3	5.6	7.0	6.1	1.2	46.3	5.2	16.6	55.7	8.3	6.6	6.0	8.2	25.3	6.1	3.0	23.9	8.4	4.4	7.1	10.2	2.6	4.9	10.0	10.5	6.2	1.8	4.7	12.2	14.9	9.2	2.5	4.3	9.2	4.1	7.9	23.8	3.8	2.8	7.9	7.9	14.4	6.6	10.2	13.1	86.7	50.5	7.9	3.0	11.2	9.6	8.8	13.9	4.7
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA		6500	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	5.9	5.8	3.7	10.5	4.4	33.8	10.7	5.9	4.9	8.6	4.2	10.3	9.8	11.1	5.4	9.3	9.5	6.7	5.4	6.0	2.9	8.7	13.0	6.8	16.4	3.3	3.2	15.6	7.6	7.1	4.7	7.3	3.2	7.9	12.6	11.5	5.8	8.0	5.6	12.9	9.1	7.7	3.8	8.0	7.2	8.3	3.7	23.4	10.3	4.7	16.1	6.3	7.1	4.3	52.8	49.3	49.1	28.1	12.2	14.7	58.3	38.4	24.0	66.6	49.9	50.2	21.4	56.4	25.9	18.1	42.0	47.2	66.9	34.0	63.2	42.1	58.1	43.9	40.7	36.5	7.6	70.7	38.1	7.8	12.2	50.0	16.8	30.4	28.6	70.3	62.6	21.6	33.3	50.3	93.2	59.2	40.5	29.8	46.1	68.1	61.2	55.3	30.7	47.7	67.5	30.7	62.2	18.2	24.1	30.4	64.4	30.0	13.7	36.9	42.5	50.4	69.5	36.2	51.7	76.9	36.4	51.7	66.1	16.6	5.0	3.6	8.6	8.4	7.6	10.7	10.3	7.4	7.2	9.1	8.0	6.9	5.6	7.9	4.9	6.0	11.4	6.5	3.7	4.4	5.9	4.9	6.0	2.9	3.3	3.2	3.2	3.8	3.7	4.3	4.0	0.0	3.3	4.6	5.6	8.4	6.9	7.1	4.0	4.2	5.2	4.7	3.1	4.3	4.6	9.2	2.1	21.0	4.7	3.6	9.8	8.9	3.0	6.0	6.3	4.3	4.2	45.7	11.8	6.3	25.2	6.4	4.1	6.5	5.7	14.0	3.3	6.0	9.1	1.7	7.3	6.9	4.1	3.2	3.1	2.7	4.1	4.9	0.0	3.7	3.8	9.5	2.1	2.5	5.5	4.1	4.0	8.2	16.4	2.3	3.2	6.6	11.0	6.0	0.0	5.3	8.4	13.4	9.1	9.5	5.4	8.9	7.9	18.7	10.6	4.2
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.9"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 278.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.3;K-562: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm		NA	NA		48000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	1.7	2.3	1.3	1.1	1.7	26.9	2.8	2.1	3.4	2.2	1.8	1.8	1.2	2.0	4.4	2.4	2.0	1.2	3.5	1.4	1.6	2.5	2.5	1.5	3.1	1.8	1.6	2.9	3.6	3.9	2.8	1.6	1.7	3.1	1.4	3.6	4.7	1.4	5.8	7.6	1.4	1.4	1.6	2.4	2.5	12.2	1.7	4.9	3.3	3.5	3.2	2.3	1.9	2.2	3.6	5.5	1.0	3.5	3.4	6.2	0.0	1.9	2.9	3.1	3.1	4.4	3.8	5.8	3.8	1.6	7.3	5.2	3.8	3.0	3.3	8.7	3.3	41.3	5.2	1.6	4.3	3.8	4.2	2.8	5.5	4.0	3.6	2.8	3.1	17.1	78.3	4.5	4.9	2.4	12.4	16.4	4.4	1.6	5.2	6.0	0.7	2.6	1.1	2.1	5.3	3.8	5.4	2.4	0.0	0.3	2.8	2.0	1.6	3.9	3.1	2.9	3.4	3.9	10.1	4.7	3.4	4.5	2.1	0.0	0.7	0.4	3.6	0.9	9.6	3.9	8.7	6.2	1.6	3.3	12.7	7.5	0.0	6.1	0.9	1.9	5.4	2.7	1.3	1.7	2.1	3.4	1.4	1.6	1.8	1.6	1.7	1.6	1.7	2.2	2.0	12.8	3.3	1.6	2.8	3.2	4.5	6.0	3.4	2.1	2.3	3.4	7.8	0.0	5.5	1.8	0.0	3.5	4.2	0.5	1.9	2.4	18.2	2.3	2.4	1.4	0.0	278.7	1.6	1.8	12.1	3.2	2.0	1.8	3.8	2.0	2.9	2.1	3.8	1.7	1.9	1.1	14.2	1.6	0.8	8.5	1.8	1.2	0.0	2.8	2.3	3.8	3.1	0.0	1.7	1.7	0.3	1.2	1.0	2.5	0.9	2.9	5.3	1.9	6.6	2.8	2.7	37.2	14.3	4.5	6.8	2.1	4.6	2.5	1.2	2.5
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 119.5;Karpas-707: 112.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	9.9	7.1	23.9	17.7	59.5	41.4	12.2	49.2	38.0	11.9	11.6	26.7	28.1	9.6	8.8	35.9	9.3	19.4	8.2	24.3	36.4	17.7	48.3	12.6	17.6	74.2	53.0	8.5	18.8	12.1	6.8	11.9	71.2	18.3	23.2	21.1	13.1	12.7	15.8	7.5	22.8	13.3	48.6	19.2	23.3	26.6	52.2	26.0	39.0	13.1	29.4	20.3	16.2	93.8	22.9	43.4	10.7	15.0	21.6	28.1	6.1	15.6	25.8	15.5	18.7	15.4	50.5	7.0	19.4	21.4	33.0	32.2	18.4	30.8	22.4	119.5	11.2	40.5	11.0	38.6	18.0	20.2	20.0	19.0	18.8	23.7	46.9	22.6	15.6	21.2	18.2	112.2	16.0	8.7	4.9	19.4	15.2	51.1	24.9	17.3	18.7	43.2	22.8	48.6	12.0	15.8	8.9	10.3	9.1	24.4	15.9	27.7	29.7	8.6	14.9	8.7	24.1	41.4	33.0	9.4	36.4	15.8	7.4	28.6	16.2	33.7	16.8	9.3	20.6	7.8	18.5	16.3	10.8	6.9	16.0	14.5	55.3	14.4	9.9	1.3	29.6	15.5	23.9	59.5	49.2	38.0	24.3	36.4	74.2	53.0	71.2	48.6	52.2	93.8	6.5	41.7	27.4	0.0	12.6	6.0	11.9	7.4	5.2	10.6	9.9	3.8	1.3	20.0	17.3	0.0	14.6	9.4	12.1	33.7	1.9	8.4	41.0	13.0	6.8	6.6	15.0	23.8	0.0	15.1	1.7	9.3	23.0	18.1	25.3	5.4	9.3	35.2	7.2	6.7	0.0	26.4	6.1	16.3	16.9	109.1	3.1	16.1	1.8	0.0	22.6	20.8	25.7	0.0	0.0	16.8	19.3	4.5	12.9	28.1	16.7	20.4	11.7	34.9	6.6	15.2	5.7	15.9	10.8	16.2	6.1	5.1	23.7	3.1	18.9	39.5
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385526-76394517	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	11.6	20.6	18.0	14.6	18.4	25.0	11.7	12.6	21.1	11.7	12.5	30.8	33.1	12.8	18.2	12.9	13.6	19.9	16.3	20.6	27.2	27.0	29.2	12.4	11.6	16.9	18.4	11.7	16.4	23.8	12.0	13.2	27.0	13.0	22.9	14.7	11.0	9.9	14.9	5.1	28.2	11.9	14.2	10.2	29.0	16.7	21.6	12.0	19.7	18.7	11.2	13.9	5.9	13.5	21.9	23.2	13.9	18.1	20.5	20.3	41.8	25.2	18.6	17.8	13.9	8.2	13.3	35.3	28.7	18.2	32.3	22.9	19.3	16.5	35.3	10.4	18.0	11.2	30.4	26.2	36.7	37.9	25.6	13.5	29.3	21.4	23.2	19.9	58.3	30.4	30.6	28.7	36.1	20.8	49.3	13.3	18.1	51.2	22.7	26.7	18.3	8.9	82.0	10.6	35.0	12.7	26.9	37.2	22.9	18.1	9.4	20.2	35.9	18.5	33.3	40.1	35.6	30.7	32.3	12.4	30.7	33.3	25.9	5.2	9.8	3.6	5.0	19.9	7.5	5.8	7.3	6.0	11.8	4.4	7.0	6.7	1.4	8.5	21.1	4.3	7.4	9.8	18.0	18.4	12.6	21.1	20.6	27.2	16.9	18.4	27.0	14.2	21.6	13.5	27.3	16.0	9.2	5.9	22.9	45.4	23.8	15.3	22.2	50.4	24.5	20.6	37.9	34.3	20.1	42.3	20.9	54.1	18.4	158.8	60.7	64.9	191.7	37.8	18.5	46.2	28.2	48.8	18.0	189.3	352.0	33.5	33.1	42.3	12.0	18.0	124.2	40.9	33.2	11.8	19.3	23.1	40.7	57.6	26.6	118.1	22.1	29.9	30.2	10.3	25.2	44.7	9.2	7.1	6.5	220.6	68.3	65.1	12.7	33.6	79.9	142.8	27.7	28.7	0.0	23.0	21.7	91.8	64.1	18.8	40.5	123.5	23.1	18.8	33.7	22.6
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 94.7"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	3.4	1.1	3.2	2.2	3.8	0.0	1.8	5.7	3.2	10.2	5.4	15.2	13.9	1.7	0.4	0.6	2.9	0.6	0.7	2.7	3.4	2.4	0.1	1.2	0.2	19.1	4.2	2.9	0.3	0.3	2.1	0.6	19.4	4.3	10.4	0.3	2.2	0.3	5.5	1.3	15.2	0.5	3.9	0.1	94.7	0.2	3.7	0.2	0.1	3.2	0.1	0.5	1.3	3.4	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.8	5.7	3.2	2.7	3.4	19.1	4.2	19.4	3.9	3.7	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HHSteC: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		1100000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	28.3	24.3	9.9	3.8	9.7	10.2	24.6	8.5	11.8	25.5	7.8	26.5	11.1	25.3	1.6	24.1	23.0	10.9	19.5	8.7	9.0	22.9	78.5	18.7	5.4	10.4	9.3	29.7	42.6	11.1	20.0	5.9	9.5	23.5	3.2	1.4	22.0	6.9	45.4	27.1	16.7	7.7	9.0	14.9	27.7	23.2	9.6	4.6	19.8	10.5	2.7	24.0	18.6	9.7	20.3	19.2	5.6	19.1	13.9	11.8	24.4	18.5	10.1	8.2	6.2	11.6	13.7	4.5	13.0	29.1	17.4	10.8	3.9	15.8	1.5	6.0	19.7	6.7	4.4	48.5	69.3	2.4	14.2	22.5	9.9	14.7	24.9	16.5	15.8	15.2	8.5	16.9	6.6	24.1	15.1	6.5	5.5	13.5	20.1	10.2	7.0	10.6	9.5	11.8	9.7	24.9	7.1	10.7	54.7	6.2	32.1	13.7	6.1	13.1	17.9	12.7	10.2	22.9	4.5	5.0	16.8	4.4	11.7	1.0	1.9	2.0	1.7	0.5	0.6	1.0	1.1	1.6	1.4	1.2	1.1	0.6	0.7	0.2	0.7	1.1	2.5	0.6	9.9	9.7	8.5	11.8	8.7	9.0	10.4	9.3	9.5	9.0	9.6	9.7	24.3	6.4	12.4	30.7	7.6	9.7	11.9	8.3	6.8	26.9	33.3	35.4	12.8	18.6	5.6	23.9	25.0	5.5	14.2	20.9	7.9	7.8	3.7	14.9	24.4	12.1	11.4	5.7	20.7	15.1	3.3	27.2	18.8	19.0	1.3	52.5	21.8	47.1	9.6	11.8	20.3	14.0	12.2	15.2	6.3	13.3	21.8	14.7	10.6	16.9	6.2	29.8	3.1	20.6	13.5	12.4	16.3	19.9	4.9	15.9	14.0	31.3	6.8	27.8	0.0	28.0	19.4	14.4	6.2	9.0	10.2	3.7	10.4	32.8	13.5	8.7
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32205001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"brain: 10.2;prostate: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 17.6;Inhibitory neurons: 8.6"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.0	0.5	1.5	0.0	1.9	0.4	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	0.0	0.1	1.7	0.7	0.3	0.0	0.0	0.1	0.0	1.7	3.8	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	10.2	2.3	0.9	1.7	0.7	1.7	0.0	1.0	1.6	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.4;liver: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.1;Langerhans cells: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.1;monocytes: 9.7"	"Cell line enriched"	"Detected in some"	20	"U-2 OS: 68.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	68.4	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.4	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769118-55773420	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.3;monocytes: 3.5"	"Cell line enriched"	"Detected in some"	19	"U-2 OS: 40.2"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"		"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"		"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 15.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0"									"HPA059324, HPA066464"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130453	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	11.8	12.5	5.7	14.5	6.2	8.3	12.5	5.5	6.6	9.0	4.9	11.8	10.3	9.1	13.0	12.1	12.4	10.5	9.0	6.1	5.3	8.7	14.0	9.2	16.7	5.6	5.2	12.5	22.3	15.6	6.2	13.8	5.9	9.3	13.2	4.3	18.0	10.4	5.1	9.9	10.5	11.2	5.5	9.9	10.4	13.5	5.4	14.2	14.6	6.7	15.8	12.6	8.8	8.0	39.1	36.3	24.3	39.0	27.9	29.5	50.6	34.8	32.3	59.2	53.7	35.9	74.6	51.0	21.3	33.5	55.6	40.7	55.4	56.8	51.9	48.4	24.5	50.6	24.8	36.0	48.8	46.7	28.4	31.4	46.8	79.6	57.1	26.2	37.9	52.7	27.1	45.2	39.4	39.6	44.2	27.3	48.8	67.5	47.3	18.1	23.5	77.5	32.8	26.1	13.8	18.7	43.0	30.9	31.2	26.2	23.3	65.5	25.5	54.3	35.2	37.7	69.1	28.6	37.1	38.4	38.9	58.8	58.3	50.2	40.2	18.4	22.2	40.5	22.5	21.2	20.6	22.9	42.9	35.5	23.7	23.7	13.4	23.1	29.4	48.9	20.1	25.7	5.7	6.2	5.5	6.6	6.1	5.3	5.6	5.2	5.9	5.5	5.4	8.0	6.0	3.2	3.7	8.8	8.7	5.0	10.8	18.3	5.2	4.6	7.6	5.5	7.4	11.5	12.6	9.2	4.2	39.4	6.0	5.1	1.9	17.4	1.9	5.6	9.5	8.1	2.4	17.7	9.4	21.1	33.1	9.2	4.1	5.7	2.5	17.8	10.4	10.7	22.0	5.0	8.9	6.4	10.2	9.9	5.0	2.3	8.7	9.8	7.2	9.4	11.7	5.8	3.1	7.5	11.3	12.2	8.8	6.0	19.3	9.1	5.7	5.6	8.3	6.4	0.0	7.0	8.7	10.1	8.9	8.0	4.3	24.2	7.7	22.0	11.7	8.1
RFTN1	"FLJ23866, KIAA0084, MIG2, Raftlin"	ENSG00000131378	"Raftlin, lipid raft linker 1"	Q14699	3	16313574-16514026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 87.6;monocytes: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048725	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"HPA048725: AB_2680502"	"unprognostic (1.98e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.55e-3)"	"unprognostic (9.99e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.81e-1)"	57.2	11.2	15.1	44.7	18.3	13.3	33.2	13.6	22.7	28.2	15.8	15.2	9.3	36.6	4.9	14.5	26.0	15.4	44.7	18.3	20.2	18.4	24.8	46.9	117.0	21.7	14.9	30.4	4.7	9.0	7.4	51.0	16.1	16.4	14.1	11.4	11.3	10.3	25.5	17.1	22.8	31.3	13.9	45.5	11.8	7.0	15.2	73.2	53.4	26.6	117.4	26.2	14.5	17.5	0.1	2.9	5.3	0.0	151.7	75.7	7.7	38.8	65.9	19.3	15.6	21.5	1.0	122.9	18.6	71.2	4.3	0.6	0.1	51.4	25.5	177.5	9.0	19.8	4.9	0.3	78.6	14.7	10.8	111.3	3.4	60.7	19.0	67.5	40.5	19.8	0.5	0.4	47.0	6.6	31.3	5.0	3.5	0.0	1.4	29.6	60.8	15.0	8.0	0.1	0.1	132.6	1.3	1.3	7.2	7.4	0.2	12.2	59.9	47.3	23.0	47.8	16.8	0.4	0.5	82.5	22.0	38.6	19.2	56.0	19.6	13.2	35.3	46.4	18.1	16.3	27.2	37.6	33.6	32.0	18.4	27.8	1.2	80.1	81.7	25.8	60.4	38.3	15.1	18.3	13.6	22.7	18.3	20.2	21.7	14.9	16.1	13.9	15.2	17.5	37.9	22.4	40.0	8.1	51.2	6.5	0.3	2.3	0.0	3.2	0.7	1.5	14.3	5.7	6.9	0.0	0.0	6.2	61.1	0.1	0.0	7.2	38.0	2.6	51.8	34.4	1.2	10.3	87.6	0.9	1.1	32.4	3.1	2.0	24.7	2.1	36.0	7.2	10.5	0.0	16.5	0.0	0.0	17.6	63.6	12.2	18.6	27.0	10.6	19.7	143.8	37.2	64.9	3.0	2.4	0.9	0.1	8.6	43.2	0.6	0.0	0.4	3.3	3.2	0.0	28.2	35.2	2.8	2.4	0.8	5.1	2.5	39.5	12.6	0.3	0.4
RFTN2	"C2orf11, FLJ30574, Raftlin-2"	ENSG00000162944	"Raftlin family member 2"	Q52LD8	2	197568224-197676045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 70.9"	"Group enriched"	"Detected in many"	7	"Astrocytes: 152.8;Early spermatids: 125.0;Late spermatids: 351.7;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 320.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.8;ASC diff: 15.5;ASC TERT1: 8.7;HSkMC: 10.7;TIME: 6.4;WM-115: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035232, HPA043190"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA035232: AB_10601495, HPA043190: "	"unprognostic (1.15e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.77e-2)"	10.8	4.7	30.0	1.9	48.9	0.3	3.2	39.2	32.6	4.4	3.7	1.8	0.7	4.6	1.2	2.5	2.2	4.4	3.4	28.3	29.4	2.0	1.0	2.4	2.5	42.5	36.6	9.9	1.9	0.6	0.7	6.2	49.5	1.7	1.9	4.3	3.3	1.6	1.5	2.3	1.3	3.3	40.2	1.9	1.5	3.0	33.7	0.8	1.9	5.8	1.5	2.7	2.4	70.9	0.2	0.0	19.8	0.4	15.5	8.7	0.7	0.2	1.3	0.0	1.1	0.3	0.4	0.4	0.5	1.8	0.4	0.6	0.0	0.0	0.0	0.8	0.1	0.1	1.0	0.0	2.2	0.3	0.3	10.7	0.4	0.1	0.0	0.1	2.3	0.6	0.0	0.2	0.4	0.9	0.1	0.1	0.8	0.8	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.2	0.0	0.0	3.0	3.4	0.1	0.0	6.4	1.7	0.3	0.1	0.3	0.5	1.1	0.2	1.6	0.0	9.6	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.0	30.0	48.9	39.2	32.6	28.3	29.4	42.5	36.6	49.5	40.2	33.7	70.9	14.8	0.0	0.6	152.8	0.2	2.4	0.2	0.1	0.0	1.3	1.3	1.4	2.2	2.8	0.1	0.0	0.0	0.2	0.5	0.1	0.0	1.0	125.0	0.9	9.7	13.0	0.0	0.0	1.2	0.0	0.1	16.3	0.0	0.4	0.0	8.6	19.6	0.3	0.4	3.3	1.5	0.0	0.0	0.6	3.3	351.7	15.8	0.7	16.0	32.8	0.0	23.5	0.0	198.5	320.6	0.1	0.0	22.2	1.6	0.3	0.0	0.1	0.2	1.5	6.6	16.2	8.3	4.5	2.8	0.5	2.3	0.0	0.6	3.3	0.0	0.1
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961530-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 144.2;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	5.8	6.1	1.2	2.0	1.2	2.4	6.4	4.3	2.4	9.8	0.5	6.0	2.3	7.0	0.8	7.7	7.4	1.3	7.4	1.3	1.6	7.2	8.7	6.6	1.7	1.1	1.1	8.8	7.8	2.2	16.6	1.5	0.7	8.0	0.5	1.1	7.3	1.6	7.9	7.4	7.1	0.6	0.5	9.2	6.7	22.1	2.0	1.7	9.9	0.8	1.0	5.9	7.7	0.8	3.3	3.2	1.7	2.1	1.0	1.2	5.1	1.8	1.1	2.0	1.7	3.3	3.2	1.8	3.6	0.9	1.7	4.2	1.2	1.2	0.7	2.0	7.0	2.1	3.8	3.0	1.8	2.1	4.3	0.9	1.3	1.8	1.0	1.7	1.5	1.5	5.5	1.9	1.0	4.8	3.9	4.6	3.9	1.7	4.8	3.4	1.8	2.6	1.9	1.7	6.9	3.7	3.0	2.6	2.6	0.9	2.9	2.2	1.8	3.4	2.8	3.8	3.1	4.7	2.3	1.2	2.7	2.0	3.1	0.2	1.1	0.6	0.4	0.4	0.4	1.0	0.5	0.5	0.6	1.1	0.5	0.6	3.7	1.1	0.7	1.2	0.3	0.4	1.2	1.2	4.3	2.4	1.3	1.6	1.1	1.1	0.7	0.5	2.0	0.8	26.1	16.0	8.9	3.6	25.9	5.6	8.8	8.7	10.8	29.6	25.9	21.1	11.2	14.3	11.3	22.0	35.5	9.7	34.4	24.0	9.8	11.9	144.2	14.3	31.2	13.4	16.7	29.9	12.0	9.6	12.7	14.5	14.3	25.2	11.4	10.2	20.3	17.5	10.7	23.5	10.2	19.5	10.2	24.5	12.0	119.2	25.7	17.2	1.8	10.3	15.4	13.4	14.4	4.5	4.9	9.7	14.0	27.8	19.9	6.8	13.8	17.4	4.6	46.7	13.1	25.8	13.1	33.9	20.5	7.8	7.5	19.0	20.4	8.3	15.6	6.7
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 163.7;Late spermatids: 196.2;Respiratory ciliated cells: 103.8;Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"neutrophil: 23.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.4;SCLC-21H: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	9.8	2.0	9.0	2.2	8.0	9.5	6.9	12.1	8.1	5.9	35.2	19.4	3.3	16.2	1.2	8.0	20.8	5.0	7.8	10.4	8.7	2.2	1.7	10.5	1.5	15.5	21.2	6.7	4.4	1.8	10.4	0.9	12.7	6.0	1.8	1.3	3.2	2.3	2.0	11.2	8.8	5.3	15.4	2.9	7.0	56.9	12.7	4.2	3.5	0.6	1.6	9.6	6.3	11.7	5.3	3.9	6.2	12.3	3.2	1.9	3.9	3.3	4.3	2.6	4.1	1.8	6.0	5.7	3.4	4.1	5.7	7.6	1.6	6.2	3.6	1.4	0.9	8.8	4.0	1.8	3.6	4.1	19.4	2.2	5.3	5.8	3.0	3.1	4.0	7.7	6.0	0.2	2.6	2.6	7.7	5.5	1.7	6.8	2.6	2.1	3.9	0.6	3.3	9.5	24.2	3.4	3.0	2.4	1.7	0.6	4.2	4.3	6.1	1.1	5.6	4.3	3.3	8.2	2.9	3.3	3.2	14.4	2.3	0.0	2.7	1.1	0.1	0.5	0.0	0.4	0.5	0.3	2.1	0.2	0.5	0.6	23.6	0.7	1.6	0.0	0.1	0.8	9.0	8.0	12.1	8.1	10.4	8.7	15.5	21.2	12.7	15.4	12.7	11.7	12.0	25.6	31.6	84.2	2.6	26.4	33.7	11.5	12.5	3.6	8.5	10.9	7.6	15.7	26.0	3.7	2.1	5.9	2.0	4.1	3.9	5.6	163.7	69.0	9.5	13.2	13.8	6.5	5.2	1.8	8.8	23.0	2.6	4.7	46.2	14.7	12.1	2.8	7.0	0.0	5.5	4.4	2.0	6.2	17.3	196.2	8.1	13.0	7.2	8.4	5.1	5.7	5.2	3.0	1.8	3.5	1.6	4.1	2.4	7.9	4.6	2.1	103.8	3.5	26.3	49.2	11.4	113.2	13.5	6.3	22.0	5.6	5.6	2.6	5.1	22.0
RFX3		ENSG00000080298	"Regulatory factor X3"	P48380	9	3218297-3526004	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.3;choroid plexus: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 394.4;Early spermatids: 182.8;Excitatory neurons: 333.6;Inhibitory neurons: 208.8;Microglial cells: 188.3;Oligodendrocyte precursor cells: 256.9;Oligodendrocytes: 179.6;Respiratory ciliated cells: 150.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 26.4;HDLM-2: 16.2;SCLC-21H: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035689	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA035689: AB_10671224"	"prognostic favorable (1.47e-4)"	"unprognostic (8.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.52e-1)"	"unprognostic (8.89e-3)"	3.0	1.9	10.0	2.0	14.6	6.3	3.3	21.7	31.3	4.2	40.7	2.6	2.2	3.2	2.7	1.4	11.5	2.2	2.0	27.6	11.0	2.1	1.6	4.2	3.4	14.0	21.3	3.7	2.4	3.3	4.4	2.7	8.2	3.0	2.4	9.0	2.2	1.8	3.2	2.4	2.8	1.5	17.6	3.0	3.1	21.2	13.2	6.3	2.7	1.5	3.7	2.2	2.9	11.8	2.5	3.3	26.4	6.4	1.0	1.1	2.6	1.0	2.9	2.3	1.7	1.0	3.1	3.9	1.1	1.4	1.8	1.4	6.5	2.8	3.9	16.2	1.8	7.3	3.6	2.2	1.3	1.5	1.0	1.6	1.3	2.7	4.4	4.4	4.0	5.0	1.4	3.9	2.4	1.9	4.7	5.4	7.0	2.1	1.4	4.9	1.8	1.0	3.6	1.9	14.1	6.2	1.5	0.8	2.4	5.1	1.3	3.9	2.5	1.7	3.8	0.9	1.6	1.3	0.6	7.8	1.8	1.7	1.8	2.4	2.2	4.7	5.9	3.3	3.6	4.1	5.3	4.7	2.2	5.1	3.6	4.5	6.1	4.0	1.0	3.2	7.2	2.7	10.0	14.6	21.7	31.3	27.6	11.0	14.0	21.3	8.2	17.6	13.2	11.8	15.7	6.4	7.7	394.4	20.9	5.0	8.0	6.4	6.2	24.7	7.7	6.2	6.9	2.8	23.2	3.7	25.0	2.0	11.3	2.4	0.0	3.9	182.8	89.4	16.1	18.5	141.1	7.4	333.6	2.5	2.7	7.3	7.1	11.2	6.3	8.4	15.0	1.0	3.1	38.7	208.8	9.4	6.1	7.3	5.7	120.8	7.2	8.6	1.8	188.3	5.4	14.5	5.2	256.9	179.6	4.2	4.9	7.5	8.1	6.1	2.9	2.2	150.3	24.7	0.0	22.8	11.4	8.9	5.2	4.9	6.3	1.4	12.2	5.9	6.0	3.9
RFX4		ENSG00000111783	"Regulatory factor X4"	Q33E94	12	106583004-106762803	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.1;testis: 75.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 346.7;Spermatocytes: 98.7"	"Cancer enriched"	"Detected in single"	54	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"AF22: 48.0"	"Low region specificity"	"Detected in all"							HPA050527	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050527: AB_2681158"	"unprognostic (3.67e-1)"		"unprognostic (4.86e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.97e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.46e-2)"		0.1	0.0	32.0	0.0	36.0	0.0	0.0	32.8	27.6	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.8	54.1	0.0	0.0	0.0	0.0	52.7	46.7	0.0	0.1	0.0	9.9	0.0	40.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	75.0	38.8	0.0	0.1	0.0	0.0	0.0	0.0	34.0	0.0	0.3	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.0	36.0	32.8	27.6	28.8	54.1	52.7	46.7	40.2	40.5	38.8	34.0	0.0	0.0	0.0	346.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	41.8	0.0	0.1	0.2	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.4	0.0	0.0	0.0	0.0	29.2	2.1	0.0	0.0	7.5	0.1	0.1	0.0	27.6	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.1	98.7	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347326	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018519, HPA079241"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Vesicles	"HPA018519: AB_1856209, HPA079241: "	"unprognostic (1.17e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	18.4	25.6	13.3	43.3	13.7	24.0	14.9	17.8	13.2	18.2	11.7	22.7	31.6	22.0	13.1	18.3	18.4	23.4	18.3	12.3	16.8	18.3	13.1	27.9	67.7	17.1	17.6	10.1	9.6	22.1	18.1	12.4	18.5	20.4	28.1	14.6	16.0	25.1	17.0	13.1	26.1	31.8	15.4	50.7	19.6	15.5	15.7	50.5	23.7	23.8	71.8	26.5	11.4	13.3	37.7	41.8	57.6	32.8	27.6	24.0	12.6	17.8	30.0	43.6	57.7	13.7	50.9	145.2	63.9	21.5	42.6	59.5	24.9	34.4	31.9	177.4	39.7	54.8	89.4	23.0	17.7	48.9	59.4	25.2	18.8	28.8	13.2	35.7	39.9	92.0	26.8	88.3	33.8	34.2	78.7	36.2	41.9	30.5	21.2	97.1	32.3	80.1	42.0	49.1	20.4	60.0	35.7	55.0	52.8	69.2	51.6	114.3	39.9	23.8	25.1	11.8	33.7	110.9	118.2	168.6	37.8	26.4	31.3	5.6	22.6	11.5	17.4	28.2	15.3	47.9	13.9	17.4	47.4	53.3	10.9	12.2	3.1	31.4	30.8	25.1	28.5	21.5	13.3	13.7	17.8	13.2	12.3	16.8	17.1	17.6	18.5	15.4	15.7	13.3	8.4	9.6	7.5	4.9	32.0	6.6	12.5	11.4	14.2	7.6	9.4	6.5	5.1	8.6	12.1	7.3	0.0	8.8	16.9	3.8	9.8	15.7	8.4	7.5	6.3	9.9	4.2	16.6	3.2	9.2	3.4	6.1	5.6	12.8	24.1	9.4	10.8	7.3	12.4	1.7	7.0	5.1	10.2	18.5	15.7	17.9	5.0	13.3	5.4	8.4	40.8	7.2	21.6	3.0	2.4	8.6	2.7	9.8	9.5	14.1	11.2	10.7	7.4	2.7	6.6	5.3	5.7	15.5	7.5	14.2	6.1	3.4	13.7	15.7	7.3	14.6
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.5;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
RFX7	"FLJ12994, RFXDC2"	ENSG00000181827	"Regulatory factor X7"	Q2KHR2	15	56087280-56245082	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035462, HPA057957"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear membrane"		"HPA035462: AB_10602152, HPA057957: "	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	3.4	5.9	3.9	5.6	3.5	8.5	5.2	11.6	4.0	5.2	1.3	4.0	5.3	5.6	5.3	4.7	5.7	4.0	3.2	3.0	4.4	3.5	4.0	4.8	8.9	3.5	3.3	6.3	3.2	5.7	2.7	5.4	3.7	4.6	5.0	11.0	3.8	5.3	8.8	9.9	4.5	5.7	3.0	7.4	4.8	8.7	3.5	15.2	5.1	9.8	9.3	5.7	2.9	4.2	7.7	15.6	31.3	22.0	11.0	13.9	7.6	6.6	9.1	8.3	13.1	8.4	6.3	24.0	9.7	9.9	7.7	20.9	18.7	14.7	11.1	13.3	6.6	31.5	19.0	17.6	11.6	24.1	4.6	12.0	21.7	9.0	19.5	12.2	14.7	24.1	14.2	12.7	11.9	9.8	21.3	6.9	13.4	5.9	4.5	23.1	20.0	19.8	9.2	24.0	16.4	18.8	8.2	8.3	9.4	21.5	7.1	15.3	11.9	21.8	11.3	5.1	13.2	10.2	11.4	27.6	7.8	22.2	9.7	2.0	0.2	0.5	0.5	0.3	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.6	0.0	0.5	0.2	0.5	1.1	0.3	3.9	3.5	11.6	4.0	3.0	4.4	3.5	3.3	3.7	3.0	3.5	4.2	8.6	6.4	13.4	108.4	9.7	13.4	4.4	9.5	20.5	16.2	9.9	7.5	6.5	2.8	6.2	7.3	10.4	4.2	7.3	5.3	3.9	3.4	19.9	7.2	10.3	9.4	4.8	17.1	149.4	4.7	1.4	6.8	4.6	6.4	12.6	14.2	7.9	8.9	5.6	16.8	164.0	5.7	10.2	9.5	8.8	15.9	6.5	8.8	5.4	91.8	8.4	5.1	2.1	187.0	169.7	3.7	6.0	10.5	7.9	6.6	4.3	4.2	8.5	9.1	0.0	13.2	7.0	6.6	6.8	16.8	17.6	1.6	9.0	10.6	6.8	5.6
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA049157: AB_2680658, HPA053330: AB_2682114"	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	30.2	20.2	27.3	21.4	30.2	41.1	29.6	29.4	34.8	28.6	25.8	30.5	21.4	28.4	14.1	40.2	34.8	13.6	27.4	27.1	29.3	36.6	20.6	25.8	31.1	31.1	28.1	27.1	29.6	23.1	24.3	18.2	29.0	32.3	11.1	8.7	34.1	14.2	31.6	34.9	27.6	13.0	28.6	38.9	31.8	12.7	28.7	28.4	38.0	15.0	22.1	26.1	27.1	29.9	60.0	36.6	25.6	50.2	8.7	24.2	64.5	29.0	30.3	48.8	47.7	30.7	121.4	58.2	72.9	30.2	20.8	43.6	21.9	56.2	21.5	40.4	33.7	46.7	36.7	45.1	89.4	66.8	94.6	44.7	32.4	42.8	31.0	29.8	49.1	56.8	94.4	64.2	27.1	119.3	88.0	88.3	30.7	62.6	82.0	73.5	26.1	101.9	41.5	39.8	21.0	43.6	30.3	38.2	70.4	17.1	54.1	134.8	49.1	25.4	27.9	63.3	47.6	73.5	86.9	87.7	37.6	82.3	52.2	48.5	29.4	52.2	23.9	32.7	20.4	41.7	27.2	26.5	34.2	41.4	27.1	26.6	13.4	33.3	24.6	54.2	40.5	29.0	27.3	30.2	29.4	34.8	27.1	29.3	31.1	28.1	29.0	28.6	28.7	29.9	33.4	32.1	36.9	6.5	28.9	22.0	33.8	77.9	28.5	10.0	30.5	33.5	3.4	31.5	39.5	31.3	2.1	63.5	24.9	46.2	76.3	44.0	6.4	48.4	29.7	35.7	37.2	45.8	1.2	57.4	61.3	26.8	35.2	37.7	31.8	31.4	33.2	16.7	63.1	15.2	1.4	40.0	40.7	44.5	27.8	11.1	30.4	34.1	21.4	8.4	57.8	27.6	36.0	3.5	3.3	59.3	44.4	19.2	27.9	27.0	56.5	70.7	57.6	12.3	39.5	14.6	37.5	6.3	20.1	35.4	24.6	45.6	29.4	28.5	46.9	27.1
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 415.4;lung: 694.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 159.9;T-reg: 90.9"	"Lineage enriched"	"Detected in many"	15	"T-cells: 159.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		910000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	197.6	21.5	186.3	27.7	226.9	415.4	132.6	218.8	236.7	36.1	148.2	34.7	16.9	43.6	7.6	18.6	31.1	42.2	145.9	195.8	196.6	56.9	25.0	694.9	38.1	209.1	204.8	9.1	41.3	48.1	35.3	150.7	205.3	61.5	9.2	5.7	111.5	19.0	47.3	58.0	29.1	33.5	186.7	37.0	37.8	24.8	198.2	70.5	144.0	61.8	21.0	47.5	39.6	241.0	1.1	0.5	34.9	0.0	6.7	57.5	1.4	0.8	316.0	0.2	1.2	44.8	0.7	105.1	0.9	4.0	0.1	1.0	1.2	2.1	0.4	11.1	5.1	0.0	7.9	3.5	3.3	3.7	1.2	4.5	6.7	1.2	43.1	0.6	36.1	24.0	8.3	0.1	1.0	0.3	24.0	2.3	0.5	4.7	0.8	0.1	0.0	0.1	0.3	0.0	1.3	0.4	0.3	0.0	0.7	3.0	0.9	20.1	24.6	0.2	3.8	2.2	0.4	0.2	0.1	111.9	0.3	2.4	0.8	0.0	0.8	0.1	5.6	0.5	5.6	5.3	46.5	14.7	6.1	10.7	159.9	35.0	0.6	0.4	0.1	1.8	90.9	10.2	186.3	226.9	218.8	236.7	195.8	196.6	209.1	204.8	205.3	186.7	198.2	241.0	1286.2	246.8	39.8	57.5	131.8	86.5	676.2	15.2	14.2	1.0	269.9	314.7	25.8	1.5	37.5	3.7	2.1	6.4	249.2	3.0	35.2	0.6	42.3	103.0	47.2	474.6	84.8	322.7	2.5	0.0	9.3	205.1	65.2	69.0	48.9	0.3	31.8	2.5	349.1	0.0	1.2	22.1	14.2	32.0	590.1	13.2	8.1	315.9	193.9	36.5	6.4	1.5	4.1	51.8	115.3	0.3	4.5	2.2	371.2	1415.5	0.1	0.8	33.7	3.1	124.9	45.4	116.0	155.3	5.0	11.2	65.1	11.1	532.4	43.8	7.8	159.7
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928532	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;HSkMC: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	24.7	16.8	22.7	19.9	25.3	1.6	17.1	17.3	27.0	18.6	21.5	11.3	8.7	18.0	6.3	10.6	15.2	22.5	17.0	27.1	21.7	28.6	16.2	20.9	22.9	23.7	20.7	19.2	6.8	8.9	9.5	16.1	17.4	13.2	12.8	15.7	7.7	11.6	2.7	8.9	10.6	22.2	21.1	45.4	6.9	14.7	23.9	8.7	9.1	7.7	10.1	18.7	8.9	28.5	0.3	1.5	26.3	4.0	35.0	16.1	26.7	12.4	20.6	5.5	6.8	12.2	0.7	0.3	11.3	8.8	4.3	0.6	1.8	3.1	5.4	0.4	1.9	0.2	2.6	12.6	9.3	0.4	1.5	54.9	0.7	14.0	3.3	26.2	20.8	2.7	0.0	19.6	11.8	0.1	2.9	0.2	9.6	0.9	0.7	23.7	1.7	24.3	1.5	7.5	3.3	7.9	3.9	4.2	2.1	8.5	0.2	0.3	15.3	7.9	3.1	24.7	6.8	2.0	0.5	0.1	8.3	0.3	22.2	0.0	0.8	0.0	0.0	2.1	0.1	0.0	0.3	0.0	0.9	0.0	0.4	0.2	0.0	0.0	0.8	0.0	0.2	0.5	22.7	25.3	17.3	27.0	27.1	21.7	23.7	20.7	17.4	21.1	23.9	28.5	9.4	9.6	12.3	133.5	1.6	8.2	2.2	2.5	5.2	5.1	6.7	4.6	8.7	5.7	9.0	5.5	0.0	5.1	0.6	2.6	5.9	4.0	13.8	7.9	23.2	19.7	0.0	0.4	176.1	0.9	2.6	22.0	3.6	24.1	3.8	11.0	41.4	2.6	43.3	8.4	141.8	0.8	4.1	109.1	50.4	17.6	13.1	43.7	5.4	76.8	1.7	23.0	0.0	38.7	184.3	1.0	0.1	20.7	0.1	3.5	2.8	30.1	14.2	2.0	26.3	1.2	9.7	4.0	2.5	5.8	4.7	5.2	2.2	13.1	0.6	2.9
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33298942	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	10.4	8.7	2.6	0.6	2.8	2.3	9.1	2.7	1.6	13.0	8.9	10.0	2.2	11.0	0.0	5.4	12.5	2.0	8.9	2.1	3.7	8.9	2.5	11.4	0.8	6.0	3.0	12.9	6.9	2.7	20.7	5.6	2.5	9.5	0.6	0.1	7.5	3.0	18.5	5.7	8.0	4.0	2.5	24.2	9.9	5.4	4.0	1.0	16.0	8.5	0.2	9.3	7.4	2.2	15.7	2.8	0.2	1.0	2.1	7.2	0.0	1.5	6.0	2.4	1.5	0.2	2.5	2.7	14.0	2.8	5.4	0.3	0.6	5.8	1.4	0.9	0.6	6.5	0.0	2.8	12.9	1.8	5.3	5.4	6.0	5.0	3.6	2.6	19.0	0.0	4.0	0.1	2.4	0.0	1.9	7.9	1.6	1.0	9.7	4.4	0.4	4.1	4.8	3.5	2.9	11.8	0.1	0.0	20.4	0.0	0.0	4.9	22.6	5.1	5.1	3.0	14.8	2.8	1.9	1.6	3.4	4.1	10.4	4.3	4.2	8.8	2.0	3.1	1.7	1.6	1.3	1.5	3.3	2.1	0.7	1.1	9.6	2.4	1.1	0.4	1.3	2.8	2.6	2.8	2.7	1.6	2.1	3.7	6.0	3.0	2.5	2.5	4.0	2.2	75.5	16.0	41.5	52.2	20.6	28.4	36.5	30.3	37.0	30.4	58.8	40.4	28.7	20.0	38.6	22.0	22.9	30.4	18.4	8.4	13.7	21.2	5.1	19.9	13.6	60.8	28.6	7.8	13.0	14.5	39.0	20.1	16.3	21.1	11.4	21.4	75.7	10.7	32.3	32.0	18.2	10.8	22.4	27.0	23.4	17.4	16.8	23.0	17.8	30.9	13.4	22.5	19.6	17.6	11.1	22.4	25.5	14.7	7.8	30.5	5.6	11.7	39.9	30.9	26.3	20.4	26.9	26.2	18.9	20.0	24.3	102.2	16.5	28.3	10.0	39.2
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419328	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.1;parathyroid gland: 45.9;thyroid gland: 64.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Collecting duct cells: 51.5;Gastric mucus-secreting cells: 48.4;Sertoli cells: 39.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CACO-2: 10.4;RT4: 22.0;SK-BR-3: 9.7;T-47d: 15.9"	"Region enriched"	"Detected in many"	6	"cerebellum: 9.0"	"Low region specificity"	"Detected in many"			"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	7.3	11.5	1.8	0.7	1.6	0.0	7.4	1.9	2.5	13.3	6.9	2.9	1.4	4.8	9.5	1.1	9.5	2.1	9.2	2.2	2.2	41.1	10.6	8.9	0.6	2.7	2.4	2.5	21.0	45.9	15.4	5.6	2.8	6.5	1.3	0.8	5.9	9.4	2.0	1.3	1.8	0.8	1.7	8.2	13.8	0.6	2.9	0.2	64.9	0.6	0.3	5.3	5.7	2.3	0.0	0.6	0.0	0.1	1.1	0.2	17.7	1.1	1.4	0.6	2.0	10.4	7.4	0.0	6.5	1.3	2.6	4.6	0.0	0.0	0.1	0.0	0.0	0.1	4.2	3.3	2.7	0.0	0.0	0.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.9	1.4	0.0	0.7	2.2	6.3	22.0	1.0	5.2	0.2	9.7	3.3	3.7	15.9	0.0	0.0	3.3	0.0	2.5	0.9	0.0	0.6	1.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.9	2.5	2.2	2.2	2.7	2.4	2.8	1.7	2.9	2.3	3.1	19.2	21.0	32.3	1.1	0.1	2.1	0.4	1.8	0.3	3.3	4.6	4.6	12.8	12.4	51.5	0.0	12.9	0.0	2.2	11.7	8.6	0.0	14.8	9.6	5.8	10.3	0.0	0.5	4.2	11.9	4.1	48.4	18.4	1.3	3.1	26.0	5.8	3.0	0.0	0.6	7.7	2.0	7.4	0.3	0.2	3.7	1.5	5.4	4.7	0.0	16.9	0.0	1.5	0.5	5.7	5.3	0.4	0.6	1.4	0.0	4.6	1.7	0.6	39.5	9.9	18.7	0.6	1.7	0.0	0.0	12.0	0.2	0.8	2.4	2.0
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 164.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 23.8;Early spermatids: 18.1;NK-cells: 52.5;T-cells: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 393.6;neutrophil: 516.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 516.3"	"Group enriched"	"Detected in many"	5	"MOLT-4: 26.3;U-937: 61.0"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	3.8	3.1	0.1	7.6	0.2	164.4	0.5	2.0	0.8	0.3	0.3	1.2	4.1	3.1	0.0	1.9	0.9	4.6	2.8	0.2	0.0	1.5	1.3	4.8	11.5	0.6	0.1	3.9	3.4	0.1	0.5	1.7	1.0	1.4	1.1	10.6	4.6	0.2	3.0	5.6	4.1	0.6	0.1	19.8	2.4	3.8	0.1	8.4	3.1	0.9	8.1	3.8	0.5	1.1	1.6	0.5	5.8	2.5	0.0	0.0	2.5	1.8	0.0	0.0	0.0	1.3	1.1	1.9	0.4	0.0	1.0	2.8	0.0	0.0	0.0	2.0	3.6	0.9	2.5	0.3	0.0	3.4	3.8	0.0	0.0	0.0	0.0	2.9	0.0	2.0	2.1	3.0	0.0	1.0	26.3	3.6	0.4	0.6	0.8	9.3	2.0	1.4	0.0	1.7	1.8	2.7	1.7	3.7	0.6	3.1	1.2	2.0	2.5	3.2	1.9	2.2	1.1	5.3	0.8	1.3	1.9	61.0	1.6	98.0	2.9	393.6	57.4	20.8	59.6	6.5	74.1	66.2	5.4	5.2	104.6	93.8	516.3	35.2	84.6	0.7	114.2	37.4	0.1	0.2	2.0	0.8	0.2	0.0	0.6	0.1	1.0	0.1	0.1	1.1	0.7	0.0	4.4	0.3	5.9	0.9	0.0	0.0	0.0	0.5	0.4	0.5	0.5	1.5	1.3	0.0	2.1	0.0	23.8	0.0	0.0	2.4	18.1	0.1	0.3	0.3	0.0	8.8	0.4	1.7	0.1	0.6	2.6	0.2	1.3	0.1	0.4	0.3	0.1	1.7	0.5	0.0	0.0	1.6	0.7	2.0	0.0	3.5	1.8	0.0	2.5	0.0	52.5	0.5	0.4	2.2	0.0	0.0	3.4	0.0	0.0	0.3	0.0	2.8	0.0	0.3	0.5	5.9	0.0	0.0	0.3	0.0	51.8	0.1	0.1	0.1
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758585	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favorable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	9.8	10.4	7.5	8.7	6.9	5.6	8.5	6.6	6.7	7.9	3.4	12.9	10.7	8.8	7.8	8.6	8.3	6.0	12.9	7.3	7.8	11.5	7.4	9.1	7.5	5.8	6.3	10.1	10.7	19.1	10.5	9.3	6.0	8.7	13.4	7.8	11.0	11.4	17.3	9.4	11.6	9.8	5.6	7.4	10.3	6.4	8.0	8.9	12.2	18.6	9.6	8.0	6.5	5.9	18.0	16.6	18.9	15.8	17.3	18.6	11.1	13.9	20.1	18.9	17.4	14.2	6.7	13.9	9.7	17.8	34.9	9.9	18.3	26.2	15.5	18.6	10.7	11.9	32.9	10.7	16.3	13.0	16.1	18.8	32.8	19.9	24.0	27.0	22.7	10.6	8.2	7.5	17.3	8.5	4.0	4.7	7.9	14.7	19.2	13.2	13.5	9.9	16.5	12.4	13.8	14.9	12.3	17.0	11.2	16.6	14.2	6.2	29.0	15.1	18.9	10.5	11.8	11.1	16.5	14.3	21.5	5.4	19.7	1.1	0.2	0.4	0.7	0.4	1.1	0.8	0.5	0.8	0.1	1.0	0.6	0.7	0.7	1.1	0.6	0.6	0.5	0.2	7.5	6.9	6.6	6.7	7.3	7.8	5.8	6.3	6.0	5.6	8.0	5.9	13.9	6.4	12.6	0.0	23.4	5.7	24.5	14.8	9.1	40.8	15.0	10.0	16.6	18.6	15.8	27.6	20.9	10.9	19.1	46.1	13.7	20.1	17.5	9.8	8.3	14.9	43.3	8.6	0.2	17.6	10.6	7.5	18.8	14.9	5.7	33.4	16.1	16.4	7.5	16.8	0.1	26.0	22.4	7.7	6.1	36.8	8.4	5.7	1.8	0.0	11.1	18.8	25.7	0.0	0.1	20.6	38.3	10.9	15.2	25.3	36.3	14.2	17.7	22.3	6.6	11.8	9.3	16.6	6.1	8.1	5.3	10.3	16.4	7.1	28.9	28.8
RGPD1	RGP1	ENSG00000187627	"RANBP2 like and GRIP domain containing 1"	P0DJD0	2	86907953-87013976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 8.6;placenta: 6.8;testis: 15.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Early spermatids: 2.5;Excitatory neurons: 4.3;granulocytes: 3.8;Inhibitory neurons: 4.0;Microglial cells: 2.8;Oligodendrocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;MOLT-4: 10.7;NTERA-2: 3.1;RPMI-8226: 2.4;SuSa: 5.3"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (8.24e-2)"	"unprognostic (6.05e-2)"		"unprognostic (6.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.06e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.80e-1)"		"unprognostic (2.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.99e-2)"	0.1	0.1	0.2	0.1	0.2	0.0	0.1	2.0	0.4	8.6	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.2	1.5	0.3	0.1	1.6	0.3	1.5	6.8	1.2	0.1	0.0	2.1	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.3	15.4	0.6	0.9	0.2	0.0	0.5	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	10.7	0.2	3.1	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.7	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.0	0.4	0.1	0.6	1.5	0.3	1.2	0.1	0.6	0.3	0.1	0.0	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.4	4.3	0.0	0.0	0.8	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.5	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.2	0.8	0.0	0.0	0.3	1.0	0.0	0.0	0.0
RGPD2	"RANBP2L2, RGP2"	ENSG00000185304	"RANBP2 like and GRIP domain containing 2"	P0DJD1	2	87755960-87825952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.0;dendritic cells: 5.1;Early spermatids: 5.5;Excitatory neurons: 4.3;Late spermatids: 6.7;Plasma cells: 7.5;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	11	"T-cells: 9.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.0;JURKAT: 5.4;MOLT-4: 13.3;NTERA-2: 5.4;SuSa: 15.2;THP-1: 5.2"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (4.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.59e-1)"	1.8	2.8	0.8	1.3	0.7	8.9	1.4	2.6	1.4	10.5	1.6	1.7	2.0	1.4	0.4	0.9	3.2	0.4	1.2	0.6	0.6	1.2	9.6	2.6	2.2	1.7	0.8	2.6	7.9	0.3	5.8	9.5	2.0	1.7	0.7	3.4	1.3	0.7	1.0	1.2	3.7	0.5	0.4	3.2	2.7	16.6	1.0	5.6	1.8	0.3	2.5	0.8	1.6	0.7	0.0	0.0	0.6	0.0	0.0	0.0	11.0	0.5	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	2.6	0.2	0.0	0.1	0.0	5.4	4.0	0.3	0.0	0.4	13.3	0.0	5.4	2.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	2.7	4.5	0.1	0.0	15.2	0.0	5.2	0.1	0.8	0.1	0.0	0.0	2.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.3	0.6	2.1	0.4	0.0	0.8	1.0	0.2	0.3	0.1	0.0	0.0	9.6	0.3	0.8	0.7	2.6	1.4	0.6	0.6	1.7	0.8	2.0	0.4	1.0	0.7	0.9	0.0	1.1	1.0	4.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	7.0	0.0	0.0	0.0	0.0	0.4	5.1	0.2	0.0	0.1	5.5	1.7	2.3	0.7	0.0	0.0	4.3	0.2	0.6	0.9	0.5	0.7	0.0	0.2	0.4	0.3	0.1	0.0	3.4	0.0	0.0	0.0	0.4	6.7	0.0	1.7	0.0	1.9	0.0	0.0	0.0	1.5	2.2	0.1	0.0	0.0	7.5	0.1	0.0	0.1	0.8	1.7	0.0	1.0	0.8	2.5	0.6	0.0	0.0	1.0	4.5	0.1	0.0	0.0
RGPD3	RGP3	ENSG00000153165	"RANBP2 like and GRIP domain containing 3"	A6NKT7	2	106391290-106468413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 6.9"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 1.5;MOLT-4: 4.6;RPMI-8226: 1.4"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.34e-1)"	0.2	0.1	0.4	0.1	0.4	0.4	0.2	0.4	0.5	0.1	0.9	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	0.4	0.7	0.7	0.2	0.1	1.0	0.6	0.2	0.2	0.2	0.5	0.2	1.1	0.2	0.1	0.9	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.6	0.1	6.9	0.7	1.9	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.1	0.6	0.1	0.2	0.1	0.0	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.4	0.3	0.0	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.4	0.5	0.4	0.4	1.0	0.6	1.1	0.4	0.7	0.5	0.0	0.0	1.1	1.6	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.1	0.5	0.0	0.0	2.4	0.2	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.3	4.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.4	3.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RGPD4	"DKFZp686P0288, RGP4"	ENSG00000196862	"RANBP2 like and GRIP domain containing 4"	Q7Z3J3	2	107826892-107892544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 5.8;Early spermatids: 10.4;Late spermatids: 3.1;Spermatocytes: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (4.96e-2)"	"unprognostic (3.04e-1)"			"unprognostic (4.38e-1)"	"unprognostic (1.31e-1)"		"unprognostic (2.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.69e-2)"		0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.3	3.7	0.5	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.0	0.3	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RGPD5	"BS-63, DKFZp686I1842, RGP5"	ENSG00000015568	"RANBP2 like and GRIP domain containing 5"	Q99666	2	109792758-109857705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.50e-2)"				"unprognostic (1.55e-1)"			"unprognostic (3.49e-1)"		"unprognostic (2.23e-1)"		"unprognostic (4.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-3)"		"unprognostic (3.19e-1)"		10.2	8.3	12.0	5.8	16.4	13.8	10.3	5.9	21.9	8.1	8.1	8.2	7.4	10.4	17.5	5.4	7.6	7.2	8.9	16.5	14.7	7.3	6.8	10.3	6.0	3.5	3.4	13.0	13.5	14.7	8.2	11.1	4.3	12.3	7.2	22.3	7.0	9.6	6.5	11.6	7.4	7.4	2.7	6.4	7.0	41.2	12.6	3.8	14.4	9.7	5.3	7.5	3.9	14.0	24.3	7.8	26.0	19.5	7.7	8.0	1.2	19.3	16.1	13.8	11.2	20.9	7.8	0.6	12.4	11.7	14.6	8.0	14.3	7.0	17.3	3.7	6.4	18.5	4.1	10.2	8.8	1.5	3.1	8.5	9.5	13.3	14.2	14.5	9.4	7.6	8.8	5.4	10.7	4.5	4.0	0.6	12.7	3.0	9.9	4.3	14.4	0.1	10.4	13.7	31.9	4.5	10.0	1.5	14.0	16.5	0.5	5.4	15.6	14.3	21.1	1.0	14.1	12.2	0.5	0.6	11.7	0.2	4.6	5.4	2.0	2.5	1.9	1.0	3.6	1.7	1.5	2.1	1.4	4.2	2.0	2.1	5.5	2.0	1.2	2.5	1.9	0.6	12.0	16.4	5.9	21.9	16.5	14.7	3.5	3.4	4.3	2.7	12.6	14.0	12.9	3.2	11.8	0.0	9.0	3.4	5.0	0.8	2.8	17.7	2.5	1.4	13.8	0.0	3.7	12.9	16.7	2.4	15.9	1.7	0.0	1.7	4.1	12.3	12.0	7.4	5.3	0.0	7.3	1.0	1.8	7.4	5.1	18.6	0.0	9.4	4.2	0.9	1.8	3.3	4.5	1.4	0.0	2.9	6.5	1.7	2.5	6.6	1.8	1.0	0.9	3.8	0.0	0.0	0.2	1.5	1.7	1.2	10.7	5.5	1.7	0.4	2.6	20.3	0.0	9.7	7.8	4.1	2.9	1.2	3.3	4.4	12.4	1.6	1.0	7.3
RGPD6	RGP6	ENSG00000183054	"RANBP2 like and GRIP domain containing 6"	Q99666	2	110513802-110577222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 9.6;Alveolar cells type 2: 17.1;Club cells: 8.1;Excitatory neurons: 10.7;Inhibitory neurons: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;SCLC-21H: 10.5"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.11e-2)"				"unprognostic (6.38e-2)"			"unprognostic (1.18e-1)"		"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.14e-4)"		"unprognostic (2.04e-1)"		12.9	8.4	5.0	0.7	2.3	6.3	13.3	6.3	6.4	13.3	6.4	11.5	1.5	9.7	0.9	7.4	12.2	0.0	12.9	2.3	4.9	9.5	14.0	14.4	2.3	4.5	1.5	15.2	18.1	2.0	22.9	1.8	2.8	14.8	0.6	1.9	9.7	0.1	14.7	17.2	12.0	1.0	3.9	9.6	11.8	31.9	2.5	0.7	14.2	2.1	0.7	10.8	10.7	7.6	7.0	2.6	1.2	2.0	0.0	0.5	2.9	1.3	0.0	0.8	0.1	5.7	1.5	0.4	4.2	2.5	3.4	5.2	0.2	2.4	0.0	1.6	11.5	6.8	0.9	1.0	0.1	2.2	0.3	0.4	1.5	1.3	3.1	1.0	0.0	2.1	2.7	2.0	0.0	3.7	1.8	0.0	7.6	1.4	6.7	2.6	4.1	0.0	2.6	0.7	10.5	4.8	1.1	0.2	3.1	4.1	0.1	0.4	1.5	1.4	4.0	0.4	6.0	3.8	0.4	0.5	2.6	0.0	2.5	4.7	1.5	2.0	1.6	0.8	2.4	2.0	2.3	1.7	1.0	3.1	2.3	1.4	4.7	1.5	1.8	2.2	0.5	0.3	5.0	2.3	6.3	6.4	2.3	4.9	4.5	1.5	2.8	3.9	2.5	7.6	0.1	9.6	17.1	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.3	0.3	0.0	0.5	1.8	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2 like and GRIP domain containing 8"	O14715	2	112368369-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 16.2;hTEC/SVTERT24-B: 13.4"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	4.3	1.8	2.7	2.8	3.6	10.6	4.5	8.6	7.6	2.8	4.5	2.1	1.6	3.1	5.4	1.4	2.2	2.9	1.8	3.7	3.5	2.4	5.1	3.3	2.4	2.2	2.4	3.2	3.0	2.2	2.6	3.3	1.9	2.6	2.3	7.9	2.5	2.9	1.7	3.8	2.1	2.6	1.1	3.0	1.7	15.6	2.6	3.2	2.4	2.2	3.0	2.6	1.6	5.5	6.1	2.6	4.3	2.6	1.6	3.6	0.1	2.4	1.9	2.3	1.5	5.3	0.4	0.0	1.7	4.0	2.0	2.9	12.3	1.7	2.4	8.7	4.0	16.2	4.5	4.1	2.2	0.1	0.2	0.6	2.2	13.4	3.4	5.7	1.9	2.8	8.4	0.4	3.6	2.5	8.7	2.1	3.0	0.9	3.7	0.0	0.5	0.1	1.3	2.5	2.7	0.5	8.1	0.1	1.7	3.0	1.2	6.8	8.9	1.3	1.8	6.9	4.4	0.0	0.0	0.0	0.5	2.9	0.3	1.3	0.4	0.4	1.0	0.3	1.4	0.5	0.7	0.9	0.4	0.6	1.0	0.6	0.3	0.5	0.8	0.7	0.4	0.3	2.7	3.6	8.6	7.6	3.7	3.5	2.2	2.4	1.9	1.1	2.6	5.5	1.0	9.6	3.6	1.6	2.8	0.4	0.4	0.2	5.2	0.8	0.3	0.3	8.0	1.5	1.9	0.0	2.1	0.2	0.7	0.1	0.0	0.5	24.3	0.6	0.5	1.5	0.0	2.5	9.8	1.1	0.1	2.2	2.6	0.6	5.1	0.6	0.7	0.2	0.4	0.0	7.0	0.4	0.0	0.6	0.8	10.1	0.3	2.0	0.0	9.4	2.3	0.4	0.0	7.5	5.2	0.9	0.0	0.0	2.4	0.0	0.0	0.1	6.7	0.7	0.0	0.9	0.9	6.8	2.7	2.7	0.0	0.4	3.1	0.0	0.0	0.3
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575763-192580024	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 25.7;T-reg: 21.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.7;T-cells: 21.9"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 962.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 85.5"	HPA074572	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	34.7	88.2	18.2	170.3	17.4	151.6	57.9	22.1	77.4	50.7	42.2	75.4	24.7	19.2	5.2	68.3	22.8	112.8	31.4	14.6	43.7	19.9	59.9	78.9	142.9	39.1	21.7	14.3	19.1	25.6	40.0	22.2	27.9	50.7	112.7	26.6	56.0	13.8	2.9	17.9	72.7	44.9	29.3	74.6	36.6	8.5	25.3	154.2	23.9	5.1	90.7	127.7	39.3	46.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	4.3	0.0	0.0	2.8	4.6	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	220.6	0.0	0.0	0.4	5.6	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	962.6	4.1	3.5	0.0	0.1	0.2	0.0	0.0	25.7	0.8	0.1	1.9	0.0	5.1	4.5	0.7	0.0	0.4	3.7	0.1	0.7	0.1	4.9	21.9	0.7	18.2	17.4	22.1	77.4	14.6	43.7	39.1	21.7	27.9	29.3	25.3	46.7	10.8	12.8	103.2	0.0	170.6	49.2	6.9	0.3	5.7	0.7	11.7	18.7	1.2	4.3	13.2	0.0	0.0	2.1	148.8	1.4	0.0	1.4	1.8	1.7	2.0	32.7	4.8	16.4	0.0	2.8	2.8	15.4	47.4	2.5	1398.7	0.0	5.3	3.8	390.4	0.0	0.0	1.6	0.0	211.2	1133.6	7.4	3.1	860.4	250.8	7.5	333.9	0.9	2.1	0.0	0.0	0.2	3.5	0.7	902.4	3.7	1.3	1.2	11.3	1.9	19.7	2.0	8.5	0.4	1.2	3.5	40.2	6.0	748.2	0.2	4.0	8.3
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499817-119542719	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 222.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 474.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		840000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	25.1	20.6	20.0	59.3	20.2	74.5	40.7	22.3	30.4	63.9	22.3	114.3	34.2	38.5	15.8	51.5	28.5	38.3	13.4	20.7	24.5	18.8	11.4	28.1	119.0	28.6	24.5	22.5	7.0	6.9	13.8	45.6	28.9	43.2	49.7	2.6	41.0	20.3	31.5	22.9	58.3	42.8	26.1	48.7	30.0	4.9	26.1	222.9	33.0	11.6	96.5	50.3	45.8	37.2	165.2	31.2	2.4	294.7	41.4	262.6	25.9	74.9	118.1	45.3	73.5	9.8	38.7	66.8	38.1	60.9	45.7	35.4	44.3	48.2	123.8	32.0	42.8	183.1	8.9	24.2	63.1	40.0	474.0	100.7	63.1	88.3	84.4	159.4	88.2	65.4	47.6	58.5	55.0	79.2	221.9	134.8	13.5	21.2	71.1	43.8	0.3	26.1	24.7	40.4	10.8	9.3	14.4	192.6	285.3	36.3	35.1	71.7	108.3	25.4	21.9	36.1	67.8	2.7	46.0	27.0	7.6	166.5	11.4	184.8	116.0	1.4	77.9	151.4	82.9	36.0	169.6	134.9	224.3	21.7	397.5	303.3	52.5	44.3	130.4	133.2	202.3	372.5	20.0	20.2	22.3	30.4	20.7	24.5	28.6	24.5	28.9	26.1	26.1	37.2	10.4	0.0	13.1	2.6	60.3	36.8	25.7	104.5	27.9	0.2	68.9	96.6	1.1	1.5	39.7	1.8	0.0	14.0	70.1	7.1	60.7	0.8	2.1	89.8	25.1	12.7	18.7	156.6	0.2	6.4	34.8	68.6	11.2	53.6	291.2	101.2	13.2	1.5	528.1	0.0	1.8	85.7	32.6	297.2	358.3	5.1	50.1	529.3	94.3	67.5	294.5	1.8	50.4	0.5	0.2	9.9	10.0	9.4	32.1	88.8	3.3	5.2	24.6	0.8	13.1	14.4	31.8	0.3	9.3	39.6	28.1	10.1	164.7	3.5	19.3	41.4
RGS11		ENSG00000076344	"Regulator of G protein signaling 11"	O94810	16	268301-275980	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2;pituitary gland: 56.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Bipolar cells: 69.7;Cone photoreceptor cells: 120.9;Excitatory neurons: 31.9;Inhibitory neurons: 33.6;Oligodendrocytes: 28.0;Rod photoreceptor cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;ASC TERT1: 2.2;fHDF/TERT166: 2.0;HHSteC: 3.1;hTERT-RPE1: 2.4;SCLC-21H: 3.0;SH-SY5Y: 2.3;T-47d: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041692, HPA043039"	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA041692: AB_2677619, HPA043039: AB_2678282"	"unprognostic (8.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-1)"	14.7	4.5	13.4	1.0	14.8	0.0	8.4	21.8	40.2	8.8	7.5	21.7	7.1	4.2	0.3	7.4	4.5	0.9	22.3	13.4	11.2	5.4	2.4	9.0	0.4	15.4	14.2	0.8	16.8	4.4	56.4	2.6	15.3	19.2	0.7	8.9	3.8	2.7	2.2	2.5	6.9	1.1	10.2	3.4	15.0	0.8	12.8	0.0	4.2	1.1	0.0	9.2	8.8	14.4	0.0	0.0	0.0	0.0	2.1	2.2	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.3	1.2	0.0	0.5	0.0	2.5	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	21.8	40.2	13.4	11.2	15.4	14.2	15.3	10.2	12.8	14.4	1.8	0.0	0.0	31.0	0.1	0.1	0.2	0.1	0.6	69.7	1.0	0.6	7.5	1.5	0.0	0.0	120.9	0.1	0.3	0.9	0.0	0.1	0.0	1.9	5.2	1.8	10.3	0.0	31.9	1.0	0.2	8.6	3.1	3.3	0.0	0.4	6.1	0.0	0.2	10.1	33.6	0.4	2.0	0.0	1.1	0.0	0.9	0.2	1.8	4.7	0.6	3.3	0.0	18.1	28.0	0.4	7.1	1.9	0.0	0.5	5.8	0.0	0.0	67.5	0.0	1.5	7.2	0.5	1.5	0.3	0.6	0.8	0.3	0.1	1.4	0.1
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660311	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 520.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	39	"basophil: 6.8"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 6.8"	"Cell line enriched"	"Detected in some"	20	"Daudi: 47.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076656	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA076656: "	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	0.5	0.0	0.0	9.5	0.0	0.7	2.3	0.0	0.0	1.6	0.0	2.3	3.1	1.0	0.7	1.7	0.3	3.7	0.1	0.0	0.0	0.0	0.0	3.9	48.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.3	0.6	0.0	0.3	5.7	1.2	0.0	0.3	2.0	0.1	0.1	1.3	0.0	0.2	35.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	30.8	0.0	4.8	1.9	2.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	1.3	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	7.1	0.0	0.2	0.0	0.0	0.9	12.2	0.0	520.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.6	7.1	0.0	0.0	3.8	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	3.9	1.7	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	7.9	0.5	1.6	0.1
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604389	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132.2;thyroid gland: 103.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 535.4;Muller glia cells: 265.9;Smooth muscle cells: 581.5;Theca cells: 253.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 132.2"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 109.3;NB-4: 60.7;SCLC-21H: 109.6;U-266/70: 124.0;U-698: 162.8"	"Region enriched"	"Detected in all"	5	"thalamus: 79.9"	"Group enriched"	"Detected in many"	7	"midbrain: 76.5;pons: 68.5;thalamus: 124.2"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	39.6	10.4	22.7	11.7	10.0	4.8	7.8	9.6	9.9	2.7	16.5	13.1	2.8	3.3	4.8	6.2	12.1	16.5	9.2	7.5	47.0	15.4	13.1	26.7	17.9	17.5	71.3	4.0	7.8	5.7	50.4	12.1	13.2	4.8	5.3	60.4	6.4	6.3	6.0	5.6	6.8	12.0	12.1	14.3	8.8	1.0	132.2	8.6	103.6	8.9	6.6	38.3	2.9	17.8	0.8	0.1	6.4	0.0	1.0	0.2	48.6	0.2	1.7	0.0	0.1	0.1	0.3	109.3	0.5	0.0	0.0	0.5	11.9	1.0	0.1	12.5	8.8	11.5	1.2	0.0	1.8	18.4	9.5	2.5	17.8	0.0	0.7	0.0	0.0	3.9	0.5	18.6	0.0	12.3	0.6	60.7	34.2	1.0	3.5	0.2	35.1	26.2	0.1	5.1	109.6	11.5	0.2	9.1	0.2	6.4	3.6	14.6	0.1	0.3	2.4	3.1	5.5	124.0	6.1	162.8	0.6	11.8	5.8	2.6	0.3	0.6	0.3	0.4	0.6	4.7	4.3	0.5	0.5	2.2	1.9	0.6	1.2	2.6	0.9	9.7	2.9	1.1	22.7	10.0	9.6	9.9	7.5	47.0	17.5	71.3	13.2	12.1	132.2	17.8	80.8	134.6	185.5	6.2	48.3	82.3	10.0	3.8	37.5	535.4	25.8	94.5	25.7	0.0	18.7	9.2	18.8	8.5	28.7	11.2	0.0	1.6	0.4	21.4	41.5	181.8	50.5	20.4	0.1	2.4	201.9	103.7	17.3	30.5	71.8	0.5	18.9	2.6	19.1	32.0	8.3	12.1	16.2	2.8	116.7	0.0	0.3	18.4	81.8	0.0	11.9	265.9	0.0	0.0	0.7	2.9	4.7	0.4	64.3	12.4	1.1	0.8	2.6	46.9	65.7	47.3	581.5	0.2	2.1	37.0	63.1	34.5	33.5	253.5	6.4	9.7
RGS17	"RGS-17, RGSZ2"	ENSG00000091844	"Regulator of G protein signaling 17"	Q9UGC6	6	153004459-153131282	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 41.9;Excitatory neurons: 54.4;Inhibitory neurons: 57.2;Oligodendrocyte precursor cells: 62.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.9;hTERT-HME1: 7.0;LHCN-M2: 8.7;RH-30: 6.7;U-87 MG: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022276, HPA056493"	Approved		Approved	Vesicles		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022276: AB_10794628, HPA056493: AB_2683152"	"unprognostic (2.77e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.33e-2)"	"unprognostic (5.96e-12)"	"unprognostic (2.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	0.8	0.3	2.0	0.4	1.8	1.3	0.6	3.5	1.8	1.4	0.0	0.4	0.5	0.5	0.2	1.6	0.5	1.1	0.2	1.8	3.2	0.6	0.1	0.3	0.5	1.7	3.1	0.9	1.0	0.0	1.9	0.1	1.4	1.3	0.4	1.7	0.7	0.3	0.1	0.6	0.5	0.2	2.2	0.3	0.9	0.9	2.8	0.6	2.3	0.0	0.1	0.9	0.7	1.2	0.1	2.0	2.2	0.2	1.0	7.9	0.1	0.2	0.7	0.5	1.3	0.0	0.3	0.3	0.4	0.4	4.2	0.3	2.0	1.9	1.0	0.2	0.3	0.4	0.4	0.1	1.9	0.2	1.0	2.3	0.1	3.3	7.0	1.8	3.8	1.1	0.1	0.3	8.7	0.9	0.1	0.3	1.4	0.1	1.4	0.1	6.7	0.1	2.3	0.9	1.7	4.3	0.1	0.0	0.0	0.4	0.1	0.3	1.8	1.4	1.1	1.5	2.5	0.3	0.1	0.1	9.3	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.0	1.8	3.5	1.8	1.8	3.2	1.7	3.1	1.4	2.2	2.8	1.2	0.3	0.0	0.0	12.7	0.6	0.3	1.2	1.4	0.0	15.9	0.6	0.6	1.0	2.8	7.2	0.0	0.0	0.2	3.7	0.0	0.0	17.1	0.2	0.7	3.5	1.4	41.9	0.4	54.4	0.4	0.2	4.2	4.6	0.8	11.4	0.6	0.0	0.2	0.3	3.3	57.2	0.1	0.0	0.8	3.2	0.6	3.1	0.8	0.0	1.9	0.5	2.7	7.2	62.8	2.2	1.4	1.6	9.1	0.9	6.6	0.0	0.1	3.4	3.5	0.0	3.6	2.4	1.4	9.2	0.1	0.0	0.3	1.7	0.5	0.3	8.7
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158462-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.2;lymphoid tissue: 25.4"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 527.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 353.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 353.1"	"Group enriched"	"Detected in some"	5	"HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		340000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	4.3	2.3	0.7	14.1	0.6	13.2	2.3	0.9	0.7	2.4	0.9	2.4	2.9	1.0	0.5	1.9	1.3	5.3	0.8	0.6	1.2	1.0	5.3	4.1	8.4	1.5	1.0	0.8	0.8	0.4	0.3	2.2	1.5	1.1	2.9	0.6	0.7	1.0	0.9	0.4	5.8	2.9	1.3	25.4	1.9	0.4	0.8	4.2	0.8	3.1	4.4	4.8	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	39.9	0.0	195.5	50.7	353.1	0.8	66.7	6.8	0.1	0.8	1.3	51.0	0.2	0.1	0.2	164.8	0.6	82.1	12.0	0.0	94.4	0.7	0.6	0.9	0.7	0.6	1.2	1.5	1.0	1.5	1.3	0.8	1.6	0.3	6.4	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.0	1.8	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	16.0	0.0	0.0	0.0	0.8	0.0	0.0	24.7	0.0	5.7	1.1	7.3	0.0	0.0	0.0	0.0	124.9	27.3	0.8	0.3	527.4	0.0	15.9	128.3	0.1	28.8	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.3	1.5	0.3	13.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	7.6	0.0	0.1	0.0
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.2;lymphoid tissue: 77.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 97.8;dendritic cells: 82.0;Hofbauer cells: 135.0;Kupffer cells: 104.6;Macrophages: 101.6;monocytes: 86.3;NK-cells: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 154.2;NB-4: 128.1;THP-1: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	12.5	8.8	7.1	28.5	6.8	57.2	9.0	7.3	7.8	5.9	6.3	6.7	7.5	5.1	2.0	8.1	6.9	6.0	6.4	6.7	7.3	7.6	5.9	19.6	35.2	12.3	8.8	2.3	7.0	2.7	4.3	7.2	10.0	7.3	2.2	0.3	8.5	2.5	2.5	8.4	21.1	4.3	11.4	77.5	8.2	1.8	11.8	13.9	6.8	2.2	17.3	8.3	6.9	12.2	16.1	24.1	6.8	12.2	3.0	4.9	11.5	10.0	6.9	20.2	8.4	36.0	21.8	28.1	27.0	6.2	21.6	15.4	7.0	12.8	4.8	14.0	13.2	40.3	12.3	14.8	4.0	83.0	154.2	3.3	7.7	8.6	3.0	4.0	13.3	18.4	15.5	14.5	6.2	28.6	61.6	128.1	7.0	13.8	30.3	51.1	4.0	20.4	5.7	7.8	12.9	12.1	10.3	6.3	13.6	3.4	8.3	107.3	14.0	18.9	9.5	3.3	9.8	9.1	7.6	34.7	10.5	62.6	12.8	289.5	273.2	760.9	96.6	396.0	99.2	125.7	91.1	92.6	228.8	125.7	62.4	64.9	606.5	75.1	458.3	130.8	107.1	204.7	7.1	6.8	7.3	7.8	6.7	7.3	12.3	8.8	10.0	11.4	11.8	12.2	19.0	3.2	4.1	2.0	97.8	9.7	6.4	8.0	4.0	0.1	10.4	13.3	3.9	2.8	5.7	1.8	0.0	3.0	82.0	0.5	0.0	12.0	0.5	2.8	8.3	17.2	0.0	14.7	1.4	14.3	8.1	6.5	4.6	2.2	48.8	4.5	15.0	0.8	135.0	0.0	1.0	0.5	4.1	104.6	50.0	1.1	4.4	101.6	5.4	17.8	86.3	0.3	140.1	2.5	0.2	16.9	3.8	1.2	25.0	14.5	0.1	2.4	3.3	0.2	13.1	2.4	8.8	0.3	7.0	5.2	8.9	1.8	57.1	3.7	0.9	8.8
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851795-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.5;choroid plexus: 3.9;retina: 4.9"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 238.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.7;SK-MEL-30: 30.4;U-87 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA070193: AB_2732150"	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.1	0.0	8.5	0.0	12.5	0.0	0.1	6.6	11.3	0.8	3.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.2	6.3	0.0	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.1	1.2	5.0	0.0	0.0	4.9	0.3	0.0	0.0	2.6	0.0	0.0	5.4	0.0	0.0	0.1	7.3	0.0	1.3	0.0	0.2	0.0	1.0	7.8	14.6	10.1	19.3	0.3	0.7	2.3	0.0	7.9	4.6	6.7	4.0	0.0	8.8	0.0	0.4	2.2	27.7	10.6	0.4	12.8	4.5	0.0	1.5	2.5	1.5	1.7	3.1	0.0	0.9	0.4	8.1	5.5	16.0	14.9	2.6	0.0	0.7	0.0	11.3	0.0	0.0	0.4	0.3	2.1	4.0	0.0	0.6	0.0	12.9	0.9	12.0	1.1	0.6	0.0	30.4	2.8	0.0	0.1	8.5	1.7	0.0	14.4	5.9	2.4	0.0	0.0	28.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	12.5	6.6	11.3	8.2	6.3	5.4	5.1	5.0	5.4	7.3	7.8	0.2	0.0	0.0	238.6	0.1	2.0	0.5	10.9	0.6	1.3	0.2	0.0	0.8	0.0	2.7	0.0	31.3	0.7	0.0	0.1	0.0	0.6	0.5	4.2	1.0	0.2	0.0	0.0	3.2	0.4	0.8	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	6.0	0.0	4.1	0.0	0.0	0.0	0.3	0.1	5.4	9.4	0.0	5.5	0.0	5.0	0.7	1.3	0.0	0.0	0.0	5.1	0.0	0.0	2.6	13.7	0.0	0.1	0.5	0.1	1.3	0.4	0.4	0.7	0.1	0.0	0.0	0.6
RGS21		ENSG00000253148	"Regulator of G protein signaling 21"	Q2M5E4	1	192316992-192367285	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA052843	Uncertain					NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"			"HPA052843: AB_2681971"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932429-72566530	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 11.5;Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	4.7	0.2	1.1	0.6	2.2	1.4	4.0	0.6	8.6	4.9	0.0	1.0	0.3	1.4	2.6	0.4	2.2	1.2	11.2	3.5	2.8	2.6	0.1	0.9	0.1	19.2	16.0	1.2	0.2	8.1	1.7	3.0	20.2	0.4	1.0	1.7	0.8	1.4	1.1	0.9	0.8	1.3	5.4	0.9	0.4	10.6	6.4	0.3	5.7	0.8	0.5	0.7	0.9	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	40.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.3	1.2	1.1	2.2	0.6	8.6	3.5	2.8	19.2	16.0	20.2	5.4	6.4	3.4	5.8	0.0	0.0	97.3	0.2	0.3	0.0	0.0	0.0	2.2	2.1	2.4	22.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	173.5	2.8	0.9	2.6	0.0	5.3	652.7	0.2	0.1	3.1	0.0	7.1	0.0	0.4	0.0	0.0	0.2	0.0	256.1	0.0	0.0	0.0	0.0	298.0	1.8	8.3	0.0	44.0	5.1	0.0	0.0	36.2	8.9	0.0	0.0	7.5	0.2	0.0	0.0	0.4	0.0	0.4	13.1	0.4	18.6	2.3	1.3	0.2	0.1	0.8	0.5	0.1	0.0	0.7
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775514-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 28.1;retina: 12.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 288.3;Excitatory neurons: 1353.2;Inhibitory neurons: 1095.0;Oligodendrocyte precursor cells: 615.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 6.2;HaCaT: 5.3;hTERT-HME1: 7.2;RH-30: 6.4;SH-SY5Y: 5.6;U-2 OS: 5.9;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.0	8.0	11.6	0.0	13.5	0.0	0.1	18.9	28.1	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.0	15.9	8.6	2.4	0.4	0.1	0.3	2.5	3.8	0.4	0.5	0.2	2.8	0.0	6.8	0.1	0.1	12.8	0.0	0.5	0.0	0.1	0.1	0.0	2.6	0.2	2.9	5.3	6.4	0.0	0.0	0.0	0.2	0.0	0.0	13.9	0.9	0.0	0.0	0.0	0.2	0.7	0.0	2.5	4.8	6.2	0.4	0.0	0.0	0.0	0.3	3.3	3.4	5.3	0.0	0.0	3.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.5	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.3	0.3	0.2	0.0	6.4	0.0	0.0	0.0	5.3	5.6	0.3	0.2	0.2	0.2	0.0	0.0	2.6	0.0	5.9	0.3	7.2	0.0	4.1	0.0	0.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.6	13.5	18.9	28.1	15.9	8.6	2.5	3.8	6.8	2.6	6.4	13.9	0.0	0.0	0.0	288.3	2.8	0.0	0.1	0.0	0.0	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	2.3	0.0	3.5	0.2	7.2	0.0	1353.2	0.0	0.0	0.5	1.5	0.1	0.0	10.0	0.4	0.4	0.1	62.2	1095.0	0.4	0.0	0.0	0.3	4.1	0.0	0.1	0.0	29.0	0.0	1.0	0.0	615.8	86.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.7	6.3	10.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506015-64612319	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 122.5;Inhibitory neurons: 170.6;Oligodendrocyte precursor cells: 67.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HUVEC TERT2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: AB_2676591"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	1.9	3.2	3.2	0.5	12.2	0.0	0.5	1.0	26.0	4.0	0.0	0.6	0.9	2.3	3.7	1.7	7.8	1.7	2.6	7.2	1.2	2.0	1.0	1.4	0.3	0.2	3.3	2.4	0.2	0.1	0.8	0.0	0.0	5.3	0.7	4.8	1.8	7.4	0.1	0.3	1.0	1.4	0.0	0.7	0.8	0.8	10.2	0.0	0.3	1.0	0.1	0.9	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.2	1.0	26.0	7.2	1.2	0.2	3.3	0.0	0.0	10.2	5.0	0.4	0.0	0.0	5.5	0.1	0.0	0.1	0.1	0.6	6.5	0.7	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	5.1	4.6	0.0	2.7	122.5	0.0	0.0	0.8	0.0	4.7	0.0	0.1	23.2	0.1	0.0	0.0	170.6	0.0	0.0	0.3	0.0	1.9	7.2	0.1	0.0	12.2	0.0	3.6	0.0	67.8	6.4	0.0	0.0	13.9	0.0	0.1	0.0	0.2	2.2	2.1	6.6	0.1	13.2	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.2
RGS8	"MGC119067, MGC119068, MGC119069"	ENSG00000135824	"Regulator of G protein signaling 8"	P57771	1	182641816-182684576	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 82.5;retina: 34.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 65.6;Early spermatids: 11.7;Inhibitory neurons: 18.0;Late spermatids: 22.1;Theca cells: 14.0"	"Group enriched"	"Detected in some"	13	"glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;Daudi: 2.1;SCLC-21H: 15.9;U-698: 3.3"	"Region enhanced"	"Detected in all"		"cerebellum: 425.5"	"Low region specificity"	"Detected in many"			HPA076764	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA076764: AB_2732321"	"unprognostic (6.75e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"		"unprognostic (9.29e-3)"		"unprognostic (1.16e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.02e-1)"	0.1	1.1	16.4	0.0	43.5	0.0	0.0	13.6	14.9	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	22.3	0.0	0.0	0.0	0.1	27.1	31.7	0.4	0.0	0.0	1.4	0.0	27.3	0.0	0.0	34.4	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	2.9	82.5	0.0	6.7	0.0	0.3	0.0	0.0	3.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	43.5	13.6	14.9	3.6	22.3	27.1	31.7	27.3	0.7	82.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	18.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0"	"Group enriched"	"Detected in many"	42	"NK-cells: 4.0;T-cells: 9.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1"	"Region enriched"	"Detected in all"	9	"basal ganglia: 248.1"	"Region enriched"	"Detected in all"	10	"basal ganglia: 110.0"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	0.8	1.5	6.2	1.2	23.5	0.2	0.8	4.3	9.4	1.6	3.8	8.5	1.1	1.7	2.5	1.5	10.3	1.0	0.8	5.1	9.3	2.4	2.3	5.1	2.1	5.3	5.9	2.6	1.4	5.5	12.1	1.2	6.9	4.6	1.3	1.3	1.3	3.3	0.1	1.4	3.8	1.4	5.2	1.7	3.8	0.4	7.4	0.6	0.6	0.3	3.0	2.9	2.8	4.6	0.4	0.0	1.3	0.1	0.1	0.2	0.0	0.1	2.6	0.0	0.3	0.2	0.0	1.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	25.9	0.6	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.2	4.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.7	0.0	2.5	0.0	0.8	6.8	0.0	0.0	0.0	3.2	0.1	4.0	0.0	0.1	0.0	1.7	6.2	23.5	4.3	9.4	5.1	9.3	5.3	5.9	6.9	5.2	7.4	4.6	1.3	3.2	1.5	33.3	0.4	0.4	1.4	0.9	0.6	25.0	7.8	14.5	0.4	0.0	1.3	1.8	325.2	0.0	27.5	0.1	3.9	8.9	0.6	2.5	1.8	2.6	59.7	0.0	2.3	3.1	0.1	5.8	1.1	4.2	0.0	3.3	1.1	0.0	0.1	52.2	2.3	2.3	0.0	0.0	3.0	2.4	0.9	2.9	1.8	1.9	19.4	39.2	18.6	2.5	1.2	2.7	0.1	4.9	6.3	0.1	0.1	14.2	0.8	480.2	0.0	0.5	1.9	0.1	0.4	0.0	0.1	0.1	10.3	12.8	0.6	0.3
RGS9BP	"FLJ45744, PERRS, R9AP"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675848-32678300	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 28.9;retina: 17.4;skeletal muscle: 9.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.0;Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 75.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.3;HMC-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.0	0.1	0.8	0.0	0.7	0.0	0.0	0.8	0.8	0.0	28.9	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.3	3.3	0.9	0.3	0.0	0.3	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	17.4	0.1	0.1	9.0	0.1	0.0	0.0	0.5	0.0	0.1	0.4	1.5	0.1	0.0	3.2	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.1	6.3	0.1	0.0	0.1	0.1	1.6	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.8	0.1	0.2	0.0	1.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.3	0.0	0.2	0.3	0.1	0.1	0.3	0.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.8	0.8	3.3	0.9	1.1	1.4	0.9	0.5	1.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.0	0.4	0.4	4.6	0.0	0.0	1.8	56.3	0.3	0.6	0.5	0.0	0.0	5.1	0.2	0.1	0.7	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.8	0.7	0.0	0.2	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.9	0.0	75.4	0.0	0.4	0.2	0.5	0.4	0.0	0.0	0.0	0.1	1.1	0.4	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"bone marrow: 119.6"	"Cell type enriched"	"Detected in some"	170	"Erythroid cells: 494.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	202	"HEL: 506.0;K-562: 491.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				0.2	0.0	0.0	0.0	0.0	119.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.1	0.4	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.4	0.1	0.3	0.0	494.2	0.2	0.2	0.6	0.3	0.0	0.6	2.5	0.0	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.3	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	10.3	8.9	11.2	13.6	20.9	11.9	11.5	12.2	13.6	11.6	1.8	11.5	10.3	13.6	12.5	11.5	12.9	10.9	10.3	8.8	15.2	12.0	15.1	9.9	16.1	15.6	15.0	13.6	13.9	16.5	4.4	9.9	17.1	13.1	11.2	7.4	9.6	13.3	8.9	8.8	11.8	14.3	15.7	14.2	11.4	17.4	16.8	37.5	15.6	8.6	16.9	11.5	7.0	22.8	10.7	9.3	9.9	15.1	28.6	28.8	0.0	24.1	20.9	12.6	14.6	8.3	18.7	10.1	19.8	25.2	18.0	11.9	0.1	26.8	23.9	25.1	9.9	15.3	5.9	6.7	31.5	15.2	8.0	25.6	38.2	23.8	51.4	14.3	9.8	26.7	41.7	25.6	13.4	18.9	27.8	8.5	0.0	12.2	10.3	12.0	0.1	14.9	10.3	13.3	9.7	7.3	13.6	5.1	18.8	17.6	14.1	18.9	13.1	5.6	12.2	22.0	7.5	28.8	14.9	73.9	17.8	19.6	16.2	10.4	13.7	12.8	7.3	20.0	11.8	22.1	11.0	8.9	17.2	24.5	12.6	10.6	3.3	11.8	13.8	21.1	16.2	10.8	11.2	20.9	12.2	13.6	8.8	15.2	15.6	15.0	17.1	15.7	16.8	22.8	6.6	12.8	6.4	66.9	28.4	5.2	8.5	7.2	8.0	8.0	7.6	4.2	16.6	4.3	8.1	11.0	16.7	7.6	9.3	6.6	3.9	7.0	16.7	8.3	8.6	6.8	1.8	15.2	28.4	9.3	4.1	9.3	8.2	7.8	8.2	22.7	3.3	14.0	5.2	11.8	41.5	6.1	6.1	8.2	4.4	24.4	5.6	7.6	12.4	57.1	6.2	6.3	9.2	55.8	109.0	8.3	1.9	6.8	48.8	13.2	6.8	3.4	7.1	6.3	0.0	5.6	6.6	15.2	9.5	7.3	5.5	5.6	8.6	25.7	5.7	8.9
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 380.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 300.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 398.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	43.9	232.5	247.5	20.0	248.6	26.9	47.7	169.0	313.0	46.7	224.2	39.4	35.7	36.4	59.3	48.5	47.0	23.2	54.7	255.0	380.1	97.7	99.8	72.0	16.2	216.3	252.8	61.2	56.8	182.8	299.6	16.5	274.5	79.0	16.0	39.1	53.3	94.8	35.0	49.4	44.9	11.8	187.5	50.2	57.6	87.2	321.2	19.9	91.1	11.6	12.5	45.3	43.6	208.3	24.0	80.2	34.5	57.9	16.3	11.5	12.8	12.8	50.6	26.6	27.2	43.6	59.7	7.5	13.0	26.3	59.4	33.7	22.4	17.6	10.3	25.9	46.3	9.0	48.0	41.4	45.0	13.8	61.5	25.0	35.7	31.1	12.3	43.9	20.4	51.2	19.0	51.6	26.9	165.3	26.1	74.9	31.7	41.0	45.1	19.4	22.7	66.8	47.2	42.9	43.3	88.7	59.3	107.8	47.9	23.2	66.3	23.2	20.4	43.5	39.6	29.2	27.9	48.4	18.5	12.9	50.4	20.4	59.9	398.8	62.8	79.0	80.0	66.1	68.9	51.7	89.1	71.7	63.0	50.8	72.5	65.3	104.7	63.6	35.1	49.7	126.8	61.2	247.5	248.6	169.0	313.0	255.0	380.1	216.3	252.8	274.5	187.5	321.2	208.3	20.5	41.7	31.9	16.6	23.7	23.2	46.5	127.6	18.2	34.9	42.3	22.4	8.8	55.8	76.8	86.5	33.3	54.8	20.7	48.3	19.6	94.1	171.2	30.2	12.8	26.9	89.8	10.3	27.0	102.1	41.3	34.7	39.8	16.2	192.7	72.4	57.8	43.1	45.5	18.5	31.9	35.1	128.1	35.9	32.7	300.8	42.6	47.8	60.5	5.6	21.4	68.8	29.9	13.0	11.0	78.1	37.6	52.6	27.9	47.8	52.8	52.5	89.3	35.7	6.6	19.0	26.4	57.3	29.7	27.9	23.7	52.0	61.2	198.1	30.2	50.1
RHBDD3	"C22orf3, PTAG"	ENSG00000100263	"Rhomboid domain containing 3"	Q9Y3P4	22	29259872-29268209	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043979	Approved		Approved	Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Microtubules		"HPA043979: AB_10960539"	"unprognostic (9.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.67e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.11e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.42e-3)"	7.6	20.7	6.8	2.4	7.7	2.9	6.9	6.7	10.8	7.2	6.4	7.3	4.9	9.0	1.3	8.6	8.6	1.7	10.2	6.4	7.2	10.0	16.8	6.7	1.9	8.7	7.9	8.0	11.8	2.6	14.8	2.1	7.7	13.4	0.6	0.9	7.7	4.4	10.1	6.2	7.1	1.6	7.1	10.7	7.1	22.2	7.3	2.3	10.7	0.5	0.9	7.0	6.0	7.6	4.6	7.7	4.2	12.3	1.3	2.2	23.5	2.9	3.8	3.5	4.4	6.9	10.1	12.6	12.4	2.8	2.1	14.2	2.5	2.3	0.4	16.7	19.9	4.6	6.5	8.6	15.0	10.4	11.5	6.6	6.2	1.5	4.2	2.5	4.8	5.1	5.6	8.3	2.6	9.0	6.8	15.8	19.8	2.9	8.6	11.9	7.8	14.6	1.5	4.6	9.2	4.8	9.9	10.6	12.3	1.0	7.0	9.0	7.0	9.5	4.2	4.0	4.4	20.3	6.6	15.1	4.0	4.6	8.1	0.0	4.6	1.9	2.5	4.1	3.1	1.8	2.4	3.7	4.7	0.9	1.8	2.5	1.4	3.6	3.8	11.2	3.9	2.5	6.8	7.7	6.7	10.8	6.4	7.2	8.7	7.9	7.7	7.1	7.3	7.6	8.4	6.4	7.0	22.2	5.1	6.1	11.7	19.9	5.2	17.2	12.1	9.8	8.4	8.6	16.0	14.7	6.2	44.4	12.8	19.0	0.0	18.6	9.0	19.0	12.8	10.0	8.4	11.2	14.4	19.8	18.7	14.1	21.9	24.6	0.0	21.7	12.8	15.7	25.6	16.8	16.5	15.1	12.2	9.7	5.5	7.4	14.0	7.5	7.2	12.2	7.8	14.5	7.2	11.1	9.9	13.2	16.1	12.0	9.5	16.0	15.9	7.1	12.1	22.9	6.6	9.0	10.2	29.8	26.6	8.6	6.0	38.3	7.4	26.3	17.7	9.6
RHBDF2	"FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG"	ENSG00000129667	"Rhomboid 5 homolog 2"	Q6PJF5	17	76470891-76501790	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 58.4;Kupffer cells: 57.3;NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 75.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018080	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA018080: AB_2178634"	"unprognostic (1.19e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.11e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.79e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.96e-11)"	"unprognostic (5.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	18.3	10.1	9.4	31.2	8.6	29.7	13.6	11.7	11.0	8.8	11.6	9.0	6.5	7.4	1.6	23.9	10.1	10.3	10.3	9.7	12.1	10.9	6.3	24.8	27.6	26.6	17.2	8.0	19.5	3.1	5.3	9.7	22.4	9.1	4.4	2.9	11.6	2.6	13.5	29.1	26.6	6.4	20.9	42.2	10.5	3.0	30.0	6.5	12.3	3.1	21.3	11.0	15.7	28.8	38.3	43.3	1.3	10.7	0.4	1.1	30.1	8.6	26.9	6.7	9.1	13.3	45.0	41.5	28.6	10.9	39.0	29.9	7.3	40.8	6.2	7.1	13.6	2.8	3.5	21.8	25.6	1.8	5.9	4.5	20.2	18.1	20.7	15.4	20.3	5.9	4.3	18.3	4.6	30.7	4.3	4.7	6.7	25.7	26.1	10.3	0.4	75.3	17.8	14.0	9.2	12.6	9.9	28.7	38.7	8.5	24.7	11.4	32.4	0.6	14.4	0.7	11.0	44.3	22.6	33.7	24.3	11.2	27.1	6.3	13.4	4.3	8.0	13.1	5.5	12.7	2.1	5.8	6.5	7.4	1.5	3.6	10.2	4.9	12.2	10.0	1.1	8.8	9.4	8.6	11.7	11.0	9.7	12.1	26.6	17.2	22.4	20.9	30.0	28.8	22.3	6.4	6.9	2.3	58.4	17.6	15.3	35.0	8.0	4.2	4.7	5.5	3.3	18.6	19.2	3.7	2.1	1.0	47.1	2.0	0.0	21.3	0.5	4.2	0.8	15.3	1.8	1.3	0.6	9.8	2.2	4.7	7.7	6.6	0.0	15.4	7.9	3.4	37.6	0.0	0.5	4.1	6.1	57.3	42.7	0.7	0.9	48.8	10.6	38.4	40.1	1.1	64.9	1.0	0.1	14.2	4.8	0.4	36.5	20.4	1.9	1.8	16.2	1.4	6.6	3.6	3.2	0.7	7.1	9.9	29.3	1.6	22.3	2.8	7.8	20.4
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RHBDL2	FLJ20435	ENSG00000158315	"Rhomboid like 2"	Q9NX52	1	38885807-38941830	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 74.6;Club cells: 44.8;Distal enterocytes: 52.2;Ionocytes: 46.8;Oligodendrocytes: 53.9;Pancreatic endocrine cells: 53.0;Urothelial cells: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 12.7;CAPAN-2: 41.7;HaCaT: 21.7;RT4: 40.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043807	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA043807: AB_10961118"	"unprognostic (3.34e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.57e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.47e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.20e-2)"	2.2	0.4	4.1	1.7	8.8	0.4	2.0	5.6	7.1	4.3	0.3	18.0	1.3	0.6	0.2	24.4	1.1	3.4	7.7	4.0	4.9	0.9	0.4	1.0	0.8	10.0	9.5	0.3	0.6	0.3	1.3	1.1	7.3	1.8	18.0	1.1	7.8	0.5	0.5	16.6	0.8	1.1	4.1	0.4	15.7	7.3	7.4	0.7	0.7	0.0	7.1	9.7	12.8	11.4	12.7	4.3	0.4	0.2	0.2	1.2	1.2	0.7	0.1	0.9	0.1	0.9	41.7	0.3	3.0	6.3	4.2	21.7	0.0	7.1	0.6	0.3	0.2	0.2	2.9	2.5	0.5	0.1	0.5	0.9	1.0	6.0	0.1	4.0	1.0	0.4	0.0	0.4	0.9	0.0	0.1	0.3	0.2	1.3	1.2	0.2	0.2	0.0	0.0	40.4	0.4	0.3	5.0	11.4	0.4	0.6	5.6	0.4	0.9	4.4	0.5	0.3	0.3	0.4	0.5	0.5	4.1	0.8	0.2	1.5	0.6	0.4	0.2	0.4	0.1	0.7	0.2	0.1	0.7	0.3	0.2	0.2	1.7	0.3	0.2	0.7	0.3	0.3	4.1	8.8	5.6	7.1	4.0	4.9	10.0	9.5	7.3	4.1	7.4	11.4	1.3	0.0	0.5	11.1	0.7	17.7	8.0	74.6	5.2	2.7	3.9	2.4	0.4	5.7	44.8	3.7	0.0	0.4	0.2	52.2	0.0	12.4	3.9	4.7	3.4	1.4	2.4	0.0	19.0	15.8	0.3	2.1	27.5	8.4	4.5	1.6	1.8	0.0	0.2	1.7	21.9	17.3	46.8	0.0	2.7	1.0	0.6	0.4	1.8	4.7	0.6	1.3	0.0	10.6	53.9	53.0	22.3	0.0	0.2	13.4	0.2	0.3	33.2	1.8	6.6	1.2	4.0	0.3	0.1	19.0	28.4	0.7	0.5	0.2	30.2	49.9
RHBDL3	"RHBDL4, VRHO"	ENSG00000141314	"Rhomboid like 3"	P58872	17	32265832-32324659	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.0;heart muscle: 13.8;retina: 26.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 41.8;Excitatory neurons: 46.8;Horizontal cells: 102.6;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 34.2"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;AF22: 4.7;AN3-CA: 3.8;GAMG: 5.5;HDLM-2: 6.0;NTERA-2: 6.5;U-2 OS: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059607	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059607: AB_2684081"	"unprognostic (7.70e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.87e-2)"	0.4	5.1	9.4	0.4	10.6	0.1	0.4	14.1	23.0	2.2	3.4	0.8	0.2	1.6	0.7	0.5	2.3	0.2	13.8	13.6	9.6	0.6	0.0	0.3	0.1	14.2	19.0	2.2	0.5	0.8	2.9	0.2	15.9	1.6	0.5	26.1	0.3	3.0	0.1	0.3	0.4	0.7	12.1	0.1	0.7	2.0	11.6	0.2	0.3	0.1	0.2	2.3	1.8	14.8	0.0	4.6	4.7	3.8	0.7	0.0	0.1	0.2	0.5	1.4	1.7	0.0	0.0	0.0	0.2	0.5	5.5	0.0	1.2	0.0	0.3	6.0	1.5	0.8	3.1	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.2	0.0	0.3	0.5	0.0	0.3	0.1	0.1	0.0	6.5	0.0	0.0	0.8	0.0	0.0	0.0	2.6	0.1	1.3	0.6	0.1	0.1	1.5	0.3	0.0	0.0	0.0	4.4	0.2	2.2	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.6	14.1	23.0	13.6	9.6	14.2	19.0	15.9	12.1	11.6	14.8	0.6	0.0	0.0	41.8	0.0	0.4	0.5	0.0	0.0	12.1	0.8	0.6	7.4	0.0	0.0	0.0	6.2	1.5	0.1	0.0	0.0	0.1	3.2	0.3	0.2	0.7	0.0	0.0	46.8	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.4	0.0	0.4	102.6	15.2	0.4	0.0	0.3	0.3	2.4	0.9	0.1	0.0	4.7	0.0	7.4	0.0	75.9	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	34.2	0.0	0.1	0.5	0.1	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.6
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496589	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 4022.4;vagina: 1728.8"	"Cell type enriched"	"Detected in many"	21	"Squamous epithelial cells: 1544.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.8;hTCEpi: 2.0;RT4: 1.2"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 8.4"	"Low region specificity"	"Detected in some"			"HPA041874, HPA043317"	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	1.3	2.1	5.3	0.0	5.4	0.0	0.8	4.9	6.9	823.5	3.9	0.5	0.0	0.6	0.0	4022.4	0.7	0.7	1.4	5.1	4.9	117.4	3.4	0.3	0.0	4.8	4.9	0.8	3.2	0.0	4.3	0.0	4.8	3.4	0.0	2.5	593.6	0.8	1.0	14.6	0.9	0.3	5.1	0.6	3.5	1.3	5.0	0.8	0.5	0.0	461.7	3.7	1728.8	5.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.4	4.9	6.9	5.1	4.9	4.8	4.9	4.8	5.1	5.0	5.2	0.0	0.0	0.0	2.0	0.3	1.3	28.9	22.9	6.2	1.0	0.9	0.5	0.7	0.0	47.6	14.7	0.0	0.0	0.0	0.6	15.6	1.5	2.0	0.0	0.1	0.7	0.0	0.0	6.0	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.7	1.4	0.0	1.5	0.0	0.0	0.0	64.4	0.0	4.0	0.3	0.7	4.8	0.0	0.0	34.8	0.0	0.0	1.6	2.8	0.0	0.0	5.4	1.5	0.1	1544.7	17.8	0.0	0.3	0.0	0.2	70.5
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.8"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.4	0.5	1.0	15.8	0.1	1.4	0.7	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.1	0.1	0.2	0.7	0.3	0.1	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.1	1.9	2.4	0.0	3.8	2.0	0.3	0.0	0.0	0.6	0.2	0.5	0.5	0.1	0.3	0.0	0.1	0.1	0.1	1.2	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.4	1.0	1.4	0.7	0.4	0.1	0.3	0.1	0.2	0.0	0.5	1.2	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RHEB	RHEB2	ENSG00000106615	"Ras homolog, mTORC1 binding"	Q15382	7	151466012-151520120	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 724.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019436	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB019436: AB_2178777"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.08e-5)"	"unprognostic (9.37e-2)"	"unprognostic (4.76e-3)"	"unprognostic (9.76e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.15e-1)"	118.6	136.8	124.2	62.0	127.4	108.1	100.9	124.3	173.8	77.1	108.4	130.2	52.9	116.2	160.1	73.0	90.2	56.3	134.4	136.9	133.0	103.7	98.4	93.1	44.3	124.5	129.1	87.0	86.5	81.6	84.3	104.9	130.2	83.0	60.5	106.8	72.4	97.0	193.5	66.9	62.6	114.5	121.5	63.6	85.2	47.3	130.2	71.8	98.9	160.8	47.6	117.2	76.8	125.3	335.9	100.3	173.3	165.7	211.5	172.3	131.3	241.7	211.1	198.0	240.4	145.0	354.0	86.4	370.3	215.2	517.4	111.6	126.3	116.8	255.5	91.7	96.9	73.7	113.2	109.5	329.6	137.7	115.2	132.7	183.1	158.1	211.1	207.7	155.2	128.6	231.7	387.1	276.5	216.7	196.0	195.7	285.7	241.5	145.0	94.1	152.6	173.9	233.1	118.4	166.3	208.6	245.4	235.0	283.0	167.7	88.0	169.9	171.0	156.1	65.5	271.9	395.5	145.2	212.2	123.8	376.9	252.7	432.0	39.5	34.1	47.0	24.8	30.5	41.0	23.6	34.2	31.5	26.7	23.9	24.5	30.5	33.9	36.5	34.4	47.0	37.3	39.6	124.2	127.4	124.3	173.8	136.9	133.0	124.5	129.1	130.2	121.5	130.2	125.3	230.5	60.9	45.8	72.5	87.3	398.2	611.3	272.9	114.4	72.8	187.7	179.2	102.0	81.5	169.0	108.5	18.8	207.0	111.9	126.2	416.7	211.7	53.4	107.7	102.6	168.8	98.2	122.9	64.7	213.3	384.1	179.0	40.8	160.8	106.1	95.0	103.9	137.6	233.9	121.1	49.6	76.3	290.9	111.1	384.6	33.2	112.2	174.5	318.4	29.0	114.3	473.6	65.9	30.2	30.6	271.5	109.2	151.6	119.9	620.3	87.8	296.6	85.0	68.7	124.9	149.4	312.2	355.1	173.4	144.7	405.6	421.1	110.4	86.9	79.7	724.9
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064676-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.6;Granulosa cells: 12.2;NK-cells: 14.4;Plasma cells: 8.2;Respiratory ciliated cells: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 16.1;T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;U-266/84: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Centrosome"		"HPA053111: AB_2682047, HPA061001: AB_2684409"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	0.8	0.2	2.2	1.5	2.3	2.1	0.8	2.1	4.1	0.3	1.7	0.5	0.5	1.4	1.0	0.4	2.6	0.5	0.5	2.2	2.2	0.3	0.3	1.2	3.6	2.3	2.1	0.3	0.2	0.2	0.3	0.6	2.1	0.2	0.8	0.8	0.4	0.2	0.2	2.6	0.9	0.5	1.9	2.5	0.6	1.5	2.1	1.6	0.3	1.1	1.9	0.4	0.4	2.4	1.7	3.4	2.2	4.8	1.2	0.2	2.1	1.4	4.8	9.1	9.9	3.2	2.9	4.7	1.5	0.4	4.7	1.8	1.5	1.8	3.9	30.8	0.4	4.9	2.9	1.9	1.0	2.4	10.1	0.5	0.8	4.5	1.4	0.6	3.5	8.3	6.1	14.8	3.3	1.7	2.3	13.3	3.0	6.0	3.9	4.7	3.2	7.9	0.7	0.2	1.0	2.9	1.4	1.3	8.4	2.6	0.5	3.5	1.3	2.7	4.4	5.3	1.7	17.8	61.0	3.0	2.3	7.2	1.2	16.1	0.3	0.7	7.6	1.8	10.4	2.0	3.2	4.1	0.8	2.9	1.0	3.8	0.7	1.4	1.7	1.0	6.7	1.4	2.2	2.3	2.1	4.1	2.2	2.2	2.3	2.1	2.1	1.9	2.1	2.4	2.8	0.0	0.0	0.3	6.8	1.3	0.5	1.9	4.0	1.8	1.2	1.7	1.5	1.5	1.8	0.0	0.0	0.1	10.6	0.1	0.0	0.5	0.5	2.8	0.3	2.6	0.0	8.0	6.9	0.2	0.5	1.4	0.5	0.4	0.0	12.2	1.8	0.1	1.8	3.3	2.3	0.2	0.0	0.3	2.0	0.6	0.0	3.7	0.0	0.0	4.5	0.6	14.4	0.5	0.3	0.2	0.0	0.0	8.2	0.4	0.1	0.1	12.0	0.4	0.0	1.3	1.8	0.9	5.4	4.8	2.0	0.1	5.7	0.2	0.4	0.2
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528639-129535344	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5994	"retina: 4062.1"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 4509.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4062.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	369.9	0.0	0.0	0.6	0.0	0.0	0.0	454.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	218.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	590.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4509.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RHOA	"ARH12, ARHA, Rho12, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359139-49412998	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	452.4	315.0	234.6	357.9	258.6	473.4	360.0	257.1	274.1	310.4	237.4	351.9	274.6	293.8	298.6	362.6	269.2	267.1	269.6	220.8	271.2	286.9	274.5	430.9	396.3	282.9	245.8	297.2	225.3	269.4	164.3	396.8	287.2	244.5	369.3	113.3	238.0	315.6	331.0	281.3	281.0	416.9	259.3	329.1	292.1	154.1	257.5	387.7	326.3	298.5	454.9	358.2	273.6	292.5	470.4	406.1	500.9	512.7	569.9	858.9	370.8	930.1	735.7	790.3	722.4	347.6	527.4	721.8	251.6	1404.1	448.8	259.5	560.4	630.6	817.6	505.7	323.3	678.8	488.0	416.0	604.2	647.9	472.8	668.2	437.8	643.2	508.1	799.7	1038.0	391.9	361.1	437.9	967.5	254.3	717.3	739.0	441.4	548.2	497.1	325.5	451.4	610.5	701.9	559.6	167.7	387.3	599.0	464.5	495.4	499.4	301.7	819.6	972.1	558.4	483.2	737.2	725.7	388.0	775.6	754.8	567.9	691.6	678.3	716.9	1105.5	1160.5	480.1	1358.8	423.8	432.7	415.6	479.6	806.9	379.3	314.5	397.1	1282.7	440.9	1398.1	645.5	554.9	1884.8	234.6	258.6	257.1	274.1	220.8	271.2	282.9	245.8	287.2	259.3	257.5	292.5	502.8	387.8	265.2	20.5	374.6	270.9	260.0	236.1	251.6	47.1	239.4	223.1	141.1	178.7	220.9	180.3	6.2	355.8	373.1	447.2	340.4	339.5	48.2	174.2	243.7	413.8	234.4	319.3	26.1	347.8	709.8	386.2	313.9	201.0	257.3	141.6	312.7	173.2	760.0	82.4	27.0	344.9	191.2	771.9	495.8	55.6	335.2	683.7	327.3	52.5	710.0	219.9	389.3	24.6	51.4	398.0	354.6	407.7	375.7	334.1	341.3	350.8	201.1	40.8	276.1	354.1	450.1	264.4	253.6	390.8	279.6	525.2	359.5	299.1	347.7	371.4
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 50.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 77.7;Excitatory neurons: 33.3;Proximal enterocytes: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 85.7;hTCEpi: 73.6;RT4: 126.9"	"Low region specificity"	"Detected in all"							HPA060938	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	6.5	8.8	17.9	7.5	31.7	2.3	8.4	3.6	27.6	6.8	7.1	6.2	8.5	7.7	5.3	4.8	9.8	6.5	21.8	21.4	7.3	11.2	2.4	50.5	14.9	4.2	10.3	25.8	8.0	9.6	14.2	11.2	4.1	7.7	2.5	5.6	6.4	23.0	16.5	5.5	21.2	6.5	0.8	12.6	8.3	8.1	22.8	8.9	18.5	13.6	16.7	10.4	4.5	15.1	6.8	13.2	10.4	16.7	12.4	8.7	14.0	9.2	12.0	14.2	10.7	34.2	6.6	85.7	13.8	13.3	18.5	13.2	5.0	51.5	6.8	7.4	3.0	9.3	17.8	9.7	6.0	5.5	18.5	11.3	73.6	14.8	7.4	9.8	10.4	6.1	2.3	8.2	9.5	19.7	3.5	8.8	11.0	19.7	9.2	4.7	16.8	5.9	10.1	126.9	6.8	12.5	7.1	21.2	14.5	7.7	4.0	14.0	12.8	17.7	12.8	32.0	10.6	20.7	21.5	30.2	17.2	7.9	14.0	2.9	0.6	0.8	1.7	1.0	1.1	5.1	0.4	0.8	0.6	4.3	0.6	0.6	0.1	2.9	1.1	1.8	0.9	0.8	17.9	31.7	3.6	27.6	21.4	7.3	4.2	10.3	4.1	0.8	22.8	15.1	4.1	64.1	77.7	13.1	7.6	2.9	2.5	5.2	2.8	31.1	2.9	3.2	10.2	5.7	9.1	7.3	4.2	14.7	4.5	0.2	1.9	2.1	0.8	1.9	4.8	6.2	6.0	1.3	33.3	3.7	8.5	5.5	6.1	3.2	4.5	2.4	7.9	1.9	14.3	16.8	13.1	5.8	0.0	2.5	2.6	0.8	6.2	3.5	1.8	5.6	1.5	7.3	8.2	7.1	1.8	4.1	2.6	6.4	4.2	1.2	57.2	6.2	3.1	6.1	0.0	7.2	4.2	0.9	1.9	0.5	0.6	5.6	2.5	2.9	2.8	0.9
RHOC	"ARH9, ARHC"	ENSG00000155366	"Ras homolog family member C"	P08134	1	112701127-112707434	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1020.9;Pancreatic endocrine cells: 1304.7;Paneth cells: 945.4;Proximal enterocytes: 952.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 1396.1"	"Lineage enriched"	"Detected in all"	4	"monocytes: 1396.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 2444.5"									HPA051461	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA051461: AB_2681493"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (2.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.51e-3)"	265.2	201.7	183.2	122.7	184.1	20.8	239.2	177.4	207.7	204.7	169.7	297.2	293.2	254.7	312.7	105.1	200.5	185.9	333.8	176.1	209.5	304.7	144.7	278.8	55.3	209.2	192.0	189.1	120.1	643.1	110.0	226.9	194.8	232.1	250.5	87.6	149.3	282.7	85.8	165.7	311.4	253.0	192.8	231.6	150.2	93.9	204.6	88.8	160.8	119.9	50.5	218.8	179.8	180.3	774.3	314.4	178.1	203.7	334.3	571.7	204.7	672.2	825.1	476.1	402.8	253.8	236.1	10.6	281.8	1000.8	221.5	217.5	136.2	630.2	456.9	181.7	83.9	89.1	201.2	202.9	559.5	14.3	394.1	687.8	421.1	804.3	535.4	543.3	1286.4	108.3	180.5	157.1	876.7	410.2	38.7	72.4	49.5	300.7	567.0	65.7	208.7	34.8	572.1	212.8	8.3	79.6	346.2	218.5	436.6	348.5	482.0	66.6	1113.9	651.1	459.7	905.9	505.9	99.8	90.4	33.0	739.2	59.1	2444.5	1.7	68.8	1.8	216.7	805.0	144.6	49.5	41.6	87.5	244.1	65.9	10.1	65.9	18.2	346.9	1396.1	185.7	51.3	315.6	183.2	184.1	177.4	207.7	176.1	209.5	209.2	192.0	194.8	192.8	204.6	180.3	576.7	16.0	33.3	10.4	28.2	184.4	308.2	443.8	63.2	2.2	224.6	231.8	84.4	92.9	180.1	239.1	4.2	328.5	118.2	1020.9	164.4	755.7	13.2	73.0	132.3	424.6	84.9	21.0	0.2	839.7	495.0	181.4	62.2	102.4	62.7	75.5	335.2	50.3	162.4	6.7	0.2	248.7	166.8	92.7	290.7	39.2	150.1	146.3	245.5	11.2	299.1	550.3	289.4	11.1	1.1	1304.7	945.4	206.9	12.6	380.2	952.7	705.3	71.1	15.3	216.9	95.3	292.6	13.6	42.0	54.8	168.6	258.6	108.8	205.5	209.6	422.0
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	6.5	13.3	11.5	26.6	9.9	47.4	5.5	21.6	12.0	14.3	10.6	24.3	31.8	13.2	21.8	11.7	10.0	9.8	15.0	10.4	11.0	16.2	3.9	20.6	41.0	13.0	12.2	8.9	6.1	7.7	5.1	5.7	13.4	9.2	19.3	9.9	11.5	9.8	11.8	9.2	32.3	11.5	8.7	33.3	28.2	9.0	10.6	25.6	14.6	2.8	31.4	9.1	7.3	11.7	58.3	69.2	12.4	15.3	4.4	6.4	5.6	5.3	5.2	2.5	4.4	28.8	129.0	6.3	42.6	6.0	1.4	8.6	23.2	33.7	2.2	177.1	8.0	37.9	47.5	27.7	10.1	38.6	25.8	9.0	7.5	5.4	2.9	23.8	17.6	44.7	5.6	9.9	1.4	41.7	50.7	56.7	10.4	13.6	147.3	26.5	0.7	10.8	127.9	4.9	9.9	9.4	38.5	4.5	2.6	5.6	19.9	15.0	21.4	4.0	40.1	12.5	1.5	12.3	7.6	20.0	5.0	42.9	2.6	23.8	10.9	41.5	97.0	36.5	92.7	55.5	77.2	82.5	31.0	45.2	59.5	73.2	24.4	61.4	69.8	74.3	90.2	43.3	11.5	9.9	21.6	12.0	10.4	11.0	13.0	12.2	13.4	8.7	10.6	11.7	3.1	38.5	10.7	1.0	54.1	8.7	1.9	5.5	3.4	8.1	9.3	3.8	1.5	15.7	11.3	23.9	0.0	2.7	111.8	273.9	41.1	34.0	20.2	16.5	5.6	3.5	6.7	12.2	5.3	55.3	3.9	5.3	50.4	37.1	20.8	13.1	10.0	4.0	14.4	0.0	3.9	28.6	2.0	10.9	224.9	53.8	4.1	40.3	21.4	3.7	241.2	4.7	103.0	1.0	1.2	191.7	279.6	2.2	39.4	3.8	121.6	15.1	13.5	9.7	6.6	2.6	4.5	17.7	2.9	2.5	13.2	5.5	99.2	23.4	17.3	44.3
RHOG	"ARHG, MGC125835, MGC125836"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840959	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 625.4"	"Low region specificity"	"Detected in all"							HPA039871	Enhanced					NA	NA		86000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	61.2	39.5	62.6	82.5	90.0	273.1	45.7	84.0	70.5	46.2	56.0	50.1	44.7	46.7	19.5	82.6	44.6	34.4	47.0	60.4	71.2	35.6	39.3	87.5	85.2	91.1	83.6	38.0	30.5	18.3	25.4	43.5	91.7	36.8	28.3	4.3	39.1	28.4	53.0	50.1	64.2	39.2	76.5	168.4	42.2	15.3	81.7	68.0	29.0	27.0	67.3	56.5	48.6	107.2	74.1	99.0	19.8	34.1	74.8	84.1	21.4	48.1	59.6	73.7	77.8	61.0	78.7	74.9	24.9	89.2	74.9	85.3	31.2	68.0	47.6	66.6	75.3	170.3	44.7	57.9	75.3	150.0	625.4	82.0	61.1	46.1	44.4	42.6	85.8	99.5	101.3	80.8	61.0	86.5	126.5	206.8	31.5	53.4	78.8	63.7	21.4	44.4	53.1	50.9	10.6	26.7	34.0	77.7	39.4	22.5	41.0	111.6	67.2	88.8	44.5	95.3	57.2	44.8	66.4	42.5	81.0	135.8	50.6	441.3	351.1	739.9	114.8	468.1	101.8	79.8	125.6	128.7	310.8	78.1	87.4	101.6	981.2	97.9	561.9	77.2	206.6	346.7	62.6	90.0	84.0	70.5	60.4	71.2	91.1	83.6	91.7	76.5	81.7	107.2	38.4	19.2	21.5	2.9	109.0	68.7	62.4	35.3	22.8	0.9	24.0	26.3	6.6	20.0	26.9	20.2	0.0	100.4	105.2	99.1	15.6	67.2	1.6	10.2	20.6	58.5	16.2	71.9	1.9	56.6	82.1	38.2	22.4	19.1	200.0	62.8	43.5	19.5	247.7	3.3	1.9	26.7	14.2	365.2	356.6	3.6	38.5	250.6	53.4	8.4	391.7	18.0	166.9	3.0	45.9	86.6	143.6	36.1	45.1	70.4	135.4	24.8	9.7	3.0	19.7	21.6	34.0	10.2	23.9	45.1	59.5	124.2	124.8	11.2	28.9	95.7
RHOH	"ARHH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.9;lymphoid tissue: 98.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	2.2	0.9	0.7	36.4	0.6	62.9	13.2	0.5	0.8	2.9	0.6	6.3	4.8	1.6	0.9	2.9	1.5	6.4	0.7	0.6	0.8	1.2	2.7	5.7	86.0	1.1	1.3	0.9	1.4	0.4	0.7	0.9	0.9	2.7	5.6	0.0	3.9	0.9	0.6	1.2	20.6	1.5	1.0	42.6	8.2	0.7	0.8	98.2	1.8	0.3	85.2	10.6	1.6	1.0	0.2	0.4	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	126.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	2.6	0.0	18.8	0.1	0.0	0.0	21.1	92.5	1.5	0.0	0.0	0.0	0.1	0.1	123.7	1.4	1.2	0.0	0.0	179.4	13.3	2.3	0.0	0.4	19.1	0.3	4.3	0.0	0.0	0.1	0.1	0.3	0.8	0.2	0.1	5.7	0.5	0.5	0.0	0.5	0.1	0.2	65.5	56.8	116.3	0.1	4.4	0.1	210.3	1.1	168.7	112.2	0.8	99.3	164.3	176.9	151.1	1.9	212.1	274.3	220.5	8.4	74.2	1.2	26.1	268.4	124.1	0.7	0.6	0.5	0.8	0.6	0.8	1.1	1.3	0.9	1.0	0.8	1.0	2.9	3.2	9.9	0.3	273.0	7.1	1.4	0.3	1.8	0.0	11.1	6.7	1.1	1.5	2.9	0.0	0.0	0.1	90.5	0.3	0.0	0.1	0.6	0.6	0.5	2.3	0.0	23.4	0.3	0.0	0.2	3.6	9.7	1.0	141.8	0.0	1.8	0.2	2.2	0.0	0.3	0.4	0.0	4.4	16.2	0.7	0.0	28.4	56.9	8.4	11.3	0.0	64.9	0.5	0.1	0.0	0.1	0.0	183.1	1.4	0.0	0.4	1.0	0.0	0.0	2.0	2.0	0.3	0.2	0.3	7.0	0.3	223.6	0.1	0.3	2.0
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293508	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	19.6	3.3	12.5	8.5	14.6	0.1	17.4	10.8	16.9	12.9	8.5	14.2	7.5	27.9	17.3	15.5	18.5	25.3	17.9	14.0	11.1	11.7	4.2	21.5	9.6	10.9	11.0	14.2	4.4	3.5	6.4	9.3	11.0	11.8	10.7	5.5	8.4	13.8	7.9	7.6	9.8	31.4	8.3	12.6	9.3	2.8	14.5	3.1	13.8	13.4	4.9	19.7	9.4	13.0	0.0	0.0	63.8	0.0	0.0	0.0	0.0	10.6	42.6	3.6	6.2	0.0	0.0	0.0	5.9	0.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	0.1	8.0	35.8	375.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	5.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.6	1.1	0.1	0.0	100.9	0.1	1.1	0.8	6.1	0.0	0.0	0.0	0.0	0.0	106.5	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.5	14.6	10.8	16.9	14.0	11.1	10.9	11.0	11.0	8.3	14.5	13.0	41.0	0.0	1.3	176.0	0.3	5.9	0.3	0.1	0.0	0.3	1.2	5.2	3.8	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.5	0.3	6.7	72.5	0.0	0.0	11.1	0.9	0.0	31.0	0.0	0.3	0.0	0.5	41.4	0.5	0.1	0.0	2.2	0.0	0.0	1.9	7.7	1.6	11.8	1.0	3.6	35.6	0.0	11.1	0.0	43.2	0.4	0.1	0.0	16.1	2.5	0.6	0.0	0.0	0.0	0.4	6.6	34.6	17.0	0.1	0.4	0.9	4.8	0.1	0.6	6.9	0.0	1.4
RHOT1	"ARHT1, FLJ11040, MIRO-1, MIRO1"	ENSG00000126858	"Ras homolog family member T1"	Q8IXI2	17	32142454-32253374	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010687, CAB068223, CAB068224"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813"	"unprognostic (3.28e-2)"	"unprognostic (4.02e-3)"	"unprognostic (6.85e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.59e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.08e-2)"	19.1	26.9	19.9	9.6	20.8	19.7	19.5	20.5	29.4	16.6	12.5	19.8	11.4	16.3	15.0	14.9	14.4	11.4	24.8	22.0	18.5	17.6	16.8	17.3	10.9	18.1	17.5	17.7	15.5	38.1	14.2	18.6	19.8	17.1	11.3	50.9	17.3	19.1	28.4	28.5	12.2	16.0	18.7	12.2	17.3	12.3	19.9	19.4	25.0	34.5	11.2	16.6	15.5	24.8	14.1	26.2	21.9	22.8	25.8	28.9	13.2	22.7	18.2	24.2	26.0	13.8	9.0	18.2	22.3	18.7	26.5	24.9	34.3	13.8	29.1	14.4	25.9	21.4	15.8	21.0	35.4	28.1	15.3	15.3	40.7	20.7	23.8	40.5	21.1	36.7	48.1	14.9	21.5	10.6	52.1	23.0	18.0	16.7	12.6	28.6	32.4	32.2	17.5	8.4	20.0	18.1	22.8	14.1	38.4	26.1	31.9	38.1	16.3	17.0	17.5	19.6	16.2	22.0	22.9	19.9	20.5	26.7	28.9	3.0	5.8	5.4	2.1	4.9	2.3	2.1	2.3	2.1	5.3	4.0	1.8	2.3	3.6	3.4	5.2	1.8	1.3	2.8	19.9	20.8	20.5	29.4	22.0	18.5	18.1	17.5	19.8	18.7	19.9	24.8	16.5	28.9	38.8	88.8	17.8	25.9	13.5	14.4	27.9	61.5	21.4	18.0	38.1	14.3	18.7	16.5	70.9	28.4	14.1	12.3	33.2	17.0	19.6	14.5	15.5	17.9	16.9	31.5	97.3	13.1	20.3	19.3	15.3	13.9	27.3	24.8	18.9	18.3	33.7	57.2	89.9	9.3	22.4	46.4	29.1	20.6	30.1	33.2	16.0	76.8	45.1	128.9	29.9	68.3	65.9	13.5	14.4	24.0	11.6	13.7	22.8	21.3	15.1	58.7	26.3	24.8	21.9	63.0	40.3	24.3	53.0	22.7	18.9	24.5	13.9	11.4
RHOT2	"ARHT2, C16orf39, MIRO-2"	ENSG00000140983	"Ras homolog family member T2"	Q8IXI1	16	668105-674174	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 264.8;Rod photoreceptor cells: 284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012624, HPA012895"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA012624: AB_1856272, HPA012895: AB_1856271"	"unprognostic (1.59e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (4.68e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-2)"	32.3	48.6	28.9	20.4	28.4	28.1	34.9	27.9	36.4	38.7	32.8	42.8	29.1	32.8	7.8	37.7	38.2	12.8	53.6	29.2	27.4	46.6	44.9	34.4	26.0	29.1	28.1	34.5	34.2	20.4	51.5	14.7	28.0	50.3	8.1	36.4	35.9	17.3	33.5	38.7	45.1	9.2	27.0	57.1	41.4	36.7	28.8	20.3	45.7	15.5	11.6	37.5	35.6	28.1	25.0	52.4	25.6	39.7	13.1	13.7	44.7	41.7	19.2	33.9	26.2	70.3	37.1	29.5	28.8	16.6	11.8	47.3	17.7	39.6	8.7	41.9	77.2	32.5	65.5	52.2	24.7	29.9	44.2	21.3	29.5	25.0	14.2	17.9	24.5	35.9	62.6	22.1	17.3	108.2	33.1	32.5	67.3	21.5	33.5	72.6	30.5	59.1	20.6	48.8	57.7	70.1	39.2	50.6	22.8	11.0	49.6	46.4	38.9	25.4	41.7	23.5	30.8	56.0	40.0	38.6	17.9	28.3	39.6	5.5	19.5	21.8	22.9	23.0	13.9	11.6	18.3	18.4	19.4	12.1	13.7	11.7	16.8	12.0	18.4	20.3	23.0	17.6	28.9	28.4	27.9	36.4	29.2	27.4	29.1	28.1	28.0	27.0	28.8	28.1	30.1	32.1	27.5	53.2	37.1	33.8	26.8	80.0	25.6	98.6	29.6	25.8	25.7	30.0	38.3	29.5	264.8	63.2	46.7	63.3	21.5	40.2	6.3	16.5	21.7	26.6	43.0	17.1	46.5	35.8	52.1	26.5	51.0	21.9	51.4	40.6	20.0	34.7	35.8	85.8	36.2	52.2	61.1	30.3	29.8	7.5	27.1	26.0	28.4	20.6	45.2	40.1	46.4	17.1	27.3	43.8	46.8	25.6	23.7	25.0	47.3	24.3	27.9	284.9	52.6	19.9	31.5	44.5	51.4	19.3	31.7	67.0	42.1	45.5	54.2	23.3
RHOU	"ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1"	ENSG00000116574	"Ras homolog family member U"	Q7L0Q8	1	228735479-228746664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 119.2;Endometrial stromal cells: 100.4;Extravillous trophoblasts: 91.5;Oligodendrocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 99.2;MOLT-4: 46.5;RT4: 43.3;THP-1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049592	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA049592: AB_2680827"	"unprognostic (7.90e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.26e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-2)"	29.2	11.1	21.9	5.6	34.2	8.4	16.5	25.9	39.8	17.0	14.6	15.2	23.6	13.8	5.7	6.1	18.9	16.8	12.2	21.8	24.9	11.4	26.0	13.8	3.8	28.6	31.3	25.6	18.6	13.8	7.3	17.5	27.1	17.8	9.9	2.3	18.5	10.4	37.3	6.2	23.9	8.5	25.4	15.4	22.5	9.5	31.9	4.7	13.7	5.0	1.1	18.3	8.9	41.5	1.0	2.5	7.9	0.6	1.8	0.9	99.2	0.5	0.9	0.6	0.4	11.0	14.8	0.0	5.8	1.3	0.5	0.6	2.9	0.0	0.5	16.0	5.6	0.1	0.7	3.4	11.0	8.1	0.9	0.5	0.8	0.2	0.5	0.1	0.2	4.0	0.0	0.0	0.5	2.5	46.5	8.5	2.5	13.5	0.9	0.2	2.5	1.3	0.4	43.3	2.9	8.7	0.9	6.7	0.0	16.9	0.0	29.9	0.7	0.1	1.2	0.0	0.1	2.3	10.6	0.0	0.0	20.5	5.2	0.0	0.3	0.4	0.4	0.5	0.8	0.0	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.0	0.1	21.9	34.2	25.9	39.8	21.8	24.9	28.6	31.3	27.1	25.4	31.9	41.5	76.4	16.0	16.4	16.6	0.7	4.6	3.6	0.5	0.0	4.5	27.4	18.9	77.3	38.6	15.6	1.8	0.0	25.9	5.1	82.1	0.0	4.7	0.7	119.2	100.4	28.9	3.0	3.2	13.6	8.9	91.5	28.9	20.4	83.7	0.0	56.8	30.7	40.8	21.9	8.4	6.9	10.3	4.1	28.3	38.6	3.1	1.8	29.9	16.0	5.6	15.1	5.5	1.0	24.6	139.5	5.1	35.7	1.2	1.9	23.0	64.3	1.2	21.0	0.9	0.0	21.5	10.2	1.5	2.8	0.3	3.3	33.9	5.9	1.2	9.6	18.6
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874234	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 211.8;skin 1: 129.8;vagina: 92.2"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 328.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053343	Enhanced					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.5	0.1	0.9	0.2	0.9	0.2	16.0	1.1	1.8	26.3	0.5	2.8	0.6	0.7	9.5	211.8	2.7	0.5	0.1	1.0	1.1	5.5	0.2	2.3	0.2	2.1	0.8	0.3	16.3	2.2	3.0	3.2	2.4	16.6	2.6	0.0	44.3	2.4	0.2	129.8	0.6	0.1	0.8	0.1	1.2	0.3	1.9	2.6	0.5	0.0	23.3	20.7	92.2	0.9	1.6	9.7	0.1	2.7	0.2	0.0	5.2	0.1	0.8	0.4	0.2	4.0	4.4	0.0	2.4	0.0	0.3	77.9	4.5	0.6	0.2	10.5	12.5	0.5	11.3	0.6	0.0	0.5	0.0	0.3	6.0	0.3	0.1	0.4	0.1	2.3	2.1	0.5	0.0	27.2	0.6	2.3	1.7	19.3	3.7	4.0	0.4	1.8	5.1	34.3	4.0	0.8	8.0	328.9	0.2	0.5	40.9	0.3	0.1	0.0	1.1	0.2	0.3	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.1	1.8	1.0	1.1	2.1	0.8	2.4	0.8	1.9	0.9	0.6	0.0	3.2	0.3	0.5	84.1	42.5	80.9	19.9	0.0	75.2	48.5	0.9	2.8	103.0	29.5	0.0	60.7	1.9	43.1	13.7	107.5	0.0	18.5	1.9	2.5	22.7	0.0	1.5	56.2	6.0	2.0	7.1	25.5	1.3	0.4	0.0	0.0	4.6	0.0	0.5	54.7	67.1	0.0	13.3	0.0	0.0	0.8	32.0	0.0	3.6	0.0	0.0	0.0	0.3	13.8	142.3	0.7	0.1	89.8	1.0	0.9	26.2	0.0	0.0	0.2	7.3	0.0	0.9	375.0	283.0	42.4	1.9	0.0	66.3	275.1
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109051-120115913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 15.1"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 4.9"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	1.7	1.2	2.3	0.1	2.3	0.1	1.4	3.7	3.4	1.5	2.7	1.7	0.0	0.8	0.0	0.5	2.4	0.2	0.6	2.3	2.7	1.8	0.9	0.5	0.3	2.7	2.7	3.5	0.3	0.1	1.7	0.0	2.7	1.4	0.0	2.5	0.6	0.2	0.2	1.2	1.0	0.1	2.4	1.3	0.7	15.1	2.6	0.2	1.1	0.0	0.1	1.0	0.8	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.0	2.3	2.3	3.7	3.4	2.3	2.7	2.7	2.7	2.7	2.4	2.6	2.7	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	1.3	0.3	0.5	1.3	0.0	0.0	0.0	4.2	0.1	0.2	0.1	1.9	0.2	1.5	0.2	0.1	0.5	0.0	0.0	0.8	0.4	0.4	0.2	0.0	0.1	0.0	8.3	0.0	0.2	0.1	0.0	1.5	0.3	0.0	0.0	0.0	3.8	0.6	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	2.4	1.3	0.0	0.0	0.3	3.3	123.8	0.0	0.3	0.0	0.2	0.7	0.2	0.0
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158613-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 6.6;Spermatogonia: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.0	11.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.5	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	2.1	0.5	0.1	0.7	0.9	0.7	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120072264-120077690	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 21.2"	"Cell type enriched"	"Detected in single"	6	"Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HL-60: 596.6;K-562: 903.3;NB-4: 1129.0"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	596.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	903.3	0.0	0.0	0.0	0.0	1129.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	94.3	3.0	0.0	0.0	0.6	0.2	0.0	156.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHPN1	"KIAA1929, ODF5, RHPN"	ENSG00000158106	"Rhophilin Rho GTPase binding protein 1"	Q8TCX5	8	143368876-143384221	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.1;thyroid gland: 20.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Collecting duct cells: 38.6;Cone photoreceptor cells: 31.3;Respiratory ciliated cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.3;MOLT-4: 25.8;RPMI-8226: 19.0;T-47d: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024288, HPA024671"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA024288: AB_1856274, HPA024671: AB_1856275"	"unprognostic (2.04e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-2)"	2.6	1.6	11.8	0.9	9.1	2.1	4.7	6.7	12.9	3.3	8.5	2.0	0.1	1.3	1.3	2.4	5.0	0.7	1.1	13.5	8.2	13.6	1.3	3.5	1.1	7.5	9.3	0.7	4.2	2.9	20.1	0.1	7.2	4.0	0.1	0.6	3.6	1.9	0.3	2.7	3.0	0.3	5.9	5.3	3.0	4.0	9.9	8.8	20.4	0.0	0.5	2.6	1.9	7.1	2.9	4.9	1.2	3.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	1.9	0.2	9.8	0.0	0.2	1.3	0.0	0.0	0.0	0.6	4.4	0.0	3.5	0.3	0.4	0.3	3.1	0.0	0.8	0.0	0.0	0.9	1.0	11.5	1.1	5.8	0.0	28.3	25.8	2.6	1.7	5.9	13.4	7.0	0.0	19.0	3.9	4.6	7.2	2.7	1.5	8.1	1.8	0.0	44.2	0.0	0.0	0.0	5.1	0.1	0.2	1.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	9.1	6.7	12.9	13.5	8.2	7.5	9.3	7.2	5.9	9.9	7.1	6.7	6.4	7.5	47.0	2.0	2.5	2.7	3.9	3.4	3.4	13.4	8.9	1.0	2.8	5.9	38.6	31.3	1.6	3.3	2.4	11.7	8.7	5.1	21.9	1.2	5.7	22.7	1.7	20.2	2.8	0.2	1.1	11.7	4.1	0.0	6.6	5.3	1.4	3.2	6.7	10.2	3.1	6.1	1.3	6.0	11.2	0.3	1.6	7.2	3.7	1.4	11.5	0.0	15.1	3.6	3.3	1.2	1.5	1.4	3.2	0.0	15.8	38.6	25.2	0.0	0.7	1.5	7.6	7.2	2.5	1.4	1.9	5.5	1.1	4.3	3.7
RHPN2		ENSG00000131941	"Rhophilin Rho GTPase binding protein 2"	Q8IUC4	19	32978592-33064888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.0;Endometrial ciliated cells: 90.2;Gastric mucus-secreting cells: 94.8;Glandular and luminal cells: 108.8;Muller glia cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 52.4;OE19: 50.7;RPTEC TERT1: 52.9;SK-BR-3: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051749	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA051749: AB_2681589"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.32e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (1.22e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	3.0	0.8	5.5	4.4	5.9	0.0	12.7	5.8	6.6	8.4	7.8	23.6	21.7	5.4	2.4	1.2	15.0	13.6	1.5	5.2	5.8	14.5	19.6	4.1	1.3	6.3	6.9	1.7	12.4	16.9	4.8	8.2	6.1	27.1	19.0	20.2	19.4	2.2	0.3	10.5	17.8	1.8	5.1	0.9	35.2	0.7	7.2	1.9	5.4	0.9	2.6	11.5	1.1	6.4	28.6	52.4	4.9	8.6	1.0	0.1	24.5	6.6	5.0	10.0	10.5	45.9	28.6	0.0	41.1	3.7	8.8	13.5	15.9	5.8	12.4	13.2	9.7	3.2	5.9	17.9	6.6	0.0	4.1	1.2	11.5	8.4	4.7	7.6	1.3	1.2	7.2	0.0	3.0	24.4	0.1	2.9	10.5	50.7	8.4	0.0	6.0	5.6	52.9	14.0	11.0	5.8	11.2	54.5	13.4	13.9	15.2	1.4	0.7	0.1	12.7	3.6	11.2	6.3	4.6	2.1	1.6	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.9	5.8	6.6	5.2	5.8	6.3	6.9	6.1	5.1	7.2	6.4	0.3	22.4	1.1	20.2	3.9	1.3	6.3	6.2	7.4	1.9	30.4	15.4	0.9	17.2	14.7	12.9	12.5	18.2	2.1	61.0	3.9	31.0	0.4	90.2	11.1	1.1	4.8	0.0	1.3	13.1	6.8	6.4	94.8	108.8	1.3	0.2	3.3	13.0	1.9	0.0	1.4	22.2	18.3	3.0	0.0	0.3	2.1	1.6	1.8	4.7	0.0	76.8	0.0	9.5	1.6	33.8	52.6	1.2	6.1	23.5	11.7	19.8	51.9	10.1	0.0	0.6	3.7	0.0	1.4	3.8	1.8	3.4	1.1	0.0	23.3	36.1
RIBC2	"C22orf11, DKFZp566F0546, FLJ25720"	ENSG00000128408	"RIB43A domain with coiled-coils 2"	Q9H4K1	22	45413693-45432509	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 14.4;fallopian tube: 9.8;testis: 30.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 218.6;Endometrial ciliated cells: 77.5;Late spermatids: 40.4;Respiratory ciliated cells: 101.4;Spermatocytes: 159.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 7.6;CAPAN-2: 7.7;MCF7: 9.2;SiHa: 13.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 14.9"	HPA003210	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003210: AB_1078347"	"unprognostic (2.55e-1)"	"prognostic favorable (7.08e-8)"	"unprognostic (3.58e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.51e-3)"	"unprognostic (7.21e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (9.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.13e-1)"	0.0	0.1	0.9	0.6	0.9	1.9	0.2	0.3	0.3	0.9	14.4	0.5	0.3	0.6	0.4	0.7	9.8	0.4	0.0	0.6	0.5	0.1	0.0	0.8	0.4	2.5	2.6	0.2	0.2	1.2	1.4	0.3	1.7	0.6	0.3	0.2	0.2	0.1	0.0	0.9	0.5	0.2	1.6	0.1	0.5	30.7	0.8	0.5	0.5	0.0	0.4	0.1	0.5	2.2	5.9	4.0	0.6	0.0	0.0	0.0	0.5	7.6	0.6	1.5	2.1	4.2	7.7	0.0	1.8	0.7	0.0	6.8	0.0	0.0	1.1	0.0	0.2	0.0	5.7	0.2	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.8	0.9	0.0	0.0	0.5	9.2	4.0	2.0	0.9	0.1	2.2	4.5	0.0	0.0	2.1	0.8	3.9	0.0	13.0	2.6	0.0	0.4	4.8	2.8	0.4	0.0	0.0	4.6	0.0	2.2	2.3	0.0	0.0	1.2	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.9	0.3	0.3	0.6	0.5	2.5	2.6	1.7	1.6	0.8	2.2	0.2	0.0	0.0	0.0	0.1	0.3	0.8	3.6	0.0	0.0	0.6	0.8	0.2	1.5	7.7	0.0	0.0	1.5	0.4	0.8	1.9	0.1	218.6	77.5	1.8	0.3	0.0	4.0	0.9	0.0	0.6	0.9	0.5	2.5	0.0	0.6	0.0	0.0	1.1	0.0	0.3	1.8	12.2	0.0	0.4	40.4	1.2	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.4	0.1	0.0	101.4	3.6	0.0	0.0	1.9	159.4	22.2	1.2	0.1	0.3	0.4	0.1	1.1	0.3
RIC1	"bA207C16.1, KIAA1432"	ENSG00000107036	"RIC1 homolog, RAB6A GEF complex partner 1"	Q4ADV7	9	5629025-5776557	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 62.3;Excitatory neurons: 84.5;Inhibitory neurons: 79.6;Microglial cells: 98.4;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.6;Plasma cells: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 73.3;HEL: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051578	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"			"HPA051578: AB_2681541"	"unprognostic (1.78e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.16e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	11.8	7.2	3.2	12.7	7.3	13.2	9.8	10.2	5.2	11.6	11.1	8.4	10.0	11.6	8.7	11.4	8.8	11.4	6.9	4.2	5.6	7.5	9.9	10.1	17.3	7.3	5.5	10.3	10.5	8.9	4.9	14.3	7.4	8.2	9.4	7.4	11.3	10.5	17.6	13.5	9.3	13.3	4.3	11.8	7.9	11.6	6.3	14.8	11.3	15.7	16.5	11.0	10.0	10.1	18.5	10.7	18.3	12.6	20.8	24.1	15.3	26.1	24.0	17.6	22.8	9.8	3.9	41.8	3.1	27.1	7.0	8.8	13.9	14.4	24.4	73.3	9.2	91.5	23.3	10.6	17.2	14.4	15.7	22.7	9.7	12.1	18.7	20.1	21.2	13.0	5.5	48.5	14.7	4.6	11.9	26.0	9.2	7.0	5.3	22.8	12.0	16.9	9.2	7.1	5.0	12.4	14.2	8.8	7.3	29.1	7.9	24.1	20.5	14.2	17.7	8.0	12.4	13.4	18.0	51.8	5.8	5.5	4.9	0.3	0.6	0.5	0.3	1.0	0.4	0.7	0.4	0.5	0.5	0.2	0.2	0.3	0.3	1.0	0.5	0.7	0.5	0.5	3.2	7.3	10.2	5.2	4.2	5.6	7.3	5.5	7.4	4.3	6.3	10.1	11.7	9.6	4.8	62.3	45.9	0.0	5.8	0.0	42.1	7.1	6.9	5.5	4.4	10.0	0.0	0.0	4.2	7.4	12.1	5.6	1.9	3.9	9.6	8.1	12.8	8.7	3.6	17.9	84.5	5.4	4.6	13.5	25.0	10.1	5.1	7.6	9.7	10.7	7.8	21.9	79.6	2.7	0.0	25.7	0.0	9.5	8.7	19.8	0.0	98.4	20.8	2.5	7.2	69.9	70.6	5.6	2.7	6.4	80.1	6.1	7.0	3.3	0.7	5.9	13.1	10.1	11.1	8.0	4.1	32.0	0.0	7.3	15.3	6.4	2.8	8.1
RIC3	"AYST720, FLJ11608, PRO1385"	ENSG00000166405	"RIC3 acetylcholine receptor chaperone"	Q7Z5B4	11	8106056-8169055	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065016	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"			"HPA065016: AB_2685404"	"unprognostic (2.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.45e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-9)"	"unprognostic (4.37e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.52e-2)"	3.1	13.5	17.9	5.2	17.8	1.9	6.4	24.6	21.7	8.9	14.8	11.3	1.9	10.9	21.5	5.7	10.1	3.5	9.8	17.0	20.3	10.5	3.5	3.7	7.7	15.5	15.5	19.7	18.0	11.7	31.3	0.3	16.0	16.9	2.1	42.2	16.0	10.3	5.9	14.2	8.2	6.1	14.1	7.3	8.5	7.4	16.2	2.1	22.9	2.4	7.1	10.5	5.9	17.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.3	5.8	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.1	1.2	0.5	0.0	0.0	0.1	0.0	0.1	4.5	0.6	1.3	2.2	0.8	1.4	11.9	4.6	2.4	0.6	12.8	6.7	5.9	1.9	1.8	1.7	1.6	2.6	0.8	17.9	17.8	24.6	21.7	17.0	20.3	15.5	15.5	16.0	14.1	16.2	17.3	1.5	6.4	15.5	56.2	79.1	36.3	55.9	8.2	58.6	175.2	34.8	47.0	14.0	42.9	20.7	23.9	143.9	0.5	7.2	0.1	0.0	33.5	2.9	0.2	1.6	4.2	7.7	4.4	95.3	28.5	0.3	10.8	2.0	0.2	24.6	9.5	6.4	4.9	0.2	95.9	90.1	4.4	8.2	1.0	2.2	4.5	33.5	2.2	12.4	17.8	3.3	52.3	4.1	101.0	50.4	14.6	1.4	46.6	18.6	38.6	3.1	6.6	19.4	204.9	0.0	9.0	7.0	51.0	39.5	15.9	39.6	0.5	19.8	1.1	1.5	38.2
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		10000	"Cluster 44: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"CAB046012: AB_11129402, HPA041491: AB_2677510"	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	39.2	39.6	43.0	34.8	43.6	40.6	37.4	42.1	48.5	41.2	46.6	46.3	29.5	44.2	41.8	43.1	41.1	30.6	42.9	45.4	43.7	36.5	37.8	37.6	37.6	43.5	44.4	39.7	39.3	34.2	38.1	34.1	44.2	39.0	30.8	24.8	34.4	40.3	32.8	39.5	38.1	49.4	43.4	41.6	38.1	44.0	44.0	41.6	33.7	28.3	41.8	45.9	36.6	45.0	176.3	83.9	66.8	66.7	89.7	73.4	46.3	124.1	99.2	166.0	114.2	72.6	121.1	69.6	50.5	189.0	125.7	93.4	76.4	131.4	92.0	84.5	76.7	39.4	59.5	67.8	72.3	66.5	125.8	80.6	114.3	103.2	92.6	85.2	82.8	72.8	68.7	66.0	129.3	71.1	79.6	52.6	61.1	74.0	103.0	74.0	66.0	47.5	96.9	45.6	69.2	62.2	96.3	107.1	67.1	63.9	76.1	52.8	93.4	109.2	96.5	40.4	117.3	72.6	117.6	67.8	107.7	59.5	83.5	72.9	41.1	88.3	79.0	49.7	78.2	64.4	70.1	69.0	43.7	55.1	59.9	60.6	59.9	73.0	61.0	35.8	65.0	86.6	43.0	43.6	42.1	48.5	45.4	43.7	43.5	44.4	44.2	43.4	44.0	45.0	30.9	16.0	21.1	10.7	28.7	17.7	20.5	38.6	17.1	28.1	22.5	27.2	23.5	28.6	25.5	25.8	10.4	41.4	46.5	26.3	27.4	53.1	20.2	15.9	24.3	27.2	20.3	27.4	9.4	44.2	60.0	30.4	23.0	19.7	17.7	28.8	27.8	17.1	46.8	32.0	8.4	19.2	30.5	27.4	11.5	17.3	30.7	27.5	28.4	11.2	38.9	43.4	30.9	5.0	7.8	71.6	25.5	39.9	35.2	26.5	29.9	23.0	20.8	33.1	19.7	20.7	35.4	93.2	62.5	20.9	19.5	32.4	34.8	30.2	25.0	17.0
RIC8B	"FLJ10620, hSyn, RIC8"	ENSG00000111785	"RIC8 guanine nucleotide exchange factor B"	Q9NVN3	12	106774621-106889316	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.4;Inhibitory neurons: 93.9;Microglial cells: 58.1;Oligodendrocyte precursor cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039970, HPA042746"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"HPA039970: , HPA042746: AB_2678143"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.87e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	5.5	5.3	7.7	3.2	26.1	1.3	4.9	7.9	9.7	5.5	6.6	6.4	3.1	7.0	4.3	3.1	6.3	5.6	8.7	6.8	8.7	7.2	5.8	3.7	2.5	6.6	11.5	5.8	6.2	11.5	7.8	3.7	6.5	4.5	3.9	12.6	3.5	8.2	7.3	2.7	4.1	6.4	5.4	4.7	4.1	4.4	9.3	6.5	9.3	8.2	2.4	5.9	4.3	8.4	3.6	11.0	20.7	8.3	9.7	11.7	2.5	11.7	9.3	10.3	9.6	3.7	3.1	2.2	8.0	6.7	4.1	6.2	7.5	4.1	12.3	25.0	10.0	7.5	5.2	4.7	7.5	7.2	4.9	6.8	5.2	6.7	3.4	12.2	9.6	7.7	4.7	0.1	9.4	2.9	8.2	7.8	10.4	5.6	11.0	7.1	12.0	7.2	8.7	3.2	15.1	9.7	8.5	5.3	5.9	7.8	4.7	4.9	9.3	8.3	4.6	5.6	8.5	6.1	13.7	0.1	4.0	4.9	12.4	0.9	1.4	1.2	1.9	0.8	2.2	0.4	1.0	0.9	1.3	0.2	0.8	0.8	0.6	0.9	0.7	0.8	1.1	1.0	7.7	26.1	7.9	9.7	6.8	8.7	6.6	11.5	6.5	5.4	9.3	8.4	10.0	6.4	7.8	47.7	5.9	3.3	3.9	5.5	5.2	14.4	8.5	7.4	33.9	25.8	5.8	3.7	10.4	7.1	5.0	10.9	7.9	21.7	5.7	12.7	17.5	11.2	18.6	5.5	96.4	4.0	3.7	10.5	7.7	7.3	8.2	10.4	15.0	9.2	3.6	6.7	93.9	7.8	8.2	6.6	3.9	5.0	12.8	4.6	7.2	58.1	3.8	5.5	14.4	76.9	52.9	6.6	4.8	19.2	2.6	1.7	7.2	6.7	10.8	45.0	13.1	18.6	9.3	18.4	8.8	2.6	2.8	1.4	7.6	10.6	6.7	1.5
RICTOR	"AVO3, KIAA1999, MGC39830, PIA"	ENSG00000164327	"RPTOR independent companion of MTOR complex 2"	Q6R327	5	38937920-39074399	"Predicted intracellular proteins"	"Host-virus interaction"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 258.9;Oligodendrocytes: 343.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037802, HPA037803"	Approved		Approved	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA037802: AB_10672286, HPA037803: AB_2675676"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-2)"	7.7	5.5	7.3	8.8	10.2	24.5	9.4	17.4	9.9	7.7	0.9	7.1	5.4	9.2	6.3	5.5	6.9	6.2	10.0	8.4	7.2	7.0	7.7	9.9	11.3	9.1	7.0	10.0	6.2	6.7	4.9	8.9	10.6	6.6	6.6	26.3	6.4	5.1	11.7	8.4	7.9	6.8	9.2	10.2	7.0	9.3	7.6	12.8	8.6	11.5	9.2	7.1	7.2	16.9	5.9	10.6	7.6	7.6	9.5	10.8	11.1	8.1	18.7	8.7	8.7	6.5	10.5	9.7	3.0	8.0	13.2	9.5	6.7	8.8	10.5	8.6	6.0	11.4	25.4	7.9	6.1	9.7	14.6	9.2	6.4	10.8	11.8	8.6	14.6	7.8	9.4	18.1	5.9	3.1	9.9	16.0	4.9	3.1	8.2	7.9	13.6	8.6	7.2	9.7	6.4	4.4	21.1	7.8	10.9	7.1	5.4	10.5	12.5	17.6	8.5	7.2	6.1	8.0	5.3	9.5	7.5	12.7	6.6	8.7	1.4	8.5	4.9	1.4	4.0	3.8	4.9	4.3	1.5	4.6	5.2	6.0	30.3	3.7	3.4	5.1	3.3	0.8	7.3	10.2	17.4	9.9	8.4	7.2	9.1	7.0	10.6	9.2	7.6	16.9	32.9	64.1	50.2	72.8	62.4	48.8	39.6	38.7	27.3	69.6	28.6	13.5	38.4	28.6	34.7	27.6	204.3	40.5	65.6	28.0	0.0	25.9	2.3	33.0	31.1	43.0	43.6	73.4	153.8	15.9	20.6	37.4	30.1	35.1	33.0	32.9	49.2	33.0	19.3	52.2	153.9	26.0	22.4	40.6	47.6	5.3	47.5	36.3	33.8	108.7	45.2	28.8	74.2	258.9	343.1	28.1	29.9	32.4	48.7	65.8	30.7	15.3	38.0	176.0	13.1	43.6	34.6	36.5	33.2	18.3	45.0	96.5	70.9	21.3	19.6	74.6
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 496.2;liver: 1536.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.1	48.4	93.1	11.4	96.4	7.5	19.1	95.5	131.7	11.2	83.8	24.5	30.5	8.4	22.7	14.3	9.4	22.7	32.3	89.2	95.0	496.2	1536.9	9.5	10.1	91.6	97.8	23.4	27.0	24.6	10.0	10.8	95.5	19.3	24.6	26.6	16.4	11.6	40.0	10.6	21.8	10.8	92.6	7.4	24.8	17.2	100.0	11.2	15.9	41.0	12.3	15.5	7.9	91.0	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	93.1	96.4	95.5	131.7	89.2	95.0	91.6	97.8	95.5	92.6	100.0	91.0	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	6.1	5.0	4.4	7.4	8.4	21.7	10.0	13.8	7.0	6.5	2.6	5.6	4.3	8.2	4.0	5.6	5.6	5.6	3.5	4.6	5.1	5.5	6.7	5.1	8.5	4.4	5.1	11.2	7.0	6.8	3.5	8.0	5.4	6.0	6.1	8.2	7.7	5.0	7.5	7.2	4.6	6.2	4.9	6.5	6.1	11.0	4.5	10.7	9.1	9.5	7.9	7.3	4.6	13.8	20.8	17.4	26.8	20.5	10.7	13.8	25.9	24.8	18.0	21.6	25.5	28.9	16.4	39.2	21.7	17.3	17.9	21.3	41.2	17.1	36.1	27.8	19.8	63.4	21.4	21.0	11.2	64.7	20.2	10.3	11.3	38.8	28.7	12.3	21.3	23.5	52.2	32.6	22.1	13.8	38.3	22.9	43.2	11.2	22.9	38.4	42.1	26.1	11.6	24.9	24.2	18.8	32.0	14.6	16.5	18.8	12.9	23.1	27.0	32.9	22.8	20.3	26.7	16.0	29.6	55.4	15.3	25.5	22.5	6.3	2.5	3.0	4.3	1.7	4.9	4.0	3.6	3.2	1.8	3.1	4.8	3.7	2.8	7.7	3.5	1.6	2.8	1.7	4.4	8.4	13.8	7.0	4.6	5.1	4.4	5.1	5.4	4.9	4.5	13.8	53.1	96.1	49.7	41.1	43.5	49.3	47.5	21.9	33.0	48.2	30.4	29.8	38.2	28.6	38.0	14.7	31.3	39.2	40.3	19.6	1.9	38.5	22.6	38.0	61.7	48.0	25.0	84.3	68.5	21.9	35.9	51.3	34.7	65.0	34.1	88.6	27.1	19.7	23.0	47.1	72.4	30.9	14.2	26.4	27.0	14.0	43.8	37.6	30.2	48.7	44.1	35.8	32.0	73.9	126.3	29.9	23.5	34.3	45.1	53.2	14.9	12.9	21.3	42.8	85.5	106.5	51.2	122.8	113.1	28.9	41.6	40.9	45.3	58.9	34.6	45.4
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"							HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.0	1.6	1.9	0.0	2.5	0.0	0.0	3.5	2.5	1.4	0.4	1.0	0.0	0.8	0.1	0.1	24.9	0.0	0.4	2.2	2.5	0.8	0.0	2.4	0.0	1.2	0.9	0.1	0.8	0.1	34.7	0.0	0.5	0.4	0.3	4.8	0.0	0.4	0.1	0.0	0.3	0.3	0.3	0.0	0.9	16.9	2.3	0.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	3.5	2.5	2.2	2.5	1.2	0.9	0.5	0.3	2.3	1.1	0.0	19.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	8.5	1.1	0.4	15.7	0.0	9.3	5.5	16.7	0.0	0.0	0.1	3.9	3.8	88.9	133.2	0.8	0.4	46.2	0.0	1.8	0.9	0.0	1.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	3.2	0.0	0.0	0.0	57.1	0.6	0.2	3.6	0.0	0.0	0.8	0.0	1.0	0.2	0.4	0.1	1.5	0.0	0.1	0.1	3.0	73.9	3.0	0.0	0.5	1.8	30.1	8.9	0.0	0.0	0.0	0.2	0.1	0.8	0.0
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533719	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 62.4;skeletal muscle: 88.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	7.8	9.0	17.1	3.1	21.1	2.6	7.5	18.6	18.3	10.7	17.9	10.5	1.3	12.0	4.1	5.1	9.5	3.4	62.4	15.2	16.7	6.8	4.2	6.8	1.8	19.0	19.7	8.5	3.7	6.6	6.4	7.3	18.6	9.1	1.4	3.0	6.8	7.4	88.9	6.8	4.2	6.3	15.9	4.4	5.5	4.1	18.0	1.5	13.3	41.1	1.0	9.5	7.5	27.1	8.3	11.4	10.1	7.9	11.1	10.4	10.6	14.6	8.1	7.8	6.9	7.1	1.9	0.3	7.1	14.3	5.6	8.9	7.5	7.0	3.1	8.4	13.8	1.1	8.1	10.6	19.4	0.4	3.0	11.9	13.6	8.7	12.5	19.5	8.0	1.5	6.6	0.4	8.0	13.8	0.9	2.7	7.4	2.4	11.9	1.3	5.5	0.4	5.6	8.5	1.6	9.3	7.8	6.7	17.9	5.5	9.0	0.2	16.0	10.2	5.1	14.8	9.4	1.7	0.9	0.2	10.4	0.0	6.5	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.5	0.4	1.1	0.3	0.3	0.3	0.2	0.2	17.1	21.1	18.6	18.3	15.2	16.7	19.0	19.7	18.6	15.9	18.0	27.1	13.0	38.5	11.7	32.3	0.7	4.6	5.1	3.4	6.2	14.1	4.6	14.7	9.8	4.3	7.2	11.0	6.2	9.1	0.7	0.2	1.9	2.2	1.8	6.3	18.0	8.5	0.0	0.0	28.8	2.2	6.2	9.4	1.1	7.4	1.3	18.9	9.7	1.6	5.7	23.5	16.4	1.3	0.0	1.3	2.4	1.6	15.5	3.3	5.4	18.7	0.9	21.4	0.0	13.6	64.9	2.2	0.5	8.2	0.3	5.1	0.1	2.6	4.1	6.4	6.6	14.4	9.9	0.9	2.9	2.3	3.8	9.3	2.0	21.5	0.7	3.3
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123415039-123436684	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 116.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.8;Macrophages: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.8;NB-4: 235.2;THP-1: 149.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	21.4	7.5	9.3	27.4	9.7	116.2	15.8	8.2	11.1	26.3	14.2	6.3	5.4	19.3	11.2	7.6	18.4	15.7	8.2	9.5	10.2	18.6	11.9	24.1	23.8	9.7	9.7	13.1	8.0	11.4	3.5	14.4	9.2	18.6	5.8	1.4	23.2	23.7	4.6	5.5	6.5	13.8	9.1	26.7	10.3	3.2	10.3	15.2	27.8	5.9	17.7	20.5	7.0	8.6	14.2	12.7	4.6	21.8	29.8	23.6	13.3	16.1	41.0	15.3	12.7	16.2	5.5	7.6	15.2	25.1	8.4	9.2	10.3	12.3	14.2	29.1	9.8	103.8	9.9	24.2	33.2	81.2	50.6	18.3	9.3	16.0	11.6	19.8	15.7	20.4	11.1	3.8	12.4	9.4	28.0	235.2	2.9	4.5	13.9	19.8	14.1	15.4	16.0	26.1	1.0	6.7	21.9	0.7	16.9	9.2	19.5	149.0	17.0	12.5	9.2	22.8	9.9	6.2	8.0	18.2	12.3	55.1	5.3	98.6	133.3	159.3	24.0	106.0	22.4	55.8	51.1	42.7	98.7	41.9	19.7	22.5	176.8	22.4	121.5	46.7	67.7	63.8	9.3	9.7	8.2	11.1	9.5	10.2	9.7	9.7	9.2	9.1	10.3	8.6	75.7	35.3	75.2	7.2	149.8	24.5	68.4	67.8	32.5	1.4	45.3	35.9	5.1	17.2	43.3	22.0	2.1	10.1	75.0	2.4	25.4	20.1	2.1	51.9	24.8	73.2	4.2	24.2	7.5	21.0	5.4	28.2	9.2	27.0	62.6	8.4	84.3	13.3	72.9	1.7	2.6	8.1	0.0	112.5	129.7	2.7	50.4	288.7	37.4	10.3	117.8	18.7	42.2	5.5	2.3	22.7	6.4	66.2	25.7	82.6	1.5	63.5	47.1	2.1	6.6	13.1	30.1	1.4	13.0	12.5	15.3	8.1	92.5	10.1	4.8	69.2
RIMBP3	"KIAA1666, RIMBP3.1, RIMBP3A"	ENSG00000275793	"RIMS binding protein 3"	Q9UFD9	22	18605815-18611919	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"brain: 35.7;choroid plexus: 24.5;testis: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.0;THP-1: 3.2"									HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.55e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	"unprognostic (6.06e-3)"	"unprognostic (9.58e-2)"	"unprognostic (8.49e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	7.9	0.4	10.8	0.1	0.0	35.7	22.0	0.1	24.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	11.0	11.7	0.0	0.0	0.2	0.8	14.9	10.1	0.1	0.1	0.3	0.1	0.2	26.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	19.6	0.7	0.2	28.4	13.5	1.0	0.4	0.0	0.5	0.0	0.0	32.4	0.4	1.3	0.5	0.4	0.7	0.3	0.0	0.5	1.4	0.6	0.7	0.0	0.0	0.3	0.6	0.2	0.4	0.3	0.3	0.0	0.1	1.4	0.4	0.6	0.3	0.5	0.0	2.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.1	0.2	0.3	0.5	0.6	3.0	1.7	0.6	0.6	0.1	1.2	1.6	0.2	0.1	0.1	0.8	0.1	1.2	0.0	0.2	0.1	0.1	3.2	0.1	1.0	0.7	0.5	0.3	0.0	0.4	0.3	0.5	0.7	1.1	0.0	0.2	0.2	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.3	7.9	10.8	35.7	22.0	11.0	11.7	14.9	10.1	26.2	19.6	13.5	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMBP3B		ENSG00000274600	"RIMS binding protein 3B"	A6NNM3	22	21383374-21389478	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"brain: 41.3;choroid plexus: 18.4;testis: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RH-30: 1.1;THP-1: 2.1"									HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (3.78e-1)"	"unprognostic (3.54e-2)"			"unprognostic (1.53e-2)"			"unprognostic (1.51e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.35e-2)"		"unprognostic (4.37e-1)"	"unprognostic (3.61e-4)"	"unprognostic (1.69e-2)"		"unprognostic (7.11e-2)"		0.0	0.1	8.2	0.4	12.8	0.0	0.0	41.3	19.1	0.0	18.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	10.4	13.6	0.0	0.0	0.1	0.3	16.5	12.6	0.0	0.1	0.2	0.0	0.2	19.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.2	0.2	0.0	13.6	13.2	0.4	0.1	0.0	0.2	0.0	0.0	29.6	0.0	0.5	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.2	0.2	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.2	0.9	1.2	0.1	0.2	0.1	0.8	1.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	2.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.2	0.1	8.2	12.8	41.3	19.1	10.4	13.6	16.5	12.6	19.2	16.2	13.2	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMBP3C		ENSG00000183246	"RIMS binding protein 3C"	A6NJZ7	22	21545678-21551461	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 6.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.7;Late spermatids: 49.4;Spermatocytes: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.74e-1)"	"unprognostic (4.05e-2)"			"unprognostic (3.49e-2)"	"unprognostic (2.18e-1)"		"unprognostic (8.30e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.17e-6)"	"unprognostic (3.04e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.76e-6)"	"unprognostic (1.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.6	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RIMKLA	"FAM80A, MGC47816, NAAGS-II, RP11-157D18.1"	ENSG00000177181	"Ribosomal modification protein rimK like family member A"	Q8IXN7	1	42380792-42424232	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.0;retina: 11.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.9;Cone photoreceptor cells: 43.8;Distal enterocytes: 46.3;Excitatory neurons: 39.1;Horizontal cells: 35.3;Inhibitory neurons: 35.9;Rod photoreceptor cells: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.4;JURKAT: 5.8;Karpas-707: 8.3;SCLC-21H: 9.9;U-266/70: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027826	Uncertain		Uncertain	"Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"		"HPA027826: AB_10603992"	"unprognostic (4.04e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.68e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.63e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	0.2	0.2	2.9	0.4	3.6	0.0	0.2	3.7	15.0	0.1	0.0	3.0	0.3	0.1	0.0	0.1	0.2	0.5	3.2	4.5	2.3	0.8	0.1	1.9	0.1	5.7	2.2	0.0	1.0	2.2	1.2	0.2	6.2	0.5	3.2	11.2	0.5	0.2	0.7	0.2	0.4	0.6	1.2	0.2	1.0	0.7	6.2	0.0	0.6	1.0	0.0	0.4	0.2	6.3	0.0	0.7	0.1	6.4	0.1	0.0	1.3	0.0	0.0	0.2	0.5	0.3	0.2	0.0	1.4	0.0	1.2	0.0	4.2	0.0	0.3	3.7	2.5	0.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	8.3	0.0	0.3	2.0	0.0	3.5	0.5	5.1	0.0	0.2	0.3	0.6	1.7	9.9	4.2	0.3	0.3	0.1	0.7	0.3	1.9	0.0	0.0	0.4	0.0	0.7	7.4	4.4	5.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2.9	3.6	3.7	15.0	4.5	2.3	5.7	2.2	6.2	1.2	6.2	6.3	0.9	16.0	3.9	1.3	0.2	0.6	1.1	1.0	0.0	25.9	0.9	1.0	14.4	1.5	1.1	1.8	43.8	1.4	0.3	46.3	1.9	3.3	5.3	0.4	0.0	2.2	11.4	0.0	39.1	4.8	20.1	0.5	0.5	0.1	0.0	0.3	0.7	0.0	1.0	35.3	35.9	8.0	2.0	0.3	1.4	10.5	0.3	0.3	5.4	2.8	0.0	5.1	0.0	7.1	3.9	9.4	14.2	0.0	0.1	1.7	0.3	3.7	0.2	24.6	0.0	0.8	0.6	1.1	4.8	0.0	0.1	1.6	0.7	0.3	5.2	1.0
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 365.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 653.2;Inhibitory neurons: 572.7;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in many"	16	"cerebellum: 365.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;EFO-21: 8.8;LHCN-M2: 10.0;RPTEC TERT1: 15.0;SH-SY5Y: 10.7;TIME: 5.4;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 352.9"	HPA076565	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.2	1.2	5.5	0.8	14.1	0.0	0.5	365.0	22.5	0.3	0.0	0.3	0.7	0.2	0.0	2.1	0.0	3.9	0.1	16.3	8.4	0.0	0.0	0.2	0.0	0.3	9.0	0.0	0.4	1.6	2.4	0.0	20.8	3.0	0.1	7.4	1.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	1.4	4.1	5.4	0.0	0.0	0.9	0.0	0.1	0.0	13.2	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.2	1.4	0.0	0.2	0.0	0.0	5.2	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	15.0	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.7	0.0	5.4	5.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	14.1	365.0	22.5	16.3	8.4	0.3	9.0	20.8	0.0	5.4	13.2	0.2	0.0	0.5	120.2	0.0	0.0	0.2	2.1	0.0	69.1	3.0	3.2	1.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.9	2.5	0.0	0.0	653.2	0.8	0.0	1.8	0.0	0.0	1.3	0.3	3.6	0.0	0.0	62.2	572.7	0.0	2.0	0.0	0.0	10.2	0.3	0.3	3.6	16.9	0.0	109.7	0.0	323.2	76.5	0.5	0.0	1.5	0.0	1.0	0.0	0.4	3.6	9.9	0.0	1.3	2.7	21.3	13.6	0.0	0.1	0.0	0.1	0.3	0.0	0.5
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500696-104256094	"Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 50.6;brain: 48.2;retina: 102.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.2	50.6	22.4	0.2	27.1	0.4	0.7	35.5	48.2	7.5	0.0	0.1	0.4	0.6	0.9	0.3	5.9	0.9	0.1	18.4	16.4	0.3	0.1	0.1	0.3	5.5	9.7	2.0	0.7	0.0	15.0	0.4	6.4	1.7	0.1	102.3	0.8	1.0	0.2	0.3	0.5	1.3	3.5	0.1	0.6	2.8	16.7	0.8	1.3	0.1	0.2	1.7	2.4	29.4	4.6	0.0	4.8	0.0	0.0	0.1	0.0	0.4	0.3	1.0	1.3	0.1	0.3	9.2	0.1	0.1	1.4	0.3	1.9	0.8	2.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.0	1.5	0.0	1.2	0.0	0.5	0.0	0.4	0.9	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	7.3	16.5	3.3	0.0	0.1	0.7	8.8	0.4	0.2	0.0	0.0	6.5	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	22.4	27.1	35.5	48.2	18.4	16.4	5.5	9.7	6.4	3.5	16.7	29.4	0.4	28.9	22.5	38.5	0.2	0.3	1.8	2.8	1.8	383.6	0.7	0.6	0.9	1.5	16.9	0.0	706.8	0.5	0.1	0.2	1.9	0.1	34.2	2.1	0.4	4.9	8.4	0.0	1589.3	0.0	0.3	3.7	0.0	3.7	16.4	18.0	0.7	0.3	0.3	67.3	1234.9	0.9	0.0	0.6	0.8	20.1	72.1	2.5	1.8	63.7	0.6	86.6	1.0	577.0	27.0	0.3	1.2	29.3	0.3	4.1	2.0	0.2	10.6	1088.7	0.0	0.8	1.0	34.8	15.7	0.8	0.4	0.1	2.1	0.1	1.5	1.1
RIMS4	"C20orf190, dJ781B1.3"	ENSG00000101098	"Regulating synaptic membrane exocytosis 4"	Q9H426	20	44751808-44810546	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.9"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.6;glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060928	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA060928: AB_2684387"	"unprognostic (1.54e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-2)"		"unprognostic (4.63e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"	0.4	1.1	17.6	0.2	22.8	0.0	1.1	6.9	35.9	7.2	0.0	0.6	0.1	1.9	0.4	0.5	8.1	0.6	0.6	22.5	12.1	0.1	0.0	0.9	0.1	15.5	9.2	6.1	0.0	0.0	12.0	0.0	10.6	2.5	0.5	2.9	1.1	0.9	1.0	0.4	0.4	2.6	7.7	0.0	1.8	10.5	10.9	0.2	5.0	1.6	0.4	0.1	1.5	20.1	0.0	0.5	0.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.9	0.1	2.0	0.0	19.3	0.2	0.0	0.0	8.2	0.0	0.8	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	13.4	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	39.9	20.4	14.0	0.0	0.2	0.5	6.1	0.7	0.0	0.0	9.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	22.8	6.9	35.9	22.5	12.1	15.5	9.2	10.6	7.7	10.9	20.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	1.8	0.0	11.3	0.0	0.0	0.4	0.0	0.4	0.0	110.3	0.0	0.0	0.1	38.7	14.4	0.8	0.0	0.0	0.0	2.9	7.2	0.2	0.0	0.0	0.0	1.0	0.0	2.0	0.6	0.1	0.1	13.2	0.0	0.0	0.0	0.0	0.0	1.4	26.3	0.2	1.2	1.2	5.7	0.0	0.1	0.0	0.0	0.5	0.5	0.0
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330241-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 9.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 44.3;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.8	4.3	3.7	2.3	4.9	1.1	4.4	3.3	5.7	8.3	1.5	5.2	2.7	4.4	0.2	20.4	5.6	1.4	3.4	6.3	1.6	4.3	1.3	4.9	0.5	1.0	1.2	3.7	5.2	0.4	7.2	1.4	1.1	7.1	1.0	0.2	5.1	0.8	7.5	26.6	4.3	0.6	0.8	6.1	6.8	3.7	2.0	0.5	2.4	0.5	0.4	5.4	11.3	2.6	2.3	5.7	2.3	5.3	2.8	14.5	1.2	13.7	18.0	14.4	6.8	3.3	9.3	0.5	5.0	13.6	5.2	12.9	0.0	24.3	1.8	1.1	0.0	0.8	4.4	4.1	5.5	0.1	4.2	15.9	44.3	12.4	8.0	17.1	2.8	0.6	0.3	0.1	6.1	0.5	0.3	11.0	0.6	3.9	12.6	0.1	5.4	0.1	3.9	3.0	10.9	2.3	3.2	2.5	20.5	0.6	1.8	1.3	6.5	18.7	7.9	40.7	3.3	0.3	0.9	0.0	26.9	3.5	6.3	0.1	2.7	0.0	0.2	4.7	0.6	0.1	0.4	0.2	1.7	0.0	0.5	0.2	0.0	0.1	9.7	0.0	0.1	1.8	3.7	4.9	3.3	5.7	6.3	1.6	1.0	1.2	1.1	0.8	2.0	2.6	3.9	0.0	0.5	1.3	0.8	13.4	9.3	25.7	23.3	3.8	3.5	4.3	0.8	4.3	4.8	0.0	0.0	0.8	0.5	9.6	0.0	4.1	0.5	2.4	5.1	5.3	3.0	0.0	6.0	6.9	4.8	5.6	5.6	1.8	4.5	0.1	7.9	0.2	4.7	0.0	2.3	4.5	2.0	8.7	6.5	2.0	4.4	6.4	1.8	1.0	8.1	0.7	1.0	0.5	0.5	8.9	7.8	1.9	1.4	4.0	9.1	0.1	3.4	1.2	0.0	4.2	3.4	1.2	0.9	18.6	15.2	0.3	2.2	1.6	9.2	5.8
RIN2	RASSF4	ENSG00000132669	"Ras and Rab interactor 2"	Q8WYP3	20	19757606-20002457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.5;Microglial cells: 191.1;Oligodendrocyte precursor cells: 296.6;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034641	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA034641: AB_10671230"	"unprognostic (8.23e-3)"	"unprognostic (8.09e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.27e-2)"	"prognostic favorable (8.34e-6)"	"unprognostic (3.10e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.63e-2)"	14.2	6.4	8.7	8.6	13.5	6.1	9.5	9.4	7.1	14.4	14.4	12.5	13.3	14.1	3.9	13.6	11.7	17.8	18.7	9.5	10.8	12.1	5.3	18.3	4.7	14.6	13.2	15.0	6.5	4.6	1.4	19.8	12.8	9.4	12.7	5.5	15.6	13.5	9.4	8.2	14.7	16.2	9.5	16.8	8.8	1.8	12.7	3.0	13.7	13.2	5.3	8.1	3.8	14.0	6.7	22.4	4.1	13.7	23.3	14.2	13.1	5.9	22.8	5.7	3.0	10.0	5.8	0.0	24.0	14.6	10.6	24.7	0.1	33.5	6.3	2.7	0.1	0.0	3.5	0.8	5.4	0.0	0.1	21.7	6.1	10.7	11.9	13.4	30.6	0.0	0.1	0.4	17.0	5.3	0.1	0.4	0.7	3.2	47.1	0.1	13.8	3.4	7.2	9.2	3.5	0.9	5.3	23.7	0.1	4.1	2.0	1.4	33.7	11.4	2.9	8.1	9.2	0.1	0.1	0.0	8.0	0.0	2.0	0.2	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.0	0.4	8.7	13.5	9.4	7.1	9.5	10.8	14.6	13.2	12.8	9.5	12.7	14.0	52.3	64.1	17.5	198.5	1.4	41.9	18.5	30.9	24.5	6.1	25.6	18.4	34.3	14.3	23.7	31.3	8.4	6.8	0.2	30.4	43.0	17.5	1.0	50.0	47.3	52.7	14.4	0.4	5.9	34.5	7.4	33.2	10.7	87.3	0.0	32.4	105.3	4.2	100.2	6.7	82.8	17.2	26.4	60.3	40.3	0.8	19.3	37.7	21.4	191.1	21.4	33.2	1.0	296.6	202.4	26.2	10.5	15.4	0.8	22.3	23.0	50.1	27.1	1.9	0.0	25.4	22.6	0.5	0.8	33.6	54.0	7.1	2.9	43.1	21.9	32.2
RIN3	FLJ22439	ENSG00000100599	"Ras and Rab interactor 3"	Q8TB24	14	92513781-92688994	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.1;Macrophages: 78.7;Microglial cells: 100.2;monocytes: 109.8;NK-cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 35.7;classical monocyte: 43.4;eosinophil: 54.1;intermediate monocyte: 40.4;myeloid DC: 41.6;neutrophil: 40.2;NK-cell: 21.5;non-classical monocyte: 50.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA079218	Approved					NA	NA		7400	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA079218: "	"unprognostic (1.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.69e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	10.5	13.6	4.3	9.6	3.6	46.3	8.1	4.1	5.3	7.3	2.8	19.1	6.6	15.4	1.6	6.7	8.7	8.1	8.6	4.4	6.6	4.5	12.4	16.3	6.1	9.6	5.9	6.7	2.2	5.4	2.7	6.4	7.0	7.0	4.8	0.2	5.1	5.1	3.2	5.3	9.7	10.2	7.5	22.8	6.4	5.2	9.1	10.9	5.0	2.9	5.3	10.6	8.6	8.6	10.3	19.8	4.4	1.7	1.7	14.3	15.0	12.9	14.0	12.0	8.0	7.5	17.5	0.0	12.1	19.1	8.2	22.0	3.1	0.1	5.5	10.6	3.9	21.4	1.5	8.1	8.7	6.9	108.1	8.1	7.7	11.5	4.8	4.7	7.1	2.6	3.1	0.5	5.0	6.5	3.3	16.3	2.7	1.1	6.0	2.7	2.1	0.2	4.9	6.9	1.0	0.0	6.2	2.1	9.5	4.3	0.1	2.5	12.5	13.8	10.8	20.1	10.9	3.1	0.0	0.2	13.5	0.3	18.1	35.7	43.4	54.1	10.1	40.4	3.4	7.8	4.7	4.9	41.6	8.5	6.8	7.7	40.2	21.5	50.8	1.8	3.0	24.5	4.3	3.6	4.1	5.3	4.4	6.6	9.6	5.9	7.0	7.5	9.1	8.6	19.2	0.0	8.9	18.3	28.2	3.8	2.0	3.4	0.6	2.2	3.7	5.5	4.7	1.5	2.2	0.0	0.0	5.1	44.0	9.2	0.0	1.6	10.2	2.2	3.5	15.4	0.0	12.6	6.9	1.4	3.1	4.2	1.1	2.6	51.4	5.4	8.2	14.9	49.3	0.0	5.2	7.3	4.1	125.1	50.8	6.6	5.3	78.7	12.4	100.2	109.8	0.0	114.4	20.6	0.9	10.1	3.8	18.8	9.7	3.8	9.5	6.2	2.5	0.3	13.1	10.1	4.6	19.1	4.0	1.1	2.7	12.7	32.5	1.9	8.9	3.6
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208500-33212722	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	38.6	42.4	39.2	21.6	42.7	18.1	36.8	39.7	45.6	60.2	42.2	45.4	21.3	51.5	20.8	37.4	51.8	19.3	37.0	38.7	41.4	50.7	51.2	39.3	20.9	39.4	42.7	59.4	44.7	34.2	80.8	19.4	40.6	55.8	7.2	15.7	37.0	23.2	37.3	34.7	37.0	29.6	39.9	41.2	37.5	46.9	43.4	34.4	67.1	25.4	17.3	41.3	42.2	47.5	38.8	24.9	38.2	33.3	35.0	13.2	15.5	36.5	55.1	32.7	40.5	35.2	22.9	30.1	19.0	41.2	45.8	21.0	31.6	29.7	24.5	69.5	16.5	60.2	50.4	40.2	75.9	37.7	57.0	0.0	26.7	34.4	53.6	38.1	16.5	30.4	49.2	37.2	37.2	0.0	6.3	22.1	13.6	24.5	17.0	18.1	27.1	59.6	42.9	41.5	43.6	32.4	26.3	34.8	62.9	11.6	40.2	56.7	26.1	37.6	29.7	5.6	43.8	56.4	37.1	32.6	25.5	36.0	28.7	0.0	0.4	1.6	0.0	0.2	0.6	0.8	0.5	0.6	0.4	0.2	0.6	1.3	0.6	0.5	0.5	1.1	0.8	0.4	39.2	42.7	39.7	45.6	38.7	41.4	39.4	42.7	40.6	39.9	43.4	47.5	27.5	0.0	20.2	22.5	23.6	27.5	40.6	28.6	51.2	32.1	26.8	25.3	23.9	21.5	22.1	22.0	16.7	41.9	30.8	23.7	15.6	32.8	34.7	28.4	29.0	26.8	30.6	16.8	23.2	34.7	35.2	32.2	31.6	29.5	19.7	19.7	35.0	36.9	29.1	25.2	23.0	24.1	8.2	26.5	23.5	21.5	40.0	22.3	17.8	12.2	21.0	44.8	21.6	12.5	20.3	31.2	25.1	29.7	32.2	29.4	36.6	34.8	25.9	21.6	26.3	38.3	30.9	33.4	18.9	32.7	30.5	63.1	27.6	32.6	21.8	30.2
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867830-38878275	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.5;NK-cells: 45.3;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.2;Karpas-707: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.3	2.5	2.2	5.3	2.7	2.8	4.2	2.6	2.8	2.8	2.9	3.9	1.6	2.0	0.9	6.3	3.3	1.7	3.5	2.1	2.3	6.1	7.8	4.3	9.7	2.6	2.1	1.5	13.2	2.7	7.2	1.6	2.9	2.5	1.4	2.5	5.3	1.1	2.3	3.6	8.4	1.0	1.9	15.8	4.2	1.1	2.2	3.9	5.1	0.9	7.6	4.6	3.7	2.2	0.0	1.8	0.4	0.2	0.7	0.3	2.8	0.4	0.3	0.4	0.4	1.9	9.2	9.1	3.1	0.4	0.1	0.2	1.7	2.4	0.5	1.7	0.6	10.1	2.6	4.8	1.9	6.4	14.2	2.0	0.4	1.2	0.5	0.3	3.5	5.1	1.8	24.6	0.0	1.6	1.6	4.3	0.8	5.2	0.3	1.2	0.1	6.5	1.7	0.2	3.2	1.3	4.2	6.7	3.6	0.4	0.8	7.7	2.6	0.1	1.9	0.5	0.1	9.1	9.3	6.3	0.7	2.8	0.5	5.3	1.1	1.6	10.3	2.5	6.5	17.4	6.9	7.7	2.0	21.9	5.3	6.4	3.0	5.2	2.5	16.0	8.1	3.6	2.2	2.7	2.6	2.8	2.1	2.3	2.6	2.1	2.9	1.9	2.2	2.2	6.7	3.2	7.7	0.0	22.4	3.2	5.3	2.9	4.6	4.0	5.8	4.7	3.5	8.6	2.3	3.7	8.4	13.9	32.5	0.6	7.9	7.3	0.5	2.8	1.6	6.9	7.2	9.0	2.2	7.3	7.1	4.3	5.1	6.3	15.2	1.3	8.2	7.5	9.3	0.0	1.6	0.7	14.2	6.8	2.7	1.3	3.1	4.3	10.6	1.0	10.5	6.2	45.3	3.5	0.6	5.1	1.7	2.6	14.8	2.3	0.6	12.7	1.3	10.6	0.0	30.3	2.3	2.7	4.4	6.4	3.8	4.1	24.6	5.0	1.3	3.6
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532169-105567677	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	7.3	6.1	2.8	9.0	3.1	15.2	10.0	6.9	3.7	8.2	5.6	8.1	9.4	8.6	7.2	11.3	8.0	6.7	8.2	3.1	3.1	9.3	10.5	6.7	13.4	2.8	2.7	8.0	11.6	9.7	5.4	8.8	3.1	7.8	9.3	10.3	11.3	6.1	16.7	8.7	7.1	6.4	3.2	8.8	9.7	11.1	2.7	9.9	8.8	13.3	13.7	8.4	5.7	4.1	28.8	23.5	12.1	27.8	18.8	24.9	15.9	27.2	19.2	26.4	29.6	27.4	18.4	31.6	31.3	24.1	29.4	19.0	22.5	21.0	34.7	17.0	25.9	18.3	26.1	18.5	14.5	38.9	17.8	17.9	16.4	28.1	16.3	20.3	29.1	16.3	39.5	23.2	30.3	46.9	29.3	28.6	26.1	23.8	23.1	17.5	20.5	45.4	14.2	23.6	20.5	22.4	28.9	47.7	20.6	20.9	19.4	12.5	20.3	30.2	24.0	83.1	34.8	46.6	59.7	61.4	20.0	31.8	34.6	4.4	3.9	4.4	6.7	5.8	11.6	9.0	9.8	9.2	6.0	7.8	8.6	9.4	0.7	9.1	4.8	4.0	10.5	6.2	2.8	3.1	6.9	3.7	3.1	3.1	2.8	2.7	3.1	3.2	2.7	4.1	6.7	3.2	9.8	10.4	12.4	6.6	9.6	7.7	8.6	5.8	5.9	5.3	10.5	1.5	9.4	3.7	8.4	11.2	13.4	6.0	9.8	8.1	10.8	9.0	6.4	6.8	5.4	4.6	25.6	6.3	10.3	9.4	12.2	5.5	10.1	7.5	4.2	5.1	7.3	6.7	26.0	5.8	10.2	5.6	3.4	6.2	8.7	5.2	5.4	9.4	5.7	7.8	7.2	9.0	18.2	6.7	4.0	9.8	17.9	6.5	5.5	6.8	18.1	8.9	6.6	8.3	8.0	29.2	12.4	8.3	7.7	12.0	10.8	7.5	6.4	8.3
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389793-7418037	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	12.1	9.3	4.1	10.8	4.1	20.6	11.0	5.0	5.3	10.0	3.7	7.9	6.5	10.5	5.2	11.4	8.2	7.5	8.0	4.2	5.1	6.4	7.9	7.1	14.0	4.7	5.1	10.9	10.2	7.3	4.7	11.4	4.6	8.0	8.6	7.3	7.0	8.1	11.5	9.1	6.3	10.8	4.2	9.4	7.0	19.9	4.5	15.7	7.3	10.3	15.9	14.9	7.6	4.7	20.4	11.7	18.3	45.8	27.0	22.6	28.7	25.6	16.6	22.1	18.5	33.1	10.0	51.8	43.3	19.7	19.4	20.3	45.7	19.5	29.0	35.8	49.6	28.3	18.3	39.4	23.0	81.5	37.5	17.2	27.2	24.1	50.4	11.5	20.1	38.6	72.1	12.3	21.0	26.7	56.8	50.2	39.6	36.3	26.1	42.9	23.3	56.6	13.8	19.9	60.8	30.4	20.8	13.3	41.6	48.4	18.9	28.4	19.9	24.4	18.9	17.5	38.3	17.1	33.0	75.7	7.7	44.0	38.7	12.0	11.5	9.0	14.9	15.6	18.0	21.5	15.4	15.9	20.5	23.0	17.8	19.2	2.3	26.7	14.0	17.3	16.2	11.3	4.1	4.1	5.0	5.3	4.2	5.1	4.7	5.1	4.6	4.2	4.5	4.7	22.2	6.4	26.4	5.5	27.5	52.8	32.3	29.5	38.1	10.0	18.9	22.0	22.8	4.3	35.2	7.3	10.4	34.1	25.3	9.9	3.9	15.9	74.8	14.9	28.4	24.8	7.2	17.9	10.2	11.7	34.7	29.8	16.8	19.1	33.6	13.4	19.2	10.2	22.6	5.0	12.0	17.4	20.3	11.2	25.1	12.5	19.9	19.7	17.8	11.2	15.1	8.9	6.2	13.0	8.4	12.2	8.2	19.9	27.0	33.7	7.1	9.3	20.9	13.7	19.7	33.8	23.9	58.9	75.4	33.7	64.8	27.9	29.0	23.9	16.9	23.8
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183247	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	15.0	14.6	12.5	13.5	13.7	21.5	14.7	16.6	21.3	12.9	14.1	13.3	13.0	11.6	12.2	13.5	12.3	7.8	16.3	12.5	14.7	14.2	18.1	10.3	14.3	13.5	13.5	14.8	16.7	11.3	15.1	12.1	13.5	12.0	12.7	19.4	11.8	9.3	21.4	11.3	11.2	9.3	13.9	14.6	13.3	12.6	13.7	13.7	11.9	14.2	13.6	13.2	12.1	15.9	19.0	22.0	20.3	38.5	25.9	28.6	32.1	48.1	29.0	33.0	43.2	30.4	32.5	41.7	53.1	21.3	51.6	21.7	34.2	27.4	44.9	29.3	18.5	20.3	44.0	42.9	23.6	38.5	27.2	18.5	20.8	40.1	39.8	25.0	27.0	30.8	31.7	25.4	38.0	31.9	46.4	47.8	22.5	10.6	23.9	51.9	38.3	61.9	25.7	16.9	23.7	17.9	27.5	28.3	35.6	29.6	29.6	36.4	28.5	41.2	28.9	33.0	51.8	25.3	36.4	95.2	24.0	39.7	38.4	17.9	26.2	15.8	24.6	30.7	34.4	24.0	31.5	27.8	29.4	18.6	33.9	36.5	5.0	30.7	23.8	29.2	31.7	22.7	12.5	13.7	16.6	21.3	12.5	14.7	13.5	13.5	13.5	13.9	13.7	15.9	14.9	9.6	12.8	7.8	16.9	26.4	17.9	25.2	12.5	16.2	11.1	11.4	20.5	10.0	17.4	7.3	12.5	19.6	26.9	6.4	17.6	17.3	1.3	10.7	18.0	14.0	9.6	8.4	10.9	14.9	24.8	21.1	14.8	10.5	27.9	12.7	8.2	8.1	18.3	13.5	11.0	12.7	18.3	9.4	9.2	3.0	13.4	11.0	5.4	3.7	16.5	13.4	14.4	9.0	15.0	11.4	10.1	16.1	19.1	10.4	11.8	17.3	13.3	17.7	6.6	17.4	22.9	23.5	20.7	10.1	18.9	17.4	19.6	19.4	12.6	12.0
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23453287-23486603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 174.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 338.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	23.1	18.5	5.5	20.4	7.1	174.3	19.2	7.9	10.2	17.4	8.3	47.5	51.6	16.7	12.4	65.5	14.8	24.3	32.7	5.9	6.7	29.6	55.6	22.7	22.8	9.3	7.3	15.7	27.6	22.8	5.4	34.9	8.9	20.1	43.5	19.6	23.2	14.5	52.9	33.3	62.5	19.7	7.5	21.5	38.5	36.6	6.9	21.5	22.2	48.8	30.2	25.8	27.0	10.6	41.9	15.7	17.8	25.0	31.8	37.7	28.5	38.9	29.8	27.6	28.4	17.3	47.5	27.6	52.3	43.7	26.9	57.6	25.9	45.4	38.9	29.5	12.0	25.9	26.9	22.2	71.7	74.7	25.8	39.0	91.2	44.1	66.7	36.7	38.4	19.2	39.8	34.7	45.0	19.4	25.8	15.6	17.6	59.0	31.3	31.3	33.2	41.2	39.3	50.0	39.5	28.9	50.1	28.4	37.4	41.0	21.9	45.0	63.7	48.4	10.9	21.2	28.9	66.1	56.0	38.2	31.0	36.7	38.2	50.1	24.5	14.8	15.0	34.6	10.8	14.0	12.3	12.6	19.1	18.5	9.8	11.2	17.2	15.0	39.0	8.6	19.4	20.7	5.5	7.1	7.9	10.2	5.9	6.7	9.3	7.3	8.9	7.5	6.9	10.6	49.7	80.1	57.7	23.2	46.4	120.4	92.4	78.6	113.8	44.1	49.3	35.6	69.1	51.5	81.5	25.8	56.3	43.0	74.6	338.1	25.4	51.0	271.5	130.1	85.5	44.1	62.8	259.8	35.5	52.7	64.6	48.8	93.8	267.2	63.3	40.0	29.6	88.5	41.1	28.6	34.2	119.9	50.8	59.9	51.2	305.8	22.4	85.7	42.7	15.9	80.6	18.3	53.5	34.2	49.5	148.4	210.7	30.1	63.4	118.5	199.5	52.5	72.3	46.4	6.6	43.9	51.6	28.4	10.1	164.2	143.6	88.4	57.3	71.1	77.2	244.4
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	14.6	9.7	9.8	14.5	11.3	2.2	13.9	9.5	11.2	11.6	8.3	12.4	6.9	10.7	10.6	22.3	10.4	7.3	10.1	9.5	12.3	14.4	14.3	11.0	14.2	12.4	12.4	10.4	18.2	10.8	10.2	15.6	12.0	10.4	12.3	16.8	19.8	9.6	32.0	17.8	10.3	10.4	12.9	8.4	12.8	6.7	10.9	6.9	46.4	11.3	15.0	16.4	15.5	13.6	42.6	27.8	9.1	17.4	20.5	30.3	22.8	20.1	14.3	22.0	18.5	18.6	22.8	59.7	21.2	25.1	34.3	24.3	28.9	28.2	32.5	109.9	13.8	19.2	13.5	19.1	33.4	37.1	7.0	24.5	38.8	17.6	44.4	13.1	23.9	26.4	26.2	23.3	22.1	11.5	29.7	14.5	19.9	47.3	34.4	0.0	32.2	58.7	21.4	24.1	49.6	17.6	25.7	28.7	34.4	10.1	24.7	15.3	16.3	22.9	24.0	13.7	39.9	37.7	18.3	55.5	29.1	37.8	23.8	1.9	13.2	0.7	10.3	11.9	15.8	15.9	14.9	12.0	16.9	13.3	15.0	12.5	0.8	10.8	15.8	26.0	15.2	10.5	9.8	11.3	9.5	11.2	9.5	12.3	12.4	12.4	12.0	12.9	10.9	13.6	18.3	9.6	14.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	14.9	11.2	0.0	0.0	10.5	7.3	0.0	33.7	5.7	0.0	49.0	16.4	0.0	25.7	14.9	5.8	0.0	0.0	0.0	13.2	43.5	7.3	0.0	12.6	2.5	20.2	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.5	0.0	0.0	11.6	13.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	31.2	2.2	24.8	0.0	0.0
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757806-89791064	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	4.1	1.6	4.0	5.6	4.0	8.9	5.1	4.0	5.5	4.7	3.3	2.9	1.7	5.5	2.4	3.0	2.7	9.4	4.4	4.1	5.5	3.7	5.6	6.0	6.5	4.6	4.0	2.5	4.4	4.2	1.9	4.7	5.1	5.3	2.9	1.5	5.0	2.7	0.6	4.2	2.4	5.7	5.3	4.8	2.9	2.9	3.7	2.8	4.2	1.3	6.7	9.4	2.6	6.0	17.8	6.0	3.2	4.9	7.9	10.8	5.5	19.2	36.1	10.7	13.6	4.6	9.7	14.4	28.0	11.7	7.6	4.2	8.9	6.9	20.2	8.7	8.0	11.9	2.8	5.5	22.2	4.5	5.8	8.8	5.6	15.6	49.8	11.4	11.4	0.0	5.4	4.7	10.2	3.4	0.0	9.6	1.5	8.4	14.4	3.2	4.1	7.5	26.1	8.4	0.4	3.1	4.7	12.6	10.0	4.0	12.0	5.6	10.1	6.5	6.0	11.2	9.1	8.9	4.2	8.8	16.2	0.4	4.3	13.7	6.6	23.2	3.5	12.5	4.1	7.6	5.4	4.6	8.1	4.8	4.9	5.4	5.1	4.4	14.9	2.6	1.3	4.6	4.0	4.0	4.0	5.5	4.1	5.5	4.6	4.0	5.1	5.3	3.7	6.0	19.3	35.3	18.1	25.5	29.8	57.6	33.7	13.3	16.5	2.1	17.2	8.9	5.2	4.3	22.9	3.7	0.0	13.3	32.8	2.8	5.9	80.1	6.6	82.3	23.7	15.0	0.0	9.9	12.9	60.8	45.7	27.3	9.7	156.1	43.1	7.1	6.1	3.2	41.7	3.3	9.1	5.4	24.4	32.4	121.3	2.5	7.8	105.1	19.6	15.0	42.1	12.1	8.2	15.6	12.8	50.0	2.7	6.0	22.0	59.2	2.2	10.4	11.6	0.3	13.1	19.2	19.6	7.9	12.8	14.7	48.3	83.7	30.4	7.5	8.1	49.5
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767089	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 52.3;Endometrial ciliated cells: 76.5;Gastric mucus-secreting cells: 61.2;Glandular and luminal cells: 174.2;Squamous epithelial cells: 71.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.2;GAMG: 41.2;HaCaT: 47.5;hTCEpi: 31.4;RPTEC TERT1: 28.3;RT4: 30.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA030942	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.6	0.0	0.1	0.4	0.0	0.6	4.3	0.0	0.1	11.8	3.7	3.1	9.7	1.1	2.4	72.2	5.8	5.2	1.5	0.1	0.1	11.5	19.1	4.2	0.1	0.3	0.6	0.1	14.3	7.4	10.8	2.3	0.1	10.7	2.0	0.6	14.8	9.8	0.0	21.5	13.6	0.1	0.1	0.0	15.5	2.0	0.1	7.8	7.9	0.0	5.2	6.3	22.3	0.1	14.3	9.0	0.0	0.0	0.0	0.0	13.7	0.1	0.1	0.2	0.2	23.5	32.2	0.0	13.3	2.9	41.2	47.5	0.7	19.2	0.0	0.0	9.4	0.0	6.9	8.8	0.0	0.0	0.0	0.0	31.4	0.2	4.2	0.0	0.0	14.3	0.0	0.0	0.0	10.3	2.0	0.0	0.8	9.3	26.1	0.0	0.0	2.3	28.3	30.8	4.5	0.3	15.5	15.7	15.1	1.3	9.6	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	4.2	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.1	0.1	28.9	9.1	0.0	0.1	15.8	27.4	24.0	52.3	0.0	13.0	12.4	1.1	17.2	28.0	3.7	0.0	8.3	0.3	22.8	9.8	12.4	1.5	76.5	16.9	0.9	22.7	0.0	0.0	10.4	5.1	0.6	61.2	174.2	2.5	0.0	0.0	17.0	1.0	0.0	0.0	14.2	16.2	0.6	1.4	1.6	0.0	0.9	7.2	0.0	0.0	0.4	0.0	0.0	0.0	19.0	11.8	0.0	0.0	24.0	26.5	13.5	22.2	0.9	0.0	0.0	1.3	1.4	2.5	71.2	15.2	2.5	1.5	0.0	11.2	24.1
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	44.4	28.1	27.6	23.4	30.6	27.2	37.7	26.4	38.6	39.9	7.5	36.0	8.8	45.2	6.0	18.5	36.2	21.5	53.6	33.6	16.3	67.6	16.7	55.8	20.8	26.6	17.1	33.2	30.1	20.6	26.5	29.8	25.4	30.6	7.4	43.8	22.8	20.2	34.9	21.4	32.7	25.2	12.3	61.2	25.9	18.6	21.5	10.8	36.4	22.3	17.5	37.1	30.4	18.6	44.0	36.6	16.1	25.3	40.0	35.7	35.7	45.7	44.9	51.6	43.0	75.7	31.5	6.0	62.4	78.8	26.0	24.4	32.7	41.3	33.2	19.3	17.0	57.9	53.6	17.4	44.7	4.6	28.0	35.5	18.8	69.7	47.1	36.8	55.2	10.2	6.5	6.4	38.7	47.7	13.8	14.4	4.4	8.5	29.1	46.8	29.0	31.2	39.0	22.1	12.1	31.9	85.1	13.8	28.6	15.9	30.2	10.7	96.8	58.3	34.2	49.8	32.2	9.0	6.8	17.8	38.8	11.1	31.7	0.1	11.2	9.3	1.2	15.6	1.8	15.8	1.0	0.5	10.2	9.4	0.7	0.7	6.6	1.7	15.1	14.4	0.8	6.0	27.6	30.6	26.4	38.6	33.6	16.3	26.6	17.1	25.4	12.3	21.5	18.6	49.2	16.0	16.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	12.1	8.8	0.0	0.0	1.8	7.3	0.0	0.8	3.7	0.0	0.0	15.8	0.0	9.3	17.9	23.6	0.0	0.0	0.0	12.5	1.3	6.9	0.0	18.5	10.1	7.9	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	2.3	0.0	0.0	5.8	2.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	2.1	2.3	16.6	0.0	0.0
RIPOR3	"C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C"	ENSG00000042062	"RIPOR family member 3"	Q96MK2	20	50586108-50691542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 3.7;Endometrial stromal cells: 6.5;Fibroblasts: 3.8;monocytes: 2.0;Proximal tubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 16.7;HEL: 55.9;HSkMC: 33.0;K-562: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051823, HPA054759"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051823: AB_2681626, HPA054759: AB_2682596"	"unprognostic (7.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.66e-5)"	"unprognostic (4.96e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.58e-2)"	19.4	13.3	2.7	3.4	3.0	22.4	11.7	2.7	3.5	38.5	5.1	8.5	2.5	18.2	1.0	5.3	27.7	3.2	16.6	2.7	2.6	28.9	14.1	5.3	4.7	3.0	2.9	8.3	3.0	0.8	9.1	1.9	2.9	6.0	1.5	0.1	6.9	0.6	7.8	5.5	11.3	4.4	2.6	7.5	5.8	6.1	2.8	4.7	7.5	3.8	1.3	8.2	16.6	2.6	0.0	0.0	0.9	0.0	36.0	16.7	0.1	0.0	11.6	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.2	4.3	0.0	0.0	33.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.9	0.0	3.2	0.0	0.0	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.7	3.0	2.7	3.5	2.7	2.6	3.0	2.9	2.9	2.6	2.8	2.6	1.1	3.2	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.6	3.7	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.8	6.5	0.2	0.0	0.0	0.0	0.4	0.4	3.8	0.0	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903341	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 3.4;liver: 5.8"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 4.3;Proximal tubular cells: 1.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.2;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RH-30: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052284	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	3.4	5.8	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
RIPPLY2	"C6orf159, dJ237I15.1"	ENSG00000203877	"Ripply transcriptional repressor 2"	Q5TAB7	6	83853266-83857515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.2;choroid plexus: 9.6;pituitary gland: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.0;Excitatory neurons: 10.0;Horizontal cells: 11.8;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 13.0;Rod photoreceptor cells: 8.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 6.2;SCLC-21H: 26.0;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047454	Uncertain					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA047454: AB_2680053"		"unprognostic (2.09e-1)"			"unprognostic (7.43e-2)"	"unprognostic (2.51e-1)"		"unprognostic (1.20e-3)"			"unprognostic (2.69e-3)"	"unprognostic (3.66e-1)"		"unprognostic (6.94e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	0.3	1.4	13.8	0.2	14.4	0.0	0.2	17.9	21.2	0.9	9.6	1.3	0.2	0.8	0.0	0.2	0.5	0.3	0.2	14.6	14.6	0.2	0.0	0.1	0.0	13.9	12.7	0.4	1.1	0.0	11.2	0.0	13.8	0.7	0.2	4.2	0.1	0.4	0.3	0.1	0.4	0.3	13.3	0.0	0.7	0.8	13.5	0.0	0.2	0.0	0.0	1.4	0.5	14.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	19.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	1.5	0.0	0.0	1.1	26.0	17.7	1.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.4	17.9	21.2	14.6	14.6	13.9	12.7	13.8	13.3	13.5	14.2	0.2	0.0	0.0	2.0	0.0	0.0	0.4	0.3	1.8	12.0	0.0	0.1	3.5	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	1.8	0.0	10.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.5	0.0	4.1	0.0	0.3	0.5	0.3	0.0	0.0	1.0	0.0	1.4	0.0	13.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	8.5	0.0	2.9	1.0	0.8	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1
RIPPLY3	DSCR6	ENSG00000183145	"Ripply transcriptional repressor 3"	P57055	21	37006150-37019662	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.0;Extravillous trophoblasts: 2.9;Hepatic stellate cells: 1.8;Squamous epithelial cells: 1.6;Urothelial cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;PC-3: 1.0;RPTEC TERT1: 1.3;RT4: 1.2;SCLC-21H: 3.9;T-47d: 3.2"	"Low region specificity"	"Detected in many"							HPA055541	Uncertain					NA	NA					"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA055541: AB_2682840"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.57e-4)"	"unprognostic (2.69e-1)"	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	1.3	1.2	3.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	1.2	0.0	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.2	3.0	0.0	0.2	0.0	2.9	0.4	0.0	0.6	0.0	0.2	1.8	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.4	0.4	1.6	0.4	0.0	0.0	0.2	0.1	1.4
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	19.8	13.8	10.7	22.9	12.1	80.7	13.3	12.0	13.0	16.6	12.1	14.0	12.7	14.8	15.4	37.3	10.8	18.5	15.7	10.3	11.8	25.1	12.2	22.7	18.3	13.5	12.7	12.8	13.8	16.5	11.0	23.0	13.3	13.8	14.3	16.0	14.4	18.0	10.8	12.8	12.5	21.3	11.6	21.7	19.7	12.2	12.8	21.5	13.4	16.5	23.6	23.6	21.9	13.3	21.0	22.9	42.3	21.7	21.5	26.6	12.0	37.2	37.4	35.2	35.4	24.1	40.0	9.6	50.0	43.9	25.3	24.7	32.0	18.5	29.4	12.9	16.4	21.0	24.4	15.6	55.7	22.5	37.9	37.1	22.5	40.9	27.4	47.7	48.7	19.7	21.0	26.3	54.3	27.3	30.7	14.9	23.0	36.2	13.9	24.0	33.3	19.6	29.9	44.2	19.7	30.7	27.1	51.1	34.8	76.9	37.3	29.4	62.5	31.7	22.3	27.3	30.7	31.1	30.9	38.8	33.9	22.8	43.0	22.8	41.0	46.9	19.5	25.5	15.6	16.9	16.8	18.5	31.1	17.1	20.2	18.1	106.3	28.8	29.3	12.5	23.8	30.0	10.7	12.1	12.0	13.0	10.3	11.8	13.5	12.7	13.3	11.6	12.8	13.3	45.8	48.1	23.9	12.4	22.4	28.9	36.5	43.7	21.6	8.1	17.4	12.3	14.2	8.6	40.4	18.4	10.4	14.5	41.8	14.1	21.5	39.4	10.4	20.4	25.7	50.5	12.6	16.4	5.1	23.4	16.8	20.8	13.3	32.5	14.0	15.2	24.7	7.0	50.7	6.7	5.3	11.5	42.7	45.6	107.9	10.3	7.2	62.6	33.8	11.2	79.2	25.9	16.5	8.5	8.1	28.3	15.4	15.8	13.4	48.8	15.4	70.6	21.9	11.9	26.3	18.2	26.1	12.7	23.2	26.0	30.7	33.5	32.7	20.7	10.0	79.2
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554"	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.8	25.4	17.0	7.1	17.4	7.1	7.7	16.0	20.2	8.7	14.6	9.7	13.1	8.1	6.4	14.3	14.0	5.9	15.0	17.5	15.7	15.9	29.6	6.9	11.1	15.1	15.3	10.6	10.6	9.5	12.6	4.7	15.2	10.1	5.9	4.4	13.7	8.3	31.7	10.8	14.2	4.6	12.6	9.5	8.8	7.4	16.9	9.7	10.4	27.2	8.2	8.5	8.1	15.3	27.0	34.3	8.7	23.0	11.5	8.8	15.6	17.2	35.3	24.9	19.8	40.7	13.0	50.8	26.0	14.6	21.4	20.0	20.0	22.3	14.4	31.3	28.4	17.4	16.6	26.6	18.7	23.4	14.0	13.6	20.2	24.6	13.8	34.5	20.7	24.7	34.0	9.2	14.9	38.6	26.1	63.1	29.2	22.9	41.8	23.2	9.3	43.2	20.3	37.8	28.9	16.6	21.7	45.2	38.2	10.6	38.2	35.5	13.7	15.7	22.3	18.2	24.7	31.6	28.6	56.0	23.4	19.4	22.5	43.7	14.6	9.9	15.3	6.6	15.3	11.0	13.5	13.9	16.5	11.8	13.2	14.6	0.3	20.7	8.6	22.5	16.1	13.5	17.0	17.4	16.0	20.2	17.5	15.7	15.1	15.3	15.2	12.6	16.9	15.3	8.1	0.0	11.3	2.9	11.1	6.4	7.1	14.0	7.4	7.4	14.7	14.7	6.6	12.8	9.1	14.7	4.2	19.3	9.8	17.0	49.0	19.2	10.8	16.7	7.3	9.3	11.4	8.8	6.5	16.4	16.9	7.0	8.2	7.3	0.0	8.7	8.6	37.5	14.2	15.2	6.7	12.5	8.2	7.8	2.4	29.6	9.9	6.3	5.4	2.8	5.9	11.0	19.6	2.0	3.7	15.2	12.9	8.2	14.7	10.1	62.0	51.9	17.1	6.0	6.6	7.7	7.5	4.5	7.8	13.8	6.5	10.1	9.0	17.2	12.7	7.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 265.6"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	14.9	0.1	16.9	0.1	0.0	15.0	20.8	0.0	16.7	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	15.7	14.5	0.0	0.0	0.0	0.0	14.5	14.2	0.0	0.0	0.0	2.6	0.0	14.3	0.0	0.1	265.6	0.0	0.0	0.1	0.0	0.4	0.1	14.0	0.0	0.2	0.9	14.9	0.0	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.9	16.9	15.0	20.8	15.7	14.5	14.5	14.2	14.3	14.0	14.9	14.9	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"RLF zinc finger"	Q13129	1	40161387-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	8.7	4.9	5.5	6.2	6.0	32.8	8.3	12.0	7.9	8.4	2.5	7.6	5.1	7.9	4.7	7.3	7.0	6.6	7.5	6.0	5.6	4.9	7.7	8.2	7.7	4.1	4.3	8.3	5.6	6.5	5.1	7.3	4.2	6.6	5.2	15.4	5.7	5.4	8.5	12.2	6.2	6.1	4.3	6.2	5.7	10.3	5.2	10.2	5.8	7.1	8.5	7.8	8.4	8.2	18.3	6.9	13.3	13.9	11.6	9.4	15.8	6.7	9.9	11.3	14.9	14.0	9.4	18.1	8.6	8.6	8.4	16.8	16.9	11.8	20.4	8.5	11.4	14.9	8.0	8.7	9.2	12.5	8.7	9.3	12.1	12.0	13.5	13.5	7.8	9.8	23.0	10.8	10.4	5.8	10.6	7.5	17.8	6.7	7.9	8.2	21.8	10.6	7.2	18.2	9.4	13.1	12.5	16.5	12.0	20.5	7.8	44.6	6.7	13.2	14.1	11.0	12.6	9.8	9.8	16.6	11.5	11.4	8.4	6.9	1.5	3.0	1.8	2.0	2.4	2.3	1.8	1.9	1.9	2.1	2.3	2.0	3.2	2.4	2.4	0.8	1.8	1.3	5.5	6.0	12.0	7.9	6.0	5.6	4.1	4.3	4.2	4.3	5.2	8.2	36.7	32.1	15.1	52.2	55.8	65.6	50.3	12.7	30.7	17.8	25.5	18.4	16.9	2.8	23.9	3.7	16.7	8.9	40.6	10.4	5.9	13.8	41.3	43.8	41.6	24.9	20.2	11.3	87.1	6.7	10.6	34.9	29.6	56.0	26.6	23.0	16.1	9.0	9.7	26.9	84.7	8.8	14.2	13.8	45.2	8.7	9.0	39.9	17.8	60.9	17.5	14.1	9.2	71.9	89.0	10.1	15.5	7.9	44.6	28.7	8.9	5.5	26.0	17.2	13.1	52.8	36.1	32.2	20.8	29.3	61.1	17.2	45.8	17.0	10.8	33.0
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RMC1	"C18orf8, HsT2591, MIC1, WDR98"	ENSG00000141452	"Regulator of MON1-CCZ1"	Q96DM3	18	23503470-23531822	"Cancer-related genes, Predicted intracellular proteins"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 14.5;Proximal tubular cells: 19.9;Syncytiotrophoblasts: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043589	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043589: AB_2678568"	"unprognostic (6.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.13e-2)"	12.8	9.8	4.9	11.2	6.0	27.4	11.2	5.5	7.3	10.9	8.5	11.1	16.7	11.2	9.3	11.7	10.6	10.3	8.8	6.2	6.6	13.0	19.1	14.4	21.3	5.3	4.8	9.6	11.7	11.4	16.6	8.5	5.7	9.3	10.9	25.4	12.2	10.6	13.4	12.5	17.1	10.6	5.1	15.6	14.6	17.2	5.3	15.8	9.8	7.4	19.1	14.8	10.5	7.2	13.9	13.9	10.3	18.1	23.0	16.6	13.5	21.5	22.8	28.2	33.6	12.9	8.1	20.8	17.5	18.7	40.9	26.6	27.1	12.0	24.8	21.6	15.4	10.2	8.7	13.1	30.1	27.7	36.0	14.9	18.6	35.2	19.8	16.2	16.9	17.7	16.7	21.9	18.8	18.1	23.8	13.0	5.6	19.7	21.4	18.3	15.4	20.4	14.7	13.0	13.8	17.9	28.1	13.7	18.2	14.2	10.5	17.6	16.2	23.6	6.0	9.8	18.6	34.1	27.4	23.6	24.5	18.7	18.4	50.5	16.4	37.7	23.8	31.0	24.5	32.5	20.7	23.3	20.0	29.5	14.0	17.2	15.2	32.9	44.5	44.5	30.5	18.7	4.9	6.0	5.5	7.3	6.2	6.6	5.3	4.8	5.7	5.1	5.3	7.2	9.1	9.6	13.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.6	5.8	0.0	0.0	3.7	7.3	0.0	10.7	13.4	0.0	5.9	11.6	0.0	11.4	5.9	2.9	0.0	0.0	0.0	12.1	7.6	3.4	0.0	14.5	3.8	8.7	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.8	0.0	0.0	0.0	0.0	11.3	0.0	0.0	1.9	0.0	0.0	19.9	1.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	19.2	6.3	8.3	0.0	0.0
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	35.6	26.1	25.8	20.9	30.1	24.7	24.3	30.4	27.8	15.5	25.3	26.7	28.7	17.6	19.8	29.4	21.1	22.5	63.0	23.0	29.5	51.7	56.8	23.4	30.3	29.8	29.7	17.0	17.5	26.3	12.9	18.9	30.0	21.2	29.0	30.9	16.4	20.7	71.7	32.8	29.2	20.2	28.3	25.2	30.6	26.4	29.6	23.0	50.4	70.5	31.5	20.1	16.3	30.5	64.0	27.1	31.3	17.8	60.3	97.8	38.5	45.9	41.1	35.8	34.6	32.2	39.9	76.2	38.1	38.2	33.2	61.0	39.8	46.0	42.1	64.6	31.9	40.2	32.8	82.1	32.1	18.4	1.0	53.3	42.6	47.6	72.9	63.9	81.6	44.3	42.4	40.7	57.5	57.3	65.1	8.6	15.9	111.3	67.5	36.6	43.6	78.9	42.5	39.3	14.8	32.8	38.2	149.2	67.6	32.5	83.9	33.6	44.6	39.5	64.0	50.8	28.2	52.4	46.5	59.7	51.2	28.7	54.4	16.4	38.5	94.2	26.6	50.7	31.1	42.2	27.1	31.3	45.2	30.8	22.3	29.0	15.5	39.0	70.3	51.3	43.2	30.7	25.8	30.1	30.4	27.8	23.0	29.5	29.8	29.7	30.0	28.3	29.6	30.5	24.0	41.7	39.0	38.8	23.8	13.5	13.2	40.1	22.2	14.5	16.8	15.0	117.3	20.0	42.4	20.2	16.7	42.5	29.9	22.2	49.0	42.9	97.8	28.3	26.6	24.3	10.2	27.3	22.5	53.0	57.1	24.0	32.1	24.8	1.3	18.9	21.8	57.7	53.7	20.2	29.9	20.6	18.3	40.1	14.8	77.1	13.1	28.3	16.0	33.7	48.5	27.4	21.6	42.3	51.9	45.8	17.2	9.1	21.8	9.2	45.7	73.0	34.4	21.5	0.0	19.9	32.9	65.7	33.5	31.0	15.5	28.5	21.6	53.1	26.9	15.2
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 42.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	42.5	3.8	4.1	3.5	3.4	5.3	4.8	4.5	7.7	2.9	12.4	8.4	5.1	9.2	3.4	3.9	6.2	4.4	4.1	2.6	7.8	29.2	11.3	4.6	3.9	2.6	2.8	4.1	3.2	3.0	3.9	2.6	7.2	10.6	4.2	3.7	12.8	5.1	2.9	13.9	5.8	3.0	20.0	4.4	21.7	3.6	5.9	5.4	3.2	2.9	4.3	3.5	3.7	3.3	4.7	2.6	1.8	10.4	11.4	1.5	7.0	9.3	3.6	3.2	1.1	10.9	2.2	2.8	9.9	2.2	3.5	0.8	5.1	4.9	5.0	3.0	3.6	1.6	3.1	5.3	0.0	3.8	16.2	4.6	4.5	0.7	5.4	2.0	1.8	4.4	2.1	6.8	1.3	0.9	4.5	5.1	6.5	3.8	0.0	0.8	0.6	9.0	2.7	2.1	7.5	5.7	0.7	7.3	2.2	1.1	5.9	3.8	4.4	5.1	2.5	2.6	3.8	7.7	4.6	5.4	1.1	4.6	0.0	2.8	0.7	2.0	4.6	3.1	4.1	1.0	1.3	1.8	2.3	1.0	2.2	2.7	3.7	3.5	3.4	0.1	1.4	3.8	3.5	4.8	4.5	4.1	2.6	3.9	2.6	2.6	3.0	3.6	3.7	3.4	28.9	29.6	25.1	6.5	2.4	6.8	16.3	8.6	3.5	1.9	4.2	5.3	11.5	20.0	5.5	2.1	2.1	6.0	20.9	7.9	5.4	270.4	3.7	11.8	4.6	4.8	3.0	33.8	3.8	1.0	9.2	2.6	3.1	15.8	13.1	5.3	15.5	4.7	5.0	24.5	11.4	6.1	6.3	1.7	163.5	9.3	4.8	5.4	19.7	4.4	4.7	6.2	39.2	7.1	2.5	6.1	6.0	1.8	2.2	29.6	6.7	10.2	2.6	6.6	6.4	5.1	9.4	4.8	1.7	2.4	0.8	3.9	77.6	15.2	2.3
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No		42000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	30.1	22.7	37.2	16.2	40.2	24.1	26.7	38.4	48.6	18.0	31.2	18.1	43.8	15.9	5.4	22.6	18.8	16.7	16.4	36.3	36.1	18.4	37.0	36.5	15.6	40.2	38.6	17.2	27.2	36.3	10.9	19.4	36.0	17.2	9.0	6.7	33.3	15.4	20.7	21.1	51.7	11.2	37.7	13.0	21.5	13.8	42.9	15.0	19.9	14.1	8.4	20.3	17.6	41.2	19.7	17.7	21.0	35.9	19.2	17.2	36.3	50.2	19.8	34.9	25.6	63.7	21.7	16.7	65.0	27.0	26.0	66.3	26.9	37.3	3.7	44.2	33.1	53.6	51.4	31.6	62.9	36.4	41.1	30.9	34.0	25.2	23.9	16.3	24.8	32.6	57.4	44.9	15.1	40.0	27.7	23.6	16.7	52.7	34.6	42.6	25.1	38.9	28.8	32.7	49.8	18.1	39.9	53.4	19.5	8.2	41.6	39.1	37.3	37.8	27.0	51.1	42.5	34.0	42.7	26.7	26.8	38.2	42.2	4.0	13.2	5.5	28.2	17.8	25.0	16.0	20.6	26.0	14.4	13.7	15.9	17.3	2.1	65.1	22.3	54.2	20.3	26.6	37.2	40.2	38.4	48.6	36.3	36.1	40.2	38.6	36.0	37.7	42.9	41.2	20.1	32.1	28.1	18.6	11.0	15.7	16.4	26.9	15.9	20.0	21.0	13.6	8.1	15.7	27.8	18.4	4.2	44.4	22.4	17.2	1.9	27.7	2.8	20.7	17.8	18.1	4.9	42.7	23.5	22.0	28.5	17.8	13.7	22.0	19.0	8.6	17.5	36.4	110.7	18.5	18.2	12.3	26.4	14.7	10.4	3.4	16.8	21.0	19.6	8.4	11.7	21.6	43.3	16.1	21.8	21.8	16.7	14.3	18.0	17.3	77.6	14.5	29.3	17.3	6.6	22.2	16.0	40.4	40.4	21.9	11.9	62.8	18.3	16.7	21.4	23.1
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11381662	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.4	1.5	2.2	12.3	2.0	9.9	5.1	1.0	2.2	4.8	0.9	12.5	7.5	2.9	3.9	10.8	2.1	2.2	1.6	2.3	1.3	3.4	4.3	1.9	31.4	1.2	1.3	3.0	1.8	1.3	0.6	19.3	1.2	3.2	14.4	0.5	2.4	2.1	0.9	10.2	8.8	2.3	1.0	3.5	7.0	14.0	1.4	36.8	1.5	0.6	34.9	4.5	4.4	1.8	60.3	39.5	75.2	32.6	3.3	15.8	33.0	35.9	26.8	31.6	51.8	15.4	69.2	83.8	29.1	15.8	35.3	34.4	32.4	32.5	50.5	16.6	30.5	45.3	22.6	102.5	1.3	17.6	19.5	3.7	6.1	14.5	13.3	12.3	17.4	36.2	65.3	63.2	16.5	70.3	60.9	83.1	64.1	82.6	15.7	73.1	81.1	89.3	18.7	38.0	44.1	35.0	28.5	47.4	26.1	43.5	80.4	25.8	5.6	25.1	23.3	49.3	5.0	18.1	30.9	99.3	23.3	57.4	47.2	0.0	0.0	0.4	0.3	0.0	0.0	4.2	0.1	0.0	0.2	1.1	0.8	0.3	0.1	0.1	0.0	0.2	1.4	0.1	2.2	2.0	1.0	2.2	2.3	1.3	1.2	1.3	1.2	1.0	1.4	1.8	1.3	0.0	0.5	0.0	4.5	6.8	5.4	1.4	6.2	0.2	3.4	3.2	1.0	4.3	1.6	7.3	0.0	123.8	0.5	3.3	5.9	2.6	3.0	0.8	2.1	2.8	2.4	38.5	0.0	0.5	34.1	6.4	4.1	2.2	0.0	19.7	1.1	1.1	18.5	0.0	0.0	7.7	0.0	0.8	6.5	5.9	15.8	3.7	3.6	0.0	1.1	0.2	1.0	0.0	0.0	1.0	4.0	42.5	2.4	2.1	1.3	0.4	0.1	0.6	32.9	0.0	2.2	36.6	51.8	11.3	5.4	47.7	1.9	6.5	10.3	7.5
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452158	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.6	13.9	7.7	6.4	8.1	4.4	13.6	7.8	8.9	9.9	8.2	10.3	13.4	8.9	11.7	7.5	11.9	8.0	12.1	7.8	8.6	36.9	30.5	7.5	9.2	8.2	8.1	14.6	9.5	8.9	6.3	9.6	8.4	6.8	11.3	7.1	7.1	7.7	10.9	7.7	12.1	7.5	8.0	7.3	8.0	9.1	8.6	8.1	18.6	10.0	10.1	9.2	8.1	8.2	16.0	7.2	15.1	32.3	20.6	46.7	21.3	24.6	23.4	18.6	25.4	21.5	11.7	14.9	17.4	16.1	23.1	13.5	29.3	14.9	32.1	17.7	23.8	24.1	11.0	44.5	43.4	53.9	7.2	33.4	19.5	26.9	39.7	22.8	25.0	22.6	26.3	11.5	29.0	54.1	18.6	18.1	11.1	16.8	14.3	21.0	19.7	18.2	26.7	7.2	26.1	25.5	17.9	22.2	29.5	18.6	36.6	34.8	13.8	14.6	19.0	30.6	20.0	12.1	17.5	17.6	36.7	42.3	17.5	1.9	5.6	7.1	6.4	8.2	10.4	11.6	7.6	9.1	7.0	8.9	10.1	9.3	2.8	13.3	13.3	3.2	11.8	4.5	7.7	8.1	7.8	8.9	7.8	8.6	8.2	8.1	8.4	8.0	8.6	8.2	11.6	0.0	11.2	12.1	6.9	3.8	6.4	10.2	9.1	8.9	15.4	13.7	11.9	5.7	11.9	12.9	12.5	27.0	7.4	7.6	17.6	15.6	9.4	10.9	18.4	7.8	3.0	8.0	22.4	10.7	21.7	8.8	4.1	12.4	9.5	25.0	10.8	16.7	13.7	5.0	20.6	9.7	6.1	12.5	5.7	6.4	6.8	9.8	3.6	8.4	12.3	7.7	10.3	15.6	21.7	9.9	11.2	6.4	5.8	3.6	33.8	45.1	9.3	6.9	0.0	6.7	14.9	13.0	16.8	8.3	2.7	16.8	8.4	27.3	15.3	5.3
RMND5A	"FLJ13910, GID2, GID2A, p44CTLH, RMD5"	ENSG00000153561	"Required for meiotic nuclear division 5 homolog A"	Q9H871	2	86720291-86778041	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046795, HPA060843"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA046795: AB_10963573, HPA060843: AB_2684378"	"unprognostic (4.54e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.32e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.56e-1)"	17.8	11.2	19.4	9.3	24.3	31.2	16.2	54.5	25.2	13.4	20.0	19.7	16.4	13.0	13.3	31.3	12.9	6.8	38.2	21.6	17.5	18.2	42.9	10.5	11.6	18.4	20.6	11.1	11.6	20.8	7.9	11.6	18.3	12.4	21.2	18.9	11.4	11.1	63.6	22.4	15.5	13.7	20.4	14.3	12.1	7.8	18.7	31.4	13.0	37.0	14.0	10.0	17.0	28.8	19.4	10.2	17.6	10.5	22.9	10.1	36.3	7.5	6.1	9.7	11.0	37.6	20.3	66.7	22.4	6.9	11.3	22.6	45.1	15.8	15.0	19.4	34.4	58.7	21.8	34.2	23.1	43.2	18.6	15.4	30.5	10.2	35.2	11.0	17.0	48.7	37.7	37.3	7.9	12.6	40.1	36.9	29.8	23.1	13.0	47.3	54.2	42.3	20.1	22.8	32.6	25.1	16.9	33.5	27.9	24.8	16.8	36.8	16.3	6.7	12.9	12.2	11.7	16.7	18.8	45.0	5.6	51.3	7.8	37.5	11.9	8.1	8.1	10.1	9.7	4.7	6.2	9.1	9.4	6.4	8.4	11.6	27.5	8.8	12.5	7.4	4.7	8.6	19.4	24.3	54.5	25.2	21.6	17.5	18.4	20.6	18.3	20.4	18.7	28.8	32.8	12.8	15.9	15.3	27.0	41.9	23.4	10.4	46.7	26.3	25.5	15.6	93.2	24.3	10.5	11.0	6.2	21.0	36.2	73.3	23.5	13.1	13.7	33.8	28.7	26.0	39.5	105.2	27.3	14.1	18.6	20.1	24.5	35.3	8.2	16.3	25.0	76.7	15.1	23.5	27.2	57.4	14.2	34.4	42.7	5.6	19.3	26.3	32.0	14.0	23.7	15.3	30.9	10.6	42.3	21.9	30.9	17.3	30.1	34.8	38.1	34.4	26.6	16.3	6.6	22.7	20.1	17.9	27.8	50.0	54.8	24.6	31.4	24.6	28.7	34.0
RMND5B	"FLJ22318, GID2, GID2B"	ENSG00000145916	"Required for meiotic nuclear division 5 homolog B"	Q96G75	5	178130996-178150568	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 186.6;Late spermatids: 415.4;Spermatocytes: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 130.3;MCF7: 185.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047778	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA047778: AB_2680153"	"unprognostic (2.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (7.66e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.22e-8)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.43e-2)"	"unprognostic (5.78e-2)"	18.9	23.4	19.8	11.2	19.7	13.2	18.8	19.2	20.3	24.0	19.4	24.5	13.2	22.7	12.2	69.8	19.2	9.6	28.1	19.7	18.7	22.4	27.2	17.4	18.0	22.3	19.4	17.1	25.4	23.5	20.7	16.4	19.1	19.0	11.4	10.5	24.2	15.9	45.6	29.6	17.3	15.9	19.6	19.2	23.2	81.6	21.2	23.7	20.5	32.4	23.0	22.1	28.2	20.9	21.3	37.5	21.4	53.5	27.4	2.8	71.3	16.9	18.2	25.1	29.2	42.1	30.2	44.6	32.9	11.9	27.6	27.6	21.5	36.7	8.8	130.3	28.7	46.8	39.1	22.8	29.0	21.9	16.3	5.9	27.1	17.3	27.3	14.0	25.5	14.7	40.1	28.8	8.1	185.2	15.5	12.5	29.5	25.9	20.4	19.7	15.8	31.6	21.1	32.4	22.5	32.2	22.8	73.0	40.3	17.3	56.9	29.5	17.7	13.9	21.9	12.8	21.3	42.4	43.4	37.0	18.2	21.2	19.6	21.8	16.5	42.5	6.5	20.1	2.8	18.3	13.0	7.3	8.8	24.9	20.4	11.3	11.4	4.2	27.2	13.7	22.4	12.4	19.8	19.7	19.2	20.3	19.7	18.7	22.3	19.4	19.1	19.6	21.2	20.9	13.5	12.8	6.9	7.8	20.5	9.6	20.6	15.3	14.2	48.6	19.3	16.1	22.2	27.1	12.2	31.3	52.1	31.7	8.0	17.6	23.5	21.0	186.6	7.8	10.2	13.3	9.0	28.0	15.4	19.1	29.8	16.7	23.0	10.5	5.1	16.4	15.0	14.0	21.7	48.8	16.6	15.0	28.5	15.0	9.6	415.4	28.9	10.5	7.2	10.3	22.7	30.9	14.4	8.5	14.1	19.1	13.3	25.2	14.8	20.6	26.1	21.6	7.3	61.4	13.1	17.5	16.3	133.0	35.7	28.9	13.4	44.5	10.9	18.5	17.9	20.0
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20802855	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"pancreas: 9121.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7;myeloid DC: 20.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.3;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1100000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	694.2	501.3	336.6	131.3	466.1	6.2	353.3	404.4	556.1	203.9	294.9	378.4	176.7	139.4	112.0	194.0	232.0	406.4	377.7	351.3	380.9	253.0	54.5	775.9	187.8	438.9	408.3	190.6	9121.6	60.6	43.9	897.4	403.7	83.9	425.2	3.1	168.0	149.7	127.6	118.1	201.8	285.6	357.3	353.1	1003.5	977.5	465.4	177.6	119.7	280.6	68.8	374.7	107.9	533.7	0.0	1.4	0.5	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	0.0	0.3	1.7	0.0	2.2	0.6	0.0	1.4	0.0	0.1	0.1	5.3	0.1	0.8	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	286.8	0.0	31.4	0.4	0.0	0.0	0.3	2.0	1.2	67.4	0.0	0.2	0.1	1.5	0.2	114.2	1.2	1.4	0.0	0.8	0.3	2.0	0.3	0.1	179.3	0.0	2.7	1.8	0.3	0.6	0.1	0.1	4.6	0.1	3.8	1.6	9.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	2.4	336.6	466.1	404.4	556.1	351.3	380.9	438.9	408.3	403.7	357.3	465.4	533.7	826.6	929.5	818.4	1.6	11.1	35.6	1.0	1.9	15.9	0.1	6.2	11.7	59.8	27.1	174.0	16.5	0.0	12.9	5.7	261.8	0.0	8.8	20.0	3.8	1.9	581.7	48.7	28.0	0.5	315.2	14.6	58.4	821.1	3.4	25.2	103.8	650.3	7.9	1583.4	1.7	0.8	663.8	8.2	267.9	197.5	57.1	32.0	632.8	40.9	36.5	3.4	0.8	0.0	1.0	232.3	286.8	246.7	10.9	7.5	1.4	81.7	0.9	34.9	2.7	98.6	20.7	31.4	16.4	6.6	16.6	28.1	25.9	10.6	392.8	162.9	3.8
RNASE10	"RAH1, RNASE9"	ENSG00000182545	"Ribonuclease A family member 10 (inactive)"	Q5GAN6	14	20505537-20511169	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Fertilization"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.0;testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 7.2;U-2 OS: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052593	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052593: AB_2681878"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.03e-3)"	"unprognostic (5.58e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.88e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.62e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.58e-1)"	2.1	1.8	3.2	1.6	3.0	1.1	0.4	2.8	4.3	0.5	2.8	0.7	1.6	2.0	1.1	1.1	1.1	0.6	0.4	3.2	2.4	0.9	0.8	1.6	0.8	3.8	3.0	1.1	0.4	0.4	0.5	0.8	3.2	1.2	0.4	0.5	0.9	0.7	2.0	2.5	1.7	0.5	1.8	1.3	1.1	1.9	3.1	0.5	0.7	0.2	0.4	0.7	0.5	5.2	4.4	2.0	0.9	1.9	0.2	0.4	2.8	0.2	0.4	0.1	0.3	0.9	1.2	0.5	1.3	0.5	0.6	2.3	0.0	0.3	0.1	1.7	0.7	0.0	1.5	0.6	0.5	0.1	2.0	0.7	1.5	0.1	2.3	0.4	1.0	0.7	1.0	2.3	0.0	1.2	0.7	1.1	0.5	0.6	0.2	3.3	0.3	2.6	0.7	1.8	1.1	1.4	7.2	1.7	0.9	0.9	1.6	0.7	0.4	0.7	10.8	0.9	0.8	2.2	0.9	0.2	0.8	0.6	0.9	1.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.3	0.0	0.0	3.2	3.0	2.8	4.3	3.2	2.4	3.8	3.0	3.2	1.8	3.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RNASE11	"C14orf6, RAJ1"	ENSG00000173464	"Ribonuclease A family member 11 (inactive)"	Q8TAA1	14	20583559-20609884	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 444.4"	"Group enriched"	"Detected in some"	63	"Early spermatids: 32.1;Late spermatids: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003724	Uncertain				"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA003724: AB_1079817"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	444.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE12	RAI1	ENSG00000258436	"Ribonuclease A family member 12 (inactive)"	Q5GAN4	14	20590193-20590823	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	300	"epididymis: 862.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044175, HPA059465"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"					"HPA044175: AB_10960390, HPA059465: AB_2732638"																		0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	862.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955487-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"bone marrow: 1713.7"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 457.5;eosinophil: 1352.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1352.6"	"Group enriched"	"Detected in some"	303	"HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		200000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	7.1	6.0	3.0	9.1	2.8	1713.7	1.7	2.9	5.5	2.3	4.4	2.2	0.2	2.1	0.3	0.9	5.7	2.6	4.0	2.8	4.2	1.7	4.6	12.2	1.9	5.4	4.1	1.5	1.7	0.5	1.7	1.8	4.4	1.7	0.7	1.7	1.9	0.2	0.7	2.9	1.4	9.7	4.5	35.1	2.1	0.7	4.2	14.8	0.9	0.6	0.6	5.2	1.4	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	0.0	539.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	539.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	1405.4	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.7	0.0	1295.9	0.0	457.5	109.0	1352.6	0.4	19.3	0.8	0.3	0.4	0.0	191.8	0.4	0.4	0.4	9.8	0.1	2.8	2.6	0.1	39.9	3.0	2.8	2.9	5.5	2.8	4.2	5.4	4.1	4.4	4.5	4.2	6.3	0.2	3.2	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.0	1.9	0.0	0.5	0.0	0.0	1.3	0.0	30.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.4	2.2	13.0	0.0	0.0	0.0	0.0	174.3	0.7	1.7	0.3	82.2	0.0	0.0	54.6	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RNASE3	"ECP, RAF1, RNS3"	ENSG00000169397	"Ribonuclease A family member 3"	P12724	14	20891399-20892348	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"bone marrow: 934.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	22	"eosinophil: 304.6"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 304.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8"									HPA056183	Enhanced				"Secreted to blood"	NA	NA	4200000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA056183: AB_2683059"	"unprognostic (2.54e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.21e-2)"		"unprognostic (6.45e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"		"unprognostic (8.62e-7)"	"unprognostic (6.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.37e-1)"	0.4	0.4	0.5	0.5	0.5	934.3	0.1	0.5	1.2	0.1	0.3	0.2	0.0	0.1	0.3	0.1	0.3	0.3	0.2	0.5	1.0	0.2	2.0	2.7	0.7	1.1	0.7	0.2	0.1	0.0	0.3	0.6	0.9	0.2	0.1	3.8	1.2	0.1	0.1	1.7	0.1	1.0	1.0	9.8	0.1	1.8	0.5	9.4	0.1	0.0	0.0	0.3	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	150.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	301.8	0.0	11.3	8.8	304.6	0.0	1.2	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	4.3	0.0	0.5	1.6	0.0	4.4	0.5	0.5	0.5	1.2	0.5	1.0	1.1	0.7	0.9	1.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	10.9	0.3	3.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781268-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 1238.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 65.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000698	Approved				"Secreted to blood"	NA	NA		2600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.2	29.5	8.0	59.6	7.5	27.5	24.0	7.8	13.6	31.6	10.0	27.7	17.3	10.6	78.4	16.0	11.3	47.7	11.7	7.3	10.9	12.2	21.1	29.6	110.5	13.6	10.1	9.9	8.4	9.0	4.3	44.8	11.9	7.9	34.0	1.8	11.2	17.2	2.0	8.6	33.4	23.6	10.8	62.1	14.9	4.5	12.6	43.8	5.5	6.0	84.5	43.3	5.1	19.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	1.7	4.7	0.6	0.2	0.0	0.0	1.9	4.6	0.0	0.0	0.0	0.2	0.0	65.6	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	441.1	537.3	12.8	5.3	124.8	12.0	324.7	13.6	5.6	513.3	410.3	6.4	1.0	199.0	36.7	2.0	1238.8	1.1	329.8	8.0	7.5	7.8	13.6	7.3	10.9	13.6	10.1	11.9	10.8	12.6	19.5	1.6	6.4	7.5	0.0	108.0	4.5	0.2	0.0	1.8	0.0	1.4	2.8	0.6	14.3	1.2	0.0	0.0	1.1	221.7	2.6	0.0	0.0	0.8	0.1	0.0	3.8	0.0	12.0	0.0	0.0	1.6	1.4	1.1	0.2	0.0	0.0	8.6	3.3	207.9	0.0	0.0	0.5	2.0	551.2	198.4	4.8	2.8	270.3	21.4	1.9	115.8	0.0	9.2	0.0	0.0	0.0	12.6	0.7	52.4	0.2	0.4	0.5	0.2	0.4	13.1	0.6	0.6	0.1	0.7	0.6	3.8	2.2	7.8	0.0	3.4	1.2
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042316-21044234	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 74.9;lymphoid tissue: 24.1;skin 1: 27.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.2;Cholangiocytes: 8.6;Prostatic glandular cells: 7.3;Urothelial cells: 27.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 24.7;hTCEpi: 10.3;hTERT-HME1: 53.3"									"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"	NA	NA		280000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	74.9	0.0	6.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.5	0.0	4.7	0.5	0.3	27.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.0	0.0	0.0	24.1	0.2	9.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.1	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	30.2	1.5	0.0	0.0	0.1	2.4	0.5	8.6	0.4	0.0	0.0	1.5	0.0	0.1	0.0	4.5	0.9	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.3	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.3	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	5.3	0.3	0.0	0.2	27.2
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909747-51024120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 132.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 351.0;NB-4: 259.8;REH: 286.0;THP-1: 258.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	17.7	14.8	13.2	28.6	13.5	58.4	19.5	14.5	15.2	16.0	8.7	22.3	16.7	18.8	14.1	17.6	24.9	17.1	25.2	11.9	11.5	14.8	15.0	20.5	45.7	12.2	12.1	21.2	25.7	17.1	8.3	19.6	12.0	19.2	22.0	4.7	20.2	21.6	23.8	13.5	19.8	26.8	12.4	26.3	19.2	17.3	13.7	132.6	27.4	6.0	38.4	22.9	9.4	15.4	41.1	33.1	17.6	37.5	22.9	45.9	41.7	28.6	32.4	40.6	34.0	43.1	61.2	114.4	17.8	29.4	38.4	38.2	55.8	26.1	48.4	42.2	47.1	102.7	22.4	25.4	31.2	191.2	66.0	17.9	33.4	35.9	31.8	36.8	36.3	238.0	58.7	52.7	55.4	19.2	351.0	259.8	57.9	87.2	25.7	286.0	51.4	77.7	30.6	23.6	38.8	56.8	34.4	12.6	38.0	22.8	19.7	258.7	25.6	36.0	30.1	42.7	64.3	69.8	50.3	135.6	9.5	140.6	43.1	3.5	37.5	17.8	31.6	43.3	35.7	104.2	61.9	51.4	55.1	86.4	54.4	51.9	6.1	38.0	38.3	94.0	107.5	54.1	13.2	13.5	14.5	15.2	11.9	11.5	12.2	12.1	12.0	12.4	13.7	15.4	21.2	38.5	23.8	17.6	85.8	18.7	30.5	43.7	22.2	14.1	31.1	35.8	47.4	18.6	27.4	16.5	6.2	40.7	92.3	9.7	29.4	41.7	74.0	30.1	33.2	14.9	12.1	107.7	31.1	50.5	55.7	26.7	13.7	18.2	52.6	62.0	16.4	15.1	97.3	1.7	35.4	21.8	24.4	59.0	22.0	38.2	27.7	50.4	16.0	45.0	86.4	11.7	45.3	44.2	59.5	24.7	9.9	29.7	75.6	34.5	12.1	28.4	37.3	6.2	13.1	21.8	28.9	91.4	44.3	26.9	21.0	17.9	56.5	36.9	35.4	29.3
RNASEH2C	"AGS3, AYP1"	ENSG00000172922	"Ribonuclease H2 subunit C"	Q8TDP1	11	65714005-65720818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 388.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065375	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA065375: AB_2685481"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	17.4	23.8	15.7	9.6	16.4	19.6	16.8	16.8	19.4	30.6	16.4	35.0	8.5	27.3	6.5	14.6	28.2	6.3	18.9	15.9	15.5	27.5	16.8	16.4	13.9	15.3	15.7	34.0	16.9	7.5	32.3	5.5	16.1	34.4	3.9	7.7	16.5	9.6	10.1	11.9	25.0	6.1	14.5	33.1	23.1	13.3	15.8	9.8	22.1	3.6	8.0	27.9	22.2	17.6	13.5	12.9	16.6	13.1	13.3	6.3	5.4	7.4	4.6	18.6	15.4	15.8	15.4	19.9	7.7	6.8	24.1	19.5	14.0	10.3	12.2	13.5	30.2	20.2	40.9	7.4	2.3	3.5	17.7	7.3	3.6	16.7	4.7	11.0	8.0	21.4	10.9	22.7	7.8	19.9	33.9	19.0	10.3	6.4	15.6	27.1	11.3	27.4	4.9	7.8	20.6	20.4	3.5	14.5	8.1	5.1	17.6	7.1	8.2	17.9	15.7	18.3	11.7	20.6	6.3	6.7	26.6	16.8	14.8	3.3	14.6	3.7	9.2	10.7	9.9	12.7	6.2	6.8	9.2	12.8	7.6	5.7	3.0	11.2	8.0	23.3	6.9	9.8	15.7	16.4	16.8	19.4	15.9	15.5	15.3	15.7	16.1	14.5	15.8	17.6	94.0	25.6	39.9	8.5	90.6	31.6	109.5	59.8	23.9	26.7	82.2	102.7	69.8	94.4	44.5	68.0	8.4	73.5	89.5	64.6	105.7	62.6	40.0	34.1	75.5	77.7	128.4	124.2	14.3	46.6	107.8	89.5	32.6	36.7	65.4	168.7	104.6	103.6	128.0	23.5	12.5	52.7	42.7	93.6	51.4	138.2	135.8	73.1	64.0	7.5	90.7	47.5	145.2	8.5	16.9	43.4	83.1	100.1	119.0	74.5	132.5	271.4	37.5	23.5	111.7	66.1	101.7	66.5	68.5	44.1	36.9	208.0	68.6	388.0	53.9	95.9
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 246.4;Macrophages: 174.7;Plasma cells: 253.2;Squamous epithelial cells: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	309.4	592.6	276.9	173.8	296.6	292.9	278.5	285.0	391.0	252.6	339.9	271.8	161.1	254.5	135.1	241.5	239.4	173.3	325.9	298.9	381.3	515.3	280.2	347.4	217.8	307.5	307.5	265.2	233.9	287.8	505.1	158.7	323.9	255.0	118.2	81.6	246.4	161.1	321.9	297.0	229.1	144.9	275.9	396.8	275.2	180.2	300.6	159.6	256.0	226.6	166.8	231.1	225.3	288.4	223.4	353.3	160.9	276.4	406.6	363.4	142.8	224.5	389.5	283.9	320.6	149.6	205.6	157.2	221.3	435.5	343.2	328.5	199.1	274.7	153.6	319.2	520.8	157.0	264.7	252.9	466.1	99.9	748.3	462.4	321.7	338.5	194.0	316.1	344.6	168.0	138.1	327.7	348.4	206.0	137.0	327.4	111.7	178.2	314.0	160.7	92.3	180.9	374.2	192.4	82.1	291.9	191.0	135.6	421.5	157.8	176.0	177.3	322.5	304.6	132.8	383.9	289.3	267.6	278.0	68.6	475.7	225.3	253.2	993.4	1136.6	1378.0	373.6	1031.0	369.9	593.4	413.9	381.0	848.3	542.0	329.5	321.0	2175.1	420.9	1007.1	1070.5	451.1	1052.7	276.9	296.6	285.0	391.0	298.9	381.3	307.5	307.5	323.9	275.9	300.6	288.4	21.3	57.7	65.7	0.0	109.7	20.5	9.2	16.3	246.4	16.3	21.6	14.9	0.8	8.6	47.9	5.5	41.7	5.3	31.5	21.0	3.9	21.4	5.8	45.4	32.4	37.9	13.2	62.0	0.0	5.5	3.4	58.9	110.1	38.6	54.2	14.4	20.0	16.2	14.2	11.8	0.0	15.9	8.2	62.3	47.0	6.2	9.0	174.7	21.4	0.0	42.4	7.6	28.8	0.0	0.0	12.1	10.8	6.4	253.2	12.1	20.4	6.7	58.8	31.5	26.3	11.4	35.6	3.6	1.2	250.2	21.7	11.8	98.0	15.9	15.1	13.8
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 59.4;Club cells: 31.1;granulocytes: 60.5;Respiratory ciliated cells: 56.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.9;THP-1: 3.7;U-87 MG: 3.7"									"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	1.9	4.1	0.0	0.2	0.0	0.6	1.6	0.1	0.2	2.4	0.0	1.7	0.0	1.4	0.0	2.1	1.4	0.0	2.4	0.2	0.0	5.5	2.1	2.5	0.0	0.1	0.0	1.6	1.5	0.1	3.5	0.0	0.0	1.5	0.0	0.0	1.8	0.1	2.2	1.9	1.6	0.1	0.0	2.7	1.9	1.7	0.0	0.0	1.8	0.0	0.1	1.2	1.6	0.0	0.7	2.0	0.2	0.3	0.0	0.0	0.6	1.3	1.0	1.5	1.1	1.3	0.6	1.0	0.1	0.0	0.1	0.3	0.4	2.9	0.4	0.0	2.4	0.0	1.3	0.5	1.4	0.0	0.3	0.0	0.0	0.9	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.7	1.1	1.3	1.2	0.3	0.6	0.8	0.0	0.0	0.4	0.4	0.2	1.0	0.0	0.0	0.2	0.1	0.3	3.7	0.0	0.0	0.1	1.9	0.5	0.0	0.4	0.2	3.7	0.3	0.0	2.4	2.3	1.9	0.5	1.6	0.8	1.0	0.7	0.4	2.0	0.9	0.6	0.6	3.8	0.5	1.8	2.1	0.5	1.7	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	64.1	59.4	0.0	2.6	0.4	0.0	0.3	0.6	0.0	0.9	0.3	0.0	0.0	31.1	0.0	0.0	0.3	0.7	3.2	3.9	8.3	0.0	0.3	0.2	6.5	5.4	1.3	0.0	8.2	0.2	5.3	0.0	0.3	60.5	0.0	0.7	0.1	0.6	0.0	0.0	3.2	0.0	1.2	0.8	0.0	0.3	14.8	0.0	0.0	4.8	0.0	0.0	0.0	0.0	7.7	6.1	0.4	2.8	0.1	3.9	0.5	56.2	0.0	0.0	0.1	1.3	0.2	0.1	2.0	1.0	0.8	5.9	0.1	2.6	0.1
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	5.6	6.4	3.2	8.8	3.5	3.6	5.9	3.4	3.9	6.6	3.7	8.1	7.0	6.5	9.6	6.2	5.2	6.9	3.4	2.9	3.4	6.2	3.5	6.9	9.6	3.4	3.5	11.3	3.1	7.9	5.4	6.9	3.6	7.2	9.0	5.7	5.0	8.3	2.0	5.4	8.0	7.1	2.8	8.9	7.8	2.2	3.6	8.0	9.1	4.5	9.9	6.0	6.3	3.3	2.6	3.6	1.5	0.6	7.9	13.7	2.8	4.9	6.1	4.9	4.5	2.1	5.6	5.6	8.4	5.6	2.2	4.7	3.6	5.1	1.9	4.5	3.1	6.6	1.3	0.3	4.1	12.4	12.5	9.8	11.4	2.6	0.7	3.1	2.1	8.2	2.4	4.2	4.3	3.8	3.6	5.1	1.2	8.4	1.0	5.3	1.2	2.9	5.2	3.4	0.7	0.2	4.4	5.3	4.3	3.9	5.4	13.6	2.8	2.5	2.0	2.7	2.7	3.7	1.3	0.7	4.0	7.5	3.8	41.7	14.8	53.1	9.4	15.8	12.4	10.3	11.1	10.1	12.4	7.9	17.3	12.8	55.3	10.9	30.3	14.7	10.0	10.5	3.2	3.5	3.4	3.9	2.9	3.4	3.4	3.5	3.6	2.8	3.6	3.3	4.5	6.4	4.2	5.2	6.5	1.0	2.9	4.9	1.2	4.3	2.8	2.4	1.3	1.5	9.0	3.7	4.2	4.2	8.2	14.8	7.9	6.7	0.0	2.5	9.6	5.1	2.4	4.8	4.2	1.8	3.7	6.4	7.7	3.4	5.7	5.5	3.9	1.6	6.2	1.7	6.6	9.3	8.2	9.7	1.2	0.8	2.8	5.8	0.0	1.9	7.3	8.7	5.2	6.0	3.6	2.2	3.2	6.4	2.7	3.5	7.2	7.3	9.1	6.1	19.7	5.8	5.2	0.4	0.9	4.5	1.0	2.6	7.5	12.1	4.0	4.6
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166922113-166957191	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 490.2;Glandular and luminal cells: 761.3;Hofbauer cells: 382.2;Kupffer cells: 484.7;Macrophages: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 497.9"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		15000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	34.9	35.0	50.1	68.6	50.4	124.3	50.2	52.2	65.9	161.5	52.3	74.0	57.6	49.1	140.7	24.8	134.6	69.6	19.8	49.5	53.5	31.2	52.4	47.2	117.4	68.2	54.3	36.2	144.7	40.7	26.3	43.5	66.2	51.9	89.9	8.3	112.8	94.1	7.3	25.4	65.4	27.8	61.9	195.1	72.9	13.3	59.1	43.8	76.7	12.1	86.9	54.9	32.2	79.8	12.8	14.2	12.6	37.8	57.0	40.6	8.4	15.8	21.2	7.3	7.4	33.7	19.9	11.1	149.8	41.3	16.7	41.0	20.8	18.6	4.3	15.9	35.1	10.2	20.6	84.6	19.1	152.7	37.3	23.9	33.6	4.3	2.7	30.4	10.1	21.7	20.9	94.5	10.9	44.9	12.6	109.5	6.4	140.0	13.0	25.0	16.6	131.7	136.3	9.9	4.4	28.7	32.0	100.4	8.3	22.3	13.1	497.9	19.3	14.9	9.8	43.7	13.5	15.0	19.5	1.4	32.3	149.2	10.3	116.9	185.6	674.8	29.1	277.0	53.4	136.7	159.9	72.3	226.4	119.6	128.4	41.4	438.9	30.7	368.8	369.3	90.8	179.8	50.1	50.4	52.2	65.9	49.5	53.5	68.2	54.3	66.2	61.9	59.1	79.8	21.8	19.2	29.3	10.1	270.1	43.3	116.4	45.1	72.3	10.5	97.0	95.1	9.5	47.1	28.0	38.6	0.0	63.4	286.8	133.7	23.5	59.2	10.3	490.2	78.9	44.9	75.4	27.6	13.6	27.4	58.8	45.8	80.0	761.3	71.7	38.6	19.2	20.0	382.2	13.5	37.1	204.0	24.4	484.7	187.7	11.3	35.4	418.2	58.7	113.4	146.1	24.4	64.9	14.6	1.7	74.1	324.8	29.3	158.6	61.2	178.5	19.6	19.0	7.1	26.3	31.9	18.6	10.0	23.1	58.3	34.5	27.8	149.2	15.3	193.0	103.9
RND2	"ARHN, Rho7, RhoN"	ENSG00000108830	"Rho family GTPase 2"	P52198	17	43025231-43032041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 64.2;choroid plexus: 17.8;testis: 37.2"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 590.2"	"Group enriched"	"Detected in many"	5	"glioma: 44.4;testis cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;AN3-CA: 15.5;HAP1: 12.1;NTERA-2: 17.2;SH-SY5Y: 10.4;SuSa: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077757	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA077757: AB_2732361"	"unprognostic (2.19e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.55e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.22e-4)"	"unprognostic (7.85e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.13e-3)"	"unprognostic (9.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.57e-2)"	0.6	3.0	30.8	0.2	41.7	0.2	1.0	46.5	29.9	2.2	17.8	4.1	0.3	3.6	2.5	1.1	2.0	0.8	2.2	23.1	48.4	1.5	4.1	0.5	0.2	64.2	59.0	3.7	0.6	5.6	7.0	0.1	52.4	2.6	0.4	3.9	0.8	3.7	0.5	2.2	1.2	2.4	47.8	0.1	1.3	37.2	46.3	0.4	6.5	0.2	0.3	2.1	1.6	38.8	0.0	0.3	12.0	15.5	0.9	0.6	0.3	0.5	0.7	2.1	1.6	1.9	0.2	0.1	2.8	1.6	0.7	0.1	12.1	0.2	1.8	0.0	6.2	0.0	0.2	0.2	0.9	0.1	0.1	0.8	0.1	2.4	0.1	0.3	0.2	1.3	3.1	0.1	0.0	0.5	4.9	0.2	17.2	0.0	0.1	0.9	0.0	0.1	0.2	0.0	3.3	10.4	0.0	0.2	0.1	7.9	2.3	0.0	0.1	0.3	0.4	0.1	0.0	1.1	3.3	0.2	1.9	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	30.8	41.7	46.5	29.9	23.1	48.4	64.2	59.0	52.4	47.8	46.3	38.8	1.5	0.0	1.5	2.0	0.1	1.3	4.8	0.6	6.8	2.8	2.0	3.3	2.1	1.5	2.0	3.7	0.0	2.1	0.0	0.1	5.9	1.2	136.3	1.9	12.6	1.2	0.0	0.0	2.2	0.8	1.9	3.2	0.0	1.0	1.3	10.5	1.4	3.3	0.6	5.0	7.2	0.0	0.0	0.6	0.7	590.2	5.0	0.8	1.8	1.0	0.0	27.2	1.0	11.6	1.6	0.3	0.1	4.5	0.1	1.6	0.0	2.3	6.5	3.7	0.0	6.2	2.9	38.3	6.1	0.8	1.8	1.6	0.6	2.6	0.1	1.6
RND3	"ARHE, Rho8, RhoE"	ENSG00000115963	"Rho family GTPase 3"	P61587	2	150468195-150539011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 155.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1633.3;Endometrial stromal cells: 521.7;Suprabasal keratinocytes: 924.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 680.9;BJ hTERT+: 1331.5;hTERT-HME1: 650.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060504	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA060504: AB_2684295"	"unprognostic (8.03e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-2)"	58.0	50.0	12.1	27.8	8.6	1.2	99.2	8.6	9.2	47.8	8.1	27.2	16.8	45.2	7.3	155.4	14.0	59.9	23.6	8.8	10.2	14.6	131.9	23.2	11.4	8.5	8.4	8.4	16.2	1.9	7.8	46.4	18.4	46.0	27.1	5.2	28.9	37.7	14.4	50.5	19.9	62.3	7.1	39.5	20.2	4.7	14.2	8.2	7.4	14.0	24.5	108.8	44.1	7.0	46.5	27.5	49.2	93.8	137.1	65.7	0.4	680.9	1331.5	335.0	189.1	34.8	31.4	0.0	42.5	277.8	173.1	108.2	1.9	43.9	268.5	0.0	20.4	0.0	35.1	1.1	391.2	0.1	0.5	46.2	78.6	344.9	650.7	62.9	65.4	0.4	0.0	158.2	145.0	27.5	0.3	0.3	15.4	47.5	42.3	0.1	37.7	21.5	74.5	80.7	15.0	46.4	71.5	29.3	37.2	35.9	33.3	1.1	67.4	296.3	55.3	137.8	73.8	35.7	0.4	0.4	234.2	0.1	209.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	8.6	8.6	9.2	8.8	10.2	8.5	8.4	18.4	7.1	14.2	7.0	81.3	38.5	5.8	2.0	0.4	1633.3	231.2	304.7	368.2	40.5	131.9	218.1	95.6	45.8	192.5	9.2	14.6	71.7	1.8	359.8	3.9	63.4	1.9	389.9	521.7	46.3	32.8	5.3	0.6	14.6	12.8	353.4	56.6	400.3	4.5	0.6	26.4	129.3	12.2	1.7	35.3	130.5	97.6	76.8	83.0	2.2	10.5	12.0	136.9	15.0	0.0	9.6	0.0	0.5	0.5	107.4	249.5	10.5	4.6	102.4	174.8	3.9	157.0	2.7	19.7	182.0	166.8	0.9	3.4	458.0	924.7	91.1	10.9	36.8	117.5	262.9
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577588	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 286.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	79.5	104.3	99.0	52.7	101.2	184.8	68.1	97.2	135.0	63.9	108.8	90.1	58.8	61.6	96.1	103.0	58.5	50.1	191.2	101.7	98.4	108.3	81.7	74.4	53.6	99.0	102.9	65.6	75.2	75.8	71.3	65.9	97.8	69.0	65.8	76.6	68.1	61.7	307.2	77.8	61.2	77.8	99.3	78.7	81.0	96.8	100.9	57.9	60.7	208.8	69.5	73.2	69.3	107.2	109.7	141.6	68.3	109.3	130.9	103.0	80.6	100.7	113.9	81.8	86.4	117.1	49.3	129.5	89.4	167.3	64.0	73.9	126.6	136.5	116.0	127.5	71.0	132.1	77.5	123.0	175.3	120.0	89.5	105.5	155.0	115.1	156.8	141.8	168.5	95.7	134.2	86.7	124.3	125.3	79.4	131.1	104.0	101.7	139.9	69.8	87.5	185.4	164.4	221.1	66.9	72.7	140.0	89.5	78.9	94.2	144.2	68.6	134.8	59.3	65.7	95.5	65.9	74.7	146.8	90.8	97.5	80.2	65.0	154.2	53.8	173.8	45.5	45.8	48.9	35.7	44.7	52.4	60.0	31.2	39.5	40.6	118.0	46.1	54.3	30.7	60.7	52.9	99.0	101.2	97.2	135.0	101.7	98.4	99.0	102.9	97.8	99.3	100.9	107.2	56.2	25.6	32.6	30.3	54.0	61.9	51.1	27.1	52.3	39.9	63.8	42.9	99.3	32.9	28.4	47.8	22.9	62.1	58.9	93.5	164.4	49.7	72.7	54.1	53.2	45.9	49.2	286.5	43.1	58.7	69.4	47.8	64.7	78.9	36.8	42.0	42.8	48.8	36.9	55.5	42.9	50.3	34.6	52.5	63.1	41.7	56.8	54.7	56.9	16.9	48.7	43.3	56.7	32.2	52.4	59.8	49.1	54.9	71.2	63.1	73.8	70.0	21.6	54.5	52.6	52.3	55.0	118.0	55.2	74.5	65.8	111.8	59.1	74.1	47.3	77.8
RNF103	"hkf-1, KF1, ZFP103"	ENSG00000239305	"Ring finger protein 103"	O00237	2	86603398-86623866	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057922	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA057922: AB_2683555"	"unprognostic (4.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.77e-5)"	14.6	15.3	25.7	9.0	28.8	13.6	20.9	35.8	31.6	15.9	22.6	21.9	18.7	23.7	45.4	14.0	16.9	19.4	37.7	24.8	25.1	15.3	54.5	11.3	8.1	26.8	27.2	16.0	24.7	25.2	15.6	15.6	25.7	23.3	16.5	10.3	18.7	17.7	21.4	14.3	23.0	21.0	27.2	10.5	22.6	15.4	26.7	8.1	10.2	19.1	10.0	14.4	13.9	30.6	9.6	12.9	6.4	9.9	28.6	18.3	10.3	13.6	20.6	6.8	9.2	7.5	16.1	15.9	15.9	20.4	24.8	11.5	8.7	10.7	10.2	13.4	11.7	9.1	5.4	16.7	27.1	3.0	13.0	26.9	21.8	10.1	12.6	24.3	20.7	7.4	3.3	9.3	19.0	11.9	7.0	8.0	2.9	19.0	9.0	4.3	27.5	9.4	25.1	14.9	10.2	10.4	16.0	35.2	14.0	8.0	13.5	7.4	23.6	13.2	6.3	13.4	8.2	32.3	11.5	10.7	10.5	5.1	6.5	4.5	0.5	7.2	0.7	0.7	1.0	0.9	1.1	1.6	1.1	1.0	1.2	0.9	1.0	2.3	0.4	0.8	2.5	0.6	25.7	28.8	35.8	31.6	24.8	25.1	26.8	27.2	25.7	27.2	26.7	30.6	22.6	9.6	14.5	0.0	16.6	48.3	35.5	13.9	33.6	15.8	45.9	31.1	40.0	31.5	22.1	20.2	4.2	13.6	15.7	72.4	1.9	17.6	16.8	20.4	17.9	22.4	31.8	16.4	0.0	28.4	7.8	27.6	44.4	30.0	18.4	19.9	22.9	68.9	9.6	18.5	0.0	45.9	12.2	14.1	29.5	9.3	25.4	19.8	10.6	0.0	8.0	17.2	2.1	0.0	0.0	33.9	41.5	23.0	41.1	45.0	56.1	12.9	33.6	9.5	6.6	40.3	25.7	27.5	12.6	32.6	44.2	40.9	19.5	9.0	24.3	48.6
RNF103-CHMP3	RNF103-VPS24	ENSG00000249884	"RNF103-CHMP3 readthrough"		2	86505668-86721122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 3.9;heart muscle: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Excitatory neurons: 17.6;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4"									"HPA015673, HPA073383"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015673: AB_1858761, HPA073383: AB_2732224"	"unprognostic (3.77e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.39e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-4)"	"unprognostic (3.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.83e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.94e-3)"	0.4	0.3	1.1	0.9	1.4	4.3	1.1	3.6	3.9	0.4	0.0	0.5	0.7	0.4	0.0	0.7	0.6	0.4	4.1	1.6	0.4	0.2	0.4	0.2	0.3	2.0	0.7	0.3	0.1	0.3	0.2	0.6	1.0	0.4	0.3	0.4	0.1	0.4	2.2	0.3	0.3	0.3	0.4	0.3	0.9	1.2	0.8	0.6	0.2	0.5	0.5	0.1	0.2	1.9	1.5	0.4	0.9	1.0	1.0	0.0	1.6	1.2	0.6	0.7	1.0	1.3	2.0	2.3	0.8	0.7	11.4	0.6	0.3	0.3	0.2	1.6	0.6	0.8	0.0	1.0	0.2	1.0	1.3	0.8	0.2	0.4	1.1	1.1	0.1	2.5	0.9	1.2	1.3	0.3	2.0	1.0	0.0	0.6	0.2	4.7	2.1	0.1	0.1	1.2	1.7	1.5	1.7	1.8	0.7	0.2	0.2	1.2	0.5	0.6	3.9	0.8	0.9	1.8	0.4	2.1	0.8	1.4	0.2	0.0	0.3	0.2	0.1	0.4	0.5	1.3	0.3	0.4	0.4	1.7	0.1	0.1	2.0	0.7	0.0	1.8	0.2	0.2	1.1	1.4	3.6	3.9	1.6	0.4	2.0	0.7	1.0	0.4	0.8	1.9	0.0	0.0	1.1	5.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.3	17.6	0.4	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.5	0.0	0.0	1.0	10.1	4.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0
RNF11	"CGI-123, MGC51169, Sid1669p"	ENSG00000123091	"Ring finger protein 11"	Q9Y3C5	1	51236273-51273447	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 22.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045781	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045781: AB_2679450"	"unprognostic (2.66e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.92e-2)"	70.1	70.6	79.0	24.5	82.5	71.2	46.9	67.7	117.5	49.8	51.5	45.2	34.3	48.5	51.9	66.8	35.8	40.5	69.0	88.2	82.5	65.5	61.2	42.5	20.7	71.3	82.9	77.2	27.4	67.6	51.4	47.1	79.6	51.3	30.4	64.7	37.3	48.5	107.1	35.2	34.7	48.2	78.4	33.3	34.6	29.2	82.6	23.6	72.1	94.5	25.8	53.4	46.1	75.2	66.3	15.7	32.6	44.7	114.2	91.8	49.6	72.3	83.5	62.4	76.5	18.4	24.6	0.5	72.1	133.4	77.1	22.2	36.6	53.9	105.2	124.5	40.4	43.2	23.7	28.7	78.6	20.4	113.0	67.8	87.3	68.3	71.5	97.4	80.2	23.6	14.9	26.2	130.4	24.1	24.9	17.2	46.5	33.1	40.6	19.1	59.8	29.4	111.2	61.4	31.7	34.3	53.9	61.8	79.3	77.9	35.8	28.9	85.8	97.6	51.9	76.1	82.8	58.9	62.9	6.6	51.3	40.5	60.9	22.1	1.6	7.1	2.6	2.3	3.9	0.9	2.6	3.6	1.7	0.7	2.8	3.6	6.2	3.6	2.1	6.7	3.2	3.6	79.0	82.5	67.7	117.5	88.2	82.5	71.3	82.9	79.6	78.4	82.6	75.2	54.7	57.7	41.6	19.9	30.0	136.9	108.7	37.5	84.8	37.0	70.5	33.1	120.6	37.1	41.1	40.5	25.0	38.6	63.4	62.7	105.7	56.7	154.4	44.5	46.0	61.3	77.0	110.7	56.4	60.7	43.3	61.7	40.2	53.0	54.7	21.4	57.1	63.4	30.6	35.3	62.1	38.5	57.0	41.5	84.2	171.5	57.5	88.0	65.8	23.4	39.7	75.3	37.0	26.2	38.0	64.7	35.5	86.9	43.8	117.7	51.9	132.6	33.8	37.5	39.5	47.8	55.6	59.1	33.9	97.7	168.8	196.9	49.6	39.4	29.5	173.9
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 81.6;Inhibitory neurons: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	8.2	7.5	2.0	11.8	3.1	17.3	7.8	8.7	5.3	8.6	1.4	7.2	8.4	9.0	6.7	11.4	8.7	9.3	7.3	3.5	4.7	8.8	10.5	8.4	10.8	1.4	1.7	11.4	9.2	11.9	4.3	11.4	2.1	8.7	7.2	12.5	8.1	8.3	9.5	8.2	8.0	8.3	1.2	11.0	9.0	9.4	3.2	11.5	11.6	11.8	13.3	10.3	7.2	4.3	13.8	31.3	19.6	16.8	16.6	18.5	16.7	17.6	20.6	17.2	22.0	13.9	8.9	16.8	19.4	24.8	14.7	26.3	5.3	13.1	21.3	17.6	11.1	20.9	12.6	10.7	18.0	12.3	22.6	14.7	14.0	18.6	20.4	15.6	19.5	15.4	19.7	16.4	21.5	6.7	16.3	7.9	16.1	4.3	12.0	16.2	27.9	13.8	13.1	24.2	16.0	23.3	15.8	15.5	14.7	22.7	12.2	14.9	22.6	27.4	22.8	14.5	17.1	11.8	17.3	19.9	16.7	19.5	21.1	11.4	15.0	15.7	7.0	11.0	7.1	11.8	7.2	6.5	8.3	10.9	7.9	6.3	41.0	5.6	13.0	7.9	10.0	3.4	2.0	3.1	8.7	5.3	3.5	4.7	1.4	1.7	2.1	1.2	3.2	4.3	11.7	3.2	14.4	34.6	31.9	20.1	12.3	7.3	26.7	12.2	13.0	10.2	19.7	7.2	10.6	12.9	8.4	9.0	12.8	10.0	3.9	12.6	27.6	14.4	15.1	15.3	16.2	11.6	81.6	6.9	10.5	15.0	17.3	15.8	15.8	12.3	17.9	11.2	13.4	10.1	80.4	10.0	12.2	19.8	15.7	7.5	7.8	21.2	12.4	56.2	22.7	8.4	16.5	65.4	66.2	12.9	11.4	14.7	19.5	14.5	11.6	9.9	14.9	13.6	26.3	15.1	13.6	13.8	8.9	27.3	19.9	32.0	21.4	11.8	9.2	21.2
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Bipolar cells: 6.6;Excitatory neurons: 19.6;Inhibitory neurons: 11.6;Muller glia cells: 7.6;Oligodendrocyte precursor cells: 13.6;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;fHDF/TERT166: 6.2;SCLC-21H: 6.0;SH-SY5Y: 10.6;U-87 MG: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015970	Enhanced		Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.2	5.4	20.2	1.5	21.9	0.1	1.9	33.8	25.0	3.2	7.2	9.4	1.8	3.0	4.5	1.7	3.2	2.8	3.6	24.7	16.8	3.9	1.0	2.8	0.7	12.7	14.2	2.4	1.3	0.0	5.5	0.5	14.0	12.3	2.8	1.5	1.2	2.0	1.3	1.9	6.9	2.2	12.9	3.0	2.5	2.3	16.6	0.2	2.2	1.3	0.2	8.4	3.2	23.2	0.0	0.0	0.1	0.4	1.4	5.2	0.2	0.3	1.2	0.1	0.0	0.2	0.0	0.0	0.1	6.2	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	4.2	0.0	0.1	2.1	0.2	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.4	0.1	0.2	0.2	0.0	0.0	6.0	10.6	0.1	0.0	0.0	1.4	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.1	0.0	0.0	34.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	21.9	33.8	25.0	24.7	16.8	12.7	14.2	14.0	12.9	16.6	23.2	1.1	0.0	0.0	8.1	0.0	1.0	0.0	0.2	0.0	6.6	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.0	19.6	0.0	0.0	3.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	11.6	0.2	0.0	0.6	0.4	0.2	0.0	0.3	0.0	4.7	0.1	7.6	1.0	13.6	3.3	0.0	1.4	3.8	0.0	0.2	0.5	0.0	0.1	0.7	6.6	1.4	1.5	1.7	0.7	0.3	1.0	0.3	0.2	0.0	0.1	0.1
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871733	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000160: AB_1079821, HPA076658: AB_2732319"	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.23e-4)"	11.0	9.6	11.5	13.0	12.1	35.3	10.2	13.0	14.4	10.5	11.3	11.4	13.2	9.8	9.6	11.3	10.2	8.2	12.7	11.7	13.9	9.2	17.7	11.0	24.7	12.7	13.0	13.4	19.1	9.2	10.0	9.0	13.1	8.9	9.5	15.6	14.4	8.8	12.3	17.1	17.5	7.5	11.9	24.3	12.1	3.4	13.1	24.7	9.9	10.6	19.0	10.8	10.3	12.6	16.9	22.9	11.0	17.7	20.7	14.9	22.3	14.8	25.0	17.6	21.0	19.7	14.1	28.0	28.1	13.8	25.1	20.4	24.4	19.1	13.1	21.9	18.0	17.0	25.8	23.5	28.3	33.7	28.3	18.4	20.6	17.7	26.0	20.7	17.1	19.4	12.2	38.4	17.3	47.5	23.5	39.9	16.1	29.5	32.8	21.7	23.2	45.3	18.5	20.6	14.7	12.9	23.1	35.5	33.1	12.9	8.7	32.9	13.1	18.6	6.6	26.7	29.7	43.2	36.0	27.9	16.8	44.1	12.3	96.4	59.5	109.5	73.9	60.3	74.4	83.6	78.3	79.0	63.4	88.6	81.3	73.1	27.5	65.9	72.6	53.3	96.6	73.6	11.5	12.1	13.0	14.4	11.7	13.9	12.7	13.0	13.1	11.9	13.1	12.6	14.8	9.6	14.8	2.6	42.8	24.3	17.2	26.6	30.7	11.5	13.6	21.1	8.9	18.6	21.4	14.7	14.6	18.5	51.6	10.8	9.8	18.3	0.5	13.1	18.8	17.4	4.2	10.3	3.0	16.8	37.6	15.2	16.3	16.5	26.5	14.4	18.2	13.1	24.4	13.5	4.1	16.8	14.2	17.6	23.1	1.4	12.2	17.0	26.6	5.6	17.2	16.5	39.1	2.0	6.2	15.5	17.8	9.8	59.6	12.3	34.9	25.1	19.6	17.7	6.6	8.3	19.3	2.9	5.8	20.9	24.4	26.4	50.2	15.9	15.5	14.3
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953885	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 561.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	32.8	32.0	43.3	29.7	48.2	51.6	31.2	46.6	45.1	37.2	41.0	45.0	42.8	28.7	32.8	30.8	34.7	28.8	37.6	40.4	44.9	48.6	49.0	37.9	39.3	47.3	46.5	39.0	52.2	30.2	28.1	35.1	46.6	33.9	40.0	16.7	41.0	34.1	83.3	24.2	40.8	25.4	47.1	52.4	35.9	166.1	47.2	39.1	37.9	52.8	37.3	28.9	28.7	49.9	83.9	80.5	42.9	43.7	84.3	57.8	118.0	73.0	86.2	153.2	64.4	241.7	67.6	39.9	142.9	40.1	91.6	66.3	62.5	74.7	90.6	73.5	44.3	51.5	50.1	173.2	73.3	95.3	59.5	51.5	68.8	58.4	39.9	52.6	36.8	69.7	98.0	46.7	45.5	281.0	82.6	98.0	42.3	67.4	114.3	85.7	45.5	73.6	83.4	67.9	63.2	45.4	88.8	561.6	118.5	45.4	149.7	86.6	47.8	134.6	62.3	71.6	87.0	93.6	107.1	79.2	76.4	63.2	76.1	112.2	97.8	86.1	48.1	92.5	53.1	63.9	52.6	48.6	75.3	71.2	61.6	50.2	100.5	57.8	112.5	61.9	68.9	92.7	43.3	48.2	46.6	45.1	40.4	44.9	47.3	46.5	46.6	47.1	47.2	49.9	47.1	48.1	53.7	13.4	69.9	107.2	127.8	103.4	63.2	24.4	50.7	55.8	46.1	41.5	101.4	69.9	12.5	91.3	61.0	61.7	72.4	107.5	1500.7	72.2	36.3	55.3	60.4	45.4	22.8	101.1	77.4	61.9	41.3	71.4	45.0	31.9	46.1	63.7	110.6	40.4	24.4	79.5	42.7	76.6	146.5	923.4	70.5	66.0	71.2	27.2	96.3	38.0	56.7	10.6	26.2	92.1	77.9	59.8	81.9	122.5	96.4	120.9	75.8	22.6	39.5	45.5	59.2	558.0	138.4	45.8	87.1	124.8	69.2	46.5	80.4	113.3
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824095	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	8.9	5.0	7.7	4.6	7.3	7.5	7.5	16.1	9.0	7.1	6.1	9.0	3.4	12.2	4.1	5.7	7.9	4.7	24.9	7.7	6.8	5.6	5.1	5.9	5.0	6.3	6.8	5.5	5.3	6.8	5.3	3.5	6.6	7.3	3.7	13.9	5.9	5.2	32.1	6.1	5.5	11.1	5.7	5.0	5.8	3.9	7.5	5.0	6.1	25.3	4.7	7.9	5.6	7.1	11.0	4.5	5.4	3.9	9.6	12.5	4.2	8.1	15.1	5.9	7.1	4.9	3.8	7.7	9.0	11.7	5.7	7.5	6.0	5.5	6.3	7.7	3.9	6.1	5.9	4.6	6.1	9.7	13.7	7.3	4.8	6.0	7.1	6.7	7.7	5.9	6.1	12.2	10.8	8.3	7.1	6.0	6.8	7.0	9.4	6.7	5.4	6.4	11.6	3.6	5.3	7.4	6.6	8.0	6.3	6.6	8.9	9.1	9.4	8.4	6.6	5.1	8.7	10.2	10.3	8.0	4.2	6.4	5.4	6.4	1.0	1.6	1.4	0.8	1.2	1.5	1.0	1.4	0.8	1.2	1.0	1.4	0.7	1.6	0.8	1.1	1.0	0.7	7.7	7.3	16.1	9.0	7.7	6.8	6.3	6.8	6.6	5.7	7.5	7.1	168.4	16.0	29.2	61.7	43.5	20.6	32.6	24.4	23.9	101.3	35.9	29.1	152.5	38.6	27.0	18.4	114.7	26.8	155.6	13.2	33.2	44.8	68.5	52.9	45.4	72.3	27.1	60.6	91.2	80.3	28.7	60.8	28.1	55.8	31.7	39.1	71.7	33.1	37.2	82.4	77.6	23.5	28.5	41.5	36.2	25.3	39.4	38.9	39.2	84.3	71.0	64.4	90.6	81.4	83.9	52.4	18.8	80.9	90.5	76.0	22.5	46.6	29.6	111.1	59.2	60.2	53.5	76.5	63.7	23.7	18.0	19.8	75.7	65.2	23.6	40.2
RNF121	FLJ11099	ENSG00000137522	"Ring finger protein 121"	Q9H920	11	71929018-71997597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046041	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA046041: AB_10965850"	"unprognostic (1.36e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.72e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.70e-1)"	7.2	9.5	8.8	6.6	8.7	5.8	11.3	8.5	9.2	9.8	9.7	8.1	15.9	8.4	20.0	7.4	11.6	7.8	10.0	8.8	9.0	16.4	11.5	7.6	8.1	8.8	9.1	11.2	10.9	24.3	9.5	11.1	8.8	10.6	10.3	15.7	15.1	13.6	17.2	8.3	13.9	11.8	9.0	6.7	9.2	8.7	9.1	7.7	12.9	14.9	10.4	9.1	7.1	8.7	10.9	22.7	20.5	14.6	19.1	15.2	13.8	16.7	17.7	25.4	26.9	46.0	20.9	9.2	14.9	18.5	26.7	22.1	22.7	21.2	26.7	13.8	13.1	14.0	21.5	21.9	14.3	12.8	11.5	14.8	17.9	28.7	18.2	27.9	46.7	13.5	23.2	8.6	22.7	23.5	9.0	14.1	13.7	43.4	21.9	11.0	44.5	7.9	28.3	18.4	13.7	14.6	22.9	20.4	30.4	20.6	22.5	9.5	32.8	19.0	17.2	11.8	14.6	9.6	10.2	9.4	16.5	8.3	17.1	4.4	2.2	2.2	3.0	2.9	3.5	3.2	2.3	2.4	2.3	1.3	2.7	2.9	1.2	3.2	2.1	3.7	2.1	2.9	8.8	8.7	8.5	9.2	8.8	9.0	8.8	9.1	8.8	9.0	9.1	8.7	9.6	6.4	9.6	12.7	9.4	8.8	11.2	22.8	10.2	16.1	12.1	10.9	9.7	12.8	13.3	20.2	20.9	32.0	17.9	15.2	7.9	26.0	6.3	8.9	10.3	6.5	9.6	13.0	19.3	32.3	26.5	11.8	9.2	10.9	7.0	11.6	8.9	14.4	14.2	10.1	16.9	13.2	26.4	6.6	12.9	3.0	13.1	7.6	10.6	15.0	15.0	19.0	10.3	18.1	19.0	29.0	11.0	12.4	17.1	10.3	31.0	20.9	10.3	21.1	19.7	10.0	14.2	25.1	19.6	6.4	5.8	31.1	10.0	13.4	9.4	9.9
RNF122	FLJ12526	ENSG00000133874	"Ring finger protein 122"	Q9H9V4	8	33547754-33567128	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.7;Glandular and luminal cells: 19.8;Plasma cells: 13.1;Skeletal myocytes: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 83.7;Karpas-707: 53.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003888	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA003888: AB_1079822"	"unprognostic (2.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.46e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.95e-2)"	"prognostic favorable (5.37e-4)"	"prognostic unfavorable (4.50e-7)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (7.15e-2)"	36.0	15.0	2.4	9.5	2.2	7.4	19.0	13.7	3.6	11.0	2.2	13.5	2.7	10.4	5.4	6.4	29.1	13.4	28.4	2.2	3.0	10.1	7.3	28.9	7.1	4.8	4.1	48.1	5.6	3.4	4.3	3.0	3.6	10.2	5.0	4.9	7.9	2.4	25.8	9.9	10.1	14.7	3.4	12.4	11.1	5.7	4.3	5.9	6.5	5.8	8.8	13.7	12.8	3.2	0.7	4.4	22.3	9.4	2.0	0.6	3.0	1.4	2.1	2.8	4.5	0.7	0.9	10.7	6.8	3.6	3.8	0.8	4.9	2.0	1.5	0.7	83.7	2.2	1.1	6.1	1.2	0.7	16.9	2.1	1.8	1.5	1.1	4.6	9.0	9.2	2.2	53.9	2.3	2.0	9.5	7.2	12.2	3.4	2.5	10.3	4.3	8.5	3.3	1.3	4.3	24.8	1.6	0.6	3.5	7.7	1.0	3.0	5.2	3.8	3.5	7.0	1.6	21.5	13.0	19.5	2.4	2.9	0.6	5.9	1.0	8.9	1.6	5.0	1.4	3.1	0.9	1.1	0.9	4.9	1.5	1.6	7.6	2.0	11.9	16.2	0.7	0.4	2.4	2.2	13.7	3.6	2.2	3.0	4.8	4.1	3.6	3.4	4.3	3.2	34.7	0.0	0.6	0.0	5.3	4.2	0.6	0.2	6.2	0.0	2.6	1.3	5.1	2.8	0.1	0.0	0.0	0.1	8.1	1.9	0.0	2.7	2.2	9.1	3.8	10.1	0.0	4.0	0.8	0.6	0.6	7.3	4.1	19.8	0.0	1.8	5.7	0.1	1.5	0.0	0.9	1.0	0.0	5.9	7.6	0.9	1.5	4.8	0.0	3.7	0.6	0.7	1.0	2.0	0.9	1.0	2.8	1.2	13.1	0.3	0.2	0.8	0.0	1.5	0.0	13.4	6.7	0.0	0.7	2.8	2.0	0.0	3.0	1.2	1.3	1.1
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689538-49721529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.1;tongue: 112.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	13.0	19.0	18.9	9.0	19.2	34.6	12.5	18.5	23.9	13.1	21.0	17.8	19.5	14.7	10.5	13.4	12.5	9.7	27.8	19.6	16.5	22.0	57.7	12.3	10.4	17.5	16.9	11.6	13.5	16.3	17.4	9.4	17.2	14.6	6.8	6.0	14.4	9.2	156.1	14.5	18.2	9.3	14.7	17.9	17.9	23.7	18.0	13.7	14.6	112.0	7.3	14.2	12.0	17.9	9.7	12.6	15.5	16.2	23.2	13.9	17.1	12.1	15.9	15.0	16.0	14.1	16.1	23.2	10.9	17.6	13.3	11.8	11.6	18.1	10.0	15.8	15.0	19.7	27.8	31.6	23.1	19.3	19.8	17.6	17.9	14.4	16.5	14.8	16.2	23.0	20.0	20.0	13.2	14.1	19.8	30.7	8.2	11.5	21.0	9.3	9.7	24.4	21.5	16.4	10.6	20.8	16.4	14.4	18.7	8.7	15.4	33.0	16.2	13.4	16.3	11.9	14.9	26.4	28.4	9.5	19.2	23.6	20.5	8.9	6.9	5.6	6.7	6.2	4.0	7.1	4.5	4.1	5.5	7.0	5.3	5.0	4.0	5.5	6.8	7.9	3.6	3.8	18.9	19.2	18.5	23.9	19.6	16.5	17.5	16.9	17.2	14.7	18.0	17.9	7.1	9.6	5.3	16.3	6.5	2.3	3.1	4.7	1.8	8.6	7.1	6.1	1.1	11.5	5.8	3.7	4.2	6.8	9.3	10.4	5.9	5.3	13.3	8.1	5.8	5.9	6.7	52.4	18.0	5.5	4.6	5.9	11.2	7.5	7.0	9.5	10.0	29.8	5.6	6.7	14.6	6.1	10.2	9.6	1.4	16.5	7.5	6.0	3.6	5.6	6.3	5.4	7.2	7.5	7.2	7.2	6.3	5.7	7.0	5.0	19.2	10.2	5.4	8.9	0.0	7.6	5.6	10.7	8.9	4.6	3.0	8.5	6.0	7.5	6.9	4.1
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.2	1.3	2.0	5.2	3.7	18.4	6.3	2.7	2.7	3.9	1.6	5.0	10.5	2.9	0.5	2.5	3.4	3.3	2.6	1.9	2.3	1.0	12.5	4.7	7.0	3.6	3.2	1.4	3.1	1.7	0.3	3.7	3.4	1.8	6.4	0.3	2.2	1.4	2.3	4.9	11.3	3.3	2.6	5.9	3.4	1.0	3.8	5.3	1.4	2.9	4.0	3.0	1.7	6.2	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.7	2.7	2.7	1.9	2.3	3.6	3.2	3.4	2.6	3.8	6.2	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663233	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	21.2	23.4	11.8	16.0	13.0	21.8	21.7	10.8	19.4	19.1	3.8	26.6	21.6	20.8	2.7	42.3	19.1	4.6	25.9	13.4	9.7	20.7	40.2	19.3	14.1	13.2	10.3	16.8	23.0	6.8	20.2	8.8	13.1	20.2	4.9	4.3	21.0	7.0	61.6	45.3	27.2	4.9	10.2	30.6	24.3	49.4	11.9	10.1	14.7	12.8	5.8	21.6	24.0	16.6	79.7	26.5	21.0	30.6	4.8	6.7	38.5	40.6	15.0	22.5	21.2	52.1	26.9	64.2	25.9	16.5	8.9	51.7	12.6	30.0	6.2	43.8	98.8	32.7	24.5	47.0	18.2	64.9	46.0	11.3	22.9	18.5	14.3	9.0	20.6	51.8	68.5	63.4	12.0	62.9	67.7	35.0	62.4	22.5	50.6	48.9	18.1	102.0	17.0	43.6	52.0	42.1	30.1	39.8	42.4	7.2	25.3	51.5	28.6	40.6	30.6	62.1	71.1	112.3	59.5	77.6	52.1	39.2	43.0	3.7	14.7	12.3	25.1	18.4	21.1	23.9	23.1	24.7	19.0	25.5	17.7	16.6	3.7	27.7	22.6	21.5	28.3	14.8	11.8	13.0	10.8	19.4	13.4	9.7	13.2	10.3	13.1	10.2	11.9	16.6	34.2	12.8	7.4	9.1	66.9	137.9	61.2	44.3	45.5	31.4	35.7	39.6	27.6	27.1	23.2	9.2	16.7	72.8	74.8	60.9	54.8	60.6	146.4	20.2	17.8	31.0	21.7	37.8	11.9	75.6	139.2	29.3	40.2	22.7	14.7	23.1	22.9	22.9	43.2	32.0	9.9	39.3	26.4	26.7	58.9	36.8	21.5	32.9	42.7	3.7	47.5	32.7	112.3	7.1	15.7	136.2	70.0	19.5	76.5	98.2	68.1	40.8	14.8	24.6	59.2	22.0	40.5	153.6	65.3	74.4	144.8	88.1	60.7	43.2	58.1	87.0
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128"	Q8TEB7	X	106693794-106797016	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.1;liver: 124.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Cholangiocytes: 50.1;Distal enterocytes: 49.3;Gastric mucus-secreting cells: 54.6;Hepatocytes: 76.9;Proximal enterocytes: 85.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.9;CAPAN-2: 35.0;Hep G2: 30.6;OE19: 96.2;RPTEC TERT1: 30.5;RT4: 88.8;WM-115: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	0.7	35.0	2.6	1.8	2.4	0.0	7.9	1.9	2.4	0.6	0.8	21.8	62.1	0.1	0.5	4.6	1.0	33.1	0.5	2.5	4.2	31.5	124.6	14.7	0.2	2.7	2.2	2.0	16.4	0.7	6.6	11.1	3.3	2.8	19.6	0.1	28.6	2.1	8.9	6.9	60.8	0.6	1.6	0.1	46.9	0.6	4.3	2.8	29.4	4.1	0.2	20.0	2.0	1.6	11.1	0.0	0.0	0.0	3.4	1.8	41.9	0.1	0.3	0.0	0.0	18.8	35.0	0.0	0.0	0.6	0.4	13.3	0.1	0.0	0.0	0.0	20.6	0.0	0.3	30.6	0.0	0.0	0.0	0.1	14.4	0.0	0.1	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	96.2	0.3	0.0	0.1	0.1	30.5	88.8	0.2	0.0	0.0	2.3	2.2	0.3	2.3	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	15.1	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	1.9	2.4	2.5	4.2	2.7	2.2	3.3	1.6	4.3	1.6	0.1	67.3	19.6	6.2	0.5	6.8	6.6	13.1	10.2	0.0	9.7	4.2	0.5	50.1	15.0	33.1	0.0	23.4	0.1	49.3	0.0	14.7	0.1	0.0	0.0	0.3	24.7	2.7	17.9	15.6	3.3	0.3	54.6	0.0	0.0	0.1	1.8	76.9	1.9	0.0	19.6	33.3	2.0	2.7	0.4	0.2	0.0	0.4	3.6	3.7	0.0	0.0	0.0	25.1	13.8	25.6	23.6	0.0	0.0	1.9	85.4	25.3	8.7	0.0	0.0	0.0	1.3	0.0	2.0	11.5	5.3	16.6	0.2	0.5	28.7	8.5
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF130	"G1RZFP, GOLIATH, GP"	ENSG00000113269	"Ring finger protein 130"	Q86XS8	5	179911651-180072113	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 295.7;Kupffer cells: 393.7;Macrophages: 283.0;monocytes: 276.4;Oligodendrocytes: 514.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 261.6;classical monocyte: 513.2;eosinophil: 331.3;intermediate monocyte: 355.0;myeloid DC: 407.4;neutrophil: 890.5;non-classical monocyte: 328.7;plasmacytoid DC: 317.2"	"Group enriched"	"Detected in all"	11	"dendritic cells: 407.4;granulocytes: 890.5;monocytes: 513.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 179.3"	"Low region specificity"	"Detected in all"							HPA014499	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA014499: AB_1856328"	"unprognostic (2.01e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.38e-2)"	94.2	43.4	79.7	47.7	103.2	94.0	50.2	102.3	114.1	55.5	75.5	40.1	28.1	42.1	35.6	26.4	46.8	55.9	36.2	81.4	85.8	49.4	167.1	62.6	39.2	112.8	94.6	52.2	64.2	28.0	16.6	48.4	110.6	35.1	41.9	14.3	84.6	60.2	33.2	14.6	32.6	52.6	98.4	51.8	34.7	17.5	92.3	17.7	32.3	53.7	25.8	51.6	19.3	138.2	32.7	26.8	125.5	110.9	117.4	54.5	21.9	20.9	29.1	24.1	25.3	8.4	31.8	0.1	69.6	47.5	47.7	3.0	81.5	49.7	26.0	0.3	54.6	57.7	11.8	25.4	27.3	14.9	179.3	52.2	25.9	2.3	15.3	65.6	42.3	57.3	9.7	0.4	27.0	71.0	28.7	68.8	32.7	6.7	33.8	65.9	27.9	0.1	38.7	7.4	68.4	28.8	43.2	34.4	126.5	45.7	40.8	38.6	36.6	50.6	18.9	38.8	27.1	0.4	24.1	6.2	7.7	132.0	41.2	261.6	513.2	331.3	25.4	355.0	21.7	15.8	10.9	12.3	407.4	15.8	12.4	13.6	890.5	53.6	328.7	317.2	1.6	323.8	79.7	103.2	102.3	114.1	81.4	85.8	112.8	94.6	110.6	98.4	92.3	138.2	75.0	19.2	21.4	119.1	22.4	14.1	22.6	27.0	12.5	26.9	55.0	45.5	35.1	81.5	34.7	42.3	52.1	11.2	123.7	26.9	23.5	56.8	11.8	49.0	38.8	48.3	16.3	69.2	119.0	76.5	16.6	57.9	25.5	38.3	82.9	28.9	47.5	147.0	295.7	6.7	144.0	36.1	36.7	393.7	170.7	24.2	36.7	283.0	32.0	141.5	276.4	21.8	28.8	242.8	514.2	41.6	32.1	48.2	11.7	27.2	32.6	52.0	56.3	20.3	46.0	32.4	48.5	13.2	32.9	10.9	12.9	8.8	26.2	33.7	52.9	23.3
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30970984-30999911	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 63.3"					"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA021576: AB_1856331, HPA052404: AB_2681817"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	20.9	12.9	11.1	13.5	12.5	11.6	18.6	11.2	14.2	16.0	15.1	17.5	13.6	13.3	16.5	22.4	15.7	9.6	8.5	10.4	11.3	21.6	8.6	15.5	13.9	13.9	13.2	12.6	13.5	16.8	5.6	18.1	12.4	14.0	18.0	2.3	15.2	15.2	7.4	26.2	13.9	13.7	12.8	25.8	11.9	5.1	16.4	7.9	15.8	10.1	12.6	14.8	17.3	13.8	12.7	25.6	1.5	25.4	34.0	28.5	22.7	9.7	14.9	9.4	8.4	0.0	9.4	11.5	14.8	19.0	17.0	17.0	13.2	12.1	7.8	10.0	5.6	4.8	8.1	0.0	24.3	12.8	10.7	27.7	63.3	10.1	33.5	16.1	15.8	0.0	0.0	34.9	15.6	17.0	0.1	13.5	10.5	25.7	14.4	27.9	0.0	39.2	13.6	18.2	9.8	0.5	14.9	5.9	14.9	16.6	39.4	20.2	13.3	0.0	3.5	15.6	11.5	0.4	1.3	7.3	16.5	22.1	13.3	25.3	61.6	31.3	12.8	57.3	7.2	28.4	6.8	6.8	46.4	28.4	3.7	6.2	54.0	13.9	70.2	17.1	10.1	29.2	11.1	12.5	11.2	14.2	10.4	11.3	13.9	13.2	12.4	12.8	16.4	13.8	14.1	3.2	5.9	7.8	14.1	9.3	13.4	16.8	22.2	0.1	13.1	15.0	4.0	7.2	7.8	11.0	0.0	47.5	10.5	23.4	29.4	9.9	0.4	14.5	12.8	13.2	4.9	11.2	0.8	18.6	37.1	13.2	5.6	12.4	1.3	14.1	25.4	2.7	51.1	0.0	1.0	12.0	8.2	73.9	8.4	1.6	16.8	35.5	16.0	26.2	45.3	3.9	19.6	9.0	0.7	11.9	13.1	15.4	9.0	22.2	27.5	49.3	10.4	0.6	26.3	8.2	14.2	0.7	4.0	24.1	14.6	43.6	7.5	10.6	14.6	11.2
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474880-124488618	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 93.2"	"Group enriched"	"Detected in all"	10	"Early spermatids: 810.1;Late spermatids: 992.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"			"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	23.5	20.8	10.0	15.9	11.1	93.2	18.9	14.8	12.7	16.6	11.2	15.6	9.2	20.2	13.6	16.5	16.7	16.8	15.3	11.0	11.0	15.3	26.1	16.6	17.3	11.0	10.8	23.6	14.4	11.8	10.2	19.4	11.0	14.9	14.8	12.4	16.5	13.3	20.3	17.2	14.2	20.3	11.8	13.9	13.9	68.7	11.7	19.3	16.3	22.6	14.8	16.7	12.4	15.0	26.6	17.1	21.6	20.3	43.2	34.1	16.6	23.5	44.4	18.6	24.7	10.9	21.6	27.5	27.8	31.7	14.3	19.7	18.3	28.4	28.9	37.6	24.5	41.1	11.9	22.9	33.3	19.6	23.2	30.5	41.0	20.5	55.9	27.1	26.2	26.8	29.1	41.3	22.2	70.2	32.9	13.6	14.3	52.6	25.6	13.2	14.9	27.0	35.3	34.4	9.4	22.3	31.0	76.5	33.4	16.5	35.7	20.7	20.6	13.9	29.7	22.2	26.3	32.9	40.9	28.6	19.9	31.7	13.9	2.7	6.2	10.1	8.7	4.1	11.0	7.9	7.8	10.5	8.4	7.1	8.1	8.4	8.5	7.2	11.4	4.0	11.4	6.7	10.0	11.1	14.8	12.7	11.0	11.0	11.0	10.8	11.0	11.8	11.7	15.0	21.1	3.2	8.4	11.8	66.2	66.2	62.1	27.2	58.6	14.5	31.6	19.7	16.2	34.3	18.5	22.0	6.2	42.3	58.5	22.5	11.7	19.9	810.1	31.3	22.6	24.9	21.7	27.1	12.9	18.0	55.9	40.1	23.4	37.1	20.3	23.2	22.9	31.8	25.0	16.8	12.8	18.5	10.2	33.7	74.4	992.2	29.5	43.4	35.6	12.2	26.5	21.3	26.8	8.5	18.5	22.5	11.4	27.1	35.4	41.1	17.0	16.9	20.1	22.7	19.7	39.7	49.2	62.3	24.3	46.7	70.5	75.5	83.5	22.6	18.2	55.5
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990292	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	48.4	51.8	31.5	26.0	32.7	20.2	45.6	32.7	42.8	36.6	30.6	40.7	33.2	33.6	43.2	32.6	29.7	32.6	71.2	33.3	35.6	65.3	67.6	30.2	32.3	35.3	38.2	32.3	37.2	104.0	23.7	39.8	36.3	44.0	41.2	40.4	37.1	40.2	66.7	23.5	36.4	43.3	33.4	28.9	35.4	74.5	36.5	36.7	55.1	85.8	33.7	32.1	23.4	33.7	38.3	62.5	43.1	85.1	75.7	78.8	29.0	76.8	42.6	52.8	58.1	52.4	43.4	67.1	87.5	79.3	79.4	20.6	55.6	75.4	47.0	51.1	48.5	42.9	30.2	24.0	83.2	47.7	36.9	59.7	64.9	70.3	87.6	45.6	66.2	46.0	53.0	91.7	109.4	45.7	46.6	15.3	18.3	46.2	71.0	30.2	47.8	73.8	71.7	65.2	47.5	38.3	67.3	121.3	133.2	47.8	85.0	36.7	69.3	69.6	22.6	33.2	74.0	56.8	72.1	61.8	59.7	57.4	87.9	79.6	22.0	23.2	26.9	26.9	26.0	19.5	23.2	26.9	27.4	18.1	17.6	25.9	5.5	30.1	33.9	28.9	29.1	19.7	31.5	32.7	32.7	42.8	33.3	35.6	35.3	38.2	36.3	33.4	36.5	33.7	18.1	9.6	19.3	12.7	12.5	10.7	15.9	19.6	11.4	20.2	18.4	15.0	45.4	11.5	18.1	22.0	16.7	29.1	13.3	22.9	68.4	29.2	257.1	14.1	20.8	21.7	15.0	59.1	25.1	24.9	26.1	18.2	18.3	16.4	22.2	32.0	20.7	33.1	24.5	23.5	22.9	14.9	24.4	29.7	10.4	39.3	19.3	17.1	32.0	13.1	14.8	28.7	29.9	15.6	18.6	26.3	14.0	33.4	13.5	19.2	28.3	50.5	15.8	16.3	39.5	15.8	23.0	38.7	25.8	15.6	10.5	60.5	16.4	25.0	15.0	15.0
RNF141	"ZFP26, ZNF230"	ENSG00000110315	"Ring finger protein 141"	Q8WVD5	11	10511673-10541230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 1045.8;Late spermatids: 666.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018133	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Microtubules	Nucleoplasm	"HPA018133: AB_1859142"	"unprognostic (7.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.88e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-2)"	24.0	28.3	41.2	26.8	61.9	19.8	26.9	56.4	61.6	17.6	22.9	17.3	21.7	13.7	19.7	56.3	16.3	14.5	22.7	34.0	51.6	23.5	21.8	21.7	17.9	61.3	52.7	10.9	14.5	30.6	10.0	14.9	63.4	22.6	16.8	18.6	38.3	14.2	43.4	42.9	30.0	13.3	52.1	27.7	21.6	82.7	48.4	18.8	22.9	35.7	25.6	21.0	22.9	79.7	48.3	24.6	34.5	21.1	51.7	50.2	24.6	32.2	26.1	12.6	15.1	38.3	176.3	19.9	28.3	25.0	22.3	34.8	15.3	38.4	19.0	21.7	20.1	13.3	15.8	19.9	20.0	22.2	15.2	33.0	44.0	6.7	41.1	45.8	33.9	25.2	38.4	18.7	31.6	20.6	21.2	8.3	17.5	32.3	14.0	27.3	14.8	22.9	20.4	52.9	11.0	21.5	31.1	36.8	20.6	29.5	23.4	11.3	36.3	30.1	18.5	24.6	10.4	8.2	16.5	22.7	37.7	31.3	37.3	34.2	52.3	92.7	8.3	106.8	13.9	67.6	9.6	8.1	28.9	69.9	10.5	7.3	152.4	9.2	103.9	26.6	12.8	33.9	41.2	61.9	56.4	61.6	34.0	51.6	61.3	52.7	63.4	52.1	48.4	79.7	15.1	19.2	49.2	14.4	39.4	40.8	39.7	47.7	37.0	20.3	31.7	22.0	46.7	18.6	36.9	20.2	12.5	14.4	18.8	16.6	41.1	21.2	1045.8	18.5	14.0	18.4	21.0	15.4	10.7	24.7	15.1	15.9	16.8	23.0	13.3	18.8	21.0	28.0	41.6	37.0	11.8	28.2	16.2	107.4	10.5	666.5	19.6	52.6	19.6	4.7	41.7	27.8	4.1	12.1	67.9	41.6	11.2	19.5	15.2	53.3	58.8	33.5	48.0	11.0	6.6	19.1	18.6	83.4	39.4	49.1	40.1	17.9	11.7	23.3	21.1	74.8
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468870	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 71.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	9.4	2.0	7.4	15.6	7.4	24.0	29.1	7.9	9.0	9.5	9.1	4.2	1.8	5.7	4.7	8.4	11.8	6.2	8.1	6.4	7.7	14.0	15.5	19.4	11.3	11.8	11.9	1.6	3.2	2.9	1.7	15.1	9.4	13.1	2.8	5.0	16.9	7.3	56.9	21.1	3.3	6.2	8.9	13.1	5.7	2.3	10.5	5.1	40.9	14.1	12.9	9.4	7.1	8.7	4.6	1.0	0.4	0.0	0.3	2.0	9.8	5.3	5.7	11.0	11.8	0.1	0.4	192.8	50.7	2.3	0.6	16.3	0.1	16.0	15.5	0.9	1.4	0.2	0.2	4.2	0.2	0.2	0.2	2.7	59.1	4.3	13.2	4.9	55.6	4.3	0.1	0.0	2.7	2.0	1.5	0.0	1.6	0.6	1.1	0.7	1.7	11.8	33.2	10.6	1.9	0.2	1.2	23.9	18.5	1.5	28.2	0.5	56.1	8.6	1.9	0.8	1.2	0.0	0.1	160.6	1.0	0.4	0.7	0.4	20.7	12.9	0.5	38.9	1.6	4.6	0.8	0.6	13.3	3.6	1.6	1.0	36.7	0.6	71.9	18.4	0.5	7.1	7.4	7.4	7.9	9.0	6.4	7.7	11.8	11.9	9.4	8.9	10.5	8.7	28.8	44.8	15.0	34.9	21.7	634.4	48.8	86.0	14.8	0.9	35.7	26.3	12.8	17.2	48.3	38.6	2.1	14.1	9.8	2.2	19.6	8.6	2.1	49.0	5.8	34.6	1.2	3.8	2.3	8.9	3.7	7.8	10.7	58.5	3.8	0.1	47.2	21.9	15.0	0.0	99.0	1.8	14.2	109.4	296.9	1.8	1.2	171.7	60.5	92.8	54.1	17.9	1.0	3.5	2.5	5.2	3.6	3.0	3.4	112.3	0.9	20.6	36.7	1.2	0.0	9.0	7.8	2.2	3.2	30.0	1501.1	1.5	4.9	0.1	2.3	42.6
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 278.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 619.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 619.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	26.7	15.2	7.7	40.3	7.5	52.3	16.3	7.7	9.7	17.7	12.3	15.7	16.8	12.4	16.3	35.5	16.9	18.9	12.5	7.6	8.9	16.3	26.6	30.5	18.3	9.9	8.5	15.9	22.3	17.9	10.4	21.8	9.6	12.6	15.8	7.8	18.3	10.1	8.5	25.6	18.2	12.9	8.5	53.1	19.1	15.8	9.1	15.2	12.2	9.4	19.6	29.1	22.7	10.9	19.9	11.4	8.8	11.3	31.6	31.3	49.7	24.0	31.8	32.1	35.8	29.0	51.6	6.1	28.3	23.9	42.9	39.0	12.5	24.6	29.7	16.9	16.6	12.4	9.9	50.0	42.1	13.4	19.2	28.9	40.0	37.9	25.1	24.7	58.9	13.0	10.7	18.0	32.4	16.9	18.8	14.0	6.1	27.1	20.0	11.5	14.2	23.4	38.0	48.0	11.5	8.5	14.4	36.0	37.2	9.5	9.7	17.8	39.6	16.2	9.1	24.5	5.3	35.5	22.5	0.2	5.2	18.6	12.2	44.0	73.6	90.3	43.8	118.1	41.8	13.2	40.0	45.3	27.9	8.5	28.2	30.2	619.9	15.3	134.1	52.5	53.8	69.8	7.7	7.5	7.7	9.7	7.6	8.9	9.9	8.5	9.6	8.5	9.1	10.9	19.9	48.1	48.1	44.7	55.2	76.9	78.1	63.5	54.7	20.4	29.7	15.9	13.0	41.5	48.4	55.2	56.3	65.2	112.4	53.1	1.9	59.1	97.9	41.8	31.9	30.0	8.5	22.7	82.8	42.2	73.0	53.5	37.2	63.1	39.2	17.3	27.1	46.2	85.9	8.4	71.6	31.7	12.2	278.6	144.2	37.2	30.7	209.0	40.9	50.6	116.5	11.6	61.8	34.7	59.6	54.3	52.3	19.5	125.5	73.5	45.9	25.8	44.8	20.7	59.2	40.5	30.1	36.6	40.3	128.3	91.6	128.1	115.7	23.8	32.8	154.1
RNF150	KIAA1214	ENSG00000170153	"Ring finger protein 150"	Q9ULK6	4	140859807-141212877	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Excitatory neurons: 184.5;Inhibitory neurons: 174.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 285.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.7;fHDF/TERT166: 27.1;SH-SY5Y: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037987	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037987: AB_10669512"	"prognostic favorable (1.41e-4)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.88e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.41e-2)"	11.3	12.4	6.8	1.7	12.5	0.3	3.1	7.5	7.7	8.0	0.0	16.5	1.0	11.9	10.8	6.8	12.4	3.4	14.9	7.7	8.1	8.3	0.9	1.3	3.3	1.3	1.3	10.8	2.0	0.5	7.8	1.9	6.1	8.3	3.8	31.8	31.7	11.1	18.7	0.9	3.7	12.2	1.9	5.4	4.0	1.4	5.6	2.0	6.2	12.5	3.1	6.5	3.9	2.0	0.3	0.5	4.8	4.2	19.7	1.4	0.2	6.8	3.5	2.5	1.2	0.0	0.1	0.0	0.9	27.1	0.1	0.1	9.8	0.1	1.3	0.1	4.6	0.0	8.9	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.0	4.8	0.0	0.1	0.9	0.1	4.7	0.2	2.2	0.0	1.8	2.6	12.4	0.1	2.8	0.0	2.0	37.0	0.7	0.3	1.9	2.5	0.1	0.1	0.1	12.6	5.2	8.7	3.1	0.3	0.1	0.0	0.2	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	12.5	7.5	7.7	7.7	8.1	1.3	1.3	6.1	1.9	5.6	2.0	0.8	0.0	0.5	65.6	0.0	1.1	0.7	0.3	3.4	53.9	3.1	7.4	72.5	1.5	2.2	11.0	112.6	1.3	0.0	0.1	1.9	0.4	4.6	17.8	43.9	2.7	1.8	0.0	184.5	0.5	0.1	10.0	0.0	22.8	0.0	11.4	2.2	0.2	0.7	26.9	174.3	0.0	0.0	0.6	2.9	2.7	28.6	2.0	0.0	114.3	0.0	13.4	0.0	285.5	5.7	0.1	0.0	18.0	0.0	1.1	0.0	1.0	0.2	69.1	13.1	34.5	17.4	0.0	2.0	0.5	0.6	0.4	0.4	47.6	0.0	0.1
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142465-76240493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 86.9;retina: 59.0;skeletal muscle: 73.9;testis: 31.4;tongue: 43.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	13.6	3.3	36.4	3.7	39.1	2.2	4.9	34.1	86.9	1.4	9.8	9.8	9.6	1.4	3.4	1.0	1.8	1.3	6.4	56.9	34.5	5.8	2.5	1.4	5.2	59.7	41.9	1.2	3.4	14.6	6.3	1.6	61.1	1.9	7.0	59.0	1.9	1.5	73.9	1.0	10.3	1.8	34.1	3.5	3.9	31.4	51.5	2.8	3.4	43.7	2.7	3.0	1.0	58.1	0.2	7.1	29.3	10.7	8.8	4.4	13.4	0.3	8.9	1.9	1.3	3.3	3.1	0.0	4.2	0.5	6.9	0.2	26.0	0.1	1.6	100.9	8.9	0.0	2.9	4.7	1.7	1.4	10.9	2.4	0.1	3.7	0.1	1.5	0.2	4.7	16.0	0.3	3.6	8.0	4.4	0.8	4.8	5.5	21.1	0.0	0.3	0.1	3.4	3.2	5.1	24.0	5.3	0.1	11.5	6.5	0.7	5.1	0.2	1.9	2.3	14.4	9.6	50.6	45.5	0.1	0.8	0.1	15.1	2.2	0.2	0.3	1.6	0.1	3.4	0.2	3.4	2.7	0.1	0.4	5.8	3.9	1.2	0.7	0.2	0.3	1.3	1.0	36.4	39.1	34.1	86.9	56.9	34.5	59.7	41.9	61.1	34.1	51.5	58.1	2.8	3.2	3.3	33.3	1.5	2.0	0.8	0.2	0.6	114.1	0.8	0.9	9.0	11.5	1.3	1.8	189.7	0.6	5.0	5.3	0.0	1.9	27.8	0.6	3.7	4.4	2.4	5.5	64.6	1.1	0.4	3.1	0.0	1.5	0.0	0.9	0.7	4.3	0.4	180.0	92.7	7.4	0.0	0.8	6.0	29.1	11.5	1.1	1.8	3.7	1.4	35.9	8.2	62.8	35.0	0.1	3.4	13.9	2.1	0.9	19.3	9.1	0.7	70.9	0.0	2.9	1.3	22.7	25.0	0.0	2.3	0.3	15.5	1.3	18.2	1.5
RNF165	"Ark2C, ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;retina: 18.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	0.6	0.5	3.1	0.3	3.7	0.3	0.7	7.6	6.4	0.6	0.0	0.4	0.0	0.2	1.9	1.2	1.2	0.3	1.0	4.7	0.2	1.6	5.2	0.3	0.2	0.0	0.3	0.0	0.3	2.4	4.1	0.2	0.0	2.2	0.1	18.2	0.8	1.3	1.5	1.2	0.3	0.1	0.1	2.0	0.2	0.5	1.3	0.9	4.0	0.8	0.4	0.3	0.5	1.9	1.6	0.1	10.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.3	0.5	1.0	0.0	0.0	1.1	0.1	7.5	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	2.3	0.0	0.2	0.0	0.0	2.6	0.9	1.7	0.4	1.3	2.7	0.6	6.4	0.7	2.2	13.9	13.2	2.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	3.1	3.7	7.6	6.4	4.7	0.2	0.0	0.3	0.0	0.1	1.3	1.9	9.1	3.2	1.7	1.6	0.3	2.7	9.5	12.9	28.5	44.0	2.9	7.2	8.4	1.5	2.8	0.0	100.1	0.2	10.0	0.2	3.9	0.0	3.8	1.5	9.3	5.0	0.0	0.0	47.4	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.8	8.9	0.1	80.8	34.4	0.0	2.0	1.9	1.3	5.1	2.5	0.4	1.8	1.9	0.3	5.0	41.2	35.7	1.8	0.1	0.0	4.1	0.4	5.0	0.1	0.1	0.6	49.1	0.0	4.5	0.7	0.4	0.9	3.7	2.0	0.3	3.2	3.2	0.0	2.4
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	75.0	110.6	141.9	53.0	146.7	69.0	73.1	146.4	179.9	93.2	138.6	111.5	66.6	94.9	76.4	122.1	84.3	45.3	131.8	141.5	146.4	106.7	184.2	77.5	64.5	146.3	145.4	87.4	115.1	105.8	96.8	50.7	146.3	95.0	65.7	98.1	92.5	70.5	152.9	127.8	100.5	52.8	142.4	113.8	111.8	110.6	150.3	98.1	93.4	94.2	71.6	106.7	90.4	153.3	102.6	143.1	61.1	73.7	132.8	68.7	92.7	63.4	76.1	119.7	93.4	96.2	43.3	71.5	120.3	93.5	63.9	147.5	103.2	114.8	86.1	74.5	166.1	121.9	164.4	94.9	100.6	59.0	245.0	79.6	176.5	129.8	116.2	74.6	77.2	101.0	49.9	237.5	96.2	66.3	92.8	70.6	75.4	102.0	86.8	62.8	61.9	91.5	137.3	77.4	49.2	61.1	56.0	92.9	81.9	83.1	87.3	55.9	49.5	76.6	48.3	66.8	119.3	79.5	88.0	23.7	98.4	80.6	77.9	108.4	88.8	236.9	195.3	94.0	153.4	100.4	148.0	195.7	73.9	98.7	103.2	152.2	219.8	118.8	117.7	75.9	153.0	177.0	141.9	146.7	146.4	179.9	141.5	146.4	146.3	145.4	146.3	142.4	150.3	153.3	36.9	0.0	3.9	12.4	54.3	68.6	44.4	65.8	51.8	43.2	56.6	44.7	15.8	77.2	38.9	49.7	20.9	120.1	64.7	65.2	56.7	78.5	59.6	29.8	25.1	36.4	31.8	60.6	11.3	66.7	139.7	36.3	36.2	32.2	14.0	26.3	45.7	95.1	58.4	18.5	11.2	45.7	65.1	41.3	43.6	86.5	48.7	36.1	39.2	6.5	53.1	46.9	114.4	10.1	17.9	60.7	44.9	53.8	59.1	32.6	108.2	64.0	31.1	32.3	39.5	28.4	35.1	127.1	106.7	61.4	83.3	125.2	82.5	37.2	59.6	48.0
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748849-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	4.2	2.8	3.8	6.7	6.2	14.4	5.6	6.2	4.4	5.5	5.4	4.4	4.0	7.6	4.2	10.1	5.6	4.8	3.2	4.0	4.4	4.6	5.0	5.9	6.3	5.4	5.0	7.6	4.4	5.6	2.1	4.7	5.4	5.2	5.3	6.1	4.5	4.3	6.8	5.5	4.4	7.6	4.4	7.3	4.6	2.9	4.6	7.7	5.8	5.8	6.7	5.2	5.4	9.2	10.2	7.7	9.1	9.0	5.8	7.7	3.7	7.9	7.4	8.6	7.4	13.0	7.5	18.2	7.9	9.5	5.8	9.6	12.4	9.3	11.2	9.1	8.0	12.6	15.3	5.1	6.6	6.8	10.1	7.1	7.2	9.8	22.1	9.6	14.0	12.2	11.4	14.1	8.7	8.6	11.6	12.0	3.6	12.9	5.0	10.7	21.7	9.9	5.5	10.6	4.1	7.4	10.6	8.0	16.6	7.3	9.9	8.6	9.4	14.2	11.8	9.0	7.1	10.2	5.8	21.1	2.8	7.3	8.4	1.2	0.5	0.4	0.4	0.3	0.3	0.0	0.4	0.2	0.2	0.1	0.3	0.2	1.4	0.3	0.3	0.2	0.3	0.2	3.8	6.2	6.2	4.4	4.0	4.4	5.4	5.0	5.4	4.4	4.6	9.2	18.8	9.6	11.4	51.6	18.4	19.9	30.6	7.1	20.5	58.2	12.6	9.8	3.0	17.2	8.3	3.7	52.1	5.5	24.6	9.8	5.9	10.2	2.8	30.5	26.7	17.2	12.0	18.3	40.8	11.1	6.4	16.0	14.8	30.1	7.0	24.4	10.8	12.3	8.5	37.0	43.2	8.7	2.0	15.6	19.9	3.1	7.5	16.6	10.6	25.3	12.6	22.9	26.8	42.7	68.7	10.1	6.8	10.5	18.5	49.7	6.3	12.1	8.9	33.7	26.3	31.9	18.7	9.4	11.7	16.4	18.6	8.1	22.2	14.0	10.4	42.2
RNF17	"FLJ11045, Mmip-2, SPATA23, TDRD4"	ENSG00000132972	"Ring finger protein 17"	Q9BXT8	13	24764169-24879921	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 24.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 22.2;Late spermatids: 27.6;Spermatocytes: 67.0;Spermatogonia: 24.3"	"Cancer enriched"	"Detected in single"	41	"testis cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"HPA039699, HPA040111"	Approved					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA039699: AB_10795254, HPA040111: AB_10795414"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-2)"		"unprognostic (1.37e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.26e-1)"		"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.61e-2)"			"unprognostic (5.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	3.8	0.0	0.0	0.1	0.8	1.2	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	22.2	0.0	0.1	0.2	0.0	0.0	2.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	27.6	0.9	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	67.0	24.3	0.0	0.0	1.0	0.0	0.0	0.0	0.1
RNF170	"ADSA, DKFZP564A022, SNAX1"	ENSG00000120925	"Ring finger protein 170"	Q96K19	8	42849637-42897290	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050931, HPA054621"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"			"HPA050931: AB_2681279, HPA054621: AB_2682545"	"unprognostic (3.06e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.54e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.61e-3)"	"unprognostic (4.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.13e-1)"	9.3	11.7	14.5	7.5	15.6	2.4	12.7	16.3	16.8	7.9	11.5	11.1	10.3	9.5	14.9	14.2	9.3	9.2	7.7	14.1	15.8	16.4	19.7	9.3	9.4	15.9	15.5	12.3	8.1	13.5	9.5	19.2	16.2	11.0	11.3	35.6	11.0	10.6	11.9	15.1	11.4	7.6	15.0	9.1	10.7	5.9	15.6	6.1	28.8	9.2	9.9	7.6	8.5	18.3	11.4	18.1	18.2	9.2	29.4	29.7	10.8	13.3	18.1	12.3	13.2	8.5	36.0	13.6	15.7	12.8	22.1	9.6	9.6	13.2	10.8	9.4	10.4	15.9	8.5	9.3	16.1	2.0	10.9	26.0	20.4	9.3	18.8	16.0	13.3	15.0	14.6	15.8	19.9	3.4	17.0	9.5	8.6	24.1	6.5	8.7	24.2	7.7	19.6	10.8	4.7	14.3	12.8	8.9	23.0	17.7	23.1	9.5	19.5	13.2	5.8	17.8	4.3	25.2	26.4	15.7	18.2	6.7	13.6	1.4	5.7	2.1	2.9	5.7	4.2	6.6	4.8	5.3	8.8	3.9	5.6	4.1	0.6	4.9	5.5	8.9	6.7	4.5	14.5	15.6	16.3	16.8	14.1	15.8	15.9	15.5	16.2	15.0	15.6	18.3	13.5	48.1	20.5	41.1	16.1	7.6	13.1	22.3	5.7	44.8	14.9	9.5	11.5	15.7	29.2	23.9	89.6	41.6	9.8	22.1	17.6	21.6	1.7	16.0	14.5	15.2	13.1	5.5	36.7	27.8	19.4	20.0	11.2	13.3	9.5	25.5	21.8	21.7	22.9	21.9	43.7	15.3	20.3	18.5	9.2	2.4	15.2	15.4	8.8	15.9	21.9	31.8	30.9	36.2	75.9	32.2	18.4	20.7	10.7	9.6	34.5	22.1	33.3	72.1	13.1	23.9	12.1	14.9	19.3	12.5	11.5	31.2	12.8	25.7	16.6	12.2
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165843-64372869	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.5;Inhibitory neurons: 151.6;Oligodendrocyte precursor cells: 162.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	5.4	5.1	3.2	1.5	3.9	0.3	3.6	2.6	5.1	4.1	2.9	3.3	1.7	7.7	7.7	4.2	4.9	4.2	7.0	2.8	8.2	8.1	4.5	3.7	1.3	3.9	5.8	7.6	4.2	25.3	3.5	0.6	4.7	7.3	1.3	6.0	4.6	10.6	2.7	4.1	1.4	5.7	4.4	3.0	2.6	3.4	6.6	0.7	14.0	4.1	0.9	3.3	2.3	4.5	0.0	0.1	1.4	0.0	0.0	0.0	0.3	1.2	0.5	1.2	0.7	0.0	0.1	0.0	0.1	0.9	0.7	0.2	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.3	0.1	3.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.6	0.0	1.4	0.1	3.7	29.4	2.1	0.3	0.3	0.1	0.0	0.3	0.0	1.8	1.5	0.1	0.1	0.0	3.5	0.1	3.3	0.0	0.0	0.0	0.6	0.0	3.9	1.2	0.6	1.7	0.6	0.2	0.9	0.5	1.0	1.1	0.2	0.8	1.4	1.3	1.0	0.8	0.3	0.4	0.7	0.0	3.2	3.9	2.6	5.1	2.8	8.2	3.9	5.8	4.7	4.4	6.6	4.5	9.5	16.0	12.3	51.6	0.5	4.6	8.9	1.3	7.4	16.6	8.1	4.2	10.9	10.0	4.9	16.5	14.6	0.0	0.0	0.0	7.9	5.8	12.5	14.2	6.1	6.3	1.2	0.0	90.5	2.6	0.1	7.9	6.1	32.9	0.0	5.7	14.3	5.9	0.1	11.8	151.6	1.9	0.0	0.6	1.1	8.8	34.5	0.5	5.4	32.8	0.0	30.1	0.0	162.3	50.1	3.1	2.7	25.2	0.0	6.4	1.2	15.9	1.9	16.9	39.5	24.2	20.4	18.9	12.0	2.9	7.4	0.0	0.3	4.1	1.6	4.5
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597708	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 851.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	110.4	135.0	87.6	60.2	92.4	76.7	109.8	93.3	101.9	105.5	85.7	101.3	75.1	85.2	85.0	118.0	87.4	50.2	141.1	88.9	93.2	174.3	169.5	114.0	69.1	92.8	91.5	90.7	168.5	80.1	61.9	82.9	91.8	111.0	69.0	36.0	110.0	73.0	172.1	102.6	91.4	65.2	93.7	101.2	121.8	107.6	94.5	59.5	93.8	105.1	89.6	107.5	98.7	97.7	125.7	120.4	96.3	103.8	94.3	113.4	152.2	104.7	195.4	207.7	199.7	185.2	132.2	118.8	196.8	150.6	206.2	117.5	83.5	164.8	223.8	133.9	104.0	91.6	58.5	224.7	168.0	104.8	122.1	122.0	208.5	144.5	237.1	166.2	175.4	110.8	109.1	119.7	282.7	193.0	97.8	235.6	68.6	164.9	180.2	105.1	202.5	171.7	200.8	109.3	57.2	74.5	88.4	126.2	171.7	114.8	125.4	136.2	160.1	104.9	77.2	218.4	149.6	170.3	143.5	143.1	166.4	144.9	95.5	213.9	418.5	339.7	176.1	326.0	164.6	251.9	181.4	169.2	321.4	214.8	156.4	153.0	356.6	195.5	254.9	360.4	262.0	439.0	87.6	92.4	93.3	101.9	88.9	93.2	92.8	91.5	91.8	93.7	94.5	97.7	89.3	147.4	104.8	7.8	89.3	116.9	102.5	343.7	75.7	27.1	92.8	95.4	122.8	124.4	200.2	150.8	2.1	237.1	104.2	148.1	416.7	236.5	365.7	70.5	63.6	102.8	70.2	85.2	2.2	290.4	260.2	113.7	55.0	93.2	102.7	59.0	99.6	214.4	263.4	18.5	2.2	138.4	185.1	154.0	182.3	250.6	88.3	147.6	170.7	3.7	188.7	80.4	94.7	2.0	6.9	304.0	201.5	78.2	113.8	123.8	271.9	851.7	141.7	29.1	59.2	66.3	108.8	121.3	33.1	97.9	118.6	221.2	86.7	62.6	102.0	115.6
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980310	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;choroid plexus: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 81.3;RPTEC TERT1: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.1	0.1	12.2	0.1	13.3	8.4	0.6	22.5	17.7	0.8	12.7	0.2	0.2	0.6	1.1	0.3	1.2	0.2	0.3	17.6	12.2	1.1	0.0	3.3	0.2	16.9	17.7	0.3	1.7	5.8	1.8	1.3	16.5	0.4	0.1	8.8	1.3	2.1	0.2	0.4	0.3	0.3	14.2	0.2	0.2	3.7	24.7	1.5	1.3	0.1	0.0	0.3	0.4	12.2	0.2	6.5	12.0	0.0	4.1	5.0	0.7	6.3	8.6	17.0	16.4	0.3	0.1	0.0	0.1	6.8	18.5	0.0	14.3	0.1	30.9	0.0	4.7	0.4	81.3	0.0	0.0	0.1	0.0	2.8	0.0	26.3	0.2	19.5	0.3	3.5	0.5	0.0	11.9	0.2	0.1	2.2	6.9	0.1	23.9	3.8	2.9	1.0	67.3	0.0	14.2	13.7	0.6	0.0	24.8	4.4	0.0	2.4	6.5	20.7	4.4	0.2	14.3	0.0	0.0	0.0	14.1	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	13.3	22.5	17.7	17.6	12.2	16.9	17.7	16.5	14.2	24.7	12.2	0.2	0.0	0.0	85.2	0.1	0.3	0.1	0.0	0.0	19.3	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.4	0.1	0.2	0.0	9.7	8.6	0.0	0.1	0.4	0.0	0.1	0.0	5.4	0.0	0.1	0.1	15.2	1.5	0.1	0.0	0.0	0.3	1.4	0.3	0.0	0.0	5.6	0.0	14.7	0.0	2.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.1	1.3	6.6	0.0	1.3	5.7	3.2	0.0	0.0	0.3	0.3	0.0	0.1	0.1
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.4;kidney: 11.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057675	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"			"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.1	0.1	0.3	0.4	0.2	0.0	1.0	0.2	0.4	1.5	0.2	0.5	0.4	1.2	16.4	4.9	1.3	5.7	0.1	0.2	0.1	11.5	0.2	0.3	0.0	0.2	0.2	0.3	0.3	0.1	2.0	0.0	0.2	1.0	0.4	1.2	6.8	0.3	0.0	0.4	0.3	0.0	0.3	0.1	3.4	5.0	0.4	0.0	0.4	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.5	0.0	0.4	15.9	0.0	0.6	3.8	2.9	0.4	5.7	9.8	5.5	0.0	0.0	0.2	0.9	1.9	0.2	0.2	13.4	1.1	0.5	8.4	0.0	0.0	0.9	0.1	0.2	4.6	20.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	22.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.2	0.7	0.4	0.0	0.5	0.2	26.4	13.0	3.3	0.0	0.4	0.6	3.3	0.7	1.4	0.0	0.0	0.3	0.1	1.5	1.0
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815283	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 67.2;intestine: 131.1;pancreas: 43.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 41.6;Enteroendocrine cells: 86.6;Intestinal goblet cells: 46.6;Paneth cells: 123.4;Proximal tubular cells: 142.7;Undifferentiated cells: 110.3"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 18.5;renal cancer: 12.1;stomach cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034547, HPA035558"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.3	0.0	0.0	5.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	18.7	131.1	0.1	67.2	0.0	0.0	0.4	0.0	0.0	0.0	26.1	0.8	0.0	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	0.0	0.3	15.4	0.0	0.3	0.4	0.0	0.0	44.8	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	41.6	5.9	9.6	0.0	0.8	0.1	0.1	86.6	0.0	0.0	18.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	123.4	0.0	0.0	0.1	16.1	142.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	110.3	0.2
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487382-228496188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 189.0"					"Low region specificity"	"Detected in all"			HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	26.8	66.6	16.2	7.5	16.2	11.3	25.8	14.8	24.3	40.5	3.4	28.1	8.6	31.8	4.3	59.1	28.7	5.6	35.4	15.9	16.9	40.7	52.0	23.6	7.3	19.4	15.2	39.3	34.5	22.5	47.7	5.5	18.4	33.5	3.7	9.0	39.7	8.2	64.2	45.0	22.5	5.6	15.6	37.0	27.6	20.8	18.5	8.5	36.1	19.8	6.1	29.9	41.2	19.8	26.7	23.1	14.8	28.9	16.8	12.5	26.6	21.5	17.3	15.6	12.7	12.8	19.2	65.9	43.1	28.9	11.4	20.9	19.1	22.1	5.8	25.9	28.5	20.8	13.2	12.6	46.1	22.1	34.4	20.4	44.7	11.6	15.8	18.3	14.0	52.6	35.6	115.2	12.4	17.7	35.2	20.8	30.7	19.1	24.0	27.8	12.5	61.5	11.4	17.2	29.9	30.0	21.9	44.1	62.3	4.3	34.6	50.2	27.8	18.3	16.9	19.6	19.3	189.0	56.7	36.4	46.7	22.7	28.7	0.0	0.5	3.6	0.6	1.0	0.7	0.5	0.7	1.0	0.6	1.0	0.6	0.7	0.1	0.4	1.4	0.7	0.6	0.3	16.2	16.2	14.8	24.3	15.9	16.9	19.4	15.2	18.4	15.6	18.5	19.8	54.0	25.6	15.5	8.1	47.2	36.2	42.9	10.6	38.7	85.2	59.5	58.5	70.8	65.8	14.2	40.5	18.8	19.7	52.2	39.8	113.5	15.2	0.8	35.5	47.2	32.1	40.0	118.4	16.6	24.5	27.1	54.4	34.7	32.0	44.5	45.0	41.7	67.4	27.4	55.5	17.2	36.6	2.0	40.1	30.5	4.2	24.5	35.8	39.2	12.2	29.7	145.3	62.8	7.1	12.6	21.4	23.4	25.9	35.4	44.0	32.9	126.4	10.3	47.7	19.7	52.2	38.4	4.2	21.5	57.0	55.3	17.6	54.6	217.5	38.6	31.7
RNF19A	"DKFZp566B1346, dorfin, RNF19"	ENSG00000034677	"Ring finger protein 19A, RBR E3 ubiquitin protein ligase"	Q9NV58	8	100257060-100336218	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 178.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011455, HPA023652"	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB011455: AB_2180446, HPA023652: AB_1847836"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (8.44e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.28e-5)"	32.0	18.8	29.1	32.7	28.7	57.4	28.6	22.7	25.5	52.0	17.6	25.9	24.0	41.3	16.4	21.6	30.5	43.1	25.0	25.3	48.3	30.0	49.3	34.7	55.4	40.2	36.0	27.4	25.9	16.1	15.2	26.9	33.0	22.0	26.5	27.2	22.3	18.7	28.0	31.8	37.9	32.6	37.3	31.5	27.4	53.0	36.1	34.3	18.8	31.0	43.8	35.9	27.3	40.7	26.7	16.9	14.8	16.9	27.7	23.1	18.7	23.4	22.5	22.0	19.9	9.0	17.3	15.7	41.6	24.7	10.2	18.9	11.6	17.4	29.6	65.3	9.4	26.1	86.8	13.5	22.8	5.3	15.6	23.3	26.1	17.5	33.1	26.9	34.3	17.3	14.8	178.6	21.8	13.5	24.6	9.0	5.4	18.2	15.5	9.8	10.0	30.7	60.2	41.7	11.4	24.6	24.5	14.9	23.3	30.6	13.1	20.5	33.9	25.3	19.9	18.7	14.3	85.5	59.3	10.4	16.2	17.4	15.4	26.3	8.6	8.1	16.3	6.8	10.4	15.5	13.4	12.6	5.7	13.9	6.9	9.8	19.6	6.2	14.2	14.1	14.7	5.8	29.1	28.7	22.7	25.5	25.3	48.3	40.2	36.0	33.0	37.3	36.1	40.7	70.8	51.3	51.6	106.7	101.7	40.1	83.4	56.9	18.8	29.9	44.7	32.5	40.6	110.1	83.6	44.1	60.5	11.0	184.8	61.6	7.9	65.0	183.8	165.9	78.2	66.3	20.8	124.8	76.9	40.2	14.5	62.5	67.8	242.1	43.0	172.0	32.2	42.9	23.0	58.9	69.7	25.9	42.7	30.5	41.8	259.4	58.4	39.2	21.4	73.1	24.1	43.5	65.9	35.7	39.9	49.0	32.0	68.8	161.7	66.3	50.9	54.1	106.2	48.4	19.7	77.4	46.3	77.8	47.2	26.1	60.4	8.2	204.6	46.3	21.8	144.9
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964809	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 79.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 16.9"	"Cell line enhanced"	"Detected in all"		"Daudi: 107.6;Karpas-707: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	14.5	19.1	10.7	24.3	9.6	74.1	10.9	14.5	10.7	16.8	7.6	23.3	25.0	15.0	5.0	35.3	12.3	17.4	10.4	9.9	12.1	21.1	11.3	21.1	17.7	10.7	9.6	9.7	9.2	11.5	7.9	14.9	11.8	11.0	25.8	18.9	15.4	8.9	16.2	22.6	21.7	18.0	11.6	15.1	13.1	79.0	10.8	13.0	9.0	11.1	30.6	30.1	20.9	11.6	18.7	14.3	11.9	11.3	7.1	9.6	79.5	8.5	10.0	14.7	15.6	16.8	54.9	107.6	14.2	10.7	18.2	26.5	14.3	19.8	13.3	39.6	9.5	9.2	10.5	16.9	22.5	14.7	19.0	7.9	36.3	32.5	39.3	17.2	31.9	10.3	11.7	124.8	14.5	6.1	9.6	18.4	19.2	21.1	15.8	12.7	17.3	11.3	11.5	26.4	18.9	9.6	27.0	9.1	63.1	29.1	8.0	20.8	35.1	8.1	11.5	21.1	15.1	29.6	16.1	38.0	11.9	14.7	12.5	6.1	2.0	4.0	1.6	1.9	1.3	1.2	1.4	0.7	1.4	1.5	0.4	0.6	16.9	1.0	1.7	0.6	1.7	0.8	10.7	9.6	14.5	10.7	9.9	12.1	10.7	9.6	11.8	11.6	10.8	11.6	20.6	12.8	4.4	5.5	8.7	46.1	27.0	26.7	24.5	4.6	15.8	11.7	16.2	10.0	9.9	7.3	2.1	12.6	14.6	48.0	1.9	12.9	34.8	25.4	7.3	15.3	11.3	5.2	9.7	11.5	6.3	8.4	13.3	36.9	4.5	3.2	7.1	4.8	13.5	3.3	9.8	22.1	6.1	20.9	37.7	26.3	2.1	42.4	5.4	19.7	39.5	2.8	2.1	7.5	6.6	25.7	31.9	3.8	4.6	34.2	38.6	9.2	14.4	7.7	0.0	5.9	9.6	34.7	16.3	23.9	32.5	7.4	10.3	2.3	16.3	41.7
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045526-185102603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	9.5	8.1	5.4	10.2	6.7	13.8	12.5	6.1	7.0	10.3	3.7	9.3	8.4	10.7	8.5	8.4	8.6	9.4	7.4	7.0	7.5	9.6	8.3	8.3	11.5	4.0	4.8	9.3	9.6	8.7	5.6	21.7	4.8	8.5	9.7	11.8	9.6	10.4	8.2	6.4	6.5	10.9	4.5	10.4	9.6	21.9	7.9	12.3	10.8	9.0	12.3	16.5	8.7	5.1	34.0	18.6	62.8	25.4	17.8	30.3	65.3	24.0	28.4	35.5	28.3	29.9	53.3	10.2	29.2	29.0	24.4	11.5	43.7	32.7	41.7	31.1	28.4	54.9	10.2	25.8	27.5	56.1	29.7	29.7	19.6	29.6	36.4	27.9	36.6	34.4	44.7	22.5	25.1	21.2	48.5	17.6	86.3	27.4	11.0	55.1	41.3	9.8	25.7	23.6	18.9	33.4	17.3	9.9	46.7	67.8	19.7	27.5	28.4	25.4	33.6	25.1	29.8	39.0	26.2	36.3	16.1	25.7	28.9	31.0	22.4	27.7	17.1	27.7	24.4	20.1	15.5	15.8	25.7	21.9	15.1	15.6	9.8	24.4	29.9	13.4	17.8	16.3	5.4	6.7	6.1	7.0	7.0	7.5	4.0	4.8	4.8	4.5	7.9	5.1	22.6	3.2	6.4	11.4	23.6	23.2	27.6	10.2	26.7	10.3	18.2	11.8	8.4	7.2	6.6	9.2	4.2	25.4	24.5	11.2	23.5	11.5	6.1	11.2	10.8	20.3	29.5	29.4	23.1	12.6	53.0	17.9	12.8	10.3	12.7	16.9	23.2	8.8	20.1	6.7	20.5	9.2	8.2	21.4	55.2	5.6	9.6	22.0	21.4	20.6	25.4	13.3	10.3	18.6	15.1	11.3	16.9	11.7	15.5	30.2	4.1	16.4	8.8	7.2	0.0	11.7	13.4	35.6	83.1	15.8	20.3	28.5	20.7	15.6	11.3	38.0
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533853-101563344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	17.8	17.8	21.3	16.3	24.6	14.8	19.0	22.0	22.8	17.0	21.4	17.7	11.1	19.0	19.2	21.6	19.8	14.1	26.4	20.4	23.2	21.4	15.7	16.3	18.6	22.8	23.7	21.5	21.3	28.1	10.3	14.6	23.7	20.9	16.9	30.4	16.7	17.9	29.7	17.3	12.3	18.9	22.0	17.6	14.5	32.5	22.6	19.9	23.4	24.9	21.0	15.0	15.0	26.8	25.8	64.2	36.4	40.0	43.8	34.4	31.0	44.1	35.3	43.1	37.6	39.2	26.8	56.8	23.2	34.3	36.0	64.0	42.6	37.5	44.1	59.7	19.8	30.5	55.9	39.7	32.2	53.0	35.2	34.0	39.4	38.2	49.2	32.4	25.7	20.7	29.5	32.5	47.4	33.6	41.4	14.0	80.5	57.8	32.3	39.4	125.7	28.3	17.8	24.5	38.7	48.6	62.1	32.9	36.1	36.3	29.7	24.7	36.6	39.8	39.7	28.6	37.3	35.1	118.0	30.4	35.1	19.6	49.2	24.5	15.2	23.7	20.4	20.3	15.5	15.3	16.7	15.4	14.6	12.4	17.3	16.4	15.7	17.1	30.0	9.2	14.7	13.4	21.3	24.6	22.0	22.8	20.4	23.2	22.8	23.7	23.7	22.0	22.6	26.8	15.9	25.6	31.2	10.7	16.8	6.4	9.7	13.7	17.1	32.4	11.6	11.4	49.5	8.6	23.9	22.0	6.2	16.7	10.2	17.9	5.9	18.3	54.5	20.3	18.5	18.7	24.6	22.3	16.3	13.8	11.5	16.9	10.2	11.5	22.1	19.7	11.7	18.1	16.4	43.7	18.7	12.1	16.2	27.4	4.3	21.4	18.0	20.0	10.6	8.4	31.4	31.4	33.0	11.1	21.9	11.0	13.0	23.7	13.1	9.3	10.1	11.5	28.5	26.5	32.9	21.8	17.5	76.0	16.7	18.3	5.8	7.7	16.1	15.4	15.3	6.4
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 31.8;Basal respiratory cells: 31.7;Club cells: 28.3;Urothelial cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.2;HaCaT: 7.6;HeLa: 7.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA028378: AB_10601157, HPA042535: AB_2678042"	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	3.3	3.3	3.2	1.3	3.2	0.0	3.1	4.0	4.2	9.5	5.9	5.8	2.0	4.3	1.5	5.9	7.9	0.9	34.7	3.2	3.1	9.8	7.6	1.7	0.9	3.7	2.9	2.5	6.9	1.2	5.5	1.2	3.7	11.8	1.4	2.1	6.7	3.8	1.7	1.2	4.4	1.2	2.6	1.4	4.1	1.2	3.2	0.5	6.7	4.2	1.3	6.3	5.4	3.0	2.6	4.5	0.4	2.9	0.2	0.3	3.1	1.3	1.0	0.2	0.3	2.2	17.2	0.2	1.3	1.1	0.0	7.6	0.4	1.0	0.1	2.8	1.7	0.1	7.0	2.2	1.3	1.7	0.1	1.1	0.2	0.0	0.0	3.8	0.1	0.3	0.7	3.6	0.1	1.8	0.2	0.3	0.2	0.3	3.8	0.0	0.7	2.9	2.2	3.9	0.4	1.1	2.8	1.5	1.1	0.7	2.7	0.1	0.5	0.0	0.8	0.4	0.0	3.9	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.2	3.2	4.0	4.2	3.2	3.1	3.7	2.9	3.7	2.6	3.2	3.0	2.9	9.6	3.9	2.0	1.7	0.3	31.8	31.7	6.2	4.0	4.4	4.3	19.5	14.3	28.3	18.4	2.1	15.6	0.4	8.5	0.0	15.4	0.7	2.3	6.8	2.9	3.6	0.4	13.2	9.8	6.3	4.6	17.3	2.7	0.0	1.7	1.1	3.9	1.1	3.3	13.2	15.6	10.2	0.0	0.7	0.2	0.0	1.6	0.0	0.0	2.2	7.5	0.0	3.5	1.7	19.0	3.5	1.2	1.5	21.3	9.5	3.5	10.1	16.3	6.6	1.5	5.0	0.1	2.8	3.8	0.4	5.6	1.9	2.0	6.4	37.1
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 25.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;MCF7: 55.7;REH: 44.9;RPMI-8226: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	6.1	23.1	29.0	0.8	27.1	0.6	6.8	5.0	83.0	8.9	0.0	9.4	1.6	4.9	0.6	32.5	8.1	0.8	42.3	36.9	7.5	15.6	22.6	5.0	0.8	21.1	8.4	5.0	9.0	5.6	19.8	0.5	20.0	14.2	0.4	2.6	13.1	4.1	15.4	15.3	5.1	0.6	2.2	5.2	10.0	5.8	19.8	0.4	14.4	3.7	0.9	7.8	13.4	36.9	1.5	2.8	1.9	3.3	1.3	0.3	5.8	0.8	1.1	1.4	1.2	8.3	5.2	0.7	4.1	0.9	0.3	4.4	4.6	0.2	0.3	2.1	1.7	5.9	10.1	23.5	4.2	1.2	2.0	1.0	1.5	1.3	0.6	5.1	1.4	8.4	8.3	0.4	0.5	55.7	3.0	2.8	2.4	5.5	6.1	44.9	0.4	25.1	1.4	0.2	5.4	19.0	0.6	1.7	1.2	1.0	19.5	4.3	0.6	0.9	1.2	2.0	0.1	0.7	0.8	0.3	2.6	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.0	27.1	5.0	83.0	36.9	7.5	21.1	8.4	20.0	2.2	19.8	36.9	1.9	6.4	2.2	2.9	1.2	0.4	1.0	2.0	0.6	9.3	7.7	5.8	9.3	4.3	1.7	7.3	12.5	0.3	0.4	5.5	25.4	5.3	0.6	4.4	1.2	1.4	7.8	0.4	13.1	2.2	0.2	1.4	1.5	5.9	0.0	13.0	1.4	9.1	1.3	16.8	13.4	4.4	0.0	0.6	0.8	1.1	1.2	1.8	1.8	5.6	1.6	8.7	0.0	1.5	2.9	3.6	5.1	3.4	0.3	1.9	4.4	9.4	3.9	5.6	0.0	2.5	1.8	1.5	2.4	2.7	1.8	0.3	0.5	2.7	3.8	1.6
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113564	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Spermatocytes: 52.3;Spermatogonia: 42.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.3;ovarian cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;HeLa: 39.4;JURKAT: 18.0;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057527	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	1.5	1.2	1.0	0.7	1.5	2.0	1.6	4.4	1.1	1.5	1.1	1.7	0.4	1.0	1.0	1.2	2.1	0.8	0.7	1.0	0.8	4.5	0.2	1.4	1.0	0.8	0.6	5.0	9.2	1.3	7.4	0.3	0.9	1.8	0.6	1.3	1.7	0.5	0.5	1.9	1.1	0.8	0.9	1.1	1.0	3.0	0.8	0.8	3.2	0.6	0.7	0.9	1.8	1.0	11.8	0.7	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	5.3	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.0	18.0	0.1	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	3.8	0.0	22.6	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.5	0.2	1.2	0.2	0.4	0.6	1.1	0.3	0.0	0.1	0.0	0.1	0.2	0.3	1.0	1.5	4.4	1.1	1.0	0.8	0.8	0.6	0.9	0.9	0.8	1.0	1.1	3.2	6.9	1.3	1.3	2.8	5.6	1.5	13.6	3.0	3.9	4.8	0.6	1.5	6.8	0.0	2.1	0.0	1.1	0.5	62.6	3.8	3.9	0.5	2.5	0.8	4.9	0.0	4.7	0.9	0.2	11.7	1.1	1.1	4.5	1.9	0.4	0.0	0.6	0.0	1.7	2.8	0.0	0.8	1.8	7.5	8.4	1.8	0.0	2.8	0.9	5.1	2.1	0.0	4.4	0.8	1.6	0.7	0.8	4.6	0.7	8.9	2.2	6.4	0.0	6.8	1.7	52.3	42.4	4.5	3.1	0.3	1.8	2.1	1.2	4.5
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 27.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 42.9;Proximal tubular cells: 44.9;Spermatocytes: 94.6;Spermatogonia: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;Daudi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053574	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053574: AB_2682195"	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	27.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	5.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.2	42.9	0.2	0.2	0.1	0.0	0.0	3.5	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	2.2	0.5	0.0	0.0	0.0	9.5	0.9	3.2	0.0	0.0	1.6	0.2	0.0	0.5	1.6	0.1	0.0	0.4	0.1	0.0	1.0	44.9	0.0	0.3	0.0	0.1	0.1	94.6	24.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0
RNF213	"ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol		NA	NA		3500	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	7.4	9.9	6.8	18.6	12.9	25.6	7.0	9.0	11.3	8.0	13.0	9.0	8.7	7.8	8.7	7.1	8.6	10.7	6.5	5.1	6.9	10.5	6.2	13.2	17.9	23.5	11.4	9.0	7.8	34.2	6.6	10.0	18.3	7.1	7.8	12.0	10.8	6.8	6.6	8.8	10.6	9.1	13.8	18.7	11.1	3.4	16.5	20.2	11.0	7.6	14.5	11.0	7.1	17.3	40.1	69.7	6.9	4.9	24.4	37.0	5.1	9.9	21.4	43.7	37.1	7.5	18.1	2.6	8.3	20.8	46.6	22.7	9.3	12.9	14.7	90.8	4.3	6.3	29.9	13.3	10.5	6.7	6.2	20.5	8.6	24.6	10.6	13.7	34.3	28.3	11.8	14.5	16.5	9.7	26.7	2.8	5.1	7.5	16.0	18.0	15.9	3.1	12.1	34.1	6.6	9.2	24.1	50.3	17.3	15.3	11.6	8.2	44.5	24.2	19.0	14.4	10.3	6.3	6.3	7.0	18.2	7.6	8.9	19.5	20.8	10.4	26.2	18.5	17.5	15.3	18.6	21.6	5.4	15.5	14.6	18.2	84.5	26.1	17.1	32.0	15.4	4.8	6.8	12.9	9.0	11.3	5.1	6.9	23.5	11.4	18.3	13.8	16.5	17.3	76.1	89.8	56.9	56.8	89.9	35.8	37.2	39.2	43.3	21.2	59.9	41.7	32.6	75.8	50.3	101.2	50.1	21.0	240.8	117.4	13.7	120.3	1.4	58.7	58.9	90.7	46.0	30.3	23.6	162.4	31.5	50.8	158.0	93.4	46.7	140.7	74.3	56.4	98.0	23.5	15.5	68.2	32.6	136.5	94.9	3.7	60.9	128.9	30.2	87.1	194.6	26.1	396.5	32.2	70.4	166.1	76.2	51.6	167.6	100.8	116.3	92.2	66.2	68.5	65.7	52.3	53.7	1.4	8.2	43.0	34.4	21.8	211.6	84.7	54.9	66.5
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 20.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 6.4;T-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	10.9	11.7	8.9	8.8	10.2	12.4	10.8	10.5	9.9	11.4	6.0	10.8	9.4	11.0	8.5	9.2	9.9	8.9	10.5	7.8	10.1	10.3	13.2	9.1	10.8	9.9	9.4	13.2	21.8	11.5	12.5	11.0	9.6	9.6	9.4	12.2	11.3	10.0	17.9	10.1	10.1	11.2	7.3	11.4	12.7	18.6	10.4	14.4	13.5	13.4	10.6	11.0	9.6	11.9	12.0	14.1	31.7	19.1	15.6	15.6	17.9	19.3	17.5	20.5	21.7	21.6	28.1	16.8	32.7	22.6	19.6	15.7	34.8	16.9	21.1	31.3	10.2	53.3	11.7	16.6	30.5	25.2	19.8	14.4	18.2	25.4	37.6	23.1	25.7	29.0	30.7	17.9	21.1	9.0	20.8	21.0	17.2	20.7	14.0	22.5	21.1	22.4	19.3	17.8	20.5	22.2	22.1	14.8	10.4	24.7	25.1	16.9	24.4	20.7	16.6	11.4	16.3	10.3	7.7	20.2	7.6	20.3	24.3	6.4	2.5	2.7	2.3	2.4	1.4	1.9	7.8	4.0	2.2	1.9	2.2	2.1	1.1	1.2	2.5	2.5	20.5	1.6	8.9	10.2	10.5	9.9	7.8	10.1	9.9	9.4	9.6	7.3	10.4	11.9	19.1	25.6	15.1	23.5	14.8	5.0	9.6	10.6	21.6	23.8	11.1	14.5	12.8	15.7	14.8	5.5	10.4	14.9	10.0	9.0	9.8	13.3	46.8	15.7	26.2	11.9	9.0	14.7	20.9	12.7	13.6	12.9	14.8	15.5	5.1	21.6	7.9	7.1	12.8	13.5	24.7	8.5	10.2	10.6	6.3	20.0	10.2	13.5	8.8	12.2	12.7	14.0	14.4	33.7	24.5	10.6	9.8	12.8	14.9	7.1	10.6	12.1	10.0	37.1	13.1	20.9	19.5	64.6	57.5	15.5	5.1	19.4	17.8	28.2	8.8	7.6
RNF215		ENSG00000099999	"Ring finger protein 215"	Q9Y6U7	22	30368811-30421771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.9;Cone photoreceptor cells: 12.5;Rod photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029427, HPA056498"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	Nucleoli	"HPA029427: AB_2732447, HPA056498: AB_2683154"	"unprognostic (1.24e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.67e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (6.37e-10)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	8.4	8.7	19.2	5.6	19.0	7.0	9.3	18.7	22.5	17.6	17.9	11.8	7.8	15.2	9.2	6.7	13.3	6.8	9.5	19.2	20.4	12.1	11.1	8.7	4.7	20.2	18.7	13.7	13.2	10.7	10.0	6.9	18.3	13.1	3.9	8.5	6.5	8.3	8.0	6.1	7.7	7.9	16.9	11.6	8.9	10.5	20.0	2.8	12.2	2.9	3.9	12.3	10.8	17.4	6.8	14.0	14.4	23.4	13.8	14.3	14.2	11.4	10.1	11.3	6.8	3.8	7.4	2.7	20.1	9.3	21.1	8.4	8.9	13.1	9.0	15.8	10.8	4.5	17.8	5.1	18.9	3.6	18.5	19.4	15.8	19.3	10.3	36.7	13.3	7.0	4.0	12.6	13.6	11.0	2.6	8.5	4.5	9.7	15.4	12.2	8.4	10.8	14.9	10.3	6.3	16.2	11.6	8.3	8.9	13.1	7.6	3.9	18.6	30.2	13.3	8.8	6.7	13.3	3.4	3.7	17.7	2.6	11.9	0.4	0.9	1.5	0.9	0.7	1.0	1.0	1.0	0.8	0.5	1.9	1.8	1.7	0.5	2.5	0.8	1.4	0.5	0.4	19.2	19.0	18.7	22.5	19.2	20.4	20.2	18.7	18.3	16.9	20.0	17.4	7.1	3.2	3.9	8.8	1.4	0.3	1.2	1.6	2.8	12.9	3.2	3.9	2.2	1.5	2.7	0.0	12.5	1.9	3.7	1.0	0.0	1.5	0.8	3.7	6.4	3.5	0.0	0.4	5.0	1.4	1.5	5.4	6.1	6.6	0.0	8.2	4.6	2.3	1.8	8.4	4.6	0.5	2.0	1.2	0.5	0.4	0.9	1.9	1.8	1.0	2.3	11.7	1.0	2.5	1.1	1.9	0.2	1.2	1.8	1.3	0.7	1.0	0.6	13.7	6.6	4.8	4.8	2.1	0.9	0.6	0.1	1.6	2.0	5.3	0.7	1.2
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 42.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.8;Oligodendrocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	8.0	3.0	3.4	2.0	2.5	11.0	6.0	3.0	2.3	6.3	4.9	7.2	1.3	4.4	2.0	5.0	7.4	4.2	5.1	3.0	2.7	1.9	5.7	6.3	0.7	3.0	1.8	8.6	2.8	42.7	2.9	3.9	2.4	3.5	1.3	3.6	4.7	3.6	7.6	9.1	2.5	4.1	1.1	1.8	3.5	6.9	2.6	1.5	5.8	5.9	0.4	5.3	5.7	5.4	4.9	5.0	1.7	0.6	6.1	2.4	9.7	6.6	8.9	4.4	5.8	0.0	4.6	0.0	9.0	6.3	10.1	7.0	1.0	5.9	6.2	0.0	5.5	2.7	7.6	1.5	5.7	0.0	0.2	6.5	5.4	3.3	9.7	5.2	5.0	0.0	14.0	0.0	7.8	0.0	0.0	0.0	1.5	0.0	1.3	0.1	6.8	0.0	4.5	2.2	0.8	0.0	2.9	0.7	2.5	4.8	4.8	0.8	8.1	3.6	11.5	0.0	14.3	0.0	0.0	0.0	2.7	0.0	4.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	3.0	2.3	3.0	2.7	3.0	1.8	2.4	1.1	2.6	5.4	25.0	22.4	21.0	49.0	0.6	48.2	15.8	17.5	18.2	6.3	10.0	10.7	14.4	4.3	12.1	5.5	16.7	24.2	0.9	1.3	0.0	8.1	127.8	11.4	21.5	19.0	3.0	6.5	56.3	9.6	29.7	23.1	4.6	22.8	1.3	9.0	15.7	26.9	9.8	21.9	65.0	2.4	12.2	14.6	20.9	62.1	25.7	11.3	19.6	51.5	9.8	4.2	1.0	37.7	102.1	11.8	2.0	21.1	0.4	21.6	6.9	2.3	9.6	5.7	6.6	44.9	12.3	1.7	2.9	17.5	47.0	17.9	1.8	5.3	4.3	16.3
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 121.3"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 2136.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027577, HPA027578"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	7.5	5.9	37.9	7.3	67.0	10.8	6.8	49.1	49.3	7.4	0.4	9.1	7.8	8.9	5.9	6.6	8.1	2.9	8.7	36.2	45.1	6.6	5.2	5.7	5.9	64.1	53.3	7.6	7.0	5.7	7.1	6.2	63.0	5.9	3.9	7.5	7.4	4.5	24.3	8.6	7.7	5.5	38.1	6.9	6.6	8.2	68.3	7.1	6.3	10.1	5.8	7.0	7.0	121.3	11.6	5.4	22.9	7.8	8.7	7.9	17.1	13.4	12.3	10.1	14.9	9.3	11.2	22.3	11.6	10.8	14.4	7.5	25.8	11.0	13.7	28.0	22.9	30.9	17.9	16.3	14.1	22.0	15.2	8.7	24.7	11.3	17.9	8.4	5.9	11.6	23.1	10.7	6.3	8.1	21.8	16.7	24.9	12.6	12.2	18.3	13.5	15.9	6.5	7.1	10.3	12.7	11.4	7.8	17.4	7.9	5.8	38.1	9.1	10.7	11.4	10.2	25.1	24.4	25.2	16.0	8.7	69.5	6.5	0.9	0.8	1.2	1.2	0.7	0.9	0.8	0.3	1.6	1.3	1.2	0.7	0.6	0.6	0.8	0.5	2.5	1.3	0.6	37.9	67.0	49.1	49.3	36.2	45.1	64.1	53.3	63.0	38.1	68.3	121.3	16.2	9.6	13.4	66.3	26.9	15.2	13.4	13.2	30.1	25.1	24.7	20.8	22.0	25.8	10.4	23.9	25.0	17.3	33.7	29.0	17.6	17.9	13.1	23.4	20.7	17.2	18.0	41.9	21.9	28.7	24.5	16.7	19.4	20.5	10.8	18.8	17.9	31.4	25.7	23.5	12.9	24.3	22.4	29.3	9.8	16.2	19.3	21.3	12.4	298.9	23.9	19.2	15.5	7.1	2136.9	25.3	20.9	13.9	26.1	22.5	26.5	35.6	8.2	18.3	6.6	23.5	14.8	30.6	31.3	25.1	17.5	10.1	26.1	17.6	26.7	20.5
RNF222		ENSG00000189051	"Ring finger protein 222"	A6NCQ9	17	8390704-8397826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.9;skin 1: 6.9;vagina: 5.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.3;NK-cells: 2.1;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.4;Syncytiotrophoblasts: 1.2;Urothelial cells: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048916	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA048916: AB_2680555"	"unprognostic (2.49e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.19e-4)"	"unprognostic (2.81e-1)"	"unprognostic (5.30e-2)"		"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.97e-2)"	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.6	0.2	3.3	0.2	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	1.9	0.0	0.1	6.9	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.2	0.0	5.9	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.2	0.0	0.3	0.1	0.2	0.1	0.2	0.4	0.2	0.0	1.3	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.0	0.0	0.4	0.2	0.2	0.1	0.0	1.4	1.2	0.7	0.1	0.0	1.7
RNF24	G1L	ENSG00000101236	"Ring finger protein 24"	Q9Y225	20	3927309-4015558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 112.5;Inhibitory neurons: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 238.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 238.2"	"Cell line enhanced"	"Detected in all"		"ASC TERT1: 81.7"	"Low region specificity"	"Detected in all"							HPA011900	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA011900: AB_10671089"	"unprognostic (6.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.65e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (2.67e-7)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.24e-1)"	9.0	7.8	9.5	8.0	9.7	51.8	7.0	4.9	10.9	6.6	0.0	5.7	2.5	5.7	14.9	7.5	5.3	5.9	6.5	10.7	9.5	11.3	2.7	13.9	2.3	7.4	7.6	5.1	4.8	2.5	6.2	3.4	7.6	8.7	3.5	4.7	6.9	6.9	2.1	8.8	4.5	5.3	6.6	12.5	5.7	4.1	8.9	5.4	7.3	3.7	3.8	7.9	5.9	7.2	19.8	9.0	12.9	11.2	48.8	81.7	4.6	16.4	35.4	16.5	23.6	6.0	19.3	4.1	3.5	33.7	25.3	12.9	5.2	18.7	27.4	2.8	3.9	36.4	16.2	4.7	42.1	73.8	13.8	27.6	5.7	43.8	36.8	18.3	15.5	12.6	47.1	9.6	26.9	5.2	11.8	15.1	19.5	18.2	12.6	14.0	10.9	3.3	9.3	10.5	12.1	9.8	44.4	26.3	11.6	18.8	9.6	25.3	23.3	39.8	12.9	27.1	19.7	7.5	7.9	1.4	20.2	24.7	12.7	108.9	23.5	51.3	3.7	8.5	3.0	1.4	7.0	5.4	19.3	4.6	4.2	5.4	238.2	7.5	12.7	0.5	3.4	11.5	9.5	9.7	4.9	10.9	10.7	9.5	7.4	7.6	7.6	6.6	8.9	7.2	6.2	3.2	19.1	34.0	7.8	48.8	36.9	24.1	26.2	18.1	26.9	19.3	2.7	4.3	18.6	49.7	16.7	1.9	9.1	5.7	7.9	33.6	16.3	17.2	37.4	13.9	13.1	43.3	112.5	25.6	6.7	42.4	9.7	31.4	4.5	12.6	17.2	1.2	5.7	38.7	127.2	6.6	10.2	24.7	71.6	22.6	36.7	30.9	39.2	16.9	25.2	10.4	7.2	74.4	21.1	29.2	5.8	60.2	5.9	73.8	2.2	1.8	6.8	9.6	19.7	12.4	32.3	21.4	22.4	12.8	54.4	2.9	17.0	7.4	4.8	75.1
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	10.9	11.4	18.5	8.9	18.6	7.3	10.9	18.3	21.0	12.2	17.1	12.0	6.2	12.7	15.8	11.7	12.4	10.8	13.9	18.6	19.7	10.4	11.1	10.4	14.5	18.4	18.4	14.5	11.5	15.1	11.4	11.4	19.0	11.8	8.2	7.0	11.0	13.9	15.0	14.5	7.9	13.6	18.5	10.3	9.4	14.3	19.2	15.1	14.1	17.1	11.9	14.0	9.7	19.0	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	18.5	18.6	18.3	21.0	18.6	19.7	18.4	18.4	19.0	18.5	19.2	19.0	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337309	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	14.3	15.8	12.7	11.5	12.6	22.0	13.3	13.7	15.1	15.4	10.6	19.2	14.5	23.5	10.3	20.9	16.6	10.5	13.2	12.7	12.5	13.6	23.6	12.4	11.8	15.2	13.1	17.1	13.8	18.5	10.4	14.2	15.5	14.8	12.6	8.4	14.9	18.6	8.5	15.7	17.0	19.0	12.7	14.6	19.1	15.1	14.7	13.3	13.2	7.1	12.8	18.9	14.2	13.1	43.8	47.4	43.4	51.4	41.8	32.8	46.0	46.3	49.7	52.8	41.5	80.6	88.9	38.3	62.5	55.5	80.1	77.2	61.9	69.8	33.0	46.0	34.2	101.0	21.8	67.3	31.9	42.8	40.4	34.3	35.2	66.1	59.0	34.7	40.8	58.1	50.0	58.4	36.9	94.9	39.5	44.3	43.5	50.2	59.8	40.5	44.5	30.4	32.7	31.1	30.8	29.9	37.4	46.8	12.5	41.4	106.1	35.4	27.0	63.5	41.8	33.7	43.0	14.0	24.6	0.4	21.3	71.0	50.6	9.5	21.6	5.6	20.8	19.2	13.4	11.1	15.7	18.4	19.0	16.7	17.5	15.5	1.5	14.0	20.2	11.0	8.7	24.9	12.7	12.6	13.7	15.1	12.7	12.5	15.2	13.1	15.5	12.7	14.7	13.1	5.1	3.2	9.4	1.0	9.1	6.9	13.3	15.4	12.5	9.2	10.9	9.8	0.8	22.8	11.1	11.0	2.1	44.0	6.2	9.3	5.9	20.8	6.6	5.9	7.9	8.6	13.8	18.5	3.2	17.0	66.0	11.5	9.2	5.9	7.6	16.9	11.4	23.4	21.5	5.0	2.9	13.0	8.2	14.8	5.9	8.6	14.0	6.6	1.8	1.0	11.6	11.6	15.5	4.5	2.7	14.1	7.5	17.7	4.3	14.2	15.6	12.5	4.8	9.4	6.6	6.5	10.6	19.9	10.5	14.3	8.5	24.4	8.3	8.8	18.6	9.8
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160660	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.3	18.5	4.9	9.1	4.8	9.5	14.3	4.2	6.6	16.7	3.6	15.0	7.1	18.2	6.9	16.2	14.8	6.9	19.6	4.6	4.1	17.5	15.8	14.9	10.4	5.3	4.4	17.8	23.9	10.4	18.7	6.9	4.5	16.6	6.6	4.1	16.9	7.1	41.5	19.3	15.9	9.6	4.5	26.1	17.9	16.4	4.8	11.7	16.5	17.9	9.6	15.1	14.0	4.4	6.1	10.8	10.5	14.8	6.1	6.3	23.2	9.9	15.1	18.2	15.6	10.2	13.5	10.9	6.9	11.8	10.2	7.6	5.4	11.8	9.7	13.2	4.2	11.0	9.5	32.5	12.8	17.5	18.8	12.3	10.4	7.2	12.9	9.6	12.0	7.9	5.9	12.9	7.7	17.3	17.6	8.6	5.3	9.9	12.7	10.1	9.8	6.8	8.9	20.8	9.9	12.7	8.6	25.6	12.5	9.2	7.4	13.3	11.1	12.6	10.2	8.8	8.9	21.4	21.2	11.5	4.4	6.1	13.6	0.0	0.8	0.8	0.6	1.7	1.8	0.4	0.9	0.6	0.5	0.4	0.6	0.4	1.7	1.7	1.0	1.8	1.1	0.4	4.9	4.8	4.2	6.6	4.6	4.1	5.3	4.4	4.5	4.5	4.8	4.4	0.9	0.0	4.6	16.0	5.2	0.6	0.3	0.0	4.6	0.6	1.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	1.0	0.8	0.0	0.3	0.1	1.0	1.3	1.3	0.0	3.8	8.8	0.0	0.5	1.3	7.7	0.9	0.0	1.1	0.4	0.8	0.4	0.0	8.2	0.3	2.0	0.6	1.5	0.4	0.3	2.7	0.0	10.3	0.5	0.3	3.1	9.5	7.3	0.2	0.2	0.0	8.7	0.2	0.5	0.2	0.8	0.8	0.0	1.4	1.2	1.6	0.8	5.7	0.9	0.5	4.3	0.8	0.1	0.3
RNF32	"FKSG33, HSD15, LMBR2"	ENSG00000105982	"Ring finger protein 32"	Q9H0A6	7	156640281-156677130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 60.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 325.5;Late spermatids: 487.1;Spermatocytes: 243.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 12.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;HDLM-2: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019516, HPA073560"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA019516: , HPA073560: AB_2686616"	"unprognostic (9.23e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.85e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.71e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.08e-4)"	"unprognostic (4.64e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.44e-1)"	1.9	1.3	1.6	1.5	2.3	1.7	1.1	1.3	2.2	0.9	1.0	1.9	1.6	0.9	11.0	0.9	3.2	2.4	0.6	1.7	2.3	2.2	1.1	1.6	2.1	2.1	1.7	2.6	2.0	0.7	1.7	1.4	2.1	2.1	1.6	2.7	0.9	0.9	1.1	2.2	1.3	0.3	2.0	1.4	3.0	60.9	2.7	1.1	2.5	0.1	1.2	0.7	0.9	3.5	4.5	2.3	0.5	1.2	1.0	0.6	0.8	0.7	0.2	1.1	0.9	11.8	5.0	7.2	5.5	0.7	1.2	0.1	0.0	0.2	2.2	13.2	3.0	0.9	1.1	0.5	1.0	2.1	4.1	1.7	0.8	0.6	2.3	0.7	0.5	6.3	10.7	2.0	3.5	7.8	2.9	5.2	2.5	7.6	5.6	2.9	0.1	3.4	1.6	1.5	7.2	5.4	4.3	0.4	2.3	1.1	1.3	1.5	1.9	0.0	0.2	0.9	0.6	10.2	4.8	4.2	0.8	4.8	1.7	12.6	0.4	1.4	0.4	0.2	1.5	2.6	1.5	0.4	1.0	1.6	0.3	0.5	0.0	0.4	0.5	2.6	2.0	0.6	1.6	2.3	1.3	2.2	1.7	2.3	2.1	1.7	2.1	2.0	2.7	3.5	0.9	6.4	2.6	2.3	1.9	0.3	2.2	2.8	2.8	2.3	1.7	2.2	1.1	4.3	5.4	3.7	0.0	0.0	0.3	2.4	5.9	2.0	325.5	12.7	0.9	1.1	4.2	0.4	2.0	3.2	0.5	0.7	4.6	2.9	5.7	0.6	2.5	2.9	0.4	1.7	1.9	2.5	2.0	0.0	0.9	487.1	6.5	2.1	1.8	1.0	0.1	2.5	0.0	5.0	5.3	3.1	0.5	4.1	2.4	1.3	2.8	6.4	35.4	2.2	0.0	1.4	1.1	243.4	35.6	2.0	0.6	0.1	1.1	0.2	2.1	1.5
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"Early spermatids: 503.1;Late spermatids: 1314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favorable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	15.8	11.9	10.5	13.2	10.9	37.8	17.2	15.6	15.1	17.3	5.2	19.9	10.5	23.4	19.6	15.9	17.8	11.8	15.8	11.0	10.7	19.2	11.3	18.9	18.4	9.2	11.5	36.7	20.5	15.7	6.6	20.5	9.7	17.6	15.8	23.9	14.1	19.1	12.7	12.1	13.3	22.9	8.6	19.5	10.7	68.4	11.4	21.3	22.5	19.6	18.5	16.7	12.9	9.4	14.4	8.0	30.5	18.2	13.7	12.6	29.8	8.8	11.0	10.6	13.8	13.8	7.8	21.6	9.1	17.1	14.0	5.5	19.6	10.3	16.3	19.3	8.4	26.2	11.6	13.6	10.6	19.4	22.9	13.0	10.9	13.4	12.9	17.6	27.4	21.0	5.5	20.2	17.4	5.0	20.1	10.2	20.5	9.5	5.7	18.3	13.8	12.0	18.1	16.4	12.7	13.6	10.0	9.9	10.0	35.5	9.6	19.6	27.2	10.1	15.2	6.0	10.6	13.2	29.6	15.0	9.2	16.1	13.2	10.7	2.9	5.0	4.4	2.7	3.6	3.5	4.0	4.7	2.7	3.7	4.2	4.3	5.3	5.9	2.8	2.2	5.9	3.1	10.5	10.9	15.6	15.1	11.0	10.7	9.2	11.5	9.7	8.6	11.4	9.4	32.8	12.8	11.7	80.6	16.8	17.3	10.9	8.7	14.8	16.5	21.9	15.2	15.9	10.0	11.5	7.3	18.8	13.2	29.9	19.6	9.8	11.2	503.1	13.1	14.6	25.0	16.8	9.0	71.2	12.0	11.9	14.4	14.8	16.7	6.3	20.5	24.7	16.6	11.4	26.9	72.8	12.8	10.2	27.0	23.7	1314.3	32.9	19.0	19.6	82.4	19.5	19.3	20.6	53.3	81.5	14.5	6.8	39.9	18.6	23.9	10.4	16.5	10.1	23.2	13.1	19.3	20.9	40.4	20.2	14.4	14.9	14.9	23.3	13.2	14.3	17.5
RNF39	"FAP216, HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.5;skin 1: 63.3;vagina: 21.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 79.9;Basal respiratory cells: 96.2;Club cells: 55.7;Prostatic glandular cells: 57.2;Urothelial cells: 233.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.5;U-266/84: 3.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 8.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 9.0;cerebral cortex: 8.0;hippocampal formation: 4.4"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	1.1	0.8	0.0	0.0	0.1	0.0	8.6	0.1	0.3	16.8	0.0	0.6	0.2	0.6	0.0	24.5	1.4	0.1	0.3	0.1	0.1	0.4	0.2	1.9	0.0	0.2	0.0	1.3	1.7	0.1	1.4	0.0	0.2	7.2	0.0	0.5	15.8	0.1	0.4	63.3	0.5	0.0	0.0	0.2	8.3	1.6	0.1	0.0	0.4	0.0	0.4	3.9	21.6	0.1	1.2	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	1.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	0.9	0.3	0.2	0.0	0.4	0.0	0.5	0.0	4.5	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.8	3.6	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.3	3.2	2.7	0.0	0.0	17.8	79.9	96.2	42.1	0.5	23.7	28.6	0.3	7.2	55.7	0.0	0.0	0.0	0.8	1.8	0.0	6.4	0.6	3.6	2.4	1.1	0.0	0.0	0.0	3.3	0.0	1.2	17.3	20.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	14.2	0.0	2.1	0.0	1.2	0.4	3.6	0.0	0.6	0.0	0.0	0.0	0.0	24.2	2.2	1.2	0.0	57.2	0.1	0.0	13.0	0.4	0.0	0.0	3.0	0.1	0.4	11.3	23.9	0.7	0.6	0.0	0.9	233.1
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041330: AB_10793872, HPA054227: AB_2682422"	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	24.4	28.7	23.4	26.7	25.9	55.3	21.5	25.5	24.8	26.7	26.2	26.0	24.9	29.3	15.5	31.8	25.4	26.0	16.3	25.8	22.4	19.9	20.9	22.5	26.9	25.9	24.3	35.2	29.8	35.2	21.7	21.4	23.0	22.6	17.6	18.1	33.7	22.5	17.5	27.4	24.7	21.5	22.3	24.7	23.4	38.0	26.1	24.6	29.0	16.0	22.3	21.4	22.7	28.8	58.5	87.9	53.0	52.7	41.9	43.3	58.6	58.7	47.4	66.8	52.4	72.4	53.7	46.5	82.9	50.5	45.5	62.1	99.2	55.5	53.0	66.7	120.9	45.2	99.9	77.2	53.3	79.8	54.0	41.3	43.5	83.3	48.8	44.2	57.7	40.6	101.3	46.1	42.5	98.3	76.4	74.4	55.6	47.7	55.4	149.9	58.8	91.6	29.8	52.0	89.9	65.0	45.0	58.7	41.8	27.9	88.9	88.5	60.8	74.6	37.4	53.8	67.7	66.1	87.2	93.0	62.3	70.6	77.1	6.5	13.6	17.1	13.1	14.1	13.1	8.1	7.1	10.0	13.9	5.9	5.3	8.8	16.1	11.1	17.1	6.6	6.7	16.2	23.4	25.9	25.5	24.8	25.8	22.4	25.9	24.3	23.0	22.3	26.1	28.8	13.5	12.8	24.9	18.3	17.2	13.9	12.3	10.2	16.5	12.8	18.9	15.6	3.2	28.6	11.5	22.0	4.2	16.0	20.7	27.7	88.0	15.2	23.7	24.7	20.8	14.9	13.9	37.4	10.3	13.3	16.9	14.5	26.0	29.2	4.5	19.3	10.8	22.9	21.5	5.0	11.2	23.2	10.2	23.0	12.6	22.0	18.0	16.9	17.8	4.7	16.7	16.5	11.3	13.0	8.7	16.3	15.4	17.7	21.8	15.8	24.2	26.5	12.4	13.7	13.1	15.8	13.3	27.1	11.3	20.6	19.7	22.7	16.0	22.2	25.8	11.2
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	32.2	24.6	22.5	18.0	23.3	19.6	21.4	15.7	23.8	21.2	13.0	23.8	12.4	22.3	13.2	23.1	24.3	25.5	32.7	24.6	24.8	19.7	15.1	23.8	23.4	16.8	19.1	22.9	23.0	27.4	22.8	21.3	21.2	33.9	19.0	23.8	15.0	20.7	34.0	15.0	16.1	28.5	15.3	20.6	17.0	15.9	23.5	26.5	28.6	40.8	25.1	28.2	17.0	19.2	21.6	32.6	34.7	55.2	71.0	51.3	25.8	70.8	69.5	62.2	50.2	40.0	27.6	41.6	36.7	60.2	20.6	24.3	47.4	34.1	44.9	43.8	25.7	55.8	22.3	23.2	148.3	61.6	58.3	66.0	78.6	52.0	91.0	81.7	61.3	34.5	40.4	41.3	35.1	34.9	35.6	27.6	41.9	21.6	37.8	38.2	24.9	25.3	33.3	31.3	62.9	38.1	61.9	35.0	55.4	34.3	49.2	71.3	37.3	31.3	32.9	40.6	27.8	29.6	36.6	37.5	37.2	36.4	38.0	59.1	27.2	99.9	27.6	26.7	24.9	50.3	23.0	24.3	30.6	55.1	23.4	24.0	36.2	33.1	28.3	23.7	29.4	31.0	22.5	23.3	15.7	23.8	24.6	24.8	16.8	19.1	21.2	15.3	23.5	19.2	18.9	44.8	22.6	11.1	42.2	12.0	19.9	8.6	19.9	30.7	22.2	21.1	24.6	24.3	18.8	16.5	22.9	15.2	17.0	10.2	17.6	15.3	92.8	13.9	14.2	20.7	20.4	11.1	15.0	21.3	18.5	22.7	9.7	14.2	25.9	16.8	30.0	16.7	19.3	28.6	15.7	13.9	8.2	34.9	22.7	58.0	23.0	25.0	7.2	9.4	33.5	26.2	15.5	14.6	12.3	20.8	20.3	25.9	14.6	33.5	12.3	19.6	18.0	18.3	26.3	23.2	27.4	10.4	14.2	14.4	16.6	16.8	16.6	17.1	14.3	23.1
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58353676-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 41.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7"									HPA008079	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.2	10.9	1.7	2.0	3.1	0.7	5.5	9.6	2.7	2.6	1.5	13.4	22.7	1.7	4.4	10.4	4.8	2.7	2.7	2.0	1.3	6.1	9.1	3.6	0.4	1.8	3.4	0.9	8.2	5.2	4.3	4.8	1.9	9.4	19.3	1.2	9.3	4.8	0.3	11.3	16.9	0.6	1.4	0.5	5.8	3.4	2.3	3.7	1.9	0.0	1.5	2.1	5.2	1.4	1.1	17.0	2.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	24.7	8.2	0.0	8.5	0.0	1.9	4.6	0.6	6.8	0.0	8.6	11.3	1.9	0.8	49.4	0.0	0.2	0.1	0.0	13.4	0.0	2.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.1	0.2	0.4	54.7	1.0	0.3	0.0	2.2	5.9	9.0	1.6	0.1	1.6	0.7	0.5	5.4	2.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.4	0.1	0.3	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.0	1.7	3.1	9.6	2.7	2.0	1.3	1.8	3.4	1.9	1.4	2.3	1.4	0.3	3.2	8.9	29.0	2.5	9.6	17.5	14.1	67.7	2.5	17.3	13.6	4.0	17.2	5.8	18.4	2.1	26.0	2.2	33.0	15.6	5.3	1.2	14.6	1.1	1.8	15.5	0.8	1.8	2.7	3.1	0.7	9.7	12.7	0.0	7.2	0.7	11.9	2.6	5.0	1.3	41.6	12.2	0.8	0.9	1.5	0.3	1.3	14.2	4.7	2.8	12.0	10.3	0.0	0.7	6.2	21.1	0.4	1.0	9.9	28.7	2.9	5.6	2.8	0.0	0.5	1.1	1.0	0.8	28.4	6.1	5.9	3.1	0.4	63.6	6.3
RNF44	KIAA1100	ENSG00000146083	"Ring finger protein 44"	Q7L0R7	5	176526712-176538025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 105.1;Late spermatids: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038981	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038981: AB_10674846"	"unprognostic (1.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.57e-7)"	"unprognostic (1.50e-1)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.15e-2)"	16.7	17.8	15.9	28.9	14.0	42.7	18.1	8.6	19.3	18.3	6.1	26.3	20.2	16.3	5.4	25.9	19.1	9.1	17.0	14.2	14.4	21.7	14.6	22.0	37.7	12.5	12.0	24.9	19.5	10.3	15.7	13.1	9.9	19.5	12.6	8.4	23.2	9.3	11.8	30.5	34.6	7.8	8.5	54.7	20.4	20.2	15.0	30.9	25.1	7.5	24.2	18.0	21.1	11.4	9.3	20.9	32.7	30.6	6.4	5.3	87.6	5.3	4.6	3.5	4.5	31.9	20.2	17.7	32.0	3.0	16.0	24.8	14.8	31.8	4.0	69.0	26.1	18.9	20.1	29.8	8.1	22.1	25.0	10.3	25.1	3.9	11.7	11.4	9.8	33.8	21.4	25.9	4.8	32.1	51.6	49.3	43.4	12.1	25.5	21.0	8.6	25.8	12.0	21.4	40.1	48.8	8.0	21.7	31.2	21.5	24.0	43.9	16.0	8.8	13.1	7.1	10.0	32.6	26.3	24.1	4.3	44.7	11.7	0.0	1.5	2.9	3.0	1.8	2.2	1.9	2.3	2.5	1.0	2.3	2.2	2.7	5.3	2.1	1.6	1.1	3.1	1.8	15.9	14.0	8.6	19.3	14.2	14.4	12.5	12.0	9.9	8.5	15.0	11.4	18.3	12.8	28.6	22.9	39.0	40.3	10.5	24.4	43.3	17.1	30.7	25.4	13.3	20.0	18.2	12.9	10.4	10.5	46.6	41.7	7.9	12.3	105.1	15.3	13.7	19.9	40.7	10.1	20.5	16.2	11.7	11.1	21.4	20.2	15.8	13.7	15.7	10.5	15.3	28.6	24.7	40.7	18.3	56.5	19.6	398.5	19.9	26.8	5.4	21.5	38.4	9.2	40.2	13.0	12.2	21.2	24.3	12.4	17.0	22.2	27.1	10.8	13.9	8.5	6.6	14.1	13.0	3.6	12.0	35.0	49.6	12.0	40.3	12.9	35.7	15.3
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178405-32180793	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 371.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	38.2	75.9	60.4	29.2	63.4	40.4	44.5	64.6	66.0	44.9	59.4	59.5	61.6	44.8	45.8	37.5	54.1	46.1	81.7	59.2	60.6	115.6	126.2	38.7	43.1	65.0	60.6	60.4	41.6	55.5	17.2	30.1	62.6	44.0	62.4	42.9	43.9	31.7	89.6	44.6	76.5	30.5	62.8	38.8	55.3	29.5	61.8	60.7	48.6	76.5	43.4	45.1	38.8	67.0	51.2	66.1	43.7	167.5	46.9	31.3	34.0	20.6	26.5	44.4	48.7	89.1	42.1	65.2	70.8	47.9	62.5	41.7	80.3	45.1	45.2	41.8	107.5	53.9	69.5	184.4	55.0	0.2	101.2	32.3	60.3	73.3	53.6	77.2	89.1	115.0	136.6	67.8	63.8	71.9	66.5	151.5	0.3	71.8	28.7	44.4	48.2	88.2	124.0	32.6	44.8	92.1	39.9	42.4	46.7	39.9	87.0	183.0	40.3	48.1	44.7	0.5	79.1	38.6	63.5	79.3	33.2	116.4	29.6	64.8	45.7	75.8	64.8	65.9	55.6	64.6	52.5	57.6	64.7	56.2	57.5	58.3	22.1	79.6	46.7	264.6	58.2	75.0	60.4	63.4	64.6	66.0	59.2	60.6	65.0	60.6	62.6	62.8	61.8	67.0	38.3	19.2	41.1	2.9	52.7	95.7	70.0	146.6	52.3	23.6	61.8	56.5	62.9	87.2	79.5	92.0	0.0	78.1	70.3	151.9	283.7	110.8	21.6	47.2	31.7	50.9	73.2	126.3	3.4	91.3	101.7	44.6	28.5	31.7	56.3	41.5	47.8	131.5	68.9	33.7	3.5	83.0	132.2	51.1	171.7	22.6	59.4	43.3	85.4	1.0	69.5	91.3	65.9	1.5	10.0	78.5	173.0	72.6	45.5	58.4	270.6	371.6	73.4	27.6	65.7	50.6	63.0	55.7	37.7	44.4	84.4	84.1	53.8	42.8	100.3	56.5
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 99.1;Late spermatids: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	18.9	17.3	12.4	18.7	13.3	32.5	17.9	13.4	18.4	13.4	13.5	18.4	17.5	12.4	13.7	18.5	14.5	13.7	13.7	13.9	11.7	18.2	16.6	16.2	22.4	10.4	13.5	11.5	14.1	22.3	10.7	19.9	11.5	16.0	18.5	26.6	13.5	13.9	21.2	17.3	18.8	15.7	10.8	19.7	17.2	33.6	13.7	25.3	17.5	15.3	23.8	18.3	10.1	11.5	33.3	28.9	10.7	15.8	36.3	28.2	23.9	56.3	45.2	35.4	24.9	36.4	41.8	59.5	27.3	53.5	31.5	43.7	30.2	45.3	58.4	57.7	19.2	64.8	23.9	31.3	56.6	68.7	65.4	26.8	86.1	39.8	84.2	34.3	36.0	25.5	25.6	0.1	55.3	30.0	38.5	39.8	8.7	59.5	19.8	30.4	41.5	23.7	43.6	43.3	19.3	11.9	29.9	54.0	54.1	24.8	20.7	66.3	47.6	30.4	18.6	41.1	40.5	14.8	14.9	34.9	27.8	38.4	40.7	46.6	14.5	34.7	15.6	18.4	17.1	18.6	17.1	17.7	17.6	12.5	16.8	14.8	9.7	20.0	23.3	9.1	19.2	14.2	12.4	13.3	13.4	18.4	13.9	11.7	10.4	13.5	11.5	10.8	13.7	11.5	20.9	22.4	19.8	6.8	26.5	30.5	12.7	17.5	14.8	22.2	15.1	10.5	13.5	5.7	19.7	7.3	25.0	20.2	31.6	24.8	33.2	15.1	99.1	37.4	16.9	23.0	11.4	24.8	14.4	15.4	21.8	16.1	17.3	19.9	26.6	12.1	17.5	12.3	17.5	30.3	17.2	15.5	24.4	22.4	19.9	191.0	14.6	23.0	14.2	12.2	21.6	24.9	29.9	11.6	16.2	24.4	20.1	11.3	18.0	22.0	15.8	21.4	40.1	43.2	26.3	21.6	14.5	83.5	29.1	19.2	29.1	42.1	26.2	17.1	12.6	23.5
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738249-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 898.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	67.1	114.5	62.7	40.8	65.6	65.0	63.5	63.4	80.0	69.5	72.2	98.2	69.7	58.7	70.8	86.5	61.0	46.1	102.8	64.2	67.2	92.3	83.9	58.4	44.5	64.4	64.8	73.8	80.3	44.0	81.5	51.2	65.7	77.6	59.8	37.6	59.8	43.8	142.0	72.0	64.1	47.8	65.1	58.7	68.3	71.2	66.3	45.4	52.6	113.1	44.1	77.9	71.9	65.9	172.6	67.4	98.1	80.0	91.6	125.7	65.5	94.6	87.5	78.2	82.6	79.4	82.5	57.7	214.5	104.7	192.7	80.8	61.5	88.1	98.3	56.0	119.1	56.6	64.8	116.4	122.6	89.7	52.9	118.2	96.9	63.4	105.5	104.3	112.3	96.1	61.6	77.0	117.2	131.0	56.6	100.1	105.1	170.7	113.3	61.1	63.1	124.0	169.2	74.0	54.8	68.1	108.7	108.8	161.4	126.4	102.4	114.8	86.2	78.1	75.6	139.2	80.5	73.7	66.5	121.2	122.4	98.4	90.3	119.0	128.2	87.7	78.0	116.4	77.7	82.6	82.8	83.2	112.9	74.1	79.6	83.7	45.5	61.8	125.7	103.4	108.8	121.6	62.7	65.6	63.4	80.0	64.2	67.2	64.4	64.8	65.7	65.1	66.3	65.9	128.7	60.9	55.2	7.5	81.4	132.4	143.0	290.5	150.2	34.3	159.7	207.3	104.1	105.8	151.1	101.2	27.1	183.8	133.2	262.0	254.3	225.1	348.9	99.3	112.0	134.9	125.7	41.4	12.9	247.3	249.1	114.2	73.9	100.0	72.9	206.4	129.9	132.0	214.4	28.6	12.6	195.2	134.3	126.7	123.5	898.4	117.8	137.6	144.1	18.7	174.1	111.7	140.1	10.6	19.6	233.2	261.4	121.9	102.0	181.8	295.1	324.1	105.7	56.7	85.5	84.3	126.2	212.2	129.1	183.7	144.6	129.8	112.7	281.4	174.5	185.9
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353979-37394734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.0"	"Not detected"	"Not detected"							"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	5.0	7.8	10.0	3.5	10.1	4.6	5.2	11.8	14.3	7.7	9.3	6.3	3.1	7.0	2.1	10.6	6.0	4.0	8.6	10.1	10.5	8.8	4.8	5.9	4.2	10.2	10.6	7.6	4.5	7.4	6.6	4.8	10.3	6.0	3.6	9.0	6.2	5.2	8.1	7.6	5.0	4.9	9.4	4.7	5.2	11.2	11.2	5.8	4.5	10.6	6.6	6.5	7.8	9.9	12.5	7.3	17.3	20.7	13.7	19.6	4.9	12.6	15.5	23.4	25.6	11.0	6.8	15.3	7.5	12.4	20.1	11.4	24.4	16.0	24.4	16.2	23.7	26.5	12.0	16.6	7.8	14.3	18.7	9.8	15.2	14.0	16.2	14.3	22.9	17.9	18.1	5.2	13.6	8.3	17.4	17.5	12.1	6.3	9.4	13.5	16.0	10.6	12.1	8.7	34.0	11.4	9.5	10.6	18.0	11.3	9.5	13.6	10.4	15.4	13.5	14.7	18.8	15.2	21.8	76.0	7.5	20.1	18.0	1.0	4.3	2.5	9.5	5.8	8.8	8.1	7.0	9.2	7.8	4.9	6.1	8.1	0.5	7.9	8.8	3.3	9.1	5.2	10.0	10.1	11.8	14.3	10.1	10.5	10.2	10.6	10.3	9.4	11.2	9.9	21.0	19.2	25.9	13.4	15.0	18.2	22.2	26.0	26.2	26.7	16.5	20.4	31.1	12.8	18.5	25.8	39.6	24.8	18.2	10.3	15.6	24.7	41.1	68.5	32.2	19.2	22.2	18.7	17.0	18.9	25.8	28.0	16.3	52.3	28.5	37.0	27.8	16.5	17.5	50.5	15.9	16.5	14.2	13.9	17.7	30.2	26.8	24.0	10.6	11.2	19.6	25.4	37.0	12.5	20.5	28.8	18.1	30.9	13.7	31.8	11.8	20.6	23.8	32.3	13.1	23.2	20.8	46.5	34.5	34.2	22.0	5.9	19.3	22.0	18.0	21.9
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;pituitary gland: 5.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	0.4	1.0	9.8	0.5	9.8	1.0	0.2	5.7	13.8	0.2	2.9	0.3	0.5	0.2	0.8	0.4	0.3	0.4	0.4	10.6	8.4	0.7	0.1	0.3	1.1	11.8	7.6	0.4	0.2	0.4	5.1	1.0	11.9	0.2	0.3	4.9	0.6	0.2	0.6	0.6	0.5	0.2	4.2	0.8	0.3	3.7	7.9	1.4	0.5	0.1	1.2	0.2	0.1	9.3	1.3	7.3	2.9	9.8	0.1	0.1	6.8	0.5	0.5	1.6	1.2	3.3	1.2	6.5	1.9	0.1	2.2	1.3	7.8	0.6	0.9	7.0	4.6	1.1	5.5	2.4	1.1	0.5	4.9	0.2	0.1	3.6	0.8	0.9	0.3	4.4	8.0	2.1	0.1	4.0	7.6	1.1	4.5	1.9	1.3	4.1	1.5	3.4	2.0	1.2	5.0	4.8	1.8	0.8	1.9	2.6	5.0	1.7	0.4	1.0	4.5	2.2	2.5	3.6	14.9	8.5	4.0	0.5	0.6	1.1	0.2	0.2	0.3	0.1	0.1	0.7	0.3	0.3	0.1	0.8	0.6	0.7	0.7	0.5	0.3	0.7	0.2	0.2	9.8	9.8	5.7	13.8	10.6	8.4	11.8	7.6	11.9	4.2	7.9	9.3	0.9	0.0	0.5	11.8	2.2	0.0	0.3	0.2	0.0	17.9	0.7	0.3	1.2	1.5	0.2	7.3	16.7	3.1	0.3	0.5	0.0	0.9	49.3	0.7	0.3	1.9	4.2	0.4	22.7	0.2	3.0	0.6	1.1	0.6	0.0	3.8	0.4	0.2	2.2	10.1	28.7	0.8	2.0	1.9	0.8	56.4	0.6	0.7	1.8	3.7	1.0	5.5	0.0	18.6	7.0	0.6	0.1	1.5	2.0	0.2	0.6	1.0	1.4	10.3	0.0	0.7	0.9	3.8	5.2	0.2	0.0	1.6	0.5	1.1	0.8	0.2
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 262.3;monocytes: 299.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	163.5	137.2	27.3	29.0	41.8	46.3	133.7	42.4	33.9	156.4	28.9	123.0	27.1	140.8	10.0	215.0	119.5	29.7	198.0	26.3	32.5	118.6	111.9	146.7	30.8	48.6	39.7	119.1	89.5	25.6	80.6	27.3	38.2	100.9	8.8	5.6	112.5	31.0	145.9	257.4	91.1	25.3	35.3	113.3	101.1	90.1	38.3	15.6	106.6	21.8	13.9	144.5	160.3	49.4	86.5	123.9	13.2	39.8	66.3	93.8	43.9	70.6	51.3	68.9	58.3	61.9	92.9	41.8	54.3	175.1	41.9	72.7	20.6	76.5	10.4	51.3	104.9	28.2	28.5	65.7	243.3	39.8	90.0	77.1	108.2	40.2	46.7	29.2	47.9	27.7	36.2	71.3	37.7	86.6	30.5	78.4	19.8	45.3	112.6	37.7	22.3	55.8	40.7	34.6	35.7	23.2	41.8	59.1	73.7	7.4	44.6	122.2	77.3	109.3	32.8	39.8	49.5	44.9	53.0	32.2	117.5	81.9	74.3	37.6	246.2	57.3	51.1	298.9	59.9	63.0	55.3	51.1	262.3	48.4	49.8	45.1	17.1	54.2	299.1	71.7	58.4	236.5	27.3	41.8	42.4	33.9	26.3	32.5	48.6	39.7	38.2	35.3	38.3	49.4	156.0	112.2	83.5	18.9	92.3	202.1	239.0	265.0	89.4	102.4	82.0	105.5	83.3	88.6	138.6	79.1	110.5	222.2	85.3	126.6	225.0	188.8	105.1	72.8	132.4	136.1	57.4	59.7	10.9	164.4	217.4	194.9	64.2	82.8	140.2	93.8	101.7	68.6	374.0	168.2	14.5	115.6	148.5	191.8	323.0	42.7	211.6	230.3	193.9	12.2	334.2	144.6	79.3	10.1	70.8	171.6	120.5	179.8	101.7	161.0	139.4	242.3	97.9	146.4	177.5	99.1	178.0	153.4	157.8	140.0	260.0	305.5	96.5	199.7	114.4	217.4
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	10.9	9.6	11.8	12.6	12.1	43.3	15.3	12.2	13.0	11.3	17.2	11.6	8.5	14.0	11.5	11.3	11.2	9.0	20.3	12.1	14.2	11.6	11.2	9.5	14.4	13.6	15.2	17.2	12.1	13.0	13.9	15.2	14.8	11.6	10.4	27.4	12.1	10.5	18.4	14.2	10.5	12.5	10.9	12.1	10.6	16.7	11.7	14.9	17.5	15.6	15.2	11.4	10.7	12.6	24.9	14.4	27.4	20.9	20.0	25.1	19.2	19.9	24.7	20.3	27.4	17.3	11.7	27.7	23.9	20.6	31.6	9.8	32.7	28.6	34.0	15.4	17.6	21.0	14.8	16.4	21.9	54.9	17.1	19.4	30.5	21.4	59.9	26.6	15.9	31.1	31.8	26.9	23.3	15.4	35.2	19.7	21.0	50.1	11.2	22.7	29.0	37.9	18.6	19.2	21.1	31.7	22.5	16.4	38.1	27.8	14.3	22.6	16.5	40.6	56.8	33.3	21.5	53.8	63.6	56.9	29.9	20.8	20.6	45.1	17.6	12.8	16.7	14.6	13.6	23.9	15.8	14.2	11.8	25.7	20.5	16.2	9.8	14.1	17.3	29.5	19.0	5.6	11.8	12.1	12.2	13.0	12.1	14.2	13.6	15.2	14.8	10.9	11.7	12.6	62.5	73.7	29.9	48.6	148.5	70.4	67.3	97.9	75.1	115.6	50.7	56.1	56.5	35.8	56.5	46.0	123.0	66.3	143.4	46.5	68.4	51.0	75.4	85.2	88.3	43.7	74.8	37.4	75.3	48.0	59.2	71.6	66.3	113.9	34.9	85.6	40.7	38.5	39.8	106.0	83.9	56.3	85.5	59.4	63.6	21.1	72.7	78.8	49.8	45.0	68.0	51.0	60.8	56.8	78.9	56.1	47.0	60.9	99.7	72.3	49.0	64.8	48.0	148.3	39.5	85.6	60.0	111.4	115.1	50.7	68.3	126.4	113.1	48.8	50.0	50.3
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		7800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	25.2	31.1	8.0	22.8	8.3	25.2	25.8	8.1	8.5	26.7	16.1	53.6	68.5	25.6	39.0	53.8	40.6	22.3	14.7	8.5	8.7	25.9	32.4	30.5	22.1	9.9	9.1	23.4	34.1	25.4	13.3	27.5	9.1	25.9	57.0	4.2	38.3	27.6	18.8	37.0	58.1	28.1	9.1	33.4	28.5	17.9	10.6	21.7	33.2	12.7	26.5	23.3	28.8	11.8	66.2	71.0	40.8	62.7	65.1	61.3	102.1	49.5	95.6	60.9	67.6	51.8	83.1	14.3	61.8	87.8	38.0	117.4	52.5	97.2	42.4	39.1	67.6	35.5	32.5	48.7	55.1	92.3	121.3	55.9	97.9	54.1	62.0	74.7	110.6	34.8	82.5	21.6	62.1	61.0	12.8	40.2	58.4	105.4	34.4	48.3	57.5	101.6	128.7	61.2	46.9	39.9	122.2	155.9	52.1	78.9	116.6	52.4	79.9	28.9	38.0	28.7	61.3	45.3	39.6	12.9	27.8	77.3	58.1	22.9	14.9	22.1	3.0	25.9	4.1	2.5	3.2	3.4	19.8	4.6	2.8	3.2	11.0	2.9	29.9	7.2	5.4	4.0	8.0	8.3	8.1	8.5	8.5	8.7	9.9	9.1	9.1	9.1	10.6	11.8	26.7	9.6	21.5	8.5	19.7	28.8	40.5	31.2	40.5	15.5	32.8	33.1	12.2	38.6	26.7	25.8	10.4	116.6	21.4	136.6	19.6	71.1	5.4	35.9	17.7	26.1	44.9	19.0	12.7	51.2	91.1	26.1	45.3	21.5	15.2	23.2	27.1	51.4	103.7	11.8	11.1	71.9	14.2	81.0	39.4	4.9	25.4	72.9	24.9	15.0	86.7	12.6	17.5	5.5	8.1	47.8	83.4	23.0	23.6	25.0	201.7	65.8	39.1	8.0	26.3	11.4	28.2	22.7	9.5	53.6	21.6	87.6	17.7	33.2	86.6	34.8
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	40.3	31.4	29.1	14.1	29.6	21.7	32.0	29.0	38.7	15.6	27.0	39.6	20.2	16.8	5.6	52.4	17.0	12.1	79.4	27.9	27.8	42.7	50.6	35.9	23.8	31.5	30.0	12.0	64.2	10.9	9.1	10.6	30.3	34.7	9.5	0.8	28.9	13.1	63.7	35.3	39.8	9.4	31.0	56.4	48.4	9.9	31.4	15.9	19.2	17.1	12.1	34.1	23.2	31.1	13.7	22.4	4.9	13.2	17.6	18.1	16.6	8.6	21.1	9.5	11.6	6.3	39.3	3.9	4.3	21.8	13.3	14.6	5.5	16.1	0.9	23.9	7.7	9.0	7.3	37.2	44.1	5.9	15.5	21.6	25.5	4.9	9.6	15.1	32.8	15.2	6.8	25.7	6.5	19.3	7.5	22.4	6.5	26.5	9.0	15.5	7.4	33.3	39.3	18.5	4.6	9.8	5.8	19.7	39.9	5.6	13.9	26.8	22.7	10.2	10.4	14.4	10.0	24.1	3.9	4.8	20.9	16.6	15.7	9.2	11.2	30.5	14.8	9.9	12.7	8.2	11.3	13.4	8.2	8.7	6.4	9.5	20.0	10.7	10.1	9.5	14.7	7.9	29.1	29.6	29.0	38.7	27.9	27.8	31.5	30.0	30.3	31.0	31.4	31.1	27.9	22.4	25.7	10.4	27.8	7.8	15.0	8.4	2.8	6.4	18.8	9.1	35.6	24.3	12.9	12.9	0.0	7.1	80.4	138.9	17.6	24.6	3.1	12.1	11.0	22.7	26.4	22.3	9.5	49.6	6.8	12.3	104.5	27.4	34.2	31.8	30.0	42.2	43.8	3.3	8.6	58.7	8.2	74.3	21.0	5.9	8.7	47.1	23.2	9.4	52.0	15.9	79.3	5.5	10.3	65.0	70.0	13.5	20.5	20.2	77.1	35.6	7.2	6.9	13.1	14.8	16.4	1.3	8.2	13.0	9.2	5.1	47.9	17.4	60.5	23.0
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268397	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	82.8	78.7	91.9	55.1	96.1	144.9	83.4	82.6	112.6	89.0	60.5	108.8	51.3	98.8	51.1	98.0	84.6	39.9	101.0	99.1	93.0	81.4	63.8	73.5	76.5	96.0	84.5	92.6	71.8	52.5	101.4	53.5	94.9	95.0	43.9	47.4	70.0	54.9	229.7	97.3	84.0	52.4	72.5	94.9	76.8	88.4	88.5	69.8	74.2	105.2	71.3	94.1	83.6	90.7	119.6	154.5	167.7	163.9	89.0	78.6	194.2	125.2	88.4	170.6	147.0	306.1	142.8	251.1	124.0	103.2	108.6	160.0	217.3	152.5	128.9	175.2	283.2	172.8	133.9	198.3	150.2	185.5	159.0	99.3	168.3	149.1	207.1	80.8	134.8	144.6	302.1	195.3	143.3	259.7	296.2	363.6	340.1	135.2	128.4	441.4	196.6	322.3	122.5	66.6	354.8	218.3	172.3	157.6	166.4	77.1	152.7	187.7	102.2	155.4	155.2	143.0	182.1	199.7	282.5	582.9	63.3	168.0	185.6	48.1	144.0	123.2	169.5	170.5	167.7	177.9	162.2	172.9	153.8	205.5	153.3	162.0	43.4	182.9	187.8	131.6	196.1	290.2	91.9	96.1	82.6	112.6	99.1	93.0	96.0	84.5	94.9	72.5	88.5	90.7	90.6	44.8	62.7	29.7	148.2	206.6	208.7	148.9	119.5	119.7	99.5	95.9	36.3	65.8	85.5	51.5	139.7	182.3	138.5	90.8	70.5	115.5	16.3	76.5	88.9	102.1	122.0	130.4	72.1	93.2	237.4	90.7	79.0	108.4	103.4	114.9	77.1	37.5	104.7	97.6	61.1	100.6	124.1	71.3	117.0	21.4	94.1	80.1	97.8	23.4	123.9	98.0	180.2	31.7	37.3	121.7	76.5	68.8	117.2	209.5	81.1	64.3	50.2	132.8	85.5	103.9	102.3	132.9	267.4	117.6	212.4	162.0	131.7	101.7	125.7	203.5
RO60	"SSA2, TROVE2"	ENSG00000116747	"Ro60, Y RNA binding protein"	P10155	1	193059454-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 53.0;Cardiomyocytes: 53.0;Cytotrophoblasts: 47.1;dendritic cells: 41.3;Extravillous trophoblasts: 45.2;Hofbauer cells: 33.4;Syncytiotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002835	Uncertain		Supported	Cytosol		NA	NA		50000	"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA002835: AB_1857490"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	10.8	8.3	10.6	8.8	16.4	29.7	8.1	15.5	8.7	7.3	3.9	7.5	6.0	9.5	6.4	9.5	6.5	7.4	10.0	6.8	13.9	7.4	9.3	7.6	9.8	17.7	12.8	10.0	7.5	7.0	4.7	8.7	18.6	8.8	6.1	15.4	6.9	6.1	9.9	7.6	6.4	9.4	15.9	10.0	6.4	13.0	11.1	8.2	9.7	10.2	8.9	8.4	7.5	22.6	13.4	25.5	22.5	25.2	20.0	17.7	15.9	19.5	19.8	14.8	18.9	11.8	18.0	25.1	15.7	18.4	14.5	18.7	19.0	13.3	23.2	40.7	14.4	31.4	22.2	15.6	16.5	35.4	23.4	15.9	13.2	25.4	25.1	11.4	19.4	11.5	34.7	38.0	20.3	26.6	21.1	9.3	16.1	10.2	10.8	18.2	21.1	30.7	11.8	28.0	9.4	17.6	25.0	24.8	25.0	15.3	24.2	14.4	26.8	26.0	11.4	25.7	25.8	20.5	29.0	26.8	11.8	18.1	38.9	102.1	31.6	46.0	53.4	29.9	52.3	47.7	37.2	47.0	32.4	44.6	39.6	45.2	53.9	45.2	33.2	29.1	44.7	39.8	10.6	16.4	15.5	8.7	6.8	13.9	17.7	12.8	18.6	15.9	11.1	22.6	53.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	47.1	41.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	45.2	17.8	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	48.0	6.2	0.0	0.0	0.0
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597239-79767998	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 309.4;Inhibitory neurons: 1518.9;Oligodendrocyte precursor cells: 348.3;Oligodendrocytes: 479.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"		NA	NA		16000000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256"	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.4	8.6	12.7	10.7	13.7	0.2	4.9	4.3	9.5	13.4	0.0	7.8	3.1	9.5	7.2	12.3	4.7	7.7	6.7	7.8	10.8	3.1	3.6	7.6	9.3	8.8	16.3	16.4	1.9	1.8	7.4	7.8	9.9	12.9	6.0	3.9	5.4	11.9	4.5	20.5	4.3	10.5	7.5	9.0	4.8	10.3	15.5	13.3	4.8	5.4	18.2	13.9	11.1	12.4	0.2	26.9	25.7	41.3	35.0	22.8	1.4	21.1	28.0	16.3	13.8	0.6	11.5	0.0	0.1	26.2	13.0	10.9	31.5	21.6	20.5	0.4	39.1	16.4	51.4	43.4	8.4	0.3	4.1	38.3	28.9	61.9	29.1	30.5	16.5	0.0	2.2	49.0	16.8	13.1	0.0	0.1	32.8	7.9	9.6	0.9	27.2	0.3	0.1	8.9	19.7	13.7	45.5	9.9	16.2	24.6	31.8	0.4	0.3	54.1	23.4	32.7	36.1	1.7	0.0	0.0	49.2	0.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	12.7	13.7	4.3	9.5	7.8	10.8	8.8	16.3	9.9	7.5	15.5	12.4	4.3	3.2	11.0	81.0	1.9	33.1	20.6	17.9	39.9	11.7	4.1	3.6	3.6	0.0	9.0	7.3	4.2	9.7	0.0	0.1	0.0	0.5	23.9	1.6	23.2	14.3	1.2	4.0	309.4	0.2	8.3	34.6	3.6	2.3	1.3	5.1	16.1	0.3	1.5	1.7	1518.9	1.4	22.4	2.6	10.0	65.9	19.9	1.5	14.2	51.5	1.9	5.7	0.0	348.3	479.3	0.2	5.1	24.5	1.3	20.5	4.9	0.4	2.9	1.0	13.1	24.7	16.8	2.7	7.0	30.3	33.8	5.6	0.9	71.1	2.6	52.7
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111813	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 406.2;Late spermatids: 505.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	8.0	4.2	3.8	5.7	4.8	18.2	6.0	4.4	3.9	5.3	4.6	5.0	3.6	5.9	4.6	4.2	6.3	4.2	5.5	2.8	3.5	4.4	4.8	7.6	5.5	5.4	4.0	5.4	5.1	2.9	2.9	4.4	4.9	4.4	3.2	4.8	4.4	3.4	2.6	3.7	5.2	3.2	4.4	6.2	5.8	2.6	4.5	5.5	4.5	1.9	4.2	6.6	5.4	5.3	6.5	3.9	3.9	3.8	7.2	7.7	6.3	8.9	4.3	3.9	4.2	6.6	2.7	8.0	6.2	10.5	2.1	5.2	3.6	5.2	7.8	11.4	4.1	6.4	7.3	2.9	3.6	17.9	9.6	5.6	4.6	5.8	4.7	3.2	6.0	3.1	3.7	7.9	4.6	4.1	8.5	3.8	3.2	4.3	6.6	11.9	4.5	3.1	3.7	5.9	4.5	3.5	7.1	4.6	3.6	3.4	4.6	6.7	9.9	7.7	6.4	7.1	7.2	10.7	5.3	9.0	5.8	7.5	4.8	3.0	5.0	6.8	5.0	3.2	4.0	3.9	3.6	3.8	4.2	5.0	3.5	3.5	18.0	2.8	4.0	5.5	3.6	2.5	3.8	4.8	4.4	3.9	2.8	3.5	5.4	4.0	4.9	4.4	4.5	5.3	98.2	96.1	88.7	64.6	112.6	46.3	60.4	30.7	43.9	100.4	32.2	35.6	138.6	28.6	61.4	33.1	131.3	57.5	136.9	36.6	15.6	62.5	406.2	64.8	86.9	94.4	99.0	47.9	81.3	38.0	64.9	78.4	62.7	73.8	72.7	68.5	60.0	47.4	60.3	60.6	74.2	45.8	40.7	135.3	126.7	505.0	97.6	166.2	65.8	106.8	137.1	52.3	204.9	87.0	140.0	70.9	62.8	138.8	83.2	63.2	32.3	21.0	44.6	128.6	170.9	81.4	197.6	107.4	80.9	38.7	36.7	43.0	127.4	70.5	38.9	73.3
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
ROGDI	FLJ22386	ENSG00000067836	"Rogdi atypical leucine zipper"	Q9GZN7	16	4796968-4802880	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amelogenesis imperfecta, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 105.6"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 179.2;Rod photoreceptor cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 74.6;intermediate monocyte: 62.7;myeloid DC: 61.5;non-classical monocyte: 61.8;plasmacytoid DC: 34.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 61.5;monocytes: 74.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041000	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA041000: AB_10794077"	"unprognostic (1.74e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.79e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.71e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.71e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.08e-2)"	7.5	24.1	82.9	11.6	84.5	78.0	7.3	81.3	105.6	8.8	64.3	17.6	24.8	7.5	6.6	18.1	14.5	14.4	44.2	91.4	83.9	19.3	19.7	15.5	8.6	84.0	84.9	5.9	22.9	26.4	18.2	7.9	80.9	19.0	7.6	61.9	25.3	16.6	63.1	6.5	21.4	11.3	79.4	15.6	21.1	8.2	96.8	10.1	4.6	32.9	8.7	11.2	6.4	97.6	13.5	18.8	9.5	42.4	12.2	6.2	36.4	9.4	4.6	8.2	3.6	12.5	15.3	5.9	15.1	19.9	5.3	26.7	9.9	28.7	3.2	4.8	13.3	8.0	28.9	28.1	19.8	10.4	6.5	8.3	11.7	12.4	8.3	21.6	14.5	11.5	5.7	3.5	14.1	74.9	9.4	51.0	15.3	15.4	14.2	30.1	26.1	30.1	19.8	18.1	55.3	24.5	38.6	42.4	9.9	11.9	50.9	40.8	22.3	7.3	17.0	52.5	6.5	14.2	17.0	5.2	8.6	40.0	6.5	10.5	74.6	8.1	2.1	62.7	6.6	2.5	5.4	4.9	61.5	2.8	4.7	5.5	6.7	6.7	61.8	34.5	6.1	38.0	82.9	84.5	81.3	105.6	91.4	83.9	84.0	84.9	80.9	79.4	96.8	97.6	7.0	19.2	7.8	17.3	6.7	5.1	28.0	84.4	32.5	179.2	23.0	22.5	58.1	21.5	36.7	27.6	110.5	46.9	11.5	23.4	39.2	22.2	30.3	17.6	8.5	12.0	52.0	38.7	33.2	16.0	73.4	15.9	11.7	7.2	5.7	9.8	24.3	19.7	64.8	25.2	19.2	29.7	69.2	28.7	29.0	57.0	6.8	31.0	12.4	10.3	77.0	102.5	6.2	7.5	90.2	13.5	23.7	19.2	4.6	12.7	65.7	80.8	21.3	149.7	6.6	8.2	15.3	6.5	20.7	24.8	5.8	30.6	9.5	64.7	23.1	22.3
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	18	"retina: 1186.9"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	12.8	7.9	57.9	2.2	60.5	1.2	9.3	56.8	67.4	9.1	48.1	9.8	1.8	7.7	4.7	7.6	10.7	4.6	8.1	54.5	59.0	7.0	7.1	6.0	2.5	67.4	61.0	13.5	3.6	5.2	7.0	1.4	62.1	8.2	2.6	1186.9	4.2	5.0	3.3	5.4	5.3	5.4	60.0	7.5	7.0	6.2	63.1	1.6	6.0	3.7	2.5	9.6	7.3	62.1	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	57.9	60.5	56.8	67.4	54.5	59.0	67.4	61.0	62.1	60.0	63.1	62.1	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
ROMO1	"bA353C18.2, C20orf52, MTGMP"	ENSG00000125995	"Reactive oxygen species modulator 1"	P60602	20	35699272-35700984	"Predicted intracellular proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1349.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012782	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA012782: AB_1845685"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.84e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	126.3	185.8	164.8	71.6	170.7	112.3	125.8	174.7	216.3	112.3	182.8	131.7	99.8	113.0	81.6	185.6	102.9	50.8	246.2	165.5	169.8	188.4	206.2	99.8	79.2	171.0	170.0	111.3	134.7	122.3	163.6	63.0	170.5	126.4	66.3	33.0	133.9	79.6	259.2	122.0	105.1	51.7	170.2	104.6	126.0	121.6	175.1	102.3	122.5	168.9	59.3	108.6	119.7	176.4	304.5	493.7	164.5	202.1	125.3	169.2	269.2	165.7	196.2	256.6	251.0	1196.7	263.5	154.6	370.6	125.5	380.3	320.6	88.5	438.3	64.9	84.6	615.1	267.2	547.2	1349.5	259.4	166.6	134.7	216.2	204.3	182.1	133.1	118.5	209.7	285.9	224.6	309.7	124.7	966.0	373.0	456.6	251.8	327.6	867.8	246.5	319.0	342.3	246.9	516.1	229.3	236.0	288.6	546.5	306.6	150.0	502.6	353.8	172.5	425.0	240.1	281.1	279.8	504.6	481.5	409.3	371.0	130.9	249.7	602.8	590.1	459.5	398.5	511.9	378.4	587.2	408.8	393.7	573.0	523.1	346.7	384.9	330.0	391.8	486.2	1054.9	538.0	726.4	164.8	170.7	174.7	216.3	165.5	169.8	171.0	170.0	170.5	170.2	175.1	176.4	168.1	102.5	187.2	2.3	147.5	118.3	87.5	339.7	124.7	28.7	235.9	237.9	662.8	264.5	256.3	257.5	8.4	284.8	101.0	691.8	403.0	364.1	23.8	334.5	192.2	150.9	328.1	152.3	2.2	571.6	256.0	194.8	253.8	268.5	193.2	125.9	166.7	641.1	219.9	20.2	2.1	412.9	203.4	157.9	164.3	50.9	130.5	165.0	236.5	3.7	266.4	176.1	108.1	1.0	4.8	567.4	574.0	128.2	323.2	124.8	573.0	753.7	355.8	39.5	118.3	109.7	262.4	283.9	225.4	270.7	153.2	326.9	141.5	64.4	387.0	115.6
ROPN1	"CT91, ODF6, ROPN1A, ropporin"	ENSG00000065371	"Rhophilin associated tail protein 1"	Q9HAT0	3	123968521-123992178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 158.8"	"Group enriched"	"Detected in some"	9	"Early spermatids: 1370.6;Late spermatids: 629.0;Spermatocytes: 355.0"	"Cancer enriched"	"Detected in some"	4	"melanoma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-MEL-30: 28.7"	"Low region specificity"	"Detected in single"							HPA052530	Supported					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA052530: AB_2681861"	"unprognostic (1.75e-5)"			"unprognostic (2.24e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.66e-2)"			"unprognostic (1.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.13e-1)"			"unprognostic (2.08e-2)"	"unprognostic (8.35e-4)"			0.0	0.0	0.3	0.0	0.2	0.0	20.5	0.1	0.2	0.0	0.0	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.5	0.3	6.1	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	158.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	49.4	81.7	7.8	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1370.6	0.2	0.0	1.4	2.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	629.0	8.7	1.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	355.0	5.7	0.0	0.0	0.0	0.4	0.0	0.5	0.0
ROPN1B		ENSG00000114547	"Rhophilin associated tail protein 1B"	Q9BZX4	3	125969160-125983454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 214.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 2012.7;Late spermatids: 1967.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SK-MEL-30: 54.6;WM-115: 18.5"									HPA052530	Supported					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 34: Spermatids - Unknown function"			"HPA052530: AB_2681861"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.89e-3)"	"unprognostic (3.78e-2)"	0.3	0.5	1.3	0.2	1.6	0.1	38.2	2.0	1.8	0.2	0.0	0.1	0.1	0.3	22.1	0.1	0.5	0.0	3.0	1.3	1.2	0.3	1.2	0.3	0.6	0.8	1.3	0.3	0.3	0.0	3.0	0.2	0.9	0.7	0.0	1.8	14.6	0.2	0.4	7.0	0.1	0.0	0.5	0.1	0.1	214.2	0.9	0.0	0.7	0.8	0.3	0.4	0.1	2.0	0.0	0.0	0.3	0.2	0.0	0.0	2.9	0.0	0.3	0.2	0.2	0.2	2.4	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.1	1.1	0.2	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.3	0.9	0.3	0.1	0.0	54.6	0.1	0.7	0.7	0.0	0.0	0.5	0.2	0.2	5.4	1.1	0.3	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.6	2.0	1.8	1.3	1.2	0.8	1.3	0.9	0.5	0.9	2.0	0.6	0.0	0.0	1.3	0.3	3.7	0.1	1.4	0.0	0.2	60.1	86.2	18.8	0.0	3.9	0.0	0.0	0.3	2.0	0.0	0.0	0.2	2012.7	3.1	0.1	1.6	0.0	0.0	0.5	0.2	2.5	1.3	0.0	0.1	0.0	0.2	0.0	0.5	0.1	3.3	0.4	0.0	2.0	0.0	2.0	1967.9	19.0	1.5	149.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	9.8	0.0	0.6	0.0	0.1	17.8	0.2	19.7	0.0	1.0	493.4	11.8	0.0	0.6	0.1	0.5	0.0	0.0	1.2
ROPN1L	"ASP, FLJ25776, RSPH11"	ENSG00000145491	"Rhophilin associated tail protein 1 like"	Q96C74	5	10441524-10472029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 323.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 9.6;ovarian cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 105.3"	"Cell line enriched"	"Detected in some"	5	"NB-4: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039193, HPA041830"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA039193: AB_10673415, HPA041830: AB_2677695"	"unprognostic (2.39e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.22e-2)"	0.7	0.2	1.3	0.3	1.3	4.3	0.8	0.7	0.8	2.0	6.5	0.2	0.0	0.8	0.0	0.1	27.4	0.3	0.6	1.8	1.5	0.8	0.3	5.3	0.4	5.0	8.4	0.2	1.1	0.0	1.2	0.2	4.9	0.6	0.0	1.0	0.1	0.1	0.2	0.3	0.3	0.0	4.2	4.5	0.3	323.0	1.3	0.2	0.8	0.3	0.0	0.2	0.1	2.1	0.1	0.4	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.5	0.5	0.1	0.1	0.0	1.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.7	0.0	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.0	13.4	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.9	1.5	0.1	0.1	0.4	0.0	1.5	1.6	0.3	45.1	0.8	55.0	4.0	0.3	2.7	0.0	3.5	4.7	0.1	0.0	2.3	2.7	105.3	0.4	1.4	0.0	5.8	2.1	1.3	1.3	0.7	0.8	1.8	1.5	5.0	8.4	4.9	4.2	1.3	2.1	2.0	3.2	2.0	1.6	0.1	0.3	0.0	38.0	0.0	0.2	0.4	0.4	0.4	0.0	45.3	0.0	0.0	0.0	2.2	0.0	0.0	1.0	3125.2	311.3	2.0	4.0	0.0	0.0	5.4	0.0	0.1	0.9	0.0	3.4	1.3	0.0	7.5	0.2	0.1	3.3	4.0	0.0	38.7	0.6	0.3	3173.9	36.1	2.2	0.0	0.0	0.2	0.2	0.0	1.0	0.3	0.1	0.0	18.4	0.1	0.3	0.0	1.3	482.3	3.3	13.1	0.4	14.1	987.8	35.8	0.0	0.1	0.1	0.8	2.9	0.0	0.1
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.2;spinal cord: 3.7"	HPA021868	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	6.9	5.7	0.8	3.9	0.6	0.1	4.4	0.4	0.5	18.7	28.2	32.7	2.2	23.7	1.5	8.2	11.6	8.6	11.1	1.4	0.8	1.4	0.5	5.5	0.5	1.7	2.1	13.9	1.6	16.6	1.6	3.5	0.9	13.9	2.2	1.0	1.6	13.3	0.3	4.2	7.7	11.0	1.2	3.3	12.8	3.4	1.2	3.0	5.6	0.7	1.0	17.5	10.6	0.7	0.0	0.2	24.5	0.0	5.3	0.5	6.8	0.4	6.3	4.0	7.8	0.0	0.0	0.0	0.1	0.8	3.9	0.2	5.2	0.0	1.7	0.0	4.2	0.0	18.3	0.0	63.1	0.0	0.0	52.2	0.0	5.6	0.0	0.0	0.0	0.2	14.7	0.0	0.0	0.4	0.1	3.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.2	0.6	0.0	0.0	5.0	14.8	0.0	0.0	0.0	4.8	2.0	0.0	38.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.5	1.4	0.8	1.7	2.1	0.9	1.2	1.2	0.7	0.3	0.0	0.0	1.6	0.1	3.1	11.3	0.9	1.2	1.4	3.7	3.0	8.2	1.5	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.5	4.5	18.4	19.3	1.4	3.0	0.0	1.4	1.5	0.2	14.4	2.6	7.5	1.3	0.1	0.4	0.0	0.8	0.0	18.6	2.8	0.0	0.0	4.8	8.6	5.9	0.4	5.4	15.9	1.6	7.4	0.0	27.6	0.4	0.6	1.6	9.1	0.1	8.6	0.0	0.0	0.2	0.5	6.6	0.0	2.9	2.3	14.3	0.1	2.3	0.4	0.7	0.4	0.8	5.3
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
RORB	"NR1F2, ROR-BETA, RZRB"	ENSG00000198963	"RAR related orphan receptor B"	Q92753	9	74497335-74693177	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;retina: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 393.7;Endometrial stromal cells: 436.8;Excitatory neurons: 190.0;Horizontal cells: 1399.8;Muller glia cells: 390.7;Rod photoreceptor cells: 190.3"	"Group enriched"	"Detected in some"	5	"glioma: 2.1;prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 18.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 22.5;HSkMC: 12.4;JURKAT: 23.3;MOLT-4: 6.9;SH-SY5Y: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008393	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA008393: AB_1079830"	"unprognostic (6.89e-3)"	"unprognostic (4.06e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.81e-8)"	"unprognostic (5.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.00e-2)"	1.1	3.4	0.0	0.1	1.3	0.0	0.3	0.0	18.0	9.8	0.0	0.2	0.1	3.9	0.0	0.4	0.3	1.7	1.6	3.7	0.7	0.5	0.0	0.6	0.0	0.0	0.3	0.2	0.1	0.3	1.7	2.0	0.0	4.6	0.3	55.6	0.1	5.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.6	0.4	0.4	0.3	0.1	0.3	0.7	0.8	5.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	22.5	0.0	0.7	12.4	0.0	0.0	0.0	0.0	0.0	23.3	0.0	3.6	0.0	0.1	6.9	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.1	0.0	0.0	0.0	0.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	18.0	3.7	0.7	0.0	0.3	0.0	0.0	0.4	5.1	0.1	0.0	4.8	393.7	0.4	1.7	0.8	0.0	6.8	156.4	0.4	0.6	14.1	0.0	0.0	0.0	120.9	0.2	2.7	0.1	0.0	0.0	6.6	11.9	436.8	4.2	0.0	0.0	190.0	0.0	0.4	10.7	0.0	6.9	1.3	0.2	0.7	0.0	0.6	1399.8	6.4	0.0	0.0	0.3	2.1	1.9	0.0	1.8	1.8	10.3	0.1	390.7	1.0	12.5	28.6	0.1	0.0	0.0	0.8	2.8	0.0	8.9	0.7	190.3	0.0	8.7	9.9	3.0	0.7	1.4	0.4	0.1	3.0	0.3	0.1	0.9
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117287353-117425942	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"epididymis: 58.6;lung: 31.7"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 78.5"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 19.3;HSkMC: 10.1;hTCEpi: 21.7;LHCN-M2: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.4	0.0	0.0	58.6	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.1	31.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	2.2	0.4	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.1	21.7	0.2	1.9	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	0.0	3.1	1.7	0.2	2.1	0.0	0.0	0.0	1.9	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.0	78.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	1.8	0.2	0.0	0.0	0.0	17.8	0.0	0.0	0.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1 axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"retina: 236.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 333.6;Rod photoreceptor cells: 1115.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HDLM-2: 5.2;hTERT-RPE1: 2.0;RPTEC TERT1: 10.2;U-2197: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA042257	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.7	0.1	3.5	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	236.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.1	0.0	0.7	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.5	16.0	4.8	0.0	0.0	0.0	0.0	1.2	0.0	72.5	3.0	1.4	0.4	0.0	31.1	5.5	333.6	0.0	0.0	0.0	3.9	0.0	0.3	81.9	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	32.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	130.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	149.0	1115.8	0.0	0.0	0.4	3.2	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
RP1L1	DCDC4B	ENSG00000183638	"RP1 like 1"	Q8IWN7	8	10606349-10712187	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	114	"retina: 44.1"	"Group enriched"	"Detected in some"	20	"Cone photoreceptor cells: 93.8;Rod photoreceptor cells: 68.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024686, HPA024744"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA024686: AB_2671650, HPA024744: AB_2671668"	"unprognostic (3.27e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.08e-4)"	"unprognostic (8.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	44.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.6	0.8	0.1	0.0	4.0	0.2	0.3	0.8	0.0	0.0	0.0	93.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.5	0.6	0.1	0.0	0.4	0.0	0.7	0.0	0.1	0.0	68.0	0.0	1.6	0.5	0.0	0.5	0.0	0.9	0.0	0.1	0.1	0.0	1.0
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RP9	PAP-1	ENSG00000164610	"RP9 pre-mRNA splicing factor"	Q8TA86	7	33094797-33109404	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	12.6	15.0	26.3	8.7	26.1	21.6	12.6	28.0	51.2	17.0	26.7	16.7	9.0	14.4	15.5	10.1	14.0	6.2	29.2	25.8	26.3	17.2	13.8	12.0	15.6	26.6	26.3	16.2	20.2	10.5	10.3	10.2	26.7	14.4	9.8	16.7	11.5	11.7	36.3	13.8	15.9	8.4	25.8	20.8	13.5	18.1	26.9	13.8	16.0	34.3	16.7	14.3	13.1	27.4	20.9	28.8	29.7	34.1	18.5	17.2	14.3	26.4	21.6	28.9	23.0	25.6	14.6	26.2	17.0	21.1	35.4	20.4	36.4	22.0	36.8	11.9	25.1	19.2	22.8	24.4	32.4	26.0	13.0	17.5	20.2	32.8	64.5	23.3	24.0	27.1	35.2	23.0	29.1	42.6	27.7	69.6	25.4	27.2	21.9	28.2	26.4	17.1	21.1	19.3	28.7	39.5	18.7	39.6	46.2	35.1	20.8	35.0	19.4	28.4	40.9	25.6	42.8	38.1	37.2	51.7	20.0	36.3	56.1	21.9	12.0	21.6	15.2	9.8	14.1	57.8	16.3	17.4	13.2	77.3	19.1	18.0	2.0	15.7	12.5	28.4	15.8	8.8	26.3	26.1	28.0	51.2	25.8	26.3	26.6	26.3	26.7	25.8	26.9	27.4	21.3	12.8	10.1	4.9	35.6	21.0	15.1	11.3	29.0	15.8	17.7	27.9	41.7	17.2	10.9	14.7	14.6	20.2	16.8	12.6	21.5	16.0	5.6	14.6	28.2	24.1	10.2	19.4	6.5	15.8	20.0	20.4	20.4	16.6	3.8	26.8	15.4	16.4	18.4	8.4	7.5	19.3	24.4	10.1	14.9	3.2	18.0	12.0	23.2	5.6	10.1	21.9	21.6	3.0	8.7	14.6	8.0	16.1	24.4	22.9	16.1	18.6	8.5	16.4	26.3	19.4	30.3	31.6	54.3	24.4	18.0	10.4	19.9	22.9	18.4	12.0
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA		82000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	21.1	17.7	14.1	22.5	15.7	22.0	20.6	18.1	16.3	21.8	15.6	21.8	20.8	22.8	17.5	23.4	25.4	15.5	26.7	14.4	17.1	14.6	17.1	17.1	35.8	15.0	15.2	31.8	15.3	18.9	14.8	16.9	17.2	22.2	17.2	22.4	21.8	21.8	52.4	25.9	20.6	21.9	16.6	21.8	17.0	14.4	16.3	37.6	23.2	34.3	37.8	22.1	19.7	19.0	93.5	90.7	77.9	76.2	35.3	35.9	88.1	73.5	40.7	85.1	87.7	132.0	41.2	128.4	68.1	41.3	34.9	83.4	93.4	58.3	93.5	86.3	116.3	77.8	113.6	51.0	23.4	57.7	65.5	29.9	37.0	84.1	36.2	30.1	62.9	77.0	75.8	72.4	60.2	47.8	127.3	33.7	63.5	58.2	53.2	173.8	44.0	72.1	37.3	62.3	34.9	54.7	103.9	35.1	63.8	52.0	75.1	43.4	56.2	66.5	56.7	75.3	113.9	19.8	56.5	76.0	46.5	88.6	82.2	43.2	25.0	54.5	53.1	36.4	54.2	51.2	55.1	53.0	30.2	35.8	53.0	48.4	11.9	80.8	47.8	31.7	56.7	60.5	14.1	15.7	18.1	16.3	14.4	17.1	15.0	15.2	17.2	16.6	16.3	19.0	14.9	9.6	14.7	12.4	24.3	29.6	16.3	22.4	17.6	19.2	25.1	21.0	23.7	22.8	14.4	40.5	4.2	69.4	27.0	13.5	5.9	20.6	18.9	13.4	16.6	21.7	15.6	67.6	12.2	19.8	68.9	23.2	7.7	14.2	33.7	25.0	25.4	24.2	46.1	37.0	14.0	19.3	26.4	49.1	14.6	42.4	32.3	35.1	28.4	14.0	37.6	39.7	35.0	12.1	18.2	15.0	7.2	34.6	23.0	14.1	24.6	11.7	19.4	19.5	0.0	19.2	21.5	14.7	21.8	24.3	29.1	43.5	30.3	15.6	23.1	11.7
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPA3	REPA3	ENSG00000106399	"Replication protein A3"	P35244	7	7636518-7718607	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 428.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005708	Approved					NA	NA		17000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA005708: AB_1856411"	"unprognostic (2.06e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.20e-3)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.83e-2)"	16.4	25.7	12.4	22.9	14.4	46.2	24.4	14.3	19.7	12.5	19.9	25.2	15.8	10.5	37.1	19.6	25.5	10.6	20.5	12.3	15.7	35.7	40.5	14.6	37.9	13.9	13.1	12.7	15.4	46.4	27.2	16.4	15.3	11.5	19.9	34.1	14.5	13.6	18.7	13.3	18.4	9.6	14.7	23.4	20.8	22.5	13.8	51.8	19.3	12.5	35.6	16.3	12.5	15.7	174.1	95.9	94.8	102.3	35.2	31.9	67.2	47.6	44.3	73.0	116.2	92.3	153.1	88.4	45.2	36.0	235.9	129.2	64.5	85.9	106.4	41.1	112.0	48.1	111.9	189.2	15.3	102.5	38.9	23.4	29.9	85.0	59.6	36.0	41.9	168.6	119.5	132.6	70.8	257.0	83.9	198.1	149.9	104.9	125.1	98.3	154.9	141.6	52.3	84.0	70.5	86.8	88.2	91.6	51.0	137.9	122.0	107.4	19.3	60.5	169.1	99.8	113.7	102.7	199.9	167.7	89.7	119.3	118.5	17.9	25.3	27.2	34.1	40.8	40.9	75.4	55.7	44.0	31.9	76.9	45.6	46.3	22.2	29.7	49.0	61.6	68.5	35.7	12.4	14.4	14.3	19.7	12.3	15.7	13.9	13.1	15.3	14.7	13.8	15.7	35.6	38.5	39.5	2.9	93.2	40.5	65.0	160.8	41.5	24.1	54.7	73.9	39.0	60.1	89.5	71.7	10.4	152.2	53.2	61.9	273.9	84.8	96.9	144.8	34.9	35.7	25.3	218.2	5.2	105.4	257.5	43.3	39.8	61.8	53.9	43.2	36.0	154.5	131.4	16.8	5.6	75.1	83.4	48.7	54.2	24.4	39.1	49.9	56.9	1.9	68.2	63.7	56.7	6.0	5.8	64.1	70.4	24.5	75.8	25.9	74.3	428.6	269.9	44.7	6.6	34.7	46.9	112.7	65.9	59.6	34.4	66.2	68.7	46.1	90.5	66.2
RPA4	HSU24186	ENSG00000204086	"Replication protein A4"	Q13156	X	96883908-96885467	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 1.8;testis: 1.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.6;Syncytiotrophoblasts: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									HPA066010	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA066010: AB_2685596"	"unprognostic (6.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-6)"	"unprognostic (1.33e-1)"	"unprognostic (6.33e-2)"	"unprognostic (9.75e-4)"	"unprognostic (3.15e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.47e-12)"	"unprognostic (8.95e-3)"	"unprognostic (6.05e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.59e-2)"	0.4	0.1	0.3	0.0	0.5	0.2	0.2	0.0	0.4	0.5	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.7	0.0	0.7	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.7	0.6	0.1	0.3	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.5	0.3	0.0	0.5	0.7	0.4	0.2	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.4	0.3	0.3	0.0	0.3	0.5	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.2	3.3	0.0	3.3	0.0	0.7	0.8	0.3	0.7	0.6	0.3	0.4	0.5	0.1	2.8	0.8	0.0	0.0	4.6	1.6	2.1	0.0	0.8	1.1	0.9	1.5	2.0	3.6	0.0	0.0	0.6	1.1	1.3	2.6	1.7	0.0	3.4	0.4	1.9	1.9	0.0	0.0	2.5	4.1	2.2	1.1	1.0	1.5	2.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	1.4	2.9	1.5	0.3	0.4	1.1	0.1	0.1	1.6	6.6	3.5	1.0	20.6	6.7	1.1	1.3	9.9	0.8	1.1	1.7	0.2
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	18.1	24.5	38.4	14.7	38.6	21.0	27.8	38.5	52.6	17.5	38.0	18.7	15.9	18.8	27.1	17.1	22.2	16.7	33.2	38.8	39.7	23.3	28.6	16.0	22.2	38.6	38.3	20.9	20.9	20.8	21.7	16.5	39.3	18.7	20.1	24.4	17.1	15.8	51.1	17.1	13.6	18.4	38.5	15.4	21.1	15.1	39.0	35.9	16.8	38.0	22.3	19.6	11.4	39.7	31.5	65.5	65.1	57.0	50.2	35.8	32.0	31.9	54.9	59.8	55.3	39.9	13.9	37.7	41.9	19.4	47.3	35.5	75.1	27.6	52.2	38.3	71.1	30.4	38.0	54.0	60.6	33.2	57.6	31.7	53.5	38.7	77.6	73.6	53.2	117.1	31.7	20.9	33.9	25.1	78.8	65.9	39.4	42.7	34.0	40.3	44.7	32.7	51.2	35.1	40.9	82.6	27.3	23.7	76.0	50.8	31.9	45.3	26.8	20.2	28.0	18.5	62.7	21.7	35.5	34.7	30.8	39.8	34.4	40.9	37.3	59.2	31.6	33.4	39.3	75.3	43.5	40.4	34.2	57.3	53.2	46.0	6.4	36.1	32.1	55.6	62.4	32.4	38.4	38.6	38.5	52.6	38.8	39.7	38.6	38.3	39.3	38.5	39.0	39.7	58.0	70.5	61.7	22.9	67.2	63.2	78.4	120.4	76.2	47.9	79.6	97.3	38.2	57.2	91.7	40.5	52.1	77.8	65.1	50.3	103.7	72.1	92.1	103.7	68.6	48.6	110.2	65.6	32.7	57.6	46.5	53.8	55.0	129.3	62.0	99.3	47.8	39.8	56.0	47.1	31.2	49.8	134.3	48.1	47.1	18.2	70.8	43.4	48.0	24.4	58.9	80.9	48.4	32.6	40.7	75.2	58.8	71.8	33.0	86.9	42.1	82.0	89.2	62.1	72.3	71.2	65.1	100.4	34.1	59.2	74.9	59.7	62.4	71.9	67.0	98.9
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041739: AB_2677647"	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (4.30e-3)"	7.0	5.7	4.9	6.1	5.4	3.5	5.1	4.4	5.2	5.4	3.7	7.2	5.7	6.4	3.2	8.1	6.7	3.9	6.7	5.1	4.2	4.0	4.9	4.7	7.2	5.0	5.1	8.0	5.9	7.2	3.9	5.9	4.8	6.1	4.6	2.8	7.0	5.6	19.0	7.0	5.2	6.6	4.7	6.5	6.1	6.5	5.0	6.9	5.2	11.6	6.8	6.9	5.3	5.9	13.3	15.3	20.8	21.9	17.1	12.3	17.7	12.8	11.0	16.4	15.8	42.3	11.7	10.3	20.6	14.2	26.1	30.5	37.9	18.7	13.8	18.3	18.5	19.6	21.2	18.8	10.7	16.3	11.9	12.6	23.3	19.2	13.3	11.0	18.4	23.1	46.4	11.5	15.2	8.3	17.6	10.0	36.9	20.3	14.3	31.4	18.0	11.2	7.2	30.5	19.0	25.4	16.4	16.9	8.8	18.0	28.1	20.0	16.9	25.3	16.4	25.5	20.6	19.2	57.5	11.6	18.1	17.4	24.4	0.0	1.9	0.0	4.6	2.4	4.0	2.9	2.6	2.8	2.9	3.3	3.7	3.4	0.0	3.1	4.4	1.9	3.1	2.5	4.9	5.4	4.4	5.2	5.1	4.2	5.0	5.1	4.8	4.7	5.0	5.9	4.1	3.2	5.4	10.4	7.7	2.8	4.4	4.6	8.6	10.2	5.1	5.2	9.0	2.8	4.7	5.5	12.5	6.5	6.1	3.9	1.9	5.5	1.5	3.7	6.5	5.8	2.4	11.2	7.7	5.3	5.8	6.1	8.6	5.2	2.5	11.9	5.0	9.6	4.8	16.8	6.7	5.6	6.1	5.2	2.8	1.7	3.7	3.5	1.8	6.5	6.0	5.0	5.2	7.5	9.3	5.3	2.7	9.4	4.4	6.7	4.1	3.0	5.2	7.4	0.0	6.5	4.6	10.6	9.5	6.1	4.1	2.7	7.0	10.8	7.5	3.1
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92299059-92402056	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	1.4	1.9	3.2	2.2	4.1	3.9	2.2	12.6	8.7	1.6	0.3	1.4	1.8	2.1	3.2	1.3	1.4	1.5	1.6	3.3	0.9	2.2	3.0	1.4	2.6	1.2	0.2	2.1	2.5	2.0	1.7	1.5	1.8	2.1	1.6	9.3	2.1	1.3	3.0	3.2	1.7	1.5	0.2	2.3	1.8	2.0	1.8	2.8	2.7	2.3	1.9	1.4	1.1	8.4	4.0	2.3	4.1	3.8	3.3	4.2	3.4	3.0	2.1	2.0	1.6	1.7	1.7	5.9	5.1	2.3	2.7	2.7	3.4	1.9	3.0	4.0	2.4	3.5	4.6	2.3	1.9	6.3	3.4	2.1	2.4	2.5	2.5	2.9	2.1	3.6	3.7	3.7	3.0	2.0	5.4	3.9	3.1	2.2	2.7	3.9	5.4	2.5	2.6	3.4	3.8	2.7	4.4	4.5	2.5	3.0	2.3	4.7	3.6	2.8	3.7	3.3	4.4	3.7	4.5	3.0	2.0	3.9	1.9	1.9	0.7	0.6	1.3	0.5	1.5	1.1	1.0	1.1	0.6	1.3	1.0	1.2	1.4	1.3	0.7	1.1	1.0	0.4	3.2	4.1	12.6	8.7	3.3	0.9	1.2	0.2	1.8	0.2	1.8	8.4	23.1	64.1	78.5	66.9	20.1	9.2	16.7	15.7	23.9	63.6	16.3	16.5	24.7	10.0	44.5	7.3	110.5	21.3	31.5	6.4	11.7	19.2	68.1	18.8	48.6	23.4	12.6	13.3	97.1	13.6	14.2	24.8	13.3	17.6	62.0	37.7	9.3	8.0	9.7	35.3	91.3	13.3	14.2	8.7	4.6	9.7	19.0	15.6	1.8	43.1	16.6	31.4	42.2	68.3	78.8	13.8	13.6	21.4	28.5	15.9	11.9	15.6	45.0	95.2	26.3	44.4	20.3	27.3	20.0	16.8	9.8	23.7	35.8	42.3	12.1	10.4
RPAP3	"FLJ21908, hSpagh, spag, Tah1"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	10.0	10.6	6.1	19.1	6.0	12.7	15.8	8.4	7.1	12.7	6.5	12.5	13.8	13.9	14.6	13.6	14.6	12.1	16.2	5.7	7.6	13.0	15.4	10.2	29.6	6.2	8.6	19.4	8.5	17.3	8.2	13.1	7.8	12.9	12.8	11.1	9.7	12.5	22.8	11.2	12.6	15.4	6.4	17.4	11.0	15.8	7.9	23.5	13.8	23.7	29.2	16.9	9.2	7.8	42.6	39.1	46.5	32.1	24.5	34.7	39.2	41.4	42.5	51.4	43.8	54.5	47.2	93.9	55.6	37.0	37.0	41.5	40.7	24.6	59.5	50.2	38.0	63.3	25.1	26.6	21.1	68.0	42.4	17.1	29.6	60.2	21.7	41.7	32.6	36.2	70.6	28.0	45.9	30.5	58.7	48.9	49.9	39.1	33.2	46.9	56.1	46.0	41.9	38.3	33.5	24.3	48.5	39.4	41.9	49.0	40.5	40.4	23.5	35.4	47.0	39.3	46.5	21.8	43.7	66.5	33.3	148.5	22.3	3.7	10.6	32.9	10.2	20.5	10.5	20.9	11.5	11.1	14.3	17.9	14.5	13.3	19.7	13.3	25.8	9.9	15.7	9.0	6.1	6.0	8.4	7.1	5.7	7.6	6.2	8.6	7.8	6.4	7.9	7.8	16.8	12.8	17.6	11.4	30.0	13.3	14.8	20.3	24.5	18.1	18.3	19.3	41.7	11.5	21.2	11.0	8.4	23.4	33.7	7.3	23.5	17.3	9.5	51.3	23.4	13.8	13.1	18.3	15.3	19.7	16.3	21.0	15.3	26.9	12.0	22.5	8.6	18.0	18.3	11.8	12.7	12.2	14.2	19.2	16.9	7.1	21.8	24.9	7.2	14.0	44.0	13.4	25.7	16.1	16.8	11.7	16.8	20.7	31.0	7.5	9.6	30.2	30.1	14.8	6.6	16.8	18.2	48.0	37.1	22.7	10.2	17.0	21.3	18.0	14.6	9.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	21.9	27.6	15.9	20.1	20.0	19.4	25.4	18.3	21.7	19.7	11.9	24.0	21.8	22.6	22.3	29.1	21.0	19.8	14.5	16.2	14.7	30.0	27.4	17.9	25.1	11.0	13.3	25.4	15.1	21.0	17.2	29.4	12.8	22.5	31.8	17.8	20.6	31.1	11.0	19.7	19.8	29.3	14.6	19.2	24.2	15.3	16.5	22.9	29.5	27.4	29.4	27.4	17.4	23.1	62.4	81.0	47.5	47.9	71.3	68.0	85.4	80.2	60.9	67.9	93.1	118.7	92.1	39.9	50.6	58.8	104.1	59.9	69.7	81.9	103.3	49.7	47.8	78.2	112.3	112.3	98.8	80.7	56.1	51.7	75.4	83.2	107.5	60.2	94.8	39.1	79.7	57.2	55.5	106.7	43.5	63.5	68.2	121.4	59.8	52.4	58.4	56.7	78.6	94.7	56.6	31.4	70.2	63.7	52.3	85.6	54.4	85.2	80.0	96.7	66.9	47.5	73.8	31.9	49.5	88.6	69.6	76.0	62.5	20.2	40.2	19.1	23.1	51.0	19.8	20.2	17.7	21.7	69.5	21.6	23.4	21.0	3.7	77.2	34.8	25.4	26.7	28.8	15.9	20.0	18.3	21.7	16.2	14.7	11.0	13.3	12.8	14.6	16.5	23.1	14.9	6.4	7.5	14.4	13.1	16.6	15.2	21.6	13.1	13.2	13.2	10.3	6.2	10.0	20.1	18.4	20.9	35.4	18.1	14.0	31.3	24.5	10.7	13.5	17.4	14.3	10.2	17.2	61.9	17.5	42.8	17.4	14.3	11.2	6.3	18.1	18.2	17.5	37.0	10.1	44.7	14.6	14.2	19.4	45.8	11.8	11.1	17.2	14.2	15.0	19.7	8.9	26.8	27.2	39.2	19.4	11.6	14.7	12.2	19.9	14.2	48.6	15.9	12.7	6.6	11.1	16.1	14.7	17.4	20.1	20.3	25.6	10.5	24.8	21.3	14.8
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA						"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	3.1	0.0	0.0	1.9	0.0	0.7	0.0	8.4	0.3	1.3	0.5	0.0	0.5	0.1	0.1	0.0	0.3	1.8	0.0	0.6	0.2	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.5	2.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.2	4.4	0.0	0.0	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.7	0.0
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84498352	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	24.4	21.6	13.7	19.0	17.4	44.9	24.7	14.7	19.4	23.5	15.8	28.1	17.7	26.0	23.0	27.0	23.2	14.1	34.2	13.5	15.4	28.0	26.1	20.5	26.8	13.7	14.0	20.7	22.8	18.8	21.0	14.9	13.8	20.8	20.9	16.8	21.9	15.5	42.7	26.1	23.2	18.1	13.4	26.2	25.6	25.3	13.9	29.4	23.3	23.9	28.1	24.9	23.3	14.8	43.1	29.2	36.6	30.2	27.1	35.5	40.5	46.8	36.5	53.2	47.0	21.4	17.6	31.9	50.1	33.9	89.0	31.7	54.3	43.2	57.7	51.0	57.6	85.2	30.7	37.8	37.2	80.0	25.4	29.0	63.0	56.0	39.2	30.7	42.6	60.7	79.9	40.7	46.9	21.8	76.3	53.0	91.5	43.0	62.5	48.3	58.5	25.7	51.3	47.6	45.2	42.2	27.7	52.7	107.3	32.8	29.6	53.4	30.3	40.1	41.3	64.8	90.4	29.5	39.0	73.0	19.2	71.0	37.0	64.0	35.2	34.6	41.4	41.0	45.4	65.4	46.0	42.0	37.4	58.6	51.3	50.7	14.7	52.6	46.3	39.5	52.9	47.4	13.7	17.4	14.7	19.4	13.5	15.4	13.7	14.0	13.8	13.4	13.9	14.8	28.2	38.5	39.5	7.2	35.8	34.7	41.5	71.6	12.0	15.7	20.4	19.6	39.3	30.0	43.0	16.5	16.7	35.5	51.7	18.0	74.3	60.3	72.7	34.9	27.6	35.0	33.5	17.2	10.1	64.1	33.1	25.0	16.8	26.5	65.2	18.6	28.9	36.6	44.0	8.4	9.8	29.6	28.5	31.7	30.2	13.2	32.6	28.4	28.4	9.4	37.0	30.1	60.8	8.5	10.4	53.0	23.6	35.0	16.2	26.8	21.7	67.4	53.8	25.6	46.0	23.4	43.3	94.7	63.7	18.0	32.7	27.5	40.3	21.4	36.0	39.7
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327544	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA001593: AB_1079835, HPA073455: AB_2686603"	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	19.2	5.7	4.7	4.4	4.6	12.2	16.8	5.2	5.5	10.2	15.5	9.1	3.0	11.6	2.5	5.5	15.0	5.5	9.8	4.6	6.3	6.2	3.7	14.8	3.7	7.6	7.0	6.2	7.5	2.6	32.9	3.7	5.8	6.9	3.6	12.1	5.2	2.6	12.1	6.0	9.4	4.5	6.6	5.1	6.8	8.1	5.3	4.7	9.7	3.7	3.2	8.7	8.2	5.4	4.7	6.0	3.4	3.2	3.6	5.2	2.7	5.8	6.5	4.1	4.8	2.7	2.6	7.1	1.8	3.9	3.4	4.4	4.1	1.8	5.6	7.5	7.9	2.5	2.7	5.5	3.3	31.8	5.8	8.0	2.4	8.7	9.2	1.6	18.9	7.5	3.3	0.0	5.7	1.5	9.1	17.7	8.7	2.9	7.5	6.8	11.7	6.4	3.6	3.0	2.7	5.2	6.4	2.6	7.2	5.1	1.7	5.4	22.4	4.5	8.0	10.7	7.2	1.9	3.9	6.0	10.6	6.1	6.2	1.3	2.6	5.9	1.3	2.4	2.9	1.9	1.5	1.8	2.6	1.5	2.2	1.8	14.6	1.7	2.0	1.8	1.9	1.8	4.7	4.6	5.2	5.5	4.6	6.3	7.6	7.0	5.8	6.6	5.3	5.4	75.2	16.0	32.6	21.2	21.8	7.9	13.5	6.6	7.4	29.5	8.8	8.8	8.0	8.6	18.0	1.8	62.6	5.8	14.0	12.6	3.9	15.3	51.4	146.1	30.4	61.3	17.4	5.5	21.8	8.6	9.5	11.8	9.2	21.0	20.3	73.5	121.7	9.7	7.8	35.3	20.0	13.5	10.2	16.2	8.4	9.1	7.8	14.5	5.4	18.7	15.5	9.4	14.4	9.0	17.1	9.9	8.9	4.5	11.0	10.2	5.0	3.1	119.2	85.7	0.0	23.1	12.9	24.9	25.3	4.8	5.8	8.2	17.2	6.6	8.9	11.2
RPGRIP1	"CORD13, LCA6, RGI1, RPGRIP"	ENSG00000092200	"RPGR interacting protein 1"	Q96KN7	14	21280083-21351301	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Cone-rod dystrophy, Disease variant, Glaucoma, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	80	"retina: 185.3;testis: 59.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 231.4;Early spermatids: 177.3;Late spermatids: 108.9;Rod photoreceptor cells: 117.5;Spermatocytes: 51.7"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.3;granulocytes: 8.8;monocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"RT4: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042955, HPA060190"	Supported	Supported				NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042955: AB_2678239, HPA060190: AB_2684218"	"unprognostic (9.02e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.83e-2)"	0.2	0.1	0.5	0.7	0.3	1.2	0.6	0.8	0.6	0.3	0.4	0.5	0.9	0.2	0.0	0.2	0.1	0.3	0.2	0.4	0.3	0.2	0.8	0.5	0.5	0.4	0.2	0.1	0.1	0.2	0.1	1.2	0.6	0.4	0.6	185.3	0.1	0.1	0.1	0.5	0.8	0.0	0.1	1.5	0.2	59.6	0.5	0.1	0.3	0.2	0.3	0.5	0.1	0.3	0.3	0.8	0.8	0.4	0.0	0.0	1.1	0.3	0.0	0.0	0.4	0.5	0.5	1.1	0.2	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.5	0.4	0.8	0.2	0.0	0.9	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.7	0.1	0.0	0.3	0.3	0.5	1.2	0.5	0.3	0.4	0.7	0.9	0.0	3.8	0.6	0.5	0.7	0.8	0.2	0.6	0.3	0.5	0.3	0.2	0.2	0.8	0.6	0.9	0.9	1.0	0.4	0.6	0.2	0.7	3.7	0.0	0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.1	0.1	0.0	8.8	0.3	0.0	0.0	0.0	1.0	0.5	0.3	0.8	0.6	0.4	0.3	0.4	0.2	0.6	0.1	0.5	0.3	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.3	1.0	0.0	0.0	0.0	231.4	0.9	0.0	0.0	0.0	0.0	177.3	0.1	0.1	0.6	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.9	0.0	1.2	0.0	0.0	2.7	0.9	108.9	1.8	0.8	0.0	1.0	0.5	4.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	117.5	0.0	0.1	0.1	51.7	2.2	0.0	0.1	1.5	0.1	0.1	0.0	0.1
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 40.5;Excitatory neurons: 59.8;Respiratory ciliated cells: 85.9;Spermatocytes: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: AB_2677023"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	1.6	3.5	2.3	2.1	2.2	1.5	3.2	1.0	5.2	3.1	9.5	1.7	1.3	3.8	3.7	2.2	6.8	2.7	1.9	2.7	3.0	3.0	1.1	1.9	1.8	2.4	3.2	3.5	2.0	7.6	6.0	2.1	1.9	2.9	1.7	2.9	1.7	2.8	1.0	1.9	0.9	3.5	1.0	0.9	1.9	13.5	3.5	2.6	4.6	1.4	1.8	2.2	1.8	3.2	11.8	13.7	11.6	10.7	13.9	13.3	5.6	12.7	7.9	9.8	2.7	7.1	9.5	7.5	8.5	11.1	7.8	12.5	9.4	11.6	19.1	4.6	7.2	2.8	12.1	7.5	6.0	6.7	5.0	8.1	6.9	11.4	6.9	11.4	8.9	10.0	7.2	4.3	14.8	4.5	11.2	4.7	7.4	3.7	6.3	19.3	15.9	9.4	14.0	3.1	19.9	7.5	14.3	6.4	5.3	6.7	10.0	5.7	7.8	12.2	8.6	9.7	11.0	5.4	6.9	13.1	18.9	3.9	7.3	0.7	0.2	0.3	1.2	0.3	1.2	1.1	0.8	1.0	0.2	1.5	0.8	1.8	0.6	0.8	0.3	0.7	0.7	0.4	2.3	2.2	1.0	5.2	2.7	3.0	2.4	3.2	1.9	1.0	3.5	3.2	3.1	6.4	4.8	15.7	2.9	4.6	2.8	11.1	4.6	5.5	6.9	8.0	9.8	1.5	15.1	11.0	8.4	5.5	1.5	1.3	17.6	7.4	21.5	40.5	20.7	3.9	0.0	3.0	59.8	3.3	7.4	12.9	5.1	8.6	7.0	12.9	2.5	3.8	2.9	3.3	36.6	5.6	4.1	1.2	3.1	12.0	4.7	1.9	1.8	9.4	1.8	6.3	2.1	14.1	8.6	3.3	0.5	6.4	2.1	1.7	0.2	19.8	85.9	8.7	6.6	7.8	9.7	43.2	11.2	4.7	5.4	1.6	2.7	11.5	4.4	2.4
RPH3A	"exophilin-1, KIAA0985, rabphilin"	ENSG00000089169	"Rabphilin 3A"	Q9Y2J0	12	112570380-112898881	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.5;Excitatory neurons: 71.6;Inhibitory neurons: 100.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 7.4;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002475	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002475: AB_1079837"	"unprognostic (5.50e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.46e-2)"	0.5	3.6	15.0	1.5	23.9	20.7	0.8	23.8	85.5	0.3	0.0	0.8	1.0	1.3	2.4	0.9	0.6	1.9	0.6	16.8	14.4	0.6	0.8	0.5	3.4	27.2	24.0	0.8	2.4	0.2	0.4	1.3	7.7	0.7	1.2	9.7	0.9	0.4	0.6	2.1	1.1	1.3	17.3	1.8	0.6	1.4	50.1	0.6	1.1	0.4	1.9	0.8	0.2	46.0	0.7	0.3	0.7	1.2	0.3	0.5	2.0	0.0	0.4	0.5	0.1	0.6	1.0	1.1	0.3	0.0	0.6	2.0	0.3	0.5	0.9	0.4	1.4	1.9	3.2	2.1	0.4	1.1	1.8	0.6	0.2	1.3	1.0	0.7	0.0	0.3	0.1	2.7	1.8	0.7	0.6	1.5	1.1	0.2	1.1	0.0	0.9	7.4	0.0	1.5	0.9	16.5	0.2	0.1	0.1	1.6	0.7	0.1	0.1	1.6	1.2	1.5	0.9	1.2	0.3	1.1	1.0	0.8	0.4	1.2	6.3	0.2	0.2	3.0	0.1	0.3	0.1	0.2	0.6	0.8	0.2	0.3	2.3	0.5	4.6	0.2	0.0	1.8	15.0	23.9	23.8	85.5	16.8	14.4	27.2	24.0	7.7	17.3	50.1	46.0	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.0	24.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.2	0.0	0.0	71.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.6	0.0	0.0	1.2	0.0	7.2	0.0	3.2	0.0	2.8	5.8	1.2	0.0	12.5	3.8	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPH3AL	Noc2	ENSG00000181031	"Rabphilin 3A like (without C2 domains)"	Q9UNE2	17	212389-386254	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 52.5;pituitary gland: 44.4"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 35.2;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.1;PC-3: 7.2;TIME: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024311	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA024311: AB_1856429"	"unprognostic (4.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.43e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (1.03e-8)"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.59e-3)"	10.0	18.5	1.3	1.0	1.4	0.3	9.5	3.6	1.7	4.8	1.5	6.9	5.2	3.0	4.6	8.1	3.9	2.8	6.2	1.2	2.3	13.5	24.2	9.5	1.2	4.5	2.2	10.8	52.5	1.6	44.4	2.5	4.5	5.5	2.6	2.0	3.4	2.2	8.3	5.0	6.5	1.0	1.4	17.7	9.1	2.8	2.1	1.4	12.0	1.5	1.5	5.3	6.0	1.9	0.3	22.1	0.3	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	3.0	3.8	0.4	3.1	2.2	1.4	0.3	0.8	0.2	0.0	0.9	1.4	0.0	1.8	5.2	0.6	0.2	2.2	0.0	0.1	0.0	0.0	0.7	0.9	2.3	1.5	4.5	1.3	5.4	0.3	0.1	1.2	2.6	7.2	0.4	0.2	4.0	4.0	4.9	0.3	0.7	0.3	0.1	0.3	1.3	2.0	2.1	7.2	0.3	2.9	0.5	0.6	0.7	0.2	0.2	0.3	3.0	0.0	0.3	0.7	1.5	0.8	2.2	0.3	0.6	0.4	0.6	1.1	0.6	0.7	0.4	1.6	0.3	1.8	2.8	0.3	0.3	1.3	1.4	3.6	1.7	1.2	2.3	4.5	2.2	4.5	1.4	2.1	1.9	21.8	22.4	17.0	1.3	2.0	2.4	13.4	9.7	5.2	1.5	8.8	6.5	2.3	17.2	5.2	22.0	0.0	0.2	7.8	13.2	5.9	10.3	3.6	7.7	7.8	15.9	35.2	2.7	4.6	8.7	0.3	3.4	23.4	4.9	7.0	14.3	28.2	43.3	11.6	11.8	6.2	14.2	12.2	7.0	2.9	4.0	5.3	2.9	3.6	12.2	2.0	26.4	3.1	6.0	1.3	7.7	12.9	1.9	0.9	3.9	9.3	5.9	2.1	1.9	6.6	6.1	3.4	3.4	1.8	6.9	3.1	0.4	1.7	7.6	10.8	9.4
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		520000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	3787.4	2419.1	1394.0	2169.7	1436.7	4648.6	4838.0	1413.7	1627.7	4522.8	1418.2	3090.4	1960.7	3234.2	2327.8	3175.9	4434.1	1996.7	2795.8	1340.4	1450.2	2318.6	2457.5	2593.7	4447.8	1490.4	1395.4	7892.2	8248.7	1574.9	1262.1	1879.3	1495.2	2998.1	2852.0	605.3	3991.5	2220.8	4760.6	4580.4	2644.6	2899.6	1535.3	3002.5	3262.2	372.8	1456.6	3691.0	2499.0	3882.7	5285.1	3395.7	3633.5	1537.6	5771.5	2604.6	2556.3	1973.1	5665.6	10627.4	2257.6	2147.4	4944.5	4036.4	5092.8	2323.7	2507.2	11250.6	5101.5	3609.5	4017.7	2175.5	5072.8	5166.9	3441.7	2507.6	4032.6	1534.4	1719.4	2591.8	6623.5	3314.4	2163.5	8104.7	8023.2	2435.8	7540.7	6953.8	6482.3	4734.1	2197.3	3482.7	4027.7	2869.8	3643.7	3212.1	2023.6	5617.9	4482.1	4301.7	2425.2	6334.8	4477.5	2015.0	2043.5	3397.3	526.0	4516.0	6630.0	2442.8	1643.7	4541.0	3144.3	1405.7	2655.1	3210.9	4865.5	8226.6	6458.7	11466.6	2139.0	4722.1	1803.6	2544.3	4388.3	622.1	4542.5	3596.8	7775.4	8121.0	7534.8	5653.3	4873.3	7698.6	8993.4	6990.0	410.0	5161.3	3275.5	5417.4	5907.4	18184.4	1394.0	1436.7	1413.7	1627.7	1340.4	1450.2	1490.4	1395.4	1495.2	1535.3	1456.6	1537.6	5788.7	1791.6	2556.0	46.7	10527.8	12070.0	13158.5	11320.6	8610.2	480.8	13969.8	18711.5	332.5	4499.5	4867.7	2039.7	248.1	6871.3	8329.8	1997.2	6751.9	4614.2	76.2	2214.5	6544.8	5970.8	2893.6	4044.6	45.3	13505.4	10754.4	5761.0	3039.8	3854.9	2982.2	5292.3	6493.4	4196.6	7070.4	269.2	50.7	6837.3	3196.2	8756.2	13887.5	284.8	8462.7	6722.9	8167.8	49.6	10601.8	1879.6	6844.6	56.3	89.0	7721.0	5174.6	3567.3	7282.8	12796.7	5976.0	8673.5	1751.3	859.1	2991.1	7996.0	6645.8	94.6	354.5	9576.3	14556.9	7562.7	9597.3	5236.0	6657.3	13414.3
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468401-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		740000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	1323.4	939.9	613.7	824.8	622.4	2051.4	2092.0	591.3	764.2	1803.2	604.3	1445.1	776.4	1350.0	1255.9	1583.0	1911.2	720.6	845.6	594.7	625.1	957.2	840.9	835.2	1625.6	619.7	603.1	3180.4	1894.4	682.3	731.1	747.7	627.8	1322.3	1178.3	255.2	1271.7	1007.2	1411.5	2166.4	1075.0	1114.2	654.0	1063.9	1188.8	230.5	628.8	1585.0	1084.1	1009.5	1733.0	1434.0	1506.3	642.7	1205.5	1211.3	1349.6	1275.9	1967.9	3560.6	1522.8	1213.7	2475.5	1671.2	1320.9	1765.5	1126.2	3571.4	1089.8	1650.2	819.4	1036.0	1832.7	2764.1	1374.0	1249.1	1618.0	1375.9	1007.0	2501.0	2909.6	2031.3	1096.1	4179.2	3172.8	1225.0	4066.4	2689.3	2481.9	1760.1	1652.9	1712.2	1920.0	2112.5	2158.4	2452.2	1421.3	1879.5	1057.5	1681.9	1298.7	2801.6	2124.0	1949.5	945.6	1384.7	747.8	1688.0	3632.5	1076.1	1831.0	3628.9	1450.9	541.4	975.4	729.4	1559.5	1073.4	1889.4	2381.8	681.1	2322.7	992.7	215.5	1232.7	120.6	1478.3	1210.1	2629.7	3176.9	2436.2	1905.6	1990.0	2806.5	3252.5	2601.9	113.1	2069.4	1077.8	1875.3	2059.9	5496.8	613.7	622.4	591.3	764.2	594.7	625.1	619.7	603.1	627.8	654.0	628.8	642.7	973.2	535.2	1036.5	19.2	3101.2	5399.7	5910.9	3550.3	2636.7	221.4	4627.1	4144.2	270.8	1742.9	1828.0	597.7	73.0	4048.8	1980.0	867.3	2983.7	1701.7	243.5	992.0	2446.8	1604.3	1512.3	1533.0	23.1	3272.4	5396.6	1667.3	884.8	1150.5	917.2	2228.2	1601.0	1519.3	2201.2	109.4	23.8	2834.0	1084.4	1989.9	3307.5	430.7	2517.0	1457.1	2406.5	17.8	2486.8	530.4	1845.5	31.7	32.4	2092.1	2269.8	1479.8	1382.6	4479.8	1447.6	2791.4	790.8	252.3	769.2	3139.6	1955.7	236.4	357.1	3510.2	6623.0	4105.6	2341.0	2848.1	3482.8	5438.5
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651781	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 92.0"	"Group enriched"	"Detected in some"	17	"Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"U-2 OS: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	41.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	10.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	581.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.3	19.2	224.4	6.2	0.9	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	6.6	0.1	0.1	0.1	0.0	6.6	2.9	20.8	310.1	14.7	0.0	18.8	0.3	2.4	0.2	2.0	4.3
RPL11	"L11, uL5"	ENSG00000142676	"Ribosomal protein L11"	P62913	1	23691742-23696835	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA002734	Approved					NA	NA		420000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 32: Non-specific - Translation"			"HPA002734: AB_1079838"	"prognostic favorable (2.55e-4)"	"unprognostic (3.98e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.70e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (5.93e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.90e-1)"	2197.5	1349.1	758.6	346.3	785.5	806.8	2374.3	764.5	1074.4	2495.3	749.2	1713.2	317.9	1551.7	1107.6	2043.6	1984.4	265.0	1422.6	736.6	795.9	1543.3	1447.9	1462.7	701.7	809.3	768.6	3879.7	3207.9	637.6	1144.7	507.5	800.5	1788.9	985.9	386.7	1763.2	645.4	1526.0	2752.4	1715.1	689.7	795.4	1949.2	2314.0	460.2	781.0	1219.1	1414.8	880.4	1842.1	1717.0	2090.6	813.7	662.3	1068.4	1257.9	639.1	2123.4	2978.6	437.2	431.4	1845.0	1641.4	1217.1	1937.6	719.7	1370.3	470.9	1511.4	665.7	543.3	1611.2	2187.0	1824.5	492.7	2157.9	633.6	3936.3	2610.9	1589.8	1086.5	499.1	2928.6	3156.8	1394.3	2498.9	2009.5	1767.1	2371.5	747.4	713.2	1768.6	2068.0	650.7	1737.1	313.0	2165.7	1216.9	800.7	608.8	1319.0	1877.2	1173.3	491.0	601.2	337.3	697.8	1360.9	1083.0	514.3	1352.0	524.4	391.2	546.3	672.8	554.2	658.6	643.2	968.8	499.0	1529.0	458.4	1028.5	1455.4	431.6	1270.6	1217.3	2184.9	3261.3	2593.8	1881.3	1736.4	2812.9	3379.5	2575.7	211.5	1567.3	990.9	1725.9	2092.7	5471.7	758.6	785.5	764.5	1074.4	736.6	795.9	809.3	768.6	800.5	795.4	781.0	813.7	3418.4	1179.5	2275.5	43.8	6392.9	6628.5	7570.4	5085.6	5306.4	352.5	7418.2	12717.3	617.0	3247.0	2566.9	1125.5	154.3	4728.5	4068.6	1693.1	4807.1	2915.5	1052.2	1501.4	3771.6	3056.2	2161.7	2833.3	27.2	6657.0	7929.6	2968.4	2193.7	2008.2	2101.5	4064.4	3524.6	3426.2	3894.7	206.9	29.6	3865.1	1462.8	4584.6	6984.2	2224.6	4602.4	3661.8	3758.4	46.9	5264.1	1582.9	3300.8	24.1	64.1	4149.5	3575.9	2083.0	3334.0	6327.0	4545.4	5429.1	1260.7	664.2	1413.4	3920.1	3380.5	604.1	699.6	6295.1	7993.4	4651.9	5029.1	4961.7	4420.7	7534.5
RPL12	L12	ENSG00000197958	"Ribosomal protein L12"	P30050	9	127447674-127451406	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 16277.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003403	Approved		Approved	"Golgi apparatus"		NA	NA		710000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"		"HPA003403: AB_1856432"	"unprognostic (5.89e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (4.98e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.80e-2)"	1951.8	1231.3	835.3	1038.0	851.8	2761.0	2915.7	839.5	1071.0	1971.7	849.8	1701.0	1014.9	1367.8	2197.8	1898.6	2181.0	1058.6	1075.1	814.9	877.7	1217.9	1183.9	1195.7	2118.1	883.8	861.1	3020.6	2703.8	700.7	888.2	879.2	891.8	1637.0	1384.7	360.7	1784.8	997.7	2166.7	2609.6	1237.2	1202.9	884.9	1349.8	1401.3	339.2	851.4	1696.8	1423.5	1318.1	2422.7	1851.7	1787.9	901.5	1511.6	1359.5	1474.8	2976.3	2773.6	6171.2	2266.6	1317.9	3562.5	2315.3	1802.2	2949.5	1529.4	2855.4	1745.3	2256.0	1161.2	1774.7	1887.1	3068.4	1578.4	1451.5	1731.1	1678.1	1705.9	2724.4	5881.5	2596.8	1735.1	6766.3	6013.6	1628.4	6142.1	4589.1	3178.6	1755.1	2307.8	2371.9	2920.2	5170.1	2464.7	3988.0	2166.2	4448.6	2519.6	2073.6	2828.6	3141.2	3458.6	1497.1	1295.6	1882.9	989.8	3291.6	4287.8	1727.6	2707.1	3536.1	1796.2	866.3	1546.2	1504.9	2645.1	1223.5	1630.1	2951.4	901.8	2447.8	1351.3	354.9	961.6	274.4	997.8	982.9	1845.3	2714.4	1857.1	1366.2	1536.6	2602.0	2177.6	1891.8	114.3	1265.6	973.6	1398.4	1772.9	3151.7	835.3	851.8	839.5	1071.0	814.9	877.7	883.8	861.1	891.8	884.9	851.4	901.5	2021.8	695.5	1593.2	9.1	5219.3	6047.5	4680.5	5696.6	6688.2	186.4	9458.0	16277.6	445.0	2522.1	2427.5	1272.7	85.5	3455.7	2702.3	1424.3	4073.5	2502.6	320.6	1210.9	3910.1	2415.0	2095.3	2939.8	7.4	7126.9	5794.1	2409.3	2320.1	1688.1	1876.4	1940.1	3301.1	2861.4	3348.2	95.9	7.5	4283.6	1810.7	5716.7	5579.1	839.4	5405.5	2945.4	3601.9	13.1	4509.5	782.7	2582.9	5.5	13.4	4166.6	2911.7	2389.9	2741.9	4582.4	3159.4	6003.0	879.7	309.3	986.1	3458.1	2319.6	334.8	584.2	7183.3	6963.2	3724.4	3677.5	3289.4	4446.0	4896.3
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560677-89564542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	2508.9	1855.2	1068.8	1015.2	1070.1	2207.4	2514.6	1007.8	1300.0	2885.7	1027.9	2382.3	1082.7	1830.7	799.8	2804.1	2342.7	756.7	1661.7	984.6	1007.1	1722.4	2142.4	1560.6	2106.2	1129.1	1023.0	5001.9	4316.1	896.0	1581.0	636.9	1076.3	2852.9	719.0	215.3	2413.8	826.7	2404.7	4466.0	2067.4	689.9	1159.2	2545.7	2148.6	856.8	1078.9	1718.3	1609.7	1175.1	1635.1	2301.1	2682.5	1123.0	1402.1	1524.2	1063.0	1733.2	1869.8	3083.4	2218.9	863.7	1857.6	1768.8	712.9	2316.0	2113.8	1954.1	1729.3	1484.1	700.0	1903.0	1279.4	2281.5	873.2	551.7	3534.0	666.7	817.4	3149.0	3985.0	818.9	781.2	3770.4	4759.6	1136.6	2847.0	2870.3	1870.2	2424.6	2074.1	1084.5	1380.2	4385.7	2272.4	6404.2	2180.5	2755.6	1601.9	3323.5	1128.8	2786.0	2205.4	1162.1	1491.3	2176.3	1195.0	1544.6	2735.2	665.7	3044.3	4780.1	1101.8	1132.3	1218.4	1008.8	1211.3	1626.1	1668.7	2104.6	1479.4	2863.7	1220.5	1017.1	3191.4	507.1	3779.3	2446.7	7007.7	7792.3	6813.4	5173.6	3626.5	8215.0	8509.1	6722.0	323.4	4085.8	1910.1	5071.9	5277.8	13749.1	1068.8	1070.1	1007.8	1300.0	984.6	1007.1	1129.1	1023.0	1076.3	1159.2	1078.9	1123.0	3260.3	1804.5	3489.0	39.8	9318.5	12528.7	15921.0	7329.9	8523.7	675.1	10709.1	13191.6	465.3	3808.9	4064.9	1616.6	189.7	6201.2	5935.5	1800.0	4652.6	4068.5	4125.7	2011.7	5627.8	4627.9	2937.8	3784.5	39.1	10909.9	11178.8	4536.6	2934.8	2679.4	2651.1	6392.0	5119.5	4261.1	5228.5	249.0	52.5	6292.1	2089.4	7058.1	8832.3	12884.5	8244.9	5051.4	5457.0	66.5	7569.8	1941.5	5395.5	158.3	86.4	7077.2	4715.7	3652.3	4667.7	14016.4	5245.4	7448.2	1834.7	786.9	2084.0	5936.3	5693.8	1721.1	1052.9	9022.1	16171.5	6165.5	7831.2	7839.7	7465.8	15137.1
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487510-49493057	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	2188.0	2248.7	1092.3	1522.1	1122.8	3160.3	2279.6	1064.6	1616.8	2808.8	1147.7	1987.3	1681.3	1743.7	742.1	2699.3	2138.4	1061.8	1522.6	1034.5	1074.4	1532.8	1642.1	1467.3	2995.9	1117.3	1065.6	4462.0	4145.5	956.8	1244.7	1070.5	1119.3	2042.8	957.8	585.8	2381.8	963.3	2940.7	3275.0	1966.3	780.3	1131.1	2267.8	2148.1	451.9	1123.9	2070.4	1594.9	1484.8	1783.2	2092.3	2369.7	1115.7	2693.9	3191.9	1553.5	4384.1	2927.6	4606.7	1812.7	2265.3	2944.1	1696.6	1823.7	2817.9	2001.2	6730.4	1792.9	1804.0	687.0	1724.4	1978.2	3463.6	974.1	1895.7	4496.8	3377.7	1945.3	3984.3	3562.3	5127.9	2581.9	5363.6	5688.6	1203.5	4051.7	3536.9	2763.2	2430.9	2982.0	2472.0	1975.0	2322.6	3629.2	5266.7	2905.4	2535.0	2987.2	3504.5	3396.6	2968.4	2319.3	4481.3	2545.5	3362.0	1184.7	5205.9	5408.7	1180.0	2303.0	5907.2	3249.6	2026.5	2165.3	1276.1	3061.9	2474.5	3628.5	3102.4	1267.1	3505.6	1898.9	1499.6	2615.2	669.3	3673.1	2167.5	5384.1	8504.2	6249.9	5035.0	3741.0	7985.6	7293.6	5930.8	400.5	4696.2	1914.5	4364.8	5054.0	13490.7	1092.3	1122.8	1064.6	1616.8	1034.5	1074.4	1117.3	1065.6	1119.3	1131.1	1123.9	1115.7	759.0	1618.6	1998.3	5.9	5793.5	11583.3	12255.7	8593.4	1801.8	534.6	8903.0	5580.5	544.1	4340.8	4712.7	1590.9	214.8	7997.8	3602.5	2445.5	5433.2	4560.9	304.1	1462.1	3740.3	3725.7	3984.3	2696.0	5.1	12776.9	10340.4	3277.8	916.9	2114.2	2546.8	1496.7	5087.0	4397.2	5887.8	220.4	6.0	7002.5	2705.8	7291.2	8449.9	709.7	9127.2	3169.3	5695.4	9.4	7891.8	1658.7	5864.1	8.0	12.4	7364.8	6114.5	4432.7	1348.9	11217.2	5888.9	7303.9	2192.4	723.4	2655.9	5724.7	2897.9	456.9	817.2	2602.1	14282.8	8401.6	4958.9	2454.2	8198.9	13221.0
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		270000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	193.3	125.9	50.3	29.2	53.0	64.2	199.2	53.9	66.4	280.8	49.7	204.9	39.0	173.8	28.5	178.6	203.5	25.3	89.8	49.2	53.3	157.1	133.0	157.7	45.3	54.0	50.7	401.6	236.4	45.5	161.1	40.7	52.9	180.5	39.8	37.0	173.9	58.2	165.5	226.7	125.3	33.5	54.0	126.1	193.3	27.8	53.7	59.1	161.1	62.9	56.0	210.4	214.5	49.9	53.1	23.4	116.6	55.7	103.6	281.6	80.4	85.8	140.4	152.1	110.9	48.9	18.5	205.9	64.9	64.6	76.4	17.2	78.1	103.7	104.9	79.7	80.6	115.3	43.1	44.7	149.4	153.1	53.2	172.9	301.8	70.6	143.1	220.9	168.3	179.7	111.7	30.1	117.1	38.1	53.4	111.8	44.8	172.9	75.7	26.9	65.6	95.4	140.3	33.2	46.3	75.2	43.2	40.2	102.6	128.0	58.5	74.5	93.3	50.8	41.5	67.4	102.5	90.9	129.3	125.0	22.9	106.1	47.5	15.4	49.1	19.2	76.5	46.0	118.9	98.6	110.8	98.1	62.1	89.8	133.6	126.9	6.5	56.9	38.0	54.4	97.1	236.2	50.3	53.0	53.9	66.4	49.2	53.3	54.0	50.7	52.9	54.0	53.7	49.9	1374.3	830.1	1146.4	29.7	2884.7	3113.4	5120.8	2595.4	3076.6	225.8	3891.2	6163.2	346.3	1634.2	1633.6	676.8	102.2	3352.5	2285.9	971.2	2529.8	2063.4	290.0	898.3	1997.2	1471.6	1228.6	2245.7	39.0	4163.8	4729.5	1652.6	1184.6	1362.2	1565.2	1640.0	1678.7	1340.0	2207.8	101.0	45.7	2528.3	805.6	2102.2	2691.6	617.6	2160.3	1804.6	1782.2	32.8	2894.7	491.4	2368.7	23.1	41.3	2772.7	2061.9	1084.8	1855.0	4343.4	2359.1	3658.8	667.3	328.8	966.3	2109.4	2212.8	265.0	405.3	4161.2	3418.2	3314.5	2819.7	1921.9	2787.9	4891.9
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 2876.9;Squamous epithelial cells: 3332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	1966.5	1982.7	942.7	997.8	948.6	2559.4	2698.3	978.7	1418.8	2426.3	974.0	2075.1	880.2	1747.2	1295.2	2261.4	2040.5	820.1	1417.0	919.9	975.3	1619.5	1470.2	1410.7	2009.4	955.0	944.3	4472.1	4182.0	862.3	1495.0	888.2	967.1	1829.2	1089.6	612.3	1788.1	899.7	1351.1	2405.0	1619.7	912.2	988.0	1850.3	2038.0	574.8	969.5	1637.0	1607.1	868.1	1672.5	1972.7	2087.9	978.7	2205.3	1360.2	1937.9	2315.0	3146.0	6392.2	1829.3	2400.4	2783.7	2229.8	1677.4	1860.7	1039.7	3785.8	1572.2	2399.7	1250.1	2569.5	2690.1	4329.7	2377.4	1547.4	2773.8	1999.8	1500.4	2560.9	2718.4	6578.1	1526.2	6150.1	4787.7	2333.9	5487.0	5189.2	3100.5	2538.6	1995.5	2685.2	2794.0	1781.7	2386.9	4203.2	1993.4	1327.9	1110.7	2333.6	2538.1	4932.3	3037.1	2571.4	1462.8	1741.2	882.6	1827.5	3949.5	2366.9	1726.9	4230.9	2473.3	1633.3	1389.1	815.2	2570.9	2341.0	2404.3	3520.5	1564.3	3936.3	1593.2	312.8	840.7	151.3	1081.4	743.0	2106.6	1907.9	1763.3	1442.8	1305.7	1574.1	1936.2	1697.1	104.4	1431.9	618.7	1427.3	1509.5	2477.8	942.7	948.6	978.7	1418.8	919.9	975.3	955.0	944.3	967.1	988.0	969.5	978.7	104.8	663.4	916.1	0.0	1445.5	701.8	237.9	319.7	2876.9	15.3	704.3	451.7	0.7	348.9	969.4	103.0	10.4	396.5	311.7	386.7	497.0	864.7	195.8	102.2	169.2	426.4	819.2	1193.5	0.0	1630.2	582.5	558.6	1132.5	98.5	998.9	58.9	414.1	217.3	272.3	10.1	0.0	1233.6	81.4	561.1	588.8	452.1	527.2	616.8	291.7	0.0	973.9	42.7	515.9	0.0	0.0	1268.6	909.2	272.3	1659.1	177.3	768.9	648.6	561.5	23.8	249.8	401.7	297.5	100.8	100.5	3332.8	922.5	414.8	1066.7	61.1	1437.8	216.6
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 153.8;Alveolar cells type 2: 154.3;Club cells: 96.6;granulocytes: 65.6;Respiratory ciliated cells: 117.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		41.7	77.7	109.4	35.7	111.6	49.1	49.6	117.5	159.2	36.5	113.7	43.7	51.3	32.2	70.3	25.7	31.1	38.6	63.6	106.0	119.4	96.0	85.0	42.2	35.1	116.3	112.8	34.4	51.8	84.3	9.4	35.3	116.2	48.7	41.6	104.7	54.5	34.4	30.1	22.2	48.3	26.7	116.2	35.9	55.7	30.5	112.3	32.8	53.4	38.2	27.2	38.1	5.2	126.1	29.4	25.0	57.3	47.1	55.7	42.3	42.7	34.6	36.6	27.9	32.9	7.7	33.8	21.8	74.0	33.5	30.5	29.6	26.2	29.7	31.1	67.7	20.2	28.0	15.7	28.3	56.6	46.3	59.2	50.5	65.0	22.5	42.3	61.4	35.2	48.6	19.2	60.9	79.2	16.8	41.4	26.8	20.1	28.0	13.0	26.2	21.2	59.4	115.2	34.7	64.5	120.0	22.0	36.8	76.1	41.4	50.3	45.4	33.0	37.4	25.7	23.4	36.8	106.2	60.1	24.9	42.0	26.0	42.7	92.6	30.2	71.3	23.0	41.1	33.4	28.3	27.1	26.5	27.9	20.3	23.3	31.2	85.1	22.3	48.5	38.4	30.9	49.2	109.4	111.6	117.5	159.2	106.0	119.4	116.3	112.8	116.2	116.2	112.3	126.1	0.5	153.8	154.3	0.3	0.4	0.3	0.7	0.3	0.6	0.4	0.5	0.5	0.0	0.0	96.6	0.0	0.0	0.1	0.2	0.2	0.0	0.2	2.8	0.3	0.7	17.8	0.0	0.0	0.1	0.2	0.1	18.5	0.5	0.4	65.6	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.0	20.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.3	117.3	0.3	0.0	0.2	0.4	1.0	0.5	1.0	0.1	0.3	9.1	0.5	0.1	0.5
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619184	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 16079.5"					"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: AB_2679705"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	1000.7	1074.9	985.7	753.7	981.5	1976.6	1333.2	932.2	1170.2	1491.2	910.5	995.0	912.2	1051.5	782.6	1786.5	1415.0	719.4	754.8	924.1	955.5	756.7	974.7	730.6	1740.2	980.7	953.9	3084.6	2343.7	580.6	905.7	746.8	972.6	1262.1	814.4	139.0	1779.2	702.0	1056.9	1944.3	956.6	709.9	999.1	1151.6	1122.4	332.2	993.5	1091.5	880.0	643.0	1399.0	1017.9	1356.0	989.5	1874.4	2697.1	1148.7	1520.6	1267.0	2299.6	1455.1	1042.7	1489.0	1754.3	1471.6	2497.8	1407.6	3436.1	874.1	1007.2	803.9	1400.0	1211.2	2056.9	844.3	1349.6	3380.2	1286.3	1234.0	2438.1	2166.6	1793.6	1309.6	2633.8	3015.8	1031.9	1603.7	1760.0	1836.8	2149.2	1629.3	2043.5	1297.6	2236.5	1926.2	16079.5	1421.6	3171.4	1469.5	2058.1	1073.4	2438.4	1527.9	2370.7	1410.8	1739.1	850.4	2306.0	2082.3	641.1	1241.4	2618.1	1220.9	1032.3	1275.0	727.4	2119.8	1970.9	2939.2	1934.2	649.6	2246.7	1257.7	381.1	1022.8	217.6	1066.6	890.3	1889.0	2384.8	1921.2	1461.0	1380.1	2368.0	2373.9	1981.4	140.7	1357.8	681.2	1451.1	1707.2	3192.5	985.7	981.5	932.2	1170.2	924.1	955.5	980.7	953.9	972.6	999.1	993.5	989.5	1729.2	593.0	983.1	22.9	4066.2	4468.5	4767.6	3561.4	4933.7	393.5	3680.3	5354.2	264.0	1637.1	1809.1	708.1	143.9	3891.0	2534.2	1344.7	1387.2	1853.2	80.5	1067.0	2619.6	1812.4	1673.5	1713.1	21.7	4530.2	5344.1	1765.9	1597.9	1584.8	1021.6	2791.1	1810.1	1426.6	2225.3	134.6	28.2	3186.8	1253.2	2491.6	3341.9	221.3	3248.9	2059.4	2278.5	16.9	2958.8	1413.2	2345.1	22.6	51.3	3022.6	2516.1	1459.7	2801.6	4727.0	2534.3	1832.5	697.3	433.7	1032.1	2596.1	2246.5	283.4	558.4	5421.3	5559.5	4138.0	2961.3	3084.2	3163.6	5183.8
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859910-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 682.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No		44000	"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	1984.9	1325.9	783.3	1207.3	801.9	2675.9	2006.4	765.1	966.5	2276.5	976.5	1896.2	1072.6	1684.5	414.2	2432.1	1900.0	848.3	1178.2	738.0	778.4	1205.8	1161.2	1350.6	2511.2	806.4	757.5	3627.6	3907.4	541.6	923.3	757.2	789.9	1596.6	718.5	205.8	2590.5	635.5	2533.1	3581.5	1721.9	686.3	819.5	2048.4	1928.7	350.6	801.3	1573.9	1398.1	1213.3	1488.2	1737.1	2164.1	808.5	2623.4	2001.4	1299.0	1847.0	1923.3	3152.4	3291.2	1559.5	1979.9	2038.9	1930.5	2789.2	2550.3	3921.7	3523.0	1365.1	805.3	1913.5	1555.9	3350.6	708.6	2020.7	4206.5	1833.5	1792.6	3238.9	3314.5	2660.3	1916.4	3952.5	4349.3	1127.8	2410.2	2094.2	2265.6	3157.8	2386.5	2462.6	1313.5	4085.3	3633.0	3514.7	3067.9	2909.3	3049.2	3210.9	1376.3	4708.0	1887.0	2464.1	1879.4	2817.6	554.3	3813.0	5042.2	637.7	1814.7	5079.9	1738.1	1244.6	1438.8	2512.2	2674.5	3251.9	3283.4	2639.9	1632.9	4270.0	1580.0	1247.5	4513.0	690.0	4974.8	4521.9	8679.3	14996.3	8499.1	6207.0	6569.7	15438.5	9988.2	7821.6	433.2	5415.3	3633.6	7634.4	8027.2	21239.5	783.3	801.9	765.1	966.5	738.0	778.4	806.4	757.5	789.9	819.5	801.3	808.5	1797.3	519.2	1033.4	1.3	6570.0	8683.5	6503.8	6346.6	5314.4	252.0	7203.4	8120.9	437.2	2077.4	2572.8	923.2	127.2	4676.6	3414.9	1440.2	2387.0	3503.1	57.0	1112.5	3101.7	2919.9	1842.7	2735.0	1.8	8949.1	8763.1	2652.7	2316.6	1639.3	1447.9	3627.9	2837.8	2144.2	3317.2	131.2	2.2	3965.3	1881.8	4748.0	8399.9	194.1	4165.1	3240.6	4747.4	1.9	6119.2	908.2	3084.5	1.5	2.5	5684.1	3130.7	1627.9	3619.6	6541.4	3169.3	3629.8	1019.5	499.6	1255.6	3061.1	4561.4	199.9	834.7	6806.4	11135.4	4659.3	4511.8	4057.7	4606.2	8094.9
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204840	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 37509.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	2108.0	1641.8	1232.8	1325.7	1302.0	3445.4	2213.5	1236.2	1473.8	2449.2	1230.5	1983.7	1161.3	1717.3	1256.1	2160.0	1997.7	1159.4	1539.0	1175.0	1252.5	1725.6	1485.2	1453.6	2835.1	1303.7	1237.8	3638.0	3006.2	1537.0	1362.5	1050.7	1304.9	1733.7	1231.5	383.6	2136.0	1214.5	2763.0	2809.4	1733.8	1104.6	1324.2	2003.5	1872.5	615.5	1268.5	2335.8	1462.6	1879.2	2543.6	1915.1	2121.1	1325.7	1943.7	2617.7	1849.0	2258.4	3300.1	4133.6	1894.3	1788.5	3631.1	3629.7	2895.6	2872.0	1801.2	4740.4	3047.1	2580.8	2122.7	3228.2	2807.4	3714.8	1852.4	1922.4	4931.8	1693.5	1876.5	3797.5	5133.2	4201.0	2240.4	4647.6	3995.5	2805.3	5031.4	3396.2	3177.6	3991.6	3007.3	2696.5	2544.2	1939.5	5610.7	5814.7	1891.0	2269.3	1912.1	3270.3	2620.6	4777.9	3324.4	2419.1	2225.5	2457.9	1084.0	37509.3	5867.6	1982.1	3626.8	5201.1	1883.8	1410.9	1894.7	2165.8	3336.2	3504.5	3756.7	3505.5	1906.0	3147.3	1854.1	1051.1	2648.2	975.0	2486.9	2147.2	3862.3	4698.0	3984.2	3158.7	3263.9	4349.1	4920.5	4086.9	380.6	2830.2	1793.7	3012.9	3456.9	9398.3	1232.8	1302.0	1236.2	1473.8	1175.0	1252.5	1303.7	1237.8	1304.9	1324.2	1268.5	1325.7	2477.2	884.6	1438.4	49.0	5591.4	5551.7	6227.1	4092.6	3998.1	241.7	5532.9	7926.2	556.3	2332.0	2100.3	1138.5	93.8	3720.2	4011.1	1443.7	3623.4	3025.0	1451.9	1129.0	2357.2	2714.5	1957.2	2708.2	30.8	6238.2	5441.3	2425.2	1705.4	1503.7	1586.0	3024.3	2836.8	2406.3	4189.9	132.9	33.6	3550.3	1464.8	4218.0	5326.1	4539.9	3920.2	3259.8	3272.8	46.9	4282.6	1495.1	3932.1	20.1	51.1	3972.8	3267.4	2040.2	3289.0	6219.8	3226.4	5182.0	1049.1	390.5	1531.7	3215.1	3875.5	962.9	981.4	5376.4	6619.2	3899.7	4615.5	3399.1	3895.2	7406.6
RPL21	"DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252"	ENSG00000122026	"Ribosomal protein L21"	P46778	13	27251309-27256691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047252	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		34000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA047252: AB_2680000"	"unprognostic (4.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.55e-2)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-1)"	1565.0	1042.6	1087.8	714.2	1108.1	2293.7	1689.3	1066.4	1946.8	2047.0	1061.5	1733.4	625.1	1329.1	725.7	1504.9	1718.1	553.6	1306.5	1047.9	1131.1	1421.7	1085.9	1181.3	1633.8	1112.2	1089.9	3100.5	2449.9	514.5	1047.0	626.6	1107.4	1381.0	803.3	419.1	1325.3	643.2	1855.2	1987.4	1471.7	594.3	1106.4	1794.1	1487.8	317.3	1103.9	1072.9	1114.9	769.6	1395.1	1631.4	1650.9	1117.2	942.9	772.1	1337.0	1086.2	1361.4	2569.1	1130.1	1664.7	1515.8	1277.2	822.1	1875.1	1700.0	3578.7	627.8	1332.5	571.7	1220.3	1552.8	1694.0	1495.8	1139.5	1410.3	2803.5	738.9	1470.3	1284.7	3871.3	1063.8	2304.6	2722.2	837.5	2112.0	1751.9	1454.0	1562.9	1181.8	865.5	1468.6	1340.3	1970.6	2398.9	1754.3	2792.4	1281.4	1446.1	2566.6	1511.2	1201.2	1111.2	1153.8	1071.6	773.3	1531.6	1390.1	1120.4	1033.9	3406.6	1619.7	563.1	731.3	895.3	1384.6	579.7	874.2	2583.3	722.1	2415.5	978.6	948.5	1201.5	493.2	1996.0	1257.2	3233.0	3717.7	2993.5	2504.4	1607.9	3347.5	4294.2	3510.3	249.1	2178.4	1308.5	2181.4	2271.1	6723.7	1087.8	1108.1	1066.4	1946.8	1047.9	1131.1	1112.2	1089.9	1107.4	1106.4	1103.9	1117.2	1464.4	1685.9	2658.5	9.4	6395.0	7645.1	5673.8	7552.7	1649.3	375.0	4496.8	3380.2	191.6	4000.5	3789.8	1565.1	143.9	5240.1	4382.0	1695.3	5290.4	3849.1	74.4	1089.9	2417.7	2670.0	2385.5	4124.1	9.0	7829.6	6183.8	2401.4	924.6	1200.5	2817.5	2227.4	4446.9	4944.4	3952.9	159.9	10.1	4869.4	2518.7	7461.4	9266.1	225.9	3957.2	3114.0	5229.4	7.5	9465.6	1525.3	6167.9	8.5	14.1	4983.3	3923.7	2403.1	2133.1	4379.8	4261.8	6230.7	1742.7	634.1	1899.8	4878.6	2645.8	650.7	1016.0	2107.5	8226.2	5507.4	5413.5	1829.5	5416.3	4837.4
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870208	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 651.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 912.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	41.4	32.0	10.4	64.2	12.0	93.6	46.7	10.7	20.6	25.6	9.8	36.1	19.0	24.8	17.8	75.3	32.3	17.2	23.5	10.4	11.6	27.4	47.9	25.9	75.3	11.9	11.5	34.0	47.5	8.3	22.4	17.2	12.1	25.1	33.0	7.7	34.2	15.7	9.9	46.6	32.9	26.5	11.4	67.4	38.6	13.7	11.8	39.8	16.9	6.2	63.2	61.3	38.0	16.4	153.8	169.2	54.4	632.1	156.8	912.4	165.5	152.9	349.5	121.7	78.4	72.8	34.8	472.8	34.5	143.1	379.6	39.3	136.4	390.2	67.7	28.8	24.7	43.2	21.4	166.4	632.4	88.7	60.1	670.6	775.2	38.9	409.7	189.0	418.9	257.7	30.4	29.8	672.0	194.3	650.6	49.7	849.1	58.6	31.0	857.7	19.4	72.7	305.4	337.4	9.2	45.7	15.4	75.6	72.1	29.2	105.6	77.2	196.3	23.3	175.9	47.2	216.8	47.1	36.0	76.2	420.5	53.7	489.4	2.2	9.5	4.3	13.2	12.6	26.9	47.1	19.4	17.9	10.7	34.8	12.9	14.5	2.1	28.8	17.8	51.2	13.1	6.9	10.4	12.0	10.7	20.6	10.4	11.6	11.9	11.5	12.1	11.4	11.8	16.4	153.2	9.6	43.7	4.6	379.6	197.6	240.2	260.8	198.6	13.9	185.1	397.2	18.1	55.8	111.4	20.2	4.2	89.8	241.9	111.5	66.5	160.8	37.6	128.4	279.6	138.5	144.6	266.7	3.3	232.3	297.4	169.0	146.3	116.8	106.5	202.8	103.9	129.5	184.7	8.4	4.5	240.7	93.6	187.4	101.4	36.3	139.4	148.9	78.2	2.8	108.7	54.2	69.0	7.5	10.1	400.8	137.1	89.1	651.0	421.5	99.1	94.1	60.5	21.0	46.0	189.5	472.0	67.2	58.9	511.7	247.8	98.4	173.7	260.4	197.5	356.3
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847860-38853764	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	2078.9	1410.2	882.7	972.2	902.3	2444.5	2530.4	888.8	1161.1	2151.7	925.6	1577.9	805.2	1497.6	1786.7	1678.9	1807.0	820.5	1232.2	860.7	927.0	1410.9	1228.9	1247.9	1934.3	926.0	901.9	3960.2	2100.0	1007.4	906.0	1087.5	937.4	1501.3	1208.1	512.2	1409.8	893.5	1901.2	2283.1	1290.8	1029.7	943.8	1607.9	1409.4	336.7	908.6	1998.6	1268.0	1617.6	2264.0	1591.5	1782.4	943.3	1912.8	1871.0	2422.1	2063.9	4227.9	5507.5	1695.5	1866.3	2802.6	2301.3	1716.5	2721.1	1652.1	4214.1	1806.8	2066.8	1701.9	3284.2	2131.0	3622.1	2803.5	1466.9	3178.0	1553.9	2573.8	3929.6	3170.2	4326.7	1561.7	5216.3	4409.6	2003.4	4154.8	4103.3	2475.7	2891.2	2507.1	2069.3	3000.0	1705.8	3818.5	4600.5	1778.3	2488.3	1131.0	2560.7	3549.4	4180.4	3262.5	2384.2	1643.0	2433.7	1001.5	1707.3	3998.7	3317.1	2828.9	5324.1	1746.6	1052.1	1617.9	1666.2	3155.0	1327.3	2217.4	3326.8	1613.0	2551.5	1388.0	568.8	1536.7	318.0	1179.7	1207.3	1463.1	2374.0	1868.0	1451.6	2065.6	2159.5	2473.1	2142.2	227.0	1404.4	1069.0	2578.5	1498.0	3233.2	882.7	902.3	888.8	1161.1	860.7	927.0	926.0	901.9	937.4	943.8	908.6	943.3	764.4	1012.8	1606.1	8.5	1481.6	2446.7	2204.6	1828.9	747.3	147.1	1240.8	1011.2	532.6	1243.9	1379.0	472.6	68.8	1809.9	1282.7	652.1	1352.0	1390.0	309.2	1084.8	2160.4	1122.6	919.7	808.5	11.3	2090.7	2633.3	985.1	306.3	1353.6	1350.3	1137.2	1572.1	1581.2	1666.5	58.9	10.9	1609.3	594.1	2477.5	2490.5	233.0	2682.2	1456.6	1108.1	11.2	2741.1	735.2	1365.6	5.0	11.5	1909.4	1437.5	1447.7	491.4	2347.2	799.6	2260.6	650.8	223.6	749.4	1743.9	1908.2	259.2	219.9	1022.2	3164.9	1904.2	1207.9	1159.8	1854.8	2378.9
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719985-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		86000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: AB_2681593, HPA077474: AB_2686841"	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	1584.8	1113.1	654.3	671.5	688.0	1394.2	1570.3	652.4	1022.2	2187.2	625.1	1445.1	612.6	1394.1	718.6	1571.9	1634.3	535.3	1187.3	618.4	650.0	1099.0	883.0	1093.0	1433.2	673.2	651.5	3435.1	1784.0	525.5	1098.5	674.5	679.4	1319.5	821.4	343.6	1355.9	639.7	2007.1	2167.8	1341.4	670.2	718.7	1621.7	1365.0	394.3	691.1	970.1	1098.0	887.1	1529.3	1516.5	1724.7	701.9	1011.7	2016.2	1187.9	1478.2	1541.3	2460.3	1167.5	919.9	1609.3	1530.9	1285.0	2069.6	945.7	2272.0	842.9	1288.6	794.8	1336.2	1604.1	2059.1	1570.9	1207.4	4393.8	1090.0	1875.4	2228.4	1393.9	2286.0	1078.5	2415.4	2592.8	1218.4	1907.0	2198.5	1679.1	1024.9	1440.9	1494.0	1555.3	1668.7	2566.5	3014.5	1145.8	2554.4	1212.9	1485.1	2158.1	2703.9	1672.0	2029.6	1233.6	1432.9	656.5	4676.5	2224.2	1655.3	2336.4	2637.5	1009.1	833.0	1177.1	985.4	1663.8	1819.6	1831.8	1323.2	1314.2	1241.1	939.6	1095.3	1931.7	552.4	4031.6	2107.3	5926.1	6793.2	5786.8	5255.4	2964.7	5683.7	6315.4	5951.4	244.7	4162.0	1738.1	3784.3	4293.0	7336.1	654.3	688.0	652.4	1022.2	618.4	650.0	673.2	651.5	679.4	718.7	691.1	701.9	987.8	862.2	1387.4	42.1	4276.8	5192.7	5364.3	4497.6	1889.4	237.4	3483.7	2581.2	292.2	2254.7	2254.3	864.4	70.9	4486.2	3010.4	1253.0	3083.4	2444.1	968.0	1089.8	2060.3	2031.0	1846.3	1943.9	13.5	4593.6	6595.0	1928.4	821.6	1503.9	1512.6	1814.9	2939.2	2626.6	2651.7	163.2	17.2	3659.6	1310.2	3406.8	5015.0	360.5	4557.4	1983.9	3066.4	14.0	3997.3	1072.1	4293.5	16.1	23.3	2801.3	3326.6	2366.6	1803.5	5056.3	2925.9	3669.2	886.9	363.6	1709.2	3461.4	2748.7	674.8	779.0	2554.1	6196.5	4927.6	3651.6	2266.4	3979.8	5957.0
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686718	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	1220.4	963.7	1179.4	795.9	1197.2	1813.7	2016.7	1206.7	1802.8	1786.4	1168.9	1269.8	843.8	1272.5	1658.1	1155.1	1363.2	709.5	1161.8	1152.6	1190.2	1145.5	1195.3	882.4	1514.7	1190.0	1168.8	2886.8	1989.8	967.9	1101.6	889.8	1190.1	1124.9	937.9	588.3	1605.5	795.5	1501.5	1285.7	866.2	822.5	1216.9	917.6	1117.4	324.3	1203.7	1558.3	1217.1	1347.0	1338.5	1222.0	1282.4	1226.6	3341.0	1122.5	1638.4	1892.9	1823.4	3249.1	2499.1	1832.0	2161.4	2560.1	1868.3	2262.4	1480.2	3669.7	2253.5	1494.6	1002.0	1749.4	1967.8	2398.5	2584.5	1982.6	1939.0	2147.6	857.8	1715.0	1772.2	2451.8	1122.7	3142.6	3062.3	1585.9	2863.5	2474.3	2226.2	1741.3	2028.0	1830.4	2427.7	2323.0	2566.8	3835.9	2991.2	3052.1	2372.1	2332.6	1598.0	3622.8	2686.7	1508.6	3587.0	1629.7	966.3	1775.0	4454.7	1413.3	2184.7	4483.3	1579.9	1138.3	2019.4	613.4	2332.7	1512.4	2049.7	6425.0	1484.6	2643.4	1919.2	668.3	1239.3	311.8	1468.5	1083.5	2151.6	2246.8	2305.6	1787.9	1641.5	2185.0	2880.6	2249.1	194.6	1677.3	1115.5	1957.8	2261.4	4700.1	1179.4	1197.2	1206.7	1802.8	1152.6	1190.2	1190.0	1168.8	1190.1	1216.9	1203.7	1226.6	1628.0	948.7	1279.6	15.7	2074.3	2283.7	3314.0	1938.2	2129.6	268.3	2541.6	4149.7	333.2	1313.9	1327.7	610.6	85.5	2064.2	1870.1	882.2	2267.6	1579.1	885.8	1200.6	2281.6	1502.9	1364.3	1421.6	22.5	2930.3	3255.0	1518.4	813.5	1574.5	1350.0	1547.4	1509.5	1509.9	1594.8	117.8	22.0	2147.0	708.0	1759.2	2028.7	689.6	3003.4	1452.0	1378.5	30.0	2166.2	1045.3	1578.8	20.1	26.8	2412.1	1728.7	1501.5	1499.8	3372.3	1679.5	2895.9	676.1	432.6	874.4	2783.8	2675.9	498.4	345.7	2210.2	2326.7	2341.6	1952.8	2206.1	2242.3	3363.9
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383213	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030449, CAB037301"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	2647.0	1834.7	1444.0	1225.0	1483.6	3862.9	4202.6	1437.9	2302.9	2923.7	1394.3	2148.4	1286.2	1911.1	2229.1	2565.8	2254.3	1396.5	1756.1	1402.1	1503.8	2006.1	1826.0	1615.6	3047.7	1494.3	1433.2	4732.1	3616.6	1250.6	1067.0	1536.3	1496.7	2026.5	2044.1	815.9	2073.2	1272.7	2625.9	3123.9	1921.8	1379.7	1515.1	2060.3	2137.9	548.8	1463.6	2241.2	1926.2	1911.5	2840.0	2178.2	2560.6	1538.3	2791.7	2553.3	2428.3	2899.9	4595.7	7595.7	2377.2	2357.4	3627.6	3234.3	2430.6	2732.4	1406.4	4875.0	2641.6	2899.3	1278.3	3012.9	3173.2	4954.7	3806.7	1824.4	5711.8	1893.9	2682.1	3218.0	5344.6	2835.2	2347.9	6463.5	9908.8	2638.4	7949.9	4443.9	4106.5	2739.0	2210.9	1423.8	3478.6	1967.6	3153.9	3903.4	2275.5	2924.4	1691.8	3097.3	2453.7	3094.4	4394.8	2116.9	1014.7	2144.2	1268.6	2353.7	5882.6	2142.4	2417.5	3740.1	2492.5	1270.3	1564.9	1765.2	4201.2	1119.0	1485.1	2188.6	2074.1	4071.7	1920.7	490.8	1528.6	300.6	1323.8	1277.1	1928.7	2409.5	1960.7	1734.1	1901.2	2152.5	2270.0	2008.9	167.6	1562.4	1173.0	1634.7	1803.3	3235.4	1444.0	1483.6	1437.9	2302.9	1402.1	1503.8	1494.3	1433.2	1496.7	1515.1	1463.6	1538.3	2207.3	897.4	1239.5	29.0	4966.6	5577.5	3390.4	3434.2	4618.4	256.5	5263.8	5691.4	292.0	3039.7	1994.1	1004.2	133.5	4514.0	3481.7	1395.1	3946.3	2664.5	884.0	1146.1	2485.1	2507.8	2284.5	2894.1	39.3	4897.5	7026.7	2100.3	1725.3	1470.3	1868.6	1738.7	3416.5	2960.2	3431.5	136.3	33.9	4440.7	1062.0	5356.7	6335.6	1657.9	4777.0	3085.5	3198.1	45.9	6036.5	747.5	3887.8	22.1	39.7	3561.4	3590.4	2157.9	2546.9	3577.0	3412.0	5475.1	856.5	477.7	1512.0	4011.2	2218.8	568.4	716.4	6164.5	7093.8	4568.3	3804.2	2012.8	4955.7	3367.7
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 408.0;Spermatocytes: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	27.4	45.8	28.0	28.9	29.2	39.1	27.3	29.7	39.1	23.5	26.4	24.5	25.2	28.5	37.7	37.5	26.6	22.1	37.8	31.0	29.8	43.7	47.9	22.1	34.4	29.3	28.9	25.7	24.9	34.5	30.3	23.8	30.6	25.5	26.2	17.9	24.6	28.9	37.8	21.3	21.9	26.0	28.1	26.8	26.2	91.2	29.3	34.0	29.5	28.1	29.0	30.4	25.4	29.1	129.8	114.7	101.9	140.8	68.9	72.3	131.7	120.6	70.6	170.5	151.1	141.1	135.3	96.6	301.5	166.6	181.6	82.1	170.1	239.8	156.4	124.1	220.9	71.6	122.8	174.5	135.1	105.7	60.8	91.0	99.2	176.1	122.3	69.1	99.2	93.6	100.3	79.0	123.1	286.6	129.5	165.6	65.2	59.7	180.5	93.3	157.5	128.4	101.0	80.1	102.0	62.7	110.6	100.2	167.6	64.7	122.8	111.5	105.4	193.2	109.0	114.3	92.5	70.3	119.0	182.3	152.6	130.2	117.6	25.4	86.6	39.9	33.1	80.5	42.7	50.4	40.4	46.1	99.5	38.1	32.9	42.0	42.9	39.5	72.2	68.1	55.8	55.7	28.0	29.2	29.7	39.1	31.0	29.8	29.3	28.9	30.6	28.1	29.3	29.1	41.5	41.7	32.8	4.6	29.8	48.8	56.9	191.3	32.5	18.8	50.2	61.8	45.5	41.5	82.7	58.8	18.8	111.6	28.7	36.2	181.9	119.0	408.0	98.4	70.0	47.7	40.2	49.2	4.5	113.0	124.5	45.3	29.6	70.6	26.6	60.2	41.4	132.1	115.0	15.2	5.2	48.6	93.6	48.6	51.9	79.9	37.9	45.6	51.6	2.8	93.5	61.7	49.4	2.0	5.0	138.0	38.6	41.0	59.2	67.9	48.2	216.2	92.4	20.2	19.7	35.6	56.1	316.7	178.6	70.5	52.8	78.9	28.9	81.1	59.1	57.7
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		170000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	1871.8	1549.8	1111.3	1009.9	1116.5	2929.2	1962.9	1098.5	1512.7	2052.8	1111.9	1884.1	802.3	1550.5	994.9	1984.2	1652.8	740.8	1495.4	1092.8	1126.1	1276.4	1316.9	1278.5	1999.4	1122.6	1109.6	2598.8	2232.2	850.4	894.8	951.0	1119.0	1483.8	894.1	394.5	1530.7	749.8	2544.6	2726.6	1467.8	854.4	1124.4	1802.0	1559.6	409.4	1127.1	1682.4	1067.7	1510.1	1378.5	1650.9	1820.8	1132.8	2288.0	2867.0	1701.7	2480.6	2983.9	4422.4	2741.5	2594.6	2162.4	2777.2	1979.1	4107.0	1751.0	4309.7	2143.3	2087.9	1477.4	1948.8	2000.9	3363.7	2670.5	1996.4	4741.8	1694.3	2147.4	4431.8	3669.4	4908.1	1698.9	4175.7	2847.4	1867.0	2381.3	2795.0	2356.9	2241.9	3237.8	2584.2	2618.6	2253.4	4127.7	4153.0	2577.8	2634.0	1821.4	2841.1	4775.1	4927.8	2374.2	3092.9	1909.6	2094.8	1016.8	1982.1	4341.5	2299.8	3341.2	5076.5	2617.1	2021.7	1988.7	2497.2	3885.7	2219.6	4004.7	4327.4	1816.5	3030.7	2107.7	1007.1	1762.8	553.5	1773.1	1633.6	2518.3	3055.1	2633.3	2095.8	2115.1	2792.7	2987.8	2673.6	358.7	2155.7	1284.9	2726.2	2059.6	4601.4	1111.3	1116.5	1098.5	1512.7	1092.8	1126.1	1122.6	1109.6	1119.0	1124.4	1127.1	1132.8	770.3	734.0	1103.9	11.1	2217.2	2530.2	2296.2	1759.2	941.8	138.9	1779.8	1725.0	725.8	1302.6	1175.0	518.6	89.6	2093.8	1873.8	948.5	1496.7	1822.6	435.6	524.0	1202.0	1245.7	912.0	1291.4	9.9	3028.9	3551.3	1025.1	510.7	660.9	991.3	983.7	1689.1	1859.0	2118.7	65.6	10.7	2016.4	671.4	2560.1	2977.0	1070.0	2434.3	1522.8	1426.5	22.5	3232.7	722.9	2669.4	7.5	16.3	2450.0	1585.4	1279.6	957.2	2462.7	1301.2	2383.0	574.6	230.6	867.8	1669.6	1874.7	384.8	476.4	1644.1	3371.3	2184.8	1833.0	1266.3	2175.4	2628.2
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682788-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		89000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA060776: AB_2684359, HPA063379: AB_2684997"	"prognostic favorable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	1867.4	1586.5	1112.4	1138.4	1139.6	3242.1	2016.3	1103.5	1682.4	2307.6	1117.4	1835.7	1119.4	1509.5	1253.5	2532.6	1777.9	901.6	1434.4	1090.3	1137.3	1438.8	1513.7	1440.4	2469.0	1140.1	1117.4	3180.8	3079.8	550.4	1329.2	1034.8	1141.6	1798.9	1352.8	562.4	1872.7	559.2	2167.5	2731.4	1875.3	912.5	1148.6	2263.5	1881.1	397.9	1138.3	1569.0	1606.9	1159.8	2278.0	1816.8	2187.8	1161.9	3374.8	2282.4	1427.2	1723.1	1917.9	3636.8	2160.5	2131.4	2659.7	2386.0	1819.2	2904.7	3041.6	4726.7	1635.8	1877.3	1019.4	2400.8	1914.2	2976.5	1781.2	1742.6	4109.6	2101.8	2068.1	3642.3	3180.6	3846.3	2350.4	4015.9	5180.1	380.2	3959.2	3267.2	2398.7	2766.7	2203.9	1446.0	2043.8	2521.0	2863.4	5717.8	2332.9	2478.6	2375.5	2469.8	1504.9	2920.6	2292.2	3298.8	1631.2	2917.9	797.7	2987.9	3547.0	1494.5	1322.2	4282.8	2203.9	778.3	2093.9	2005.3	2746.5	1629.9	3909.0	3975.9	1772.1	2585.6	1433.3	3535.7	5105.6	1567.8	7665.6	4887.2	9888.7	13013.7	10807.7	9082.0	7409.3	11343.1	12593.4	10685.9	1149.1	6890.0	4553.8	7100.8	8081.2	27172.4	1112.4	1139.6	1103.5	1682.4	1090.3	1137.3	1140.1	1117.4	1141.6	1148.6	1138.3	1161.9	715.7	1121.8	1863.9	8.8	3163.6	4858.0	6358.1	4908.5	492.3	215.3	3316.7	1895.8	934.4	2174.7	2795.5	987.7	114.7	5885.0	2461.3	1680.5	2856.5	2520.9	861.4	1138.4	2272.9	2077.8	2118.2	1701.9	7.1	5396.5	7518.8	1703.8	407.8	1787.8	2132.2	1410.6	3162.6	2776.8	4393.9	80.8	8.6	5111.4	1617.4	4642.2	6081.0	1902.1	3623.5	2177.5	2833.5	7.5	4730.9	1006.9	4985.7	8.0	11.0	3962.9	4511.8	1957.0	678.2	5412.4	4146.2	3282.9	1236.0	352.8	1558.1	2338.6	2218.2	503.8	482.7	1064.4	6060.7	6015.7	2992.7	1341.3	5098.3	7041.0
RPL28	"FLJ43307, L28"	ENSG00000108107	"Ribosomal protein L28"	P46779	19	55385932-55403250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050459	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		59000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA050459: AB_2681135"	"unprognostic (4.70e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.53e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.61e-5)"	"unprognostic (4.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.93e-3)"	1699.3	1623.4	886.6	1036.7	911.3	1692.7	1588.2	866.7	1087.6	1691.4	831.5	1387.1	786.4	1130.4	427.2	2645.2	1324.3	653.4	1156.8	864.8	915.4	1350.2	1453.1	1333.4	1734.7	956.6	879.5	2652.0	1969.1	378.5	1116.3	552.2	916.9	1628.8	522.1	208.8	1399.3	400.8	1186.7	2587.8	1467.4	476.4	902.1	1941.7	1283.5	567.2	901.9	1193.8	1266.0	498.5	1354.2	1493.5	1855.4	933.4	2243.1	2533.7	864.1	1730.7	1508.5	2405.0	1458.3	1477.7	1395.5	1261.2	1162.7	2486.9	1155.9	3331.0	1034.2	1346.2	537.3	1368.2	990.0	1898.1	555.1	1300.1	5651.9	2060.0	1543.0	3091.3	2500.4	2420.6	1734.1	3402.5	2668.8	941.2	1887.2	1654.8	1374.4	1572.5	1626.1	2656.3	1143.0	2568.8	2720.0	2234.9	2081.9	1893.1	2751.4	2723.1	1246.5	2559.5	1626.4	4386.3	1096.5	1810.3	938.4	3055.7	2388.9	476.2	1271.7	2542.5	1684.9	1122.2	1263.5	907.5	2391.6	2167.6	3426.2	2120.9	1433.4	2921.9	969.0	496.8	1137.3	329.5	1018.8	1004.1	1587.4	1951.6	1708.1	1346.5	1318.5	1929.0	1893.1	1734.6	340.9	999.2	858.7	1243.7	1726.0	3392.3	886.6	911.3	866.7	1087.6	864.8	915.4	956.6	879.5	916.9	902.1	901.9	933.4	2277.5	314.1	560.5	22.5	7020.4	3787.2	4681.7	3181.0	5272.9	276.7	5169.2	6848.9	155.6	1921.6	1378.1	1166.0	162.6	3178.0	4378.0	2153.4	2551.3	2493.5	1487.6	1657.5	3885.3	2452.6	2284.3	3256.0	27.3	4366.2	5807.8	2324.7	2571.4	2448.5	856.5	4232.7	3114.5	2411.6	4091.1	180.0	34.4	4783.0	842.3	6210.8	5627.4	4180.3	3448.6	4457.1	2114.8	50.6	5756.7	1363.1	3267.8	27.2	73.5	4770.7	4210.6	1643.7	4445.1	5429.7	4982.5	3325.8	652.2	516.8	972.9	2174.1	2361.8	832.0	896.6	8321.4	4904.2	3384.7	6066.8	4186.4	5252.8	7113.6
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993522-51995895	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	1695.8	1400.7	669.4	719.9	687.1	2111.2	1659.2	668.9	816.3	1854.9	645.4	1352.4	866.4	1208.8	657.8	1772.7	1470.3	645.8	1073.9	646.1	673.9	1112.9	1155.6	972.4	1348.0	697.9	665.1	2740.8	2740.5	537.5	708.8	534.7	696.9	1307.1	624.9	229.3	1478.4	550.2	2689.5	2458.5	1155.7	567.4	721.7	1239.3	1341.7	440.2	684.7	1075.5	982.6	1287.3	991.6	1339.6	1643.6	729.6	1208.7	1467.7	1123.3	1808.9	1933.5	3007.1	1603.5	1299.2	1540.3	1693.7	1396.9	1757.3	1831.7	3226.6	553.5	1292.3	1044.1	1084.1	1622.7	2689.1	802.7	1335.2	2202.3	1689.2	1892.1	3037.1	2287.6	2548.8	1630.1	3714.1	3735.4	1254.5	2210.9	1936.9	1920.9	1420.6	1338.0	2536.8	1264.3	2629.0	2238.9	3210.8	1965.5	1755.6	2463.0	1038.1	1267.3	3258.5	2211.8	2509.3	948.0	1820.6	969.6	2279.1	2378.1	706.9	1710.1	4227.3	1745.3	1001.3	1324.5	1559.7	2006.9	1615.8	2498.1	2399.9	1326.2	2953.0	1357.6	556.4	1184.0	333.4	895.8	882.9	1488.2	1886.9	1446.6	1149.2	1356.0	1749.9	1662.7	1421.4	145.3	1115.6	724.8	1154.7	1444.1	3507.7	669.4	687.1	668.9	816.3	646.1	673.9	697.9	665.1	696.9	721.7	684.7	729.6	2092.1	189.1	415.6	35.3	3749.3	3975.7	5198.9	3485.6	4465.8	234.8	4763.1	7627.1	82.4	1611.4	1245.9	711.7	102.2	2537.2	2453.7	1497.3	2181.5	1773.3	1117.1	1158.9	3170.1	1957.3	1430.9	2176.2	28.2	4573.5	5119.4	1862.6	1826.2	1529.2	694.4	3951.5	2026.4	1661.0	2373.7	107.7	33.6	3051.9	1043.6	2693.9	3423.6	4294.3	3611.5	2216.3	2218.0	37.5	2893.8	989.3	2520.1	18.1	49.2	3180.2	2816.5	1583.5	2556.8	5203.2	3720.1	3760.6	507.1	405.3	1143.9	2535.7	2110.2	564.9	465.2	5714.8	5075.9	2455.2	2765.1	5917.8	3455.9	5933.8
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA		470000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	2058.6	1934.3	965.6	1484.2	985.8	2965.1	2704.2	936.9	1071.1	2705.4	1023.2	2078.1	1515.1	2007.3	1653.7	2522.3	2423.9	1128.4	1326.4	894.6	951.2	1745.2	1894.1	1421.2	2460.9	984.1	951.1	4838.0	4514.8	1462.2	1861.5	1099.8	977.1	2180.0	1361.7	809.1	2210.1	1551.8	558.4	3337.9	1722.9	1388.1	1050.0	1824.1	1982.0	752.6	1002.9	2006.1	1709.0	417.1	2320.5	2012.9	2317.5	996.1	2010.5	1836.9	2035.9	2149.6	2535.3	5394.1	2745.1	1497.8	2703.5	1400.5	1249.7	2327.8	1425.1	8262.2	2062.9	1734.1	873.2	1246.8	2275.3	3060.5	923.2	1448.3	2207.4	2039.5	2153.8	3438.2	3887.7	2932.6	1619.9	5321.2	4063.7	1265.0	4504.5	3956.7	2765.5	2217.6	2407.8	2657.6	2135.0	2597.5	2974.5	4241.1	2054.6	2172.9	1273.8	2369.5	1924.0	4017.5	2609.2	2927.6	1823.4	2180.2	936.2	2925.4	5031.9	1242.2	2226.2	4761.3	2864.1	951.4	1534.4	1027.8	1788.2	2074.0	1741.6	3606.5	2111.3	2564.4	1093.9	638.7	1690.8	351.4	3488.7	1481.6	5383.7	5629.1	4993.5	4037.9	2821.8	5113.1	6376.7	5111.7	215.7	4472.3	1339.8	3182.6	3668.7	11623.3	965.6	985.8	936.9	1071.1	894.6	951.2	984.1	951.1	977.1	1050.0	1002.9	996.1	2118.4	984.0	2299.9	16.3	4551.5	10412.0	9836.0	9475.4	2792.1	1065.7	9967.6	10172.3	182.6	4213.6	3849.3	1441.9	425.4	5623.9	4123.0	1288.7	5893.0	2943.4	2097.6	1061.7	2644.4	3666.1	2726.6	2263.9	17.0	6539.7	7508.2	2678.8	1207.4	1390.0	1784.7	4203.6	3429.3	2085.8	3282.5	358.4	18.3	3696.8	2925.6	3062.8	6215.2	4622.8	5581.1	2203.8	5104.8	17.8	3733.3	2455.8	4243.1	9.5	25.1	3814.3	2946.3	3499.2	2308.1	8261.9	3481.6	5422.4	1350.6	1305.5	1577.7	4469.5	4329.1	1074.6	1014.8	3712.4	12290.3	5489.4	4201.1	4673.7	4830.3	9407.7
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		310000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	2169.1	1286.7	1542.9	1403.8	1616.7	3766.6	4078.2	1552.0	2178.4	2624.2	1490.6	1879.4	1171.1	1990.6	2424.1	1907.8	2592.8	1319.4	1503.2	1501.7	1591.6	1375.6	2352.0	1477.3	3296.1	1596.1	1538.2	5616.9	2583.9	1413.7	1079.4	1341.1	1621.2	1773.7	1967.2	634.7	2148.1	1530.1	2778.6	2895.1	1788.4	1618.1	1613.6	1983.8	1841.8	658.7	1566.5	3112.9	1744.0	2442.9	3898.8	2116.9	2144.4	1661.2	3358.5	2302.6	2395.7	2319.1	3463.7	6460.5	2290.5	1929.4	3501.7	3277.9	2880.0	2560.3	3121.6	4403.5	4934.1	2851.4	1408.4	2158.4	3072.1	3675.9	3436.7	1734.7	2547.3	3817.6	2173.7	3445.6	5063.9	2047.0	1830.0	5463.0	5859.2	2408.7	6912.4	3818.6	3479.7	3804.8	2814.6	2850.5	2866.9	4562.1	4848.6	3870.2	2142.9	8254.3	3304.7	2578.5	1815.0	4130.4	2718.3	3174.1	3464.7	2947.9	1117.1	2785.7	4699.0	2414.5	3667.8	4793.0	1873.6	1253.2	1328.9	1885.1	2357.7	2931.8	2681.4	3686.5	1758.0	4203.3	1869.4	1087.1	1542.9	674.9	2014.7	1325.2	2975.8	3533.8	3482.3	2704.0	1937.3	3224.2	4471.8	3686.3	520.5	2037.1	1212.6	1921.8	2476.6	4634.7	1542.9	1616.7	1552.0	2178.4	1501.7	1591.6	1596.1	1538.2	1621.2	1613.6	1566.5	1661.2	3373.1	852.5	1462.3	22.2	6269.8	3791.4	4320.2	2146.2	5538.1	251.5	4342.6	9218.9	66.3	1441.3	1424.1	555.4	139.7	2675.7	4184.6	1233.9	1792.1	1872.1	1333.5	1359.6	3432.8	2196.1	1647.4	2350.9	24.2	3733.5	3914.4	2206.6	1829.8	1820.2	1560.7	3526.6	2224.6	2204.3	2298.9	144.7	28.3	3237.2	642.9	2912.4	4020.1	2532.2	4373.5	3115.9	1988.6	33.7	3957.1	1623.5	3901.2	18.1	54.5	2580.0	2676.0	2403.1	3084.7	4207.4	2142.3	2511.0	640.5	392.2	1406.8	3481.1	2754.6	926.1	635.4	5831.2	4174.6	2901.7	5319.1	2561.6	3407.3	4410.9
RPL31	L31	ENSG00000071082	"Ribosomal protein L31"	P62899	2	101002229-101024032	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA072263	Approved					NA	NA		110000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA072263: AB_2686502"	"unprognostic (4.82e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.51e-2)"	2836.5	1934.3	1831.5	1386.1	1850.8	4256.9	3080.8	1746.6	2503.7	3518.1	1791.4	2505.6	1186.7	2435.5	1712.5	2918.7	2787.5	926.1	2000.5	1782.3	1807.5	2132.0	1653.2	1865.3	2372.9	1811.2	1791.3	5933.5	3677.5	1196.2	2117.3	1310.0	1804.2	2434.0	1371.4	636.0	2261.9	957.0	2619.9	3250.2	2054.7	1032.7	1858.5	2183.6	2282.1	766.8	1876.1	2235.6	1952.8	1399.7	2240.6	2587.6	3039.2	1851.7	2131.8	1223.9	2161.3	3354.1	4081.4	5576.9	4033.6	3365.3	2630.1	2057.6	1635.4	3869.0	2441.5	5448.6	2542.4	2168.0	2092.3	2298.5	2112.3	3408.0	2154.0	1942.4	3326.5	3222.5	3926.9	4547.4	3203.0	5735.5	2507.1	4590.2	5268.6	1810.4	4133.3	4419.6	2364.2	2877.4	3081.2	1252.2	2394.2	2822.0	4274.2	7185.2	4047.5	2859.0	1460.9	2363.2	3273.8	4437.9	3238.0	3345.3	2666.9	2906.1	1424.2	4883.1	6312.3	1954.6	2369.4	7643.6	3601.4	1663.1	2960.9	1965.0	2671.1	2618.3	3840.8	3720.7	2310.8	5301.1	1651.1	1913.5	3911.6	860.5	4359.8	2983.4	7228.7	8467.2	7801.4	6122.4	5140.0	7039.0	10632.6	8774.1	567.2	5348.4	2507.4	5182.9	5414.0	14433.2	1831.5	1850.8	1746.6	2503.7	1782.3	1807.5	1811.2	1791.3	1804.2	1858.5	1876.1	1851.7	371.3	1352.6	2182.1	17.3	2271.0	3559.8	3859.2	3734.6	1044.3	69.1	2577.6	1284.6	809.5	1870.1	2378.5	1259.8	33.3	4002.6	1393.0	1267.4	3644.9	2181.4	1237.0	750.6	1149.8	1613.1	1770.7	1556.4	23.5	4152.0	4687.5	1518.2	498.9	849.8	2176.4	458.5	2626.5	2193.9	2563.9	48.8	19.5	3731.2	1055.9	2680.9	4079.7	2108.6	4234.0	1331.1	2459.9	16.9	3560.2	409.0	3318.3	21.6	16.7	3288.7	2799.4	2097.7	609.8	3081.4	2175.4	4409.4	1292.7	99.5	1255.6	2624.5	1366.9	600.1	397.6	1504.9	4376.2	3853.0	2405.7	543.9	3818.3	3606.7
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841582	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		45000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	1907.8	1194.0	1183.6	985.6	1234.6	2971.9	2518.6	1157.9	1625.9	2186.9	1121.8	1558.0	888.8	1458.5	2020.0	1799.9	1857.7	928.0	1266.4	1148.0	1212.7	1252.7	1295.7	1185.9	2346.7	1206.9	1168.5	3697.3	2765.5	775.2	986.3	974.3	1231.2	1537.4	1561.1	523.9	1561.0	780.3	2422.9	2644.1	1380.3	1321.4	1242.7	1511.9	1420.5	567.9	1204.2	1741.0	1134.2	1544.1	2984.9	1566.9	1867.1	1268.7	1494.9	1746.7	1497.4	1918.8	2298.7	4080.5	4927.7	1200.0	2217.5	2476.7	1684.5	2327.2	1482.5	2572.0	1066.1	1735.3	812.9	909.5	1718.2	2495.2	2023.2	1198.1	2874.3	1501.4	2099.3	2562.1	3427.6	2450.0	1456.5	3696.3	5338.3	1895.4	3629.5	2438.7	2198.5	1863.5	1879.0	2323.9	2054.2	4479.6	2773.8	4208.3	2534.9	2129.5	3285.7	2180.2	1344.1	3390.6	2540.9	2434.9	945.7	1887.9	807.8	2141.2	2740.7	1329.5	3137.0	4624.7	1280.6	1066.6	1359.4	1419.3	2254.0	1557.7	2671.2	4640.8	1357.9	3466.6	1629.6	1259.1	2347.0	621.3	2399.6	1800.7	4325.6	5980.2	4749.7	3485.2	3077.9	5413.0	6661.3	5216.7	320.4	2897.7	1489.1	3049.5	3940.9	9478.6	1183.6	1234.6	1157.9	1625.9	1148.0	1212.7	1206.9	1168.5	1231.2	1242.7	1204.2	1268.7	3508.6	1070.5	1834.7	48.6	7663.9	9224.7	7932.7	5817.1	6926.2	342.4	9401.1	14609.2	488.6	3061.2	2689.8	1460.3	166.8	4947.7	4337.7	1512.3	4560.6	3028.0	1986.6	1422.0	4295.9	4075.7	2307.8	4056.3	39.3	6515.0	7623.3	3321.2	2414.9	1972.5	2387.6	3801.4	4734.3	3694.7	4285.0	180.0	41.2	5268.2	1723.2	5797.3	8513.9	7985.2	6662.4	3978.7	4845.2	43.1	6310.8	1703.6	4092.7	18.1	47.3	4383.7	3899.5	2998.1	3398.6	7138.0	3381.8	6786.8	1088.2	684.5	1965.6	5442.0	4616.2	1064.1	1260.6	8612.8	10963.5	4878.3	6299.1	5026.8	5534.7	8006.9
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620569-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	2425.0	1591.7	1002.0	785.6	1018.3	2268.5	2730.5	987.4	1524.6	3162.1	962.2	2061.8	823.2	1963.6	1544.1	2142.7	2352.9	621.4	1521.5	956.2	997.4	1752.0	1479.4	1498.1	1670.2	1010.6	982.1	4574.1	4126.6	561.6	1616.2	716.9	1015.1	2107.6	914.8	439.0	1967.4	729.0	1791.6	2675.3	1965.7	686.3	1052.9	2223.5	2008.0	507.9	1033.0	1276.7	1700.7	739.6	1511.2	2044.7	2481.9	1055.4	825.0	541.4	1026.2	1485.8	2018.1	3044.8	1023.2	1230.1	1393.2	916.9	752.8	1358.5	1395.7	2413.4	723.7	1117.5	499.4	564.9	1064.4	1792.9	1160.3	927.5	1680.3	1034.0	1087.0	2109.6	1708.0	2628.2	1118.4	2837.7	2381.1	773.6	1701.2	1839.1	1618.7	1345.9	1731.4	1357.1	1479.3	1452.6	1625.9	3123.7	1214.4	1794.1	1095.2	1473.5	1112.4	1478.1	1929.2	1234.1	1099.4	1409.8	510.1	2915.7	1881.3	805.7	957.1	2348.2	1357.7	674.5	926.3	711.3	1121.6	1020.7	1327.3	1913.0	924.1	1533.2	859.0	1744.5	3024.8	943.1	2796.0	2242.1	4811.7	7783.4	5669.6	3854.8	3005.0	6460.3	7498.4	5716.8	610.2	3571.6	1985.1	3793.7	4557.8	12314.4	1002.0	1018.3	987.4	1524.6	956.2	997.4	1010.6	982.1	1015.1	1052.9	1033.0	1055.4	3354.3	1413.4	2496.4	19.9	8040.6	12566.5	10934.5	14134.5	6505.0	343.4	12055.8	16944.0	1156.9	4838.4	5399.5	2164.7	75.0	6443.9	5150.7	1717.5	6914.3	3577.3	1527.0	2002.3	4683.1	4313.0	2720.0	3488.0	31.4	8680.5	7464.2	3471.8	2274.2	2664.1	3308.2	3093.0	5696.3	5781.3	4151.7	154.8	29.1	6030.2	3912.2	6966.0	11139.9	2023.8	7477.3	4326.2	5839.5	43.1	7738.0	1718.3	4866.1	18.1	28.5	5645.0	4899.2	4032.5	3437.1	5962.5	5302.3	9409.4	2362.8	535.0	1913.0	6558.2	3975.1	787.2	678.5	6369.9	15308.7	6380.6	7015.5	2344.3	6469.6	8608.5
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	1898.8	1508.6	1462.7	973.8	1489.9	2729.0	1959.9	1434.2	1780.8	2116.4	1400.9	1768.2	809.5	1343.7	793.9	2540.7	1694.2	839.0	1467.3	1421.2	1502.6	1380.8	1746.4	1271.3	1990.2	1480.9	1456.2	3011.1	3413.2	853.0	1225.5	743.7	1484.9	1709.2	708.6	273.8	1811.1	736.6	2552.7	3033.7	1383.2	717.4	1498.9	1708.9	1567.2	669.4	1507.0	1569.3	1349.1	1589.5	1380.7	1655.0	2080.7	1516.5	2104.6	3225.4	1780.5	2469.8	1923.1	4033.9	2443.2	1626.3	2589.3	3295.8	2235.0	5370.0	2030.1	3127.8	1631.9	1836.1	1970.9	3986.3	2097.6	3578.7	1209.0	1929.9	3742.5	1266.5	4071.9	3541.9	3433.2	2856.0	1626.0	3759.1	5481.9	1973.9	3480.3	1809.7	2473.6	2927.1	2775.1	3857.2	2523.6	6848.9	3384.5	6510.7	3362.5	6272.1	4016.6	2849.6	2744.6	7026.2	2896.8	2469.0	2412.8	1946.7	1466.3	3452.9	3423.3	876.8	3508.4	4592.6	1269.5	1472.5	1558.9	2578.9	3357.6	2151.5	5523.9	4935.8	2059.7	2982.8	2523.1	753.7	1769.0	695.2	2322.2	1602.3	3101.1	4455.5	3086.5	2676.2	2564.2	4099.1	3218.0	2834.7	221.1	2414.5	1352.2	3650.6	2715.7	7293.7	1462.7	1489.9	1434.2	1780.8	1421.2	1502.6	1480.9	1456.2	1484.9	1498.9	1507.0	1516.5	1202.7	637.8	1152.6	15.3	3024.6	5507.5	4326.2	3639.5	1752.9	221.3	4389.9	4459.0	750.7	1732.9	1653.3	1134.8	85.5	2799.3	2227.9	1319.7	2701.9	2347.8	1562.9	826.5	1969.5	1751.1	1298.1	2073.6	9.0	6137.7	4495.9	1544.5	976.6	1135.5	1308.1	2164.6	2362.3	3182.4	2826.7	109.4	9.7	3044.7	1249.2	3375.2	4877.3	6025.8	2777.4	1833.7	2821.1	11.2	3348.5	925.7	2482.0	9.5	16.2	3542.4	2346.8	1285.2	1756.4	4196.5	2319.0	3772.0	618.9	410.0	992.7	2309.7	3771.2	790.9	905.5	3017.8	7263.3	2464.8	2473.5	1760.1	3346.1	3998.4
RPL36	"DKFZp566B023, L36"	ENSG00000130255	"Ribosomal protein L36"	Q9Y3U8	19	5674947-5691875	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 11665.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA047153	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Endoplasmic reticulum"	"HPA047153: AB_2679958"	"unprognostic (2.81e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	1009.1	1529.4	633.1	565.3	634.4	1235.3	1113.6	595.7	819.4	1302.6	608.6	897.6	514.0	791.6	277.7	1382.3	1064.1	279.1	713.6	609.7	641.8	787.8	824.0	679.5	784.0	618.3	610.5	2559.9	2201.5	235.6	765.2	343.8	618.4	1153.6	282.7	134.9	1110.6	274.7	800.3	1876.9	864.7	214.7	626.9	1033.9	985.2	314.7	650.9	453.3	617.6	257.5	447.0	934.9	1204.6	640.0	1624.4	856.8	563.8	1439.8	676.2	1344.8	823.6	876.3	668.8	1021.0	840.8	1615.3	852.5	1173.9	1993.7	460.6	429.9	1130.5	516.6	1284.8	273.3	856.5	3892.1	744.2	839.2	1347.5	1732.2	1494.3	939.2	1304.3	1881.9	661.5	1160.1	829.4	856.6	1550.4	977.0	3630.2	553.6	1856.8	1934.9	2131.5	1915.2	955.3	2992.0	1187.0	608.1	3086.6	902.4	1141.2	1016.4	1276.6	521.4	1536.1	2592.7	259.3	1192.0	2488.2	811.2	603.9	762.9	875.4	1932.2	1609.3	1644.9	1795.1	1144.8	2480.1	859.7	649.8	1088.5	429.3	1239.7	894.7	1916.1	2491.9	2383.9	1779.7	1355.7	2443.4	2607.7	2240.3	143.2	1263.2	776.1	1337.7	2019.7	4662.9	633.1	634.4	595.7	819.4	609.7	641.8	618.3	610.5	618.4	626.9	650.9	640.0	2057.7	580.1	876.3	15.3	4029.9	6658.4	3062.7	4422.0	4306.5	233.8	7828.9	11665.5	326.1	1947.4	1831.0	1239.6	81.3	2834.0	2054.5	1783.8	2625.6	2857.3	568.5	1386.5	2987.3	2294.5	2048.6	1929.4	11.4	8143.9	4805.4	1873.1	2019.4	2045.2	1297.2	3141.8	3392.5	2952.1	2803.1	97.6	12.3	5548.2	1243.1	3831.3	4994.8	1712.7	3252.6	2108.4	3041.6	26.2	4068.5	1058.4	1988.7	10.1	18.4	5545.1	3883.8	1542.9	2258.4	3579.6	3704.5	3521.3	847.6	346.8	927.0	2285.6	1750.6	385.0	717.0	5107.2	9200.4	2783.1	3173.4	2031.0	4778.3	3290.7
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396155	"Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 3019.1;Undifferentiated cells: 3021.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2852.7"	"Low region specificity"	"Detected in all"							"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	1674.1	1002.0	390.2	179.6	390.9	502.0	1779.0	387.0	608.7	1862.0	390.9	1384.5	163.9	1291.5	278.5	1823.7	1542.2	94.6	878.4	384.9	392.9	1127.4	829.5	1066.3	304.6	398.8	389.8	3553.5	2580.0	160.2	799.7	230.4	393.6	1347.0	290.4	94.6	1304.2	219.6	1546.0	2491.5	1369.6	209.8	398.2	1575.2	1319.0	266.3	391.9	430.4	981.5	224.1	502.0	1430.5	1751.0	405.9	508.3	1045.1	465.5	237.5	640.1	1232.0	273.6	198.9	532.7	642.1	1017.6	1196.0	360.1	571.6	367.5	318.1	399.5	350.5	727.8	641.2	651.0	309.1	1445.2	205.8	1919.5	1159.3	803.0	413.1	364.3	985.5	1395.8	436.6	895.6	931.0	576.9	563.1	486.8	660.7	546.2	2852.7	288.5	1285.4	583.8	1637.7	1118.7	367.7	384.8	863.5	633.5	811.3	314.8	508.8	116.8	506.3	608.3	459.4	238.4	806.3	187.0	206.4	369.8	477.2	350.9	330.0	475.0	470.0	223.6	749.5	240.3	130.7	562.7	109.4	608.3	591.8	1102.4	1242.0	1212.6	866.9	814.7	957.9	1322.5	1179.8	51.0	760.6	615.8	919.8	678.7	1804.2	390.2	390.9	387.0	608.7	384.9	392.9	398.8	389.8	393.6	398.2	391.9	405.9	309.5	439.1	987.0	0.0	1100.1	917.4	432.3	574.6	595.8	28.9	1600.3	970.8	16.1	885.0	946.8	174.7	14.6	762.3	615.9	641.2	434.3	1235.1	9.4	124.9	331.6	566.0	1100.8	1215.5	0.0	3019.1	1125.2	523.5	315.0	164.3	1272.4	137.9	1387.8	738.4	609.1	15.2	0.0	2744.0	183.1	2089.7	1144.3	49.3	1055.9	565.6	524.7	0.0	1620.0	187.9	710.6	0.0	0.0	2338.4	1805.5	418.6	559.4	350.6	1349.6	611.7	329.9	41.2	236.7	512.1	467.7	28.7	99.3	758.7	1122.1	751.4	875.8	153.1	3021.8	351.4
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498825-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		87000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA065327: AB_2685469"	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	2894.2	2485.3	3571.1	1229.7	3641.9	2540.7	3450.6	3500.1	5561.8	3540.4	3427.6	2751.2	1111.0	2511.3	1607.3	3586.9	2970.5	473.7	2704.2	3470.4	3604.5	2072.8	2064.6	1905.6	1484.2	3596.9	3545.7	5492.1	4241.2	2106.3	2029.8	971.3	3587.7	2527.0	1539.4	1236.7	2385.3	1378.1	5240.2	4441.1	2070.2	1297.7	3658.7	2374.5	2568.6	1257.5	3665.2	3015.1	1910.2	4156.0	2246.3	2758.2	3080.7	3688.7	2117.5	1757.0	3750.8	2542.5	3820.2	6666.2	2783.2	2804.7	3711.8	2778.8	2362.0	4478.9	2000.9	2310.8	3821.8	3450.3	3000.1	2165.8	3570.4	4118.4	2861.6	2653.7	3779.3	3786.9	3130.5	6449.1	6532.0	4206.8	2285.8	7292.0	8500.4	2410.8	6755.9	7614.5	3897.7	4509.9	3008.0	3296.4	3653.4	4222.0	4025.0	8611.8	4350.4	4680.8	1985.4	2874.3	2818.9	2846.9	3975.2	3650.5	2425.5	2719.7	1032.7	3199.3	6926.2	5291.2	2027.5	7146.0	2649.0	2006.9	2201.6	1991.6	3119.4	3471.7	5348.9	4515.3	2242.4	2876.4	2081.6	1025.7	2303.5	546.8	2463.3	1720.1	3379.1	4446.9	3801.3	3078.0	3061.9	4258.4	4343.3	4006.9	281.8	2725.4	1469.9	4230.5	3011.4	6099.2	3571.1	3641.9	3500.1	5561.8	3470.4	3604.5	3596.9	3545.7	3587.7	3658.7	3665.2	3688.7	1310.3	1198.7	1865.0	20.2	3813.1	4936.9	3370.7	3086.2	2318.0	513.1	5676.7	3353.1	1482.9	2713.7	2139.1	1265.3	185.6	3021.4	2978.5	1879.2	3155.8	2994.2	3958.3	1634.1	3979.9	2334.0	2623.6	2835.7	16.8	8453.9	5257.7	1903.5	1194.2	2334.1	2170.9	3057.7	3945.8	4967.1	3060.4	200.2	18.2	4863.9	935.8	4892.5	4112.7	7778.0	5740.1	2453.8	2853.1	15.9	3968.7	2304.7	3980.5	11.1	24.2	6102.8	5240.6	2969.2	2205.6	3694.1	3198.7	3898.4	964.1	755.8	2005.0	4215.6	2775.8	2230.8	1623.5	4320.7	7355.8	3208.5	2814.6	1760.7	5273.7	3405.9
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA052543: AB_2681864"	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	1529.9	1174.4	1493.3	822.1	1517.9	1450.0	1568.3	1474.2	1847.8	1873.4	1400.3	1523.8	648.5	1256.8	845.0	1496.0	1435.2	271.4	1470.8	1447.8	1522.6	1124.6	1109.4	1065.7	1010.8	1521.8	1487.5	3163.1	1992.1	754.3	941.5	546.1	1528.1	1267.5	660.1	379.7	1190.0	533.6	2848.0	1967.6	1244.9	535.6	1533.5	1419.7	1231.8	784.8	1535.7	1452.5	1083.8	1900.3	1197.5	1373.2	1569.6	1604.3	1720.7	1654.5	1568.1	1609.4	2096.5	2459.6	1552.1	1818.4	1160.9	1622.8	1130.0	1870.1	1274.6	3002.4	1237.3	1565.8	1504.9	1512.7	1888.2	2361.4	1266.0	844.7	3028.3	1724.1	1374.6	2467.9	2443.9	3251.8	1474.0	4777.2	3230.5	1527.0	2469.4	2179.8	2416.1	2387.7	2155.9	1622.2	1375.7	1793.0	3170.7	3903.4	1837.0	3823.2	2488.8	2259.2	3321.0	2695.8	1971.0	1317.5	1415.6	2630.5	757.0	3129.9	4282.5	1942.0	2389.2	3316.1	1592.2	1347.1	2210.4	1254.4	2416.6	2187.4	3677.2	3159.9	1104.9	2101.7	1314.4	1192.1	1841.8	676.2	1819.2	1524.9	2176.5	2904.1	3073.8	2304.5	2001.8	2772.2	3429.7	3037.1	575.3	1491.2	1383.9	2455.1	2101.1	4458.5	1493.3	1517.9	1474.2	1847.8	1447.8	1522.6	1521.8	1487.5	1528.1	1533.5	1535.7	1604.3	863.9	451.9	901.6	12.7	2204.9	2331.7	1278.1	1084.7	961.2	186.6	2059.8	1364.6	753.8	1509.9	820.1	614.3	73.0	1330.3	1639.9	1230.1	1441.9	1518.1	1413.7	1051.3	1657.7	1158.2	1469.3	1411.7	9.9	2875.9	2467.6	981.1	490.8	1223.8	1223.7	933.3	2189.2	2371.8	1800.6	87.5	9.1	3044.0	413.0	2925.5	2553.8	3689.8	3016.5	1394.9	1213.1	7.5	2817.4	751.3	2063.9	7.1	15.2	2380.8	2171.4	1509.4	769.1	1476.4	2127.6	2377.0	565.8	266.1	959.8	1959.8	1054.6	956.0	1132.1	1084.0	2690.5	1450.3	1884.0	684.7	2643.7	1293.5
RPL39	"L39, RPL39P42"	ENSG00000198918	"Ribosomal protein L39"	P62891	X	119786504-119791630	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047105	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA047105: AB_2679933"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.23e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (3.26e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-3)"	2758.9	1920.7	1297.4	1564.1	1330.8	4434.2	4785.2	1314.0	2217.5	2681.7	1288.0	2199.2	1365.1	1529.6	1766.4	2603.2	2080.4	1019.9	1834.5	1268.3	1332.4	1680.5	2213.0	1756.2	2882.6	1342.4	1305.9	4396.1	3205.9	1232.9	926.0	1220.7	1347.9	1885.2	1997.2	671.1	2109.2	1109.0	2836.0	3741.5	2121.3	1211.3	1382.7	2696.3	1936.3	366.7	1332.6	2522.8	1546.2	2540.4	3209.8	2184.0	2432.2	1381.5	3790.9	2372.2	3355.8	2743.6	5777.8	7348.5	3178.2	3493.5	4019.6	3974.8	3532.9	2448.7	2820.6	5944.9	3525.9	3582.5	2637.3	3088.9	5379.6	4672.4	4104.6	2114.7	8156.7	2834.5	3244.6	3575.6	4849.7	4998.5	2254.4	7107.5	8225.4	3115.6	5824.5	5356.6	4678.2	3946.7	3572.9	4114.3	3734.8	5153.1	3507.5	9057.2	5322.7	8755.2	5275.2	3233.9	4361.7	7431.3	4643.9	3008.5	1991.1	4035.7	4464.5	4033.9	6372.9	3147.0	2124.6	5293.9	3527.2	1439.4	1421.9	3886.7	5654.4	2576.9	4797.0	6316.6	2145.5	7095.7	1744.6	1417.6	2604.1	867.7	1828.2	1821.3	2930.8	4593.5	4019.7	2791.2	2704.3	4082.4	4601.8	3724.8	584.5	2142.6	1686.8	3008.0	2822.1	6382.9	1297.4	1330.8	1314.0	2217.5	1268.3	1332.4	1342.4	1305.9	1347.9	1382.7	1332.6	1381.5	3052.5	865.4	1237.9	15.7	9102.0	7445.1	4567.7	6856.6	8468.5	201.2	9097.0	13551.0	642.9	2480.7	2636.8	938.0	85.5	3985.6	4514.3	1526.9	2089.5	2510.9	62.3	2477.4	5388.1	2798.9	2432.4	3741.9	16.0	5763.7	7685.9	2812.1	3289.6	4119.0	1733.1	4292.9	4501.6	5863.2	3870.0	80.8	19.4	5577.5	1761.9	7840.8	7734.3	305.0	5968.4	4747.5	3858.0	20.6	6326.8	988.4	3492.3	9.0	20.0	4404.6	5124.9	2210.6	4802.9	3960.4	3756.8	2888.1	1088.6	368.1	1498.8	4028.0	2561.6	55.7	245.9	10630.2	8681.3	4615.1	6523.4	2580.5	6330.7	4299.6
RPL39L	RPL39L1	ENSG00000163923	"Ribosomal protein L39 like"	Q96EH5	3	187120948-187180908	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 210.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.6;Late spermatids: 245.5;Spermatocytes: 785.0;Spermatogonia: 161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047105	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA047105: AB_2679933"	"unprognostic (1.01e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.05e-4)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (6.94e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.02e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.60e-1)"	7.8	3.0	9.6	7.9	10.4	19.4	12.8	12.8	12.0	11.2	8.5	12.5	3.4	8.7	4.6	8.9	12.0	3.6	11.6	9.5	12.7	6.9	4.5	5.4	13.2	8.4	8.9	4.7	20.2	5.9	4.8	6.0	8.6	9.9	4.5	6.8	8.3	7.1	2.1	12.0	6.2	8.2	6.6	7.0	6.8	210.5	10.0	16.5	4.0	2.3	14.1	8.5	10.7	12.5	213.2	67.3	22.4	35.9	10.2	15.3	20.9	56.6	44.0	51.0	54.8	5.6	33.3	78.7	203.7	32.7	98.2	64.7	56.4	10.8	77.5	136.5	9.1	1.5	69.7	1.3	19.3	18.7	20.3	12.7	8.2	42.2	35.9	38.9	52.6	95.4	42.8	90.3	19.4	62.7	2.1	66.0	162.8	65.0	122.7	69.5	31.0	58.9	17.0	4.8	54.6	56.8	47.3	120.2	138.0	94.1	118.8	55.4	24.8	1.4	59.6	48.5	59.2	118.6	138.1	153.4	30.8	69.9	117.0	6.1	10.7	2.6	25.1	10.4	12.3	33.1	25.1	22.5	10.8	22.7	17.2	26.1	2.2	16.5	7.3	12.2	47.5	30.9	9.6	10.4	12.8	12.0	9.5	12.7	8.4	8.9	8.6	6.6	10.0	12.5	3.0	3.2	7.1	2.3	21.0	25.0	37.0	32.5	19.4	3.4	30.4	35.9	48.4	14.3	10.7	3.7	0.0	26.0	9.1	3.3	7.9	13.0	545.6	16.4	14.7	8.1	0.0	8.8	1.8	2.6	95.7	16.8	5.1	9.2	7.0	21.1	23.6	50.4	40.3	6.7	1.6	4.5	16.2	19.1	25.5	245.5	21.8	9.9	23.2	1.0	4.3	16.6	34.0	3.0	1.3	10.5	2.2	11.7	27.2	31.6	0.7	2.3	10.2	2.2	6.6	8.5	26.4	785.0	161.7	12.7	21.2	14.9	16.0	14.5	8.4	30.4
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 943.6;tongue: 422.7"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 134.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	0.3	0.4	0.9	0.2	0.6	1.7	1.4	1.7	0.8	0.0	1.0	0.2	0.6	0.3	0.4	8.5	0.1	0.5	174.0	0.5	0.4	0.4	0.3	0.2	0.4	0.1	0.0	0.3	11.5	0.0	0.1	0.2	0.1	4.2	0.0	1.2	6.9	0.1	943.6	0.7	0.5	0.0	0.0	0.4	0.2	6.4	0.1	0.1	0.4	422.7	0.1	0.2	0.1	1.0	1.1	1.2	0.3	1.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	4.0	2.1	0.6	0.7	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.6	0.4	0.9	1.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.7	0.0	0.7	0.4	2.8	0.0	0.6	0.8	1.0	0.6	1.2	2.5	0.4	0.3	0.9	0.1	0.4	1.6	0.5	0.5	1.4	0.6	0.7	0.7	0.6	0.6	0.6	1.4	0.8	0.4	1.2	0.6	0.5	0.8	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	0.3	0.3	1.2	0.2	0.3	0.4	0.1	0.1	0.9	0.6	1.7	0.8	0.5	0.4	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.2	0.0	0.0	0.1	0.6	134.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.1	1.3	0.0	5.3	0.1	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	23.7	2.2	0.7	2.4	0.0	0.4	0.0	0.2	0.1	0.1	0.5
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034600	Uncertain		Approved	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	831.6	565.7	367.7	738.6	404.0	1928.0	2030.6	377.1	545.7	1385.7	370.7	970.8	451.2	1276.0	1088.2	1289.4	1454.2	776.9	914.1	385.6	388.6	751.5	914.9	666.3	1630.2	376.4	380.9	3022.1	1740.5	954.0	504.0	746.1	386.6	709.1	1143.5	350.6	1234.8	1092.1	1314.7	1327.1	507.9	1353.5	383.2	776.9	643.8	296.4	373.4	1883.4	1289.5	1921.7	2451.3	1322.4	782.5	406.8	1192.9	2343.4	973.0	1646.3	4272.4	7697.6	1710.1	1416.1	2899.7	2143.0	1648.1	2611.3	2025.2	4676.6	1572.3	3396.6	1011.9	2105.0	7026.5	5476.3	2352.2	1301.4	4208.3	2872.9	1955.7	2201.2	6007.7	3042.0	1376.1	7627.4	6980.3	2334.4	9237.8	2620.8	3489.1	2180.2	2682.6	1785.2	3252.1	1956.0	2044.2	1348.1	2136.9	2634.2	1661.9	2256.2	2213.4	4588.3	2958.1	2321.4	1718.4	1794.6	872.3	2447.5	3515.4	2022.2	1812.5	4303.4	2059.2	1111.1	1662.1	1048.4	2297.9	1736.5	2937.8	3118.9	1368.2	4015.4	1281.7	46.4	455.3	62.2	359.4	370.9	668.1	711.1	698.6	506.5	586.8	644.5	888.5	721.6	26.9	478.1	361.3	372.8	589.8	1758.0	367.7	404.0	377.1	545.7	385.6	388.6	376.4	380.9	386.6	383.2	373.4	406.8	393.9	451.9	1004.9	28.1	1553.4	2423.4	2769.6	2082.8	1295.3	122.6	1594.0	1140.4	403.3	760.7	1165.2	342.1	81.3	2059.9	1055.8	364.9	1651.3	1162.8	672.5	337.9	821.0	840.2	761.1	1195.8	26.2	2141.0	3735.7	879.7	467.9	430.0	945.5	899.2	711.0	715.5	1211.2	40.4	23.9	1089.8	636.8	1281.3	2031.3	1392.4	1334.0	991.6	1088.5	27.2	1920.9	417.7	1196.8	15.1	30.0	1239.9	737.1	996.0	1019.5	2031.3	370.6	1572.3	603.9	169.9	460.2	1196.4	934.7	376.4	454.9	1632.1	2583.2	2398.3	1289.5	1184.6	1371.2	2628.6
RPL41	L41	ENSG00000229117	"Ribosomal protein L41"	P62945	12	56116590-56117967	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 35670.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053169	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA053169: AB_2682067"	"unprognostic (7.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	3936.1	4294.0	3557.6	3101.7	3613.5	6945.6	7552.2	3463.0	4861.4	4729.6	3626.0	4637.2	3164.3	3213.6	5188.3	5197.9	4452.5	2395.7	3076.1	3477.3	3785.5	3342.3	4356.3	3110.7	5506.9	3599.0	3568.2	8695.6	8504.0	4160.3	3131.9	2392.0	3600.6	4113.2	4408.4	1725.9	5119.7	2985.6	6133.0	6292.8	3521.6	2870.0	3637.4	3885.7	4297.4	964.0	3697.2	5319.2	3521.9	4727.8	6456.2	4672.0	4325.6	3592.3	6313.5	7806.3	7002.4	4830.9	7462.6	11563.8	4509.5	5592.4	7268.0	6990.8	5609.0	7636.8	7281.1	11851.0	7075.7	7144.1	2202.9	5093.1	8802.0	9018.4	6003.8	4866.6	8636.4	5198.6	5743.2	7893.5	8420.9	9422.8	4324.7	12971.4	11986.3	6362.7	13815.8	13392.7	8210.7	6311.2	5234.4	11000.9	6880.6	11434.7	8612.8	13968.6	8415.8	7977.4	7366.9	6352.2	6645.3	9568.4	9027.5	8830.5	4162.2	7204.8	5240.2	7801.5	11830.4	4744.8	9323.1	11208.4	5182.2	2985.4	5510.3	3766.0	5664.5	4989.5	9471.9	9750.5	4626.0	7490.8	3249.4	5072.5	5556.2	2971.9	6805.5	4758.3	9483.2	13388.0	10983.9	8845.1	6687.5	11498.7	11453.0	10037.6	2088.9	6839.0	4546.0	8108.0	9032.3	22344.5	3557.6	3613.5	3463.0	4861.4	3477.3	3785.5	3599.0	3568.2	3600.6	3637.4	3697.2	3592.3	5593.1	2484.0	4469.3	30.3	8258.1	20641.6	3999.9	15748.5	2099.5	489.3	25242.7	35670.2	584.2	6852.9	7643.1	3948.6	218.9	5477.3	8310.1	4631.3	10318.6	6428.1	822.2	3402.2	5615.0	4720.6	5139.1	3676.0	34.1	17900.6	8796.9	4448.1	803.8	4299.0	3546.3	5173.9	6544.8	10920.0	5896.5	213.7	31.0	11437.4	4752.5	9497.7	16486.3	3378.1	6739.8	4472.1	11120.4	34.7	11045.4	2983.4	7243.1	20.1	42.9	11407.4	10209.4	2920.3	2410.0	4695.0	12534.2	12547.9	4754.9	804.3	2143.1	4895.2	5070.6	550.0	666.0	3054.1	25829.7	5993.0	7150.4	4176.6	12114.5	4014.3
RPL5	"L5, PPP1R135, uL18"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92832013-92841924	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		430000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	1236.3	1035.1	515.2	786.9	538.3	1743.3	1798.7	522.4	778.1	1690.1	510.7	1412.8	798.0	1295.2	1388.7	1185.6	1420.7	647.6	890.3	487.5	544.8	858.2	794.9	794.7	1435.7	527.8	511.9	3356.4	2236.0	695.4	869.5	736.1	541.3	1103.1	982.0	346.6	1189.5	847.1	1115.8	1320.8	960.1	962.1	549.0	899.0	1135.5	374.3	528.7	1351.4	1179.5	830.7	1438.8	1309.6	1274.2	552.5	2211.5	924.6	1611.4	1369.2	2045.7	4096.6	2577.6	1283.0	1703.7	1560.0	1108.9	2467.5	933.6	4112.3	2002.9	1451.6	1477.1	1370.3	1871.2	2405.7	1976.3	1314.2	2557.4	2142.3	1402.4	2303.5	2447.2	3322.0	864.6	3382.6	3711.3	1390.4	3027.2	2813.9	2191.6	2129.9	2706.3	2106.7	1814.5	1247.7	2665.7	3741.2	2497.9	1659.1	1724.1	2407.7	3118.5	2702.2	1912.0	1798.7	1367.2	1632.0	836.3	2298.6	3961.6	1316.4	1268.8	4480.6	1345.5	781.6	1429.6	1498.4	2357.4	1290.8	1314.5	2793.5	531.3	2814.4	544.2	234.9	665.6	101.3	758.7	619.1	1520.2	1320.3	1385.5	1151.0	1138.3	1105.7	1729.8	1570.9	56.7	1005.7	552.2	942.7	1140.0	2356.3	515.2	538.3	522.4	778.1	487.5	544.8	527.8	511.9	541.3	549.0	528.7	552.5	1586.8	653.9	1042.2	29.7	3056.7	2843.0	4383.1	2206.0	3168.8	339.6	3182.0	5498.6	375.2	1522.7	1266.7	412.0	89.6	2557.1	2009.8	595.2	1993.7	1697.1	1438.3	840.8	2334.8	1567.8	1236.6	1980.6	35.0	2708.5	4211.6	1464.3	978.1	1009.8	1041.9	2287.9	1546.3	1087.2	1452.5	146.4	33.8	1986.9	720.2	1758.7	2200.6	1189.4	2829.9	1536.8	1406.9	35.6	2171.5	806.3	1969.1	27.2	37.7	1851.6	1567.8	2156.4	2067.8	3935.4	1225.7	2454.6	571.0	298.8	1051.8	2546.2	2122.7	682.8	501.7	3198.9	2893.0	2613.1	2318.2	2797.0	2572.8	3991.1
RPL6	"L6, TAXREB107, TXREB1"	ENSG00000089009	"Ribosomal protein L6"	Q02878	12	112405189-112418838	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060903, HPA068418"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No		620000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Microtubules, Cytokinetic bridge"		"HPA060903: AB_2732653, HPA068418: AB_2685987"	"unprognostic (5.95e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.90e-2)"	1199.2	1080.7	788.0	937.3	801.7	2387.8	1856.5	776.8	1063.3	1357.1	828.3	1249.1	789.1	1236.7	1570.4	1485.5	1241.3	734.2	856.8	756.3	814.1	985.6	1026.1	803.0	1847.2	805.2	807.2	2777.7	1984.2	1103.8	1049.8	763.3	801.3	1017.4	1222.4	531.8	1632.2	850.0	1451.0	1598.1	946.0	1018.7	822.2	1015.0	1214.8	279.2	808.0	1815.8	1223.2	1298.0	2204.7	1349.1	1216.0	818.0	1973.8	1887.6	2227.1	2264.4	2725.6	4486.8	2932.4	1843.2	2670.8	2471.8	1408.6	2975.9	1213.3	4225.2	1547.6	2008.9	962.8	1881.4	2395.5	3288.1	2456.2	1682.6	3199.4	2274.7	1590.4	2693.3	2854.8	4103.6	1708.4	4171.2	4542.3	1876.9	4294.7	4571.2	2818.5	2754.1	3060.8	1134.5	2888.4	2727.7	3013.0	6699.3	3096.5	4209.0	2233.7	2731.0	2375.5	4144.9	3118.1	3283.8	2050.1	2651.9	1297.5	3446.9	3342.3	2007.3	3621.2	4189.6	1657.8	1215.8	1484.2	1572.8	2110.7	1542.6	2549.7	3377.6	1573.3	2948.5	1861.4	730.3	2260.1	463.1	2285.0	1851.6	3814.8	3463.8	3465.4	2972.5	2896.3	3116.2	3751.8	3251.5	262.6	2839.0	1688.0	3372.7	3027.9	7777.8	788.0	801.7	776.8	1063.3	756.3	814.1	805.2	807.2	801.3	822.2	808.0	818.0	1483.8	798.0	1587.2	31.0	3121.1	3145.3	3907.2	3373.8	2996.4	271.4	3790.3	6493.7	262.3	1818.7	1733.0	636.4	137.6	3077.0	2809.4	731.3	3502.2	2270.2	414.6	1133.8	2774.3	1661.9	1388.1	1929.0	42.6	3043.9	4721.2	1695.5	1135.6	1287.6	1290.2	1743.7	1854.3	1727.8	1880.0	121.1	48.2	2036.2	1112.9	2566.7	2790.5	714.3	2849.7	1964.8	1899.7	30.9	3399.6	854.8	2699.3	34.7	48.9	2582.7	1646.1	1589.9	2173.6	3165.2	1095.4	3376.3	776.7	412.3	927.0	2550.9	1835.3	376.5	461.6	3977.5	3650.1	3068.7	2710.6	2783.0	2512.8	3577.6
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290242-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 17748.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		380000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: AB_2683694"	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	2254.0	1352.4	835.1	1322.3	886.2	3071.3	3298.9	846.6	1224.8	2495.7	843.0	1841.6	1316.8	1844.3	1839.2	2058.4	2057.2	1033.9	1342.4	799.0	860.0	1634.0	1593.8	1327.3	2285.6	859.3	828.4	4528.2	3067.3	1217.6	1195.0	1202.5	870.8	1650.4	1681.7	889.4	1843.5	1261.6	2391.6	2826.4	1420.5	1381.5	914.8	1388.9	1853.0	527.0	848.2	2225.3	1616.5	1832.1	2665.8	1978.5	2103.5	900.4	2902.0	2050.6	2163.3	2615.7	4308.7	5473.7	2120.8	3100.6	2474.6	2069.9	1621.0	2487.3	2940.4	8517.8	2467.6	2517.8	1409.2	2703.0	2888.8	3960.2	3204.7	2313.1	2394.1	4682.9	2687.5	2594.4	2583.2	3343.2	2298.0	5174.5	4574.0	1921.5	5950.9	3797.5	3412.0	2840.5	4261.7	3140.1	2980.2	2448.1	5345.2	5080.8	2528.5	5238.5	2182.9	3552.8	2474.4	3353.9	3241.5	2848.0	2977.1	2160.3	1454.9	17748.7	4599.1	1766.2	4497.4	4312.2	3227.1	1575.4	2407.3	2031.7	2913.1	1799.2	2782.6	5514.9	1649.7	4062.8	2654.8	3331.3	7192.1	1787.5	6932.4	5967.0	12630.9	14333.5	12042.7	9069.1	9565.2	12188.2	17585.4	12433.8	894.5	9240.8	5307.0	7970.3	10207.4	26909.6	835.1	886.2	846.6	1224.8	799.0	860.0	859.3	828.4	870.8	914.8	848.2	900.4	622.3	817.3	1610.8	26.1	2654.7	8054.8	9929.5	10766.1	1684.6	268.0	5251.9	4462.2	623.2	2396.3	3812.0	1311.3	125.1	4882.8	1798.3	926.5	5576.1	2795.4	1720.0	1068.3	2371.5	2338.1	1617.8	1779.1	27.0	5044.8	7032.5	2096.9	721.7	1300.7	1491.1	1110.8	2680.0	1876.1	3252.9	94.2	27.6	3112.1	3057.8	3661.5	5169.4	806.4	4246.4	1893.5	3705.1	25.3	4752.6	1792.8	3105.1	19.6	33.6	3149.3	2514.2	2310.6	952.9	5766.4	2274.7	5797.7	1454.2	380.6	1459.4	4118.3	2651.4	953.5	374.0	2143.1	9487.1	4878.7	2546.9	2145.3	4018.0	7816.6
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 6599.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		170000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	1100.4	864.4	197.2	397.5	201.1	1020.7	1162.7	197.3	361.6	1387.5	199.5	1138.7	688.7	1042.4	63.7	1406.6	1118.6	146.4	962.6	174.2	193.7	889.8	709.6	796.1	424.5	214.1	195.2	2192.7	2021.1	150.3	784.2	264.4	199.9	974.9	110.0	22.9	1320.1	201.8	1651.4	1800.7	885.7	115.6	222.7	918.6	1003.5	304.7	218.2	150.0	739.9	194.0	196.4	1099.7	1240.2	218.1	2486.1	2860.3	200.1	874.6	220.0	496.0	1913.2	1747.7	325.3	522.4	369.7	2518.8	1299.5	3296.6	2461.9	208.4	174.3	1470.7	263.8	609.1	95.7	1446.1	3218.7	1962.1	2166.5	1805.2	546.9	1299.9	1027.5	537.1	680.7	235.9	400.8	246.5	387.8	703.1	2695.3	742.2	226.0	6599.2	1862.9	1754.6	1865.3	674.7	3196.8	1806.5	1154.4	3160.7	280.1	1842.0	1215.9	2028.4	1677.7	899.2	2541.5	81.0	2093.2	1233.3	1573.7	689.8	2622.6	1454.9	2127.3	1344.2	1235.8	2856.3	1372.4	2117.5	968.7	534.8	1464.1	574.8	1160.0	1504.9	1934.6	2970.9	1937.9	1430.4	2051.1	2991.2	2181.6	1718.2	166.1	1469.4	1479.6	1129.7	2070.5	5473.9	197.2	201.1	197.3	361.6	174.2	193.7	214.1	195.2	199.9	222.7	218.2	218.1	2510.5	852.5	1309.5	28.7	4225.5	6439.6	7085.5	5724.6	4563.8	424.0	6122.9	9469.1	1049.0	1988.8	2513.8	1028.1	268.9	4313.8	1790.8	1780.8	4433.5	2429.1	891.2	1083.4	2465.0	2455.7	1698.3	2407.7	24.0	5851.2	6733.6	2161.3	1804.3	1452.8	1044.4	2390.5	2116.1	1309.7	3031.0	166.5	28.5	3563.5	1698.8	2811.4	5097.7	2782.3	3122.7	2281.9	3520.0	30.9	2951.5	1300.3	1607.7	16.1	32.8	3402.4	3311.1	1432.3	3168.7	6500.7	3930.7	4195.9	961.7	689.1	1078.1	2701.0	3865.8	591.8	583.4	5817.5	8224.4	4365.8	2704.6	3472.7	4291.2	7522.7
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452587-39458931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 2512.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	1868.9	1181.0	377.9	809.5	384.9	2487.2	2132.6	378.2	2512.5	2407.6	382.9	1776.6	737.5	1418.3	2338.6	1568.7	1896.6	785.0	1168.4	368.3	462.3	1318.1	1056.3	1130.2	613.9	381.0	381.1	3607.4	2794.6	510.7	1060.0	419.0	382.5	1562.6	605.5	314.2	1387.6	681.5	1550.4	2153.4	1327.8	551.1	407.5	1400.1	1484.5	386.8	388.4	43.6	1072.2	1767.5	705.8	1675.7	1773.4	395.9	52.4	41.7	2173.3	48.2	57.0	90.0	72.9	1109.3	1618.3	1306.1	981.0	131.1	1243.5	2771.5	93.8	1081.2	1040.1	1169.0	67.3	79.3	1422.3	964.2	2080.2	80.0	415.4	131.2	81.3	153.2	711.1	113.8	3249.4	56.1	1445.8	1907.5	69.6	70.4	2126.4	1196.8	60.9	69.4	1556.5	163.4	1954.7	1523.9	57.6	1417.2	2327.7	76.3	1656.7	63.7	74.3	915.0	31.6	899.8	115.5	1976.1	1864.0	98.7	63.2	51.1	72.1	1486.9	134.2	1806.3	2754.2	2483.9	1456.9	1717.2	56.6	447.2	556.1	171.7	664.4	585.3	1320.8	1566.4	1311.6	919.0	779.1	1361.8	1804.5	1436.1	94.8	927.3	456.8	1013.2	1101.2	2263.3	377.9	384.9	378.2	2512.5	368.3	462.3	381.0	381.1	382.5	407.5	388.4	395.9	1634.0	663.4	908.4	2.3	3629.4	4132.6	5621.6	3089.9	1994.2	406.0	4149.6	3833.2	428.0	2051.8	1359.8	709.9	160.6	3011.2	2723.2	1300.0	2733.2	2184.8	1549.9	1126.9	2738.2	2121.2	1850.2	1755.0	3.0	4399.8	5910.8	1698.9	828.7	1534.0	913.2	2226.7	2439.5	1991.3	2775.3	198.5	3.2	3581.7	1053.8	3282.8	3322.0	1707.8	4819.6	2242.3	1851.6	2.8	4568.2	1398.0	3045.4	3.0	3.6	3145.0	2925.6	2394.1	1420.3	4718.4	2823.2	3698.3	656.7	581.0	1512.0	3760.1	2630.9	684.0	593.6	2325.1	4675.5	3400.0	2937.1	2567.2	3793.6	5564.6
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196699-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003512, HPA073501"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		770000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	1626.2	1344.7	561.3	1155.2	565.6	3283.8	2720.3	554.1	640.3	1534.6	616.4	1752.1	1554.5	1257.0	987.6	2694.1	2220.6	979.7	1047.9	552.7	585.8	878.9	1433.5	1081.9	1835.1	618.4	571.6	2860.3	3265.5	696.8	753.7	1202.7	602.2	1195.7	1776.6	523.0	1791.6	848.6	2407.5	2585.8	1260.0	1337.9	603.4	1135.2	1608.7	396.8	599.5	1835.9	1154.9	1590.0	2433.7	1778.7	1703.7	603.6	3354.4	3355.3	2339.0	4061.4	4653.6	7635.7	3627.8	2397.9	4274.8	3734.5	2395.4	4364.8	1919.1	7137.6	2541.5	4307.9	945.2	2583.2	4120.3	5060.1	2324.4	2764.8	3209.4	3343.3	2263.6	4630.2	5153.3	4498.4	2490.2	6817.1	8686.1	2619.4	8018.0	6670.0	4528.8	4037.2	4292.7	2014.6	3645.7	5140.3	4443.4	5661.6	4494.0	3290.9	3704.7	3321.6	3175.0	5868.8	3881.1	5170.2	2606.2	3183.0	1722.7	2593.0	5541.7	2631.2	4773.6	6518.2	3016.5	1807.3	2718.5	2322.7	3249.7	4551.6	5143.0	3549.4	3136.7	3560.7	1492.7	337.6	1714.3	136.4	1750.8	1555.9	3999.6	3712.1	3171.7	2361.5	3455.6	3456.2	3255.0	2728.7	123.0	2340.3	927.0	3805.3	2342.6	7075.7	561.3	565.6	554.1	640.3	552.7	585.8	618.4	571.6	602.2	603.4	599.5	603.6	594.8	586.5	1363.0	12.7	2571.7	3876.3	4947.2	3409.7	5507.4	208.7	3351.1	3986.1	277.8	1312.6	1946.7	562.8	154.3	4464.2	1352.3	967.9	1886.1	2150.7	448.8	811.6	1878.9	1354.0	1217.3	2826.9	12.8	4812.2	7058.4	1577.5	1782.3	1217.8	796.8	1334.4	963.1	1249.9	2014.1	94.2	19.7	2395.8	950.1	1281.9	2122.5	944.5	1740.7	1327.5	1700.4	17.8	1794.6	366.3	1030.9	19.6	28.6	2966.5	1712.5	795.1	4088.9	4142.9	1870.9	2089.5	859.3	486.4	420.7	1701.5	3223.9	309.4	759.2	7221.2	4751.9	4413.0	1892.0	2405.0	3317.6	5180.7
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809965-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053635, HPA075365"	Approved		Approved	"Nuclear speckles,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		2900000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear speckles, Cytosol"	"Mitotic spindle"	"HPA053635: AB_2682212, HPA075365: "	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	2013.7	831.3	1119.2	993.1	1162.5	2166.9	1656.6	1099.7	1368.9	1256.2	1084.1	1277.1	1016.8	930.2	701.6	1241.3	1240.4	564.0	869.3	1057.5	1116.3	885.0	657.0	851.0	1924.7	1138.0	1095.8	2092.8	2087.8	545.7	595.5	830.9	1154.3	925.8	887.8	180.9	1908.3	775.7	1802.7	1760.4	1191.7	624.4	1204.8	1543.8	1006.0	377.6	1167.5	1545.7	785.0	936.1	1715.4	1075.5	1137.9	1217.7	2773.5	2229.6	1070.4	1864.1	2343.2	2458.2	2389.5	1728.2	1285.0	2090.8	1638.4	3307.6	2218.5	3851.6	1225.0	1629.9	1107.9	2546.7	1786.2	2778.3	836.3	1713.6	8117.9	1901.7	1416.9	3996.4	2837.3	3540.8	1905.4	3393.9	4684.6	764.1	2182.7	1860.8	2111.9	2798.2	3432.2	2040.5	1317.9	2656.6	2969.5	6002.3	3188.8	3394.5	6045.3	3345.1	1465.6	4369.9	1759.0	1281.0	2222.2	3142.1	1118.5	2825.8	3582.4	885.1	1198.9	3577.2	1881.2	1142.3	1393.9	964.1	1981.6	3838.4	3778.8	3419.3	1790.5	2952.3	1340.6	1565.3	3908.1	1299.1	4402.2	3129.1	6208.3	10718.3	8296.0	6323.4	4273.6	9867.1	10158.6	8083.9	529.9	4310.4	2525.7	5882.9	5140.5	13330.7	1119.2	1162.5	1099.7	1368.9	1057.5	1116.3	1138.0	1095.8	1154.3	1204.8	1167.5	1217.7	1311.8	1067.3	1685.0	16.3	5889.9	6113.3	6658.4	2808.0	2619.1	206.2	5955.7	4736.9	638.4	2505.0	1972.2	1601.9	79.2	5046.4	3469.2	2296.4	2592.4	3688.3	1403.0	1105.9	2434.1	2724.8	2370.2	3482.2	18.6	7413.9	8045.8	2074.3	1401.2	1787.6	1721.9	1543.2	4028.6	3068.9	4514.0	146.4	17.8	5925.5	870.8	5458.4	6404.8	3133.4	6393.4	3169.4	2986.4	27.2	5854.8	1052.2	5787.9	6.0	19.0	5201.1	4547.7	2821.7	2403.4	6640.3	4473.8	4234.1	900.4	235.5	1991.9	3688.9	2346.3	1123.1	2093.1	4264.4	7887.4	5841.1	4889.3	1629.7	6189.1	7014.0
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241619	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	112.6	132.5	48.2	131.9	50.4	180.8	146.1	49.9	55.9	161.8	98.0	156.9	125.5	108.7	344.1	106.8	122.9	119.8	107.3	49.5	56.5	145.1	212.1	129.7	109.2	54.0	50.6	94.8	159.6	180.9	79.1	257.9	53.9	164.4	175.2	117.0	158.2	157.5	110.4	91.5	110.9	156.6	53.8	118.1	145.1	144.2	55.4	108.5	232.5	75.1	143.3	165.4	87.9	61.9	328.2	290.6	302.7	401.2	413.1	308.2	586.7	426.7	516.8	544.8	459.2	939.2	564.8	255.3	501.6	572.3	506.4	468.4	318.8	516.4	492.0	121.2	196.5	295.3	308.4	634.1	398.9	468.4	467.0	294.6	505.1	432.3	447.5	519.8	530.4	239.2	458.7	805.1	389.1	300.9	270.6	451.0	240.4	839.3	415.7	242.3	549.1	852.7	371.6	304.3	246.4	261.0	517.9	1231.1	489.4	353.6	606.1	765.6	338.0	600.8	358.2	317.1	371.9	474.7	608.4	259.9	583.4	314.9	493.2	424.2	427.5	285.5	365.5	410.5	417.0	291.0	336.1	363.8	481.2	232.4	298.8	308.7	78.3	398.8	357.6	591.0	338.2	676.5	48.2	50.4	49.9	55.9	49.5	56.5	54.0	50.6	53.9	53.8	55.4	61.9	85.7	118.6	158.0	22.2	107.8	61.8	134.1	264.6	62.0	72.6	90.0	74.2	81.4	133.0	197.7	80.9	45.9	461.6	109.6	113.9	23.5	278.0	37.3	73.2	103.5	98.6	63.0	91.7	18.8	241.1	599.6	127.4	84.1	151.2	105.2	109.3	100.6	206.3	233.2	63.9	18.6	168.5	162.8	150.4	75.3	24.4	105.0	117.0	90.7	20.6	122.2	136.8	65.9	24.1	20.5	160.1	109.5	110.9	392.3	121.3	64.6	82.3	98.5	100.8	85.5	65.3	122.0	335.2	288.9	67.7	57.8	621.0	81.5	213.7	138.7	117.6
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954418-74956772	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 25.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 25.8;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory bulb: 23.0"	HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	6.0	13.2	7.4	2.7	8.9	0.4	4.5	14.6	8.5	7.1	6.5	7.9	7.2	3.7	1.8	6.9	4.4	4.5	5.5	4.9	10.8	5.1	3.1	5.8	3.9	16.5	12.7	15.4	7.6	23.0	5.2	7.2	16.4	4.2	4.8	12.8	4.6	1.7	1.4	4.9	5.7	2.5	10.8	10.8	7.1	3.0	12.8	2.4	8.9	1.5	3.4	7.7	5.4	12.7	23.6	17.5	4.4	0.1	1.5	0.9	7.4	4.3	5.2	1.3	1.2	24.1	21.0	0.0	19.4	4.4	1.2	6.9	13.7	0.8	0.3	8.9	0.7	0.1	19.9	0.5	46.0	0.0	13.3	5.9	0.6	8.5	0.0	0.9	20.4	5.5	16.1	0.0	4.6	9.1	3.8	6.3	20.8	40.9	7.0	0.1	0.0	15.8	4.2	0.4	42.9	32.1	32.6	28.8	67.4	2.2	5.7	18.7	4.6	0.0	1.4	3.8	0.2	0.4	0.1	0.1	2.3	36.6	25.1	0.0	5.2	0.0	2.3	10.1	1.3	3.4	1.5	1.8	5.1	3.7	3.8	3.0	0.4	0.5	7.7	25.8	0.7	2.5	7.4	8.9	14.6	8.5	4.9	10.8	16.5	12.7	16.4	10.8	12.8	12.7	5.3	3.2	1.1	0.3	4.9	11.0	7.5	9.1	11.4	95.1	11.8	9.9	1.6	14.3	6.4	9.2	4.2	2.3	17.0	24.4	13.7	13.7	0.3	1.6	4.7	8.9	10.2	0.8	0.7	19.3	4.3	23.9	14.8	3.6	0.0	3.4	31.8	1.6	77.0	21.9	10.0	12.5	14.2	14.8	8.6	2.6	39.4	9.3	14.2	1.0	16.1	13.4	4.1	0.0	6.3	13.8	20.5	30.1	8.2	19.1	27.5	16.6	1.3	72.3	13.1	4.3	10.4	1.4	6.5	18.2	11.5	2.3	2.1	26.6	20.7	10.5
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 118.4"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA052187: AB_2681755, HPA059698: AB_2684106"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (8.21e-4)"	17.2	23.2	30.5	13.8	31.7	9.7	18.3	32.7	36.2	20.6	28.4	26.4	27.5	19.9	12.5	28.2	20.1	14.5	46.8	30.5	31.5	30.6	51.4	11.8	20.7	31.9	30.6	19.5	23.0	24.0	17.4	12.2	32.3	24.5	14.4	4.8	23.1	15.1	118.4	17.5	26.4	10.5	30.8	26.5	21.9	16.0	33.0	22.5	18.5	103.1	13.9	20.5	18.5	30.2	42.6	54.0	21.9	21.4	21.4	20.2	21.5	18.1	18.5	28.9	33.1	24.3	28.2	32.8	27.1	11.0	13.5	28.1	33.2	44.2	10.4	66.1	44.5	19.5	37.9	36.2	46.1	20.5	28.3	35.2	42.4	24.3	55.3	25.1	30.8	44.5	31.6	34.1	22.7	45.8	42.9	76.4	20.1	43.4	48.7	37.2	23.0	33.2	31.9	22.1	14.6	8.5	32.9	36.6	21.6	10.8	33.6	35.7	14.5	9.1	26.3	22.3	15.1	16.4	30.8	38.6	27.6	41.3	44.7	71.2	55.6	56.4	38.2	48.5	47.3	57.1	44.5	40.3	47.8	67.3	51.8	49.8	51.9	56.6	57.5	39.3	68.4	39.6	30.5	31.7	32.7	36.2	30.5	31.5	31.9	30.6	32.3	30.8	33.0	30.2	12.9	0.0	15.1	6.5	20.7	11.1	50.4	61.9	24.5	7.8	30.9	39.9	34.4	22.8	30.5	20.2	2.1	61.8	14.4	55.7	99.7	31.0	3.3	10.3	21.5	17.5	33.6	12.6	3.0	19.8	38.1	18.4	17.9	13.7	10.2	16.4	27.1	77.5	32.0	0.0	3.9	44.7	38.7	33.6	10.4	6.0	22.4	18.4	12.4	3.7	33.1	25.6	51.5	2.0	3.4	18.9	61.6	15.4	14.7	40.8	132.7	82.2	21.0	12.3	6.6	18.2	18.8	50.3	24.0	30.6	14.8	41.9	17.4	47.7	50.1	44.4
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 555.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	14.0	12.9	9.1	12.3	9.4	12.4	19.8	12.4	11.7	14.0	15.1	16.3	15.8	15.0	16.7	16.2	19.3	11.2	13.0	9.4	9.5	17.2	19.4	13.8	20.1	8.9	9.0	14.6	15.2	14.2	13.4	11.5	8.9	13.9	16.7	13.4	14.4	12.1	19.0	17.2	16.6	12.5	8.8	17.7	15.4	48.1	9.3	15.6	16.2	14.8	18.0	17.6	13.3	10.1	40.6	29.4	15.6	20.3	20.7	21.2	27.9	18.7	14.0	29.0	29.3	29.6	40.3	33.2	19.3	17.6	23.7	36.2	31.8	32.4	26.2	26.0	28.6	34.3	17.3	26.2	44.4	19.5	27.5	25.3	43.8	23.4	20.5	21.9	23.2	33.0	40.1	22.7	22.0	32.6	34.9	20.9	18.0	49.0	14.0	28.3	15.9	41.5	37.0	15.3	14.7	18.5	25.7	44.4	53.6	25.6	39.7	30.8	18.8	13.1	22.8	28.3	25.2	31.6	36.5	44.9	25.8	23.3	12.6	21.9	48.5	49.7	49.1	49.0	48.6	58.7	49.7	60.8	51.9	66.0	57.2	52.4	16.2	41.5	40.8	52.3	47.3	43.4	9.1	9.4	12.4	11.7	9.4	9.5	8.9	9.0	8.9	8.8	9.3	10.1	15.5	16.0	22.0	4.2	24.0	31.5	41.9	34.7	14.2	14.2	22.5	26.0	7.1	11.5	40.3	9.2	6.2	30.2	18.6	18.6	27.4	34.2	555.3	54.4	18.7	19.2	13.2	15.2	3.3	33.2	42.1	15.7	16.8	16.0	12.7	15.5	19.6	32.4	24.7	8.4	3.5	25.4	36.7	18.8	12.6	231.1	23.6	13.4	8.8	5.6	21.6	17.7	33.0	4.5	5.5	29.6	16.8	19.9	14.5	46.8	26.9	33.9	89.2	31.0	13.1	14.9	14.6	68.0	34.6	17.2	36.1	32.2	21.5	23.6	24.0	43.8
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994717-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Theca cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	5.2	11.4	4.4	4.3	4.4	4.9	6.7	4.2	5.7	5.1	3.7	3.4	2.9	4.1	3.6	8.6	3.2	2.9	3.4	4.4	5.3	3.5	7.4	2.0	5.8	4.4	4.5	3.6	3.9	3.8	3.5	3.4	4.6	2.8	3.1	0.7	2.6	2.7	5.6	6.1	2.4	4.6	4.6	4.6	3.0	6.0	5.4	4.7	3.4	3.3	5.4	8.0	5.3	4.7	13.0	21.2	6.6	18.7	11.9	15.1	20.7	12.5	6.3	23.4	18.4	29.0	9.7	27.8	53.6	13.1	32.2	13.4	13.7	19.3	20.9	10.6	27.4	17.5	12.8	39.5	14.0	22.8	9.6	11.8	16.2	23.5	23.0	5.2	23.4	25.2	28.1	5.4	17.3	36.8	11.6	39.0	10.9	15.2	34.0	24.4	12.5	51.0	12.2	13.8	23.5	6.8	11.7	11.1	13.2	17.3	20.2	18.7	11.2	30.6	20.7	20.9	29.1	9.7	43.7	22.0	5.8	37.8	16.1	0.0	7.1	0.0	3.3	11.9	4.9	8.1	5.7	4.1	12.9	7.2	7.6	7.1	0.0	8.6	3.9	6.4	9.1	5.2	4.4	4.4	4.2	5.7	4.4	5.3	4.4	4.5	4.6	4.6	5.4	4.7	7.3	0.0	1.1	2.0	5.3	12.4	10.4	20.6	6.8	0.2	6.3	9.3	4.5	0.0	9.5	1.8	0.0	13.3	3.6	2.2	11.7	7.9	8.1	9.1	13.7	10.9	3.0	2.5	3.6	9.4	14.5	5.8	4.6	4.6	0.0	11.7	6.4	5.5	11.5	0.0	3.1	4.2	6.1	2.5	4.7	3.7	5.6	3.2	8.8	1.9	3.7	1.2	3.1	3.5	3.1	4.3	2.1	4.9	5.7	7.7	0.7	15.1	10.6	0.5	0.0	8.3	8.4	15.1	24.1	12.6	14.8	9.6	3.6	30.8	7.4	7.7
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.0;Late spermatids: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	23.3	34.8	40.6	16.4	44.4	11.3	24.7	40.7	59.9	21.1	34.6	29.6	19.0	25.7	115.2	23.6	25.3	18.5	29.1	45.5	43.2	26.7	21.8	19.2	19.5	39.5	40.3	24.1	23.4	26.1	27.8	17.8	40.0	29.6	20.5	41.5	28.3	28.9	54.7	20.9	19.0	21.3	41.4	22.3	21.3	28.0	42.6	19.9	32.1	46.5	19.3	27.6	20.0	44.4	31.6	34.1	57.0	60.8	30.6	35.8	35.5	55.6	54.5	31.7	44.5	9.4	34.2	44.1	57.2	40.7	16.9	51.2	64.1	56.3	44.7	39.2	36.6	46.9	48.9	37.0	53.9	78.9	24.3	27.6	73.7	30.2	85.4	39.8	46.0	51.5	42.8	46.7	41.1	39.3	42.4	33.3	45.9	16.2	24.4	34.7	18.3	70.8	48.4	66.9	99.1	83.4	46.5	25.7	48.3	46.2	35.2	55.9	56.4	33.0	20.6	17.7	46.0	52.5	77.6	45.0	33.6	64.1	33.9	0.7	4.7	2.2	2.9	6.3	4.4	5.0	4.0	3.4	7.8	5.4	5.0	4.0	3.5	7.0	4.2	5.4	2.3	3.3	40.6	44.4	40.7	59.9	45.5	43.2	39.5	40.3	40.0	41.4	42.6	44.4	19.0	32.1	20.7	54.9	40.6	34.4	35.9	23.6	54.7	49.6	29.9	22.2	39.4	17.2	21.0	35.0	31.3	17.1	28.7	13.6	27.4	21.0	233.0	36.3	30.2	23.1	28.8	24.6	105.0	19.9	17.6	19.0	25.0	52.5	13.3	50.7	20.7	29.3	9.8	37.0	91.0	16.7	22.4	20.1	24.2	362.4	22.1	18.8	30.2	58.1	18.1	32.2	18.6	84.9	98.5	20.4	25.2	23.0	33.1	41.5	17.8	26.2	20.3	50.8	13.1	26.1	27.0	39.5	42.2	45.2	38.2	14.6	21.9	51.9	22.2	38.2
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033725-38127780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA070590, HPA072645"	Enhanced		Supported	Nucleoplasm		NA	NA		28000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066290: AB_2685650, HPA070590: , HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"	13.3	12.4	8.9	12.3	10.7	35.2	14.1	11.8	10.4	14.5	9.1	12.3	10.2	16.3	12.4	14.5	16.5	10.8	23.6	7.6	11.7	14.5	72.5	12.0	21.7	9.5	9.0	13.7	12.8	17.3	10.9	11.9	10.1	15.1	12.8	18.1	12.2	12.1	34.8	14.4	13.3	12.7	7.4	13.8	12.4	13.3	9.4	16.3	15.0	25.9	29.8	17.5	12.5	13.6	29.6	14.4	28.4	13.0	18.8	25.2	28.3	21.3	20.4	27.9	23.7	70.7	30.8	27.0	27.5	17.0	26.1	34.2	26.3	40.3	33.3	11.1	13.3	44.1	18.6	39.0	22.6	35.0	13.9	20.1	40.0	27.9	34.0	19.0	17.3	28.8	36.9	20.4	21.6	23.0	49.3	27.5	14.1	37.0	29.6	28.3	56.7	26.7	15.0	27.5	28.0	19.7	38.0	60.0	27.8	18.1	29.7	33.7	17.0	46.0	28.8	18.5	24.8	26.8	26.9	48.1	27.8	21.1	15.3	0.6	5.8	5.8	4.6	6.6	5.7	3.4	4.4	4.1	6.0	3.2	5.5	5.1	4.6	3.9	9.0	2.9	2.9	5.0	8.9	10.7	11.8	10.4	7.6	11.7	9.5	9.0	10.1	7.4	9.4	13.6	13.6	16.0	21.9	20.5	16.2	15.8	12.0	9.8	13.1	16.4	22.7	16.9	49.3	17.2	11.8	18.4	18.8	14.7	12.8	15.7	15.6	7.6	9.4	11.9	17.9	16.2	23.4	17.4	28.6	8.6	12.4	18.0	16.8	14.8	13.3	18.5	24.3	87.9	12.3	18.5	26.3	20.7	4.1	22.7	9.5	10.3	10.5	18.4	10.6	21.5	9.7	10.3	4.1	30.7	41.1	9.8	11.6	13.2	17.4	23.7	17.1	17.4	22.4	19.1	6.6	19.1	14.7	15.2	12.3	19.1	18.6	15.6	14.8	18.3	14.5	19.8
RPRD2	"FLJ32145, HSPC099, KIAA0460"	ENSG00000163125	"Regulation of nuclear pre-mRNA domain containing 2"	Q5VT52	1	150363091-150476566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 132.9;Inhibitory neurons: 133.8;Oligodendrocyte precursor cells: 136.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061693	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		66000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA061693: AB_2684587"	"unprognostic (1.68e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.38e-1)"	10.8	11.4	6.1	10.8	7.4	13.7	12.0	17.4	11.0	16.0	3.2	13.2	10.6	18.9	14.2	14.0	21.1	10.7	13.2	7.3	8.1	16.0	11.4	12.9	13.6	4.2	5.3	29.8	14.5	19.2	10.7	9.8	4.3	14.3	14.5	17.4	14.0	16.2	24.5	12.8	12.1	17.8	3.8	14.0	11.9	14.1	7.7	19.5	23.0	22.8	15.7	12.7	11.3	7.9	24.6	18.4	23.9	24.3	24.3	20.5	22.6	17.4	20.7	18.8	18.4	16.1	29.4	38.8	19.5	21.4	10.4	26.6	34.0	25.9	20.4	17.9	14.2	22.3	21.2	19.5	17.4	33.8	26.3	21.8	19.3	26.2	34.4	20.9	23.5	23.2	22.1	40.9	19.3	35.4	29.8	10.9	30.0	30.9	20.6	27.0	17.7	39.4	27.7	22.4	25.4	25.6	35.6	30.0	22.6	21.2	23.7	29.5	21.7	17.3	17.8	14.6	24.9	24.9	29.5	28.7	17.2	24.8	17.4	5.8	2.9	3.5	5.6	1.8	5.1	5.4	5.3	4.5	2.6	5.2	6.1	6.2	1.4	3.9	7.3	3.1	7.0	2.4	6.1	7.4	17.4	11.0	7.3	8.1	4.2	5.3	4.3	3.8	7.7	7.9	18.7	19.2	25.9	97.3	30.8	15.4	10.5	17.1	25.0	35.0	22.0	19.8	27.6	17.2	24.5	33.1	16.7	14.0	27.2	20.6	7.9	14.6	11.0	31.8	30.1	21.6	25.8	16.8	132.9	12.9	9.1	23.4	16.8	33.5	17.7	28.5	26.0	27.1	14.7	11.8	133.8	22.1	18.3	22.6	10.5	6.6	37.9	16.6	10.6	56.2	18.6	22.9	27.8	136.2	112.2	14.1	17.7	39.9	29.6	16.4	21.6	30.8	29.9	29.8	32.9	37.1	20.6	21.1	21.3	26.4	14.6	10.0	27.6	27.3	22.3	16.9
RPRML	MGC43894	ENSG00000179673	"Reprimo like"	Q8N4K4	17	46978156-46979253	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"brain: 12.8"	"Group enriched"	"Detected in some"	6	"Enteroendocrine cells: 31.8;Excitatory neurons: 17.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Group enriched"	"Detected in many"	4	"amygdala: 4.9;basal ganglia: 12.8;cerebral cortex: 9.8;hippocampal formation: 7.1;white matter: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 12.4;HEK 293: 3.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 90.0"	HPA062668	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA062668: AB_2684827"			"unprognostic (7.79e-4)"		"unprognostic (1.66e-2)"		"unprognostic (8.35e-2)"	"unprognostic (2.42e-2)"		"unprognostic (2.31e-1)"	"unprognostic (8.93e-4)"	"unprognostic (2.78e-2)"		"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"			0.2	0.0	4.9	0.0	12.8	0.0	0.3	0.1	9.8	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.2	0.0	0.7	7.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	1.9	0.2	0.0	0.0	0.0	0.3	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.2	5.6	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.5	0.7	0.2	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	12.8	0.1	9.8	7.1	0.2	0.0	0.0	0.0	0.0	2.0	5.6	2.2	0.0	0.0	1.6	0.4	0.4	0.0	0.0	0.0	2.5	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.2	31.8	0.0	17.4	3.9	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	2.3	0.0	0.0	0.5	0.0	0.3	0.0	1.8	1.0	0.0	0.0	0.0	1.0	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.5	1.1	0.0	0.0	0.0	0.3	0.0
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426069	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 4571.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	1437.4	1373.5	1054.1	937.6	1054.4	2688.5	2003.3	1013.6	1284.2	1984.1	1022.8	1472.3	919.9	1332.0	1064.3	1995.2	1606.9	756.7	1024.5	1010.7	1034.1	1114.4	1161.4	1006.5	2137.6	1058.2	1024.2	2878.3	2424.5	633.4	929.2	829.4	1051.3	1432.9	916.2	273.2	1532.7	895.2	1419.3	2399.7	1342.9	909.8	1088.6	1538.6	1455.3	558.6	1091.1	1486.2	1090.6	774.4	1696.6	1470.6	1716.1	1069.7	2314.3	1481.2	1486.9	3397.3	2550.1	3757.4	2454.7	1847.4	2604.3	3061.1	2200.4	3633.8	1140.6	4393.3	1873.0	2105.8	1522.9	1688.8	2814.8	3224.9	1840.0	1869.0	5082.5	1974.1	1475.4	3504.8	3492.4	3158.5	2028.2	4156.0	5548.7	2111.2	3977.8	2642.2	2725.4	2459.5	3452.0	2175.2	2327.1	3633.7	2591.3	4761.0	2242.3	5664.1	2144.7	2409.8	1736.7	4221.2	2314.1	2558.9	2492.6	1515.7	1328.4	2213.1	5332.3	1391.5	2878.1	7936.5	1837.0	1338.8	1699.0	1543.5	3072.5	1764.4	4423.0	3815.8	732.4	4092.2	2465.9	746.2	1242.2	378.2	1406.3	996.8	2067.1	2824.8	2408.2	1994.5	1679.6	2732.8	3083.6	2462.3	251.9	1676.0	963.1	1983.5	1767.5	5386.9	1054.1	1054.4	1013.6	1284.2	1010.7	1034.1	1058.2	1024.2	1051.3	1088.6	1091.1	1069.7	597.4	359.0	714.8	0.0	2967.8	1351.9	563.2	354.6	3754.5	62.0	1279.7	1271.1	65.3	1096.6	494.1	263.0	29.2	1497.5	1221.5	911.7	598.7	1451.9	447.1	169.2	282.1	670.4	1232.9	1778.0	0.0	2404.1	1918.4	612.0	1241.6	181.4	589.1	215.5	1258.9	970.6	1034.5	52.2	0.0	2462.2	130.2	1695.5	1330.7	1537.7	849.0	1006.5	633.3	0.0	1923.1	488.6	1562.3	0.0	0.0	1813.3	1843.4	472.4	2267.5	640.3	2166.8	1066.8	284.9	103.5	263.0	652.5	649.4	268.8	270.0	4571.8	1657.0	1454.1	1851.6	284.8	2985.5	573.4
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 58.7;Club cells: 19.2;granulocytes: 10.1;Respiratory ciliated cells: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	7.7	6.6	5.9	6.3	5.2	9.5	5.5	3.3	9.0	7.2	0.0	5.0	1.4	4.1	0.1	9.6	4.3	1.5	17.0	6.0	6.3	8.6	10.2	6.3	3.2	7.1	6.7	6.3	7.7	2.0	6.1	4.5	7.3	5.7	1.3	1.4	5.6	0.6	18.6	4.9	4.4	2.9	6.8	6.8	5.1	8.9	7.3	3.8	5.8	8.6	2.3	5.8	7.2	4.8	17.6	6.0	16.0	27.3	11.6	8.0	16.2	13.0	7.0	10.3	10.3	6.7	9.2	22.9	22.2	8.7	23.4	11.5	23.7	7.1	12.5	15.1	9.9	35.1	11.3	19.4	4.2	33.2	38.4	3.2	14.9	15.2	31.6	14.2	10.1	20.7	35.9	22.7	13.2	17.8	33.9	16.4	7.9	38.5	5.8	18.7	13.5	15.0	10.5	19.1	24.6	8.7	9.6	10.0	34.1	10.1	15.1	59.6	7.9	15.3	22.9	7.0	18.2	11.3	18.3	28.8	2.1	20.2	23.7	11.2	5.9	27.3	3.2	6.8	3.3	6.0	3.7	3.6	7.5	5.9	3.6	3.4	4.3	5.0	6.9	5.3	3.7	5.4	5.9	5.2	3.3	9.0	6.0	6.3	7.1	6.7	7.3	6.8	7.3	4.8	0.0	35.3	58.7	2.6	0.0	0.8	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	8.3	0.4	0.1	3.8	0.0	0.3	10.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.5	0.0	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.5	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	11.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	2.3	0.0	0.0	0.2
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499708	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		39000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: AB_2680860"	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	2814.3	1967.1	2353.0	1926.7	2400.8	5134.9	4378.8	2317.2	2969.3	3860.2	2321.9	2702.6	1771.3	2682.7	2738.1	2407.0	3426.0	1647.5	1778.5	2271.3	2375.3	2155.4	2117.7	1996.8	4054.9	2375.8	2309.1	6075.5	3741.4	1881.9	2119.6	1859.8	2411.6	2569.3	2712.5	1006.4	2752.4	1960.9	3200.5	3819.2	2355.1	2297.6	2434.1	2818.2	2473.8	735.7	2397.5	3791.6	1978.6	3380.1	4757.2	2689.4	2908.0	2437.6	2932.3	4522.4	3340.7	5169.4	4778.9	7228.3	2239.9	2418.7	4891.5	3444.6	3294.2	3167.0	2392.5	7154.4	1461.9	3373.2	1470.8	1926.2	4003.2	4879.0	3375.9	3065.7	6870.8	4318.3	2858.4	4634.4	4446.2	7694.0	3083.3	7191.2	7968.8	2279.2	5867.3	5774.3	5106.5	4307.3	4374.9	3709.1	3792.3	3324.7	3612.0	5845.5	3067.8	7346.6	4594.6	3450.4	4209.9	3875.7	5006.0	6932.7	3555.4	4741.2	1646.4	5505.8	3793.8	3223.4	1790.9	7907.9	2886.2	2667.3	2377.5	1302.4	3236.1	3646.3	6191.7	5179.5	1104.6	5297.2	2335.7	1161.8	2103.1	653.8	1900.0	1810.3	2537.9	4890.5	2741.7	2206.3	2979.8	4589.4	3192.9	2762.8	507.2	2120.9	1563.8	3733.9	2382.4	6125.5	2353.0	2400.8	2317.2	2969.3	2271.3	2375.3	2375.8	2309.1	2411.6	2434.1	2397.5	2437.6	820.0	836.6	1502.6	30.0	2589.7	2685.3	2499.6	1615.7	971.5	289.1	1028.9	947.2	716.6	1155.3	1344.7	474.5	143.9	1915.2	1891.9	1130.4	1216.9	1295.8	900.1	1044.9	2292.8	1236.5	1501.5	1404.7	9.6	2816.1	3575.5	1178.0	550.0	1527.0	1341.6	1228.9	1633.8	1645.8	1898.6	94.2	12.1	2720.4	612.3	2780.4	3206.1	1773.6	3212.5	1749.5	1538.5	22.5	2825.6	1123.6	2614.9	10.1	22.3	2021.0	1960.1	1538.8	1006.3	2063.5	1353.7	1873.6	857.0	493.5	874.4	2214.3	2008.7	603.1	589.5	1334.2	3413.1	2356.3	1587.9	1273.7	2434.5	2570.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814569-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		450000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	2199.7	1325.2	1393.3	1767.2	1454.1	5388.1	3551.2	1388.1	2027.8	2357.3	1375.8	1849.3	1597.8	1747.6	1664.7	2450.9	2149.5	1415.7	1311.3	1347.6	1419.0	1576.6	1443.7	1565.4	3948.0	1445.0	1406.0	4883.9	3660.2	1000.1	871.2	1633.7	1443.1	1696.0	1905.2	608.3	2167.8	1216.4	1965.9	3365.2	1692.7	1357.1	1484.2	2110.3	1718.3	682.0	1446.6	2534.1	1959.6	1376.9	3053.4	2011.6	2108.4	1482.0	1993.8	1568.3	2260.4	3581.3	4521.2	5855.0	2728.8	2502.9	3598.4	2772.7	2665.2	3294.5	1880.3	4497.8	3443.9	3368.1	1338.8	1900.3	2613.1	4373.5	2576.9	2895.0	3346.5	3013.3	1944.0	4743.1	5047.1	8481.4	2221.0	6167.0	7332.7	2340.5	8322.4	4658.3	3754.7	3556.4	5166.0	2858.9	3487.9	4342.3	3620.8	5030.3	2772.9	3420.0	2533.0	3993.0	1799.7	2884.6	3698.6	2185.9	1991.3	1573.0	833.4	5314.3	7184.2	2173.7	2276.5	8489.5	3027.8	1121.1	3111.7	3721.2	4696.8	4153.6	4104.8	3493.8	3635.1	5063.0	1621.7	599.0	1545.5	220.8	2412.5	1426.7	3728.9	4156.1	4210.9	3131.6	1971.7	3564.5	5201.1	4454.7	151.1	2031.9	1170.8	2722.3	2519.7	7450.3	1393.3	1454.1	1388.1	2027.8	1347.6	1419.0	1445.0	1406.0	1443.1	1484.2	1446.6	1482.0	3755.5	1660.2	3063.5	22.9	9470.7	8277.4	8259.7	3758.1	8926.6	531.5	10637.2	15674.0	827.7	3777.4	2693.4	1237.8	179.3	7566.9	6150.1	1808.1	4574.3	4058.0	792.6	1406.5	4602.8	3829.0	2863.4	5499.5	18.9	8085.7	9433.9	3353.4	3537.2	2309.6	1773.2	3890.7	4755.4	5136.7	5871.9	212.0	17.7	6806.4	1116.9	6161.6	5357.0	2335.6	6075.0	4790.9	3938.0	20.6	6667.5	2216.0	5160.7	10.1	25.0	6009.9	4480.8	2990.3	4762.0	10484.3	3517.1	5647.3	792.4	713.1	1617.2	5397.5	3117.8	1035.0	3063.2	11325.5	10512.6	7894.9	7990.4	4517.7	6783.0	9815.1
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074388-17077715	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	1087.7	732.8	827.4	821.7	866.8	2404.4	2065.5	844.9	1205.2	1301.5	834.4	1135.5	854.6	1115.2	1152.5	1160.4	1285.2	950.2	1064.7	797.8	862.5	845.3	1101.5	696.5	2031.2	867.4	824.3	2669.7	1736.0	646.3	520.4	981.3	878.5	814.1	1136.1	660.8	1368.0	829.6	1934.5	1450.1	817.7	947.1	897.4	1102.7	962.6	356.6	856.5	1737.4	997.0	1525.9	1845.3	1318.5	1070.0	910.6	2115.6	1619.7	1524.1	1279.1	2680.1	4138.4	1660.6	1430.9	1991.9	2194.7	1774.8	2580.3	2640.4	3164.1	975.4	1710.4	1405.0	1546.0	2213.2	2387.6	2309.0	1326.2	4617.5	1347.9	1531.6	2761.0	3226.4	2821.8	1400.8	3174.0	3942.6	917.4	3647.4	2486.7	2632.2	2073.1	2128.5	1736.5	2173.6	2173.4	2377.2	3920.5	1727.0	2853.9	3099.3	2189.8	2064.2	2008.3	2147.5	2483.2	1249.0	2080.7	682.1	2723.3	3495.9	1527.1	1238.1	4255.9	1550.7	997.4	1660.5	2271.0	1835.2	1186.2	2726.3	2444.2	1143.1	2407.0	1352.5	582.6	2489.7	362.9	1356.0	1807.4	2715.0	3719.8	2904.9	2027.9	3004.4	3245.9	4371.9	3365.9	232.1	1880.4	1483.8	3192.8	2173.3	6018.5	827.4	866.8	844.9	1205.2	797.8	862.5	867.4	824.3	878.5	897.4	856.5	910.6	2429.5	926.3	1565.1	24.8	4390.9	4567.0	4447.1	4666.4	4408.4	271.6	5079.9	8516.0	778.1	1998.8	2361.4	665.8	104.3	3971.3	2743.0	912.1	2915.1	2434.7	1352.5	1075.0	2375.9	2226.1	1369.9	2311.8	19.4	4554.7	5434.6	2170.0	1711.1	1305.6	1506.6	2246.3	2328.4	2036.1	2923.8	90.9	24.7	2896.7	1501.4	4367.6	4707.0	1820.3	3551.8	2950.1	2180.6	30.9	4862.5	1677.2	2326.5	18.6	33.1	2988.2	2321.6	1774.6	2669.5	4100.7	1793.2	3790.7	1206.8	482.6	874.4	3314.3	2545.4	616.6	352.4	5638.8	5447.9	4488.7	3426.6	2642.9	3153.8	4835.4
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449739	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		810000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	1391.9	1014.8	819.9	689.6	838.3	1880.5	1567.1	800.3	929.8	1696.9	799.6	1268.2	563.9	1214.3	1001.9	1525.4	1339.5	469.2	1022.8	786.7	832.9	949.3	1027.8	936.0	1126.0	832.7	803.8	2394.3	2431.0	731.9	809.7	636.1	843.8	1228.1	796.4	300.5	1310.9	690.3	1536.8	2210.9	1198.3	684.3	868.0	1343.1	1319.3	344.8	845.6	1142.5	1013.3	1030.0	1170.9	1289.1	1444.9	851.7	1196.9	1768.7	1201.2	2749.6	1497.8	2857.8	1828.0	815.2	1278.2	1298.3	1158.5	2702.9	1799.1	2098.0	1280.9	1583.7	1411.4	1091.9	1548.1	3878.5	782.1	1066.7	2153.7	879.0	1504.7	2171.0	2252.7	2642.0	1164.7	2193.0	1297.4	1441.2	3088.3	1496.2	1933.8	1975.8	1067.3	1250.1	1720.0	2804.7	1499.8	2478.0	1323.5	1935.2	1959.3	1446.0	1134.7	3166.8	2005.3	1827.0	1339.8	1410.9	634.1	3959.4	3109.0	892.6	1703.5	3152.8	1107.3	925.5	711.0	723.0	1229.2	1511.3	1853.6	1722.2	1174.2	2578.4	634.9	2439.8	6736.3	1518.4	6807.8	4685.2	9622.7	14519.2	11377.7	8377.3	7039.4	12461.6	16778.9	11703.6	982.1	6730.0	4055.3	8079.0	8024.6	34303.5	819.9	838.3	800.3	929.8	786.7	832.9	832.7	803.8	843.8	868.0	845.6	851.7	1954.3	1336.5	2464.0	15.0	5469.0	11670.8	9205.1	9468.6	4143.2	501.8	11009.9	13334.3	1873.1	3179.9	4229.9	1478.7	185.6	7225.8	4299.3	2121.7	4527.4	3485.4	1233.0	1626.2	3782.1	3867.8	2390.3	3230.5	23.3	8687.4	8833.9	3287.4	1852.2	2336.3	2293.4	4816.8	4223.5	4186.4	4707.3	203.6	20.0	5595.6	2931.6	5536.1	9991.5	1739.5	4356.7	3703.4	6474.4	21.5	6224.3	2062.0	4655.1	13.0	31.1	5196.5	4753.4	2235.0	3173.0	7998.6	5612.4	5302.3	1902.7	691.9	1604.1	3185.0	5116.9	726.4	815.9	6399.3	15358.6	7126.8	5488.0	4091.6	6155.8	10058.0
RPS15	"MGC111130, RIG, S15"	ENSG00000115268	"Ribosomal protein S15"	P62841	19	1438358-1440495	"Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054510, HPA057793"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		460000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA054510: AB_2682510, HPA057793: AB_2683528"	"unprognostic (4.47e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-2)"	1492.7	1253.1	1112.3	594.4	1143.2	1201.0	1547.4	1088.6	1395.0	1699.5	1028.4	1466.7	565.2	1205.7	337.6	1872.1	1415.6	166.3	1222.6	1051.4	1084.5	1226.1	1106.2	1025.6	705.7	1119.1	1079.2	2717.3	2330.8	409.2	1315.7	346.3	1114.3	1664.9	298.2	234.6	1381.1	396.4	1841.8	2676.2	1250.1	283.0	1143.2	1523.9	1350.1	477.9	1143.5	649.3	1103.0	594.2	600.6	1316.7	1721.5	1162.3	1863.6	1949.4	837.1	1144.5	771.7	1118.2	1433.0	948.7	754.2	1116.7	871.3	3150.8	639.1	2285.2	829.1	618.8	394.6	1156.9	825.1	1177.6	426.5	1914.8	4301.3	748.4	1695.6	3041.6	811.7	1925.8	1374.1	1376.2	1406.1	757.0	737.2	1077.8	988.8	2049.0	1550.5	3197.1	703.7	3284.2	1608.3	2585.9	1887.0	1480.4	2481.0	1646.7	996.2	3053.8	1040.3	2026.5	1343.5	1589.3	801.9	1364.7	2927.8	442.0	1044.2	2555.0	1017.1	939.2	1077.7	1889.0	2131.4	2749.8	2994.2	2300.7	930.5	1737.0	1099.9	1348.7	2387.0	1017.0	2368.1	2005.8	3279.4	5335.9	3615.4	2988.4	3232.2	4867.3	4338.2	3612.2	457.2	2451.1	1592.7	2680.6	3662.4	7245.4	1112.3	1143.2	1088.6	1395.0	1051.4	1084.5	1119.1	1079.2	1114.3	1143.2	1143.5	1162.3	2203.3	910.2	1539.7	53.8	4976.8	9160.6	6537.1	4454.9	5021.3	436.1	7563.8	10700.9	365.8	2203.3	2335.6	1533.8	175.2	3985.2	3071.1	1757.4	3887.6	2275.1	984.8	1187.0	2584.3	2724.2	1811.8	2836.0	34.2	5298.7	6326.9	2621.6	1808.4	1631.3	1777.8	3650.4	3121.2	3161.6	3741.9	153.1	40.3	4148.0	1395.6	4863.0	7853.2	3297.3	3973.6	3101.3	4637.0	35.6	4562.7	1951.5	3042.3	20.1	73.6	3575.5	3343.2	2100.7	3087.8	6046.3	4380.3	5701.1	1076.4	622.3	1341.1	3160.4	2955.8	681.9	901.2	5781.9	12628.8	3849.3	4291.2	2492.1	4237.1	6173.2
RPS15A	S15A	ENSG00000134419	"Ribosomal protein S15a"	P62244	16	18781295-18790383	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047103	Supported					NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA047103: AB_10959516"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.29e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.32e-2)"	1970.0	1316.4	740.7	928.8	746.5	3569.4	3976.1	743.0	1047.9	2330.6	756.0	1675.7	847.1	1456.5	1497.7	1966.7	1828.8	966.6	1259.9	724.5	761.8	1225.1	1479.2	1277.8	2624.3	763.7	745.6	3672.5	2825.0	884.7	861.8	1063.8	768.4	1550.5	1291.3	508.4	1888.5	919.1	2290.4	2650.7	1631.3	927.8	766.3	1903.2	1606.5	471.5	753.7	2503.3	1210.8	1847.2	2069.4	1599.0	1979.1	771.8	1665.9	1632.7	2483.5	1708.0	3039.9	5447.7	1905.0	1623.5	2499.0	2223.5	1758.2	2282.2	1828.8	3795.4	3246.5	2258.0	820.6	1567.7	2367.9	3334.7	2557.8	1538.5	4026.8	1666.6	1734.7	5714.8	3899.2	2810.4	1310.7	5282.8	5288.0	1830.6	3782.4	3411.7	2803.0	2251.7	2437.4	2161.9	2389.3	3901.5	2848.5	3593.9	2324.8	2105.3	1704.5	3870.4	2300.4	4873.8	2757.3	1533.9	1781.7	1390.8	1259.1	2592.9	2737.5	1803.4	2342.6	4322.0	2001.0	1037.6	1004.2	1091.0	1617.6	1951.9	2709.1	3415.2	1339.3	2810.8	1215.2	519.8	1342.8	390.9	1643.8	974.2	2426.6	3134.0	2875.1	2323.1	1708.7	2591.0	3584.0	2850.7	215.0	1946.6	909.4	1602.5	2413.8	5373.8	740.7	746.5	743.0	1047.9	724.5	761.8	763.7	745.6	768.4	766.3	753.7	771.8	2629.8	1083.3	1663.6	11.4	6665.9	5978.3	5499.3	3924.8	5776.0	267.9	7331.7	10612.6	72.1	2372.0	2186.7	866.2	100.1	4677.6	4677.4	1392.4	2952.4	1975.3	1210.8	1172.7	3078.3	2808.5	2157.8	4096.4	11.0	3924.4	6676.0	2500.4	2125.4	1458.1	1587.3	3408.3	3436.1	3628.1	3635.3	119.5	11.6	4611.7	1194.2	5381.3	5449.1	622.7	5241.5	3453.2	2995.4	12.2	5190.0	1097.8	5097.9	13.6	16.0	2845.4	3571.7	2307.6	4358.8	5125.0	3359.1	4622.0	964.4	472.3	1393.7	3419.0	2181.1	798.5	662.3	7088.8	7535.8	4526.0	6066.2	2447.3	4984.8	5522.2
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433137-39435949	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064222	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		No	No		66000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA064222: AB_2685218"	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	2066.2	1324.7	798.1	879.8	835.8	1620.8	2008.5	795.8	967.9	2510.0	825.8	2148.1	738.9	1858.7	479.5	2097.7	1978.7	622.2	1817.6	766.2	806.7	1441.4	1565.9	1510.3	1710.4	830.8	794.2	4203.5	2970.3	547.7	934.3	739.1	834.3	1615.4	540.7	353.9	1548.0	495.9	2746.6	2516.9	1665.1	572.1	839.0	1889.3	1918.6	461.2	832.1	1190.8	1324.5	1391.5	1152.9	1877.2	2027.6	843.8	2467.5	5000.7	1350.4	1532.5	1939.7	2339.0	1237.4	1101.9	1229.3	1357.5	1238.9	3198.4	1315.0	2031.9	1385.6	1352.5	532.5	799.6	1562.2	2618.4	848.4	2412.3	3743.7	1628.3	1567.4	3393.7	1972.1	2412.1	1062.9	2779.4	3934.7	1215.3	1923.9	1896.4	1761.4	2602.9	2091.4	2251.5	1431.2	3675.5	3334.0	2400.6	1675.5	3079.8	1839.9	2199.4	1395.6	2489.8	1527.5	2664.4	1347.7	1950.3	825.4	3672.6	2999.5	905.9	1052.2	4589.3	1111.5	1149.8	1537.2	1247.2	2447.7	3155.8	3400.5	2644.9	1202.5	2217.9	1146.0	350.3	1144.7	180.1	1224.6	931.6	1759.2	2334.1	2023.4	1543.3	1424.7	2147.3	2531.4	2095.3	201.2	1187.1	800.4	1650.5	1520.8	4276.8	798.1	835.8	795.8	967.9	766.2	806.7	830.8	794.2	834.3	839.0	832.1	843.8	910.4	1131.4	1882.8	14.4	3414.1	3891.4	3738.4	2461.1	2290.1	317.5	2872.0	2269.1	1043.3	1983.2	1869.9	814.7	193.9	4378.5	2221.4	1360.9	2208.9	2060.1	596.1	1173.6	2134.8	1782.9	1477.7	1833.5	9.9	4296.3	6085.5	1656.8	846.6	1591.3	1121.0	1849.0	1788.3	2609.9	2812.3	114.4	14.5	2971.8	767.0	3231.7	4694.9	1402.8	4220.6	2451.1	2036.6	23.4	4047.9	1192.7	2671.5	6.0	23.9	2510.0	2427.6	1858.1	1983.1	3836.9	1742.4	3524.6	1041.6	614.4	1281.9	2376.7	1775.6	466.9	929.6	2878.6	4533.1	4741.0	2853.2	1988.4	3314.4	4435.0
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540459	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 5841.9;Extravillous trophoblasts: 6575.5;Prostatic glandular cells: 6309.4;Urothelial cells: 5768.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: AB_2682686"	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	1722.3	1537.3	1226.9	1519.3	1244.9	3816.2	3065.8	1206.6	1768.4	1818.7	1277.0	1724.0	1318.8	1489.3	1967.3	2266.9	1763.0	881.9	1192.2	1197.9	1253.8	1298.7	1646.6	1132.3	2832.4	1261.6	1218.6	3571.4	3388.7	859.1	987.5	1099.1	1264.1	1418.3	1477.9	477.2	2051.9	967.4	1588.9	2566.0	1319.4	1188.3	1265.4	1560.6	1555.5	375.1	1245.4	2012.1	1216.9	1063.5	2563.2	1567.2	1790.5	1281.2	3535.7	4567.8	3027.7	2844.3	3850.6	6013.0	3418.3	3504.2	3142.7	2924.3	2235.3	5420.6	3683.5	5561.4	3680.3	3142.1	2276.7	4963.3	6162.5	4765.3	2251.9	4262.2	8647.1	3224.4	5009.5	4698.1	5817.4	4197.2	2100.2	5478.2	7877.0	1959.5	6027.1	4520.5	3281.1	3993.8	3909.8	4288.1	3200.3	6205.4	3467.9	7403.5	4567.2	4224.9	2885.2	3333.8	3746.8	4676.4	3425.9	6945.5	2678.6	3325.2	2101.9	4289.8	9110.0	3205.5	3707.5	10012.4	2932.1	2388.1	3534.7	2353.9	6119.2	3312.3	7992.5	5635.5	2580.9	8286.2	2335.3	519.6	1072.5	302.9	1155.2	949.1	1830.0	2371.9	1954.3	1477.4	1685.5	2173.6	2280.0	1986.3	148.5	1335.8	859.0	1700.9	1707.8	3337.5	1226.9	1244.9	1206.6	1768.4	1197.9	1253.8	1261.6	1218.6	1264.1	1265.4	1245.4	1281.2	118.0	814.1	1488.0	8.1	1824.1	43.2	5841.9	11.0	675.6	83.2	1696.6	859.5	428.3	2093.2	1039.5	176.6	50.1	3419.1	1523.2	487.4	545.9	1846.4	75.5	269.9	496.3	1390.0	963.5	1971.9	5.5	3041.8	6575.5	973.4	375.1	305.1	937.3	67.5	2470.1	3241.0	2716.5	42.1	6.3	2545.9	2.0	3330.0	46.3	229.6	4400.2	1201.6	30.2	7.5	3519.0	296.5	3137.0	6.0	10.1	2490.2	2021.5	1873.5	547.9	6309.4	1840.9	1036.8	504.2	121.4	1183.3	2746.2	689.9	611.9	701.6	1140.4	63.9	3414.9	1379.0	53.7	3448.3	5768.6
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272075-33276511	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	3268.2	2353.2	1862.8	2097.6	1883.3	6071.7	6110.7	1827.2	2345.5	3989.9	1782.7	3060.6	2024.5	2386.7	2877.9	4570.6	3069.7	1608.3	1778.5	1806.3	1863.3	2052.0	2248.2	2034.3	4842.9	1889.4	1840.1	6497.6	5554.4	1294.1	1412.1	1956.1	1895.2	2780.5	2977.4	697.1	3045.6	1415.3	2861.9	6539.3	2565.0	1891.5	1948.2	3087.2	2634.1	789.9	1920.2	3097.1	2084.7	2140.2	4485.9	3011.2	3685.5	1926.5	4603.2	2645.2	3377.1	8930.5	5769.4	11474.6	5486.7	4471.1	6678.3	5939.4	4461.0	6787.2	2617.5	15106.6	4694.9	4890.5	2759.3	3293.1	5472.9	7251.7	4665.1	4722.4	8590.2	5617.0	2868.6	9108.9	11226.3	9771.0	2849.3	12386.6	14318.8	4498.5	13349.4	5436.5	5770.2	4373.8	7686.7	4590.7	5362.0	7880.9	4994.9	10924.1	4652.3	5367.0	3798.3	5853.7	5446.7	10293.5	5524.1	6007.1	3902.3	5714.2	1754.6	8884.0	14781.0	2429.4	6105.7	16713.0	4642.3	2714.4	3129.5	2894.4	5978.6	5376.3	12310.7	11828.5	1512.3	10665.4	3350.2	578.7	1878.9	236.8	2362.1	1653.6	4023.7	5634.6	4545.5	3382.7	3273.4	4515.8	4968.4	4374.8	184.7	3177.0	1265.3	2962.7	3727.6	9405.4	1862.8	1883.3	1827.2	2345.5	1806.3	1863.3	1889.4	1840.1	1895.2	1948.2	1920.2	1926.5	4065.5	1480.8	2569.4	9.4	8276.1	20537.2	16151.5	18150.8	5757.2	343.9	19342.8	26385.3	596.5	4185.0	6755.1	1841.0	231.4	8761.7	5535.7	2348.6	5106.4	4750.1	1164.5	1985.2	7580.0	5826.2	3089.9	3782.1	7.5	12662.2	14558.3	4617.6	2073.4	3457.9	3051.1	5393.6	6329.9	4513.1	6281.1	159.9	8.1	7793.0	4418.8	6115.9	12428.1	3197.4	9895.8	4296.2	8448.8	13.1	6356.1	1521.4	4753.9	5.0	11.5	8283.0	5985.7	4056.9	3499.7	14221.0	5563.4	5974.5	1936.4	683.4	2005.0	7010.5	6802.2	773.3	1827.1	8678.7	31942.8	8778.2	6742.0	7987.5	9896.2	16152.8
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	98.5	123.0	122.2	43.1	124.5	61.7	94.6	126.7	159.0	73.5	115.9	117.1	43.5	65.5	31.5	94.2	65.6	19.3	114.6	121.2	119.7	123.1	158.5	80.4	48.0	126.5	124.2	68.9	109.6	47.1	66.5	30.2	123.7	108.1	19.2	23.9	94.4	42.8	104.7	80.0	78.3	19.7	124.8	100.5	101.5	65.8	128.4	40.5	96.7	45.4	34.6	99.9	73.7	123.9	94.8	117.6	54.5	80.4	60.7	39.7	110.8	102.0	87.3	92.5	74.0	131.1	62.1	118.9	107.4	64.5	74.8	73.8	87.8	111.3	32.2	163.8	261.5	110.0	105.5	118.0	88.2	166.8	142.3	60.1	83.1	80.3	96.8	49.4	64.9	87.6	128.0	83.8	61.0	108.0	80.6	164.1	95.1	210.9	209.5	127.3	70.0	182.0	99.7	95.8	121.2	66.9	85.8	137.3	203.1	33.6	98.8	134.8	74.0	77.5	168.8	85.7	141.7	140.3	145.4	188.4	103.3	116.8	183.1	126.8	147.4	187.3	133.0	141.6	123.5	159.7	135.1	140.6	122.4	173.9	129.9	132.8	168.7	128.9	119.4	193.1	165.1	138.3	122.2	124.5	126.7	159.0	121.2	119.7	126.5	124.2	123.7	124.8	128.4	123.9	113.6	44.8	51.4	13.1	109.5	137.1	94.3	124.3	84.2	98.0	178.6	205.7	73.8	105.8	83.0	97.5	52.1	152.9	114.7	205.5	217.2	174.9	23.6	68.6	69.8	121.0	142.6	83.5	8.7	192.2	231.9	92.0	76.0	81.6	69.8	62.0	116.0	184.8	204.3	35.3	10.9	207.5	130.2	116.4	233.3	40.3	137.0	110.8	108.5	8.4	147.8	139.1	162.7	5.5	18.7	233.5	202.2	126.0	193.3	206.8	274.9	362.2	54.0	103.7	78.9	74.4	100.9	61.6	138.0	87.6	147.9	131.6	115.2	103.1	165.9	132.4
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962058-1964841	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		320000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	1690.3	1371.4	724.2	1077.5	741.5	2753.6	1803.0	715.7	944.0	1873.9	730.0	1509.2	957.5	1382.0	615.7	2558.8	1584.3	696.4	1237.7	712.7	742.4	1051.6	1423.2	1204.2	1914.1	797.8	741.9	3256.7	4556.8	388.1	972.5	832.6	777.7	1473.5	762.9	148.1	1477.9	636.9	2367.2	2781.5	1482.9	616.5	775.9	1849.7	1599.6	419.7	767.4	1570.4	1025.2	1558.8	1602.3	1750.8	1810.5	777.2	2258.0	3020.8	1716.3	5571.2	2433.0	5946.5	3093.8	1506.8	3381.7	3653.7	2581.3	5415.0	1451.8	4124.7	2329.8	2599.8	1226.5	2625.3	2553.6	4786.8	1372.0	2720.7	4959.5	1437.5	3382.8	4939.7	6019.8	3263.4	2174.4	8105.2	6715.4	3155.0	5057.6	3734.5	3606.2	3601.3	3014.4	2244.9	2591.9	9854.0	4110.2	5683.0	5591.7	2742.4	2706.1	4981.3	2846.5	4915.9	3411.9	1993.3	3154.5	2856.4	1465.0	4355.3	3538.6	1481.8	2933.7	5612.6	1757.9	1961.2	2605.3	499.3	3123.2	908.6	1554.7	5464.5	1056.9	2809.3	2532.6	74.1	438.2	239.9	562.4	545.5	932.7	1765.0	1096.6	864.3	805.8	1525.5	1366.1	1034.5	88.0	667.8	449.4	803.5	844.5	749.9	724.2	741.5	715.7	944.0	712.7	742.4	797.8	741.9	777.7	775.9	767.4	777.2	1261.2	519.2	1240.7	8.8	5674.4	11938.0	10835.5	3903.6	3510.9	362.3	12291.0	12660.6	252.4	2427.7	2182.1	910.4	187.7	8328.8	4158.8	1406.9	3212.6	4491.8	298.5	1154.3	4108.9	4082.2	2111.6	4032.5	13.2	11401.9	14898.5	2987.2	1703.4	1777.4	1021.9	4053.7	3477.4	2195.6	6029.4	277.6	15.7	4569.6	1627.6	5640.5	9869.6	489.7	4210.7	3709.4	5115.6	15.9	6772.9	965.3	3821.9	13.0	25.5	5585.7	2941.4	1575.6	3202.3	9790.4	2044.2	2439.2	906.1	477.8	1255.6	4193.6	3603.8	388.8	1997.9	5900.2	15069.3	8184.0	4718.2	6863.0	6345.9	11758.5
RPS20	"S20, uS10"	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067254-56074510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	2422.2	1415.6	1315.1	1437.6	1380.2	4350.7	2956.6	1314.4	2021.9	2421.6	1346.7	1883.7	1075.9	1542.4	1867.0	1732.4	1773.1	1364.6	1704.0	1265.2	1344.7	1472.6	1677.3	1532.7	3682.4	1368.1	1323.4	4823.5	2312.4	967.6	1157.1	1216.1	1376.0	1847.0	1162.5	646.1	2385.0	1153.2	2332.3	2599.0	1612.4	1057.6	1411.0	2022.1	1776.0	770.6	1360.6	2421.2	1631.2	1656.7	2569.3	1939.8	2002.2	1419.8	3154.0	2878.4	2662.3	2623.1	3875.2	4572.0	2296.1	2060.3	3243.9	2550.2	2328.3	3056.4	2994.9	4688.2	2496.8	2293.0	1686.1	1922.9	1731.7	3416.4	2167.2	2011.7	2418.6	3834.9	2434.8	3830.1	3733.9	2152.1	2396.3	4425.9	3555.4	1638.9	4725.2	3971.6	3184.3	3477.9	3210.0	2689.0	2585.6	4101.1	5915.4	4351.3	3574.7	4325.3	1233.6	3196.9	977.9	2459.6	3093.5	3500.9	896.6	2761.2	891.7	2403.8	4246.6	2210.3	3493.0	4411.0	1954.8	1824.1	3074.6	2401.4	3337.6	2829.2	2756.3	3479.1	2754.4	3895.2	1655.6	2076.5	2125.0	869.1	2514.0	1746.2	3620.8	5471.6	4594.4	3362.7	2643.7	4621.2	5940.0	4391.6	374.5	2151.7	1671.8	3772.4	3333.2	8768.9	1315.1	1380.2	1314.4	2021.9	1265.2	1344.7	1368.1	1323.4	1376.0	1411.0	1360.6	1419.8	531.6	1259.6	2162.2	18.6	2262.9	3750.0	3713.6	2367.9	409.2	140.6	956.6	590.0	1017.9	1684.3	1791.9	693.4	112.6	2885.6	1645.2	793.6	2201.1	1970.4	1979.3	746.1	1507.7	1533.9	1208.0	1268.8	13.3	4091.1	4246.0	1266.3	189.1	983.9	1670.0	570.3	2543.6	2301.4	2511.0	55.5	11.6	2235.2	679.5	3405.9	3567.2	1769.8	4496.9	1619.2	1949.5	15.0	3676.2	815.3	2747.7	10.1	16.2	3313.5	1714.9	1990.1	364.9	3196.6	1259.1	3235.5	956.0	354.6	1400.3	1958.0	1531.1	1536.1	1483.5	473.0	3924.2	3019.4	2078.3	664.6	2291.2	4097.9
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387103-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		250000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	1584.8	1416.8	1374.5	789.4	1408.7	2392.8	1877.1	1365.4	1771.9	2177.4	1327.1	1555.5	746.0	1459.7	550.8	2064.4	1803.0	465.4	989.2	1361.6	1356.9	1244.1	1088.1	1150.8	1513.8	1351.9	1347.8	3181.1	2441.5	527.1	968.9	561.5	1373.6	1408.6	629.9	210.2	1471.7	509.7	2133.5	2936.6	1592.2	420.1	1392.9	1836.6	1581.4	476.4	1420.6	1510.6	1172.3	873.8	982.5	1503.0	1900.1	1424.0	2398.5	2358.8	1184.4	2320.2	1321.3	2309.7	1609.5	1472.3	1141.8	3554.0	1348.8	7961.3	3131.7	2835.0	3019.8	1156.5	1283.3	3239.7	1343.1	4099.0	1252.7	729.2	3445.4	4723.0	3120.5	6137.2	2650.8	3692.8	2066.1	2581.1	5669.7	1370.4	2496.5	1451.4	1705.6	3116.1	2436.0	2351.9	1269.6	3506.2	4242.3	5294.5	1862.4	4129.5	7157.1	2799.7	3043.3	4437.6	1745.8	2581.8	2240.7	2206.7	1508.4	6850.0	3365.8	753.9	2935.2	4792.0	1810.4	2182.4	2852.5	1853.4	2993.0	3660.0	4580.0	3219.1	2607.4	2209.6	1179.5	379.7	1000.3	242.1	1322.7	872.6	1890.4	2692.5	2242.4	1753.8	1447.0	2532.7	2648.9	2404.8	152.8	1251.1	707.2	2013.1	1578.6	3102.5	1374.5	1408.7	1365.4	1771.9	1361.6	1356.9	1351.9	1347.8	1373.6	1392.9	1420.6	1424.0	1364.6	586.5	941.1	7.8	3935.3	2655.4	1626.1	981.0	3107.4	142.2	3889.4	5494.5	366.2	1229.6	931.4	489.2	223.1	1664.7	2299.9	1067.8	692.6	1619.1	132.9	556.3	999.9	1124.0	1212.9	2581.9	9.4	3548.5	2106.0	1019.6	1460.2	940.4	958.8	1067.6	1729.4	1728.5	1271.3	149.7	8.2	2684.6	321.4	2098.5	2590.7	133.6	1556.1	1493.7	974.7	5.6	1999.4	676.9	2139.1	4.0	6.5	2264.9	2168.9	802.3	2205.5	1561.5	1866.1	1305.7	429.3	305.3	558.8	1930.9	1036.6	265.6	853.2	3960.0	3136.3	1638.4	2731.0	645.0	3215.9	1523.2
RPS23	"S23, uS12"	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273320-82278396	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA054853: AB_2682625"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	1840.0	1001.7	1102.6	919.8	1139.3	2295.9	2649.1	1097.2	1494.2	1922.8	1136.2	1575.0	866.4	1493.4	1196.0	1539.8	1672.4	756.6	1211.1	1074.2	1125.0	1218.3	1076.0	1134.6	1864.9	1130.3	1100.3	3535.9	1900.1	984.2	838.4	1032.9	1137.0	1249.4	1205.8	470.0	1327.3	986.0	2805.4	2306.5	1430.2	1131.3	1171.9	1552.4	1316.7	366.8	1148.1	2694.5	1038.7	2442.4	2518.1	1468.9	1717.5	1161.6	2194.6	847.0	2383.6	1836.5	3911.6	5242.6	2418.7	2052.4	3094.7	3039.4	2997.3	1198.9	1451.9	5113.6	1398.9	2675.8	1875.0	1105.9	3616.3	5911.6	3136.4	1871.9	2042.4	2101.5	1239.3	1178.4	5159.4	3068.6	1461.8	5082.4	6870.2	2325.0	6036.4	4522.6	3980.7	3201.0	2227.1	1562.5	2659.7	1412.7	3396.2	3089.5	1523.5	1162.4	1956.0	2244.6	3408.7	4676.7	2983.4	911.2	1526.7	1982.2	1057.1	1810.3	4447.1	2355.6	1377.1	4649.1	2839.5	428.0	1674.5	1057.9	3279.8	2227.0	3570.0	3590.9	1014.3	3878.9	965.3	193.0	852.3	128.5	784.5	761.0	1202.8	1945.0	1339.2	1065.9	1358.1	1736.1	1731.5	1494.5	80.8	943.5	645.5	1540.2	1054.5	2806.0	1102.6	1139.3	1097.2	1494.2	1074.2	1125.0	1130.3	1100.3	1137.0	1171.9	1148.1	1161.6	2726.7	1064.1	1527.2	28.7	6648.3	5904.9	6058.5	4170.7	4319.6	392.6	6217.4	10450.4	305.7	2573.6	2153.2	1138.5	173.0	4912.5	4340.2	1276.9	3813.2	2523.5	1016.2	1431.7	3705.0	3112.3	1903.4	3545.2	24.5	4768.9	7030.8	2927.9	1667.2	2001.0	1700.8	3926.3	3285.8	3044.2	4261.2	233.9	28.5	4024.3	1175.9	4330.3	6276.8	1790.6	6175.3	3562.9	2865.5	41.2	5041.5	1465.2	3478.9	19.1	34.1	3569.5	3167.2	3089.2	3083.4	6281.6	3384.4	5720.4	861.0	665.2	1702.6	4593.8	3792.9	734.0	995.2	6141.4	7107.0	5202.6	4322.9	3981.9	4731.8	6359.5
RPS24	"eS24, S24"	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033760-78056813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		90000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	2458.4	1993.8	1538.1	1424.8	1549.0	4673.1	4757.9	1530.6	2756.8	3012.3	1536.9	2576.1	1756.5	2519.4	2811.2	2293.7	2474.3	1606.6	1604.1	1488.8	1645.6	1754.0	2209.3	1458.8	2669.4	1576.3	1569.3	5844.6	2955.3	1438.5	1178.1	1754.5	1586.4	1958.8	2573.9	964.5	2512.4	1637.4	3019.3	3045.0	1693.7	1946.0	1586.5	1916.9	1651.7	776.1	1538.2	2798.0	2252.7	2553.7	2707.5	2652.8	2547.2	1623.3	3390.5	1308.2	3303.3	5221.9	4021.6	7048.4	2884.3	3654.6	5055.0	3773.7	3323.4	1878.5	2339.0	7039.0	1940.5	3205.9	1303.4	2612.8	3847.7	4674.9	3460.7	2403.0	4325.8	2868.1	822.8	1879.0	4533.9	6943.1	1575.6	6732.0	6867.2	2652.4	9675.7	7591.6	4592.2	2981.8	4007.0	1455.6	4191.8	1388.2	3770.5	11229.0	2318.2	5976.0	12085.6	2567.9	3934.7	3482.3	4773.4	1608.2	1658.6	3234.9	1805.2	6010.8	4716.9	3414.2	3356.5	7559.6	3894.3	1175.5	2712.7	1570.9	4896.7	1774.5	3875.7	5354.8	1459.5	9444.0	970.5	1058.0	2124.4	809.3	1585.0	2036.3	2627.9	2796.4	2178.6	2037.5	2932.4	2380.3	2861.9	2644.0	276.9	2801.9	1626.7	2569.0	1916.3	4390.5	1538.1	1549.0	1530.6	2756.8	1488.8	1645.6	1576.3	1569.3	1586.4	1586.5	1538.2	1623.3	2643.8	743.6	1535.6	44.1	4070.7	4105.7	5007.7	2774.6	5333.8	344.3	4139.9	6421.4	617.1	2051.8	1719.2	801.9	108.4	3406.3	3424.5	1200.3	3279.1	2335.3	1414.9	1799.8	4602.7	2194.2	2090.5	3250.6	40.4	4508.1	6260.1	2099.8	2310.4	2451.6	1237.2	3541.5	2346.6	2252.0	3311.9	151.4	42.6	3944.5	880.9	4754.9	4734.0	5440.1	5670.8	3861.9	2031.3	49.6	5590.7	1395.6	3262.7	23.1	45.9	2886.9	3231.4	2588.2	3109.6	4622.7	2703.3	3770.5	768.5	465.7	1268.8	3609.7	2661.0	653.8	709.0	7289.7	4590.1	3541.8	3518.7	4105.6	4384.9	4943.2
RPS25	S25	ENSG00000118181	"Ribosomal protein S25"	P62851	11	119015712-119018691	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031801, HPA078683"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		150000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA031801: AB_10610419, HPA078683: "	"unprognostic (1.60e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.75e-3)"	"prognostic unfavorable (3.00e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.20e-1)"	1030.5	759.2	703.6	735.1	728.1	1650.9	1487.8	698.3	1133.9	1226.7	679.4	957.6	596.1	817.3	1030.4	898.8	1058.0	573.8	771.4	675.6	730.6	879.4	830.1	672.8	1488.5	718.4	700.7	2254.5	1279.5	535.1	807.7	633.7	726.5	841.2	697.9	460.2	1068.5	606.0	1873.7	1107.6	773.8	578.5	748.0	889.7	875.5	283.5	722.1	1100.8	817.0	1278.8	1307.1	967.1	1005.4	749.3	960.2	646.9	1024.1	1063.6	1461.7	2371.7	994.2	1098.1	1159.2	724.7	635.6	1753.4	1580.0	2269.6	2031.5	853.8	782.5	1146.8	951.4	1305.8	852.5	1166.9	1278.1	3013.6	598.3	1718.0	1102.2	2122.0	924.8	2043.3	2460.8	647.0	1673.7	2154.5	1384.9	1739.3	1670.1	1288.7	1072.8	2396.1	2072.1	3727.7	1045.8	2204.6	1573.1	1447.7	1055.6	2743.5	1319.2	1228.3	830.4	1737.6	578.1	1850.5	1467.1	1175.2	1533.2	2972.9	1144.8	703.2	768.0	724.7	1198.9	1051.5	1232.2	2109.6	489.5	2563.2	806.5	997.3	1197.8	775.1	1976.3	1284.0	3220.0	3716.4	3654.3	2784.5	1945.5	3077.2	4507.9	3661.8	319.1	2123.4	1145.7	2384.0	2614.1	5186.2	703.6	728.1	698.3	1133.9	675.6	730.6	718.4	700.7	726.5	748.0	722.1	749.3	1697.5	810.9	1658.7	42.7	4105.7	3970.2	4377.8	2769.0	2486.4	284.5	3671.0	4464.2	177.0	2040.3	1857.3	932.5	114.7	3745.3	2579.2	1009.2	3273.2	1883.0	1859.4	927.5	1934.9	1947.4	1330.6	2078.2	25.4	3163.4	4115.0	1768.2	946.5	1319.1	2024.6	5691.5	2726.5	2709.6	2534.6	134.6	27.4	2786.8	895.2	3338.1	3963.7	2384.8	3824.6	2101.3	2186.0	30.9	4048.0	1305.0	2802.3	16.6	39.3	2301.3	2254.2	1713.3	1821.2	4000.4	2308.2	4494.5	909.9	475.7	1334.5	2501.7	2382.7	788.8	827.3	3140.7	4661.0	3656.0	3604.7	1427.9	2788.0	4153.7
RPS26	"eS26, S26"	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044697	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 494.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	720.5	1265.1	387.6	271.7	388.8	395.5	690.2	382.8	480.4	707.7	384.0	731.2	177.1	569.7	410.7	875.4	724.0	123.3	713.0	380.9	416.6	701.8	926.6	521.9	512.9	396.3	399.7	1120.6	1170.2	274.3	476.7	251.6	389.9	627.3	403.3	69.8	592.3	335.9	778.2	857.3	744.1	307.2	383.4	832.0	717.5	208.8	394.0	616.8	544.1	390.6	715.6	734.3	698.0	389.2	639.2	763.3	853.6	319.5	1153.3	1696.4	852.0	633.4	929.5	1027.7	596.0	1182.7	281.7	1408.3	383.5	670.6	339.5	293.2	970.5	544.0	698.1	558.9	1552.8	743.9	482.1	719.0	1062.3	490.5	392.2	1036.9	1705.6	544.3	614.0	404.0	794.3	989.6	517.2	458.1	845.1	983.2	371.8	886.0	839.7	766.7	1710.8	496.7	254.8	884.3	871.4	634.9	318.2	552.4	245.8	542.2	372.2	252.1	479.4	538.6	260.8	255.0	524.3	328.0	518.0	369.3	810.2	770.9	284.0	969.2	334.4	334.8	394.8	262.5	650.7	410.2	723.2	872.3	841.4	711.8	508.4	720.3	898.4	863.6	154.8	607.5	373.0	643.6	963.7	1264.1	387.6	388.8	382.8	480.4	380.9	416.6	396.3	399.7	389.9	383.4	394.0	389.2	1114.5	224.4	237.7	5.2	2483.4	1760.6	852.7	2533.9	3266.8	131.0	1968.1	2542.2	29.2	1425.5	985.7	430.4	62.6	1237.2	1377.0	1803.5	972.4	1031.5	85.4	862.0	876.0	992.0	860.5	1977.9	5.2	2625.0	2835.4	1006.2	1666.7	861.2	514.4	1242.7	1647.4	2125.4	1369.2	75.7	5.1	1406.6	732.4	1557.8	1925.7	57.3	295.4	1146.8	1462.1	6.5	754.7	706.4	563.4	6.6	7.1	1806.8	1756.4	221.5	2590.7	1221.2	2448.3	1503.0	557.4	193.1	309.0	719.1	935.9	305.9	304.0	4236.6	1814.2	1708.2	2103.6	1318.5	1411.0	1000.6
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	Yes		230000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	1440.7	1208.5	1115.0	1077.7	1151.0	2567.0	2511.6	1098.2	1883.7	2166.1	1099.2	1563.5	823.5	1450.9	1105.1	1698.4	1726.7	572.2	943.7	1085.1	1131.6	1254.8	1162.3	1097.1	1955.6	1133.6	1117.0	3146.7	2043.5	730.2	1057.5	872.9	1131.4	1430.2	1045.0	631.9	1387.4	917.9	1089.6	1767.3	1328.6	814.7	1172.6	1719.2	1478.2	405.9	1150.4	1520.4	1201.6	793.7	1774.4	1506.3	1694.7	1157.1	2384.4	1092.2	1412.2	1842.3	1892.6	3200.3	2412.6	1824.5	1779.4	1692.3	1069.1	2073.7	1987.4	3081.3	2833.2	1698.5	1115.0	1784.3	2061.7	2465.1	1981.0	2899.1	2419.0	2693.9	1088.0	2758.1	2705.9	3674.4	1605.2	3166.1	4213.4	1280.5	3401.6	3015.5	2415.9	1959.5	2469.0	2228.9	1937.3	1509.9	2307.6	4328.7	2831.1	2690.2	1710.6	2086.4	3051.2	3173.8	1994.3	1817.4	1546.0	1319.2	1064.4	4071.8	3843.7	2065.9	1811.0	3411.1	2108.9	1351.7	2395.8	1318.7	3006.7	2322.2	1881.5	1867.9	1923.5	3226.7	1392.6	1301.5	1656.9	637.7	2924.2	1530.8	4268.2	4727.8	4504.3	3592.2	2219.0	4232.8	5675.0	4744.3	351.6	3178.7	1388.8	3292.5	3058.2	8225.2	1115.0	1151.0	1098.2	1883.7	1085.1	1131.6	1133.6	1117.0	1131.4	1172.6	1150.4	1157.1	3051.9	1272.4	2321.3	39.8	7158.8	8321.0	8963.0	6850.9	5010.5	446.4	8189.8	10987.6	438.8	3029.7	3486.3	1397.8	214.8	5340.9	5465.1	1499.3	4055.8	3640.9	1050.2	1695.4	3081.0	3385.0	2057.4	3362.1	45.8	7348.0	6754.1	3043.5	1762.0	1917.3	3014.6	3565.0	3729.5	3181.0	3498.7	218.7	47.8	3995.4	2199.2	5051.0	6045.7	1576.9	5081.5	3382.7	3639.2	59.0	6346.8	2229.4	5579.8	29.1	61.0	5045.3	3396.0	2881.2	3458.4	8189.2	3670.3	5961.1	1726.4	760.9	1643.5	5220.3	4020.2	1047.7	863.4	5750.5	8931.2	5390.3	6365.7	3721.9	4717.6	7980.9
RPS27AP5		ENSG00000231767	"Ribosomal protein S27a pseudogene 5"		1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 16.3"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.6;SK-MEL-30: 4.2;THP-1: 4.7"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	0.2	0.3	0.2	0.8	0.2	0.7	0.5	0.2	0.6	0.2	0.2	0.2	0.8	0.5	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.1	1.1	0.2	0.3	0.7	0.0	0.0		0.2	0.3	0.2	0.0	0.3	1.0	0.1	1.1	0.1	0.5	0.0	0.2	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.3	0.0		0.3	1.0	0.4	0.2	0.6	0.3	0.0	2.5	0.1	0.5	0.0	0.3	0.0	0.7	0.2	2.5	0.0	0.2	1.0	0.1	0.3	0.0	0.9	0.5	0.4	0.4	1.9	0.2	0.7	1.3	0.3	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.5	0.9	4.6	1.1	0.1	0.2	1.0	0.3	0.6	0.3	1.3	0.8	1.6	0.2	1.5	4.2	0.1	1.0	4.7	0.5	0.6	1.2	0.8	2.4	1.5	1.1	0.9	0.8	0.7	0.1	1.2	0.9	0.5	2.0	1.3	2.8	4.2	3.5	2.2	1.8	3.8	4.4	4.5	0.3	3.0	1.0	1.6	2.5	5.6	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RPS28	"eS28, S28"	ENSG00000233927	"Ribosomal protein S28"	P62857	19	8321158-8323340	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 19765.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047132	Approved		Approved	Cytosol		NA	NA		730000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047132: AB_10962147"	"unprognostic (3.47e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (3.09e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.81e-2)"	227.9	202.9	129.8	113.7	134.6	286.7	226.8	128.6	189.9	226.5	130.2	188.9	127.8	147.3	52.5	328.4	172.3	94.9	213.0	124.0	129.7	184.6	247.5	171.0	220.2	132.2	129.3	313.0	432.4	72.1	162.7	88.2	129.5	211.1	47.8	20.3	227.8	60.6	252.9	353.8	197.1	42.6	134.1	273.4	219.4	55.7	138.6	117.3	177.4	80.8	98.0	176.7	240.0	131.6	245.9	97.7	86.6	197.5	122.3	183.2	136.6	156.9	141.7	177.6	144.5	133.2	104.7	364.4	189.3	91.7	75.9	183.0	114.9	269.0	25.6	223.2	772.6	176.4	110.4	134.5	219.6	204.6	188.5	294.9	303.7	129.7	116.4	110.9	165.2	279.0	251.6	402.9	80.2	152.5	314.8	725.0	260.8	141.4	587.2	222.7	92.9	390.9	118.6	115.5	165.7	162.3	112.7	206.7	289.3	27.6	157.0	340.9	210.4	147.0	125.1	288.1	266.5	468.3	265.8	248.1	155.7	389.3	101.2	21.3	61.7	13.2	54.5	39.3	76.6	105.0	88.5	64.5	55.9	90.7	98.9	70.0	8.8	44.6	36.3	98.0	61.0	166.2	129.8	134.6	128.6	189.9	124.0	129.7	132.2	129.3	129.5	134.1	138.6	131.6	4308.7	1458.3	2798.6	9.8	6575.7	7900.9	4267.0	4952.1	5103.9	484.0	11594.7	19765.7	382.7	3044.0	2801.5	1340.8	296.1	3851.9	4608.0	2028.0	3335.8	3189.3	262.2	1687.9	4074.7	3610.1	2654.0	3550.8	7.4	7271.1	4542.0	2535.5	2746.2	2586.9	1954.3	4062.9	5016.7	5562.8	4537.9	267.5	9.3	5334.5	1287.8	5745.6	5979.8	559.6	3915.0	3716.8	3523.6	21.5	5150.0	1694.4	3560.3	6.6	14.5	5090.4	4152.6	1644.9	4225.1	3830.4	4316.3	5555.1	1153.6	729.0	1084.7	3477.1	2508.7	367.9	953.1	7848.6	10873.6	4244.9	5017.4	2121.3	5894.5	4043.4
RPS29	"S29, uS14"	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004107	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA004107: AB_1079848"	"prognostic favorable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	2915.6	2346.5	1747.8	1549.0	1785.8	3286.7	3207.7	1739.1	2601.7	3116.1	1718.3	2990.1	1407.8	1886.3	910.5	3294.5	2641.4	401.1	2127.4	1719.9	1762.6	2371.4	2697.6	2200.4	2364.9	1769.5	1741.7	4756.3	4388.2	1049.0	1483.6	887.0	1779.0	2246.8	1122.6	586.1	2625.0	797.7	3625.5	4604.2	3272.8	594.9	1830.7	4088.6	2645.0	1036.8	1800.8	3083.3	1906.9	1770.0	2079.7	2435.8	2777.8	1817.5	3057.7	1984.5	2021.5	1823.8	2271.9	3830.2	2675.3	2042.2	1722.2	1821.1	1483.1	2020.7	2733.7	2772.5	2264.9	1729.0	895.7	2605.0	2373.0	2922.0	2014.3	1811.3	4267.9	2191.4	1630.4	3564.5	2776.6	5612.2	1803.4	4011.6	4623.6	1204.7	3464.6	3181.7	2623.2	4723.4	2489.2	3498.4	1791.5	4047.4	3845.0	3454.4	2484.9	5075.2	5572.2	3178.5	2521.0	3196.6	2248.6	2696.4	1527.3	1753.1	1455.4	2636.2	5088.5	1938.5	3444.4	4786.4	2459.7	1381.7	3726.2	1295.6	1836.9	4014.0	4872.1	3856.3	973.0	2256.8	1363.0	3144.8	4379.9	1967.1	6689.0	3436.4	8449.9	11659.9	12162.6	8749.3	5025.2	10334.9	13471.6	11360.1	968.3	5389.4	3185.1	6778.8	7617.0	26592.8	1747.8	1785.8	1739.1	2601.7	1719.9	1762.6	1769.5	1741.7	1779.0	1830.7	1800.8	1817.5	1348.6	1131.4	2051.0	7.8	5426.0	3418.6	1043.1	2689.6	672.1	235.2	4463.4	3147.6	609.1	2805.3	2104.4	1074.1	129.3	3390.8	4425.2	2370.0	2424.1	2731.6	1371.1	1272.1	2960.5	1727.4	2673.2	2790.5	10.7	7061.8	4966.0	1443.2	650.3	1997.1	3019.4	2592.2	4092.8	7356.4	3048.0	107.7	12.0	6874.6	769.0	5623.6	5164.4	3280.3	3747.1	2396.2	2002.8	10.3	4580.9	1122.2	5206.1	10.1	17.9	5207.4	5628.6	1617.8	1584.1	1084.2	4951.5	3523.5	985.2	355.1	1091.3	1292.9	1159.9	1090.2	994.1	1255.0	4894.6	3673.2	4742.9	954.8	6917.3	1177.5
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399515-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		560000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA063339: AB_2684990"	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	1139.4	747.7	431.1	955.9	446.8	2080.0	1950.0	427.3	575.6	1529.6	427.4	1220.4	946.0	1060.9	708.7	1669.8	1270.5	556.5	734.1	417.1	441.6	672.3	631.7	846.0	1663.4	446.6	430.8	2914.0	1761.9	356.4	660.5	760.6	442.8	929.1	919.3	352.7	1049.9	662.1	1125.5	1783.9	1128.2	739.8	444.4	1346.4	1082.2	287.7	435.1	1403.5	717.1	749.0	1360.4	1054.9	1384.5	446.9	1899.8	1145.7	1595.6	1767.5	1970.0	3482.1	2060.8	1763.7	2256.3	2289.4	1481.2	3331.6	2196.8	6547.1	2108.6	1598.8	1261.5	2672.3	2085.6	3290.7	2093.8	1749.1	1618.9	2688.6	1042.6	1490.2	2931.1	4398.6	1690.0	4124.1	4397.7	1568.8	4323.1	2684.0	3055.0	2876.5	2736.9	1809.7	2089.7	2071.2	2660.9	2112.4	2007.4	6591.3	1342.5	2482.3	5580.2	4834.0	2275.9	1551.8	1366.7	1933.6	1299.3	3050.2	1897.1	1535.9	3123.3	3289.9	2470.7	1099.6	1822.9	1515.3	1627.3	1647.2	2198.0	7283.3	660.4	2409.4	1138.1	430.3	770.8	245.5	1405.7	515.5	1924.9	1602.2	1823.1	1489.0	1099.3	1454.0	2102.1	1633.9	174.3	1142.6	512.4	960.4	1283.7	4244.2	431.1	446.8	427.3	575.6	417.1	441.6	446.6	430.8	442.8	444.4	435.1	446.9	1993.9	932.7	1604.3	18.6	4790.5	6297.7	7369.7	5554.5	4497.7	423.9	6945.0	9521.7	418.9	2088.9	2555.7	726.4	133.5	6188.6	4009.1	1694.4	2183.4	2376.0	430.9	939.2	3054.9	2780.8	2067.1	3428.9	28.3	5373.2	9079.0	2364.6	1651.9	1363.9	1641.6	4246.7	2916.7	1369.0	3662.5	132.9	32.6	4425.4	1621.5	3089.2	4666.7	968.5	3755.0	2393.1	2835.3	38.4	3626.4	957.1	4120.5	19.6	47.5	3805.0	3535.7	1803.2	2848.0	5827.8	2969.4	2226.4	797.6	505.5	1117.5	3204.8	3221.9	449.3	618.6	5734.6	7842.8	5867.5	4904.4	4865.2	5657.1	7206.9
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099624-151104642	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	2233.9	1361.3	1032.4	1357.8	1063.0	4321.5	4603.8	1034.9	1672.3	3236.5	1041.5	1964.3	1314.5	1964.8	2303.4	2250.6	2307.9	1186.8	1430.3	992.0	1052.4	1657.2	1371.0	1471.0	3341.7	1038.8	1025.1	4877.7	3514.8	1107.6	1325.8	1372.7	1059.4	1982.7	1778.1	861.8	2107.7	1322.9	1967.9	2992.3	1848.5	1337.8	1102.5	2038.6	1898.7	586.2	1056.2	2991.3	1965.5	1499.1	2764.4	1969.9	2486.8	1089.1	2090.9	1501.8	2780.1	2751.6	3524.5	6867.8	2849.1	2150.7	3334.5	3006.4	1848.2	2933.6	2944.4	9381.3	1048.4	2383.2	1050.5	1339.3	2877.1	3624.3	2840.5	2075.6	2762.0	2023.6	1589.8	3421.2	4067.8	4855.0	1999.1	5125.5	7353.9	1849.5	4874.5	4195.4	3639.4	3417.8	3320.0	4722.3	3632.8	3124.8	5289.7	5604.8	2624.1	3296.7	1147.0	3798.0	2719.3	3175.4	3505.2	2487.1	2668.0	2635.2	971.4	3495.1	5019.9	1954.5	2341.0	5780.5	2212.2	1451.6	1915.8	1618.1	2424.7	3626.8	6367.6	5820.6	1863.4	3508.9	1758.5	1918.8	3362.4	977.5	3828.9	2626.4	6462.8	7155.1	6390.5	5052.0	5393.2	6165.0	8750.8	7174.2	495.2	5199.2	2256.0	6377.8	5103.3	18540.3	1032.4	1063.0	1034.9	1672.3	992.0	1052.4	1038.8	1025.1	1059.4	1102.5	1056.2	1089.1	2387.5	971.2	1605.1	15.0	5574.2	6158.3	8280.0	5535.6	4255.3	412.4	6080.4	8681.6	381.3	2194.8	2530.5	825.8	120.9	4538.4	4799.4	1188.9	4284.8	2316.3	1754.6	1570.1	3613.3	2564.2	2154.3	3366.6	17.8	3732.2	7502.1	2388.6	1599.9	1895.7	1468.6	3424.3	2653.9	1441.0	3403.7	163.2	18.6	4137.0	1454.6	4309.4	5658.7	4012.5	4428.4	3332.7	3260.3	20.6	5502.6	1760.6	4551.0	23.6	22.4	2788.3	3029.1	2592.3	2412.5	6111.5	2682.0	5073.3	1084.8	593.9	1768.4	4410.8	3918.5	834.4	820.8	5042.0	6756.0	4591.7	4520.4	4186.2	5049.9	7641.8
RPS4X	"CCG2, DXS306, FLJ40595, RPS4, S4, SCAR, SCR10"	ENSG00000198034	"Ribosomal protein S4 X-linked"	P62701	X	72255679-72277248	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 16435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000857	Supported					NA	NA		980000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA000857: AB_1079849"	"unprognostic (1.09e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.53e-3)"	"unprognostic (7.05e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.50e-6)"	"unprognostic (1.03e-2)"	"unprognostic (9.78e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (6.87e-2)"	853.8	549.4	365.5	430.2	373.9	1256.3	1420.5	357.6	559.4	1390.0	369.5	841.1	599.4	968.2	1434.8	912.9	1165.4	410.4	553.0	353.4	385.3	665.8	559.4	576.4	1101.4	373.6	367.7	2123.3	1665.4	423.6	820.3	437.3	376.6	759.1	654.5	265.5	841.5	561.1	852.5	1451.3	689.9	713.6	385.5	728.1	763.9	139.7	375.8	1163.5	773.4	435.5	1050.0	832.7	1178.3	380.8	824.3	739.2	978.8	721.5	1348.9	2149.0	712.1	558.1	1459.1	1258.7	996.5	1211.2	569.5	2612.6	1327.0	527.8	931.7	464.3	958.1	1188.4	1312.8	543.5	2220.1	451.1	868.8	902.3	1721.6	1110.2	1087.7	2272.6	1372.4	541.6	1732.2	1232.7	1089.7	840.1	744.8	1579.2	1236.8	1205.1	1334.9	1776.2	969.4	2272.0	857.4	801.1	1371.1	2103.2	827.3	1083.2	911.3	1105.5	920.3	2068.4	1790.3	583.4	413.6	1715.2	586.9	296.5	830.9	619.4	542.5	594.3	598.6	815.8	516.1	2034.5	625.5	307.3	853.9	161.2	1093.0	761.1	1737.7	2010.7	1780.2	1421.2	1240.9	1781.6	2191.8	1787.8	76.4	1291.3	725.8	1413.6	1556.5	3744.0	365.5	373.9	357.6	559.4	353.4	385.3	373.6	367.7	376.6	385.5	375.8	380.8	2558.8	541.7	1356.5	33.0	4448.1	7308.4	7295.0	5549.2	4584.9	274.3	11267.1	16435.1	373.2	2240.4	2347.4	958.2	64.6	4734.2	3564.6	1259.3	5636.8	2116.8	40.7	1732.9	3743.4	2920.8	2538.3	2604.8	30.8	6446.6	7517.1	2559.8	1270.6	1992.9	1314.0	3898.1	2557.6	2057.1	3296.7	67.3	32.6	4050.7	1755.7	2881.5	4938.2	172.0	3729.8	2563.0	3656.9	35.6	3293.0	890.5	2435.7	18.1	46.7	3064.4	3542.1	2188.7	3329.3	5760.5	3103.2	4152.2	995.8	383.9	1216.2	3044.3	3471.7	48.8	229.8	5478.7	9764.3	5159.5	3869.0	4946.8	5023.8	7162.0
RPS4Y1	"MGC119100, MGC5070, RPS4Y, S4"	ENSG00000129824	"Ribosomal protein S4 Y-linked 1"	P22090	Y	2841602-2932000	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1273.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 187.7"	"Region enriched"	"Detected in all"	28	"cerebral cortex: 427.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1076.6;HSkMC: 1195.7;U-698: 1701.8"									HPA000857	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"			"HPA000857: AB_1079849"			"unprognostic (7.04e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.35e-2)"		"unprognostic (1.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.55e-2)"	262.4	239.9	12.9	80.7	13.5	227.3	234.8	13.1	427.8	0.2	14.7	220.0	79.9	0.4	302.0	177.6	0.3	129.8	178.2	12.6	14.9	252.9	174.1	176.3	59.1	15.1	13.7	0.9	327.4	116.8	115.7	116.3	14.6	297.2	258.4	83.4	178.5	225.3	295.6	242.4	188.4	0.2	14.5	202.7	221.9	102.5	14.1	0.0	172.8	382.7	253.8	215.0	0.6	15.1	2.8	270.9	0.0	0.1	0.2	0.8	383.9	452.8	783.0	697.8	586.5	0.5	0.0	1076.6	1.4	645.0	0.0	0.6	0.0	0.3	849.8	317.4	0.1	683.8	0.1	829.0	953.5	1.4	0.7	1195.7	784.4	0.0	0.0	0.0	0.6	97.3	1.7	0.0	717.3	0.4	615.0	1.9	0.6	0.0	0.9	0.6	342.6	163.5	658.9	507.6	391.3	1.2	1.0	1.0	1.3	252.6	0.7	481.4	579.5	263.3	4.5	0.9	451.8	410.9	1.1	1701.8	0.0	1.1	0.1	42.4	97.3	21.2	112.8	84.1	168.6	156.3	187.2	116.0	159.3	142.4	227.6	213.3	21.8	125.1	56.8	65.4	170.1	252.1	12.9	13.5	13.1	427.8	12.6	14.9	15.1	13.7	14.6	14.5	14.1	15.1	0.0	201.9	459.1	9.8	493.4	849.9	981.5	1273.9	537.3	115.3	0.0	0.0	109.8	343.1	479.2	215.2	41.7	568.8	126.2	24.6	471.6	302.8	13.7	0.0	0.0	354.9	99.5	292.5	10.9	8.3	368.5	281.0	208.5	0.0	354.6	0.0	476.2	51.1	281.6	53.8	9.4	159.2	256.3	426.3	758.3	52.3	809.3	248.7	588.7	11.2	407.2	321.0	472.7	5.0	6.4	213.6	56.1	431.8	202.7	816.8	115.7	893.6	314.5	153.4	276.1	292.4	214.8	103.3	227.3	594.7	989.7	464.4	523.1	0.0	183.8	904.0
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4 Y-linked 2"	Q8TD47	Y	20756108-20781032	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 1.9;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.5;Basal keratinocytes: 3.2;Basal prostatic cells: 3.5;Langerhans cells: 3.4;Prostatic glandular cells: 2.1;Spermatogonia: 2.6;Suprabasal keratinocytes: 5.8"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 7.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Cell line enriched"	"Detected in single"	5	"U-266/84: 2.0"									HPA000857	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"			"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.1	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.2	3.5	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.7	0.6	1.1	2.6	0.0	5.8	0.3	0.4	0.0	0.0	1.3
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 11301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		880000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	1081.7	1079.0	621.2	604.4	637.5	1609.5	1273.6	612.1	781.7	1432.2	592.8	1109.0	590.3	1053.8	378.7	1577.3	1221.4	504.3	811.8	587.0	617.8	800.1	997.5	789.2	1269.3	637.9	617.7	2437.6	2886.2	520.6	669.0	520.1	631.9	1225.4	575.6	182.5	1064.0	484.2	1456.9	2062.5	905.6	571.2	657.5	1033.5	1075.5	331.4	642.5	1007.9	830.1	821.3	1002.1	1098.4	1304.4	641.0	1779.4	2543.8	953.2	1524.9	1812.8	2328.6	1485.9	967.6	1590.9	1162.4	737.1	1909.7	1270.7	3655.5	1185.5	1379.5	1134.2	1126.2	1529.9	2381.7	478.7	1000.1	11301.4	1451.3	1247.3	2444.6	2241.6	2459.7	1183.1	2980.8	3882.4	1210.7	2740.2	1288.9	1539.0	1662.6	1880.1	1897.8	1260.5	1432.8	2399.9	1683.0	1589.7	2782.4	3399.7	2289.6	1364.6	3236.9	1296.9	2199.0	1424.2	1776.2	677.7	1916.6	2066.3	556.4	1109.2	2923.7	980.7	1743.4	1276.4	705.7	2149.8	2527.3	4650.9	2768.7	1092.1	1817.9	980.8	322.0	652.6	131.2	739.4	621.6	1360.4	2219.4	1272.0	962.1	1196.9	2071.6	1829.6	1435.3	92.8	1022.1	467.6	1253.3	1128.4	2583.3	621.2	637.5	612.1	781.7	587.0	617.8	637.9	617.7	631.9	657.5	642.5	641.0	1118.4	679.5	1091.0	10.1	3747.2	5916.6	5060.2	3028.2	3999.8	242.5	5685.5	7711.0	243.7	1499.9	1654.2	526.0	123.0	3220.8	1739.2	1023.0	1823.4	1792.4	490.1	640.6	1967.1	1631.2	1236.3	2005.8	10.6	4571.3	4191.9	1629.9	1014.8	915.6	1003.0	2412.5	1452.8	1468.4	1973.5	163.2	15.2	2390.3	958.2	1800.2	3567.2	1482.6	2160.0	1414.9	2431.5	12.2	1874.2	700.7	1618.0	12.1	25.1	2022.9	1856.1	945.2	2346.5	4934.9	1734.6	2607.0	711.5	456.9	696.8	2096.0	3046.0	489.6	758.2	4308.1	7256.9	3174.7	2382.2	2244.1	2922.0	4637.7
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380236	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 16920.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		320000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favorable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	2449.1	1527.7	1230.0	1483.1	1315.9	3988.9	3070.3	1218.7	1877.5	2746.3	1206.5	2056.1	1485.0	2008.1	1857.3	2788.4	2192.6	927.2	1419.4	1155.2	1268.7	1807.1	1330.8	1520.1	2961.1	1299.0	1255.9	4555.2	3817.4	1069.3	1427.4	1008.9	1322.1	2250.4	1643.0	716.4	2066.9	969.4	1747.9	3577.8	1929.2	1124.2	1314.7	2032.4	2122.9	697.6	1262.2	2341.4	1663.3	1250.8	2493.5	2378.2	2538.4	1357.3	3146.0	2013.7	2004.4	2363.6	3318.8	5075.0	2399.4	2066.1	2675.8	2423.3	2011.5	1686.4	1409.3	7139.0	1986.4	1988.0	859.3	1500.9	2274.1	3180.3	2611.8	3750.0	2173.6	4721.4	2328.7	3106.0	4041.3	2533.2	2256.0	4248.4	5692.5	1620.0	4727.2	3469.1	2964.4	3160.6	2022.8	2830.1	2653.9	1886.9	5406.2	16920.1	3772.8	2466.3	1354.6	4159.9	2025.5	3447.5	3412.7	2646.9	1993.2	2674.3	781.7	3280.0	4564.1	1597.1	2139.0	9080.4	2194.5	1386.6	1486.6	1453.3	3293.5	1324.9	2750.6	4935.9	939.6	3747.0	829.8	1125.0	2374.7	735.3	3116.0	2085.1	5427.4	7104.3	5693.8	4240.7	4059.2	6035.0	7515.6	6032.8	374.2	4153.1	1946.8	3766.4	4744.0	14744.9	1230.0	1315.9	1218.7	1877.5	1155.2	1268.7	1299.0	1255.9	1322.1	1314.7	1262.2	1357.3	1666.2	1653.8	3379.0	28.7	5653.1	9735.5	13864.1	9387.7	4797.6	270.6	10286.6	10100.4	820.4	2965.4	5237.5	1276.3	127.2	5414.0	3535.8	1396.0	5791.2	3073.2	2516.7	1356.0	3150.4	3882.7	2052.9	3987.8	23.0	6777.1	9231.6	2652.7	1988.8	1730.0	3234.5	2265.7	4298.1	2248.6	4065.7	75.7	23.7	4887.3	2541.0	4150.7	6491.3	7208.8	4631.0	3029.8	4605.0	37.5	5131.6	1404.2	4136.0	25.1	42.9	4532.4	4207.9	2423.4	2549.8	11104.9	2807.8	6997.6	2168.7	461.5	1485.7	4699.9	4234.9	1260.7	962.3	6520.0	12082.7	5409.2	4876.4	2935.1	6434.2	12610.3
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	34.2	9.0	40.3	8.0	41.0	10.5	27.8	35.0	35.2	18.1	8.6	16.6	6.1	26.0	7.1	20.1	18.7	18.2	61.8	37.8	42.1	13.6	6.6	45.1	7.5	48.3	41.7	29.2	19.4	49.6	27.2	17.9	42.0	14.9	10.3	28.9	14.7	14.2	24.1	16.4	16.5	22.7	35.3	26.0	21.4	7.7	47.3	5.9	36.3	30.5	7.3	24.5	14.9	49.3	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	40.3	41.0	35.0	35.2	37.8	42.1	48.3	41.7	42.0	35.3	47.3	49.3	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847861-91060641	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	2.6	0.9	2.4	2.9	7.8	3.3	7.5	14.7	3.7	3.1	1.0	6.6	3.7	4.9	0.3	5.3	4.1	2.8	2.6	1.6	3.0	1.9	1.7	2.8	3.4	4.1	3.8	4.6	1.5	3.0	2.6	3.4	4.1	3.1	5.1	3.0	4.9	4.3	9.0	3.7	4.9	3.9	2.9	3.1	5.4	2.4	4.5	5.0	4.0	9.9	3.5	5.4	4.1	8.0	1.3	2.1	2.7	1.4	0.0	0.5	9.4	0.9	1.3	2.9	4.1	1.2	2.7	6.7	2.8	2.8	1.8	4.7	2.2	1.8	5.1	1.0	3.5	7.5	1.8	0.4	0.0	7.1	31.8	0.8	4.3	1.7	1.3	0.7	3.2	5.1	0.7	7.1	2.9	3.1	2.0	2.2	0.9	4.6	3.4	3.3	11.2	3.2	3.2	2.9	10.4	3.2	2.7	14.8	8.1	1.8	3.0	1.9	0.6	0.8	1.5	0.6	3.4	2.8	3.5	5.9	1.7	5.0	10.6	16.9	3.0	9.0	3.7	2.5	6.1	4.5	4.6	3.5	2.7	5.8	5.5	3.0	19.8	10.4	3.5	1.2	7.9	2.6	2.4	7.8	14.7	3.7	1.6	3.0	4.1	3.8	4.1	2.9	4.5	8.0	13.2	19.2	26.5	80.3	53.7	40.4	45.2	20.4	53.5	32.9	41.4	42.9	20.7	14.3	22.7	7.3	16.7	43.7	21.0	36.7	0.0	11.1	9.1	96.2	19.0	21.4	16.3	22.5	65.4	5.1	6.5	21.8	13.3	162.0	92.2	32.5	20.3	6.5	7.1	26.9	32.5	17.3	4.1	17.6	13.4	3.1	14.0	21.8	19.6	53.4	21.2	10.5	23.7	36.7	156.1	3.5	13.0	11.7	26.0	29.3	41.9	3.7	31.3	32.1	13.1	51.9	22.3	21.2	23.7	35.5	46.3	111.8	48.6	7.2	20.8	52.7
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84188199	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.3;Inhibitory neurons: 70.7;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.1;PC-3: 7.9;RH-30: 9.9;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.4	2.0	2.6	0.5	3.1	0.1	1.7	3.2	3.0	2.0	2.6	2.9	1.2	1.7	3.1	0.8	2.2	1.1	0.6	2.7	3.4	5.7	0.6	0.6	0.2	2.7	2.4	2.6	0.9	7.0	5.8	0.3	2.2	2.8	2.3	7.0	1.7	2.7	1.6	2.0	1.3	1.0	1.5	0.4	1.7	1.5	2.4	1.0	8.1	0.4	0.3	1.3	1.4	2.0	0.0	2.4	2.6	0.0	2.4	2.2	0.0	5.2	2.7	2.3	1.9	1.9	2.0	0.0	0.0	2.6	0.0	0.1	6.4	4.6	5.1	0.0	3.5	0.0	0.1	0.0	2.7	0.0	0.0	1.4	0.0	0.0	2.4	3.0	0.6	0.0	0.0	0.1	2.0	0.0	1.1	0.1	8.1	0.0	7.9	0.0	9.9	0.0	0.5	5.4	0.0	9.4	0.0	3.4	0.0	3.8	1.4	0.0	0.0	0.1	2.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	2.6	3.1	3.2	3.0	2.7	3.4	2.7	2.4	2.2	1.5	2.4	2.0	0.3	9.6	2.7	6.2	0.7	0.3	5.3	0.3	3.4	21.1	3.6	3.4	2.6	12.8	1.9	18.4	25.0	2.6	0.1	6.7	1.9	0.5	0.7	1.9	1.2	1.2	25.0	2.7	75.3	1.2	0.7	2.2	2.0	0.9	0.0	21.8	1.1	1.3	0.2	1.7	70.7	3.6	0.0	0.0	0.0	0.4	4.4	0.5	0.0	3.7	0.1	2.1	1.0	31.2	5.8	1.3	3.4	6.0	0.0	9.2	1.8	4.3	3.7	18.2	0.0	4.9	1.5	8.4	6.2	2.5	0.4	2.3	0.9	2.0	6.5	5.2
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950574	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	14.0	11.3	7.1	11.9	7.8	18.0	13.3	11.8	9.8	11.8	9.4	10.7	10.0	13.8	10.1	16.3	10.2	9.4	10.6	7.2	6.6	9.8	15.2	9.9	14.2	7.3	7.0	14.9	16.9	14.9	7.4	15.4	7.5	10.6	11.0	10.9	9.4	10.2	22.7	10.6	9.3	14.3	6.2	12.4	11.1	6.9	7.5	15.2	11.9	18.3	17.3	14.9	11.0	9.6	34.5	33.5	27.5	26.2	18.1	26.2	20.8	31.2	28.3	26.3	29.3	27.6	16.8	41.7	37.9	25.4	32.1	17.3	36.0	27.3	42.7	23.3	41.5	28.7	21.2	31.2	26.9	44.5	27.1	26.7	20.7	31.0	22.8	21.9	35.0	26.0	38.5	25.9	19.7	243.6	53.2	18.4	18.6	29.8	24.9	30.8	46.7	38.8	21.9	25.1	20.1	23.8	26.2	15.2	16.6	31.7	29.7	24.2	31.1	25.8	42.9	21.2	42.0	46.2	42.0	46.3	19.4	26.7	21.2	43.8	12.1	11.4	12.7	12.2	15.5	10.4	11.6	14.7	15.3	9.4	13.5	14.3	11.5	11.9	14.4	9.5	11.9	10.3	7.1	7.8	11.8	9.8	7.2	6.6	7.3	7.0	7.5	6.2	7.5	9.6	22.8	22.4	34.2	29.0	32.6	33.0	21.4	13.0	30.7	18.0	23.1	17.8	16.8	12.8	30.4	3.7	18.8	24.3	33.5	12.4	3.9	12.9	5.1	24.0	31.7	25.5	13.2	11.8	47.3	16.4	18.2	24.8	26.0	37.7	23.4	20.0	13.6	15.1	12.1	18.5	45.2	14.1	4.1	15.2	20.4	3.8	15.8	19.0	10.6	28.1	20.0	12.8	18.6	25.6	54.8	15.1	10.9	18.0	34.6	27.9	9.3	9.2	21.1	18.9	26.3	33.4	32.6	13.0	13.7	34.5	32.0	30.5	29.9	26.0	13.9	25.4
RPS6KB2	"KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435401	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	16.2	28.0	9.7	13.8	10.8	28.2	17.0	9.9	12.4	23.5	13.2	22.8	26.5	17.7	6.0	71.9	20.0	10.6	22.1	9.1	9.3	21.3	50.2	19.5	18.4	10.9	10.3	16.2	35.4	17.5	20.6	13.6	10.6	31.6	12.8	4.2	31.5	9.9	37.9	81.6	25.4	10.1	10.2	33.7	35.2	9.6	9.9	24.0	20.1	26.0	20.1	19.3	31.4	11.3	58.2	42.7	22.8	39.0	10.4	20.0	30.0	27.4	33.9	49.7	34.2	67.2	37.5	21.1	46.3	26.9	31.0	41.8	25.9	41.4	19.9	36.9	70.0	34.5	54.2	55.5	35.2	43.7	40.4	25.5	42.8	26.3	26.9	12.5	37.5	54.8	55.8	54.8	25.4	88.5	68.1	68.4	24.9	83.7	54.6	50.0	31.8	100.5	23.0	32.6	34.4	37.1	28.0	76.8	59.8	13.2	90.4	35.7	15.8	25.8	27.6	63.1	31.1	48.8	43.9	34.4	42.4	27.3	33.1	18.8	37.2	28.5	23.8	42.6	24.5	23.4	22.9	23.9	44.1	21.9	16.1	17.9	24.7	29.6	49.9	30.4	34.5	37.3	9.7	10.8	9.9	12.4	9.1	9.3	10.9	10.3	10.6	10.2	9.9	11.3	22.0	9.6	20.5	6.8	48.1	49.8	28.0	48.9	19.9	25.3	32.6	27.8	1.3	28.6	31.2	7.3	10.4	71.8	45.0	66.9	43.0	44.5	14.9	16.0	16.9	17.9	46.2	65.0	7.7	64.8	89.1	21.9	48.9	19.3	27.9	23.2	18.2	57.4	61.3	33.7	7.1	67.7	34.6	45.8	29.1	29.4	20.2	36.9	19.6	3.7	56.6	28.5	73.2	5.0	12.1	46.6	70.4	17.3	82.1	43.7	115.0	42.2	16.0	27.6	19.7	16.7	26.9	15.8	16.0	52.5	63.6	103.6	41.7	27.5	58.3	39.4
RPS6KC1	"humS6PKh1, RSKL1"	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274774	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Excitatory neurons: 273.2;Inhibitory neurons: 151.2;Microglial cells: 101.2;Oligodendrocyte precursor cells: 116.6;Oligodendrocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	8.3	8.8	9.7	7.1	11.5	4.9	7.2	8.2	13.9	8.8	4.3	7.8	6.2	9.4	5.2	6.7	7.6	7.7	6.4	12.9	8.8	6.4	7.4	7.1	5.2	8.6	8.8	9.2	9.2	10.2	4.5	8.4	8.6	11.5	6.5	9.3	6.8	11.3	10.0	4.3	6.0	12.6	8.6	7.9	8.6	19.3	9.9	5.4	6.9	11.6	5.4	8.1	4.6	13.2	11.0	9.3	15.0	16.3	15.0	21.6	13.2	14.1	20.7	21.5	24.6	7.7	11.9	6.9	9.3	21.4	14.1	8.9	18.3	11.6	16.2	14.7	6.7	18.7	10.9	10.5	13.6	11.9	21.4	14.3	9.8	18.8	10.2	17.9	18.2	6.7	24.6	10.5	22.3	6.3	5.0	3.9	21.8	9.8	10.4	5.9	14.1	6.8	9.7	10.9	8.7	22.6	15.3	11.9	20.6	25.5	17.1	4.9	17.0	14.6	13.3	16.9	9.3	6.1	12.6	5.2	6.2	4.5	15.2	16.8	4.5	3.5	2.5	6.4	2.1	2.4	2.0	2.2	8.5	1.6	1.3	3.0	0.5	3.8	6.7	1.0	1.6	2.2	9.7	11.5	8.2	13.9	12.9	8.8	8.6	8.8	8.6	8.6	9.9	13.2	10.1	9.6	5.8	86.2	8.8	2.9	2.7	4.5	7.4	17.4	6.6	5.6	9.6	7.2	4.3	0.0	14.6	3.5	7.7	4.8	0.0	5.2	33.6	7.4	12.1	9.9	3.6	12.4	273.2	8.0	4.0	10.1	15.3	9.9	7.6	16.6	7.9	9.3	7.1	20.2	151.2	3.3	6.1	11.4	7.7	45.2	11.1	15.1	7.2	101.2	13.1	5.6	10.3	116.6	137.6	6.6	2.1	7.5	8.1	5.4	4.4	5.7	4.7	20.0	13.1	13.7	9.1	19.6	19.6	9.1	4.4	3.8	10.4	6.1	4.3	3.2
RPS6KL1	"MGC11287, RSKL2"	ENSG00000198208	"Ribosomal protein S6 kinase like 1"	Q9Y6S9	14	74903951-74923302	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.3;Cone photoreceptor cells: 83.4;Horizontal cells: 40.4;Rod photoreceptor cells: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.5;SCLC-21H: 25.1;SK-BR-3: 19.7;U-266/70: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	"unprognostic (2.71e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.49e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.52e-2)"	3.7	4.5	22.4	1.1	23.1	3.0	4.1	21.6	29.4	1.9	17.6	6.7	2.2	4.1	4.8	2.9	2.5	1.8	13.7	23.4	21.2	4.8	4.2	2.5	1.4	20.8	21.3	0.9	7.9	1.3	18.8	0.5	20.5	3.8	3.2	20.6	3.1	3.0	19.1	2.3	3.1	4.0	19.3	3.2	2.5	13.9	21.7	0.6	4.3	4.2	1.1	3.4	1.7	22.9	3.3	0.5	1.3	4.4	0.2	0.0	6.3	0.7	0.2	1.6	0.4	5.8	2.4	0.1	4.5	1.1	0.7	0.4	1.9	0.1	1.6	0.0	0.6	2.7	1.2	4.8	5.7	3.2	17.5	0.5	3.5	2.3	0.0	0.0	7.9	0.0	3.2	0.9	0.1	10.7	0.1	1.1	1.3	1.0	5.1	2.0	0.1	9.7	2.3	0.0	25.1	3.8	0.4	19.7	3.4	2.7	1.5	2.1	5.8	0.1	0.2	4.0	0.0	13.8	8.1	6.9	1.8	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	2.3	0.0	0.1	22.4	23.1	21.6	29.4	23.4	21.2	20.8	21.3	20.5	19.3	21.7	22.9	2.6	0.0	0.0	10.4	0.9	0.8	2.7	1.2	0.6	72.3	4.3	3.9	6.1	0.0	0.8	3.7	83.4	1.7	2.0	2.4	1.9	1.3	7.7	0.8	0.6	2.6	6.7	5.2	24.5	6.2	1.7	1.0	0.5	0.7	0.0	0.7	1.1	2.6	3.7	40.4	19.7	2.1	4.1	0.3	1.3	7.4	2.1	1.0	3.6	3.7	0.0	5.0	3.1	15.6	15.1	3.8	1.6	2.6	0.5	2.1	1.5	1.9	4.5	73.6	6.6	3.8	3.1	27.0	22.9	1.2	1.3	1.4	1.0	1.5	3.1	1.6
RPS7	"eS7, S7"	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575260-3580920	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	Yes		820000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA056586: AB_2683179"	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	1083.4	764.7	778.0	774.7	787.2	2152.4	2194.5	772.7	1112.6	1124.8	800.2	1044.1	766.0	867.6	1309.0	1281.8	1152.1	642.5	744.5	755.7	779.1	925.4	1082.6	717.6	1622.5	785.1	770.8	2394.6	1624.1	725.0	686.2	939.7	784.8	887.8	1166.3	603.2	1213.7	697.3	906.5	1419.8	866.8	895.3	805.3	964.6	1011.3	396.3	795.7	1665.6	797.7	843.0	1841.7	1038.2	1063.0	798.4	1235.6	1178.5	1778.9	1923.5	1725.8	3754.0	2913.5	1458.3	2527.9	2370.8	1371.5	2053.4	1890.4	4081.0	2369.1	1697.7	1646.1	1321.0	2038.5	2370.0	2077.4	1289.4	2743.3	1496.8	758.2	2998.2	4156.0	2622.8	1489.1	3183.4	3497.5	1475.1	3176.3	2552.1	2816.8	3707.9	2356.3	2015.2	2433.4	1661.0	2930.2	5815.8	2638.6	3679.7	1810.5	2300.9	1812.6	3670.5	2725.7	1487.1	2016.6	3028.5	771.7	2931.1	4670.0	1487.2	1615.3	3727.3	1327.2	1415.1	931.1	987.9	2387.5	2240.1	4420.9	4079.3	1489.6	3113.0	1617.9	337.1	656.8	243.1	808.8	570.7	1192.3	1411.3	1159.2	1036.9	1063.6	1172.7	1254.6	1132.2	129.3	1032.8	553.2	1016.6	1083.5	2065.3	778.0	787.2	772.7	1112.6	755.7	779.1	785.1	770.8	784.8	805.3	795.7	798.4	2544.8	496.8	793.2	28.1	3845.5	3923.3	4252.7	2961.9	3989.5	401.5	4245.2	7977.4	154.5	1720.0	1620.6	647.4	325.2	3627.9	2815.0	730.8	2606.1	2129.9	1517.5	1255.0	3316.9	1997.7	1250.9	2352.4	33.5	3434.0	5702.2	1854.2	1378.2	1489.1	1171.5	2855.2	2067.5	1515.6	2338.1	141.3	37.2	2244.0	929.8	2534.9	3126.0	485.1	2927.6	2110.0	2001.1	50.6	3250.8	1257.2	2634.4	27.6	49.8	2878.9	1747.3	1748.6	2572.7	4420.1	1233.7	4372.3	847.1	741.6	1452.9	1699.5	3261.7	1248.6	775.4	4912.8	5050.7	3716.9	3078.6	3673.3	2604.1	4351.5
RPS9	S9	ENSG00000170889	"Ribosomal protein S9"	P46781	19	54200809-54249003	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048746	Approved					NA	Yes		64000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA048746: AB_2680510"	"prognostic favorable (9.23e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	1846.1	1581.0	641.4	518.8	641.4	1359.3	1991.4	639.9	975.3	2001.5	638.1	1524.9	564.9	1523.5	469.1	2126.8	1633.0	302.8	1353.2	643.2	640.4	1437.6	1647.5	1359.5	682.3	654.2	658.1	3458.6	3439.2	314.2	932.7	325.4	645.0	1662.3	355.4	79.1	1512.6	167.0	1680.6	2686.6	1454.5	368.3	640.7	1812.7	1610.9	455.4	649.9	968.4	1272.0	627.6	652.3	1582.5	1861.8	647.6	500.8	204.0	257.8	695.7	1424.1	1563.5	602.5	440.1	254.9	246.2	124.4	216.2	861.6	899.9	518.5	785.5	398.8	677.4	922.7	1119.2	196.3	505.5	310.3	328.7	42.2	221.0	1293.3	708.5	711.7	2154.8	1199.7	686.8	882.1	838.6	861.4	831.0	452.2	978.5	693.8	148.0	1452.1	2013.6	770.5	636.4	200.7	865.5	406.3	1507.6	1201.0	228.9	532.3	926.3	255.6	749.5	1308.2	304.6	1003.0	2054.0	249.1	425.4	652.4	545.4	725.2	748.9	663.0	773.2	638.7	752.2	525.7	178.8	847.5	163.1	533.1	712.2	877.4	1075.6	917.4	673.0	741.2	1129.0	1237.5	1060.6	534.1	658.8	677.2	1018.9	627.1	2882.7	641.4	641.4	639.9	975.3	643.2	640.4	654.2	658.1	645.0	640.7	649.9	647.6	1501.4	458.3	1166.6	22.2	3076.3	6471.6	6044.0	4452.4	2423.9	346.2	6390.8	6524.1	198.1	1996.0	1877.7	886.5	175.2	2267.8	2511.4	1539.2	2488.7	1954.7	794.3	1011.6	2061.6	2294.9	1974.5	1549.2	13.6	5626.0	4374.8	1874.4	911.8	1416.2	838.2	2875.5	2494.0	2045.6	2693.9	175.0	14.6	3345.8	1377.3	3888.3	5294.3	1889.2	2872.7	2675.0	3283.5	25.3	3499.1	1219.7	2250.3	16.6	45.8	2925.9	2828.6	1518.0	1474.4	5077.4	3010.2	3183.8	786.3	682.9	1051.8	3030.1	2744.3	526.5	484.2	2627.6	7500.0	2470.4	2489.3	2886.3	3908.4	5842.9
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406716-39412542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	1063.0	929.1	813.4	685.7	824.8	1574.8	1068.4	782.0	979.1	1260.0	761.8	1158.4	605.8	1022.1	351.0	1922.5	1128.3	372.5	783.9	778.6	794.3	905.9	972.5	894.3	1281.4	817.8	809.6	2153.7	2616.3	605.5	813.4	468.8	812.9	1212.6	872.2	273.3	1039.7	446.9	1087.1	1529.4	1133.1	718.3	842.4	1525.8	1209.3	358.0	831.9	1259.9	862.6	730.4	1466.4	1127.5	1293.1	821.5	1800.4	1646.5	1367.5	2265.9	1203.3	2661.2	2155.0	1251.2	2005.9	2775.9	1611.8	1811.6	1513.7	3949.6	737.0	2535.3	747.6	695.4	2983.8	2945.7	2402.3	1459.6	1599.6	1783.6	1390.5	1750.2	2322.7	2546.4	1649.2	3043.3	4729.8	2147.2	3475.3	2030.8	2942.7	2343.5	1909.3	1883.8	2031.1	1282.1	3031.0	1960.4	4574.2	2756.9	2755.1	1412.2	1958.4	2974.8	2004.4	814.2	985.3	1989.0	674.8	5156.5	2202.9	1843.5	1509.0	3544.5	1156.6	845.2	1545.8	1422.3	3102.3	1440.6	2363.4	2437.5	1355.7	2481.7	1143.9	98.3	240.5	56.7	572.9	294.6	993.1	1010.3	942.1	758.8	654.2	951.8	1036.2	936.1	34.3	726.0	247.5	723.6	765.5	1499.7	813.4	824.8	782.0	979.1	778.6	794.3	817.8	809.6	812.9	842.4	831.9	821.5	532.1	519.2	800.2	10.7	2802.5	1802.5	2606.9	1585.5	2040.3	270.4	1864.7	1423.4	64.0	1095.2	906.4	325.5	95.9	2852.5	1768.9	625.4	992.0	1598.4	144.3	536.7	1178.5	891.2	1033.6	1733.9	21.3	3417.4	4473.1	927.1	821.6	747.7	778.4	1654.5	937.3	717.7	1608.4	173.3	21.5	1847.0	455.7	1304.9	1469.6	283.7	1240.5	1086.9	738.2	12.2	1605.2	621.1	1858.9	19.1	29.3	1889.5	1184.2	747.4	1501.8	2136.7	724.4	1257.1	476.2	364.4	473.3	1053.5	1002.2	352.2	1255.8	2879.8	1916.2	2420.7	2100.0	1539.2	2442.4	2884.6
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 52.2;skin 1: 29.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"	NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	29.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	52.2	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	5.9	4.6	3.5	4.4	3.3	4.1	3.6	2.0	4.4	4.3	0.1	5.7	4.8	5.6	1.8	4.5	4.5	2.9	6.1	3.8	2.6	3.1	3.4	4.2	3.3	3.3	2.8	4.8	5.5	5.3	4.0	3.6	3.3	4.5	2.4	2.6	4.6	5.0	14.1	5.1	4.5	4.6	2.0	3.8	4.4	4.0	3.5	4.4	3.6	7.0	2.7	5.4	3.6	3.2	16.2	34.7	6.8	12.9	9.5	7.0	15.5	12.7	9.5	17.9	12.4	21.5	13.8	13.3	10.1	12.9	13.8	11.6	10.5	15.7	8.9	5.6	19.6	20.8	16.8	21.2	8.9	19.8	15.3	12.3	9.9	17.3	9.1	5.9	16.6	15.7	24.9	4.6	8.6	8.8	12.4	7.8	7.4	9.2	24.0	10.2	12.9	11.2	4.6	17.8	13.4	17.4	14.4	22.9	14.9	6.6	16.3	14.5	9.6	37.1	17.8	11.6	15.7	8.9	3.9	12.6	22.4	10.1	23.6	0.0	0.1	0.0	0.5	0.3	0.3	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.0	0.4	3.5	3.3	2.0	4.4	3.8	2.6	3.3	2.8	3.3	2.0	3.5	3.2	4.3	0.0	3.9	46.0	8.5	3.2	3.0	2.4	4.6	6.8	4.2	3.3	4.5	5.7	1.6	5.5	4.2	4.4	7.2	3.8	1.9	3.6	6.7	3.9	5.4	4.3	6.0	4.8	70.1	3.8	5.9	4.8	8.2	4.9	2.5	7.5	2.2	7.5	4.7	11.8	66.3	3.1	6.1	5.7	3.2	10.9	3.1	6.7	1.8	32.8	1.7	4.3	2.1	50.8	66.2	4.7	3.5	5.3	9.4	4.5	4.6	2.7	2.0	7.0	0.0	5.5	4.1	4.5	3.5	5.1	3.0	4.4	9.3	6.0	5.6	3.8
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridine synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	11.8	12.9	12.3	9.7	11.9	13.5	12.0	11.2	21.1	11.0	6.8	14.9	9.8	13.1	3.1	18.7	10.6	4.7	12.0	12.5	10.0	13.0	15.3	9.5	11.3	12.9	10.7	9.2	16.1	4.5	11.2	4.2	10.9	14.6	2.5	2.2	15.2	5.1	11.2	18.1	15.6	3.6	9.7	21.9	17.0	7.2	12.4	8.3	11.0	3.1	5.3	13.1	11.8	11.6	28.2	32.5	7.8	35.7	6.8	7.9	36.2	22.9	13.0	29.4	21.3	76.4	25.8	38.9	24.3	11.1	20.6	47.2	18.1	23.1	5.3	35.7	74.0	19.2	52.1	28.0	10.9	35.8	31.1	11.7	21.9	25.4	6.7	8.7	20.4	22.6	45.7	17.1	10.2	89.2	44.8	37.4	40.0	13.0	55.4	79.0	21.0	80.5	10.9	17.0	40.8	29.4	26.4	42.7	26.1	4.6	22.0	43.9	23.3	29.1	37.9	30.9	33.6	27.2	29.6	45.7	14.1	27.8	24.5	16.5	14.8	13.7	12.7	13.7	12.6	10.2	10.7	14.1	17.0	12.0	10.7	11.1	9.2	13.4	13.6	15.8	14.8	13.1	12.3	11.9	11.2	21.1	12.5	10.0	12.9	10.7	10.9	9.7	12.4	11.6	9.4	3.2	3.3	3.6	12.9	15.9	3.5	13.2	10.8	42.0	12.8	13.3	4.4	5.7	5.2	9.2	2.1	20.5	13.7	23.0	7.9	19.5	0.4	4.7	7.1	8.1	13.2	6.3	6.0	26.9	25.7	6.8	17.9	8.2	0.0	10.9	9.3	5.1	19.6	1.7	4.2	11.5	10.2	5.7	7.0	1.8	6.8	9.0	14.2	1.9	19.2	11.1	23.7	1.5	3.5	29.9	16.6	6.4	19.5	6.3	21.1	10.2	3.4	3.8	13.1	3.6	9.4	3.6	11.4	11.5	16.8	14.6	11.9	13.3	20.7	5.0
RPUSD2	"C15orf19, C18B11, FLJ31409, PUS9"	ENSG00000166133	"RNA pseudouridine synthase domain containing 2"	Q8IZ73	15	40569299-40574949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042079, HPA042194"	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Microtubules"		"HPA042079: AB_10794643, HPA042194: AB_10794416"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.63e-7)"	"unprognostic (7.27e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.75e-2)"	5.1	8.9	5.7	4.8	6.2	9.7	5.8	5.8	6.4	6.6	6.2	7.5	4.8	9.2	5.3	7.1	7.2	2.4	9.5	5.6	5.6	8.0	8.9	4.5	6.7	5.4	5.6	7.7	5.3	5.3	7.9	3.7	5.8	6.5	4.0	2.5	7.7	4.7	14.5	9.5	7.0	3.6	4.9	8.0	6.3	6.1	5.5	6.1	6.1	7.6	6.2	6.2	5.2	6.0	10.4	11.5	9.6	16.0	8.1	6.1	18.2	9.0	10.8	15.4	12.2	14.3	6.4	9.9	12.8	10.5	14.1	27.7	22.3	15.9	8.7	11.5	15.3	17.1	15.9	17.1	12.1	14.7	12.1	8.6	14.7	10.1	13.8	7.1	9.7	16.1	21.9	11.4	7.7	12.3	17.7	18.6	12.4	15.0	12.4	22.3	10.7	15.3	10.0	8.9	10.9	12.6	12.3	13.8	7.6	7.9	13.2	19.9	6.0	10.5	12.3	13.7	10.5	11.8	25.2	27.3	9.2	22.9	8.4	0.1	6.4	5.6	23.4	8.0	21.3	28.2	22.6	24.9	12.5	35.5	26.8	22.5	0.7	33.6	18.4	16.5	26.3	14.4	5.7	6.2	5.8	6.4	5.6	5.6	5.4	5.6	5.8	4.9	5.5	6.0	5.7	6.4	2.6	2.3	10.4	10.6	16.4	11.5	10.8	11.7	6.4	8.6	8.2	8.6	7.0	7.3	16.7	15.7	9.3	5.4	25.4	9.6	2.1	5.4	5.7	5.7	13.2	8.2	2.8	10.9	9.3	7.6	6.6	4.6	4.5	9.0	3.6	9.1	7.1	18.5	2.9	6.2	12.2	2.2	3.1	1.7	7.2	2.6	3.6	1.0	3.4	15.6	7.2	4.0	3.1	6.5	5.0	10.1	8.9	9.0	4.9	13.2	9.9	16.0	13.1	11.6	8.1	7.1	15.1	9.6	10.7	5.6	7.3	12.4	8.5	8.0
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridine synthase D3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	18.8	28.8	25.1	13.2	25.4	21.3	19.8	24.3	31.3	20.3	22.0	25.3	17.6	21.5	14.7	32.3	20.0	8.7	37.2	26.5	25.4	24.7	30.7	16.1	17.4	23.8	24.1	17.8	24.5	26.1	20.3	16.7	23.8	19.9	16.5	15.5	19.9	17.4	72.7	27.4	20.1	16.7	21.6	21.0	22.8	54.3	25.3	15.2	16.0	48.2	21.3	24.2	21.0	26.0	30.5	44.8	33.6	21.7	55.1	40.5	249.3	25.9	36.7	41.9	44.3	39.4	30.6	52.4	31.6	29.0	61.7	25.6	75.2	46.3	33.2	40.7	78.9	69.8	39.6	42.5	43.1	43.5	42.3	50.0	63.3	48.9	56.5	34.2	55.9	69.3	52.7	35.4	41.9	72.0	59.6	78.9	36.4	44.4	66.3	41.5	27.5	88.5	46.2	23.0	25.9	21.5	32.6	41.0	69.9	47.9	70.3	46.3	33.6	16.7	30.0	29.8	38.4	52.3	67.4	70.0	35.1	81.3	39.5	35.4	51.0	26.5	44.1	38.2	45.7	50.3	41.4	42.3	46.8	41.9	46.3	41.7	12.3	84.9	26.7	45.0	64.9	41.5	25.1	25.4	24.3	31.3	26.5	25.4	23.8	24.1	23.8	21.6	25.3	26.0	11.8	19.2	9.6	10.1	19.5	8.0	21.4	27.8	13.1	22.8	17.1	21.5	25.4	21.5	20.8	14.7	20.9	44.3	19.8	16.4	46.9	31.1	80.3	6.9	13.7	15.8	13.2	24.6	9.9	31.6	48.6	16.3	15.8	9.7	21.0	20.1	22.1	28.3	39.1	11.8	10.6	17.0	12.2	14.7	7.3	59.5	21.5	15.2	16.0	3.7	27.2	20.6	54.6	8.0	6.3	25.8	20.6	21.4	18.8	19.5	28.1	55.4	12.9	22.2	6.6	13.3	17.2	100.7	20.6	22.3	12.8	17.2	20.5	33.9	28.6	16.2
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridine synthase D4"	Q96CM3	11	126202096-126211692	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.5;tongue: 75.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	14.8	12.7	10.2	9.8	10.4	10.6	14.0	10.5	11.2	13.8	10.7	12.1	10.4	12.6	7.7	15.1	12.9	8.1	27.2	10.5	10.4	11.8	20.5	9.4	13.8	10.2	10.2	18.3	26.8	7.8	8.8	6.8	10.5	11.5	10.1	6.1	14.4	7.0	135.5	17.1	12.1	9.2	10.6	14.4	20.0	8.8	10.5	13.2	10.1	75.2	15.5	12.4	13.4	10.5	15.6	14.0	17.0	19.7	24.5	34.3	12.5	16.2	22.7	16.6	15.1	46.4	27.3	35.7	16.8	14.1	23.7	25.1	40.3	25.8	17.3	32.4	23.9	84.1	15.0	40.5	18.3	42.5	17.1	29.8	35.0	18.4	22.9	24.8	33.4	28.8	51.8	25.1	20.2	13.5	26.6	46.3	18.4	49.3	29.1	31.0	25.2	33.3	25.7	19.8	29.3	20.5	21.5	29.7	16.7	17.0	46.2	21.9	20.9	18.6	13.3	15.4	19.9	10.1	12.4	30.7	8.8	47.2	19.7	1.6	12.7	1.4	15.9	11.7	19.6	14.4	18.0	14.3	16.3	14.5	20.4	16.8	0.9	14.3	14.0	7.0	18.1	13.3	10.2	10.4	10.5	11.2	10.5	10.4	10.2	10.2	10.5	10.6	10.5	10.5	10.0	3.2	8.4	6.8	15.3	27.5	20.4	13.2	17.1	9.9	13.1	9.1	35.4	12.8	7.4	7.3	8.4	14.0	12.3	7.2	9.8	12.3	1.8	6.7	7.1	11.9	15.5	6.7	7.0	19.6	17.1	10.2	10.7	7.4	5.7	15.2	13.6	11.3	13.3	11.8	8.4	10.7	2.0	15.9	8.7	2.3	9.6	8.6	10.6	8.4	21.0	5.3	14.4	6.6	7.8	13.5	7.4	8.6	12.4	17.4	15.6	14.5	7.0	8.2	6.6	15.6	9.9	10.3	16.7	13.2	24.0	13.3	13.1	18.3	18.8	14.7
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925536	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 305.8;skeletal muscle: 769.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 302.0;Endometrial ciliated cells: 477.6;Glandular and luminal cells: 245.5;Respiratory ciliated cells: 214.9;Skeletal myocytes: 179.2;Smooth muscle cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 194.2;U-87 MG: 51.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	56.5	18.1	4.1	5.5	6.4	4.7	24.4	16.8	14.6	34.6	12.0	16.3	3.4	21.0	1.7	101.2	35.2	11.9	305.8	5.0	5.3	45.0	5.1	52.3	4.0	4.2	6.0	18.8	2.5	1.7	14.4	32.6	4.2	18.4	1.1	2.5	29.4	3.5	769.7	19.9	10.9	6.3	4.9	2.8	13.9	6.7	5.6	1.7	13.7	28.3	3.2	27.4	32.9	6.3	0.1	8.5	0.2	0.1	0.0	0.8	0.3	4.9	0.5	0.8	4.2	2.2	5.9	0.2	4.8	0.3	1.5	0.4	0.2	0.3	0.7	194.2	0.3	0.0	0.3	2.1	8.0	0.0	0.6	2.3	0.9	14.3	0.2	3.3	0.0	0.1	0.2	3.8	0.6	0.2	0.0	0.5	0.7	0.0	0.3	0.6	0.2	0.0	0.9	0.1	0.3	0.6	4.5	0.0	0.0	0.7	0.0	0.5	0.0	0.4	0.5	0.3	0.4	6.2	0.2	0.5	51.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	6.4	16.8	14.6	5.0	5.3	4.2	6.0	4.2	4.9	5.6	6.3	17.0	70.5	150.0	3.3	33.6	9.4	3.7	11.3	4.0	21.4	10.7	15.9	302.0	0.0	18.9	68.0	10.4	4.1	22.5	9.7	23.5	47.4	1.6	477.6	36.7	18.1	10.7	0.0	0.8	3.2	8.2	39.4	10.7	245.5	34.2	26.4	0.7	0.0	1.4	1.7	1.0	7.8	14.2	1.9	36.2	0.7	0.6	24.6	23.2	1.9	0.6	2.4	0.0	0.5	0.6	55.3	5.0	5.3	59.5	30.7	3.4	11.3	214.9	3.2	111.7	179.2	232.6	1.7	5.2	148.1	10.1	5.6	12.4	0.5	6.9	2.6
RRAGA	"FIP-1, RAGA"	ENSG00000155876	"Ras related GTP binding A"	Q7L523	9	19049427-19051025	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (6.30e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.05e-1)"	79.3	73.7	73.6	39.6	75.1	30.2	72.8	77.5	82.5	67.3	74.6	74.0	38.6	94.8	77.4	62.1	74.7	49.7	87.1	76.7	83.5	67.7	68.3	51.9	46.4	73.5	74.2	83.0	46.7	47.6	68.7	71.0	77.5	58.1	45.6	39.7	53.3	73.8	128.9	72.5	57.1	82.7	80.2	52.9	57.1	40.2	78.1	53.2	57.1	104.5	47.9	70.7	58.0	84.5	115.2	92.7	74.9	78.4	263.8	167.0	51.5	112.7	134.4	96.2	117.7	35.8	34.7	22.6	61.1	190.8	86.7	42.8	64.8	106.6	101.2	97.7	72.8	145.3	122.6	139.0	172.8	20.3	52.7	148.8	101.3	82.2	55.7	132.4	116.1	36.9	33.4	32.1	202.5	72.5	56.2	118.8	41.9	59.5	70.6	43.0	48.8	32.6	147.9	98.8	61.4	76.6	61.9	55.5	60.4	67.5	71.3	54.0	91.0	116.2	44.6	83.6	85.3	22.5	39.4	51.6	127.9	30.8	43.1	155.3	85.6	147.8	74.5	98.0	72.7	49.4	77.1	74.6	81.0	50.4	70.1	69.8	58.9	81.9	109.3	58.2	100.0	107.8	73.6	75.1	77.5	82.5	76.7	83.5	73.5	74.2	77.5	80.2	78.1	84.5	84.3	25.6	27.7	16.0	35.0	61.1	123.7	138.8	50.7	47.8	43.2	57.9	51.8	41.5	63.8	53.3	18.8	130.9	28.1	32.9	105.7	95.9	92.5	74.0	70.6	86.5	17.5	38.1	17.5	61.4	98.6	80.3	28.1	47.2	33.6	38.0	71.4	61.9	64.6	48.8	20.0	29.8	81.4	37.1	33.2	28.3	93.8	39.2	56.9	20.6	51.0	95.4	49.4	21.1	29.6	52.3	44.3	103.0	24.0	50.8	51.4	130.1	75.4	37.0	32.9	65.3	79.1	113.8	22.9	47.7	59.2	121.4	37.3	61.6	34.8	74.8
RRAGB		ENSG00000083750	"Ras related GTP binding B"	Q5VZM2	X	55717749-55758774	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.31e-5)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (3.64e-6)"	"unprognostic (8.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	12.6	14.8	13.1	7.1	13.4	8.2	14.7	11.0	12.9	14.0	9.9	12.3	6.9	18.5	34.7	8.9	20.5	13.0	15.2	13.5	14.2	16.2	8.0	11.1	8.3	11.2	14.0	22.2	8.0	23.1	14.9	11.4	12.5	16.4	9.6	17.1	8.9	18.0	12.0	12.1	8.8	17.3	12.4	11.3	9.6	9.2	15.2	10.2	22.9	15.9	8.7	12.0	10.0	12.5	11.9	8.9	10.0	7.6	34.7	32.2	2.6	10.3	19.0	9.1	12.2	5.2	7.7	3.5	72.6	14.4	7.6	7.5	9.1	5.8	8.4	6.5	12.7	5.2	12.1	10.5	24.6	8.4	8.0	38.4	21.9	6.8	8.8	36.8	12.3	9.3	7.3	8.1	15.3	8.8	4.5	11.7	10.4	3.2	14.4	17.0	11.1	10.0	13.9	15.3	10.0	8.9	14.2	4.4	15.6	25.4	12.9	8.8	6.8	11.2	5.2	10.4	5.6	11.1	16.4	6.7	8.5	18.2	5.0	7.1	4.7	4.1	5.0	6.7	7.5	6.8	6.5	6.9	7.3	10.4	7.4	7.5	1.4	6.5	3.9	4.6	7.5	4.0	13.1	13.4	11.0	12.9	13.5	14.2	11.2	14.0	12.5	12.4	15.2	12.5	14.5	12.8	17.4	22.9	16.0	8.7	15.3	16.1	19.4	20.4	9.7	10.2	16.4	4.3	10.4	18.4	14.6	7.4	6.8	4.9	27.4	9.8	1.8	14.3	16.1	12.7	4.2	11.1	32.4	5.0	5.5	15.6	10.7	11.9	17.1	16.7	5.7	2.6	7.3	20.2	29.6	5.1	8.2	5.4	7.8	2.9	9.9	7.9	5.4	23.4	7.8	27.0	2.1	28.6	38.2	4.3	10.8	15.4	6.4	9.0	7.3	19.3	10.4	25.6	0.0	17.9	16.6	7.7	14.6	11.2	7.7	4.8	11.8	26.9	6.9	6.9
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859772	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	37.0	16.9	18.0	16.6	19.2	30.2	25.2	20.0	19.4	17.1	16.4	21.5	18.7	16.1	14.0	24.9	13.9	17.7	21.6	17.6	20.4	24.5	18.5	19.3	20.5	20.4	21.3	21.6	14.2	24.0	10.0	28.5	21.3	14.9	17.0	16.1	14.2	16.9	17.4	29.8	16.2	21.9	19.5	17.3	15.1	17.5	19.8	18.8	16.7	18.9	21.8	19.0	18.1	21.3	37.0	16.6	21.3	23.3	110.7	74.6	33.0	33.7	68.6	44.8	47.2	12.7	23.9	23.0	18.9	52.6	71.8	21.7	40.1	22.2	36.8	37.6	28.3	22.1	19.2	14.7	135.6	26.0	23.9	66.7	55.2	48.0	61.9	35.4	47.5	24.5	22.9	44.9	65.7	10.2	19.0	14.7	27.2	15.9	28.0	18.1	37.6	15.6	31.6	42.5	11.1	16.5	27.0	20.0	73.2	47.5	18.3	19.5	42.5	54.3	22.4	60.0	29.2	35.0	60.5	26.8	50.5	29.1	28.8	0.5	2.4	5.5	1.7	2.3	2.9	3.3	2.6	2.2	2.3	3.6	2.2	2.1	5.9	1.7	1.8	8.4	2.5	1.6	18.0	19.2	20.0	19.4	17.6	20.4	20.4	21.3	21.3	19.5	19.8	21.3	31.2	32.1	28.0	6.5	42.1	111.9	47.1	19.2	40.9	20.0	31.0	25.0	22.2	24.3	16.1	12.9	12.5	84.9	38.4	30.3	11.7	55.7	56.3	32.0	26.6	34.3	14.4	24.0	7.4	48.1	57.7	39.4	12.2	42.9	16.5	16.9	35.7	14.2	72.1	38.7	8.3	10.3	20.3	34.4	65.0	49.8	30.7	49.2	53.4	9.4	63.3	43.4	10.3	7.5	15.8	47.0	14.0	37.2	20.1	47.3	21.5	30.4	15.0	22.8	19.7	28.1	37.5	24.7	28.5	46.1	140.5	224.1	23.3	18.6	12.2	51.1
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
RRAS	R-Ras	ENSG00000126458	"RAS related"	P10301	19	49635292-49640143	"Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.6;Pancreatic endocrine cells: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 20.9;non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	7	"monocytes: 25.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010160, HPA060364, CAB069439"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010160: AB_2180086, CAB069439: AB_1622637, HPA060364: AB_2684264"	"unprognostic (9.23e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (8.54e-2)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (2.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.74e-2)"	167.4	59.1	36.6	43.6	36.8	5.2	129.6	35.7	49.4	162.6	33.9	241.7	40.3	187.0	24.9	58.4	168.3	47.1	201.9	34.4	39.0	99.2	40.9	168.9	37.2	40.1	36.2	79.9	31.1	14.6	28.5	63.5	38.1	147.8	23.6	4.9	52.8	160.2	51.9	52.9	89.5	84.2	37.2	100.2	117.7	35.3	39.7	15.0	83.8	49.8	20.1	173.3	139.4	35.4	82.1	99.4	12.5	25.3	212.7	236.1	3.8	105.8	148.7	50.6	65.9	13.7	134.2	5.1	54.0	156.8	73.2	53.6	7.3	108.5	20.7	33.4	5.5	9.7	32.3	8.4	197.2	0.6	20.3	167.3	95.1	63.9	50.7	213.5	130.4	3.7	6.4	39.1	91.3	32.4	0.5	9.3	2.5	69.5	80.0	7.7	30.4	15.3	111.4	16.3	0.2	11.6	41.5	36.8	6.7	32.4	52.5	7.8	187.3	147.3	58.9	26.0	30.9	28.7	13.0	1.3	153.1	6.3	47.4	0.0	5.4	0.1	0.6	20.9	0.5	2.0	1.6	0.5	3.7	0.4	1.7	0.4	0.0	0.6	25.0	1.0	0.7	2.2	36.6	36.8	35.7	49.4	34.4	39.0	40.1	36.2	38.1	37.2	39.7	35.4	215.6	38.5	7.9	2.3	6.2	29.6	54.4	126.4	11.4	1.7	44.4	57.4	61.1	27.1	48.7	51.5	2.1	4.9	7.4	60.8	9.8	65.9	0.9	12.5	90.0	75.4	10.2	3.6	1.2	55.7	41.2	76.6	16.3	29.9	10.2	2.3	79.2	7.1	31.5	5.0	0.6	22.2	30.5	28.3	23.2	6.1	60.3	32.1	26.6	8.4	32.9	59.1	4.1	0.0	0.8	150.4	33.0	76.0	6.0	62.0	53.3	10.7	14.5	2.5	78.9	35.2	135.9	1.8	5.4	11.9	19.2	7.1	9.4	9.3	17.8	54.4
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277922-14364506	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	30.8	14.1	8.0	16.1	8.0	5.2	21.2	9.7	10.7	21.7	14.9	22.3	20.8	19.7	9.2	15.4	14.2	11.9	44.4	12.0	10.5	39.3	39.1	22.9	28.3	7.0	8.1	18.3	18.2	17.2	8.5	29.4	8.0	20.1	18.7	12.1	18.0	19.3	40.8	12.1	39.5	18.0	6.3	16.3	17.7	25.1	10.4	14.4	29.0	34.0	37.7	23.4	14.0	6.3	89.3	38.2	35.7	30.8	122.0	121.1	52.8	309.1	160.7	260.5	328.1	78.0	108.7	102.2	46.8	209.0	84.3	97.1	61.0	110.8	260.5	88.7	49.6	6.8	21.5	62.4	133.6	0.3	0.7	129.5	205.0	104.2	331.2	106.5	131.7	24.8	45.9	0.2	229.3	43.5	21.5	5.6	98.3	18.2	31.4	19.0	118.5	1.9	133.7	48.8	9.7	18.4	74.7	46.0	42.5	119.9	30.6	6.2	303.1	139.6	74.0	272.1	85.1	0.2	0.2	48.4	56.0	0.1	29.0	2.1	0.0	0.0	5.5	0.0	2.4	11.8	1.0	2.8	0.0	6.6	0.5	2.1	0.4	3.8	0.0	0.2	0.0	0.9	8.0	8.0	9.7	10.7	12.0	10.5	7.0	8.1	8.0	6.3	10.4	6.3	6.6	19.2	18.9	14.4	57.8	69.3	76.2	17.7	23.9	5.5	22.6	13.7	31.5	40.0	20.6	18.4	0.0	36.5	31.2	30.5	23.5	46.5	55.2	25.8	16.0	15.2	19.1	3.2	32.8	18.4	58.0	29.7	12.8	34.7	8.9	15.6	13.6	33.4	8.2	13.5	35.4	16.0	14.2	2.4	12.0	45.2	16.4	2.3	26.6	9.4	2.0	21.7	56.7	28.6	4.9	57.1	30.1	11.3	22.0	120.3	89.9	112.9	15.0	10.1	19.7	20.7	21.4	39.5	42.1	20.3	49.9	29.0	29.5	13.3	20.8	96.5
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 497.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 588.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.8;plasmacytoid DC: 44.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		320000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	64.2	72.3	27.0	62.8	41.9	28.1	54.6	41.1	32.2	69.1	52.3	98.3	76.1	59.5	55.0	67.8	45.1	71.5	59.1	27.5	35.3	77.4	219.0	80.2	28.2	49.3	42.2	48.3	497.7	72.4	63.4	107.9	45.5	66.5	65.9	17.7	228.2	63.4	21.9	43.6	82.7	46.0	37.7	57.7	123.1	48.4	40.9	14.4	130.4	14.7	27.0	57.6	55.2	49.2	173.5	121.0	35.7	80.4	160.3	172.2	186.2	264.3	221.3	110.0	148.2	271.2	159.3	66.5	87.3	252.2	113.4	170.4	38.7	215.4	89.1	30.9	29.7	76.2	34.9	283.6	229.4	29.0	93.0	228.9	63.8	178.7	104.3	161.7	109.7	23.4	32.6	62.9	167.6	78.8	11.4	65.5	41.6	383.3	115.8	20.1	94.2	231.3	93.0	58.4	18.2	13.7	151.1	353.2	108.4	75.0	62.0	43.5	198.7	232.7	85.9	122.1	88.5	114.6	93.6	21.6	88.1	30.7	121.1	11.7	8.4	37.8	4.3	5.5	3.2	1.0	1.4	2.6	4.6	1.4	1.4	1.6	7.8	10.7	8.4	44.4	1.5	3.1	27.0	41.9	41.1	32.2	27.5	35.3	49.3	42.2	45.5	37.7	40.9	49.2	146.8	96.1	197.1	15.0	72.5	59.1	92.3	90.3	55.2	21.9	127.0	76.3	46.4	144.4	158.2	95.6	31.3	262.0	180.6	588.9	45.0	199.7	47.2	117.5	228.4	155.8	97.0	31.6	3.0	414.6	235.8	219.7	294.6	322.8	118.9	78.1	118.9	279.9	117.4	25.2	4.9	507.9	50.8	62.0	85.7	44.3	127.1	91.6	71.2	17.8	75.1	144.3	79.3	23.1	27.6	357.7	452.3	83.1	570.6	145.6	221.6	57.2	121.8	35.5	32.9	165.1	169.8	77.5	139.9	73.2	55.8	532.9	56.9	114.6	329.3	218.5
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: AB_2674357"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	10.9	12.1	4.3	7.8	3.6	31.6	10.8	4.4	2.2	10.2	12.5	10.8	11.9	7.8	5.6	26.2	8.7	6.4	8.3	2.7	4.2	8.2	18.3	9.1	6.5	9.1	6.6	9.8	18.1	12.2	6.3	8.1	6.5	8.1	9.8	5.7	15.0	6.2	16.6	16.2	13.1	6.2	5.4	10.7	10.7	11.6	7.6	9.2	12.0	7.9	7.9	7.9	14.2	5.5	13.1	12.3	10.3	11.9	9.5	6.3	40.1	5.2	7.3	6.2	7.6	20.3	10.0	6.6	10.9	9.9	6.9	9.3	14.7	16.5	5.9	9.2	11.3	24.8	9.6	23.5	13.1	15.0	18.5	10.5	12.7	9.3	13.8	4.2	7.5	15.2	44.6	0.1	6.5	16.5	8.8	35.2	4.9	10.6	10.0	13.1	12.4	10.4	9.0	25.1	2.8	2.6	12.4	16.0	11.1	15.3	12.3	31.0	13.0	11.4	7.1	8.8	6.4	4.1	4.7	9.0	3.3	11.4	9.3	5.5	2.7	6.6	1.5	2.1	1.3	2.2	1.0	1.0	1.7	1.0	1.6	1.3	2.0	3.3	2.4	5.7	0.5	1.7	4.3	3.6	4.4	2.2	2.7	4.2	9.1	6.6	6.5	5.4	7.6	5.5	39.3	25.6	28.7	44.4	19.0	31.5	22.4	30.1	27.9	0.9	27.0	16.9	24.2	31.5	31.4	36.8	70.9	25.8	31.9	62.7	7.9	14.7	46.2	35.5	24.7	22.5	31.8	31.1	3.9	16.3	32.8	16.3	30.1	63.0	10.1	20.7	30.7	70.4	33.4	0.0	0.7	35.7	14.2	66.1	54.9	9.0	19.9	42.1	23.2	78.7	32.6	9.5	13.4	2.0	0.9	22.3	36.3	19.2	27.7	37.1	34.5	16.8	23.9	27.5	52.6	25.5	15.2	13.7	17.4	48.9	34.7	45.8	15.7	27.4	45.0	54.3
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	16.6	21.2	5.1	24.8	5.3	32.8	22.7	7.1	6.1	16.9	4.7	25.7	19.3	16.2	10.1	26.5	15.5	11.8	16.4	5.1	5.7	13.4	18.4	12.8	34.4	6.1	5.5	16.4	14.6	24.7	7.1	20.4	6.6	18.5	29.4	23.6	14.7	16.0	30.3	36.1	20.2	20.1	6.2	13.0	17.6	17.9	5.1	56.7	15.6	30.0	45.2	15.6	18.9	6.2	221.6	117.8	188.4	110.0	28.4	56.2	73.0	198.0	98.2	220.7	225.9	106.8	163.8	237.4	47.0	100.1	95.9	173.0	176.9	143.2	259.3	117.3	187.9	121.0	159.8	83.1	11.2	208.9	84.6	26.6	37.8	121.7	86.4	48.3	107.8	140.1	161.1	107.3	186.8	99.6	246.7	41.9	118.2	152.2	119.2	196.1	147.0	84.3	59.4	61.8	159.8	88.1	175.1	104.8	30.0	75.8	102.8	71.4	62.3	203.4	106.0	206.9	147.4	70.3	103.5	252.5	114.1	137.6	130.3	8.3	4.0	4.5	11.3	11.2	21.1	9.2	22.3	16.6	7.3	5.2	17.2	15.0	0.0	10.5	15.6	4.4	41.7	10.3	5.1	5.3	7.1	6.1	5.1	5.7	6.1	5.5	6.6	6.2	5.1	6.2	12.4	19.2	14.4	4.9	17.0	33.4	26.8	31.0	17.6	15.6	15.1	14.4	33.5	14.3	24.7	18.4	6.2	62.8	14.9	13.3	7.9	25.6	69.9	11.5	14.5	15.7	18.0	81.2	11.2	22.2	62.5	22.0	20.4	13.9	7.0	27.3	10.8	15.0	28.3	18.5	12.0	25.0	16.2	11.7	10.3	83.9	13.1	13.9	10.6	6.5	10.7	24.0	5.2	12.1	11.9	15.8	10.4	16.6	31.3	10.1	12.5	8.4	15.5	22.7	13.1	19.5	27.1	102.8	63.1	36.5	29.0	39.7	23.2	18.1	34.3	20.6
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102238961	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.5	21.2	10.5	11.5	12.1	7.1	12.1	13.6	11.5	12.5	26.5	15.3	15.0	11.6	15.1	11.2	13.5	11.9	16.7	10.1	13.7	24.4	22.6	22.0	20.1	13.6	12.4	12.0	13.5	45.0	10.3	13.8	13.9	15.7	15.5	21.9	10.9	13.8	30.4	11.0	10.1	11.7	14.1	14.3	9.5	9.7	12.6	10.1	39.9	34.9	19.6	11.2	5.4	16.8	15.3	26.5	30.7	18.3	43.7	41.3	24.6	34.8	41.4	18.1	21.0	9.6	11.9	97.5	31.8	38.7	18.5	5.7	15.1	35.2	25.3	15.8	16.2	24.4	10.3	20.9	35.3	7.6	50.0	53.1	66.1	20.2	30.5	43.0	51.8	16.3	18.2	14.6	59.1	15.2	13.1	14.6	17.7	16.5	19.2	8.2	12.7	20.1	43.1	17.1	7.8	15.4	17.9	9.7	21.1	76.3	25.5	17.1	39.4	27.8	53.7	19.6	9.6	15.3	15.3	88.0	41.0	11.5	30.2	15.7	6.3	7.0	2.7	5.4	3.8	6.6	2.3	3.2	7.7	8.6	2.6	2.8	23.1	4.1	11.5	2.2	1.8	3.3	10.5	12.1	13.6	11.5	10.1	13.7	13.6	12.4	13.9	14.1	12.6	16.8	16.2	57.7	29.3	10.1	33.5	19.4	8.2	11.8	34.1	13.5	17.0	9.4	22.8	20.0	23.9	40.5	14.6	13.8	13.9	7.3	25.4	6.8	2.3	36.2	11.1	14.9	29.4	3.8	14.6	8.2	5.9	14.8	6.1	11.8	11.4	11.2	18.5	23.6	12.6	10.1	17.6	9.7	10.2	26.2	39.5	1.4	14.3	23.8	17.8	20.6	18.2	24.5	7.2	16.1	12.1	5.7	5.7	14.7	9.3	10.7	8.1	22.7	39.9	18.3	6.6	16.2	16.8	13.2	14.5	26.2	18.5	4.8	12.2	8.6	12.1	6.7
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060033-15094311	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	"Nucleoli rim"		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli rim"		"HPA049837: AB_2680906"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	21.9	17.1	8.5	11.2	8.2	28.1	20.1	10.8	13.5	15.3	7.5	16.1	7.0	16.6	11.1	13.3	16.0	12.0	16.3	8.3	9.0	15.2	31.1	12.7	15.6	8.2	10.5	20.7	20.0	20.7	15.5	12.2	9.0	16.9	18.2	23.9	13.0	13.3	41.4	15.6	14.7	13.5	8.1	16.2	15.1	13.7	9.0	19.0	16.4	39.1	18.1	18.2	14.0	10.2	17.3	8.5	25.6	22.8	20.2	24.2	7.6	19.4	19.9	28.5	29.9	5.6	31.6	39.2	28.9	27.8	27.7	18.0	40.5	26.3	46.9	20.4	21.9	95.6	17.3	52.4	44.5	17.9	103.4	19.9	41.4	38.2	41.0	25.2	20.9	13.6	18.6	32.0	44.9	26.3	17.0	44.1	25.5	23.3	4.6	61.7	26.4	41.0	26.6	18.4	42.3	33.8	30.5	38.2	24.7	16.4	43.3	25.4	19.4	34.5	14.2	19.8	26.8	27.7	32.8	56.1	20.4	30.2	43.7	8.4	3.4	3.9	3.8	2.3	5.3	4.7	2.8	3.4	3.6	2.2	4.1	3.0	0.4	6.8	2.7	1.8	3.1	4.6	8.5	8.2	10.8	13.5	8.3	9.0	8.2	10.5	9.0	8.1	9.0	10.2	31.6	9.6	13.7	13.1	28.1	17.8	10.3	8.6	28.5	14.4	16.5	12.8	22.3	8.6	10.2	16.5	20.9	11.7	21.4	14.3	5.9	10.1	18.1	9.6	22.3	20.2	7.2	22.5	13.7	8.0	10.9	19.9	20.9	15.0	10.1	22.4	15.4	18.2	15.1	11.8	16.4	17.0	12.2	14.1	15.0	7.7	14.6	21.2	16.0	14.0	15.9	19.0	18.6	13.6	12.7	11.0	13.7	18.0	23.2	12.2	12.8	15.1	5.9	18.9	0.0	14.9	19.1	15.5	21.3	27.9	21.9	6.7	27.6	19.4	14.9	11.0
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA047426: AB_2680041"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	17.1	21.3	16.5	14.1	20.0	11.9	21.9	18.8	18.1	22.4	20.6	21.0	27.4	22.0	26.0	21.8	28.2	17.7	14.9	15.9	17.1	18.6	28.4	17.7	19.5	20.7	18.7	26.5	27.6	25.4	20.5	14.8	18.8	25.0	17.4	17.9	27.2	22.9	30.2	29.1	24.0	14.8	18.2	20.4	23.8	24.4	18.6	14.2	29.4	22.8	17.0	22.5	20.9	22.9	14.6	28.3	20.6	20.3	54.2	24.7	31.3	10.8	32.8	18.3	13.7	15.3	65.7	24.8	31.6	17.1	25.7	60.7	28.9	25.4	7.3	49.5	24.3	15.0	27.5	11.6	34.1	22.4	39.2	38.4	47.5	18.3	34.3	21.5	15.5	21.8	36.3	54.1	9.9	35.3	11.6	26.0	23.9	63.2	8.7	18.7	13.6	58.1	21.8	15.6	26.7	38.2	19.2	38.7	24.0	31.2	51.5	47.2	15.0	11.3	13.8	17.7	14.7	62.7	67.7	31.8	12.7	24.9	13.9	4.1	1.8	2.7	3.5	1.3	3.6	1.7	3.3	2.5	3.2	2.3	2.7	3.0	4.0	4.0	2.3	1.2	5.1	1.7	16.5	20.0	18.8	18.1	15.9	17.1	20.7	18.7	18.8	18.2	18.6	22.9	9.5	6.4	15.1	11.4	15.8	10.1	21.5	13.5	22.2	11.2	20.0	19.9	7.1	31.5	13.9	3.7	12.5	24.9	8.9	16.4	9.8	12.7	60.2	12.3	6.4	9.7	9.6	14.3	4.6	13.1	17.2	11.2	18.3	10.9	5.1	8.7	12.5	19.5	10.9	8.4	6.3	16.9	14.2	11.1	4.9	14.7	11.1	9.6	8.8	4.7	10.1	20.5	5.2	5.5	15.9	9.3	12.8	9.4	14.8	21.4	36.5	12.8	13.9	13.6	13.1	9.6	9.6	20.6	23.2	18.9	11.5	32.4	8.1	8.2	16.2	18.0
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	8.0	8.2	8.0	6.5	8.7	5.3	7.3	7.4	10.2	6.9	4.8	6.4	5.0	7.1	3.3	16.0	6.4	4.0	7.0	9.2	7.2	7.6	13.0	5.3	8.1	8.9	8.1	8.0	9.7	4.8	5.5	4.9	8.0	7.2	3.0	1.7	8.1	4.2	12.9	11.9	5.9	3.4	6.6	8.2	7.5	7.9	7.6	5.0	6.0	5.3	6.1	7.3	7.9	10.8	37.6	19.6	13.5	22.6	7.3	8.2	25.6	18.5	10.9	25.7	18.1	52.1	21.6	35.5	14.9	10.4	23.8	18.8	25.2	18.5	11.7	17.7	47.9	50.4	18.8	32.1	14.9	32.6	17.5	11.0	17.0	26.0	20.6	6.7	13.7	32.9	67.3	26.9	12.2	43.2	28.7	44.7	44.8	26.1	28.7	52.0	10.7	66.4	13.4	20.5	31.6	18.8	19.3	21.0	25.3	3.8	21.5	22.1	15.6	17.2	19.1	18.2	33.0	32.1	29.8	37.1	25.7	53.7	22.6	0.1	5.0	1.7	10.7	4.8	13.4	11.0	11.0	11.1	10.2	13.0	11.9	8.0	1.1	13.1	2.3	8.8	6.8	7.0	8.0	8.7	7.4	10.2	9.2	7.2	8.9	8.1	8.0	6.6	7.6	10.8	12.9	16.0	19.4	9.4	17.3	72.3	40.2	55.9	23.3	18.7	14.4	12.7	6.1	18.6	45.3	7.3	20.9	31.4	12.7	18.6	7.9	40.0	4.2	14.9	15.5	18.8	20.9	19.0	6.2	33.1	39.0	24.5	18.8	16.1	20.3	20.1	9.3	16.0	32.7	8.4	6.3	19.3	32.6	8.4	35.0	2.7	19.3	13.6	42.7	2.8	15.3	12.3	13.4	2.5	11.6	41.4	9.1	20.7	19.2	59.4	10.5	21.0	24.3	17.6	32.9	23.8	20.6	21.4	30.0	32.2	70.2	30.4	15.0	21.4	29.5	46.1
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285293-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	4.0	2.6	1.7	3.3	1.7	4.1	4.7	2.5	2.4	3.0	1.4	3.0	2.1	3.7	2.7	3.0	2.9	1.9	4.9	1.8	1.9	3.4	3.5	2.8	3.7	1.4	2.0	3.8	2.9	4.5	1.8	3.6	1.6	3.1	2.9	2.2	2.6	2.4	9.6	3.5	2.4	3.4	1.5	2.9	2.6	2.4	1.8	2.6	3.5	7.7	3.5	3.9	2.8	1.9	9.8	7.2	7.9	5.7	5.6	7.8	6.7	9.8	7.3	10.0	7.2	14.1	8.8	14.0	13.1	7.6	6.7	8.7	13.5	13.0	16.6	5.7	10.1	10.9	6.6	7.8	11.6	17.0	5.6	5.4	7.8	13.1	17.4	4.4	6.6	6.5	22.7	4.4	11.4	8.9	11.3	8.3	15.7	7.8	14.8	7.8	4.9	13.8	8.0	8.9	9.0	13.1	8.3	15.3	15.0	9.3	11.0	12.1	9.3	8.0	7.6	14.3	18.3	5.4	8.9	14.4	9.1	8.1	13.1	0.3	0.8	0.1	1.6	1.3	2.3	2.4	2.0	1.4	1.2	2.3	2.6	2.6	0.2	1.6	1.1	1.7	1.3	0.7	1.7	1.7	2.5	2.4	1.8	1.9	1.4	2.0	1.6	1.5	1.8	1.9	33.7	32.1	28.1	7.5	36.0	65.3	33.6	28.7	24.5	31.1	32.6	31.0	68.4	22.8	25.0	36.8	10.4	38.1	32.7	13.5	27.4	39.7	17.0	22.6	47.3	27.9	12.1	41.0	18.4	52.2	59.1	32.2	19.9	28.5	31.0	18.6	21.8	44.2	33.6	26.9	16.1	20.8	6.1	17.3	18.5	4.6	37.6	17.4	21.4	7.5	20.8	21.2	24.7	7.5	9.0	36.8	9.0	24.8	13.0	34.9	5.2	37.2	11.7	23.6	26.3	72.1	33.0	59.7	69.1	24.3	47.6	18.1	26.4	20.4	32.1	23.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42508344-42519796	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	14.0	16.5	15.8	9.8	18.0	12.3	15.4	14.3	17.0	13.9	11.6	13.9	6.2	13.7	28.2	18.7	13.9	4.7	15.6	16.4	14.1	22.3	18.4	13.0	14.2	15.0	15.3	17.3	14.5	11.1	11.2	6.6	15.5	22.3	6.1	5.2	15.6	7.5	13.8	15.7	13.8	6.4	13.1	18.4	15.0	12.8	14.6	10.3	13.6	5.2	10.2	14.8	14.0	15.7	23.9	34.6	21.1	24.7	13.7	8.8	35.9	21.0	13.7	27.0	22.8	47.4	14.3	41.4	10.6	15.5	13.4	29.3	25.4	28.1	11.1	11.2	50.3	21.8	26.4	23.6	11.2	57.1	19.4	12.1	16.4	35.6	17.7	10.5	15.6	21.6	30.7	12.1	15.9	51.5	54.8	23.0	17.9	20.5	25.5	88.9	19.9	17.6	13.7	31.5	9.8	8.4	14.8	50.5	20.7	8.9	18.2	23.9	12.4	22.9	25.1	16.4	21.1	18.5	16.0	48.8	18.2	20.3	31.2	16.1	28.0	22.4	21.2	33.2	20.4	26.1	18.4	19.7	21.8	32.5	20.0	18.8	5.7	20.4	37.2	37.6	17.1	26.2	15.8	18.0	14.3	17.0	16.4	14.1	15.0	15.3	15.5	13.1	14.6	15.7	32.2	22.4	36.6	5.9	48.6	43.8	95.1	41.4	12.5	26.6	28.6	28.3	16.0	31.5	37.2	22.0	16.7	93.0	50.3	48.4	17.6	71.3	55.8	24.2	25.4	38.6	26.4	64.6	7.5	27.2	133.8	31.0	34.7	28.8	47.5	46.3	37.5	32.6	94.8	26.9	6.8	39.8	28.5	43.3	47.4	118.3	22.1	39.5	33.8	6.5	116.5	24.8	68.0	1.0	7.9	52.1	46.0	18.4	51.4	94.3	38.5	42.1	34.4	28.5	6.6	30.2	37.0	33.5	24.7	27.3	37.8	120.4	40.2	45.2	59.4	106.3
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595072-6603616	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	10.8	10.2	10.9	5.8	10.6	18.4	10.5	10.6	14.9	12.7	9.3	21.8	6.7	11.0	9.8	11.4	10.5	3.4	15.4	10.0	9.9	13.3	21.5	9.2	8.6	10.3	10.7	9.3	10.0	5.3	8.2	6.1	10.4	15.8	6.5	7.6	7.4	8.8	9.5	12.6	10.3	6.2	10.9	14.2	12.1	10.7	10.6	6.8	10.6	4.1	8.4	16.8	11.1	12.1	12.3	12.0	4.7	6.1	9.6	8.3	6.7	6.2	7.7	14.0	13.1	12.4	14.1	17.1	6.0	5.9	10.3	12.1	13.6	10.9	14.7	8.3	19.5	8.1	14.0	14.3	11.0	14.8	10.8	7.1	14.0	6.7	12.1	9.2	14.7	8.0	16.3	9.7	11.2	15.2	14.5	22.0	11.6	21.4	10.7	12.8	3.8	3.9	13.4	9.7	7.2	8.4	8.9	18.0	10.7	7.7	9.8	12.9	7.6	13.2	6.1	13.0	12.2	10.8	10.5	16.7	11.2	14.8	8.7	26.3	10.0	10.4	11.5	10.7	11.2	9.1	11.3	10.7	13.0	11.9	11.0	11.7	3.9	13.6	11.8	9.9	11.9	9.0	10.9	10.6	10.6	14.9	10.0	9.9	10.3	10.7	10.4	10.9	10.6	12.1	17.0	22.4	15.0	37.2	19.6	23.2	18.5	13.3	14.2	17.3	14.1	11.7	20.7	8.6	14.7	9.2	14.6	23.5	20.7	12.2	11.7	19.0	7.4	13.7	22.8	16.4	7.2	37.7	45.0	15.9	21.2	15.5	21.4	14.0	17.7	14.7	12.5	23.5	18.9	3.3	32.6	16.2	12.2	9.4	13.4	13.6	13.1	13.1	8.8	21.5	18.4	14.2	22.6	27.2	34.6	22.7	18.2	9.8	15.2	15.8	13.7	29.8	10.3	30.5	0.0	15.3	20.0	23.7	18.0	18.3	27.1	20.0	17.7	25.2	17.3	15.0
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933429-51941904	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	20.5	20.1	9.8	13.7	10.7	12.4	17.3	9.9	12.1	17.1	8.2	13.2	10.9	16.4	5.3	17.7	15.8	6.8	14.5	10.4	9.8	17.7	16.2	13.9	15.7	10.1	10.0	15.8	14.2	10.4	10.5	9.1	9.5	14.6	7.6	5.6	11.6	9.0	28.9	17.8	12.5	9.1	9.3	14.6	13.1	10.8	10.5	9.2	12.6	13.2	10.5	19.1	15.5	10.6	35.8	50.0	23.5	56.2	33.8	18.8	59.5	38.4	20.9	63.7	40.3	85.5	39.6	102.7	15.9	27.3	86.5	32.3	81.9	59.4	25.5	47.1	35.8	69.5	30.6	77.5	67.9	76.6	55.6	39.0	43.0	80.1	75.3	15.5	24.9	35.8	67.0	25.2	28.5	56.7	65.3	76.2	92.6	54.7	126.9	39.7	26.7	78.6	31.4	52.1	28.9	34.1	34.8	38.5	38.8	20.0	20.1	49.2	24.1	44.3	59.4	111.0	160.8	43.0	75.6	96.2	39.5	94.2	71.4	2.1	9.1	0.5	16.4	13.2	17.5	16.4	14.1	14.5	17.0	13.5	10.9	13.2	0.6	18.8	6.5	18.0	12.5	10.0	9.8	10.7	9.9	12.1	10.4	9.8	10.1	10.0	9.5	9.3	10.5	10.6	9.2	0.0	10.5	3.6	15.2	66.8	27.1	29.7	13.1	12.9	11.2	10.3	4.1	10.0	14.0	5.5	4.2	26.8	14.8	8.3	15.6	24.3	8.1	11.2	12.7	12.7	8.4	7.2	1.9	13.4	40.5	12.6	9.7	9.3	15.2	14.4	5.0	7.0	23.4	16.8	1.3	7.2	22.4	5.3	13.4	6.6	8.7	8.7	21.4	1.0	12.9	10.6	16.5	2.0	1.6	20.0	10.3	9.1	11.6	34.2	6.2	22.2	11.9	10.7	6.6	15.6	36.7	8.0	23.8	15.0	50.4	16.7	12.5	16.4	18.9	14.6
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator 1 homolog"	Q15050	8	66429014-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Supported	Nucleoli		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	18.6	14.6	9.8	12.0	9.9	6.5	14.4	9.1	8.9	14.3	10.3	15.5	8.2	19.2	3.8	18.3	16.6	3.6	16.7	8.1	8.5	14.0	14.9	9.8	10.2	14.5	9.9	17.2	41.0	6.0	6.2	5.9	9.9	10.9	5.2	4.4	11.4	6.9	50.0	16.9	12.0	7.4	9.7	13.1	19.0	5.1	11.4	6.5	8.4	14.5	9.5	18.6	13.8	8.6	68.2	83.7	16.9	35.7	17.8	14.3	27.2	41.7	18.3	31.6	23.3	37.7	43.8	91.3	14.2	22.1	44.6	62.5	41.7	47.5	34.7	50.6	70.2	72.8	25.4	67.8	26.3	43.6	37.2	18.9	37.7	34.9	46.1	12.9	20.8	27.5	64.7	37.6	23.3	78.6	87.3	79.2	109.5	76.0	97.2	18.4	21.6	38.3	44.8	54.9	23.0	50.6	20.4	33.4	48.9	17.4	57.6	38.5	36.0	58.5	53.4	49.5	97.5	67.1	64.7	69.8	27.2	68.0	40.4	0.0	13.1	1.0	14.1	17.5	24.8	9.3	17.6	16.5	22.7	8.8	16.1	18.8	0.4	17.3	12.1	10.6	14.2	10.2	9.8	9.9	9.1	8.9	8.1	8.5	14.5	9.9	9.9	9.7	11.4	8.6	8.6	32.1	16.2	3.6	10.0	70.0	42.9	17.9	20.5	9.7	11.8	9.9	29.6	8.6	18.3	12.9	12.5	21.2	13.1	7.1	11.7	28.7	0.2	6.9	16.4	14.6	6.7	13.2	1.5	28.3	23.1	13.6	11.7	8.9	7.6	11.5	12.5	14.8	20.3	6.7	2.8	13.4	8.2	12.2	11.9	1.0	19.0	9.8	23.2	0.0	15.6	8.6	26.8	0.5	2.0	22.1	9.5	17.3	8.7	37.9	3.4	30.0	9.6	13.1	19.7	28.9	21.6	6.2	16.8	19.6	59.8	38.6	20.1	17.9	22.1	30.6
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639688-18672108	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	207	"retina: 213.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 160.6;Rod photoreceptor cells: 162.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059546	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	6.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	1.9	0.0	0.0	0.0	160.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0
RSAD1	"FLJ11164, HemW"	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478860-50485974	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Mitotic chromosome,Mitochondria"		Yes	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Mitochondria	"Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	23.9	41.4	34.7	16.4	37.8	12.8	23.5	37.5	43.4	36.9	32.9	24.3	17.1	24.2	17.5	17.3	24.5	12.5	43.3	34.4	33.9	40.9	44.0	21.1	19.8	34.5	34.9	31.8	48.9	27.5	23.6	12.4	35.1	25.2	17.6	21.2	27.3	14.9	66.0	22.2	23.9	14.4	34.2	31.8	32.5	14.2	35.4	18.4	29.1	57.0	17.8	26.1	23.6	37.0	13.0	43.2	20.3	33.7	34.0	27.6	7.2	22.2	21.6	27.9	23.5	43.0	16.1	34.9	48.0	15.6	27.6	12.1	23.2	31.0	23.9	38.9	42.0	47.0	20.5	42.4	23.7	28.6	31.7	20.2	33.7	18.6	35.7	23.0	27.5	84.1	36.9	32.3	23.7	30.3	48.1	20.9	8.2	54.6	45.9	19.6	23.2	31.6	34.0	19.4	11.1	37.9	5.7	26.3	29.7	25.6	39.6	28.7	19.6	29.0	30.8	22.3	26.4	50.0	37.6	13.5	21.8	40.3	20.6	1.1	4.2	3.8	8.5	4.4	8.5	4.5	7.3	8.4	4.9	6.9	9.4	9.5	0.0	6.6	4.2	5.4	6.2	5.7	34.7	37.8	37.5	43.4	34.4	33.9	34.5	34.9	35.1	34.2	35.4	37.0	15.1	3.2	13.1	18.3	16.0	10.1	4.4	7.2	19.4	14.8	12.1	12.8	29.4	12.8	7.7	16.5	2.1	21.4	24.1	10.8	23.5	14.4	8.8	5.3	10.4	12.4	25.2	12.0	24.0	29.5	11.1	13.1	12.2	7.4	3.8	15.8	10.0	18.5	16.1	8.4	21.5	11.7	8.2	7.2	6.1	7.4	15.5	9.6	17.8	16.9	12.5	32.1	19.6	13.6	12.4	11.8	6.2	10.9	18.7	6.5	11.1	11.1	3.8	7.8	13.1	16.0	11.3	11.5	21.9	10.6	9.9	10.1	18.7	43.6	12.9	3.4
RSAD2	"cig5, vig1, Viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865557-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Lyase	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.6;Alveolar cells type 1: 35.3;Distal enterocytes: 72.3;Erythroid cells: 44.2;Paneth cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 30.7;eosinophil: 43.3;neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 75.7;BJ hTERT+ SV40 Large T+ RasG12V: 117.6;HMC-1: 55.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	4.2	2.3	2.9	4.0	3.7	13.7	3.0	2.1	3.7	6.5	4.6	5.2	3.6	2.1	2.1	1.5	2.8	5.5	5.7	2.7	2.7	2.7	3.5	8.3	2.9	5.1	3.1	2.1	1.5	1.1	3.9	6.6	4.7	1.7	3.0	1.1	21.0	1.9	5.7	0.8	2.9	4.5	11.8	10.1	6.3	2.0	3.0	7.4	1.8	7.6	1.8	2.5	1.4	3.3	0.2	0.0	0.2	0.1	0.0	0.5	0.9	0.0	1.2	75.7	117.6	0.0	2.5	1.1	0.1	0.0	11.6	1.2	0.0	0.0	0.2	0.2	0.0	17.8	0.1	0.0	0.1	0.0	55.7	0.1	0.0	5.7	0.0	0.0	0.0	2.6	1.6	1.0	0.0	0.1	7.0	1.5	0.2	0.0	0.4	0.3	0.0	0.1	0.1	1.1	0.1	0.3	0.1	0.1	3.6	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	1.4	1.5	0.0	0.1	1.2	0.4	30.7	4.9	43.3	2.3	7.5	2.8	0.3	2.6	2.2	2.7	0.4	3.7	3.0	25.2	2.5	7.0	0.3	1.3	2.7	2.9	3.7	2.1	3.7	2.7	2.7	5.1	3.1	4.7	11.8	3.0	3.3	35.6	35.3	3.9	3.9	1.5	0.5	3.3	2.4	1.2	0.8	1.0	0.6	5.2	2.8	3.2	0.0	2.1	0.6	1.9	72.3	0.0	3.8	1.3	19.2	3.1	21.7	9.0	44.2	12.6	6.2	0.8	3.8	34.7	16.1	23.5	8.3	8.9	0.6	9.5	0.0	13.2	2.6	6.1	1.6	2.2	1.1	1.5	8.5	0.0	21.5	7.0	6.3	6.2	17.1	0.9	7.7	107.7	2.2	1.7	4.1	1.7	0.1	13.4	0.7	0.0	2.5	2.8	0.4	0.5	1.2	0.3	2.9	3.6	1.7	1.0	7.4
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	6.4	6.0	4.6	7.7	4.7	34.4	8.2	12.7	6.1	7.9	2.8	8.4	6.2	10.3	6.5	7.3	7.9	6.4	5.2	4.2	5.3	8.0	6.4	7.5	10.6	3.1	3.7	14.2	11.0	11.0	5.1	6.6	3.2	7.9	8.6	13.7	6.8	6.9	8.0	7.5	7.5	7.0	3.9	9.2	6.8	10.7	4.3	12.3	9.0	7.9	10.5	6.4	5.5	5.2	14.6	4.1	13.7	8.2	8.0	9.2	6.6	5.1	10.9	10.1	10.5	4.9	4.3	12.7	7.9	6.3	4.6	6.2	9.8	6.2	16.4	12.3	7.1	9.6	4.4	5.6	6.0	18.1	9.9	7.0	6.7	8.6	8.2	8.6	8.1	14.0	14.7	7.7	7.5	14.9	14.7	10.8	11.6	4.6	6.9	26.3	13.4	6.6	6.0	6.2	13.8	11.0	9.7	9.4	8.7	6.8	4.5	12.1	9.7	9.0	9.7	13.5	8.3	10.3	8.2	15.9	9.3	10.9	15.4	53.3	14.5	25.6	29.1	11.7	29.3	32.2	31.2	27.2	12.8	33.1	31.9	26.2	29.0	25.4	13.4	27.3	30.6	12.6	4.6	4.7	12.7	6.1	4.2	5.3	3.1	3.7	3.2	3.9	4.3	5.2	37.4	35.3	20.1	16.0	52.7	74.7	39.2	26.9	45.5	90.0	35.0	46.7	21.5	24.3	29.6	25.8	66.7	26.3	68.0	55.5	19.6	22.3	25.6	26.2	39.4	38.9	49.4	37.5	34.3	26.0	24.1	41.5	17.9	28.8	36.1	23.4	32.5	18.7	19.2	97.6	34.2	58.5	28.5	26.3	37.7	9.0	50.4	25.7	40.9	30.9	35.0	56.7	62.8	33.7	34.6	21.2	54.0	49.7	34.7	44.3	40.2	17.2	27.8	106.5	39.5	43.8	54.9	96.8	37.0	34.3	65.1	31.5	84.8	24.2	52.7	37.8
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696459-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 349.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 60.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	7.3	6.4	8.7	11.5	9.1	8.2	12.1	19.0	12.1	10.3	10.2	11.3	9.0	12.5	10.3	10.8	9.5	7.3	5.6	8.5	10.5	9.1	11.3	10.5	16.1	8.2	9.0	14.5	11.2	10.3	6.9	9.9	8.6	10.3	11.7	30.2	9.6	11.4	8.2	7.8	10.4	11.0	9.0	15.0	11.0	26.3	8.6	18.3	16.5	7.6	15.0	9.6	8.2	11.6	15.8	11.9	19.6	34.5	13.4	17.0	9.5	11.5	12.4	16.0	18.2	14.9	27.6	32.4	4.4	12.0	20.2	13.4	26.8	15.0	22.8	17.7	14.4	25.8	18.4	14.7	11.3	32.1	23.3	12.2	10.7	14.7	16.0	12.1	13.5	21.2	35.7	33.0	16.8	18.2	27.7	32.1	14.0	20.3	10.6	28.3	19.6	34.2	10.0	20.5	22.9	24.0	17.5	31.4	12.6	19.9	19.2	16.9	12.9	23.9	21.9	14.5	17.7	14.7	16.7	51.6	11.4	29.2	16.0	21.6	7.4	13.5	9.5	5.8	7.3	11.0	8.4	7.1	4.4	13.5	7.8	8.6	60.6	6.4	6.7	13.9	9.3	2.6	8.7	9.1	19.0	12.1	8.5	10.5	8.2	9.0	8.6	9.0	8.6	11.6	53.6	57.7	60.3	27.1	85.0	78.8	102.1	76.1	88.8	246.8	52.1	57.3	22.1	61.5	84.4	55.2	235.6	52.7	101.5	77.1	39.2	38.1	271.3	55.5	63.3	60.8	77.5	47.7	44.3	50.4	34.1	55.6	51.5	45.6	70.3	51.3	49.2	56.5	43.7	158.2	47.5	104.6	57.0	48.1	69.0	85.2	101.5	46.4	64.0	34.7	59.0	83.2	132.8	53.8	50.1	35.1	62.7	119.6	74.6	56.7	49.6	28.4	72.0	349.9	72.3	44.2	73.0	108.0	156.7	56.2	75.3	38.7	90.2	61.7	79.1	84.0
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	1.5	0.1	2.6	0.3	4.1	1.9	0.4	1.1	1.3	1.1	1.4	0.5	1.9	0.3	4.2	1.9	1.9	3.0	0.4	0.0	4.6	8.3	2.3	2.9	0.6	0.0	1.9	1.1	2.9	0.5	3.2	0.6	2.0	2.0	2.4	0.2	1.4	0.2	0.8	1.4	3.7	0.3	0.8	1.3	2.4	0.6	2.0	2.4	4.9	4.1	2.2	1.0	1.7	4.1	4.7	5.7	3.8	6.9	4.8	7.5	3.4	5.6	9.2	8.5	7.8	6.5	9.2	3.2	7.6	4.6	2.8	14.9	4.8	11.2	6.0	3.8	8.5	9.1	8.4	1.6	12.6	4.2	3.8	0.0	15.8	8.7	2.2	5.9	6.1	23.6	8.3	6.8	4.1	6.7	0.0	6.2	2.4	2.7	5.6	8.0	3.8	2.2	7.5	4.6	1.9	6.3	2.9	4.9	4.8	4.0	1.1	5.8	4.7	8.5	4.2	2.5	2.6	5.2	15.6	1.9	3.4	3.4	0.0	0.4	0.1	0.1	0.9	0.4	0.3	0.1	0.6	0.9	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.7	0.5	0.1	0.3	0.4	1.1	0.4	0.0	0.6	0.0	0.6	0.3	0.6	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	12.5	17.9	10.8	16.5	12.9	25.7	15.4	43.9	13.7	17.1	1.5	12.8	9.4	20.0	8.9	14.1	14.5	16.6	14.0	8.7	15.4	14.3	11.7	13.2	15.3	8.3	8.5	26.3	16.9	17.3	6.5	18.5	8.5	15.4	12.6	25.9	10.2	13.4	11.7	9.3	10.8	17.5	8.0	16.3	13.5	23.8	12.0	22.6	22.3	13.4	13.5	17.0	8.4	15.5	27.7	18.2	62.0	33.3	20.6	25.9	23.3	31.7	31.0	25.5	31.4	48.0	37.5	46.7	33.2	22.3	39.4	28.1	36.8	23.8	47.7	33.4	16.3	43.9	25.1	13.0	19.6	42.2	30.0	21.8	17.5	35.0	55.8	29.7	32.7	15.2	72.8	43.0	29.7	18.7	29.7	23.4	36.1	32.9	24.8	49.1	107.5	30.6	13.5	35.5	37.3	37.6	48.8	19.1	18.5	32.2	34.3	20.6	41.2	45.0	38.8	71.0	23.1	25.7	35.7	106.3	11.9	28.1	34.5	49.3	17.8	32.8	27.4	16.9	18.8	34.3	16.6	17.6	14.2	35.0	22.7	22.9	46.4	23.7	30.1	32.0	17.0	7.5	10.8	12.9	43.9	13.7	8.7	15.4	8.3	8.5	8.5	8.0	12.0	15.5	100.3	118.6	113.5	99.6	98.0	90.5	69.3	89.7	93.9	123.0	68.8	85.1	97.1	54.3	84.3	73.5	75.0	57.8	85.1	53.0	46.9	79.2	112.4	72.9	95.2	96.5	85.6	71.8	129.4	55.3	50.6	90.5	51.0	86.0	95.5	132.5	79.9	46.2	45.6	146.4	129.3	64.7	71.2	62.9	68.5	40.3	126.8	66.5	56.9	98.4	93.9	124.6	120.5	157.8	144.7	73.1	63.4	118.1	74.8	97.6	44.1	38.2	69.7	97.6	105.2	99.3	100.4	114.8	109.4	57.2	84.0	67.5	99.9	141.7	58.1	91.6
RSKR	"FLJ25006, SgK494"	ENSG00000167524	"Ribosomal protein S6 kinase related"		17	28601827-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.1;Extravillous trophoblasts: 2.4;Hofbauer cells: 4.1;Syncytiotrophoblasts: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.83e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.33e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.62e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.45e-5)"	"unprognostic (1.20e-7)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-3)"	0.2	0.5	1.2	0.8	1.2	1.6	0.2	1.4	1.7	0.4	1.2	0.2	0.3	0.3	0.1	0.1	0.4	0.0	0.2	1.1	1.2	0.9	0.2	0.2	0.3	1.3	1.2	0.5	0.1	0.1	0.4	0.3	1.4	0.3	0.3	5.8	0.1	0.1	0.5	0.7	0.3	0.1	1.1	0.4	0.2	1.1	1.3	0.4	0.3	0.1	0.3	0.3	0.2	1.5	0.4	0.5	0.6	0.8	0.2	0.1	0.2	0.0	0.0	0.6	0.2	0.9	0.1	1.2	0.1	0.0	0.4	0.6	0.8	0.1	0.6	0.3	0.6	1.0	0.4	0.4	0.0	0.2	0.8	0.0	0.4	0.3	0.4	0.1	0.2	1.2	0.6	0.2	0.1	1.3	0.4	1.0	1.2	1.2	0.1	0.8	2.2	0.7	0.5	1.3	0.4	0.4	0.4	0.1	0.9	0.9	0.5	0.5	0.4	0.3	0.8	0.7	0.5	0.6	0.4	0.6	0.4	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.4	1.7	1.1	1.2	1.3	1.2	1.4	1.1	1.3	1.5	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.8	0.2	0.0	0.0	0.0
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851580	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	39.3	32.2	11.1	36.9	11.7	46.7	78.8	13.4	14.1	47.6	12.2	35.7	32.6	44.0	28.8	38.2	44.5	30.5	33.7	11.9	12.5	33.0	39.1	26.4	48.2	11.6	11.4	118.5	43.6	28.8	13.2	30.0	12.2	33.3	37.9	15.1	42.0	34.0	87.3	34.1	29.2	36.6	13.3	26.9	25.1	22.4	13.3	41.8	34.8	51.7	65.1	48.0	26.4	15.4	90.7	84.3	69.1	87.1	88.6	157.9	81.9	82.1	91.4	104.0	105.9	82.6	83.1	225.6	133.1	68.6	72.1	62.5	186.7	124.4	168.4	88.8	100.7	111.6	75.9	188.0	165.4	159.5	71.3	116.6	173.2	107.6	248.2	77.8	102.4	87.0	198.6	101.5	129.3	100.8	125.7	92.6	177.7	108.1	86.1	129.2	127.3	240.1	92.9	78.0	96.4	79.2	155.0	116.6	110.0	70.9	100.5	122.2	63.2	69.0	77.3	66.0	120.0	81.3	126.2	261.7	75.0	164.9	94.1	14.1	123.2	12.6	69.7	119.1	129.6	132.6	129.5	91.7	130.8	117.3	185.4	136.8	7.1	124.6	120.7	80.2	100.9	253.0	11.1	11.7	13.4	14.1	11.9	12.5	11.6	11.4	12.2	13.3	13.3	15.4	111.2	141.1	156.6	5.5	198.1	330.9	338.6	251.0	299.3	39.9	241.1	344.4	188.4	74.4	198.1	49.7	22.9	186.4	118.7	41.2	135.0	134.5	22.8	76.0	181.1	118.1	94.5	104.5	11.0	186.2	286.8	180.9	88.2	100.0	152.6	106.6	64.2	78.5	147.6	38.7	11.6	126.4	107.8	153.0	177.3	18.5	199.4	141.0	92.5	3.7	276.5	52.8	113.3	3.5	7.3	135.4	75.1	126.0	104.6	226.5	110.5	155.0	81.3	30.8	59.2	245.4	151.5	111.2	136.0	203.5	290.2	160.6	166.5	162.8	184.3	225.1
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197049	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062724, HPA063392"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	67.0	62.0	47.9	60.2	50.4	238.6	121.8	59.7	71.1	69.6	43.9	57.9	48.2	89.8	68.7	55.2	59.8	55.2	66.1	50.0	51.9	64.2	73.0	48.3	88.0	49.1	49.1	138.6	77.0	52.5	34.2	45.8	50.1	55.1	53.0	54.1	65.2	49.0	91.2	51.6	48.7	61.8	51.3	52.0	60.3	51.0	49.0	82.2	74.3	74.5	76.6	75.0	46.1	59.9	122.0	115.2	130.2	168.5	95.7	172.4	104.6	126.1	127.5	95.6	117.0	112.2	70.8	361.8	110.5	86.5	100.9	141.4	165.3	137.2	125.9	183.6	104.1	191.3	89.1	148.7	219.6	365.0	121.7	154.1	282.4	98.9	286.0	162.6	120.5	275.2	352.0	256.2	114.3	122.5	202.5	324.3	159.8	246.9	105.9	156.7	162.8	565.2	148.3	108.8	181.0	218.7	57.6	159.2	430.1	100.6	152.3	524.9	90.4	82.1	98.5	99.3	181.6	249.5	420.2	382.3	129.3	353.9	142.4	61.3	99.2	51.1	76.9	101.5	124.8	123.6	115.9	98.2	116.9	98.1	173.9	134.8	24.9	103.3	108.9	90.0	142.4	229.9	47.9	50.4	59.7	71.1	50.0	51.9	49.1	49.1	50.1	51.3	49.0	59.9	146.9	99.3	79.8	6.8	259.2	580.6	425.7	437.4	275.4	85.4	258.9	299.5	69.0	140.2	177.6	84.6	22.9	150.2	219.9	51.2	285.7	182.2	100.6	127.2	177.7	154.9	140.2	189.9	14.8	271.1	247.6	191.9	99.4	126.3	152.8	103.6	114.5	64.0	143.1	15.2	15.2	128.0	197.4	212.2	414.4	40.8	203.5	164.2	284.6	11.2	247.2	91.0	170.0	8.5	13.9	218.9	118.2	149.3	174.8	347.4	114.6	355.1	105.0	62.8	157.8	274.6	215.6	116.9	151.8	173.3	522.2	174.4	251.7	118.3	144.3	332.5
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head component 1"	Q8WYR4	21	42472486-42496246	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 161.5"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Group enriched"	"Detected in some"	4	"MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.4	3.5	12.7	0.8	13.3	0.3	2.1	10.7	11.8	6.7	30.2	4.0	7.5	5.4	17.0	0.9	161.5	3.0	0.2	11.9	13.1	7.7	0.6	14.2	0.3	20.1	25.0	1.2	3.2	5.1	25.9	0.1	20.4	3.2	3.6	12.4	1.4	3.3	0.7	3.6	5.6	1.0	17.0	0.2	5.2	30.9	14.1	1.5	8.0	0.1	0.3	1.5	0.8	15.5	1.6	1.2	0.1	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.4	0.1	0.5	0.0	0.4	1.9	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	11.0	0.1	0.2	0.3	39.0	0.5	0.0	0.4	0.0	15.4	1.3	2.5	0.9	2.4	3.7	0.3	0.0	4.2	0.4	0.2	0.0	0.1	0.1	0.0	0.4	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.1	0.1	12.7	13.3	10.7	11.8	11.9	13.1	20.1	25.0	20.4	17.0	14.1	15.5	0.4	0.0	6.2	6.5	0.9	5.1	4.5	64.6	2.8	13.3	7.2	5.8	0.6	24.3	107.1	18.4	37.5	0.1	2.9	10.5	39.2	12.6	73.9	857.0	6.2	1.3	9.0	0.0	11.5	3.8	0.0	2.7	4.6	13.9	0.0	0.4	0.0	0.2	0.1	3.3	5.9	13.5	61.1	0.0	0.0	113.4	1.8	0.9	0.0	0.0	1.0	19.9	0.0	0.5	0.3	1.9	11.2	2.6	0.8	9.5	21.4	15.7	1058.1	28.1	0.0	0.9	23.9	79.3	16.8	0.7	4.5	0.8	1.3	2.1	10.6	6.4
RSPH10B		ENSG00000155026	"Radial spoke head 10 homolog B"	P0C881	7	5925550-5970683	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.4;testis: 19.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 59.2;Late spermatids: 143.2;Respiratory ciliated cells: 41.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA049182	Supported					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA049182: AB_2680666"	"unprognostic (4.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-3)"	0.1	0.3	0.8	0.0	0.8	0.0	0.1	0.7	0.8	0.8	3.9	0.1	0.0	0.3	0.2	0.1	8.4	0.0	0.1	1.2	1.2	0.2	0.4	1.4	0.0	2.4	3.4	0.2	0.1	0.9	1.1	0.0	1.5	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	2.2	1.0	0.1	19.7	1.7	0.0	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	0.8	1.2	1.2	2.4	3.4	1.5	2.2	1.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	59.2	10.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	143.2	0.3	0.1	1.8	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.1	4.9	1.1	0.0	0.3	0.0	0.1	0.9	0.0	0.0
RSPH10B2		ENSG00000169402	"Radial spoke head 10 homolog B2"	B2RC85	7	6754109-6799365	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.1;testis: 19.5"	"Group enriched"	"Detected in some"	8	"Early spermatids: 32.1;Late spermatids: 64.3;Respiratory ciliated cells: 47.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049182	Supported					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA049182: AB_2680666"	"unprognostic (7.74e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.28e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.05e-3)"		"unprognostic (2.58e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.02e-2)"	0.0	0.1	0.6	0.0	0.6	0.3	0.0	0.7	0.5	0.4	4.8	0.0	0.0	0.2	0.4	0.0	10.1	0.0	0.0	0.8	1.0	0.1	0.1	1.4	0.1	2.6	4.1	0.1	0.0	1.2	0.6	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.6	0.3	0.1	19.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.5	0.8	1.0	2.6	4.1	1.8	1.6	0.8	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	5.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	64.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 139.7;Late spermatids: 252.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 7.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 7.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.3	2.0	7.7	0.2	9.4	0.2	0.4	5.9	11.8	1.0	9.4	0.6	0.2	0.8	3.5	0.4	12.4	1.3	0.4	8.3	9.9	7.3	0.4	1.5	0.2	8.6	10.9	3.9	0.9	2.4	3.7	0.1	7.7	0.8	0.2	11.4	0.6	1.7	0.7	1.1	0.3	0.3	7.6	0.5	0.7	25.0	7.2	0.1	1.9	0.1	0.2	0.2	0.4	9.5	0.2	2.5	1.9	2.0	0.0	0.9	0.1	0.0	0.5	0.4	0.4	0.4	0.7	0.5	0.7	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.1	1.0	0.0	0.2	0.4	0.0	1.2	0.0	0.8	0.0	1.0	0.0	0.3	0.3	0.4	0.0	0.6	0.0	0.1	0.0	2.0	4.2	0.0	2.7	0.9	0.0	0.0	0.1	0.1	0.3	0.5	0.0	1.5	0.5	0.1	0.0	4.9	1.9	1.6	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	7.7	0.1	1.8	0.0	0.0	0.6	7.7	9.4	5.9	11.8	8.3	9.9	8.6	10.9	7.7	7.6	7.2	9.5	1.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	1.1	0.2	0.5	0.1	1.5	3.7	0.0	4.2	0.0	0.2	0.0	7.9	1.0	139.7	17.8	0.5	0.4	0.0	0.0	3.5	0.2	0.0	0.5	0.0	0.5	0.0	1.2	0.7	0.0	0.1	11.8	2.8	0.1	0.0	0.0	0.0	252.0	2.1	0.3	0.0	0.0	0.0	4.6	0.0	1.0	1.1	0.4	0.0	1.9	0.1	0.2	0.0	17.7	29.2	5.1	0.0	0.8	0.9	29.4	8.3	0.0	0.0	0.0	0.4	2.8	0.1	0.3
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3"		6	158972871-159000202	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.3;Respiratory ciliated cells: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039109	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA039109: AB_10794423"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	2.9	4.7	0.8	2.2	1.0	1.6	3.7	0.2	4.7	3.9	14.5	4.2	5.9	3.4	4.6	5.7	6.1	3.3	3.8	2.0	1.0	6.3	2.7	4.6	1.4	1.9	2.6	3.4	4.3	13.2	3.5	3.1	1.5	5.2	3.7	6.7	4.4	4.1	1.5	3.8	5.6	3.7	1.6	2.3	4.1	9.9	1.1	1.8	7.6	2.2	2.0	2.9	3.0	1.6	8.5	3.7	2.1	4.9	4.8	6.3	2.2	6.2	7.0	1.9	2.8	1.2	4.6	1.7	4.8	7.2	6.3	6.1	1.4	5.6	2.8	4.4	2.9	2.2	3.9	2.6	4.6	2.4	1.6	7.1	9.5	3.8	6.9	10.0	2.5	2.5	2.8	2.6	4.5	4.3	1.5	2.7	1.2	3.8	2.7	2.2	0.3	1.6	8.6	2.6	2.8	4.0	11.6	3.8	2.2	2.4	4.7	5.3	5.4	2.0	5.5	4.8	3.0	2.9	6.1	1.2	10.1	2.9	3.9	0.9	4.0	0.6	0.6	3.0	1.2	0.9	0.9	1.2	4.0	2.4	0.7	1.1	10.5	1.7	7.0	4.6	1.3	1.5	0.8	1.0	0.2	4.7	2.0	1.0	1.9	2.6	1.5	1.6	1.1	1.6	2.3	25.6	17.9	15.0	4.0	7.4	17.2	19.1	6.2	14.2	12.2	7.6	17.5	17.2	25.1	22.0	35.5	10.3	5.7	25.6	13.7	15.8	149.3	67.0	6.9	6.0	13.1	2.1	32.8	10.2	11.4	7.6	10.2	12.7	2.5	9.2	7.9	8.4	10.1	3.3	18.5	17.6	16.2	9.5	16.5	62.9	14.0	12.6	7.2	4.7	8.3	14.4	4.1	6.0	3.5	13.1	21.1	17.7	5.7	18.4	33.1	19.7	120.4	32.5	6.6	5.9	10.2	57.3	10.9	18.6	8.8	5.9	6.1	12.2	13.1	23.1
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head component 4A"	Q5TD94	6	116616479-116632985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 21.0;fallopian tube: 37.2"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.3;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.5"	"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.6	0.5	1.5	0.3	1.6	0.9	0.6	1.3	0.6	1.7	21.0	0.3	0.3	1.6	0.5	0.2	37.2	0.5	0.4	1.5	2.0	0.7	0.5	4.6	0.3	6.1	6.2	0.8	0.8	2.0	4.3	0.1	3.8	0.5	0.2	6.0	0.4	0.2	0.9	0.5	0.5	0.4	4.5	0.9	0.5	2.8	2.4	0.5	0.8	0.2	0.3	0.3	0.3	2.8	0.0	0.1	0.6	1.4	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.3	0.5	0.4	0.1	0.0	0.5	0.1	0.1	0.2	0.2	0.3	0.5	0.2	0.2	0.5	0.0	0.3	0.4	0.1	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.7	3.3	1.3	0.2	1.2	0.5	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.3	0.6	1.5	2.0	6.1	6.2	3.8	4.5	2.4	2.8	0.8	3.2	3.4	7.2	0.3	0.0	0.1	4.9	0.0	3.3	0.4	0.8	0.6	0.0	22.9	0.0	2.1	0.0	0.1	0.1	1.9	0.4	33.1	92.4	1.6	2.2	0.0	0.0	10.6	0.4	0.1	1.1	0.5	1.4	2.5	0.7	1.8	0.0	0.1	1.7	12.9	0.0	10.2	0.0	0.0	9.3	0.3	0.4	1.8	0.0	0.0	2.0	0.0	3.5	5.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	260.6	3.7	0.0	2.0	2.4	9.3	1.6	0.0	0.1	0.3	0.5	5.7	0.0	0.1
RSPH6A	"RSHL1, RSP4, RSP6, RSPH4B"	ENSG00000104941	"Radial spoke head 6 homolog A"	Q9H0K4	19	45795713-45815308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 29.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 80.7;Spermatocytes: 49.0"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA045382	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045382: AB_10959735"	"unprognostic (1.99e-1)"	"unprognostic (3.23e-1)"		"unprognostic (6.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"		"unprognostic (4.16e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.72e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.99e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	49.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0
RSPH9	"C6orf206, CILD12, FLJ30845, MRPS18AL1"	ENSG00000172426	"Radial spoke head component 9"	Q9H1X1	6	43645036-43672600	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.3;testis: 15.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 195.6;Endometrial ciliated cells: 96.3;Respiratory ciliated cells: 327.5;Spermatocytes: 89.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-87 MG: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031703	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA031703: AB_10602126"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.73e-2)"	0.6	0.7	1.0	0.3	0.9	0.6	0.6	1.9	1.0	1.5	3.8	0.7	0.2	1.3	0.2	0.6	8.3	0.3	0.7	0.8	1.6	0.8	0.5	2.1	0.2	1.7	2.1	0.7	0.4	0.2	3.3	0.4	0.9	1.1	0.1	1.0	0.5	0.3	0.6	0.5	0.5	0.4	0.8	0.7	0.8	15.2	1.9	0.1	0.5	0.1	0.1	0.7	0.8	0.5	0.3	0.1	0.5	0.5	0.1	1.6	0.5	0.7	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.3	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.4	0.2	0.2	1.3	0.5	0.2	0.5	0.0	0.5	0.0	0.2	0.1	0.3	0.5	0.5	0.0	0.4	0.3	0.6	0.2	1.7	0.4	0.2	0.4	0.4	0.0	0.5	0.6	0.8	0.0	0.4	0.5	0.6	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.6	1.0	0.5	2.0	0.4	0.6	0.1	0.6	0.3	0.6	0.2	0.5	0.7	0.4	0.3	0.5	1.5	0.5	0.4	1.0	0.6	0.1	0.3	0.5	0.8	1.0	0.9	1.9	1.0	0.8	1.6	1.7	2.1	0.9	0.8	1.9	0.5	0.4	0.0	4.8	0.3	0.4	0.5	0.6	24.0	0.0	0.4	0.3	2.7	1.0	2.8	28.9	0.0	2.1	0.5	0.0	0.3	0.0	0.6	195.6	96.3	2.3	1.9	1.2	0.0	1.4	0.0	3.0	3.4	0.0	1.5	3.8	0.6	0.4	0.2	0.6	1.7	1.5	0.2	38.7	0.3	0.3	26.4	2.8	4.2	7.2	1.0	1.2	6.4	0.0	0.5	0.5	0.4	0.1	1.5	0.0	0.4	0.4	0.3	327.5	1.7	0.0	1.8	8.4	89.9	2.3	0.0	0.3	0.5	0.4	1.1	0.3	0.1
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634892	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 28.9;endometrium 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 7.7;Breast myoepithelial cells: 15.6;Fibroblasts: 5.4;Langerhans cells: 2.9"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;THP-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	11.3	0.1	0.0	0.8	0.1	0.1	7.9	0.1	0.1	28.9	0.0	1.8	1.1	41.4	2.2	3.1	20.0	2.7	0.7	0.1	0.0	0.8	0.1	4.0	1.9	0.1	0.1	2.1	0.5	0.1	0.1	0.4	0.1	6.7	0.5	0.1	1.3	1.8	0.0	6.6	3.3	13.1	0.0	0.8	4.0	0.2	0.1	0.0	0.0	0.5	3.0	1.5	19.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	15.6	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083642	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;intestine: 13.9;placenta: 17.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 75.3;Inhibitory neurons: 86.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-266/70: 4.2"	"Group enriched"	"Detected in many"	7	"amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2"	"Group enriched"	"Detected in many"	4	"amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031"	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.2	0.0	2.8	0.7	4.4	0.1	0.0	1.3	16.2	3.4	2.6	13.9	3.4	0.0	1.7	5.9	0.0	3.2	0.2	6.6	13.2	0.0	0.4	7.1	0.0	2.6	23.0	0.3	0.0	0.0	2.9	17.3	2.0	8.7	7.8	0.3	0.0	2.3	0.0	0.0	4.6	0.3	2.1	0.0	7.6	0.7	3.5	0.0	0.0	0.0	0.0	1.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.4	1.3	16.2	6.6	13.2	2.6	23.0	2.0	2.1	3.5	6.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	86.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.7	0.0	0.0	1.0	0.0	0.2	0.0	0.0
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118671-127199481	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 51.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 18.5;Endothelial cells: 42.4;Fibroblasts: 73.0;Hepatic stellate cells: 26.4;Inhibitory neurons: 17.8;Leydig cells: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 21.9;BJ hTERT+: 3.6;hTERT-RPE1: 6.3;U-138 MG: 4.6;U-87 MG: 4.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 21.2"	HPA029957	Uncertain				"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	30.9	15.1	2.1	16.1	2.4	0.0	12.4	3.3	4.9	13.8	0.0	7.4	2.2	51.4	28.4	5.4	25.3	11.1	0.9	8.5	1.5	4.0	6.5	5.1	3.7	1.6	1.4	3.6	1.6	0.1	3.1	35.4	0.3	6.3	6.6	0.1	5.4	20.0	39.8	2.8	10.3	48.1	0.0	1.8	13.3	1.0	1.0	2.4	3.6	5.0	1.4	8.6	7.1	0.9	0.0	21.9	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	6.3	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	1.8	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	3.3	4.9	8.5	1.5	1.6	1.4	0.3	0.0	1.0	0.9	3.6	0.0	0.0	0.7	0.1	0.9	0.1	0.0	0.6	1.5	0.2	0.9	0.5	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.4	12.3	0.3	18.5	42.4	0.0	0.0	5.9	0.0	1.1	73.0	5.1	0.3	0.0	0.0	26.4	0.4	1.6	0.0	17.8	0.0	0.0	1.0	0.8	2.2	27.4	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	6.6	2.1	3.5	0.1	0.4	0.4	0.1	1.6	0.1	0.1	0.0	0.2
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002311	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.0;lung: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Early spermatids: 6.6;Late spermatids: 7.3;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;EFO-21: 2.0;fHDF/TERT166: 2.4;NTERA-2: 6.3;SK-BR-3: 4.3;U-2 OS: 6.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"			HPA048887	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA048887: AB_2680545"	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	0.3	0.2	4.3	0.6	4.6	0.0	1.3	2.1	6.7	0.6	1.1	0.3	0.1	0.3	1.4	0.8	1.6	0.4	0.5	3.4	7.6	0.6	0.3	12.6	0.0	13.0	8.4	0.4	0.3	0.3	2.1	0.2	12.6	0.4	0.0	1.2	0.4	0.2	0.1	3.0	0.3	0.0	3.8	0.2	0.2	3.2	9.6	0.0	3.0	0.0	0.4	0.2	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.2	0.0	0.1	0.0	0.0	0.0	0.8	2.0	2.4	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.6	2.1	6.7	3.4	7.6	13.0	8.4	12.6	3.8	9.6	2.2	0.0	0.0	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.0	0.0	2.9	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.8	7.3	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	2.1	0.9	0.0	0.4	0.3	0.0	0.0	0.0	0.0
RSPRY1	KIAA1972	ENSG00000159579	"Ring finger and SPRY domain containing 1"	Q96DX4	16	57186137-57240469	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003729	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003729: AB_10964215"	"unprognostic (2.73e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.81e-3)"	10.1	8.9	8.8	10.1	10.1	7.0	13.2	9.4	9.5	15.1	19.0	14.4	16.0	13.1	12.6	11.7	11.6	16.0	8.6	8.2	9.1	16.1	19.7	9.5	13.4	10.0	9.7	14.4	18.5	15.3	8.3	15.1	9.3	13.8	16.2	8.5	11.5	14.0	9.1	9.7	16.2	15.3	8.6	9.7	13.4	21.8	10.6	17.5	17.3	10.6	17.3	16.1	9.2	11.7	17.0	25.7	39.5	20.4	24.6	30.8	23.5	29.7	30.5	39.1	31.0	27.4	21.8	23.8	37.6	39.7	27.0	21.6	34.7	28.6	44.4	16.2	14.4	12.7	18.9	39.5	32.1	22.7	33.5	37.3	27.7	38.4	53.6	29.6	53.5	27.2	21.3	9.6	34.3	9.9	38.7	15.3	25.6	28.4	29.1	48.9	27.2	22.0	46.6	17.1	13.4	29.8	47.8	17.8	12.3	22.4	17.5	22.9	37.8	27.9	27.2	17.6	24.6	25.0	24.7	38.6	24.5	22.0	30.3	27.6	22.5	30.1	24.8	24.7	22.6	26.1	22.7	22.9	26.0	24.0	26.2	25.2	24.5	26.4	36.3	16.5	30.0	18.2	8.8	10.1	9.4	9.5	8.2	9.1	10.0	9.7	9.3	8.6	10.6	11.7	18.6	32.1	13.1	22.5	24.0	34.0	21.0	27.5	38.7	17.1	28.5	17.3	17.5	42.9	23.2	18.4	10.4	26.9	18.9	27.4	25.4	25.2	107.2	22.2	36.7	23.8	21.5	24.8	22.0	23.4	37.7	29.2	25.5	28.9	10.8	31.1	22.5	41.8	17.3	15.2	25.6	32.9	28.5	22.9	23.8	65.9	20.2	19.8	14.2	19.7	25.1	19.7	15.5	36.2	35.8	25.5	15.5	21.4	21.2	29.1	29.5	28.1	23.3	18.2	6.6	25.5	25.2	60.9	52.3	27.9	37.1	27.9	21.8	37.7	23.5	23.0
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	18.5	17.1	13.2	11.8	12.0	15.1	16.4	16.9	17.2	16.0	6.2	14.8	8.7	14.2	11.6	12.7	10.7	10.2	16.0	8.0	12.7	15.9	16.5	10.6	13.7	14.5	15.5	12.8	15.6	15.6	11.6	11.8	12.6	13.1	13.5	18.7	13.5	12.3	19.3	12.9	10.2	13.8	11.0	11.8	12.1	11.3	17.6	13.2	17.0	11.0	14.2	13.6	13.4	13.8	73.6	37.3	24.1	32.1	60.7	41.4	34.1	36.2	29.3	37.8	41.5	51.8	56.8	68.6	66.9	42.9	47.2	32.8	48.4	31.8	58.3	107.6	40.4	71.0	30.4	41.3	9.3	61.5	43.2	32.3	30.0	32.4	29.1	43.4	17.7	38.8	45.4	50.2	31.6	63.7	43.2	41.5	21.4	44.3	33.4	54.7	45.4	86.1	29.5	23.8	47.4	51.7	40.7	26.6	44.6	27.1	59.2	51.7	20.3	52.6	31.6	63.3	69.4	41.0	51.0	72.6	48.5	79.5	61.2	40.4	36.3	20.3	25.1	38.6	25.9	49.5	25.6	24.3	22.0	45.5	23.9	25.7	25.4	17.7	37.2	62.3	22.4	12.9	13.2	12.0	16.9	17.2	8.0	12.7	14.5	15.5	12.6	11.0	17.6	13.8	36.0	32.1	23.1	51.6	51.1	37.3	36.1	32.3	15.4	78.1	39.4	28.7	44.9	45.8	27.0	82.8	33.3	37.5	41.1	33.2	74.3	52.6	49.9	32.8	48.4	35.5	33.0	68.8	71.3	60.5	52.8	47.5	26.0	29.9	76.5	44.0	32.2	74.5	38.3	63.9	82.4	54.9	40.7	45.6	67.6	11.0	46.3	42.4	44.4	80.6	50.0	52.2	44.3	46.3	142.2	45.8	34.2	35.7	35.4	27.7	21.8	67.8	29.7	95.6	19.7	34.8	49.5	39.5	40.4	27.4	27.4	29.6	37.4	39.8	35.9	29.3
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503454-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: AB_2680302"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	12.6	12.2	11.5	11.0	11.4	65.7	13.2	17.6	18.4	14.6	11.3	13.9	8.6	14.1	12.5	17.4	12.3	13.6	13.1	11.3	15.3	16.3	11.4	13.8	16.8	12.1	13.7	16.4	13.8	8.0	14.5	13.3	11.7	12.7	12.0	17.1	12.6	9.5	28.5	12.7	12.5	8.8	7.7	11.6	10.8	14.0	11.8	13.2	15.4	16.1	10.7	14.0	15.0	14.0	21.4	24.8	23.2	9.5	18.4	11.2	16.9	38.8	12.0	16.0	8.7	35.5	8.6	24.4	32.0	13.3	9.7	13.3	25.9	10.8	15.7	22.8	23.9	42.1	32.0	38.3	10.1	37.0	24.8	14.5	12.3	13.6	23.2	20.1	11.6	10.7	27.8	14.6	14.1	16.3	26.8	27.8	19.6	17.8	19.6	19.6	20.9	15.9	21.1	39.8	18.4	16.7	29.6	10.0	22.0	23.1	15.9	13.4	18.1	16.5	20.3	18.4	21.7	16.7	42.8	39.5	9.8	21.6	9.4	27.5	17.7	25.4	17.2	14.7	14.3	28.3	15.3	13.9	18.0	33.4	19.3	15.4	18.7	18.3	22.2	17.0	22.4	12.3	11.5	11.4	17.6	18.4	11.3	15.3	12.1	13.7	11.7	7.7	11.8	14.0	176.8	86.6	102.0	44.7	208.7	202.3	376.1	94.0	118.4	114.3	155.6	146.0	103.3	104.4	107.1	93.8	79.2	149.1	219.3	193.5	195.6	109.3	247.3	223.6	218.6	141.7	156.3	143.1	39.1	97.2	183.8	169.3	89.7	238.0	216.5	127.5	84.9	113.7	94.3	149.7	39.9	185.7	101.7	87.6	184.9	107.1	119.9	139.0	126.3	35.6	107.0	132.9	133.9	34.2	49.6	107.3	171.0	105.7	134.2	219.0	110.1	132.7	128.5	131.0	124.9	194.8	176.7	229.2	165.3	116.0	187.0	280.1	210.3	107.6	154.8	287.1
RSRP1	"C1orf63, DJ465N24.2.1"	ENSG00000117616	"Arginine and serine rich protein 1"	Q9BUV0	1	25242249-25338213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058992, HPA067651"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058992: AB_2683873, HPA067651: AB_2685879"	"unprognostic (1.03e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.81e-2)"	"unprognostic (5.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.73e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.87e-2)"	"prognostic favorable (2.91e-5)"	31.1	31.2	19.6	3.5	27.1	12.8	18.6	25.7	29.4	54.5	25.8	34.0	4.7	29.6	4.4	39.3	38.9	16.3	42.9	20.7	18.1	53.5	35.1	42.4	5.8	37.3	23.6	47.8	19.6	0.9	59.9	8.8	26.0	56.3	2.0	8.5	39.1	18.2	18.8	22.4	26.0	2.1	22.9	37.6	27.2	24.4	25.0	24.4	41.3	21.2	11.4	33.4	52.7	34.8	7.7	16.8	2.2	2.4	18.3	2.7	6.6	7.1	1.3	8.2	9.2	13.7	8.5	6.1	23.0	1.0	3.0	11.4	14.7	1.3	2.8	14.4	8.9	21.0	20.5	17.9	3.9	9.7	11.3	1.8	8.9	3.8	0.0	3.2	4.8	6.3	17.7	49.9	2.3	7.6	2.2	18.5	9.1	17.1	9.7	9.2	6.9	9.1	6.1	0.3	8.9	1.9	4.7	4.7	5.1	1.4	3.9	10.6	10.7	5.7	5.6	5.0	4.1	29.1	24.0	6.3	4.3	24.1	4.5	149.6	57.0	87.4	25.5	38.0	26.7	24.8	26.8	21.6	60.4	23.5	25.3	17.3	130.4	36.6	54.5	37.9	37.6	30.9	19.6	27.1	25.7	29.4	20.7	18.1	37.3	23.6	26.0	22.9	25.0	34.8	351.6	60.9	77.0	121.1	332.7	0.0	229.7	0.0	338.6	86.9	200.1	217.0	47.7	45.8	37.8	93.8	141.8	80.3	456.5	385.9	21.5	43.0	29.8	115.2	142.0	150.0	130.6	140.9	172.6	21.1	82.8	169.0	183.0	146.4	217.1	140.1	71.4	19.6	61.9	84.1	125.4	200.1	0.0	72.2	0.0	16.5	140.1	197.5	0.0	140.5	160.6	69.3	200.8	93.0	278.8	43.6	340.3	90.3	248.4	130.3	397.9	15.2	59.0	138.8	124.9	214.1	141.8	107.6	102.8	283.0	0.0	121.2	346.7	123.8	159.6	196.8
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025927	Uncertain		Approved	Vesicles		NA	NA		33000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	35.6	14.2	8.8	22.0	8.9	27.9	25.4	8.8	10.1	21.2	10.1	27.8	12.0	30.3	19.9	27.7	19.2	19.7	25.1	8.7	10.1	19.4	16.7	27.7	22.3	10.5	9.4	21.8	21.2	14.1	3.9	23.2	9.8	17.9	23.8	9.9	14.5	27.0	15.8	15.9	13.7	41.8	8.6	20.4	15.6	5.5	10.4	18.1	18.7	13.8	22.3	24.0	18.0	9.6	27.3	18.6	15.0	88.5	78.4	80.3	18.3	66.3	28.2	45.1	48.6	17.3	25.0	27.0	10.5	91.2	24.1	23.9	18.3	34.7	48.3	40.6	14.6	85.2	11.1	16.7	34.5	13.1	47.8	40.0	36.0	43.3	13.7	40.9	47.8	27.8	14.0	18.2	61.6	17.6	30.5	23.5	15.7	39.6	10.5	19.6	20.3	18.4	44.0	10.0	5.9	11.6	33.1	21.6	33.6	26.8	7.6	34.4	58.8	38.4	13.3	48.5	34.6	15.9	20.6	23.3	51.0	37.1	16.9	33.0	20.9	22.8	24.7	26.0	28.0	16.6	28.1	26.7	34.7	17.9	20.5	25.8	14.6	31.3	25.5	25.9	36.0	48.5	8.8	8.9	8.8	10.1	8.7	10.1	10.5	9.4	9.8	8.6	10.4	9.6	111.1	35.3	24.5	26.4	29.9	36.7	30.3	74.0	12.0	1.7	22.5	36.2	41.2	27.1	48.3	42.3	2.1	131.9	41.6	57.0	68.4	72.1	80.5	20.7	47.2	69.6	7.2	74.7	52.8	119.2	83.0	52.8	28.5	24.8	34.2	20.5	64.2	32.7	121.7	3.3	34.7	19.0	52.9	61.1	80.7	163.3	39.4	106.2	60.5	52.5	92.3	5.8	66.9	45.8	51.7	81.2	16.8	68.4	36.7	17.4	14.9	58.3	48.8	17.9	65.7	32.4	136.1	3.9	22.6	34.1	42.8	96.2	46.8	35.9	27.2	24.9
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266216-100292769	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	21.7	20.8	14.1	20.4	15.0	31.9	17.1	14.7	17.0	13.1	15.7	22.2	34.5	12.9	26.6	23.8	12.7	16.7	28.4	15.4	16.3	34.5	22.4	15.8	26.3	15.6	14.0	11.0	24.1	23.7	14.3	23.2	16.2	21.6	23.3	22.3	18.7	14.5	39.3	15.8	31.6	15.5	14.0	21.7	23.9	12.5	15.0	19.2	18.0	35.4	23.4	18.5	15.7	15.7	56.8	28.6	27.8	37.4	34.5	55.4	75.7	65.7	32.0	41.9	35.9	47.0	27.7	57.6	48.4	42.0	51.4	28.0	34.3	31.1	50.2	57.8	28.5	38.0	32.8	59.9	52.9	70.2	57.3	45.5	48.0	54.9	72.5	41.3	52.9	41.1	66.6	84.7	64.1	18.6	36.4	54.3	42.7	40.0	54.8	25.7	49.6	25.5	51.7	45.5	22.2	27.6	42.3	60.5	93.3	43.3	13.2	88.5	45.7	39.2	27.5	62.0	80.1	48.7	51.9	46.3	82.5	60.0	23.7	11.8	10.9	9.4	11.8	14.4	15.5	10.6	11.1	14.2	9.6	9.0	10.2	11.6	5.3	13.5	26.1	9.3	24.7	9.3	14.1	15.0	14.7	17.0	15.4	16.3	15.6	14.0	16.2	14.0	15.0	15.7	20.5	6.4	16.2	15.0	27.1	13.6	13.7	23.2	17.6	24.2	19.8	14.0	52.8	11.5	20.4	18.4	12.5	56.7	30.9	30.5	25.4	42.1	19.3	23.0	17.2	20.7	19.2	25.0	20.7	34.5	85.9	18.8	18.8	24.0	13.3	19.8	21.0	17.4	80.9	21.9	22.2	26.2	20.3	48.8	14.5	9.0	19.3	29.5	16.0	21.5	46.2	25.5	25.7	21.1	33.5	57.3	31.9	12.8	36.0	16.1	79.4	73.9	21.0	29.7	6.6	14.3	20.2	43.0	23.2	21.7	14.6	46.4	32.1	25.7	33.0	20.2
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412248	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		73000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: AB_2666021, HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	43.5	44.5	33.3	39.0	36.0	31.4	51.2	37.5	40.8	37.7	35.6	56.1	93.9	43.9	43.7	49.4	46.5	32.6	45.8	33.5	38.1	75.9	75.2	36.3	45.6	36.7	37.0	45.6	45.8	73.0	39.8	45.5	39.1	45.9	73.8	44.1	47.2	47.4	71.1	76.9	79.1	56.0	38.3	43.7	48.4	32.0	36.3	72.9	41.5	63.6	87.9	53.9	39.2	40.2	116.1	101.9	125.0	94.3	106.8	79.1	99.3	98.8	118.5	154.6	145.9	133.2	45.9	28.5	64.6	116.1	95.2	76.7	144.7	143.5	198.6	144.3	144.8	81.4	83.0	122.1	73.4	192.4	71.2	78.3	93.7	153.3	147.8	85.1	141.3	78.5	98.2	78.7	114.3	96.4	82.5	66.4	71.7	133.4	91.7	126.0	134.7	147.1	106.0	99.0	128.3	71.1	107.2	68.5	129.2	130.6	75.5	73.8	107.3	84.8	124.8	74.7	96.5	54.4	46.6	102.1	87.8	85.6	113.4	112.5	135.3	89.2	93.0	151.3	104.4	143.5	96.6	97.4	161.4	150.4	114.8	99.1	13.2	125.7	118.7	90.4	131.7	156.3	33.3	36.0	37.5	40.8	33.5	38.1	36.7	37.0	39.1	38.3	36.3	40.2	32.0	32.1	33.4	15.3	40.3	60.5	54.9	84.9	47.8	51.6	35.4	27.6	35.8	47.1	60.6	35.0	20.9	112.6	43.0	74.8	66.5	108.4	4.8	46.3	28.6	45.4	46.7	36.4	22.4	95.6	87.9	35.8	45.9	53.8	42.6	50.5	41.0	58.3	85.4	52.2	19.6	62.2	116.0	47.4	45.9	10.8	35.1	43.2	30.2	25.3	80.0	66.9	34.0	28.6	35.1	106.5	62.1	47.8	36.0	64.3	178.2	146.9	48.2	56.9	26.3	35.4	43.0	67.0	65.1	52.7	76.0	97.8	34.1	59.3	61.3	73.8
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.8	23.2	24.7	18.8	26.3	45.1	22.4	26.8	42.7	24.3	19.2	21.6	19.2	25.1	19.5	21.4	17.1	20.3	24.6	27.1	24.0	19.0	19.9	19.4	28.2	21.0	21.3	29.4	16.6	36.9	11.4	24.5	20.9	23.4	22.4	26.4	16.7	22.8	49.4	25.9	19.8	26.3	20.0	23.8	20.8	29.8	23.9	28.8	29.5	34.8	25.0	23.1	17.5	24.6	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	24.7	26.3	26.8	42.7	27.1	24.0	21.0	21.3	20.9	20.0	23.9	24.6	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	73.8	72.7	101.4	65.9	113.3	128.5	65.7	117.4	106.7	66.2	88.3	79.2	60.5	70.6	48.9	64.2	64.8	49.2	85.9	97.2	106.7	68.7	63.8	58.1	70.7	113.7	109.6	71.1	59.3	63.0	67.8	55.4	115.0	58.2	54.2	61.3	51.2	62.2	181.4	69.6	60.8	65.4	111.1	67.8	59.3	57.0	108.4	79.2	60.6	111.1	76.2	73.8	57.5	123.5	132.8	93.3	91.1	91.3	111.1	97.9	85.9	198.5	148.1	280.0	158.5	192.6	125.2	110.4	232.0	161.5	139.7	144.9	92.4	153.8	190.7	52.6	72.9	138.9	97.4	150.8	127.9	201.3	186.6	88.1	156.5	126.0	106.9	119.7	121.3	118.1	109.6	114.3	139.1	253.9	171.6	173.0	68.8	185.2	175.9	116.3	247.2	149.5	119.1	86.1	95.1	103.1	208.2	355.0	199.0	66.7	165.0	191.7	131.5	242.2	156.0	133.0	165.1	94.6	116.1	156.9	190.7	134.7	135.1	309.4	205.4	562.3	125.6	192.8	106.2	115.7	106.4	122.5	223.6	134.0	119.7	110.6	580.4	197.4	200.5	189.6	152.2	254.1	101.4	113.3	117.4	106.7	97.2	106.7	113.7	109.6	115.0	111.1	108.4	123.5	87.2	51.3	61.2	0.0	20.9	0.0	0.0	0.0	0.0	0.0	54.1	56.9	0.0	0.0	34.0	66.2	0.0	162.8	50.9	0.0	156.5	104.5	0.0	47.8	51.2	38.8	0.0	0.0	0.0	96.3	109.5	37.3	0.0	47.7	90.8	57.9	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	92.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	5.3	0.0	0.0	149.9	34.2	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	182.9	26.4	89.8	0.0	0.0
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425835-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 149.6;liver: 124.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 2.3;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.6;NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	9.8	8.3	69.5	5.0	104.1	0.6	11.3	85.4	84.6	13.5	51.9	20.3	31.8	8.7	3.5	20.8	12.7	14.2	17.3	72.0	84.3	54.4	124.7	10.3	3.1	100.4	95.5	7.7	30.8	20.7	14.7	11.8	95.7	19.1	12.6	1.9	26.0	9.5	12.8	32.0	25.3	6.3	73.4	5.2	15.3	3.3	93.5	6.3	19.5	7.5	5.3	8.3	16.6	149.6	50.4	15.5	19.5	56.3	11.8	13.7	82.1	7.6	9.9	11.0	8.0	76.3	26.8	0.3	21.2	7.4	13.6	67.2	7.3	48.6	5.3	9.9	31.3	12.0	2.8	96.7	7.2	0.0	0.1	8.4	37.7	9.5	30.0	20.2	5.5	0.7	6.2	0.3	16.5	35.8	1.9	10.1	20.9	70.9	30.3	11.1	60.6	7.6	52.4	0.3	19.0	18.8	20.7	79.3	45.2	17.5	44.6	4.4	0.6	20.5	14.0	9.3	10.6	4.8	3.7	1.8	19.6	0.1	19.5	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.1	0.2	0.6	1.0	0.0	0.1	0.0	2.3	0.0	6.6	0.0	0.4	69.5	104.1	85.4	84.6	72.0	84.3	100.4	95.5	95.7	73.4	93.5	149.6	4.3	9.6	11.8	4.9	2.0	20.0	22.1	37.2	19.4	0.1	14.4	12.2	3.1	28.6	18.3	11.0	2.1	46.7	4.5	21.7	21.5	43.0	0.7	12.6	6.1	8.8	30.7	1.3	0.5	20.1	8.3	8.9	15.8	26.0	1.3	4.9	5.3	40.1	10.1	0.0	0.9	20.1	18.3	2.2	3.8	1.5	12.8	1.1	28.4	3.7	0.7	6.9	5.2	34.7	48.2	30.5	31.0	8.6	1.4	35.4	44.7	54.7	5.8	0.4	6.6	36.9	3.9	1.1	5.6	12.9	21.6	33.4	2.5	3.1	30.5	15.6
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 77.5"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 1753.2;Early spermatids: 480.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Immune cell enriched"	"Detected in some"	8	"T-reg: 16.7"	"Lineage enriched"	"Detected in single"	72	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"A-431: 45.2;HaCaT: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.2	0.1	0.1	1.7	0.4	0.8	1.1	0.6	1.6	1.5	0.0	1.6	1.3	0.9	0.1	7.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	77.5	3.5	0.0	0.0	0.2	0.1	0.4	0.8	1.3	0.0	1.1	2.0	0.9	1.4	0.2	0.0	1.2	1.5	0.4	0.0	1.4	1.2	7.6	0.1	3.9	0.6	0.0	3.4	1.2	3.1	0.5	45.2	2.6	23.2	10.8	0.0	0.1	5.6	6.4	7.4	7.2	11.2	18.7	8.9	0.1	2.8	2.6	7.3	35.3	13.1	1.0	7.4	6.4	8.9	7.5	5.4	7.8	0.1	9.9	5.6	0.3	0.6	8.8	0.9	3.8	1.1	11.8	0.5	0.2	9.7	5.6	19.8	13.1	9.8	6.7	8.7	16.9	24.9	0.1	4.6	19.5	12.6	14.5	4.3	14.8	6.0	6.8	13.4	5.6	0.1	3.3	20.8	0.2	16.5	0.1	0.1	17.2	4.2	0.0	5.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.4	0.1	0.1	0.6	0.3	0.2	0.1	0.0	0.1	16.7	0.2	0.1	0.4	0.6	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1753.2	45.8	0.3	1.5	4.7	10.2	3.0	0.0	0.7	5.0	3.6	0.5	1.5	10.9	0.0	0.0	9.0	2.0	1.9	0.0	1.6	480.3	5.6	1.4	0.7	1.8	1.7	21.5	1.6	7.2	2.9	7.1	10.8	3.8	12.9	1.1	0.0	2.4	0.0	2.5	8.5	6.1	0.6	2.9	102.8	2.1	2.1	1.8	1.0	0.4	0.3	0.0	0.5	1.0	15.4	0.7	1.9	3.3	9.7	0.5	1.9	2.8	0.5	0.0	0.6	3.4	23.5	24.6	26.2	1.8	2.1	17.4	2.9	7.0	97.3
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100879753-100903722	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.6;brain: 7.7;placenta: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 572.5"					"Low region specificity"	"Detected in many"			"HPA066979, HPA077601"	Enhanced		Approved	Cytosol		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"		Cytosol		"HPA066979: AB_2685759, HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.1	1.6	1.6	0.0	0.7	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	3.4	4.2	0.6	0.1	0.0	0.2	2.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	18.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	572.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.9	1.3	1.2	7.7	3.4	4.2	7.7	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RTL10	"BOP, C22orf29, FLJ21125"	ENSG00000215012	"Retrotransposon Gag like 10"	Q7L3V2	22	19846138-19854896	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Cytotrophoblasts: 20.6;Distal tubular cells: 13.7;Extravillous trophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 95.9"									"HPA000721, HPA001419"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"			"HPA000721: AB_1079000, HPA001419: AB_1078999"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.55e-2)"	3.0	3.5	2.4	3.9	3.3	4.8	4.5	2.4	4.2	4.5	0.6	3.0	7.1	4.6	6.7	7.5	8.8	2.5	3.1	3.9	1.5	3.5	3.7	5.1	5.1	1.3	0.4	5.1	7.3	6.1	4.0	5.1	0.9	6.2	3.0	3.5	7.1	5.0	4.3	13.3	4.7	3.8	0.0	4.1	4.2	2.3	1.8	10.8	5.7	3.9	7.2	4.1	4.6	1.6	18.9	7.6	8.5	9.5	9.1	8.0	10.7	10.4	12.0	15.0	9.1	15.5	10.4	16.4	4.3	17.8	4.6	26.4	8.6	17.0	6.6	5.6	12.9	8.7	17.6	10.9	5.8	25.7	7.4	6.0	19.9	12.6	10.6	7.2	14.1	9.9	95.9	6.0	14.5	12.5	21.0	7.8	4.6	21.4	10.3	11.8	25.1	4.0	5.5	17.3	13.9	5.0	10.8	12.2	10.3	8.8	13.4	5.7	18.2	14.7	16.8	4.8	10.0	5.3	5.0	9.8	5.6	6.9	9.9	2.6	1.4	3.1	1.8	1.6	1.7	1.1	2.0	1.8	1.3	1.4	3.9	3.0	2.3	0.8	4.0	2.6	3.0	1.8	2.4	3.3	2.4	4.2	3.9	1.5	1.3	0.4	0.9	0.0	1.8	1.6	3.6	22.4	9.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.3	5.8	0.0	0.0	5.0	9.2	0.0	20.6	2.2	0.0	13.7	7.6	0.0	8.8	5.0	4.4	0.0	0.0	0.0	5.0	16.6	2.4	0.0	9.7	1.3	10.8	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.4	0.0	0.0	5.4	5.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.7	2.1	6.4	0.0	0.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656068-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 2.8"					"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	1.1	0.0	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	1.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.4"	"Region enhanced"	"Detected in many"		"cerebellum: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	1.3	1.3	1.0	0.3	1.0	0.2	1.2	3.4	0.8	2.3	1.8	2.2	0.4	2.6	2.0	0.5	2.2	1.1	0.8	0.5	1.2	1.4	0.8	1.4	0.3	0.1	0.0	2.8	0.6	1.1	7.2	1.0	0.2	1.5	0.4	0.7	0.8	1.3	0.3	0.4	1.0	1.2	0.0	0.8	1.9	1.4	1.2	0.1	3.8	0.4	0.1	1.7	1.5	0.1	0.0	0.1	3.7	4.2	0.9	1.1	0.2	1.4	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.1	0.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	7.0	0.2	0.0	0.0	1.5	0.1	0.0	0.4	0.5	0.4	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	3.4	0.8	0.5	1.2	0.1	0.0	0.2	0.0	1.2	0.1	2.9	3.2	3.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	1.8	0.0	0.0	0.1	2.7	0.0	1.9	0.1	0.0	3.8	8.9	0.6	0.0	0.0	0.0	0.0	0.4	2.0	0.0	2.3	2.5	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	1.1	7.0	0.0	0.0
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492583-44498233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	10.6	12.1	21.3	7.2	19.2	3.2	8.9	15.1	18.9	11.2	8.3	12.5	8.8	15.7	12.1	8.2	16.6	11.0	15.3	20.1	17.4	9.3	3.2	9.4	6.3	18.8	20.0	19.2	11.0	17.8	8.7	5.1	17.1	9.8	9.1	9.6	7.2	13.6	15.5	3.4	8.4	16.9	18.8	7.5	9.7	11.2	21.9	14.2	10.2	18.0	4.8	10.4	5.4	17.2	13.8	18.9	23.9	31.9	18.3	14.8	6.3	17.9	21.1	24.6	19.2	6.3	8.0	0.0	10.9	33.5	18.5	11.8	16.3	17.7	15.1	6.5	31.8	0.0	35.8	0.0	22.6	1.8	8.7	16.2	16.8	22.5	17.3	33.4	22.3	21.6	7.8	0.1	16.9	24.3	44.4	4.1	14.7	15.1	20.0	12.1	12.7	0.0	21.1	15.8	25.6	30.0	29.2	14.0	18.1	11.5	14.0	19.3	23.1	19.2	25.7	25.7	14.5	8.3	3.5	0.0	28.5	4.5	29.2	0.0	0.7	0.0	1.8	0.3	1.9	0.0	1.0	1.5	0.5	0.0	0.4	1.0	0.0	0.4	0.4	0.0	0.2	1.1	21.3	19.2	15.1	18.9	20.1	17.4	18.8	20.0	17.1	18.8	21.9	17.2	5.8	0.0	5.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.1	6.5	0.0	0.0	2.5	12.9	0.0	2.9	4.8	0.0	0.0	8.4	0.0	7.4	12.9	4.0	0.0	0.0	0.0	6.5	2.7	3.5	0.0	8.1	0.0	13.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.7	0.0	0.0	5.7	7.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.2	1.8	5.2	0.0	0.0
RTL9	"KIAA1318, Mar9, Mart9, RGAG1, SIRH10"	ENSG00000243978	"Retrotransposon Gag like 9"	Q8NET4	X	110358816-110456334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5;choroid plexus: 2.4;testis: 10.3"	"Cell type enriched"	"Detected in single"	6	"Theca cells: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 2.0;U-2197: 1.5;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA001242	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA001242: AB_1079804"	"unprognostic (6.03e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-4)"	"unprognostic (8.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.98e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.10e-2)"	0.1	0.1	0.5	0.0	0.8	0.0	0.0	0.5	0.7	0.1	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	2.1	0.0	0.2	0.0	0.0	0.7	2.5	0.8	0.0	0.0	0.2	0.7	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	10.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.7	0.1	0.0	0.0	0.3	0.8	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	2.0	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	1.5	0.5	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.5	0.7	0.2	2.1	0.7	2.5	3.5	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485294-45497055	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 509.8;tongue: 207.7"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.3;Extravillous trophoblasts: 145.7;Skeletal myocytes: 73.2;Syncytiotrophoblasts: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.2;eosinophil: 2.6;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.6;granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.3;RT4: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA034941: AB_10671358, HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	9.9	13.6	21.4	3.4	25.7	1.7	12.0	15.9	43.6	5.9	7.8	21.8	2.8	15.2	2.5	12.1	4.6	7.9	21.9	24.7	22.0	7.1	3.9	8.2	4.7	27.3	19.3	1.9	4.8	10.1	7.6	19.2	27.0	17.0	2.2	5.7	22.3	10.6	509.8	9.1	8.7	7.3	14.1	11.2	7.9	1.6	25.1	1.1	4.9	207.7	2.0	12.4	7.8	29.0	3.8	5.2	8.6	6.7	14.4	17.6	16.9	8.5	20.0	5.2	9.9	10.4	3.2	3.3	11.4	9.3	4.2	7.2	5.6	4.1	1.7	7.9	8.2	23.0	3.9	7.8	6.2	1.4	25.0	19.5	2.2	2.3	4.2	9.2	9.6	0.9	12.9	6.2	15.6	2.9	0.0	4.3	6.3	17.0	6.8	3.6	44.3	18.8	3.0	45.0	24.1	23.1	1.7	40.7	13.2	8.0	32.3	9.1	8.6	14.7	4.4	0.4	1.9	3.5	8.7	7.7	3.9	5.2	7.7	6.2	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.3	1.6	0.0	0.2	21.4	25.7	15.9	43.6	24.7	22.0	27.3	19.3	27.0	14.1	25.1	29.0	9.8	3.2	8.1	2.6	0.8	6.4	27.7	8.9	6.8	10.4	18.4	21.1	4.6	4.3	4.6	3.7	6.2	134.3	2.9	0.9	0.0	21.3	0.3	2.1	7.0	15.3	11.4	1.7	21.0	6.8	145.7	14.0	3.1	3.4	16.5	4.2	18.9	3.1	27.3	23.5	13.3	2.2	12.2	12.9	12.0	0.4	5.6	10.7	23.2	1.9	6.5	9.1	1.0	4.5	2.1	13.1	0.3	6.8	2.5	13.0	0.3	0.3	1.3	13.6	13.1	73.2	12.3	0.5	3.9	2.3	3.4	120.1	1.0	16.4	0.7	23.2
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 514.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1074.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 1074.7;monocytes: 400.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		130000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	207.5	81.8	361.4	54.1	412.2	108.5	93.3	338.4	514.5	87.6	190.7	88.1	54.0	62.5	81.2	55.7	88.5	56.3	57.4	428.4	378.9	92.8	87.5	77.8	36.0	404.5	309.1	48.1	91.1	109.9	81.0	62.2	417.2	53.3	79.9	194.4	138.8	76.1	70.2	103.7	65.2	80.1	329.2	51.7	57.0	46.6	334.0	53.7	175.5	43.7	48.5	55.7	54.2	384.0	157.5	113.8	134.0	128.4	242.3	170.9	53.4	139.3	147.5	120.5	128.4	99.6	338.1	184.2	231.7	210.0	115.7	157.2	194.0	68.7	157.5	149.5	103.5	236.5	151.3	70.4	201.1	212.8	182.4	113.5	199.2	146.7	162.3	200.7	165.2	158.9	136.2	290.1	107.4	129.2	113.4	235.2	156.7	127.3	127.3	148.4	93.8	342.9	239.7	87.5	282.7	164.0	226.2	245.3	271.5	95.4	271.1	172.7	155.2	71.3	95.6	251.1	108.4	183.4	169.9	145.6	274.7	173.8	77.2	441.0	400.1	487.7	41.4	187.6	44.8	28.6	41.6	41.3	130.8	19.4	30.1	32.7	1074.7	41.7	240.4	79.0	68.6	323.0	361.4	412.2	338.4	514.5	428.4	378.9	404.5	309.1	417.2	329.2	334.0	384.0	62.8	134.6	67.5	110.7	35.9	144.5	103.5	63.0	101.3	157.7	125.2	59.9	36.1	81.5	91.9	244.6	70.9	68.6	55.6	118.2	29.4	154.4	35.8	96.4	74.3	68.1	99.8	85.8	398.8	117.1	105.6	96.7	60.1	129.2	77.3	71.4	85.6	81.3	143.7	82.4	372.7	83.5	122.1	178.3	110.8	71.2	79.2	151.4	113.8	100.2	178.0	150.3	42.2	200.6	294.8	103.3	82.0	89.9	94.8	79.4	94.5	55.9	156.0	97.6	78.9	53.1	78.6	194.7	133.5	85.9	146.2	86.5	48.8	51.7	96.5	99.8
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 3547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 95.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1801.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		3400000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	586.2	302.7	376.3	150.9	461.9	115.4	253.1	465.9	534.3	118.0	297.1	186.9	236.2	153.9	176.5	217.9	130.0	196.8	166.0	411.8	431.6	442.5	551.9	211.8	83.6	498.6	456.5	132.0	122.7	236.7	84.0	177.3	524.8	223.9	179.2	640.6	127.1	183.4	996.0	252.9	292.5	246.4	440.8	110.3	124.0	78.6	453.2	87.1	130.7	777.9	88.2	291.2	147.9	591.2	402.9	285.3	273.3	71.7	908.4	845.0	153.2	1301.6	1097.4	393.5	365.7	235.5	371.7	87.1	673.8	889.9	657.7	355.6	181.5	524.4	596.2	248.3	139.4	120.3	159.6	376.6	1801.9	218.1	59.7	638.5	490.8	540.3	1041.9	792.3	751.3	215.6	249.8	195.0	1724.1	117.8	268.3	222.0	245.9	86.8	252.0	118.5	360.3	180.0	924.0	475.9	179.2	211.3	297.7	173.3	378.1	465.1	147.2	165.1	1074.9	764.8	326.1	304.8	756.5	118.0	103.4	56.1	778.7	247.9	630.1	95.8	9.5	27.5	9.2	11.6	7.6	6.8	14.7	8.2	9.2	3.8	24.1	10.2	15.6	41.1	19.0	13.7	37.6	9.9	376.3	461.9	465.9	534.3	411.8	431.6	498.6	456.5	524.8	440.8	453.2	591.2	451.4	176.3	203.4	201.4	102.3	1062.1	1456.6	367.0	225.9	644.6	297.6	260.6	182.0	243.1	251.0	676.8	379.5	529.6	173.6	408.6	291.6	559.7	459.7	316.6	264.6	308.0	222.1	98.2	454.5	323.4	611.9	421.9	98.4	324.7	150.4	161.5	181.3	633.4	669.1	425.7	370.4	280.5	231.9	339.0	578.4	266.6	167.4	371.7	341.5	215.5	396.4	3547.4	137.0	249.3	1334.3	571.2	309.7	226.1	81.6	921.4	897.1	678.3	233.6	540.0	216.9	420.5	324.6	382.7	90.1	247.1	1059.3	362.0	145.5	100.1	238.1	1226.5
RTN4IP1	NIMP	ENSG00000130347	"Reticulon 4 interacting protein 1"	Q8WWV3	6	106570771-106629498	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036357	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036357: AB_10673128"	"prognostic unfavorable (9.18e-6)"	"unprognostic (5.87e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.62e-1)"	"unprognostic (9.82e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.76e-2)"	2.5	6.8	2.8	3.1	3.0	1.8	3.2	3.3	3.9	2.6	3.3	6.3	4.8	2.7	5.5	4.2	2.7	1.6	14.7	2.7	2.7	6.4	7.4	2.0	4.6	2.5	2.5	2.2	3.2	5.2	4.5	2.2	2.8	2.7	6.0	6.0	4.6	2.7	15.6	2.9	4.5	2.9	2.5	4.2	5.9	5.5	2.8	3.0	4.0	15.4	6.1	2.9	2.8	3.4	7.6	10.8	7.3	12.6	5.9	3.5	8.6	5.0	7.0	7.7	7.4	17.4	4.1	11.6	7.6	6.5	15.1	10.8	13.0	10.7	12.1	8.1	7.4	12.1	8.4	14.0	6.1	12.5	8.1	5.2	8.3	10.3	6.7	4.7	6.9	16.3	21.7	4.7	8.5	11.3	4.7	14.4	9.1	10.7	7.9	16.1	13.3	8.8	12.4	8.1	7.1	5.7	4.7	12.3	11.2	7.5	15.5	8.0	3.6	4.4	6.1	8.8	8.9	3.5	5.7	24.8	11.5	18.1	9.6	0.1	4.6	2.2	3.2	5.1	3.3	11.4	4.4	3.4	10.7	16.0	4.0	3.9	0.8	6.5	3.7	5.6	8.2	3.3	2.8	3.0	3.3	3.9	2.7	2.7	2.5	2.5	2.8	2.5	2.8	3.4	1.6	0.0	2.8	7.8	8.1	0.8	1.9	6.4	0.6	5.5	2.8	1.7	18.4	4.3	3.1	1.8	8.4	12.5	1.3	5.2	27.4	6.7	8.5	7.6	2.0	2.1	4.2	1.3	15.6	8.6	15.0	2.1	4.1	4.2	2.5	3.6	2.5	5.5	7.3	0.0	17.2	3.0	10.2	5.4	1.8	3.4	0.6	3.6	0.0	8.4	0.9	3.7	1.0	6.6	17.5	4.9	3.0	1.9	4.2	1.2	3.3	14.5	5.4	6.2	13.1	2.1	2.5	11.9	16.7	4.1	1.0	5.6	2.8	5.6	6.4	2.0
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025334	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 12.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	Yes	NA		35000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	4.0	3.1	4.6	0.3	4.0	0.0	6.4	0.0	9.2	2.1	0.0	0.4	0.1	0.8	0.2	1.3	1.5	0.6	2.3	12.3	0.3	1.6	2.6	1.6	0.1	0.0	0.5	0.9	1.8	1.3	5.9	0.3	0.0	3.4	0.1	8.5	4.4	2.0	1.8	9.6	0.5	0.3	0.0	1.1	0.7	0.8	1.9	0.2	1.4	0.4	0.1	1.5	2.2	0.0	1.4	1.6	1.8	2.5	2.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.9	0.2	10.8	4.6	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.1	0.0	3.6	0.0	0.0	2.5	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.2	0.0	0.3	0.8	1.7	0.2	13.3	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	0.0	9.2	12.3	0.3	0.0	0.5	0.0	0.0	1.9	0.0	1.0	0.0	2.2	1.6	0.1	2.7	0.2	0.0	1.8	20.6	5.4	4.3	3.0	1.5	1.3	3.7	37.5	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.0	43.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.1	3.3	1.8	33.7	18.6	0.0	0.0	0.3	0.4	1.1	0.0	0.1	3.6	7.5	0.0	1.8	0.0	8.5	1.7	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.5	10.0	0.0	0.0	0.6	0.0	0.2	0.5	2.8	0.0	0.2	0.0	0.0	0.3
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368385-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 33.2;Ductal cells: 46.4;Urothelial cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.9;GAMG: 14.2;HDLM-2: 12.3;Karpas-707: 9.7;REH: 9.9;SK-MEL-30: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA064887: AB_2685383, HPA071189: AB_2686357"	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (4.35e-4)"	"prognostic favorable (1.45e-4)"	2.1	2.7	2.4	5.1	2.5	1.1	6.0	2.3	3.0	4.8	2.0	5.9	9.1	4.3	3.2	1.9	10.8	6.2	3.2	2.1	2.4	4.4	6.1	7.0	8.1	3.1	2.4	4.0	2.5	0.6	1.1	2.2	2.8	4.0	6.0	0.2	10.7	5.2	1.0	2.4	8.2	4.5	3.5	8.5	8.1	1.0	2.5	9.2	1.9	2.3	5.8	8.2	2.7	2.7	3.1	0.0	0.0	0.0	1.4	4.9	0.1	0.0	1.2	2.0	1.8	0.0	10.9	1.4	0.0	1.3	14.2	3.6	0.0	0.1	0.0	12.3	0.0	0.0	0.0	0.1	1.8	0.0	2.7	1.2	0.0	0.4	0.0	0.4	0.4	0.3	0.0	9.7	0.0	0.0	7.3	0.0	0.0	0.0	0.0	9.9	0.0	8.0	2.6	7.9	0.0	0.0	0.0	0.2	19.7	0.1	0.0	4.9	0.2	0.1	0.2	0.0	0.1	7.8	2.6	0.1	0.0	2.7	6.0	7.0	8.3	5.9	11.5	10.2	11.5	6.2	9.1	10.5	7.1	5.3	6.9	8.2	2.3	14.9	13.2	0.2	19.8	6.7	2.4	2.5	2.3	3.0	2.1	2.4	3.1	2.4	2.8	3.5	2.5	2.7	7.4	6.4	4.5	0.3	4.3	1.7	33.2	10.5	1.8	0.0	4.0	5.5	0.7	11.5	11.3	5.5	0.0	0.1	4.2	6.0	15.6	46.4	0.0	13.6	4.3	9.6	9.1	0.4	0.0	9.8	0.5	4.2	10.7	6.1	1.3	1.6	10.8	4.5	5.5	0.0	0.1	9.6	6.1	7.8	2.5	0.0	2.1	6.4	1.8	1.9	8.9	3.7	25.7	1.0	0.7	16.9	9.4	4.9	2.0	12.9	17.9	3.1	24.6	0.1	0.0	1.3	3.0	0.1	0.1	1.3	1.3	0.3	8.3	12.0	7.8	52.6
RTP5	"C2orf85, CXXC11, FLJ33590, Z3CXXC5"	ENSG00000188011	"Receptor transporter protein 5 (putative)"	Q14D33	2	241869600-241873823	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.8;Inhibitory neurons: 4.1;Late spermatids: 2.8;Oligodendrocyte precursor cells: 17.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"MOLT-4: 1.3;SCLC-21H: 2.6"					"Low region specificity"	"Detected in all"			HPA050902	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA050902: AB_2681268"	"unprognostic (3.26e-2)"	"unprognostic (5.38e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.40e-4)"	"unprognostic (8.68e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.34e-4)"	"unprognostic (3.30e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.91e-1)"	"unprognostic (9.08e-8)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.72e-2)"	0.3	0.0	25.8	0.1	10.0	0.3	0.1	0.0	18.9	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	29.7	32.9	0.1	0.1	0.5	0.5	5.1	17.3	0.0	0.0	0.0	0.1	0.0	16.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	6.2	1.4	0.3	0.4	25.4	0.3	0.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	10.0	0.0	18.9	29.7	32.9	5.1	17.3	16.3	6.2	25.4	1.3	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	1.0	0.0	0.0	0.0	17.6	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
RTRAF	"C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1"	ENSG00000087302	"RNA transcription, translation and transport factor"	Q9Y224	14	51989514-52010694	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039824	Supported		Supported	Nucleoplasm		NA	NA		48000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA039824: AB_10793922"	"unprognostic (2.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-1)"	92.9	92.7	47.2	73.7	48.9	138.9	87.2	50.8	60.3	69.3	52.5	93.5	61.3	71.1	87.0	79.1	64.5	67.8	151.6	46.6	50.9	77.3	78.9	64.0	105.5	50.4	48.6	96.5	114.0	74.1	65.6	68.2	49.4	66.6	88.7	56.3	76.8	58.7	155.8	79.6	67.3	76.9	51.4	61.2	98.9	142.2	49.0	107.0	81.2	102.2	105.3	87.9	62.8	54.6	214.6	142.1	239.8	233.7	157.7	208.3	228.8	166.9	183.6	180.9	203.1	153.2	184.0	290.8	174.0	139.5	142.2	167.1	226.2	152.6	234.7	158.0	126.5	113.3	287.8	206.7	252.1	243.8	125.0	158.5	155.6	136.6	223.5	210.1	207.2	269.6	118.8	135.1	177.3	237.6	310.8	306.3	187.1	247.8	238.1	278.6	228.0	138.0	176.1	245.2	169.0	171.6	211.0	376.7	274.7	301.3	252.8	190.4	146.0	196.6	216.4	167.2	212.7	50.5	76.2	295.7	96.9	189.3	228.7	54.8	93.3	58.7	73.5	104.7	91.1	108.8	102.0	88.6	117.6	90.9	93.2	95.2	19.2	96.1	112.5	107.9	144.0	126.6	47.2	48.9	50.8	60.3	46.6	50.9	50.4	48.6	49.4	51.4	49.0	54.6	168.6	44.8	67.2	0.0	39.2	0.0	0.0	0.0	0.0	0.0	181.7	232.8	0.0	0.0	39.0	73.5	0.0	316.0	83.1	0.0	309.1	226.6	0.0	164.3	108.1	77.5	0.0	0.0	0.0	289.7	349.6	77.4	0.0	103.6	61.8	242.8	0.0	0.0	240.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	154.5	0.0	0.0	0.0	0.0	232.4	0.0	0.0	13.0	0.0	0.0	303.7	49.6	0.0	0.0	0.0	95.2	0.0	0.0	0.0	0.0	261.6	53.6	233.9	0.0	0.0
RTTN	DKFZP434G145	ENSG00000176225	Rotatin	Q86VV8	18	70003031-70205726	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 69.3;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041343, HPA041967, HPA075089"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Centrosome	"HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: "	"unprognostic (1.76e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.25e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	1.4	1.2	3.5	1.6	5.0	3.1	2.1	3.6	3.4	1.5	2.1	1.3	1.1	1.8	1.5	1.1	1.6	1.2	2.8	2.6	3.0	2.3	2.7	1.6	2.2	4.5	4.0	2.7	1.8	1.7	0.8	1.6	5.1	1.1	1.5	4.1	1.3	0.6	1.8	1.3	1.3	1.0	4.2	2.0	1.3	3.3	6.0	3.6	0.9	1.1	1.9	0.9	1.1	7.1	4.4	6.6	9.4	2.7	1.8	2.0	3.9	7.5	3.4	6.8	7.0	2.5	2.5	3.8	1.0	4.7	6.0	5.4	6.9	11.0	11.1	13.1	3.0	4.1	5.9	3.1	1.3	7.7	4.0	1.6	10.9	7.2	21.2	3.1	4.2	5.8	4.3	8.4	6.1	2.0	7.4	2.1	1.8	1.0	5.8	6.0	8.6	3.9	1.1	3.2	4.0	4.3	4.6	2.6	2.8	6.2	2.8	4.4	3.4	8.8	2.3	3.1	5.7	4.1	3.8	7.8	5.1	4.9	6.0	0.2	0.2	0.1	0.2	0.0	0.4	0.6	0.4	0.3	0.0	0.2	0.6	0.3	0.1	0.3	0.0	0.2	0.3	0.1	3.5	5.0	3.6	3.4	2.6	3.0	4.5	4.0	5.1	4.2	6.0	7.1	6.1	0.0	8.6	19.6	7.1	1.5	1.7	10.1	1.8	8.2	3.9	3.9	5.0	1.5	5.7	0.0	0.0	4.0	4.9	2.9	0.0	1.1	10.6	6.0	5.2	3.4	0.0	4.2	25.4	1.6	1.9	4.0	6.1	6.0	5.1	10.9	1.8	3.7	2.3	16.8	25.8	1.5	2.0	1.3	1.4	3.2	2.1	3.3	0.0	69.3	1.3	1.9	3.1	48.7	110.8	2.0	2.4	1.9	14.7	1.1	2.2	4.1	1.7	9.7	13.1	5.1	4.0	10.6	6.7	3.5	1.7	3.0	5.8	2.5	2.6	2.3
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"Rubicon autophagy regulator"	Q92622	3	197668867-197749727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 67.5;Plasma cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	8.3	7.5	16.2	11.6	16.3	8.5	7.2	10.5	17.0	9.2	4.4	10.4	7.3	8.8	4.0	12.0	8.5	7.2	11.4	17.0	19.0	7.7	5.6	11.8	15.3	20.0	17.8	10.7	9.1	6.8	15.8	5.8	15.9	7.4	5.7	10.9	7.3	7.2	8.9	9.1	13.1	7.8	14.5	19.2	8.1	14.6	23.7	8.8	7.1	8.1	16.1	8.9	8.4	17.4	30.9	7.4	8.2	16.2	14.4	8.3	8.6	13.8	9.2	17.0	14.2	12.7	8.4	33.6	26.7	15.8	16.1	17.0	15.0	8.0	13.6	9.3	13.9	21.6	13.4	4.9	8.4	12.0	18.0	7.0	9.6	14.8	17.6	7.9	10.7	14.4	12.3	87.7	11.5	24.4	15.7	7.5	7.1	8.8	23.2	14.9	8.6	22.6	9.6	13.9	34.3	7.9	10.2	19.8	10.8	5.5	29.2	8.1	13.7	9.9	9.9	27.8	18.9	36.5	34.2	27.0	13.6	22.4	8.7	0.8	2.6	17.5	3.7	3.9	2.4	7.7	3.1	4.7	1.6	8.5	2.2	3.2	2.9	1.8	4.8	16.6	4.4	1.7	16.2	16.3	10.5	17.0	17.0	19.0	20.0	17.8	15.9	14.5	23.7	17.4	8.5	6.4	11.2	0.0	33.9	0.0	6.0	0.0	8.0	21.0	7.3	7.0	0.0	7.2	4.3	12.9	18.8	1.8	28.9	3.8	1.9	5.8	21.7	4.8	6.2	6.7	0.0	5.7	0.0	6.4	3.7	4.8	7.1	9.8	2.5	6.1	9.3	3.5	9.2	21.9	0.0	3.7	0.0	16.3	0.0	16.4	5.0	18.7	0.0	0.0	67.5	15.0	14.4	0.0	0.0	8.5	1.5	6.4	48.3	8.9	5.8	2.7	0.7	14.3	6.6	9.7	6.8	34.1	21.3	5.6	0.0	6.4	15.9	4.9	2.8	12.3
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Group enriched"	"Detected in some"	4	"Daudi: 179.1;U-698: 341.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	4.2	1.3	3.7	18.0	3.8	14.8	4.0	3.5	4.1	6.6	2.5	11.9	3.0	3.7	1.2	1.0	3.7	4.0	1.0	3.4	6.8	1.1	2.2	5.2	41.2	6.2	4.8	0.6	0.7	0.3	2.0	4.2	6.1	1.5	16.2	3.9	3.0	2.6	10.1	2.0	13.2	3.6	4.9	20.3	2.2	15.7	6.3	22.9	1.9	1.4	40.6	7.5	1.3	5.9	0.5	0.1	3.6	0.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	7.5	0.2	179.1	1.8	0.0	0.9	0.2	0.1	0.0	0.1	0.7	0.3	0.2	0.2	0.1	0.0	0.2	0.2	4.7	0.0	0.6	0.9	0.0	0.0	8.2	0.3	0.4	0.0	0.1	1.9	1.4	1.5	0.0	1.4	62.6	0.1	6.1	0.0	0.1	3.4	0.1	0.2	0.3	4.4	10.8	0.2	53.0	0.1	0.2	1.6	0.3	0.4	0.9	37.3	341.2	1.1	0.3	0.2	0.5	4.5	0.1	0.1	8.9	0.1	161.2	0.3	0.1	5.1	155.8	0.1	0.1	124.0	3.5	7.1	106.2	0.2	7.5	3.7	3.8	3.5	4.1	3.4	6.8	6.2	4.8	6.1	4.9	6.3	5.9	0.2	3.2	6.1	0.0	20.7	0.0	0.0	0.0	0.0	0.0	2.9	3.9	0.0	0.0	2.5	0.0	0.0	0.3	0.3	0.0	0.0	1.4	0.0	1.3	6.7	0.4	0.0	0.0	0.0	1.2	0.4	1.1	0.0	2.5	2.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550554-179610012	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		25000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	28.2	33.1	9.6	13.4	10.5	13.3	26.1	9.8	10.2	27.2	11.3	29.1	9.4	27.5	8.1	33.9	24.5	8.8	20.4	9.5	10.1	24.1	21.3	26.6	14.2	10.2	10.0	23.9	24.4	13.5	22.7	9.0	10.1	22.4	8.2	7.4	25.8	8.6	33.8	33.1	25.9	7.8	9.9	35.2	24.2	10.9	10.0	13.6	24.7	10.1	11.5	26.3	27.2	10.6	13.9	22.5	11.8	15.7	22.3	18.2	13.4	24.2	17.2	14.1	16.3	22.0	31.6	22.4	13.4	29.6	16.2	12.6	21.9	31.6	16.4	71.2	16.6	39.2	17.1	16.0	22.8	22.0	20.7	18.5	17.1	9.5	27.0	24.6	15.5	12.5	16.2	20.8	12.7	42.0	23.5	15.2	12.6	15.0	10.5	20.9	8.4	20.9	23.5	22.4	11.7	16.7	35.4	22.5	13.2	14.8	18.0	26.6	18.8	18.3	6.2	10.0	19.3	12.8	21.2	39.8	16.9	39.0	17.2	14.9	4.8	11.9	2.2	5.1	1.3	3.8	2.7	2.3	4.2	5.7	1.9	2.4	7.9	1.8	7.1	4.8	4.5	29.8	9.6	10.5	9.8	10.2	9.5	10.1	10.2	10.0	10.1	9.9	10.0	10.6	19.8	35.3	30.8	30.0	23.6	10.3	11.5	11.7	16.5	9.3	17.8	17.5	22.8	28.6	23.1	14.7	20.9	21.7	15.7	20.0	9.8	19.7	8.0	28.2	21.9	20.9	10.8	27.7	31.8	14.4	15.8	19.7	19.9	20.0	29.8	20.4	12.5	14.1	31.1	11.8	28.4	17.5	8.2	30.7	21.0	3.4	23.0	137.2	10.6	21.5	43.7	11.9	15.5	23.1	33.9	22.1	18.5	27.1	18.3	14.2	14.1	34.0	32.8	12.0	6.6	20.8	17.8	11.1	8.4	21.9	11.4	21.2	19.5	25.0	15.3	10.2
RUFY2	"FLJ10063, KIAA1537, RABIP4R, ZFYVE13"	ENSG00000204130	"RUN and FYVE domain containing 2"	Q8WXA3	10	68341107-68407294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 93.1;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039792	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039792: AB_10673363"	"unprognostic (1.23e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.40e-2)"	5.8	4.7	8.4	3.8	12.7	1.9	6.5	13.5	18.7	5.9	3.7	4.9	3.3	8.4	4.6	4.9	5.7	5.0	4.5	9.6	10.5	5.6	1.8	5.4	4.1	13.7	10.9	9.8	4.4	6.9	3.6	5.5	12.9	6.3	5.4	10.0	4.7	4.9	5.1	5.0	4.0	7.0	11.3	4.9	4.9	4.2	12.3	5.6	6.4	4.4	4.2	5.7	5.2	19.0	11.7	4.5	7.3	9.8	9.2	13.5	4.5	9.8	12.1	10.2	10.2	6.9	10.8	3.8	7.2	16.0	4.5	8.3	3.2	10.9	10.2	1.6	8.2	2.6	3.6	3.7	9.7	3.7	1.7	12.0	11.4	12.1	12.4	16.2	11.5	3.2	4.9	5.6	10.9	4.8	3.1	5.0	3.2	3.6	13.1	4.3	5.9	2.3	10.8	7.1	8.4	7.9	7.0	9.3	6.0	9.1	13.8	4.6	13.2	12.7	9.6	7.6	13.8	5.6	3.2	1.9	12.0	3.6	5.6	0.6	0.5	1.1	0.8	0.6	0.8	0.8	1.1	1.1	0.3	0.9	1.1	1.4	0.5	2.6	0.8	0.5	0.4	0.3	8.4	12.7	13.5	18.7	9.6	10.5	13.7	10.9	12.9	11.3	12.3	19.0	22.8	32.1	15.1	40.1	15.9	6.6	15.2	14.8	8.0	47.7	11.7	11.2	11.4	4.3	20.7	25.8	60.5	9.3	13.0	7.2	1.9	16.1	8.5	24.1	30.2	20.3	10.2	13.5	93.1	12.9	6.0	24.8	14.3	20.2	7.6	24.2	22.5	6.5	6.5	32.0	84.7	12.0	10.2	10.0	7.7	5.5	24.2	11.2	12.4	45.0	13.1	20.2	12.3	58.8	153.7	17.9	5.4	17.7	12.0	15.6	6.3	10.1	21.7	62.0	13.1	31.7	24.7	11.1	24.4	15.9	8.1	9.6	11.8	22.8	7.7	10.7
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70808619	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 120.3"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 189.4;Cone photoreceptor cells: 264.8;Excitatory neurons: 192.9;Oligodendrocytes: 197.8;Rod photoreceptor cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA022952: AB_2671005, HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	19.4	34.8	57.1	18.2	63.7	11.6	18.7	63.3	77.0	28.6	27.6	18.9	12.0	29.4	23.3	24.4	18.0	17.7	16.0	63.8	72.0	22.1	22.2	21.9	21.7	77.1	63.0	35.8	19.2	8.2	41.1	17.5	81.5	19.2	16.0	120.3	18.9	15.6	25.6	46.5	15.0	20.8	61.4	25.4	19.1	39.0	63.6	32.5	45.7	11.7	17.3	19.9	25.7	99.3	8.5	5.8	67.0	15.9	30.8	35.2	26.6	26.6	10.2	8.5	9.4	9.9	20.2	33.2	10.8	22.4	19.1	8.4	10.3	11.8	13.6	18.2	13.4	7.2	8.4	11.6	18.0	8.4	4.3	24.7	18.0	11.4	13.3	39.5	18.3	35.4	20.2	32.9	18.8	10.4	52.8	9.6	16.1	14.7	7.3	12.8	21.0	15.2	16.7	8.0	61.7	30.6	9.7	17.0	16.2	25.8	11.7	4.2	15.7	28.8	20.0	8.8	6.2	37.2	18.0	35.7	29.4	6.1	6.0	0.6	3.4	0.3	1.5	4.8	1.9	3.5	1.2	1.3	4.9	2.6	1.2	1.3	0.1	2.6	4.9	6.6	0.5	0.8	57.1	63.7	63.3	77.0	63.8	72.0	77.1	63.0	81.5	61.4	63.6	99.3	31.9	35.3	82.1	189.4	18.7	19.4	23.3	9.9	15.9	126.9	22.1	11.8	19.3	12.8	30.6	23.9	264.8	15.0	19.5	7.5	7.9	14.7	70.0	32.9	63.6	32.6	15.0	7.4	192.9	21.1	7.0	43.7	23.4	36.0	21.0	53.1	32.9	25.7	10.5	139.7	175.0	8.4	14.2	37.3	36.4	122.5	47.2	31.0	42.7	72.1	67.0	43.9	13.4	136.7	197.8	19.1	5.2	50.8	17.2	40.2	11.6	19.6	28.3	198.6	26.3	53.2	35.9	14.8	27.6	36.7	28.8	7.7	11.5	40.9	10.1	19.3
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;lymphoid tissue: 2.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 9.5;Langerhans cells: 4.0;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"Karpas-707: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037980	Uncertain					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"	0.1	0.2	0.5	0.9	0.6	0.8	0.1	0.4	1.8	0.1	0.4	0.2	0.7	0.0	0.0	0.4	0.2	0.5	0.0	0.9	0.4	0.1	0.2	0.4	1.1	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.1	0.5	0.1	0.5	0.1	0.0	0.3	0.7	0.0	0.5	2.2	0.6	0.1	0.4	1.7	0.1	0.0	0.8	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.4	1.8	0.9	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.0	0.0	0.0	2.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.3	4.0	0.3	0.0	0.9	0.0	1.0	2.0	0.0	0.0	13.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	5.5	8.0	8.7	6.6	11.0	6.8	10.0	6.5	11.0	8.6	9.7	9.4	6.5	8.7	12.1	6.6	14.5	6.1	7.3	9.6	8.8	8.4	5.0	6.9	7.2	6.3	6.8	5.0	7.9	12.0	9.4	4.8	6.2	12.1	7.6	8.5	7.5	8.5	11.6	7.1	7.8	8.6	5.8	8.1	10.1	6.8	7.9	6.7	10.2	9.0	7.7	8.4	6.2	8.2	12.9	22.1	8.8	11.9	14.7	8.8	9.3	12.2	12.6	17.1	12.7	14.0	7.2	8.6	10.7	12.1	11.6	15.8	11.3	12.3	18.9	9.7	17.7	5.8	12.8	13.5	9.4	12.6	11.9	6.6	14.7	15.1	10.0	13.6	9.2	9.3	11.2	5.3	9.9	9.3	15.6	8.9	9.9	18.3	13.8	11.2	12.3	8.6	14.3	17.0	12.8	11.8	9.6	9.0	10.2	12.9	17.5	13.9	7.6	15.4	9.6	9.2	14.7	12.6	13.1	7.5	11.0	6.6	9.8	4.7	2.3	7.9	1.3	3.8	1.7	3.7	1.6	1.1	1.8	3.7	1.6	1.7	5.4	1.1	2.8	5.6	2.0	1.0	8.7	11.0	6.5	11.0	9.6	8.8	6.3	6.8	6.2	5.8	7.9	8.2	5.3	44.8	38.4	6.5	18.7	15.0	11.0	5.8	9.1	18.9	19.2	9.8	13.7	22.8	17.2	5.5	22.9	9.8	19.1	28.7	21.5	11.8	8.1	26.4	9.6	10.3	19.2	5.7	13.8	9.8	7.3	8.6	20.4	19.5	11.4	8.4	10.4	6.1	8.4	38.7	11.0	16.9	6.1	10.5	14.7	4.5	9.9	9.5	3.6	7.5	14.3	14.3	12.3	5.0	6.2	10.1	16.4	14.3	11.7	16.6	15.1	12.8	24.7	33.2	19.7	8.5	9.6	22.9	14.9	7.2	14.6	5.5	13.9	10.4	17.8	17.0
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 208.4;pituitary gland: 98.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4"	"Group enriched"	"Detected in many"	5	"glioma: 8.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 62.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	0.3	14.3	149.2	0.4	159.5	2.3	0.3	93.0	208.4	0.2	45.6	3.4	1.2	0.5	0.2	0.8	0.2	0.3	1.8	169.4	105.3	1.8	0.2	0.4	0.2	108.0	106.4	0.8	3.8	3.1	98.3	1.5	108.5	0.8	0.6	31.2	0.3	0.3	0.1	7.9	1.3	0.5	79.2	1.6	2.3	15.2	109.4	0.4	1.4	0.3	0.1	0.2	0.7	135.7	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	4.3	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.9	0.2	0.0	0.5	0.3	0.3	0.1	0.1	1.1	0.3	0.1	62.5	40.3	0.3	0.0	0.3	0.1	0.5	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.2	159.5	93.0	208.4	169.4	105.3	108.0	106.4	108.5	79.2	109.4	135.7	0.1	0.0	0.6	17.3	0.0	0.3	0.3	0.0	0.0	55.4	0.2	0.3	1.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	1.3	24.4	0.2	0.3	0.2	39.0	18.7	46.1	3.1	0.0	1.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	32.0	30.4	0.5	4.1	0.3	0.5	83.4	1.5	0.3	0.0	4.7	0.1	6.5	1.0	16.1	12.5	1.0	1.2	3.4	0.0	0.4	0.0	0.8	0.0	16.8	0.0	0.8	0.5	1.4	1.3	0.0	0.4	0.1	0.1	3.0	0.1	0.3
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.3;brain: 6.3;liver: 5.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155, HPA075760"	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favorable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	0.4	7.3	3.1	0.1	2.9	0.0	0.6	6.3	3.9	1.4	0.0	1.3	2.8	1.9	0.6	0.5	1.0	0.9	0.7	2.0	3.7	1.9	5.6	0.4	0.2	2.5	1.5	1.2	0.1	0.3	0.2	0.0	2.2	0.6	1.5	1.7	0.3	0.4	0.1	0.5	2.5	2.1	0.8	0.1	0.1	1.9	4.0	0.1	0.2	0.1	0.2	0.5	0.3	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.5	0.4	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.7	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	6.3	3.9	2.0	3.7	2.5	1.5	2.2	0.8	4.0	1.3	15.3	0.0	0.0	5.5	0.6	4.8	0.1	0.1	2.2	7.9	1.0	1.1	2.5	7.2	0.1	0.0	6.2	0.5	0.9	12.2	1.9	1.1	4.6	5.6	0.5	30.8	0.0	2.7	167.5	0.2	0.8	1.1	0.0	2.0	0.0	0.7	1.4	18.9	0.1	11.8	170.9	2.9	0.0	0.0	2.3	1.7	4.1	0.6	3.6	108.7	0.2	0.7	4.1	15.1	5.7	0.6	6.5	1.5	0.1	0.2	18.2	11.6	0.2	8.0	0.0	0.3	2.0	21.2	18.8	0.4	3.0	1.2	0.8	1.6	4.2	0.1
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"RUNX family transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	14.8	3.8	2.9	20.3	2.1	45.5	27.1	2.6	4.0	15.3	5.1	6.7	5.1	3.3	3.1	9.2	4.7	16.0	6.3	2.8	3.2	4.6	7.0	22.4	11.3	6.0	4.3	6.3	4.0	1.5	5.1	8.5	6.5	13.5	6.5	0.3	39.2	3.5	18.9	11.6	6.8	9.2	4.9	10.2	16.9	3.8	9.1	28.2	4.8	1.4	9.9	20.8	12.8	7.9	50.9	3.8	0.1	0.3	12.5	16.0	32.0	28.1	28.4	15.3	11.6	2.5	37.7	24.9	1.8	24.9	25.5	45.0	3.0	33.6	21.4	38.7	3.8	251.3	10.1	11.6	22.9	29.4	145.3	30.9	19.8	46.6	45.6	21.2	8.8	226.3	17.3	14.1	32.7	10.7	119.3	46.5	2.2	27.4	14.5	119.2	84.6	15.3	20.7	19.9	1.4	0.0	28.9	7.2	10.5	6.8	14.7	67.8	37.0	25.1	32.4	37.8	42.8	46.4	20.7	23.3	31.2	63.4	37.4	23.9	3.1	7.1	3.4	1.4	3.2	4.1	3.0	3.2	0.9	3.6	4.5	3.7	3.4	1.5	4.7	3.4	4.5	2.2	2.9	2.1	2.6	4.0	2.8	3.2	6.0	4.3	6.5	4.9	9.1	7.9	6.2	54.5	35.4	1.6	27.0	41.6	52.7	61.2	54.7	2.3	175.5	94.6	3.2	28.6	60.8	20.2	0.0	2.1	39.5	18.7	1.9	39.7	19.4	89.6	21.5	9.2	6.0	47.3	3.5	28.1	21.4	49.2	84.6	155.8	17.7	29.2	4.6	5.4	68.4	0.0	3.2	12.4	28.5	77.0	122.5	27.1	4.7	84.4	28.4	195.8	42.2	0.5	39.1	1.5	1.6	101.0	15.8	4.5	27.7	43.6	8.3	1.6	78.6	0.8	0.0	111.3	51.2	29.0	28.0	53.7	20.2	2.5	41.6	2.7	17.0	75.3
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 partner transcriptional co-repressor 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 93.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 93.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	7.0	2.8	9.4	2.1	13.2	0.2	5.1	93.1	8.7	8.4	0.0	6.5	1.2	7.4	3.6	2.5	4.7	5.0	8.2	13.1	2.3	1.4	0.6	3.8	1.3	1.4	12.8	4.7	1.0	1.0	3.0	5.8	4.6	2.5	2.4	5.2	3.1	2.4	3.9	2.4	2.5	6.5	4.2	1.9	2.7	3.6	3.6	0.5	3.7	4.8	1.1	3.8	3.9	1.2	0.0	0.0	0.4	1.9	5.0	7.2	0.0	7.6	11.6	5.0	7.6	0.0	0.0	19.6	0.0	16.5	0.0	0.0	4.0	0.5	3.3	0.0	3.2	35.9	0.0	0.0	1.9	0.0	0.0	13.6	0.0	8.4	0.4	0.0	10.8	0.0	0.1	0.0	1.3	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	6.0	0.0	0.0	0.0	7.8	0.0	0.0	1.2	0.4	0.0	0.9	0.0	3.8	0.0	6.3	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	13.2	93.1	8.7	13.1	2.3	1.4	12.8	4.6	4.2	3.6	1.2	44.9	0.0	1.1	90.8	0.1	6.2	0.2	0.0	0.6	142.1	1.2	5.1	46.0	0.0	0.6	0.0	16.7	1.1	0.5	0.2	1.9	0.0	2.6	1.1	65.8	64.3	47.7	2.7	196.9	0.2	0.3	77.7	0.5	1.1	1.3	2.1	124.2	1.5	1.9	35.3	326.3	0.6	0.0	4.1	9.4	7.5	96.3	1.2	10.6	103.0	0.0	3.9	0.0	262.4	17.3	0.2	0.0	98.9	0.0	0.3	0.0	0.1	0.0	7.2	65.7	24.4	43.1	3.3	16.8	0.9	4.8	1.1	1.1	20.7	0.0	0.1
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320894-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	27.0	26.6	42.0	11.6	40.7	12.8	23.2	39.9	66.0	38.0	11.3	39.2	21.6	28.8	8.7	49.5	24.8	16.8	28.8	38.9	41.1	32.1	12.6	23.7	10.7	55.2	34.0	27.5	22.5	11.7	45.0	18.2	53.2	32.1	22.9	11.9	32.0	20.3	14.1	37.3	29.9	18.6	28.3	18.0	27.3	6.6	41.4	18.6	19.3	13.3	11.3	26.6	39.2	41.0	70.4	43.5	24.5	36.4	29.6	32.1	47.2	32.7	20.8	42.2	47.1	50.1	45.2	13.7	24.4	33.2	24.2	95.1	38.3	47.4	18.2	18.8	48.8	19.8	44.7	26.6	24.5	19.9	32.9	33.0	29.3	42.5	14.6	20.4	43.9	29.7	30.5	9.4	36.9	133.4	25.0	25.3	48.4	128.4	68.3	33.6	17.1	24.3	40.3	52.7	25.2	40.5	27.6	76.9	16.8	39.8	114.8	33.6	20.2	54.0	44.4	51.4	65.8	7.4	18.0	8.6	38.2	26.5	15.0	5.8	8.0	4.0	6.3	9.8	7.2	3.6	5.1	6.4	8.8	1.5	2.8	6.0	1.1	3.3	25.2	8.4	5.5	5.4	42.0	40.7	39.9	66.0	38.9	41.1	55.2	34.0	53.2	28.3	41.4	41.0	18.2	9.6	12.7	4.9	8.0	28.0	20.1	29.5	22.8	16.9	21.3	19.3	10.2	15.7	27.9	18.4	6.2	30.8	14.8	82.2	23.5	22.4	0.4	9.9	14.7	20.0	15.6	14.5	23.8	17.7	76.6	19.1	25.5	23.6	8.2	9.8	16.4	7.8	21.0	37.0	30.5	51.7	18.3	12.8	20.3	0.5	18.3	11.9	19.6	6.5	11.7	13.4	15.5	7.1	8.2	25.6	43.7	18.0	8.4	29.4	51.8	27.9	10.4	7.0	19.7	12.7	22.2	2.3	8.9	41.4	34.9	38.0	15.2	6.7	40.1	26.0
RUSC2	KIAA0375	ENSG00000198853	"RUN and SH3 domain containing 2"	Q8N2Y8	9	35490111-35561898	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.6;Excitatory neurons: 61.5;Inhibitory neurons: 63.5;Microglial cells: 43.1;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"TIME: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021297	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021297: AB_1856510"	"unprognostic (4.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.46e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.38e-3)"	21.0	17.9	28.0	5.9	30.6	5.8	16.7	17.9	40.2	22.0	3.0	34.3	5.1	22.1	5.6	12.5	18.7	9.3	25.9	29.7	17.3	17.6	11.9	16.8	2.8	19.5	16.4	18.9	13.0	7.0	21.7	8.0	19.9	18.5	3.9	12.2	12.2	15.3	45.2	12.9	9.3	15.1	11.4	12.1	14.8	22.4	19.7	1.5	18.1	36.1	2.0	32.3	16.1	30.5	12.2	18.4	6.6	6.4	17.6	15.9	7.3	35.5	21.7	16.3	14.4	5.4	4.8	0.0	11.8	29.5	44.3	2.4	6.0	11.1	7.2	0.0	5.2	2.2	30.7	4.2	25.5	0.0	31.3	13.9	5.9	28.4	28.2	26.4	17.5	4.9	5.2	0.1	27.5	3.6	1.1	0.8	5.0	0.1	8.4	7.4	4.6	0.1	10.4	1.3	1.6	11.1	8.3	16.6	6.7	9.2	10.4	4.3	49.3	25.1	17.0	22.3	18.4	0.3	0.6	0.0	24.8	6.9	17.1	3.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	28.0	30.6	17.9	40.2	29.7	17.3	19.5	16.4	19.9	11.4	19.7	30.5	7.7	6.4	4.8	33.6	0.0	2.7	3.6	1.6	4.6	15.2	2.2	3.2	6.1	8.6	2.4	7.3	14.6	0.8	0.2	0.1	1.9	7.8	8.7	1.4	4.4	10.4	0.0	1.3	61.5	6.7	6.1	7.8	1.1	3.2	5.7	3.0	5.3	2.1	2.4	13.5	63.5	0.2	0.0	2.2	3.2	3.5	8.7	2.6	5.4	43.1	0.4	6.9	0.0	52.3	38.7	8.4	0.0	7.5	0.3	4.3	0.4	3.1	3.0	7.5	0.0	5.0	10.0	9.5	2.6	0.8	1.7	0.7	0.4	1.3	0.7	1.4
RUSF1	"C16orf58, FLJ13868"	ENSG00000140688	"RUS family member 1"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	27.1	31.8	19.6	20.0	18.9	21.5	28.8	12.0	21.3	45.4	14.2	29.6	31.3	43.2	20.7	26.5	38.2	23.0	28.5	19.9	19.7	29.5	57.9	25.0	19.8	17.0	16.0	49.6	56.8	46.2	48.4	25.7	18.5	39.1	19.1	22.4	64.8	34.2	9.4	26.9	30.3	25.6	13.8	22.3	39.5	21.4	17.0	18.0	42.0	9.8	15.6	31.8	31.4	17.0	28.6	37.2	22.7	39.7	51.7	34.3	42.3	33.4	56.6	25.5	30.2	11.3	49.1	24.5	69.4	49.8	32.9	39.0	22.9	31.0	11.8	35.8	23.0	24.8	20.6	28.8	74.8	29.4	28.6	41.7	33.1	33.7	68.5	50.2	24.9	38.4	37.3	40.9	25.3	53.9	13.7	19.8	17.8	41.8	24.1	31.1	34.2	74.8	29.3	17.6	24.8	38.2	25.2	65.3	52.8	21.5	56.6	42.9	22.0	44.3	24.7	28.7	22.1	59.0	37.0	18.8	56.7	44.7	62.5	3.1	5.7	7.6	7.8	8.4	7.2	6.7	8.2	7.8	9.7	6.3	7.9	7.0	0.9	9.4	8.1	8.9	9.4	7.2	19.6	18.9	12.0	21.3	19.9	19.7	17.0	16.0	18.5	13.8	17.0	17.0	5.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	22.3	0.4	0.0	0.0	0.0
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RWDD1	PTD013	ENSG00000111832	"RWD domain containing 1"	Q9H446	6	116571409-116597675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028712, HPA028713"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028712: AB_10602793, HPA028713: AB_10601485"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.58e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.63e-1)"	58.9	47.4	39.7	31.0	45.0	59.9	51.5	47.0	51.5	51.0	36.7	70.1	36.2	47.3	37.3	41.0	47.3	34.8	67.2	38.3	46.2	50.8	45.2	41.3	40.8	44.4	42.7	54.0	72.0	47.1	32.3	31.4	44.2	45.5	33.7	60.5	59.1	37.1	128.5	34.8	35.5	36.0	46.7	33.0	49.9	23.9	43.9	35.0	36.1	96.6	38.8	55.3	45.3	49.9	48.4	30.1	65.5	142.2	102.8	127.3	41.4	111.7	69.8	66.3	74.5	53.8	27.9	70.5	68.2	74.7	78.6	37.7	52.6	70.1	90.7	84.6	81.5	62.4	45.8	77.7	81.4	102.7	51.2	79.3	81.3	44.8	77.0	95.4	78.1	69.9	99.8	96.9	101.2	44.1	97.9	136.0	32.9	82.2	58.4	82.0	43.0	63.3	84.9	38.2	57.1	56.5	35.1	70.1	133.7	64.5	46.6	93.3	57.9	78.1	42.1	74.6	120.9	70.3	86.6	133.3	69.9	79.4	84.7	63.9	42.2	44.7	64.7	55.0	83.2	69.7	85.3	74.6	51.0	57.7	78.0	78.3	16.7	89.0	73.4	75.5	118.0	51.9	39.7	45.0	47.0	51.5	38.3	46.2	44.4	42.7	44.2	46.7	43.9	49.9	139.4	70.5	75.9	14.4	118.0	206.5	166.2	212.3	135.5	133.5	153.3	211.5	205.0	134.4	120.1	130.6	116.7	106.5	130.5	105.1	440.3	130.2	191.5	68.0	120.8	148.5	90.3	108.2	15.5	184.4	147.0	151.9	67.2	76.3	107.2	100.8	172.1	209.3	162.1	106.0	17.6	131.2	150.5	194.0	173.3	149.3	220.3	121.0	209.9	2.8	146.9	169.7	196.7	7.5	19.4	145.4	114.1	222.3	145.1	226.5	183.5	479.7	75.9	179.2	170.9	176.9	188.4	164.4	119.5	164.1	213.5	97.4	144.8	166.2	138.5	159.3
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193357-83198935	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.3;Spermatocytes: 65.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	2.9	6.9	7.1	2.1	7.0	0.5	3.2	6.1	8.1	3.4	6.3	2.9	2.5	3.3	9.4	1.7	3.8	4.6	4.4	6.9	7.9	4.5	5.9	2.8	2.5	5.6	6.0	4.0	9.6	4.0	5.6	2.5	5.9	11.5	2.5	4.7	6.0	4.7	2.3	1.9	2.7	3.2	5.7	2.9	3.9	8.9	8.4	1.8	6.2	4.0	2.6	2.6	1.8	6.1	2.1	1.9	4.4	8.3	5.2	3.7	3.0	4.8	10.1	3.5	4.2	2.8	1.1	1.6	3.8	5.8	8.0	2.1	3.7	2.8	5.4	2.0	3.8	1.9	3.0	6.2	8.0	0.5	1.5	4.9	4.6	4.4	9.2	11.5	6.6	4.5	3.1	2.8	4.3	3.1	0.7	1.5	1.5	1.9	1.9	2.4	9.1	1.0	7.4	2.4	1.5	5.3	2.9	4.5	4.4	6.3	2.8	2.9	7.1	2.4	1.5	3.5	2.1	6.2	2.7	0.9	2.8	0.8	2.9	0.3	0.9	0.0	1.2	0.8	1.8	1.9	1.7	1.7	1.0	1.0	2.2	2.1	0.3	0.4	2.2	3.5	2.2	1.0	7.1	7.0	6.1	8.1	6.9	7.9	5.6	6.0	5.9	5.7	8.4	6.1	2.4	0.0	6.7	9.8	4.2	3.7	3.6	5.3	3.4	5.6	3.7	3.2	5.4	2.8	3.3	1.8	0.0	7.7	3.9	2.4	5.9	8.9	52.3	4.8	4.5	3.5	5.4	0.4	10.8	9.1	3.3	6.5	3.6	4.0	0.0	7.0	5.0	6.8	5.0	1.7	11.2	6.1	8.2	1.6	2.5	14.8	9.0	2.2	8.8	3.7	3.8	11.0	0.0	13.6	4.5	5.8	2.5	6.0	11.2	8.7	4.1	13.3	4.9	5.0	6.6	7.0	5.2	65.2	10.5	1.2	2.4	5.7	2.9	6.3	3.4	2.8
RWDD2B	"C21orf6, GL011"	ENSG00000156253	"RWD domain containing 2B"	P57060	21	29004384-29019360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA018316	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA018316: AB_1845702"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	0.6	0.9	0.6	0.5	0.5	0.3	0.7	0.9	1.0	0.7	0.2	0.6	0.3	0.6	1.0	0.7	0.6	0.7	1.4	0.7	0.4	0.9	1.2	0.5	1.0	0.8	0.4	0.5	0.8	1.0	0.7	0.6	0.7	0.7	0.7	1.1	0.9	0.7	3.5	1.2	0.4	0.8	0.2	0.6	0.6	0.9	0.6	0.6	1.0	2.9	0.8	0.6	0.4	1.1	1.2	0.6	1.0	1.6	4.6	1.9	0.2	1.2	1.9	1.6	1.9	1.4	1.0	2.1	1.3	2.1	1.0	0.7	1.4	1.4	1.4	1.3	1.0	3.0	0.7	1.0	2.4	0.3	0.1	2.1	1.3	1.8	2.5	1.7	2.0	0.9	1.2	2.0	2.2	2.4	0.6	1.2	1.4	3.4	1.1	0.4	1.2	2.8	1.7	1.4	1.8	2.6	3.0	1.6	3.2	0.7	2.8	1.7	1.5	2.1	1.2	1.5	0.5	2.7	2.7	1.2	1.7	1.9	1.9	3.0	0.4	0.3	0.6	0.3	0.4	0.8	0.3	0.5	0.3	0.6	0.2	0.4	1.1	0.4	0.7	0.5	0.1	0.3	0.6	0.5	0.9	1.0	0.7	0.4	0.8	0.4	0.7	0.2	0.6	1.1	9.0	16.0	14.3	2.6	5.3	3.3	3.2	12.0	7.4	2.4	11.0	11.6	29.9	21.5	7.7	12.9	0.0	12.6	8.7	3.2	29.4	9.0	14.7	6.4	12.9	8.3	12.0	6.5	5.2	9.2	11.2	10.7	7.1	6.1	1.3	5.0	5.7	23.1	8.2	0.0	4.7	7.0	10.2	6.0	3.9	12.5	11.1	4.6	8.8	1.9	12.9	6.9	16.5	5.5	2.9	8.0	8.3	13.5	5.3	4.9	6.7	27.4	4.5	1.3	6.6	10.3	9.6	41.5	17.7	13.2	4.7	6.4	6.2	22.9	6.1	3.3
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.9	52.1	9.2	8.9	9.6	14.7	19.1	10.9	12.5	12.3	14.5	12.0	11.0	12.1	14.3	14.5	13.7	12.7	16.2	9.2	11.7	23.7	15.9	9.6	10.7	9.8	10.2	40.4	26.2	11.8	19.0	11.6	9.5	15.2	12.1	6.2	20.6	11.0	44.9	11.2	10.0	10.7	9.5	9.8	13.7	10.0	10.9	15.9	22.2	32.2	12.5	14.0	10.4	10.1	25.6	14.6	22.0	27.2	35.1	36.5	16.7	31.8	25.4	38.9	24.7	9.5	32.8	38.6	7.1	26.6	18.8	11.8	31.1	29.7	40.8	25.5	14.0	27.7	16.4	24.4	24.7	42.5	20.3	24.2	30.0	21.6	24.0	30.2	29.8	29.7	27.0	48.5	42.0	10.8	44.7	36.7	14.7	9.8	19.2	30.7	17.0	24.8	38.5	12.1	21.0	29.6	29.9	34.4	29.0	16.9	17.3	25.8	20.9	16.3	8.0	17.6	24.9	16.2	13.1	13.1	30.6	31.8	23.7	3.2	3.4	6.8	4.4	4.5	4.4	3.8	4.0	4.2	4.4	2.5	3.7	3.9	2.9	6.5	5.5	4.7	5.7	3.5	9.2	9.6	10.9	12.5	9.2	11.7	9.8	10.2	9.5	9.5	10.9	10.1	29.4	22.4	19.5	7.2	25.6	33.6	35.4	32.0	27.3	17.9	39.2	40.8	11.5	37.1	25.3	18.4	6.2	25.9	32.9	19.7	74.3	38.8	10.6	38.4	28.6	27.3	21.7	30.3	10.3	77.5	42.4	33.4	28.1	28.2	35.5	35.9	26.4	35.6	36.1	10.1	9.5	21.6	38.7	30.1	21.9	9.9	74.0	23.8	56.9	6.5	34.7	30.9	32.0	6.6	7.7	55.8	17.1	70.7	32.5	90.3	19.6	116.1	32.0	22.1	19.7	44.5	27.4	47.7	59.7	46.0	35.5	27.1	26.7	70.2	25.4	59.1
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 7.6;endometrium 1: 6.2"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	4	"amygdala: 4.6;basal ganglia: 5.3;cerebral cortex: 7.6;hippocampal formation: 4.6;white matter: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 11.8;hippocampal formation: 7.8"	HPA027067	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.1	5.3	4.6	0.2	5.3	0.0	0.1	0.0	7.6	2.7	0.0	0.2	0.1	6.2	1.0	0.1	0.8	0.7	0.0	4.6	1.2	2.1	1.4	3.8	0.4	0.0	0.0	0.3	0.1	0.2	0.1	2.7	0.0	0.4	0.1	0.0	0.1	2.8	0.0	0.0	0.2	0.8	0.0	0.3	0.4	0.2	0.0	0.0	1.3	0.0	0.3	0.1	0.8	3.5	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.3	0.0	7.6	4.6	1.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.4	23.5	4.2	0.0	1.7	167.9	0.0	0.0	0.2	0.0	174.6	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	7.5	0.0	0.0	0.0	10.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.6	0.8	0.0	0.1	0.1	0.6	0.0	0.0	0.0
RXFP3	"GPCR135, RLN3R1, RXFPR3, SALPR"	ENSG00000182631	"Relaxin family peptide receptor 3"	Q9NSD7	5	33936386-33938918	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027833	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA027833: AB_1849247"	"unprognostic (1.93e-2)"					"unprognostic (3.66e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.86e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-1)"		"unprognostic (8.67e-3)"				0.0	0.9	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	0.8	1.1	2.1	1.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 218.9;Kupffer cells: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	40.5	22.7	33.5	14.5	36.4	18.9	11.2	25.5	29.4	12.2	16.9	16.6	25.8	13.5	8.7	28.5	16.5	13.6	19.4	27.1	30.2	16.0	32.9	18.8	8.2	32.9	31.3	21.7	25.4	45.1	3.5	14.5	30.8	15.6	10.0	5.4	21.7	17.1	106.5	88.1	28.0	11.1	30.4	25.1	14.7	7.9	42.7	6.0	17.6	51.9	7.6	16.2	8.2	22.6	19.6	36.4	14.7	21.9	42.8	19.1	66.7	14.1	16.1	9.6	6.5	20.7	28.0	0.0	25.8	22.5	15.1	105.5	7.7	32.8	2.9	26.3	7.2	0.1	47.5	30.0	20.4	18.8	4.8	29.0	52.1	11.5	10.6	12.9	12.8	1.6	26.0	1.1	8.7	61.8	1.1	59.5	17.5	63.4	16.9	7.4	30.3	36.7	12.2	64.3	17.2	10.5	37.3	46.9	10.6	7.1	44.9	78.8	16.5	16.2	23.4	17.4	9.7	1.7	0.2	0.4	11.6	33.9	12.7	1.3	8.1	6.6	1.4	12.9	0.2	0.3	0.9	1.0	3.2	0.1	0.2	1.2	19.5	2.2	11.2	0.7	1.2	3.2	33.5	36.4	25.5	29.4	27.1	30.2	32.9	31.3	30.8	30.4	42.7	22.6	32.1	32.1	22.9	36.2	4.6	34.5	16.5	21.1	12.5	6.0	16.7	14.4	38.8	72.9	26.2	9.2	25.0	30.1	11.0	72.3	1.9	13.9	4.3	19.8	16.6	28.9	9.6	30.9	9.1	14.1	29.5	23.7	17.9	17.4	1.3	21.3	71.0	218.9	31.9	33.7	17.6	21.2	10.2	134.2	30.0	18.8	32.3	50.4	12.4	10.3	80.4	36.5	14.4	29.1	6.0	15.9	32.4	21.1	7.4	17.7	55.6	19.9	34.4	19.9	19.7	34.6	30.6	0.9	9.4	34.4	46.9	23.9	12.6	15.5	27.5	32.8
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200665	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB002003: , HPA063653: AB_2685076"	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	26.8	29.1	1.5	2.0	1.5	2.3	27.1	1.6	5.7	33.9	1.4	34.4	3.9	31.9	7.4	27.0	31.4	3.3	31.4	1.5	2.6	29.5	34.4	27.2	1.4	1.5	1.7	32.9	32.3	0.0	33.0	2.5	1.5	32.8	1.6	3.2	27.0	3.3	42.5	26.3	28.6	9.6	1.6	38.3	28.3	20.0	1.6	2.8	37.7	12.3	9.1	30.6	29.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	10.0	0.0	10.4	7.1	0.0	11.0	4.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	8.9	0.0	0.0	0.5	3.2	0.0	0.0	0.1	14.4	0.0	8.0	12.1	0.0	7.4	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	4.8	0.0	0.0	11.1	11.8	9.2	0.0	0.0	0.0	2.3	0.4	1.7	1.1	0.3	0.8	1.0	1.3	1.3	0.6	0.3	1.1	0.8	0.7	0.8	0.6	0.6	1.1	0.3	1.5	1.5	1.6	5.7	1.5	2.6	1.5	1.7	1.5	1.6	1.6	1.7	21.2	41.7	13.3	14.4	19.2	17.3	14.9	8.9	18.2	25.2	22.4	18.9	16.1	15.7	14.7	5.5	20.9	23.6	26.3	21.8	25.4	19.9	2.7	10.6	14.7	18.2	22.0	8.6	14.9	16.2	17.9	18.3	23.0	11.9	10.2	22.5	14.3	15.9	15.8	18.5	12.9	21.8	16.2	14.7	9.2	8.6	16.1	12.2	16.0	10.3	18.8	16.6	33.0	14.1	15.2	13.6	20.2	16.1	12.0	16.3	23.2	14.1	10.8	20.4	26.3	19.3	20.0	17.7	12.5	16.8	18.8	28.7	19.4	18.7	24.5	12.7
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
RYBP	"AAP1, DEDAF, YEAF1"	ENSG00000163602	"RING1 and YY1 binding protein"	Q8N488	3	72371825-72446623	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 524.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053357	Approved		Supported	Nucleoplasm		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053357: AB_2682124"	"unprognostic (6.80e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.50e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.22e-1)"	8.6	5.4	2.0	0.8	2.0	2.7	7.8	1.4	2.3	9.4	0.9	9.5	0.8	10.0	0.6	7.1	8.5	1.2	5.7	1.8	2.2	7.6	8.6	11.5	0.8	1.5	1.6	10.9	4.7	0.8	5.9	2.2	1.4	8.7	1.0	2.1	6.7	1.2	4.4	8.3	7.4	1.4	1.4	8.6	7.0	8.1	2.0	1.5	5.8	0.8	1.0	8.8	7.9	2.0	0.9	0.9	1.7	1.6	1.5	1.5	1.1	0.9	2.0	1.7	2.1	1.6	1.2	1.0	0.9	1.5	2.0	0.4	1.9	1.4	2.1	6.0	1.0	4.7	1.2	0.7	1.1	0.9	1.1	2.3	1.7	2.2	3.5	2.2	0.5	1.1	1.4	3.1	1.4	1.4	1.3	0.9	3.1	2.7	1.1	1.4	1.5	0.6	1.3	1.0	1.3	5.2	2.4	2.3	1.2	2.7	0.7	1.1	1.3	2.2	1.6	1.3	0.8	2.5	2.7	0.9	1.1	1.6	2.4	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.8	0.1	0.2	0.2	0.1	0.1	2.0	2.0	1.4	2.3	1.8	2.2	1.5	1.6	1.4	1.4	2.0	2.0	67.4	57.7	27.6	29.4	39.1	107.2	67.8	19.2	46.1	74.7	75.5	51.4	39.2	32.9	28.9	42.3	16.7	26.9	63.1	58.7	33.2	21.1	27.3	67.5	103.7	70.9	81.2	42.7	49.5	24.0	51.7	61.5	13.7	87.5	69.0	27.1	55.0	40.5	16.5	38.7	64.2	50.5	26.4	37.6	77.3	13.4	25.7	71.3	35.6	60.9	31.9	22.4	27.8	42.7	524.1	32.8	49.0	43.6	49.0	65.0	16.8	24.7	32.3	40.8	32.9	74.9	42.1	57.9	37.0	51.7	97.0	186.9	44.3	98.5	34.9	65.1
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor like tyrosine kinase"	P34925	3	134065303-134250859	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	31.8	25.2	15.7	15.7	16.2	17.1	42.8	15.4	19.8	40.2	19.9	34.5	20.1	46.1	40.0	29.6	33.4	24.3	30.3	14.5	15.3	25.4	22.3	25.3	18.9	15.9	15.6	82.1	24.5	29.7	17.0	36.6	15.5	36.3	26.2	15.9	26.9	43.9	25.3	34.7	21.4	40.6	16.3	22.9	23.2	47.0	16.5	21.2	40.9	32.2	20.5	34.7	32.6	16.4	78.8	20.6	63.3	48.7	79.8	84.4	48.8	51.0	117.7	66.4	74.2	65.6	58.8	15.3	82.4	63.1	63.7	71.6	45.5	64.3	94.5	25.9	20.5	40.6	22.4	42.4	62.2	20.0	34.4	56.1	74.0	41.2	82.2	72.5	56.5	26.4	14.5	7.5	66.0	37.6	28.0	25.9	53.4	65.2	24.3	13.7	48.4	32.4	54.5	57.3	31.0	45.6	61.7	44.5	79.1	40.5	55.7	35.8	42.1	54.8	49.6	57.8	41.8	3.1	4.2	8.3	34.8	33.1	39.6	4.6	0.8	1.6	1.1	0.8	1.3	0.6	2.0	1.3	0.3	1.2	1.9	1.5	0.3	1.6	0.8	0.0	0.5	0.5	15.7	16.2	15.4	19.8	14.5	15.3	15.9	15.6	15.5	16.3	16.5	16.4	62.5	12.8	27.9	31.6	20.6	41.3	36.6	26.3	39.3	23.1	45.4	37.2	34.9	18.6	23.7	44.1	29.2	19.4	23.1	15.9	0.0	15.9	16.2	27.6	41.7	31.0	13.9	13.2	69.5	21.1	14.7	41.3	15.8	32.7	17.7	121.2	40.7	24.1	11.3	13.5	59.7	20.9	12.2	18.6	21.6	7.4	33.2	16.1	14.2	65.6	12.8	26.8	13.4	65.9	57.9	21.7	19.7	32.7	12.9	42.8	15.4	10.5	13.9	39.8	46.0	33.8	38.1	24.6	40.9	33.7	38.1	10.8	18.4	50.8	22.2	38.9
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38587564	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1618.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4"	"Low region specificity"	"Detected in single"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		46000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	1.4	2.4	10.3	1.6	8.0	0.3	2.1	8.5	9.3	2.1	1.0	1.2	0.5	0.7	1.3	17.2	1.7	1.1	0.9	7.5	20.5	1.9	0.4	2.6	2.1	8.6	9.7	0.9	0.4	1.9	1.5	1.8	7.7	3.8	0.3	10.6	14.0	1.4	1618.9	13.3	1.3	0.8	2.6	1.7	1.0	8.9	22.6	1.5	1.2	286.6	2.6	1.0	3.3	6.1	0.0	7.7	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.4	0.5	6.3	0.0	0.0	18.9	0.2	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	1.7	7.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.0	15.3	1.5	0.8	0.0	0.0	1.5	30.7	0.0	0.0	0.6	0.7	5.9	0.0	0.0	12.4	0.3	0.0	0.4	1.4	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.2	0.2	0.1	0.3	2.9	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.3	10.3	8.0	8.5	9.3	7.5	20.5	8.6	9.7	7.7	2.6	22.6	6.1	0.3	0.0	1.1	29.4	1.4	11.3	3.8	6.6	22.8	8.9	0.5	7.9	3.6	0.0	1.1	0.0	2.1	0.2	1.2	0.0	5.9	0.1	6.7	0.2	0.9	1.0	0.0	0.4	10.2	0.0	0.4	0.9	0.0	0.5	0.0	0.3	0.7	0.0	8.8	1.7	17.2	0.0	2.0	2.9	15.2	5.9	3.1	6.2	0.0	49.6	1.3	50.6	0.0	13.6	2.0	0.0	0.0	1.9	0.9	0.8	0.0	0.2	0.4	1.8	0.0	41.7	1.2	6.3	7.4	7.5	4.7	0.3	2.6	0.4	0.0	0.7
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 132.0"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	0.7	0.7	9.1	0.8	15.9	0.0	0.6	8.7	24.0	1.5	0.0	2.0	0.2	0.7	0.4	2.9	0.7	1.9	132.0	10.5	0.0	0.1	0.1	1.8	0.1	0.0	0.0	2.9	8.4	0.0	1.8	1.2	0.0	2.9	0.5	6.5	0.5	1.7	0.1	0.3	0.5	0.7	0.0	1.3	1.5	1.1	0.0	0.1	4.4	0.3	0.0	1.2	0.4	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.9	0.3	0.0	0.0	7.7	8.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.0	0.0	0.0	2.7	3.1	0.6	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.1	15.9	8.7	24.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.2	0.0	0.5	17.0	0.0	0.4	0.0	0.0	0.0	74.2	0.3	0.1	2180.6	0.0	1.3	1.8	10.4	0.1	0.1	0.0	0.0	0.0	21.1	0.2	3.4	10.6	3.5	0.0	1320.5	2.9	0.1	53.6	0.0	0.5	0.0	0.5	1.1	0.0	0.1	1.7	790.6	0.0	0.0	0.0	0.2	15.3	1.2	1.3	8.8	48.7	0.0	1.3	0.0	29.7	140.6	0.4	0.0	0.0	0.1	0.0	1.0	0.2	0.7	5.3	0.0	0.5	21.6	5.8	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373711-153375621	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3489.7"	"Group enriched"	"Detected in many"	20	"Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 1321.1;neutrophil: 1781.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 1781.4;monocytes: 1321.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.6;THP-1: 1.6"					"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	NA	NA	28500000	8300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	54.9	3.2	2.6	82.0	3.1	3489.7	7.0	2.9	7.7	21.9	3.2	5.5	1.7	2.1	0.0	52.4	19.3	6.7	16.6	2.7	2.6	15.2	25.6	148.4	1.9	3.2	2.9	2.1	3.6	1.3	4.3	19.8	3.9	3.5	0.4	0.3	11.4	0.2	4.0	3.7	4.4	40.4	3.0	523.2	8.9	0.9	2.9	30.2	6.0	14.8	46.5	41.9	33.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	1321.1	5.2	1.9	44.9	1.0	3.2	0.8	1.5	122.7	1.0	1.1	0.5	1781.4	0.4	9.6	8.3	2.0	1031.8	2.6	3.1	2.9	7.7	2.7	2.6	3.2	2.9	3.9	3.0	2.9	2.9	0.0	19.2	24.4	0.0	6.1	0.1	0.3	9.8	0.0	0.0	0.1	0.0	1.1	8.6	9.2	1.8	0.0	0.5	2.9	0.0	0.0	0.1	1.4	0.0	0.0	2.1	0.0	14.1	0.1	0.2	0.9	4.1	1.1	0.0	13.9	0.0	6.8	3.8	8.6	0.0	0.1	0.0	0.0	711.7	0.8	1.8	0.0	475.0	0.0	1.0	998.3	0.0	36.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	7.8	0.0	0.0	0.8	0.4	0.0	0.2	5.7	0.0	0.5	6.9	0.0	0.1	0.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3574.5;kidney: 1380.0;urinary bladder: 1097.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	4.0	2.1	2.5	4.1	2.7	1.0	17.3	2.4	3.6	279.9	2.0	3.1	0.8	2.5	16.1	3574.5	5.6	1.8	3.9	2.3	3.2	1380.0	1.7	12.0	0.5	4.1	3.0	1.9	2.1	0.1	5.4	0.8	3.0	48.1	1.6	0.4	377.1	16.9	3.3	429.6	1.6	1.9	3.0	1.5	3.6	2.8	3.4	6.3	11.9	1.4	416.1	1097.4	747.3	3.5	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.5	2.7	2.4	3.6	2.3	3.2	4.1	3.0	3.0	3.0	3.4	3.5	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 94.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.4;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 15.8"	"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		240000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	7.6	1.1	0.9	3.6	1.1	1.8	4.2	0.8	1.3	6.9	0.6	2.8	0.5	3.9	0.2	17.2	3.3	1.7	2.6	0.8	1.4	13.8	0.2	16.6	1.8	1.4	1.6	1.1	0.8	0.1	0.7	2.2	1.2	3.0	1.1	0.0	4.2	1.7	1.0	94.6	1.9	2.1	1.1	0.8	1.4	0.5	2.8	0.4	1.5	1.9	5.1	6.9	9.6	1.4	7.3	87.0	0.1	0.1	8.1	5.2	0.0	6.1	31.4	7.9	12.8	2.6	2.8	0.1	19.0	16.1	10.7	22.2	0.1	45.7	3.7	0.3	0.0	0.3	51.4	15.3	2.2	0.0	0.3	4.1	24.9	17.9	19.9	4.5	1.7	0.0	0.0	0.0	39.8	0.5	0.0	0.0	0.6	0.2	11.5	0.0	5.9	4.7	26.0	18.3	1.2	0.0	5.4	6.1	2.0	24.7	0.2	0.6	8.6	2.9	4.8	47.4	6.3	1.4	1.6	0.2	38.2	0.7	19.1	0.0	0.1	0.0	0.0	3.1	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	7.4	0.1	0.4	0.9	1.1	0.8	1.3	0.8	1.4	1.4	1.6	1.2	1.1	2.8	1.4	2.0	3.2	0.5	0.7	0.0	10.3	2.3	15.4	4.0	0.0	0.3	0.4	0.3	1.5	5.9	0.0	0.0	0.3	0.0	0.0	1.9	21.7	0.0	2.3	18.4	7.4	0.0	1.3	0.0	24.0	4.4	8.4	0.0	1.3	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.1	0.1	4.1	0.4	1.8	0.0	3.6	0.0	0.0	0.0	0.0	24.2	0.0	0.4	0.0	1.5	0.0	0.3	1.1	0.0	0.0	24.7	9.6	0.1	0.0	5.6	6.5	1.5	0.5	1.1	0.0	2.0
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 37545.1;Urothelial cells: 17431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 17071.6;RPTEC TERT1: 20988.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	1873.9	666.6	435.5	1129.7	452.5	2003.6	1499.2	456.2	549.9	2306.1	425.9	2872.2	1504.1	1058.4	404.8	1300.4	879.9	1485.5	1046.0	425.8	593.7	2326.6	91.9	2216.9	365.1	520.2	488.9	556.8	204.2	68.4	311.2	709.2	489.1	827.7	2252.2	36.6	1123.5	1169.3	478.1	858.6	1367.0	965.1	488.8	519.1	1586.3	170.1	573.3	191.6	970.0	1010.8	504.8	3867.5	1276.0	530.4	3666.6	4412.8	4.3	330.6	7597.2	10482.0	9.3	4560.1	13403.9	2582.7	3352.7	273.3	8022.5	4.5	1319.7	7774.8	2078.7	1589.3	80.7	7340.5	1322.0	1340.0	1.6	731.2	2579.1	255.8	2730.2	28.1	458.7	4550.0	6406.8	2638.7	4734.2	3259.1	6078.3	0.7	3.2	12.3	7052.7	589.4	11.4	292.3	9.6	17071.6	7563.4	5.5	463.0	1250.1	20988.4	3918.8	1019.8	142.6	6251.9	6380.9	4628.4	3.7	835.3	1095.9	7473.3	2228.2	489.8	4463.8	7452.6	8.8	11.9	15.5	8619.0	728.4	4773.0	5517.3	6053.2	2413.8	1806.1	3258.0	1983.1	937.8	1664.9	1773.1	4240.8	583.7	1037.2	1378.3	9637.7	297.4	3066.5	2145.0	2217.6	8320.4	435.5	452.5	456.2	549.9	425.8	593.7	520.2	488.9	489.1	488.8	573.3	530.4	1177.8	4708.3	2663.1	17.6	343.0	1488.3	6868.7	7856.4	2416.5	4.9	1494.4	1445.2	326.6	1474.1	7013.9	8165.9	0.0	1368.2	999.9	8832.0	7446.5	6206.3	21.3	1148.6	3473.2	1801.5	2035.6	637.5	14.7	9903.1	2440.0	4102.1	2276.3	814.3	1817.4	126.3	946.3	21.6	2430.3	58.9	7.1	6823.9	5706.7	2853.5	7378.0	115.0	3013.4	3110.9	3070.0	30.0	6073.8	168.0	926.9	7.5	23.0	37545.1	9094.3	1143.8	346.6	9900.7	8570.5	224.3	4962.3	8.7	131.5	3234.0	2978.8	28.7	13.2	1718.7	997.6	1573.4	1283.0	5881.5	3218.9	17431.0
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 1065.7;lymphoid tissue: 1239.6;skin 1: 346.5;vagina: 1020.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 59.3;Club cells: 70.4;Ionocytes: 18.3;Suprabasal keratinocytes: 89.6;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1201.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 7.2;SK-BR-3: 16.9"									"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	NA	NA		14000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	1.0	0.2	0.9	0.0	0.8	0.8	15.6	1.4	2.1	174.8	0.7	0.3	0.0	1.2	27.6	1065.7	0.3	0.2	0.5	0.8	0.8	0.1	0.5	0.4	0.2	0.9	0.8	0.5	0.4	0.0	0.2	0.2	0.8	0.5	0.0	0.0	55.5	0.2	0.4	346.5	0.2	1.4	0.8	0.3	0.4	0.3	0.7	12.4	0.2	0.0	1239.6	1.2	1020.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.2	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.7	16.9	0.0	0.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.4	2.1	0.8	0.8	0.9	0.8	0.8	0.8	0.7	1.1	0.0	0.0	0.0	0.0	0.0	11.7	0.2	59.3	0.0	0.0	1.1	0.0	0.0	0.0	70.4	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.3	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.3	0.0	0.0	0.0	4.7	0.2	0.2	3.8	89.6	26.4	0.1	8.4	0.6	0.4
S100A7A	"S100A15, S100A7f, S100A7L1"	ENSG00000184330	"S100 calcium binding protein A7A"	Q86SG5	1	153416520-153423222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 5.6;lymphoid tissue: 5.9;skin 1: 1.6;vagina: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 2.8;Late spermatids: 3.0;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 25.6;melanoma: 12.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006997	Supported		Uncertain	Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA006997: AB_1079860"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-1)"				"unprognostic (3.73e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"				"unprognostic (1.17e-1)"			"unprognostic (4.40e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0
S100A7L2	s100a7b	ENSG00000197364	"S100 calcium binding protein A7 like 2"	Q5SY68	1	153437058-153439949	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057828	Uncertain					NA	NA									"HPA057828: AB_2683540"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"intestine: 238.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"breast cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"CAB017688, HPA028920, HPA055873"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.0	0.1	0.1	0.3	0.1	1.1	0.7	0.1	0.0	0.1	0.3	238.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.1	0.6	0.5	0.1	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.8;Spermatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA027242: AB_2672174, HPA027328: AB_2672221"	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	9.5	10.9	12.1	10.0	19.4	14.2	9.6	13.3	14.1	14.3	13.9	10.8	6.1	12.2	10.1	7.2	12.5	10.0	7.0	10.7	16.1	7.9	8.8	9.2	15.7	14.2	14.1	16.9	6.9	6.5	11.1	10.9	13.7	10.0	7.6	14.0	8.9	8.5	7.0	8.4	11.3	10.9	12.0	15.6	8.2	34.5	15.1	18.7	11.6	8.1	14.9	10.0	10.2	17.6	11.7	15.0	32.2	17.8	15.0	21.0	16.6	22.3	15.7	20.5	22.7	9.5	18.6	36.5	17.2	14.8	19.7	18.3	31.7	13.1	25.2	18.6	10.6	45.7	31.1	12.1	17.6	21.1	18.0	15.2	12.3	19.5	23.9	27.9	21.8	30.8	27.5	27.2	25.0	6.8	32.6	19.0	38.2	7.9	11.7	29.7	34.5	31.3	9.3	7.6	15.0	14.6	22.9	6.6	24.9	49.2	13.8	13.0	11.4	28.3	18.9	24.3	14.7	40.2	39.2	36.5	13.8	22.2	15.9	7.5	3.6	6.5	6.6	2.0	7.9	8.7	5.2	7.1	3.8	5.4	3.6	5.2	4.6	18.7	1.7	11.3	5.5	3.8	12.1	19.4	13.3	14.1	10.7	16.1	14.2	14.1	13.7	12.0	15.1	17.6	18.3	12.8	21.0	32.3	20.0	10.5	10.4	12.5	26.2	21.2	18.0	16.1	6.0	18.6	13.6	20.2	35.5	14.8	32.6	7.7	13.7	11.0	7.8	13.0	20.6	15.4	8.4	23.1	17.9	5.0	17.0	15.5	12.8	13.1	14.5	29.1	21.4	11.5	15.2	18.5	23.9	7.8	8.2	19.3	9.6	6.9	19.0	14.5	5.4	48.7	10.6	13.1	33.0	51.8	78.8	6.6	4.4	17.7	29.2	9.7	12.6	5.9	9.8	25.0	26.3	12.5	16.6	109.9	74.4	17.6	7.1	6.2	22.0	12.3	9.9	6.5
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6"	"Cell line enriched"	"Detected in some"	6	"U-698: 81.9"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"			HPA051929	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	0.3	0.2	1.1	2.0	0.6	2.4	0.2	0.4	1.1	0.0	0.1	0.3	0.4	0.1	0.1	0.3	0.1	0.7	0.1	0.5	0.5	0.1	0.3	0.7	0.9	0.6	0.6	0.0	0.9	0.1	0.1	1.2	0.6	0.2	0.4	0.0	0.2	0.1	0.2	0.0	0.8	0.6	0.5	3.2	0.4	0.2	1.0	0.8	0.1	0.0	2.5	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	2.7	0.1	0.2	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	1.0	0.1	81.9	3.3	0.0	0.0	2.5	35.0	31.8	0.8	34.0	0.2	4.7	0.5	0.1	19.5	2.1	0.0	0.0	11.8	0.7	39.6	0.1	0.7	10.5	1.1	0.6	0.4	1.1	0.5	0.5	0.6	0.6	0.6	0.5	1.0	1.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	2.1	2.1	0.0	0.2	0.2	0.5	0.2	0.0	0.5	0.4	0.0	7.4	0.0	2.0	0.0	0.0	8.7	1.1	0.0	0.0	11.8	3.6	32.8	26.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.0
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;brain: 60.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 93.9;NK-cells: 164.8;Oligodendrocytes: 26.6;T-cells: 33.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 299.4;MAIT T-cell: 184.9;memory CD8 T-cell: 144.9;naive CD8 T-cell: 109.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 299.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.5;HBEC3-KT: 10.9;RT4: 18.7;T-47d: 11.6;U-2 OS: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA029683: AB_10603237"	"unprognostic (9.07e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.55e-4)"	"unprognostic (4.21e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.46e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-1)"	0.8	0.4	21.1	0.8	35.7	19.7	0.6	32.4	44.7	5.4	8.6	0.3	0.2	0.3	4.4	12.8	0.2	0.2	0.6	19.7	23.2	0.8	1.6	3.0	1.0	39.0	34.0	0.2	1.4	0.1	0.4	1.7	35.8	2.5	0.1	0.0	2.4	0.5	0.6	18.7	0.3	0.2	26.0	11.1	0.3	0.7	30.1	0.9	0.5	0.2	2.1	2.2	10.9	60.2	1.9	2.8	0.6	0.0	0.0	0.1	0.2	0.6	0.5	0.9	0.5	0.3	0.1	0.0	7.6	0.3	1.2	28.5	1.8	10.9	2.0	0.0	1.8	0.2	2.3	0.0	0.1	0.0	0.1	0.0	5.0	3.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	3.7	1.1	0.0	4.5	0.6	0.5	0.0	2.1	0.0	0.0	18.7	0.0	0.0	4.7	0.0	0.5	1.9	11.6	3.3	0.0	1.5	10.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.5	0.5	1.2	299.4	0.2	184.9	0.6	36.3	144.9	0.6	0.5	10.8	109.3	3.9	44.5	1.1	0.8	0.6	64.2	21.1	35.7	32.4	44.7	19.7	23.2	39.0	34.0	35.8	26.0	30.1	60.2	1.0	3.2	1.9	0.0	0.6	3.6	2.2	10.9	7.4	0.0	0.1	0.9	0.9	1.5	0.9	0.0	0.0	0.1	93.9	0.0	0.0	0.0	6.2	0.1	0.2	0.6	0.0	0.8	0.1	0.2	0.3	1.7	0.5	0.0	2.5	0.0	1.8	0.3	0.2	0.0	0.1	0.0	0.0	0.8	0.3	2.3	0.0	0.6	0.0	2.8	1.2	0.0	164.8	0.0	26.6	0.2	0.0	0.0	14.7	0.2	0.0	0.1	0.4	0.0	0.0	0.1	1.9	0.0	0.2	4.8	5.1	0.1	33.1	0.0	0.0	0.4
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"liver: 127.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 20.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.6;EFO-21: 1.5;GAMG: 1.1;HaCaT: 1.0"									HPA060139	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA060139: AB_2684210"	"prognostic favorable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	23.7	1.5	0.0	1.5	0.0	0.0	5.1	0.0	0.3	15.2	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.2	127.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0	18.8	0.2	5.2	0.4	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.6	0.0	0.0	0.6	0.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231355-18236802	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"liver: 1943.5"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 28.8"	"Not detected"	"Not detected"							"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	7.4	0.5	0.3	0.4	0.3	0.0	6.7	0.3	0.6	15.6	0.3	0.2	0.0	0.0	0.2	0.5	0.5	1.0	0.1	0.3	0.3	0.4	1943.5	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.8	0.0	0.3	1.2	0.0	0.1	11.4	0.1	3.4	0.5	0.1	0.1	0.3	1.2	0.1	1.3	0.4	0.9	0.0	0.0	0.2	0.1	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.1	28.8	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	184.7	0.0	0.0	2.1	1.4	0.0	18.6	172.6	0.0	0.0	0.0	0.0	3.5	0.0	4.0	0.6	0.4	0.0	1.6	0.0	21.5	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	27.5	2132.8	0.1	0.0	0.0	0.0	71.2	38.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	706.8	0.0	0.0	0.0	23.6	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.5
SAAL1	FLJ41463	ENSG00000166788	"Serum amyloid A like 1"	Q96ER3	11	18069935-18106087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039003, HPA039004"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039003: AB_2676303, HPA039004: AB_10673602"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.87e-1)"	6.0	5.3	4.9	8.2	4.8	19.1	10.0	5.6	6.1	6.2	4.3	9.6	8.0	7.5	7.7	6.6	5.6	4.8	6.5	4.6	5.0	5.4	8.3	4.9	14.6	4.8	5.3	8.2	8.1	5.4	5.2	7.0	4.9	6.0	11.9	8.2	5.6	5.8	5.8	5.7	6.7	9.6	4.8	7.5	6.7	12.8	5.1	13.7	6.1	7.2	15.6	7.8	6.1	5.7	27.1	41.5	29.5	40.5	19.5	21.8	24.6	29.9	20.4	44.8	52.8	57.8	10.1	73.0	15.5	16.9	62.3	34.9	56.9	48.5	62.6	32.5	57.4	33.6	24.9	35.0	15.9	57.1	28.6	15.2	22.2	28.7	42.9	16.8	38.5	62.8	50.5	23.9	37.2	36.2	66.7	54.2	38.5	41.7	39.0	65.7	51.8	25.4	25.7	31.4	36.4	34.3	26.9	28.4	36.4	37.1	18.2	25.9	15.8	51.0	35.0	29.4	43.2	11.6	37.7	80.6	21.2	45.2	47.5	11.1	12.9	4.3	14.0	15.4	13.5	16.5	16.2	12.3	22.3	11.7	12.3	13.3	0.6	10.4	14.6	11.4	20.9	10.8	4.9	4.8	5.6	6.1	4.6	5.0	4.8	5.3	4.9	4.8	5.1	5.7	7.6	0.0	10.8	7.5	15.9	4.6	7.8	16.0	9.6	9.0	7.2	6.9	8.5	2.8	7.4	1.8	2.1	22.0	13.6	6.3	5.9	9.6	21.9	4.4	8.0	8.7	28.1	11.1	8.5	10.2	23.1	8.0	4.6	4.2	14.0	15.3	5.7	4.6	16.1	0.0	9.5	10.7	8.2	10.9	7.3	3.5	8.1	7.7	5.4	6.5	10.7	6.5	4.1	15.1	11.7	6.6	7.5	7.9	17.3	3.8	6.9	7.7	6.0	8.5	6.6	6.1	10.5	41.5	24.9	8.3	5.4	10.4	9.9	10.1	15.1	6.1
SAC3D1	"HSU79266, SHD1"	ENSG00000168061	"SAC3 domain containing 1"		11	65040901-65044828	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.1;Late spermatids: 121.5;Spermatocytes: 166.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042677	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA042677: AB_10797506"	"unprognostic (1.35e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.00e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (9.67e-6)"	"unprognostic (4.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (2.97e-3)"	"unprognostic (5.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.49e-1)"	3.8	3.4	9.9	2.7	9.5	4.1	2.0	9.6	10.6	3.1	7.5	3.6	3.1	3.1	0.6	3.6	2.8	0.7	2.6	9.8	9.1	2.1	3.7	2.1	2.8	11.7	9.9	2.5	2.8	1.3	2.7	1.4	10.7	2.8	1.2	0.6	2.7	2.0	9.3	3.7	2.6	2.0	9.4	3.1	2.9	13.5	10.4	7.1	1.4	2.1	2.1	2.6	2.5	10.2	48.3	27.4	13.3	15.1	6.8	5.0	18.9	28.2	6.3	15.9	13.8	13.4	11.3	20.8	22.2	7.7	17.6	32.1	14.4	15.6	2.7	33.0	44.9	15.5	24.5	42.3	5.1	14.5	11.6	3.9	13.4	12.2	5.4	4.4	5.5	20.3	25.7	16.3	6.1	32.6	39.7	75.9	12.1	13.5	61.2	38.0	19.4	31.7	6.8	10.6	29.9	19.6	21.9	22.2	19.4	3.8	20.8	15.3	6.7	13.6	36.9	37.8	20.0	35.6	30.8	22.7	8.0	15.2	4.5	0.0	1.4	0.2	0.6	1.1	0.5	0.9	0.9	0.7	0.7	1.1	1.0	0.6	0.1	0.2	1.5	1.6	0.9	0.4	9.9	9.5	9.6	10.6	9.8	9.1	11.7	9.9	10.7	9.4	10.4	10.2	7.6	3.2	0.5	3.6	7.1	8.7	5.4	2.5	15.9	6.9	19.0	22.7	5.8	11.5	1.5	9.2	0.0	21.9	11.2	26.3	7.9	3.1	94.1	6.4	13.6	6.4	7.2	16.2	4.0	1.6	42.9	10.7	8.2	7.1	5.7	28.0	5.3	17.9	30.4	5.0	4.2	18.5	0.0	15.1	5.5	121.5	17.7	10.4	10.6	1.0	10.5	13.6	13.4	2.5	5.5	2.4	15.2	13.9	11.3	11.2	14.5	14.7	1.3	9.3	0.0	8.1	10.6	166.7	42.2	20.1	7.7	6.7	11.1	22.2	27.6	3.9
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SACS	"ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6"	ENSG00000151835	"Sacsin molecular chaperone"	Q9NZJ4	13	23328826-23433740	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5;Excitatory neurons: 86.3;Inhibitory neurons: 108.2;Oligodendrocyte precursor cells: 76.4;Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017714	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017714: "	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.21e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.65e-4)"	4.8	4.4	4.7	4.0	10.0	5.6	4.3	7.2	16.1	4.8	0.0	8.0	0.9	6.2	2.7	3.7	5.8	2.2	8.7	7.6	3.0	3.2	2.2	4.8	4.3	8.4	5.2	4.7	4.8	15.2	6.8	1.3	9.4	7.6	1.5	4.6	6.6	2.3	14.0	2.4	5.0	4.9	2.0	8.5	5.1	6.8	10.3	4.2	2.6	13.1	3.6	9.9	4.4	11.4	8.1	10.5	21.3	6.5	6.5	24.3	3.1	18.1	23.2	6.9	5.7	5.0	4.2	5.5	7.4	38.8	9.0	1.6	30.7	10.8	22.5	12.9	12.6	20.7	8.1	7.4	4.8	38.1	7.9	7.8	2.5	44.3	21.2	9.7	23.1	17.0	12.1	2.6	31.6	3.8	13.6	14.6	17.5	2.8	8.2	16.0	38.7	16.7	12.0	0.9	15.4	14.8	10.0	3.6	7.8	9.7	1.9	10.0	49.8	21.1	17.4	11.5	34.6	5.0	5.7	13.3	10.1	13.2	18.7	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.4	0.7	0.2	0.3	0.0	0.3	0.0	0.3	0.7	0.1	4.7	10.0	7.2	16.1	7.6	3.0	8.4	5.2	9.4	2.0	10.3	11.4	10.3	0.0	1.3	70.5	14.5	6.1	5.4	2.0	6.8	16.5	8.2	8.0	21.3	1.5	1.4	1.8	0.0	0.4	15.3	0.2	0.0	9.0	13.1	5.6	28.1	11.6	1.2	9.7	86.3	10.4	1.5	17.4	3.1	3.3	2.5	18.8	3.6	0.7	3.4	25.2	108.2	0.4	2.0	4.9	19.4	11.6	4.1	8.1	8.8	19.7	3.9	13.6	6.2	76.4	111.0	16.7	0.2	5.3	12.9	8.1	0.0	1.3	1.2	5.3	13.1	45.6	20.9	20.5	9.5	5.3	5.1	0.0	18.1	20.0	0.8	2.9
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		37000	"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	43.9	34.7	33.1	18.7	33.9	21.5	38.9	30.2	39.9	47.8	29.7	115.7	9.9	58.5	4.9	53.0	44.5	14.7	44.3	34.2	34.3	29.4	32.4	39.5	23.1	33.4	33.5	36.4	29.3	22.1	27.2	21.6	33.4	38.5	15.8	11.0	31.0	22.3	53.6	41.3	43.2	27.6	30.5	51.8	59.1	76.6	35.6	36.5	50.8	17.7	24.9	68.1	42.3	34.4	126.7	71.6	189.2	81.8	57.9	68.8	51.3	180.7	130.3	154.7	192.7	76.0	61.6	131.4	72.6	112.0	89.6	49.4	179.6	93.2	141.0	138.4	172.0	117.4	45.2	62.7	68.4	142.3	81.7	64.0	42.2	75.4	72.0	58.9	142.2	141.3	138.7	51.3	135.9	68.0	127.1	396.8	87.3	116.0	68.5	171.7	110.2	47.9	56.2	77.1	59.9	79.3	126.8	87.9	79.3	84.3	70.8	75.9	72.7	71.0	103.8	47.0	161.9	97.0	352.1	206.5	44.7	108.7	98.5	55.3	37.6	21.7	41.6	34.7	45.2	37.2	50.4	43.2	45.2	29.6	69.9	54.6	18.9	63.8	23.6	30.1	69.4	65.3	33.1	33.9	30.2	39.9	34.2	34.3	33.4	33.5	33.4	30.5	35.6	34.4	29.2	9.6	18.7	11.4	24.1	25.6	32.6	33.2	16.5	20.1	19.2	16.3	21.9	15.7	18.6	12.9	6.2	77.7	20.5	18.5	11.7	41.6	13.1	13.3	34.4	39.4	19.2	36.6	20.9	34.9	107.2	30.8	17.3	22.0	15.2	40.2	22.1	21.0	57.6	20.2	21.8	25.2	42.7	17.2	25.0	19.1	15.5	19.2	46.2	10.3	48.5	25.8	41.2	10.6	16.3	38.1	20.1	18.8	26.3	32.6	11.4	15.6	7.2	16.6	52.6	16.5	39.0	151.3	113.7	22.4	24.6	57.5	33.5	35.4	32.5	30.5
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAG	"ARRESTIN, RP47"	ENSG00000130561	"S-antigen visual arrestin"	P10523	2	233307816-233347055	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital stationary night blindness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	474	"retina: 1466.0"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 6946.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA004946	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA004946: AB_2667304"	"unprognostic (4.76e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.95e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-9)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1466.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	1.6	0.2	0.0	651.7	0.2	0.3	1.0	0.0	0.0	0.0	869.5	1.5	0.7	0.6	0.0	0.0	40.4	0.9	0.2	41.6	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	338.2	0.5	0.0	0.0	1.5	2.3	121.5	0.9	0.5	0.0	0.0	0.7	1191.9	0.0	0.5	0.2	0.0	0.0	0.0	0.4	1.2	0.9	0.0	0.2	6946.1	13.1	1.7	0.4	2.1	1.6	0.0	0.6	0.4	0.9	0.1	0.2	1.2
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 4.8"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	8.9	23.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.3	0.4	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521080-21537216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6"	"Cancer enhanced"	"Detected in many"		"glioma: 16.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	3.9	5.4	40.2	1.4	37.7	0.2	5.5	43.2	31.0	13.1	16.6	13.3	1.7	13.5	6.3	2.9	12.7	3.2	5.4	29.4	43.7	6.2	0.9	4.5	1.7	41.3	45.2	17.2	4.3	20.6	27.0	1.2	36.9	7.0	2.1	16.9	3.1	9.2	1.5	2.6	6.7	9.5	39.2	2.8	6.0	1.6	49.1	6.5	10.5	2.8	1.7	8.7	6.3	28.7	0.1	2.4	109.2	24.2	1.9	1.6	0.0	2.1	2.7	7.1	7.2	2.3	1.2	0.1	2.2	3.2	3.1	0.2	24.5	2.7	10.0	2.0	12.5	0.0	0.7	2.2	3.2	0.0	0.1	7.3	0.9	3.4	0.0	18.4	2.2	10.9	16.6	0.0	6.2	2.1	16.0	0.1	85.7	0.1	0.5	14.3	2.3	0.0	8.3	11.6	30.4	17.3	0.0	0.6	0.3	36.2	9.2	0.2	0.0	0.9	11.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.5	0.5	0.1	40.2	37.7	43.2	31.0	29.4	43.7	41.3	45.2	36.9	39.2	49.1	28.7	0.8	3.2	3.6	13.4	0.0	0.6	0.6	1.1	8.0	13.9	3.4	2.8	0.9	2.8	1.5	5.5	8.4	0.1	0.2	0.0	1.9	1.8	0.3	0.5	3.2	1.0	0.0	0.4	2.5	0.0	0.1	3.9	0.0	0.4	0.0	7.2	2.5	0.1	0.1	13.5	9.3	0.0	4.1	0.0	0.3	0.7	5.0	0.2	0.0	0.0	0.0	11.2	0.0	10.6	2.6	0.3	0.0	6.0	0.2	0.4	0.0	0.8	0.0	2.8	0.0	3.9	3.0	0.0	0.5	1.0	0.6	0.1	0.8	3.9	0.0	0.1
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;prostate: 6.0;vagina: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 12.5"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"			"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.0	0.0	5.7	0.0	6.2	0.0	0.0	5.8	5.7	1.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	5.2	8.2	3.3	0.0	0.0	0.0	9.0	6.5	0.0	0.0	0.0	1.2	0.0	7.2	6.0	0.0	1.8	0.7	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.3	6.3	0.0	0.0	0.0	0.0	0.4	8.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.2	5.8	5.7	5.2	8.2	9.0	6.5	7.2	9.4	6.3	7.5	0.2	0.0	0.0	25.5	0.0	0.0	7.4	0.0	0.0	14.7	0.0	0.1	1.8	0.0	0.0	1.8	47.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	25.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	4.8	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	1.8	6.6	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9;thyroid gland: 5.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.4	0.2	0.2	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.4	0.8	1.6	0.2	0.1	0.2	0.3	0.1	2.1	2.0	0.5	0.2	0.2	2.4	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.2	3.9	0.3	0.0	5.8	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087851-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Mitochondria	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favorable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (7.98e-5)"	"prognostic favorable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	24.7	18.1	53.2	18.3	51.9	22.3	21.2	49.0	50.5	29.9	33.9	32.3	20.1	30.0	8.7	37.0	24.7	8.2	37.6	48.6	49.6	25.8	24.2	24.5	21.4	57.0	51.6	27.5	24.8	8.0	14.9	10.8	54.4	21.8	14.2	7.1	20.2	14.0	50.9	39.7	29.4	11.7	51.7	38.2	28.6	26.3	52.6	44.5	20.6	22.6	17.7	29.4	30.4	54.0	73.2	54.8	47.3	67.3	28.7	29.7	71.8	39.3	9.4	39.5	31.7	41.5	35.3	125.1	51.2	25.6	18.9	57.9	51.5	29.5	19.5	84.3	42.8	55.5	73.7	76.0	25.9	33.1	33.1	20.7	47.5	27.4	9.2	37.6	23.5	79.6	67.9	33.8	22.9	110.2	69.0	129.2	96.7	53.0	47.9	92.1	41.9	91.8	33.5	35.2	86.5	86.1	34.8	46.6	26.6	25.0	29.6	70.0	26.1	68.7	62.1	69.5	50.7	62.0	58.1	105.2	41.0	89.0	28.4	0.2	1.3	2.5	0.8	0.5	1.0	2.1	0.9	1.0	1.2	1.4	1.2	0.9	0.2	3.7	0.5	0.9	1.1	0.8	53.2	51.9	49.0	50.5	48.6	49.6	57.0	51.6	54.4	51.7	52.6	54.0	42.0	3.2	6.7	0.7	10.9	11.5	4.6	14.4	18.8	31.4	25.2	31.4	11.9	21.5	5.5	11.0	6.2	3.9	22.4	48.6	1.9	11.2	0.3	24.4	21.6	19.4	24.7	43.6	0.3	11.1	9.3	14.3	9.7	24.5	8.2	15.2	13.6	13.8	15.5	52.2	0.4	24.0	6.1	25.7	16.1	2.2	19.3	19.6	10.6	0.0	11.3	19.4	2.1	1.0	0.9	13.0	18.9	18.8	13.3	6.6	23.6	6.6	10.6	8.5	13.1	7.5	18.8	0.8	20.4	29.2	17.2	1.8	14.1	8.2	30.5	4.8
SAMD10	C20orf136	ENSG00000130590	"Sterile alpha motif domain containing 10"	Q9BYL1	20	63974116-63980008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 3.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040973	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA040973: AB_10794258"	"unprognostic (5.89e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.94e-3)"	1.6	3.4	6.8	4.0	9.4	2.4	2.9	11.6	10.0	2.9	4.2	3.9	4.3	0.8	1.6	13.8	3.3	2.2	4.5	6.4	5.3	8.9	5.7	2.7	6.6	5.0	4.9	0.4	5.2	3.0	3.5	1.9	5.1	5.5	2.1	3.1	5.6	1.6	1.1	7.7	5.4	0.8	4.3	6.5	6.2	3.5	6.7	4.2	3.7	1.0	6.2	3.7	5.9	5.9	8.2	0.0	2.6	0.2	0.6	0.8	0.1	2.6	2.1	5.2	2.4	7.8	15.5	0.5	5.3	1.3	0.3	11.0	2.6	3.2	2.6	16.6	5.4	2.7	8.8	11.8	1.1	13.8	21.3	0.7	5.8	2.8	0.5	3.7	2.4	5.7	6.7	6.5	1.0	6.3	6.2	12.8	4.2	11.7	12.3	8.7	0.1	14.6	8.6	14.1	2.9	6.2	1.8	14.9	3.4	1.1	10.1	6.8	2.3	1.6	3.7	0.1	0.4	1.3	1.0	4.7	5.0	11.0	1.5	0.0	0.1	0.3	2.7	0.1	1.4	1.6	1.7	1.6	0.3	0.6	3.1	3.4	0.0	0.6	0.3	0.5	1.4	1.1	6.8	9.4	11.6	10.0	6.4	5.3	5.0	4.9	5.1	4.3	6.7	5.9	1.9	3.2	0.0	5.2	3.5	1.0	2.3	3.9	0.0	5.7	4.9	4.3	2.4	0.0	3.6	9.2	2.1	3.0	5.1	2.5	1.9	3.2	0.0	2.3	0.4	1.9	4.9	2.1	5.1	3.4	0.5	0.3	5.1	3.3	0.0	3.3	2.5	1.1	1.2	0.0	5.8	4.4	4.1	1.0	0.4	0.2	0.0	0.9	1.8	0.0	2.1	2.9	8.2	1.5	0.0	8.4	1.8	0.0	0.5	3.0	4.1	3.5	3.0	3.3	0.0	0.1	0.9	0.5	1.3	6.4	1.8	2.7	4.7	0.4	2.5	3.9
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189455-118622112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.6;U-266/70: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	0.7	1.4	2.4	1.1	4.9	0.4	3.0	0.7	8.8	2.3	0.0	4.0	3.7	1.1	4.0	4.1	5.3	3.6	6.9	7.5	0.8	5.2	1.6	4.2	0.7	1.4	0.5	0.9	1.9	9.6	3.3	0.1	2.6	3.7	4.7	5.9	2.4	5.0	0.8	0.8	2.0	0.7	0.9	2.6	5.7	1.3	2.1	1.0	10.2	0.1	2.0	4.4	1.1	8.4	10.2	0.7	0.9	0.0	0.0	0.0	2.1	3.4	10.4	7.8	4.3	1.1	12.1	3.4	0.8	8.2	1.6	1.9	2.0	4.7	11.9	0.1	1.1	0.0	5.7	0.0	0.0	0.0	0.2	0.0	2.3	4.6	0.4	2.8	0.2	5.9	0.0	6.0	6.0	2.0	1.6	0.0	0.8	13.2	1.3	0.0	0.0	9.7	5.4	13.5	4.0	0.0	2.8	34.6	0.0	2.1	0.5	0.0	0.0	0.1	3.8	1.4	1.2	14.9	10.2	0.4	1.8	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.0	1.5	0.8	0.5	0.0	1.0	1.0	0.6	0.1	0.6	0.0	0.3	0.8	0.2	2.4	4.9	0.7	8.8	7.5	0.8	1.4	0.5	2.6	0.9	2.1	8.4	4.7	112.2	95.0	53.5	8.0	1.7	10.1	10.3	13.1	16.8	10.9	5.1	12.1	12.8	57.5	29.5	43.8	0.0	3.3	10.5	19.6	12.9	5.2	12.1	1.5	13.0	14.3	2.1	537.6	12.4	0.1	9.1	26.5	16.4	56.8	4.4	7.5	5.2	0.1	30.3	531.7	11.2	14.2	0.3	0.0	6.1	0.3	6.5	7.2	163.0	0.7	4.5	4.1	122.6	1158.0	13.0	3.5	0.4	16.9	5.0	8.6	17.4	68.0	26.9	0.0	0.5	0.9	0.5	2.4	15.9	1.7	0.0	8.9	4.5	11.9	13.6
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;choroid plexus: 26.9;intestine: 22.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 20.3;Intestinal goblet cells: 18.0;Oligodendrocytes: 16.4;Paneth cells: 33.2;Spermatocytes: 22.5;Undifferentiated cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"basophil: 12.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 12.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA058929	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favorable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	0.9	3.4	22.3	1.5	30.7	2.8	2.4	11.3	25.7	1.6	26.9	19.5	3.4	1.7	4.1	0.8	4.1	1.8	2.4	19.6	29.0	1.4	0.4	0.9	1.2	29.0	29.4	0.3	1.8	1.2	1.0	0.8	27.7	4.0	22.0	0.8	17.6	2.1	6.2	1.2	3.8	2.5	29.9	1.1	6.1	13.1	35.5	2.8	9.8	3.0	0.6	1.8	0.4	32.5	0.5	2.3	1.1	3.5	3.6	3.3	2.3	0.3	0.2	0.3	0.2	0.0	3.4	3.6	6.3	0.1	0.7	0.4	0.4	1.2	0.5	2.0	1.7	1.3	1.7	0.3	0.8	4.4	0.0	1.3	1.6	0.1	1.0	2.5	8.2	7.8	0.5	1.1	1.0	1.1	5.1	0.5	3.5	2.9	2.3	0.5	2.5	1.5	6.5	2.1	1.4	5.1	0.1	0.1	8.1	1.4	1.0	4.1	1.4	1.4	0.3	0.3	1.0	2.4	0.5	6.3	0.3	3.8	1.1	12.5	0.3	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.7	0.7	0.3	0.4	0.1	0.5	0.3	0.8	0.0	0.3	22.3	30.7	11.3	25.7	19.6	29.0	29.0	29.4	27.7	29.9	35.5	32.5	1.7	0.0	0.6	2.0	0.3	0.4	0.7	0.7	0.6	1.2	3.8	2.9	1.0	2.8	1.1	1.8	0.0	4.5	0.1	20.3	5.9	2.1	5.6	5.4	1.6	1.6	11.4	6.1	5.2	0.6	0.6	1.4	3.6	4.7	5.7	2.0	3.3	0.1	1.5	0.0	5.8	18.0	0.0	2.4	1.6	5.8	1.8	1.4	8.8	6.5	0.4	2.7	0.0	7.1	16.4	1.1	33.2	2.6	0.1	2.0	3.8	2.9	1.1	0.1	0.0	1.8	0.7	22.5	5.5	2.2	0.3	0.8	0.7	4.1	21.3	1.2
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.9	0.8	14.0	0.3	0.5	19.4	15.4	1.6	0.0	1.0	0.2	3.1	0.8	0.5	0.5	0.3	1.2	15.3	11.0	3.1	0.8	6.0	0.3	9.4	8.8	1.3	0.2	0.7	3.4	0.7	8.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	6.0	1.7	1.1	2.1	11.2	0.1	0.9	0.5	0.5	1.8	1.1	10.1	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	14.0	19.4	15.4	15.3	11.0	9.4	8.8	8.5	6.0	11.2	10.1	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 15.3;testis: 17.7"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.5	0.8	1.7	0.3	2.8	0.6	1.0	0.7	1.5	0.7	7.7	0.2	0.3	1.0	5.3	0.2	4.5	1.1	0.1	1.7	3.4	1.9	0.1	0.8	1.4	2.8	3.5	0.7	2.0	2.4	2.4	0.3	2.0	0.7	0.3	15.3	0.3	0.7	0.2	0.5	0.2	0.3	1.4	0.2	0.4	17.7	2.7	0.4	3.9	0.0	1.4	0.8	0.2	0.8	2.5	3.4	1.3	2.7	0.3	1.4	1.2	1.0	0.9	2.6	2.3	2.5	2.2	2.8	1.1	1.0	2.3	2.4	0.9	1.4	3.7	0.2	0.5	0.4	1.0	0.6	0.1	0.5	2.9	1.3	0.9	2.3	0.2	1.1	1.8	1.4	0.3	0.7	1.1	7.6	0.6	0.2	0.5	0.6	1.0	1.2	1.2	0.1	4.6	1.4	2.8	1.8	3.5	0.5	0.5	0.5	4.3	0.8	0.7	2.5	1.4	2.6	1.3	0.4	2.4	1.8	3.1	0.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.7	1.5	1.7	3.4	2.8	3.5	2.0	1.4	2.7	0.8	0.7	0.0	0.0	1.0	0.3	0.3	0.5	0.6	0.0	11.2	0.9	0.9	1.9	2.8	1.8	0.0	62.6	0.3	0.8	0.7	1.9	2.8	81.8	38.8	4.6	0.5	3.6	0.0	1.3	0.6	0.2	1.0	0.0	1.4	0.0	1.3	0.4	0.0	0.1	3.3	0.6	0.5	0.0	0.0	0.0	111.7	1.5	0.3	0.0	0.0	0.1	5.5	0.0	0.5	0.4	0.9	0.1	0.0	0.0	0.2	0.0	3.5	41.5	75.7	0.0	1.0	1.0	59.3	7.3	0.0	0.0	0.3	0.3	6.0	0.1	0.3
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54566117-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 94.3;testis: 107.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1176.0;Late spermatids: 2275.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"	Cytosol	"HPA043061: AB_2678299, HPA065309: AB_2685462"	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	16.6	4.2	27.4	8.9	33.1	0.4	13.1	42.3	24.9	13.0	14.1	37.6	3.2	26.1	4.0	6.7	12.0	6.0	47.8	22.6	40.3	12.4	16.6	21.2	4.6	79.0	46.2	4.5	6.2	3.8	6.1	9.2	69.4	14.5	4.8	2.6	7.0	9.4	94.3	8.9	10.4	17.1	64.1	7.1	10.9	107.9	41.8	1.1	7.0	39.3	3.1	17.7	12.8	60.8	32.9	2.9	6.7	3.4	14.0	21.3	11.7	27.4	41.4	22.3	22.0	36.8	7.8	1.8	14.0	41.7	8.8	22.6	6.6	14.2	32.8	16.5	2.8	0.0	4.0	7.7	7.7	0.0	0.2	12.6	5.3	15.9	23.4	6.5	17.1	0.0	2.6	0.0	11.0	2.4	0.4	0.1	3.1	0.2	7.5	0.9	13.5	0.1	11.0	10.8	1.0	10.7	4.0	5.2	15.9	13.8	21.0	0.3	37.1	26.6	41.1	6.6	8.7	0.1	0.1	0.0	7.5	0.6	8.4	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	27.4	33.1	42.3	24.9	22.6	40.3	79.0	46.2	69.4	64.1	41.8	60.8	16.0	25.6	1.5	170.1	7.4	39.6	47.0	12.0	1.2	2.4	6.2	6.1	278.5	14.3	9.9	18.4	8.4	10.5	1.6	4.4	3.9	9.9	1176.0	13.7	45.3	30.9	6.0	5.7	64.6	8.0	1.8	47.3	1.5	29.3	22.8	0.8	10.8	62.6	11.6	10.1	173.7	1.5	6.1	15.3	28.9	2275.7	14.6	13.0	24.9	72.1	12.8	1.5	1.0	380.5	140.7	19.8	5.5	23.7	0.3	55.1	5.6	22.9	4.0	5.4	13.1	79.7	37.1	17.1	7.6	0.4	24.3	1.9	5.7	0.3	1.7	44.5
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016800, HPA059385"	Approved		Enhanced	Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA016800: AB_1856552, HPA059385: AB_2684000"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	46.1	39.7	37.3	24.5	48.1	20.3	42.1	31.1	37.5	56.6	18.1	47.1	18.9	49.7	16.8	65.0	47.3	26.7	39.6	34.2	34.5	33.2	31.2	45.7	15.1	51.9	45.9	60.8	34.2	36.3	48.1	26.2	39.9	41.9	15.8	23.4	42.8	33.3	36.0	54.9	34.9	27.9	35.9	32.9	40.2	41.4	40.7	19.2	44.1	19.2	15.1	46.1	52.9	53.6	97.8	131.0	65.6	49.7	62.7	75.1	54.1	55.1	60.0	43.2	35.7	114.6	53.2	32.3	70.2	88.4	56.0	46.2	65.3	50.4	29.5	65.3	106.1	32.4	55.5	48.6	64.7	35.5	32.7	74.1	58.5	70.8	52.3	52.6	41.3	42.9	97.6	34.0	53.3	65.8	38.1	17.3	52.2	63.5	51.6	45.9	42.2	28.3	36.3	77.8	66.6	65.0	72.1	48.8	39.2	49.4	39.5	37.8	54.6	70.0	50.6	153.5	97.8	64.0	62.2	35.8	93.4	26.7	70.2	1.2	1.0	1.5	1.0	0.4	0.7	1.2	0.8	0.9	0.8	0.6	1.3	0.9	2.7	0.9	0.3	0.9	0.3	0.5	37.3	48.1	31.1	37.5	34.2	34.5	51.9	45.9	39.9	35.9	40.7	53.6	28.8	12.8	30.4	55.8	21.6	33.3	62.7	22.4	12.0	56.9	37.1	32.9	8.4	24.3	18.9	36.8	166.8	25.7	21.7	26.4	5.9	26.2	6.9	44.9	42.5	31.9	51.0	19.8	26.6	27.3	23.1	39.1	19.9	55.3	18.9	39.0	36.8	26.6	20.7	52.2	31.0	28.1	10.2	25.5	38.2	5.4	43.8	28.5	19.6	25.3	18.4	31.4	16.5	34.2	106.0	41.0	19.6	33.1	19.3	65.7	20.2	12.3	30.7	67.9	65.7	43.9	30.9	70.3	42.7	15.6	43.5	54.6	20.4	33.8	24.5	65.9
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.7;Distal enterocytes: 104.6;NK-cells: 109.2;Paneth cells: 171.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 28.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 66.7;GAMG: 66.0"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	4.1	3.6	1.1	13.2	1.0	9.9	3.5	1.1	1.0	8.0	1.4	11.0	7.5	3.5	2.9	39.1	3.0	7.2	2.4	1.1	1.6	3.2	3.7	7.7	15.8	2.8	1.5	5.8	1.6	1.0	0.9	7.0	2.0	2.0	11.3	0.3	4.3	2.4	0.6	1.9	7.7	4.0	2.9	17.7	10.7	1.0	2.1	20.7	2.0	2.3	15.9	7.0	8.3	2.5	28.5	3.6	1.0	0.2	12.0	15.2	0.3	10.9	45.2	51.0	66.7	0.2	30.9	11.9	16.8	27.1	66.0	32.6	0.1	10.0	17.1	40.5	1.3	17.3	18.0	0.0	5.4	19.5	23.1	6.8	14.1	16.8	4.6	2.8	7.7	13.1	1.2	28.6	10.9	0.1	29.2	15.9	0.1	0.0	7.9	9.5	9.2	13.5	0.3	3.6	4.4	0.4	8.4	3.3	9.1	0.1	1.0	9.5	33.8	11.8	4.2	36.0	6.0	16.9	3.4	10.8	12.3	11.2	12.1	21.8	4.2	15.7	8.3	8.1	7.7	5.6	6.4	7.3	3.6	5.9	6.7	6.1	17.8	8.8	12.8	2.5	8.8	3.2	1.1	1.0	1.1	1.0	1.1	1.6	2.8	1.5	2.0	2.9	2.1	2.5	43.9	9.6	3.7	0.7	53.4	2.3	8.2	40.2	4.0	1.4	4.4	5.1	1.2	5.7	33.7	14.7	0.0	1.9	92.7	104.6	0.0	23.5	0.1	21.1	18.5	29.0	3.0	19.4	0.4	12.3	7.1	14.6	37.8	7.0	43.6	21.8	12.1	1.2	11.5	6.7	1.5	34.9	20.3	29.9	9.6	0.7	15.2	32.7	3.6	21.5	41.6	2.2	109.2	2.0	2.4	50.4	171.0	12.4	35.9	7.0	12.6	2.3	37.5	0.1	13.1	14.4	12.6	0.2	0.0	21.1	1.8	0.4	69.4	25.4	5.6	34.3
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130056-93148385	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.3"	"Cell type enhanced"	"Detected in many"		"monocytes: 64.8;NK-cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 54.0;GAMG: 44.1;HDLM-2: 51.2;Karpas-707: 131.4"	"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	10.2	6.0	4.0	24.4	4.6	10.0	7.5	3.6	4.4	7.2	3.7	10.5	11.5	7.3	4.5	6.3	6.5	13.8	6.2	3.6	4.9	6.8	6.1	21.9	27.1	9.5	4.5	9.1	3.2	1.9	3.9	12.6	5.9	4.3	11.4	2.4	12.9	4.2	2.9	4.1	11.7	9.1	8.0	38.3	14.4	2.9	5.4	22.9	6.7	4.6	16.2	11.9	6.3	6.3	7.2	0.4	0.0	0.4	9.3	18.7	0.2	6.2	25.7	34.5	54.0	0.0	15.9	4.7	7.7	16.7	44.1	3.1	0.0	2.2	5.5	51.2	0.0	4.3	1.9	0.0	7.5	9.6	7.0	7.2	0.8	6.9	1.0	6.4	15.1	7.1	0.0	131.4	14.6	0.0	15.3	8.5	0.5	0.0	1.8	6.3	2.2	11.0	1.8	0.6	0.0	0.3	1.3	0.2	9.8	0.1	0.4	5.0	35.8	10.1	2.2	29.6	3.8	36.4	13.0	1.3	10.6	8.6	10.1	30.1	6.7	16.7	13.4	13.3	11.6	15.1	7.4	10.0	6.3	10.3	4.3	7.7	29.2	8.2	12.8	4.7	11.8	4.0	4.0	4.6	3.6	4.4	3.6	4.9	9.5	4.5	5.9	8.0	5.4	6.3	37.4	35.3	11.2	15.7	28.5	2.3	2.3	6.0	4.6	0.0	8.0	5.5	1.8	2.8	9.6	11.0	0.0	0.3	34.2	18.8	9.8	12.7	0.1	4.9	16.3	28.0	1.2	10.1	0.2	5.7	1.0	14.3	20.4	2.4	34.2	12.2	27.5	0.4	24.4	0.0	0.1	12.6	6.1	20.4	12.9	1.1	9.6	36.5	7.2	44.0	64.8	14.1	91.6	0.0	0.2	16.2	50.2	11.7	28.1	3.1	5.1	4.2	18.6	0.4	6.6	15.0	7.7	0.3	0.2	4.1	2.3	0.1	34.0	12.2	4.1	8.0
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955442-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	41.7	50.6	26.1	27.0	27.0	32.5	35.8	29.8	30.6	43.4	31.1	35.6	50.8	27.0	29.3	31.7	41.9	29.3	65.5	27.1	29.2	48.8	37.2	22.2	34.6	29.8	28.5	40.0	33.3	114.4	24.4	20.1	30.4	26.5	35.5	25.5	35.2	25.1	240.4	35.9	38.3	27.7	27.0	24.4	43.8	26.1	28.5	34.4	28.1	177.0	37.0	27.9	24.0	28.0	64.6	59.8	57.1	69.5	72.2	75.9	79.8	61.7	65.7	89.1	76.4	86.1	46.0	105.9	44.3	70.8	51.4	75.6	85.4	82.6	79.7	29.4	105.3	57.5	73.9	102.6	50.4	184.0	83.1	88.3	64.7	77.0	35.5	62.3	93.1	49.9	49.9	34.0	80.9	91.7	72.6	72.0	56.0	77.4	70.9	83.8	61.8	85.9	74.4	81.0	34.1	55.4	68.3	72.2	104.1	60.4	67.7	59.8	57.7	57.3	68.8	53.6	51.2	50.1	74.4	82.1	72.0	66.3	58.7	47.5	39.2	46.9	39.8	39.0	55.4	55.1	36.6	40.5	67.7	51.0	37.8	36.0	6.1	39.1	31.8	26.7	45.7	40.2	26.1	27.0	29.8	30.6	27.1	29.2	29.8	28.5	30.4	27.0	28.5	28.0	52.9	35.3	18.9	10.4	31.6	20.6	27.0	72.0	30.7	20.1	32.1	40.9	68.6	18.6	39.5	9.2	8.4	41.6	31.7	36.1	60.7	47.2	40.3	47.3	24.9	35.1	18.6	51.4	12.0	55.5	54.1	24.6	42.3	32.7	27.3	43.9	30.0	41.8	51.1	32.0	12.7	35.2	46.8	28.6	20.5	50.1	26.1	25.0	16.0	12.2	41.4	32.8	33.0	9.5	9.1	43.7	34.5	30.5	31.0	16.2	82.4	116.8	39.9	30.1	19.7	23.2	33.4	45.8	31.2	34.3	22.6	20.5	28.5	69.9	59.8	19.3
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	125.7	164.3	140.9	122.9	152.2	242.3	121.6	149.6	198.9	120.4	137.8	141.8	137.4	123.8	97.5	159.2	112.9	82.4	195.8	147.4	160.7	190.4	171.1	106.5	118.0	154.7	153.8	109.5	134.6	114.2	129.6	111.7	157.7	109.7	58.5	89.5	126.3	73.0	297.9	119.5	127.5	51.7	164.1	107.6	119.5	194.3	155.7	115.5	110.7	156.3	64.8	131.7	118.5	170.7	182.1	99.3	159.5	173.1	169.0	140.5	246.9	227.1	167.2	205.5	151.3	181.1	342.4	187.3	272.0	189.1	223.4	186.5	198.1	142.4	231.5	288.0	100.4	267.6	121.2	305.9	191.8	367.1	207.5	143.0	159.7	157.5	187.1	158.4	157.3	223.1	128.8	103.6	188.2	231.0	417.0	599.0	200.7	501.5	109.7	261.1	251.4	187.1	295.7	160.7	185.0	161.1	145.7	213.8	296.5	176.5	206.8	528.0	192.6	126.0	141.9	230.1	268.9	159.6	243.6	536.7	122.5	214.9	236.4	433.0	431.5	540.0	344.1	485.0	349.3	493.7	418.2	410.9	427.8	443.6	405.9	402.9	430.5	395.3	547.4	568.8	517.5	909.3	140.9	152.2	149.6	198.9	147.4	160.7	154.7	153.8	157.7	164.1	155.7	170.7	638.0	134.6	143.5	15.0	291.7	458.6	336.3	640.9	310.7	101.5	298.9	594.9	592.9	194.5	383.8	233.6	41.7	566.2	397.4	353.6	759.2	396.5	1259.5	334.1	231.1	273.1	234.5	214.4	20.8	365.6	528.0	374.0	170.2	256.2	258.6	176.6	180.2	242.0	396.0	119.5	23.4	364.5	468.0	189.5	440.9	206.0	342.3	260.4	407.4	17.8	385.0	370.8	233.8	19.6	26.2	401.9	417.6	303.6	182.3	325.9	475.0	1100.6	446.8	132.3	203.8	362.5	438.3	547.7	319.9	271.7	422.2	908.3	338.8	254.2	344.7	419.9
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 77.2;Macrophages: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	17.4	12.9	17.4	13.3	19.7	23.4	12.8	18.4	21.6	13.9	16.1	25.6	9.5	13.2	9.6	9.9	16.9	8.6	20.4	17.0	18.2	6.2	9.0	12.8	8.0	19.3	18.2	14.6	7.3	4.5	8.1	7.1	19.2	11.4	7.0	16.3	11.6	9.7	10.5	8.5	12.5	12.4	18.7	15.7	18.4	24.7	17.6	10.3	10.6	7.4	6.6	19.5	12.6	25.3	49.0	16.3	46.3	45.2	29.0	17.9	10.1	22.5	19.3	24.7	30.4	7.0	19.4	43.9	10.3	26.3	31.1	12.0	37.8	19.1	18.9	49.6	35.9	58.7	39.6	20.0	27.5	34.0	35.9	29.8	9.2	21.1	21.2	34.7	29.3	31.5	30.8	181.4	32.2	20.9	48.4	38.0	20.5	21.7	31.3	38.9	16.5	31.6	15.1	7.8	37.5	79.1	31.8	31.9	14.9	11.8	13.5	20.0	29.1	17.6	23.9	41.4	52.8	101.5	39.1	41.8	56.8	81.6	51.2	0.4	1.3	0.0	0.6	0.7	0.2	0.1	0.3	0.4	1.0	0.2	0.0	0.2	0.5	0.0	0.4	0.0	0.4	0.2	17.4	19.7	18.4	21.6	17.0	18.2	19.3	18.2	19.2	18.7	17.6	25.3	42.1	0.0	2.3	11.1	7.2	51.7	6.6	3.9	16.5	26.2	25.5	29.3	28.9	4.3	3.7	7.3	22.9	2.1	22.5	4.8	0.0	2.2	23.1	23.6	34.3	27.3	19.7	20.2	12.5	3.5	9.3	19.9	19.4	7.4	7.0	13.5	14.6	9.0	9.3	25.2	14.6	10.5	0.0	77.2	13.8	6.2	10.2	77.0	33.8	3.7	15.2	57.7	2.1	7.1	15.4	2.4	2.7	6.4	17.6	8.6	6.4	6.2	9.9	46.3	52.6	12.5	31.7	63.7	15.2	16.1	53.0	1.2	27.0	12.3	11.1	4.1
SAP30BP	"HCNGP, HTRG, HTRP"	ENSG00000161526	"SAP30 binding protein"	Q9UHR5	17	75667251-75708062	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042382, HPA052943"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA042382: AB_10793881, HPA052943: AB_2681995"	"unprognostic (6.92e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.31e-3)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.06e-2)"	"unprognostic (6.58e-2)"	17.7	13.1	30.7	14.5	31.9	23.2	17.3	31.1	33.5	20.6	37.9	22.1	11.9	17.0	17.1	20.0	17.0	15.3	19.6	30.8	30.8	20.3	19.0	15.1	19.6	34.6	32.6	17.3	16.2	18.6	17.7	18.0	31.8	19.8	15.1	14.7	23.0	17.1	17.8	17.8	16.0	17.0	31.8	21.1	18.2	14.7	31.6	22.7	15.8	22.2	22.9	19.6	19.0	36.5	28.2	36.9	27.8	26.7	25.6	26.9	31.5	29.2	31.4	53.2	54.8	31.8	23.2	30.2	15.1	27.8	48.8	23.5	33.5	32.0	53.1	10.7	40.1	23.7	26.2	33.2	25.4	25.4	21.5	25.5	28.7	39.9	43.2	30.6	73.5	30.8	29.2	23.0	41.9	29.9	42.0	24.4	23.7	41.7	41.0	27.4	40.4	22.7	44.7	24.7	19.3	31.8	26.4	28.2	33.7	40.7	42.8	22.9	28.7	47.0	30.9	20.9	40.5	17.1	7.1	35.9	31.4	18.8	38.4	18.0	23.1	24.6	24.3	19.8	26.8	21.6	22.0	25.2	19.4	21.7	22.0	22.7	22.8	27.7	23.7	32.0	25.6	22.9	30.7	31.9	31.1	33.5	30.8	30.8	34.6	32.6	31.8	31.8	31.6	36.5	72.4	54.5	62.7	25.5	54.1	49.5	117.7	65.5	34.1	19.6	34.0	43.2	53.5	30.0	71.1	22.0	12.5	59.5	68.3	71.2	68.4	71.3	47.5	32.8	48.4	63.5	35.9	26.9	15.9	73.2	67.0	55.9	45.9	56.3	77.2	38.9	52.8	34.2	57.5	10.1	14.2	43.8	59.0	35.5	48.1	93.6	44.4	48.0	56.9	10.3	59.7	72.6	55.6	22.6	30.5	103.3	109.2	34.6	57.4	52.0	43.3	47.2	58.0	17.3	65.7	50.9	64.3	34.8	34.3	36.1	45.5	96.0	59.8	31.7	37.2	94.0
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445997-154461053	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	10.0	8.4	12.2	5.3	13.7	1.6	11.3	13.0	13.2	14.0	10.2	14.9	10.5	13.4	9.0	7.1	12.9	6.7	9.8	11.1	12.9	13.1	8.0	9.3	6.8	13.2	13.4	19.7	6.4	13.8	5.0	7.7	12.7	10.6	8.7	6.1	7.3	12.4	14.1	11.4	11.0	11.6	13.7	8.9	8.9	7.7	13.1	9.9	9.3	15.3	8.3	10.9	10.0	13.8	9.0	7.3	13.3	8.8	28.4	22.5	6.5	9.2	19.9	10.4	11.2	4.9	5.0	9.7	7.2	14.0	12.1	7.1	10.1	7.5	11.6	4.9	9.9	7.9	6.8	3.6	8.5	10.5	5.7	8.2	13.4	4.6	11.3	16.0	8.5	9.1	3.3	6.0	8.8	4.5	9.9	6.7	3.3	8.2	5.0	9.4	13.3	4.8	6.0	4.4	8.0	10.5	7.3	15.6	17.6	12.4	5.6	12.8	12.1	7.2	5.3	9.6	6.6	5.6	8.6	5.0	10.6	8.1	4.2	0.0	0.3	0.3	0.5	0.4	0.6	0.2	0.6	0.6	0.3	0.5	0.6	0.4	0.2	1.4	1.2	0.4	0.6	0.3	12.2	13.7	13.0	13.2	11.1	12.9	13.2	13.4	12.7	13.7	13.1	13.8	25.7	19.2	6.9	7.8	7.1	17.3	8.7	4.2	8.0	4.5	17.0	14.1	19.8	17.2	6.3	3.7	6.2	7.7	15.5	26.5	3.9	4.8	22.4	15.6	18.4	17.6	7.2	11.0	6.6	8.2	12.3	18.1	4.6	9.8	1.3	16.4	15.7	16.3	8.5	10.1	6.5	11.4	0.0	9.7	12.4	18.0	20.5	11.3	10.6	9.4	10.7	21.4	14.4	6.0	12.1	10.6	13.9	18.0	7.8	16.9	32.7	10.5	9.5	5.8	0.0	14.9	16.0	16.1	17.2	5.5	18.2	6.3	8.9	10.5	12.1	13.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		660000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (7.00e-5)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	77.1	52.8	41.8	38.4	43.5	163.2	48.1	45.1	45.7	43.1	53.3	39.1	26.6	41.0	47.0	41.4	37.3	35.0	44.8	43.8	48.3	43.3	70.2	51.4	36.7	42.8	44.9	41.0	33.9	44.2	37.9	76.0	44.0	38.9	35.5	42.0	39.9	38.9	51.1	38.5	34.5	49.7	47.3	40.7	37.9	23.5	48.4	33.2	39.8	56.3	38.4	45.8	36.2	52.1	85.8	56.3	75.7	131.9	246.1	143.1	61.1	128.3	154.4	115.6	140.0	169.7	78.2	74.4	67.1	153.7	52.8	96.6	94.5	75.9	111.6	103.9	44.3	54.1	65.8	82.5	112.4	86.7	56.6	155.9	68.4	76.4	133.2	119.0	63.8	55.9	68.7	105.9	110.0	60.0	73.8	72.6	65.2	55.6	141.3	70.8	84.4	42.5	88.7	69.7	42.6	73.8	98.0	134.6	72.2	66.8	65.8	59.7	88.6	63.7	94.3	92.2	91.3	72.3	141.3	114.0	84.9	111.7	48.7	75.5	63.5	74.0	88.0	80.9	94.8	47.7	68.5	85.9	58.5	38.6	65.7	88.7	67.9	103.3	72.9	44.8	53.2	95.9	41.8	43.5	45.1	45.7	43.8	48.3	42.8	44.9	44.0	47.3	48.4	52.1	88.4	128.2	110.2	6.8	53.5	235.7	138.0	120.2	25.0	38.6	99.2	62.4	74.7	57.2	105.3	49.7	33.3	120.6	109.8	51.6	54.8	78.4	3.0	52.3	85.8	85.2	42.7	46.1	21.2	77.3	199.0	127.8	23.9	89.7	53.2	46.3	69.7	114.1	101.0	26.9	22.2	72.1	65.1	51.2	208.9	5.6	54.7	68.1	113.8	21.5	58.4	61.9	75.2	16.1	26.4	78.8	56.2	58.6	97.7	141.4	59.1	95.9	67.1	33.4	78.9	73.7	158.8	64.1	51.8	37.2	248.8	238.9	86.3	45.2	53.2	175.2
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601149-134649271	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 413.3;Hepatocytes: 267.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		430000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favorable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	30.9	46.4	27.5	24.2	40.6	26.0	35.8	40.8	41.7	27.3	40.6	40.9	68.5	14.9	34.9	36.0	17.7	28.2	46.8	31.0	37.5	57.1	163.9	19.7	24.4	43.9	40.5	13.5	32.8	64.9	24.7	20.7	44.7	38.7	36.5	20.3	36.3	29.7	147.5	16.8	69.7	26.7	40.3	20.0	43.4	66.0	35.9	22.7	29.7	140.6	33.6	36.2	20.3	53.9	57.8	49.6	36.0	81.3	111.6	53.4	48.3	95.4	80.0	84.1	127.9	84.3	79.7	31.9	78.3	98.6	116.6	52.1	62.8	92.5	108.0	73.6	37.0	33.6	78.0	81.5	91.7	29.1	44.7	60.4	57.8	97.7	82.7	42.3	64.1	40.9	44.3	71.9	87.0	85.3	38.6	43.6	12.7	70.7	34.4	33.7	62.7	70.2	61.7	91.2	36.8	16.0	67.2	36.1	71.4	47.2	74.2	35.5	51.7	72.8	44.0	66.7	72.3	90.0	215.4	58.7	56.2	55.7	81.6	22.2	70.5	55.0	42.3	71.2	52.9	52.7	48.2	49.7	64.0	34.7	42.9	41.6	25.5	35.8	80.5	43.6	77.1	71.3	27.5	40.6	40.8	41.7	31.0	37.5	43.9	40.5	44.7	40.3	35.9	53.9	49.3	32.1	36.9	21.5	45.6	37.6	44.0	112.9	22.2	30.4	56.0	35.7	86.7	61.5	102.6	57.0	41.7	33.1	44.5	77.0	56.7	47.6	413.3	43.0	51.3	35.3	27.6	44.2	31.6	83.9	43.5	46.1	68.3	45.8	26.6	28.3	38.9	267.7	52.8	33.7	32.8	55.2	89.5	52.9	56.6	76.9	36.7	47.1	64.0	20.6	38.3	41.8	20.6	29.7	66.5	60.4	36.2	44.8	165.8	75.1	210.7	121.4	99.8	40.3	19.7	41.2	47.7	106.8	47.3	51.1	51.1	115.2	47.0	43.0	46.3	96.5
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 47.9;liver: 114.4;pancreas: 43.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.1	2.2	3.6	2.5	3.5	0.9	0.8	1.9	3.9	2.6	0.7	1.1	1.8	2.0	47.9	0.6	1.9	1.3	2.4	3.3	3.5	12.0	114.4	2.6	4.1	4.4	3.1	3.0	43.2	2.1	4.1	0.9	3.4	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.9	1.3	3.0	0.7	4.2	4.3	1.6	0.3	2.4	1.1	1.0	3.1	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.5	1.9	3.9	3.3	3.5	4.4	3.1	3.4	2.9	4.2	3.1	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SARM1	"KIAA0524, SAMD2, SARM"	ENSG00000004139	"Sterile alpha and TIR motif containing 1"	Q6SZW1	17	28364356-28404049	"Enzymes, Predicted intracellular proteins"	"Differentiation, Immunity, Innate immunity, Neurogenesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.8;Cone photoreceptor cells: 29.2;Inhibitory neurons: 28.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024359, HPA024759"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA024359: AB_1856582, HPA024759: AB_1856581"	"unprognostic (1.40e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-4)"	"unprognostic (6.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.62e-4)"	2.2	5.9	3.9	3.3	3.6	1.4	2.1	7.3	4.2	3.1	1.6	3.3	7.5	4.0	4.0	1.4	3.6	1.5	1.8	3.9	3.1	2.7	3.4	2.0	2.0	3.3	2.7	2.8	7.1	2.6	6.1	1.2	3.2	3.5	2.2	7.0	2.6	4.2	1.5	2.3	5.2	3.5	2.4	4.4	3.3	1.3	3.6	1.1	2.8	1.0	2.1	3.8	1.9	2.8	0.2	3.0	3.8	4.8	2.7	1.9	0.6	2.1	4.1	4.4	2.9	32.2	0.5	0.6	0.2	3.0	2.6	1.3	2.7	0.1	3.7	7.0	1.8	0.0	5.5	0.8	2.0	0.1	1.9	1.3	0.2	2.1	0.6	4.2	0.2	0.9	0.1	2.4	1.2	2.8	0.4	0.0	2.6	0.6	0.2	1.1	3.2	0.8	1.4	2.2	9.9	9.2	9.2	1.3	3.5	1.6	0.4	0.7	0.4	4.0	0.4	1.4	2.9	4.0	2.9	0.6	4.2	0.3	2.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.1	0.3	0.5	0.0	0.4	0.1	3.9	3.6	7.3	4.2	3.9	3.1	3.3	2.7	3.2	2.4	3.6	2.8	2.7	3.2	4.2	19.6	4.0	0.9	1.8	1.2	4.6	27.8	3.1	4.2	0.8	7.2	4.8	3.7	29.2	0.6	2.9	3.0	3.9	4.4	6.6	3.8	5.4	2.9	9.5	0.4	23.5	10.7	0.8	3.5	8.2	3.7	4.5	6.1	3.6	2.3	1.5	21.9	28.9	4.1	2.0	13.8	0.3	3.5	3.4	2.8	3.6	2.8	2.4	6.1	3.1	27.6	14.8	3.4	2.3	1.5	2.6	2.3	9.9	5.9	4.3	17.2	6.6	5.9	4.0	0.3	0.4	3.1	0.6	0.5	4.7	2.0	4.9	1.4
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SARS1	"SARS, SERS"	ENSG00000031698	"Seryl-tRNA synthetase 1"	P49591	1	109213918-109238182	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 98.8;Cytotrophoblasts: 186.0;Extravillous trophoblasts: 147.6;Hofbauer cells: 88.1;Syncytiotrophoblasts: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	86.9	89.4	78.6	55.9	78.6	35.7	80.5	77.2	98.1	79.3	57.4	89.1	63.6	85.8	64.2	97.1	71.5	53.6	96.0	81.9	92.6	77.4	102.4	102.3	60.9	88.3	81.1	78.5	150.1	102.1	88.6	76.2	91.1	66.2	74.8	68.0	86.1	73.9	113.3	111.9	69.9	79.3	72.9	64.5	112.4	46.3	78.1	66.7	139.8	87.9	76.4	88.3	82.1	90.9	208.5	82.1	152.3	230.3	224.2	201.4	261.6	213.1	222.1	183.7	227.1	161.4	62.7	224.1	107.7	307.2	102.8	111.6	241.1	305.9	212.4	159.0	150.4	86.6	96.3	118.4	448.1	110.5	93.7	249.4	526.5	217.1	467.7	155.9	221.9	279.5	201.9	273.2	181.3	205.8	124.8	57.5	63.4	125.6	193.5	101.1	192.5	102.6	139.9	111.0	210.0	111.2	102.5	164.7	601.4	114.9	93.5	131.2	174.5	108.3	135.0	155.5	151.8	205.6	89.6	183.7	341.3	119.8	376.7	191.5	193.9	219.6	228.6	212.2	240.0	235.8	238.2	227.3	198.8	252.4	246.4	229.4	89.7	193.5	226.6	128.2	300.9	460.5	78.6	78.6	77.2	98.1	81.9	92.6	88.3	81.1	91.1	72.9	78.1	90.9	30.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.8	0.0	0.0	0.0	0.0	186.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	147.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	188.4	5.9	0.0	0.0	0.0
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	7.3	17.3	4.2	7.2	4.7	9.3	8.2	4.4	6.8	9.7	3.6	10.1	9.3	9.3	2.8	14.3	8.5	5.9	12.4	4.7	4.4	14.6	18.7	6.6	9.8	5.0	4.4	9.8	15.9	7.8	11.9	7.6	5.3	12.2	5.3	2.3	11.3	6.2	16.4	12.3	10.2	5.1	4.2	12.0	11.9	10.7	4.4	7.5	14.4	11.5	6.6	9.4	9.6	5.4	17.6	47.3	15.5	10.7	5.8	13.3	23.7	10.7	12.6	23.1	17.7	36.0	18.4	17.2	16.3	12.5	9.7	13.9	14.7	29.2	5.3	12.7	24.4	33.7	17.7	32.0	15.4	29.1	31.9	20.7	13.5	14.5	7.6	9.5	14.2	26.3	29.9	14.2	10.6	28.4	21.4	20.7	18.5	21.6	8.5	31.2	16.4	18.6	20.5	36.2	29.1	18.1	14.2	32.7	8.9	4.6	21.8	19.1	11.4	13.7	17.7	11.7	15.1	11.0	7.1	13.2	10.9	18.5	13.8	0.0	8.0	1.0	14.2	14.4	11.5	12.0	10.7	14.7	25.2	10.7	7.5	8.6	0.5	14.0	13.7	9.9	13.4	8.9	4.2	4.7	4.4	6.8	4.7	4.4	5.0	4.4	5.3	4.2	4.4	5.4	2.7	6.4	7.9	6.2	8.4	4.2	3.8	8.3	3.4	8.0	7.0	5.3	8.1	7.2	6.8	5.5	8.4	40.1	5.6	8.9	15.6	15.5	15.7	3.6	3.6	3.8	11.4	13.2	6.8	12.7	23.0	4.8	9.7	3.9	5.7	7.4	6.1	10.1	12.9	5.0	6.7	9.2	10.2	6.7	4.2	56.9	4.7	4.8	3.6	1.9	7.7	3.1	5.2	1.5	3.1	8.4	5.6	4.9	10.1	2.6	7.4	10.3	5.1	13.4	0.0	2.7	4.2	1.9	8.2	12.8	4.1	29.1	7.4	10.6	17.8	3.2
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP"	O43290	11	65961728-65980137	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	24.6	18.3	15.5	18.3	16.8	41.6	23.1	15.4	17.4	29.2	14.7	26.0	15.6	29.1	8.0	22.7	25.6	8.6	23.2	14.9	16.1	20.4	21.8	22.9	20.3	16.6	16.2	29.2	25.8	11.7	21.4	14.0	15.9	21.7	7.7	8.0	22.2	14.4	38.1	32.0	24.3	10.9	14.6	32.7	24.8	23.5	15.7	20.9	23.5	13.0	13.3	26.2	24.6	17.9	50.4	60.8	27.2	36.8	26.1	20.7	40.8	37.5	27.2	43.8	28.6	44.2	34.3	56.9	42.4	33.8	52.9	48.7	34.6	35.6	22.0	45.8	33.5	65.6	43.6	41.4	39.0	57.4	52.7	26.2	26.4	40.8	36.3	17.4	27.6	42.3	42.2	39.8	25.6	92.6	74.0	83.5	45.7	27.3	55.9	80.8	39.0	60.7	18.4	33.7	30.5	43.0	35.6	37.2	45.5	12.6	41.7	47.0	40.6	54.5	53.0	53.9	54.1	59.6	49.4	48.3	45.0	28.8	47.0	1.4	2.8	8.1	4.3	3.5	3.6	3.9	4.8	4.4	3.6	3.5	3.5	3.9	4.1	2.8	2.0	3.2	5.4	1.8	15.5	16.8	15.4	17.4	14.9	16.1	16.6	16.2	15.9	14.6	15.7	17.9	17.5	6.4	9.1	7.8	27.8	22.7	24.0	12.2	17.6	19.2	12.2	9.1	9.4	21.5	11.3	16.5	10.4	34.1	27.2	30.5	5.9	23.7	9.0	14.2	16.3	19.8	12.5	32.8	5.1	29.3	31.9	17.6	21.9	16.8	32.4	21.8	21.0	15.6	29.4	16.8	4.8	26.5	16.2	22.5	23.6	8.7	37.0	22.9	17.8	6.5	35.7	23.8	34.0	7.1	7.8	26.3	20.1	33.1	31.2	20.5	28.3	18.5	17.5	26.0	32.9	27.6	34.9	26.7	29.7	18.3	21.7	45.3	28.4	15.5	27.5	18.2
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552048	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 194.8;Astrocytes: 426.7;Microglial cells: 179.9;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 328.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"classical monocyte: 1.2;intermediate monocyte: 2.6;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	26	"monocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 198.0;ASC TERT1: 74.7;fHDF/TERT166: 73.4;HUVEC TERT2: 75.0;WM-115: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	76.1	6.1	45.5	6.6	62.5	0.3	47.6	58.2	35.4	24.5	10.3	18.1	6.8	13.6	5.1	45.2	15.9	19.7	17.0	40.0	43.0	15.0	9.3	26.5	6.2	72.1	60.0	6.5	9.5	14.2	5.1	30.3	59.4	11.6	9.8	15.4	19.8	9.2	17.9	31.0	11.8	16.1	49.1	13.7	9.5	4.6	65.1	5.1	39.0	22.5	7.8	13.8	27.9	59.3	4.8	2.9	23.6	7.9	198.0	74.7	3.9	27.3	65.6	20.2	30.7	6.2	5.7	0.0	14.1	73.4	10.1	5.7	7.3	6.7	16.9	0.0	5.3	0.0	13.6	5.7	6.1	0.0	1.3	35.1	6.8	30.6	8.3	8.3	75.0	0.0	0.4	0.1	19.1	5.5	0.0	0.0	6.9	2.6	3.8	0.0	16.8	0.2	15.1	15.1	0.9	0.0	8.4	30.8	21.5	6.1	2.4	14.0	65.6	19.7	4.0	63.1	5.9	0.0	0.0	0.0	31.6	0.0	95.6	0.0	1.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	45.5	62.5	58.2	35.4	40.0	43.0	72.1	60.0	59.4	49.1	65.1	59.3	194.8	16.0	21.7	426.7	0.6	41.0	6.2	5.1	29.6	21.9	17.7	24.0	18.5	5.7	18.3	46.0	6.2	20.6	0.8	4.4	7.9	3.1	0.8	45.3	36.2	104.7	4.8	0.0	16.4	2.4	59.5	66.5	8.2	40.1	2.5	2.3	60.3	8.1	8.8	3.3	120.7	5.3	10.2	42.4	18.5	1.6	18.3	15.6	42.7	179.9	4.9	100.4	0.0	186.5	328.6	1.5	2.9	28.2	1.3	6.4	2.3	15.0	15.5	4.7	78.9	49.9	73.2	0.5	3.7	46.3	33.0	32.7	1.6	3.1	7.2	7.4
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	1.3	1.2	1.0	2.9	1.2	6.0	2.8	1.6	1.5	1.6	0.8	2.2	2.8	2.0	2.2	2.1	1.4	1.0	1.0	0.8	1.0	1.0	1.4	1.3	4.2	1.1	1.2	1.8	1.4	3.9	1.6	2.0	1.1	2.1	3.0	5.7	1.8	1.5	1.3	2.1	2.2	1.8	1.1	2.1	2.1	6.7	1.0	4.3	1.5	0.9	3.6	1.4	1.6	1.3	17.0	5.2	13.1	11.5	1.5	2.6	19.3	10.7	4.7	13.5	15.6	9.0	8.5	18.5	8.0	3.7	8.0	14.8	18.0	6.5	18.6	8.9	17.8	16.2	10.9	11.3	0.9	26.8	14.5	1.3	2.8	11.4	9.0	2.7	7.3	12.2	25.8	17.6	6.7	4.8	22.2	12.9	17.5	11.1	10.7	16.1	25.9	9.4	6.5	8.1	9.5	14.0	9.9	17.0	8.7	9.4	8.6	15.9	3.8	9.5	11.6	10.9	14.9	7.4	18.5	24.6	7.7	17.7	5.3	3.9	0.1	1.0	0.7	0.6	0.9	1.6	0.8	0.7	0.5	0.7	0.7	0.6	0.7	0.6	0.5	0.2	0.9	0.3	1.0	1.2	1.6	1.5	0.8	1.0	1.1	1.2	1.1	1.1	1.0	1.3	7.2	0.0	2.3	8.5	12.8	4.0	2.8	7.1	6.8	19.4	8.4	9.4	2.9	7.2	5.9	1.8	16.7	13.6	13.5	2.4	1.9	7.5	15.7	7.4	5.8	5.8	4.2	33.2	7.6	5.6	17.3	7.0	7.1	5.4	5.7	15.0	6.8	3.1	9.1	8.4	9.6	4.8	14.2	8.4	4.7	6.2	8.1	5.8	1.8	5.6	6.1	13.3	20.6	5.0	16.1	6.2	2.7	10.9	19.7	4.5	2.2	4.3	4.9	23.0	0.0	12.6	5.9	77.4	36.0	11.9	4.1	5.1	7.9	4.0	8.8	2.1
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 8151.3;Langerhans cells: 13855.3;Prostatic glandular cells: 7419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3422.0;non-classical monocyte: 2519.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 3422.0;monocytes: 2519.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 551.5;hTERT-HME1: 821.9;RPTEC TERT1: 694.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781"	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	843.8	307.2	171.6	568.4	175.0	1484.9	454.0	167.0	279.5	337.8	219.7	339.0	630.9	319.0	170.8	407.4	322.7	600.8	604.4	171.8	202.0	739.5	885.0	1252.9	431.3	186.2	178.6	197.9	229.3	268.7	548.5	603.5	188.6	413.1	364.3	108.3	786.6	342.2	66.2	200.1	509.5	175.4	185.5	706.6	562.6	116.2	197.7	231.8	757.0	79.0	333.4	536.2	241.6	206.6	62.2	123.1	30.8	48.3	256.0	103.8	83.6	89.2	149.8	21.7	50.2	59.0	179.3	102.7	160.0	21.1	172.4	91.9	16.4	551.5	78.8	34.1	74.3	49.9	60.0	503.5	327.5	48.8	46.1	216.2	412.0	169.0	821.9	197.2	181.5	16.4	21.4	88.4	63.8	59.1	35.9	219.1	20.6	455.2	56.3	30.0	19.8	126.1	694.6	126.0	8.7	8.9	91.2	204.8	179.2	222.3	31.5	10.7	68.9	175.6	8.9	106.6	44.7	37.1	9.6	23.1	104.8	28.8	34.2	557.6	720.4	478.9	66.0	1930.3	41.6	125.3	77.4	53.8	324.8	79.1	45.9	53.3	3422.0	33.8	2519.0	161.2	231.5	742.5	171.6	175.0	167.0	279.5	171.8	202.0	186.2	178.6	188.6	185.5	197.7	206.6	798.0	734.0	1585.4	98.9	875.4	2435.0	3753.4	8151.3	1203.6	54.9	895.9	574.4	454.2	574.7	5509.5	829.4	116.7	853.1	409.5	1249.8	1189.5	5869.5	17.3	3940.5	859.6	1554.6	526.9	195.2	40.3	3065.2	1643.7	1211.3	1347.1	5651.2	870.6	110.6	558.3	994.1	2115.2	72.3	77.6	852.3	3733.2	4693.0	13855.3	55.2	165.3	5207.7	3922.0	213.6	5274.6	501.9	189.5	90.5	14.2	2774.1	1293.8	92.2	1091.8	7419.8	1851.7	2065.2	4274.2	114.4	151.2	765.7	857.5	31.6	14.7	1022.4	1468.3	2880.9	899.3	260.2	804.4	6549.5
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1060.0;Proximal tubular cells: 1313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced					NA	NA		11000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	28.3	102.8	27.7	9.6	28.4	11.3	26.8	28.7	37.5	26.2	32.9	30.5	92.7	25.2	25.1	17.2	26.1	15.8	33.5	27.9	29.2	97.6	139.8	19.0	9.5	28.4	28.5	44.5	47.4	36.0	30.4	8.6	28.3	27.4	15.4	21.1	27.0	16.4	31.8	19.0	65.5	17.1	28.9	29.1	33.4	17.1	29.2	8.0	28.2	20.5	11.8	22.6	19.8	28.8	17.9	27.3	24.1	44.9	37.5	43.6	3.0	12.2	44.3	27.2	33.8	9.3	8.9	3.3	6.8	11.9	30.4	15.3	15.4	11.1	18.0	5.1	41.9	3.6	15.8	49.2	45.3	0.1	12.3	54.6	28.3	16.2	11.9	36.6	39.9	3.5	2.5	5.3	28.8	1.6	0.3	4.1	9.9	10.2	16.6	6.6	11.8	4.2	42.8	20.6	2.6	22.4	11.4	23.4	26.3	21.4	15.5	3.3	17.3	13.2	8.5	0.3	19.3	9.9	9.6	0.7	44.5	5.2	19.7	7.6	41.9	9.5	14.2	28.3	16.7	13.6	12.0	14.6	30.7	12.7	17.8	12.7	2.7	12.4	14.9	14.0	19.5	22.5	27.7	28.4	28.7	37.5	27.9	29.2	28.4	28.5	28.3	28.9	29.2	28.8	70.3	44.8	121.2	76.4	76.2	82.6	90.6	83.2	134.3	121.9	124.1	140.8	62.8	257.4	82.6	80.9	68.8	70.8	68.7	80.4	422.6	135.9	19.4	66.9	79.0	69.8	132.7	25.9	86.2	66.2	33.7	97.3	43.3	59.2	62.1	181.4	114.5	289.0	165.3	129.5	64.6	116.4	124.1	142.7	165.1	28.0	181.7	110.7	94.3	25.3	103.4	156.9	49.4	32.6	36.9	92.8	129.1	119.2	92.9	108.6	1060.0	1313.7	83.9	148.6	72.3	91.2	92.2	30.4	7.8	79.6	56.1	79.2	67.0	321.2	116.8	103.9
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345377-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 374.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 113.7"	"Group enriched"	"Detected in all"	4	"NK-cells: 63.4;T-cells: 113.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	16.1	10.3	13.4	28.8	19.1	42.8	13.2	0.8	32.2	11.4	2.6	29.9	16.0	13.6	24.0	12.2	17.9	17.6	26.0	23.4	0.4	10.8	15.4	15.7	38.1	0.3	6.1	13.8	28.8	32.4	22.5	4.9	0.0	22.5	18.5	29.8	44.0	25.9	89.5	21.4	21.0	11.8	1.4	27.4	18.5	6.7	0.9	374.2	24.5	49.0	27.8	24.6	12.3	11.0	2.1	0.0	12.7	0.0	17.2	16.6	1.4	3.4	12.3	2.9	9.8	0.5	22.9	4.7	0.4	4.1	1.0	0.2	46.4	5.4	5.9	455.3	28.0	0.1	1.1	0.0	2.5	26.7	3.8	7.4	4.0	0.1	0.6	35.1	3.3	213.3	0.6	24.3	2.2	0.4	107.7	33.9	18.5	1.5	1.5	126.5	6.2	4.9	4.8	15.7	5.9	34.5	0.0	3.9	0.3	10.0	98.5	192.7	1.7	12.6	7.9	5.9	3.7	1.3	0.4	10.0	10.3	101.3	5.7	21.1	1.9	4.6	44.2	2.0	78.6	1.6	29.9	23.0	3.5	13.0	113.7	69.5	4.1	63.4	1.1	4.0	6.0	26.6	13.4	19.1	0.8	32.2	23.4	0.4	0.3	6.1	0.0	1.4	0.9	11.0	19.3	25.6	29.6	48.3	44.6	14.3	12.3	10.9	12.0	12.1	33.2	18.0	70.0	22.8	15.0	31.3	87.6	0.5	71.1	11.0	1.9	16.9	8.2	31.6	15.3	17.0	32.4	22.5	180.2	12.5	0.2	16.4	8.6	11.6	23.4	20.6	35.0	20.9	9.3	0.0	283.4	30.8	4.1	41.5	36.4	4.3	8.4	45.5	10.6	41.2	23.0	15.5	56.7	168.9	28.8	10.5	23.6	8.2	20.6	21.7	24.6	9.1	50.9	63.1	6.6	8.3	10.2	3.2	9.3	20.5	22.0	0.3	84.0	16.8	25.7	19.7
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 13.9;intestine: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.7;Enteroendocrine cells: 99.7;Excitatory neurons: 363.9;Intestinal goblet cells: 66.9;Paneth cells: 70.0;Undifferentiated cells: 84.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Group enriched"	"Detected in many"	84	"basal ganglia: 10.9;cerebral cortex: 13.9;hippocampal formation: 4.6;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 45.1;THP-1: 59.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 29.2"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 46.4;hippocampal formation: 37.1"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.7	4.8	0.0	4.3	10.9	0.3	2.2	0.0	13.9	2.7	0.0	34.2	1.5	1.7	0.9	0.8	1.4	1.3	0.7	4.6	0.0	4.0	3.0	0.9	0.5	0.0	0.0	1.9	3.9	2.1	1.0	0.6	0.0	1.9	39.5	0.8	1.5	2.8	2.2	1.8	5.7	3.0	0.0	0.7	1.0	2.8	0.0	0.2	1.6	2.7	1.0	1.6	3.1	3.9	2.6	1.7	17.6	8.1	8.3	9.9	1.3	6.2	8.9	4.4	5.7	0.4	5.8	0.9	0.2	13.3	6.9	0.5	14.0	3.7	7.0	9.4	12.3	40.3	4.1	4.9	1.9	18.7	17.1	4.8	6.4	8.8	5.6	11.3	0.4	6.0	45.1	0.0	12.8	0.9	0.8	22.9	3.2	2.0	2.9	1.7	6.0	0.1	6.6	0.6	3.8	0.0	3.1	0.0	9.5	3.1	3.6	59.8	6.2	31.5	5.9	10.1	16.6	2.6	8.9	25.9	21.7	14.6	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	13.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.4	0.0	1.1	18.6	0.6	1.8	2.7	0.5	0.6	2.4	0.9	0.4	1.5	0.0	0.7	0.0	4.2	0.1	0.2	129.7	1.9	0.3	1.0	0.9	3.9	1.5	99.7	0.0	363.9	2.7	0.3	3.6	0.0	0.7	0.0	1.6	1.8	5.4	0.8	0.0	3.5	66.9	0.0	2.5	3.0	0.9	2.5	1.0	5.4	9.4	0.6	0.5	0.0	21.1	34.1	1.2	70.0	1.2	0.0	4.3	19.1	7.6	0.2	0.5	0.0	1.7	10.4	6.1	4.1	0.8	3.0	0.1	1.3	3.9	84.7	2.2
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092284-85243911	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 6.8;Distal tubular cells: 3.9;Early spermatids: 5.4;granulocytes: 6.3;Late spermatids: 14.0;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	12.8	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	6.8	0.0	0.0	0.0	0.2	0.0	3.9	0.0	5.4	0.3	0.3	1.2	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.2	6.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	14.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.4	0.7	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0
SAV1	"salvador, WW45, WWP4"	ENSG00000151748	"Salvador family WW domain containing protein 1"	Q9H4B6	14	50632058-50668306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001808	Approved		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA001808: AB_2666441"	"prognostic favorable (2.92e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.20e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (2.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.90e-3)"	32.2	16.4	14.0	12.8	16.7	7.3	35.3	15.1	16.9	24.5	22.0	17.0	15.3	23.3	18.8	15.8	21.2	26.2	24.2	12.8	15.0	22.9	17.6	20.2	15.7	16.5	15.1	37.7	34.4	27.0	8.5	17.0	16.1	27.6	12.6	17.6	45.5	19.2	23.1	17.8	13.2	17.7	14.7	18.6	18.9	30.6	16.6	10.3	34.2	27.1	14.7	16.7	18.7	19.6	96.3	10.7	17.8	12.4	43.5	39.8	22.4	26.6	87.3	34.1	43.4	16.0	47.8	14.9	63.9	26.4	17.8	42.8	25.7	28.9	62.9	45.6	20.8	16.4	16.4	11.4	21.3	17.9	14.0	24.9	36.5	15.3	33.8	25.8	24.5	15.9	27.5	7.2	42.5	17.9	15.1	11.0	33.1	21.6	17.3	17.2	49.5	6.1	21.5	13.6	22.2	16.8	47.1	27.7	41.3	28.9	20.3	18.0	17.7	16.2	55.5	22.4	16.4	11.3	15.4	9.0	11.1	7.2	22.1	0.6	0.3	0.0	0.9	0.3	0.9	3.3	0.7	0.5	0.3	3.4	0.5	0.7	0.5	0.5	0.4	1.2	1.0	0.4	14.0	16.7	15.1	16.9	12.8	15.0	16.5	15.1	16.1	14.7	16.6	19.6	76.4	35.3	44.0	9.4	35.8	65.9	37.2	19.1	24.5	19.6	76.4	60.6	39.1	15.7	35.1	18.4	25.0	19.9	14.7	11.2	17.6	40.5	92.5	39.6	47.3	76.9	5.4	27.0	10.4	47.6	23.0	59.3	11.7	58.1	2.5	46.4	59.3	14.5	10.5	5.0	10.0	10.1	10.2	13.5	61.5	26.1	66.8	34.1	30.2	12.2	11.6	26.9	2.1	12.5	27.0	66.5	14.6	42.5	7.4	81.4	12.1	16.3	33.3	26.4	6.6	41.8	45.1	41.4	38.8	14.6	59.5	23.1	9.4	17.7	9.6	34.1
SAXO1	"C9orf138, FAM154A, MGC35182"	ENSG00000155875	"Stabilizer of axonemal microtubules 1"	Q8IYX7	9	18858906-19049358	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	94	"testis: 38.5"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 572.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023899	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA023899: AB_1845813"	"unprognostic (4.23e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.28e-3)"	"unprognostic (8.64e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.38e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.40e-2)"	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	38.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	0.0	5.2	0.2	0.0	0.1	0.0	0.6	0.2	0.7	0.9	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	572.8	1.2	0.4	0.6	0.0	0.0	1.0	0.4	0.0	0.3	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	1.1	0.1	0.0	1.2	0.0	65.8	4.7	0.2	0.0	1.0	0.3	0.2	0.0	1.5	3.7	0.1	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.2	11.6	2.4	0.2	0.0	0.1	0.3	0.1	0.1	0.2
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 59.9;testis: 21.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.1	2.1	0.3	2.2	0.6	3.2	2.3	2.7	2.3	8.3	1.3	0.7	2.2	17.9	0.6	59.9	1.0	1.3	2.5	2.3	2.7	0.9	8.0	1.2	3.2	5.0	1.7	1.6	4.7	4.9	0.4	2.4	2.6	2.0	6.9	2.8	1.2	1.3	2.1	1.6	0.6	3.1	1.2	2.5	21.6	2.5	2.6	3.5	0.8	1.6	1.3	1.0	3.7	1.4	1.9	1.1	4.1	0.9	1.8	0.5	0.5	0.3	0.8	1.5	0.2	2.3	1.4	1.0	0.0	2.2	10.5	1.8	1.6	1.8	1.0	6.8	0.5	3.4	0.0	0.1	0.3	0.4	1.2	2.2	1.4	1.2	2.3	1.7	2.9	10.0	0.7	1.0	1.0	0.5	0.0	2.7	0.5	0.8	1.4	0.5	0.9	0.8	0.9	7.8	1.2	1.1	0.0	1.5	0.6	4.0	0.4	0.2	2.0	1.1	4.2	0.8	2.1	2.6	0.9	1.9	0.5	1.3	0.0	0.0	3.0	0.5	0.0	0.8	1.3	0.2	1.5	0.1	3.3	0.9	0.4	0.0	2.0	0.1	0.8	0.0	0.3	2.1	2.2	2.3	2.7	2.5	2.3	3.2	5.0	2.4	3.1	2.5	3.7	1.8	0.0	2.7	9.1	1.5	0.0	2.0	0.0	2.8	2.7	4.5	4.1	2.7	1.5	24.1	3.7	4.2	0.5	0.9	0.1	1.9	0.7	90.9	71.5	1.5	0.9	2.4	0.8	21.1	0.5	0.4	1.5	10.2	2.0	1.3	3.7	0.4	0.3	0.1	0.0	16.4	1.9	0.0	0.6	0.0	175.4	2.5	0.5	0.0	3.7	0.0	3.7	0.0	9.0	8.0	0.3	0.1	2.2	1.9	1.5	0.3	4.6	201.9	5.0	6.6	1.0	1.0	57.7	12.7	0.9	0.0	0.3	0.7	3.0	0.5	1.6
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294219	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 105.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: AB_2681280"	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	13.3	7.6	8.6	6.2	9.2	4.0	9.2	6.4	7.7	15.2	5.1	9.3	6.8	11.3	9.1	11.6	10.2	10.4	8.9	6.7	7.7	13.8	9.5	7.4	3.9	6.9	8.1	18.0	5.1	17.1	4.6	14.2	7.2	10.6	10.5	14.9	9.3	11.4	4.7	7.4	6.6	10.9	7.1	7.8	9.5	10.8	7.1	6.1	16.7	8.9	4.2	11.2	8.2	8.2	15.1	12.1	20.8	15.0	27.1	35.4	105.4	11.6	20.9	13.1	18.2	9.1	18.1	5.8	6.2	20.6	19.1	9.8	12.5	9.8	22.9	6.2	8.6	2.5	9.1	11.9	10.6	5.6	8.0	17.5	12.3	6.6	25.8	20.2	21.8	12.1	5.1	5.2	15.8	4.3	8.1	1.5	9.1	13.5	13.3	7.5	14.5	7.6	11.9	13.4	6.9	15.4	15.7	22.4	10.0	10.6	6.7	4.0	24.4	23.1	11.5	24.3	9.5	1.7	4.6	8.0	17.4	2.7	17.0	0.0	0.7	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	1.1	0.3	1.6	0.1	0.1	0.2	8.6	9.2	6.4	7.7	6.7	7.7	6.9	8.1	7.2	7.1	7.1	8.2	50.2	44.8	83.9	224.6	16.4	25.5	43.4	24.1	27.3	35.1	16.4	14.5	31.4	22.8	30.8	16.5	75.0	13.8	14.6	20.3	3.9	13.9	18.3	17.8	31.1	40.9	43.8	11.4	244.9	8.8	12.9	40.0	40.8	30.1	21.5	41.7	49.6	16.6	18.6	37.0	367.4	16.2	24.4	55.0	34.1	9.2	51.0	44.8	30.2	273.6	37.6	12.0	29.9	290.5	228.4	13.5	21.2	27.1	9.5	56.5	14.5	13.1	38.3	71.6	26.3	44.0	34.8	24.5	17.4	30.6	30.7	13.8	20.6	25.9	20.1	47.4
SBK2	SGK069	ENSG00000187550	"SH3 domain binding kinase family member 2"	P0C263	19	55528611-55537133	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 87.2;tongue: 28.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.5;Late spermatids: 2.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;MCF7: 2.5;NTERA-2: 7.7;RH-30: 7.0;SuSa: 3.5;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030631	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA030631: AB_10602088"	"unprognostic (1.33e-1)"			"unprognostic (1.85e-3)"	"unprognostic (4.57e-1)"	"unprognostic (3.49e-1)"				"unprognostic (5.43e-3)"	"unprognostic (4.18e-3)"		"unprognostic (2.08e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-1)"			0.6	0.0	0.1	0.0	0.2	0.5	0.0	0.9	0.1	0.0	0.8	0.0	0.2	0.3	0.0	0.2	0.0	0.1	87.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.4	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.3	0.0	2.5	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.6	1.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.5	2.5	0.0	0.1	7.7	0.0	0.0	0.2	7.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	3.5	0.0	0.2	0.1	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SBNO1	"FLJ10701, FLJ10833, MOP3, Sno"	ENSG00000139697	"Strawberry notch homolog 1"	A3KN83	12	123289109-123364847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.6"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 265.4;Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042388	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042388: AB_10795704"	"unprognostic (1.61e-2)"	"unprognostic (9.61e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-2)"	5.5	5.7	5.9	6.8	7.4	16.8	6.5	11.5	9.2	5.4	5.7	6.1	5.3	6.7	6.4	7.2	5.5	4.2	5.3	8.2	5.7	6.4	6.2	4.8	8.9	5.7	5.4	7.2	5.0	6.9	5.1	5.6	5.8	6.8	6.6	10.2	5.1	6.3	11.6	8.3	5.9	6.1	5.6	7.1	5.3	37.6	5.9	9.6	10.0	7.8	8.7	5.7	5.5	7.9	14.0	24.3	11.7	21.6	16.6	11.9	22.8	11.7	11.6	10.0	8.2	19.1	8.3	31.0	13.6	14.4	11.0	16.8	22.3	13.9	16.8	19.8	9.2	27.1	15.6	18.0	10.2	33.8	22.9	10.0	13.1	14.5	15.3	13.8	10.9	16.4	35.2	8.6	18.7	14.7	20.2	25.0	18.0	13.5	13.2	20.7	15.4	15.9	10.8	31.3	18.3	9.5	19.5	16.4	13.6	13.1	24.4	17.8	14.7	15.1	16.7	16.7	11.9	9.9	19.5	34.2	10.3	21.9	17.2	5.0	4.5	4.5	7.2	5.0	7.5	6.0	6.6	5.8	4.0	5.0	6.9	6.9	5.9	4.6	8.0	4.4	5.2	4.5	5.9	7.4	11.5	9.2	8.2	5.7	5.7	5.4	5.8	5.6	5.9	7.9	29.8	28.9	25.7	42.1	59.3	63.3	48.1	40.4	37.0	92.6	38.0	30.4	39.6	25.8	38.3	36.8	79.2	65.8	54.3	22.1	23.5	36.5	62.5	53.1	56.0	34.7	40.2	47.9	58.3	27.2	49.6	36.5	23.9	44.0	29.2	47.3	32.2	26.7	26.2	63.9	47.6	25.1	52.9	35.3	46.4	35.2	25.4	41.2	33.8	31.9	56.5	49.7	54.6	27.2	46.2	38.1	21.2	60.5	33.0	55.5	29.8	27.5	36.4	59.9	26.3	51.5	58.1	265.4	219.3	40.7	61.4	106.0	53.3	42.1	38.9	44.3
SBNO2	"FLJ00173, KIAA0963, Sno, Stno"	ENSG00000064932	"Strawberry notch homolog 2"	Q9Y2G9	19	1107637-1174268	"Predicted intracellular proteins"	"Differentiation, Osteogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 45.3;HDLM-2: 65.2;U-266/70: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041867	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA041867: AB_2677715"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (8.48e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (7.98e-8)"	"unprognostic (1.34e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.88e-1)"	61.3	42.8	2.8	8.5	2.9	11.4	40.2	1.8	5.0	35.7	4.6	31.8	1.9	28.0	0.2	51.8	33.8	3.0	27.1	0.9	3.2	57.8	41.5	68.4	2.7	12.0	5.4	30.9	21.4	0.2	37.8	2.4	5.4	42.7	0.3	0.1	42.9	0.7	38.6	43.0	30.8	2.1	3.5	60.0	30.0	19.3	8.6	1.5	34.2	0.5	2.5	32.1	35.7	5.5	45.3	5.7	0.8	0.5	0.1	2.8	16.1	13.0	1.4	2.9	1.6	0.3	7.3	9.0	18.2	2.2	2.3	14.6	0.0	2.0	1.0	65.2	9.8	9.9	18.3	0.1	2.4	5.8	28.7	6.8	1.8	4.3	1.7	2.2	2.8	3.9	15.3	12.4	1.1	5.5	5.7	7.4	12.3	0.9	19.1	13.1	7.9	11.0	4.0	2.1	10.3	16.1	7.9	14.2	15.8	1.1	5.0	4.6	15.0	7.9	6.2	23.6	22.1	49.0	24.8	7.8	15.7	5.3	9.0	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.5	0.1	0.1	0.1	0.0	0.1	2.8	2.9	1.8	5.0	0.9	3.2	12.0	5.4	5.4	3.5	8.6	5.5	28.8	9.6	22.8	4.6	8.8	14.9	13.2	10.7	11.4	5.7	39.7	23.9	5.4	5.7	18.8	3.7	2.1	4.7	13.2	22.3	3.9	9.4	2.8	19.3	21.9	25.3	3.0	0.4	4.4	6.8	5.7	13.1	33.6	39.1	3.8	10.4	13.9	10.8	10.3	6.7	3.4	10.2	14.2	15.9	20.7	1.6	9.3	20.2	8.8	5.6	13.0	3.3	5.2	3.5	5.8	17.9	15.1	4.1	16.2	20.8	7.9	1.8	14.5	4.9	6.6	12.0	12.9	7.7	9.0	10.6	18.8	10.9	14.4	9.5	12.3	22.1
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1056.2;skin 1: 2444.7;vagina: 756.5"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 1017.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 355.2;melanoma: 153.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.9;cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.2;ASC TERT1: 107.5;HSkMC: 146.1;U-2197: 51.6;U-87 MG: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		89000000		"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	2.9	0.6	0.5	0.1	3.9	0.7	94.3	0.4	1.3	465.7	0.3	1.0	0.0	0.5	0.0	1056.2	0.2	0.3	1.4	0.5	0.4	0.4	1.7	0.9	0.0	0.5	0.4	0.7	1.5	0.0	0.9	0.3	0.5	0.5	0.0	0.0	351.8	0.0	13.1	2444.7	0.7	0.2	0.4	0.5	1.1	1.0	0.5	6.5	0.7	0.0	168.9	1.1	756.5	0.4	0.1	0.1	0.0	0.1	62.2	107.5	0.1	5.1	7.2	2.4	0.9	0.0	0.1	0.1	1.2	4.8	1.7	0.3	0.0	1.8	1.0	0.1	0.2	0.0	0.1	0.0	0.6	0.0	0.1	146.1	8.2	30.0	7.1	2.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.3	0.2	0.0	0.4	18.4	3.8	51.6	1.4	0.5	0.3	0.0	119.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.9	0.4	1.3	0.5	0.4	0.5	0.4	0.5	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	89.3	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.4	0.8	1.8	0.0	0.0	0.2	0.6	0.2	3.1	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	25.2	4.0	0.0	0.2	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.2	0.2	13.4	1017.6	0.3	0.7	0.0	0.0	0.4
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064543-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 36.5;Collecting duct cells: 42.3;Muller glia cells: 48.5;Peritubular cells: 26.7;Smooth muscle cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 7.5;pons: 6.3;spinal cord: 7.7;white matter: 16.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 9.5;RPTEC TERT1: 16.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.4	3.0	0.4	1.4	0.5	0.3	3.4	1.2	0.6	5.2	0.6	4.7	0.9	4.4	4.5	9.5	8.2	1.3	2.3	0.8	0.8	8.3	0.6	3.9	1.5	7.5	0.9	3.3	1.2	0.1	1.6	9.4	6.3	15.1	1.1	9.0	4.6	10.8	0.6	1.9	2.5	8.9	7.7	1.1	9.6	2.6	0.4	0.2	2.5	1.4	0.2	17.9	4.7	16.7	0.2	0.2	0.4	0.5	0.0	0.0	1.3	9.5	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.3	0.9	0.5	0.2	0.2	0.1	0.0	16.9	0.1	0.5	0.5	1.0	0.4	0.1	3.1	0.2	0.1	0.5	0.1	1.5	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.6	0.8	0.8	7.5	0.9	6.3	7.7	0.4	16.7	0.6	9.6	0.0	1.0	0.2	1.3	6.9	0.0	36.5	2.4	5.8	11.6	3.8	4.3	0.0	42.3	2.1	0.2	1.0	0.5	1.9	1.3	10.3	7.2	1.4	1.7	0.0	0.0	0.5	0.0	0.4	13.2	10.7	14.9	0.0	0.2	1.4	0.2	0.4	0.0	0.4	0.2	0.0	0.0	0.4	3.2	12.2	0.4	3.6	0.0	0.0	48.5	0.0	1.0	0.2	0.6	0.0	26.7	0.0	1.8	0.0	3.6	0.0	2.2	6.6	0.9	28.7	11.4	4.4	0.6	1.3	0.4	0.5	0.2	0.1	0.5
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642209-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: AB_2682536"	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	25.4	22.6	24.5	19.0	22.8	17.4	23.7	11.2	31.1	27.2	0.0	30.3	19.3	32.2	6.9	28.1	26.5	18.0	28.3	29.5	13.6	21.1	26.2	21.5	20.4	31.1	21.7	28.9	22.2	17.8	29.4	16.0	22.7	26.7	8.7	11.2	23.2	11.3	47.3	28.3	22.3	15.1	10.7	23.5	23.0	28.2	22.5	17.3	24.7	16.9	13.9	28.7	24.9	21.3	84.1	143.1	38.7	64.0	18.0	17.1	47.2	61.9	20.0	28.4	23.8	78.2	50.6	48.5	41.4	22.9	42.8	63.2	28.0	37.9	8.3	75.4	80.5	54.6	72.9	40.1	30.8	52.1	52.0	28.7	23.5	34.1	24.0	27.4	23.1	19.5	71.6	48.1	22.6	53.4	53.2	28.3	49.6	37.8	86.1	64.7	53.6	50.1	18.7	118.5	57.2	62.7	63.5	66.0	23.4	23.4	46.2	29.0	63.9	102.0	59.1	37.0	91.6	68.5	110.2	46.3	61.6	32.8	59.1	2.0	1.4	1.4	1.9	1.2	1.2	2.8	1.0	1.3	1.1	2.1	1.0	1.1	3.6	1.0	1.1	2.4	0.2	1.8	24.5	22.8	11.2	31.1	29.5	13.6	31.1	21.7	22.7	10.7	22.5	21.3	16.4	6.4	0.0	7.8	17.0	12.1	8.8	12.4	22.2	12.3	15.7	12.7	3.0	12.8	6.0	22.0	4.2	14.6	13.4	32.1	7.9	13.0	31.8	18.6	14.1	10.8	14.4	9.4	7.0	13.1	14.7	12.9	17.3	21.1	5.7	22.1	18.2	14.7	14.5	10.1	8.4	21.1	12.2	9.1	6.9	97.4	22.1	12.3	10.6	8.4	9.5	10.6	10.3	9.0	8.7	19.0	22.7	23.7	18.0	13.4	22.9	13.1	10.6	8.0	13.1	16.5	17.1	24.9	17.8	23.0	11.9	22.0	12.6	17.5	19.8	11.1
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	31.1	21.2	22.3	41.7	29.6	89.6	40.1	38.7	23.7	28.0	36.5	31.6	29.4	34.5	41.2	26.7	26.6	30.9	30.0	19.7	25.2	29.9	42.4	31.0	54.7	30.2	26.5	37.7	23.5	39.8	17.2	31.5	32.5	29.4	34.9	60.8	27.0	24.9	35.2	40.3	31.7	29.2	25.9	43.0	29.6	29.0	26.3	44.4	34.7	38.6	49.8	31.8	23.6	38.3	56.4	49.4	60.6	50.7	41.0	55.7	56.0	64.7	52.6	54.8	39.3	180.3	60.1	116.7	71.0	69.3	32.3	54.0	62.4	52.2	61.9	62.1	42.1	108.8	64.5	47.0	32.3	115.6	70.4	46.4	54.7	47.2	71.1	62.9	57.1	50.0	85.1	62.3	70.3	51.9	87.2	63.4	47.0	0.6	67.4	70.2	81.7	57.9	52.4	70.5	34.2	35.0	71.9	60.8	35.0	47.6	56.4	123.4	71.6	55.9	46.3	42.5	34.9	44.4	36.0	187.9	47.0	245.0	21.8	39.4	19.6	29.5	21.7	19.9	19.9	28.6	20.6	21.3	16.0	28.2	22.2	20.0	51.5	21.3	23.5	30.2	20.8	12.9	22.3	29.6	38.7	23.7	19.7	25.2	30.2	26.5	32.5	25.9	26.3	38.3	180.2	176.3	164.0	91.4	200.4	128.5	127.6	87.4	132.1	134.9	101.8	96.8	187.4	88.6	131.7	79.1	127.2	86.3	229.6	96.1	54.8	117.8	57.7	133.3	148.7	146.2	103.3	118.4	75.3	107.9	72.5	135.3	69.3	152.4	222.7	224.7	114.5	138.9	109.8	107.7	81.7	123.3	67.1	158.0	160.9	39.2	121.8	157.3	67.6	141.5	211.7	105.2	185.3	119.6	122.4	103.4	103.4	103.8	126.4	121.6	97.2	83.5	149.6	198.4	124.9	176.3	129.7	157.6	82.5	116.4	120.5	61.0	170.6	114.2	107.5	145.0
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143528	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 200.1;Excitatory neurons: 327.4;Inhibitory neurons: 171.6;Rod photoreceptor cells: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	1.7	2.5	3.3	1.8	3.7	2.9	1.9	0.3	4.2	2.1	5.2	1.9	1.1	2.1	1.5	1.4	2.1	1.2	1.3	2.4	0.3	1.5	1.5	3.2	2.9	0.0	0.4	2.7	1.7	1.5	1.7	0.9	0.0	1.9	1.7	7.5	1.4	1.0	1.7	2.4	1.5	1.3	0.0	1.9	1.5	1.9	0.9	11.2	1.9	1.0	2.3	1.5	1.7	0.9	3.2	2.4	3.2	3.1	1.7	4.2	5.4	2.0	4.1	2.1	2.9	3.1	3.0	5.7	1.5	2.0	2.4	5.3	4.2	2.2	4.2	4.1	1.5	3.8	4.4	2.8	2.4	4.0	2.8	1.6	1.8	3.2	2.1	3.5	3.0	10.2	5.4	6.6	3.2	3.5	13.0	2.8	3.2	6.1	2.6	8.1	5.1	5.0	1.4	4.3	3.3	2.1	4.7	2.5	2.4	3.5	6.3	1.8	3.1	1.9	3.5	3.2	3.5	3.6	7.3	5.5	2.2	3.3	2.8	0.2	0.3	0.0	0.2	0.4	0.3	0.5	0.4	0.3	0.2	0.6	0.6	0.4	0.2	0.6	0.1	0.8	0.7	0.3	3.3	3.7	0.3	4.2	2.4	0.3	0.0	0.4	0.0	0.0	0.9	0.9	7.3	70.5	28.2	49.0	19.7	2.8	7.9	6.0	10.2	46.4	8.7	5.6	4.8	14.3	9.4	18.4	200.1	6.6	14.6	6.3	1.9	4.1	14.5	9.4	8.5	8.0	13.1	23.3	327.4	2.0	4.7	7.5	8.2	14.2	5.1	74.5	12.5	8.7	4.2	16.8	171.6	8.4	16.2	6.6	5.5	5.9	9.6	5.4	3.6	55.3	5.4	25.8	22.6	72.9	61.0	2.9	7.3	6.0	14.3	9.6	8.3	3.1	10.3	136.5	0.0	11.3	8.3	34.7	21.5	12.4	4.3	2.6	14.8	28.9	11.2	4.4
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905372-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	23.2	27.4	31.1	15.5	39.9	11.4	25.4	41.3	33.3	28.1	33.6	23.3	19.8	26.0	17.5	39.9	38.3	19.5	15.5	28.9	33.1	34.4	28.3	25.5	15.6	51.5	42.9	27.1	36.5	15.8	31.8	18.8	47.7	31.7	9.8	7.4	43.9	20.4	13.9	36.3	20.3	12.3	39.7	25.1	26.4	22.0	40.6	8.3	32.7	5.8	9.4	22.0	25.0	53.5	53.6	53.9	25.7	56.8	50.7	31.7	29.6	35.5	33.1	39.3	46.7	44.9	51.1	22.5	32.1	30.7	23.1	63.7	24.7	38.2	14.5	34.8	21.7	15.8	19.0	44.3	65.6	16.9	23.2	48.8	24.2	34.8	21.2	32.9	27.2	25.2	35.7	25.3	23.3	67.8	21.5	31.6	38.8	31.1	18.6	25.9	18.1	34.6	49.8	47.5	33.8	45.0	23.9	49.9	31.4	18.1	50.6	41.5	29.6	44.8	30.5	81.1	35.7	57.8	62.6	21.0	59.1	26.9	30.1	1.7	4.4	1.9	3.9	4.9	2.0	5.1	2.7	2.6	4.8	3.4	1.5	2.9	2.1	5.8	4.5	12.0	2.3	3.7	31.1	39.9	41.3	33.3	28.9	33.1	51.5	42.9	47.7	39.7	40.6	53.5	16.9	9.6	7.3	12.1	22.9	17.1	25.0	20.8	33.0	19.7	40.0	23.5	3.0	21.5	14.1	49.7	75.0	40.0	59.6	53.0	7.9	20.8	0.8	63.2	23.2	17.8	18.7	11.6	8.3	12.5	38.1	18.2	43.3	42.1	17.2	27.8	15.7	13.4	38.0	21.9	8.0	36.1	20.3	20.1	24.9	1.9	21.8	24.2	21.4	5.6	21.0	29.6	33.0	16.6	18.9	16.1	25.3	17.3	16.0	30.0	47.6	10.1	33.2	52.2	0.0	15.8	15.7	19.0	26.1	30.8	20.2	59.0	20.4	26.9	31.1	28.1
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 179.9;parathyroid gland: 103.1;retina: 283.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"plasmacytoid DC: 27.7"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 27.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	3.0	20.6	106.7	4.3	125.2	2.6	3.1	75.1	179.9	2.8	12.5	5.8	41.6	5.7	3.6	1.5	5.0	5.6	5.5	128.7	74.8	16.7	4.2	2.8	7.9	113.9	67.4	6.0	53.4	103.1	67.7	6.7	112.5	4.6	4.9	283.7	7.2	2.7	0.6	2.1	30.4	3.2	35.8	8.5	15.6	10.7	80.6	4.4	6.5	0.8	10.0	5.9	1.8	124.4	1.5	17.8	3.8	12.6	0.3	0.2	0.5	0.4	0.6	4.0	1.4	4.9	8.9	28.0	8.5	1.1	3.3	1.2	15.6	1.1	1.4	4.4	2.0	3.5	2.1	25.8	2.7	0.4	11.5	1.3	2.1	1.0	0.3	2.8	1.7	10.1	0.2	22.1	1.0	15.1	1.1	10.2	13.4	2.1	7.1	0.4	3.2	6.7	1.0	8.6	88.1	49.3	19.8	13.6	27.6	2.7	7.7	34.0	1.1	1.2	8.2	1.6	1.3	1.8	2.4	2.6	3.0	21.2	4.3	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.8	0.4	0.1	27.7	0.0	0.4	106.7	125.2	75.1	179.9	128.7	74.8	113.9	67.4	112.5	35.8	80.6	124.4	2.2	0.0	1.1	14.7	2.5	0.3	0.5	0.4	2.8	113.3	3.2	2.7	3.0	7.2	0.4	5.5	125.1	0.1	35.5	2.9	1.9	4.4	0.5	0.4	0.7	3.6	62.5	0.0	75.1	43.3	0.3	1.9	12.8	0.3	0.0	4.1	6.8	0.6	13.8	70.7	99.3	5.0	0.0	6.9	0.2	0.7	2.1	2.0	1.8	6.5	0.4	29.9	0.0	32.2	26.2	6.8	5.3	6.4	8.9	0.8	34.0	13.0	2.7	168.0	0.0	0.9	2.8	1.8	4.7	1.7	0.1	0.1	0.6	2.0	2.7	0.3
SCAP	KIAA0199	ENSG00000114650	"SREBF chaperone"	Q12770	3	47413681-47477126	"Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Theca cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004713	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA004713: AB_1079868"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.33e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-3)"	23.4	135.2	30.2	15.8	27.7	17.1	25.8	35.3	37.5	29.0	35.2	36.8	24.5	31.4	17.4	37.5	28.2	14.5	29.8	27.8	26.2	33.3	73.7	22.2	15.9	32.1	27.5	35.4	34.1	28.3	34.0	18.2	30.1	29.1	21.8	27.5	25.1	18.6	27.5	47.0	34.3	20.5	18.8	37.1	32.3	39.2	34.0	18.6	30.6	19.3	15.6	31.7	29.3	26.0	19.7	28.2	28.8	45.6	51.6	26.4	51.3	18.8	27.9	30.0	28.3	38.0	31.9	31.5	26.7	30.4	30.7	20.3	41.1	38.8	31.7	23.6	29.0	54.1	37.7	40.9	51.4	33.4	32.5	33.2	40.1	36.4	42.2	24.9	26.1	32.0	38.5	21.4	24.8	28.9	37.1	49.2	30.7	39.7	40.1	20.1	25.9	37.5	24.4	37.1	19.0	35.1	27.1	33.8	18.8	36.8	29.5	37.6	22.0	27.2	33.1	39.7	26.8	21.2	24.6	18.3	27.6	30.2	20.9	6.0	5.9	6.5	6.6	4.9	8.7	5.5	5.4	6.0	7.0	5.3	6.1	6.1	15.8	6.7	4.2	5.4	7.3	5.0	30.2	27.7	35.3	37.5	27.8	26.2	32.1	27.5	30.1	18.8	34.0	26.0	15.0	0.0	16.0	34.0	11.6	11.6	9.8	14.5	19.9	23.2	20.2	18.9	14.6	11.5	16.2	20.2	29.2	27.6	9.8	55.3	0.0	13.9	13.0	11.5	12.8	12.9	12.0	10.1	39.3	15.1	15.8	16.9	26.5	16.3	7.0	53.5	7.9	46.0	16.3	53.8	39.7	20.7	10.2	13.4	8.3	28.6	19.6	10.4	24.9	15.0	7.7	18.6	14.4	27.6	30.2	10.6	33.8	21.4	18.5	10.2	40.6	9.7	17.9	34.7	32.9	14.0	22.3	14.6	25.0	19.6	11.6	79.1	12.1	100.1	31.4	9.0
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 136.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 238.6;Collecting duct cells: 66.2;Cytotrophoblasts: 45.8;Muller glia cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 179.9;HeLa: 203.2;HUVEC TERT2: 140.1;U-2 OS: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	23.8	7.2	53.4	15.7	58.6	0.0	17.6	55.6	57.8	58.7	29.9	34.5	5.0	87.9	9.5	23.7	86.8	30.5	13.9	50.3	68.1	11.3	3.9	15.2	13.4	136.5	89.5	13.8	4.1	1.5	9.6	19.5	79.2	25.6	8.5	8.8	35.7	66.5	2.6	17.5	15.4	68.1	80.3	2.8	14.7	3.2	79.2	15.9	51.3	8.0	23.0	31.1	20.7	71.4	1.8	61.0	9.4	0.2	49.9	179.9	40.0	23.8	38.2	25.8	19.1	22.7	15.8	0.0	52.7	50.3	21.1	44.5	0.1	44.9	12.7	0.2	5.1	17.8	203.2	0.8	5.3	0.0	0.1	75.6	2.9	40.2	2.3	35.0	140.1	4.6	0.0	0.2	15.0	11.8	0.2	0.1	12.3	0.0	22.3	0.1	0.0	0.3	8.2	27.4	0.2	5.9	5.7	32.0	0.1	4.8	31.1	0.5	49.9	20.7	120.1	77.2	12.8	0.1	0.1	0.2	35.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	58.6	55.6	57.8	50.3	68.1	136.5	89.5	79.2	80.3	79.2	71.4	2.3	0.0	0.5	238.6	0.0	3.6	16.2	4.8	14.8	1.0	12.6	19.8	2.2	8.6	6.0	66.2	0.0	45.8	0.6	0.1	0.0	0.4	2.9	3.8	10.1	6.4	0.0	0.0	38.4	0.8	20.4	25.1	1.5	2.0	0.0	5.3	15.4	0.4	4.7	0.0	30.4	0.1	0.0	0.3	2.1	1.3	15.8	0.5	17.8	21.5	0.6	52.4	0.0	19.1	18.1	2.2	0.1	6.4	0.0	5.4	0.0	0.0	6.5	1.5	6.6	1.8	14.7	0.2	1.5	6.2	3.8	8.2	0.3	1.9	0.3	10.3
SCARA5	"FLJ23907, MGC45780, NET33"	ENSG00000168079	"Scavenger receptor class A member 5"	Q6ZMJ2	8	27869883-27992673	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 90.0"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 174.0;Leydig cells: 135.8;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	121	"plasmacytoid DC: 21.1"	"Lineage enriched"	"Detected in single"	211	"dendritic cells: 21.1"	"Cell line enriched"	"Detected in some"	20	"ASC diff: 229.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"spinal cord: 19.5"	HPA024661	Approved					NA	NA		1400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA024661: AB_1853902"	"unprognostic (2.76e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	60.5	4.0	0.4	7.2	0.8	0.0	34.6	0.8	1.8	16.6	4.9	38.5	8.7	2.9	8.2	21.1	23.7	22.5	90.0	0.6	0.4	1.0	4.1	20.2	2.4	0.3	0.2	11.2	2.4	0.2	5.4	12.5	0.2	8.4	33.7	0.3	29.0	3.3	15.1	31.1	26.3	6.5	0.5	3.3	27.3	11.6	0.2	3.2	21.1	34.5	2.1	77.1	36.8	0.3	0.0	7.9	0.0	0.0	229.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	11.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.1	0.4	0.8	0.8	1.8	0.6	0.4	0.3	0.2	0.2	0.5	0.2	0.3	7.1	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.6	0.0	0.5	0.6	4.6	0.0	0.0	0.0	0.0	0.1	6.7	0.2	0.0	0.0	1.5	0.7	27.9	2.4	0.0	0.0	0.3	0.0	0.4	174.0	4.1	0.8	0.0	0.0	0.0	0.0	0.4	0.0	2.9	0.0	0.0	0.0	17.0	4.6	135.8	1.3	7.2	5.6	0.0	1.9	0.0	0.0	0.2	0.0	0.0	11.3	0.8	0.1	0.0	0.0	0.0	0.1	0.0	7.4	3.6	0.7	1.1	0.9	6.0	0.1	1.1	44.5	0.3	0.1
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adrenal gland: 995.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 133.9;Granulosa cells: 114.6;Hepatocytes: 159.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 6.2;myeloid DC: 8.9;plasmacytoid DC: 21.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 21.0;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 148.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	59.2	995.8	12.3	4.0	22.7	1.3	55.4	7.2	13.2	12.9	21.7	14.7	12.5	13.7	0.9	9.2	13.1	12.9	10.5	12.3	8.9	6.8	235.7	15.3	6.2	11.0	10.0	54.8	9.6	4.0	15.2	111.5	12.0	13.0	9.2	12.0	21.2	2.3	9.8	26.4	14.9	7.8	7.2	12.7	8.8	19.1	15.5	2.9	11.7	5.0	10.4	12.3	12.7	11.5	30.1	50.0	22.2	51.4	12.3	23.1	0.0	24.2	20.0	21.4	12.1	56.7	61.7	91.6	66.4	12.4	31.1	39.2	58.0	109.3	13.2	45.5	51.4	18.5	53.1	68.3	33.2	35.9	17.2	39.5	19.7	41.0	32.5	36.7	57.2	9.1	41.5	21.5	4.3	27.7	12.9	23.5	22.8	30.7	66.0	51.0	18.8	148.7	0.8	32.9	38.8	12.1	126.5	95.9	70.2	13.3	55.8	29.9	4.6	2.6	23.8	14.3	29.8	10.1	3.8	15.7	11.3	29.0	23.9	0.0	6.2	0.0	0.2	3.0	0.1	2.3	0.0	0.2	8.9	0.9	0.0	0.0	0.8	0.0	0.6	21.0	0.0	3.8	12.3	22.7	7.2	13.2	12.3	8.9	11.0	10.0	12.0	7.2	15.5	11.5	133.9	3.2	2.7	25.8	8.6	5.6	3.6	9.0	6.8	6.1	14.8	17.0	6.5	8.6	5.3	3.7	29.2	10.7	10.5	46.7	3.9	5.4	18.1	1.0	5.3	44.2	10.7	8.2	21.0	7.4	13.8	7.9	11.7	3.4	1.3	114.6	21.4	159.4	51.6	16.8	24.8	13.1	8.2	14.8	11.4	12.6	9.0	16.7	48.0	74.9	5.9	52.9	0.0	23.1	27.3	5.8	12.9	5.3	8.0	9.9	10.0	2.9	4.7	7.5	0.0	3.1	5.0	25.0	1.6	6.5	3.1	43.4	1.8	60.0	9.4	4.4
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158737-76234536	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 499.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA		9200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	60.6	24.0	33.5	27.7	63.5	7.3	56.7	58.9	38.9	60.8	18.9	61.6	39.2	44.1	58.4	33.9	45.4	60.0	61.6	29.6	48.6	46.8	89.9	77.1	20.2	62.2	49.6	58.9	58.9	63.6	11.1	80.2	62.5	72.3	64.0	53.2	80.5	55.4	89.8	26.0	49.1	57.8	60.1	47.0	60.7	19.4	50.7	21.3	65.9	81.3	20.6	65.3	25.1	92.9	39.8	38.4	48.9	97.1	499.7	242.0	35.8	131.5	250.2	114.0	178.2	72.5	112.3	0.0	85.1	262.3	109.6	28.3	28.3	78.9	96.0	138.8	30.1	3.2	32.9	25.3	129.9	19.0	12.1	186.9	72.3	117.3	54.5	268.9	200.6	10.0	15.6	188.6	159.2	58.2	1.6	4.0	9.7	120.3	23.6	23.3	82.7	42.0	64.4	43.6	101.3	110.2	104.7	61.3	115.5	49.3	34.6	17.1	131.3	125.9	48.5	104.7	47.5	167.6	98.8	0.2	158.1	22.2	170.9	12.5	14.1	3.1	2.8	26.0	2.6	3.8	1.9	1.5	8.2	3.0	2.6	4.3	1.9	1.1	24.9	28.9	3.0	6.1	33.5	63.5	58.9	38.9	29.6	48.6	62.2	49.6	62.5	60.1	50.7	92.9	89.0	176.3	52.4	47.3	20.1	24.0	90.5	64.8	34.1	109.6	69.7	36.4	53.0	87.2	52.1	99.3	60.5	35.3	43.6	109.0	7.9	119.9	7.1	50.3	74.0	69.9	102.4	28.6	57.4	72.9	47.5	108.3	40.8	88.8	3.8	84.8	79.6	108.7	143.4	60.6	55.4	77.1	44.7	165.7	27.5	5.6	45.4	76.2	67.6	38.4	43.5	87.2	6.2	106.1	201.1	78.0	68.3	66.5	82.2	133.5	103.2	27.6	54.4	81.7	92.1	91.0	68.1	18.2	16.5	34.8	33.8	59.4	16.3	56.5	55.3	93.4
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645744	"Predicted intracellular proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035108, HPA072936"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA035108: AB_10670289, HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.2	5.0	1.5	3.1	1.8	0.4	12.7	1.4	3.4	5.6	1.4	5.2	0.0	6.0	0.9	2.7	6.5	2.2	11.8	1.6	1.8	7.5	7.5	16.3	2.1	2.7	1.7	2.6	3.1	0.1	3.8	4.3	2.2	4.6	1.2	0.2	4.2	0.0	5.3	3.1	5.4	1.2	1.7	25.6	4.2	1.6	1.7	0.5	18.8	1.9	1.0	5.6	4.6	2.8	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.3	12.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	11.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	1.8	1.4	3.4	1.6	1.8	2.7	1.7	2.2	1.7	1.7	2.8	65.9	22.4	17.6	6.5	0.6	3.4	0.4	0.7	1.2	1.2	0.8	0.9	3.5	0.0	2.9	3.7	4.2	0.4	2.0	4.9	1.9	0.4	0.3	0.5	0.9	51.3	0.0	3.4	5.4	0.2	0.2	2.5	4.1	1.1	3.8	0.3	62.4	2.3	9.0	0.0	3.5	4.4	0.0	15.7	37.7	0.4	1.2	10.1	3.6	26.2	4.8	0.7	0.0	0.5	1.1	0.3	1.2	1.2	0.0	0.7	3.0	0.2	3.0	2.0	0.0	2.1	3.0	0.5	0.6	0.3	2.7	1.2	1.0	1.3	2.2	0.8
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424584-20437826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	15.1	5.4	2.4	1.9	2.6	0.4	10.7	0.5	3.3	19.1	4.1	10.0	1.3	22.4	0.5	3.6	15.5	3.6	10.3	2.1	3.9	10.6	3.6	23.2	1.3	5.1	3.2	20.2	4.0	0.4	5.4	3.7	2.2	15.5	0.3	0.1	4.6	4.5	3.1	10.1	6.0	2.2	2.0	9.4	7.8	2.7	4.7	0.2	11.8	0.4	0.2	13.3	13.2	1.3	0.7	0.4	5.8	10.1	3.4	4.8	2.3	25.5	10.8	6.2	3.3	0.1	0.1	0.4	14.6	12.7	0.4	0.2	3.4	0.1	0.7	0.9	21.6	2.1	0.5	4.9	21.3	0.0	1.1	8.2	0.1	3.0	1.5	3.0	3.0	0.1	0.2	0.2	2.2	1.1	0.0	0.5	7.8	0.0	3.3	0.6	16.1	0.0	0.1	0.1	2.5	28.5	0.1	0.0	31.7	1.1	0.9	0.1	3.7	38.7	40.7	1.0	5.9	1.2	0.5	0.4	0.1	0.5	19.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	2.6	0.5	3.3	2.1	3.9	5.1	3.2	2.2	2.0	4.7	1.3	3.6	0.0	0.0	1.6	0.1	2.8	1.6	0.7	0.0	2.9	0.3	0.9	44.8	0.0	0.3	0.0	2.1	0.4	0.3	0.1	0.0	0.0	0.3	2.6	8.9	10.5	0.0	0.0	1.9	0.0	1.6	21.2	1.5	1.0	0.0	0.6	3.9	0.7	0.7	0.0	5.2	0.2	0.0	0.8	2.4	0.5	13.4	0.4	3.6	6.5	0.0	0.3	1.0	3.0	1.1	0.0	0.1	17.7	0.2	7.1	0.0	0.2	4.2	0.8	13.1	1.4	19.5	1.1	0.7	0.3	2.7	0.4	1.2	2.1	0.2	0.6
SCART1	CD163c-alpha	ENSG00000214279	"Scavenger receptor family member expressed on T cells 1"	Q4G0T1	10	133453928-133523558	"Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043101	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043101: AB_10797026"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-2)"	"unprognostic (8.20e-4)"	"unprognostic (1.29e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.24e-5)"	"unprognostic (8.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.8	1.0	0.1	0.7	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	3.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.2	4.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	1.0	0.7	0.4	0.2	0.4	0.2	0.2	0.4	0.3	0.8	0.0	1.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.9	0.8	0.5	0.0	0.0	1.3	0.2	0.0	0.4	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.1	0.0
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724409-246768137	"Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 159.5"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1380.7;Spermatocytes: 822.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	20	"basophil: 872.9"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 872.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	26.6	53.7	35.1	14.4	45.5	35.7	23.6	51.5	43.2	22.6	40.8	27.2	34.4	26.2	17.6	9.3	31.6	21.6	32.8	35.3	45.4	49.8	158.2	21.0	13.5	64.0	45.2	22.4	18.8	36.5	24.3	23.8	64.3	39.4	26.8	31.7	15.3	26.0	60.7	24.1	34.6	24.0	57.0	11.5	28.0	159.5	47.3	20.1	33.5	54.7	10.6	81.5	12.0	86.8	55.3	53.2	37.7	22.8	44.5	55.7	0.5	42.3	58.8	70.1	58.3	32.7	150.6	29.3	53.8	49.0	38.9	17.7	32.4	12.6	71.6	40.8	11.9	49.6	46.9	65.9	41.6	97.1	40.7	37.6	5.9	47.4	4.8	65.7	76.4	60.0	62.9	0.1	70.9	13.5	101.6	122.6	56.5	29.6	41.7	83.8	48.5	0.3	216.6	128.2	42.7	48.0	57.3	2.5	39.0	20.2	42.1	99.6	49.8	32.1	28.5	78.7	110.5	138.0	51.1	17.4	54.7	130.2	43.3	872.9	24.3	44.1	18.1	22.2	22.4	11.2	5.4	15.7	10.7	9.4	7.1	22.0	6.4	34.1	15.4	18.2	4.0	17.1	35.1	45.5	51.5	43.2	35.3	45.4	64.0	45.2	64.3	57.0	47.3	86.8	25.0	6.4	11.5	25.8	8.0	30.1	40.6	54.6	1.8	31.2	42.4	17.5	38.0	55.8	40.5	152.6	18.8	41.4	14.6	42.4	31.3	67.2	1380.7	72.7	39.4	23.6	44.9	54.7	23.7	69.0	17.4	35.7	32.6	111.9	57.2	49.2	22.5	187.8	89.4	6.7	20.5	27.4	52.9	45.7	13.7	245.6	47.5	29.7	48.0	10.3	20.3	67.4	18.6	27.2	37.3	75.2	27.8	47.4	8.3	49.2	138.4	69.7	79.4	39.2	19.7	36.7	39.4	822.3	76.2	5.6	68.5	84.6	17.0	42.8	55.0	201.9
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347233-100364826	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1233.7;brain: 839.9;liver: 583.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 389.6;Granulosa cells: 187.3;Hepatocytes: 840.3;Oligodendrocytes: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 2534.2;CAPAN-2: 1824.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	1233.7	131.2	408.7	25.7	525.8	23.0	261.5	535.7	522.1	43.2	156.6	42.9	93.1	15.4	25.5	107.8	5.0	28.7	47.1	349.1	457.5	18.5	583.8	142.8	17.2	775.0	508.9	49.6	22.6	79.5	10.3	19.9	637.8	100.1	39.7	17.9	112.6	11.2	6.1	27.0	36.0	15.9	574.4	15.3	25.2	51.8	538.7	18.4	13.0	7.2	21.0	22.5	41.9	839.9	411.2	373.3	777.6	536.4	2534.2	1449.4	158.2	43.4	948.3	101.6	536.6	323.8	1824.4	173.3	33.7	102.2	461.8	716.4	433.7	1549.5	88.9	59.4	179.6	97.5	219.3	653.4	488.4	136.9	100.9	795.5	459.4	395.0	688.9	273.1	196.2	375.3	275.4	513.3	41.7	646.8	155.9	163.3	270.7	120.7	106.3	72.6	287.4	550.4	443.8	455.3	48.9	185.3	85.8	399.7	834.9	224.2	447.7	291.3	79.0	10.0	115.9	9.1	89.8	141.4	81.5	262.9	184.4	416.0	65.9	0.0	0.8	0.0	1.4	1.6	2.3	0.6	0.5	0.7	2.7	0.9	0.4	1.3	0.1	1.4	0.0	1.5	0.0	1.2	408.7	525.8	535.7	522.1	349.1	457.5	775.0	508.9	637.8	574.4	538.7	839.9	3.8	54.5	389.6	34.0	15.7	3.7	4.5	121.8	0.6	6.5	16.1	6.2	11.2	28.6	66.2	0.0	6.2	3.0	4.7	21.5	0.0	14.6	52.6	13.9	9.0	12.5	25.8	15.8	4.8	67.9	71.7	15.9	25.0	26.9	6.3	187.3	32.9	840.3	34.1	26.9	5.2	16.4	52.9	113.5	4.2	93.0	3.7	21.2	58.7	8.4	10.2	11.9	2.1	18.6	451.5	29.6	2.7	1.5	3.7	31.4	16.2	4.9	31.0	6.2	0.0	3.6	25.7	2.0	1.2	26.7	2.3	17.4	6.6	97.8	38.9	8.2
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798796	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.7;brain: 353.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 69.2;RPTEC TERT1: 90.1"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	6.8	156.7	226.1	3.7	283.7	2.9	5.7	302.5	260.4	10.6	85.2	12.9	4.5	12.5	97.6	5.8	18.7	9.3	8.1	212.6	277.4	33.1	2.5	15.0	3.0	353.6	272.7	93.7	40.9	18.7	31.4	7.5	291.0	12.7	4.0	70.2	18.0	24.3	1.3	8.2	6.0	12.0	314.1	4.5	10.6	33.3	255.6	10.6	35.5	4.2	4.4	7.7	8.7	316.2	11.2	7.1	36.0	18.6	19.7	12.5	0.6	69.2	33.9	29.7	22.8	0.5	1.7	22.5	23.5	14.5	8.0	19.9	10.6	7.6	37.0	4.4	4.7	1.0	8.1	0.7	2.9	10.0	6.9	10.0	30.6	5.9	5.2	30.5	48.4	25.8	1.3	2.2	15.6	4.4	42.6	2.1	2.6	0.2	5.0	35.6	21.5	17.9	90.1	11.2	20.1	11.5	11.4	0.5	6.8	3.5	1.3	5.0	59.5	31.5	18.1	11.9	18.9	6.0	2.5	2.2	15.3	10.5	9.0	1.9	0.6	0.1	3.9	0.2	2.5	0.2	0.8	2.3	0.3	0.4	0.7	2.6	0.7	1.1	0.4	0.7	0.2	1.2	226.1	283.7	302.5	260.4	212.6	277.4	353.6	272.7	291.0	314.1	255.6	316.2	1.4	44.8	3.9	248.4	0.8	10.7	16.5	16.3	5.7	101.4	6.8	4.8	2.9	27.1	25.7	27.6	25.0	1.9	3.9	0.4	13.7	79.7	115.0	13.5	9.3	7.7	7.7	0.0	84.3	46.9	0.2	16.8	2.6	14.8	0.0	10.5	10.4	0.2	1.1	101.0	107.0	0.3	10.2	1.3	3.3	100.3	55.0	1.8	3.6	23.4	1.9	145.3	4.1	892.7	513.6	8.9	0.0	58.3	0.7	11.3	0.2	20.4	13.0	14.6	6.6	3.6	11.5	2.9	3.7	2.7	7.2	0.1	3.2	137.4	2.0	9.3
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCFD1	"C14orf163, KIAA0917, RA410, SLY1, STXBP1L2"	ENSG00000092108	"Sec1 family domain containing 1"	Q8WVM8	14	30622291-30737694	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003579	Approved					NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003579: AB_1079872"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.32e-2)"	23.2	29.3	11.8	22.3	12.4	9.9	29.2	12.3	12.6	34.0	13.0	27.6	22.2	21.8	40.8	29.7	21.7	19.6	29.6	11.9	12.4	32.5	35.1	22.5	26.2	11.8	12.1	23.6	46.4	41.8	29.3	27.8	11.8	27.7	29.8	14.9	52.3	24.0	24.6	19.5	23.8	22.9	11.5	19.0	28.0	26.6	11.6	25.6	44.3	29.3	29.1	30.0	20.8	12.0	71.7	26.0	37.8	22.9	64.1	67.0	53.4	57.0	68.4	69.5	83.5	42.2	58.9	36.9	24.2	79.7	38.8	44.5	41.3	46.5	80.0	53.2	22.2	30.7	28.6	149.5	77.9	50.2	32.4	49.1	39.1	48.9	78.1	58.5	45.5	26.5	42.6	68.0	74.7	66.8	30.7	27.8	40.7	83.9	45.1	30.2	42.1	42.2	70.7	45.6	35.9	33.0	58.7	54.4	53.6	42.9	70.5	35.3	48.1	41.9	44.0	43.0	45.3	45.3	40.8	49.4	26.9	36.7	52.9	26.8	17.2	20.2	14.0	23.2	17.8	20.1	16.2	17.3	23.7	14.7	15.2	14.1	3.0	23.1	27.8	16.9	24.4	16.1	11.8	12.4	12.3	12.6	11.9	12.4	11.8	12.1	11.8	11.5	11.6	12.0	33.0	51.3	31.3	67.9	47.7	25.0	55.2	55.1	18.2	35.0	26.9	27.1	35.3	18.6	50.8	25.8	43.8	61.9	51.3	31.8	64.6	49.2	29.3	34.9	51.6	32.3	47.2	24.2	123.0	50.6	61.0	47.9	20.9	34.2	53.7	32.1	24.3	20.6	44.9	30.3	112.8	44.9	36.7	27.7	33.4	16.6	38.5	35.5	37.4	90.9	66.9	31.1	62.8	112.6	106.6	41.2	23.5	40.3	70.9	42.3	28.8	40.9	52.1	39.9	13.1	53.7	49.0	71.8	53.5	20.5	24.4	83.0	41.4	47.8	30.0	43.5
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366066	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	7.3	9.0	5.7	7.3	6.2	7.6	7.3	5.5	6.6	6.2	4.8	6.3	5.6	6.9	3.3	8.5	4.6	4.5	6.4	5.6	6.8	7.1	5.6	5.2	7.4	6.5	6.0	6.6	6.1	5.6	5.8	6.0	6.8	4.4	6.2	4.0	5.5	5.1	7.6	7.2	4.3	7.5	5.6	5.8	5.8	2.8	6.9	6.5	5.2	6.2	7.9	6.0	6.6	8.3	13.5	12.2	6.8	16.0	22.2	22.3	8.3	30.0	22.6	10.3	8.7	8.7	16.6	25.7	22.8	57.7	11.1	8.1	22.2	26.2	19.6	7.7	13.0	14.1	12.1	10.6	10.3	18.3	24.8	15.5	15.6	19.9	7.8	9.9	18.2	6.5	24.4	14.3	17.7	15.2	25.0	10.8	4.3	37.6	15.0	15.4	6.6	26.8	11.4	8.7	19.5	11.3	6.8	25.0	13.7	7.9	9.8	8.2	16.3	22.1	14.2	25.7	22.3	16.5	9.8	29.7	15.1	20.7	65.0	0.1	7.2	1.8	9.2	12.2	9.5	8.0	7.4	10.6	19.6	6.4	10.9	10.1	1.4	17.9	13.5	12.7	7.1	11.1	5.7	6.2	5.5	6.6	5.6	6.8	6.5	6.0	6.8	5.6	6.9	8.3	5.4	0.0	3.1	63.0	10.3	3.7	5.4	5.8	8.0	4.1	3.9	3.4	2.9	11.5	3.5	3.7	6.2	8.4	5.4	3.5	1.9	3.8	2.9	2.6	8.4	4.2	1.2	5.5	126.2	5.1	6.7	7.3	5.6	3.6	12.7	5.9	4.2	6.0	5.3	5.0	131.6	3.5	2.0	2.5	3.1	1.5	6.5	10.0	5.4	82.4	2.7	2.7	3.1	182.0	153.7	2.5	2.8	5.7	14.3	2.8	2.4	8.5	4.3	3.3	0.0	5.3	3.8	5.4	3.5	10.5	5.4	4.2	6.8	16.4	4.9	3.5
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.0;pituitary gland: 402.7"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.7	61.1	54.0	3.3	62.0	0.3	3.7	52.2	100.4	1.0	77.3	7.9	17.9	5.3	42.5	0.5	3.4	5.5	1.3	58.9	75.1	0.9	3.6	3.8	1.3	56.5	48.3	3.2	133.0	73.7	402.7	0.3	58.7	5.0	9.8	26.7	0.2	0.9	0.2	1.3	5.6	6.7	57.7	0.5	37.8	5.3	56.3	0.3	5.8	0.1	0.3	2.6	2.7	58.9	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	62.0	52.2	100.4	58.9	75.1	56.5	48.3	58.7	57.7	56.3	58.9	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lung: 3079.0"	"Cell type enriched"	"Detected in some"	4	"Club cells: 43564.7"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	71	"HaCaT: 1977.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	NA	NA		13000000		"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	1.1	2.0	0.6	0.9	0.7	0.1	0.3	1.3	1.1	0.6	0.3	0.2	0.4	0.2	0.7	11.0	334.2	0.2	0.6	0.5	0.6	0.2	0.4	3079.0	0.2	0.6	0.9	2.0	1.9	0.0	2.4	1.7	0.5	85.1	0.0	0.2	0.5	0.9	0.3	0.3	1.6	0.0	0.5	7.2	4.3	0.2	1.0	2.8	0.4	0.0	5.9	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	1977.1	0.0	0.3	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.0	0.6	1.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.0	1.0	2.0	0.0	1.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.3	1.1	0.5	0.6	0.6	0.9	0.5	0.5	1.0	0.5	0.0	1125.0	2573.3	0.0	0.0	0.0	71.4	3938.5	0.0	0.0	0.0	0.0	0.0	0.0	43564.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	113.5	0.0	0.0	0.1	0.0	0.0	304.5	0.0	0.5	691.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4534.8	0.0	0.0	0.7	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	134.7	0.0	0.0	9997.0	0.0	0.0	0.0	850.3	0.0	0.0	3.9	0.0	0.0	83.7	0.0	0.0	800.2
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242239-62244812	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 1227.2;cervix: 4002.8"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 10.4"									HPA035318	Approved				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"			"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		12.9	4.9	4.1	0.0	4.0	0.0	1227.2	3.2	5.4	4002.8	13.8	0.3	0.1	89.0	355.8	10.1	110.3	0.1	3.1	3.5	4.4	10.1	0.2	0.1	0.1	4.7	5.7	1.1	4.5	0.5	5.2	0.2	4.2	8.6	0.2	1.8	69.2	2.9	7.2	342.4	0.4	0.0	3.5	0.0	0.3	0.2	4.3	0.4	0.6	6.0	0.0	0.2	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.1	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.0	3.2	5.4	3.5	4.4	4.7	5.7	4.2	3.5	4.3	4.6	2.1	0.0	0.0	0.0	1.6	27.4	4.8	0.0	0.0	0.5	647.8	251.6	10.9	0.0	0.0	7.3	0.0	0.0	5.3	0.0	23.5	0.3	0.0	3242.1	409.9	12.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	3417.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	15.0	823.6	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	46.1	0.0	0.9	0.0	0.2	8.6	0.0	0.0	0.0	7.0	0.1	20.0	0.0	0.0	1.1
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208673-62213943	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 2021.0;epididymis: 1372.0"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 971.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 8.6"									HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (1.22e-4)"	"prognostic favorable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.2	0.0	0.0	57.8	0.0	0.0	2021.0	0.1	12.7	1.3	118.8	1372.0	4.2	238.4	13.4	0.2	0.1	0.4	1.9	0.1	2.4	0.0	3.5	1.4	0.7	17.2	1.1	5.1	0.1	0.8	6.8	16.3	0.0	29.6	15.6	0.0	8.6	1.0	2.2	0.5	0.0	45.9	0.0	1.1	2.7	5.8	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	1.6	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.5	1.4	0.8	0.5	1.1	0.2	0.6	0.0	4.8	0.0	0.4	0.1	3.8	4.8	0.0	0.0	123.6	71.0	0.0	48.6	10.1	16.5	0.0	0.2	1.6	9.7	3.9	6.6	0.0	2506.4	397.7	7.6	37.1	0.0	0.0	5.3	0.0	3.8	26.5	2597.0	0.0	0.3	0.0	0.1	4.9	0.0	0.0	59.9	10.2	0.3	0.0	0.0	0.0	14.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	15.3	10.8	0.0	0.0	27.0	0.7	0.1	109.3	0.0	0.0	0.0	8.5	0.0	0.0	1.7	0.4	0.0	13.7	0.1	7.0	16.6
SCGB2A2	"MGB1, MGC71974, PSBP1, UGB2"	ENSG00000110484	"Secretoglobin family 2A member 2"	Q13296	11	62270158-62273160	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"breast: 2805.9;skin 1: 708.1"	"Group enriched"	"Detected in some"	11	"Breast glandular cells: 2119.6;Breast myoepithelial cells: 1028.8;Melanocytes: 1762.7"	"Cancer enriched"	"Detected in many"	23	"breast cancer: 823.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	124	"SK-BR-3: 18.0"									CAB026270	Enhanced				"Secreted in female reproductive system"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"CAB026270: AB_912980"	"unprognostic (2.38e-1)"	"unprognostic (7.28e-2)"		"prognostic favorable (9.57e-8)"						"unprognostic (4.17e-1)"				"unprognostic (3.75e-1)"				34.4	0.2	0.0	0.0	0.0	0.0	2805.9	0.0	0.0	309.2	0.0	0.4	0.0	4.1	0.0	76.6	0.1	0.0	4.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	1.6	1.3	0.0	0.2	0.0	0.0	159.3	0.1	1.8	708.1	0.2	0.0	0.0	0.2	0.3	1.1	0.0	2.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.6	49.6	0.3	0.0	0.0	0.0	2119.6	1028.8	0.1	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	1.4	41.9	21.6	11.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	141.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	3.2	1762.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	10.9	0.0	9.2	0.0	0.0	0.0
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 8.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 63.6;Excitatory neurons: 32.8;Inhibitory neurons: 45.3;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 104.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;U-266/70: 1.0"									HPA046806	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.3	0.4	0.7	0.0	1.0	0.1	0.9	0.4	0.9	0.1	0.1	0.2	0.1	0.3	2.6	0.9	0.3	0.2	0.3	0.6	0.7	0.3	0.5	0.5	0.3	1.0	1.0	0.2	8.6	0.3	0.3	0.2	0.9	0.3	0.2	0.6	0.3	0.5	0.7	2.9	0.2	0.1	0.5	0.4	0.3	2.0	1.0	0.1	0.5	1.1	0.3	0.4	0.1	0.9	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.2	0.4	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.4	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.4	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.4	0.9	0.6	0.7	1.0	1.0	0.9	0.5	1.0	0.9	0.0	0.0	0.0	63.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.1	0.0	0.2	0.0	0.0	32.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.3	0.0	0.0	0.0	0.0	31.0	0.0	0.0	3.6	17.8	0.0	0.0	0.0	52.8	104.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	46	"dendritic cells: 6.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	2.9	46.5	0.2	56.3	0.8	1.2	52.6	55.0	2.5	28.9	11.1	1.0	3.9	0.7	3.4	2.3	1.9	80.4	50.0	48.7	2.5	0.7	2.9	0.5	51.0	48.2	0.5	0.4	0.2	11.8	10.9	52.6	5.6	1.1	3.6	1.9	1.4	101.3	0.4	3.6	5.4	55.6	4.8	4.6	1.9	46.9	0.8	0.8	92.8	0.2	0.7	1.2	81.0	0.1	0.0	27.0	49.2	0.0	0.2	0.0	0.2	0.1	0.1	1.1	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.7	1.1	0.3	11.2	0.4	58.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	29.8	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	167.0	0.0	0.0	0.2	7.0	0.0	3.1	10.9	0.6	1.5	0.4	2.5	2.1	0.0	0.0	0.7	2.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	46.5	56.3	52.6	55.0	50.0	48.7	51.0	48.2	52.6	55.6	46.9	81.0	4.5	6.4	1.7	0.0	0.1	0.4	4.8	2.5	1.2	5.4	0.6	0.8	14.2	0.0	2.2	3.7	2.1	1.5	2.7	0.1	0.0	0.3	0.0	4.4	0.4	6.0	0.0	2.1	0.0	0.2	0.5	1.6	0.0	3.1	0.0	0.1	2.2	0.5	0.2	15.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	3.6	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	1.4	3.7	0.6	0.0	7.0	2.9	0.0	0.4	0.4	0.6	0.8	0.2	0.2	0.0	1.4
SCIMP	"C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783"	ENSG00000161929	"SLP adaptor and CSK interacting membrane protein"	Q6UWF3	17	5208920-5234860	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.4;Hofbauer cells: 26.2;Kupffer cells: 120.3;Macrophages: 66.3;monocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.7"	"Group enriched"	"Detected in many"	8	"classical monocyte: 110.6;intermediate monocyte: 239.0;memory B-cell: 145.8;myeloid DC: 84.2;naive B-cell: 124.5;non-classical monocyte: 265.5"	"Group enriched"	"Detected in all"	9	"B-cells: 145.8;dendritic cells: 84.2;monocytes: 265.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 6.8;U-698: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006117	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA006117: AB_1858633"	"unprognostic (2.53e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.95e-2)"	5.9	4.1	0.0	30.4	0.1	5.1	1.4	2.7	1.3	1.5	3.6	4.5	5.4	2.9	1.1	1.9	3.1	7.3	1.7	0.3	0.0	2.3	10.6	16.2	39.4	0.6	0.1	3.6	3.9	0.8	0.7	3.9	0.1	3.1	4.6	7.5	4.0	1.4	4.3	3.2	10.2	6.1	0.0	49.2	5.0	2.8	0.0	5.1	3.4	0.8	44.9	6.0	0.6	0.4	1.0	1.5	2.5	3.3	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.7	2.1	4.8	0.9	0.0	1.8	1.0	0.0	0.0	0.0	0.8	2.1	2.0	6.8	0.7	0.0	0.2	0.7	0.0	0.1	0.0	0.2	1.2	0.0	4.2	0.1	1.2	0.0	1.6	2.4	0.7	1.1	0.3	1.4	2.2	0.5	0.5	0.0	0.6	1.8	0.8	1.8	0.6	1.3	0.7	2.6	2.4	0.3	0.3	1.1	1.4	0.6	0.7	0.3	10.8	1.2	0.3	0.7	16.8	110.6	3.0	1.3	239.0	1.5	145.8	0.8	1.2	84.2	124.5	1.7	1.2	19.0	5.3	265.5	3.2	1.4	68.0	0.0	0.1	2.7	1.3	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.5	0.0	4.4	2.6	66.4	0.4	0.4	0.0	0.0	2.5	0.4	0.5	0.4	1.5	0.6	0.0	12.5	0.3	1.5	0.0	0.0	0.7	1.4	0.4	0.3	2.0	0.0	0.4	6.5	0.9	0.3	0.6	0.0	0.1	1.3	0.4	3.3	1.9	26.2	1.7	4.9	0.0	0.0	120.3	4.2	0.7	0.3	66.3	0.0	8.4	60.3	0.4	10.3	4.0	2.3	0.4	0.0	0.4	1.7	0.3	0.0	1.0	1.6	4.1	0.0	0.7	0.3	0.5	0.8	0.0	0.4	0.1	3.2	0.2	0.0	0.4
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SCLT1	"FLJ30655, hCAP-1A"	ENSG00000151466	"Sodium channel and clathrin linker 1"	Q96NL6	4	128864921-129093600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 110.0;Excitatory neurons: 111.1;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 109.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 66.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 66.0;monocytes: 31.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036560, HPA036561"	Approved		Uncertain	Microtubules,Cytosol		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Microtubules, Cytosol"		"HPA036560: AB_2675190, HPA036561: AB_10673658"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.05e-2)"	"unprognostic (8.92e-2)"	3.6	3.0	3.7	6.4	4.5	14.4	3.5	7.4	4.8	3.7	0.9	3.7	4.3	3.5	2.2	3.9	3.1	4.6	3.6	2.4	2.8	2.7	3.5	3.5	7.3	4.5	4.3	4.5	3.3	2.9	2.9	4.6	3.5	2.4	4.4	2.9	2.6	2.7	1.5	3.2	3.4	3.6	4.7	7.5	3.5	4.9	5.3	8.8	3.0	1.8	6.7	4.4	3.4	3.9	19.9	5.3	18.8	12.4	6.5	10.5	10.3	16.5	14.8	17.8	16.3	5.7	17.1	17.0	10.4	9.3	12.4	7.4	12.5	12.2	18.5	38.9	10.0	22.7	10.2	6.5	8.9	27.1	17.0	6.7	4.3	14.2	14.2	8.5	14.0	8.6	25.7	39.8	15.6	8.8	20.8	13.0	8.4	14.2	10.5	12.2	19.2	10.6	11.4	5.5	28.1	8.2	12.7	11.5	11.1	8.2	6.8	10.8	13.2	14.5	17.6	19.7	22.3	19.3	15.5	29.0	8.1	29.7	22.2	18.3	16.9	36.8	3.8	24.6	2.2	3.9	2.6	2.7	9.5	3.7	2.5	3.4	66.0	10.2	31.1	4.4	3.7	6.5	3.7	4.5	7.4	4.8	2.4	2.8	4.5	4.3	3.5	4.7	5.3	3.9	16.1	12.8	9.8	110.0	18.0	11.1	8.9	5.8	8.0	15.2	6.1	7.4	21.2	15.7	9.0	1.8	29.2	13.8	34.8	9.1	3.9	6.5	63.2	20.3	18.4	11.9	5.4	9.0	111.1	6.3	21.5	16.3	28.1	14.3	12.0	16.5	9.3	1.6	13.3	16.8	116.0	8.1	8.2	21.6	18.0	51.8	10.8	28.4	8.8	87.1	33.8	8.9	82.4	109.1	90.5	9.0	9.8	9.1	24.0	2.7	8.2	3.1	16.7	21.6	13.1	14.4	16.5	19.6	12.1	13.1	13.9	9.3	21.2	30.5	10.6	5.6
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060924-238099413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.1"	"Group enriched"	"Detected in many"	13	"Early spermatids: 90.6;Late spermatids: 156.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	5.1	4.3	7.2	5.3	9.4	5.0	4.9	9.4	9.3	6.8	6.4	7.3	8.5	8.1	5.6	5.9	6.3	3.8	8.1	6.8	8.2	12.9	39.1	4.7	5.7	9.2	8.8	6.3	22.8	6.1	5.0	2.0	9.4	5.9	3.2	4.6	4.4	4.1	6.4	3.5	8.6	3.9	7.3	7.2	5.8	16.8	8.3	5.9	7.2	3.5	4.3	7.8	5.1	10.4	11.1	19.1	11.9	31.1	9.0	6.4	23.2	11.2	5.6	11.3	14.3	11.6	8.0	18.9	3.3	5.9	35.4	16.4	44.1	21.5	10.9	21.2	41.8	21.1	24.0	37.6	16.7	17.6	18.2	7.1	11.6	21.3	22.0	5.1	21.0	26.1	38.0	5.1	11.7	16.9	17.9	33.0	36.4	16.0	15.6	22.0	23.3	18.2	11.3	3.6	13.1	28.9	12.0	19.4	20.6	8.2	6.3	26.5	8.5	16.3	11.8	24.2	23.7	14.2	13.3	9.3	11.3	37.0	14.4	1.1	3.2	4.0	2.6	2.3	2.0	2.6	3.1	4.4	3.3	1.6	2.3	2.6	0.5	2.9	3.5	0.6	3.2	2.8	7.2	9.4	9.4	9.3	6.8	8.2	9.2	8.8	9.4	7.3	8.3	10.4	2.2	0.0	0.0	0.0	4.6	1.7	2.4	1.9	5.7	5.4	1.7	1.9	2.6	1.5	1.2	0.0	8.4	1.4	3.4	1.9	3.9	5.3	90.6	1.7	3.4	2.4	2.4	9.4	0.0	3.7	2.1	1.9	5.1	2.6	0.0	3.5	1.8	3.3	4.0	6.7	0.0	3.3	8.2	0.9	3.2	156.3	3.1	2.1	1.8	0.0	2.7	2.6	2.1	0.0	0.0	3.0	5.0	0.0	4.9	1.9	3.9	2.7	1.9	6.9	0.0	1.9	3.2	6.2	5.6	3.4	1.6	0.7	4.4	2.2	4.8	1.8
SCML1		ENSG00000047634	"Scm polycomb group protein like 1"	Q9UN30	X	17737449-17754988	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 581.3;Spermatogonia: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 19.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 88.1"									"HPA035270, HPA035271, HPA061397"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503"	"unprognostic (6.36e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-3)"	10.7	11.5	5.6	6.4	5.9	3.1	8.2	5.8	8.9	11.1	6.7	7.9	8.1	7.9	3.1	6.0	9.8	5.4	7.8	5.6	6.0	9.5	28.8	9.8	8.3	6.5	5.8	20.8	8.2	3.9	9.2	10.1	6.0	9.2	7.2	30.7	3.7	6.3	12.7	6.3	7.6	7.6	5.5	8.4	6.8	26.6	5.7	7.6	5.4	14.6	5.5	6.5	8.1	6.1	23.2	6.1	19.4	6.8	18.0	23.7	2.2	22.2	21.4	23.8	30.2	11.9	10.6	0.0	9.4	15.0	15.7	13.3	25.4	15.6	35.4	0.0	50.0	1.7	18.6	25.6	23.6	0.0	12.0	15.6	14.1	30.7	23.2	5.3	0.4	8.9	3.9	0.0	22.7	7.0	0.0	0.0	3.0	17.2	24.6	0.0	9.9	10.7	9.6	5.5	3.8	4.9	10.0	0.1	8.9	11.2	3.5	0.5	10.8	23.4	9.6	88.1	14.5	13.4	13.1	0.0	18.7	2.1	6.7	0.0	1.2	1.0	0.2	3.5	0.2	1.7	3.3	0.3	2.6	3.7	19.0	9.0	1.0	9.6	4.2	0.6	0.5	2.1	5.6	5.9	5.8	8.9	5.6	6.0	6.5	5.8	6.0	5.5	5.7	6.1	42.4	19.2	25.7	25.5	16.1	95.0	36.7	10.0	58.6	55.6	21.5	14.7	26.6	15.7	14.1	16.5	68.8	5.1	6.1	14.8	9.8	5.8	26.8	23.5	24.4	41.1	11.3	1.7	13.9	8.7	2.3	42.0	25.5	40.0	10.8	35.3	16.1	60.5	19.5	38.7	26.8	20.0	12.2	17.0	62.8	20.3	59.4	32.3	28.4	22.5	6.2	33.3	2.1	15.6	24.5	4.3	21.1	34.3	2.5	33.8	28.4	5.6	10.4	86.9	52.6	71.5	40.4	581.3	205.9	38.6	114.1	5.6	15.1	44.4	31.3	31.1
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239313-18354688	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.7;REH: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	1.4	4.0	0.9	1.2	1.0	6.3	2.0	1.3	1.5	2.3	1.0	1.8	1.1	2.6	1.1	1.0	1.5	0.7	0.8	1.0	1.2	0.7	1.4	0.5	1.1	0.9	0.8	6.0	1.3	1.7	1.5	1.9	1.1	1.1	1.3	3.5	8.8	1.1	1.3	2.0	0.9	2.5	0.8	1.2	0.6	11.6	0.9	3.4	2.4	1.4	1.2	1.4	1.7	1.3	1.9	6.8	24.7	5.9	1.9	2.5	7.2	4.0	2.9	7.3	8.3	9.2	1.3	0.0	0.9	1.9	5.7	0.1	32.7	0.6	9.4	0.0	26.0	0.0	5.7	4.0	0.9	21.1	5.0	1.5	1.1	5.7	6.9	1.9	0.4	20.2	16.0	0.0	5.1	3.2	33.3	10.0	39.7	0.7	9.0	37.8	11.9	4.5	0.2	0.4	14.0	16.3	7.7	6.5	0.1	26.0	8.2	8.8	1.0	6.8	4.9	15.2	3.6	0.0	20.4	32.0	2.6	13.8	5.4	0.0	0.1	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.5	0.6	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.9	1.0	1.3	1.5	1.0	1.2	0.9	0.8	1.1	0.8	0.9	1.3	0.5	0.0	0.5	3.6	1.7	3.6	1.0	0.0	2.8	2.3	0.8	1.3	1.8	0.0	0.6	0.0	0.0	1.8	1.7	0.4	0.0	0.3	1.3	0.9	2.5	1.2	1.2	4.2	7.7	0.2	0.4	2.4	0.0	0.2	0.0	6.1	0.0	0.9	1.9	6.7	15.3	0.7	0.0	0.0	0.5	1.6	1.8	0.6	0.0	0.0	0.2	1.7	0.0	17.1	10.2	0.2	0.0	1.2	0.3	1.2	0.1	0.8	0.0	3.8	0.0	2.6	0.6	26.3	27.5	1.8	4.1	0.4	0.5	9.8	1.2	0.3
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845764-39052157	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;placenta: 1.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.4;Astrocytes: 7.8;Early spermatids: 7.0;Sertoli cells: 6.6;Spermatocytes: 4.4;Spermatogonia: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036746, HPA036747"	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.5	0.1	0.4	0.2	0.2	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.4	0.3	0.5	0.2	0.1	0.2	0.3	0.4	0.1	0.1	0.0	0.3	1.9	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.4	0.5	0.3	0.3	3.0	0.1	1.3	0.5	0.2	0.1	0.0	0.1	0.8	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.5	0.4	5.4	0.0	0.0	7.8	0.1	0.8	0.9	0.0	0.0	0.2	0.2	0.3	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	7.0	0.4	0.5	2.5	0.0	2.7	1.6	0.2	0.1	0.6	0.0	0.2	0.0	1.1	1.4	0.4	0.3	0.0	1.0	0.0	0.0	0.3	1.6	2.1	0.0	0.2	1.8	0.0	0.1	0.5	0.0	1.5	2.4	0.1	0.0	0.0	0.1	0.7	0.0	0.2	2.3	0.5	6.6	1.0	0.4	4.4	6.3	0.0	0.9	0.3	0.6	0.7	0.0	0.8
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 26.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 440.4;Inhibitory neurons: 364.7;Oligodendrocyte precursor cells: 246.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.1;U-138 MG: 3.4;U-266/84: 8.1;U-87 MG: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	0.2	1.3	15.8	0.1	17.5	0.0	0.7	26.1	20.1	0.2	0.0	0.1	0.2	0.5	0.9	0.0	0.1	0.8	0.1	22.2	8.0	3.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.1	0.0	0.1	0.1	4.6	0.2	0.4	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.3	2.5	0.3	0.0	0.0	0.0	0.1	0.3	5.8	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.3	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.2	0.2	0.0	0.3	8.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	17.5	26.1	20.1	22.2	8.0	0.0	0.0	0.0	0.0	2.5	5.8	0.1	0.0	1.7	18.3	0.5	0.3	0.1	0.2	0.0	49.8	0.3	4.7	0.8	0.0	0.0	11.0	47.9	0.1	0.2	0.0	5.9	0.2	1.6	0.1	2.3	0.3	0.0	0.0	440.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.2	364.7	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	60.9	0.0	3.4	0.0	246.3	17.0	0.3	0.0	6.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	0.6	0.0	0.9	0.1	0.1	0.0	0.4	1.0	0.0	0.0
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087526-165204050	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 16.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 78.4;Excitatory neurons: 227.3;Inhibitory neurons: 169.4;Oligodendrocyte precursor cells: 358.4"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.2;naive B-cell: 15.3"	"Lineage enriched"	"Detected in single"	32	"B-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 5.9;Karpas-707: 10.3;MOLT-4: 30.3;RPTEC TERT1: 14.9;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035396: AB_2674607"	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	1.0	1.5	10.9	0.5	10.9	0.2	1.0	7.2	12.1	0.6	0.0	0.6	0.3	0.4	0.1	0.4	0.4	0.5	0.6	10.1	16.9	0.5	0.2	0.2	0.8	6.0	8.8	0.6	0.5	0.4	0.1	0.1	9.2	0.2	0.7	1.0	0.1	0.4	0.9	0.0	0.5	0.5	3.0	0.5	0.9	0.5	13.4	3.1	0.2	0.6	1.2	0.5	0.0	6.5	0.0	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.3	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	4.9	0.0	5.9	0.0	10.3	0.1	0.0	30.3	0.0	0.0	0.1	2.4	0.1	1.3	0.0	14.9	0.0	3.8	6.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.2	0.1	0.8	0.0	1.4	0.6	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.2	0.0	0.4	0.1	0.1	10.9	10.9	7.2	12.1	10.1	16.9	6.0	8.8	9.2	3.0	13.4	6.5	0.9	0.0	0.5	8.5	6.5	0.0	0.2	0.0	0.6	4.4	0.1	0.4	6.5	0.0	0.0	1.8	12.5	0.0	0.0	0.0	0.0	0.2	78.4	0.0	0.0	2.9	8.9	0.0	227.3	0.0	0.0	0.5	1.1	0.0	0.0	0.3	0.0	0.2	0.1	5.0	169.4	1.2	0.0	0.0	0.3	11.5	0.3	0.2	1.8	19.7	0.0	0.3	0.0	358.4	9.2	0.1	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.8	13.1	0.3	31.8	0.7	2.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cell line enhanced"	"Detected in many"		"BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	1.7	1.7	5.3	0.9	4.2	2.0	0.6	0.1	3.4	0.6	0.0	3.2	0.5	0.2	0.1	0.5	0.4	1.2	0.4	2.9	21.9	1.7	3.9	2.0	0.6	8.2	19.4	0.3	2.0	0.1	1.5	4.3	12.0	0.3	3.1	0.7	0.4	0.4	0.2	0.7	1.8	2.4	2.2	3.1	0.4	5.1	18.2	1.6	0.3	0.6	0.4	0.5	0.5	1.7	0.0	2.5	0.1	0.0	9.6	7.9	0.0	23.0	16.8	5.2	1.7	0.5	0.1	0.0	0.0	2.8	0.2	0.1	6.5	0.6	8.6	0.0	2.1	1.7	1.8	1.9	19.0	0.1	0.0	0.6	0.2	9.1	1.7	15.6	1.1	1.2	6.1	6.6	0.8	0.0	3.6	0.0	1.9	0.1	0.6	0.8	3.3	9.0	2.4	9.5	1.0	9.5	0.0	0.1	0.3	4.8	0.3	0.0	0.1	0.0	1.5	0.1	0.4	0.1	0.1	0.0	3.2	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.5	0.1	23.6	0.0	0.1	5.3	4.2	0.1	3.4	2.9	21.9	8.2	19.4	12.0	2.2	18.2	1.7	0.9	12.8	23.8	0.7	1.3	1.0	0.4	0.5	0.6	0.6	0.8	0.9	2.5	8.6	4.4	5.5	0.0	0.3	43.2	9.0	3.9	23.4	2.5	0.1	0.1	5.7	33.0	4.2	15.8	31.5	0.3	2.0	0.0	0.1	3.8	18.1	13.6	9.5	67.5	0.0	48.2	19.3	10.2	1.9	42.8	3.2	1.2	11.3	3.6	2.8	1.0	2.3	0.0	133.7	0.4	12.7	7.8	0.0	1.2	0.3	14.7	11.5	2.2	0.2	0.0	7.8	1.6	1.3	0.4	0.5	0.4	1.1	0.9	4.4	12.9	0.2
SCNM1	MGC3180	ENSG00000163156	"Sodium channel modifier 1"	Q9BWG6	1	151156664-151170296	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 269.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052439, HPA054324"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052439: AB_2681834, HPA054324: AB_2682451"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (2.17e-13)"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.71e-2)"	27.6	19.9	37.6	27.5	37.7	46.1	24.3	38.6	40.6	24.4	34.3	25.8	20.1	25.2	17.3	25.8	21.8	18.7	23.2	36.6	38.0	22.8	16.8	21.6	39.9	38.7	37.9	20.8	15.0	17.6	16.4	21.1	38.1	23.7	17.4	13.7	20.2	17.2	65.0	29.1	23.4	21.6	37.9	34.1	21.3	18.3	38.4	35.0	18.0	34.3	34.7	29.8	23.0	40.0	46.5	32.0	35.0	41.4	47.9	35.9	58.3	35.9	41.5	85.7	66.5	69.9	44.2	73.3	57.1	39.0	22.4	61.5	41.3	33.1	41.4	46.6	45.7	63.5	44.5	45.5	69.2	85.2	60.0	37.8	63.3	60.3	53.4	40.2	52.4	50.5	51.7	54.7	42.6	114.0	61.2	132.0	89.0	72.1	49.2	82.3	41.7	91.7	46.7	30.6	43.0	69.0	40.5	65.4	83.5	43.2	60.5	269.9	38.7	40.8	38.3	42.5	78.1	70.7	104.3	117.4	42.5	89.5	53.6	286.7	189.1	203.3	80.4	146.0	77.6	125.9	97.4	92.0	254.9	112.7	89.0	76.9	190.5	131.6	95.1	260.8	131.4	182.3	37.6	37.7	38.6	40.6	36.6	38.0	38.7	37.9	38.1	37.9	38.4	40.0	21.0	3.2	15.2	0.0	33.7	26.6	17.8	47.8	33.0	19.9	20.2	26.3	32.9	17.2	34.1	29.5	18.8	36.6	52.3	21.4	54.8	34.0	33.5	24.0	23.1	26.9	14.4	34.7	0.0	31.9	33.6	26.5	26.0	15.2	40.5	15.8	27.5	11.9	74.1	8.4	0.0	20.4	54.9	57.2	62.0	25.3	31.1	55.1	21.4	0.0	67.6	25.7	64.9	0.0	0.0	41.9	31.2	21.4	23.2	16.6	36.3	37.1	38.5	16.9	32.9	14.2	43.9	27.9	15.1	33.6	18.3	27.5	37.8	14.7	16.8	22.0
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 subunit alpha"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 157.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 114.0;Distal enterocytes: 230.9;Glandular and luminal cells: 189.8;Intestinal goblet cells: 180.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 6.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 300.5;HBEC3-KT: 202.4;hTCEpi: 85.3;RPTEC TERT1: 103.7;RT4: 114.1;SK-BR-3: 96.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	3.4	12.5	0.2	5.6	0.1	0.5	20.6	1.1	0.2	64.7	113.6	66.4	18.7	7.6	43.2	140.1	57.9	17.7	0.7	6.8	0.0	148.5	8.2	62.9	0.2	0.1	0.3	3.5	40.0	0.7	16.6	0.4	0.1	43.7	65.4	0.0	157.3	49.5	0.5	54.6	26.0	2.9	0.1	0.7	63.6	4.7	1.3	1.9	94.3	0.1	12.5	20.8	57.6	0.1	21.6	4.1	0.0	1.9	0.3	0.4	17.6	0.0	0.1	0.1	0.0	6.1	300.5	0.3	0.8	0.1	0.1	14.0	0.0	202.4	0.0	0.0	0.0	0.0	17.5	3.1	20.9	0.0	0.1	5.1	85.3	0.0	61.6	0.4	0.0	0.5	0.0	0.1	0.5	1.9	0.1	0.3	17.6	38.9	0.8	0.2	0.0	0.5	103.7	114.1	1.2	0.1	2.3	96.7	0.1	17.1	22.3	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	1.5	0.0	0.0	1.0	0.5	0.1	0.2	0.1	1.1	0.2	6.8	0.0	0.1	0.3	0.1	0.1	1.3	0.1	1.7	73.7	75.7	0.0	1.3	1.9	25.1	17.0	10.8	0.9	17.7	21.2	0.8	54.3	52.5	114.0	4.2	1.4	1.8	230.9	5.9	45.0	0.5	85.3	17.8	3.2	27.1	0.0	0.3	33.9	0.3	2.0	97.3	189.8	2.5	1.3	1.4	3.2	0.3	1.7	0.2	180.3	63.1	1.9	3.1	0.6	1.8	2.5	0.0	0.0	1.6	0.3	1.0	0.5	0.1	39.4	95.8	1.5	0.3	30.9	12.2	6.2	36.7	1.4	0.0	5.6	4.3	1.2	3.7	48.1	8.8	1.6	3.6	0.2	31.5	42.1
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 subunit beta"	P51168	16	23278231-23381294	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 82.8;intestine: 94.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Club cells: 64.8;Collecting duct cells: 57.0;Distal enterocytes: 262.8;Ionocytes: 107.8;Paneth cells: 73.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 26.4"	"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 33.3;RPMI-8226: 9.2;RT4: 18.5;U-266/70: 55.4;U-266/84: 20.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			HPA015612	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA015612: AB_1856629"	"unprognostic (7.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.74e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.32e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-2)"	18.5	0.4	0.0	1.1	0.0	0.2	17.7	1.0	0.0	48.5	0.0	94.2	2.5	2.8	0.1	82.8	3.7	0.5	0.3	0.0	0.0	31.7	0.2	23.9	0.8	0.0	0.0	0.7	2.1	0.3	1.0	3.6	0.1	10.5	35.6	0.0	39.5	2.4	1.4	36.0	4.3	0.8	0.0	3.7	24.1	0.3	0.0	0.7	9.2	0.8	5.4	8.3	56.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	7.0	0.0	0.0	9.2	0.0	18.5	0.2	0.0	0.0	0.5	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	55.4	20.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.7	99.3	28.3	0.0	7.1	3.1	15.4	27.8	5.7	0.0	4.4	3.0	0.7	0.0	64.8	57.0	0.0	0.7	0.1	262.8	0.0	0.0	0.1	11.9	1.6	6.2	7.7	0.0	0.3	0.4	0.3	1.0	36.7	23.4	8.2	0.0	1.1	0.1	0.1	0.0	0.3	21.4	107.8	0.0	0.0	0.2	0.0	1.0	10.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	73.7	0.0	38.7	6.1	0.0	0.1	9.2	0.0	0.0	0.1	0.7	0.1	0.4	29.8	5.4	2.2	1.4	0.0	15.2	19.7
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 subunit delta"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Early spermatids: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 9.3"					"Low region specificity"	"Detected in all"			HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	5.6	7.1	10.3	1.7	10.4	3.2	6.0	11.7	18.1	11.1	5.9	9.4	5.2	8.0	0.9	4.0	14.0	1.2	6.2	9.7	7.5	7.7	13.7	3.7	2.3	10.7	8.5	14.7	4.8	0.7	18.5	1.1	10.9	9.7	0.3	1.7	5.8	1.7	3.4	4.7	7.6	0.8	6.9	8.0	6.3	35.5	9.9	0.9	6.3	1.4	0.7	5.1	7.6	11.7	0.5	4.2	1.6	4.3	1.1	0.6	0.7	2.8	0.8	1.3	1.5	0.8	2.4	3.0	1.5	1.2	2.2	0.7	0.7	0.6	0.2	5.8	2.5	0.4	5.9	1.1	1.1	0.1	2.9	1.8	0.9	2.3	0.0	1.8	0.4	5.5	2.1	7.0	0.3	1.5	1.2	2.0	0.8	0.5	3.0	8.1	0.3	0.7	0.6	0.2	2.2	3.1	1.2	1.2	1.9	0.6	5.4	1.6	1.2	2.6	2.1	4.1	0.9	9.3	0.6	2.5	2.3	5.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	10.4	11.7	18.1	9.7	7.5	10.7	8.5	10.9	6.9	9.9	11.7	1.7	3.2	2.3	10.7	1.0	0.8	0.2	1.2	1.2	3.7	2.2	3.4	4.0	0.0	1.7	0.0	4.2	0.1	0.6	1.0	0.0	0.5	10.5	0.6	2.1	0.6	1.2	2.7	5.2	0.5	0.4	1.7	4.1	1.3	2.5	3.2	0.7	3.5	0.4	5.0	6.0	0.4	0.0	0.8	0.5	4.0	0.9	1.1	0.0	1.0	0.1	1.4	0.0	4.5	5.4	2.0	3.8	1.9	0.7	0.1	3.9	0.7	1.9	2.8	0.0	1.8	1.5	2.8	2.2	0.8	1.6	0.0	1.0	0.5	0.9	0.3
SCO1	SCOD1	ENSG00000133028	"Synthesis of cytochrome C oxidase 1"	O75880	17	10672474-10698375	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021565, HPA021579"	Enhanced					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA021565: AB_1856631, HPA021579: AB_1856632"	"unprognostic (6.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.02e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.84e-2)"	"prognostic favorable (9.69e-7)"	"unprognostic (4.94e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.12e-2)"	16.4	18.5	9.2	12.2	9.4	8.9	14.2	9.7	9.5	12.5	14.5	18.8	19.9	13.6	8.0	16.5	10.6	8.0	24.2	9.2	10.1	20.0	30.1	10.2	12.0	9.7	9.4	10.4	9.6	15.7	12.5	11.3	9.7	12.8	14.6	9.2	11.9	9.7	24.9	12.1	16.8	9.2	9.6	12.0	13.2	12.0	10.0	9.6	13.1	17.2	9.9	13.5	12.3	10.2	32.6	46.9	19.0	25.5	22.8	19.4	40.7	35.2	18.3	31.1	29.9	24.0	18.5	56.8	37.4	31.6	19.1	35.0	38.0	33.4	34.7	30.1	48.4	29.3	28.8	34.0	32.5	20.5	20.8	24.7	21.4	29.3	46.3	16.2	22.5	36.9	30.3	9.8	32.4	18.4	28.7	21.1	42.0	36.6	23.9	33.8	23.6	25.4	40.3	23.2	10.1	29.2	41.6	25.4	37.2	24.4	32.1	14.4	26.9	23.7	20.2	25.6	37.1	15.5	16.5	21.6	19.3	25.5	26.3	6.6	15.5	14.8	11.5	18.5	12.2	13.2	10.0	12.0	15.2	9.8	12.2	12.8	5.1	11.1	20.5	10.9	14.3	12.2	9.2	9.4	9.7	9.5	9.2	10.1	9.7	9.4	9.7	9.6	10.0	10.2	18.1	22.4	19.8	5.9	24.3	11.5	23.3	32.2	13.1	20.4	14.0	13.2	39.5	18.6	23.4	18.4	66.7	61.0	15.5	34.6	41.1	26.1	4.0	13.7	25.2	19.1	15.7	22.1	4.2	20.4	102.6	19.7	24.5	15.9	8.8	22.4	19.6	38.2	29.8	16.8	4.7	25.3	26.4	18.9	9.5	5.4	18.6	15.9	10.6	6.5	28.4	20.7	22.6	2.5	5.4	24.1	19.3	19.2	18.4	33.1	31.6	49.8	16.1	37.7	6.6	23.8	19.1	28.4	37.0	21.5	11.8	60.5	17.5	43.0	35.6	23.0
SCO2	"MYP6, SCO1L"	ENSG00000284194	"Synthesis of cytochrome C oxidase 2"	O43819	22	50523568-50526461	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Cardiomyopathy, Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 112.2;Paneth cells: 131.5;Proximal enterocytes: 110.7;Suprabasal keratinocytes: 98.9"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046943, HPA056254"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA046943: AB_2732536, HPA056254: AB_2683080"																		16.8	10.3	14.0	13.4	13.8	36.5	7.8	14.4	16.8	6.8	18.2	22.0	25.6	3.6	4.7	12.3	15.8	7.7	10.3	14.3	14.4	8.1	18.4	14.4	9.1	18.8	19.1	1.8	11.5	7.2	1.5	8.3	17.5	5.1	10.5	0.1	21.3	6.7	10.2	11.0	19.7	12.7	16.4	11.4	10.2	4.1	17.4	11.2	2.3	10.1	10.3	13.0	2.5	17.4	37.4	29.9	1.3	12.5	17.7	24.2	18.7	19.5	24.1	38.0	32.8	35.3	17.8	42.7	19.7	22.6	9.6	36.0	19.3	31.5	6.1	7.6	82.5	13.8	20.2	46.7	44.6	43.8	18.3	38.4	48.6	19.4	15.8	10.6	24.4	5.8	15.6	32.9	16.8	55.7	13.3	76.5	11.0	15.5	54.8	26.1	7.5	65.0	29.6	21.3	16.6	23.7	24.4	70.7	63.5	1.3	26.1	24.7	25.8	16.3	22.6	30.2	22.2	26.1	15.6	29.2	35.7	28.7	14.5	19.1	21.8	12.2	43.9	19.9	42.2	40.1	38.9	44.1	34.9	33.4	29.2	32.6	21.6	27.7	21.1	56.2	37.0	37.7	14.0	13.8	14.4	16.8	14.3	14.4	18.8	19.1	17.5	16.4	17.4	17.4	0.0	3.2	2.7	2.9	20.0	85.7	21.6	75.5	44.3	7.3	0.1	0.0	16.8	21.5	31.4	0.0	2.1	0.0	5.3	112.2	0.0	0.0	15.1	0.1	0.2	13.8	25.8	14.1	2.7	0.0	0.0	14.1	24.5	0.1	15.9	0.0	18.2	53.5	0.0	11.8	2.7	63.2	48.8	28.2	63.6	25.6	16.4	29.2	42.7	5.6	47.3	5.5	25.7	5.5	1.4	0.1	131.5	10.9	32.1	40.0	110.7	0.1	42.6	7.1	0.0	30.4	29.5	17.3	35.7	56.1	98.9	0.0	14.9	0.1	90.7	22.3
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978129-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 300.9"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 456.2;Club cells: 304.9;Respiratory ciliated cells: 397.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 319.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 389.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	64.1	121.5	25.7	32.6	26.4	75.8	91.0	27.3	42.9	69.8	34.5	46.9	31.4	37.5	73.1	54.8	48.5	71.2	60.1	27.2	30.9	88.6	32.0	95.1	48.7	30.1	29.5	53.6	17.0	300.9	28.7	20.8	30.6	61.6	33.7	8.1	90.0	102.9	15.8	46.3	40.3	60.9	28.7	44.8	54.2	14.3	28.4	14.6	135.1	32.5	60.6	71.1	51.1	33.6	48.3	20.9	49.4	41.4	389.3	85.6	26.0	23.3	119.6	41.9	77.8	13.7	33.3	63.3	126.4	55.9	65.8	44.0	22.0	105.4	46.8	82.0	36.1	19.8	28.2	8.7	89.1	39.1	190.1	103.7	45.0	52.0	43.0	37.5	72.3	24.3	5.1	257.9	59.1	20.3	19.9	100.4	20.4	15.2	39.3	24.2	53.8	41.4	9.3	143.7	13.8	33.8	56.3	45.6	33.3	57.1	19.1	104.1	34.1	118.3	29.9	68.8	26.5	250.5	187.2	35.9	88.1	28.5	34.4	2.1	228.5	319.0	11.8	137.1	8.0	56.0	8.2	8.3	105.7	55.1	11.3	12.3	34.8	23.7	141.0	18.0	10.2	118.7	25.7	26.4	27.3	42.9	27.2	30.9	30.1	29.5	30.6	28.7	28.4	33.6	48.8	44.8	61.8	25.1	52.7	23.7	208.6	456.2	37.5	12.7	52.4	110.7	32.5	10.0	304.9	95.6	16.7	9.9	20.5	2.0	19.6	22.2	1.0	51.5	24.5	27.1	24.4	21.2	37.2	6.8	19.4	115.4	4.6	13.6	8.2	4.3	62.8	15.7	160.5	10.1	24.9	5.0	126.1	135.0	33.7	3.4	64.3	110.2	24.9	20.6	142.2	18.9	25.7	21.1	20.7	4.8	1.6	68.1	39.0	74.1	62.4	29.7	397.8	17.0	52.6	28.1	63.2	4.4	12.3	38.1	19.9	11.1	18.8	67.1	8.0	122.6
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribble planar cell polarity protein"	Q14160	8	143790920-143815773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	18.7	17.1	11.5	7.2	10.8	5.6	23.6	6.0	10.4	45.6	0.0	32.3	9.1	24.7	0.9	100.5	26.0	3.4	24.6	8.7	2.7	27.7	25.4	21.3	4.0	10.7	8.1	23.0	38.8	5.2	24.8	5.0	5.9	28.4	3.4	1.0	40.2	5.2	54.3	68.3	26.5	2.0	4.9	22.9	30.0	26.4	9.0	3.0	24.6	1.7	3.9	27.8	52.6	15.3	55.7	33.1	12.7	20.5	5.1	6.9	33.0	30.9	5.3	11.2	9.1	15.3	29.8	24.2	39.7	7.2	4.6	52.4	7.9	32.9	1.7	30.8	58.5	24.6	30.5	26.1	10.8	13.0	14.8	5.1	29.9	9.4	5.5	5.1	11.5	19.8	42.2	6.4	7.5	93.0	38.1	26.9	15.7	25.0	55.1	44.5	10.6	25.0	5.6	45.5	29.6	27.1	31.4	30.5	33.6	4.5	41.5	28.2	25.7	10.1	64.1	25.2	44.7	31.6	31.0	23.8	13.1	9.5	19.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	10.8	6.0	10.4	8.7	2.7	10.7	8.1	5.9	4.9	9.0	15.3	12.3	0.0	9.9	33.0	4.4	8.5	5.0	10.2	13.6	11.3	16.8	17.0	11.1	11.5	8.3	14.7	14.6	11.0	9.7	28.7	3.9	8.6	1.5	14.0	7.7	7.8	13.8	13.7	5.0	9.4	6.3	7.3	29.6	27.3	0.0	17.9	3.6	8.8	6.5	5.0	6.2	17.8	18.3	6.0	4.1	0.7	9.0	6.6	8.8	6.5	5.0	10.0	5.2	12.1	15.2	11.5	22.8	9.8	5.6	9.3	16.9	4.5	9.9	16.0	13.1	12.0	8.7	9.4	10.0	19.9	10.7	5.1	7.3	8.0	23.2	7.1
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920104-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.0"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 326.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		160000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	13.9	27.9	112.4	13.1	118.9	8.1	14.3	128.2	117.9	22.2	52.2	27.5	6.5	27.4	16.2	19.0	26.0	16.5	19.8	112.5	129.0	23.7	2.6	16.4	14.3	112.5	159.0	32.4	36.7	54.5	34.0	15.8	115.5	27.9	10.4	102.5	18.0	37.2	2.4	11.1	15.8	34.3	116.1	10.8	19.3	23.0	122.5	28.9	13.5	11.0	21.6	22.0	17.8	127.1	106.3	75.0	119.9	48.6	83.1	126.9	0.5	97.0	128.8	102.5	110.0	87.1	81.8	13.0	83.7	124.7	227.3	46.7	137.7	41.2	148.9	0.6	29.0	43.8	49.7	56.6	105.9	0.3	0.5	106.5	58.1	93.5	49.6	139.4	95.9	28.0	0.5	33.3	146.6	59.5	15.5	0.1	109.4	0.2	79.6	0.3	127.7	1.1	71.7	51.5	43.7	103.1	99.9	64.1	112.5	149.7	86.3	6.9	106.7	132.2	113.3	1.7	123.7	10.8	177.0	1.1	62.4	0.5	326.5	3.7	3.4	10.3	0.9	14.1	10.7	14.0	0.2	1.0	10.9	7.6	0.7	1.4	0.5	7.1	25.4	10.8	0.0	3.5	112.4	118.9	128.2	117.9	112.5	129.0	112.5	159.0	115.5	116.1	122.5	127.1	5.9	28.9	14.1	42.7	15.4	3.1	12.6	14.0	14.2	66.9	7.6	5.2	15.8	20.0	22.3	33.1	45.9	0.4	16.2	1.1	15.6	24.1	61.1	7.3	11.9	10.9	12.1	2.5	52.0	25.1	1.9	17.2	5.6	6.7	8.2	22.9	1.8	0.3	5.4	69.0	51.4	0.7	14.2	8.8	13.9	68.1	13.7	11.1	7.2	16.9	11.5	80.8	12.3	31.2	35.6	21.2	17.3	21.1	12.5	17.4	0.1	2.8	29.2	41.1	6.6	9.6	11.9	3.1	11.0	5.1	1.7	1.0	2.8	8.5	1.2	22.3
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SCRN3	FLJ23142	ENSG00000144306	"Secernin 3"	Q0VDG4	2	174395730-174429575	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034689, HPA034690"	Approved		Approved	Vesicles,Cytosol		NA	NA		27000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Cytosol"		"HPA034689: AB_2674282, HPA034690: AB_10670574"	"unprognostic (5.39e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	16.4	16.4	11.8	9.9	14.4	5.2	13.5	14.7	16.0	9.5	7.0	12.9	18.5	11.9	11.4	16.2	10.4	11.2	26.0	10.8	13.6	20.2	22.0	12.2	11.4	14.6	13.4	13.2	14.7	27.7	14.0	13.1	13.6	15.2	13.2	22.8	11.0	12.5	40.5	13.8	14.3	14.0	12.9	11.8	12.4	10.6	14.1	12.4	20.3	35.8	12.1	10.4	8.3	18.5	15.9	9.7	25.8	22.8	18.8	21.1	13.7	24.1	19.0	18.2	22.0	9.6	11.4	3.0	15.6	24.2	14.0	15.5	19.3	21.1	23.9	34.8	17.8	29.7	21.1	7.5	27.8	22.8	15.0	23.5	25.4	34.4	24.5	20.4	21.8	16.7	20.2	11.1	25.0	18.0	18.9	22.2	12.0	35.4	41.0	9.3	25.7	17.5	21.2	16.5	16.0	44.5	16.6	16.2	30.7	26.4	21.8	21.7	15.7	20.9	10.9	25.6	21.0	29.4	32.8	0.5	22.9	11.2	21.8	7.2	5.2	2.2	4.8	3.3	3.4	8.6	5.1	4.6	5.1	11.0	7.8	6.3	20.0	6.9	4.3	8.0	5.6	2.6	11.8	14.4	14.7	16.0	10.8	13.6	14.6	13.4	13.6	12.9	14.1	18.5	7.8	9.6	15.6	18.6	7.0	3.6	12.1	23.7	12.5	12.8	7.9	6.3	22.8	4.3	12.5	9.2	10.4	10.7	3.8	8.4	13.7	9.1	5.1	9.4	8.3	6.0	6.0	11.6	21.0	9.8	6.3	6.9	11.2	5.4	8.8	9.5	8.6	8.7	9.3	18.5	26.3	7.3	20.3	5.8	2.2	4.0	4.7	6.2	3.6	6.5	6.1	22.6	7.2	27.6	25.7	12.2	4.0	6.8	10.3	5.4	9.9	12.5	13.6	15.0	0.0	8.2	7.1	18.9	7.1	20.4	4.8	6.8	5.8	13.0	6.4	9.7
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 64.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.0	0.5	3.4	0.0	4.8	0.0	0.0	12.5	64.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	19.4	0.0	0.0	0.0	0.0	22.9	8.5	0.0	0.3	0.0	3.4	0.0	18.1	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.8	12.5	64.2	1.6	19.4	22.9	8.5	18.1	0.1	26.2	23.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.1	1.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.3	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	14.2	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SCT		ENSG00000070031	Secretin	P09683	11	626309-627181	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 44.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 92.8;Enteroendocrine cells: 267.8;Intestinal goblet cells: 46.4;Proximal enterocytes: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	138	"plasmacytoid DC: 126.7"	"Lineage enriched"	"Detected in single"	138	"dendritic cells: 126.7"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050961	Enhanced				"Secreted to blood"	NA	NA	571000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA050961: AB_2681291"	"unprognostic (5.28e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.45e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-1)"	0.1	0.2	0.7	0.1	1.8	0.6	0.0	1.9	1.9	0.3	0.0	0.9	44.2	0.1	0.3	0.3	0.2	0.0	1.8	0.7	0.3	0.4	0.4	2.2	1.3	1.3	0.7	0.4	0.2	0.0	2.0	0.7	1.5	0.6	0.1	0.2	0.2	0.0	10.3	0.1	8.6	0.0	0.1	3.3	0.7	3.0	1.4	0.4	0.5	1.3	0.7	0.3	0.1	4.1	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.9	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.9	0.0	126.7	0.0	0.4	0.7	1.8	1.9	1.9	0.7	0.3	1.3	0.7	1.5	0.1	1.4	4.1	0.1	0.0	0.0	0.7	4.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.4	1.5	0.0	0.0	0.0	0.1	92.8	1.6	1.9	0.0	1.7	0.3	0.3	0.1	267.8	0.0	0.0	0.0	0.0	1.9	1.1	0.4	0.0	3.5	0.4	0.0	0.2	0.0	0.1	46.4	0.0	0.0	1.2	1.1	1.5	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.2	39.2	0.2	0.0	0.0	0.0	1.6	0.2	0.8	10.2	0.0	0.1	0.0	0.1	0.1	3.2	0.2
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 26.6;pancreas: 68.2"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 54.4;Ductal cells: 92.0;Exocrine glandular cells: 93.8;Pancreatic endocrine cells: 41.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA007269	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.3	0.4	0.3	0.2	0.3	0.3	0.0	0.6	1.2	0.0	0.3	0.1	26.6	0.2	0.2	0.3	0.4	0.4	0.3	0.4	0.4	12.5	0.4	8.6	0.1	0.3	0.2	0.4	68.2	0.1	0.2	0.1	0.4	0.0	0.0	2.4	0.0	0.0	0.2	0.2	3.8	0.0	0.2	0.3	4.5	0.5	0.6	0.1	0.9	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.6	1.2	0.4	0.4	0.3	0.2	0.4	0.2	0.6	0.4	0.0	0.0	54.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.4	0.0	1.8	5.5	0.0	0.0	0.0	0.1	11.7	92.0	4.5	0.0	0.2	0.1	2.4	0.0	3.0	93.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.7	5.0	4.1	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	1.0	1.6	0.3	0.0	0.0	0.7	41.9	0.0	0.0	0.0	0.1	0.1	0.5	0.0	1.9	0.0	0.0	0.6	0.3	0.9	0.0	0.0	0.3	0.4	0.0	0.1	0.0
SCUBE1		ENSG00000159307	"Signal peptide, CUB domain and EGF like domain containing 1"	Q8IWY4	22	43197280-43343372	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 26.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 13.3;Granulosa cells: 37.2;Peritubular cells: 45.5;Theca cells: 14.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 49.8;THP-1: 20.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003190	Approved				"Secreted to blood"	NA	NA	2170000	190000		"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA003190: AB_1079882"	"unprognostic (5.29e-2)"	"unprognostic (7.15e-6)"	"unprognostic (6.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-3)"	1.8	6.1	0.8	0.8	1.1	0.1	1.2	0.1	1.4	0.9	4.1	3.8	5.9	1.1	0.1	3.6	1.2	0.8	0.2	0.6	3.8	3.5	5.1	6.8	0.0	1.7	10.2	26.4	0.1	9.1	3.8	2.6	7.0	1.9	2.0	0.4	3.6	0.5	9.6	0.6	7.7	0.5	0.3	5.7	7.0	7.1	1.2	0.1	3.1	1.9	0.0	3.3	0.7	0.4	0.0	0.0	2.2	7.8	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.1	0.1	0.3	0.1	0.7	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.2	0.2	49.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.3	0.1	20.4	0.0	0.3	0.2	0.6	0.0	2.1	4.3	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.1	1.4	0.6	3.8	1.7	10.2	7.0	0.3	1.2	0.4	0.2	9.6	1.7	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.9	0.1	1.4	0.0	0.6	0.0	0.0	0.2	0.2	0.0	1.9	0.1	3.0	1.3	1.2	1.3	0.0	0.0	0.4	0.0	13.3	2.6	0.5	3.4	1.3	37.2	0.4	1.9	0.8	0.0	0.3	0.2	0.0	0.0	0.4	4.6	7.8	0.2	0.0	0.0	0.1	4.1	0.0	0.0	0.3	0.1	0.0	45.5	0.4	0.0	0.0	0.4	0.7	0.2	0.0	0.4	1.2	3.8	2.0	0.0	0.1	0.4	2.8	14.3	0.0	0.1
SCUBE2	"Cegb1, Cegf1, FLJ16792"	ENSG00000175356	"Signal peptide, CUB domain and EGF like domain containing 2"	Q9NQ36	11	9019476-9138114	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 48.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.3;Basal prostatic cells: 51.4;Breast glandular cells: 45.0;Breast myoepithelial cells: 31.5;Prostatic glandular cells: 39.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 54.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.7;SK-MEL-30: 8.1;T-47d: 28.4"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 4.6;thalamus: 2.7"	"Low region specificity"	"Detected in all"			"HPA006353, HPA029871"	Uncertain				"Secreted to blood"	NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"			"HPA006353: AB_1856642, HPA029871: AB_10602299"	"prognostic favorable (2.41e-4)"	"unprognostic (5.72e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-4)"	"unprognostic (3.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-4)"	"unprognostic (4.35e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-1)"	14.8	2.0	3.5	3.7	3.5	0.0	32.2	13.7	3.1	17.6	0.2	11.1	3.6	13.4	48.8	4.5	18.2	7.9	4.3	4.0	4.9	1.3	0.9	4.6	3.9	3.0	3.6	0.9	22.0	19.5	9.6	22.5	3.7	33.3	4.5	1.9	2.3	8.7	9.0	12.3	16.3	13.0	5.4	5.0	21.4	2.2	4.7	2.4	5.2	6.2	7.6	28.6	6.9	5.1	0.0	0.1	1.5	0.9	0.5	0.6	0.2	1.6	0.8	0.9	0.6	0.3	0.0	0.0	0.6	3.9	0.1	0.0	5.7	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.9	0.0	0.0	0.1	0.0	0.2	0.4	3.1	0.7	1.0	1.1	0.1	8.1	1.3	28.4	0.0	0.0	0.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.5	3.5	13.7	3.1	4.0	4.9	3.0	3.6	3.7	5.4	4.7	5.1	30.3	16.0	9.2	1.6	0.0	7.4	51.4	0.3	1.2	0.4	45.0	31.5	0.6	0.0	5.6	1.8	0.0	0.2	0.1	1.0	0.0	0.1	3.4	2.2	8.8	3.3	1.2	0.0	3.1	1.8	0.2	9.4	0.0	6.4	0.0	0.3	1.1	0.1	0.8	13.5	14.9	5.2	6.1	0.3	1.5	2.5	0.3	0.7	19.6	5.6	0.1	0.0	0.0	13.6	4.6	0.1	4.3	0.7	0.0	39.8	0.6	0.0	1.5	0.3	0.0	5.2	1.5	0.6	0.7	0.1	1.8	0.4	0.3	6.6	9.6	15.6
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 28.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	490000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.7	2.4	0.7	0.9	1.1	0.1	0.4	2.0	1.0	0.5	2.9	4.2	0.1	0.6	0.9	0.7	0.8	0.5	3.4	0.5	0.6	2.9	0.1	0.7	0.1	0.8	1.0	0.5	0.1	0.1	1.7	0.7	0.3	2.2	0.9	1.4	0.2	4.5	0.3	0.8	0.7	0.9	0.1	0.2	1.4	1.1	0.7	0.1	28.9	0.0	0.2	5.1	0.9	0.8	0.0	0.1	26.0	0.2	76.7	102.2	0.3	6.7	3.3	0.1	0.1	0.5	0.1	0.0	0.9	15.5	0.0	0.0	5.3	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	48.1	0.0	30.1	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	1.2	0.0	0.4	0.1	0.0	0.0	0.1	2.9	0.5	0.0	0.1	0.7	1.9	10.2	0.7	0.1	1.5	29.1	1.3	0.0	0.2	0.1	0.0	0.0	4.6	0.0	25.2	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.7	1.1	2.0	1.0	0.5	0.6	0.8	1.0	0.3	0.1	0.7	0.8	0.2	0.0	0.6	0.7	0.5	0.0	0.2	0.4	0.0	2.6	0.3	0.0	3.5	0.0	2.0	1.8	2.1	1.2	0.5	0.0	0.0	0.0	2.1	1.2	0.4	0.6	10.8	0.0	2.2	0.0	2.1	1.3	0.0	0.4	1.3	0.5	0.0	0.1	0.3	10.1	3.2	0.1	0.0	0.6	0.4	3.3	0.9	0.2	1.8	0.0	0.1	3.0	0.0	4.0	3.5	0.1	0.0	3.8	0.4	0.1	0.0	0.1	0.9	7.1	0.0	0.6	3.2	0.5	2.1	0.0	0.0	0.7	0.2	0.1	0.0	0.2
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266453-144268481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.2;Horizontal cells: 16.8"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HaCaT: 5.3"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Low region specificity"	"Detected in some"			HPA043183	Uncertain					NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	1.4	3.4	3.0	0.9	2.3	0.6	1.4	7.8	7.0	7.8	2.9	8.3	0.9	2.9	0.5	3.4	3.8	0.1	11.0	2.7	2.9	8.4	2.1	3.5	0.4	6.2	1.9	2.5	3.8	0.8	19.6	0.2	5.4	4.5	0.2	0.1	2.7	0.1	13.8	3.2	5.0	0.2	0.9	4.6	5.9	5.2	2.3	0.7	38.1	1.2	0.1	2.6	3.2	1.8	2.0	0.4	0.1	0.5	0.0	0.0	4.8	0.1	0.0	0.1	0.0	0.1	1.4	1.3	1.4	0.2	0.2	5.3	0.0	0.0	0.0	0.9	0.8	0.3	1.9	0.2	0.2	0.1	2.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.2	0.6	0.1	3.0	0.5	1.1	1.1	0.4	2.3	1.6	0.2	0.8	0.1	2.0	0.2	0.9	0.5	1.8	2.2	0.1	2.3	0.9	0.3	0.4	3.5	1.6	0.3	1.8	0.6	0.3	0.8	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.3	7.8	7.0	2.7	2.9	6.2	1.9	5.4	0.9	2.3	1.8	3.4	0.0	2.7	8.5	2.5	0.0	1.2	0.0	0.6	14.2	6.7	8.3	6.2	1.5	1.3	3.7	0.0	1.5	7.5	2.2	1.9	0.6	0.2	5.7	1.4	1.2	2.4	0.0	5.9	1.4	0.6	1.2	8.2	7.1	0.0	3.2	0.4	0.4	0.4	16.8	8.5	2.3	0.0	0.6	0.0	0.9	0.3	0.9	0.0	1.0	0.0	8.2	1.0	2.5	0.3	1.5	2.1	0.7	0.7	2.7	1.5	0.2	0.0	1.5	0.0	4.2	6.4	2.5	9.0	0.6	0.0	1.1	3.1	0.3	1.8	1.0
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015015	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	43.4	69.3	36.6	26.4	37.4	32.8	41.1	33.1	53.9	46.8	37.1	46.7	28.0	49.4	32.5	40.0	44.0	26.3	59.7	39.2	34.1	45.7	83.2	42.4	30.7	36.0	35.2	52.4	61.6	35.5	44.7	34.6	35.5	47.3	17.2	12.4	48.5	33.7	104.5	44.5	39.6	27.5	30.9	46.4	50.0	50.6	37.7	23.4	48.8	51.6	21.8	47.8	39.5	39.0	55.0	45.9	36.6	50.9	65.4	56.6	50.0	66.6	89.4	77.7	60.4	66.9	32.2	39.2	65.7	86.9	66.2	49.1	38.7	50.1	27.0	46.6	49.7	46.4	50.8	78.3	92.8	30.8	64.0	79.1	48.6	66.9	49.4	54.2	51.6	39.7	49.2	53.8	49.0	118.9	41.4	70.4	35.3	36.9	63.4	41.4	28.5	72.5	48.1	48.4	33.7	35.7	41.2	89.6	74.5	22.4	88.8	38.4	51.4	61.3	41.0	100.7	40.1	73.8	55.8	41.4	71.0	25.3	43.7	2.9	21.1	28.4	20.7	20.0	16.6	14.0	19.6	20.9	23.5	14.3	15.2	15.0	41.9	18.2	13.6	17.0	14.4	19.8	36.6	37.4	33.1	53.9	39.2	34.1	36.0	35.2	35.5	30.9	37.7	39.0	22.7	19.2	16.7	11.4	25.7	21.9	29.8	30.9	25.0	25.4	29.9	20.1	5.8	21.5	26.0	20.2	12.5	64.6	18.5	47.4	37.2	37.5	25.7	17.3	22.7	23.7	30.5	22.3	14.6	43.4	70.0	34.1	38.2	25.4	25.4	34.0	22.1	35.0	38.1	16.8	12.8	39.9	28.5	19.2	24.3	25.2	45.7	24.5	30.2	11.2	34.3	26.6	21.6	6.6	10.5	36.4	31.4	45.5	53.4	44.8	50.8	37.2	15.3	22.0	13.1	24.4	33.8	39.5	21.8	27.5	23.2	138.6	23.2	44.3	36.2	38.5
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	"SCY1 like pseudokinase 2"	Q6P3W7	12	100267140-100341715	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021050	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA021050: AB_1846175"	"unprognostic (7.01e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.18e-1)"	13.4	13.4	6.2	16.4	7.3	21.5	16.8	9.9	8.2	14.0	7.6	22.9	20.2	14.5	20.9	22.1	10.9	16.2	14.9	7.6	8.6	21.2	28.7	17.2	15.0	5.6	5.4	8.8	17.9	20.9	12.9	21.0	6.3	17.0	26.9	16.7	15.7	15.9	15.6	13.7	17.0	17.4	6.3	14.7	16.4	14.6	7.5	19.0	15.6	19.1	19.8	21.5	11.5	7.2	37.7	29.0	45.8	37.7	28.8	31.1	43.2	38.0	42.8	34.8	29.6	28.1	19.4	23.4	17.7	46.9	23.7	32.1	36.4	27.8	40.6	36.5	24.2	76.0	18.5	20.3	25.7	36.2	72.8	23.1	42.5	39.5	44.9	41.3	44.4	26.0	40.8	19.7	37.4	29.2	29.2	31.7	28.6	21.7	32.6	23.4	33.6	22.7	31.6	61.1	28.3	25.3	43.0	44.2	36.2	48.2	64.9	27.8	41.7	29.7	17.2	27.8	24.8	22.6	32.1	28.3	14.6	24.6	34.4	12.3	5.2	10.0	4.0	6.5	5.1	3.3	4.2	3.8	6.6	2.3	4.5	4.9	6.7	8.6	5.7	2.0	6.2	4.0	6.2	7.3	9.9	8.2	7.6	8.6	5.6	5.4	6.3	6.3	7.5	7.2	24.4	16.0	35.2	37.9	20.4	35.9	21.3	17.4	33.0	16.8	29.6	17.1	30.1	7.2	26.8	20.2	27.1	31.3	22.7	44.1	5.9	16.8	8.5	24.4	19.1	24.8	21.7	28.6	50.3	21.7	22.2	20.2	37.8	31.2	27.9	15.1	16.4	37.1	25.1	15.2	54.1	30.6	12.2	34.6	47.4	4.7	13.4	29.2	16.0	44.0	27.5	10.9	17.5	64.3	47.2	24.0	32.1	15.4	22.2	36.8	16.2	26.3	18.3	16.2	0.0	13.1	20.9	24.9	12.0	36.8	34.7	59.4	22.6	19.2	33.6	52.8
SCYL3	"PACE-1, PACE1"	ENSG00000000457	"SCY1 like pseudokinase 3"	Q8IZE3	1	169849631-169894267	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005624	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nuclear bodies"	"HPA005624: AB_1854916"	"unprognostic (2.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.54e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (8.85e-4)"	5.6	5.8	2.7	7.4	3.0	4.0	10.9	4.0	3.5	6.7	5.0	7.8	7.7	7.0	8.3	7.3	6.3	7.6	5.2	3.0	3.0	7.5	11.3	6.2	10.5	2.9	2.8	7.6	6.1	12.0	4.1	8.1	3.1	7.6	9.6	11.4	8.2	6.7	7.9	7.7	6.8	6.2	2.9	7.5	7.7	6.6	3.0	9.7	7.6	9.1	9.8	7.3	6.5	3.9	4.1	5.2	7.9	5.5	9.9	7.2	9.1	6.3	8.1	7.2	6.7	4.8	7.7	8.4	4.5	6.5	4.0	9.4	4.7	5.5	6.4	15.5	4.4	5.8	6.1	3.1	7.0	8.5	7.3	7.0	5.4	5.0	6.8	6.7	6.9	9.2	9.4	10.8	6.9	3.2	6.9	6.5	6.4	27.5	2.5	6.3	4.3	10.1	7.6	7.3	5.9	8.6	5.0	16.3	10.1	11.2	9.1	7.8	5.2	5.1	3.4	6.2	5.1	14.4	13.7	9.9	3.9	6.3	5.7	13.5	3.2	8.6	6.3	3.4	8.5	6.7	8.3	7.0	5.1	6.2	7.0	5.8	6.7	10.7	3.8	11.5	8.1	4.8	2.7	3.0	4.0	3.5	3.0	3.0	2.9	2.8	3.1	2.9	3.0	3.9	5.9	6.4	14.4	11.8	9.6	2.4	2.5	3.6	6.2	10.2	9.6	8.3	4.2	22.8	7.8	1.8	10.4	17.6	19.0	14.0	9.8	7.4	5.1	11.1	8.2	6.6	9.1	4.2	15.8	9.1	5.1	5.1	7.1	5.8	5.7	7.2	11.0	13.2	6.5	10.1	12.5	10.4	8.2	11.4	3.5	2.6	4.4	5.3	1.8	9.4	8.4	10.0	16.5	17.6	14.1	6.2	10.2	5.7	10.5	4.7	13.3	6.4	9.0	19.9	6.6	5.5	5.4	10.9	6.8	8.3	1.8	11.6	11.0	6.3	10.3	3.3
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Human disease related genes, Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	14.6	13.5	10.5	14.8	10.8	7.2	17.9	8.4	12.3	13.6	8.5	14.3	11.9	17.6	19.0	15.3	12.7	8.7	14.3	10.9	11.0	15.0	15.8	12.6	21.2	9.6	8.9	13.7	17.7	17.7	8.9	12.9	9.3	14.2	15.1	6.8	15.0	16.2	22.9	14.8	11.1	17.1	8.5	15.5	14.0	21.3	11.1	16.4	21.2	16.4	20.2	18.8	11.7	10.2	29.8	11.8	28.5	38.9	33.1	29.8	30.6	41.3	35.9	34.0	29.1	36.6	42.0	46.7	30.2	38.1	32.4	29.7	44.5	40.5	42.3	41.2	23.0	39.9	24.4	30.6	32.7	68.5	43.9	26.4	45.0	36.3	40.4	21.1	30.0	31.2	72.7	37.8	36.4	33.1	69.6	25.1	47.4	48.3	18.1	41.8	53.5	39.3	32.7	32.6	43.3	35.6	28.1	57.0	48.9	31.1	26.4	39.6	29.1	36.6	36.7	44.4	34.8	33.9	37.6	62.0	40.7	31.1	46.0	10.4	14.5	4.1	19.1	19.1	23.8	17.8	23.0	21.1	15.3	20.1	23.0	19.5	2.3	23.4	27.5	13.0	21.5	15.9	10.5	10.8	8.4	12.3	10.9	11.0	9.6	8.9	9.3	8.5	11.1	10.2	36.2	19.2	34.7	15.0	45.7	27.5	26.8	45.1	35.3	21.1	21.3	29.1	12.3	14.3	46.0	22.0	6.2	30.6	35.7	14.5	35.2	37.7	109.0	12.1	29.9	25.2	22.8	35.3	34.0	24.9	32.2	27.4	20.9	18.7	49.4	26.3	18.9	22.1	37.9	13.5	31.8	22.6	36.7	24.3	16.3	106.7	25.4	30.0	24.9	30.9	40.3	23.7	42.2	23.6	29.9	33.4	18.3	33.1	49.0	37.1	17.1	46.6	26.1	20.0	19.7	33.2	38.7	75.6	100.7	47.5	33.1	25.0	38.1	33.2	27.9	22.4
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 491.6;liver: 484.7;skin 1: 447.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"midbrain: 17.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	3100000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 22: Epithelial cell types - Mixed function"	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	2.4	17.4	0.7	17.2	0.2	1.2	23.8	2.3	0.8	127.2	0.7	61.8	75.8	2.2	19.9	491.6	10.5	77.1	0.6	0.3	2.0	99.5	484.7	59.6	7.3	0.6	17.3	1.6	16.6	5.4	2.0	32.6	0.8	56.3	33.3	0.7	85.8	25.9	1.6	447.4	53.6	2.2	0.2	20.1	87.3	3.3	2.5	5.1	18.3	0.0	43.2	104.8	242.1	0.1	252.6	137.6	42.7	108.1	11.6	1.6	134.9	68.7	65.4	62.7	52.8	29.5	148.9	0.3	24.8	48.8	34.8	241.4	19.0	482.2	41.8	1.3	12.5	0.0	12.2	150.2	10.3	11.0	1.0	6.4	436.6	56.5	132.9	87.2	6.9	0.0	6.4	94.7	34.0	149.6	0.6	2.6	38.7	189.6	263.1	5.3	15.7	189.9	80.5	370.0	12.4	99.7	51.9	342.4	15.2	17.1	34.5	2.8	10.7	246.9	78.6	9.2	470.0	467.4	1069.8	1.0	74.5	0.6	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	2.3	0.8	0.3	2.0	0.6	17.3	0.8	0.2	2.5	0.1	0.4	93.0	99.0	0.0	33.0	113.9	189.1	162.8	81.4	0.6	29.9	26.7	0.9	267.4	161.8	42.3	0.0	3.8	0.7	147.2	31.3	61.3	0.1	16.6	5.0	3.5	10.8	13.5	0.3	21.8	46.3	5.0	55.0	22.9	6.3	7.5	7.5	603.1	2.3	21.9	0.2	73.1	50.8	10.6	11.9	0.3	0.6	2.5	21.4	0.0	0.6	0.3	0.0	1.0	0.0	111.4	78.0	1.2	165.1	78.0	106.5	88.5	43.4	0.4	0.0	0.1	15.0	1.0	14.0	246.6	229.0	250.8	4.0	0.1	85.1	492.8
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493813-96611790	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 460.8;thyroid gland: 424.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 229.7;Hepatocytes: 235.5;Smooth muscle cells: 183.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"AF22: 643.1;EFO-21: 297.8;fHDF/TERT166: 288.4;RPTEC TERT1: 341.3;U-138 MG: 305.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	109.5	36.3	35.2	35.9	41.0	10.2	66.6	37.6	49.9	157.0	26.4	77.9	21.8	76.0	15.2	50.1	84.6	44.5	68.9	32.1	51.8	88.9	460.8	56.8	18.9	41.1	46.6	170.5	61.2	30.2	61.5	124.4	37.5	63.4	40.1	29.7	25.0	104.4	19.9	25.3	39.8	90.9	38.5	25.8	41.9	25.5	49.6	5.3	424.5	58.5	8.0	84.0	58.1	33.7	0.5	0.3	643.1	0.3	230.2	214.1	0.6	94.8	113.4	54.3	60.5	19.8	0.2	0.2	297.8	288.4	8.0	0.5	114.3	1.8	47.1	0.3	44.4	0.6	56.7	250.2	7.4	1.9	2.9	83.1	2.8	123.5	3.1	210.2	1.9	0.1	64.3	0.3	23.1	6.0	0.3	16.9	68.1	0.0	0.7	0.7	101.5	2.4	341.3	57.2	19.1	49.5	0.2	0.3	4.9	217.8	27.6	73.0	51.3	305.1	91.5	1.5	53.2	6.0	0.3	1.1	96.9	0.4	97.5	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.6	0.0	0.1	0.0	0.0	0.6	35.2	41.0	37.6	49.9	32.1	51.8	41.1	46.6	37.5	38.5	49.6	33.7	11.9	57.7	38.1	93.7	1.7	53.8	78.9	29.6	15.9	36.6	41.4	30.2	32.7	37.1	5.1	57.0	12.5	1.9	0.5	0.1	29.4	14.4	31.6	29.3	65.1	10.7	3.5	10.7	4.6	15.3	2.5	229.7	9.7	76.4	1.3	44.3	17.5	235.5	109.8	5.0	22.0	1.5	138.4	20.5	154.7	18.6	52.5	62.9	62.2	21.5	68.2	17.4	0.0	7.1	1.7	8.9	1.2	104.9	2.5	41.7	0.8	56.4	4.0	12.5	32.9	100.0	183.1	5.5	57.6	1.3	39.2	3.8	4.2	33.3	5.7	17.6
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869466-30908758	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6"	"Group enriched"	"Detected in all"	5	"glioma: 115.2;melanoma: 102.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 249.5;WM-115: 342.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	33.9	99.1	103.9	22.9	123.9	3.0	17.9	97.0	105.4	36.5	38.1	57.3	12.3	62.3	12.3	17.6	29.8	30.0	22.7	91.6	111.1	10.4	22.3	22.5	36.4	140.3	121.2	9.3	7.5	13.2	11.8	18.1	107.9	26.9	14.6	27.2	15.9	52.7	27.1	10.1	16.5	66.2	112.4	91.0	19.7	3.3	124.4	6.4	9.8	9.1	7.6	32.7	13.4	91.9	12.9	10.4	80.4	36.5	60.6	14.8	13.8	31.4	48.0	15.0	9.5	2.0	12.3	0.9	68.6	95.3	21.8	16.3	8.7	7.6	10.0	5.7	6.3	0.0	4.1	1.8	56.9	0.3	8.2	35.4	35.9	1.0	15.4	86.6	20.1	3.6	6.2	0.5	30.6	15.0	0.3	0.2	36.4	10.2	9.4	0.8	75.2	2.8	19.7	14.9	28.9	17.5	40.3	5.7	249.5	50.8	5.7	6.1	19.3	18.6	28.2	2.0	7.5	0.1	0.5	0.9	1.9	0.2	342.9	1.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.2	0.2	0.2	103.9	123.9	97.0	105.4	91.6	111.1	140.3	121.2	107.9	112.4	124.4	91.9	37.3	0.0	2.2	64.6	0.5	2.5	3.4	4.7	4.0	9.6	14.9	25.5	4.9	14.3	2.6	47.8	0.0	2.1	0.2	0.8	0.0	10.7	17.7	14.1	59.8	17.9	3.0	0.0	14.7	3.1	3.4	16.6	3.1	28.6	0.0	17.5	20.3	1.0	14.3	0.0	13.9	1.1	6.1	174.8	3.1	82.4	2.1	24.4	19.6	18.7	4.0	2.5	1.0	108.6	6.8	6.0	1.3	7.9	1.5	8.5	0.0	0.6	0.4	27.8	0.0	1.1	9.1	0.7	0.4	1.3	2.3	3.6	2.3	15.4	1.6	5.7
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 410.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 512.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		320000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	68.0	73.1	90.3	26.3	116.8	10.1	113.1	90.2	120.7	53.0	68.5	102.6	37.8	53.0	11.8	124.3	76.6	72.2	65.9	66.4	90.2	166.9	410.9	168.3	9.8	120.5	127.8	26.3	90.3	34.7	43.2	27.3	95.4	53.0	62.6	35.1	103.7	45.9	101.5	190.4	42.4	53.8	89.9	32.3	140.1	47.1	151.9	8.2	51.1	35.4	35.2	124.7	68.7	71.4	162.1	20.7	11.1	0.8	269.2	164.3	474.4	201.5	273.0	222.9	158.6	242.7	400.0	0.2	88.1	255.4	224.5	203.1	8.2	512.2	269.0	46.7	7.4	4.9	15.8	95.8	292.4	1.0	8.2	223.1	336.5	92.4	223.2	123.3	29.9	3.7	8.2	0.5	130.5	159.9	0.2	14.2	20.4	139.9	63.1	0.3	99.7	0.6	367.7	211.7	4.3	15.6	277.2	169.4	51.4	125.2	123.1	9.7	56.4	169.4	141.4	17.3	131.8	8.5	6.7	0.7	266.2	16.4	103.2	1.5	1.6	0.4	0.7	0.6	2.1	0.3	2.0	0.8	1.5	0.3	0.4	0.5	0.8	0.7	0.6	1.4	4.4	0.7	90.3	116.8	90.2	120.7	66.4	90.2	120.5	127.8	95.4	89.9	151.9	71.4	21.9	291.7	391.2	106.7	3.8	373.7	322.2	352.8	75.1	14.5	208.8	90.6	59.3	245.9	218.4	189.4	12.5	38.9	7.8	174.3	64.6	296.0	1.2	116.6	20.8	16.0	55.1	7.4	0.2	515.9	230.0	43.0	170.7	179.0	13.9	10.8	11.4	260.6	18.8	0.0	0.3	131.9	160.7	19.3	106.0	3.8	4.1	39.5	76.5	5.6	33.0	10.0	0.0	3.5	1.8	476.4	121.7	5.3	2.1	284.2	59.0	153.8	178.6	23.6	0.0	34.9	33.5	1.8	2.5	170.9	472.8	67.5	16.8	3.2	90.7	423.9
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"SHH signaling and ciliogenesis regulator SDCCAG8"	Q86SQ7	1	243256034-243500091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 284.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Centrosome		"HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527"	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	11.6	9.8	7.1	3.8	7.6	3.5	11.3	7.1	7.4	9.6	6.8	8.4	2.9	7.9	7.3	8.0	9.4	7.5	8.8	7.6	7.1	9.3	7.4	11.8	5.2	8.6	7.9	11.0	14.3	7.0	11.6	4.5	7.7	8.9	3.1	3.7	8.4	3.8	12.1	8.1	7.6	3.0	8.3	8.3	8.4	5.3	7.7	3.3	17.1	2.3	2.7	8.9	8.9	8.9	6.2	5.4	2.0	3.8	7.3	3.4	6.3	4.4	3.4	2.1	1.7	4.9	10.9	2.4	6.5	3.7	0.7	2.2	0.6	4.9	2.0	3.7	6.9	2.3	3.7	2.0	3.7	2.2	5.1	7.0	6.2	4.8	7.7	7.9	5.5	5.2	3.2	3.3	3.9	1.9	0.9	4.9	1.2	9.4	9.5	3.1	1.1	2.1	7.5	4.1	5.6	5.7	4.3	2.6	10.6	0.9	4.3	2.8	5.2	6.8	1.5	2.4	2.5	5.1	2.7	1.2	3.0	4.1	29.9	7.6	7.8	6.6	3.8	8.0	2.8	5.2	4.3	5.3	7.1	6.9	6.1	4.2	4.7	9.0	4.5	5.6	3.8	3.8	7.1	7.6	7.1	7.4	7.6	7.1	8.6	7.9	7.7	8.3	7.7	8.9	30.6	41.7	103.6	139.7	39.0	37.2	39.6	59.1	56.9	69.8	34.9	37.1	28.5	50.1	52.0	40.5	87.6	48.1	16.1	16.5	76.3	63.1	17.8	60.9	31.6	36.2	31.9	23.3	170.5	30.0	86.3	38.5	24.5	31.4	49.9	29.8	45.7	27.8	130.1	65.6	153.2	18.1	63.1	51.0	32.5	33.8	52.8	51.7	35.6	188.3	45.9	67.1	22.6	165.4	284.0	50.1	26.4	44.4	30.8	33.6	31.5	39.0	73.5	80.3	39.5	34.8	32.0	51.4	20.7	38.8	49.2	26.3	23.1	50.0	25.2	29.9
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999343	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	17.4	8.5	5.5	11.3	7.0	32.9	11.8	6.4	6.6	9.0	4.8	8.3	9.0	11.8	7.8	9.6	7.4	10.5	7.7	4.9	6.0	9.2	14.6	9.2	12.4	6.9	6.6	10.2	9.6	11.1	4.4	11.8	6.6	9.8	9.1	5.1	6.7	7.3	12.7	10.8	9.0	9.8	6.6	10.4	7.7	8.3	6.1	22.8	12.5	9.6	10.6	11.6	7.8	8.4	13.1	9.3	14.9	15.9	10.2	11.3	18.5	13.7	12.9	18.4	14.0	13.7	14.7	19.2	20.9	11.6	7.2	16.5	18.9	11.9	22.2	14.7	15.3	21.1	7.9	12.7	18.6	21.0	24.6	12.5	16.9	19.6	24.6	10.3	12.8	22.6	39.3	22.6	13.7	3.8	29.5	16.6	20.8	20.2	9.8	24.4	19.1	24.9	11.1	9.2	13.3	22.0	15.6	16.9	26.3	11.9	16.6	25.4	12.7	15.6	11.0	20.3	30.4	13.4	10.3	23.4	16.1	12.9	31.5	21.8	6.3	5.9	8.0	6.4	10.8	8.0	8.1	7.8	7.1	7.0	8.1	7.7	18.5	13.5	7.9	8.1	6.7	6.9	5.5	7.0	6.4	6.6	4.9	6.0	6.9	6.6	6.6	6.6	6.1	8.4	36.0	28.9	22.6	4.2	39.9	43.6	17.2	11.2	29.0	6.2	19.8	13.6	9.4	2.8	20.1	9.2	0.0	9.6	29.3	14.3	15.6	6.5	72.8	24.8	15.1	24.8	17.4	56.2	4.7	7.1	10.2	17.8	13.3	35.9	35.5	9.7	12.8	20.6	11.1	15.2	5.0	10.8	16.2	16.4	28.8	20.4	9.9	27.0	19.6	1.9	7.4	12.6	10.3	4.5	8.6	9.7	9.4	6.4	26.6	14.2	9.5	12.7	12.7	8.9	6.6	28.8	23.9	23.9	14.4	26.5	59.1	14.2	23.2	21.0	9.9	18.2
SDF2L1	"AP000553.C22.4, OTTHUMT00000075032"	ENSG00000128228	"Stromal cell derived factor 2 like 1"	Q9HCN8	22	21642302-21644299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 170.0"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 646.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 330.5"	"Low region specificity"	"Detected in all"							HPA005638	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA005638: AB_1079888"	"unprognostic (1.09e-1)"	"unprognostic (2.76e-2)"	"unprognostic (6.17e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (8.81e-3)"	"unprognostic (2.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.79e-2)"	28.5	40.4	14.0	31.1	15.1	25.8	23.6	15.9	18.8	25.0	22.2	36.3	24.9	33.0	21.7	30.9	29.8	5.7	41.0	14.3	20.7	43.8	170.0	35.9	16.9	19.0	16.2	16.0	94.6	10.0	77.3	11.7	16.0	32.7	9.8	1.4	48.0	11.5	17.3	19.5	35.7	7.1	16.2	68.2	40.9	35.0	17.0	9.6	89.9	1.7	11.9	33.2	21.5	17.2	77.3	64.6	15.9	53.4	9.2	11.9	99.6	66.5	16.6	31.4	34.5	66.8	44.9	70.1	59.4	16.0	50.7	62.2	29.8	45.9	8.5	51.4	179.7	53.3	70.1	147.5	52.8	53.7	89.6	8.9	19.6	29.4	30.6	10.9	31.1	37.1	330.5	175.8	13.4	146.4	52.8	76.4	17.6	82.8	110.3	48.6	36.4	58.9	22.2	57.0	33.8	52.2	33.6	56.8	36.5	12.5	54.5	62.9	35.9	16.6	92.1	55.7	41.4	160.6	70.7	52.0	32.7	62.1	49.8	114.0	98.9	44.6	173.3	106.8	130.2	131.8	109.2	156.8	72.6	124.9	86.5	102.7	29.8	101.0	102.2	218.5	126.9	106.3	14.0	15.1	15.9	18.8	14.3	20.7	19.0	16.2	16.0	16.2	17.0	17.2	52.3	25.6	28.5	2.6	164.7	114.2	125.1	89.0	16.5	5.6	80.2	57.8	35.8	62.9	50.3	49.7	35.5	94.7	98.0	194.2	25.4	121.2	52.3	59.3	47.7	58.0	186.1	51.1	1.5	177.5	342.9	64.6	53.0	65.0	111.3	19.0	61.4	286.2	224.1	5.0	2.2	344.8	48.8	68.7	205.4	31.4	32.3	85.9	211.7	6.5	69.4	62.0	145.2	4.0	4.6	175.5	169.6	16.6	646.4	203.8	129.8	96.5	40.9	13.0	39.5	26.2	53.0	276.5	218.9	23.9	112.5	168.1	85.1	37.5	188.1	129.4
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216909-1232067	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 406.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	86.5	91.8	44.2	78.8	47.8	56.2	80.2	47.2	65.3	84.4	72.5	95.9	117.1	91.8	43.9	66.3	74.6	66.2	134.6	45.5	44.8	89.6	160.7	82.0	53.4	53.2	46.1	85.4	104.6	61.5	78.5	73.3	47.0	76.9	60.4	25.7	83.5	52.2	78.9	72.9	116.8	58.2	43.5	78.0	93.6	71.7	50.5	34.6	81.8	47.7	39.6	82.2	71.6	45.9	139.7	123.7	67.1	214.0	320.0	160.4	80.5	266.1	241.4	191.2	159.4	147.0	236.2	87.8	201.8	258.0	137.4	140.4	77.5	117.1	58.2	147.9	133.0	153.6	185.7	207.8	147.4	156.7	199.2	199.0	59.5	144.6	81.2	186.5	155.9	57.3	129.2	225.0	95.7	101.1	77.8	158.9	61.7	158.0	167.1	85.8	86.5	234.4	127.2	66.4	243.3	86.7	177.2	208.2	182.8	59.0	108.0	176.7	198.8	196.2	107.0	149.5	154.2	138.9	141.2	144.6	222.9	289.7	87.1	14.4	21.5	30.8	19.3	14.6	14.6	13.5	27.6	28.4	21.9	16.8	16.0	14.1	16.9	26.8	23.2	14.0	25.1	11.8	44.2	47.8	47.2	65.3	45.5	44.8	53.2	46.1	47.0	43.5	50.5	45.9	92.9	22.4	19.2	18.6	62.5	119.8	74.0	24.6	46.7	34.5	51.2	47.6	35.7	68.6	28.9	49.7	18.8	124.1	68.4	240.0	11.7	79.0	39.1	49.0	76.2	77.8	65.5	32.8	21.1	71.4	284.4	117.1	81.1	60.8	36.2	61.4	76.4	117.1	122.4	38.7	23.5	174.9	30.5	73.7	154.8	36.8	95.4	62.8	167.2	13.1	50.8	64.9	111.2	13.6	17.5	73.0	213.5	76.0	202.5	101.5	406.2	57.7	18.4	40.0	59.2	69.8	75.1	101.7	63.5	53.2	114.2	168.0	73.4	88.7	181.0	71.1
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61446733	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	27.5	37.1	36.2	26.4	37.4	45.6	28.9	37.9	38.2	23.8	37.4	27.2	24.7	23.8	34.8	28.8	28.7	25.5	40.4	35.9	40.2	36.5	46.4	23.8	39.9	37.9	37.6	26.9	24.0	32.9	41.0	24.9	37.9	29.0	29.1	23.4	26.3	20.9	38.9	26.3	27.0	26.9	37.7	34.7	27.6	22.1	38.0	38.0	28.6	44.7	41.6	32.8	21.7	39.2	45.0	58.4	36.5	25.1	57.2	52.2	27.0	33.3	58.0	48.9	41.8	52.8	46.8	42.3	58.4	55.6	62.8	45.4	45.4	51.4	56.6	60.4	39.7	33.2	35.5	71.9	52.8	41.4	48.1	55.6	58.7	50.2	45.8	35.3	80.8	43.5	42.2	50.9	63.5	86.0	49.2	89.3	56.1	47.0	78.6	45.9	45.9	76.6	63.7	57.9	36.9	40.6	46.9	53.5	99.0	38.5	83.0	40.2	53.3	45.0	32.7	54.3	37.5	31.2	51.2	54.7	43.4	37.3	46.0	125.3	68.8	126.6	82.5	64.5	103.1	89.7	93.0	91.7	55.9	84.8	101.5	97.5	97.9	97.9	53.3	63.3	126.7	78.6	36.2	37.4	37.9	38.2	35.9	40.2	37.9	37.6	37.9	37.7	38.0	39.2	32.8	35.3	33.2	11.1	28.9	20.6	34.6	53.7	10.2	14.0	27.9	35.1	22.3	14.3	33.5	29.5	6.2	77.0	41.9	29.5	54.8	55.3	15.8	19.3	21.7	36.5	34.2	30.3	13.2	60.3	51.4	28.4	16.8	19.0	32.3	22.2	42.5	42.3	52.7	15.2	13.3	31.4	59.0	36.5	22.8	17.8	31.4	29.7	44.4	8.4	66.4	49.4	69.0	16.6	18.1	62.9	34.9	30.9	16.3	30.8	34.0	51.9	31.5	19.7	32.9	17.3	27.2	23.1	25.8	10.9	22.4	99.6	41.5	45.1	27.6	38.8
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97117698-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 148.7;Early spermatids: 136.0;Proximal tubular cells: 150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	12.4	17.5	9.3	12.4	9.8	16.7	18.7	10.5	13.3	15.0	13.5	20.7	19.9	12.4	22.2	15.0	14.6	13.0	27.0	9.4	11.2	33.5	32.1	8.4	18.5	10.6	10.4	10.7	18.4	12.2	3.6	9.6	11.0	14.8	20.3	16.4	22.0	12.0	29.0	14.1	17.4	12.2	11.6	11.2	18.3	14.5	10.2	24.5	19.0	25.6	14.5	12.8	3.7	12.1	36.6	27.6	24.5	82.3	15.8	12.8	14.8	15.8	7.6	15.6	22.8	5.0	30.7	57.4	40.1	14.1	20.7	13.4	49.6	38.8	33.7	44.2	59.6	34.6	24.8	54.8	23.8	89.4	16.0	24.3	30.3	25.7	32.0	11.6	14.5	57.2	99.5	1.6	34.8	0.0	94.5	126.7	37.3	74.1	34.6	21.0	14.0	83.7	26.0	24.9	63.8	40.7	38.5	47.9	55.5	33.9	0.4	31.6	16.0	4.2	53.2	88.6	10.7	41.4	87.0	139.5	14.6	144.7	51.9	30.0	21.4	8.0	26.5	26.3	36.3	36.3	33.3	39.1	27.9	32.1	45.9	44.4	20.2	23.9	26.7	82.6	33.2	37.9	9.3	9.8	10.5	13.3	9.4	11.2	10.6	10.4	11.0	11.6	10.2	12.1	24.4	19.2	12.5	8.5	34.4	0.0	23.1	0.0	29.0	13.8	38.6	44.4	37.9	18.6	6.8	25.8	4.2	35.2	31.3	7.2	148.7	30.6	136.0	31.3	20.6	17.3	13.3	32.6	16.6	39.1	30.0	20.1	29.0	21.4	5.1	22.2	16.4	55.9	31.1	10.1	14.3	24.2	0.0	20.1	0.0	20.7	22.7	20.2	0.0	9.4	13.9	44.8	36.0	14.6	18.5	24.0	29.1	24.8	30.9	17.0	35.1	150.9	16.0	19.5	32.9	19.5	20.4	32.7	49.3	53.5	0.0	9.6	26.3	45.6	39.8	25.0
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	11.2	12.3	7.1	4.2	7.5	4.3	10.5	6.8	10.5	6.6	7.3	6.8	5.0	5.8	9.3	7.5	10.3	4.2	14.5	7.6	9.4	12.5	8.5	5.4	6.0	6.9	6.3	6.4	6.6	14.4	12.7	6.8	7.3	7.6	6.7	10.0	8.7	5.4	23.6	8.6	5.4	4.2	5.8	5.6	7.0	5.3	7.8	6.4	7.3	10.6	5.2	6.8	6.7	7.6	13.3	4.2	18.8	11.6	9.0	13.6	3.5	7.1	5.1	3.4	5.0	3.8	11.3	9.1	12.7	3.8	8.0	2.3	6.2	5.9	5.2	18.3	4.3	6.6	1.8	3.9	15.3	6.3	5.1	9.6	19.3	2.6	14.8	11.6	8.0	14.8	4.2	13.9	11.0	9.0	5.9	15.7	8.8	6.5	4.5	6.4	12.6	10.8	14.9	4.4	16.8	12.1	4.3	2.1	9.6	8.0	9.6	16.5	6.3	3.5	2.7	2.8	7.7	6.2	4.5	3.1	3.9	15.1	8.5	4.0	4.6	4.4	3.4	4.3	3.3	3.7	3.7	4.1	5.1	4.7	3.9	3.8	3.3	4.7	4.6	6.2	4.2	3.0	7.1	7.5	6.8	10.5	7.6	9.4	6.9	6.3	7.3	5.8	7.8	7.6	5.4	12.8	13.9	4.9	3.3	0.0	7.9	0.0	3.4	7.4	6.5	7.5	21.3	10.0	5.6	7.3	8.4	10.5	5.0	2.9	23.5	9.1	5.5	20.2	8.2	5.0	3.6	2.5	7.7	11.6	8.5	6.6	2.6	6.0	5.1	6.1	4.2	11.8	10.0	18.5	7.5	5.8	0.0	5.3	0.0	2.5	12.5	6.2	0.0	2.8	10.1	10.1	3.1	12.1	7.7	13.2	5.3	6.8	2.2	9.5	6.2	16.8	13.8	6.4	13.1	5.1	4.9	10.0	6.1	5.7	0.0	5.1	3.9	6.1	5.3	8.0
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDHD	"cybS, PGL, PGL1"	ENSG00000204370	"Succinate dehydrogenase complex subunit D"	O14521	11	112086824-112120016	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 530.2;Proximal tubular cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA045727	Approved				"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045727: AB_10963114"	"unprognostic (9.13e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.99e-10)"	"unprognostic (5.14e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.51e-2)"	117.5	95.7	60.0	84.5	63.1	72.9	102.6	68.6	76.3	92.5	65.1	185.2	208.1	88.2	96.7	126.7	92.6	85.6	254.7	60.1	65.4	319.9	391.8	79.3	131.7	63.4	62.5	91.6	77.8	152.4	37.0	95.0	63.2	87.9	190.8	37.4	112.6	100.9	354.7	64.3	175.6	98.1	64.7	85.1	101.1	34.1	63.7	102.5	136.8	449.6	124.8	117.9	76.4	68.2	84.0	67.3	58.1	89.4	212.0	170.7	97.3	97.5	147.6	106.8	132.2	244.8	222.1	155.5	288.4	131.0	156.1	203.5	175.4	139.8	129.8	129.9	92.4	142.8	51.9	140.1	165.6	222.4	107.5	189.6	160.2	110.5	189.1	124.6	153.0	109.6	156.0	208.7	135.0	95.2	143.9	215.0	77.4	333.8	211.6	126.2	145.8	294.4	221.6	175.2	83.5	55.8	135.3	194.8	107.0	81.8	198.9	164.2	108.0	103.8	132.3	114.7	95.0	59.1	73.2	270.7	58.8	297.0	100.5	233.7	293.3	208.8	158.4	390.1	173.1	235.2	170.8	168.8	308.7	198.1	204.3	191.8	257.5	207.9	322.9	151.7	189.9	348.9	60.0	63.1	68.6	76.3	60.1	65.4	63.4	62.5	63.2	64.7	63.7	68.2	104.3	80.1	51.1	12.4	78.0	81.6	102.2	262.2	83.6	12.2	61.0	78.4	216.5	120.1	108.1	90.1	8.4	154.3	55.2	203.8	530.2	82.9	9.9	41.6	67.6	76.4	50.4	70.2	9.6	58.9	124.1	104.6	75.4	41.2	65.9	32.3	76.8	169.7	162.9	11.8	11.2	129.1	154.6	97.1	74.4	37.0	104.1	94.2	76.5	9.4	118.6	52.9	75.2	8.0	9.7	54.1	134.2	99.6	80.9	61.6	253.1	449.9	60.5	18.9	92.1	78.3	110.7	70.4	55.8	127.1	74.4	179.0	71.4	86.2	176.0	98.6
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301252-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.1;Excitatory neurons: 222.4;Inhibitory neurons: 551.0;Late spermatids: 190.0;Microglial cells: 201.4;Oligodendrocyte precursor cells: 112.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.5;BEWO: 10.5;RPTEC TERT1: 8.7;RT4: 11.2;SuSa: 10.3;U-2 OS: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol		NA	NA		9500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 25: Pancreas - Digestion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	3.6	0.4	0.4	4.0	1.0	0.8	2.1	0.0	1.6	9.4	4.8	4.0	1.0	3.2	2.6	1.6	2.6	1.4	1.1	3.4	1.0	1.7	0.1	4.0	1.5	1.6	2.1	2.2	12.6	0.8	2.2	1.7	2.5	1.6	1.3	1.5	0.8	4.1	0.9	1.4	2.4	2.7	0.8	5.3	2.0	3.5	1.6	2.5	0.5	1.6	1.9	5.2	2.2	0.5	2.2	1.8	8.5	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.4	0.0	3.4	0.2	0.9	0.0	0.2	0.0	5.0	0.0	0.4	0.3	4.1	0.0	0.0	1.7	0.0	0.4	0.5	0.0	0.7	0.1	0.0	0.0	4.2	2.2	0.0	0.0	2.9	0.1	0.0	6.3	5.9	0.0	8.7	11.2	5.3	7.7	0.0	0.0	0.0	10.3	0.0	2.8	0.2	0.0	13.2	0.0	3.8	0.0	0.0	0.0	0.0	1.8	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	1.6	3.4	1.0	1.6	2.1	2.5	0.8	1.6	0.5	1.2	0.0	3.0	31.3	0.1	1.3	0.5	2.3	0.6	22.3	0.6	1.8	20.2	1.5	5.5	5.5	0.0	3.6	1.3	0.0	0.0	1.5	96.1	16.9	57.1	1.9	4.9	0.0	222.4	5.4	0.7	11.6	0.5	9.9	0.0	23.4	1.1	0.0	0.5	1.7	551.0	0.5	0.0	0.3	2.1	190.0	1.8	0.7	5.4	201.4	0.0	0.2	0.0	112.1	14.3	2.2	0.0	5.7	0.0	0.7	0.0	1.5	6.7	1.2	6.6	1.7	7.8	9.8	5.5	0.3	0.4	1.9	0.7	1.4	0.1	0.4
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300005-56320776	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.9;lung: 34.4;skin 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 155.9;Basal respiratory cells: 325.1;Club cells: 141.9;Ionocytes: 120.1;Pancreatic endocrine cells: 99.5;Respiratory ciliated cells: 82.5;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	35	"memory B-cell: 4.7;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	47	"B-cells: 4.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.8;HaCaT: 10.3;hTCEpi: 16.7;OE19: 24.8;T-47d: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025224	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	1.7	3.0	1.8	0.0	9.1	1.6	4.4	15.6	0.5	2.2	2.3	0.0	0.0	51.9	0.2	0.4	0.2	2.2	1.5	0.1	0.0	34.4	0.4	4.8	2.0	0.2	0.4	0.0	0.5	0.0	4.9	0.3	3.9	1.1	16.8	0.0	0.3	62.6	15.7	0.2	0.9	0.0	18.1	0.8	2.8	0.3	0.0	0.2	21.9	6.3	24.9	1.8	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	10.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	24.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	4.4	2.2	1.5	4.8	2.0	4.9	0.9	2.8	1.8	1.7	48.1	155.9	0.0	1.7	51.1	6.2	325.1	4.6	0.3	5.5	2.4	0.2	5.7	141.9	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.4	0.0	0.1	2.3	0.0	0.0	4.3	1.4	0.0	0.9	10.2	0.1	3.8	0.0	0.0	0.0	0.0	0.0	1.1	19.7	120.1	0.0	3.6	0.4	0.6	0.4	3.6	0.0	0.6	12.3	0.0	0.0	0.3	99.5	3.4	0.0	0.0	9.5	0.3	0.0	82.5	1.6	0.0	0.1	4.9	0.3	5.5	36.6	72.2	0.0	0.6	0.0	5.3	26.0
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	41.5	73.9	55.4	14.8	56.9	28.9	44.6	59.7	65.1	40.4	53.4	43.3	16.9	33.5	17.7	35.1	35.8	11.6	83.7	54.0	55.7	60.2	57.9	35.1	22.6	56.7	57.9	47.2	50.1	22.7	58.1	14.4	56.6	47.2	9.3	37.9	38.0	23.1	96.7	40.1	42.1	11.6	57.4	57.7	47.5	34.7	58.5	27.8	38.7	72.5	14.1	41.1	33.4	57.3	20.1	35.4	25.5	30.0	34.8	26.5	24.4	11.5	16.3	26.4	30.2	27.4	26.0	28.4	30.0	13.4	19.6	37.1	22.8	29.2	11.5	38.2	39.5	25.3	26.1	74.1	16.9	23.7	23.4	29.7	34.6	19.0	27.2	26.9	28.5	65.5	23.1	24.5	26.3	36.2	40.2	39.2	24.1	31.3	32.6	50.9	13.2	20.9	47.5	27.1	43.8	36.8	30.3	55.4	28.3	15.1	38.1	34.9	14.2	8.0	25.5	23.7	15.3	38.3	26.9	35.7	21.1	30.6	21.2	39.1	38.3	23.8	40.3	23.7	39.2	49.7	30.7	32.3	43.7	49.7	43.2	45.2	11.4	58.4	20.3	60.7	40.2	33.0	55.4	56.9	59.7	65.1	54.0	55.7	56.7	57.9	56.6	57.4	58.5	57.3	34.9	28.9	21.7	10.1	35.0	26.5	40.8	40.1	21.6	37.2	44.2	47.2	0.2	45.8	36.5	40.5	12.5	48.4	41.6	19.7	121.3	29.1	16.9	16.9	15.9	27.3	27.6	35.3	12.2	19.9	24.3	24.8	13.3	17.8	36.1	28.4	21.0	38.6	30.2	28.6	12.6	25.8	38.7	19.3	19.6	26.3	32.9	21.6	42.7	12.2	22.9	63.4	37.0	11.1	17.0	15.7	17.7	31.6	34.4	24.9	21.3	71.7	26.8	47.4	0.0	25.5	24.0	67.1	22.6	21.0	27.3	56.1	28.6	27.0	22.5	29.8
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011481	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"skin 1: 9.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 10.0;Ionocytes: 10.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.3;NK-cells: 2.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 9.5;hTCEpi: 12.1;MCF7: 8.3;RT4: 20.6;SCLC-21H: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	0.5	0.1	0.0	0.9	0.1	0.4	4.4	0.0	0.1	1.2	0.1	2.4	5.6	1.3	1.9	3.6	1.7	1.1	0.6	0.0	0.2	1.9	1.8	1.6	1.3	0.1	0.1	0.3	3.2	2.1	1.3	0.3	0.1	1.7	1.7	0.0	3.1	0.9	0.0	9.2	4.7	1.1	0.0	0.8	2.6	1.1	0.2	1.6	1.9	0.0	2.4	2.3	2.4	0.0	3.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.9	0.0	1.8	0.0	0.4	9.5	0.0	6.5	0.0	0.0	0.6	0.0	1.7	0.0	0.3	0.0	0.0	0.3	12.1	1.5	5.9	0.0	0.0	0.0	1.6	0.0	0.8	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	2.5	20.6	8.2	0.0	0.2	4.3	0.0	0.2	0.1	0.0	0.2	0.0	4.3	0.0	0.0	4.0	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	1.1	2.3	0.7	1.2	0.1	1.0	2.2	1.6	0.0	2.0	0.0	0.1	1.5	0.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.0	1.1	0.0	2.7	5.9	3.5	6.1	6.2	0.0	5.8	3.9	2.6	7.2	3.3	1.8	0.0	0.6	1.1	2.7	3.9	10.0	1.3	2.8	0.7	0.5	2.4	0.4	0.0	7.5	0.2	0.4	1.1	3.2	0.0	0.4	0.0	3.7	0.0	0.0	0.0	6.0	10.2	0.0	0.3	2.0	0.0	0.2	1.8	0.0	0.0	0.0	1.0	0.0	0.1	6.3	4.5	0.0	1.1	3.8	9.7	2.9	3.6	0.0	0.0	0.0	0.5	8.4	6.2	5.6	9.1	0.3	1.2	0.1	4.1	4.4
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 1024.6"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"myeloid DC: 11.6"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	3.2	10.0	13.5	4.3	18.8	1.5	1.9	13.2	13.0	1.1	8.7	3.3	1.9	0.9	0.3	0.3	0.6	4.1	1.2	13.4	15.2	0.5	1024.6	6.3	0.8	30.0	27.7	0.5	1.0	0.8	1.1	2.9	16.1	1.1	2.3	3.0	2.7	0.1	0.8	0.2	2.0	0.5	10.5	1.7	2.9	0.4	19.1	0.4	1.0	0.0	0.3	3.8	0.3	11.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.2	0.0	0.3	0.5	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.0	0.4	13.5	18.8	13.2	13.0	13.4	15.2	30.0	27.7	16.1	10.5	19.1	11.4	0.2	0.0	0.6	15.0	5.1	2.4	0.4	0.0	0.0	0.2	0.4	1.5	0.5	17.2	0.0	0.0	0.0	0.8	0.3	0.1	0.0	2.8	0.0	0.1	0.2	1.3	0.0	29.5	0.1	0.4	1.3	0.6	0.0	0.1	0.0	0.1	18.9	364.6	199.4	0.0	0.1	0.0	0.0	45.1	111.9	0.0	0.0	93.7	1.8	0.0	97.6	1.9	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.4	3.1	2.5	2.4	0.8	0.0	0.1
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422380-113438276	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2;Hepatocytes: 116.7;Hofbauer cells: 95.7;monocytes: 103.1;Proximal tubular cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 8.7;intermediate monocyte: 10.0;myeloid DC: 18.5;plasmacytoid DC: 17.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 18.5;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;MCF7: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA		48000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	4.5	33.1	12.7	7.1	14.2	3.2	4.9	16.4	15.2	4.6	10.8	12.2	16.8	4.8	9.9	2.5	7.9	7.7	12.8	11.8	16.1	34.9	104.6	5.7	3.4	18.7	16.2	4.6	18.7	12.4	15.5	4.4	16.0	8.5	8.5	2.4	4.8	6.6	3.0	1.3	12.2	5.2	15.8	5.8	9.1	10.6	16.4	1.5	23.9	1.3	1.7	6.2	1.4	17.4	8.5	33.3	4.7	14.1	0.9	1.9	3.2	4.8	1.2	5.2	4.4	14.1	8.7	0.4	24.2	8.1	14.4	8.6	2.2	11.4	1.7	20.5	8.4	22.1	8.5	6.3	27.5	2.8	51.4	4.4	16.0	12.8	18.8	5.9	8.0	0.0	17.3	6.6	6.5	90.2	0.1	10.2	4.6	9.6	14.6	0.0	7.0	16.5	13.6	10.6	1.5	0.5	20.6	23.6	18.4	4.2	28.6	24.8	7.2	6.2	11.9	26.9	4.2	1.4	1.4	0.3	26.3	8.4	7.8	0.2	8.7	0.0	0.0	10.0	0.0	2.2	0.0	0.0	18.5	0.1	0.0	0.0	0.4	1.8	1.3	17.8	0.3	2.5	12.7	14.2	16.4	15.2	11.8	16.1	18.7	16.2	16.0	15.8	16.4	17.4	1.2	0.0	5.1	2.0	3.1	0.9	2.2	7.0	0.0	0.5	15.3	10.2	18.2	27.1	6.3	29.5	2.1	16.3	4.9	43.7	78.2	36.1	0.5	14.8	7.7	4.0	31.8	10.1	1.3	20.1	3.0	4.5	12.8	10.1	43.8	15.3	6.4	116.7	95.7	3.3	0.6	36.4	4.1	18.1	8.4	1.5	2.8	36.9	3.6	1.9	103.1	33.5	0.0	1.5	2.0	16.2	63.2	5.7	0.0	6.1	63.2	115.7	3.8	2.6	0.0	0.2	7.3	0.2	0.4	1.1	0.6	7.3	1.9	29.5	31.0	5.9
SEBOX	"OG9, OG9X"	ENSG00000274529	"SEBOX homeobox"	Q9HB31	17	28364268-28365244	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 36.1"	"Not detected"	"Not detected"			HPA045689	Uncertain					NA	NA									"HPA045689: AB_2679419"							"unprognostic (8.66e-2)"							"unprognostic (3.10e-3)"				0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139866-59158832	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	24.6	76.7	110.0	86.5	117.5	63.1	81.8	122.9	140.5	57.8	94.4	92.3	126.7	40.1	284.6	42.5	41.4	47.3	30.0	112.9	146.4	70.2	219.0	62.7	104.2	137.3	130.2	29.9	374.0	153.9	155.2	28.4	136.8	225.7	78.2	108.1	397.3	62.3	15.7	29.7	97.8	30.1	123.7	81.4	138.5	28.1	113.5	53.0	163.7	20.0	117.8	59.4	21.2	135.8	82.4	100.0	52.9	74.1	31.9	6.8	64.7	72.4	62.9	89.9	55.2	78.3	42.5	176.8	109.9	46.6	67.6	82.8	84.7	59.0	58.4	523.5	113.8	58.5	69.3	242.3	99.3	199.4	87.6	20.4	140.7	56.2	161.1	20.2	33.7	78.4	67.4	546.2	34.6	100.0	79.0	79.2	48.1	140.4	60.5	72.8	50.0	1150.0	67.5	76.1	223.2	90.5	43.1	162.5	252.8	29.9	76.0	148.5	24.7	98.5	45.4	36.5	86.9	587.3	434.4	176.0	99.4	131.8	124.5	76.4	70.7	57.9	146.1	97.6	187.6	197.8	150.4	142.5	78.8	127.9	77.7	105.4	12.2	108.3	108.8	299.6	223.7	222.1	110.0	117.5	122.9	140.5	112.9	146.4	137.3	130.2	136.8	123.7	113.5	135.8	64.8	28.9	120.7	19.2	295.9	32.6	49.3	92.4	12.5	63.6	120.0	128.3	59.3	144.4	102.5	60.7	50.1	70.8	148.7	76.3	88.0	164.4	45.4	58.7	34.2	60.3	339.3	43.8	12.2	263.1	109.1	29.2	60.6	147.1	47.5	21.5	56.4	224.7	112.9	50.5	13.3	223.1	685.6	37.1	56.9	18.8	12.5	63.9	256.1	10.3	46.4	544.7	96.8	17.1	31.2	148.9	78.4	23.0	1164.8	380.9	99.3	118.8	81.3	89.3	6.6	23.1	70.6	110.2	81.5	35.5	45.5	149.7	92.3	40.1	88.3	79.2
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321112	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	62.1	71.5	51.0	61.8	55.6	58.4	58.9	55.9	57.6	83.7	59.2	68.8	114.7	66.4	59.4	72.6	57.4	47.5	71.1	52.2	57.2	67.4	92.1	64.3	54.6	54.6	54.6	52.6	85.2	64.6	109.2	68.5	55.2	53.8	65.7	21.2	96.2	64.9	111.5	62.7	96.6	76.6	54.3	59.4	67.3	39.4	54.2	70.3	57.6	87.3	65.4	69.9	59.2	58.2	122.6	182.1	142.9	55.2	228.0	251.6	474.4	243.8	296.1	279.3	319.8	150.3	97.6	110.7	109.6	390.1	156.8	49.0	186.4	218.3	142.4	97.8	194.5	136.2	137.3	363.7	311.8	156.7	115.5	224.7	173.1	292.6	181.5	205.6	337.0	146.2	148.4	159.8	219.5	250.2	153.8	169.9	160.9	158.0	218.7	148.1	102.4	198.2	172.4	90.2	80.3	99.4	107.3	98.7	101.3	119.3	127.5	150.8	253.6	114.2	130.2	172.6	213.3	131.7	198.4	258.6	215.5	217.5	193.0	127.3	163.2	106.6	84.4	144.9	94.6	96.5	83.6	82.1	222.5	82.6	68.0	71.2	105.8	93.9	116.4	198.3	106.1	176.5	51.0	55.6	55.9	57.6	52.2	57.2	54.6	54.6	55.2	54.3	54.2	58.2	23.9	48.1	61.9	14.0	45.8	39.4	50.4	73.6	31.3	16.2	29.5	26.4	40.2	30.0	68.3	27.6	10.4	119.9	36.5	60.1	66.5	79.3	25.6	31.8	44.0	51.0	41.4	33.0	17.3	109.2	166.6	74.1	73.9	47.1	43.1	35.5	33.9	57.3	104.9	11.8	13.7	108.2	50.8	33.0	46.7	10.2	53.4	45.0	26.6	12.2	64.2	37.4	35.0	11.6	12.6	81.8	56.1	52.6	203.2	52.4	187.5	112.0	64.5	21.1	13.1	37.7	63.6	54.9	38.9	43.7	40.2	168.6	36.5	35.8	74.2	62.3
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396941-30425303	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 86.0;liver: 243.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 146.3;Muller glia cells: 112.6;Pancreatic endocrine cells: 115.2;Proximal enterocytes: 52.8;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 93.9;hTCEpi: 47.3;hTERT-RPE1: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	2.8	1.4	33.1	2.6	43.3	4.1	44.4	35.8	37.1	6.0	35.4	3.4	21.6	3.4	86.0	20.6	3.1	7.4	2.4	34.3	39.7	8.0	243.8	2.7	3.1	45.4	39.5	2.6	2.6	11.0	11.1	1.5	33.2	52.3	1.3	64.2	9.3	13.7	0.7	7.0	24.3	3.4	30.4	1.1	5.9	1.3	41.4	4.2	9.0	0.5	4.5	3.2	7.7	32.2	24.8	5.5	5.0	6.4	6.5	16.8	0.4	18.0	15.5	12.0	13.1	1.6	15.9	0.5	5.6	22.7	20.5	20.0	3.0	93.9	13.8	2.2	4.1	0.4	5.4	8.0	9.2	0.0	7.1	11.5	47.3	11.5	20.8	55.5	29.7	4.2	0.1	0.5	22.2	4.0	3.0	0.5	0.1	13.9	7.6	1.2	8.0	0.6	20.7	7.8	2.8	3.1	13.3	3.2	11.2	0.6	14.7	0.5	41.2	15.8	10.4	6.8	12.7	0.3	0.2	0.8	32.4	0.1	12.6	0.0	0.1	0.2	0.5	0.1	0.2	0.4	1.4	0.3	0.0	0.3	3.7	2.7	0.3	0.0	0.0	0.5	0.7	0.8	33.1	43.3	35.8	37.1	34.3	39.7	45.4	39.5	33.2	30.4	41.4	32.2	1.1	3.2	5.8	33.6	1.1	4.1	18.0	25.2	6.8	9.2	36.5	21.7	1.2	12.8	10.3	0.0	16.7	4.2	3.2	0.6	5.9	22.9	8.3	2.9	2.3	2.4	1.2	17.2	9.8	18.7	0.3	5.1	5.6	5.8	5.7	0.7	7.1	146.3	0.5	13.5	6.7	2.0	4.1	4.4	0.4	10.7	1.2	2.6	7.2	1.9	0.2	112.6	0.0	21.6	13.2	115.2	0.0	0.7	2.5	15.3	52.8	8.7	3.9	56.0	0.0	2.8	4.0	0.6	1.2	5.6	2.0	3.0	7.4	0.1	2.1	7.8
SEC14L3	TAP2	ENSG00000100012	"SEC14 like lipid binding 3"	Q9UDX4	22	30447959-30472017	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;liver: 2.9;retina: 9.0"	"Group enriched"	"Detected in some"	8	"Muller glia cells: 27.6;Respiratory ciliated cells: 22.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA059450	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"			"HPA059450: AB_2684024"		"unprognostic (2.42e-1)"		"unprognostic (2.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.00e-4)"	"unprognostic (3.62e-3)"		"unprognostic (6.68e-2)"	"unprognostic (3.19e-1)"		"unprognostic (2.41e-10)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.10e-1)"		0.0	0.1	0.2	0.1	0.1	3.8	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	2.9	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		48000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	16.8	18.2	6.4	16.6	6.7	35.3	17.1	8.0	9.4	16.6	19.3	17.3	14.9	17.9	9.0	17.9	16.4	12.4	14.5	7.0	5.2	14.3	37.9	19.4	16.9	4.4	4.9	16.2	29.2	14.0	24.3	10.8	3.5	18.7	10.5	9.2	25.8	13.1	23.5	19.7	19.1	10.7	2.4	20.7	27.2	17.6	5.2	17.4	15.3	11.9	12.3	15.9	14.5	5.0	26.5	57.7	28.5	47.2	29.6	30.3	33.6	32.1	27.9	23.4	17.8	41.9	22.1	26.4	22.1	39.2	28.8	71.3	31.8	46.2	12.7	56.2	20.7	26.9	55.1	33.7	28.6	46.2	45.8	32.8	32.5	32.7	38.1	18.9	32.2	34.5	34.1	35.6	25.0	114.3	31.2	24.9	25.1	79.0	40.4	44.3	35.2	45.0	23.8	35.0	40.0	26.6	41.6	62.2	19.8	13.8	63.6	35.9	47.0	37.6	28.1	30.8	25.2	16.9	27.7	33.4	29.2	20.6	38.3	1.7	2.8	1.2	2.5	3.1	2.7	2.3	2.6	3.0	1.6	1.4	1.6	2.8	2.0	1.5	3.4	2.6	1.9	2.4	6.4	6.7	8.0	9.4	7.0	5.2	4.4	4.9	3.5	2.4	5.2	5.0	20.0	25.6	41.7	16.6	16.4	24.9	15.3	18.4	10.8	20.2	38.7	30.6	11.5	12.8	23.6	12.9	25.0	8.1	17.5	30.1	7.9	14.2	5.1	26.9	19.5	18.2	40.7	12.0	27.4	16.4	11.8	16.0	46.9	38.2	23.5	25.4	17.9	62.2	16.5	33.7	19.2	65.5	20.3	23.4	19.5	6.0	13.1	22.3	14.2	17.8	19.5	13.0	11.3	9.5	14.7	22.8	14.7	16.6	25.1	26.3	22.3	10.1	34.7	17.1	13.1	20.5	16.6	24.4	16.1	17.2	26.9	15.1	17.8	15.8	22.8	22.1
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.4;liver: 36.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.3;Late spermatids: 50.4;Proximal enterocytes: 34.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.6;CAPAN-2: 7.2;EFO-21: 5.4;HDLM-2: 5.8;Karpas-707: 4.8;RPMI-8226: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	4.0	2.5	0.5	1.1	1.1	0.3	3.2	0.0	2.9	3.0	0.0	3.6	28.0	3.5	2.0	2.0	3.5	4.3	2.6	0.8	0.1	3.4	36.4	2.4	1.1	0.0	0.3	4.2	9.0	0.5	1.4	0.8	0.1	1.6	4.0	5.7	3.6	2.1	9.3	2.7	28.4	2.7	0.0	5.8	8.7	1.4	0.3	0.4	2.1	3.1	0.9	1.4	1.1	1.2	1.9	1.5	0.1	1.5	1.9	6.6	0.0	1.5	0.5	0.1	0.7	1.0	7.2	0.6	5.4	1.2	0.1	0.0	0.4	0.2	0.0	5.8	0.1	0.0	0.0	3.4	0.1	0.1	0.0	3.8	0.5	0.2	0.0	0.2	2.2	0.0	0.0	4.8	3.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	6.5	0.1	0.1	0.6	1.2	0.1	0.2	0.8	0.0	0.1	1.3	0.7	1.0	0.2	0.6	0.0	1.5	0.7	0.1	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	2.9	0.8	0.1	0.0	0.3	0.1	0.0	0.3	1.2	7.7	0.0	2.0	2.9	0.7	0.3	0.3	0.4	1.8	1.3	6.3	1.8	0.5	7.2	1.9	1.8	2.1	0.5	0.0	0.9	0.0	0.6	10.1	2.3	1.6	3.9	3.6	0.0	15.8	1.1	0.0	1.9	9.2	2.7	1.3	1.9	3.6	66.3	0.6	11.8	4.8	4.6	0.0	3.2	0.4	50.4	2.5	0.7	1.8	3.7	0.6	1.4	0.0	1.0	1.3	1.1	5.2	1.2	2.9	0.1	34.8	3.1	3.3	4.7	0.0	2.7	1.0	0.3	0.8	0.6	1.0	0.0	0.3	0.1	5.4	0.2
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"SEC23 homolog B, COPII coat complex component"	Q15437	20	18507520-18561415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles		NA	Yes		16000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA008216: AB_1079895, HPA069974: AB_2686223"	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	19.6	38.3	18.7	32.0	27.1	36.0	37.8	24.7	25.9	36.2	27.4	31.6	23.8	17.2	53.8	28.4	29.5	23.1	8.5	19.5	22.4	37.4	30.6	29.7	30.5	27.2	23.8	16.9	57.1	50.6	32.6	24.2	27.2	34.8	32.7	40.7	70.9	35.9	4.1	18.2	23.3	18.5	24.5	25.5	38.2	34.8	23.2	27.6	59.5	6.2	38.0	30.5	12.6	38.9	85.0	93.9	49.8	48.7	32.3	36.6	116.0	69.8	45.3	80.0	68.7	84.9	73.8	37.5	44.9	50.4	107.0	88.5	88.5	120.7	86.2	47.5	43.1	64.9	35.6	130.6	70.5	90.2	78.7	28.0	71.8	118.0	151.4	47.6	50.6	34.0	74.8	82.4	55.1	90.7	59.8	49.5	48.0	118.9	101.6	62.4	77.7	122.1	83.0	85.6	78.8	58.0	83.6	188.9	80.6	62.6	82.3	94.4	45.3	53.1	29.8	58.4	87.1	104.2	155.9	60.1	45.3	47.8	74.4	147.9	94.1	106.0	57.2	95.6	78.7	67.2	56.8	61.4	107.9	61.2	51.3	54.0	48.0	78.8	94.9	80.7	75.4	103.7	18.7	27.1	24.7	25.9	19.5	22.4	27.2	23.8	27.2	24.5	23.2	38.9	8.5	16.0	43.5	15.3	24.7	11.5	21.0	34.3	10.2	21.0	21.5	15.6	3.0	20.0	42.5	31.3	16.7	34.3	36.0	26.2	58.7	36.1	95.6	25.4	12.4	11.3	19.7	7.4	17.9	33.4	30.0	11.7	25.0	31.3	15.9	13.6	11.0	25.6	42.9	13.5	20.5	34.7	26.4	38.7	21.0	11.3	14.3	30.3	23.2	15.0	33.1	23.9	9.2	23.1	27.0	31.8	24.2	10.5	59.0	30.1	11.8	53.2	45.4	20.4	19.7	12.4	12.2	48.7	22.1	15.8	14.2	65.8	21.0	16.0	21.5	28.3
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892730-119944657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	10.3	9.7	3.5	12.0	3.9	14.1	11.8	6.2	4.6	11.2	6.4	12.6	10.4	11.9	12.1	9.4	8.8	9.6	7.7	4.0	4.0	10.3	12.6	10.2	13.7	4.2	4.3	10.0	11.1	9.8	8.5	12.4	4.0	13.1	13.0	9.0	10.3	9.9	9.8	10.4	9.5	16.4	3.1	11.7	17.5	11.5	4.6	11.1	12.5	8.4	13.4	12.0	8.3	6.3	32.4	30.2	24.3	31.9	22.4	25.3	19.0	27.2	39.5	26.1	31.6	31.0	22.9	30.2	14.7	36.2	32.5	23.9	27.9	29.2	39.5	27.2	28.7	25.1	16.3	34.0	31.0	29.6	29.9	31.4	18.4	30.8	30.5	28.3	36.3	15.5	19.1	21.4	28.7	19.2	25.9	28.2	29.5	28.6	20.9	23.7	44.7	17.3	26.1	25.6	9.6	25.5	25.0	19.9	24.1	24.9	17.5	21.7	29.6	15.8	18.5	23.8	35.1	33.5	32.6	38.7	27.6	37.4	14.1	14.3	10.5	10.3	10.7	16.3	13.9	11.3	10.5	12.4	11.9	9.1	11.1	10.7	3.8	13.0	18.1	7.2	11.9	9.6	3.5	3.9	6.2	4.6	4.0	4.0	4.2	4.3	4.0	3.1	4.6	6.3	15.1	12.8	28.3	21.9	20.9	8.4	19.3	18.1	13.1	17.3	19.1	12.1	17.4	27.1	24.5	18.4	6.2	17.8	18.7	19.7	5.9	16.8	26.1	15.1	22.1	19.9	19.9	21.2	28.3	14.4	18.9	21.4	44.9	15.5	22.1	21.0	14.3	25.5	23.3	11.8	30.2	24.3	26.4	24.6	12.2	24.9	14.0	23.3	8.8	39.4	21.3	14.6	16.5	31.7	37.5	20.2	19.8	15.1	23.7	23.4	16.0	19.2	25.4	23.7	0.0	16.8	17.9	25.0	19.8	19.1	13.9	23.1	18.2	24.2	20.8	21.1
SEC24A		ENSG00000113615	"SEC24 homolog A, COPII coat complex component"	O95486	5	134648785-134727909	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038901, HPA056825"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center, Vesicles"		"HPA038901: AB_10674843, HPA056825: AB_2683249"	"unprognostic (9.10e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.18e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.97e-2)"	9.7	13.3	2.2	13.3	2.2	17.6	10.0	3.6	3.9	11.7	13.6	11.7	21.3	8.7	8.1	10.5	5.4	10.5	6.3	2.6	3.4	9.0	34.6	7.6	10.7	2.4	3.7	6.5	15.6	11.8	7.9	15.5	2.2	10.0	13.0	6.9	16.9	8.1	11.9	5.8	22.0	10.7	1.8	9.6	14.6	6.0	2.7	9.0	11.5	7.3	14.2	13.4	7.2	2.7	21.6	12.1	22.3	17.1	32.4	32.6	24.1	32.6	40.2	25.7	44.1	45.0	12.9	16.1	21.6	38.1	27.3	12.0	28.2	25.3	44.4	19.8	13.3	13.7	18.6	33.5	23.0	16.3	26.4	20.5	14.1	24.8	18.1	22.4	23.7	11.2	18.9	24.3	25.9	11.7	15.6	11.9	14.6	19.7	7.6	15.7	19.8	18.9	16.8	16.9	9.4	9.7	21.2	10.1	26.8	38.6	17.8	13.4	26.0	21.2	8.0	27.0	19.8	42.7	40.6	26.5	24.9	17.0	41.2	3.3	2.1	1.5	1.6	2.3	2.7	2.1	1.7	1.6	2.5	1.3	1.6	1.9	1.2	2.0	2.5	1.6	1.7	1.2	2.2	2.2	3.6	3.9	2.6	3.4	2.4	3.7	2.2	1.8	2.7	2.7	14.4	6.4	8.4	15.3	15.2	31.9	14.0	10.7	8.0	7.8	20.6	9.1	6.3	11.5	18.6	3.7	12.5	10.3	14.6	22.1	5.9	6.3	12.0	25.6	33.4	12.2	9.5	6.7	29.6	13.6	17.2	18.1	32.6	70.1	12.7	8.3	15.7	54.8	11.5	13.5	25.7	19.9	8.2	16.2	32.0	5.7	8.4	20.7	14.2	15.0	9.8	6.6	6.2	35.2	23.2	15.0	11.5	13.5	89.1	22.0	42.6	12.3	13.8	7.7	6.6	19.6	12.8	15.2	8.2	17.0	32.4	22.7	13.1	8.0	15.2	36.0
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 88.1;Oligodendrocytes: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	19.3	13.7	7.2	13.2	7.5	28.0	17.4	14.7	9.9	16.3	15.0	15.7	14.1	16.9	12.9	17.2	15.0	13.8	15.6	6.8	7.6	16.7	46.2	14.8	13.9	7.5	6.9	21.4	18.6	21.9	11.2	20.6	7.8	15.6	16.1	32.6	14.3	16.1	28.1	19.8	12.7	17.9	7.3	14.7	13.3	11.3	7.4	27.2	18.5	22.9	16.7	17.5	16.0	9.6	21.1	18.9	29.3	22.1	34.9	34.7	16.8	27.0	32.8	22.5	19.8	17.4	23.8	19.4	13.8	41.1	19.3	17.4	33.2	26.9	33.0	24.0	16.6	20.3	16.6	19.2	23.4	27.0	22.9	34.4	33.7	25.8	30.8	31.8	33.7	19.7	31.5	17.3	33.6	17.1	39.2	12.5	11.2	26.1	15.0	25.1	25.9	11.3	27.1	25.8	20.6	16.5	20.8	43.8	16.0	30.0	12.9	10.3	31.3	26.2	17.6	23.1	19.5	16.6	22.3	18.1	23.3	10.7	21.5	6.1	9.5	11.5	8.6	10.4	9.5	10.3	9.5	9.0	11.8	8.9	10.8	9.3	9.2	11.5	10.5	4.6	9.1	9.0	7.2	7.5	14.7	9.9	6.8	7.6	7.5	6.9	7.8	7.3	7.4	9.6	25.1	25.6	15.4	63.0	23.0	35.4	20.1	11.8	28.5	27.0	12.9	10.8	30.5	14.3	17.4	5.5	6.2	13.3	13.2	22.7	5.9	10.4	4.4	18.7	14.6	22.5	15.6	11.6	71.1	13.1	9.2	16.4	19.9	21.9	11.4	15.9	16.8	29.9	12.3	16.8	84.1	15.6	4.1	17.6	16.8	7.9	20.5	18.7	17.8	88.1	14.5	20.3	13.4	76.9	91.6	12.6	18.7	21.8	21.3	22.5	16.5	9.6	19.6	22.0	13.1	16.3	16.8	14.7	13.6	22.2	36.7	16.1	17.0	9.9	14.4	30.3
SEC24C	KIAA0079	ENSG00000176986	"SEC24 homolog C, COPII coat complex component"	P53992	10	73744372-73772161	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040196, HPA040213"	Supported		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040196: AB_10796449, HPA040213: AB_10796451"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.46e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.34e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-2)"	27.8	42.9	20.1	31.6	21.2	16.2	27.4	23.1	26.8	42.5	20.7	34.2	27.4	36.4	33.2	69.0	30.7	24.0	34.5	20.4	21.2	29.8	45.8	30.5	31.4	21.4	20.1	33.2	34.9	50.5	45.4	36.4	20.9	37.7	27.6	29.1	36.9	31.1	49.7	35.8	31.7	32.1	18.3	37.1	34.1	27.7	22.7	35.2	34.0	33.9	43.3	35.5	38.8	23.0	72.7	71.8	55.6	99.9	59.2	48.3	45.6	53.6	90.4	70.4	65.7	67.2	47.9	57.3	43.3	72.0	48.1	61.4	78.3	70.7	60.4	76.6	55.6	53.1	50.5	71.2	47.0	80.7	71.1	41.5	76.8	61.8	76.4	89.2	73.6	44.6	64.1	80.8	69.9	64.7	60.4	55.3	34.8	68.3	259.2	65.2	45.0	47.0	46.5	40.8	20.0	51.7	41.9	144.6	60.1	51.7	106.3	70.6	72.7	29.5	53.1	57.7	62.5	82.0	85.9	84.0	84.0	80.8	35.0	28.2	15.8	13.6	27.4	21.4	35.5	12.6	16.2	21.6	18.1	9.4	11.7	15.8	11.5	22.4	19.1	14.8	10.9	22.7	20.1	21.2	23.1	26.8	20.4	21.2	21.4	20.1	20.9	18.3	22.7	23.0	12.1	35.3	28.6	16.3	11.6	8.7	4.7	11.5	6.2	15.1	17.0	14.9	2.3	14.3	17.6	14.7	16.7	17.8	18.6	24.7	3.9	15.1	8.8	10.9	13.0	11.0	19.2	5.9	14.6	19.4	16.4	9.7	19.9	17.0	22.2	20.1	16.4	19.9	17.1	15.2	15.7	18.4	8.2	11.7	8.4	6.0	11.8	12.4	5.4	6.5	12.3	10.3	17.5	14.1	16.8	23.8	14.4	11.7	21.9	10.8	20.0	10.4	8.2	14.7	6.6	10.0	9.7	10.3	8.3	11.5	11.4	25.2	16.9	14.7	16.1	10.9
SEC24D	KIAA0755	ENSG00000150961	"SEC24 homolog D, COPII coat complex component"	O94855	4	118722823-118838683	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041626, HPA053486"	Approved		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA041626: AB_10796348, HPA053486: AB_2682166"	"unprognostic (9.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (3.42e-6)"	"unprognostic (1.09e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	21.1	13.3	2.7	27.2	3.3	17.6	19.4	1.1	4.4	49.0	4.5	24.4	37.5	26.4	36.9	12.4	20.7	31.9	20.1	5.5	4.6	9.5	52.0	22.9	18.4	1.3	2.3	15.3	35.8	10.2	23.3	36.8	1.6	22.0	32.3	1.6	22.9	26.4	5.8	9.9	40.8	41.3	0.6	18.0	29.6	18.4	2.8	14.6	35.6	6.1	21.9	28.9	16.7	2.6	29.6	15.4	35.3	28.6	98.0	130.2	24.8	124.5	136.8	62.1	73.5	16.9	21.3	23.2	17.3	198.7	32.1	10.0	19.4	39.2	66.8	19.4	10.5	25.7	22.8	70.6	99.8	68.6	46.0	77.9	21.6	54.9	89.2	110.3	103.9	15.8	6.7	69.1	98.5	20.6	33.2	20.4	33.3	66.5	24.8	20.1	25.8	41.2	55.6	14.7	20.9	41.8	17.8	89.1	15.3	50.9	12.6	53.9	113.9	48.0	15.3	69.7	28.6	53.1	21.1	38.6	104.5	42.8	68.5	5.8	5.6	16.3	3.1	6.0	6.3	1.7	3.2	4.4	5.8	1.5	2.1	2.7	4.8	5.0	7.4	2.9	4.7	2.6	2.7	3.3	1.1	4.4	5.5	4.6	1.3	2.3	1.6	0.6	2.8	2.6	13.0	3.2	15.3	4.9	19.4	21.0	15.2	19.4	25.6	4.5	19.0	10.2	5.9	17.2	25.5	14.7	0.0	24.3	24.2	18.2	0.0	10.3	101.3	17.4	61.3	23.2	41.3	6.1	57.4	25.3	54.2	49.7	37.2	39.4	8.2	14.2	21.8	70.0	28.1	1.7	6.5	81.0	12.2	34.0	54.4	84.6	45.7	25.1	17.8	48.7	18.3	1.3	13.4	37.7	3.7	13.0	13.6	38.4	118.8	30.7	48.1	4.2	23.0	2.9	26.3	17.5	38.7	14.5	9.7	10.4	17.6	45.0	16.3	34.2	19.1	40.1
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486646-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Bipolar cells: 32.2;Cone photoreceptor cells: 39.6;Excitatory neurons: 38.1;Horizontal cells: 40.4;Inhibitory neurons: 40.7;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.1;JURKAT: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavorable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.2	1.5	2.0	1.1	2.0	2.5	2.0	2.3	2.9	2.6	1.2	2.5	0.3	2.1	1.0	0.8	2.6	0.8	2.8	1.8	1.9	2.2	2.0	1.7	1.6	1.9	1.7	2.8	0.6	1.7	3.7	0.7	1.8	2.3	0.8	1.5	1.6	0.8	5.9	1.3	2.3	0.8	1.5	3.0	1.7	2.7	1.9	2.9	2.0	8.3	1.3	1.8	1.5	2.2	0.1	0.0	2.0	0.5	0.6	1.0	0.1	0.4	0.9	0.2	0.6	0.1	0.0	0.4	0.6	0.0	0.1	0.0	1.1	0.2	0.5	2.5	0.5	1.0	1.5	0.2	0.9	0.8	0.8	1.8	1.0	0.1	1.2	9.1	0.3	8.9	0.1	1.3	0.0	0.0	1.4	2.3	0.0	0.2	0.4	2.0	0.0	0.9	0.6	0.0	0.1	0.7	0.2	0.0	0.4	1.5	0.4	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.6	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	2.3	2.9	1.8	1.9	1.9	1.7	1.8	1.5	1.9	2.2	2.5	6.4	4.5	28.7	2.4	1.1	0.9	1.7	1.2	32.2	2.9	2.0	8.0	4.3	2.3	11.0	39.6	1.2	4.5	3.8	0.0	0.4	2.3	1.3	3.4	2.6	5.4	0.4	38.1	0.2	0.3	2.4	3.1	1.6	1.3	7.7	2.9	6.1	2.2	40.4	40.7	3.3	0.0	4.8	1.7	1.7	3.4	3.5	1.8	7.5	5.2	3.6	1.0	32.6	21.5	0.2	2.0	4.1	2.5	1.2	2.4	1.0	2.2	5.8	0.0	1.9	2.2	7.7	3.2	1.8	1.1	0.8	4.6	4.7	4.0	1.1
SEC61B		ENSG00000106803	"SEC61 translocon subunit beta"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 1573.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	173.5	235.8	101.0	154.7	104.0	255.5	153.4	104.3	120.8	179.4	105.3	139.3	155.0	167.7	259.4	169.8	155.0	129.8	106.7	104.4	110.8	213.7	465.3	169.0	184.0	104.5	102.1	158.5	546.0	145.9	209.5	98.3	105.8	168.0	102.8	48.5	347.7	124.3	61.0	122.5	132.9	106.3	106.8	173.1	186.5	76.4	103.8	188.8	179.8	44.2	146.7	148.8	139.1	111.6	226.5	213.3	244.1	243.7	234.5	296.0	293.9	327.6	335.8	299.9	259.2	307.3	172.6	305.3	244.3	298.7	328.9	272.0	171.9	259.5	143.1	325.4	238.7	160.7	200.7	440.3	509.9	278.9	198.3	268.0	389.4	237.3	210.3	268.1	369.8	246.7	255.0	581.1	285.6	407.7	255.6	404.9	196.3	533.9	497.7	244.2	207.7	398.1	332.3	158.3	252.7	179.2	183.6	421.1	441.5	190.8	163.4	378.6	265.1	215.3	260.0	363.5	277.7	312.0	226.6	200.7	359.3	176.6	145.6	875.3	460.3	453.3	354.6	387.9	480.8	356.5	389.3	360.4	481.0	257.1	242.9	267.7	388.5	325.7	350.8	1661.8	388.0	525.0	101.0	104.0	104.3	120.8	104.4	110.8	104.5	102.1	105.8	106.8	103.8	111.6	255.6	102.5	206.1	18.3	370.9	395.8	308.3	712.8	213.9	59.3	499.1	530.7	55.5	271.7	416.8	200.5	31.3	336.6	605.9	239.9	633.9	498.6	184.2	274.7	410.2	286.1	302.0	226.8	16.2	792.5	577.9	343.2	214.1	391.3	214.8	258.8	213.8	822.0	509.8	53.8	15.5	534.0	406.9	295.3	553.2	51.8	328.0	316.3	496.2	17.8	1573.9	197.3	284.2	15.6	25.9	633.4	280.0	304.3	1190.6	654.2	290.3	767.6	331.4	81.5	138.1	237.1	404.7	218.4	171.0	337.5	443.4	553.8	270.1	333.0	334.0	501.5
SEC61G	SSS1	ENSG00000132432	"SEC61 translocon subunit gamma"	P60059	7	54752250-54759974	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	5	"glioma: 333.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053196	Uncertain					NA	NA		37000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053196: AB_2682077"	"unprognostic (1.39e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.64e-7)"	"prognostic unfavorable (3.85e-6)"	"unprognostic (2.09e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (6.60e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.95e-3)"	"unprognostic (8.43e-2)"	161.2	163.7	83.1	143.3	82.2	171.1	170.0	85.9	111.2	177.6	94.5	189.7	116.6	127.8	342.2	169.6	132.0	99.5	206.8	82.6	89.1	212.8	221.5	144.2	127.9	84.0	81.7	120.9	311.7	101.6	253.4	115.5	83.7	143.8	162.5	82.4	160.4	121.0	148.3	113.3	126.5	142.4	84.5	140.6	149.3	110.8	84.5	130.9	159.6	126.6	156.5	134.9	134.4	87.6	448.7	256.0	343.4	384.8	339.4	415.5	216.8	705.5	430.3	352.0	647.6	378.3	294.7	383.8	355.2	517.5	758.6	332.9	285.5	491.4	749.5	328.2	249.7	250.0	571.0	439.5	495.2	457.8	248.9	318.2	418.6	364.5	623.2	491.9	479.3	246.2	375.2	950.4	755.2	232.8	243.1	785.9	497.1	547.5	414.9	180.4	206.4	655.7	435.6	281.6	328.5	400.7	287.3	678.0	324.3	602.4	347.0	435.6	405.2	323.1	423.5	1273.5	526.0	385.8	392.5	737.5	672.8	256.9	639.4	294.5	135.4	119.7	145.8	141.0	201.1	144.6	166.5	156.3	154.9	105.5	116.8	140.5	45.1	124.5	156.1	696.8	168.7	136.4	83.1	82.2	85.9	111.2	82.6	89.1	84.0	81.7	83.7	84.5	84.5	87.6	258.9	99.3	139.0	10.4	318.3	378.8	264.8	1105.6	180.4	51.0	330.4	343.8	235.2	283.1	456.4	252.0	8.4	282.2	361.6	467.4	602.6	646.0	67.0	317.2	405.1	256.9	306.5	224.3	8.1	1006.7	775.2	325.7	311.4	524.7	147.2	190.2	267.0	706.0	472.5	23.5	13.1	735.0	506.6	333.3	450.8	46.8	251.0	258.2	498.0	13.1	537.4	166.1	292.5	6.6	12.5	814.2	476.0	222.7	962.7	544.6	544.6	652.0	343.1	45.4	111.7	229.4	500.1	287.6	233.4	290.4	463.9	507.3	257.1	192.2	423.4	362.5
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	104.9	86.5	82.9	58.6	94.3	94.4	64.5	88.1	120.6	74.4	74.6	60.9	58.5	74.7	131.9	44.4	52.3	58.5	49.1	81.8	108.1	118.6	193.7	67.6	63.3	94.9	97.7	75.9	116.5	109.7	41.5	71.0	97.9	82.5	56.6	128.9	130.4	83.5	55.3	27.4	59.4	68.3	95.5	83.5	91.1	34.6	92.3	51.1	120.9	60.2	67.0	63.7	31.7	99.9	140.4	96.6	74.2	66.3	217.9	114.7	46.7	175.5	128.3	80.0	82.5	104.0	143.9	156.8	190.7	125.9	132.5	130.3	92.3	84.8	124.7	123.1	89.2	108.6	57.2	105.6	157.9	111.6	68.5	115.0	79.7	88.0	85.3	108.8	80.1	47.3	68.0	147.2	96.3	117.2	58.9	59.0	76.4	110.8	62.5	77.6	107.6	212.8	115.1	88.5	76.1	71.9	143.7	155.8	125.3	71.3	233.5	101.0	107.8	113.1	51.0	95.6	143.1	168.8	134.9	240.8	118.5	85.1	108.0	17.2	34.8	62.3	44.2	37.1	49.2	77.6	40.6	43.5	30.9	82.1	50.9	46.6	52.0	31.8	29.0	35.1	39.1	27.6	82.9	94.3	88.1	120.6	81.8	108.1	94.9	97.7	97.9	95.5	92.3	99.9	419.0	237.2	291.5	64.6	362.7	254.4	252.8	511.1	144.0	362.0	223.3	278.5	582.1	320.3	431.7	680.5	277.3	218.7	209.5	144.7	195.6	256.4	31.6	302.9	424.8	363.7	261.1	874.1	79.3	347.6	215.0	396.3	104.5	455.3	293.5	105.2	463.7	1081.6	214.7	452.6	86.8	285.4	364.2	237.2	268.0	43.4	560.1	208.4	279.3	48.7	280.0	486.8	183.4	47.3	103.1	283.4	217.4	435.6	469.8	223.5	233.7	416.9	385.8	418.4	295.9	358.9	423.4	206.5	142.2	90.2	172.3	434.1	205.5	175.9	182.2	176.8
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958208	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	27.5	33.0	11.6	22.0	14.3	32.9	23.3	14.4	12.9	30.2	25.7	19.2	16.8	25.2	29.6	19.5	21.8	22.0	19.0	12.4	15.3	20.0	46.6	21.7	16.7	13.3	12.0	40.4	61.2	31.7	14.4	20.9	14.2	27.7	18.6	21.2	77.8	23.3	14.3	15.5	18.0	22.2	12.3	16.1	23.1	33.0	12.1	22.6	52.1	14.1	17.3	21.8	14.0	17.7	28.5	17.1	46.0	57.6	47.1	55.2	41.4	59.2	65.0	27.8	39.2	30.8	34.6	52.8	49.4	53.7	34.4	40.9	32.3	38.3	42.5	63.8	35.7	57.2	25.2	31.6	73.2	65.9	32.5	43.5	61.4	44.5	97.6	50.0	39.3	31.7	48.5	82.8	57.7	22.7	20.6	29.5	36.4	30.0	18.1	65.2	54.4	43.7	33.5	37.1	40.3	45.7	32.9	48.8	59.1	31.2	34.9	95.8	42.5	41.6	25.8	42.2	46.6	31.4	25.0	52.9	45.9	56.4	48.7	5.6	5.2	5.0	4.8	4.7	7.5	4.4	3.9	3.9	5.4	4.0	4.3	3.4	1.7	7.1	9.8	6.9	2.2	3.5	11.6	14.3	14.4	12.9	12.4	15.3	13.3	12.0	14.2	12.3	12.1	17.7	55.6	118.6	143.3	38.2	64.4	85.0	70.5	90.9	42.7	57.7	67.8	54.2	78.8	81.5	125.5	53.3	39.6	80.8	71.6	39.2	11.7	86.0	40.3	48.7	102.8	61.6	53.5	31.5	52.5	125.4	96.4	107.1	46.9	54.8	68.9	84.8	59.6	126.7	62.7	47.1	50.8	80.0	83.4	56.7	78.9	23.9	106.2	54.8	80.0	42.2	54.3	61.0	59.8	60.3	64.8	81.9	53.5	118.8	144.6	91.1	37.2	38.4	116.7	49.9	46.0	108.2	77.2	143.1	75.0	44.7	80.0	91.0	52.3	354.8	60.8	73.8
SECISBP2	SBP2	ENSG00000187742	"SECIS binding protein 2"	Q96T21	9	89318500-89359663	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 332.4;Late spermatids: 440.3;Spermatocytes: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044314, HPA054905"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA044314: AB_10964885, HPA054905: "	"unprognostic (1.07e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (8.98e-9)"	"unprognostic (5.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.55e-3)"	22.9	27.2	17.7	22.6	21.0	35.1	28.2	22.2	19.9	29.2	25.1	26.0	23.5	27.4	28.0	19.7	28.1	18.6	18.2	18.5	21.3	31.6	29.2	25.9	31.9	19.4	18.7	40.8	40.8	25.3	28.1	27.1	19.6	25.2	27.5	49.0	27.1	16.3	41.6	29.7	29.3	15.3	17.8	34.8	27.0	68.9	19.9	33.8	35.3	21.3	27.5	24.7	23.6	28.0	29.9	19.9	53.5	31.1	24.7	26.5	38.8	16.9	20.9	19.8	19.4	11.2	24.4	44.4	14.6	15.9	31.5	37.1	36.4	17.0	18.3	29.4	21.6	21.8	16.5	28.7	21.3	44.2	31.5	16.7	31.5	16.8	19.9	21.8	25.0	58.5	28.4	51.1	19.1	27.7	60.9	22.6	55.7	74.5	19.5	29.1	26.2	29.3	22.2	22.7	39.0	38.3	15.3	33.7	45.9	35.4	29.9	37.8	23.2	19.2	22.3	26.0	26.4	61.7	42.3	18.2	33.3	28.3	28.1	17.0	8.2	14.7	10.8	8.9	10.5	14.2	10.9	10.7	7.4	14.8	16.2	13.9	23.0	10.2	11.5	13.0	14.3	6.5	17.7	21.0	22.2	19.9	18.5	21.3	19.4	18.7	19.6	17.8	19.9	28.0	72.5	44.8	58.0	43.8	81.2	19.5	72.0	29.9	38.1	113.8	49.0	59.8	18.3	31.5	40.2	40.5	91.8	70.6	67.7	41.0	43.0	39.4	332.4	44.8	34.6	46.2	37.3	60.4	55.2	31.4	47.2	36.1	42.8	47.7	36.1	51.8	36.0	36.9	26.9	57.2	55.4	56.7	30.5	32.6	19.4	440.3	40.0	69.6	21.4	51.5	47.2	44.8	69.0	46.8	77.5	35.9	49.6	25.6	81.5	64.1	49.2	54.5	41.8	112.9	32.9	63.2	36.3	338.9	223.2	44.2	25.4	91.8	54.3	43.9	50.0	65.4
SECISBP2L	KIAA0256	ENSG00000138593	"SECIS binding protein 2 like"	Q93073	15	48988476-49046447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039875	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA039875: AB_10673365"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-3)"	"unprognostic (9.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.65e-8)"	"unprognostic (1.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.28e-1)"	18.8	16.1	36.4	11.9	72.7	22.6	18.6	61.1	57.1	18.6	5.8	13.5	9.6	18.4	21.9	17.0	18.4	14.6	15.4	39.5	43.2	25.0	18.7	37.2	13.7	69.2	58.2	19.5	15.0	76.3	9.2	29.9	61.8	20.8	11.6	32.4	45.0	17.5	12.1	11.0	11.4	14.9	58.8	15.1	19.1	13.9	54.7	14.9	23.9	18.3	13.4	12.9	11.8	119.4	9.5	10.4	20.7	18.0	28.6	21.9	12.9	31.3	25.8	25.1	31.6	11.2	8.2	6.6	15.1	24.0	26.5	8.0	26.2	8.2	30.0	40.7	7.0	18.4	14.1	8.4	15.5	10.0	20.0	17.5	9.7	22.1	12.3	27.0	25.3	16.2	11.4	16.0	29.9	4.2	11.8	9.6	7.5	5.9	9.0	11.1	23.2	25.4	32.8	19.5	3.7	14.7	21.5	36.5	29.5	34.7	11.2	11.4	31.7	23.3	11.3	23.6	15.1	13.5	25.0	11.5	17.9	14.8	30.8	10.8	5.3	16.3	8.9	5.1	8.2	12.8	7.9	6.2	3.8	14.4	10.7	8.6	9.9	8.7	6.9	8.8	6.3	4.5	36.4	72.7	61.1	57.1	39.5	43.2	69.2	58.2	61.8	58.8	54.7	119.4	41.6	115.4	248.6	60.7	47.8	14.8	15.1	24.3	18.2	34.7	26.0	21.7	43.1	18.6	55.2	33.1	27.1	105.2	33.3	27.3	15.6	28.1	15.0	94.8	49.2	39.4	9.6	15.8	105.9	18.6	37.8	37.8	34.1	153.2	33.5	32.3	29.6	25.2	26.5	57.2	74.0	14.9	28.5	20.8	18.3	11.1	33.5	29.8	46.2	53.4	30.9	39.7	37.0	82.4	429.8	37.8	15.7	36.5	48.8	31.3	20.9	37.9	86.4	27.2	6.6	47.0	35.2	22.2	31.1	18.8	13.5	711.3	35.6	21.1	11.7	41.5
SECTM1	K12	ENSG00000141574	"Secreted and transmembrane 1"	Q8WVN6	17	82321024-82334074	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 63.4;Kupffer cells: 52.7;Macrophages: 36.8;Paneth cells: 48.2;Proximal enterocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 154.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 154.2;monocytes: 58.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 83.3;BJ hTERT+: 86.7;BJ hTERT+ SV40 Large T+: 66.1;BJ hTERT+ SV40 Large T+ RasG12V: 64.4;PC-3: 70.2;SiHa: 122.5;SK-BR-3: 66.9;U-2197: 92.8"					"Low region specificity"	"Detected in some"			HPA051214	Approved				"Secreted to blood"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA051214: AB_2732565"	"unprognostic (2.42e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.55e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	20.7	4.0	1.4	40.5	1.3	11.7	13.0	1.1	2.9	15.0	2.4	36.7	66.8	11.0	1.7	12.8	14.3	12.4	5.9	1.3	2.0	35.9	5.9	28.7	17.4	3.4	1.9	5.8	4.1	1.9	2.4	13.1	2.7	13.9	23.6	0.1	34.6	5.7	2.4	15.9	90.4	14.6	1.8	42.4	24.4	1.6	2.1	5.8	3.8	2.5	8.5	17.8	13.4	1.9	20.4	4.5	0.0	1.4	33.3	83.3	1.7	9.9	86.7	66.1	64.4	2.1	40.9	0.0	0.4	29.1	1.0	60.4	0.0	4.0	2.5	6.5	0.2	8.3	28.2	5.5	25.4	0.0	0.0	35.8	8.6	3.6	1.5	4.9	1.9	0.2	0.3	0.1	42.7	0.8	0.1	0.1	0.2	5.3	70.2	0.0	0.5	1.0	19.0	0.1	4.5	0.5	122.5	66.9	1.5	0.2	5.6	1.8	0.7	7.5	0.6	92.8	0.1	0.3	0.0	0.1	1.7	0.0	0.4	0.1	30.9	0.0	0.4	58.2	0.3	0.0	0.6	0.2	8.3	0.0	0.1	0.1	154.2	0.0	56.3	3.5	0.0	4.5	1.4	1.3	1.1	2.9	1.3	2.0	3.4	1.9	2.7	1.8	2.1	1.9	8.2	12.8	2.4	0.0	1.0	9.4	4.6	0.8	5.2	0.0	4.4	1.5	0.9	0.0	3.0	1.8	0.0	0.3	1.8	63.4	0.0	9.5	0.1	3.0	4.4	6.0	0.0	0.0	0.0	9.9	0.9	6.1	8.6	7.3	1.3	0.0	3.6	1.3	7.1	0.0	0.0	8.7	2.0	52.7	10.7	0.4	5.3	36.8	1.8	0.0	19.5	0.0	1.0	0.0	0.0	5.4	48.2	0.0	1.1	19.5	62.5	3.2	3.6	0.0	0.0	0.6	1.8	0.1	0.2	0.9	3.4	0.3	1.1	0.0	1.3	21.3
SEH1L	"SEC13L, Seh1, SEH1A, SEH1B"	ENSG00000085415	"SEH1 like nucleoporin"	Q96EE3	18	12947133-12987536	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039964	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039964: AB_10795241"	"unprognostic (5.14e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.05e-2)"	17.4	12.0	15.8	16.5	17.0	12.8	14.5	14.8	22.9	12.5	12.5	15.0	11.6	13.7	12.2	19.7	12.1	9.8	15.6	19.8	18.3	14.9	22.4	12.3	19.8	12.2	12.1	12.1	15.1	10.7	14.2	12.6	12.7	11.1	13.9	6.5	11.9	9.1	37.3	15.8	12.0	13.4	13.4	13.2	12.0	15.0	16.6	23.8	12.5	26.9	21.5	19.2	13.2	17.8	53.6	40.6	30.9	49.2	21.2	31.5	45.1	45.5	46.3	52.3	59.8	104.7	27.5	114.8	54.0	53.1	46.8	26.6	72.8	52.0	67.5	31.9	46.8	71.6	38.4	62.3	47.7	197.0	45.4	22.5	40.1	60.6	88.8	21.8	27.7	51.6	98.1	41.5	42.9	57.9	106.3	84.4	39.2	215.5	41.9	70.6	71.8	74.6	40.6	53.4	59.8	35.7	58.2	43.7	47.9	22.3	27.3	64.7	22.4	53.5	123.6	81.4	80.7	30.6	48.1	122.1	35.1	70.1	35.0	4.1	23.5	5.6	14.0	31.6	18.5	23.7	16.3	17.0	37.8	23.9	20.9	18.0	2.6	23.6	26.4	20.6	12.2	22.6	15.8	17.0	14.8	22.9	19.8	18.3	12.2	12.1	12.7	13.4	16.6	17.8	13.1	6.4	20.2	8.5	26.5	54.7	47.0	24.6	40.9	8.0	16.3	12.8	14.0	14.3	18.3	12.9	12.5	23.6	16.1	12.9	9.8	15.0	9.2	18.5	19.2	19.3	19.2	26.1	15.3	13.3	31.8	17.9	15.8	27.6	7.6	17.8	13.2	21.6	21.3	3.3	10.1	20.3	14.2	13.2	20.4	11.4	9.3	19.7	16.0	12.2	16.9	5.8	7.2	6.0	13.3	16.0	15.3	10.9	23.9	46.7	11.5	16.5	8.5	10.1	13.1	26.8	22.3	16.9	14.0	41.6	59.8	23.7	16.0	19.6	24.9	43.0
SEL1L	"Hrd3, IBD2, SEL1L1"	ENSG00000071537	"SEL1L adaptor subunit of ERAD E3 ubiquitin ligase"	Q9UBV2	14	81471547-81533853	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 403.4"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 238.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 339.5;U-266/84: 313.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024267	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA024267: AB_1856659"	"unprognostic (4.94e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.86e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.25e-2)"	30.6	19.1	13.9	31.1	17.8	17.7	25.2	17.0	17.0	21.4	11.5	35.7	36.7	24.2	18.1	16.8	17.1	22.0	22.8	14.5	17.4	28.8	66.6	27.6	21.6	18.9	16.7	17.1	403.4	29.9	8.7	38.4	19.3	31.6	31.8	15.7	19.6	22.8	22.2	15.5	32.5	28.1	18.4	30.6	35.0	11.2	17.6	17.8	54.3	21.1	29.3	29.0	12.1	25.9	35.3	69.3	27.4	35.5	60.2	58.6	48.5	54.6	52.3	31.2	33.0	26.6	53.7	36.0	58.8	63.2	38.1	32.8	19.2	30.6	56.1	56.0	13.6	26.3	21.7	33.2	86.0	53.6	60.3	47.8	72.0	31.4	68.0	45.9	51.7	29.5	16.2	195.2	38.6	42.7	30.6	15.1	8.7	58.7	29.6	21.2	38.9	28.4	24.0	54.1	15.5	25.7	42.7	39.4	44.9	23.5	68.5	35.5	86.8	87.7	49.0	49.2	34.1	339.5	313.1	35.4	96.5	24.1	34.4	31.5	19.7	24.8	16.8	25.6	13.7	14.2	12.9	13.4	18.9	13.1	12.0	12.9	45.7	16.7	22.5	13.7	14.0	14.5	13.9	17.8	17.0	17.0	14.5	17.4	18.9	16.7	19.3	18.4	17.6	25.9	51.6	12.8	35.2	27.1	44.8	26.8	19.0	27.1	15.9	23.5	31.5	18.9	67.0	32.9	24.9	27.6	31.3	23.5	44.1	48.8	5.9	24.1	3.5	21.1	48.9	40.0	21.6	15.4	35.9	45.6	21.9	44.7	37.8	28.0	34.2	32.0	38.9	125.7	31.9	30.3	35.2	38.9	50.8	58.1	40.4	5.4	23.6	47.6	53.4	29.0	39.7	18.3	30.9	42.3	70.7	40.1	33.1	28.2	238.9	40.0	34.8	20.2	27.8	18.3	46.0	28.5	51.8	14.0	18.8	16.0	26.1	41.9	32.9	38.9	32.0	33.9
SEL1L2	"C20orf50, DKFZp434C1826"	ENSG00000101251	"SEL1L2 adaptor subunit of ERAD E3 ligase"	Q5TEA6	20	13849247-13996443	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 188.3;Late spermatids: 155.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059121	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA059121: AB_2683911"	"unprognostic (6.70e-2)"	"unprognostic (1.64e-2)"		"unprognostic (2.72e-3)"	"unprognostic (2.19e-1)"				"unprognostic (8.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.12e-2)"	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.3	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	155.8	1.2	0.1	0.0	1.0	0.0	0.0	0.0	3.5	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	24.2	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722640-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 56.1"	"Cell type enriched"	"Detected in some"	4	"Endothelial cells: 379.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002143	Enhanced					NA	NA	8140000	180000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	29.6	5.5	1.2	12.6	0.8	0.5	12.0	0.5	1.7	4.1	4.1	4.2	0.7	5.3	0.5	4.0	23.8	10.7	8.0	0.8	1.6	7.6	6.9	10.3	3.0	1.8	1.2	3.3	1.2	12.5	4.0	1.4	1.7	27.7	2.6	0.3	3.1	3.8	0.8	5.5	2.3	18.7	1.3	0.0	5.2	2.4	2.9	8.4	13.8	1.0	3.6	56.1	5.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.5	1.7	0.8	1.6	1.8	1.2	1.7	1.3	2.9	1.1	34.6	0.0	3.8	0.0	0.0	46.1	1.1	0.0	1.2	0.0	0.5	0.3	4.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.3	379.5	0.0	0.0	0.1	0.0	0.0	12.7	0.0	0.2	1.3	0.0	3.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	81.9	3.0	0.0	0.9	46.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.3	4.1	0.2	0.0	1.2	47.7	0.0	3.4	0.1	0.1	2.5
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364304-151372707	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 509.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		59000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	128.3	18.7	49.8	24.9	53.0	95.9	76.3	45.5	54.8	57.0	47.4	509.3	74.7	31.3	43.4	31.8	132.7	52.2	69.1	47.1	48.2	77.2	261.7	181.0	10.9	47.8	51.0	49.4	29.0	11.9	15.0	20.4	46.5	44.2	471.7	3.9	61.6	48.8	72.9	25.2	94.2	49.5	46.9	51.1	126.4	6.1	51.0	7.1	115.1	138.1	6.8	58.3	29.3	45.7	0.0	17.2	31.9	1.8	144.9	59.1	8.4	5.9	2.6	3.1	6.5	18.1	5.4	0.0	30.7	10.7	0.0	0.4	0.0	0.4	2.8	0.1	14.8	120.5	53.1	28.9	30.5	0.2	0.0	75.9	1.0	5.3	0.1	0.4	19.0	0.0	12.4	0.0	8.0	13.2	0.0	0.0	26.6	92.8	32.2	0.1	1.7	0.7	7.1	0.0	0.4	0.7	0.5	274.4	0.0	25.1	49.4	1.8	1.8	0.0	1.1	16.8	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	49.8	53.0	45.5	54.8	47.1	48.2	47.8	51.0	46.5	46.9	51.0	45.7	36.6	294.9	525.6	38.2	4.0	10.8	27.7	56.4	30.7	0.3	73.0	59.9	135.7	75.8	123.9	5.5	0.0	2.4	1.9	1056.9	115.4	17.1	0.7	30.9	14.9	27.5	155.0	590.9	0.1	9.1	2.1	85.2	163.6	14.1	27.3	10.9	26.0	501.5	15.3	0.0	0.1	137.2	79.3	39.6	12.4	4.2	66.5	3.9	33.8	13.1	0.2	37.4	0.0	0.0	2.0	6.5	451.4	80.9	0.8	25.6	251.0	148.3	101.5	1.4	52.6	15.6	102.3	0.1	0.3	22.7	9.9	4.0	5.7	30.5	452.4	71.0
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	96.0	167.2	38.4	31.6	41.1	39.4	95.6	36.4	70.0	91.4	39.5	82.0	31.7	73.7	11.9	135.0	72.7	20.6	117.5	39.9	43.2	125.6	171.2	85.9	42.5	38.2	38.7	96.4	110.8	9.2	104.6	26.2	39.6	110.6	13.1	5.4	99.4	16.2	117.0	79.6	88.0	15.0	37.5	130.1	91.3	66.8	41.1	14.5	103.2	6.2	27.9	87.0	86.3	39.7	116.5	84.5	79.8	47.6	7.6	29.1	18.8	43.1	30.3	36.4	19.8	26.7	56.2	51.0	120.7	15.4	31.0	50.9	26.6	47.1	8.3	75.7	85.3	67.8	59.0	66.4	63.7	105.1	140.0	38.4	43.3	39.0	19.4	39.9	50.4	68.9	70.2	44.0	23.7	112.6	103.5	181.1	155.6	32.8	89.6	122.5	75.6	106.7	23.6	62.2	46.0	105.1	39.1	35.2	133.6	18.3	102.2	79.7	64.1	41.1	101.2	90.3	64.2	269.8	226.2	41.3	95.3	89.0	106.1	295.2	385.8	204.5	160.2	417.6	151.4	346.4	209.6	171.4	396.4	349.2	282.1	208.8	29.7	187.7	394.2	488.1	175.3	469.5	38.4	41.1	36.4	70.0	39.9	43.2	38.2	38.7	39.6	37.5	41.1	39.7	182.7	166.7	151.8	0.0	61.0	0.0	0.0	0.0	0.0	0.0	273.3	267.0	0.0	0.0	74.3	150.8	0.0	288.7	77.7	0.0	444.1	256.7	0.0	175.5	95.2	90.2	0.0	0.0	0.0	315.1	280.8	68.4	0.0	104.1	133.7	148.5	0.0	0.0	416.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	119.1	0.0	0.0	102.4	0.0	0.0	0.0	0.0	288.7	0.0	0.0	14.8	0.0	0.0	588.6	142.8	0.0	0.0	0.0	74.7	0.0	0.0	0.0	0.0	147.2	49.0	190.5	0.0	0.0
SELENOI	"EPT1, KIAA1724, SELI, SEPI"	ENSG00000138018	"Selenoprotein I"	Q9C0D9	2	26308547-26395891	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Endometrial ciliated cells: 16.3;Glandular and luminal cells: 15.3;Pancreatic endocrine cells: 13.6;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064125	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA064125: "	"unprognostic (6.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.00e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.42e-2)"	3.6	6.4	7.9	5.5	8.4	12.1	8.1	11.2	10.6	5.4	5.0	8.6	12.3	4.1	5.4	11.1	3.5	4.0	3.9	10.3	9.3	7.9	23.2	4.4	5.7	6.8	7.3	3.5	9.0	17.2	4.5	4.7	8.6	6.2	8.7	9.3	6.2	4.2	7.0	18.3	18.4	3.7	9.7	4.3	7.1	4.4	7.2	6.3	7.1	6.6	6.1	7.5	7.1	10.0	42.7	25.7	20.9	21.0	12.8	10.2	32.0	20.3	9.2	10.0	10.2	54.5	26.6	49.5	24.2	9.5	21.4	34.1	32.4	17.9	14.4	13.7	15.4	31.3	17.5	32.3	12.2	41.9	9.7	8.1	15.6	22.3	21.9	6.1	9.4	17.6	35.9	16.6	13.5	18.4	25.1	20.7	26.8	21.6	17.4	22.6	49.2	25.0	19.3	32.4	45.7	19.4	17.3	36.2	16.4	17.3	17.4	12.4	15.1	17.1	22.0	22.7	31.7	22.6	60.8	65.8	17.5	25.4	15.6	0.0	0.7	0.0	0.9	1.0	0.9	2.5	0.9	1.2	0.7	1.0	1.2	2.0	0.2	0.9	0.9	1.3	1.8	0.4	7.9	8.4	11.2	10.6	10.3	9.3	6.8	7.3	8.6	9.7	7.2	10.0	9.1	12.8	8.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	12.2	7.1	0.0	0.0	3.1	22.0	0.0	6.1	11.7	0.0	0.0	10.4	0.0	16.3	12.8	3.7	0.0	0.0	0.0	10.4	6.2	2.9	0.0	15.3	1.3	8.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.6	0.0	0.0	3.9	0.0	0.0	5.6	2.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	16.6	4.7	11.5	0.0	0.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884417-53891962	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 471.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 471.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	39.6	51.9	52.3	27.0	53.0	70.1	35.8	55.2	67.9	29.8	52.3	35.9	23.3	29.1	64.4	27.8	33.9	23.4	90.1	52.0	55.8	42.1	74.2	38.3	23.7	55.0	53.7	48.6	51.7	55.7	62.8	26.5	55.5	34.6	29.3	86.5	29.7	28.5	86.7	24.1	30.4	18.7	55.7	32.3	39.6	32.0	53.3	26.7	43.0	61.2	29.4	35.5	26.1	58.4	22.4	14.9	34.3	23.3	52.1	32.8	36.8	32.0	40.5	43.4	48.9	33.4	33.1	33.8	13.8	23.4	48.7	13.8	40.7	24.5	37.8	59.6	50.3	21.1	61.4	77.6	49.1	28.3	48.6	19.8	40.3	30.1	39.4	25.2	35.3	25.1	20.1	86.3	38.5	24.7	18.5	33.5	33.4	27.5	55.1	11.5	20.9	61.9	51.3	37.1	17.5	49.5	21.9	29.4	32.7	37.5	19.6	44.0	20.6	24.4	28.7	62.2	45.7	62.8	76.3	31.4	36.8	37.3	38.2	471.4	41.7	110.7	69.5	47.2	67.5	60.3	63.0	70.0	36.6	49.0	55.0	63.0	94.1	52.2	56.6	66.3	72.1	82.6	52.3	53.0	55.2	67.9	52.0	55.8	55.0	53.7	55.5	55.7	53.3	58.4	223.1	134.6	103.9	0.0	173.5	0.0	0.0	0.0	0.0	0.0	233.7	237.5	0.0	0.0	53.9	149.0	0.0	162.3	373.5	0.0	189.8	258.5	0.0	150.1	113.5	62.7	0.0	0.0	0.0	199.6	239.6	86.9	0.0	237.9	237.1	59.1	0.0	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	282.5	0.0	0.0	110.6	0.0	0.0	415.0	53.9	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	350.1	155.9	94.7	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 154.8;T-cells: 233.0"	"Cell line enhanced"	"Detected in many"		"BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	241.8	95.4	126.7	55.7	126.7	2.9	239.8	127.3	170.7	458.8	189.9	575.4	37.2	600.2	14.8	86.1	437.8	28.6	227.2	130.0	149.3	162.5	36.7	157.5	25.9	137.1	138.6	262.4	154.3	94.7	241.1	32.2	131.0	339.6	16.4	8.1	198.8	140.1	109.9	114.8	193.9	85.3	139.6	97.6	285.6	42.1	142.1	10.2	225.8	18.6	15.3	462.3	290.7	132.3	12.8	25.7	7.4	42.7	68.8	80.5	82.2	152.2	143.8	69.2	50.0	0.8	2.0	1.6	30.9	89.9	31.2	1.2	6.9	9.2	4.7	7.0	25.6	2.7	7.8	13.3	183.7	0.0	13.1	78.5	27.1	33.1	12.6	33.1	9.0	2.2	2.4	14.7	17.9	6.6	0.5	1.4	9.6	11.8	27.3	0.1	0.1	18.1	11.1	0.1	16.2	35.7	47.3	41.6	0.7	2.5	57.5	0.9	30.9	20.8	59.0	77.8	0.1	13.2	6.5	1.0	83.1	0.2	13.8	18.3	10.5	5.1	105.3	19.9	137.9	154.8	174.5	127.0	6.4	129.5	233.0	137.8	8.2	39.1	40.1	2.5	179.0	102.6	126.7	126.7	127.3	170.7	130.0	149.3	137.1	138.6	131.0	139.6	142.1	132.3	168.6	54.5	126.5	0.0	38.8	0.0	0.0	0.0	0.0	0.0	373.6	436.2	0.0	0.0	32.2	309.0	0.0	11.7	23.2	0.0	309.1	101.2	0.0	22.8	349.5	61.8	0.0	0.0	0.0	586.6	149.5	161.3	0.0	18.1	30.3	30.8	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	42.9	0.0	0.0	0.0	0.0	166.2	0.0	0.0	22.3	0.0	0.0	152.5	20.4	0.0	0.0	0.0	225.6	0.0	0.0	0.0	0.0	23.4	24.8	30.5	0.0	0.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818221	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058076	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA058076: AB_2683598"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favorable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	65.7	48.0	51.6	34.0	51.2	17.0	60.8	45.5	53.3	43.8	74.2	42.5	17.4	48.8	19.5	36.5	40.2	30.1	60.7	49.6	48.5	52.5	20.3	51.8	20.5	72.8	55.2	51.7	60.1	37.0	40.2	38.9	52.1	58.2	20.8	11.7	45.7	39.6	56.3	30.2	31.0	56.2	54.1	43.4	43.4	12.0	62.6	13.6	53.8	39.7	16.3	46.9	35.6	50.2	52.6	49.5	160.9	138.4	102.5	178.8	54.4	62.2	93.4	67.7	53.9	12.9	54.2	0.1	40.4	94.6	74.8	49.9	42.4	66.2	51.1	55.8	32.6	51.4	18.2	16.0	73.8	11.0	116.6	191.7	43.8	71.0	35.5	79.9	214.4	17.4	18.5	7.2	64.7	26.8	2.3	15.7	61.0	40.9	33.7	45.4	70.3	6.4	27.7	14.8	33.5	56.9	39.4	35.3	52.7	43.0	35.6	36.1	180.5	68.4	46.2	126.6	37.1	5.8	0.2	1.4	94.8	15.9	84.4	2.7	1.2	1.6	0.7	1.0	0.4	0.7	0.6	0.5	0.8	0.4	0.9	0.6	0.2	0.3	1.1	0.1	0.7	0.4	51.6	51.2	45.5	53.3	49.6	48.5	72.8	55.2	52.1	54.1	62.6	50.2	99.2	9.6	10.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	23.0	19.3	0.0	0.0	3.7	20.2	0.0	16.4	3.8	0.0	0.0	18.6	0.0	6.5	22.4	21.5	0.0	0.0	0.0	42.3	11.4	12.5	0.0	13.5	2.5	31.2	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.9	0.0	0.0	14.9	3.6	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	13.0	2.2	8.6	0.0	0.0
SELENOO	SELO	ENSG00000073169	"Selenoprotein O"	Q9BVL4	22	50200979-50217616	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071795, HPA079100"	Approved		Supported	"Mitotic chromosome,Mitochondria"	"Intracellular and membrane"	Yes	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Mitotic chromosome"	"HPA071795: , HPA079100: "	"unprognostic (1.79e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (8.32e-4)"	6.7	6.7	2.3	4.5	3.4	13.9	4.8	11.7	6.8	5.6	2.5	5.3	8.0	5.9	2.8	8.2	5.7	4.1	5.3	3.0	1.1	6.6	27.9	4.7	6.4	4.6	2.7	5.0	13.1	3.0	4.1	3.0	3.7	5.6	2.0	2.9	7.7	4.1	12.3	8.2	6.5	2.4	2.3	6.5	7.0	3.7	3.1	4.4	5.1	4.1	3.9	5.1	6.1	6.0	12.0	7.7	4.2	4.7	5.6	4.1	8.6	11.8	5.6	7.0	5.5	10.6	7.5	7.9	9.2	4.7	3.9	26.2	6.5	10.7	1.4	2.3	29.9	5.7	17.4	6.4	2.8	10.6	6.9	5.4	7.2	4.5	3.5	4.5	5.8	5.3	7.8	5.6	2.9	18.6	5.7	16.4	3.7	2.8	15.6	17.6	5.9	11.8	4.3	15.3	8.4	9.3	12.8	11.3	7.5	2.1	8.7	7.5	9.5	6.0	8.3	6.5	7.1	13.8	3.6	4.7	6.8	6.9	3.5	0.0	1.1	1.3	0.2	0.4	0.5	0.0	0.2	0.5	1.1	0.2	0.1	0.4	0.5	0.0	0.4	0.4	0.2	0.3	2.3	3.4	11.7	6.8	3.0	1.1	4.6	2.7	3.7	2.3	3.1	6.0	11.8	0.0	21.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	13.3	13.2	0.0	0.0	5.6	9.2	0.0	3.1	12.2	0.0	15.6	3.6	0.0	11.8	10.9	3.0	0.0	0.0	0.0	4.6	2.4	6.0	0.0	15.2	3.8	34.7	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.5	0.0	0.0	41.7	3.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	1.9	5.5	29.6	0.0	0.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 606.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 606.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	65.6	75.4	30.6	48.4	32.8	50.6	55.0	33.8	39.8	50.1	39.7	82.4	80.0	41.9	75.5	55.6	44.6	45.5	66.3	29.8	32.7	48.7	84.7	59.6	49.2	35.2	33.2	41.6	103.7	51.1	44.5	57.6	35.3	53.6	87.2	28.7	73.8	49.1	71.0	48.4	82.2	42.9	33.7	58.7	67.2	92.7	32.4	24.1	55.8	48.7	53.1	60.7	45.3	36.3	45.3	68.8	61.2	54.5	129.8	91.1	52.4	136.4	100.2	89.8	90.2	82.3	105.0	33.6	49.6	117.5	150.8	125.1	66.6	59.7	58.6	63.5	91.8	57.2	62.5	86.8	206.5	43.5	63.9	80.2	166.3	60.3	177.7	70.7	68.1	44.3	58.3	369.0	97.4	71.7	31.7	67.6	46.8	169.9	45.7	41.6	50.1	74.7	90.7	104.2	34.5	88.5	93.0	85.7	193.8	79.9	64.0	96.2	73.6	84.0	57.1	116.4	103.3	272.5	246.3	49.9	92.2	50.8	104.2	134.4	66.4	81.2	94.1	84.0	91.1	62.2	71.4	101.1	58.6	51.4	53.7	79.6	23.1	95.6	100.1	606.9	71.4	63.7	30.6	32.8	33.8	39.8	29.8	32.7	35.2	33.2	35.3	33.7	32.4	36.3	164.0	118.6	108.6	0.0	47.8	0.0	0.0	0.0	0.0	0.0	172.5	129.4	0.0	0.0	64.4	154.5	0.0	125.9	87.7	0.0	31.3	183.9	0.0	127.0	165.2	53.3	0.0	0.0	0.0	189.3	229.2	91.6	0.0	211.7	30.3	53.5	0.0	0.0	120.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	92.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	101.0	0.0	0.0	73.0	56.9	0.0	0.0	0.0	78.5	0.0	0.0	0.0	0.0	303.7	40.4	100.9	0.0	0.0
SELENOT	SELT	ENSG00000198843	"Selenoprotein T"	P62341	3	150602875-150630445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039780	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA039780: AB_10805594"	"unprognostic (1.13e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.91e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	49.2	73.5	44.0	56.4	47.2	100.0	47.8	49.8	58.9	44.0	44.8	49.1	51.2	39.2	62.7	41.0	49.1	38.9	51.9	46.0	52.2	75.4	72.4	51.0	80.5	46.9	46.9	36.0	45.4	84.2	45.6	60.6	49.9	49.5	56.6	69.7	45.5	48.8	44.9	28.3	50.3	54.1	50.5	46.4	45.1	39.7	47.7	58.3	67.2	54.0	73.2	63.4	32.0	53.9	232.1	94.9	57.1	51.8	86.7	84.0	111.3	174.3	127.3	120.7	79.6	145.9	129.1	125.6	192.2	128.7	107.5	76.1	89.6	110.3	177.7	124.8	77.3	130.9	48.4	68.1	94.6	77.1	102.5	74.1	86.5	107.6	92.1	86.7	132.2	58.2	31.0	359.9	173.4	137.6	107.5	46.1	65.4	134.2	99.0	79.0	73.8	215.4	102.6	132.7	64.2	39.8	106.4	64.4	74.8	71.2	133.6	96.2	125.7	65.1	41.1	121.1	172.6	261.3	151.4	176.1	88.8	142.1	56.9	218.1	163.8	142.5	133.7	138.4	148.5	119.6	111.3	125.4	126.5	102.3	87.4	110.1	198.8	106.3	155.7	90.7	132.3	324.7	44.0	47.2	49.8	58.9	46.0	52.2	46.9	46.9	49.9	50.5	47.7	53.9	80.6	60.9	67.9	0.0	53.4	0.0	0.0	0.0	0.0	0.0	97.2	66.5	0.0	0.0	29.1	108.5	0.0	215.1	114.7	0.0	97.8	166.8	0.0	63.9	46.8	35.5	0.0	0.0	0.0	135.0	230.6	30.9	0.0	64.7	45.4	31.5	0.0	0.0	238.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	0.0	123.5	0.0	0.0	0.0	0.0	206.0	0.0	0.0	21.0	0.0	0.0	176.8	32.8	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	489.3	48.1	63.4	0.0	0.0
SELENOV	SELV	ENSG00000186838	"Selenoprotein V"	P59797	19	39515113-39520686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.9"	"Cell type enhanced"	"Detected in single"		"Breast myoepithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059274	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 44: Endometrium - Transcription"			"HPA059274: AB_2683964"				"unprognostic (1.38e-3)"	"unprognostic (2.70e-2)"				"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"		"unprognostic (8.31e-2)"		"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.43e-4)"		0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	2.3	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.4	0.2	0.3	0.6	0.3	0.4	0.1	0.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 150.4;lymphoid tissue: 231.4"	"Group enriched"	"Detected in many"	5	"B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		4700000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	29.3	2.3	2.8	118.8	4.5	150.4	2.6	8.4	6.2	3.7	2.7	6.8	3.2	2.6	1.7	5.5	4.7	24.1	3.1	3.2	4.0	3.0	12.1	19.4	231.4	7.4	4.5	1.0	3.7	28.0	13.9	11.2	6.1	3.7	7.1	1.0	3.8	1.9	3.4	0.6	17.0	14.5	6.4	166.8	5.6	1.1	3.9	132.2	2.8	13.6	202.0	37.9	1.4	8.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.7	0.0	0.3	11.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	7.7	1.3	0.5	0.0	0.0	0.0	0.0	1.8	29.4	0.1	1.4	0.0	1.8	21.2	0.3	0.1	0.4	0.3	7.8	0.2	0.7	6.1	0.3	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.0	0.0	0.6	0.2	0.0	0.0	38.8	0.0	19.4	2.0	11.1	0.3	3688.4	992.6	1696.7	284.3	211.6	78.1	613.0	528.9	294.2	756.3	734.4	1169.2	683.6	4201.4	2551.1	93.1	622.9	1011.2	2052.5	2.8	4.5	8.4	6.2	3.2	4.0	7.4	4.5	6.1	6.4	3.9	8.0	1.8	9.6	13.7	0.7	221.4	0.4	0.3	0.0	0.6	0.1	0.5	0.3	0.6	2.8	1.8	11.0	0.0	13.9	206.0	0.1	0.0	0.2	0.0	0.1	0.0	3.4	0.0	25.2	0.2	0.0	0.6	3.3	2.6	0.1	10.1	0.5	3.9	1.1	5.6	0.0	0.1	0.1	0.0	68.9	2.7	0.2	0.6	86.3	1.8	1.0	208.7	2.5	110.2	0.0	0.8	0.1	0.0	0.0	25.8	0.0	0.0	0.9	1.5	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.1	28.5	104.9	0.5	0.0	0.6
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.7;Endothelial cells: 51.8;Hepatic stellate cells: 33.9;Macrophages: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 8.3;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.3;T-cells: 8.8"	"Group enriched"	"Detected in some"	38	"EFO-21: 36.0;HEL: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced					NA	NA		520000000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	11.3	2.3	0.2	11.9	0.6	2.2	10.6	0.0	0.6	8.9	3.7	3.3	5.1	6.4	4.1	5.1	6.7	9.5	6.7	0.3	0.0	5.6	2.5	12.6	7.0	0.2	0.2	1.8	1.2	3.1	2.2	6.3	0.2	6.1	4.1	0.0	2.7	5.7	1.0	3.6	4.8	14.2	0.1	1.0	2.8	0.7	0.7	2.6	4.0	1.8	12.6	14.4	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.4	0.6	0.0	0.2	0.0	1.1	0.5	0.2	0.0	0.1	0.2	0.1	2.1	0.3	0.0	0.1	8.8	7.8	0.2	0.6	0.0	0.6	0.3	0.0	0.2	0.2	0.2	0.1	0.7	0.2	14.7	0.0	3.6	0.3	0.4	3.7	0.1	0.0	0.6	0.0	0.2	0.1	1.9	1.5	0.0	1.8	0.0	2.6	0.1	0.0	0.0	0.0	2.0	0.1	0.1	51.8	0.0	5.2	0.5	0.2	0.0	1.5	0.0	0.0	0.0	0.0	33.9	0.4	0.2	0.0	0.2	0.0	0.0	1.5	3.6	0.1	0.3	10.1	3.6	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	3.4	4.1	0.5	0.0	0.0	0.3
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles		NA	NA		2700000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	17.5	9.1	12.1	47.4	10.5	21.1	6.9	11.7	12.1	9.2	8.2	9.6	8.6	3.7	2.1	8.6	7.8	17.0	5.0	12.0	14.1	4.0	6.5	40.8	62.2	17.8	13.5	2.8	3.4	4.4	3.0	13.0	16.4	3.3	8.4	0.7	7.0	3.9	2.2	4.7	15.5	11.5	17.0	86.6	11.3	2.2	17.2	52.1	3.4	7.3	30.6	21.5	3.3	24.5	0.5	0.4	1.4	0.8	0.7	1.5	0.8	4.9	4.8	1.8	1.4	0.3	1.9	0.5	1.7	7.4	2.0	0.3	0.1	0.1	1.3	136.2	0.0	45.7	0.2	0.2	0.4	35.1	130.0	1.8	0.5	2.5	0.6	5.0	0.4	102.2	0.8	195.1	6.0	0.0	28.3	18.9	0.2	0.1	1.6	0.3	0.5	286.7	2.9	0.0	0.3	0.0	0.6	0.2	2.2	3.3	0.1	42.6	1.7	2.6	0.8	3.5	1.4	326.8	214.5	6.4	1.5	74.2	1.9	1543.6	297.6	940.2	419.2	509.2	344.3	22.0	396.6	362.9	299.9	22.3	300.3	323.7	1257.2	309.2	762.7	518.3	662.2	1035.5	12.1	10.5	11.7	12.1	12.0	14.1	17.8	13.5	16.4	17.0	17.2	24.5	1.2	3.2	12.4	0.0	11.6	3.4	0.1	0.2	0.0	0.2	0.6	1.4	2.2	4.3	2.7	0.0	0.0	0.5	159.7	0.2	0.0	0.3	8.2	1.8	0.6	2.6	0.0	10.9	0.2	0.2	2.3	2.4	2.6	0.9	29.7	0.4	3.6	2.2	40.1	0.0	0.3	0.0	0.0	84.9	49.6	12.2	0.3	64.8	7.2	15.9	123.8	0.0	154.5	0.0	0.1	0.5	0.0	0.0	65.1	0.1	0.0	0.5	6.4	0.2	0.0	1.2	0.9	0.8	0.5	0.5	1.8	1.0	65.9	0.1	0.0	0.0
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 636.7;Endometrial ciliated cells: 571.3;Exocrine glandular cells: 537.4;Extravillous trophoblasts: 712.8;Pancreatic endocrine cells: 543.9;Proximal tubular cells: 533.4;Syncytiotrophoblasts: 872.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	137.1	178.9	100.5	118.2	101.2	77.8	124.2	101.7	161.4	135.9	100.3	146.0	121.8	132.5	118.5	193.9	114.9	34.8	193.2	98.4	108.9	130.0	262.8	102.7	87.9	102.6	107.5	167.3	103.7	105.5	122.2	106.7	103.0	118.2	77.8	85.0	131.4	69.0	360.5	144.8	116.1	64.2	98.6	96.9	126.7	183.7	101.2	136.8	106.6	150.2	84.7	113.4	144.8	104.0	570.7	327.0	448.1	468.1	187.4	162.3	241.7	453.4	220.0	186.9	232.5	298.3	459.4	373.6	1096.4	222.8	575.9	288.2	379.5	306.5	263.6	437.4	285.9	448.3	505.7	472.5	171.2	670.0	321.4	208.4	233.7	279.8	283.7	291.4	253.8	438.4	592.4	444.7	193.0	716.9	760.9	942.6	607.0	572.4	297.3	291.6	576.4	441.1	273.2	555.6	367.8	463.6	845.0	701.6	497.9	681.4	200.6	502.2	525.6	365.3	641.2	683.1	575.0	278.3	818.9	1080.9	399.4	574.3	515.8	292.6	385.3	109.0	279.9	443.1	268.4	336.4	363.1	332.7	570.6	312.5	282.4	284.0	27.0	300.4	392.8	622.8	546.6	375.7	100.5	101.2	101.7	161.4	98.4	108.9	102.6	107.5	103.0	98.6	101.2	104.0	288.2	173.1	224.5	0.0	47.2	0.0	0.0	0.0	0.0	0.0	212.6	325.2	0.0	0.0	103.4	244.6	0.0	636.7	93.1	0.0	412.8	382.5	0.0	571.3	314.1	127.6	0.0	0.0	0.0	537.4	712.8	129.5	0.0	450.0	102.2	258.9	0.0	0.0	393.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.0	0.0	0.0	241.3	0.0	0.0	0.0	0.0	543.9	0.0	0.0	19.6	0.0	0.0	533.4	149.4	0.0	0.0	0.0	140.3	0.0	0.0	0.0	0.0	872.3	65.9	187.2	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.4;Cone photoreceptor cells: 45.9;Excitatory neurons: 89.7;Rod photoreceptor cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 129.3;BJ: 102.9;fHDF/TERT166: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	6.8	0.2	3.8	3.8	5.8	0.1	1.5	0.6	3.0	4.4	0.0	9.8	1.4	1.0	2.2	5.8	1.6	5.6	2.5	2.0	0.7	0.4	0.4	2.3	3.3	3.8	0.2	0.4	0.4	0.5	2.1	10.4	4.6	2.9	5.7	22.6	0.4	0.4	0.1	1.1	2.4	4.7	0.6	3.8	2.0	1.2	0.3	0.5	1.7	0.5	1.6	5.4	0.6	4.4	11.8	32.8	129.3	0.1	3.8	3.1	8.4	102.9	60.0	8.5	5.3	11.4	30.7	0.0	4.8	112.0	1.1	57.0	0.3	24.6	11.8	0.0	4.2	0.0	6.0	0.0	3.3	2.6	0.0	3.9	0.0	18.1	4.4	26.2	32.1	0.1	0.1	0.2	3.4	0.6	0.0	0.0	48.6	0.5	11.6	2.3	55.3	3.4	18.5	0.8	9.8	5.2	0.8	0.2	1.1	20.7	0.6	1.1	18.3	11.2	11.6	32.6	15.1	7.6	5.5	0.0	11.5	4.5	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.8	5.8	0.6	3.0	2.0	0.7	3.8	0.2	4.6	0.6	0.3	4.4	1.0	3.2	1.7	58.4	0.0	0.9	0.0	15.4	0.0	15.1	0.2	0.3	6.0	0.0	22.4	0.0	45.9	0.4	0.3	0.1	0.0	0.1	0.2	2.0	0.7	7.3	0.0	0.0	89.7	2.0	0.2	9.3	0.0	9.0	1.3	3.5	1.8	0.1	1.0	3.3	10.0	0.0	2.0	0.3	2.7	0.2	2.5	0.5	1.8	7.5	0.0	19.6	0.0	9.5	5.8	5.5	0.0	0.0	0.0	0.3	0.0	0.0	15.6	66.3	0.0	1.5	2.1	1.7	1.9	0.4	1.3	0.3	1.1	18.6	0.0	0.2
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 174.5;brain: 184.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Distal enterocytes: 129.1;Gastric mucus-secreting cells: 208.0;Oligodendrocytes: 157.8;Proximal enterocytes: 336.4;Syncytiotrophoblasts: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 73.7;Hep G2: 105.7;SK-BR-3: 54.5;WM-115: 173.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 27.9"	HPA030651	Uncertain				"Secreted in other tissues"	NA	NA		790000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"			"HPA030651: AB_10602224"	"prognostic favorable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	33.6	174.5	50.2	9.0	124.4	0.2	17.3	87.7	78.2	46.2	35.2	53.6	41.3	45.7	2.2	9.1	37.0	10.0	40.3	53.1	66.4	70.9	6.1	49.2	0.3	125.7	101.9	24.5	41.4	10.6	10.4	35.3	98.6	34.0	10.5	2.0	12.7	20.6	7.4	7.9	62.8	14.2	76.2	5.1	56.8	14.8	110.4	0.6	24.2	8.7	0.3	19.6	32.3	184.2	12.7	8.2	0.8	8.0	0.6	1.0	2.0	16.3	22.3	4.7	7.9	5.5	29.7	0.0	14.3	15.3	0.0	1.8	0.4	26.2	1.8	0.2	0.7	0.0	73.7	105.7	16.8	0.0	0.8	5.1	0.5	5.4	4.1	19.9	0.0	0.1	0.2	2.2	0.8	22.4	0.0	0.7	1.1	23.4	4.5	0.3	1.2	0.6	7.4	1.4	1.0	3.8	4.2	54.5	9.2	2.4	3.6	0.1	0.5	1.3	15.4	4.3	5.3	4.4	0.2	0.2	7.9	0.2	173.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	124.4	87.7	78.2	53.1	66.4	125.7	101.9	98.6	76.2	110.4	184.2	6.5	163.5	18.6	45.1	1.8	0.0	8.3	0.0	6.2	3.7	19.3	8.5	14.5	44.3	18.6	64.4	0.0	3.6	1.2	129.1	1.9	38.3	11.2	29.8	11.6	6.1	10.3	0.0	0.6	23.1	1.0	35.3	208.0	73.1	11.4	11.4	5.7	1.2	1.9	0.0	0.8	45.7	0.0	1.6	0.0	21.4	4.1	2.8	0.0	12.2	0.7	17.3	0.0	3.0	157.8	32.5	79.9	3.0	0.6	14.1	336.4	40.4	5.1	1.6	6.6	19.0	7.5	6.6	11.4	2.0	0.0	111.6	2.4	0.2	31.5	32.7
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 47.8;thyroid gland: 45.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 157.4;Leydig cells: 52.5;Peritubular cells: 62.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 28.4;HaCaT: 28.7;TIME: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		120000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	3.2	2.9	5.9	1.0	1.9	0.0	5.9	0.8	4.6	5.6	0.0	2.8	1.8	2.4	2.6	1.7	5.1	1.7	2.2	6.2	4.7	3.8	1.0	3.6	3.3	2.3	8.9	1.9	0.7	0.2	0.5	0.7	2.2	8.3	3.4	2.2	4.3	1.9	0.0	2.4	3.3	1.4	3.0	47.8	3.3	3.8	3.2	0.3	45.4	0.9	1.4	3.1	0.7	3.2	0.0	0.0	12.1	0.0	0.0	0.0	0.5	7.6	8.2	8.8	4.2	0.0	0.0	0.0	2.2	28.4	0.2	28.7	3.1	0.0	5.8	0.0	5.8	0.0	3.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	7.2	10.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	7.5	2.1	8.9	6.8	2.8	0.0	0.1	1.1	0.0	0.0	0.4	13.8	0.4	0.0	44.2	0.0	2.7	0.4	0.0	5.4	3.4	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	0.8	4.6	6.2	4.7	2.3	8.9	2.2	3.0	3.2	3.2	2.8	0.0	3.3	18.3	1.8	3.6	2.4	0.1	0.0	2.6	0.8	8.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	157.4	1.6	0.3	14.8	26.5	0.0	12.3	0.2	0.0	15.3	0.0	4.3	2.5	0.2	2.9	0.0	1.3	1.7	5.1	0.7	2.0	0.0	5.7	23.3	52.5	0.5	12.4	19.7	0.0	1.9	0.0	3.0	0.9	0.0	0.0	62.4	0.0	5.8	1.9	4.7	0.8	4.1	0.0	0.7	2.0	0.7	0.8	0.1	2.4	0.0	0.5	11.2	1.0	0.4
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649139	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	1.2	0.1	3.1	0.2	2.8	0.0	2.8	0.6	2.3	1.8	0.1	2.1	0.6	1.9	0.3	1.2	0.6	2.3	0.1	5.0	5.3	0.1	0.1	2.2	0.0	1.6	4.3	0.1	0.4	0.0	0.2	0.2	1.3	4.3	1.7	3.9	2.2	3.3	0.2	0.5	1.2	1.1	3.2	0.0	1.3	0.0	4.3	1.7	0.6	1.0	0.1	3.2	0.7	3.7	0.2	1.1	0.2	0.0	0.5	3.1	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	3.4	0.0	1.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.4	1.1	0.0	2.0	0.0	0.0	0.8	0.1	0.0	0.0	19.9	0.0	3.2	1.6	0.0	0.0	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.6	2.3	5.0	5.3	1.6	4.3	1.3	3.2	4.3	3.7	10.5	176.3	110.2	2.9	0.2	1.1	1.3	1.6	0.0	75.7	19.0	7.5	1.7	18.6	43.2	1.8	0.0	0.8	0.2	0.1	0.0	3.9	1.1	3.8	1.2	10.7	0.0	0.0	84.9	1.1	0.4	21.3	3.1	9.3	24.0	0.2	0.0	0.3	0.1	0.0	12.3	0.0	4.1	1.0	2.1	0.0	0.9	3.6	1.8	1.0	1.0	29.6	0.0	250.3	6.0	6.2	0.0	0.0	0.3	2.6	0.1	0.5	35.7	3.6	0.0	0.8	1.0	0.3	0.6	0.3	0.4	0.3	2.8	0.0	0.0	2.5
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	7900000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	33.8	9.0	8.8	8.6	5.7	2.7	31.9	5.1	8.1	28.3	12.0	10.5	13.4	14.5	5.4	100.8	15.6	10.8	22.6	5.0	9.2	49.2	4.8	46.2	3.7	10.2	12.7	3.6	6.7	5.5	11.1	30.4	8.7	32.7	6.3	22.0	24.6	32.5	10.4	75.1	12.5	9.1	6.3	50.7	17.3	2.4	21.8	6.1	27.1	6.1	12.6	27.0	55.4	4.7	13.9	3.1	0.7	14.2	0.2	1.3	3.0	8.0	24.2	6.5	10.2	5.4	6.1	0.5	77.9	1.1	0.7	47.5	6.9	100.7	2.4	0.1	1.8	0.8	108.1	18.5	5.7	1.7	3.2	6.2	55.3	15.1	45.4	90.7	187.0	1.2	2.9	0.1	1.3	12.4	1.5	7.5	8.6	6.2	10.1	11.8	0.0	0.5	7.2	112.3	1.1	2.6	12.8	170.2	0.3	10.4	67.2	7.3	338.6	4.2	31.9	29.7	5.5	0.2	0.0	0.9	0.3	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	5.7	5.1	8.1	5.0	9.2	10.2	12.7	8.7	6.3	21.8	4.7	40.2	0.0	1.1	0.0	0.2	6.8	3.0	9.2	5.7	23.4	10.7	6.0	9.2	1.5	6.6	18.4	10.4	11.2	0.6	5.5	0.0	0.3	0.0	6.5	2.4	24.4	0.0	0.0	0.7	0.8	0.5	1.1	16.3	6.9	0.0	0.2	25.4	0.6	1.4	6.7	1.1	10.7	0.0	0.3	0.8	0.3	0.3	0.2	0.0	3.7	0.0	8.7	0.0	0.0	0.1	6.8	3.8	0.0	0.0	2.5	5.7	0.7	5.4	19.8	0.0	0.5	2.5	0.0	0.4	17.7	8.9	6.3	0.4	0.2	5.2	8.6
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433035-52445103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 80.1;breast: 64.2"	"Cell type enriched"	"Detected in many"	6	"Adipocytes: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 26.1;Hep G2: 7.1;HUVEC TERT2: 7.4;THP-1: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	NA	NA		5600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	80.1	1.9	9.9	3.4	9.4	0.1	64.2	18.9	11.4	5.1	6.2	6.8	3.0	5.9	1.3	4.5	5.2	5.9	18.6	8.4	9.0	19.8	1.3	23.9	1.6	10.8	10.0	3.2	3.1	1.8	2.4	26.7	11.3	4.6	3.7	0.4	10.6	2.5	12.8	12.7	9.6	3.9	9.9	8.0	5.7	1.3	12.1	1.7	7.7	18.6	1.8	8.3	7.8	9.1	0.0	0.1	0.1	0.2	26.1	0.2	2.5	0.0	0.0	0.0	0.0	0.7	0.3	3.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.9	0.2	7.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	7.4	2.6	0.0	0.4	0.0	0.3	0.2	4.3	1.2	0.7	0.1	0.0	0.0	4.1	0.0	0.3	0.5	0.5	0.0	0.4	0.5	0.1	1.9	6.5	2.9	0.1	2.4	0.0	0.0	0.5	2.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	9.9	9.4	18.9	11.4	8.4	9.0	10.8	10.0	11.3	9.9	12.1	9.1	151.5	3.2	1.3	0.0	0.3	0.4	0.1	0.1	0.0	1.7	5.1	5.5	10.7	0.0	0.0	3.7	0.0	1.7	0.9	0.3	0.0	0.0	3.0	2.8	1.6	20.4	9.6	0.0	0.0	0.0	0.2	3.6	1.1	5.8	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	5.0	0.3	0.5	0.0	24.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	9.4	0.0	0.1	0.2	0.0	4.1	3.0	0.1	0.1	0.5	0.1	7.5	0.4	0.1	0.2	0.0
SEMA4A	"CORD10, FLJ12287, SEMAB, SemB"	ENSG00000196189	"Semaphorin 4A"	Q9H3S1	1	156147366-156177752	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis"	"Developmental protein"	"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 51.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 63.7;Plasma cells: 61.2;Skeletal myocytes: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 123.9;eosinophil: 120.2;intermediate monocyte: 132.7;myeloid DC: 183.0;neutrophil: 210.7;non-classical monocyte: 76.1"	"Group enriched"	"Detected in all"	13	"dendritic cells: 183.0;granulocytes: 210.7;monocytes: 132.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 151.8;U-698: 67.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069136	Supported					NA	NA		3300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA069136: AB_2686093"	"unprognostic (1.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (8.77e-2)"	"unprognostic (4.63e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.28e-2)"	6.1	1.0	22.7	24.8	21.5	37.5	9.1	6.1	23.2	10.8	4.7	6.9	3.6	3.0	51.3	32.5	7.9	8.8	3.0	25.3	23.0	18.1	2.1	15.2	31.5	12.2	15.5	5.2	4.0	1.5	3.6	1.8	15.3	16.3	6.1	2.0	19.2	12.5	3.1	32.3	4.8	3.6	11.4	26.9	10.6	4.1	29.0	8.1	23.1	2.2	33.1	10.8	17.4	13.1	12.6	0.0	0.5	0.0	0.0	0.9	0.3	0.2	0.4	0.1	0.2	0.1	0.3	8.1	0.3	0.6	0.1	11.7	0.9	10.0	0.4	3.5	0.0	0.4	0.2	0.4	0.4	18.5	1.1	0.6	9.2	0.2	0.4	2.3	0.9	2.8	1.3	151.8	0.5	15.2	0.1	6.5	3.6	12.4	0.0	0.6	0.3	5.4	17.9	24.1	0.1	0.3	0.0	19.2	1.0	1.7	22.3	23.3	0.9	0.0	0.1	0.0	0.0	29.3	3.0	67.6	0.5	17.5	0.4	16.0	123.9	120.2	4.0	132.7	8.5	13.2	1.3	8.0	183.0	10.9	0.2	1.3	210.7	4.3	76.1	25.7	1.4	66.4	22.7	21.5	6.1	23.2	25.3	23.0	12.2	15.5	15.3	11.4	29.0	13.1	13.6	19.2	63.7	25.8	13.9	23.5	22.5	25.8	24.5	1.9	28.3	27.6	5.9	14.3	13.8	40.5	0.0	0.9	9.8	6.5	1.9	6.1	6.4	12.9	21.6	9.5	3.6	1.3	7.5	0.7	0.4	20.9	22.4	33.5	17.7	0.6	9.3	0.6	15.4	0.0	5.2	24.1	8.2	22.8	42.1	4.3	1.8	37.8	16.0	1.0	32.6	6.3	2.1	1.0	1.0	1.1	7.2	1.2	61.2	14.2	0.8	0.7	9.6	0.4	0.0	100.1	11.3	3.1	0.7	39.0	27.6	1.8	10.0	1.4	17.6	15.6
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"	Q9NPR2	15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA		61000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	11.9	37.6	20.3	18.0	21.9	9.8	22.5	18.8	21.6	35.1	12.8	50.2	30.2	17.1	8.2	124.4	22.6	17.1	24.9	17.3	21.0	47.7	43.2	20.5	12.0	23.5	24.0	21.6	38.5	18.1	18.6	18.3	21.4	31.4	12.1	27.1	41.2	17.6	7.8	50.9	34.7	13.3	21.0	30.3	32.2	10.7	22.9	13.2	34.2	7.9	13.0	42.2	59.8	26.8	21.2	56.3	4.2	13.2	3.8	2.6	30.4	6.4	13.9	7.8	8.3	7.0	182.4	14.9	69.2	4.7	45.0	97.8	3.7	91.2	6.4	85.4	11.7	19.7	13.5	9.4	15.1	2.6	8.7	10.8	39.1	8.5	17.5	32.5	8.8	4.4	9.6	23.0	4.3	15.6	5.4	8.4	18.7	46.8	51.1	6.4	3.1	33.1	111.1	124.0	13.3	13.5	22.3	35.4	8.5	9.3	24.7	6.0	20.0	6.3	11.4	13.1	14.5	33.0	43.2	7.5	58.8	16.1	6.3	0.0	2.4	0.3	0.9	1.4	0.6	16.9	0.5	0.5	1.2	14.9	0.5	0.6	5.1	0.4	2.8	0.2	0.2	1.5	20.3	21.9	18.8	21.6	17.3	21.0	23.5	24.0	21.4	21.0	22.9	26.8	1.8	16.0	22.5	67.3	29.2	65.0	40.0	51.4	23.9	5.7	29.1	18.9	7.8	8.6	44.6	16.5	25.0	13.9	2.4	47.8	3.9	27.3	0.9	15.6	19.6	4.4	4.2	4.0	23.5	35.5	74.5	6.4	34.1	28.3	0.0	8.6	4.6	16.8	13.3	16.8	28.2	17.5	18.3	6.9	7.5	1.2	13.1	5.5	5.4	2.8	5.3	25.1	1.0	8.0	8.3	44.7	26.1	12.0	8.0	46.9	19.6	4.5	22.6	48.3	19.7	5.7	15.3	0.7	3.2	65.3	57.1	12.4	4.3	5.2	20.2	52.0
SEMA4C	"Semacl1, Semaf, SEMAI"	ENSG00000168758	"Semaphorin 4C"	Q9C0C4	2	96859718-96870757	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 137.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"BEWO: 298.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011090	Approved					NA	NA		700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA011090: AB_2185705"	"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (7.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (9.50e-7)"	"unprognostic (4.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.08e-1)"	21.3	8.9	11.5	11.3	24.2	3.0	17.7	16.8	19.9	29.0	0.5	42.1	7.4	37.2	6.0	14.0	33.3	15.3	20.2	11.8	15.6	14.9	13.3	14.4	9.8	24.9	21.1	23.1	9.4	7.1	10.2	41.8	21.0	20.8	5.7	7.0	16.5	20.6	7.5	15.9	14.6	19.3	18.7	28.5	15.1	2.7	19.0	6.5	12.3	13.4	5.3	32.3	22.3	39.1	8.0	11.7	35.6	39.7	8.4	10.5	298.5	13.9	17.4	13.4	13.5	11.8	13.3	0.0	22.3	8.5	13.3	8.1	10.2	6.9	6.5	15.2	11.8	5.4	10.5	22.2	19.2	2.2	13.7	16.1	5.4	12.3	10.4	14.9	9.9	2.6	36.5	11.6	12.7	41.0	0.1	17.4	49.1	0.4	10.6	12.5	20.0	13.8	4.8	17.1	22.4	32.4	11.2	24.6	60.8	27.6	8.7	21.4	3.1	21.9	27.3	30.9	14.6	0.2	1.0	0.1	10.6	17.2	37.1	0.5	0.0	0.0	0.6	0.2	0.8	0.0	0.2	0.4	0.0	0.0	0.4	0.1	0.0	1.4	1.5	0.8	0.3	0.4	11.5	24.2	16.8	19.9	11.8	15.6	24.9	21.1	21.0	18.7	19.0	39.1	28.1	0.0	10.3	15.3	1.1	11.5	7.9	7.6	18.2	32.2	9.9	8.3	6.9	12.8	8.6	5.5	10.4	46.8	9.7	1.8	1.9	9.7	0.5	7.4	15.8	26.6	5.4	2.1	7.2	5.0	137.3	17.3	3.1	11.6	1.3	10.2	23.9	9.8	7.9	15.2	4.1	5.7	6.1	4.4	6.1	1.5	13.4	9.2	21.4	18.7	3.2	23.6	12.3	4.5	35.5	10.5	1.2	9.1	3.6	9.4	0.1	0.8	7.4	38.8	19.7	11.4	24.1	0.6	4.2	13.0	10.2	45.0	9.5	4.9	3.9	4.8
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 260.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.5;NK-cells: 92.7;Oligodendrocytes: 310.5;T-cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 133.2;HMC-1: 97.2;JURKAT: 89.1;MOLT-4: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved					NA	NA		7500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (4.06e-5)"	7.2	12.8	73.5	35.1	149.7	28.7	6.1	129.0	122.7	9.1	34.2	10.4	10.6	6.5	12.2	27.3	11.0	12.3	12.1	72.0	88.4	32.0	4.1	14.2	62.4	165.2	145.6	6.5	8.0	6.0	13.8	5.5	147.8	11.9	9.7	5.0	12.0	6.6	88.0	17.4	28.9	5.5	119.1	51.3	16.7	10.6	127.0	43.4	11.8	27.5	49.8	11.4	16.2	260.2	12.7	9.2	8.4	12.4	0.4	0.8	19.0	1.1	0.5	2.6	1.7	6.1	13.8	47.3	5.1	0.2	9.7	6.4	7.5	3.6	1.1	133.2	7.5	20.1	3.3	0.7	1.5	26.4	97.2	0.3	2.8	0.6	0.3	0.3	4.9	89.1	4.8	31.5	0.0	20.9	120.9	33.9	20.6	25.0	0.5	38.2	2.8	13.4	16.5	13.0	19.7	13.1	3.4	8.9	0.3	11.7	10.1	14.4	3.2	0.1	7.6	1.0	6.1	34.9	16.3	6.6	6.0	32.1	7.6	17.2	7.5	38.2	22.0	7.0	13.3	4.3	17.5	18.6	2.6	2.5	19.9	23.2	37.0	9.4	8.1	8.0	17.7	14.5	73.5	149.7	129.0	122.7	72.0	88.4	165.2	145.6	147.8	119.1	127.0	260.2	3.4	6.4	15.7	33.6	35.4	4.6	3.3	2.1	3.4	12.4	9.5	5.5	18.7	5.7	6.9	11.0	2.1	9.0	76.5	1.5	3.9	5.4	2.2	10.9	6.4	5.2	1.8	23.1	44.5	3.3	2.1	6.7	7.7	15.4	42.5	8.0	5.3	1.6	21.6	33.7	17.2	6.3	4.1	28.2	6.1	3.8	7.5	37.4	1.8	49.6	43.7	8.9	92.7	12.1	310.5	3.7	0.7	15.1	53.7	6.5	0.5	14.2	5.7	5.1	0.0	11.4	2.6	0.9	26.1	7.1	5.4	3.7	89.7	2.3	3.3	7.7
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5;Inhibitory neurons: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: AB_2732710, HPA065969: AB_2685590"	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (5.94e-5)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (4.69e-2)"	3.2	2.3	5.4	0.9	7.0	0.4	3.2	3.2	8.2	4.1	0.1	2.5	0.5	3.6	1.7	1.3	3.3	0.8	2.7	8.0	6.3	3.5	1.0	2.5	1.5	4.2	2.1	5.3	2.6	3.0	7.2	0.9	3.9	3.1	1.0	4.7	2.7	1.4	1.4	1.9	2.1	1.6	1.5	2.6	2.2	4.1	8.1	1.2	3.1	1.3	1.4	2.6	3.2	3.8	6.1	3.4	3.7	5.5	5.8	3.3	2.6	3.9	8.9	7.4	6.5	1.4	3.3	2.3	5.0	6.2	14.4	1.9	6.7	5.7	7.5	5.3	7.0	4.4	1.4	3.8	2.3	1.0	5.4	2.6	6.0	4.9	2.4	14.1	2.9	4.4	0.2	0.2	4.8	2.1	3.3	0.8	2.6	2.7	4.0	0.0	5.4	0.0	6.0	2.6	2.9	5.8	7.0	1.8	6.5	5.0	2.6	0.7	4.9	11.5	5.8	2.9	7.1	5.2	5.6	0.3	13.4	0.3	5.6	0.3	0.1	0.7	1.9	0.0	1.2	1.1	1.1	1.7	0.0	0.8	1.1	1.3	0.3	1.0	0.2	0.0	0.9	0.8	5.4	7.0	3.2	8.2	8.0	6.3	4.2	2.1	3.9	1.5	8.1	3.8	2.2	0.0	6.5	4.9	2.7	0.4	1.8	1.8	2.2	8.8	1.8	2.5	2.4	5.7	4.8	5.5	12.5	0.8	1.4	0.7	1.9	2.1	3.2	0.6	0.6	2.2	7.2	0.8	44.5	1.6	2.4	3.3	1.5	1.0	2.5	3.0	3.3	0.6	0.8	11.8	22.7	0.6	2.0	0.0	0.7	3.7	0.9	0.7	0.0	4.7	1.5	3.3	4.1	4.5	5.8	2.7	1.4	1.5	0.7	1.3	0.4	0.3	1.3	6.7	6.6	3.1	1.4	5.6	11.2	0.5	0.4	0.4	3.5	0.5	1.0	1.6
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 84.6;liver: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	2.4	12.7	13.1	5.9	10.9	0.4	3.6	18.9	12.3	6.9	12.8	53.6	53.4	3.5	32.1	3.6	5.9	9.0	3.0	10.0	11.6	19.1	102.4	5.8	2.5	11.2	14.4	18.9	31.3	7.3	9.9	3.9	11.5	20.2	84.6	7.3	8.5	3.0	2.6	18.3	41.2	4.6	9.6	3.1	20.9	3.7	17.0	0.8	15.3	0.8	0.9	4.0	5.0	9.9	0.2	31.7	8.0	3.4	5.0	1.6	6.8	1.2	3.4	1.7	1.7	30.5	5.2	0.5	4.2	1.5	0.6	2.1	8.0	1.4	1.4	0.7	4.9	1.7	3.0	113.8	12.5	1.2	1.0	8.3	1.8	1.6	0.9	22.2	4.4	3.5	3.3	0.4	2.5	2.0	0.5	1.2	1.3	69.1	1.8	3.1	0.7	1.5	7.4	1.0	2.5	12.5	1.1	2.1	3.2	8.7	8.7	1.5	3.0	1.0	3.7	0.8	0.3	1.1	0.6	0.5	0.9	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	10.9	18.9	12.3	10.0	11.6	11.2	14.4	11.5	9.6	17.0	9.9	0.3	3.2	1.1	3.9	1.2	0.0	0.6	0.7	0.6	3.5	2.5	2.0	1.2	20.0	0.2	0.0	0.0	8.8	0.0	66.4	0.0	2.7	0.2	1.6	0.7	0.6	8.5	0.8	3.0	2.6	1.9	2.0	27.0	0.3	0.0	3.4	2.2	60.5	0.9	11.8	14.1	34.6	2.0	3.3	0.0	0.2	2.1	0.2	1.8	0.0	0.0	0.9	0.0	3.5	5.5	2.4	38.5	1.2	0.2	3.0	47.6	6.4	2.4	1.6	0.0	0.1	0.4	1.1	1.9	0.5	0.1	2.9	0.2	12.7	45.9	0.9
SEMA5A	"SEMAF, semF"	ENSG00000112902	"Semaphorin 5A"	Q13591	5	9035033-9546075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 1189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004632	Approved					NA	NA		13000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA004632: AB_1079905"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.15e-2)"	"prognostic favorable (3.66e-8)"	"unprognostic (8.51e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.01e-2)"	4.6	1.2	7.8	2.7	9.1	0.0	6.8	5.6	23.6	13.0	3.6	9.5	2.9	8.9	2.2	3.1	2.9	5.4	9.5	35.4	17.0	11.6	4.9	11.1	4.7	10.9	11.1	1.7	4.4	1.9	2.3	7.0	17.1	2.9	7.5	7.0	2.1	4.9	1.3	4.4	5.3	2.4	8.3	6.3	1.9	1.6	16.4	1.7	1.9	3.1	3.7	5.8	3.8	13.4	0.0	0.0	15.0	0.0	10.1	14.1	0.0	24.2	64.2	4.7	2.5	0.0	0.1	0.0	0.0	37.1	0.3	21.6	0.0	1.4	2.4	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.1	3.6	0.7	5.3	21.6	10.5	0.0	0.0	0.0	0.0	5.7	0.7	0.0	0.0	1.5	13.2	1.1	0.0	0.0	0.9	1.8	66.7	3.1	0.3	0.2	0.0	19.9	5.1	0.0	0.0	0.0	23.0	0.5	0.0	0.5	0.0	0.0	0.0	21.4	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	9.1	5.6	23.6	35.4	17.0	10.9	11.1	17.1	8.3	16.4	13.4	8.0	150.6	5.6	63.6	0.3	9.2	6.4	30.8	8.0	2.8	1.6	49.0	37.0	22.8	14.3	1.8	0.0	1.8	9.6	23.9	0.0	3.4	32.6	6.3	151.5	6.4	5.4	0.0	60.6	2.3	1.2	27.8	0.5	9.3	1.3	1.8	5.3	4.3	1.3	247.3	53.1	10.9	0.0	0.0	5.2	50.5	10.2	0.8	33.8	134.9	0.1	44.8	0.0	1189.7	152.3	1.2	8.0	14.7	0.0	8.2	16.9	14.4	2.0	3.6	39.5	4.3	40.5	0.6	0.5	11.4	4.8	1.9	1.4	29.0	20.5	14.1
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909082-123028605	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.7	1.5	12.1	0.4	11.8	0.0	1.3	7.3	15.9	1.8	6.7	1.3	0.9	1.4	2.8	0.7	3.5	2.5	9.5	16.2	8.0	9.1	0.9	1.2	0.6	8.4	8.5	1.4	1.7	0.6	2.7	2.6	9.7	1.4	0.8	7.1	0.4	1.4	0.9	1.5	1.5	1.9	7.7	0.2	0.6	0.7	7.8	0.2	2.6	0.5	0.6	1.6	1.6	10.9	0.0	0.0	79.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	21.3	0.0	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	11.8	7.3	15.9	16.2	8.0	8.4	8.5	9.7	7.7	7.8	10.9	1.2	0.0	1.1	9.4	0.0	0.0	0.0	0.1	0.0	7.2	0.1	0.0	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.8	0.0	0.0	30.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.6	7.3	0.0	45.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	14.3	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4581776	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 43.6;Alveolar cells type 1: 28.9;Alveolar cells type 2: 44.6;Endothelial cells: 40.1;Excitatory neurons: 30.6;granulocytes: 29.7;Hepatic stellate cells: 37.5;Inhibitory neurons: 30.3;Macrophages: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 124.5;HMC-1: 198.1;HUVEC TERT2: 83.8;TIME: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced					NA	NA		1100000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741"	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (9.55e-2)"	25.6	19.7	44.0	11.0	30.7	7.8	17.1	0.6	72.3	8.7	0.0	6.6	4.0	10.6	0.4	3.6	8.8	5.8	20.2	65.2	12.4	13.3	2.9	10.7	1.2	13.5	11.0	3.3	4.1	9.2	7.2	8.9	1.8	7.0	1.0	1.4	3.9	1.3	6.0	4.6	7.3	6.9	0.5	31.9	6.1	1.9	30.2	0.7	9.1	4.3	0.7	10.0	6.7	17.4	7.2	25.0	2.3	21.4	0.1	1.2	0.2	0.0	0.7	2.4	0.6	0.2	2.0	0.0	23.7	0.0	3.8	4.4	6.5	0.0	0.9	0.1	1.0	0.0	0.4	124.5	0.4	0.0	198.1	7.5	0.1	0.2	0.2	24.9	83.8	0.1	1.6	0.3	0.7	6.5	0.0	0.0	26.8	1.7	0.3	0.4	46.8	0.6	1.7	0.1	17.7	1.7	0.1	1.7	11.5	1.8	2.7	1.1	107.8	3.1	34.7	0.5	18.6	1.3	0.0	0.4	0.8	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	30.7	0.6	72.3	65.2	12.4	13.5	11.0	1.8	0.5	30.2	17.4	43.6	28.9	44.6	2.6	2.3	4.7	1.5	0.5	0.0	9.0	2.1	1.9	1.9	1.5	19.3	1.8	4.2	0.6	2.3	0.2	0.0	1.1	1.1	1.1	2.5	40.1	0.0	8.4	30.6	0.2	0.6	8.2	0.0	2.0	29.7	0.5	37.5	6.0	3.3	18.5	30.3	0.1	0.0	6.1	18.1	0.4	0.6	35.2	7.2	7.5	1.4	2.0	1.0	19.1	1.4	0.2	0.1	0.7	1.1	1.2	0.0	0.4	17.7	4.1	0.0	8.8	1.8	2.0	2.2	0.0	5.1	0.3	5.4	1.6	0.1	0.9
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.1;retina: 34.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		NA	NA		38000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.0	2.5	4.6	7.0	11.0	9.9	1.9	19.1	14.4	2.2	0.9	2.4	1.5	2.9	0.9	4.8	1.4	1.8	2.3	5.1	8.2	2.8	1.6	8.1	13.2	19.9	11.6	7.8	0.9	1.9	2.7	16.3	22.9	1.8	0.9	34.6	2.2	1.2	2.0	8.5	10.8	1.1	10.6	60.1	3.5	29.5	17.2	9.4	1.3	0.3	12.9	8.2	2.5	20.2	16.7	0.2	4.8	1.4	6.0	20.1	39.7	75.2	30.1	15.5	23.8	6.5	26.6	0.1	4.3	34.2	12.6	4.9	1.5	4.8	16.0	1.3	0.9	30.0	0.1	8.3	1.3	0.9	275.8	14.3	0.2	108.7	6.0	39.0	0.2	2.0	17.5	10.1	51.2	1.4	4.3	9.9	5.2	0.4	11.3	0.6	3.3	4.4	6.5	7.1	0.3	0.5	0.5	13.4	6.1	4.1	1.0	6.0	3.0	28.8	19.2	14.1	166.3	1.8	1.3	0.3	92.4	3.4	1.5	1.8	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	4.6	11.0	19.1	14.4	5.1	8.2	19.9	11.6	22.9	10.6	17.2	20.2	1.8	3.2	0.0	1.0	22.6	0.4	1.6	3.1	0.6	13.7	1.2	1.3	1.4	0.0	4.0	1.8	68.8	25.6	5.2	0.6	0.0	19.8	0.5	4.6	1.5	5.3	0.0	21.7	12.4	13.9	58.8	1.8	1.5	10.6	8.2	65.1	0.7	0.7	7.2	1.7	5.9	0.0	0.0	0.3	12.0	2.5	3.7	4.8	8.8	0.0	28.6	6.8	1.0	4.0	16.3	91.0	0.1	1.9	6.4	3.3	0.1	0.1	2.0	58.3	0.0	0.2	9.0	0.9	0.8	0.2	1.4	166.4	5.7	22.0	0.0	24.4
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin 1"	P04279	20	45207033-45209768	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"seminal vesicle: 30405.5"	"Group enriched"	"Detected in some"	18	"Basal prostatic cells: 7.5;Prostatic glandular cells: 3.4"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	239	"eosinophil: 26.8"	"Lineage enriched"	"Detected in single"	269	"granulocytes: 26.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;THP-1: 3.1"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.1	0.0	0.0	0.0	30405.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1
SEMG2	SGII	ENSG00000124157	"Semenogelin 2"	Q02383	20	45221373-45224458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"seminal vesicle: 10407.9"	"Group enriched"	"Detected in some"	9	"Basal prostatic cells: 1.2;Collecting duct cells: 3.7;Early spermatids: 1.2;Late spermatids: 1.8;Prostatic glandular cells: 1.9"	"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	NA	NA		5000000		"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 22: Epithelial cell types - Mixed function"			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0	10407.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	7.4	7.3	13.4	4.4	15.8	10.7	7.5	13.3	16.2	6.0	12.0	7.8	6.0	6.1	9.7	6.5	7.2	4.5	8.3	13.9	13.1	7.3	9.5	6.4	6.2	12.9	13.6	10.0	7.4	9.6	10.5	9.0	12.4	6.6	6.1	12.8	7.6	6.3	18.9	9.2	6.6	4.8	12.2	6.7	8.0	15.1	14.2	8.1	7.2	13.0	6.0	7.1	6.3	14.4	24.4	4.6	11.6	13.4	20.6	13.8	15.1	10.9	12.6	13.8	14.6	18.3	7.5	13.2	20.3	10.2	23.6	12.6	24.3	9.0	20.3	9.7	11.6	8.9	9.8	11.0	10.9	13.2	5.6	8.6	13.3	7.8	9.5	10.2	9.6	12.5	10.8	18.1	12.0	12.0	11.4	14.7	42.4	12.3	8.1	13.1	15.8	22.1	7.7	7.9	11.9	13.4	9.3	20.4	18.3	23.0	27.8	17.5	6.1	9.0	9.8	16.4	17.7	20.9	26.8	23.8	14.9	13.9	12.5	5.1	1.3	2.6	1.6	1.3	1.6	1.3	1.3	1.3	1.0	1.9	1.5	1.5	3.4	2.3	1.6	2.0	1.3	0.9	13.4	15.8	13.3	16.2	13.9	13.1	12.9	13.6	12.4	12.2	14.2	14.4	12.3	28.9	27.4	17.9	21.2	10.8	23.7	12.6	6.2	22.8	21.6	15.4	24.2	11.5	26.2	9.2	31.3	25.0	22.6	15.7	5.9	12.9	249.6	26.3	12.0	12.8	5.4	11.1	42.9	15.2	19.9	16.1	15.3	25.2	10.8	21.3	17.2	20.5	13.2	11.8	43.0	15.1	14.2	12.5	9.1	43.0	22.7	11.1	17.8	26.2	13.6	17.8	21.6	41.2	41.3	17.9	6.6	17.7	25.7	17.0	24.2	18.2	28.8	38.1	19.7	23.2	16.3	84.2	31.8	13.4	12.5	39.7	18.2	33.7	15.8	22.5
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
SENP7		ENSG00000138468	"SUMO specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 44.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	15.1	9.7	9.7	13.7	12.7	24.7	16.9	21.8	11.8	15.8	9.7	12.5	7.3	26.8	14.7	7.8	16.1	14.2	9.5	9.3	12.3	11.4	8.7	12.8	23.1	13.9	11.7	26.3	12.8	16.9	10.2	19.4	14.0	12.7	10.8	26.0	8.9	11.5	11.2	20.8	12.4	14.7	10.1	16.9	14.1	9.1	11.5	20.5	17.5	11.2	17.7	11.8	11.4	20.3	9.2	6.1	29.4	16.4	5.6	8.2	5.3	5.2	3.8	8.5	10.4	4.0	8.3	7.0	7.9	5.1	7.8	9.1	9.4	4.8	17.0	13.0	2.7	12.7	5.1	5.5	4.5	7.4	12.2	6.4	8.5	4.3	9.6	7.6	12.2	13.4	10.5	17.6	8.1	6.1	13.7	8.6	6.0	4.8	6.3	15.2	8.0	6.4	10.1	5.2	11.3	8.8	4.8	4.8	6.5	15.0	8.0	9.8	10.2	11.8	7.1	3.9	5.2	12.2	7.8	16.4	4.1	9.7	9.8	44.1	5.9	5.9	5.8	5.4	7.3	6.4	7.8	5.8	4.8	9.0	10.3	7.1	17.3	9.3	6.3	4.1	6.9	6.1	9.7	12.7	21.8	11.8	9.3	12.3	13.9	11.7	14.0	10.1	11.5	20.3	44.5	16.0	24.9	78.4	33.0	9.1	8.4	7.4	21.1	48.3	14.4	12.2	21.6	2.8	18.4	16.5	20.9	5.8	30.8	5.4	5.9	8.1	4.1	33.1	48.5	28.4	13.1	18.7	62.4	5.2	2.7	23.4	21.4	34.1	37.2	28.6	32.9	10.3	8.2	52.2	109.6	6.5	12.2	20.5	9.5	4.0	18.3	19.1	10.6	80.6	13.6	16.7	35.0	157.3	134.4	6.9	4.1	19.5	23.5	4.8	7.0	8.5	27.5	33.8	46.0	29.7	23.3	22.8	19.9	13.4	9.9	2.5	41.0	21.1	5.9	6.1
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.6"	"Group enriched"	"Detected in many"	11	"Early spermatids: 86.5;Late spermatids: 222.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	1.1	1.7	2.7	1.1	2.4	2.8	2.0	1.1	3.1	1.7	0.0	1.9	1.8	1.7	3.3	2.3	2.5	1.9	4.0	2.2	2.1	4.4	2.5	1.5	1.5	1.4	1.7	2.4	1.5	2.4	2.1	1.7	1.9	2.1	1.9	4.6	1.6	1.7	6.3	1.6	1.5	1.6	0.4	1.5	2.0	15.6	1.7	1.5	5.0	5.7	1.2	1.7	1.0	2.6	1.5	2.7	4.7	3.8	5.6	6.9	2.7	4.1	2.5	2.2	2.0	2.1	3.4	1.5	5.7	2.4	4.0	3.4	7.4	5.9	3.3	1.6	4.0	2.5	3.7	1.9	3.9	2.8	1.3	3.3	5.8	1.4	6.2	2.9	2.1	4.4	3.7	2.7	5.4	3.8	2.9	3.7	4.0	3.4	2.5	1.9	4.2	3.3	6.0	2.6	5.8	2.0	4.4	3.3	4.2	5.6	5.1	2.1	2.2	4.5	1.7	7.8	2.0	2.2	2.9	1.8	2.1	4.0	3.3	1.1	0.9	0.7	0.8	2.2	1.1	1.9	1.3	1.2	2.9	0.6	1.5	1.8	0.3	3.5	3.2	0.8	1.1	1.0	2.7	2.4	1.1	3.1	2.2	2.1	1.4	1.7	1.9	0.4	1.7	2.6	1.2	6.4	5.3	3.9	0.4	0.3	1.4	2.5	1.2	4.5	2.4	2.4	5.4	1.5	4.5	1.8	4.2	6.7	0.3	1.5	13.7	3.3	86.5	2.5	2.7	1.8	1.2	3.2	4.6	1.7	3.4	2.6	4.1	2.6	0.0	3.4	1.8	1.5	2.1	1.7	6.1	1.5	2.0	2.6	0.6	222.9	1.8	1.7	0.0	2.8	3.8	10.6	0.0	6.0	4.0	1.4	3.2	1.2	0.2	1.7	2.3	8.1	6.0	4.0	0.0	2.3	1.3	10.7	12.6	1.4	0.4	7.8	1.0	3.0	2.2	1.0
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317428-13348298	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA037645: AB_10671631, HPA062118: AB_2732676"	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	27.8	28.6	23.2	23.6	23.9	25.3	33.5	25.3	22.3	25.6	28.1	31.2	23.2	32.3	35.9	24.6	35.3	23.8	30.8	21.7	24.1	56.5	48.6	24.3	29.3	26.7	28.4	35.7	33.6	48.1	23.5	27.8	23.1	26.4	32.7	25.0	26.9	24.7	33.3	20.9	24.6	33.2	25.9	21.8	25.6	22.1	24.6	64.3	55.4	36.6	34.3	24.8	17.4	24.4	127.7	90.8	182.4	176.3	59.4	45.1	85.8	55.4	42.6	115.6	97.9	103.5	116.4	123.1	67.2	65.0	55.9	79.6	195.2	91.4	120.5	186.7	80.9	67.4	66.8	132.9	61.4	92.0	41.4	39.6	64.6	67.7	39.5	53.9	95.0	255.9	90.7	97.5	83.2	168.1	228.8	39.3	301.8	119.8	40.9	176.3	88.8	73.7	62.2	51.0	64.5	119.5	169.6	74.1	75.7	157.7	93.8	96.1	64.1	51.1	96.3	67.6	117.6	71.3	143.4	228.1	41.2	67.6	41.9	10.2	11.6	8.8	7.7	17.1	9.5	9.5	7.8	8.9	13.6	6.4	10.0	9.4	1.7	15.4	24.8	15.4	13.3	8.3	23.2	23.9	25.3	22.3	21.7	24.1	26.7	28.4	23.1	25.9	24.6	24.4	24.1	12.8	13.1	8.1	12.3	17.2	16.5	19.3	9.6	17.1	23.8	19.4	14.1	20.0	18.0	22.0	0.0	31.6	27.1	17.6	33.2	26.4	13.5	16.9	15.4	26.1	16.7	19.3	8.2	30.1	45.2	18.0	11.7	16.1	15.8	27.7	19.6	32.7	21.1	21.9	8.3	13.7	20.3	10.1	11.7	14.1	14.9	13.1	16.0	4.7	8.0	35.2	9.2	4.0	12.9	34.1	15.3	18.4	18.7	17.5	16.4	44.6	13.4	15.6	6.6	14.2	26.1	17.6	21.2	15.0	16.9	25.6	13.2	25.9	18.0	15.1
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30445874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 402.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 385.4;Proximal tubular cells: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 477.5"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No		29000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	27.5	30.6	16.8	33.7	17.5	26.0	33.8	18.5	19.9	24.8	21.2	75.5	136.0	19.9	23.9	20.4	20.5	34.0	27.8	18.5	20.5	158.5	402.6	28.8	44.8	18.5	18.9	14.9	35.2	48.9	20.4	25.1	19.5	28.7	65.9	19.7	33.6	23.2	41.7	21.1	105.8	25.9	18.6	29.8	62.5	11.5	20.2	43.5	37.7	32.3	41.9	27.7	14.2	19.8	77.6	68.9	23.8	83.1	71.7	45.7	62.5	52.3	64.5	50.5	62.2	42.9	57.7	110.8	79.0	56.0	45.7	42.1	44.5	47.9	51.0	71.2	137.5	110.8	35.9	204.0	90.5	62.0	477.5	58.4	100.5	47.6	87.7	31.6	47.0	80.1	91.1	69.7	45.4	114.5	93.9	127.8	59.3	58.0	51.4	90.2	41.8	85.3	62.6	68.9	50.5	43.1	44.8	129.3	179.7	47.8	113.7	204.2	39.6	52.2	37.1	50.9	32.0	59.6	103.4	57.6	45.3	114.3	59.7	8.7	19.4	30.2	14.8	16.1	22.2	17.8	20.9	21.4	21.6	20.2	25.0	17.2	17.6	31.9	20.5	15.4	22.8	14.8	16.8	17.5	18.5	19.9	18.5	20.5	18.5	18.9	19.5	18.6	20.2	19.8	76.2	44.8	40.3	3.9	34.3	37.5	1.4	47.6	58.6	0.5	66.2	52.7	49.4	1.5	39.4	64.4	0.0	1.3	41.5	108.9	385.4	112.2	0.1	34.2	25.1	32.4	35.5	20.8	6.7	82.7	1.1	30.4	68.8	59.2	31.0	20.5	0.7	9.1	1.4	0.0	8.6	31.0	63.1	2.9	34.9	0.1	0.0	42.5	44.4	5.6	37.1	0.2	1.0	5.5	4.6	57.4	42.4	0.0	30.6	1.6	11.1	384.9	27.2	1.1	0.0	2.0	49.4	0.8	0.8	45.4	42.6	1.2	35.7	52.6	46.0	0.9
SEPTIN1	"DIFF6, PNUTL3, SEPT1"	ENSG00000180096	"Septin 1"	Q8WYJ6	16	30378133-30395991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 16.7;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.7;Cytotrophoblasts: 11.4;dendritic cells: 25.9;Fibroblasts: 4.9;Hofbauer cells: 9.2;Plasma cells: 10.2;Syncytiotrophoblasts: 4.9;T-cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;JURKAT: 48.5;MOLT-4: 66.3;REH: 39.0;U-266/70: 21.6;U-266/84: 33.4;U-698: 23.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.6	0.9	1.0	3.6	1.1	0.7	1.1	1.2	1.9	1.9	1.0	3.4	4.1	1.4	0.7	2.0	2.0	0.3	0.8	1.0	1.1	1.4	1.9	2.6	15.3	1.0	1.0	1.6	0.8	0.5	0.7	0.3	1.1	1.7	0.0	0.1	3.2	0.8	0.2	1.3	16.7	0.7	1.0	35.9	4.4	0.2	1.4	16.0	1.9	0.6	6.6	2.0	1.6	1.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	38.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.3	3.0	0.0	0.0	0.3	0.0	5.1	1.2	0.2	0.1	0.1	0.0	0.7	0.0	48.5	0.3	16.7	0.0	0.0	66.3	1.4	0.0	0.0	0.7	39.0	0.0	2.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	21.6	33.4	23.2	0.6	7.0	0.0	118.4	2.5	102.2	319.3	2.3	245.1	170.1	286.7	292.4	9.6	179.4	264.6	268.7	8.5	230.4	1.6	270.6	329.6	272.6	1.0	1.1	1.2	1.9	1.0	1.1	1.0	1.0	1.1	1.0	1.4	1.0	1.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	11.4	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.9	6.1	0.0	0.0	0.0
SEPTIN10	"FLJ11619, SEPT10"	ENSG00000186522	"Septin 10"	Q9P0V9	2	109542799-109614143	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.4;Cardiomyocytes: 21.8;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 59.4;Fibroblasts: 15.5;Hofbauer cells: 19.6;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047860, HPA056304, HPA060310"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA047860: AB_2680187, HPA056304: AB_2683094, HPA060310: AB_2684249"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.18e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.12e-2)"	57.0	24.2	16.1	22.6	29.5	0.7	52.9	29.8	20.3	41.5	58.7	52.0	22.3	44.5	21.7	88.4	33.4	41.8	41.7	15.1	24.2	43.4	66.5	60.4	18.4	46.8	29.5	46.7	20.3	26.9	9.5	50.4	41.6	40.6	39.8	13.6	34.7	42.2	28.5	73.4	24.3	58.0	31.9	36.3	30.5	76.9	26.1	19.9	43.3	39.0	22.8	55.1	43.2	44.5	104.7	27.7	99.6	64.1	78.1	145.8	61.1	166.5	290.6	114.8	133.3	52.2	59.0	0.0	82.2	130.4	72.2	47.7	42.8	105.2	151.6	199.4	31.2	0.2	38.5	75.3	58.7	0.2	13.4	91.5	46.9	103.5	135.1	123.9	154.3	0.0	2.7	0.4	141.5	9.9	0.1	10.3	74.4	61.3	53.7	0.1	80.9	17.4	95.7	136.8	29.6	61.8	97.8	2.1	77.0	115.2	26.5	1.2	158.5	120.1	85.1	46.9	69.6	61.4	36.0	0.9	106.7	2.3	148.1	0.0	2.4	0.0	0.1	1.6	0.1	0.8	1.5	0.4	0.6	0.3	0.7	0.2	0.1	0.0	1.0	0.0	3.5	0.8	16.1	29.5	29.8	20.3	15.1	24.2	46.8	29.5	41.6	31.9	26.1	44.5	56.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	59.4	15.5	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0
SEPTIN11	"FLJ10849, SEPT11"	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949751-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 495.8;fHDF/TERT166: 604.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		2800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	84.8	13.0	34.6	27.5	46.5	7.9	39.3	24.3	51.4	40.4	0.0	50.1	21.8	33.8	18.0	22.5	17.4	45.4	30.8	40.5	13.7	52.4	33.9	40.5	24.1	5.2	8.5	20.0	22.3	17.3	11.3	84.1	4.5	21.0	40.4	22.3	11.6	26.1	26.0	13.3	35.3	40.6	0.0	25.6	25.2	7.8	16.6	12.7	21.1	18.3	22.8	39.3	21.5	50.6	87.6	34.9	328.1	293.8	192.8	152.9	94.6	495.8	382.7	110.6	154.5	64.3	62.9	2.0	100.9	604.4	51.9	36.6	109.8	73.8	171.2	114.0	36.7	171.2	44.6	47.1	168.0	93.0	69.7	195.5	34.4	160.2	59.8	87.7	169.0	34.3	72.0	46.6	331.2	50.4	122.8	3.3	111.1	71.4	18.1	142.6	372.8	10.1	62.6	94.0	112.1	83.6	96.2	54.4	77.9	209.9	49.5	37.3	184.4	368.7	109.4	182.8	93.1	28.5	24.3	1.1	140.5	10.0	76.4	12.2	2.4	32.5	8.1	2.2	5.0	3.6	9.2	11.2	7.8	6.7	3.5	9.4	0.6	38.4	7.4	20.8	5.8	6.6	34.6	46.5	24.3	51.4	40.5	13.7	5.2	8.5	4.5	0.0	16.6	50.6	33.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	90.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	266.8	40.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	60.5	5.6	0.0	0.0	0.0
SEPTIN14	"FLJ44060, SEPT14"	ENSG00000154997	"Septin 14"	Q6ZU15	7	55793540-55862755	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 22.5"	"Cell type enriched"	"Detected in single"	5	"Extravillous trophoblasts: 1.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 6.2;U-266/84: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA073255	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA073255: AB_2686590"					"unprognostic (1.29e-1)"					"unprognostic (3.50e-1)"				"unprognostic (1.98e-2)"	"unprognostic (1.57e-1)"			0.9	0.6	1.0	1.4	1.0	2.3	0.9	1.3	1.3	0.7	0.1	0.6	0.5	1.0	1.0	0.7	0.7	0.9	0.6	0.9	1.0	1.1	2.3	0.7	1.0	0.8	0.6	1.1	0.6	1.1	1.3	1.1	1.0	1.2	0.7	2.0	0.8	0.5	0.6	1.4	0.5	0.7	0.3	1.2	0.9	22.5	1.0	1.2	1.2	0.6	0.8	0.8	0.0	1.1	1.2	0.3	1.3	2.9	1.3	1.0	6.2	0.8	0.7	0.6	0.9	0.2	0.8	0.9	0.2	0.5	1.3	1.1	1.4	1.0	1.7	1.6	0.7	0.6	2.3	2.3	2.8	1.3	1.4	1.1	1.8	0.8	1.5	1.2	0.7	2.2	2.3	1.3	1.0	0.6	1.8	1.7	1.1	2.0	0.2	0.7	1.2	1.4	1.0	0.9	1.0	1.3	0.3	0.7	1.2	1.4	0.8	1.8	0.6	0.8	0.8	0.9	0.6	1.7	5.7	1.3	0.7	4.6	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.0	1.0	1.3	1.3	0.9	1.0	0.8	0.6	1.0	0.3	1.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN3	"SEP3, SEPT3"	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 233.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 27.9"	"Group enriched"	"Detected in many"	5	"glioma: 24.6;melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	0.2	4.6	134.7	0.4	160.5	0.1	1.3	82.4	233.7	0.2	30.5	0.8	0.3	0.2	1.4	0.2	0.1	0.4	0.2	167.0	89.5	0.3	0.1	0.7	0.5	86.2	73.4	0.2	1.2	18.6	7.8	5.7	83.8	1.3	0.5	28.4	0.4	0.0	0.1	1.6	0.4	0.3	56.9	0.2	0.7	2.1	91.4	0.9	0.8	0.2	0.5	0.3	0.4	150.7	1.5	1.7	26.6	20.1	0.3	0.0	13.3	0.3	0.3	1.8	0.8	0.4	3.1	22.3	0.7	0.2	11.4	0.1	14.0	0.1	0.7	9.2	4.6	0.1	0.5	0.0	0.2	0.0	0.9	0.2	1.0	0.1	0.0	0.0	0.0	12.1	0.0	3.4	0.0	2.4	3.7	0.2	18.2	0.2	0.7	17.9	0.0	1.3	0.0	2.7	71.4	14.8	10.9	0.1	18.2	2.5	2.6	6.7	0.0	0.0	9.2	0.9	1.0	14.1	13.1	0.2	0.3	9.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	134.7	160.5	82.4	233.7	167.0	89.5	86.2	73.4	83.8	56.9	91.4	150.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0
SEPTIN4	"ARTS, C17orf47, CE5B3, FLJ40121, H5, hCDCREL-2, hucep-7, MART, PNUTL2, SEPT4"	ENSG00000108387	"Septin 4"	"O43236, Q8NEP4"	17	58520250-58544368	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 1288.2;choroid plexus: 593.0;retina: 404.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 52.0;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.0;hTERT-RPE1: 19.4;SK-MEL-30: 32.8"									"CAB006855, HPA021587, HPA022905, HPA028424"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687, HPA028424: AB_10601690"	"unprognostic (1.12e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (6.40e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.75e-3)"	46.6	165.0	832.1	5.0	1011.1	0.5	33.5	861.9	1288.2	13.9	593.0	15.3	4.9	12.4	6.9	5.9	14.2	17.1	56.3	774.4	799.2	31.8	56.6	39.6	14.4	864.7	904.6	15.8	8.7	9.4	23.1	20.9	859.8	8.6	5.3	404.5	9.2	6.5	10.8	11.1	12.1	11.7	798.0	49.5	11.5	25.7	925.2	4.4	23.2	13.7	7.3	12.2	12.1	1080.0	0.0	0.6	1.2	3.6	1.4	0.2	0.6	0.2	0.5	2.1	2.4	0.2	0.5	0.0	5.1	0.8	3.2	0.4	1.8	1.4	0.5	0.3	0.9	1.3	0.3	7.6	14.0	0.1	0.7	7.2	2.9	0.5	2.6	19.4	0.6	1.9	0.0	3.8	0.2	0.5	0.0	0.1	0.6	0.0	0.9	0.2	0.0	1.6	0.0	0.1	3.9	2.1	0.1	0.2	32.8	1.6	0.8	0.4	0.0	0.3	1.6	0.0	1.4	1.0	0.6	0.0	1.1	0.0	0.4	0.0	3.6	0.8	4.9	0.5	1.5	1.6	1.0	1.3	3.7	0.3	1.8	1.4	1.9	1.0	0.0	0.2	0.7	3.6	832.1	1011.1	861.9	1288.2	774.4	799.2	864.7	904.6	859.8	798.0	925.2	1080.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
SEPTIN5	"H5, HCDCREL-1, PNUTL1, SEPT5"	ENSG00000184702	"Septin 5"	Q99719	22	19714503-19724224	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 321.9"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 3.4;Smooth muscle cells: 2.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	32	"eosinophil: 15.4;neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"K-562: 281.6;THP-1: 75.9"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		860000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Actin filaments, Cytosol"		"CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	17.7	17.7	152.8	5.7	215.6	41.0	16.4	49.2	321.9	54.1	61.9	19.8	5.2	28.1	46.2	62.1	38.8	14.7	165.4	233.6	49.3	12.7	5.2	17.4	8.4	40.9	45.2	29.3	17.0	127.3	82.7	12.0	39.4	20.1	6.3	30.3	15.9	9.9	10.8	126.5	8.8	17.3	24.7	14.3	16.3	29.1	73.1	15.9	33.4	16.2	8.1	13.5	42.8	168.6	0.4	10.6	42.0	64.0	3.9	13.1	0.3	15.8	20.1	17.9	10.5	0.7	5.6	1.5	6.1	35.8	26.0	6.0	30.2	6.0	8.8	9.6	3.4	0.7	2.4	0.2	16.2	0.8	47.2	17.4	7.4	6.0	2.5	5.1	7.5	23.1	281.6	0.6	28.2	4.2	4.6	31.2	5.4	1.0	10.4	41.4	1.3	7.2	1.3	1.4	62.3	49.2	2.4	3.5	2.8	10.2	17.3	75.9	3.0	46.4	55.6	2.0	3.2	4.5	0.0	0.4	5.8	2.2	15.2	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.8	0.0	0.0	0.3	0.0	6.0	152.8	215.6	49.2	321.9	233.6	49.3	40.9	45.2	39.4	24.7	73.1	168.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEPTIN6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2, SEPT6"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 231.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 20.3;Cytotrophoblasts: 43.9;dendritic cells: 66.5;Extravillous trophoblasts: 50.1;Hofbauer cells: 54.8;Plasma cells: 28.4;Syncytiotrophoblasts: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 273.0;MOLT-4: 300.5;REH: 271.8;SH-SY5Y: 394.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol		NA	NA		2900000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	13.1	73.4	14.5	66.7	12.8	61.1	12.7	16.9	16.9	11.5	7.8	47.4	14.3	11.2	16.9	17.9	18.1	17.5	16.1	12.4	20.8	18.1	21.3	16.5	119.7	18.3	18.0	11.4	4.6	9.9	9.8	14.7	22.1	13.4	18.5	38.9	18.2	40.5	4.6	7.1	35.3	24.4	13.5	61.9	20.0	40.3	20.5	231.3	7.6	5.9	103.9	18.6	9.7	12.0	6.5	10.1	37.9	68.5	3.5	7.7	53.9	18.9	41.7	31.4	53.8	3.4	14.4	130.7	14.6	23.9	32.6	3.7	60.2	12.1	21.7	80.6	13.9	58.1	20.3	23.5	9.1	66.3	29.4	14.0	2.6	24.8	0.6	13.1	46.4	273.0	43.6	68.0	18.7	4.8	300.5	38.6	40.2	1.9	31.0	271.8	31.3	106.7	33.5	6.8	16.8	394.7	49.1	17.9	20.6	40.7	24.3	33.8	29.0	8.5	17.2	27.5	4.7	33.8	14.5	170.7	0.8	69.0	6.3	34.2	17.2	39.9	58.6	26.1	61.4	65.0	75.3	68.6	34.0	64.0	79.3	69.4	11.8	81.3	38.8	63.7	112.4	53.9	14.5	12.8	16.9	16.9	12.4	20.8	18.3	18.0	22.1	13.5	20.5	12.0	13.8	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	43.9	66.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	50.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	43.0	15.5	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SEPTIN8	"KIAA0202, SEP2, SEPT8"	ENSG00000164402	"Septin 8"	Q92599	5	132750819-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 393.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 14.1;Cytotrophoblasts: 31.0;Extravillous trophoblasts: 12.1;Fibroblasts: 9.5;Hofbauer cells: 12.1;Smooth muscle cells: 8.8;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: AB_2797226"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	26.9	19.5	192.8	18.0	273.3	8.3	22.2	279.1	238.2	28.2	111.6	26.3	26.2	18.8	18.5	34.0	21.4	25.2	33.0	188.3	218.5	34.8	13.0	26.2	14.9	319.9	262.0	25.2	23.3	23.9	22.3	44.3	304.7	20.5	26.9	74.6	33.4	20.6	10.9	49.7	25.8	21.3	238.1	14.8	26.8	6.9	250.4	18.0	32.3	12.4	18.6	36.1	31.1	393.6	55.8	26.4	37.3	76.7	50.8	49.5	122.0	58.9	56.2	54.7	66.5	46.6	39.2	0.3	51.1	57.3	32.4	42.3	70.5	96.4	59.9	71.3	50.8	54.4	35.5	40.5	37.2	19.4	76.0	35.9	30.6	25.3	35.8	53.5	77.4	47.7	84.6	10.6	29.7	53.0	63.3	18.2	19.8	33.7	17.0	57.4	43.5	4.7	32.0	141.1	50.0	31.0	50.0	11.5	32.9	107.4	100.6	25.4	80.9	60.6	39.2	15.1	42.5	14.3	14.3	2.0	38.7	28.6	46.5	0.5	1.0	0.0	2.0	0.6	2.0	0.4	1.6	2.5	1.2	0.1	0.4	1.0	0.0	0.2	0.3	0.0	1.9	1.0	192.8	273.3	279.1	238.2	188.3	218.5	319.9	262.0	304.7	238.1	250.4	393.6	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	31.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	12.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	10.1	0.6	0.0	0.0	0.0
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERAC1	FLJ14917	ENSG00000122335	"Serine active site containing 1"	Q96JX3	6	158109519-158168280	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 95.8;Late spermatids: 111.7;Oligodendrocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025715, HPA025716"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA025715: AB_1856697, HPA025716: AB_2185128"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.03e-2)"	2.8	7.1	3.7	1.6	3.9	0.6	3.1	3.7	5.3	3.2	4.1	3.7	3.1	3.6	3.5	6.2	2.2	3.7	3.0	4.1	3.7	4.7	2.9	2.7	2.0	3.9	3.9	2.5	7.8	3.4	2.5	2.4	4.6	3.9	3.2	6.3	4.4	3.8	5.7	4.6	3.1	6.0	3.6	2.5	3.8	6.2	3.7	1.9	5.2	4.5	2.5	3.6	3.8	4.3	4.0	5.9	9.4	11.3	6.7	4.8	4.1	5.0	5.2	8.6	11.2	3.1	1.5	1.9	3.6	10.3	6.1	3.5	9.1	3.8	7.2	2.1	5.2	6.2	2.1	5.3	6.9	2.7	2.8	3.0	6.5	6.7	6.8	13.3	5.6	4.4	5.5	1.3	7.5	1.8	2.6	3.1	4.1	6.3	3.0	1.7	6.5	2.5	9.4	3.3	6.4	4.9	5.4	6.3	4.6	7.7	2.9	4.4	6.6	5.8	4.4	13.4	10.8	1.5	2.9	1.7	4.0	3.3	5.8	1.2	2.2	0.6	1.0	2.5	1.1	0.3	0.7	0.9	2.4	0.3	0.7	0.8	1.1	1.1	1.7	0.6	0.8	1.1	3.7	3.9	3.7	5.3	4.1	3.7	3.9	3.9	4.6	3.6	3.7	4.3	4.3	3.2	14.1	9.4	3.2	6.9	4.3	4.7	4.0	9.5	5.6	2.8	5.8	7.2	10.7	1.8	4.2	2.7	6.5	7.2	1.9	11.7	95.8	18.0	3.1	5.3	5.4	3.8	22.4	5.8	1.1	4.6	5.1	11.1	12.0	14.7	4.6	4.6	4.9	5.0	19.1	4.4	10.2	7.6	17.7	111.7	5.0	6.8	10.6	7.5	6.4	5.0	4.1	10.6	47.5	6.3	8.3	6.4	4.0	8.0	7.4	5.5	9.8	10.7	0.0	4.5	4.8	16.8	9.7	5.8	11.5	5.7	6.3	7.3	5.0	8.1
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	116.2	79.6	45.9	110.1	48.9	130.5	106.9	45.7	48.5	98.3	44.4	91.2	99.6	89.9	65.7	188.2	81.5	66.5	93.4	42.5	46.5	85.9	131.4	76.6	123.8	51.6	47.5	86.8	121.1	131.5	48.0	92.9	52.4	77.3	84.5	47.6	119.0	66.2	336.9	149.6	92.7	82.1	50.3	81.4	94.1	82.9	49.3	125.7	91.1	159.0	118.1	101.4	118.4	52.8	444.4	272.4	274.9	280.4	236.9	214.0	420.9	452.9	163.8	294.7	241.6	524.8	195.4	828.9	341.1	236.0	294.6	337.4	435.2	411.2	309.5	375.7	535.8	764.1	488.7	460.7	207.0	614.9	290.8	221.3	272.1	384.6	356.0	205.9	319.7	276.0	867.4	293.0	236.2	314.9	494.9	412.9	978.1	298.1	355.2	566.3	600.4	429.8	231.0	349.8	468.8	330.8	351.0	385.6	442.4	231.1	212.0	386.4	345.9	283.4	351.5	421.2	618.3	273.6	369.2	747.9	233.0	603.3	326.9	37.8	84.1	53.7	100.4	92.5	125.4	101.3	99.0	100.9	107.5	102.1	114.6	105.6	27.1	147.4	90.1	98.2	131.5	119.2	45.9	48.9	45.7	48.5	42.5	46.5	51.6	47.5	52.4	50.3	49.3	52.8	251.3	250.0	225.5	17.6	262.6	686.4	437.3	363.8	536.7	146.7	262.1	251.8	144.8	214.4	311.4	117.7	91.8	271.5	343.7	200.0	242.6	324.4	555.9	368.1	411.9	314.9	230.1	398.8	24.1	361.5	531.0	231.0	169.7	400.5	219.2	215.6	179.2	331.5	297.9	143.0	24.6	338.7	183.1	247.7	281.2	240.9	221.2	214.2	192.1	27.2	298.4	153.6	325.4	26.7	33.2	349.3	192.0	278.7	277.4	540.5	168.4	323.0	206.3	139.7	138.1	301.6	516.0	569.8	281.6	597.9	719.7	229.3	271.4	318.8	405.0	470.2
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013047	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	16.1	17.5	35.9	9.4	37.4	6.4	16.4	49.6	42.8	19.5	32.2	25.4	7.4	16.8	18.4	12.5	16.5	9.9	18.9	39.0	39.1	19.6	14.0	14.0	10.7	37.4	53.9	27.5	23.1	17.1	36.8	5.7	43.8	21.3	12.3	22.5	15.1	18.0	22.7	20.2	13.8	16.4	34.8	12.8	19.7	5.0	37.3	12.3	27.7	21.7	13.5	21.5	17.7	39.1	10.8	13.2	10.6	22.3	19.1	18.6	7.2	9.0	18.3	9.5	12.0	8.5	3.7	9.5	11.0	12.2	26.1	14.5	37.3	27.6	7.5	21.0	37.7	15.3	10.6	36.3	21.5	13.5	16.6	17.7	27.4	4.8	20.4	28.6	10.5	20.8	9.2	17.6	15.2	16.0	14.0	30.0	8.9	33.7	16.2	18.3	13.0	10.0	21.2	16.1	27.1	5.9	15.8	16.1	17.1	21.1	7.2	12.1	6.2	8.9	12.1	13.1	10.2	12.3	16.1	12.9	15.5	15.4	10.2	15.6	21.3	17.1	34.5	17.6	28.6	25.5	35.5	25.8	26.1	18.7	34.8	30.5	2.3	22.4	17.5	10.5	41.4	25.9	35.9	37.4	49.6	42.8	39.0	39.1	37.4	53.9	43.8	34.8	37.3	39.1	12.7	6.4	6.8	58.4	14.3	26.5	25.3	30.5	15.9	14.1	18.5	20.8	11.6	10.0	13.6	11.0	2.1	6.4	14.4	7.8	39.2	17.1	155.4	3.3	5.1	9.0	48.5	7.4	114.9	24.5	12.5	14.4	4.6	5.2	14.5	26.7	12.5	14.7	14.3	11.8	123.9	14.7	34.6	17.8	14.9	258.3	19.6	9.3	21.4	44.0	12.9	31.7	17.5	82.9	46.5	14.0	9.8	21.4	11.6	18.7	12.3	46.0	7.6	10.9	6.6	13.3	16.9	9.0	7.6	8.7	20.2	3.1	18.2	15.6	13.0	20.0
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 235.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.3;Distal enterocytes: 530.1;Ductal cells: 735.4;Pancreatic endocrine cells: 457.4;Paneth cells: 465.1;Proximal enterocytes: 422.0;Syncytiotrophoblasts: 446.6;Urothelial cells: 432.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 305.6;HaCaT: 349.2;HBEC3-KT: 553.0;hTCEpi: 307.8;RT4: 381.9;SK-BR-3: 311.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	6.5	23.8	1.2	15.0	1.4	8.1	33.8	1.5	1.2	68.9	2.9	111.0	118.7	15.3	21.4	120.7	18.9	59.1	3.2	1.0	1.7	114.1	235.5	20.9	3.5	1.8	2.2	0.9	37.7	45.8	9.7	44.5	1.9	56.6	56.2	0.1	151.0	62.1	76.8	53.5	105.6	2.6	1.6	3.4	90.7	4.9	5.8	8.8	28.4	24.5	9.5	116.5	39.3	1.8	87.3	20.5	17.7	57.0	37.3	50.4	48.2	162.8	119.5	10.6	13.1	31.1	305.6	57.0	209.5	154.6	12.9	349.2	2.3	553.0	2.1	5.5	13.2	0.0	17.2	16.6	42.0	0.5	64.1	46.0	307.8	66.5	144.2	45.5	6.7	6.9	2.6	0.5	18.2	14.2	2.1	2.0	18.3	172.1	42.4	0.4	34.8	19.5	57.9	381.9	7.6	42.4	41.7	311.0	6.5	8.5	182.8	9.9	40.7	2.8	13.0	1.8	3.4	2.9	2.1	2.6	1.4	1.6	13.7	0.0	2.4	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.6	1.2	1.4	1.5	1.2	1.0	1.7	1.8	2.2	1.9	1.6	5.8	1.8	2.2	16.0	8.9	0.0	2.7	12.4	108.7	374.7	37.0	0.0	162.9	72.9	0.7	138.7	173.3	117.7	0.0	466.3	4.2	530.1	72.4	735.4	6.4	61.6	18.2	8.8	116.6	3.6	0.4	326.3	91.2	5.4	80.0	140.7	0.0	1.6	5.7	54.5	47.5	0.0	0.4	195.0	183.1	5.1	5.0	12.9	2.1	13.1	40.9	1.0	48.4	0.6	0.0	0.0	0.2	457.4	465.1	0.0	0.1	192.2	422.0	71.0	54.3	0.0	0.0	23.5	19.3	0.7	9.5	30.8	21.2	446.6	3.5	0.1	145.7	432.5
SERINC3	"AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1"	ENSG00000132824	"Serine incorporator 3"	Q13530	20	44496221-44522085	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048116	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA048116: AB_2680269"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	81.6	91.6	50.1	49.3	60.0	48.7	61.8	57.8	80.4	73.3	22.4	56.6	47.2	62.4	48.9	65.2	54.8	68.9	72.8	66.1	60.3	49.2	92.7	67.7	46.4	57.6	56.7	67.6	50.3	107.0	44.6	115.8	61.5	57.7	63.2	47.9	66.3	63.5	81.6	63.9	53.3	70.1	56.8	57.1	54.1	110.2	55.7	60.0	81.5	81.1	50.3	63.3	50.1	67.9	70.3	73.9	34.8	44.1	297.4	211.8	53.7	140.8	243.1	111.5	101.3	167.3	169.2	51.0	187.5	168.8	127.1	123.0	41.9	144.9	117.3	59.5	47.1	59.7	71.9	85.7	161.4	74.2	124.5	152.1	207.4	109.7	163.3	135.3	110.0	81.6	67.5	146.2	117.7	88.2	76.5	58.9	20.5	91.6	110.9	38.1	51.9	78.5	88.7	79.5	43.4	32.9	135.2	129.8	91.8	47.9	93.0	82.6	141.5	262.1	43.3	117.0	99.1	86.2	102.0	38.9	195.3	51.7	83.9	217.1	92.6	119.4	96.5	96.7	98.4	57.6	82.9	94.5	95.4	63.4	84.7	85.0	177.3	111.0	113.5	87.4	104.4	137.7	50.1	60.0	57.8	80.4	66.1	60.3	57.6	56.7	61.5	56.8	55.7	67.9	139.7	73.7	70.7	20.5	52.1	54.8	75.3	96.5	60.3	39.2	55.3	44.4	75.9	78.6	84.7	47.8	35.5	85.8	86.1	84.4	15.6	77.2	239.8	44.5	76.2	115.1	66.4	94.9	58.7	69.9	85.6	97.5	41.3	65.1	102.5	32.9	122.4	105.7	57.7	45.4	52.4	60.4	71.2	93.5	50.0	558.0	105.0	79.7	39.2	34.7	44.2	47.4	37.0	27.6	63.8	100.4	63.8	114.0	76.1	75.3	55.6	24.6	65.4	36.6	98.6	69.5	88.9	210.9	99.3	54.6	84.1	165.4	72.0	85.9	54.7	82.2
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256048	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 222.5;Urothelial cells: 254.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: AB_2675727"	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	12.9	34.8	19.2	9.8	31.0	6.3	11.8	27.2	20.7	16.4	17.4	28.3	9.2	9.2	21.1	17.6	16.2	14.2	5.3	18.0	22.7	6.2	45.4	14.1	8.2	26.5	27.6	15.1	7.6	7.1	4.1	16.5	26.8	33.7	29.4	16.3	13.3	7.0	2.7	19.1	9.7	7.6	22.2	4.8	16.6	29.2	28.0	7.9	5.8	2.9	11.4	17.8	11.3	44.4	11.3	19.7	6.6	4.2	8.9	9.5	19.6	9.0	6.0	3.9	4.0	40.0	56.7	1.7	9.0	11.7	9.2	31.7	8.9	23.9	5.6	1.6	4.8	1.4	2.2	21.7	3.3	1.3	4.1	10.8	13.1	10.2	26.0	11.0	7.3	54.0	3.6	9.4	10.4	19.4	22.8	5.5	9.3	15.8	6.8	26.9	5.8	3.0	11.5	54.4	0.4	6.3	8.0	18.5	35.4	33.5	8.2	6.9	8.0	11.3	3.2	11.6	11.3	7.1	3.5	28.1	21.0	3.9	46.9	10.4	9.1	6.7	2.1	4.9	1.6	0.8	18.7	5.7	5.8	1.1	23.3	14.1	5.2	0.6	1.5	1.4	6.6	7.5	19.2	31.0	27.2	20.7	18.0	22.7	26.5	27.6	26.8	22.2	28.0	44.4	48.5	60.9	30.2	46.0	10.5	6.4	56.8	5.6	19.9	3.6	27.7	14.1	8.2	31.5	18.3	16.5	0.0	16.1	12.9	127.4	9.8	26.5	1.7	82.0	29.6	24.5	60.1	24.8	20.9	19.5	25.7	24.9	40.2	157.0	8.2	27.6	35.3	82.7	21.8	3.3	78.3	60.0	4.1	29.2	27.8	7.6	18.3	38.4	5.4	66.5	44.8	65.1	1.0	223.2	222.5	35.4	56.4	39.9	8.7	148.2	27.7	5.1	4.3	5.3	32.9	7.5	17.4	3.1	12.8	44.4	9.8	129.2	37.7	15.2	85.9	254.2
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541998-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 542.5;U-266/70: 735.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	74.6	94.0	52.9	64.4	56.5	86.8	103.9	51.5	67.7	104.3	55.1	78.5	63.4	51.0	158.0	80.6	80.2	48.2	39.0	54.2	56.1	73.9	157.7	82.3	66.1	54.3	51.2	80.7	255.6	57.2	84.6	60.2	53.2	92.4	67.8	26.1	185.5	69.8	16.9	52.8	64.2	45.0	56.1	87.8	114.8	37.5	56.0	66.4	113.3	17.0	74.5	64.6	64.2	58.8	216.1	46.3	68.9	52.5	99.7	116.0	152.9	150.4	98.7	82.2	96.5	121.6	93.7	175.8	274.8	111.7	67.7	102.2	113.6	79.5	108.6	104.7	93.3	187.1	38.4	123.9	193.9	170.8	117.4	69.6	139.4	47.7	236.7	89.2	97.7	118.1	92.7	241.0	70.8	95.3	144.5	143.3	128.1	138.5	115.1	181.2	52.5	542.5	100.4	69.7	116.8	99.3	57.8	128.4	244.5	83.2	112.8	165.0	93.8	38.9	69.6	84.4	117.0	735.1	230.5	236.0	70.9	165.2	36.8	347.2	410.6	375.2	237.4	399.6	304.5	239.7	250.3	238.5	317.6	222.1	244.0	227.3	299.9	188.5	456.8	321.1	268.0	508.0	52.9	56.5	51.5	67.7	54.2	56.1	54.3	51.2	53.2	56.1	56.0	58.8	168.0	67.3	162.7	66.0	468.4	538.0	677.4	277.8	363.7	74.5	500.8	451.2	44.5	158.7	246.5	172.9	58.4	284.6	337.7	351.1	365.9	231.3	361.1	246.5	198.9	189.5	254.0	157.5	51.6	304.3	553.8	213.0	218.2	359.7	219.7	135.4	249.5	480.7	373.5	42.1	48.0	563.2	168.9	662.6	477.8	627.0	219.6	512.6	348.6	25.3	558.1	174.5	279.1	63.3	60.6	349.0	564.2	190.3	923.0	744.8	326.1	293.7	218.5	69.6	111.7	98.1	192.4	208.0	91.3	347.4	592.7	944.7	335.5	94.2	404.3	1101.9
SERP2	"bA269C23.1, C13orf21"	ENSG00000151778	"Stress associated endoplasmic reticulum protein family member 2"	Q8N6R1	13	44373665-44397714	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7;choroid plexus: 53.7"	"Group enriched"	"Detected in many"	11	"Early spermatids: 577.8;Late spermatids: 237.7"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.7;SH-SY5Y: 5.1;U-2197: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (6.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	1.2	2.0	67.6	1.0	70.7	0.0	2.6	60.7	87.7	2.7	53.7	3.9	2.9	4.0	9.0	0.8	2.3	0.9	18.8	71.5	67.0	3.3	1.2	1.1	1.4	63.4	66.0	4.7	1.7	1.3	8.5	0.3	65.0	3.5	1.1	14.2	1.1	3.8	2.1	0.6	2.0	2.0	61.1	0.4	2.7	27.3	66.7	1.9	1.2	0.4	1.2	2.0	2.0	68.4	0.0	0.0	2.1	0.0	0.3	1.8	0.0	0.4	0.6	2.3	1.5	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.4	0.0	0.1	1.9	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.4	5.1	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	0.1	4.7	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	67.6	70.7	60.7	87.7	71.5	67.0	63.4	66.0	65.0	61.1	66.7	68.4	4.0	0.0	1.5	19.6	0.1	1.8	3.7	1.9	4.6	21.0	12.0	7.2	20.0	4.3	1.0	9.2	14.6	2.5	1.1	2.9	17.6	11.3	577.8	0.7	4.6	3.9	14.4	0.8	34.6	12.9	2.5	10.3	0.5	1.2	17.8	7.8	1.4	6.2	0.2	15.2	29.8	4.0	0.0	0.0	1.1	237.7	13.1	0.7	12.4	9.4	0.6	25.0	1.0	13.0	27.1	6.3	1.7	19.2	0.1	3.4	3.9	8.9	1.3	23.3	26.3	15.1	10.0	8.5	12.5	0.4	1.0	2.1	1.8	4.6	4.4	3.2
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612384-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 9176.5;pancreas: 4910.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 449.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	94000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	91.8	58.0	100.4	43.4	116.5	2.1	371.0	117.7	293.8	368.8	110.3	79.5	11.7	44.9	11.5	42.5	116.6	146.0	311.7	103.6	320.0	215.5	9176.5	169.9	5.0	196.3	183.1	181.5	4910.2	1.0	271.2	14.6	138.3	580.5	13.3	131.5	1505.8	54.9	177.8	55.7	91.6	83.1	141.4	31.7	290.5	66.9	176.3	2.6	72.6	38.9	6.4	207.4	70.4	173.0	0.2	0.5	0.0	0.3	0.2	0.8	0.3	0.1	0.1	0.0	0.0	1.2	4.9	0.6	4.5	0.0	3.3	0.9	0.0	4.4	0.0	2.7	0.0	1.0	0.2	449.9	56.9	1.9	0.7	52.0	63.9	0.0	2.5	5.4	0.0	0.0	0.3	0.2	0.0	17.1	0.5	0.5	0.8	1.6	0.0	0.6	2.2	0.2	3.8	0.2	0.1	0.0	1.8	2.5	65.6	0.4	2.4	0.0	0.6	0.0	8.5	0.1	19.4	1.1	2.0	2.1	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	116.5	117.7	293.8	103.6	320.0	196.3	183.1	138.3	141.4	176.3	173.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.5	1.8	0.0	5.6	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	3.7	0.2	0.1	0.3	0.0	0.0	0.0	33.0	0.0	68.6	9.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	18.7	0.0	0.4	0.3	0.5	0.0	0.1	1.5	0.0	0.0	1.7	0.8	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593118	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 484.5;liver: 785.6;testis: 432.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078846	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA078846: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	5.1	484.5	1.8	3.3	2.4	0.0	19.6	2.2	1.7	29.6	3.0	5.3	5.5	31.8	1.2	0.8	26.3	160.5	19.0	1.6	7.2	151.4	785.6	1.0	3.6	3.5	3.8	30.1	173.9	0.2	3.2	0.1	5.3	6.8	1.9	14.0	9.4	153.3	46.4	3.3	3.6	2.1	1.7	112.2	12.1	432.4	2.8	0.9	4.1	152.6	4.7	2.3	4.0	3.7	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	12.0	12.2	0.0	8.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	261.3	0.3	0.4	0.0	1.7	0.3	0.1	0.0	2.3	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.5	0.2	3.9	0.1	0.4	17.4	0.2	0.1	7.9	0.9	0.1	0.0	0.5	0.0	0.6	0.4	1.5	0.2	0.1	0.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	2.2	1.7	1.6	7.2	3.5	3.8	5.3	1.7	2.8	3.7	0.9	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.2	18.9	14.1	0.8	400.4	0.1	33.1	2.1	0.0	0.1	0.0	64.6	103.2	78.7	175.2	19.7	40.3	0.0	2.7	0.0	122.2	0.0	18.2	0.5	345.3	0.0	78.2	2.5	198.2	0.0	8.4	0.0	0.0	0.0	3.2	0.7	277.8	57.2	1.9	0.0	0.0	0.6	5.4	0.0	0.0	0.2	18.3	0.0	144.4	0.0	0.1	0.0	7.5	0.0	1.4	6.6	11.6	1.5	11.1	2.9	0.0	0.6	0.3	1.8	58.7	0.0	0.1
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 776.6"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 204.5;Hepatocytes: 390.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"T-47d: 961.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	37000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	1.9	0.0	3.5	0.1	0.5	0.0	0.0	12.6	35.1	0.0	0.0	0.0	43.5	776.6	0.1	0.0	0.0	0.0	0.3	17.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	114.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.4	4.5	0.1	0.4	0.0	0.1	0.7	0.0	0.0	961.9	0.0	0.0	0.5	0.0	0.6	0.0	0.3	0.0	0.5	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	4.4	0.0	0.4	204.5	0.3	0.0	0.0	0.3	0.0	0.4	1.9	33.1	0.0	62.6	0.3	0.4	9.0	16.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	9.7	390.8	0.0	0.0	0.0	0.8	2.0	8.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.0	1.2	0.0	0.0	0.0	0.1	43.0	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.1
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 282.2"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 182.8"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	475	"Hep G2: 69.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	282.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	182.8	0.0	0.0	0.0	0.7	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 56.6;esophagus: 180.4;vagina: 135.0"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 58.8;Club cells: 54.8;Squamous epithelial cells: 148.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 45.9;head and neck cancer: 27.6;lung cancer: 12.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	129	"HaCaT: 198.9;hTCEpi: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		210000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear speckles, Cytosol"		"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	56.6	0.0	0.0	0.0	0.0	0.0	180.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	35.7	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	22.9	3.3	135.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.7	1.9	58.8	13.1	0.0	0.0	0.1	0.1	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	8.5	0.0	0.0	0.0	1.0	0.0	0.0	148.6	1.3	0.5	0.0	0.0	0.0	19.9
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903888	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 239.1;lymphoid tissue: 81.2;skin 1: 89.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2243.9;Suprabasal keratinocytes: 1053.6;Syncytiotrophoblasts: 439.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.3;thalamus: 1.1"	"Immune cell enhanced"	"Detected in some"		"basophil: 22.0;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 282.7;HaCaT: 699.1;U-138 MG: 807.0;U-2197: 1243.9"	"Region enriched"	"Detected in single"	15	"cerebellum: 2.6"	"Not detected"	"Not detected"			"HPA015480, HPA076596, HPA076608"	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"			"HPA015480: AB_1855456, HPA076596: , HPA076608: "	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.55e-5)"	21.0	0.3	0.0	8.6	0.0	36.5	8.7	0.0	1.3	21.0	0.0	0.5	0.1	0.7	0.0	239.1	8.4	0.7	1.0	0.0	0.2	0.2	0.3	2.8	0.0	0.0	0.1	0.3	1.1	0.2	0.1	50.1	0.0	0.2	0.0	0.0	31.2	0.0	0.3	89.2	0.1	1.7	0.0	0.3	0.8	0.0	1.1	2.6	0.1	0.2	81.2	6.6	45.4	0.0	1.4	0.0	0.0	0.8	1.3	0.6	0.2	169.2	179.2	6.0	13.1	0.9	0.4	0.2	0.0	6.1	282.7	699.1	0.0	143.7	118.6	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.5	1.5	13.9	81.7	37.0	1.8	0.6	0.0	0.6	0.4	2.8	0.0	0.2	0.4	0.3	0.2	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	1.1	0.0	0.6	0.7	15.7	13.9	807.0	0.4	1243.9	0.0	0.2	0.1	0.0	21.6	1.8	96.7	22.0	4.9	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.5	0.0	0.2	2243.9	4.1	82.1	0.0	0.0	0.6	0.1	0.7	0.0	153.4	0.0	0.0	6.2	0.1	0.0	0.0	92.6	0.0	0.1	0.1	5.5	0.0	0.0	0.0	7.1	1.7	11.0	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	26.4	2.9	86.4	0.0	0.0	73.1	94.3	0.0	3.9	0.0	0.0	0.0	0.0	167.2	0.0	0.0	1.0	18.9	0.0	0.0	94.5	0.0	0.0	0.3	14.8	0.0	0.0	94.7	1053.6	439.3	2.5	0.0	0.0	52.0
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661893	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix: 418.5;esophagus: 809.7;vagina: 669.6"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 6903.4;Club cells: 6726.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 186.5;head and neck cancer: 69.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		9100000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.1	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	418.5	0.0	0.1	0.0	3.2	0.0	809.7	0.2	0.2	0.4	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	7.6	0.0	0.0	100.0	0.0	0.1	42.9	0.1	0.0	0.0	0.1	0.5	1.9	0.0	4.8	0.1	0.0	19.6	73.8	669.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	6.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	35.2	6903.4	2.2	0.0	0.0	0.0	0.0	0.0	6726.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	31.4	0.1	0.2	0.5	0.0	0.0	0.0	8.9	0.0	3.0	0.0	0.9	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	986.7	0.0	0.0	55.4	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	60.2	0.0	0.2	447.6	0.0	0.0	0.0	178.1	1.0	0.3	413.5	0.0	0.3	0.8	0.0	0.0	265.9
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644256	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 78.6;esophagus: 93.3;vagina: 150.9"	"Cell type enriched"	"Detected in some"	4	"Basal respiratory cells: 3577.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.1;head and neck cancer: 29.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;HSkMC: 1.1;SiHa: 1.7;U-2197: 6.1"									"HPA048341, HPA049988, HPA055992"	Supported					NA	NA		10000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.6	0.0	93.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	0.0	23.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.5	21.0	150.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	3577.0	0.0	0.0	0.0	0.0	0.0	0.0	825.8	0.0	0.0	0.0	0.0	0.0	0.0	23.9	1.4	0.1	0.1	0.2	0.0	0.0	0.0	21.7	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	97.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	32.4	0.0	0.3	53.0	0.0	0.0	0.0	10.7	0.1	0.0	14.8	0.0	0.8	0.0	0.0	0.0	60.5
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476958-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 216.6;skin 1: 239.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		770000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.6	0.0	0.0	4.3	0.0	0.2	37.1	0.1	0.1	38.5	0.1	4.8	16.7	0.1	0.1	216.6	1.4	2.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	9.9	4.5	0.0	37.6	1.7	1.4	239.7	22.1	0.2	0.0	0.0	9.7	2.8	0.0	13.9	0.1	0.0	39.9	90.9	78.7	0.1	80.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	73.4	0.1	3.8	0.0	0.1	1279.3	0.0	425.6	0.0	0.0	0.0	0.0	95.8	0.2	0.0	0.0	0.6	0.1	875.0	0.0	217.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	179.9	93.4	0.1	0.0	0.2	0.0	95.1	1.4	0.0	60.2	0.3	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.2	0.9	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	964.1	358.7	272.9	224.3	0.0	5.1	27.3	0.2	0.0	90.0	3.7	0.0	0.3	0.1	14.2	0.0	0.1	9.0	6.2	0.1	5.4	3.5	0.0	0.3	0.0	0.2	5.8	12.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.3	34.6	0.0	57.6	18.6	0.6	1.8	62.2	0.0	0.0	0.0	0.0	0.0	0.1	16.3	51.7	0.0	2.5	85.4	13.5	0.1	85.4	0.0	0.0	0.0	7.1	6.6	2.2	535.4	1215.3	0.1	4.0	0.1	30.6	564.9
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 563.0;Late spermatids: 1154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	122.7	170.7	101.1	66.9	108.4	66.6	107.9	103.6	134.3	135.9	103.8	133.7	191.2	95.9	82.2	131.5	118.9	77.7	243.9	98.6	104.2	136.7	63.3	151.7	52.7	111.7	107.1	169.7	282.5	94.4	92.0	133.5	110.6	160.4	103.3	56.4	92.5	95.6	232.0	50.9	210.3	89.4	105.8	164.5	115.0	203.8	106.7	26.7	101.3	266.8	47.2	107.7	95.5	115.4	156.2	99.6	32.2	134.3	85.6	189.2	99.2	142.1	170.7	109.9	127.3	35.0	108.5	0.8	161.6	161.7	124.8	228.8	90.3	144.1	102.2	204.9	41.2	90.7	111.8	60.0	148.5	1.1	53.0	109.4	98.5	104.8	26.9	191.1	263.7	0.5	118.7	2.0	198.0	110.7	0.5	1.5	19.1	175.5	188.8	10.1	59.3	130.7	138.7	37.1	1.5	82.5	116.9	17.3	162.4	118.6	75.3	73.8	188.7	111.1	41.4	252.0	97.1	3.0	0.6	2.7	85.4	90.8	117.8	60.6	104.9	121.2	51.5	107.6	25.7	27.3	28.9	35.5	103.6	22.9	33.7	56.1	8.6	86.0	90.7	10.3	5.0	91.1	101.1	108.4	103.6	134.3	98.6	104.2	111.7	107.1	110.6	105.8	106.7	115.4	127.8	51.3	69.6	34.3	33.0	20.5	68.4	141.8	23.9	28.4	62.4	63.0	142.6	42.9	141.6	75.4	20.9	146.4	56.8	237.9	99.7	194.6	563.0	89.4	91.4	137.5	73.0	29.9	14.2	338.3	346.6	84.9	108.6	47.8	104.5	83.5	232.7	31.9	182.3	30.3	21.5	169.7	114.0	181.9	70.2	1154.3	83.3	124.2	64.0	92.8	151.8	172.4	46.4	31.7	56.2	318.5	237.0	85.0	17.4	99.3	418.3	216.4	174.2	50.4	78.9	119.7	104.6	233.2	33.1	34.0	26.3	161.4	42.2	65.0	206.5	94.9
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 38.4;skin 1: 129.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 79.5;Basal respiratory cells: 353.3;Club cells: 120.7;Ductal cells: 157.8;Extravillous trophoblasts: 82.2;Pancreatic endocrine cells: 276.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.0;head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 240.4;fHDF/TERT166: 170.8;HaCaT: 412.8;HBEC3-KT: 131.9;HBF TERT88: 223.0;hTERT-HME1: 130.9;U-138 MG: 219.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"cerebral cortex: 12.9;hippocampal formation: 11.4"	HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		160000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.5	0.0	0.0	0.4	0.0	0.0	13.0	0.0	0.0	3.0	0.0	0.7	0.0	0.7	0.0	1.8	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.7	0.0	0.5	129.5	0.0	0.1	0.0	0.0	0.7	0.4	0.1	4.5	0.0	0.0	38.4	0.0	4.8	0.0	28.2	0.1	0.0	0.1	0.0	3.7	0.0	240.4	48.2	36.0	26.6	0.0	1.0	0.1	0.1	170.8	62.5	412.8	0.1	131.9	223.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	8.6	22.9	5.5	130.9	1.8	0.0	0.0	0.0	0.8	21.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.8	0.1	0.2	0.0	219.4	8.1	4.7	22.8	0.1	0.0	0.0	22.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	79.5	0.9	353.3	0.0	0.0	0.1	0.0	0.0	0.0	120.7	0.0	0.0	1.9	0.0	0.5	0.0	157.8	0.1	0.0	0.0	0.5	0.0	0.0	0.2	8.8	82.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	2.0	0.0	3.0	0.0	0.0	0.2	3.6	0.0	1.6	0.0	0.0	0.5	0.3	276.5	1.1	0.0	0.0	4.5	0.0	0.3	13.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	21.9	6.2	0.1	0.0	0.0	8.2
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.1;placenta: 52.3"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	11.6	11.0	6.4	35.4	6.7	18.9	5.3	7.5	7.9	7.8	5.9	5.3	4.4	4.4	3.1	9.2	8.3	11.3	9.1	6.3	8.0	5.2	16.3	26.4	40.9	8.8	7.8	3.0	2.4	6.7	8.8	52.3	8.7	5.2	6.5	4.7	4.3	2.8	2.4	2.7	10.8	5.9	8.4	28.2	5.0	8.7	7.2	13.8	7.6	1.8	41.1	17.0	7.4	8.2	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.4	6.7	7.5	7.9	6.3	8.0	8.8	7.8	8.7	8.4	7.2	8.2	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1341	"liver: 5056.6"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.7	5056.6	0.3	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.2	1.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.3	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 1253.1"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.3	0.2	0.1	0.0	0.8	0.2	0.4	1.7	0.8	1.0	87.7	0.0	0.0	2.0	0.0	0.1	0.9	0.4	1.1	1.7	0.0	0.3	1253.1	2.5	0.0	0.0	0.0	1.8	0.5	10.1	0.8	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.8	1.7	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 418.0"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	13000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	215.5	75.3	3.1	91.6	3.4	1.7	56.2	5.2	12.8	62.1	5.0	31.7	7.4	31.1	1.0	16.4	41.3	360.3	136.0	3.9	6.6	166.2	345.8	260.2	21.3	6.4	3.7	105.6	135.1	11.8	12.3	418.0	4.5	37.8	5.4	4.9	10.6	8.0	17.8	21.2	13.1	74.3	4.8	13.8	30.3	5.5	12.7	6.7	59.5	4.3	3.5	359.9	19.2	6.0	77.3	64.4	1.2	5.1	766.6	1511.0	89.3	3483.8	654.6	1717.6	1487.4	9.4	5.5	2.7	812.6	1117.9	2367.3	18.1	0.4	269.4	1756.2	4.3	0.7	1.1	5.2	61.4	1532.6	0.2	3.8	596.1	106.9	2641.4	1374.8	928.5	4014.7	0.2	6.4	2.5	3874.5	0.4	0.6	2.2	18.2	1.3	41.7	0.6	6.1	4.8	5.1	30.3	1.0	0.8	286.3	77.2	8.3	410.9	3.3	9.9	10032.6	4609.6	204.0	1593.8	4256.0	0.6	2.9	4.2	1150.5	2.4	45.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	9.5	0.0	0.3	0.0	0.8	3.1	3.4	5.2	12.8	3.9	6.6	6.4	3.7	4.5	4.8	12.7	6.0	35.8	0.0	7.7	0.0	1.1	40.0	43.7	97.4	14.2	0.3	0.3	2.3	2.5	4.3	11.0	5.5	0.0	56.0	1.0	0.4	0.0	65.1	0.0	4.7	53.8	165.1	5.3	0.0	0.5	4.5	75.1	162.1	0.5	3.2	10.2	12.4	40.4	112.3	15.9	0.0	0.3	0.2	8.2	4.6	9.6	1.1	17.7	11.1	7.2	5.6	1.1	0.7	0.0	0.0	0.0	231.8	0.0	12.0	3.6	9.7	0.1	0.0	8.2	0.3	39.5	55.4	239.3	0.0	0.1	9.0	24.7	651.7	2.3	2.1	0.5	8.1
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;pancreas: 1.3;retina: 1.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.9;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.5;Spermatocytes: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA051904: AB_2681659, HPA055804: AB_2682928"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	0.7	0.1	0.3	0.2	0.6	0.0	0.1	1.7	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.7	0.2	0.1	0.2	0.0	0.3	0.5	0.3	0.1	1.3	0.0	0.1	0.0	0.6	0.1	0.0	1.8	0.1	0.0	0.0	0.8	0.7	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.6	0.8	0.2	0.5	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	1.7	0.9	0.7	0.2	0.5	0.3	0.6	0.2	0.3	0.8	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.2	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	2.9	0.0	0.9	0.0	0.0	0.5	0.7	0.0	0.0
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1762029-1777565	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1875.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 245.2"	"Region enhanced"	"Detected in many"		"hippocampal formation: 85.4"	"Immune cell enriched"	"Detected in many"	18	"plasmacytoid DC: 1454.4"	"Lineage enriched"	"Detected in all"	121	"dendritic cells: 1454.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	44000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	535.5	57.5	5.7	124.2	9.6	11.9	490.2	17.9	28.0	558.7	1875.2	131.3	41.9	358.2	90.2	109.3	557.4	559.7	376.5	85.4	1.1	35.1	974.8	158.9	133.5	0.1	5.1	408.3	207.6	11.2	62.4	311.6	1.3	202.8	52.0	61.4	124.6	105.8	434.8	162.9	131.7	221.7	2.8	133.2	124.7	277.7	25.4	106.2	193.1	465.5	117.7	323.4	273.5	7.0	0.5	3.7	2.8	2.0	1232.0	956.3	20.4	56.8	49.8	0.6	0.0	9.7	0.5	2.3	1.9	71.8	0.3	3.2	86.0	4.4	0.0	0.6	46.0	1.0	1.2	606.0	410.6	1.1	1.1	1313.4	6.9	0.9	1.1	11.4	0.6	4.2	117.5	0.4	63.2	0.2	7.0	7.2	30.7	0.3	1.0	2.9	219.9	1.6	0.1	6.0	1.9	42.2	0.7	0.7	57.0	3.4	6.7	184.2	2.0	0.5	17.6	14.1	1.2	0.7	2.4	28.1	1.7	0.6	0.8	0.1	12.0	1.1	0.6	4.4	0.4	9.0	0.7	0.9	79.8	5.2	2.0	5.5	1.7	1.3	0.2	1454.4	0.8	14.2	5.7	9.6	17.9	28.0	85.4	1.1	0.1	5.1	1.3	2.8	25.4	7.0	59.0	3.2	10.4	0.3	10.8	95.0	238.0	697.8	27.9	59.3	6.7	71.2	12.1	11.5	167.7	1.8	223.1	795.6	226.1	0.0	0.0	0.3	11.2	12.5	372.4	26.2	0.0	19.2	5.3	24.5	98.7	951.9	11.2	6.7	22.9	1.7	28.2	765.0	151.6	3.3	2.6	0.0	366.2	60.4	262.6	53.0	1818.0	79.0	108.5	9.4	79.0	11.6	1.0	0.5	2.0	6.8	0.1	1045.7	7.0	155.5	0.2	27.3	105.5	39.1	19.7	193.3	202.8	12.7	8.7	4.5	78.6	534.8	14.3	10.2	0.3	47.7
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1578.5"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	11.6	2.0	1.4	4.3	1.5	0.4	18.3	1.2	2.2	7.1	11.1	4.2	0.7	8.7	101.4	3.0	19.6	0.7	2.5	2.0	1.4	74.1	1578.5	12.9	3.0	1.6	1.6	7.7	9.2	0.1	1.9	0.8	1.7	21.4	0.5	0.5	6.1	32.6	4.3	5.5	11.6	1.8	1.3	7.1	3.7	12.5	1.8	2.6	7.9	0.4	3.5	7.3	5.8	2.2	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.4	1.5	1.2	2.2	2.0	1.4	1.6	1.6	1.7	1.3	1.8	2.2	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2622.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	971.5	144.2	27.4	90.0	27.5	10.9	733.0	27.1	36.0	629.4	53.4	358.7	52.0	616.7	163.3	162.0	793.2	533.0	547.1	26.2	34.8	337.3	2622.4	785.0	147.6	67.4	34.7	918.3	267.5	55.2	138.2	198.9	34.2	329.3	97.0	34.5	250.5	258.1	151.8	293.5	283.5	226.8	42.3	240.7	344.8	50.6	37.2	36.1	338.2	173.4	64.4	555.9	519.8	35.1	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	27.4	27.5	27.1	36.0	26.2	34.8	67.4	34.7	34.2	42.3	37.2	35.1	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 291.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	Yes		920000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	214.1	101.9	46.2	106.5	50.4	3.7	107.1	51.1	291.0	137.7	66.7	95.2	23.2	160.7	27.6	41.7	119.4	72.1	159.3	46.1	50.5	116.9	52.5	199.3	21.1	59.9	47.3	157.4	40.1	18.1	50.8	251.3	58.3	66.1	36.7	2.0	40.7	53.2	22.2	47.6	51.3	207.3	51.6	53.9	76.9	27.7	54.0	21.6	91.2	33.2	18.2	156.8	85.9	60.1	57.7	192.9	349.5	722.0	528.8	484.2	162.2	514.3	349.6	380.4	483.5	1018.3	294.1	0.4	470.2	1215.2	3.1	337.2	242.2	163.2	182.5	27.5	47.0	42.7	174.0	216.5	1029.5	0.9	7.2	580.9	165.2	365.0	121.3	475.5	530.8	22.1	90.5	16.1	182.5	457.6	1.2	74.8	315.6	215.8	50.7	29.3	200.3	48.8	95.6	107.8	9.1	119.1	326.9	59.7	102.0	539.6	144.4	72.7	284.6	388.6	324.6	270.6	128.3	23.1	25.5	6.1	168.0	0.2	535.6	4.1	1.1	0.1	6.0	1.1	5.2	0.9	3.9	4.0	4.4	0.7	4.0	3.3	0.2	5.9	0.1	3.7	3.5	2.1	46.2	50.4	51.1	291.0	46.1	50.5	59.9	47.3	58.3	51.6	54.0	60.1	142.3	38.5	32.0	4.9	2.9	81.8	473.6	56.5	74.0	5.3	28.3	39.5	36.6	14.3	21.0	25.8	58.4	217.0	3.2	33.0	0.0	64.5	2.9	21.8	273.3	194.9	61.1	11.4	0.4	11.9	342.1	287.6	15.3	33.0	9.5	144.1	124.9	9.9	94.2	6.7	0.2	55.7	22.4	5.7	110.0	6.0	164.4	43.6	44.4	18.7	9.8	14.3	8.2	1.0	0.5	22.5	24.3	120.7	6.5	139.8	12.4	22.8	11.9	1.2	92.1	31.4	295.1	29.3	23.0	14.1	44.5	165.8	68.8	79.8	62.8	73.4
SERPINI1	PI12	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825569	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 301.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		750000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	13.1	15.8	138.8	4.1	157.7	2.3	11.7	115.9	301.4	8.4	82.1	5.1	2.2	8.6	8.2	5.5	7.9	6.3	14.0	162.0	129.1	32.1	4.1	6.4	4.6	122.8	153.6	6.9	39.5	6.9	42.8	6.7	123.9	11.8	4.4	84.4	23.0	7.4	3.2	3.1	4.4	6.1	134.6	8.7	10.8	15.8	134.5	4.4	11.2	8.1	8.2	4.9	6.0	164.8	0.8	3.5	5.5	0.4	10.3	2.2	0.3	1.9	2.7	1.3	2.2	1.5	5.9	29.2	9.5	1.3	4.5	1.3	3.9	3.8	1.5	7.7	6.5	8.9	22.5	10.7	0.7	1.4	1.1	3.8	1.4	0.8	1.3	2.9	0.4	10.5	18.9	29.1	1.2	2.7	0.8	1.9	3.3	4.2	4.5	2.7	0.4	3.2	11.2	1.0	2.2	13.4	3.6	6.8	8.3	12.4	10.6	4.4	1.0	5.5	0.5	0.5	10.3	23.0	28.4	18.8	4.2	7.7	3.2	1.5	0.3	0.8	9.3	0.7	6.9	22.1	9.7	10.2	0.5	25.2	6.9	8.1	0.9	9.5	0.5	7.2	27.2	5.2	138.8	157.7	115.9	301.4	162.0	129.1	122.8	153.6	123.9	134.6	134.5	164.8	49.8	6.4	1.5	43.1	10.7	3.7	13.2	6.4	14.2	219.4	3.6	14.1	8.2	1.5	6.7	5.5	14.6	6.1	6.2	0.7	7.9	1.8	0.4	2.0	1.0	16.0	4.8	7.4	176.9	18.0	6.0	8.9	2.6	1.7	2.5	2.3	3.9	0.6	2.3	5.0	228.8	0.3	73.2	0.6	3.2	2.4	4.1	0.9	7.2	25.3	1.2	78.0	2.1	31.2	174.7	3.0	0.0	2.6	14.6	6.7	0.0	39.9	13.6	35.4	26.3	5.2	54.7	3.0	27.4	0.5	1.7	5.1	6.2	1.1	0.3	2.3
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 177.6;Basal squamous epithelial cells: 153.1;Suprabasal keratinocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.1	6.7	4.3	13.8	5.8	85.7	9.4	5.3	5.5	12.7	3.8	8.5	6.2	8.6	7.9	22.8	6.9	9.4	10.3	5.0	4.5	7.5	14.6	9.7	19.2	6.3	5.9	13.5	6.6	10.7	3.6	12.6	5.8	9.3	8.7	15.6	11.7	8.5	8.6	18.8	9.0	8.1	5.4	19.3	9.2	7.2	5.3	35.3	8.1	9.6	27.3	15.9	16.8	7.1	30.9	9.0	16.5	16.6	13.9	35.2	18.9	24.2	23.2	14.1	13.2	23.1	23.0	26.0	13.0	39.8	19.6	12.0	10.9	14.8	29.6	2.5	16.4	17.2	8.8	16.8	3.1	15.3	8.4	24.0	19.1	32.2	20.9	21.1	8.6	12.7	10.9	14.1	33.2	7.4	16.5	16.7	9.0	16.9	23.6	14.3	28.2	10.2	19.1	28.0	19.1	7.5	17.1	11.9	31.5	15.3	7.9	12.1	26.1	75.7	39.1	44.8	19.9	24.0	9.8	29.6	28.0	27.7	30.3	1.3	1.6	2.3	0.9	1.5	0.5	2.5	0.9	1.0	1.5	2.5	2.2	1.6	2.0	1.5	1.8	4.9	0.5	0.9	4.3	5.8	5.3	5.5	5.0	4.5	6.3	5.9	5.8	5.4	5.3	7.1	25.6	6.4	23.6	22.9	40.8	177.6	40.9	22.5	153.1	24.8	28.7	28.6	26.4	32.9	25.9	9.2	18.8	38.6	33.0	31.6	1.9	12.8	51.2	57.8	18.5	35.4	11.3	26.5	27.3	10.0	42.8	35.1	17.3	97.7	8.8	4.8	25.4	24.1	23.6	10.1	19.8	17.1	18.3	39.3	84.7	35.4	17.1	43.6	39.2	38.4	27.4	20.0	14.4	19.6	35.5	20.7	45.4	10.5	28.1	43.9	11.6	9.5	24.9	24.3	13.1	26.8	31.0	10.8	6.7	135.4	148.3	60.1	25.5	3.7	13.3	71.5
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232796-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.1	0.3	0.6	0.3	1.6	0.0	3.6	1.0	1.1	2.0	0.2	4.8	0.4	3.8	0.6	4.2	1.7	0.7	3.0	0.6	1.0	1.9	0.0	1.5	0.1	0.9	1.4	1.0	0.1	0.6	0.9	1.0	1.0	1.8	1.4	0.1	5.9	1.4	0.2	3.3	0.8	2.7	1.2	0.1	1.4	0.2	0.8	0.6	1.4	0.7	0.7	0.6	1.8	1.1	7.5	0.1	1.6	0.0	0.8	0.7	7.4	1.8	1.8	1.4	2.4	0.3	0.8	0.0	0.2	0.4	1.1	3.6	0.2	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	1.7	0.2	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.2	6.0	0.3	0.0	2.4	0.0	1.2	1.3	7.4	6.3	1.2	8.5	0.1	2.9	10.5	0.0	2.3	2.0	8.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	1.0	1.1	0.6	1.0	0.9	1.4	1.0	1.2	0.8	1.1	5.0	6.4	3.9	1.6	0.0	16.7	9.6	16.0	28.5	2.5	23.1	9.3	0.7	1.5	10.9	9.2	0.0	14.2	0.0	1.5	7.9	2.1	0.5	4.8	1.2	5.2	1.2	0.0	10.1	3.9	54.9	7.5	2.6	5.8	0.0	9.3	2.5	0.0	1.4	0.0	3.7	5.6	24.4	0.0	5.0	0.6	0.6	0.3	10.6	3.7	0.0	0.5	0.0	1.0	9.4	8.1	1.3	1.5	0.0	2.5	0.0	0.4	13.9	0.3	0.0	1.8	3.7	0.1	1.7	27.4	4.7	4.4	0.3	0.1	6.5	3.4
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259518-28282491	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 46.5;SK-MEL-30: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	10.9	9.0	6.4	2.9	6.3	19.4	8.5	5.8	7.5	7.4	5.2	10.1	7.6	8.2	1.6	20.0	7.9	3.3	6.3	5.9	7.1	15.9	24.7	9.6	2.0	7.5	7.5	27.9	10.6	4.4	6.6	4.8	6.9	6.2	4.0	1.4	8.5	1.9	7.6	5.3	8.8	2.9	6.8	6.9	11.1	10.7	9.5	2.4	5.3	2.4	2.0	7.6	8.8	7.1	5.6	3.0	7.1	11.8	11.3	8.9	38.6	10.5	9.6	6.3	7.4	4.3	4.0	6.3	4.3	4.8	7.0	5.5	8.3	7.4	4.3	5.7	7.7	2.6	4.3	7.3	37.0	9.5	13.7	28.1	46.5	16.9	40.0	2.9	7.0	14.6	15.2	29.3	5.9	3.2	3.5	2.6	5.7	2.6	6.0	5.3	1.9	14.6	4.2	9.3	2.4	2.8	3.0	2.4	58.5	7.8	6.5	13.4	4.1	3.2	9.9	7.3	6.4	37.9	10.4	10.0	7.5	9.5	7.2	0.0	1.5	1.3	5.7	1.2	2.7	1.1	2.0	2.8	1.5	0.7	1.2	2.5	3.9	2.5	1.9	1.7	2.4	1.8	6.4	6.3	5.8	7.5	5.9	7.1	7.5	7.5	6.9	6.8	9.5	7.1	26.4	0.0	5.0	3.6	9.9	17.0	21.1	14.2	26.7	11.6	21.4	15.1	7.3	12.8	9.0	7.3	8.4	31.2	30.6	35.9	3.9	24.3	6.5	11.8	8.9	7.8	13.1	2.7	3.9	16.9	27.0	11.8	13.7	12.1	4.5	10.9	9.3	19.8	13.8	0.0	6.1	11.2	16.2	5.7	22.2	3.7	2.5	20.0	7.2	4.7	5.9	6.6	9.2	3.5	1.4	31.9	15.2	3.4	13.0	13.6	27.7	23.4	8.3	7.8	0.0	7.9	14.3	5.6	12.5	19.8	12.5	66.9	20.7	7.3	12.8	29.9
SESTD1	"DKFZp434O0515, Solo"	ENSG00000187231	"SEC14 and spectrin domain containing 1"	Q86VW0	2	179101678-179264832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 175.5;Horizontal cells: 301.2;Oligodendrocytes: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058236, HPA077408"	Approved		Enhanced	"Intermediate filaments"		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments"		"HPA058236: AB_2732619, HPA077408: AB_2732344"	"unprognostic (2.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (9.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"unprognostic (9.21e-2)"	"prognostic favorable (2.78e-11)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-2)"	15.4	2.4	11.6	3.2	17.2	4.7	11.2	12.5	11.4	6.2	0.9	7.1	2.0	5.8	3.9	4.5	4.5	6.4	6.3	8.2	10.3	6.7	3.4	9.2	3.4	16.2	13.5	4.5	3.3	3.9	3.6	6.8	14.6	4.2	3.8	7.5	11.0	4.6	3.6	4.5	5.4	8.1	15.1	3.5	5.5	9.0	18.1	2.9	3.7	5.8	4.9	10.0	4.8	23.6	0.0	2.1	25.5	4.6	45.2	19.5	13.5	9.0	3.7	3.7	6.3	4.6	6.0	4.5	11.7	8.7	4.5	4.2	11.0	5.1	6.8	3.3	2.9	5.5	11.2	12.3	3.5	3.1	2.3	14.6	2.1	5.7	14.3	8.9	15.2	4.6	0.8	2.3	6.4	3.1	7.2	0.3	6.6	4.7	2.6	10.3	16.8	2.9	10.0	23.2	5.6	9.5	8.0	3.4	2.5	18.7	0.5	3.4	26.7	12.3	6.2	6.3	4.7	1.3	0.0	11.0	6.2	1.2	3.7	0.0	0.9	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.2	11.6	17.2	12.5	11.4	8.2	10.3	16.2	13.5	14.6	15.1	18.1	23.6	46.2	109.0	29.9	53.2	30.6	9.8	24.7	19.1	7.4	31.3	30.4	15.6	15.3	28.6	32.9	12.9	18.8	10.7	5.7	11.9	17.6	31.3	9.8	61.3	33.1	32.1	25.0	7.2	110.8	27.7	73.4	65.1	13.7	175.5	0.0	23.1	21.4	9.6	12.3	301.2	147.9	7.3	14.2	28.7	43.4	7.3	12.2	37.2	14.2	89.0	21.9	33.4	5.2	86.5	311.1	33.3	13.3	30.5	4.7	67.7	22.5	39.1	42.8	10.4	19.7	43.7	29.2	34.9	66.0	10.2	10.1	18.1	5.7	9.8	9.7	119.9
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A, histone lysine methyltransferase"	O15047	16	30957754-30984664	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	10.2	10.0	6.0	7.3	5.5	20.1	10.0	8.4	8.3	11.0	3.0	13.0	6.6	13.0	2.8	9.0	10.5	4.1	8.5	5.5	5.5	8.4	10.4	8.2	8.6	5.6	5.4	12.4	10.6	8.0	11.9	5.0	5.4	10.2	3.3	3.1	9.3	6.1	15.1	12.3	10.5	6.3	4.1	11.8	10.0	20.8	6.0	10.0	11.8	7.1	5.1	10.2	9.3	6.9	13.1	24.4	15.9	19.4	8.7	6.3	18.0	13.6	10.6	11.9	10.1	20.2	12.8	34.2	15.2	13.0	12.0	16.4	15.0	14.6	9.3	18.5	56.1	16.0	47.1	23.2	8.9	26.6	26.2	11.0	11.3	17.1	10.8	9.2	9.3	19.5	32.3	19.0	6.4	27.2	32.3	27.7	23.4	9.0	15.4	48.7	15.9	21.9	7.6	13.9	17.6	18.1	18.7	15.1	10.8	8.7	16.2	22.1	12.8	17.7	17.1	11.6	14.9	28.0	36.2	32.4	14.3	22.9	13.5	0.0	0.1	0.6	0.2	0.3	0.3	0.0	0.2	0.2	0.1	0.5	0.1	0.2	0.0	0.2	0.1	0.6	0.1	0.2	6.0	5.5	8.4	8.3	5.5	5.5	5.6	5.4	5.4	4.1	6.0	6.9	7.8	3.2	9.2	9.1	8.8	15.7	5.1	3.8	15.4	8.1	9.5	8.3	3.9	5.7	4.0	7.3	6.2	4.6	11.4	6.8	0.0	4.2	3.1	6.1	8.2	9.9	10.3	6.7	6.4	4.2	3.7	7.8	6.1	8.6	3.8	9.5	7.5	9.1	6.5	13.5	6.1	7.9	2.0	4.7	7.1	2.9	9.9	5.5	8.8	6.5	4.7	4.8	7.2	2.5	5.7	5.4	4.8	11.7	7.9	8.3	5.1	2.8	4.0	5.2	6.6	10.8	7.8	17.5	23.3	15.7	12.9	2.9	8.6	10.3	6.9	4.8
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B, histone lysine methyltransferase"	Q9UPS6	12	121804009-121832656	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	14.3	8.9	2.8	8.6	2.5	15.1	12.1	7.6	4.4	19.4	1.3	28.5	7.5	26.0	4.7	14.0	19.6	4.5	8.0	2.7	0.7	8.4	11.3	9.2	6.9	1.7	1.4	15.8	12.5	5.5	9.2	5.5	0.7	15.6	3.7	3.4	11.4	10.0	9.0	11.6	15.6	7.1	0.5	13.1	16.7	9.4	1.6	8.4	13.9	4.2	4.8	22.0	14.1	1.5	7.4	14.8	7.4	12.5	6.9	4.7	11.2	6.8	5.4	5.1	2.9	8.1	4.4	5.4	6.1	7.6	3.2	11.3	8.6	5.3	3.0	9.7	10.5	16.3	20.3	7.1	5.9	15.3	14.0	5.7	6.4	7.0	5.6	6.2	5.6	10.6	17.1	3.7	3.9	17.1	22.5	21.5	10.6	3.6	8.5	17.3	4.8	7.9	5.0	15.1	9.0	6.9	15.0	10.5	5.7	5.5	12.8	13.8	9.5	7.6	9.4	10.8	7.7	7.3	4.0	3.2	6.3	9.7	8.8	1.4	0.2	0.6	0.4	0.5	0.3	0.3	0.3	0.4	0.2	0.3	0.5	0.3	1.0	0.3	0.2	0.5	0.3	0.2	2.8	2.5	7.6	4.4	2.7	0.7	1.7	1.4	0.7	0.5	1.6	1.5	10.1	3.2	7.3	9.8	11.2	11.7	3.2	5.7	26.2	13.8	12.7	9.5	9.7	10.0	6.7	5.5	8.4	7.9	17.6	8.5	0.0	5.1	9.8	13.9	14.5	9.5	7.3	7.8	10.6	7.2	7.0	8.5	8.6	20.3	3.8	10.1	12.1	13.8	6.5	11.8	11.7	7.8	4.1	17.7	14.8	21.4	11.5	10.8	1.8	5.6	13.9	5.0	9.2	5.0	6.8	6.5	10.5	10.1	11.2	9.1	6.8	3.2	5.4	10.0	6.6	10.6	12.9	11.3	3.5	29.4	12.9	13.1	13.3	8.1	6.6	9.1
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2, histone lysine methyltransferase"	Q9BYW2	3	47016429-47164113	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	9.9	6.5	8.2	10.7	10.5	23.8	10.3	24.1	8.3	12.6	10.8	9.7	9.1	13.3	6.1	9.8	11.0	8.5	7.2	6.2	6.7	10.8	10.0	9.4	13.5	8.3	8.5	15.3	13.3	16.2	2.2	11.4	8.4	10.2	11.0	10.6	9.6	9.7	11.1	9.0	10.3	11.9	8.1	11.4	10.7	13.1	7.9	19.2	15.5	14.5	13.3	9.8	4.0	12.8	21.1	13.2	25.4	14.5	15.3	18.9	11.3	17.9	17.0	20.8	19.9	15.4	13.8	43.5	11.6	25.5	20.0	12.4	29.5	17.6	27.6	27.5	12.2	47.3	24.8	12.4	11.7	34.1	26.5	15.2	17.3	20.7	24.6	15.3	20.1	22.8	29.9	16.6	17.8	9.5	26.7	8.5	20.6	9.4	15.4	17.5	25.6	23.2	12.4	26.6	10.9	17.6	29.5	11.8	12.0	17.2	12.9	27.5	26.7	24.6	18.1	21.5	29.9	22.0	25.4	43.7	14.2	19.6	14.6	1.3	1.2	2.9	2.0	1.1	1.1	2.2	1.2	1.6	1.4	2.5	1.7	1.6	3.3	3.6	1.1	1.5	0.6	0.6	8.2	10.5	24.1	8.3	6.2	6.7	8.3	8.5	8.4	8.1	7.9	12.8	50.5	48.1	58.8	115.9	58.3	33.3	22.6	15.6	54.1	40.5	31.0	29.1	67.2	27.1	53.2	11.0	41.7	20.3	58.2	32.6	11.7	20.9	26.1	62.8	63.0	41.2	22.1	38.9	131.4	22.4	12.7	39.2	56.6	66.2	58.8	68.9	23.6	29.8	16.8	26.9	129.4	28.2	14.2	28.8	26.5	35.1	30.4	42.7	17.8	148.9	37.9	22.7	43.3	113.1	143.2	23.7	22.3	33.1	54.0	31.2	24.6	11.5	49.7	39.9	13.1	56.1	42.6	71.0	29.3	60.2	35.7	18.5	65.3	57.1	29.5	34.7
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3, actin histidine methyltransferase"	Q86TU7	14	99397748-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	38.8	26.6	49.6	25.2	50.6	23.5	30.1	46.9	59.2	29.2	45.1	49.5	36.3	26.2	83.5	36.6	46.6	29.4	79.0	48.1	47.8	96.1	47.2	37.4	24.1	46.4	45.5	22.0	37.6	40.1	21.6	42.6	45.9	35.9	37.9	64.5	57.8	41.6	174.0	31.6	37.4	39.4	46.2	28.4	29.1	85.0	52.2	24.5	53.4	118.2	24.8	36.3	24.4	52.1	39.9	44.6	33.1	31.7	37.6	42.0	117.1	49.4	37.4	50.3	51.1	43.5	65.7	38.8	39.5	55.6	39.5	50.4	40.8	55.2	79.6	38.5	22.0	35.3	27.8	40.2	46.9	53.6	51.2	29.6	71.3	44.7	64.8	37.9	63.4	57.2	28.3	56.9	56.3	74.7	56.6	57.9	19.9	98.5	50.7	34.1	67.8	32.0	72.6	48.4	58.9	27.4	44.3	45.4	38.4	59.7	61.6	46.2	56.6	22.6	31.5	153.8	38.2	40.6	49.3	42.1	42.6	52.5	35.3	7.6	18.1	24.9	17.7	21.5	20.6	11.4	15.0	16.6	22.4	8.9	12.3	15.4	10.8	20.6	19.2	14.1	12.2	14.8	49.6	50.6	46.9	59.2	48.1	47.8	46.4	45.5	45.9	46.2	52.2	52.1	31.1	25.6	44.5	43.1	16.9	24.3	18.6	14.4	21.6	26.0	22.8	17.1	83.0	18.6	24.8	25.8	27.1	61.9	37.3	37.2	33.2	24.7	206.6	29.9	24.9	29.1	21.7	11.3	47.7	28.0	45.4	22.2	17.3	30.7	32.9	7.5	22.9	27.5	35.8	18.5	43.6	28.2	14.2	29.7	23.2	121.0	19.0	35.9	10.6	52.5	27.9	47.6	60.8	38.2	36.8	25.7	20.3	21.1	23.6	26.1	30.1	101.5	28.1	39.5	6.6	25.3	23.0	130.4	73.0	25.0	32.4	30.0	27.9	9.2	30.5	20.8
SETD4	"C21orf18, C21orf27"	ENSG00000185917	"SET domain containing 4"	Q9NVD3	21	36034541-36079389	"Predicted intracellular proteins"	"Inflammatory response"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.3;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024073, HPA035405"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA024073: AB_1856755, HPA035405: AB_2674612"	"unprognostic (4.23e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.05e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.17e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.28e-2)"	8.8	9.3	9.1	6.9	9.9	8.4	9.1	9.4	10.4	10.2	15.8	9.5	11.4	9.7	11.1	10.9	10.8	7.8	10.1	9.4	10.5	9.7	7.2	8.4	8.7	9.0	8.3	9.7	7.8	10.0	8.9	9.0	9.5	10.2	9.4	9.6	10.0	7.9	9.8	13.6	9.3	10.9	8.4	8.5	9.9	23.1	9.9	11.1	10.1	8.8	10.9	9.9	10.7	12.1	13.3	9.2	13.6	17.3	6.5	7.9	21.9	17.1	15.0	17.3	11.5	19.2	11.5	7.1	11.9	7.8	13.3	9.7	10.3	10.2	15.0	12.7	12.4	19.2	16.2	12.6	15.9	18.3	10.7	8.3	17.2	11.7	15.0	9.8	13.1	9.6	25.5	12.7	10.7	14.3	12.3	26.3	28.2	11.3	11.6	18.2	10.0	17.3	18.9	9.3	11.2	17.9	17.4	18.5	17.6	11.7	16.3	15.2	11.0	15.0	5.6	9.4	15.9	20.3	31.7	11.2	15.6	24.9	13.2	5.9	12.5	11.3	8.1	10.0	9.0	16.2	10.3	8.8	14.6	13.2	7.3	8.6	9.5	11.0	10.2	15.6	13.0	7.7	9.1	9.9	9.4	10.4	9.4	10.5	9.0	8.3	9.5	8.4	9.9	12.1	9.7	9.6	7.0	11.1	10.8	12.1	11.3	18.6	15.4	13.3	9.0	8.9	9.2	7.2	13.7	9.2	31.3	16.3	13.4	7.9	5.9	12.7	54.3	16.8	10.9	9.3	3.6	7.2	17.4	8.2	9.6	10.4	8.6	8.7	11.4	17.0	7.5	5.5	10.6	3.3	19.2	13.4	26.4	6.9	5.1	10.4	9.6	5.0	10.6	4.7	8.0	7.6	14.4	19.6	19.8	10.0	9.4	10.1	6.2	11.2	20.7	10.3	23.8	21.0	6.6	8.9	9.0	63.1	20.8	13.2	9.1	9.4	8.1	14.8	11.3	11.3
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	24.9	28.1	22.3	19.3	22.0	14.9	25.4	33.7	24.9	29.5	20.9	30.5	15.2	27.6	30.2	25.0	30.2	18.8	23.0	23.5	22.3	18.3	27.6	33.5	23.1	20.5	20.3	33.2	28.5	18.0	26.5	24.0	21.1	25.6	20.9	33.9	28.3	20.4	23.9	32.8	25.6	23.2	18.6	26.1	23.9	17.8	22.2	25.5	30.5	21.5	26.7	26.5	28.1	24.2	25.3	28.6	57.8	27.0	36.5	33.6	138.5	24.9	30.2	31.6	35.4	29.1	30.2	53.5	14.3	33.4	29.8	20.0	50.6	29.8	35.5	38.4	27.6	50.6	56.4	29.8	36.7	42.0	31.9	35.0	52.2	49.3	55.1	37.3	35.7	35.6	50.0	40.0	32.6	36.4	35.7	38.1	42.2	19.5	23.9	37.7	47.6	26.2	29.6	37.7	22.3	34.6	34.2	29.8	22.6	52.6	39.7	30.8	41.6	35.3	41.6	21.0	28.9	27.4	34.2	83.6	26.9	30.4	33.2	0.4	0.4	0.2	0.9	0.2	0.8	0.7	0.6	0.7	0.3	0.7	0.5	0.5	1.1	1.1	0.2	0.8	0.1	0.1	22.3	22.0	33.7	24.9	23.5	22.3	20.5	20.3	21.1	18.6	22.2	24.2	51.5	41.7	50.6	136.1	53.6	93.9	54.4	28.5	86.6	110.6	45.1	26.2	25.5	41.5	50.0	42.3	114.7	38.9	50.4	39.1	3.9	37.3	7.9	45.9	60.3	62.5	62.4	34.3	175.0	34.0	41.3	62.2	45.9	49.4	48.1	60.6	63.1	50.1	24.4	55.5	188.5	51.9	26.4	32.4	70.7	11.7	66.8	30.8	44.4	108.7	39.7	33.4	39.1	263.9	131.7	44.2	46.2	53.8	67.7	88.2	39.4	12.8	52.9	60.9	13.1	65.3	52.8	50.6	37.8	75.2	91.5	57.3	49.6	56.2	47.8	84.2
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6, protein lysine methyltransferase"	Q8TBK2	16	58515479-58523842	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	8.6	12.4	3.8	2.9	3.6	2.6	9.1	8.9	4.6	9.4	3.9	8.4	3.8	8.4	5.4	13.4	9.7	2.7	11.3	3.9	3.8	12.5	13.5	7.0	4.6	3.8	3.5	9.1	19.6	6.5	12.5	2.5	3.9	10.9	4.3	7.9	11.1	5.9	15.0	14.6	9.2	3.3	3.5	10.6	11.4	12.7	3.8	2.8	12.2	3.9	4.4	8.3	10.8	3.8	2.5	6.1	1.3	10.7	4.3	2.8	15.9	4.0	5.4	7.1	3.8	10.1	6.1	19.9	5.4	4.6	0.9	8.1	9.0	6.3	4.9	2.2	23.6	0.9	11.0	17.2	4.3	14.4	7.8	3.8	13.2	5.6	8.8	4.8	4.5	0.2	14.7	2.6	1.5	10.1	0.3	17.7	21.0	9.7	9.6	0.4	2.5	26.7	7.3	0.4	19.6	12.6	16.8	15.9	7.8	6.2	10.0	2.0	3.7	2.5	6.0	3.1	7.3	11.7	8.1	13.7	5.3	6.9	4.6	2.5	1.1	0.2	2.0	1.5	1.4	1.5	1.6	2.2	1.8	1.5	2.0	2.2	0.7	4.4	1.6	2.0	1.6	1.3	3.8	3.6	8.9	4.6	3.9	3.8	3.8	3.5	3.9	3.5	3.8	3.8	5.2	6.4	6.9	6.8	7.1	13.9	10.5	7.5	13.6	14.3	12.0	11.0	7.6	17.2	8.5	9.2	14.6	17.5	8.6	5.3	1.9	10.1	9.2	10.8	6.9	6.8	4.8	10.3	11.5	12.2	9.9	8.4	8.2	10.0	1.3	14.9	4.2	7.9	3.5	11.8	11.3	5.0	2.0	3.5	5.6	16.9	9.0	3.4	5.4	5.6	5.6	15.0	6.2	7.5	4.7	6.1	4.2	10.1	6.8	13.8	6.5	9.4	12.0	13.4	13.1	10.1	7.4	15.0	22.9	12.1	12.1	12.6	7.1	6.1	7.4	6.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated histone lysine methyltransferase 2"	Q96T68	13	49444374-49495003	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	5.3	8.9	4.2	10.4	4.6	8.2	11.1	5.7	5.2	7.4	6.2	7.5	6.4	9.0	6.1	5.9	6.3	7.7	10.5	4.7	4.1	8.1	8.0	8.1	16.7	3.4	3.9	16.0	7.1	7.8	3.9	6.3	3.6	7.6	9.3	9.5	8.2	6.9	2.5	7.8	7.2	7.5	3.8	13.1	8.0	15.3	4.7	10.1	11.1	5.3	13.9	6.4	4.7	5.5	3.0	2.0	6.0	6.2	8.3	9.3	3.0	8.4	10.5	7.4	6.9	12.5	7.1	37.1	1.6	5.5	5.5	6.0	6.4	5.7	7.2	8.5	5.6	12.9	5.7	7.6	11.7	19.9	7.1	7.3	10.2	5.6	18.5	8.0	6.3	11.8	5.7	5.0	6.8	2.6	7.6	14.8	3.2	7.9	4.8	14.6	7.5	8.0	6.8	2.8	3.1	3.5	3.7	5.2	18.2	5.1	4.4	17.0	3.8	7.0	2.5	9.4	3.4	6.1	8.9	19.4	2.2	15.9	3.3	3.0	2.7	3.3	4.2	3.6	3.6	5.4	4.4	4.4	4.9	5.5	6.1	4.7	0.9	5.1	3.0	3.4	6.5	2.8	4.2	4.6	5.7	5.2	4.7	4.1	3.4	3.9	3.6	3.8	4.7	5.5	7.8	28.9	13.3	18.6	26.9	6.9	5.7	3.9	7.4	14.4	8.0	7.4	23.2	10.0	8.0	5.5	27.1	5.6	17.0	9.7	9.8	4.0	22.1	8.6	14.7	8.8	11.5	8.8	32.9	4.2	3.3	8.5	9.7	6.8	6.3	18.8	6.4	7.6	17.1	13.5	30.4	7.0	6.1	21.5	19.8	16.5	9.9	26.4	14.2	15.9	13.8	11.0	20.6	24.1	21.5	3.6	3.7	8.2	28.9	3.5	6.7	5.5	9.8	28.1	0.0	7.5	7.7	25.5	13.1	9.2	6.0	2.9	17.3	30.7	8.6	2.5
SETSIP	SETP18	ENSG00000230667	"SET like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.4;Cardiomyocytes: 3.5;Early spermatids: 1.7;granulocytes: 3.8;NK-cells: 3.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA						"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	3.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.7	0.0	0.0	0.5	0.4	0.0	0.0	0.9
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SEZ6		ENSG00000063015	"Seizure related 6 homolog"	Q53EL9	17	28954901-29006440	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.7;pituitary gland: 15.8;retina: 27.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 58.7;Cone photoreceptor cells: 47.9;Excitatory neurons: 15.9;Horizontal cells: 43.7;Inhibitory neurons: 24.6;Rod photoreceptor cells: 18.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 16.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.1;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011777	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA011777: AB_1856758"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.15e-3)"	"unprognostic (3.63e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	0.1	0.6	48.4	0.2	54.7	0.4	0.0	50.8	36.3	0.0	5.5	0.9	1.0	0.0	0.3	0.0	0.0	0.0	0.1	36.3	25.0	0.1	0.0	0.1	0.0	20.4	33.0	0.1	0.6	0.0	15.8	0.0	53.5	0.2	0.5	27.0	0.0	0.1	0.2	0.2	0.5	0.1	13.7	0.1	0.5	0.5	25.4	0.0	0.1	0.0	0.0	0.1	0.0	21.1	0.0	0.4	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.1	0.1	0.1	0.0	0.0	53.5	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	1.1	0.2	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.2	2.0	0.1	0.2	0.3	0.0	0.1	48.4	54.7	50.8	36.3	36.3	25.0	20.4	33.0	53.5	13.7	25.4	21.1	0.4	0.0	0.0	3.3	0.9	0.4	0.7	0.0	0.0	58.7	0.1	0.1	0.6	1.5	0.0	0.0	47.9	0.3	5.0	0.3	0.0	0.2	0.1	0.1	0.2	0.7	7.3	0.0	15.9	0.4	0.3	0.3	0.0	0.2	8.9	1.0	0.4	0.0	0.2	43.7	24.6	0.1	0.0	1.9	1.0	0.4	0.9	1.1	0.0	4.7	5.0	6.1	5.2	3.5	4.7	0.5	0.1	0.0	0.1	0.8	0.7	0.1	0.0	18.2	0.0	0.9	0.3	1.3	1.8	0.0	0.0	0.3	1.4	0.2	0.6	0.2
SEZ6L2	"FLJ90517, PSK-1"	ENSG00000174938	"Seizure related 6 homolog like 2"	Q6UXD5	16	29871159-29899547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.6;pituitary gland: 91.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.6;Cone photoreceptor cells: 185.6;Enteroendocrine cells: 132.5;Horizontal cells: 188.4;Rod photoreceptor cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064471	Enhanced					NA	NA		5600000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA064471: AB_2685271"	"unprognostic (2.56e-2)"	"prognostic unfavorable (7.46e-4)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.08e-1)"	4.6	23.2	47.3	1.4	43.6	0.1	4.5	37.0	101.6	11.8	0.0	4.5	10.3	9.0	0.7	1.1	4.0	9.6	2.3	43.7	93.1	7.8	0.6	4.5	0.9	69.2	29.2	5.4	41.2	21.3	91.9	3.0	62.5	14.4	3.4	25.8	22.1	4.3	1.0	2.4	5.8	4.1	21.1	1.9	16.6	11.2	46.4	0.4	1.0	0.0	1.4	3.1	1.8	57.3	1.4	11.6	0.9	11.0	0.1	0.5	7.7	14.4	6.7	13.3	7.3	17.2	53.8	5.8	76.7	17.5	11.1	4.9	4.4	3.4	4.0	0.1	9.6	0.9	9.2	35.7	28.7	0.0	33.9	32.3	6.5	15.8	4.3	48.1	1.0	5.1	1.8	34.5	6.7	59.4	0.2	0.1	17.2	19.6	19.8	0.0	0.0	1.6	12.1	5.1	51.3	41.2	4.9	36.5	2.3	9.1	34.3	51.3	0.6	44.3	21.6	0.3	0.9	3.9	3.6	0.3	53.8	9.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	43.6	37.0	101.6	43.7	93.1	69.2	29.2	62.5	21.1	46.4	57.3	3.2	3.2	16.4	4.2	0.8	2.9	9.4	6.2	2.8	236.6	49.6	30.6	8.6	77.2	5.5	3.7	185.6	0.3	0.5	19.9	0.0	61.7	2.8	25.1	48.2	4.9	132.5	0.0	28.6	39.4	2.7	12.2	34.7	33.4	1.3	3.5	2.5	0.2	1.3	188.4	46.3	32.9	10.2	0.3	0.0	5.4	1.2	1.0	12.4	3.7	0.6	20.8	0.0	5.5	13.1	45.2	22.1	1.9	1.4	23.5	15.3	5.0	3.4	230.3	13.1	0.9	15.2	8.2	4.7	1.0	1.4	1.4	0.7	26.8	29.0	9.1
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	111.7	89.1	47.2	73.1	47.9	230.4	100.8	70.8	73.7	106.8	39.7	112.6	62.3	110.5	46.3	98.2	118.7	53.8	93.0	44.2	64.4	97.9	100.4	85.0	95.8	51.5	40.2	142.4	103.3	52.0	97.7	53.4	42.2	105.7	42.5	46.3	87.4	58.4	149.2	96.3	110.5	63.4	27.7	133.6	104.5	110.2	53.3	91.2	99.6	73.3	80.4	98.4	92.3	57.9	141.2	165.4	151.1	131.0	82.4	65.5	178.8	98.9	83.6	130.3	100.3	142.0	154.8	223.6	120.2	111.4	119.4	163.8	172.2	171.0	110.3	167.1	115.0	144.6	107.6	107.0	130.7	155.0	143.7	86.0	87.1	165.2	172.3	77.0	118.9	145.0	216.4	141.5	100.8	145.1	294.2	217.9	206.5	126.2	117.5	253.2	104.7	177.7	87.5	151.8	119.6	157.4	138.1	118.8	138.3	95.6	182.7	163.6	104.6	145.1	131.7	134.5	158.2	163.6	139.4	205.6	129.1	132.2	180.2	3.4	9.7	10.7	12.9	10.8	12.9	9.3	9.6	12.7	9.6	7.3	11.2	11.9	13.7	9.2	9.7	10.9	10.5	9.4	47.2	47.9	70.8	73.7	44.2	64.4	51.5	40.2	42.2	27.7	53.3	57.9	131.9	60.9	88.7	82.3	326.5	184.2	205.1	121.4	350.0	267.2	158.4	127.8	63.5	107.2	87.2	55.2	225.2	118.6	194.5	133.6	37.2	80.4	156.9	156.6	180.5	134.3	209.8	115.7	60.6	73.8	116.8	126.1	138.6	170.1	107.8	212.6	164.2	120.7	98.2	175.0	52.1	115.6	109.9	137.2	167.6	67.1	157.5	122.0	96.0	72.1	146.4	121.9	166.9	62.4	141.0	88.3	106.3	113.2	188.1	192.8	118.5	56.0	83.1	325.8	78.9	145.3	132.0	116.8	84.3	246.9	183.8	148.7	250.2	249.6	129.6	194.3
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236824-2248655	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm		NA	NA		43000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favorable (7.16e-4)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	44.8	22.6	23.0	25.7	24.9	40.8	44.0	32.9	35.2	58.9	14.9	46.8	29.5	65.4	5.4	47.6	52.2	11.4	33.5	21.2	24.7	30.4	29.9	38.2	30.3	26.8	22.8	74.2	38.3	9.1	35.6	17.7	23.4	46.8	6.3	7.0	36.5	19.2	38.8	60.2	42.8	11.5	20.4	49.2	37.3	78.9	23.1	34.2	37.8	11.9	17.9	43.1	49.3	27.5	110.8	50.3	65.2	66.2	17.1	25.8	110.2	40.4	27.9	57.9	56.5	73.5	39.3	121.4	41.3	28.6	38.8	89.0	57.8	49.8	13.2	93.9	94.2	79.8	51.7	63.9	46.9	100.9	94.8	39.3	43.8	49.3	35.6	28.7	56.4	93.5	92.7	111.7	20.9	62.4	127.7	90.4	124.6	41.9	39.6	221.5	40.7	108.9	26.2	33.5	81.4	128.6	60.4	46.0	53.3	24.8	61.9	111.8	57.4	61.7	68.0	133.2	125.4	122.7	123.4	120.8	47.0	75.4	64.7	0.8	1.9	7.2	2.9	2.5	2.2	1.7	2.4	3.0	1.8	1.6	2.1	1.9	1.7	1.3	1.9	2.5	3.0	2.1	23.0	24.9	32.9	35.2	21.2	24.7	26.8	22.8	23.4	20.4	23.1	27.5	31.7	3.2	4.5	5.9	49.0	39.0	28.1	38.3	64.3	6.4	21.4	19.9	2.0	18.6	16.8	11.0	4.2	70.7	32.3	18.0	25.4	24.4	66.7	14.2	18.5	24.0	13.1	49.4	6.1	9.6	79.9	28.8	36.2	17.0	16.5	32.6	35.0	4.0	32.6	8.4	5.6	22.1	24.4	24.9	34.3	91.0	46.0	26.4	32.0	9.4	14.1	6.2	11.3	8.0	9.5	11.8	24.5	32.0	51.7	20.1	38.7	20.2	10.7	12.3	13.1	20.4	27.4	63.6	71.6	41.7	25.3	59.0	51.5	15.8	26.2	24.7
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990075	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		57000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	24.6	23.4	22.3	29.2	22.6	57.9	31.7	24.1	29.0	25.6	23.2	25.1	20.4	30.5	33.7	23.3	27.5	19.1	18.6	22.0	22.8	26.0	27.4	22.9	39.0	22.6	22.6	32.1	20.3	30.6	16.2	25.4	22.9	24.9	30.0	29.9	23.5	28.8	49.6	29.2	21.4	31.7	22.3	27.4	20.0	27.5	23.4	43.4	26.9	27.4	44.6	28.1	18.8	24.0	84.4	57.0	108.1	90.8	63.3	57.7	129.6	82.2	69.1	131.9	106.4	97.2	84.4	165.8	68.1	73.6	51.6	71.5	136.7	108.6	162.3	74.9	125.7	206.3	92.3	86.7	57.9	261.1	93.5	54.9	75.4	135.5	88.4	58.6	89.9	112.6	176.1	60.0	95.2	53.2	131.4	123.0	268.0	80.4	89.9	156.8	197.0	110.7	59.4	83.5	95.8	69.4	104.2	47.1	83.9	95.1	54.0	90.3	82.0	70.3	79.6	64.9	157.2	57.6	89.5	166.4	65.6	215.6	92.1	37.2	41.3	28.4	56.1	53.3	55.0	54.9	65.3	56.7	53.1	68.9	69.4	58.9	4.6	56.2	61.8	32.5	75.5	61.7	22.3	22.6	24.1	29.0	22.0	22.8	22.6	22.6	22.9	22.3	23.4	24.0	37.3	51.3	35.0	11.4	42.2	47.3	38.6	46.6	55.2	37.0	21.3	27.7	22.7	20.0	42.3	22.0	22.9	59.1	40.7	12.1	39.2	44.4	37.9	23.7	42.4	35.8	15.6	53.6	15.7	38.1	69.2	41.6	15.3	25.3	42.4	43.0	25.0	23.6	51.5	26.9	14.9	23.9	34.6	28.0	39.8	14.0	39.7	34.2	39.2	6.5	82.9	45.6	44.3	11.1	11.5	35.4	13.1	54.2	41.5	28.5	19.0	29.2	27.8	38.6	39.5	47.2	68.3	120.8	55.2	36.5	41.8	33.0	42.9	53.5	31.4	24.0
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197388515-197435079	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		94000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	183.8	173.9	101.7	132.7	112.4	304.8	180.7	120.5	126.1	222.8	136.8	170.9	110.4	195.8	200.0	136.8	183.8	123.2	135.7	98.2	100.8	135.4	168.5	162.8	203.0	105.7	101.9	226.5	200.7	154.9	147.8	165.3	111.0	163.2	147.3	138.4	180.4	133.2	172.4	156.5	231.6	116.5	107.5	287.8	169.2	91.4	104.9	221.9	167.8	144.8	199.3	154.4	167.1	135.8	134.9	105.4	288.6	155.9	222.8	219.2	237.8	172.6	196.7	163.2	205.9	233.0	147.2	247.5	116.6	193.1	165.8	133.7	273.4	151.2	271.8	196.5	154.8	237.5	257.4	294.3	155.4	270.1	198.6	232.1	163.0	175.9	209.3	278.6	205.9	171.0	210.2	174.0	192.3	134.2	251.1	285.6	231.4	167.5	163.8	234.4	197.9	182.9	245.8	286.4	154.2	186.7	174.7	118.2	139.2	345.1	115.2	242.5	186.8	126.9	109.4	123.3	145.8	168.7	238.8	342.0	123.7	174.8	146.5	49.8	50.4	57.5	54.5	51.7	55.4	46.1	46.2	50.9	60.5	44.1	48.7	49.2	60.8	56.7	52.5	37.5	71.3	56.2	101.7	112.4	120.5	126.1	98.2	100.8	105.7	101.9	111.0	107.5	104.9	135.8	175.6	179.5	222.9	92.4	187.4	119.0	172.0	127.1	125.7	103.4	96.4	83.3	129.2	72.9	194.0	92.0	73.0	116.8	224.1	90.1	56.7	104.8	9.2	123.9	191.0	143.1	110.5	109.0	55.5	94.8	102.3	151.6	132.0	179.0	246.9	171.1	107.1	74.4	100.6	94.2	59.7	108.1	89.5	124.7	144.1	20.6	120.2	166.1	76.5	75.9	163.9	111.1	116.4	87.0	121.1	112.0	68.3	104.6	195.6	103.8	84.2	70.5	221.5	98.5	118.3	159.5	227.9	104.6	100.5	94.3	118.8	142.7	216.2	119.4	91.4	156.1
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	116.0	96.0	117.5	80.4	127.1	144.6	109.0	119.4	139.5	123.3	125.1	97.4	70.7	111.6	95.5	96.6	112.3	55.2	94.7	117.9	120.4	107.1	112.0	104.3	99.0	124.2	118.9	136.1	137.4	88.9	137.2	80.6	121.3	99.2	77.0	96.5	91.3	73.8	108.1	116.9	98.5	80.0	121.4	113.9	102.9	145.2	124.0	109.4	115.2	54.6	114.0	108.3	104.7	136.9	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	117.5	127.1	119.4	139.5	117.9	120.4	124.2	118.9	121.3	121.4	124.0	136.9	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149927803	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"		NA	NA		36000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: AB_2685314"	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	35.6	36.8	27.9	42.3	28.4	74.3	31.6	30.1	35.8	36.0	29.3	55.8	39.6	48.5	37.5	45.1	51.8	33.8	28.9	28.6	30.4	29.9	27.1	36.8	48.5	31.1	28.3	47.5	34.6	53.4	26.0	40.1	28.7	32.3	44.2	20.8	40.1	47.9	22.5	62.4	40.1	46.7	28.0	39.4	32.4	46.4	29.1	58.0	39.1	26.9	57.6	50.3	33.4	29.8	153.0	144.1	119.4	110.9	75.5	58.4	172.0	119.0	118.2	188.0	143.0	152.0	125.6	144.2	87.1	139.7	103.0	154.3	150.9	158.2	161.8	95.3	110.7	130.0	77.3	112.8	121.7	156.6	163.5	74.7	122.6	184.0	84.5	59.0	94.6	126.7	116.6	119.6	172.9	456.6	203.9	148.9	199.4	175.9	146.1	157.9	106.4	157.6	137.4	128.2	79.6	147.6	109.8	151.1	92.5	141.4	229.9	205.1	78.3	154.9	170.0	122.9	222.8	169.0	259.4	161.2	124.2	133.8	147.5	70.5	81.1	130.5	84.0	109.8	87.4	80.2	79.6	90.4	71.3	73.1	74.3	71.9	111.2	104.7	120.0	84.6	100.1	67.5	27.9	28.4	30.1	35.8	28.6	30.4	31.1	28.3	28.7	28.0	29.1	29.8	30.4	16.0	13.4	4.2	39.9	54.2	47.5	83.2	65.4	20.0	34.3	41.4	3.9	21.5	41.2	23.9	4.2	80.8	54.2	42.2	60.7	64.3	80.3	38.9	30.4	30.6	26.0	34.3	4.1	51.6	77.5	31.8	27.0	44.5	39.3	32.9	16.8	14.7	53.0	8.4	4.8	40.0	59.0	24.7	42.5	13.3	45.1	34.9	24.9	3.7	61.8	27.5	44.3	4.5	7.0	62.3	35.9	29.3	38.6	32.2	28.5	43.0	49.8	15.9	46.0	30.8	64.6	64.0	51.5	47.0	51.3	94.7	44.9	27.9	36.7	43.8
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067586-24076373	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm		NA	NA		11000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	79.0	86.5	82.4	65.1	84.1	211.2	137.9	86.4	125.3	99.1	82.5	106.2	91.1	84.7	141.9	123.5	89.2	78.2	89.3	82.7	85.7	111.5	132.6	67.3	102.8	85.9	84.2	93.7	63.7	103.0	62.9	88.3	86.3	81.2	108.7	64.4	71.6	84.2	74.7	76.4	84.7	89.0	88.6	65.1	70.4	66.6	82.0	138.6	104.9	106.2	123.3	117.2	85.2	92.4	307.2	152.4	231.6	207.9	182.7	292.8	139.3	233.6	253.8	279.1	284.2	329.9	197.0	236.6	117.3	213.1	265.4	187.7	245.2	293.7	345.5	218.0	263.4	256.6	197.2	299.4	324.4	314.3	151.3	268.5	342.5	281.3	319.3	286.4	288.8	199.4	290.2	181.3	294.2	250.3	234.1	486.1	194.7	362.8	264.0	170.6	327.7	239.1	334.6	189.0	214.4	320.7	123.6	268.3	570.9	195.4	122.7	309.4	173.9	159.6	213.6	157.3	384.4	171.2	239.1	655.3	215.4	515.8	224.5	225.0	118.9	185.7	96.0	133.5	108.1	153.9	122.9	117.8	138.9	114.7	118.0	130.0	173.5	133.7	124.3	129.6	179.6	143.8	82.4	84.1	86.4	125.3	82.7	85.7	85.9	84.2	86.3	88.6	82.0	92.4	207.4	70.5	91.5	11.8	125.1	0.0	280.4	0.0	208.3	50.7	194.3	320.5	120.8	133.0	55.1	138.0	16.7	296.5	149.2	217.1	389.4	206.1	195.9	226.4	208.1	149.0	180.3	164.7	9.2	167.4	413.2	153.0	85.6	210.7	100.1	185.1	142.1	167.1	232.7	18.5	10.2	253.5	0.0	129.3	0.0	49.4	210.3	132.6	0.0	10.3	227.4	175.4	149.3	11.6	19.4	205.4	314.5	180.5	134.0	327.5	381.2	423.1	78.0	68.4	118.3	155.0	158.9	272.4	173.7	257.8	0.0	271.7	126.6	344.4	242.7	438.1
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 618.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.8	4.1	13.0	5.9	13.1	6.6	5.5	10.2	9.8	3.4	5.1	2.8	2.0	4.0	3.7	1.1	4.0	3.5	4.0	7.5	17.6	3.0	1.3	4.7	7.3	20.4	15.0	9.1	1.3	5.7	6.4	3.4	17.1	6.6	3.2	18.0	2.3	3.1	4.2	1.7	4.0	3.3	12.7	9.0	3.1	1.8	27.7	4.5	6.8	2.6	5.8	4.1	4.2	19.0	0.0	4.0	0.3	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.4	7.9	0.0	13.0	0.0	0.7	8.0	1.1	1.1	0.4	0.0	0.3	0.0	0.1	10.0	11.5	23.0	0.0	3.5	7.0	14.3	1.6	0.0	0.0	21.0	2.2	20.2	0.0	0.8	2.0	16.6	0.0	0.1	0.0	2.1	1.3	25.0	0.0	0.0	2.6	0.4	0.2	10.1	13.3	0.0	1.1	16.5	0.3	0.1	0.2	1.1	0.7	2.3	0.4	0.0	0.2	0.5	0.4	0.0	1.0	0.6	0.1	0.9	4.6	3.1	0.0	0.2	13.0	13.1	10.2	9.8	7.5	17.6	20.4	15.0	17.1	12.7	27.7	19.0	8.2	0.0	5.2	148.2	10.2	1.5	1.5	0.0	1.2	8.1	9.3	8.6	9.7	1.5	0.6	0.0	81.3	7.7	22.1	0.1	0.0	0.4	0.2	0.8	15.8	10.1	4.2	6.1	77.3	0.2	2.5	4.2	2.0	3.5	4.5	7.1	5.7	1.1	15.5	0.0	103.9	0.0	0.0	15.7	9.9	0.8	5.0	26.3	5.4	618.3	11.4	12.4	15.5	26.2	113.7	0.1	0.0	2.2	25.8	11.4	0.0	0.3	0.7	34.1	0.0	4.4	2.6	0.3	3.9	0.2	1.3	4.4	25.8	2.5	0.2	0.6
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2461.5;skin 1: 1219.1;vagina: 692.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	3.1	0.8	1.9	11.6	1.8	2.0	29.1	1.8	9.5	350.2	0.4	95.4	48.8	8.0	0.7	2461.5	2.2	21.4	1.3	1.9	1.6	16.0	3.7	56.1	0.2	9.0	4.4	0.9	2.2	0.1	2.7	1.6	4.3	77.2	32.5	0.6	332.8	3.2	5.0	1219.1	40.8	3.3	1.2	0.9	66.6	0.7	5.2	22.1	2.0	0.1	147.9	167.6	692.0	2.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	1.8	1.8	9.5	1.9	1.6	9.0	4.4	4.3	1.2	5.2	2.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193145	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	62.9	46.7	25.1	62.1	26.0	215.1	53.2	38.5	32.3	54.0	23.4	46.9	44.6	60.2	51.0	59.8	54.6	39.9	43.8	24.8	30.7	48.8	50.6	40.8	76.4	30.2	27.2	74.4	52.8	44.9	34.4	51.8	25.2	49.8	54.4	47.4	52.8	35.6	63.9	60.0	47.6	52.9	23.0	54.1	48.0	45.8	24.9	85.5	44.8	27.4	94.5	58.1	52.5	44.6	180.5	147.3	251.1	142.9	60.5	90.0	234.7	96.1	97.1	160.4	116.3	161.5	126.4	325.6	130.1	111.8	100.6	160.4	276.1	188.3	217.0	175.2	183.0	245.5	156.2	193.6	81.5	258.2	140.1	72.4	71.7	139.4	67.3	70.9	142.3	169.1	282.6	150.9	158.3	156.8	304.2	220.1	299.7	107.8	140.7	304.5	170.4	213.6	156.2	214.4	180.1	200.3	138.6	106.3	147.1	174.4	125.0	181.7	152.3	127.7	188.3	84.7	208.9	171.2	156.5	327.6	91.1	168.6	185.9	2.6	4.1	3.0	4.7	5.8	5.4	4.1	4.6	3.8	3.8	4.5	4.3	4.8	2.1	3.4	4.7	7.3	5.6	2.3	25.1	26.0	38.5	32.3	24.8	30.7	30.2	27.2	25.2	23.0	24.9	44.6	286.7	169.9	237.7	149.8	317.4	357.5	239.3	80.6	234.5	230.0	231.6	191.0	149.6	82.9	146.2	110.3	191.8	206.5	339.0	149.7	82.2	120.1	126.8	230.1	318.9	222.2	219.6	198.9	127.3	138.4	222.9	255.8	267.6	333.1	155.8	450.5	123.5	109.1	141.4	171.6	143.4	189.5	59.0	129.4	216.9	361.9	142.9	258.5	140.5	104.9	146.2	152.6	127.7	248.8	183.1	162.0	126.7	116.6	291.8	159.9	94.8	87.6	114.8	223.6	52.6	530.6	259.2	199.1	171.9	287.9	327.3	305.5	313.7	223.7	220.0	167.7
SFR1	"bA373N18.1, C10orf78, FLJ41960, MEI5, MEIR5"	ENSG00000156384	"SWI5 dependent homologous recombination repair protein 1"	Q86XK3	10	104122058-104126385	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Spermatocytes: 233.6;Spermatogonia: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039617	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA039617: AB_10805482"	"unprognostic (2.79e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (6.20e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.19e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.24e-2)"	4.8	4.4	5.6	7.2	8.2	10.0	6.6	7.1	7.9	3.8	6.1	5.2	4.7	5.4	7.3	4.9	5.4	4.9	7.6	5.5	5.9	4.9	3.1	6.3	9.0	7.9	7.0	8.9	5.9	3.5	2.9	3.9	7.6	3.9	6.4	4.2	4.0	3.4	4.1	4.4	6.1	5.6	6.5	6.3	5.5	18.3	7.0	11.7	7.3	5.3	7.6	5.4	3.2	11.2	22.2	12.4	13.1	5.5	5.0	8.9	7.7	11.6	14.0	7.4	9.7	5.5	45.7	17.7	10.9	3.1	15.5	18.4	6.6	15.8	11.8	15.6	7.5	13.3	5.4	7.0	9.3	15.7	8.5	4.9	5.8	14.8	20.3	9.9	15.3	18.2	8.6	12.5	9.3	6.8	16.0	28.3	6.2	13.0	9.0	19.8	19.1	9.4	16.0	5.9	7.2	7.4	7.4	4.0	9.9	10.9	10.1	6.9	7.1	4.2	15.2	12.9	18.8	14.9	19.2	18.0	12.2	16.6	5.7	23.6	16.8	10.4	14.3	16.5	14.6	16.6	14.9	15.2	11.9	19.2	21.7	18.3	5.4	12.8	12.1	10.3	13.5	14.9	5.6	8.2	7.1	7.9	5.5	5.9	7.9	7.0	7.6	6.5	7.0	11.2	12.1	3.2	11.8	1.3	9.9	21.5	14.6	10.4	2.8	3.5	6.8	7.0	8.5	8.6	13.8	1.8	0.0	9.7	9.8	4.7	17.6	12.1	20.0	8.0	6.3	13.7	3.0	21.8	1.3	12.3	13.7	10.2	2.6	7.8	12.0	8.1	18.2	1.9	17.6	5.0	2.6	6.3	18.3	16.3	12.4	11.3	9.6	12.5	3.6	4.7	17.8	9.6	15.5	1.0	14.0	19.1	5.1	6.0	4.5	5.1	5.7	10.1	5.3	4.9	0.0	13.0	9.0	233.6	76.7	5.5	7.4	3.8	10.4	5.6	7.2	8.7
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261962-41309473	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 299.3;choroid plexus: 509.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 3203.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1300000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	88.4	12.9	9.2	10.5	12.7	1.4	299.3	18.2	15.0	203.7	509.2	24.5	12.2	132.5	1.8	26.1	98.5	61.3	124.8	29.4	8.5	115.3	6.1	4.7	4.0	29.9	10.5	46.8	6.2	1.4	1.2	19.5	29.7	42.6	30.1	2.2	236.9	102.3	2.6	55.4	18.9	82.9	7.7	21.4	24.4	28.4	10.8	3.1	12.7	32.8	3.2	44.9	95.6	24.7	0.1	29.0	75.9	1.9	67.5	3.9	14.5	132.9	694.5	197.9	187.2	0.0	17.8	0.0	0.6	0.7	15.8	0.9	10.8	53.7	277.6	0.0	2.3	0.0	0.0	0.0	6.4	0.0	0.7	11.8	255.9	19.9	19.3	3203.5	6.2	0.2	0.0	0.0	3.7	0.0	0.0	0.2	205.8	0.1	0.3	0.0	15.7	0.0	422.6	0.0	4.1	18.5	5.5	0.0	41.5	264.7	0.1	2.1	1.9	0.1	19.6	0.2	18.3	0.0	0.0	0.0	0.2	0.0	279.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.7	18.2	15.0	29.4	8.5	29.9	10.5	29.7	7.7	10.8	24.7	8.4	0.0	0.0	2.0	1.2	11.2	134.0	1.4	147.4	1.8	710.9	1158.6	266.3	0.0	0.7	62.5	2.1	2.2	9.1	0.0	80.3	4.4	5.0	3.0	131.6	21.0	0.0	0.0	0.2	0.0	82.0	229.5	16.8	3.4	0.0	19.3	53.6	0.3	2.0	1.7	12.1	0.0	0.0	0.3	4.0	25.7	578.4	4.0	99.6	0.0	0.0	76.2	0.0	7.5	20.6	0.1	0.0	130.1	2.1	29.7	0.0	3.2	0.0	1.8	0.0	34.9	18.0	2.3	16.8	53.7	5.5	0.8	7.3	72.6	0.0	9.3
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 619.9;endometrium 1: 467.1;fallopian tube: 214.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 472.1;Fibroblasts: 196.4;Granulosa cells: 102.8;Peritubular cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.0;HSkMC: 3.9;U-937: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 53.5"	"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		2500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	29.1	15.6	2.3	1.4	3.0	0.8	60.0	2.7	4.5	619.9	2.1	4.4	1.2	467.1	18.7	2.3	214.0	17.3	22.4	2.5	4.6	4.3	0.6	14.7	7.3	4.0	4.8	79.2	5.0	2.8	20.5	0.2	3.2	16.1	2.6	2.3	6.5	43.9	4.1	1.5	1.4	87.9	4.0	13.9	2.3	16.8	2.7	1.6	14.9	7.0	2.0	37.4	61.0	3.9	0.0	1.8	2.1	0.0	10.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	2.2	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	1.5	0.1	0.3	0.0	3.9	0.5	0.4	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.8	1.2	0.1	0.4	0.1	0.1	0.2	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	2.7	4.5	2.5	4.6	4.0	4.8	3.2	4.0	2.7	3.9	5.5	0.0	1.8	0.3	0.7	1.0	1.5	0.1	0.6	0.0	0.5	2.3	1.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	1.0	22.5	472.1	4.6	0.0	0.0	0.0	0.5	0.3	196.4	0.0	14.1	0.0	102.8	3.3	0.1	0.2	0.0	0.5	0.0	0.0	0.0	4.4	2.8	41.7	7.1	0.0	2.8	0.0	2.7	0.0	17.6	0.2	0.1	0.0	188.4	0.0	2.4	0.0	1.8	0.0	0.3	0.0	30.5	25.3	0.2	0.4	0.1	1.6	0.3	9.2	1.2	0.1	0.5
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	26.9	18.3	18.5	10.1	20.8	28.1	26.3	18.5	24.8	27.1	13.7	25.9	10.1	24.6	4.0	23.2	24.5	4.8	20.2	18.2	19.0	24.9	19.4	20.3	11.3	20.4	19.3	29.0	21.9	7.4	21.7	8.1	19.8	21.8	4.3	9.3	20.2	6.8	29.5	32.6	24.6	5.6	16.9	28.4	20.8	16.3	21.2	12.6	24.5	6.7	7.6	22.3	24.3	25.1	26.1	23.0	16.0	17.0	12.6	10.3	35.8	19.7	13.6	22.9	15.6	22.6	12.3	31.9	18.0	14.8	11.9	23.9	22.7	18.1	13.2	9.9	36.0	29.0	12.9	27.0	13.4	37.8	27.4	11.7	20.4	20.8	24.9	18.2	14.3	24.3	40.9	12.3	10.4	32.7	31.9	57.1	41.9	14.0	38.0	36.7	16.2	25.2	13.3	18.8	25.1	28.3	18.7	15.6	25.1	12.5	22.5	29.1	18.6	19.0	24.8	14.8	22.3	35.0	41.2	31.7	18.7	25.5	25.9	2.0	4.1	1.9	3.0	2.7	3.0	2.1	2.8	2.6	2.9	3.7	3.0	3.4	5.6	5.4	3.4	7.2	2.4	1.8	18.5	20.8	18.5	24.8	18.2	19.0	20.4	19.3	19.8	16.9	21.2	25.1	46.4	73.7	44.5	48.6	37.9	38.9	41.5	19.0	42.1	49.7	25.4	25.9	19.3	21.5	38.6	14.7	66.7	30.4	52.6	22.1	0.0	23.1	21.4	27.0	48.8	39.3	21.6	38.7	55.1	26.6	31.8	39.2	37.8	39.7	38.0	47.1	21.4	16.7	22.1	42.1	43.2	24.9	14.2	27.4	21.4	12.9	30.1	30.3	23.2	36.5	35.4	33.7	50.4	58.3	85.1	28.6	24.1	29.7	43.6	44.7	20.8	11.8	30.7	62.4	46.0	52.1	38.1	39.5	42.8	39.7	46.9	43.6	45.9	48.4	22.9	48.2
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
SFT2D2	"dJ747L4.C1.2, UNQ512"	ENSG00000213064	"SFT2 domain containing 2"	O95562	1	168225938-168253021	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 142.6;Late spermatids: 142.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 53.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042207	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042207: AB_10794789"	"unprognostic (4.34e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.62e-3)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.15e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.71e-1)"	7.2	6.2	11.0	6.7	11.1	32.3	10.3	6.4	8.3	9.1	8.7	8.0	4.9	17.7	7.1	13.2	8.2	6.1	5.2	11.4	10.0	8.4	9.7	8.7	10.6	14.3	10.2	14.6	6.2	6.8	12.4	5.0	12.4	6.5	8.1	3.0	11.6	4.7	3.8	15.3	9.0	10.0	8.8	11.0	6.8	18.5	11.7	8.4	6.5	3.5	11.3	5.4	8.6	15.2	15.6	19.4	7.7	14.2	22.0	12.4	15.8	10.7	7.9	8.3	9.3	20.7	15.6	13.9	16.1	15.8	7.5	51.3	13.2	11.9	11.1	19.4	4.9	10.3	26.3	15.0	11.8	17.3	15.7	14.5	8.9	11.0	9.8	6.4	11.6	18.9	9.8	17.8	9.5	6.5	15.0	12.8	9.2	23.1	4.4	16.4	10.6	10.8	12.3	18.4	4.9	9.4	13.4	16.8	14.6	12.5	13.4	15.4	12.8	10.8	8.2	11.6	14.3	6.8	13.5	20.6	8.6	12.1	11.6	20.6	12.1	4.4	8.9	22.0	5.2	7.3	5.2	5.8	16.9	6.9	4.8	5.5	5.7	7.1	27.5	53.2	6.4	8.1	11.0	11.1	6.4	8.3	11.4	10.0	14.3	10.2	12.4	8.8	11.7	15.2	22.3	44.8	33.1	3.3	43.4	28.0	16.2	30.0	23.3	0.7	39.7	37.3	5.1	25.8	39.1	38.6	4.2	9.5	142.6	63.9	1.9	23.6	65.7	64.2	45.6	32.9	31.8	31.6	1.2	20.5	26.4	44.9	32.1	86.1	49.4	35.7	33.5	54.3	45.5	3.3	0.3	24.8	18.3	99.4	77.3	142.5	24.2	60.5	42.7	13.1	58.5	11.3	40.2	3.0	9.4	37.0	21.4	33.8	23.0	33.0	36.8	37.3	46.6	6.5	26.3	25.7	22.2	30.6	10.1	44.8	48.3	9.9	38.2	23.4	28.6	23.0
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1048	"lung: 7084.8"	"Cell type enriched"	"Detected in some"	11	"Alveolar cells type 2: 13480.7"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	27	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 43.2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.5	6.7	0.1	2.6	0.1	0.0	0.5	0.3	0.3	0.9	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	0.8	0.2	0.0	0.2	0.9	7084.8	0.0	0.0	0.0	6.3	0.7	0.0	0.3	1.4	0.0	1.0	0.0	0.0	0.2	4.8	0.8	0.8	0.4	0.0	0.0	4.9	3.8	0.3	0.0	1.5	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.1	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1160.3	13480.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560407	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	404	"lung: 10798.8"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 2: 16905.3"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BEWO: 7.3;NB-4: 8.3;RPMI-8226: 26.1;U-2197: 14.7"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.7	12.1	0.4	4.6	0.6	0.0	1.0	3.1	0.9	1.4	0.0	1.4	0.0	0.2	0.1	0.4	0.2	0.0	1.1	0.5	0.4	0.4	1.1	10798.8	0.0	1.2	0.0	6.5	1.3	0.0	0.4	2.3	1.3	26.7	2.6	0.2	0.4	8.3	1.0	1.1	0.5	0.1	0.0	6.7	10.5	0.5	0.3	2.7	0.8	0.0	0.1	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.4	0.0	0.0	0.2	0.0	26.1	0.0	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	14.7	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.6	3.1	0.9	0.5	0.4	1.2	0.0	1.3	0.0	0.3	0.6	0.0	1593.0	16905.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	22.3	1.8	0.0	0.3	3.1	0.0	22.0	0.0	0.2	431.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.2	2.0	0.0	0.0	1.0	0.0	0.1	135.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.7	0.0	2.4	0.1
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"lung: 3566.0"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 15343.4"	"Cancer enriched"	"Detected in many"	5	"lung cancer: 1306.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.5;U-2197: 6.7;U-266/70: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		80000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.8	4.4	1.5	2.2	1.4	0.4	0.5	1.7	3.0	0.5	1.1	0.5	0.3	0.2	0.7	0.4	0.3	0.2	1.4	1.3	2.1	2.1	1.2	3566.0	0.3	1.4	1.1	11.0	0.9	0.2	5.4	1.5	1.5	1.2	0.4	2.9	0.5	2.0	1.2	0.8	0.7	0.1	0.8	4.1	5.1	0.4	1.4	0.3	113.1	0.3	0.2	0.2	0.4	1.5	0.1	0.2	0.2	0.5	0.3	0.5	2.8	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.1	0.1	1.4	0.0	0.3	0.2	0.1	0.5	0.0	0.4	0.3	0.4	0.1	0.3	1.1	3.5	1.6	0.5	0.4	1.3	0.2	0.3	0.2	0.3	0.4	0.3	0.0	0.4	0.2	0.3	0.3	0.3	0.0	0.2	0.6	6.7	0.1	2.4	0.6	0.2	0.6	0.5	0.1	0.3	0.6	0.2	0.2	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	0.2	0.7	0.2	0.4	0.4	1.5	1.4	1.7	3.0	1.3	2.1	1.4	1.1	1.5	0.8	1.4	1.5	0.0	3650.6	15343.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1930.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	14.4	0.0	0.0	0.2	0.2	0.0	26.9	0.0	0.0	262.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	0.3	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	185.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	36.5	0.0	0.0	0.2
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	795	"lung: 18462.2"	"Cell type enriched"	"Detected in some"	12	"Alveolar cells type 2: 107013.9"	"Cancer enriched"	"Detected in some"	218	"lung cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;NB-4: 12.4;SCLC-21H: 5.1;U-2197: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010928	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA010928: AB_1857425"		"unprognostic (1.84e-1)"			"unprognostic (1.96e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.13e-1)"	"unprognostic (2.97e-1)"		"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.32e-2)"		2.6	23.2	10.3	10.3	12.1	0.0	0.9	10.8	15.8	1.6	8.3	1.3	0.0	0.4	0.3	0.9	0.4	0.0	2.8	10.2	10.6	1.0	2.8	18462.2	0.0	11.9	11.2	21.5	1.7	0.0	1.1	4.7	10.8	3.0	0.0	0.0	0.8	8.9	2.0	3.1	2.3	0.0	10.3	14.0	6.4	2.8	11.4	0.0	4.3	0.1	0.2	0.1	0.9	15.3	0.0	0.1	0.0	0.0	0.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	5.1	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.1	24.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.1	10.8	15.8	10.2	10.6	11.9	11.2	10.8	10.3	11.4	15.3	0.0	8535.2	107013.9	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1416.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	67.8	0.0	0.0	0.9	0.0	0.0	174.6	0.0	0.0	986.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	30.4	0.0	106.6	23.2	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	339.6	0.0	6.6	0.0	0.3	0.1	0.1	0.0	0.6	0.0	163.4	0.4	0.0	0.1
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937467-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"lung: 507.9"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 2: 1863.1"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 10.0;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	18	"monocytes: 36.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	NA	NA		8200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	1.1	1.8	2.2	0.4	2.4	19.7	0.9	1.7	2.5	1.3	2.3	1.0	0.1	0.5	1.3	1.8	1.8	0.9	1.1	2.2	2.4	1.6	1.0	507.9	0.0	1.7	2.0	1.1	4.2	2.0	3.4	0.7	1.8	1.4	0.1	0.3	1.0	1.2	0.2	5.0	0.4	0.4	1.4	0.6	1.1	1.3	2.6	0.5	5.8	0.2	0.2	0.3	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	10.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.9	2.2	2.4	1.7	2.5	2.2	2.4	1.7	2.0	1.8	1.4	2.6	1.7	0.3	439.1	1863.1	1.0	0.2	0.9	1.3	7.8	1.2	1.7	1.4	1.8	0.7	0.0	38.0	5.5	0.0	0.1	0.0	0.0	1.9	1.4	7.4	0.6	0.1	1.5	0.0	0.0	4.9	5.8	3.0	4.4	0.0	0.9	20.2	1.6	0.4	0.7	0.1	0.0	3.5	0.0	0.0	0.0	2.7	12.2	1.2	2.9	0.0	1.9	0.6	2.8	0.0	0.0	0.6	2.0	0.1	0.4	0.0	0.8	0.0	0.2	9.6	0.5	0.0	1.8	0.4	0.4	0.3	0.6	1.8	0.1	4.3	0.1	0.1	0.6
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 99.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 99.8;T-cells: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	7.6	15.4	14.0	18.2	14.8	21.9	8.1	15.0	17.4	9.3	15.0	28.1	19.3	8.5	8.0	14.7	8.7	9.8	12.3	13.3	15.3	41.6	99.7	5.9	27.0	12.1	12.6	18.7	13.1	15.8	12.9	15.3	13.2	9.6	17.7	20.7	9.6	10.4	10.9	8.8	20.1	11.3	13.0	10.5	14.6	6.6	13.8	24.0	10.5	15.7	27.0	13.8	11.2	14.8	39.9	123.1	61.7	67.0	21.0	44.4	99.2	99.1	41.5	81.3	78.3	156.5	77.6	82.3	74.9	51.9	100.4	49.7	119.0	171.9	87.8	202.1	102.4	60.6	103.4	69.0	30.3	119.6	73.3	36.5	33.1	90.3	39.2	48.3	63.3	74.9	89.1	63.4	60.2	138.3	140.3	9.7	48.7	66.5	41.1	116.3	63.1	87.8	31.3	154.2	104.6	66.7	95.6	88.9	47.8	50.5	43.1	38.3	62.3	63.9	100.3	47.5	130.2	80.2	101.8	184.6	105.1	104.9	68.1	99.8	5.1	26.3	26.2	6.7	21.4	10.7	36.4	29.2	7.3	9.3	28.4	29.3	1.6	12.7	4.3	3.5	32.3	14.2	14.0	14.8	15.0	17.4	13.3	15.3	12.1	12.6	13.2	13.0	13.8	14.8	6.0	3.2	13.5	55.2	29.1	19.5	33.5	30.6	48.9	59.3	13.7	9.9	18.1	17.2	18.8	18.4	47.9	41.4	19.0	68.9	25.4	27.7	1.2	10.9	23.3	14.2	31.2	45.4	77.3	18.7	74.2	24.8	26.0	11.3	9.5	38.1	12.8	98.7	17.2	77.4	62.9	23.9	26.4	8.1	11.4	4.0	47.2	9.5	10.6	30.9	9.0	19.8	37.0	55.3	60.1	31.8	20.1	35.0	63.4	31.6	89.8	51.1	15.5	49.9	26.3	21.7	23.1	2.8	7.4	43.6	21.6	30.9	61.9	67.2	21.7	27.0
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.9;parathyroid gland: 12.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	1.5	1.1	1.2	1.9	2.8	3.0	2.8	3.9	1.7	1.6	3.6	1.9	2.5	2.7	3.6	1.4	3.6	1.1	0.6	1.8	0.8	17.9	4.2	1.6	2.6	1.0	0.5	3.4	3.1	12.7	2.7	3.4	1.2	2.2	3.0	2.7	4.9	1.3	0.7	1.9	1.9	1.1	0.2	2.1	3.3	1.2	1.8	3.2	3.8	0.2	1.9	0.9	0.7	2.1	4.2	2.3	3.5	3.7	1.3	0.9	5.1	1.4	0.6	1.8	0.9	7.2	1.9	9.1	2.7	1.2	1.0	3.0	0.7	4.8	1.0	1.6	2.8	13.1	4.4	4.5	0.6	7.5	1.1	1.0	0.7	1.8	1.8	1.1	1.7	7.7	6.0	4.2	1.1	4.0	11.5	2.5	2.3	4.0	0.8	5.5	4.3	1.3	1.7	3.5	2.6	2.5	1.2	3.1	0.6	1.4	38.4	1.6	1.2	1.4	4.4	1.8	3.1	4.6	6.5	7.9	1.7	9.0	1.2	1.6	0.5	0.2	1.9	0.2	1.7	0.8	1.9	2.0	0.7	2.5	3.0	2.5	0.9	1.9	0.3	1.7	2.0	0.7	1.2	2.8	3.9	1.7	1.8	0.8	1.0	0.5	1.2	0.2	1.8	2.1	1.0	0.0	10.1	5.2	3.8	0.9	3.0	0.8	4.0	6.1	7.3	5.2	2.5	4.3	2.0	1.8	33.3	9.1	2.4	2.5	9.8	1.9	0.8	7.3	4.2	2.2	3.6	4.2	5.4	2.8	4.4	3.2	8.2	10.0	0.0	9.2	5.0	21.2	9.6	0.0	5.5	5.0	0.0	7.5	0.6	0.5	2.1	2.4	0.0	8.4	0.8	1.1	4.1	7.1	2.9	1.4	0.8	1.5	6.7	4.4	2.4	43.1	0.4	15.1	0.0	2.7	1.7	1.2	1.3	3.3	1.3	4.5	2.8	2.6	7.3	2.9
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Metabolic proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 177.5;Proximal enterocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	20.1	10.7	16.2	11.8	19.0	6.2	14.9	19.4	21.2	17.9	15.7	13.9	31.7	18.0	21.5	8.1	18.3	16.4	15.1	19.7	12.9	12.0	4.3	21.3	7.9	18.5	15.8	12.7	9.1	18.3	9.0	21.0	19.2	12.0	10.4	23.4	11.1	16.5	3.6	22.2	37.5	25.4	12.7	10.7	11.0	7.2	18.2	6.4	9.9	7.9	7.1	14.9	14.7	19.3	44.4	16.9	1.7	5.2	43.5	46.0	4.4	26.4	92.7	33.0	26.4	28.1	47.4	1.9	24.8	62.1	27.7	31.8	7.9	57.7	14.4	12.3	10.2	5.3	27.1	20.4	29.8	4.2	41.2	31.8	8.3	29.1	27.3	91.8	73.5	12.5	0.4	1.4	54.4	7.3	1.9	6.4	2.1	16.2	40.3	4.3	32.5	12.0	48.5	6.8	9.0	44.1	14.4	1.7	39.3	11.8	13.8	31.2	60.9	29.0	22.7	26.0	13.1	6.6	2.7	0.2	70.7	23.7	23.7	10.6	18.1	9.1	11.0	13.4	8.5	2.4	7.4	7.6	19.1	1.1	4.5	5.6	3.2	5.5	7.8	2.9	8.7	11.7	16.2	19.0	19.4	21.2	19.7	12.9	18.5	15.8	19.2	12.7	18.2	19.3	17.1	12.8	5.3	7.5	3.9	13.9	5.0	6.3	2.8	60.2	6.9	7.0	3.2	18.6	4.6	5.5	47.9	1.2	21.2	7.3	1.9	31.7	51.9	25.2	13.4	17.5	5.4	4.8	14.2	15.3	40.9	17.4	7.7	5.6	14.5	55.5	20.0	0.9	37.4	10.1	12.2	7.8	4.1	21.3	29.9	177.5	17.4	24.3	33.8	1.0	12.0	7.7	9.2	5.0	16.0	38.5	10.8	14.7	10.4	2.9	119.1	14.3	38.8	24.0	13.1	6.7	12.0	1.4	0.7	1.3	10.9	10.9	19.7	2.7	5.6	3.4
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	3.2	11.7	52.1	4.6	45.5	13.7	2.5	40.0	63.6	3.2	21.9	6.1	6.9	3.1	16.6	3.1	4.2	4.0	3.5	48.0	45.2	11.4	29.4	3.6	3.9	51.5	49.2	2.6	2.4	2.0	3.5	3.7	41.4	4.2	5.7	6.2	2.2	4.5	7.7	4.5	6.5	3.9	42.6	5.6	4.6	2.4	57.0	4.9	3.7	4.6	3.0	3.8	2.3	37.4	4.2	9.1	13.7	11.5	3.0	5.0	5.4	8.4	5.4	13.3	6.9	13.7	10.7	2.3	8.8	8.9	9.2	3.7	10.8	11.1	6.0	10.2	6.7	10.7	11.0	18.7	4.4	5.9	11.1	5.8	3.5	9.0	1.1	4.9	7.4	3.2	9.5	2.9	4.3	8.7	1.5	9.5	17.1	8.1	6.6	10.6	12.2	3.1	8.1	10.5	9.0	2.7	8.6	4.3	3.5	7.7	2.2	5.3	6.8	4.1	13.5	6.1	10.2	4.0	4.1	3.1	15.0	10.3	5.3	4.7	6.0	3.5	0.6	2.6	0.9	1.6	0.3	0.7	2.7	2.4	0.4	0.5	4.6	4.3	3.2	1.9	0.7	1.7	52.1	45.5	40.0	63.6	48.0	45.2	51.5	49.2	41.4	42.6	57.0	37.4	7.1	0.0	4.4	405.2	4.8	4.7	4.3	7.6	4.6	26.8	6.9	5.5	5.8	7.2	4.8	36.8	33.3	12.4	6.8	18.4	3.9	5.1	96.4	5.1	13.1	7.6	13.8	13.7	84.4	9.1	2.4	8.9	9.2	11.2	0.0	42.8	9.3	61.3	12.4	20.2	57.4	8.6	2.0	8.7	9.6	168.4	10.5	9.6	8.8	43.1	19.7	65.8	10.3	40.2	29.9	8.0	6.5	11.3	7.1	3.6	17.5	22.2	3.2	42.3	13.1	12.2	8.8	11.2	15.7	7.3	9.2	4.2	6.3	15.9	8.8	2.3
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175928	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 155.6;skeletal muscle: 522.4;tongue: 237.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 128.4;Early spermatids: 162.6;Late spermatids: 705.4;Skeletal myocytes: 195.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.4;memory B-cell: 3.3;myeloid DC: 2.2;naive B-cell: 3.3;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	15	"B-cells: 3.3;dendritic cells: 2.2;monocytes: 1.8"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 78.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	12.2	1.5	1.8	7.3	2.9	0.0	4.3	3.5	2.2	10.1	1.0	53.7	5.3	36.9	1.6	22.8	18.1	11.9	155.6	1.4	1.5	2.7	4.8	29.7	0.5	1.6	1.5	5.1	1.3	0.8	0.9	6.7	1.8	26.0	3.2	0.1	8.7	27.1	522.4	12.4	14.8	23.0	1.1	3.4	24.1	1.7	1.7	2.3	3.4	237.0	0.4	46.5	11.6	4.7	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.1	0.0	1.4	0.0	3.3	0.0	0.0	2.2	3.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.4	1.8	2.9	3.5	2.2	1.4	1.5	1.6	1.5	1.8	1.1	1.7	4.7	1.1	0.0	0.0	0.0	1.3	8.7	0.5	0.4	0.0	0.6	0.1	0.5	128.4	0.0	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.6	162.6	0.0	0.2	4.6	0.0	0.0	0.0	5.8	0.1	30.4	0.5	0.0	0.0	0.0	2.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	16.5	705.4	3.1	0.8	8.8	1.9	1.9	0.0	0.0	0.0	0.1	4.1	0.0	3.8	0.1	0.6	0.0	2.1	0.0	0.0	13.1	195.2	48.2	2.3	1.9	0.1	9.9	0.3	0.9	0.0	0.0	0.2
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038299	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 105.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 203.7"	"Cancer enhanced"	"Detected in all"		"glioma: 56.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.7"	"Low region specificity"	"Detected in all"							"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	32.7	21.6	27.1	9.5	30.3	0.5	14.7	28.0	32.2	23.4	21.4	32.9	13.1	28.1	11.1	21.9	20.5	19.5	57.2	25.3	27.7	35.0	10.8	15.2	6.1	29.7	28.4	20.1	6.5	47.0	13.9	24.2	30.3	25.0	16.2	16.6	13.5	27.2	105.7	7.2	14.9	37.3	29.0	11.1	14.0	16.0	28.3	5.6	9.2	81.3	4.5	20.4	15.7	33.4	11.4	13.7	27.8	10.6	104.7	78.5	10.1	62.8	79.9	34.5	36.2	3.7	14.9	3.0	11.8	82.9	53.5	5.5	20.9	23.1	36.7	18.8	7.8	0.2	11.8	6.8	42.8	6.8	3.6	86.8	15.9	29.9	17.3	89.8	46.1	10.7	0.1	0.1	74.5	4.4	15.1	0.1	10.0	4.6	20.4	0.0	14.8	0.2	29.2	3.8	16.2	28.4	39.9	1.9	14.1	31.0	5.2	4.1	47.0	50.8	17.0	24.1	56.6	14.9	20.4	5.5	37.5	2.4	59.7	0.3	1.0	0.0	2.1	0.5	2.1	2.6	2.5	2.3	0.5	2.3	1.7	2.2	0.5	0.3	0.4	1.0	4.2	1.0	27.1	30.3	28.0	32.2	25.3	27.7	29.7	28.4	30.3	29.0	28.3	33.4	38.9	32.1	13.1	15.3	6.6	13.4	25.8	70.2	9.6	22.0	8.6	19.7	88.8	25.8	19.6	12.9	6.2	5.7	2.8	15.6	1.9	28.7	61.1	32.6	48.1	27.2	16.3	0.0	17.3	51.8	49.8	64.6	12.8	29.7	2.5	16.7	36.0	15.7	2.8	28.6	21.2	4.2	8.2	2.1	8.7	203.7	38.8	2.7	26.6	24.4	1.9	23.6	1.0	38.7	38.1	53.8	6.0	91.4	4.6	11.7	32.6	64.6	20.4	16.5	46.0	102.8	59.8	12.2	17.4	8.0	10.5	6.3	7.3	14.2	15.1	13.5
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180979-23325162	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 118.8;skeletal muscle: 158.0;tongue: 144.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 134.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 66.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA007476	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	14.3	0.6	0.0	0.1	0.1	0.0	2.2	0.0	1.9	0.4	0.0	1.1	0.1	0.1	8.0	3.3	1.1	0.8	118.8	0.1	0.0	0.3	0.0	4.8	0.0	0.3	0.0	0.2	0.1	2.1	0.3	0.0	0.2	3.2	0.6	0.3	4.3	0.4	158.0	3.4	0.6	0.1	0.0	0.1	0.9	1.5	0.2	0.1	0.1	144.1	0.1	3.0	1.4	0.4	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	66.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	0.2	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.3	0.0	0.2	0.0	0.2	0.4	0.2	0.0	0.0	0.3	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	1.3	0.0	0.0	12.5	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	3.4	3.0	7.5	0.2	5.4	1.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.2	3.8	13.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SGCZ	ZSG1	ENSG00000185053	"Sarcoglycan zeta"	Q96LD1	8	14084845-15238431	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;ovary: 1.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 477.1;Inhibitory neurons: 2304.3;Oligodendrocyte precursor cells: 1235.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017585	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017585: AB_1856799"					"unprognostic (3.83e-1)"						"unprognostic (1.41e-1)"			"unprognostic (5.87e-4)"	"unprognostic (1.21e-1)"			0.1	0.0	0.9	0.0	0.7	0.0	0.4	1.7	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.0	0.0	0.0	0.7	2.3	1.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	1.7	1.2	0.6	2.3	0.7	2.3	0.7	0.5	2.1	0.4	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	477.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2304.3	0.0	0.0	0.0	0.0	0.7	0.9	0.1	0.0	73.1	0.0	0.1	0.0	1235.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 222.2;Late spermatids: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	16.8	16.1	13.6	11.2	15.6	12.4	16.5	16.7	14.6	26.8	13.8	28.0	12.8	29.1	9.5	12.0	27.6	9.1	15.3	13.4	14.9	11.1	19.9	14.0	16.9	15.2	14.4	33.3	25.6	10.7	10.3	7.1	15.4	16.4	7.2	7.8	16.6	16.7	51.1	16.0	18.8	12.0	14.9	16.2	19.8	43.0	14.6	14.1	17.6	19.8	10.2	23.5	16.4	16.8	13.1	21.3	16.3	10.5	10.6	10.9	29.5	8.5	9.6	21.7	20.2	24.6	11.5	39.1	21.1	6.7	13.2	15.0	12.4	15.4	6.1	12.8	24.0	24.3	12.9	33.7	27.1	22.1	26.1	11.5	20.0	13.1	13.2	11.7	8.3	24.5	20.8	19.4	7.9	43.4	25.5	43.2	22.7	9.6	20.5	38.9	10.6	34.2	11.3	19.5	26.3	12.2	13.3	25.3	15.0	5.8	20.7	18.4	5.9	15.4	12.9	9.2	15.3	22.4	35.7	22.7	10.9	36.9	12.5	20.6	47.0	50.0	53.6	41.8	65.2	57.9	74.2	65.8	47.6	65.9	84.1	66.3	13.4	55.1	33.7	71.4	78.3	58.7	13.6	15.6	16.7	14.6	13.4	14.9	15.2	14.4	15.4	14.9	14.6	16.8	11.2	16.0	16.7	0.0	20.0	0.0	18.1	0.0	32.5	5.5	12.5	21.1	0.0	12.8	7.4	18.4	14.6	17.3	27.1	7.9	9.8	12.6	222.2	8.5	10.1	8.7	3.6	17.1	0.0	12.9	11.8	12.7	10.2	7.7	6.3	16.9	11.0	17.3	14.2	0.0	0.0	8.8	0.0	12.9	0.0	384.4	30.7	13.5	0.0	0.0	17.1	11.8	22.6	0.0	0.0	10.1	15.7	21.8	16.7	9.5	40.1	23.7	6.6	14.1	19.7	18.3	13.0	10.5	30.9	17.0	0.0	21.1	21.0	14.8	11.9	12.0
SGIP1	DKFZp761D221	ENSG00000118473	"SH3GL interacting endocytic adaptor 1"	Q9BQI5	1	66533383-66751139	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 131.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 390.1;Cone photoreceptor cells: 350.3;Excitatory neurons: 323.3;Inhibitory neurons: 401.5;Oligodendrocyte precursor cells: 482.0;Oligodendrocytes: 363.6;Rod photoreceptor cells: 344.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 29.9;BJ hTERT+: 38.0;fHDF/TERT166: 24.5;hTERT-RPE1: 15.8;RPTEC TERT1: 27.5;SH-SY5Y: 15.3;U-138 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	7.4	4.3	12.2	1.9	15.5	0.2	2.7	6.3	17.4	10.4	0.0	3.1	1.6	10.6	4.6	2.7	3.8	4.6	5.0	15.3	5.8	18.0	0.7	8.3	0.7	5.1	5.7	1.6	0.5	0.2	7.7	1.9	5.3	5.8	1.5	131.4	1.7	5.0	2.5	1.6	2.0	3.8	1.6	0.3	3.3	4.4	5.5	0.7	8.9	1.2	0.4	2.7	5.4	10.1	0.0	0.0	0.0	0.0	0.9	5.5	0.0	29.9	38.0	2.3	3.4	0.0	0.0	0.0	0.1	24.5	0.2	0.0	0.0	0.1	4.3	0.0	0.0	1.1	0.4	0.0	6.5	0.0	0.0	4.1	0.0	2.3	0.0	15.8	11.3	0.2	0.0	0.0	13.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	27.5	0.0	0.7	15.3	0.0	0.0	0.0	0.6	0.0	1.1	1.9	27.3	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	15.5	6.3	17.4	15.3	5.8	5.1	5.7	5.3	1.6	5.5	10.1	5.0	0.0	0.0	390.1	0.1	1.0	0.3	0.4	0.0	89.8	0.2	4.7	2.5	2.8	0.0	9.2	350.3	0.1	0.0	0.1	7.9	0.5	0.6	2.9	7.8	13.8	0.0	0.0	323.3	0.0	0.0	15.8	0.5	5.7	10.1	0.0	0.4	0.2	0.2	74.0	401.5	0.0	0.0	0.0	1.1	1.2	2.1	0.4	10.6	48.7	0.0	49.4	0.0	482.0	363.6	0.0	0.0	11.3	0.8	0.8	0.0	0.2	0.0	344.1	13.1	3.2	32.2	0.2	0.4	0.1	1.0	0.3	0.5	0.0	0.1	0.3
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.5;kidney: 53.6;liver: 63.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.5	1.4	4.9	1.5	14.8	0.5	6.1	12.6	10.5	3.5	0.7	37.7	31.6	1.8	33.8	1.0	3.7	10.0	1.2	6.0	7.7	53.6	63.2	1.0	0.2	18.1	13.3	6.6	16.2	0.5	3.0	0.8	14.3	2.6	40.5	5.6	1.8	2.9	0.4	6.2	20.1	1.6	11.8	1.1	22.8	1.8	13.3	0.3	1.7	0.4	0.3	4.2	3.0	24.5	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	14.8	12.6	10.5	6.0	7.7	18.1	13.3	14.3	11.8	13.3	24.5	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66712734-66862022	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 56.0;monocytes: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.4"									"HPA006699, HPA027146"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	5.2	5.3	13.4	9.8	25.7	8.5	24.1	21.3	16.9	10.5	36.0	10.3	8.9	8.0	8.6	7.6	6.9	7.5	5.4	14.6	17.3	14.7	13.6	10.0	7.8	29.4	21.6	9.1	15.6	28.3	6.2	5.7	28.3	7.4	10.3	2.4	7.0	7.1	2.9	13.3	11.3	5.3	19.3	8.9	7.5	9.4	20.9	5.8	17.5	3.5	6.9	5.0	5.7	49.0	14.2	3.7	0.6	2.4	3.9	6.5	7.7	8.1	7.4	4.2	5.1	6.1	8.6	10.2	2.2	7.7	13.6	4.9	7.3	5.5	5.4	5.3	11.7	9.7	2.6	6.7	4.1	8.9	10.5	2.9	3.7	1.7	7.9	4.3	7.4	7.4	1.5	4.6	10.0	2.4	6.2	5.8	1.9	8.5	5.0	11.7	5.3	7.6	6.4	3.3	2.9	2.2	3.4	6.5	14.4	6.0	28.4	16.9	9.0	4.4	3.9	3.9	3.4	6.1	12.8	12.7	4.5	14.2	4.9	21.1	15.0	5.1	8.7	9.9	13.8	4.7	8.8	8.0	13.8	6.4	8.7	7.1	2.0	7.2	5.1	8.9	5.7	9.0	13.4	25.7	21.3	16.9	14.6	17.3	29.4	21.6	28.3	19.3	20.9	49.0	20.7	6.4	28.1	0.0	12.5	13.3	8.1	3.3	8.6	1.7	56.0	30.5	7.6	7.2	8.5	11.0	18.8	9.2	24.9	13.3	15.6	7.0	0.9	16.7	6.6	15.3	16.2	10.3	0.0	18.2	1.4	8.9	6.6	12.3	15.2	11.0	17.5	20.7	22.9	0.0	0.0	9.3	8.2	41.9	14.3	2.2	4.1	42.6	8.8	0.0	53.4	3.8	19.6	0.0	0.0	14.8	8.4	7.9	18.3	9.3	14.0	36.8	15.4	1.7	0.0	5.9	4.2	5.9	13.7	9.9	15.8	4.8	19.4	5.2	10.4	5.3
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.6;Basal prostatic cells: 167.4;Endometrial ciliated cells: 172.1;Glandular and luminal cells: 147.8;Urothelial cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.7;eosinophil: 2.4;intermediate monocyte: 1.5;myeloid DC: 4.2;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 4.2;granulocytes: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	8.6	3.0	5.2	9.0	15.3	4.6	5.2	10.1	7.8	12.7	36.7	12.3	19.5	8.8	4.6	16.4	12.5	39.6	9.1	3.3	6.5	14.5	20.4	27.8	1.1	13.9	14.3	1.1	11.7	3.6	4.7	5.1	13.0	9.6	10.6	0.8	9.2	4.6	2.5	3.6	16.5	29.1	10.2	1.1	13.8	9.6	10.6	0.8	18.0	3.4	2.9	13.9	4.2	21.6	20.8	7.7	1.1	5.8	12.9	29.9	0.4	25.0	18.8	11.6	12.1	3.5	42.1	1.5	9.7	40.0	10.1	7.6	14.5	22.1	20.7	5.9	5.7	0.9	16.5	1.2	14.8	14.2	0.1	10.4	15.1	22.7	27.4	24.2	26.1	0.3	0.2	0.5	18.6	6.9	0.5	0.1	0.7	12.1	8.6	0.5	9.9	2.9	30.7	10.0	2.0	0.1	19.1	26.9	3.3	3.0	14.5	0.4	44.7	13.9	21.9	20.1	11.7	1.4	0.5	0.8	18.7	3.4	5.9	0.0	3.7	2.4	0.0	1.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	1.0	5.2	15.3	10.1	7.8	3.3	6.5	13.9	14.3	13.0	10.2	10.6	21.6	3.4	86.6	126.6	7.2	1.0	56.0	167.4	12.8	18.2	0.5	20.9	10.4	17.8	28.6	88.0	16.5	0.0	1.0	2.9	32.3	3.9	19.8	71.4	172.1	13.5	10.7	8.9	0.0	8.0	19.5	0.9	26.6	58.1	147.8	10.1	2.8	11.4	25.0	5.5	1.7	10.0	26.0	14.2	22.1	43.0	11.1	2.5	28.2	8.8	1.9	23.3	0.2	2.1	0.5	18.5	37.9	60.5	0.4	0.4	96.9	33.5	12.4	104.0	0.1	0.0	46.1	22.0	0.9	3.1	38.1	72.9	13.8	3.3	0.1	21.8	159.7
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200584096	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	3.3	0.9	0.6	4.4	0.9	6.8	1.9	0.8	0.9	0.9	0.3	3.1	2.5	1.8	0.7	2.4	1.4	1.2	1.0	0.5	0.9	0.9	0.8	1.5	7.9	0.9	0.9	1.9	0.5	1.1	0.3	2.6	0.9	1.4	3.2	0.9	0.7	0.7	0.4	2.3	2.6	2.0	0.7	2.0	1.8	32.6	0.9	14.9	1.2	0.6	8.1	1.5	0.9	1.2	34.6	16.2	37.0	17.4	5.2	7.9	23.7	38.7	16.6	32.0	33.1	24.3	23.5	22.5	18.6	18.1	34.4	25.3	33.6	20.1	54.5	48.0	16.9	43.5	21.6	17.5	1.6	43.9	33.1	3.4	2.5	32.9	17.3	8.0	29.4	31.3	33.1	31.6	61.4	15.4	35.9	17.9	26.7	24.9	41.2	28.8	49.1	21.3	13.3	13.6	22.2	15.4	28.6	13.3	16.3	29.2	14.1	25.2	18.1	33.9	34.0	31.6	34.0	14.3	33.5	49.8	21.4	28.9	49.4	16.7	1.4	4.5	2.2	1.4	1.4	2.7	2.4	2.2	0.8	3.2	1.8	2.2	1.0	2.0	1.7	1.7	3.6	1.2	0.6	0.9	0.8	0.9	0.5	0.9	0.9	0.9	0.9	0.7	0.9	1.2	9.4	3.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.8	7.1	0.0	0.0	6.2	0.0	0.0	11.6	7.8	0.0	3.9	3.9	0.0	12.1	5.3	3.3	0.0	0.0	0.0	2.7	31.0	6.7	0.0	3.6	11.4	23.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.7	0.0	0.0	2.5	8.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.4	3.8	4.0	0.0	0.0
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815948-70881184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	12.0	12.7	15.8	18.0	17.4	6.8	13.0	15.2	16.3	17.6	11.0	16.7	16.0	14.4	18.8	27.9	15.3	12.6	6.4	14.7	16.4	15.5	22.9	10.7	18.1	18.6	16.7	9.0	18.5	21.0	9.4	10.0	17.4	17.5	17.9	10.8	14.3	12.4	9.6	30.4	22.8	13.9	17.4	16.1	12.3	14.0	17.7	17.9	20.1	6.0	20.1	25.0	14.7	19.8	26.9	35.2	33.2	38.1	8.9	11.5	22.1	15.5	16.4	16.5	21.4	38.4	57.8	24.2	18.0	15.8	15.9	44.1	28.8	31.0	23.5	39.1	15.6	2.5	17.5	46.2	33.6	10.6	20.9	21.8	51.4	22.1	57.6	34.6	10.4	22.3	7.2	20.4	23.6	29.6	13.2	7.1	15.0	35.4	19.5	16.6	25.2	9.1	26.3	112.1	22.6	27.5	30.9	46.6	28.5	25.9	24.3	7.5	20.3	14.8	38.7	11.6	30.1	8.4	12.6	11.0	14.7	19.3	10.7	1.1	18.2	14.0	18.0	34.6	16.5	7.2	11.5	14.7	16.2	8.7	8.5	13.5	15.0	18.8	44.9	8.9	11.8	12.4	15.8	17.4	15.2	16.3	14.7	16.4	18.6	16.7	17.4	17.4	17.7	19.8	3.8	16.0	6.4	32.3	11.0	12.2	17.8	21.4	8.0	6.3	15.8	9.8	6.3	27.1	23.2	46.0	20.9	7.3	16.0	41.5	3.9	36.2	2.9	30.2	13.3	7.3	25.1	4.4	48.7	37.6	13.8	10.1	6.6	46.1	14.7	23.1	7.1	44.5	27.6	15.2	38.8	21.2	22.4	43.1	16.1	5.2	11.5	25.7	7.2	35.6	22.7	9.8	25.7	41.7	43.8	55.6	18.8	20.3	5.9	26.0	53.5	12.0	26.6	9.7	6.6	13.3	19.0	20.0	34.0	15.9	22.7	6.3	11.1	18.2	20.9	25.3
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684216-63728065	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 61.8;Oligodendrocytes: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	7.9	10.6	5.3	6.0	6.0	3.0	6.4	5.8	7.9	6.4	3.6	7.0	3.8	7.4	6.2	4.9	5.7	5.5	4.9	5.3	5.9	15.9	19.5	6.9	13.3	6.6	6.2	5.8	12.7	10.2	5.6	12.0	6.6	7.4	5.3	4.1	4.8	4.0	4.2	3.8	8.8	4.8	7.3	9.3	5.5	5.4	5.8	5.8	5.8	2.6	12.9	5.8	6.8	8.0	19.7	6.2	3.0	8.6	10.7	9.9	35.9	15.7	10.9	9.6	10.7	2.7	10.9	43.8	4.5	8.0	8.0	20.3	4.8	9.3	15.3	17.3	5.7	4.0	3.4	4.4	13.1	7.3	12.2	7.3	14.7	8.4	13.2	9.7	4.6	8.2	2.3	1.2	14.1	7.3	8.6	0.1	2.1	3.2	13.1	2.1	8.4	3.5	15.2	9.7	1.8	5.0	11.0	10.2	8.4	9.2	13.3	2.6	5.2	13.2	9.1	9.5	7.9	10.1	6.5	57.4	9.7	0.0	5.8	6.9	0.2	1.7	0.5	1.4	0.5	1.8	0.5	0.3	0.3	0.4	0.8	0.6	0.2	0.3	2.1	0.1	1.3	0.3	5.3	6.0	5.8	7.9	5.3	5.9	6.6	6.2	6.6	7.3	5.8	8.0	5.3	12.8	16.2	22.2	22.6	9.7	6.1	4.1	8.0	4.0	9.4	5.2	3.8	24.3	3.2	51.5	0.0	23.4	10.9	11.9	0.0	6.0	2.4	6.3	12.1	6.5	18.6	9.7	32.6	9.1	27.0	12.8	3.1	10.1	11.4	5.0	6.1	43.6	23.7	10.1	38.5	10.2	2.0	61.8	20.1	1.2	6.2	18.6	17.8	21.5	6.8	8.2	2.1	31.7	60.0	13.2	13.5	17.0	5.7	8.1	3.2	22.7	2.6	5.4	6.6	8.1	11.3	7.4	3.5	4.6	13.5	33.0	10.4	10.3	10.3	5.6
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	16.6	45.9	1.7	12.2	2.3	3.6	17.2	0.7	5.2	13.5	8.8	14.8	12.7	17.2	4.6	11.0	16.0	10.6	9.9	2.0	5.4	15.7	9.5	18.1	13.4	4.4	7.6	12.3	20.4	16.0	17.0	12.4	4.2	19.7	6.5	2.8	21.8	11.1	7.0	18.9	16.7	10.6	2.5	28.4	17.8	3.9	5.3	4.2	21.2	4.6	6.9	15.5	11.5	1.8	2.6	7.9	9.8	15.6	22.5	20.2	10.4	16.0	40.4	27.7	24.2	9.0	9.5	0.1	25.7	24.9	13.2	9.9	6.2	11.7	4.7	5.3	9.6	0.0	22.3	25.0	62.2	0.0	5.9	33.9	12.0	9.9	10.5	5.8	50.7	4.7	7.1	26.2	17.9	16.2	0.3	0.2	3.3	10.0	13.2	1.4	3.7	21.1	20.2	18.5	2.0	11.7	18.4	44.1	10.6	4.9	32.8	0.5	32.5	31.9	7.0	11.4	7.4	26.1	3.6	3.9	13.6	0.0	16.3	0.0	20.6	0.0	12.1	8.0	16.0	3.5	10.5	11.3	20.4	3.8	8.2	6.7	2.1	9.3	8.0	1.5	13.5	12.7	1.7	2.3	0.7	5.2	2.0	5.4	4.4	7.6	4.2	2.5	5.3	1.8	7.5	3.2	10.8	4.2	5.5	5.1	3.7	5.9	5.7	3.7	9.3	9.3	1.7	5.7	7.3	7.3	8.4	18.2	5.2	12.0	0.0	8.9	0.2	5.3	9.2	10.1	3.0	2.7	2.6	15.9	8.7	10.1	17.9	10.0	0.0	13.6	9.7	4.5	17.7	0.0	3.4	9.3	4.1	18.2	7.6	0.5	11.5	13.0	1.8	2.8	8.4	4.1	6.2	4.5	1.7	6.8	6.0	14.3	5.5	5.5	8.1	4.9	3.8	3.9	13.1	4.0	5.3	0.3	0.5	6.4	5.5	27.0	7.2	32.0	8.0	2.9
SGSM1	"KIAA1941, RUTBC2"	ENSG00000167037	"Small G protein signaling modulator 1"	Q2NKQ1	22	24806169-24927578	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.5;heart muscle: 11.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 97.0;Inhibitory neurons: 76.4;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.9;RPMI-8226: 2.2;SCLC-21H: 2.0;SH-SY5Y: 1.3;U-266/84: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003986	Approved					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003986: AB_1856513"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.40e-4)"	"unprognostic (4.79e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.61e-6)"	"unprognostic (1.46e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.93e-2)"	0.5	3.3	12.5	0.4	11.5	0.2	0.9	6.8	12.9	1.2	4.3	2.0	0.4	0.6	1.0	0.3	4.7	0.6	11.5	10.1	20.5	1.8	0.1	1.1	0.4	11.2	15.4	1.8	3.6	7.8	10.5	0.3	19.0	1.6	1.6	1.5	1.3	0.8	0.6	3.2	0.9	0.5	7.5	0.3	2.9	1.8	18.2	0.3	2.1	0.2	0.3	1.7	1.1	9.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.9	0.3	0.0	0.0	2.2	0.0	0.3	2.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.1	12.5	11.5	6.8	12.9	10.1	20.5	11.2	15.4	19.0	7.5	18.2	9.4	1.4	3.2	6.9	2.6	0.7	3.8	9.8	0.1	2.2	3.2	1.5	1.9	26.4	1.5	1.5	5.5	4.2	0.3	3.2	3.1	3.9	1.7	0.5	10.3	0.9	3.7	17.3	0.0	97.0	1.9	0.1	4.5	7.1	6.6	1.3	0.1	11.4	0.1	1.9	1.7	76.4	6.4	0.0	0.3	8.4	0.5	0.3	0.8	10.6	12.2	0.1	2.1	5.2	33.7	58.6	1.3	5.4	0.4	0.5	5.6	0.5	0.7	1.5	1.5	13.1	3.1	2.5	1.2	7.9	0.4	3.8	0.3	2.3	0.3	4.8	4.8
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	22.2	30.2	84.3	20.2	83.0	28.4	31.0	52.5	102.7	32.1	53.8	37.0	15.5	26.3	51.7	36.0	27.4	21.2	27.1	83.0	81.3	36.5	19.3	28.2	24.3	64.0	67.5	28.9	27.9	27.4	80.7	15.8	62.6	53.7	10.1	15.7	41.9	21.6	21.6	33.3	32.6	17.9	58.4	37.6	33.6	30.0	76.9	17.5	41.4	13.9	14.1	31.8	28.7	68.4	20.7	31.1	27.9	39.0	15.5	18.6	41.4	17.4	20.4	23.6	23.9	31.2	38.6	9.9	18.5	25.3	8.7	28.4	17.2	20.6	8.2	14.5	35.3	17.2	55.6	33.8	13.3	10.4	25.0	20.1	13.4	24.1	13.7	34.1	24.9	26.4	10.5	14.4	14.3	43.5	22.4	14.0	13.7	14.7	13.5	48.5	14.2	8.0	30.5	42.5	13.5	31.9	21.7	16.2	13.4	17.1	41.9	12.3	29.3	18.9	21.5	28.1	23.4	11.8	1.9	9.5	16.4	13.6	17.0	7.0	0.3	1.3	0.9	0.1	0.8	0.1	0.3	0.5	0.4	0.3	1.1	0.6	0.1	0.9	0.0	0.5	0.6	0.4	84.3	83.0	52.5	102.7	83.0	81.3	64.0	67.5	62.6	58.4	76.9	68.4	9.4	6.4	24.7	52.9	5.4	6.8	8.3	13.8	5.7	59.6	31.9	24.0	15.6	11.5	23.5	12.9	135.5	13.8	9.3	7.1	0.0	6.7	18.2	9.9	11.0	11.8	13.8	5.7	39.7	4.5	8.8	10.0	14.3	14.7	20.3	18.1	14.3	8.3	7.8	30.3	38.2	9.9	16.2	7.6	9.9	38.1	8.1	9.2	5.4	16.9	6.3	11.9	7.2	22.6	10.3	6.4	4.5	12.0	4.6	15.0	7.0	4.0	16.5	51.2	19.7	9.6	11.0	4.1	6.7	11.9	7.7	14.1	11.6	15.2	8.2	13.5
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	24.8	42.6	34.6	26.1	34.8	19.3	29.4	27.3	43.6	37.3	32.6	46.6	32.8	31.9	14.5	49.2	37.1	28.7	37.0	33.2	33.3	36.4	37.3	33.8	32.9	36.5	34.3	30.8	107.7	24.7	55.0	21.9	34.8	62.6	24.3	11.0	70.1	25.9	34.2	36.7	46.1	17.4	27.6	51.5	91.4	39.8	33.6	27.5	48.7	23.4	28.3	33.1	35.6	31.9	37.8	21.1	30.6	34.1	33.2	18.1	43.4	35.0	22.9	26.0	33.7	12.0	30.9	23.3	23.7	37.9	15.6	30.0	29.2	42.9	10.4	58.4	68.8	15.9	56.9	11.3	31.6	23.1	33.1	30.2	29.5	29.1	17.4	29.2	46.0	48.6	19.8	31.4	19.4	60.5	32.1	23.5	20.5	75.8	14.0	59.3	19.3	51.1	26.8	33.0	18.8	24.2	38.6	55.4	27.5	24.2	46.3	38.9	40.2	8.8	31.8	23.4	20.6	47.1	23.2	31.0	37.4	19.0	22.9	1.1	14.6	16.3	18.7	15.7	15.6	17.7	11.5	14.9	18.9	22.3	13.8	11.3	3.3	35.4	11.9	31.6	11.7	15.8	34.6	34.8	27.3	43.6	33.2	33.3	36.5	34.3	34.8	27.6	33.6	31.9	5.3	3.2	10.3	14.0	32.8	11.5	32.4	33.1	14.8	57.0	12.1	7.1	8.3	27.1	42.1	7.3	18.8	42.8	23.9	46.4	1.9	20.2	17.5	5.1	3.8	14.3	31.3	18.1	27.1	45.3	54.3	14.0	176.4	6.7	15.9	3.1	21.8	24.0	24.2	26.9	34.6	135.3	50.8	17.2	8.3	31.7	22.7	11.8	16.0	13.1	21.6	13.4	30.9	15.6	15.1	21.3	40.6	19.2	30.5	46.1	36.2	4.4	60.2	34.0	39.5	14.4	13.8	83.5	44.4	19.8	10.4	45.6	16.7	3.3	47.7	60.0
SGTA	SGT	ENSG00000104969	"Small glutamine rich tetratricopeptide repeat containing alpha"	O43765	19	2754715-2783362	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056309	Approved		Approved	Nucleoplasm		NA	NA		81000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA056309: AB_2683096"	"unprognostic (2.31e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.04e-1)"	38.4	46.4	60.2	16.8	61.7	29.0	39.8	61.4	76.0	40.8	45.4	53.4	27.3	44.2	18.6	53.3	42.0	13.8	91.0	60.1	57.6	54.7	72.3	37.5	19.9	64.9	62.9	52.8	57.8	22.1	56.5	22.0	60.4	51.1	9.3	17.2	36.2	18.6	110.8	40.2	37.6	14.9	61.7	49.2	47.7	54.1	61.3	31.6	47.9	43.4	13.2	43.7	38.1	66.5	67.9	58.8	57.4	56.5	21.7	23.9	45.9	46.8	35.7	71.3	60.8	95.4	31.4	61.5	37.7	39.4	44.4	53.3	70.2	79.5	24.6	0.0	59.3	37.8	25.0	81.8	56.0	49.0	46.5	39.1	39.2	58.5	45.6	27.5	51.5	60.5	95.6	57.6	38.3	46.4	87.8	70.8	98.2	51.6	57.3	113.8	43.7	80.8	48.0	43.0	104.2	85.6	31.6	61.0	73.4	21.5	66.8	76.0	41.0	50.7	53.2	91.3	86.8	101.1	88.1	82.6	65.6	122.2	81.1	17.3	21.4	20.9	17.4	28.1	20.4	15.4	19.0	19.1	23.6	13.9	14.4	14.4	20.7	21.2	27.8	20.5	25.4	21.8	60.2	61.7	61.4	76.0	60.1	57.6	64.9	62.9	60.4	61.7	61.3	66.5	31.6	9.6	15.7	15.3	26.3	23.7	24.0	21.2	17.1	42.3	32.5	30.4	46.8	12.8	14.9	18.4	25.0	52.2	19.3	54.1	35.2	40.0	65.4	26.1	21.9	26.9	32.2	16.6	9.8	45.1	56.5	25.8	30.5	31.0	28.5	34.4	17.5	24.8	37.4	38.7	9.6	36.3	26.4	22.0	23.6	49.8	22.1	26.2	19.6	4.7	30.3	42.9	17.5	10.6	34.2	40.5	38.2	27.4	24.9	27.4	36.1	27.5	10.6	48.8	13.1	26.6	25.9	39.3	21.6	23.2	24.6	92.8	19.9	31.5	46.2	29.7
SGTB	"FLJ39002, Sgt2"	ENSG00000197860	"Small glutamine rich tetratricopeptide repeat containing beta"	Q96EQ0	5	65665928-65723035	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5;Horizontal cells: 70.7;Langerhans cells: 40.0;Muller glia cells: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 10.0;monocytes: 6.7;T-cells: 13.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044689, HPA063674"	Enhanced		Uncertain	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA044689: AB_10960838, HPA063674: AB_2685084"	"unprognostic (9.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.92e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.05e-3)"	4.4	2.6	5.9	7.5	9.0	10.0	2.5	3.0	18.0	3.0	0.0	2.7	1.4	4.7	2.0	2.9	2.4	3.0	4.2	10.4	6.1	2.5	2.5	3.9	7.0	6.8	5.0	2.9	1.8	2.6	3.1	3.7	6.8	4.8	2.5	16.4	1.7	2.1	2.7	2.0	2.1	5.4	1.8	4.7	1.8	1.9	5.3	4.1	4.2	4.6	4.9	3.9	2.3	8.0	7.6	4.8	9.0	9.2	13.3	17.3	8.9	31.4	9.7	10.3	14.0	6.5	3.2	10.3	16.5	24.5	18.1	7.6	12.9	11.9	16.7	7.7	12.7	4.6	13.0	13.2	34.3	3.4	7.3	13.0	10.3	22.3	29.3	7.2	10.0	8.0	7.9	6.9	16.3	2.8	7.5	5.4	6.0	0.6	2.5	8.7	15.7	10.7	4.6	2.8	14.1	7.5	12.9	2.2	14.8	8.9	3.1	5.0	15.2	13.5	14.5	14.5	7.0	5.4	8.8	13.9	6.9	9.7	5.4	10.0	5.5	1.4	2.6	6.7	2.5	1.4	6.3	3.6	2.3	1.2	6.7	3.9	5.9	1.0	5.7	0.5	13.6	3.1	5.9	9.0	3.0	18.0	10.4	6.1	6.8	5.0	6.8	1.8	5.3	8.0	11.3	16.0	5.5	10.4	7.4	6.4	3.3	2.7	4.6	8.8	2.0	2.8	4.3	2.8	4.1	1.8	0.0	1.5	8.5	0.4	0.0	3.5	2.0	2.7	8.0	8.5	1.8	7.0	43.5	2.0	5.1	9.7	3.6	5.8	21.0	4.4	3.3	3.9	23.5	70.7	38.0	1.4	2.0	19.9	40.0	1.7	4.1	18.5	12.4	3.7	27.3	67.5	4.1	10.6	16.3	4.9	1.7	4.1	9.9	3.7	0.1	2.9	1.9	5.2	13.1	18.5	10.4	4.4	5.3	3.4	4.5	1.2	24.0	2.4	0.4	1.8
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	36.7	57.4	53.8	32.8	54.8	38.6	39.5	58.6	75.2	58.5	42.8	59.7	46.4	54.9	20.9	39.4	54.3	30.0	52.9	53.6	47.0	62.1	44.6	35.6	39.2	49.0	47.8	69.4	53.4	55.2	70.1	20.9	48.8	57.7	28.5	29.1	49.2	36.8	58.2	40.6	57.1	24.8	38.1	63.4	51.9	48.8	51.4	36.5	71.6	50.6	25.2	47.1	44.9	58.4	29.9	43.2	32.3	41.7	33.3	28.2	26.9	30.4	17.1	23.4	25.3	29.0	49.2	27.4	41.7	24.5	20.2	46.4	21.3	33.9	13.2	35.9	27.6	24.4	111.3	45.0	25.2	24.8	22.4	39.4	27.2	32.9	13.3	40.0	27.4	27.8	39.8	39.1	31.3	40.3	37.2	36.4	41.9	15.6	17.3	62.3	19.4	46.1	27.2	22.2	36.9	49.7	14.7	42.4	22.3	19.1	33.4	26.5	38.8	26.9	22.5	23.8	23.6	74.0	40.2	30.9	41.8	43.0	27.5	3.3	1.4	0.6	2.0	1.1	1.9	1.6	1.6	1.4	1.1	1.7	1.2	1.1	2.1	0.6	1.1	1.9	1.8	0.9	53.8	54.8	58.6	75.2	53.6	47.0	49.0	47.8	48.8	38.1	51.4	58.4	14.1	6.4	13.7	37.5	13.9	10.8	15.9	15.4	22.8	26.7	17.4	13.8	18.4	17.2	15.7	22.0	33.3	16.6	12.8	31.1	15.6	9.5	2.2	11.0	11.0	12.7	27.6	7.8	25.6	12.9	8.2	15.0	19.4	11.4	6.3	20.1	13.9	8.9	12.2	28.6	26.8	24.7	14.2	8.7	7.2	5.4	22.1	10.8	3.6	13.1	10.7	18.1	22.6	21.6	19.0	12.8	24.9	23.7	10.5	10.4	26.3	10.2	12.5	28.9	26.3	12.9	15.7	9.9	12.8	17.4	11.1	13.7	15.3	20.4	28.4	12.3
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.4;Extravillous trophoblasts: 67.0;Plasma cells: 30.0;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.4;granulocytes: 1.8;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;Karpas-707: 60.7;RPMI-8226: 46.7;U-266/70: 56.1;U-266/84: 106.7;U-698: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.4	1.8	6.3	5.8	4.9	3.6	3.6	4.3	5.3	4.6	1.3	2.6	2.2	4.5	0.3	1.9	4.6	1.5	2.2	3.9	9.3	6.0	1.8	5.7	10.7	10.6	11.2	1.9	1.9	1.0	3.0	1.8	7.0	4.4	0.5	0.8	2.8	0.7	37.3	3.6	5.5	0.9	7.1	14.5	2.4	3.4	10.4	0.8	4.5	13.8	5.5	4.0	3.4	3.5	3.7	2.8	3.0	6.6	0.7	0.3	27.6	1.3	0.5	0.8	0.6	0.8	0.6	64.2	6.4	0.5	2.8	3.7	0.7	0.9	0.3	8.1	2.8	0.0	1.7	0.6	0.6	0.5	2.2	0.6	0.9	0.5	0.2	1.1	0.2	1.6	0.4	60.7	1.3	6.9	0.3	11.5	7.0	2.3	11.5	8.1	3.3	46.7	2.1	1.0	3.2	11.4	2.3	5.6	1.6	2.3	1.0	8.4	0.2	1.0	6.2	11.0	1.3	56.1	106.7	88.3	3.9	2.3	1.5	0.0	0.3	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.3	3.4	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	6.3	4.9	4.3	5.3	3.9	9.3	10.6	11.2	7.0	7.1	10.4	3.5	5.6	0.0	0.0	6.2	31.4	2.5	2.5	0.0	1.8	6.8	3.4	2.9	1.1	1.5	0.0	0.0	0.0	9.3	2.9	0.8	0.0	0.2	0.4	3.8	2.4	7.3	1.8	0.4	2.2	0.0	67.0	2.0	1.1	5.4	0.0	1.0	2.2	0.8	7.8	5.0	4.8	0.6	0.0	14.1	17.6	2.0	0.6	15.1	7.2	2.8	6.0	9.2	1.0	1.0	0.5	0.1	0.5	0.4	30.0	5.7	0.1	13.0	0.0	1.4	0.0	6.6	2.0	1.1	15.8	0.6	1.6	58.1	1.3	0.4	1.3	2.2
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SH2D1B	EAT2	ENSG00000198574	"SH2 domain containing 1B"	O14796	1	162395268-162412138	"Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;skeletal muscle: 12.1;tongue: 6.6"	"Group enriched"	"Detected in some"	7	"dendritic cells: 47.3;NK-cells: 154.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"NK-cell: 376.5;non-classical monocyte: 149.2"	"Group enriched"	"Detected in many"	38	"monocytes: 149.2;NK-cells: 376.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;EFO-21: 2.7;Karpas-707: 4.4;TIME: 1.3"	"Not detected"	"Not detected"							HPA054791	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054791: AB_2682600"	"unprognostic (7.82e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.89e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.15e-3)"	0.5	0.0	0.7	0.7	1.1	4.5	0.2	0.0	1.0	0.1	0.1	0.5	0.8	0.7	0.1	1.4	0.2	0.5	0.1	0.7	0.1	0.4	1.0	2.2	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.3	0.6	12.1	0.0	1.1	0.1	0.1	7.5	0.1	0.3	0.2	0.2	0.1	6.6	1.0	0.2	1.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	1.1	6.7	31.0	0.4	0.3	0.1	1.8	6.8	0.1	0.4	1.3	3.0	376.5	149.2	0.5	0.4	67.3	0.7	1.1	0.0	1.0	0.7	0.1	0.1	0.2	0.2	0.1	0.2	1.2	0.1	3.2	0.6	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	47.3	0.2	0.0	0.0	0.1	1.4	0.3	0.2	0.0	5.3	4.3	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.8	0.6	0.1	0.0	0.5	0.0	0.0	1.6	0.3	0.5	0.0	2.0	0.0	1.0	1.6	0.0	154.5	0.0	0.7	0.5	0.0	0.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	13.9	0.0	0.1	0.0
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816848	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.9;dendritic cells: 139.5;NK-cells: 113.3;T-cells: 103.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"NK-cells: 28.5;T-cells: 66.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.5;HMC-1: 33.3;Karpas-707: 81.0;RPMI-8226: 24.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 1.6"	HPA074482	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"	3.5	0.9	1.0	11.4	1.1	4.3	1.3	3.8	1.6	1.8	1.9	2.2	2.5	1.7	0.3	1.2	1.5	3.3	2.5	0.9	1.5	2.5	2.2	5.4	9.4	1.9	1.1	0.6	1.0	0.3	1.8	0.8	1.5	2.5	2.0	3.4	0.9	0.7	0.4	0.4	5.4	1.6	1.2	13.0	2.9	0.3	1.1	14.9	1.6	0.0	5.9	3.7	1.2	1.3	2.6	0.4	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	1.7	2.4	0.0	6.8	0.0	0.0	0.0	0.4	1.3	0.1	46.5	0.1	6.8	0.5	0.9	0.2	0.4	33.3	0.5	0.0	0.2	3.3	0.0	0.3	11.8	1.9	81.0	0.0	0.2	5.9	0.7	4.9	4.1	8.3	0.9	0.0	24.5	0.1	0.3	7.5	0.0	1.6	0.9	0.8	0.5	0.2	1.3	2.2	0.0	0.0	0.3	0.5	11.6	16.6	8.3	0.0	6.9	0.2	1.0	0.1	0.0	66.5	0.0	61.8	1.1	27.6	40.8	0.1	0.3	10.4	27.2	1.5	28.5	0.2	0.1	34.1	18.6	1.0	1.1	3.8	1.6	0.9	1.5	1.9	1.1	1.5	1.2	1.1	1.3	1.2	3.2	2.3	0.0	4.6	2.2	0.3	0.4	1.2	33.9	1.0	1.9	0.9	0.0	1.3	0.0	0.0	0.1	139.5	1.2	0.0	0.3	0.2	0.2	2.5	0.6	1.2	6.1	0.0	0.6	1.0	4.8	9.2	0.5	8.2	0.3	1.8	0.9	1.1	0.0	0.0	0.9	0.0	1.9	2.1	0.0	0.0	4.1	0.0	1.9	1.1	1.3	113.3	0.0	0.5	6.1	1.4	0.0	24.2	0.5	0.3	0.2	0.7	1.6	0.0	0.5	2.9	0.1	4.9	3.0	1.3	0.1	103.2	0.1	1.8	0.5
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.9	0.4	0.2	4.6	0.2	3.4	7.5	0.1	0.6	8.0	0.5	12.8	14.3	1.2	1.0	32.5	4.3	3.5	0.6	0.1	0.1	19.6	2.6	10.8	5.2	0.4	0.2	0.8	19.7	5.9	2.8	5.9	0.2	18.1	5.4	0.9	18.7	4.1	1.5	27.6	14.4	0.3	0.2	5.7	14.2	4.4	0.3	3.3	13.0	0.0	4.1	9.1	17.0	0.5	43.2	6.2	0.1	0.2	0.0	0.0	22.6	0.3	0.0	0.0	0.0	20.3	30.8	6.6	19.6	0.0	0.0	34.2	2.3	67.4	0.0	3.6	6.6	0.3	6.9	2.6	0.1	0.6	8.6	0.0	30.3	0.0	5.9	0.8	0.0	14.8	7.3	14.3	0.0	15.3	3.2	0.2	1.6	21.5	12.0	1.2	0.1	24.8	11.5	31.4	0.0	0.2	2.3	31.7	0.1	1.0	22.0	0.4	0.7	0.7	2.2	0.5	0.4	14.1	15.8	9.2	0.2	4.8	0.3	0.1	0.0	0.0	2.6	0.1	4.2	3.6	5.9	5.2	0.1	5.6	7.7	4.2	0.1	1.8	0.1	0.4	3.2	0.9	0.2	0.2	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.2	0.3	0.5	0.7	19.2	14.2	0.3	25.8	30.7	117.9	51.4	25.0	4.1	13.6	11.4	1.9	40.0	43.9	40.5	10.4	23.8	7.7	46.6	1.9	54.1	1.6	15.4	2.9	2.8	12.1	7.8	0.1	37.1	52.8	2.6	50.0	24.9	5.7	0.3	1.8	2.9	3.6	0.0	0.2	37.9	28.5	0.6	10.3	0.8	0.6	2.2	3.6	0.0	4.2	0.8	14.4	0.0	0.1	81.3	69.7	0.0	8.0	58.6	53.9	13.1	27.0	4.6	0.0	2.2	3.5	8.7	11.4	17.6	39.9	10.8	18.0	1.1	32.0	87.9
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	27.3	7.6	11.2	15.9	10.5	11.2	24.9	11.7	13.2	12.2	2.8	7.6	4.5	15.8	1.2	5.8	12.6	9.2	44.7	10.7	9.6	19.9	4.7	52.2	25.8	8.6	7.5	5.0	4.8	3.9	7.1	15.8	8.4	8.5	1.8	0.8	6.8	3.5	14.6	7.4	15.1	7.3	8.1	47.2	7.3	5.1	8.9	27.8	22.9	11.4	10.5	10.9	9.4	8.0	0.1	0.2	0.9	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.5	1.1	0.0	1.1	0.7	0.0	0.0	0.0	15.6	0.3	7.3	0.1	0.0	0.3	5.6	53.3	0.3	0.2	0.3	0.1	0.0	60.0	11.6	0.2	20.6	0.0	0.1	5.1	16.8	0.8	0.0	0.0	60.7	0.9	46.1	0.0	0.0	14.5	4.4	0.3	0.1	0.0	1.4	0.1	9.6	50.1	0.0	1.2	0.1	0.1	20.3	22.2	20.3	0.4	4.8	0.0	34.0	29.9	37.8	32.3	94.7	26.4	26.2	18.8	30.4	32.8	29.5	16.6	17.5	82.2	34.6	124.8	59.8	21.6	34.2	11.2	10.5	11.7	13.2	10.7	9.6	8.6	7.5	8.4	8.1	8.9	8.0	52.6	3.2	5.8	0.7	15.9	1.3	0.3	1.9	0.6	3.2	1.1	1.7	10.5	2.8	0.9	0.0	0.0	0.3	29.7	0.0	0.0	0.5	13.8	2.2	2.8	52.2	4.2	3.6	10.8	0.0	0.2	3.1	2.0	0.8	11.4	0.0	41.7	0.7	6.0	3.3	10.7	0.3	0.0	6.0	3.7	16.3	1.2	10.7	1.8	23.4	13.4	3.6	21.6	3.0	0.7	0.1	0.0	0.7	7.6	0.1	0.0	0.1	0.8	2.4	6.6	1.2	12.5	1.8	1.5	0.9	0.4	0.7	15.5	2.0	0.1	0.2
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313693-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	5.0	8.8	1.6	4.1	1.4	0.1	6.2	1.2	2.0	13.6	1.9	13.6	12.7	4.0	1.7	20.4	9.1	11.1	3.1	1.6	1.5	12.6	39.1	15.8	1.0	1.6	1.6	36.9	13.1	18.2	1.4	17.7	1.9	7.4	10.8	9.6	24.0	10.1	0.6	7.2	12.6	2.0	1.3	3.3	29.9	2.2	1.5	1.3	16.8	1.6	7.4	18.3	10.5	2.0	60.5	67.3	0.2	0.1	6.5	8.0	44.9	73.9	36.6	70.7	68.3	55.7	53.4	0.0	17.4	181.7	11.2	30.5	2.7	20.0	73.6	0.2	1.0	0.0	40.7	8.6	38.3	1.6	0.3	7.8	24.5	48.4	8.8	42.5	0.3	0.0	0.1	0.1	12.0	27.2	0.1	0.7	15.8	102.5	25.4	0.1	0.0	19.5	19.5	62.6	4.1	0.1	66.0	70.6	0.2	10.4	13.3	5.3	1.2	22.9	0.1	130.8	22.4	0.0	0.7	0.2	23.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.2	0.0	1.8	0.1	0.0	0.0	0.1	0.0	1.6	1.4	1.2	2.0	1.6	1.5	1.6	1.6	1.9	1.3	1.5	2.0	8.5	64.1	33.9	6.5	0.9	1.5	15.0	22.2	5.2	2.2	9.4	5.6	2.0	34.3	26.2	46.0	27.1	87.7	0.3	20.1	43.0	50.3	25.3	30.9	6.0	5.4	3.0	0.0	1.5	67.0	69.4	11.7	67.8	34.4	1.3	43.3	2.5	45.5	37.7	1.7	1.0	24.8	54.9	8.5	1.6	53.5	6.2	6.3	0.0	1.9	0.6	3.5	0.0	11.1	0.3	99.1	8.3	11.3	0.4	14.6	20.5	10.9	46.9	36.2	19.7	3.0	6.5	0.5	2.8	31.9	2.6	30.6	1.0	52.0	26.3	31.2
SH2D4B		ENSG00000178217	"SH2 domain containing 4B"	Q5SQS7	10	80537902-80646560	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.8;Inhibitory neurons: 1.0;Spermatogonia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	87	"REH: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040022	Uncertain					NA	NA					"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA040022: AB_10805601"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-6)"	"unprognostic (9.37e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.81e-1)"	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"		2	85418931-85437029	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"intestine: 1.9"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 10.7;Gastric mucus-secreting cells: 18.3;Proximal tubular cells: 16.7;Spermatocytes: 6.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"LHCN-M2: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053873	Uncertain					NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.8	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0		0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	0.0	0.0	0.0	1.3	0.2	0.0	0.5	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	1.9	0.0	0.3	0.1	0.1	0.0	10.7	0.0	0.6	0.0	0.0	0.1	18.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	2.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.0	2.4	0.1	2.3	0.4	0.1	0.3	0.6	16.7	0.0	0.2	0.0	0.8	0.2	6.8	2.3	0.0	0.0	0.1	0.3	0.1	1.5	0.0
SH2D7	LOC646892	ENSG00000183476	"SH2 domain containing 7"	A6NKC9	15	78077808-78104909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"intestine: 2.1;testis: 3.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 21.1;Late spermatids: 35.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051320, HPA058382, HPA076728"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA051320: AB_2681439, HPA058382: , HPA076728: "	"unprognostic (1.22e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	1.7	0.1	0.2	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.7	1.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	21.1	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	3.0	0.0	0.0	0.4	0.0
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 1268.3;tongue: 578.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 180.2;Distal tubular cells: 46.9;Early spermatids: 151.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 101.0"					"Low region specificity"	"Detected in all"			CAB003685	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"CAB003685: AB_425682"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	8.9	24.0	41.8	3.6	44.9	2.0	11.2	42.0	72.4	10.8	37.3	39.4	6.6	12.3	28.5	20.3	8.1	9.5	154.1	43.7	43.0	13.2	11.8	5.4	2.0	43.8	40.8	6.0	11.0	10.7	25.6	2.1	44.4	25.1	7.0	14.7	14.2	21.2	1268.3	4.8	8.5	11.0	41.0	3.3	16.9	20.1	42.4	3.2	16.3	578.1	2.1	20.8	8.1	50.5	2.0	2.9	3.7	4.2	5.5	9.2	1.0	2.7	0.6	1.9	1.5	1.6	3.9	6.6	8.9	10.9	14.5	0.3	1.2	3.1	2.9	3.9	7.6	7.6	0.9	3.1	15.1	2.8	1.3	7.6	13.5	7.0	12.1	3.4	1.8	13.9	5.0	7.7	7.8	9.4	3.7	4.2	3.2	6.2	6.2	6.5	13.1	4.5	8.3	1.8	10.0	4.0	5.8	4.9	5.4	2.3	19.8	0.5	1.6	5.0	0.6	3.1	7.9	26.3	5.7	6.7	101.0	5.0	6.9	0.0	0.2	0.0	0.2	0.9	0.9	1.4	0.4	0.9	0.9	0.6	1.6	1.2	0.2	1.2	0.9	3.7	0.1	0.4	41.8	44.9	42.0	72.4	43.7	43.0	43.8	40.8	44.4	41.0	42.4	50.5	2.4	3.2	3.9	15.3	1.4	2.7	12.8	5.9	1.8	2.1	11.4	25.0	180.2	5.7	4.4	5.5	4.2	3.7	3.2	2.3	46.9	5.1	151.2	11.3	5.0	3.1	1.2	0.8	6.4	21.3	1.7	5.6	3.6	10.6	4.5	5.3	2.2	9.2	2.4	5.0	6.5	1.7	4.1	1.6	2.0	35.4	2.1	1.5	12.4	5.6	1.2	21.2	0.0	3.0	14.6	4.8	3.2	5.7	1.0	3.3	2.3	14.4	6.7	6.2	6.6	22.7	16.9	32.4	23.6	1.1	1.7	1.9	1.4	4.7	2.7	4.6
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81202102-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles		NA	NA		13000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA051248: AB_2681405"	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	112.1	120.0	92.4	101.1	92.4	176.7	170.8	98.1	126.3	146.2	94.3	180.8	87.6	208.5	148.8	130.4	112.3	149.1	61.1	88.0	108.2	126.0	62.6	133.0	154.9	104.8	95.6	130.7	81.3	112.3	83.5	86.4	105.2	153.1	108.5	24.9	112.5	284.9	16.5	67.1	98.1	231.7	104.4	144.4	87.0	54.3	96.1	145.1	104.7	50.2	126.8	178.3	76.0	116.3	1.0	38.2	133.4	154.1	172.1	232.0	9.2	83.4	158.3	30.1	61.1	12.5	114.6	113.7	70.1	122.9	42.4	20.7	95.9	60.0	48.0	98.7	33.3	151.2	59.7	7.4	41.6	107.3	286.0	135.6	42.9	42.4	37.6	231.4	133.8	75.9	53.0	279.6	165.9	53.9	117.0	138.7	105.2	1.4	62.3	102.0	60.9	60.8	155.7	52.8	0.4	58.5	0.1	4.2	77.9	88.0	44.8	321.2	136.9	82.7	34.1	76.4	35.0	64.3	60.6	105.6	95.1	215.9	62.9	793.9	358.5	570.7	124.9	477.3	134.8	236.3	154.7	147.8	306.2	207.4	140.8	148.8	126.7	183.0	560.5	148.0	257.5	462.3	92.4	92.4	98.1	126.3	88.0	108.2	104.8	95.6	105.2	104.4	96.1	116.3	191.3	112.2	92.6	73.8	216.1	126.3	131.5	150.4	83.1	16.2	174.6	150.2	19.7	72.9	106.4	121.4	0.0	7.1	183.9	33.2	344.4	86.9	6.3	74.9	120.0	130.7	93.3	172.9	62.8	74.7	6.0	152.4	63.2	62.6	219.7	92.8	139.9	17.8	431.4	5.0	82.4	87.0	109.9	400.9	430.7	19.2	174.3	379.0	147.7	102.1	459.0	154.2	224.6	82.9	54.3	48.0	104.2	314.1	114.4	83.5	91.2	214.3	113.6	8.5	263.0	132.4	308.8	4.5	5.9	76.0	119.5	5.7	163.4	205.9	90.3	146.4
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26280086-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		41000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	221.9	102.0	289.8	423.0	302.9	530.2	141.8	306.0	380.2	135.5	269.7	416.3	161.9	85.8	708.2	368.2	101.4	177.5	120.8	299.4	321.7	115.9	121.6	289.5	404.4	316.2	340.4	66.7	157.4	85.5	83.2	155.4	320.6	82.5	437.9	32.2	139.6	112.3	47.6	305.9	164.7	202.6	297.0	313.1	223.2	26.2	351.0	306.7	82.9	81.0	437.0	424.5	176.3	325.7	501.1	274.9	187.5	265.7	769.3	2090.9	23.2	895.6	1315.0	959.2	611.0	220.3	460.4	120.8	297.9	1963.3	268.2	182.6	108.9	1030.2	642.6	192.0	109.3	976.3	212.1	213.3	604.8	280.1	1447.9	836.8	652.4	912.9	742.0	1115.0	1200.3	244.7	112.2	430.6	1767.3	337.8	182.1	478.2	221.6	434.8	2003.4	341.1	229.0	170.5	762.6	216.7	119.7	189.8	331.2	338.1	374.1	199.3	65.7	431.9	1451.5	1071.0	370.8	1492.9	402.3	135.7	241.6	104.0	2253.9	792.3	532.5	4277.3	7085.6	6427.9	4340.1	6247.2	3228.5	2422.2	3706.5	4249.4	5891.3	2181.2	1591.2	3072.9	7753.8	2344.8	6190.5	3152.1	5092.0	13045.6	289.8	302.9	306.0	380.2	299.4	321.7	316.2	340.4	320.6	297.0	351.0	325.7	445.2	96.1	168.0	9.8	603.5	984.1	995.1	708.3	373.9	17.1	216.7	227.1	7.8	193.0	290.5	367.8	4.2	133.1	1060.9	1614.6	313.1	1108.5	15.8	178.9	410.9	502.9	339.8	220.0	12.9	1031.5	436.1	493.8	388.4	344.0	1017.6	67.2	346.6	121.7	2516.1	16.8	8.2	1430.3	205.4	1796.4	2368.4	52.8	139.1	2209.6	779.1	16.9	1116.8	76.9	1251.3	4.0	20.2	2492.4	1309.6	162.1	397.9	1754.9	391.7	498.6	202.8	16.4	151.2	71.9	336.4	9.1	23.5	788.1	1058.7	227.1	1380.4	99.2	507.5	2342.3
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656117	"Metabolic proteins, Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.5;HMC-1: 45.4;NB-4: 44.7"	"Low region specificity"	"Detected in all"							HPA000757	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavorable (3.48e-7)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.2	3.6	3.4	14.2	3.4	14.4	3.4	3.7	6.2	12.2	2.7	19.4	18.1	3.2	0.7	37.7	4.0	2.1	2.0	4.1	4.5	3.2	2.6	8.8	12.1	6.0	3.9	3.4	2.8	2.2	2.1	5.1	4.7	7.6	4.5	0.2	9.3	2.0	0.7	27.0	20.9	2.0	4.8	27.0	4.3	5.7	4.7	8.2	2.5	0.5	7.7	10.5	21.1	5.7	20.1	1.0	3.9	3.4	0.9	3.9	28.6	3.8	6.4	6.3	7.0	5.9	2.3	12.6	2.7	2.4	2.0	43.5	2.0	26.0	2.6	36.9	13.7	18.5	0.6	8.6	3.3	25.9	45.4	4.9	6.3	7.9	0.9	5.2	1.0	6.3	6.4	4.8	0.6	12.7	3.0	44.7	7.6	13.7	3.8	15.7	3.2	11.0	0.8	22.2	3.8	10.1	1.0	5.3	17.9	3.9	6.7	22.1	1.3	2.3	10.8	0.5	0.2	29.9	10.2	9.0	3.2	26.4	13.0	1.8	1.4	4.6	1.0	1.8	1.0	0.3	1.1	1.1	0.7	0.1	0.6	1.4	0.9	0.8	3.7	1.2	1.1	0.6	3.4	3.4	3.7	6.2	4.1	4.5	6.0	3.9	4.7	4.8	4.7	5.7	1.2	0.0	7.2	0.7	23.7	19.1	22.2	42.5	23.3	0.3	3.3	4.1	1.2	4.3	8.0	0.0	2.1	47.5	36.1	55.0	0.0	3.0	0.4	0.6	4.3	1.7	4.2	7.8	5.6	4.7	43.9	6.0	11.2	1.3	14.0	3.4	4.2	0.5	48.3	8.4	0.8	29.9	12.2	33.3	19.0	0.1	5.0	45.6	5.4	2.8	36.0	3.0	53.5	5.0	0.9	2.0	46.8	1.9	20.9	29.6	41.9	0.3	11.4	0.5	0.0	0.9	3.6	3.4	6.0	23.6	15.3	37.5	52.7	5.0	23.6	42.0
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793071-2841098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036789, HPA036790"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA036789: , HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	15.3	6.8	17.2	30.0	20.6	48.2	7.9	20.1	16.6	7.0	6.8	12.3	11.4	6.8	9.8	7.1	8.9	8.7	6.7	14.4	22.3	13.1	12.1	17.0	23.2	34.0	30.5	5.8	9.6	4.8	5.0	12.8	25.2	5.3	9.1	5.2	10.4	8.3	16.9	39.7	16.0	10.5	21.5	43.9	16.7	5.2	36.1	8.4	4.7	4.8	13.3	12.3	9.7	14.8	11.2	5.2	7.4	8.7	4.6	14.6	7.2	16.8	13.0	11.1	10.9	6.9	31.6	18.0	20.5	14.2	9.7	5.6	0.3	10.5	7.5	12.2	6.8	41.4	15.2	6.1	17.1	15.4	29.1	27.7	10.5	7.1	5.9	11.8	25.7	13.7	2.5	37.2	15.0	9.6	2.7	24.3	13.3	21.6	13.3	0.6	7.4	9.9	20.1	16.1	25.4	16.4	12.8	10.7	10.3	6.8	15.7	30.8	35.4	12.1	8.9	4.2	13.8	19.5	10.6	4.3	14.1	40.2	14.4	4.1	21.0	13.6	13.8	36.5	8.2	3.0	3.8	8.8	15.9	6.9	1.9	5.0	33.8	8.3	44.6	6.7	6.9	12.1	17.2	20.6	20.1	16.6	14.4	22.3	34.0	30.5	25.2	21.5	36.1	14.8	27.6	3.2	5.8	40.5	19.5	38.1	10.0	35.3	8.6	0.8	19.8	10.0	8.3	7.2	25.3	40.5	0.0	1.3	43.7	42.5	3.9	6.3	8.5	9.7	11.0	31.3	10.2	14.9	0.4	22.0	1.2	11.3	18.3	22.0	9.5	11.6	33.9	59.0	49.3	0.0	2.7	14.2	30.5	81.5	63.3	10.8	13.7	71.9	19.6	18.7	48.9	23.7	57.7	2.5	0.5	25.3	27.1	10.1	18.1	16.1	23.7	43.7	12.3	6.4	39.5	5.2	16.0	1.9	3.7	18.6	83.4	4.2	22.0	25.5	15.4	20.1
SH3BP4		ENSG00000130147	"SH3 domain binding protein 4"	Q9P0V3	2	234952017-235055714	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 83.5"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.0;plasmacytoid DC: 3.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 3.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037533, HPA037534"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 35: Glandular cells - Unknown function"			"HPA037533: AB_10672903, HPA037534: AB_2675528"	"unprognostic (2.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.07e-6)"	"unprognostic (2.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.17e-2)"	12.4	9.0	17.8	5.7	21.8	1.1	35.3	21.7	15.9	20.8	20.4	13.8	17.2	12.5	14.5	7.7	17.5	19.0	10.2	14.5	16.2	18.3	26.1	13.2	2.2	21.3	21.1	22.5	61.3	5.8	4.0	18.2	20.5	20.3	13.7	2.4	83.5	16.8	9.5	16.6	11.1	13.6	15.8	5.6	25.6	10.2	19.7	4.7	11.1	9.4	3.8	9.4	7.5	28.1	49.3	30.6	77.7	5.8	33.8	22.4	35.2	70.2	66.6	54.6	48.8	23.5	28.8	0.0	19.0	140.4	126.8	26.1	22.6	47.2	64.8	0.2	10.3	0.0	39.5	64.1	55.8	0.0	0.1	43.9	69.9	76.6	41.4	52.4	58.7	0.1	0.4	0.2	81.4	37.8	0.1	0.2	42.5	56.2	16.8	0.0	16.0	9.3	50.0	9.9	47.9	19.3	15.8	101.4	42.7	55.2	11.9	0.2	47.2	59.8	52.2	47.1	45.7	0.0	0.1	0.2	55.6	0.1	89.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	17.8	21.8	21.7	15.9	14.5	16.2	21.3	21.1	20.5	15.8	19.7	28.1	23.5	3.2	9.1	4.2	1.0	14.8	50.2	15.6	14.2	2.3	37.3	18.0	6.6	18.6	22.5	7.3	6.2	8.7	3.9	6.0	9.8	24.7	3.4	21.4	10.9	22.9	6.6	1.3	0.7	24.8	29.9	11.7	14.8	29.2	1.3	10.0	17.2	26.8	2.1	3.3	1.4	9.1	16.2	1.4	13.1	4.9	8.1	10.9	24.9	20.6	2.6	1.3	0.0	18.1	52.4	39.6	6.3	9.4	0.2	96.9	0.8	1.9	20.7	0.7	0.0	1.9	12.4	0.8	2.8	8.8	11.1	37.1	0.5	5.5	18.0	30.4
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SH3BP5L	KIAA1720	ENSG00000175137	"SH3 binding domain protein 5 like"	Q7L8J4	1	248810446-248825915	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.7;eosinophil: 4.1;neutrophil: 4.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038067, HPA038068"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA038067: AB_2675814, HPA038068: AB_10670651"	"unprognostic (2.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.66e-2)"	9.6	10.5	18.0	10.1	18.7	9.0	7.7	17.3	21.0	8.8	13.9	12.2	13.5	10.5	7.8	15.8	10.0	8.0	14.1	19.4	15.8	9.5	10.5	9.2	11.3	17.0	16.7	8.6	10.0	12.0	5.9	11.4	16.9	9.1	7.3	5.3	11.9	11.6	30.6	18.4	12.4	9.9	15.8	12.3	9.9	9.5	17.1	13.8	8.1	17.8	10.2	9.0	9.1	18.3	23.2	14.7	18.5	21.2	25.7	17.1	24.6	51.1	17.4	29.2	21.8	14.3	20.0	11.6	29.7	44.1	7.3	24.6	17.9	22.1	15.0	25.4	6.3	18.6	16.4	11.9	15.8	20.4	21.9	14.4	23.4	33.0	12.9	20.7	19.6	21.4	33.0	12.0	20.2	7.9	19.7	16.5	32.4	25.5	36.9	21.9	13.0	23.5	20.5	10.6	21.1	29.2	15.6	19.3	17.9	14.0	21.0	42.4	27.5	36.9	15.7	14.7	80.2	30.5	34.3	10.5	26.8	23.5	15.4	7.7	1.2	4.1	0.7	0.8	0.7	0.6	1.0	0.6	1.1	0.6	0.3	0.3	4.6	0.3	0.3	0.4	0.2	0.8	18.0	18.7	17.3	21.0	19.4	15.8	17.0	16.7	16.9	15.8	17.1	18.3	5.2	0.0	2.0	5.9	4.3	4.6	2.1	2.9	4.0	8.3	6.1	5.0	9.4	1.5	2.3	11.0	0.0	9.6	4.7	15.1	1.9	8.8	1.3	10.5	5.4	6.0	7.7	6.9	6.5	6.0	5.2	4.9	7.7	6.1	0.0	9.0	6.1	10.0	6.0	8.4	5.7	8.4	2.0	5.3	4.5	1.0	4.4	5.6	3.6	3.7	7.1	4.7	6.2	6.0	6.4	10.6	8.1	5.7	5.4	3.0	13.8	9.2	5.1	3.5	0.0	3.7	5.8	8.8	7.0	7.0	4.7	11.4	6.3	5.4	7.3	3.3
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	70.8	15.7	9.8	12.8	14.9	0.2	31.5	6.0	9.6	22.5	104.9	44.2	44.4	23.2	10.7	40.8	23.7	63.7	64.1	6.8	11.6	27.2	49.9	36.2	5.1	8.8	10.3	42.9	15.2	19.9	5.0	27.9	8.8	27.1	48.3	12.8	17.3	40.5	17.7	30.0	49.0	41.4	5.1	7.4	22.6	12.4	11.5	3.9	25.1	33.8	7.9	33.3	20.6	18.6	26.3	19.2	12.1	9.5	190.3	161.0	26.0	31.8	34.0	13.9	14.4	24.9	31.6	0.0	12.5	29.9	22.7	19.2	12.8	36.6	13.5	0.1	10.1	0.0	22.2	26.7	46.0	0.1	0.1	129.1	27.6	20.9	32.0	23.9	81.9	0.0	0.0	0.1	36.9	10.9	0.0	0.4	24.3	40.3	27.6	0.0	0.9	0.4	17.3	18.3	0.9	16.3	22.7	23.0	18.5	24.7	7.5	0.1	59.9	43.6	15.6	19.5	12.9	0.1	0.0	0.1	22.6	0.1	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.8	14.9	6.0	9.6	6.8	11.6	8.8	10.3	8.8	5.1	11.5	18.6	36.7	22.4	32.5	8.1	2.9	28.6	14.1	12.3	18.8	6.6	20.5	25.0	88.5	34.3	29.2	16.5	14.6	25.9	5.0	103.5	5.9	11.9	4.4	17.6	38.1	29.1	18.6	7.0	55.8	15.4	20.7	77.9	38.7	13.7	21.5	37.5	21.8	46.4	7.4	6.7	30.0	35.6	10.2	4.6	20.2	6.7	62.1	4.8	26.6	74.0	1.2	20.8	5.2	263.9	360.1	21.3	55.9	48.2	3.2	41.5	88.2	27.2	52.4	11.0	13.1	46.0	26.3	2.9	6.0	16.7	38.5	27.2	5.5	20.3	54.0	41.2
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306368-36329340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;thyroid gland: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042212, HPA042456, HPA066168"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.1	0.7	2.4	2.5	1.1	1.3	10.8	0.2	6.8	4.4	0.0	3.4	14.0	2.2	1.4	6.9	1.2	2.0	2.0	0.8	0.0	8.8	0.8	3.9	2.0	1.1	0.2	3.5	0.5	0.3	1.7	3.1	1.0	6.7	3.7	3.2	13.4	1.4	0.8	17.4	20.9	1.1	0.0	2.2	2.0	6.8	0.8	0.7	27.8	0.3	3.0	1.3	7.2	0.2	11.2	0.3	2.0	2.2	0.5	1.3	14.4	6.1	0.9	2.8	1.3	7.1	4.3	2.2	5.5	1.6	0.3	21.1	1.4	3.3	2.1	0.9	2.1	2.1	4.8	5.3	1.1	1.2	3.2	0.9	3.0	1.9	1.4	21.7	1.0	4.3	0.4	2.6	1.6	7.3	1.4	1.1	1.2	2.6	2.4	2.3	0.3	1.2	3.7	1.8	4.4	2.1	1.1	11.0	3.4	10.3	0.7	0.3	3.2	1.6	1.2	4.3	1.0	3.3	1.0	2.2	3.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.4	1.1	0.2	6.8	0.8	0.0	1.1	0.2	1.0	0.0	0.8	0.2	1.1	0.0	2.0	0.3	1.7	3.1	1.7	3.0	1.8	6.9	6.2	4.3	1.4	0.0	1.9	5.5	0.0	2.9	1.9	15.3	1.9	0.6	14.2	2.5	2.0	1.6	0.0	0.0	1.6	0.4	2.2	1.9	4.6	7.7	1.3	2.6	1.1	0.3	7.7	11.8	1.2	2.9	2.0	6.1	7.7	53.6	1.2	5.0	3.6	0.0	2.2	1.2	1.0	0.0	0.2	4.3	5.8	2.6	2.9	2.6	14.9	1.1	2.3	1.2	0.0	0.7	2.1	2.6	1.2	2.4	3.1	5.7	1.3	3.2	1.6	1.3
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol		NA	NA		390000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	61.1	64.7	25.0	29.4	28.8	54.4	50.0	32.8	38.1	69.8	24.2	41.3	40.9	45.1	8.2	175.8	43.9	25.4	37.6	34.4	20.5	39.2	57.4	43.8	22.8	24.8	22.5	49.0	41.8	10.8	46.8	38.9	23.8	48.8	9.2	7.0	51.8	24.0	21.2	119.8	43.7	20.8	21.1	46.8	35.9	28.1	24.7	16.8	37.1	10.1	19.8	53.0	91.6	28.0	111.3	49.2	50.0	66.8	57.4	89.0	92.2	94.2	80.3	82.2	81.1	77.4	56.8	24.9	39.0	94.1	39.8	89.5	35.6	103.7	21.9	33.1	59.8	30.0	66.5	102.7	82.6	27.2	32.6	75.0	70.9	69.4	42.4	40.6	97.8	23.7	78.9	55.1	67.1	92.6	26.5	28.4	126.0	40.4	54.3	20.8	69.8	43.6	65.8	96.4	49.1	75.7	83.3	81.9	59.3	23.5	56.5	42.5	149.3	78.6	57.1	166.7	97.2	34.8	23.2	26.7	112.9	70.0	110.4	0.8	2.3	3.1	2.7	1.1	2.6	3.7	4.0	3.9	3.0	2.7	2.2	2.5	5.6	2.3	3.4	3.8	4.1	2.3	25.0	28.8	32.8	38.1	34.4	20.5	24.8	22.5	23.8	21.1	24.7	28.0	31.6	9.6	21.5	11.8	15.2	60.8	41.0	43.2	19.4	17.1	17.1	15.7	3.6	11.5	25.1	9.2	6.2	41.2	14.7	23.6	13.7	32.1	7.2	17.9	33.8	30.7	10.2	30.7	23.4	29.3	153.7	37.5	19.9	29.5	9.5	23.4	32.9	27.3	51.5	10.1	14.0	18.6	20.3	19.4	51.8	6.7	32.6	22.3	23.2	14.0	14.7	20.3	15.5	12.5	10.3	50.4	17.0	24.0	16.4	38.0	61.6	22.9	15.4	8.7	13.1	17.2	29.3	15.7	11.5	36.8	85.8	44.2	15.1	50.1	19.8	67.1
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SH3GL3	"CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13"	ENSG00000140600	"SH3 domain containing GRB2 like 3, endophilin A3"	Q99963	15	83447228-83618743	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 77.2;choroid plexus: 19.4;testis: 26.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 557.6;Late spermatids: 1307.0;Oligodendrocytes: 1142.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 35.8;HEK 293: 16.8;K-562: 29.9;RH-30: 11.1;SuSa: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039381, HPA077877"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA039381: AB_10794635, HPA077877: AB_2686863"	"unprognostic (1.10e-3)"	"unprognostic (6.62e-2)"		"unprognostic (4.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.01e-2)"		"unprognostic (2.37e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.43e-6)"	"unprognostic (4.42e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.78e-4)"	0.1	0.1	43.6	0.0	53.8	0.2	0.1	35.9	72.3	0.5	19.4	0.1	0.0	0.5	0.6	1.7	2.2	0.0	0.2	43.8	46.1	0.9	0.0	2.5	0.1	42.3	47.6	0.0	0.0	0.0	0.8	0.5	46.0	0.5	0.0	4.9	0.8	0.5	0.0	0.3	0.0	0.0	40.5	0.0	0.0	26.5	43.2	9.1	0.0	0.0	0.7	0.5	0.5	77.2	0.1	0.0	3.0	2.8	0.0	0.0	2.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.6	0.0	35.8	2.0	0.0	0.0	16.8	6.2	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.0	0.0	8.1	29.9	0.0	0.1	0.8	2.4	0.0	4.4	0.0	1.1	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	15.2	0.0	0.0	0.4	0.0	2.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	53.8	35.9	72.3	43.8	46.1	42.3	47.6	46.0	40.5	43.2	77.2	0.1	9.6	1.7	5.9	0.0	0.9	1.4	0.5	18.2	5.4	0.1	0.4	0.6	0.0	0.3	3.7	0.0	0.9	0.0	0.0	0.0	0.6	557.6	0.1	0.1	0.9	0.0	0.0	192.6	0.0	1.7	2.6	0.0	0.1	0.0	0.2	0.4	0.0	0.4	77.4	225.2	0.0	0.0	0.0	0.0	1307.0	9.3	0.5	1.8	6.5	0.0	3.1	0.0	29.1	1142.7	0.3	0.0	4.1	0.0	0.9	0.0	0.1	3.8	1.1	0.0	0.0	0.8	29.0	8.5	9.0	0.1	0.7	0.0	17.6	0.0	0.7
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 234.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	32.7	49.1	86.7	19.2	93.6	59.4	46.0	69.4	127.6	60.5	63.5	56.3	42.1	47.9	17.1	101.4	52.7	22.0	32.4	95.0	74.5	63.9	25.3	35.4	24.9	81.3	71.1	45.2	71.5	69.1	88.4	37.7	82.2	71.8	16.1	11.7	60.8	50.2	50.0	116.7	47.9	18.5	68.8	42.1	71.2	24.4	78.0	37.2	45.9	19.0	22.6	72.6	66.8	93.1	49.7	41.2	19.9	27.1	11.7	14.8	59.2	17.0	37.8	33.0	30.0	25.8	83.2	51.9	13.3	30.1	25.5	119.2	6.3	36.7	9.3	34.0	27.5	13.2	70.5	22.9	24.4	11.9	30.7	10.6	41.1	16.8	14.9	36.2	28.0	66.8	17.8	67.2	16.9	121.5	68.4	31.5	17.8	83.2	28.7	136.3	37.2	234.3	36.7	59.1	62.0	50.3	24.7	62.6	26.3	16.4	90.5	17.5	25.8	15.3	26.1	39.3	37.7	65.6	34.0	33.8	35.6	14.7	8.3	2.1	1.6	3.5	1.9	0.8	2.3	3.5	2.2	1.8	1.3	2.0	1.6	1.3	1.3	2.6	2.5	3.7	2.0	1.5	86.7	93.6	69.4	127.6	95.0	74.5	81.3	71.1	82.2	68.8	78.0	93.1	36.3	16.0	28.4	28.1	20.3	20.8	27.5	11.6	9.6	26.9	59.7	62.9	10.6	18.6	19.8	47.8	8.4	127.9	29.4	58.2	15.6	14.5	11.2	36.3	19.6	15.6	25.3	29.5	24.4	26.0	19.2	23.3	84.6	63.6	6.3	29.9	12.1	9.9	20.7	47.1	14.2	35.9	12.2	11.9	11.6	24.4	19.0	14.3	14.2	17.8	6.9	36.0	6.2	23.6	95.6	24.6	50.3	20.3	25.9	23.0	39.4	7.6	21.5	20.6	13.1	32.0	39.7	8.6	6.6	27.6	53.6	149.5	16.3	18.3	34.6	58.3
SH3KBP1	CIN85	ENSG00000147010	"SH3 domain containing kinase binding protein 1"	Q96B97	X	19533977-19887600	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 207.8;monocytes: 289.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003351, HPA003355, CAB021892"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954"	"unprognostic (1.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.96e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.92e-2)"	45.1	11.0	17.1	45.5	16.8	68.6	26.6	14.2	20.3	18.2	47.3	37.1	13.7	10.6	11.3	8.5	11.9	21.2	24.4	16.4	20.8	13.5	15.6	26.0	68.1	19.9	22.9	8.7	6.9	14.4	11.9	32.5	20.3	6.7	35.3	5.1	10.4	7.4	13.0	24.0	18.4	14.8	18.5	37.0	18.9	5.7	26.0	55.0	20.5	32.4	68.7	17.7	11.2	27.1	52.5	54.3	8.4	19.4	41.6	80.0	44.2	46.4	67.4	23.3	37.2	37.2	105.6	97.4	47.6	67.5	67.0	5.9	19.8	18.4	37.3	32.3	13.4	21.2	13.6	30.1	27.2	134.0	160.2	47.4	18.0	48.5	141.9	64.6	35.4	67.6	8.0	114.2	59.7	23.5	80.4	135.4	14.8	63.1	71.2	49.1	82.0	9.1	27.1	10.6	6.0	6.2	43.2	5.6	65.3	53.8	5.4	155.2	113.6	40.6	34.9	52.2	51.9	165.6	119.0	86.0	86.5	109.4	183.5	49.2	104.7	171.1	180.2	77.7	140.4	55.4	174.2	187.8	132.6	50.3	143.3	142.5	210.0	76.5	96.9	148.4	224.1	195.9	17.1	16.8	14.2	20.3	16.4	20.8	19.9	22.9	20.3	18.5	26.0	27.1	40.3	16.0	54.4	5.5	75.6	12.0	3.5	7.5	5.2	5.1	5.4	6.2	78.1	11.5	25.0	9.2	16.7	26.2	174.3	207.8	1.9	8.3	0.7	6.3	28.5	26.5	50.8	23.3	72.3	18.9	39.3	56.9	23.4	8.3	96.6	5.9	27.8	17.6	55.8	8.4	126.3	34.4	10.2	87.4	102.1	1.9	52.8	113.0	33.8	108.7	289.2	0.1	175.1	87.0	145.9	48.0	153.3	38.4	63.5	3.5	26.4	40.3	20.1	2.8	59.2	12.1	72.2	24.3	22.7	1.9	10.9	22.6	138.7	26.7	59.4	7.7
SH3PXD2A	"FISH, KIAA0418, SH3MD1"	ENSG00000107957	"SH3 and PX domains 2A"	Q5TCZ1	10	103594027-103855543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.8;BJ hTERT+: 84.8;fHDF/TERT166: 68.5;HSkMC: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037922, HPA037923"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA037922: AB_10697088, HPA037923: AB_10672612"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.62e-2)"	18.9	8.5	49.2	11.5	45.1	1.4	14.5	25.6	38.6	49.0	2.9	27.3	5.7	31.2	7.2	30.3	25.7	17.4	16.9	32.8	32.2	7.0	23.0	17.2	4.7	38.1	40.9	29.5	8.4	1.2	14.0	16.3	39.1	18.5	13.4	17.1	14.1	13.9	19.0	29.4	14.3	26.7	44.8	13.3	13.0	3.0	42.4	6.7	9.2	14.3	5.9	21.5	31.9	64.7	1.3	5.3	13.7	16.5	48.1	86.8	7.3	39.5	84.8	13.1	12.4	0.5	0.4	0.0	7.7	68.5	1.5	13.3	0.8	35.5	11.6	2.3	14.3	16.5	21.8	19.2	31.0	8.2	4.5	64.5	27.2	20.1	43.5	9.8	8.8	17.9	6.1	9.7	16.6	0.5	0.2	8.0	5.8	11.4	2.5	6.8	5.2	1.0	5.5	4.8	10.2	5.5	3.8	0.9	19.9	7.4	0.2	5.8	15.4	11.0	7.6	14.3	17.7	10.9	24.1	0.5	10.7	11.1	42.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	49.2	45.1	25.6	38.6	32.8	32.2	38.1	40.9	39.1	44.8	42.4	64.7	22.6	6.4	45.4	10.1	7.6	91.0	26.4	45.2	56.3	46.1	9.3	13.5	22.9	22.8	37.8	3.7	27.1	12.1	3.4	48.1	0.0	5.3	3.2	7.7	109.9	23.9	37.1	10.5	59.5	0.6	32.0	42.2	12.8	11.5	17.7	21.8	23.9	87.3	13.0	89.2	96.6	74.8	22.4	7.6	34.9	7.3	105.9	7.7	33.8	15.0	19.0	1.7	2.1	5.0	117.2	6.2	27.0	80.5	7.9	32.1	4.1	1.3	21.6	35.7	39.5	32.1	55.6	1.9	3.7	37.5	38.1	4.7	6.8	15.0	22.7	61.1
SH3PXD2B	"FLJ20831, KIAA1295"	ENSG00000174705	"SH3 and PX domains 2B"	A1X283	5	172325000-172454525	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.1;Leydig cells: 39.7;Oligodendrocytes: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.2;ASC TERT1: 79.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036471	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036471: AB_10670799"	"unprognostic (3.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (5.38e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (8.45e-4)"	22.6	25.4	9.2	11.2	12.8	0.1	19.0	12.9	11.5	36.4	9.6	14.0	2.3	32.6	5.4	10.5	17.9	18.9	7.4	9.8	10.7	2.4	2.9	17.6	3.5	14.5	12.8	18.4	9.8	6.6	5.0	8.9	16.0	12.8	5.6	3.6	18.3	13.9	3.5	19.8	11.5	23.2	10.1	6.5	13.1	6.3	13.7	4.2	8.0	3.4	3.4	18.3	18.1	15.4	1.0	14.3	52.3	34.6	95.2	79.9	44.3	8.6	29.7	5.4	10.7	4.0	1.3	0.1	11.5	33.4	16.7	8.1	18.7	9.8	5.3	0.8	3.5	0.1	13.3	2.9	30.6	0.0	36.5	51.5	15.1	22.4	6.4	5.2	37.9	3.8	0.1	0.2	24.1	3.1	0.1	4.6	20.1	8.1	3.3	17.3	8.5	5.1	5.7	1.5	4.6	29.2	6.0	3.8	10.7	16.5	1.4	2.1	40.9	33.4	13.2	20.7	3.8	0.0	0.0	0.2	22.6	2.2	27.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.8	12.9	11.5	9.8	10.7	14.5	12.8	16.0	10.1	13.7	15.4	11.3	0.0	1.1	91.1	0.4	10.1	3.2	13.9	8.6	0.6	6.2	6.5	1.8	5.7	12.0	0.0	0.0	4.5	0.2	1.3	0.0	9.9	0.9	5.5	30.8	6.4	2.4	0.0	5.0	16.0	31.0	29.8	6.1	13.4	0.0	5.8	3.3	1.8	3.1	1.7	11.2	2.1	18.3	28.4	9.4	2.0	39.7	13.6	14.2	13.1	1.3	6.3	0.0	25.1	63.0	21.8	1.0	27.1	0.0	6.9	0.2	1.9	3.8	0.3	13.1	6.0	10.5	0.8	4.2	4.7	8.1	2.2	0.5	22.3	2.7	5.7
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094259-169270956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 146.3;Oligodendrocytes: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.5;monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	9.8	3.7	8.7	4.4	10.0	3.4	8.2	7.6	13.1	5.7	5.9	15.1	13.8	4.3	5.7	5.9	5.6	11.9	5.7	18.2	8.6	12.2	8.0	9.4	3.3	8.8	9.7	8.5	10.4	3.7	3.7	7.4	9.4	14.3	13.6	2.4	15.8	8.4	9.4	5.1	13.1	4.0	8.2	3.9	24.7	6.1	9.5	2.0	19.9	10.0	3.2	9.3	4.4	13.0	15.2	12.2	11.0	31.9	11.5	14.3	14.1	40.5	19.7	30.0	13.8	12.5	17.8	0.0	1.9	43.1	8.1	9.8	8.9	16.2	32.4	0.1	5.2	8.7	27.4	6.5	26.0	3.1	0.3	8.5	8.6	25.7	19.9	37.3	18.7	3.3	0.1	0.0	27.8	6.0	3.1	2.9	5.6	19.2	10.5	4.5	3.6	0.6	13.6	11.8	8.3	9.9	10.4	15.7	4.2	4.7	5.2	1.3	17.1	14.2	11.0	23.6	14.7	1.1	0.0	0.1	16.0	3.0	17.3	0.0	1.0	0.0	0.0	4.2	0.0	0.3	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.6	8.7	10.0	7.6	13.1	18.2	8.6	8.8	9.7	9.4	8.2	9.5	13.0	28.0	64.1	37.7	146.3	3.4	34.3	48.3	11.9	13.6	3.5	21.1	15.6	11.2	44.3	34.4	27.6	0.0	12.7	0.4	69.3	11.7	42.2	5.5	28.5	14.2	13.0	31.3	2.1	54.9	63.7	22.1	16.5	65.7	46.5	10.2	5.6	11.4	12.4	7.4	0.0	54.9	27.1	12.2	9.3	5.3	3.5	12.2	11.1	3.6	52.5	3.9	11.3	0.0	89.5	213.0	68.4	37.2	12.0	2.4	63.2	28.9	18.4	31.7	1.2	65.7	24.1	36.9	5.4	10.7	9.4	12.6	13.1	1.7	6.5	34.4	72.0
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936578-146081791	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 58.1;skeletal muscle: 42.4;skin 1: 56.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7869.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 6.1;cerebral cortex: 4.1;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 70.3;GAMG: 29.8;hTERT-RPE1: 33.5"	"Region enriched"	"Detected in many"	14	"basal ganglia: 26.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.7"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	1.9	0.9	0.6	2.5	6.1	0.0	4.7	0.0	4.1	7.6	0.2	14.3	16.0	1.1	3.6	34.1	6.1	11.9	58.1	0.9	0.5	0.9	7.0	2.7	0.2	0.0	0.3	0.4	15.4	0.0	1.6	0.1	0.0	2.7	14.3	0.5	12.1	0.6	42.4	56.8	13.7	1.1	0.0	0.0	20.5	6.8	1.7	1.0	6.3	8.8	7.7	1.2	20.6	0.4	21.0	5.7	0.2	1.1	0.0	0.0	0.0	0.2	1.7	4.1	1.7	70.3	19.0	0.0	10.5	0.9	29.8	18.9	0.0	22.4	4.0	0.3	0.3	0.0	8.5	9.5	1.2	0.0	0.0	0.2	11.9	6.4	14.8	33.5	0.2	0.5	0.0	0.0	1.8	0.1	0.0	0.0	1.6	17.3	1.5	0.0	0.2	0.0	8.7	2.0	0.0	0.0	1.2	0.4	0.5	1.0	6.6	0.1	9.8	0.8	17.3	1.5	6.7	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	6.1	0.0	4.1	0.9	0.5	0.0	0.3	0.0	0.0	1.7	0.4	4.1	16.0	2.3	1.6	0.0	55.1	5.4	14.5	38.7	0.4	3.9	3.3	510.0	8.6	6.7	1.8	0.0	0.2	0.2	38.9	0.0	5.7	1511.3	11.9	0.9	9.7	1.2	0.0	10.5	8.7	0.0	15.4	50.4	26.7	1.3	0.1	0.7	8.4	0.2	0.0	2.2	16.1	8.2	0.0	4.9	7869.1	25.7	2.6	8.8	10.3	0.6	1.6	0.0	1.5	0.7	21.4	22.9	34.6	0.6	2.2	26.6	0.9	4.4	0.1	13.1	1.6	6.3	31.4	20.7	70.9	50.0	0.0	0.7	2.9	33.2	6.6
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.6;retina: 3.9"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 270.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No				"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	4.7	0.0	8.0	0.1	0.1	5.1	5.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	3.6	5.1	0.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.0	5.8	0.0	0.0	1.5	7.1	0.0	0.0	0.1	0.0	0.1	0.0	12.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.1	2.6	1.5	0.0	1.8	0.1	0.6	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	1.6	0.0	1.3	0.0	0.7	3.6	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.0	5.1	5.0	3.6	5.1	7.1	6.9	7.3	5.8	7.1	12.6	1.9	3.2	3.7	0.3	0.1	0.9	0.8	1.0	0.0	1.4	0.7	0.4	1.7	1.5	3.8	0.0	4.2	0.8	0.0	0.6	0.0	0.6	6.4	0.3	0.1	2.8	0.0	0.0	0.4	0.2	0.4	0.5	0.0	0.5	2.5	0.1	1.4	0.3	0.4	0.0	0.4	0.0	2.0	1.8	0.7	2.3	0.3	2.2	0.0	4.7	0.1	2.3	0.0	0.0	270.4	1.6	0.0	0.0	0.1	1.2	0.0	0.1	4.1	25.4	0.0	0.3	0.4	2.3	0.9	1.0	0.9	11.9	0.3	0.1	0.2	8.8
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 223.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	13.6	32.0	26.6	11.9	27.7	11.6	54.8	27.5	37.2	31.8	28.3	45.6	35.1	27.0	40.8	43.8	43.6	45.2	11.0	26.8	25.5	145.6	11.6	35.7	22.1	27.4	26.8	28.6	161.6	55.7	33.9	26.9	27.8	34.4	53.2	10.7	114.0	24.3	13.4	75.0	51.7	11.9	26.4	16.0	72.3	17.0	27.9	15.4	59.2	8.3	28.0	49.3	27.1	33.1	12.7	2.4	13.5	6.0	18.1	16.8	9.0	15.7	17.4	5.8	6.0	33.6	46.3	0.6	7.3	13.8	3.9	51.6	3.4	67.6	5.4	10.2	2.4	3.0	3.9	10.9	14.5	1.5	3.8	18.6	68.2	3.5	11.0	28.7	8.7	17.2	0.9	2.3	12.0	37.1	13.4	6.9	4.4	223.4	2.6	6.4	4.1	0.9	41.4	69.8	5.5	9.1	2.6	64.1	11.9	17.5	44.0	10.6	6.6	2.9	0.8	16.9	6.9	1.7	0.1	1.2	28.8	20.7	9.8	38.9	2.5	1.9	4.5	3.1	14.3	12.6	22.4	11.5	6.1	10.1	33.9	20.5	1.5	22.9	4.9	5.5	30.6	8.2	26.6	27.7	27.5	37.2	26.8	25.5	27.4	26.8	27.8	26.4	27.9	33.1	14.8	57.7	116.7	51.2	29.7	82.7	173.5	174.4	42.7	19.3	140.2	130.3	6.6	313.1	139.7	101.2	22.9	197.7	15.8	84.5	291.6	129.2	136.6	148.5	32.3	15.9	49.1	3.8	62.3	143.9	69.9	22.6	31.1	216.6	15.8	51.9	19.2	7.9	26.5	26.9	57.1	97.4	109.9	9.5	17.0	113.1	36.7	14.9	72.9	23.4	15.2	9.4	30.9	44.2	87.2	104.6	115.3	41.0	4.7	166.3	125.1	606.2	85.2	9.7	26.3	20.4	20.5	63.3	23.2	29.5	115.4	247.0	35.7	37.1	123.8	245.3
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50659255-50719802	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 71.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.7;Excitatory neurons: 29.6;Horizontal cells: 8.4;Inhibitory neurons: 32.9;Oligodendrocyte precursor cells: 7.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 28.8;cerebral cortex: 71.1;hippocampal formation: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 5.2;THP-1: 2.4;U-138 MG: 2.7;U-2 OS: 7.3;U-87 MG: 2.9;U-937: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: AB_2674169"	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.0	1.2	20.6	0.0	28.8	0.3	0.1	1.5	71.1	0.5	0.0	0.1	0.0	0.4	0.1	0.0	2.4	0.2	0.1	36.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	1.1	0.1	0.0	0.1	0.0	5.3	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.5	7.5	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.1	0.1	0.5	0.8	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	2.4	1.6	2.7	7.3	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.8	1.5	71.1	36.8	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	29.6	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.4	32.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.1	0.0	7.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467854-71252577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 7.7;basal ganglia: 7.5;cerebral cortex: 9.3;hippocampal formation: 9.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Nuclear speckles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	1.3	1.2	7.7	0.5	7.5	0.0	4.5	0.2	9.3	1.3	31.7	2.4	1.5	1.0	2.2	3.4	5.1	0.8	0.0	9.5	0.0	4.9	3.8	3.7	0.1	0.0	0.0	0.1	7.5	0.1	2.2	1.9	0.0	3.2	2.0	5.5	9.8	1.8	0.0	0.9	1.3	0.4	0.0	1.1	3.0	0.9	1.0	0.0	6.0	0.0	0.4	1.1	0.3	0.9	0.5	7.4	4.1	0.0	0.6	0.4	4.5	0.7	0.3	0.0	0.0	6.6	3.1	6.2	2.2	0.0	0.1	1.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	1.9	0.1	1.8	0.0	0.0	1.6	0.0	0.1	0.0	17.5	1.7	10.5	0.0	0.1	3.5	10.2	0.3	0.0	9.9	8.2	5.2	15.9	3.5	1.1	0.0	8.4	0.0	5.2	16.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.5	0.2	9.3	9.5	0.0	0.0	0.0	0.0	0.0	1.0	0.9	8.0	41.7	17.0	21.5	0.2	0.0	3.2	3.2	0.6	17.9	26.9	13.0	3.7	11.5	5.4	7.3	0.0	12.8	0.4	3.2	3.9	8.4	1.7	30.0	3.2	1.3	0.0	0.0	153.5	2.2	2.9	1.8	10.2	13.0	2.5	1.2	0.4	21.9	1.2	136.3	167.5	7.9	8.2	0.0	0.3	2.1	0.0	0.4	5.4	14.0	0.0	4.6	0.0	41.7	5.3	10.7	2.7	0.7	0.4	10.9	0.6	10.8	23.3	1.0	0.0	0.3	1.3	0.7	0.9	1.3	0.6	14.6	0.3	0.1	5.5	4.0
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.3;TIME: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	34.9	4.0	38.9	4.9	21.6	1.1	33.5	73.5	54.7	12.8	0.0	7.5	3.4	13.4	2.0	5.2	12.4	5.8	26.2	44.7	14.9	11.9	4.4	20.3	4.2	10.0	15.3	4.3	4.0	3.5	5.2	13.7	2.6	8.3	1.2	0.7	8.2	4.2	23.3	7.1	6.4	5.1	0.0	50.4	5.7	2.2	38.6	1.7	14.8	8.9	1.4	10.7	10.1	16.2	6.6	2.6	6.2	4.8	0.5	1.6	3.2	1.3	0.0	0.4	0.5	1.6	2.4	0.0	4.0	1.0	3.1	1.2	0.9	2.3	0.0	0.0	10.4	8.0	1.8	7.1	1.9	1.8	0.4	2.2	1.8	0.1	0.3	0.1	33.3	1.9	0.2	0.2	0.5	2.6	1.4	0.5	3.2	0.6	2.2	7.5	0.0	1.7	0.4	1.3	2.3	3.0	2.7	0.0	3.1	0.7	0.3	0.7	37.6	0.4	9.3	2.0	0.7	0.3	0.4	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	21.6	73.5	54.7	44.7	14.9	10.0	15.3	2.6	0.0	38.6	16.2	195.3	0.0	1.1	4.6	0.5	0.3	0.1	0.5	4.0	1.2	1.3	2.4	27.6	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.9	3.9	2.4	65.0	2.4	0.0	28.3	0.0	0.0	3.3	0.0	1.5	0.0	0.3	70.3	6.5	0.4	0.0	21.7	0.0	2.0	3.1	0.0	0.4	0.0	0.3	0.0	44.0	0.0	1.4	0.0	25.1	31.3	0.1	0.0	0.4	0.0	0.2	0.0	0.9	0.9	0.0	0.0	1.0	3.8	0.2	0.8	1.0	0.3	0.0	0.6	0.7	0.1	0.3
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 1255.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024825, HPA044453"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA024825: , HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	29.9	39.2	38.5	16.5	39.9	32.6	27.2	39.1	52.2	29.9	35.7	37.7	20.7	29.4	11.2	29.9	28.8	19.4	44.4	36.0	39.2	36.7	39.1	27.1	21.8	41.7	39.7	27.4	35.1	28.7	26.7	17.2	39.9	33.8	12.7	8.9	33.8	22.2	49.4	27.1	26.3	17.3	37.7	33.4	34.2	94.7	39.8	19.6	29.1	39.7	13.9	31.2	26.4	38.7	26.9	43.5	20.4	17.9	34.2	35.1	22.5	23.5	29.5	34.0	32.9	24.9	42.0	12.0	38.5	30.6	17.1	28.4	10.8	42.2	8.2	33.0	23.3	31.4	40.1	29.9	61.6	11.6	23.1	40.4	59.4	28.3	30.8	37.6	36.8	36.6	18.2	27.3	30.2	43.8	35.2	26.6	9.3	53.6	124.2	23.6	16.7	39.4	35.2	28.3	20.3	30.7	45.0	62.1	41.5	14.3	69.4	35.8	34.0	26.5	38.9	32.5	32.4	30.0	25.4	16.3	38.3	25.9	23.5	22.6	33.5	53.5	29.9	41.2	32.4	23.3	28.5	38.3	30.0	21.8	23.5	24.7	17.5	33.9	34.8	42.7	34.1	22.4	38.5	39.9	39.1	52.2	36.0	39.2	41.7	39.7	39.9	37.7	39.8	38.7	56.3	9.6	18.1	10.4	39.4	24.0	32.9	37.0	26.2	27.1	43.5	44.4	20.9	31.5	26.1	35.0	4.2	56.7	44.4	87.2	119.3	53.8	391.4	28.3	26.8	38.9	35.4	88.0	8.0	49.5	52.6	35.9	52.0	24.4	13.3	35.1	36.4	37.2	59.0	48.8	9.5	45.6	44.7	42.1	32.9	1255.3	49.0	33.0	46.2	15.0	57.7	45.4	59.8	9.0	14.3	95.2	81.3	43.6	31.2	36.1	83.1	86.4	20.6	28.9	52.6	26.8	44.2	181.7	67.9	33.5	32.4	43.1	38.8	37.4	59.0	33.9
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37915898-38069227	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"OE19: 35.3"	"Low region specificity"	"Detected in all"							"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	12.8	7.6	6.4	1.9	9.6	3.1	9.8	6.1	9.2	8.8	8.2	11.2	3.6	6.6	1.2	26.2	7.2	4.9	24.9	6.7	6.3	23.1	35.2	13.9	1.3	8.5	9.7	4.7	20.0	4.1	15.0	2.5	7.8	16.1	2.6	0.9	23.2	4.6	6.8	17.3	7.1	3.2	5.6	6.6	10.6	4.1	9.4	1.7	8.3	1.3	2.5	13.6	16.1	12.8	8.3	14.6	1.4	0.2	1.5	3.8	2.5	9.8	11.5	6.9	5.0	4.5	5.8	0.0	10.9	8.5	16.9	8.8	5.8	14.2	4.8	6.7	11.0	0.0	5.3	10.7	10.8	0.4	0.4	3.4	4.9	11.2	7.8	16.1	6.5	1.4	3.6	2.4	7.7	6.2	0.9	0.3	3.7	35.3	13.0	0.4	4.3	0.5	13.1	3.8	15.8	12.1	1.3	10.9	2.2	11.9	6.5	0.4	9.2	3.3	11.0	1.6	16.2	0.7	0.2	0.1	18.3	0.8	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.6	6.1	9.2	6.7	6.3	8.5	9.7	7.8	5.6	9.4	12.8	21.5	6.4	5.6	9.8	0.6	20.4	96.9	9.9	33.0	0.6	12.7	6.0	9.6	35.8	9.0	22.0	8.4	10.2	1.1	17.3	15.6	18.0	1.9	8.3	2.5	19.0	7.8	5.2	6.4	20.3	1.5	5.5	14.8	18.3	0.0	0.9	10.4	21.6	6.1	0.0	5.4	12.1	2.0	2.6	19.4	3.8	0.6	5.8	7.2	8.4	0.4	2.9	0.0	5.0	43.7	22.2	6.8	0.4	1.9	31.1	7.5	24.9	5.1	1.4	0.0	5.7	3.9	1.2	9.4	19.3	34.0	4.0	1.2	9.3	11.1	45.9
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	147.4	103.8	30.9	90.3	29.8	72.8	126.7	28.9	32.0	91.3	32.2	71.8	72.1	86.0	53.7	73.5	87.5	88.8	67.0	28.0	33.2	71.4	94.5	106.3	50.6	36.2	32.6	70.7	57.7	61.8	120.5	77.0	36.4	85.0	70.9	16.5	58.7	70.2	63.3	59.2	73.0	107.6	32.7	72.8	69.7	23.3	39.5	47.4	86.4	56.2	52.8	96.6	83.2	30.4	110.8	223.7	168.9	272.3	180.6	359.3	88.6	393.5	355.3	223.6	168.7	80.2	258.5	59.3	314.0	476.4	64.1	92.9	45.5	389.6	200.2	72.7	25.0	152.0	185.7	143.9	471.1	49.3	164.8	538.3	452.4	279.4	344.0	605.8	497.7	25.0	68.2	461.3	473.8	90.0	56.8	29.8	147.9	89.7	94.2	51.1	56.1	122.6	107.1	82.5	21.6	582.1	234.8	130.2	126.3	293.3	189.8	102.9	595.6	349.6	217.5	75.1	209.0	206.6	146.2	101.7	341.4	65.9	463.5	32.4	36.7	58.0	39.0	47.7	38.7	22.4	30.7	34.6	38.0	20.8	24.6	22.4	29.2	23.2	48.2	17.5	24.6	39.1	30.9	29.8	28.9	32.0	28.0	33.2	36.2	32.6	36.4	32.7	39.5	30.4	86.0	28.9	23.6	7.5	14.1	35.7	54.5	76.5	40.9	5.1	24.0	30.6	2.2	20.0	19.1	5.5	6.2	25.7	13.1	44.1	7.9	29.0	0.7	14.7	58.8	88.0	12.6	16.0	5.4	28.0	58.0	36.3	26.0	26.9	17.7	16.8	77.8	44.5	23.3	25.2	3.7	24.5	34.6	22.3	25.1	2.7	23.0	19.5	17.8	2.8	14.5	8.7	11.3	4.5	2.1	34.0	27.6	34.6	29.1	53.5	34.4	9.6	13.0	7.4	19.7	22.7	35.7	3.8	4.9	26.9	36.4	60.9	16.2	24.5	22.4	50.0
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 109.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4"									HPA006136	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	16.0	19.9	21.4	1.6	17.9	0.1	17.5	9.5	31.1	28.2	5.1	22.0	6.3	24.2	2.0	5.0	23.6	10.9	18.2	17.0	32.0	12.2	63.8	17.3	1.7	24.9	18.6	14.1	109.8	7.0	48.0	7.6	19.6	32.6	0.4	1.2	24.5	5.1	5.0	10.2	10.6	2.9	15.7	26.6	21.4	9.6	29.0	0.3	32.7	1.2	0.3	10.0	11.7	19.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.5	0.3	0.0	0.0	0.4	0.0	4.9	0.0	1.2	0.4	1.1	0.0	0.0	1.1	1.7	0.0	0.0	2.8	5.6	0.0	1.9	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.9	0.0	12.6	11.4	0.0	0.0	0.0	2.3	0.3	2.0	0.0	0.5	3.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	17.9	9.5	31.1	17.0	32.0	24.9	18.6	19.6	15.7	29.0	19.0	44.8	6.4	8.8	33.3	0.5	1.9	2.0	0.8	0.6	11.4	11.3	10.0	9.9	18.6	1.5	0.0	2.1	0.1	0.9	0.1	0.0	25.2	2.5	2.8	4.9	16.6	8.4	2.7	22.1	38.5	0.1	9.5	3.6	4.1	0.0	15.4	45.3	56.7	0.9	48.8	33.1	3.5	6.1	5.3	1.7	7.2	9.0	0.4	8.8	15.0	1.0	29.5	0.0	49.8	28.4	21.1	0.1	11.3	0.2	11.3	0.3	0.4	1.4	3.5	0.0	4.5	13.8	14.7	11.0	0.4	3.1	0.0	1.0	1.6	0.9	3.7
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178818	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.1"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 155.2;Inhibitory neurons: 179.2;Oligodendrocyte precursor cells: 333.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.1"	"Group enriched"	"Detected in many"	9	"amygdala: 16.8;basal ganglia: 24.9;cerebral cortex: 28.1;hippocampal formation: 23.6;white matter: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;hTERT-RPE1: 22.6;RT4: 7.9;SH-SY5Y: 7.6;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.0	9.0	16.8	0.2	24.9	0.0	1.7	0.0	28.1	5.8	0.0	1.4	0.4	1.7	0.9	1.0	1.7	1.8	1.1	23.6	0.0	1.4	0.2	4.6	0.2	0.0	0.0	0.2	4.0	2.7	1.1	0.2	0.0	1.0	0.7	2.3	5.0	0.6	0.3	1.8	0.7	1.0	0.0	0.1	0.8	0.3	2.3	0.0	0.6	0.6	0.2	1.4	2.9	11.4	1.4	0.4	20.7	0.0	4.5	1.4	0.0	1.5	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.0	3.1	0.0	2.1	0.0	22.6	5.5	0.1	0.0	0.0	0.0	0.2	0.0	1.3	2.7	0.3	0.3	0.3	0.0	4.5	4.5	7.9	2.8	7.6	0.5	0.0	0.0	0.2	0.0	0.4	3.2	0.8	0.1	1.3	0.1	0.0	0.0	0.0	11.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	24.9	0.0	28.1	23.6	0.0	0.0	0.0	0.0	0.0	2.3	11.4	0.3	0.0	21.0	17.6	0.0	0.1	0.3	0.1	1.2	7.6	1.1	1.0	1.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	1.9	0.1	1.1	0.4	1.8	0.5	0.0	0.0	155.2	0.9	0.1	4.4	0.0	0.2	0.0	0.3	0.0	0.0	0.2	3.3	179.2	0.0	0.0	0.0	1.1	1.6	1.5	0.3	1.8	15.0	0.0	7.2	0.0	333.8	9.6	0.1	0.0	3.8	0.0	0.0	0.1	0.6	0.9	0.6	0.0	0.9	0.9	0.3	0.6	0.7	0.6	0.4	0.3	0.8	0.0	0.8
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHCBP1L	C1orf14	ENSG00000157060	"SHC binding and spindle associated 1 like"	Q9BZQ2	1	182899865-182953525	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1147	"testis: 114.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 593.7;Spermatocytes: 593.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036124, HPA036125, HPA064821"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360"		"unprognostic (1.29e-3)"								"unprognostic (1.03e-1)"				"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	593.7	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	86.9	6.8	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	593.1	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4279266-4290722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.0;heart muscle: 17.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	178	"plasmacytoid DC: 17.8"	"Lineage enriched"	"Detected in single"	178	"dendritic cells: 17.8"	"Group enriched"	"Detected in some"	45	"RH-30: 58.4;SH-SY5Y: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.0	0.1	4.2	0.6	3.6	0.7	0.0	7.0	8.6	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.1	17.8	2.4	9.6	0.0	1.5	0.0	0.6	7.4	6.4	0.0	0.0	0.1	0.2	0.0	5.6	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	4.6	0.1	0.0	0.1	10.0	0.1	0.0	1.7	0.3	0.1	0.0	6.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	58.4	0.1	0.0	0.0	0.5	193.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	4.2	3.6	7.0	8.6	2.4	9.6	7.4	6.4	5.6	4.6	10.0	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.8	21.7	137.5	1.9	0.0	0.1	0.1	0.0	0.2	13.2	5.3	2.8	0.0	0.6	0.4	0.0	0.1	8.9	0.0	0.7	57.3	0.4	10.1	4.2	54.6	0.0	0.6	0.0	0.4	0.0	0.6	0.0	1.0	0.2	0.9	0.0	9.0	0.3	0.0	78.8	0.0	0.0	0.0	43.1	0.0	0.0	0.4	0.0	2.5	0.1	0.0	2.9	0.0	0.0	4.4	0.8	0.0	49.4	0.0
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26052016	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.4;skeletal muscle: 14.2;thyroid gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.5	0.0	1.1	0.2	2.3	0.1	12.4	1.5	2.0	1.7	0.9	0.1	0.7	0.1	7.8	0.2	0.2	0.5	0.2	2.0	1.5	4.7	0.0	4.3	0.5	1.9	1.5	0.3	0.3	0.1	1.6	0.0	1.6	0.5	0.1	0.0	2.7	0.3	14.2	1.1	0.7	0.1	2.2	0.2	2.1	1.2	1.6	2.5	21.0	1.2	0.7	0.7	0.0	5.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.4	4.2	1.4	0.0	0.0	1.7	26.7	1.0	20.8	0.0	0.0	18.7	1.2	2.3	0.5	15.5	8.4	8.2	0.0	46.3	0.3	1.7	6.5	0.4	0.0	0.4	0.0	5.4	2.6	0.7	0.2	1.6	0.1	0.7	30.4	7.0	0.0	0.0	0.0	0.0	0.0	4.1	0.8	0.1	0.5	0.1	0.2	0.2	0.1	0.4	0.1	0.0	0.2	1.0	1.6	0.4	0.2	0.3	0.1	0.2	0.1	1.1	2.3	1.5	2.0	2.0	1.5	1.9	1.5	1.6	2.2	1.6	5.4	4.7	0.0	13.1	0.0	0.4	5.4	14.6	2.3	0.6	0.0	24.1	6.2	0.5	0.0	1.5	3.7	0.0	0.3	0.3	0.1	0.0	6.0	2.6	1.0	0.5	5.1	0.0	0.0	0.0	0.2	0.3	2.8	3.1	2.5	0.0	2.4	1.1	0.0	0.8	0.0	1.0	0.1	8.2	0.3	2.3	1.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.5	10.9	1.2	0.0	0.4	0.2	3.9	0.0	0.3	1.1	0.0	0.0	7.6	1.6	0.7	5.1	0.4	1.7	0.1	1.1	0.7	0.0	19.6
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;skeletal muscle: 219.7"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 37.5"	"Cancer enhanced"	"Detected in all"		"glioma: 49.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 24.6;intermediate monocyte: 8.1;neutrophil: 9.1;non-classical monocyte: 10.2"	"Group enriched"	"Detected in many"	10	"granulocytes: 24.6;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	6.7	26.9	64.6	2.0	71.6	0.5	5.9	61.5	59.4	9.2	27.3	7.7	0.4	10.9	3.5	2.7	6.9	3.6	48.6	55.5	53.3	6.4	3.2	5.2	0.8	63.9	64.9	10.7	5.1	3.9	9.2	2.3	58.0	8.5	0.9	4.7	15.7	4.0	219.7	3.6	3.5	3.7	59.1	2.8	6.7	5.7	68.4	0.3	11.4	58.3	0.6	8.6	6.4	57.1	1.3	10.5	1.6	7.8	12.7	7.7	1.3	9.1	19.3	5.2	6.5	2.0	4.1	0.0	10.6	12.6	17.2	3.4	0.1	1.4	3.0	1.3	0.6	0.1	2.8	1.3	8.2	0.1	6.7	7.6	4.3	6.5	3.0	23.2	8.0	0.1	0.2	0.7	8.1	1.3	0.0	0.0	0.8	0.9	11.3	0.4	0.0	2.1	5.0	4.1	0.5	6.6	3.3	1.6	10.9	7.6	4.4	1.0	7.5	6.3	5.5	3.9	4.4	2.4	2.9	0.1	9.2	0.0	11.2	0.0	1.7	24.6	1.7	8.1	0.8	0.0	0.3	0.4	0.9	0.0	0.0	0.3	9.1	0.0	10.2	0.0	0.0	0.7	64.6	71.6	61.5	59.4	55.5	53.3	63.9	64.9	58.0	59.1	68.4	57.1	12.8	0.0	1.7	14.4	0.3	14.1	4.5	7.4	6.8	11.7	8.2	14.4	20.9	8.6	3.7	11.0	4.2	2.0	0.9	0.1	33.2	24.9	0.7	2.4	10.0	11.1	1.8	0.0	8.4	15.4	27.2	19.2	3.6	2.7	1.3	10.4	12.5	12.1	3.2	5.0	6.5	0.1	6.1	6.9	25.1	2.3	15.8	3.7	23.2	1.0	4.6	37.5	0.0	17.6	19.2	9.5	0.0	29.3	0.2	7.4	0.0	6.3	1.3	3.8	19.7	9.2	18.0	1.4	0.8	0.9	6.8	2.7	1.5	2.3	0.1	2.1
SHISA5	"hShisa5, SCOTIN"	ENSG00000164054	"Shisa family member 5"	Q8N114	3	48467798-48504826	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042295	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA042295: AB_10794794"	"unprognostic (3.52e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.72e-6)"	"unprognostic (3.82e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-2)"	97.5	71.8	74.2	68.3	71.9	65.0	82.2	58.8	92.2	99.6	113.0	82.1	60.6	91.4	45.3	140.6	94.9	70.6	75.0	72.3	88.9	94.3	115.0	101.7	80.1	76.8	73.6	86.3	58.3	48.0	70.2	138.4	72.0	107.9	39.5	13.7	69.1	69.8	22.8	60.1	74.5	67.1	70.8	114.3	73.5	35.5	87.6	84.4	76.8	31.7	66.9	116.8	98.3	65.2	71.0	141.9	82.4	132.0	153.1	194.7	417.7	115.3	209.0	254.3	187.9	157.4	175.6	97.7	123.2	200.9	240.9	91.7	91.5	148.3	70.7	116.4	63.6	89.2	91.2	128.2	256.7	61.9	164.0	200.9	169.3	205.7	141.7	141.7	193.2	129.0	56.6	115.6	138.2	154.1	70.4	111.1	150.4	101.2	113.0	48.2	36.7	133.4	130.5	446.6	24.6	13.8	74.9	79.1	155.6	136.8	91.5	91.2	153.6	90.5	100.8	155.2	112.0	87.0	76.3	85.8	128.2	118.3	90.2	205.9	301.6	252.5	320.7	267.5	283.4	165.0	264.1	293.8	167.3	222.6	210.9	219.4	910.2	138.7	306.9	126.7	345.7	500.0	74.2	71.9	58.8	92.2	72.3	88.9	76.8	73.6	72.0	70.8	87.6	65.2	69.8	41.7	39.4	12.1	55.8	27.8	73.0	52.2	114.4	22.7	29.6	29.8	17.3	51.5	37.6	64.4	16.7	279.7	56.3	43.0	11.7	79.4	4.2	29.2	49.8	79.4	37.8	22.9	10.8	104.3	229.9	57.4	36.2	31.2	34.8	41.5	66.0	88.0	103.0	6.7	11.0	48.3	14.2	57.5	27.3	5.7	49.0	47.7	46.2	18.7	46.5	30.1	101.0	10.6	10.4	80.2	31.2	39.1	54.5	50.2	64.9	43.3	38.0	5.0	32.9	22.1	43.9	5.1	8.8	85.9	32.1	120.5	74.0	49.9	40.3	50.5
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55443277	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 2.9;HMC-1: 2.8;THP-1: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.0	0.4	20.2	0.0	19.7	1.1	0.0	0.5	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	10.4	0.0	0.0	0.0	0.0	5.1	4.9	0.0	0.0	0.0	4.9	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.3	9.6	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	19.7	0.5	20.2	25.9	10.4	5.1	4.9	3.6	4.6	9.6	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	13.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	16.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.1	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"adrenal gland: 13.8;brain: 51.1"	"Cell type enriched"	"Detected in some"	18	"Horizontal cells: 477.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"cerebellum: 51.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEK 293: 19.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.8;olfactory bulb: 15.7;white matter: 4.0"	"Low region specificity"	"Detected in all"			HPA059173	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.0	13.8	1.7	0.5	0.5	0.1	0.0	51.1	3.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.6	0.7	0.4	0.0	0.1	1.2	1.5	3.4	0.0	0.0	0.1	1.7	0.0	3.8	0.1	0.0	0.3	0.8	0.0	0.3	0.3	1.5	0.0	5.3	2.5	0.2	0.2	5.4	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	51.1	3.4	0.6	0.7	1.5	3.4	3.8	5.3	5.4	0.8	0.1	0.0	0.0	0.3	10.8	0.0	0.0	0.0	0.0	11.5	22.7	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.5	0.0	1.9	0.0	1.1	5.2	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	477.8	25.9	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.0	1.6	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	4.5	0.0	0.0	0.1	1.9	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243665-44312951	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.2;endometrium 1: 33.6;smooth muscle: 29.3"	"Cell type enriched"	"Detected in single"	6	"Endometrial stromal cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	1.0	1.8	18.6	1.2	17.2	0.0	0.2	0.0	21.4	16.6	0.0	18.7	1.9	33.6	0.4	1.6	4.5	3.1	0.9	18.0	15.3	0.5	0.1	0.3	0.4	10.8	17.8	1.0	0.8	0.1	2.6	0.5	2.4	3.7	2.0	5.6	0.3	11.0	0.0	0.7	2.4	29.3	0.3	0.1	1.6	1.1	43.2	2.6	0.4	0.1	0.7	11.9	5.2	2.8	0.0	0.3	3.5	1.2	0.0	0.0	0.0	1.0	2.3	2.4	1.4	0.0	0.0	0.0	0.0	2.3	14.5	0.0	5.0	0.3	0.3	0.0	2.3	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.8	11.2	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	3.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	12.9	0.0	36.2	0.1	0.2	0.4	0.0	0.3	0.1	13.1	2.0	80.8	0.5	0.0	0.0	0.0	46.3	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	17.2	0.0	21.4	18.0	15.3	10.8	17.8	2.4	0.3	43.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633168-52669683	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.3;dendritic cells: 9.8;Endometrial stromal cells: 2.6;Hofbauer cells: 1.8;Macrophages: 2.2;T-cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.7"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.1;Karpas-707: 9.4;NB-4: 2.9;RPMI-8226: 13.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.0"	"Low region specificity"	"Detected in some"			HPA030744	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.4	0.2	0.8	2.3	0.7	1.7	0.2	0.8	1.0	1.0	0.4	0.4	0.3	0.4	0.7	0.2	0.6	0.3	0.1	0.5	8.7	0.3	0.2	0.7	5.6	1.0	1.6	0.0	0.2	0.0	2.0	0.1	1.1	0.4	0.3	0.1	0.3	0.3	0.3	0.0	3.7	0.0	0.9	5.4	0.5	0.8	2.5	1.0	0.7	0.2	5.2	0.3	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	2.9	1.6	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.0	0.0	3.9	10.1	6.2	5.6	0.0	9.8	4.3	2.6	0.0	5.9	0.0	0.0	2.1	1.6	0.8	0.7	0.8	1.0	0.5	8.7	1.0	1.6	1.1	0.9	2.5	1.2	0.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.6	2.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.4	0.5	0.0	0.0
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690442-64718190	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 3.0;pancreas: 4.9;stomach 1: 2.8"	"Group enriched"	"Detected in some"	13	"Breast glandular cells: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA011778	Enhanced					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	4.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	9.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	3.0	1.4	0.2	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHKBP1	"PP203, Sb1"	ENSG00000160410	"SH3KBP1 binding protein 1"	Q8TBC3	19	40576853-40591399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041887	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Cell Junctions"		"HPA041887: AB_10794639"	"unprognostic (1.26e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.52e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.64e-2)"	33.7	32.1	14.6	39.4	16.5	66.8	29.1	15.3	19.4	35.3	15.4	34.9	18.4	34.4	7.7	47.0	33.3	14.4	29.6	14.8	16.1	42.3	30.0	52.3	40.9	19.7	16.6	25.2	37.6	15.8	21.8	14.3	17.2	35.1	10.4	1.3	31.7	13.5	15.8	32.6	45.5	15.8	15.6	127.1	41.2	17.2	19.4	29.5	35.0	6.8	25.0	36.5	35.6	20.0	70.9	107.1	21.1	30.2	18.0	20.0	39.7	26.8	39.9	41.1	56.2	46.9	47.5	73.9	52.1	42.3	35.0	30.2	27.3	50.8	19.4	114.6	65.1	53.9	29.4	32.1	38.8	50.6	147.9	32.4	36.2	37.4	23.3	30.0	60.8	81.7	30.7	60.2	32.0	61.6	52.1	70.5	15.3	63.5	39.2	92.9	27.4	55.7	34.0	57.0	17.4	40.2	41.4	22.3	25.1	20.2	35.5	82.7	46.4	41.2	54.0	65.1	54.1	56.4	28.4	50.6	66.2	59.5	37.4	223.9	217.9	216.7	74.2	202.2	60.1	77.5	71.4	76.5	157.3	69.0	41.1	48.2	453.9	72.3	246.4	46.4	109.8	213.1	14.6	16.5	15.3	19.4	14.8	16.1	19.7	16.6	17.2	15.6	19.4	20.0	28.8	12.8	19.9	1.3	53.1	8.5	20.5	41.7	10.2	2.1	9.5	7.2	4.3	17.2	30.8	29.5	6.2	24.5	40.8	35.2	29.4	42.5	8.6	5.4	9.3	25.0	22.8	25.0	2.1	38.6	53.1	13.5	37.2	13.3	51.5	18.2	26.7	13.2	76.5	3.3	1.8	17.9	48.8	82.0	36.3	18.4	14.6	66.8	23.2	3.7	93.3	6.3	56.7	1.5	6.4	39.0	35.9	12.4	33.9	11.5	28.1	31.7	14.2	1.8	0.0	7.0	15.2	3.5	26.8	19.3	9.8	29.6	45.0	14.4	22.0	20.7
SHLD1	"C20orf196, FLJ25067, RINN3"	ENSG00000171984	"Shieldin complex subunit 1"	Q8IYI0	20	5750393-5864395	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 55.7;U-698: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040749	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA040749: AB_10673093"	"unprognostic (2.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (4.05e-5)"	4.0	9.7	5.0	6.2	5.8	16.7	5.3	7.2	6.1	5.1	4.6	5.1	9.1	3.8	5.3	5.4	3.9	4.4	8.6	4.9	5.8	6.7	3.0	4.8	14.3	5.6	5.3	5.1	5.2	2.4	6.0	3.0	6.3	6.3	4.9	4.0	8.4	3.7	12.0	4.1	7.1	2.6	4.6	9.9	4.7	3.1	5.4	13.3	6.6	7.7	12.1	4.5	4.7	6.4	9.2	9.6	4.6	2.3	2.8	2.8	2.3	2.5	4.5	3.1	4.3	4.5	9.4	33.3	6.3	2.5	2.5	4.1	2.8	6.1	3.6	10.3	3.4	12.9	1.4	18.2	6.2	16.2	5.7	3.3	7.2	4.7	3.1	3.0	6.4	8.7	17.8	13.9	5.9	3.5	20.4	55.7	6.3	10.3	5.2	16.5	7.1	15.1	5.0	4.5	8.2	7.4	4.6	4.7	10.0	2.6	3.9	13.2	4.3	3.6	5.4	3.5	5.4	8.7	16.6	45.8	1.8	13.9	6.4	21.7	12.4	22.5	21.3	14.8	16.4	27.7	25.2	21.5	12.7	33.1	22.9	17.2	4.9	23.5	16.9	15.1	31.5	13.0	5.0	5.8	7.2	6.1	4.9	5.8	5.6	5.3	6.3	4.6	5.4	6.4	9.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	6.4	8.6	0.0	0.0	0.0	12.9	0.0	7.5	13.1	0.0	19.6	7.9	0.0	6.4	4.4	2.8	0.0	0.0	0.0	14.2	7.5	1.7	0.0	5.2	0.0	7.3	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.3	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	5.9	6.4	5.0	0.0	0.0
SHLD2	"bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2"	ENSG00000122376	"Shieldin complex subunit 2"	Q86V20	10	87094161-87191465	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	15.6	20.1	10.8	12.6	8.4	9.6	17.3	7.3	10.0	11.9	10.2	15.7	22.3	11.4	7.0	12.8	11.2	10.7	10.3	8.6	10.5	32.1	37.2	11.6	13.1	27.5	10.9	12.7	12.4	6.1	10.9	9.7	8.8	14.9	16.5	15.6	14.3	9.5	10.6	12.0	24.8	12.2	9.3	11.9	12.0	8.0	10.1	10.4	23.3	11.7	14.4	13.3	11.2	8.7	33.6	26.7	14.9	34.4	16.4	15.8	21.7	22.1	31.0	29.0	31.8	30.8	25.2	24.4	12.1	30.2	17.0	21.9	37.2	16.9	29.8	35.1	24.6	33.9	24.3	29.1	25.4	53.4	28.5	14.5	30.4	26.6	45.4	25.6	19.6	26.3	43.7	42.7	27.2	19.2	43.7	37.8	17.2	24.2	18.4	26.8	29.6	27.0	26.6	27.7	7.4	30.6	17.1	19.9	29.8	13.7	44.0	29.6	19.4	16.5	15.0	24.8	44.7	23.9	55.8	58.5	27.8	65.4	9.1	7.1	7.3	2.8	6.7	11.8	13.7	9.2	10.0	10.0	11.3	8.8	10.0	10.1	0.1	12.5	9.5	3.9	10.4	8.7	10.8	8.4	7.3	10.0	8.6	10.5	27.5	10.9	8.8	9.3	10.1	8.7	21.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	20.9	13.2	0.0	0.0	0.0	5.5	0.0	7.2	17.4	0.0	31.3	12.6	0.0	16.7	28.6	4.2	0.0	0.0	0.0	13.7	15.1	7.9	0.0	29.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	14.7	0.0	0.0	7.6	0.0	0.0	48.2	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	2.2	7.8	19.1	0.0	0.0
SHLD3	"AC008560.1, CTC-534A2.2, FLJ26957, RINN1"	ENSG00000253251	"Shieldin complex subunit 3"	Q6ZNX1	5	65625027-65630928	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 17.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	2.3	2.7	2.4	2.7	2.5	17.5	4.2	2.8	3.6	1.8	1.8	2.8	2.8	2.3	3.1	1.5	1.9	2.4	1.8	2.3	2.1	2.9	2.6	2.5	4.8	2.4	2.1	1.5	3.4	2.1	2.5	2.5	2.3	4.3	3.0	3.7	2.0	2.5	1.8	2.9	2.7	1.7	2.4	2.5	2.4	3.2	2.4	3.9	2.4	1.9	3.6	2.5	1.3	3.2	2.6	3.6	5.0	10.8	2.9	3.5	6.3	3.8	3.5	5.8	7.0	5.9	8.0	4.9	4.2	4.6	6.5	3.1	5.1	4.7	8.5	6.7	6.5	4.3	10.3	8.3	2.5	5.0	7.5	2.1	6.8	6.0	6.1	1.6	3.7	7.7	6.4	11.5	4.7	6.9	6.7	7.7	4.0	1.5	2.2	4.4	4.9	7.9	4.9	6.0	6.7	5.5	3.2	3.3	11.0	3.4	3.8	4.6	3.0	5.0	6.8	4.1	6.6	7.2	14.3	10.7	3.7	6.1	4.7	15.9	3.0	6.4	3.8	2.9	4.0	3.9	4.5	4.0	2.8	3.1	6.1	5.6	3.3	4.9	3.1	3.2	6.2	2.1	2.4	2.5	2.8	3.6	2.3	2.1	2.4	2.1	2.3	2.4	2.4	3.2	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	3.6	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	3.9	3.1	0.0	1.9	1.8	0.8	0.0	0.0	0.0	2.9	3.8	0.9	0.0	2.1	0.0	2.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.1	1.8	2.1	0.0	0.0
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229573-57234935	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 2292.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		390000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	25.4	25.4	18.5	43.3	18.6	41.4	23.8	20.7	22.2	22.5	18.4	32.4	35.5	19.4	18.9	46.5	23.3	20.2	24.2	21.1	20.3	32.4	182.3	23.6	52.2	20.6	20.6	25.8	62.2	15.6	15.8	33.6	21.2	13.8	27.2	13.9	30.7	11.7	36.6	36.4	27.0	27.3	20.1	34.9	32.2	5.1	21.8	36.0	34.7	30.5	58.6	26.4	23.6	23.0	246.9	137.6	123.5	368.0	101.8	152.4	238.1	140.8	237.9	197.0	176.5	200.1	120.4	499.8	217.3	186.5	80.6	167.3	229.4	250.6	108.9	265.0	201.9	199.7	79.6	180.1	680.9	333.1	181.0	191.2	351.9	163.4	538.4	176.0	175.3	283.8	223.0	472.3	141.0	210.6	271.0	217.9	123.1	111.8	223.4	181.2	2292.7	433.6	95.9	151.1	265.4	119.9	73.0	170.1	518.3	48.5	222.9	424.2	108.8	84.6	150.5	96.1	185.0	574.1	338.4	421.4	169.6	320.2	154.0	34.9	41.2	23.3	26.6	50.6	31.5	127.5	46.3	29.4	59.6	137.9	21.1	22.0	2.0	40.1	34.1	20.4	202.8	53.8	18.5	18.6	20.7	22.2	21.1	20.3	20.6	20.6	21.2	20.1	21.8	23.0	9.1	9.6	14.1	4.2	58.2	34.7	23.0	43.5	39.9	7.0	26.5	24.0	12.1	21.5	23.5	3.7	0.0	55.4	11.6	9.6	13.7	45.7	0.4	6.3	22.6	17.1	9.6	53.8	3.7	47.7	52.7	25.5	23.4	10.9	29.2	18.7	22.1	182.8	50.2	8.4	3.2	24.2	34.6	36.0	25.1	0.9	18.0	23.5	39.2	3.7	32.0	45.3	21.6	4.0	2.4	40.1	18.7	16.1	74.4	18.2	15.9	63.6	13.3	6.2	6.6	23.9	40.2	1.9	6.6	52.9	32.5	37.4	21.1	39.5	37.4	23.8
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2 leucine rich repeat scaffold protein"	Q9UQ13	10	110919593-111013666	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	25.0	16.3	16.4	22.5	17.8	45.7	19.3	19.3	22.1	20.3	12.0	20.4	16.4	20.7	21.0	21.6	16.4	20.1	19.5	19.4	22.3	21.9	23.7	17.9	29.9	16.6	21.7	19.8	20.4	30.3	14.6	20.8	22.0	18.0	21.5	19.7	14.2	17.5	21.3	15.4	18.4	23.3	16.4	22.2	17.3	36.4	18.2	26.9	25.2	26.8	31.2	25.0	14.8	15.5	29.2	17.8	22.7	38.2	50.9	51.2	14.5	35.0	51.9	31.9	38.5	16.5	25.8	63.1	17.1	62.8	19.9	24.1	27.8	25.0	46.2	34.7	16.5	28.8	25.7	16.2	37.0	49.6	49.4	57.3	38.6	36.9	69.1	43.6	32.8	22.1	18.3	43.8	45.7	15.6	24.7	38.9	14.1	15.6	18.6	34.8	45.2	18.1	33.3	19.4	11.7	23.4	30.7	15.0	34.9	25.8	77.2	41.5	33.3	25.6	22.6	32.5	24.3	40.2	44.0	100.1	30.6	50.3	18.6	52.3	22.8	33.5	12.6	26.8	15.5	30.3	14.8	15.0	22.3	24.4	15.6	15.2	65.8	19.5	27.8	15.2	19.2	23.9	16.4	17.8	19.3	22.1	19.4	22.3	16.6	21.7	22.0	16.4	18.2	15.5	73.8	54.5	48.1	35.6	95.4	55.8	35.2	37.5	27.9	27.6	51.4	39.1	83.6	45.8	42.3	31.3	16.7	22.2	77.5	80.8	64.6	48.5	44.2	65.1	54.6	63.5	26.3	67.5	59.9	59.2	23.0	50.7	49.5	54.9	73.4	20.2	53.2	69.0	29.4	30.3	53.1	36.2	46.8	78.3	67.3	89.7	65.6	76.0	49.8	57.1	116.5	31.5	57.7	46.3	61.0	64.0	51.6	80.9	53.4	37.1	51.7	67.7	57.0	32.7	72.3	59.9	58.7	108.8	69.3	38.1	69.9	60.6	65.8	17.0	30.1	49.7
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608240-3636250	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 19.1;Proximal enterocytes: 18.9;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		350000	"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	7.4	9.9	3.5	3.9	5.0	4.8	6.9	4.1	4.4	9.8	3.1	6.4	13.5	4.8	2.9	9.4	6.2	3.6	4.5	3.4	3.5	10.2	23.3	4.7	3.9	3.9	4.8	7.5	10.9	8.6	4.5	6.2	4.2	5.7	6.0	7.1	7.0	5.4	3.3	9.7	11.5	3.5	3.0	4.4	8.4	4.2	4.3	4.5	5.5	3.3	5.3	5.6	7.8	8.7	6.7	13.5	14.0	9.1	5.7	5.7	7.8	4.4	4.0	8.5	5.0	23.3	6.2	7.9	9.5	8.6	7.9	12.8	18.8	14.3	6.1	12.8	18.3	8.6	11.6	17.0	6.9	7.6	11.8	9.7	6.8	9.4	6.3	7.2	16.1	6.2	11.6	9.8	8.3	12.0	9.8	5.9	7.0	15.3	8.9	13.3	7.3	12.6	12.0	8.5	4.1	10.7	16.2	14.7	4.6	8.4	13.2	4.4	11.6	12.8	6.1	12.5	10.9	3.3	4.5	5.2	13.9	6.7	6.7	1.5	2.2	2.5	1.9	2.3	2.0	2.1	1.8	1.6	3.0	1.5	3.0	1.9	0.4	3.2	1.8	3.2	1.6	2.5	3.5	5.0	4.1	4.4	3.4	3.5	3.9	4.8	4.2	3.0	4.3	8.7	2.6	0.0	3.2	11.1	2.0	0.0	1.0	0.1	3.4	5.9	3.2	2.3	1.0	4.3	0.8	5.5	16.7	10.0	1.1	9.2	1.9	3.3	0.5	2.6	2.5	2.9	3.5	5.2	4.5	4.7	10.1	3.3	4.6	2.9	0.0	5.0	3.6	19.1	8.4	15.2	5.3	6.0	0.0	2.2	0.4	0.4	4.1	2.2	0.0	8.4	2.7	2.5	1.0	4.0	8.2	5.3	6.7	2.6	2.0	2.2	18.9	8.5	1.0	18.2	0.0	4.8	1.8	0.6	1.2	3.0	0.4	5.6	2.1	16.9	6.5	1.8
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	4.9	4.2	3.1	4.7	3.7	4.2	7.2	18.4	5.1	5.4	3.2	4.3	4.2	7.7	6.0	4.3	5.2	4.6	3.5	3.0	2.5	5.5	4.6	4.2	6.9	2.8	2.6	12.2	3.9	6.7	2.0	4.5	4.5	5.5	5.0	16.3	5.8	5.1	4.2	9.7	4.5	5.7	2.5	6.4	5.4	7.6	2.9	7.2	8.4	5.2	5.8	4.3	3.3	5.5	4.2	3.2	15.3	9.1	7.0	7.3	7.2	4.9	3.9	5.9	7.6	7.0	2.9	14.5	5.9	3.7	4.6	7.0	9.5	6.9	7.7	6.5	10.9	14.6	7.6	6.1	5.2	31.2	8.6	5.2	7.8	5.6	8.0	5.8	6.4	10.0	20.3	7.9	5.1	3.7	19.8	11.6	10.3	6.9	5.4	14.1	23.6	5.0	8.0	4.1	12.6	8.8	8.7	7.9	5.4	10.5	4.2	14.6	7.2	3.7	7.0	7.4	5.8	6.4	9.4	17.1	3.9	13.0	6.0	0.7	0.9	1.9	1.7	0.9	1.5	1.5	1.4	1.1	1.1	2.5	1.5	1.3	0.0	1.5	1.0	2.0	1.4	0.5	3.1	3.7	18.4	5.1	3.0	2.5	2.8	2.6	4.5	2.5	2.9	5.5	31.4	28.9	23.4	106.7	31.0	21.2	17.9	14.5	19.4	117.2	21.5	20.3	17.2	20.0	20.7	22.0	210.6	16.1	34.6	9.1	7.9	18.6	20.4	20.9	52.8	26.0	19.2	15.3	131.0	12.9	7.0	25.9	23.9	18.1	13.3	145.7	15.7	20.5	12.0	94.2	140.3	14.7	6.1	21.4	9.8	8.0	50.7	19.8	14.2	93.7	30.6	40.7	36.0	143.7	164.6	15.9	8.8	34.3	23.5	18.8	17.2	7.5	14.9	158.5	72.3	47.1	39.1	83.2	65.0	16.5	19.7	6.6	26.4	61.5	18.0	12.5
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	5.9	7.0	7.3	8.1	10.1	9.2	8.1	7.1	7.6	6.7	6.1	8.8	6.7	7.1	11.4	6.4	10.7	5.6	10.1	5.1	6.6	7.4	8.0	6.2	8.9	7.1	7.0	7.6	7.0	8.5	4.6	5.3	7.4	5.7	8.7	5.5	5.7	6.0	9.1	7.5	6.1	8.0	5.2	7.0	6.4	10.0	8.0	15.3	8.2	8.6	10.0	8.4	5.1	10.4	13.5	18.1	12.0	20.3	15.7	19.2	12.1	21.8	15.8	22.4	24.6	14.5	10.7	22.4	10.2	15.2	18.2	10.9	24.9	20.5	27.5	20.1	19.6	23.3	14.1	17.3	15.9	39.7	18.8	19.2	15.4	33.1	13.6	10.4	21.2	35.8	19.0	13.5	18.5	20.2	113.4	14.1	33.9	41.5	22.7	27.1	18.8	17.3	19.7	17.6	7.6	30.4	20.3	14.3	10.6	16.0	14.7	14.9	15.1	18.0	17.5	30.1	19.5	24.9	53.8	32.7	16.1	32.0	18.3	0.9	11.9	4.3	14.2	13.5	19.1	13.7	15.8	15.4	12.3	13.3	17.7	15.4	0.5	24.2	12.3	17.6	14.4	14.5	7.3	10.1	7.1	7.6	5.1	6.6	7.1	7.0	7.4	5.2	8.0	10.4	5.9	12.8	6.9	8.8	8.3	13.3	4.3	6.9	5.7	7.5	7.2	5.3	9.5	4.3	6.5	5.5	0.0	6.1	9.9	4.3	7.9	8.6	6.9	11.5	9.6	9.1	4.2	10.3	12.1	6.1	7.9	7.1	5.6	8.0	15.2	6.6	11.4	7.6	6.9	3.3	13.5	6.8	4.1	6.6	6.2	1.9	5.9	5.7	5.4	20.6	4.1	3.2	2.1	16.1	33.9	6.5	4.3	5.7	6.1	5.1	4.7	5.7	16.2	5.4	0.0	8.0	5.9	9.1	19.5	10.8	10.2	5.7	7.6	14.8	9.3	3.9
SHROOM1	"APXL2, KIAA1960"	ENSG00000164403	"Shroom family member 1"	Q2M3G4	5	132822141-132830659	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 116.9;prostate: 73.9;urinary bladder: 62.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.0;Hepatocytes: 79.2;Proximal enterocytes: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037690, HPA037691"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA037690: AB_2675613, HPA037691: AB_2675614"	"unprognostic (2.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.22e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.26e-3)"	9.3	2.4	25.2	2.6	32.0	0.2	8.2	28.9	26.9	12.6	10.4	20.5	6.1	11.3	2.1	5.1	8.4	6.7	7.6	20.2	23.6	10.7	116.9	10.5	0.6	42.1	30.9	5.6	16.2	4.9	6.8	11.8	33.3	73.9	11.1	3.4	7.0	15.2	1.7	1.5	16.6	3.9	26.1	2.3	10.9	1.7	31.2	0.6	6.9	1.3	0.5	62.4	9.3	55.7	8.6	5.1	0.9	0.8	1.4	4.0	9.0	9.1	7.7	7.0	7.8	11.2	5.7	1.5	12.5	4.9	3.8	0.8	3.1	5.7	4.3	9.5	11.0	0.3	8.7	10.5	4.1	0.7	3.1	1.7	3.0	4.9	3.0	4.8	4.8	0.1	7.3	8.1	6.1	4.8	0.2	4.0	1.4	6.7	8.1	0.5	0.0	0.8	1.2	24.4	5.7	1.5	8.8	0.7	4.9	4.5	5.2	2.9	4.5	8.1	11.7	1.1	11.5	9.2	6.8	0.1	7.9	0.0	2.5	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	25.2	32.0	28.9	26.9	20.2	23.6	42.1	30.9	33.3	26.1	31.2	55.7	18.3	25.6	22.3	18.9	1.8	1.3	15.4	2.3	3.4	3.7	9.3	5.5	2.2	30.0	11.3	9.2	10.4	6.8	1.0	135.0	1.9	6.0	0.9	7.1	17.3	18.1	22.8	2.7	3.0	10.7	4.8	6.1	33.6	15.1	8.2	9.0	25.0	79.2	6.6	16.8	1.0	28.6	0.0	8.7	5.5	1.1	4.7	4.6	0.0	23.4	8.1	19.9	3.1	6.6	37.5	7.1	53.6	4.9	3.6	31.6	65.5	3.5	9.1	13.3	26.3	2.8	5.1	7.6	5.1	1.8	2.0	2.9	2.5	1.4	35.5	17.3
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435229-76783253	"Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 313.1;Distal enterocytes: 154.5;Endometrial ciliated cells: 182.9;Glandular and luminal cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 40.8;AF22: 38.2;BJ hTERT+: 36.9;EFO-21: 39.9;OE19: 40.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA047784: AB_2680155"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	2.0	0.4	6.1	1.8	0.1	15.4	12.4	3.4	5.9	18.5	20.0	15.2	3.0	13.9	17.5	15.7	17.8	3.9	0.9	0.0	7.0	6.2	8.5	0.4	6.1	2.1	0.5	6.5	12.9	3.3	4.4	5.9	9.0	17.2	9.7	25.7	6.3	0.1	3.0	14.7	9.7	5.6	6.1	21.9	0.7	0.2	0.9	3.5	0.1	2.4	4.9	2.3	3.0	40.8	7.9	38.2	25.2	0.0	0.6	1.4	12.4	36.9	0.8	1.6	6.8	26.3	0.6	39.9	34.6	3.0	20.4	5.1	17.8	0.7	0.1	6.7	0.0	7.5	0.0	0.2	0.0	0.0	0.3	4.3	1.3	6.7	9.7	0.7	0.3	0.0	9.7	0.8	3.6	0.7	0.1	16.0	40.5	4.7	3.5	6.3	6.3	6.0	0.9	15.0	19.9	5.2	28.2	2.1	23.2	6.8	0.2	0.0	6.5	5.5	0.2	5.4	12.0	13.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	12.4	3.4	0.9	0.0	6.1	2.1	5.9	5.6	0.2	3.0	0.6	89.8	53.4	313.1	1.0	0.9	5.8	14.0	2.8	35.8	69.9	46.1	11.0	81.5	40.0	35.0	75.0	0.4	0.6	154.5	0.0	33.6	7.1	182.9	27.1	2.1	86.9	2.7	54.5	36.4	0.7	4.7	103.0	350.1	0.0	11.9	0.7	42.2	0.2	1.7	19.1	104.0	30.5	1.6	0.3	3.2	0.3	1.8	3.6	29.0	1.6	7.2	0.0	6.0	2.1	73.8	92.3	0.0	0.3	35.8	102.7	6.8	65.7	31.1	0.0	0.3	7.4	3.4	2.4	3.5	0.3	0.1	1.7	0.3	70.5	11.9
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.1	1.8	9.8	1.9	20.0	1.2	5.4	17.1	12.4	3.3	0.9	1.8	1.1	3.6	1.6	2.7	2.2	3.0	7.8	8.9	12.6	5.3	0.9	13.3	0.9	23.8	17.6	1.3	0.9	1.9	2.0	9.0	21.8	2.2	1.4	1.3	2.0	1.8	3.6	1.7	1.5	4.1	13.8	1.0	1.3	0.6	17.3	0.6	3.3	5.0	1.0	3.5	2.3	30.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.0	17.1	12.4	8.9	12.6	23.8	17.6	21.8	13.8	17.3	30.7	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 545.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	545.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.0	0.0	0.0	0.0	0.0	0.0	448.2	0.8	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 104.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		2200000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	18.7	17.3	16.8	11.8	21.6	3.7	15.9	26.9	19.8	13.0	38.9	97.8	34.3	7.1	34.3	13.6	19.3	16.7	43.8	16.1	27.1	62.1	43.4	20.6	5.8	25.3	23.7	5.7	17.3	45.3	14.4	11.8	24.7	20.4	104.4	6.2	18.4	15.3	26.7	13.0	35.8	10.4	23.0	9.1	19.0	10.3	24.9	3.7	54.0	33.3	6.7	16.8	7.8	26.3	8.9	14.0	8.0	34.6	88.6	91.3	20.9	16.8	24.0	4.3	2.6	10.9	61.4	5.5	24.2	21.5	9.4	17.3	12.8	18.7	4.2	26.0	3.9	8.6	3.7	11.1	41.8	0.7	7.2	98.9	24.9	11.4	17.3	58.5	30.6	11.0	7.1	37.5	14.8	16.5	0.2	0.6	5.0	97.7	28.5	3.2	0.2	8.4	51.4	12.1	2.4	5.1	46.5	18.6	8.0	24.0	36.8	3.2	34.1	23.6	4.3	26.5	4.0	9.4	7.5	0.7	8.3	4.6	9.8	7.6	2.9	0.1	0.4	2.1	0.3	0.5	1.3	0.6	1.9	0.7	1.7	1.1	0.5	0.2	3.7	0.5	0.6	1.8	16.8	21.6	26.9	19.8	16.1	27.1	25.3	23.7	24.7	23.0	24.9	26.3	4.2	19.2	58.0	11.8	2.4	3.2	6.3	6.7	7.4	6.5	10.1	4.3	59.5	12.8	9.4	36.8	0.0	7.6	0.6	102.4	9.8	15.2	14.0	9.1	9.3	6.9	14.5	5.2	15.0	3.8	8.8	7.5	12.8	14.0	1.3	3.9	8.9	30.0	4.5	5.0	9.1	31.0	4.1	3.5	1.6	12.0	3.1	4.3	3.6	6.5	4.5	1.9	1.0	8.0	6.7	5.2	53.0	1.2	3.9	7.4	51.6	26.2	11.9	1.8	0.0	4.9	7.9	14.8	9.6	12.2	5.3	6.7	2.0	8.9	63.6	7.1
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	23.3	14.1	12.0	10.8	13.9	28.2	22.8	16.2	16.0	19.3	13.3	15.9	16.0	19.4	15.6	14.0	17.4	15.8	15.0	12.3	12.4	14.6	22.6	17.6	14.0	13.6	14.6	19.2	14.1	14.6	10.3	50.1	13.2	16.8	14.6	19.1	16.1	13.8	21.5	22.3	16.2	14.5	12.2	13.4	15.7	23.3	13.5	14.1	17.5	17.3	13.0	14.1	17.1	16.9	15.5	13.7	29.1	26.3	24.5	21.3	29.6	14.2	19.2	20.6	10.1	10.5	19.7	20.1	15.3	18.0	14.4	17.6	20.3	20.7	25.3	8.1	16.4	10.8	10.6	27.8	34.2	10.7	15.8	25.8	36.5	12.1	27.9	23.1	17.5	18.5	17.7	18.4	17.0	10.6	29.1	21.9	35.5	17.1	21.0	33.3	43.7	21.3	19.5	19.3	33.1	29.3	42.0	20.9	37.7	24.8	13.3	24.4	18.8	22.0	19.8	12.0	15.4	24.0	10.7	36.8	16.3	13.1	20.2	13.7	8.1	35.4	4.1	3.6	4.5	20.4	4.4	6.3	13.0	19.2	8.7	6.6	4.7	8.7	2.2	12.5	2.5	5.8	12.0	13.9	16.2	16.0	12.3	12.4	13.6	14.6	13.2	12.2	13.5	16.9	43.0	12.8	9.7	8.8	24.7	85.7	55.7	45.0	71.2	22.3	43.5	32.0	13.3	20.0	20.5	16.5	8.4	187.4	15.3	27.3	31.3	24.5	70.5	21.9	26.7	35.7	22.6	27.0	20.1	22.7	34.0	42.5	21.9	34.5	4.5	37.8	33.9	23.6	34.3	35.3	20.9	17.8	40.7	20.3	99.2	71.3	22.7	31.1	49.8	23.4	27.0	38.3	4.1	25.6	40.2	22.3	18.2	19.5	17.9	49.7	23.5	28.9	17.0	18.6	19.7	36.2	34.4	70.0	51.0	67.7	75.7	746.2	17.3	17.4	20.6	50.8
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.7	0.1	0.9	0.1	0.0	2.3	0.8	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	0.7	0.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.3	0.8	0.6	0.7	0.8	3.0	0.8	0.6	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532555-113629575	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 33.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035862	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.2	2.8	5.2	5.2	5.6	3.4	5.4	4.7	6.4	3.1	0.0	6.2	2.0	0.7	0.2	1.4	1.9	3.7	0.4	6.4	3.6	0.8	0.6	1.8	8.8	2.8	3.5	0.2	0.7	0.5	5.4	1.0	2.1	5.1	10.2	0.4	10.8	1.5	0.3	0.5	5.4	0.7	5.7	7.1	3.5	0.9	4.9	5.2	0.4	0.4	8.8	4.5	0.9	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	1.5	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	4.2	0.0	15.4	4.2	0.2	0.0	16.2	21.0	6.2	0.0	0.5	0.0	14.9	0.2	0.1	0.0	4.2	0.2	0.0	13.8	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	7.0	0.1	7.1	7.5	4.7	5.8	1.5	6.6	5.9	5.1	0.3	9.1	0.0	33.7	3.9	3.4	5.2	5.6	4.7	6.4	6.4	3.6	2.8	3.5	2.1	5.7	4.9	3.3	1.6	6.4	3.3	7.2	47.4	0.4	1.4	1.9	0.0	1.4	9.7	4.7	1.1	4.3	4.2	1.8	0.0	0.0	34.5	17.2	0.0	0.4	5.0	3.1	0.7	1.0	10.2	0.8	117.8	1.1	0.2	0.4	8.2	6.3	3.8	0.0	0.4	0.5	11.2	0.0	86.8	23.3	2.0	3.5	1.8	1.5	0.0	10.1	5.4	23.4	2.6	0.1	21.6	4.5	4.0	0.8	3.9	0.0	14.5	3.9	2.2	0.1	9.3	0.2	0.0	0.7	0.7	0.2	0.1	0.9	0.3	0.1	16.4	0.3	7.0	1.9
SIDT2	CGI-40	ENSG00000149577	"SID1 transmembrane family member 2"	Q8NBJ9	11	117178736-117197445	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 83.5;non-classical monocyte: 151.0"	"Lineage enriched"	"Detected in all"	7	"monocytes: 151.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052352	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA052352: AB_2681797"	"unprognostic (3.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (4.18e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.22e-3)"	40.2	25.1	23.5	21.2	28.4	12.4	36.3	27.4	27.1	32.8	19.4	28.8	44.2	30.5	16.0	15.1	31.3	18.5	31.8	24.1	23.2	20.6	40.8	36.4	23.4	37.0	29.2	60.2	113.4	13.6	35.7	22.4	33.9	48.6	23.1	14.4	31.5	21.2	25.2	32.7	42.3	20.8	29.7	34.6	75.9	28.5	29.2	10.0	31.7	12.3	20.4	26.2	20.4	48.9	8.7	8.8	10.5	15.4	34.4	30.7	34.8	14.8	19.5	9.3	8.6	25.1	32.8	8.9	23.1	39.1	11.7	9.0	10.2	11.5	7.6	13.2	12.4	6.3	15.8	17.3	17.8	5.3	15.5	38.1	12.8	12.0	12.9	28.6	19.1	11.4	12.0	19.2	22.1	18.2	7.5	6.2	4.9	45.6	6.5	5.6	7.2	25.5	12.2	9.1	3.2	7.9	15.8	38.1	2.6	11.7	30.8	6.3	11.9	12.3	7.9	8.2	3.4	13.6	5.3	9.4	7.1	10.8	9.2	0.3	14.2	0.5	1.9	83.5	1.5	18.3	1.1	1.3	11.5	21.2	1.7	1.3	1.7	1.5	151.0	6.2	1.4	9.6	23.5	28.4	27.4	27.1	24.1	23.2	37.0	29.2	33.9	29.7	29.2	48.9	12.2	6.4	12.3	11.8	24.1	67.7	25.4	4.1	4.0	13.0	11.1	13.0	7.9	4.3	4.5	11.0	6.2	9.2	6.7	16.7	0.0	4.4	7.4	11.6	22.2	12.7	11.4	8.2	7.7	9.6	33.4	19.7	61.2	11.2	2.5	43.5	16.4	25.6	16.9	18.5	8.8	32.9	2.0	54.2	29.3	11.5	13.4	30.6	19.6	7.5	13.6	6.1	7.2	12.1	16.8	8.0	9.4	13.5	6.6	20.5	40.7	1.8	6.0	12.1	19.7	46.1	18.7	5.8	4.8	4.2	42.9	32.3	9.5	38.2	13.5	15.5
SIGIRR	"IL-1R8, TIR8"	ENSG00000185187	"Single Ig and TIR domain containing"	Q6IA17	11	405716-417455	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 401.9;Proximal tubular cells: 627.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 136.0;MCF7: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023188	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center, Cytosol"		"HPA023188: AB_1856856"	"unprognostic (6.21e-3)"	"prognostic favorable (7.44e-5)"	"unprognostic (7.30e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (6.85e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (1.00e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (1.54e-5)"	21.3	6.8	47.5	32.4	46.6	33.2	22.3	47.3	58.7	21.5	42.5	45.0	28.9	20.5	19.1	19.1	29.9	19.9	36.0	46.1	47.4	68.4	87.7	33.9	45.8	52.4	47.6	12.9	47.6	16.3	15.8	9.5	51.8	32.8	13.7	5.6	33.4	17.4	6.7	9.7	46.4	10.3	48.0	68.3	42.0	7.8	48.9	18.5	31.0	10.0	18.0	23.1	17.9	49.9	22.2	59.6	3.7	20.7	3.2	16.9	42.7	3.3	5.1	10.0	8.8	27.7	136.0	6.2	16.2	19.1	1.1	31.4	9.7	11.2	1.6	19.0	35.9	12.7	11.8	0.7	10.6	11.0	20.4	9.2	2.3	1.6	1.3	5.6	29.0	24.0	12.7	0.4	2.8	74.4	31.4	35.6	21.3	44.9	32.6	38.3	0.0	21.6	7.1	14.8	35.9	17.6	0.4	20.1	26.4	9.0	25.4	8.6	34.4	3.0	3.9	5.0	0.0	7.4	13.5	16.2	13.3	24.0	11.6	77.8	42.3	39.0	123.6	48.4	98.7	37.6	101.8	108.3	43.0	28.7	91.7	90.1	22.0	102.4	61.8	16.3	106.1	82.6	47.5	46.6	47.3	58.7	46.1	47.4	52.4	47.6	51.8	48.0	48.9	49.9	83.1	28.9	34.4	16.6	46.5	16.3	34.1	33.2	43.9	8.6	44.3	40.0	21.3	72.9	35.0	55.2	12.5	17.7	105.6	163.9	62.6	54.1	1.0	47.9	15.0	62.7	78.9	14.7	2.6	73.3	11.4	37.0	80.0	40.7	40.6	15.4	79.6	401.9	51.2	26.9	2.5	106.1	63.1	52.7	31.9	5.1	31.4	61.7	85.4	4.7	46.9	109.2	218.3	1.5	10.4	79.6	153.7	29.7	37.9	24.6	105.3	627.4	75.8	19.2	26.3	21.2	34.7	6.0	69.8	21.1	12.8	10.1	117.3	10.2	93.6	43.6
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3712600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hofbauer cells: 78.6;Kupffer cells: 93.4;Macrophages: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enriched"	"Detected in single"	19	"THP-1: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053457	Supported				"Intracellular and membrane"	NA	NA		260000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA053457: AB_2682158"	"unprognostic (2.05e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.83e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	23.0	13.7	2.0	7.7	2.9	12.3	8.6	1.9	6.5	1.8	7.5	10.2	5.1	2.0	1.8	2.2	7.0	8.5	6.4	1.8	2.2	3.9	8.4	16.7	12.7	10.2	3.3	2.7	1.6	0.5	2.3	18.8	10.9	1.9	6.6	0.3	5.4	1.2	3.7	3.0	11.2	7.7	5.0	18.9	5.1	2.5	10.9	3.6	3.7	2.6	1.9	7.6	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.0	2.9	1.9	6.5	1.8	2.2	10.2	3.3	10.9	5.0	10.9	3.9	0.5	3.2	4.4	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.3	2.4	0.0	0.6	0.0	2.1	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.3	0.0	0.0	93.4	6.3	0.1	0.0	42.6	0.0	3.7	2.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	1.4	1.0	0.0	0.1	0.6	0.6	1.9	0.4	0.0	0.0	0.0
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410020-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.0;granulocytes: 39.3;Kupffer cells: 93.9;Macrophages: 51.5"	"Cancer enhanced"	"Detected in all"		"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 765.3;intermediate monocyte: 252.0;non-classical monocyte: 539.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 765.3;monocytes: 539.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HDLM-2: 9.0;HEL: 14.9;HMC-1: 10.7;NB-4: 10.4;U-698: 21.3;U-937: 12.0"	"Not detected"	"Not detected"							"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	3.5	6.4	3.9	33.9	4.8	14.9	2.1	4.3	6.0	2.1	3.5	5.4	7.0	2.1	1.0	2.0	2.4	3.7	1.4	3.9	6.2	1.7	3.2	8.5	19.9	11.4	6.9	1.6	3.5	1.0	1.4	1.8	8.8	3.0	4.6	1.1	2.2	1.1	0.7	1.2	12.2	4.5	6.3	38.5	4.7	1.3	6.3	4.0	1.0	1.1	19.5	5.5	1.2	9.4	0.2	0.0	0.5	0.5	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	1.3	28.8	0.9	0.1	0.3	0.5	0.0	0.2	0.0	9.0	2.5	14.9	0.3	0.1	0.0	6.4	10.7	0.1	0.0	0.1	0.0	0.1	0.0	1.7	0.7	1.4	0.0	0.6	0.2	10.4	0.8	0.7	0.4	1.9	0.1	0.5	0.0	0.3	0.4	0.4	0.3	0.1	0.2	0.5	0.1	5.2	0.7	0.7	1.3	0.6	0.2	1.3	0.3	21.3	0.5	12.0	0.5	14.0	41.9	765.3	0.8	252.0	0.4	41.4	0.5	0.5	38.0	27.4	0.3	0.5	87.2	0.4	539.2	2.2	1.1	40.7	3.9	4.8	4.3	6.0	3.9	6.2	11.4	6.9	8.8	6.3	6.3	9.4	0.7	3.2	1.3	0.3	33.0	0.1	1.2	0.0	0.0	1.4	0.4	0.9	0.3	0.0	0.0	1.8	2.1	0.1	0.6	0.1	0.0	0.0	0.9	0.0	0.0	4.2	0.0	5.2	0.6	0.0	0.1	0.8	0.0	0.1	39.3	0.1	0.4	1.0	8.1	0.0	0.2	0.1	0.0	93.9	6.3	0.4	0.0	51.5	0.0	15.0	14.8	0.2	6.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.7	0.0	2.0	0.4	0.5	0.7	0.0	1.3	0.1	2.7	0.1	0.0	0.9
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 23.1;ovary: 65.5"	"Group enriched"	"Detected in some"	7	"Granulosa cells: 196.9;Theca cells: 192.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.4;monocytes: 1.3"	"Cell line enriched"	"Detected in single"	16	"HEL: 10.1"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	1.1	7.3	0.5	1.8	0.8	0.4	0.4	0.4	0.7	0.3	0.6	0.5	0.8	0.3	0.2	0.1	0.9	0.3	0.4	0.6	0.6	0.4	1.7	1.7	0.6	1.4	1.0	65.5	2.7	0.1	0.2	1.8	1.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	1.0	1.2	0.8	23.1	4.7	1.5	1.6	0.1	0.2	0.1	0.0	0.6	0.2	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	10.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	1.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.1	0.5	0.8	0.4	0.7	0.6	0.6	1.4	1.0	1.3	0.8	1.6	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	19.6	0.0	0.6	0.2	0.3	1.0	0.0	0.0	0.0	1.1	0.1	4.3	0.0	0.3	0.0	196.9	5.3	0.6	7.9	0.0	0.0	0.0	0.0	26.8	0.2	0.1	0.0	6.1	0.0	5.6	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	7.5	1.7	0.7	0.0	0.1	0.1	0.2	192.3	0.0	0.0
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.7;lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0"	"Cancer enriched"	"Detected in single"	5	"urothelial cancer: 1.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"neutrophil: 152.5;non-classical monocyte: 49.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 152.5;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"HMC-1: 59.2;U-937: 25.6"									"HPA009085, CAB024900"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.4	0.4	0.3	6.6	0.6	14.7	0.2	0.3	1.2	0.2	0.0	0.7	0.1	0.3	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.3	1.5	3.4	3.1	0.4	0.3	0.1	0.2	0.3	0.1	0.8	0.5	0.3	0.7	0.2	0.3	0.1	0.0	0.0	2.0	0.9	0.4	12.4	0.6	0.8	0.4	0.7	0.2	0.4	2.2	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	15.5	22.2	0.5	0.0	24.2	0.0	2.5	0.0	0.0	15.6	2.0	0.0	0.0	152.5	0.7	49.3	5.0	0.0	8.4	0.3	0.6	0.3	1.2	0.3	0.3	0.4	0.3	0.5	0.4	0.4	0.6	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	10.4	1.2	0.5	0.3	4.4	0.0	1.0	3.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 106.7"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.6	0.1	0.2	3.0	0.3	0.5	0.7	0.4	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.0	0.1	0.1	4.3	3.8	0.1	0.1	0.1	0.3	0.1	0.0	106.7	0.2	1.0	3.1	0.4	0.5	0.7	0.5	0.5	3.3	1.3	0.0	1.7	2.6	0.3	0.2	0.7	0.0	0.6	4.2	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.2	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.9;lymphoid tissue: 6.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;renal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	38	"eosinophil: 290.2"	"Lineage enriched"	"Detected in single"	719	"granulocytes: 290.2"	"Cell line enriched"	"Detected in some"	44	"HMC-1: 147.5"									HPA012556	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.3	4.0	4.9	1.6	5.2	0.5	1.4	5.3	6.1	0.9	1.7	1.8	1.8	0.6	0.7	0.7	0.7	1.4	0.2	4.5	6.2	0.1	0.8	2.5	6.8	13.3	6.6	0.2	0.5	1.0	0.4	0.1	10.1	0.6	1.6	0.7	0.6	0.5	0.1	0.5	2.8	0.9	7.3	6.3	1.4	0.3	11.6	2.1	0.4	0.2	2.5	1.0	0.3	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.1	0.0	0.0	147.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.2	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.1	0.1	7.6	0.4	290.2	0.2	0.3	0.1	0.2	0.2	0.1	0.1	0.3	0.1	0.2	2.5	0.3	0.4	0.2	0.1	0.2	4.9	5.2	5.3	6.1	4.5	6.2	13.3	6.6	10.1	7.3	11.6	14.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	2.5	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SIGLEC9	CD329	ENSG00000129450	"Sialic acid binding Ig like lectin 9"	Q9Y336	19	51124906-51136651	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.7"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 42.1;Kupffer cells: 39.8;Langerhans cells: 13.4;Macrophages: 26.8;monocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 198.9;intermediate monocyte: 182.5;myeloid DC: 169.1;neutrophil: 212.0;non-classical monocyte: 121.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 169.1;granulocytes: 212.0;monocytes: 198.9"	"Group enriched"	"Detected in some"	10	"Karpas-707: 23.4;RPMI-8226: 16.5"									HPA010682	Uncertain					NA	NA		270000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA010682: AB_1079968"	"unprognostic (2.31e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.03e-3)"	"prognostic unfavorable (6.17e-5)"	"unprognostic (6.56e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-1)"	8.0	5.4	2.0	17.9	2.1	9.0	1.9	2.2	4.3	1.4	2.8	2.1	1.7	0.9	0.2	0.9	2.5	5.0	2.1	1.9	3.4	1.4	5.5	8.3	5.0	5.4	4.0	3.2	1.2	4.1	0.9	7.9	5.0	1.1	2.4	0.3	1.5	0.9	0.4	0.5	2.2	6.4	4.0	20.7	1.4	1.7	6.2	1.4	0.9	1.3	2.5	5.4	0.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	23.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	1.5	0.0	17.3	198.9	1.6	15.2	182.5	8.6	0.2	2.5	5.8	169.1	0.1	0.6	2.7	212.0	3.1	121.9	9.2	0.9	84.9	2.0	2.1	2.2	4.3	1.9	3.4	5.4	4.0	5.0	4.0	6.2	5.9	0.1	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.3	0.0	0.0	0.2	2.7	0.0	0.0	0.0	1.8	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.1	5.3	0.8	42.1	0.0	0.2	0.0	0.0	39.8	13.4	0.4	5.0	26.8	0.0	5.6	10.4	0.0	7.2	0.0	0.1	0.0	0.0	2.2	0.4	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.1	0.3	1.3	2.8	0.0	0.0
SIGLECL1	"C19orf75, FLJ40235, SIGLEC23P, SIGLECP7"	ENSG00000179213	"SIGLEC family like 1"	Q8N7X8	19	51246348-51269330	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 22.5"	"Group enriched"	"Detected in some"	8	"Early spermatids: 46.6;Late spermatids: 65.9;Spermatocytes: 73.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA079471	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA079471: "															"unprognostic (5.41e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	65.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637844	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 187.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 98.7;Hepatocytes: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.42e-4)"	42.0	52.4	25.2	19.4	25.3	20.5	38.1	26.2	27.1	53.0	27.4	42.0	46.0	50.7	45.0	54.1	46.9	22.1	34.0	25.8	30.2	25.5	187.6	27.5	16.9	28.3	28.7	46.1	45.7	39.0	22.0	27.6	29.4	35.5	31.2	7.2	35.0	38.5	17.6	53.9	40.0	34.8	26.2	24.2	42.1	20.2	33.3	19.1	29.7	13.5	22.2	46.3	43.5	27.1	184.3	162.6	59.8	175.3	205.7	138.7	66.5	127.1	91.2	115.8	105.9	97.6	76.8	87.8	71.9	151.7	69.8	108.8	94.5	151.3	57.8	144.7	175.6	78.0	225.0	112.7	131.7	145.0	67.6	142.9	163.0	131.2	197.7	59.4	90.2	114.5	30.1	156.2	139.7	1.8	88.2	215.2	68.8	101.5	184.4	101.4	59.6	258.3	111.0	36.5	57.6	65.5	123.3	89.5	70.0	32.0	106.9	98.7	68.5	90.0	69.9	96.4	19.2	43.2	71.6	2.5	97.2	123.9	191.8	24.3	39.5	24.2	43.0	39.3	46.2	26.5	62.5	51.3	48.9	21.1	51.7	43.6	10.7	28.7	42.5	35.1	65.5	43.5	25.2	25.3	26.2	27.1	25.8	30.2	28.3	28.7	29.4	26.2	33.3	27.1	11.0	3.2	13.6	6.8	12.3	18.4	16.8	24.6	14.2	10.1	26.8	18.9	9.2	15.7	12.1	7.3	0.0	44.8	10.7	33.0	0.0	33.0	0.9	7.0	23.7	14.4	10.3	23.5	5.6	33.5	98.7	29.2	18.3	10.1	7.0	19.4	13.9	97.5	38.8	5.0	6.4	28.2	12.2	10.5	7.8	1.8	27.4	10.8	19.6	5.6	9.5	13.8	14.4	5.0	4.4	32.1	31.5	25.6	22.4	25.9	58.4	13.7	6.8	7.7	19.7	12.1	23.9	6.0	10.3	40.0	21.5	36.5	13.6	26.2	47.3	16.1
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427131	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7"	"Low region specificity"	"Detected in all"							"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	24.5	8.3	0.7	6.2	0.4	10.5	19.5	0.5	1.8	17.5	0.8	7.0	0.4	4.4	0.0	18.5	18.6	15.1	16.0	0.3	1.1	5.1	20.9	12.7	4.3	1.0	1.0	26.9	11.8	5.9	12.5	12.5	0.8	9.2	0.7	8.5	12.1	13.3	13.0	88.0	5.4	5.3	0.0	7.2	12.2	3.0	0.7	11.0	6.2	1.3	4.6	16.9	14.4	0.5	1.2	3.4	4.3	0.1	0.3	1.6	1.7	2.0	0.7	3.5	2.7	5.1	0.1	5.4	1.5	0.4	19.8	23.6	3.5	35.3	2.0	0.3	1.1	1.6	63.1	2.0	4.8	1.7	0.2	2.1	45.4	0.9	10.7	20.7	0.7	0.1	0.2	0.2	45.5	0.3	0.9	3.9	1.9	0.0	3.4	0.1	0.8	5.7	4.0	13.3	0.1	0.0	24.2	4.0	0.8	0.7	2.3	0.6	8.1	0.9	4.2	0.4	0.1	9.5	37.7	1.0	10.0	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.5	1.8	0.3	1.1	1.0	1.0	0.8	0.0	0.7	0.5	23.7	28.9	77.3	0.0	18.4	302.0	0.8	123.5	26.7	0.3	8.6	6.3	11.7	7.2	68.4	12.9	0.0	0.8	13.4	16.4	0.0	3.2	0.0	23.2	4.8	18.4	27.6	0.0	0.0	2.1	1.3	11.1	15.3	29.1	19.6	2.3	4.2	7.7	1.7	0.0	0.0	16.5	85.5	3.8	141.9	0.1	0.0	10.1	96.0	0.0	1.6	1.3	0.0	0.0	0.0	7.3	24.3	0.0	36.3	0.5	23.8	0.2	50.7	0.2	0.0	2.4	27.4	0.1	0.4	35.1	422.7	2.5	16.4	0.8	20.3	1.2
SIK1B		ENSG00000275993	"Salt inducible kinase 1B (putative)"	A0A0B4J2F2	21	6111131-6123778	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 243.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Alveolar cells type 1: 25.6;Alveolar cells type 2: 27.2;Endometrial ciliated cells: 17.1;Glandular and luminal cells: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 95.3;hTERT-RPE1: 117.7;Karpas-707: 120.6;LHCN-M2: 83.0;SiHa: 87.2"									"HPA038211, HPA078064"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA038211: AB_2675894, HPA078064: "	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.62e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.41e-2)"	67.6	52.0	6.5	16.1	5.6	42.4	53.5	5.3	12.3	21.8	7.4	22.2	7.6	16.2	0.4	32.0	31.0	30.4	49.9	6.1	11.2	21.8	71.2	38.1	9.8	10.7	8.0	93.5	47.0	8.0	39.5	14.2	8.3	33.5	12.3	20.9	41.5	41.6	40.1	243.9	17.4	10.5	6.2	18.0	37.5	7.3	7.1	8.2	17.9	4.3	4.7	44.3	46.7	5.7	9.5	47.5	3.5	3.0	0.7	0.4	8.3	1.1	0.6	1.7	1.0	53.3	7.0	3.2	1.4	0.2	7.1	0.8	5.5	0.0	0.6	8.9	1.7	7.4	95.3	10.3	3.1	1.2	0.7	1.2	39.6	4.8	26.5	117.7	2.0	1.5	3.0	120.6	83.0	4.7	0.9	2.3	4.9	8.8	5.1	2.0	21.1	14.3	4.6	16.4	4.4	2.1	87.2	5.5	5.0	2.3	0.9	4.1	2.3	1.4	4.4	2.0	19.9	15.9	37.7	1.6	12.6	3.0	5.6	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.6	1.8	0.0	0.0	6.5	5.6	5.3	12.3	6.1	11.2	10.7	8.0	8.3	6.2	7.1	5.7	11.9	25.6	27.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.0	2.7	0.0	0.0	3.7	1.8	0.0	0.7	4.1	0.0	0.0	0.5	0.0	17.1	3.4	1.4	0.0	0.0	0.0	0.2	0.9	1.5	0.0	30.0	6.3	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	2.4	0.0	0.0	0.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602449-111730855	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	29.7	9.3	9.2	5.3	12.4	3.1	20.7	7.9	11.1	7.6	11.0	7.9	5.9	7.3	5.0	5.9	8.1	10.0	12.3	9.5	14.7	11.4	22.7	11.7	4.4	11.9	11.9	14.9	31.8	21.3	16.6	5.8	10.6	6.7	6.2	30.7	13.8	6.2	33.1	8.9	7.5	5.9	5.5	4.6	17.6	3.0	9.3	5.4	8.7	23.2	4.3	7.7	6.1	11.6	9.2	6.0	10.3	11.1	50.3	14.8	6.1	7.9	11.2	5.9	6.7	20.5	9.6	7.2	10.7	9.2	6.9	12.7	8.2	5.9	7.6	5.4	3.4	7.9	5.2	10.1	10.9	7.7	4.9	14.5	8.6	8.7	11.1	11.7	7.1	7.1	7.4	10.3	9.4	4.3	8.0	7.0	3.5	7.6	5.9	10.6	11.0	8.7	13.1	8.2	4.8	11.3	11.6	4.7	4.5	9.4	11.5	6.2	9.9	12.9	7.7	8.3	10.9	2.9	2.4	14.8	4.2	10.6	8.8	0.3	0.7	0.6	0.7	0.7	0.3	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.3	0.5	0.6	0.3	0.5	0.5	9.2	12.4	7.9	11.1	9.5	14.7	11.9	11.9	10.6	5.5	9.3	11.6	22.1	19.2	24.8	113.3	14.1	14.7	6.2	5.2	18.2	15.7	10.5	9.9	21.3	27.1	10.0	16.5	66.7	4.4	11.4	15.6	5.9	10.4	16.5	27.7	14.9	18.8	18.0	12.4	217.6	7.9	4.6	20.1	27.5	45.3	9.5	24.3	9.3	38.7	5.4	32.0	132.4	11.3	4.1	12.4	16.9	14.1	11.5	13.3	19.6	73.1	6.0	14.5	4.1	86.0	191.9	8.4	10.3	14.7	8.9	6.9	8.3	23.1	13.4	60.9	0.0	19.1	19.0	3.9	6.4	10.3	11.9	5.2	12.6	5.0	11.5	7.1
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"	Q9Y2K2	11	116843402-117098437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	10.1	7.2	19.3	11.4	36.6	12.7	9.2	15.0	34.3	9.6	0.0	11.7	8.5	12.6	7.2	10.4	12.4	9.8	12.8	19.7	19.4	10.3	13.8	9.7	9.9	22.0	23.1	16.5	15.4	17.7	10.0	12.1	22.5	8.2	8.8	19.1	9.8	11.3	19.5	7.5	8.7	14.1	11.5	11.8	9.7	21.4	36.1	12.3	17.1	14.4	10.4	10.1	7.5	41.1	11.8	8.9	13.9	14.7	11.7	12.6	22.2	8.8	15.7	6.8	7.6	21.8	13.3	13.9	14.0	16.3	15.0	18.1	11.6	12.7	9.4	38.5	7.4	31.2	9.7	13.6	10.9	11.2	11.8	13.9	7.2	14.5	23.3	8.7	9.2	9.0	15.2	10.1	9.4	4.0	10.2	12.1	7.7	8.0	6.6	12.9	8.0	11.1	9.3	2.2	13.5	10.8	23.7	10.3	4.4	10.5	6.8	11.8	10.6	8.3	10.4	14.0	8.9	7.1	5.6	17.5	7.7	18.2	11.4	2.0	0.4	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.6	1.0	0.0	0.0	0.9	0.6	1.5	0.0	0.0	0.2	19.3	36.6	15.0	34.3	19.7	19.4	22.0	23.1	22.5	11.5	36.1	41.1	25.8	9.6	22.1	375.5	34.9	26.5	26.0	6.8	7.4	42.6	26.1	21.5	22.2	10.0	12.4	5.5	112.6	8.7	47.3	12.5	5.9	7.6	89.2	64.4	27.9	20.4	17.3	12.4	384.4	7.3	2.8	22.1	12.8	71.5	17.2	37.4	17.2	26.3	7.7	47.1	399.6	11.1	6.1	21.7	45.1	214.9	10.2	31.4	16.0	161.1	25.6	36.3	12.3	457.9	1679.9	9.2	8.2	14.3	28.1	22.0	9.7	6.9	20.5	63.9	0.0	35.0	23.2	18.0	14.8	7.4	24.3	29.7	44.2	14.8	11.4	30.0
SIKE1	"FLJ21168, SIKE"	ENSG00000052723	"Suppressor of IKBKE 1"	Q9BRV8	1	114769479-114780685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024177, HPA025726"	Supported		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Focal adhesion sites"	Vesicles	"HPA024177: AB_1848798, HPA025726: AB_1848800"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.52e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.05e-1)"	8.8	6.9	5.9	9.7	6.0	9.8	9.6	8.5	6.7	9.1	5.7	8.6	9.8	9.4	7.6	7.7	6.0	6.9	7.3	4.9	7.7	10.8	12.2	6.8	12.1	7.0	6.8	8.6	6.8	9.7	4.9	9.6	7.0	7.6	9.4	8.0	7.3	7.5	6.7	13.4	8.5	9.2	6.4	9.5	8.4	5.6	8.2	13.6	10.1	7.4	12.0	7.2	5.6	7.1	16.3	4.4	22.9	21.2	27.6	21.4	22.0	13.9	12.4	18.9	25.3	12.2	9.1	30.6	12.5	11.8	8.0	15.7	24.3	16.7	27.0	19.4	13.3	16.4	13.9	15.6	26.3	18.8	12.9	21.0	19.6	14.1	22.4	13.6	17.5	26.2	25.2	17.7	15.7	62.7	37.1	19.9	52.1	10.5	12.3	21.2	43.7	15.3	16.0	13.5	15.7	18.5	20.0	23.2	25.5	20.8	12.6	72.0	13.9	15.6	19.0	26.8	19.0	16.4	14.1	29.1	23.7	31.1	34.0	6.0	1.7	2.0	2.2	2.3	2.8	2.0	2.2	2.2	2.2	2.1	2.6	2.8	1.2	2.6	2.4	2.7	1.7	1.4	5.9	6.0	8.5	6.7	4.9	7.7	7.0	6.8	7.0	6.4	8.2	7.1	29.2	25.6	14.8	13.1	32.7	31.9	26.7	40.0	30.1	10.7	22.7	23.2	41.0	20.0	30.2	31.3	10.4	29.7	43.9	30.3	50.9	27.1	34.8	20.1	34.9	26.3	18.6	29.9	16.2	25.7	33.6	27.9	18.8	26.8	19.7	77.1	27.1	40.0	27.7	8.4	19.7	21.4	48.8	19.7	26.6	58.1	28.3	24.8	23.2	4.7	25.4	15.8	32.0	10.1	16.6	31.1	18.3	19.9	37.7	30.5	25.7	62.8	21.3	16.1	19.7	26.5	28.8	35.5	39.6	33.0	36.4	36.0	37.4	48.3	21.2	23.6
SIL1	"BAP, MSS, ULG5"	ENSG00000120725	"SIL1 nucleotide exchange factor"	Q9H173	5	138946724-139293557	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 195.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011949	Enhanced				"Intracellular and membrane"	NA	NA		710000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA011949: AB_1856875"	"unprognostic (1.06e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.34e-4)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.22e-2)"	26.4	46.4	9.0	19.7	10.6	24.1	21.6	8.5	11.8	21.7	17.9	20.0	24.6	21.7	32.5	16.5	19.2	23.2	29.5	9.2	9.3	20.9	54.9	22.6	14.1	10.6	9.9	19.1	67.7	33.7	28.5	28.7	10.5	23.9	12.8	5.7	36.7	25.8	41.4	23.2	16.4	17.2	8.2	17.3	29.5	49.8	11.3	9.0	36.2	18.0	10.0	20.6	16.2	10.3	33.7	34.9	11.3	56.2	84.0	48.3	65.0	54.0	58.2	26.6	57.3	36.9	78.9	12.4	89.7	74.2	32.2	29.8	12.0	76.0	15.8	33.7	20.7	16.4	23.9	40.9	67.2	4.9	72.6	60.7	73.1	46.4	79.0	42.7	40.5	15.4	8.7	131.3	32.2	52.1	12.4	15.1	2.4	38.6	4.2	8.9	7.8	92.7	38.9	17.7	19.5	13.0	46.3	44.3	74.5	24.8	38.4	30.6	30.6	46.8	10.9	17.9	23.6	56.3	31.6	8.2	34.3	38.1	39.9	18.1	47.7	19.4	17.4	52.4	10.9	20.1	12.1	16.8	51.3	14.7	12.1	15.1	5.7	22.1	42.3	37.3	11.7	27.1	9.0	10.6	8.5	11.8	9.2	9.3	10.6	9.9	10.5	8.2	11.3	10.3	22.5	19.2	47.0	51.6	32.5	22.0	33.4	61.6	15.4	9.0	33.8	21.6	30.3	38.6	48.1	42.3	37.5	121.2	19.0	41.5	11.7	61.8	109.1	25.5	37.0	21.9	33.5	7.6	75.7	81.7	104.2	46.3	38.7	32.1	60.3	29.2	29.3	143.8	70.3	25.2	73.7	64.3	52.9	33.9	21.0	195.7	28.6	36.7	48.0	49.6	113.8	15.2	17.5	66.4	57.6	46.2	34.9	22.2	114.5	32.1	51.1	46.5	51.6	26.6	19.7	21.4	27.7	96.9	61.8	13.0	23.9	153.6	16.9	60.3	43.0	30.1
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 47.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	5.3	28.0	6.8	4.0	6.2	3.8	4.3	7.0	6.8	12.0	7.5	7.1	5.8	12.2	9.9	4.3	13.4	4.0	4.1	6.0	7.3	3.9	8.7	5.0	5.3	4.7	5.0	47.0	6.5	6.0	14.1	5.1	5.3	9.6	6.9	4.6	3.7	6.5	12.1	5.4	7.5	8.5	3.9	10.2	10.2	33.5	8.2	6.8	4.0	4.4	5.5	8.4	6.4	5.9	2.8	6.9	21.6	17.2	11.1	11.3	11.2	9.6	8.7	9.8	11.2	25.7	7.3	0.1	11.5	10.7	20.0	2.5	24.2	18.1	11.9	4.8	17.9	12.7	4.7	3.3	24.5	13.7	9.3	7.4	7.1	6.4	12.1	6.9	9.3	4.6	32.6	11.5	11.5	12.5	13.2	12.3	8.2	3.3	7.5	19.2	15.2	16.6	6.8	5.1	14.3	15.0	11.0	1.7	10.6	8.3	6.1	26.4	6.6	11.6	6.2	10.6	8.4	3.1	3.5	18.9	4.3	9.2	6.9	7.2	3.7	7.0	3.3	3.5	4.0	4.4	4.0	2.6	5.2	4.1	3.3	2.7	0.4	7.3	2.8	2.6	2.9	2.7	6.8	6.2	7.0	6.8	6.0	7.3	4.7	5.0	5.3	3.9	8.2	5.9	4.9	9.6	5.6	24.2	12.6	2.9	5.9	3.2	8.6	18.1	2.1	3.0	4.0	2.8	3.4	1.8	4.2	0.4	15.0	8.9	1.9	3.8	46.5	2.9	15.6	3.6	13.2	2.5	49.1	3.6	2.9	9.2	19.9	4.9	0.0	58.2	5.3	7.2	2.2	18.5	57.4	9.9	0.0	5.7	2.0	14.4	29.8	4.2	5.4	30.9	5.7	6.1	11.3	30.7	7.7	4.7	7.8	34.6	5.7	7.1	12.0	1.9	3.0	5.3	32.9	5.6	6.3	83.1	33.8	5.9	2.6	0.8	7.7	102.8	8.9	3.1
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829398-16880353	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	38.6	31.7	30.1	21.7	28.4	12.6	42.0	8.6	33.3	57.2	12.7	35.9	15.0	59.3	24.1	25.9	49.9	20.4	27.3	30.1	22.7	31.6	19.8	43.6	26.8	19.8	21.8	58.0	25.5	37.8	32.3	29.0	27.0	43.9	12.3	10.0	30.9	35.2	24.7	32.9	36.4	30.6	10.3	43.0	27.2	51.7	24.8	13.2	42.8	14.9	18.1	34.0	43.7	24.5	28.1	14.7	24.4	31.5	19.7	18.1	76.8	23.3	19.2	31.6	27.9	36.4	25.7	25.0	25.5	27.2	26.7	23.6	20.4	20.9	29.1	26.2	36.8	27.0	35.6	16.7	25.9	15.8	20.8	29.9	26.9	21.3	18.2	25.1	29.1	19.7	22.2	15.0	22.4	33.7	21.7	25.5	30.4	14.6	46.6	28.4	22.4	16.6	18.0	23.5	18.0	22.5	29.6	22.5	18.4	32.5	15.9	14.7	38.6	30.5	18.5	44.6	26.5	21.3	16.8	25.0	21.1	20.6	23.1	0.1	4.2	3.9	1.0	3.8	0.6	3.5	0.9	1.1	1.3	2.7	1.1	0.8	2.0	1.2	3.4	1.5	0.3	1.5	30.1	28.4	8.6	33.3	30.1	22.7	19.8	21.8	27.0	10.3	24.8	24.5	45.4	22.4	11.9	30.7	18.9	7.9	11.6	7.4	14.2	20.3	14.4	18.4	8.3	1.5	8.6	3.7	14.6	21.9	9.5	7.0	3.9	10.6	11.4	16.3	34.6	18.8	4.9	6.9	29.9	8.6	29.2	16.0	13.7	36.2	5.1	29.9	10.8	7.0	17.6	10.1	29.8	8.4	0.0	14.6	5.5	24.2	50.7	13.9	5.4	19.7	14.6	8.0	10.3	21.6	26.3	14.5	4.0	66.5	22.0	14.2	4.2	7.5	6.9	14.5	6.6	17.5	13.7	9.7	9.2	14.4	8.1	124.9	11.7	34.5	7.3	17.9
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.5;Extravillous trophoblasts: 118.8;Glandular and luminal cells: 149.3;monocytes: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 600.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	16.2	11.6	1.1	22.8	2.0	25.6	26.7	2.8	2.0	24.0	10.1	24.3	21.5	51.9	18.0	25.1	36.2	15.2	8.7	1.0	1.1	36.3	7.7	16.6	34.4	2.0	1.5	28.1	22.6	22.6	24.8	26.3	1.5	26.9	25.9	4.0	25.8	30.3	3.2	24.0	19.6	33.3	1.5	17.4	19.5	17.0	1.3	50.9	14.0	3.6	33.6	34.1	23.7	1.4	27.8	29.9	128.7	26.6	8.0	12.0	238.3	10.7	10.3	25.9	36.7	91.6	74.8	95.9	94.9	3.9	26.7	48.1	105.4	48.4	51.0	92.6	42.6	61.7	21.2	66.6	28.4	105.2	54.7	13.0	82.0	21.6	102.2	45.3	61.6	98.9	88.0	39.1	11.4	17.5	173.7	71.7	600.6	81.7	19.0	159.6	62.4	80.0	57.3	67.8	180.0	113.5	26.5	54.1	71.8	280.2	24.6	64.5	58.5	6.0	36.1	2.8	46.4	40.3	50.5	156.9	17.9	42.9	34.0	29.5	12.9	19.8	21.8	15.8	24.8	59.1	30.4	25.9	27.5	48.5	35.8	29.0	3.9	50.4	24.2	71.9	15.3	29.6	1.1	2.0	2.8	2.0	1.0	1.1	2.0	1.5	1.5	1.5	1.3	1.4	31.0	76.9	35.8	0.0	26.5	0.0	0.0	0.0	0.0	0.0	52.3	48.8	0.0	0.0	56.3	46.0	0.0	75.1	37.7	0.0	82.2	70.1	0.0	150.5	37.8	21.8	0.0	0.0	0.0	43.2	118.8	14.9	0.0	149.3	11.4	48.8	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	154.5	0.0	0.0	0.0	0.0	56.0	0.0	0.0	11.1	0.0	0.0	41.1	59.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	60.5	18.6	18.3	0.0	0.0
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638101-65650918	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.5;NK-cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	21.6	17.2	16.4	48.7	15.5	53.8	16.2	14.1	16.8	20.6	10.3	24.0	12.5	20.9	3.4	14.3	19.5	16.0	25.7	15.8	13.2	17.0	15.0	37.0	60.7	22.3	16.0	13.1	8.4	3.5	7.5	19.4	19.5	17.1	6.0	0.9	14.1	10.0	10.0	8.1	37.8	12.0	19.5	95.6	15.9	4.7	24.5	21.3	14.9	6.4	32.5	18.8	15.3	21.0	1.6	13.3	9.1	20.1	5.4	11.1	21.7	14.9	12.7	11.7	11.3	3.9	14.5	21.3	33.2	7.6	0.4	7.8	3.4	5.1	3.9	22.7	8.1	52.6	20.7	7.4	9.6	21.5	21.5	11.4	2.3	16.2	2.1	11.5	34.4	21.8	30.3	9.2	5.8	5.8	8.6	36.1	6.4	5.4	12.3	38.8	5.1	19.3	4.4	0.8	3.4	20.9	7.5	12.6	31.7	8.5	9.6	32.5	49.2	14.2	28.7	15.2	3.0	14.1	12.2	48.4	19.5	33.0	42.0	3.2	3.3	9.3	5.8	3.9	4.1	4.1	2.8	3.7	2.3	4.7	2.0	3.1	11.1	4.7	4.8	2.1	3.0	3.0	16.4	15.5	14.1	16.8	15.8	13.2	22.3	16.0	19.5	19.5	24.5	21.0	22.5	6.4	5.2	7.5	59.0	6.8	24.7	23.2	17.6	2.1	24.8	26.5	7.2	21.5	19.2	23.9	0.0	10.1	82.5	16.5	37.2	19.8	3.0	8.3	6.8	26.8	21.0	31.6	0.1	14.5	19.6	12.2	11.2	14.9	7.0	37.1	42.8	22.0	38.4	5.0	0.2	12.8	30.5	44.4	11.4	9.8	8.1	40.2	10.6	14.0	23.7	7.6	88.6	0.5	4.0	27.2	12.7	13.2	29.6	29.0	39.0	20.7	6.0	1.8	13.1	7.4	20.9	0.8	13.8	14.4	11.1	13.5	50.4	30.9	14.3	31.9
SIPA1L1	"E6TP1, KIAA0440, SPAR1"	ENSG00000197555	"Signal induced proliferation associated 1 like 1"	O43166	14	71320449-71741229	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 575.1;Inhibitory neurons: 447.6;Oligodendrocyte precursor cells: 221.2;Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 101.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002875, HPA077689"	Approved		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments"	"HPA002875: AB_1079974, HPA077689: "	"unprognostic (1.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (6.80e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.03e-2)"	6.2	14.5	29.7	11.6	33.4	11.7	9.0	6.1	27.8	9.4	31.3	12.1	10.3	7.1	11.0	14.4	13.8	15.5	3.3	30.9	4.5	14.9	12.3	11.5	11.0	2.7	0.5	4.7	12.7	19.2	16.0	5.1	1.4	7.9	11.7	13.3	10.7	8.5	3.0	8.7	11.1	10.5	0.6	25.3	18.1	19.8	10.1	12.5	14.3	2.8	15.8	12.7	6.1	11.3	27.0	8.3	18.9	14.2	5.6	16.0	34.2	35.9	42.4	14.3	18.1	48.1	14.8	12.6	9.1	59.1	12.9	26.1	13.9	32.3	27.1	11.4	6.5	26.5	55.3	11.3	46.3	3.2	9.8	11.7	26.7	22.1	52.0	16.3	15.5	17.5	11.8	30.7	19.8	40.5	10.8	3.0	10.8	24.6	22.4	15.7	20.4	13.4	10.2	41.1	23.2	61.9	36.8	28.6	2.6	12.1	17.0	1.4	43.3	101.4	37.2	11.6	20.8	25.0	30.3	18.3	17.3	8.6	34.6	6.9	5.2	1.1	1.7	5.8	3.8	3.2	1.5	2.4	1.3	7.4	1.0	1.1	22.9	2.2	7.1	0.4	1.6	2.3	29.7	33.4	6.1	27.8	30.9	4.5	2.7	0.5	1.4	0.6	10.1	11.3	14.4	67.3	30.5	163.9	53.8	11.9	15.2	20.2	30.7	19.6	13.0	21.2	5.3	21.5	23.6	14.7	18.8	7.8	23.9	19.3	13.7	24.6	74.4	28.8	18.8	12.9	32.4	1.3	575.1	19.9	8.5	11.3	46.9	35.3	13.9	26.4	5.0	17.5	5.1	58.9	447.6	16.8	10.2	21.4	67.2	31.2	7.8	49.2	5.4	120.9	34.6	58.2	9.2	221.2	251.3	23.0	15.5	35.3	24.9	16.2	18.3	28.4	34.4	15.9	0.0	5.4	18.2	22.4	36.8	17.3	8.4	9.4	24.3	102.0	22.5	27.2
SIPA1L2	"KIAA1389, SPAR2"	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232630571	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane, Nuclear bodies"	"Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	12.1	3.3	8.5	6.4	7.2	5.4	9.2	9.6	11.7	10.0	0.5	19.4	3.9	4.4	2.8	20.3	4.5	8.5	31.3	9.6	16.0	7.7	6.4	16.2	3.0	44.0	21.7	11.9	3.6	4.4	8.1	18.3	44.6	8.1	18.9	14.7	8.7	4.7	7.1	9.0	9.2	7.4	14.4	9.6	5.7	7.2	18.7	2.4	8.0	9.5	3.3	12.5	14.9	9.0	0.0	7.5	69.7	0.2	0.6	0.0	29.3	1.2	2.5	3.1	2.2	2.9	0.1	5.9	13.3	26.4	2.9	1.7	13.8	2.3	2.9	0.0	12.8	0.0	7.0	0.0	5.9	1.0	7.2	3.8	9.1	0.6	6.2	0.0	15.7	25.4	0.0	0.1	1.6	3.5	7.4	0.7	53.9	0.2	10.2	0.0	0.0	3.4	8.1	11.5	3.5	11.9	23.8	0.8	9.5	15.8	1.4	0.6	5.6	8.1	0.0	17.8	2.9	6.5	0.0	0.0	10.0	6.2	46.1	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.3	0.3	0.0	0.1	8.5	7.2	9.6	11.7	9.6	16.0	44.0	21.7	44.6	14.4	18.7	9.0	53.7	6.4	1.8	22.9	0.8	8.8	9.8	8.7	15.4	23.5	10.7	8.6	62.6	12.8	10.4	3.7	52.1	4.9	4.4	29.9	0.0	7.1	11.7	19.0	21.4	22.7	7.2	0.4	80.2	0.5	7.1	15.2	5.1	47.5	1.3	16.0	1.8	3.8	10.0	5.0	95.9	29.5	14.2	16.6	7.2	9.8	0.9	19.5	14.2	183.6	6.3	12.7	1.0	104.0	21.0	1.4	39.9	1.9	0.5	13.2	9.1	0.4	7.7	35.7	0.0	21.8	23.9	6.9	24.0	45.8	7.4	14.8	2.0	11.9	23.4	23.0
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 157.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 138.1;Excitatory neurons: 87.4;Hofbauer cells: 100.8;Macrophages: 82.5;monocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.8"	"Group enriched"	"Detected in many"	150	"dendritic cells: 13.9;granulocytes: 50.8;monocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 142.7;RPTEC TERT1: 100.3;SK-MEL-30: 120.2"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced					NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	49.7	40.4	145.5	49.2	146.6	44.1	41.2	98.9	157.3	27.2	56.0	16.6	27.0	15.0	19.9	13.1	23.3	27.3	30.3	155.1	105.0	27.3	53.4	42.3	22.5	101.0	123.4	19.5	12.6	4.8	15.9	26.3	94.9	15.6	14.8	39.8	29.9	15.3	17.4	29.8	22.3	21.6	99.9	28.1	11.8	6.9	135.2	7.1	12.2	9.0	16.9	35.4	21.9	126.6	11.8	25.2	12.5	23.2	29.4	27.5	1.8	60.5	51.1	16.2	4.9	16.2	0.3	0.0	14.3	142.7	43.6	11.6	10.0	70.6	6.7	0.1	7.1	0.0	2.8	9.0	35.4	24.4	28.5	24.9	32.5	13.8	16.6	46.1	50.8	0.2	1.4	15.4	22.0	0.7	0.0	33.9	13.9	0.0	11.2	0.1	22.2	16.1	100.3	0.0	1.7	3.7	8.2	0.0	120.2	4.5	4.0	76.9	76.6	71.1	36.7	46.4	30.5	0.1	0.1	0.2	22.2	77.3	8.2	0.3	24.1	48.7	0.0	6.0	0.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	50.8	0.0	2.2	0.9	0.1	10.0	145.5	146.6	98.9	157.3	155.1	105.0	101.0	123.4	94.9	99.9	135.2	126.6	60.6	3.2	6.5	138.1	4.3	14.3	12.8	28.3	6.2	13.2	18.8	27.7	12.7	34.3	10.1	9.2	14.6	20.2	0.6	2.8	1.9	26.8	0.5	1.5	2.2	13.7	9.6	4.4	87.4	2.1	2.1	23.7	1.1	4.8	17.7	1.6	20.3	29.3	100.8	15.2	44.2	3.5	2.0	57.2	54.3	1.2	5.0	82.5	23.2	33.7	85.0	23.7	0.0	40.7	51.1	25.1	9.9	1.9	1.6	9.7	17.7	16.1	5.1	26.8	6.6	3.4	7.8	0.2	8.3	2.8	6.7	36.5	2.1	0.0	2.6	7.7
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4"	"Group enriched"	"Detected in many"	329	"dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	5.6	2.4	1.1	12.0	1.2	6.5	1.6	1.3	1.6	1.8	1.8	1.5	0.9	0.9	0.1	1.8	1.6	3.7	1.4	1.1	1.5	1.1	1.8	7.2	7.0	2.7	2.1	0.5	0.7	0.6	0.6	7.5	2.4	0.9	1.7	0.2	1.3	0.6	0.5	0.9	2.0	4.1	1.6	13.1	1.2	0.5	2.7	1.4	0.7	1.8	3.2	3.9	0.9	2.6	4.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.8	0.0	8.5	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	3.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	8.3	0.0	3.0	51.1	31.7	0.1	30.4	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	69.5	0.0	24.4	0.6	0.0	18.9	1.1	1.2	1.3	1.6	1.1	1.5	2.7	2.1	2.4	1.6	2.7	2.6	0.0	0.0	1.1	0.0	0.5	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.1	1.3	0.0	1.4	0.2	5.1	0.0	0.1	0.0	0.0	20.0	3.3	0.0	0.0	9.5	0.0	14.0	8.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.1	0.7	0.3	0.1	0.0	0.6
SIRPD	"dJ576H24.4, PTPNS1L2"	ENSG00000125900	"Signal regulatory protein delta"	Q9H106	20	1534251-1557705	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 57.8"	"Group enriched"	"Detected in some"	118	"Early spermatids: 427.6;Late spermatids: 522.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 37.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 37.2;monocytes: 21.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.5;HMC-1: 1.9;NB-4: 2.6;THP-1: 5.6;U-937: 1.2"					"Not detected"	"Not detected"			HPA042663	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA042663: AB_2678102"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-2)"			"unprognostic (3.01e-2)"	"unprognostic (4.47e-1)"		"unprognostic (2.49e-1)"		"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.66e-8)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.44e-2)"	0.2	0.1	0.2	2.8	0.1	2.7	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.4	0.1	0.1	0.1	0.1	0.2	1.9	1.1	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.1	1.5	0.1	57.8	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	21.0	21.5	0.1	13.5	0.2	0.1	0.1	0.2	6.8	0.0	0.1	0.0	37.2	0.0	6.1	4.3	0.3	6.6	0.2	0.1	0.0	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	427.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	4.0	0.0	522.7	3.4	2.2	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.4	30.2	8.9	11.0	10.4	19.8	17.5	15.6	11.9	17.1	7.8	12.5	9.2	18.5	11.9	10.9	11.9	14.0	10.6	8.5	9.9	13.4	17.3	12.6	17.7	9.3	9.2	25.1	12.1	14.0	6.9	12.7	10.0	14.0	12.0	13.5	9.9	11.2	14.6	9.6	9.7	13.7	8.8	14.3	10.3	26.8	9.4	19.2	14.7	18.5	15.1	15.5	9.5	12.9	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	8.9	10.4	15.6	11.9	8.5	9.9	9.3	9.2	10.0	8.8	9.4	12.9	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SIRT3	SIR2L3	ENSG00000142082	"Sirtuin 3"	Q9NTG7	11	215030-236931	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026809, CAB037142"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"CAB037142: AB_1079982, HPA026809: AB_10601160"	"unprognostic (1.76e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.85e-9)"	"unprognostic (1.04e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.75e-2)"	11.1	13.8	24.5	10.4	28.8	11.8	18.6	19.7	28.8	14.3	26.1	13.9	13.3	12.6	40.1	9.9	14.4	7.6	24.4	25.1	20.8	17.2	25.8	10.3	13.8	19.0	20.4	18.3	18.0	11.2	28.0	5.8	18.4	16.7	14.2	26.8	12.6	12.4	27.3	20.2	14.6	9.7	19.0	14.7	13.5	25.2	21.6	6.8	15.7	19.9	14.9	11.5	11.1	24.0	9.7	11.1	16.7	17.7	19.1	24.1	8.0	13.6	11.0	10.1	7.9	11.5	22.8	5.9	6.2	8.5	9.8	18.6	8.2	7.4	9.8	11.2	12.7	7.4	15.7	12.6	8.4	9.7	17.3	17.8	14.1	10.2	10.9	17.3	6.7	11.1	15.3	11.0	4.6	10.8	4.0	15.0	7.5	8.5	13.2	10.8	13.2	9.8	10.2	6.6	9.3	7.5	11.5	16.7	6.4	10.8	11.9	2.2	9.3	11.4	5.4	3.2	4.1	19.4	17.3	8.4	12.4	7.7	5.9	0.1	3.1	3.1	3.6	2.5	3.8	5.3	3.3	4.1	2.8	4.3	6.0	4.9	3.1	8.1	6.6	4.8	4.0	2.7	24.5	28.8	19.7	28.8	25.1	20.8	19.0	20.4	18.4	19.0	21.6	24.0	6.0	3.2	6.5	17.0	10.4	5.0	7.0	13.1	12.5	7.4	16.0	15.5	23.4	14.3	7.4	5.5	8.4	12.6	7.2	7.2	33.2	7.5	22.0	7.4	5.8	6.7	6.0	14.3	19.2	5.8	10.3	8.6	11.7	4.6	10.2	8.4	7.5	18.3	8.8	10.1	18.3	8.1	10.2	5.5	3.3	21.0	9.0	6.4	10.6	8.4	3.5	13.5	5.2	9.0	11.6	5.1	9.3	9.1	14.6	5.5	14.3	18.9	9.0	9.5	0.0	7.3	6.5	25.5	9.6	9.9	4.1	6.8	8.4	14.2	11.2	4.0
SIRT4	SIR2L4	ENSG00000089163	"Sirtuin 4"	Q9Y6E7	12	120302316-120313249	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage"	Transferase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029691, HPA029692"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029691: AB_10600118, HPA029692: AB_10611520"	"unprognostic (2.62e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.74e-3)"	"unprognostic (2.31e-1)"	0.9	3.9	2.9	1.0	2.6	0.3	1.1	3.7	3.2	1.9	3.1	2.8	3.5	2.0	0.8	1.4	1.4	1.2	4.5	2.8	2.5	3.2	3.9	1.6	1.4	2.8	2.5	2.5	1.9	2.8	0.9	0.9	2.8	1.3	1.0	3.7	3.0	1.5	9.8	3.1	1.6	1.8	2.3	1.5	2.2	6.2	2.6	2.2	1.8	7.2	1.0	1.5	1.3	2.9	0.6	1.4	1.9	0.9	5.9	1.9	0.9	1.4	1.6	1.1	2.9	1.5	0.9	1.0	1.6	0.8	1.5	0.3	1.9	0.7	1.9	2.0	2.5	0.0	0.3	1.2	1.4	1.1	0.5	1.7	1.6	0.6	0.4	3.2	1.5	2.8	2.0	0.1	1.7	0.8	1.9	1.6	1.1	0.4	1.1	2.3	3.5	1.0	1.6	0.1	1.9	1.6	1.0	0.1	0.9	3.2	2.3	0.4	0.2	0.9	1.5	0.8	0.3	2.3	2.1	0.3	0.9	0.6	1.4	6.7	1.4	0.2	3.8	0.6	5.8	2.7	2.5	3.1	0.8	3.5	4.4	3.9	0.0	2.5	0.1	3.8	0.2	1.2	2.9	2.6	3.7	3.2	2.8	2.5	2.8	2.5	2.8	2.3	2.6	2.9	1.3	6.4	2.0	3.6	2.3	0.4	0.8	0.6	1.2	0.8	1.3	2.4	4.5	0.0	2.4	0.0	2.1	1.2	2.2	0.1	7.9	1.7	29.7	1.2	1.5	0.4	0.0	0.8	5.5	1.1	1.0	1.2	1.1	1.0	0.0	2.8	0.4	1.4	0.7	5.0	7.0	0.9	0.0	0.0	0.6	4.0	1.2	0.4	0.0	1.0	0.0	1.8	0.0	3.5	2.5	0.6	2.9	2.2	0.7	0.4	4.5	6.1	0.4	2.9	0.0	1.1	1.5	6.3	0.9	1.5	1.4	0.8	1.3	6.3	0.9	0.1
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574227-13615158	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 52.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	7.2	6.0	9.4	5.2	10.6	5.8	6.6	10.4	12.2	5.4	13.5	8.1	7.7	6.1	5.6	5.6	9.2	5.2	28.6	10.5	10.6	11.5	33.5	5.4	8.3	9.2	9.6	10.1	6.7	16.2	7.3	5.6	9.9	6.4	8.7	6.1	10.6	6.8	33.4	7.9	9.8	5.9	8.4	9.6	8.2	6.8	10.9	8.2	9.0	38.0	7.2	6.0	5.4	11.1	10.5	8.9	8.1	10.4	5.7	8.9	7.6	5.1	5.3	6.1	8.0	12.9	11.1	14.1	35.7	4.3	10.9	16.9	7.4	11.1	7.6	5.9	10.3	8.5	5.6	20.5	11.0	6.7	6.7	7.8	19.9	4.5	19.9	12.7	10.3	20.3	13.8	4.6	6.5	12.3	8.2	13.2	7.7	16.9	13.7	15.4	4.4	24.4	10.3	11.0	13.7	4.5	4.3	7.9	25.9	25.0	11.6	4.9	8.6	6.6	3.4	4.2	5.8	11.6	15.4	10.7	4.5	7.3	8.4	0.7	6.0	16.7	9.9	9.2	10.7	14.0	13.0	9.5	6.3	12.7	11.8	10.8	2.6	11.8	17.3	5.9	10.7	7.9	9.4	10.6	10.4	12.2	10.5	10.6	9.2	9.6	9.9	8.4	10.9	11.1	16.6	28.9	3.2	30.0	8.2	4.1	11.4	14.9	10.8	7.3	9.7	9.9	52.5	15.7	16.8	11.0	0.0	20.5	6.6	9.4	52.8	13.0	2.9	13.1	5.4	12.3	6.1	15.8	36.6	6.7	10.5	6.7	6.6	8.1	0.0	23.5	9.7	25.7	9.4	1.7	39.2	13.2	8.2	13.9	3.8	2.0	8.1	8.4	5.4	14.0	6.3	11.6	10.3	15.1	25.8	7.2	13.4	5.7	4.7	6.2	18.1	34.1	22.5	7.2	0.0	9.8	6.6	8.5	12.0	9.8	4.5	10.7	7.9	13.2	15.0	9.0
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Distal enterocytes: 199.2;Paneth cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm,Vesicles		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	8.2	12.0	10.4	7.8	10.6	10.4	8.6	10.3	15.1	10.5	8.7	23.6	10.0	10.6	2.4	12.3	9.2	3.5	10.0	10.7	10.2	13.7	11.0	8.9	7.1	11.2	10.3	7.5	14.1	5.2	13.3	4.3	10.5	12.7	7.5	1.9	9.3	5.0	8.0	11.8	14.2	2.6	9.8	15.3	9.8	6.0	12.1	4.9	10.1	2.7	3.9	9.9	9.7	10.6	25.7	16.8	8.3	10.4	6.5	6.2	12.9	12.0	8.9	10.1	8.8	11.2	9.5	16.0	12.9	8.1	9.1	15.9	4.6	12.9	1.6	30.8	10.0	6.8	9.7	10.3	14.3	17.4	25.2	7.9	10.4	10.3	6.4	7.7	8.7	15.0	15.2	35.3	5.4	19.2	23.9	18.3	14.5	9.3	15.2	18.9	7.7	18.8	9.7	11.4	11.0	18.1	11.0	10.2	24.1	3.2	10.2	23.0	12.2	10.4	10.5	36.9	17.4	45.6	25.7	18.4	20.8	28.1	12.7	5.3	13.1	12.2	10.8	16.3	6.4	9.6	7.5	8.7	14.3	10.1	6.4	6.1	11.8	5.6	13.5	11.9	12.6	8.5	10.4	10.6	10.3	15.1	10.7	10.2	11.2	10.3	10.5	9.8	12.1	10.6	9.2	12.8	7.3	5.9	13.8	10.3	10.3	32.3	9.6	12.6	6.6	6.3	3.2	7.2	18.4	5.5	18.8	24.1	7.1	199.2	13.7	32.2	1.9	6.2	7.9	11.8	26.4	9.5	8.9	26.7	24.2	9.3	19.9	9.2	5.7	5.6	13.6	6.8	24.0	13.5	10.4	29.1	18.3	11.7	10.1	2.6	11.5	15.0	5.4	1.9	27.0	15.2	14.4	3.5	6.3	32.5	129.7	8.2	10.3	9.7	28.2	14.3	11.0	13.8	0.0	7.2	11.3	7.4	9.6	13.3	12.6	25.6	10.6	7.9	30.9	11.9
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	8.8	8.0	6.8	7.4	7.3	23.2	8.6	7.5	8.6	12.5	7.4	17.3	12.9	7.0	1.9	42.1	8.0	5.4	6.4	6.9	6.7	11.5	14.2	9.6	11.8	7.6	7.0	6.0	12.8	5.4	6.9	4.2	7.4	9.8	5.8	0.6	14.1	3.7	6.2	22.4	17.1	3.6	7.0	18.7	17.9	13.3	7.6	9.4	7.9	3.7	7.2	10.8	18.0	7.6	26.5	21.7	2.8	9.5	6.9	6.4	17.0	13.1	10.8	15.1	14.1	18.7	20.7	11.8	9.9	7.3	9.6	18.8	10.5	8.1	4.9	10.2	22.9	10.4	10.7	29.7	20.4	13.6	20.5	6.5	25.0	14.5	11.9	6.4	11.3	6.5	11.3	5.8	7.2	20.9	14.6	19.5	6.8	40.6	22.3	9.7	5.5	11.1	14.7	17.4	11.1	14.6	15.0	35.9	17.7	5.0	15.1	32.1	9.0	6.8	14.9	12.9	24.2	9.5	3.2	9.0	16.6	18.4	11.3	4.5	2.6	22.2	2.8	3.8	0.9	4.5	2.1	2.3	1.4	7.0	2.0	0.7	4.4	1.8	3.3	2.1	1.2	1.5	6.8	7.3	7.5	8.6	6.9	6.7	7.6	7.0	7.4	7.0	7.6	7.6	15.2	12.8	12.2	12.4	41.4	38.0	25.8	21.1	28.5	23.4	27.4	19.0	4.4	18.6	18.7	18.4	56.3	31.1	62.8	99.0	9.8	22.4	21.8	28.8	14.0	15.4	20.4	16.0	14.3	13.6	33.2	12.4	152.9	37.0	11.4	20.1	15.0	16.0	26.1	30.3	10.6	34.6	28.5	26.4	33.5	14.1	14.3	29.4	24.9	5.6	47.3	14.7	71.1	6.6	13.8	52.7	74.5	10.1	33.2	29.1	74.7	16.0	29.6	39.1	0.0	12.5	15.5	41.3	37.4	52.4	55.5	49.3	50.8	17.9	44.6	53.9
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 95.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 78.9;dendritic cells: 31.2;Plasma cells: 19.8;T-cells: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	46	"gdT-cell: 119.1;MAIT T-cell: 202.7;memory B-cell: 213.6;memory CD4 T-cell: 249.2;memory CD8 T-cell: 223.4;naive B-cell: 192.1;naive CD4 T-cell: 170.4;naive CD8 T-cell: 169.5;plasmacytoid DC: 203.1;T-reg: 352.4"	"Group enriched"	"Detected in many"	56	"B-cells: 213.6;dendritic cells: 203.1;T-cells: 352.4"	"Group enriched"	"Detected in some"	5	"Daudi: 113.1;HDLM-2: 70.6;JURKAT: 58.7;U-698: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018506	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favorable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"	0.9	0.7	0.1	19.1	0.1	1.9	0.9	0.0	0.2	0.5	0.1	2.4	2.9	0.5	1.1	0.8	0.5	1.7	0.5	0.1	0.1	0.7	0.7	2.8	50.6	0.3	0.1	0.5	0.2	0.1	0.1	0.2	0.3	0.6	2.2	0.0	2.6	0.3	0.3	0.7	13.2	0.6	0.1	23.6	4.7	0.2	0.6	95.4	0.8	0.1	32.5	3.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.1	0.0	0.0	0.0	19.1	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.1	0.0	0.0	104.4	0.0	0.0	0.0	1.4	1.3	0.7	119.1	0.8	202.7	213.6	249.2	223.4	1.8	192.1	170.4	169.5	4.5	0.8	0.8	203.1	352.4	123.9	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.3	0.1	0.6	0.2	0.9	0.0	0.0	0.0	78.9	5.6	0.0	0.0	1.2	0.0	1.0	1.0	0.2	1.5	0.0	0.0	0.0	0.0	31.2	0.7	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.7	0.0	0.0	1.9	0.9	2.0	0.0	0.0	0.0	1.4	0.2	5.3	0.0	0.0	0.0	0.0	2.7	7.4	0.0	0.0	3.4	5.4	0.0	2.5	0.0	4.1	0.0	0.0	0.1	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.5	3.7	0.3	86.8	0.0	0.3	0.0
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709539-60724351	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 6.0;parathyroid gland: 15.1;salivary gland: 6.9;skeletal muscle: 14.4;tongue: 15.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9;Endometrial ciliated cells: 36.1;Glandular and luminal cells: 37.8;Prostatic glandular cells: 23.8;Respiratory ciliated cells: 30.3;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 32.1;hTERT-RPE1: 23.3;RH-30: 30.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA031794	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	0.7	0.7	1.0	0.2	0.8	0.1	1.6	2.0	2.6	2.2	6.0	0.3	0.1	0.9	0.7	0.2	2.4	0.6	0.5	1.0	1.6	0.8	0.1	0.7	0.0	2.4	1.6	1.4	1.5	15.1	2.7	0.9	2.3	2.6	0.0	0.3	6.9	0.6	14.4	0.1	0.1	0.4	1.2	0.0	1.5	0.3	1.4	1.3	1.0	15.7	0.1	1.1	0.4	1.5	32.1	2.1	1.9	7.9	7.2	8.7	14.5	7.1	10.5	2.0	3.0	1.5	10.2	0.0	4.6	3.5	2.0	11.8	8.4	5.8	4.7	2.6	6.4	0.9	3.2	2.1	2.3	3.4	0.3	4.2	2.7	1.7	9.5	23.3	1.8	0.6	6.6	0.0	10.6	7.6	0.0	0.3	5.3	0.2	13.2	2.1	30.2	0.0	3.8	17.3	5.0	0.5	4.3	6.7	1.9	2.8	9.7	0.2	6.4	6.3	14.0	4.2	6.3	2.2	0.1	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.0	2.6	1.0	1.6	2.4	1.6	2.3	1.2	1.4	1.5	0.1	3.2	0.5	0.0	0.1	0.4	13.9	6.9	6.8	0.5	11.9	9.7	3.3	0.0	8.3	1.8	20.9	5.0	0.3	0.1	0.0	0.2	0.1	36.1	2.9	0.9	1.8	0.0	2.6	1.1	4.1	3.2	0.0	37.8	1.3	0.1	0.4	0.3	0.3	0.0	3.2	0.0	2.0	0.0	0.3	0.0	0.3	0.7	1.8	0.0	0.0	1.6	0.0	4.0	0.1	2.9	0.0	1.5	1.3	23.8	0.0	0.3	30.3	0.4	0.0	9.7	2.5	0.4	1.3	2.2	0.6	3.1	0.9	0.1	0.0	17.2
SIX5	DMAHP	ENSG00000177045	"SIX homeobox 5"	Q8N196	19	45764785-45769252	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042068	Approved					NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA042068: AB_10795390"	"unprognostic (3.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (9.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.99e-2)"	19.1	23.5	8.8	5.8	8.4	0.6	20.5	8.5	10.0	37.5	13.5	35.8	6.7	34.6	8.7	14.7	37.8	8.1	25.2	7.6	8.5	20.9	24.6	12.6	4.2	11.2	10.5	45.8	41.0	9.3	15.9	8.4	8.5	34.0	4.3	0.6	28.0	15.9	16.0	12.7	14.2	12.6	9.9	12.1	25.4	8.0	9.1	2.3	29.4	5.7	2.9	30.8	22.5	7.9	3.3	19.3	25.6	39.2	16.0	15.9	13.2	7.3	15.5	11.1	9.7	4.8	12.4	1.8	7.0	11.9	13.6	7.5	7.7	8.4	3.7	9.3	11.6	2.1	18.7	13.8	14.1	0.5	11.9	15.6	13.1	7.2	9.2	16.8	9.4	7.6	9.0	3.9	3.2	10.6	2.6	18.2	17.4	10.4	10.9	9.7	2.3	7.9	12.1	4.1	1.6	10.5	21.7	10.7	16.8	10.1	10.0	18.8	5.7	11.0	10.3	10.0	8.1	4.7	5.1	1.9	15.9	0.9	12.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	8.4	8.5	10.0	7.6	8.5	11.2	10.5	8.5	9.9	9.1	7.9	5.2	0.0	7.2	7.5	1.0	3.2	5.4	7.9	4.6	0.1	11.6	14.7	0.3	11.5	3.4	5.5	0.0	6.1	0.3	2.1	3.9	6.2	0.4	7.3	14.9	5.2	3.0	0.0	0.0	6.0	13.1	9.1	4.1	8.3	0.0	11.0	6.8	7.0	1.1	5.0	0.0	8.6	2.0	0.8	1.4	1.2	15.8	0.9	0.0	3.7	0.0	3.1	0.0	0.0	0.1	5.0	2.1	12.8	5.5	6.1	0.7	1.9	4.0	0.5	0.0	8.2	8.8	0.5	3.5	4.2	2.6	4.0	0.8	4.5	5.0	1.4
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60509146-60512850	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 28.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 29.2;Horizontal cells: 48.8;Muller glia cells: 160.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Group enriched"	"Detected in some"	18	"hypothalamus: 3.9;thalamus: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 13.4;MOLT-4: 44.0"	"Region enriched"	"Detected in single"	14	"hypothalamus: 3.6"	"Region enriched"	"Detected in single"	12	"hypothalamus: 1.6"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	1.3	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SKA1	"C18orf24, MGC10200"	ENSG00000154839	"Spindle and kinetochore associated complex subunit 1"	Q96BD8	18	50375040-50394168	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.0;lymphoid tissue: 4.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3;Extravillous trophoblasts: 9.2;Plasma cells: 10.0;Spermatocytes: 16.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 82.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045495	Approved		Approved	Microtubules		NA	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules		"HPA045495: AB_10960405"	"unprognostic (2.18e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.66e-3)"	"unprognostic (5.93e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (9.60e-8)"	"unprognostic (1.03e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.91e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.50e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	0.4	0.5	0.9	2.2	0.8	12.0	0.3	2.5	1.1	0.4	0.8	1.6	1.7	0.6	0.2	2.5	0.2	0.3	0.2	1.0	0.5	0.1	0.3	0.4	4.9	1.0	0.9	0.2	0.4	0.1	0.0	1.6	1.2	0.3	2.1	0.4	0.3	0.1	0.6	1.5	1.4	1.1	0.3	1.3	0.8	4.3	1.3	3.6	0.3	0.2	4.8	0.5	0.7	2.4	27.1	10.8	18.6	19.0	1.2	2.1	9.9	30.7	10.6	29.9	28.5	4.7	10.6	21.1	7.6	11.0	25.8	23.6	25.6	13.0	31.4	34.6	2.6	27.0	5.5	18.3	2.3	42.2	26.8	1.5	1.3	20.7	8.2	3.2	20.0	20.0	30.8	82.6	26.4	5.7	34.6	12.1	14.2	6.5	6.4	17.3	18.3	23.5	8.5	1.6	13.7	10.9	17.2	9.9	13.6	15.3	11.4	20.2	10.1	32.8	19.0	12.8	31.8	27.5	41.6	32.4	18.2	34.9	33.3	0.9	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.2	0.3	0.2	0.1	0.6	0.6	0.2	0.2	0.4	0.2	0.9	0.8	2.5	1.1	1.0	0.5	1.0	0.9	1.2	0.3	1.3	2.4	0.2	0.0	2.2	0.0	2.8	1.0	0.2	0.4	0.0	0.4	0.7	0.6	0.4	0.0	0.8	0.0	2.1	4.4	0.7	1.6	0.0	0.1	4.5	0.5	0.7	0.4	1.2	22.3	0.2	0.0	9.2	1.4	0.5	1.1	0.0	4.9	2.2	0.1	5.3	0.0	0.1	2.7	0.0	0.8	0.9	2.2	0.3	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	1.1	0.0	10.0	0.4	0.1	0.1	0.2	0.8	0.0	0.2	1.4	16.7	13.5	3.7	0.3	1.5	1.4	0.5	3.4	1.0
SKA2	"FAM33A, FLJ12758"	ENSG00000182628	"Spindle and kinetochore associated complex subunit 2"	Q8WVK7	17	59109857-59155260	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059235	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA059235: AB_2683953"	"unprognostic (2.67e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.93e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.70e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-1)"	19.9	12.6	30.8	20.1	33.4	24.2	11.8	43.3	39.5	18.4	29.1	22.1	18.8	20.3	12.5	24.4	18.1	13.0	34.5	27.8	36.3	21.9	22.4	16.1	33.6	34.3	37.6	16.7	11.5	26.1	14.9	22.9	34.3	16.3	20.0	44.4	10.9	19.9	12.6	13.9	16.8	24.6	37.2	15.8	18.3	12.5	34.4	53.7	25.5	20.4	28.5	20.3	18.1	38.3	217.6	78.6	249.4	85.6	32.4	24.5	76.8	107.1	102.8	163.1	182.5	120.2	122.6	114.1	118.8	87.0	124.3	90.9	162.9	149.3	231.0	197.8	127.4	179.4	142.2	75.1	36.8	142.3	112.5	35.6	63.1	104.8	84.5	64.4	77.2	127.3	114.3	164.5	117.1	297.7	215.4	71.9	66.6	238.3	145.1	114.0	281.3	81.0	121.4	93.2	112.3	96.2	119.1	53.8	66.9	165.4	179.2	112.0	68.0	160.5	153.4	130.5	244.8	111.7	255.6	135.9	85.4	105.3	117.6	26.7	13.1	17.2	18.7	23.5	14.4	18.4	25.6	24.1	15.4	13.7	19.8	22.4	2.4	22.9	38.3	18.3	48.3	12.8	30.8	33.4	43.3	39.5	27.8	36.3	34.3	37.6	34.3	37.2	34.4	38.3	24.8	25.6	18.2	23.2	24.6	21.4	21.6	49.2	25.6	36.1	10.8	17.1	46.3	12.8	26.7	9.2	25.0	62.6	25.8	16.1	39.2	38.3	20.8	22.4	30.2	26.9	10.3	96.8	10.9	25.2	61.7	26.9	30.5	21.0	18.3	26.6	25.4	33.0	46.3	50.5	20.1	23.0	14.2	37.0	22.6	9.4	27.1	28.2	23.2	15.0	42.9	49.3	39.1	15.1	26.3	31.9	24.7	25.6	52.0	8.9	12.8	32.1	26.8	39.4	0.0	13.8	41.5	38.8	30.7	34.1	13.5	30.9	35.0	33.8	35.2	18.9
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133442-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.1;granulocytes: 120.1;Late spermatids: 156.1;NK-cells: 213.1;T-cells: 147.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.3;HDLM-2: 16.0;HMC-1: 13.0;JURKAT: 22.2;Karpas-707: 15.7;RPMI-8226: 19.8;RPTEC TERT1: 22.6;U-266/70: 14.8;U-266/84: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"	1.4	6.4	0.1	11.2	0.2	6.5	8.3	0.0	0.2	10.1	0.0	3.4	2.7	3.8	17.2	1.7	13.7	3.6	0.5	0.3	0.5	11.9	3.1	5.4	28.7	0.9	0.2	0.8	5.4	13.8	9.8	0.5	0.4	1.0	4.6	0.0	6.1	6.2	0.2	0.8	5.3	1.1	1.4	12.2	4.9	9.5	0.2	35.8	1.0	0.5	26.6	6.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	29.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	15.7	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.8	22.6	0.0	0.0	0.0	1.7	0.0	0.2	0.0	7.8	0.0	0.1	0.0	0.1	0.0	0.0	14.8	11.2	0.0	0.0	0.0	0.0	12.6	0.7	1.8	171.0	0.5	144.2	15.9	139.7	155.6	0.7	54.5	121.2	135.4	3.7	121.0	1.1	0.9	268.9	126.8	0.1	0.2	0.0	0.2	0.3	0.5	0.9	0.2	0.4	1.4	0.2	0.3	3.1	3.2	10.5	1.0	27.1	2.0	0.1	0.0	2.8	0.1	9.7	5.3	0.8	0.0	3.1	9.2	0.0	0.1	107.1	0.5	46.9	0.5	58.1	12.3	1.6	2.4	1.2	9.0	7.0	2.0	0.1	1.1	7.7	14.0	120.1	0.0	7.5	28.7	0.3	0.0	1.4	1.1	0.0	5.4	3.1	156.1	1.5	3.8	1.8	12.2	2.6	1.6	213.1	0.5	1.6	1.3	0.3	0.7	31.0	0.2	0.8	2.0	1.5	0.3	6.6	0.7	1.1	46.4	9.9	0.7	1.3	0.3	147.0	1.2	0.3	0.6
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667068-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 313.5;Kupffer cells: 192.2;Late spermatids: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 149.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	32.1	24.0	6.6	30.1	7.3	21.2	16.3	5.9	7.6	9.8	4.3	23.2	15.9	5.1	17.7	13.7	13.6	14.1	4.5	7.3	8.4	27.9	11.9	25.5	32.0	16.0	8.3	18.8	6.0	26.9	4.0	8.0	15.3	9.0	21.9	4.0	5.4	11.9	6.6	10.9	21.0	13.0	19.4	36.3	12.5	15.7	9.3	11.4	7.2	3.2	30.0	25.5	9.2	26.0	38.1	19.8	2.0	48.5	9.0	7.4	12.0	15.2	22.5	7.4	18.4	15.8	149.4	29.2	65.2	28.9	54.1	20.2	26.9	15.5	15.6	16.8	43.0	32.3	5.3	20.9	11.9	60.2	109.0	32.3	14.2	21.6	29.2	1.3	45.4	0.0	17.5	14.8	29.6	7.0	0.1	30.2	1.7	33.9	19.3	38.8	4.7	2.3	90.2	29.4	23.7	0.9	27.6	14.8	20.9	10.9	20.4	31.2	67.0	12.2	0.4	41.2	15.9	23.1	31.7	50.8	29.3	76.3	48.0	28.7	33.9	55.8	9.6	42.1	13.2	26.3	5.2	7.8	26.4	21.5	1.2	7.0	100.9	23.5	53.7	33.8	10.1	20.0	6.6	7.3	5.9	7.6	7.3	8.4	16.0	8.3	15.3	19.4	9.3	26.0	93.0	19.2	28.3	9.4	98.9	26.5	38.7	9.9	42.7	12.5	29.5	27.2	5.3	2.8	12.4	23.9	12.5	13.4	101.2	51.4	64.6	8.3	313.5	20.1	1.8	50.5	43.1	54.7	76.1	23.1	22.7	34.5	9.7	19.9	53.2	11.1	110.7	10.8	91.4	5.0	36.0	65.2	34.6	192.2	58.9	354.2	9.0	149.4	19.6	119.0	115.4	12.3	63.8	3.0	15.9	19.4	37.6	10.9	29.9	18.3	54.4	103.1	20.2	12.8	0.0	11.5	33.5	26.7	45.0	38.1	43.3	18.6	36.4	41.8	48.8	35.1
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228319-2310213	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	38.3	14.3	22.0	14.1	20.9	11.5	31.5	59.5	24.2	37.5	3.4	34.6	9.3	42.0	8.3	23.5	34.1	14.6	34.4	24.1	11.0	23.6	24.3	33.9	11.6	20.1	16.9	36.4	13.1	7.3	23.0	13.9	17.2	26.8	7.0	5.1	25.2	19.8	22.1	38.6	24.1	16.8	17.1	22.9	22.6	13.2	19.4	8.7	25.4	11.7	10.2	30.8	29.2	15.7	18.3	10.4	24.5	23.9	40.0	23.8	16.1	26.7	14.8	16.3	11.9	15.8	13.7	11.5	19.5	34.4	6.8	21.0	13.8	21.6	15.0	12.7	30.0	29.0	16.4	22.5	26.7	16.5	29.8	25.8	11.8	24.5	18.2	30.0	20.2	4.8	16.6	8.6	20.2	11.6	2.0	18.1	24.8	12.0	19.8	9.1	15.5	9.6	13.9	7.0	35.0	22.9	26.0	22.9	26.7	15.6	7.7	20.9	36.9	27.7	17.5	39.6	21.1	6.7	5.2	10.5	14.8	28.2	11.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	22.0	20.9	59.5	24.2	24.1	11.0	20.1	16.9	17.2	17.1	19.4	15.7	44.2	9.6	12.6	18.9	18.8	47.0	13.1	7.0	32.5	8.9	20.3	25.8	12.7	11.5	6.7	7.3	0.0	7.3	32.2	7.3	1.9	8.2	0.8	10.1	28.9	34.3	6.0	14.7	22.6	6.9	15.5	35.5	9.7	18.5	13.3	6.4	33.9	23.0	13.7	11.8	24.1	14.3	0.0	16.4	29.5	5.0	49.7	28.9	16.0	48.7	9.4	11.1	12.3	11.6	11.4	13.0	9.4	55.3	16.9	14.9	8.1	6.0	4.0	4.4	46.0	36.2	37.3	4.7	12.8	32.2	45.0	16.3	33.4	6.7	10.7	11.4
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"	Q1XH10	10	21513475-21526368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.1;Early spermatids: 17.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.3	0.6	0.4	0.1	0.6	0.6	0.2	0.4	2.3	0.5	0.0	0.6	0.1	0.2	0.2	0.2	0.5	0.1	1.2	0.5	0.0	1.3	1.4	0.3	0.1	0.1	0.0	1.3	0.5	1.1	0.5	0.8	0.0	0.3	0.2	1.5	0.5	0.6	0.2	1.0	0.2	0.3	0.0	0.1	0.2	1.7	0.0	0.2	1.2	0.2	0.1	0.3	0.3	0.9	0.5	1.1	26.1	6.7	0.5	0.3	12.1	0.5	0.4	0.0	0.1	2.5	0.2	0.2	1.0	0.4	0.2	1.6	2.4	0.5	0.0	0.0	2.9	0.1	1.3	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.4	0.2	0.2	0.1	1.1	0.9	0.1	1.6	0.0	0.0	0.4	0.8	0.0	0.5	0.7	2.9	6.0	0.9	4.5	0.1	2.1	0.4	5.4	0.4	0.2	0.8	0.2	0.6	0.1	0.0	0.3	1.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	2.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	1.5	5.2	0.2	1.5	1.0	0.6	6.8	19.1	1.8	2.2	6.9	4.3	1.4	1.8	0.0	5.3	0.0	0.1	7.9	0.1	17.9	0.4	1.3	4.3	0.0	0.0	2.8	0.6	3.4	2.1	0.0	0.3	1.3	3.3	4.6	10.3	3.2	1.7	2.2	0.0	0.0	2.2	0.3	10.2	1.5	0.6	0.0	1.0	0.0	6.1	0.0	3.5	2.1	0.3	0.0	2.2	0.1	0.7	0.0	8.5	0.6	4.7	6.6	1.5	1.2	6.5	5.1	4.2	1.8	3.4	0.1	5.2	0.0	0.2
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	11.9	12.0	6.1	18.8	7.3	23.1	9.0	8.5	10.0	9.4	8.3	10.4	13.8	12.0	8.2	9.2	6.4	21.1	12.0	6.6	10.9	10.3	15.6	16.1	13.8	10.7	10.8	9.2	9.6	5.7	11.0	13.9	10.5	11.6	9.7	9.6	7.4	8.9	11.0	5.8	14.2	10.5	12.0	7.2	15.9	13.0	11.4	9.2	11.3	21.4	18.4	14.6	8.8	13.2	19.9	24.0	15.6	10.4	20.0	8.7	29.1	19.6	13.6	13.8	10.6	4.9	42.2	24.9	60.5	18.2	23.1	44.8	9.9	9.0	21.3	43.6	9.2	32.8	24.8	11.0	17.8	13.7	17.4	15.3	8.8	19.9	15.0	42.9	34.1	2.4	14.7	27.9	28.4	21.3	5.9	4.5	61.2	21.8	8.1	13.6	52.8	5.0	20.8	31.7	11.5	14.1	48.3	47.4	10.3	31.6	32.2	14.2	66.1	38.2	35.9	33.0	37.1	36.2	18.6	47.3	14.3	7.1	18.3	3.1	3.4	1.8	1.3	8.3	1.8	3.6	1.1	1.7	2.4	4.4	1.9	2.0	4.0	2.8	10.3	1.6	0.5	1.9	6.1	7.3	8.5	10.0	6.6	10.9	10.7	10.8	10.5	12.0	11.4	13.2	104.1	73.7	72.8	21.2	142.1	72.7	88.8	52.5	67.7	25.6	79.3	38.1	12.4	21.5	70.4	35.0	54.2	14.8	124.9	45.9	15.6	56.7	115.7	118.4	80.9	86.0	23.8	3.0	48.6	111.4	58.3	100.6	93.8	102.0	204.8	46.3	72.5	32.0	26.3	53.8	21.6	62.4	22.4	65.4	85.2	35.8	37.9	121.7	35.6	60.0	42.1	12.7	14.4	26.2	27.5	176.5	29.1	68.1	104.3	43.5	41.3	45.9	82.1	30.5	26.3	143.6	63.6	53.9	37.6	61.3	96.0	41.2	81.5	17.5	31.3	117.8
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SKOR1	"CORL1, FUSSEL15, LBXCOR1"	ENSG00000188779	"SKI family transcriptional corepressor 1"	P84550	15	67819704-67834582	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.6;Early spermatids: 20.5;Late spermatids: 36.2;Spermatocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.0;U-266/70: 2.4;U-266/84: 2.0;U-698: 2.1"	"Group enriched"	"Detected in some"	11	"cerebellum: 3.7;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 5.0"	HPA071150	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA071150: "	"unprognostic (8.98e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.44e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.40e-5)"	"unprognostic (5.51e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.13e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	0.5	0.4	0.4	0.0	0.3	0.3	0.5	5.5	1.2	0.7	0.0	0.7	0.2	0.7	0.1	0.2	0.6	0.1	0.3	0.4	0.8	0.3	0.2	0.4	0.0	2.5	0.5	0.9	0.4	0.0	1.1	0.1	1.6	0.5	0.0	0.5	0.3	0.1	0.4	0.8	0.5	0.1	2.1	0.4	0.4	1.1	0.3	0.2	0.4	0.0	0.0	0.5	0.5	0.9	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.1	0.5	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.1	2.4	2.0	2.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	5.5	1.2	0.4	0.8	2.5	0.5	1.6	2.1	0.3	0.9	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.6	0.7	0.2	0.1	5.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.9	0.0	20.5	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	36.2	0.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.0	0.7	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.5	0.3	8.0	0.3	0.1	0.4	0.0	0.0	0.2	0.1	0.1
SKOR2	"CORL2, Fussel-18, FUSSEL18"	ENSG00000215474	"SKI family transcriptional corepressor 2"	Q2VWA4	18	47206169-47251660	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.8;Spermatocytes: 2.5;Spermatogonia: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"NTERA-2: 3.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.4"	"Not detected"	"Not detected"			HPA046206	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046206: AB_2679588"					"unprognostic (1.53e-1)"					"unprognostic (1.93e-1)"				"unprognostic (1.92e-1)"	"unprognostic (6.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.8	0.6	1.8	0.2	1.1	2.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134176964	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		880000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	430.5	566.7	442.5	194.9	463.6	363.7	559.0	471.7	648.6	455.4	486.2	529.3	230.1	441.3	490.7	401.9	437.8	330.1	650.5	470.8	492.5	588.6	442.8	346.6	305.9	465.9	457.1	525.4	266.6	776.2	501.0	394.6	474.2	420.9	350.2	484.3	366.9	550.9	1056.8	419.5	354.9	422.6	494.4	304.8	385.9	380.4	470.5	456.1	551.5	814.1	332.0	452.9	391.6	515.0	657.0	500.1	730.3	986.5	1103.6	891.8	519.2	744.6	939.1	854.0	877.1	773.0	620.0	481.9	1084.9	1009.8	974.9	356.6	738.2	1124.1	988.3	442.6	519.5	380.7	724.0	555.8	518.7	296.3	452.0	771.1	886.2	750.1	588.7	1060.4	928.4	611.2	467.4	411.8	1295.2	515.6	642.0	314.8	423.9	619.6	530.7	349.2	780.7	591.7	952.3	724.6	594.6	463.8	1010.2	254.4	726.9	942.4	738.5	454.6	705.3	547.5	338.4	578.2	766.4	254.7	459.1	717.8	762.3	555.5	608.0	1745.5	851.4	1484.9	884.6	841.7	1011.4	1202.8	1264.6	1099.9	817.8	1094.4	1495.5	1174.8	811.4	1096.1	1027.0	728.1	1416.7	2538.6	442.5	463.6	471.7	648.6	470.8	492.5	465.9	457.1	474.2	494.4	470.5	515.0	430.1	285.2	306.3	64.0	403.6	674.3	1025.7	1354.7	380.1	230.0	539.8	558.4	700.9	497.6	767.4	594.1	73.0	881.0	417.7	441.8	1696.3	644.9	593.3	511.9	405.3	410.1	356.0	617.8	66.5	376.9	749.4	561.5	270.1	439.0	336.9	433.9	340.2	376.9	471.6	223.8	65.8	402.2	1192.2	296.1	505.1	1048.6	601.4	344.8	718.6	33.7	565.4	792.8	338.8	43.7	87.0	378.1	564.0	712.8	278.2	744.7	630.0	1577.8	965.7	217.5	506.2	480.4	668.1	753.5	652.7	349.0	645.6	1347.0	511.1	500.4	410.4	837.6
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36196849	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 37.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 274.7;RH-30: 286.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	4.9	4.0	3.6	5.8	3.9	11.4	4.9	4.7	4.5	5.9	3.9	6.1	6.3	4.7	4.3	8.3	5.1	2.9	2.5	3.9	3.1	2.3	9.8	4.2	7.9	3.7	3.5	5.2	3.8	2.5	4.0	37.9	3.9	4.0	6.1	4.6	4.0	3.7	2.2	5.7	6.5	4.1	3.9	5.9	4.0	2.6	3.7	12.3	3.1	1.6	8.3	4.7	5.6	5.4	25.4	14.8	35.6	54.3	15.5	20.1	274.7	31.2	25.7	89.5	48.7	83.3	22.8	43.3	10.6	20.0	13.3	28.3	53.3	46.7	71.0	19.2	46.7	23.9	51.4	47.1	6.1	44.8	11.4	18.1	12.2	16.9	8.5	7.7	24.2	40.2	37.9	9.1	31.9	16.4	58.9	26.8	51.5	23.8	24.2	53.7	286.7	28.3	7.2	28.1	45.5	46.8	94.3	27.4	14.1	32.2	22.7	33.3	8.0	31.4	36.1	13.5	24.5	12.4	13.1	50.8	15.2	61.3	21.9	9.2	6.6	13.4	4.2	6.1	6.9	5.2	4.7	4.5	14.0	6.0	6.4	4.6	1.1	6.2	3.2	3.5	4.8	4.7	3.6	3.9	4.7	4.5	3.9	3.1	3.7	3.5	3.9	3.9	3.7	5.4	4.4	22.4	8.9	11.8	8.7	3.7	2.4	7.1	12.0	8.2	3.6	4.2	1.3	1.5	1.7	1.8	10.4	134.4	7.4	2.4	1.9	2.4	0.7	5.2	6.5	6.5	3.0	14.1	22.4	2.9	227.3	11.6	7.1	2.4	2.5	20.9	1.8	11.9	35.0	0.0	13.1	6.0	4.1	9.3	3.1	0.3	4.1	5.3	1.8	12.2	7.6	2.5	9.2	11.6	29.5	2.6	3.4	6.4	10.9	1.0	3.2	1.4	6.2	6.8	0.0	11.5	4.1	1.4	6.4	19.8	4.0	83.9	5.6	11.8	9.6	1.2
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036728-133102912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 97.4;lymphoid tissue: 156.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	25.2	13.1	9.5	82.9	6.4	97.4	9.5	6.1	11.5	11.1	8.2	10.8	7.9	5.2	2.9	9.4	7.0	20.9	5.2	8.2	9.1	6.4	16.9	25.9	78.6	12.0	8.4	3.0	5.8	3.1	3.1	15.2	10.3	5.2	8.4	1.3	4.6	3.6	1.5	4.0	20.7	12.5	9.7	70.3	12.5	1.4	16.9	156.6	27.6	4.4	71.0	22.0	4.2	14.6	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	0.1	2.3	0.0	0.0	0.0	6.3	47.9	0.8	0.0	0.6	0.0	0.2	0.0	201.5	0.1	129.2	0.0	0.0	35.8	9.3	0.0	0.0	0.0	0.2	0.3	7.8	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.1	0.0	15.3	0.0	0.1	0.3	0.2	0.1	6.9	76.1	0.0	0.6	55.6	0.0	0.7	110.2	203.6	87.6	123.1	110.1	41.0	79.7	88.2	79.8	48.3	75.3	77.4	262.3	132.6	148.4	6.3	124.4	158.9	9.5	6.4	6.1	11.5	8.2	9.1	12.0	8.4	10.3	9.7	16.9	14.6	2.4	9.6	19.1	0.7	36.6	2.2	0.3	0.0	0.0	9.7	0.9	1.3	3.3	1.5	10.5	0.0	0.0	0.4	224.2	0.2	0.0	0.2	0.2	0.7	0.7	5.9	0.0	13.2	1.0	0.0	1.2	4.5	3.6	0.5	37.2	1.7	8.9	2.9	67.4	0.0	1.3	0.5	0.0	199.4	15.0	1.0	0.3	154.2	5.4	14.0	36.7	0.1	109.2	0.0	0.1	0.0	0.0	0.0	83.0	0.1	0.0	0.3	5.1	0.3	6.6	1.4	1.9	0.0	0.1	0.3	2.7	0.1	160.0	0.1	0.1	0.2
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341529-48426201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		210000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	24.9	12.6	7.0	14.6	6.6	15.5	17.0	10.5	9.0	21.4	9.0	27.3	13.4	23.6	18.6	38.7	25.7	18.5	40.6	6.1	7.2	18.6	26.7	21.0	16.5	6.9	7.1	22.2	15.1	29.6	7.8	22.2	6.8	25.8	24.0	15.8	19.1	30.2	71.8	32.5	16.3	35.4	6.0	16.3	18.2	40.3	8.1	24.4	20.0	98.8	21.0	26.3	21.9	8.5	32.8	12.7	22.2	22.0	33.9	41.6	15.6	49.3	62.3	43.0	44.5	12.6	26.8	19.4	29.7	56.7	76.7	21.2	91.5	46.1	75.6	16.1	9.5	34.1	17.5	14.4	36.5	31.5	33.4	35.4	67.1	50.0	58.0	32.2	25.8	17.1	22.3	21.1	43.7	16.5	36.4	25.9	9.4	25.7	18.2	20.6	43.1	12.4	38.0	35.4	14.7	18.7	20.0	14.8	21.2	20.4	18.6	22.2	33.0	46.8	44.2	29.9	50.5	28.6	32.1	16.3	36.8	35.2	34.5	9.5	6.5	7.7	6.6	4.7	7.2	5.1	8.1	9.9	6.6	7.5	6.6	7.1	5.8	8.8	7.3	2.3	5.7	3.6	7.0	6.6	10.5	9.0	6.1	7.2	6.9	7.1	6.8	6.0	8.1	8.5	37.2	54.5	38.7	43.8	27.9	84.2	50.6	32.6	38.7	15.8	26.5	19.4	79.6	18.6	32.3	27.6	14.6	29.3	31.7	35.0	21.5	29.9	162.4	145.1	64.7	28.8	25.2	16.6	47.0	34.9	29.1	31.9	28.5	57.4	21.6	20.3	21.8	33.0	21.6	35.3	47.3	34.5	22.4	20.5	31.0	319.2	27.4	29.2	19.6	38.4	37.5	20.7	28.8	54.3	43.1	32.2	27.9	36.9	26.2	53.9	23.4	26.4	85.1	41.0	32.9	54.1	43.1	98.7	48.8	55.0	91.5	75.5	35.0	32.8	25.6	58.3
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608106-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 76.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 29.8;Melanocytes: 14.2;monocytes: 22.9;Plasma cells: 49.2;T-cells: 35.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 66.3"	"Group enriched"	"Detected in many"	10	"B-cells: 22.7;T-cells: 66.3"	"Cell line enriched"	"Detected in some"	104	"HDLM-2: 195.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	NA	NA		350000	"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	1.1	0.5	0.0	13.6	0.0	6.6	1.6	0.0	0.1	1.1	0.3	2.6	3.7	0.4	0.1	1.4	0.4	2.3	1.1	0.0	0.0	0.9	0.9	2.1	21.6	0.3	0.0	0.4	0.3	0.1	0.1	3.0	0.1	0.6	3.0	0.0	1.7	0.3	0.3	0.7	3.9	0.9	0.1	6.7	3.9	0.2	0.1	76.6	0.6	0.0	19.1	8.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	195.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.4	0.0	1.8	0.0	0.1	0.2	0.0	10.7	0.0	66.3	16.5	46.3	33.0	0.3	22.7	17.5	4.4	0.6	0.0	0.1	4.4	61.7	9.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	1.4	0.0	5.2	0.0	29.8	2.0	0.1	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.6	1.8	0.0	0.0	4.8	0.0	0.0	0.0	4.1	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	10.7	8.5	0.0	5.2	14.2	1.0	22.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	49.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.8	0.1	0.1	0.0	1.7	0.1	35.6	0.0	0.1	0.1
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;dendritic cells: 19.7;Late spermatids: 22.1;NK-cells: 45.3;Plasma cells: 21.4;T-cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Daudi: 88.2;U-698: 127.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	1.7	1.1	0.2	20.6	0.2	3.2	2.2	0.8	0.4	2.0	0.3	3.8	2.7	1.3	1.4	2.1	1.3	4.6	1.0	0.2	0.1	0.9	4.0	4.4	61.7	0.3	0.1	1.2	0.9	0.2	0.2	1.8	0.3	1.3	3.5	0.1	2.2	0.5	0.4	0.6	13.8	1.4	0.1	32.2	5.5	1.2	0.4	19.3	1.7	0.5	48.6	5.7	1.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	6.7	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.8	0.1	0.0	0.0	21.8	1.3	0.1	0.7	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	14.2	127.4	0.0	0.6	0.0	11.2	0.3	23.1	56.1	1.0	38.9	36.2	35.6	71.4	0.3	35.4	19.5	39.5	2.5	41.3	3.1	1.0	45.6	22.2	0.2	0.2	0.8	0.4	0.2	0.1	0.3	0.1	0.3	0.1	0.4	0.3	0.1	0.0	1.3	0.0	23.6	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.1	9.4	0.1	0.1	0.3	0.0	3.2	0.0	0.2	0.0	0.4	0.5	0.1	1.3	0.0	3.3	1.1	1.1	0.0	0.0	0.0	0.0	4.3	0.8	22.1	0.0	1.1	0.0	0.0	1.6	0.0	45.3	0.0	0.0	0.1	0.1	0.0	21.4	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.3	0.0	26.1	0.0	0.0	0.0
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6;lymphoid tissue: 62.0;stomach 1: 34.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 58.3;monocytes: 120.2;NK-cells: 76.2;Plasma cells: 240.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 283.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"	2.2	3.0	0.2	34.6	0.2	9.7	11.3	0.2	0.6	3.4	0.7	32.6	32.2	2.2	1.7	5.9	2.1	8.7	1.6	0.2	0.2	1.4	7.9	14.5	50.8	0.4	0.2	2.3	1.1	0.4	0.3	1.4	0.6	2.6	28.6	0.0	13.7	2.4	0.5	1.7	25.5	3.7	0.4	42.3	34.2	1.4	0.3	14.7	1.6	0.2	62.0	22.2	2.1	0.5	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	1.0	0.8	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.2	0.0	7.6	0.0	2.5	0.7	0.0	0.2	0.0	7.2	0.0	0.0	0.1	0.0	0.2	1.4	0.0	0.1	0.1	10.0	0.0	0.8	0.0	0.1	0.0	0.0	59.5	0.0	0.0	0.1	0.2	0.0	3.8	0.0	0.2	283.7	26.4	0.2	7.9	0.2	0.0	0.2	5.1	1.4	100.5	34.8	77.3	11.0	10.2	69.0	23.6	2.3	3.0	40.1	3.5	55.5	53.1	89.7	0.0	33.6	0.2	0.2	0.2	0.6	0.2	0.2	0.4	0.2	0.6	0.4	0.3	0.5	0.4	9.6	6.0	0.0	37.4	0.8	1.6	0.3	0.0	0.0	0.2	0.6	1.3	1.5	1.0	0.0	0.0	0.1	58.3	0.2	0.0	0.7	0.0	0.2	0.2	1.4	0.0	3.6	0.0	2.7	0.1	1.7	1.5	0.4	8.8	0.0	0.7	0.6	8.4	0.0	0.0	0.0	0.0	7.3	9.2	0.1	0.0	28.2	19.6	1.0	120.2	0.0	76.2	0.0	0.0	8.6	0.0	0.0	240.9	2.5	0.0	0.2	1.7	0.0	0.0	4.8	1.3	0.0	0.1	0.7	0.4	0.3	37.1	0.0	0.4	3.7
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826811-159837492	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	9	"Hofbauer cells: 36.9;Kupffer cells: 19.8;Langerhans cells: 61.8;Macrophages: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 14.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.7;HL-60: 1.4;U-138 MG: 1.9;U-87 MG: 1.0;U-937: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA067601: AB_2685870"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	6.9	3.7	1.7	29.8	1.8	0.9	3.0	1.8	3.6	3.8	2.9	7.6	6.6	1.5	0.7	4.2	2.8	8.0	2.6	1.4	2.3	3.9	3.3	16.1	32.9	4.9	3.9	2.8	2.1	0.6	3.5	5.5	5.3	2.5	9.5	0.3	3.4	1.4	0.9	2.8	9.3	7.6	2.5	11.7	4.9	0.8	9.2	10.5	3.0	0.6	17.7	10.3	2.1	4.9	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	1.0	1.2	0.0	0.0	5.8	0.0	3.5	8.0	0.2	0.0	1.2	4.6	14.3	0.0	0.2	2.7	0.5	8.8	0.5	0.1	0.0	3.1	1.7	1.8	1.8	3.6	1.4	2.3	4.9	3.9	5.3	2.5	9.2	4.9	0.3	0.0	2.3	0.0	1.0	1.8	0.0	0.0	0.0	0.4	0.1	0.4	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.8	0.0	0.4	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.2	36.9	0.0	0.1	0.0	0.0	19.8	61.8	0.0	0.3	41.1	0.0	1.0	1.3	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	2.9	0.1	0.0	0.0	1.0	0.5	1.3	0.0	0.0	0.0
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954237	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Langerhans cells: 53.9;Late spermatids: 38.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HEL: 5.1;PC-3: 2.0;SK-MEL-30: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"		"Cluster 36: HEL - Hemostasis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	0.5	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.5	0.4	0.8	0.0	0.7	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.4	9.4	0.0	0.0	1.0	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.7	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.8	6.8	0.0	0.0	0.0	0.0	1.3	53.9	38.5	0.3	7.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.9	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.7
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	164	"liver: 426.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 147.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.4	0.1	0.5	0.3	0.0	2.5	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.1	426.9	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.5	2.5	1.2	0.8	0.4	0.4	0.4	0.3	0.0	0.5	0.5	0.4	0.0	0.0	1.3	0.6	0.1	0.1	0.4	0.0	0.6	0.2	0.1	0.5	5.7	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	1.1	0.1	0.6	0.7	0.0	2.7	4.2	0.0	0.1	0.6	0.5	0.6	0.0	0.1	1.4	147.2	0.1	0.0	2.7	0.0	2.0	3.8	0.0	5.4	0.0	0.3	0.0	2.8	0.0	0.2	0.0	3.0	2.4	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	0.0	3.4	0.7	0.1	0.0	0.2	0.0	0.3	1.7	0.2	0.0	0.1
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066417	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 80.8"	"Cell type enriched"	"Detected in some"	29	"Proximal enterocytes: 371.2"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	16.9	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	80.8	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.2	0.5	0.3	0.5	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	371.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 63.6;Syncytiotrophoblasts: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"basophil: 218.6"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 218.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	23.3	22.9	6.1	13.1	6.2	34.0	21.0	6.8	7.9	27.1	5.8	22.5	13.9	29.6	18.4	31.2	22.8	21.3	23.2	5.9	6.1	20.6	10.3	22.7	15.1	7.4	6.8	40.8	22.8	9.6	18.8	21.1	7.4	22.9	8.3	2.0	17.4	15.7	18.3	42.9	18.7	13.5	6.9	19.3	18.9	8.9	8.1	9.8	20.6	9.4	11.2	31.8	26.0	7.7	66.4	27.0	7.3	38.3	25.2	27.6	48.9	49.2	29.2	32.5	32.3	25.0	31.8	51.0	91.1	46.8	41.3	55.9	24.4	24.7	8.6	32.7	11.8	15.9	36.0	20.3	47.0	19.0	24.9	34.8	28.1	29.9	15.8	28.5	22.6	8.7	17.6	48.6	21.6	90.0	10.2	17.0	5.9	32.4	54.9	16.8	19.9	38.8	24.7	24.2	6.8	12.0	29.8	55.4	13.0	8.5	17.9	15.0	29.5	38.0	23.9	89.6	63.2	34.3	35.6	52.8	40.9	39.6	20.2	218.6	4.5	21.1	12.9	6.5	9.6	5.3	8.5	9.2	3.9	5.2	6.0	5.9	6.1	8.8	5.6	9.5	6.4	6.3	6.1	6.2	6.8	7.9	5.9	6.1	7.4	6.8	7.4	6.9	8.1	7.7	13.3	3.2	7.0	2.3	21.1	22.6	27.1	15.2	50.7	2.8	13.7	11.8	4.0	15.7	7.3	18.4	6.2	49.5	17.4	22.1	7.9	17.8	3.6	13.0	14.8	15.8	10.2	11.1	1.6	19.4	63.6	21.2	13.7	21.0	12.7	15.8	16.8	2.3	19.4	3.3	1.4	15.5	4.1	8.4	19.6	1.2	27.1	22.7	3.6	1.0	13.2	3.0	23.7	1.5	1.6	20.9	16.0	13.2	19.8	14.1	17.2	10.4	6.9	1.9	6.6	12.1	14.3	1.9	2.9	45.5	27.8	103.0	24.5	5.4	11.7	23.5
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.8"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.5	0.2	1.8	1.1	0.1	0.0	4.6	0.9	0.0	1.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	9.0	0.2	0.1	0.2	0.0	8.6	36.8	0.1	0.1	0.0	6.7	0.0	23.3	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.6	0.1	0.5	0.4	3.8	0.0	0.4	0.0	0.0	0.1	0.6	2.6	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	4.6	0.2	9.0	8.6	36.8	23.3	0.6	3.8	2.6	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693631-81695058	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.9;liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 4.1;Enteroendocrine cells: 3.6;Gastric mucus-secreting cells: 6.1;Hepatocytes: 2.8;Proximal enterocytes: 7.2;Respiratory ciliated cells: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.6"	"Not detected"	"Not detected"							HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.1	0.2	0.9	0.3	0.9	0.0	0.2	1.8	1.4	0.3	0.0	2.8	3.2	0.3	0.7	0.3	0.3	1.7	0.2	0.8	0.9	1.8	11.3	0.2	0.0	0.6	0.7	0.3	1.0	0.2	1.0	0.0	0.7	0.6	3.7	0.5	0.3	0.2	0.2	0.4	3.9	0.2	0.2	0.3	3.4	0.1	1.0	0.1	0.5	0.3	0.2	0.3	0.2	0.8	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.5	0.0	0.0	0.2	0.3	0.1	0.2	0.2	0.8	0.6	1.3	0.5	0.1	0.0	0.1	0.1	0.6	0.2	0.8	0.6	0.1	0.2	0.5	0.3	0.3	0.2	0.2	0.4	0.0	3.6	0.2	0.0	0.1	0.2	0.2	1.4	0.5	0.3	0.1	0.2	0.1	0.1	0.5	0.1	0.3	0.3	0.5	0.4	0.5	0.3	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.8	1.4	0.8	0.9	0.6	0.7	0.7	0.2	1.0	0.8	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.1	1.9	0.4	0.0	0.4	0.3	0.2	3.6	0.0	0.9	1.1	0.1	0.1	6.1	0.3	0.0	0.3	0.7	2.8	0.0	0.0	0.8	1.5	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	1.9	0.0	0.0	0.4	7.2	1.7	4.1	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.4	0.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849384	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1;skin 1: 13.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 59.5;Late spermatids: 191.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016662	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	5.2	0.3	0.1	0.7	0.3	0.0	2.8	0.1	0.2	3.1	0.0	0.4	0.1	0.5	0.3	9.1	0.6	1.0	0.7	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.3	0.1	0.7	0.6	0.2	0.1	0.3	0.4	0.3	0.0	1.5	0.2	0.7	13.4	0.2	1.0	0.1	0.2	0.3	4.3	0.9	0.3	1.0	1.1	1.2	0.9	4.7	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.1	0.9	0.7	9.3	0.0	0.0	6.2	0.0	13.8	0.0	0.8	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	1.7	1.0	2.6	0.0	0.0	2.5	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.2	191.7	1.5	0.1	0.0	2.8	0.0	0.0	0.0	3.5	4.8	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.2	1.2	0.6	6.0	24.9	0.0	0.0	0.0	0.0	0.2
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	5.4	4.6	2.6	4.9	4.0	6.0	6.0	3.2	2.6	7.2	1.7	7.0	4.6	4.9	12.0	5.8	4.4	5.6	2.9	2.9	3.6	3.8	7.2	5.9	5.6	4.6	3.8	5.6	6.5	3.7	3.6	8.9	4.9	6.3	9.2	3.9	6.9	3.3	2.2	3.7	5.4	5.9	3.8	5.3	9.7	3.4	3.5	6.5	7.0	3.2	5.9	4.7	4.8	5.1	5.2	1.7	12.2	5.0	8.6	10.3	5.8	6.3	8.2	5.7	5.8	4.7	21.6	9.6	4.4	6.9	3.6	5.2	7.2	8.6	6.8	11.1	3.5	11.8	4.2	8.5	5.5	20.5	18.3	4.9	6.8	6.9	8.7	3.1	10.2	10.2	13.2	25.6	4.3	3.6	15.6	5.2	2.2	11.4	8.6	8.6	8.9	13.7	4.0	3.8	3.7	3.1	4.3	12.8	5.3	6.4	7.5	8.1	5.8	5.1	5.4	7.8	4.4	20.7	24.9	13.4	7.0	8.2	7.4	10.9	3.0	4.5	3.7	4.8	3.8	3.9	3.7	3.3	4.0	2.8	3.5	3.4	0.3	5.1	3.9	2.7	4.9	2.2	2.6	4.0	3.2	2.6	2.9	3.6	4.6	3.8	4.9	3.8	3.5	5.1	10.8	3.2	3.9	44.4	7.9	3.3	4.2	2.0	2.8	6.8	5.2	3.7	2.1	8.6	3.2	1.8	4.2	6.4	8.2	6.2	1.9	4.0	2.3	4.8	6.2	5.4	4.8	9.9	34.3	5.1	13.2	6.1	11.2	6.0	22.9	5.8	8.9	10.3	5.8	8.4	37.1	14.7	2.0	7.3	3.1	1.2	7.5	6.1	0.0	50.6	4.9	3.4	6.2	62.4	82.0	3.6	3.4	4.9	15.8	3.3	4.2	1.9	7.3	11.8	0.0	4.0	5.5	7.0	4.5	5.2	4.8	6.2	8.6	2.3	7.6	4.1
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 78.6;lymphoid tissue: 46.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	14.1	8.5	3.5	7.1	4.3	6.7	4.9	3.9	11.1	2.7	4.7	3.5	0.2	2.2	0.1	1.6	7.4	1.0	8.0	3.3	5.0	3.4	5.1	78.6	0.2	7.4	5.2	1.7	3.2	0.3	3.1	2.7	6.9	3.2	0.0	0.6	3.2	0.1	1.7	1.5	2.2	1.9	5.2	46.6	3.0	0.9	17.3	0.3	2.7	1.3	0.0	7.2	2.4	7.4	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.2	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	6.1	0.6	0.3	4.5	0.2	0.1	0.2	0.1	1.9	0.2	0.3	0.2	4.1	0.2	6.0	0.2	0.2	2.0	3.5	4.3	3.9	11.1	3.3	5.0	7.4	5.2	6.9	5.2	17.3	7.4	1.5	22.4	38.5	1.6	4.1	0.9	4.3	1.9	1.2	3.1	4.5	4.6	8.6	2.8	13.8	9.2	0.0	1.8	3.1	1.8	9.8	1.3	1.8	6.1	2.3	17.0	1.2	1.7	1.3	2.1	7.8	5.8	2.0	2.8	25.3	0.9	6.8	7.3	108.0	1.7	0.9	4.0	6.1	166.8	6.3	0.5	2.1	209.4	1.8	4.7	101.2	12.9	10.3	0.5	1.4	0.4	1.6	0.7	5.6	3.9	2.5	11.7	11.0	3.3	19.7	2.9	4.2	0.8	1.8	2.1	1.0	8.1	6.7	3.3	2.9	3.3
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189677	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 75.6"	"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 153.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	8.4	17.5	15.0	10.8	48.4	4.4	43.9	46.3	23.2	7.2	40.4	48.5	41.7	8.4	2.4	4.6	6.0	39.4	6.1	13.5	31.1	6.6	4.2	10.3	5.6	40.8	43.1	5.4	6.1	14.7	5.5	4.9	38.6	23.5	58.9	16.8	75.6	2.6	15.4	28.4	49.1	10.2	27.1	4.5	61.8	8.0	32.4	4.1	8.6	8.3	6.0	7.3	3.5	64.8	13.5	65.3	65.8	25.6	16.1	10.4	13.6	12.2	9.1	8.6	8.9	26.4	20.9	19.9	16.1	10.6	7.8	39.5	12.7	14.0	13.2	20.0	15.8	5.7	11.4	3.8	4.9	7.3	9.5	11.1	5.0	19.1	11.2	6.4	14.2	8.5	9.4	13.2	13.4	14.2	13.0	6.1	7.7	153.6	21.1	7.1	18.5	8.2	10.0	45.0	11.5	7.3	24.6	10.6	9.9	7.0	5.9	3.7	24.1	21.2	14.2	16.3	15.7	11.0	10.7	21.6	11.2	4.2	17.6	0.3	0.4	0.2	1.1	0.7	1.9	1.7	1.0	1.4	0.6	2.1	1.1	1.6	0.2	2.4	0.5	6.4	1.1	0.3	15.0	48.4	46.3	23.2	13.5	31.1	40.8	43.1	38.6	27.1	32.4	64.8	38.3	16.0	46.2	23.8	20.5	22.9	20.1	44.9	10.8	76.6	186.9	86.7	18.0	137.2	52.1	33.1	127.2	1.4	34.4	48.2	1.9	68.6	55.8	33.1	43.1	44.2	74.4	2.5	160.6	48.2	2.7	21.3	199.3	38.4	18.4	28.8	12.8	8.8	4.2	80.8	73.2	480.6	57.0	8.6	12.0	95.3	85.4	11.4	204.5	105.9	2.5	22.6	11.3	55.3	566.6	50.1	60.6	29.0	20.2	131.6	38.8	10.6	19.6	86.4	72.3	33.9	64.3	29.1	27.1	14.9	30.0	1.4	21.1	14.1	370.0	21.5
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041138	Approved		Approved	Endosomes		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Endosomes		"HPA041138: AB_10794544"	"unprognostic (5.07e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.26e-1)"	30.2	29.1	11.0	11.8	13.6	5.0	28.9	15.2	10.9	33.5	60.6	32.4	7.2	34.0	8.6	13.0	27.5	14.7	46.1	10.8	13.7	20.2	17.4	34.7	9.4	17.5	17.0	23.9	19.1	23.2	13.0	27.2	14.8	30.4	5.8	3.7	18.0	26.8	20.9	24.3	16.5	27.3	14.9	15.4	18.6	12.3	14.8	12.0	35.4	16.8	5.7	27.3	23.2	15.3	13.4	17.5	13.3	25.3	43.0	37.5	71.6	39.9	41.1	33.5	29.1	35.2	20.8	4.7	19.3	55.3	18.7	23.7	6.2	49.2	25.2	4.8	5.3	3.4	23.4	38.9	48.7	0.4	16.0	41.6	31.6	45.3	16.3	39.1	21.0	8.6	10.9	3.8	46.6	2.1	5.2	13.3	10.0	3.8	9.2	5.3	25.1	4.4	18.5	11.4	0.1	8.0	76.1	4.5	6.8	32.8	35.8	5.4	28.8	47.6	33.4	21.4	17.6	23.2	6.3	8.0	27.9	3.6	42.1	7.1	2.5	1.2	0.8	3.3	0.5	0.3	0.5	0.5	1.4	0.5	0.4	0.4	0.9	1.9	2.4	0.7	0.9	1.1	11.0	13.6	15.2	10.9	10.8	13.7	17.5	17.0	14.8	14.9	14.8	15.3	25.8	16.0	9.1	10.4	2.4	10.1	15.8	13.3	17.6	1.2	3.9	6.6	26.9	2.8	10.6	14.7	0.0	30.1	2.2	0.5	0.0	13.7	3.5	4.0	10.7	15.6	0.0	2.5	0.2	8.3	16.4	19.5	3.1	3.2	1.3	10.9	12.1	10.3	8.0	0.0	0.3	0.1	24.4	5.3	4.3	2.7	19.9	4.2	10.6	4.7	11.4	20.5	3.1	2.0	0.7	15.5	0.1	36.5	10.8	16.9	0.1	5.3	8.3	1.0	39.5	17.3	23.1	12.0	9.1	2.4	5.3	63.5	2.6	13.9	0.2	12.9
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060150	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 145.8;retina: 117.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 244.0;Cone photoreceptor cells: 383.7;Excitatory neurons: 92.7;Inhibitory neurons: 91.3;Rod photoreceptor cells: 170.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.9;NB-4: 50.8;SK-BR-3: 24.8;U-2 OS: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA072058: AB_2686485"	"unprognostic (2.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.44e-4)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.61e-4)"	"unprognostic (8.78e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-2)"	1.5	26.7	101.3	0.9	103.5	0.4	1.0	97.6	145.8	0.9	14.9	1.4	1.0	0.7	0.9	0.4	0.5	0.7	5.1	107.0	96.6	1.1	1.2	2.5	2.2	76.3	80.5	2.3	2.2	1.8	41.5	2.0	69.9	1.0	0.9	117.4	0.7	0.5	0.4	0.6	1.6	0.4	69.3	3.0	1.9	7.8	86.7	2.9	0.7	0.2	1.4	0.6	0.7	88.4	0.0	15.2	6.6	4.9	0.6	0.0	1.5	0.6	0.0	0.0	0.5	2.0	0.0	5.8	22.5	0.4	5.9	1.4	4.3	2.3	0.4	3.7	5.7	4.9	3.0	24.9	2.5	0.0	6.5	0.8	0.0	0.0	0.3	10.0	1.4	5.4	9.3	0.0	0.0	23.1	3.5	50.8	2.4	2.1	7.7	5.8	4.2	1.3	2.3	0.0	8.1	11.5	2.9	24.8	7.9	6.0	9.0	14.4	2.3	2.7	28.0	0.2	1.1	0.0	4.2	8.2	5.9	5.9	0.2	0.0	0.6	0.0	1.1	0.4	0.5	0.4	0.1	0.1	0.1	0.5	2.4	1.3	0.0	0.4	0.1	0.0	1.9	0.3	101.3	103.5	97.6	145.8	107.0	96.6	76.3	80.5	69.9	69.3	86.7	88.4	2.2	0.0	0.0	10.4	0.4	0.5	0.0	0.0	0.0	244.0	0.8	2.2	1.2	0.0	0.0	0.0	383.7	1.6	0.9	0.0	1.9	0.1	1.9	0.4	0.1	2.9	19.9	4.4	92.7	0.2	2.5	0.4	1.5	0.6	0.0	14.4	4.6	1.3	19.8	13.5	91.3	0.7	0.0	2.6	5.3	6.1	0.0	3.4	5.4	10.3	0.6	28.2	0.0	3.5	6.3	0.4	0.0	0.0	0.8	0.2	0.0	0.3	0.0	170.9	0.0	0.0	2.2	4.2	7.7	0.1	0.6	1.6	1.0	8.5	0.3	0.1
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229784-34338060	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 15.2;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	6.4	4.0	5.9	11.5	7.4	26.8	5.5	7.2	7.9	11.9	2.5	5.5	7.3	5.2	7.0	18.8	4.6	5.2	7.3	6.5	7.3	15.9	3.9	9.1	10.1	8.9	7.3	4.2	3.5	3.1	5.6	4.3	9.3	3.5	6.1	31.1	6.4	3.8	10.6	7.6	9.1	4.9	6.6	12.9	6.7	25.9	7.7	15.5	9.0	10.9	11.6	8.3	17.6	8.4	4.4	5.2	3.1	4.7	10.0	11.4	2.4	5.9	15.1	4.9	7.1	3.1	7.2	3.1	5.9	7.2	4.3	44.0	7.9	5.3	5.8	1.2	5.1	24.6	14.0	7.0	6.4	14.5	24.6	6.9	9.1	14.1	29.1	10.9	14.9	6.8	5.4	6.8	6.7	1.6	1.6	11.0	2.4	3.8	5.7	7.1	5.5	3.3	5.5	11.2	7.2	5.0	7.1	0.2	1.5	7.1	2.8	4.8	9.4	5.9	4.2	21.0	1.4	6.4	6.8	1.9	6.6	10.5	2.2	15.2	1.4	2.6	0.6	1.8	0.4	1.4	0.9	0.9	0.9	2.4	1.6	1.4	23.4	0.7	0.8	1.0	3.2	1.0	5.9	7.4	7.2	7.9	6.5	7.3	8.9	7.3	9.3	6.6	7.7	8.4	16.4	22.4	21.0	30.0	32.0	1.1	4.5	1.5	7.4	15.3	5.2	4.3	8.7	5.7	4.2	5.5	85.5	3.2	11.5	8.6	0.0	5.6	15.6	9.8	7.4	17.7	6.7	35.9	47.7	4.7	1.6	7.0	17.9	22.4	5.1	8.4	16.1	7.5	13.2	8.4	52.0	7.0	2.0	37.1	3.8	8.3	8.1	25.6	0.0	50.6	34.5	8.7	15.5	40.7	58.4	13.1	9.7	8.6	29.9	6.5	18.3	16.4	4.2	56.6	19.7	7.0	4.0	39.9	21.2	14.8	0.9	1.1	18.0	4.1	7.4	43.6
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050384-1112063	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.3"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	21.1	14.6	8.9	7.2	8.0	4.0	18.8	7.2	10.4	15.8	12.3	24.1	24.0	13.8	1.0	8.0	16.6	12.0	77.3	7.9	12.0	45.1	72.4	23.1	5.7	8.0	10.7	12.3	27.6	4.4	20.5	2.9	8.0	20.7	5.4	5.5	18.9	3.0	6.3	15.8	31.9	3.3	6.8	34.9	28.1	29.9	9.4	7.8	24.7	3.1	2.2	14.5	10.8	7.1	3.8	10.0	5.5	17.3	0.8	0.9	8.7	0.2	1.1	0.8	0.0	24.5	6.4	0.0	20.0	0.3	6.8	7.6	4.6	6.1	0.0	23.0	6.1	4.8	13.4	8.6	12.2	0.0	10.4	1.8	0.8	0.0	1.8	0.3	5.5	2.2	7.6	0.2	0.0	12.0	14.8	0.1	11.9	14.4	16.3	43.9	24.0	20.5	6.5	14.8	3.1	3.8	5.6	0.1	6.0	3.3	9.7	2.7	4.8	0.0	5.7	0.0	0.0	0.3	0.0	2.5	0.0	0.6	2.8	0.2	1.8	0.0	1.1	2.7	1.2	0.6	1.1	1.3	2.1	0.6	1.2	1.2	0.0	1.4	3.8	0.9	1.1	1.3	8.9	8.0	7.2	10.4	7.9	12.0	8.0	10.7	8.0	6.8	9.4	7.1	21.3	9.6	15.2	8.5	7.3	7.0	6.3	8.9	6.8	25.3	18.4	13.8	35.8	31.5	13.6	29.5	2.1	0.2	14.2	42.0	1.9	23.5	0.4	40.9	11.0	27.9	13.2	19.1	0.3	18.1	0.4	11.6	39.8	63.4	8.2	16.6	11.7	34.5	19.8	281.0	0.5	19.4	18.3	28.0	19.8	1.9	3.7	29.0	16.0	14.0	9.1	5.2	5.2	1.5	0.0	28.8	35.8	5.7	5.3	15.7	27.3	23.2	23.1	3.6	19.7	5.2	8.4	1.0	3.4	3.5	6.8	0.3	9.8	5.4	19.3	15.2
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867010	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	6.9	8.1	7.4	8.7	11.2	7.6	6.3	10.7	10.8	8.3	6.5	8.3	7.8	8.2	1.2	7.3	6.7	9.5	4.2	7.3	8.7	7.4	6.8	8.2	7.3	12.5	10.6	6.7	10.5	6.3	3.6	14.0	11.4	8.0	5.6	0.7	7.4	6.4	2.6	7.9	8.3	6.7	10.1	14.1	7.0	2.7	9.3	5.9	5.8	3.1	3.8	9.2	6.1	13.1	16.1	12.4	4.2	33.9	12.4	7.3	42.2	7.9	15.1	11.7	16.6	17.7	26.7	11.5	25.1	15.0	18.8	17.3	7.3	17.6	3.1	12.3	12.1	4.4	13.8	12.6	15.1	5.4	18.0	18.0	9.9	9.3	9.4	9.5	23.2	9.1	10.5	6.1	16.8	49.8	5.7	25.5	8.3	33.3	24.6	13.3	4.2	17.9	11.6	14.3	7.0	15.8	8.7	61.7	16.7	7.0	7.7	19.1	14.5	14.4	14.3	23.8	14.4	3.2	13.7	4.0	10.2	18.0	17.4	0.0	1.5	0.0	0.2	1.8	0.3	0.6	0.1	0.1	2.4	0.6	0.2	0.1	1.4	0.2	1.9	1.2	0.3	0.9	7.4	11.2	10.7	10.8	7.3	8.7	12.5	10.6	11.4	10.1	9.3	13.1	10.6	3.2	16.1	3.9	12.3	11.0	12.0	6.9	10.8	6.6	12.6	11.0	2.1	11.5	10.1	18.4	2.1	90.0	21.7	14.1	0.0	12.7	0.9	5.6	9.1	13.6	11.4	1.7	2.0	13.4	28.2	10.2	18.3	9.5	1.3	14.7	15.7	6.9	31.2	6.7	2.6	13.6	10.2	23.9	18.3	0.7	9.0	27.2	8.8	3.7	24.6	18.7	8.2	6.0	5.8	14.9	23.7	6.4	9.7	8.3	14.7	10.9	4.8	6.7	13.1	9.4	7.3	1.7	7.8	12.9	11.4	50.2	13.4	17.2	19.6	9.6
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 81.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 452.1"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053615, HPA062714"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	0.1	27.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	75.3	452.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.1	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 119.6;kidney: 38.2;salivary gland: 44.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 290.2;Proximal tubular cells: 97.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014963	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	6.1	119.6	0.0	3.0	0.0	0.0	6.8	0.0	0.0	0.0	38.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.8	44.9	11.4	0.0	3.1	90.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	13.7	10.9	0.6	27.1	1.6	3.7	12.5	0.0	0.7	29.3	9.8	0.7	0.0	0.0	0.0	0.2	4.8	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	31.4	0.0	0.0	0.4	0.0	0.0	0.7	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	15.7	0.0	0.0	0.0	290.2	97.8	0.3	0.4	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	25.8	0.5
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"choroid plexus: 809.0"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 786.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 45.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.0	0.0	1.6	0.0	0.7	0.0	0.0	9.2	3.4	0.7	809.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.1	45.4	0.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.2	0.0	1.4	54.4	0.6	0.0	0.0	2.3	0.5	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	3.9	12.9	0.0	0.0	0.0	2.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	30.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	9.2	3.4	45.4	0.7	0.9	1.7	0.6	0.7	12.9	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.1	0.0	3.4	0.1	0.1	1.9	0.0	0.1	0.0	4.2	189.9	0.0	0.0	0.0	0.2	0.6	0.5	0.5	1.0	0.0	0.0	2.7	0.0	9.5	1.2	0.0	0.1	0.0	0.1	0.0	0.0	14.9	3.3	3.0	0.0	0.0	0.0	0.3	0.5	0.3	0.4	0.0	1.0	0.0	2.1	0.0	3.5	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.1	4.3	14.9	0.0	0.6	0.3	0.3	0.5	0.0	0.1	786.0	0.1	0.1	0.0	0.4
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;prostate: 78.3;urinary bladder: 90.9"	"Group enriched"	"Detected in many"	7	"Adipocytes: 136.6;Astrocytes: 228.5;Basal prostatic cells: 313.4;Erythroid cells: 102.5;Prostatic glandular cells: 192.6;Urothelial cells: 249.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 4.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"GAMG: 273.4;RT4: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	3.4	1.6	70.2	1.0	97.1	15.2	2.0	110.5	53.6	3.6	24.9	1.7	1.3	0.5	0.7	0.4	0.3	10.1	23.7	60.5	96.0	37.9	1.1	4.3	2.3	109.4	131.0	0.3	1.7	0.9	1.0	1.6	114.2	78.3	1.3	0.3	2.3	3.0	3.9	4.1	3.4	0.5	97.7	4.6	1.8	0.2	133.8	7.7	6.4	7.8	2.3	90.9	2.2	104.6	0.0	0.4	0.0	0.1	0.0	0.2	0.7	0.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	273.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	38.3	0.0	0.2	0.0	0.2	0.3	0.1	0.9	0.3	0.0	0.3	0.2	0.0	0.0	0.2	3.0	113.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.5	0.9	0.1	4.1	0.2	0.1	2.7	1.3	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.3	0.9	0.9	0.0	0.3	0.2	1.5	0.0	0.9	0.0	0.1	4.1	0.6	70.2	97.1	110.5	53.6	60.5	96.0	109.4	131.0	114.2	97.7	133.8	104.6	136.6	0.0	0.6	228.5	3.1	0.3	313.4	0.1	0.6	0.3	5.4	1.5	10.9	5.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.6	0.0	0.1	28.7	0.0	102.5	0.6	0.2	0.1	3.8	0.0	0.1	0.0	0.2	21.4	0.3	0.1	0.0	0.7	0.2	18.3	0.6	0.3	0.4	0.0	2.0	12.4	5.6	0.1	0.0	5.2	3.5	0.7	0.3	0.0	1.2	2.1	192.6	0.0	0.0	0.0	0.2	0.0	1.7	3.7	0.1	0.2	0.2	0.4	0.0	6.1	0.1	0.0	249.9
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 203.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.3	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.4	4.5	151.6	5.5	5.9	2.1	0.1	43.1	0.0	0.2	0.6	6.1	18.2	0.1	0.3	0.3	0.6	0.1	8.3	20.6	0.3	0.1	0.4	1.4	2.7	0.0	0.5	0.5	0.7	23.2	203.0	0.4	0.1	0.1	1.2	0.2	1.4	0.2	0.3	0.0	0.6	2.5	3.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.6	0.4	0.2	0.6	0.3	0.6	0.4	0.1	1.4	0.7	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937060-60952653	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 90.6;Kupffer cells: 59.3;Macrophages: 65.5;monocytes: 70.9;Muller glia cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.0;intermediate monocyte: 12.8;memory B-cell: 4.9;myeloid DC: 6.5;neutrophil: 13.4;non-classical monocyte: 6.4;plasmacytoid DC: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.4;BJ hTERT+ SV40 Large T+: 58.0;BJ hTERT+ SV40 Large T+ RasG12V: 74.0;HHSteC: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.5	12.8	11.6	30.7	10.3	35.3	18.2	10.7	15.1	19.7	13.0	34.9	12.0	13.9	3.9	9.3	18.2	19.1	27.1	9.7	13.1	14.9	15.1	52.2	40.1	14.5	10.9	29.2	6.5	4.4	8.4	27.5	13.8	16.7	9.4	17.5	10.0	8.5	6.4	7.9	28.7	15.1	13.5	63.9	18.5	5.5	14.3	12.9	10.5	10.1	15.7	15.6	17.6	15.5	4.3	0.0	2.2	0.0	12.6	9.9	23.4	1.2	21.8	58.0	74.0	0.1	1.9	9.7	0.3	8.8	14.2	1.7	0.0	0.7	3.4	9.4	0.0	0.1	0.1	0.6	34.9	0.0	0.9	6.6	0.0	15.3	0.0	0.1	2.8	0.0	0.0	0.5	3.6	0.5	0.0	1.8	9.8	0.0	0.1	3.9	0.0	3.3	0.0	1.3	0.0	0.1	2.8	9.6	0.4	0.4	4.2	5.7	0.3	0.3	1.2	1.0	0.1	0.0	0.0	3.8	3.9	0.0	13.7	0.0	9.0	1.2	0.1	12.8	0.0	4.9	0.0	0.0	6.5	1.9	0.9	0.9	13.4	0.0	6.4	10.7	0.0	2.4	11.6	10.3	10.7	15.1	9.7	13.1	14.5	10.9	13.8	13.5	14.3	15.5	19.3	9.6	13.2	0.0	7.7	1.7	0.2	4.5	2.2	1.6	0.7	1.4	2.5	1.5	3.7	0.0	0.0	3.6	9.6	1.1	0.0	0.3	7.9	0.1	2.0	12.6	0.0	0.4	0.1	2.2	15.1	5.6	1.1	0.3	15.2	3.7	20.3	3.1	90.6	5.0	0.0	1.2	2.0	59.3	35.5	3.8	8.1	65.5	1.8	4.7	70.9	211.7	1.0	0.0	0.1	2.2	2.8	4.9	2.0	0.1	0.3	0.1	3.1	5.5	13.1	3.1	3.0	4.2	0.7	0.6	1.4	2.6	1.9	4.5	1.1	0.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793194-128823958	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 125.8;Early spermatids: 92.3;Late spermatids: 110.1;Muller glia cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 31.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	11.0	6.3	3.5	10.8	4.8	22.1	9.0	5.3	4.3	10.1	27.4	6.8	6.0	12.5	5.0	9.4	9.2	10.4	9.9	3.8	4.7	7.3	15.1	10.1	17.5	6.2	4.4	10.3	7.7	7.5	3.6	9.6	6.4	7.6	5.7	23.3	6.1	8.8	27.8	10.1	6.0	12.5	5.6	11.5	7.4	11.3	4.6	11.4	7.5	19.9	19.6	10.3	7.2	7.6	12.0	19.3	4.9	10.8	41.9	26.9	17.9	20.6	17.1	14.3	16.1	8.9	16.9	43.7	10.6	18.0	14.3	13.5	13.5	12.8	15.5	21.6	12.5	6.0	11.1	15.8	43.7	20.2	6.2	17.4	22.9	11.9	31.0	42.9	10.1	8.8	9.9	26.9	29.5	8.4	10.8	5.5	17.4	13.0	11.3	9.0	10.6	17.2	28.3	15.4	8.8	7.3	8.5	15.8	22.5	13.1	21.0	5.8	15.5	15.9	8.9	8.1	12.7	9.0	21.1	20.3	21.5	14.2	0.2	0.0	2.8	7.2	7.3	3.8	3.6	2.9	1.3	4.4	1.7	2.8	1.4	3.5	18.8	6.8	1.6	31.8	0.7	3.1	3.5	4.8	5.3	4.3	3.8	4.7	6.2	4.4	6.4	5.6	4.6	7.6	8.6	19.2	8.0	15.7	14.8	10.3	8.7	10.4	8.6	11.4	10.2	12.3	8.5	12.8	9.0	22.0	12.5	5.5	125.8	4.5	1.9	24.9	92.3	9.3	14.1	6.5	10.8	11.8	23.6	11.1	7.0	14.5	6.6	40.1	11.4	9.7	12.8	20.0	22.0	15.2	23.0	4.4	4.1	24.6	28.2	110.1	12.5	24.5	24.9	21.5	33.0	91.6	45.3	37.7	25.7	24.8	6.8	13.5	11.6	9.3	5.5	6.1	5.1	15.6	6.6	14.4	11.4	51.1	10.6	7.5	9.1	4.0	16.7	10.8	6.5	6.9
SLC15A5		ENSG00000188991	"Solute carrier family 15 member 5"	A6NIM6	12	16188485-16277685	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Astrocytes: 2.0;Early spermatids: 4.2;Excitatory neurons: 1.1;Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041638	Uncertain					NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041638: AB_2677590"	"unprognostic (3.68e-3)"				"unprognostic (1.64e-1)"								"unprognostic (4.89e-6)"		"unprognostic (1.34e-1)"	"unprognostic (1.72e-3)"		0.2	0.0	0.4	0.0	0.4	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034982-230068993	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 11.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	4.6	3.9	7.9	1.7	7.2	5.6	3.2	8.9	7.7	5.0	2.4	3.7	1.0	3.9	2.3	4.0	3.1	2.8	2.4	7.1	7.2	2.3	2.0	1.9	1.3	5.2	6.1	7.3	0.8	7.0	1.4	1.2	4.7	4.5	4.0	2.5	18.6	3.6	1.0	11.0	1.3	3.8	3.8	5.9	1.4	1.2	9.4	2.2	1.5	2.0	1.5	2.0	2.7	4.7	2.9	1.6	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.3	0.1	0.0	0.5	5.1	1.4	0.1	0.0	9.7	0.2	3.1	0.0	0.3	24.2	0.0	0.5	3.6	0.0	0.0	3.9	0.2	4.7	0.0	15.2	0.3	0.0	2.4	2.7	1.0	0.3	2.7	19.5	0.0	17.3	5.6	2.6	6.3	2.3	4.9	0.0	0.1	0.1	7.7	1.9	0.0	0.0	1.3	3.3	2.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	11.3	0.4	0.0	0.3	0.3	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	7.2	8.9	7.7	7.1	7.2	5.2	6.1	4.7	3.8	9.4	4.7	17.0	0.0	0.0	2.3	1.5	2.5	0.5	1.9	3.4	3.3	1.2	0.8	3.9	0.0	3.5	0.0	2.1	0.0	0.1	1.8	0.0	0.8	0.0	0.5	2.6	10.8	3.6	0.0	18.5	0.6	0.0	2.3	0.0	0.3	0.0	0.2	4.2	2.1	0.1	3.3	21.1	0.3	4.1	0.3	0.6	0.0	1.2	0.1	1.8	45.0	0.0	1.9	0.0	13.6	1.8	0.8	1.0	3.0	8.4	0.9	0.0	0.3	1.6	1.6	0.0	0.5	1.4	0.2	0.2	6.8	4.7	0.3	1.4	8.4	1.3	0.3
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82217934-82261129	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1667.1;Syncytiotrophoblasts: 748.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 109.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA		260000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	30.4	16.9	3.8	25.3	5.8	22.7	15.7	6.6	9.7	26.2	5.0	28.9	11.6	11.6	1.3	42.4	18.5	12.8	26.0	4.5	7.3	48.2	11.3	46.4	5.7	17.3	8.5	9.1	5.8	2.5	12.1	24.7	11.9	19.6	5.7	5.7	27.5	5.9	198.3	8.4	22.9	6.0	8.4	57.5	22.0	32.0	13.8	2.9	29.1	73.2	5.2	26.3	28.5	15.1	52.8	24.4	0.6	1.3	7.8	28.8	51.7	225.6	107.7	117.4	142.2	10.1	119.1	0.7	158.0	122.5	127.9	18.9	15.6	242.0	51.8	78.1	1.2	87.4	144.0	236.4	164.1	105.2	111.5	64.8	38.2	77.0	38.5	185.8	69.1	2.2	1.0	26.6	116.1	14.0	1.4	166.3	1.9	22.1	223.5	0.9	1.6	33.2	75.9	3.0	2.9	1.7	196.7	166.9	3.2	20.4	25.4	131.4	124.0	281.7	5.1	4.5	200.9	97.3	1.9	3.9	140.2	94.7	3.0	56.6	32.6	92.1	9.6	30.4	13.4	8.1	7.7	10.5	24.1	6.2	4.2	5.3	109.1	25.3	31.4	15.2	7.3	16.0	3.8	5.8	6.6	9.7	4.5	7.3	17.3	8.5	11.9	8.4	13.8	15.1	19.2	9.6	9.8	3.6	27.9	6.5	47.5	210.1	2.8	13.4	3.2	2.5	6.1	4.3	182.3	57.0	4.2	67.6	72.4	216.7	0.0	136.1	3.0	33.7	15.4	29.9	20.9	9.1	0.3	18.0	1667.1	17.2	45.3	65.1	75.0	15.9	16.8	1.1	271.0	127.9	0.3	28.3	148.5	99.9	84.6	3.8	3.1	168.6	14.2	9.4	184.9	20.3	40.2	0.0	1.0	305.5	190.2	3.8	35.7	16.5	62.4	5.6	91.1	11.6	0.0	1.6	50.5	1.9	9.5	1.6	6.7	748.8	38.5	0.8	33.4	119.6
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 51.0;epididymis: 33.3;retina: 31.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	13	"SK-MEL-30: 481.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	1.5	2.7	3.0	7.2	4.8	9.7	5.8	4.3	4.3	1.6	51.0	0.7	0.5	2.6	33.3	10.9	0.9	1.3	0.9	5.0	5.2	0.7	1.4	3.0	5.3	5.1	4.2	1.5	0.5	0.1	1.7	2.3	5.3	0.6	0.8	31.0	2.2	4.2	5.0	4.5	1.2	0.8	2.4	5.7	1.0	2.3	5.2	1.6	3.5	0.7	4.7	2.1	2.6	3.2	2.1	1.8	0.6	0.8	0.4	0.6	14.2	0.8	18.0	1.7	1.2	0.7	2.5	17.6	1.4	0.0	0.2	0.6	2.5	0.0	0.7	5.4	1.3	1.4	2.2	22.3	3.2	5.7	1.1	0.8	0.2	1.0	1.0	1.7	0.8	2.5	1.1	3.8	0.0	18.1	8.5	3.6	0.2	0.1	1.0	0.1	0.4	2.4	0.8	1.5	4.2	0.3	0.8	10.7	481.5	3.8	15.0	3.5	2.7	5.9	1.1	0.5	2.0	4.2	17.5	14.6	36.0	4.6	2.6	0.8	3.1	0.2	1.8	2.7	0.8	0.4	0.6	1.4	1.9	0.0	0.4	0.8	5.4	0.4	1.4	0.3	1.5	0.9	3.0	4.8	4.3	4.3	5.0	5.2	5.1	4.2	5.3	2.4	5.2	3.2	0.6	0.0	2.5	1.6	1.8	0.3	0.2	0.1	1.2	8.2	2.5	0.9	0.8	0.0	4.0	9.2	22.9	0.4	8.4	0.0	0.0	0.0	0.7	4.7	2.5	3.2	0.0	2.7	6.7	0.0	11.5	0.9	0.5	27.4	1.3	0.1	0.7	0.3	5.6	0.0	6.2	0.0	0.0	16.7	7.0	0.3	0.0	21.8	10.6	4.7	11.1	6.2	5.2	0.5	0.8	0.0	0.0	1.9	5.0	0.2	0.0	0.3	1.6	45.1	0.0	0.8	0.3	1.7	0.7	6.7	0.4	0.4	5.3	0.4	0.1	0.2
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 79.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338381-22379503	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.4;Rod photoreceptor cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	229	"SCLC-21H: 30.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 51.9;hypothalamus: 139.9;midbrain: 172.4;pons and medulla: 86.4;thalamus: 164.9"	"Low region specificity"	"Detected in many"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.0	0.0	6.6	0.0	1.5	0.0	0.0	13.4	11.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	16.6	0.0	0.0	0.0	0.0	38.3	16.1	0.0	0.2	0.0	3.6	0.0	35.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	13.4	11.0	3.8	16.6	38.3	16.1	35.6	7.1	39.6	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	63	"brain: 405.4;retina: 315.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 362.7;Cone photoreceptor cells: 369.1;Excitatory neurons: 107.8;Rod photoreceptor cells: 358.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Group enriched"	"Detected in many"	7	"amygdala: 176.7;basal ganglia: 243.4;cerebral cortex: 289.7;hippocampal formation: 405.4;white matter: 169.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 20.8;K-562: 7.0;REH: 4.0;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 201.2;cerebellum: 204.6;cerebral cortex: 339.5;hippocampal formation: 471.2"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported				NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086"	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	5.7	1.4	176.7	0.2	243.4	0.0	3.0	32.2	289.7	2.0	0.0	1.5	0.4	1.2	0.6	1.1	2.2	0.9	2.8	405.4	0.0	1.0	0.3	0.6	1.0	31.7	0.8	0.6	0.6	0.6	1.6	0.1	37.8	0.5	0.5	315.8	1.2	0.3	1.7	2.2	1.5	0.6	0.0	0.1	0.9	2.3	0.0	0.3	2.3	2.5	0.6	1.6	1.8	169.9	0.0	0.3	0.2	0.4	1.6	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	1.2	0.1	1.9	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.1	0.3	0.0	0.3	0.0	0.3	7.0	1.0	0.0	0.2	0.0	0.1	0.0	0.3	0.3	4.0	0.1	0.1	0.0	0.0	4.9	0.4	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	2.3	0.9	0.0	0.4	0.3	0.3	0.6	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.7	243.4	32.2	289.7	405.4	0.0	31.7	0.8	37.8	0.0	0.0	169.9	1.9	0.0	0.0	9.4	0.0	1.3	0.2	0.0	0.0	362.7	0.5	0.8	3.2	0.0	0.0	0.0	369.1	0.1	0.0	0.2	0.0	0.0	5.6	0.0	0.0	1.7	0.0	0.0	107.8	0.0	0.1	5.5	0.0	0.1	0.0	0.1	0.0	0.0	0.3	11.8	3.4	0.0	0.0	0.0	1.3	0.5	6.5	0.3	1.8	11.2	0.0	22.6	0.0	6.0	8.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	358.0	6.6	0.4	4.3	3.5	4.4	0.6	0.6	0.0	0.1	0.0	0.3	0.1
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"adrenal gland: 25.1"	"Cell type enriched"	"Detected in some"	27	"Enteroendocrine cells: 139.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	19	"midbrain: 3.9"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 2.8"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.1	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	1.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	3.8	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	139.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132813339	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Hofbauer cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029747	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Cytosol	"HPA029747: AB_10600797"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.9	8.9	21.0	6.3	21.6	4.6	9.7	22.5	28.0	9.4	23.1	9.7	14.5	6.4	5.8	13.6	9.8	11.9	3.9	21.2	22.2	12.7	7.6	5.7	7.7	21.6	22.3	6.9	9.9	12.9	8.3	15.7	21.0	5.4	10.1	2.6	13.1	4.5	3.2	9.5	10.5	5.9	22.8	8.3	16.1	2.0	25.1	7.9	10.2	3.5	8.1	11.1	7.2	22.8	6.8	6.5	10.0	0.0	1.5	3.2	5.7	2.5	7.2	4.4	13.4	14.9	13.8	0.2	9.2	1.5	7.9	17.3	13.4	15.4	3.3	10.3	27.6	3.6	11.3	16.8	7.5	3.0	0.3	9.3	13.7	7.2	14.5	7.3	13.6	20.7	40.4	2.5	3.8	9.4	10.5	0.3	14.1	15.8	8.7	15.7	11.7	11.8	36.6	11.4	21.2	0.0	12.9	25.2	20.1	6.0	8.9	0.1	6.0	1.9	5.3	2.1	5.7	8.5	0.5	0.4	11.5	0.1	1.7	0.0	14.4	0.8	4.3	3.2	8.1	6.6	6.5	6.0	19.9	9.7	9.5	6.6	0.8	3.4	0.3	15.5	11.9	8.1	21.0	21.6	22.5	28.0	21.2	22.2	21.6	22.3	21.0	22.8	25.1	22.8	10.4	0.0	6.5	93.4	15.2	10.1	10.3	30.4	22.8	5.5	13.0	7.4	3.1	40.0	20.6	27.6	2.1	53.1	8.2	5.4	9.8	32.0	0.2	12.6	4.8	7.8	16.3	49.1	32.2	15.1	19.3	7.8	20.4	5.8	0.0	5.8	18.2	15.6	65.6	0.0	25.3	11.9	32.6	21.5	9.0	0.5	6.8	26.7	14.2	27.2	11.4	9.3	5.2	51.3	4.4	14.6	6.0	4.5	6.6	8.8	7.2	6.4	27.9	3.5	0.0	8.6	4.8	0.3	0.5	25.5	10.9	28.5	7.3	21.7	15.3	13.2
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45573365	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 82.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 158.0;Syncytiotrophoblasts: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 102.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 102.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	7.7	9.4	8.2	5.7	4.0	8.1	5.9	5.6	12.4	10.0	82.6	6.8	22.5	6.4	0.9	3.2	6.9	1.9	4.2	11.8	2.7	8.0	20.9	15.7	4.2	5.3	5.2	11.8	6.9	0.8	5.4	13.6	6.0	5.8	0.8	2.3	3.3	0.8	2.6	3.9	7.9	1.1	3.0	15.1	7.4	4.6	6.6	2.2	13.8	0.5	0.7	4.3	5.2	4.1	28.9	23.7	4.9	19.4	1.5	2.1	40.2	12.5	1.9	11.1	7.0	55.1	26.1	26.8	24.9	2.8	9.1	14.1	9.0	8.5	2.7	25.2	51.2	54.7	12.4	38.8	6.1	37.2	8.5	2.7	6.3	11.6	3.3	3.3	9.1	27.3	67.6	11.8	3.5	29.3	49.6	29.9	28.5	11.2	30.0	66.5	5.4	79.2	4.6	16.9	29.7	26.7	14.9	23.5	11.2	6.7	18.4	41.4	10.7	14.6	18.8	4.3	21.1	4.8	18.5	23.5	6.7	56.4	11.9	1.6	18.5	24.1	0.9	16.3	2.8	2.5	1.4	2.0	13.4	0.8	2.0	1.5	102.9	1.1	10.8	4.1	3.2	7.9	8.2	4.0	5.6	12.4	11.8	2.7	5.3	5.2	6.0	3.0	6.6	4.1	1.4	48.1	6.3	13.7	2.9	2.4	2.0	2.6	1.8	23.6	3.9	3.4	2.5	1.5	6.2	0.0	0.0	158.0	0.5	8.2	0.0	8.0	3.7	2.2	5.8	3.4	0.0	6.7	3.4	4.9	21.5	3.7	4.1	4.5	1.3	12.7	1.1	16.2	27.3	8.4	4.0	4.1	8.2	11.1	5.0	6.6	6.5	8.6	3.6	23.4	8.3	5.7	0.0	2.0	1.7	7.6	5.4	11.3	9.4	4.6	20.5	2.4	0.9	3.6	0.0	3.3	4.1	1.5	4.8	1.8	1.6	362.4	2.6	5.1	8.5	0.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169485944	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1;tongue: 84.9"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	42.2	17.8	3.0	8.3	3.1	8.7	20.9	5.1	4.2	10.5	9.3	11.8	3.5	8.6	6.1	11.3	21.3	25.8	31.2	4.0	3.6	13.0	37.1	19.5	2.6	4.9	3.7	20.5	22.2	24.8	19.0	18.1	4.0	10.5	4.3	7.5	12.5	3.8	124.1	16.5	11.4	6.1	3.7	2.8	19.2	7.8	4.2	4.1	15.7	84.9	2.8	18.1	12.9	3.5	7.4	5.1	11.4	9.0	34.4	12.7	25.0	5.8	4.3	4.6	6.5	20.9	7.6	6.5	6.4	3.9	8.5	7.7	13.9	8.5	5.1	18.8	13.0	6.2	16.7	19.3	18.7	15.8	5.9	15.0	12.2	7.4	18.8	6.4	7.0	11.3	25.3	4.1	7.9	5.0	8.2	7.1	25.8	14.1	7.7	0.0	24.6	7.5	12.2	15.5	9.9	13.3	8.0	13.6	29.2	12.8	8.5	10.1	5.8	5.5	7.7	6.9	11.4	5.6	5.6	2.1	8.1	6.0	7.4	0.0	0.6	1.1	0.3	0.2	1.1	0.4	0.4	0.7	0.7	0.4	1.0	1.0	0.4	0.9	2.0	0.2	0.3	0.2	3.0	3.1	5.1	4.2	4.0	3.6	4.9	3.7	4.0	3.7	4.2	3.5	13.6	9.6	19.3	11.8	7.3	29.6	16.5	4.4	43.9	5.3	34.1	13.6	27.7	7.2	11.4	5.5	2.1	26.9	11.3	10.6	0.0	7.4	4.3	22.6	9.7	3.7	9.0	5.2	15.6	5.3	4.5	52.7	49.5	42.7	10.2	4.1	1.1	29.8	7.0	6.7	22.8	6.4	12.2	2.9	8.8	2.7	6.8	18.3	21.4	7.5	1.0	2.5	2.1	16.1	3.3	9.6	5.4	4.9	14.0	16.5	5.6	2.0	12.7	5.1	0.0	84.5	14.2	6.7	4.1	35.2	50.4	156.4	7.5	3.1	6.7	28.9
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 294.5;U-266/70: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	4.3	26.4	49.1	9.1	46.8	13.4	13.6	32.1	48.6	14.0	18.0	9.4	6.1	12.8	8.2	7.5	4.8	3.9	6.2	43.4	56.6	1.9	9.0	4.9	10.7	37.2	43.1	13.2	29.6	5.5	13.7	6.6	52.1	9.6	8.4	19.3	7.5	7.1	40.1	18.6	5.6	12.3	29.5	7.5	8.1	11.7	59.9	20.5	5.7	17.0	19.0	4.8	6.2	30.3	15.3	11.6	6.6	34.9	14.7	9.5	9.4	28.5	14.0	11.7	19.8	3.2	2.2	49.7	6.5	44.8	14.7	43.2	13.7	3.6	12.0	20.1	5.4	26.0	13.1	30.9	31.0	43.8	23.1	4.4	73.8	15.8	24.2	3.9	7.3	49.1	20.7	122.0	8.4	13.5	37.7	29.1	4.7	20.1	13.9	13.5	1.9	125.5	4.9	7.7	29.3	14.1	17.9	16.1	294.5	3.0	19.3	47.8	1.6	16.0	19.0	31.2	17.5	132.8	71.2	118.8	23.6	86.5	86.2	0.0	2.1	1.8	0.9	4.8	1.2	0.9	0.9	1.5	3.9	0.3	0.0	0.8	0.0	5.1	9.4	7.2	3.5	1.4	49.1	46.8	32.1	48.6	43.4	56.6	37.2	43.1	52.1	29.5	59.9	30.3	3.6	0.0	2.7	69.9	13.6	20.0	2.1	6.7	46.1	6.3	21.0	7.1	5.5	1.5	1.7	1.8	33.3	2.4	20.2	2.9	0.0	2.0	32.4	5.4	8.2	5.3	8.4	6.1	20.6	9.3	1.3	4.0	5.1	5.6	7.0	49.2	7.5	13.1	17.7	6.7	25.5	9.0	6.1	6.8	11.8	47.5	11.1	11.1	85.4	8.4	5.1	14.6	2.1	5.0	3.9	7.1	0.8	29.7	65.7	2.6	0.4	1.5	5.4	17.7	0.0	5.1	7.3	2.0	0.9	5.9	6.1	2.5	10.9	0.4	5.8	1.0
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 148.6;Erythroid cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 95.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	97.2	15.9	5.8	29.6	6.5	60.9	77.7	6.6	6.1	57.4	6.1	50.1	16.2	39.1	98.0	98.0	48.9	36.5	26.4	5.9	8.5	45.6	8.1	65.3	27.9	15.8	11.1	45.8	73.2	2.9	24.5	46.9	13.3	98.6	42.4	1.4	120.5	77.0	8.5	55.7	36.2	33.0	9.5	40.4	55.5	40.3	9.8	19.9	14.1	10.7	30.3	109.6	83.0	11.5	179.6	323.6	76.3	116.1	194.7	164.3	180.0	249.6	283.0	183.2	264.1	296.1	197.1	194.8	118.9	624.2	105.2	281.1	224.9	296.9	135.5	130.1	203.7	324.3	115.1	281.9	501.3	228.2	182.9	268.6	727.3	215.5	541.1	61.3	98.9	255.0	348.9	500.1	99.5	304.5	105.4	611.1	134.0	636.5	140.9	117.8	86.5	282.7	104.2	384.8	117.3	86.0	123.4	331.8	275.4	58.8	191.6	296.6	74.1	109.4	174.1	86.4	205.7	308.0	325.3	164.0	206.3	281.0	274.3	0.1	36.1	2.9	14.1	55.0	11.4	17.8	8.0	9.9	50.2	8.1	1.9	6.0	1.0	21.0	66.3	95.8	15.5	27.8	5.8	6.5	6.6	6.1	5.9	8.5	15.8	11.1	13.3	9.5	9.8	11.5	63.6	0.0	17.3	0.0	31.1	57.7	148.6	95.9	64.9	0.2	52.0	43.1	20.3	21.5	41.2	0.0	0.0	80.8	86.3	44.6	3.9	38.5	27.0	2.6	32.9	29.0	10.7	143.3	0.6	65.7	129.3	48.0	21.9	2.7	29.2	20.9	29.6	0.7	38.4	0.0	0.8	111.3	40.7	21.6	34.7	14.0	19.0	39.8	19.6	3.7	26.0	0.6	12.3	0.0	0.6	43.4	74.8	19.5	68.6	59.0	6.5	23.1	13.0	0.8	6.6	15.8	44.0	35.9	4.0	69.0	28.3	24.4	38.7	6.1	62.9	100.0
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 88.2;testis: 28.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in all"	6	"cerebellum: 88.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 136.3"	"Region enhanced"	"Detected in all"		"cerebellum: 53.8"	"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.1	0.2	9.1	0.2	10.8	0.9	0.4	88.2	14.4	0.1	0.5	0.2	0.3	0.4	1.7	0.1	0.2	0.2	0.2	14.5	5.0	0.1	0.2	0.2	0.3	3.7	7.5	0.3	0.6	0.9	0.3	0.7	8.1	0.5	0.3	2.3	0.4	0.5	0.3	8.6	0.3	0.2	3.2	0.4	0.2	28.0	6.6	0.2	0.3	0.1	0.3	0.1	0.1	5.1	0.1	0.1	0.3	0.4	0.2	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.4	7.4	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.6	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.2	0.2	2.8	0.0	1.1	0.3	0.1	0.0	0.3	1.1	0.3	0.1	0.5	0.1	28.3	0.1	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	9.1	10.8	88.2	14.4	14.5	5.0	3.7	7.5	8.1	3.2	6.6	5.1	0.0	0.0	0.0	0.7	0.0	3.2	0.7	0.0	0.0	17.1	0.0	0.1	2.1	0.0	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	35.3	0.0	0.1	0.1	0.0	0.0	8.2	0.4	9.9	0.4	0.0	0.0	0.0	5.8	0.0	0.0	0.5	23.5	8.6	0.0	0.0	0.0	0.7	31.8	0.6	0.0	0.0	1.0	0.0	0.7	0.0	4.5	0.9	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.0	0.4	2.2	6.3	0.0	6.8	40.0	0.0	0.0	0.0	0.1
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 40.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 207.7;Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 72.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	8	"HHSteC: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	1.6	0.2	1.5	0.2	1.0	0.0	1.1	1.0	1.5	1.4	0.8	1.0	2.3	1.3	0.0	1.2	1.8	5.2	1.6	1.2	1.1	0.4	1.0	0.6	0.1	1.6	1.9	2.4	0.2	0.4	0.1	0.2	1.8	0.8	0.0	40.2	0.5	0.0	1.3	0.8	3.1	0.0	1.5	0.0	0.8	0.5	2.3	0.0	0.6	3.0	0.0	1.0	1.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.0	1.0	1.5	1.2	1.1	1.6	1.9	1.8	1.5	2.3	1.2	1.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.6	0.0	0.0	0.0	70.9	0.1	3.0	2.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.2	5.9	4.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.2	0.5	0.0	7.5	0.0	8.5	16.5	0.0	0.1	0.0	4.0	1.2	0.7	0.0	17.7	0.7	0.0	72.3	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.3	0.0
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645939-112663825	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 353.3;Paneth cells: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 522.4;U-87 MG: 507.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	36.1	11.7	16.2	33.2	24.3	74.6	15.6	27.8	26.3	11.8	25.0	53.6	14.4	13.7	8.4	15.0	14.5	26.4	21.8	20.7	19.8	22.1	49.0	29.2	37.1	25.5	20.7	9.2	30.7	10.4	15.9	29.7	25.2	13.3	21.9	52.3	12.8	9.3	19.7	14.5	28.4	15.0	18.6	29.5	20.2	15.7	24.5	27.2	15.9	7.5	27.5	40.8	13.3	21.2	69.0	55.5	71.1	57.8	52.9	128.8	54.4	181.6	215.3	79.1	102.2	85.0	164.9	124.0	97.5	67.7	305.0	70.5	78.8	138.0	114.8	68.5	80.4	105.5	57.1	81.3	78.2	61.2	178.9	66.0	53.8	279.1	193.9	522.4	102.2	52.9	199.5	126.3	346.7	26.8	83.9	235.9	119.3	31.8	147.6	77.8	63.5	34.9	114.5	312.8	64.4	60.8	91.7	54.9	127.9	31.4	56.0	42.9	223.6	143.5	94.7	50.8	142.4	52.1	143.7	102.2	507.2	57.9	178.3	13.4	33.5	30.1	52.8	59.8	59.4	8.3	22.2	38.4	25.4	5.0	17.5	27.6	14.7	50.2	37.2	41.8	14.6	33.9	16.2	24.3	27.8	26.3	20.7	19.8	25.5	20.7	25.2	18.6	24.5	21.2	61.7	12.8	25.9	42.4	40.3	112.8	59.1	38.7	104.7	60.0	41.9	31.6	49.6	32.9	35.3	9.2	210.6	44.7	119.1	353.3	13.7	18.1	1.5	86.0	34.3	48.2	35.7	53.2	47.3	14.0	13.5	61.5	96.4	167.8	25.3	20.6	41.0	58.1	28.2	20.2	27.2	85.8	32.6	58.5	86.2	3.3	3.7	80.5	26.6	19.7	42.8	31.8	66.9	18.6	26.1	26.9	261.6	4.9	59.8	34.0	156.3	5.2	59.6	84.6	0.0	36.9	25.9	8.5	18.7	119.5	61.8	74.3	70.4	19.0	96.5	90.3
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 609.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.1	0.4	0.3	0.0	0.9	0.3	0.3	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	609.6	0.4	0.2	0.1	0.1	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.5	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.5	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	72	"epididymis: 10.6;kidney: 31.9;placenta: 33.4"	"Group enriched"	"Detected in some"	19	"Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;Hep G2: 1.0"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	654.0	0.0	0.0	5.9	0.0	1.2	0.0	0.2	1.7	0.0	0.0	0.0	0.4	22.5	3.4	0.0	0.0	0.0	0.0	0.4	0.2	50.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.3	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1520.6	0.2	0.1	0.2	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	204	"kidney: 109.4"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 173.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	109.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278757	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"kidney: 9.0"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035603, HPA035962"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976513-116070054	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.6;brain: 31.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.3;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.3;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 36.0;hTERT-HME1: 47.4;NB-4: 27.4;THP-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	3.2	3.1	7.8	2.3	16.5	30.6	1.7	12.3	12.0	3.1	0.9	1.3	1.0	1.1	1.3	5.2	1.5	1.9	4.7	8.6	11.6	3.4	1.1	4.9	0.9	13.3	11.6	1.1	3.1	4.2	2.7	2.0	14.3	1.9	1.7	6.7	4.5	1.6	0.6	9.4	1.9	1.0	11.6	3.4	3.5	1.1	13.1	0.5	2.8	1.0	1.1	1.7	5.0	31.8	3.0	0.2	2.1	0.0	3.7	4.4	1.5	4.7	6.9	2.8	5.0	0.0	0.5	3.3	5.0	2.3	2.4	4.5	3.6	9.7	2.7	0.0	2.3	3.2	3.7	0.5	12.3	4.9	4.3	4.5	36.0	0.1	47.4	0.2	0.0	0.0	0.1	0.0	4.7	2.7	0.0	27.4	3.0	2.8	2.3	0.0	0.0	0.1	3.9	1.6	2.2	1.9	8.1	1.7	13.8	3.1	0.4	29.4	0.0	5.0	2.7	1.0	1.2	4.8	4.8	0.4	5.3	8.0	8.1	0.3	0.8	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.1	7.8	16.5	12.3	12.0	8.6	11.6	13.3	11.6	14.3	11.6	13.1	31.8	0.2	0.0	13.7	46.7	2.3	2.8	3.1	3.6	5.2	3.0	0.3	0.4	7.8	0.0	3.2	5.5	10.4	0.6	0.8	0.5	1.9	1.1	1.3	2.5	0.7	0.2	8.4	0.4	44.2	0.4	0.4	4.6	4.6	1.4	1.3	0.6	1.1	0.0	2.8	8.4	33.9	0.3	0.0	9.4	0.5	0.1	0.9	6.9	1.8	9.4	8.7	1.0	1.0	53.3	250.2	1.6	1.2	0.4	0.7	1.1	0.1	0.3	5.2	2.1	0.0	0.4	1.4	0.3	0.7	5.7	3.0	0.0	1.0	1.2	0.5	1.3
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 20.5;testis: 21.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.6	0.2	20.5	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	3.8	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.5	0.0	21.4	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	7.3	30.1	159.4	3.9	159.6	0.6	11.8	98.0	159.1	25.4	372.6	24.6	4.6	14.8	10.3	4.4	19.1	6.4	22.0	145.5	304.0	16.3	2.5	8.3	3.4	165.6	143.8	17.0	17.2	11.4	149.1	5.0	145.5	39.8	2.4	26.4	25.4	25.7	1.5	7.6	10.2	7.0	125.5	4.2	13.3	8.9	231.8	1.7	19.1	2.7	1.6	15.2	17.9	139.5	0.0	1.9	20.7	31.4	23.2	11.4	3.4	7.5	11.6	2.5	1.9	0.0	1.9	0.0	2.8	11.0	6.6	0.4	0.7	0.5	0.0	0.0	1.4	4.4	0.0	0.2	13.1	0.0	4.4	16.7	1.2	2.6	0.0	11.3	0.8	9.1	0.0	0.2	3.8	3.2	0.1	0.2	11.3	0.0	0.0	0.0	0.7	0.2	0.0	2.0	19.9	41.5	5.8	0.0	0.0	4.0	3.5	0.6	0.0	2.9	8.9	16.6	0.0	0.1	3.2	0.0	1.9	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	159.4	159.6	98.0	159.1	145.5	304.0	165.6	143.8	145.5	125.5	231.8	139.5	7.7	0.0	2.7	46.7	2.3	12.6	18.6	2.6	12.5	53.0	23.4	30.1	10.0	2.8	5.5	20.2	43.8	2.4	1.0	0.0	1.9	0.7	0.2	1.8	10.6	12.0	20.8	1.7	71.4	1.3	4.9	21.7	3.6	0.6	4.5	12.0	16.8	0.9	1.0	201.9	111.1	0.0	0.0	0.6	5.1	2.3	21.1	1.2	7.2	19.7	0.7	74.2	0.0	120.6	49.2	1.5	0.0	42.9	9.2	31.3	0.0	16.9	3.2	69.0	0.0	14.1	18.0	1.1	2.3	3.0	10.9	4.8	2.0	4.5	0.3	6.1
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 42.3;liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 368.4;Late spermatids: 499.1;Paneth cells: 385.7;Proximal enterocytes: 730.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.4;Karpas-707: 29.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	6.9	3.0	0.1	2.1	0.1	1.5	6.7	0.0	1.2	6.5	0.8	27.8	42.3	6.8	0.2	13.3	8.2	4.0	16.7	0.1	1.0	16.7	45.2	6.8	2.3	0.6	0.5	4.8	6.4	1.7	3.2	5.4	0.4	8.0	4.2	0.0	10.3	2.8	1.7	16.1	28.0	0.9	0.2	9.1	11.3	2.1	1.0	0.7	12.0	0.0	1.1	6.5	9.7	0.8	2.3	14.1	0.0	7.2	1.3	2.0	5.8	4.4	7.4	2.5	4.2	8.0	33.4	1.0	14.1	5.8	5.6	7.3	0.4	0.7	0.5	6.8	1.3	0.3	3.3	7.4	13.5	0.1	6.2	5.7	1.3	2.1	0.4	2.2	0.0	4.5	0.3	29.1	1.4	6.8	0.2	0.8	0.7	10.6	3.3	2.6	0.0	4.7	1.1	4.2	0.3	2.5	1.8	17.6	15.7	0.1	3.6	3.8	0.5	1.9	4.2	6.1	0.3	5.5	1.4	0.3	7.7	3.9	7.5	32.1	28.7	27.4	6.8	28.2	3.7	4.2	5.1	4.8	17.9	3.0	2.7	4.0	42.3	6.3	22.9	13.2	9.4	13.5	0.1	0.1	0.0	1.2	0.1	1.0	0.6	0.5	0.4	0.2	1.0	0.8	1.6	6.4	9.6	1.6	5.6	7.4	22.5	48.8	14.2	1.2	16.8	11.0	11.2	54.3	29.0	27.6	0.0	102.6	9.0	368.4	7.9	31.4	161.7	9.3	5.3	2.7	19.8	1.3	3.0	8.7	20.9	9.4	47.9	14.1	15.9	7.6	6.4	158.6	46.3	0.0	0.6	93.2	52.9	33.0	16.7	499.1	10.5	23.5	19.6	4.7	18.8	6.9	10.3	0.5	1.6	22.5	385.7	7.5	3.1	10.2	730.9	122.1	26.6	1.1	0.0	2.7	11.2	5.8	4.1	19.2	8.8	181.3	13.7	7.3	121.3	20.3
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887344-2903575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 17.7;kidney: 11.1;liver: 14.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 7.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	3.2	0.6	0.5	2.2	0.6	0.2	0.7	0.5	1.7	0.7	0.5	17.7	13.4	0.8	0.4	1.2	0.4	1.7	0.3	0.6	1.0	11.1	14.9	0.6	0.4	0.9	0.9	0.4	0.3	0.0	0.3	2.3	1.1	0.8	10.2	0.3	1.8	0.1	0.1	1.1	9.7	0.7	0.8	0.7	1.6	0.5	0.8	0.1	0.3	0.0	0.1	0.7	0.9	1.1	1.2	9.4	0.3	0.5	0.0	0.0	0.9	0.5	0.4	0.0	0.2	2.2	9.4	0.0	0.8	0.0	0.6	0.5	0.0	0.3	0.0	0.4	0.1	0.0	0.8	5.8	0.7	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.5	0.0	0.9	0.0	18.8	0.0	0.4	0.2	8.4	0.3	0.3	0.0	1.0	0.8	0.0	0.1	0.3	0.9	0.4	35.8	0.2	0.0	0.9	1.9	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.2	2.6	14.8	4.0	7.0	1.2	0.2	3.9	0.1	0.0	0.1	0.2	3.9	0.0	0.0	0.1	1.6	0.4	2.9	0.0	0.6	2.4	0.5	0.6	0.5	1.7	0.6	1.0	0.9	0.9	1.1	0.8	0.8	1.1	0.6	0.0	0.5	0.0	1.3	0.5	1.1	6.3	1.2	0.0	1.2	0.9	0.4	1.5	2.7	7.3	0.0	19.5	0.4	163.3	9.8	1.7	0.1	0.1	0.3	0.7	9.1	3.2	0.4	0.8	9.8	1.4	2.6	0.5	1.3	0.0	2.9	22.7	17.7	0.0	0.1	26.2	6.1	6.3	5.5	0.2	0.3	6.4	3.6	0.0	4.6	0.0	0.0	0.0	0.1	2.4	124.4	0.0	0.0	1.0	75.7	104.0	1.0	0.0	0.0	0.0	0.6	0.1	0.4	2.1	1.1	80.7	0.9	0.8	48.5	2.5
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"kidney: 153.9"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 92.0;Proximal tubular cells: 198.3"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.9"	"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	153.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.1	92.0	0.6	7.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	198.3	0.0	0.0	0.0	1.0	0.6	0.1	0.3	0.0	0.3	0.1	1.4	0.0	0.0	0.0
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457050	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.3	3.4	17.7	4.5	28.9	9.6	8.4	25.4	25.0	9.1	1.8	18.4	20.7	4.1	12.2	23.7	11.0	4.9	3.6	16.2	18.6	7.7	18.1	8.3	4.4	29.9	29.7	4.1	15.5	27.1	8.8	8.5	30.4	18.6	14.8	4.8	14.6	2.4	8.9	17.1	22.4	2.8	22.1	6.3	26.5	11.5	30.2	7.2	5.6	7.8	5.9	4.3	15.5	50.9	4.3	10.1	20.1	22.6	7.2	7.8	26.6	0.7	0.3	1.2	0.5	22.5	0.7	1.0	2.5	4.8	18.2	6.1	4.2	10.8	0.4	3.5	13.1	10.4	3.9	18.9	1.0	0.7	0.6	2.0	21.3	19.4	1.0	4.3	0.7	5.4	9.6	5.3	0.7	5.3	1.0	2.4	7.1	23.2	3.9	2.2	1.3	18.1	0.1	26.9	2.4	0.3	5.7	7.8	7.0	20.9	31.8	0.2	5.6	12.0	4.0	15.9	2.6	12.7	0.2	0.4	21.2	0.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	17.7	28.9	25.4	25.0	16.2	18.6	29.9	29.7	30.4	22.1	30.2	50.9	22.6	6.4	17.5	46.7	1.0	11.6	5.0	18.7	4.6	8.0	9.5	8.1	2.8	10.0	18.0	5.5	8.4	16.1	0.5	43.3	0.0	2.9	86.8	11.6	2.5	8.2	4.2	11.0	59.9	8.0	1.3	1.9	39.8	4.1	0.0	13.1	6.4	12.7	12.9	0.0	67.4	49.7	12.2	13.0	3.0	229.3	1.8	4.8	3.6	77.8	6.4	8.6	0.0	45.8	285.5	6.1	20.5	0.7	0.4	13.9	34.3	4.2	42.0	3.5	0.0	4.5	2.6	2.5	1.2	10.3	12.6	9.2	1.3	0.1	25.3	4.5
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins"	"Ion transport, Lipid metabolism, Steroid metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;kidney: 4.4"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 5.9;Proximal tubular cells: 11.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045015: AB_2679183"							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.4;Hepatocytes: 6.4;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.2"	"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294394-132344190	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.7"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 57.0;Proximal enterocytes: 25.6;Respiratory ciliated cells: 78.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.1;U-138 MG: 24.4"	"Region enhanced"	"Detected in all"		"cerebellum: 64.5"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"CAB015468: , HPA036974: AB_2732474"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	1.9	3.0	2.1	2.9	1.9	20.7	2.2	3.7	1.8	1.5	1.1	2.0	3.5	1.4	1.4	0.4	11.3	1.9	1.9	1.9	3.6	7.1	0.8	2.9	0.3	4.0	3.7	2.1	0.6	2.6	2.6	1.0	3.4	4.0	2.2	2.2	1.7	1.4	7.2	1.3	9.1	1.0	3.6	5.1	1.4	0.6	3.4	0.4	0.7	2.7	0.2	1.4	0.9	2.9	1.9	3.0	0.2	0.7	1.3	1.0	0.9	12.9	59.1	9.7	10.1	1.1	3.3	0.6	3.6	7.6	7.2	3.2	0.0	2.1	6.8	2.6	0.3	0.1	5.6	0.2	1.0	4.1	0.0	2.3	0.4	5.3	4.9	3.5	4.3	0.3	5.3	6.7	7.6	1.1	0.0	9.5	0.3	0.3	3.2	0.0	0.8	0.4	1.5	0.2	0.8	0.4	14.0	0.9	0.4	0.4	0.6	2.4	5.2	24.4	2.4	9.7	3.3	0.0	2.7	0.0	7.2	4.7	2.9	0.0	5.6	5.8	0.0	1.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	36.2	0.0	0.4	0.3	0.0	1.2	2.1	1.9	3.7	1.8	1.9	3.6	4.0	3.7	3.4	3.6	3.4	2.9	1.1	3.2	0.0	5.5	0.1	0.8	1.0	3.8	1.8	2.0	1.9	1.3	0.8	1.5	10.0	0.0	0.0	1.0	0.1	8.8	0.0	3.2	0.0	4.7	1.8	3.8	1.2	57.0	7.2	0.4	2.3	3.1	0.5	2.2	0.0	0.6	1.4	0.0	4.0	3.3	8.0	0.8	4.1	0.8	0.8	0.3	0.6	3.7	0.0	1.9	2.2	1.6	0.0	4.5	2.3	1.9	1.7	0.0	0.1	1.7	25.6	8.6	78.5	0.4	0.0	9.3	1.8	0.3	0.4	0.2	0.4	2.5	0.2	0.1	1.0	0.9
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"kidney: 196.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 310.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.0	0.0	1.3	0.0	2.5	0.0	0.0	3.6	2.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	196.5	0.0	0.0	0.0	7.0	5.5	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	3.6	2.3	1.3	3.8	7.0	5.5	3.1	3.3	7.6	1.2	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	310.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 427.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	47.6	427.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.5	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"choroid plexus: 111.4;kidney: 335.0"	"Cell type enriched"	"Detected in some"	38	"Proximal tubular cells: 347.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.0	111.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	335.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.7	3.6	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	1.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	347.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Region enhanced"	"Detected in some"		"midbrain: 3.2"	"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.2	0.1	0.1	1.2	0.2	2.8	0.2	1.1	0.2	2.3	0.1	3.3	26.3	0.7	0.0	0.3	54.2	2.4	0.1	0.2	0.4	40.2	22.5	0.9	1.7	1.1	3.2	0.3	1.2	0.3	0.2	0.1	0.8	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.3	0.2	0.1	1.3	1.5	0.2	0.2	5.5	0.2	0.0	1.2	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.1	0.2	1.1	0.2	0.2	0.4	1.1	3.2	0.8	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	10.2	99.3	26.3	8.2	27.2	7.8	9.4	24.1	26.0	13.5	88.4	9.4	6.4	12.9	8.7	6.1	15.9	10.1	8.3	28.5	26.7	13.0	57.0	12.1	10.2	28.1	32.0	38.5	10.0	17.7	23.3	8.1	29.5	12.5	6.1	107.2	5.9	10.3	3.3	11.4	12.5	10.0	25.6	20.9	9.4	11.4	34.6	8.2	25.0	4.5	9.9	18.9	8.9	33.1	21.2	24.5	32.2	12.2	22.2	12.4	40.9	8.9	12.1	10.3	9.6	12.7	23.6	9.6	9.4	12.4	29.1	20.1	9.1	24.2	19.2	6.0	16.2	13.3	4.3	48.0	12.5	18.9	7.6	10.6	13.8	25.8	15.4	21.5	15.2	15.5	9.3	7.9	13.7	7.9	20.7	10.5	11.4	16.9	14.9	19.0	21.2	14.3	5.6	34.2	10.7	12.0	17.0	17.7	63.3	11.4	9.8	10.9	13.1	23.0	10.7	27.8	17.4	11.2	22.2	25.5	8.1	11.2	36.8	0.0	1.1	0.1	1.1	0.7	1.0	1.8	0.8	0.8	1.5	1.0	0.8	0.8	1.2	0.3	0.9	2.4	0.5	0.9	26.3	27.2	24.1	26.0	28.5	26.7	28.1	32.0	29.5	25.6	34.6	33.1	9.3	6.4	7.2	50.3	14.5	7.4	4.5	7.0	12.5	236.8	8.3	7.4	7.9	15.7	9.4	14.7	114.7	4.9	12.6	0.8	0.0	5.0	4.6	2.8	10.1	13.0	7.2	8.6	102.8	5.5	6.6	14.2	3.6	1.9	8.2	13.5	17.5	71.3	10.6	85.8	117.4	1.9	0.0	30.2	7.5	9.3	20.2	16.3	16.0	60.0	8.8	24.8	7.2	77.4	78.3	3.4	6.7	29.3	11.9	8.2	0.6	1.3	7.8	71.5	13.1	12.6	12.2	0.6	8.0	5.5	6.1	4.0	8.2	65.6	2.8	14.7
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	34	"retina: 193.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	4.0	3.0	2.4	1.9	2.2	1.8	4.9	5.7	2.7	4.8	2.5	2.6	2.2	3.8	4.7	2.4	5.1	3.8	1.6	2.1	2.1	5.1	2.9	3.1	3.3	2.3	2.3	5.4	2.9	3.8	2.7	3.6	2.3	3.2	2.4	193.5	2.6	3.1	1.0	5.1	3.0	2.9	2.3	3.9	2.5	4.1	2.1	2.4	5.1	1.3	1.8	3.0	3.2	2.5	1.5	3.0	3.2	2.9	4.7	7.9	4.0	3.7	4.2	3.7	2.4	1.4	6.5	2.1	12.4	3.7	1.3	4.1	3.9	4.2	2.1	2.2	2.8	4.6	2.5	6.8	6.8	3.1	6.0	6.7	5.9	2.1	12.3	5.1	6.4	4.8	5.0	7.0	6.0	6.4	2.0	2.8	4.1	13.5	1.2	2.0	1.0	1.4	5.6	6.0	1.5	2.1	1.0	2.8	8.0	4.4	6.0	4.2	9.3	3.7	3.7	1.4	2.6	2.8	5.5	2.4	3.9	6.4	3.1	2.6	0.4	0.7	0.4	0.4	0.5	0.4	0.4	0.4	0.3	1.0	0.3	0.4	0.6	0.8	0.2	0.8	0.1	0.1	2.4	2.2	5.7	2.7	2.1	2.1	2.3	2.3	2.3	2.3	2.1	2.5	4.0	6.4	5.1	5.2	3.4	1.5	1.4	1.2	1.8	29.8	3.5	2.8	2.3	0.0	3.8	0.0	27.1	4.2	1.6	2.9	0.0	1.5	1.6	6.3	5.4	15.6	1.8	1.7	2.2	1.3	2.7	2.6	4.1	7.9	2.5	4.7	3.6	1.4	1.9	20.2	2.0	2.5	2.0	3.1	1.6	2.5	3.1	2.7	1.8	4.7	1.2	26.1	2.1	3.0	1.4	2.6	0.5	2.2	3.3	1.4	2.6	0.7	4.1	338.3	0.0	3.4	2.5	20.3	10.1	2.9	1.0	2.5	2.5	8.3	2.6	0.9
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940053	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	35.6	52.5	69.2	33.8	70.7	31.7	32.0	77.7	79.8	35.3	70.8	46.7	47.5	36.7	22.1	50.5	41.6	30.7	233.6	76.8	73.6	66.6	66.7	30.0	40.7	69.2	72.7	30.7	27.9	70.8	36.4	27.6	69.6	34.0	36.1	23.2	41.6	38.4	314.5	48.7	40.2	33.4	70.2	37.5	39.9	10.9	77.0	45.1	38.5	450.4	33.9	38.5	33.3	71.5	51.1	134.6	67.3	66.3	64.7	39.9	47.3	56.2	57.2	96.2	79.3	85.1	24.7	78.3	74.5	55.3	46.8	99.6	88.1	101.5	37.8	99.6	113.8	86.4	70.9	74.5	66.0	37.6	100.7	57.7	65.1	85.4	71.7	46.7	67.8	83.2	38.7	74.1	82.7	91.2	121.6	38.3	35.6	56.1	89.6	108.6	41.4	71.0	74.8	52.6	59.9	62.1	70.9	79.0	65.2	33.6	73.3	58.7	46.0	43.0	28.1	58.8	109.7	39.3	25.4	30.7	84.8	62.6	108.4	126.0	170.3	132.3	98.8	176.8	90.8	87.5	75.1	87.8	160.4	74.3	74.1	81.2	111.8	151.6	165.1	107.0	97.3	186.2	69.2	70.7	77.7	79.8	76.8	73.6	69.2	72.7	69.6	70.2	77.0	71.5	39.7	25.6	23.3	12.7	32.9	38.1	47.1	92.7	25.6	60.3	47.5	51.3	150.6	51.5	40.0	66.2	16.7	132.2	39.0	67.0	185.9	60.7	15.2	30.3	29.7	41.0	27.6	50.3	8.0	53.6	138.7	40.2	30.5	28.2	39.3	45.6	33.5	61.5	109.1	47.1	10.5	51.6	99.7	45.3	44.4	19.6	30.4	56.2	51.6	9.4	106.9	59.2	47.4	9.5	10.4	47.4	58.7	38.4	45.8	43.1	99.9	202.5	26.5	56.0	52.6	43.1	48.4	15.1	31.3	46.9	44.3	102.5	38.4	57.5	88.3	42.1
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171783405-171999859	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.7;Excitatory neurons: 148.5;Inhibitory neurons: 175.2;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA		9100	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	11.1	11.5	8.5	4.0	9.0	2.8	11.6	9.3	12.3	11.5	6.1	25.2	2.2	13.4	4.3	12.7	11.7	3.7	62.7	8.9	9.0	13.4	1.8	7.1	4.4	6.9	6.7	14.5	3.9	12.0	17.1	3.2	6.8	13.7	6.1	15.8	16.8	9.5	97.0	14.5	10.7	8.5	5.8	8.9	16.4	6.1	7.4	5.6	15.1	51.1	5.2	16.2	12.4	8.4	4.9	3.0	4.2	8.0	9.5	11.7	0.0	5.3	11.2	7.7	7.3	2.2	3.2	14.5	2.6	7.5	4.3	4.3	7.9	8.5	10.7	6.3	10.4	6.9	4.4	5.5	3.8	14.8	4.9	12.6	7.0	11.0	2.3	4.1	8.0	7.0	5.0	5.2	4.4	3.2	9.7	6.5	3.0	3.8	4.7	9.6	4.7	7.4	8.0	4.5	5.1	1.6	2.6	8.5	4.0	2.5	2.8	3.1	6.4	6.2	2.0	6.0	3.2	8.8	4.2	13.6	9.1	7.5	2.9	0.0	0.4	0.1	1.0	0.4	0.8	0.7	0.5	0.9	0.4	0.5	0.9	1.5	0.0	0.9	0.7	0.1	0.7	0.4	8.5	9.0	9.3	12.3	8.9	9.0	6.9	6.7	6.8	5.8	7.4	8.4	9.8	0.0	9.8	71.2	11.3	6.9	10.2	13.2	19.9	25.5	9.3	11.8	97.7	0.0	18.4	18.4	25.0	7.5	10.7	11.6	19.6	1.7	3.2	5.0	10.3	8.7	14.4	6.9	148.5	3.3	1.8	15.1	12.8	6.1	10.8	7.3	7.9	0.6	4.5	37.0	175.2	6.1	16.2	8.4	5.4	2.1	12.5	7.2	16.0	25.3	9.7	19.8	5.2	111.6	44.1	2.0	4.7	24.5	19.5	4.6	4.1	13.2	11.2	25.5	13.1	12.5	16.6	7.8	9.1	16.8	7.7	1.2	15.0	11.0	7.6	8.3
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40812460	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 37.6;liver: 88.3;pancreas: 52.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042146	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	2.3	1.4	2.0	4.1	2.2	5.6	4.6	2.3	2.5	2.1	2.3	5.9	37.6	3.1	1.1	3.2	2.6	5.0	2.8	1.9	2.6	5.6	88.3	2.3	4.8	2.6	2.3	2.9	52.1	3.4	1.3	2.8	2.5	2.8	6.5	2.8	3.4	1.8	5.9	3.7	26.7	3.4	2.1	2.5	5.5	9.4	2.4	5.3	17.3	6.0	5.3	2.6	1.6	2.9	7.4	14.7	16.5	21.3	6.5	8.2	17.3	5.6	2.9	6.8	3.9	17.6	15.2	48.0	6.4	10.3	12.7	12.6	26.6	15.5	7.0	11.9	12.4	37.0	8.6	26.6	12.7	15.0	5.3	9.0	8.6	9.6	21.9	4.6	11.2	23.8	18.1	7.8	11.8	28.2	10.2	9.9	33.2	32.7	7.9	25.5	12.0	10.6	11.7	7.0	7.7	20.1	10.2	18.4	10.1	11.5	13.6	23.2	8.4	8.4	12.1	12.7	17.0	8.9	9.6	27.9	8.4	11.4	16.4	1.3	0.5	0.1	1.6	0.9	1.0	0.6	1.0	1.1	1.1	0.7	1.0	2.0	0.7	1.4	0.5	0.5	0.9	0.5	2.0	2.2	2.3	2.5	1.9	2.6	2.6	2.3	2.5	2.1	2.4	2.9	0.3	3.2	0.5	3.9	1.3	0.3	1.0	0.8	2.2	1.4	2.1	1.4	1.1	1.5	0.2	0.0	0.0	2.2	1.3	0.6	7.9	2.1	4.6	1.2	2.1	0.9	1.2	9.0	2.4	4.3	44.5	1.0	1.5	2.1	0.0	1.5	0.7	39.8	1.7	0.0	4.3	0.6	2.0	1.6	0.3	6.8	0.6	1.0	1.8	1.0	0.0	0.4	2.1	5.0	1.4	1.7	2.7	0.0	6.2	1.6	19.0	4.3	0.1	1.9	0.0	1.0	1.1	5.4	9.3	2.1	0.1	1.5	3.2	4.3	3.5	0.8
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477998-68527523	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	10.3	3.6	5.1	2.1	5.3	3.7	4.1	7.1	7.9	2.1	0.0	3.2	3.8	3.5	3.2	2.6	2.1	2.3	2.8	5.0	5.6	5.8	11.4	3.1	2.7	2.7	3.5	2.3	5.1	3.5	2.6	2.8	3.4	8.2	2.8	4.7	4.5	2.8	4.9	3.0	3.8	2.6	2.2	2.4	4.5	1.5	7.0	2.0	3.5	2.3	2.0	2.7	2.1	6.1	2.8	1.1	3.2	4.4	4.2	5.0	3.4	3.8	4.2	2.4	2.6	6.6	1.9	3.0	2.7	7.6	1.3	1.6	10.2	1.9	6.1	2.2	6.3	1.6	3.5	2.9	5.1	5.2	3.4	4.3	4.9	4.6	6.4	3.6	2.0	2.6	1.8	4.8	5.2	2.6	2.9	3.7	0.7	0.8	14.8	1.6	2.3	1.0	6.8	9.2	2.2	1.8	5.4	5.2	4.4	2.2	2.9	2.1	8.9	3.6	4.8	6.1	4.5	4.9	2.8	4.9	3.5	4.2	1.6	1.4	0.7	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.8	0.4	0.6	1.3	0.6	0.4	0.8	0.4	0.3	5.1	5.3	7.1	7.9	5.0	5.6	2.7	3.5	3.4	2.2	7.0	6.1	9.6	44.8	20.7	23.5	9.9	6.4	6.3	4.9	4.6	19.2	11.0	6.7	10.4	12.8	7.4	12.9	39.6	19.0	12.4	12.9	11.7	8.1	9.9	9.6	9.3	7.8	15.0	9.9	44.0	19.2	32.3	8.8	20.9	14.1	8.2	6.1	13.9	37.7	10.6	20.2	53.7	9.4	8.2	10.3	6.5	13.0	3.1	7.9	1.8	13.1	8.2	9.5	15.5	29.7	48.0	14.4	7.8	7.9	16.4	13.5	17.7	21.4	9.9	31.2	0.0	13.4	11.3	4.5	2.5	10.5	6.8	59.8	9.4	9.4	9.0	10.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	7.4	12.3	9.4	5.3	9.2	3.3	14.3	9.9	10.7	9.3	11.5	6.3	5.4	13.2	19.6	7.1	11.4	5.7	4.3	9.2	10.2	13.6	16.9	6.6	9.4	9.9	9.6	20.6	8.8	13.6	9.2	10.0	9.7	10.7	7.3	9.2	9.8	5.9	3.9	9.6	6.0	10.5	10.1	7.3	7.8	10.0	10.0	9.3	12.7	3.6	9.7	8.1	7.2	11.2	23.5	13.5	21.0	18.5	12.8	15.9	16.8	20.7	22.7	32.5	35.7	16.5	8.8	26.7	12.2	20.4	17.7	18.6	30.6	16.6	33.4	27.0	41.3	31.1	18.4	21.1	18.3	35.8	16.2	15.3	22.8	28.6	18.4	14.7	19.4	21.4	46.5	12.9	26.5	19.2	22.0	24.2	17.7	33.2	20.6	23.8	32.4	40.3	27.6	19.7	14.2	12.5	42.8	26.6	26.7	20.3	22.0	10.7	11.8	18.5	24.4	16.1	19.2	13.9	29.6	25.7	19.7	18.4	20.4	7.0	3.3	4.2	4.9	3.9	6.9	8.4	5.8	5.5	4.2	7.6	8.2	6.7	1.5	8.3	3.3	5.4	8.6	4.7	9.4	9.2	9.9	10.7	9.2	10.2	9.9	9.6	9.7	10.1	10.0	11.2	8.4	19.2	9.5	23.2	10.9	16.6	16.8	29.8	10.8	12.1	13.6	9.3	4.0	7.2	20.7	12.9	8.4	39.8	8.0	5.8	21.5	17.9	9.6	17.9	16.5	10.4	6.1	11.6	17.3	17.7	31.9	15.9	8.2	14.2	5.1	15.5	8.2	24.8	12.9	11.8	21.5	6.5	26.4	7.9	6.0	16.0	27.1	7.4	16.0	7.5	17.6	7.9	10.3	18.1	28.0	18.1	4.4	26.7	11.9	18.1	8.2	21.1	15.0	7.0	32.9	9.3	11.6	51.0	38.0	11.7	17.2	28.6	9.7	16.4	7.5	14.9
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302635-141304049	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 6.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 18.2;Late spermatids: 12.0;Spermatocytes: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856926-48898904	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 96.1;RPMI-8226: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	20.7	29.9	16.3	11.9	18.2	10.7	17.9	18.6	16.4	8.3	15.3	26.5	65.6	10.4	4.6	9.1	12.8	15.7	62.8	15.5	17.9	25.6	148.3	15.6	14.6	17.7	17.4	5.9	30.4	17.3	11.6	7.3	17.8	11.7	23.5	4.5	19.9	9.0	66.5	10.4	52.7	15.1	17.4	20.6	21.0	9.1	17.5	17.3	11.4	61.1	16.1	11.3	8.4	18.4	4.1	12.8	9.7	13.8	30.1	11.8	1.9	22.3	11.8	15.2	15.8	16.3	19.1	19.0	15.6	35.1	18.7	4.1	24.5	9.8	11.6	47.9	11.8	26.4	19.2	20.4	14.0	27.8	48.1	14.9	11.2	20.6	3.8	6.1	20.2	28.1	24.1	96.1	20.2	10.9	30.4	13.7	5.1	22.9	27.6	10.6	5.9	138.4	16.4	10.1	3.9	13.6	20.7	0.2	11.4	13.6	30.5	12.9	16.6	17.2	3.2	25.5	16.4	35.6	27.0	21.8	24.5	19.5	23.3	60.8	101.1	215.2	97.4	79.7	62.2	36.8	53.1	71.2	97.5	33.0	41.2	69.1	48.6	64.6	83.7	120.5	60.7	112.3	16.3	18.2	18.6	16.4	15.5	17.9	17.7	17.4	17.8	17.4	17.5	18.4	7.5	6.4	2.7	13.1	7.0	1.8	2.5	4.6	3.4	1.1	4.0	3.6	42.2	4.3	4.4	0.0	6.2	2.3	13.6	28.4	3.9	3.5	1.3	2.3	4.6	5.5	7.3	16.4	2.2	4.3	2.3	6.1	9.2	2.1	1.3	3.8	7.5	64.2	16.9	0.0	3.8	12.7	2.0	13.4	4.5	1.8	10.5	10.0	1.8	1.0	31.3	2.9	32.0	1.0	6.0	3.7	16.4	12.4	12.6	3.9	51.8	16.7	5.9	1.3	0.0	5.4	5.3	8.3	7.1	4.1	1.3	1.2	14.4	27.7	16.6	2.9
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36677921-37172606	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"K-562: 26.4;Karpas-707: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	0.9	1.2	0.2	0.3	0.3	6.3	0.5	0.3	0.3	0.6	0.1	0.6	0.7	1.3	0.2	1.2	0.7	0.6	1.3	0.2	0.4	1.6	0.4	0.5	0.1	0.4	0.3	2.0	2.8	0.9	0.3	0.1	0.4	1.6	0.3	1.0	1.6	0.4	0.7	0.3	1.2	0.7	0.4	0.5	0.8	3.9	0.3	0.3	1.5	0.9	0.1	0.6	0.3	0.5	1.3	1.0	0.4	3.2	0.1	1.0	0.0	0.3	0.8	1.7	0.7	0.2	0.9	0.1	1.4	0.4	0.0	1.0	0.0	0.7	0.6	0.8	9.5	0.9	0.8	0.8	1.0	0.0	0.0	0.7	1.1	0.0	0.5	0.9	3.9	0.0	26.4	54.4	0.8	2.7	0.0	0.0	2.1	0.0	4.1	0.0	0.0	0.0	0.8	3.9	2.6	0.0	2.6	0.2	1.3	0.4	2.9	0.0	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.0	0.0	2.3	0.2	1.0	1.8	1.8	6.8	0.1	1.0	0.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.9	1.4	0.1	1.0	0.7	1.8	27.8	14.1	10.0	0.0	0.9	0.0	0.2	0.0	0.4	0.7	0.3	0.2	1.7	10.4	0.5	2.0	0.0	0.4	1.4	1.5	0.1	0.0	4.7	0.0	4.3	0.0	11.6	5.2	3.7	0.0	0.7	0.0	2.7	0.1	4.2	0.4	1.5	0.0	1.1	1.1	3.1	3.6	3.6	0.9	0.0	0.1	1.9	1.0	0.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 238.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.2;Proximal enterocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	28.8	38.0	144.8	12.0	238.7	0.8	18.0	77.5	200.1	32.1	72.0	94.4	39.3	41.8	24.0	64.7	36.6	21.4	79.0	206.5	95.1	45.0	38.5	24.0	9.2	108.8	98.2	33.6	24.2	58.8	22.2	4.7	109.5	35.0	49.1	41.2	68.9	40.0	90.8	33.5	40.5	65.5	82.7	11.9	41.3	9.5	101.4	7.2	60.7	78.2	31.2	55.8	31.1	115.8	58.2	22.9	32.2	101.9	42.3	18.6	14.9	17.0	26.4	31.0	37.2	58.2	37.1	32.2	40.0	41.3	34.1	48.0	66.3	39.0	24.3	0.1	58.6	23.2	46.7	46.2	39.2	1.6	52.5	53.3	33.4	27.6	12.0	62.9	32.8	34.7	68.8	39.4	6.2	41.6	20.7	32.8	23.6	61.0	71.1	10.0	8.8	49.4	83.3	10.2	2.4	31.9	11.7	70.8	30.0	34.8	37.1	50.1	11.7	9.8	41.8	2.6	11.2	7.3	10.7	28.3	4.5	54.2	15.6	0.5	0.0	0.0	2.0	0.0	0.4	1.0	1.1	0.9	0.2	0.4	1.5	1.4	0.0	0.3	0.0	0.4	1.3	0.4	144.8	238.7	77.5	200.1	206.5	95.1	108.8	98.2	109.5	82.7	101.4	115.8	6.2	9.6	20.9	11.8	7.0	10.5	8.8	11.5	12.0	13.1	18.9	15.6	39.5	47.1	10.0	46.0	8.4	1.4	4.5	164.2	19.6	54.7	15.9	8.2	6.4	8.0	13.8	1.3	24.7	28.5	1.8	10.2	12.8	17.5	7.0	17.9	16.1	38.0	2.7	8.4	17.9	34.5	10.2	3.0	2.6	71.2	19.0	1.4	17.8	12.2	1.0	28.7	4.1	17.1	12.6	55.5	57.9	29.3	17.6	13.6	106.8	28.7	6.4	22.0	13.1	12.1	12.7	0.5	4.6	34.1	23.3	0.8	5.2	39.5	34.2	30.3
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134043-108200849	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		19000	"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	10.0	6.2	0.8	5.3	0.7	3.8	8.2	0.6	1.3	12.5	0.8	13.5	11.4	6.6	3.2	6.0	6.7	6.8	4.9	0.7	0.8	6.3	1.6	9.1	5.1	0.8	0.7	5.9	4.2	8.2	2.8	9.4	0.9	4.0	16.0	6.7	6.7	4.6	3.7	4.3	12.3	8.7	0.6	5.7	6.9	3.2	1.0	5.0	7.1	4.5	4.9	10.1	7.0	0.7	38.2	8.9	28.8	8.6	17.9	23.4	11.4	13.0	17.0	25.1	27.4	11.3	12.9	0.0	10.3	28.7	10.9	14.1	7.9	24.0	35.1	7.9	4.4	2.4	13.4	5.2	14.9	6.1	4.9	17.6	17.0	15.0	18.5	16.8	19.6	5.7	6.2	13.0	32.2	28.7	3.7	1.4	14.3	17.3	8.1	5.7	33.9	12.6	16.9	22.8	5.0	8.7	17.4	14.9	17.5	27.5	13.3	10.7	10.5	13.8	6.2	23.2	15.0	3.0	2.3	0.0	5.0	11.8	8.2	0.4	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.3	0.1	0.2	0.7	0.3	0.4	0.1	0.8	0.7	0.6	1.3	0.7	0.8	0.8	0.7	0.9	0.6	1.0	0.7	33.9	54.5	27.8	5.5	24.2	15.6	20.4	20.6	17.1	14.7	25.5	16.8	15.5	17.2	33.5	18.4	8.4	7.1	16.3	126.7	21.5	31.2	3.2	62.0	46.7	28.6	18.1	6.7	18.0	36.9	60.2	23.2	40.2	61.7	22.2	20.9	29.6	1.2	54.1	10.1	14.9	43.2	18.3	51.8	32.8	2.9	19.6	50.0	23.2	16.9	44.7	12.7	11.3	14.6	20.8	67.6	51.2	18.0	9.7	14.3	54.4	24.9	55.2	33.9	52.6	27.2	26.5	6.2	2.4	24.8	14.9	6.2	23.9	41.8	59.1	33.8
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	55.3	22.9	16.0	12.5	16.5	9.5	22.9	14.7	19.7	33.2	10.6	17.2	11.9	26.8	3.3	35.0	40.7	39.9	12.8	18.1	17.4	28.6	136.5	27.9	11.2	19.9	18.1	25.3	82.6	19.6	45.7	11.5	17.9	15.2	7.8	31.2	16.5	14.2	82.0	24.4	18.3	26.3	15.4	15.6	23.7	7.6	19.6	15.3	18.9	21.1	6.2	19.0	21.4	14.9	9.5	9.8	13.6	19.8	10.1	8.6	9.0	19.3	17.8	15.9	10.5	17.7	9.7	12.2	5.8	9.0	8.8	16.6	10.8	6.3	6.0	14.3	8.9	7.1	21.6	10.7	16.0	8.3	15.7	11.0	6.0	15.5	11.3	5.2	10.9	20.1	26.1	25.7	10.1	22.9	14.7	8.4	13.8	30.5	15.1	14.3	11.6	26.1	6.1	9.8	33.6	14.5	20.2	12.9	27.8	5.3	14.2	4.7	7.0	17.9	10.6	13.6	19.3	22.3	42.2	13.2	12.1	4.4	15.0	2.6	1.7	0.9	3.0	5.1	1.6	1.2	3.4	3.1	3.1	1.8	2.7	4.9	0.3	1.0	6.1	1.0	2.7	3.2	16.0	16.5	14.7	19.7	18.1	17.4	19.9	18.1	17.9	15.4	19.6	14.9	59.3	22.4	34.2	17.6	9.3	26.1	46.2	24.3	56.3	18.8	71.7	73.5	3.2	58.6	22.8	20.2	127.2	10.1	7.6	45.6	11.7	11.2	0.3	72.0	34.5	44.7	51.7	11.0	19.7	11.5	12.9	21.0	43.8	110.3	8.2	18.7	26.0	84.5	9.1	18.5	20.5	26.5	28.5	20.1	42.9	1.5	9.3	16.8	21.4	13.1	12.6	15.2	12.3	11.1	2.4	12.1	42.7	8.2	14.5	28.6	47.7	10.2	30.8	70.4	19.7	48.1	40.3	5.6	7.9	89.5	43.0	23.0	14.2	11.9	22.3	58.3
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291116-100306547	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 419.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	28.0	44.6	57.6	5.3	66.1	13.5	34.4	71.1	74.2	46.8	72.2	20.2	8.1	32.1	37.5	36.3	84.4	12.2	30.5	56.9	57.8	124.5	35.9	44.1	8.1	91.8	69.3	49.9	22.2	6.6	62.8	6.6	83.8	69.1	5.3	47.4	45.5	12.6	11.9	42.4	18.5	8.2	68.7	20.5	26.6	44.8	66.8	8.8	419.6	6.0	5.7	26.9	27.0	94.9	11.0	23.2	29.7	39.0	6.8	2.5	17.4	8.2	8.9	16.8	9.9	5.4	6.7	0.0	20.4	2.8	8.6	11.5	12.7	4.2	5.6	4.2	5.4	10.4	35.8	9.9	16.1	6.1	13.0	7.4	12.9	7.7	7.1	25.5	23.3	35.7	3.4	1.2	4.9	34.8	37.9	33.6	14.8	9.7	22.5	49.1	12.4	0.8	55.5	7.7	42.9	52.8	19.3	13.2	15.4	12.5	33.0	10.2	24.5	6.1	11.7	8.6	12.9	2.9	1.3	1.4	6.9	14.9	7.6	1.5	1.1	2.1	0.9	0.2	0.0	0.1	0.4	0.9	1.2	0.5	0.1	0.6	1.2	0.1	0.0	0.5	0.6	0.2	57.6	66.1	71.1	74.2	56.9	57.8	91.8	69.3	83.8	68.7	66.8	94.9	23.5	9.6	26.5	108.7	5.8	6.5	16.3	14.8	22.8	17.9	57.1	38.5	1.4	11.5	23.3	123.2	75.0	6.2	17.8	9.4	17.6	31.4	19.7	136.7	24.8	20.9	20.9	3.8	26.4	11.8	0.7	10.9	12.2	136.0	14.5	22.6	31.8	9.5	7.4	21.9	22.4	8.8	12.2	2.8	30.0	62.4	2.5	11.7	10.6	30.9	8.8	21.0	12.3	42.7	78.5	14.2	17.0	6.0	4.1	39.6	4.6	13.1	45.1	82.7	13.1	7.0	12.6	4.2	5.0	24.5	6.5	18.6	6.4	6.3	14.3	13.8
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	272	"testis: 47.3"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539465-9585173	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 27.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 422.0;Late spermatids: 559.8;Spermatocytes: 358.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	11.3	3.4	12.4	2.6	13.6	9.0	6.0	15.1	13.8	2.5	11.9	4.6	2.2	3.0	12.6	2.9	3.0	3.7	5.2	12.2	14.5	10.0	12.6	2.7	3.3	14.1	14.7	2.7	3.7	3.9	5.6	1.4	13.7	4.1	3.7	11.2	5.4	2.0	18.1	2.5	2.6	2.7	14.5	2.3	4.4	13.4	15.8	3.5	5.1	27.5	3.5	4.0	2.3	14.5	6.9	3.1	8.7	13.4	7.0	4.0	5.6	6.5	6.1	10.8	9.5	6.9	5.2	19.8	7.8	5.4	11.3	2.8	22.2	4.3	13.3	15.3	13.9	19.5	4.2	27.5	15.1	19.6	14.8	4.8	7.5	10.8	5.2	2.6	6.4	14.5	19.2	10.0	6.1	7.2	12.5	13.4	10.7	12.5	7.3	16.5	9.2	12.8	6.9	3.8	15.1	9.7	7.3	22.2	20.0	7.5	8.2	14.2	2.8	6.8	9.0	9.2	8.4	11.8	23.6	33.5	4.9	21.6	8.4	2.8	0.3	0.1	0.5	0.4	0.3	0.8	0.4	0.3	0.6	0.3	0.6	0.7	0.4	0.5	0.4	0.5	0.0	0.1	12.4	13.6	15.1	13.8	12.2	14.5	14.1	14.7	13.7	14.5	15.8	14.5	25.7	3.2	13.1	59.1	34.4	51.5	107.3	4.2	69.4	15.1	60.0	39.5	9.3	37.1	6.8	9.2	52.1	14.0	32.9	22.5	199.6	11.5	422.0	38.1	19.0	19.9	66.3	8.2	12.3	15.1	38.6	27.2	30.1	39.8	23.6	9.5	11.4	55.8	21.3	10.1	18.2	27.5	6.1	9.2	66.8	559.8	9.9	30.7	32.0	5.6	11.7	195.3	9.2	13.6	13.7	11.5	14.4	10.1	20.4	94.7	6.6	29.5	8.0	53.3	6.6	41.5	37.0	358.5	115.1	42.6	35.8	39.3	22.7	16.7	32.4	96.2
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295400	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	5.7	8.3	2.9	4.9	3.9	6.1	8.6	3.5	4.4	10.0	4.6	7.7	6.1	13.4	7.6	5.4	7.1	5.2	4.8	2.9	3.2	15.0	4.6	6.8	5.0	3.9	4.0	2.9	12.2	6.1	12.8	4.1	4.1	8.7	5.3	4.5	6.4	5.2	2.2	4.5	7.7	4.1	3.3	8.9	12.5	24.5	4.4	5.2	9.1	1.5	3.5	6.0	5.0	4.2	5.0	13.5	2.4	10.0	7.5	2.9	5.5	3.2	2.8	3.4	3.7	1.6	12.4	5.8	3.3	3.7	7.1	11.0	2.8	3.8	1.9	3.2	3.6	4.8	11.1	1.9	2.7	0.7	12.8	5.9	2.1	6.5	1.2	2.5	5.4	6.8	1.4	2.0	2.9	2.7	5.3	2.7	0.8	3.4	4.4	5.8	1.6	2.6	2.6	12.6	1.2	3.0	9.2	5.4	4.1	2.4	12.2	3.6	7.6	2.3	1.7	5.6	2.7	4.3	2.9	2.1	5.9	8.6	6.1	4.1	5.6	7.6	4.0	8.8	3.3	1.9	3.7	4.3	5.7	3.6	1.3	2.5	1.1	2.8	6.5	3.0	4.1	2.5	2.9	3.9	3.5	4.4	2.9	3.2	3.9	4.0	4.1	3.3	4.4	4.2	3.1	0.0	5.4	5.2	3.6	0.8	1.5	1.4	2.8	4.3	6.3	4.1	1.0	5.7	1.8	11.0	8.4	9.2	2.1	3.8	11.7	2.8	3.8	10.2	1.9	2.8	9.0	4.6	0.5	7.1	2.3	3.0	5.1	10.6	5.1	1.3	1.8	2.8	6.7	1.7	0.7	3.0	2.0	6.4	1.5	5.5	1.5	4.2	0.0	4.7	5.8	7.9	3.1	1.0	2.5	3.2	6.0	1.2	3.7	1.9	2.4	7.3	2.0	9.0	0.0	1.1	1.2	20.9	0.8	1.9	0.3	17.4	3.2	9.1	3.1	1.9
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140980995	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	27.1	22.2	16.6	14.3	16.2	61.6	33.5	16.2	22.7	31.9	13.9	25.7	30.9	34.4	47.7	15.0	32.6	18.4	39.8	16.1	20.1	38.7	4.2	27.5	21.3	17.0	16.4	39.0	45.2	28.9	26.9	26.4	17.5	27.1	19.5	42.6	23.4	20.8	38.4	22.5	22.9	19.2	16.9	20.1	34.0	23.8	18.2	20.6	31.8	20.8	17.6	23.0	23.9	21.5	52.3	11.5	36.0	30.8	33.0	40.7	46.2	19.4	23.6	18.2	27.3	28.6	24.0	42.1	46.9	17.3	31.2	34.9	40.1	15.2	40.6	33.8	36.5	33.9	29.8	20.9	45.9	48.8	21.3	44.1	61.1	15.4	45.8	44.4	22.0	32.0	17.6	27.4	29.2	22.8	30.6	34.1	37.8	12.8	18.4	34.2	32.0	59.6	23.5	17.7	22.4	38.2	26.7	45.1	80.9	30.3	32.6	29.2	24.1	29.5	17.1	52.2	19.0	56.4	36.8	51.2	36.0	21.1	15.0	10.7	9.2	15.1	9.6	11.5	11.8	16.3	9.6	10.2	14.0	15.1	13.5	12.6	1.7	18.3	13.5	9.7	9.9	9.8	16.6	16.2	16.2	22.7	16.1	20.1	17.0	16.4	17.5	16.9	18.2	21.5	60.3	99.3	143.0	85.5	47.6	68.2	68.0	38.1	116.7	106.0	72.2	77.5	90.3	38.6	52.0	71.7	133.5	58.8	58.2	22.7	64.6	26.4	10.6	113.4	78.0	45.8	59.3	27.3	127.7	38.3	38.0	73.9	58.1	106.3	65.9	92.8	35.7	0.5	26.5	92.5	115.6	32.5	30.5	38.2	45.8	16.0	59.7	38.4	56.9	46.9	36.9	68.2	25.7	108.6	109.1	29.3	22.8	59.5	48.2	88.9	44.9	57.5	98.8	121.8	59.2	80.0	59.2	59.4	68.8	61.3	54.4	49.4	49.1	83.2	46.8	78.9
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528956-23575463	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 57.7"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 57.7"	"Cell line enhanced"	"Detected in all"		"HEL: 118.7;hTERT-RPE1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	14.5	41.9	13.5	16.5	16.9	138.4	17.9	13.4	21.0	26.8	15.2	11.4	50.6	9.8	6.0	9.9	17.2	6.7	15.3	13.4	14.0	20.1	25.2	26.4	6.0	15.0	14.1	23.0	29.5	10.9	15.0	8.0	15.4	35.5	5.7	10.3	36.7	7.5	16.2	10.1	21.8	5.7	13.0	46.1	11.1	6.8	15.0	2.8	14.6	12.7	5.0	13.4	20.4	14.6	9.6	10.3	10.7	9.9	13.7	16.8	15.7	7.4	9.6	5.3	5.9	10.4	19.9	15.3	8.7	6.3	34.5	12.0	9.9	20.0	7.2	2.3	4.9	118.7	19.4	3.7	11.5	6.7	4.4	14.5	19.2	11.6	11.5	65.9	8.4	12.3	26.3	7.5	8.5	4.2	8.1	28.1	5.4	11.6	7.5	8.3	5.3	6.0	16.4	5.2	3.2	4.6	10.1	15.2	7.6	10.0	4.4	10.3	13.3	25.6	3.8	15.3	14.5	5.9	2.4	9.4	24.1	16.1	16.5	1.4	3.0	2.7	1.1	1.1	0.9	2.3	0.6	0.5	2.8	1.5	2.1	1.2	57.7	1.3	1.5	0.6	1.3	1.4	13.5	16.9	13.4	21.0	13.4	14.0	15.0	14.1	15.4	13.0	15.0	14.6	43.5	38.5	61.7	36.6	45.5	93.3	125.2	95.8	28.5	35.6	120.0	49.1	35.6	61.5	75.8	77.3	68.8	44.6	19.1	78.4	15.6	93.8	707.8	33.1	68.6	94.5	20.4	4197.2	44.0	226.4	76.4	95.4	43.8	50.0	36.8	49.7	151.3	38.8	41.7	6.7	37.3	44.7	36.7	59.0	141.2	1087.9	52.5	86.8	69.4	73.1	45.5	30.5	10.3	16.1	21.9	176.9	47.7	37.2	24.0	347.1	189.0	34.1	42.5	59.7	19.7	55.9	52.3	24.6	42.3	23.3	53.8	18.3	32.4	86.7	70.3	137.6
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383370-39397351	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	19.1	35.4	22.2	18.8	23.3	70.0	21.0	25.9	26.8	23.8	33.6	28.1	25.3	27.3	27.6	14.5	27.3	19.4	20.7	22.9	26.3	28.7	58.0	21.0	36.2	24.2	24.1	44.1	45.6	38.7	30.7	15.4	25.3	29.2	36.9	23.0	22.5	23.9	48.2	16.7	25.2	20.3	22.6	27.2	33.8	18.7	26.0	33.6	52.0	35.7	35.4	27.8	19.1	23.3	24.3	38.3	24.3	41.2	56.4	46.4	30.8	33.6	46.1	48.3	43.7	26.3	5.6	67.8	19.6	31.6	40.7	18.4	55.2	40.1	36.0	43.6	45.0	52.0	33.5	40.2	75.6	37.7	33.9	58.8	46.1	46.2	93.2	44.6	31.5	52.8	47.7	40.6	36.4	35.2	44.7	67.0	66.2	35.9	44.3	16.2	26.4	47.7	37.5	45.4	24.3	31.1	11.9	65.9	34.0	44.5	33.5	35.0	26.9	38.3	26.4	56.2	48.9	54.7	93.1	41.9	29.3	48.3	24.7	30.7	9.6	18.1	38.8	5.7	44.7	50.8	39.1	43.3	14.9	37.8	41.7	40.5	1.0	57.0	8.4	18.5	55.3	29.2	22.2	23.3	25.9	26.8	22.9	26.3	24.2	24.1	25.3	22.6	26.0	23.3	10.4	22.4	27.4	8.5	35.6	11.5	13.0	12.5	28.5	13.2	26.1	22.6	16.8	22.8	9.6	27.6	6.2	35.2	33.1	21.9	21.5	15.7	6.5	26.6	16.3	11.1	12.6	73.7	8.9	16.9	32.6	13.7	16.8	38.5	22.2	24.0	9.7	27.0	15.2	5.0	10.1	25.6	12.2	7.0	13.7	12.9	15.5	9.8	12.4	1.9	11.2	18.9	29.9	7.1	6.2	13.4	22.2	13.5	23.3	17.7	23.1	31.3	12.3	12.6	6.6	15.2	14.9	11.0	7.8	19.4	10.2	19.4	36.6	32.8	26.7	8.4
SLC25A39	"CGI-69, FLJ22407"	ENSG00000013306	"Solute carrier family 25 member 39"	Q9BZJ4	17	44319625-44324870	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Heme biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 491.0;Erythroid cells: 1310.3;Late spermatids: 756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026785	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026785: AB_10601715"	"unprognostic (8.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.21e-2)"	52.4	123.2	71.4	49.3	72.6	305.6	49.6	72.1	84.4	53.3	84.4	77.5	73.9	47.3	39.8	143.4	44.6	41.7	68.4	67.8	72.4	178.0	142.8	56.1	48.7	75.3	72.7	44.9	120.8	98.9	73.4	46.3	74.9	75.3	47.3	9.4	77.7	43.9	44.7	87.1	62.7	30.4	72.4	89.2	81.8	89.4	76.2	35.6	87.1	47.9	40.2	55.9	62.2	71.4	247.0	152.9	47.0	198.0	89.3	68.8	163.0	79.9	71.8	101.8	78.3	151.9	116.0	131.0	137.7	114.0	180.6	124.0	147.2	242.6	35.9	154.9	236.2	68.9	131.2	281.2	97.1	120.9	145.0	104.8	211.9	95.5	122.2	92.2	105.2	195.3	205.7	204.0	87.4	463.5	153.3	118.0	92.5	187.3	417.4	182.6	129.1	375.6	177.9	128.8	316.1	118.2	92.5	146.5	166.8	85.9	281.3	102.4	76.2	132.9	185.9	229.6	160.3	126.9	165.1	122.6	119.7	93.8	82.4	36.5	56.2	29.2	73.7	83.5	83.0	96.1	79.1	79.0	89.5	78.0	80.3	74.1	8.2	139.6	87.7	103.5	80.3	93.2	71.4	72.6	72.1	84.4	67.8	72.4	75.3	72.7	74.9	72.4	76.2	71.4	36.1	9.6	25.4	17.6	52.2	53.3	71.2	117.2	42.1	18.8	93.2	77.0	27.0	52.9	79.9	69.9	10.4	93.1	42.3	123.7	491.0	188.1	223.6	28.6	24.7	44.5	65.3	1310.3	20.7	310.6	166.3	35.2	71.9	54.1	32.9	44.4	30.0	75.7	134.7	13.5	19.5	120.9	132.2	62.5	44.7	756.5	39.7	61.6	92.5	10.3	99.9	45.3	62.8	8.0	16.0	176.7	88.9	38.7	80.0	162.4	130.9	322.8	41.3	15.3	19.7	27.9	52.3	134.4	105.5	110.7	64.6	117.5	51.8	75.4	157.7	108.2
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC25A40	MCFP	ENSG00000075303	"Solute carrier family 25 member 40"	Q8TBP6	7	87833568-87876360	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055197	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA055197: AB_2682735"	"unprognostic (4.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.80e-2)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.52e-5)"	"unprognostic (8.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.85e-2)"	4.8	7.0	4.0	8.5	4.3	7.6	8.0	6.4	6.5	5.9	2.6	7.8	6.6	6.8	6.1	5.8	6.2	5.5	9.7	4.6	4.6	8.2	6.7	5.9	10.6	4.7	4.9	8.6	4.3	9.4	3.6	3.8	4.9	8.6	9.6	8.7	6.0	5.1	6.3	8.1	7.1	5.3	2.9	8.9	7.1	4.8	6.0	9.6	7.1	5.2	9.9	5.2	4.2	5.0	20.3	5.3	16.3	6.3	6.5	10.4	4.8	14.3	12.6	10.1	14.7	4.6	28.2	23.8	9.1	7.1	16.3	8.7	8.0	8.2	14.5	15.1	4.0	12.6	12.3	5.7	6.2	30.8	16.2	6.3	5.8	9.2	7.2	8.5	11.0	18.9	13.9	34.0	17.5	8.6	35.7	25.6	7.6	16.6	5.9	17.6	20.6	21.0	14.7	10.8	8.0	19.2	18.4	17.8	14.1	13.1	8.7	24.0	7.7	17.3	12.8	27.2	13.8	18.7	21.6	30.6	12.0	37.0	36.1	9.1	3.5	5.0	1.1	3.7	1.8	1.5	1.6	1.6	3.9	1.7	1.7	1.6	1.9	4.0	4.0	1.0	1.9	1.5	4.0	4.3	6.4	6.5	4.6	4.6	4.7	4.9	4.9	2.9	6.0	5.0	5.8	3.2	5.3	33.0	12.3	7.5	6.1	4.0	12.0	5.7	8.3	5.2	16.6	12.8	7.7	7.3	10.4	8.6	10.5	9.6	15.6	3.8	10.0	5.7	5.0	5.9	3.0	17.9	35.2	3.9	8.4	5.7	9.2	6.4	5.1	9.1	6.1	8.1	11.1	3.3	37.0	8.9	6.1	28.6	4.1	3.9	7.8	19.4	21.4	19.7	17.5	4.5	5.2	32.2	30.8	6.5	13.8	10.9	18.8	3.5	7.2	8.6	5.2	4.9	13.1	4.6	4.4	9.0	5.0	10.4	8.0	3.7	9.4	9.1	10.0	5.5
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.3;choroid plexus: 4.3;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 92.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;U-937: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043591	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.1	0.1	4.7	0.0	5.3	0.0	0.0	4.6	6.3	0.2	4.3	0.6	0.0	0.1	0.0	0.3	0.2	0.0	0.3	4.8	4.7	0.2	0.3	0.0	0.0	4.6	4.6	0.3	0.1	0.0	0.2	0.0	4.9	0.4	0.0	0.3	0.1	0.1	0.3	0.2	0.2	0.1	4.4	0.1	0.2	2.1	4.5	0.0	0.2	0.0	0.0	0.3	0.2	4.4	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.6	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.3	4.6	6.3	4.8	4.7	4.6	4.6	4.9	4.4	4.5	4.4	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.3	0.0	1.0	0.2	0.3	0.5	0.0	0.0	0.0	2.1	0.4	0.1	0.4	0.0	0.3	92.2	0.1	0.1	0.0	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	3.3	4.5	0.4	0.0	0.0	0.0	20.6	0.9	0.1	0.0	0.0	0.0	1.1	0.0	1.0	1.6	0.6	0.2	0.0	0.0	0.2	0.2	0.2	0.1	1.2	0.0	0.1	0.1	0.3	0.6	0.0	0.3	0.5	0.0	0.0	0.4	0.1
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.7;NK-cells: 103.0;Proximal enterocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;Karpas-707: 22.8;RPMI-8226: 17.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA042495, HPA050821"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA042495: , HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	3.7	3.3	3.1	5.8	3.3	4.9	4.7	2.8	4.1	1.9	2.6	3.4	5.6	1.8	2.5	2.5	2.0	2.0	3.8	3.1	3.1	6.5	12.1	3.9	10.1	3.7	3.1	1.9	34.2	3.0	6.6	1.9	3.5	3.8	1.8	0.3	6.3	1.9	7.1	2.9	7.6	1.3	3.3	13.3	2.8	1.9	3.1	8.0	12.1	3.7	6.6	2.0	1.9	4.0	0.4	5.8	0.2	8.5	1.5	0.7	4.2	1.0	2.6	0.5	0.5	1.4	2.7	5.2	4.7	2.4	2.1	0.8	0.6	0.4	0.0	17.5	1.2	5.7	3.2	0.4	0.9	1.8	5.7	1.9	0.1	0.7	0.5	0.4	0.9	9.9	0.8	22.8	0.9	1.9	4.2	0.1	0.3	0.3	2.6	7.7	1.1	17.1	0.9	0.1	2.8	3.7	1.8	4.5	1.0	0.5	2.4	0.9	1.7	0.6	2.0	5.5	0.4	9.5	6.4	1.5	1.7	1.3	3.3	10.5	6.3	4.8	8.8	11.2	9.3	10.6	7.8	8.5	6.9	11.9	12.4	9.3	3.9	17.1	13.3	23.0	7.7	3.1	3.1	3.3	2.8	4.1	3.1	3.1	3.7	3.1	3.5	3.3	3.1	4.0	5.0	0.0	5.6	0.3	40.0	2.8	5.9	4.2	3.4	12.3	10.7	7.7	5.6	8.6	4.7	12.9	0.0	2.1	46.7	14.4	0.0	5.9	5.1	6.2	3.1	6.0	6.7	3.0	5.2	5.4	1.7	7.7	5.6	7.9	4.5	21.8	6.8	14.0	7.3	6.7	0.6	16.7	4.1	9.7	14.4	3.9	6.8	11.7	5.4	4.7	18.4	5.5	103.0	1.5	3.9	5.2	12.5	3.8	15.3	7.0	90.9	6.9	12.3	0.4	6.6	12.6	3.6	2.2	0.4	2.2	2.0	1.5	31.6	11.8	13.3	4.6
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 238.9;Late spermatids: 448.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	22.9	15.9	10.4	19.9	11.8	17.6	16.4	12.7	16.7	18.5	7.8	22.1	23.8	14.7	10.5	21.2	10.7	15.8	31.1	12.2	12.2	29.7	30.0	16.7	22.5	12.4	10.2	11.7	15.4	20.6	4.9	17.0	13.2	15.7	21.6	18.8	13.3	16.0	55.8	14.9	20.9	20.8	10.3	15.7	20.1	21.9	11.2	24.8	19.8	60.2	26.8	19.0	6.6	14.1	36.2	27.7	25.7	20.7	65.2	60.2	9.9	44.3	55.9	47.5	59.3	37.6	28.7	96.8	44.8	50.1	61.9	29.6	41.0	71.2	54.3	61.8	20.8	40.1	35.2	25.6	53.1	37.3	40.2	49.9	25.4	55.5	39.6	29.5	31.9	37.2	31.4	56.4	54.1	27.3	54.0	17.2	18.1	25.7	24.7	26.0	57.0	71.5	35.1	39.2	46.7	33.5	37.7	29.7	49.7	23.7	30.9	35.3	42.5	43.6	21.0	40.7	54.4	111.8	76.2	68.4	48.0	43.8	24.0	29.2	16.0	13.2	12.3	19.0	12.5	14.4	13.7	12.9	17.0	14.5	14.5	14.8	6.6	20.9	17.7	11.1	18.2	17.4	10.4	11.8	12.7	16.7	12.2	12.2	12.4	10.2	13.2	10.3	11.2	14.1	21.3	22.4	24.8	40.8	26.7	22.9	9.1	16.0	31.9	16.8	15.7	10.8	63.5	11.5	12.9	20.2	22.9	21.7	18.0	34.8	19.6	18.1	238.9	10.4	20.1	18.9	23.4	29.9	73.3	25.6	18.2	22.6	34.7	12.1	19.0	16.2	26.7	43.9	27.2	18.5	63.9	28.3	32.6	26.1	21.0	448.2	21.1	23.9	30.2	31.9	28.1	21.9	17.5	49.8	91.8	18.9	22.8	22.2	73.8	8.0	26.5	41.7	14.9	14.1	19.7	18.5	22.6	23.3	14.2	30.0	26.9	20.5	23.9	22.7	24.0	6.8
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.2;skeletal muscle: 8.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 31.0;Distal tubular cells: 9.8;Proximal enterocytes: 11.1;Proximal tubular cells: 45.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;HEK 293: 2.0;HEL: 1.7;RPMI-8226: 1.9;SCLC-21H: 1.9;U-2 OS: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Intermediate filaments"	"Actin filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	0.9	0.1	13.5	0.3	14.4	0.2	1.1	10.9	16.4	0.3	4.8	0.9	0.7	0.2	0.1	0.4	0.1	0.2	0.2	14.4	17.7	7.5	0.5	0.0	0.3	14.7	18.0	0.1	2.1	0.0	0.1	0.4	17.5	0.4	0.9	0.5	1.7	0.0	8.8	1.9	2.4	0.1	16.8	0.2	0.1	0.4	18.3	0.0	0.2	2.3	0.1	0.1	0.2	28.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	2.7	0.0	0.0	0.3	2.0	1.7	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	1.9	0.1	0.2	1.9	0.2	0.3	0.2	0.4	0.7	1.0	0.2	0.1	0.1	2.3	0.1	0.1	0.8	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	13.5	14.4	10.9	16.4	14.4	17.7	14.7	18.0	17.5	16.8	18.3	28.2	0.1	0.0	0.0	31.0	0.0	2.4	0.1	0.0	0.0	0.2	2.3	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	9.8	0.0	0.0	2.0	1.2	0.1	0.0	0.0	0.6	0.0	0.2	0.7	0.0	7.1	0.0	0.0	0.0	1.3	0.1	0.0	3.1	2.8	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.0	5.0	4.2	0.1	5.0	0.0	0.0	0.3	11.1	45.8	0.0	0.2	0.0	0.5	0.1	0.5	4.3	0.0	0.9	0.1	0.1	0.0	1.6	0.1
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468422-119471396	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	178.1	178.3	116.9	176.0	116.1	260.9	161.3	141.6	126.0	155.0	114.3	458.7	740.2	134.5	63.9	411.0	118.6	100.4	196.1	109.0	141.5	491.8	336.1	216.5	255.4	120.6	118.0	108.2	629.1	295.3	89.0	138.1	126.4	111.9	503.0	127.7	250.2	103.8	61.6	294.9	562.8	150.5	119.3	182.6	492.1	54.2	126.4	351.9	128.8	65.1	297.7	200.8	235.3	121.5	845.1	789.6	303.3	525.4	189.5	277.3	561.0	306.8	331.3	631.7	560.8	662.4	518.4	1059.3	400.9	296.1	456.1	576.9	752.1	640.5	572.5	281.1	711.2	357.5	418.7	477.0	239.8	984.0	566.1	303.7	705.2	652.2	412.6	240.1	660.4	535.0	292.5	425.9	350.1	1868.4	878.6	995.1	640.4	1147.6	1244.3	474.5	383.4	825.7	486.9	663.6	365.0	344.5	526.7	793.3	646.7	306.7	327.7	491.0	279.5	297.3	428.9	670.8	1122.2	494.6	656.3	847.4	329.5	987.7	492.2	113.4	603.4	170.2	170.7	1045.7	198.1	459.2	248.3	224.6	872.6	376.0	243.3	232.1	99.2	318.1	824.2	476.1	443.1	931.8	116.9	116.1	141.6	126.0	109.0	141.5	120.6	118.0	126.4	119.3	126.4	121.5	260.4	163.5	308.6	28.7	339.6	815.7	567.0	1615.3	398.9	109.8	406.2	413.5	131.2	301.7	609.2	187.6	60.5	1038.8	336.2	1379.0	2533.6	578.2	4.0	137.3	134.2	257.5	401.0	349.1	16.8	1056.4	463.1	214.4	543.3	157.6	192.9	306.0	146.7	333.6	881.7	26.9	25.5	856.4	1129.1	610.6	650.9	18.1	145.4	473.2	547.8	15.0	441.2	140.8	218.3	24.1	19.2	554.1	1061.8	110.6	419.9	522.3	2785.2	1622.3	239.5	199.0	131.5	163.9	506.7	11.5	119.2	1046.8	960.2	1589.1	291.2	626.6	1053.7	809.7
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 93.6;Late spermatids: 169.6;Spermatocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	9.0	3.1	3.1	5.0	3.5	12.0	4.1	3.4	4.4	5.4	2.3	4.5	7.5	4.1	4.7	5.6	3.4	5.0	4.5	3.7	4.1	6.3	3.1	5.2	5.7	3.4	3.3	3.8	5.9	8.3	4.1	4.7	4.0	3.5	4.1	4.8	4.7	3.7	6.1	5.7	6.0	5.8	2.6	5.7	4.3	8.0	3.1	5.6	4.6	7.4	6.5	4.3	3.5	4.4	12.4	10.1	7.3	11.6	34.4	15.2	7.4	10.6	10.7	8.8	12.6	13.0	5.2	26.2	5.9	24.2	12.5	6.1	19.6	14.5	16.5	18.0	6.1	8.0	27.5	18.0	19.1	12.5	11.1	15.3	16.7	13.4	16.6	13.6	16.1	24.4	17.9	20.2	19.1	7.3	15.2	3.2	9.2	12.7	7.1	10.6	9.9	16.1	8.7	8.9	15.2	10.0	8.3	10.1	6.0	12.2	5.4	13.7	17.3	14.7	17.4	7.2	12.8	7.7	17.5	17.5	19.4	9.3	12.3	16.7	1.5	2.8	1.6	3.1	2.7	2.6	1.7	2.3	1.1	1.5	1.6	1.8	1.3	1.9	1.3	0.5	2.7	0.9	3.1	3.5	3.4	4.4	3.7	4.1	3.4	3.3	4.0	2.6	3.1	4.4	4.3	9.6	1.1	13.4	9.3	4.7	5.8	7.6	8.6	4.0	5.1	3.8	6.3	5.7	4.6	1.8	4.2	3.7	7.6	3.8	17.6	9.5	93.6	2.5	5.3	4.3	3.6	6.9	22.0	7.2	14.1	5.2	8.2	5.1	3.8	3.4	3.9	3.6	11.7	1.7	21.3	5.8	0.0	5.7	4.7	169.6	3.7	8.8	1.8	19.7	8.4	5.3	3.1	16.1	22.1	7.3	7.2	4.1	14.3	3.8	17.4	16.8	2.2	3.7	0.0	4.3	4.5	44.0	10.2	11.7	5.8	4.0	6.5	4.8	3.6	3.8
SLC25A52	MCART2	ENSG00000141437	"Solute carrier family 25 member 52"	Q3SY17	18	31759584-31760880	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 8.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 55.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (8.97e-2)"	"unprognostic (4.85e-2)"			"unprognostic (2.93e-1)"	"unprognostic (4.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.30e-4)"	"unprognostic (7.15e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A53	MCART6	ENSG00000269743	"Solute carrier family 25 member 53"	Q5H9E4	X	104099214-104157009	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 6.1;Karpas-707: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034959	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA034959: AB_10602025"	"unprognostic (4.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.94e-2)"	"unprognostic (9.76e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-2)"	0.1	0.3	1.0	1.0	1.0	0.4	0.2	1.3	1.1	0.2	0.3	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.3	1.1	0.9	0.1	0.1	0.2	1.9	0.9	1.1	0.4	0.5	0.1	0.2	0.1	0.9	0.2	0.4	0.4	0.1	0.1	0.1	0.2	1.0	0.2	1.0	1.3	0.4	0.6	1.0	0.5	0.1	0.0	1.6	0.2	0.1	1.3	0.0	0.1	1.7	1.1	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	6.1	0.1	0.0	0.3	0.1	2.0	0.0	0.1	0.5	0.8	0.7	0.2	0.1	0.1	1.1	0.7	0.3	0.0	0.2	0.0	0.3	0.4	0.6	0.1	13.9	0.1	0.1	0.2	0.1	2.2	0.1	0.4	2.5	0.9	0.2	0.3	0.2	1.5	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.8	0.1	0.4	0.1	0.0	2.2	0.1	1.6	0.4	0.2	0.1	0.2	0.3	0.1	0.6	0.5	0.3	0.5	0.1	0.4	0.0	0.3	0.7	0.2	0.0	0.0	0.5	0.1	1.0	1.0	1.3	1.1	1.1	0.9	0.9	1.1	0.9	1.0	1.0	1.3	6.6	6.4	4.6	26.4	11.4	5.2	8.8	6.2	4.0	3.5	7.2	5.7	15.1	5.7	4.6	9.2	0.0	3.7	9.6	17.3	25.4	4.3	6.8	6.9	4.7	5.3	7.2	19.4	15.5	6.0	4.2	7.6	7.7	7.2	7.0	2.7	6.4	25.1	10.6	3.3	14.1	7.8	4.1	8.8	5.7	1.3	3.1	7.5	1.8	16.9	11.4	4.0	17.5	17.1	23.5	7.8	21.8	3.0	10.2	8.8	19.7	25.9	10.8	8.1	0.0	5.2	5.0	4.8	2.3	4.7	5.7	6.2	11.0	3.0	4.5	11.3
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	356.6	410.1	227.8	223.3	241.4	441.5	307.3	210.8	296.7	253.7	351.6	350.9	466.0	277.9	80.6	344.8	243.4	127.2	201.5	227.9	216.1	386.8	130.0	239.4	275.0	222.6	222.8	460.8	626.9	323.5	275.8	147.1	228.0	264.1	141.5	108.3	697.7	178.8	115.5	331.3	387.7	129.4	208.3	263.7	413.9	62.2	227.4	232.7	321.5	89.2	159.3	292.0	244.6	219.2	290.4	596.8	393.8	422.6	267.5	527.4	466.2	396.8	386.1	296.8	289.2	796.7	330.6	1023.0	334.1	264.9	445.6	179.2	269.5	482.0	89.8	260.3	886.0	545.0	396.0	899.7	642.2	398.1	649.8	870.1	882.2	235.8	335.9	367.5	441.6	315.7	407.2	233.8	284.5	575.4	791.1	733.3	516.0	105.5	802.2	378.8	333.8	828.3	351.4	693.6	682.9	1096.5	271.1	817.7	1239.7	224.1	466.1	832.5	505.5	305.1	169.6	596.5	422.1	606.7	110.5	705.9	48.7	389.9	170.3	34.2	739.8	47.2	319.5	808.7	466.9	671.4	431.3	377.9	985.9	532.5	396.1	399.7	34.4	359.9	832.3	461.2	447.6	1120.7	227.8	241.4	210.8	296.7	227.9	216.1	222.6	222.8	228.0	208.3	227.4	219.2	194.2	147.4	244.3	13.7	724.4	1151.2	1447.6	1800.6	421.8	286.1	981.3	710.8	106.0	371.8	704.7	316.3	98.0	1581.2	448.5	690.4	1659.2	752.6	11.4	164.4	388.1	473.0	928.4	471.3	15.1	1473.5	1229.8	507.8	374.1	245.3	343.6	698.0	529.4	149.7	1264.7	242.3	20.4	1208.1	819.9	1553.5	1299.4	45.8	667.9	764.0	754.2	17.8	1450.5	184.6	531.4	8.0	13.7	789.8	1127.8	366.3	604.9	1452.4	1564.9	1320.8	180.3	280.0	341.8	631.7	665.6	13.3	80.7	796.7	1321.5	1744.1	494.7	847.8	1524.3	1723.2
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	12.2	36.5	27.4	8.9	24.8	16.4	11.8	14.1	23.2	16.3	21.9	12.1	7.2	11.6	8.9	7.5	13.5	7.6	7.1	21.1	45.5	19.1	10.2	18.8	14.1	27.8	33.3	22.5	10.6	11.8	35.1	9.0	30.1	16.8	4.1	11.6	11.3	9.2	5.9	13.0	11.2	6.0	17.7	22.6	10.0	4.8	42.2	3.4	24.8	3.6	5.6	11.6	12.1	17.4	0.7	12.4	14.3	11.1	7.1	5.2	16.1	6.7	8.4	15.6	9.4	13.6	2.5	0.1	13.1	7.4	11.3	4.4	8.0	5.2	6.1	15.7	14.4	0.0	17.5	13.5	18.6	0.0	2.2	9.5	8.4	7.5	3.4	1.4	13.3	2.7	6.4	16.8	9.3	11.6	0.6	0.3	6.5	3.5	11.7	0.5	1.6	5.7	14.2	13.6	5.4	16.9	6.8	17.0	18.3	22.0	20.4	0.3	9.9	11.8	6.9	10.4	0.9	17.8	7.4	1.8	6.2	0.0	10.1	0.0	1.0	0.0	0.7	0.4	1.1	0.2	1.2	1.0	0.6	0.1	1.9	0.8	0.0	0.0	0.1	0.0	1.7	0.9	27.4	24.8	14.1	23.2	21.1	45.5	27.8	33.3	30.1	17.7	42.2	17.4	8.8	6.4	13.4	22.2	3.9	4.6	8.9	5.0	5.2	27.2	9.6	9.9	2.5	5.7	5.6	12.9	58.4	14.5	5.6	3.2	1.9	7.5	0.6	7.1	7.0	12.4	10.2	2.7	13.4	6.0	8.8	8.1	3.6	11.6	1.3	15.4	8.2	2.2	15.2	3.3	17.2	3.2	8.2	11.4	10.5	0.7	17.1	15.1	3.6	12.2	4.2	22.8	5.2	12.1	13.3	3.4	3.9	12.4	2.2	9.0	7.0	6.0	4.4	40.8	32.9	6.4	7.7	0.2	5.3	2.4	4.7	26.0	8.2	16.4	2.6	5.3
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960758-149993455	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 212.0"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	5.2	30.7	2.2	7.8	2.3	2.5	9.2	9.5	3.8	6.3	4.0	212.0	12.9	9.3	22.8	10.7	5.0	5.5	2.8	2.2	3.5	4.9	1.7	7.3	4.0	3.8	3.4	4.8	3.4	37.7	7.1	34.0	3.5	12.2	189.6	20.8	35.8	18.4	3.9	7.8	16.1	9.3	3.8	3.7	3.3	4.2	3.9	4.2	4.5	3.7	5.9	4.7	3.0	3.4	9.5	8.6	10.5	17.3	12.6	8.8	2.5	8.9	8.0	7.0	8.5	44.7	5.1	7.4	66.1	9.5	16.8	6.8	10.0	20.5	12.4	6.0	6.4	9.3	6.7	5.2	9.4	17.3	15.2	9.8	11.8	11.7	15.2	17.3	16.8	9.0	2.4	7.1	29.6	3.0	6.6	9.1	3.2	3.2	13.5	9.5	16.3	3.9	151.7	41.6	3.2	8.1	15.6	3.6	27.2	8.1	7.3	10.0	80.4	16.0	11.8	14.2	10.7	5.2	7.3	4.3	14.7	20.6	23.5	4.9	0.5	0.3	0.9	0.3	1.1	0.5	0.5	0.8	0.7	0.5	0.8	0.9	0.3	1.1	1.6	0.7	1.1	0.5	2.2	2.3	9.5	3.8	2.2	3.5	3.8	3.4	3.5	3.8	3.9	3.4	47.4	44.8	11.3	3.3	8.5	4.6	13.2	22.9	7.4	17.1	23.8	14.6	7.8	7.2	24.2	33.1	16.7	219.2	11.5	2026.2	1.9	6.1	32.7	237.0	92.3	29.8	21.1	16.6	5.4	9.9	7.7	21.5	5.1	684.5	90.0	29.6	17.2	2.0	30.4	6.7	7.9	52.5	20.3	15.3	11.8	15.7	17.4	17.4	90.7	17.8	19.6	15.2	15.5	16.6	6.0	12.1	177.4	12.4	15.2	15.1	91.7	5.1	26.6	84.5	0.0	18.7	13.9	8.7	11.4	73.9	5.1	808.9	14.0	26.3	208.9	5.5
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 1120.4"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 2328.4"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036055	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	1.1	0.0	0.0	19.7	0.0	0.0	59.5	0.2	0.1	0.3	0.0	1120.4	576.9	0.9	15.3	0.5	0.8	17.8	0.0	0.0	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.1	878.8	0.1	0.0	129.9	0.0	0.1	118.5	15.0	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	165.9	4.2	0.0	0.3	0.0	0.0	0.0	51.4	41.7	0.3	34.3	0.0	0.0	0.0	0.0	0.0	2328.4	0.0	0.0	6.4	1.8	0.1	0.3	14.3	0.0	110.2	0.0	0.0	0.1	0.0	0.2	26.7	0.2	0.0	0.1	0.0	0.0	114.3	32.5	0.0	0.0	0.0	0.6	0.3	0.1	0.0	89.9	0.0	0.0	0.0	101.6	182.1	0.0	503.4	0.0	0.0	0.3	388.9	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	86.0	0.1
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"thyroid gland: 263.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Group enriched"	"Detected in many"	88	"amygdala: 4.0;basal ganglia: 10.2;cerebral cortex: 11.8;hippocampal formation: 8.8"	"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	4.0	0.1	10.2	0.0	0.8	0.0	11.8	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	8.8	0.0	6.4	0.1	0.5	0.4	0.0	0.0	0.3	0.3	3.9	0.3	0.3	0.0	3.8	0.2	0.1	0.4	0.2	0.5	0.2	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	263.7	0.1	0.2	1.5	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	10.2	0.0	11.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.7;Intestinal goblet cells: 34.0;Paneth cells: 40.9;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.6	6.8	4.8	5.2	5.2	18.1	5.5	5.1	6.5	9.3	5.4	28.0	8.2	7.4	3.6	5.2	6.6	3.7	8.1	4.7	5.0	19.6	7.6	9.5	3.9	5.6	5.1	7.3	11.4	3.6	5.5	5.5	5.9	12.4	21.6	4.1	5.8	4.2	9.5	6.7	22.4	5.6	5.2	12.5	26.8	5.6	5.6	3.8	6.3	6.1	3.2	6.6	7.9	6.2	8.5	8.9	13.2	15.0	39.9	19.8	11.2	13.7	17.7	25.8	27.4	17.6	7.6	12.0	4.6	11.6	28.7	11.2	12.1	12.5	7.2	9.3	12.0	10.8	29.6	34.3	29.4	5.2	16.5	27.4	44.0	17.7	12.4	22.1	8.0	12.4	8.6	13.2	6.2	9.8	10.4	27.0	18.5	23.0	17.9	5.2	4.8	14.5	18.8	7.9	3.3	6.2	17.7	21.3	25.2	17.9	11.2	19.2	6.9	11.6	9.2	15.0	31.7	15.7	17.8	5.6	9.7	20.5	28.4	6.8	11.1	2.3	3.0	10.8	2.7	0.9	1.8	1.9	9.0	0.2	1.0	1.5	1.5	0.6	10.1	5.1	3.4	5.0	4.8	5.2	5.1	6.5	4.7	5.0	5.6	5.1	5.9	5.2	5.6	6.2	4.3	3.2	5.9	10.7	2.1	3.2	2.6	8.0	5.7	2.1	3.8	2.7	6.6	1.5	3.8	1.8	14.6	9.3	2.4	69.7	0.0	2.9	1.2	1.3	3.2	5.1	20.4	4.0	2.0	6.3	15.0	4.0	13.3	2.7	0.0	3.1	4.2	6.3	7.0	5.0	2.1	34.0	10.2	5.3	7.4	0.9	3.7	6.3	5.4	1.9	5.8	1.6	6.2	2.5	2.5	5.8	40.9	9.4	5.8	2.0	43.6	6.2	3.7	6.9	0.0	1.3	4.5	2.9	6.9	2.4	3.4	10.5	3.8	13.5	26.8	1.0
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.2	0.1	0.6	0.3	0.5	4.8	0.1	0.8	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.1	0.0	0.1	0.3	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.8	0.8	0.4	1.1	0.9	0.6	1.1	0.3	0.9	0.2	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 72.4;stomach 1: 33.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.3	0.2	0.0	0.0	0.1	0.0	7.7	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	72.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.4	0.3	5.3	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.1	0.0	3.2	50.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.2	0.0	2.7	1.8	0.0	0.0	0.0	0.0	1.9	4.3	0.5	0.2	0.0	0.3	0.0	0.0	0.1	2.2	0.0	1.7	29.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.4	0.0	25.4	2.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.0	0.4
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 157.7;liver: 288.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.0	1.7	2.9	2.0	6.5	13.3	1.7	3.2	1.6	9.2	18.2	11.1	0.3	65.9	2.6	10.9	2.3	0.0	2.7	2.4	157.7	288.0	1.7	1.5	0.8	1.1	0.1	7.2	4.1	12.4	17.3	0.8	5.4	16.2	3.4	0.9	1.0	0.0	1.2	21.3	0.8	0.8	0.4	1.8	0.9	2.5	0.5	4.6	0.0	1.7	3.6	1.2	0.7	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.7	2.0	1.7	3.2	2.7	2.4	0.8	1.1	0.8	0.8	2.5	0.7	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.3;MCF7: 30.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	18.9	5.0	4.1	3.3	4.1	2.5	17.7	3.3	5.7	8.3	4.6	8.8	2.4	6.3	37.7	6.1	9.8	5.7	8.3	4.0	4.1	11.1	20.4	19.0	4.7	4.2	5.6	9.2	8.0	9.2	9.9	6.4	3.9	7.1	5.0	0.6	5.1	8.0	3.1	12.3	7.7	5.8	3.6	8.6	19.3	12.2	3.9	2.3	9.4	3.7	2.8	7.4	9.5	4.0	2.6	0.5	3.1	1.5	53.3	10.8	0.8	0.5	3.9	1.2	1.0	1.8	1.8	1.1	1.6	2.4	0.6	9.3	3.0	1.5	0.7	0.4	1.4	1.5	2.8	1.9	6.7	1.4	5.8	5.5	6.6	0.3	1.4	1.1	7.0	0.3	0.8	1.4	0.3	30.8	0.3	8.1	3.4	12.2	1.4	8.6	0.6	0.9	1.5	0.9	2.7	1.7	0.6	9.6	3.0	4.1	3.9	5.5	0.0	1.5	2.8	3.3	0.1	2.4	2.4	0.3	2.5	5.7	1.2	9.5	10.7	12.6	2.1	8.8	1.3	0.6	0.6	2.1	7.4	0.7	0.2	0.6	0.9	2.5	11.1	1.0	0.2	3.4	4.1	4.1	3.3	5.7	4.0	4.1	4.2	5.6	3.9	3.6	3.9	4.0	47.3	19.2	51.8	6.5	5.5	11.7	12.6	9.0	8.0	0.9	4.4	11.3	4.6	34.3	10.1	3.7	0.0	27.2	20.7	4.2	0.0	4.3	0.6	5.1	12.1	42.4	4.2	0.4	2.6	7.3	13.0	20.3	16.8	7.9	25.4	1.8	106.1	30.6	33.2	1.7	2.6	23.7	6.1	31.7	39.8	3.2	19.0	21.3	23.2	1.9	44.6	2.0	35.0	0.5	1.6	3.1	42.3	14.3	7.9	3.4	2.5	3.6	6.6	1.0	6.6	3.4	15.7	1.7	2.9	5.5	7.7	8.8	13.0	5.2	10.7	7.0
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340527-128361470	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.7;Proximal enterocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	11.4	14.7	22.5	8.5	23.7	2.7	11.6	25.4	30.3	17.2	12.4	22.8	66.9	14.4	6.3	61.8	10.4	7.3	20.4	22.7	25.9	28.8	40.0	11.8	6.4	29.4	23.9	8.3	21.6	15.5	12.1	5.6	28.8	13.1	9.4	6.8	16.4	7.5	16.1	41.8	41.1	9.3	19.7	11.6	16.4	25.8	27.1	5.8	15.5	6.2	9.6	15.5	23.5	24.1	20.8	41.8	21.1	28.1	31.5	9.8	23.3	16.7	11.7	20.3	14.5	30.1	20.7	19.1	13.5	19.8	24.8	70.6	25.5	20.7	6.7	19.5	37.2	11.4	35.6	28.5	17.1	21.0	17.8	12.7	29.6	21.2	17.0	9.4	23.1	26.3	27.5	13.7	20.2	56.2	26.0	22.7	9.2	51.6	63.0	30.4	19.6	36.4	38.1	32.0	34.8	19.2	27.6	57.0	20.3	11.3	26.7	8.8	32.4	23.7	22.9	26.6	22.0	11.4	17.4	6.5	24.3	13.0	27.7	0.0	2.5	1.7	4.7	3.3	3.4	2.1	2.9	3.6	4.4	0.9	2.3	2.4	1.0	1.4	4.3	3.9	2.2	2.4	22.5	23.7	25.4	30.3	22.7	25.9	29.4	23.9	28.8	19.7	27.1	24.1	4.7	0.0	1.1	12.7	2.0	2.8	1.4	4.0	1.2	9.6	5.8	3.0	5.2	7.2	2.8	9.2	12.5	6.1	2.1	53.7	1.9	13.1	4.8	3.6	5.2	5.3	13.1	4.0	27.7	16.0	6.8	3.5	14.3	9.3	8.9	5.9	3.6	20.1	11.3	8.4	29.2	18.6	8.2	6.1	1.9	5.4	1.2	5.4	1.8	15.9	10.0	5.0	6.2	8.5	26.4	26.4	30.0	4.1	3.2	3.2	100.6	9.7	1.8	7.8	6.6	4.4	4.4	11.8	7.9	11.9	6.1	5.2	2.4	7.9	25.7	2.8
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 1023.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 144.4;Hepatocytes: 439.9;Late spermatids: 464.4"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	5.9	9.9	35.8	3.3	36.3	3.7	6.5	34.5	49.9	7.5	32.7	7.7	2.5	5.4	2.9	5.4	9.1	2.9	6.6	35.4	36.0	11.0	1023.6	4.0	4.4	35.3	36.7	6.8	10.6	7.1	10.8	1.6	35.2	8.0	1.7	3.0	9.9	4.5	4.8	6.6	3.9	4.4	35.4	5.2	7.2	20.7	38.2	6.2	6.6	4.3	4.6	8.2	6.2	34.9	41.2	55.0	9.6	10.2	9.0	9.3	6.1	2.3	5.3	7.5	10.3	4.4	8.7	52.9	6.5	2.8	1.4	8.4	11.0	35.3	3.2	24.8	37.0	35.8	58.3	46.7	13.5	18.9	12.2	10.9	5.9	1.2	20.5	12.9	3.9	39.4	33.5	0.0	9.1	33.4	47.2	39.8	5.8	34.4	31.9	23.4	0.2	72.6	25.0	19.3	13.1	17.8	0.1	53.5	12.1	2.7	15.8	16.3	3.1	0.0	6.8	0.0	4.7	33.5	41.0	22.7	10.9	35.0	2.0	0.1	4.0	3.8	13.5	5.3	29.6	24.3	17.5	18.0	10.8	15.8	21.3	21.7	0.5	18.1	4.0	18.2	23.3	13.9	35.8	36.3	34.5	49.9	35.4	36.0	35.3	36.7	35.2	35.4	38.2	34.9	12.5	0.0	7.3	3.3	9.8	9.1	15.5	16.0	14.2	11.8	50.1	73.2	8.3	20.0	9.9	5.5	0.0	7.3	6.9	4.6	39.2	9.6	144.4	12.4	10.1	11.3	10.1	25.0	4.3	15.4	3.3	8.9	8.6	8.0	5.1	20.2	16.8	439.9	10.5	10.1	5.3	4.7	6.1	16.7	9.6	464.4	10.8	6.7	16.0	1.9	3.4	12.0	12.3	5.0	7.4	8.0	1.2	9.4	8.9	32.2	1.8	57.6	11.5	8.5	6.6	7.4	18.4	50.9	12.7	15.5	14.1	3.4	11.3	26.7	6.1	15.0
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.1;kidney: 48.2;liver: 111.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.0	37.9	0.0	0.5	0.1	0.7	0.2	1.0	0.1	0.3	48.2	111.3	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	1.2	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.3	0.7	0.4	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 92.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.4	0.7	0.4	0.1	0.0	0.3	0.4	2.6	0.0	9.5	68.0	0.5	0.4	0.1	0.1	9.8	0.3	0.3	0.1	3.5	0.8	0.1	0.3	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.1	34.6	0.7	0.2	0.0	0.3	0.3	92.3	0.0	0.1	0.2	22.8	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.4	0.1	0.2	0.6	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340758	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.4;salivary gland: 12.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 10.7;Breast glandular cells: 9.5;Cholangiocytes: 8.6;Ductal cells: 24.9;Endometrial ciliated cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.2	0.0	0.1	0.3	0.0	9.4	8.9	0.1	0.0	1.0	22.4	0.7	1.0	0.5	0.5	4.2	2.3	7.3	0.4	0.8	0.1	0.1	0.3	1.1	0.1	0.9	1.0	0.0	8.2	0.1	1.2	0.3	0.4	0.1	2.5	0.0	12.0	2.8	0.0	10.0	1.9	0.1	0.4	0.3	0.8	0.4	0.3	0.5	0.1	0.0	1.3	0.3	1.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	6.2	0.7	1.5	0.8	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	58.1	0.1	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.0	0.1	0.0	0.5	0.1	9.3	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.9	1.0	0.4	0.4	0.3	0.1	0.0	0.0	0.5	1.6	0.1	0.3	0.0	10.7	0.0	0.0	9.5	3.8	0.8	8.6	4.2	1.8	0.0	0.2	0.3	0.7	0.0	24.9	1.4	9.2	0.8	0.2	3.0	0.0	0.4	3.1	0.1	0.5	2.0	6.7	1.3	1.5	0.0	0.0	2.1	0.0	0.4	5.4	2.0	1.2	0.0	2.5	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.0	0.1	4.5	0.3	0.0	0.4	0.1	1.0	0.0	4.2	0.0	0.0	0.0	0.4	0.6	0.3	3.4	0.9	0.1	0.1	0.0	4.8	0.2
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219553-44234142	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 216.6;Extravillous trophoblasts: 224.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	26	"eosinophil: 1046.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	76.4	95.8	10.2	22.3	10.2	53.4	50.4	13.0	14.8	25.4	4.5	59.7	13.1	37.3	15.9	25.3	34.5	44.2	119.7	10.1	12.2	17.8	57.9	33.1	25.9	13.2	10.2	12.9	91.2	22.8	22.6	58.8	15.3	16.5	17.8	21.1	35.6	19.3	144.5	53.0	17.2	46.2	9.5	14.5	53.7	14.9	10.7	81.3	30.7	100.7	17.0	32.8	17.7	10.8	85.3	84.2	58.5	95.1	87.8	8.1	347.1	61.2	24.0	83.6	57.4	91.8	34.8	171.2	60.8	18.5	51.7	103.8	105.2	72.8	51.9	97.6	97.2	150.5	57.8	122.5	14.1	170.3	139.7	10.9	18.4	123.0	42.7	171.6	216.0	137.2	205.4	100.1	46.9	94.0	142.0	114.4	89.0	218.4	55.4	94.0	117.8	208.9	49.1	49.5	75.0	97.0	18.4	58.9	43.9	61.5	80.7	107.1	333.1	46.4	74.8	62.6	117.7	67.0	93.8	221.9	28.8	136.8	57.1	21.9	12.1	1046.6	5.1	38.8	4.2	4.4	2.7	3.9	6.8	2.4	1.1	2.4	1.8	3.1	32.5	40.0	8.2	6.6	10.2	10.2	13.0	14.8	10.1	12.2	13.2	10.2	15.3	9.5	10.7	10.8	64.2	0.0	10.5	1.3	4.0	10.7	9.0	4.1	2.2	10.9	20.2	30.1	46.4	17.2	6.0	7.3	14.6	216.6	5.7	3.0	3.9	24.2	0.5	4.3	3.5	31.7	31.2	49.2	18.4	56.7	224.6	40.0	26.5	11.2	8.2	25.4	25.7	16.7	63.6	5.0	25.4	2.9	79.3	37.0	13.3	2.8	32.9	19.2	35.6	16.9	8.3	4.3	0.0	5.0	2.6	61.9	3.4	53.8	14.2	18.2	0.7	0.9	6.9	11.9	92.1	21.0	22.5	0.4	11.0	4.6	15.6	42.0	3.2	4.1	6.2	9.8
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 90.8;tongue: 47.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	6.7	0.9	4.2	2.5	4.3	0.8	7.4	9.8	5.6	1.9	4.2	5.7	7.8	0.9	3.1	3.3	3.6	1.4	11.9	4.1	4.0	6.9	1.5	4.4	2.8	7.4	6.9	0.7	8.7	12.9	6.1	4.1	8.2	5.2	4.1	3.1	7.2	2.4	90.8	2.8	7.4	0.3	4.1	2.1	9.4	0.5	5.9	2.3	5.4	47.3	1.9	1.2	2.6	3.7	14.2	11.4	8.2	1.8	1.2	0.3	44.3	0.6	0.0	0.4	0.6	20.2	53.5	6.1	10.4	0.1	3.1	12.9	11.4	9.7	0.0	0.5	18.6	11.7	12.4	1.5	1.3	21.9	0.4	0.7	4.3	1.5	4.1	5.2	0.5	5.1	33.0	0.0	0.0	34.5	1.6	31.9	21.8	35.1	8.1	1.3	0.3	26.4	22.2	10.4	16.1	6.6	1.0	18.4	1.2	2.4	55.2	4.1	0.0	0.3	11.2	0.4	0.0	0.3	0.8	0.5	0.9	0.5	0.7	0.0	0.0	0.0	1.3	0.0	0.4	0.2	0.7	1.7	0.3	0.7	1.7	1.7	0.1	0.0	0.0	0.6	0.1	0.5	4.2	4.3	9.8	5.6	4.1	4.0	7.4	6.9	8.2	4.1	5.9	3.7	0.6	3.2	6.3	9.4	2.2	0.6	4.7	5.4	1.2	2.5	7.6	5.8	12.3	4.3	6.5	14.7	12.5	46.4	0.7	6.0	3.9	5.0	0.1	2.1	0.5	0.9	2.4	2.1	11.2	6.7	16.5	1.7	11.2	5.4	4.5	1.8	0.4	0.9	4.4	5.0	10.8	9.2	4.1	0.8	0.4	0.0	0.0	0.5	0.0	2.8	0.9	2.3	0.0	7.5	0.8	3.5	4.7	0.4	1.5	4.7	1.6	0.5	3.8	3.7	0.0	4.4	2.1	0.4	0.5	3.5	0.0	13.5	2.1	0.4	10.6	3.4
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709649-46736347	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 43.6;Intestinal goblet cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	75	"basophil: 20.9"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041015, HPA055673"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA041015: AB_2677252, HPA055673: AB_2682879"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	7.0	5.9	4.0	3.5	4.1	1.2	15.3	3.4	3.9	19.4	18.9	12.7	5.4	7.9	8.7	5.1	9.9	10.3	5.2	3.8	3.7	3.5	41.4	6.9	1.7	5.2	4.7	9.9	17.4	19.5	6.3	11.6	4.0	31.3	16.0	1.6	24.0	9.9	1.5	3.6	5.3	8.5	3.8	2.6	22.8	2.6	4.0	1.6	19.5	2.7	2.1	9.3	8.4	3.4	0.0	0.1	11.3	11.7	45.8	38.9	34.2	22.2	30.2	10.1	12.0	0.9	38.9	0.0	16.3	40.6	0.0	0.2	0.0	1.1	4.8	0.0	0.3	3.3	0.0	18.6	32.2	0.0	0.0	56.6	1.0	6.2	0.0	11.8	4.2	0.0	0.2	0.1	17.5	41.3	0.0	1.2	4.3	49.8	2.9	0.0	1.6	0.1	0.0	10.6	0.0	1.8	4.3	7.2	60.3	8.1	5.4	9.2	2.6	21.7	9.1	17.2	2.9	0.3	0.1	0.0	0.1	0.0	4.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.0	4.1	3.4	3.9	3.8	3.7	5.2	4.7	4.0	3.8	4.0	3.4	4.2	6.4	6.3	12.4	0.8	0.6	6.1	7.8	5.2	0.0	29.6	14.4	6.4	7.2	15.8	1.8	0.0	2.7	0.4	11.4	0.0	7.4	0.2	3.2	17.8	4.6	3.6	6.1	0.1	5.6	16.3	16.7	23.4	4.0	6.3	10.7	8.6	43.6	1.1	0.0	0.4	56.6	12.2	1.9	1.3	1.6	26.4	0.4	1.8	2.8	0.0	5.5	0.0	10.1	0.3	5.1	10.3	17.3	2.8	23.9	1.7	0.8	27.5	0.5	13.1	5.1	6.3	0.8	0.3	4.2	1.0	2.1	0.5	3.6	14.6	10.9
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 298.2;Rod photoreceptor cells: 188.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 9.2"					"Low region specificity"	"Detected in all"			"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	2.3	6.3	3.9	1.7	3.7	1.1	3.3	5.3	4.5	4.8	3.4	5.2	1.2	3.4	3.0	1.6	3.6	1.3	10.2	3.3	4.1	16.5	5.1	2.3	2.7	3.7	3.7	4.9	12.9	6.1	13.2	2.7	4.1	5.1	2.0	19.5	3.9	2.9	6.3	2.3	4.6	1.8	3.0	4.2	4.4	3.2	4.1	0.7	7.2	1.9	2.2	4.3	2.2	3.5	2.2	1.0	1.2	5.7	1.2	2.5	0.6	1.3	1.6	1.4	0.9	1.3	1.5	2.7	0.7	1.7	1.2	1.7	2.4	0.8	0.7	2.0	2.2	1.3	2.5	2.0	1.8	1.3	1.4	1.0	2.4	2.0	1.7	6.3	0.5	2.1	0.5	6.4	0.7	2.2	0.3	0.5	2.1	1.3	1.6	3.7	0.2	3.1	4.3	0.6	3.2	1.8	0.6	9.2	2.2	1.5	4.8	0.7	0.4	0.5	0.9	0.5	0.6	5.5	1.6	2.6	1.1	0.9	1.4	0.4	0.1	0.4	0.2	0.3	0.1	0.6	0.2	0.2	0.0	0.5	0.4	0.2	0.2	0.3	0.2	1.4	0.0	0.1	3.9	3.7	5.3	4.5	3.3	4.1	3.7	3.7	4.1	3.0	4.1	3.5	2.9	19.2	15.0	14.4	23.4	3.2	9.3	4.4	8.6	56.0	15.0	13.5	31.2	7.2	5.6	25.8	298.2	9.8	15.5	5.7	13.7	4.9	8.4	4.8	8.2	4.4	10.8	5.0	21.6	5.6	9.8	8.3	5.1	5.3	2.5	19.5	6.1	7.3	5.8	37.0	30.0	5.8	10.2	4.8	4.6	10.4	9.3	4.3	3.6	4.7	4.2	16.4	10.3	8.0	14.2	2.7	2.7	9.8	15.2	7.3	3.7	24.7	6.3	188.8	0.0	11.8	7.5	4.2	5.7	5.3	3.1	20.0	8.3	28.3	7.5	6.0
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133987581-134052624	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.5	1.0	3.6	0.3	4.8	0.0	1.1	7.8	4.6	3.0	87.3	2.1	7.3	8.2	2.1	6.1	2.8	2.6	10.7	5.7	2.6	5.8	6.8	3.1	0.1	2.3	3.1	1.2	1.1	2.3	1.4	1.6	2.5	22.4	1.0	2.3	5.1	9.3	3.8	2.7	9.8	3.1	1.6	0.1	14.3	0.4	3.4	1.0	0.2	4.1	1.2	3.5	1.2	3.1	2.5	0.9	2.3	0.0	1.4	0.7	0.1	1.5	5.4	0.7	2.9	0.0	7.6	0.3	1.2	0.1	5.7	5.9	0.0	0.5	1.0	0.0	5.3	0.0	0.8	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	14.8	0.4	0.4	0.5	0.8	0.1	0.8	0.1	0.1	2.0	0.0	0.5	0.0	1.0	2.2	1.6	0.8	0.2	0.7	0.1	2.1	0.0	21.7	0.1	0.0	0.1	0.2	7.6	0.2	0.9	3.2	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	4.8	7.8	4.6	5.7	2.6	2.3	3.1	2.5	1.6	3.4	3.1	0.2	0.0	7.7	24.8	0.1	2.0	1.0	3.3	8.6	0.4	0.5	2.2	6.3	0.0	2.2	0.0	0.0	2.0	0.1	1.2	3.9	1.5	0.1	3.4	0.4	2.3	4.2	0.0	8.0	0.2	0.6	2.2	2.6	1.6	0.0	0.4	0.0	1.1	0.3	0.0	3.2	0.2	6.1	0.0	0.3	0.0	0.0	0.1	0.0	4.7	0.1	9.8	0.0	4.5	14.5	1.1	2.4	1.5	1.6	10.5	0.5	0.5	10.4	0.5	0.0	2.1	1.3	0.0	0.0	8.6	1.8	36.7	0.2	3.5	0.4	1.3
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755025-40106089	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 506.5;Inhibitory neurons: 465.0;Oligodendrocyte precursor cells: 351.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	6.8	3.4	9.6	0.9	2.5	0.0	14.2	12.4	15.6	7.8	6.3	5.8	5.1	3.4	2.6	3.9	5.0	9.7	10.2	10.7	6.4	3.7	1.6	0.2	11.9	2.1	5.1	22.6	4.0	4.7	3.5	2.7	7.0	3.2	4.6	2.2	0.6	1.5	8.5	4.3	0.1	2.2	5.6	1.8	9.8	1.7	1.6	1.4	1.1	3.6	2.9	2.0	0.6	3.6	2.6	1.2	18.0	7.4	5.1	5.7	4.2	2.6	3.3	0.0	1.7	2.2	4.1	4.7	3.5	0.3	1.8	1.8	2.1	1.9	5.1	1.8	9.1	1.3	2.8	5.1	2.8	3.7	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	6.0	0.7	0.7	4.3	2.8	0.0	2.3	0.0	3.9	1.3	4.7	2.3	3.3	3.3	2.3	4.5	1.5	3.9	2.5	4.5	1.0	3.4	1.2	12.4	3.4	4.1	0.1	1.4	6.2	2.9	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.8	9.6	0.0	14.2	9.7	10.2	0.2	11.9	3.5	0.1	9.8	2.0	6.5	9.6	14.7	31.3	5.4	4.1	1.6	1.2	2.2	5.3	3.7	2.0	4.4	12.8	2.2	9.2	0.0	6.3	3.9	58.3	0.0	5.6	3.8	2.2	7.7	4.6	20.4	5.7	506.5	12.6	2.9	14.3	23.0	1.3	10.2	3.7	11.0	9.1	8.6	92.5	465.0	33.1	4.1	10.8	4.1	3.3	23.0	10.3	16.0	109.6	7.1	2.5	8.2	351.8	14.4	10.5	40.2	7.5	6.4	2.4	28.2	8.3	7.0	1.3	6.6	5.2	6.6	3.3	2.3	3.4	5.3	3.7	6.0	21.0	16.7	2.1
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 81.3"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.8	5.7	0.7	0.3	0.9	6.2	0.9	4.7	1.0	0.2	1.8	0.9	0.2	0.2	0.2	1.5	0.4	0.9	0.7	1.5	0.9	0.6	3.0	0.5	0.5	0.2	0.1	2.7	6.6	0.0	0.4	1.1	0.5	1.2	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	81.3	1.3	0.2	0.2	0.1	0.2	1.0	0.3	0.5	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.7	0.9	4.7	1.0	1.5	0.9	0.2	0.1	0.5	0.0	1.3	0.5	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936187	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 427.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 166.1;neutrophil: 223.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.4"	"Group enriched"	"Detected in many"	5	"BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	124.9	19.3	26.3	58.2	28.4	427.9	77.0	26.0	38.3	16.4	26.4	29.6	6.7	20.8	2.0	12.7	27.4	56.1	62.3	33.3	31.6	37.7	28.0	92.8	29.4	28.9	25.6	26.4	11.2	7.9	28.0	102.8	33.0	19.7	12.7	87.3	12.3	5.6	24.1	20.7	15.7	41.5	24.6	45.7	19.8	4.9	31.1	18.4	43.3	10.0	20.8	98.7	26.2	23.3	0.3	7.9	68.5	27.4	25.2	85.9	1473.1	24.7	26.7	23.9	55.9	1646.2	11.0	1.6	0.0	17.1	33.1	0.6	2.4	3.9	43.0	48.4	2.0	96.3	6.5	219.3	67.3	35.0	135.4	36.2	2.8	63.6	28.5	55.8	22.6	7.5	44.8	22.8	21.9	0.1	2.6	38.4	300.9	1.2	0.0	2.1	8.0	1.4	0.1	0.1	0.3	0.6	0.0	2.4	32.8	1119.9	0.0	4.9	23.1	29.7	15.6	57.4	2.5	0.2	68.8	5.2	86.9	15.9	16.6	166.1	19.3	29.7	25.3	2.3	20.2	7.4	16.9	19.5	10.0	7.0	10.8	14.8	223.4	15.6	1.0	0.8	24.9	17.4	26.3	28.4	26.0	38.3	33.3	31.6	28.9	25.6	33.0	24.6	31.1	23.3	362.1	144.2	98.8	5.5	301.0	129.5	3.5	1.7	8.6	33.0	5.1	7.6	21.0	7.2	26.8	3.7	62.6	69.6	112.1	0.2	0.0	0.2	3.1	5.0	84.3	356.2	1.2	13.7	24.4	0.0	382.4	188.9	12.2	4.3	485.1	6.5	96.4	2.4	113.4	5.0	20.8	0.3	0.0	76.4	710.4	3.1	10.2	305.2	183.2	34.7	43.4	28.5	41.2	6.6	5.0	0.7	1.3	7.9	93.2	5.3	0.1	1.4	10.3	70.2	118.3	21.5	187.1	2.4	1.2	4.9	82.0	111.4	328.9	41.7	0.1	4.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8;skeletal muscle: 223.6"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	16.9	5.2	1.4	0.2	1.7	1.1	11.2	0.9	1.5	9.2	0.9	53.1	0.8	9.3	1.2	5.9	11.3	0.7	98.8	1.3	1.1	2.6	3.7	2.1	0.2	1.0	1.5	3.2	0.8	3.4	4.4	0.6	1.2	9.9	1.1	0.4	6.3	3.3	223.6	4.1	9.7	4.3	1.0	0.3	11.7	3.3	1.3	0.1	4.5	63.2	0.0	27.0	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.9	1.5	1.3	1.1	1.0	1.5	1.2	1.0	1.3	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035106-9088478	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 97.3;intestine: 109.1;skeletal muscle: 78.8;testis: 76.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 23.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 23.3"	"Group enriched"	"Detected in some"	5	"Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	7.7	3.4	9.2	5.4	9.2	97.3	5.1	10.5	11.8	2.6	10.1	4.8	109.1	1.3	10.5	3.9	2.6	1.1	2.3	10.3	12.0	38.4	0.6	1.2	20.4	24.1	14.5	2.8	0.6	1.5	2.9	4.9	20.4	15.1	3.6	2.7	2.4	5.1	78.8	6.9	85.3	4.4	14.3	5.6	0.9	76.4	16.1	1.7	0.8	65.9	18.3	3.0	4.2	19.6	0.3	0.1	0.0	0.2	0.2	1.2	0.5	0.2	0.7	0.0	0.6	1.3	0.0	190.3	0.2	0.4	0.1	0.4	1.7	0.1	0.4	25.1	0.2	0.2	3.4	0.0	0.3	3.0	1.6	2.7	2.6	0.6	0.0	2.9	0.0	0.1	0.3	2.0	0.0	0.0	0.1	10.0	0.2	0.0	0.2	4.9	0.0	5.9	0.2	2.0	0.6	0.3	0.3	0.5	0.7	0.1	0.3	47.8	0.2	3.0	0.9	0.5	0.2	154.0	0.2	178.2	0.2	68.2	0.2	4.8	2.5	0.2	0.2	0.5	0.2	4.3	0.2	0.2	0.9	23.3	0.2	0.2	1.4	0.3	0.1	0.2	0.1	1.2	9.2	9.2	10.5	11.8	10.3	12.0	24.1	14.5	20.4	14.3	16.1	19.6	0.3	0.0	0.0	2.0	5.2	2.0	2.0	0.2	10.2	0.0	0.1	0.4	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.4	7.9	0.3	64.3	0.1	0.3	4.9	1.2	0.0	1.0	0.0	1.1	0.8	0.0	0.4	1.3	0.1	0.4	0.1	4.3	0.0	1.2	7.6	0.0	0.8	1.2	19.3	2.8	2.7	0.0	31.9	0.6	0.6	0.0	2.5	0.9	0.6	55.6	0.4	35.3	2.1	189.4	24.2	0.0	0.1	6.6	2.1	0.4	83.2	8.2	2.7	0.6	0.5	0.3	0.3	8.0	0.2
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471094-133479127	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;granulocytes: 47.4;monocytes: 60.4;Paneth cells: 39.8;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 73.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.1;HMC-1: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	4.0	3.8	5.9	4.6	5.7	4.3	2.9	6.6	9.2	1.3	2.5	2.4	0.9	2.5	0.7	1.1	1.5	0.8	4.7	5.7	7.4	3.9	3.5	8.4	4.1	11.9	7.1	0.9	2.7	0.5	2.3	0.7	11.9	1.9	0.4	0.6	1.5	0.4	1.1	1.0	6.7	0.9	4.7	13.3	2.5	1.6	8.1	0.5	1.8	0.3	2.3	4.5	1.4	6.1	5.7	9.6	3.2	9.4	1.8	2.7	2.8	5.2	8.5	4.9	5.2	4.3	7.5	4.5	14.0	4.8	23.3	8.3	2.0	5.7	1.1	33.1	1.9	5.5	6.8	5.2	6.3	0.1	67.8	3.7	0.9	7.2	0.8	0.3	5.0	5.3	0.8	4.3	3.4	12.4	2.9	5.3	4.8	2.2	12.0	2.3	5.8	23.3	6.8	14.5	4.0	5.5	8.2	3.9	2.6	1.7	14.9	2.4	13.9	12.3	5.0	14.0	4.2	2.4	2.0	6.3	3.2	1.3	2.8	46.3	18.2	1.8	1.6	36.9	1.1	9.3	0.3	1.1	16.3	8.8	0.5	1.3	0.9	1.2	73.2	17.3	0.2	9.3	5.9	5.7	6.6	9.2	5.7	7.4	11.9	7.1	11.9	4.7	8.1	6.1	6.2	3.2	4.1	9.1	24.6	0.4	1.2	17.3	0.6	25.9	1.1	0.1	1.8	5.7	6.2	3.7	52.1	0.4	31.3	2.8	0.0	36.0	6.0	1.2	1.1	9.6	3.6	0.4	21.7	8.9	0.7	2.6	5.1	1.9	47.4	1.2	2.5	0.6	4.5	23.5	15.6	2.4	2.0	15.6	10.3	2.4	0.9	30.6	3.6	1.9	60.4	5.6	4.1	3.5	6.9	21.5	39.8	0.0	10.8	1.0	1.9	0.3	3.3	46.0	32.9	3.8	7.6	2.2	6.8	0.2	0.4	0.3	5.5	5.2	2.3	0.6
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 3.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039931	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Endometrial stromal cells: 86.5;Late spermatids: 310.1;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 75.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 75.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 122.9;Hep G2: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	17.3	46.9	23.0	7.5	24.8	3.4	13.1	22.5	22.7	19.7	14.6	42.1	15.7	16.5	13.4	12.0	11.1	6.4	18.2	20.9	18.4	15.4	41.0	11.5	7.4	23.6	23.3	12.0	12.4	6.3	9.9	11.6	20.9	17.8	5.3	3.1	10.2	11.6	33.1	14.2	15.5	6.0	23.5	16.7	23.1	64.2	22.8	1.6	14.8	12.7	3.6	60.6	12.8	25.5	4.9	18.8	8.4	18.5	0.0	0.0	26.3	7.4	4.9	11.5	6.9	122.9	4.5	7.5	16.3	3.9	18.4	25.4	10.1	11.7	2.9	7.2	16.2	1.1	15.4	73.3	10.5	0.0	7.8	0.2	10.6	1.1	4.7	5.7	9.0	10.2	8.1	16.4	4.7	35.1	0.0	0.2	13.4	27.1	29.4	2.9	11.5	20.7	11.0	50.6	13.8	9.6	17.6	29.8	6.6	10.6	19.2	4.3	7.9	0.0	11.7	0.8	16.7	49.7	50.6	11.3	7.8	0.0	8.9	0.0	7.0	16.6	10.4	13.5	7.7	5.0	3.3	7.1	10.6	4.7	0.7	2.5	0.5	3.3	12.5	75.9	15.0	4.7	23.0	24.8	22.5	22.7	20.9	18.4	23.6	23.3	20.9	23.5	22.8	25.5	10.8	9.6	8.4	6.2	6.4	11.1	7.4	8.5	9.6	9.5	12.2	10.7	7.6	8.6	7.8	5.5	10.4	78.3	24.5	12.5	15.6	15.6	145.8	6.0	86.5	10.2	12.1	7.0	7.7	16.7	12.8	11.0	10.7	8.0	7.0	15.9	12.1	26.8	75.0	6.7	7.7	14.9	2.0	16.7	8.5	310.1	10.8	14.9	26.6	2.8	7.2	13.4	13.4	2.0	5.4	17.4	22.3	11.7	8.5	14.1	35.0	14.0	5.3	8.4	13.1	11.6	8.6	98.7	15.5	8.7	10.5	67.3	5.9	9.3	19.8	5.8
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211579161	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 86.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	14.8	18.0	15.7	10.9	17.0	29.8	8.5	15.2	19.3	18.6	27.8	15.4	28.2	10.8	9.9	8.0	12.5	12.4	10.0	16.9	15.4	20.5	86.1	7.2	6.1	17.9	17.3	7.8	11.3	10.3	4.6	10.1	16.8	7.8	13.6	6.1	9.3	7.9	1.8	16.0	19.9	11.6	16.7	15.4	9.5	13.4	18.9	4.5	16.9	4.8	7.1	12.2	7.5	13.2	10.3	15.0	7.7	9.9	32.4	14.9	70.5	27.3	19.3	13.8	13.6	6.4	46.6	5.8	24.1	24.4	19.3	17.2	11.5	15.4	16.4	15.0	9.3	4.7	28.8	14.7	18.1	15.8	10.0	22.5	37.5	17.7	28.4	20.5	8.6	3.4	18.7	25.5	17.2	9.1	3.2	9.9	24.2	10.6	12.0	10.0	3.7	20.4	42.5	26.4	7.8	13.7	26.7	13.6	62.7	14.2	7.0	20.2	14.6	10.4	24.8	35.4	22.1	11.9	19.0	4.5	9.8	15.7	9.3	1.4	1.3	0.5	0.4	1.5	0.5	0.2	0.3	0.2	0.9	0.1	0.3	0.4	0.1	0.4	1.2	0.5	0.3	0.4	15.7	17.0	15.2	19.3	16.9	15.4	17.9	17.3	16.8	16.7	18.9	13.2	29.7	9.6	9.8	3.9	8.8	28.6	8.2	3.0	16.5	11.0	24.9	14.7	21.0	18.6	4.2	36.8	6.2	11.6	19.9	54.5	1.9	6.9	44.0	37.0	19.1	27.3	9.5	26.1	0.6	12.5	32.7	15.9	8.6	66.4	5.1	7.5	17.9	94.9	32.0	6.7	0.6	22.8	2.0	27.2	14.5	6.8	9.9	25.5	21.4	3.7	18.8	29.0	1.0	1.0	0.1	9.5	41.7	7.5	8.6	13.9	49.2	29.8	6.4	9.4	6.6	15.9	11.7	37.9	17.4	24.2	46.2	24.5	14.2	14.8	23.3	13.7
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 23.9;liver: 33.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HEL: 1.5;K-562: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.0	0.0	6.0	0.0	6.1	0.3	0.0	4.4	7.6	0.0	7.4	3.8	23.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	5.7	0.0	33.5	0.0	0.0	5.4	5.9	0.2	0.0	0.0	0.0	0.0	5.6	0.1	5.0	0.4	0.0	0.0	0.7	0.1	8.9	0.0	4.5	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.1	6.0	6.1	4.4	7.6	5.9	5.7	5.4	5.9	5.6	4.5	6.5	4.7	0.0	0.0	0.0	20.2	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	1.2	1.5	0.1	0.0	0.0	0.1	0.0	44.3	0.0	0.2	38.3	0.0	0.0	1.0	0.0	2.7	4.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.4	21.1	0.1	0.0	4.3	0.6	0.0	0.6	0.3	36.1	1.2	0.0	1.8	9.4	0.0	3.1	0.0	3.0	3.3	0.0	14.4	1.5	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.9	0.0	0.1	0.3	0.0	1.3	0.8	0.0
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.2;epididymis: 68.5;testis: 35.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.3"	"Group enriched"	"Detected in many"	10	"amygdala: 14.5;basal ganglia: 10.3;cerebral cortex: 18.2;hippocampal formation: 22.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0"	"Group enriched"	"Detected in all"	4	"amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7"	"Group enriched"	"Detected in many"	6	"amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.1	2.1	14.5	0.1	10.3	0.3	0.1	0.0	18.2	0.2	0.0	0.1	0.0	0.4	68.5	0.1	0.3	0.1	7.9	22.2	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.2	0.0	0.5	0.3	0.0	0.8	0.3	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	35.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	1.5	0.4	1.3	0.1	2.0	0.2	0.2	0.3	0.0	0.0	1.3	1.4	0.5	0.5	0.0	0.1	0.0	8.8	0.3	11.2	0.0	0.3	0.0	1.2	5.9	0.5	12.0	0.2	0.2	2.3	0.0	0.0	0.6	0.0	0.2	0.9	2.9	1.7	0.1	0.2	3.9	0.1	0.4	1.8	0.4	0.0	22.8	11.0	1.4	0.0	0.3	0.0	0.7	2.8	0.0	0.0	0.1	0.0	0.8	0.1	0.3	5.1	0.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	14.5	10.3	0.0	18.2	22.2	0.0	0.5	0.0	0.8	0.0	0.0	1.5	0.3	0.0	0.0	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.8	0.0	0.1	0.4	0.0	0.0	15.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	42.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	15.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	16.6	10.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093949-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	25.8	25.6	9.8	21.0	10.3	19.6	30.3	11.7	15.9	29.7	17.4	26.9	24.7	25.6	38.2	19.3	24.3	24.0	24.1	9.7	10.6	29.1	29.0	21.1	24.7	10.1	11.4	22.3	33.0	35.9	24.0	27.4	10.2	29.4	24.7	18.5	30.8	24.0	16.4	27.1	23.6	22.8	9.7	21.9	26.3	16.4	10.9	20.8	37.5	16.5	23.7	23.6	19.7	12.1	37.4	29.9	26.3	46.2	69.1	53.2	82.5	58.8	53.6	36.4	55.1	26.0	45.7	50.2	70.6	41.4	63.7	38.8	38.6	46.1	61.5	60.2	43.5	55.7	35.0	43.2	55.0	34.8	58.3	35.7	57.1	38.3	46.5	50.1	36.6	34.2	34.9	57.0	46.1	46.9	46.4	71.6	29.4	25.3	33.3	35.5	33.2	89.9	53.6	34.5	46.0	36.8	47.4	45.0	84.5	36.0	43.7	76.2	33.3	23.2	29.5	58.7	58.2	49.5	67.5	37.9	46.6	62.3	58.9	11.9	5.1	8.5	4.1	5.3	4.4	6.9	6.4	6.2	6.3	4.3	5.9	4.8	4.1	4.0	5.5	9.6	4.9	2.8	9.8	10.3	11.7	15.9	9.7	10.6	10.1	11.4	10.2	9.7	10.9	12.1	17.3	19.2	21.5	14.7	26.9	18.7	27.9	27.5	19.9	15.3	28.5	20.6	29.2	18.6	23.2	25.8	22.9	42.0	35.3	19.9	29.4	22.0	6.9	28.8	35.8	19.3	13.2	29.9	29.6	27.1	80.4	24.8	34.7	23.7	41.3	15.4	21.8	19.8	22.3	8.4	30.6	27.9	32.6	17.2	18.4	9.9	24.2	16.8	14.2	19.7	21.2	14.9	15.5	22.1	23.3	19.0	16.7	22.2	51.8	34.7	16.9	21.3	27.7	24.7	26.3	17.5	21.4	11.0	14.9	26.6	21.5	51.6	23.4	20.9	23.2	28.6
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	10.3	8.9	4.0	8.5	4.8	4.2	10.1	5.2	4.8	10.1	5.1	10.0	8.6	9.2	7.5	8.8	8.0	9.0	7.6	4.0	4.5	11.7	11.2	8.4	9.8	5.0	4.4	9.0	10.4	11.3	4.3	12.1	4.9	8.8	10.0	6.0	7.7	7.8	7.8	8.0	8.4	9.4	4.8	7.8	9.2	6.2	4.4	9.4	11.8	7.6	10.3	9.9	5.6	6.2	27.7	20.3	20.5	18.0	25.4	22.6	22.7	25.3	25.0	20.4	18.5	15.8	25.4	13.1	16.4	20.4	23.4	17.0	24.7	17.4	25.8	26.6	13.7	28.6	10.9	20.3	16.3	30.4	16.9	17.0	26.7	27.4	21.8	20.7	16.6	9.2	24.6	17.2	23.6	10.2	16.1	13.9	31.0	30.8	10.6	14.2	24.7	19.3	22.5	23.9	15.3	23.3	19.9	21.2	20.4	19.0	11.7	13.6	14.3	25.9	14.3	17.2	30.3	23.1	43.5	19.2	23.0	23.4	26.6	12.8	2.4	1.9	2.5	2.0	3.5	3.0	2.3	2.8	2.9	2.7	3.4	3.2	2.4	7.0	2.3	2.0	4.6	2.0	4.0	4.8	5.2	4.8	4.0	4.5	5.0	4.4	4.9	4.8	4.4	6.2	8.6	9.6	9.9	19.9	14.9	9.1	5.3	14.9	13.6	4.5	9.0	5.7	4.1	8.6	8.3	7.3	6.2	19.8	8.4	9.5	5.9	7.5	2.8	7.4	10.1	10.9	3.6	13.2	29.2	8.7	14.7	9.5	11.7	10.5	3.8	12.9	11.4	15.3	10.7	1.7	31.0	7.9	14.2	8.8	9.3	1.0	6.5	6.6	8.8	10.3	7.7	7.5	12.3	27.2	37.2	9.8	7.0	7.9	20.0	8.7	9.1	8.3	10.0	7.1	13.1	7.3	7.3	12.3	9.4	13.6	6.3	27.5	9.5	9.0	9.0	5.2
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981757	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	6.8	6.8	2.5	7.2	3.0	6.7	6.5	3.7	3.5	7.2	6.6	5.9	6.6	4.7	7.8	5.0	4.6	6.7	4.2	2.5	3.0	5.3	10.2	9.3	7.5	2.9	3.1	4.5	8.0	6.8	5.7	8.7	3.0	5.9	7.1	4.7	8.6	3.6	2.6	6.1	6.1	4.4	2.7	7.1	7.6	3.0	3.2	7.0	6.9	2.1	7.0	7.8	5.3	3.9	11.3	5.2	6.1	12.5	16.5	14.9	16.2	8.5	17.0	7.3	9.4	5.3	7.7	5.0	17.2	14.1	4.9	10.7	6.5	11.1	12.7	6.4	4.7	8.5	8.4	11.4	19.5	11.7	7.6	17.3	8.4	12.9	18.9	10.9	15.3	8.4	4.9	15.9	12.5	4.4	9.4	8.1	7.7	5.6	5.5	4.2	10.8	5.8	10.6	10.0	3.3	7.4	11.4	15.8	12.2	5.3	6.7	8.1	17.9	18.2	6.3	19.9	13.7	14.0	5.7	4.6	23.1	11.1	5.7	8.3	5.8	4.2	5.2	6.6	4.9	2.7	5.3	4.8	3.9	2.5	5.5	5.7	2.7	3.5	8.7	3.9	4.3	3.1	2.5	3.0	3.7	3.5	2.5	3.0	2.9	3.1	3.0	2.7	3.2	3.9	28.3	32.1	21.6	32.3	26.3	57.4	19.7	22.8	21.1	10.1	25.8	13.2	6.1	20.0	22.1	23.9	6.2	32.6	24.5	24.1	1.9	24.1	0.9	14.9	27.0	34.5	22.8	11.6	44.8	26.4	24.3	29.1	29.0	29.4	37.4	16.3	33.5	44.6	22.1	5.0	39.6	38.3	14.2	37.0	39.1	1.1	17.1	28.5	32.0	34.7	29.6	6.5	28.8	52.8	59.2	36.0	27.9	16.6	48.1	46.0	20.7	15.7	23.5	13.7	6.6	30.2	20.9	11.4	9.2	19.3	63.9	41.7	28.8	34.8	24.3	32.7
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 61.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.2	0.2	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.2	4.3	0.0	0.1	0.1	0.2	0.1	0.0	61.8	0.3	0.3	0.3	0.3	0.1	0.2	0.2	12.9	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.2	0.3	0.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990502-42090461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004014	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	8.8	15.4	11.4	6.9	12.4	5.8	13.8	12.0	16.1	11.8	12.2	13.4	12.6	10.3	16.0	9.3	9.9	8.6	21.1	12.8	11.9	30.5	14.2	8.9	7.4	11.1	11.3	11.1	12.9	22.7	14.6	9.4	11.6	13.6	13.9	19.8	12.2	10.0	14.7	9.6	11.6	8.5	10.9	7.9	12.9	6.8	11.5	9.1	17.3	20.5	7.8	9.5	8.0	11.7	12.7	6.2	20.3	23.2	15.3	21.3	11.4	17.3	20.8	14.8	17.5	6.4	16.2	13.0	12.2	20.0	19.1	6.3	17.3	14.3	21.1	4.4	10.2	14.9	10.7	10.9	27.1	20.8	10.3	17.0	14.4	12.7	16.5	23.8	16.3	12.9	20.4	6.0	26.2	6.1	12.0	19.6	15.6	19.7	8.5	5.9	18.4	10.8	30.2	10.6	22.5	25.3	12.3	13.5	15.9	14.3	17.2	15.5	17.7	17.4	10.1	17.6	20.3	11.9	9.5	12.3	23.8	17.4	15.5	3.1	1.8	1.0	1.2	2.3	1.3	1.3	1.3	1.5	2.5	1.1	1.7	1.4	0.8	2.1	1.9	1.8	1.6	1.4	11.4	12.4	12.0	16.1	12.8	11.9	11.1	11.3	11.6	10.9	11.5	11.7	19.7	48.1	44.5	48.3	26.5	15.2	22.8	24.7	24.5	34.9	30.3	16.9	90.7	32.9	33.8	38.6	25.0	44.4	11.4	33.8	103.7	35.9	7.1	27.3	29.2	22.1	33.5	32.2	70.0	36.4	34.0	27.7	37.8	26.8	34.2	33.3	21.4	25.4	24.2	50.5	74.7	36.7	30.5	22.2	21.1	8.7	20.8	23.8	24.9	43.1	28.0	29.7	9.2	63.3	84.7	34.3	17.4	22.6	35.8	27.1	25.5	111.7	43.6	39.3	6.6	29.3	28.1	16.1	18.0	40.8	22.7	49.4	21.2	44.8	38.3	24.2
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221544-113264492	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 20.9;intermediate monocyte: 26.8;myeloid DC: 16.3;neutrophil: 8.2;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.3;granulocytes: 8.2;monocytes: 31.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013810	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	11.5	23.9	5.7	11.1	5.8	11.7	12.7	6.6	6.5	20.7	26.3	16.3	45.1	7.2	13.7	12.0	6.5	9.6	7.4	6.9	6.6	28.7	107.6	17.7	6.3	7.2	6.9	4.9	19.1	15.2	5.8	13.5	11.7	21.3	17.0	7.1	66.5	12.8	3.5	18.5	37.4	10.0	6.8	7.6	19.4	6.4	7.0	5.5	10.9	5.8	12.4	14.3	6.5	6.5	22.1	23.4	18.7	41.4	42.0	29.8	68.8	38.3	58.0	26.0	30.1	33.5	18.8	17.2	15.2	33.0	32.9	53.3	35.8	21.8	29.0	15.2	19.9	14.2	18.7	37.6	102.3	26.1	20.6	36.1	48.3	33.6	54.6	17.4	24.0	19.6	32.8	30.9	24.8	23.6	17.9	13.2	30.4	84.2	26.0	18.3	49.1	17.2	23.6	27.2	17.7	23.1	37.0	73.0	101.5	26.2	37.2	22.0	22.3	19.3	11.9	39.1	23.2	18.5	40.5	23.6	31.9	24.2	23.1	3.0	20.9	2.5	2.3	26.8	3.2	1.7	1.6	2.4	16.3	1.5	1.8	1.7	8.2	4.4	31.0	2.3	1.8	7.6	5.7	5.8	6.6	6.5	6.9	6.6	7.2	6.9	11.7	6.8	7.0	6.5	8.0	35.3	33.5	7.5	6.6	15.2	10.6	27.4	10.2	12.6	21.4	14.9	7.4	21.5	50.8	5.5	33.3	16.5	6.9	40.2	9.8	18.3	0.3	16.2	15.6	11.6	9.0	25.4	16.8	27.2	24.1	16.0	15.3	14.5	5.1	11.4	11.4	97.1	43.4	6.7	17.0	18.9	42.7	39.4	19.9	0.9	6.2	40.3	12.4	20.6	21.8	12.2	4.1	16.1	12.3	22.3	11.1	7.2	16.1	28.9	61.7	24.7	30.1	11.2	6.6	8.4	15.2	24.4	30.7	15.1	15.8	22.4	5.5	15.2	19.9	22.6
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724486-38729372	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			0.0	0.0	12.4	0.0	39.8	0.2	0.0	3.4	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	36.5	0.3	0.0	0.0	0.0	14.2	6.8	0.0	0.0	0.0	7.6	0.0	8.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	39.8	3.4	22.0	2.4	36.5	14.2	6.8	8.7	6.3	5.1	1.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	14.7	0.0	0.0	0.4	0.0	0.1	0.0	4.2	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	20.7	0.0	0.0	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042430	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Vesicles, Cytosol"		"HPA042430: AB_10806238"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	8.8	11.0	3.9	4.9	4.8	2.9	8.4	4.6	4.7	12.3	9.2	7.2	6.9	8.8	12.9	8.0	9.5	7.8	7.6	4.6	5.3	10.4	17.2	8.4	5.0	4.4	4.2	8.0	30.9	11.6	5.9	6.6	4.6	8.3	6.4	6.8	11.2	11.0	4.7	6.4	7.7	7.1	5.2	5.8	8.8	5.4	5.2	7.1	18.8	4.8	6.2	6.8	7.9	7.3	18.9	17.7	7.3	8.3	24.4	23.5	12.9	13.1	21.2	19.8	18.7	8.5	22.0	9.9	24.1	13.1	19.8	17.1	14.3	15.2	20.8	16.5	13.3	11.3	6.5	15.8	41.5	13.3	8.9	18.4	26.7	9.7	49.5	20.5	19.8	12.4	8.6	27.8	14.3	14.3	5.0	3.7	6.8	17.7	14.9	5.6	8.1	29.1	9.7	11.8	7.9	5.9	11.1	24.5	21.4	11.3	8.1	11.2	21.4	10.1	4.9	17.9	13.1	33.2	14.4	12.3	14.6	8.8	14.0	12.7	8.4	6.2	8.9	6.3	9.6	5.4	6.0	6.8	10.4	3.5	5.4	5.5	1.7	6.6	6.5	16.1	5.7	5.9	3.9	4.8	4.6	4.7	4.6	5.3	4.4	4.2	4.6	5.2	5.2	7.3	9.0	22.4	25.0	16.0	14.8	8.9	11.7	20.8	18.2	17.5	16.0	9.0	23.8	18.6	21.5	11.0	27.1	18.2	21.1	14.2	5.9	15.3	13.7	11.2	20.3	13.7	12.5	8.4	17.9	15.4	28.3	19.7	20.9	16.6	12.0	12.8	16.4	64.3	19.5	18.5	17.4	18.1	12.2	14.7	15.8	13.2	18.6	15.2	12.4	10.3	19.0	15.4	12.3	11.1	20.8	14.4	5.3	21.4	33.3	19.5	18.9	17.1	23.4	23.0	13.1	16.0	16.0	19.5	9.2	12.2	9.5	37.6	15.3	10.2	13.9	10.9
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 9.7;kidney: 13.6"	"Group enriched"	"Detected in some"	9	"Proximal enterocytes: 83.7;Proximal tubular cells: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.5	0.2	0.0	2.9	0.4	0.5	0.2	0.2	0.2	13.6	0.0	0.3	0.2	1.8	2.0	0.0	0.6	0.0	1.2	0.0	0.5	0.3	0.0	0.2	1.6	0.0	0.1	0.4	9.7	0.0	0.5	0.2	0.4	0.4	0.8	0.0	0.3	0.0	0.0	0.1	0.5	1.1	0.6	1.2	0.7	1.5	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	4.0	0.5	0.1	0.0	0.1	1.8	0.0	0.0	0.1	2.8	0.3	0.1	3.3	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.6	0.0	7.6	0.0	0.1	0.3	0.7	0.8	0.9	0.5	0.0	0.0	0.6	0.0	1.3	0.4	0.9	0.2	0.6	2.2	0.0	0.3	0.3	0.3	1.5	0.1	0.7	0.3	0.3	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	1.8	2.0	0.5	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	83.7	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	15.8	20.5	13.7	12.7	14.3	15.9	14.9	14.3	14.8	18.7	19.4	29.3	17.3	13.1	28.4	24.7	32.6	15.2	15.0	14.5	15.8	19.8	31.8	18.2	11.4	14.6	15.0	9.3	30.0	24.7	21.3	19.9	15.4	17.1	28.2	3.1	23.8	14.8	14.0	21.9	18.0	11.7	14.4	14.7	25.0	7.1	15.9	11.8	15.4	7.2	14.7	19.8	15.4	15.9	48.8	55.2	18.8	27.3	36.5	31.6	29.7	49.7	54.1	51.3	59.9	64.0	84.5	18.8	22.2	54.2	64.4	67.0	51.7	40.0	39.7	27.9	34.0	20.5	33.1	49.6	47.8	38.7	40.9	35.7	69.9	48.6	39.8	28.9	30.6	25.9	38.7	29.8	37.6	47.1	20.5	35.0	39.7	55.3	67.7	22.3	35.5	61.1	44.4	39.1	21.8	36.1	52.9	54.5	28.7	35.1	80.8	30.7	28.2	30.3	30.6	55.4	27.5	45.1	32.8	19.6	38.4	34.1	40.3	18.1	22.3	40.0	15.3	23.4	15.8	10.7	12.6	13.9	27.7	9.9	8.3	14.6	24.2	13.8	17.5	27.7	13.1	11.9	13.7	14.3	14.3	14.8	14.5	15.8	14.6	15.0	15.4	14.4	15.9	15.9	16.2	9.6	17.0	3.3	13.1	14.1	11.7	29.0	2.8	4.5	26.5	10.9	5.2	10.0	23.5	16.5	0.0	31.0	15.6	24.1	3.9	27.4	3.3	24.2	12.0	13.5	12.7	19.0	2.6	32.3	30.6	14.0	18.8	16.8	2.5	8.0	11.0	15.6	23.4	6.7	2.5	31.5	28.5	10.1	14.5	1.3	9.9	12.3	10.6	4.7	21.9	9.4	8.2	4.5	4.4	27.1	19.7	10.9	19.3	18.7	17.8	10.5	50.5	5.7	6.6	9.7	19.4	10.3	6.8	10.9	17.5	48.0	13.8	12.2	21.7	23.4
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035634	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 211.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	11.6	7.3	4.3	10.4	5.1	11.4	18.3	6.6	5.8	19.1	10.0	53.3	49.7	9.6	11.4	14.4	13.1	13.5	5.5	4.1	4.7	21.3	37.3	11.5	8.0	4.7	4.6	8.1	11.5	19.8	4.8	10.2	5.1	23.0	53.8	6.9	22.0	11.6	4.9	10.8	41.4	8.8	4.5	7.9	33.4	2.8	4.9	18.9	24.9	6.1	8.9	10.5	10.2	6.3	28.3	7.6	6.7	7.1	14.8	12.9	26.7	24.5	14.8	9.4	13.6	4.9	15.1	15.1	30.0	14.3	13.3	16.0	12.7	11.0	21.6	18.7	9.4	13.7	10.7	11.8	9.2	22.1	1.6	6.8	12.1	11.5	22.2	11.3	11.1	11.9	23.0	21.9	19.3	7.1	14.6	11.4	8.2	16.0	24.9	4.5	20.4	9.4	17.1	16.0	8.6	4.8	17.0	32.3	13.7	6.2	19.7	16.6	13.0	14.3	13.0	32.0	13.3	12.9	16.2	11.2	23.0	13.5	6.1	4.4	2.1	1.1	2.2	2.1	2.5	2.5	2.2	2.6	1.7	1.8	2.7	2.3	0.6	4.3	1.7	5.0	2.8	1.9	4.3	5.1	6.6	5.8	4.1	4.7	4.7	4.6	5.1	4.5	4.9	6.3	23.5	80.1	28.6	12.4	17.8	25.0	21.6	30.5	18.8	15.7	33.9	15.4	8.8	27.1	50.5	55.2	20.9	19.4	51.4	211.0	7.9	18.1	4.4	49.4	22.4	20.5	19.8	9.7	24.4	15.3	30.5	17.0	43.3	46.3	17.1	19.5	20.7	49.3	14.2	10.1	26.6	110.6	22.4	17.8	17.1	2.1	13.4	14.2	8.8	23.4	18.0	19.0	14.4	30.2	46.7	21.7	82.8	13.2	25.6	43.3	112.4	25.3	92.6	25.1	6.6	14.4	17.7	16.2	8.3	21.2	29.7	23.3	23.8	12.8	116.4	48.4
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585579	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	15.5	19.3	18.2	13.4	23.9	5.7	14.8	22.4	26.9	15.5	18.4	15.6	16.7	15.6	16.0	14.3	14.6	15.4	9.7	18.1	21.4	20.2	21.0	14.7	15.7	24.0	21.7	17.9	9.5	17.2	9.1	18.4	24.3	16.0	16.1	21.7	11.4	13.9	6.1	9.2	18.3	15.9	23.2	14.2	14.5	18.8	21.2	12.7	26.1	10.2	15.3	12.6	8.3	30.0	20.4	18.4	31.2	18.8	39.3	37.4	18.0	33.2	23.7	27.5	31.5	13.6	22.8	18.1	27.4	28.8	31.3	25.3	22.4	15.6	34.6	14.2	11.1	23.2	15.9	11.4	33.6	20.7	21.5	31.8	30.9	24.3	14.9	34.8	25.1	13.8	13.5	22.1	38.7	7.2	16.2	13.1	20.8	24.0	19.2	14.4	11.4	19.7	34.2	14.9	18.3	24.1	21.3	10.4	38.0	20.9	14.2	13.9	28.3	40.3	21.8	8.6	15.7	15.7	24.4	32.2	29.9	17.2	30.8	14.8	16.4	21.0	10.9	25.9	10.3	14.7	10.2	8.6	19.7	13.6	13.6	11.2	14.6	7.3	27.4	9.4	11.2	10.8	18.2	23.9	22.4	26.9	18.1	21.4	24.0	21.7	24.3	23.2	21.2	30.0	9.9	3.2	10.1	13.1	12.5	6.4	8.3	9.9	11.4	12.8	8.5	6.5	5.5	7.2	12.6	14.7	0.0	36.1	12.5	16.4	9.8	7.8	156.8	9.2	9.1	12.9	7.7	9.2	15.0	7.7	25.6	14.0	10.7	10.0	14.0	9.0	19.6	13.1	17.9	37.0	15.2	11.8	20.3	23.2	9.2	23.5	17.1	13.0	26.6	5.6	14.0	20.3	9.2	23.1	36.6	8.1	13.1	17.3	14.3	8.5	25.8	14.8	10.4	16.9	26.3	9.6	10.6	14.9	15.7	8.9	6.7	29.8	10.7	14.6	10.0	6.5
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700934-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	13.4	9.9	16.8	15.6	17.1	19.4	18.6	17.3	20.0	16.7	21.7	19.9	26.8	11.4	52.8	17.2	18.1	12.5	32.2	17.1	20.0	28.8	46.4	15.3	14.3	17.4	17.8	8.5	18.4	31.6	13.7	17.0	17.4	13.7	24.2	17.0	16.4	15.5	61.4	10.8	26.0	15.6	16.5	12.4	17.4	14.0	18.4	15.3	36.0	60.3	21.6	23.0	7.9	17.2	45.2	75.5	52.4	87.7	47.5	32.9	59.7	46.4	77.8	98.7	80.5	156.6	52.3	31.5	104.7	66.7	55.0	32.6	87.1	55.3	103.5	38.3	65.3	38.5	43.8	94.0	85.3	71.9	34.9	31.9	60.3	73.1	83.6	24.6	64.7	46.5	40.0	84.2	68.1	94.2	51.9	52.5	23.6	82.4	92.2	37.4	56.6	85.6	47.1	45.5	45.8	60.4	25.9	21.3	34.0	57.7	68.7	50.0	26.6	74.0	33.3	84.0	61.9	48.3	79.6	42.7	50.2	54.6	63.8	25.1	27.2	10.1	15.8	27.7	12.0	11.6	10.9	15.4	32.1	6.8	11.2	10.0	11.2	13.5	19.3	43.3	13.6	16.1	16.8	17.1	17.3	20.0	17.1	20.0	17.4	17.8	17.4	16.5	18.4	17.2	32.1	16.0	29.7	10.7	37.1	22.3	40.0	56.4	22.8	28.2	37.1	29.0	40.5	21.5	45.3	27.6	35.5	57.8	47.4	34.9	35.2	78.4	52.4	19.1	25.1	39.2	50.6	20.4	11.7	101.7	121.0	28.6	16.3	24.1	42.5	22.8	27.8	56.6	73.5	21.9	10.4	56.2	59.0	28.0	45.2	17.6	30.1	34.0	37.4	4.7	39.6	44.6	26.8	11.6	11.2	77.5	33.2	20.7	103.7	70.1	139.9	51.3	33.9	35.4	13.1	25.3	47.9	63.2	41.2	24.5	25.1	80.4	31.1	24.1	41.7	50.6
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	20.1	36.7	21.2	19.6	25.7	18.4	25.2	27.0	42.3	23.3	24.1	27.1	19.6	28.5	29.5	17.5	26.2	30.0	26.4	19.5	23.3	30.3	30.6	21.7	21.5	25.8	25.1	21.3	41.8	42.5	14.6	25.0	25.6	24.0	28.8	14.6	46.4	27.4	22.4	21.9	23.9	29.7	26.1	24.7	30.6	14.7	26.1	18.5	24.4	23.7	22.3	28.1	19.5	30.9	87.2	48.8	61.4	117.6	106.4	102.3	44.1	95.1	152.3	89.3	109.4	43.3	79.3	19.2	81.9	117.3	97.7	81.1	42.5	106.3	64.4	57.4	53.3	39.8	37.9	59.5	94.1	85.2	61.5	107.0	112.1	85.5	43.1	129.1	67.4	43.2	56.8	81.4	112.5	106.9	32.5	71.0	27.2	271.3	58.9	30.9	38.3	100.2	100.3	65.5	75.4	71.4	45.9	52.2	109.6	37.6	93.3	75.7	65.8	71.0	46.2	71.3	83.3	62.4	75.7	45.6	95.6	67.6	147.5	51.9	14.5	23.5	33.1	11.4	28.3	19.7	18.6	25.2	12.9	13.2	16.6	22.0	1.3	20.3	3.9	23.5	16.4	17.7	21.2	25.7	27.0	42.3	19.5	23.3	25.8	25.1	25.6	26.1	26.1	30.9	8.0	6.4	11.5	8.5	19.2	13.5	32.0	58.3	23.9	9.7	31.6	30.1	7.8	37.1	34.8	27.6	2.1	59.2	15.3	15.2	13.7	84.0	0.6	16.0	17.8	11.1	19.7	10.5	3.5	73.8	52.1	27.5	14.3	19.5	34.9	11.9	13.6	18.7	38.4	10.1	4.3	21.6	57.0	11.4	10.8	2.3	23.3	22.0	53.4	4.7	22.0	38.8	23.7	9.5	13.8	67.4	25.9	19.9	23.3	36.3	18.8	13.5	18.4	12.5	0.0	18.3	24.5	21.0	60.8	17.4	13.9	35.2	14.0	14.8	31.5	24.2
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8411435-8435561	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	11.3	9.7	6.0	10.2	7.6	4.6	12.9	6.3	10.6	12.2	7.2	24.2	14.8	9.4	43.0	10.3	9.6	15.1	10.3	6.3	6.2	16.4	23.4	10.6	12.2	7.2	6.6	8.1	18.4	14.6	12.0	14.7	7.1	12.1	24.9	5.2	15.0	17.4	5.7	10.7	16.9	9.4	6.4	13.4	17.9	8.8	6.6	9.9	18.2	4.5	11.8	12.3	10.9	9.4	14.8	7.7	10.4	14.1	23.4	35.7	8.5	37.9	31.4	13.5	17.3	24.7	13.9	12.5	20.9	27.7	19.5	10.6	11.5	10.3	22.6	18.0	8.4	6.1	6.1	15.0	24.5	9.1	13.2	24.4	14.3	14.3	15.5	17.5	18.5	7.4	13.2	5.1	30.5	10.2	6.9	13.7	8.2	20.6	9.2	6.2	9.7	12.6	36.7	13.2	9.9	8.4	9.8	8.6	17.9	29.6	6.5	18.4	15.9	22.3	6.4	15.9	17.2	12.8	23.9	6.3	12.8	10.0	29.6	5.4	4.5	4.8	6.2	3.5	6.9	4.2	6.2	6.6	4.0	5.8	7.0	5.5	5.2	10.8	5.8	2.7	7.0	4.3	6.0	7.6	6.3	10.6	6.3	6.2	7.2	6.6	7.1	6.4	6.6	9.4	13.3	6.4	10.6	21.9	14.9	13.5	13.0	29.4	10.8	5.7	20.9	10.3	9.1	20.0	27.5	29.5	4.2	21.1	18.5	42.8	7.9	20.5	9.9	28.6	19.4	15.1	14.9	5.5	19.5	24.3	29.1	21.8	28.1	15.5	6.3	11.5	18.5	23.6	19.9	10.1	17.7	47.3	36.7	15.1	10.4	7.6	15.5	11.3	21.4	24.4	16.7	7.1	13.4	30.7	65.7	15.4	33.4	12.0	22.2	22.6	31.1	27.5	46.8	3.7	13.1	9.9	15.7	32.1	14.2	13.7	17.6	16.4	13.1	10.7	33.5	22.9
SLC35B4	"FLJ14697, YEA4"	ENSG00000205060	"Solute carrier family 35 member B4"	Q969S0	7	134289332-134316930	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 95.2;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049779	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA049779: AB_2680878"	"unprognostic (1.84e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.00e-1)"	5.1	6.4	8.8	5.2	8.7	1.9	3.3	9.8	8.5	4.0	7.6	4.0	2.9	6.0	6.3	3.3	4.4	3.9	2.5	8.5	8.9	10.4	8.5	3.3	4.5	8.0	8.5	6.4	2.6	4.6	4.2	11.8	7.7	5.2	3.5	12.3	2.3	6.1	2.5	3.1	4.1	7.1	7.7	4.2	3.5	4.7	10.1	4.8	3.4	2.9	4.8	4.0	2.8	8.7	6.8	22.5	19.3	29.0	18.4	15.3	9.9	16.9	14.1	14.7	12.4	8.7	6.3	22.9	5.6	18.3	19.2	7.2	29.0	15.0	24.3	14.5	21.4	15.5	12.9	11.6	13.6	22.1	13.4	13.6	6.3	17.7	14.9	11.0	14.4	15.6	15.2	8.2	22.2	6.1	19.7	16.1	40.0	7.0	20.0	14.1	17.0	11.2	8.3	8.3	6.7	39.5	15.1	5.0	19.0	16.0	2.7	12.4	16.1	19.0	6.2	11.5	16.9	26.9	39.9	25.9	34.0	20.5	22.4	0.7	1.5	0.3	1.6	2.1	2.5	1.3	1.5	2.1	3.1	1.4	1.4	2.1	0.1	1.9	1.7	2.1	1.7	1.4	8.8	8.7	9.8	8.5	8.5	8.9	8.0	8.5	7.7	7.7	10.1	8.7	7.2	9.6	5.4	22.9	10.2	2.2	5.7	10.7	6.2	52.6	4.9	3.4	6.9	11.5	8.5	1.8	45.9	95.2	3.7	2.2	11.7	8.1	2.4	5.3	15.2	11.8	4.2	8.8	33.4	5.3	27.8	13.3	14.8	6.5	1.3	27.8	7.5	15.1	20.9	42.1	36.6	5.7	22.4	9.3	3.9	3.4	11.1	11.9	5.4	14.0	8.4	16.2	14.4	24.1	24.3	9.0	4.9	12.4	9.2	4.9	7.0	13.9	6.2	21.6	6.6	10.0	10.0	10.8	24.0	9.3	3.3	83.2	10.7	31.3	4.1	3.7
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813016	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	28.2	7.3	6.6	10.7	6.3	2.4	19.8	7.0	7.0	9.6	6.1	19.8	24.4	8.8	2.3	41.5	7.3	12.2	9.0	6.2	7.2	7.0	84.5	10.2	6.6	8.2	7.9	6.3	13.4	5.6	10.4	15.0	7.7	9.9	14.3	1.6	26.1	5.9	6.8	5.1	24.1	9.9	6.5	8.4	18.5	5.2	8.8	4.5	6.6	6.9	10.0	13.8	14.9	6.3	10.3	25.8	6.3	16.3	19.9	19.8	19.5	22.1	20.1	13.3	14.4	10.7	15.2	10.4	9.9	27.3	19.4	26.0	13.4	13.6	6.5	24.8	14.5	5.9	20.4	20.6	42.6	11.4	16.2	23.8	16.3	9.2	11.1	16.2	17.6	10.3	13.3	13.8	14.4	21.8	5.9	9.0	27.5	39.9	34.6	7.2	10.5	21.5	15.1	25.4	6.0	8.6	16.6	16.3	9.5	6.6	13.7	6.0	25.7	25.0	14.7	46.1	15.6	9.8	26.9	4.9	18.5	14.4	14.2	9.7	11.6	12.5	11.0	11.9	12.3	5.0	18.0	14.7	9.6	3.7	9.3	8.0	1.8	5.6	8.7	8.2	13.0	10.1	6.6	6.3	7.0	7.0	6.2	7.2	8.2	7.9	7.7	6.5	8.8	6.3	5.5	0.0	11.2	2.6	6.2	3.6	8.9	12.7	3.4	1.9	11.1	3.0	50.6	22.8	26.7	5.5	2.1	13.8	6.4	54.6	0.0	18.4	4.9	7.3	6.7	10.6	9.6	3.6	2.0	41.9	14.0	10.5	23.4	11.4	2.5	5.2	6.8	42.2	14.7	3.3	2.1	40.6	4.1	9.3	4.8	6.0	6.5	6.3	1.8	2.8	9.5	2.8	7.2	1.0	2.1	50.6	54.0	5.7	13.6	11.8	58.0	4.7	11.4	1.1	0.0	3.6	9.7	4.0	4.3	12.7	2.4	15.3	6.5	5.7	26.4	20.1
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96313444-96383711	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 117.2;Proximal enterocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 103.8;Hep G2: 132.3"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	14.7	8.8	13.5	14.4	20.6	11.4	16.4	17.8	20.6	16.5	12.3	49.1	65.1	14.9	12.1	13.7	14.6	20.6	12.2	14.3	16.0	32.1	56.4	19.2	12.4	25.5	19.7	17.3	31.4	16.4	7.2	25.5	22.1	14.2	46.4	4.3	13.0	11.0	3.9	9.4	65.8	13.9	16.6	10.0	43.1	7.2	20.1	7.5	29.5	6.9	11.7	17.2	13.1	27.8	33.2	27.6	15.8	30.2	20.3	37.3	27.9	14.7	30.2	21.6	17.5	60.4	103.8	0.6	24.5	13.5	49.9	47.6	22.2	21.8	18.7	16.4	16.8	11.3	9.8	132.3	32.5	0.1	0.0	32.2	27.6	16.3	48.7	51.0	46.7	0.0	22.3	0.4	23.7	27.2	0.3	0.1	13.2	67.5	28.5	0.1	0.0	0.0	54.4	21.3	5.5	35.9	11.9	24.8	68.5	53.3	16.4	24.7	41.3	14.5	16.2	21.2	13.8	0.0	0.9	0.1	30.2	0.1	20.4	1.2	0.9	0.6	1.3	1.1	1.6	0.7	2.1	2.9	1.2	0.9	0.7	1.4	0.1	1.8	2.1	0.2	3.9	0.5	13.5	20.6	17.8	20.6	14.3	16.0	25.5	19.7	22.1	16.6	20.1	27.8	14.5	9.6	11.0	12.1	4.3	5.2	8.9	2.1	1.8	1.1	15.1	13.1	7.2	27.1	4.6	12.9	2.1	28.1	12.9	61.7	11.7	8.1	0.2	21.0	14.0	12.6	9.6	1.3	0.8	24.5	45.1	9.5	20.4	31.6	4.5	20.0	13.2	43.2	20.5	1.7	1.1	42.0	4.1	23.0	9.7	0.6	10.8	17.7	17.8	20.6	8.9	10.2	7.2	11.1	117.2	25.4	43.5	6.0	6.3	15.5	67.0	23.6	6.7	3.6	13.1	6.8	11.2	1.4	4.4	8.6	5.4	26.5	14.6	7.0	34.9	17.9
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572415	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	10.7	9.8	5.9	5.6	4.8	8.0	9.6	3.7	6.6	9.6	6.3	9.2	6.6	8.5	5.9	11.5	7.4	6.1	10.1	5.6	4.7	7.8	11.4	9.1	7.1	4.8	5.9	8.8	22.3	15.2	11.2	7.2	5.0	11.7	6.1	7.4	15.4	10.0	20.5	11.9	7.7	6.8	3.6	6.7	15.3	4.1	9.1	8.5	9.2	14.0	8.1	10.1	8.7	4.5	26.2	10.4	6.9	16.2	25.2	19.8	16.4	17.8	20.3	15.1	18.2	11.8	18.7	13.6	30.2	29.3	14.9	17.6	19.7	21.5	15.2	15.8	29.5	11.9	11.6	14.4	21.1	19.6	14.5	16.5	24.2	17.0	24.5	19.2	14.8	16.0	19.9	17.3	19.4	25.3	15.3	9.3	8.1	24.8	34.6	14.9	10.6	16.6	15.7	16.1	11.9	11.9	12.3	19.6	11.5	8.3	14.7	9.9	15.3	19.5	9.6	26.9	21.2	23.6	26.9	15.1	29.3	21.4	12.6	1.8	1.3	3.2	1.3	0.9	1.8	2.2	1.4	1.3	1.0	0.8	1.0	0.8	1.3	1.8	2.0	1.1	1.8	1.1	5.9	4.8	3.7	6.6	5.6	4.7	4.8	5.9	5.0	3.6	9.1	4.5	21.7	38.5	42.5	6.8	14.9	21.9	15.3	22.1	5.7	28.8	34.1	21.5	16.1	22.8	31.3	29.5	35.5	14.4	43.3	25.2	0.0	20.4	3.6	26.6	20.1	20.2	18.5	13.7	13.9	36.8	29.8	14.8	13.3	50.8	8.2	21.2	22.9	26.9	17.4	30.3	13.9	29.7	8.2	21.1	28.0	4.2	17.1	23.3	8.8	10.3	22.8	19.4	17.5	9.0	6.2	41.7	13.1	21.1	29.3	30.9	22.1	7.0	24.0	29.4	6.6	30.1	14.3	10.2	14.3	13.6	25.9	32.6	29.4	16.2	20.4	28.4
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692795	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	21.0	29.7	38.1	20.9	35.9	17.3	25.8	30.7	38.5	35.3	31.3	30.8	31.9	31.8	34.2	20.8	29.2	19.5	19.4	38.8	27.8	27.8	26.1	22.9	32.4	28.8	29.9	39.0	30.7	20.3	43.1	20.4	29.4	30.2	22.1	42.6	29.1	22.5	29.1	29.5	34.1	30.6	26.2	40.1	28.7	10.9	31.1	34.5	30.8	14.6	28.0	26.0	26.5	33.3	13.0	17.4	58.3	49.8	42.3	40.0	16.9	15.6	35.8	16.9	19.7	12.8	33.6	22.6	24.2	33.7	20.9	16.9	23.0	14.9	16.8	28.4	20.1	30.6	37.2	21.7	31.5	24.6	26.2	35.0	31.2	21.4	30.5	47.3	35.5	40.9	31.1	30.8	19.4	9.2	32.3	29.2	19.0	11.2	18.5	28.3	15.9	29.5	29.1	13.1	50.9	46.8	26.4	31.5	50.8	23.8	38.9	34.8	33.5	29.9	12.6	11.7	8.6	25.0	19.6	35.2	22.8	45.2	16.5	1.8	3.7	2.8	7.0	3.3	7.6	3.9	5.9	8.1	2.4	3.9	6.8	5.9	5.5	4.0	2.4	7.6	6.0	5.0	38.1	35.9	30.7	38.5	38.8	27.8	28.8	29.9	29.4	26.2	31.1	33.3	8.2	12.8	28.3	9.8	19.8	7.4	7.1	14.1	18.8	35.5	12.0	8.6	17.1	34.3	24.6	3.7	77.2	14.1	26.0	28.3	0.0	5.7	1.1	9.1	14.8	16.8	25.4	21.5	12.0	6.1	9.6	18.4	30.5	6.8	23.4	13.9	25.4	22.2	10.5	30.3	12.1	24.3	18.3	31.5	8.2	3.9	30.4	13.8	12.4	9.4	21.8	12.3	29.9	14.6	12.9	6.2	17.8	26.7	28.0	9.3	38.1	3.4	23.4	66.5	6.6	16.8	12.0	8.5	16.1	16.3	9.7	8.8	23.1	10.1	26.4	8.7
SLC35E3	BLOV1	ENSG00000175782	"Solute carrier family 35 member E3"	Q7Z769	12	68746125-68793964	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049403	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA049403: AB_2680747"	"unprognostic (1.49e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.26e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.80e-1)"	0.9	1.3	1.2	0.6	1.2	1.5	0.7	2.6	1.6	0.8	0.4	0.7	0.4	0.6	0.8	0.9	0.5	0.5	0.7	1.1	0.6	0.7	1.1	0.8	0.7	1.2	0.7	0.7	1.0	0.3	0.6	0.3	1.5	0.8	0.3	1.4	1.0	0.2	0.9	1.5	0.7	0.3	0.3	0.9	0.6	0.4	1.4	0.5	0.6	0.3	0.4	0.8	0.8	2.6	0.4	0.4	0.6	0.5	0.5	0.4	0.7	0.4	0.2	0.3	0.1	0.8	0.4	1.6	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.5	0.5	0.7	1.0	0.9	0.2	0.6	0.5	0.5	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.9	0.3	0.4	0.3	1.1	0.5	0.2	0.6	2.1	0.8	0.3	0.2	0.7	0.5	0.7	0.6	0.6	0.3	0.3	0.6	0.4	0.5	0.9	0.4	0.7	0.5	1.0	0.5	2.2	0.9	0.6	0.4	2.0	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.3	0.1	0.7	0.3	0.4	1.9	0.6	0.3	0.5	0.4	0.1	1.2	1.2	2.6	1.6	1.1	0.6	1.2	0.7	1.5	0.3	1.4	2.6	15.1	12.8	22.4	10.7	21.5	7.9	23.7	20.7	8.6	72.0	16.9	17.3	18.4	12.8	19.7	18.4	39.6	24.8	22.7	5.0	5.9	18.8	7.8	17.7	15.7	16.2	13.1	15.6	16.0	22.7	23.9	20.7	6.1	15.2	18.3	32.9	16.8	23.7	15.7	43.7	19.1	10.2	12.2	29.6	6.6	2.0	15.2	30.2	7.2	4.7	27.4	29.2	28.8	17.6	40.4	18.9	6.7	23.0	24.3	17.1	11.2	11.7	19.4	68.2	26.3	31.0	16.3	8.8	14.3	19.0	7.5	12.4	20.9	30.3	12.6	17.9
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635781-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 122.2;Late spermatids: 108.6;Spermatocytes: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.8;U-2197: 21.0;U-87 MG: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	2.6	1.8	3.5	1.4	5.0	1.5	2.2	2.9	6.7	2.6	0.4	3.2	1.0	3.5	1.3	2.8	2.5	1.1	3.4	4.1	3.5	2.4	0.5	2.0	0.8	4.7	4.5	1.9	1.7	1.7	2.3	0.4	4.7	2.3	1.7	1.5	2.1	1.3	11.1	5.3	1.8	1.4	1.9	1.9	3.4	22.9	4.5	0.3	1.6	2.8	0.5	3.1	2.8	7.3	10.0	4.3	1.6	3.2	4.3	10.9	0.9	6.4	5.6	4.3	4.0	0.3	2.6	0.7	3.4	6.6	6.1	6.2	2.8	3.7	2.2	22.8	3.1	0.1	3.3	0.3	6.1	0.4	2.7	3.5	1.6	17.3	5.4	6.8	14.9	0.8	0.9	2.8	6.8	2.8	0.4	1.9	1.9	2.9	16.2	1.8	3.2	0.3	2.0	0.8	8.7	3.4	6.6	2.8	3.2	0.7	2.0	0.7	20.0	18.2	5.8	21.0	6.2	0.8	0.9	0.3	22.3	0.3	4.9	0.6	0.6	0.1	0.2	0.8	0.4	0.0	0.6	0.9	1.1	0.1	0.5	0.5	0.2	0.6	0.7	0.3	0.7	0.3	3.5	5.0	2.9	6.7	4.1	3.5	4.7	4.5	4.7	1.9	4.5	7.3	5.7	0.0	1.5	2.6	2.7	14.5	2.5	1.9	8.0	10.6	2.0	3.7	1.9	0.0	1.2	1.8	22.9	0.1	4.8	5.4	0.0	3.4	122.2	6.0	4.9	9.1	2.4	0.8	4.2	2.3	0.5	3.7	2.6	2.0	1.3	4.1	4.2	0.3	1.8	11.8	4.9	4.4	2.0	1.2	7.7	108.6	3.4	8.0	3.6	4.7	2.5	17.2	1.0	2.5	9.2	2.5	11.1	3.8	3.1	1.7	1.2	0.4	5.7	10.5	0.0	3.9	5.0	55.1	3.8	4.2	19.0	0.1	4.9	2.4	5.0	2.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 37.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 188.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048185, HPA060150"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA048185: AB_2680304, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	4.1	1.2	3.3	7.2	3.9	5.1	5.5	2.3	3.6	16.3	3.2	17.9	19.0	6.3	11.6	12.2	13.5	5.1	3.5	3.8	4.2	10.0	0.5	5.7	7.9	3.5	3.4	5.0	5.4	6.0	3.4	3.2	3.3	22.3	20.4	12.7	37.4	6.1	1.1	20.5	17.8	4.6	4.3	4.0	7.0	4.5	3.5	5.5	7.2	1.5	13.9	7.9	9.5	3.6	30.8	19.8	2.3	30.1	15.2	22.6	29.0	6.8	3.9	17.3	22.7	84.2	31.4	51.2	67.7	20.1	94.1	63.1	37.3	60.5	34.2	40.3	34.8	28.5	18.1	34.1	24.8	65.0	14.2	15.7	36.9	58.3	123.1	53.2	91.7	38.3	74.0	20.7	13.0	17.0	28.3	69.7	20.5	67.5	188.4	57.7	23.9	68.9	100.1	26.7	46.6	20.1	21.9	54.8	14.8	24.7	38.1	15.2	68.0	33.4	53.9	0.8	73.5	54.6	62.5	53.9	21.4	22.0	22.4	0.3	0.2	0.0	3.1	0.1	8.2	10.6	5.3	5.4	6.9	6.5	1.9	2.7	0.6	3.7	0.0	0.3	13.5	1.8	3.3	3.9	2.3	3.6	3.8	4.2	3.5	3.4	3.3	4.3	3.5	3.6	2.7	9.6	1.5	2.0	10.3	46.0	34.5	6.4	14.8	1.1	3.7	2.3	0.6	7.2	9.6	3.7	12.5	0.9	2.5	21.5	3.9	9.5	0.3	13.6	2.8	13.7	6.0	1.7	3.9	8.2	19.1	8.3	6.1	22.9	2.5	5.0	0.7	0.0	4.8	0.0	4.4	10.1	4.1	0.3	15.0	1.0	0.9	3.6	23.2	6.5	3.7	1.2	1.0	4.0	0.4	25.9	10.0	2.6	23.6	20.6	15.1	6.4	0.1	8.0	6.6	2.8	3.1	0.3	7.5	8.6	50.3	4.5	5.7	4.9	24.7	16.6
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904676-234324511	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	35	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	35	"dendritic cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.0	1.1	6.9	0.3	17.7	0.1	2.5	9.5	15.5	0.3	0.0	0.4	0.1	0.3	0.7	0.5	0.4	0.1	0.0	5.4	0.7	0.7	0.0	0.2	0.8	1.6	0.3	0.1	3.5	1.4	2.6	0.0	1.9	0.5	0.1	0.3	2.5	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.7	0.2	2.5	2.3	0.5	0.1	0.5	0.0	0.5	9.5	3.0	7.9	1.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.1	0.2	0.6	0.1	7.7	0.0	111.9	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	9.0	0.0	0.0	0.0	7.7	0.0	4.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.9	17.7	9.5	15.5	5.4	0.7	1.6	0.3	1.9	0.2	2.5	9.5	0.1	0.0	0.0	8.5	0.9	0.4	2.4	0.3	10.8	2.1	3.0	8.9	0.7	0.0	0.1	0.0	0.0	0.0	9.5	0.0	3.9	1.4	0.7	5.9	1.6	0.1	1.8	0.0	485.2	3.4	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	216.1	0.1	26.4	0.0	0.0	0.9	0.0	0.6	0.0	9.4	0.9	0.0	0.0	190.5	45.4	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.6	1.5	0.8	0.1	0.0	0.4	0.0	0.0	0.2
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563920-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.6;retina: 6.4;seminal vesicle: 3.5"	"Cell type enriched"	"Detected in some"	12	"Inhibitory neurons: 166.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 1.5;U-87 MG: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.0	0.0	0.7	0.0	0.9	0.0	0.0	5.6	0.7	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.1	0.0	0.0	0.0	1.8	1.3	0.0	6.4	0.0	3.5	0.0	0.0	0.0	0.3	2.9	0.0	0.0	1.0	2.3	0.0	0.8	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	5.6	0.7	0.4	1.4	1.7	1.4	1.8	2.9	2.3	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	11.7	0.1	0.0	0.2	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	166.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	5.3	0.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	13.7	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35F5	FLJ22004	ENSG00000115084	"Solute carrier family 35 member F5"	Q8WV83	2	113705011-113756693	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034828, HPA049229"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA034828: AB_2674350, HPA049229: AB_2680682"	"unprognostic (1.59e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.83e-2)"	9.8	22.8	4.6	6.0	5.9	8.0	14.3	12.0	6.6	9.3	31.5	14.7	13.7	10.3	11.5	11.1	8.0	11.1	11.0	6.1	6.4	18.0	14.6	9.9	9.0	6.7	4.8	12.4	15.1	17.4	5.2	11.1	7.1	11.2	13.6	14.1	9.8	6.9	12.3	20.3	12.9	8.9	5.4	10.1	12.9	7.1	5.2	5.7	23.7	11.2	10.0	8.0	6.3	12.0	9.7	9.6	7.7	4.9	48.6	36.8	14.0	15.9	13.2	7.7	12.9	24.3	18.9	18.5	22.1	21.9	21.3	8.7	12.2	12.5	17.9	5.7	4.9	9.7	9.6	19.7	20.8	12.8	24.0	46.8	17.4	17.9	25.9	22.1	15.2	4.6	7.7	11.2	19.1	8.5	5.6	14.0	3.6	15.0	5.2	6.5	13.1	9.7	52.5	15.8	2.1	6.0	12.9	14.5	11.5	12.8	9.4	12.6	12.7	14.3	6.3	9.2	6.7	9.7	8.7	8.2	16.8	8.9	13.6	2.9	0.7	0.6	0.5	0.8	0.6	0.9	0.5	0.4	0.6	1.2	0.6	0.6	2.1	1.0	1.2	0.9	0.9	0.6	4.6	5.9	12.0	6.6	6.1	6.4	6.7	4.8	7.1	5.4	5.2	12.0	18.9	22.4	19.8	39.5	18.0	25.4	31.1	20.0	31.9	10.3	20.4	9.8	25.4	21.5	30.4	73.5	22.9	46.3	11.6	44.1	11.7	28.7	28.3	32.4	21.9	15.4	14.5	9.9	43.4	28.5	72.0	24.8	28.5	38.6	24.1	14.4	12.5	20.8	28.3	5.0	47.0	25.6	12.2	13.4	17.2	15.6	12.5	14.6	8.8	39.4	15.5	21.0	7.2	65.4	83.2	23.1	29.7	13.9	37.5	35.3	47.9	45.1	26.3	19.6	0.0	14.2	22.7	60.0	20.5	32.7	34.0	66.4	10.8	41.0	24.8	35.1
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 129.9;Karpas-707: 117.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	18.6	20.7	9.6	7.3	10.5	4.6	16.2	10.1	9.2	14.5	8.4	10.1	7.9	11.9	7.3	22.0	10.7	7.3	13.8	9.6	11.8	19.5	17.7	11.9	6.5	13.9	12.9	8.5	10.3	21.3	10.8	9.4	12.3	11.4	5.7	5.8	14.5	8.1	12.8	21.2	10.0	10.1	10.4	10.8	11.3	5.1	13.0	5.7	16.0	9.9	7.6	12.1	13.0	11.6	24.6	43.6	12.3	32.6	41.7	19.4	20.4	14.9	20.3	16.8	15.2	27.9	44.5	6.6	23.4	18.7	42.0	29.4	18.1	26.9	11.8	11.5	10.1	7.6	16.4	23.3	129.9	7.8	36.4	29.8	26.9	18.9	62.7	7.6	19.9	9.6	14.2	117.3	16.9	40.5	10.0	7.0	7.6	17.2	10.9	8.9	35.9	10.9	44.1	20.3	9.6	12.7	22.8	37.4	25.4	10.1	14.1	8.2	19.2	21.8	24.0	30.7	15.2	23.9	32.6	12.9	23.6	13.4	21.0	12.1	18.1	8.0	11.9	25.6	7.0	4.8	8.2	10.8	11.4	3.6	5.3	7.9	11.7	13.6	30.9	7.8	5.9	9.5	9.6	10.5	10.1	9.2	9.6	11.8	13.9	12.9	12.3	10.4	13.0	11.6	39.0	12.8	10.5	11.8	5.9	17.0	13.2	10.2	7.4	17.2	17.5	10.2	13.5	28.6	11.1	33.1	6.2	24.1	12.0	21.5	7.9	34.2	1.7	13.4	29.7	20.8	9.1	0.8	6.9	38.7	22.3	25.2	12.2	22.8	1.3	11.9	31.8	25.4	51.2	15.2	7.9	11.2	8.2	61.0	16.8	1.5	18.3	28.8	28.4	4.7	19.8	19.2	11.3	9.0	10.8	48.2	14.3	12.0	5.5	18.3	21.5	57.2	9.0	11.1	26.3	17.8	20.2	3.7	7.1	14.9	25.7	38.0	10.6	16.8	11.2	11.7
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855888	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	14.9	15.4	20.9	2.1	21.2	0.5	11.1	23.1	26.4	5.1	16.5	3.8	1.0	4.3	4.6	2.6	5.7	5.3	8.1	20.0	24.4	3.9	4.4	7.0	1.9	21.4	25.0	5.5	7.6	6.7	19.3	7.4	26.9	4.1	2.0	5.3	3.1	2.6	2.4	3.7	2.9	5.1	22.1	3.2	2.9	14.4	22.6	2.8	8.5	5.4	1.2	6.5	5.0	21.0	3.9	10.7	10.6	4.8	20.8	17.1	0.0	16.9	73.1	24.7	37.0	10.1	5.7	0.0	12.7	17.5	39.3	1.3	12.7	0.7	22.8	0.1	3.5	3.2	12.0	6.3	26.6	0.1	0.0	24.2	1.8	21.5	5.9	18.0	18.8	6.8	1.8	0.1	32.1	0.0	4.7	3.3	2.3	0.0	7.9	4.2	7.1	0.2	21.1	0.9	17.5	11.7	13.7	0.0	24.0	3.6	0.0	1.8	13.1	18.4	4.7	8.2	18.6	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	20.9	21.2	23.1	26.4	20.0	24.4	21.4	25.0	26.9	22.1	22.6	21.0	22.4	12.8	7.0	54.2	2.5	3.3	4.9	12.0	7.4	4.7	0.7	0.8	2.5	1.5	7.1	1.8	12.5	1.3	2.7	0.8	1.9	3.3	65.4	1.0	1.6	30.6	4.2	4.4	34.0	10.7	1.3	12.4	0.5	1.3	2.5	3.6	27.8	2.3	0.7	6.7	42.4	1.0	0.0	2.2	7.3	30.3	9.9	2.1	3.6	17.8	3.7	7.8	15.5	15.6	6.1	10.0	0.1	3.0	3.7	4.7	0.6	0.7	1.4	4.6	6.6	4.7	4.8	35.5	16.1	1.2	3.0	2.2	3.8	3.1	0.6	2.0
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492379	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.3;parathyroid gland: 103.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.9;Early spermatids: 76.7;Excitatory neurons: 92.8;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 48.7;Proximal enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	9	"cerebellum: 76.3"	"Group enriched"	"Detected in many"	4	"basophil: 21.7;classical monocyte: 8.7;neutrophil: 19.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.7;monocytes: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	6.3	4.9	2.0	7.9	2.8	29.5	4.0	76.3	8.4	3.6	0.0	14.8	44.2	4.0	4.4	5.4	3.3	10.4	3.1	3.1	0.0	4.7	2.8	5.6	6.1	4.6	3.2	3.2	6.2	103.2	3.7	5.5	5.3	12.5	22.5	1.9	4.8	6.2	7.8	4.9	39.3	6.6	0.0	8.5	4.4	13.4	0.6	18.4	3.1	5.9	5.3	6.0	4.2	4.1	5.4	9.2	4.7	3.2	11.6	8.5	25.4	15.4	8.6	10.4	11.7	21.2	7.8	12.4	8.9	18.5	11.1	13.0	15.1	9.5	10.2	3.4	13.1	3.8	14.7	7.1	14.9	9.3	20.3	6.2	10.8	8.8	5.8	2.9	9.4	6.7	9.0	10.5	8.9	5.9	2.7	4.6	4.7	6.8	8.6	0.0	11.4	4.9	2.7	8.0	4.2	8.0	9.6	11.4	5.6	9.5	8.7	13.4	9.5	13.8	7.7	22.8	8.7	5.0	7.6	7.9	8.8	16.0	9.4	21.7	8.7	3.6	1.5	3.8	1.1	2.0	1.4	2.5	3.0	2.1	1.1	1.0	19.6	0.4	4.1	0.6	1.6	1.3	2.0	2.8	76.3	8.4	3.1	0.0	4.6	3.2	5.3	0.0	0.6	4.1	2.1	0.0	1.7	10.4	2.3	1.5	1.4	1.1	1.2	1.0	4.1	1.3	3.0	4.3	1.3	1.8	2.1	0.6	1.9	52.9	0.0	1.8	76.7	1.1	3.6	1.4	0.0	32.4	92.8	2.0	8.1	3.6	10.2	1.3	1.3	18.0	3.6	2.0	13.9	1.7	62.1	5.4	0.0	22.7	3.0	29.5	5.0	10.6	1.8	11.2	6.2	0.8	1.0	48.7	30.4	1.8	22.2	11.7	2.3	1.9	48.4	4.6	0.6	1.1	0.0	1.7	2.4	0.5	2.0	4.5	1.3	0.3	2.4	0.8	9.8	1.8
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314972-151347590	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 67.6;skeletal muscle: 80.2;tongue: 29.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 53.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044002, HPA062229"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.2	0.1	0.0	67.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	80.2	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	29.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.4	0.2	0.2	1.1	0.4	0.1	0.4	0.1	0.1	0.2	0.1	0.8	0.6	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.9	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144174-93197991	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	5.8	7.4	4.2	9.3	4.6	19.4	4.6	8.1	5.8	5.1	6.2	5.4	2.0	7.1	2.1	5.3	4.8	5.7	6.0	4.0	8.5	9.4	7.8	6.0	5.3	7.2	6.9	5.7	5.7	6.5	7.7	6.2	7.7	4.9	6.4	15.3	3.7	5.9	2.4	4.1	3.1	8.1	5.5	4.1	4.3	4.3	6.1	7.3	8.8	2.3	6.7	6.9	3.6	7.0	10.4	18.2	36.5	7.3	12.7	25.6	20.5	17.6	29.2	25.6	31.0	14.6	33.1	12.5	9.9	16.5	13.3	12.5	11.4	6.5	23.4	21.1	13.3	14.5	35.3	9.8	10.0	36.6	20.6	12.4	20.0	14.9	9.2	12.0	14.0	17.6	1.3	0.2	26.5	2.6	16.3	27.4	14.8	4.0	18.4	7.2	21.7	5.1	8.7	15.1	33.6	43.8	25.7	9.9	6.4	26.4	18.0	10.6	15.7	48.0	14.8	28.6	26.0	5.1	10.9	0.0	10.9	15.0	25.4	0.1	4.9	5.3	0.8	2.6	1.0	0.9	0.6	1.0	1.9	1.0	1.5	1.0	1.5	0.5	1.7	0.7	0.5	1.1	4.2	4.6	8.1	5.8	4.0	8.5	7.2	6.9	7.7	5.5	6.1	7.0	11.9	12.8	11.5	35.9	29.5	30.7	43.2	9.7	25.6	21.2	10.3	8.0	11.5	20.0	7.1	20.2	22.9	10.7	13.6	3.1	35.2	24.4	9.9	15.5	19.2	18.5	27.6	5.5	66.8	43.6	25.8	21.9	18.8	5.7	4.5	29.0	13.2	9.1	13.6	26.9	71.0	19.6	10.2	52.3	47.1	4.2	18.0	50.1	21.4	27.2	42.8	20.7	13.4	45.2	59.4	33.2	6.3	15.4	22.1	70.4	0.4	16.2	20.8	24.2	6.6	18.0	18.1	7.3	3.3	11.8	32.0	16.3	15.7	20.6	4.3	30.6
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 308.6;Late spermatids: 319.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 125.4;MCF7: 50.1;OE19: 54.0;SK-BR-3: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"			"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.61e-2)"	4.2	8.9	7.2	10.3	6.0	12.5	9.1	5.8	6.4	5.4	1.8	23.9	45.8	3.3	6.3	13.7	9.6	13.5	4.4	5.5	6.5	6.0	5.7	11.7	9.8	5.7	4.7	3.9	6.5	3.7	17.9	5.4	5.4	15.1	19.5	6.4	19.3	5.1	9.5	6.6	39.2	3.4	4.7	9.2	24.0	8.3	5.6	7.1	12.3	3.4	9.3	12.5	8.6	4.1	13.7	5.3	1.4	2.5	0.1	0.2	11.5	0.5	0.0	0.5	0.3	3.3	27.0	9.6	13.7	0.0	8.2	5.4	2.7	6.9	0.0	4.5	6.6	125.4	4.6	0.2	3.2	2.7	11.9	0.7	4.0	0.1	0.3	0.0	4.0	10.8	2.5	12.9	0.0	50.1	9.7	7.0	9.3	54.0	3.1	9.9	0.0	0.3	11.2	25.8	14.1	1.7	8.0	42.4	3.5	1.3	16.1	14.0	7.1	0.0	2.5	0.1	0.0	24.7	16.4	9.2	0.0	20.6	1.4	5.4	4.9	37.1	7.5	13.2	9.5	11.1	5.2	6.7	7.0	7.4	4.3	6.1	5.7	6.9	17.0	19.8	3.0	6.8	7.2	6.0	5.8	6.4	5.5	6.5	5.7	4.7	5.4	4.7	5.6	4.1	6.7	19.2	27.7	11.8	17.7	2.2	8.5	9.9	0.6	3.0	36.6	7.0	4.1	17.2	17.6	12.9	6.2	7.1	20.9	59.5	0.0	26.1	308.6	34.1	3.6	5.2	30.1	11.0	18.6	30.9	6.0	3.1	52.5	18.9	1.3	3.2	3.9	5.5	8.8	3.3	16.0	39.6	14.2	9.1	3.0	319.3	7.2	12.3	7.2	18.7	15.2	36.6	1.0	6.0	1.5	33.8	56.2	2.6	17.2	27.0	61.9	2.2	32.9	4.1	0.0	2.2	5.4	51.7	5.4	4.7	1.6	8.6	10.6	2.7	37.9	20.8
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063302-125090516	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.5;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	4.2	24.2	1.7	16.9	2.6	1.4	4.6	2.4	3.7	2.3	2.1	8.0	9.1	1.0	1.3	13.4	1.2	5.1	1.5	1.9	2.3	0.7	5.9	5.9	5.7	4.3	2.7	1.0	1.2	1.1	0.2	7.4	3.8	2.6	10.2	0.5	78.8	1.4	0.6	20.9	7.7	3.1	3.2	15.8	2.1	1.6	5.2	2.1	0.6	0.9	5.1	11.9	7.7	7.3	33.8	0.1	1.0	0.4	0.6	0.8	0.6	1.6	2.8	1.0	2.5	0.2	70.3	0.4	9.4	0.4	2.5	21.0	0.4	20.9	3.8	0.9	0.6	6.6	1.6	2.4	0.1	0.3	0.9	0.7	34.9	2.6	64.8	2.7	1.7	1.3	0.5	2.2	3.1	0.3	0.3	4.6	1.9	0.2	1.0	0.4	2.7	0.8	1.0	17.6	0.3	0.3	4.8	2.9	2.6	0.5	0.3	1.8	3.7	47.2	1.9	0.7	1.6	1.8	1.5	1.1	1.7	2.4	4.1	0.2	12.3	0.0	0.0	14.1	0.0	0.4	0.0	0.1	5.5	0.1	0.1	0.1	1.3	0.0	19.2	0.2	0.0	5.4	1.7	2.6	2.4	3.7	1.9	2.3	4.3	2.7	3.8	3.2	5.2	7.3	0.7	0.0	0.6	0.3	3.8	0.3	1.4	0.5	1.2	1.5	1.4	1.1	1.1	1.5	1.6	0.0	2.1	0.6	0.7	13.4	0.0	0.1	1.6	1.9	1.4	1.3	0.0	2.7	0.3	0.0	0.8	0.5	0.0	4.9	2.5	0.4	1.8	0.3	36.5	0.0	0.3	0.1	0.0	22.0	1.4	2.2	0.9	22.7	0.0	8.4	7.3	0.3	3.1	1.0	0.2	0.1	3.3	1.2	1.7	1.0	0.0	0.1	0.2	0.8	0.0	0.8	0.6	2.7	1.1	5.7	0.9	3.4	1.2	0.4	0.1	3.2
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"liver: 139.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 171.6;Hepatocytes: 175.9;Proximal enterocytes: 277.2;Proximal tubular cells: 183.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.3;HEK 293: 28.0;Hep G2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	4.5	8.0	4.6	2.5	4.7	2.4	5.0	4.5	6.9	5.1	4.6	10.8	36.1	3.5	20.8	4.7	5.5	1.7	5.4	4.8	4.7	49.4	139.9	4.6	1.5	4.9	4.7	5.3	40.1	3.4	6.3	2.5	4.7	9.4	6.6	4.6	7.0	5.5	30.0	4.9	27.3	1.3	4.8	7.1	12.0	7.1	4.7	1.1	5.3	3.8	0.9	4.6	4.7	4.9	1.2	12.2	5.6	6.2	7.5	3.2	4.9	0.7	9.7	2.6	6.9	29.3	2.8	3.8	7.2	3.9	5.4	0.7	2.3	14.9	4.4	4.1	28.0	10.3	3.4	37.1	2.8	6.0	2.0	0.5	4.2	1.5	7.1	10.7	8.7	0.6	4.7	11.2	4.5	25.9	0.3	13.3	0.1	3.6	13.6	8.4	0.0	21.1	5.5	12.9	7.3	6.4	0.0	2.6	5.4	5.8	5.4	4.2	0.0	0.0	4.9	1.3	5.4	1.7	2.9	1.3	1.2	15.6	2.0	0.0	0.9	1.3	1.4	1.6	1.2	0.7	1.0	1.7	0.3	0.5	1.0	1.1	0.0	0.9	0.7	0.1	1.0	0.6	4.6	4.7	4.5	6.9	4.8	4.7	4.9	4.7	4.7	4.8	4.7	4.9	7.9	3.2	7.8	7.5	5.8	1.8	8.3	10.1	5.7	7.5	13.0	10.7	4.5	171.6	8.2	16.5	0.0	30.1	3.2	23.8	31.3	29.5	14.0	11.5	6.6	9.2	24.7	28.6	4.5	25.3	21.4	5.5	13.7	11.2	0.0	72.3	19.2	175.9	28.8	16.8	4.2	26.3	14.2	11.1	2.4	3.3	9.6	7.9	3.6	7.5	10.0	93.4	2.1	3.5	2.9	19.7	27.5	10.5	5.7	12.5	277.2	183.0	12.6	11.3	0.0	4.4	5.6	11.2	25.8	5.9	2.7	15.2	5.4	6.7	50.3	8.4
SLC38A1	"ATA1, NAT2, SAT1"	ENSG00000111371	"Solute carrier family 38 member 1"	Q9H2H9	12	46183063-46270017	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 443.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 386.1"	"Low region specificity"	"Detected in all"							"HPA039460, HPA052272"	Uncertain	Supported				NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA039460: , HPA052272: AB_2681781"	"unprognostic (8.92e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.74e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (2.01e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	8.2	5.3	20.0	38.5	18.6	26.0	81.8	48.2	18.9	13.6	0.6	39.3	16.7	16.4	8.7	26.6	15.5	16.6	44.6	15.3	42.3	20.3	6.4	13.2	64.4	44.1	25.4	9.9	23.8	78.7	19.3	22.5	34.6	29.5	38.5	79.0	20.5	35.6	90.7	30.5	22.9	27.8	48.4	31.9	21.3	1.1	26.8	59.5	42.5	82.4	54.4	23.4	11.2	59.7	77.6	79.2	28.2	104.9	12.4	4.5	142.8	60.6	98.2	27.3	42.7	136.6	74.9	176.3	113.0	74.7	83.6	116.5	94.8	124.5	50.4	109.6	49.8	12.3	127.4	51.2	108.3	126.1	4.5	21.7	186.7	8.2	325.1	67.5	61.6	112.0	65.2	144.2	86.5	96.5	112.7	22.0	104.1	0.1	122.7	99.8	6.9	124.6	105.4	109.8	111.6	77.2	126.2	152.9	71.7	108.0	88.9	91.1	129.8	21.2	19.7	0.6	62.7	136.2	126.5	386.1	67.9	242.2	18.6	1.0	0.8	26.3	51.8	0.2	71.0	50.4	54.1	61.0	34.9	57.8	62.6	57.1	2.4	68.3	0.4	44.3	63.5	46.4	20.0	18.6	48.2	18.9	15.3	42.3	44.1	25.4	34.6	48.4	26.8	59.7	10.3	35.3	44.7	75.4	150.0	97.8	73.8	103.8	30.1	443.5	136.5	64.8	207.5	38.6	61.8	213.3	141.8	106.9	216.3	99.3	3.9	56.3	0.2	78.1	9.8	26.7	40.6	25.6	104.7	46.4	79.3	14.6	19.4	123.7	3.8	30.9	5.7	6.1	12.2	8.4	157.8	73.6	79.3	12.9	76.1	0.3	2.1	23.3	26.6	30.9	13.6	51.4	107.1	94.5	59.7	53.5	52.8	0.7	138.8	66.5	23.6	1.1	29.7	54.2	0.0	62.9	34.5	0.1	0.4	70.3	122.7	185.7	167.9	1.6	93.6	75.4
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81244811-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		70000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	37.6	37.0	12.7	23.4	14.0	30.8	31.2	12.7	16.1	33.0	14.7	31.7	31.8	35.3	17.3	24.0	31.7	25.8	36.8	10.5	13.8	31.6	75.2	31.4	21.4	21.5	14.9	37.7	91.4	15.6	62.1	24.6	15.7	34.2	9.5	4.4	51.1	20.8	20.0	25.2	34.7	15.4	13.3	43.8	38.8	30.5	16.6	12.9	41.3	6.3	10.6	37.6	26.8	19.4	45.2	77.5	13.3	70.2	49.8	23.3	77.6	53.7	48.2	32.5	38.2	36.1	73.0	34.4	59.2	37.3	36.0	53.0	13.5	27.1	12.0	34.7	40.0	34.6	28.5	61.2	44.4	34.1	78.4	40.7	19.7	29.2	18.9	26.2	62.2	24.5	26.3	51.3	24.6	56.5	21.0	59.4	12.9	41.3	37.6	33.8	27.8	34.8	22.2	42.3	25.7	65.7	43.2	26.9	59.2	18.3	38.1	70.0	61.9	52.2	29.9	38.9	29.4	44.6	21.4	20.0	30.9	51.8	54.5	12.7	10.6	18.6	7.4	11.9	8.7	6.2	7.1	9.1	6.2	7.0	4.8	5.4	8.0	4.6	15.9	9.8	5.6	9.5	12.7	14.0	12.7	16.1	10.5	13.8	21.5	14.9	15.7	13.3	16.6	19.4	24.4	25.6	35.6	25.8	28.6	8.3	12.3	21.9	13.6	10.9	25.3	18.0	19.3	31.5	24.6	11.0	18.8	61.0	29.8	66.4	5.9	31.9	25.4	17.3	13.7	22.4	45.0	22.3	12.3	26.9	62.4	35.9	44.9	32.8	15.2	64.6	27.5	79.2	49.3	25.2	14.3	58.8	12.2	40.6	15.1	75.6	32.9	35.7	14.2	28.1	29.1	27.7	23.7	9.0	20.5	25.1	53.1	27.4	96.5	16.0	59.1	23.9	21.4	9.1	32.9	17.0	21.2	19.7	22.8	11.8	7.2	62.5	25.0	39.9	48.2	11.4
SLC38A11	"AVT2, FLJ39822"	ENSG00000169507	"Solute carrier family 38 member 11"	Q08AI6	2	164896186-164955525	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.7;epididymis: 38.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 28.6;Enteroendocrine cells: 174.1;Excitatory neurons: 53.4;Sertoli cells: 72.3;Smooth muscle cells: 39.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 7.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 1.6;naive B-cell: 3.9"	"Lineage enriched"	"Detected in single"	39	"B-cells: 3.9"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 249.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043432	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA043432: AB_10793948"	"unprognostic (1.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.36e-2)"	2.0	4.0	6.0	1.5	6.4	0.1	0.8	3.8	11.2	2.6	28.7	1.5	6.0	1.7	38.6	1.0	0.8	17.7	1.3	6.2	3.9	7.9	2.6	0.4	2.0	3.9	4.2	0.3	2.2	1.3	3.3	0.3	4.3	10.8	2.7	0.3	0.6	16.9	0.9	0.6	2.7	2.0	3.5	8.1	11.7	0.2	5.8	0.3	2.1	4.0	1.3	1.5	1.1	6.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	28.9	249.7	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	6.4	3.8	11.2	6.2	3.9	3.9	4.2	4.3	3.5	5.8	6.3	0.9	0.0	0.0	6.2	7.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.9	28.6	0.0	3.7	0.0	0.7	2.7	0.5	0.0	3.2	2.1	0.1	0.5	2.7	174.1	2.7	53.4	0.6	0.6	0.3	5.1	0.1	0.0	0.0	0.4	3.7	0.0	0.0	2.9	6.4	0.0	0.0	0.3	1.2	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.5	1.2	0.8	2.3	0.0	0.0	3.2	1.0	2.0	0.0	0.1	72.3	0.5	39.8	0.1	0.0	0.2	0.3	1.5	0.9	4.4	0.7	0.2
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358188-46372773	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 1198.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035180, HPA069672"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"		"HPA035180: AB_10669901, HPA069672: "	"unprognostic (6.61e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.68e-2)"	112.8	113.0	36.1	71.6	48.5	95.4	88.5	53.9	50.2	91.7	25.8	58.3	33.6	92.9	38.6	108.1	83.6	131.3	60.7	32.4	46.1	64.8	307.3	117.0	67.1	52.2	42.7	130.1	74.7	91.5	27.9	162.1	53.5	52.8	49.7	27.0	77.2	43.1	108.5	204.4	54.4	115.8	44.2	75.3	63.0	25.4	44.2	100.4	63.1	174.7	78.1	98.9	88.0	73.0	83.7	179.9	157.6	444.1	356.7	347.7	118.1	382.8	921.2	313.0	254.0	108.2	151.2	0.1	504.2	627.9	215.3	271.1	107.9	335.1	299.1	67.0	61.0	105.8	208.7	339.9	548.8	88.0	108.7	357.2	718.4	199.5	1198.9	778.5	265.7	116.3	103.8	163.1	560.4	100.0	110.3	122.8	138.2	0.1	185.1	97.5	115.5	200.9	191.6	173.4	103.9	89.8	263.5	68.5	233.7	171.0	140.5	193.8	467.3	156.7	121.8	67.8	62.2	187.8	194.3	100.6	148.0	304.5	76.8	41.1	24.9	18.9	22.7	13.1	17.4	19.2	19.0	23.0	35.2	17.8	23.5	24.8	17.5	51.6	18.4	40.6	23.7	27.6	36.1	48.5	53.9	50.2	32.4	46.1	52.2	42.7	53.5	44.2	44.2	73.0	237.7	83.3	77.4	31.3	187.7	1118.3	134.1	262.8	653.9	40.5	315.7	252.2	153.6	108.7	123.9	57.0	70.9	53.8	292.3	114.6	5.9	41.2	5.5	228.5	245.0	234.7	76.7	109.0	54.6	51.1	49.3	219.1	328.2	464.0	81.6	138.3	227.7	265.9	54.0	53.8	58.9	175.0	130.2	143.3	303.6	12.4	263.2	193.8	250.8	59.0	52.6	74.3	70.0	42.3	136.2	79.4	83.5	85.0	322.2	181.7	67.4	24.4	50.3	68.7	282.7	184.8	339.5	6.7	15.5	532.6	1078.3	38.4	252.4	84.0	110.7	150.8
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470260	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 237.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	4.2	1.9	29.9	13.0	21.8	55.7	2.5	22.6	26.3	9.4	10.6	13.2	13.3	4.2	2.7	10.2	4.9	3.7	6.1	21.6	22.5	1.8	0.9	25.3	8.8	30.4	23.1	6.7	237.2	0.4	0.9	1.1	28.0	5.6	16.2	3.4	9.3	8.6	0.6	21.3	9.2	7.0	22.0	13.8	15.9	0.7	30.4	8.5	20.3	1.3	9.1	9.4	8.7	21.1	143.0	0.3	0.1	1.6	2.8	11.6	0.3	9.4	0.0	0.3	0.1	0.4	0.3	147.8	0.2	61.7	0.3	214.0	164.4	326.7	0.0	47.4	0.2	80.7	300.0	102.4	23.2	166.7	0.2	22.0	237.8	2.9	0.6	0.2	2.8	35.5	150.7	282.8	32.2	0.2	36.3	57.9	74.2	0.0	0.7	131.5	0.7	539.6	0.0	0.1	13.1	0.7	0.1	0.9	0.2	1.1	0.5	6.9	4.7	0.6	0.4	0.4	0.4	0.4	1.0	53.0	1.6	0.8	0.7	0.1	0.4	0.4	17.3	0.6	24.2	11.4	18.6	16.4	2.3	8.9	8.7	11.3	0.5	9.6	0.1	13.1	21.7	9.1	29.9	21.8	22.6	26.3	21.6	22.5	30.4	23.1	28.0	22.0	30.4	21.1	2.3	0.0	0.6	0.3	15.4	26.6	2.7	196.3	17.1	3.2	0.2	0.3	0.4	0.0	33.6	5.5	18.8	0.2	6.7	9.9	0.0	5.5	0.4	1.1	9.1	11.8	0.0	74.3	0.3	80.8	0.6	8.9	3.6	2.7	4.5	1.0	0.4	0.4	2.4	0.0	0.5	17.5	4.1	0.3	3.9	1.3	2.5	2.1	8.8	32.8	1.8	0.3	8.2	0.5	0.2	129.4	5.5	1.2	62.3	4.5	1.2	0.0	4.2	0.3	0.0	0.7	4.6	0.1	0.4	6.4	8.5	0.0	9.5	4.6	21.4	1.9
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 57.8"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 182.5;Early spermatids: 262.6;Syncytiotrophoblasts: 619.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	6.1	4.8	5.4	8.8	7.3	7.1	8.2	8.1	6.3	6.5	4.1	9.4	8.1	6.6	6.6	8.4	5.0	8.3	3.8	4.3	6.6	7.4	16.6	8.0	11.2	6.3	5.9	5.4	12.1	10.7	3.3	57.8	6.6	6.1	9.8	10.0	6.4	6.0	4.4	7.6	6.6	8.5	5.5	8.4	8.1	19.2	6.3	8.8	7.7	3.8	14.5	8.4	4.8	8.9	17.9	17.3	17.1	20.0	22.0	20.4	110.0	16.5	21.3	18.3	30.4	29.5	27.2	31.6	28.6	12.7	32.1	22.5	20.2	18.2	22.8	15.4	18.4	10.8	16.4	18.7	31.1	18.9	10.8	26.3	21.0	20.2	25.7	13.7	20.0	21.3	20.9	18.6	16.5	15.0	23.6	16.4	29.4	7.2	15.6	17.6	28.6	32.2	24.7	14.0	8.1	14.5	17.3	9.3	25.4	24.0	20.1	34.4	29.6	3.6	11.7	26.8	16.6	20.5	47.6	20.8	10.9	17.4	11.4	3.3	9.3	5.5	5.2	8.7	7.5	7.4	4.5	6.1	8.4	4.2	6.2	5.3	2.0	7.7	6.9	8.0	5.9	4.9	5.4	7.3	8.1	6.3	4.3	6.6	6.3	5.9	6.6	5.5	6.3	8.9	7.3	6.4	3.1	21.9	14.2	3.2	4.2	8.5	2.8	6.6	5.7	3.9	2.8	11.5	9.8	9.2	8.4	182.5	10.4	8.9	1.9	8.9	262.6	4.4	9.2	8.1	4.2	8.4	56.2	11.4	71.5	7.2	8.6	7.3	2.5	8.0	10.4	22.1	26.3	1.7	57.3	4.3	8.2	10.0	8.0	82.4	7.5	11.7	5.4	38.4	11.0	5.6	4.1	55.8	103.2	10.9	9.7	4.9	8.4	4.6	4.4	7.2	6.3	7.4	6.6	3.3	7.0	15.8	6.5	8.1	3.4	619.9	8.7	4.0	5.2	4.7
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416496	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	13	"Early spermatids: 298.2;Late spermatids: 905.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	40.9	42.4	28.3	24.2	31.4	8.3	37.5	30.6	36.3	51.1	30.4	53.4	14.0	77.9	8.8	21.8	48.1	20.2	59.5	26.0	27.3	80.4	26.7	61.4	18.2	33.0	29.7	50.9	42.3	27.2	51.3	40.6	30.4	52.7	6.8	11.0	31.3	26.2	31.4	32.4	31.8	26.6	26.8	36.5	41.2	73.4	35.0	12.3	46.8	12.6	8.7	45.6	37.4	28.5	23.3	20.4	23.5	26.7	56.3	78.2	6.8	89.7	66.2	50.4	57.0	8.1	15.7	8.8	22.9	69.6	49.6	38.3	7.1	61.7	13.9	25.7	25.9	4.7	52.7	16.7	84.3	8.1	11.0	65.4	43.4	31.9	26.1	62.9	53.4	16.9	4.5	19.6	54.8	20.7	17.4	11.5	11.0	19.8	28.2	20.6	33.6	8.9	86.1	11.1	19.9	37.0	26.9	49.1	26.2	8.7	32.8	11.7	76.0	76.6	34.6	88.1	42.7	14.9	5.2	4.1	85.2	11.2	57.3	2.1	3.6	3.2	12.4	13.3	8.5	4.1	8.2	8.9	4.6	5.1	7.5	6.4	6.6	7.4	15.3	4.9	4.5	5.9	28.3	31.4	30.6	36.3	26.0	27.3	33.0	29.7	30.4	26.8	35.0	28.5	20.0	9.6	6.4	18.6	6.7	18.2	18.3	23.0	17.1	24.0	11.5	15.6	18.3	15.7	8.0	29.5	12.5	11.1	11.6	3.4	9.8	32.9	298.2	6.5	20.3	20.9	9.6	4.4	9.6	20.7	16.4	37.8	6.6	13.1	5.7	15.4	21.8	6.2	18.9	32.0	11.7	7.9	14.2	5.3	12.2	905.5	32.9	9.3	19.6	4.7	26.6	16.7	11.3	8.0	10.1	35.5	8.3	40.3	8.1	23.5	8.2	8.8	4.5	17.0	46.0	16.1	36.2	12.7	6.4	2.4	4.1	19.6	9.6	36.7	5.7	8.3
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367278-22434129	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 551.3;pancreas: 252.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 266.7;Hepatocytes: 611.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 321.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	63.5	72.4	13.0	35.5	11.0	1.4	39.8	11.9	13.1	17.3	39.7	48.2	142.2	30.2	6.2	11.6	25.9	32.0	76.7	14.5	22.9	30.8	551.3	23.9	7.6	43.0	30.4	27.7	252.7	12.9	21.5	19.0	25.7	22.3	50.3	18.6	21.8	18.7	43.0	20.0	84.9	33.0	13.3	8.1	80.5	26.5	25.3	6.0	87.7	17.4	6.9	56.0	14.5	14.8	51.8	68.3	18.4	37.6	65.1	54.7	40.1	72.8	321.0	111.3	173.5	226.9	47.9	51.1	39.9	86.1	288.9	55.6	92.8	91.1	181.9	53.1	49.2	40.8	51.0	230.7	154.3	28.5	43.2	58.4	72.6	198.0	136.9	56.3	50.5	36.5	36.2	51.2	57.3	24.0	43.4	18.2	113.4	81.9	49.8	60.1	34.9	110.8	40.8	22.3	31.3	48.7	74.3	31.3	151.4	39.7	25.1	39.4	28.0	137.3	69.2	87.4	75.7	29.2	28.7	66.9	194.3	37.7	81.9	0.0	0.4	2.1	6.7	0.1	7.2	4.0	3.8	5.0	1.5	1.9	4.3	5.9	0.1	2.7	0.1	0.7	3.4	3.4	13.0	11.0	11.9	13.1	14.5	22.9	43.0	30.4	25.7	13.3	25.3	14.8	12.4	3.2	7.7	11.4	9.1	33.3	11.5	10.8	18.8	7.8	20.3	16.6	66.6	41.5	3.8	7.3	2.1	0.4	3.6	91.6	1.9	47.6	0.5	136.1	58.3	32.2	33.4	10.5	26.2	74.7	2.7	58.8	47.9	266.7	0.0	20.8	29.6	611.4	1.8	48.8	24.6	60.6	6.1	15.4	25.8	3.2	23.9	2.9	44.4	6.5	2.7	5.2	2.1	9.0	3.9	47.3	39.1	41.8	13.5	26.5	75.6	24.6	1.1	8.2	0.0	47.1	32.2	0.7	3.0	4.1	21.0	0.5	7.4	14.7	43.5	9.4
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.8;seminal vesicle: 33.2;skin 1: 37.5"	"Cell type enhanced"	"Detected in some"		"Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	71	"HaCaT: 23.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.0	0.2	0.1	0.2	0.0	1.9	0.3	0.3	8.0	0.2	1.9	0.0	0.3	0.1	18.8	0.5	0.4	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.3	0.1	0.3	0.2	12.2	1.3	3.7	4.1	33.2	0.2	37.5	0.1	0.2	0.3	0.0	0.0	0.1	0.3	2.8	0.0	0.0	2.7	0.3	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	0.0	0.2	0.8	0.3	0.4	0.0	0.7	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	12.0	6.0	0.3	0.0	0.0	1.4	4.4
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740028	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 302.1;Late spermatids: 433.3;Spermatocytes: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 409.6"	"Low region specificity"	"Detected in all"							"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	17.9	27.0	19.0	14.7	22.0	46.3	17.4	18.3	23.6	19.6	14.8	18.4	16.7	25.1	30.5	17.3	23.2	15.3	23.3	23.6	18.5	19.8	32.8	16.3	19.1	20.0	18.0	13.5	20.7	34.7	27.2	12.3	18.7	19.3	14.4	10.2	21.3	17.8	22.9	14.9	16.5	23.0	16.7	22.7	17.4	100.3	20.1	21.8	20.5	24.7	16.1	22.3	14.4	18.6	53.3	44.1	32.5	80.3	66.1	45.0	30.6	38.6	46.5	71.3	72.4	47.8	35.0	32.2	23.6	68.2	56.3	42.9	50.2	52.7	44.3	0.4	37.1	144.4	31.4	48.9	72.1	123.2	209.5	40.6	83.3	53.1	43.3	25.6	36.9	61.8	162.8	147.6	48.6	35.2	61.4	99.0	34.6	48.8	59.4	81.4	20.9	100.7	34.1	42.7	44.1	40.3	33.9	24.4	82.4	20.9	42.4	162.7	22.4	49.5	27.0	75.6	56.4	38.7	66.6	32.6	37.4	409.6	59.7	41.1	36.0	67.9	35.9	35.6	30.1	53.3	30.5	29.2	48.9	53.7	24.5	29.2	16.7	29.7	34.1	83.9	21.2	35.2	19.0	22.0	18.3	23.6	23.6	18.5	20.0	18.0	18.7	16.7	20.1	18.6	18.1	3.2	2.8	2.6	31.6	10.3	16.6	37.1	2.2	19.2	25.5	23.6	7.8	24.3	22.6	7.3	8.4	37.5	16.8	20.2	17.6	50.7	302.1	17.8	16.4	21.8	24.0	57.6	5.0	61.8	56.3	18.4	10.7	13.3	24.8	24.2	21.8	31.0	64.9	48.8	5.9	19.7	32.6	25.7	12.9	433.3	21.5	39.3	24.9	4.7	26.7	33.5	26.8	6.6	5.6	46.9	25.8	27.8	12.9	33.3	23.0	23.6	17.6	22.0	26.3	14.0	23.6	185.8	29.7	10.5	9.8	26.4	14.5	29.4	25.6	17.6
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108531-36129385	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 307.0;Prostatic glandular cells: 197.9"	"Group enriched"	"Detected in all"	4	"breast cancer: 361.9;prostate cancer: 127.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	27.3	25.9	23.3	21.6	28.5	11.6	147.2	28.6	26.1	34.5	48.9	13.9	9.6	56.9	56.2	17.0	63.6	24.2	14.0	20.0	28.8	28.2	16.5	18.9	17.3	28.8	33.6	43.1	37.7	86.5	23.9	31.7	30.6	129.0	13.4	50.2	30.9	114.3	12.7	51.3	8.9	30.2	28.6	15.5	16.4	19.3	26.7	18.5	37.3	16.6	28.4	52.6	16.1	34.2	43.7	54.0	127.1	75.1	131.4	96.6	33.0	116.2	137.3	76.5	88.7	30.3	47.5	47.1	57.3	113.1	53.1	104.1	112.4	109.2	115.5	105.4	40.7	20.6	69.5	44.4	83.2	69.8	49.6	88.7	236.1	116.2	100.5	69.9	11.7	38.6	10.7	92.1	108.9	67.0	69.0	15.6	30.6	24.0	30.4	70.6	72.8	61.4	84.4	145.2	132.8	116.8	143.5	41.5	200.6	52.1	56.7	32.4	18.9	184.9	30.5	35.5	59.2	85.9	90.0	35.7	64.0	48.3	99.8	29.2	13.3	31.2	16.3	19.7	19.7	16.7	13.8	14.7	16.4	17.3	12.0	17.7	10.2	18.1	19.4	33.6	17.0	14.2	23.3	28.5	28.6	26.1	20.0	28.8	28.8	33.6	30.6	28.6	26.7	34.2	13.3	38.5	18.7	8.8	22.5	45.9	58.2	79.6	59.2	41.5	307.0	132.2	19.6	10.0	66.4	42.3	33.3	6.6	36.7	4.0	1.9	53.1	21.3	37.1	76.1	12.9	25.6	4.6	13.0	37.8	56.7	45.6	9.2	73.8	23.5	18.9	8.9	11.0	20.4	23.5	23.9	7.4	38.7	20.1	30.0	18.1	37.3	26.0	67.6	1.9	25.7	38.2	10.3	34.2	36.5	39.5	1.9	47.8	24.4	197.9	2.7	13.6	44.3	41.3	39.5	40.4	38.6	43.9	27.8	32.6	74.4	23.8	23.2	23.0	5.7	69.3
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	52.5	73.7	2.2	3.6	2.4	2.4	51.1	2.5	2.7	51.0	5.4	66.7	7.2	60.8	8.6	47.1	44.4	5.8	63.2	2.0	2.8	45.1	75.0	64.9	3.0	3.1	2.6	40.9	98.7	12.8	74.1	8.2	3.2	55.8	8.7	1.9	90.9	7.5	31.5	38.4	58.5	8.3	2.5	47.7	71.4	29.0	3.2	2.8	67.2	2.8	4.4	42.4	41.2	2.9	10.7	9.6	8.6	8.2	25.8	15.9	13.2	17.8	25.3	23.1	23.1	16.7	6.6	5.1	11.9	22.9	12.4	7.5	8.3	14.5	9.7	16.6	10.1	9.4	10.0	25.1	18.2	10.0	30.7	16.0	13.6	15.1	20.6	13.5	11.7	8.3	15.5	7.7	10.2	9.8	4.3	7.4	8.1	23.2	9.9	5.7	6.8	12.2	14.0	5.8	6.8	5.1	8.6	37.2	13.2	5.4	25.0	10.3	10.9	13.1	17.4	8.2	9.8	18.3	15.1	3.9	7.5	8.7	15.0	2.2	1.8	2.0	3.3	1.1	4.4	1.2	2.0	1.2	0.7	1.2	1.8	1.7	0.8	2.1	1.0	1.3	1.0	1.5	2.2	2.4	2.5	2.7	2.0	2.8	3.1	2.6	3.2	2.5	3.2	2.9	40.0	25.6	34.8	7.2	23.4	36.1	29.4	53.6	19.4	27.4	36.7	18.5	33.1	34.3	54.7	25.8	29.2	103.0	22.9	75.5	5.9	73.8	0.8	26.9	47.3	40.9	25.3	28.4	4.3	86.1	129.1	64.4	66.8	53.7	20.8	29.5	28.2	34.4	42.9	11.8	5.9	135.1	48.8	14.8	35.3	2.7	46.0	22.1	40.9	5.6	23.7	42.9	24.7	8.5	8.3	67.8	54.9	42.9	91.6	60.2	56.0	25.9	28.3	26.8	19.7	35.4	43.0	9.4	11.5	26.0	40.9	168.7	23.1	69.2	61.7	51.3
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462390	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.2	21.6	17.3	12.1	17.5	10.7	24.4	17.7	24.6	18.2	20.9	20.3	21.5	14.8	25.6	23.1	15.6	14.3	12.2	17.4	18.9	29.8	43.0	15.6	12.7	17.0	17.3	13.7	28.5	26.4	22.8	17.7	17.0	19.0	21.5	12.7	33.8	15.1	7.9	18.3	19.4	15.5	18.7	16.0	21.8	8.9	18.3	18.0	22.2	11.6	17.8	15.3	15.3	20.1	55.0	46.3	26.9	28.7	46.2	34.6	25.1	31.9	40.2	30.7	34.8	35.4	49.7	49.3	23.8	39.8	14.2	45.3	30.9	30.5	37.4	31.9	17.0	28.9	23.0	24.8	36.0	20.9	38.1	30.3	50.3	27.1	40.5	30.6	30.8	38.1	22.2	44.2	32.5	33.6	33.0	26.1	20.9	47.7	31.2	32.8	37.6	30.3	40.9	56.1	28.3	46.1	32.2	55.1	22.2	20.2	76.9	37.8	30.4	50.8	36.2	22.1	24.6	48.8	27.4	36.6	47.1	25.4	42.0	11.2	10.3	9.4	7.9	9.7	8.1	6.9	6.8	7.7	11.3	4.8	6.7	7.0	8.7	6.8	9.4	5.9	5.5	6.8	17.3	17.5	17.7	24.6	17.4	18.9	17.0	17.3	17.0	18.7	18.3	20.1	13.3	19.2	12.6	37.9	13.4	12.1	8.0	19.2	17.1	8.4	27.7	14.1	7.9	18.6	18.0	16.5	6.2	14.1	7.3	42.8	5.9	15.0	16.2	16.0	16.1	17.0	29.4	15.4	31.0	25.1	17.3	14.3	22.4	17.8	12.0	13.8	22.1	67.7	15.9	10.1	30.9	30.3	14.2	24.5	8.7	22.4	13.1	13.8	7.2	24.4	16.4	9.5	12.3	30.2	37.0	28.6	22.4	12.8	18.6	18.7	34.6	15.8	24.6	11.2	6.6	12.6	12.0	13.9	9.2	18.3	12.5	17.8	9.2	14.2	25.7	20.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789094-205813748	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 99.3;tongue: 75.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 175.0;Theca cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	9.7	10.8	10.1	6.4	10.4	5.8	4.7	11.0	8.2	4.8	36.7	5.8	2.1	6.5	5.1	5.6	11.0	7.1	99.3	8.6	6.4	9.2	1.4	8.4	7.4	11.1	10.2	11.3	61.6	9.3	4.6	3.7	9.5	7.5	1.8	6.1	3.7	6.7	48.8	3.8	3.8	6.0	8.9	5.3	9.8	18.5	13.7	5.7	17.8	75.9	5.1	6.2	3.9	9.5	18.2	16.1	9.6	15.6	11.7	11.6	13.2	17.9	17.8	18.2	15.9	8.0	10.1	25.9	11.3	16.5	14.9	18.5	9.5	13.4	6.2	48.6	14.8	6.4	16.5	1.2	11.2	0.0	17.4	14.9	10.8	20.8	14.7	14.9	11.3	20.5	11.9	10.5	14.7	11.2	11.8	1.8	11.5	4.8	7.1	13.8	29.0	6.4	4.1	22.0	8.1	10.4	14.0	12.3	11.0	8.0	8.8	6.7	14.3	21.5	13.8	19.9	19.2	34.7	24.9	8.5	16.6	8.3	13.6	0.0	0.1	0.0	1.6	0.1	2.0	0.6	1.5	1.5	0.0	0.7	1.4	1.5	0.0	0.4	0.0	0.0	1.5	1.0	10.1	10.4	11.0	8.2	8.6	6.4	11.1	10.2	9.5	8.9	13.7	9.5	18.2	3.2	23.0	20.5	11.2	20.8	24.3	4.6	10.8	14.6	14.4	10.2	175.0	5.7	8.5	0.0	50.1	1.8	11.5	1.6	1.9	9.6	2.4	6.8	9.8	24.1	6.0	6.5	5.3	11.0	14.5	15.7	11.7	6.2	7.0	13.9	8.6	2.2	3.4	18.5	6.6	2.7	4.1	2.4	6.5	2.7	9.9	3.5	8.8	15.9	0.8	17.0	8.2	7.1	8.3	9.3	1.3	9.4	8.3	24.9	0.0	15.7	7.9	20.3	0.0	29.7	16.1	8.1	12.9	7.5	18.2	3.1	14.5	100.2	1.5	22.0
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 100.6;Hepatocytes: 51.6;Inhibitory neurons: 93.8;Oligodendrocyte precursor cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"myeloid DC: 4.1;plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 56.2;SK-BR-3: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favorable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	8.6	8.7	4.5	8.1	5.9	1.3	10.3	6.0	6.1	9.4	9.1	21.0	31.4	4.6	15.8	1.9	3.2	14.4	2.4	4.8	9.9	8.3	114.9	6.5	4.8	1.5	3.6	5.3	18.3	8.6	6.3	3.7	4.3	3.2	15.1	1.9	14.2	9.4	0.7	1.4	27.8	8.6	0.3	3.2	37.1	8.5	9.0	2.8	12.1	1.6	4.7	5.6	1.6	3.1	11.6	25.6	0.9	5.3	21.0	15.2	9.9	7.9	12.9	5.4	9.1	16.1	10.8	4.7	8.4	15.8	19.8	1.1	5.7	2.6	10.1	56.2	14.4	0.4	9.6	7.3	4.6	1.8	6.2	5.2	2.1	5.8	1.6	11.7	7.0	3.1	0.3	11.9	0.9	5.3	2.3	0.1	2.4	20.6	8.2	1.0	11.0	11.2	21.5	0.3	10.1	2.6	13.5	44.5	2.2	3.9	17.3	0.1	2.0	8.2	5.8	8.7	9.0	14.1	19.1	6.2	13.0	0.9	5.7	0.2	0.2	0.0	0.1	0.1	0.8	0.5	0.1	0.1	4.1	0.2	0.3	0.1	0.2	0.3	0.0	12.2	0.1	0.3	4.5	5.9	6.0	6.1	4.8	9.9	1.5	3.6	4.3	0.3	9.0	3.1	3.8	19.2	9.6	16.6	4.5	2.4	3.2	1.8	1.8	2.6	6.3	2.3	0.8	25.8	6.5	7.3	0.0	1.7	4.4	34.0	0.0	27.9	29.5	6.4	2.5	2.5	1.2	0.0	100.6	38.5	19.7	12.3	29.0	16.7	0.0	0.4	1.8	51.6	5.3	5.0	93.8	9.8	2.0	2.9	33.2	5.9	2.1	8.5	0.0	10.3	18.7	1.8	1.0	55.3	5.2	29.9	9.2	6.4	6.9	4.9	37.0	7.4	3.1	0.1	0.0	4.7	4.8	6.4	4.3	0.2	2.3	9.0	2.2	0.5	11.8	4.9
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006357-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	29.5	47.2	53.3	13.3	55.6	11.3	29.5	55.0	56.1	42.4	53.0	24.8	18.1	44.4	55.1	22.2	40.2	28.6	34.3	57.7	54.9	27.7	14.3	21.4	18.1	56.8	54.0	54.5	32.7	34.9	40.0	19.7	59.6	23.1	19.2	25.7	31.1	23.7	61.8	24.6	23.8	29.4	49.8	19.6	27.8	44.7	54.7	34.4	32.0	47.9	19.3	28.9	29.6	48.4	43.7	17.4	28.5	24.1	78.7	45.3	42.4	24.4	42.1	32.9	39.0	23.3	38.7	31.4	44.8	48.9	35.7	33.3	10.8	42.1	29.0	31.1	32.0	17.2	32.1	34.2	65.3	31.4	18.4	44.0	50.8	20.0	41.1	48.7	46.5	38.2	14.7	26.2	44.0	22.2	35.1	25.7	21.7	57.4	26.3	18.6	29.3	43.5	39.6	31.6	22.1	23.8	37.8	12.3	104.0	26.6	12.2	41.9	32.2	30.8	23.2	47.1	28.0	19.4	17.2	15.8	27.7	14.0	28.9	13.0	6.3	4.6	12.0	9.4	9.6	9.4	11.1	12.2	9.8	9.0	9.6	9.1	1.2	14.9	6.1	9.6	21.8	6.1	53.3	55.6	55.0	56.1	57.7	54.9	56.8	54.0	59.6	49.8	54.7	48.4	25.6	16.0	10.9	9.8	13.5	13.8	22.3	24.9	20.5	15.4	22.9	23.5	14.4	32.9	20.5	22.0	4.2	34.6	14.6	7.5	3.9	35.8	36.7	34.1	15.3	28.5	21.1	5.0	17.0	24.7	36.1	19.7	11.7	17.9	5.7	21.2	35.0	7.2	16.1	28.6	20.7	12.1	30.5	12.8	10.3	14.7	37.6	8.6	14.2	15.0	13.5	25.9	7.2	11.6	8.0	24.3	6.8	54.9	10.3	15.3	14.7	12.6	14.8	12.1	26.3	23.1	20.7	16.7	45.4	18.2	15.3	25.3	17.7	42.4	15.6	19.0
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 128.6;pancreas: 233.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.9	10.7	3.6	4.7	4.2	35.7	11.1	2.7	5.0	13.1	2.7	15.7	8.7	12.6	10.3	4.4	13.5	18.2	8.6	3.6	2.8	7.3	128.6	9.9	7.4	3.8	3.2	20.3	233.2	1.8	4.4	6.3	3.5	12.8	9.4	1.3	13.8	6.2	17.1	18.8	9.2	8.7	2.7	8.5	30.4	3.4	3.4	2.1	12.7	9.1	6.6	16.2	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	4.2	2.7	5.0	3.6	2.8	3.8	3.2	3.5	2.7	3.4	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569268-1628886	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 399.3;Syncytiotrophoblasts: 943.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	16.1	8.4	5.4	12.0	5.5	12.4	12.3	6.3	6.4	6.5	0.7	8.6	6.1	6.7	3.1	3.4	12.0	3.0	5.5	4.7	5.7	37.1	3.4	21.6	2.8	10.8	5.2	4.1	6.1	1.8	15.8	22.4	10.5	7.9	1.8	1.4	14.7	2.0	60.5	5.3	15.9	2.3	5.2	30.6	9.9	4.7	9.0	3.1	13.0	4.7	1.6	11.2	3.8	4.9	1.1	2.9	0.9	8.6	1.6	1.4	11.5	0.6	0.3	2.1	0.9	17.8	2.0	5.2	5.8	0.9	0.8	2.1	5.2	1.0	0.3	0.0	0.4	0.9	2.4	4.5	2.0	0.2	1.6	1.8	1.6	1.2	0.5	0.2	8.3	0.6	2.3	0.0	0.3	4.2	10.9	1.0	0.9	2.8	0.4	3.0	0.0	6.2	3.8	10.1	3.4	1.8	2.6	7.1	0.2	3.6	7.0	6.2	10.3	0.2	1.2	2.3	0.7	0.5	11.1	2.5	0.4	1.0	0.3	3.2	6.5	6.2	0.3	4.9	0.1	1.3	0.2	0.2	3.4	1.1	0.2	0.2	15.6	0.5	5.2	1.7	0.2	2.8	5.4	5.5	6.3	6.4	4.7	5.7	10.8	5.2	10.5	5.2	9.0	4.9	16.4	16.0	35.9	17.3	19.0	4.8	6.0	20.8	0.0	29.4	12.2	10.7	2.9	12.8	37.4	36.8	25.0	399.3	13.2	13.7	19.6	26.7	3.4	11.5	12.1	10.9	11.3	0.8	20.5	7.1	42.0	11.6	6.6	12.1	12.0	0.7	12.1	1.2	90.2	20.2	18.3	13.6	87.5	102.6	91.3	3.0	10.8	93.5	0.0	14.0	84.3	19.6	6.2	11.1	5.0	6.7	17.8	9.1	15.7	6.3	92.2	25.6	33.2	39.3	0.0	10.1	8.0	3.4	2.9	1.6	4.3	943.4	5.5	11.7	11.4	5.3
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 146.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 85.8;monocytes: 146.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.3"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	61.4	16.8	5.2	34.8	5.9	58.0	50.3	5.9	7.3	40.2	6.8	23.7	8.3	28.1	4.5	34.8	30.0	28.5	34.8	5.5	7.1	15.9	146.9	46.9	26.5	6.7	6.4	24.3	13.7	3.9	4.9	14.3	7.3	14.4	11.8	0.9	35.2	7.5	15.6	34.6	20.6	25.5	6.3	20.8	20.1	4.7	11.1	23.2	76.3	13.3	28.9	30.7	28.2	8.5	289.2	0.0	16.0	0.4	52.9	76.9	0.7	22.0	93.0	31.6	54.1	0.0	61.4	165.0	9.8	52.0	16.3	161.8	47.0	28.8	63.3	1.0	0.2	257.3	93.0	0.0	106.6	513.8	428.4	231.7	0.9	306.5	3.5	22.9	89.7	75.0	299.8	154.4	123.7	0.6	108.6	328.2	24.3	0.0	5.3	221.8	3.3	570.9	76.1	0.0	38.0	0.0	62.2	1.4	263.5	1.5	24.1	77.3	48.1	1.5	81.4	209.2	62.5	0.3	0.9	41.3	187.3	183.2	532.1	15.2	105.7	23.4	19.6	127.0	22.2	9.6	13.5	26.8	85.8	7.1	10.4	10.5	9.0	3.9	146.3	85.7	26.5	60.7	5.2	5.9	5.9	7.3	5.5	7.1	6.7	6.4	7.3	6.3	11.1	8.5	19.8	16.0	49.1	1.6	6.1	46.8	7.4	30.8	48.3	0.5	8.0	14.2	3.7	28.6	26.1	1.8	0.0	0.6	11.9	0.3	0.0	75.5	1.0	1.0	3.1	33.0	0.0	38.3	0.1	6.4	5.0	33.4	2.0	3.0	67.0	2.9	14.3	61.7	73.7	0.0	0.2	0.6	16.2	21.0	74.6	1.7	9.9	47.0	30.2	8.4	10.2	0.6	3.1	8.5	0.8	9.4	0.5	12.4	22.5	14.5	0.0	0.1	4.9	0.1	65.7	15.5	22.0	0.7	1.1	13.6	17.6	0.8	11.8	12.3	1.2	3.0
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.9"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	16.9	13.3	112.9	12.9	204.4	11.4	26.2	166.7	138.7	16.7	79.4	50.2	22.6	15.9	32.4	18.4	15.2	20.2	12.7	116.2	136.1	21.8	38.0	18.4	9.7	204.3	167.7	14.1	15.1	23.2	5.3	23.3	205.5	11.8	49.0	14.1	9.6	25.0	9.4	21.5	27.0	17.3	161.1	9.5	35.2	3.5	150.8	13.6	43.6	20.2	15.5	21.8	15.6	284.9	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	112.9	204.4	166.7	138.7	116.2	136.1	204.3	167.7	205.5	161.1	150.8	284.9	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644557	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.1;Extravillous trophoblasts: 257.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 333.2;SK-BR-3: 306.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	74.7	33.2	69.6	43.9	85.0	65.0	72.7	78.4	67.4	64.6	33.4	58.3	26.7	43.0	36.2	81.6	59.0	55.8	71.4	62.7	69.7	68.7	17.8	98.5	75.3	99.6	76.5	32.3	41.2	48.7	20.5	157.5	87.0	43.8	49.5	29.1	55.5	65.8	141.2	78.3	50.8	43.6	84.3	115.5	112.9	82.5	79.1	48.8	64.9	92.4	77.7	56.3	69.2	97.6	333.2	8.3	70.0	42.1	103.9	63.5	201.1	69.6	169.5	112.3	131.6	75.6	154.9	65.6	91.1	193.9	13.6	254.1	10.7	53.2	71.6	1.7	9.3	42.0	39.3	3.1	115.0	0.6	33.9	69.2	69.8	42.3	37.2	91.0	86.8	30.2	20.2	10.8	172.6	243.6	35.1	32.1	24.9	96.9	29.3	74.1	102.7	2.9	37.1	171.8	6.9	42.0	56.7	306.1	7.7	73.8	123.0	3.2	79.8	50.1	18.4	60.5	18.0	4.0	7.9	64.8	12.5	29.1	57.3	146.3	39.4	227.9	114.1	113.0	90.4	92.1	78.5	87.4	20.7	94.8	83.3	87.1	482.8	79.2	278.3	100.4	95.7	147.4	69.6	85.0	78.4	67.4	62.7	69.7	99.6	76.5	87.0	84.3	79.1	97.6	84.0	54.5	29.1	32.3	53.4	9.7	17.3	17.2	13.1	12.3	45.8	29.1	38.6	28.6	47.7	92.0	14.6	137.8	51.9	49.9	1.9	44.1	171.1	15.8	31.4	52.7	9.6	45.0	14.3	44.3	257.0	22.6	84.6	38.6	20.3	7.1	75.7	1.9	37.0	3.3	15.5	17.7	14.2	38.7	3.9	35.1	38.8	22.8	5.4	15.9	10.2	36.4	88.6	18.6	18.4	41.1	31.9	56.4	18.9	9.8	20.1	3.7	19.0	3.0	59.2	26.3	29.4	3.2	2.9	33.5	8.5	93.4	41.2	6.8	23.4	20.6
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"OE19: 35.9;RPTEC TERT1: 101.4;RT4: 69.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	2.2	8.8	15.7	6.2	15.3	0.1	8.1	17.9	16.9	8.8	14.0	31.5	26.1	7.2	6.6	9.4	8.0	10.9	3.9	14.8	17.0	29.3	6.3	10.3	0.8	20.7	16.4	1.7	27.0	5.2	15.0	3.4	16.4	10.8	35.4	4.3	23.4	7.7	0.2	6.0	28.0	2.8	17.6	0.9	29.3	2.5	15.7	4.9	5.2	0.6	2.2	22.1	6.5	18.3	23.4	3.2	0.8	0.0	2.5	3.2	15.9	0.4	3.4	0.8	3.7	21.4	5.8	0.0	15.4	0.4	6.9	7.7	3.5	5.5	1.4	0.0	4.1	0.0	1.2	1.7	1.1	0.0	0.0	9.9	5.1	1.6	0.0	6.3	0.4	0.0	0.0	0.0	1.4	3.4	0.0	0.3	1.0	35.9	0.8	1.8	0.7	1.3	101.4	69.5	10.4	17.0	1.0	10.8	7.8	7.3	6.2	0.7	0.0	0.5	3.5	1.5	0.2	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	15.3	17.9	16.9	14.8	17.0	20.7	16.4	16.4	17.6	15.7	18.3	0.4	25.6	6.7	26.1	0.6	3.1	27.8	14.6	4.0	0.7	15.6	8.3	5.7	37.1	22.7	12.9	0.0	15.9	0.1	18.2	15.6	33.4	32.5	12.8	3.2	1.3	16.3	0.0	1.4	27.8	0.8	3.8	16.3	22.5	1.3	5.3	0.7	2.1	1.3	0.0	4.6	32.2	20.3	0.3	0.4	5.3	5.0	0.8	5.4	2.8	1.0	17.0	0.0	5.5	2.0	38.3	36.5	10.9	0.0	12.9	22.8	38.6	11.4	0.2	0.0	9.6	3.4	0.1	0.2	10.2	3.8	6.7	0.8	4.1	42.8	30.3
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	0.3	0.7	1.5	0.5	1.9	0.3	5.5	0.0	3.4	1.1	0.0	2.1	1.2	0.7	0.4	6.6	3.6	1.0	2.5	2.3	1.7	2.0	1.0	0.6	0.5	2.6	1.6	1.1	1.7	3.7	3.1	3.8	2.8	0.8	2.7	2.5	1.4	0.2	1.6	10.7	1.4	0.2	2.0	0.8	1.5	4.5	2.3	2.5	0.7	1.5	2.1	1.6	2.0	1.2	0.2	0.2	4.6	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.7	0.6	1.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	2.7	2.7	0.0	0.0	1.9	0.0	4.7	3.2	0.6	0.0	0.0	2.3	7.4	5.2	1.1	11.5	0.0	4.8	0.0	11.7	0.2	0.0	14.7	0.4	1.3	0.0	1.5	2.1	2.1	3.2	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.9	0.0	3.4	2.3	1.7	2.6	1.6	2.8	2.0	2.3	1.2	0.1	0.0	1.1	12.4	0.4	1.9	1.0	0.4	0.0	4.0	2.9	1.7	0.8	0.0	1.0	0.0	0.0	9.1	0.0	2.0	0.0	0.1	86.9	1.0	0.1	0.6	2.4	0.0	274.5	0.9	3.9	0.4	0.0	0.3	0.0	20.1	7.5	0.0	1.1	0.0	563.3	1.0	0.0	0.0	0.2	35.2	0.9	0.1	0.0	6.5	0.0	0.0	0.0	265.4	10.1	0.2	0.2	0.0	0.1	1.1	0.0	0.1	2.5	0.8	0.0	0.6	0.2	0.4	0.4	0.9	6.7	3.8	0.1	0.5	1.2	3.6
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8318114-8344167	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.0;Horizontal cells: 10.1;Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;GAMG: 2.7;HHSteC: 4.9;U-87 MG: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	2.2	1.8	3.4	0.5	3.3	0.0	2.1	2.6	5.6	3.5	1.9	4.0	0.5	5.1	0.8	0.9	4.3	1.1	1.9	3.4	3.7	4.2	0.2	0.9	0.4	5.0	3.3	3.0	1.0	1.1	6.7	0.3	6.0	2.9	0.3	1.6	0.9	2.1	1.2	0.8	1.9	1.1	1.1	1.4	1.7	1.4	3.9	0.1	1.4	1.3	0.1	3.0	2.6	2.9	0.0	1.8	0.3	0.8	3.7	2.6	0.0	0.1	0.8	0.2	0.5	0.0	0.2	0.0	0.2	0.5	2.7	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	4.9	0.0	1.4	1.2	0.1	0.6	0.0	0.9	0.4	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.8	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.3	1.5	0.2	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.1	0.0	0.6	0.6	0.8	0.3	0.4	0.4	0.1	0.0	0.2	0.3	0.0	0.0	3.9	0.0	0.3	0.4	3.4	3.3	2.6	5.6	3.4	3.7	5.0	3.3	6.0	1.1	3.9	2.9	6.3	0.0	0.0	5.2	0.6	0.4	1.8	0.8	0.6	7.0	0.3	0.0	1.4	0.0	0.1	1.8	4.2	0.1	0.2	0.0	0.0	0.6	2.5	0.6	2.4	2.9	0.0	0.0	10.0	0.2	0.0	3.1	0.0	0.9	0.0	1.6	1.1	0.0	0.1	10.1	11.1	0.2	0.0	0.3	1.5	5.4	3.4	0.7	0.0	0.0	0.0	6.1	0.0	5.0	4.4	0.1	0.0	5.7	0.3	0.9	0.0	0.5	0.1	5.0	6.6	2.7	2.5	0.6	0.5	0.0	0.3	0.0	1.0	1.4	0.1	0.4
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680509	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"prostate: 306.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	382	"basophil: 40.5"	"Lineage enriched"	"Detected in single"	382	"granulocytes: 40.5"	"Cell line enriched"	"Detected in many"	29	"HMC-1: 834.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	1.4	3.6	6.7	3.2	19.5	0.8	1.6	17.6	13.4	3.7	1.9	4.8	4.6	1.7	0.5	1.6	2.1	3.8	1.5	8.0	10.3	2.1	11.2	3.4	2.7	25.1	17.3	2.7	0.8	0.3	4.7	0.5	21.8	306.4	3.2	0.1	2.8	0.6	5.6	1.5	4.8	1.0	12.6	12.4	16.8	1.4	16.6	0.5	1.0	2.3	0.8	2.8	1.1	44.7	9.7	3.0	2.8	2.7	0.0	0.1	2.2	1.3	0.3	3.3	2.7	7.1	18.0	2.7	4.6	0.3	3.0	3.5	1.6	3.3	0.5	3.9	2.9	29.0	0.6	2.0	1.9	5.0	834.2	0.3	1.1	2.3	0.0	2.2	9.4	4.5	4.9	1.7	1.4	2.3	0.8	8.5	12.2	16.7	10.7	1.0	4.1	1.5	3.7	13.7	1.2	2.9	1.5	20.6	3.9	2.3	4.7	1.4	9.6	1.4	9.5	3.5	7.1	0.4	0.6	0.4	1.8	1.5	7.1	40.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	19.5	17.6	13.4	8.0	10.3	25.1	17.3	21.8	12.6	16.6	44.7	0.2	0.0	3.2	1.0	4.0	0.0	1.0	0.6	0.0	0.4	1.5	1.8	2.0	2.8	1.0	1.8	0.0	0.5	0.1	5.7	0.0	1.7	0.2	1.9	0.2	1.7	0.0	3.4	0.2	0.5	0.1	0.7	19.9	0.2	119.2	0.2	0.7	6.6	1.9	0.0	0.3	6.9	2.0	1.0	0.3	0.4	1.8	2.0	0.0	0.0	0.6	0.1	0.0	2.0	47.1	3.9	8.0	1.5	0.3	67.2	0.9	1.8	3.2	0.1	6.6	0.1	0.8	0.0	2.6	0.4	0.1	0.0	0.9	0.2	6.7	0.9
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 8.3;neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 18.3;OE19: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	3.5	2.5	3.8	3.7	4.8	5.8	2.9	1.2	16.6	7.1	14.7	4.4	2.3	4.3	1.5	3.3	7.1	2.7	6.6	5.1	1.5	10.2	0.9	6.7	2.7	6.6	1.0	3.1	7.9	2.5	14.9	5.0	6.6	6.6	1.6	5.4	7.8	5.3	4.6	5.7	4.1	1.7	0.7	4.8	12.5	13.7	2.2	2.3	5.8	1.4	2.0	3.4	2.8	6.1	4.6	9.8	3.7	5.9	0.3	0.3	16.1	2.5	1.5	2.2	1.7	6.4	12.2	0.9	11.8	1.0	3.1	3.7	2.1	1.2	1.0	7.2	3.3	2.7	3.1	0.0	1.7	1.1	18.3	0.8	1.9	1.6	0.9	0.5	1.5	5.0	5.6	0.7	0.8	11.9	11.0	2.5	4.7	30.8	4.1	3.3	0.2	3.1	8.9	7.9	5.5	4.6	2.7	0.8	4.5	2.6	1.9	7.2	0.8	0.0	2.4	3.8	4.9	3.9	12.7	1.3	2.1	4.3	4.0	1.1	0.1	8.3	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	7.0	0.2	0.1	0.3	0.2	0.1	3.8	4.8	1.2	16.6	5.1	1.5	6.6	1.0	6.6	0.7	2.2	6.1	3.3	9.6	12.7	6.5	3.0	2.7	6.6	3.6	5.2	33.1	6.4	5.8	13.5	15.7	8.9	49.7	54.2	8.7	7.5	14.7	0.0	9.3	12.5	57.6	10.8	3.4	2.4	0.0	29.0	2.7	0.8	2.9	37.2	97.1	1.3	1.8	1.1	0.0	6.7	3.3	21.7	7.7	8.2	2.5	3.3	5.9	2.1	8.6	3.6	7.5	1.8	4.3	5.2	6.6	0.9	7.8	4.5	2.2	5.3	6.0	3.7	3.2	22.3	9.2	0.0	1.5	3.2	5.7	2.6	4.4	2.4	16.3	4.6	4.0	5.1	11.3
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394642-28407197	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 93.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Hepatocytes: 27.8;Hofbauer cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	6.7	24.8	8.1	5.7	10.6	3.4	5.7	14.7	9.2	5.6	26.7	5.7	93.9	4.6	8.5	2.4	13.4	4.6	4.6	8.0	8.4	7.5	27.3	6.9	5.5	11.2	9.7	8.7	11.2	15.0	15.5	8.2	10.4	7.4	5.6	8.7	12.5	9.0	3.6	2.3	40.5	5.5	9.8	11.1	5.5	3.1	10.0	23.4	6.4	2.8	2.1	5.0	2.6	12.1	5.4	22.5	7.4	12.2	5.9	1.3	22.9	6.3	4.6	5.1	5.7	205.4	6.4	0.4	3.6	3.4	14.8	17.3	8.4	14.1	4.3	13.1	19.6	0.2	14.0	17.6	2.1	0.1	10.1	2.8	25.3	5.3	15.8	7.1	0.4	1.8	8.9	1.2	0.9	7.2	0.1	0.6	4.4	5.2	2.9	0.3	6.0	2.7	4.0	11.8	19.4	10.2	43.6	20.1	2.4	10.1	15.6	3.4	0.6	0.8	8.6	1.2	6.6	9.0	11.1	0.3	1.2	1.3	4.7	5.2	0.9	0.6	0.4	3.0	0.7	1.6	0.4	0.3	1.4	0.8	0.5	0.8	1.0	1.6	2.6	0.5	0.9	0.5	8.1	10.6	14.7	9.2	8.0	8.4	11.2	9.7	10.4	9.8	10.0	12.1	1.2	12.8	5.3	7.5	1.0	0.4	1.9	2.8	4.0	26.6	5.1	6.1	2.3	17.2	2.2	7.3	4.2	20.8	0.2	3.7	0.0	3.5	3.6	18.2	1.8	1.9	1.2	0.4	2.8	4.6	9.7	3.6	3.1	1.5	1.3	4.2	1.8	27.8	25.7	20.2	4.6	2.4	0.0	21.5	1.0	19.5	4.1	8.0	0.0	5.6	2.0	2.2	0.0	8.0	6.9	3.8	3.6	3.4	3.0	2.6	3.9	4.6	4.3	6.0	6.6	3.7	1.4	0.3	0.3	1.2	0.3	4.4	0.6	5.8	1.3	1.6
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890876	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 16.5;lung: 10.4;lymphoid tissue: 16.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 39.8;Endometrial ciliated cells: 15.8;Glandular and luminal cells: 6.9;Kupffer cells: 11.8;monocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 24.6;intermediate monocyte: 12.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"		"Cluster 11: Alveolar cells - Smell perception"			"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.1	0.0	0.1	0.6	0.1	0.1	0.9	0.5	0.2	16.5	0.0	0.0	0.0	3.0	4.7	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	24.1	0.0	0.4	0.0	0.9	0.0	0.6	0.5	16.0	0.0	0.0	0.1	3.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.1	12.1	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.0	10.1	0.2	0.0	6.6	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.3	0.0	0.0	39.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	15.8	0.8	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	6.9	0.0	0.0	0.4	0.1	2.1	0.0	0.4	0.0	0.0	11.8	1.8	4.4	0.0	4.1	0.0	0.0	12.4	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 76.0;liver: 96.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.0;T-47d: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	13.8	11.7	5.1	10.2	5.7	2.9	10.0	7.7	5.2	14.7	10.0	19.8	46.7	5.6	11.1	4.0	7.5	23.8	12.3	4.7	5.7	18.2	96.0	11.5	16.3	5.9	6.0	3.9	6.7	23.9	10.2	9.5	6.1	6.5	18.8	15.9	9.0	9.9	8.5	4.2	76.0	8.2	6.6	18.2	7.8	11.0	6.6	11.6	12.5	8.6	11.1	7.0	2.2	5.6	0.0	2.8	0.0	7.6	6.0	2.3	0.2	2.7	15.7	3.0	4.4	0.1	6.6	5.2	4.7	4.0	11.5	0.6	3.5	1.4	4.5	3.9	6.2	3.6	0.0	0.0	11.4	0.0	4.3	9.8	2.9	4.5	7.3	3.0	5.6	15.7	3.9	0.0	14.5	3.0	8.6	0.6	0.3	8.0	2.2	3.5	13.3	0.2	27.0	0.9	1.2	0.4	0.0	14.1	5.7	3.1	20.6	4.6	2.0	1.4	2.7	0.4	16.0	4.0	2.0	0.8	0.9	0.0	2.8	33.1	8.9	3.8	10.3	13.1	8.6	7.4	8.0	10.1	11.7	9.7	11.4	10.8	9.8	7.0	19.4	11.0	10.6	8.7	5.1	5.7	7.7	5.2	4.7	5.7	5.9	6.0	6.1	6.6	6.6	5.6	6.2	0.0	5.4	16.0	14.5	1.9	0.1	7.4	1.8	33.7	15.1	3.3	9.6	17.2	15.6	9.2	8.4	0.6	16.4	49.0	1.9	15.5	4.6	2.1	1.7	12.2	3.6	4.6	11.6	5.6	0.3	6.2	0.0	2.1	25.9	53.2	17.5	51.3	10.8	21.9	13.0	6.8	2.0	32.1	36.6	1.8	1.5	22.5	7.2	16.9	9.3	14.2	12.3	14.6	15.6	3.5	5.3	2.2	6.5	0.6	125.0	10.1	15.4	9.8	0.0	2.8	7.2	2.6	0.9	4.9	1.7	0.7	11.4	16.8	13.9	0.2
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 127.3;kidney: 100.3;liver: 103.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 12.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.6;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA		18000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	1.9	127.3	2.1	0.8	2.6	2.7	1.3	3.5	15.8	29.4	9.3	2.0	1.3	16.2	2.5	1.9	7.4	3.8	5.4	15.7	1.6	100.3	103.9	7.0	1.6	3.0	2.5	7.7	0.3	1.4	16.5	0.4	3.1	6.3	1.0	1.2	2.6	12.3	34.1	25.0	1.3	7.7	2.5	3.7	1.2	14.5	4.3	1.5	6.2	37.7	1.3	1.0	10.6	3.3	0.1	21.3	0.6	16.7	0.5	0.1	0.1	0.6	0.5	2.5	2.3	0.0	0.6	0.2	3.9	3.1	8.3	0.1	7.4	0.6	0.6	0.1	9.8	0.2	10.6	41.5	0.2	0.2	0.5	0.4	3.7	1.9	0.3	2.8	5.9	0.0	0.0	0.0	0.0	3.0	0.1	0.4	2.2	0.3	0.8	0.2	0.2	0.2	0.0	1.3	3.9	3.4	7.0	0.1	1.9	5.6	7.1	1.9	0.0	0.1	0.8	0.3	2.0	31.0	13.1	0.1	0.8	0.1	3.6	0.3	1.4	12.2	0.3	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.0	0.1	6.6	0.0	0.5	2.1	2.6	3.5	15.8	15.7	1.6	3.0	2.5	3.1	2.5	4.3	3.3	0.5	6.4	3.7	0.7	1.3	4.7	2.3	0.4	6.2	0.9	0.1	0.8	4.1	4.3	0.1	1.8	0.0	0.0	1.7	0.0	3.9	0.1	15.5	3.0	1.3	1.2	0.0	0.0	3.5	0.0	0.0	4.4	0.0	9.2	5.7	189.2	0.0	43.3	1.5	0.0	14.4	0.0	0.0	2.9	1.2	4.8	3.7	2.5	1.8	3.7	0.4	1.4	0.0	2.5	0.3	0.0	0.0	1.5	3.9	2.3	0.0	52.9	0.8	0.9	6.6	67.8	3.3	0.6	1.1	1.1	6.7	0.0	1.7	0.3	0.0	1.5
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782751	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 102.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favorable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	27.5	37.4	98.8	6.9	131.6	12.3	27.6	116.7	104.3	26.8	58.5	26.8	7.4	20.2	16.2	28.9	28.4	15.4	29.0	96.2	99.8	44.1	15.2	22.3	7.0	125.5	127.0	53.1	19.5	29.4	17.7	17.7	113.4	20.4	10.6	11.2	20.2	22.7	29.9	22.0	14.3	16.6	103.2	25.8	22.1	9.9	126.8	7.9	52.6	21.5	8.2	27.6	22.6	135.6	11.9	36.3	5.7	42.8	36.4	15.5	12.3	8.3	18.3	7.8	8.0	11.7	31.0	7.2	102.7	23.3	15.5	45.4	7.3	9.6	6.0	59.1	6.8	49.4	30.4	16.1	20.8	13.3	27.9	9.2	19.3	11.2	13.6	40.6	22.1	20.0	13.1	28.3	5.1	24.7	6.5	13.7	3.9	21.9	17.1	6.0	1.6	39.0	31.5	31.3	7.3	3.3	11.0	13.8	7.8	10.2	46.0	12.2	12.3	10.9	14.3	21.1	6.0	21.6	14.3	2.2	14.2	62.8	6.7	0.1	17.9	12.4	5.2	13.5	4.7	10.4	6.4	5.5	12.9	9.9	7.7	6.4	36.7	2.0	7.7	2.6	5.5	6.3	98.8	131.6	116.7	104.3	96.2	99.8	125.5	127.0	113.4	103.2	126.8	135.6	35.2	9.6	13.5	35.3	6.2	6.6	9.7	6.4	22.2	11.1	15.5	15.2	16.4	20.0	5.5	51.5	2.1	9.5	2.3	9.0	23.5	10.4	8.5	10.9	6.2	22.3	8.4	53.0	9.1	9.8	2.3	15.6	4.6	18.0	1.3	16.4	16.8	11.8	24.1	15.2	8.3	13.5	6.1	18.0	9.9	12.5	32.6	14.1	5.4	8.4	28.4	26.8	2.1	11.1	100.3	6.6	5.2	23.0	10.1	12.9	9.2	34.9	2.3	11.2	6.6	11.9	11.6	4.1	10.5	20.9	11.9	3.6	3.3	18.0	7.5	11.6
SLC49A3	"FLJ22269, LP2561, MFSD7"	ENSG00000169026	"Solute carrier family 49 member 3"	Q6UXD7	4	681829-689271	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.8;Breast glandular cells: 14.6;Collecting duct cells: 14.7;Ductal cells: 19.2;Extravillous trophoblasts: 33.9;Hofbauer cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;CAPAN-2: 5.8;SK-BR-3: 8.2;T-47d: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043593	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"			"HPA043593: AB_10959611"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.11e-1)"	8.2	3.2	2.4	4.4	2.1	3.5	9.0	2.7	3.0	4.5	3.5	4.2	5.9	3.4	4.2	4.4	3.3	3.7	8.3	1.7	2.3	8.3	5.8	8.1	3.0	3.2	2.2	1.2	4.8	4.6	1.9	2.7	3.0	5.0	2.3	12.6	8.4	2.1	3.0	10.2	5.9	2.1	2.7	8.5	8.4	8.9	3.5	0.6	8.5	1.9	1.7	4.3	4.9	2.9	0.1	0.1	2.7	1.9	1.9	3.7	8.7	1.0	0.0	0.7	0.6	0.4	5.8	0.1	0.2	4.5	0.4	0.2	0.0	0.0	0.2	0.6	0.6	1.6	0.7	0.2	0.8	0.0	1.2	2.5	0.0	3.4	0.0	0.0	1.3	0.3	0.4	0.5	0.0	0.1	0.1	0.7	0.3	0.4	0.5	0.0	0.3	0.6	0.0	0.3	0.9	0.7	0.0	8.2	0.5	0.5	25.8	1.6	0.3	0.8	0.3	0.4	0.3	2.8	1.6	0.1	0.3	0.7	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	0.2	0.0	0.1	0.3	2.4	2.1	2.7	3.0	1.7	2.3	3.2	2.2	3.0	2.7	3.5	2.9	12.8	3.2	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.6	8.4	0.0	0.0	1.8	14.7	0.0	0.7	3.1	0.0	1.9	19.2	0.0	2.1	6.0	4.3	0.0	0.0	0.0	0.4	33.9	4.3	0.0	4.1	0.0	0.8	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.9	0.7	0.5	0.0	0.0
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 407.2"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.5	0.3	0.7	0.3	0.7	407.2	0.2	2.2	1.4	0.1	1.7	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.9	0.6	0.5	72.1	2.2	1.8	0.4	0.8	0.6	0.1	0.2	0.0	0.6	10.9	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.8	0.3	0.3	1.1	0.7	0.3	1.5	0.1	0.1	0.1	1.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.7	2.2	1.4	0.6	0.5	0.8	0.6	0.9	0.3	1.1	1.7	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.3;choroid plexus: 121.4;retina: 34.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 604.4;Inhibitory neurons: 560.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 21.3"	"Immune cell enriched"	"Detected in some"	8	"MAIT T-cell: 63.3"	"Lineage enriched"	"Detected in single"	65	"T-cells: 63.3"	"Cell line enriched"	"Detected in single"	11	"Karpas-707: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034755, HPA076725"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034755: AB_10670296, HPA076725: "	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	0.0	2.0	6.3	0.7	10.3	0.2	0.2	0.2	21.3	0.1	121.4	1.8	0.3	0.0	1.3	0.0	0.6	0.4	0.0	11.8	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.2	1.3	34.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	63.3	0.0	1.2	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.5	6.3	10.3	0.2	21.3	11.8	1.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	21.2	0.1	0.0	0.0	0.0	0.0	116.3	0.0	0.0	0.6	0.0	0.0	0.0	8.4	0.0	2.6	1.1	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.0	604.4	0.0	0.0	0.0	0.5	0.0	2.5	0.0	1.8	0.6	0.0	0.0	560.9	2.8	0.0	0.6	0.0	10.5	0.0	0.1	0.0	16.9	0.5	2.8	1.0	129.2	16.5	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	9.4	0.0	0.3	0.0
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA036679: AB_2675244"	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.79e-4)"	13.7	16.6	15.3	16.1	16.2	15.8	14.5	17.9	20.9	11.8	12.7	12.3	12.6	13.4	12.4	15.1	12.7	10.4	20.6	16.4	16.2	16.0	16.2	13.9	17.4	15.7	15.6	15.5	14.4	21.1	12.7	15.7	15.7	12.9	12.9	19.8	12.9	12.0	30.6	16.4	13.3	13.2	13.3	15.0	13.9	33.9	15.6	17.1	15.3	22.1	16.9	12.6	12.0	16.4	44.6	25.4	25.1	23.6	25.3	23.2	36.8	36.1	24.8	37.2	30.3	37.4	31.7	28.0	32.7	29.1	39.2	31.0	40.6	28.0	33.2	39.2	33.2	32.2	26.2	41.5	30.7	46.6	29.5	20.9	34.8	37.1	34.8	31.2	38.4	27.1	47.5	29.7	34.7	27.1	31.5	45.4	25.4	29.3	24.7	25.9	54.9	32.4	38.5	20.4	27.2	26.8	28.1	37.9	36.0	25.2	23.0	30.1	39.3	34.5	31.3	24.2	42.7	48.5	73.8	88.4	37.4	36.8	28.2	104.8	33.4	48.9	31.6	32.6	31.8	26.1	28.6	28.0	25.8	36.7	34.5	29.1	31.9	43.7	37.6	20.8	34.9	28.0	15.3	16.2	17.9	20.9	16.4	16.2	15.7	15.6	15.7	13.3	15.6	16.4	17.1	32.1	28.9	14.7	17.3	11.9	12.3	27.1	14.8	19.9	13.3	11.0	30.1	11.5	29.1	18.4	18.8	24.5	21.0	11.4	5.9	28.4	47.2	22.0	20.3	21.9	16.3	11.8	25.5	36.9	20.3	17.4	13.3	20.4	38.6	18.5	15.4	13.9	24.4	25.2	23.7	11.5	16.2	13.9	8.2	7.9	17.4	18.9	17.8	8.4	31.5	21.6	19.6	12.5	18.2	30.5	9.3	19.2	22.1	8.7	11.5	16.1	24.4	21.1	32.9	23.3	21.7	143.4	82.4	15.7	11.9	24.4	21.8	21.5	10.1	10.8
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076526	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"choroid plexus: 492.1"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019339	Enhanced		Uncertain	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	28.4	34.8	16.9	19.2	29.4	12.7	23.7	29.1	21.9	38.9	492.1	45.0	22.5	40.3	4.9	21.0	31.1	19.7	31.3	39.4	23.2	38.6	52.3	33.2	13.1	32.8	27.9	31.9	52.5	72.4	13.8	27.0	32.0	28.2	7.1	4.7	23.1	14.0	18.8	21.7	29.3	16.5	20.2	27.0	82.2	13.7	32.7	12.4	25.4	12.3	6.3	31.9	25.8	40.2	60.9	196.9	37.8	78.9	37.6	17.9	87.1	72.9	37.0	56.9	48.0	113.0	91.6	35.8	154.1	35.0	84.6	58.2	38.2	31.4	9.8	105.3	59.1	48.5	91.9	57.5	59.6	25.2	147.0	29.0	27.4	65.6	15.7	60.9	31.3	50.6	151.8	27.1	44.3	118.0	69.2	43.3	90.4	80.7	73.2	55.2	21.2	42.2	44.6	41.0	31.5	113.9	67.0	118.4	62.0	27.3	51.2	46.7	72.0	78.1	39.1	77.5	106.5	31.2	47.7	20.5	118.7	61.4	160.6	0.0	1.6	0.4	0.8	1.6	0.7	0.9	0.7	0.7	1.0	0.3	0.7	0.8	0.2	0.1	1.0	2.1	0.2	0.9	16.9	29.4	29.1	21.9	39.4	23.2	32.8	27.9	32.0	20.2	32.7	40.2	15.6	9.6	8.2	9.8	7.2	11.1	5.9	13.6	15.4	7.7	14.5	11.9	4.0	18.6	9.6	20.2	25.0	36.1	14.2	17.6	17.6	35.7	1.0	21.9	18.9	13.6	27.6	2.5	0.4	35.8	9.4	13.6	30.1	17.0	47.1	62.1	17.9	34.6	26.0	15.2	1.4	12.1	16.2	16.1	12.0	1.6	13.7	17.0	26.6	4.7	11.6	21.6	3.1	3.0	16.8	43.8	14.0	19.9	9.9	5.9	24.9	19.1	11.4	8.2	13.1	12.8	17.6	3.1	7.9	10.6	7.0	91.5	8.5	11.2	22.1	4.5
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 73.4;retina: 42.0;thyroid gland: 26.7"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 168.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 8.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5"	"Low region specificity"	"Detected in many"			HPA036621	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.6	0.7	3.3	1.1	5.2	2.3	1.4	12.5	4.6	1.3	73.4	1.2	0.7	1.4	2.3	0.9	2.1	1.0	1.4	6.1	4.1	1.0	1.0	2.6	1.8	5.3	4.8	1.6	1.5	12.4	2.4	0.6	4.8	1.2	0.7	42.0	1.7	1.3	1.8	5.0	1.0	1.5	2.8	1.3	0.9	16.1	5.3	1.0	26.7	1.5	0.8	1.1	1.1	8.5	0.3	0.5	0.9	0.9	0.9	1.6	0.9	0.2	0.9	0.5	0.7	0.3	0.7	1.5	0.2	0.0	0.3	0.1	1.0	0.1	0.2	1.2	0.6	2.2	0.7	0.5	0.1	0.5	1.3	0.4	1.3	0.0	0.2	0.5	0.3	1.0	0.5	1.5	0.2	3.5	0.3	1.5	0.4	0.5	0.3	0.8	0.7	0.0	0.2	0.6	0.6	1.2	0.3	1.1	1.6	0.7	0.8	1.5	0.0	0.9	1.6	0.9	0.3	8.8	1.4	1.0	0.6	0.8	0.2	4.3	0.3	0.3	0.6	0.3	0.4	0.7	1.0	0.9	0.3	0.9	0.8	1.0	1.9	0.7	0.1	2.5	1.2	0.2	3.3	5.2	12.5	4.6	6.1	4.1	5.3	4.8	4.8	2.8	5.3	8.5	1.1	3.2	10.8	16.0	0.5	0.6	0.6	0.3	0.0	13.9	0.6	0.5	0.4	1.5	2.6	0.0	35.5	0.1	3.3	0.3	0.0	0.4	0.6	1.0	0.7	0.9	0.0	0.4	7.3	0.6	0.0	0.8	0.0	0.8	0.0	1.1	0.7	0.0	0.1	168.2	10.6	0.5	0.0	0.0	0.4	0.6	1.2	0.4	1.8	4.7	0.1	3.3	2.1	4.0	31.1	0.5	0.3	0.4	0.1	0.6	0.3	0.1	4.1	40.4	0.0	2.5	1.1	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.2	0.7
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	8.6	5.1	3.2	9.0	5.2	4.0	18.7	3.4	16.9	10.5	1.6	16.2	57.6	6.4	8.2	8.6	6.0	13.7	7.8	19.3	2.5	12.7	3.9	8.3	11.2	0.5	3.2	6.8	3.4	1.7	3.4	5.8	0.6	7.9	7.4	72.9	5.8	8.7	5.0	4.6	17.4	6.6	1.8	7.0	6.0	7.1	4.4	5.8	4.9	27.2	10.3	12.1	8.8	2.6	13.0	23.8	21.0	9.8	9.6	17.2	15.0	43.3	20.0	16.3	12.6	6.5	6.6	29.4	3.6	16.8	15.7	5.5	20.2	21.1	25.7	25.1	6.6	13.5	15.4	7.1	16.5	30.9	11.3	13.7	9.0	24.8	78.9	34.2	27.1	19.0	9.1	10.1	33.8	4.7	31.1	7.2	13.8	1.6	23.4	21.0	16.7	5.9	38.1	9.2	5.3	13.1	19.7	14.4	6.9	17.9	32.9	11.8	19.0	38.2	10.6	26.7	33.7	3.8	4.3	16.6	33.3	21.4	17.8	0.0	0.2	0.0	1.0	0.2	0.7	0.4	1.3	1.4	0.5	0.5	0.5	0.9	0.0	1.0	0.3	0.7	1.2	0.3	3.2	5.2	3.4	16.9	19.3	2.5	0.5	3.2	0.6	1.8	4.4	2.6	30.0	0.0	11.2	10.7	37.5	29.3	39.5	23.4	11.4	130.2	72.4	30.4	23.1	21.5	22.8	62.5	733.9	5.8	51.8	5.5	9.8	15.5	10.2	73.6	40.7	53.6	38.2	7.2	46.2	7.1	29.3	52.2	15.8	124.1	23.5	24.6	17.5	6.2	17.0	6.7	88.7	58.5	36.7	48.4	61.6	7.6	9.0	46.5	35.6	185.5	26.7	45.7	20.6	60.8	20.9	19.1	23.4	9.8	27.8	93.1	142.5	10.2	9.6	704.2	39.5	56.4	43.7	40.0	21.7	21.7	30.7	8.1	56.1	19.0	26.7	35.2
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 130.7;Intestinal goblet cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	23.0	42.3	9.3	17.0	9.4	14.2	22.5	10.2	11.0	28.2	11.9	45.4	40.4	16.0	101.5	34.3	21.3	13.9	13.3	9.6	11.3	44.4	48.1	26.3	21.4	10.7	9.8	13.2	57.8	34.3	18.1	18.2	12.6	29.9	53.7	2.6	28.9	15.3	6.5	32.3	36.1	15.7	9.6	35.4	47.3	11.9	11.1	17.1	27.6	6.6	26.9	20.3	19.7	10.7	48.0	15.0	13.5	16.9	42.9	42.4	31.2	19.1	28.9	24.6	31.7	28.7	166.5	34.1	58.8	27.3	34.6	62.6	16.3	52.5	14.7	72.7	8.4	29.2	17.9	18.3	72.0	18.2	35.1	44.0	144.2	41.3	98.0	43.1	25.7	20.5	32.2	53.1	23.6	56.0	15.0	21.6	18.7	99.7	59.1	26.3	9.5	117.8	53.0	16.9	23.5	19.2	31.2	63.7	50.6	21.0	140.3	19.3	13.3	18.0	17.9	25.6	9.8	68.5	45.1	32.0	30.1	42.0	19.4	22.9	24.1	24.5	20.0	36.2	24.3	54.5	25.2	24.0	29.7	60.6	27.0	23.8	10.3	51.7	34.6	30.3	28.8	30.8	9.3	9.4	10.2	11.0	9.6	11.3	10.7	9.8	12.6	9.6	11.1	10.7	33.0	22.4	33.6	2.6	40.4	16.2	21.1	43.5	18.8	7.4	78.8	22.5	5.3	12.8	41.3	23.9	12.5	37.0	26.3	66.5	13.7	43.7	0.6	28.7	20.7	33.2	23.4	20.4	4.3	48.8	130.7	21.4	60.6	42.2	24.1	17.7	24.7	22.1	45.2	6.7	4.8	195.0	71.2	32.2	33.4	1.5	13.4	35.8	28.4	5.6	33.8	5.3	16.5	4.0	1.8	42.1	54.3	5.7	47.0	40.8	69.8	23.8	38.6	7.2	6.6	11.1	20.4	8.2	5.2	27.9	18.5	62.8	23.2	28.5	52.5	39.3
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 subunit alpha"	Q86UW1	3	196211487-196243178	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"intestine: 64.5;liver: 71.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045488	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	1.3	5.2	0.2	1.3	0.2	5.9	1.2	0.1	0.7	2.0	0.0	11.3	30.5	0.8	0.8	1.4	1.6	0.6	1.3	0.2	0.4	5.5	71.3	2.0	0.6	0.2	0.1	1.4	0.9	2.7	1.2	0.2	0.3	1.1	0.7	0.7	1.2	0.0	1.6	2.5	64.5	0.2	0.0	1.8	0.9	4.1	0.7	0.1	1.5	0.0	0.5	1.0	1.8	0.5	0.5	0.7	0.6	0.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.5	0.0	0.4	0.0	0.0	0.0	0.3	1.3	0.5	0.4	0.8	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.3	0.0	0.6	0.0	0.1	0.9	3.9	0.0	0.2	0.0	0.4	0.1	0.2	0.2	1.4	0.1	0.1	1.1	0.2	0.2	0.7	0.3	0.6	0.4	1.5	2.0	0.2	0.5	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.4	0.2	0.1	0.3	0.0	0.7	0.5	1.1	0.0	0.5	0.3	1.0	3.3	2.5	10.9	0.0	0.5	0.6	0.3	4.1	1.5	18.2	0.0	4.2	0.7	3.0	43.5	3.9	0.2	20.7	2.7	1.6	1.6	0.0	2.7	1.0	0.2	0.4	2.4	0.0	1.6	0.0	2.3	3.9	49.1	0.6	1.7	0.7	8.4	22.4	4.4	7.3	12.9	61.5	1.3	3.6	1.0	0.8	0.4	1.0	0.5	0.2	0.1	12.1	101.5	0.8	1.5	271.8	11.5	18.0	1.1	144.7	2.3	2.6	2.4	1.3	0.0	2.6	1.0	3.0	13.6	11.8	2.8
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC52A2	"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2"	ENSG00000185803	"Solute carrier family 52 member 2"	Q9HAB3	8	144333957-144361286	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Host cell receptor for virus entry, Receptor"	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 149.0;PC-3: 167.6"	"Low region specificity"	"Detected in all"							HPA063036	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA063036: AB_2684928"	"unprognostic (7.80e-3)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (7.74e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	29.7	31.6	13.7	5.4	13.4	5.6	27.8	15.3	18.5	21.7	14.5	35.7	9.4	23.0	8.0	33.3	17.3	3.2	26.4	13.5	14.5	29.2	16.9	24.6	5.6	15.0	14.9	15.6	41.6	5.3	24.5	7.7	14.6	22.2	5.7	1.3	29.8	6.3	13.5	30.4	29.6	4.3	14.0	34.8	31.4	31.5	15.1	4.0	21.7	2.7	4.1	24.9	21.2	14.1	38.7	65.0	7.5	17.9	19.3	12.3	37.3	28.1	18.9	26.5	24.6	57.9	42.3	16.3	42.3	27.5	20.7	42.6	18.4	25.3	9.8	18.3	34.5	26.3	31.3	50.1	51.7	9.4	29.4	14.8	34.7	27.4	24.4	19.2	15.8	16.2	40.9	23.7	18.7	149.0	15.6	38.0	17.9	51.5	167.6	29.8	8.9	44.9	30.6	34.4	25.9	29.4	31.1	44.1	35.7	9.9	27.8	18.7	20.2	20.9	46.9	48.2	37.9	9.4	13.8	12.4	37.8	26.6	25.7	0.5	4.2	9.2	5.6	5.9	3.8	3.3	3.9	5.6	4.5	9.8	3.6	2.6	1.1	5.2	7.5	7.6	5.7	1.5	13.7	13.4	15.3	18.5	13.5	14.5	15.0	14.9	14.6	14.0	15.1	14.1	31.9	6.4	8.7	5.5	24.3	31.2	27.0	41.5	12.0	11.1	30.6	17.0	3.1	12.8	34.4	12.9	2.1	85.0	36.3	81.8	0.0	62.3	3.3	11.6	16.6	24.3	17.4	7.8	3.2	66.9	92.1	22.2	42.3	21.5	10.2	16.6	18.9	5.5	52.4	11.8	3.7	56.3	36.7	13.5	27.8	5.8	12.8	21.4	30.2	2.8	40.7	14.3	19.6	7.1	2.4	85.1	46.7	19.9	43.3	54.7	52.4	14.5	11.7	10.8	19.7	12.1	31.1	34.0	40.2	20.2	36.1	52.5	24.8	23.4	65.6	36.7
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.2;testis: 40.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.1	0.2	11.0	1.5	8.9	0.4	2.6	9.5	11.4	2.3	5.5	11.5	14.4	2.0	2.0	4.9	1.8	2.6	5.7	9.0	11.1	9.4	0.1	1.2	0.4	12.9	9.8	0.9	1.6	0.2	0.3	4.3	12.3	8.0	7.1	0.6	6.1	4.0	0.6	1.8	19.2	1.7	9.8	0.2	5.6	40.1	12.5	0.1	0.5	0.9	0.8	4.9	2.5	9.7	6.6	2.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	4.6	42.1	0.0	7.0	0.0	0.6	6.9	0.0	6.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.6	31.8	4.5	0.0	0.0	1.1	0.0	12.3	0.1	0.2	7.2	15.4	0.1	0.8	20.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.8	0.5	0.1	0.3	0.1	0.2	11.0	8.9	9.5	11.4	9.0	11.1	12.9	9.8	12.3	9.8	12.5	9.7	3.8	9.6	3.1	0.0	0.1	0.6	2.2	5.3	1.8	0.4	3.2	2.4	0.7	4.3	5.3	23.9	2.1	32.8	0.0	18.8	1.9	6.6	1.1	8.9	1.1	10.8	0.0	0.0	0.1	2.0	0.9	0.4	4.6	21.3	0.0	5.9	0.0	0.0	2.6	0.0	0.0	6.0	6.1	0.0	1.3	3.2	0.9	0.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	5.2	21.7	0.4	0.1	4.3	35.5	0.1	2.4	0.1	0.0	0.4	0.6	0.6	0.8	2.3	1.1	52.1	0.2	1.3	10.8	5.8
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 41.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 33.7;Proximal tubular cells: 76.9"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.8;non-classical monocyte: 4.8"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.8"	"Cell line enriched"	"Detected in some"	5	"U-937: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052014	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.2	0.2	0.1	0.6	0.1	2.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.0	0.0	41.6	0.5	0.4	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.9	1.4	0.0	0.1	3.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.8	0.3	8.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	33.7	0.0	0.5	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	0.0	0.7	0.1	0.0	76.9	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.6	0.0	0.0	0.0
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 54.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 59.7;Late spermatids: 145.7;Proximal tubular cells: 142.9;Spermatocytes: 31.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041603	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	54.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	3.7	0.3	0.2	0.3	0.1	0.2	0.0	0.5	0.2	0.4	0.5	1.5	0.1	9.2	0.0	0.2	0.1	0.1	7.9	0.6	59.7	0.6	0.5	0.2	0.0	0.0	0.1	0.5	0.1	0.4	1.5	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.5	2.0	0.0	0.5	145.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	1.5	0.0	0.1	4.7	142.9	1.7	0.2	0.0	0.1	0.2	31.7	1.1	0.0	0.3	0.1	1.4	0.1	0.6	0.0
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 163.3;salivary gland: 64.4;stomach 1: 58.8"	"Cell type enriched"	"Detected in some"	40	"Gastric mucus-secreting cells: 244.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.7"	"Group enriched"	"Detected in many"	5	"cerebellum: 5.6;hippocampal formation: 10.6;thalamus: 3.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.3	0.2	0.1	0.3	0.1	5.6	1.4	5.6	163.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	10.6	0.1	0.0	0.0	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	64.4	0.0	0.4	0.2	0.2	0.0	0.1	0.2	58.8	0.4	3.3	0.0	12.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	1.1	0.1	0.1	0.3	0.4	0.4	0.3	0.9	0.1	0.2	0.3	1.2	0.9	0.6	0.2	0.1	0.1	0.6	0.3	0.3	0.1	5.6	1.4	10.6	0.1	0.2	0.7	0.4	0.1	3.3	0.3	0.0	0.0	0.6	0.3	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.6	1.3	0.1	244.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.1	0.0	0.0	2.9	0.0	0.0	1.2	0.2	0.1	6.1	0.2	0.3	0.0	0.9	0.0	0.0	0.2
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 310.9;SK-BR-3: 337.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	42.4	8.6	27.5	14.2	25.2	18.1	31.5	24.0	30.6	9.4	46.2	13.0	20.9	14.3	67.4	10.9	11.5	7.5	7.7	23.4	23.9	8.5	104.0	7.9	13.8	24.0	24.4	10.2	11.6	9.8	8.0	39.1	25.9	9.3	12.7	6.4	12.5	11.1	17.0	10.0	15.3	9.7	23.9	9.1	10.1	23.4	30.6	11.6	8.0	8.8	26.5	11.3	8.8	21.9	78.9	79.6	49.9	66.1	45.4	16.5	310.9	28.1	19.1	41.8	28.7	118.8	27.0	54.2	41.3	15.4	44.7	42.8	108.3	32.4	29.1	42.2	63.5	96.6	34.9	184.4	53.8	125.1	47.8	57.1	27.1	51.4	39.7	11.1	38.2	43.3	143.6	21.1	27.0	161.0	42.7	60.4	144.8	90.1	29.0	70.7	58.7	78.2	24.0	74.5	42.0	61.7	30.3	337.1	40.1	48.6	74.9	26.0	17.5	45.3	62.5	27.9	76.1	35.7	88.6	84.7	24.5	86.1	65.2	0.1	5.9	1.8	7.4	6.6	8.9	5.8	7.0	7.0	8.7	5.3	7.1	8.6	0.3	6.3	8.9	8.9	7.6	5.8	27.5	25.2	24.0	30.6	23.4	23.9	24.0	24.4	25.9	23.9	30.6	21.9	2.5	0.0	4.4	7.8	13.4	8.0	8.6	3.8	7.4	5.3	41.9	31.9	6.8	8.6	3.1	7.3	4.2	119.1	12.5	6.7	1.9	9.8	15.1	3.9	7.4	6.2	5.4	12.6	7.2	8.2	111.7	6.0	5.6	6.9	0.0	18.1	7.1	67.7	21.8	11.8	9.0	9.2	4.1	9.1	6.0	32.0	7.2	6.6	0.0	29.0	47.9	2.5	6.2	6.6	5.0	7.0	4.3	13.9	10.0	14.1	11.7	3.9	2.9	3.1	13.1	5.5	5.2	35.1	21.5	7.6	6.3	227.9	8.6	9.4	15.2	7.8
SLC66A1	"FLJ20320, LAAT-1, LAAT1, PQLC2"	ENSG00000040487	"Solute carrier family 66 member 1"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 26.9;Extravillous trophoblasts: 17.0;Hofbauer cells: 37.4;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.7	24.8	12.4	5.6	13.8	13.1	10.7	17.9	14.7	12.9	11.3	11.6	10.7	10.8	9.1	9.8	10.1	6.9	11.3	12.5	13.0	15.2	26.6	10.7	7.9	15.7	13.6	11.0	17.4	7.9	23.2	7.1	14.7	14.2	4.7	12.1	10.5	6.3	14.2	14.1	16.7	5.7	12.1	14.6	14.5	18.6	14.2	4.3	13.5	6.1	5.6	9.9	10.6	15.1	14.6	15.0	13.9	22.4	13.3	12.4	17.6	18.0	24.6	24.7	20.7	22.1	18.0	4.7	23.0	13.3	34.2	10.6	13.7	16.2	11.1	9.9	16.5	3.6	13.4	24.0	37.8	3.1	6.3	20.6	16.7	34.9	11.1	13.8	9.6	8.1	26.8	10.7	24.0	12.8	2.1	10.2	13.3	5.2	13.3	8.1	17.5	8.2	18.9	9.4	17.2	14.3	13.5	9.1	35.5	12.4	15.1	35.8	12.8	20.4	11.8	35.0	16.1	18.4	13.8	2.7	25.1	18.3	17.3	1.3	10.5	10.3	3.7	9.1	2.6	6.0	3.9	3.1	13.7	5.4	1.1	2.3	6.4	4.1	13.8	20.5	3.8	4.5	12.4	13.8	17.9	14.7	12.5	13.0	15.7	13.6	14.7	12.1	14.2	15.1	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	26.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	60.5	0.1	0.0	0.0	0.0
SLC66A2	"FLJ22378, PQLC1"	ENSG00000122490	"Solute carrier family 66 member 2"	Q8N2U9	18	79902420-79951657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.3;Cardiomyocytes: 10.8;Cytotrophoblasts: 14.3;dendritic cells: 9.6;Extravillous trophoblasts: 14.6;Hofbauer cells: 36.1;Syncytiotrophoblasts: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051666	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA051666: AB_2681567"	"unprognostic (6.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-2)"	57.1	24.4	32.1	14.4	30.4	38.3	53.4	25.3	40.0	30.3	33.5	38.0	9.7	27.4	5.6	46.5	27.0	14.5	32.4	37.0	26.9	49.0	185.4	37.4	18.1	34.5	31.2	21.6	33.8	11.5	23.8	10.3	31.9	32.2	7.5	7.2	38.9	9.9	83.9	55.5	24.5	8.5	29.1	34.4	25.6	77.0	34.3	12.3	68.4	25.9	8.9	26.3	34.2	29.2	34.8	11.7	11.9	23.0	26.0	16.6	16.0	22.4	15.1	17.6	16.6	15.6	18.5	14.6	8.5	20.4	10.3	34.8	16.2	23.8	4.7	44.3	23.8	18.2	16.7	42.6	30.9	44.2	44.5	18.6	23.2	16.2	6.2	9.0	15.3	15.8	6.9	11.6	9.2	26.6	22.1	47.6	3.9	4.7	31.5	38.7	12.4	24.6	12.0	24.4	34.8	15.7	16.9	21.3	25.6	3.1	12.7	48.0	19.4	26.8	27.2	14.3	17.2	5.8	10.0	18.8	20.5	53.2	12.1	0.3	1.7	2.0	0.6	1.7	0.4	0.8	0.7	0.3	1.9	0.6	0.9	1.1	1.2	1.0	1.6	3.5	0.8	0.8	32.1	30.4	25.3	40.0	37.0	26.9	34.5	31.2	31.9	29.1	34.3	29.2	20.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	14.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	14.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	20.8	2.0	0.0	0.0	0.0
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039247	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.3;liver: 87.3;retina: 37.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 221.0;Inhibitory neurons: 332.3;Microglial cells: 108.7;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 107.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.9	0.8	51.5	0.4	56.0	2.2	1.0	45.4	67.1	3.3	0.0	1.1	0.4	1.2	2.9	9.1	1.2	1.2	4.1	35.8	53.6	2.9	87.3	2.0	0.5	39.4	63.5	2.1	0.3	15.9	3.6	0.8	34.8	2.4	0.5	37.0	0.4	4.0	2.7	1.7	0.9	0.5	43.0	0.7	0.5	4.1	71.3	17.6	0.7	0.8	0.4	0.9	2.6	39.4	0.2	0.2	0.5	0.3	0.4	0.1	0.3	0.2	0.0	0.2	0.3	0.4	0.3	0.4	0.1	0.1	0.5	0.4	0.6	0.2	0.2	0.0	0.5	0.4	1.6	0.8	0.2	0.6	0.6	0.3	0.0	0.0	0.3	0.1	0.1	0.5	0.3	1.0	0.0	0.3	0.2	0.5	0.2	0.3	0.4	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.0	0.3	0.3	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.1	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	51.5	56.0	45.4	67.1	35.8	53.6	39.4	63.5	34.8	43.0	71.3	39.4	0.3	0.0	0.5	221.0	0.0	0.3	0.0	0.0	6.2	26.6	0.1	0.0	2.1	14.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	2.6	0.0	0.0	3.7	0.0	0.0	1.4	0.0	0.0	2.5	0.2	0.0	25.2	0.0	0.0	332.3	0.0	0.0	0.8	0.0	1.6	5.6	0.2	0.0	108.7	0.0	36.6	0.0	130.2	107.9	0.0	0.0	10.1	0.0	0.0	0.0	0.2	0.0	3.7	13.1	9.4	6.8	3.8	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.2;kidney: 36.0;liver: 81.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Hepatocytes: 22.7;monocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.8;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	50	"classical monocyte: 5.7;intermediate monocyte: 5.7;myeloid DC: 2.4;neutrophil: 3.0;non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 2.4;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;RPTEC TERT1: 13.8;SuSa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.2	0.4	22.6	1.1	23.3	0.1	0.4	18.0	35.2	0.8	12.4	0.7	4.5	1.1	6.8	0.0	3.4	1.0	0.3	18.5	21.5	36.0	81.5	2.4	0.5	19.8	25.2	0.3	1.6	0.4	0.8	0.5	20.9	0.1	1.8	0.5	0.1	0.0	0.1	0.2	0.8	0.9	16.5	0.5	2.4	1.6	22.4	0.3	6.3	0.0	0.3	0.4	0.3	17.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.4	0.0	0.0	0.1	2.9	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.0	0.0	7.9	0.0	0.0	1.9	22.6	23.3	18.0	35.2	18.5	21.5	19.8	25.2	20.9	16.5	22.4	17.7	0.1	0.0	0.5	4.2	0.6	0.1	0.0	0.0	0.0	0.5	0.9	0.6	0.7	0.0	0.1	46.0	0.0	0.0	0.0	1.6	1.9	0.0	4.6	3.5	1.7	0.2	0.0	0.0	0.4	0.4	0.0	0.6	2.0	8.8	0.0	0.1	0.7	22.7	2.4	0.0	0.3	1.7	0.0	1.9	2.5	6.2	0.6	1.6	0.0	8.4	10.7	5.2	0.0	0.5	9.2	0.0	1.2	0.0	0.0	0.0	0.0	8.0	0.0	0.4	6.6	0.6	0.4	2.3	4.5	0.0	0.4	0.8	0.1	0.1	1.0	0.1
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436606-116461458	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.0;salivary gland: 20.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 115.7;Basal respiratory cells: 94.9;Club cells: 225.6;Pancreatic endocrine cells: 170.4;Respiratory ciliated cells: 58.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 3.4;OE19: 1.2"									HPA003193	Uncertain		Approved	Vesicles		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.1	2.2	0.0	0.1	7.7	0.3	0.1	7.0	0.0	1.4	0.9	0.2	0.0	2.3	0.2	0.8	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	1.0	0.7	0.0	20.6	1.3	0.0	3.2	0.6	0.1	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	1.1	1.6	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	22.4	115.7	0.0	0.1	0.1	0.3	94.9	0.0	0.0	17.6	11.6	0.2	0.0	225.6	0.0	0.0	0.0	0.1	18.1	0.0	17.6	0.1	0.2	0.0	0.5	2.4	0.0	0.0	32.0	0.0	1.0	10.7	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.1	0.0	0.5	16.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	10.2	0.0	0.0	10.5	0.2	0.0	58.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.4	0.0	0.4	0.0	8.9	23.4
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859491-84913629	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.9;retina: 15.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.2;melanoma: 7.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	0.6	1.4	8.0	0.2	7.8	0.0	0.4	4.0	12.7	0.9	0.0	0.4	0.1	0.5	0.0	2.8	0.2	0.0	0.0	6.9	12.9	0.2	0.0	0.1	0.0	7.4	21.9	0.3	0.0	0.0	5.5	3.8	16.7	0.2	0.2	15.7	0.8	0.1	0.0	1.4	0.4	0.3	0.2	0.0	0.1	0.4	8.8	0.1	0.3	1.6	0.2	0.2	1.3	5.0	0.0	2.5	10.3	0.0	93.5	55.4	0.1	0.1	21.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	12.0	1.2	0.0	23.7	0.1	0.0	25.1	0.0	4.1	0.0	33.5	0.0	0.2	31.4	48.2	11.9	135.3	25.3	0.3	0.0	0.0	0.0	25.9	0.0	0.1	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.7	22.6	0.1	31.1	71.0	0.2	0.0	0.0	0.0	12.7	6.5	0.1	0.0	0.0	0.0	0.1	23.1	0.0	27.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	7.8	4.0	12.7	6.9	12.9	7.4	21.9	16.7	0.2	8.8	5.0	0.0	0.0	0.0	4.2	0.1	2.7	0.0	3.1	42.1	19.7	0.1	0.1	0.5	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	63.9	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	57.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	32.0	1.9	0.0	1.1	0.0	4.0	46.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.1	0.0	0.5	1.0	0.4	0.5	5.8	0.6	0.3	0.0	0.0	0.0	0.0
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150494-110202202	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.9;pituitary gland: 25.3"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 60.6;Inhibitory neurons: 59.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	0.4	5.9	21.6	0.2	26.3	0.1	0.3	1.2	52.9	0.1	0.0	0.3	0.0	0.1	1.0	0.4	0.1	0.1	0.1	20.1	9.6	1.3	0.0	0.1	0.0	13.7	8.2	0.0	1.4	8.8	25.3	0.8	10.5	0.1	0.1	6.0	0.6	0.1	0.1	6.2	0.1	0.1	0.0	0.0	0.7	1.8	24.8	0.0	0.3	0.1	0.0	0.1	0.1	15.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.5	0.5	2.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.8	6.2	1.9	36.0	1.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	7.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	26.3	1.2	52.9	20.1	9.6	13.7	8.2	10.5	0.0	24.8	15.7	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.1	0.0	5.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	1.2	0.0	0.0	0.5	0.0	0.0	60.6	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	59.4	0.0	4.1	0.0	0.0	0.7	0.0	0.0	10.6	3.7	0.0	0.7	0.0	4.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.7	0.4	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225381-1246189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	76	"kidney: 8.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 55.6"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	55.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392794-1445440	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 60.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Cardiomyocytes: 1.2;Smooth muscle cells: 1.4"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	26	"midbrain: 60.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"midbrain: 80.6;thalamus: 29.0"	"Region enriched"	"Detected in some"	152	"midbrain: 302.6"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.0	0.0	60.6	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.1	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.6	0.3	0.0	2.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 68.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 59.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.6;RPTEC TERT1: 111.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.9	25.6	1.7	8.4	6.9	54.7	8.5	5.0	7.7	11.3	0.0	3.9	0.9	10.4	0.0	6.7	6.7	9.4	24.4	3.5	3.8	12.2	1.5	20.5	7.5	9.6	6.6	28.9	2.3	2.5	7.4	7.9	6.7	4.3	2.4	68.5	17.1	7.2	30.9	18.3	17.1	6.9	1.7	15.6	9.4	3.7	11.0	4.5	9.3	8.7	9.1	8.1	6.1	6.8	4.1	18.4	4.6	10.1	11.6	5.7	15.9	4.3	26.4	8.4	6.2	8.8	5.6	12.6	4.5	10.9	11.7	4.3	4.5	10.1	16.5	3.7	9.7	8.8	66.6	24.2	0.0	3.7	22.3	1.9	2.6	7.8	1.6	7.7	14.5	6.2	10.1	3.5	18.6	8.1	9.4	20.3	6.1	7.1	10.8	6.1	7.3	24.9	111.8	28.5	7.2	4.6	3.1	3.2	0.6	36.8	11.5	4.5	15.3	9.7	3.9	5.2	6.2	3.9	6.0	7.1	19.3	6.6	23.2	5.6	9.2	8.6	2.5	7.3	1.3	4.0	2.7	3.0	2.8	2.1	0.5	0.6	59.2	1.8	9.4	1.4	8.7	4.6	1.7	6.9	5.0	7.7	3.5	3.8	9.6	6.6	6.7	1.7	11.0	6.8	42.7	6.4	21.5	1.3	16.4	49.3	17.1	51.5	43.9	126.1	9.5	6.9	4.2	7.2	52.8	20.2	571.3	3.0	14.5	0.5	0.0	12.0	19.6	82.1	23.0	29.4	14.4	9.4	17.4	8.2	15.8	13.5	29.0	126.9	13.3	2.5	11.7	0.6	27.2	10.1	18.5	3.5	46.8	60.1	59.5	16.6	17.4	58.8	17.8	32.8	110.9	30.8	10.3	3.0	23.9	31.1	12.6	17.3	13.3	17.6	51.3	23.3	69.5	547.8	0.0	11.4	8.3	0.4	1.3	15.7	23.9	5.1	25.5	46.8	3.6	16.8
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150190062-150222788	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	37	"brain: 21.5;intestine: 5.5"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 41.5"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.1	0.0	10.2	0.3	12.7	0.0	0.1	14.6	21.5	0.1	0.0	5.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	10.6	3.2	0.0	0.0	0.1	0.1	1.9	3.4	0.0	0.0	0.0	0.1	0.0	2.1	0.0	4.0	0.1	0.2	0.0	0.0	0.0	3.3	0.1	2.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	12.7	14.6	21.5	10.6	3.2	1.9	3.4	2.1	2.0	9.4	8.9	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	41.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	5.4	0.0	0.0	0.4	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.5	1.6	0.1	8.7	0.0	0.0	0.1	1.9	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.1
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SLC7A1	"ATRC1, CAT-1, ERR, HCAT1, REC1L"	ENSG00000139514	"Solute carrier family 7 member 1"	P30825	13	29509414-29595688	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 235.6;Microglial cells: 162.1;Squamous epithelial cells: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039721, HPA077838"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039721: AB_10672893, HPA077838: "	"unprognostic (1.85e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.20e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.37e-3)"	6.2	6.0	34.8	10.7	21.9	11.3	7.7	28.6	31.1	8.5	24.4	10.1	10.2	8.4	10.2	55.1	7.4	4.5	7.5	31.0	25.9	6.6	2.0	4.9	8.6	40.5	27.6	2.8	30.5	4.5	7.5	3.0	41.4	7.7	7.4	9.0	16.1	9.2	2.1	17.7	14.8	9.1	33.9	5.9	11.3	6.9	39.5	7.8	9.6	1.7	10.4	11.0	11.1	27.6	42.2	33.2	28.7	58.0	14.5	28.6	32.6	87.8	58.3	74.2	55.0	68.0	72.1	82.9	23.3	134.5	82.8	188.0	50.4	62.2	97.1	78.3	30.1	62.1	36.3	37.0	75.0	91.6	39.4	36.6	129.4	82.6	96.9	17.4	37.1	92.8	40.5	37.6	31.5	56.5	67.2	24.6	27.5	74.2	22.1	45.7	59.1	48.3	47.2	27.5	97.3	46.3	50.0	48.3	79.4	17.9	21.3	76.6	35.1	58.2	40.6	51.6	63.6	42.1	33.1	93.8	46.4	36.3	60.1	0.0	0.4	0.1	1.0	0.4	0.8	0.6	0.7	0.8	0.6	0.4	0.5	0.9	0.0	0.2	1.0	1.2	0.6	0.7	34.8	21.9	28.6	31.1	31.0	25.9	40.5	27.6	41.4	33.9	39.5	27.6	12.1	0.0	5.0	7.2	14.4	49.8	53.9	33.0	235.6	15.6	21.4	12.8	10.2	12.8	16.2	71.7	16.7	1.1	10.3	14.7	1.9	19.9	0.2	32.5	10.0	29.2	31.1	54.7	28.9	56.9	40.0	10.3	26.5	69.2	7.0	8.0	5.7	0.4	6.1	25.2	27.0	34.5	26.4	5.7	18.2	0.8	6.2	8.6	8.8	162.1	5.7	3.1	3.1	23.6	13.1	56.5	21.1	3.8	36.8	55.2	20.7	0.3	10.1	18.6	6.6	28.1	9.0	4.5	2.1	175.1	34.9	4.0	11.3	10.8	33.5	41.6
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 31.8;brain: 12.7;breast: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 40.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	31.8	0.3	7.9	0.1	9.7	0.0	12.7	10.1	11.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	9.2	0.5	0.0	0.0	0.2	8.5	12.4	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	0.5	0.8	0.0	0.1	0.2	0.5	0.0	6.0	0.0	0.1	0.5	12.7	0.0	0.5	0.4	0.3	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.7	10.1	11.1	7.3	9.2	8.5	12.4	8.4	6.0	12.7	5.1	0.1	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.4	0.0	9.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A4	"CAT-4, HCAT3, VH"	ENSG00000099960	"Solute carrier family 7 member 4"	O43246	22	21028718-21032840	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 21.2;Endometrial ciliated cells: 16.4;Glandular and luminal cells: 32.0;Intestinal goblet cells: 8.9;Ionocytes: 12.2;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"BEWO: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031023	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA031023: AB_10669669"	"unprognostic (1.02e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	2.7	2.6	3.1	0.2	2.6	0.0	1.0	3.8	2.8	1.5	4.5	1.1	1.0	1.0	0.3	5.6	1.1	1.3	1.1	2.3	3.8	0.4	0.3	0.8	0.3	1.8	2.6	0.3	0.2	0.5	4.7	3.3	4.5	2.5	0.9	0.3	2.2	3.2	0.4	1.6	1.2	0.3	0.3	0.5	1.4	15.4	4.8	0.3	0.0	0.0	0.5	1.1	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	140.5	0.0	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.3	0.5	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	3.1	2.6	3.8	2.8	2.3	3.8	1.8	2.6	4.5	0.3	4.8	0.7	0.0	6.4	1.9	0.3	0.0	0.0	0.3	7.4	0.6	0.5	0.7	0.6	0.3	1.5	3.1	0.0	0.0	21.2	0.0	0.5	0.0	0.0	0.3	16.4	2.1	0.3	1.2	0.0	1.4	0.4	7.7	2.0	1.1	32.0	4.5	0.7	1.1	0.0	1.4	0.0	0.8	8.9	12.2	0.0	0.0	1.8	1.8	0.1	0.0	1.0	0.0	2.0	0.0	0.0	0.1	0.8	0.3	0.7	0.0	0.5	0.3	0.0	2.6	0.1	0.0	0.3	0.4	0.3	1.5	1.8	0.0	10.1	0.7	0.0	0.6	0.6
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869507	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 110.7;brain: 121.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 17.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.2"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	10.6	3.9	121.9	18.3	87.8	110.7	6.0	89.5	119.4	11.0	64.5	11.4	6.6	5.2	35.7	100.2	6.4	6.6	21.1	96.0	91.0	18.0	26.6	9.8	14.1	111.3	104.3	8.1	14.0	1.8	22.8	17.0	104.9	9.8	2.7	42.5	28.6	10.4	30.1	25.1	8.9	3.2	93.0	16.7	34.4	65.6	117.1	6.9	3.9	2.8	11.5	24.6	22.6	88.1	187.4	693.5	13.2	192.1	5.1	10.6	487.3	147.1	52.8	87.4	56.3	456.3	260.4	170.1	126.7	187.6	30.5	818.3	142.5	1326.5	61.0	179.9	71.9	140.3	618.0	331.2	199.5	131.2	246.0	35.9	2229.0	107.8	791.4	28.5	18.0	588.8	212.6	185.1	71.1	1264.6	159.2	192.7	63.3	116.7	166.0	152.0	52.4	264.1	98.3	15.7	109.2	43.5	1873.1	368.9	406.9	123.0	170.0	171.8	14.3	30.9	201.3	127.8	114.5	237.9	213.2	728.2	120.1	322.1	296.4	1.0	0.0	0.0	1.0	0.0	1.3	0.5	0.5	0.9	0.4	0.0	0.1	0.4	0.2	0.2	0.0	17.2	1.6	0.5	121.9	87.8	89.5	119.4	96.0	91.0	111.3	104.3	104.9	93.0	117.1	88.1	3.7	0.0	0.6	8.1	23.0	73.3	17.9	27.0	178.7	15.2	12.0	8.9	2.9	2.8	6.3	1.8	16.7	15.4	80.0	3.4	0.0	18.1	1.0	20.5	7.6	29.1	86.3	86.3	12.0	9.6	35.4	9.5	43.3	51.0	66.9	4.5	1.8	17.3	9.2	10.1	13.2	6.3	8.2	3.0	50.5	5.0	1.8	51.0	39.2	109.6	2.6	14.8	2.1	15.1	1.6	25.7	2.3	1.5	135.1	18.2	1.0	0.4	3.2	52.7	0.0	33.6	31.5	1.6	4.5	58.8	37.5	107.4	65.8	2.7	4.2	42.8
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 55.3;Syncytiotrophoblasts: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050713	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	35.3	8.8	1.7	15.5	1.9	8.4	26.9	6.5	3.3	5.5	17.3	8.3	3.9	5.8	11.5	4.5	8.6	4.4	18.5	3.3	2.2	5.9	2.0	10.9	18.6	1.0	1.3	2.7	3.8	2.5	9.6	18.6	1.5	6.2	11.1	5.0	7.3	5.2	75.0	10.2	12.0	7.7	1.0	10.7	6.6	5.1	2.2	37.6	16.7	26.9	21.5	6.8	4.8	1.1	22.6	22.1	16.3	16.8	46.9	27.6	42.9	24.9	18.7	36.9	30.6	97.9	16.2	43.7	19.8	33.4	10.9	33.1	32.0	32.2	39.7	9.5	22.9	23.8	47.3	31.0	7.7	28.2	20.3	19.3	26.1	27.5	13.5	11.4	25.3	21.0	35.1	7.3	20.5	11.7	36.4	19.3	12.4	14.6	8.1	45.0	10.2	36.0	12.0	19.6	23.7	13.5	75.7	20.8	6.8	13.4	30.9	13.3	38.4	24.6	19.0	20.5	32.8	16.7	33.5	50.3	15.6	20.1	17.2	3.4	3.2	2.8	4.3	1.7	5.4	6.8	6.6	4.3	3.6	6.3	11.7	6.7	6.1	7.1	1.4	16.8	3.1	1.5	1.7	1.9	6.5	3.3	3.3	2.2	1.0	1.3	1.5	1.0	2.2	1.1	8.5	41.7	18.8	12.4	18.4	19.6	9.3	8.5	13.6	6.1	5.9	4.8	19.9	2.8	4.9	18.4	37.5	25.1	23.3	7.3	0.0	3.3	5.5	10.7	16.8	12.0	2.4	2.1	39.3	4.0	2.5	12.8	4.1	3.3	4.5	1.8	6.8	1.4	14.6	10.1	40.3	10.5	4.1	8.5	12.1	18.3	5.9	9.9	10.6	55.3	10.0	1.8	14.4	13.0	10.7	5.6	5.9	3.8	16.0	8.0	2.5	0.6	10.4	2.7	0.0	10.8	7.2	17.3	10.9	6.7	21.9	47.9	23.5	4.3	7.8	2.6
SLC7A6OS	"FLJ13291, Iwr1"	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	13.9	8.8	9.6	10.1	11.2	13.9	12.0	11.7	10.8	10.1	9.1	9.8	8.2	9.0	10.1	8.3	9.6	6.1	13.4	9.1	9.6	9.1	6.1	8.5	16.0	11.1	10.7	9.5	8.9	8.1	6.7	9.4	11.2	9.0	7.7	8.8	9.2	6.9	17.0	9.0	11.3	6.8	10.2	13.2	9.5	6.7	10.4	13.0	10.2	8.7	12.3	9.3	8.9	12.5	11.3	11.4	16.4	12.3	9.4	12.8	18.2	14.4	8.1	16.7	14.4	29.3	15.9	19.4	12.6	9.3	10.4	20.0	15.6	12.1	14.5	7.4	10.0	13.1	20.1	24.2	12.1	18.7	13.8	9.9	13.5	13.9	21.7	14.6	12.5	16.6	20.7	8.6	15.2	16.9	24.3	19.1	11.8	13.0	9.7	28.4	10.1	24.3	10.4	14.8	17.3	12.6	27.4	6.1	15.7	12.7	16.5	17.2	18.5	13.0	11.2	12.7	11.3	21.0	18.6	29.2	13.4	22.4	13.8	28.5	12.8	26.3	14.3	15.1	16.6	14.2	14.4	13.3	10.3	15.1	15.5	12.1	11.6	14.8	14.2	12.7	16.2	12.7	9.6	11.2	11.7	10.8	9.1	9.6	11.1	10.7	11.2	10.2	10.4	12.5	15.8	9.6	6.3	2.9	20.6	9.2	13.0	12.4	9.6	22.9	8.3	11.0	1.4	12.8	9.3	12.9	35.5	24.1	24.7	7.0	17.6	13.0	3.0	10.8	16.2	13.6	13.8	8.0	4.8	11.2	12.4	12.7	11.2	10.5	14.0	20.5	13.9	6.2	21.5	16.8	5.2	7.8	12.2	14.1	7.4	2.5	15.8	11.9	12.4	1.0	20.2	25.5	30.9	5.0	4.8	17.0	7.3	16.1	15.7	16.9	10.0	9.8	13.9	23.5	0.0	11.4	11.0	16.7	18.5	10.2	6.7	22.0	21.6	19.7	9.5	14.2
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 331.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 9.3;eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	27.6	15.2	1.2	7.0	7.1	1.6	27.7	5.5	7.6	31.3	42.8	12.5	36.3	43.6	4.8	37.5	45.9	18.6	7.9	3.4	6.5	119.3	6.9	15.4	4.5	3.4	3.1	67.5	19.9	331.1	15.8	16.0	5.8	39.2	13.7	13.9	23.8	35.5	49.4	31.6	24.2	20.9	0.0	18.5	63.4	21.2	6.7	4.9	23.7	15.4	9.0	29.9	37.5	1.4	1.6	0.0	52.9	0.1	68.8	8.5	110.6	6.0	26.3	0.3	2.0	60.4	3.6	0.4	0.8	13.9	5.4	11.7	8.5	3.5	0.3	0.0	5.2	0.6	0.3	0.0	25.5	0.2	35.8	54.1	33.2	0.9	0.9	11.6	5.2	5.4	136.9	0.3	1.5	1.2	0.3	0.8	64.0	12.9	47.4	0.1	0.9	12.5	0.7	21.4	8.2	0.3	0.2	12.0	32.3	60.1	42.8	0.6	0.5	2.3	1.8	0.7	0.0	0.3	15.9	0.2	6.9	0.0	0.4	9.3	0.1	14.0	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.5	2.3	1.2	7.1	5.5	7.6	3.4	6.5	3.4	3.1	5.8	0.0	6.7	1.4	0.5	16.0	15.0	2.3	1.8	3.1	28.8	6.4	29.0	26.4	31.6	15.2	5.7	0.0	9.0	16.5	0.0	18.7	0.5	8.3	5.9	1.9	2.2	13.6	74.1	2.1	33.0	0.0	24.8	2.4	4.4	15.5	53.5	18.4	5.1	27.3	66.4	1.3	59.2	26.9	53.5	33.7	4.1	90.0	3.3	3.1	9.6	15.3	19.6	15.9	0.5	39.3	0.0	4.0	2.6	3.0	6.5	7.9	1.6	26.4	27.3	144.8	1.0	4.4	0.0	2.8	4.7	1.1	1.3	25.3	3.0	41.3	2.9	3.4	18.5	32.3
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 124.6;kidney: 68.2"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.7	0.1	0.7	0.0	0.3	0.7	0.9	0.8	0.6	0.8	78.3	0.4	1.4	0.2	0.5	0.2	0.1	0.7	0.7	68.2	17.3	0.2	0.1	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.7	1.0	0.2	1.0	0.2	0.2	0.0	0.3	124.6	0.2	0.6	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.6	0.7	0.7	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47471893	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.6;Excitatory neurons: 40.3;Inhibitory neurons: 13.6;Oligodendrocytes: 6.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 3.0;SCLC-21H: 8.9;SH-SY5Y: 4.4;SiHa: 3.9;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	0.3	2.6	16.9	0.1	22.5	0.0	0.1	31.6	34.0	0.8	0.0	5.9	0.2	6.5	0.1	1.1	1.9	0.1	0.1	38.3	7.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	7.7	0.0	7.8	0.0	0.0	0.8	0.3	3.4	0.2	2.5	0.2	0.1	0.8	3.5	0.0	0.0	1.3	1.5	2.5	0.1	0.1	0.0	0.0	2.0	0.5	13.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	8.9	4.4	3.9	0.4	0.3	0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	22.5	31.6	34.0	38.3	7.6	0.0	0.0	0.0	0.0	2.5	13.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	14.6	0.6	0.3	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.3	2.1	0.3	0.1	0.2	1.8	0.0	40.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.4	0.0	5.0	6.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.4	1.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SLC8B1	"FLJ22233, NCKX6, NCLX, SLC24A6"	ENSG00000089060	"Solute carrier family 8 member B1"	Q6J4K2	12	113298759-113359493	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 75.4"	"Cell type enhanced"	"Detected in many"		"Theca cells: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040668	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA040668: AB_10793861"	"prognostic favorable (9.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.54e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.02e-4)"	18.5	75.4	7.6	14.8	10.3	17.7	15.1	8.6	8.6	19.3	4.4	15.6	10.6	11.9	7.9	15.8	13.1	11.3	11.0	7.5	8.0	17.2	17.6	20.6	13.8	14.2	9.5	55.5	18.1	7.5	15.3	8.1	10.6	16.9	9.3	1.4	16.9	9.1	10.0	19.4	16.9	6.9	9.3	29.4	12.1	13.6	11.6	18.0	13.1	5.6	9.9	12.7	15.2	11.2	25.3	5.5	3.2	7.0	15.5	10.9	10.6	8.3	23.8	10.6	10.3	5.4	21.1	6.6	18.5	10.8	9.2	20.1	9.8	5.7	5.1	16.3	3.1	13.3	13.1	6.2	25.8	33.9	28.7	11.1	16.9	12.2	5.2	9.1	24.5	24.0	27.7	3.3	6.0	5.9	10.6	27.5	5.7	8.2	14.2	3.9	4.2	8.3	11.4	34.7	0.2	5.4	22.5	45.1	5.4	4.2	8.0	13.1	54.3	7.5	8.8	22.4	5.0	4.5	10.3	5.0	9.6	19.2	6.0	4.1	16.5	32.8	8.0	24.1	10.2	3.3	14.5	7.9	19.1	4.4	28.8	13.5	10.3	6.1	24.8	14.3	19.4	15.8	7.6	10.3	8.6	8.6	7.5	8.0	14.2	9.5	10.6	9.3	11.6	11.2	9.3	12.8	12.6	13.7	5.8	4.5	13.2	8.0	4.6	2.4	8.4	6.5	4.3	8.6	10.9	12.9	10.4	7.8	9.2	30.6	5.9	13.0	1.5	6.0	9.4	9.6	4.9	1.7	7.7	17.4	8.6	13.6	14.3	15.5	21.5	32.4	6.4	12.0	21.6	0.0	3.9	13.3	4.1	21.8	22.6	1.5	24.5	32.4	1.8	22.5	17.8	2.8	5.2	4.0	6.2	22.5	20.7	28.2	3.3	19.1	23.6	3.3	4.5	0.8	32.9	9.9	13.3	1.0	3.9	12.2	7.1	10.7	9.8	96.7	13.3	21.3
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098809-27166981	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 76.5;stomach 1: 65.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	9.6	10.7	6.1	10.4	14.7	11.5	9.0	2.8	10.8	10.9	0.2	18.6	29.3	10.9	8.0	11.0	7.6	16.9	13.7	2.3	5.3	5.8	2.4	13.2	7.0	13.8	4.7	7.0	8.6	20.7	8.2	21.9	11.2	9.0	13.6	4.5	76.5	19.4	4.6	10.5	19.0	10.7	0.5	11.6	65.9	10.1	10.4	6.3	9.5	4.9	6.7	15.1	9.2	2.4	32.3	10.7	9.9	10.1	21.8	15.7	60.8	25.9	38.5	21.7	23.5	13.0	20.0	14.4	21.9	33.4	10.5	38.9	9.8	62.4	13.4	17.4	9.4	21.9	7.1	5.5	66.1	13.1	16.0	19.7	29.5	36.5	50.7	15.8	36.3	9.8	6.3	13.4	32.3	18.7	6.8	6.4	14.0	38.2	21.9	11.8	9.0	6.7	10.9	46.3	11.4	3.7	21.5	28.4	12.6	10.0	13.3	7.9	39.9	23.0	9.4	21.7	14.5	12.6	8.6	4.3	24.6	14.1	13.5	0.0	0.6	0.6	0.7	0.3	1.5	0.1	0.8	0.7	0.2	0.3	0.5	0.6	2.0	0.1	0.6	0.0	0.3	0.8	6.1	14.7	2.8	10.8	2.3	5.3	13.8	4.7	11.2	0.5	10.4	2.4	13.5	6.4	14.8	6.5	7.9	31.2	17.9	14.6	13.1	7.4	21.7	23.2	13.5	7.2	8.3	11.0	0.0	40.3	11.9	81.5	0.0	9.1	26.5	13.8	15.9	9.7	12.5	0.4	14.1	12.5	19.4	12.7	160.0	26.5	27.3	7.5	6.8	1.2	12.9	20.2	14.1	15.0	4.1	5.7	5.1	14.4	9.3	12.7	7.2	8.4	4.3	8.2	12.3	4.0	4.6	28.1	43.1	13.2	4.8	9.6	38.9	1.2	5.9	3.8	6.6	20.8	9.8	3.6	4.4	15.0	25.1	52.9	9.8	4.8	18.3	18.3
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 568.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.9;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	234.7	81.7	107.0	20.7	98.6	0.7	181.7	83.4	119.7	92.6	60.6	77.4	27.2	92.7	10.7	47.3	77.7	34.8	568.2	82.4	88.5	207.5	408.3	289.1	22.0	96.4	95.5	57.9	47.7	24.0	95.6	51.3	99.3	129.1	11.9	3.0	149.1	42.4	144.6	45.3	81.2	18.8	87.0	143.8	109.5	36.3	116.2	7.9	188.4	109.0	7.4	77.4	72.6	94.7	32.5	188.6	5.0	38.6	6.2	8.6	5.7	138.1	81.9	67.9	22.5	25.4	41.9	0.1	63.4	59.2	9.1	30.9	15.0	13.7	7.1	0.4	45.0	3.1	80.8	61.6	44.3	0.5	13.9	9.2	13.7	20.2	5.9	32.1	68.2	15.0	24.0	2.9	4.8	306.8	0.6	35.7	7.5	76.8	281.2	27.6	8.1	50.5	16.0	2.9	35.3	33.1	9.7	188.3	12.8	5.0	152.6	16.8	176.4	21.5	30.7	1.9	193.6	5.1	4.6	0.7	2.5	3.6	202.4	0.0	2.2	0.0	0.5	1.6	0.2	0.0	0.1	0.1	3.9	0.0	0.4	0.5	0.0	0.0	0.5	2.9	0.1	0.7	107.0	98.6	83.4	119.7	82.4	88.5	96.4	95.5	99.3	87.0	116.2	94.7	1013.8	3.2	10.5	4.2	7.3	15.2	19.6	17.1	7.4	2.6	79.5	65.0	25.5	88.6	47.3	12.9	0.0	1.0	11.4	13.3	5.9	36.1	16.1	37.2	36.8	398.9	21.5	17.3	3.4	8.8	0.8	53.5	33.6	67.8	0.0	5.1	374.4	227.4	2.6	3.3	5.5	77.0	22.4	30.9	35.1	35.8	82.0	7.0	33.8	31.9	2.2	17.2	7.2	4.0	3.6	326.8	9.3	44.4	4.9	51.8	1.2	14.7	27.3	5.0	26.3	22.3	69.1	7.0	15.4	3.4	11.4	1.0	8.8	9.5	18.0	66.6
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473226-102533972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"stomach 1: 53.8"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;OE19: 6.8;RT4: 4.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 10.6;olfactory bulb: 6.8"	"Low region specificity"	"Detected in single"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.0	0.4	0.1	0.5	0.8	0.2	0.7	0.7	0.3	0.0	0.0	2.0	0.1	0.1	1.5	0.1	1.2	0.6	0.4	0.4	8.6	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	1.3	0.5	1.4	0.4	0.0	0.0	0.0	0.2	53.8	0.3	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.5	6.8	0.2	0.0	0.2	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.7	0.4	0.4	0.1	0.1	0.2	0.0	0.2	0.6	0.0	3.2	3.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	25.8	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	54.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.0	0.3	0.3
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272191	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6;lymphoid tissue: 17.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.1;Horizontal cells: 16.8;Inhibitory neurons: 12.2;Oligodendrocyte precursor cells: 7.1;Spermatocytes: 17.2;Theca cells: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	0.9	0.6	4.2	0.3	6.6	0.1	1.0	5.4	6.5	0.8	2.5	0.5	0.4	0.4	1.0	0.2	0.5	0.6	1.6	4.6	3.9	0.8	0.2	1.4	0.8	4.8	4.1	1.2	0.6	0.1	0.8	0.6	5.3	0.9	0.3	1.2	0.8	0.3	1.8	1.5	0.5	0.1	3.4	17.4	0.5	3.2	4.2	0.1	0.8	0.7	0.4	0.4	0.5	4.0	0.3	2.9	2.6	0.9	4.7	3.2	0.3	1.1	4.1	2.4	2.2	0.1	2.0	0.0	0.6	1.2	1.2	0.1	0.6	0.4	1.0	0.8	0.8	2.1	0.5	0.7	0.5	1.0	4.7	3.8	1.0	1.5	0.2	4.5	1.0	0.9	0.5	1.3	1.6	1.7	0.0	0.2	1.5	0.2	0.2	0.0	0.5	0.7	0.4	0.5	1.6	0.9	2.4	0.1	1.2	0.6	1.1	0.2	0.8	6.4	0.9	1.1	0.4	2.4	0.5	1.3	4.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.2	6.6	5.4	6.5	4.6	3.9	4.8	4.1	5.3	3.4	4.2	4.0	0.6	3.2	2.8	4.2	0.4	0.6	0.2	0.1	1.2	3.4	1.8	1.3	1.5	1.5	0.2	0.0	0.0	0.3	0.1	0.5	0.0	0.3	1.8	0.2	0.8	0.8	1.2	0.0	11.1	0.2	0.1	0.7	0.0	0.9	0.0	0.9	1.4	0.0	0.1	16.8	12.2	0.3	0.0	0.0	0.4	0.7	0.3	0.5	0.0	1.9	0.6	0.3	0.0	7.1	2.6	0.5	0.1	2.2	0.0	0.5	0.2	0.0	0.7	0.9	0.0	0.6	1.4	17.2	4.6	0.3	0.9	0.0	0.3	6.8	0.3	0.2
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	5.3	6.8	3.9	7.0	3.7	20.3	4.5	3.0	3.4	4.4	2.0	5.4	5.7	4.2	3.9	8.6	4.8	4.8	3.8	3.5	4.5	3.9	6.4	5.5	6.7	5.4	4.4	3.9	5.6	5.5	5.0	3.7	4.0	5.0	5.0	4.0	6.5	4.2	11.4	4.2	5.7	3.3	4.1	8.1	7.6	6.7	5.0	6.8	6.5	4.8	5.8	5.4	4.4	3.9	5.7	10.3	4.5	4.5	5.6	3.5	11.4	5.8	7.8	10.8	5.1	7.3	12.7	6.8	7.3	8.3	8.9	12.5	4.8	5.9	5.5	6.0	2.7	3.4	7.1	3.8	7.8	6.1	8.0	6.7	6.6	5.7	11.5	5.6	4.7	8.9	6.7	6.9	6.7	6.3	5.6	4.1	3.7	8.6	4.8	4.1	5.3	4.9	6.4	6.1	4.5	3.9	9.6	35.3	7.0	3.0	11.5	9.8	7.1	14.7	8.1	7.2	5.7	10.5	4.9	4.9	20.1	8.0	6.2	1.9	0.6	1.6	0.9	0.4	0.9	0.7	0.7	0.8	0.6	0.8	0.7	0.4	2.9	0.4	0.7	0.3	0.5	0.7	3.9	3.7	3.0	3.4	3.5	4.5	5.4	4.4	4.0	4.1	5.0	3.9	6.3	12.8	8.8	24.5	9.9	2.5	4.4	9.2	4.0	5.7	5.7	5.0	4.9	7.2	14.8	3.7	14.6	6.1	10.6	17.9	1.9	7.1	2.7	12.3	6.5	5.4	6.7	9.3	13.8	6.4	4.1	5.1	19.4	18.7	22.2	7.0	8.6	15.5	5.1	6.7	20.0	7.0	6.1	9.2	4.1	8.4	3.7	11.8	1.8	19.7	5.8	5.7	5.2	15.1	25.3	9.4	9.0	4.9	8.0	5.2	7.6	3.4	21.5	9.6	0.0	5.9	5.2	8.9	6.7	10.2	1.8	3.4	9.8	4.7	7.3	9.4
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848485	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		280000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	12.8	5.1	9.7	8.8	14.4	2.0	5.3	12.5	11.3	6.9	6.9	7.3	3.0	4.2	3.7	12.8	6.8	9.6	5.4	9.9	16.3	2.3	7.1	5.9	14.7	20.4	13.5	7.9	1.0	3.0	3.4	15.9	19.5	8.8	5.8	1.3	4.5	8.5	2.1	7.7	7.0	8.0	14.4	13.1	5.0	1.8	13.8	15.5	3.5	5.0	13.5	11.4	7.7	18.2	0.5	0.5	0.8	1.0	19.3	24.9	0.3	1.0	6.6	0.5	3.1	0.0	0.2	3.0	0.2	2.9	1.5	0.7	0.9	1.9	0.8	12.8	0.2	1.6	0.4	0.0	2.2	0.8	1.3	17.6	5.2	0.7	0.9	1.1	0.3	2.3	0.0	62.8	4.2	0.0	1.5	0.0	0.2	0.0	0.5	2.6	0.1	30.4	0.0	0.5	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.6	0.0	2.4	0.6	2.8	1.4	29.1	0.1	0.1	4.3	0.4	1.2	0.2	6.2	0.7	4.7	10.6	4.0	3.3	4.9	7.5	8.4	3.7	2.7	4.0	0.5	4.2	9.0	0.6	9.3	4.8	9.7	14.4	12.5	11.3	9.9	16.3	20.4	13.5	19.5	14.4	13.8	18.2	4.5	0.0	1.1	149.8	13.2	3.7	10.4	8.7	22.8	0.2	0.6	1.3	1.5	0.0	3.4	3.7	2.1	0.5	10.4	0.0	0.0	1.0	4.8	0.8	10.1	4.4	0.0	9.9	25.6	0.2	0.5	26.5	7.1	0.8	0.0	0.7	21.8	0.0	55.4	0.0	159.5	0.0	6.1	30.5	9.9	4.4	9.3	31.0	7.2	396.3	24.3	2.8	13.4	272.9	431.8	0.8	0.1	7.2	10.9	11.1	0.0	0.4	1.6	0.1	0.0	18.0	7.0	0.3	0.4	23.9	5.1	1.1	19.7	3.7	0.1	3.9
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.8"	"Group enriched"	"Detected in many"	5	"B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.8	6.0	11.2	5.2	11.7	4.6	5.7	10.9	12.8	6.2	3.2	6.2	1.1	6.8	2.3	3.4	5.6	7.6	6.2	12.5	11.1	2.5	38.7	3.6	5.9	11.4	9.1	6.7	2.4	0.3	8.5	3.9	12.7	4.1	2.7	12.8	2.4	5.0	3.0	3.0	3.7	7.7	7.0	3.6	4.9	3.6	10.0	3.6	2.9	3.5	5.6	6.5	4.9	11.2	4.9	2.1	5.2	10.5	26.0	20.7	0.0	22.0	7.8	3.2	3.0	2.5	3.0	29.3	3.7	24.3	5.1	1.4	12.2	9.3	4.8	24.7	7.5	30.2	7.5	21.8	13.5	22.5	8.8	18.7	10.8	7.7	27.3	11.1	15.3	8.3	10.1	22.1	10.7	1.7	15.3	10.8	4.4	0.1	6.4	0.0	6.0	12.2	9.0	2.4	17.5	14.9	10.0	2.3	6.0	1.4	2.6	13.4	17.6	7.5	4.3	11.6	6.9	16.8	14.2	21.7	8.7	17.5	3.0	0.0	0.1	0.0	4.9	0.0	6.4	5.1	5.1	4.1	0.9	3.0	3.1	3.8	0.0	11.8	0.1	1.6	2.4	1.8	11.2	11.7	10.9	12.8	12.5	11.1	11.4	9.1	12.7	7.0	10.0	11.2	13.9	0.0	0.5	15.0	15.6	4.8	3.4	2.0	6.2	9.7	3.1	2.8	2.5	8.6	1.1	0.0	27.1	0.5	6.5	0.2	0.0	14.1	12.1	1.1	8.6	17.8	3.0	17.2	57.9	68.5	2.3	13.2	22.4	0.9	1.3	10.3	6.1	39.5	1.4	8.4	57.2	1.1	4.1	1.3	5.3	6.9	5.6	3.4	10.6	5.6	3.9	0.7	0.0	32.6	17.6	94.7	0.3	5.3	12.0	4.9	0.0	1.4	1.1	2.3	6.6	16.5	11.5	5.8	4.2	5.6	3.8	0.3	7.9	4.8	0.3	1.3
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500460-173603072	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.9;testis: 6.0"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.3	1.2	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.2	0.2	0.5	0.3	1.3	1.2	0.8	0.8	0.4	0.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	1.3	0.0	6.2	0.1	1.3	0.1	0.0	0.1	6.2	1.7	0.1	0.4	0.0	0.0	5.0	0.0	0.5	0.3	0.0	0.1	0.0	0.5	0.4	1.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	4.7	0.0	0.7	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.1	0.1	5.4	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SLCO1B3-SLCO1B7	"LST-3TM12, OATP1B3-1B7"	ENSG00000257046	"SLCO1B3-SLCO1B7 readthrough"		12	20815674-21090245	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"breast: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.7;A549: 1.1;CAPAN-2: 1.7;HeLa: 2.9"									HPA050892	Uncertain					NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 20: HeLa - Mitochondria"				"HPA050892: AB_2681265"						"unprognostic (2.74e-1)"	"unprognostic (1.39e-3)"					"unprognostic (3.44e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932701-134052184	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 123.7"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 90.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013742	Enhanced					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	30.4	42.5	1.6	16.8	1.6	0.0	18.1	1.3	2.7	30.9	9.1	24.7	10.2	46.3	6.1	18.8	28.3	18.8	26.4	1.5	1.6	52.8	2.4	123.7	9.2	2.0	1.6	5.2	20.8	28.7	15.8	23.4	2.2	36.5	18.0	0.0	20.8	84.7	2.1	13.5	29.3	33.5	1.9	24.2	23.6	1.3	2.3	8.4	89.3	3.4	9.6	21.3	20.3	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	4.3	0.5	0.0	0.1	0.1	0.0	90.6	0.9	0.0	11.2	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	2.4	0.0	0.0	3.4	0.2	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.6	6.0	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	4.6	1.5	0.0	3.7	0.1	0.0	22.1	0.0	4.5	0.1	0.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.6	1.3	2.7	1.5	1.6	2.0	1.6	2.2	1.9	2.3	1.7	19.8	0.0	2.5	0.0	2.1	5.1	9.1	0.5	8.6	0.0	0.8	3.9	4.6	1.5	1.6	3.7	0.0	1.5	0.0	47.1	0.0	2.8	1.0	0.9	0.2	65.2	1.2	0.0	8.1	3.3	4.0	8.7	18.8	1.6	1.3	0.1	146.7	0.6	0.2	0.0	1.7	4.1	0.0	2.2	0.4	0.8	0.3	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.1	14.0	15.8	0.0	0.0	1.5	3.2	2.1	0.8	0.0	0.0	0.4	1.1	0.4	0.2	2.0	1.7	0.8	1.1	0.1	0.6	2.2
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853708-92172435	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.7	6.2	19.3	6.8	29.5	9.6	8.6	33.7	23.0	8.4	24.1	4.0	1.8	5.3	3.3	10.6	6.9	6.3	26.4	20.3	20.2	10.6	2.9	13.8	6.3	30.2	29.6	4.2	3.0	15.7	6.7	1.0	27.8	4.3	3.4	1.5	4.7	6.2	5.8	15.7	4.2	5.0	22.5	11.1	4.6	17.9	26.1	2.6	10.6	9.6	6.2	8.6	10.8	39.5	10.1	12.3	13.9	0.2	20.9	12.6	0.2	4.0	3.4	1.6	0.4	0.0	63.1	12.1	5.3	1.3	9.1	95.5	2.7	6.3	0.2	8.8	0.4	27.8	20.9	0.0	0.9	0.6	55.3	5.7	6.7	2.9	7.3	5.4	0.0	3.6	0.0	0.1	0.0	1.8	0.0	5.1	3.7	0.2	1.7	0.0	1.1	44.0	13.4	10.0	2.0	3.3	10.5	0.9	0.1	2.0	0.1	8.5	0.0	3.3	4.7	0.0	10.3	25.5	16.0	11.7	4.2	16.9	6.0	4.3	2.4	6.9	1.4	2.0	1.1	0.2	1.5	1.7	1.6	0.0	0.5	0.6	7.5	0.3	1.7	0.0	2.7	0.6	19.3	29.5	33.7	23.0	20.3	20.2	30.2	29.6	27.8	22.5	26.1	39.5	53.5	48.1	32.0	17.0	4.3	39.0	29.3	14.2	22.8	28.1	3.1	13.0	44.0	24.3	16.4	51.5	4.2	0.0	33.1	6.2	1.9	26.6	105.6	15.8	29.0	26.2	37.8	6.1	89.5	8.7	0.1	22.9	0.5	36.2	22.8	94.9	34.6	0.8	4.6	0.0	149.4	7.2	8.2	24.7	95.2	38.5	5.0	34.0	10.6	56.2	43.6	5.2	25.7	20.6	625.8	8.4	11.1	3.0	17.3	41.5	0.0	0.4	22.1	3.1	39.5	17.4	62.0	69.5	11.9	22.6	60.1	0.0	23.3	0.8	7.9	38.2
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 197.2;RPTEC TERT1: 193.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	32.4	5.6	26.2	1.8	24.0	1.3	23.4	24.2	35.7	11.1	19.6	9.8	1.2	8.7	0.3	16.7	13.1	1.8	48.6	23.9	25.4	35.8	5.0	57.2	2.4	26.5	24.8	6.5	4.9	3.8	2.9	4.7	28.0	5.9	1.8	21.5	8.5	1.0	18.8	25.6	9.2	0.8	25.7	6.6	13.5	2.1	31.6	1.1	8.6	5.6	3.2	12.0	16.8	24.9	14.8	19.1	0.8	10.8	2.5	2.1	26.5	4.7	16.6	14.1	5.4	32.0	14.9	17.8	44.2	0.5	9.6	22.0	16.4	1.0	5.4	2.1	9.6	21.7	22.1	23.8	0.1	16.6	6.7	0.0	6.5	0.3	6.2	4.2	2.5	10.7	17.1	4.6	0.0	14.8	17.2	63.9	5.4	74.1	197.2	30.6	1.1	26.2	193.9	14.2	17.4	25.1	4.1	4.4	15.7	6.5	1.0	7.5	2.8	0.4	10.5	7.0	27.2	9.2	15.9	11.1	38.1	24.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.9	0.7	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.2	26.2	24.0	24.2	35.7	23.9	25.4	26.5	24.8	28.0	25.7	31.6	24.9	61.8	3.2	1.3	1.3	13.1	27.3	1.4	19.8	1.2	14.1	1.2	0.8	4.4	1.5	5.9	25.8	31.3	2.1	3.7	7.5	0.0	5.9	0.3	8.7	3.6	40.3	0.0	2.1	7.9	2.5	239.4	4.3	20.9	35.6	0.0	0.0	14.6	0.6	5.5	0.0	6.6	8.4	2.0	9.7	33.5	0.7	0.3	11.9	60.5	3.7	0.0	6.1	0.0	1.5	0.3	11.8	1.9	0.7	19.1	3.5	0.8	9.6	1.3	43.2	0.0	1.9	2.9	0.2	3.0	1.1	16.1	23.5	5.6	0.1	7.5	11.0
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667046-69834978	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory bulb: 6.7"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 12.8"	HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.1	0.0	0.3	0.9	0.4	0.9	0.1	0.0	0.4	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.3	0.2	3.7	0.2	0.6	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.4	0.0	1.5	0.0	0.2	2.3	0.4	0.7	0.3	0.0	7.6	0.1	0.3	0.1	0.0	0.5	0.2	0.3	0.1	6.5	0.0	11.1	0.9	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	3.7	0.0	0.6	0.6	0.6	3.6	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	2.1	0.3	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.6	0.2	0.0	0.2	0.0	0.1	0.1	0.1	3.2	0.0	3.6	3.6	0.3	1.8	0.0	0.6	10.1	0.2	0.3	14.4	0.0	0.6	0.0	2.1	0.0	0.0	0.6	0.0	1.8	0.6	0.4	1.7	2.0	15.6	0.0	8.6	1.3	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	1.7	30.1	2.0	0.0	0.0	3.6	0.6	0.0	0.7	0.0	3.7	21.2	0.5	0.0	26.2	2.2	2.1	0.1	0.0	14.3	11.8	0.0	0.1	0.0	0.3	0.0	3.4	2.0	1.1	2.6	0.4	0.4	0.0	0.1	0.4	1.5	1.5
SLCO6A1	"CT48, MGC26949, OATP6A1, OATPY"	ENSG00000205359	"Solute carrier organic anion transporter family member 6A1"	Q86UG4	5	102371774-102499016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 30.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 168.8;Spermatocytes: 127.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA054126	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA054126: AB_2682390"		"unprognostic (1.17e-1)"			"unprognostic (2.59e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.65e-1)"		"unprognostic (1.84e-1)"					"unprognostic (2.60e-2)"		"unprognostic (6.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	26.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	127.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLF1	"ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121"	ENSG00000133302	"SMC5-SMC6 complex localization factor 1"	Q9BQI6	5	94618669-94739436	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 142.1;Spermatogonia: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HeLa: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040793, HPA054213"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA040793: AB_10796560, HPA054213: AB_2682419"	"unprognostic (7.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-5)"	"unprognostic (1.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-6)"	"unprognostic (3.27e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.32e-2)"	1.6	1.5	1.7	1.9	1.4	3.4	1.9	4.0	2.1	1.3	0.0	1.9	2.0	1.7	0.9	1.4	2.2	2.0	2.2	1.1	0.6	1.7	1.5	1.4	3.3	0.0	0.4	2.8	2.2	1.3	0.6	1.6	0.1	1.3	2.3	1.8	0.8	1.1	0.9	3.5	2.3	1.5	0.0	2.3	1.2	7.7	0.7	3.5	1.7	1.4	2.5	1.2	0.6	1.7	5.3	6.8	9.4	8.9	3.0	3.5	6.0	7.9	4.0	9.1	12.5	3.6	7.1	8.2	5.3	2.3	11.2	7.0	7.8	6.5	12.0	2.9	6.2	5.3	54.2	3.2	0.9	2.9	5.9	1.8	1.8	8.1	3.5	3.0	3.7	4.9	6.2	5.0	7.8	4.6	8.1	3.7	10.0	3.0	3.6	4.9	10.8	9.1	2.8	3.8	9.4	9.6	9.7	4.1	3.4	7.3	5.5	8.1	2.7	4.3	5.9	6.1	10.7	3.7	8.3	6.7	6.5	8.1	8.8	1.1	1.3	0.8	1.7	1.0	0.9	2.3	2.6	3.3	0.8	3.6	1.2	1.6	7.3	1.1	0.9	1.3	1.7	0.7	1.7	1.4	4.0	2.1	1.1	0.6	0.0	0.4	0.1	0.0	0.7	1.7	16.1	3.2	6.4	0.0	18.2	0.0	4.7	0.0	4.6	25.3	8.9	9.5	0.0	2.8	7.4	5.5	27.1	15.0	17.3	5.3	1.9	8.1	9.1	30.6	10.5	9.5	2.4	28.0	0.0	7.0	14.8	8.3	8.6	5.5	15.2	19.9	11.4	5.6	7.8	20.2	0.0	4.4	0.0	6.0	0.0	7.4	5.6	10.8	0.0	0.0	10.8	8.1	20.6	0.0	0.0	8.9	4.5	6.0	14.0	2.3	31.4	10.3	20.4	37.3	0.0	11.6	7.0	142.1	111.1	7.0	0.0	6.2	34.5	12.3	8.1	3.2
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912963-100965134	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.1	17.2	17.3	10.9	29.2	11.8	8.8	20.4	23.1	14.0	9.3	12.6	7.9	20.8	48.6	8.9	17.6	8.0	10.8	17.0	24.9	11.3	11.6	10.8	14.7	24.5	24.7	25.1	13.1	7.9	23.8	15.4	25.7	15.2	10.1	11.7	9.4	12.9	17.8	13.4	12.7	10.7	19.1	23.1	10.4	25.8	25.3	12.2	11.3	13.3	11.5	11.3	11.2	46.2	25.7	20.6	29.6	31.4	16.1	20.9	11.3	26.3	18.5	24.1	29.0	15.2	17.5	24.1	15.8	11.3	17.9	25.3	20.4	8.8	29.1	26.6	16.6	21.7	14.2	31.0	11.7	28.0	24.9	10.0	13.2	18.6	19.9	25.1	15.7	14.7	15.6	22.5	37.3	17.7	19.1	16.0	13.7	9.9	15.2	18.5	145.7	8.3	10.1	12.8	6.6	12.9	16.5	4.6	30.6	14.1	26.3	10.7	20.6	28.2	23.4	18.0	31.1	18.1	28.5	19.1	20.0	32.9	15.1	6.1	6.6	7.0	9.8	6.7	8.9	8.6	7.8	8.5	5.2	11.0	8.5	7.8	3.6	9.1	7.5	7.5	8.0	4.6	17.3	29.2	20.4	23.1	17.0	24.9	24.5	24.7	25.7	19.1	25.3	46.2	18.4	25.6	18.9	0.0	18.2	0.0	8.4	0.0	12.5	33.8	13.8	12.6	0.0	5.7	8.6	25.8	25.0	17.4	29.4	9.0	13.7	11.0	8.4	22.7	64.8	20.8	12.2	11.3	0.0	8.0	7.1	20.2	10.7	25.0	24.0	32.3	26.7	12.8	17.9	38.7	0.0	10.5	0.0	18.2	0.0	10.4	108.1	18.6	0.0	0.0	19.2	19.7	46.4	0.0	0.0	7.0	8.4	105.7	12.3	9.4	9.3	8.9	13.8	31.4	19.7	44.5	12.8	33.5	43.0	10.4	0.0	5.1	19.7	77.6	8.2	6.0
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 118.2"					"Low region specificity"	"Detected in many"			"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	31.7	8.2	5.6	20.0	6.1	12.8	17.1	6.4	5.2	21.1	8.2	10.2	6.2	12.1	42.2	8.4	20.6	18.3	20.0	6.0	8.0	6.4	6.8	37.7	21.2	9.5	6.3	23.1	5.4	6.1	6.5	10.5	9.7	9.1	11.1	1.4	11.8	12.3	7.3	5.2	13.9	19.1	7.6	23.3	9.0	2.7	11.0	22.9	24.1	19.0	20.9	17.9	12.6	9.4	29.3	25.6	0.1	0.0	25.4	72.0	0.4	35.3	25.2	59.9	103.9	0.0	0.0	0.2	0.6	46.4	18.8	13.9	78.8	0.0	72.1	16.6	94.2	63.0	0.3	0.0	33.0	82.4	0.1	29.5	0.9	66.5	0.2	0.0	99.4	46.8	0.1	0.3	10.1	0.0	118.2	66.4	0.6	0.0	0.1	98.9	73.3	0.2	0.7	13.8	0.2	0.1	0.0	13.0	0.1	0.0	20.7	58.6	52.1	16.3	0.4	61.9	53.7	2.3	1.0	0.2	12.2	70.3	36.0	0.5	18.2	2.1	6.1	27.6	8.4	4.6	3.8	5.5	14.0	1.5	2.8	4.1	1.4	3.1	18.2	19.4	6.3	8.7	5.6	6.1	6.4	5.2	6.0	8.0	9.5	6.3	9.7	7.6	11.0	9.4	70.6	0.0	5.2	0.3	19.5	7.5	1.1	1.1	5.7	0.4	6.7	2.8	9.2	1.5	2.7	1.8	0.0	1.4	39.9	0.1	0.0	0.0	1.4	5.9	16.0	38.8	0.0	9.9	0.3	0.6	0.5	29.2	6.6	2.2	3.8	0.3	15.0	0.4	32.8	0.0	2.6	0.1	0.0	36.5	53.0	1.7	10.2	47.0	12.4	17.8	17.2	0.3	3.1	0.0	0.1	0.1	1.2	3.0	24.7	1.3	0.1	0.2	13.3	0.1	6.6	7.9	38.8	0.0	0.2	1.9	8.5	0.8	37.3	7.7	0.1	0.7
SLFN12	FLJ10260	ENSG00000172123	"Schlafen family member 12"	Q8IYM2	17	35410922-35433283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.0;monocytes: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 54.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA022523	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA022523: AB_2670945"	"unprognostic (7.08e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.72e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	6.5	4.5	2.0	4.6	2.6	2.3	5.3	1.7	1.5	6.6	4.8	2.9	3.4	5.5	2.7	2.6	5.1	7.0	4.1	1.7	2.4	3.7	1.9	7.9	5.9	3.4	2.0	6.0	1.9	2.5	0.9	6.1	3.3	3.0	3.5	0.8	3.5	4.4	1.0	2.2	3.6	5.8	1.9	10.5	3.2	1.8	3.1	3.4	7.1	2.1	4.6	5.9	2.1	3.1	0.2	0.3	22.2	0.1	5.5	9.2	0.1	19.1	10.7	42.1	42.2	0.0	0.0	0.1	36.8	16.0	30.3	12.3	0.4	11.6	40.3	1.0	3.3	6.7	20.0	0.1	7.1	9.3	5.0	15.1	4.1	18.2	3.7	10.5	31.6	0.3	0.0	2.6	32.9	0.0	0.0	12.3	0.5	0.0	0.1	0.9	29.8	0.0	15.9	21.1	0.1	0.0	0.0	4.9	14.6	0.7	9.4	8.6	35.3	20.8	28.9	6.6	24.4	7.0	1.8	0.3	7.8	8.6	26.7	54.5	16.1	12.8	3.2	9.5	2.9	2.9	1.7	2.9	11.1	2.3	0.8	2.5	7.6	10.1	5.0	1.8	3.8	3.5	2.0	2.6	1.7	1.5	1.7	2.4	3.4	2.0	3.3	1.9	3.1	3.1	24.0	6.4	3.1	0.3	4.1	0.8	1.4	8.2	5.2	0.0	7.0	5.3	3.0	4.3	8.5	12.9	0.0	0.9	17.2	0.5	3.9	5.9	0.1	12.7	18.4	15.8	0.0	3.0	0.0	1.4	2.1	11.4	6.6	14.9	14.0	6.8	11.7	0.5	8.1	0.0	0.0	1.4	4.1	11.6	3.5	0.7	1.8	13.1	0.0	9.4	31.2	1.2	15.5	0.0	0.0	3.5	0.2	3.0	4.0	0.8	0.3	9.0	4.9	0.0	19.7	3.6	9.9	0.2	0.2	3.5	0.9	0.3	8.8	16.0	0.8	0.4
SLFN12L		ENSG00000205045	"Schlafen family member 12 like"	Q6IEE8	17	35464249-35487857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	8	"dendritic cells: 16.0;NK-cells: 42.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.0;NK-cells: 3.6;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.7;Karpas-707: 5.5"									HPA024447	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA024447: AB_1856614"	"unprognostic (1.93e-3)"	"unprognostic (2.10e-4)"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.18e-3)"	"unprognostic (2.98e-5)"	"unprognostic (4.59e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.25e-6)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (8.88e-3)"	0.6	0.3	0.9	2.4	0.9	3.0	0.6	2.5	1.8	0.5	0.9	0.6	1.7	0.5	0.3	0.3	0.3	1.0	0.2	0.7	0.4	0.3	0.6	1.3	3.0	0.3	0.0	0.4	0.3	0.1	0.0	0.2	0.3	0.3	0.8	0.8	0.9	0.2	0.5	0.6	1.5	0.4	0.0	3.1	1.2	0.3	0.5	1.0	0.4	0.3	2.2	0.7	0.1	1.5	0.5	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.6	1.4	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.7	9.7	0.1	1.3	0.8	0.1	0.0	0.3	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.3	5.5	0.1	0.0	0.4	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.6	0.3	1.2	0.5	0.2	2.0	2.0	0.1	0.2	0.3	0.5	1.0	0.3	1.0	1.9	0.0	0.8	0.3	0.8	1.4	0.2	0.3	1.0	1.0	0.9	3.6	0.1	0.2	0.5	0.4	0.9	0.9	2.5	1.8	0.7	0.4	0.3	0.0	0.3	0.0	0.5	1.5	3.5	3.2	2.7	0.0	1.5	0.3	0.6	0.4	0.0	0.0	0.3	0.3	1.3	1.5	0.7	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.8	0.5	0.2	1.4	0.0	0.4	0.0	0.0	0.0	0.5	1.5	0.3	1.3	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	1.1	0.0	1.0	0.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.4	0.0	0.3	0.1	0.0	31.7	0.1	0.1	0.2
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.6;salivary gland: 32.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.3;Endometrial ciliated cells: 59.9;NK-cells: 60.8;Plasma cells: 38.2;Respiratory ciliated cells: 75.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 5.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;NK-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.9;HL-60: 131.9;REH: 75.0;U-266/70: 63.2"									"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.1	0.9	1.5	9.1	1.1	25.6	9.9	1.2	0.9	6.2	5.7	5.8	8.5	4.8	2.9	3.5	16.9	6.6	1.8	1.0	1.2	2.6	2.1	6.4	10.5	1.3	1.4	1.1	3.2	14.5	0.5	1.9	1.2	2.1	6.5	0.1	32.5	4.2	0.7	2.3	4.5	4.2	1.0	13.7	11.3	0.6	1.2	10.0	7.9	0.8	11.6	2.5	1.5	1.7	0.2	7.0	13.7	0.1	0.4	1.4	0.2	1.7	0.5	6.7	10.6	0.0	0.1	0.0	38.9	1.3	0.3	11.7	1.4	4.9	7.6	3.9	2.2	37.2	6.5	0.1	0.6	131.9	1.0	0.4	0.6	3.6	0.1	0.0	2.2	0.4	0.1	36.8	0.2	0.1	0.9	28.4	6.8	0.0	0.0	75.0	0.5	3.8	11.6	34.1	0.0	0.0	0.0	6.2	0.3	0.9	9.8	20.9	0.3	0.1	2.0	10.1	0.5	63.2	9.5	0.2	0.2	20.9	1.0	3.7	0.2	4.5	1.2	0.3	1.0	0.9	0.5	0.6	0.2	0.9	0.4	0.3	0.8	5.3	0.1	0.1	0.5	0.4	1.5	1.1	1.2	0.9	1.0	1.2	1.3	1.4	1.2	1.0	1.2	1.7	6.2	0.0	3.7	0.0	7.3	1.0	3.1	4.7	5.7	0.2	14.5	9.1	0.8	27.1	12.5	5.5	0.0	0.8	56.3	2.1	1.9	1.2	0.1	59.9	3.6	3.4	3.0	19.1	0.1	0.4	0.4	1.6	8.2	11.7	3.8	3.8	1.8	0.6	1.6	0.0	0.1	4.5	12.2	1.0	1.7	0.0	0.9	3.2	0.0	2.8	1.8	0.2	60.8	0.0	0.1	1.3	0.6	0.4	38.2	1.0	0.5	1.3	75.4	0.2	0.0	0.4	3.8	0.2	0.6	6.7	1.1	0.0	16.6	3.3	4.2	1.4
SLFN14		ENSG00000236320	"Schlafen family member 14"	P0C7P3	17	35543985-35560819	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"bone marrow: 3.9"	"Group enriched"	"Detected in some"	41	"Erythroid cells: 16.8;Macrophages: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022994, HPA023065"	Uncertain					NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA022994: AB_10670035, HPA023065: AB_2671055"	"unprognostic (4.27e-3)"	"unprognostic (4.72e-4)"		"unprognostic (1.21e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.59e-8)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-3)"	0.0	0.0	0.1	0.3	0.1	3.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	18.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLFN5	MGC19764	ENSG00000166750	"Schlafen family member 5"	Q08AF3	17	35243071-35273655	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 261.6;Respiratory ciliated cells: 133.0;T-cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 24.7;MAIT T-cell: 30.6;memory CD4 T-cell: 30.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 37.5;naive CD8 T-cell: 31.2;NK-cell: 42.3;T-reg: 68.8"	"Group enriched"	"Detected in all"	7	"NK-cells: 42.3;T-cells: 68.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 108.6;hTERT-HME1: 146.8"	"Low region specificity"	"Detected in all"							HPA017760	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA017760: AB_2189993"	"unprognostic (3.43e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.48e-1)"	17.8	8.7	2.7	23.9	2.5	5.4	11.6	2.1	2.5	20.0	3.8	6.4	7.0	14.1	3.4	8.9	14.0	12.1	8.6	2.6	3.5	5.0	5.8	21.1	32.4	6.1	2.2	5.6	3.7	6.7	1.5	14.1	4.9	10.3	7.8	2.3	18.0	15.7	20.7	5.0	8.0	11.5	4.9	25.8	9.9	2.0	3.5	40.9	11.5	10.1	28.2	19.9	5.2	5.7	21.3	10.7	1.7	1.8	30.2	52.2	4.2	54.3	85.4	44.5	49.2	0.2	13.5	2.7	34.1	54.0	11.8	87.1	1.0	24.5	30.9	0.7	1.9	0.4	11.6	1.3	108.6	1.6	0.6	59.9	60.5	34.0	146.8	26.8	20.6	22.0	0.2	31.1	31.4	1.7	26.9	1.3	1.7	4.7	8.0	0.0	17.9	0.2	11.6	51.8	3.6	0.0	6.0	5.6	93.7	6.0	35.9	0.8	81.2	17.6	6.8	12.9	12.5	6.0	0.6	0.4	51.9	0.3	26.0	6.3	4.3	2.9	24.7	6.4	30.6	0.9	30.7	28.9	3.6	1.6	37.5	31.2	1.8	42.3	7.8	1.2	68.8	18.2	2.7	2.5	2.1	2.5	2.6	3.5	6.1	2.2	4.9	4.9	3.5	5.7	126.9	60.9	71.7	1.6	8.4	4.6	27.1	97.8	8.0	1.6	16.5	15.9	10.1	28.6	92.3	18.4	0.0	0.3	75.6	1.8	1.9	71.7	1.9	95.0	23.2	90.4	1.2	3.6	4.1	38.8	5.3	30.3	18.8	56.0	61.3	1.4	79.2	4.7	13.2	6.7	3.6	4.6	46.8	26.5	14.4	0.4	7.5	22.6	12.4	12.2	49.1	6.7	261.6	3.0	10.1	70.0	3.8	1.5	17.6	122.5	1.7	1.9	133.0	4.2	13.1	34.9	29.8	0.5	1.9	10.2	4.0	0.3	128.6	5.4	1.0	74.2
SLIRP	"C14orf156, DC50"	ENSG00000119705	"SRA stem-loop interacting RNA binding protein"	Q9GZT3	14	77708071-77761104	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020291	Approved		Supported	Mitochondria		No	Yes		32000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020291: AB_1845563"	"unprognostic (9.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	121.9	131.0	241.0	80.4	251.7	122.7	155.0	250.5	391.0	92.8	228.9	161.3	112.5	91.5	196.3	163.7	89.6	68.3	336.8	249.8	251.6	203.0	211.2	81.1	82.8	251.4	247.5	82.0	110.5	145.2	120.2	91.9	248.6	95.7	141.3	109.9	105.0	90.3	364.5	92.1	107.6	97.0	248.2	92.9	140.2	122.9	245.9	97.4	94.6	442.3	113.5	123.8	101.8	261.2	422.5	867.3	340.9	330.8	226.0	227.7	441.2	240.0	234.8	484.1	419.6	1187.1	387.1	314.2	238.9	284.7	295.6	415.7	645.4	508.0	647.3	166.5	717.2	316.3	816.1	1199.5	343.4	211.8	216.6	242.5	332.3	387.3	428.2	232.4	408.7	403.2	321.2	172.8	430.0	1442.6	325.3	562.2	525.1	938.0	1211.5	294.8	282.9	345.6	508.8	840.3	425.5	274.1	253.3	533.0	360.3	373.7	555.7	360.9	227.0	237.1	422.5	254.0	416.9	184.8	374.7	605.0	325.7	407.2	309.6	88.9	276.1	103.9	105.2	275.3	112.0	169.4	139.0	104.6	239.8	143.1	143.4	120.3	87.8	93.3	288.8	247.4	154.9	216.2	241.0	251.7	250.5	391.0	249.8	251.6	251.4	247.5	248.6	248.2	245.9	261.2	130.4	109.0	140.0	8.5	112.3	178.8	164.5	542.9	92.8	68.8	168.8	154.3	1099.6	270.2	303.9	264.8	47.9	393.0	82.7	330.9	770.9	405.1	548.5	163.7	141.9	169.0	246.8	203.2	10.8	530.1	382.3	166.0	119.3	123.7	171.5	73.1	179.2	793.4	313.6	43.7	9.6	373.1	388.6	202.8	119.5	123.0	168.0	135.2	250.8	2.8	211.4	206.4	93.7	8.5	16.7	440.6	334.4	170.0	136.9	190.5	563.3	1027.1	254.5	126.8	170.9	178.6	202.7	382.6	210.3	178.5	214.4	240.5	80.6	84.7	404.0	163.8
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20251905-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 256.7;Inhibitory neurons: 544.9;Oligodendrocytes: 157.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.0;BJ hTERT+: 200.8;BJ hTERT+ SV40 Large T+: 97.8;fHDF/TERT166: 117.8;HBF TERT88: 112.0;HEK 293: 88.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"	NA	NA		77000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	8.0	24.9	3.2	3.3	6.4	0.0	9.4	0.0	14.0	24.0	11.7	11.5	2.4	16.4	9.9	5.8	13.1	9.4	7.8	6.6	20.5	12.3	2.0	34.9	1.8	7.9	3.1	4.3	2.8	1.5	8.8	25.2	4.5	12.6	5.4	13.2	6.1	15.7	2.9	3.8	4.8	24.9	0.4	14.2	9.0	1.3	17.6	2.4	9.2	5.1	1.2	13.1	13.9	2.4	0.1	0.0	54.6	0.0	37.8	34.8	1.7	98.0	200.8	97.8	36.9	0.4	0.1	0.0	3.4	117.8	0.2	1.2	15.7	7.9	112.0	0.2	88.3	0.0	0.4	0.0	7.2	0.9	0.0	8.5	0.0	63.6	18.6	2.1	35.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	1.7	0.0	6.3	61.2	0.5	0.0	1.0	0.1	3.5	0.8	0.0	0.2	0.4	1.9	0.2	0.2	2.0	34.9	5.0	35.0	54.2	0.0	0.1	0.0	0.9	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	6.4	0.0	14.0	6.6	20.5	7.9	3.1	4.5	0.4	17.6	2.4	1.6	0.0	9.0	10.1	0.0	8.0	2.0	0.1	0.6	47.6	1.0	0.6	5.2	1.5	1.3	0.0	0.0	1.1	0.0	0.6	1.9	1.7	0.6	6.4	1.9	2.0	1.2	0.0	256.7	0.5	1.2	58.8	0.0	7.1	2.5	1.3	4.2	0.2	1.9	0.0	544.9	0.0	0.0	1.0	9.7	1.7	26.4	0.7	8.8	31.9	0.0	1.3	0.0	43.7	157.9	0.2	0.0	26.7	0.1	3.7	0.0	11.5	7.4	2.1	6.6	3.2	6.4	0.2	1.7	1.2	6.7	2.1	1.1	20.3	0.1	1.9
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882474	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 13.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.3;Excitatory neurons: 18.4;Inhibitory neurons: 14.0;Oligodendrocyte precursor cells: 25.1;Oligodendrocytes: 14.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 3.0;AF22: 1.2;LHCN-M2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074835	Enhanced				"Secreted in brain"	NA	NA		330000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"			"HPA074835: "	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.0	0.1	5.6	0.0	11.0	0.0	0.0	0.0	13.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	2.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	1.1	0.0	1.9	0.0	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	9.6	3.0	0.0	1.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	11.0	0.0	13.2	10.0	2.4	1.2	0.2	0.9	0.0	4.5	9.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	15.3	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.1	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.0;fallopian tube: 9.6;liver: 7.9"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 8.4;Excitatory neurons: 11.0;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HAP1: 2.2;SCLC-21H: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		No	NA		2600000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA017636: AB_1857232, HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.1	0.1	3.4	1.0	3.1	0.0	0.1	4.1	8.4	5.4	0.0	2.6	0.4	7.3	0.9	4.4	9.6	0.2	0.4	9.0	2.8	0.1	7.9	0.3	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.0	0.5	1.7	1.6	3.1	0.2	5.4	0.3	0.0	1.1	3.7	0.9	0.0	0.4	0.4	0.7	0.0	0.1	0.0	0.0	0.5	0.9	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.1	4.1	8.4	9.0	2.8	0.2	0.1	0.5	0.9	0.7	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	15.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	21.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLITRK4	DKFZp547M2010	ENSG00000179542	"SLIT and NTRK like family member 4"	Q8IW52	X	143622790-143636101	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.1;brain: 9.0;skeletal muscle: 8.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.3;Granulosa cells: 33.9;Inhibitory neurons: 48.8;Leydig cells: 49.7;Oligodendrocyte precursor cells: 29.7;Sertoli cells: 26.3"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.6"	"Group enriched"	"Detected in many"	64	"dendritic cells: 3.2;granulocytes: 11.6;monocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.4;HHSteC: 2.7;LHCN-M2: 2.0;T-47d: 8.8;U-2 OS: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000431	Enhanced					NA	NA		420000	"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000431: AB_2665991"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.23e-3)"	4.2	11.1	4.9	0.3	6.5	1.3	2.0	9.0	8.1	5.1	0.0	0.2	0.1	1.2	2.8	0.6	0.4	0.3	2.2	6.9	1.3	3.0	0.0	0.4	0.3	0.0	1.4	3.6	1.0	0.4	0.0	0.4	0.0	1.6	0.3	0.4	1.0	1.3	8.3	1.7	0.2	0.9	0.0	0.1	0.1	1.1	2.8	0.6	0.3	4.7	0.0	0.3	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.7	0.4	0.5	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	4.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.9	4.9	6.5	9.0	8.1	6.9	1.3	0.0	1.4	0.0	0.0	2.8	1.4	0.6	0.0	0.0	3.3	0.0	12.0	0.6	0.0	0.0	3.3	3.2	2.2	1.3	2.8	0.0	3.7	0.0	0.0	0.0	0.1	1.9	0.0	0.5	0.4	2.1	1.1	0.0	0.0	52.3	1.5	0.0	11.0	0.0	1.6	0.0	33.9	0.0	0.0	4.1	0.0	48.8	0.0	0.0	4.3	18.5	2.1	49.7	4.7	21.4	1.0	6.6	0.0	1.0	29.7	2.6	0.7	0.0	16.1	0.0	1.4	0.0	0.9	0.0	0.4	26.3	4.1	4.5	0.4	1.1	0.0	11.6	0.0	1.1	6.4	0.0	0.6
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.9;salivary gland: 3.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 9.7;Excitatory neurons: 20.4;Horizontal cells: 21.9;Inhibitory neurons: 13.3;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HeLa: 3.7;hTERT-RPE1: 3.2;U-138 MG: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013843, HPA073230"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA013843: AB_1857233, HPA073230: "	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.1	1.3	0.0	1.9	0.0	0.1	0.8	2.6	0.1	0.0	0.3	0.0	0.0	0.4	0.1	2.9	0.0	0.1	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.7	0.1	0.7	3.7	1.3	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	1.5	0.0	0.9	0.1	0.1	0.0	0.5	1.1	0.0	0.7	7.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.3	0.9	3.7	0.0	0.4	0.0	0.0	1.5	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.7	0.1	0.1	0.2	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.5	1.7	0.0	2.4	0.0	0.0	0.4	1.1	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.3	1.9	0.8	2.6	1.9	0.6	0.0	0.1	0.0	0.2	1.5	1.1	0.0	0.0	1.1	1.3	0.0	0.1	1.5	0.0	0.0	9.7	0.6	1.7	1.8	1.5	0.0	0.0	4.2	0.0	5.9	0.2	0.0	0.4	0.7	2.1	0.5	1.0	0.0	2.7	20.4	0.0	0.0	1.6	0.0	5.0	1.3	0.5	0.0	0.0	0.0	21.9	13.3	1.9	0.0	0.0	0.0	1.0	5.9	0.5	0.0	1.0	0.1	7.0	0.0	11.1	0.9	0.0	0.1	4.9	0.0	2.5	0.0	0.1	1.5	1.6	0.0	4.6	0.3	5.5	0.2	0.4	0.0	0.0	0.1	0.0	0.2	1.1
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792790-85806683	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.7;urinary bladder: 14.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1;urothelial cancer: 18.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7"	"Region enhanced"	"Detected in many"		"thalamus: 22.6"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		28000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.1	0.2	1.0	0.9	4.4	0.0	3.2	2.2	1.9	1.2	0.1	5.5	3.5	1.0	2.5	1.9	0.5	1.4	1.5	0.2	2.0	0.1	0.9	3.3	0.0	0.6	2.3	0.0	0.2	0.0	0.1	0.9	0.9	7.6	6.8	4.8	27.7	2.2	0.0	5.6	5.7	0.4	0.3	0.1	1.5	0.3	5.7	0.2	0.3	0.1	0.1	14.7	1.4	0.4	0.0	2.9	0.1	0.5	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.9	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	28.8	0.0	3.3	2.7	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	24.2	1.9	0.2	0.0	0.0	0.0	101.4	1.0	1.2	0.5	0.1	0.1	1.7	0.5	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.4	2.2	1.9	0.2	2.0	0.6	2.3	0.9	0.3	5.7	0.4	0.1	0.0	1.8	0.0	0.0	3.8	5.0	22.8	0.0	41.7	5.3	1.5	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	4.3	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	2.7	0.0	2.2	2.2	0.0	0.2	0.0	0.4	1.7	16.2	0.0	0.6	0.0	9.6	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.5	0.0	0.1	41.6	2.0	0.0	0.0	0.8	0.0	0.1	3.8	2.4	0.0	0.2	0.1	0.5	4.5
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967140-104029233	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	20.5	15.1	10.9	15.2	19.9	28.9	21.7	20.9	13.7	19.9	15.3	20.4	13.3	21.3	16.2	56.4	14.1	21.3	22.4	11.7	10.0	20.6	17.8	24.0	11.8	11.5	11.1	24.0	16.7	26.3	9.6	25.8	11.7	17.6	20.8	15.1	21.9	17.7	23.1	26.3	14.7	20.6	10.3	14.9	24.1	15.2	12.3	15.2	22.4	25.1	17.5	30.5	28.6	18.5	50.5	28.9	33.7	24.3	36.6	50.1	14.2	30.6	40.7	22.5	20.9	18.4	53.7	26.6	18.6	31.8	19.1	53.7	18.0	39.5	33.5	21.3	24.7	27.0	23.5	15.6	26.6	32.7	22.4	25.5	49.5	30.9	87.6	31.7	40.9	16.9	34.6	17.9	29.8	18.6	23.0	18.0	8.4	32.4	18.2	22.2	41.4	13.8	29.0	60.3	8.0	13.8	26.6	25.7	25.8	17.2	13.8	23.4	63.4	16.6	16.9	30.6	36.3	21.6	28.0	16.7	24.2	43.1	10.7	0.6	0.5	1.7	1.4	0.5	1.5	0.4	0.8	1.0	0.5	0.6	0.6	1.0	2.7	0.5	0.4	0.9	0.8	0.3	10.9	19.9	20.9	13.7	11.7	10.0	11.5	11.1	11.7	10.3	12.3	18.5	73.5	179.5	129.5	38.5	19.9	57.0	87.1	30.9	26.7	32.2	32.0	35.1	110.4	30.0	100.9	44.1	25.0	37.4	40.1	70.0	3.9	34.0	8.4	43.3	77.1	80.2	18.5	25.5	35.3	54.0	13.6	52.6	44.9	90.3	35.3	54.6	50.7	25.3	19.9	25.2	39.3	37.2	18.3	24.5	36.9	16.6	46.6	37.5	8.8	34.7	43.9	25.7	27.8	34.2	63.9	85.5	81.6	63.2	22.3	67.8	21.9	11.5	57.9	25.4	6.6	68.1	49.3	46.3	35.3	61.4	68.5	52.4	44.2	71.7	37.4	201.0
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57930003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 295.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		9200	"Cluster 49: Eosinophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	25.9	28.1	8.3	35.2	14.7	15.5	21.9	13.4	9.2	25.6	11.3	126.5	34.0	93.5	14.2	116.8	48.6	31.6	134.7	7.5	7.3	24.9	16.4	17.6	16.4	7.8	7.4	37.5	16.1	36.6	11.5	23.5	8.3	65.6	38.2	20.4	20.1	100.3	64.0	21.5	37.7	137.6	6.5	14.9	52.3	31.8	9.2	19.8	28.7	42.0	18.3	87.5	29.0	8.7	43.3	23.1	23.0	25.7	31.8	28.9	24.2	40.8	41.9	27.0	25.5	59.4	54.6	25.1	17.9	30.4	48.4	23.5	38.5	54.5	36.8	32.2	20.6	49.9	31.1	47.6	29.1	47.8	26.5	20.0	39.1	33.6	60.8	38.1	31.8	25.0	39.7	23.7	28.5	11.7	28.0	20.4	29.7	29.3	38.7	12.4	21.0	28.0	47.7	44.3	10.0	12.8	49.9	37.4	23.7	26.7	19.9	27.4	38.1	33.0	23.1	28.2	52.8	28.9	57.1	36.7	25.5	45.4	27.9	3.3	3.8	10.9	3.6	2.7	3.2	3.7	2.8	3.2	3.2	2.5	3.2	3.4	9.5	5.2	2.4	1.4	4.1	3.6	8.3	14.7	13.4	9.2	7.5	7.3	7.8	7.4	8.3	6.5	9.2	8.7	17.3	38.5	39.6	90.1	25.6	92.0	45.4	49.3	54.1	28.0	25.0	23.7	295.9	40.0	40.0	33.1	50.1	19.0	34.4	53.9	19.6	45.8	40.2	45.9	24.6	22.8	14.4	28.6	113.3	34.3	12.2	28.6	41.3	72.4	3.8	34.8	18.2	22.7	15.6	32.0	121.5	26.8	20.3	20.3	25.9	26.2	32.6	27.8	28.4	76.8	25.1	86.8	34.0	101.0	97.7	64.1	36.6	71.8	39.0	93.3	36.4	24.8	46.5	32.4	52.6	26.8	82.2	87.4	47.0	54.5	73.3	16.3	26.1	52.0	28.7	126.9
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 27919.2;salivary gland: 14140.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	79	"neutrophil: 321.8"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 321.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	9600000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	259.4	13.8	4.1	70.8	4.3	353.5	306.7	5.0	22.5	27919.2	28.9	97.8	4.5	107.1	16.5	1372.7	714.2	294.7	68.4	4.5	4.8	382.6	268.0	1181.7	2.0	5.6	5.5	11.5	36.1	5.5	470.2	8.3	5.5	112.6	106.7	0.6	14140.1	2946.3	599.9	272.4	19.9	14.0	4.8	22.5	154.7	28.1	10.4	47.7	30.4	51.5	215.8	226.6	685.3	4.8	4.9	19.4	0.0	0.3	0.2	0.0	1.1	0.1	0.0	0.1	0.0	1.5	318.7	0.9	1719.5	0.2	23.9	132.8	0.0	64.1	0.0	8.6	0.3	0.3	227.1	0.2	326.4	0.5	1.0	8.8	2037.1	0.1	134.0	0.0	0.2	0.0	0.2	0.3	0.0	0.4	0.4	24.4	0.4	767.9	120.1	0.6	0.7	0.1	355.5	14.6	0.3	0.0	622.1	131.4	1.8	0.4	2.8	531.8	0.3	0.4	8.5	1.2	1.1	1.2	9.7	6.1	0.0	33.0	0.5	3.6	0.9	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	321.8	0.0	4.0	0.0	0.0	7.9	4.1	4.3	5.0	22.5	4.5	4.8	5.6	5.5	5.5	4.8	10.4	4.8	6.3	1807.7	4134.5	0.3	5.4	100.7	1330.7	18759.4	2.2	0.0	594.2	607.6	3.9	1609.9	20435.8	3428.2	0.0	2.3	10.1	225.8	0.0	407.5	381.6	632.0	170.7	43.3	200.2	18.7	0.0	258.9	1.2	326.0	193.7	1398.8	77.0	0.0	15.7	508.5	6.8	0.0	0.0	74.7	2616.3	8.5	73.3	69.8	25.4	27.1	39.2	0.0	5.3	0.0	0.0	1.0	0.1	901.6	370.3	0.0	1.3	1289.4	2.7	3.4	8096.4	0.0	0.0	8.6	971.2	1.8	1.8	347.3	138.9	2.1	29.5	0.0	224.5	3338.5
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879050-58933679	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	31.2	21.5	27.3	31.5	30.6	57.7	29.5	35.6	34.6	29.9	26.3	30.0	30.0	27.6	20.8	38.5	27.8	23.8	28.4	25.6	28.6	33.6	34.9	28.2	42.7	28.3	29.1	29.6	24.9	36.1	28.4	21.0	28.6	29.2	32.1	44.9	30.6	24.2	46.1	35.1	33.4	25.8	27.5	38.1	38.9	27.8	28.7	57.3	34.1	43.6	44.1	33.8	31.3	31.3	77.8	84.1	72.0	36.6	48.1	36.2	60.6	55.1	64.3	49.9	48.2	58.4	45.7	144.6	50.5	50.8	54.4	67.9	72.3	62.9	68.7	93.7	46.4	105.4	91.8	44.7	42.0	83.8	78.1	34.1	61.0	52.8	44.1	30.4	46.9	66.0	95.5	81.7	58.2	56.1	84.1	64.6	80.9	46.3	40.5	63.6	65.4	70.1	60.2	99.8	58.9	50.8	57.0	55.1	57.8	79.3	44.0	90.1	48.6	60.2	88.5	66.3	74.6	57.3	123.1	105.5	47.6	101.7	61.5	67.9	30.3	44.4	45.2	29.5	46.1	53.5	36.0	39.3	31.2	47.3	39.2	35.6	42.8	47.0	37.7	53.6	36.5	22.7	27.3	30.6	35.6	34.6	25.6	28.6	28.3	29.1	28.6	27.5	28.7	31.3	92.5	153.8	161.2	61.4	125.8	96.9	100.2	85.6	107.0	116.3	77.3	66.0	107.8	64.3	122.8	106.7	98.0	73.5	155.9	88.4	78.2	98.4	100.8	110.5	99.0	94.7	73.4	115.7	67.7	115.7	160.1	94.3	99.4	119.1	118.9	75.3	63.9	104.1	63.9	119.5	67.3	94.4	59.0	88.6	73.0	120.8	86.3	108.8	78.2	72.1	121.0	84.9	126.7	74.4	141.8	131.1	76.5	88.4	140.0	92.4	57.4	90.6	103.9	145.3	72.3	106.6	95.6	215.1	85.2	100.0	104.6	112.5	134.9	78.0	94.0	125.6
SLU7	9G8	ENSG00000164609	"SLU7 homolog, splicing factor"	O95391	5	160401641-160421711	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035907, HPA058120"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles"	"HPA035907: AB_10671717, HPA058120: AB_2683612"	"unprognostic (3.70e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.01e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	22.1	23.2	26.2	19.5	27.2	48.6	27.4	27.7	46.6	21.1	22.3	20.8	17.0	19.9	25.9	21.9	18.0	18.7	25.8	28.3	26.7	24.4	24.4	23.3	27.3	25.6	27.2	21.3	16.4	24.6	10.9	21.1	26.0	21.2	20.9	29.4	24.7	19.7	32.6	22.6	21.5	18.2	24.6	27.9	23.4	27.2	26.6	30.4	32.2	33.0	31.3	21.5	12.1	28.9	24.5	29.6	26.0	36.2	33.4	35.1	33.1	33.9	49.3	35.9	43.8	40.1	29.1	39.5	34.2	36.6	36.9	27.0	22.9	37.7	45.2	65.1	33.0	29.4	39.0	26.2	33.7	49.8	34.9	38.1	34.3	33.8	38.1	37.7	25.7	35.3	26.7	36.0	33.2	21.5	24.7	32.1	18.6	25.2	26.5	21.4	53.4	40.4	31.6	37.8	30.9	42.7	40.1	35.6	62.2	21.6	47.7	46.4	32.7	34.5	18.2	26.1	36.3	40.1	48.8	34.9	51.2	33.1	33.4	49.9	22.2	39.2	26.7	24.9	25.5	30.0	25.2	27.2	20.2	26.1	27.2	26.7	54.2	33.9	36.5	21.6	29.4	22.8	26.2	27.2	27.7	46.6	28.3	26.7	25.6	27.2	26.0	24.6	26.6	28.9	42.7	67.3	67.8	9.8	53.7	44.7	39.9	55.5	24.5	70.2	25.7	26.3	71.4	24.3	57.1	25.8	25.0	38.1	70.9	34.1	50.9	52.2	126.2	43.0	41.6	44.1	39.5	68.8	19.8	55.8	39.7	43.0	17.9	51.3	46.3	34.7	35.3	24.6	38.4	57.2	18.3	34.7	54.9	47.3	57.3	34.3	47.8	46.9	65.8	20.6	65.8	61.6	64.9	9.0	15.2	50.5	45.3	47.4	33.1	40.0	39.8	39.5	62.0	49.4	46.0	49.6	50.1	88.9	54.6	27.4	41.5	94.1	52.0	41.9	27.8	52.5
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SLX1A	GIYD1	ENSG00000132207	"SLX1 homolog A, structure-specific endonuclease subunit"	Q9BQ83	16	30193875-30197561	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 48.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (3.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"		"unprognostic (1.26e-6)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.86e-1)"	19.8	24.0	15.0	18.1	14.9	31.1	19.2	13.7	23.5	12.2	13.1	29.5	61.5	7.2	6.1	25.8	6.8	8.1	20.7	14.4	14.1	31.0	59.4	16.8	15.3	22.4	15.6	4.1	31.5	6.5	12.9	13.6	16.8	12.0	11.3	5.3	18.2	11.1	26.3	16.8	52.2	6.2	15.0	39.4	31.9	5.5	17.5	4.8	13.4	6.3	15.9	16.3	12.7	19.2	75.9	38.8	33.3	16.3	7.0	10.0	117.1	27.4	34.2	25.3	24.4	7.0	59.4	60.3	62.9	11.9	16.0	48.7	12.8	18.4	9.3	46.3	46.8	40.9	12.1	70.0	21.2	47.6	65.8	10.7	21.4	12.2	12.2	17.4	37.9	36.6	28.9	49.8	15.1	65.3	33.3	106.8	42.5	46.8	42.0	106.8	34.2	159.5	29.6	18.0	29.7	96.0	6.0	145.3	29.5	5.1	21.6	28.2	17.3	36.4	41.4	39.6	25.4	157.6	98.3	42.7	40.8	42.8	29.0	27.7	199.5	219.4	79.3	183.6	56.2	68.1	58.9	65.1	167.1	64.0	29.0	49.7	80.8	73.6	142.6	65.8	112.2	119.3	15.0	14.9	13.7	23.5	14.4	14.1	22.4	15.6	16.8	15.0	17.5	19.2	1.5	0.0	1.1	0.0	1.7	0.6	1.3	1.7	0.0	0.6	0.4	0.3	3.1	1.5	1.3	3.7	0.0	5.9	1.4	4.4	0.0	7.2	0.6	0.3	0.1	1.4	3.6	4.6	0.0	12.0	2.3	0.8	3.1	0.2	0.0	0.3	1.4	2.5	2.8	0.0	0.0	6.3	2.0	6.9	5.5	0.1	0.9	2.1	7.2	0.0	3.3	0.2	1.0	0.0	0.0	10.5	7.8	0.0	0.5	1.0	48.3	3.6	0.5	0.3	0.0	0.2	1.6	0.4	0.5	0.0	2.3	4.1	1.9	0.1	5.0	0.7
SLX1B	"GIYD2, MGC5178"	ENSG00000181625	"SLX1 homolog B, structure-specific endonuclease subunit"	Q9BQ83	16	29454501-29458219	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Erythroid cells: 12.4;Plasma cells: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 59.3"									HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (2.93e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.51e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.44e-1)"	"unprognostic (5.25e-3)"	15.7	8.3	11.1	12.8	12.0	11.8	14.9	12.2	19.9	14.7	10.5	11.6	22.4	15.3	0.5	9.0	14.5	1.4	7.5	11.5	12.4	8.8	30.4	16.4	7.2	11.2	10.7	12.1	7.6	4.4	6.5	5.4	12.7	11.0	3.8	4.4	19.0	2.6	32.5	17.3	21.3	3.6	9.9	15.8	16.2	1.3	11.1	15.8	16.2	3.5	5.9	15.3	11.8	12.2	6.7	10.7	17.2	6.4	2.9	2.3	6.7	4.1	8.5	10.4	6.0	3.9	20.4	4.0	5.9	5.1	7.3	7.1	3.0	7.7	3.4	2.8	2.7	5.4	9.1	22.8	6.4	4.5	10.3	5.2	2.1	12.1	6.9	12.2	1.7	29.3	2.3	25.6	4.0	16.1	13.4	7.0	7.5	19.8	2.6	26.7	0.2	19.2	8.2	9.5	5.8	8.4	1.4	59.3	4.5	4.1	8.3	13.5	11.2	15.9	2.0	7.2	2.9	8.5	17.9	11.1	16.9	6.8	9.1	3.6	18.1	9.2	6.7	22.2	2.6	10.0	6.8	7.5	16.5	7.7	3.4	4.0	13.3	8.4	15.5	3.9	18.2	9.7	11.1	12.0	12.2	19.9	11.5	12.4	11.2	10.7	12.7	9.9	11.1	12.2	0.3	0.0	0.5	0.0	1.7	0.0	0.1	0.0	2.8	0.0	0.3	0.1	14.8	0.0	0.0	0.0	0.0	1.7	0.1	0.5	0.0	0.8	0.1	0.1	0.2	1.7	0.0	12.4	0.0	1.5	0.6	1.6	2.6	0.1	0.0	0.1	0.4	0.5	1.1	0.0	0.0	0.2	0.0	0.9	0.4	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	3.7	0.3	3.6	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.3	0.1	1.4	1.7	0.0	0.6	0.2
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611606	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	1.8	2.1	2.1	2.9	1.9	3.0	1.6	7.1	2.7	2.1	0.4	2.3	2.2	2.1	1.3	2.4	2.0	1.1	1.9	2.3	2.1	1.9	1.9	2.1	4.1	2.3	2.0	1.6	1.7	1.1	3.9	1.1	1.8	2.3	0.9	1.7	1.6	1.0	2.7	1.8	2.8	1.2	1.1	3.4	2.2	10.6	1.9	2.7	1.8	1.3	2.9	2.1	2.0	2.1	2.7	8.4	5.3	6.7	2.0	2.1	5.6	4.3	2.2	4.9	5.4	4.2	3.3	10.0	4.2	2.2	3.8	6.0	3.6	3.0	2.9	8.4	4.6	6.8	6.5	2.7	1.8	6.7	9.3	1.5	2.2	4.6	2.6	1.2	3.6	5.6	6.7	5.3	3.9	4.7	4.2	5.9	4.5	1.7	3.1	8.2	8.9	2.8	1.9	1.9	4.5	4.1	3.8	2.6	1.3	2.8	6.5	5.2	4.3	5.6	7.8	4.9	5.1	4.8	4.0	11.4	1.8	6.7	5.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.9	7.1	2.7	2.3	2.1	2.3	2.0	1.8	1.1	1.9	2.1	2.7	0.0	2.3	4.6	4.5	0.8	0.8	1.1	4.0	8.7	2.0	1.4	1.7	1.5	3.2	0.0	2.1	1.7	3.4	2.0	0.0	1.5	6.5	5.5	4.2	1.8	0.0	6.5	9.5	2.4	1.6	2.4	3.6	4.6	0.0	4.8	1.1	1.4	2.9	0.0	9.3	2.4	2.0	2.9	1.6	2.3	2.1	5.1	0.0	4.7	2.2	2.7	4.1	7.1	5.5	2.0	0.3	1.9	4.0	0.4	2.3	0.6	2.3	10.1	0.0	4.9	2.5	20.0	9.1	2.3	0.6	1.0	4.4	3.0	2.1	0.6
SLX4IP	"C20orf94, dJ1099D15.3"	ENSG00000149346	"SLX4 interacting protein"	Q5VYV7	20	10435305-10636829	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046372	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA046372: AB_2679641"	"unprognostic (4.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.56e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (6.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.55e-2)"	1.5	2.0	3.0	1.7	3.7	1.7	2.1	3.3	3.3	1.8	3.1	2.1	1.8	1.2	4.8	2.7	2.2	1.9	1.4	2.8	3.8	2.7	3.2	1.4	2.2	3.7	3.6	1.6	2.9	3.3	4.7	1.6	3.7	2.3	2.3	5.3	1.9	1.3	4.1	3.7	2.1	1.0	3.4	2.5	2.3	2.4	3.9	2.6	2.7	0.8	2.4	1.7	2.3	4.3	3.3	6.1	3.0	8.2	1.7	2.3	2.5	1.6	1.8	2.5	2.7	4.6	4.1	5.2	2.6	1.9	3.5	6.4	4.6	4.8	4.0	0.0	1.7	4.7	2.1	6.2	2.9	5.1	2.7	3.2	4.1	3.2	6.2	3.3	2.5	4.5	3.9	4.3	3.1	2.8	7.7	7.5	5.5	4.0	2.0	5.5	8.0	4.7	3.7	3.2	5.4	4.1	4.7	7.3	4.9	4.2	8.0	2.6	3.7	2.0	4.2	2.5	1.9	4.5	11.1	6.3	1.5	4.8	3.6	0.3	1.0	0.4	0.7	1.3	1.2	1.1	1.1	0.9	1.2	1.2	1.0	0.9	0.8	1.3	1.7	2.0	1.5	0.5	3.0	3.7	3.3	3.3	2.8	3.8	3.7	3.6	3.7	3.4	3.9	4.3	3.2	6.4	6.4	57.1	6.9	0.6	5.6	5.1	3.4	11.8	6.9	5.0	3.6	8.6	7.6	1.8	16.7	11.3	2.9	7.2	11.7	9.8	2.1	10.5	7.3	5.9	10.2	7.4	33.6	3.9	8.3	4.8	8.2	7.4	8.2	12.3	18.9	6.4	8.1	10.1	40.7	8.1	4.1	6.5	2.3	4.2	5.0	4.7	5.4	53.4	11.0	10.0	11.3	55.3	111.8	3.9	8.4	4.5	5.9	3.7	6.8	10.8	3.3	19.6	0.0	6.3	6.6	8.0	10.6	8.4	1.6	6.6	5.1	8.6	8.1	4.8
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145559176	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 195.9;Endothelial cells: 76.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 46.2;non-classical monocyte: 22.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 46.2;monocytes: 22.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	19.6	5.3	16.7	10.9	21.9	5.8	15.9	15.3	18.2	20.4	6.9	20.4	15.4	29.0	32.7	16.3	24.4	17.1	13.1	13.2	16.6	12.6	20.2	12.3	17.6	14.6	18.3	11.7	13.3	29.1	6.0	11.4	14.5	12.5	20.8	6.5	12.9	17.2	20.7	24.4	15.7	30.4	13.6	14.0	10.6	13.9	16.4	18.3	17.4	17.8	13.7	17.9	8.9	13.6	9.6	12.6	23.5	27.3	8.7	12.8	11.5	13.9	32.6	22.0	16.4	6.2	34.0	9.8	8.0	31.8	9.7	14.1	26.6	30.2	12.8	0.0	13.5	0.0	10.0	13.1	23.2	15.8	2.4	17.6	35.2	11.8	22.9	17.9	110.7	20.7	11.1	0.4	27.0	9.6	24.4	0.3	21.8	15.3	14.6	47.0	21.1	28.5	25.9	17.1	35.3	17.6	18.8	40.3	9.6	14.1	14.0	0.2	32.4	10.5	14.5	11.3	8.6	31.1	0.0	56.1	16.7	0.3	11.1	46.2	3.6	1.5	0.0	9.4	0.0	0.0	0.6	0.0	6.8	0.1	0.3	0.0	0.0	2.4	22.2	0.0	1.3	1.3	16.7	21.9	15.3	18.2	13.2	16.6	14.6	18.3	14.5	13.6	16.4	13.6	62.9	9.6	10.9	54.9	0.1	11.5	17.5	22.0	45.5	6.6	8.6	9.3	3.6	12.8	16.3	14.7	14.6	5.2	0.8	13.2	7.9	12.6	195.9	19.5	12.1	76.3	9.1	8.4	47.7	18.5	2.7	11.5	12.2	24.8	0.0	10.0	10.4	12.0	2.5	10.1	43.2	10.4	28.5	6.5	2.7	80.7	4.4	4.5	1.8	26.2	3.2	5.3	0.0	66.9	22.0	12.0	10.2	5.7	0.3	17.5	6.6	11.5	12.7	5.9	0.0	19.0	10.6	8.3	16.8	19.9	12.6	2.2	1.2	6.9	8.8	17.2
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: AB_2685803"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	48.6	52.6	38.0	38.6	42.4	37.5	46.5	46.2	36.7	43.2	35.6	47.5	36.7	38.6	41.0	55.0	46.8	39.6	53.8	32.9	48.6	43.3	35.6	46.7	44.5	50.2	43.2	52.5	40.4	44.6	20.3	42.7	51.9	36.4	48.7	70.5	36.7	44.8	57.4	34.0	37.4	47.9	47.8	47.5	45.2	51.5	42.4	72.4	75.7	55.5	55.2	53.8	31.1	59.4	81.1	113.7	68.0	66.2	106.1	128.5	77.4	86.1	102.7	87.9	101.8	43.8	75.6	124.8	60.3	110.0	123.0	86.6	77.2	96.1	116.9	136.4	39.3	106.4	164.4	71.9	123.2	149.6	104.1	95.8	121.4	75.5	172.9	102.1	98.6	99.7	50.3	101.6	109.6	52.7	103.4	71.6	33.6	4.4	26.7	74.4	98.9	85.9	197.8	137.2	62.8	73.3	103.7	70.1	85.7	65.8	53.5	97.7	111.4	129.5	74.2	35.6	63.6	99.0	102.7	108.3	89.6	99.9	97.1	58.8	33.6	38.7	23.8	38.5	29.8	16.7	32.3	29.9	32.8	13.9	35.3	27.6	34.1	38.6	33.0	23.3	40.5	31.6	38.0	42.4	46.2	36.7	32.9	48.6	50.2	43.2	51.9	47.8	42.4	59.4	55.0	44.8	36.1	55.8	36.3	54.4	44.1	38.3	54.1	48.0	44.2	30.2	49.2	41.5	45.5	77.3	212.7	48.2	53.0	42.8	39.2	36.5	68.1	58.6	53.0	53.1	51.0	36.4	63.4	43.5	40.3	40.5	44.4	68.1	21.5	80.0	56.4	29.6	43.9	35.3	50.5	46.1	38.7	57.3	41.8	131.9	41.7	48.7	51.6	104.9	63.9	44.8	72.1	96.0	130.0	44.0	31.6	53.4	34.5	66.1	37.9	39.5	41.8	88.1	32.9	53.5	39.6	37.2	39.4	59.2	61.8	69.5	47.4	41.7	42.3	77.2
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195173	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 162.5;Prostatic glandular cells: 149.3;Urothelial cells: 276.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	30.0	6.3	17.9	15.8	22.4	18.8	22.2	6.8	16.1	32.2	31.5	15.4	17.7	20.3	13.6	51.9	23.3	21.2	28.1	16.1	9.3	35.7	19.8	21.4	16.8	17.0	9.0	30.7	18.2	10.5	14.5	16.8	9.3	24.4	12.9	6.2	17.2	13.8	55.0	29.1	21.6	21.1	10.9	15.4	22.2	3.9	12.9	19.6	30.2	39.0	25.7	43.6	31.5	8.5	49.3	157.0	30.6	13.9	50.8	115.9	22.5	27.6	114.0	37.8	30.7	33.7	125.3	16.5	36.6	79.4	169.8	111.3	31.2	116.9	38.1	13.1	11.9	1.8	43.4	26.2	38.2	6.6	2.7	106.5	26.7	33.2	27.7	83.2	128.2	5.2	40.3	40.8	47.1	24.2	1.5	26.0	17.7	26.1	50.5	1.6	9.1	5.9	25.2	149.4	0.8	10.3	36.6	19.5	32.5	59.2	5.3	30.2	109.4	50.4	47.1	36.5	31.7	16.5	5.0	21.0	45.8	7.0	45.9	0.0	1.0	2.3	3.2	0.9	3.3	1.2	3.6	3.4	1.0	2.8	1.6	1.4	0.0	0.3	0.9	1.5	1.9	1.1	17.9	22.4	6.8	16.1	16.1	9.3	17.0	9.0	9.3	10.9	12.9	8.5	18.2	48.1	19.9	28.4	33.9	89.0	90.2	70.6	53.5	10.8	13.3	10.5	12.2	17.2	49.6	36.8	6.2	1.1	19.7	48.2	3.9	61.9	1.0	23.6	30.2	26.6	3.5	9.1	63.2	50.7	4.2	42.6	28.5	75.2	24.1	162.5	11.4	12.6	10.7	0.0	6.9	13.0	24.4	6.2	40.8	5.7	26.8	18.8	21.4	67.5	9.7	8.5	20.6	140.2	1.3	99.7	49.2	20.7	10.6	149.3	34.2	14.0	52.2	0.6	26.3	28.9	27.5	0.6	2.3	70.3	48.9	1.6	21.6	18.8	16.6	276.2
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	16.4	11.8	9.0	10.9	10.3	10.6	17.2	21.7	10.5	18.5	11.2	14.9	11.9	20.6	9.8	15.7	16.3	12.8	14.1	11.7	10.0	16.1	19.1	13.1	12.7	9.0	8.2	24.0	21.4	19.9	11.3	18.9	9.4	21.8	14.3	18.3	14.0	18.0	24.9	14.6	12.1	18.9	8.0	13.9	15.2	14.2	11.9	17.7	21.4	24.9	14.5	13.5	13.1	13.8	16.4	22.5	59.4	16.6	23.9	36.6	31.4	27.7	32.2	39.4	49.6	13.0	3.8	25.9	7.8	25.6	19.6	24.9	33.6	13.2	40.7	19.3	14.8	20.6	20.5	15.9	23.7	34.8	13.1	16.6	21.9	19.1	27.8	37.0	28.7	14.0	21.9	25.8	23.5	9.0	18.8	10.0	31.2	9.1	14.3	23.3	30.6	26.9	18.2	7.4	34.4	20.3	27.0	5.0	18.8	24.8	13.3	19.4	20.0	34.5	13.3	8.8	19.7	30.6	28.6	26.2	21.2	12.8	22.6	0.3	0.6	0.6	1.0	0.4	1.1	0.7	1.0	0.8	1.2	0.9	1.2	1.5	1.0	1.0	0.4	1.0	1.4	0.5	9.0	10.3	21.7	10.5	11.7	10.0	9.0	8.2	9.4	8.0	11.9	13.8	32.5	22.4	29.1	55.2	21.0	25.6	20.9	15.1	18.8	17.1	27.3	20.4	38.8	24.3	19.3	22.0	20.9	20.7	24.0	22.7	11.7	16.9	10.6	30.4	36.6	26.2	39.6	12.4	37.0	12.5	20.6	30.3	28.5	35.2	4.5	132.4	28.5	44.1	15.1	15.2	39.0	32.1	16.2	28.5	20.9	16.2	33.2	21.1	28.4	49.6	16.9	20.4	17.5	41.2	72.5	20.1	21.0	30.5	24.8	36.3	26.7	22.6	22.4	20.0	26.3	32.2	34.2	17.2	18.8	20.9	27.3	12.6	20.1	22.1	24.5	29.7
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 91.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 91.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058931: AB_2683856"	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	18.0	13.7	11.0	10.9	17.4	10.1	17.6	33.9	15.4	18.5	10.4	14.1	12.8	25.7	14.4	16.8	16.5	14.2	15.0	7.9	14.5	15.4	20.4	13.0	11.6	13.1	13.9	29.8	13.3	21.2	7.3	24.9	12.6	17.4	16.8	15.7	13.2	16.4	14.9	27.3	11.8	20.1	13.0	14.9	14.2	11.7	15.1	11.3	17.3	21.6	13.5	14.3	15.5	18.7	36.1	30.0	35.3	31.4	37.3	57.2	37.4	48.2	34.0	32.7	48.3	134.1	25.4	39.1	39.8	38.1	33.5	32.0	42.0	56.0	51.9	16.8	26.6	25.7	32.8	24.4	31.0	15.9	26.9	43.2	32.6	50.8	34.2	32.9	40.2	19.3	25.6	26.1	35.0	14.1	13.2	16.2	21.1	12.5	14.8	27.2	68.2	23.1	18.9	37.2	31.8	33.1	42.3	11.0	41.2	42.3	24.6	19.2	46.3	48.1	30.0	35.5	48.5	29.8	37.9	48.3	31.0	19.9	37.6	91.6	12.8	29.3	14.4	8.4	11.2	14.2	8.4	9.7	13.3	14.8	2.6	8.6	2.1	20.8	10.1	15.5	2.6	5.8	11.0	17.4	33.9	15.4	7.9	14.5	13.1	13.9	12.6	13.0	15.1	18.7	95.8	41.7	32.4	34.3	24.1	46.4	38.6	31.1	79.6	29.2	36.1	46.9	38.3	42.9	36.3	31.3	20.9	19.8	25.8	19.7	23.5	24.5	25.7	32.7	80.9	57.5	99.8	17.2	27.2	26.6	12.1	63.9	41.8	38.5	8.8	62.1	53.9	61.3	14.0	52.2	36.3	36.6	22.4	33.7	21.7	24.1	70.8	21.6	21.4	52.5	20.2	50.1	25.7	45.2	57.1	31.5	21.7	72.6	40.5	48.1	10.3	43.9	32.2	27.7	46.0	87.4	58.2	23.3	23.6	66.4	50.6	11.8	18.2	68.7	30.6	35.9
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48952052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;Distal enterocytes: 56.6;Hepatic stellate cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1;eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	17.9	5.9	7.1	8.6	7.3	17.8	14.5	12.0	7.3	17.4	9.6	12.7	10.3	11.2	2.9	4.8	8.2	10.2	46.1	5.4	5.1	11.6	8.6	21.9	5.8	10.9	8.7	7.5	5.3	12.3	6.6	18.9	8.5	11.3	11.9	3.2	6.3	8.6	10.7	8.3	15.0	9.3	10.0	5.9	12.5	1.3	7.9	3.7	16.6	6.7	5.2	13.3	12.2	8.4	3.7	2.8	2.8	8.3	14.3	5.0	21.1	18.6	7.1	6.5	3.1	1.0	5.3	0.3	32.2	13.1	6.0	19.2	6.1	5.8	3.6	38.4	9.4	0.3	10.5	6.9	2.1	6.9	18.6	5.1	4.8	7.8	7.8	32.2	1.1	0.6	6.6	25.9	9.1	1.2	0.0	1.9	17.3	27.7	1.1	2.1	2.5	9.0	9.1	4.2	4.8	10.3	8.0	3.5	6.6	21.2	3.3	5.6	17.3	18.5	9.9	5.3	16.5	13.4	7.1	2.0	8.1	4.9	3.1	4.1	0.1	5.6	0.8	0.5	0.6	0.1	0.8	0.7	0.1	0.0	0.2	0.5	0.0	1.7	0.1	0.0	1.2	0.2	7.1	7.3	12.0	7.3	5.4	5.1	10.9	8.7	8.5	10.0	7.9	8.4	30.4	54.5	9.4	3.9	7.0	12.9	3.5	7.2	14.2	6.1	14.7	10.3	9.7	1.5	11.2	11.0	6.2	9.9	43.7	56.6	9.8	14.4	0.2	43.2	30.5	25.0	12.7	0.0	6.5	13.9	3.3	15.5	8.2	45.9	18.9	4.0	71.4	3.1	8.9	0.0	5.0	19.1	2.0	23.3	8.9	1.1	1.5	14.7	0.0	19.7	8.2	1.4	11.3	5.5	16.3	31.5	17.3	3.4	13.8	3.0	28.7	7.1	3.3	2.5	6.6	11.3	14.1	0.1	0.6	14.2	11.8	12.9	25.2	1.3	12.4	2.6
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Enteroendocrine cells: 51.6;Glandular and luminal cells: 73.4;Hepatic stellate cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.9;HEK 293: 12.3;SH-SY5Y: 40.2"					"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: AB_2673767"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.47e-2)"	4.0	2.6	10.7	2.8	7.8	0.1	1.6	10.7	6.8	4.8	1.2	5.1	2.3	8.9	9.8	4.2	4.3	7.0	5.6	10.3	16.3	3.2	0.9	4.9	2.2	17.2	10.9	9.2	0.9	2.4	1.9	6.5	16.9	13.9	5.3	7.0	21.0	11.2	3.0	1.5	2.5	6.7	15.5	0.9	3.7	2.3	9.6	0.5	38.7	5.1	2.9	3.3	2.1	21.3	0.0	0.1	0.8	8.6	2.6	1.1	0.3	10.5	1.1	2.7	1.7	0.0	0.2	0.2	7.2	12.9	0.9	0.4	9.3	0.2	2.8	0.3	12.3	0.0	4.4	6.6	2.4	0.8	0.1	4.4	0.8	0.0	0.0	5.7	5.3	1.1	0.1	0.0	6.0	0.6	0.1	0.8	1.2	0.3	1.1	0.2	9.2	0.0	0.0	1.5	7.6	40.2	1.9	0.2	0.5	2.3	0.6	0.4	9.6	4.0	3.5	2.4	2.6	0.1	0.0	0.1	2.8	0.3	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	10.7	7.8	10.7	6.8	10.3	16.3	17.2	10.9	16.9	15.5	9.6	21.3	22.5	28.9	11.5	48.0	0.4	2.8	4.3	1.8	1.8	13.1	2.5	2.2	5.9	2.8	6.9	11.0	4.2	0.2	0.2	3.3	1.9	0.3	0.1	30.3	14.0	26.7	51.6	0.0	18.1	0.2	0.6	11.6	3.6	73.4	0.0	19.7	43.9	0.1	0.1	0.0	33.0	15.6	8.2	2.2	1.9	0.3	18.6	1.1	0.0	31.9	0.0	20.4	0.0	14.1	39.3	0.5	3.4	15.1	0.0	17.2	0.0	7.3	1.6	3.2	0.0	7.2	10.1	1.2	14.1	0.2	1.8	0.3	1.4	0.5	5.7	1.2
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862011	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 325.7;Late spermatids: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	17.0	12.8	24.4	16.1	27.8	18.6	13.6	19.5	44.8	15.2	13.3	27.5	26.8	14.1	18.0	28.4	10.2	17.4	23.1	27.6	24.3	14.1	16.6	14.9	15.4	22.7	25.3	11.1	37.2	28.5	8.6	16.1	23.7	17.6	28.3	24.8	18.0	15.2	32.9	20.4	26.7	19.7	20.1	13.7	20.9	30.9	24.4	24.8	21.1	20.1	22.4	18.1	16.1	29.2	60.3	18.6	28.5	35.3	26.0	33.9	46.4	26.6	29.5	21.4	20.9	27.9	17.4	31.4	28.1	32.0	30.5	18.5	27.4	28.1	35.5	36.3	39.4	34.7	16.5	23.6	17.2	25.5	28.0	22.3	31.3	24.2	29.2	39.6	34.2	16.1	33.8	36.9	33.8	35.0	19.2	31.4	21.3	30.9	21.9	36.0	107.9	51.8	38.1	36.0	40.7	28.7	16.9	23.3	17.1	24.2	31.0	37.3	33.6	17.2	29.7	11.4	23.5	34.3	32.9	16.0	13.0	29.4	24.2	35.0	16.4	18.4	18.2	18.3	20.7	14.8	24.3	21.0	14.0	12.7	12.1	15.7	22.6	25.6	20.0	13.7	25.3	23.4	24.4	27.8	19.5	44.8	27.6	24.3	22.7	25.3	23.7	20.1	24.4	29.2	45.0	38.5	39.4	58.1	39.3	66.9	37.7	66.9	33.0	51.8	39.6	47.2	38.8	52.9	46.0	38.6	37.5	26.2	47.6	111.3	54.8	78.9	325.7	26.1	46.8	43.2	41.9	28.8	120.1	151.0	48.8	40.3	64.7	52.1	48.2	42.9	58.5	41.3	56.6	55.5	104.3	82.3	61.1	61.2	59.8	281.1	50.7	53.0	32.0	60.0	64.1	69.7	64.9	115.6	72.7	108.2	99.5	67.0	51.8	76.3	92.6	69.6	21.1	38.6	65.7	36.3	53.3	105.2	84.2	89.3	77.3	31.7	64.9	44.1	75.8	51.6
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 216.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 338.4;dendritic cells: 258.0;Kupffer cells: 284.4;Macrophages: 256.8;monocytes: 291.7;Plasma cells: 224.4;T-cells: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 177.1;THP-1: 302.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	65.3	24.0	44.2	136.7	50.7	80.9	33.3	35.7	54.3	43.9	33.8	33.5	17.5	17.9	14.1	26.2	30.7	46.3	17.2	52.1	48.2	19.2	73.5	58.4	205.8	41.8	41.1	17.1	23.8	27.4	43.9	38.0	42.9	20.0	32.1	48.5	29.5	19.0	30.0	33.3	99.2	40.1	38.3	216.3	41.8	17.0	48.0	158.3	19.2	21.2	199.5	52.2	19.3	47.2	25.1	9.3	22.0	22.2	31.4	60.0	12.2	38.4	34.7	38.9	37.9	11.7	16.8	93.1	18.4	34.4	16.0	10.2	41.1	29.4	53.3	177.1	34.8	51.7	14.2	25.5	28.1	54.3	153.7	51.7	24.3	50.4	21.6	19.1	22.4	71.6	94.9	95.2	47.0	16.8	79.3	51.2	13.4	24.7	84.7	30.3	20.4	96.3	18.9	28.9	37.1	17.1	18.1	46.1	29.9	16.8	14.8	302.3	12.4	42.8	17.6	40.2	29.9	31.3	37.1	75.9	38.8	53.1	28.2	12.4	87.7	102.0	14.5	153.8	18.2	43.7	23.3	22.1	49.3	58.6	32.4	30.1	195.4	31.6	195.8	9.3	35.5	52.1	44.2	50.7	35.7	54.3	52.1	48.2	41.8	41.1	42.9	38.3	48.0	47.2	12.8	25.6	28.4	10.1	338.4	18.0	11.4	8.5	4.0	34.7	17.5	13.6	15.3	30.0	24.5	7.3	22.9	5.5	258.0	11.0	5.9	12.6	12.7	78.2	15.8	18.7	9.5	66.7	75.7	18.7	9.6	17.1	26.0	25.0	28.4	10.4	38.6	66.3	43.5	26.9	52.4	9.8	12.2	284.4	140.1	19.5	5.3	256.8	28.4	89.9	291.7	15.0	129.8	54.8	33.6	17.1	8.9	4.9	224.4	9.6	10.0	9.1	70.2	25.6	32.9	12.8	27.9	15.9	11.6	12.7	17.8	4.1	199.9	14.6	9.5	14.6
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	19.0	78.6	15.7	9.0	17.8	0.3	20.6	14.0	18.1	27.9	36.0	20.9	6.7	27.2	34.7	11.3	20.1	21.4	24.5	19.9	31.6	23.9	62.1	16.3	4.6	17.0	19.0	72.6	15.8	44.6	34.8	38.0	20.3	36.7	7.0	26.7	18.5	35.4	17.3	8.1	8.4	25.9	17.1	8.9	17.3	57.7	26.7	7.9	45.3	19.8	4.2	30.0	14.0	18.1	23.5	53.5	104.8	67.9	76.3	67.1	36.6	46.8	133.2	68.6	76.7	18.3	80.9	0.0	71.8	88.7	81.1	22.1	66.6	27.5	76.4	0.1	12.9	0.2	46.9	100.0	32.6	0.0	0.1	84.2	7.8	49.0	9.3	104.3	50.4	13.1	12.4	5.7	76.1	0.0	0.6	0.2	42.6	9.0	31.0	0.0	56.7	0.2	67.4	28.3	26.0	69.8	6.6	0.9	12.1	73.1	46.9	0.6	35.7	46.0	23.3	30.3	26.4	0.0	0.0	0.2	40.7	0.0	28.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.5	0.0	0.2	0.0	0.1	15.7	17.8	14.0	18.1	19.9	31.6	17.0	19.0	20.3	17.1	26.7	18.1	23.2	96.1	55.0	24.2	1.5	23.3	35.4	28.3	47.3	26.5	34.8	24.1	80.5	12.8	47.6	40.5	45.9	56.9	1.8	0.1	29.4	30.1	3.7	32.2	80.2	25.6	16.8	3.2	29.3	12.0	15.7	64.3	23.4	42.7	2.5	84.3	22.9	67.0	15.0	92.5	43.4	2.6	14.2	3.2	9.9	18.4	142.9	3.0	28.4	22.5	5.7	47.7	0.0	41.2	17.2	14.0	0.1	125.6	0.1	24.9	0.2	34.9	41.0	13.4	65.7	40.0	49.7	11.4	23.9	17.5	11.8	58.4	2.0	82.9	2.3	29.2
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960932-11079426	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 372.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004208, HPA048340"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nucleoli fibrillar center, Nucleoli rim"	"CAB004208: AB_626762, HPA048340: "	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.8	16.2	14.4	22.6	14.3	31.8	13.0	15.3	23.7	16.1	13.2	18.1	19.9	14.5	9.5	32.9	20.8	13.3	16.2	15.4	9.6	15.7	8.6	17.9	27.0	10.4	10.4	14.9	18.3	22.9	11.1	20.2	11.0	17.7	12.9	19.7	25.9	15.6	23.7	28.1	17.2	14.5	3.9	19.5	20.4	30.2	11.8	43.1	20.6	13.9	23.7	17.4	14.7	19.3	92.5	5.0	157.2	149.8	30.3	25.4	68.9	62.7	37.2	74.6	54.9	126.9	4.0	215.4	94.2	54.9	3.0	65.9	123.6	77.5	40.8	89.5	93.3	171.3	76.5	149.6	45.7	125.5	82.0	43.1	36.7	63.1	64.5	33.3	67.5	92.0	156.7	78.3	59.2	188.0	210.0	107.5	159.9	45.1	134.7	220.6	99.5	111.7	47.9	114.8	177.8	161.7	66.6	84.4	73.5	50.1	71.9	93.3	90.9	110.3	57.3	102.5	104.9	160.6	192.2	209.1	62.6	118.5	96.0	5.7	5.8	6.4	9.3	6.9	8.2	5.3	6.8	7.9	6.1	6.8	7.6	7.5	3.4	8.5	10.8	7.9	6.4	4.7	14.4	14.3	15.3	23.7	15.4	9.6	10.4	10.4	11.0	3.9	11.8	19.3	25.4	67.3	72.6	27.4	28.5	37.0	43.7	43.8	24.5	91.3	42.2	28.4	372.9	40.0	62.7	44.1	70.9	65.9	21.2	60.1	41.1	79.8	53.0	58.8	49.2	58.3	63.2	41.8	32.2	61.4	57.3	43.8	50.0	63.5	30.4	75.3	28.5	21.9	42.3	101.0	39.6	47.7	57.0	23.8	21.5	37.6	26.1	30.4	16.0	14.0	43.8	36.1	23.7	32.6	28.1	76.4	41.8	13.5	37.6	66.0	29.8	27.6	62.5	69.1	13.1	45.1	66.4	99.4	86.0	52.2	51.7	61.0	30.4	68.1	60.5	50.1
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMARCAL1	"HARP, HHARP"	ENSG00000138375	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1"	Q9NZC9	2	216412414-216483053	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020337	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA020337: AB_2670410"	"unprognostic (4.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.35e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	9.2	9.8	7.5	8.9	10.3	9.1	8.8	8.0	9.7	10.6	7.6	8.0	6.8	10.7	7.5	9.8	11.0	9.5	8.9	8.0	9.0	7.2	6.7	7.9	13.1	10.6	9.1	16.3	8.2	10.8	9.3	9.1	10.6	8.1	7.4	5.6	8.0	8.9	10.5	10.6	7.9	10.1	8.4	9.7	8.0	10.3	10.2	15.1	10.2	10.6	11.9	8.8	9.0	14.2	16.7	16.3	22.2	12.7	21.5	25.1	21.3	22.0	22.7	23.0	26.1	26.7	20.3	15.0	21.8	27.6	28.8	12.3	19.1	24.4	30.5	45.7	18.9	42.8	12.0	19.9	22.0	11.5	23.9	16.7	25.7	24.9	24.4	24.0	27.6	23.5	42.6	15.8	26.3	12.3	22.2	26.8	16.1	14.7	8.9	24.6	14.6	9.3	18.2	11.4	18.4	11.9	12.0	9.1	18.7	38.2	12.4	18.1	21.3	28.3	13.0	13.7	13.9	18.0	18.6	13.3	28.8	15.6	20.2	25.9	9.5	14.1	12.2	10.5	11.6	9.6	11.5	14.3	14.9	9.2	9.6	11.8	1.7	21.0	18.1	18.0	14.7	8.5	7.5	10.3	8.0	9.7	8.0	9.0	10.6	9.1	10.6	8.4	10.2	14.2	6.3	6.4	6.1	20.2	8.2	0.9	3.3	4.6	8.6	5.1	4.3	3.4	5.0	7.2	3.7	0.0	0.0	10.4	6.7	3.4	5.9	7.4	14.5	10.4	7.2	7.0	3.6	11.4	20.6	3.8	12.2	8.0	5.6	5.8	17.7	11.0	4.2	3.2	9.7	8.4	30.8	3.7	2.0	8.9	3.1	13.7	6.2	6.2	1.8	12.2	10.1	4.7	10.3	24.6	35.9	4.0	13.3	8.6	7.0	1.3	4.7	5.8	4.4	4.8	13.1	6.0	6.8	7.7	4.4	5.3	1.3	7.3	6.5	7.5	5.3	2.0
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838009	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	35.9	46.4	2.3	6.9	2.5	3.3	40.3	4.1	10.0	51.5	2.7	40.9	8.1	51.4	0.4	51.0	40.4	2.2	44.0	2.3	2.3	47.0	36.9	32.3	5.8	4.3	2.7	63.1	43.9	1.2	48.0	1.2	2.7	36.6	1.1	25.3	44.1	0.6	48.1	50.1	51.7	0.6	2.2	51.7	40.4	68.3	2.3	3.5	41.3	1.8	1.5	37.5	40.9	2.9	2.4	1.6	28.2	2.6	2.7	0.7	5.8	9.2	2.7	2.7	4.3	3.4	2.6	24.2	7.9	1.2	2.9	4.4	6.9	4.6	4.5	4.1	10.5	20.1	3.2	2.1	3.0	21.7	5.6	1.6	3.4	3.2	6.9	1.4	1.4	3.0	5.6	12.9	1.7	6.1	17.6	5.0	8.6	7.2	5.7	11.0	23.1	10.8	2.3	4.5	13.4	10.1	2.2	0.6	17.9	14.8	2.2	3.3	2.2	2.4	9.8	3.8	2.7	13.8	14.3	17.7	1.8	11.3	6.8	7.1	12.8	6.4	4.4	13.4	6.4	24.4	5.5	5.7	12.0	9.2	4.5	3.0	1.1	9.8	16.8	13.3	10.4	8.1	2.3	2.5	4.1	10.0	2.3	2.3	4.3	2.7	2.7	2.2	2.3	2.9	33.6	6.4	8.6	17.0	120.2	50.2	73.3	85.1	51.2	55.4	42.9	49.1	6.1	47.1	37.4	47.8	20.9	120.6	61.8	36.6	84.1	94.6	42.6	40.9	54.9	37.4	71.8	57.8	14.1	77.1	228.1	46.2	41.8	41.1	34.8	112.2	41.0	20.3	76.1	67.3	18.4	54.6	99.7	23.0	41.7	18.9	35.8	36.5	56.9	15.9	51.2	92.4	45.3	17.1	18.1	74.7	53.1	32.0	139.6	74.4	41.9	86.4	28.5	49.6	19.7	47.7	62.8	138.9	163.3	64.5	53.0	160.1	42.0	96.8	65.4	65.1
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMARCC2	"BAF170, CRACC2, Rsc8"	ENSG00000139613	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2"	Q8TAQ2	12	56162359-56189567	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004321, HPA021213, HPA061788"	Supported		Enhanced	Nucleoplasm		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	36.6	33.5	48.1	23.8	52.1	23.5	38.5	48.7	56.3	43.8	19.9	39.3	27.7	42.9	22.8	30.5	40.8	23.3	26.4	49.6	50.9	31.6	19.8	29.7	29.5	44.2	43.8	51.9	32.6	35.5	32.4	25.3	40.2	34.8	23.4	39.2	37.2	33.5	46.7	36.5	34.5	28.4	40.2	31.9	33.0	32.8	49.1	39.0	49.8	30.5	28.7	39.1	37.4	51.6	49.3	74.9	77.2	56.4	47.2	48.9	32.4	42.6	45.3	50.3	48.4	43.5	59.5	71.4	40.0	50.0	47.7	54.8	49.9	42.9	45.1	54.3	47.6	112.2	51.6	27.8	25.6	53.4	79.8	46.4	31.5	47.6	23.7	91.3	65.4	54.7	65.5	57.2	48.1	52.1	90.4	56.0	26.4	39.0	50.4	53.5	62.0	55.0	38.6	63.4	56.6	59.0	72.8	49.4	20.6	40.3	84.3	49.3	56.1	42.5	51.7	38.4	31.8	54.8	41.9	48.4	44.3	35.5	46.9	15.4	8.5	21.0	11.4	10.2	12.3	8.6	8.2	8.6	7.3	9.4	6.0	7.6	7.9	8.3	13.9	6.0	8.6	11.6	48.1	52.1	48.7	56.3	49.6	50.9	44.2	43.8	40.2	40.2	49.1	51.6	40.8	67.3	43.5	40.1	40.9	20.5	43.2	24.5	62.6	59.3	26.6	28.8	25.7	34.3	40.6	42.3	39.6	20.4	39.0	17.9	7.9	25.4	1.6	24.3	42.8	38.5	22.7	51.9	39.5	18.0	11.9	40.2	33.6	36.3	65.1	56.3	33.9	17.3	16.6	38.7	37.5	22.3	32.6	20.6	20.7	7.8	69.0	29.3	19.6	23.4	36.0	42.3	70.0	33.2	23.4	22.7	17.1	55.3	44.6	32.2	19.8	17.3	25.0	66.0	19.7	47.9	42.3	45.5	31.7	55.9	22.6	13.3	49.9	36.6	21.4	37.7
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50085200-50100707	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	25.8	28.1	25.2	23.2	27.6	44.0	24.9	24.4	27.0	23.5	20.8	22.0	23.2	27.9	27.1	27.5	23.8	17.9	18.3	26.3	23.8	25.3	19.0	23.9	35.0	25.7	25.7	26.4	22.5	47.3	19.7	28.9	25.3	23.2	27.2	25.1	24.3	21.8	16.9	24.3	27.8	28.8	24.8	31.3	20.5	23.8	25.8	57.2	26.8	16.1	47.6	23.5	21.7	27.6	28.4	47.6	134.8	75.8	41.1	38.9	68.1	35.1	62.0	100.3	58.2	130.0	42.1	109.4	51.0	67.2	44.4	35.4	112.9	91.5	87.3	84.4	87.0	107.2	49.4	75.8	49.3	95.0	41.1	40.2	60.2	59.8	107.4	66.1	119.5	114.0	93.1	64.8	50.6	67.7	137.6	54.0	166.0	43.2	76.6	165.5	34.9	96.0	57.3	66.1	71.4	121.3	73.1	35.2	139.3	100.4	79.4	78.7	70.4	50.1	56.0	31.7	69.9	91.6	88.2	95.4	40.6	37.7	56.9	3.4	1.2	2.2	2.9	1.2	2.9	3.6	1.6	2.0	1.8	2.7	1.0	3.3	0.5	1.7	1.9	3.5	2.7	1.2	25.2	27.6	24.4	27.0	26.3	23.8	25.7	25.7	25.3	24.8	25.8	27.6	29.7	0.0	9.6	11.1	42.9	16.6	22.3	17.7	42.7	33.7	33.2	30.2	6.5	15.7	20.5	27.6	20.9	21.1	39.6	21.6	52.8	32.8	4.3	20.0	36.9	30.1	31.1	25.7	9.3	29.0	19.4	17.8	14.8	30.5	16.5	40.0	17.5	15.1	17.3	26.9	10.5	18.2	10.2	14.4	13.1	9.1	16.4	16.8	17.8	7.5	27.1	26.5	29.9	11.1	17.1	36.8	14.8	16.1	28.9	28.8	19.5	47.9	9.4	28.8	32.9	31.6	28.2	28.4	36.5	31.3	19.6	11.1	30.0	26.8	19.1	15.9
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA		33000	"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	16.6	11.8	8.7	28.4	11.7	30.3	17.2	15.0	9.5	13.8	9.6	20.0	18.6	21.0	8.0	17.1	16.7	11.5	15.6	7.8	9.5	16.3	18.8	16.0	34.4	10.2	10.7	19.1	14.4	25.8	6.3	18.2	10.7	14.0	18.4	21.0	15.1	13.0	17.9	18.1	15.9	22.9	8.7	20.1	15.7	7.8	11.3	58.1	16.8	18.8	29.9	15.5	12.4	13.9	110.0	115.1	92.4	76.1	32.4	35.4	51.5	68.0	37.0	76.4	59.4	71.6	60.5	115.8	54.1	40.7	105.2	78.9	162.9	92.6	85.1	91.7	176.0	94.3	133.9	51.1	15.4	134.9	120.9	20.6	23.3	86.0	52.8	19.4	67.5	68.7	144.7	64.7	58.6	69.2	122.0	40.8	139.9	47.8	55.6	117.2	165.5	100.1	34.4	69.4	92.8	83.5	176.9	84.4	33.5	122.8	87.9	54.0	45.7	63.3	68.0	65.1	62.2	45.8	77.9	91.9	39.1	152.1	64.1	2.7	6.8	4.5	7.3	8.5	7.6	5.4	5.8	6.7	8.4	5.8	5.2	6.3	2.7	4.6	12.4	4.6	5.7	6.7	8.7	11.7	15.0	9.5	7.8	9.5	10.2	10.7	10.7	8.7	11.3	13.9	40.7	44.8	39.9	16.0	45.6	24.1	37.0	27.7	28.5	46.6	30.7	27.4	63.5	27.1	47.4	20.2	27.1	43.2	57.7	49.6	7.9	31.6	10.5	46.5	62.6	41.7	19.9	70.7	12.0	27.1	61.4	37.2	29.0	44.0	35.4	42.7	18.9	54.1	47.6	60.6	14.2	43.5	22.4	41.1	27.6	7.6	37.9	51.5	23.2	24.4	55.2	38.1	59.8	16.6	30.2	33.1	23.6	36.1	61.2	40.7	29.0	24.6	47.1	48.4	39.5	49.5	71.0	54.5	51.2	39.8	24.4	48.4	47.9	34.0	51.4	32.0
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	98	"testis: 31.1"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 897.6;Spermatogonia: 448.5"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	18.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	75.6	0.5	0.2	0.8	0.0	0.0	1.4	0.0	0.9	0.3	0.0	0.2	0.0	0.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	36.9	5.6	0.5	0.0	1.0	0.0	0.3	0.0	1.0	1.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	1.0	98.6	0.4	0.2	897.6	448.5	0.0	0.0	0.8	0.1	0.0	0.0	0.2
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567695-110606048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 994.2;Spermatogonia: 799.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043206	Approved		Supported	Nucleoplasm		NA	NA		630000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA043206: AB_2678362"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	19.5	13.3	9.0	18.7	10.9	43.9	19.1	18.5	11.7	18.5	11.7	18.3	15.5	20.3	15.7	19.2	16.5	11.1	12.9	8.6	10.2	14.0	15.3	14.5	25.2	10.2	9.4	25.7	19.6	20.0	14.2	20.7	10.4	14.0	16.7	27.6	16.2	15.2	21.1	20.6	19.4	16.9	9.6	18.6	14.7	38.1	9.5	39.2	16.5	14.1	24.3	15.5	17.8	12.7	73.1	44.5	95.4	67.8	30.7	26.3	40.9	57.7	56.7	51.9	50.7	56.4	59.7	94.2	24.5	38.6	40.0	56.5	68.7	35.0	78.6	77.3	60.1	76.5	56.2	51.2	30.8	109.8	56.6	21.1	28.0	57.4	89.5	48.5	38.8	31.7	61.7	70.4	45.4	38.1	85.2	58.3	66.1	38.6	35.1	71.1	171.5	51.4	32.4	31.7	53.7	61.8	62.0	17.7	48.6	61.8	28.5	53.1	40.1	41.6	65.5	47.6	84.4	40.9	38.8	99.6	37.5	103.9	34.8	20.7	6.1	15.8	9.6	8.4	12.1	11.0	11.3	10.6	6.8	11.0	11.3	11.2	6.5	12.6	7.6	8.7	14.5	6.2	9.0	10.9	18.5	11.7	8.6	10.2	10.2	9.4	10.4	9.6	9.5	12.7	74.9	80.1	62.0	16.6	73.5	60.5	53.2	64.1	34.7	81.3	44.3	49.9	64.5	47.1	64.4	55.2	75.0	119.6	94.3	29.8	25.4	96.9	56.9	52.0	65.0	74.9	40.7	104.6	26.2	45.6	111.4	66.0	20.9	49.0	56.3	124.9	40.4	31.9	59.1	60.6	29.2	40.7	54.9	37.9	42.5	34.6	115.2	49.8	37.4	19.7	96.1	54.9	98.9	33.2	43.4	53.0	70.1	114.0	65.0	44.7	70.7	30.3	68.3	78.9	184.1	102.0	110.6	994.2	799.1	48.1	64.5	49.1	80.9	112.7	51.9	37.5
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434954	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 74.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes		25000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	6.8	6.5	1.0	21.2	2.0	36.3	6.8	1.2	1.7	6.3	1.5	13.2	14.0	7.4	2.3	23.5	4.5	7.6	7.3	0.9	1.9	5.9	7.8	11.8	37.1	1.7	1.4	5.9	7.8	3.8	2.0	16.2	1.6	5.8	14.9	7.7	4.6	5.0	3.6	11.0	15.4	10.1	1.3	14.7	11.8	32.5	1.9	60.6	9.0	6.8	31.6	9.6	4.3	3.2	386.3	72.8	155.0	73.0	31.5	30.9	72.1	181.2	88.8	206.0	176.8	94.4	209.7	236.6	101.9	81.1	140.0	212.5	183.0	95.0	332.4	297.9	113.8	234.7	123.3	33.6	17.3	158.3	182.6	14.6	13.3	114.4	96.5	78.5	94.8	103.2	130.3	272.2	133.9	78.3	183.2	44.4	91.8	106.7	149.3	180.1	238.8	177.3	43.4	54.8	93.7	94.0	141.4	135.1	65.5	76.6	156.9	128.6	84.8	132.2	105.2	119.9	349.8	181.1	192.2	412.0	96.7	166.9	151.9	74.4	6.0	23.6	11.5	8.9	11.4	17.2	18.2	14.3	6.6	15.0	11.4	10.2	10.8	15.3	15.9	11.7	30.3	9.5	1.0	2.0	1.2	1.7	0.9	1.9	1.7	1.4	1.6	1.3	1.9	3.2	24.6	105.8	174.0	3.9	43.7	40.8	18.2	33.1	30.7	14.9	21.5	21.0	41.3	25.8	35.0	35.0	8.4	74.6	54.4	41.4	3.9	20.9	48.6	35.2	27.0	44.8	30.1	305.8	3.5	14.7	138.1	50.7	32.6	36.1	79.1	77.3	38.2	20.4	61.3	0.0	2.9	44.5	24.4	29.7	43.5	28.3	25.1	36.4	17.8	17.8	39.3	9.3	46.4	3.5	30.1	13.5	26.5	48.2	95.9	14.1	25.9	8.6	25.4	25.8	131.5	21.7	73.2	339.8	239.4	58.1	35.7	34.1	58.4	34.6	69.7	19.1
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258978-70354873	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054900	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA054900: AB_2682634"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	10.2	7.7	4.3	15.0	4.8	26.0	16.6	10.4	5.0	12.2	9.0	15.0	13.5	15.2	12.8	10.8	12.3	12.9	9.9	4.2	6.1	8.0	14.8	12.8	18.5	5.2	5.7	25.2	19.4	10.4	9.6	14.8	5.7	11.4	16.9	8.3	17.1	8.7	13.8	9.0	13.9	10.7	4.2	12.0	14.5	13.5	4.9	18.2	14.3	8.2	16.1	16.4	11.3	7.8	43.9	10.8	26.6	16.2	15.1	28.3	20.9	29.8	25.8	15.9	17.3	4.1	23.3	43.7	9.5	22.5	13.9	39.3	28.9	19.8	31.7	19.9	10.3	25.5	18.3	13.1	19.2	41.8	25.3	19.9	13.5	21.5	24.5	25.4	16.9	25.8	19.1	17.1	29.9	6.7	55.4	14.7	20.4	33.5	14.9	32.4	43.6	13.7	16.1	21.3	18.9	14.2	29.5	18.7	8.3	19.2	11.2	17.6	18.6	21.3	22.4	29.2	41.2	20.9	29.9	29.9	17.9	21.6	25.9	14.1	5.6	10.4	8.5	6.3	8.0	8.4	7.3	8.1	4.6	8.2	8.0	7.4	3.7	8.1	7.6	8.7	8.4	4.0	4.3	4.8	10.4	5.0	4.2	6.1	5.2	5.7	5.7	4.2	4.9	7.8	48.9	57.7	70.3	61.7	54.6	45.6	102.0	30.3	59.7	26.8	39.2	34.0	34.6	41.5	62.0	20.2	29.2	32.1	65.2	38.8	9.8	61.3	47.9	65.3	58.9	37.6	28.1	29.0	72.2	54.8	37.5	62.1	40.8	89.1	51.8	52.5	16.1	25.9	16.4	38.7	66.4	34.8	20.3	22.9	30.8	15.9	53.4	37.9	24.9	74.0	65.4	17.2	54.6	85.5	94.6	68.3	37.9	59.5	40.6	105.5	23.6	11.7	51.0	35.7	26.3	66.2	52.2	80.0	55.0	52.5	41.9	35.6	56.7	58.4	45.0	105.8
SMC6	"FLJ22116, SMC6L1"	ENSG00000163029	"Structural maintenance of chromosomes 6"	Q96SB8	2	17663812-17800242	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.4;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035057, CAB037186, HPA042733"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.94e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.25e-2)"	8.4	5.2	6.8	14.7	7.6	13.3	8.5	11.4	7.7	9.5	31.9	11.9	9.0	9.4	17.4	13.2	8.7	9.4	8.6	8.0	8.4	8.9	17.2	9.0	21.6	6.2	6.9	6.9	6.1	6.0	11.6	14.2	7.4	6.7	13.3	6.8	12.4	10.8	9.4	14.7	11.4	8.7	5.3	14.9	9.8	35.2	8.4	14.3	7.7	8.8	22.6	8.6	11.4	10.6	50.6	24.8	31.9	26.6	33.6	32.2	32.2	26.4	18.6	16.7	16.2	27.9	19.4	43.9	16.6	24.2	27.9	34.4	38.5	31.0	25.7	52.3	25.2	60.3	16.2	42.1	31.3	42.3	31.2	24.3	21.4	27.0	35.1	20.5	38.9	26.4	67.5	35.4	31.9	20.8	32.8	21.7	43.3	25.3	19.7	38.7	90.0	29.9	16.2	27.7	28.0	29.9	38.4	20.0	30.0	35.1	12.7	18.7	42.7	41.3	16.5	32.5	47.2	25.0	43.5	87.9	21.0	45.7	30.0	2.2	3.8	8.2	7.8	4.2	6.6	24.8	6.0	7.1	5.1	26.4	4.3	6.0	3.1	7.5	6.7	27.7	14.4	4.1	6.8	7.6	11.4	7.7	8.0	8.4	6.2	6.9	7.4	5.3	8.4	10.6	25.6	48.1	12.5	34.9	63.7	18.2	21.6	41.5	68.3	15.2	8.4	9.3	36.5	14.3	30.8	5.5	12.5	15.2	51.5	18.9	11.7	17.0	153.4	33.0	26.3	21.9	11.3	36.6	51.1	11.7	27.5	21.0	32.1	18.2	20.8	38.6	15.7	19.3	17.6	6.7	47.9	15.7	16.2	10.0	9.1	123.7	22.4	20.1	26.6	30.0	22.0	12.5	25.7	56.3	60.5	19.7	17.2	27.4	25.3	25.1	16.0	14.5	27.2	17.4	46.0	41.2	67.8	150.0	87.9	37.4	14.2	12.4	22.2	28.9	21.2	14.9
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655726-2805017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 363.7;Plasma cells: 391.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 58.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	13.6	6.9	5.4	24.6	6.6	41.1	12.4	11.4	8.3	16.5	6.8	14.4	13.7	14.9	9.2	8.7	14.1	12.4	10.1	5.0	6.6	6.5	8.4	19.0	33.9	7.2	6.1	15.4	16.3	11.9	7.9	16.3	7.4	13.4	14.7	16.3	10.1	11.2	11.0	9.1	20.3	12.8	6.4	28.6	12.4	14.1	6.3	25.6	9.6	11.5	22.4	15.0	14.2	8.7	24.1	10.7	35.8	22.6	15.0	21.8	25.7	23.7	16.8	22.0	27.7	20.3	7.7	51.6	10.2	21.2	24.7	13.0	29.1	13.6	34.4	10.7	15.1	32.3	21.7	19.5	16.8	93.9	24.3	14.4	12.2	27.9	22.8	16.8	18.3	25.5	38.3	31.1	21.3	8.6	39.4	23.9	14.4	13.0	12.4	31.7	29.1	22.9	13.6	36.5	29.2	18.4	32.0	10.6	18.8	19.8	7.9	39.3	17.5	27.1	37.4	37.1	44.0	18.8	30.4	46.5	17.4	17.1	24.0	5.1	2.5	6.6	3.6	1.7	2.6	5.8	4.8	4.3	0.9	7.5	5.9	3.8	58.7	2.3	2.3	2.6	5.4	1.3	5.4	6.6	11.4	8.3	5.0	6.6	7.2	6.1	7.4	6.4	6.3	8.7	96.5	44.8	44.7	71.5	363.7	27.1	35.3	14.5	48.9	112.1	33.3	32.8	53.0	15.7	27.7	18.4	100.1	36.5	232.7	102.7	5.9	23.4	117.2	43.6	83.3	53.0	22.7	69.0	98.4	19.4	22.3	52.8	68.3	75.9	40.4	54.2	30.7	16.4	19.4	99.3	127.2	35.5	10.2	65.4	69.7	38.6	42.0	116.3	30.2	121.8	142.5	32.3	120.5	111.1	130.4	23.6	60.1	38.0	391.1	52.0	46.5	6.1	22.5	88.5	39.5	59.7	69.8	166.7	115.3	41.3	24.9	46.9	257.9	45.9	30.4	57.8
SMCO2	"C12orf70, LOC341346"	ENSG00000165935	"Single-pass membrane protein with coiled-coil domains 2"	A6NFE2	12	27466810-27502185	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.8;Excitatory neurons: 9.4;Inhibitory neurons: 3.7;Late spermatids: 5.7;Prostatic glandular cells: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HDLM-2: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014366	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA014366: AB_1845544"	"unprognostic (2.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.86e-3)"	"unprognostic (5.44e-3)"	"unprognostic (2.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-1)"	0.1	0.1	0.9	0.4	0.9	0.0	0.1	0.6	1.1	0.1	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.8	0.7	0.0	0.2	0.1	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.3	0.9	1.5	0.1	0.0	0.0	0.4	0.2	0.2	1.0	0.9	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.6	0.0	1.4	0.0	0.3	0.0	0.5	0.2	0.1	0.2	0.4	2.2	0.0	0.0	0.5	0.0	0.0	0.8	0.1	0.4	0.2	0.3	1.2	0.3	0.7	0.3	0.0	0.6	0.0	0.1	0.3	0.9	0.3	0.6	0.7	0.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.3	0.7	1.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.6	1.1	0.8	0.7	0.7	1.3	0.7	0.5	1.5	1.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.4	0.0	0.0	0.1	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	14.8	0.2	0.0	0.2	0.0	0.0	9.4	0.8	0.1	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	1.1	5.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.4	0.0	4.4	0.2	0.4	0.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.3
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.4;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"spinal cord: 3.6"	"HPA040574, HPA047804"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	0.5	0.4	0.0	0.1	0.2	0.3	0.2	0.1	0.1	3.4	0.3	0.2	0.0	0.3	0.1	0.0	0.3	1.8	0.9	0.1	0.2	3.0	1.5	1.1	0.5	0.1	0.2	0.2	0.2	0.5	0.2	1.1	0.1	0.8	0.1	1.3	0.1	1.6	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	1.9	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.5	2.8	0.0	1.8	0.0	0.1	0.0	0.0	5.9	0.2	0.0	0.0	0.2	0.3	0.0	2.7	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
SMCO4	"C11orf75, FN5"	ENSG00000166002	"Single-pass membrane protein with coiled-coil domains 4"	Q9NRQ5	11	93478472-93543391	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 195.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Paneth cells: 165.3;Proximal enterocytes: 200.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 113.7"	"Low region specificity"	"Detected in all"							HPA041120	Uncertain					NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA041120: AB_2677309"	"unprognostic (7.45e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.51e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (5.81e-7)"	"unprognostic (1.61e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.01e-2)"	21.0	70.4	8.9	30.6	8.2	7.3	23.0	8.2	12.6	17.0	17.3	35.3	45.9	18.9	13.9	23.1	27.9	16.8	53.5	10.2	22.9	66.3	135.1	35.8	31.4	11.9	14.7	25.3	60.0	5.8	48.0	11.4	11.2	55.2	25.7	3.4	195.8	11.5	17.0	24.3	37.6	15.2	11.1	61.8	50.1	43.4	32.4	17.5	71.7	5.9	22.9	12.4	22.8	12.8	8.3	15.3	23.9	5.5	8.0	10.6	15.4	25.2	7.5	10.8	19.9	26.6	33.0	24.6	29.0	22.1	16.8	5.0	24.1	3.5	7.3	68.6	22.2	5.9	32.4	58.0	7.4	24.4	26.1	15.0	13.2	5.0	3.8	13.6	16.7	81.5	13.8	113.7	3.3	13.9	24.4	50.2	25.0	62.6	23.9	42.8	12.0	11.2	21.5	19.8	4.2	18.5	19.6	26.3	2.1	30.2	10.4	33.7	10.9	9.7	40.6	33.4	20.8	4.6	0.7	19.7	7.6	40.9	4.9	40.2	263.5	6.9	4.1	316.4	18.4	25.0	26.9	8.0	150.3	26.9	3.7	3.2	61.4	32.0	296.3	155.5	11.7	91.5	8.9	8.2	8.2	12.6	10.2	22.9	11.9	14.7	11.2	11.1	32.4	12.8	26.0	25.6	18.4	0.3	11.5	32.8	33.4	17.4	6.2	2.1	62.0	50.5	36.7	70.1	17.2	49.7	0.0	6.6	27.7	105.1	211.3	43.2	123.5	14.3	2.9	24.9	44.9	6.1	4.8	70.2	9.0	19.0	27.5	16.1	2.5	21.3	15.7	103.9	140.4	3.3	10.6	116.4	6.1	91.3	80.3	146.8	12.8	87.7	30.2	13.1	123.3	6.4	11.3	0.5	4.4	31.1	165.3	10.5	15.0	92.8	200.0	64.8	9.6	1.3	6.6	4.2	14.1	11.2	46.6	16.6	21.3	4.8	15.0	6.4	58.7	47.3
SMCP	MCSP	ENSG00000163206	"Sperm mitochondria associated cysteine rich protein"	P49901	1	152878322-152885047	"Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	958	"testis: 748.1"	"Group enriched"	"Detected in some"	80	"Early spermatids: 3632.3;Late spermatids: 13748.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.2;hTERT-HME1: 1.1"					"Not detected"	"Not detected"			"HPA035105, HPA077113"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA035105: AB_10601590, HPA077113: "						"unprognostic (5.51e-2)"												0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	748.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3632.3	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13748.1	84.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	107.5	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMCR8	"DENND8A, FLJ34716"	ENSG00000176994	"SMCR8-C9orf72 complex subunit"	Q8TEV9	17	18315293-18328056	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021557, HPA024646"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA021557: AB_1857283, HPA024646: AB_1857284"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.11e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.09e-3)"	"unprognostic (7.11e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.41e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.27e-2)"	5.2	5.0	1.7	5.0	1.9	12.5	5.0	2.2	1.9	4.7	2.6	5.8	3.3	5.3	2.6	5.3	4.8	2.7	4.5	1.8	2.4	4.6	4.0	5.5	5.7	2.0	1.8	4.9	5.1	5.8	5.3	2.9	1.9	4.8	3.7	2.7	6.4	3.0	6.4	5.8	7.2	3.0	1.6	8.4	6.2	4.9	2.2	5.4	4.7	3.5	5.6	5.3	3.9	2.3	7.0	9.6	4.7	5.5	6.5	4.3	8.6	4.9	6.6	8.5	8.1	14.8	2.9	4.1	3.6	6.1	9.6	9.1	9.4	5.8	7.8	8.4	7.9	7.7	10.0	4.2	7.0	3.0	18.1	5.5	7.3	9.8	6.1	5.6	6.1	5.9	6.5	3.8	5.1	4.3	5.1	4.4	4.5	9.0	4.0	5.6	12.1	6.5	3.9	7.9	2.5	5.8	5.6	7.1	10.5	24.7	14.4	6.1	6.1	4.8	5.8	12.8	6.6	5.7	7.0	2.1	6.7	4.7	5.0	2.5	0.5	0.4	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.7	0.3	0.2	0.3	1.7	1.9	2.2	1.9	1.8	2.4	2.0	1.8	1.9	1.6	2.2	2.3	5.6	6.4	11.0	2.3	7.0	0.4	3.4	0.0	4.6	6.7	8.2	6.1	3.3	5.7	5.6	11.0	2.1	3.8	6.4	8.2	0.0	5.4	3.3	8.9	9.0	6.3	3.6	5.2	5.1	5.4	2.9	4.6	7.7	13.9	8.8	7.4	10.4	5.3	8.7	6.7	5.5	6.0	0.0	23.5	0.3	2.0	4.1	15.1	0.0	5.6	18.7	2.9	4.1	2.5	3.7	6.9	4.5	4.1	3.5	6.8	6.3	6.4	2.2	5.9	0.0	5.4	4.3	9.3	7.8	3.9	0.6	6.0	6.3	6.2	6.1	7.5
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1 nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804860-18926408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	12.9	8.4	11.0	16.1	11.0	39.0	19.5	42.6	12.6	13.4	11.9	14.4	11.6	14.1	15.8	14.2	12.1	10.8	13.5	12.0	7.5	14.6	17.8	11.4	21.6	7.5	6.7	18.6	13.0	15.2	10.2	11.5	9.9	12.1	15.9	20.9	12.0	10.9	53.1	42.0	13.6	13.2	1.9	15.9	12.8	14.5	12.6	29.9	18.1	35.4	19.1	15.4	13.2	16.6	42.2	27.5	25.5	18.1	28.6	29.9	18.8	19.1	18.8	20.4	22.7	24.4	15.1	57.5	26.8	26.8	21.5	23.3	29.6	16.7	32.3	37.2	18.4	26.2	25.8	31.4	23.1	35.7	19.9	17.7	27.5	42.4	50.5	20.1	29.1	30.7	41.0	31.0	22.8	22.0	24.8	20.9	27.2	15.3	15.7	28.4	34.2	19.8	17.6	32.1	23.0	17.6	29.9	19.9	20.8	20.8	15.9	22.3	37.0	30.2	20.4	19.0	28.7	15.8	21.8	37.0	20.2	27.1	18.6	31.7	2.7	4.2	6.6	3.2	3.2	4.0	4.4	4.8	2.9	7.6	5.7	5.1	8.4	2.6	7.2	5.3	4.5	1.4	11.0	11.0	42.6	12.6	12.0	7.5	7.5	6.7	9.9	1.9	12.6	16.6	83.2	76.9	85.4	58.4	98.8	193.2	73.0	26.9	112.1	52.0	71.3	40.5	48.1	32.9	67.1	27.6	75.0	21.3	97.4	65.5	3.9	21.7	20.3	88.1	81.1	66.5	39.4	44.8	81.5	23.6	19.0	57.3	90.7	140.0	39.3	66.1	37.9	46.1	24.1	42.1	75.2	41.8	36.7	48.0	112.8	24.9	29.8	82.5	39.2	68.4	61.4	20.5	72.1	48.7	87.5	34.6	76.9	26.4	82.2	94.2	43.0	15.6	45.9	44.8	46.0	118.2	63.1	49.6	32.2	107.1	204.4	30.0	97.6	37.6	46.4	95.4
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6 nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303785	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.2	13.0	15.5	12.3	14.6	13.6	10.5	17.6	15.0	16.4	13.2	11.4	9.3	26.6	11.1	16.4	21.7	17.2	14.0	13.8	17.8	12.3	7.4	11.9	12.3	19.9	17.3	37.5	7.4	14.4	13.3	10.5	14.3	13.9	9.4	19.2	10.4	12.8	12.9	16.0	10.9	18.9	12.5	9.8	9.6	19.5	16.0	23.1	11.7	9.1	10.9	13.1	12.0	14.8	14.9	22.5	31.7	20.6	33.6	27.0	16.3	23.6	25.9	26.3	22.2	27.6	7.3	15.7	8.3	34.8	12.0	21.3	23.5	20.1	27.4	15.7	14.7	15.3	11.8	13.5	19.2	8.2	10.5	38.5	14.5	21.2	18.6	42.6	24.3	15.3	12.8	18.5	19.9	11.7	20.8	6.6	10.2	8.9	11.7	21.4	20.2	6.2	15.2	13.5	5.3	16.1	24.6	7.1	10.2	22.2	11.1	6.0	32.2	24.0	13.1	25.6	25.1	16.0	10.5	7.2	19.1	9.1	14.0	3.0	0.7	0.8	1.3	0.3	1.3	0.5	1.1	1.3	0.4	0.7	1.5	1.1	0.5	2.0	1.6	1.3	0.6	0.6	15.5	14.6	17.6	15.0	13.8	17.8	19.9	17.3	14.3	12.5	16.0	14.8	17.2	22.4	18.4	41.4	13.2	7.9	13.8	13.1	10.2	35.6	13.8	14.5	8.0	7.2	11.8	14.7	75.0	16.5	17.7	17.9	5.9	13.8	22.5	19.4	37.1	20.3	4.2	12.8	57.1	12.4	10.7	21.0	18.3	21.3	10.8	20.3	17.9	9.1	10.3	47.1	61.7	14.4	16.2	8.7	6.8	36.9	16.8	10.6	8.8	81.5	15.9	24.8	21.6	44.7	64.3	17.2	15.2	19.9	14.6	14.7	10.1	7.6	17.9	50.5	26.3	27.1	20.4	63.7	59.0	15.1	8.7	17.4	24.9	22.4	13.5	14.2
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7 nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	17.4	16.2	19.2	21.9	20.8	43.1	17.0	28.1	24.4	19.6	21.4	20.0	20.5	19.6	15.4	22.9	25.9	15.3	22.0	20.4	18.1	21.8	22.7	18.7	25.8	16.5	17.8	25.9	21.8	24.8	20.4	18.9	16.0	17.0	23.8	32.0	21.6	16.1	25.8	25.3	20.5	17.9	16.0	21.5	22.4	67.5	19.5	35.7	23.5	27.9	30.2	18.1	19.3	20.0	56.4	33.6	47.5	37.3	31.8	29.8	78.9	33.8	61.8	36.9	28.0	50.1	42.8	78.9	37.9	42.1	33.5	59.4	64.5	50.1	43.4	35.2	28.1	63.8	36.3	41.0	32.1	84.4	39.1	27.3	45.0	50.6	116.1	30.0	41.0	42.9	80.6	54.0	38.8	56.9	59.7	37.1	82.4	66.9	19.1	37.2	53.0	61.9	28.3	51.7	63.7	49.7	52.2	73.1	40.5	80.4	72.9	34.0	39.3	41.5	42.9	41.7	48.5	58.6	74.3	63.5	33.8	46.9	45.3	2.0	5.8	6.2	5.6	5.7	5.1	5.5	5.0	5.5	6.6	4.7	5.5	5.9	6.8	5.9	3.2	7.0	4.9	5.1	19.2	20.8	28.1	24.4	20.4	18.1	16.5	17.8	16.0	16.0	19.5	20.0	31.3	22.4	20.6	66.3	26.8	27.0	11.6	13.9	23.3	22.6	21.4	15.6	31.8	20.0	20.5	27.6	31.3	11.4	23.9	38.5	9.8	12.1	58.1	39.8	23.6	26.8	34.6	28.8	63.0	15.8	16.5	14.9	31.1	48.0	22.1	19.4	25.4	45.2	13.2	30.3	63.0	23.0	6.1	38.6	48.6	49.5	15.2	25.2	10.6	52.5	20.0	9.6	15.5	70.9	99.1	17.6	19.9	12.4	36.2	16.7	30.4	12.9	30.5	19.0	39.5	14.5	23.8	35.2	23.8	30.8	26.9	10.8	24.2	13.0	18.8	23.2
SMG8	"C17orf71, FLJ10587, FLJ23205"	ENSG00000167447	"SMG8 nonsense mediated mRNA decay factor"	Q8ND04	17	59209400-59215239	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024841	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA024841: AB_10600790"	"unprognostic (2.68e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-3)"	"unprognostic (9.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-1)"	5.9	7.0	5.0	6.4	5.3	10.9	8.5	5.7	6.8	7.4	5.5	6.0	5.9	7.4	6.9	6.5	8.5	5.1	7.5	5.3	6.4	7.1	7.7	6.3	9.5	5.2	5.7	11.2	5.2	9.4	4.1	9.2	5.8	6.6	6.0	4.6	6.3	6.9	8.3	7.3	5.4	7.2	5.7	7.4	5.9	7.5	6.2	10.2	8.1	8.4	10.1	6.7	3.9	6.3	16.2	22.6	17.4	17.5	21.4	18.0	23.5	23.1	23.5	31.7	27.3	15.5	14.1	23.8	35.2	22.1	24.6	19.2	28.3	21.4	30.6	31.5	27.0	27.3	12.2	22.2	24.6	26.8	22.6	23.6	26.2	23.2	17.2	21.0	21.1	14.7	33.5	12.2	22.0	36.2	25.9	12.4	17.1	23.3	22.0	17.3	26.0	22.5	14.9	11.5	15.4	24.9	16.2	8.9	19.3	21.7	26.9	18.7	20.5	11.9	27.0	13.0	20.8	23.7	36.3	27.3	15.2	14.0	19.8	26.7	18.6	9.6	8.7	24.2	10.2	10.0	8.1	8.3	15.0	6.2	8.0	7.3	4.7	10.2	26.4	5.0	8.3	9.0	5.0	5.3	5.7	6.8	5.3	6.4	5.2	5.7	5.8	5.7	6.2	6.3	1.0	3.2	2.6	4.6	3.8	0.6	0.3	0.9	1.8	0.8	0.7	0.4	0.9	0.0	1.8	0.0	0.0	1.0	1.2	2.4	0.0	2.7	0.3	1.6	1.9	1.8	1.8	1.3	3.4	2.8	1.0	1.6	3.1	1.6	5.7	1.5	1.1	1.0	0.8	3.3	3.7	0.5	0.0	2.4	0.0	0.0	0.9	2.4	0.0	0.0	2.3	0.6	1.0	4.5	5.0	2.9	6.3	0.7	3.6	0.2	0.8	0.6	3.5	1.1	0.0	1.6	3.0	1.2	1.3	3.1	0.6	1.4	2.3	2.1	1.5	0.3
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9 nonsense mediated mRNA decay factor"	Q9H0W8	19	43727983-43754962	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.2;Late spermatids: 329.5;Syncytiotrophoblasts: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"HPA041763: AB_2677659, HPA042096: AB_2677845"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.09e-4)"	9.0	11.7	10.3	10.9	10.8	8.4	8.7	10.9	13.5	10.6	5.9	9.0	8.0	9.0	7.7	9.2	7.7	6.8	7.7	10.2	10.6	7.7	6.6	10.0	13.0	13.1	11.6	7.8	5.8	8.8	9.4	10.1	13.6	11.5	6.2	5.9	12.0	6.9	7.5	10.7	10.0	8.1	9.5	13.5	8.7	33.8	11.6	11.8	8.3	7.1	12.0	10.0	9.9	14.9	25.3	27.2	19.5	12.5	13.4	18.9	13.1	35.1	20.8	38.4	28.7	19.4	32.5	27.4	16.9	24.1	13.2	10.7	22.9	19.7	24.9	21.1	13.2	49.2	20.5	12.9	15.6	37.4	25.9	10.1	16.6	27.9	29.6	32.1	15.8	25.0	37.7	23.6	18.0	17.9	39.9	10.6	9.4	48.0	18.2	21.2	16.1	12.3	20.4	20.4	32.4	15.9	36.7	27.4	21.3	15.4	16.6	20.5	19.2	59.7	35.4	22.3	27.1	11.5	26.8	33.4	17.9	28.4	49.7	1.0	5.3	3.3	5.1	7.7	4.5	7.4	5.1	4.3	6.9	5.3	6.7	4.5	1.3	4.2	11.7	6.1	4.1	11.3	10.3	10.8	10.9	13.5	10.2	10.6	13.1	11.6	13.6	9.5	11.6	14.9	7.7	32.1	8.3	20.9	13.7	9.3	15.0	16.8	11.4	13.2	10.0	11.0	4.4	4.3	9.0	9.2	4.2	49.5	11.3	9.5	1.9	12.2	103.2	5.5	7.0	12.0	4.2	7.8	19.5	8.7	15.8	11.4	15.8	8.9	9.5	12.1	11.0	3.3	21.4	13.5	23.0	11.3	8.2	10.3	9.2	329.5	13.1	12.1	10.6	11.2	16.2	6.0	4.1	16.1	29.6	13.6	9.2	12.0	11.2	15.9	8.5	6.8	8.4	9.2	6.6	11.2	8.5	42.6	16.2	8.4	7.1	95.4	9.3	11.8	12.2	11.1
SMIM1	Vel	ENSG00000235169	"Small integral membrane protein 1 (Vel blood group)"	B2RUZ4	1	3772749-3775982	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;testis: 42.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"eosinophil: 48.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 48.5"	"Group enriched"	"Detected in many"	4	"HEL: 68.0;Hep G2: 32.5;K-562: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA069088	Enhanced					NA	NA		340000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA069088: AB_2686080"	"unprognostic (9.50e-3)"	"unprognostic (7.19e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.32e-2)"	2.6	2.7	1.8	0.4	2.6	32.1	3.2	3.8	3.0	5.8	6.2	2.9	0.7	2.8	1.1	1.4	3.4	1.3	40.3	1.4	3.9	16.9	13.1	3.7	1.0	8.7	5.3	8.7	9.4	4.3	16.0	2.1	9.0	6.9	0.1	0.4	17.3	5.5	1.1	2.1	2.1	0.2	5.5	4.0	6.6	42.2	3.6	0.4	9.3	0.2	0.5	3.4	3.6	6.2	0.3	1.4	1.4	3.0	0.0	0.0	5.0	0.9	1.2	0.0	0.0	3.5	3.9	0.1	6.3	0.0	0.2	1.3	0.4	1.5	0.0	6.1	3.6	68.0	0.0	32.5	2.4	0.0	1.2	2.1	0.8	0.3	0.5	2.9	0.0	0.3	33.9	1.2	0.0	7.8	0.0	2.1	0.3	3.4	6.0	0.0	0.0	9.9	3.8	1.0	1.6	6.3	0.2	6.8	4.8	0.5	7.0	3.7	0.4	0.0	0.8	0.0	0.0	2.8	0.8	0.2	0.0	0.0	0.2	4.4	2.0	48.5	1.1	1.0	0.4	2.5	1.6	0.6	0.6	3.7	4.0	1.9	3.2	0.2	0.4	0.6	1.2	2.2	1.8	2.6	3.8	3.0	1.4	3.9	8.7	5.3	9.0	5.5	3.6	6.2	1.1	6.4	20.1	0.7	5.9	1.7	13.1	4.4	10.2	0.4	31.1	35.9	57.0	8.6	8.1	16.5	0.0	23.4	1.4	1.6	84.1	17.2	10.8	3.7	1.2	3.9	5.4	404.4	0.1	14.5	18.8	10.1	6.6	3.5	1.3	81.5	3.9	50.2	10.4	1.7	0.1	3.9	8.2	8.9	1.0	27.8	9.9	8.5	42.7	0.0	4.3	47.0	2.1	0.0	1.6	13.7	1.7	9.8	11.1	10.2	1.9	247.9	2.2	1.5	0.0	3.6	4.3	8.7	20.4	1.7	1.1	6.7	4.6	3.0	4.3	9.1
SMIM11A	"C21orf51, FAM165B, SMIM11"	ENSG00000205670	"Small integral membrane protein 11A"	P58511	21	34375480-34416961	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Focal adhesion sites"		"HPA051321: AB_2681440"	"unprognostic (2.62e-2)"	"unprognostic (4.28e-2)"			"unprognostic (1.27e-1)"		"unprognostic (5.86e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.04e-1)"		"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"		"unprognostic (8.84e-2)"	"unprognostic (4.83e-3)"	10.2	8.9	19.8	12.1	20.6	13.0	6.6	20.4	32.6	10.3	24.4	7.5	14.9	9.7	14.5	9.3	9.2	13.6	21.9	19.9	20.8	17.8	14.5	8.1	15.8	21.4	20.2	16.7	11.6	11.2	3.6	5.8	21.0	10.5	6.5	13.2	14.3	4.8	35.9	6.3	11.7	11.3	21.5	11.4	30.5	6.3	20.0	6.7	20.6	11.4	6.5	12.7	2.7	23.5	24.7	9.8	11.1	33.0	21.0	6.5	22.6	9.0	4.3	12.5	25.1	12.7	22.7	57.4	11.8	11.6	16.5	15.1	18.8	0.7	11.9	32.0	8.9	33.1	23.0	12.7	19.0	55.6	7.8	15.5	10.8	13.6	31.1	24.5	14.2	12.1	51.4	65.7	13.2	13.2	2.2	43.5	52.2	15.5	34.5	31.1	25.2	82.5	10.8	6.2	28.3	20.4	14.8	18.5	39.0	20.3	18.2	25.1	18.1	18.1	13.4	8.0	16.9	25.1	28.3	54.0	33.6	70.0	33.0	5.6	6.3	14.9	6.9	10.1	11.4	6.5	11.7	16.8	8.5	17.1	8.5	11.4	3.6	14.4	9.2	7.6	14.1	9.5	19.8	20.6	20.4	32.6	19.9	20.8	21.4	20.2	21.0	21.5	20.0	23.5	0.1	3.2	2.6	0.0	0.4	0.0	0.4	0.0	0.0	0.8	0.8	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.3	1.9	1.5	0.4	0.1	0.4	0.7	1.2	0.0	0.0	0.7	0.3	0.7	12.8	0.2	0.0	0.2	0.7	1.4	0.7	0.0	0.0	0.8	0.0	0.6	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.4	0.6	0.3	1.4	2.2	2.2	0.4	0.0	0.3	0.3	0.6	0.5	0.0	0.0	0.1	0.4	0.1	0.6	0.1
SMIM11B		ENSG00000273590	"Small integral membrane protein 11B"	Q8TCY0	21	7744962-7777853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 5.6;Club cells: 4.3;Distal tubular cells: 3.9;granulocytes: 5.1;Respiratory ciliated cells: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Focal adhesion sites"		"HPA051321: AB_2681440"					"unprognostic (1.99e-1)"					"unprognostic (1.78e-1)"				"unprognostic (1.35e-1)"				14.6	17.0	22.5	1.1	22.6	0.5	15.6	21.7	24.1	17.6	21.7	23.3	2.1	16.8	15.0	9.3	19.2	3.1	30.7	22.3	22.5	24.3	20.6	11.3	4.8	24.7	23.1	20.6	18.6	9.1	21.3	4.2	22.2	17.4	5.7	10.0	15.4	11.2	37.3	9.8	13.9	3.4	19.7	14.0	58.2	6.5	22.4	12.2	19.5	16.3	8.5	18.4	14.3	23.4	23.6	9.6	7.7	17.3	19.0	37.9	0.2	8.8	30.0	11.2	0.8	1.0	1.4	1.1	7.0	14.3	23.8	1.1	17.0	27.7	10.0	34.3	45.9	19.2	1.2	13.8	19.5	3.1	25.9	18.8	26.6	0.4	1.4	7.9	14.5	29.3	31.2	3.6	10.6	11.9	26.6	2.1	0.6	36.3	0.6	1.1	0.4	1.2	34.7	6.2	16.2	1.9	21.6	15.3	17.7	0.6	28.2	0.8	3.1	10.9	4.5	9.2	9.8	19.2	20.6	1.5	0.1	9.9	1.5	1.5	11.0	4.6	11.6	5.8	11.3	19.6	9.1	6.0	11.4	12.2	16.1	9.7	0.9	1.4	5.0	8.4	14.7	6.4	22.5	22.6	21.7	24.1	22.3	22.5	24.7	23.1	22.2	19.7	22.4	23.4	0.1	16.0	5.6	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.8	0.3	0.0	1.5	4.3	0.0	0.0	0.3	0.3	0.3	3.9	0.5	0.2	0.2	0.1	0.4	0.0	2.7	0.0	0.4	0.3	2.1	0.0	0.1	5.1	0.1	0.4	0.6	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.3	0.3	1.9	10.9	0.3	0.0	0.9	0.1	0.3	0.4	0.0	0.0	0.3	0.6	0.1	0.5	0.3
SMIM12	"C1orf212, FLJ90372"	ENSG00000163866	"Small integral membrane protein 12"	Q96EX1	1	34712737-34859755	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065331	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA065331: AB_2685470"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (7.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.52e-2)"	40.2	56.6	31.7	26.5	32.1	24.8	33.5	29.5	35.3	20.9	29.2	34.0	30.1	26.0	17.7	41.3	23.5	17.3	53.8	31.5	35.7	42.3	87.9	31.6	25.0	32.6	32.7	17.1	26.4	31.8	26.9	24.8	33.1	19.9	28.0	12.8	24.1	20.5	56.2	29.7	30.8	31.5	29.6	31.9	30.4	28.0	31.9	30.3	24.9	51.1	27.3	29.2	25.7	33.3	52.9	39.8	43.3	31.6	55.2	43.3	30.1	55.8	48.1	70.2	60.3	40.0	65.0	55.1	49.2	57.6	55.5	51.7	55.5	74.7	53.5	67.3	41.6	98.1	65.6	49.1	51.3	107.9	55.4	66.2	71.9	76.5	61.3	25.3	72.9	47.0	71.0	72.3	63.0	38.6	52.6	55.4	70.1	40.8	52.7	44.1	42.7	71.7	62.2	54.6	41.5	32.9	52.0	48.1	81.5	53.9	32.8	29.9	69.9	47.8	49.3	74.3	66.7	40.4	60.2	56.9	45.2	63.7	32.1	104.2	76.0	126.4	65.8	82.0	77.9	57.7	60.4	72.0	86.0	59.2	50.1	64.3	50.2	62.6	67.5	62.4	76.2	87.5	31.7	32.1	29.5	35.3	31.5	35.7	32.6	32.7	33.1	29.6	31.9	33.3	51.2	25.6	13.1	4.9	37.0	68.2	26.3	49.8	23.3	14.4	36.4	30.1	33.9	42.9	30.4	22.0	10.4	50.7	38.5	46.7	86.1	78.7	58.3	17.1	19.0	56.2	21.8	53.9	10.4	83.7	60.2	24.9	20.9	20.6	23.5	18.9	48.2	89.3	83.8	20.2	9.5	23.4	46.8	41.7	61.6	32.7	14.9	41.0	39.2	7.5	89.8	24.9	54.6	6.6	7.0	87.5	41.0	23.3	27.5	40.8	62.9	90.6	26.8	17.3	13.1	21.8	52.3	37.6	23.0	41.4	75.6	58.0	40.8	33.7	39.6	41.7
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11093834-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	4.7	4.6	15.4	3.4	16.1	2.9	3.4	21.4	23.8	4.3	5.6	4.1	3.6	5.0	3.4	4.8	2.9	4.1	6.6	16.7	18.0	4.3	9.7	3.5	3.0	17.6	16.7	4.1	3.0	6.4	4.1	12.7	19.3	4.6	3.6	17.1	3.7	4.8	11.5	4.9	3.1	5.2	15.8	2.9	3.1	3.4	20.0	3.4	3.0	14.2	3.0	4.9	3.7	19.4	9.9	8.3	12.6	10.6	12.7	14.4	13.2	26.7	11.3	13.4	14.9	11.1	3.1	12.1	35.9	8.6	13.3	8.6	26.3	9.3	24.0	7.1	19.1	12.7	9.1	8.8	16.9	23.8	2.9	17.4	25.5	13.7	18.0	10.6	14.4	11.0	18.3	5.0	25.7	5.4	10.1	14.0	5.9	6.5	7.1	13.5	23.1	17.2	8.2	7.6	29.4	16.3	5.6	18.2	32.4	17.2	4.6	9.9	20.7	20.3	15.0	8.6	18.1	9.5	33.0	17.1	4.8	9.9	31.8	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	15.4	16.1	21.4	23.8	16.7	18.0	17.6	16.7	19.3	15.8	20.0	19.4	14.3	12.8	1.5	12.4	9.1	75.1	17.1	13.7	10.8	16.4	10.6	10.3	12.7	12.8	5.2	11.0	20.9	29.3	14.4	5.7	3.9	5.2	10.3	11.8	15.6	11.4	3.6	11.8	26.8	7.4	36.6	11.9	6.1	12.0	10.8	4.2	7.9	25.6	13.5	30.3	31.4	8.1	10.2	8.1	29.4	4.3	2.8	12.0	16.0	10.3	6.3	7.6	7.2	18.6	28.0	10.5	3.1	4.1	14.6	18.8	5.8	7.8	4.6	15.2	0.0	7.7	9.8	16.8	24.8	12.7	39.5	65.1	12.9	10.4	8.7	16.2
SMIM14	"C4orf34, FLJ13289"	ENSG00000163683	"Small integral membrane protein 14"	Q96QK8	4	39546336-39638902	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 553.9;Intestinal goblet cells: 408.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 269.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051299	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051299: AB_2681429"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.48e-2)"	"prognostic favorable (3.00e-6)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-3)"	21.7	45.5	12.6	22.4	15.7	4.7	33.2	15.0	14.8	36.2	14.8	41.4	17.7	19.2	38.4	20.0	27.5	19.8	10.2	13.3	17.4	22.9	118.4	22.4	38.9	15.6	15.1	23.2	24.3	25.4	17.5	8.4	16.6	35.6	36.8	12.3	40.8	19.8	6.7	14.3	21.1	14.5	16.7	27.2	46.6	14.2	15.9	15.5	27.9	9.4	45.2	19.4	14.5	19.4	12.4	20.9	9.9	9.6	64.4	71.8	17.7	16.9	21.5	7.4	10.8	6.8	44.2	269.3	15.8	19.2	11.8	4.6	2.0	3.6	6.1	7.1	2.2	0.3	8.9	12.2	22.0	1.8	2.8	27.4	13.1	7.6	4.9	26.4	11.3	11.8	2.9	8.6	12.5	38.4	2.9	4.8	4.7	54.2	14.4	11.9	0.5	3.0	15.5	10.8	7.5	9.4	19.0	25.1	6.8	3.9	25.1	4.0	37.8	17.0	3.8	22.1	2.9	28.0	6.4	1.1	27.9	3.4	6.7	53.5	52.7	28.0	20.7	46.0	22.6	103.9	14.5	18.4	55.9	107.1	11.0	16.2	37.3	40.4	49.1	100.1	9.1	44.5	12.6	15.7	15.0	14.8	13.3	17.4	15.6	15.1	16.6	16.7	15.9	19.4	55.3	57.7	124.4	29.4	228.9	49.3	76.5	83.4	42.7	80.6	150.3	96.6	17.0	65.8	143.4	104.8	35.5	38.3	74.9	242.2	84.1	86.9	238.5	115.3	65.6	45.8	106.1	25.3	34.0	144.8	49.6	108.6	85.1	73.4	45.7	19.2	57.1	553.9	43.6	92.5	52.4	408.8	126.1	79.8	85.1	31.5	113.1	62.6	46.2	36.5	108.0	109.7	36.0	29.1	85.5	226.2	132.4	124.5	19.8	199.0	75.0	117.9	225.3	48.5	59.2	56.5	58.8	66.2	25.0	95.0	59.8	104.1	28.8	65.7	118.3	124.0
SMIM17		ENSG00000268182	"Small integral membrane protein 17"	P0DL12	19	56643159-56657247	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 18.0;Inhibitory neurons: 32.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;HEK 293: 1.8;SCLC-21H: 1.7"					"Low region specificity"	"Detected in all"			"HPA071857, HPA071861"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071857: AB_2686461, HPA071861: AB_2686462"	"unprognostic (1.32e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (9.02e-3)"	"unprognostic (3.46e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.71e-3)"	"unprognostic (7.51e-3)"	0.4	0.3	6.0	0.2	4.9	0.2	0.6	3.7	8.9	0.4	0.0	0.7	0.3	0.6	1.3	0.3	0.5	0.2	0.4	6.4	8.9	0.3	0.2	0.3	0.2	6.9	6.7	0.5	0.3	0.1	1.6	0.2	8.2	0.4	0.3	2.7	0.4	1.0	0.5	0.7	0.2	0.4	3.3	0.3	0.3	0.4	7.5	0.3	0.3	0.2	0.2	0.4	0.3	2.8	0.1	0.0	2.0	0.5	0.3	0.2	0.5	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0.2	0.1	1.8	1.1	0.4	0.4	0.3	1.0	0.3	0.3	0.3	0.1	0.3	0.3	0.2	1.1	0.1	0.0	0.5	0.0	1.3	0.3	0.1	0.0	0.3	0.7	1.2	0.1	0.1	0.0	1.7	0.3	0.6	0.1	0.3	0.3	0.0	0.4	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.9	3.7	8.9	6.4	8.9	6.9	6.7	8.2	3.3	7.5	2.8	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638580-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;pituitary gland: 5.4;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.0	0.9	2.2	0.0	1.9	0.9	0.0	4.0	3.7	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.8	0.9	0.0	0.0	0.0	2.3	4.4	0.0	0.4	0.0	5.4	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.2	0.6	0.6	1.1	0.4	1.1	0.9	0.7	0.6	0.3	0.9	0.9	1.3	0.7	0.0	0.8	1.4	1.0	0.1	2.2	1.9	4.0	3.7	2.0	3.8	2.3	4.4	3.0	1.7	2.7	1.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.1	1.8	0.0	2.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0
SMIM19	C8orf40	ENSG00000176209	"Small integral membrane protein 19"	Q96E16	8	42541155-42555195	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011145, HPA074830"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011145: AB_1078360, HPA074830: "	"unprognostic (2.12e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (7.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-3)"	55.2	57.1	34.7	18.4	35.4	32.5	64.9	35.8	44.3	31.9	35.8	41.7	30.0	32.6	80.0	33.2	57.0	27.8	59.6	36.1	35.8	76.9	136.8	31.5	36.9	34.2	34.9	42.2	68.5	36.2	26.8	23.3	35.1	31.9	34.6	21.1	62.6	30.1	121.8	44.8	38.9	25.1	35.7	33.3	46.2	43.9	35.0	36.6	73.5	74.1	33.9	36.4	29.9	37.3	38.9	28.5	61.0	52.6	35.9	43.2	19.9	29.9	40.2	23.4	27.8	6.8	84.4	42.4	12.2	25.1	57.0	27.2	31.8	19.2	24.3	33.8	26.3	35.9	17.9	15.5	73.9	25.7	9.0	35.4	16.1	19.6	62.7	45.3	21.5	49.1	28.8	94.5	23.7	38.0	18.8	39.0	72.1	90.4	19.5	21.1	43.4	72.4	60.7	28.5	12.7	46.0	30.0	32.2	93.1	32.6	68.0	48.2	27.3	14.7	12.5	40.8	19.6	88.7	53.8	56.9	62.2	40.9	39.6	92.2	42.3	31.4	46.3	34.0	56.5	71.3	59.6	57.0	65.1	68.3	55.6	54.3	15.3	80.7	28.8	107.2	78.2	40.0	34.7	35.4	35.8	44.3	36.1	35.8	34.2	34.9	35.1	35.7	35.0	37.3	53.1	22.4	45.9	5.9	43.0	45.8	63.5	89.8	70.6	25.2	89.9	108.8	75.7	88.6	66.2	33.1	6.2	90.1	58.6	36.2	201.5	67.9	183.9	109.6	26.0	43.9	16.3	45.6	12.7	126.8	62.9	65.5	43.3	54.8	40.0	52.3	47.8	142.5	78.3	23.5	13.4	74.4	61.1	45.9	51.0	77.5	69.0	47.3	92.5	11.2	64.0	66.7	42.2	10.6	14.6	85.5	69.5	59.5	29.0	53.3	161.9	228.2	110.9	14.3	26.3	67.6	50.7	131.3	48.6	58.4	49.6	47.2	43.3	76.4	74.8	63.2
SMIM2	"C13orf44, MGC5590"	ENSG00000139656	"Small integral membrane protein 2"	Q9BVW6	13	44143150-44161257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.5;OE19: 4.8"					"Low region specificity"	"Detected in single"			"HPA026891, HPA077071"	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA026891: AB_10602924, HPA077071: "	"unprognostic (4.34e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.87e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.05e-2)"	0.2	0.2	0.6	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.5	0.8	0.8	0.0	2.9	0.3	0.2	0.3	0.9	0.5	0.4	0.8	0.4	0.2	0.0	0.1	0.6	0.1	0.6	0.0	0.2	0.4	0.1	0.2	0.0	0.3	0.5	0.1	0.9	0.3	1.9	0.5	0.1	0.2	0.5	23.4	0.3	4.9	0.3	0.0	0.0	0.3	0.0	0.4	0.4	0.2	0.4	0.0	0.0	0.0	0.4	0.0	2.5	0.5	0.0	0.5	0.1	0.7	0.4	0.0	0.4	1.2	0.0	1.0	0.7	0.0	0.7	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.3	4.8	0.4	0.4	0.0	0.0	0.0	0.1	1.1	0.5	1.3	0.5	0.9	0.9	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.0	0.0	0.2	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.2	1.9	0.5	0.4	0.1	0.6	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted to blood"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	27.9	36.7	36.7	16.6	37.7	13.1	27.2	38.1	50.2	22.2	39.8	30.9	39.9	23.9	72.2	15.7	23.8	23.9	46.8	36.5	38.4	46.0	38.2	19.7	30.4	36.9	36.1	33.9	43.4	28.2	17.6	14.1	36.9	23.9	25.5	29.9	35.1	17.5	95.9	13.9	35.1	17.8	37.9	23.6	38.6	20.5	36.8	17.4	31.4	61.4	24.8	28.8	19.1	39.2	29.9	24.5	32.3	31.3	34.9	75.4	43.0	28.4	34.3	24.0	30.4	21.9	51.6	48.8	48.1	31.7	49.6	8.5	37.9	36.3	33.4	27.9	30.1	28.3	16.4	42.0	59.1	34.0	18.0	53.9	71.6	30.6	46.1	46.7	18.7	32.5	45.9	15.5	29.6	19.1	37.0	57.5	61.0	39.6	36.1	30.1	42.0	31.7	53.5	21.6	41.3	38.4	18.3	12.7	66.0	35.2	26.3	47.5	31.4	25.8	30.5	29.3	36.8	30.2	26.9	52.6	39.2	35.6	33.4	30.6	31.5	15.9	26.2	37.7	34.5	47.3	37.5	33.2	36.9	47.9	50.4	41.1	16.3	35.6	29.4	38.3	42.9	31.7	36.7	37.7	38.1	50.2	36.5	38.4	36.9	36.1	36.9	37.9	36.8	39.2	21.5	9.6	41.6	9.4	48.0	21.9	30.4	89.4	26.7	7.7	49.8	63.1	61.8	61.5	59.0	36.8	8.4	63.7	22.5	50.9	131.0	70.0	11.5	34.7	30.6	23.1	19.3	9.2	3.8	62.5	59.7	40.0	31.6	34.6	10.8	37.1	21.8	66.5	69.7	1.7	4.6	64.0	59.0	62.9	32.1	23.1	37.6	44.5	44.4	4.7	42.9	95.3	38.1	9.5	7.9	46.2	44.6	48.2	38.4	38.9	130.1	166.5	47.0	22.2	72.3	26.8	35.8	44.5	36.4	27.3	19.5	43.8	29.8	71.2	65.4	30.8
SMIM21	C18orf62	ENSG00000206026	"Small integral membrane protein 21"	Q3B7S5	18	75409476-75427703	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 2.8"	"Group enriched"	"Detected in some"	67	"Early spermatids: 73.8;Late spermatids: 48.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.1"									HPA041686	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA041686: AB_10961179"												"unprognostic (7.45e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM29	"C6orf1, LBH, MGC57858"	ENSG00000186577	"Small integral membrane protein 29"	Q86T20	6	34246381-34249108	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 175.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Ductal cells: 50.9;Hofbauer cells: 104.0;monocytes: 44.5;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037659, HPA037660"	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"			"HPA037659: AB_2675591, HPA037660: AB_10671881"	"unprognostic (2.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (7.98e-4)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.66e-1)"	19.4	29.7	133.7	14.4	129.9	14.7	19.5	131.5	175.9	26.5	98.3	24.2	8.4	19.8	34.5	26.9	17.0	17.1	29.8	131.3	135.5	22.5	18.7	27.8	21.3	138.0	136.0	16.4	15.4	18.6	33.4	13.2	142.4	22.8	6.1	16.1	16.2	16.3	24.5	48.8	17.9	12.2	133.5	30.8	16.9	11.7	139.1	14.6	25.7	23.5	15.5	24.0	26.0	128.0	25.1	31.1	6.2	33.3	79.2	62.2	6.7	24.6	58.4	27.4	34.4	7.6	12.3	14.1	19.8	28.6	56.6	15.6	12.7	31.3	8.9	36.0	17.3	10.5	6.1	19.9	45.4	12.0	62.0	33.7	28.4	38.5	37.6	38.4	40.9	11.6	13.5	81.8	64.0	17.9	13.5	24.2	1.9	42.8	21.5	5.5	3.8	25.1	33.1	32.4	26.0	12.1	2.6	23.8	70.9	5.3	14.1	19.1	26.4	62.1	14.4	65.1	21.6	42.9	66.1	4.7	35.4	25.7	82.9	99.1	83.8	412.8	78.7	62.7	52.6	133.3	62.4	69.1	59.7	126.4	41.8	61.8	231.6	57.1	48.3	50.1	90.3	64.0	133.7	129.9	131.5	175.9	131.3	135.5	138.0	136.0	142.4	133.5	139.1	128.0	18.1	9.6	13.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	28.5	20.8	0.0	0.0	6.8	31.3	0.0	37.8	13.6	0.0	72.4	50.9	0.0	9.9	8.6	15.5	0.0	0.0	0.0	24.0	11.8	8.0	0.0	15.0	12.6	10.8	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	44.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	1.9	0.0	0.0	43.8	10.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	35.4	9.4	17.8	0.0	0.0
SMIM34A		ENSG00000243627	"Small integral membrane protein 34A"	A8MWV9	21	34418715-34423951	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 1.2;kidney: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029085	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"					"HPA029085: AB_10669867"																		0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.2	0.1	0.2	2.5	0.2	0.3	0.0	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.2	0.3	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM34B		ENSG00000278961	"Small integral membrane protein 34B"	P0DPE8	21	7784482-7793954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"breast: 4.8;kidney: 17.2"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.9;Endometrial ciliated cells: 5.0;Respiratory ciliated cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 3.0"									HPA029085	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029085: AB_10669867"																		0.1	0.2	0.6	0.0	0.9	0.0	4.8	1.1	1.0	0.2	2.1	0.1	0.0	0.1	0.5	0.1	3.2	0.2	0.6	0.9	0.0	17.2	0.3	0.7	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.2	0.1	0.0	1.6	0.1	0.3	0.5	1.1	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.9	1.1	1.0	0.9	0.0	0.1	0.4	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 121.9;skeletal muscle: 130.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 252.4;Distal tubular cells: 213.2;Proximal tubular cells: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	22.6	121.9	14.6	12.9	15.3	7.4	22.1	21.8	20.5	16.0	20.5	19.1	12.3	14.3	10.4	16.3	14.5	3.7	100.3	15.3	15.5	37.3	20.2	20.3	10.5	15.6	18.2	41.5	25.7	31.6	56.4	6.1	16.9	26.2	10.4	13.9	28.9	13.6	130.3	20.1	15.0	5.0	15.0	15.8	20.4	17.3	15.4	6.6	48.6	50.2	8.7	20.2	13.3	18.0	58.7	19.0	22.9	58.5	26.5	13.7	47.0	25.9	12.0	29.2	25.3	24.6	15.4	25.1	11.6	10.9	29.4	30.2	7.6	20.9	11.8	16.9	60.1	23.6	58.2	50.2	40.1	28.4	31.6	29.6	12.7	24.6	17.7	15.8	26.8	27.0	31.9	36.4	19.9	25.4	26.4	39.4	39.1	31.9	42.4	18.1	22.2	50.1	17.0	25.2	24.9	31.4	50.6	16.5	52.6	12.9	17.0	23.6	24.0	16.0	53.1	76.4	53.5	42.3	50.6	57.3	87.9	52.2	22.5	8.1	44.1	17.3	19.1	35.8	18.8	24.6	27.3	23.9	49.7	22.7	29.1	27.0	1.6	22.5	15.2	26.5	29.6	20.0	14.6	15.3	21.8	20.5	15.3	15.5	15.6	18.2	16.9	15.0	15.4	18.0	35.4	48.1	46.3	1.3	30.3	27.1	37.3	52.2	41.5	17.6	80.9	84.1	252.4	60.1	63.1	53.3	12.5	42.9	26.6	58.3	213.2	52.9	21.9	71.9	30.6	32.8	79.3	22.1	1.9	86.1	24.7	36.0	34.1	48.9	59.5	16.9	55.6	160.4	116.4	3.3	2.1	62.9	30.5	80.8	46.7	15.1	65.0	51.1	37.4	0.0	28.5	102.8	15.5	2.5	3.2	57.8	39.9	101.2	19.7	19.7	89.5	215.6	52.1	15.3	46.0	22.8	56.8	9.8	14.2	34.8	34.5	27.6	25.8	44.3	73.5	23.6
SMIM5	C17orf109	ENSG00000204323	"Small integral membrane protein 5"	Q71RC9	17	75633434-75641404	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	56	"plasmacytoid DC: 207.6"	"Lineage enriched"	"Detected in many"	56	"dendritic cells: 207.6"	"Cell line enhanced"	"Detected in some"		"HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065332, HPA071268"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Golgi apparatus"	"HPA065332: AB_2685471, HPA071268: AB_2686377"	"unprognostic (6.97e-2)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.29e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.64e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.58e-1)"	1.3	0.6	4.5	1.9	8.5	11.4	1.5	8.5	6.4	8.4	10.7	10.5	9.6	1.2	0.8	27.4	7.4	4.4	12.2	5.0	5.6	28.4	1.4	3.1	1.1	11.2	8.8	2.7	2.5	3.4	2.4	1.9	9.6	4.2	2.6	0.7	7.8	1.9	0.5	14.3	15.2	0.5	7.2	4.8	10.1	2.2	7.8	0.6	15.9	0.3	3.6	6.1	14.6	16.4	1.8	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	10.5	0.1	0.0	0.0	2.8	0.1	0.3	0.3	0.0	0.0	2.0	0.8	0.0	0.0	4.5	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.5	0.5	1.1	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.1	0.0	207.6	0.0	13.7	4.5	8.5	8.5	6.4	5.0	5.6	11.2	8.8	9.6	7.2	7.8	16.4	0.7	9.6	7.0	0.7	1.6	1.1	7.3	4.8	0.6	1.5	1.2	0.9	25.1	10.0	13.9	125.0	2.1	3.1	51.9	48.4	92.0	2.9	0.1	69.4	10.1	1.8	14.4	142.5	0.0	0.5	5.8	2.3	26.0	67.6	0.0	0.3	1.8	0.2	0.7	0.0	0.0	16.1	44.7	0.6	0.9	0.3	0.6	17.0	7.2	0.0	1.2	3.3	1.0	0.0	17.9	10.7	54.2	1.5	0.9	7.4	15.5	0.9	48.0	2.1	0.0	1.4	3.1	0.4	0.5	10.0	8.4	32.8	0.8	0.3	2.3	90.6
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMIM7	"C19orf42, MGC2747"	ENSG00000214046	"Small integral membrane protein 7"	Q9BQ49	19	16630751-16660442	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043127	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"		"HPA043127: AB_10806378"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.64e-2)"	41.6	39.5	39.6	24.8	41.8	19.9	47.2	41.4	48.5	36.7	39.8	34.1	34.4	32.5	72.9	30.0	36.9	30.5	35.8	37.8	41.3	52.7	66.7	33.5	33.7	42.9	41.1	32.2	47.7	54.1	16.1	34.7	42.2	46.5	42.0	18.6	52.3	39.3	18.7	32.1	25.4	36.4	43.0	26.7	38.2	21.0	41.7	29.3	50.0	21.0	34.0	32.8	17.9	44.2	60.6	52.1	48.7	42.3	74.4	64.4	48.9	50.4	69.4	70.7	68.8	45.2	111.8	44.4	67.7	69.3	50.5	48.0	44.5	69.8	86.7	38.1	34.4	42.4	34.9	48.5	43.3	64.2	46.5	49.3	49.8	51.5	52.9	43.0	68.9	40.3	59.9	53.7	81.6	120.2	42.4	55.1	45.2	121.5	77.4	41.3	32.9	43.4	83.4	66.3	26.0	48.2	37.8	41.0	51.2	26.8	59.9	80.5	41.5	55.4	35.7	130.3	83.2	46.4	72.6	56.0	56.3	75.6	71.2	47.5	73.3	38.3	37.1	65.8	35.3	49.6	38.0	37.0	58.8	44.3	37.0	33.6	31.0	42.8	78.3	79.2	44.9	45.3	39.6	41.8	41.4	48.5	37.8	41.3	42.9	41.1	42.2	43.0	41.7	44.2	63.5	67.3	64.5	29.0	75.5	34.2	62.8	114.3	70.6	70.1	69.0	84.6	38.5	57.2	68.8	57.0	95.9	144.1	68.5	67.6	129.1	85.2	18.4	58.2	60.8	61.5	73.0	54.7	35.3	86.3	105.2	74.9	57.1	51.5	50.1	42.3	66.0	85.7	115.6	63.9	32.1	78.3	77.3	77.2	43.9	21.6	88.9	64.6	48.0	21.5	102.4	101.3	98.9	21.6	44.8	87.6	87.0	83.1	76.5	77.6	85.1	140.0	54.6	121.4	72.3	42.3	64.8	84.0	81.0	74.7	35.8	156.4	54.7	66.7	62.7	57.7
SMIM8	"C6orf162, dJ102H19.2, DKFZP586E1923"	ENSG00000111850	"Small integral membrane protein 8"	Q96KF7	6	87322583-87399749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007401, HPA067453"	Approved		Approved	Vesicles		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA007401: AB_1078357, HPA067453: AB_2685844"	"unprognostic (2.54e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.86e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.01e-1)"	5.0	5.0	8.0	3.8	8.0	6.0	5.2	8.5	9.5	6.4	8.1	6.0	5.2	6.5	6.7	4.1	5.5	2.7	7.7	8.1	8.3	7.3	7.0	3.9	5.0	7.8	8.0	6.5	4.7	6.2	7.2	3.4	7.8	4.7	4.6	8.7	4.0	3.9	10.6	4.3	4.8	4.1	8.1	4.1	4.1	4.9	8.5	6.7	4.8	8.7	4.0	5.3	5.5	8.0	5.3	4.6	9.3	16.2	5.3	6.0	4.1	5.8	4.5	4.8	9.2	3.2	4.8	10.8	6.8	5.8	8.4	6.5	7.6	4.4	9.1	9.6	8.2	15.9	5.2	6.4	5.0	16.8	5.5	5.7	5.9	4.9	5.2	5.4	7.0	13.8	18.1	17.7	5.5	4.0	10.1	13.3	5.7	7.9	7.1	16.1	13.8	6.2	6.2	5.2	15.9	6.5	8.5	5.0	10.1	8.4	4.6	16.5	6.8	2.5	7.2	10.8	5.7	7.8	13.6	7.2	8.1	7.9	7.6	5.8	8.8	15.7	11.2	8.6	11.4	18.5	13.2	13.6	10.1	11.4	19.3	16.9	14.7	9.7	10.3	8.5	18.4	9.1	8.0	8.0	8.5	9.5	8.1	8.3	7.8	8.0	7.8	8.1	8.5	8.0	19.4	12.8	5.8	18.9	17.6	13.8	20.6	29.7	8.6	24.4	12.8	16.0	47.3	17.2	16.6	23.9	37.5	17.7	8.7	8.0	45.0	10.7	18.7	32.1	19.0	15.0	8.5	17.1	21.7	10.3	12.3	17.8	12.8	9.6	5.1	31.4	22.5	13.8	14.9	37.0	19.8	9.4	36.7	12.3	11.5	14.5	15.8	11.1	8.8	8.4	11.0	28.4	13.4	8.0	13.3	8.1	11.6	20.7	14.0	10.1	15.5	23.0	17.5	22.9	26.3	21.1	17.9	23.9	28.4	10.7	14.8	14.9	14.8	30.7	16.5	13.4
SMIM9	CXorf68	ENSG00000203870	"Small integral membrane protein 9"	A6NGZ8	X	154823348-154834662	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Early spermatids: 28.6;Late spermatids: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060970	Uncertain					NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA060970: AB_2684399"													"unprognostic (2.63e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 56.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.2	56.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3"									"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	28.0	21.8	5.7	4.9	6.1	21.8	26.8	7.6	7.5	33.8	5.0	25.8	2.1	24.7	12.8	25.8	31.5	7.4	20.4	6.3	7.1	22.6	37.6	22.0	15.5	6.5	5.7	36.8	27.6	6.9	26.4	5.1	6.1	25.6	7.8	12.1	21.5	3.8	31.5	24.0	19.6	8.2	5.9	22.6	20.3	24.8	5.7	2.4	24.2	1.5	1.9	26.1	27.6	6.6	11.3	2.1	3.5	4.0	19.3	23.0	62.8	3.5	4.9	5.3	3.8	4.1	4.1	4.6	69.5	9.9	5.8	7.4	5.4	3.7	4.2	1.0	5.2	65.4	6.2	6.2	1.3	7.9	5.8	1.5	29.8	1.8	1.8	31.4	3.0	4.1	2.7	6.4	2.7	3.2	120.5	77.9	4.4	0.9	2.1	6.0	15.9	58.0	2.4	5.2	11.4	16.2	6.5	23.4	69.4	2.4	88.9	21.2	32.7	33.8	3.8	3.1	7.5	4.2	3.0	60.0	4.9	4.8	120.3	9.8	7.4	4.3	6.4	12.2	17.6	13.2	10.2	7.7	11.2	7.2	13.1	14.5	2.1	8.7	13.5	13.1	16.1	6.3	5.7	6.1	7.6	7.5	6.3	7.1	6.5	5.7	6.1	5.9	5.7	6.6	5.0	9.6	11.5	0.0	5.6	13.9	4.6	10.7	0.6	4.7	4.1	4.3	22.4	7.2	29.9	1.8	10.4	7.9	7.0	2.3	5.9	6.8	18.2	5.6	5.5	6.8	6.0	9.9	1.3	4.6	8.4	11.8	4.1	4.4	19.6	4.0	5.0	2.9	4.8	3.3	1.1	4.2	10.2	3.4	4.4	12.9	9.3	5.2	5.4	0.0	6.1	1.4	12.3	1.0	1.3	6.5	1.8	6.4	5.1	2.9	3.8	4.5	28.1	7.8	13.1	7.4	8.5	16.0	17.2	6.9	12.5	8.8	7.2	5.6	4.2	4.1
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049638-70078522	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 41.8;Club cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2"									"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	19.7	15.6	1.6	4.5	1.8	13.8	19.4	1.0	2.3	20.3	1.0	19.2	0.5	20.0	16.9	17.1	15.2	13.6	16.0	1.1	7.2	14.4	23.2	16.4	13.8	1.7	2.0	25.9	18.3	8.4	20.5	3.8	2.0	18.8	5.6	3.0	15.1	5.8	26.0	17.0	13.6	14.0	1.3	14.7	14.5	16.5	1.6	0.1	17.3	0.0	0.1	16.0	20.9	2.3	61.3	0.6	0.6	0.4	16.1	20.9	122.7	31.7	21.1	42.0	44.0	0.4	0.4	1.2	86.6	31.8	1.1	28.8	0.9	0.0	50.1	0.8	1.2	68.6	0.0	2.1	0.0	1.1	0.0	0.3	36.0	0.0	1.1	14.3	0.7	0.0	0.0	0.6	0.0	0.6	125.1	106.2	0.5	0.0	0.5	0.0	45.8	55.3	31.5	0.3	30.5	70.7	60.2	6.7	89.7	0.0	41.4	25.2	53.4	27.2	1.3	0.4	0.7	0.6	1.1	72.4	0.4	0.0	76.2	8.0	9.9	5.2	12.1	16.5	14.6	16.8	14.4	10.1	16.6	20.0	17.0	14.8	1.8	10.9	11.4	16.3	12.7	13.4	1.6	1.8	1.0	2.3	1.1	7.2	1.7	2.0	2.0	1.3	1.6	2.3	2.0	6.4	7.8	0.0	2.7	13.6	3.4	9.7	1.8	0.3	2.7	2.8	41.8	0.0	20.2	1.8	0.0	6.9	4.0	1.1	5.9	2.7	14.1	3.3	4.0	6.6	1.8	3.4	0.0	1.0	3.3	10.1	2.6	3.2	8.2	1.2	2.5	3.1	2.6	1.7	0.0	3.1	6.1	2.6	6.8	8.9	7.2	3.3	1.8	0.0	2.9	0.6	2.1	0.0	0.0	2.3	1.6	5.3	2.5	1.7	2.7	3.8	14.0	1.1	0.0	5.3	6.4	12.0	11.4	3.1	12.6	7.1	5.0	1.0	2.5	2.8
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188633-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Granulosa cells: 13.0;Leydig cells: 20.8;Muller glia cells: 16.6;Peritubular cells: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.3;AN3-CA: 84.9;NTERA-2: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	5.2	6.0	9.4	2.6	10.8	0.4	5.5	9.9	9.6	27.4	18.4	9.6	2.5	19.2	18.6	12.0	14.5	8.4	8.0	8.9	10.0	19.0	23.9	3.6	2.2	12.4	12.4	28.3	6.3	16.1	19.2	2.6	9.9	20.0	2.1	2.0	11.5	12.3	3.7	17.1	5.7	8.1	11.8	2.8	6.3	5.6	11.4	4.4	9.1	3.7	2.0	9.0	16.7	9.7	1.6	18.2	45.3	84.9	1.1	0.2	14.3	5.2	6.7	10.1	5.8	13.8	0.1	0.0	13.9	10.4	22.8	28.3	27.4	1.5	3.9	0.0	23.0	9.4	0.0	22.5	5.5	0.4	0.0	16.2	11.0	3.3	0.0	19.9	5.8	24.9	1.5	0.0	3.1	0.0	24.4	0.1	64.2	0.0	5.3	35.1	19.7	0.0	5.2	0.0	1.3	30.2	0.0	0.0	12.3	16.8	11.1	5.8	0.0	0.7	14.1	17.6	10.1	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.8	9.9	9.6	8.9	10.0	12.4	12.4	9.9	11.8	11.4	9.7	0.4	0.0	0.0	27.4	0.2	1.9	2.3	3.9	2.8	0.7	3.3	5.2	1.4	2.8	3.8	11.0	0.0	0.3	0.4	0.0	1.9	3.4	0.4	1.0	8.6	0.6	0.0	0.0	1.4	1.1	0.3	7.6	0.0	1.3	0.0	13.0	1.4	8.4	4.2	0.0	0.8	0.1	2.0	1.6	1.8	1.3	20.8	1.0	0.0	3.7	0.6	16.6	0.0	4.5	0.5	1.3	0.1	21.8	0.0	2.7	0.0	3.9	0.7	0.4	6.6	3.5	3.9	0.0	2.0	3.3	2.8	0.5	0.1	6.9	0.6	0.7
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.2;liver: 67.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 104.4;Oligodendrocyte precursor cells: 372.4;Oligodendrocytes: 81.1;Peritubular cells: 133.2"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 50.3;HeLa: 122.6;HSkMC: 38.3;SiHa: 72.1;SK-BR-3: 30.6;U-266/70: 42.3;U-87 MG: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		140000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	15.9	10.3	29.2	0.5	30.3	0.1	6.2	53.2	29.1	9.4	17.5	1.3	1.9	2.2	7.7	0.3	6.6	0.5	8.3	27.9	31.6	3.0	67.9	0.6	0.9	38.4	38.8	1.4	10.3	0.3	4.4	8.0	36.8	33.4	1.0	2.4	5.8	38.8	12.7	2.4	1.4	1.0	41.2	27.2	3.8	35.7	29.6	0.4	4.2	2.7	0.5	1.3	6.3	52.8	0.0	3.3	50.3	0.0	9.8	6.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	2.9	0.0	0.0	20.4	0.0	122.6	17.4	0.1	0.0	0.0	38.3	11.9	1.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.0	0.2	72.1	30.6	0.0	0.3	0.0	0.0	0.4	0.3	2.9	0.0	0.0	42.3	0.0	0.0	51.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	29.2	30.3	53.2	29.1	27.9	31.6	38.4	38.8	36.8	41.2	29.6	52.8	0.3	0.0	0.0	12.1	2.5	0.3	0.0	0.7	0.0	2.1	1.3	3.8	2.0	7.2	0.1	0.0	16.7	24.2	4.0	0.0	0.0	0.3	4.7	11.9	0.6	2.9	15.6	0.0	1.0	2.3	0.8	6.0	3.6	1.5	0.0	1.4	3.3	104.4	2.8	0.0	13.5	0.1	14.2	2.5	0.4	19.0	7.8	0.3	0.0	1.0	0.1	0.3	0.0	372.4	81.1	3.7	0.1	133.2	12.4	0.0	0.0	0.0	1.1	0.3	0.0	0.7	2.3	2.1	3.9	0.0	0.4	40.2	0.4	0.4	0.0	0.1
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358327-68448508	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.5;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.1;Gastric mucus-secreting cells: 70.8;Horizontal cells: 301.2;Proximal enterocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 29.7;cerebral cortex: 24.9;hippocampal formation: 25.4"	"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 138.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 138.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.7;MOLT-4: 14.7;RPMI-8226: 12.4;SCLC-21H: 13.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 115.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 67.7"	"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	6.8	2.1	8.0	3.6	29.7	1.8	2.8	1.8	24.9	2.7	0.1	13.8	61.5	1.4	0.1	2.1	3.8	9.0	1.5	25.4	0.5	4.0	7.4	2.5	4.2	0.0	0.2	4.8	2.6	0.1	16.5	0.2	0.6	4.6	6.9	6.5	3.0	0.3	2.4	13.6	57.7	0.7	0.5	3.4	23.2	8.6	5.1	52.0	2.7	0.0	1.9	1.7	2.5	2.3	0.3	0.8	0.4	0.1	0.0	0.0	5.5	0.4	0.0	0.4	0.1	3.1	1.0	0.4	0.6	0.3	0.2	1.2	0.0	0.0	0.1	0.3	0.7	0.1	2.7	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.9	0.3	0.3	0.2	14.7	2.8	0.6	4.9	0.1	0.7	0.2	12.4	0.0	0.1	13.4	2.7	0.4	1.6	0.7	0.2	1.1	0.9	0.0	0.4	0.8	1.4	0.1	2.3	1.2	0.3	0.2	0.9	0.2	4.4	0.0	20.7	2.3	0.1	0.3	1.7	0.2	0.6	0.1	0.9	0.6	0.3	0.1	0.1	0.0	138.9	1.9	1.2	8.0	29.7	1.8	24.9	25.4	0.5	0.0	0.2	0.6	0.5	5.1	2.3	0.3	3.2	1.1	1.0	2.6	0.1	1.5	0.6	0.0	50.8	1.8	0.6	2.9	15.7	1.5	0.0	0.0	0.0	77.1	44.7	0.0	1.3	8.5	3.0	0.3	0.6	25.8	0.4	33.8	0.9	0.1	5.2	70.8	0.5	0.0	0.2	0.7	9.4	0.3	301.2	20.4	34.7	2.0	1.0	0.5	18.6	15.2	2.9	0.0	1.9	0.6	0.9	1.0	10.6	1.7	1.6	39.9	45.9	2.5	3.6	115.1	0.0	14.6	3.9	0.0	0.2	0.3	10.0	2.1	0.1	1.0	0.0	6.2	0.2	21.6	5.4
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360760-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"salivary gland: 59.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7;liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940709-21994837	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	29.7	94.3	52.0	34.7	53.5	50.8	49.6	56.0	61.9	42.7	43.7	52.0	54.9	44.7	63.6	30.6	28.6	40.5	53.0	53.9	50.2	119.9	44.3	36.2	47.8	48.6	46.7	91.2	24.1	28.0	31.5	114.2	49.1	136.0	50.4	49.5	39.7	42.2	34.6	21.4	50.9	39.6	47.0	41.3	39.3	30.2	53.9	50.7	55.3	32.5	47.3	55.1	32.0	49.6	664.3	161.2	265.3	107.1	71.9	121.4	86.3	174.6	102.6	261.7	249.1	204.0	213.0	239.5	59.8	180.0	722.9	142.2	265.5	318.2	508.2	111.0	128.6	124.4	201.0	145.5	129.4	242.2	103.8	76.8	93.7	266.4	497.2	189.2	254.5	93.6	270.6	32.7	366.7	139.2	181.3	244.1	474.9	149.0	244.3	176.0	188.5	182.9	354.3	90.1	131.4	105.7	143.1	181.8	489.1	687.6	163.9	101.3	232.3	194.4	193.6	405.0	294.5	23.8	52.6	142.2	378.4	107.5	275.6	9.1	57.5	102.5	18.9	59.9	23.7	34.6	29.6	33.3	51.1	22.0	19.1	22.8	55.7	31.4	73.9	10.7	55.4	37.3	52.0	53.5	56.0	61.9	53.9	50.2	48.6	46.7	49.1	47.0	53.9	49.6	43.4	25.6	21.9	33.6	61.5	65.9	203.0	206.1	42.1	35.7	116.2	66.3	36.1	81.5	115.0	110.3	12.5	644.3	46.7	61.2	608.4	246.3	1.9	126.4	70.4	61.9	58.8	95.2	45.6	152.3	313.1	86.6	57.6	215.9	40.5	249.5	59.6	49.8	364.7	21.9	40.2	103.6	146.5	157.3	200.3	7.1	95.4	153.1	92.5	21.5	250.7	46.8	48.4	22.1	8.1	165.6	63.9	103.4	45.6	276.2	137.0	466.7	78.9	43.2	65.7	76.6	114.2	6.0	181.3	54.1	50.6	869.6	63.7	271.2	119.1	153.1
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SMU1	"BWD, FLJ10805, fSAP57, SMU-1"	ENSG00000122692	"SMU1 DNA replication regulator and spliceosomal factor"	Q2TAY7	9	33041765-33076674	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019708	Supported		Approved	Vesicles		NA	NA		25000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA019708: AB_1857300"	"unprognostic (2.20e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.98e-3)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.67e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.96e-2)"	11.5	11.3	11.2	10.6	13.0	16.0	11.9	13.9	12.1	11.4	8.6	10.9	8.6	13.1	11.8	10.6	11.4	8.6	10.3	10.7	11.5	11.2	12.9	10.0	12.8	12.4	11.9	14.7	8.2	15.8	8.1	8.4	12.4	11.9	10.9	12.6	9.3	11.5	14.4	12.8	9.4	13.2	12.6	12.1	9.1	8.5	11.7	14.1	11.2	13.0	15.2	11.5	9.9	16.6	26.3	20.4	24.0	20.9	25.4	19.3	18.7	20.1	18.1	26.9	26.5	20.8	10.7	33.0	14.4	25.1	14.6	15.7	31.1	24.1	29.7	38.1	14.9	24.8	33.4	24.5	22.1	43.5	22.4	20.4	27.0	24.9	17.6	20.1	22.9	22.7	23.4	20.5	22.7	12.1	34.2	46.3	33.1	19.6	21.4	28.8	19.9	17.9	20.5	19.4	20.3	17.7	27.2	19.4	13.1	18.6	18.7	15.7	24.6	17.2	19.1	25.2	23.8	9.1	18.1	38.0	19.2	20.2	12.5	23.4	13.9	11.5	12.4	15.4	13.3	12.9	14.0	11.6	15.8	11.7	13.9	14.3	8.1	12.4	17.9	20.0	12.6	10.8	11.2	13.0	13.9	12.1	10.7	11.5	12.4	11.9	12.4	12.6	11.7	16.6	45.5	25.6	31.4	17.9	48.0	53.7	45.7	41.0	43.3	29.5	23.8	22.4	30.6	30.0	39.9	20.2	37.5	34.9	72.7	19.1	21.5	32.3	29.6	41.6	42.8	38.2	28.1	24.4	23.4	24.3	36.3	37.7	17.9	47.3	39.2	32.1	21.4	29.4	30.8	23.5	25.3	19.5	44.7	29.2	40.8	8.7	32.3	40.2	23.2	14.0	39.7	34.8	32.0	21.6	28.3	27.9	20.1	25.9	28.3	33.3	18.1	31.7	44.1	39.3	19.7	53.9	44.7	41.4	30.5	36.3	57.5	57.7	43.7	37.0	23.5	35.5
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027440-99144108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 100.2;Microglial cells: 89.9;Oligodendrocytes: 211.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 9.2;BJ: 15.2;EFO-21: 12.8;HDLM-2: 8.1;PC-3: 18.2;U-2 OS: 8.3;U-251 MG: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	17.7	13.9	0.7	0.3	0.8	1.1	14.3	0.5	0.9	13.4	1.1	12.7	0.0	12.3	0.0	22.0	12.2	0.0	9.0	0.8	0.3	11.6	11.7	18.5	0.0	1.1	0.7	20.6	15.5	0.0	11.2	0.0	1.0	13.3	0.0	0.7	15.0	0.0	12.7	20.2	11.7	0.0	0.1	10.0	16.1	20.9	0.8	0.0	8.5	0.0	0.0	12.4	15.5	1.8	9.2	0.0	0.1	0.2	0.0	0.0	1.3	15.2	0.1	0.4	0.0	0.0	0.4	1.6	12.8	0.0	0.3	4.5	0.0	0.1	0.0	8.1	2.3	0.0	0.7	0.7	0.1	0.1	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.1	0.8	0.1	1.3	1.9	2.8	0.0	18.2	2.5	1.2	0.0	0.0	0.4	0.3	1.5	0.7	0.5	0.9	0.3	0.3	0.0	1.4	0.0	8.3	1.3	9.4	2.0	4.9	1.3	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	0.9	0.8	0.3	1.1	0.7	1.0	0.1	0.8	1.8	9.7	19.2	27.5	59.4	8.9	25.9	25.5	10.0	25.0	28.2	10.3	7.2	4.4	20.0	18.5	12.9	8.4	7.7	4.6	17.1	1.9	14.7	6.2	13.3	8.8	12.8	11.4	0.4	100.2	16.0	10.3	10.8	46.9	23.3	2.5	6.8	9.7	9.3	6.6	26.9	77.0	11.0	4.1	4.1	10.9	8.5	6.2	8.8	8.8	89.9	5.5	3.3	5.2	70.4	211.9	34.8	14.9	13.9	5.4	37.9	7.1	5.5	22.1	7.6	6.6	10.4	15.1	32.8	2.4	19.3	22.0	21.1	8.8	6.5	8.1	77.5
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542282-64662307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 221.1;HBF TERT88: 157.4;LHCN-M2: 164.1;TIME: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA071508: AB_2686406"	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	6.8	4.3	3.3	6.2	3.9	5.9	5.2	5.3	3.4	7.3	3.4	5.3	6.9	5.9	2.3	4.4	5.8	7.1	4.1	3.1	3.3	7.0	3.8	10.5	5.0	4.6	2.7	4.8	6.5	6.3	3.4	13.3	2.8	7.4	4.8	12.5	6.2	5.2	3.0	5.0	10.1	6.1	3.2	5.4	7.8	13.0	3.6	7.8	8.3	6.2	6.5	7.5	3.2	3.8	67.0	17.8	15.3	9.1	11.0	41.5	7.6	221.1	103.2	88.2	73.4	10.4	45.5	8.6	14.5	38.8	29.9	15.2	16.0	37.2	157.4	4.3	12.9	9.1	10.9	11.8	12.0	12.2	5.5	11.8	16.1	109.5	48.5	52.7	97.0	11.9	13.0	7.5	164.1	13.2	28.3	4.8	9.9	8.8	23.8	6.1	38.4	5.2	20.1	11.1	16.0	17.9	14.4	5.8	10.0	24.6	11.7	8.4	207.6	93.8	44.4	39.2	139.6	10.4	11.7	13.9	23.7	7.3	28.4	1.0	0.6	1.4	1.0	0.4	1.1	0.7	0.8	1.1	0.7	0.9	0.9	0.9	1.4	2.7	0.3	0.6	0.2	0.5	3.3	3.9	5.3	3.4	3.1	3.3	4.6	2.7	2.8	3.2	3.6	3.8	40.2	32.1	26.0	96.3	18.6	43.8	30.8	10.0	25.0	26.4	23.3	18.7	10.3	7.2	16.1	9.2	43.8	13.2	35.4	13.8	9.8	18.1	29.0	29.0	37.2	39.3	17.9	2.5	46.1	10.0	3.6	28.1	12.2	39.7	13.3	21.4	38.2	5.1	13.6	26.9	40.9	11.2	10.2	17.3	25.5	9.2	12.5	22.8	21.4	101.2	13.2	21.4	20.6	101.0	52.8	26.5	24.7	12.0	18.0	25.2	28.0	9.6	14.4	46.7	0.0	37.4	23.3	37.1	21.3	13.7	39.8	7.3	33.5	16.2	13.8	24.6
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067825-88113384	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 160.4;skeletal muscle: 493.6;tongue: 301.3"	"Cell type enriched"	"Detected in some"	27	"Cardiomyocytes: 208.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9;stomach cancer: 1.6"	"Region enriched"	"Detected in some"	4	"basal ganglia: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HSkMC: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			0.0	0.0	0.2	0.2	4.1	0.0	5.4	0.1	1.0	0.0	0.0	17.9	2.0	0.0	0.0	7.3	0.0	0.0	160.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	2.4	0.0	0.0	0.3	4.0	1.9	0.0	3.9	0.0	493.6	0.1	7.0	28.1	0.1	0.0	7.3	0.3	0.1	0.4	0.1	301.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.1	1.0	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	208.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 198.8;skeletal muscle: 92.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 148.0;Cytotrophoblasts: 168.7;Early spermatids: 134.5;Extravillous trophoblasts: 110.5;Late spermatids: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Mitochondria	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	15.5	15.0	12.4	9.0	13.0	8.9	18.7	13.5	32.1	12.2	17.8	12.9	13.8	9.5	7.5	18.1	27.6	9.3	198.8	14.6	16.1	20.4	26.2	18.1	13.5	14.7	16.7	12.0	19.1	6.9	17.1	27.3	14.2	12.1	14.3	14.3	13.7	8.1	92.4	11.4	12.6	10.1	14.5	15.1	19.2	24.3	14.4	22.6	20.3	4.2	14.2	11.8	10.1	14.4	64.4	14.5	22.7	16.8	21.7	37.7	102.4	36.6	28.8	41.8	46.6	68.3	52.0	34.6	36.7	39.8	19.7	28.9	21.3	63.5	36.8	28.3	29.8	10.1	30.0	46.7	19.9	47.6	7.4	42.9	31.2	30.5	21.6	27.2	32.1	29.5	35.0	7.5	36.4	33.5	32.6	26.1	21.3	32.4	26.3	20.6	59.9	27.8	33.9	45.2	23.7	55.3	28.9	95.0	73.3	47.8	75.5	30.1	38.6	32.9	49.6	18.0	55.2	33.2	13.0	39.2	43.1	35.1	37.8	15.8	10.0	14.4	15.0	5.7	17.8	15.4	22.5	19.9	9.5	7.5	19.3	18.0	0.9	29.2	1.9	6.4	26.7	13.0	12.4	13.0	13.5	32.1	14.6	16.1	14.7	16.7	14.2	14.5	14.4	14.4	10.5	19.2	9.7	7.5	13.7	20.6	16.5	40.0	25.0	8.7	16.8	19.9	148.0	24.3	17.7	3.7	0.0	168.7	12.2	10.0	31.3	34.3	134.5	48.7	9.9	15.6	4.2	8.6	60.7	20.0	110.5	11.1	11.7	17.4	3.8	27.9	17.2	20.3	38.4	15.2	26.9	13.4	14.2	21.5	10.6	120.4	11.8	11.4	16.0	22.5	11.7	28.1	9.2	7.1	10.3	26.1	11.7	3.8	16.4	16.1	21.9	34.6	69.6	8.0	13.1	6.8	16.7	13.9	39.6	28.9	18.0	85.9	16.8	30.0	19.3	10.9
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.2;K-562: 162.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	7.9	12.1	9.5	5.0	9.6	9.7	11.1	16.4	9.6	9.1	5.8	7.5	5.0	7.1	22.1	6.4	10.3	8.2	6.7	10.4	10.2	9.4	6.0	9.8	7.7	7.0	10.3	8.2	7.8	9.5	9.2	5.3	9.8	6.8	8.8	7.0	6.6	5.4	11.6	8.0	6.0	6.7	4.4	5.7	7.3	8.7	11.6	10.8	16.0	9.8	7.7	10.1	5.9	6.8	20.8	12.6	17.8	15.4	19.9	27.1	17.3	28.7	21.4	33.4	74.4	16.2	23.7	33.5	22.6	27.0	20.8	13.2	16.3	32.1	111.3	17.7	16.4	20.0	17.9	19.5	37.3	20.1	402.2	73.5	7.6	44.3	28.5	25.3	23.1	23.5	162.0	11.5	33.0	7.0	38.8	38.8	15.9	29.1	19.5	35.5	21.3	48.9	24.5	29.3	41.9	19.8	13.5	2.0	26.4	19.3	16.5	33.8	17.6	15.9	11.0	11.4	34.8	57.0	16.7	17.3	30.5	27.3	18.8	13.1	4.6	11.5	12.9	4.1	13.7	14.2	13.7	16.4	8.0	15.8	15.1	16.1	3.2	27.5	4.6	5.0	16.2	12.1	9.5	9.6	16.4	9.6	10.4	10.2	7.0	10.3	9.8	4.4	11.6	6.8	14.2	6.4	30.7	406.1	16.2	12.2	14.7	26.5	13.1	7.7	8.7	9.3	9.1	4.3	18.9	12.9	22.9	8.1	15.8	5.1	15.6	22.3	54.8	24.9	14.3	12.7	25.1	6.3	725.6	31.1	42.6	15.9	9.2	13.6	110.9	25.7	12.5	4.9	12.3	10.1	788.3	7.9	26.4	4.1	10.2	110.9	11.1	6.0	12.4	277.3	3.7	7.6	16.5	372.4	136.5	24.0	3.7	17.3	19.9	4.8	4.0	19.3	36.9	13.2	0.0	12.1	20.7	19.6	27.5	12.0	11.5	7.3	18.3	46.3	8.8	10.0
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	7.4	6.6	4.1	6.0	3.6	3.4	7.3	8.0	4.5	7.9	3.7	7.5	7.0	6.5	5.0	3.9	7.3	3.6	7.0	3.5	3.5	3.7	4.9	5.6	6.8	3.7	3.2	9.5	6.7	3.6	6.6	4.7	4.0	6.5	4.8	7.6	7.3	5.6	13.7	6.6	7.4	5.9	2.2	6.3	4.9	5.8	4.3	6.2	5.7	10.2	6.5	7.2	6.2	5.6	7.4	13.7	13.5	9.6	9.0	6.1	15.7	11.9	6.7	12.3	12.5	22.0	6.2	19.7	7.8	4.8	8.3	14.2	12.9	7.7	15.3	5.7	13.1	7.2	15.9	6.0	4.5	7.4	6.8	4.4	6.8	12.7	11.1	6.3	6.2	16.6	7.6	7.5	9.7	4.6	13.6	5.3	6.2	8.7	6.6	16.7	6.9	5.0	4.9	8.8	5.5	7.6	11.0	4.5	11.1	10.9	6.7	4.5	5.9	12.0	6.1	10.0	10.4	5.2	7.5	7.1	6.8	6.4	11.9	12.0	2.4	2.3	5.1	3.0	4.3	4.0	3.0	3.3	1.5	2.7	3.4	5.0	1.3	3.1	2.4	4.5	3.5	2.1	4.1	3.6	8.0	4.5	3.5	3.5	3.7	3.2	4.0	2.2	4.3	5.6	22.9	6.4	27.8	6.5	12.9	5.0	9.3	11.9	14.8	19.3	6.9	8.4	6.3	14.3	14.0	7.3	33.3	9.7	16.5	6.9	1.9	5.7	20.2	3.7	8.9	10.9	3.6	9.7	11.7	3.3	10.9	14.2	4.1	3.5	7.6	14.7	17.2	6.7	12.9	26.9	12.1	5.2	12.2	23.3	9.2	5.9	27.1	17.4	5.4	13.1	16.4	7.9	43.3	4.5	7.1	4.2	2.0	24.8	10.1	7.2	23.3	2.9	17.8	19.9	46.0	43.6	23.9	12.6	14.8	5.1	6.7	8.1	12.1	6.1	6.4	3.5
SMYD5	"NN8-4AG, RAI15, RRG1, ZMYND23"	ENSG00000135632	"SMYD family member 5"	Q6GMV2	2	73214222-73227221	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015514, HPA049002"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA015514: AB_2669205, HPA049002: AB_2680595"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.66e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.58e-7)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.40e-1)"	13.3	19.1	27.2	12.1	27.8	11.6	14.8	24.3	30.5	15.5	22.0	12.5	7.3	14.4	19.4	14.1	19.5	7.3	17.9	28.2	28.0	18.8	15.2	9.8	13.1	28.9	26.5	28.3	18.4	17.9	15.4	13.1	28.8	15.4	11.3	13.0	12.2	13.4	17.7	14.5	12.4	14.5	25.9	16.2	11.4	17.4	26.9	8.2	14.3	13.0	16.0	17.5	13.1	26.9	24.3	45.2	27.0	25.9	19.3	28.4	45.7	22.8	23.0	43.4	26.6	59.4	24.4	43.1	20.9	38.6	52.1	24.4	42.2	49.4	39.1	26.3	29.7	41.8	19.5	65.9	26.0	41.5	16.5	24.0	31.4	39.7	47.3	19.2	26.7	33.9	44.9	20.2	27.9	34.1	38.8	27.1	42.2	50.8	36.3	25.6	50.6	35.5	28.6	34.6	17.4	25.9	20.7	30.7	26.4	24.4	25.0	14.7	18.5	29.7	46.3	36.5	38.1	22.0	17.7	38.2	33.5	35.2	24.3	0.0	1.4	0.0	5.1	3.9	11.1	6.0	7.0	6.8	3.2	6.2	7.0	7.7	0.0	4.5	4.3	3.0	3.1	4.5	27.2	27.8	24.3	30.5	28.2	28.0	28.9	26.5	28.8	25.9	26.9	26.9	4.1	3.2	5.6	5.2	5.6	5.1	3.9	2.3	1.8	10.2	5.4	6.7	7.2	2.8	4.4	5.5	4.2	9.0	3.4	2.4	1.9	8.5	0.5	2.8	4.2	4.9	0.0	9.5	5.0	8.8	10.4	4.5	2.6	3.7	7.0	9.5	2.9	4.8	5.9	5.0	5.2	4.4	4.1	2.4	2.5	2.9	2.8	2.7	5.4	2.8	3.7	4.0	4.1	1.5	3.5	5.6	1.5	3.0	3.1	5.0	1.3	8.1	1.3	5.3	6.6	4.0	4.6	6.7	11.1	5.7	3.4	4.8	4.5	4.6	5.6	3.6
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982980-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 28.1;TIME: 39.3;WM-115: 25.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 7.0"	"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146"	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (8.82e-7)"	"unprognostic (1.88e-2)"	30.3	12.0	2.5	4.4	2.3	4.5	16.8	2.7	2.8	6.1	2.7	5.1	1.0	7.0	0.7	2.7	9.6	16.5	16.0	2.2	3.8	8.3	5.2	16.7	2.1	4.5	2.7	2.4	5.1	1.3	6.5	7.2	2.6	4.1	0.8	0.3	3.9	2.4	2.3	4.6	3.3	3.1	2.4	9.7	5.9	3.9	4.2	0.8	15.4	1.3	0.7	9.4	4.6	3.0	1.2	0.9	5.4	0.7	1.6	1.0	10.9	4.7	5.8	0.9	0.6	8.9	1.4	0.7	12.6	8.4	5.6	0.1	1.6	0.0	0.5	0.1	1.1	0.6	2.0	5.4	13.6	1.5	4.3	3.1	0.3	2.0	0.0	14.3	14.0	0.7	7.0	0.2	0.0	2.0	0.1	1.6	7.2	0.8	3.8	2.5	1.4	0.8	6.4	0.0	2.3	5.6	28.1	7.1	1.2	4.6	1.4	6.5	39.3	0.0	6.8	0.0	0.1	0.2	0.1	7.5	2.3	2.1	25.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.5	2.3	2.7	2.8	2.2	3.8	4.5	2.7	2.6	2.4	4.2	3.0	191.3	0.0	5.3	0.3	11.8	5.2	2.4	0.5	5.2	0.6	18.6	37.0	4.5	2.8	3.8	0.0	0.0	8.3	29.7	2.8	0.0	1.5	3.0	5.8	18.6	54.4	1.8	0.0	0.6	0.2	79.9	31.7	5.6	8.7	1.3	1.0	17.5	0.3	8.0	3.3	0.4	4.5	2.0	6.4	40.3	0.8	5.6	35.6	5.4	0.0	1.0	0.8	0.0	0.0	0.7	4.7	1.6	14.3	2.2	1.6	1.4	0.2	1.0	0.4	6.6	7.6	17.5	1.4	3.8	7.2	4.8	14.0	12.2	7.2	3.0	0.6
SNAI2	"SLUG, SLUGH, SLUGH1, SNAIL2"	ENSG00000019549	"Snail family transcriptional repressor 2"	O43623	8	48917598-48921740	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Deafness, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.8;Basal prostatic cells: 119.4;Basal respiratory cells: 98.9;Endometrial stromal cells: 129.2;Melanocytes: 87.2;Suprabasal keratinocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 243.2;ASC TERT1: 247.8;HSkMC: 181.3;hTERT-HME1: 180.3;LHCN-M2: 228.8;U-138 MG: 206.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011671	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB011671: AB_777968"	"unprognostic (3.52e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.83e-4)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (4.69e-8)"	"unprognostic (1.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.16e-4)"	28.2	10.6	0.5	15.7	0.8	0.4	22.9	3.6	1.4	51.1	1.7	11.6	4.3	43.0	11.3	15.8	34.4	21.8	15.0	0.8	0.5	12.4	9.6	11.1	8.1	0.8	0.5	40.8	8.0	3.6	2.3	16.2	0.6	19.8	7.6	0.1	16.8	23.2	4.6	39.8	11.5	27.5	0.4	14.2	9.4	3.7	0.6	6.9	9.5	7.7	7.9	37.8	51.3	0.5	17.7	0.6	38.5	0.4	243.2	247.8	0.1	38.6	69.0	38.1	52.3	0.0	17.4	0.0	0.0	50.1	56.7	28.9	0.4	111.8	40.2	0.0	0.8	0.0	7.2	0.1	88.5	0.1	0.1	181.3	116.8	31.9	180.3	5.4	1.3	0.0	0.0	18.5	228.8	0.3	0.0	0.1	2.3	0.0	34.7	0.0	122.2	0.2	0.1	6.8	5.1	3.8	3.3	0.1	69.2	18.9	0.2	0.2	10.6	206.6	7.4	36.6	20.9	0.0	0.1	4.2	74.9	0.0	78.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.6	1.4	0.8	0.5	0.8	0.5	0.6	0.4	0.6	0.5	11.7	0.0	0.0	0.0	0.1	162.8	119.4	98.9	60.9	1.9	2.1	22.0	1.2	1.5	14.0	0.0	0.0	1.7	0.3	0.0	0.0	3.0	0.6	5.2	129.2	19.5	0.0	0.0	0.6	2.3	0.5	69.9	0.0	4.8	0.0	0.0	40.0	6.8	1.7	0.0	0.5	0.0	10.2	0.8	30.7	1.7	73.7	1.9	87.2	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.0	67.4	1.4	18.4	0.0	0.0	2.4	0.2	52.6	24.7	59.2	0.2	0.4	32.3	147.9	2.2	2.3	21.8	0.0	25.0
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 675.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		3900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	44.4	30.3	23.0	62.9	27.7	35.1	38.2	25.7	46.3	37.5	28.6	52.8	50.3	43.2	35.3	31.9	29.8	40.2	44.6	23.5	24.8	42.4	44.4	45.2	84.6	28.0	25.9	34.6	24.2	36.2	12.9	68.9	31.3	49.2	51.2	12.8	45.2	30.9	43.9	26.5	56.4	48.3	25.6	70.3	39.9	36.1	27.5	38.0	33.1	28.7	78.7	42.5	23.9	37.2	58.3	29.7	55.7	54.7	91.8	70.4	85.1	77.6	61.8	50.8	59.1	93.0	27.8	35.1	91.3	52.3	48.1	52.7	63.2	50.1	70.9	58.4	35.3	149.2	30.5	89.1	66.8	57.4	136.6	59.1	37.9	43.5	70.4	64.7	192.9	69.4	121.6	31.4	67.1	24.1	68.3	69.4	46.0	94.3	22.8	122.4	33.8	55.1	71.8	57.8	9.0	36.3	57.2	51.3	56.4	83.5	76.2	91.6	155.0	46.6	61.2	52.1	80.4	59.1	122.3	153.2	56.3	120.0	62.8	244.8	159.8	675.6	51.4	237.6	60.2	110.2	53.5	50.2	148.2	103.9	68.0	52.4	361.9	70.7	236.0	62.6	66.4	179.4	23.0	27.7	25.7	46.3	23.5	24.8	28.0	25.9	31.3	25.6	27.5	37.2	58.9	112.2	30.5	30.7	79.0	50.7	107.6	30.8	34.7	7.7	41.9	19.8	19.2	38.6	32.8	20.2	20.9	75.9	45.3	61.3	56.7	71.1	207.6	34.4	38.6	77.1	14.9	25.0	21.2	52.2	109.5	44.3	32.6	41.2	83.5	22.4	77.4	28.0	88.9	5.0	23.6	80.2	52.9	125.4	112.8	326.0	39.1	131.8	44.4	36.5	120.0	14.6	53.5	39.7	54.6	110.8	52.8	60.5	27.9	79.9	55.0	76.2	42.6	18.4	52.6	42.1	40.6	16.7	7.9	29.3	38.5	142.6	48.2	47.8	39.7	64.7
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	20	"brain: 1658.7;retina: 492.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 28.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		9000		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	1.5	43.6	251.0	4.1	383.5	0.2	4.4	598.0	1658.7	0.8	0.0	5.7	3.7	7.9	12.9	0.5	7.7	2.3	3.2	420.4	142.2	1.4	1.0	1.8	0.4	427.4	24.7	6.9	6.3	1.2	54.3	0.6	386.6	3.2	2.3	492.0	0.5	19.6	0.8	0.7	3.9	8.1	38.1	0.2	6.3	3.6	147.6	0.5	0.7	0.1	0.4	1.1	1.6	726.9	0.0	4.7	3.9	0.0	0.4	0.1	0.0	2.0	0.0	4.8	1.4	0.0	0.0	0.0	4.3	0.0	3.4	0.8	0.6	0.0	9.6	0.5	0.3	0.0	6.8	0.7	3.5	0.0	0.5	4.4	0.0	3.9	0.0	10.7	0.0	2.8	0.0	23.8	1.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.1	0.9	0.0	78.2	46.6	0.7	0.1	0.0	2.4	0.0	6.5	0.0	5.0	6.8	0.0	2.3	0.1	12.9	0.1	56.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	251.0	383.5	598.0	1658.7	420.4	142.2	427.4	24.7	386.6	38.1	147.6	726.9	0.5	0.0	0.0	117.2	0.0	0.8	1.4	0.1	0.0	559.2	0.2	1.3	0.5	8.6	0.0	0.0	106.3	0.0	0.2	0.0	0.0	0.2	16.3	0.1	0.7	5.2	43.5	0.0	1015.8	0.0	0.1	3.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	65.6	552.8	3.4	0.0	0.0	0.4	83.3	17.1	0.1	1.8	120.9	0.0	71.9	0.0	179.4	113.3	1.0	2.6	68.8	0.0	0.6	0.1	3.0	0.0	254.4	0.0	0.0	1.3	1.1	0.4	0.0	0.9	0.0	0.0	2.6	0.1	0.1
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20859007-20891214	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 524.1;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 220.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151"	"unprognostic (1.76e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	18.3	18.0	10.8	17.1	11.5	18.9	15.9	12.8	18.0	15.3	11.7	19.9	17.4	14.5	11.1	23.1	12.8	13.7	18.9	12.0	11.4	16.8	35.8	13.9	17.0	12.6	11.7	13.6	17.3	18.7	11.0	19.1	12.4	13.5	17.8	14.4	15.8	14.1	31.2	19.0	16.6	18.1	11.2	16.8	18.6	56.5	11.0	24.1	12.3	27.4	19.7	15.6	15.7	12.5	48.4	19.4	27.1	22.3	30.0	43.5	35.0	44.8	40.3	49.5	49.5	26.8	16.7	30.1	27.9	42.2	50.0	27.8	35.8	30.4	53.2	43.5	27.3	50.0	20.9	29.2	42.7	44.6	38.8	34.6	42.2	51.9	37.2	34.0	35.1	25.5	220.8	41.5	46.2	33.1	40.7	42.9	8.9	55.9	20.2	38.9	60.6	12.1	29.1	25.5	22.0	26.2	48.0	29.9	51.0	33.3	46.8	35.3	30.7	50.1	45.5	34.6	35.6	42.4	74.0	55.3	37.5	29.8	36.7	49.0	43.7	52.4	21.7	61.5	22.7	23.7	21.2	23.7	38.0	22.6	19.3	19.8	49.0	60.0	77.9	43.6	34.5	34.6	10.8	11.5	12.8	18.0	12.0	11.4	12.6	11.7	12.4	11.2	11.0	12.5	24.4	12.8	29.0	8.8	19.0	16.7	24.5	34.7	17.6	12.4	26.4	22.5	22.5	21.5	22.9	23.9	12.5	80.1	35.9	40.0	43.0	40.3	524.1	26.3	28.2	30.1	22.1	36.4	9.6	50.0	146.0	28.4	26.5	22.3	29.2	25.0	29.6	46.5	74.4	20.2	7.2	27.6	32.6	49.4	23.1	191.7	33.2	46.7	35.6	2.8	51.4	30.6	48.4	10.6	12.1	59.4	21.4	36.5	44.1	26.7	38.8	36.8	37.4	13.2	39.5	21.9	27.9	113.5	81.1	28.2	15.5	98.2	26.5	70.3	25.3	29.7
SNAP47	"C1orf142, SNAP-47, SVAP1"	ENSG00000143740	"Synaptosome associated protein 47"	Q5SQN1	1	227728200-227781826	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028167	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028167: AB_10603032"	"unprognostic (3.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-1)"	14.2	43.8	19.8	10.0	22.0	10.1	16.9	18.3	23.8	23.9	12.5	20.5	10.1	28.9	15.3	14.0	25.9	12.4	38.6	22.4	17.0	19.4	27.0	11.7	18.1	14.4	15.4	47.2	16.5	23.5	27.4	20.1	15.2	17.3	8.9	12.9	18.2	12.1	36.3	16.6	15.3	18.5	15.3	14.6	17.0	38.6	16.7	17.1	17.1	23.4	14.1	19.9	14.7	17.7	33.5	44.2	27.2	27.7	30.3	25.1	35.0	21.2	33.7	35.5	26.5	29.4	29.8	23.8	37.9	33.2	27.3	36.2	33.6	37.9	27.6	48.1	63.4	19.8	28.0	18.9	21.6	30.8	17.8	28.0	32.2	43.3	24.7	28.3	29.4	28.7	37.6	23.7	32.1	22.0	31.5	29.0	44.3	42.5	65.1	32.8	32.3	37.7	20.4	28.1	50.5	32.1	33.6	44.0	33.5	26.4	55.1	27.8	21.3	30.9	38.4	30.7	52.5	30.2	23.2	28.9	28.0	23.0	40.8	19.1	21.0	34.0	29.4	21.2	28.3	22.6	33.1	34.2	23.3	21.3	27.1	25.4	7.4	30.5	27.7	24.0	46.4	25.4	19.8	22.0	18.3	23.8	22.4	17.0	14.4	15.4	15.2	15.3	16.7	17.7	10.1	6.4	13.1	9.4	16.1	13.4	15.9	16.2	16.5	30.8	16.5	14.7	13.0	22.8	13.2	14.7	27.1	24.3	18.7	8.7	35.2	19.9	49.4	7.2	14.3	11.7	16.2	13.5	12.0	18.2	28.4	15.1	10.7	6.9	5.7	21.0	11.0	13.8	16.3	42.1	9.6	8.6	22.4	8.8	6.2	95.9	25.7	7.6	12.4	8.4	22.3	30.5	45.3	6.6	6.1	17.0	3.3	20.7	22.7	16.5	12.4	15.8	8.9	33.5	13.1	12.0	14.0	41.9	26.4	8.5	15.3	27.5	19.4	23.3	10.5	10.1
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 80.8;pituitary gland: 25.8;retina: 91.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5;prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	25	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.8"	"Group enriched"	"Detected in some"	10	"GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA		28000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	0.3	7.9	42.1	1.0	52.0	0.0	0.6	61.2	80.8	1.1	0.0	1.2	0.3	0.7	0.1	0.1	0.7	1.0	0.7	51.3	31.6	0.1	0.0	0.3	3.0	40.9	11.1	2.1	1.5	1.1	25.8	0.5	41.1	3.1	0.6	91.8	0.5	0.6	0.2	0.1	0.8	0.7	7.2	1.4	0.9	12.1	23.0	0.3	0.9	1.5	1.9	0.4	0.4	40.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	7.4	0.3	1.0	0.0	0.0	0.4	1.4	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.2	0.3	23.7	14.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	42.1	52.0	61.2	80.8	51.3	31.6	40.9	11.1	41.1	7.2	23.0	40.8	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	49.8	0.1	0.0	1.3	0.0	0.0	0.0	62.6	1.5	0.1	0.1	0.0	0.0	23.9	0.2	1.4	0.3	0.0	0.0	336.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.0	296.9	0.0	0.0	0.0	0.0	12.8	0.9	0.0	0.0	31.9	0.0	10.9	0.0	209.1	89.0	0.4	0.0	1.2	0.0	0.5	0.0	0.0	0.0	59.8	0.0	0.0	0.1	29.6	4.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNAPC5	SNAP19	ENSG00000174446	"Small nuclear RNA activating complex polypeptide 5"	O75971	15	66490135-66497780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024379	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024379: AB_2671552"	"unprognostic (4.43e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.56e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.69e-2)"	22.4	26.0	31.5	17.3	32.0	15.0	21.8	33.3	40.5	20.4	34.9	32.9	15.7	25.1	41.1	15.8	22.9	13.9	42.3	32.4	34.2	33.0	35.1	19.4	23.8	31.8	33.2	20.9	22.3	32.9	27.4	18.2	33.0	24.4	18.7	28.6	18.5	22.1	60.1	15.1	19.7	20.2	31.3	22.8	23.2	32.6	33.3	21.3	26.9	27.5	22.3	27.3	17.8	33.6	17.3	54.2	23.4	50.4	27.8	26.5	26.3	19.4	27.1	24.5	17.2	31.1	40.3	21.2	44.6	22.6	22.4	35.5	62.6	27.0	27.3	37.7	34.6	28.5	56.2	47.0	33.0	72.8	30.2	22.4	33.2	20.2	49.9	16.5	17.0	38.6	92.8	43.3	18.2	37.7	35.0	28.5	24.3	72.2	23.0	33.8	23.0	79.5	30.2	24.9	30.1	24.3	22.1	44.0	86.5	49.4	40.5	48.7	17.8	23.0	43.2	25.1	33.3	30.2	56.5	36.3	23.7	93.2	47.9	32.5	26.7	34.7	33.6	43.3	42.3	43.8	40.4	45.2	22.6	32.7	53.5	45.3	13.0	49.2	47.0	39.1	50.7	32.3	31.5	32.0	33.3	40.5	32.4	34.2	31.8	33.2	33.0	31.3	33.3	33.6	24.2	22.4	19.2	13.1	20.1	9.4	16.2	33.0	8.6	13.7	19.1	24.5	53.1	18.6	27.9	27.6	10.4	33.4	23.9	13.9	84.1	27.1	118.4	28.4	18.1	23.3	13.9	17.9	8.6	47.6	26.6	22.5	11.7	14.0	19.6	25.1	12.5	48.2	47.2	18.5	10.2	18.1	38.7	18.2	11.8	98.3	26.8	20.3	26.6	8.4	33.2	22.2	43.3	8.5	13.6	27.9	11.1	27.8	19.2	28.7	17.1	79.7	46.4	19.7	0.0	21.3	25.5	92.3	40.7	15.7	9.7	22.3	26.0	30.0	18.6	19.2
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658703-153661852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	34.6	50.8	41.5	18.5	42.9	13.1	30.3	44.3	43.0	23.9	38.7	35.7	12.8	30.7	34.1	35.1	27.5	21.7	63.7	39.9	43.5	37.8	32.1	21.0	27.4	43.1	42.3	24.0	17.5	41.2	16.4	19.0	42.9	24.4	20.2	25.1	22.1	29.4	91.5	27.9	23.2	30.4	44.5	30.9	26.3	19.2	43.0	30.6	25.5	77.0	31.9	31.1	23.5	45.1	50.8	60.6	51.5	31.0	63.2	42.7	32.4	41.7	46.1	57.8	43.9	43.9	39.3	35.8	82.6	42.9	29.0	65.6	42.5	54.4	40.9	49.3	57.4	39.6	41.3	21.1	65.4	39.3	24.4	50.5	41.1	43.6	49.0	61.0	54.8	41.7	34.7	27.8	59.5	82.7	46.0	23.9	27.5	78.6	64.7	42.9	44.1	96.8	65.0	47.6	38.9	67.8	48.0	55.0	57.8	50.3	84.0	43.5	48.4	27.2	40.5	54.4	40.0	65.6	77.4	56.0	51.4	24.9	36.1	106.2	146.9	139.7	86.8	154.1	100.6	130.1	88.2	88.9	153.5	119.6	96.9	87.9	30.4	118.1	126.8	115.6	136.3	146.6	41.5	42.9	44.3	43.0	39.9	43.5	43.1	42.3	42.9	44.5	43.0	45.1	41.7	19.2	16.6	7.2	31.6	20.6	35.1	88.7	35.9	14.2	39.1	44.4	39.8	40.0	45.3	29.5	8.4	64.4	35.9	18.0	74.3	71.4	9.6	31.5	24.2	34.9	13.8	33.6	5.9	65.2	49.5	31.2	16.3	25.6	30.4	31.9	40.7	35.1	90.2	21.9	6.5	20.0	40.7	48.3	21.8	26.6	30.7	34.7	26.6	4.7	76.5	84.8	59.8	8.0	14.4	53.5	25.5	49.7	23.8	34.7	26.6	76.7	40.9	21.7	46.0	25.3	39.7	29.3	42.6	45.5	23.4	73.7	26.9	44.2	24.6	36.2
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;ovary: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"							HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.1	1.0	2.5	2.5	7.8	0.3	1.4	7.2	3.0	17.2	10.1	1.1	1.2	19.5	1.3	0.6	5.1	2.5	1.3	2.9	2.9	1.7	0.1	1.2	2.1	4.6	5.2	37.5	0.5	0.2	1.2	2.0	4.2	1.9	1.1	0.5	0.4	2.7	0.3	1.8	0.7	12.0	3.0	5.2	1.0	4.5	5.7	1.7	0.8	1.6	1.5	4.1	2.5	4.3	0.0	0.0	5.2	0.1	0.0	0.0	0.1	2.2	5.1	0.8	0.4	0.0	0.1	0.1	0.1	2.2	0.4	0.0	2.1	0.3	3.2	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.1	2.5	3.0	0.0	0.1	0.0	5.2	0.2	0.6	0.9	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.5	0.3	0.4	0.0	0.0	0.2	0.2	0.0	0.1	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.5	7.8	7.2	3.0	2.9	2.9	4.6	5.2	4.2	3.0	5.7	4.3	6.1	0.0	0.5	84.5	0.0	1.8	3.8	0.5	1.8	0.4	0.4	1.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	68.1	4.6	56.9	7.1	0.0	0.0	21.8	0.0	0.1	5.6	0.0	1.4	1.3	0.1	18.9	0.2	0.3	0.0	62.8	0.0	0.0	0.8	0.4	16.6	5.3	0.6	1.8	13.1	0.0	0.5	0.0	30.7	1.9	0.4	0.7	5.7	0.0	3.0	0.0	0.3	14.9	0.0	0.0	0.5	2.3	4.1	2.1	1.8	2.7	0.1	0.4	0.1	0.2	1.5
SNCB		ENSG00000074317	"Synuclein beta"	Q16143	5	176620082-176630556	"Human disease related genes, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 439.2;retina: 182.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 105.1;Excitatory neurons: 36.8;Horizontal cells: 50.5;Inhibitory neurons: 32.6;Rod photoreceptor cells: 49.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 11.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002681, HPA035876"	Enhanced	Supported				NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB002681: , HPA035876: AB_10670592"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-2)"		"unprognostic (6.07e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.41e-5)"	"unprognostic (1.31e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.42e-3)"	0.1	3.2	81.7	0.0	154.5	0.0	0.1	74.3	439.2	0.1	0.0	1.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	136.3	41.9	0.1	0.2	0.2	0.2	104.2	23.8	0.3	0.8	0.0	17.1	0.0	77.7	0.1	0.0	182.2	0.1	0.0	1.9	0.3	0.4	0.0	1.3	0.2	0.3	0.6	63.1	0.0	0.2	2.8	0.0	0.1	0.1	237.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.7	0.0	6.0	0.3	2.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	1.8	1.0	0.0	0.0	3.9	0.0	2.3	0.0	0.0	0.3	0.0	0.0	54.6	2.0	0.0	0.2	5.4	0.1	2.5	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	154.5	74.3	439.2	136.3	41.9	104.2	23.8	77.7	1.3	63.1	237.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	105.1	0.0	0.0	1.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	50.5	32.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	10.3	0.0	3.5	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958599-86963258	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 268.3;brain: 411.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 279.9"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581, CAB080022"	Enhanced	Supported				NA	NA		23000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (2.29e-8)"	"prognostic unfavorable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	208.2	268.3	215.6	11.9	150.8	0.0	98.1	199.9	313.3	33.3	44.0	27.0	9.2	22.9	15.1	25.4	64.5	12.7	31.7	190.2	387.7	22.3	4.3	13.9	11.6	411.2	276.4	42.1	5.3	3.3	11.1	11.9	357.8	36.6	4.9	52.7	22.9	101.6	14.6	28.6	18.8	10.1	155.3	64.2	16.4	5.4	304.7	9.0	20.3	13.7	25.6	204.8	38.9	148.8	2.6	6.8	0.7	1.1	0.3	3.9	0.7	0.8	0.0	0.0	0.0	1.1	748.2	0.0	22.6	1.4	0.0	71.0	0.0	3.4	0.0	0.1	1.4	3.6	109.6	2.0	1.4	0.0	1.8	2.8	55.5	0.0	0.6	0.2	49.8	0.0	5.3	0.0	0.0	0.6	0.2	0.4	11.3	0.0	0.4	0.0	0.4	0.3	0.2	483.5	0.1	0.0	6.5	8.7	0.9	1.0	151.7	0.3	160.9	1.1	3.7	0.3	0.0	0.2	0.0	0.0	0.8	3.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	215.6	150.8	199.9	313.3	190.2	387.7	411.2	276.4	357.8	155.3	304.7	148.8	164.9	0.0	0.0	7.5	1.5	28.8	65.9	16.3	11.4	32.2	61.1	156.1	1.9	8.6	14.6	55.2	6.2	19.4	2.8	0.1	125.2	3.6	0.6	0.4	0.8	143.3	0.0	2.7	9.9	1.1	0.6	14.2	0.5	0.6	0.0	0.1	206.0	0.8	5.5	87.5	28.0	0.0	20.3	1.8	27.3	3.7	59.0	2.2	23.2	6.5	0.9	66.4	0.0	4.5	7.5	4.7	2.2	9.8	0.0	14.2	0.3	1.3	2.4	109.3	92.1	2.5	234.3	0.6	0.7	2.6	19.7	6.2	2.7	16.9	0.0	358.3
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNED1	"FLJ00133, Snep, SST3"	ENSG00000162804	"Sushi, nidogen and EGF like domains 1"	Q8TER0	2	240998618-241095568	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Excitatory neurons: 86.0;Leydig cells: 95.1;Microglial cells: 77.8;Peritubular cells: 71.1;Skeletal myocytes: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"ASC TERT1: 410.4;HSkMC: 211.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036414, HPA036415"	Uncertain				"Secreted to blood"	NA	NA		27000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA036414: AB_10960852, HPA036415: AB_10964128"	"unprognostic (1.41e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.62e-2)"	"unprognostic (7.77e-4)"	"unprognostic (3.49e-2)"	"unprognostic (4.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.95e-3)"	23.8	9.3	4.2	6.4	8.5	1.2	15.8	14.1	6.9	34.1	32.4	7.3	4.5	18.0	11.8	6.1	21.6	18.7	11.1	10.7	11.7	7.1	8.0	13.3	4.7	8.3	6.4	21.9	7.3	3.1	7.2	1.9	4.8	12.5	3.4	2.5	14.6	7.5	19.8	12.1	10.4	6.3	0.6	14.1	5.7	9.3	2.2	3.3	30.2	9.1	2.9	11.5	10.7	5.9	0.1	0.6	0.4	4.8	61.1	410.4	0.3	2.4	1.5	0.5	0.2	0.2	0.2	0.1	1.0	4.4	0.5	0.2	0.4	0.0	0.3	2.7	1.0	0.2	4.5	0.4	2.6	0.2	0.5	211.6	0.1	0.5	0.3	28.4	9.5	0.2	0.1	2.7	11.5	2.4	1.6	0.2	0.7	0.1	0.3	0.2	8.1	0.1	5.6	0.5	0.8	0.3	1.9	8.3	4.2	0.6	1.8	0.8	23.7	8.7	0.6	50.9	1.5	0.8	0.4	1.5	11.7	0.1	2.6	0.0	0.0	0.0	0.0	0.3	0.3	1.9	0.4	0.2	0.0	0.6	0.2	0.2	0.0	0.0	0.7	0.0	0.4	0.0	4.2	8.5	14.1	6.9	10.7	11.7	8.3	6.4	4.8	0.6	2.2	5.9	8.0	6.4	11.0	95.0	8.4	3.6	0.9	0.4	2.8	2.8	1.1	1.8	2.4	1.5	8.5	5.5	0.0	0.1	0.3	0.3	0.0	1.2	1.3	10.6	16.8	10.9	2.4	3.2	86.0	1.2	0.1	22.1	2.6	10.7	0.0	5.0	22.9	5.8	0.2	1.7	32.5	0.2	0.0	2.9	5.9	5.9	95.1	2.7	1.8	77.8	0.6	7.4	0.0	11.6	7.0	0.7	0.1	71.1	0.9	3.0	0.0	0.5	4.2	1.2	26.3	53.7	4.9	0.6	1.5	0.7	2.6	0.4	1.8	36.4	0.5	0.6
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8 subunit of ESCRT-II"	Q96H20	17	48929316-48944842	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 341.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA059320: AB_2683977"	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	28.7	31.7	24.6	26.0	26.9	35.2	26.6	25.8	27.1	21.5	24.7	28.4	27.6	21.3	32.1	26.9	20.3	20.5	42.7	23.9	25.7	33.0	33.1	21.9	24.8	25.9	25.9	18.5	29.7	26.1	18.3	22.0	26.1	20.1	30.7	18.1	29.6	21.5	48.6	23.7	24.4	25.8	25.6	22.7	30.0	18.4	25.5	27.8	25.5	48.5	32.5	26.7	20.5	29.2	60.9	119.3	73.2	93.3	73.7	42.4	114.0	49.9	68.1	95.0	84.8	294.6	61.5	55.3	85.5	94.3	106.0	39.8	68.0	70.1	105.4	80.1	110.7	61.6	158.7	126.1	64.2	83.8	66.6	52.7	68.9	91.0	69.2	70.5	90.4	71.7	61.4	54.7	98.2	120.7	90.8	71.4	35.6	139.1	101.3	58.9	132.8	65.8	57.1	67.4	48.0	96.3	60.1	28.1	73.5	125.2	70.9	101.3	77.2	103.6	81.1	65.3	95.1	79.6	97.5	66.0	92.1	45.1	81.5	0.9	4.4	9.2	2.5	5.0	1.3	4.4	3.5	2.8	5.0	5.4	2.3	1.9	1.9	1.6	5.7	6.2	4.7	1.1	24.6	26.9	25.8	27.1	23.9	25.7	25.9	25.9	26.1	25.6	25.5	29.2	77.4	44.8	34.4	14.7	60.0	59.8	76.5	46.4	26.2	67.9	75.0	80.9	49.0	68.6	34.4	64.4	14.6	119.6	71.3	126.4	148.7	147.8	111.9	48.3	57.6	63.5	70.8	71.8	21.4	218.4	175.7	62.8	52.5	41.7	43.1	87.5	61.8	75.2	149.1	25.2	22.7	93.2	48.8	84.4	96.2	341.1	62.7	82.7	85.4	8.4	137.9	95.1	80.3	12.1	17.6	166.6	78.7	62.1	88.6	100.0	125.4	210.1	33.7	86.7	46.0	51.9	123.3	68.0	76.3	58.6	72.5	95.1	57.7	75.0	98.9	95.9
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554293	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	3.2	3.8	3.5	2.8	3.5	5.5	4.3	4.4	4.4	3.5	3.6	3.3	2.5	3.7	3.2	3.9	2.7	2.3	3.1	3.7	3.9	2.8	6.3	2.7	3.7	3.5	3.5	3.5	3.4	3.9	3.1	2.4	3.5	3.8	2.5	3.9	3.4	3.1	3.1	3.4	3.5	2.8	3.2	3.9	3.6	4.4	3.8	4.1	2.9	3.2	4.2	3.1	3.0	4.0	4.9	2.6	5.2	5.1	6.2	5.9	3.5	6.2	6.9	5.7	5.0	2.6	4.1	6.6	4.6	6.5	3.7	5.0	4.9	5.6	4.7	6.0	7.0	10.3	4.4	5.3	7.0	9.6	5.5	5.6	6.5	5.7	7.2	6.2	5.6	5.0	7.3	5.7	4.1	3.5	5.7	7.3	8.5	4.0	6.1	5.0	8.8	5.6	4.3	4.6	4.1	8.4	6.4	4.1	8.3	5.4	3.6	5.1	9.2	4.3	4.9	5.6	6.0	7.0	8.8	5.3	5.3	6.7	4.1	1.5	0.9	1.3	1.5	0.8	1.5	1.0	1.0	1.5	0.8	0.9	1.4	1.2	1.4	1.0	1.2	1.3	1.3	0.6	3.5	3.5	4.4	4.4	3.7	3.9	3.5	3.5	3.5	3.2	3.8	4.0	14.4	19.2	11.9	3.9	18.5	16.2	11.8	6.9	22.8	10.6	18.0	12.1	6.1	17.2	13.9	5.5	8.4	5.4	20.7	11.8	1.9	7.3	7.5	34.4	25.8	9.2	8.4	7.2	6.5	7.1	4.7	12.4	13.7	58.1	12.0	11.0	11.7	10.9	4.6	10.1	6.1	11.0	10.2	8.8	9.2	11.7	8.1	11.4	8.8	4.7	9.5	9.9	12.3	7.1	6.8	8.4	5.8	7.9	15.7	9.7	6.0	4.4	9.7	16.6	0.0	13.6	11.1	14.4	15.1	19.5	18.0	10.1	16.9	8.0	6.5	12.6
SNN		ENSG00000184602	Stannin	O75324	16	11668455-11679152	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.0;skeletal muscle: 114.9"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 108.2;Macrophages: 64.7;Muller glia cells: 146.9"	"Cancer enhanced"	"Detected in all"		"glioma: 62.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"AF22: 74.9;REH: 73.1"	"Low region specificity"	"Detected in all"							HPA011055	Approved		Uncertain	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA011055: AB_1857326"	"unprognostic (1.94e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (4.51e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-1)"	"unprognostic (4.72e-2)"	57.4	29.4	114.1	19.8	126.0	24.5	24.3	91.6	101.7	18.3	49.4	16.9	9.1	14.0	20.2	19.1	12.8	22.0	28.4	117.4	87.9	14.5	9.3	21.6	30.8	92.8	102.9	17.0	8.7	9.9	15.4	8.2	83.6	14.3	5.7	40.5	18.3	21.9	114.9	14.8	14.4	10.5	93.3	34.6	14.1	3.9	108.9	28.6	17.3	36.9	27.5	18.5	14.6	89.0	7.6	7.2	74.9	20.5	48.7	13.8	7.2	3.2	6.8	9.0	9.1	11.7	5.2	7.8	30.6	10.6	15.9	14.6	22.7	9.1	6.9	2.1	5.1	25.8	8.1	15.3	12.9	1.8	14.9	12.1	40.7	4.8	10.0	12.7	16.8	22.4	4.1	12.0	8.4	12.7	21.0	5.8	39.0	9.5	5.2	73.1	10.0	53.8	8.5	21.9	44.4	18.0	17.4	22.6	11.5	29.1	9.1	15.2	15.1	10.4	21.3	61.2	3.3	4.8	3.3	18.1	6.2	22.0	13.4	0.1	21.0	16.0	0.6	36.2	0.6	15.2	3.3	1.5	19.9	15.5	6.1	4.5	53.0	0.7	48.6	8.0	2.2	17.1	114.1	126.0	91.6	101.7	117.4	87.9	92.8	102.9	83.6	93.3	108.9	89.0	27.5	0.0	6.1	11.8	46.8	18.4	19.9	9.5	18.8	7.5	7.3	10.0	16.6	14.3	6.9	5.5	0.0	1.3	16.8	0.4	25.4	16.7	0.7	6.8	7.8	17.9	5.3	0.0	28.6	18.3	23.1	9.4	3.1	8.4	13.4	5.7	27.1	3.0	20.7	6.7	11.6	0.5	14.2	39.5	108.2	0.5	5.0	64.7	21.4	11.2	58.2	146.9	4.1	8.5	5.0	14.6	0.3	15.4	2.9	14.6	0.9	5.2	6.7	6.5	6.6	17.7	16.9	0.4	3.8	15.3	19.0	1.4	12.1	1.1	0.4	13.2
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;breast: 14.2;skin 1: 32.2"	"Group enriched"	"Detected in some"	22	"Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.8"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.3	0.9	6.7	0.2	14.1	0.5	14.2	21.2	8.5	0.7	0.2	3.3	0.9	0.7	0.5	1.0	1.2	0.0	0.8	11.9	23.5	1.3	7.4	0.8	0.6	37.8	14.8	0.7	1.7	0.3	1.6	0.2	28.3	1.5	0.3	0.6	4.7	0.1	1.0	32.2	1.7	0.1	38.2	1.1	0.8	8.1	14.2	0.1	0.6	0.0	0.0	0.9	0.8	55.0	0.9	0.0	0.3	1.4	1.0	1.6	2.4	0.3	0.0	0.3	0.7	0.0	0.2	0.0	0.7	0.1	0.5	0.5	0.0	0.0	0.0	0.6	2.1	0.5	0.4	59.6	0.8	0.1	1.7	0.0	1.3	0.4	0.8	0.7	1.6	0.6	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	2.2	0.4	0.6	0.4	0.1	0.9	0.2	0.8	0.4	0.0	2.2	1.0	0.1	2.6	0.9	0.2	0.8	0.8	0.8	3.8	4.7	0.2	0.1	1.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.1	21.2	8.5	11.9	23.5	37.8	14.8	28.3	38.2	14.2	55.0	3.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	367.0	324.9	0.0	0.0	0.0	1.8	0.0	0.1	10.1	0.0	5.9	0.5	0.0	3.8	0.4	6.3	0.0	0.0	0.0	0.8	0.1	2.9	0.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	2.3	0.9	0.0	0.0
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266280-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 75.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 24.3;Excitatory neurons: 60.6;Horizontal cells: 30.3;Inhibitory neurons: 71.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	1.6	3.7	47.2	1.5	49.6	0.6	1.6	7.5	75.5	4.0	0.0	8.4	1.5	6.4	1.9	1.8	6.5	2.6	7.1	54.0	19.0	2.7	0.3	2.4	1.6	38.0	19.0	2.1	3.5	4.4	12.5	0.6	38.1	5.9	0.8	12.9	6.1	11.1	7.2	1.2	4.6	4.8	7.1	1.7	5.1	3.9	33.3	0.9	5.0	1.6	0.8	4.7	3.0	44.3	2.3	7.6	0.1	6.5	7.6	4.0	0.0	4.1	5.2	4.4	2.0	0.3	0.7	0.4	2.4	4.9	10.9	1.2	1.0	5.7	0.8	1.6	1.8	4.7	1.2	0.1	4.0	0.0	7.1	2.7	2.7	4.5	0.9	4.3	5.6	4.5	0.9	0.2	4.0	0.0	0.4	0.2	2.4	0.0	5.7	0.0	1.5	0.1	5.8	3.4	0.4	2.0	4.1	0.2	5.8	0.6	0.3	0.1	9.6	7.1	5.3	6.4	1.2	0.6	1.4	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.1	0.5	47.2	49.6	7.5	75.5	54.0	19.0	38.0	19.0	38.1	7.1	33.3	44.3	0.5	0.0	0.0	45.7	0.6	0.1	0.1	2.2	1.2	24.3	2.4	0.9	4.7	4.3	1.2	3.7	6.2	0.0	2.3	0.9	0.0	0.4	10.4	0.2	0.7	1.0	8.4	0.0	60.6	0.6	0.1	1.3	5.6	0.5	0.0	2.1	2.2	0.0	0.3	30.3	71.7	1.0	2.0	0.0	0.3	5.4	1.5	0.2	0.0	9.4	0.2	2.7	1.0	38.2	1.7	1.1	1.0	4.1	0.4	1.6	0.1	1.7	1.2	20.3	6.6	2.6	1.7	1.3	0.5	0.2	0.1	0.0	1.6	1.2	1.8	0.1
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNRNP27	"RY1, U4/U6.U5-27K"	ENSG00000124380	"Small nuclear ribonucleoprotein U4/U6.U5 subunit 27"	Q8WVK2	2	69893956-69905575	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034541	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA034541: AB_10602408"	"unprognostic (2.24e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	31.0	33.4	25.3	23.9	26.6	43.2	26.1	28.0	40.1	19.9	21.5	18.2	17.4	23.5	24.3	19.8	19.1	21.5	39.5	27.3	27.6	23.5	24.6	19.2	32.8	23.6	26.5	21.7	18.5	32.1	16.3	30.3	25.2	23.7	20.9	25.3	21.8	19.3	62.2	19.5	20.4	24.0	26.0	22.6	18.4	14.2	25.3	31.7	26.9	71.8	27.7	24.8	13.4	30.7	27.9	16.2	52.0	31.4	44.7	49.0	41.7	38.5	45.4	54.2	42.9	34.0	31.3	29.6	30.5	31.5	56.0	15.3	34.9	16.1	67.3	33.3	34.1	34.2	14.4	42.2	40.1	43.6	57.9	36.0	38.6	35.4	30.4	44.4	42.0	41.6	49.0	46.6	72.1	15.6	59.4	73.9	38.1	30.1	16.2	46.0	42.9	31.1	60.0	18.5	53.0	41.9	28.7	30.8	42.7	39.0	28.1	35.4	24.6	37.1	51.3	53.7	58.5	28.5	29.9	45.7	33.2	52.4	71.7	43.2	25.1	38.9	23.6	23.5	25.2	37.9	25.7	23.4	22.2	32.2	27.8	27.7	13.7	32.2	25.2	40.8	30.3	25.1	25.3	26.6	28.0	40.1	27.3	27.6	23.6	26.5	25.2	26.0	25.3	30.7	45.3	54.5	39.3	6.5	57.1	49.1	40.5	47.0	44.9	31.6	53.0	32.4	60.7	47.1	36.1	62.5	14.6	49.2	69.9	40.5	74.3	57.7	37.4	37.0	44.8	42.0	38.9	82.7	14.1	55.1	70.1	50.5	18.8	44.6	60.0	24.5	56.4	78.8	57.4	23.5	11.6	52.7	22.4	57.7	46.6	12.4	51.3	48.5	37.4	8.4	50.6	41.8	68.0	4.0	7.6	70.4	42.8	57.9	60.2	34.3	33.9	63.8	47.2	31.2	39.5	32.4	45.2	76.2	61.7	33.9	46.0	52.5	51.7	20.3	37.5	37.7
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123458088-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	19.0	20.0	33.1	16.0	34.8	17.6	18.7	36.2	46.3	24.2	33.4	20.8	15.4	22.2	15.1	26.2	19.0	10.3	41.2	32.7	35.3	29.2	26.4	19.1	20.1	34.6	34.0	17.1	19.2	20.5	24.5	16.8	34.1	24.9	17.8	18.3	23.7	12.7	79.5	26.5	23.3	16.2	32.0	30.8	22.9	16.4	34.8	18.7	23.3	43.3	19.3	18.4	21.4	37.2	22.8	23.7	28.1	14.4	20.0	18.6	24.6	19.5	28.4	20.1	14.6	14.9	15.3	45.0	14.0	28.4	14.5	23.0	24.3	34.9	17.2	33.0	19.7	21.1	22.0	34.6	14.0	21.8	32.5	22.7	24.0	18.0	17.1	36.3	27.8	14.0	27.5	8.9	28.4	48.0	23.6	49.1	19.6	30.5	22.4	18.0	12.3	24.0	46.8	45.2	23.9	35.3	17.3	36.1	28.2	27.8	43.6	29.1	32.4	13.3	24.3	16.9	17.7	22.0	23.8	26.6	21.7	21.1	18.6	81.0	45.6	74.3	43.3	48.5	43.0	71.5	54.3	49.2	47.0	66.2	41.9	45.2	70.2	47.9	47.0	47.8	79.3	36.8	33.1	34.8	36.2	46.3	32.7	35.3	34.6	34.0	34.1	32.0	34.8	37.2	21.4	51.3	20.1	14.0	25.0	14.0	19.1	57.3	13.1	30.9	16.3	19.3	29.5	18.6	36.7	33.1	12.5	51.6	31.3	26.9	50.9	35.2	38.3	26.1	21.2	22.5	14.9	29.2	8.4	33.6	34.8	19.3	27.0	22.9	13.3	19.9	23.9	27.1	33.1	15.2	12.1	22.4	44.7	17.0	10.2	10.9	24.2	19.3	16.0	11.2	35.9	37.1	39.1	12.1	27.1	35.0	33.4	25.9	15.9	20.6	37.4	48.9	32.5	28.6	32.9	19.0	24.1	25.3	24.2	18.9	14.5	42.0	24.4	18.3	18.1	25.4
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296788	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	17.9	18.9	10.7	21.2	14.6	30.0	20.7	15.5	12.6	17.7	10.3	20.6	16.4	20.1	21.7	19.1	22.5	13.1	14.2	10.4	12.5	17.6	19.3	15.8	35.4	14.5	13.3	20.8	13.0	18.0	15.9	22.3	15.4	20.1	22.1	19.1	15.0	20.8	20.9	18.5	17.6	21.7	13.7	21.3	16.6	21.2	12.8	40.3	18.0	18.1	40.2	24.0	16.7	20.1	71.6	53.6	95.5	78.6	46.7	38.4	66.2	58.8	57.4	104.7	101.9	76.7	69.8	91.8	56.4	46.1	53.9	66.4	145.7	69.8	105.9	99.2	109.3	135.2	72.1	83.9	58.4	150.0	59.3	36.2	54.7	102.1	75.6	34.4	86.1	80.2	129.0	52.9	60.5	51.6	111.3	87.9	171.6	71.1	76.5	87.3	134.5	71.1	44.2	57.7	65.1	63.6	92.3	47.4	116.2	88.0	47.2	94.9	59.5	57.9	85.2	81.5	112.9	43.5	57.1	126.1	47.1	139.3	96.4	102.8	75.8	82.3	98.6	97.3	113.1	93.8	95.1	98.2	93.0	82.6	101.1	115.1	16.4	110.5	92.0	78.4	110.2	161.1	10.7	14.6	15.5	12.6	10.4	12.5	14.5	13.3	15.4	13.7	12.8	20.1	44.1	3.2	6.1	14.7	51.5	53.0	50.2	90.8	41.5	15.6	24.4	30.6	16.5	21.5	32.5	16.5	18.8	108.7	35.7	11.9	43.0	42.5	7.1	21.0	27.5	39.4	34.8	80.8	23.7	35.9	91.3	38.1	28.5	13.9	34.3	36.2	28.9	22.3	56.2	10.1	24.3	18.6	69.2	20.7	48.6	5.4	26.8	31.5	42.7	15.0	44.7	23.8	44.3	23.6	49.0	36.4	20.2	34.3	40.6	55.0	17.0	45.0	27.6	22.2	32.9	31.0	35.1	105.5	89.7	39.6	54.8	61.3	52.4	45.9	36.9	40.6
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590198-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	5.4	3.8	4.8	5.5	5.1	10.4	6.9	8.5	6.7	7.0	4.4	5.4	5.7	6.4	4.6	4.7	5.7	4.0	7.2	4.6	5.0	6.0	7.3	4.5	7.3	5.7	4.9	7.7	5.7	3.7	3.6	5.3	5.9	5.8	5.5	7.3	5.3	4.4	9.7	6.3	6.7	5.4	4.7	6.1	5.4	2.7	5.1	7.1	5.8	7.1	5.9	5.6	5.8	5.9	10.0	7.9	16.2	30.3	8.5	12.5	10.9	11.2	10.4	12.0	13.1	16.9	8.1	23.6	11.8	9.4	11.5	12.6	20.2	12.1	18.2	18.2	19.8	17.0	24.1	32.7	8.9	20.5	10.9	8.8	18.3	13.5	10.2	14.2	10.5	20.8	24.1	3.6	16.8	5.7	33.7	29.6	21.9	17.1	8.8	35.8	13.9	31.6	10.8	8.7	25.0	6.8	21.8	5.6	19.6	29.7	10.9	7.2	11.8	15.8	7.1	9.5	19.6	5.8	34.6	14.5	5.3	16.1	28.9	0.1	0.7	0.4	0.7	0.5	1.2	0.6	0.8	0.9	0.9	1.1	0.7	1.3	2.3	1.1	0.3	1.0	0.7	0.6	4.8	5.1	8.5	6.7	4.6	5.0	5.7	4.9	5.9	4.7	5.1	5.9	18.6	19.2	10.3	8.1	15.7	35.7	20.2	13.6	12.0	18.7	12.6	14.6	32.1	15.7	17.3	9.2	20.9	16.3	22.7	19.2	11.7	18.0	2.5	18.0	14.8	20.5	11.4	17.7	20.4	20.1	15.6	18.0	8.2	19.6	24.1	16.8	20.3	23.4	15.9	5.0	18.8	18.2	0.0	15.1	22.1	2.5	17.7	14.9	8.8	13.1	21.7	15.5	19.6	14.6	23.8	12.1	17.9	16.6	11.5	21.4	27.1	20.1	8.5	17.8	6.6	20.9	23.2	16.1	17.0	11.5	34.0	16.3	18.5	11.2	17.1	20.1
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		74000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	77.2	106.0	30.1	41.3	28.2	49.5	79.1	29.2	46.0	108.1	29.8	90.6	39.4	96.6	21.0	103.9	95.4	13.8	88.1	28.4	32.4	83.4	96.3	81.2	43.5	28.6	28.5	107.7	95.9	28.6	104.9	26.8	27.9	107.4	21.9	18.5	92.9	23.3	104.2	95.2	90.5	20.7	24.6	106.7	94.3	72.9	28.4	45.8	103.5	16.7	33.0	81.9	94.4	34.1	178.5	224.0	142.3	101.6	56.4	34.3	155.3	125.4	81.7	136.1	118.1	140.4	103.5	203.9	127.1	89.0	123.1	152.2	176.6	128.2	101.0	137.0	468.2	185.9	103.6	164.9	29.2	209.1	125.2	48.0	35.4	99.6	67.2	64.5	103.0	107.2	195.4	65.7	84.4	175.3	218.8	338.3	175.3	102.9	167.4	254.7	133.7	124.6	87.9	113.7	112.3	136.9	158.3	96.1	94.8	94.5	98.9	132.3	147.0	101.8	190.5	86.7	223.5	164.3	156.5	263.2	84.1	135.9	95.2	0.8	2.0	1.8	1.8	1.5	1.1	4.0	1.4	0.8	2.0	1.7	2.0	1.5	0.8	4.1	1.8	1.7	1.2	0.8	30.1	28.2	29.2	46.0	28.4	32.4	28.6	28.5	27.9	24.6	28.4	34.1	86.6	19.2	63.0	198.5	107.2	139.4	166.8	78.4	93.9	108.7	97.8	109.5	31.6	55.8	66.0	75.4	89.6	179.7	97.5	89.8	46.9	108.1	23.7	101.8	141.9	84.2	118.0	76.6	81.0	105.1	208.6	92.3	110.1	123.0	55.1	111.7	61.4	97.4	125.8	114.4	99.2	121.4	77.3	58.7	97.7	21.3	130.1	77.8	69.4	74.0	75.8	82.6	76.2	110.6	151.9	116.0	80.0	110.6	112.0	177.1	95.0	77.5	59.3	109.6	124.9	102.3	101.2	109.7	108.6	92.3	130.7	176.4	96.3	115.4	119.6	154.7
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619"	"unprognostic (3.53e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	45.3	42.1	33.3	40.8	36.6	59.9	47.0	33.8	39.6	61.7	36.1	54.4	36.4	54.8	42.6	55.1	58.4	18.2	38.6	32.7	35.7	48.2	44.9	48.5	57.1	34.5	34.5	69.2	38.0	20.5	47.7	28.7	34.4	55.0	33.8	10.8	41.1	33.0	51.0	41.2	52.7	30.2	34.5	65.2	45.9	36.5	33.9	63.5	56.2	27.6	48.2	53.8	51.7	35.0	143.4	134.6	157.2	129.4	44.2	56.8	125.9	53.8	76.8	145.5	151.9	119.4	129.8	197.2	70.1	75.6	76.2	114.2	162.0	149.6	126.7	96.7	191.5	137.0	115.2	150.0	64.9	159.8	90.0	56.1	36.6	101.4	164.6	78.2	131.7	180.1	167.5	101.2	98.5	145.4	273.7	285.1	164.1	133.1	134.8	251.6	102.0	154.5	100.8	88.4	117.8	113.4	102.4	113.4	90.6	84.3	110.1	150.8	73.8	77.4	127.8	77.5	131.2	107.4	121.6	252.9	78.0	179.3	100.0	3.2	28.0	7.5	27.6	32.2	29.2	28.1	29.2	32.4	56.5	26.4	29.6	27.9	2.5	28.0	16.2	34.7	31.8	23.0	33.3	36.6	33.8	39.6	32.7	35.7	34.5	34.5	34.4	34.5	33.9	35.0	39.3	12.8	15.2	4.9	53.0	35.9	51.6	63.7	63.7	7.2	49.8	67.2	7.2	15.7	27.0	25.8	2.1	87.1	39.6	34.9	43.0	41.6	32.7	22.7	31.1	34.2	33.0	65.4	5.4	49.4	127.0	43.7	51.0	37.6	32.4	67.0	31.4	21.9	60.1	5.0	6.5	44.9	48.8	29.9	35.0	14.6	37.3	37.5	23.2	3.7	50.4	17.8	29.9	6.0	9.5	44.6	29.4	28.2	56.6	38.9	34.6	35.2	17.5	5.1	19.7	28.2	75.7	60.7	66.2	85.1	33.1	66.4	50.9	44.3	61.2	47.7
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	113.4	110.5	45.0	110.7	45.1	345.4	111.6	50.8	54.5	103.7	48.5	108.1	102.6	119.4	66.7	177.1	93.7	62.7	90.1	46.7	47.1	103.6	91.9	111.7	166.7	47.7	45.1	93.8	78.0	83.1	72.5	82.9	47.4	87.9	86.5	25.0	99.7	62.4	112.6	148.5	109.2	85.9	48.6	139.0	100.7	83.2	46.8	168.9	77.1	59.9	154.0	109.3	108.9	50.4	782.5	1063.7	376.7	340.4	83.8	149.1	418.7	334.6	259.8	693.8	556.2	1209.6	555.7	588.8	210.6	203.2	556.7	567.8	370.7	636.2	350.3	239.7	658.6	400.5	190.0	1148.0	290.0	560.3	236.6	171.3	237.9	564.0	252.6	132.2	389.0	491.1	561.0	414.6	288.7	543.0	897.1	916.2	825.2	405.8	520.8	531.3	379.0	711.4	266.8	407.8	405.6	442.7	414.5	554.3	503.2	162.8	524.5	612.9	266.7	404.4	340.9	360.8	764.8	345.5	938.8	877.1	137.7	623.8	419.5	167.9	166.7	133.0	202.8	210.9	170.5	210.7	178.0	179.5	226.7	210.6	144.2	167.5	87.8	166.0	221.6	237.4	241.5	266.0	45.0	45.1	50.8	54.5	46.7	47.1	47.7	45.1	47.4	48.6	46.8	50.4	197.0	44.8	69.1	4.6	206.9	478.6	335.2	309.4	150.2	46.8	156.8	151.8	17.9	112.9	167.3	93.8	12.5	365.2	251.9	163.6	144.8	347.3	17.1	98.3	143.0	202.9	142.0	170.0	6.8	295.8	647.8	155.4	89.2	128.4	144.5	215.0	83.2	60.8	294.8	30.3	6.3	239.4	203.4	102.7	308.3	20.4	159.1	158.0	190.3	6.5	189.5	68.9	265.7	6.0	8.5	404.6	171.9	123.8	176.9	421.8	119.3	143.6	98.9	57.5	157.8	169.6	228.5	329.6	308.3	181.5	423.1	373.4	210.1	306.7	293.5	433.2
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742564	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 524.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 381.4;SK-MEL-30: 378.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: AB_2681245, HPA076104: AB_2732301"	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.5	27.6	23.9	30.9	24.9	53.9	31.0	24.3	35.7	22.3	26.0	26.4	24.3	29.0	35.2	20.8	24.4	21.9	25.0	24.9	25.9	42.3	30.1	22.2	43.3	24.9	25.2	29.1	18.3	26.9	22.6	28.7	24.7	21.9	26.5	11.2	21.1	21.6	30.2	17.0	24.6	27.1	25.6	28.4	23.4	22.6	24.7	37.3	25.6	27.2	36.6	28.9	19.8	27.3	76.0	73.3	94.3	59.1	46.1	57.8	104.7	73.4	60.9	78.0	76.1	84.6	83.5	121.0	56.0	63.0	119.2	69.3	74.9	85.5	111.0	40.0	62.8	111.8	22.4	157.4	53.9	132.0	73.8	57.6	56.0	71.5	55.6	58.1	74.4	81.3	93.8	53.6	80.6	79.2	152.5	159.6	84.2	381.4	97.0	86.1	113.1	84.9	76.9	50.8	49.8	142.3	54.5	147.6	378.7	69.4	93.8	106.5	63.7	71.0	71.2	64.4	122.7	46.9	102.8	134.7	33.7	77.8	157.1	51.8	29.4	47.4	27.3	38.6	35.8	31.5	34.7	31.5	31.6	29.1	30.0	33.4	12.8	31.7	40.5	45.9	48.0	29.9	23.9	24.9	24.3	35.7	24.9	25.9	24.9	25.2	24.7	25.6	24.7	27.3	125.9	44.8	58.0	6.2	128.6	89.1	186.9	238.2	60.3	30.7	93.8	118.5	67.4	107.2	126.5	93.8	0.0	281.4	150.1	79.6	215.2	165.9	163.3	105.3	150.3	124.6	93.3	131.7	12.9	169.2	288.3	120.8	50.0	120.5	132.5	103.2	140.3	139.3	227.3	48.8	14.3	133.3	152.5	157.9	124.6	35.1	172.7	120.5	110.3	8.4	195.4	77.7	153.5	15.1	21.5	169.4	102.7	155.7	91.2	143.8	94.9	524.6	107.2	25.1	98.6	118.7	147.5	192.4	130.4	60.8	96.0	376.9	150.1	94.7	127.7	170.2
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNRPD1	"HsT2456, Sm-D1, SNRPD"	ENSG00000167088	"Small nuclear ribonucleoprotein D1 polypeptide"	P62314	18	21612314-21633524	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040516	Supported					NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA040516: AB_10673236"	"unprognostic (1.83e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (7.90e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.83e-1)"	45.9	35.7	33.1	54.5	32.6	94.6	39.0	34.4	51.8	37.1	31.0	48.8	42.2	37.3	26.4	67.0	33.6	23.0	33.0	32.6	34.0	52.3	37.7	33.1	72.6	32.6	34.0	42.0	29.9	23.5	41.9	36.5	33.5	33.1	44.2	33.0	35.0	17.8	48.7	39.6	44.9	28.4	32.8	43.7	36.6	45.0	32.8	79.3	28.9	24.8	71.6	47.3	41.4	33.7	246.1	123.1	377.9	184.5	59.1	49.4	174.4	264.5	85.4	176.9	170.4	234.4	125.5	328.0	214.6	102.7	245.2	231.2	246.0	167.7	191.3	210.4	201.4	276.3	193.1	284.2	78.5	673.4	232.5	52.9	92.1	173.1	156.1	122.0	96.8	327.9	286.5	178.5	120.4	179.7	436.3	470.2	297.7	468.0	214.2	345.1	275.7	351.0	129.9	176.2	235.7	244.4	219.0	165.9	207.3	167.0	120.5	390.7	155.0	179.0	354.4	154.6	455.6	319.8	317.6	671.2	130.4	409.8	203.3	50.1	129.4	48.5	122.5	162.0	134.4	204.4	154.0	152.1	221.4	194.6	160.7	141.6	10.8	137.0	189.7	224.2	193.3	147.3	33.1	32.6	34.4	51.8	32.6	34.0	32.6	34.0	33.5	32.8	32.8	33.7	105.6	80.1	76.3	5.2	123.2	202.5	227.3	343.6	109.8	58.4	116.4	157.6	55.4	111.5	200.4	99.3	12.5	423.3	101.8	101.8	215.2	210.8	15.6	119.2	136.9	138.4	122.8	229.5	12.1	194.3	544.1	132.0	86.2	109.4	100.8	158.7	99.9	113.2	242.9	47.1	12.5	192.1	215.7	106.3	152.5	26.3	108.7	96.9	113.8	6.5	163.6	102.6	117.4	10.1	11.8	236.3	113.2	88.8	122.6	343.1	87.3	214.8	153.4	50.0	98.6	149.0	183.0	282.8	265.2	177.2	221.9	261.9	112.5	161.1	229.8	233.9
SNRPD2	"Sm-D2, SNRPD1"	ENSG00000125743	"Small nuclear ribonucleoprotein D2 polypeptide"	P62316	19	45687460-45692569	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041437	Supported		Supported	Cytosol		NA	NA		76000	"Cluster 30: Non-specific - Translation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA041437: AB_10795119"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.95e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.12e-2)"	201.0	215.1	305.0	237.7	317.2	478.3	390.9	309.5	374.8	267.3	297.8	253.3	170.1	228.8	331.5	244.5	318.1	195.9	265.5	312.2	321.0	215.6	200.1	157.1	442.7	312.2	308.3	440.0	184.9	263.5	202.9	215.3	310.8	201.9	253.5	120.8	197.4	209.7	306.0	245.1	168.1	235.2	311.1	202.2	189.1	167.5	315.5	501.0	214.7	305.6	406.4	312.2	216.4	312.6	970.0	1429.6	863.8	905.4	843.8	797.5	475.5	630.8	777.8	933.3	974.0	814.6	582.4	1119.3	493.9	788.2	624.9	543.7	1180.4	1184.6	888.6	721.6	1428.6	1066.5	756.6	1040.6	585.1	1287.9	646.4	894.2	862.7	798.3	759.9	639.5	960.3	1111.6	996.6	713.1	765.9	1329.7	1274.7	1129.0	780.8	1758.5	776.2	848.1	890.0	896.5	782.0	1249.4	792.7	880.4	828.1	842.8	808.7	705.9	500.2	1378.5	614.2	422.3	694.7	397.5	1198.8	717.5	1949.8	1775.2	601.5	1087.8	691.3	306.6	525.1	275.0	810.3	500.5	1045.6	1309.4	1076.4	964.5	789.1	1155.8	1244.5	1083.7	62.7	885.6	393.8	876.0	1144.9	1776.3	305.0	317.2	309.5	374.8	312.2	321.0	312.2	308.3	310.8	311.1	315.5	312.6	150.6	147.4	211.1	8.1	407.6	470.5	564.5	724.2	463.9	43.1	361.2	650.5	443.3	233.1	372.3	329.2	22.9	607.0	294.3	318.8	665.2	368.8	563.3	190.9	310.2	225.3	310.2	315.9	7.9	350.7	787.7	305.2	199.8	198.2	266.0	284.4	232.3	265.4	475.4	37.0	8.3	492.0	376.4	269.9	470.6	1325.8	347.9	232.5	434.0	9.4	373.9	162.6	373.9	3.5	12.2	318.2	348.5	231.7	341.2	553.5	356.9	768.7	309.3	65.2	164.3	279.4	382.1	286.3	274.7	562.6	422.7	482.8	426.5	216.2	556.9	534.0
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SNRPG	Sm-G	ENSG00000143977	"Small nuclear ribonucleoprotein polypeptide G"	P62308	2	70281362-70293740	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064152, HPA067814"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064152: AB_2685199, HPA067814: AB_2685903"	"unprognostic (6.42e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.41e-2)"	66.9	92.0	55.9	85.9	58.0	118.0	85.1	58.4	85.7	50.4	60.2	87.9	62.1	55.2	103.0	95.5	45.6	40.5	102.2	55.3	58.3	97.1	95.5	59.8	100.7	58.9	58.0	49.2	53.1	69.5	60.4	83.8	59.5	53.7	80.3	92.7	59.2	46.0	88.3	43.5	63.2	51.6	59.1	76.6	61.1	60.1	58.4	139.9	61.2	83.8	96.9	91.4	56.3	63.1	398.0	414.3	412.2	240.0	146.5	157.1	369.0	255.4	230.5	332.8	307.2	718.7	258.1	355.1	180.6	202.2	404.9	253.9	415.1	355.7	356.7	333.2	404.5	474.0	256.6	875.4	194.0	602.3	313.6	140.2	198.1	312.8	308.8	135.0	341.5	301.1	645.3	254.8	266.9	479.0	541.5	961.8	430.4	489.9	340.2	350.4	507.9	419.0	483.9	367.1	238.1	204.4	235.9	201.1	295.8	250.7	202.1	470.1	232.9	235.3	440.2	246.3	520.4	188.1	228.3	731.8	211.1	510.0	260.9	163.1	168.5	181.1	144.2	219.2	147.4	209.1	193.4	168.8	202.5	166.0	157.8	188.9	88.1	135.8	222.4	273.0	230.1	264.8	55.9	58.0	58.4	85.7	55.3	58.3	58.9	58.0	59.5	59.1	58.4	63.1	191.7	201.9	198.9	7.2	237.0	299.1	340.3	625.6	143.4	88.8	192.3	239.1	145.7	178.7	314.8	202.3	33.3	655.3	175.7	249.1	534.1	389.6	51.0	253.2	184.7	209.1	186.6	319.4	7.4	391.5	818.7	173.3	119.3	188.4	213.3	140.7	175.3	391.8	390.8	65.6	8.7	301.5	370.2	186.6	270.8	45.4	175.8	194.0	224.1	5.6	329.1	446.1	208.1	4.5	13.8	434.1	271.6	159.1	251.9	366.1	226.5	676.1	401.8	91.4	184.1	181.3	244.4	340.7	367.4	236.6	318.2	521.5	220.2	125.9	324.1	375.1
SNRPN	"HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN"	ENSG00000128739	"Small nuclear ribonucleoprotein polypeptide N"	P63162	15	24823637-24978723	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 457.8;Horizontal cells: 333.1;Proximal tubular cells: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 789.5;SuSa: 505.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003482, HPA067842"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (9.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (8.93e-8)"	"unprognostic (4.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.74e-2)"	54.8	181.8	453.6	46.5	472.5	36.5	69.4	441.8	553.5	112.3	351.6	87.3	36.4	65.2	332.5	44.0	121.9	141.2	483.2	474.3	510.7	192.0	69.9	76.4	93.5	454.7	440.5	147.8	111.8	243.4	375.5	37.4	458.5	174.2	34.8	161.7	125.7	147.6	232.7	38.2	62.5	59.0	415.8	85.2	88.3	60.7	467.8	136.8	300.4	272.4	80.6	82.5	66.4	470.8	1.0	148.6	260.8	180.1	153.4	69.5	1.1	46.9	100.0	31.7	57.8	138.1	69.1	0.2	91.6	118.7	47.9	26.7	0.0	142.7	18.2	81.1	0.1	89.3	90.1	151.5	181.8	107.1	76.8	132.6	60.6	69.4	81.8	213.2	95.7	189.8	24.8	0.4	183.3	0.0	216.9	1.5	789.5	0.0	63.0	113.3	97.8	0.5	172.3	222.2	155.7	147.1	0.7	3.6	174.0	505.7	93.6	271.3	62.3	79.2	78.2	0.3	28.8	215.3	126.9	140.4	65.9	72.9	59.8	234.8	68.0	106.8	313.9	74.2	355.8	371.9	385.3	359.0	65.2	342.1	508.0	420.8	18.5	291.2	77.4	531.9	434.4	581.7	453.6	472.5	441.8	553.5	474.3	510.7	454.7	440.5	458.5	415.8	467.8	470.8	57.1	9.6	45.5	0.0	106.2	2.2	102.6	4.4	53.5	171.0	77.1	96.5	185.2	218.8	23.0	178.4	52.1	1.0	157.6	10.0	457.8	150.0	92.9	36.8	27.9	57.7	142.7	31.1	0.0	81.6	1.2	54.9	27.5	24.5	62.7	136.9	63.1	31.9	62.7	333.1	0.0	34.5	6.1	28.9	2.5	111.3	77.3	38.1	0.0	0.0	43.8	210.3	115.4	0.0	0.0	61.5	33.7	116.6	86.7	110.6	38.7	300.2	26.9	112.3	52.6	61.5	65.0	67.9	54.0	22.1	1.7	1.6	104.2	110.4	23.6	65.1
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407957-33443763	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.3;skeletal muscle: 307.9;tongue: 327.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 117.2;Cardiomyocytes: 175.1;Muller glia cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 10.4"	"Group enriched"	"Detected in many"	4	"B-cells: 5.7;dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.5"	"Low region specificity"	"Detected in all"							"CAB037059, HPA067154"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037059: AB_261497, HPA067154: "	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	39.2	18.7	162.7	4.5	179.8	2.0	25.5	158.2	198.3	24.9	127.9	23.7	6.6	16.9	8.0	22.6	20.4	7.6	195.9	158.1	149.3	23.0	16.6	8.0	5.9	167.9	166.0	20.6	13.5	20.9	12.4	3.1	144.5	19.6	3.0	15.0	31.3	18.1	307.9	15.0	13.7	9.3	147.4	5.0	23.8	19.3	178.7	3.4	77.8	327.9	5.2	38.6	17.0	144.5	13.0	6.5	2.9	28.2	66.5	13.0	2.8	9.8	13.6	18.3	15.2	16.9	4.3	9.3	11.6	16.8	33.4	16.9	8.4	5.4	3.2	1.9	10.8	0.5	15.7	23.9	18.8	0.9	1.6	12.0	6.7	8.0	3.0	10.1	2.8	8.8	22.8	3.5	9.3	1.6	17.7	2.2	1.6	1.9	37.2	11.1	20.8	10.3	3.8	11.6	12.3	10.6	38.5	11.5	19.4	2.2	17.8	1.6	4.6	9.0	17.5	36.1	9.2	21.2	11.7	5.6	19.5	1.7	1.4	0.0	0.0	0.0	0.9	0.0	1.9	5.7	0.9	0.9	0.0	2.8	0.3	0.7	0.0	0.0	0.0	10.4	1.1	0.3	162.7	179.8	158.2	198.3	158.1	149.3	167.9	166.0	144.5	147.4	178.7	144.5	4.6	3.2	2.0	117.2	5.1	3.2	4.7	1.3	1.2	5.7	6.2	8.0	175.1	8.6	1.9	1.8	4.2	1.2	4.9	1.3	39.2	2.0	1.0	1.2	3.7	4.4	4.2	5.7	12.7	2.6	1.9	13.4	5.1	4.1	0.0	10.1	3.9	9.1	1.9	0.0	8.3	1.6	8.2	1.9	2.3	2.3	25.1	1.6	5.4	10.3	0.0	83.7	3.1	5.0	6.3	3.3	1.6	28.2	2.3	5.7	5.4	33.5	0.8	36.5	26.3	12.7	36.7	1.8	4.9	3.5	2.8	0.8	9.3	3.2	1.6	5.6
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024659	Uncertain				"Intracellular and membrane"	NA	NA		25000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	7.9	66.4	7.5	5.5	6.5	18.9	8.0	5.8	5.9	5.6	42.9	6.2	5.7	4.4	2.7	8.4	6.0	4.3	4.9	6.1	11.8	12.6	89.3	15.4	7.3	7.2	11.4	2.5	45.0	1.4	2.6	8.6	7.8	4.8	6.4	4.8	34.8	3.4	28.2	9.8	6.3	3.1	6.0	11.9	24.1	9.8	9.1	3.4	61.4	32.4	3.5	3.9	3.6	6.5	0.1	1.8	0.7	0.0	11.3	22.9	0.1	6.0	36.7	1.8	2.7	12.0	1.6	0.0	10.7	6.8	0.0	0.1	2.0	0.0	1.3	5.6	6.5	0.0	0.3	84.9	1.2	16.9	0.0	11.4	0.0	10.1	0.0	14.9	0.4	10.4	0.0	32.3	5.9	3.3	0.0	13.7	2.1	78.5	8.7	0.0	43.8	0.1	34.4	2.0	0.1	0.4	2.4	12.5	30.2	0.7	1.5	30.5	0.0	23.7	1.4	0.0	2.0	77.2	33.0	34.8	18.4	49.0	26.7	1.8	0.8	2.7	2.2	0.4	0.5	0.5	0.4	1.1	0.6	0.2	1.1	1.1	0.1	1.6	0.3	0.0	0.0	0.6	7.5	6.5	5.8	5.9	6.1	11.8	7.2	11.4	7.8	6.0	9.1	6.5	1.9	12.8	27.2	70.2	4.7	0.4	0.7	0.9	1.8	2.4	8.5	6.0	2.0	2.8	9.0	5.5	2.1	0.8	8.4	1.3	9.8	1.5	9.3	2.4	5.8	4.2	0.0	14.1	2.4	10.9	2.2	9.8	11.2	6.2	1.3	8.8	13.2	66.8	11.3	0.0	3.1	3.9	16.2	29.9	4.3	4.2	4.7	18.1	1.8	45.9	12.1	16.0	18.6	2.5	12.2	4.3	1.9	13.2	2.8	1.1	0.1	3.3	13.8	0.7	13.1	3.9	14.3	1.1	0.2	10.1	1.0	0.3	12.0	11.0	4.1	0.6
SNTG1	"G1SYN, SYN4"	ENSG00000147481	"Syntrophin gamma 1"	Q9NSN8	8	49909789-50796692	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;lymphoid tissue: 2.8"	"Group enriched"	"Detected in some"	25	"Excitatory neurons: 1498.8;Inhibitory neurons: 1490.6;Oligodendrocyte precursor cells: 1948.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RH-30: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072282	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA072282: AB_2686506"					"unprognostic (4.60e-2)"		"unprognostic (1.72e-2)"		"unprognostic (2.47e-1)"		"unprognostic (1.05e-2)"			"unprognostic (6.94e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.16e-3)"	0.0	0.4	2.3	0.0	5.4	0.4	0.0	0.8	10.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	5.5	2.7	0.3	0.5	0.0	0.1	0.0	2.4	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.1	0.0	0.2	0.0	0.1	0.0	2.8	0.1	0.7	5.3	0.1	0.1	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	2.3	5.4	0.8	10.5	5.5	2.7	0.0	2.4	0.0	0.0	5.3	3.7	0.0	0.0	0.5	27.7	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.4	0.0	0.6	1.8	0.0	0.0	0.2	0.0	0.0	0.0	21.5	0.1	0.0	0.1	0.0	0.0	1498.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	1490.6	0.0	0.0	0.0	0.0	56.2	0.6	0.1	0.0	64.6	0.0	0.4	0.0	1948.8	18.3	0.3	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.1	7.8	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950849-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.2;Excitatory neurons: 24.4;Horizontal cells: 90.9;Late spermatids: 44.7;Spermatocytes: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HAP1: 1.7;JURKAT: 1.6;MOLT-4: 1.1;NTERA-2: 2.0;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	2.0	0.3	0.6	0.0	0.7	0.0	1.8	1.0	0.6	1.0	1.1	0.5	0.1	1.2	0.2	0.5	1.2	0.2	0.4	1.7	0.7	0.1	0.0	0.3	0.0	1.7	0.9	0.2	0.9	0.0	2.9	0.0	1.3	0.6	0.2	2.1	0.5	0.0	0.4	1.1	0.6	0.7	0.4	3.2	0.3	1.8	0.7	0.2	0.7	0.9	0.1	0.8	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.0	0.6	1.7	0.7	1.7	0.9	1.3	0.4	0.7	0.6	6.8	0.0	0.0	0.7	0.4	0.9	0.1	0.0	0.6	0.8	0.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.2	0.1	0.9	7.3	0.0	0.0	24.4	0.2	0.5	0.8	0.0	0.0	0.0	3.0	0.0	0.0	0.1	90.9	10.7	0.0	0.0	0.0	1.2	44.7	0.3	0.0	1.8	9.4	0.0	0.6	0.0	1.5	1.3	0.0	0.0	4.1	0.0	0.3	0.0	0.5	0.0	4.6	0.0	0.3	0.4	22.0	5.4	0.1	0.1	0.0	0.2	0.2	0.0	0.2
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652675-63679020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 173.4"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA043322, HPA058399"	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.1	0.2	0.6	0.6	0.5	0.8	0.2	3.9	1.9	3.6	0.0	0.3	0.4	2.9	0.4	0.2	173.4	0.5	0.0	0.7	0.2	0.1	0.1	13.4	0.8	1.0	1.1	0.3	0.9	0.1	0.0	0.2	1.2	0.4	0.5	1.0	0.3	0.2	0.3	1.1	0.5	0.3	0.0	0.3	0.8	0.3	0.8	0.1	17.8	0.1	0.2	0.1	0.0	1.4	0.2	0.1	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	1.0	0.2	0.1	0.7	0.1	0.2	0.6	0.1	0.0	0.2	0.5	0.9	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.3	1.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.6	0.5	3.9	1.9	0.7	0.2	1.0	1.1	1.2	0.0	0.8	1.4	0.0	3.2	4.2	0.3	0.0	0.0	0.1	34.0	0.0	0.0	0.3	0.1	0.3	0.0	60.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	3.6	410.9	2.3	0.3	0.0	0.0	0.1	0.4	0.0	1.4	0.0	4.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	38.7	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	726.5	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.5	0.2
SNU13	"15.5K, FA-1, NHP2L1, SNRNP15-5, SPAG12, SSFA1"	ENSG00000100138	"Small nuclear ribonucleoprotein 13"	P55769	22	41673933-41690504	"Predicted intracellular proteins, Ribosomal proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1057.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA029199	Uncertain					NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA029199: AB_10601041"	"unprognostic (3.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.43e-1)"	64.9	125.6	156.5	74.5	157.7	135.7	80.7	146.4	159.5	81.8	134.4	77.8	64.9	64.6	99.0	65.5	91.2	55.7	145.1	159.1	191.3	75.7	65.2	61.9	97.4	159.5	159.4	96.7	74.8	113.6	52.7	67.5	173.3	65.8	73.5	85.5	74.8	70.9	187.1	73.3	56.1	71.4	150.1	71.2	66.3	94.9	173.3	98.2	90.1	178.0	108.4	88.7	34.0	151.9	222.8	100.2	151.8	203.7	192.7	173.5	160.1	212.6	181.4	303.0	259.6	215.1	195.0	148.6	165.5	183.6	91.6	160.3	183.6	239.0	205.5	178.1	428.0	163.0	191.1	313.1	249.5	345.3	217.9	157.7	247.0	226.6	330.2	142.1	175.2	161.2	227.3	244.8	200.6	262.7	238.0	369.7	215.6	852.4	240.8	252.7	126.7	505.5	279.6	128.9	135.9	125.0	102.4	249.4	333.7	160.6	116.8	218.1	125.1	152.6	175.3	191.0	166.8	273.7	366.5	353.6	206.9	195.5	218.1	205.5	224.8	210.8	210.5	233.3	225.3	357.4	252.0	226.6	240.3	311.2	266.1	247.4	67.5	205.3	208.5	288.2	346.2	339.9	156.5	157.7	146.4	159.5	159.1	191.3	159.5	159.4	173.3	150.1	173.3	151.9	217.9	80.1	121.9	0.0	265.1	0.0	390.5	0.0	196.9	160.1	224.4	272.3	0.0	190.1	65.0	185.8	25.0	367.3	205.8	42.1	655.4	310.0	1057.6	223.4	169.0	198.0	70.4	144.7	0.0	302.3	438.5	172.4	125.4	251.9	77.0	162.3	181.3	205.0	293.1	109.4	0.0	118.9	0.0	140.1	0.0	318.4	211.9	162.9	0.0	0.0	186.3	181.8	151.4	0.0	0.0	340.9	127.7	174.2	261.9	630.5	202.2	462.5	68.5	128.4	138.1	169.0	143.0	505.9	279.5	219.8	0.0	460.5	208.0	193.8	139.5	505.0
SNUPN	"RNUT1, SNURPORTIN-1, Snurportin1"	ENSG00000169371	"Snurportin 1"	O95149	15	75598083-75626469	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.1;Spermatocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005004	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB005004: AB_425829"	"unprognostic (2.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-3)"	"unprognostic (9.07e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.14e-2)"	18.2	16.0	21.0	15.5	21.6	13.8	23.5	20.5	26.3	20.4	21.9	18.1	14.9	18.9	20.3	14.3	23.7	13.5	16.4	22.1	20.9	20.1	22.1	14.9	20.1	19.5	20.1	26.3	12.7	21.0	12.1	15.2	20.1	16.5	17.4	13.2	19.8	17.6	34.7	16.7	15.4	24.5	18.7	17.2	15.8	34.3	20.5	22.1	20.9	30.5	21.1	18.0	15.5	21.2	26.1	34.1	30.4	21.6	42.1	46.8	23.2	26.1	38.5	44.2	47.8	25.4	62.6	47.4	35.7	34.0	36.6	29.9	60.3	38.3	34.5	27.3	56.1	56.4	29.3	16.4	40.6	39.4	37.3	44.6	37.3	32.8	41.0	40.1	42.4	36.8	36.8	30.9	45.4	9.0	38.5	38.7	40.6	42.7	19.5	48.7	23.7	46.7	39.7	13.6	28.5	19.9	11.4	38.7	68.9	37.5	33.0	73.8	27.9	35.3	32.8	19.4	23.3	21.9	43.7	69.8	38.7	59.6	47.0	10.3	39.5	12.2	47.4	37.7	57.3	34.7	48.9	45.8	47.7	41.1	63.2	53.0	6.7	36.9	40.1	47.0	42.1	41.0	21.0	21.6	20.5	26.3	22.1	20.9	19.5	20.1	20.1	18.7	20.5	21.2	19.1	12.8	14.5	7.8	13.1	13.3	10.4	30.5	18.2	19.0	18.7	21.5	11.7	14.3	16.8	9.2	12.5	28.7	19.2	10.3	54.8	23.1	137.1	14.9	23.6	14.4	16.2	14.1	9.0	19.3	38.5	25.2	10.7	12.8	12.7	20.4	17.2	18.5	24.7	13.5	8.2	12.4	14.2	17.7	17.3	60.3	31.4	19.1	19.6	7.5	24.2	18.3	25.7	3.0	7.6	14.7	10.5	29.3	9.9	11.5	17.6	34.1	15.1	20.4	19.7	16.6	14.5	93.2	14.6	15.0	10.9	11.9	16.2	27.3	18.1	5.7
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	47.1	33.3	27.6	33.6	29.5	91.2	42.7	30.6	35.9	39.2	29.1	38.4	32.6	39.0	28.4	38.4	38.3	26.7	39.5	27.0	29.0	38.7	33.6	37.1	46.2	29.5	28.6	41.4	38.6	31.3	30.3	33.0	29.8	32.2	32.1	43.3	34.0	21.9	64.8	50.7	38.5	30.9	28.6	44.6	36.6	48.5	28.4	49.0	33.9	35.9	41.9	38.8	38.0	32.9	91.0	66.6	67.0	70.8	54.5	60.6	76.5	61.3	54.6	66.8	61.2	66.0	81.0	88.3	54.5	46.1	50.8	88.2	81.8	58.9	90.3	71.1	63.5	71.8	59.1	66.7	77.7	50.5	81.0	46.8	76.1	60.0	82.8	71.5	65.8	83.7	103.9	64.7	51.9	93.1	90.7	85.4	74.2	103.1	87.8	97.3	85.5	61.7	61.4	82.6	71.2	76.5	84.7	73.6	87.3	68.1	106.6	95.5	69.9	71.6	81.7	64.9	73.9	62.9	95.5	98.7	65.5	79.8	80.9	94.5	71.0	95.6	57.5	76.9	65.5	59.2	64.5	65.9	72.6	67.0	67.6	63.9	67.8	94.5	92.1	43.2	94.5	76.1	27.6	29.5	30.6	35.9	27.0	29.0	29.5	28.6	29.8	28.6	28.4	32.9	86.5	93.0	49.3	13.1	64.2	56.5	80.4	89.1	33.6	56.0	40.1	50.0	49.9	47.1	77.9	53.3	35.5	79.4	75.4	38.0	76.3	79.0	43.5	97.2	81.3	69.9	43.6	85.0	17.9	70.1	100.1	64.9	26.5	80.5	92.3	61.5	55.6	33.7	76.4	38.7	18.6	50.8	54.9	53.6	52.0	24.0	77.9	70.7	39.2	30.0	95.6	66.7	65.9	15.6	31.9	71.3	43.8	74.1	46.3	48.9	48.8	57.3	88.1	72.2	65.7	60.9	89.5	300.5	140.7	39.7	54.3	109.0	76.8	54.4	47.9	70.9
SNX1	"HsT17379, MGC8664, SNX1A, Vps5"	ENSG00000028528	"Sorting nexin 1"	Q13596	15	64094123-64146090	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 177.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA047373, HPA052761"	Approved		Enhanced	Endosomes,Lysosomes		NA	NA		6100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA047373: AB_2680018, HPA052761: AB_2681939"	"unprognostic (3.99e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (9.88e-6)"	"unprognostic (2.27e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.95e-1)"	63.4	69.0	47.1	59.0	64.1	34.8	46.2	60.9	49.8	52.8	44.5	60.2	49.8	47.6	67.7	60.6	37.5	42.9	50.4	46.2	51.4	56.8	69.3	54.7	67.1	67.5	63.6	39.0	44.3	72.1	32.0	57.8	66.4	51.9	47.6	27.0	55.4	64.4	69.1	48.5	52.4	53.0	62.5	61.0	54.8	34.2	57.2	79.5	102.9	36.8	66.8	62.1	51.2	76.8	75.4	93.5	69.1	60.8	116.4	81.3	23.0	93.5	91.5	81.4	94.5	64.6	115.6	74.4	100.5	86.7	79.7	113.8	102.6	95.2	63.5	136.1	56.0	101.2	110.4	98.2	63.6	94.7	108.0	102.9	62.6	65.2	50.2	59.7	86.1	77.0	74.0	29.2	85.1	107.8	111.4	80.2	54.5	103.2	52.1	100.0	65.3	118.1	127.1	170.5	56.3	56.4	91.4	61.1	86.3	59.5	87.0	86.6	103.0	80.1	120.2	50.8	52.5	93.4	220.5	120.1	72.9	123.5	85.8	144.1	149.1	162.1	83.4	143.1	70.9	101.1	70.4	82.2	127.3	101.9	67.0	66.6	113.7	98.1	144.2	86.1	95.8	156.0	47.1	64.1	60.9	49.8	46.2	51.4	67.5	63.6	66.4	62.5	57.2	76.8	34.4	115.4	74.2	35.6	32.9	26.5	38.1	39.3	29.0	18.9	29.7	29.2	50.6	34.3	52.8	18.4	22.9	51.5	51.6	32.1	33.2	40.9	3.7	36.4	36.7	34.2	26.5	26.5	44.2	37.2	35.1	36.2	27.5	44.9	39.2	44.9	35.3	34.2	72.2	15.2	39.3	28.3	28.5	46.8	27.4	4.0	32.3	42.7	32.0	44.0	56.3	19.7	35.0	121.7	177.7	34.6	30.3	37.6	34.0	32.7	39.2	53.6	31.9	16.5	46.0	36.0	64.0	33.3	23.4	33.8	27.1	47.7	35.0	39.3	28.8	33.9
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291862-26374383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 285.7;Hofbauer cells: 148.7;Kupffer cells: 215.5;Macrophages: 166.5;monocytes: 152.3;Muller glia cells: 310.5;Proximal tubular cells: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 336.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 103.1;U-937: 87.3;WM-115: 297.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	23.7	14.5	26.4	34.7	27.8	42.1	11.0	17.6	45.9	4.5	6.1	5.6	4.1	9.0	1.1	2.9	3.0	8.8	1.8	30.2	42.2	37.8	69.1	41.2	36.9	29.1	28.2	1.1	7.8	1.3	4.7	10.9	40.3	3.5	6.4	47.1	1.7	2.1	1.0	1.4	6.2	9.5	18.6	42.1	3.9	5.1	32.0	15.8	2.9	2.7	24.8	10.9	1.6	26.8	55.8	5.0	0.2	10.1	0.1	0.0	57.8	0.0	3.9	0.1	0.0	0.5	18.4	24.0	41.4	0.0	36.2	1.7	13.5	3.6	0.0	33.3	12.4	2.5	0.4	36.3	0.1	52.2	8.9	0.6	5.4	0.0	4.2	0.1	0.8	30.7	1.5	0.3	0.0	9.7	22.2	54.3	15.3	0.9	5.1	0.1	0.1	1.3	103.1	12.0	22.5	7.1	11.7	8.5	62.7	18.1	15.2	72.6	0.3	0.1	12.2	0.2	13.7	17.9	15.5	16.4	0.5	87.3	297.4	55.9	144.7	3.7	18.6	158.5	18.2	82.3	13.2	16.4	101.2	71.7	6.9	12.0	336.7	47.7	162.5	37.0	29.6	70.0	26.4	27.8	17.6	45.9	30.2	42.2	29.1	28.2	40.3	18.6	32.0	26.8	3.3	3.2	14.7	6.8	63.4	5.4	1.2	0.7	1.8	20.3	17.6	9.5	1.8	34.3	4.4	23.9	2.1	14.9	18.6	2.5	285.7	66.0	1.3	2.1	40.7	7.6	9.5	19.1	63.1	27.1	111.8	3.4	0.0	2.3	31.1	2.9	2.2	109.8	148.7	35.3	53.4	3.3	0.0	215.5	130.3	2.1	1.2	166.5	8.8	19.7	152.3	310.5	33.0	7.1	8.5	14.1	1.5	0.0	8.0	4.4	4.5	204.9	0.8	23.2	0.0	0.7	4.7	7.1	29.5	0.8	3.0	28.7	31.6	0.9	8.7	1.3
SNX11		ENSG00000002919	"Sorting nexin 11"	Q9Y5W9	17	48103357-48123601	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044787, HPA054660"	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"	Vesicles	"HPA044787: AB_10795988, HPA054660: AB_2682560"	"unprognostic (1.75e-1)"	"unprognostic (6.86e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.22e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.89e-2)"	14.3	12.0	18.0	18.1	19.1	21.5	11.1	18.2	19.4	10.5	16.4	13.8	8.7	10.5	12.5	19.9	9.6	8.9	12.5	18.3	18.4	15.8	14.5	11.4	21.7	20.1	18.9	8.8	11.7	13.4	10.7	11.3	18.8	12.1	12.5	11.9	12.2	8.7	12.8	11.6	12.4	17.0	20.1	24.0	12.4	11.4	19.8	16.1	20.0	15.3	29.1	13.3	11.6	20.7	20.6	25.4	21.9	21.1	18.1	8.3	22.8	21.8	13.9	26.5	28.8	36.0	17.7	21.6	27.3	24.1	15.5	18.6	21.2	21.0	29.2	52.4	24.5	32.5	17.5	17.5	18.4	36.0	22.7	13.8	20.8	25.1	23.7	16.5	22.4	20.4	19.8	21.7	17.4	17.0	21.8	22.8	12.2	23.6	21.3	13.5	39.7	24.8	16.1	20.1	15.7	28.6	14.2	9.7	37.7	26.6	20.1	25.4	18.8	30.6	18.2	20.3	26.3	34.0	54.1	26.0	22.1	16.4	19.6	28.7	34.6	35.6	19.0	43.3	13.1	22.1	10.5	12.9	28.2	21.2	8.6	14.7	92.9	16.8	54.5	12.9	10.1	24.0	18.0	19.1	18.2	19.4	18.3	18.4	20.1	18.9	18.8	20.1	19.8	20.7	8.7	6.4	2.0	2.9	15.4	6.0	5.0	5.9	7.4	8.9	6.4	6.2	5.3	1.5	4.3	16.5	2.1	11.7	14.2	13.3	5.9	11.4	1.9	6.2	4.6	8.0	14.9	3.6	4.1	15.3	12.2	6.0	6.6	7.1	2.5	5.4	6.1	6.9	19.9	15.2	3.9	9.0	6.1	23.2	4.6	2.1	5.3	15.9	5.4	2.8	37.5	14.2	14.4	5.0	8.8	18.1	5.6	6.8	6.3	6.9	9.9	9.9	2.9	9.3	13.1	4.6	8.8	10.3	21.2	8.9	5.1	16.4	7.5	7.7	8.0	6.4
SNX12		ENSG00000147164	"Sorting nexin 12"	Q9UMY4	X	71056332-71073426	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070423	Approved					NA	NA		89000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB070423: AB_11153407"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.83e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (1.51e-7)"	"unprognostic (3.52e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	26.6	37.6	36.4	27.4	38.3	28.1	29.6	34.4	39.9	31.9	26.0	35.9	37.4	36.1	34.2	49.7	33.2	30.0	40.7	33.7	40.2	42.1	25.0	26.9	23.4	36.8	38.7	39.2	24.8	59.6	18.8	35.6	37.2	33.7	34.3	28.5	27.9	43.9	44.3	43.3	42.8	41.0	37.4	24.1	32.6	16.1	40.6	25.2	42.0	51.3	29.3	40.4	31.2	34.4	67.9	97.6	53.6	46.8	79.9	73.2	58.7	75.8	75.7	74.1	65.7	73.2	110.7	36.4	62.9	89.7	120.3	57.4	104.8	89.4	64.3	29.0	55.4	39.3	108.8	40.7	65.4	38.4	46.0	57.9	94.3	94.5	67.5	61.3	87.1	37.6	60.8	61.3	108.6	69.7	46.5	28.9	71.6	109.7	84.6	45.2	81.6	57.2	60.5	58.3	36.9	28.4	101.4	55.9	65.1	65.2	35.5	30.1	101.5	66.8	64.8	92.6	46.0	35.0	54.8	42.7	64.8	83.9	47.8	6.9	2.9	4.9	2.6	4.2	3.0	4.2	2.9	2.3	3.3	3.1	2.2	3.5	2.5	3.5	2.5	2.7	4.7	1.6	36.4	38.3	34.4	39.9	33.7	40.2	36.8	38.7	37.2	37.4	40.6	34.4	12.2	0.0	6.7	2.9	11.8	15.3	22.5	17.2	22.2	10.1	15.4	13.5	21.4	21.5	12.8	11.0	2.1	40.2	5.6	21.8	11.7	27.3	0.5	3.6	11.8	16.8	10.8	10.1	6.4	24.4	22.5	13.5	10.7	8.2	14.5	6.6	16.8	13.8	24.3	15.2	6.0	16.8	16.2	17.6	11.2	1.2	10.8	12.8	17.8	1.9	24.1	12.5	15.5	7.1	4.8	31.5	9.0	19.9	5.9	12.3	48.1	29.7	3.4	10.2	26.3	8.7	14.8	5.9	14.7	22.2	16.3	33.1	10.1	25.8	16.5	18.0
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027439-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.1	13.3	17.3	10.2	18.5	10.5	15.3	19.4	19.2	16.6	9.0	22.5	15.3	15.8	6.4	14.9	12.9	7.4	15.0	18.4	17.1	17.0	10.1	11.9	9.3	19.3	18.2	14.8	12.7	10.7	9.4	7.3	16.1	12.9	8.8	5.8	12.3	10.9	25.7	17.5	16.8	8.9	16.1	10.8	16.4	5.3	17.8	9.4	10.6	15.5	7.4	18.0	14.9	18.5	31.1	22.3	14.7	14.2	17.3	12.4	7.9	10.0	13.6	23.3	21.3	17.6	23.7	30.7	16.7	17.4	29.3	16.8	16.8	15.2	9.8	47.0	14.0	15.8	18.2	30.2	18.3	10.7	24.5	10.6	22.2	24.7	14.5	13.0	14.1	22.6	27.0	19.6	12.5	18.8	29.2	36.8	15.5	12.0	21.9	23.7	8.4	34.0	17.6	6.7	25.6	19.2	25.3	23.0	23.2	9.7	23.4	18.6	27.5	23.5	22.9	24.1	14.7	20.9	38.3	30.3	23.2	14.5	8.4	9.2	13.6	13.6	7.6	16.2	6.2	8.9	7.8	6.8	9.4	8.7	5.6	5.1	2.1	4.3	23.6	6.4	8.3	7.3	17.3	18.5	19.4	19.2	18.4	17.1	19.3	18.2	16.1	16.1	17.8	18.5	0.3	0.0	3.3	0.0	0.8	1.0	0.1	0.4	4.0	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.4	0.1	5.6	0.0	4.8	0.0	0.1	0.2	0.9	7.8	1.3	0.0	3.1	0.6	0.4	1.1	0.1	8.2	0.4	0.7	0.1	1.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	7.9	0.2	0.0	0.0	0.0	3.9	8.0	0.4	1.1	0.0	6.5	0.6	0.7	0.4	0.0	0.7	1.0	0.0	0.0	1.5	0.4	0.4	1.1	0.2	5.6	0.1
SNX16		ENSG00000104497	"Sorting nexin 16"	P57768	8	81799581-81842866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 82.8;Late spermatids: 137.3;Spermatocytes: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024730, HPA024731, HPA024817"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313"	"unprognostic (5.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.41e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.73e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-1)"	10.1	5.2	4.7	6.0	5.7	10.7	8.2	6.6	7.6	8.6	2.5	6.3	6.4	9.7	8.3	17.3	6.2	10.8	8.1	5.3	6.6	6.6	5.5	6.7	5.1	6.1	7.4	9.6	3.1	8.9	3.7	5.5	8.6	7.3	6.6	4.9	5.7	7.7	4.6	11.2	5.7	11.9	5.8	12.0	9.0	14.9	5.7	9.4	8.7	9.4	6.7	7.0	7.7	6.7	13.8	3.8	6.6	6.3	22.9	13.7	7.3	16.6	20.2	14.1	20.6	3.4	11.1	2.2	10.0	11.4	16.5	11.0	5.1	6.8	19.5	19.9	3.1	7.1	5.2	6.2	17.4	2.9	11.5	10.5	10.6	5.4	12.5	15.8	10.0	7.8	4.5	26.0	32.9	7.2	15.6	5.1	2.8	12.6	6.2	6.6	9.5	2.4	12.7	6.7	10.9	8.3	3.1	3.9	8.3	9.8	10.3	5.5	7.7	19.5	15.6	13.5	7.2	15.1	12.5	5.7	8.4	9.1	15.7	9.2	4.5	6.1	2.1	2.8	2.0	1.6	2.5	1.7	4.0	4.4	2.9	2.8	6.2	2.6	2.4	3.0	5.0	1.9	4.7	5.7	6.6	7.6	5.3	6.6	6.1	7.4	8.6	5.8	5.7	6.7	10.6	6.4	9.4	9.8	6.4	25.2	12.1	5.0	9.6	5.5	12.1	7.6	8.8	7.2	9.3	5.5	4.2	2.3	3.7	7.5	5.9	5.9	82.8	9.4	7.8	11.5	3.0	8.2	24.7	6.0	4.0	8.5	10.7	16.2	8.2	5.0	13.9	3.5	5.7	55.5	18.4	6.2	8.2	7.0	10.0	137.3	23.3	7.2	3.6	8.4	2.3	4.3	1.0	23.1	22.2	6.7	5.5	16.1	8.6	12.6	3.7	7.3	10.9	5.2	19.7	12.1	9.3	74.2	26.5	13.0	32.0	9.9	5.4	4.2	4.7	20.7
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377535	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	62.5	74.6	32.2	23.1	32.6	19.8	57.0	35.3	31.8	59.7	32.1	58.5	17.3	62.8	16.6	62.2	57.7	22.1	60.3	30.3	32.7	54.6	62.9	53.8	32.3	33.5	33.1	62.4	53.9	42.5	61.1	28.1	37.1	54.2	23.3	12.8	50.3	31.6	49.2	57.0	53.3	33.4	36.3	80.8	54.1	34.1	35.0	43.9	54.3	33.9	33.8	59.8	50.9	37.0	40.1	70.0	45.3	56.4	85.9	71.5	29.0	47.3	85.2	71.8	52.2	43.5	37.8	39.5	55.4	113.9	61.9	23.7	42.4	63.8	57.9	40.7	72.5	44.8	20.3	55.4	80.9	47.6	41.6	66.9	56.7	49.6	59.5	54.1	78.3	32.7	35.5	32.8	87.2	47.7	50.2	31.3	29.2	62.5	67.1	22.7	74.0	64.9	53.5	34.1	46.3	55.1	38.6	39.0	18.1	31.9	30.5	29.6	50.6	57.4	31.6	33.8	45.5	56.8	47.5	49.4	50.0	49.8	60.9	87.5	138.7	88.9	65.6	135.2	66.9	72.7	61.2	67.6	135.6	73.2	57.5	60.6	30.8	72.2	146.9	73.8	78.5	231.9	32.2	32.6	35.3	31.8	30.3	32.7	33.5	33.1	37.1	36.3	35.0	37.0	60.8	16.0	39.1	6.5	68.3	32.5	48.2	78.3	32.5	30.9	47.1	61.3	31.5	35.8	43.3	29.5	14.6	173.5	69.3	56.9	82.2	84.0	8.9	34.4	39.9	52.7	55.1	49.2	6.8	63.9	132.7	60.3	35.2	25.6	43.1	64.5	47.5	64.9	134.9	45.4	7.7	48.3	79.3	118.1	42.7	9.7	58.4	83.4	69.4	2.8	141.9	80.1	76.2	11.1	11.2	64.8	54.1	85.0	60.3	41.4	75.4	95.3	38.6	23.2	32.9	41.4	68.4	58.0	53.2	55.0	34.4	99.6	63.2	102.1	60.0	34.9
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546586	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 90.0;Kupffer cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	14.9	8.7	12.1	11.2	21.3	68.0	9.1	20.4	13.1	11.5	9.1	9.2	9.3	13.5	6.4	10.1	9.4	11.4	7.4	10.3	12.2	12.8	15.1	11.3	13.3	22.8	19.9	26.6	9.3	12.0	3.6	21.8	19.6	8.6	5.5	14.8	11.2	11.5	7.2	7.6	9.5	14.1	18.8	18.8	12.0	7.3	18.6	5.6	15.6	8.0	7.0	11.2	7.7	25.2	9.0	7.4	11.4	13.0	26.2	27.8	61.7	14.8	37.1	7.6	12.6	9.1	16.4	0.4	23.1	23.1	13.9	8.2	10.8	14.5	9.6	4.6	7.7	2.7	4.6	5.7	43.5	5.0	2.5	44.1	17.2	10.4	10.8	13.5	16.1	6.5	4.8	60.7	13.3	8.6	4.7	5.7	5.7	3.7	7.6	12.4	6.4	14.5	7.4	26.0	14.1	8.3	12.4	14.2	16.2	17.4	16.7	8.4	5.5	28.4	13.8	21.1	15.6	40.0	41.8	2.5	11.0	11.8	29.9	0.0	0.9	0.1	0.7	1.5	0.1	0.8	0.3	0.4	1.1	0.6	0.1	0.5	3.8	1.0	3.8	2.5	0.2	0.3	12.1	21.3	20.4	13.1	10.3	12.2	22.8	19.9	19.6	18.8	18.6	25.2	14.4	54.5	26.8	7.5	16.6	9.8	4.4	12.8	10.2	10.0	13.6	10.5	16.5	7.2	22.5	22.0	73.0	26.5	48.2	4.2	15.6	14.2	0.3	7.5	9.8	16.5	6.1	3.4	10.3	15.2	30.3	23.0	27.5	6.2	5.7	90.0	43.9	28.1	41.6	5.0	9.2	7.3	12.2	87.4	26.2	2.5	14.0	52.1	10.6	37.5	42.6	11.2	35.0	6.6	21.6	12.8	7.3	17.7	12.7	5.6	8.6	6.9	24.0	47.5	0.0	13.3	38.5	3.6	13.1	8.9	11.8	8.2	12.5	58.6	10.8	13.1
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130866250-130916479	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	15.9	18.5	19.0	12.4	24.3	8.7	14.8	18.0	17.9	15.5	18.2	22.3	11.8	18.0	19.1	14.7	16.3	14.9	20.1	15.3	17.6	16.6	19.3	14.6	11.0	27.4	22.5	14.0	19.4	16.1	17.2	12.6	21.1	16.6	14.1	15.5	19.4	14.4	23.8	12.9	15.4	19.5	22.1	15.2	19.0	21.3	23.8	11.1	21.5	13.1	11.7	19.1	13.5	28.7	13.8	23.2	17.4	27.7	52.9	36.9	13.2	35.7	38.1	17.9	18.1	20.6	26.2	12.4	27.0	40.3	45.3	25.6	3.2	25.1	20.8	20.9	13.7	24.3	18.3	0.1	30.9	0.0	19.1	42.1	24.4	20.0	17.9	35.3	20.9	17.9	23.5	0.1	35.3	10.9	18.6	10.6	4.9	30.0	19.3	16.1	17.2	8.0	11.9	27.8	19.6	16.4	16.7	22.4	11.1	13.4	46.6	13.0	34.4	26.7	20.9	21.8	21.3	4.5	0.0	0.1	9.7	13.5	28.9	6.5	3.6	2.5	2.1	3.2	3.0	2.8	1.9	2.5	2.9	1.8	2.3	2.0	1.7	1.6	4.0	2.7	1.9	3.5	19.0	24.3	18.0	17.9	15.3	17.6	27.4	22.5	21.1	22.1	23.8	28.7	12.6	25.6	7.9	44.4	14.8	4.0	7.2	7.8	8.6	25.6	11.6	9.1	20.4	15.7	12.9	23.9	10.4	10.3	10.0	19.4	9.8	11.5	35.8	10.8	14.3	12.2	11.4	7.4	30.0	16.0	5.7	11.4	15.8	11.0	18.4	13.5	13.9	21.3	10.1	16.8	34.9	12.5	6.1	11.7	5.2	44.7	13.7	11.9	3.6	20.6	9.6	22.4	13.4	35.7	112.6	16.6	14.5	15.8	15.5	10.2	14.4	8.6	16.9	37.9	13.1	12.7	9.8	37.1	15.5	9.8	4.3	14.0	9.2	13.1	10.3	10.8
SNX2		ENSG00000205302	"Sorting nexin 2"	O60749	5	122775079-122834543	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 290.2;naive B-cell: 289.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037400	Approved		Supported	Endosomes,Lysosomes		NA	NA		150000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA037400: AB_10670381"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.76e-7)"	"unprognostic (8.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	40.6	31.0	6.0	17.9	6.5	14.2	33.8	9.5	8.5	27.8	6.2	32.6	13.4	28.2	12.5	30.1	29.0	12.8	22.4	6.2	6.5	37.8	28.0	33.7	26.5	6.4	7.0	37.1	31.3	14.1	23.2	19.2	6.5	24.2	14.5	7.1	29.1	10.1	27.0	29.0	34.8	17.9	6.9	52.4	32.9	17.1	7.1	10.4	38.3	7.7	24.0	33.6	26.1	8.5	18.9	14.1	18.7	13.1	27.8	19.0	79.6	6.2	21.1	15.1	24.2	27.1	27.2	18.8	18.5	14.9	37.4	6.1	24.6	16.2	18.0	13.4	12.2	23.3	15.8	29.7	19.7	7.7	10.8	16.1	12.8	9.6	16.6	17.6	16.8	15.4	10.1	14.9	14.0	16.1	5.5	11.6	6.3	22.2	10.7	20.2	14.3	25.4	17.3	33.9	12.0	13.3	16.0	19.8	17.0	46.4	24.2	16.0	10.7	13.7	6.9	19.1	11.7	4.4	14.9	24.4	13.6	32.1	15.6	77.9	78.5	57.0	15.4	89.1	18.3	290.2	25.7	24.2	66.5	289.1	23.6	21.0	34.7	18.5	86.6	20.1	48.7	72.7	6.0	6.5	9.5	8.5	6.2	6.5	6.4	7.0	6.5	6.9	7.1	8.5	48.4	35.3	42.8	33.0	260.8	40.7	46.9	82.3	45.5	43.1	23.8	29.3	34.4	40.0	62.4	80.9	8.4	153.9	36.2	19.9	131.0	69.1	25.5	71.5	44.7	49.0	31.8	34.3	38.5	51.8	244.9	62.1	52.5	52.2	65.1	41.8	89.6	31.4	349.2	26.9	42.2	32.6	69.2	125.8	75.8	15.0	53.4	133.0	33.8	61.8	215.8	71.7	23.7	51.8	51.4	35.7	37.0	53.0	37.5	28.1	57.8	114.7	77.8	38.0	46.0	42.8	74.5	89.1	75.9	32.9	38.9	122.9	47.2	92.4	39.8	37.5
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.0;lymphoid tissue: 33.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.3;Cardiomyocytes: 16.4;dendritic cells: 23.7;Hofbauer cells: 17.6;Kupffer cells: 17.2;Langerhans cells: 25.2;Macrophages: 19.3;monocytes: 26.1;NK-cells: 24.7;T-cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.7;HMC-1: 78.5;NB-4: 48.0;RPMI-8226: 20.6;THP-1: 21.3;U-266/70: 25.7;U-937: 28.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.3	1.0	1.5	20.0	1.5	18.0	1.1	1.8	1.7	1.1	1.5	2.7	2.9	1.0	0.6	1.6	1.0	4.0	0.8	1.3	1.8	0.8	2.2	7.7	27.8	3.4	2.1	0.6	0.5	0.4	0.5	2.7	2.5	1.1	3.6	0.3	1.9	0.7	0.8	2.4	6.1	2.7	2.1	19.2	3.7	0.5	2.6	33.2	0.9	1.1	27.0	6.1	0.7	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.7	0.0	5.2	0.0	0.0	0.0	7.4	78.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	48.0	0.0	0.0	0.0	2.4	0.2	20.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.2	0.0	0.0	0.1	0.0	25.7	14.3	6.5	0.0	28.4	0.0	306.6	66.9	208.0	41.6	118.3	52.2	22.6	73.8	50.9	123.4	22.6	56.1	38.9	62.3	51.3	147.5	34.3	137.5	81.8	1.5	1.5	1.8	1.7	1.3	1.8	3.4	2.1	2.5	2.1	2.6	2.9	0.2	0.0	0.0	0.3	15.3	0.8	0.0	0.0	0.0	0.2	0.3	0.6	16.4	2.8	1.3	0.0	0.0	0.1	23.7	0.0	0.0	0.0	0.1	0.3	0.1	1.5	0.0	6.5	0.0	0.0	0.2	0.5	0.5	0.1	5.1	0.0	1.1	0.4	17.6	1.7	0.0	0.0	0.0	17.2	25.2	0.0	0.0	19.3	0.0	0.0	26.1	0.1	24.7	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.1	13.1	0.5	0.5	0.2	0.1	0.0	0.6	0.4	21.3	0.1	0.2	0.0
SNX21	"C20orf161, dJ337O18.4, SNX-L"	ENSG00000124104	"Sorting nexin family member 21"	Q969T3	20	45833799-45843276	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Theca cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.8;classical monocyte: 1.6;eosinophil: 4.8;intermediate monocyte: 2.6;non-classical monocyte: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.8;monocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 17.9;PC-3: 29.8;U-87 MG: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046359	Approved		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Centriolar satellite"		"HPA046359: AB_10963216"	"unprognostic (1.97e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.18e-1)"	25.0	27.8	4.9	1.1	4.1	0.7	18.7	5.8	7.9	26.4	4.9	15.8	3.7	28.6	0.8	14.1	24.6	5.0	14.9	3.5	2.8	11.9	6.2	10.9	1.3	9.2	5.1	30.5	4.2	3.3	10.9	2.9	6.5	14.4	1.2	0.7	9.7	4.8	31.9	47.9	7.5	1.9	3.0	7.3	11.3	6.1	7.2	0.5	9.1	6.7	0.6	25.7	19.5	4.6	4.3	6.7	1.0	6.5	7.8	7.5	4.3	6.8	5.0	5.0	4.0	5.0	3.0	0.1	17.9	4.8	4.1	5.5	0.2	4.5	0.8	0.3	1.4	0.1	4.1	4.6	3.3	0.0	1.3	3.9	2.7	4.8	0.4	1.7	3.6	1.1	0.1	0.0	0.9	11.1	0.1	0.8	1.8	0.8	29.8	0.1	0.5	0.2	1.0	0.7	1.2	11.6	14.6	10.3	8.1	0.8	5.9	1.2	6.4	6.0	7.2	17.2	5.5	0.2	0.9	0.2	18.1	0.0	4.4	2.8	1.6	4.8	0.0	2.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.4	0.3	4.9	4.1	5.8	7.9	3.5	2.8	9.2	5.1	6.5	3.0	7.2	4.6	11.1	9.6	8.3	25.1	1.0	10.1	4.7	6.4	8.6	18.4	8.6	8.5	4.8	7.2	10.3	5.5	8.4	4.9	0.4	10.3	25.4	10.3	3.7	5.0	27.0	10.3	9.0	0.0	4.8	11.7	5.2	37.0	6.6	7.5	0.0	27.0	10.4	4.3	4.8	15.2	5.7	9.2	4.1	7.1	10.0	18.3	19.6	5.4	10.6	3.7	3.3	14.8	1.0	8.5	6.5	8.4	5.9	17.0	0.8	3.7	15.9	15.7	6.6	15.6	6.6	16.4	20.1	0.9	2.4	4.1	22.7	2.5	2.2	62.2	7.0	3.4
SNX24	SBBI31	ENSG00000064652	"Sorting nexin 24"	Q9Y343	5	122843439-123029354	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044566, HPA073934"	Approved		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA044566: AB_10797034, HPA073934: AB_2686644"	"unprognostic (2.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (7.93e-6)"	"unprognostic (2.31e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.69e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.50e-2)"	8.1	8.1	12.3	5.5	15.1	4.5	7.5	19.0	15.5	9.5	13.1	11.1	15.2	6.5	11.8	36.8	7.6	10.5	12.3	11.4	15.6	20.6	14.1	17.3	6.5	19.3	15.6	5.9	10.6	25.6	7.8	25.3	18.6	6.1	12.5	12.5	12.3	6.5	9.5	16.8	11.5	11.0	16.9	7.7	16.4	8.7	17.1	2.5	18.5	14.0	8.8	9.2	14.2	23.9	33.2	14.7	23.5	15.8	8.5	21.7	47.2	28.7	26.7	32.9	42.1	20.8	30.0	0.0	24.0	28.3	31.9	6.7	15.2	36.8	50.3	17.8	9.3	4.7	13.4	29.8	43.4	0.2	5.4	18.3	53.4	16.6	64.4	28.5	16.0	5.7	6.1	26.3	25.1	29.5	0.8	1.3	9.6	6.0	9.3	4.2	37.3	16.3	47.8	19.8	14.4	17.2	27.1	19.7	31.2	30.4	35.5	10.4	13.9	35.4	27.3	14.0	46.6	9.1	12.9	5.0	30.3	0.6	73.4	0.0	1.4	0.0	0.6	2.8	0.3	0.3	0.6	0.5	0.7	0.2	0.2	0.1	0.0	1.3	3.2	0.1	1.4	0.5	12.3	15.1	19.0	15.5	11.4	15.6	19.3	15.6	18.6	16.9	17.1	23.9	7.8	44.8	24.6	45.4	1.1	10.5	7.5	10.6	3.4	18.3	8.7	5.8	14.9	14.3	6.3	20.2	6.2	45.1	3.7	17.7	35.2	15.6	75.8	18.6	11.1	6.5	1.2	4.0	51.8	11.8	57.1	12.6	7.1	15.0	0.0	19.1	8.6	12.9	66.1	11.8	52.1	6.7	6.1	51.9	4.7	95.9	9.0	21.0	3.6	60.9	16.0	12.4	4.1	46.8	63.5	21.9	4.4	9.4	2.7	16.2	35.2	39.9	12.0	18.0	13.1	7.0	9.1	5.0	9.6	19.5	16.8	39.7	3.9	39.2	8.9	11.8
SNX29	"FLJ12363, RUNDC2A"	ENSG00000048471	"Sorting nexin 29"	Q8TEQ0	16	11976734-12574287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 354.5;Late spermatids: 430.7;Microglial cells: 169.6;Oligodendrocytes: 241.6;Rod photoreceptor cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 22.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008889, HPA062810"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoli, Cytosol"	"HPA008889: AB_1079856, HPA062810: "	"unprognostic (2.50e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.82e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.08e-2)"	"prognostic favorable (1.38e-7)"	"unprognostic (3.85e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.03e-4)"	8.6	3.5	7.4	8.2	18.8	9.5	6.2	13.6	11.8	6.6	7.4	5.3	2.3	5.8	2.6	8.2	8.4	4.8	4.5	7.5	9.9	19.0	2.3	6.8	13.0	17.0	15.6	10.2	3.5	22.5	7.1	8.0	18.3	3.5	3.4	23.8	5.6	4.8	6.0	6.9	4.6	5.7	11.4	9.0	4.3	8.5	17.9	21.0	6.5	5.7	16.0	6.3	5.0	26.7	5.0	2.9	4.4	3.5	25.4	20.8	5.7	10.7	29.1	4.3	4.7	0.6	5.7	18.7	13.9	16.6	2.8	4.2	2.9	6.8	6.2	7.2	3.0	2.5	2.5	6.4	4.9	2.7	6.6	19.1	4.4	6.3	2.8	6.5	7.6	6.1	3.9	5.2	4.4	6.7	5.0	3.1	2.4	3.2	2.6	11.3	5.6	15.2	19.3	4.6	5.2	4.4	12.2	7.2	2.5	3.8	4.1	3.2	11.7	7.6	3.0	5.8	2.1	29.5	24.4	11.5	14.1	2.8	4.9	3.8	6.9	1.6	2.0	4.5	2.5	10.6	4.3	2.7	2.5	22.3	5.2	3.6	2.5	1.3	2.3	7.4	4.0	1.9	7.4	18.8	13.6	11.8	7.5	9.9	17.0	15.6	18.3	11.4	17.9	26.7	14.4	12.8	22.9	71.2	61.0	15.3	6.5	5.3	19.9	63.9	8.5	7.4	9.7	4.3	10.8	16.5	354.5	18.6	26.9	4.4	21.5	4.6	124.0	35.3	27.8	13.8	13.1	6.1	59.0	2.9	5.0	20.8	14.8	62.6	42.5	15.2	17.9	4.8	28.7	92.5	54.6	4.6	8.2	29.3	39.6	430.7	21.5	36.7	12.4	169.6	24.3	23.1	16.5	51.8	241.6	7.7	4.3	15.4	23.9	3.6	3.3	42.6	27.2	256.1	6.6	20.8	14.2	20.0	10.8	21.9	15.5	17.1	15.4	14.1	4.0	5.5
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750760-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.9;Oligodendrocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	3.5	3.6	8.0	7.3	16.5	8.4	6.8	9.7	12.3	9.1	0.0	10.2	7.1	5.5	3.4	3.8	3.1	4.7	3.0	7.9	13.5	21.2	4.6	21.3	8.6	14.5	12.9	5.7	4.6	5.2	3.0	4.5	12.2	3.4	10.3	4.0	5.0	3.5	2.0	4.8	8.2	6.5	8.6	7.0	4.2	11.9	16.1	3.8	2.6	2.1	8.1	4.0	3.2	25.8	8.2	5.0	8.5	6.8	10.5	9.6	7.2	6.9	14.2	5.7	5.4	18.1	1.9	13.6	5.7	17.9	10.2	9.6	10.4	4.1	8.8	4.4	4.9	4.2	4.6	7.3	7.5	4.2	7.2	7.8	5.6	8.8	6.5	14.4	4.9	3.4	6.7	7.5	7.8	5.7	2.8	4.9	9.4	13.2	5.2	5.9	19.9	3.5	11.1	14.2	12.6	4.0	9.0	12.3	17.6	8.7	9.2	7.4	5.6	8.4	9.0	25.0	5.9	19.6	19.5	6.3	10.8	3.9	16.9	0.0	2.0	0.6	0.2	0.7	0.6	0.0	0.3	0.4	1.6	0.2	0.2	0.2	0.2	0.3	0.8	0.2	0.6	0.7	8.0	16.5	9.7	12.3	7.9	13.5	14.5	12.9	12.2	8.6	16.1	25.8	4.4	6.4	77.9	11.4	3.5	8.2	2.0	3.1	7.4	5.9	10.5	5.5	4.3	2.8	7.6	5.5	10.4	0.6	3.6	26.2	5.9	2.6	9.1	16.2	7.5	4.8	4.8	6.6	39.0	3.2	2.1	5.3	5.6	20.1	7.0	15.6	8.9	7.7	13.4	8.4	24.1	10.8	2.0	22.4	17.0	8.1	5.6	19.8	21.4	36.5	22.3	2.4	2.1	22.6	91.2	4.4	20.3	7.9	5.8	2.5	11.9	34.2	2.3	3.1	0.0	4.7	2.8	6.6	10.0	7.3	11.1	0.4	5.7	3.7	9.6	6.3
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.5;urinary bladder: 16.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.6	0.1	1.0	0.0	1.2	0.2	0.4	0.8	3.1	0.4	0.6	0.3	0.0	0.3	0.2	6.5	0.3	1.1	1.7	1.0	1.1	0.2	0.5	0.1	0.4	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.4	0.1	0.7	4.0	0.7	0.3	0.5	0.5	3.6	16.4	1.7	1.5	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.2	0.8	3.1	1.0	1.1	0.0	0.0	0.0	0.4	0.7	1.5	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833834-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 37.8;choroid plexus: 15.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.3	0.1	22.8	0.1	24.0	0.3	0.3	17.1	37.8	0.6	15.0	1.0	1.0	0.7	0.2	0.1	0.7	0.8	0.2	23.7	17.8	0.2	0.0	0.1	0.1	18.1	18.2	0.7	0.1	0.2	0.4	0.0	18.3	0.2	0.4	1.1	0.0	0.1	0.0	0.4	0.5	0.5	16.9	0.2	0.2	2.1	18.7	0.4	0.1	0.2	0.2	0.4	0.2	23.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.5	5.8	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	7.0	1.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.3	0.2	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	22.8	24.0	17.1	37.8	23.7	17.8	18.1	18.2	18.3	16.9	18.7	23.1	0.3	0.0	0.6	25.5	0.6	0.4	0.3	0.0	1.2	2.4	0.7	1.0	0.8	0.0	0.6	0.0	0.0	0.1	0.1	0.6	0.0	0.1	11.3	0.3	3.6	0.6	0.0	0.8	48.4	0.0	0.4	0.9	1.1	0.5	3.8	2.8	0.4	0.0	0.3	0.0	34.2	0.8	0.0	0.3	0.3	12.3	0.3	0.2	1.8	3.7	0.0	0.9	1.0	12.1	10.2	0.2	0.5	1.2	0.5	0.2	3.9	0.4	0.7	0.6	0.0	1.0	0.8	6.1	1.7	0.5	0.4	0.0	0.7	1.3	1.7	0.1
SNX33	"MGC32065, SH3PX3, SH3PXD3C, SNX30"	ENSG00000173548	"Sorting nexin 33"	Q8WV41	15	75647912-75662301	"Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040988	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA040988: AB_10794983"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (5.00e-3)"	"unprognostic (3.00e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	26.2	17.2	11.1	7.1	11.1	0.5	21.3	9.5	9.8	29.3	11.8	19.7	12.1	23.6	8.4	42.5	21.9	14.3	19.6	10.2	9.9	12.5	29.0	19.3	8.2	14.2	10.8	25.6	27.2	11.1	7.0	11.9	10.3	23.5	10.0	1.6	20.6	16.6	5.9	29.6	15.5	14.6	10.1	11.8	18.8	3.5	13.0	7.6	16.7	9.2	10.6	20.2	30.2	9.1	14.9	13.1	12.6	13.5	48.7	31.5	13.9	14.3	29.8	15.6	14.2	8.3	15.3	0.4	10.3	31.7	22.3	35.1	15.7	37.4	8.3	16.4	5.3	4.6	15.5	15.2	32.3	0.4	4.7	32.6	44.5	15.2	21.2	37.4	10.0	1.4	11.0	2.0	18.4	2.9	0.1	9.4	12.1	9.3	7.3	2.3	9.9	0.7	15.9	22.1	1.1	8.6	21.1	22.7	17.4	23.4	13.6	10.5	14.6	22.1	10.4	16.6	7.7	0.3	0.4	0.1	22.3	5.4	6.0	0.0	0.5	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	11.1	11.1	9.5	9.8	10.2	9.9	14.2	10.8	10.3	10.1	13.0	9.1	8.3	6.4	5.6	2.9	0.2	12.1	3.4	9.3	6.2	0.0	6.8	5.7	3.8	2.8	8.2	7.3	2.1	3.1	1.2	13.5	0.0	7.5	0.3	4.8	7.5	5.7	9.1	0.4	0.5	6.5	4.1	13.3	14.3	4.8	1.3	6.8	10.0	12.6	5.1	0.0	0.1	8.1	8.2	2.8	7.8	0.6	13.1	2.9	3.6	2.8	3.0	3.8	0.0	2.5	0.2	15.9	7.6	15.1	1.1	7.5	12.4	3.7	9.5	0.2	19.7	8.5	9.5	0.1	0.6	5.5	11.2	1.4	1.8	2.5	7.3	11.3
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446650-125520202	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	16.7	22.1	11.0	12.7	11.2	16.3	25.3	11.5	16.7	19.9	12.4	24.9	35.8	14.1	13.7	14.9	14.2	19.8	16.5	11.1	12.3	53.8	56.5	18.1	16.3	11.9	11.1	14.9	19.5	18.0	14.4	31.7	12.0	22.7	27.7	9.1	22.4	11.4	18.9	10.2	34.2	13.4	11.8	13.0	21.6	16.1	10.8	21.1	44.9	23.3	17.1	16.8	11.3	14.0	34.8	10.9	34.5	21.8	20.9	17.4	39.1	18.5	17.5	35.9	32.1	23.7	15.5	22.0	21.4	22.5	15.5	18.0	32.4	15.6	42.9	20.6	23.8	35.6	14.5	36.0	24.5	37.8	22.1	22.7	17.0	18.2	14.5	20.0	34.1	31.8	38.6	10.9	27.6	26.2	41.8	25.4	20.2	37.6	13.0	38.2	42.0	40.3	33.0	30.6	36.1	50.9	29.8	38.3	47.4	32.0	37.7	61.3	22.3	18.0	22.9	23.4	21.9	22.1	20.1	60.2	22.0	23.8	27.8	12.4	14.0	25.8	9.7	18.8	13.0	13.8	12.4	11.2	18.3	10.3	15.8	13.8	2.6	17.4	19.1	16.1	15.1	12.0	11.0	11.2	11.5	16.7	11.1	12.3	11.9	11.1	12.0	11.8	10.8	14.0	27.1	28.9	39.4	33.6	24.5	12.1	17.9	21.3	12.5	13.4	27.2	17.1	17.7	37.1	34.1	22.0	0.0	87.2	20.6	39.9	60.7	45.4	21.6	23.8	22.1	24.7	30.0	22.7	46.7	36.6	57.8	26.9	26.0	20.9	31.0	30.9	24.7	75.8	50.9	18.5	44.9	37.0	46.8	27.0	22.6	31.5	22.1	28.3	30.2	31.9	45.7	21.3	34.0	37.7	47.8	42.9	37.9	18.0	26.2	22.5	48.8	163.4	37.1	12.0	13.1	27.8	30.3	33.0	29.8	23.0	11.8	41.2	22.9	27.2	29.6	15.7
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 271.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 639.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol		NA	NA		8200	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020679: , HPA051187: AB_2681379, HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	42.4	51.4	12.5	43.7	15.2	57.5	37.6	14.9	12.4	35.7	14.5	37.6	47.1	28.3	49.4	35.2	33.5	24.9	28.5	11.0	13.5	59.3	33.7	36.1	59.1	15.5	13.6	51.4	32.0	24.8	21.7	28.9	16.8	23.6	40.1	14.2	34.3	17.2	70.8	28.7	40.2	24.4	17.2	57.5	33.1	15.5	14.0	21.2	70.2	21.8	51.2	34.7	32.5	21.2	103.0	108.6	45.3	49.6	29.6	49.8	270.7	84.1	43.3	49.9	55.9	104.8	140.2	169.6	48.6	49.9	69.7	112.2	63.8	124.6	67.2	44.1	57.8	150.1	49.5	639.4	48.0	106.6	173.9	49.2	54.2	54.6	98.3	37.1	72.8	111.3	72.8	109.6	58.6	79.6	94.2	92.6	48.4	87.0	55.3	110.0	115.2	126.1	61.2	116.4	45.0	26.4	76.0	113.7	102.1	34.0	62.4	67.8	57.3	77.8	98.7	49.2	101.5	77.8	129.2	137.2	38.5	37.6	69.6	69.6	58.7	83.6	54.8	81.7	50.0	80.6	49.6	54.6	71.9	75.2	29.7	42.7	4.8	39.0	92.3	37.2	67.3	54.9	12.5	15.2	14.9	12.4	11.0	13.5	15.5	13.6	16.8	17.2	14.0	21.2	35.6	64.1	113.1	21.5	93.0	31.7	45.7	49.0	48.3	19.1	48.9	44.2	38.5	38.6	59.8	49.7	27.1	101.0	54.9	59.6	160.4	47.8	43.6	51.1	42.3	48.7	31.7	98.4	18.8	44.8	137.7	57.7	52.0	66.9	130.8	47.9	139.9	41.4	151.9	16.8	19.9	54.4	34.6	174.6	47.2	16.0	60.9	88.2	26.6	31.9	68.4	66.3	55.6	24.6	20.3	37.2	58.3	51.6	96.7	49.2	100.0	271.5	52.0	19.8	19.7	50.7	39.6	19.1	44.6	83.5	32.4	78.5	53.0	66.5	100.1	57.4
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561093-34630160	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA049374: AB_2680734"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	50.0	36.5	38.0	46.8	44.4	42.0	36.7	41.2	62.9	40.4	40.2	50.4	74.2	33.6	30.1	40.0	31.2	39.7	33.7	35.4	41.0	44.4	38.9	33.4	56.5	45.4	42.9	31.3	25.1	78.3	14.9	74.5	44.9	25.8	49.1	14.8	27.2	29.5	30.5	30.3	49.1	43.9	44.8	49.2	39.6	36.0	42.1	45.1	34.1	29.2	47.8	50.2	29.6	51.4	112.3	65.3	73.5	48.9	114.5	224.7	99.4	113.1	124.0	110.4	95.4	61.6	115.4	73.2	79.0	153.2	44.1	67.8	81.1	85.8	187.9	93.5	31.7	44.6	34.9	115.9	108.5	77.2	46.8	154.1	98.9	80.7	109.7	100.4	151.7	53.3	48.8	56.3	146.9	68.4	69.9	41.4	40.2	97.7	73.0	74.3	84.4	64.1	135.2	84.6	56.7	61.1	89.9	72.9	94.6	65.0	77.6	47.5	150.8	74.6	52.6	67.8	72.0	55.9	95.9	82.9	37.6	41.6	86.1	73.5	74.2	93.4	73.1	97.4	95.8	71.5	97.0	84.8	66.5	68.0	73.3	79.2	126.5	74.0	101.3	47.6	102.0	109.0	38.0	44.4	41.2	62.9	35.4	41.0	45.4	42.9	44.9	44.8	42.1	51.4	130.2	86.6	49.7	17.6	77.5	51.4	63.0	109.7	69.4	43.4	51.1	67.8	73.4	27.1	87.2	80.9	22.9	166.7	108.9	73.0	125.2	88.1	6.6	74.9	110.1	87.5	52.0	55.5	25.5	64.7	126.3	88.0	68.8	114.3	85.4	93.5	124.6	36.8	251.1	21.9	31.2	62.7	67.1	196.1	73.0	15.3	64.3	155.7	62.2	26.2	155.4	69.6	88.6	21.1	52.5	74.1	77.9	94.8	51.2	84.0	54.8	127.0	73.3	39.4	59.2	74.2	133.8	164.6	167.9	90.0	65.8	254.6	109.4	346.2	82.0	76.8
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037419	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Cell Junctions"	"HPA037419: AB_10671754"	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.5	13.8	10.2	7.5	9.5	0.1	17.1	8.6	9.9	20.6	7.5	30.1	23.5	19.4	12.6	16.6	15.6	16.2	22.1	10.1	13.6	24.9	12.8	11.3	3.4	11.6	12.7	11.3	13.7	15.1	8.4	16.8	10.7	14.3	29.9	3.2	14.1	16.4	5.4	11.0	22.9	25.8	9.8	5.4	16.9	15.7	16.4	3.6	12.2	10.9	4.7	20.3	14.3	10.8	50.4	26.7	15.8	21.6	54.9	86.3	8.9	31.3	56.6	45.9	59.2	15.6	18.4	0.0	39.7	77.1	37.7	14.2	16.8	44.4	45.5	0.2	32.3	0.0	41.2	27.1	32.4	0.0	0.0	43.5	46.8	37.8	16.5	51.7	64.9	0.7	0.0	0.1	73.3	10.3	0.4	0.0	15.2	20.0	38.0	0.0	35.4	0.1	45.3	39.8	7.8	93.5	41.6	39.0	23.7	26.2	0.0	1.8	44.9	44.7	24.8	35.0	64.2	0.0	0.1	0.1	63.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.2	9.5	8.6	9.9	10.1	13.6	11.6	12.7	10.7	9.8	16.4	10.8	14.1	19.2	6.7	23.2	0.5	14.7	44.7	60.0	9.6	0.7	16.3	23.0	49.1	27.1	22.0	23.9	0.0	34.1	0.1	37.4	37.2	47.0	19.3	29.4	33.0	17.8	21.0	0.0	18.3	80.7	33.8	37.9	20.9	19.6	1.3	22.4	17.9	12.0	12.9	3.3	25.7	26.6	48.8	2.1	13.7	23.9	34.2	5.0	35.6	12.2	37.2	12.8	0.0	58.8	8.2	56.8	25.7	52.6	0.1	28.5	34.1	69.0	27.2	0.8	32.9	23.1	36.2	15.5	10.5	27.1	16.3	14.1	1.6	30.2	49.1	57.3
SNX8	Mvp1	ENSG00000106266	"Sorting nexin 8"	Q9Y5X2	7	2251770-2354318	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.9;Late spermatids: 358.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057296, HPA060194"	Approved		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA057296: AB_2683401, HPA060194: AB_2684219"	"unprognostic (2.22e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.35e-1)"	15.4	6.8	13.7	11.3	14.1	10.9	12.4	11.8	11.4	7.0	10.9	7.7	10.6	6.9	3.1	10.2	7.0	9.8	12.8	12.9	11.3	7.3	7.2	9.7	21.5	15.1	13.0	7.5	7.5	5.9	5.4	9.3	13.3	4.3	6.8	5.7	7.8	3.0	11.0	10.2	9.5	5.6	12.9	32.7	6.9	23.2	15.1	7.9	8.3	7.5	17.7	8.5	5.7	14.9	40.3	38.7	15.6	21.8	21.3	20.5	36.7	19.2	28.4	31.8	39.2	27.3	30.6	23.4	7.7	22.8	100.9	10.6	13.6	10.5	16.1	5.9	12.8	13.0	15.5	22.9	53.9	12.7	20.8	41.4	12.1	39.0	15.0	8.5	12.1	18.3	26.0	26.9	26.4	26.4	4.3	13.5	28.4	22.4	19.0	20.6	32.2	10.7	7.5	18.8	7.5	19.7	17.4	47.8	27.3	17.0	35.5	27.4	18.5	26.6	69.7	44.0	25.4	17.5	22.9	21.9	26.4	16.9	73.6	11.8	15.4	5.1	2.9	17.2	2.1	26.1	2.1	2.9	21.8	30.6	2.0	2.4	2.6	2.2	17.8	5.4	3.4	8.7	13.7	14.1	11.8	11.4	12.9	11.3	15.1	13.0	13.3	12.9	15.1	14.9	7.4	6.4	9.4	3.9	35.7	5.2	7.8	6.1	2.8	10.0	12.3	10.4	12.4	10.0	4.8	3.7	8.4	16.7	7.7	10.5	13.7	21.0	108.9	3.3	12.8	13.0	6.0	26.3	5.0	30.0	15.4	10.3	10.7	4.5	12.6	8.2	45.3	8.8	78.1	21.9	7.8	10.9	6.1	35.2	75.2	358.9	12.2	36.7	14.2	6.5	41.9	7.8	7.2	2.5	9.1	26.9	7.9	13.2	12.9	8.8	12.5	14.9	5.5	12.5	0.0	5.3	9.6	10.6	22.9	5.7	6.1	43.4	6.3	29.6	9.7	9.2
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 251.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 146.6;GAMG: 145.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	57.9	25.2	19.2	25.7	20.6	14.3	41.4	21.2	20.9	38.8	20.6	34.2	33.2	41.8	20.8	57.8	26.2	46.9	33.2	18.8	19.9	26.2	39.0	21.0	24.2	22.2	21.1	28.0	28.5	37.7	13.4	48.5	21.8	31.0	29.5	2.7	35.1	41.7	24.4	30.4	35.6	41.2	20.9	18.4	37.5	11.0	20.7	13.9	29.8	34.2	21.7	49.8	33.7	23.0	26.0	19.1	18.9	22.1	96.6	78.6	37.7	46.3	146.6	36.4	48.9	16.6	27.6	0.0	25.0	85.6	145.8	18.7	22.7	36.3	21.1	23.9	23.4	17.7	25.7	23.9	48.6	7.6	31.6	51.1	33.9	37.8	37.1	63.9	49.8	23.3	80.9	0.0	15.8	17.2	0.0	15.6	14.4	18.7	21.3	0.0	17.9	32.7	59.7	15.9	11.8	20.9	34.1	16.4	90.5	16.2	6.8	20.0	41.7	41.3	16.6	128.8	30.4	0.0	0.0	0.0	84.8	6.4	25.4	0.0	0.7	0.1	0.4	2.1	1.5	3.2	0.7	0.6	1.4	2.4	5.3	1.2	0.0	0.1	6.8	10.0	2.2	0.6	19.2	20.6	21.2	20.9	18.8	19.9	22.2	21.1	21.8	20.9	20.7	23.0	71.5	0.0	1.1	40.5	102.6	43.3	109.7	17.3	30.1	15.6	28.7	18.4	28.4	28.6	19.0	9.2	0.0	40.6	37.6	97.7	21.5	57.5	73.4	112.8	53.0	57.9	15.7	17.7	105.4	55.9	41.1	83.0	70.3	251.1	12.0	16.4	37.1	34.3	41.6	3.3	90.4	43.0	8.2	59.0	74.2	26.8	44.7	84.3	21.4	48.7	39.5	11.1	7.2	100.5	161.2	107.0	108.9	46.6	14.9	127.5	52.5	46.2	14.3	1.8	39.5	43.6	49.6	21.9	15.4	22.9	29.8	109.9	48.8	9.1	29.7	137.0
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 165.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	14.6	165.3	4.2	18.1	5.7	17.5	8.2	5.5	6.6	13.7	9.0	13.0	12.2	11.7	6.6	4.8	17.9	20.5	5.4	3.3	6.8	12.7	14.1	20.9	15.1	10.1	6.1	10.7	27.0	13.4	6.3	19.1	8.0	27.7	14.8	10.3	39.4	9.3	4.0	5.7	12.7	16.5	8.0	15.1	16.3	11.0	6.7	8.1	9.2	3.7	13.1	11.7	4.5	12.8	74.6	34.1	27.7	41.0	104.7	56.6	147.3	35.1	61.7	76.2	88.3	35.2	82.6	42.0	53.9	64.4	92.6	26.8	88.6	20.9	81.8	48.0	18.2	19.5	26.7	36.9	42.9	33.5	7.5	45.4	13.3	89.2	75.8	32.1	33.3	50.5	42.7	21.0	120.0	15.9	35.9	10.8	13.4	11.8	11.2	44.4	35.8	24.4	66.1	45.9	8.4	21.5	54.3	22.9	20.1	32.3	24.0	22.8	31.9	89.8	43.1	99.5	78.2	29.4	115.3	35.5	35.7	17.9	170.6	55.4	53.4	1.6	26.4	34.2	25.0	12.9	24.0	24.8	48.9	10.4	23.0	23.3	39.3	37.9	23.7	8.8	33.2	32.5	4.2	5.7	5.5	6.6	3.3	6.8	10.1	6.1	8.0	8.0	6.7	12.8	14.9	22.4	33.4	11.4	16.0	9.9	10.1	11.3	8.0	7.3	7.2	4.6	8.5	30.0	14.5	20.2	14.6	17.6	21.2	16.0	1.9	42.5	29.5	34.9	32.8	16.0	59.9	9.0	12.1	25.0	51.6	21.3	18.3	34.5	14.0	9.2	15.4	24.2	70.3	6.7	15.0	25.5	22.4	77.4	41.9	14.5	32.6	74.9	23.2	29.0	55.4	7.6	19.6	10.6	7.3	20.3	13.3	25.9	17.7	26.7	8.7	14.9	46.2	14.5	26.3	9.2	13.5	6.8	9.7	5.0	5.3	8.8	24.8	44.3	15.5	8.5
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107490106-107661306	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	4.5	6.6	12.4	1.7	14.5	0.0	3.4	9.0	16.9	6.2	0.4	14.6	1.2	5.6	2.0	2.0	4.3	2.7	10.9	15.3	8.2	3.4	1.6	2.4	0.9	6.7	9.1	10.8	1.4	3.1	9.4	2.3	6.2	8.2	1.3	5.3	10.4	2.6	16.7	1.2	3.2	3.9	6.5	1.9	4.8	4.2	9.5	2.7	4.2	5.9	1.1	11.9	4.4	11.4	0.0	0.3	10.5	13.9	12.9	4.9	1.2	0.0	0.0	0.3	0.6	0.0	0.0	5.7	0.3	0.0	0.9	0.0	7.0	0.2	0.2	9.0	6.8	0.6	0.0	6.8	1.6	3.0	0.5	5.2	0.0	5.1	0.0	1.1	4.2	2.6	0.0	0.3	0.0	2.9	1.3	0.3	2.5	0.3	0.9	3.1	1.3	0.0	0.0	0.2	3.3	5.6	1.2	0.0	0.1	0.4	0.4	2.0	0.0	3.3	1.1	5.7	0.5	2.6	0.5	3.5	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	14.5	9.0	16.9	15.3	8.2	6.7	9.1	6.2	6.5	9.5	11.4	6.0	3.2	9.8	175.3	9.2	0.5	10.3	11.4	3.4	40.4	0.5	7.4	19.4	17.2	6.1	23.9	0.0	0.2	1.8	0.2	0.0	2.5	96.2	0.6	15.8	4.4	10.8	5.3	260.1	0.2	0.7	23.6	3.1	0.4	0.0	149.3	5.3	1.4	3.0	92.5	287.7	0.1	4.1	9.6	4.1	61.4	45.1	1.8	3.6	51.5	0.1	7.6	0.0	263.9	278.8	0.4	0.0	48.9	0.2	9.3	0.0	11.9	10.9	10.1	26.3	42.8	21.0	61.2	5.6	0.6	0.9	0.1	1.3	13.3	0.2	1.0
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254408-11256204	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 102.5;dendritic cells: 191.9;T-cells: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 107.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.7	4.2	0.9	14.3	1.0	9.9	6.9	5.8	1.1	15.6	0.7	5.0	2.0	5.9	1.1	5.4	4.6	2.3	5.1	0.9	1.3	23.2	26.9	9.7	13.5	2.5	1.2	9.4	3.1	0.7	14.8	3.8	2.7	6.3	0.9	0.1	4.9	1.7	2.1	7.4	12.4	1.0	1.9	18.6	8.0	7.6	2.6	9.8	4.4	0.5	10.2	6.6	7.0	1.0	2.8	0.5	1.1	0.2	3.3	0.5	4.0	2.2	15.7	1.0	1.3	0.7	0.5	6.3	4.7	1.0	2.9	1.1	0.4	0.2	0.2	107.8	0.8	1.7	0.0	8.6	1.4	0.0	18.5	1.4	0.3	2.2	0.2	0.4	0.3	0.6	14.4	1.8	0.1	2.5	7.2	4.0	11.4	0.2	1.7	0.7	0.7	0.7	1.2	0.5	1.5	0.2	0.5	3.7	1.2	3.1	0.0	0.9	0.1	1.3	6.4	0.9	1.5	0.4	0.6	10.0	2.6	0.8	1.3	13.6	0.1	10.2	2.1	0.0	1.9	1.5	2.4	2.6	0.0	5.3	2.6	2.3	0.3	6.1	0.1	1.3	2.8	0.4	0.9	1.0	5.8	1.1	0.9	1.3	2.5	1.2	2.7	1.9	2.6	1.0	102.5	0.0	4.4	1.6	67.7	12.2	17.4	1.9	8.6	1.9	33.8	55.5	10.3	2.8	0.7	51.5	6.2	24.1	191.9	30.6	23.5	18.4	64.8	18.1	19.9	14.3	26.0	8.4	0.0	8.5	4.8	61.5	26.0	36.9	52.8	4.9	8.2	3.4	4.5	0.0	0.2	17.7	8.2	5.8	25.7	24.7	7.2	33.8	30.2	1.0	14.2	6.7	24.7	0.5	0.0	5.0	20.2	41.8	89.0	7.4	19.0	9.2	2.5	4.8	0.0	30.2	34.2	0.8	8.3	10.1	6.8	57.7	161.5	23.0	11.8	11.6
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 203.6;Hepatic stellate cells: 134.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 177.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 177.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 192.0;K-562: 145.6;REH: 336.6;THP-1: 142.3"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	71.5	34.8	7.8	10.4	12.0	11.5	68.0	7.2	8.5	92.6	23.1	40.5	11.7	91.8	42.0	16.5	42.4	20.7	28.6	9.8	9.2	42.8	59.1	61.9	9.2	8.1	10.9	19.2	13.8	64.5	55.3	36.5	8.8	81.4	17.0	4.8	9.5	45.4	9.5	9.4	17.3	89.5	6.6	8.5	30.8	8.7	10.4	21.4	32.8	6.1	9.1	32.1	50.4	7.8	3.5	4.9	16.8	15.2	9.1	16.6	19.8	20.8	77.0	15.2	6.6	192.0	7.8	1.0	0.7	19.3	4.1	39.8	88.6	5.9	17.3	69.0	2.5	13.9	1.2	2.7	13.8	4.2	28.5	28.3	4.9	16.7	22.7	1.6	2.1	8.7	145.6	3.1	2.4	1.8	0.8	6.8	47.4	3.2	7.4	336.6	0.3	3.6	4.1	7.4	28.8	34.2	7.3	11.5	57.5	16.0	0.2	142.3	2.3	47.2	0.7	0.3	11.7	2.0	1.1	1.4	0.9	12.0	28.8	177.8	0.2	7.7	25.4	0.5	34.2	0.4	31.2	23.3	0.2	4.3	30.6	18.4	1.1	26.8	0.4	2.0	19.8	14.4	7.8	12.0	7.2	8.5	9.8	9.2	8.1	10.9	8.8	6.6	10.4	7.8	203.6	9.6	78.7	1.0	1.4	18.0	46.0	3.2	1.2	8.2	30.5	16.9	6.5	0.0	24.3	22.0	4.2	36.3	15.5	20.8	62.6	13.7	9.8	10.5	94.9	100.5	8.3	33.2	10.9	37.4	6.7	34.6	7.1	20.2	24.1	9.9	134.6	11.6	14.2	69.0	12.3	13.3	4.1	8.9	20.7	20.3	91.6	6.0	17.8	8.4	108.4	1.5	18.6	1.0	1.3	8.8	21.2	101.2	6.4	95.2	20.0	27.5	5.4	1.2	78.9	15.8	32.9	9.9	10.5	1.8	10.5	35.0	15.7	12.7	15.7	30.1
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 501.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.5;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 9.8"	"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	501.5	50.3	19.1	99.0	20.2	126.4	114.1	18.8	27.5	35.1	21.7	119.0	19.4	53.4	1.9	72.7	306.5	190.4	76.8	16.8	21.2	72.1	84.2	234.8	46.9	43.1	22.1	55.5	46.2	23.6	55.7	77.5	24.6	61.8	27.2	4.2	36.3	17.1	26.1	55.3	64.2	125.2	23.7	52.0	123.9	5.9	32.2	115.9	54.1	37.1	11.8	187.9	31.6	19.6	6.4	10.2	7.3	3.8	2.8	44.3	19.1	31.4	28.3	32.1	13.6	6.6	4.4	0.2	6.7	7.5	20.4	2.0	1.5	3.1	12.7	154.2	0.9	5.8	24.1	1.4	14.5	0.1	2.7	73.3	2.6	24.9	9.3	19.4	14.0	0.5	17.4	58.2	15.1	3.3	3.3	1.0	5.2	1.2	12.8	0.2	36.9	1.1	51.4	6.3	0.3	4.6	9.5	2.5	1.3	26.8	2.9	1.4	8.4	62.7	17.6	22.2	18.4	76.0	46.9	0.1	51.6	0.8	4.1	0.0	1.0	0.2	0.8	0.1	1.9	0.0	2.1	0.9	1.1	0.0	3.1	0.6	9.5	0.3	0.0	1.0	1.3	0.5	19.1	20.2	18.8	27.5	16.8	21.2	43.1	22.1	24.6	23.7	32.2	19.6	989.2	48.1	125.6	0.7	64.7	164.3	120.7	75.0	125.2	1.0	176.3	136.4	23.1	18.6	51.7	38.6	2.1	14.9	42.1	20.5	5.9	44.4	0.8	106.7	207.6	635.9	33.0	11.6	0.0	38.6	46.0	394.4	125.4	166.8	36.0	5.8	307.3	20.2	94.6	0.0	0.1	25.0	30.5	78.4	381.5	1.7	78.3	231.0	85.4	1.0	33.6	7.7	1.0	0.0	1.0	43.0	28.1	2.2	115.5	72.0	24.3	11.5	38.1	2.7	13.1	485.9	381.7	0.4	1.0	36.3	133.0	62.1	88.7	5.3	41.0	90.5
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049489	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	6.6	4.9	6.1	7.9	6.7	6.8	5.7	6.7	6.7	4.7	5.6	5.2	5.3	5.8	4.2	5.1	5.2	6.6	5.6	5.9	8.7	6.3	4.9	6.7	8.9	8.1	7.1	3.8	4.1	5.5	4.5	5.7	8.2	4.8	5.6	10.8	4.5	4.5	4.9	5.1	5.3	6.0	8.1	7.6	7.0	4.3	7.0	8.0	6.9	5.1	7.6	6.5	4.2	8.8	14.2	11.0	16.2	18.9	11.0	12.2	12.0	16.4	12.1	9.9	16.0	9.6	15.2	20.8	11.3	12.4	9.7	19.1	21.4	13.5	23.1	20.8	8.8	12.8	16.3	6.1	11.1	14.3	20.9	9.9	14.4	17.6	13.0	11.5	18.5	22.0	7.4	19.2	19.3	14.6	21.9	11.6	12.7	11.7	12.0	20.3	24.5	8.5	15.2	15.0	21.1	18.5	16.6	9.8	16.8	14.8	14.0	11.2	19.3	25.5	23.9	13.1	14.0	7.4	8.3	19.6	17.2	11.8	20.2	0.9	1.2	1.2	0.8	1.3	1.3	0.8	1.0	0.8	0.9	1.1	0.6	0.6	0.7	1.8	1.8	1.2	1.0	0.5	6.1	6.7	6.7	6.7	5.9	8.7	8.1	7.1	8.2	8.1	7.0	8.8	30.7	6.4	12.4	9.8	22.3	24.0	10.8	10.7	14.8	13.6	14.7	12.3	20.2	11.5	15.8	14.7	20.9	5.2	27.5	14.7	13.7	9.4	7.4	36.8	22.5	20.9	20.4	16.8	14.3	8.7	6.2	14.8	29.0	20.6	32.9	11.8	15.0	9.4	7.4	37.0	13.6	8.3	8.2	13.3	21.8	2.6	7.2	15.6	3.6	11.2	17.3	21.0	13.4	4.5	20.4	15.6	9.6	10.1	19.4	8.1	6.7	14.6	19.7	17.4	0.0	15.8	21.5	20.7	10.9	14.7	23.2	4.9	21.7	13.7	8.1	11.5
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46780245	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	7.6	6.3	7.7	7.7	13.0	15.9	9.6	13.0	7.5	9.7	5.2	14.1	9.1	8.5	9.3	11.3	11.3	8.1	7.6	9.2	6.7	8.7	6.7	8.3	8.3	23.2	6.2	14.2	5.6	7.3	8.5	9.9	6.6	12.7	8.7	12.4	9.0	7.5	6.7	13.9	8.5	9.0	6.6	10.3	8.2	7.6	9.9	16.0	6.7	9.3	8.5	8.6	14.5	10.8	9.3	13.8	29.9	42.3	11.4	66.5	121.0	31.5	18.6	10.3	6.9	7.5	12.7	121.9	9.7	7.1	9.9	10.8	41.2	7.3	9.4	11.8	10.0	13.2	18.4	6.9	12.7	33.9	15.8	26.7	10.7	35.8	11.0	3.0	10.2	8.1	21.5	5.3	5.9	12.0	10.4	15.1	8.7	7.8	15.9	9.5	13.2	11.1	7.3	19.8	16.4	10.7	13.0	8.9	4.4	10.3	12.8	80.0	17.7	26.9	13.2	9.7	6.4	6.5	36.9	13.7	25.5	0.5	0.4	2.5	0.9	0.4	1.1	1.8	0.5	0.6	0.5	3.0	1.1	1.5	0.4	1.0	1.7	0.5	1.0	0.7	7.6	7.7	15.9	9.6	8.1	7.6	8.3	8.3	8.5	8.5	8.2	8.6	17.2	3.2	6.1	18.9	11.3	16.6	7.2	8.3	16.5	12.8	15.1	12.2	14.2	18.6	8.0	3.7	22.9	3.7	6.2	11.0	5.9	7.3	12.3	9.9	29.2	24.3	10.8	6.1	43.4	6.8	2.5	18.8	10.2	12.0	17.1	17.4	17.2	7.9	4.5	18.5	51.5	7.1	2.0	8.4	15.2	8.1	17.4	7.7	7.2	18.7	8.4	9.7	6.2	38.2	25.4	6.8	8.8	17.0	7.0	11.0	5.1	7.3	5.3	5.5	13.1	13.8	20.1	13.3	18.8	9.9	14.5	2.7	7.0	7.3	5.6	7.8
SOCS6	"CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4"	ENSG00000170677	"Suppressor of cytokine signaling 6"	O14544	18	70289045-70330199	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.6;myeloid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010189	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Cytosol	"CAB010189: AB_661195"	"unprognostic (1.76e-3)"	"unprognostic (6.83e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.80e-2)"	7.9	8.0	8.3	6.0	10.2	13.1	14.0	11.7	8.1	15.2	5.8	16.2	15.6	11.8	6.9	15.0	12.3	13.5	11.0	7.8	7.6	9.3	28.3	9.7	3.4	14.8	10.2	10.9	13.0	14.1	4.1	13.9	14.4	8.4	14.4	5.6	11.3	7.9	12.8	7.1	22.8	10.9	13.2	4.1	14.0	5.7	17.5	3.2	11.6	13.4	5.6	8.3	8.0	19.3	19.2	41.6	17.4	12.0	16.1	18.9	19.4	40.3	24.5	24.0	18.0	15.6	31.7	2.1	3.6	37.7	29.0	22.2	12.8	13.2	23.3	0.0	7.8	14.4	14.3	24.1	19.1	7.9	15.6	15.3	15.4	20.9	17.4	23.9	12.2	1.7	8.7	9.6	16.5	9.3	6.8	5.8	11.2	12.2	17.7	8.0	16.8	3.5	14.9	15.6	8.0	20.0	20.9	22.8	18.9	12.4	6.8	13.6	15.1	26.3	13.3	5.5	16.5	0.0	0.0	5.2	29.3	0.6	18.1	0.0	3.6	2.9	0.2	0.7	0.1	0.3	0.4	0.0	3.9	0.0	0.6	0.3	0.0	1.0	0.0	0.3	0.0	1.2	8.3	10.2	11.7	8.1	7.8	7.6	14.8	10.2	14.4	13.2	17.5	19.3	15.0	25.6	17.0	8.1	1.2	11.7	13.7	13.3	12.0	12.9	26.6	14.7	22.4	21.5	30.1	11.0	6.2	28.0	2.1	61.0	11.7	18.4	1.3	23.5	23.5	13.9	29.4	3.8	17.0	18.5	15.6	13.7	21.4	34.6	31.0	9.1	13.6	32.4	25.7	37.0	17.5	31.0	10.2	7.7	11.1	2.8	11.5	19.2	26.6	86.2	10.1	7.8	5.2	28.6	32.1	30.5	30.5	12.8	0.9	17.4	36.8	25.6	21.8	4.7	0.0	14.9	12.5	1.3	11.0	20.5	11.9	68.4	2.1	4.4	26.7	34.6
SOCS7	"NAP4, NCKAP4"	ENSG00000274211	"Suppressor of cytokine signaling 7"	O14512	17	38351844-38405593	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 74.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 254.0;Late spermatids: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004475	Approved		Approved	Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA004475: AB_2667194"	"prognostic unfavorable (7.49e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.62e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	4.2	7.1	8.7	4.3	9.5	4.1	4.8	24.8	9.3	5.7	0.3	6.0	3.9	7.3	6.2	6.1	5.4	2.8	5.2	10.9	5.0	3.9	3.7	4.8	3.5	4.0	6.0	7.2	14.4	11.5	6.6	3.7	3.8	5.2	4.3	12.7	6.2	4.2	14.2	7.9	4.8	5.4	4.3	3.4	7.0	74.1	6.8	6.7	7.7	5.0	4.7	4.9	4.6	6.8	12.3	13.6	14.9	11.1	8.2	6.9	12.2	5.2	4.5	6.2	5.1	10.7	3.6	8.8	7.7	8.4	8.9	7.7	12.8	3.6	7.9	15.6	11.0	8.9	16.4	11.2	2.6	19.7	14.6	4.3	14.2	6.6	8.7	7.8	5.4	4.4	7.2	5.6	7.8	6.7	16.5	12.8	4.8	13.3	2.4	16.7	24.9	7.6	4.1	14.8	26.1	14.1	13.0	8.3	8.7	12.5	15.5	10.3	5.3	6.2	5.2	11.3	16.3	19.0	14.5	12.1	8.4	9.8	12.9	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	8.7	9.5	24.8	9.3	10.9	5.0	4.0	6.0	3.8	4.3	6.8	6.8	4.0	16.0	10.1	21.2	3.5	0.8	7.0	0.0	8.6	47.5	11.1	9.8	26.8	5.7	8.1	1.8	29.2	9.5	6.1	5.3	1.9	6.0	254.0	5.9	7.9	5.1	4.9	4.2	39.0	6.5	4.8	6.4	4.1	6.5	0.0	9.8	7.9	7.8	3.2	35.3	30.6	7.0	0.0	6.8	0.7	500.2	10.5	5.0	1.8	13.1	7.4	11.7	6.2	23.1	20.6	6.6	6.2	9.1	2.1	8.3	4.4	2.9	5.3	15.8	0.0	9.1	6.8	62.1	23.9	8.1	0.9	8.1	5.0	6.0	6.8	7.6
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 436.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	510000000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	221.4	20.4	14.3	26.1	20.9	0.0	134.2	15.8	23.8	226.5	436.1	122.7	18.2	151.6	10.4	62.1	177.6	22.4	150.1	47.1	14.1	124.1	16.5	155.0	10.6	22.9	23.4	59.7	86.7	2.6	19.8	39.8	17.5	131.3	13.4	1.9	70.9	23.4	22.0	91.9	65.2	37.1	16.4	24.8	102.1	74.1	19.0	5.8	176.6	22.9	7.0	178.3	170.4	13.6	0.0	0.0	0.0	0.0	66.2	17.3	2.0	38.1	16.7	2.3	1.4	0.5	0.0	0.0	11.8	8.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	16.8	0.0	15.8	0.0	17.9	0.1	0.0	1.1	0.0	0.0	0.1	0.3	1.1	8.0	0.0	55.1	0.0	0.0	0.6	231.3	0.8	0.2	0.2	0.0	1.2	0.0	2.1	32.8	0.0	0.0	8.7	1.0	1.6	0.4	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	20.9	15.8	23.8	47.1	14.1	22.9	23.4	17.5	16.4	19.0	13.6	46.1	12.8	18.1	7.2	1.0	90.8	65.5	0.6	10.2	0.4	21.7	22.1	23.0	144.4	7.6	90.1	0.0	211.4	1.8	25.6	15.6	63.6	18.7	81.9	45.8	21.0	34.6	0.0	0.1	1.8	17.0	498.5	5.1	80.3	0.0	0.1	15.4	0.2	17.3	0.0	0.1	51.9	0.0	0.3	115.5	33.9	424.1	3.2	80.0	3.7	0.0	20.7	0.0	0.5	0.7	3.5	89.3	365.6	1.1	80.4	0.0	142.7	0.1	1.4	197.2	6.5	428.9	73.2	4.4	6.1	70.3	190.0	7.6	6.1	51.8	9.6
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777447-36863538	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.6	14.2	13.4	3.6	18.1	1.1	6.2	63.9	16.4	9.5	0.0	12.3	1.9	10.9	3.8	7.0	9.6	4.8	9.5	12.8	14.4	7.8	0.9	6.2	2.5	14.6	15.0	10.4	2.8	7.3	4.9	6.2	12.6	9.0	2.8	4.5	4.7	8.8	2.4	8.6	5.8	8.4	8.8	4.6	6.4	7.9	15.1	2.9	12.2	3.9	3.1	11.2	7.4	21.9	13.4	18.0	21.5	23.2	12.2	11.2	5.6	11.6	12.5	16.1	9.5	7.3	2.1	6.0	4.2	20.4	14.0	17.8	17.3	10.8	16.8	0.9	3.4	9.7	18.5	9.7	6.4	2.1	9.0	6.3	13.0	15.4	10.9	7.0	10.6	6.5	6.9	1.2	17.8	13.0	6.9	5.1	5.5	1.3	13.8	16.1	19.9	2.3	9.5	4.0	25.5	15.9	24.1	26.1	7.5	9.4	33.3	14.4	16.3	40.2	7.7	19.9	25.7	2.4	0.6	5.8	17.1	2.8	26.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	13.4	18.1	63.9	16.4	12.8	14.4	14.6	15.0	12.6	8.8	15.1	21.9	16.5	0.0	1.8	18.9	4.4	12.6	5.4	6.3	13.6	26.3	9.6	8.9	16.1	5.7	6.7	20.2	37.5	15.6	11.3	1.7	1.9	3.8	0.9	8.6	20.5	14.5	6.0	1.3	19.9	1.5	10.2	12.0	0.5	21.9	10.8	33.0	10.4	0.6	10.0	23.5	30.3	1.5	0.0	7.6	10.7	2.4	12.2	8.1	5.4	21.5	4.5	17.8	0.0	54.8	50.9	1.4	2.4	18.8	1.8	6.0	2.1	1.5	3.9	3.8	13.1	23.2	16.9	0.5	1.3	13.7	16.1	3.3	1.4	14.0	3.0	2.9
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	370.8	21.6	128.5	53.3	153.3	4.7	78.3	101.7	144.1	46.0	42.6	312.8	25.6	169.4	32.1	155.5	99.2	81.3	351.6	127.0	165.4	17.6	49.3	34.4	3.1	164.0	161.5	19.0	22.0	26.4	11.5	30.3	126.7	140.6	67.0	39.0	24.5	217.4	190.5	24.5	62.7	151.0	138.9	8.1	143.1	14.4	127.0	3.7	14.8	155.9	1.5	235.3	47.1	139.9	1.6	1.2	12.4	3.1	4.2	0.2	2.4	0.4	0.1	0.4	0.1	28.0	10.9	0.0	2.2	0.2	4.2	0.6	2.4	0.6	0.4	3.2	4.5	7.2	0.4	19.5	1.5	0.0	48.3	0.9	0.4	0.5	0.3	0.2	4.9	1.9	11.7	2.3	1.3	0.8	0.1	0.8	5.7	6.2	2.6	1.0	4.0	0.4	15.1	18.3	4.9	3.7	1.8	0.6	45.2	8.9	2.1	0.4	0.3	0.1	4.0	0.1	2.4	1.8	0.5	0.2	4.8	0.5	11.7	6.1	0.1	1.2	0.4	0.6	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	128.5	153.3	101.7	144.1	127.0	165.4	164.0	161.5	126.7	138.9	127.0	139.9	42.2	22.4	20.9	800.2	0.8	11.6	8.7	0.0	5.2	7.5	6.5	19.3	612.3	12.8	1.3	1.8	2.1	20.2	1.0	4.0	3.9	7.2	70.4	1.4	15.8	25.7	6.0	16.0	401.1	3.1	2.4	21.4	8.6	1.6	16.4	8.2	30.4	50.5	3.1	6.7	295.1	10.9	0.0	3.8	12.0	48.6	7.5	1.1	14.2	163.9	0.7	22.1	1.0	155.3	22.6	2.3	2.8	76.8	1.1	4.7	1.2	6.1	0.1	5.5	0.0	11.8	51.6	3.4	3.7	1.9	12.5	29.6	1.6	0.1	5.1	5.9
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 169.4;Late spermatids: 505.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA		7700	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.53e-5)"	173.3	65.3	59.3	26.2	59.7	5.1	129.0	67.6	72.6	156.9	49.9	105.2	29.9	124.0	23.6	65.5	118.8	38.7	105.8	53.0	55.3	84.8	121.2	111.9	21.1	85.0	60.6	125.6	49.3	35.7	73.3	66.6	65.6	127.2	34.9	11.4	88.7	48.5	64.7	106.8	71.2	53.7	61.7	80.0	63.7	128.2	65.7	7.6	93.8	37.3	13.4	103.5	133.9	57.6	83.0	101.8	54.6	61.9	86.4	114.4	55.7	83.0	127.8	95.0	58.8	103.6	36.2	0.7	55.3	130.1	38.3	69.7	82.5	75.7	48.9	58.1	36.2	6.9	58.3	48.4	98.2	0.8	0.5	72.6	55.6	33.3	48.4	105.2	74.6	42.7	18.4	2.6	68.4	32.8	7.1	2.4	19.3	14.1	42.5	79.0	36.8	7.7	43.7	15.8	3.1	48.9	40.4	9.8	52.7	56.8	16.7	29.2	116.9	83.8	59.8	61.9	59.3	1.7	2.5	11.5	49.0	19.4	58.3	0.0	2.5	0.6	11.4	4.7	23.4	0.8	12.6	13.4	8.1	1.3	12.7	7.6	0.5	5.8	1.1	2.7	0.6	5.2	59.3	59.7	67.6	72.6	53.0	55.3	85.0	60.6	65.6	61.7	65.7	57.6	89.6	19.2	7.2	27.1	5.8	29.2	24.6	23.3	39.9	2.7	29.0	27.8	12.2	31.5	18.3	12.9	0.0	24.1	4.7	53.5	9.8	21.3	169.4	10.9	39.5	51.9	14.6	2.1	3.8	19.2	30.5	48.8	8.6	20.5	17.2	19.3	79.9	49.5	35.3	5.0	4.5	35.2	8.2	39.0	31.5	505.8	61.2	23.8	24.9	13.1	5.7	21.9	3.1	19.6	7.6	26.2	53.2	58.6	3.7	38.8	65.1	26.0	10.7	3.5	59.2	23.1	84.1	7.0	8.0	25.3	21.3	20.5	19.7	7.1	31.3	23.7
SORCS1		ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;thyroid gland: 11.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"RH-30: 80.8;SH-SY5Y: 104.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	0.6	3.1	3.0	1.9	6.2	0.0	1.3	0.0	10.3	2.5	0.0	9.4	0.7	1.1	0.3	0.9	1.6	1.1	3.1	5.4	5.8	4.7	0.1	0.1	1.0	0.6	4.5	0.7	1.6	0.0	0.9	0.0	2.7	2.2	1.9	9.6	1.1	2.5	0.3	1.5	3.6	1.4	0.5	0.8	2.5	1.2	5.8	1.0	11.0	1.7	1.5	3.6	2.8	6.6	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	80.8	0.1	0.0	0.0	0.0	104.9	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	6.2	0.0	10.3	5.4	5.8	0.6	4.5	2.7	0.5	5.8	6.6	0.0	0.0	0.5	7.2	0.0	0.6	0.0	0.0	1.2	2.0	0.1	0.5	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.6	0.1	4.9	0.2	0.0	0.0	522.2	0.0	0.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	1.7	179.7	0.0	0.0	0.3	0.3	5.2	0.0	0.2	1.8	26.2	0.0	49.1	0.0	381.5	10.0	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	2.1	0.0	1.0	0.3	0.2	1.9	0.2	0.1	0.0	0.3	0.0	0.0	0.0
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 163.8;liver: 247.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	2.0	15.7	4.9	3.1	3.8	2.8	53.8	7.4	8.4	163.8	1.9	5.3	7.5	4.3	6.9	10.2	6.7	8.2	5.6	5.0	4.5	50.3	247.0	3.2	2.6	4.3	3.7	2.4	5.7	4.4	3.1	2.5	4.0	87.9	7.8	4.8	5.3	27.0	2.2	16.6	7.2	3.5	4.2	2.3	9.2	12.2	3.9	3.7	89.4	2.8	3.4	9.1	6.9	6.3	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.8	7.4	8.4	5.0	4.5	4.3	3.7	4.0	4.2	3.9	6.3	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452314-121633763	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 125.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 125.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA		79000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	7.0	6.1	29.1	24.4	39.1	47.4	13.9	49.5	35.5	44.4	0.0	17.3	11.6	5.4	8.9	5.4	40.1	7.3	2.4	33.8	39.7	19.0	58.2	10.4	21.1	40.3	46.8	9.0	8.0	10.4	16.8	2.3	47.0	20.8	16.9	20.3	21.8	25.4	1.7	3.4	18.1	4.5	45.3	21.8	10.3	5.1	38.8	17.0	13.5	4.0	23.0	15.7	6.6	79.1	1.3	8.1	7.3	1.1	0.0	0.0	7.4	0.4	2.4	0.3	0.0	11.9	142.8	68.7	8.5	1.8	10.5	47.4	9.1	7.0	0.1	0.0	2.6	0.0	10.3	16.8	0.1	29.6	0.1	0.0	7.6	0.0	25.8	4.0	0.0	8.7	0.0	0.7	0.0	9.7	7.1	15.3	8.8	93.5	10.8	7.7	0.4	1.6	15.8	102.1	5.1	1.5	15.2	21.5	0.0	16.0	21.0	9.5	0.3	0.1	4.9	1.0	0.0	0.0	0.0	139.8	0.1	38.6	0.4	44.3	15.9	59.1	22.1	6.9	29.3	1.9	24.6	20.0	6.6	5.1	23.1	20.8	125.7	20.9	9.4	16.4	19.3	21.2	29.1	39.1	49.5	35.5	33.8	39.7	40.3	46.8	47.0	45.3	38.8	79.1	1.6	6.4	23.3	160.9	20.7	4.5	42.3	23.3	18.2	68.8	44.5	22.0	12.3	18.6	36.8	79.1	387.8	0.4	130.1	132.1	0.0	10.3	1.2	21.6	2.9	10.3	6.1	8.8	247.4	0.7	0.7	5.8	14.3	24.7	12.0	20.6	34.6	114.5	39.1	50.5	80.1	54.6	40.7	62.4	16.9	5.0	77.9	67.0	3.6	404.7	97.5	28.0	146.2	74.9	86.0	6.4	81.1	57.9	28.6	36.1	168.6	1.0	15.6	31.2	0.0	19.5	10.3	2.9	18.8	20.8	2.4	0.4	60.2	32.7	42.2	33.4
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 285.6"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.2	11.3	71.0	12.0	168.3	21.4	25.1	124.3	114.2	17.7	21.5	29.5	22.1	24.7	139.8	41.5	27.5	17.8	64.7	131.8	90.0	38.7	6.5	37.4	2.8	151.9	133.8	6.1	17.5	46.5	11.3	44.8	153.1	18.3	26.9	40.0	25.2	44.0	85.0	19.0	21.9	27.8	102.8	10.2	18.2	43.5	118.0	6.4	42.7	71.8	10.3	16.9	18.0	285.6	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	71.0	168.3	124.3	114.2	131.8	90.0	151.9	133.8	153.1	102.8	118.0	285.6	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981549-39124345	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	17.5	8.4	8.2	14.8	10.2	10.8	9.8	14.1	10.3	13.1	6.8	11.0	14.7	14.3	10.3	12.3	11.2	13.5	9.5	9.7	10.8	11.0	11.9	11.0	16.9	9.5	10.2	20.1	9.1	17.1	0.1	17.0	9.5	13.4	12.9	13.2	9.0	12.2	13.7	9.4	15.6	13.8	6.7	12.5	11.5	10.3	8.7	15.4	15.1	16.4	17.8	13.5	0.1	10.6	24.8	15.1	22.8	16.2	29.1	35.0	23.8	15.3	18.7	12.0	11.4	16.3	14.6	35.8	10.3	20.1	18.5	14.4	26.9	13.9	22.1	36.3	11.9	55.5	12.8	22.0	11.8	17.9	134.9	21.6	20.5	16.3	15.8	19.5	18.9	8.1	23.9	16.4	15.4	13.5	19.4	15.8	14.3	30.4	10.4	21.5	20.5	10.5	12.1	19.8	22.0	22.0	18.3	32.3	18.2	18.5	10.4	9.3	21.5	19.8	16.0	15.7	15.4	19.3	20.9	18.4	15.8	17.3	12.0	0.0	0.5	1.4	1.3	0.7	1.9	1.6	1.3	1.4	0.4	1.0	1.5	1.4	0.6	2.7	0.9	0.6	0.9	0.4	8.2	10.2	14.1	10.3	9.7	10.8	9.5	10.2	9.5	6.7	8.7	10.6	72.3	16.0	31.2	120.5	20.9	20.8	15.5	10.9	19.9	19.0	18.4	16.9	33.9	18.6	17.8	9.2	10.4	10.2	27.6	19.5	1.9	11.0	64.9	30.0	36.6	43.2	12.0	12.8	226.6	11.9	8.4	22.9	21.4	34.0	3.8	30.0	12.8	18.6	10.3	8.4	224.0	16.9	26.4	19.1	13.2	11.4	22.7	19.9	7.2	161.1	19.6	15.1	26.8	173.4	125.2	14.2	14.6	21.8	37.5	25.3	28.0	12.8	20.4	11.2	6.6	27.1	22.7	11.3	7.0	17.1	25.3	10.4	33.2	18.4	17.0	28.4
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117130-50231578	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917"	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	23.8	14.9	15.3	15.3	21.4	39.5	17.9	18.2	19.5	14.3	13.5	17.4	21.5	15.2	22.4	16.4	12.7	12.9	21.5	14.0	16.8	24.5	13.2	15.8	14.4	19.7	18.6	15.3	15.9	39.3	9.1	17.0	19.1	15.4	17.3	14.0	14.5	18.7	57.6	17.9	24.5	18.0	16.8	17.8	13.7	27.9	19.6	16.5	25.1	63.8	13.5	14.8	10.5	23.9	15.3	11.1	22.1	14.9	16.6	18.0	10.4	13.5	14.8	10.0	12.5	4.9	19.8	16.0	11.9	17.3	17.3	13.8	12.1	10.2	17.7	26.9	4.4	16.1	8.5	8.5	18.3	19.1	16.6	18.8	24.6	9.3	21.6	25.2	21.8	13.1	12.5	39.0	24.2	12.7	15.9	15.1	6.9	11.4	9.6	17.0	30.8	12.1	16.1	14.4	16.0	18.7	15.0	17.5	17.8	15.9	19.4	23.0	24.1	27.3	17.8	12.5	8.9	27.3	31.7	19.6	7.1	10.5	16.4	8.0	1.1	2.8	1.1	0.9	0.9	0.6	0.7	0.8	0.8	0.7	0.8	0.7	4.6	1.7	2.0	1.4	0.0	0.4	15.3	21.4	18.2	19.5	14.0	16.8	19.7	18.6	19.1	16.8	19.6	23.9	34.1	9.6	26.3	59.4	18.4	35.7	20.9	10.5	10.2	17.2	23.8	15.6	43.7	17.2	18.2	18.4	16.7	8.2	46.3	36.0	7.9	11.3	17.0	18.7	30.4	23.5	20.4	6.3	71.5	10.7	8.0	22.2	12.8	29.8	20.3	37.4	22.9	13.8	8.8	25.2	89.6	18.5	12.2	33.3	17.5	8.6	12.5	29.0	17.8	80.6	29.0	17.6	21.6	100.5	104.8	14.5	24.6	13.5	28.6	27.3	28.6	15.8	14.3	22.5	19.7	43.4	30.8	54.3	12.3	17.7	39.6	13.0	24.2	17.4	14.9	30.6
SOWAHA	ANKRD43	ENSG00000198944	"Sosondowah ankyrin repeat domain family member A"	Q2M3V2	5	132813302-132816786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 100.9;intestine: 39.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 39.5;Horizontal cells: 132.9;Muller glia cells: 26.8;Proximal enterocytes: 108.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 13.4;T-47d: 32.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 61.0"	HPA064621	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"			"HPA064621: AB_2685302"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.75e-3)"	"unprognostic (5.34e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.65e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.92e-2)"	"prognostic favorable (9.38e-5)"	"unprognostic (4.36e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.42e-1)"	0.4	0.8	62.6	0.6	100.9	0.0	0.5	13.2	59.2	0.3	5.3	8.3	36.4	0.0	6.1	0.1	1.4	1.6	0.1	49.7	13.3	4.8	1.8	0.1	0.0	12.9	13.0	0.2	2.4	1.2	2.6	0.1	15.3	2.6	6.7	4.3	3.2	2.8	0.0	0.2	39.3	0.0	15.0	0.0	5.6	0.5	24.3	2.0	1.1	0.0	0.1	1.1	0.1	23.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	1.5	0.0	0.7	0.0	0.1	0.0	2.6	0.4	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.0	1.7	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.7	13.4	0.5	0.1	0.0	0.0	1.6	32.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	100.9	13.2	59.2	49.7	13.3	12.9	13.0	15.3	15.0	24.3	23.5	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.1	0.0	0.7	1.0	0.1	0.3	14.3	0.2	5.5	0.0	0.4	0.0	39.5	0.0	0.3	0.0	0.5	0.1	0.1	11.5	0.0	4.8	1.1	0.0	0.1	2.6	0.5	0.0	0.0	0.0	2.1	0.1	132.9	0.6	19.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	26.8	0.0	5.5	15.2	0.4	21.0	0.4	0.0	2.2	108.7	5.5	0.8	3.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.2	0.0	19.1	0.6
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894152-76898144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.0	0.3	1.2	0.7	1.4	0.0	1.3	0.0	2.8	1.0	0.7	7.7	5.5	0.3	0.8	6.2	1.1	1.3	0.0	1.8	0.1	7.7	19.1	1.6	0.0	0.5	0.0	0.0	5.8	6.9	0.4	0.6	0.6	0.8	6.3	0.2	2.4	2.7	0.0	1.5	8.1	0.2	0.0	0.0	4.6	0.0	0.0	0.2	2.4	0.0	2.3	6.0	2.2	1.1	3.9	0.1	0.3	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.9	2.6	0.0	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.5	19.4	0.1	0.0	0.0	1.7	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.0	2.8	1.8	0.1	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.5	1.9	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	4.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.1	1.1	0.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.5	6.1
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614364-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 147.6;Granulosa cells: 151.0;Squamous epithelial cells: 137.1;Suprabasal keratinocytes: 199.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 160.4;hTCEpi: 50.8;RT4: 66.2"	"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol		No	No				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA056131: AB_2683047"	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favorable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	6.3	3.6	2.5	3.5	3.2	0.6	9.4	3.0	2.7	8.0	7.6	11.3	5.1	5.1	3.9	33.3	4.5	8.4	2.0	2.7	4.3	14.0	29.3	7.0	2.9	4.8	6.2	13.0	3.6	5.2	1.9	4.2	4.1	7.0	8.7	5.5	8.3	7.3	1.1	19.3	7.3	6.2	4.0	3.3	5.9	6.5	4.2	4.3	7.9	2.1	7.5	23.1	12.0	4.5	19.3	3.6	10.8	5.9	5.3	8.8	35.1	41.3	24.1	7.1	7.4	17.0	6.0	0.0	16.6	6.3	13.4	18.1	2.5	27.1	7.7	160.4	18.0	0.0	8.6	24.3	4.9	0.0	4.8	4.7	50.8	15.3	10.9	5.9	1.8	0.0	0.3	0.1	5.5	6.4	0.0	1.7	7.6	17.5	16.2	0.0	2.4	0.3	10.7	66.2	13.5	5.8	14.2	2.5	11.3	10.5	5.3	0.4	2.7	5.6	21.6	3.3	3.0	5.3	5.5	0.1	6.6	0.6	13.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	3.2	3.0	2.7	2.7	4.3	4.8	6.2	4.1	4.0	4.2	4.5	18.9	16.0	9.8	2.9	1.2	147.6	43.2	32.0	93.9	15.7	30.5	22.7	3.6	20.0	14.7	12.9	10.4	4.3	0.7	61.1	3.9	15.9	37.8	28.7	21.1	10.8	15.6	2.7	0.2	7.1	28.6	15.6	13.3	76.9	0.0	151.0	6.8	53.2	8.0	0.0	1.2	32.7	10.2	7.0	15.1	13.7	11.8	6.2	19.6	0.0	3.4	7.3	2.1	1.5	2.4	14.2	34.2	15.1	0.6	21.0	21.5	25.1	5.5	20.7	13.1	12.1	20.8	20.8	13.2	137.1	199.3	10.0	2.2	5.3	36.7	80.9
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758588-119760202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.1;lymphoid tissue: 7.1;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.2;Extravillous trophoblasts: 38.3;Hofbauer cells: 17.5;Proximal enterocytes: 9.1;Rod photoreceptor cells: 8.2;Syncytiotrophoblasts: 9.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.9;SK-BR-3: 3.2;THP-1: 8.3;U-937: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065955	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA065955: AB_2685586"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.3	0.4	0.7	1.8	0.6	2.1	0.2	0.6	0.9	0.2	0.3	1.2	2.1	0.1	0.0	0.2	0.3	0.2	0.2	0.6	0.6	1.1	0.3	1.6	2.5	1.1	0.6	0.3	0.3	0.7	0.1	1.1	0.9	0.2	0.5	0.7	1.7	0.1	0.0	0.3	4.1	0.1	1.0	7.1	1.2	5.0	1.1	0.6	0.1	0.2	1.5	0.3	0.1	1.5	0.4	0.0	0.1	0.1	0.0	0.0	4.3	0.0	0.0	0.4	0.6	0.8	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.2	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.4	0.0	2.9	0.9	0.8	0.3	2.5	0.1	0.1	0.0	0.1	0.2	0.1	0.9	3.2	0.1	0.3	0.5	8.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	7.4	0.0	0.0	3.1	1.9	0.0	3.3	0.0	9.1	0.4	0.3	2.0	11.7	1.7	0.9	3.3	0.3	2.9	1.0	0.0	0.7	0.7	0.6	0.6	0.9	0.6	0.6	1.1	0.6	0.9	1.0	1.1	1.5	0.2	0.0	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.8	0.3	0.5	0.5	1.5	0.0	3.7	0.0	6.1	2.7	3.7	0.0	0.4	0.6	0.1	0.0	0.4	0.0	0.0	0.0	0.4	38.3	0.1	0.5	0.2	0.0	0.2	0.0	0.0	17.5	1.7	0.0	0.9	0.0	5.4	0.6	1.2	0.0	6.5	0.0	0.0	3.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	9.1	0.2	0.0	8.2	0.0	0.0	0.2	0.1	0.9	0.1	0.1	9.4	0.5	0.1	2.3	0.0
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box transcription factor 10"	P56693	22	37970686-37987422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 194.9;salivary gland: 114.3"	"Group enriched"	"Detected in some"	14	"Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	510	"SK-MEL-30: 313.9;WM-115: 432.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"CAB003171: AB_2195374, HPA068898: AB_2686054"																		2.9	2.7	76.9	2.5	133.7	0.1	21.7	103.1	102.8	11.8	24.9	26.6	1.5	0.8	1.2	2.7	2.5	2.2	8.8	82.7	89.0	0.5	0.5	0.1	0.0	134.7	114.0	1.2	0.8	0.0	1.8	0.0	123.3	6.8	2.6	0.5	114.3	5.8	0.6	17.0	7.1	1.9	87.3	0.3	6.1	2.7	114.2	0.0	0.9	1.5	0.0	8.4	9.5	194.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.9	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.7	0.0	432.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	133.7	103.1	102.8	82.7	89.0	134.7	114.0	123.3	87.3	114.2	194.9	0.3	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	32.3	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.9	0.1	35.6	0.0	0.0	0.0	0.0	61.3	59.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0
SOX11		ENSG00000176887	"SRY-box transcription factor 11"	P35716	2	5692384-5701385	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.0	0.0	2.3	0.0	2.8	0.0	0.0	1.3	1.9	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.2	3.2	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	4.4	0.0	0.0	0.0	23.6	0.0	0.0	17.9	18.2	0.7	0.0	0.0	29.1	44.0	0.0	0.3	0.0	8.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.3	0.6	1.2	0.0	0.0	11.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	2.3	2.8	1.3	1.9	1.3	5.0	2.5	2.9	2.0	3.2	4.6	3.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	6.4	8.6	13.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.9	0.0	0.8	1.2	0.0	0.0	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.5	0.0	21.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	38.8	1.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 87.4;skin 1: 48.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.2	0.9	15.0	0.8	14.6	2.7	3.4	17.4	23.3	21.1	11.8	12.4	0.7	8.2	1.7	87.4	11.0	1.0	8.6	14.5	15.3	1.7	1.3	1.5	0.5	14.3	15.0	15.3	1.0	0.2	7.9	0.3	14.1	12.1	0.5	5.0	14.6	7.1	2.3	48.2	3.5	1.3	14.5	1.1	4.7	2.6	14.7	1.0	2.3	1.8	2.8	10.4	32.7	15.0	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	15.0	14.6	17.4	23.3	14.5	15.3	14.3	15.0	14.1	14.5	14.7	15.0	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SOX17		ENSG00000164736	"SRY-box transcription factor 17"	Q9H6I2	8	54457935-54460892	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.1"	"Group enriched"	"Detected in many"	8	"Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 122.8;ovarian cancer: 96.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	49.1	1.6	2.9	1.4	2.3	0.0	32.6	2.6	3.3	20.4	1.4	8.3	0.7	18.8	1.2	3.6	23.0	7.7	19.1	2.1	2.2	5.6	1.3	9.9	0.7	2.9	2.5	4.2	1.9	0.8	2.3	5.7	2.7	6.0	0.8	0.1	3.9	1.1	10.3	5.1	5.0	4.3	2.5	13.2	5.7	3.4	2.8	0.4	5.8	5.8	0.4	8.4	9.4	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	2.6	3.3	2.1	2.2	2.9	2.5	2.7	2.5	2.8	2.6	464.9	0.0	0.0	0.0	0.2	13.9	0.3	0.0	0.0	0.1	0.7	1.3	2.1	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.6	377.3	44.5	171.5	0.0	2.7	0.0	0.2	0.1	7.7	0.0	520.0	0.0	0.0	46.8	0.1	0.1	0.0	0.0	0.0	0.0	0.9	16.6	1.8	2.5	3.5	19.6	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	7.3	5.1	3.2	6.4	0.3	13.5	0.0	4.5	0.2	0.0	3.7
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Group enriched"	"Detected in some"	6	"Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	0.3	0.9	58.0	0.5	58.5	0.0	0.2	47.1	56.6	2.1	8.6	5.5	0.4	0.1	0.2	24.5	3.1	0.2	0.5	46.5	59.0	0.0	0.1	1.8	0.0	50.5	58.9	0.3	0.1	0.0	13.6	0.0	45.2	2.5	0.4	15.0	18.4	0.3	0.1	0.6	1.4	0.2	59.8	0.0	7.9	1.9	59.2	0.4	0.1	0.1	5.3	1.3	4.8	62.2	0.1	9.0	277.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.1	0.0	0.2	0.7	118.6	3.2	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	226.2	12.4	0.5	0.0	0.6	0.0	31.0	0.4	0.5	1.2	0.0	0.0	0.1	45.7	1.7	0.1	0.0	0.0	4.2	0.0	54.0	0.0	0.0	0.0	0.2	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	58.5	47.1	56.6	46.5	59.0	50.5	58.9	45.2	59.8	59.2	62.2	0.2	0.0	6.0	0.0	0.0	0.3	35.5	28.5	362.0	4.9	0.2	0.4	0.5	0.0	48.4	3.7	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.1	1.6	19.4	0.0	1.3	0.2	0.7	0.1	0.1	0.0	0.0	0.5	38.7	0.0	0.4	0.4	0.6	0.8	3.6	0.0	0.0	383.5	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	0.0	0.1	52.8	13.1	0.0	0.2	1.6	3.9	0.4	229.1	0.4	0.3	0.6	0.2	0.0	7.5
SOX21	SOX25	ENSG00000125285	"SRY-box transcription factor 21"	Q9Y651	13	94709622-94712545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.8;esophagus: 10.3;skin 1: 15.9;stomach 1: 35.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.5;Basal squamous epithelial cells: 11.4;Gastric mucus-secreting cells: 55.5;Oligodendrocyte precursor cells: 17.1;Squamous epithelial cells: 57.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 79.7;NTERA-2: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA048337: AB_2732547, HPA064084: AB_2685187"	"unprognostic (3.33e-1)"	"prognostic favorable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favorable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	9.6	0.0	9.7	0.0	0.6	7.3	9.4	0.9	2.7	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	8.6	8.7	0.0	0.0	0.1	0.0	8.1	9.8	0.0	0.0	0.0	0.2	0.0	6.8	0.5	0.0	0.0	1.4	0.0	0.0	15.9	0.0	0.0	8.7	0.0	35.1	0.1	9.8	0.0	0.0	0.0	3.3	0.3	2.2	7.8	0.0	2.4	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	6.4	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	9.7	7.3	9.4	8.6	8.7	8.1	9.8	6.8	8.7	9.8	7.8	0.0	0.0	0.0	24.5	0.0	5.4	1.1	6.6	11.4	0.0	0.0	0.0	1.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.1	0.4	57.1	9.1	0.0	0.0	0.0	0.0	0.9
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 80.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.1	80.6	0.4	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
SOX4		ENSG00000124766	"SRY-box transcription factor 4"	Q06945	6	21593751-21598619	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 45.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 254.1;MOLT-4: 229.9"	"Region enhanced"	"Detected in all"		"olfactory bulb: 54.2"					HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	11.8	4.3	4.7	9.2	5.0	24.0	17.9	8.8	6.7	21.5	2.8	11.9	12.5	57.8	15.0	5.4	13.5	20.4	6.4	4.2	6.5	16.8	6.4	19.3	5.8	3.5	5.0	51.7	10.2	3.6	4.1	6.1	4.1	14.5	14.4	6.4	17.5	6.8	3.5	8.8	11.6	17.4	4.0	5.4	17.5	9.9	7.1	73.4	8.6	6.1	7.4	21.1	7.7	4.2	8.5	24.4	60.5	254.1	22.0	5.5	98.7	3.8	7.8	4.6	4.1	16.7	16.5	2.9	100.2	6.2	3.5	25.1	32.0	17.9	3.3	36.6	66.8	2.7	11.5	11.2	3.5	9.0	2.1	9.6	18.1	2.1	7.3	64.1	72.3	138.8	0.6	0.2	5.2	20.6	229.9	21.6	45.3	12.7	23.1	99.7	5.3	0.4	44.1	78.3	78.9	141.2	35.9	41.1	14.0	74.9	20.1	30.9	55.7	7.1	23.1	1.7	18.6	1.5	0.1	71.8	2.4	30.6	28.5	33.3	19.3	2.1	0.5	11.7	0.1	7.0	0.3	0.3	8.7	6.6	2.2	1.6	0.8	7.4	22.0	45.7	2.1	4.7	4.7	5.0	8.8	6.7	4.2	6.5	3.5	5.0	4.1	4.0	7.1	4.2	235.0	198.7	50.4	0.7	36.2	112.5	129.2	660.7	676.7	99.7	586.1	676.5	297.4	423.2	457.3	154.5	12.5	74.8	104.4	247.6	66.5	1128.5	6.1	669.0	624.2	264.5	340.8	114.3	3.2	604.4	409.4	247.3	313.0	650.9	60.6	1047.5	119.2	6.8	35.5	48.8	4.6	263.0	1320.3	78.0	266.7	12.2	12.2	94.0	243.7	3.7	91.4	189.1	17.5	70.4	1.0	1288.2	153.8	11.3	40.9	151.1	76.7	132.5	162.1	31.6	6.6	234.2	439.9	4.9	236.8	400.7	93.1	30.2	36.6	69.6	299.4	272.5
SOX6		ENSG00000110693	"SRY-box transcription factor 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favorable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.8	1.3	5.4	0.4	5.9	26.9	0.7	2.6	4.7	1.7	5.5	1.2	6.5	0.6	2.0	2.1	4.0	2.6	3.0	4.0	7.2	11.1	4.8	0.8	0.1	7.2	7.8	0.7	6.8	0.1	2.9	2.5	6.0	0.4	1.3	3.2	0.5	0.6	9.3	5.8	11.0	0.5	7.7	0.5	1.0	14.4	4.1	1.6	3.4	5.9	0.2	0.8	0.8	6.8	0.0	0.7	3.9	3.7	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.7	0.0	0.0	3.6	0.0	0.0	0.1	4.4	1.1	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	1.8	0.0	0.0	0.1	0.4	0.0	4.9	0.5	0.0	0.0	0.0	2.6	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.4	5.9	2.6	4.7	4.0	7.2	7.2	7.8	6.0	7.7	4.1	6.8	2.7	3.2	6.3	308.9	1.0	40.1	5.8	6.8	66.6	26.3	3.7	2.5	21.6	54.3	3.8	36.8	10.4	1.3	0.1	1.4	9.8	19.8	256.8	29.4	5.3	4.8	7.8	126.7	2.8	3.7	0.6	14.5	2.0	27.8	0.0	1.6	2.2	7.5	1.1	0.0	481.0	6.6	0.0	2.9	3.2	70.1	3.4	1.4	35.6	21.5	0.0	48.4	0.0	1687.9	8.9	5.5	20.3	2.2	0.1	3.2	99.8	27.1	8.3	4.3	0.0	26.2	14.6	22.1	4.5	32.7	16.1	0.5	1.1	3.0	11.8	3.7
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	23.6	18.6	10.7	23.1	15.1	29.9	26.2	20.3	12.5	23.7	11.6	24.8	30.9	29.8	21.0	38.6	25.5	25.6	13.4	10.6	11.7	20.7	17.0	22.8	24.2	16.4	14.0	29.8	18.6	22.1	10.7	23.7	16.2	20.8	29.8	20.4	27.5	22.0	25.2	40.1	31.2	26.4	13.0	28.0	28.6	19.4	13.5	36.7	19.6	25.8	30.2	24.2	25.3	17.6	34.2	31.3	40.5	31.2	34.7	39.4	32.1	23.1	29.0	27.2	26.9	27.9	70.3	43.9	29.3	27.1	18.3	49.2	43.6	32.9	33.0	31.3	23.8	38.5	48.2	18.3	24.3	39.4	33.1	40.3	36.4	27.0	53.9	55.1	31.0	35.5	37.6	63.8	23.1	50.2	53.9	31.9	22.4	28.0	25.0	37.8	38.5	28.5	25.7	57.8	21.0	30.5	47.7	42.9	26.8	33.5	52.3	42.6	29.5	35.3	30.3	26.4	25.3	21.3	25.4	42.5	26.3	29.9	28.2	3.1	2.6	1.6	1.3	1.7	1.6	1.4	1.3	1.3	1.5	1.5	1.4	1.5	6.9	1.0	1.9	1.8	1.1	1.0	10.7	15.1	20.3	12.5	10.6	11.7	16.4	14.0	16.2	13.0	13.5	17.6	29.7	22.4	15.0	13.1	18.5	23.8	19.9	22.4	33.6	10.6	28.3	19.4	8.2	24.3	26.8	31.3	8.4	16.2	16.6	55.8	5.9	16.1	64.1	21.8	23.4	24.7	12.6	25.2	7.7	13.8	16.3	21.5	23.9	34.7	6.3	17.2	28.2	28.4	18.2	16.8	7.2	29.8	6.1	38.6	16.1	50.3	27.4	24.5	8.8	16.9	42.2	22.7	18.6	12.5	20.4	18.8	21.0	25.9	12.0	35.4	34.8	20.8	23.9	10.8	13.1	31.4	21.0	29.4	22.1	44.2	31.3	21.3	14.8	11.7	26.2	47.7
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230545606	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 255.0"					"Low region specificity"	"Detected in all"			"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	66.3	53.1	11.0	65.5	12.3	189.2	53.8	11.3	17.9	42.4	20.7	46.1	46.1	35.1	30.8	29.4	34.9	55.9	52.9	10.9	14.0	46.0	60.9	72.4	94.3	19.6	14.3	44.3	41.1	10.5	18.3	54.5	16.7	34.9	36.1	2.5	72.7	33.0	24.3	35.7	60.4	38.7	16.2	78.8	47.9	9.2	16.5	54.2	41.0	32.1	81.6	56.1	37.1	17.1	56.9	16.9	0.8	7.5	80.8	123.2	13.3	70.3	151.0	162.4	255.0	10.6	67.9	22.9	57.0	77.0	103.0	25.9	0.8	66.6	120.7	55.2	1.9	41.8	27.9	24.0	120.0	47.3	51.4	105.6	38.8	79.8	71.4	120.2	125.1	18.9	23.9	37.9	61.7	15.9	32.0	57.6	2.4	25.6	25.6	24.4	40.7	18.2	45.9	45.3	0.4	0.7	30.0	9.5	130.3	2.8	9.1	48.3	140.3	78.7	21.4	49.4	41.8	50.3	16.0	59.8	71.6	54.8	38.1	149.7	84.4	115.8	116.3	74.9	93.9	152.0	113.0	102.4	64.6	160.5	107.5	95.3	284.6	119.8	106.0	67.0	116.0	110.1	11.0	12.3	11.3	17.9	10.9	14.0	19.6	14.3	16.7	16.2	16.5	17.1	171.9	153.8	56.6	0.3	236.6	70.7	71.2	96.5	49.5	0.6	31.2	36.7	72.3	42.9	74.4	33.1	2.1	32.9	150.6	50.5	43.0	102.9	4.7	61.6	58.3	122.7	9.0	66.9	0.6	105.5	69.4	77.9	46.4	58.9	56.8	39.3	73.5	34.5	81.0	0.0	0.7	32.5	63.1	72.9	70.9	4.8	46.6	104.1	71.2	140.5	114.3	0.2	128.8	4.5	4.8	89.7	56.9	52.6	95.6	74.2	72.8	45.4	68.4	0.8	39.5	61.2	65.9	0.8	1.1	28.4	68.2	16.1	151.5	74.0	25.2	73.7
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.6;lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.9;dendritic cells: 37.4;NK-cells: 50.4;Plasma cells: 77.2;T-cells: 62.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 97.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 52.4;Karpas-707: 25.2;RPMI-8226: 16.3"	"Low region specificity"	"Detected in all"							"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.7	0.8	0.7	25.0	0.8	6.6	1.2	0.8	1.6	0.6	1.0	3.5	2.9	0.9	0.8	0.9	0.7	2.9	0.6	0.8	1.1	0.9	1.6	4.4	54.6	1.8	1.2	0.4	0.3	0.2	0.6	1.2	1.5	0.9	3.9	1.0	2.6	0.5	0.2	1.6	15.6	1.0	1.3	27.8	5.1	1.5	2.1	6.8	1.3	0.1	55.8	4.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	2.4	0.0	0.3	31.1	0.0	0.0	5.2	0.0	0.0	0.1	1.8	52.4	0.0	0.0	0.0	0.6	0.2	4.4	0.1	0.5	0.0	0.5	0.6	0.4	0.0	0.3	0.0	25.2	0.6	0.0	0.0	1.5	1.3	0.0	0.0	0.1	2.8	16.3	8.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.1	0.3	1.3	0.0	0.0	9.2	4.0	1.1	2.2	0.7	0.0	0.1	3.5	12.0	23.1	7.3	25.6	97.5	22.8	25.3	8.3	71.0	11.5	15.0	33.4	15.1	10.6	0.5	22.5	10.6	0.7	0.8	0.8	1.6	0.8	1.1	1.8	1.2	1.5	1.3	2.1	1.5	1.6	0.0	2.3	3.9	149.9	0.9	0.0	0.2	0.0	0.7	0.3	0.5	0.5	0.0	0.8	0.0	8.4	0.1	37.4	0.1	0.0	0.0	17.2	0.5	0.2	1.1	0.0	9.7	5.0	0.0	0.2	0.8	1.5	0.1	0.0	0.2	2.2	0.9	11.4	0.0	5.0	0.1	0.0	8.4	8.6	4.8	0.0	13.2	7.2	26.2	13.7	0.5	50.4	2.5	2.8	0.1	0.1	1.2	77.2	0.1	0.0	0.4	2.4	1.7	0.0	0.2	1.0	1.2	0.4	0.7	1.1	0.3	62.1	0.3	0.2	0.2
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA055864	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055864: AB_2682949"	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"	9.4	9.7	3.4	18.8	3.6	13.6	8.5	3.2	3.9	7.6	4.5	8.5	11.0	7.1	6.4	7.7	7.8	8.6	5.3	3.2	3.6	9.6	15.1	11.3	24.8	5.0	4.1	11.8	4.4	1.6	3.4	10.6	4.6	6.9	9.4	1.9	12.5	6.0	5.1	3.0	16.3	6.5	4.0	25.6	8.9	1.7	4.6	12.8	5.4	4.4	20.2	10.7	8.3	4.7	13.6	2.4	3.1	9.6	15.8	17.2	17.2	19.7	22.6	16.0	25.5	1.3	15.3	10.3	20.2	15.4	28.4	2.3	0.0	14.1	26.0	27.1	0.1	18.5	11.1	10.0	29.7	15.1	19.9	14.4	7.6	23.6	15.4	13.7	23.7	15.5	4.5	9.4	29.0	7.5	22.7	21.2	10.7	9.1	7.0	7.8	28.9	8.3	14.5	16.9	0.6	2.9	4.7	9.5	11.2	19.0	14.2	15.9	26.1	14.2	10.5	8.2	15.2	13.7	9.2	14.8	18.9	15.4	25.2	21.4	7.7	4.1	15.4	10.7	18.7	29.5	14.1	12.5	8.3	32.6	19.5	17.4	7.4	23.0	12.5	3.3	9.7	9.6	3.4	3.6	3.2	3.9	3.2	3.6	5.0	4.1	4.6	4.0	4.6	4.7	30.5	32.1	35.6	1.6	58.8	1.9	13.8	14.6	1.8	2.7	9.3	9.1	4.2	11.5	21.7	16.5	18.8	9.9	40.4	16.8	0.0	22.5	16.3	7.2	16.9	23.3	3.6	9.9	2.4	18.3	17.6	14.6	23.0	14.3	42.3	18.7	13.9	9.4	20.4	0.0	2.0	10.4	16.2	17.1	11.4	5.9	4.4	23.9	5.4	29.0	13.9	1.8	49.4	2.5	1.4	20.0	20.3	8.2	33.7	10.3	14.5	3.3	28.3	1.7	6.6	18.8	14.0	0.8	1.9	7.7	2.6	11.9	47.1	31.7	8.5	23.2
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428043-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	1.9	2.5	2.1	4.5	3.2	6.8	3.6	10.0	2.5	3.7	1.4	2.0	1.7	5.5	3.0	2.2	4.3	2.5	3.8	1.7	2.8	2.9	2.1	3.5	6.5	2.4	1.8	11.3	2.3	7.2	2.5	2.0	1.9	4.0	2.4	8.9	2.2	2.7	3.6	1.9	2.4	2.9	2.1	5.9	2.9	3.8	2.7	13.5	7.8	7.6	6.8	2.9	1.7	4.4	3.6	2.2	6.7	10.6	2.1	1.4	2.0	3.4	2.2	3.6	4.7	5.5	3.5	14.1	2.3	2.0	9.6	4.2	10.0	2.9	6.9	4.6	4.5	6.5	4.6	2.1	1.5	5.4	7.7	1.4	2.4	3.8	4.3	1.8	7.1	9.6	9.5	9.2	2.9	1.3	13.8	3.7	17.5	6.4	2.7	33.1	11.6	4.6	1.2	2.2	8.8	11.0	7.1	3.0	2.5	6.6	3.6	4.0	3.2	5.7	8.3	3.5	6.5	14.0	15.0	21.0	3.4	8.7	8.1	5.7	0.8	8.9	6.9	1.0	8.2	3.7	6.4	6.6	1.0	5.9	8.2	6.9	2.1	3.9	2.1	1.8	8.4	3.8	2.1	3.2	10.0	2.5	1.7	2.8	2.4	1.8	1.9	2.1	2.7	4.4	11.0	3.2	9.0	19.6	21.8	12.6	11.6	2.5	14.2	17.5	10.0	7.5	9.7	8.6	5.7	0.0	8.4	0.9	13.1	1.6	0.0	2.2	7.0	5.4	7.0	7.8	10.7	21.9	31.0	2.2	1.3	6.3	5.6	7.9	5.1	10.8	10.8	4.6	1.8	18.5	31.3	2.2	2.0	6.0	6.4	4.8	5.6	6.0	7.2	27.2	4.5	10.3	18.6	50.3	60.2	1.7	12.3	6.8	7.1	7.7	1.2	2.0	1.6	21.0	0.0	17.3	6.9	7.3	8.4	4.8	11.1	1.5	22.2	2.8	3.1	5.3
SP7	"osterix, OSX"	ENSG00000170374	"Sp7 transcription factor"	Q8TDD2	12	53326575-53345315	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Cone photoreceptor cells: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory bulb: 28.1"	"Low region specificity"	"Detected in many"			HPA063202	Enhanced					NA	NA						"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA063202: AB_2684961"	"unprognostic (6.02e-1)"	"unprognostic (6.28e-3)"		"unprognostic (6.37e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.75e-2)"		"unprognostic (3.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.02e-1)"	"unprognostic (3.93e-7)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.95e-1)"	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.5	0.2	0.4	0.3	0.2	0.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782279-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.6;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.5;Inhibitory neurons: 5.3;Paneth cells: 1.2;Prostatic glandular cells: 2.9;Spermatocytes: 1.1;Spermatogonia: 1.5;Urothelial cells: 1.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 6.4;NTERA-2: 12.6;PC-3: 21.6"	"Group enriched"	"Detected in many"	11	"basal ganglia: 15.3;olfactory bulb: 54.5"	"Region enriched"	"Detected in some"	11	"olfactory bulb: 29.8"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.0	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.6	0.1	21.6	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.7	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.9	0.0	4.6	0.8	2.7	3.5	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.0
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334954-174338500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.2"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;fHDF/TERT166: 5.5;HEK 293: 2.2;THP-1: 11.6"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.8;olfactory bulb: 11.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.6;olfactory bulb: 21.6"	HPA062616	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.0	0.0	2.5	0.0	2.9	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	7.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.1	0.2	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	3.2	0.7	1.6	0.1	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0
SPA17	"CT22, SP17"	ENSG00000064199	"Sperm autoantigenic protein 17"	Q15506	11	124673844-124697518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 231.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1583.7;Endometrial ciliated cells: 371.2;Late spermatids: 2667.9;Respiratory ciliated cells: 368.6;Spermatocytes: 580.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037568	Enhanced		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA037568: AB_10672905"	"unprognostic (1.41e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.39e-3)"	"prognostic favorable (1.03e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.78e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.71e-1)"	3.2	4.2	2.6	1.1	2.8	1.6	3.8	2.4	2.6	4.4	9.0	5.4	1.4	4.4	10.5	5.0	24.5	2.3	4.5	2.8	3.1	11.6	2.1	7.7	1.0	4.6	4.9	1.6	4.3	4.7	13.5	0.9	4.1	4.3	3.2	1.0	3.5	2.1	1.2	2.6	3.0	1.6	3.8	1.8	4.0	231.3	3.3	2.6	8.9	0.2	1.4	3.2	3.0	3.3	4.1	5.4	12.6	4.3	4.2	6.4	4.7	3.8	8.4	5.4	4.4	1.4	11.5	2.8	2.2	6.7	4.3	3.4	4.9	8.0	7.3	2.6	3.6	3.6	0.8	2.4	2.3	1.0	1.6	2.6	4.8	7.9	4.1	4.2	4.5	5.7	5.5	2.2	12.4	5.5	0.5	0.2	4.7	8.3	4.3	3.8	1.5	0.1	12.8	3.1	6.6	5.8	9.1	2.7	1.8	4.6	17.1	3.1	3.2	4.8	3.8	2.8	4.5	1.4	0.9	1.1	5.0	0.9	5.1	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.2	2.6	2.8	2.4	2.6	2.8	3.1	4.6	4.9	4.1	3.8	3.3	3.3	5.9	3.2	12.6	3.6	0.9	2.7	4.7	26.9	1.8	2.6	6.2	6.5	2.1	17.2	54.2	20.2	4.2	6.7	2.3	13.0	19.6	29.2	1583.7	371.2	13.8	7.2	7.2	3.2	5.8	15.5	10.8	5.8	8.2	19.4	0.0	7.1	1.8	1.5	11.9	0.0	2.8	9.2	32.6	3.1	1.0	2667.9	28.0	6.6	1.8	1.9	2.6	8.1	0.0	1.0	0.7	12.7	10.0	18.0	1.4	2.9	6.3	47.0	368.6	1.2	13.1	6.2	10.5	580.0	63.6	4.9	2.3	2.7	2.6	8.4	10.4	5.6
SPACA1	SAMP32	ENSG00000118434	"Sperm acrosome associated 1"	Q9HBV2	6	88047841-88066838	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	371	"testis: 41.9"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 910.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026744, HPA043297"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026744: AB_2194642, HPA043297: AB_2678413"															"unprognostic (4.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	910.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	80.5	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	61.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA3	"ALLP17, CT54, LYC3, LYZL3, SLLP1"	ENSG00000141316	"Sperm acrosome associated 3"	Q8IXA5	17	32970376-32997877	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 125.3"	"Group enriched"	"Detected in some"	75	"Early spermatids: 1298.4;Late spermatids: 933.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"	"Cell line enriched"	"Detected in some"	16	"U-266/70: 91.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023633	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA023633: AB_1857407"	"unprognostic (6.48e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.31e-2)"		"unprognostic (3.37e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.70e-4)"			"unprognostic (3.86e-2)"	"unprognostic (1.79e-1)"		"unprognostic (4.63e-1)"	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.7	0.3	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	20.9	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.2	125.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	91.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.7	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1298.4	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	933.6	13.1	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	4.9	0.4	0.0	3.8	0.0	0.7	0.0	6.6	0.0	0.0	14.7	6.9	0.0	0.0	0.0	0.0	0.1	0.9	0.0
SPACA4	SAMP14	ENSG00000177202	"Sperm acrosome associated 4"	Q8TDM5	19	48606742-48607714	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 117.8"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 1014.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041927, HPA061302"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA041927: AB_10794162, HPA061302: AB_2684475"	"unprognostic (2.48e-2)"	"unprognostic (6.37e-4)"	"unprognostic (6.59e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.09e-3)"	"unprognostic (9.43e-6)"		"unprognostic (6.67e-3)"		"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.78e-1)"		"unprognostic (3.43e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.3	0.6	0.0	3.6	3.0	0.0	0.0	2.0	0.2	1.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.1	1.4	3.1	0.0	0.0	0.0	3.4	117.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1014.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	185.9	4.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	9.8	3.3	0.0	1.6	0.0	0.0	0.0	0.0	0.2
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Early spermatids: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.6	0.0	0.7	0.1	0.1	1.2	0.9	0.1	0.2	0.1	0.0	0.2	0.5	0.0	0.2	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.4	0.7	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.2	0.1	0.3	0.1	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	14.0	0.8	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.7	1.2	0.9	0.3	0.6	0.7	0.7	0.7	0.2	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 23.9"	"Cell type enriched"	"Detected in single"	16	"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA7	C13orf28	ENSG00000153498	"Sperm acrosome associated 7"	Q96KW9	13	112376355-112434689	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 84.1"	"Group enriched"	"Detected in some"	22	"Early spermatids: 1259.3;Late spermatids: 829.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048349	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA048349: AB_2732548"							"unprognostic (3.97e-2)"											0.0	0.1	0.1	0.1	0.4	0.5	0.0	0.7	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	84.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.7	0.4	0.2	0.2	0.3	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1259.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	829.7	6.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 74.0;testis: 131.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	5.0	7.6	17.4	1.3	17.7	1.5	5.2	17.4	19.5	9.7	18.2	11.5	1.3	8.3	74.0	9.5	39.2	5.4	10.4	16.8	19.0	12.2	2.3	7.4	2.2	20.3	22.2	11.3	5.2	3.8	11.5	3.2	19.1	7.0	1.9	8.2	9.8	7.1	1.7	11.9	3.7	4.9	21.3	3.6	6.5	131.2	18.5	7.9	15.6	1.8	3.2	6.1	8.1	19.0	3.0	3.2	4.8	3.9	6.6	8.4	5.7	1.9	3.5	2.6	2.8	0.8	9.1	0.7	4.3	8.7	5.4	4.2	2.0	5.4	2.3	3.5	3.9	0.8	2.3	1.0	9.6	2.2	0.3	9.6	11.4	6.4	6.9	10.6	3.0	48.5	0.8	2.4	7.1	6.4	7.6	8.6	1.0	5.6	3.0	3.6	1.0	2.1	10.5	1.1	1.2	4.7	8.0	1.3	6.3	3.6	10.3	0.7	2.9	5.5	3.7	5.3	0.8	1.0	1.7	2.6	10.2	0.8	2.7	4.0	1.1	1.9	1.1	1.1	1.3	3.0	1.2	0.6	1.6	2.6	1.3	1.3	1.5	4.4	1.9	0.5	2.0	0.9	17.4	17.7	17.4	19.5	16.8	19.0	20.3	22.2	19.1	21.3	18.5	19.0	3.6	3.2	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.3	17.9	0.0	0.0	5.0	23.9	0.0	18.2	0.8	0.0	33.2	8.6	0.0	99.8	7.1	1.9	0.0	0.0	0.0	7.1	12.4	3.9	0.0	8.1	0.0	6.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	23.9	63.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	0.8	7.7	0.0	0.0
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.0;Endometrial ciliated cells: 190.6;Respiratory ciliated cells: 198.6;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA023748: AB_2671304, HPA053682: AB_2682229"	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.62e-4)"	1.8	1.3	3.0	3.6	3.2	10.1	3.0	4.2	3.0	5.4	14.0	12.9	2.9	2.4	1.5	7.8	10.0	3.7	1.5	3.0	4.6	3.2	4.7	5.0	2.7	7.2	9.0	1.0	2.5	9.0	5.7	1.8	6.2	3.1	18.3	1.9	4.6	3.5	0.4	7.9	2.7	1.8	6.0	2.0	6.3	19.4	4.8	2.1	3.4	0.6	4.4	5.3	3.0	5.4	31.3	8.3	0.5	1.8	1.8	1.5	4.6	5.7	3.4	6.8	7.1	8.3	13.5	1.2	20.0	1.8	10.1	16.1	5.9	11.1	6.3	18.1	6.1	5.2	9.0	3.1	2.4	1.4	4.5	1.3	5.8	8.4	6.6	5.3	5.8	5.7	0.2	16.1	1.0	11.2	3.1	1.4	0.5	15.6	9.1	0.5	1.3	4.7	26.1	14.8	4.8	3.5	7.8	6.4	7.0	2.2	9.2	5.9	5.3	6.8	9.8	3.6	14.9	10.9	8.9	0.9	6.5	5.0	3.4	0.0	0.1	0.6	0.1	0.0	0.0	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.7	1.0	0.2	0.2	0.0	0.0	3.0	3.2	4.2	3.0	3.0	4.6	7.2	9.0	6.2	6.0	4.8	5.4	7.7	48.1	22.8	18.9	7.7	5.6	9.6	18.1	2.2	2.0	13.3	7.7	5.6	22.8	37.2	18.4	0.0	1.3	19.0	32.9	5.9	19.7	96.0	190.6	7.1	6.9	22.1	0.4	30.1	8.6	8.7	5.0	22.4	39.5	10.1	7.3	4.2	8.0	2.8	8.4	21.6	14.9	6.1	2.2	5.3	32.3	5.0	3.9	1.8	6.5	4.5	11.5	5.2	4.5	4.1	14.9	17.7	3.8	15.9	10.3	2.4	10.0	198.6	2.3	0.0	4.8	6.4	91.9	4.7	2.9	5.4	2.3	12.0	1.3	20.1	23.3
SPAG11A	"EDDM2A, HE2"	ENSG00000178287	"Sperm associated antigen 11A"	Q6PDA7	8	7847876-7868867	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11461	"epididymis: 4564.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;NB-4: 5.7;RPMI-8226: 1.7"									"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4564.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAG11B	"EDDM2B, EP2, EP2C, EP2D, HE2"	ENSG00000164871	"Sperm associated antigen 11B"	Q08648	8	7442684-7463674	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1636	"epididymis: 864.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	864.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037542	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	16.3	16.8	36.6	6.4	37.4	2.4	20.8	35.1	45.9	21.0	39.0	16.5	18.8	18.2	31.6	26.1	46.5	22.0	22.2	34.2	37.8	30.4	18.8	10.8	11.5	38.8	39.6	25.8	15.5	24.4	29.7	9.8	37.8	22.1	17.2	21.5	15.7	20.5	10.3	24.9	10.9	12.1	40.9	8.0	26.1	46.3	38.4	13.0	26.4	10.8	13.8	18.9	19.4	40.6	26.8	9.9	29.4	0.0	19.3	35.0	0.2	14.3	17.1	18.3	19.3	20.8	28.8	11.1	16.7	16.0	29.3	18.5	13.4	17.4	38.6	0.0	10.5	5.8	28.0	24.6	21.9	6.3	0.1	30.1	23.5	16.3	9.5	25.0	7.6	11.6	18.8	12.3	18.4	0.0	21.4	0.1	16.3	0.0	8.7	22.6	30.9	0.5	29.4	25.8	21.4	25.1	16.3	15.1	21.3	24.2	70.3	2.7	7.8	17.2	9.2	9.3	15.1	20.0	9.7	0.4	28.6	0.0	8.0	2.0	0.3	0.9	8.1	1.3	11.7	9.3	9.1	10.4	3.1	8.5	12.0	10.4	0.5	15.4	0.9	5.1	9.4	3.4	36.6	37.4	35.1	45.9	34.2	37.8	38.8	39.6	37.8	40.9	38.4	40.6	17.7	16.0	19.5	89.5	10.7	42.3	46.6	82.8	22.8	47.6	38.0	45.6	67.5	74.4	73.6	40.5	95.9	50.6	7.5	17.1	76.3	44.0	243.1	207.0	31.3	18.5	38.2	9.0	205.9	24.9	20.8	30.8	32.1	30.3	10.1	34.0	12.8	16.9	11.7	40.4	273.7	37.8	101.7	4.6	9.6	86.2	41.3	5.9	23.2	42.2	29.2	82.7	8.2	92.0	74.9	27.3	18.8	44.8	9.4	25.4	9.4	94.9	330.0	69.0	13.1	30.8	36.1	167.9	31.0	64.6	56.4	23.5	12.9	55.3	39.8	53.8
SPAG17	"CT143, FLJ34497, PF6, RP4-776P7.2"	ENSG00000155761	"Sperm associated antigen 17"	Q6Q759	1	117953590-118185228	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.7;testis: 14.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 263.7;Endometrial ciliated cells: 180.7;Late spermatids: 370.9;Respiratory ciliated cells: 300.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA028597, HPA028666"	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA028597: AB_10600221, HPA028666: AB_10602281"	"unprognostic (3.67e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-5)"	"unprognostic (4.81e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.67e-2)"	0.5	0.1	2.3	0.0	1.6	0.0	0.7	0.9	0.3	1.2	26.7	0.0	0.0	0.3	4.5	6.1	8.4	0.3	0.0	1.9	2.3	2.5	0.0	1.8	0.0	7.3	8.9	0.1	0.4	0.0	3.8	0.1	5.1	0.1	0.0	0.4	0.3	0.1	0.2	0.2	0.0	0.0	5.1	0.0	0.5	14.9	2.6	0.0	0.9	0.0	0.5	1.0	2.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.9	0.3	1.9	2.3	7.3	8.9	5.1	5.1	2.6	3.0	0.1	6.4	3.9	0.7	0.0	0.4	0.2	2.8	0.6	0.5	1.2	0.6	0.6	0.0	45.3	11.0	33.3	2.3	0.1	0.1	1.9	0.6	263.7	180.7	1.1	0.6	0.0	0.0	2.7	0.7	0.5	4.6	0.0	4.0	1.3	0.2	0.0	0.0	0.2	0.0	2.2	0.0	4.1	0.0	0.4	370.9	1.5	0.7	0.0	1.0	0.1	1.1	0.0	0.5	0.9	0.2	0.0	1.2	0.0	0.1	0.0	1.0	300.1	0.1	0.0	0.4	1.1	48.2	6.2	16.1	0.3	0.7	0.4	1.5	0.0	0.9
SPAG4	"CT127, SUN4"	ENSG00000061656	"Sperm associated antigen 4"	Q9NPE6	20	35615829-35621094	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 90.1;testis: 32.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.9;Late spermatids: 139.8;Plasma cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.0;hTERT-RPE1: 18.4;U-87 MG: 47.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA048393, HPA061789"	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048393: AB_2680385, HPA061789: AB_2684609"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.09e-5)"	"prognostic favorable (9.52e-8)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (6.66e-4)"	3.1	5.3	2.3	3.1	2.9	5.0	2.3	2.0	4.4	3.7	2.8	7.0	6.5	2.2	5.5	2.1	4.6	4.2	3.2	2.0	2.7	5.1	4.8	3.1	3.2	3.7	3.7	8.5	90.1	3.1	8.2	1.4	3.6	3.7	2.6	5.4	7.2	2.2	0.6	0.6	5.9	1.4	2.0	12.3	7.3	32.0	2.2	0.9	2.2	0.1	5.5	6.9	2.5	2.2	3.8	1.6	0.8	2.0	2.0	0.7	10.5	1.4	1.9	1.5	2.2	3.4	8.3	0.3	26.0	2.1	6.0	1.0	0.5	5.2	1.6	4.1	0.5	2.9	3.2	3.7	10.2	2.2	4.7	4.9	1.1	1.6	1.2	18.4	3.1	0.9	0.8	7.0	3.9	8.0	0.8	5.4	0.1	7.2	6.9	0.6	0.7	11.4	2.7	1.6	0.6	3.9	1.8	1.2	3.0	0.3	5.2	0.9	3.3	7.2	1.1	1.6	1.5	13.8	5.7	3.2	47.4	0.8	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.4	0.0	2.3	2.9	2.0	4.4	2.0	2.7	3.7	3.7	3.6	2.0	2.2	2.2	3.2	0.0	0.5	0.3	26.6	0.4	1.0	6.3	1.2	3.2	1.7	1.5	2.3	0.0	7.6	0.0	2.1	2.0	7.6	0.6	0.0	13.2	177.9	7.5	2.3	3.4	4.2	0.4	1.9	7.6	15.9	3.3	5.1	6.0	4.5	0.9	5.7	6.7	1.5	1.7	1.2	1.7	24.4	1.4	2.1	139.8	1.8	2.0	26.6	1.9	2.1	14.7	0.0	0.0	0.3	15.5	1.4	3.0	138.0	1.6	0.3	6.0	19.3	2.5	0.0	1.0	3.6	35.0	4.9	0.4	0.1	20.2	7.2	2.3	0.8	3.9
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPAG6	"CFAP194, CT141, FAP194, PF16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 63.5;fallopian tube: 49.0;testis: 96.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"U-937: 105.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 11.1"	HPA038440	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.0	0.0	4.2	0.0	4.0	0.4	1.7	1.9	1.4	1.7	63.5	0.0	0.0	0.2	0.4	0.0	49.0	0.0	0.1	3.3	5.0	0.3	0.1	7.0	0.1	17.6	16.1	0.1	0.3	1.8	14.6	0.0	9.9	1.0	0.0	5.8	0.0	0.0	0.0	0.3	0.0	0.0	16.3	0.0	0.0	96.3	6.4	0.4	0.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.9	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.1	1.7	0.8	0.2	0.0	105.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	4.2	4.0	1.9	1.4	3.3	5.0	17.6	16.1	9.9	16.3	6.4	10.1	0.0	0.0	4.8	0.0	0.1	0.1	0.1	14.0	0.0	0.2	0.5	0.3	0.6	0.0	24.5	0.0	0.0	0.1	0.2	0.1	1.9	0.3	228.6	73.2	0.4	0.2	0.0	0.0	7.1	0.0	0.0	0.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	16.2	0.0	0.2	51.4	5.0	0.5	1.8	4.7	0.0	0.3	0.0	0.5	6.0	0.4	0.0	4.9	0.3	1.8	0.0	1.4	266.4	1.2	0.0	0.0	3.7	372.6	4.8	0.0	0.1	0.0	0.5	0.1	0.0	0.1
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 305.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	51.1	56.1	55.4	37.5	56.0	46.0	48.3	58.5	63.5	50.5	56.0	67.1	37.1	67.1	41.0	52.0	68.2	38.0	156.7	56.4	57.4	84.0	69.7	46.0	44.7	58.8	56.1	42.9	45.5	69.3	38.4	52.3	59.4	45.8	38.2	47.6	48.0	40.5	305.3	48.0	45.4	50.3	56.6	51.7	56.6	35.6	58.5	47.2	56.1	215.5	41.7	54.0	47.6	58.8	41.8	90.7	116.9	65.4	79.8	115.5	67.5	80.9	91.8	77.8	59.5	53.7	53.3	52.9	116.6	100.5	54.2	58.6	59.3	123.9	35.1	77.5	52.6	57.6	74.5	75.3	111.3	32.1	82.1	127.4	87.9	66.5	123.9	118.6	99.4	66.9	39.0	53.2	96.2	66.9	58.7	71.2	66.8	58.0	29.0	61.4	74.1	38.3	135.7	52.1	32.8	64.6	68.7	27.3	68.2	59.9	59.2	50.2	96.6	52.4	34.0	26.1	67.2	46.5	40.3	32.5	101.4	45.6	69.1	96.0	88.3	82.6	82.3	72.6	89.7	97.2	77.1	77.9	103.9	81.1	95.5	84.0	23.1	67.3	73.7	105.9	95.0	91.0	55.4	56.0	58.5	63.5	56.4	57.4	58.8	56.1	59.4	56.6	58.5	58.8	40.6	57.7	52.6	11.1	54.6	55.3	103.0	252.0	52.3	62.0	62.9	66.3	135.8	77.2	125.4	99.3	45.9	183.5	61.1	82.0	324.8	161.6	23.0	63.1	49.1	64.2	57.2	33.7	7.3	144.1	183.5	66.1	40.8	48.1	73.4	68.3	70.6	72.4	139.3	92.5	8.1	73.5	156.6	64.9	88.9	21.9	46.0	65.6	104.9	2.8	221.0	89.7	97.9	7.1	12.0	128.8	82.8	42.2	39.4	98.7	116.4	239.3	127.4	69.7	72.3	53.5	70.1	55.8	50.6	52.8	50.2	230.8	52.2	89.5	74.6	105.2
SPAG8	"BS-84, CT142, HSD-1, hSMP-1, SPAG3"	ENSG00000137098	"Sperm associated antigen 8"	Q99932	9	35808045-35812272	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 5.6;choroid plexus: 16.4;fallopian tube: 14.2;testis: 10.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.2;Endometrial ciliated cells: 75.7;Late spermatids: 26.5;Respiratory ciliated cells: 123.3;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068012	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA068012: AB_2685941"	"unprognostic (1.01e-4)"	"unprognostic (3.52e-3)"	"unprognostic (6.36e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-3)"	0.3	0.5	0.9	0.2	0.8	0.3	0.3	0.9	1.1	1.7	16.4	0.8	0.4	0.7	1.0	0.2	14.2	0.6	1.7	1.4	0.8	0.7	0.1	1.3	0.4	3.8	5.6	1.3	0.3	1.0	2.5	0.2	2.9	0.7	0.1	0.2	0.3	0.4	0.4	0.2	0.3	0.2	2.0	0.6	0.4	10.3	1.0	0.7	1.4	0.8	0.3	0.5	0.3	1.3	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.3	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	0.1	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.4	0.2	0.6	0.3	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.3	0.2	1.4	0.7	0.0	0.6	0.4	0.2	0.0	0.4	0.6	1.1	0.4	0.3	0.8	0.0	0.9	0.0	0.0	1.0	0.4	0.9	0.8	0.9	1.1	1.4	0.8	3.8	5.6	2.9	2.0	1.0	1.3	1.0	0.0	1.5	8.1	1.0	0.4	1.0	6.3	0.0	4.9	0.8	1.8	3.6	0.0	10.4	5.5	8.4	0.3	1.0	0.0	1.9	0.4	51.2	75.7	1.1	1.0	3.0	0.4	4.4	0.0	0.1	1.4	0.5	1.4	1.3	0.7	1.1	0.1	1.0	3.3	4.7	0.0	8.2	0.3	0.9	26.5	1.5	1.9	0.0	1.0	1.9	5.7	0.0	3.0	7.0	0.1	0.0	1.2	0.9	0.6	0.1	1.6	123.3	8.5	0.0	1.5	4.5	58.8	3.1	0.0	0.6	0.1	1.1	1.4	0.1	0.3
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120868	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.2;neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: AB_2684528"	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (8.10e-4)"	32.2	22.6	50.9	19.0	64.6	26.7	22.4	60.7	58.4	21.5	38.2	23.1	20.4	27.6	12.3	29.1	18.7	26.7	22.6	44.2	55.1	33.0	32.9	30.4	13.6	64.0	56.0	30.1	30.6	27.4	17.5	32.0	65.1	17.9	19.7	36.6	14.3	19.3	66.3	22.6	21.0	27.0	58.7	18.4	15.9	51.0	60.1	19.3	40.1	40.6	15.7	29.6	20.0	99.1	53.3	58.5	73.3	36.0	68.0	59.9	64.7	42.6	41.5	46.8	57.9	53.0	35.7	28.6	29.1	70.3	94.1	44.7	48.5	35.8	86.4	43.5	57.7	23.9	46.4	39.5	51.1	34.9	26.8	43.4	40.7	63.3	112.4	44.9	38.9	14.2	53.6	30.9	66.9	26.6	22.0	14.5	19.5	35.5	74.8	24.7	81.8	25.3	42.8	99.4	56.6	78.8	37.6	34.5	38.8	44.0	28.5	40.9	54.6	129.6	30.3	101.0	63.4	43.5	67.4	46.2	44.3	20.4	46.0	9.2	1.2	0.7	1.2	0.8	0.9	1.0	1.0	1.2	1.3	0.9	0.6	0.8	12.1	0.4	0.5	1.0	1.7	0.5	50.9	64.6	60.7	58.4	44.2	55.1	64.0	56.0	65.1	58.7	60.1	99.1	162.5	131.4	121.3	190.3	53.1	165.1	149.7	37.5	107.6	96.0	45.7	38.7	62.6	41.5	41.1	25.8	125.1	43.2	60.2	189.0	27.4	56.7	243.0	151.6	142.1	122.9	69.8	20.4	110.2	57.6	28.4	106.5	81.6	337.1	43.1	52.8	74.3	48.7	36.7	67.3	130.5	56.0	24.4	43.3	246.6	137.8	76.1	123.1	71.2	104.9	49.8	32.7	25.7	192.5	304.7	89.6	123.5	67.0	59.7	156.9	69.6	86.9	39.0	85.5	65.7	109.0	86.4	215.1	54.8	93.8	172.3	138.9	59.4	56.3	56.3	182.5
SPAM1	"HYAL5, PH-20, SPAG15"	ENSG00000106304	"Sperm adhesion molecule 1"	P38567	7	123925237-123971414	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 17.3"	"Group enriched"	"Detected in some"	73	"Early spermatids: 270.3;Late spermatids: 111.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017984	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA017984: AB_1857413"															"unprognostic (2.44e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	270.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	111.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589708-141590762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"testis: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;GAMG: 1.3;PC-3: 1.3;U-2197: 1.5"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002594-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 88.8"	"Group enriched"	"Detected in some"	160	"Early spermatids: 686.8;Late spermatids: 2015.4"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	81.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	16.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	27.4	1.9	0.7	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	686.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2015.4	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.1	8.4	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 31.0"	"Group enriched"	"Detected in some"	209	"Early spermatids: 468.6;Late spermatids: 1668.9"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;U-2 OS: 6.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (3.56e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.2	0.0	0.3	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	1.0	0.2	0.1	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	468.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1668.9	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXD	"CT11.4, SPANXE"	ENSG00000196406	"SPANX family member D"	Q9BXN6	X	141697411-141698739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 23.2"	"Group enriched"	"Detected in some"	148	"Early spermatids: 491.4;Late spermatids: 1560.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 1.2;U-2 OS: 3.9"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1560.9	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN4	"CT11.9, SPANX-N4"	ENSG00000189326	"SPANX family member N4"	Q5MJ08	X	143025918-143034702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 25.9"	"Group enriched"	"Detected in some"	165	"Early spermatids: 97.7;Late spermatids: 298.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045730, HPA059094"	Uncertain		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Nuclear membrane"	"HPA045730: AB_10961036, HPA059094: "																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	298.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPARC	"BM-40, ON, ONT"	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151686975	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 2184.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 737.1;Endometrial stromal cells: 1209.0;Endothelial cells: 781.9;Fibroblasts: 1032.1;Peritubular cells: 1111.1;Sertoli cells: 2353.5;Smooth muscle cells: 1527.3;Theca cells: 987.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.4;classical monocyte: 8.7;neutrophil: 24.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.3;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 4911.5;BJ: 4101.8;fHDF/TERT166: 6492.5;WM-115: 4789.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	8300000	130000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	1661.2	406.4	578.0	436.4	922.0	32.4	528.6	733.1	339.2	837.2	297.8	355.6	110.5	538.9	112.7	307.7	271.4	1526.8	563.5	362.9	1554.2	176.1	158.5	498.0	232.1	1370.4	1251.5	348.2	119.2	273.1	111.4	2184.6	1224.8	227.1	185.2	36.4	113.1	378.0	258.2	286.1	157.4	1251.5	995.9	260.8	143.3	406.7	1135.4	70.9	294.1	473.5	131.6	829.5	249.0	1088.4	5.9	5.0	1196.5	57.5	4911.5	1596.0	112.6	4101.8	1336.6	1649.3	1693.8	5.5	4.2	2.0	953.7	6492.5	272.0	56.7	153.4	316.2	555.0	4.8	57.1	56.7	0.4	116.8	1441.6	2.9	5.4	2567.2	436.9	1233.8	170.8	1903.1	2315.1	13.5	53.7	44.6	944.1	0.4	4.7	35.5	556.2	0.4	4.4	2.9	1192.9	4.3	0.5	0.5	45.5	88.4	2.8	1.4	534.9	1922.1	4.7	138.2	2759.9	771.0	1195.2	350.2	1304.4	3.7	6.0	7.6	648.4	3.7	4789.0	10.4	8.7	2.7	1.0	0.3	0.0	0.1	0.0	0.1	2.3	0.2	0.3	0.0	24.3	0.0	0.1	1.9	0.0	123.9	578.0	922.0	733.1	339.2	362.9	1554.2	1370.4	1251.5	1224.8	995.9	1135.4	1088.4	737.1	83.3	27.5	7.2	6.8	164.8	25.7	23.8	28.5	85.7	11.2	100.5	43.6	5.7	18.8	16.5	2.1	115.4	2.8	0.1	0.0	4.6	14.2	41.6	1209.0	781.9	0.0	15.1	4.3	0.4	354.3	1032.1	9.7	31.5	12.0	146.5	668.6	9.9	108.2	1.7	2.9	0.0	0.0	50.0	175.7	46.8	319.3	92.0	234.7	38.4	10.7	13.6	3.1	21.6	37.3	5.5	0.0	1111.1	4.1	7.7	0.0	42.0	7.8	72.7	2353.5	510.4	1527.3	14.2	10.9	4.8	108.3	147.4	21.1	987.4	0.0	5.3
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 4430.9;Endothelial cells: 2372.1;Peritubular cells: 2523.5;Sertoli cells: 4674.1;Skeletal myocytes: 2379.0;Smooth muscle cells: 2781.9"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 24.9;SuSa: 31.4;U-266/70: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		630000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	755.6	129.5	664.6	124.5	810.9	0.5	532.1	612.4	1058.4	732.7	580.4	624.3	125.1	1244.5	443.8	308.1	754.5	487.9	600.2	744.6	723.5	72.5	25.0	481.1	99.1	655.7	730.9	286.8	91.8	128.0	197.8	315.4	663.4	584.2	187.5	95.2	228.3	999.2	244.8	130.2	280.1	1191.2	774.7	157.9	347.7	97.5	694.8	103.2	369.9	594.7	100.0	488.0	466.4	681.2	0.7	0.0	24.9	0.3	0.2	0.1	2.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	1.4	2.4	0.0	0.0	1.7	0.0	0.3	1.1	0.4	1.1	0.3	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.5	0.2	3.5	0.6	0.0	0.0	0.3	0.4	1.2	0.0	0.1	0.8	1.6	0.1	0.2	0.1	31.4	0.4	0.5	0.0	0.2	0.3	1.5	0.2	9.1	1.4	0.6	3.4	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	664.6	810.9	612.4	1058.4	744.6	723.5	655.7	730.9	663.4	774.7	694.8	681.2	4430.9	12.8	56.4	1155.7	6.2	46.3	187.2	0.6	59.7	10.7	24.4	251.6	334.2	4.3	43.3	7.3	2.1	2.2	8.6	0.0	13.7	0.8	11.8	34.9	935.8	2372.1	0.0	32.0	382.3	0.4	3.2	1413.1	6.1	46.7	7.6	1.4	899.5	9.1	9.2	3.3	450.1	0.0	0.0	5.3	55.2	47.0	659.5	31.6	56.9	261.4	0.0	179.4	0.0	210.6	53.8	0.1	0.0	2523.5	25.2	50.4	0.0	24.6	7.4	34.4	4674.1	2379.0	2781.9	5.7	7.9	56.8	39.9	2.5	26.9	38.8	0.0	124.2
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.0;Proximal tubular cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 172.7"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 172.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: AB_2676323"	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	42.3	48.4	36.9	18.0	42.8	23.6	32.5	43.4	50.6	49.2	42.3	37.8	12.7	42.4	67.1	24.5	44.5	37.4	25.7	35.3	39.4	48.4	19.9	27.0	15.7	42.4	40.5	63.6	14.6	29.5	29.6	39.8	42.1	34.7	13.3	43.3	17.3	36.4	33.5	18.4	15.4	52.8	41.2	30.7	21.1	27.6	38.3	16.7	35.6	33.7	11.2	35.5	29.9	51.0	0.1	22.4	59.5	0.0	127.9	106.6	42.4	54.1	81.3	53.7	52.8	0.1	0.0	0.0	32.9	65.9	98.2	31.2	81.4	38.0	57.5	4.4	46.9	69.4	28.3	14.6	128.0	72.8	134.3	106.2	59.5	44.4	61.9	131.7	79.6	18.7	30.6	11.9	97.5	5.2	21.7	120.8	30.0	0.0	7.8	0.0	99.4	2.5	62.5	28.2	6.2	14.5	46.3	18.3	58.9	85.3	10.5	84.7	66.8	40.0	20.1	55.9	32.2	14.2	0.2	0.1	44.6	61.8	71.0	172.7	22.1	30.1	13.5	21.7	13.1	10.1	18.6	5.4	15.7	9.7	24.5	13.1	35.0	14.2	23.8	19.3	4.8	18.1	36.9	42.8	43.4	50.6	35.3	39.4	42.4	40.5	42.1	41.2	38.3	51.0	43.5	35.3	51.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	30.8	30.1	0.0	0.0	40.2	27.6	0.0	52.7	18.6	0.0	66.5	26.2	0.0	59.4	62.6	15.9	0.0	0.0	0.0	15.0	59.7	39.8	0.0	38.1	58.0	75.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.5	0.0	0.0	90.4	65.6	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	64.3	10.8	59.2	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060664-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 20.5"	"Group enriched"	"Detected in some"	145	"Early spermatids: 464.2;Late spermatids: 1195.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;RH-30: 1.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.2	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	20.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.6	2.0	0.8	0.7	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	464.2	1.0	0.1	0.6	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.3	0.0	1195.5	5.0	0.5	0.0	1.0	0.0	0.0	0.0	1.0	0.7	1.4	0.1	5.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	2.8	0.3	0.0	0.0	0.3	0.0	0.2	0.5
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 65.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 102.6;Oligodendrocytes: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.4;HDLM-2: 46.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	6.9	14.3	17.7	18.8	31.6	31.2	14.4	26.2	31.5	10.6	34.2	11.0	11.9	9.4	14.2	3.7	9.9	12.1	8.6	19.7	23.5	21.8	24.4	20.4	23.4	42.3	31.8	14.4	38.4	6.5	9.6	10.6	37.3	14.6	12.4	4.8	8.2	6.6	2.5	7.8	13.3	7.5	25.7	65.3	17.9	6.4	29.6	18.6	12.9	6.4	16.6	9.6	5.2	40.1	3.1	5.0	25.6	3.2	0.9	2.1	1.0	7.7	33.4	3.9	3.3	6.5	13.2	20.4	4.1	7.0	2.0	5.7	7.4	2.3	9.7	46.4	8.9	4.9	4.6	7.5	1.2	7.9	3.7	2.8	0.3	4.2	2.4	3.4	6.5	10.7	0.0	16.7	4.1	11.2	14.6	2.7	8.4	21.5	6.4	12.5	9.9	11.0	17.3	9.9	9.3	7.1	1.5	16.3	15.0	5.5	2.3	4.5	7.6	5.1	4.0	0.4	5.5	3.8	0.1	0.0	4.4	7.5	24.4	5.0	6.4	0.0	33.6	8.4	26.2	2.6	28.6	35.3	4.7	2.0	30.1	31.3	39.2	20.4	10.6	5.2	29.8	13.3	17.7	31.6	26.2	31.5	19.7	23.5	42.3	31.8	37.3	25.7	29.6	40.1	9.0	3.2	23.9	61.0	8.6	5.4	3.2	2.5	4.6	3.2	39.5	17.9	5.3	0.0	17.8	14.7	0.0	1.3	18.6	27.4	3.9	25.3	10.8	58.3	12.9	29.0	32.3	6.3	9.2	15.8	14.1	12.5	51.0	102.6	70.2	4.9	0.0	0.0	10.1	0.0	11.1	24.9	4.1	0.0	8.5	6.3	7.5	29.8	5.4	62.8	15.2	14.1	66.9	19.6	206.5	13.5	32.0	7.5	2.8	23.8	25.0	7.2	40.5	0.8	0.0	21.9	8.2	2.2	2.2	4.6	6.1	22.3	37.8	34.5	23.7	17.0
SPATA16	NYD-SP12	ENSG00000144962	"Spermatogenesis associated 16"	Q9BXB7	3	172889357-173141235	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	595	"testis: 59.5"	"Group enriched"	"Detected in some"	49	"Early spermatids: 288.6;Late spermatids: 129.3;Spermatocytes: 192.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037884	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA037884: AB_2675717"															"unprognostic (3.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.6	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	129.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	192.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA17	"CFAP305, FAP305, IQCH, MOT17"	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 10.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 770.1;Endometrial ciliated cells: 117.8;Late spermatids: 518.2;Respiratory ciliated cells: 150.1;Spermatocytes: 284.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.1	0.2	0.5	0.2	0.5	1.6	0.5	0.9	0.6	0.4	2.0	0.2	0.4	0.4	3.4	0.3	4.1	0.3	0.2	0.7	0.5	0.8	0.1	0.5	0.2	1.4	1.3	0.3	0.3	2.6	0.4	0.2	1.5	0.3	0.2	1.7	0.3	0.3	2.1	0.6	0.4	0.1	0.7	0.2	0.3	10.3	0.7	0.1	0.7	0.1	0.1	0.1	0.0	0.9	0.1	0.3	0.4	0.3	0.1	0.5	0.3	0.1	0.2	0.1	0.0	0.2	0.9	0.1	0.3	0.1	0.1	0.8	0.2	0.3	0.1	0.1	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.6	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.1	0.7	0.1	0.3	0.6	0.4	0.3	0.1	0.1	0.1	0.6	0.3	1.4	0.6	0.2	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.2	0.3	0.1	0.3	0.2	0.1	0.6	0.1	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.5	0.5	0.9	0.6	0.7	0.5	1.4	1.3	1.5	0.7	0.7	0.9	0.2	3.2	0.0	10.7	0.1	0.6	0.9	6.6	0.0	0.4	2.1	1.9	2.1	0.0	18.4	3.7	20.9	0.9	0.0	0.4	5.9	2.4	770.1	117.8	3.4	0.6	1.8	0.0	5.1	0.7	0.6	1.6	0.5	3.2	0.0	2.0	0.0	0.0	0.2	0.0	3.3	1.3	12.2	0.0	0.3	518.2	8.7	0.5	1.8	2.8	0.0	4.4	0.0	5.0	1.3	0.3	0.2	6.8	0.3	1.0	0.2	10.6	150.1	18.5	0.0	2.0	2.3	284.7	8.4	0.4	1.0	0.3	0.3	2.8	0.9	0.4
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPATA19	"CT132, FLJ25851, SPAS1, spergen1"	ENSG00000166118	"Spermatogenesis associated 19"	Q7Z5L4	11	133840631-133845538	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	321	"testis: 134.6"	"Group enriched"	"Detected in some"	162	"Early spermatids: 771.9;Late spermatids: 2291.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040082	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA040082: AB_2676836"					"unprognostic (9.90e-3)"	"unprognostic (3.34e-2)"										"unprognostic (2.66e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	771.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2291.2	9.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915529	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	3.9	5.8	19.9	3.7	21.6	12.2	3.7	17.5	20.9	3.9	8.1	7.8	7.8	5.3	3.6	5.6	4.7	3.4	6.9	21.0	16.7	5.0	5.8	4.0	3.6	17.2	19.0	4.5	8.0	5.6	7.9	3.5	16.7	5.8	6.3	6.5	5.9	3.9	13.1	5.0	7.5	3.1	17.0	11.4	5.7	14.3	21.1	3.8	8.0	7.8	3.6	4.1	3.7	21.5	7.8	9.4	6.3	5.7	7.0	5.0	10.3	4.9	7.2	16.7	7.0	29.7	6.1	5.9	10.1	4.9	8.6	14.1	4.7	8.1	8.8	8.3	4.5	3.1	5.6	19.5	6.6	8.5	12.2	5.0	9.6	8.6	5.4	5.5	3.6	8.2	10.8	6.6	4.0	16.5	8.7	21.5	9.5	10.5	11.3	6.5	6.8	6.2	5.4	6.1	6.0	6.4	9.8	29.6	7.8	4.9	7.2	7.3	5.1	11.9	9.8	9.9	7.0	16.2	13.4	6.3	9.3	4.4	5.4	0.1	1.5	1.4	1.4	1.1	1.3	1.3	1.3	1.7	1.3	2.1	1.6	1.9	2.5	1.5	0.5	0.6	1.5	1.0	19.9	21.6	17.5	20.9	21.0	16.7	17.2	19.0	16.7	17.0	21.1	21.5	5.4	9.6	2.2	2.9	7.8	7.4	6.6	4.3	12.5	7.4	11.9	8.6	4.9	10.0	2.8	0.0	8.4	11.0	8.3	34.7	3.9	6.0	45.2	11.4	4.7	6.3	26.4	1.7	6.8	8.0	13.4	5.4	9.7	9.0	4.5	5.4	10.4	7.1	4.8	6.7	5.0	22.2	2.0	4.4	5.4	62.5	5.0	3.6	5.4	1.9	7.0	5.4	4.1	2.0	8.5	8.3	16.1	5.7	6.4	7.4	20.7	4.8	6.7	7.6	6.6	5.8	6.6	41.3	16.9	7.8	7.2	30.1	6.8	10.3	18.4	8.5
SPATA20	"FLJ21347, SSP411, Tisp78"	ENSG00000006282	"Spermatogenesis associated 20"	Q8TB22	17	50543058-50555852	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 117.5"	"Group enriched"	"Detected in all"	15	"Early spermatids: 594.1;Late spermatids: 1543.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 60.1;MCF7: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022023, HPA027144, HPA031442"	Enhanced		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557"	"unprognostic (9.27e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.63e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.12e-3)"	"unprognostic (4.93e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (9.69e-5)"	10.3	36.8	25.7	7.2	24.6	4.4	10.5	25.5	33.2	16.9	30.0	14.8	10.0	18.0	9.7	10.1	13.7	12.9	33.3	24.2	27.6	18.6	17.6	8.9	6.4	26.9	28.0	21.1	22.0	17.0	11.7	6.4	27.5	17.1	6.4	3.2	17.7	11.2	18.5	8.6	10.8	8.3	26.0	14.1	22.0	117.5	33.1	2.3	22.5	18.4	3.8	14.6	10.3	24.8	8.8	39.4	4.8	25.7	7.9	22.7	6.0	14.9	24.2	9.2	7.3	29.1	12.9	9.2	38.4	13.9	8.9	7.0	1.4	6.3	4.2	14.4	5.3	7.4	9.5	60.1	27.8	2.4	17.1	33.3	8.8	4.7	13.0	17.9	11.6	2.4	0.7	16.8	5.5	59.3	0.0	2.1	3.1	19.0	18.0	4.4	6.9	2.9	35.4	39.5	4.5	11.3	13.0	12.1	17.0	5.6	21.0	1.1	19.7	9.8	22.2	5.6	3.7	31.8	14.0	0.2	14.9	1.4	6.9	0.0	5.0	1.0	1.6	4.5	1.9	2.8	1.2	1.1	8.3	1.7	1.5	1.7	0.2	7.3	3.4	1.6	0.8	3.7	25.7	24.6	25.5	33.2	24.2	27.6	26.9	28.0	27.5	26.0	33.1	24.8	12.6	6.4	5.0	17.3	14.0	10.7	15.1	13.4	25.6	5.3	13.3	17.4	32.5	20.0	13.1	23.9	4.2	17.3	9.8	32.6	27.4	35.6	594.1	13.0	13.2	11.7	37.9	6.1	10.3	39.0	10.3	23.5	66.8	23.2	17.7	38.5	10.8	26.7	34.6	11.8	9.5	28.4	16.2	23.6	14.8	1543.1	38.2	20.0	21.4	6.5	19.3	26.9	12.3	8.5	2.3	23.7	31.1	38.0	17.9	12.2	18.4	38.8	5.9	2.4	6.6	18.1	19.1	10.0	13.8	11.9	8.8	9.9	11.2	39.9	23.8	17.1
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404089	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 147.0"	"Group enriched"	"Detected in many"	26	"Early spermatids: 1073.6;Late spermatids: 2829.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 85.6"									HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	2.9	7.1	6.1	2.9	5.4	1.8	4.1	5.5	7.1	3.3	5.8	4.6	6.5	4.1	21.0	3.4	15.0	3.8	20.6	5.9	6.6	15.0	5.1	3.1	7.2	7.8	8.0	4.2	5.3	12.5	12.7	3.1	7.0	4.9	2.9	6.5	6.6	4.0	23.0	2.9	7.1	2.9	7.6	4.0	4.3	147.0	6.2	3.1	7.3	19.2	5.4	3.9	3.2	6.1	13.4	8.4	11.6	6.3	3.3	6.5	9.2	3.3	6.3	7.0	12.0	18.7	17.2	21.0	9.5	6.4	23.5	7.3	8.7	14.6	7.4	85.6	10.4	6.5	15.7	14.4	12.7	1.4	11.1	5.7	7.1	10.2	12.6	7.7	8.3	13.3	6.5	36.1	9.3	7.4	13.8	10.1	8.5	5.4	7.1	31.6	7.5	28.9	16.3	7.2	8.8	8.0	12.8	24.2	6.0	28.0	7.0	14.5	15.3	4.1	5.3	7.7	9.5	8.7	8.9	19.4	7.6	10.8	3.4	0.0	2.1	1.5	3.0	1.6	4.1	3.5	3.1	3.5	2.4	1.9	3.4	4.8	0.1	2.0	0.6	1.4	1.5	1.5	6.1	5.4	5.5	7.1	5.9	6.6	7.8	8.0	7.0	7.6	6.2	6.1	2.2	0.0	4.1	2.6	3.4	1.7	6.4	6.4	2.8	0.3	3.8	3.4	24.7	7.2	3.7	5.5	8.4	6.0	2.3	3.0	13.7	4.6	1073.6	14.9	1.6	4.1	0.0	0.8	1.0	1.8	3.2	2.2	2.0	2.4	0.0	3.6	4.2	3.7	5.2	1.7	1.3	1.5	2.0	2.7	1.4	2829.6	14.3	2.4	1.8	0.0	1.5	3.3	7.2	0.5	0.9	2.6	3.1	13.5	1.7	3.3	6.8	36.5	20.8	1.4	26.3	3.7	4.1	75.0	18.2	2.4	1.8	4.5	3.2	8.5	3.1	5.4
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696357-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.7	5.1	5.7	2.3	6.6	5.0	4.9	4.8	8.7	3.9	5.2	6.2	5.9	6.1	0.7	5.8	6.2	2.2	4.9	8.0	4.9	10.3	13.6	7.1	1.5	4.9	3.8	5.4	14.2	2.2	16.7	1.8	3.1	5.9	0.8	0.6	5.7	1.3	1.3	7.7	7.1	1.4	2.6	6.0	6.9	4.9	4.2	1.7	7.0	0.3	0.8	3.8	3.5	6.3	7.4	5.8	2.0	9.6	1.5	1.6	10.7	4.9	2.3	2.3	1.5	11.1	6.2	2.5	6.6	1.6	3.1	12.5	1.8	2.8	0.5	2.5	19.9	1.7	2.2	15.3	5.1	1.3	5.0	1.6	3.5	3.6	1.1	2.6	2.6	2.9	7.7	1.7	1.6	34.0	4.3	8.0	5.4	7.6	7.5	9.4	1.0	7.4	3.4	2.6	11.0	7.0	5.3	5.4	6.5	0.9	14.0	5.7	6.7	2.3	8.5	0.4	2.3	4.2	2.8	2.3	6.9	4.1	4.4	2.8	4.0	5.3	5.5	6.5	3.9	3.7	3.9	4.2	4.4	4.1	3.5	3.9	13.7	2.1	4.9	4.6	3.7	4.1	5.7	6.6	4.8	8.7	8.0	4.9	4.9	3.8	3.1	2.6	4.2	6.3	5.9	3.2	0.5	2.3	10.8	15.7	18.7	7.7	5.2	9.5	11.0	6.6	0.4	7.2	3.1	11.0	0.0	8.7	18.4	27.8	1.9	13.7	7.4	7.6	3.2	6.3	23.8	0.0	13.6	13.8	5.7	6.4	9.2	9.3	4.5	2.1	6.1	5.7	7.4	3.3	7.1	7.6	14.2	6.1	13.2	1.5	2.8	9.1	8.8	2.8	4.3	6.6	8.2	2.5	1.3	12.7	21.8	2.2	8.6	12.7	32.3	10.3	1.5	8.0	0.0	9.3	7.0	2.7	2.5	2.6	19.9	24.9	10.5	4.7	9.3	11.7
SPATA3	TSARG1	ENSG00000173699	"Spermatogenesis associated 3"	Q8NHX4	2	230990324-231025055	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	179	"testis: 176.7"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 5258.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018254	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA018254: AB_1857419"					"unprognostic (6.94e-3)"									"unprognostic (6.98e-2)"	"unprognostic (9.62e-2)"			0.0	0.0	0.4	0.0	0.5	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	176.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.4	0.5	0.5	0.5	0.6	0.4	0.2	0.9	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	783.7	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5258.5	22.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	23.9	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31D1	"FAM75D1, FLJ46321"	ENSG00000214929	"SPATA31 subfamily D member 1"	Q6ZQQ2	9	81988772-81995253	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	112	"testis: 11.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047897	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA047897: AB_2680204"															"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31E1	"C9orf79, FAM75E1, FLJ35866"	ENSG00000177992	"SPATA31 subfamily E member 1"	Q6ZUB1	9	87882877-87888903	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 7.5;testis: 7.6"	"Group enriched"	"Detected in some"	95	"Early spermatids: 43.3;Late spermatids: 14.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"hippocampal formation: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.7;SCLC-21H: 1.4"	"Low region specificity"	"Detected in some"							HPA024253	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA024253: AB_1845839"													"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SPATA32	"AEP2, C17orf46, FLJ25414, TEX34, VAD1.2"	ENSG00000184361	"Spermatogenesis associated 32"	Q96LK8	17	45254393-45262094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	76	"testis: 43.6"	"Group enriched"	"Detected in some"	98	"Early spermatids: 194.2;Late spermatids: 615.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA024549	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA024549: AB_1845589"	"unprognostic (5.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.79e-4)"	"unprognostic (7.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.87e-3)"	"unprognostic (8.93e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.75e-4)"	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	194.2	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	615.3	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	2.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657740-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"testis: 114.0"	"Group enriched"	"Detected in all"	8	"Early spermatids: 1778.0;Late spermatids: 4200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: AB_2686570"	"unprognostic (1.05e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	3.6	4.2	7.0	2.8	7.0	3.4	4.3	6.1	8.9	5.1	9.1	5.2	5.0	4.5	8.9	5.3	12.6	2.8	4.0	7.6	6.6	11.8	6.2	5.9	2.4	6.7	7.1	3.2	5.1	3.6	9.7	1.8	6.7	6.4	2.9	6.7	4.3	2.5	2.0	4.3	9.2	2.4	5.5	5.8	5.0	114.0	6.8	3.6	8.3	1.2	2.9	4.3	4.8	6.7	11.1	11.8	13.4	5.5	3.5	3.1	4.9	7.8	2.5	10.6	4.7	11.5	10.6	1.2	3.8	5.0	8.0	15.1	6.2	3.7	8.5	2.2	9.7	2.0	17.4	16.1	1.5	2.3	4.5	3.1	5.1	7.9	3.2	4.0	2.3	11.0	12.6	1.9	7.1	14.7	7.4	6.6	7.3	7.3	9.3	14.3	7.4	4.0	6.2	3.9	13.2	7.0	17.9	3.0	4.4	6.3	13.5	3.3	2.8	7.8	10.7	6.9	5.9	4.4	7.1	4.4	8.1	14.5	3.5	2.4	1.1	2.1	1.6	1.3	2.2	2.3	1.7	2.2	0.9	0.9	1.8	1.4	1.4	3.2	1.0	2.0	1.2	1.4	7.0	7.0	6.1	8.9	7.6	6.6	6.7	7.1	6.7	5.5	6.8	6.7	14.7	6.4	9.7	4.6	10.3	7.1	8.6	16.4	8.0	18.2	14.9	14.7	6.6	15.7	13.5	29.5	64.6	4.1	10.2	16.0	23.5	15.9	1778.0	94.9	13.3	13.3	17.5	22.7	7.0	17.7	5.6	13.0	32.1	11.9	1.3	11.4	8.9	14.6	9.0	23.5	4.4	9.9	12.2	2.9	8.0	4200.3	30.4	9.5	17.8	3.7	5.8	17.0	16.5	1.0	5.1	14.2	18.9	23.7	11.1	6.7	35.6	33.4	97.8	82.5	13.1	11.8	11.4	348.5	101.2	13.5	7.1	1.4	12.8	13.9	17.1	5.5
SPATA4	"CFAP178, FAP178, SPEF1B, TSARG2"	ENSG00000150628	"Spermatogenesis associated 4"	Q8NEY3	4	176184579-176195585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 139.5"	"Group enriched"	"Detected in some"	12	"Early spermatids: 1074.2;Late spermatids: 496.7;Spermatocytes: 460.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.4;U-87 MG: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019220	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA019220: AB_1857420"	"unprognostic (1.97e-3)"	"unprognostic (6.08e-2)"		"unprognostic (2.83e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-2)"		"unprognostic (1.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-3)"	"unprognostic (9.77e-2)"	"unprognostic (4.38e-6)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.59e-1)"	0.0	0.4	0.8	0.0	0.9	0.1	0.6	0.9	1.0	0.3	1.4	0.4	0.0	0.3	3.6	0.1	8.7	0.2	0.4	0.8	1.0	2.2	0.0	1.2	0.0	1.6	1.9	0.2	0.4	0.4	1.0	0.0	1.1	0.2	0.0	2.3	0.3	0.5	1.1	0.1	0.1	0.2	1.2	0.0	0.1	139.5	1.1	0.0	1.7	0.4	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.9	0.9	1.0	0.8	1.0	1.6	1.9	1.1	1.2	1.1	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.1	2.2	0.0	0.5	1.0	1.4	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.9	0.5	1074.2	20.0	0.3	0.7	0.0	0.0	1.1	0.0	0.0	0.2	2.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.0	2.0	0.0	0.0	496.7	11.5	1.3	0.0	0.0	0.0	1.9	0.0	1.0	0.5	1.5	0.0	8.2	0.0	0.1	0.0	10.7	52.3	3.1	0.0	0.5	1.3	460.1	11.3	0.0	0.0	0.0	0.1	0.5	0.1	0.1
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 2.9;testis: 11.8"	"Group enriched"	"Detected in some"	24	"Early spermatids: 151.6;Late spermatids: 139.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-698: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049921	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles, Cytosol"		"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.2	0.1	0.3	0.1	0.5	0.3	0.3	0.4	0.9	0.1	0.0	0.3	0.1	0.3	0.7	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.4	0.4	0.8	0.7	0.4	0.1	2.9	0.1	0.3	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.5	0.5	0.5	0.2	11.8	0.6	0.1	0.4	0.5	0.4	0.2	0.0	0.7	0.1	1.5	0.3	0.9	0.2	0.7	0.9	0.1	0.0	0.3	0.4	0.3	0.2	0.3	0.0	0.0	0.6	0.1	0.6	0.0	0.3	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.6	0.8	0.9	0.1	0.3	0.2	0.3	0.5	0.8	0.1	0.0	0.7	0.1	0.3	1.0	0.6	0.0	0.0	0.3	0.2	0.5	0.0	0.3	0.0	0.7	0.4	0.4	0.7	1.7	0.1	0.6	0.4	0.0	0.1	1.6	0.2	0.3	0.3	0.1	0.0	0.0	0.2	1.1	0.2	0.3	0.8	0.1	0.2	0.0	0.1	0.1	0.3	0.5	0.4	0.9	0.2	0.4	0.7	0.4	0.5	0.5	0.6	0.7	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	5.9	0.0	151.6	0.1	0.0	0.2	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	139.9	1.5	0.2	0.0	1.0	0.6	0.0	0.0	1.0	2.1	0.1	0.0	0.4	0.0	0.0	0.8	0.3	1.5	0.0	0.0	0.0	0.1	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SPATA48	C7orf72	ENSG00000164500	"Spermatogenesis associated 48"	A4D263	7	50095883-50159256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"U-698: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026094	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA026094: AB_1859516"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402336-45421415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	4.5	4.9	4.7	4.6	5.1	6.3	4.5	5.5	6.2	5.5	4.4	5.2	5.9	4.4	3.9	10.0	5.0	2.7	5.7	4.9	5.0	6.0	7.5	3.3	4.6	4.9	4.8	6.1	5.8	4.3	3.1	5.2	5.0	4.2	4.8	4.6	4.4	3.9	8.9	7.4	5.5	4.4	5.0	4.5	4.5	3.4	5.2	4.9	5.3	5.4	5.0	5.4	6.0	5.6	10.0	6.3	9.9	7.3	8.0	7.8	12.0	8.7	7.9	9.3	9.0	17.3	6.3	7.3	9.5	5.8	16.9	22.5	14.8	10.9	10.3	10.0	8.4	9.5	11.2	13.6	9.0	12.8	4.0	6.2	12.2	7.7	10.1	10.6	7.4	9.4	15.6	11.4	10.5	6.7	8.9	24.5	7.1	24.8	9.7	9.8	13.9	6.8	11.7	9.8	13.5	6.9	7.2	15.5	8.4	11.7	13.7	23.1	4.7	4.5	6.9	27.8	18.8	9.7	20.8	11.3	11.6	20.8	8.3	0.0	0.9	1.2	1.1	0.7	0.4	0.6	0.7	1.5	0.9	0.7	0.6	0.9	1.1	1.1	1.9	1.0	0.8	0.2	4.7	5.1	5.5	6.2	4.9	5.0	4.9	4.8	5.0	5.0	5.2	5.6	4.7	0.0	1.1	7.2	8.9	5.0	8.9	4.6	5.2	7.9	3.7	2.4	6.9	7.2	5.2	3.7	16.7	12.2	7.3	5.4	3.9	6.2	20.6	6.2	5.4	6.3	3.6	2.5	11.0	7.3	11.9	5.2	9.2	8.4	4.5	8.6	1.1	5.7	8.0	6.7	10.1	6.3	0.0	3.7	7.6	7.1	7.8	7.7	3.6	6.5	7.7	5.0	2.1	16.6	14.6	5.5	3.1	3.8	8.5	6.2	9.2	5.7	2.4	6.5	0.0	4.1	4.1	6.2	5.6	10.4	6.8	6.7	5.8	6.1	7.3	8.2
SPATA6L	"C9orf68, FLJ10058"	ENSG00000106686	"Spermatogenesis associated 6 like"	Q8N4H0	9	4553386-4666674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.1;Late spermatids: 102.8;Respiratory ciliated cells: 40.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;CAPAN-2: 2.4;HDLM-2: 1.4;HeLa: 1.1;RPTEC TERT1: 1.7;SCLC-21H: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039585	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"			"HPA039585: AB_10674984"	"unprognostic (8.18e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.03e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-3)"	0.8	0.4	1.2	0.2	1.3	0.0	1.2	1.8	1.5	1.1	3.0	0.7	0.9	0.4	0.2	1.0	3.6	1.4	0.5	1.3	1.5	2.2	5.3	1.5	0.2	1.9	2.5	0.5	2.8	0.5	4.4	0.4	1.4	1.2	0.3	0.5	0.7	0.5	0.1	0.9	1.4	0.1	1.3	0.2	1.3	5.4	2.0	0.0	2.3	0.0	0.1	0.9	0.9	1.1	0.5	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	1.7	0.0	1.5	0.8	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.3	1.8	1.5	1.3	1.5	1.9	2.5	1.4	1.3	2.0	1.1	4.3	9.6	12.6	21.9	0.1	0.6	2.8	7.8	1.8	2.9	2.5	1.3	2.0	12.8	10.2	3.7	12.5	2.6	0.8	1.3	3.9	6.6	120.1	21.0	0.8	5.4	0.0	0.8	24.6	5.3	0.3	1.2	8.6	3.1	1.3	1.5	3.3	11.8	0.6	0.0	27.6	6.0	12.2	0.0	1.2	102.8	1.8	0.4	0.0	9.4	0.1	1.1	0.0	10.6	10.0	4.2	3.7	2.6	0.3	2.1	6.5	2.9	40.4	0.8	0.0	1.7	1.5	9.7	3.7	2.9	1.1	2.1	1.3	0.9	2.7	2.6
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 946.9;Late spermatids: 1152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	5.8	6.0	8.6	1.6	10.4	1.7	6.0	28.4	9.5	7.2	6.7	5.8	2.2	6.6	7.0	2.8	8.3	5.5	5.4	8.6	10.4	9.5	5.1	4.6	1.8	8.6	9.2	12.3	7.9	7.6	11.1	2.8	8.6	6.6	3.1	10.2	4.1	4.6	5.0	5.6	3.2	4.7	8.9	3.6	5.0	57.0	9.2	3.0	12.1	4.5	1.2	5.4	4.9	11.2	2.3	3.7	5.5	7.5	8.8	16.5	6.0	5.2	9.3	5.1	3.4	1.2	4.5	2.2	2.5	5.7	3.8	2.3	2.5	4.0	4.8	3.2	1.8	0.5	1.9	2.1	12.7	3.9	0.5	7.8	6.6	2.1	3.9	16.8	9.4	5.0	1.3	2.7	4.8	2.8	2.8	3.7	1.4	2.9	4.6	3.9	5.6	1.3	8.1	1.9	3.9	4.9	5.1	6.7	5.0	6.5	6.0	4.2	4.9	3.7	4.0	5.2	2.9	2.6	2.1	1.3	6.2	1.1	2.6	0.0	1.0	0.2	2.1	1.4	2.5	1.9	1.7	1.0	2.1	0.4	1.0	1.8	0.8	0.4	0.9	2.1	0.7	1.0	8.6	10.4	28.4	9.5	8.6	10.4	8.6	9.2	8.6	8.9	9.2	11.2	7.8	12.8	7.3	38.5	1.5	2.4	7.6	9.8	7.4	10.8	6.3	8.5	12.0	7.2	8.8	3.7	20.9	2.6	5.3	1.1	9.8	11.0	946.9	22.3	13.2	6.8	16.3	1.3	113.0	7.2	3.6	11.8	4.1	4.2	1.3	19.4	7.9	4.5	5.7	15.2	91.6	4.0	12.2	17.2	2.8	1152.6	20.5	6.7	8.8	25.3	4.0	12.5	2.1	49.8	54.7	5.6	4.3	17.0	0.9	3.0	1.4	26.0	32.7	20.5	6.6	15.0	7.9	37.5	14.7	3.0	2.0	1.1	3.3	20.5	4.5	3.3
SPATA9	"FLJ35906, NYD-SP16"	ENSG00000145757	"Spermatogenesis associated 9"	Q9BWV2	5	95652181-95698711	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 26.7"	"Group enriched"	"Detected in some"	18	"Early spermatids: 580.3;Late spermatids: 498.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.0;THP-1: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010848, HPA076967"	Approved		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA010848: AB_1857422, HPA076967: "	"unprognostic (4.46e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.49e-13)"	"unprognostic (3.39e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-2)"	1.1	0.3	0.1	0.1	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.4	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.0	26.7	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.3	0.1	0.2	1.0	0.0	0.5	0.0	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.2	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.9	0.3	0.0	0.0	0.1	580.3	0.3	0.5	0.2	0.0	0.0	1.9	0.0	29.2	0.4	0.0	0.2	0.0	0.9	0.0	0.1	1.3	1.7	2.6	0.1	0.0	0.3	0.0	498.7	3.7	0.2	0.0	3.7	0.1	0.5	2.1	14.1	1.7	0.0	0.4	3.4	0.1	0.3	0.1	0.0	0.2	0.4	0.0	1.7	0.3	7.7	3.2	0.0	0.1	4.2	0.1	0.6	0.2	0.2
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 208.9;Late spermatids: 472.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 3.7;cerebral cortex: 4.8;hippocampal formation: 2.9"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 36.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	7.6	23.4	4.2	1.0	3.7	1.3	8.5	0.0	4.8	11.4	0.0	9.7	1.3	9.8	0.6	7.7	6.8	1.4	11.5	2.9	0.6	7.3	1.3	5.9	1.6	0.4	0.1	13.9	11.3	1.6	14.2	1.1	0.1	32.5	0.7	0.3	6.7	2.5	5.6	10.5	6.9	0.8	0.0	8.4	8.3	48.9	0.9	1.0	6.3	0.8	1.0	9.8	11.7	0.1	2.9	0.0	3.6	6.7	2.0	4.7	1.9	4.1	2.2	2.2	1.7	0.0	1.8	9.0	8.0	5.0	2.6	0.5	0.0	3.2	0.6	8.3	6.6	21.6	1.3	5.0	0.1	0.0	8.5	5.0	1.5	0.0	0.0	4.2	7.2	10.1	37.8	13.2	3.1	5.7	7.0	2.5	15.0	4.0	18.0	15.4	4.9	10.0	3.4	0.8	1.1	6.9	3.2	1.7	8.6	2.5	5.6	8.3	0.4	6.5	8.0	9.3	6.3	21.9	12.6	6.6	8.6	11.9	6.1	1.5	5.7	36.1	4.3	6.8	5.6	7.6	6.2	5.9	8.6	7.6	9.7	9.2	0.3	6.6	4.7	7.2	7.0	3.6	4.2	3.7	0.0	4.8	2.9	0.6	0.4	0.1	0.1	0.0	0.9	0.1	20.5	0.0	0.0	3.6	13.5	23.6	11.6	21.4	18.2	6.8	11.9	14.6	1.9	12.8	6.9	3.7	0.0	3.4	10.1	7.7	15.6	16.8	208.9	6.3	14.6	15.4	60.4	12.8	2.6	20.5	17.7	18.1	13.7	8.8	0.0	18.8	14.6	0.6	13.7	3.3	2.0	16.4	8.2	8.8	24.4	472.3	32.3	9.9	28.4	1.0	5.9	5.8	6.2	3.0	3.1	17.8	6.6	31.6	28.0	24.1	6.8	13.4	2.8	3.1	19.7	12.0	14.0	17.8	14.7	17.0	40.1	3.1	11.7	4.0	18.3	8.1
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342650-44380179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 5.9;fallopian tube: 7.6;testis: 22.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 30.9;Late spermatids: 12.1;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SK-MEL-30: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.1	0.7	0.0	0.7	0.2	0.0	0.6	0.8	0.2	0.7	0.0	0.0	0.2	5.9	0.0	7.6	0.0	0.1	0.8	0.8	0.0	0.0	0.6	0.1	1.4	2.1	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.1	22.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.1	7.9	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.7	0.7	0.6	0.8	0.8	0.8	1.4	2.1	1.2	1.3	0.7	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 144.8;Spermatogonia: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 6.0;dendritic cells: 8.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	7.8	9.1	10.3	11.0	6.5	9.4	15.3	12.8	12.8	10.9	11.0	11.6	11.1	7.9	6.8	6.9	11.1	7.1	11.5	6.2	9.6	4.8	8.0	15.7	10.7	7.8	8.0	12.2	21.5	13.8	8.9	11.1	9.9	11.5	10.1	18.4	6.1	11.1	16.3	10.3	11.3	4.4	10.8	13.1	26.1	8.1	13.2	12.9	6.4	18.1	10.3	13.1	10.4	17.9	39.7	33.2	38.7	19.1	29.3	10.7	20.8	29.8	34.2	29.6	36.0	39.0	44.4	47.5	18.4	22.5	20.8	28.9	39.1	43.8	33.9	17.2	40.4	28.2	29.1	34.7	11.1	23.1	25.6	19.0	53.8	50.9	111.8	82.0	19.8	21.7	38.9	35.2	32.3	22.7	16.5	34.2	29.0	40.1	32.7	56.5	53.4	31.9	22.5	37.2	33.4	45.4	28.6	49.0	20.4	49.2	12.0	75.7	15.1	36.5	13.5	13.2	52.4	65.7	37.5	19.7	18.6	22.0	1.6	1.3	0.3	1.7	0.4	1.7	6.0	1.4	1.0	4.1	3.2	1.2	1.0	0.9	1.3	0.3	8.0	1.1	1.1	9.1	11.0	15.3	12.8	11.5	6.2	10.7	7.8	11.1	4.4	8.1	10.4	35.0	19.2	19.8	34.6	33.8	58.0	48.8	52.0	25.0	44.5	29.9	29.8	9.9	35.8	19.6	36.8	22.9	9.7	19.2	9.6	5.9	26.0	77.4	28.3	63.1	44.6	36.6	22.7	114.0	27.9	12.0	34.8	23.0	45.1	10.8	37.1	29.3	5.6	8.0	42.1	67.6	21.6	20.3	9.2	39.8	46.3	31.7	15.3	19.6	27.2	15.0	22.3	16.5	59.3	30.6	46.4	11.7	33.4	144.8	36.4	13.3	12.4	10.1	5.9	52.6	20.5	27.7	137.3	138.1	17.0	60.4	5.3	16.2	31.5	30.2	29.4
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 478.4;Paneth cells: 467.4;Proximal tubular cells: 568.2;Skeletal myocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 16.8;granulocytes: 48.0;T-cells: 31.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 475.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	47.1	27.0	36.9	37.2	38.4	10.4	31.7	35.2	48.6	77.5	44.2	85.5	82.1	37.5	26.6	65.3	81.6	114.8	117.3	41.4	41.0	70.0	110.3	47.6	24.1	42.1	45.0	66.0	60.6	41.9	40.4	68.8	44.0	50.7	83.2	16.5	166.1	67.8	70.6	33.6	82.8	51.3	43.6	39.1	101.4	28.9	39.9	40.8	42.9	36.3	22.9	81.2	45.7	46.7	174.8	94.6	113.0	13.8	74.0	96.4	43.4	299.6	100.1	193.2	143.8	262.6	190.0	1.0	69.1	197.4	108.5	167.5	35.2	186.9	130.4	109.5	47.2	1.4	80.0	315.2	138.8	28.9	12.3	121.4	182.5	134.3	128.3	138.0	75.4	21.6	41.1	119.0	280.0	55.4	4.4	8.3	28.2	303.4	226.7	0.6	388.2	11.1	475.5	134.2	3.1	31.9	77.0	45.5	127.0	165.3	23.9	39.5	120.9	131.3	129.3	41.4	170.9	34.9	36.3	2.2	104.1	14.1	179.5	48.0	5.2	7.6	5.8	5.9	14.0	2.8	6.3	6.0	16.8	3.3	2.6	3.1	4.2	6.8	4.7	12.8	31.6	2.8	36.9	38.4	35.2	48.6	41.4	41.0	42.1	45.0	44.0	43.6	39.9	46.7	83.4	86.6	26.2	104.5	11.2	91.1	262.5	123.6	67.7	21.4	63.2	51.4	127.8	403.2	70.3	172.9	12.5	19.4	9.5	478.4	111.6	157.7	75.9	129.8	59.4	64.2	55.1	15.1	116.4	147.0	38.2	101.8	151.9	56.9	56.5	51.4	94.2	230.0	82.5	60.6	202.9	246.6	54.9	139.6	98.1	22.4	165.6	56.1	128.1	68.4	18.0	8.7	2.1	79.9	106.5	210.8	467.4	142.1	9.4	284.9	153.2	568.2	167.1	56.4	78.9	470.9	89.3	38.0	82.6	68.4	77.9	9.9	28.2	6.6	78.4	198.8
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25 component of NDC80 kinetochore complex"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.5;Erythroid cells: 29.9;Extravillous trophoblasts: 37.9;Muller glia cells: 17.2;Spermatocytes: 26.2;Spermatogonia: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.74e-6)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.6	0.8	0.6	0.7	0.6	4.2	1.0	0.3	1.5	0.7	0.5	2.1	3.7	0.5	0.0	4.4	0.3	0.5	0.4	1.6	0.7	1.1	0.8	0.9	3.9	0.6	0.7	0.5	1.3	0.1	0.1	1.1	0.8	0.4	1.6	1.7	1.0	0.0	0.6	1.1	2.1	1.0	0.1	2.1	1.6	3.4	0.6	8.5	0.2	0.1	3.7	0.5	1.5	1.8	1.0	16.8	40.6	22.8	1.8	1.9	14.5	22.9	9.3	23.5	18.1	5.6	16.2	15.7	9.0	3.4	31.9	20.9	15.9	0.0	20.7	10.0	21.5	30.2	7.2	2.2	0.1	20.3	8.9	0.3	1.0	14.3	0.0	4.7	10.3	28.2	0.8	15.7	6.4	9.8	16.1	26.3	0.9	11.2	21.0	28.8	38.1	5.6	9.6	13.7	30.4	0.5	16.8	14.4	3.9	13.5	0.4	16.4	2.5	3.6	42.1	13.4	18.2	31.4	56.0	12.5	4.1	0.5	14.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.6	0.6	0.3	1.5	1.6	0.7	0.6	0.7	0.8	0.1	0.6	1.8	0.4	0.0	1.1	0.7	4.2	5.4	1.5	7.1	1.2	0.0	1.5	2.4	0.6	0.0	2.6	0.0	0.0	23.5	1.5	3.7	0.0	0.2	2.0	0.5	1.8	1.6	0.0	29.9	0.3	0.0	37.9	4.6	2.0	1.8	0.0	10.1	2.9	1.2	15.1	0.0	0.5	5.2	2.0	1.9	2.4	1.6	0.6	2.0	0.0	0.0	0.0	17.2	0.0	5.0	0.2	0.5	0.1	1.2	15.3	1.0	1.0	0.2	0.1	0.6	0.0	1.3	4.4	26.2	20.1	7.3	1.4	5.7	2.7	1.7	9.9	2.5
SPCS1	"HSPC033, SPC1, SPC12, YJR010C-A"	ENSG00000114902	"Signal peptidase complex subunit 1"	Q9Y6A9	3	52704955-52711148	"Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046091, HPA055273"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA046091: AB_10959614, HPA055273: AB_2682768"	"unprognostic (5.47e-2)"	"unprognostic (4.04e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.09e-2)"	95.3	154.7	75.1	64.1	76.6	61.3	100.5	80.7	101.1	97.4	88.7	110.1	94.8	101.0	110.8	117.0	92.1	48.4	119.7	75.4	83.9	137.3	172.8	87.8	71.2	82.3	80.5	91.1	231.2	89.5	141.1	59.4	82.1	96.3	84.7	124.6	145.2	79.1	142.2	109.0	103.9	53.0	81.7	105.6	151.1	153.2	81.4	66.6	113.2	49.7	87.1	103.0	94.7	84.9	114.6	102.2	113.4	139.3	164.9	134.4	157.2	157.6	144.5	139.4	128.4	108.1	171.0	114.6	65.7	145.4	142.5	110.2	109.9	142.5	149.1	154.3	115.8	138.6	169.2	164.6	175.1	213.3	229.1	104.7	190.5	148.5	174.4	130.5	117.4	147.5	118.8	418.0	151.8	105.5	168.8	207.2	195.8	317.2	203.9	67.9	95.7	608.6	232.7	148.3	73.6	157.4	148.7	178.1	224.2	102.4	188.1	248.1	106.2	127.3	119.1	226.3	192.1	406.2	654.1	169.8	196.5	209.4	169.8	292.7	129.9	258.2	131.1	137.0	155.1	202.0	158.5	144.2	143.9	149.3	146.8	152.1	100.1	119.6	152.5	620.5	177.1	253.8	75.1	76.6	80.7	101.1	75.4	83.9	82.3	80.5	82.1	81.7	81.4	84.9	172.5	64.1	104.2	23.8	282.3	156.5	227.9	470.7	136.1	465.4	289.0	351.0	148.7	221.6	283.6	310.8	118.9	373.5	488.1	195.2	361.9	353.8	597.8	286.4	180.8	157.6	167.7	143.9	27.1	339.4	399.8	181.9	119.8	181.5	211.6	138.7	131.4	301.8	311.0	102.6	34.4	291.3	325.5	202.9	189.9	1177.6	216.3	192.5	380.6	13.1	321.9	296.9	213.1	21.1	53.2	274.8	274.1	191.8	888.8	295.0	405.5	665.1	374.1	251.3	164.3	152.6	335.5	746.4	504.5	195.8	184.4	351.2	220.8	283.6	267.7	285.3
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979033	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 933.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013386	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	81.0	99.4	86.4	104.9	96.6	60.1	108.2	98.7	131.1	127.5	88.8	119.3	90.5	92.2	220.1	72.8	95.9	66.5	76.2	86.3	102.7	105.6	151.6	79.5	98.2	98.5	93.3	84.3	137.3	147.7	75.1	81.2	98.9	106.9	115.1	75.4	139.0	93.3	71.4	56.6	83.3	93.1	99.7	92.5	105.5	50.4	94.3	97.8	143.9	69.5	154.8	95.0	68.1	107.7	141.7	163.4	213.2	192.2	183.2	122.0	115.9	198.6	192.4	179.0	154.8	322.9	311.7	228.2	244.1	168.9	213.6	254.2	187.3	146.1	220.5	190.0	136.4	232.2	189.7	268.9	208.1	249.3	156.7	109.7	186.1	151.5	245.5	156.8	173.7	166.6	271.9	578.0	163.9	215.0	179.1	158.0	131.0	558.3	153.5	219.2	328.2	522.4	208.2	232.3	172.3	172.6	198.1	262.9	687.6	146.7	254.1	187.6	142.0	201.9	124.9	212.1	177.5	245.1	268.8	423.8	83.0	173.4	209.4	546.3	229.2	219.2	279.8	231.0	315.2	400.7	253.7	269.4	222.0	344.3	191.7	229.5	148.5	260.9	209.8	459.5	272.0	428.3	86.4	96.6	98.7	131.1	86.3	102.7	98.5	93.3	98.9	99.7	94.3	107.7	192.3	86.6	143.6	40.5	323.2	304.5	314.0	812.0	129.7	97.6	212.6	199.9	69.1	214.4	406.0	239.1	52.1	330.8	233.5	130.3	189.8	290.0	36.5	126.4	250.4	181.4	125.4	191.5	46.6	288.0	334.4	239.4	104.5	240.2	155.2	114.7	158.1	338.0	278.9	95.9	55.4	255.1	431.3	140.1	283.3	27.2	240.8	159.7	521.2	23.4	188.6	215.6	197.8	48.7	73.5	253.2	140.0	195.6	933.5	355.5	141.7	280.8	231.1	87.3	170.9	153.6	253.6	127.8	133.1	112.1	229.4	464.8	204.6	192.2	189.5	298.1
SPCS3	"FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W"	ENSG00000129128	"Signal peptidase complex subunit 3"	P61009	4	176319966-176332245	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 374.4"					"Low region specificity"	"Detected in all"			HPA053180	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053180: AB_2682071"	"unprognostic (4.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-3)"	"prognostic favorable (8.89e-6)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.44e-1)"	33.0	24.6	13.9	50.6	16.0	68.1	36.0	15.5	18.0	46.6	15.1	37.0	34.5	38.5	47.5	25.0	25.5	32.0	37.6	17.3	17.1	34.1	43.6	36.1	50.3	15.9	25.6	21.6	72.8	31.3	30.1	45.5	16.1	32.9	37.5	13.5	99.1	30.0	24.1	26.9	36.9	34.8	18.1	46.5	48.9	10.7	16.3	34.8	62.2	26.4	48.2	41.1	25.6	21.2	64.9	21.5	57.8	47.8	80.9	142.5	61.0	125.2	119.1	71.4	61.4	23.5	139.1	124.2	25.1	72.7	37.6	43.6	55.3	92.1	108.0	84.2	24.3	107.6	32.2	53.5	82.5	162.3	90.9	86.9	99.4	63.4	60.9	79.8	107.1	59.4	70.2	374.4	99.4	39.7	100.1	61.4	39.5	45.6	21.0	48.7	89.8	109.3	87.7	46.5	46.1	42.2	130.6	96.4	58.8	49.8	31.1	75.1	100.2	52.5	52.8	47.4	58.2	172.3	54.7	153.8	112.0	80.6	74.1	43.0	16.1	14.2	15.2	19.3	20.2	10.0	14.0	13.9	12.2	6.8	11.6	14.5	16.2	16.6	16.1	22.6	11.9	19.2	13.9	16.0	15.5	18.0	17.3	17.1	15.9	25.6	16.1	18.1	16.3	21.2	121.4	54.5	86.3	19.2	150.0	57.2	67.4	111.8	25.0	31.3	62.9	52.1	79.5	32.9	84.1	29.5	27.1	64.1	170.0	55.2	21.5	76.4	66.8	49.3	130.6	109.3	44.9	61.4	40.9	136.1	205.1	66.2	70.3	102.2	91.2	36.3	88.9	123.8	153.2	23.5	37.3	102.1	89.5	100.8	98.4	14.4	22.4	127.9	110.3	29.0	105.8	31.2	74.2	41.2	59.1	157.0	36.0	17.0	670.6	173.8	48.1	71.6	54.5	31.0	13.1	46.4	64.8	95.4	56.4	58.7	65.1	184.4	107.0	51.8	53.3	147.1
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583636-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 38.4;Spermatocytes: 112.9;Spermatogonia: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol		NA	Yes			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA044700: AB_2679052, HPA048146: AB_2680284"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	3.9	3.6	5.5	9.4	6.0	10.9	5.5	6.1	7.2	3.4	3.4	5.4	5.7	6.2	3.8	5.8	4.4	4.5	3.4	4.7	5.6	4.8	3.2	4.0	14.9	6.0	5.5	6.7	2.5	5.0	2.4	8.4	6.1	3.3	5.7	3.4	3.2	3.1	5.3	5.5	5.3	7.4	7.1	6.6	5.3	35.5	5.4	21.5	4.3	5.9	14.0	4.8	3.8	7.2	57.0	69.2	67.4	47.6	17.6	18.5	59.1	181.1	22.9	128.1	119.0	89.6	38.8	54.3	116.9	147.0	90.3	39.3	56.8	76.0	139.6	58.1	65.2	59.6	117.0	36.2	8.3	66.9	51.3	9.2	6.2	62.2	34.0	29.0	59.9	60.5	41.3	39.3	142.4	58.5	54.1	28.2	50.1	28.9	63.2	64.8	67.6	38.5	89.7	19.8	43.7	31.4	84.9	23.6	34.5	46.9	27.0	44.9	46.3	146.6	46.8	43.4	140.0	30.1	69.2	69.1	35.4	61.9	50.2	4.0	2.7	3.8	8.4	3.6	8.9	11.2	7.9	8.9	2.8	12.7	10.8	9.1	0.5	8.4	6.2	19.7	8.6	4.1	5.5	6.0	6.1	7.2	4.7	5.6	6.0	5.5	6.1	7.1	5.4	7.2	6.1	3.2	6.3	3.9	8.7	4.0	1.7	4.8	4.6	6.9	6.2	7.5	7.1	2.8	7.0	1.8	0.0	14.1	9.8	3.6	5.9	6.6	9.6	5.3	8.0	6.5	1.8	22.3	6.2	4.8	26.1	7.7	12.2	4.9	8.8	38.4	13.2	3.2	12.2	3.3	6.5	3.2	2.0	4.7	3.6	11.1	4.4	4.7	3.6	2.8	5.0	7.4	13.4	5.0	6.8	6.6	1.9	6.4	10.2	1.6	0.5	8.2	4.1	4.4	6.6	6.4	9.9	112.9	59.2	5.8	4.4	4.9	5.2	9.6	7.4	2.5
SPDYA	"Ringo3, SPDY1, SPY1"	ENSG00000163806	"Speedy/RINGO cell cycle regulator family member A"	Q5MJ70	2	28782517-28850611	"Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 32.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 58.8;Spermatocytes: 225.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;THP-1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035162, HPA066214"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035162: AB_2674501, HPA066214: AB_2685636"	"unprognostic (3.41e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.10e-4)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.66e-13)"	"unprognostic (8.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.55e-5)"	0.8	0.9	0.2	0.2	0.2	0.6	0.7	0.2	0.3	1.8	0.0	0.8	0.5	0.7	0.0	0.9	0.9	0.5	0.8	0.3	0.0	1.7	1.4	0.7	0.5	0.0	0.0	1.4	0.8	0.0	1.4	0.2	0.0	1.7	0.0	1.0	0.7	0.0	0.3	1.6	0.9	0.0	0.0	1.8	0.8	32.5	0.1	0.0	1.2	0.0	0.0	0.7	1.0	0.1	0.4	0.2	0.7	1.6	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.4	0.3	0.3	0.5	0.0	0.4	1.0	0.1	0.0	0.1	0.2	0.4	0.3	1.0	1.3	0.0	0.5	0.7	0.1	0.0	0.1	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.2	0.1	2.6	0.2	0.1	0.1	0.3	1.2	0.4	0.5	0.3	0.5	0.3	0.8	1.0	0.3	0.7	0.3	2.5	0.1	1.2	1.0	0.6	0.6	0.3	0.7	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	3.2	0.5	6.5	2.6	0.3	1.0	0.4	0.6	0.8	3.7	3.8	0.6	0.0	1.4	1.8	6.2	0.1	2.1	2.1	0.0	0.7	58.8	9.9	2.7	1.4	0.0	0.4	9.0	0.5	0.2	1.9	4.1	12.2	2.5	0.8	1.8	0.1	0.4	0.0	6.0	0.0	0.0	0.3	3.1	29.1	2.5	6.7	0.0	1.9	0.8	0.1	0.0	9.0	6.0	0.8	0.3	2.2	2.9	1.2	0.5	0.1	1.6	1.4	6.6	9.0	1.7	225.0	9.6	1.8	0.1	0.5	3.8	0.5	0.5	2.1
SPDYC	Ringo2	ENSG00000204710	"Speedy/RINGO cell cycle regulator family member C"	Q5MJ68	11	65170154-65173244	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"liver: 3.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Extravillous trophoblasts: 4.6;Hepatocytes: 3.0;Late spermatids: 9.8;Macrophages: 1.8;Spermatogonia: 3.3;Syncytiotrophoblasts: 1.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;HEL: 7.1;Hep G2: 3.1;K-562: 17.2"					"Not detected"	"Not detected"			HPA039891	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA039891: AB_10795260"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.35e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.08e-2)"		"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"		"unprognostic (6.60e-4)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	7.1	0.0	3.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	9.8	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0
SPDYE1	"Ringo1, SPDYE, WBSCR19"	ENSG00000136206	"Speedy/RINGO cell cycle regulator family member E1"	Q8NFV5	7	43997897-44010122	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 7.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 54.5;Late spermatids: 56.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA051750	Supported					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051750: AB_2681590"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.95e-6)"	"unprognostic (2.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.19e-2)"	0.2	0.2	0.6	0.8	1.3	2.0	0.1	1.4	1.1	0.3	0.3	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.2	0.7	0.1	0.2	0.2	0.2	0.8	0.7	0.3	0.3	0.3	0.0	0.2	0.2	0.2	0.2	0.0	1.0	0.6	0.0	2.5	1.7	0.6	0.0	0.0	0.8	0.5	7.2	1.1	0.0	0.5	0.0	0.0	0.2	0.2	1.7	1.1	0.9	1.1	1.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.8	0.6	1.1	0.6	0.0	0.4	1.7	0.0	0.0	0.0	0.8	0.9	0.5	2.8	0.5	0.0	1.9	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	1.6	2.7	0.0	1.3	0.7	1.1	1.0	0.6	0.4	1.6	0.4	0.7	0.0	1.2	0.8	0.7	1.7	0.4	0.2	1.4	0.7	0.2	1.0	1.5	1.2	0.6	1.4	1.5	1.0	1.0	0.7	1.3	1.7	1.5	0.5	0.7	0.5	0.6	0.7	0.5	0.5	0.2	0.3	0.8	0.4	0.5	1.0	0.3	0.4	0.7	0.2	0.3	0.6	1.3	1.4	1.1	0.7	0.1	0.7	0.3	0.2	0.0	1.1	1.7	0.5	0.0	1.1	4.2	0.2	0.4	0.0	0.2	0.0	1.1	0.1	0.0	1.2	0.0	1.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	54.5	1.0	1.1	0.5	0.0	0.0	6.0	0.0	0.1	0.4	0.5	0.9	1.3	0.1	0.0	0.1	0.1	1.7	4.8	0.1	0.0	0.3	0.3	56.5	0.3	0.3	0.0	1.0	0.1	0.4	0.0	4.0	4.3	0.0	0.0	0.4	0.6	0.0	0.0	0.1	0.0	2.1	0.0	0.5	0.6	0.7	0.2	0.0	0.3	0.1	0.4	0.1	0.1	0.0
SPDYE11		ENSG00000286228	"Speedy/RINGO cell cycle regulator family member E11"	P0DTA3	7	73048481-73057911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Excitatory neurons: 1.0;Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.0"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Approved					NA	NA						"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA051750: AB_2681590"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE13	SPDYE13P	ENSG00000286038	"Speedy/RINGO cell cycle regulator family member E13"		7	75281243-75287121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Uncertain					NA	NA									"HPA051750: AB_2681590"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE14	SPDYE14P	ENSG00000286137	"Speedy/RINGO cell cycle regulator family member E14"		7	75309171-75315049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Uncertain					NA	NA									"HPA051750: AB_2681590"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE15	SPDYE15P	ENSG00000286014	"Speedy/RINGO cell cycle regulator family member E15"		7	75337138-75343016	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Uncertain					NA	NA									"HPA051750: AB_2681590"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE16		ENSG00000185040	"Speedy/RINGO cell cycle regulator family member E16"	A6NNV3	7	76531319-76541459	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 19.8;Late spermatids: 36.8;Rod photoreceptor cells: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.4;Karpas-707: 1.6"									HPA051750	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA051750: AB_2681590"		"unprognostic (3.22e-1)"						"unprognostic (2.79e-1)"		"unprognostic (6.99e-3)"				"unprognostic (1.70e-1)"			"unprognostic (4.54e-2)"	0.4	0.3	0.0	0.2	0.2	0.3	0.4	0.4	0.4	0.5	0.0	0.4	0.3	0.5	0.0	0.5	0.4	0.0	0.4	0.1	0.1	0.4	0.5	0.4	0.3	0.0	0.1	0.6	0.6	0.0	0.5	0.1	0.2	0.5	0.0	0.4	0.5	0.0	0.6	0.6	0.5	0.0	0.0	0.6	0.4	1.6	0.3	0.0	0.8	0.0	0.0	0.4	0.5	0.2	0.5	0.6	0.1	0.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.2	3.4	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.6	0.0	0.3	0.3	0.3	0.3	0.1	0.1	0.4	0.1	0.7	0.0	0.3	0.2	0.1	0.6	0.2	0.2	0.5	0.1	0.4	0.8	0.6	0.4	0.3	0.2	0.3	0.3	0.6	0.3	0.7	0.3	0.8	0.1	0.8	0.2	0.5	0.2	0.8	0.3	0.5	0.1	0.2	0.4	0.5	2.0	0.2	0.2	1.2	0.3	0.2	0.0	0.2	0.4	0.4	0.1	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.4	0.0	3.3	0.0	1.3	0.0	0.1	0.0	0.6	3.5	0.4	0.4	0.6	0.0	0.6	1.8	12.5	0.1	0.5	0.3	0.0	0.1	19.8	1.8	1.1	0.5	0.0	0.4	0.9	0.0	0.4	0.5	0.5	2.1	0.0	0.4	0.0	1.3	0.4	3.3	0.6	0.1	0.0	0.6	0.0	36.8	0.0	0.3	0.0	0.0	1.0	0.7	0.0	1.0	0.6	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.7	6.2	0.0	0.6	0.4	2.4	0.3	0.9	0.0	0.7	0.4	0.5	0.2	0.2
SPDYE17		ENSG00000186645	"Speedy/RINGO cell cycle regulator family member E17"		7	77022319-77032361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 1.2;testis: 1.3"	"Group enriched"	"Detected in some"	46	"Astrocytes: 2.9;Excitatory neurons: 5.6;Inhibitory neurons: 5.3;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 4.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Supported					NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051750: AB_2681590"										"unprognostic (6.76e-2)"				"unprognostic (6.08e-2)"				0.1	0.0	0.2	0.2	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0		0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.8	0.1	0.0	0.0	0.1	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE2	MGC119295	ENSG00000205238	"Speedy/RINGO cell cycle regulator family member E2"	Q495Y8	7	102551232-102562308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.8"	"Group enriched"	"Detected in some"	4	"Astrocytes: 7.2;Excitatory neurons: 9.1;Inhibitory neurons: 7.0;Microglial cells: 6.5;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 6.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.5;Karpas-707: 10.5"									HPA051750	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051750: AB_2681590"	"unprognostic (2.04e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (7.94e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.04e-1)"	0.8	0.8	2.6	2.6	3.4	5.2	0.8	1.9	3.5	1.2	1.1	1.1	1.1	1.2	0.0	1.2	0.8	0.5	1.2	1.9	0.7	1.3	0.9	1.2	2.6	2.4	1.2	1.2	1.5	0.0	1.3	0.7	1.7	1.2	0.0	2.3	1.2	0.1	5.0	3.8	1.7	0.0	0.1	2.4	1.3	10.8	1.9	0.0	1.7	0.1	0.0	1.0	1.1	2.9	3.0	4.9	2.1	2.9	0.0	0.0	3.9	2.3	0.0	0.0	0.0	2.3	2.0	3.5	1.8	0.0	0.6	3.1	0.0	0.0	0.0	2.2	2.4	1.5	14.5	1.3	0.0	4.2	1.1	0.0	0.0	0.0	0.0	0.6	0.0	1.8	4.6	10.5	0.0	6.0	2.2	2.3	1.8	0.9	0.6	3.5	0.8	3.5	0.0	5.5	2.0	1.2	8.0	1.0	0.7	3.2	2.0	1.1	1.9	6.9	1.7	3.5	3.5	2.4	1.8	2.3	1.1	4.8	2.7	2.6	2.0	0.4	1.7	0.8	1.2	1.6	1.5	1.1	0.6	2.2	1.2	1.1	3.1	0.5	0.9	2.5	0.8	0.6	2.6	3.4	1.9	3.5	1.9	0.7	2.4	1.2	1.7	0.1	1.9	2.9	0.0	0.0	1.1	7.2	0.3	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0
SPDYE21	SPDYE21P	ENSG00000230358	"Speedy/RINGO cell cycle regulator family member E21"		7	67278714-67286664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.2"	"Not detected"	"Not detected"											HPA051750	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"						"HPA051750: AB_2681590"	"unprognostic (5.31e-4)"	"unprognostic (7.24e-3)"	"unprognostic (4.63e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (8.51e-2)"	0.0	0.1	0.9	0.0	0.4	0.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	0.1	0.0	0.0		0.2	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.2	0.4	0.0	0.1	0.4	4.2	0.2	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.1	0.6	0.4	0.5	0.9	0.1	0.6	1.0	0.1	0.2	0.9	0.4	0.8	0.6	0.3	0.4	0.6	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE2B		ENSG00000173678	"Speedy/RINGO cell cycle regulator family member E2B"	A6NHP3	7	102650325-102661398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.2;testis: 2.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.8;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.1;Karpas-707: 5.4"									HPA051750	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA051750: AB_2681590"	"unprognostic (2.67e-1)"				"unprognostic (4.29e-1)"			"unprognostic (2.29e-1)"		"unprognostic (2.09e-3)"			"unprognostic (2.68e-3)"	"unprognostic (1.48e-1)"				0.2	0.4	0.6	0.8	0.7	1.0	0.2	0.5	0.3	0.2	0.2	0.5	0.3	0.3	0.0	0.4	0.2	0.4	0.4	0.3	0.0	0.3	0.3	0.3	0.6	0.8	0.0	0.2	0.9	0.0	0.3	0.2	0.2	0.3	0.0	0.5	0.8	0.0	3.2	0.9	1.3	0.0	0.0	0.9	0.3	2.8	0.5	0.0	0.3	0.0	0.0	0.2	0.3	0.3	1.0	1.1	0.4	0.7	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.7	0.6	1.1	0.5	0.0	0.2	1.3	0.0	0.0	0.0	0.8	0.7	0.4	4.1	0.3	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	5.4	0.0	0.9	0.7	1.4	0.9	0.1	0.2	1.2	0.2	1.6	0.0	0.8	1.8	1.2	2.0	1.6	0.5	1.2	0.4	0.1	0.0	1.6	1.8	1.4	0.7	0.6	0.6	1.3	1.3	1.0	0.7	0.9	0.1	0.4	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.4	0.1	0.2	0.2	0.1	0.1	0.6	0.7	0.5	0.3	0.3	0.0	0.8	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SPDYE3		ENSG00000214300	"Speedy/RINGO cell cycle regulator family member E3"	A6NKU9	7	100307702-100322196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.5"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Supported					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051750: AB_2681590"	"prognostic favorable (8.73e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.58e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.5	8.1	0.5	1.7	0.7	1.2	0.0	5.2	0.4	0.0	2.3	1.5	1.0	0.0	10.4	0.1	1.5	0.0	0.0	0.0	181.7	1.2	1.7	0.9	0.0	0.4	13.6	0.0	0.2	0.8	0.0	0.9	0.0	1.1	0.0	0.2	0.2	0.0	11.5	0.3	4.1	0.3	0.8	44.4	2.1	0.4	0.0	3.7	0.0	0.7	0.0	11.6	8.1	0.0	0.0	1.9	0.0	0.6	0.0	0.2	1.0	3.7	0.0	1.1	0.9	3.4	1.1	0.0	1.7	0.1	0.9	0.6	0.0	0.7
SPDYE4		ENSG00000183318	"Speedy/RINGO cell cycle regulator family member E4"	A6NLX3	17	8753106-8758559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 7.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.6;HeLa: 1.7;NB-4: 1.0"					"Not detected"	"Not detected"			"HPA025704, HPA051750"	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA025704: AB_1853093, HPA051750: AB_2681590"										"unprognostic (3.20e-1)"	"unprognostic (7.16e-4)"		"unprognostic (3.15e-3)"			"unprognostic (2.79e-1)"		0.0	0.1	0.5	0.2	0.2	0.8	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.2	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE5		ENSG00000170092	"Speedy/RINGO cell cycle regulator family member E5"	A6NIY4	7	75493625-75504304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 12.1;Horizontal cells: 5.0;Inhibitory neurons: 10.2;Late spermatids: 5.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;RT4: 1.9"									HPA051750	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051750: AB_2681590"	"unprognostic (2.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.10e-4)"	"unprognostic (1.51e-10)"	"unprognostic (4.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.08e-4)"	0.4	0.5	0.2	0.5	0.4	0.9	0.5	0.5	0.4	0.6	0.2	0.5	0.3	0.4	0.0	0.5	0.4	0.4	0.4	0.1	0.0	0.7	0.7	0.5	0.6	0.0	0.1	0.7	0.7	0.0	0.7	0.2	0.1	0.7	0.0	1.2	0.6	0.0	0.5	1.7	0.7	0.0	0.0	0.8	0.5	3.1	0.2	0.0	0.8	0.0	0.0	0.4	0.5	0.4	0.5	0.5	0.6	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.3	0.3	0.7	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.3	0.2	3.1	0.3	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.7	0.0	0.8	0.4	1.1	0.4	0.1	0.4	0.4	0.2	0.0	0.0	1.9	0.5	0.4	0.5	0.4	0.1	0.5	0.8	0.1	0.6	1.0	0.3	0.6	0.6	0.6	0.2	1.1	0.1	0.6	0.6	1.3	0.5	0.3	0.9	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.4	0.4	0.9	0.2	0.5	0.6	0.1	0.2	0.2	0.4	0.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.3	0.0	0.0	3.6	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	7.0	1.2	1.2	0.7	0.0	0.4	12.1	0.0	0.0	0.4	0.0	1.2	0.0	0.2	0.4	0.4	0.1	5.0	10.2	0.0	0.0	0.6	0.0	5.5	0.0	0.4	0.0	3.7	0.6	0.4	1.0	5.5	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	0.5	1.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0
SPDYE6		ENSG00000260097	"Speedy/RINGO cell cycle regulator family member E6"	P0CI01	7	102345746-102356444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 5.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.0;Inhibitory neurons: 1.1;Microglial cells: 1.9;Oligodendrocyte precursor cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.3"									HPA051750	Approved					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051750: AB_2681590"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.84e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.49e-2)"	"unprognostic (7.81e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	0.8	0.8	0.1	1.3	0.4	1.0	0.7	1.1	0.4	0.7	0.3	1.1	0.7	0.9	0.0	1.2	0.7	0.1	1.2	0.2	0.0	1.3	1.0	1.1	1.4	0.2	0.1	0.9	1.7	0.0	1.2	0.2	0.2	1.2	0.0	0.6	1.2	0.0	2.4	1.2	1.6	0.0	0.0	1.9	1.1	5.0	0.5	0.0	1.4	0.0	0.0	0.9	1.0	0.7	1.2	0.1	0.7	0.7	0.0	0.0	1.5	1.7	0.0	0.0	0.0	0.4	1.2	1.7	0.7	0.0	0.1	1.0	0.0	0.0	0.0	0.6	1.1	1.1	2.9	0.2	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	5.3	0.0	1.2	0.7	1.3	0.7	0.2	0.1	1.4	0.2	1.7	0.0	1.4	0.8	0.5	1.8	0.9	0.5	1.1	0.4	0.8	0.5	2.0	1.1	0.9	1.0	1.2	0.9	1.2	0.4	1.3	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.4	1.1	0.4	0.2	0.0	0.2	0.1	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE8	SPDYE8P	ENSG00000273520	"Speedy/RINGO cell cycle regulator family member E8"		7	73020338-73029766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Uncertain					NA	NA									"HPA051750: AB_2681590"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE9	SPDYE9P	ENSG00000262461	"Speedy/RINGO cell cycle regulator family member E9"		7	73076165-73086038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Uncertain					NA	NA									"HPA051750: AB_2681590"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPECC1L	"CYTSA, KIAA0376"	ENSG00000100014	"Sperm antigen with calponin homology and coiled-coil domains 1 like"	Q69YQ0	22	24270817-24417739	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070614	Uncertain		Supported	"Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Actin filaments"		"HPA070614: AB_2686287"	"unprognostic (3.54e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (3.15e-3)"	"unprognostic (6.20e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.41e-1)"	13.0	13.1	12.3	12.4	12.8	13.3	13.8	34.0	13.5	16.6	17.7	15.8	7.8	15.9	9.7	17.5	15.5	12.5	18.6	10.8	15.7	14.6	14.4	17.2	12.5	18.1	16.2	22.0	13.3	17.3	14.6	10.1	18.9	20.1	16.9	10.7	16.2	15.1	12.7	9.2	11.6	19.0	15.8	11.1	11.5	31.9	16.6	14.5	24.0	13.1	13.8	14.9	13.0	13.7	31.1	22.8	42.9	23.7	40.1	39.2	14.5	43.1	34.1	36.8	36.4	25.5	8.4	44.9	10.3	39.5	29.0	27.0	39.2	24.2	43.4	26.1	21.1	28.5	12.9	23.4	26.7	51.2	27.0	33.1	19.2	32.8	34.2	28.8	44.0	18.9	24.5	19.0	39.3	17.3	26.6	18.5	20.7	22.5	17.1	24.0	43.3	16.1	18.4	23.3	37.2	38.3	36.5	27.5	23.8	37.1	18.3	14.4	46.3	77.2	43.7	19.3	29.3	22.7	23.4	20.0	22.6	19.0	29.2	3.9	2.4	4.8	3.3	3.5	2.5	2.8	2.2	1.6	2.3	3.1	2.7	2.9	3.2	1.3	1.6	3.7	1.6	1.9	12.3	12.8	34.0	13.5	10.8	15.7	18.1	16.2	18.9	15.8	16.6	13.7	11.6	16.0	21.3	0.0	10.4	3.6	2.7	5.0	10.2	8.4	13.8	9.4	13.7	14.3	9.1	12.9	10.4	7.3	7.9	32.8	1.9	6.7	26.9	8.3	14.9	12.0	14.4	7.6	0.0	7.4	3.2	11.4	8.2	9.8	16.5	13.4	15.7	11.4	7.3	10.1	0.0	12.2	14.2	7.3	2.2	93.7	16.1	6.9	14.2	0.0	14.8	6.4	9.2	0.0	0.0	9.0	15.0	13.5	10.7	5.7	8.9	6.1	11.9	8.5	13.1	11.3	12.5	24.1	28.5	9.8	3.1	5.9	9.3	7.6	8.0	3.8
SPEF1	"C20orf28, CLAMP, DKFZP434I114, SPEF1A"	ENSG00000101222	"Sperm flagellar 1"	Q9Y4P9	20	3777504-3781448	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.6;choroid plexus: 15.9;fallopian tube: 11.5;testis: 12.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 104.7;Respiratory ciliated cells: 66.5;Rod photoreceptor cells: 22.4;Spermatocytes: 24.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.2;hTEC/SVTERT24-B: 1.1;MCF7: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050786	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA050786: AB_2681238"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.08e-3)"	"unprognostic (8.12e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (7.49e-2)"	0.1	0.2	3.6	0.0	9.6	0.0	0.1	2.4	4.5	1.7	15.9	0.2	0.0	0.3	0.5	0.0	11.5	0.0	0.2	5.5	4.0	2.1	0.1	2.8	0.0	7.6	9.1	0.3	0.6	0.3	2.9	0.0	5.8	0.2	0.0	2.1	0.1	0.1	0.0	0.1	0.0	0.0	6.9	0.0	0.1	12.4	4.2	0.0	1.7	0.0	0.0	0.1	0.0	3.9	0.9	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.4	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	9.6	2.4	4.5	5.5	4.0	7.6	9.1	5.8	6.9	4.2	3.9	0.3	0.0	0.0	2.3	0.1	0.4	0.1	3.5	0.0	1.5	1.5	1.1	0.4	0.0	9.9	3.7	16.7	0.1	0.1	0.1	5.9	1.2	5.5	104.7	1.0	0.4	0.0	0.0	16.7	0.2	0.2	0.3	0.0	1.7	0.0	0.2	0.7	0.2	0.2	0.0	6.6	0.0	4.1	0.0	0.0	4.1	0.3	0.3	0.0	1.9	0.0	2.6	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	7.3	66.5	22.4	0.0	0.3	1.5	24.9	2.8	0.0	0.1	0.1	0.3	0.2	0.3	0.1
SPEF2	"CT122, FLJ23577, KPL2"	ENSG00000152582	"Sperm flagellar 2"	Q9C093	5	35617844-35814611	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.6;Endometrial ciliated cells: 143.9;Excitatory neurons: 62.9;Respiratory ciliated cells: 238.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 3.2;MAIT T-cell: 3.9;memory CD4 T-cell: 1.9;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.1;naive CD8 T-cell: 2.6;NK-cell: 3.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 3.0;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039606, HPA040343"	Enhanced					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA039606: AB_10671044, HPA040343: AB_2676930"	"unprognostic (3.81e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.71e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.50e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.12e-2)"	1.5	3.7	2.9	1.1	3.6	1.5	5.4	1.4	3.1	13.2	20.7	1.8	0.9	11.1	7.6	1.1	15.8	3.1	1.8	2.8	3.6	7.7	1.4	4.6	1.6	5.5	6.3	5.6	4.4	8.6	6.4	4.8	4.6	4.0	2.0	10.2	3.3	4.5	0.4	1.2	1.5	4.3	4.4	2.4	2.2	7.0	4.6	2.1	8.6	0.5	0.9	2.4	5.0	2.8	0.8	1.3	1.6	4.2	1.0	1.2	0.1	2.1	1.2	4.7	3.1	0.0	2.2	0.0	1.1	2.8	5.2	0.1	1.3	1.9	4.6	13.3	0.4	0.0	6.2	0.4	1.3	3.5	0.0	1.8	3.4	2.6	1.4	5.7	0.1	0.8	1.6	0.8	0.8	2.3	0.0	0.0	0.1	3.1	1.2	3.1	0.0	0.0	3.3	0.4	0.1	1.2	0.0	2.4	0.4	0.9	7.5	6.7	0.0	1.3	1.8	2.7	0.7	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.3	0.0	3.2	0.3	3.9	0.2	1.9	3.4	0.4	0.3	2.1	2.6	0.3	3.0	0.1	0.1	0.5	0.8	2.9	3.6	1.4	3.1	2.8	3.6	5.5	6.3	4.6	4.4	4.6	2.8	2.4	9.6	6.4	36.9	1.1	1.7	2.4	4.7	3.4	15.6	9.2	10.0	6.7	11.5	28.8	5.5	37.5	1.7	3.1	1.5	5.9	4.7	104.6	143.9	23.3	5.2	2.4	6.5	62.9	1.7	0.8	9.7	1.1	9.1	5.7	6.7	5.3	1.3	1.2	20.2	27.6	3.5	8.2	0.8	1.4	25.2	10.2	2.3	1.8	6.5	21.7	13.7	4.1	16.1	11.5	1.2	1.5	7.2	0.7	1.6	0.5	14.2	238.4	41.9	0.0	9.4	5.6	36.1	11.9	0.7	1.0	0.8	9.2	9.0	3.1	0.2
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, MYLK6, SPEGalpha, SPEGbeta"	ENSG00000072195	"Striated muscle enriched protein kinase"	Q15772	2	219434843-219493629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 174.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Cardiomyocytes: 61.5;Late spermatids: 39.6;Sertoli cells: 46.0;Smooth muscle cells: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 45.9;U-87 MG: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018904	Enhanced		Approved	Vesicles		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	16.1	6.8	16.8	7.7	18.7	0.0	15.3	15.5	20.7	75.5	9.7	174.8	5.3	89.5	6.2	15.6	70.0	7.3	48.5	19.8	14.5	4.1	1.3	8.7	0.6	16.1	15.8	21.9	3.4	4.4	34.3	4.5	14.6	58.8	3.8	1.0	10.0	25.5	118.0	7.8	31.9	23.1	15.3	2.4	48.1	5.4	15.3	0.5	5.9	21.7	0.2	87.7	42.1	15.6	6.1	0.5	3.1	4.9	1.6	4.7	1.8	13.1	8.5	8.6	6.4	4.5	1.9	0.0	4.5	9.7	4.3	7.2	2.5	3.1	3.4	0.0	1.7	0.0	6.1	0.3	2.1	0.0	0.5	13.2	4.6	7.8	1.9	45.9	0.0	3.2	3.5	0.0	6.1	1.6	0.1	18.8	6.5	0.0	2.4	2.8	7.0	1.1	8.5	0.0	3.4	15.1	0.6	0.0	0.3	14.3	0.3	0.2	0.0	20.6	21.3	2.4	21.1	0.4	0.0	0.2	23.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.7	15.5	20.7	19.8	14.5	16.1	15.8	14.6	15.3	15.3	15.6	2.4	0.0	2.2	45.7	0.4	3.2	6.0	1.3	2.8	5.3	10.3	14.6	61.5	4.3	0.1	1.8	2.1	0.6	1.4	4.1	0.0	1.5	21.8	0.9	3.6	2.2	6.7	2.7	20.5	1.2	0.9	10.0	3.6	1.3	0.0	1.0	5.7	3.1	1.1	5.0	20.9	4.1	0.0	5.6	1.9	39.6	10.5	1.6	3.6	4.7	1.4	8.4	0.0	5.0	1.0	0.2	3.2	18.8	0.9	6.5	8.5	4.3	0.1	0.9	46.0	17.1	32.4	11.6	3.7	0.2	1.4	1.4	1.2	0.4	3.5	5.3
SPEM2	C17orf74	ENSG00000184560	"SPEM family member 2"	Q0P670	17	7425616-7427568	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	571	"testis: 128.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023649	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 36: Testis - Spermatogenesis"			"Golgi apparatus"		"HPA023649: AB_1845606"					"unprognostic (3.00e-1)"					"unprognostic (3.88e-1)"			"unprognostic (1.12e-4)"		"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	128.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15836095-15940456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	15.3	8.6	11.3	11.5	14.6	23.2	14.0	22.6	12.9	13.3	4.8	12.0	8.8	14.4	8.5	13.3	15.5	8.0	10.8	10.4	14.6	9.6	11.0	14.8	12.9	14.2	12.4	21.3	17.5	16.4	10.7	11.8	11.4	11.1	9.1	15.1	12.8	9.9	20.5	17.3	13.4	9.8	8.0	12.7	11.0	10.3	12.6	16.6	15.6	19.8	13.3	13.0	13.6	20.7	25.4	20.9	26.1	19.6	25.0	15.2	13.8	12.9	16.6	13.5	11.4	19.3	19.5	35.6	15.0	25.1	15.9	36.0	24.0	22.6	21.4	32.1	68.5	44.6	20.5	12.4	11.3	37.1	20.8	11.2	15.9	20.2	28.9	12.9	15.5	26.5	47.1	35.9	11.1	14.0	30.7	14.7	11.6	14.4	15.9	29.5	25.1	21.9	7.5	22.4	20.5	19.9	36.2	17.4	14.8	11.6	6.5	18.4	28.9	12.8	15.5	24.4	18.5	21.5	15.0	39.6	12.2	29.2	17.9	7.4	1.9	1.6	1.4	1.7	0.9	1.3	1.1	1.0	0.5	3.0	0.9	1.0	8.5	1.1	1.3	2.8	0.9	0.5	11.3	14.6	22.6	12.9	10.4	14.6	14.2	12.4	11.4	8.0	12.6	20.7	55.7	80.1	85.3	68.9	69.4	104.6	44.9	18.3	90.5	67.1	35.0	27.9	52.6	30.0	43.2	5.5	52.1	12.2	52.8	44.4	3.9	18.5	7.0	90.4	67.4	51.6	31.7	47.1	57.2	17.6	15.0	45.9	41.8	146.5	62.6	34.3	20.0	32.6	15.2	95.9	66.0	27.4	8.2	34.6	69.6	4.9	27.4	53.2	21.4	64.6	56.3	28.3	68.0	51.8	88.7	23.6	34.6	35.7	74.5	46.7	16.8	7.5	29.4	53.2	19.7	85.7	56.6	59.5	45.9	89.8	101.6	15.7	52.3	33.1	32.8	56.3
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	3.4	1.1	0.8	1.1	0.4	2.2	1.2	1.6	1.2	1.0	1.6	1.2	1.5	6.3	2.6	1.8	3.5	3.1	1.1	1.2	2.0	1.2	1.1	0.8	1.3	1.2	3.4	1.9	4.7	1.2	12.9	1.3	3.5	1.1	2.8	1.8	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.5	73.2	1.1	0.9	1.9	1.9	0.7	2.4	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.2	1.6	1.1	1.2	1.3	1.2	1.3	1.3	1.1	1.6	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPG11	"ALS5, FLJ21439, KIAA1840"	ENSG00000104133	"SPG11 vesicle trafficking associated, spatacsin"	Q96JI7	15	44562696-44663678	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	21.1	27.1	18.4	18.2	25.7	27.4	21.6	24.4	21.3	21.5	23.9	25.6	17.1	17.9	25.3	25.6	20.2	16.1	25.5	17.5	22.2	25.0	29.8	24.8	28.4	23.8	22.1	21.4	28.6	26.7	21.3	14.9	23.9	25.3	19.9	30.5	24.7	15.0	22.9	30.4	30.1	12.7	19.1	43.0	26.0	25.5	24.6	23.7	30.9	14.3	18.6	23.8	22.6	33.4	13.2	8.8	21.9	21.6	33.7	33.0	15.8	13.4	17.4	13.0	16.6	10.8	12.5	9.7	16.5	18.2	22.5	29.0	15.1	20.8	12.5	29.3	9.0	22.1	21.1	16.4	23.7	22.2	19.2	25.3	23.3	10.7	30.5	20.4	18.6	16.6	28.8	24.2	18.6	11.5	10.1	19.7	11.5	40.3	11.6	12.9	18.5	10.6	28.0	33.6	14.2	16.8	14.6	23.3	13.1	18.0	22.0	30.2	19.9	17.1	8.5	21.4	16.5	23.8	22.6	19.2	17.6	28.8	17.9	5.7	7.7	11.8	6.5	9.2	6.9	10.0	5.4	4.9	6.2	11.3	4.3	5.3	11.6	6.2	12.4	6.3	6.1	3.7	18.4	25.7	24.4	21.3	17.5	22.2	23.8	22.1	23.9	19.1	24.6	33.4	21.0	44.8	22.2	56.2	40.4	9.3	15.6	18.8	14.2	25.1	19.0	12.6	20.1	18.6	31.3	27.6	47.9	16.5	30.1	29.3	5.9	21.3	28.2	31.7	23.2	17.6	20.0	22.3	62.9	16.9	10.1	19.3	37.2	33.6	27.3	31.9	21.8	23.5	20.1	16.8	68.1	31.2	26.4	43.3	23.5	33.2	17.7	40.4	14.2	74.9	88.1	14.0	50.4	68.3	121.4	17.7	24.0	13.9	21.4	19.3	30.8	14.9	53.6	21.7	6.6	24.8	16.3	51.7	31.6	20.1	11.1	9.3	29.5	24.4	27.3	22.2
SPG21	"ABHD21, ACP33, BM-019, GL010, MAST"	ENSG00000090487	"SPG21 abhydrolase domain containing, maspardin"	Q9NZD8	15	64963022-64990310	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 181.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040407, HPA040436"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA040407: AB_2676965, HPA040436: AB_10796454"	"unprognostic (7.47e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.19e-1)"	56.6	61.7	48.4	50.8	54.1	69.4	68.8	51.5	52.9	60.4	66.0	61.6	52.1	60.2	150.1	46.1	73.4	54.7	54.4	47.8	50.3	85.3	113.1	61.9	56.9	52.1	50.2	55.3	54.7	72.1	47.1	66.3	52.7	49.8	59.3	38.6	45.7	59.0	74.3	58.5	46.6	64.5	51.1	52.6	60.1	35.0	52.6	57.7	83.1	42.4	58.8	61.2	47.8	59.4	87.0	127.0	62.8	119.5	158.7	155.7	78.0	52.8	179.7	103.2	119.8	57.4	131.1	99.1	80.6	124.8	153.1	113.3	182.1	124.5	97.8	41.0	58.5	85.7	81.7	104.0	200.7	82.2	72.7	107.0	139.3	82.1	154.2	100.7	125.6	112.2	72.7	78.3	127.8	124.1	75.8	71.5	69.6	193.9	66.3	78.2	67.3	174.6	107.1	103.6	76.7	68.6	62.7	131.4	124.9	123.3	89.9	140.9	61.5	87.1	90.6	125.4	80.6	55.6	101.8	58.2	112.8	215.1	75.1	9.9	138.2	15.5	14.1	84.2	13.1	39.0	13.8	14.7	76.9	37.6	19.9	10.9	181.4	15.7	69.8	25.1	17.5	52.3	48.4	54.1	51.5	52.9	47.8	50.3	52.1	50.2	52.7	51.1	52.6	59.4	29.4	9.6	56.3	11.1	67.7	74.9	81.8	70.6	66.6	16.2	62.7	39.4	32.1	61.5	51.5	71.7	37.5	202.9	33.6	42.7	137.0	97.1	6.0	32.9	36.9	56.9	64.8	54.3	13.1	74.1	92.2	67.5	46.9	34.3	28.5	37.5	38.2	121.6	153.9	20.2	13.7	58.2	61.1	158.7	145.4	13.2	86.6	128.5	80.0	16.9	123.2	24.8	64.9	5.5	19.6	62.3	93.5	89.9	66.2	145.2	121.1	202.3	57.9	18.9	39.5	93.4	39.5	35.4	51.3	75.4	82.8	186.5	46.5	35.5	69.5	123.5
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory bulb: 5.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	18.9	4.1	4.0	10.5	3.0	17.3	18.0	2.1	3.9	11.0	2.3	7.0	1.9	6.7	3.9	23.8	9.4	11.9	17.5	2.9	3.9	21.4	3.8	24.3	8.1	4.0	4.1	4.3	14.4	4.8	4.9	2.5	4.5	7.3	1.1	8.4	19.9	1.5	3.2	15.6	7.0	3.2	2.3	5.0	6.7	5.8	8.5	3.5	10.6	0.8	4.1	11.3	13.1	3.9	36.9	3.7	15.2	0.8	7.6	7.0	15.8	82.6	54.0	67.8	40.8	19.4	3.9	1.8	7.4	61.0	28.9	7.7	11.7	105.4	16.4	1.6	6.2	0.5	28.3	127.6	16.6	1.3	2.9	13.6	2.1	105.9	41.3	28.8	66.0	3.7	17.3	0.2	13.5	46.6	3.5	0.6	0.9	8.2	29.7	2.5	4.1	2.8	3.7	0.5	2.0	3.6	8.3	0.9	74.4	9.1	3.0	5.1	108.9	105.8	20.8	82.3	142.1	1.7	0.4	1.6	80.5	6.5	16.1	1.5	1.9	0.0	0.7	0.9	0.2	0.0	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.0	0.2	4.8	0.0	0.8	4.0	3.0	2.1	3.9	2.9	3.9	4.0	4.1	4.5	2.3	8.5	3.9	22.0	0.0	0.0	1.0	2.8	12.6	57.0	18.6	2.8	1.5	31.1	29.1	5.3	47.1	6.6	1.8	0.0	1.2	9.1	1.0	0.0	105.4	0.2	15.3	13.5	51.2	0.0	22.3	0.5	12.7	16.9	27.5	3.1	60.7	7.0	0.4	4.2	0.2	30.1	33.7	1.6	2.4	6.1	8.9	45.4	1.4	3.7	39.9	12.4	1.0	61.5	165.1	3.1	0.0	0.1	101.8	1.2	19.9	3.5	68.9	0.8	2.5	2.0	3.9	0.0	17.3	54.3	0.0	9.5	6.7	10.7	1.4	4.2	0.8	0.4	27.0
SPHKAP	SKIP	ENSG00000153820	"SPHK1 interactor, AKAP domain containing"	Q2M3C7	2	227979955-228181687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"brain: 78.3;heart muscle: 29.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 82.2;Excitatory neurons: 67.7;Granulosa cells: 33.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 78.3;cerebral cortex: 49.3;hippocampal formation: 41.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"BJ hTERT+: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042499, HPA048168"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042499: AB_2678027, HPA048168: AB_2680296"	"unprognostic (4.91e-3)"				"unprognostic (6.46e-2)"						"unprognostic (1.33e-1)"	"unprognostic (2.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-3)"		0.0	0.1	10.6	0.0	8.8	0.0	0.8	78.3	49.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	41.1	4.2	0.0	0.0	0.1	0.0	6.8	13.3	2.1	0.0	0.0	0.0	0.0	7.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.2	11.2	0.3	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	45.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	8.8	78.3	49.3	41.1	4.2	6.8	13.3	7.1	4.2	11.2	3.3	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	7.2	2.6	3.0	82.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	67.7	0.0	0.0	2.1	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	9.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPIB	SPI-B	ENSG00000269404	"Spi-B transcription factor"	Q01892	19	50418938-50431314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 27.9;lymphoid tissue: 99.4"	"Cell type enriched"	"Detected in many"	4	"Paneth cells: 787.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	54	"memory B-cell: 307.8;naive B-cell: 260.6;plasmacytoid DC: 572.6"	"Group enriched"	"Detected in many"	106	"B-cells: 307.8;dendritic cells: 572.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 166.3;HDLM-2: 107.3;Karpas-707: 52.8;U-698: 238.2"									HPA018523	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA018523: AB_1857443"	"prognostic favorable (4.76e-5)"	"unprognostic (1.06e-5)"	"unprognostic (9.15e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.72e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.33e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.96e-8)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	1.2	0.1	0.4	41.7	0.5	6.1	0.2	1.3	0.6	0.1	0.5	22.2	13.1	0.4	0.2	0.7	0.8	1.6	0.2	0.4	0.6	0.6	0.5	1.0	87.0	1.4	0.2	0.1	1.5	0.0	0.1	0.2	0.5	1.2	18.2	0.2	2.7	0.2	1.3	0.5	27.9	0.8	0.1	29.3	8.2	0.4	0.4	7.6	0.8	0.2	99.4	4.1	0.3	1.4	0.4	1.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.2	3.1	0.2	166.3	0.2	0.1	0.0	0.2	1.4	0.0	0.0	107.3	0.3	0.7	0.3	0.1	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.8	4.6	52.8	0.1	0.5	0.1	0.6	1.5	0.1	0.0	11.6	0.9	2.0	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	5.4	0.8	0.1	3.0	0.1	0.3	5.0	3.5	238.2	0.1	2.6	0.2	4.1	0.5	0.8	0.5	0.2	0.4	307.8	0.3	0.3	6.9	260.6	0.4	0.3	2.6	3.9	0.3	572.6	0.6	14.8	0.4	0.5	1.3	0.6	0.4	0.6	1.4	0.2	0.5	0.1	0.4	1.4	0.5	0.0	1.8	0.3	162.7	1.8	2.1	0.0	0.0	0.7	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.3	192.8	28.3	0.0	0.7	0.0	1.1	0.3	0.8	19.8	0.4	0.3	1.1	0.2	1.1	2.6	0.5	4.5	0.2	0.0	0.5	1.4	0.0	0.3	18.4	0.0	0.6	38.0	0.0	0.0	13.0	7.2	0.0	1.6	0.6	1.0	0.0	0.2	0.0	787.8	0.4	2.0	1.4	5.0	0.3	0.7	1.0	0.0	1.3	0.8	0.2	1.1	0.0	1.3	0.3	2.7	0.1	37.6	1.3
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA064843	Approved		Supported	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	4.4	3.8	2.1	4.6	2.3	4.1	7.4	3.2	2.9	8.5	3.4	6.7	4.1	8.6	4.9	6.9	8.0	7.7	4.3	2.4	2.4	4.6	4.1	4.7	4.1	2.2	2.1	7.8	6.3	6.4	8.9	5.5	2.1	6.4	6.6	7.7	8.6	4.9	2.6	6.0	5.3	6.7	1.4	4.2	6.8	7.1	1.9	8.3	6.8	2.3	5.5	6.1	7.2	3.1	17.0	10.4	12.1	10.6	7.5	9.2	7.6	8.2	6.3	10.9	13.6	9.2	9.4	9.9	11.6	7.2	10.7	16.0	6.3	8.0	14.7	5.9	2.8	9.0	9.3	6.1	4.5	18.0	6.8	7.5	7.9	11.3	4.6	9.6	8.0	18.0	5.8	8.2	3.8	17.7	15.6	7.0	13.0	13.4	11.5	10.8	10.3	8.8	4.0	10.7	6.2	10.8	8.7	10.3	4.8	13.4	10.2	7.2	8.0	5.5	8.8	5.1	7.5	7.9	5.8	16.7	11.0	10.5	8.2	3.6	4.1	1.5	3.2	3.0	5.2	5.6	5.0	4.0	3.1	6.1	7.0	5.2	2.1	2.7	2.9	9.7	2.6	2.0	2.1	2.3	3.2	2.9	2.4	2.4	2.2	2.1	2.1	1.4	1.9	3.1	6.7	0.0	4.2	14.4	12.0	6.8	7.9	5.4	9.1	6.4	9.4	5.8	2.5	5.7	5.6	5.5	8.4	4.7	3.5	8.0	0.0	5.4	6.5	22.8	11.9	4.7	3.6	9.9	20.2	4.5	5.9	7.4	16.3	12.7	1.3	10.1	3.3	5.2	4.4	3.3	6.8	10.6	6.1	2.5	3.9	3.5	9.9	4.1	0.0	15.9	2.3	7.9	1.0	16.1	14.4	5.6	3.6	3.4	13.9	4.1	3.9	4.2	15.3	25.0	6.6	6.2	5.4	20.9	16.9	7.7	7.7	3.4	7.5	6.2	7.4	8.5
SPIDR	KIAA0146	ENSG00000164808	"Scaffold protein involved in DNA repair"	Q14159	8	47260878-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 122.4;Excitatory neurons: 255.4;Inhibitory neurons: 214.4;Microglial cells: 216.4;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA027201: AB_10603774, HPA041582: AB_2677563"	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.4	16.5	17.2	16.2	17.1	15.1	19.1	20.9	19.9	19.6	16.2	16.1	11.0	16.6	14.8	23.6	18.3	20.9	12.4	17.3	15.5	13.5	15.1	19.0	16.6	16.6	15.1	23.6	18.1	11.8	17.8	18.5	16.3	18.3	14.5	18.0	17.7	10.6	13.9	20.3	13.4	11.8	13.9	20.5	17.7	10.6	15.2	12.3	19.7	4.1	12.0	17.3	16.1	15.9	16.4	24.2	16.5	28.7	19.6	24.9	15.0	22.8	18.1	16.5	25.5	13.4	39.4	31.5	22.6	19.8	16.9	8.5	18.3	17.3	23.7	9.1	15.6	21.5	23.0	25.7	21.9	16.0	13.3	15.9	13.5	13.7	19.9	20.0	12.4	19.7	16.9	11.2	19.9	38.8	30.3	40.5	19.6	38.2	6.5	15.2	10.1	2.2	22.4	55.6	9.0	19.5	35.2	25.7	12.3	17.4	23.9	33.0	20.4	12.0	17.8	17.8	13.4	12.7	25.1	21.8	14.2	22.3	12.0	4.6	10.6	3.1	9.3	6.5	9.4	7.1	4.1	5.5	8.6	6.0	4.4	3.9	4.4	7.9	7.7	1.3	8.8	5.5	17.2	17.1	20.9	19.9	17.3	15.5	16.6	15.1	16.3	13.9	15.2	15.9	25.8	35.3	33.7	122.4	22.2	10.7	16.6	17.8	30.7	11.2	20.1	18.0	19.5	12.8	18.0	12.9	18.8	17.8	15.7	8.8	7.9	8.2	8.5	18.1	20.4	21.4	11.5	12.4	255.4	8.8	11.5	21.7	26.0	21.0	12.6	20.6	10.8	8.3	11.1	13.5	214.4	9.7	10.2	33.1	11.3	7.6	14.6	27.4	8.8	216.4	24.9	8.7	15.5	207.6	141.4	7.1	10.1	14.7	16.6	15.1	6.0	4.9	26.5	12.2	6.6	17.5	16.9	21.7	29.7	27.6	8.7	16.4	15.1	10.9	12.3	18.6
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388430-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.2;Oligodendrocytes: 220.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000162: AB_1080079, HPA068784: AB_2686033"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	23.3	26.6	42.3	17.4	44.7	14.7	35.2	30.1	46.2	59.3	35.4	29.0	19.3	61.3	76.9	27.7	50.9	31.7	29.5	45.4	42.4	44.8	20.9	26.1	15.9	32.5	38.8	55.9	21.7	41.7	28.7	33.1	34.4	37.8	25.1	34.8	24.4	42.2	6.9	24.9	22.5	46.1	35.5	19.3	21.3	35.6	44.0	31.0	41.3	14.1	17.3	27.3	31.5	39.5	68.5	32.8	54.0	46.2	36.0	42.1	63.0	67.1	62.0	75.1	54.8	24.6	38.9	37.7	38.5	82.8	48.5	102.4	40.6	61.1	85.7	39.6	24.4	18.0	67.4	26.4	33.3	41.8	19.0	35.2	62.4	50.9	71.2	74.0	43.4	47.2	23.5	0.1	85.5	46.8	71.1	18.8	89.2	56.9	30.5	93.6	58.6	12.2	68.3	47.2	76.1	57.2	79.5	49.7	30.1	62.2	38.3	32.7	41.4	49.6	52.4	74.3	48.2	15.3	24.2	32.3	60.1	38.0	47.3	7.4	2.6	4.1	3.9	2.2	4.1	2.5	2.8	4.0	5.0	1.9	3.9	4.4	0.4	2.6	2.1	2.3	2.8	3.1	42.3	44.7	30.1	46.2	45.4	42.4	32.5	38.8	34.4	35.5	44.0	39.5	26.4	51.3	15.4	139.4	13.1	40.0	26.1	23.1	47.3	22.9	45.4	31.2	35.8	42.9	22.2	44.1	25.0	28.6	17.0	29.1	25.4	24.2	178.2	56.4	73.3	24.5	41.3	19.6	136.8	18.3	44.4	39.6	22.4	68.5	34.8	74.3	26.4	17.5	33.6	25.2	173.3	23.6	30.5	35.2	21.8	123.4	33.5	22.8	21.4	89.9	13.0	38.5	13.4	123.1	220.1	25.4	17.7	44.4	9.6	34.6	20.9	47.6	22.2	15.1	26.3	28.3	38.0	25.7	54.1	37.7	44.8	24.9	16.9	37.9	21.8	28.9
SPIN2A	"DXF34, SPIN2, TDRD25"	ENSG00000147059	"Spindlin family member 2A"	Q99865	X	57134530-57137625	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.8;Cardiomyocytes: 5.0;Cone photoreceptor cells: 4.2;dendritic cells: 3.2;Rod photoreceptor cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;HSkMC: 3.1"									"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-5)"	"unprognostic (3.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.07e-3)"	1.2	0.8	1.0	0.9	1.1	0.2	1.1	1.5	1.4	1.6	0.0	1.2	0.7	1.0	0.3	0.8	1.0	0.7	0.8	0.9	1.6	1.2	0.9	0.8	1.3	1.0	0.7	1.3	1.0	0.4	1.6	0.5	1.0	1.4	0.7	0.6	0.9	0.6	0.4	1.2	1.1	0.8	0.3	1.5	1.0	0.5	1.0	0.5	1.5	0.6	0.8	1.2	1.6	1.2	0.4	0.8	2.2	0.4	0.3	0.4	0.6	0.8	0.3	0.1	0.3	0.4	0.7	0.2	0.3	1.4	0.2	0.5	0.5	0.4	0.1	0.3	0.3	0.3	3.1	0.4	0.7	0.3	0.4	3.1	0.3	0.1	0.1	1.0	0.2	0.3	0.3	1.0	0.4	0.5	0.2	1.0	0.8	0.0	0.3	0.4	0.5	0.3	0.3	0.4	1.4	0.4	0.4	0.2	0.1	0.7	0.4	0.4	0.3	1.1	0.5	0.5	0.2	1.0	0.1	0.1	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.1	1.5	1.4	0.9	1.6	1.0	0.7	1.0	0.3	1.0	1.2	0.8	0.0	0.5	0.0	0.4	0.3	0.5	0.6	0.0	5.8	0.3	0.1	5.0	0.0	0.2	0.0	4.2	0.2	3.2	0.8	1.9	0.4	0.0	0.8	1.8	1.3	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.9	1.3	1.5	1.4	0.0	0.2	1.7	0.1	0.3	0.0	0.0	0.3	0.0	2.8	0.2	0.0	0.0	0.5	0.3	2.1	0.0	0.1	0.2	0.2	0.0	0.3	0.4	0.0	0.1	0.1	4.5	0.0	0.7	1.1	0.0	0.0	0.0	0.4	0.0	0.8	2.0	0.2	0.4
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121548	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	9.7	10.4	14.1	5.5	13.4	5.0	9.7	12.5	16.3	14.5	13.8	16.2	4.5	11.5	11.2	8.1	11.2	7.4	11.2	13.2	13.8	13.4	8.5	9.0	10.2	13.1	12.6	11.7	9.2	7.4	14.8	6.5	13.2	13.6	11.7	7.8	8.1	10.4	9.5	8.7	10.2	10.8	12.3	12.8	11.2	5.2	13.4	7.0	12.7	6.5	9.0	13.8	12.4	13.8	15.6	12.1	14.1	10.8	14.7	14.9	9.3	9.9	6.8	13.1	8.8	15.7	12.8	3.3	16.8	10.3	11.9	2.4	16.7	5.3	14.1	6.4	20.1	9.3	38.5	21.1	11.9	8.1	7.1	13.7	10.7	8.8	9.3	13.7	10.9	8.9	11.6	10.9	14.8	24.0	11.9	15.6	13.4	4.6	13.8	11.2	17.5	15.2	15.0	7.6	9.3	10.0	18.0	4.7	9.9	21.8	10.3	6.0	10.5	11.2	10.6	19.6	6.3	10.8	7.6	9.5	8.6	15.2	6.5	1.6	6.5	0.8	10.4	7.8	15.4	13.3	13.3	14.6	8.1	12.2	14.7	12.2	0.4	15.6	7.2	11.4	16.9	10.0	14.1	13.4	12.5	16.3	13.2	13.8	13.1	12.6	13.2	12.3	13.4	13.8	9.1	19.2	7.3	3.3	9.5	5.4	7.6	11.3	8.0	10.1	7.9	11.3	9.7	4.3	5.5	11.0	0.0	8.8	7.2	8.7	15.6	6.7	0.1	7.7	7.1	9.5	11.5	7.8	5.8	5.1	6.0	8.4	5.1	6.6	11.4	5.6	6.4	3.0	5.1	11.8	6.6	9.1	18.3	2.6	4.2	0.9	12.2	8.6	8.8	3.7	3.8	5.3	10.3	5.0	5.2	3.7	8.1	18.8	5.9	4.7	5.5	12.0	3.4	5.6	26.3	6.3	10.1	0.1	0.6	7.7	8.9	3.0	8.2	7.4	10.6	5.3
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.5"					"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favorable (6.30e-4)"	4.5	6.1	7.4	3.1	7.2	0.3	5.4	7.7	7.8	7.0	4.3	4.3	2.9	6.0	4.7	3.8	6.0	3.2	3.2	7.2	7.6	5.4	6.4	3.1	4.4	6.0	6.1	6.4	8.7	2.9	8.6	2.5	6.2	5.8	4.0	8.4	5.6	4.1	3.0	3.2	5.6	4.2	5.5	4.9	5.5	3.1	8.0	1.8	4.7	1.6	4.2	5.1	5.2	6.6	4.5	6.6	3.6	0.0	6.9	5.9	2.8	3.4	2.0	2.1	2.9	3.5	5.6	0.0	2.4	3.3	7.3	4.9	5.7	2.2	3.2	0.0	1.4	0.6	20.5	2.7	3.7	0.0	4.6	5.3	4.7	2.7	4.2	4.0	1.6	0.0	2.9	8.6	4.4	3.0	0.0	3.6	7.3	2.6	5.8	0.0	3.0	1.8	3.3	5.3	7.3	5.1	4.2	3.7	4.1	5.7	9.8	1.1	1.2	4.4	6.3	7.4	2.1	3.6	2.5	0.0	4.2	0.0	3.4	1.5	0.4	0.8	0.1	0.6	0.8	1.1	1.7	0.6	0.7	0.3	1.9	0.5	0.0	2.2	0.1	0.1	0.5	1.0	7.4	7.2	7.7	7.8	7.2	7.6	6.0	6.1	6.2	5.5	8.0	6.6	2.9	0.0	3.7	11.8	3.7	0.3	4.0	1.8	2.8	2.0	5.1	4.6	1.1	2.8	2.8	7.3	0.0	2.6	0.5	0.7	1.9	4.1	0.0	3.0	4.7	2.3	0.0	0.4	23.8	3.0	2.1	3.2	2.6	2.3	1.3	4.7	2.2	1.6	0.9	1.7	23.3	0.8	2.0	1.0	1.2	0.0	4.1	0.9	1.8	7.5	1.5	0.9	1.0	25.1	10.0	3.6	0.3	2.6	2.5	1.8	1.1	2.9	1.1	3.0	6.6	1.4	2.2	0.0	0.3	1.4	0.4	0.4	1.1	5.8	1.5	2.2
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	1.8	1.7	1.4	2.7	1.3	10.2	3.3	0.9	1.7	2.4	1.7	3.6	2.2	3.4	2.3	5.9	2.7	2.1	1.3	1.3	3.1	1.5	1.3	3.1	3.5	1.6	2.0	2.9	1.7	1.7	2.3	4.4	1.6	3.3	4.1	2.0	7.2	1.7	0.5	2.0	2.2	3.5	1.2	2.8	2.2	0.7	2.5	3.1	2.5	0.5	5.6	2.1	2.7	1.8	31.7	8.0	18.2	14.9	3.9	5.5	13.1	15.6	6.5	8.9	10.6	5.4	30.7	0.0	6.7	7.3	10.2	10.3	23.7	11.2	16.2	13.7	7.5	40.5	10.3	4.9	1.7	35.5	30.3	2.6	3.9	14.9	8.0	4.3	9.9	7.0	12.5	38.2	20.4	10.7	11.9	19.0	18.8	5.2	11.5	16.4	39.2	8.7	6.5	8.3	0.1	10.0	27.9	8.1	3.0	37.4	17.4	16.9	4.3	17.9	19.9	29.8	9.8	8.4	10.4	20.5	9.5	28.8	10.7	0.7	0.8	1.6	0.5	0.9	0.2	0.4	0.3	0.3	0.6	0.4	0.1	0.4	0.0	2.6	0.8	0.0	0.2	0.4	1.4	1.3	0.9	1.7	1.3	3.1	1.6	2.0	1.6	1.2	2.5	1.8	3.0	0.0	2.0	2.3	2.9	3.3	1.4	3.5	6.2	5.7	6.0	4.3	1.5	1.5	5.8	3.7	2.1	6.1	3.9	3.6	1.9	0.6	0.0	3.4	3.2	5.1	6.7	11.1	2.4	1.4	6.8	3.4	2.0	2.1	9.5	3.5	8.6	1.3	2.6	1.7	3.3	6.7	4.1	1.0	2.1	0.4	3.1	2.2	5.4	1.9	1.1	1.3	5.2	3.0	4.5	1.3	6.3	3.4	0.7	2.3	0.6	1.3	5.7	2.8	0.0	2.5	2.6	0.1	0.5	9.8	6.3	3.3	3.1	4.3	5.7	5.7
SPINDOC	"C11orf84, SPIN-DOC"	ENSG00000168005	"Spindlin interactor and repressor of chromatin binding"	Q9BUA3	11	63813456-63827716	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040128, HPA050313"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA040128: AB_10673027, HPA050313: AB_2681083"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	11.9	10.4	25.8	12.1	26.3	6.2	8.9	27.9	38.1	16.3	20.7	19.2	5.4	19.1	5.1	10.1	15.3	9.3	15.8	26.0	31.5	13.8	5.2	16.4	15.0	25.4	26.4	16.6	8.0	3.3	17.3	26.4	27.9	18.2	3.6	9.8	9.0	10.4	8.0	6.0	11.3	8.2	22.9	13.9	11.4	38.8	31.4	12.3	13.4	7.2	9.8	18.0	12.3	25.8	34.9	45.7	65.7	57.6	12.5	12.3	24.7	26.6	22.7	47.4	32.9	48.7	23.4	58.1	60.6	15.5	60.8	44.9	60.3	13.7	17.1	55.6	26.4	64.2	46.4	42.0	20.1	36.4	53.6	14.2	14.1	37.2	13.6	24.9	28.5	54.8	36.1	27.6	20.2	48.0	75.7	98.2	112.9	10.0	42.1	100.3	45.5	19.7	16.5	20.2	50.0	63.2	40.6	25.6	55.3	39.7	35.3	43.0	32.2	52.9	60.8	64.0	47.3	40.1	61.9	58.2	27.3	31.8	38.1	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	25.8	26.3	27.9	38.1	26.0	31.5	25.4	26.4	27.9	22.9	31.4	25.8	7.2	3.2	1.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	6.7	8.6	0.0	0.0	0.6	0.0	0.0	13.3	9.4	0.0	0.0	2.2	0.0	5.6	8.0	3.1	0.0	0.0	0.0	1.8	3.0	2.7	0.0	6.5	0.0	9.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	3.8	2.8	4.0	0.0	0.0
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor Kazal type 1"	P00995	5	147824572-147831671	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"pancreas: 53063.4"	"Group enriched"	"Detected in many"	9	"Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"CACO-2: 417.2;RT4: 1139.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	NA	NA		8000000		"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favorable (2.15e-5)"	8.8	1.5	0.1	36.4	0.1	6.8	4.1	0.3	1.2	3.1	0.3	428.2	394.4	5.5	0.8	2.9	1.3	111.9	12.0	0.2	0.2	142.5	491.8	2.7	2.7	0.1	0.1	25.6	53063.4	0.0	1.9	3.2	0.2	4.4	441.3	0.6	12.8	1.4	1.2	21.1	403.9	14.1	0.0	2.5	1475.2	0.9	0.3	0.4	1.0	0.0	0.3	995.6	10.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	417.2	0.3	0.1	6.8	0.0	0.8	0.9	2.2	0.0	0.0	3.9	0.0	0.0	0.0	107.0	0.3	0.0	3.9	0.0	2.1	0.0	3.0	5.8	0.0	0.0	0.0	0.3	0.0	0.3	0.8	1.3	2.1	138.9	0.8	0.8	0.0	2.5	0.0	1139.0	0.5	1.7	0.0	0.2	0.1	5.4	0.1	0.0	0.0	0.1	13.7	1.1	3.8	2.2	5.9	3.0	16.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.2	0.2	0.2	0.1	0.1	0.2	0.0	0.3	0.6	0.0	0.0	3.6	0.0	9.7	0.0	15.1	0.3	0.0	0.0	5.5	0.8	0.1	1451.2	11.1	377.0	0.0	0.0	0.0	280.8	86.1	1286.7	0.1	0.3	0.4	9.4	517.2	18.7	1.0	50621.7	0.1	1.9	1580.5	5.0	4.5	2.0	39.3	3385.8	0.1	0.0	0.2	2087.4	0.0	30.9	0.0	0.2	0.0	13.7	0.0	0.0	269.8	0.0	0.0	0.0	0.1	16750.7	563.8	0.0	1.3	173.5	1457.1	1.6	0.7	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1365.3	649.1
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor Kazal type 13"	Q1W4C9	5	148268180-148286255	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 328.8"	"Group enriched"	"Detected in some"	6	"Leydig cells: 39.7;Peritubular cells: 26.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HeLa: 574.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036456	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.3	1.9	0.7	0.1	1.2	0.0	0.0	0.9	1.0	0.2	0.0	1.1	0.0	0.2	328.8	0.1	0.4	0.2	0.5	0.4	0.8	0.6	0.0	0.3	0.1	1.3	0.8	0.5	0.2	0.0	0.5	0.0	1.4	1.7	0.0	1.5	0.2	31.3	0.4	0.5	0.0	0.1	0.7	0.0	1.6	1.3	1.1	0.1	0.3	0.0	0.0	1.5	0.1	2.8	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	574.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.0	1.5	0.0	0.0	0.3	30.0	0.2	0.3	0.0	22.5	0.0	0.0	0.2	1.9	0.0	0.6	1.1	0.1	0.4	0.1	0.6	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	1.0	0.4	0.8	1.3	0.8	1.4	0.7	1.1	2.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	0.0	0.1	39.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.4	2.8	0.0	26.7	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5310.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.1	1.1	0.2	13.5	1.3	0.1	0.6	1.3	1.8	2.8	1.9	0.3	5310.4	0.2	0.3	0.1	7.4	0.2	0.2	0.3	0.2	0.2	4.7	0.3	0.3	0.4	0.1	0.0	4.2	0.0	0.2	3.5	2.1	0.0	2.0	240.7	1.8	0.5	3.1	0.3	0.2	1.7	3.0	346.1	0.3	3.9	0.6	2.3	4.8	0.5	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.1	0.2	0.1	0.6	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.1	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 980.5"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	84.2	0.0	0.6	0.1	0.7	0.3	0.0	0.1	639.5	263.4	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.1	0.1	0.0	0.9	2.1	0.9	0.0	0.1	0.0	980.5	92.1	0.1	0.5	0.2	0.1	638.1	42.2	0.0	0.2	1.4	0.3	0.0	0.1	0.0	0.0	0.0	17.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor Kazal type 5"	Q9NQ38	5	148025683-148137382	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 338.5;esophagus: 1015.0;skin 1: 318.2;vagina: 582.6"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 1622.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		43000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	1.1	0.3	0.0	0.5	0.1	0.0	17.5	0.0	0.2	338.5	0.0	4.8	0.3	0.6	0.3	1015.0	0.4	1.8	1.7	0.1	0.0	0.8	0.4	2.0	0.1	0.1	0.1	0.3	0.8	1.0	2.0	2.4	0.2	1.3	10.6	0.0	145.0	0.5	1.8	318.2	0.6	0.4	0.0	0.3	5.0	1.6	0.1	9.1	2.2	1.1	292.9	0.7	582.6	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	1.8	0.0	0.0	14.7	0.0	1.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.9	19.3	0.0	2.1	0.0	0.0	2.6	2.0	0.3	0.0	0.0	0.0	0.0	5.7	2.8	0.0	0.6	0.0	0.0	6.6	4.6	0.0	0.0	0.0	0.1	0.0	0.0	5.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	5.7	9.6	45.4	0.3	0.2	53.7	1.5	331.1	102.4	0.0	4.2	3.4	1.2	34.3	115.6	0.0	0.0	1.9	0.0	177.9	0.0	0.2	11.0	2.5	0.7	12.9	4.2	0.0	0.7	1.3	2.1	2.6	17.9	4.8	1.3	0.0	7.9	0.2	0.1	0.0	0.8	33.8	16.2	0.8	2.1	3.8	0.6	0.7	3.6	2.8	0.0	0.0	0.0	2.0	1.2	7.6	60.3	0.0	3.7	0.7	0.0	0.0	9.4	0.0	0.0	0.2	2.4	1.3	4.6	1622.6	64.4	1.5	1.1	1.0	97.9	2.7
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 5.7;lymphoid tissue: 4.9;salivary gland: 6.9;vagina: 10.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Hofbauer cells: 2.8;Oligodendrocyte precursor cells: 1.0;Prostatic glandular cells: 5.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	74	"HeLa: 3708.0;SiHa: 2339.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	0.6	0.2	0.1	0.0	0.7	0.0	0.2	3.0	1.1	5.7	0.1	1.7	0.0	0.0	1.2	2.4	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.3	6.9	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.4	4.9	0.0	0.1	0.0	0.6	10.1	2.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.5	3708.0	4.0	0.0	0.6	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2339.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	40.8	0.2	0.1	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	1.1	0.4	0.1	0.6	0.4	0.9	0.1	0.4	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.8	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor Kazal type 7"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 256.8;esophagus: 620.4;vagina: 614.0"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 49.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted in other tissues"	NA	NA		230000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.3	256.8	0.1	0.1	0.0	0.1	0.1	620.4	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.7	0.0	0.3	0.1	0.0	0.0	140.1	0.0	0.2	9.3	0.1	0.1	0.1	0.1	4.2	0.1	0.2	4.7	0.1	0.1	115.9	0.6	614.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	4.5
SPINK8		ENSG00000229453	"Serine peptidase inhibitor Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"bone marrow: 11.5;breast: 44.1"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 22.1;Breast myoepithelial cells: 9.9"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"eosinophil: 1.3;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Cell line enriched"	"Detected in some"	60	"SK-BR-3: 73.2"	"Region enriched"	"Detected in many"	9	"hippocampal formation: 73.7"	"Low region specificity"	"Detected in all"			HPA053151	Uncertain				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA053151: AB_2682059"	"prognostic unfavorable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	2.2	0.0	2.2	11.5	44.1	2.6	4.5	0.0	0.4	0.0	0.1	0.0	2.5	2.8	0.2	0.0	0.0	3.0	1.8	0.0	0.0	0.1	0.0	2.9	1.5	0.0	0.4	0.0	0.1	0.2	2.6	0.5	0.0	0.3	2.1	0.3	0.0	0.1	0.0	0.0	1.8	0.6	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.1	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	73.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	2.2	2.2	2.6	4.5	3.0	1.8	2.9	1.5	2.6	1.8	2.6	2.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	22.1	9.9	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.1	0.0	1.2	0.0	0.0	2.7	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6
SPINK9		ENSG00000204909	"Serine peptidase inhibitor Kazal type 9"	Q5DT21	5	148321203-148339852	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.4;U-266/84: 26.9"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		24000	"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.5	3.2	17.1	3.0	13.7	6.5	0.5	19.2	26.6	0.6	5.0	2.0	2.2	2.6	1.9	2.2	1.0	1.4	2.0	14.6	10.6	1.8	1.6	1.1	2.6	10.0	6.1	1.8	1.1	0.5	0.1	3.2	10.8	2.5	1.7	10.3	1.5	0.5	3.8	3.4	2.4	0.5	2.6	1.9	2.4	4.2	11.5	3.2	1.5	0.1	1.6	0.9	0.0	28.0	15.4	2.6	2.9	3.4	0.7	1.2	2.8	3.5	0.2	0.3	0.5	5.3	10.8	3.4	24.4	0.1	2.0	3.5	0.9	0.7	1.0	6.1	1.4	7.7	8.3	2.7	0.3	2.9	2.6	0.2	0.7	0.5	0.1	2.0	0.0	2.5	4.9	18.3	0.4	9.6	2.5	4.7	13.7	5.5	5.0	3.9	3.4	4.0	1.0	10.0	6.3	7.9	3.0	8.6	2.8	8.6	14.0	3.0	5.9	4.4	14.1	3.9	4.5	11.1	26.9	4.0	2.6	2.1	6.2	12.4	1.8	1.0	1.1	1.0	1.4	0.8	1.3	1.4	0.4	1.9	1.8	1.8	6.6	3.9	2.2	1.9	0.9	0.1	17.1	13.7	19.2	26.6	14.6	10.6	10.0	6.1	10.8	2.6	11.5	28.0	0.1	16.0	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.1	10.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	2.2	0.4	0.0	0.1	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.7	0.0	0.0	0.2
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	10.5	44.6	56.9	65.3	57.3	81.1	178.5	47.2	66.3	145.6	80.0	297.0	247.4	44.6	269.6	351.9	189.7	105.1	13.6	58.9	92.9	216.1	14.3	138.3	37.4	52.0	54.8	83.3	234.2	252.9	435.9	156.4	56.2	181.8	251.7	23.6	503.9	111.3	1.8	257.0	267.0	19.0	47.6	50.2	219.4	215.7	70.3	82.6	321.3	0.9	101.3	140.1	157.6	51.0	852.5	603.0	3.0	3.4	0.4	0.0	387.4	16.2	1.7	1.2	2.6	426.8	1219.1	6.7	65.8	4.6	1.2	274.6	42.7	587.0	1.4	7.9	51.7	159.4	15.3	0.9	0.9	1.5	0.8	0.1	662.5	0.7	278.6	71.5	2.0	144.2	4.0	0.4	1.0	652.8	25.6	2.8	60.4	1500.4	172.1	87.9	0.6	386.2	896.7	707.4	222.2	3.4	246.5	789.2	2.1	231.0	353.7	104.5	0.7	1.2	4.7	3.4	3.2	56.1	76.4	47.6	1.0	11.2	1.0	515.9	127.4	531.9	3.8	91.1	7.9	143.2	44.2	21.5	297.7	160.4	86.1	80.4	56.4	19.0	64.4	523.5	19.1	142.8	56.9	57.3	47.2	66.3	58.9	92.9	52.0	54.8	56.2	47.6	70.3	51.0	8.0	368.6	233.9	10.4	90.9	376.9	563.9	954.0	278.9	14.3	487.2	518.2	2.8	316.0	655.6	559.1	6.2	1371.3	79.5	1028.3	101.8	866.9	61.8	401.4	47.3	24.3	360.5	83.9	20.7	659.8	502.0	34.6	234.5	490.4	115.5	371.8	32.5	2.0	230.3	3.3	39.8	672.8	734.5	55.5	139.0	55.6	19.0	133.6	88.9	24.4	364.3	129.6	1.0	4.5	9.0	910.4	889.4	17.0	61.3	684.9	918.6	208.8	495.1	17.2	52.6	1.2	76.7	545.2	264.1	507.7	428.3	1413.2	42.6	3.4	582.2	989.6
SPINT3	HKIB9	ENSG00000101446	"Serine peptidase inhibitor, Kunitz type 3"	P49223	20	45512461-45515622	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.8;seminal vesicle: 10.7"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 1.5;Endometrial ciliated cells: 1.4;Glandular and luminal cells: 4.0;Suprabasal keratinocytes: 2.3;Urothelial cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026852	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 44: Endometrium - Transcription"			"HPA026852: AB_2732434"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.4
SPINT4	"C20orf137, dJ601O1.1"	ENSG00000149651	"Serine peptidase inhibitor, Kunitz type 4"	Q6UDR6	20	45722347-45725830	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	255	"epididymis: 278.8"	"Cell type enriched"	"Detected in single"	9	"Rod photoreceptor cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							HPA046703	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046703: AB_2732530"														"unprognostic (3.61e-1)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	278.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPIRE1	"KIAA1135, spir-1"	ENSG00000134278	"Spire type actin nucleation factor 1"	Q08AE8	18	12446512-12658134	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.8;Early spermatids: 167.4;Excitatory neurons: 165.2;Inhibitory neurons: 155.9;Late spermatids: 321.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.3;U-2197: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040737, HPA040942"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040737: AB_10960987, HPA040942: AB_10960492"	"unprognostic (3.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-1)"	7.6	17.4	22.1	3.8	22.8	1.0	9.0	22.5	27.8	8.6	6.6	7.7	1.7	7.6	5.5	7.2	5.2	7.2	20.7	23.5	18.9	10.7	5.0	10.8	2.8	20.4	20.3	8.0	5.1	17.5	6.1	6.4	20.3	8.3	3.1	14.7	8.9	8.0	20.6	8.4	3.2	8.3	19.9	4.5	5.5	33.6	25.3	3.4	13.2	19.3	4.0	9.1	5.8	26.8	19.0	8.2	17.7	19.7	19.5	17.3	0.9	20.1	20.7	19.4	18.4	0.9	4.1	8.9	22.2	26.0	32.2	4.1	24.0	18.0	24.4	13.4	11.9	5.5	16.9	10.7	40.0	3.9	13.6	12.0	33.4	33.6	97.3	22.4	26.3	3.0	14.2	0.2	29.1	25.2	1.0	5.2	7.5	6.7	20.2	0.0	21.8	19.0	23.5	25.5	25.9	10.6	21.8	17.9	45.3	7.9	5.7	11.7	32.3	32.0	9.5	75.4	24.1	6.6	0.7	0.6	25.6	2.4	8.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.1	22.8	22.5	27.8	23.5	18.9	20.4	20.3	20.3	19.9	25.3	26.8	10.1	25.6	43.2	151.8	0.5	3.7	9.7	8.3	1.2	60.5	15.6	12.3	28.5	7.2	13.6	12.9	8.4	0.1	2.5	0.5	21.5	8.2	167.4	5.7	25.6	10.7	3.0	0.8	165.2	4.9	0.9	13.0	2.0	7.9	15.8	11.5	5.3	4.6	14.2	26.9	155.9	3.7	0.0	17.2	5.3	321.5	5.9	12.9	17.8	30.9	2.3	15.5	0.0	93.5	91.2	11.7	0.1	10.9	1.1	23.1	0.2	1.0	8.4	13.2	19.7	20.0	15.4	17.4	17.5	2.0	2.3	0.5	2.2	16.7	0.1	16.8
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 54.9;Gastric mucus-secreting cells: 46.9;Intestinal goblet cells: 43.8;Paneth cells: 39.9;Syncytiotrophoblasts: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 29.5;T-47d: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: AB_2677464, HPA049415: AB_2680755"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.6	2.1	8.8	1.2	9.0	1.2	1.9	12.5	12.3	2.5	3.8	15.7	7.8	1.7	1.8	2.9	6.1	2.0	0.9	9.1	7.6	4.5	6.5	2.3	0.5	9.8	7.9	1.8	2.2	3.6	21.5	4.5	10.4	4.7	8.2	3.1	2.5	3.1	0.6	2.0	9.2	1.0	5.5	1.0	14.4	5.0	7.5	0.4	6.9	0.0	0.4	6.1	2.2	8.5	0.4	8.4	5.2	4.2	1.4	0.9	17.5	2.7	1.6	3.9	1.6	3.2	9.0	5.8	1.2	0.8	4.0	9.0	2.2	0.3	1.1	2.2	10.1	1.3	7.1	8.9	1.4	0.3	1.8	1.8	2.0	1.2	1.0	0.5	0.2	0.5	9.2	1.4	1.1	12.8	0.1	2.2	5.7	29.5	5.3	4.6	1.9	1.3	2.0	8.6	13.6	7.0	11.6	5.0	5.1	4.4	18.8	3.0	0.4	2.3	4.9	3.3	2.5	0.7	3.7	0.5	3.5	2.1	4.9	2.4	0.5	0.3	0.4	0.3	0.2	0.4	0.3	0.2	0.1	0.7	0.4	0.4	2.0	0.5	0.5	0.6	0.2	0.3	8.8	9.0	12.5	12.3	9.1	7.6	9.8	7.9	10.4	5.5	7.5	8.5	0.7	6.4	4.8	10.7	0.6	0.9	5.1	1.7	2.2	13.0	4.3	2.8	2.4	14.3	2.4	12.9	4.2	15.7	2.1	54.9	3.9	1.5	3.1	11.9	2.6	1.1	15.7	0.0	20.2	0.4	3.6	1.4	46.9	3.2	0.0	4.2	0.0	2.4	2.7	23.5	23.6	43.8	2.0	1.0	1.1	2.5	0.9	1.4	0.0	1.9	0.2	2.8	1.0	7.1	4.1	1.5	39.9	1.9	0.7	5.0	29.8	0.8	13.5	10.7	0.0	2.8	1.6	6.0	8.8	3.8	0.6	70.5	1.3	5.7	33.5	30.2
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	4.0	0.6	0.8	14.4	1.0	71.8	1.8	1.1	0.9	1.4	0.2	3.9	5.5	1.6	1.1	3.0	2.0	4.3	2.8	0.9	1.4	0.8	2.6	28.3	26.3	3.5	1.3	0.6	1.0	0.6	0.2	0.9	2.5	1.3	5.3	0.3	2.3	1.1	0.8	2.8	6.3	2.3	1.8	19.0	5.0	0.4	2.5	51.1	0.8	0.3	23.0	4.2	0.5	4.1	0.2	0.2	0.1	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.1	0.6	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	278.8	0.2	2.0	0.0	281.5	158.3	0.0	0.0	0.1	0.0	0.1	0.0	68.0	96.1	76.9	0.5	0.2	122.2	70.1	0.1	0.0	0.0	98.4	1.1	2.2	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.1	164.1	0.4	0.0	0.2	0.2	0.2	0.3	5.8	40.7	0.3	205.4	0.3	13.6	23.2	14.6	96.3	96.3	51.4	3.7	38.5	65.5	34.0	1.1	26.3	47.6	3.6	69.4	218.0	27.2	34.7	52.1	0.8	1.0	1.1	0.9	0.9	1.4	3.5	1.3	2.5	1.8	2.5	4.1	1.2	9.6	16.9	0.0	10.8	2.2	0.9	0.0	0.0	0.6	1.0	0.8	5.3	1.5	2.5	1.8	0.0	0.2	131.6	0.1	0.0	0.1	0.1	0.5	0.6	3.0	0.0	125.9	0.0	0.0	0.4	3.0	5.1	0.7	43.7	0.8	4.6	1.5	27.0	1.7	0.0	0.3	0.0	28.8	30.3	0.0	0.0	65.8	1.8	1.9	66.4	0.5	352.2	1.5	0.0	0.0	0.1	0.0	60.3	0.5	0.1	0.6	1.5	1.9	0.0	0.8	1.0	0.2	0.6	0.1	2.0	0.3	94.8	0.1	0.2	0.6
SPNS1	"HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	26.8	30.8	17.0	19.3	17.4	37.0	24.8	17.1	26.3	27.7	18.6	32.5	22.4	30.9	6.6	25.9	23.0	18.0	27.5	16.9	15.7	32.1	33.9	31.5	20.1	19.1	16.6	22.0	24.4	20.8	21.1	19.8	17.2	26.5	10.0	6.5	24.4	14.9	25.0	35.7	27.8	15.1	15.8	33.9	28.2	20.3	19.8	20.8	27.8	14.9	10.5	30.5	25.2	18.3	25.9	59.6	22.2	51.9	41.5	22.8	62.9	28.2	28.9	46.1	40.9	55.0	60.4	16.4	67.8	25.5	38.2	53.3	36.4	31.2	16.4	19.0	61.6	23.8	57.1	69.3	70.4	26.7	49.2	38.4	40.9	49.7	21.0	26.8	42.9	30.0	54.4	28.7	23.4	68.8	29.3	75.8	52.6	20.8	39.1	36.7	26.7	73.6	24.9	24.8	39.5	51.3	20.1	59.3	44.9	18.5	59.2	31.9	36.6	37.3	28.2	52.7	22.0	43.2	36.7	15.6	47.7	40.4	30.8	13.4	32.8	13.5	9.9	42.1	8.3	5.7	9.8	13.0	27.6	4.3	10.0	6.8	5.6	7.7	28.8	11.5	12.1	18.1	17.0	17.4	17.1	26.3	16.9	15.7	19.1	16.6	17.2	15.8	19.8	18.3	24.4	6.4	7.2	8.8	14.9	21.3	21.3	29.8	14.8	31.0	17.2	15.7	0.3	20.0	20.1	20.2	29.2	63.3	26.5	10.5	13.7	58.1	2.1	15.3	19.2	24.1	12.2	21.8	10.2	45.7	72.3	24.6	16.8	18.9	22.7	40.9	19.2	14.3	98.7	26.9	10.3	13.8	46.8	45.6	28.4	3.7	22.7	61.8	33.8	15.0	32.7	28.5	24.7	7.1	8.6	37.3	16.0	16.6	18.6	14.4	41.5	18.2	26.2	38.6	6.6	17.4	23.8	24.8	33.5	16.4	22.7	87.3	20.7	37.8	20.0	19.4
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPNS3	"MGC29671, SLC62A3"	ENSG00000182557	"Sphingolipid transporter 3 (putative)"	Q6ZMD2	17	4433940-4488208	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"bone marrow: 31.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 30.9;Langerhans cells: 16.4;Proximal tubular cells: 51.8;T-cells: 23.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"eosinophil: 354.8;plasmacytoid DC: 127.7"	"Group enriched"	"Detected in many"	37	"dendritic cells: 127.7;granulocytes: 354.8"	"Group enriched"	"Detected in some"	4	"JURKAT: 29.5;NB-4: 46.8;THP-1: 35.5;U-937: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023928	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023928: AB_1844393"	"unprognostic (4.39e-2)"	"unprognostic (8.10e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (6.18e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.3	1.4	0.2	31.2	0.3	0.4	0.4	0.2	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.7	0.2	0.2	0.7	0.2	0.1	0.2	2.0	0.8	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.7	0.1	0.6	2.1	0.3	0.0	0.5	3.6	0.0	0.0	1.1	0.3	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	2.4	0.0	0.0	8.1	46.8	0.0	0.2	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.6	0.0	22.1	0.0	0.3	6.5	354.8	1.1	1.3	0.7	0.2	0.0	1.5	47.6	0.3	0.4	1.7	1.0	0.2	0.1	127.7	0.0	6.2	0.3	0.2	0.4	0.4	0.2	0.7	0.8	0.4	0.5	0.6	0.5	0.7	0.5	3.2	1.1	0.0	4.3	1.3	0.1	0.4	0.0	0.0	1.0	0.8	0.8	1.5	1.6	0.0	0.0	0.3	30.9	0.5	3.9	2.0	1.1	0.8	0.0	0.6	0.0	4.8	0.9	0.0	6.1	0.3	2.0	0.1	0.0	0.0	0.7	0.3	1.4	0.0	0.8	2.1	6.1	5.5	16.4	2.6	0.0	9.8	1.8	3.7	6.7	0.0	11.3	0.0	0.1	1.1	1.4	0.0	0.6	0.5	10.9	51.8	5.0	0.0	0.0	0.3	0.6	0.0	0.3	0.2	0.4	0.3	23.7	0.0	2.5	2.1
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 9.7;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 13.2;Pancreatic endocrine cells: 30.9;Smooth muscle cells: 10.4;Spermatogonia: 13.1;Urothelial cells: 48.6"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.9;hTEC/SVTERT24-B: 51.5;RT4: 89.2;TIME: 46.2;U-87 MG: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	3.0	0.4	1.1	3.1	1.8	0.1	1.6	1.1	4.0	3.0	2.5	0.4	0.9	2.2	0.3	0.3	1.1	0.9	0.2	1.2	1.8	0.5	0.1	7.3	0.1	7.6	2.9	0.3	0.0	0.0	1.5	0.3	4.2	1.6	0.5	0.0	0.3	0.1	0.1	0.3	0.9	1.4	1.6	1.9	0.9	9.7	11.8	0.2	0.3	0.0	0.0	9.5	0.9	3.1	29.8	0.8	0.1	0.1	0.5	4.0	1.4	37.7	49.9	35.8	23.7	0.5	1.7	0.5	5.0	42.7	14.7	3.9	0.0	0.7	11.2	0.1	0.1	0.0	5.8	0.2	1.7	0.0	0.6	17.7	0.6	51.5	1.7	28.9	24.4	2.0	0.7	0.6	21.5	0.1	0.2	0.0	0.7	0.4	0.8	0.0	3.8	0.0	0.1	89.2	0.0	0.0	0.9	0.2	2.6	1.2	21.6	0.0	46.2	37.4	3.9	24.6	14.3	0.2	0.3	0.1	84.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	1.1	1.8	1.1	4.0	1.2	1.8	7.6	2.9	4.2	1.6	11.8	3.1	0.2	0.0	3.7	0.3	0.0	0.1	6.5	4.5	0.0	0.0	0.3	0.1	0.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.3	1.7	0.6	2.3	1.8	0.0	0.4	9.8	0.6	1.0	0.0	5.9	1.3	0.2	0.4	0.0	13.2	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	1.6	30.9	0.0	0.4	0.1	2.5	0.0	0.1	0.3	0.0	0.0	5.1	10.4	0.0	13.1	0.0	0.0	0.3	0.4	0.1	0.0	48.6
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 172.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 252.8;Inhibitory neurons: 349.9;Muller glia cells: 243.8;Oligodendrocyte precursor cells: 273.4;Oligodendrocytes: 913.1;Peritubular cells: 150.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 573.1;hTERT-RPE1: 1112.8;HUVEC TERT2: 594.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	29.7	41.4	67.9	4.1	116.3	0.3	19.0	129.2	99.5	25.6	9.9	24.9	1.2	44.2	34.3	6.1	18.6	18.6	54.2	100.5	50.9	24.3	0.2	2.9	0.6	80.7	84.5	4.8	5.5	13.7	9.9	9.3	89.8	65.6	3.2	48.7	7.6	25.5	17.5	9.3	4.6	30.7	78.4	8.5	9.1	21.7	102.6	7.5	9.4	7.1	0.4	11.4	21.7	172.9	4.6	0.9	299.4	0.4	573.1	116.0	0.4	100.6	90.0	207.7	115.9	0.0	0.6	0.4	0.2	206.7	53.3	4.4	1.4	70.3	65.3	17.8	0.6	0.2	16.7	0.0	4.0	0.0	0.4	203.8	28.5	128.6	23.2	1112.8	594.4	0.2	0.0	0.4	60.5	0.5	0.0	0.2	19.1	0.0	28.4	0.0	0.2	0.0	140.3	9.4	3.7	14.4	49.9	0.8	0.1	35.6	0.4	1.2	98.9	294.0	10.6	102.1	28.5	0.1	0.1	0.1	159.4	4.4	136.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	67.9	116.3	129.2	99.5	100.5	50.9	80.7	84.5	89.8	78.4	102.6	172.9	2.0	0.0	0.0	91.7	0.0	1.8	1.6	5.8	0.0	9.7	0.4	0.4	58.8	1.5	0.4	22.0	2.1	0.4	0.0	0.2	1.9	0.6	12.0	4.2	37.9	8.4	35.0	0.0	252.8	1.4	0.3	58.8	0.0	2.9	0.0	0.1	1.1	0.0	0.9	8.4	349.9	0.1	16.2	1.2	3.0	9.5	17.4	1.6	7.2	17.8	2.3	243.8	0.0	273.4	913.1	2.0	0.1	150.1	0.1	40.9	0.0	3.1	0.9	7.3	13.1	11.6	16.4	7.4	7.1	0.7	1.4	0.1	0.4	0.0	0.3	3.2
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059034-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.1;lymphoid tissue: 114.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3"	"Lineage enriched"	"Detected in all"	8	"T-cells: 198.8"	"Group enriched"	"Detected in some"	7	"Hep G2: 50.2;SCLC-21H: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		34000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	9.4	46.6	152.6	44.5	108.0	58.1	3.8	160.4	143.2	4.2	2.8	7.6	9.2	4.0	3.1	3.3	6.2	15.3	10.0	117.4	150.1	68.0	2.7	86.5	67.3	212.1	157.7	7.1	1.6	2.0	44.0	3.4	220.1	4.7	5.4	33.4	3.3	5.6	5.1	1.8	32.3	4.4	127.9	29.1	13.6	25.1	207.3	114.4	10.4	6.7	45.3	9.9	3.8	95.6	0.2	0.4	0.3	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	8.2	0.3	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.8	0.2	1.4	50.2	1.6	0.4	1.2	0.1	0.4	0.0	0.0	0.2	0.1	2.7	0.1	0.8	0.0	0.3	0.9	0.3	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.3	68.2	4.1	0.1	1.5	0.4	0.3	0.0	1.9	0.2	0.0	0.3	0.3	0.1	0.7	1.7	7.3	0.3	0.1	0.2	0.6	0.4	0.2	117.5	1.2	198.8	23.6	115.9	93.5	0.3	18.3	87.8	89.4	13.5	14.4	0.4	3.5	174.3	48.4	152.6	108.0	160.4	143.2	117.4	150.1	212.1	157.7	220.1	127.9	207.3	95.6	17.3	288.4	10.0	51.9	54.6	3.8	0.4	2.1	0.0	116.5	1.9	2.0	3.1	1.5	4.1	14.7	6.2	0.1	86.4	2.4	0.0	3.6	8.1	2.5	1.0	29.9	4.9	3.6	39.6	0.8	0.1	8.4	3.6	1.0	3.8	0.2	7.9	0.4	0.2	3.3	81.1	1.3	2.0	1.6	7.9	10.5	5.3	5.5	5.4	75.9	4.1	5.0	90.6	28.6	8.3	0.0	4.4	6.0	34.2	0.5	0.1	0.5	2.4	17.6	0.0	17.9	2.4	6.3	1.1	0.5	4.4	0.4	195.1	0.8	0.7	0.3
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
SPOPL	BTBD33	ENSG00000144228	"Speckle type BTB/POZ protein like"	Q6IQ16	2	138501770-138573547	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034687	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034687: AB_10670573"	"unprognostic (1.39e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (3.63e-4)"	"unprognostic (2.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.91e-3)"	7.9	5.9	6.1	9.7	8.1	14.2	12.7	6.7	8.0	6.6	4.8	8.3	7.9	8.5	3.6	6.2	6.6	7.3	5.4	5.5	6.2	8.8	9.4	7.6	11.3	7.6	9.1	10.3	5.6	7.3	4.3	6.8	7.9	9.4	8.9	9.8	11.5	8.1	4.6	8.5	8.4	7.4	7.6	11.2	9.3	3.7	7.1	4.9	8.5	8.0	9.7	8.0	6.3	9.1	13.3	4.0	7.2	7.0	5.8	9.7	13.8	9.6	7.2	5.9	7.0	14.8	10.6	14.2	9.0	8.3	5.3	5.1	9.5	8.4	12.4	11.1	7.7	9.0	9.2	23.2	6.0	10.0	12.1	6.4	12.3	11.7	10.8	12.0	9.6	3.3	3.0	19.2	10.1	12.9	1.0	9.4	6.5	9.3	6.9	5.0	12.6	8.1	9.3	18.7	8.4	10.3	14.7	13.8	7.3	8.5	7.6	10.9	9.6	9.5	8.1	12.0	14.7	27.6	21.6	10.3	15.9	9.2	8.8	0.4	1.6	2.8	0.3	1.5	0.3	1.1	0.2	0.3	2.2	1.1	0.1	0.2	5.7	0.4	1.3	0.9	0.4	0.6	6.1	8.1	6.7	8.0	5.5	6.2	7.6	9.1	7.9	7.6	7.1	9.1	16.9	12.8	13.6	25.8	25.9	55.6	11.4	7.9	13.6	9.9	38.8	13.8	13.2	15.7	20.6	3.7	4.2	6.4	15.0	20.3	7.9	10.1	1.7	11.9	10.3	12.4	19.2	5.0	55.3	13.3	7.3	12.3	17.3	11.8	8.8	12.5	8.9	13.8	8.9	18.5	67.2	19.8	18.3	31.5	37.7	2.8	17.1	33.2	12.4	48.7	27.5	9.2	9.2	63.8	54.1	21.1	12.6	15.8	11.8	19.5	11.0	16.4	16.1	16.6	6.6	18.8	18.5	10.0	18.8	10.3	44.8	6.2	10.8	4.9	12.0	21.3
SPOUT1	"C9orf114, CENP-32, HSPC109"	ENSG00000198917	"SPOUT domain containing methyltransferase 1"	Q5T280	9	128819651-128829794	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.0;Extravillous trophoblasts: 25.2;Granulosa cells: 32.5;Hofbauer cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076946	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA076946: "	"unprognostic (1.85e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.70e-2)"	17.0	19.0	20.8	14.3	21.4	13.5	18.3	20.2	25.6	20.0	19.1	18.3	11.2	17.6	5.7	25.7	19.9	9.1	21.2	20.0	20.8	26.0	45.1	16.8	18.9	20.6	20.9	20.0	22.9	9.1	20.6	9.5	19.9	32.7	5.5	6.5	18.7	8.6	20.6	23.7	20.6	8.1	19.4	30.8	22.9	13.2	21.4	13.4	22.8	6.0	10.3	22.8	19.8	21.6	13.7	31.2	25.2	37.2	14.1	14.2	44.5	14.5	8.7	26.3	14.2	44.1	24.1	27.5	15.6	14.9	26.8	56.3	23.3	22.6	8.7	26.3	24.2	21.8	51.6	36.6	15.4	32.6	39.2	14.8	18.9	18.2	18.9	11.2	19.6	40.3	44.7	24.0	14.9	88.1	40.8	66.5	33.2	63.5	39.5	44.0	24.1	48.7	17.5	25.4	29.6	28.7	27.7	40.7	19.0	14.0	40.3	36.5	20.0	37.3	16.6	25.6	38.2	26.1	47.0	28.9	23.7	28.3	30.8	5.5	11.7	6.1	24.7	12.6	25.5	19.1	19.9	22.8	13.9	19.3	19.5	19.7	2.9	25.2	10.3	15.7	19.8	17.4	20.8	21.4	20.2	25.6	20.0	20.8	20.6	20.9	19.9	19.4	21.4	21.6	9.3	3.2	10.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	19.2	12.2	0.0	0.0	8.1	9.2	0.0	34.0	10.8	0.0	11.7	15.7	0.0	6.4	10.2	6.1	0.0	0.0	0.0	17.6	25.2	4.3	0.0	7.7	13.9	32.5	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.8	0.0	0.0	19.3	4.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	10.4	5.4	12.1	0.0	0.0
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765709	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	41.1	34.7	8.3	57.6	10.9	54.5	32.0	11.1	8.5	36.6	48.6	93.4	79.6	27.9	21.5	26.5	26.8	39.4	37.1	6.8	12.3	57.9	107.0	43.4	40.2	15.3	12.8	13.6	63.7	158.5	13.0	54.1	12.5	29.5	82.8	12.5	44.5	32.6	109.3	25.2	67.6	41.0	11.2	37.3	41.7	18.5	12.1	39.5	35.2	81.8	41.7	51.7	20.9	14.5	57.3	96.9	37.0	49.2	142.3	84.3	58.2	89.1	149.1	80.5	114.1	113.1	64.3	35.1	65.0	176.3	120.7	83.5	45.2	54.3	89.5	72.2	27.5	67.0	61.5	58.9	117.4	42.0	104.5	73.9	98.3	66.8	106.7	59.4	80.2	37.7	51.3	134.2	107.6	131.5	20.1	16.2	15.8	90.8	22.0	24.2	57.3	77.6	109.7	130.4	29.7	33.4	54.0	102.7	63.4	74.0	73.2	81.6	98.9	128.7	51.7	83.7	106.7	54.0	100.2	38.8	58.1	69.4	90.3	48.7	52.3	48.9	27.9	48.6	17.4	18.3	22.3	25.5	37.4	19.2	12.4	20.5	37.7	23.5	56.6	33.1	30.4	50.2	8.3	10.9	11.1	8.5	6.8	12.3	15.3	12.8	12.5	11.2	12.1	14.5	66.2	48.1	35.9	20.5	51.9	43.1	79.1	76.3	37.5	14.8	36.4	21.3	77.5	52.9	44.3	68.0	20.9	136.5	72.7	215.5	23.5	87.1	18.8	107.2	56.6	59.6	38.4	30.3	32.0	167.1	88.3	74.3	52.0	57.3	45.7	20.5	46.8	124.1	85.9	8.4	31.4	86.5	36.7	68.7	55.7	7.0	44.7	83.0	32.0	23.4	134.5	27.5	64.9	25.6	26.2	131.9	127.3	36.5	49.9	92.2	143.0	46.8	41.8	17.2	26.3	88.0	51.6	31.7	15.3	39.3	38.8	204.5	60.6	30.8	76.0	94.1
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2355095	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 109.1;Late spermatids: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	23.1	23.2	13.7	16.7	13.6	29.1	27.4	15.5	18.6	28.4	17.4	43.4	41.6	26.4	4.4	22.5	34.0	10.7	21.6	11.8	12.1	35.9	33.0	22.2	20.7	19.2	15.6	27.2	50.7	11.0	63.8	10.4	15.5	32.5	9.2	7.1	27.2	9.8	25.3	28.9	52.6	5.9	13.2	39.1	33.9	63.5	15.1	12.0	40.5	3.1	9.9	21.9	20.9	16.4	16.6	25.9	10.9	19.5	8.8	8.9	27.8	21.1	6.1	7.6	8.1	18.2	18.4	15.7	19.4	9.9	7.1	21.7	3.6	7.3	2.3	18.4	16.0	10.4	44.7	24.9	16.5	18.6	13.1	13.1	8.2	7.2	5.2	11.9	10.7	32.2	17.3	39.0	4.7	18.4	20.2	23.6	20.4	14.7	10.5	33.4	5.8	43.9	8.3	41.0	19.4	18.3	21.2	12.8	16.7	7.1	21.3	30.8	24.3	13.8	9.7	35.3	16.9	51.0	20.1	16.7	17.3	21.4	24.5	11.5	7.7	7.4	6.2	7.7	4.4	8.2	5.6	6.0	9.4	12.5	6.9	7.7	3.3	6.4	5.4	17.0	6.0	6.4	13.7	13.6	15.5	18.6	11.8	12.1	19.2	15.6	15.5	13.2	15.1	16.4	23.6	3.2	17.2	57.1	30.8	0.0	6.5	0.0	8.0	26.1	21.6	21.5	6.0	20.0	5.0	25.8	47.9	50.6	18.8	79.5	1.9	16.6	51.4	39.3	22.2	14.4	40.7	14.5	25.3	11.5	20.8	14.2	109.1	25.5	7.0	39.9	13.2	15.1	11.8	32.0	30.3	63.2	0.0	9.4	0.0	107.7	14.9	10.8	0.0	9.4	8.0	13.2	19.6	39.7	35.2	10.4	49.9	15.8	11.5	7.3	57.8	7.9	10.9	39.4	0.0	15.0	11.7	57.0	13.5	10.8	0.0	42.8	11.0	36.4	49.8	6.0
SPPL2C	IMP5	ENSG00000185294	"Signal peptide peptidase like 2C"	Q8IUH8	17	45844881-45847067	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 36.8"	"Group enriched"	"Detected in some"	146	"Early spermatids: 202.7;Late spermatids: 615.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077339	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA077339: "	"unprognostic (6.70e-4)"				"unprognostic (1.34e-1)"													0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	615.6	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904358	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"		"HPA004194: AB_2667171, HPA059958: AB_2684179"	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	20.9	14.9	25.3	11.9	28.1	20.9	24.2	29.0	27.5	30.0	13.1	26.7	18.2	26.3	15.7	44.3	28.6	18.7	18.1	25.4	30.6	22.8	19.3	20.4	15.9	25.0	26.0	31.4	21.3	49.6	13.9	28.4	26.1	20.6	27.2	15.5	20.2	27.0	15.7	56.5	18.8	29.6	24.1	24.3	15.2	39.0	26.4	32.7	31.2	19.6	27.8	28.6	34.2	31.4	30.0	29.2	43.4	27.4	56.2	37.7	30.5	22.5	66.6	47.4	37.9	30.5	29.9	27.4	0.1	39.4	42.0	35.6	44.8	48.4	48.9	21.9	27.5	23.6	16.2	23.4	59.2	27.4	29.3	38.1	75.9	40.7	38.1	56.0	47.1	41.5	26.5	13.4	41.2	26.3	36.7	22.0	29.2	27.8	20.6	21.6	36.6	19.7	36.8	83.8	29.7	31.9	42.8	19.6	34.7	46.1	58.9	18.7	35.4	21.9	29.5	13.6	17.1	30.9	60.3	26.4	32.5	22.3	36.9	4.8	1.2	1.1	1.3	1.2	1.8	1.3	1.6	1.7	2.1	1.6	1.5	1.7	2.2	1.3	1.1	2.7	1.4	0.7	25.3	28.1	29.0	27.5	25.4	30.6	25.0	26.0	26.1	24.1	26.4	31.4	35.2	19.2	20.8	79.3	25.3	55.1	32.3	29.4	43.3	37.8	35.2	24.1	21.2	20.0	19.8	40.5	27.1	42.0	21.2	47.2	1.9	19.3	8.6	20.9	26.9	33.0	27.1	14.5	97.2	24.7	29.0	33.2	25.0	29.7	4.5	68.7	37.5	33.1	38.3	37.0	112.6	33.7	22.4	38.1	39.3	8.0	28.6	34.5	26.6	79.6	26.6	23.0	16.5	141.3	192.3	22.8	34.9	35.0	22.0	33.4	34.0	18.1	18.1	22.4	13.1	32.3	27.4	55.6	41.1	76.9	84.7	64.6	22.4	35.0	35.4	37.6
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPRED1	"FLJ33903, PPP1R147"	ENSG00000166068	"Sprouty related EVH1 domain containing 1"	Q7Z699	15	38252836-38357249	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Excitatory neurons: 163.4;Microglial cells: 199.5;Oligodendrocyte precursor cells: 277.9;Oligodendrocytes: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042193, HPA061805"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA042193: AB_10794079, HPA061805: AB_2684617"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.21e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.27e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (7.37e-5)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (6.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.01e-1)"	12.7	8.2	16.0	8.8	20.3	0.7	10.9	14.7	20.6	11.5	7.1	11.4	8.2	10.9	5.7	6.1	6.9	12.8	7.3	16.5	16.3	9.1	5.6	17.4	7.1	18.9	19.6	7.9	4.5	6.8	4.0	14.0	16.2	7.2	10.9	7.5	5.6	8.6	2.6	6.1	8.4	9.5	15.6	9.0	10.3	8.2	17.9	4.4	31.1	8.0	4.9	13.2	6.8	18.3	11.0	8.2	59.0	11.3	21.4	39.0	4.8	25.1	24.7	13.1	16.2	7.6	8.7	0.1	9.0	21.7	9.5	8.6	6.2	17.3	26.2	1.5	2.0	13.0	5.2	7.3	26.3	7.1	34.6	25.5	8.5	25.5	23.4	33.6	10.7	6.5	11.7	12.1	32.2	2.9	2.6	5.2	12.0	37.6	22.0	0.0	13.3	7.3	21.2	16.9	2.9	13.0	7.2	3.5	26.7	9.3	2.8	1.7	18.2	32.0	15.7	19.7	15.4	10.1	7.1	16.7	22.5	2.8	52.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	16.0	20.3	14.7	20.6	16.5	16.3	18.9	19.6	16.2	15.6	17.9	18.3	26.4	99.3	26.9	173.7	2.5	28.3	24.6	9.4	45.5	12.6	17.2	20.8	7.2	28.6	12.6	1.8	6.2	1.3	1.5	15.7	1.9	9.5	40.3	12.0	29.4	28.2	6.7	4.6	163.4	4.9	0.9	33.0	17.3	14.8	41.8	5.4	26.7	4.1	57.8	5.0	100.0	21.2	6.1	48.2	24.6	9.6	21.8	38.7	28.4	199.5	7.3	25.4	0.0	277.9	146.9	15.1	7.8	30.5	1.6	12.7	6.6	12.8	11.4	5.2	6.6	44.4	44.1	8.0	5.0	18.1	9.7	1.4	2.4	21.4	15.3	14.7
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 1.9;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;NK-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	23.9	11.4	12.0	9.7	15.3	7.0	21.7	11.8	22.8	13.5	5.6	16.5	14.9	16.5	8.6	10.9	13.3	13.2	14.7	14.4	11.4	13.7	24.8	18.4	14.0	14.4	12.5	14.0	18.0	16.7	11.5	15.8	11.2	12.3	16.1	10.9	15.9	10.8	8.0	11.3	13.7	11.5	11.1	8.5	19.8	7.4	13.3	28.7	17.9	13.9	15.4	15.5	14.0	12.7	60.4	32.9	32.2	32.4	41.1	40.9	22.2	16.1	25.2	10.9	14.5	43.4	16.4	41.2	9.2	20.8	29.2	18.7	18.2	37.2	21.9	52.3	11.6	9.7	9.1	45.2	21.0	25.7	18.8	33.1	22.2	37.2	36.9	22.9	6.9	24.9	39.1	16.9	17.7	40.9	22.6	26.7	16.1	43.4	35.4	17.1	28.6	24.2	34.1	52.3	13.1	45.1	18.1	14.8	44.2	20.1	15.1	23.7	11.4	27.6	35.8	23.8	27.4	33.2	13.8	73.7	44.7	27.1	54.2	0.0	0.2	0.0	0.6	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.6	1.9	0.3	4.2	0.0	0.7	12.0	15.3	11.8	22.8	14.4	11.4	14.4	12.5	11.2	11.1	13.3	12.7	49.7	19.2	16.0	108.7	1.8	39.9	29.0	12.0	41.5	17.8	22.7	17.7	7.5	14.3	6.6	9.2	6.2	11.0	3.3	32.0	13.7	11.0	1.5	16.8	11.4	18.6	11.4	1.7	138.5	8.6	8.4	21.0	14.8	35.0	1.3	2.8	13.9	14.1	6.7	25.2	122.4	24.1	8.2	7.5	67.6	4.1	17.1	10.2	19.6	68.4	26.0	7.9	0.0	124.1	23.2	13.9	21.5	12.4	0.5	23.4	17.1	7.4	7.2	9.8	26.3	17.0	17.4	3.9	10.4	16.6	16.8	3.0	3.8	4.7	10.9	24.0
SPRING1	"C12orf49, FLJ21415, LUR1, POST1, SPRING"	ENSG00000111412	"SREBF pathway regulator in golgi 1"	Q9H741	12	116710171-116738070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 37.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.5;Cytotrophoblasts: 11.5;dendritic cells: 9.8;Extravillous trophoblasts: 37.5;Hofbauer cells: 40.9;Syncytiotrophoblasts: 17.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Intracellular and membrane"	NA	NA		330000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	5.4	8.2	13.0	7.9	14.8	6.2	5.9	14.3	13.0	3.5	8.5	11.1	6.6	4.3	8.5	7.8	3.4	5.7	7.0	11.5	15.5	15.2	8.7	18.5	8.5	18.2	16.3	3.5	6.8	7.1	6.8	4.4	16.4	4.6	8.4	5.7	13.7	4.2	3.1	6.3	6.4	3.9	13.7	7.2	11.4	9.2	18.4	9.8	37.4	2.4	8.8	5.4	4.1	12.1	12.6	16.7	15.2	15.2	17.4	13.8	19.0	8.6	11.5	9.5	8.2	32.9	9.3	32.3	16.6	11.9	14.1	16.0	21.3	13.2	10.6	26.0	17.1	9.2	8.5	31.6	12.2	17.8	27.3	16.8	16.3	12.4	14.0	16.1	14.5	21.3	10.0	7.3	15.3	18.9	16.2	16.5	24.4	19.2	19.4	24.0	10.3	14.0	24.1	33.7	14.0	17.4	14.0	14.0	25.9	17.1	16.9	18.3	18.9	14.1	19.4	20.0	17.1	15.0	48.7	45.6	22.9	18.2	16.9	3.1	2.4	4.1	4.5	3.3	4.6	5.6	3.5	3.7	2.2	4.9	3.0	4.1	1.7	2.9	2.3	4.3	3.9	1.7	13.0	14.8	14.3	13.0	11.5	15.5	18.2	16.3	16.4	13.7	18.4	12.1	10.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	11.5	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	37.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	17.9	1.6	0.0	0.0	0.0
SPRR1A		ENSG00000169474	"Small proline rich protein 1A"	P35321	1	152985231-152985500	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 8971.2"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 77.2;Club cells: 33.0;Squamous epithelial cells: 41.7;Suprabasal keratinocytes: 144.8"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 1736.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HaCaT: 23.8;hTCEpi: 68.6;RT4: 26.4"									CAB011237	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB011237: "		"unprognostic (1.39e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.64e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"prognostic unfavorable (1.03e-4)"			"unprognostic (1.96e-1)"			"unprognostic (1.04e-1)"	1.1	1.2	0.0	0.0	0.0	0.0	13.2	0.1	0.0	1261.6	0.0	0.7	0.0	1.0	0.0	8971.2	1.2	69.5	3.6	0.0	0.1	1.0	2.1	0.6	0.0	0.1	0.1	1.7	2.4	0.0	2.0	0.0	0.5	1.3	0.0	0.0	892.0	0.0	1.6	244.5	1.0	0.6	0.2	1.3	5.4	0.6	0.0	18.4	0.9	0.0	918.8	223.5	1935.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.8	0.0	0.0	0.0	23.8	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	26.4	0.4	0.0	2.2	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	0.1	77.2	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	3.8	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.0	41.7	144.8	0.0	0.1	0.0	0.0	17.1
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 4257.2;esophagus: 19480.4;vagina: 6062.0"	"Cell type enriched"	"Detected in some"	11	"Squamous epithelial cells: 987.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4"	"Not detected"	"Not detected"							HPA044467	Enhanced					NA	NA		5200		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	4.0	3.5	0.0	0.1	0.0	0.0	3.0	0.0	0.0	4257.2	0.0	2.6	0.1	3.5	0.0	19480.4	3.4	38.1	7.4	0.0	0.0	2.6	5.8	1.7	0.0	0.0	0.0	4.4	8.8	0.0	11.0	0.7	0.0	3.4	0.1	0.0	3157.9	0.0	5.0	7.5	4.2	1.7	0.0	3.4	15.2	2.1	0.0	1.4	2.3	0.0	2399.3	65.1	6062.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	3.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	12.6	0.0	0.0	0.3	2.7	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	7.4	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	5.9	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.2	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.4	0.0	0.1	2.1	0.0	0.0	0.0	1.0	0.0	0.0	987.1	0.0	7.5	0.4	0.1	0.0	89.6
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970648-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 145.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 54.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	145.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 85.5;Rod photoreceptor cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	4.4	3.6	2.9	5.0	3.7	11.8	5.4	3.9	3.5	4.2	3.6	3.7	4.0	4.9	4.1	5.7	3.4	4.4	4.4	2.6	3.3	4.6	5.1	3.7	6.3	3.1	3.2	3.1	2.7	4.8	2.7	7.8	3.6	3.9	3.8	4.9	3.5	3.6	8.5	5.9	3.6	4.9	3.2	5.0	4.1	14.5	3.0	7.2	5.1	5.3	6.2	4.8	3.3	4.5	13.7	11.4	10.5	11.5	9.6	6.8	12.7	12.1	10.5	13.6	11.8	13.2	11.4	12.4	12.8	10.1	5.4	19.6	15.2	12.2	14.7	10.6	26.1	7.8	11.1	9.1	10.2	13.3	11.0	9.3	12.7	15.0	12.2	6.2	13.8	11.1	19.0	11.8	13.9	7.5	14.1	7.5	10.4	15.6	10.0	12.3	13.6	14.7	12.0	10.2	13.2	12.8	13.0	9.8	13.9	4.7	17.9	19.3	10.5	11.7	11.8	17.1	19.9	9.1	10.0	17.0	9.1	11.2	20.4	8.6	4.6	9.8	5.1	6.6	5.7	4.9	5.1	5.8	4.6	3.2	6.1	6.8	9.5	6.6	4.8	4.3	5.9	3.6	2.9	3.7	3.9	3.5	2.6	3.3	3.1	3.2	3.6	3.2	3.0	4.5	14.5	16.0	4.2	8.8	19.9	32.0	11.4	9.3	27.3	22.6	11.6	13.1	5.2	10.0	11.4	3.7	85.5	12.0	25.2	10.3	9.8	8.7	20.5	16.6	13.2	16.1	12.0	12.4	12.5	9.3	10.6	12.3	12.2	9.8	26.1	11.4	13.6	7.0	9.6	15.2	11.9	7.0	12.2	9.5	12.5	8.4	9.0	10.1	7.2	8.4	15.8	13.6	34.0	10.6	21.3	12.1	7.1	7.9	10.2	10.5	11.0	8.1	16.8	73.7	13.1	14.4	13.7	51.8	21.4	20.5	28.4	15.2	20.9	11.6	8.5	14.5
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 238.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 61.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	238.1	38.4	6.5	22.3	7.9	22.7	154.3	7.6	9.0	71.9	26.6	46.6	15.7	40.9	24.1	42.5	81.2	83.8	73.1	7.5	8.4	35.6	21.5	58.3	13.0	5.5	5.4	30.0	31.8	37.4	27.3	49.6	5.8	52.0	27.5	19.0	45.2	24.7	49.9	79.8	25.2	57.7	5.6	17.0	35.1	10.2	7.6	29.2	92.7	49.9	10.1	74.4	71.0	6.0	6.3	1.8	95.4	194.1	76.5	51.6	6.4	0.4	4.9	0.3	2.0	5.8	10.3	0.0	42.4	2.9	0.4	1.2	2.6	4.6	0.7	0.1	10.0	2.2	0.0	31.0	21.7	14.2	0.1	21.1	2.5	0.7	2.1	10.5	8.1	2.2	1.7	1.9	4.7	0.7	16.4	34.8	22.8	22.6	32.0	7.1	10.3	0.2	13.2	14.5	14.5	12.3	0.1	19.4	19.6	10.1	1.9	0.0	20.2	1.2	0.2	0.4	2.9	1.0	0.1	0.2	1.4	2.6	3.2	0.1	0.4	6.5	1.1	0.2	33.1	29.8	4.0	9.2	0.1	61.2	5.7	6.4	0.4	14.2	0.1	1.7	0.0	2.0	6.5	7.9	7.6	9.0	7.5	8.4	5.5	5.4	5.8	5.6	7.6	6.0	771.3	28.9	28.3	14.4	16.2	49.6	17.3	37.3	68.9	86.2	22.8	69.6	16.9	32.9	20.6	27.6	33.3	12.7	21.6	10.4	80.3	5.0	2.5	45.9	41.9	352.8	26.5	5.7	5.0	10.9	1.7	222.3	8.2	67.4	9.5	0.2	166.3	5.9	10.1	6.7	2.2	15.0	14.2	15.3	37.9	10.5	448.0	17.1	46.2	5.6	0.7	158.3	0.0	7.5	0.3	7.0	6.3	57.9	6.1	16.8	8.1	38.7	11.7	84.5	151.2	245.0	81.6	6.2	9.6	37.0	43.3	3.1	57.3	1.8	17.9	13.5
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80341126	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: AB_2677896"	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	69.6	24.1	37.4	11.8	38.0	29.5	66.2	57.6	42.9	31.0	27.7	40.4	17.6	29.3	15.3	20.0	46.7	30.1	50.9	38.5	36.0	21.1	27.8	31.5	8.9	50.2	40.4	16.9	27.4	10.2	17.3	13.9	40.2	26.2	27.3	34.2	34.8	18.9	39.1	26.5	25.4	23.5	42.0	30.8	25.9	4.1	39.7	11.3	27.1	41.4	4.9	27.0	30.8	43.4	1.8	7.6	84.2	267.9	108.4	70.6	5.8	69.3	31.1	15.3	18.2	34.9	10.3	0.0	11.6	28.5	10.6	6.7	4.8	13.9	17.0	0.1	15.3	12.0	4.5	8.9	24.9	63.4	4.8	31.8	14.6	26.1	63.3	95.6	29.9	13.0	4.4	0.3	35.0	1.5	8.6	28.8	33.7	23.6	19.6	25.6	112.0	0.2	28.8	11.7	1.0	46.7	5.7	3.1	156.9	32.9	6.3	56.0	44.3	14.3	5.6	30.3	13.6	0.1	0.1	0.0	97.6	23.9	136.9	0.0	0.0	2.1	0.3	0.0	0.1	0.4	0.0	0.8	0.9	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.1	37.4	38.0	57.6	42.9	38.5	36.0	50.2	40.4	40.2	42.0	39.7	43.4	48.5	25.6	29.3	59.4	2.9	43.5	38.0	12.5	53.5	5.9	12.4	21.3	20.5	18.6	6.3	1.8	6.2	8.7	12.1	33.4	5.9	11.3	0.3	25.2	17.6	22.3	12.0	8.4	22.1	8.0	2.9	65.9	11.2	41.7	16.4	7.2	32.5	17.0	10.9	8.4	15.3	36.1	4.1	27.3	10.7	1.5	29.5	12.2	14.2	15.9	0.8	68.5	3.1	39.7	17.6	18.0	33.7	5.7	1.7	23.1	7.2	8.3	4.8	23.3	26.3	57.7	67.6	0.1	1.5	16.2	29.1	9.6	11.1	8.5	27.6	11.9
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155612572-155782459	"Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3"	"Group enriched"	"Detected in some"	7	"Astrocytes: 42.7;Excitatory neurons: 40.9;Inhibitory neurons: 43.5;Microglial cells: 62.8;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7"					"Low region specificity"	"Detected in many"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	0.9	1.2	1.5	0.4	1.5	1.7	0.8	5.3	1.8	0.8	0.1	0.8	0.8	1.0	2.7	0.7	0.8	0.7	0.8	1.4	1.0	0.6	0.6	0.7	0.4	2.0	1.3	1.7	0.4	0.8	0.8	1.3	2.0	0.6	0.8	1.4	0.8	0.7	0.9	0.4	0.8	0.8	0.7	0.9	0.6	0.4	1.5	0.4	0.7	1.0	0.5	0.6	0.5	1.0	0.4	0.2	1.5	5.7	1.1	0.6	0.0	1.6	0.9	0.5	0.8	0.4	0.9	0.0	2.8	0.9	1.2	0.3	0.8	0.3	0.5	0.1	0.2	0.8	1.8	0.1	0.5	0.3	0.3	1.3	1.0	0.6	0.3	0.4	0.9	0.4	0.1	0.5	1.0	0.2	0.2	0.2	0.6	0.2	0.0	0.3	0.2	1.4	0.5	0.7	0.5	0.4	0.8	0.0	0.2	0.8	0.5	0.4	1.2	0.5	0.8	0.3	0.4	0.5	0.1	1.2	1.4	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.5	5.3	1.8	1.4	1.0	2.0	1.3	2.0	0.7	1.5	1.0	4.0	0.0	0.0	42.7	0.3	0.1	0.1	0.2	0.0	3.4	0.5	0.4	1.7	0.0	0.3	0.0	4.2	0.1	0.2	1.9	0.0	0.2	0.0	5.2	1.2	2.2	0.0	0.4	40.9	0.6	0.2	0.6	0.5	5.0	0.0	1.1	2.2	1.1	0.3	0.0	43.5	1.4	0.0	0.8	0.3	0.0	0.9	0.5	1.8	62.8	0.7	0.6	0.0	32.2	20.3	0.6	0.1	0.0	0.2	0.1	0.9	0.4	0.3	1.3	0.0	0.9	2.0	0.0	0.0	0.5	0.1	0.0	0.3	2.5	1.0	0.2
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.2;WM-115: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207"	"unprognostic (9.54e-3)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	30.6	18.9	8.4	4.8	8.4	0.0	14.3	6.6	9.9	4.9	13.1	9.3	6.4	6.6	1.5	3.2	7.4	8.1	19.7	8.7	9.4	22.1	12.4	26.8	2.7	9.5	8.2	2.6	4.6	7.0	20.1	13.8	8.5	9.1	5.2	4.3	4.4	4.7	5.1	3.9	7.8	6.2	6.4	8.7	8.7	1.8	8.4	2.0	19.5	6.5	1.4	8.1	4.0	6.3	3.0	5.0	48.4	100.2	29.0	20.7	12.7	35.9	12.0	5.7	6.0	5.2	5.1	0.0	25.0	9.2	6.1	2.4	0.0	10.6	7.2	0.1	0.0	0.2	0.0	22.9	9.5	0.0	0.2	16.7	0.2	15.8	8.6	9.3	5.5	0.1	11.7	0.1	21.9	4.3	0.0	14.0	21.5	16.8	31.3	1.1	6.8	1.3	17.7	32.2	0.6	14.1	0.7	4.7	42.5	14.1	0.4	2.1	8.3	12.6	0.2	2.5	32.4	0.1	1.7	0.2	19.4	0.1	139.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.4	6.6	9.9	8.7	9.4	9.5	8.2	8.5	6.4	8.4	6.3	39.5	6.4	49.0	6.8	0.2	1.7	3.8	1.7	17.1	9.1	7.6	10.2	3.2	1.5	1.1	3.7	0.0	1.0	0.9	7.3	0.0	2.0	0.8	10.1	4.6	32.8	13.8	0.0	11.2	0.4	2.1	12.4	6.1	17.1	3.8	0.5	37.1	3.2	0.3	0.0	17.1	7.3	0.0	2.6	1.2	1.7	0.3	0.5	7.2	22.5	0.0	1.6	0.0	96.5	0.8	5.1	2.5	0.4	0.1	4.3	5.6	1.2	0.6	0.6	19.7	17.1	24.3	0.1	1.0	3.5	0.3	3.4	1.4	1.3	7.6	1.8
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SPRYD4	DKFZp686N0877	ENSG00000176422	"SPRY domain containing 4"	Q8WW59	12	56468578-56479708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 147.2;Proximal tubular cells: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053469	Uncertain		Approved	Nucleoplasm		NA	NA		7500	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA053469: AB_2682162"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (4.52e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-1)"	1.5	3.7	1.6	1.6	1.4	2.8	3.1	3.2	1.9	2.0	0.7	2.5	2.0	2.0	3.0	3.1	2.0	1.5	3.3	1.4	1.6	3.7	20.5	1.4	1.8	0.8	0.8	2.4	6.0	2.5	3.7	1.2	1.0	2.6	3.2	3.4	2.7	1.7	4.1	2.4	2.2	1.7	0.5	2.3	2.5	1.5	1.3	1.4	2.7	5.1	1.7	2.3	2.1	1.2	2.1	2.7	2.3	1.8	2.0	1.3	3.1	1.7	1.7	3.5	2.1	2.5	3.6	2.6	2.2	2.2	2.4	3.5	2.0	2.9	2.2	1.3	4.1	3.8	3.1	3.8	1.9	2.6	3.7	2.9	1.9	2.5	2.1	1.9	3.6	1.8	2.1	11.0	3.0	3.4	1.3	1.9	1.5	2.4	3.1	1.6	1.7	5.4	3.8	2.6	2.3	1.1	3.3	3.9	2.6	1.4	6.6	0.8	1.7	1.5	2.8	2.2	1.4	1.8	1.1	0.9	1.2	2.2	1.9	1.0	1.0	0.5	0.7	0.7	0.8	1.0	0.7	0.7	0.9	1.0	0.7	0.7	0.7	1.2	0.9	1.3	0.3	0.7	1.6	1.4	3.2	1.9	1.4	1.6	0.8	0.8	1.0	0.5	1.3	1.2	4.4	0.0	7.4	2.0	7.9	4.8	16.2	24.8	10.2	13.2	14.1	12.7	17.7	18.6	16.2	22.0	16.7	38.3	5.8	17.3	54.8	26.6	1.4	4.0	7.5	8.9	17.5	19.1	0.9	21.4	24.3	8.1	14.8	9.8	10.2	10.7	10.0	147.2	20.8	16.8	1.6	14.6	28.5	12.2	2.3	1.1	9.0	6.4	5.4	1.9	11.1	10.2	8.2	2.0	2.2	18.5	10.1	10.5	6.3	10.8	19.5	101.5	5.9	17.8	0.0	8.1	8.6	5.1	10.2	22.2	5.3	36.0	4.4	30.2	16.4	19.8
SPRYD7	"C13orf1, CLLD6"	ENSG00000123178	"SPRY domain containing 7"	Q5W111	13	49912702-49936490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 131.4;Spermatocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043934	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA043934: AB_10960545"	"unprognostic (1.83e-2)"	"prognostic unfavorable (8.48e-6)"	"unprognostic (2.57e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.06e-2)"	5.3	8.6	9.4	3.8	9.9	3.2	5.6	7.9	14.6	4.9	4.8	7.6	6.3	4.3	5.3	7.7	4.7	3.1	11.6	10.3	10.4	8.4	10.7	10.2	3.2	8.6	9.0	5.4	5.5	9.5	6.0	6.2	9.8	6.4	6.6	12.3	4.7	4.9	23.9	6.0	7.2	5.2	7.9	4.0	7.0	8.9	10.0	2.6	6.7	15.4	3.6	5.7	5.4	9.1	10.1	8.5	5.4	6.0	6.5	9.2	12.3	19.5	9.1	13.5	7.7	15.5	8.1	9.8	6.1	14.4	11.1	8.5	12.1	18.1	18.7	16.3	10.9	10.5	6.5	10.9	22.1	25.4	7.2	8.0	20.0	11.8	23.0	8.4	8.4	5.5	12.0	8.6	31.6	6.2	0.9	11.9	2.1	15.3	9.6	4.7	9.1	6.0	14.1	7.6	4.5	5.6	5.7	12.8	9.8	6.8	11.9	15.7	10.8	12.2	6.8	11.3	19.8	5.3	8.8	7.5	9.5	10.2	14.0	0.7	2.0	1.7	2.0	2.3	4.1	5.3	1.9	2.6	2.5	4.3	1.5	2.3	0.4	6.8	4.6	1.7	3.1	1.8	9.4	9.9	7.9	14.6	10.3	10.4	8.6	9.0	9.8	7.9	10.0	9.1	23.7	131.4	32.8	22.2	17.0	20.3	23.3	64.1	21.1	29.4	17.2	20.1	60.1	21.5	32.1	12.9	8.4	38.8	11.2	42.4	52.8	32.1	118.5	25.9	20.0	21.5	23.4	6.5	35.5	25.8	45.0	21.4	15.3	13.3	17.7	12.5	19.2	52.1	27.9	23.5	33.3	21.4	26.4	7.6	13.9	24.3	21.1	14.1	23.2	24.4	14.6	21.6	12.3	24.6	60.1	37.2	23.6	20.3	12.4	23.9	34.5	82.1	26.6	30.7	6.6	20.1	29.8	167.1	56.9	33.8	31.0	39.8	11.9	27.7	22.2	10.4
SPSB2	"GRCC9, SSB-2"	ENSG00000111671	"SplA/ryanodine receptor domain and SOCS box containing 2"	Q99619	12	6870935-6889358	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 40.2"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055225	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055225: AB_2682746"	"unprognostic (1.13e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.39e-2)"	5.5	11.2	7.0	5.9	7.6	6.2	5.9	10.0	9.8	8.2	7.0	7.7	5.0	7.9	3.3	7.2	7.7	6.3	4.8	6.7	6.9	13.5	6.7	12.4	7.3	7.9	7.4	5.1	8.6	4.6	7.5	2.4	7.7	7.2	2.2	4.3	7.7	6.1	5.1	8.2	7.5	3.0	7.5	9.3	7.6	9.7	7.6	8.4	12.1	1.7	3.5	7.4	6.5	7.7	9.4	43.6	4.2	6.5	9.7	4.6	8.3	9.7	11.0	8.4	4.0	19.9	35.8	3.2	4.5	8.4	6.1	8.8	10.3	5.5	1.2	21.4	3.5	11.0	13.7	7.8	14.7	5.0	10.5	4.9	7.8	11.1	9.8	6.9	5.7	12.6	7.1	4.3	8.7	13.7	10.0	5.8	17.1	12.6	13.2	9.3	5.5	6.4	16.7	6.4	1.8	5.3	6.7	13.0	10.4	12.3	3.9	8.5	4.8	8.4	13.2	8.8	10.3	5.7	9.2	4.1	9.3	9.6	12.0	0.1	8.4	24.0	12.1	9.9	14.2	11.8	11.9	9.9	9.3	13.2	13.5	12.1	6.8	7.0	12.1	17.3	13.6	8.3	7.0	7.6	10.0	9.8	6.7	6.9	7.9	7.4	7.7	7.5	7.6	7.7	4.2	28.9	19.9	2.0	7.1	2.5	3.7	7.5	2.2	5.3	8.5	4.4	3.3	7.2	9.4	20.2	2.1	5.8	4.4	11.1	33.2	13.3	16.8	18.6	5.3	5.5	9.5	6.6	0.5	10.7	4.5	5.8	3.6	8.9	8.2	2.5	7.5	4.7	11.5	6.7	0.9	10.8	0.0	7.6	3.9	8.9	9.6	8.1	0.0	1.9	13.4	9.4	17.5	1.0	1.8	9.0	6.6	9.1	2.2	7.6	15.6	40.2	19.5	14.3	6.6	6.5	6.3	29.0	9.2	4.1	4.8	7.7	8.5	10.2	7.8	3.4
SPSB3	"C16orf31, SSB-3"	ENSG00000162032	"SplA/ryanodine receptor domain and SOCS box containing 3"	Q6PJ21	16	1776712-1793700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046602	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046602: AB_2679717"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.25e-7)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.72e-4)"	27.1	44.7	27.9	7.7	28.5	21.2	25.8	37.0	40.2	27.1	24.0	28.9	14.7	21.3	3.3	36.1	23.7	10.0	28.6	26.4	27.2	24.3	41.8	20.6	12.4	29.7	28.3	37.1	44.0	11.4	15.3	10.3	27.4	23.3	5.1	9.6	26.4	15.5	88.5	48.4	18.8	5.6	28.3	23.3	27.8	17.3	29.2	26.1	19.7	31.0	7.8	23.2	28.7	31.8	7.3	9.1	9.7	13.4	13.6	12.5	19.8	10.6	11.0	11.5	12.6	8.4	20.0	3.2	17.4	6.0	4.5	13.9	4.8	10.9	1.8	14.7	15.0	5.2	13.9	10.4	20.2	4.5	12.0	11.3	26.8	7.2	8.4	17.1	17.5	22.1	7.8	15.4	5.4	24.0	16.3	16.0	8.1	10.8	7.1	29.7	5.9	26.7	10.6	1.3	12.9	16.6	12.6	27.8	29.4	6.9	16.1	18.0	16.1	5.6	10.6	10.5	5.5	26.1	28.2	8.9	5.4	8.9	5.9	112.3	44.8	83.4	67.9	41.8	81.2	46.8	63.1	61.7	42.3	44.2	43.6	46.6	91.5	45.7	37.2	42.8	100.7	48.4	27.9	28.5	37.0	40.2	26.4	27.2	29.7	28.3	27.4	28.3	29.2	31.8	74.2	38.5	32.1	29.7	56.1	98.4	53.3	72.7	60.3	74.1	64.1	83.7	0.2	40.0	54.9	55.2	39.6	63.0	104.2	68.6	52.8	50.8	46.7	29.4	32.3	46.1	48.7	50.5	18.2	47.6	74.8	42.8	65.2	37.8	35.4	76.2	57.1	62.5	31.8	90.9	19.4	57.8	38.7	42.7	72.2	91.6	77.0	44.8	76.5	24.4	61.6	76.0	99.9	24.6	30.7	45.3	83.2	74.9	61.2	50.5	96.3	50.6	37.2	89.8	39.5	34.0	45.3	23.8	39.7	37.0	128.3	64.4	87.8	33.2	52.7	54.3
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610704-158686715	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"bone marrow: 75.7"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 255.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"K-562: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced					NA	NA		11000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.1	0.0	0.0	0.0	0.0	75.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.7	0.0	0.0	0.3	0.0	255.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 296.6;Cone photoreceptor cells: 310.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules		NA	NA		1600000	"Cluster 13: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	48.8	31.4	81.7	38.6	85.0	28.1	36.6	54.4	99.7	39.4	0.4	47.3	24.7	57.1	32.9	36.8	54.0	32.5	65.7	90.9	43.5	34.6	22.8	55.1	38.5	142.7	49.6	51.6	24.0	47.1	32.5	57.1	155.0	32.7	36.3	103.1	31.9	46.5	23.9	69.4	34.9	58.8	65.6	44.3	31.1	44.9	61.5	45.4	38.4	22.3	38.0	40.0	36.4	55.3	108.1	116.9	75.2	83.4	107.6	121.0	61.5	90.2	75.2	99.4	74.1	167.3	74.6	94.3	78.3	137.0	69.8	193.3	80.7	90.4	61.1	53.2	47.9	15.9	324.4	94.4	61.3	70.9	51.0	58.3	71.6	166.3	55.8	83.9	134.4	87.2	9.1	107.6	98.6	74.6	136.3	29.5	96.1	125.9	72.1	91.0	90.2	59.7	80.2	91.1	58.1	91.1	296.1	40.3	42.9	91.8	70.0	19.8	232.5	68.5	102.2	100.0	71.2	65.3	82.6	51.8	83.5	31.5	65.9	3.3	1.6	3.9	9.7	1.3	13.5	6.3	12.4	9.2	2.4	5.8	7.6	7.9	1.5	7.1	1.2	3.0	15.3	5.8	81.7	85.0	54.4	99.7	90.9	43.5	142.7	49.6	155.0	65.6	61.5	55.3	144.9	70.5	27.5	123.7	56.3	37.3	27.8	34.3	25.6	296.6	69.8	83.2	68.5	68.6	33.9	101.2	310.6	27.5	112.6	145.4	7.9	67.6	18.0	108.2	71.4	103.8	56.9	13.7	159.5	59.2	16.0	77.8	76.5	87.5	12.0	47.9	96.8	36.2	29.2	124.5	183.8	54.1	30.5	22.2	29.4	40.5	85.1	32.8	35.6	74.9	24.4	97.7	48.4	87.4	17.4	102.2	93.0	94.8	70.5	45.9	62.4	22.8	71.3	156.5	26.3	53.0	60.0	33.0	44.5	43.7	45.5	18.2	95.4	22.0	73.6	65.7
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456317-54671446	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 615.4;Peritubular cells: 663.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"		NA	Yes		1500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	187.3	70.9	210.6	34.7	205.1	37.6	78.7	97.4	166.1	54.1	94.2	62.8	32.7	52.0	36.3	41.7	56.2	69.2	135.9	156.2	99.7	65.3	83.8	131.6	28.9	141.2	154.4	73.2	45.5	129.2	27.8	97.4	120.4	43.8	52.4	56.0	55.1	74.4	54.0	39.4	46.8	59.9	134.8	58.7	55.6	32.6	214.6	29.3	72.8	87.2	30.0	45.6	38.6	163.6	96.5	150.5	60.4	57.2	234.7	158.8	74.8	40.2	82.3	63.7	61.4	101.7	66.6	0.4	112.1	142.0	55.1	110.9	85.1	128.0	66.0	0.8	35.6	43.7	118.4	166.2	97.7	59.7	24.4	62.3	64.8	193.8	119.7	77.6	151.6	95.1	50.0	64.0	86.1	21.6	105.0	14.5	66.3	129.6	70.2	116.2	95.0	37.2	92.2	120.6	36.3	113.3	121.5	39.5	88.1	58.9	19.6	9.9	235.2	89.9	79.0	110.2	58.2	62.8	42.8	32.7	98.1	17.7	163.7	2.3	0.4	2.8	3.7	0.0	3.9	3.7	3.4	3.6	1.3	3.5	5.0	3.6	0.6	5.2	0.0	1.1	3.2	3.1	210.6	205.1	97.4	166.1	156.2	99.7	141.2	154.4	120.4	134.8	214.6	163.6	615.4	407.1	124.6	233.4	45.7	83.1	50.0	64.7	42.7	94.4	60.8	58.0	262.9	144.4	100.6	145.3	73.0	28.3	31.7	343.6	7.9	223.7	12.1	140.4	80.3	426.4	83.1	21.5	231.3	121.9	42.0	271.6	139.7	115.7	35.4	68.2	228.5	184.6	14.2	141.3	195.4	135.5	77.3	17.7	47.0	31.5	503.2	16.6	147.7	294.2	9.7	131.9	36.0	154.8	283.1	243.3	109.9	663.5	76.3	75.6	142.8	44.1	187.3	93.6	164.3	340.3	171.9	54.7	53.3	79.7	68.2	11.1	49.2	56.6	151.9	88.1
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Bipolar cells: 65.2;Cone photoreceptor cells: 56.3;Excitatory neurons: 209.5;Horizontal cells: 74.0;Inhibitory neurons: 194.8;Oligodendrocyte precursor cells: 46.3;Rod photoreceptor cells: 64.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.8;Karpas-707: 2.5;SCLC-21H: 3.9;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	1.1	2.1	4.8	0.1	5.9	0.1	0.7	6.4	20.1	1.1	0.0	1.6	0.3	1.5	0.1	0.4	1.3	0.4	2.1	4.8	0.0	0.8	0.3	0.3	0.0	4.0	0.0	2.6	0.9	1.4	7.8	0.0	2.2	1.5	0.0	3.4	0.6	0.4	2.1	0.5	0.5	0.3	0.0	0.2	1.2	2.0	0.7	0.1	0.7	0.9	0.0	1.1	0.7	6.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	2.5	0.0	0.6	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.5	0.0	0.0	3.9	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.9	6.4	20.1	4.8	0.0	4.0	0.0	2.2	0.0	0.7	6.0	0.2	0.0	0.0	48.6	0.1	0.1	0.2	0.1	0.6	65.2	0.7	0.6	4.9	0.0	0.2	0.0	56.3	0.0	2.7	0.1	0.0	0.2	3.4	0.3	0.8	0.5	16.3	0.0	209.5	0.0	0.0	1.0	0.0	0.8	0.0	0.7	0.4	0.8	0.2	74.0	194.8	0.5	0.0	0.6	0.2	1.3	8.1	0.6	1.8	10.3	0.6	6.1	0.0	46.3	13.4	0.1	0.0	7.2	0.1	0.4	0.3	1.7	0.2	64.2	0.0	1.6	0.7	3.5	6.0	0.3	0.4	0.0	0.4	0.4	0.3	0.2
SPTBN5	"BSPECV, HUBSPECV, HUSPECV"	ENSG00000137877	"Spectrin beta, non-erythrocytic 5"	Q9NRC6	15	41848146-41894053	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 8.8;retina: 26.9"	"Group enriched"	"Detected in many"	22	"Cone photoreceptor cells: 210.6;Rod photoreceptor cells: 211.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.7;SCLC-21H: 5.1;TIME: 13.6;WM-115: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"spinal cord: 3.6"	HPA055283	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055283: "	"unprognostic (5.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.84e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.11e-2)"	1.0	0.3	0.4	0.7	1.3	0.4	1.1	8.8	1.4	0.6	0.1	0.5	0.3	0.4	0.8	1.7	0.5	0.9	2.0	0.6	0.1	1.7	1.6	1.2	0.6	0.8	0.3	0.6	1.1	0.5	1.9	0.2	1.0	1.6	0.2	26.9	2.7	0.3	0.4	1.7	0.5	0.2	0.1	0.5	1.0	0.8	0.1	0.0	2.1	0.4	0.1	2.6	0.7	0.8	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.8	0.0	1.5	0.4	0.0	0.2	0.0	0.8	0.1	0.0	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.3	0.0	0.3	1.4	5.1	0.1	0.2	0.4	0.1	0.4	0.8	0.0	13.6	0.0	1.3	0.3	1.7	1.5	2.3	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	8.8	1.4	0.6	0.1	0.8	0.3	1.0	0.1	0.1	0.8	1.9	0.0	2.4	2.9	0.2	0.8	0.9	0.4	1.2	7.9	1.8	2.0	4.0	0.0	1.5	0.0	210.6	0.1	0.8	0.7	0.0	0.5	1.1	1.1	0.3	3.7	0.0	0.0	2.3	0.2	0.3	0.6	2.0	3.8	1.3	1.0	0.4	0.5	2.0	3.3	0.5	0.5	0.0	0.0	0.6	0.9	0.0	1.0	1.8	0.0	0.8	9.6	1.0	6.0	0.5	1.0	1.4	0.0	0.9	0.2	0.2	0.6	0.8	211.8	0.0	0.2	0.3	0.5	0.5	3.9	1.3	0.0	0.5	0.2	0.6	1.0
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008972-13169103	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	4.6	4.3	1.4	1.4	1.4	0.6	8.3	1.2	1.3	7.4	8.5	6.1	15.7	4.7	16.8	5.9	6.7	10.9	6.4	1.5	2.7	18.2	20.0	7.8	1.3	2.4	2.1	7.1	5.6	11.0	2.7	20.9	2.4	5.9	7.4	2.8	6.7	3.6	0.4	25.6	16.2	3.9	1.8	2.9	4.5	6.4	3.8	5.0	24.4	2.0	1.7	5.7	5.1	2.5	1.5	2.4	1.8	0.0	14.1	20.2	11.4	0.0	3.2	2.1	8.2	18.6	9.3	0.0	1.2	0.6	18.2	25.0	0.0	7.0	3.0	0.0	0.1	0.0	5.6	26.4	1.3	0.0	0.2	11.5	21.4	8.4	2.8	7.7	1.4	4.4	0.0	33.3	23.7	0.5	0.1	0.0	0.1	2.2	2.9	2.3	4.2	15.1	43.7	18.2	0.0	0.3	0.2	2.3	0.1	3.1	18.6	0.5	3.3	9.2	3.1	30.4	2.2	0.2	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.4	1.4	1.2	1.3	1.5	2.7	2.4	2.1	2.4	1.8	3.8	2.5	3.6	6.4	22.3	5.2	0.1	2.4	5.3	2.3	4.6	0.1	5.4	5.0	17.9	4.3	4.9	9.2	0.0	28.4	1.0	3.4	7.9	3.0	27.9	18.7	5.2	4.6	0.0	2.1	0.5	4.4	13.0	5.4	4.6	47.4	1.3	5.6	1.8	20.7	2.8	0.0	0.9	5.7	6.1	2.6	0.4	11.6	3.7	2.4	0.0	35.6	0.0	12.3	3.1	0.0	0.1	3.2	6.7	2.6	0.1	2.3	10.9	18.6	3.5	0.4	0.0	6.1	0.8	1.2	0.1	4.9	2.3	46.1	1.2	2.9	7.3	2.6
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606403-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	7.5	8.7	2.3	8.6	2.4	34.3	10.0	3.6	5.9	10.6	4.3	7.8	7.0	7.6	5.6	8.1	6.6	10.1	4.9	3.0	2.7	8.9	10.3	7.3	8.2	2.3	2.9	9.7	7.8	8.1	4.0	8.7	2.4	8.7	8.2	4.5	9.4	5.6	7.9	7.4	6.5	7.8	2.4	7.3	7.5	4.2	2.7	8.5	10.0	7.5	9.6	9.4	5.3	3.1	11.8	11.2	9.0	12.7	14.3	15.1	13.5	17.3	18.9	14.2	16.8	10.4	5.2	27.0	9.3	16.3	11.0	12.1	15.3	13.4	20.5	14.1	14.0	10.6	6.4	9.5	14.1	22.6	20.4	12.7	13.6	9.3	17.8	10.1	15.3	15.8	15.3	41.7	15.9	12.2	15.5	9.3	8.5	22.8	12.6	14.2	25.1	11.4	14.9	16.9	8.8	12.3	15.1	17.8	12.3	11.7	11.0	9.6	13.7	13.7	11.7	27.1	10.8	14.3	19.0	21.0	16.4	12.6	11.8	4.7	1.9	2.9	2.7	2.9	4.1	1.2	2.6	2.8	1.7	1.1	2.4	2.6	2.2	3.7	2.8	1.4	3.1	1.8	2.3	2.4	3.6	5.9	3.0	2.7	2.3	2.9	2.4	2.4	2.7	3.1	42.3	25.6	47.7	5.2	38.0	55.8	19.6	17.1	32.5	13.7	55.0	39.5	21.6	18.6	29.9	27.6	10.4	14.3	75.3	31.7	17.6	25.3	2.4	47.4	53.8	29.1	44.3	15.4	9.9	24.9	26.5	35.3	40.2	74.1	57.7	20.5	22.9	28.5	16.3	11.8	9.6	39.4	24.4	33.4	49.6	3.2	19.0	44.3	16.0	15.0	24.4	12.4	49.4	9.0	8.9	27.7	29.8	13.9	83.6	28.0	21.0	17.4	47.5	11.4	32.9	42.9	28.2	14.2	17.3	41.6	66.3	27.5	69.7	27.1	24.4	29.2
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	8.6	31.1	17.5	19.6	27.0	23.0	22.1	26.8	24.0	30.7	25.4	21.6	31.0	16.4	9.1	78.7	18.6	10.7	7.2	18.6	24.4	17.1	72.3	30.9	17.7	47.3	27.7	14.3	10.7	22.7	16.5	47.5	35.1	25.0	18.6	17.8	19.1	7.6	1.4	49.4	14.0	12.3	27.6	9.7	21.8	59.4	21.8	14.2	10.5	1.6	29.4	14.7	46.2	34.6	135.5	51.5	301.6	87.2	91.7	154.1	30.5	34.9	106.3	46.5	84.7	70.6	192.3	92.7	49.2	43.2	186.0	101.0	127.3	192.4	53.6	77.1	268.3	265.2	32.6	181.1	134.6	31.5	74.6	106.1	201.4	138.8	113.3	29.8	51.5	64.2	153.8	174.8	38.1	223.7	109.6	39.3	125.2	92.6	35.2	47.5	55.4	126.6	329.3	153.3	93.9	47.6	71.6	226.3	74.1	96.5	60.7	81.3	50.8	19.2	66.0	22.9	31.6	31.6	69.6	126.6	32.0	93.7	33.8	1.5	6.3	0.7	10.6	10.8	5.0	16.6	6.0	9.5	15.2	17.1	8.2	8.6	0.2	12.6	12.7	10.8	7.1	7.7	17.5	27.0	26.8	24.0	18.6	24.4	47.3	27.7	35.1	27.6	21.8	34.6	13.2	60.9	97.9	21.5	34.7	22.9	64.0	199.9	16.5	41.8	35.6	27.3	6.1	31.5	129.6	53.3	50.1	99.7	20.6	81.6	7.9	60.3	21.0	95.9	23.3	39.7	31.7	22.3	14.3	83.6	133.7	35.3	51.0	80.5	41.3	77.1	9.7	127.9	61.1	148.0	18.8	58.0	126.1	10.9	30.1	13.2	23.9	22.2	21.4	13.1	91.0	24.3	8.2	20.1	77.9	98.6	38.4	10.9	30.6	118.0	17.3	3.7	123.0	61.1	26.3	12.5	42.0	179.5	128.6	69.5	89.1	217.1	21.1	171.8	35.0	114.8
SQOR	"CGI-44, SQR, SQRDL"	ENSG00000137767	"Sulfide quinone oxidoreductase"	Q9Y6N5	15	45631148-45691281	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 210.0"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 118.1;Exocrine glandular cells: 176.2;Hofbauer cells: 134.3;monocytes: 154.5;Pancreatic endocrine cells: 156.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 304.0"									"HPA017079, HPA041589"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017079: AB_1857467, HPA041589: AB_2677565"	"unprognostic (6.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.44e-2)"	"unprognostic (4.38e-1)"	46.4	22.6	14.5	59.5	14.6	55.6	41.2	14.6	19.7	36.3	17.2	210.0	57.7	18.8	19.3	112.9	26.6	31.4	22.0	13.6	14.7	36.6	82.6	61.5	38.2	16.7	15.1	8.8	39.8	24.1	12.5	17.6	15.6	41.2	178.8	4.9	56.3	27.8	132.8	41.7	55.9	43.2	15.9	47.3	54.4	5.1	15.8	23.7	32.5	43.7	57.7	48.8	50.3	17.2	38.3	68.0	0.1	3.9	125.5	151.4	0.4	40.8	132.3	23.6	35.7	2.7	59.0	33.7	38.7	29.9	72.6	33.3	2.0	304.0	13.9	121.7	1.1	3.0	14.5	48.2	38.8	20.2	5.1	45.2	88.2	54.9	119.8	59.4	66.1	32.0	0.4	40.6	24.6	31.3	12.2	44.9	0.0	147.7	41.8	1.4	6.7	47.1	184.9	55.2	1.2	1.2	10.1	25.8	13.1	0.8	56.9	61.7	76.8	9.7	2.2	131.6	9.0	53.5	61.0	2.0	96.9	104.6	10.9	112.5	212.1	84.6	76.6	161.0	104.6	54.3	97.9	83.6	135.2	48.6	51.8	55.2	302.5	53.4	152.4	40.5	149.0	169.6	14.5	14.6	14.6	19.7	13.6	14.7	16.7	15.1	15.6	15.9	15.8	17.2	24.4	32.1	64.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	31.4	14.7	0.0	0.0	14.9	14.7	0.0	0.7	19.8	0.0	11.7	118.1	0.0	15.9	7.0	13.9	0.0	0.0	0.0	176.2	0.9	11.3	0.0	37.6	11.4	1.3	0.0	0.0	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	0.0	0.0	154.5	0.0	0.0	0.0	0.0	156.2	0.0	0.0	3.3	0.0	0.0	45.8	24.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.8	13.5	1.6	0.0	0.0
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1183.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 2045.0;Urothelial cells: 2233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 1923.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol		No	No		81000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	335.0	472.6	171.4	86.0	208.8	135.8	269.5	199.6	207.2	242.8	218.9	262.0	112.1	278.8	91.7	192.3	207.5	188.2	310.1	163.8	200.6	221.5	392.0	263.4	81.4	203.9	183.3	235.6	231.3	121.4	181.5	118.7	190.5	206.2	82.3	46.4	289.7	174.2	1183.4	194.7	187.4	132.7	179.5	179.0	263.6	65.7	205.7	89.4	316.4	287.2	96.4	347.3	211.0	236.5	130.1	740.6	36.9	114.3	547.8	384.8	546.3	187.9	596.3	164.1	201.2	154.6	532.9	16.0	522.7	298.9	898.3	170.8	79.9	181.9	76.9	1923.9	97.6	58.5	303.9	223.4	1167.2	59.9	365.0	337.1	181.2	273.0	441.5	390.8	152.6	17.3	68.0	472.1	327.0	111.6	26.4	62.0	93.8	410.0	195.1	54.8	78.8	213.7	243.6	609.6	79.0	74.5	253.2	274.3	662.2	62.3	143.8	120.4	286.2	243.1	103.4	252.3	271.6	723.7	819.3	73.5	521.1	111.6	338.4	807.6	412.3	422.2	194.7	268.3	231.3	156.5	170.1	174.6	227.5	168.2	131.8	139.1	672.6	196.3	260.3	89.6	262.1	439.8	171.4	208.8	199.6	207.2	163.8	200.6	203.9	183.3	190.5	179.5	205.7	236.5	411.1	185.9	248.8	36.9	280.0	297.5	1289.0	320.4	799.6	81.7	280.7	253.0	38.5	314.5	247.8	121.4	54.2	266.8	276.4	572.9	234.8	906.0	34.2	408.7	255.4	415.8	340.4	89.0	35.2	686.7	133.2	516.0	1270.6	589.7	386.3	73.8	142.5	297.8	288.3	90.9	37.2	337.2	236.0	149.8	556.3	72.2	325.3	388.3	231.3	28.1	611.3	143.3	125.7	16.6	62.2	639.4	618.9	259.2	606.5	1281.6	311.3	327.1	190.1	73.5	164.3	356.4	316.1	45.5	48.0	595.4	259.1	2045.0	259.9	133.4	242.3	2233.9
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044598, HPA050153"	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	12.2	34.0	8.7	7.7	9.0	9.6	9.7	15.8	12.3	10.0	9.2	12.5	5.1	8.2	6.0	9.3	9.4	5.6	12.0	9.9	9.3	12.4	25.8	15.0	6.3	8.4	8.2	14.9	7.5	4.7	22.2	5.8	8.8	12.5	4.7	7.2	14.8	6.2	14.5	9.4	11.9	5.4	8.6	17.6	14.0	22.6	8.9	5.6	12.9	2.5	5.2	9.4	8.8	9.2	9.7	22.7	11.8	12.3	5.6	7.6	16.4	16.1	9.1	10.3	10.8	41.8	5.9	8.2	11.7	6.2	5.5	6.4	2.1	12.0	4.1	12.7	13.9	7.2	25.0	16.1	12.0	13.1	9.4	14.7	6.1	5.5	2.8	9.1	4.7	13.8	7.4	12.1	6.9	29.5	10.7	20.4	3.6	5.2	18.0	11.7	10.0	7.9	5.4	11.3	8.3	9.8	9.4	8.5	11.6	4.1	10.5	14.7	7.5	9.7	5.1	8.5	13.2	15.1	10.9	8.6	12.0	16.8	6.5	16.1	26.0	20.3	10.7	23.8	9.9	15.8	10.2	10.4	25.2	14.0	8.2	9.4	43.0	13.6	23.6	15.2	19.5	26.8	8.7	9.0	15.8	12.3	9.9	9.3	8.4	8.2	8.8	8.6	8.9	9.2	43.3	6.4	49.4	13.4	46.7	52.4	68.5	126.1	38.7	23.6	57.8	48.9	71.7	57.2	86.4	33.1	8.4	103.7	56.9	87.8	113.5	102.7	104.6	59.5	33.4	39.8	38.4	35.1	15.5	148.2	117.9	48.6	64.7	43.1	68.4	21.8	42.1	69.7	93.1	15.2	17.2	71.6	107.8	61.2	71.5	150.0	25.1	82.0	67.6	7.5	90.4	59.5	42.2	9.0	11.5	186.0	78.7	29.7	113.7	82.9	83.7	131.0	84.1	23.7	26.3	26.7	76.1	77.2	30.7	62.3	45.9	179.0	47.4	66.8	49.2	142.6
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;breast: 5.1;choroid plexus: 6.2"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 25.0;Distal tubular cells: 90.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	13	"Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.1	0.2	10.3	0.2	9.7	0.7	5.1	8.9	11.3	2.3	6.2	0.1	0.2	1.1	0.1	0.2	0.1	0.2	0.9	8.8	9.3	1.5	0.1	0.1	0.3	9.4	9.4	0.2	0.2	0.0	0.0	0.1	10.0	0.7	0.0	0.8	3.1	0.0	0.2	0.6	0.1	0.0	8.6	0.2	0.3	0.2	11.2	0.0	1.2	0.0	0.0	0.1	0.0	9.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.6	7.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.6	0.5	0.0	0.4	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.4	0.6	0.3	13.6	0.2	0.4	4.3	0.4	0.2	0.4	0.3	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.6	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.8	0.3	0.1	0.1	0.0	0.0	10.3	9.7	8.9	11.3	8.8	9.3	9.4	9.4	10.0	8.6	11.2	9.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	6.8	5.6	1.9	7.2	2.5	6.5	7.6	2.1	1.9	9.8	3.5	7.1	5.7	7.2	11.8	4.7	5.4	5.6	5.8	1.7	2.5	7.6	8.7	6.5	7.5	2.5	2.3	5.4	7.3	12.2	3.7	6.8	2.8	7.4	8.0	3.7	5.2	5.7	3.1	3.8	5.4	6.8	2.4	8.6	8.1	9.0	2.5	11.5	10.2	4.9	7.5	5.3	3.9	2.8	18.7	9.5	19.1	12.9	6.9	15.0	15.1	14.1	12.2	13.2	12.1	8.0	7.8	16.1	10.2	10.1	9.8	8.7	19.0	17.9	24.3	22.1	10.6	21.4	7.4	17.3	8.1	17.9	12.1	9.3	7.2	15.7	18.2	5.8	16.2	5.8	15.6	11.9	19.8	17.0	24.3	13.8	21.9	12.0	10.3	16.5	27.5	14.7	15.0	12.1	16.8	13.7	12.3	13.1	14.0	9.9	8.2	6.4	14.9	18.4	14.7	9.0	12.3	12.5	4.9	9.6	10.4	17.6	13.5	3.9	6.2	13.1	5.4	7.0	4.8	5.3	4.0	6.3	6.1	4.6	5.4	5.0	2.3	8.3	12.3	5.7	4.5	4.3	1.9	2.5	2.1	1.9	1.7	2.5	2.5	2.3	2.8	2.4	2.5	2.8	10.9	19.2	7.7	28.7	13.0	3.6	3.5	6.2	8.6	7.9	8.7	8.0	8.8	8.6	10.6	3.7	4.2	8.4	15.7	5.9	9.8	8.3	3.5	11.5	20.7	9.3	7.2	15.8	22.0	9.1	7.1	10.9	20.9	9.9	8.2	11.0	7.9	13.8	9.6	13.5	32.7	9.7	0.0	22.5	3.9	2.5	7.5	13.8	7.2	46.9	13.7	12.9	13.4	48.2	51.8	4.6	6.3	6.4	19.8	2.9	5.9	10.8	7.8	14.7	13.1	12.9	10.2	37.5	28.4	9.5	3.8	5.6	12.8	16.6	5.1	2.2
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	15.4	11.9	3.6	18.9	4.8	30.1	10.1	7.1	4.2	12.8	1.7	13.2	15.7	15.5	6.4	13.5	14.2	10.9	12.1	2.9	3.4	9.6	7.1	11.6	15.3	5.9	4.3	16.9	19.4	20.2	9.5	12.6	3.5	12.6	11.2	12.5	18.0	13.1	24.5	16.2	16.1	15.0	0.8	18.7	16.0	20.6	7.7	20.2	14.0	19.4	13.6	11.3	9.9	6.8	29.5	60.1	36.9	35.9	28.3	19.5	37.7	24.0	21.1	26.2	20.7	27.8	21.9	65.9	29.7	30.5	16.9	27.8	37.7	27.5	21.9	42.2	88.1	42.5	56.2	24.3	11.4	49.8	48.0	20.8	13.2	40.3	29.0	12.8	27.8	21.7	65.4	36.5	19.7	34.5	42.2	17.4	37.6	10.8	27.7	57.7	28.7	36.4	7.5	34.2	34.5	36.5	26.6	31.0	8.4	12.2	35.4	26.0	44.1	37.0	26.5	21.0	31.6	39.8	36.7	45.9	29.7	23.2	28.9	0.3	0.7	2.9	0.8	1.2	0.6	0.7	0.4	0.9	0.5	1.0	0.5	0.4	2.2	0.6	0.3	0.9	0.9	0.7	3.6	4.8	7.1	4.2	2.9	3.4	5.9	4.3	3.5	0.8	7.7	6.8	3.0	3.2	3.7	8.8	9.8	24.6	1.9	186.4	13.1	7.5	3.3	1.8	2.4	4.3	145.6	1.8	8.4	2.3	5.3	54.3	0.0	1.4	1.2	4.6	3.0	3.4	11.3	7.6	8.6	3.1	1.4	4.2	19.9	4.7	2.5	3.0	2.2	3.0	2.3	8.4	8.6	17.7	179.0	1.9	14.3	0.9	2.8	3.4	10.6	8.4	3.0	1.7	6.2	4.5	10.6	1.9	39.1	1.2	11.1	3.1	3.1	0.6	118.3	5.8	0.0	5.0	14.3	5.6	6.0	7.8	58.2	2.5	8.9	2.0	25.6	3.1
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530031-38605952	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.3;Horizontal cells: 102.6;Inhibitory neurons: 58.5;Oligodendrocytes: 261.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.76e-4)"	1.9	1.3	11.1	0.1	32.1	0.2	3.1	22.1	29.9	2.1	0.0	4.2	0.6	1.0	0.6	2.2	3.0	0.0	2.1	13.6	14.1	1.6	13.9	1.2	0.2	36.4	28.8	0.5	6.6	2.4	15.5	0.2	33.7	2.3	0.2	0.4	7.8	0.8	0.5	6.1	1.4	0.1	13.8	0.6	2.1	1.4	29.9	0.1	0.7	0.0	0.0	1.7	1.1	66.2	0.4	0.4	0.6	2.7	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.4	1.1	0.9	0.0	0.7	1.0	1.2	0.2	0.1	1.1	1.2	0.0	0.5	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.5	0.1	3.9	0.0	2.4	0.0	0.0	1.5	0.5	0.0	0.1	0.0	0.1	0.4	1.7	18.0	2.0	0.0	1.0	0.7	0.6	1.8	0.4	0.0	0.0	1.2	0.0	0.0	0.8	0.2	0.0	0.1	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	32.1	22.1	29.9	13.6	14.1	36.4	28.8	33.7	13.8	29.9	66.2	0.4	0.0	1.1	5.5	0.3	0.8	1.0	0.3	0.6	31.5	6.1	5.1	2.9	21.5	0.3	3.7	0.0	0.1	0.3	0.7	0.0	2.7	0.2	9.0	1.0	0.6	9.7	0.0	66.3	0.2	0.1	0.9	0.0	0.9	0.0	2.7	0.4	12.6	0.4	102.6	58.5	1.8	2.0	0.0	0.4	0.6	0.6	0.1	0.0	3.7	0.0	1.8	0.0	6.6	261.8	0.3	0.3	0.4	0.1	1.4	0.6	0.2	5.3	3.4	0.0	0.4	0.5	0.9	2.1	0.8	0.9	0.1	0.2	0.0	1.5	1.6
SRD5A1		ENSG00000145545	"Steroid 5 alpha-reductase 1"	P18405	5	6633427-6674386	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.2;Hepatocytes: 103.4;Ionocytes: 52.9;Squamous epithelial cells: 139.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051402	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA051402: AB_2681470"	"unprognostic (1.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.73e-6)"	"unprognostic (9.38e-3)"	"unprognostic (8.90e-2)"	"unprognostic (3.78e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.47e-2)"	1.5	2.0	4.7	1.9	5.3	2.2	11.0	7.4	8.8	3.9	0.1	2.4	4.1	1.7	3.0	11.0	1.7	1.7	1.0	5.5	3.2	4.6	29.0	1.9	2.3	6.0	3.3	2.5	2.3	1.4	1.1	1.0	6.3	1.5	2.3	3.8	2.7	1.1	1.3	13.6	4.1	1.6	1.8	1.4	2.5	1.5	6.9	1.6	1.3	0.7	4.1	1.1	6.6	8.3	5.2	6.1	8.0	6.7	7.6	7.3	3.5	5.7	4.5	5.7	3.5	6.0	5.3	7.1	8.1	8.7	9.1	9.8	6.6	4.0	6.0	4.3	2.6	2.2	15.3	3.7	3.4	3.3	1.8	5.4	11.3	4.1	3.2	4.2	2.9	2.7	3.7	6.2	7.5	7.1	1.4	3.6	4.5	4.1	4.7	5.1	5.8	2.0	7.6	5.4	14.0	6.4	18.2	7.6	5.8	6.1	2.6	0.9	5.8	8.6	3.4	14.2	7.6	2.3	3.6	2.6	7.2	3.6	8.0	3.5	1.3	0.5	0.3	1.0	0.2	0.5	0.3	0.5	1.6	0.6	0.2	0.3	0.7	0.5	1.1	0.7	0.4	0.5	4.7	5.3	7.4	8.8	5.5	3.2	6.0	3.3	6.3	1.8	6.9	8.3	3.7	3.2	2.7	7.8	11.9	18.5	6.7	19.0	67.2	5.0	14.5	9.1	2.6	11.5	12.8	5.5	4.2	0.9	5.0	8.3	7.9	9.8	8.1	2.6	4.3	3.2	2.4	4.4	15.5	4.7	7.4	4.7	16.3	3.2	1.3	6.0	4.6	103.4	13.0	6.7	14.9	7.2	52.9	19.4	11.6	2.6	3.4	11.6	7.2	6.5	50.7	5.1	10.3	9.0	7.6	6.7	10.4	7.9	7.2	9.4	24.9	23.4	10.4	3.8	0.0	3.7	6.1	3.4	4.4	139.2	30.4	0.8	5.9	5.2	12.0	10.2
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	22.8	80.7	50.1	31.1	58.7	32.3	24.5	22.3	60.5	26.5	2.5	47.1	40.8	34.4	60.5	82.0	27.4	25.3	53.8	51.8	32.3	33.3	36.2	43.2	35.2	38.5	37.8	35.8	45.8	51.4	30.5	24.5	38.3	33.5	31.6	21.0	49.1	22.9	34.1	58.4	35.9	30.1	16.1	26.1	53.8	20.4	37.8	25.0	23.3	33.5	36.2	29.7	39.0	45.1	65.5	45.8	119.4	111.6	68.4	90.9	66.7	21.4	71.1	24.8	50.5	54.3	84.2	115.8	29.7	52.6	91.1	109.6	68.7	141.8	17.5	32.9	75.0	58.0	79.7	54.6	113.8	85.7	37.9	85.8	78.7	65.1	80.6	56.7	49.2	64.2	60.6	135.9	26.4	83.1	62.5	64.5	75.7	81.2	34.9	71.3	68.1	189.0	103.3	67.6	48.2	36.3	49.1	89.3	91.7	69.5	56.3	150.2	53.0	33.2	61.0	15.9	25.8	98.3	54.3	91.7	32.4	64.0	51.9	0.0	4.7	1.6	4.6	3.6	3.1	7.0	2.5	3.3	5.0	4.8	2.2	2.6	0.7	1.4	3.1	6.3	1.5	4.8	50.1	58.7	22.3	60.5	51.8	32.3	38.5	37.8	38.3	16.1	37.8	45.1	14.5	44.8	43.3	100.6	35.4	16.3	13.5	52.2	30.7	41.0	36.3	23.1	30.3	37.1	38.0	58.8	10.4	25.4	23.5	67.0	3.9	20.3	15.9	25.2	10.5	16.8	49.1	14.1	72.6	44.3	22.6	16.3	42.8	59.2	12.7	43.2	8.2	34.3	14.8	57.2	75.1	39.4	52.9	10.3	14.8	7.0	31.4	16.3	7.2	67.5	18.1	18.6	20.6	90.5	129.5	38.4	30.5	27.4	29.2	27.9	26.3	4.8	30.0	18.7	19.7	13.7	20.5	8.4	13.8	55.7	28.1	36.5	19.0	43.0	40.3	30.2
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	5.6	6.5	6.7	4.4	6.8	20.2	5.9	8.0	8.4	7.4	9.9	6.7	4.5	8.0	5.2	5.4	7.0	4.2	4.9	6.3	7.2	4.8	6.1	6.2	5.9	6.1	6.4	6.4	8.5	6.6	8.1	5.2	6.1	5.4	4.3	9.5	7.0	3.8	4.7	9.0	7.4	3.2	6.0	7.4	6.5	4.8	7.0	5.8	8.0	3.3	4.1	5.5	5.7	7.4	5.5	6.7	8.5	5.5	3.9	7.5	9.5	6.1	3.3	3.1	3.4	9.5	6.3	8.3	7.4	4.5	4.1	7.4	4.3	5.7	5.3	6.0	10.3	7.9	18.0	7.2	3.4	7.0	8.9	4.5	5.6	3.7	4.2	6.4	5.2	4.6	7.4	5.5	3.4	5.6	7.2	16.2	4.8	2.1	3.3	10.2	4.1	6.3	5.6	9.2	10.3	7.3	5.8	2.7	5.1	6.1	7.2	8.7	5.9	5.2	3.3	7.3	6.4	6.0	4.5	8.9	5.1	11.2	5.5	4.9	2.7	2.8	2.4	2.1	2.6	3.2	2.2	2.8	2.3	3.8	2.6	2.6	2.1	3.8	1.9	3.1	2.4	1.5	6.7	6.8	8.0	8.4	6.3	7.2	6.1	6.4	6.1	6.0	7.0	7.4	72.6	93.0	143.5	70.2	67.6	66.0	84.8	69.3	58.6	64.3	64.1	51.4	80.8	60.1	98.8	46.0	116.7	84.6	72.1	59.5	37.2	59.3	46.5	91.2	124.1	83.3	77.8	65.6	71.4	55.4	86.7	80.1	72.4	107.5	97.0	80.5	55.0	68.3	50.2	67.3	73.3	64.2	79.3	54.4	50.2	62.3	83.6	55.4	42.7	40.3	62.3	63.4	53.5	98.0	85.2	54.7	41.8	76.8	70.7	83.7	49.8	32.8	112.2	89.8	46.0	92.3	87.2	78.9	62.0	49.1	69.3	120.7	63.7	85.2	62.5	91.2
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718148-64768691	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: AB_2684881"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	6.2	5.5	5.1	4.2	5.3	4.6	6.4	6.0	7.2	5.0	5.3	4.9	4.1	5.0	5.6	6.9	4.6	4.3	4.0	5.0	5.4	5.7	5.8	5.6	5.7	5.4	5.2	6.6	4.3	5.8	2.8	8.6	5.6	5.6	4.8	6.4	5.1	5.3	3.6	9.0	4.4	5.5	5.3	5.5	5.2	3.2	5.3	6.9	5.9	4.7	6.0	5.3	4.3	5.8	8.3	4.2	10.5	7.9	9.2	15.1	6.2	12.3	9.9	8.3	11.0	7.8	8.9	8.6	12.4	9.9	7.9	5.3	9.6	18.7	14.5	10.3	11.6	9.4	7.6	7.0	9.5	10.2	9.1	9.9	17.3	11.5	14.8	8.8	12.4	10.6	8.4	5.2	9.9	3.0	18.2	10.3	5.4	2.2	5.6	8.6	8.5	13.8	14.3	6.6	4.5	6.7	7.8	5.5	12.1	7.3	7.0	19.5	12.5	6.0	3.6	7.3	13.0	7.5	13.8	7.7	11.5	15.7	8.3	2.0	1.6	0.7	1.8	1.2	1.8	1.6	1.7	1.7	1.4	1.5	1.7	1.7	0.6	1.5	0.8	3.3	1.6	0.9	5.1	5.3	6.0	7.2	5.0	5.4	5.4	5.2	5.6	5.3	5.3	5.8	69.3	48.1	44.1	20.2	43.8	81.8	62.5	117.8	43.3	51.8	49.0	59.2	31.2	75.8	63.2	86.5	31.3	72.6	54.8	87.3	90.1	72.2	300.6	69.3	66.0	63.1	61.0	79.8	30.8	75.2	84.6	55.8	35.2	86.6	53.8	33.9	91.1	100.3	64.5	97.6	23.4	71.4	89.5	79.7	62.4	179.2	95.7	54.8	39.2	15.9	65.1	59.2	71.1	19.1	25.4	196.8	136.3	72.6	39.1	76.2	66.8	114.8	58.4	43.5	65.7	57.7	56.9	44.3	46.2	47.0	104.0	48.7	50.4	30.5	54.2	83.2
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961975-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042737	Approved		Approved	"Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"		"HPA042737: AB_10796583"	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	6.8	4.3	2.3	6.3	3.0	6.2	9.1	3.6	2.6	6.3	2.3	5.3	4.9	6.2	4.3	6.9	5.2	5.1	4.6	1.9	2.3	7.2	6.9	4.7	7.4	2.9	3.2	4.8	4.3	7.4	1.7	6.3	3.1	5.4	5.7	4.2	5.0	4.7	6.3	3.8	4.1	5.8	2.8	6.1	4.6	4.5	3.2	5.4	8.3	6.9	6.5	7.7	3.5	4.1	14.7	10.6	9.5	15.2	10.7	9.9	15.9	13.8	10.0	14.8	17.3	8.7	14.2	18.4	15.6	8.6	25.5	10.5	15.7	18.8	27.5	26.4	8.9	17.7	7.0	9.0	11.5	20.6	14.0	12.0	14.2	18.7	18.3	7.1	16.3	9.3	16.5	14.5	15.7	6.8	14.4	6.6	14.1	11.6	6.9	14.6	22.6	19.4	16.5	14.9	9.9	9.2	12.7	12.5	24.2	11.8	12.7	12.2	11.9	22.8	13.8	16.4	20.3	7.7	15.5	20.8	13.0	16.4	20.4	0.6	7.0	2.8	6.0	12.7	7.8	10.3	6.7	6.8	9.6	8.8	7.8	10.7	0.9	7.8	10.4	9.0	6.8	4.3	2.3	3.0	3.6	2.6	1.9	2.3	2.9	3.2	3.1	2.8	3.2	4.1	45.5	16.0	15.2	15.7	32.4	19.2	36.7	27.8	12.0	38.7	19.7	26.3	14.3	18.6	26.2	14.7	25.0	20.6	21.2	8.0	41.1	33.0	35.2	29.5	37.5	25.2	16.2	22.9	26.2	20.2	19.7	24.2	16.3	27.8	44.4	24.9	8.6	9.4	20.0	47.1	24.3	11.2	12.2	8.1	11.7	7.5	24.2	22.9	19.6	23.4	16.6	29.8	21.6	35.7	34.0	20.2	9.7	26.7	10.7	35.1	4.4	34.8	17.8	28.6	13.1	41.3	28.3	29.6	27.4	18.3	19.0	12.9	19.0	30.5	19.6	27.8
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844700-64162217	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 159.0;Early spermatids: 192.4;Microglial cells: 151.8;Muller glia cells: 136.2;Oligodendrocyte precursor cells: 159.8;Oligodendrocytes: 135.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.4;hTERT-HME1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA052416: AB_2681824, HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	4.0	3.7	5.5	1.8	8.9	0.4	3.9	7.9	4.3	4.9	0.8	3.0	1.4	4.3	1.4	2.9	3.6	2.4	2.1	4.0	8.3	3.0	0.8	6.2	1.0	11.6	12.0	4.7	4.8	6.5	1.4	1.9	9.2	2.3	2.6	6.1	4.6	0.9	1.6	1.9	2.5	2.5	7.7	2.4	1.9	3.9	10.4	0.7	4.4	1.0	0.9	2.8	3.3	7.2	5.3	11.2	17.6	1.7	13.3	23.2	3.7	16.4	14.7	6.0	5.2	5.9	4.3	0.1	6.6	30.4	14.9	3.3	1.5	9.4	6.1	4.2	1.7	0.2	7.9	6.0	16.4	0.1	0.2	21.6	8.8	16.8	46.8	8.2	5.5	0.3	0.1	0.2	8.0	3.2	0.1	0.1	1.5	2.8	6.5	0.1	3.3	0.1	7.4	2.8	2.8	5.3	6.5	6.7	4.4	2.8	1.8	0.1	11.8	12.4	2.3	13.2	7.6	0.1	0.1	0.1	10.4	1.3	5.0	0.4	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	5.5	8.9	7.9	4.3	4.0	8.3	11.6	12.0	9.2	7.7	10.4	7.2	19.1	0.0	3.3	159.0	3.5	7.8	53.3	20.4	0.0	7.8	19.7	15.1	6.4	37.1	21.7	9.2	6.2	31.7	0.9	42.5	11.7	37.3	192.4	8.3	33.3	24.8	16.7	0.0	19.6	26.0	8.6	43.5	26.0	26.0	1.3	26.8	25.0	2.0	12.2	3.3	38.4	26.6	44.7	34.3	22.2	58.4	22.1	43.5	17.8	151.8	25.1	136.2	0.0	159.8	135.8	41.7	39.8	15.8	0.8	50.5	5.2	14.7	22.1	8.1	0.0	55.1	19.7	5.5	29.1	11.6	3.8	7.3	3.6	2.0	19.6	50.7
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.0"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 497.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	23.6	19.8	29.8	15.8	32.9	22.3	18.0	114.0	41.8	16.5	21.7	12.4	5.8	13.8	13.4	12.9	14.6	11.7	12.3	36.5	34.5	15.4	8.0	20.9	15.2	48.4	41.0	18.2	7.9	25.3	10.4	20.0	55.9	9.0	6.0	9.9	10.0	9.0	6.8	46.9	10.6	15.3	43.4	24.7	8.7	10.7	42.8	13.8	9.9	18.0	13.7	11.9	16.5	57.4	45.6	30.0	99.7	25.6	46.4	41.6	39.0	38.5	28.7	32.9	35.9	20.7	34.0	17.6	21.6	42.9	43.8	36.1	30.0	25.4	32.7	22.2	24.4	36.5	56.4	31.2	19.3	25.4	39.4	37.6	21.6	42.2	29.3	35.7	57.9	22.6	30.6	55.4	21.2	31.6	20.3	22.4	32.2	8.1	34.1	45.3	40.8	42.6	14.1	8.2	33.2	15.2	32.7	23.9	47.5	37.4	29.7	44.4	57.9	32.1	38.4	39.9	35.8	36.8	35.7	16.5	38.4	34.6	80.0	1.0	12.2	0.7	3.2	11.8	1.3	2.6	2.6	3.3	8.3	5.3	1.0	2.2	17.7	2.1	14.0	16.2	4.0	3.7	29.8	32.9	114.0	41.8	36.5	34.5	48.4	41.0	55.9	43.4	42.8	57.4	45.5	9.6	12.1	9.4	18.0	23.8	6.1	7.5	8.6	39.5	3.6	4.4	4.6	11.5	7.9	11.0	4.2	4.1	17.1	0.3	0.0	7.2	57.7	16.4	18.4	37.2	1.2	13.2	72.2	2.1	18.3	18.6	10.2	9.7	8.2	12.0	28.9	2.9	19.0	1.7	105.0	3.3	0.0	46.2	62.5	51.0	7.8	54.1	16.0	497.5	25.4	6.6	5.2	54.3	58.5	4.8	1.3	2.6	16.0	4.2	1.4	0.8	14.5	5.8	0.0	18.5	17.9	19.0	11.6	12.1	36.4	4.2	11.9	9.7	1.8	5.8
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1;retina: 14.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 201.8;Bipolar cells: 217.5;Cone photoreceptor cells: 273.1;Endometrial ciliated cells: 166.0;Excitatory neurons: 223.1;Horizontal cells: 228.8;Inhibitory neurons: 281.2;Oligodendrocyte precursor cells: 159.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;HBEC3-KT: 8.2;hTCEpi: 7.8;RT4: 10.9;T-47d: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	0.7	3.3	12.3	0.7	13.9	0.3	1.5	22.1	16.9	5.2	0.3	1.0	0.7	2.2	1.5	2.3	10.9	1.0	1.8	14.5	9.1	3.2	0.5	1.0	1.1	5.1	9.8	3.7	1.1	0.6	6.1	0.7	7.4	4.5	1.1	14.8	4.2	1.4	1.3	3.7	0.9	0.7	5.6	0.7	1.5	3.5	11.9	1.8	2.6	2.1	0.9	4.1	1.7	10.0	0.5	0.5	9.3	0.4	0.6	1.2	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.1	4.8	0.2	8.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.0	0.7	7.8	0.6	0.8	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.2	2.0	0.9	1.6	0.7	1.1	0.0	0.0	3.8	10.9	1.0	1.2	0.2	2.8	0.1	2.2	10.5	0.0	0.0	0.0	0.3	0.1	0.1	2.7	0.1	0.0	0.8	1.7	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	12.3	13.9	22.1	16.9	14.5	9.1	5.1	9.8	7.4	5.6	11.9	10.0	1.0	3.2	5.6	201.8	2.3	4.1	28.7	36.3	23.3	217.5	7.9	9.8	9.6	0.0	40.6	77.3	273.1	2.4	3.5	1.4	5.9	3.2	24.1	166.0	6.0	4.2	3.0	0.8	223.1	0.5	0.8	4.9	8.2	93.8	1.3	5.4	0.7	2.1	13.2	228.8	281.2	6.2	12.2	18.6	6.0	20.2	2.5	9.4	1.8	37.5	3.3	80.6	1.0	159.8	132.2	0.6	0.5	1.2	1.4	12.3	0.5	1.4	59.4	94.8	0.0	2.9	3.9	6.1	7.1	17.2	5.8	1.4	14.7	12.0	3.1	31.2
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
SRI		ENSG00000075142	Sorcin	P30626	7	88205115-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 566.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		1100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	98.7	89.5	139.1	95.9	147.8	85.2	95.9	148.0	177.1	87.0	115.0	566.0	178.0	70.4	122.4	68.3	147.8	52.3	81.3	135.9	159.7	104.6	42.3	84.2	69.3	146.6	150.6	83.2	75.8	56.7	75.3	64.5	158.3	69.9	447.2	50.3	74.4	64.6	37.6	49.2	252.2	94.2	155.5	60.3	66.3	38.9	147.3	54.6	70.5	53.0	78.2	136.8	81.3	165.7	181.7	59.5	188.5	193.8	295.0	247.0	89.3	106.5	177.5	121.5	143.3	56.2	414.0	198.9	108.3	168.0	296.6	182.8	237.6	244.5	160.2	155.9	92.2	103.4	177.6	0.1	173.8	139.0	108.5	250.5	221.2	127.0	185.1	218.2	365.4	123.7	87.8	175.8	170.4	106.3	211.7	94.5	159.4	261.2	119.3	86.1	256.8	110.9	229.2	179.0	131.5	151.5	323.0	188.0	154.7	179.7	88.0	61.4	218.1	223.4	185.6	201.5	192.9	159.6	79.2	222.4	220.7	130.5	387.8	620.5	151.3	580.6	169.8	217.3	202.4	173.0	185.9	194.9	201.0	151.9	137.7	158.5	93.3	224.3	262.2	161.1	210.4	216.7	139.1	147.8	148.0	177.1	135.9	159.7	146.6	150.6	158.3	155.5	147.3	165.7	258.8	86.6	123.7	63.6	84.4	95.1	389.6	494.2	75.1	34.9	117.2	129.5	107.1	35.8	402.0	156.3	12.5	166.0	104.7	1172.0	442.2	223.0	89.7	307.3	148.6	135.6	94.3	198.6	29.4	418.5	1475.3	175.7	80.0	172.7	135.6	131.3	106.7	40.5	147.6	47.1	22.9	471.7	276.7	79.5	117.9	34.0	172.1	103.2	104.9	15.9	172.5	195.6	113.3	40.2	34.9	380.9	1606.5	141.4	75.2	422.9	1342.4	182.2	660.4	25.9	111.7	111.9	183.9	80.8	106.3	86.9	108.3	197.4	117.9	126.8	536.9	488.1
SRL	SAR	ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	41	"heart muscle: 280.1;skeletal muscle: 510.3;tongue: 382.3"	"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 247.3"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HSkMC: 4.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	NA	NA		230000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.0	0.4	1.0	1.2	1.0	0.2	1.7	1.0	1.5	3.2	0.8	1.3	0.4	3.0	2.3	9.6	3.1	1.8	280.1	0.8	1.2	1.4	0.4	1.2	0.7	1.2	1.3	1.3	0.6	0.2	0.5	1.3	1.1	5.6	1.1	8.5	6.4	2.6	510.3	1.1	1.7	3.4	1.0	2.2	1.1	1.0	1.1	1.7	2.3	382.3	1.1	1.4	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	1.0	1.0	1.5	0.8	1.2	1.2	1.3	1.1	1.0	1.1	1.0	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.0	247.3	0.0	0.0	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.4	0.0	0.0	8.5	0.0	0.1	0.0	0.2	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.3	0.0	1.8	0.1	0.0	1.0	0.0	1.2	0.0	1.0	0.3	0.1	0.0	3.8	0.0	0.3	0.0	0.2	0.0	12.1	6.6	5.5	15.4	0.1	0.2	0.0	0.4	0.0	0.1	0.4	0.0	0.1
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 371.7;Prostatic glandular cells: 249.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	77.5	69.5	53.9	54.3	54.8	31.5	64.5	45.9	71.1	58.1	45.4	56.2	19.1	68.7	16.0	63.9	57.8	18.7	89.5	57.1	52.5	43.3	77.5	53.7	44.4	49.4	58.9	60.6	190.8	15.1	53.4	26.0	51.8	50.1	19.8	10.2	52.4	28.7	127.1	54.2	40.1	40.8	49.0	70.7	57.6	33.0	57.9	24.2	34.4	48.3	38.2	74.5	48.6	47.5	149.6	212.1	69.1	232.5	134.8	144.6	107.7	224.9	114.7	315.1	168.1	263.5	87.4	284.3	127.8	197.2	98.8	114.0	222.6	181.6	104.2	140.5	337.0	180.1	225.3	302.0	197.7	305.6	157.6	145.9	129.1	306.0	266.0	73.8	134.8	183.2	298.1	234.7	155.8	326.5	261.7	266.3	150.5	136.0	405.4	194.6	71.3	466.2	112.4	58.3	132.3	126.5	116.8	248.4	182.3	53.1	87.1	153.2	113.4	204.3	161.7	357.5	257.1	185.6	201.7	429.6	142.4	406.2	241.2	0.0	5.9	0.4	7.4	6.8	10.8	12.5	7.2	9.3	7.0	11.3	8.5	10.0	0.2	5.7	3.5	11.2	8.8	2.3	53.9	54.8	45.9	71.1	57.1	52.5	49.4	58.9	51.8	49.0	57.9	47.5	68.5	0.0	4.6	4.9	115.2	95.0	92.6	6.9	18.2	27.4	75.7	165.7	31.7	28.6	4.0	29.5	20.9	78.0	44.9	23.0	76.3	20.0	4.1	11.0	97.9	54.5	27.5	67.9	13.9	43.2	198.4	91.8	36.2	16.6	26.7	102.0	35.0	50.5	96.4	30.3	23.0	39.9	6.1	41.2	41.7	14.7	71.7	39.8	67.6	10.3	22.4	44.0	29.9	15.6	9.6	30.4	10.8	53.0	371.7	249.9	3.5	86.0	2.5	18.3	0.0	70.7	66.3	14.1	75.9	47.8	113.1	36.0	49.5	108.3	43.1	95.5
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 1.6"	"Cell type enriched"	"Detected in single"	4	"Gastric mucus-secreting cells: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.0	0.0	0.1	0.2	0.1	0.1	0.4	0.6	0.2	0.0	0.0	0.7	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.1	0.9	1.6	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.4	0.4	0.0	0.1	0.0	0.0	6.0	0.4	0.5	0.1	1.2	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRP19		ENSG00000153037	"Signal recognition particle 19"	P09132	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029272, HPA057315"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA029272: AB_10600910, HPA057315: "	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	30.2	32.5	18.9	29.0	19.8	79.2	29.0	19.2	25.8	21.6	17.7	25.1	24.6	25.2	38.2	29.3	22.0	23.1	25.4	20.0	21.4	27.7	48.1	24.4	38.4	18.4	19.1	17.9	41.7	25.4	40.5	28.6	19.0	32.6	27.2	14.5	29.6	18.0	33.9	23.8	23.4	30.2	17.5	30.0	25.8	20.2	20.4	36.0	39.9	23.9	39.9	28.7	22.3	20.6	60.1	40.7	49.3	78.6	45.2	52.4	118.7	82.0	51.8	69.2	82.3	68.0	45.8	62.3	55.0	53.2	110.0	39.0	54.6	84.5	82.2	66.0	88.8	55.1	80.5	80.6	72.4	44.7	58.5	61.2	80.5	64.9	95.6	45.5	64.7	67.1	41.9	72.3	59.5	70.1	72.6	79.0	51.1	60.5	61.6	45.6	44.3	94.4	68.6	75.5	56.1	49.6	66.4	42.4	40.3	56.5	64.7	63.2	52.1	57.1	48.6	57.3	98.3	85.2	111.4	107.9	55.4	75.4	60.3	66.7	34.1	43.6	49.3	37.3	60.9	54.9	55.0	52.7	39.9	45.8	46.3	52.4	48.1	50.9	41.3	86.8	72.2	36.3	18.9	19.8	19.2	25.8	20.0	21.4	18.4	19.1	19.0	17.5	20.4	20.6	64.7	80.1	49.9	17.9	60.6	86.4	74.8	102.2	9.1	15.6	75.1	85.9	52.0	41.5	87.8	44.1	20.9	80.0	120.2	29.6	103.7	96.4	38.9	76.0	85.0	53.4	119.0	52.2	26.7	103.2	125.0	55.9	16.3	80.4	73.5	54.6	35.7	65.3	84.5	13.5	24.6	67.6	79.3	53.3	53.8	24.0	38.8	56.6	51.6	21.5	87.8	30.7	90.6	21.6	41.1	130.4	38.9	39.5	65.7	107.5	33.5	117.1	74.1	24.6	26.3	40.8	58.3	157.4	44.7	22.6	87.8	148.2	71.3	54.2	41.2	112.7
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 108.2"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1275.7;Late spermatids: 2280.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 219.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	14.3	16.2	27.2	15.0	29.7	10.7	18.3	20.1	46.8	16.3	0.0	13.3	11.4	18.1	15.8	16.4	14.6	16.0	14.7	31.0	30.0	13.8	14.2	12.8	17.9	27.9	25.5	17.3	14.7	15.1	12.9	17.1	30.4	18.8	14.8	24.2	15.1	14.4	11.3	24.4	11.4	18.3	19.3	17.8	16.3	108.2	26.7	41.4	15.5	11.8	20.6	18.2	11.6	47.1	36.9	24.0	37.3	74.5	39.3	43.8	21.0	35.4	40.8	34.5	39.9	18.9	30.5	23.4	43.7	45.8	38.5	21.6	38.3	37.3	43.7	40.5	33.2	33.1	21.8	16.5	45.1	31.8	47.1	30.6	67.5	29.2	54.6	33.0	59.8	54.4	33.0	92.2	38.5	69.3	118.3	23.9	31.1	20.8	25.9	37.9	41.3	51.1	49.5	56.1	54.8	37.8	40.1	59.0	37.7	49.1	22.1	21.8	39.7	62.9	45.9	60.8	33.4	100.6	106.6	56.5	24.8	32.3	48.1	50.3	30.2	103.3	41.4	21.0	24.8	45.0	31.1	31.6	27.3	44.0	29.3	33.6	219.5	38.7	25.1	23.6	38.6	25.2	27.2	29.7	20.1	46.8	31.0	30.0	27.9	25.5	30.4	19.3	26.7	47.1	35.8	28.9	29.5	128.9	62.9	212.9	60.6	68.1	49.5	76.9	45.2	40.0	23.3	28.6	41.5	23.9	50.1	52.4	87.1	16.6	27.4	52.9	1275.7	54.3	41.9	51.8	28.8	17.2	298.1	46.3	35.6	47.3	40.8	51.6	41.2	48.9	53.6	35.9	47.6	124.5	300.9	35.2	54.9	43.0	42.9	2280.6	76.7	39.2	58.7	168.6	57.0	73.7	103.0	172.4	399.8	36.4	24.4	95.9	54.8	100.7	15.7	25.9	54.2	67.6	46.0	40.3	59.1	198.8	66.0	36.7	103.3	64.4	58.2	61.4	26.1	67.9
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor subunit beta"	Q9Y5M8	3	133784023-133825772	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"		NA	NA		12000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	20.4	26.8	21.1	18.4	23.3	14.1	24.7	23.2	24.6	26.6	26.4	23.1	19.0	14.4	47.9	29.9	17.9	13.3	16.9	21.1	23.7	26.6	52.9	14.8	15.3	24.5	24.4	13.8	83.2	27.6	25.4	16.0	24.5	18.2	26.1	6.8	49.9	23.7	19.0	15.4	15.4	21.0	22.4	15.5	24.4	26.8	23.1	10.7	26.1	16.5	28.9	23.7	13.8	28.9	44.8	37.5	22.6	72.7	91.8	62.3	45.6	97.4	49.4	50.2	44.3	73.7	34.6	90.4	131.5	72.4	51.2	64.8	69.8	50.9	47.7	57.8	59.6	80.6	34.9	65.2	110.8	124.5	56.7	57.3	83.3	46.2	135.9	28.1	43.5	43.6	68.1	96.9	55.5	65.6	40.9	55.5	43.8	120.3	63.8	49.1	43.5	190.8	61.9	32.1	74.7	32.7	77.3	66.6	28.3	17.0	76.9	55.1	46.0	51.9	29.0	82.8	54.0	118.8	131.5	131.4	45.3	82.9	56.9	13.1	30.5	3.9	54.3	41.1	73.0	38.9	45.4	47.9	36.3	36.7	43.3	51.9	2.2	41.5	27.5	53.8	29.1	50.3	21.1	23.3	23.2	24.6	21.1	23.7	24.5	24.4	24.5	22.4	23.1	28.9	16.8	16.0	20.6	15.3	43.4	37.7	32.0	38.2	11.4	6.5	36.4	22.0	26.6	37.1	32.8	36.8	12.5	65.4	29.1	14.2	11.7	46.0	68.9	18.7	51.2	26.3	32.2	21.7	16.0	67.4	71.2	40.6	28.5	30.1	32.4	19.8	18.9	88.4	49.4	6.7	15.7	58.8	36.7	19.7	23.1	35.9	32.0	20.6	35.6	8.4	16.4	17.2	20.6	17.6	92.6	36.0	17.7	27.8	146.0	52.3	20.0	33.0	24.3	9.4	13.1	38.2	30.2	60.1	40.6	52.1	31.5	51.7	26.1	52.9	43.9	28.5
SRPX2	SRPUL	ENSG00000102359	"Sushi repeat containing protein X-linked 2"	O60687	X	100644195-100675788	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 20.9;Fibroblasts: 34.3;Granulosa cells: 21.6;Microglial cells: 37.5;Skeletal myocytes: 17.5;Urothelial cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 282.3;ASC TERT1: 116.9;HSkMC: 103.3;HUVEC TERT2: 72.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 2.8"	HPA038786	Approved				"Secreted to blood"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA038786: AB_10672724"	"unprognostic (4.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.59e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-3)"	"unprognostic (1.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.85e-1)"	31.8	7.5	3.6	6.3	4.5	0.2	20.7	1.3	2.6	11.3	8.5	7.1	1.2	6.0	0.9	17.7	7.1	3.1	12.7	2.8	5.8	13.9	5.4	13.8	0.4	4.3	5.6	8.3	2.9	0.7	2.5	9.3	3.1	6.3	1.8	0.1	4.6	3.8	3.4	3.7	5.1	4.4	2.0	12.9	4.5	1.1	7.4	0.3	4.3	4.8	1.2	16.8	10.9	2.5	11.7	1.2	2.9	0.1	282.3	116.9	0.0	26.3	19.8	8.0	25.1	1.4	17.6	0.0	1.1	15.9	7.5	0.7	0.2	13.1	8.6	0.1	0.1	0.2	0.9	2.8	29.3	0.2	0.6	103.3	0.3	27.8	0.9	24.6	72.7	0.0	0.0	0.1	27.1	0.0	0.0	0.0	3.4	0.2	0.3	0.0	2.5	0.0	11.4	37.6	0.4	0.0	0.0	0.8	0.2	6.1	0.3	0.1	36.7	13.8	12.3	10.3	0.9	0.1	0.0	0.1	18.3	0.0	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.5	1.3	2.6	2.8	5.8	4.3	5.6	3.1	2.0	7.4	2.5	20.9	0.0	0.6	10.1	0.3	0.4	5.0	6.5	0.6	0.0	4.8	1.8	0.9	0.0	13.7	0.0	0.0	0.2	0.0	1.9	0.0	1.6	3.6	0.6	11.2	1.6	0.0	0.0	0.4	0.0	0.4	34.3	1.1	0.4	0.0	21.6	4.6	0.2	0.9	0.0	0.2	0.1	4.1	0.3	1.6	2.7	15.8	0.3	0.0	37.5	0.0	0.0	0.0	2.0	0.1	0.8	0.0	6.0	0.2	1.6	0.0	0.1	15.5	0.0	0.0	17.5	14.6	0.2	0.1	0.6	0.4	0.5	0.3	2.6	0.4	49.1
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007529, CAB015343"	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"CAB015343: AB_2195009, HPA007529: AB_2667853"	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favorable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favorable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	10.5	7.8	11.0	6.6	11.5	13.9	8.9	12.5	13.1	6.8	13.0	9.4	6.9	7.5	10.3	10.9	8.7	8.3	10.9	9.4	13.4	9.0	8.2	6.1	6.6	11.2	12.4	8.4	11.9	12.3	4.9	5.4	12.7	8.4	7.5	16.6	10.7	7.7	15.6	11.8	5.9	7.0	11.1	6.9	8.0	7.1	12.5	9.0	11.8	6.7	5.4	8.4	5.3	11.8	14.8	27.0	42.7	17.9	24.9	24.4	22.8	29.8	20.2	19.4	20.5	25.3	18.1	27.5	4.1	29.1	14.3	30.2	12.2	11.4	24.6	32.6	26.0	14.6	20.3	9.6	22.5	4.3	8.0	22.9	11.5	41.4	21.0	21.2	28.6	28.2	15.2	19.8	43.9	8.4	28.7	5.8	10.0	13.8	19.9	45.5	48.8	13.3	22.9	6.9	9.2	23.4	26.8	3.3	14.3	14.6	20.7	10.3	21.3	21.4	14.7	24.7	19.0	16.7	26.0	5.1	36.9	13.7	29.8	4.3	8.1	5.6	8.8	8.4	9.1	10.1	11.2	9.1	15.6	10.2	9.2	12.1	1.0	15.7	14.0	11.0	8.8	8.5	11.0	11.5	12.5	13.1	9.4	13.4	11.2	12.4	12.7	11.1	12.5	11.8	5.0	3.2	3.7	3.6	2.1	2.9	3.5	17.4	1.8	8.5	5.5	4.6	4.2	1.5	8.4	1.8	0.0	5.9	3.4	3.0	13.7	9.6	1.9	6.6	5.5	5.4	1.8	5.2	3.5	6.6	3.2	5.7	3.6	4.6	0.0	13.2	8.2	3.2	9.3	16.8	4.9	2.5	12.2	4.6	4.9	1.5	4.1	3.7	5.4	4.7	9.3	11.0	5.2	5.0	7.8	6.7	0.8	5.3	6.1	2.9	2.9	6.3	10.2	5.6	0.0	4.6	6.5	23.3	13.1	4.7	2.4	3.4	2.3	9.7	3.5	4.0
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002945	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	5.0	3.5	8.4	4.1	8.8	6.2	6.2	10.4	9.7	5.5	6.2	6.0	3.6	6.3	6.1	5.3	5.5	3.7	7.6	8.7	8.0	6.4	6.9	5.3	5.6	8.2	8.2	7.1	5.5	6.7	5.1	5.3	7.7	6.8	5.2	5.8	4.9	7.2	19.6	6.0	3.9	7.0	8.1	5.4	4.9	4.8	8.6	5.7	10.5	17.1	7.3	5.5	4.2	8.6	10.7	6.3	10.6	10.9	10.8	6.5	6.1	7.4	10.4	14.7	13.5	6.2	4.6	23.6	5.1	9.7	7.4	9.5	16.6	15.6	14.3	12.2	16.5	10.4	5.5	10.1	7.6	23.1	7.8	6.2	13.4	10.5	16.4	9.7	12.9	13.8	17.2	14.5	9.7	9.2	10.4	7.3	6.6	11.7	7.9	23.3	13.2	17.0	9.7	7.6	11.2	7.6	8.5	7.6	19.7	8.8	9.1	9.0	9.9	11.3	37.2	6.4	13.1	9.5	8.3	19.4	7.7	9.4	15.0	0.3	0.5	0.2	0.7	0.4	1.0	1.1	0.8	1.0	0.5	0.6	1.1	1.2	0.4	0.9	0.4	0.4	0.2	0.3	8.4	8.8	10.4	9.7	8.7	8.0	8.2	8.2	7.7	8.1	8.6	8.6	12.1	0.0	6.4	3.6	10.6	29.7	16.2	7.5	3.4	13.0	10.0	10.5	3.0	12.8	5.9	1.8	2.1	13.3	5.9	3.7	9.8	24.9	22.4	5.8	10.6	11.2	4.8	46.9	3.1	49.0	22.9	8.9	7.7	8.9	11.4	15.1	11.0	15.4	14.1	13.5	3.0	4.5	2.0	3.8	8.6	54.9	7.2	8.6	8.8	1.0	6.1	9.8	10.3	3.5	1.9	48.9	2.4	9.1	10.4	12.1	3.4	19.9	3.2	9.3	6.6	12.6	10.3	17.8	12.9	7.7	31.8	16.7	9.1	21.7	5.9	14.7
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752626-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 150.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA		17000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	195.2	215.4	203.8	115.7	211.0	270.4	193.4	229.1	374.7	255.3	232.5	239.3	127.0	219.7	69.9	222.8	253.9	94.3	246.5	205.6	201.2	212.5	252.5	198.6	125.4	222.7	197.7	265.5	315.1	115.9	171.0	89.2	208.7	217.8	102.8	134.1	243.0	86.9	306.6	224.6	261.5	100.3	180.2	250.7	269.6	146.9	227.5	108.4	231.4	96.9	95.2	211.5	211.7	234.5	108.1	134.7	212.9	147.1	147.1	141.9	125.1	119.8	68.1	105.5	93.5	111.5	123.1	192.2	87.3	134.6	88.2	151.6	170.2	153.6	110.9	139.3	177.5	164.8	284.5	192.9	65.6	171.9	229.6	146.3	145.6	155.0	182.8	210.4	110.5	136.5	187.5	184.1	98.7	186.5	162.6	270.9	196.9	76.4	75.1	286.2	84.0	150.4	136.4	109.7	138.1	120.8	158.1	162.0	98.7	141.7	147.2	137.4	157.1	148.8	150.3	97.9	149.8	161.2	131.6	402.9	51.7	124.0	102.2	150.8	24.0	13.3	8.2	10.6	7.9	15.9	10.4	8.1	5.8	22.9	9.1	12.0	48.2	60.5	10.5	31.9	5.9	3.0	203.8	211.0	229.1	374.7	205.6	201.2	222.7	197.7	208.7	180.2	227.5	234.5	286.4	141.1	232.4	134.8	221.3	310.5	430.1	204.0	178.2	416.5	271.8	283.3	139.0	147.3	180.5	167.3	291.9	179.3	289.0	244.4	66.5	156.3	83.1	285.4	457.7	230.3	189.6	191.6	71.1	179.5	204.8	235.0	296.2	379.3	134.8	273.1	158.8	183.8	157.2	439.1	76.7	245.2	162.8	124.5	238.7	77.2	251.6	208.1	120.9	116.2	160.9	239.8	195.7	94.0	109.6	159.9	188.4	192.2	262.3	352.3	192.5	99.3	146.6	358.1	197.2	366.8	391.0	231.8	253.7	219.2	365.1	276.2	237.5	339.5	236.5	377.8
SRRM4	"KIAA1853, nSR100"	ENSG00000139767	"Serine/arginine repetitive matrix 4"	A7MD48	12	118981541-119163051	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 18.3;retina: 29.1"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 330.4;Cone photoreceptor cells: 429.5;Excitatory neurons: 182.0;Inhibitory neurons: 322.2;Rod photoreceptor cells: 372.4"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 4.4;SCLC-21H: 3.9;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052783	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA052783: AB_2681945"	"unprognostic (2.44e-2)"	"unprognostic (2.66e-1)"		"unprognostic (2.40e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"		"unprognostic (1.37e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.61e-5)"	"unprognostic (1.10e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.61e-1)"	0.0	1.1	7.1	0.0	10.4	0.1	0.0	16.4	18.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	29.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	10.4	16.4	18.3	8.8	0.1	0.0	0.1	0.1	0.0	1.3	6.4	0.0	6.4	0.0	3.6	0.0	0.0	0.1	0.0	0.0	330.4	0.0	0.0	9.9	0.0	0.6	0.0	429.5	0.8	0.0	0.0	0.0	0.0	5.6	10.6	0.9	1.5	0.0	0.0	182.0	0.0	0.3	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	28.6	322.2	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	9.4	0.0	12.1	0.0	5.5	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	372.4	6.6	0.2	1.0	0.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.1
SRRM5		ENSG00000226763	"Serine/arginine repetitive matrix 5"	B3KS81	19	43596617-43614498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 47.8"	"Group enriched"	"Detected in some"	43	"Early spermatids: 176.5;Late spermatids: 64.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA047399, HPA052924"	Uncertain		Approved	Vesicles,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Centrosome	"HPA047399: AB_10963088, HPA052924: "	"unprognostic (3.95e-3)"	"unprognostic (7.56e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.68e-5)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-3)"	0.5	0.9	1.0	0.5	1.2	0.4	0.5	2.3	1.3	0.8	0.6	0.8	0.3	0.5	0.3	1.0	0.7	0.4	0.9	0.9	1.0	1.4	1.1	0.6	1.0	1.1	0.9	0.9	1.2	0.2	1.6	0.2	1.1	1.9	0.1	1.9	0.9	0.1	0.5	0.8	0.7	0.1	0.6	0.9	0.7	47.8	1.0	0.1	1.1	0.0	0.0	0.6	0.9	1.2	1.3	1.1	0.4	0.8	0.4	0.3	0.3	0.3	0.1	0.1	0.1	0.7	0.5	0.4	0.7	0.1	0.3	0.8	0.4	0.1	0.2	0.5	0.5	0.4	1.1	0.6	0.1	0.3	0.6	0.3	0.4	0.0	0.1	0.4	0.1	0.6	0.3	1.1	0.0	1.1	0.5	0.5	0.1	0.9	0.3	0.8	0.3	0.3	0.3	1.7	0.8	0.3	0.1	0.4	0.4	0.5	0.9	0.2	0.6	1.1	0.7	0.4	0.6	1.3	0.9	0.5	0.6	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	2.3	1.3	0.9	1.0	1.1	0.9	1.1	0.6	1.0	1.2	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	2.8	0.3	0.3	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	176.5	0.3	0.4	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	64.9	1.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.9	0.0	0.8	0.1	0.7	0.6	0.8	0.3	0.1	0.2	0.3	0.1	0.1
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875103-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 251.1;Late spermatids: 329.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	50.1	64.6	38.8	47.2	43.2	115.2	52.4	44.1	43.8	69.9	41.8	54.7	37.7	56.8	30.3	63.4	56.5	28.7	46.3	38.8	43.2	63.0	74.7	49.4	62.3	43.2	40.1	71.3	63.0	33.0	64.1	33.2	40.7	73.6	25.2	30.8	59.3	30.6	51.1	69.6	60.4	26.8	37.7	75.0	55.3	159.9	42.0	51.0	64.2	23.6	40.6	49.6	60.0	44.7	104.3	122.5	123.6	121.2	51.6	36.8	115.2	112.9	56.6	113.0	96.7	161.3	114.5	172.7	75.6	82.0	84.6	96.1	149.6	101.0	56.0	154.0	128.3	163.3	150.3	134.7	46.4	213.6	270.4	55.2	39.0	100.8	28.8	51.3	62.1	103.8	147.1	135.6	79.4	180.9	198.7	235.6	127.5	89.0	107.4	183.1	94.9	103.4	73.6	113.0	97.6	94.4	111.0	136.5	75.4	62.9	85.9	130.7	95.2	127.1	122.7	109.4	154.8	85.5	132.8	185.2	70.6	141.4	122.6	7.7	14.6	22.2	28.3	23.0	18.3	12.2	18.7	38.8	15.7	15.5	16.0	23.0	10.9	10.4	18.1	14.2	9.7	20.9	38.8	43.2	44.1	43.8	38.8	43.2	43.2	40.1	40.7	37.7	42.0	44.7	22.7	25.6	49.2	17.3	37.6	38.5	27.8	24.1	63.7	23.3	22.4	21.8	21.5	14.3	39.2	16.5	14.6	42.7	43.2	24.4	7.9	31.7	251.1	25.6	36.2	25.9	32.9	51.9	8.6	32.0	50.4	29.2	51.5	41.7	27.1	31.3	12.8	13.1	26.5	26.9	8.5	29.1	18.3	15.0	35.9	329.5	33.8	28.4	16.0	9.4	25.1	29.4	26.8	12.5	12.7	26.3	17.9	27.8	67.2	22.8	16.0	12.2	30.5	46.0	19.7	31.7	41.7	133.3	65.8	52.4	43.5	54.2	62.8	33.9	32.3	21.4
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58000919-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Supported	Nucleoplasm		NA	NA		980000	"Cluster 27: Non-specific - Gene expression"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: AB_2684474"	"unprognostic (9.86e-2)"	"prognostic favorable (7.00e-4)"	"prognostic favorable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	71.1	81.1	44.0	84.0	47.5	54.7	62.8	52.1	50.0	78.6	53.8	76.1	69.7	79.1	70.0	84.0	73.5	42.5	61.8	43.0	45.9	71.0	71.4	60.8	107.1	44.1	45.7	78.4	58.6	73.0	69.2	64.8	45.0	70.2	77.1	60.5	67.5	57.4	71.2	57.2	73.4	59.6	47.4	72.6	69.0	38.9	46.3	104.5	72.7	51.5	119.7	69.3	73.6	50.7	211.4	157.1	264.9	153.3	72.3	67.3	164.6	187.0	102.9	177.9	167.8	195.9	180.6	352.0	121.1	129.8	134.3	178.9	298.4	192.6	325.5	196.8	176.1	263.0	202.2	220.9	83.2	292.4	169.9	56.3	90.5	164.6	168.3	84.3	145.1	131.9	291.0	166.9	181.2	162.6	370.2	258.4	246.5	191.7	160.9	349.4	216.1	217.1	176.6	177.5	192.4	206.8	142.5	128.6	139.5	142.0	180.8	220.5	139.3	158.6	197.0	122.7	258.8	149.7	217.3	333.3	150.1	272.2	193.8	23.9	48.3	32.5	38.9	64.4	38.6	35.7	30.7	37.1	71.1	24.9	32.8	33.3	22.0	48.1	45.1	40.5	36.9	45.2	44.0	47.5	52.1	50.0	43.0	45.9	44.1	45.7	45.0	47.4	46.3	50.7	74.1	35.3	48.3	66.0	89.1	133.7	130.0	53.1	96.2	62.9	73.1	58.0	31.3	41.5	48.6	44.1	31.3	70.3	68.1	57.5	70.5	68.2	57.8	44.9	59.2	66.2	65.8	93.2	33.0	60.1	116.6	74.7	53.5	59.3	59.6	92.2	44.6	46.3	59.1	52.2	51.8	76.2	52.9	54.0	73.5	34.0	84.2	52.3	55.2	36.5	60.7	43.5	80.3	56.3	59.2	61.4	84.9	60.2	73.3	102.8	76.3	56.4	43.4	83.1	105.2	87.7	89.5	74.6	58.0	86.6	137.5	60.9	69.4	57.3	93.3	120.6
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964347-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm		NA	Yes		49000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053805: AB_2682269, HPA053831: AB_2682275"	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.74e-4)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	57.0	59.9	22.5	46.3	23.3	119.6	46.9	26.5	30.1	51.7	29.9	48.8	38.0	49.6	40.7	43.8	56.3	29.2	40.0	23.2	24.4	56.3	56.7	49.6	61.0	23.3	23.5	61.1	50.1	37.2	43.6	42.2	24.3	47.9	45.0	46.5	45.4	32.1	37.7	40.1	50.2	41.3	25.0	49.0	47.9	34.7	23.1	55.8	61.3	24.4	57.1	43.0	45.0	28.6	110.7	89.6	142.9	92.9	88.6	68.2	98.0	133.4	53.5	116.8	102.3	83.5	112.8	239.5	82.7	63.5	73.8	99.7	163.4	89.7	140.7	140.9	122.7	134.5	160.3	115.1	62.2	164.3	107.9	44.2	68.5	74.3	72.9	66.8	89.1	92.1	187.2	83.4	99.3	77.2	167.9	118.1	196.2	139.6	84.4	162.9	99.7	127.6	102.1	86.4	104.9	85.5	98.7	88.2	100.1	97.4	94.2	129.5	89.2	94.7	99.5	89.2	126.4	94.6	134.6	189.1	83.4	185.9	112.8	112.8	67.7	74.0	51.3	84.1	65.1	80.2	58.5	60.3	58.1	68.8	62.9	55.8	43.9	74.5	82.0	69.6	75.9	72.3	22.5	23.3	26.5	30.1	23.2	24.4	23.3	23.5	24.3	25.0	23.1	28.6	115.8	112.2	112.1	39.2	188.4	42.6	115.5	23.2	183.2	159.1	104.4	103.4	59.1	97.2	85.5	79.1	160.6	116.8	150.5	85.6	78.2	94.2	115.4	96.7	138.3	109.8	122.0	154.2	54.7	89.2	164.1	111.3	93.8	106.7	93.6	181.0	86.0	63.8	82.0	99.3	50.9	92.4	36.7	51.2	41.3	118.5	127.7	83.4	26.6	44.0	101.5	131.6	111.2	54.8	67.2	78.6	85.9	110.6	169.4	122.6	67.4	74.6	94.6	287.5	105.2	121.8	125.8	188.1	150.5	140.0	45.5	63.3	142.6	335.7	106.3	100.1
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	76.4	67.0	39.4	51.4	42.6	136.8	76.9	48.1	64.6	86.6	40.0	73.7	44.7	75.9	70.0	62.1	83.7	45.1	51.9	39.4	46.5	68.8	94.1	70.1	75.8	42.0	40.7	96.3	85.7	43.0	79.8	56.1	43.7	73.7	45.0	57.7	69.5	40.8	66.3	75.9	84.9	39.3	39.7	89.8	72.9	58.4	41.4	75.4	86.2	32.9	64.7	68.5	75.0	47.9	92.8	46.2	118.4	76.2	59.5	79.7	162.4	111.6	57.5	89.0	80.3	81.6	68.0	156.6	74.7	56.5	58.4	77.4	151.5	61.4	120.7	105.9	118.1	159.0	112.4	98.5	71.1	221.0	63.3	64.2	76.0	82.5	83.5	111.3	80.4	79.0	159.1	96.1	88.7	36.4	133.3	163.1	190.9	72.3	76.9	156.1	130.9	99.9	104.3	65.7	99.3	82.1	94.5	101.1	139.8	109.1	80.9	98.1	96.0	97.8	70.4	71.3	102.3	110.4	94.5	169.9	70.2	161.3	87.7	111.7	63.5	103.6	65.7	51.6	74.9	76.3	67.0	65.2	66.1	70.7	72.2	67.8	31.7	85.8	64.6	91.7	80.4	52.7	39.4	42.6	48.1	64.6	39.4	46.5	42.0	40.7	43.7	39.7	41.4	47.9	198.6	211.5	224.9	90.4	208.6	354.0	295.5	229.6	222.5	164.8	166.9	171.7	119.6	115.8	184.5	195.0	118.9	242.0	243.4	123.8	115.4	151.0	64.4	160.0	267.9	186.8	173.8	218.5	219.0	135.3	253.1	228.9	165.6	231.0	194.1	218.1	146.3	152.6	150.4	159.9	183.0	158.3	150.5	124.9	244.4	56.9	255.7	155.4	168.9	126.5	183.1	115.5	145.2	168.9	219.8	144.9	104.7	264.4	234.9	317.8	122.1	101.4	157.8	158.1	170.9	199.1	218.3	270.0	138.0	181.4	353.6	303.7	226.2	195.5	172.9	315.0
SRSF12	"SFRS13B, SFRS19, SRrp35"	ENSG00000154548	"Serine and arginine rich splicing factor 12"	Q8WXF0	6	89095959-89118071	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 11.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 162.1;Late spermatids: 214.0;Spermatocytes: 65.7;Spermatogonia: 42.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 9.5;HAP1: 7.5;HEK 293: 7.6;REH: 7.6;SCLC-21H: 8.1;SH-SY5Y: 7.9;SuSa: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049782	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049782: AB_2680880"	"unprognostic (6.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.58e-4)"	"unprognostic (4.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.83e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.96e-3)"	0.4	0.4	3.1	0.6	3.7	0.4	0.5	4.4	3.3	1.0	0.3	0.6	0.1	0.8	0.6	0.2	0.8	0.9	0.4	3.7	4.3	1.7	0.3	0.4	0.2	2.0	2.6	1.6	0.6	1.5	2.5	0.3	2.3	1.0	0.1	2.4	0.3	0.7	0.2	0.3	0.2	0.9	2.2	0.1	0.4	11.4	4.3	0.4	1.3	0.1	0.2	0.7	0.5	2.3	0.0	0.8	9.3	9.5	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.2	0.1	0.0	0.8	0.0	0.3	0.0	7.5	0.2	1.0	0.1	7.6	0.0	0.1	0.6	1.0	0.0	0.0	0.1	0.4	0.2	0.5	0.0	0.0	0.7	0.1	0.2	0.2	0.1	0.0	0.3	2.1	0.0	0.2	7.6	0.5	0.1	4.6	0.0	8.1	7.9	0.2	0.1	1.4	5.5	0.0	2.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	3.1	3.7	4.4	3.3	3.7	4.3	2.0	2.6	2.3	2.2	4.3	2.3	0.6	0.0	1.1	9.1	0.8	1.0	3.9	1.0	0.6	9.7	1.4	1.5	3.3	0.0	0.2	0.0	8.4	0.8	1.5	0.1	1.9	5.4	162.1	1.9	4.3	1.2	0.0	0.0	20.1	3.2	0.5	2.5	2.6	3.9	0.0	2.9	0.0	0.2	0.3	0.0	18.9	0.0	0.0	0.0	0.4	214.0	3.4	1.0	3.6	1.9	6.2	6.6	0.0	14.6	3.4	3.3	0.0	2.6	0.7	4.7	0.0	3.6	0.0	1.3	6.6	4.5	2.7	65.7	42.6	1.1	0.6	0.3	1.5	0.3	0.0	1.6
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181900	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	84.7	61.1	43.4	46.8	45.4	77.5	78.2	47.6	46.6	82.3	44.1	86.7	49.6	79.7	38.6	73.5	71.7	36.4	61.9	43.0	46.9	62.9	95.8	83.5	57.4	44.8	43.7	88.2	61.6	38.7	56.0	57.6	45.6	72.0	35.6	51.8	62.5	39.6	94.1	76.2	73.1	40.6	43.0	81.9	66.7	44.5	45.0	63.2	73.7	51.7	43.4	77.7	76.6	46.1	108.2	63.5	117.0	42.8	83.9	63.0	72.5	87.6	65.5	103.3	88.0	58.6	64.9	122.2	79.9	74.5	66.9	99.0	99.7	81.4	104.5	148.6	118.9	185.7	95.6	92.9	87.2	127.8	114.0	51.1	101.1	87.7	111.8	83.9	86.6	70.2	154.8	95.7	71.1	54.1	162.2	110.4	125.2	64.4	60.0	150.6	126.9	83.3	71.1	110.0	71.3	81.4	107.4	61.5	105.8	103.4	41.0	76.3	84.2	82.9	66.1	91.0	146.4	88.0	70.6	134.5	79.4	161.0	91.9	72.7	45.7	102.2	64.6	55.1	63.3	49.0	59.7	70.5	55.8	53.1	51.0	55.0	89.6	48.4	62.3	43.2	78.9	51.1	43.4	45.4	47.6	46.6	43.0	46.9	44.8	43.7	45.6	43.0	45.0	46.1	142.3	80.1	129.8	23.8	94.2	99.8	179.6	65.0	91.0	70.2	50.2	42.9	51.1	45.8	92.8	51.5	85.5	132.7	100.0	68.4	54.8	64.9	8.2	85.4	98.4	131.0	39.0	114.3	20.1	47.2	124.6	87.8	76.5	99.4	91.7	76.2	101.0	75.9	68.8	57.2	21.1	72.7	59.0	69.8	79.0	11.6	85.7	83.4	55.2	14.0	88.6	74.8	92.7	19.6	19.6	56.3	78.8	89.1	121.4	172.3	83.1	58.3	91.7	108.3	72.3	99.5	97.4	64.7	51.9	95.9	103.3	142.8	105.1	75.9	78.7	210.4
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		23000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	210.9	188.4	68.1	149.5	72.5	456.9	229.8	60.3	108.2	174.2	125.9	231.8	129.2	222.5	218.0	217.9	240.9	130.1	154.4	75.9	69.7	119.6	183.8	214.8	210.1	75.5	71.1	220.0	136.6	188.1	215.5	105.1	74.1	172.7	164.8	233.8	235.8	126.7	217.6	282.0	256.6	180.3	66.0	211.8	212.8	104.1	69.5	214.7	224.8	68.3	155.0	189.3	177.4	97.1	456.4	133.5	313.8	141.4	192.7	179.6	177.4	214.6	239.7	177.6	183.7	164.7	283.6	473.1	110.4	301.8	174.7	210.2	242.5	309.2	209.7	407.4	142.3	354.3	386.7	183.6	224.3	334.7	255.7	350.9	201.2	199.7	216.3	260.4	247.0	401.8	255.4	268.3	114.3	382.1	385.1	232.4	182.0	356.6	128.2	324.0	148.5	183.3	237.2	563.1	165.9	236.3	364.3	214.1	296.0	188.5	235.9	292.3	299.7	98.4	264.2	110.9	205.6	261.6	184.5	754.8	232.3	286.1	140.1	137.1	65.8	103.6	93.1	117.9	94.9	109.5	83.1	85.0	70.1	108.7	81.1	79.6	161.9	86.2	129.6	99.8	74.8	77.2	68.1	72.5	60.3	108.2	75.9	69.7	75.5	71.1	74.1	66.0	69.5	97.1	380.7	253.2	309.1	218.1	392.8	138.0	768.6	610.1	204.9	387.4	248.6	259.1	195.0	240.2	386.6	183.9	239.8	444.3	542.9	471.8	320.8	201.7	190.3	224.2	169.8	293.6	302.9	195.4	199.5	171.8	261.5	288.0	188.6	225.3	480.2	251.3	249.9	225.4	217.7	378.6	177.7	376.6	380.5	236.2	154.3	105.0	345.5	314.7	133.4	104.9	323.4	277.4	428.5	128.2	268.7	226.6	538.5	267.1	212.3	376.7	484.7	228.2	373.4	317.3	276.1	583.7	354.2	201.8	149.8	196.4	145.6	749.2	456.6	201.6	275.5	542.1
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457893-43466046	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"		NA	NA		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	43.3	53.7	34.0	34.5	37.5	115.9	56.2	41.4	43.8	44.2	52.7	37.8	36.3	52.7	59.7	32.8	47.4	31.4	31.4	33.3	39.6	47.4	50.3	40.3	48.4	34.5	34.7	58.5	66.3	41.8	48.0	39.3	35.6	48.7	43.4	38.7	45.3	30.0	30.5	48.7	45.4	39.7	35.6	55.9	47.4	30.3	35.7	53.7	50.8	18.1	40.8	29.7	30.4	47.3	52.7	79.1	88.7	57.3	50.7	67.7	86.3	79.6	38.3	55.4	47.1	112.9	55.9	95.9	73.9	73.3	45.1	77.6	91.7	116.9	71.7	40.2	85.7	74.6	83.3	94.1	62.3	94.9	78.9	115.7	61.9	51.0	46.2	85.1	52.7	83.8	63.3	54.5	52.6	112.3	144.5	107.6	57.8	87.4	107.4	100.2	54.4	76.9	63.1	93.7	69.0	90.9	89.5	108.7	105.0	61.7	70.4	103.3	54.9	57.9	61.6	49.9	67.3	98.2	67.3	131.4	69.9	67.2	42.8	26.0	19.9	9.7	19.7	33.4	22.4	16.0	20.8	19.1	24.5	15.9	27.3	25.7	10.8	21.2	29.6	20.4	18.7	22.9	34.0	37.5	41.4	43.8	33.3	39.6	34.5	34.7	35.6	35.6	35.7	47.3	78.9	64.1	80.0	49.6	75.8	94.4	61.0	58.5	50.7	48.9	110.7	78.7	28.7	75.8	61.3	46.0	39.6	97.8	103.3	67.8	88.0	60.2	12.3	60.1	87.7	62.3	101.4	71.1	32.1	43.7	108.2	80.0	70.8	79.1	97.0	103.2	60.7	94.7	56.5	32.0	37.2	97.2	46.8	73.2	93.7	14.7	55.0	77.3	101.4	26.2	61.2	45.0	37.0	89.0	79.6	46.2	74.3	44.8	49.3	68.9	66.7	67.7	47.6	46.4	59.2	166.1	99.8	53.8	61.0	51.5	98.3	139.1	76.4	90.7	105.5	55.3
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavorable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	68.3	44.5	30.5	59.3	31.8	132.8	53.3	32.3	36.0	37.3	33.9	55.0	30.4	43.8	40.7	65.3	45.2	24.0	37.7	32.3	33.6	47.0	49.4	50.5	72.0	30.8	30.2	34.6	33.6	36.1	30.0	50.7	30.8	38.9	52.2	25.0	37.4	34.5	41.9	37.8	46.2	52.9	33.3	45.8	50.6	54.0	30.7	87.0	34.3	27.7	90.1	68.4	40.9	34.4	271.3	229.3	304.4	197.1	91.8	71.8	213.7	225.2	96.6	222.9	177.9	272.9	202.4	436.1	150.9	148.2	206.9	149.2	385.7	277.1	266.7	274.7	240.9	264.3	154.8	281.2	78.1	329.3	185.4	43.4	92.8	153.3	295.0	94.3	187.9	180.3	388.5	171.1	191.6	298.9	421.2	289.9	331.5	313.3	208.4	367.8	253.4	248.0	168.2	257.3	207.2	201.6	215.3	190.1	156.5	189.7	172.8	295.0	163.1	134.3	210.2	116.3	317.6	186.6	297.8	658.9	159.1	339.1	189.3	23.4	71.2	27.8	59.8	103.3	65.0	63.3	46.1	60.3	142.4	40.7	51.4	59.7	6.8	65.7	61.7	85.8	53.4	77.5	30.5	31.8	32.3	36.0	32.3	33.6	30.8	30.2	30.8	33.3	30.7	34.4	445.1	80.1	208.8	31.3	453.7	259.5	460.8	255.9	220.3	122.7	226.9	367.2	67.8	87.2	177.0	64.4	118.9	313.7	730.0	214.7	156.5	195.4	173.6	104.6	193.5	245.7	178.0	153.5	96.6	132.2	478.1	264.0	258.9	130.4	320.4	273.2	150.0	85.3	241.9	121.1	82.2	222.5	140.4	123.4	242.6	45.2	138.5	289.2	152.9	65.6	222.6	253.9	239.9	74.9	100.8	149.0	179.3	109.9	337.7	309.9	192.1	94.1	116.4	225.8	118.3	317.9	408.1	286.7	287.3	163.0	243.5	250.2	652.4	186.4	242.8	344.7
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95066919-95071225	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	14.8	13.5	16.3	12.1	16.0	14.7	16.7	16.5	18.0	14.7	16.8	15.1	15.7	17.3	16.0	14.5	15.3	12.0	13.4	15.8	17.0	19.3	15.1	13.5	17.4	15.0	15.5	20.7	21.9	17.9	15.7	14.3	15.3	19.0	15.6	10.4	19.9	16.8	13.2	14.9	17.4	14.7	16.2	20.0	15.8	5.3	17.5	12.3	23.2	14.1	14.7	13.2	13.6	17.7	7.6	7.7	19.1	0.0	24.9	15.5	21.7	11.1	12.2	5.1	5.5	18.4	24.2	40.3	32.2	16.9	9.4	16.3	16.2	24.1	5.9	24.4	17.8	33.8	9.0	16.6	18.3	34.3	17.7	20.3	25.1	5.4	25.3	15.0	16.2	18.1	25.9	21.5	10.1	10.3	17.9	30.4	10.2	19.8	21.7	22.1	5.8	32.1	20.1	24.8	24.2	24.7	13.8	24.1	16.7	12.0	9.6	18.7	15.3	9.9	13.3	13.5	11.6	11.6	19.1	21.4	5.1	22.5	22.1	10.1	2.1	0.7	5.4	1.2	7.9	9.2	9.4	8.1	4.0	7.1	12.0	9.1	0.6	6.2	1.1	3.7	10.9	4.1	16.3	16.0	16.5	18.0	15.8	17.0	15.0	15.5	15.3	16.2	17.5	17.7	32.5	44.8	29.3	8.8	82.8	0.0	51.4	0.0	57.5	49.3	54.4	60.3	21.4	58.6	11.8	33.1	33.3	39.2	56.5	41.1	150.6	36.7	1.8	22.1	27.6	45.8	56.9	122.9	18.3	45.7	52.7	31.4	40.2	33.8	10.2	43.2	52.5	57.8	26.1	18.5	16.6	82.6	0.0	24.2	0.0	6.0	41.0	41.9	0.0	18.7	40.2	45.7	97.9	13.6	29.6	28.9	40.8	60.9	46.8	46.4	53.4	110.1	9.5	50.9	32.9	34.6	31.0	7.2	6.4	63.5	0.0	51.2	58.4	52.1	67.5	38.0
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461672-120469748	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	68.2	112.1	71.2	75.5	74.3	95.0	72.0	73.9	75.2	70.3	81.0	88.7	73.0	57.5	85.5	126.6	76.1	48.7	38.8	70.6	75.1	94.7	92.0	62.1	99.3	72.7	77.2	71.2	113.8	94.2	78.2	85.2	74.0	76.9	84.2	21.8	77.1	57.4	30.0	80.6	63.5	58.9	74.4	86.7	82.6	93.3	77.6	110.2	80.6	27.5	129.1	82.9	75.6	72.1	334.7	229.2	344.3	222.7	153.6	153.7	365.3	224.3	200.7	281.5	240.2	276.9	153.1	323.6	254.7	189.4	152.7	194.9	312.0	318.9	308.5	244.7	321.9	276.3	152.8	273.5	197.7	344.7	241.8	163.4	201.8	244.6	211.0	301.2	260.4	207.0	353.6	95.3	245.9	466.8	339.7	668.7	429.6	224.8	198.2	374.2	144.1	312.9	246.4	420.4	303.9	217.3	262.5	137.3	276.2	222.4	415.9	299.4	229.1	207.8	247.0	157.8	246.3	288.6	234.5	404.9	218.8	255.7	221.5	28.7	16.9	49.3	22.5	19.8	17.5	41.2	17.4	19.9	22.5	36.7	17.3	19.1	19.7	26.5	27.7	30.7	20.1	8.7	71.2	74.3	73.9	75.2	70.6	75.1	72.7	77.2	74.0	74.4	77.6	72.1	172.6	25.6	37.2	17.3	190.1	264.9	269.7	81.2	140.0	74.5	235.6	174.4	1.7	157.3	60.4	161.8	29.2	339.2	204.5	119.5	489.1	200.6	68.5	179.1	149.9	143.8	144.7	141.9	24.1	155.1	469.4	148.9	105.5	143.9	33.7	321.3	132.8	150.0	202.9	72.3	23.6	160.5	63.1	136.3	322.0	28.5	124.5	171.3	200.9	11.2	192.7	134.4	129.8	14.1	24.1	152.4	102.2	155.0	317.8	336.8	89.8	404.3	63.6	55.3	52.6	128.1	165.5	288.5	248.8	218.2	313.4	475.4	158.1	433.1	160.6	392.2
SS18	"SSXT, SYT"	ENSG00000141380	"SS18 subunit of BAF chromatin remodeling complex"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	29.5	46.2	21.2	27.7	24.9	23.0	33.2	23.6	22.6	32.1	26.3	28.4	18.0	32.2	39.4	34.5	33.2	29.8	29.4	21.8	23.6	36.8	41.9	26.8	35.9	25.5	24.7	47.7	23.8	52.0	30.5	36.9	24.5	35.0	23.4	24.7	29.7	31.2	11.6	41.2	27.7	31.8	23.8	28.5	26.8	25.9	22.4	33.6	45.4	17.5	38.6	38.3	31.2	29.1	52.4	37.2	90.8	43.9	69.0	65.1	45.8	62.9	57.6	55.1	53.6	24.5	43.1	90.6	49.1	75.0	49.0	67.1	50.1	62.0	67.5	58.4	23.3	45.4	56.2	39.8	55.6	69.8	66.5	81.4	71.3	68.6	74.3	53.7	43.7	26.6	34.2	45.0	76.3	53.1	28.5	39.9	17.3	51.6	35.7	33.0	70.2	44.2	57.6	60.7	38.1	57.7	96.0	43.8	27.0	64.6	45.5	40.9	51.4	114.1	22.6	26.8	63.9	80.9	58.3	64.0	53.9	47.8	62.2	27.1	13.5	19.4	16.4	19.7	19.2	17.7	15.6	17.1	15.2	15.0	16.2	18.6	5.7	24.6	20.2	8.5	18.2	16.3	21.2	24.9	23.6	22.6	21.8	23.6	25.5	24.7	24.5	23.8	22.4	29.1	28.8	28.9	23.7	43.8	45.9	8.9	27.8	13.9	40.9	28.8	29.4	26.4	16.0	22.8	18.1	23.9	16.7	70.0	34.0	25.2	21.5	30.3	52.7	44.8	31.5	27.9	24.7	26.1	50.7	26.0	48.8	30.4	22.4	32.3	36.8	60.2	22.1	34.5	27.6	87.5	42.7	25.7	6.1	25.5	10.9	51.4	33.2	22.6	5.4	65.6	19.7	51.1	22.6	90.5	118.0	34.8	15.7	41.0	42.0	24.8	19.1	24.9	30.5	29.8	39.5	23.4	31.3	29.3	20.3	37.2	13.2	85.1	34.0	30.7	16.9	24.7
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1 subunit of BAF chromatin remodeling complex"	O75177	20	62143769-62182514	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: AB_2683888"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	7.7	8.8	11.3	6.6	10.1	6.6	7.8	26.1	13.9	10.3	7.5	8.2	7.7	8.0	8.4	10.9	9.2	5.0	8.3	9.7	9.7	10.5	37.8	9.7	6.4	12.2	9.5	10.6	12.1	6.4	11.9	7.1	11.6	9.0	6.1	10.7	8.5	5.4	13.3	19.8	8.4	5.6	6.7	10.1	9.2	8.9	11.1	6.5	9.1	9.4	5.8	8.5	10.1	18.9	11.1	12.5	17.7	16.3	7.6	8.8	12.9	10.3	3.9	16.6	8.0	44.1	10.2	6.6	13.3	5.8	8.6	27.9	10.5	9.8	15.2	4.5	6.9	29.6	30.9	23.5	5.7	11.2	25.6	5.5	20.5	8.4	7.0	9.7	7.5	11.3	20.3	12.8	9.6	13.2	16.7	17.2	7.3	11.0	13.7	18.5	23.1	7.8	12.5	13.9	33.4	18.6	17.7	22.4	15.6	11.3	20.8	17.6	9.3	31.8	19.0	12.0	14.6	13.8	13.2	5.6	15.9	10.6	10.9	0.0	0.4	0.1	0.3	0.3	0.2	0.1	0.2	0.3	0.3	1.2	0.6	0.2	0.6	0.4	0.7	0.2	0.2	0.1	11.3	10.1	26.1	13.9	9.7	9.7	12.2	9.5	11.6	6.7	11.1	18.9	9.7	9.6	7.0	19.6	5.2	16.4	4.8	8.9	17.1	17.9	10.8	8.8	10.3	2.8	11.4	7.3	22.9	5.6	6.7	7.1	3.9	5.0	10.8	11.9	8.1	9.7	14.3	4.8	29.5	2.7	3.3	8.9	7.7	12.8	1.3	10.8	8.6	40.4	4.8	15.2	32.8	6.6	14.2	10.4	12.7	20.8	7.5	7.4	12.4	20.6	10.0	4.4	4.1	8.5	25.5	8.2	7.3	3.4	7.4	9.5	8.3	9.1	9.0	16.5	6.6	11.1	7.7	4.6	10.2	10.6	17.5	7.7	6.0	10.6	7.1	6.9
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42596934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	21.0	17.1	27.6	18.5	28.6	33.9	21.9	28.8	37.1	19.8	26.7	17.5	19.0	12.6	17.8	21.2	15.7	10.4	18.7	28.2	28.4	24.5	32.4	19.6	35.4	28.2	27.8	19.1	21.6	13.5	25.1	9.9	28.3	35.9	13.6	13.7	19.1	8.6	16.2	24.9	25.6	7.4	28.4	31.6	22.7	10.1	27.8	23.6	20.4	11.0	30.2	19.4	18.5	31.5	32.3	14.0	29.0	26.4	34.9	27.8	17.3	20.6	22.4	28.7	32.2	27.1	29.1	43.3	18.2	13.6	31.6	17.9	33.9	28.0	30.9	21.7	40.5	46.9	28.9	45.3	25.4	62.5	36.2	22.1	17.7	23.7	21.9	20.6	31.4	39.1	43.2	65.4	23.1	29.3	44.8	76.4	45.9	42.7	34.2	23.6	20.6	61.2	32.3	38.2	16.2	23.0	17.6	27.2	29.8	30.2	35.8	57.4	19.5	18.0	29.0	42.8	38.0	46.5	76.3	73.5	26.3	66.1	17.0	60.4	56.4	84.9	88.4	66.0	121.0	120.3	116.3	106.2	62.1	104.3	99.5	101.1	75.8	83.0	50.9	74.5	139.2	90.4	27.6	28.6	28.8	37.1	28.2	28.4	28.2	27.8	28.3	28.4	27.8	31.5	39.3	12.8	16.7	5.5	96.3	107.1	70.1	101.5	91.0	16.2	78.6	77.8	19.3	42.9	46.1	27.6	8.4	57.1	102.9	39.2	56.7	43.4	4.3	47.0	37.9	37.0	55.1	67.3	13.6	49.2	75.8	39.0	39.8	71.9	45.7	39.6	32.5	61.0	66.8	23.5	11.2	51.1	79.3	38.6	51.2	3.7	34.5	43.0	51.6	6.5	69.3	38.1	88.6	3.0	25.8	50.6	58.9	15.8	72.4	75.6	121.4	85.2	28.2	26.8	13.1	26.4	32.5	19.4	24.7	84.5	138.1	37.4	103.2	34.5	53.7	99.2
SSB	"La, La/SSB, LARP3"	ENSG00000138385	"Small RNA binding exonuclease protection factor La"	P05455	2	169791933-169812064	"Predicted intracellular proteins"		RNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004643, HPA017287"	Supported		Approved	Nucleoplasm		NA	NA		93000	"Cluster 42: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB004643: AB_425691, HPA017287: AB_1852672"	"unprognostic (5.58e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.99e-4)"	"prognostic unfavorable (8.30e-8)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.81e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (6.17e-6)"	"unprognostic (9.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.38e-2)"	114.1	75.6	53.7	75.8	54.9	105.3	76.0	55.5	72.8	59.3	63.3	61.7	49.2	68.6	82.0	51.6	61.0	58.1	69.0	53.8	58.0	74.5	68.5	55.9	93.3	55.5	58.3	68.9	40.2	80.0	64.6	73.6	55.6	78.2	57.1	55.2	49.9	58.8	62.3	46.6	49.3	61.5	55.3	62.7	49.8	41.1	55.2	70.2	81.7	52.9	81.2	88.4	51.2	55.2	189.0	109.3	231.2	173.5	244.9	226.0	287.8	226.8	150.8	208.2	192.7	332.9	201.7	419.8	251.7	149.8	188.9	197.9	315.3	198.6	283.9	231.2	258.4	505.9	138.0	323.4	218.6	410.8	181.5	175.1	187.1	265.0	156.8	170.6	235.4	156.1	599.0	95.5	442.4	149.5	273.6	428.2	373.3	180.7	110.5	267.9	245.7	304.6	266.3	205.6	219.8	168.0	179.9	132.4	262.9	223.4	152.5	292.0	213.9	151.1	180.1	153.8	221.9	110.3	227.3	355.9	149.2	381.4	168.2	83.4	47.3	59.9	71.9	81.6	104.2	89.8	100.9	92.1	56.8	75.8	90.5	97.0	7.9	93.8	104.5	60.6	100.9	67.2	53.7	54.9	55.5	72.8	53.8	58.0	55.5	58.3	55.6	55.3	55.2	55.2	143.0	86.6	79.9	21.9	107.9	91.6	229.2	308.7	83.6	114.7	78.1	126.7	91.9	77.2	168.9	112.2	27.1	212.4	111.6	33.6	187.9	206.6	20.3	235.3	188.4	131.5	73.0	154.2	25.4	146.7	212.4	133.5	46.9	101.2	205.0	111.4	92.8	77.0	185.7	136.3	26.8	82.7	240.1	86.8	91.4	49.7	184.2	111.7	80.0	15.0	113.4	152.7	84.5	20.1	21.5	113.2	47.8	186.9	78.7	199.2	40.2	194.9	371.1	91.4	216.9	183.7	194.8	154.4	156.7	68.5	88.4	165.4	128.4	183.3	100.0	155.9
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738334-141787922	"Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002866	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	86.1	105.0	70.5	80.9	72.6	89.9	97.0	72.3	101.1	75.1	65.8	94.1	70.4	83.6	107.7	125.9	74.0	54.0	135.0	71.5	74.5	105.4	120.4	62.9	97.0	72.5	74.4	85.3	87.8	93.6	64.8	78.4	72.8	64.9	85.3	58.2	77.4	70.4	141.2	88.4	77.5	76.1	72.5	80.8	93.1	80.8	70.8	96.6	82.7	94.1	112.8	91.8	82.1	74.4	280.6	333.6	281.6	369.2	125.5	193.2	262.2	208.7	193.0	256.4	287.9	353.7	330.5	414.0	267.6	173.5	421.8	210.2	349.5	347.4	369.6	220.8	339.1	226.1	253.6	322.3	242.6	644.9	166.8	179.9	230.9	257.4	373.0	177.7	316.2	279.9	552.8	184.0	343.4	430.9	477.3	837.2	634.1	476.8	403.0	262.6	258.2	578.5	340.9	286.7	256.4	352.5	236.8	323.7	319.8	213.7	210.7	267.2	239.6	183.0	171.6	282.1	533.8	328.6	465.9	796.1	369.9	577.6	395.8	136.1	69.9	76.8	71.7	96.1	107.7	106.3	113.8	98.9	90.6	92.0	101.1	113.7	20.6	98.8	99.8	104.0	123.8	116.3	70.5	72.6	72.3	101.1	71.5	74.5	72.5	74.4	72.8	72.5	70.8	74.4	151.0	102.5	104.7	13.7	135.7	116.0	199.6	477.7	98.4	58.6	114.3	178.8	279.1	148.7	242.7	150.8	41.7	311.0	139.2	92.7	350.2	310.3	187.0	160.6	162.3	136.5	96.3	111.7	17.0	353.3	313.7	140.5	92.2	169.8	151.9	163.3	105.3	221.9	251.9	43.7	16.0	163.7	244.1	122.0	126.3	62.2	137.3	131.0	104.9	15.0	221.2	152.1	157.6	16.6	29.1	314.0	130.0	123.8	101.3	166.6	141.9	445.2	178.0	79.1	98.6	170.6	223.5	253.5	190.0	136.3	129.4	261.7	145.2	254.1	188.1	200.2
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 281.7;Excitatory neurons: 263.4;Inhibitory neurons: 350.0;Microglial cells: 339.2;Oligodendrocytes: 340.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 136.8;MOLT-4: 132.4;REH: 196.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605, HPA071780"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB020834: , HPA068605: AB_2732116, HPA071780: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	28.8	12.7	25.9	13.0	27.9	14.0	26.5	37.0	26.1	31.2	24.1	29.7	5.7	29.1	30.2	24.4	29.9	16.2	31.8	24.1	34.2	12.8	3.3	16.2	19.8	25.0	33.2	37.1	11.2	47.3	28.0	13.7	27.7	19.2	12.9	53.3	20.8	21.3	23.6	27.2	15.5	29.8	26.2	12.5	17.8	7.9	31.3	96.4	17.7	22.2	24.3	25.7	26.1	27.2	3.8	6.8	85.1	48.8	48.0	72.6	5.2	18.1	16.4	16.5	16.9	0.3	7.1	60.8	1.2	21.3	8.2	0.4	23.6	9.7	15.9	26.1	10.1	12.8	14.6	0.3	27.1	6.4	32.5	74.8	82.1	2.8	15.9	35.6	7.1	136.8	8.4	29.2	17.9	8.7	132.4	10.7	11.7	0.1	3.8	196.2	19.3	47.2	8.8	3.3	44.2	39.7	19.1	21.1	6.6	34.3	31.1	18.1	4.9	6.5	10.4	12.3	4.9	30.4	25.1	101.6	21.8	11.3	4.4	60.4	19.0	61.1	5.0	17.5	8.0	23.9	16.2	9.3	18.3	33.6	31.3	11.1	27.9	61.3	29.6	5.9	7.8	18.7	25.9	27.9	37.0	26.1	24.1	34.2	25.0	33.2	27.7	26.2	31.3	27.2	43.7	9.6	18.6	281.7	39.0	34.9	40.3	44.3	122.9	75.0	25.1	38.1	45.3	12.8	34.4	29.5	27.1	7.7	12.5	4.1	17.6	14.0	5.9	25.2	27.3	21.4	15.0	29.7	263.4	10.0	3.7	48.6	10.2	22.0	25.3	5.4	23.9	2.3	20.5	42.1	350.0	5.4	61.1	17.0	21.7	4.2	37.9	29.9	35.6	339.2	15.6	122.4	5.2	185.0	340.2	6.1	13.6	48.5	14.9	14.9	2.5	4.5	34.1	49.3	52.6	48.9	59.4	10.0	29.8	60.3	36.2	7.4	23.9	9.9	4.4	27.3
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409697	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.6;parathyroid gland: 7.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Distal tubular cells: 3.9;Hepatocytes: 3.7;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"EFO-21: 6.7;Hep G2: 9.6;SuSa: 10.7;U-2 OS: 25.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA		980000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 7: Non-specific - Mitochondria"			"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	0.7	0.3	0.2	0.0	0.4	0.0	0.3	0.0	0.2	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.6	0.4	0.1	0.0	0.2	0.2	0.7	2.2	7.0	2.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.1	0.0	0.5	0.0	0.0	1.0	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.1	1.0	0.5	0.0	0.0	10.7	0.2	0.0	0.0	0.0	25.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.5	1.6	0.1	0.0	0.5	0.0	0.6	0.4	1.4	1.4	2.1	0.0	0.0	11.0	0.0	0.3	0.0	0.2	3.9	1.9	0.1	0.5	0.1	0.3	0.0	0.0	1.6	1.7	1.4	0.4	0.0	0.4	0.0	0.7	1.1	3.7	2.8	1.7	1.4	0.1	0.0	0.6	0.0	0.4	0.9	0.9	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.4	0.1	0.4	0.0	0.4	0.4	1.3	0.0	0.2	0.0	0.8	0.6	0.6	3.5	1.0	0.0	0.3	0.1	0.6	0.2	0.4
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
SSH1	"KIAA1298, SSH1L"	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778191-108857590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	6.6	5.1	5.6	5.1	5.1	7.9	5.0	9.2	5.5	5.8	7.2	7.2	2.9	5.9	4.0	5.5	5.3	5.3	7.8	5.7	5.3	6.7	5.5	11.8	4.1	5.8	5.7	5.0	4.3	5.4	5.2	5.2	5.2	5.2	4.1	5.7	3.9	4.8	11.9	4.6	5.1	5.5	5.0	7.5	4.9	3.5	5.1	3.6	5.3	6.5	4.2	6.0	5.2	5.1	9.9	12.7	8.2	6.4	15.1	12.8	7.2	12.8	26.1	11.0	9.7	6.4	4.6	4.9	8.7	29.0	18.8	9.8	4.9	20.7	8.9	9.9	4.8	11.3	6.0	4.0	8.1	5.8	28.4	17.7	7.0	10.0	22.0	27.1	10.3	5.6	2.5	3.6	29.1	5.4	6.6	8.0	5.8	3.8	10.3	4.6	9.8	6.1	4.5	17.1	6.1	8.1	11.0	2.8	24.2	11.2	3.9	4.8	8.1	19.6	8.4	11.9	7.1	7.3	7.0	5.6	10.3	4.5	63.1	1.8	0.9	2.0	1.0	1.5	0.9	0.6	0.5	0.9	0.6	0.6	0.4	0.5	2.1	0.7	1.2	0.7	0.6	0.5	5.6	5.1	9.2	5.5	5.7	5.3	5.8	5.7	5.2	5.0	5.1	5.1	34.5	9.6	16.1	26.1	6.3	9.4	20.8	23.6	19.4	12.9	6.9	6.6	25.1	11.5	12.7	14.7	16.7	6.0	18.5	8.2	5.9	8.4	2.2	10.8	17.1	52.2	5.4	7.8	27.3	8.2	4.4	14.0	13.7	16.9	20.8	12.0	29.3	15.2	12.3	11.8	35.4	5.4	0.0	23.0	20.3	5.0	6.5	21.1	12.4	55.3	33.7	7.8	14.4	14.1	14.8	12.3	2.4	12.8	13.1	21.8	4.0	6.7	9.0	19.1	6.6	17.8	18.1	1.4	7.7	13.2	8.9	2.3	17.9	7.6	7.8	13.9
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 269.0;Inhibitory neurons: 255.2;Microglial cells: 254.8;Oligodendrocytes: 547.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 134.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	15.6	9.5	11.7	22.5	13.1	62.8	10.7	12.8	16.3	7.1	3.6	13.0	8.3	7.3	8.9	12.7	8.2	8.9	19.4	13.1	23.2	15.1	13.6	21.4	29.0	19.0	14.4	3.9	14.6	6.2	7.1	10.4	18.5	6.3	10.9	8.1	10.7	4.5	91.5	14.4	20.7	7.9	11.4	28.3	15.5	28.2	16.3	28.9	13.9	35.6	24.8	9.0	8.7	24.5	25.8	19.0	12.6	10.8	36.1	24.7	8.8	12.3	12.9	19.6	19.2	12.9	9.0	22.1	18.8	14.1	12.6	31.0	14.8	17.1	22.4	7.1	28.1	14.9	21.2	17.4	16.6	16.7	30.7	30.4	12.3	20.6	13.4	9.7	47.3	36.2	9.9	16.8	13.7	7.3	74.9	15.5	9.4	9.3	11.5	37.9	31.9	37.0	35.7	20.3	20.6	32.3	18.0	18.6	36.6	16.3	12.6	19.4	25.6	12.6	26.3	23.5	16.1	26.9	20.0	53.8	16.4	13.1	12.3	47.2	15.2	134.8	10.4	20.2	8.5	21.3	11.6	11.1	12.7	22.4	11.5	8.7	91.6	4.6	36.7	7.7	16.4	6.5	11.7	13.1	12.8	16.3	13.1	23.2	19.0	14.4	18.5	11.4	16.3	24.5	19.6	9.6	38.5	81.6	137.0	39.6	12.3	20.6	27.9	12.4	22.2	19.2	28.2	12.8	23.2	16.5	27.1	20.4	68.7	54.3	25.4	14.9	108.4	27.9	10.1	26.9	35.4	27.8	269.0	35.5	26.4	22.2	33.1	32.5	12.6	6.0	19.6	26.9	22.3	20.2	255.2	34.8	14.2	120.2	31.3	174.4	12.2	75.9	35.6	254.8	83.6	9.2	82.4	184.0	547.9	40.3	38.6	8.2	49.4	12.9	64.5	63.1	18.4	22.9	6.6	34.4	17.0	80.9	16.7	37.6	36.2	18.2	65.8	14.2	21.6	30.2
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	64.0	64.4	20.3	89.6	24.6	101.9	70.3	25.4	24.8	88.5	35.7	65.3	65.6	62.7	74.2	71.6	50.8	64.5	41.2	19.0	28.9	58.6	95.5	56.7	68.4	27.6	25.2	67.0	67.9	49.4	25.8	71.5	27.2	59.2	76.4	36.6	79.7	56.0	28.3	42.6	62.4	76.9	23.7	62.4	68.2	38.5	27.8	55.9	84.8	29.1	84.2	74.4	32.8	34.7	122.2	121.7	92.3	171.7	244.9	173.1	144.4	274.5	225.5	183.4	219.1	167.5	98.5	162.9	472.1	282.5	168.3	107.0	112.0	156.6	251.6	172.2	94.6	174.3	130.6	350.7	253.4	325.6	189.6	154.2	169.0	210.2	429.2	140.4	205.2	80.4	199.3	191.1	204.6	146.4	89.6	86.6	78.2	136.5	137.2	120.1	116.0	615.7	161.3	171.5	124.6	57.9	167.0	91.1	263.4	276.8	147.9	141.7	183.1	196.1	149.0	153.3	238.1	195.7	312.1	130.4	95.3	180.4	367.1	146.1	169.5	114.5	82.9	121.9	105.6	73.0	91.7	93.9	199.9	56.1	86.3	86.9	93.3	85.7	110.1	139.3	109.4	214.7	20.3	24.6	25.4	24.8	19.0	28.9	27.6	25.2	27.2	23.7	27.8	34.7	54.0	28.9	48.1	32.3	106.1	77.8	62.1	120.2	69.4	75.4	85.3	46.1	48.5	84.4	93.7	130.6	100.1	78.2	118.6	65.4	15.6	96.0	16.1	48.7	96.0	69.6	62.3	80.8	38.6	103.0	208.5	95.4	68.8	74.3	47.5	64.0	78.1	148.1	130.0	70.7	41.3	130.4	81.4	157.3	251.5	12.4	78.6	129.7	94.3	35.6	131.5	64.1	87.6	49.8	47.8	71.9	47.0	73.0	302.1	111.2	61.5	67.1	57.8	104.2	26.3	57.6	71.6	53.4	58.7	96.0	75.4	121.8	83.6	61.2	93.6	70.4
SSR3	TRAPG	ENSG00000114850	"Signal sequence receptor subunit 3"	Q9UNL2	3	156539553-156555149	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 894.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014906	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014906: AB_2195736"	"unprognostic (4.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (3.43e-4)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.68e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.23e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.29e-2)"	84.9	72.0	36.2	74.2	39.3	52.9	106.2	40.2	44.8	144.4	35.5	84.8	61.7	84.5	173.0	51.8	106.8	59.0	116.0	34.9	44.0	75.3	100.9	60.3	64.0	45.5	39.9	93.8	195.3	72.1	58.7	60.4	46.0	73.9	91.1	29.0	181.2	137.1	61.6	34.2	56.5	113.6	44.9	61.9	82.6	57.9	46.4	48.7	113.9	45.0	87.9	73.5	53.0	51.0	449.0	92.9	113.3	143.4	377.4	354.9	118.1	641.9	363.2	320.6	444.6	184.9	209.1	148.4	277.3	432.9	290.1	203.4	192.5	760.2	762.3	178.7	91.9	264.4	58.5	185.9	402.2	279.9	122.0	318.1	278.3	545.3	1081.7	309.6	400.6	129.0	151.9	528.2	930.8	131.1	96.8	63.1	138.7	253.6	181.5	136.1	185.7	969.9	300.6	105.2	91.2	76.8	166.0	246.3	358.9	176.4	252.3	143.2	508.5	424.0	204.9	325.3	721.8	485.5	207.3	249.0	254.0	231.9	248.1	111.1	88.7	71.6	60.6	104.1	95.7	76.1	64.0	75.4	115.5	46.8	42.6	52.0	30.5	66.7	136.0	162.1	81.1	72.4	36.2	39.3	40.2	44.8	34.9	44.0	45.5	39.9	46.0	44.9	46.4	51.0	103.4	109.0	167.3	22.2	205.3	83.7	132.7	182.6	41.5	33.7	157.8	263.4	153.4	117.2	151.1	73.5	31.3	113.1	142.1	85.1	109.5	238.4	98.1	89.7	281.2	124.9	71.1	91.9	10.7	229.8	470.0	174.0	103.0	160.0	95.7	145.4	123.5	219.0	388.2	25.2	14.3	247.0	69.2	218.1	224.3	38.0	214.9	196.2	145.9	10.3	241.5	89.6	73.2	17.1	18.5	233.2	81.5	223.0	894.2	257.5	90.3	214.7	81.0	37.1	72.3	96.3	178.4	177.1	69.0	74.0	78.7	188.9	109.8	119.5	148.9	157.8
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798499	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 3119.7"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 6002.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	213.5	311.6	152.0	232.1	153.6	498.9	252.7	157.1	186.5	319.0	195.6	366.6	341.6	192.4	885.6	233.5	201.7	185.2	295.2	148.9	190.3	203.4	397.6	236.5	319.0	161.8	156.3	182.8	3119.7	157.1	676.5	120.5	159.2	263.8	267.7	37.1	922.8	416.4	127.4	191.5	256.6	120.5	162.7	396.6	495.0	160.9	158.1	158.0	221.0	74.1	324.6	243.8	217.3	171.5	344.2	428.9	148.7	834.4	785.2	412.4	299.5	278.6	431.1	299.9	407.3	547.9	298.3	476.9	721.8	450.4	262.4	332.8	259.2	270.6	111.8	192.6	212.0	128.4	380.1	446.0	669.0	370.7	352.6	511.9	376.6	256.9	353.2	265.3	327.4	240.8	145.4	1027.1	239.8	616.8	222.3	578.1	90.8	941.3	685.7	247.3	178.4	922.7	394.2	413.9	285.8	228.8	159.3	301.7	333.1	161.9	188.8	821.6	263.9	174.4	189.9	324.4	377.5	1449.6	774.0	576.4	364.7	630.8	295.7	652.3	594.6	286.7	616.7	476.9	762.6	695.6	629.2	613.7	598.0	644.7	538.8	555.2	93.8	697.3	396.5	1751.9	515.9	1330.5	152.0	153.6	157.1	186.5	148.9	190.3	161.8	156.3	159.2	162.7	158.1	171.5	228.6	166.7	301.9	7.5	824.1	257.2	372.4	566.8	167.9	53.6	451.1	380.1	334.8	357.4	464.7	318.2	56.3	311.4	521.0	473.2	168.3	544.9	476.1	276.9	513.6	263.0	747.5	175.3	3.6	627.4	700.6	357.3	344.0	454.8	352.2	257.0	241.3	723.3	439.0	35.3	5.3	967.6	547.3	339.1	416.6	1753.1	336.7	344.5	1428.3	4.7	409.3	174.7	432.5	8.0	11.1	487.0	595.8	247.1	6002.3	633.3	581.0	414.8	340.6	83.4	118.3	174.3	300.7	199.4	207.9	306.1	322.2	564.6	473.4	600.1	548.8	490.0
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325986-57335892	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		42000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	52.3	42.7	37.6	62.9	39.1	78.9	53.7	37.9	46.4	61.0	37.2	64.7	48.3	64.9	47.7	67.7	68.3	37.0	47.0	39.3	41.2	48.8	43.3	51.7	76.1	38.2	38.9	74.1	74.0	60.9	57.4	57.5	37.1	46.6	66.1	36.0	55.0	49.6	140.6	67.0	55.1	58.4	38.5	52.6	59.8	45.8	42.4	87.8	54.0	63.9	91.9	58.6	56.4	40.2	353.0	332.0	308.3	226.9	95.1	105.1	150.7	188.9	181.1	321.8	229.2	230.0	255.2	424.4	196.7	166.7	204.5	264.8	493.7	293.9	402.2	297.7	276.9	271.5	233.1	250.5	149.3	455.4	195.3	106.7	175.7	331.8	456.8	149.1	213.3	320.7	376.0	207.9	222.6	237.1	463.3	400.3	406.1	186.1	201.7	386.1	520.4	412.0	151.7	249.3	321.4	271.6	267.6	226.2	286.7	157.0	275.3	177.0	162.7	218.2	287.1	298.3	328.9	240.9	259.9	431.9	185.0	251.6	294.6	0.8	4.1	4.6	8.6	5.1	8.2	8.4	7.4	9.5	6.0	10.5	8.2	11.0	1.0	7.2	5.2	10.0	9.9	5.0	37.6	39.1	37.9	46.4	39.3	41.2	38.2	38.9	37.1	38.5	42.4	40.2	31.2	76.9	91.2	4.6	51.0	74.9	78.1	52.0	55.8	27.3	38.3	39.8	26.4	44.3	78.1	29.5	25.0	115.6	31.7	29.9	13.7	92.5	83.0	40.8	47.2	52.0	28.8	106.8	10.5	99.4	116.9	45.3	32.1	33.2	41.0	55.6	33.2	39.7	57.5	25.2	9.1	45.2	32.6	37.9	45.5	158.0	42.6	34.9	28.4	8.4	42.5	26.3	40.2	6.0	8.4	69.0	32.9	44.4	72.2	80.0	32.3	25.7	101.0	18.9	19.7	53.1	66.1	58.4	108.0	75.3	76.3	67.6	43.5	46.7	78.4	70.7
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668912-187670394	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 1039.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 449.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	5.5	43.0	59.9	4.6	52.1	4.2	0.5	1.3	67.8	0.6	2.5	31.8	386.6	0.7	0.1	1.6	0.4	1.1	1.3	30.6	449.5	6.2	0.3	0.3	1.5	96.9	48.1	2.4	479.4	0.0	9.3	0.1	50.3	1.3	23.8	6.3	0.1	21.6	0.1	8.9	133.3	2.8	137.8	0.2	418.0	0.2	117.2	1.1	1.0	0.0	0.0	7.3	1.8	18.7	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	44.7	0.4	7.6	0.0	2.9	11.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	52.1	1.3	67.8	30.6	449.5	96.9	48.1	50.3	137.8	117.2	18.7	0.0	0.0	0.0	9.1	0.5	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	5.5	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.5	0.1	1404.1	0.0	1.7	0.0	0.2	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	146.2	460.2	215.7	0.0	0.0	0.1	0.0	0.0	0.0	9.4	3.6	0.0	0.0	3.0	9.1	0.0	0.6	0.0	0.0	0.0	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	13.8	0.2
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207904-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0;intestine: 13.8;stomach 1: 21.7"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 18.1;Gastric mucus-secreting cells: 16.8;Hepatic stellate cells: 27.1;Oligodendrocyte precursor cells: 24.1;Paneth cells: 10.7;Proximal enterocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 118.9;BJ hTERT+: 32.5;BJ hTERT+ SV40 Large T+: 21.4;fHDF/TERT166: 70.7;HeLa: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA003207: , HPA031506: AB_2673913"	"unprognostic (1.40e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.34e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.28e-2)"	1.0	0.3	3.9	0.3	8.8	0.0	0.9	0.5	8.7	0.8	0.0	3.5	13.8	1.0	0.4	0.3	0.9	0.4	1.0	10.0	10.0	2.0	6.8	5.2	0.0	4.7	7.0	0.8	3.6	0.0	0.9	2.6	5.6	1.0	2.3	0.3	0.3	0.4	0.7	0.3	8.2	0.5	1.4	0.6	21.7	0.1	6.1	0.0	0.3	0.9	0.0	1.8	0.7	1.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	118.9	32.5	21.4	1.8	1.2	0.0	0.0	0.0	70.7	0.0	0.2	0.0	0.0	15.4	0.0	0.0	0.0	26.7	0.1	6.3	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.5	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.1	9.6	0.2	0.0	0.0	0.1	4.7	0.0	3.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.8	0.5	8.7	10.0	10.0	4.7	7.0	5.6	1.4	6.1	1.7	1.7	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.8	2.8	0.0	1.8	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	2.4	18.1	0.0	3.9	0.8	0.0	1.0	16.8	0.0	0.0	0.0	27.1	7.2	0.0	0.0	5.5	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.1	0.3	0.2	10.7	0.0	0.1	0.1	11.8	1.9	0.0	0.1	0.0	1.0	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.2	6.2	0.0
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165010-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.1;Enteroendocrine cells: 35.7;Sertoli cells: 32.9;Smooth muscle cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	2.5	3.6	8.4	0.9	8.9	0.9	1.7	7.2	8.7	0.5	0.3	0.8	1.4	0.7	1.6	0.4	1.1	0.6	0.8	9.0	4.3	5.3	1.4	0.4	1.1	2.2	5.1	0.3	0.7	0.3	2.9	0.1	8.6	1.4	1.1	2.2	0.7	1.4	0.7	0.6	0.9	0.8	2.6	6.1	3.1	0.3	4.8	0.5	1.1	0.2	1.3	0.9	0.7	6.8	0.2	0.3	0.3	0.7	0.1	0.1	0.4	0.1	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.0	0.1	0.1	0.4	0.6	0.3	0.8	0.3	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.7	0.0	0.3	0.2	0.8	1.0	0.1	0.4	0.4	0.4	0.3	0.2	0.3	12.5	0.9	0.2	0.2	0.1	0.5	1.5	0.2	0.1	0.2	1.4	0.4	0.2	0.5	0.2	1.0	0.2	0.3	0.2	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	1.2	0.2	0.2	0.2	0.1	0.1	8.4	8.9	7.2	8.7	9.0	4.3	2.2	5.1	8.6	2.6	4.8	6.8	4.9	6.4	2.7	1.6	0.5	1.1	3.2	0.0	0.0	59.1	3.7	2.5	3.6	1.5	1.3	1.8	4.2	0.7	0.9	0.1	0.0	0.2	7.0	2.1	1.7	11.3	35.7	0.0	17.1	0.0	0.7	14.3	3.1	4.9	2.5	3.0	3.9	1.0	1.0	6.7	8.4	8.2	0.0	2.4	3.0	5.7	0.9	2.4	5.4	1.9	1.7	2.4	1.0	2.0	0.7	0.4	0.1	0.7	5.8	5.4	0.6	18.0	0.7	4.8	32.9	10.0	56.0	0.9	1.9	0.3	1.1	1.0	1.4	0.6	0.5	3.3
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204237-37212477	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;lymphoid tissue: 11.1;testis: 7.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 23.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.3	2.2	1.0	2.2	0.4	0.0	1.2	6.4	0.0	0.0	0.2	1.3	1.1	0.0	0.0	0.1	0.0	0.0	1.9	2.2	0.1	0.0	0.0	1.8	6.8	3.5	3.3	1.8	0.0	2.6	0.0	6.7	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.5	1.0	1.2	0.6	0.2	7.8	7.6	11.1	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.2	2.2	2.2	1.2	6.4	1.9	2.2	6.8	3.5	6.7	1.2	7.6	2.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0
SSTR4		ENSG00000132671	"Somatostatin receptor 4"	P31391	20	23035312-23039237	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064252	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"					"HPA064252: AB_2685227"																		0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.5;intestine: 3.7;testis: 3.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 61.7;Late spermatids: 43.6;Proximal enterocytes: 16.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	27	"Hep G2: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved					NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.2	0.0	0.5	3.7	0.2	0.0	0.2	0.2	0.4	2.5	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.1	3.3	0.1	0.0	1.6	0.3	3.9	0.0	0.0	0.8	0.1	0.1	0.2	0.2	0.1	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	9.9	0.0	0.0	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.3	0.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	61.7	1.7	0.1	3.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.2	0.0	0.7	2.2	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.4	43.6	1.2	0.2	1.8	1.0	0.0	0.0	0.0	2.0	1.4	0.1	1.2	0.4	0.0	0.1	16.1	0.9	4.0	0.0	0.0	0.4	0.7	0.5	1.1	0.3	0.1	0.0	0.1	0.5	0.8	0.2
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255392-48267444	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 6.8"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.2;Spermatogonia: 30.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	90.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.7	0.1	0.0	4.8	0.1	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	24.2	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 15.0"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, HPA071685"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 29.9"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	29.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.2	0.7	0.9	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643706-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 118.7;testis: 105.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 260.6;Early spermatids: 774.9;Late spermatids: 1095.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.9	3.1	8.2	5.8	13.1	14.9	5.1	12.9	23.4	6.8	4.4	8.1	43.2	9.3	22.6	6.4	7.2	8.7	9.4	13.8	3.6	16.5	14.5	3.9	6.4	1.1	1.4	2.0	7.1	9.2	9.6	6.3	1.4	12.7	7.8	118.7	6.9	11.8	3.5	6.5	26.8	10.7	0.0	5.4	7.1	105.7	1.5	12.1	8.2	2.6	6.3	5.7	3.5	11.9	39.1	19.0	15.1	27.7	5.0	15.7	18.4	65.6	33.2	28.3	22.7	13.7	8.4	38.6	11.3	55.8	36.5	21.4	27.0	21.2	39.5	7.7	23.0	36.4	22.2	11.9	10.3	32.1	2.9	6.7	34.1	31.9	20.1	18.9	9.7	14.7	76.5	14.1	18.1	15.0	22.5	12.7	22.3	7.4	29.6	15.1	66.0	17.0	29.5	22.3	29.4	36.7	18.4	29.6	32.9	9.5	17.2	16.4	2.9	26.8	39.2	36.9	65.9	14.7	18.7	42.0	22.4	28.2	16.9	0.8	0.8	3.9	8.2	1.9	4.5	1.2	2.6	3.3	3.5	1.2	3.3	5.1	1.1	4.6	2.6	4.5	1.5	3.9	8.2	13.1	12.9	23.4	13.8	3.6	1.1	1.4	1.4	0.0	1.5	11.9	4.4	3.2	3.0	38.2	3.7	10.5	8.6	8.7	12.5	45.6	10.5	7.0	36.8	21.5	7.3	11.0	260.6	5.3	23.9	3.9	7.9	7.3	774.9	14.9	8.9	5.0	8.4	46.7	108.5	12.0	1.9	15.7	5.6	11.6	4.5	4.2	3.6	14.9	2.7	20.2	70.2	9.3	2.0	1.9	5.6	1095.3	15.8	24.1	5.4	18.7	3.5	187.4	15.5	16.6	23.9	9.4	4.6	11.3	12.7	4.3	19.7	44.9	13.3	158.0	0.0	4.2	7.3	71.7	53.6	13.6	9.8	0.5	8.4	2.0	10.7	4.2
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346427-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 13.5"	"Group enriched"	"Detected in some"	26	"Spermatocytes: 52.7;Spermatogonia: 118.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Karpas-707: 2.1"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.7	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 4.5;U-266/84: 3.3"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 1.9;U-266/84: 9.0"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196795	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Spermatogonia: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"BEWO: 4.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.6	0.3	0.5	0.4	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644061-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;RT4: 1.7"									"HPA045683, HPA071685"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																"unprognostic (1.29e-1)"		0.0	0.0	0.4	0.1	0.5	0.2	0.0	1.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.2	0.7	0.2	0.1	0.6	0.2	0.7	0.2	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13 Hsp70 interacting protein"	P50502	22	40824535-40856639	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1091.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	163.2	157.5	131.9	84.2	148.3	99.0	161.6	149.9	171.9	163.0	140.4	135.6	96.7	197.5	137.2	116.6	180.6	122.8	121.9	123.8	156.8	254.2	296.7	97.0	111.7	147.3	140.5	542.6	126.2	150.8	92.3	135.3	154.8	145.0	108.0	146.4	111.3	142.6	341.2	98.4	108.3	165.0	147.2	89.0	111.1	107.7	136.1	131.6	176.6	217.9	126.2	131.5	113.5	191.9	249.0	195.1	290.6	255.4	265.7	407.1	263.7	229.0	293.2	279.6	242.3	353.7	144.3	356.8	193.2	232.9	253.7	177.3	387.7	226.3	331.2	228.4	250.3	255.0	379.1	406.4	241.2	374.6	198.5	365.5	235.7	252.6	169.7	351.2	293.6	219.3	313.2	151.2	271.3	187.1	329.5	200.1	166.4	302.0	130.7	375.7	246.4	281.9	284.2	369.8	96.4	97.1	265.0	211.7	337.7	334.1	205.5	233.2	220.8	232.1	223.0	197.0	188.2	173.5	367.9	333.4	317.4	172.0	228.2	108.9	79.5	85.7	84.7	108.7	129.1	146.2	133.0	101.9	107.1	131.6	206.6	160.7	26.3	110.6	146.3	75.5	122.3	162.6	131.9	148.3	149.9	171.9	123.8	156.8	147.3	140.5	154.8	147.2	136.1	191.9	187.0	141.1	220.5	28.1	217.5	311.6	384.6	267.7	279.4	89.5	364.6	359.2	140.1	334.6	232.5	171.0	16.7	382.8	141.7	192.9	563.4	284.8	513.2	431.6	349.8	204.1	262.0	296.3	37.4	205.1	381.2	239.7	107.0	289.6	207.1	305.0	227.7	539.2	328.6	38.7	41.5	263.7	183.1	270.6	374.5	1010.4	510.4	210.3	211.7	15.0	286.7	265.1	157.6	27.2	53.7	193.7	210.8	413.3	129.0	312.2	369.6	1091.8	281.8	73.0	223.5	212.0	268.7	306.9	191.2	193.5	274.5	500.9	200.6	227.3	333.2	325.8
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
ST20-MTHFS		ENSG00000259332	"ST20-MTHFS readthrough"		15	79845150-79923754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"liver: 96.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Collecting duct cells: 1.8;Erythroid cells: 4.2;Gastric mucus-secreting cells: 5.1;Squamous epithelial cells: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 492.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 492.2;monocytes: 133.6"	"Low cell line specificity"	"Detected in all"											HPA008067	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA008067: AB_1078882"	"unprognostic (9.84e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.75e-3)"	"unprognostic (6.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-1)"	9.9	10.2	7.3	15.2	7.5	10.1	7.8	8.2	12.0	8.5	8.9	9.5	10.9	6.7	10.0	3.8	7.3	7.7	6.5	8.1	8.4	38.6	96.6	11.0	11.8	8.2	8.8	6.0	15.0	24.0	2.4	9.7	8.4	15.5	8.7	12.2	12.8	8.5	10.5	3.8	14.6	7.5	7.4	7.7	12.0	7.6	9.1	10.3	11.1	10.1	12.8	7.2	1.5	9.1	16.2	33.1	6.6	6.5	24.0	14.2	19.1	13.9	22.1	27.4	24.6	15.7	35.9	20.1	29.6	13.1	25.6	29.7	44.2	13.6	17.3	24.8	14.6	20.5	20.4	24.3	25.2	10.5	3.7	21.1	32.2	8.1	27.0	19.5	7.9	26.7	37.6	19.7	13.0	20.9	13.7	26.2	16.3	56.3	13.5	20.4	12.4	22.0	32.5	14.8	16.2	9.8	33.3	22.6	40.8	24.3	26.6	21.0	11.4	11.7	19.9	1.2	10.9	10.8	37.0	21.9	6.4	45.4	9.7	76.4	82.3	223.6	38.9	87.1	48.2	53.1	51.3	42.9	50.8	53.7	58.9	51.0	492.2	77.5	133.6	35.5	60.6	75.7	7.3	7.5	8.2	12.0	8.1	8.4	8.2	8.8	8.4	7.4	9.1	9.1	0.0	0.0	0.5	0.0	1.6	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	1.4	1.8	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.2	0.1	0.0	0.2	0.8	5.1	0.2	0.0	0.1	0.0	1.5	0.3	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	1.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.3	1.4	1.6	0.0	0.3	0.0
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 75.9;PC-3: 131.8;RT4: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		860000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	25.7	22.5	8.8	22.8	8.6	22.6	12.2	5.3	9.4	11.4	12.3	6.5	3.6	11.6	12.7	14.0	15.5	19.0	53.1	9.6	6.3	44.5	67.7	19.2	23.1	7.9	11.2	13.3	15.4	10.9	9.9	13.8	6.9	8.0	5.5	10.0	24.9	10.2	43.8	5.9	9.9	10.6	7.2	21.2	16.1	4.3	7.4	17.4	66.1	49.3	21.6	34.4	10.9	7.2	14.0	6.6	3.0	8.3	28.6	15.0	14.4	15.4	35.5	5.7	4.4	13.3	15.1	3.3	10.3	28.2	2.7	4.2	9.4	11.3	4.9	37.6	1.7	28.4	22.5	25.4	22.0	5.9	22.1	17.8	5.7	19.5	11.7	27.2	26.4	7.5	0.5	42.5	4.4	14.9	8.4	8.0	2.1	75.9	131.8	9.9	3.7	24.3	2.7	102.2	0.7	2.0	6.8	23.3	6.9	15.4	4.3	8.1	26.3	18.3	28.5	15.7	6.9	53.0	39.3	3.6	41.7	19.8	18.5	47.8	8.8	41.7	24.1	8.1	22.9	22.7	25.2	28.3	5.3	38.6	34.4	32.4	16.1	43.2	20.4	12.6	17.2	18.9	8.8	8.6	5.3	9.4	9.6	6.3	7.9	11.2	6.9	7.2	7.4	7.2	29.4	6.4	56.8	38.2	68.4	5.7	14.4	14.8	21.1	13.4	13.7	8.4	63.2	12.8	22.2	1.8	2.1	9.7	65.5	4.6	5.9	41.3	3.4	8.9	29.2	44.3	0.0	38.5	36.7	25.4	53.5	47.8	10.7	28.1	8.8	12.1	37.9	159.8	37.8	60.6	34.6	0.6	16.2	52.5	29.0	2.1	36.7	48.8	14.2	49.6	59.8	11.5	47.4	5.0	2.4	39.4	0.0	71.8	29.1	10.9	0.0	48.5	6.5	23.3	13.1	28.1	23.6	0.2	2.8	30.0	3.4	26.4	79.9	6.5	0.3	43.6
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375977-70439237	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	8.6	8.3	4.7	6.4	5.8	7.4	7.2	8.4	6.5	9.3	1.6	9.2	3.5	12.5	1.1	2.6	8.2	2.5	10.5	7.1	2.9	8.2	10.3	9.0	6.3	3.1	2.6	7.2	3.6	2.6	6.4	3.2	2.6	7.1	1.6	1.7	3.2	2.8	15.8	4.2	7.1	4.1	1.9	13.2	4.7	6.7	3.3	3.6	6.0	3.1	3.4	8.4	5.6	2.9	1.7	8.6	7.7	11.2	3.9	5.4	2.3	6.1	6.0	6.2	3.0	5.5	4.0	4.6	9.8	6.3	5.8	1.9	3.2	2.5	3.3	9.9	5.0	18.0	4.5	8.7	4.7	6.7	29.4	4.1	1.5	6.7	1.3	8.2	8.6	7.6	25.1	4.2	3.7	1.5	7.5	19.8	10.1	2.9	4.5	13.9	2.9	5.9	5.1	1.5	3.7	9.4	15.8	0.6	7.1	8.1	2.4	7.3	9.9	9.0	10.0	4.0	4.7	8.6	3.9	9.7	10.0	5.9	12.5	4.2	1.9	5.2	2.0	1.8	1.7	2.0	2.3	2.0	1.0	2.9	3.8	3.0	10.1	2.8	1.3	14.3	2.6	1.1	4.7	5.8	8.4	6.5	7.1	2.9	3.1	2.6	2.6	1.9	3.3	2.9	15.4	9.6	5.2	13.4	12.6	3.3	4.2	2.1	2.2	15.7	2.8	3.0	6.8	10.0	1.9	9.2	14.6	4.7	56.1	4.5	0.0	5.7	16.9	1.7	6.5	15.0	13.2	24.8	21.3	4.4	2.5	11.0	2.6	2.2	17.7	19.7	18.2	13.1	13.7	18.5	15.2	4.5	2.0	15.4	35.1	33.2	11.8	11.9	1.8	17.8	24.9	5.6	23.7	16.6	7.4	1.8	1.5	8.2	13.5	3.0	6.8	5.7	1.3	11.1	6.6	8.5	8.8	9.3	8.9	1.1	2.4	1.8	11.5	4.7	5.6	2.3
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0;tongue: 82.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.7;Excitatory neurons: 94.4;Granulosa cells: 52.5;Inhibitory neurons: 120.1;Microglial cells: 57.1;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	12.9	14.7	28.5	5.0	27.3	11.0	11.0	30.8	32.5	14.6	22.8	19.4	2.6	16.7	9.8	8.3	12.8	6.9	26.1	27.2	29.4	9.9	13.5	8.7	6.1	27.9	29.0	14.9	8.0	6.7	17.8	6.5	29.2	13.2	4.4	24.5	8.3	13.3	88.0	7.0	6.6	13.1	23.2	7.6	9.6	22.6	30.8	4.9	8.4	82.9	3.7	16.7	10.1	28.1	4.3	2.7	23.4	11.0	17.4	21.9	3.0	15.5	30.8	14.1	13.7	2.6	6.6	7.0	8.6	19.0	7.7	3.8	2.8	10.2	15.7	8.7	5.8	15.0	10.6	7.5	14.7	6.6	7.1	12.1	7.4	9.7	21.3	26.1	12.1	18.4	8.8	13.1	25.3	2.7	7.0	11.7	9.2	1.0	8.1	11.4	3.3	6.1	11.0	2.4	9.3	13.8	5.5	2.5	14.1	9.6	3.5	30.3	10.4	8.3	3.9	13.3	15.4	10.4	6.1	6.9	11.7	15.7	15.3	1.7	2.1	1.2	3.3	1.1	2.9	2.2	2.1	2.5	1.5	2.8	3.5	2.6	2.4	2.2	1.9	3.3	2.9	3.3	28.5	27.3	30.8	32.5	27.2	29.4	27.9	29.0	29.2	23.2	30.8	28.1	6.7	6.4	19.3	59.7	6.6	3.3	3.0	4.1	5.7	9.4	4.6	3.3	34.5	1.5	3.8	3.7	0.0	3.1	2.7	2.2	5.9	2.6	19.4	2.4	6.6	7.6	2.4	8.4	94.4	2.4	1.6	9.0	1.5	2.8	24.1	52.5	4.6	8.6	3.1	18.5	120.1	1.4	4.1	2.2	3.1	14.5	3.7	4.5	3.6	57.1	3.6	6.1	5.2	66.9	66.2	2.7	0.2	11.7	4.2	2.2	0.1	6.3	4.9	17.8	19.7	5.8	9.8	8.5	5.1	2.7	1.3	1.0	6.0	15.7	1.7	10.0
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 270.0;Paneth cells: 214.3;Syncytiotrophoblasts: 962.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 111.9;neutrophil: 71.8;plasmacytoid DC: 93.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 93.7;granulocytes: 111.9"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 234.7;WM-115: 515.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049827	Approved				"Intracellular and membrane"	NA	NA		15000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	23.4	117.1	25.2	14.4	41.2	19.0	19.5	43.5	28.9	29.2	36.5	58.1	4.2	16.3	87.6	70.7	19.2	23.9	60.0	24.3	28.7	41.0	28.4	38.2	10.0	42.3	41.3	111.3	13.7	1.7	15.7	35.3	39.5	22.6	66.4	10.8	44.2	16.0	6.1	16.7	12.3	19.0	31.9	41.5	13.3	42.2	37.6	6.3	14.7	7.7	22.7	49.3	33.8	57.2	26.4	21.4	17.0	13.6	46.8	39.4	38.5	30.2	56.6	26.5	18.2	11.4	44.5	7.0	21.9	47.0	88.0	37.1	34.0	19.2	20.0	27.7	9.7	62.8	52.7	13.4	29.9	78.8	126.1	31.5	30.7	39.9	60.9	47.7	34.6	27.5	41.4	18.8	32.2	107.3	25.7	76.5	10.2	166.2	136.6	25.8	50.3	3.3	6.0	74.1	29.5	18.4	32.8	193.5	234.7	10.6	66.3	52.2	13.2	61.7	14.2	44.1	56.2	2.0	4.3	4.0	28.5	118.7	515.8	111.9	5.3	0.7	5.2	8.7	4.8	0.4	1.7	3.3	20.6	0.1	0.6	2.6	71.8	4.7	3.8	93.7	0.3	6.4	25.2	41.2	43.5	28.9	24.3	28.7	42.3	41.3	39.5	31.9	37.6	57.2	10.3	9.6	0.6	17.0	1.9	10.6	6.6	23.0	0.6	4.0	12.8	6.7	25.9	5.7	23.1	31.3	10.4	115.9	37.5	149.2	49.0	6.1	1.5	3.2	9.8	15.0	5.3	3.4	16.3	6.6	72.3	43.2	2.0	10.2	41.9	270.0	31.8	11.9	17.8	5.0	17.5	115.7	16.2	5.9	14.9	7.2	76.1	11.2	78.2	3.7	9.5	5.4	18.6	5.0	83.3	5.3	214.3	93.6	6.7	16.5	0.0	3.9	5.5	10.0	13.1	4.3	43.1	1.5	17.4	0.7	6.7	962.5	8.4	36.8	23.2	41.1
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	17.5	47.4	17.1	4.6	26.9	2.3	8.5	16.4	20.1	5.4	7.9	5.0	1.0	9.9	0.9	2.7	10.4	8.1	4.2	16.0	24.7	2.8	9.8	14.6	9.1	24.7	22.6	10.1	3.9	0.4	12.8	17.7	23.1	6.7	2.6	31.0	7.1	0.5	12.4	6.1	6.9	3.5	20.6	20.0	5.6	10.8	23.6	5.0	27.9	3.5	4.4	20.8	5.9	41.6	0.3	27.0	2.5	54.4	22.0	11.8	8.0	5.9	18.0	5.6	5.0	0.5	19.6	0.7	0.2	10.2	2.5	1.0	3.6	6.4	7.0	0.2	3.2	0.6	1.1	1.0	17.6	0.4	7.8	6.9	0.8	2.1	0.8	10.1	13.7	7.4	0.8	30.2	18.3	1.8	1.9	3.1	0.2	9.6	0.0	3.5	17.0	11.0	2.9	47.0	3.8	3.8	0.2	0.1	40.8	5.4	0.2	1.1	4.5	0.1	2.7	0.1	0.4	30.0	42.5	0.5	4.2	5.6	27.7	0.6	0.8	0.1	0.6	3.0	0.8	1.1	0.3	0.4	0.5	0.7	0.3	0.3	0.6	0.6	2.4	0.2	0.1	0.3	17.1	26.9	16.4	20.1	16.0	24.7	24.7	22.6	23.1	20.6	23.6	41.6	8.5	86.6	112.8	37.5	29.1	5.6	27.6	20.5	1.2	56.6	3.1	2.3	1.9	40.0	33.9	3.7	58.4	0.4	48.3	0.2	3.9	12.0	12.3	9.0	27.8	8.1	6.7	0.4	46.9	16.6	1.1	21.7	6.1	8.5	34.8	35.2	29.6	21.1	35.6	72.3	60.2	0.1	12.2	45.4	18.1	12.0	8.1	24.9	32.0	45.9	20.1	56.0	12.3	94.0	108.4	6.2	0.1	1.9	19.5	6.8	0.0	3.7	10.7	45.2	0.0	21.3	5.0	8.4	16.1	0.2	3.8	0.3	28.9	6.3	0.1	8.3
ST3GAL6	"SIAT10, ST3GALVI"	ENSG00000064225	"ST3 beta-galactoside alpha-2,3-sialyltransferase 6"	Q9Y274	3	98732236-98821201	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 128.8;Hepatocytes: 86.8;Microglial cells: 134.0;Oligodendrocyte precursor cells: 171.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.6;neutrophil: 57.6"	"Group enriched"	"Detected in many"	143	"dendritic cells: 24.2;granulocytes: 57.6;monocytes: 17.4"	"Group enriched"	"Detected in many"	4	"RPMI-8226: 96.5;SK-MEL-30: 114.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018792	Approved					NA	NA		5800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA018792: AB_10964349"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (9.47e-3)"	"unprognostic (6.79e-4)"	14.6	7.9	8.2	3.8	8.9	2.4	6.3	14.0	9.9	4.8	3.0	3.8	2.0	2.2	12.0	1.9	6.3	2.2	26.5	9.3	8.5	14.0	56.0	7.8	1.6	19.5	10.1	1.2	3.5	1.1	4.1	8.5	14.3	3.3	2.7	1.5	19.5	2.0	7.9	16.7	1.9	2.0	14.8	3.2	4.5	1.6	9.2	10.6	2.9	6.4	2.8	1.6	1.4	13.1	0.3	1.3	1.8	2.7	3.3	1.1	12.5	0.4	1.5	1.2	2.2	8.7	0.5	6.4	3.3	0.0	4.6	2.1	3.9	2.0	1.1	0.0	2.7	0.2	0.6	15.1	14.0	13.2	23.7	1.5	0.1	3.5	6.6	22.4	14.2	2.6	0.0	6.3	1.3	0.0	2.1	22.6	3.5	0.0	3.5	1.3	1.5	96.5	3.4	0.0	3.8	19.2	5.1	0.5	114.2	3.6	0.4	23.1	10.8	2.9	2.4	0.8	1.3	24.1	2.0	0.0	4.6	18.6	10.3	18.5	17.4	49.6	0.0	9.6	0.0	0.1	0.0	0.0	24.2	0.0	0.2	0.0	57.6	0.1	4.9	5.5	0.0	4.7	8.2	8.9	14.0	9.9	9.3	8.5	19.5	10.1	14.3	14.8	9.2	13.1	10.1	12.8	35.2	2.3	2.3	11.5	2.6	7.0	2.2	1.2	6.4	5.7	40.4	2.8	2.8	3.7	8.4	45.2	0.0	0.0	13.7	6.8	0.3	128.8	4.2	20.2	16.1	6.6	78.5	2.0	69.5	3.8	9.2	41.0	39.1	1.8	32.5	86.8	34.4	0.0	64.2	0.1	30.5	29.5	64.2	1.0	2.8	38.4	65.8	134.0	38.0	0.9	0.0	171.4	51.6	6.2	0.1	6.8	18.0	5.2	0.0	10.0	27.5	3.5	6.6	1.7	2.2	0.1	1.0	2.1	12.8	27.0	2.0	0.3	0.3	1.8
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930325-187078553	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 495.9;lymphoid tissue: 148.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 237.3;Hepatic stellate cells: 258.5;Hepatocytes: 608.7;Microglial cells: 602.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 250.6;U-266/70: 628.0;U-266/84: 887.9;U-698: 334.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	3300000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	24.5	12.5	27.0	50.2	26.2	15.2	32.5	29.8	24.8	61.4	33.3	38.1	13.9	16.1	5.9	13.5	27.0	17.8	36.0	25.8	33.9	60.0	495.9	30.1	101.7	44.0	37.5	10.1	8.1	45.5	9.8	18.5	50.3	48.8	45.4	2.6	39.3	14.6	12.8	8.3	29.1	18.9	44.1	67.5	28.8	3.5	39.2	66.6	64.8	20.2	148.1	28.0	8.9	48.3	4.3	5.0	20.6	17.1	1.1	0.0	36.3	1.6	3.0	1.4	2.0	1.9	2.0	250.6	19.5	0.1	8.8	10.1	132.7	15.4	1.6	11.3	7.4	10.1	0.8	119.0	1.3	22.8	75.0	1.7	28.3	0.0	11.5	19.9	77.5	24.2	52.2	20.3	5.2	8.7	17.0	14.7	49.9	11.3	7.6	38.2	0.4	8.1	9.9	0.5	36.4	4.1	1.5	26.6	64.6	29.1	38.9	16.8	32.6	0.2	3.3	0.6	2.1	628.0	887.9	334.0	0.5	45.4	84.7	22.6	8.9	3.6	46.9	16.2	42.9	87.9	51.3	39.7	14.2	83.3	80.4	58.4	4.2	26.9	29.3	11.9	43.8	58.7	27.0	26.2	29.8	24.8	25.8	33.9	44.0	37.5	50.3	44.1	39.2	48.3	34.6	44.8	27.4	13.4	110.0	4.0	13.8	68.0	4.6	0.3	5.1	4.1	26.2	75.8	55.9	237.3	0.0	0.3	26.3	20.7	0.0	17.1	0.5	8.9	5.0	56.0	94.1	24.8	47.2	0.9	3.5	3.7	7.7	16.1	10.8	7.3	258.5	608.7	20.3	0.0	31.5	10.9	34.6	61.3	16.4	1.1	0.3	18.2	7.2	602.4	17.2	0.1	26.8	145.3	2.8	6.0	17.8	0.7	124.3	103.6	0.6	0.5	39.8	1.1	0.0	2.2	6.8	0.0	0.5	0.8	1.6	0.7	28.4	0.3	37.3	39.0
ST6GAL2	"KIAA1877, SIAT2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0;thyroid gland: 28.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Group enriched"	"Detected in many"	77	"amygdala: 6.9;basal ganglia: 7.4;cerebral cortex: 11.0;hippocampal formation: 10.8;thalamus: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	0.5	0.1	6.9	0.2	7.4	1.0	0.7	0.0	11.0	1.7	0.0	1.1	0.2	2.6	0.3	1.8	0.7	5.1	0.5	10.8	0.0	0.4	2.6	0.6	0.3	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.8	2.3	1.9	0.8	0.8	0.1	0.7	0.4	2.0	0.0	0.1	0.6	5.3	4.6	0.1	28.7	0.0	0.3	0.6	1.0	0.1	0.0	5.3	2.8	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.4	0.0	5.9	0.0	0.0	9.6	0.2	0.0	6.1	3.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.5	0.1	0.2	0.0	9.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.9	7.4	0.0	11.0	10.8	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	58.8	0.0	0.9	0.2	0.0	18.8	6.6	0.2	3.4	1.4	0.0	0.6	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.4	0.8	12.2	0.3	1.2	6.3	78.7	0.0	0.0	1.7	0.0	0.5	0.0	111.5	2.2	0.0	0.2	0.0	44.8	3.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	2.8	0.0	0.9	0.0	94.0	1.9	0.0	1.0	0.7	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.2	2.9	0.1	1.1	4.3	0.0	0.3	0.1	0.1	3.2	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074746-76634603	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Group enriched"	"Detected in many"	4	"Microglial cells: 912.5;Oligodendrocytes: 698.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	8.8	1.4	5.8	1.8	13.3	3.1	6.4	14.3	8.4	1.9	10.4	2.0	0.7	5.9	0.5	1.9	2.7	2.5	4.4	6.9	9.0	8.7	2.0	5.2	2.0	15.2	10.6	2.3	0.9	4.4	2.1	3.1	17.2	1.1	2.4	3.9	1.1	1.6	1.6	0.8	1.4	4.5	13.3	1.4	1.5	0.3	11.3	0.9	13.3	6.5	0.7	2.6	1.6	21.0	0.2	0.0	35.8	0.0	0.6	0.0	0.0	0.0	4.2	0.6	0.4	11.9	0.1	0.6	2.4	0.3	2.3	0.1	0.0	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.0	0.0	1.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	2.9	0.0	1.8	1.7	0.0	0.0	0.0	2.7	8.8	0.0	0.0	62.3	8.3	0.0	0.2	20.6	0.3	2.8	0.1	3.3	0.0	0.0	0.0	0.0	8.4	5.5	0.0	6.3	2.8	0.0	2.2	0.0	2.6	0.3	0.5	2.3	3.8	1.3	1.4	3.9	0.3	4.3	0.0	0.0	1.9	5.8	13.3	14.3	8.4	6.9	9.0	15.2	10.6	17.2	13.3	11.3	21.0	59.8	3.2	1.5	174.3	5.6	0.3	0.2	0.0	0.6	3.2	0.6	1.0	1.2	0.0	0.0	3.7	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.1	4.5	23.2	0.0	0.4	107.0	0.0	0.1	2.5	3.6	0.1	0.0	0.8	66.0	0.8	1.1	0.0	101.4	0.5	0.0	9.8	0.7	0.8	0.0	3.7	5.4	912.5	3.0	12.3	1.0	23.1	698.3	0.2	3.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.3	0.2	0.7	0.1	0.4	0.1	2.0	6.9	0.3	0.1
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867480-77067546	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 480.3;Inhibitory neurons: 417.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.9;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;fHDF/TERT166: 5.4;HaCaT: 2.7;SH-SY5Y: 4.1;U-2 OS: 4.4;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 51.3"	"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	Yes		180000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.1	3.0	1.5	1.5	1.1	0.0	1.2	0.0	5.9	0.7	0.0	1.8	0.2	0.1	0.0	1.0	1.9	2.2	0.5	5.5	0.0	0.1	0.0	3.6	0.4	0.0	0.0	1.6	0.1	0.0	1.9	0.1	0.0	1.0	0.6	3.2	0.5	0.3	0.0	0.2	0.9	3.0	0.0	0.2	1.5	0.3	0.0	0.0	0.0	0.0	0.3	1.6	0.6	0.0	1.2	0.0	4.7	0.0	0.0	0.0	0.0	0.4	1.5	1.1	0.4	0.0	0.1	0.0	0.0	5.4	0.0	2.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.1	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	4.4	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	5.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.5	35.6	0.1	0.0	0.0	0.1	0.0	20.7	2.8	1.7	1.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.2	1.9	0.4	0.0	0.0	480.3	0.0	0.1	0.8	0.0	0.2	1.3	0.9	0.0	0.0	0.1	0.0	417.3	0.2	0.0	0.0	0.0	2.3	0.6	0.1	0.0	8.4	0.0	0.7	0.0	10.6	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.3	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.1
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 258.8;Intestinal goblet cells: 100.6;Paneth cells: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"NK-cells: 23.7;T-cells: 25.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 157.1"					"Low region specificity"	"Detected in all"			HPA018890	Approved				"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	95.8	37.4	155.5	21.4	156.0	17.7	68.7	129.5	177.8	48.7	120.2	75.5	9.5	48.6	50.0	35.0	67.2	28.4	61.3	165.6	130.9	50.1	63.5	66.7	27.5	133.4	137.2	83.0	52.8	32.4	26.0	22.0	128.3	40.2	126.4	16.0	28.3	41.5	46.0	37.4	35.2	38.0	128.3	64.1	43.9	17.6	140.6	14.9	32.5	40.2	23.1	56.6	42.6	134.6	12.0	9.2	18.9	36.9	157.1	91.9	7.4	29.7	69.6	43.7	35.9	16.3	10.0	13.8	13.4	68.1	28.4	21.9	25.6	23.7	19.0	50.9	14.0	13.4	19.0	16.7	48.1	3.3	18.9	94.9	27.5	34.0	15.1	61.6	40.9	11.9	12.2	14.6	54.9	9.9	8.4	19.3	9.1	12.3	17.5	24.6	27.0	14.3	32.2	2.4	13.1	21.3	21.4	8.8	7.6	12.3	9.3	29.0	26.7	27.6	16.3	30.5	15.8	18.4	9.8	21.5	24.5	4.1	8.7	3.3	1.2	0.1	25.3	1.9	18.5	5.3	16.5	18.8	1.8	3.9	10.0	13.7	0.6	23.7	5.0	2.1	25.6	12.4	155.5	156.0	129.5	177.8	165.6	130.9	133.4	137.2	128.3	128.3	140.6	134.6	1.3	3.2	4.3	13.1	10.5	23.2	17.2	15.7	9.1	22.0	0.9	0.6	8.7	8.6	9.5	0.0	6.2	4.3	11.7	258.8	0.0	0.3	2.5	0.8	1.7	20.6	38.5	26.1	11.5	0.4	7.7	26.6	3.6	1.4	7.0	0.2	46.8	28.5	11.6	25.2	10.7	100.6	18.3	10.0	35.6	9.4	66.5	4.1	24.9	8.4	3.2	58.7	46.4	5.5	3.8	0.3	178.3	60.9	8.9	20.5	0.3	0.0	16.1	8.5	85.5	41.2	31.9	1.4	4.8	10.3	26.9	3.6	17.7	0.5	84.7	18.6
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523514-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 36.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.7;Late spermatids: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"HPA042324: AB_10794273, HPA075418: AB_2686749"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (8.34e-5)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.16e-4)"	"prognostic favorable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	4.6	5.2	2.4	2.2	3.1	5.5	4.8	3.7	3.2	4.6	2.5	3.1	2.9	5.2	4.9	3.5	3.7	3.4	5.4	2.2	2.4	3.6	4.2	2.8	2.9	1.9	2.5	5.6	3.9	4.7	2.2	3.9	2.1	4.3	4.7	6.8	2.9	4.2	4.8	6.1	2.6	4.1	2.3	2.1	2.3	36.0	2.3	3.4	7.6	4.6	3.3	3.7	3.1	3.6	5.2	1.5	8.8	6.1	11.7	11.6	2.0	5.9	4.8	2.6	3.9	2.8	4.8	2.0	2.4	2.6	7.9	3.3	10.2	8.3	4.0	3.2	6.0	6.2	8.0	2.1	6.7	4.9	6.3	2.3	2.0	3.0	6.3	6.2	8.9	7.4	3.4	6.5	11.1	1.4	2.7	1.9	4.0	2.3	5.3	4.4	4.0	0.8	5.7	6.2	6.2	3.7	3.4	4.8	4.4	1.5	3.6	3.0	8.8	6.0	5.9	7.9	6.0	1.7	1.3	2.1	5.5	8.2	13.5	0.1	0.9	0.1	1.2	1.1	1.9	2.4	1.8	0.9	0.9	1.3	2.5	1.4	0.2	3.7	0.9	1.8	1.4	1.0	2.4	3.1	3.7	3.2	2.2	2.4	1.9	2.5	2.1	2.3	2.3	3.6	14.4	22.4	9.6	46.0	8.0	17.0	16.7	14.9	23.9	19.7	13.7	15.9	6.7	12.8	12.8	9.2	6.2	13.0	10.8	4.9	9.8	8.5	189.7	8.5	13.8	12.1	5.4	9.9	48.1	8.6	6.7	12.2	8.6	9.5	8.2	15.1	5.0	8.0	8.5	25.2	55.0	9.8	18.3	10.9	8.6	301.2	18.0	12.5	21.4	37.5	6.0	21.8	3.1	68.3	67.9	7.4	5.1	16.1	13.9	12.4	6.8	6.9	10.4	25.2	19.7	15.7	13.3	65.4	14.5	17.6	18.3	6.2	11.3	17.2	9.7	10.6
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.2;Inhibitory neurons: 152.0;Oligodendrocyte precursor cells: 198.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.5;ASC TERT1: 4.2;hTERT-RPE1: 3.0;RPTEC TERT1: 3.3;SK-MEL-30: 6.2;WM-115: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.0	3.5	7.3	2.5	7.0	1.2	2.9	15.0	6.6	2.6	0.0	3.7	0.1	2.3	0.6	1.3	1.3	1.0	2.3	6.3	9.8	0.7	0.2	2.0	4.6	11.6	9.2	1.2	0.5	6.4	0.2	0.1	9.3	3.1	1.6	6.0	1.4	2.0	0.4	2.1	1.3	2.2	8.6	1.3	1.1	0.4	6.8	0.9	0.7	0.4	4.8	4.1	1.8	6.4	0.0	0.3	6.5	0.0	1.0	4.2	0.6	0.0	0.0	0.1	0.3	0.2	0.1	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.1	0.6	3.0	0.1	0.0	0.0	0.4	0.2	0.0	0.9	0.2	1.6	2.6	0.0	0.0	0.1	0.1	3.3	0.0	0.0	0.1	0.0	0.1	6.2	0.2	0.5	0.0	0.0	0.5	0.6	0.0	1.0	0.5	0.4	0.5	1.0	0.0	6.5	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	7.3	7.0	15.0	6.6	6.3	9.8	11.6	9.2	9.3	8.6	6.8	6.4	0.6	0.0	1.8	43.1	0.4	4.5	0.4	1.4	0.0	9.6	7.2	5.8	4.1	0.0	1.6	0.0	45.9	3.6	1.7	0.1	1.9	0.0	12.8	8.7	2.9	1.3	0.0	3.2	133.2	0.0	13.8	8.3	0.0	0.3	34.1	2.6	1.8	0.0	0.9	5.0	152.0	0.0	0.0	0.0	2.7	5.0	0.3	0.5	12.4	17.8	0.2	46.2	0.0	198.0	4.7	0.0	0.0	0.0	0.7	3.5	0.0	0.5	9.4	4.2	0.0	43.9	2.3	6.3	6.3	0.0	2.4	3.7	5.9	31.3	0.0	0.2
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393881-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;heart muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.0	0.3	0.6	0.0	0.6	0.0	0.4	0.6	2.2	0.8	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.2	3.9	1.5	1.2	0.1	0.0	0.0	0.0	8.4	1.9	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	1.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.2	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.0	4.1	0.0	0.0	0.0	11.7	8.9	0.0	0.0	0.6	5.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	2.2	1.5	1.2	8.4	1.9	8.2	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57352557-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.7;pituitary gland: 8.1;retina: 7.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA063398: AB_2685004, HPA066783: AB_2685721"					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.0	4.3	8.0	0.0	21.7	0.0	0.0	6.7	15.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	12.5	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	8.1	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	21.7	6.7	15.6	12.5	14.5	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	1.6	5.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	63.9	56.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	1.2	0.0	22.1	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806933-100903282	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 91.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		980000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	5.8	1.9	2.2	14.0	2.4	7.6	2.2	1.6	2.4	1.9	2.5	3.3	3.2	1.6	0.5	1.1	1.8	5.0	2.3	1.8	4.5	0.7	2.6	5.7	12.3	4.8	3.6	0.5	0.8	1.0	0.6	11.1	5.2	1.3	4.2	0.6	1.2	0.8	0.8	0.8	4.5	2.8	2.7	11.8	3.0	0.4	4.3	9.5	2.0	1.7	10.3	5.5	1.1	4.5	0.0	6.1	41.1	0.0	2.6	3.9	1.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	0.0	1.0	0.1	1.0	0.1	0.1	69.3	0.0	2.5	0.4	0.0	0.0	13.0	5.0	3.2	0.0	0.1	0.1	5.3	7.7	10.1	0.0	57.2	2.4	0.6	18.6	27.9	0.3	0.0	0.3	10.3	0.7	44.8	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.0	11.6	2.7	0.4	0.2	0.0	0.6	18.6	20.3	3.9	1.0	15.8	5.1	58.0	18.5	22.9	13.1	21.7	9.9	11.1	8.7	11.1	12.2	9.9	5.4	10.1	91.7	10.6	24.0	3.7	17.4	12.2	2.2	2.4	1.6	2.4	1.8	4.5	4.8	3.6	5.2	2.7	4.3	4.5	35.8	6.4	14.1	1.6	49.7	8.3	0.4	2.1	2.2	0.6	0.9	0.9	2.3	1.5	10.1	0.0	0.0	9.4	44.0	0.0	1.9	0.2	0.2	0.9	1.6	28.4	0.0	8.2	6.8	0.0	42.4	5.0	1.1	0.3	24.1	0.1	7.1	0.1	22.6	0.0	73.3	0.2	4.1	92.4	149.3	0.7	0.0	57.5	14.2	101.2	97.5	3.2	34.0	4.5	1.6	0.0	0.0	0.4	73.8	0.2	0.0	0.3	16.6	0.9	13.1	1.2	3.7	0.5	0.8	0.4	5.5	19.2	37.7	0.7	0.0	0.5
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.2;brain: 17.0;parathyroid gland: 6.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		Yes	NA		24000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.1	12.2	4.0	0.0	12.9	0.2	0.0	17.0	11.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	6.2	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	6.2	0.5	0.0	1.4	0.1	0.0	0.7	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.2	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	87.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	12.9	17.0	11.4	6.2	0.0	0.4	0.1	1.4	0.0	0.0	7.7	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	7.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.0	3.1	0.0	0.1	0.2	0.0	0.0	106.1	0.0	0.0	0.2	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	75.5	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.7	0.0	1.1	0.0	32.2	9.1	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.6	0.2	0.8	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.1
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17315421-17454595	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;lung: 5.9"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 137.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 208.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	0.7	0.3	5.8	0.4	4.1	1.8	5.2	3.2	3.6	0.3	2.4	0.6	0.3	0.4	4.6	0.5	0.3	0.5	3.4	2.9	3.3	0.8	1.0	5.9	0.2	5.4	10.5	0.4	0.2	0.0	0.3	1.1	4.6	1.5	0.4	0.4	0.6	0.2	0.2	1.0	0.4	0.3	3.6	0.6	0.3	0.3	8.0	0.3	0.4	0.8	0.4	0.2	0.4	4.3	0.2	0.2	0.1	1.7	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.3	0.3	0.5	0.1	0.0	0.0	0.4	0.2	25.9	0.4	0.5	0.0	0.0	208.0	0.1	0.0	0.2	0.1	1.8	0.0	0.3	4.6	0.4	2.5	1.9	1.1	0.4	2.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	9.3	0.2	1.1	0.0	3.6	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	1.7	0.5	0.5	0.5	0.1	0.2	0.1	0.3	0.3	0.2	0.3	0.3	0.4	1.0	0.7	0.3	0.2	0.8	0.2	5.8	4.1	3.2	3.6	2.9	3.3	5.4	10.5	4.6	3.6	8.0	4.3	0.6	0.0	0.0	2.6	0.1	0.6	0.1	0.2	0.0	0.0	10.0	3.9	0.8	0.0	0.2	0.0	0.0	0.0	5.5	1.2	0.0	0.0	0.5	0.1	0.0	10.9	0.0	25.5	3.0	0.0	0.0	0.3	0.0	0.8	10.2	2.8	26.7	0.0	0.1	0.0	4.4	0.0	0.0	0.9	0.0	0.6	0.0	0.2	8.8	137.7	0.2	0.0	8.2	1.5	1.1	0.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.0	0.0	0.0	2.4	0.1	0.0	0.1
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 65.9"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000		"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.8	0.9	0.5	0.7	0.9	0.1	0.6	1.0	0.0	2.8	0.3	0.9	1.5	0.8	1.3	1.0	0.4	1.3	0.1	0.4	14.7	0.5	3.9	0.4	0.0	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.1	65.9	0.4	2.2	0.3	0.0	1.1	0.0	0.4	0.7	0.5	0.1	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.6	1.3	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380503-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"							HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	2.8	5.1	1.4	0.6	1.9	0.4	1.9	3.6	3.9	7.0	5.0	3.6	0.1	1.4	0.3	2.1	3.2	2.7	0.7	0.8	4.3	2.5	0.9	11.1	0.4	2.3	2.5	2.5	0.1	10.1	1.1	0.3	6.9	13.8	0.7	5.8	1.3	4.4	1.6	1.2	0.4	3.4	1.9	0.6	0.9	1.9	2.1	0.7	0.5	5.3	0.2	3.7	2.2	0.5	7.7	3.3	1.6	0.0	6.5	2.1	0.1	19.9	0.4	4.0	4.6	0.0	0.0	0.0	7.8	46.8	13.0	34.1	2.4	8.2	4.1	0.0	7.2	1.1	10.0	0.2	0.0	20.3	0.4	2.4	0.2	0.1	0.7	27.6	0.0	1.8	0.0	0.4	0.5	0.0	4.1	0.2	13.8	0.0	3.0	0.0	0.0	0.0	10.8	0.0	6.2	49.1	7.9	5.2	0.1	13.6	0.0	2.0	8.5	0.5	19.1	0.6	30.3	0.0	0.0	0.0	48.1	7.9	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.5	0.0	1.4	1.9	3.6	3.9	0.8	4.3	2.3	2.5	6.9	1.9	2.1	0.5	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.7	2.3	0.8	0.9	0.0	1.3	0.0	0.0	0.0	0.1	0.0	5.9	0.2	5.2	0.9	0.5	0.4	0.0	2.1	0.6	0.0	0.1	1.5	0.0	2.1	6.3	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.2	5.3	0.0	4.8	0.0	0.0	0.0	21.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	5.0	1.8	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336236-136752403	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	13.7	9.1	7.6	12.3	8.8	15.7	15.6	17.0	8.3	16.9	9.9	13.5	9.6	19.3	10.6	10.8	13.5	10.3	10.5	6.5	8.7	12.0	10.8	11.2	14.7	9.3	7.8	21.9	12.4	13.7	5.0	17.6	9.0	10.8	14.4	13.2	11.6	12.1	15.0	13.7	11.0	16.1	8.8	11.8	10.0	8.9	7.8	22.5	15.8	15.8	15.9	12.0	11.5	11.2	34.6	17.6	29.1	25.1	21.5	36.8	15.7	37.9	48.4	35.0	33.0	30.2	14.9	26.9	23.3	39.7	28.1	23.4	31.6	17.3	47.4	33.2	14.9	28.8	25.1	16.7	16.3	50.6	27.7	23.4	19.3	25.6	28.6	20.3	27.5	28.8	18.7	52.7	22.3	29.5	33.6	16.4	19.0	23.7	13.9	29.6	31.6	35.7	19.1	24.5	14.2	22.8	40.8	16.0	17.5	15.0	22.9	21.2	23.3	40.1	29.0	36.0	33.9	39.1	28.9	59.5	24.6	17.0	26.2	4.0	3.0	4.6	4.4	3.0	4.6	6.4	3.7	4.0	2.8	4.4	4.1	3.3	8.7	5.5	3.5	4.5	4.8	2.1	7.6	8.8	17.0	8.3	6.5	8.7	9.3	7.8	9.0	8.8	7.8	11.2	44.5	25.6	24.2	95.6	42.4	40.0	31.4	18.7	38.7	43.8	24.8	26.7	10.8	22.8	23.5	16.5	39.6	29.3	39.5	42.1	11.7	20.7	2.8	23.7	59.5	34.1	18.7	29.7	161.8	22.2	26.7	33.8	23.9	39.6	22.2	30.3	31.4	21.5	18.6	28.6	166.8	27.9	8.2	16.9	22.0	4.8	49.4	25.1	16.0	231.4	27.2	25.6	42.2	223.2	188.4	27.4	17.5	32.4	53.1	27.2	24.2	13.2	14.5	68.1	26.3	67.1	36.2	54.8	50.5	27.5	36.7	31.7	39.2	16.0	23.4	24.3
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	27.9	22.9	20.7	34.2	26.3	72.8	41.5	32.6	24.1	33.3	30.4	28.8	23.8	35.7	28.3	26.8	30.1	25.2	21.5	18.0	22.6	33.7	28.5	28.6	45.0	26.2	21.9	46.0	31.7	51.9	12.0	35.8	27.8	29.8	28.2	45.5	26.5	29.6	23.3	26.1	26.5	25.8	24.2	37.4	28.5	8.0	21.2	81.4	49.3	36.0	44.3	28.4	17.6	39.6	62.6	56.9	84.5	53.0	34.9	52.3	54.4	58.0	61.8	58.5	73.2	53.8	65.1	115.0	79.6	52.3	65.5	55.6	173.6	48.8	82.5	81.9	74.7	106.6	110.8	35.7	35.6	140.7	80.0	42.2	46.4	69.5	111.4	50.2	49.7	114.2	105.4	118.9	43.1	67.8	180.6	62.9	44.5	55.8	84.4	125.9	112.0	96.1	44.9	117.3	75.7	60.6	131.2	47.7	66.9	59.2	28.9	62.2	61.5	0.3	31.1	69.4	66.6	50.9	82.2	141.6	36.8	84.3	60.3	28.2	15.2	28.0	15.0	18.9	17.8	15.0	15.6	14.6	19.1	19.0	21.3	17.5	44.5	18.8	23.1	16.5	13.5	10.0	20.7	26.3	32.6	24.1	18.0	22.6	26.2	21.9	27.8	24.2	21.2	39.6	71.1	64.1	56.6	42.4	80.9	56.2	61.5	31.5	72.3	51.0	58.0	48.4	44.9	37.1	50.6	44.1	60.5	32.2	113.4	42.9	21.5	42.3	1.1	65.1	70.4	62.3	58.1	77.0	41.8	38.2	32.7	64.5	39.8	79.3	58.1	53.6	59.3	42.2	36.0	45.4	51.9	35.0	28.5	71.4	65.0	4.2	65.9	89.9	33.8	70.3	91.4	61.2	97.9	69.4	114.0	54.9	29.3	69.2	73.8	81.4	28.0	35.7	51.4	62.9	65.7	104.0	60.3	14.8	15.4	51.0	56.1	71.4	87.2	49.5	38.9	83.6
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.7;HMC-1: 54.4;U-698: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.2	0.2	0.1	0.1	0.1	0.8	0.3	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.1	54.7	0.3	0.6	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	41.7	1.1	0.0	0.1	0.2	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.4	0.0	0.1	0.8	0.2	0.0	0.3	1.4	0.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.3	1.9	0.0	2.7	2.9	56.5	6.8	10.9	1.8	1.2	7.4	1.9	1.8	2.2	10.0	1.7	7.3	2.1	2.0	12.1	1.7	13.7	0.3	29.8	26.1	2.9	4.2	1.2	8.4	6.5	0.2	3.3	4.1	0.5	7.8	1.3	4.9	4.2	29.4	2.2	20.2	6.1	5.7	0.0	2.2	8.6	23.5	4.7	4.6	5.4	5.6	4.2	2.7	13.4	5.0	5.1	0.2	0.5	1.9	2.1	8.2	1.1	6.9	15.1	7.0	0.0	8.0	5.4	152.6	60.0	0.4	8.5	2.9	10.8	2.6	2.0	11.7
STAM	STAM1	ENSG00000136738	"Signal transducing adaptor molecule"	Q92783	10	17644151-17716824	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 76.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034399, HPA043882"	Supported		Supported	Vesicles		NA	NA		82000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"CAB034399: AB_2197486, HPA043882: AB_2678713"	"unprognostic (1.09e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.44e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.02e-1)"	10.8	13.3	7.7	6.9	9.7	53.1	8.9	14.0	11.8	10.7	3.4	8.0	8.2	9.0	5.8	12.2	7.8	9.1	18.0	9.2	8.7	10.2	6.9	10.9	7.5	9.8	9.5	11.4	10.4	10.3	7.4	8.5	9.8	8.7	7.7	11.2	8.5	6.1	24.5	10.0	7.3	8.5	9.6	6.8	11.4	8.1	9.1	13.1	10.8	10.1	7.5	10.9	9.0	14.7	34.8	19.8	30.8	14.2	30.1	21.9	10.3	45.1	19.8	41.0	33.1	25.9	31.7	9.1	7.2	33.9	31.7	18.2	27.6	21.1	35.0	10.9	12.7	86.3	15.3	43.1	31.8	6.5	43.7	22.7	27.0	33.6	28.3	26.6	19.8	56.3	30.1	10.5	43.8	10.4	35.7	5.6	14.7	19.7	10.2	18.0	29.0	11.9	17.5	11.2	13.0	19.2	24.6	16.7	34.6	24.1	27.5	9.4	26.6	23.9	24.5	42.7	21.1	6.6	11.5	15.6	25.6	9.6	15.6	47.5	7.5	12.5	5.9	8.2	5.6	5.4	12.8	6.2	9.6	3.1	8.8	7.1	5.9	17.3	7.5	5.5	76.5	6.4	7.7	9.7	14.0	11.8	9.2	8.7	9.8	9.5	9.8	9.6	9.1	14.7	13.2	12.8	23.4	15.7	14.1	22.9	5.3	16.2	23.9	19.7	9.4	8.9	30.0	5.7	14.0	16.5	10.4	10.2	24.3	6.4	5.9	15.1	3.5	16.3	22.3	11.0	11.4	56.8	31.7	13.4	10.5	23.5	15.8	25.9	31.6	13.0	10.4	7.8	15.5	10.1	36.9	7.8	2.0	10.4	16.3	3.5	9.6	15.6	19.6	39.4	8.4	13.7	10.3	31.7	59.4	29.9	8.0	6.0	20.8	10.1	5.7	15.6	14.0	14.5	26.3	22.3	12.6	22.1	14.6	21.8	21.0	24.6	27.6	18.4	8.1	8.5
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175763	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	9.7	9.9	7.3	7.9	8.3	3.1	12.5	7.5	8.9	10.9	8.0	10.3	9.3	10.9	8.7	9.1	12.8	9.3	9.6	6.3	7.7	14.6	11.0	10.8	8.7	7.5	7.9	11.0	8.8	12.8	6.5	10.3	7.9	12.9	10.9	11.1	11.9	8.9	5.8	10.8	9.3	10.1	8.0	8.3	11.7	12.6	7.4	8.5	14.3	7.7	8.9	10.7	6.6	9.7	8.3	7.9	7.2	8.8	18.5	22.0	7.7	16.8	19.4	10.7	13.6	7.8	7.8	10.8	13.1	24.2	9.4	8.3	8.0	15.6	17.1	13.3	6.3	7.8	5.1	11.8	21.2	11.5	14.6	16.9	14.6	20.0	26.8	15.5	11.7	7.2	5.1	7.5	22.2	8.1	6.1	8.9	4.5	6.1	11.2	4.9	8.9	5.9	16.7	14.1	3.8	5.9	9.3	8.2	14.1	8.0	11.1	10.5	15.3	23.7	7.6	18.8	10.3	6.1	6.7	6.8	17.9	9.2	13.2	16.8	3.4	4.6	1.7	4.6	1.6	1.7	1.8	1.9	2.7	2.0	1.5	1.9	8.6	2.6	7.1	3.2	2.2	1.6	7.3	8.3	7.5	8.9	6.3	7.7	7.5	7.9	7.9	8.0	7.4	9.7	17.6	25.6	33.5	39.2	10.9	13.8	12.0	16.4	15.9	10.6	17.9	11.6	30.5	7.2	28.9	16.5	16.7	7.4	14.7	22.1	23.5	13.9	147.8	37.2	25.5	15.1	8.3	13.5	43.8	14.2	14.6	22.7	27.0	22.2	27.1	14.8	17.5	16.0	16.7	1.7	39.7	20.2	20.3	20.0	13.0	64.4	15.8	16.9	14.2	32.8	19.6	14.7	8.2	51.8	61.0	21.2	18.2	15.4	10.9	14.3	13.9	14.8	55.6	11.6	26.3	18.0	16.1	54.1	20.1	13.5	13.2	20.2	9.3	18.2	13.5	16.1
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 60.5;Microglial cells: 32.8;Spermatocytes: 40.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	23.8	5.5	10.4	6.5	5.3	2.5	2.6	9.0	2.7	0.0	8.7	6.4	4.2	0.9	4.4	2.2	4.1	8.0	6.2	1.4	1.8	1.8	3.6	16.2	1.1	0.5	12.7	2.3	3.4	5.5	1.2	2.6	1.7	9.7	4.4	1.4	1.1	0.7	3.7	7.3	3.0	1.9	7.2	5.1	18.0	0.5	7.1	1.2	1.5	12.2	6.4	2.5	5.6	14.8	16.5	1.0	0.6	14.4	27.7	0.0	31.5	28.9	19.0	16.3	0.3	25.6	18.6	2.3	15.6	12.3	6.4	4.1	4.5	17.9	16.3	10.8	4.6	10.4	0.9	10.3	20.2	5.7	10.6	1.4	31.6	9.6	18.4	0.6	20.9	0.0	7.3	50.0	3.0	34.2	21.5	6.6	13.3	14.1	3.4	13.0	3.8	6.5	4.7	9.6	11.9	3.7	1.1	37.5	3.6	2.3	4.1	4.9	17.0	12.4	20.7	19.9	17.7	19.7	17.2	18.2	19.4	16.9	9.5	1.0	8.1	10.7	1.1	14.1	17.7	15.5	13.7	1.7	14.9	16.6	10.0	1.4	23.6	0.5	27.9	28.3	8.0	5.5	6.5	2.6	9.0	6.2	1.4	1.1	0.5	2.6	1.9	0.5	5.6	2.3	0.0	4.5	10.7	16.7	9.6	5.3	1.4	1.2	3.6	2.3	1.4	8.6	0.0	0.2	5.5	0.0	0.1	18.8	7.6	0.0	1.3	54.3	1.9	6.5	1.8	9.1	3.4	60.5	1.8	0.1	7.7	3.1	1.4	5.1	7.4	1.8	2.4	3.7	6.7	26.2	9.3	4.1	1.3	9.6	20.7	7.2	3.1	0.0	32.8	1.0	9.3	12.3	26.2	1.9	1.9	2.8	1.5	14.2	1.9	7.9	0.8	5.0	0.4	0.0	20.4	6.4	40.2	2.5	5.9	11.4	0.1	17.6	14.9	14.2	2.9
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 294.5;Paneth cells: 343.4;Proximal enterocytes: 415.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 7.9;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 87.3;HaCaT: 70.3;MCF7: 104.3;RT4: 138.1"	"Region enriched"	"Detected in many"	13	"cerebellum: 20.5"	"Low region specificity"	"Detected in some"			"HPA002375, HPA027761"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (4.13e-4)"	5.6	18.1	2.6	7.5	2.7	0.4	16.6	3.6	4.2	18.1	3.5	72.8	77.5	5.7	10.6	91.0	15.1	7.1	4.9	2.7	2.4	28.5	55.3	8.2	3.2	2.4	2.2	11.5	30.6	21.3	4.4	3.4	2.7	37.9	59.7	0.5	45.4	9.8	1.2	73.9	72.0	4.0	2.0	1.5	24.2	2.0	2.5	7.9	15.3	0.7	13.0	16.5	41.0	2.6	87.3	0.4	6.2	5.8	0.4	4.7	35.7	1.6	8.8	2.8	2.2	52.0	34.8	0.1	13.3	2.8	17.9	70.3	1.1	50.3	1.6	14.9	0.7	0.3	0.4	35.1	10.9	0.1	0.7	3.5	41.7	4.8	12.2	7.0	8.9	2.1	3.4	18.6	1.3	104.3	1.3	0.7	4.8	55.3	20.4	3.6	0.8	2.2	29.4	138.1	2.1	3.5	0.1	25.9	14.6	2.2	60.7	0.3	12.5	0.2	1.2	0.7	1.8	0.1	1.4	1.3	0.3	0.4	5.7	0.4	0.1	0.0	0.6	0.0	2.3	0.6	0.8	0.1	0.7	0.1	2.3	1.4	0.1	7.9	0.0	2.2	2.5	0.8	2.6	2.7	3.6	4.2	2.7	2.4	2.4	2.2	2.7	2.0	2.5	2.6	6.7	9.6	14.4	0.3	2.4	40.5	59.8	171.4	42.7	0.6	33.8	30.1	6.9	38.6	87.2	29.5	0.0	16.9	2.3	294.5	25.4	137.5	1.2	9.0	3.6	10.1	85.8	4.4	1.5	101.0	3.0	4.5	55.5	13.4	8.9	5.2	7.5	29.6	1.8	0.0	1.2	147.5	91.6	4.1	9.4	0.9	4.7	1.8	19.6	0.0	12.5	1.0	1.0	0.5	1.8	139.4	343.4	1.9	1.4	92.6	415.7	125.0	44.9	0.8	0.0	1.7	7.9	0.6	2.6	86.0	61.8	12.4	3.3	5.7	173.2	117.0
STAR	STARD1	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38142700-38150992	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"adrenal gland: 5073.8"	"Cell type enriched"	"Detected in some"	44	"Theca cells: 2243.4"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"K-562: 436.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"			"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	1.7	5073.8	2.3	3.1	1.6	2.1	0.4	1.6	3.3	1.0	0.7	0.5	0.2	0.5	0.6	2.1	6.3	0.2	0.9	1.5	4.5	0.4	1.2	0.5	0.9	3.8	3.3	497.1	0.9	0.0	2.2	0.5	4.1	0.5	0.1	0.6	1.8	0.3	0.4	5.0	0.6	0.4	1.4	1.0	0.7	88.2	3.0	3.0	0.4	0.0	1.9	0.5	3.2	1.5	0.1	0.0	0.8	0.2	0.3	3.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	88.9	0.8	5.3	1.3	3.8	0.1	12.4	0.3	0.1	0.1	0.8	0.0	0.3	436.1	0.2	0.0	0.0	0.4	43.7	9.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.2	0.0	0.2	0.0	0.1	43.0	1.5	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	9.3	0.2	2.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	2.3	1.6	1.6	3.3	1.5	4.5	3.8	3.3	4.1	1.4	3.0	1.5	0.0	0.0	0.0	0.7	0.1	9.4	0.7	0.8	4.0	1.1	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.9	10.7	0.6	0.0	0.0	1.4	0.0	0.0	25.7	0.0	0.3	0.0	1.4	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.7	10.2	50.1	0.2	3.6	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.0	4.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.2	3.0	4.8	0.8	1.7	11.2	0.1	0.1	2243.4	0.0	0.1
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794047	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 709.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA026661: AB_1857538"	"prognostic favorable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	11.8	178.2	35.1	17.7	37.6	10.3	62.1	39.2	41.8	71.9	40.9	180.6	48.5	27.3	102.9	52.0	26.4	59.5	72.5	33.9	34.1	50.1	709.7	37.7	14.5	38.0	33.0	31.0	212.6	73.2	36.2	40.2	38.2	86.2	188.1	18.7	94.5	30.9	66.7	62.6	66.0	26.7	29.9	20.2	266.9	184.3	34.4	15.6	47.9	157.9	21.8	24.5	41.1	35.7	51.2	15.3	7.7	28.7	9.8	9.6	98.3	5.6	26.2	17.3	17.3	209.8	36.7	4.4	16.7	19.2	42.3	31.8	23.4	46.8	20.2	28.3	9.0	5.9	11.1	217.6	35.2	1.6	10.0	6.6	127.0	19.1	26.7	47.2	17.8	10.0	12.1	21.5	3.9	617.7	4.8	11.1	3.4	1316.9	20.1	4.5	13.3	3.4	23.5	61.4	13.0	10.1	8.6	427.4	73.3	32.8	235.5	6.3	13.6	17.0	11.4	6.0	10.1	22.2	19.8	7.5	4.3	5.6	6.5	12.9	2.6	16.0	1.6	1.1	1.2	4.2	1.5	1.7	1.2	2.4	1.6	1.6	21.7	7.5	0.6	2.6	2.1	1.1	35.1	37.6	39.2	41.8	33.9	34.1	38.0	33.0	38.2	29.9	34.4	35.7	10.6	35.3	74.1	8.1	18.1	31.5	76.3	41.0	25.0	10.5	163.3	125.3	45.3	270.2	76.4	55.2	22.9	212.8	17.1	362.8	123.3	70.7	520.2	26.5	6.8	18.5	302.2	22.9	11.6	94.3	93.1	21.1	372.1	25.3	25.4	10.1	30.0	660.0	26.4	33.7	13.9	717.9	85.5	26.0	34.4	2055.8	26.1	12.3	16.0	5.6	7.7	64.4	7.2	8.0	11.8	93.9	398.9	25.2	13.3	150.9	73.5	58.0	34.5	16.6	6.6	11.3	19.6	101.2	22.7	30.2	55.0	352.2	15.6	7.7	440.7	132.7
STARD13	"ARHGAP37, DLC2, GT650, LINC00464"	ENSG00000133121	"StAR related lipid transfer domain containing 13"	Q9Y3M8	13	33103137-33350630	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Astrocytes: 212.5;Excitatory neurons: 120.7;Inhibitory neurons: 135.6;Microglial cells: 167.7;Oligodendrocyte precursor cells: 212.6;Oligodendrocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 50.2;TIME: 36.0;WM-115: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039535, HPA058867"	Supported					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039535: AB_10965929, HPA058867: AB_2683839"	"unprognostic (7.42e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.29e-2)"	16.0	10.9	10.0	5.6	13.2	0.3	11.1	8.7	10.9	16.6	13.4	28.0	4.8	14.8	5.3	7.2	10.4	10.8	12.5	12.6	8.1	8.4	6.1	12.5	2.5	11.1	11.9	7.2	10.8	16.9	4.3	24.6	9.6	9.0	6.8	1.8	6.4	8.1	5.4	5.3	7.0	15.7	8.4	7.4	11.2	2.8	11.7	1.4	20.4	6.3	1.4	14.0	9.6	13.6	11.4	1.6	3.4	2.4	6.8	16.0	0.6	21.2	26.2	17.4	10.8	0.9	4.0	0.1	2.8	10.2	10.7	10.4	1.5	7.5	22.0	10.0	3.6	5.2	3.9	5.2	5.7	0.0	4.6	13.3	4.3	19.7	24.0	9.7	17.1	0.1	0.0	1.7	50.2	3.3	0.0	0.0	2.2	1.2	5.7	0.2	16.6	0.1	10.6	3.2	0.1	5.5	3.2	8.0	2.6	3.0	18.5	4.7	36.0	8.7	9.3	22.0	11.0	2.9	0.0	0.1	7.0	0.1	40.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.0	13.2	8.7	10.9	12.6	8.1	11.1	11.9	9.6	8.4	11.7	13.6	30.5	28.9	15.1	212.5	0.1	2.4	2.8	1.1	4.0	5.3	8.6	5.1	19.8	7.2	2.0	9.2	0.0	9.4	4.2	11.8	0.0	7.7	1.2	5.5	26.6	18.4	6.7	0.0	120.7	2.2	3.7	18.8	10.7	6.4	5.1	6.2	17.9	10.7	16.7	5.0	135.6	4.4	0.0	8.8	6.8	1.4	7.2	10.8	14.2	167.7	0.8	1.1	0.0	212.6	470.9	5.5	4.3	7.5	4.7	4.4	3.4	2.1	6.3	0.4	13.1	15.6	33.1	0.1	0.3	1.0	2.3	7.5	0.6	31.1	5.4	1.5
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637090-39664201	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 260.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	24.8	33.4	18.3	18.8	29.1	25.4	23.4	21.6	18.9	22.3	14.9	21.5	24.1	20.4	2.7	24.1	21.5	17.2	16.3	17.9	15.4	18.9	25.8	28.8	22.3	21.1	21.3	21.3	26.5	15.2	24.0	17.1	19.0	20.1	5.2	3.2	21.2	11.3	23.9	27.0	26.7	9.2	18.7	33.1	26.5	26.2	22.5	14.8	21.4	9.5	8.8	21.0	20.1	18.5	29.3	47.6	18.6	33.5	19.9	22.9	31.2	23.1	24.9	27.1	24.3	24.0	47.6	25.2	47.7	17.8	30.8	55.4	11.3	21.0	6.3	36.2	34.5	15.2	18.8	30.1	25.9	29.6	35.5	24.5	19.0	29.8	12.6	19.0	23.4	36.4	41.0	27.4	23.5	24.7	32.2	25.6	22.2	15.3	20.6	28.5	31.4	40.1	15.0	35.7	24.9	29.1	16.1	260.8	64.0	10.8	34.1	41.7	26.3	43.2	29.5	46.5	43.6	27.5	37.8	18.7	36.2	36.8	45.1	23.7	36.3	54.4	42.7	35.5	30.7	20.8	29.6	32.7	38.3	26.1	29.1	27.8	63.6	39.6	29.3	18.7	38.5	33.8	18.3	29.1	21.6	18.9	17.9	15.4	21.1	21.3	19.0	18.7	22.5	18.5	45.8	3.2	7.5	31.0	23.2	16.6	13.0	23.4	14.2	12.6	19.9	14.6	3.4	18.6	14.8	11.0	37.5	28.5	32.9	21.0	9.8	26.5	2.7	9.7	11.7	35.8	27.5	11.1	17.3	35.4	37.2	16.2	29.6	11.0	19.0	22.2	45.0	11.9	49.8	18.5	14.8	11.6	14.2	49.0	18.5	5.3	17.1	27.7	5.4	9.4	18.5	15.8	29.9	12.1	30.2	35.9	22.9	13.2	24.3	20.2	41.5	10.3	8.3	13.2	13.1	21.8	14.4	9.3	16.2	15.9	16.9	40.0	35.2	18.6	15.1	20.1
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178245-38230670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	26.8	21.8	35.5	23.1	37.6	37.8	22.0	39.6	41.7	31.4	29.8	21.5	18.5	32.6	27.1	12.3	27.5	22.0	27.1	35.7	44.1	34.0	17.4	32.8	21.3	42.0	46.8	24.2	16.4	17.9	25.5	49.4	48.4	40.6	23.5	26.3	14.9	21.6	17.3	6.6	20.3	33.1	40.5	27.1	17.6	32.7	41.8	22.3	32.7	17.5	15.3	29.4	14.8	42.9	40.9	42.7	92.6	60.4	62.8	62.2	32.4	65.2	67.2	63.2	82.4	34.3	63.0	31.9	64.0	59.9	192.0	42.9	51.4	49.5	95.2	29.0	45.1	64.8	22.1	47.4	55.3	71.5	72.7	58.8	24.0	67.0	53.0	72.0	116.7	86.1	75.0	53.7	98.4	25.1	40.9	115.2	65.5	33.7	33.9	49.6	85.9	14.9	89.0	37.5	36.9	86.7	22.4	58.8	64.1	127.0	40.9	93.8	80.0	43.0	61.0	67.8	93.5	57.4	62.2	12.1	87.0	125.6	142.4	33.5	46.8	56.2	52.2	43.3	23.9	30.8	21.6	39.3	42.3	28.4	18.1	35.6	53.1	71.8	47.0	30.3	24.8	47.1	35.5	37.6	39.6	41.7	35.7	44.1	42.0	46.8	48.4	40.5	41.8	42.9	45.8	19.2	47.3	15.0	33.2	20.8	57.3	43.4	20.5	8.7	26.8	15.0	18.2	14.3	25.9	31.3	12.5	48.3	67.2	15.5	31.3	31.4	125.3	37.0	42.5	45.5	21.5	28.2	21.9	34.3	91.2	34.2	19.9	33.1	23.5	36.0	51.0	12.4	65.8	5.0	24.5	20.9	32.6	63.2	77.9	115.2	18.3	56.8	26.6	17.8	24.2	34.6	114.4	27.6	26.0	34.0	21.6	25.9	34.3	55.2	19.4	50.1	22.8	13.0	13.1	23.4	38.4	48.8	37.3	12.2	16.2	42.3	47.5	24.5	19.5	46.4
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"		"HPA046177: AB_2679570, HPA048081: AB_2680253"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (2.84e-4)"	6.2	15.8	8.3	15.9	15.8	19.4	3.9	25.2	12.6	10.2	11.5	14.7	40.8	7.7	16.2	8.5	5.0	9.7	15.0	9.5	10.6	8.5	34.1	20.9	12.6	16.0	16.7	6.5	6.1	14.4	8.2	27.3	13.8	20.7	16.9	12.0	6.6	9.9	1.5	2.5	35.7	6.9	10.1	12.1	17.9	6.8	14.8	7.2	9.0	1.7	10.1	7.7	9.2	11.3	20.6	10.0	48.2	29.4	42.4	84.0	16.3	21.0	46.6	29.8	89.1	37.7	59.9	24.5	8.4	13.4	89.0	9.1	24.8	71.8	28.8	23.7	10.4	19.1	33.3	22.8	46.4	9.5	11.7	44.6	48.3	64.1	47.6	35.6	56.6	23.5	10.7	46.5	20.8	3.9	23.7	17.3	16.6	0.6	5.5	5.4	53.3	22.5	44.6	6.7	27.2	105.6	0.0	12.3	19.0	32.1	16.0	30.4	84.4	25.6	22.9	17.2	8.9	15.9	15.8	21.6	24.3	34.8	13.2	7.1	1.4	0.9	2.5	2.1	1.3	1.7	1.2	1.9	1.8	1.7	1.2	1.9	0.0	2.1	1.5	1.3	0.8	1.4	8.3	15.8	25.2	12.6	9.5	10.6	16.0	16.7	13.8	10.1	14.8	11.3	8.2	25.6	34.8	16.0	13.1	1.0	1.4	35.0	1.2	10.8	1.6	0.4	17.8	8.6	18.1	9.2	8.4	15.6	24.8	37.3	1.9	7.8	9.4	6.7	3.5	20.2	21.4	3.6	38.8	9.2	6.0	6.0	15.8	11.5	32.3	6.5	5.0	39.9	20.3	6.7	20.8	32.5	22.4	19.6	26.7	8.3	7.2	27.8	3.6	20.6	5.7	7.1	9.2	20.1	23.6	10.0	30.0	7.9	17.6	3.3	30.1	5.7	9.5	7.6	19.7	2.4	15.2	8.7	9.4	6.8	2.6	14.1	14.5	38.2	23.0	5.2
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 28.0;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	1.0	0.6	0.6	6.0	0.8	4.3	0.7	3.4	1.3	7.2	1.9	2.8	2.2	4.6	5.0	3.4	1.8	1.3	0.8	0.6	0.7	0.7	5.1	1.1	7.7	0.9	1.0	1.2	0.6	0.6	0.4	1.6	1.2	3.6	3.7	0.4	1.6	2.1	0.6	7.9	4.2	1.8	0.9	6.2	2.1	0.7	0.7	0.5	0.8	0.3	1.5	2.5	5.5	1.4	0.3	0.0	0.0	0.9	2.3	2.3	0.1	0.3	0.3	0.8	1.2	0.1	0.1	4.8	0.0	1.5	0.2	4.0	1.1	1.0	0.6	0.1	0.4	1.8	0.3	0.4	0.5	2.8	5.8	2.0	2.0	0.3	0.6	1.5	0.1	1.9	0.6	1.3	0.5	0.1	0.5	4.0	0.3	0.2	0.0	0.1	0.7	6.2	0.3	1.4	0.3	0.1	0.1	0.5	0.6	0.3	0.6	0.6	0.2	1.3	0.6	1.3	0.1	7.1	1.5	1.8	0.9	6.8	0.4	5.0	1.8	2.3	3.0	2.4	2.5	1.0	2.7	3.2	2.6	0.7	3.9	3.9	1.3	2.6	2.3	1.4	3.6	3.7	0.6	0.8	3.4	1.3	0.6	0.7	0.9	1.0	1.2	0.9	0.7	1.4	3.8	0.0	1.1	0.0	11.4	13.3	12.0	28.0	10.8	1.8	2.7	4.2	0.3	0.0	4.9	0.0	6.2	2.5	4.2	22.1	3.9	1.3	15.2	2.5	14.4	2.5	11.4	2.5	2.2	1.4	4.0	8.5	15.8	2.3	10.2	1.0	3.6	25.4	5.2	1.7	2.0	24.3	2.0	7.9	10.9	1.5	5.0	8.0	1.8	1.9	0.7	1.2	2.1	0.0	0.4	1.8	14.4	9.8	31.5	3.3	23.9	0.7	4.0	0.9	0.0	3.8	2.8	0.9	0.7	19.6	16.3	4.9	4.2	6.3	19.9	9.6
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STARD8	"ARHGAP38, KIAA0189"	ENSG00000130052	"StAR related lipid transfer domain containing 8"	Q92502	X	68647666-68725842	"Metabolic proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 27.9;Endothelial cells: 26.5;Hepatic stellate cells: 18.5;Kupffer cells: 13.7;Langerhans cells: 14.9;Macrophages: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"classical monocyte: 1.6;intermediate monocyte: 3.2;myeloid DC: 3.4;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.4;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"HEL: 16.0;K-562: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060788	Uncertain					NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA060788: AB_2684365"	"unprognostic (2.00e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (5.19e-3)"	"unprognostic (4.89e-3)"	"unprognostic (9.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-2)"	13.4	4.4	8.1	6.0	6.9	3.4	10.3	6.4	6.8	6.3	5.7	4.0	1.4	7.1	4.7	3.4	8.9	5.2	12.5	6.3	6.3	14.7	6.5	20.7	4.1	13.5	7.5	3.3	5.1	2.6	8.9	8.8	8.1	9.2	1.5	0.6	2.7	8.5	6.8	2.8	4.3	6.1	8.2	11.1	4.2	0.8	8.4	1.6	10.3	6.5	1.9	6.6	4.5	6.6	0.0	1.8	2.8	1.4	0.0	0.0	2.1	3.8	7.9	2.1	1.6	0.0	0.4	0.0	9.6	1.6	0.2	0.0	0.8	0.0	3.5	0.0	0.5	16.0	1.4	0.2	0.3	0.0	0.0	1.3	0.0	5.4	0.0	6.1	9.9	0.0	20.4	0.0	5.3	0.8	0.0	9.5	1.6	0.0	0.3	0.0	10.1	5.4	9.5	0.0	0.0	0.7	0.1	0.9	0.3	5.6	1.3	2.2	7.0	9.6	4.0	3.1	3.7	0.0	0.0	0.0	7.2	6.6	5.7	0.0	1.6	0.0	0.0	3.2	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	4.7	0.1	0.0	1.8	8.1	6.9	6.4	6.8	6.3	6.3	13.5	7.5	8.1	8.2	8.4	6.6	27.9	0.0	6.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.2	0.3	8.5	0.0	1.8	0.0	0.0	0.3	0.1	0.0	1.9	0.0	0.1	1.2	1.6	26.5	0.0	2.1	0.3	0.0	0.2	3.0	0.5	1.1	7.0	0.3	18.5	6.5	3.6	0.0	0.8	0.0	0.0	13.7	14.9	0.0	0.3	13.9	0.0	9.4	2.4	0.3	0.0	0.5	0.5	0.8	0.0	0.0	0.9	0.1	0.0	2.4	2.2	0.4	0.0	2.8	3.5	0.1	0.2	0.2	1.4	0.1	0.6	0.2	0.0	0.1
STARD9	"KIAA1300, KIF16A"	ENSG00000159433	"StAR related lipid transfer domain containing 9"	Q9P2P6	15	42575606-42720998	"Metabolic proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Early spermatids: 52.8;Excitatory neurons: 39.3;Oligodendrocytes: 80.9;Rod photoreceptor cells: 57.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA014562	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA014562: AB_10603033"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.54e-5)"	"unprognostic (7.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.83e-3)"	6.2	0.5	1.5	1.2	5.2	0.6	4.3	3.1	3.3	5.9	2.4	9.1	1.3	5.3	3.0	2.2	3.3	2.4	3.3	1.3	1.6	0.8	0.4	4.5	1.2	4.7	2.5	6.0	0.4	0.4	0.8	3.9	2.8	2.6	2.8	12.9	1.5	3.2	2.5	2.6	3.2	4.8	1.0	2.0	3.2	8.5	4.4	3.5	1.7	3.5	1.1	4.4	5.0	9.9	0.9	0.5	5.9	2.3	3.1	4.5	0.3	1.0	1.3	1.8	2.7	0.0	0.0	0.7	0.1	1.1	1.2	0.1	2.0	0.9	2.4	3.5	1.7	0.3	4.3	1.3	1.3	0.9	1.1	2.6	0.4	1.5	1.0	1.5	1.8	2.5	1.6	3.8	1.5	0.0	0.7	0.7	0.9	0.0	1.1	5.1	3.2	1.1	0.7	0.0	1.2	2.9	1.3	0.0	0.4	0.7	0.1	0.4	3.6	2.5	1.9	0.9	2.4	3.8	2.2	1.3	1.0	2.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.2	3.1	3.3	1.3	1.6	4.7	2.5	2.8	1.0	4.4	9.9	26.1	12.8	2.8	7.2	2.9	3.6	1.2	0.8	1.2	8.1	0.6	1.0	6.8	0.0	0.7	1.8	52.1	0.2	4.2	0.3	0.0	0.3	52.8	3.5	12.2	19.8	8.4	3.2	39.3	0.0	0.3	15.2	2.6	0.6	2.5	3.6	9.7	0.5	2.8	11.8	33.5	2.8	0.0	2.4	7.7	15.4	24.5	2.3	8.8	24.4	2.4	2.9	11.3	20.1	80.9	0.2	0.0	22.2	2.7	0.9	0.1	0.3	9.1	57.7	19.7	11.8	13.7	3.9	8.0	0.3	3.1	0.3	6.3	7.8	0.4	0.7
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190908460-191020960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		92000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	41.2	35.6	8.0	113.3	7.7	35.1	27.1	5.1	10.2	33.9	5.6	43.4	51.3	27.5	15.1	35.8	25.1	66.6	35.6	11.1	14.7	45.3	66.0	69.1	145.6	18.8	9.4	33.0	40.7	39.0	23.8	28.9	13.4	34.8	40.6	20.0	107.4	24.2	29.8	24.9	41.8	47.5	27.3	114.5	55.7	31.2	17.4	104.3	33.4	29.7	59.0	62.2	25.1	13.2	54.8	58.6	26.8	41.4	105.7	158.8	79.3	82.4	257.1	533.6	595.5	95.1	62.8	21.7	48.1	180.8	173.9	45.9	29.8	62.0	108.6	179.6	24.6	99.0	43.8	47.3	72.2	48.4	58.3	94.7	36.8	100.4	31.0	56.5	63.5	38.4	56.8	103.9	93.6	42.5	38.0	41.1	36.6	34.2	95.3	31.4	71.4	27.9	58.9	70.1	37.9	35.0	100.3	35.7	236.5	37.5	38.6	59.9	56.2	105.1	57.5	90.0	51.4	202.1	330.7	21.0	80.8	40.3	47.8	50.0	143.9	104.9	51.6	191.1	71.4	38.3	129.3	77.4	61.4	31.7	128.2	94.2	203.9	77.3	117.3	28.9	227.8	210.2	8.0	7.7	5.1	10.2	11.1	14.7	18.8	9.4	13.4	27.3	17.4	13.2	46.8	73.7	34.3	14.0	48.8	22.2	17.5	32.3	22.2	13.3	27.6	26.0	44.6	51.5	40.3	53.3	25.0	13.6	48.0	44.4	7.9	47.5	18.5	30.9	43.9	42.1	21.0	15.5	9.0	37.8	53.9	44.1	51.5	39.3	51.4	38.5	28.5	54.1	92.6	3.3	12.2	26.7	16.2	72.0	26.2	5.2	21.8	96.9	17.8	31.9	107.3	13.7	62.8	25.1	11.9	36.0	21.7	29.7	69.4	26.7	24.7	44.0	47.7	19.3	39.5	35.4	31.1	25.4	24.6	28.8	31.3	8.3	78.1	37.9	29.2	26.9
STAT2	STAT113	ENSG00000170581	"Signal transducer and activator of transcription 2"	P52630	12	56341597-56360167	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003858, HPA018888"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"CAB003858: AB_562227, HPA018888: AB_1857550"	"unprognostic (3.03e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.78e-13)"	"unprognostic (1.88e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.46e-3)"	17.3	6.3	2.6	19.2	2.3	7.8	10.3	2.7	3.1	18.7	2.9	10.7	10.7	11.3	5.6	11.1	12.9	20.1	8.1	3.1	2.3	8.4	20.6	22.8	19.6	4.2	2.0	17.4	9.9	12.4	8.6	15.9	3.1	10.3	12.5	5.6	18.1	9.9	4.0	7.8	13.0	21.8	5.9	25.2	10.3	4.0	4.6	19.9	10.7	8.4	20.1	18.4	5.6	6.2	15.5	8.5	11.8	12.5	98.3	58.6	26.1	19.4	94.0	92.4	93.1	8.7	16.4	17.9	22.6	38.6	24.2	14.9	21.0	15.1	18.0	13.8	4.7	27.2	7.6	9.3	58.8	5.0	20.2	86.8	13.4	19.5	22.8	70.5	25.6	14.3	15.2	44.7	35.1	9.4	7.3	3.5	5.2	15.1	9.8	6.9	22.1	17.1	21.3	18.1	4.2	10.1	31.5	18.8	43.1	22.7	16.4	17.7	11.2	22.2	10.7	8.0	3.1	32.5	32.9	9.8	30.3	7.2	9.9	14.8	17.2	11.3	7.7	22.8	7.9	5.2	7.4	7.7	11.6	7.5	5.2	5.1	6.8	4.8	18.3	10.2	9.8	13.1	2.6	2.3	2.7	3.1	3.1	2.3	4.2	2.0	3.1	5.9	4.6	6.2	36.0	12.8	41.7	40.5	24.0	14.3	10.3	13.7	17.1	17.0	17.4	15.0	11.1	15.7	24.4	18.4	20.9	11.2	28.1	23.8	1.9	14.0	13.8	20.7	36.4	26.5	15.5	8.6	29.8	10.7	24.5	27.6	19.9	26.6	10.1	24.6	27.8	64.8	25.9	3.3	28.6	16.8	6.1	50.9	25.6	43.7	19.6	45.2	32.0	24.4	42.3	10.4	18.6	27.6	111.8	11.9	21.9	17.3	24.4	11.4	24.0	10.7	24.2	21.8	26.3	20.3	22.5	3.2	5.0	12.5	14.5	11.1	20.1	13.7	14.8	13.2
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388540	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	105.6	68.1	32.4	78.5	34.5	63.2	84.4	38.7	30.2	62.6	32.4	76.9	45.9	71.6	28.2	81.6	74.0	71.7	101.2	28.6	44.6	77.2	143.1	106.0	55.3	48.4	40.7	65.4	67.3	35.3	53.3	55.6	43.4	62.9	46.5	29.9	63.5	48.2	123.9	66.8	68.1	72.1	43.9	68.0	62.3	24.6	43.0	50.5	61.9	92.1	65.2	88.6	64.3	43.1	61.5	116.0	47.4	48.2	103.7	97.6	35.4	66.5	89.7	59.6	58.3	30.3	55.8	18.5	68.2	71.2	90.3	89.2	45.8	72.6	47.7	160.6	31.4	131.2	60.4	62.4	77.3	31.8	79.0	152.1	69.8	47.4	68.9	62.2	81.1	33.4	80.1	56.4	40.1	43.8	118.7	31.3	28.5	63.4	0.0	26.6	133.8	28.1	91.3	77.2	45.2	29.8	81.4	184.9	29.2	57.2	100.5	49.1	68.7	88.9	44.9	54.8	56.5	82.9	75.3	16.4	56.1	32.8	41.6	121.1	78.4	100.0	79.5	79.9	64.4	40.2	57.5	62.6	54.3	36.6	58.7	56.5	262.6	58.3	80.8	29.3	47.9	124.5	32.4	34.5	38.7	30.2	28.6	44.6	48.4	40.7	43.4	43.9	43.0	43.1	216.0	93.0	173.7	46.0	111.6	129.5	105.3	76.8	138.3	92.6	147.1	113.0	59.7	54.3	103.2	134.3	281.5	25.2	115.1	148.9	17.6	83.2	33.5	129.3	187.0	164.7	124.0	54.3	24.2	96.8	38.2	154.0	109.1	153.9	142.0	86.3	115.3	115.7	69.1	25.2	35.8	97.8	69.2	71.0	121.7	13.7	71.7	111.7	72.9	51.5	94.1	131.3	78.2	30.7	41.7	82.9	94.5	60.9	104.6	147.9	206.4	46.3	88.5	406.7	65.7	189.5	169.7	31.5	15.3	93.4	160.1	31.2	170.2	102.3	117.5	90.6
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;testis: 29.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 139.0;Early spermatids: 275.1;Excitatory neurons: 85.9;Late spermatids: 66.0;NK-cells: 108.1;Plasma cells: 83.8;T-cells: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 76.6;T-cells: 121.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 58.8;U-266/70: 32.9;U-266/84: 12.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001860, CAB013108"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	4.7	4.0	3.4	11.5	4.4	15.7	3.0	0.1	10.4	1.6	0.1	2.8	4.5	1.9	2.6	1.4	1.6	5.1	23.0	3.8	3.6	4.5	9.5	7.8	18.0	2.1	1.7	1.5	2.2	1.2	15.0	2.6	2.0	1.8	3.4	2.1	2.2	1.3	1.2	1.1	6.9	1.4	0.6	15.5	4.4	29.2	3.4	9.0	2.4	1.0	10.4	5.9	1.8	4.5	0.1	1.7	1.1	0.0	0.0	3.6	0.3	0.6	2.2	0.6	2.2	0.4	0.8	0.0	0.2	2.8	1.6	0.9	0.0	4.7	1.2	0.0	0.8	1.3	0.0	0.0	0.6	0.0	0.1	1.5	2.3	1.1	0.5	0.1	0.0	6.0	0.0	58.8	0.2	0.0	3.5	0.0	0.3	0.0	0.9	0.0	0.0	4.3	0.2	0.1	0.1	1.2	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.1	1.6	0.0	32.9	12.8	0.0	1.2	0.0	0.1	15.7	0.4	0.1	121.2	0.8	107.3	1.8	71.6	101.2	0.6	1.0	68.1	95.8	2.8	76.6	0.8	9.3	28.1	55.3	3.4	4.4	0.1	10.4	3.8	3.6	2.1	1.7	2.0	0.6	3.4	4.5	2.9	3.2	4.2	2.6	14.5	1.3	0.6	2.9	0.0	0.9	0.9	1.1	20.3	4.3	0.6	1.8	8.4	0.4	139.0	0.5	0.0	0.6	275.1	1.1	0.5	1.2	0.0	10.5	85.9	0.2	2.9	2.9	8.6	0.7	1.3	0.8	1.1	1.1	1.1	0.0	59.4	0.3	0.0	6.3	10.6	66.0	0.3	14.4	5.4	7.5	6.3	0.0	108.1	6.0	2.4	0.1	0.3	0.4	83.8	1.0	0.0	0.8	2.4	0.2	0.0	0.6	3.7	8.3	1.2	0.4	1.7	0.5	137.4	0.1	0.3	0.7
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 78.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	78.9	40.6	4.3	28.9	5.7	52.1	48.8	5.3	4.8	19.1	5.4	24.0	8.6	17.8	5.7	9.9	19.0	13.9	13.9	3.6	7.5	13.9	8.1	23.3	37.5	8.0	7.6	22.5	12.2	2.4	10.5	7.3	7.4	15.4	9.1	1.2	15.7	13.7	23.8	18.4	22.4	14.3	6.7	29.8	14.0	4.9	7.7	24.4	13.3	13.8	27.1	24.1	15.4	8.6	3.9	4.9	0.5	0.0	35.7	17.5	0.4	2.1	8.6	4.0	2.3	0.0	3.7	0.3	9.0	8.5	0.2	0.3	0.8	0.3	1.1	101.0	0.0	153.5	9.3	1.3	15.5	13.5	85.2	36.8	2.1	1.7	2.0	0.0	12.3	2.0	262.4	0.1	2.3	0.1	163.5	64.7	1.4	2.5	0.0	4.5	1.1	13.8	1.1	2.6	0.3	0.0	10.0	3.9	17.8	0.9	2.5	13.9	7.2	8.0	2.6	3.9	0.1	0.2	0.1	0.0	1.0	25.4	2.5	9.8	15.1	7.9	10.3	18.6	14.4	8.2	18.3	15.2	18.7	6.6	18.0	15.0	18.3	17.4	24.9	6.6	14.5	12.9	4.3	5.7	5.3	4.8	3.6	7.5	8.0	7.6	7.4	6.7	7.7	8.6	14.0	0.0	10.6	2.6	18.7	7.4	3.8	4.5	5.7	2.9	35.8	24.5	29.6	5.7	3.4	5.5	0.0	1.2	17.7	5.5	5.9	5.0	0.4	7.2	5.2	21.2	0.0	33.2	0.2	13.6	2.9	15.3	5.1	11.9	22.8	6.8	6.1	3.3	21.4	0.0	1.3	4.2	0.0	24.5	41.3	3.5	32.6	31.8	8.8	5.6	41.0	3.9	8.2	2.5	5.0	9.6	8.1	41.0	12.5	12.2	1.8	14.4	8.4	0.7	6.6	13.7	10.2	0.0	0.9	4.4	7.7	1.4	29.2	7.7	6.5	7.0
STAT5B		ENSG00000173757	"Signal transducer and activator of transcription 5B"	P51692	17	42199177-42276707	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 100.5;Late spermatids: 188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004298, CAB005418, HPA042128, HPA049883, HPA051156"	Approved		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.06e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.68e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.98e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (9.19e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.13e-1)"	45.9	45.7	26.4	35.1	26.5	42.4	36.7	33.4	29.0	43.6	24.6	45.3	14.8	59.1	19.3	19.2	50.8	23.6	24.5	23.5	42.9	24.3	24.4	32.5	43.6	32.8	33.9	55.9	22.8	21.1	40.8	31.5	32.9	29.2	17.0	18.7	22.8	34.2	73.3	25.3	30.7	42.7	27.4	42.3	27.6	23.5	49.9	37.6	22.7	46.5	34.7	43.4	31.5	26.1	15.0	22.9	33.3	9.0	40.6	20.4	15.9	15.0	26.5	21.0	18.2	10.1	12.3	48.1	21.8	17.2	41.3	18.7	19.9	13.0	16.6	121.8	23.0	47.1	44.5	15.6	22.3	20.9	72.7	25.1	19.6	15.9	19.9	18.0	33.6	31.9	86.5	10.1	8.8	14.6	99.2	54.9	8.3	34.3	0.2	42.0	20.9	16.8	13.3	23.5	24.5	14.4	27.3	34.4	21.2	7.4	24.3	24.3	26.0	29.2	10.2	15.2	21.2	19.8	9.8	23.9	11.6	21.7	15.5	11.5	3.3	5.9	6.6	3.0	7.1	2.9	9.3	7.6	2.9	2.9	6.5	5.5	22.5	4.2	3.7	2.1	8.4	4.7	26.4	26.5	33.4	29.0	23.5	42.9	32.8	33.9	32.9	27.4	49.9	26.1	30.2	6.4	19.5	41.8	12.9	8.9	5.7	4.5	2.8	21.2	25.1	22.7	20.7	5.7	7.8	3.7	20.9	8.0	31.2	8.4	5.9	8.2	100.5	10.1	22.4	26.0	10.2	12.4	23.7	11.8	6.1	18.8	13.3	15.0	16.4	16.1	20.0	11.2	9.4	10.1	61.2	6.1	8.2	13.3	17.1	188.5	47.2	16.9	10.6	51.5	23.7	9.5	26.8	69.4	60.8	12.2	6.2	74.4	13.6	11.9	7.9	9.8	6.3	13.3	39.5	20.0	23.0	4.3	7.3	5.9	9.8	12.7	34.4	15.5	7.5	7.7
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (7.76e-4)"	"prognostic favorable (1.14e-4)"	76.0	84.0	22.5	68.1	24.2	40.1	67.6	19.0	25.4	85.4	29.7	91.3	79.0	81.9	49.0	93.3	82.4	66.2	50.2	22.3	21.3	68.8	75.2	83.4	78.3	22.6	20.6	93.3	48.8	52.9	18.9	45.0	22.2	81.5	71.1	3.5	70.1	68.6	14.3	108.2	99.0	80.5	21.4	111.3	78.5	15.0	24.4	81.7	57.5	20.5	91.9	96.8	81.7	22.8	60.2	55.2	13.8	24.3	153.2	138.4	39.7	53.5	103.3	49.5	37.7	26.8	78.8	145.8	78.1	106.4	0.2	82.0	18.7	89.2	38.1	70.5	4.4	32.0	57.5	32.8	93.0	39.0	97.5	213.5	75.1	67.3	55.9	145.4	91.8	45.7	23.3	19.2	69.5	21.3	44.9	41.5	20.3	81.1	12.6	50.4	1.3	49.6	95.6	92.9	0.3	1.2	46.7	35.3	45.6	19.1	53.4	90.8	68.2	0.6	30.7	51.9	0.4	0.1	1.0	35.4	48.6	39.2	67.3	12.6	19.6	11.1	6.9	19.1	6.9	8.0	6.3	6.2	14.1	6.4	5.4	5.7	34.4	6.0	15.0	6.3	6.7	26.8	22.5	24.2	19.0	25.4	22.3	21.3	22.6	20.6	22.2	21.4	24.4	22.8	27.6	48.1	60.8	5.5	45.1	29.8	44.3	33.4	31.3	1.8	23.8	21.2	15.1	27.1	43.3	49.7	0.0	2.0	38.4	80.4	15.6	38.2	8.0	35.8	33.1	32.0	33.0	26.3	13.1	36.1	10.2	36.9	80.0	51.9	58.2	27.6	38.9	41.0	36.4	0.0	1.3	40.3	24.4	73.2	51.7	17.9	59.4	54.5	21.4	26.2	66.9	3.4	42.2	0.5	1.1	45.1	63.4	50.8	10.6	49.2	80.0	27.9	53.1	1.0	26.3	20.9	31.7	1.0	1.4	37.1	32.8	6.3	31.2	29.2	42.9	62.0
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995966-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	925	"salivary gland: 9143.2"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 9.8;Early spermatids: 2.8"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	9.8	0.0	5.6	0.8	0.0	0.1	0.0	0.0	9143.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892, HPA072004"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB020839: , HPA049892: AB_2680938, HPA072004: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	46.4	40.4	33.6	34.1	36.5	66.0	40.5	35.5	41.5	41.5	33.7	45.2	54.9	42.3	36.8	47.2	66.3	48.7	49.6	33.5	35.2	88.4	122.8	41.8	36.8	39.3	39.1	36.3	69.7	81.4	15.0	49.9	39.4	46.3	47.1	36.4	39.2	46.1	62.5	41.6	50.9	52.1	37.2	33.3	52.8	35.9	36.5	42.8	69.6	47.1	40.9	51.9	31.1	42.5	113.9	85.1	90.7	40.2	90.1	111.3	100.7	84.4	100.8	246.8	111.2	292.0	121.8	77.1	141.7	106.2	118.3	121.5	122.4	150.8	205.9	30.2	70.5	63.3	62.1	233.0	76.1	51.7	59.9	89.6	126.9	100.5	117.0	100.9	123.0	57.4	112.3	46.7	94.6	72.3	90.7	83.5	74.5	109.1	117.9	69.1	119.4	75.0	100.1	98.2	104.8	93.1	209.9	199.0	124.8	91.6	127.4	72.9	113.0	148.2	128.1	92.6	101.6	41.8	52.3	86.8	108.5	54.6	87.4	31.5	19.3	19.8	17.8	15.8	19.7	16.8	18.9	19.1	16.9	15.4	17.1	16.7	38.0	14.2	20.2	15.9	22.9	13.6	33.6	36.5	35.5	41.5	33.5	35.2	39.3	39.1	39.4	37.2	36.5	42.5	76.5	89.8	82.0	45.7	66.4	112.5	125.5	79.9	95.0	32.9	87.5	65.0	63.1	97.2	71.3	77.3	14.6	105.4	72.2	98.4	93.9	130.6	18.6	146.1	80.1	83.0	76.0	137.4	47.9	118.2	45.0	84.8	71.4	87.3	48.1	79.2	72.8	158.3	64.7	43.7	42.2	77.5	59.0	62.9	91.3	21.9	65.6	66.8	49.8	26.2	85.9	57.0	61.8	39.2	51.2	138.5	89.9	70.0	86.8	189.7	107.8	170.0	105.9	29.1	59.2	72.6	74.2	109.1	69.8	92.1	119.8	194.4	78.5	64.6	69.3	196.5
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 278.9;Inhibitory neurons: 298.3;Oligodendrocyte precursor cells: 157.8;Oligodendrocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 152.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	20.2	22.7	24.8	15.8	30.5	24.6	17.8	35.0	39.6	15.3	5.5	17.6	14.9	18.2	19.0	35.1	16.6	24.2	70.6	34.8	22.8	29.5	25.7	17.3	19.3	25.3	25.6	18.2	16.1	29.6	12.5	17.6	25.0	20.9	18.6	34.6	20.5	20.8	110.6	15.0	20.8	23.4	16.2	16.7	16.3	16.8	20.7	35.0	22.9	110.0	22.0	20.8	14.2	35.3	34.7	40.7	63.5	34.5	35.5	25.2	19.3	30.4	27.5	27.1	35.4	15.6	36.0	55.1	31.5	23.9	24.3	27.2	44.5	29.2	39.1	56.1	21.2	74.7	19.4	25.5	18.6	28.4	25.8	18.1	21.6	23.2	15.1	55.8	54.8	48.2	50.5	24.2	36.8	22.6	152.7	22.5	31.4	57.5	26.8	44.9	29.6	46.3	57.6	38.1	24.0	40.2	16.4	43.1	27.4	46.8	51.2	33.3	43.4	26.3	46.0	26.2	22.7	39.4	41.7	51.8	29.3	42.3	22.1	24.4	18.0	42.8	28.6	17.9	21.5	15.7	19.0	24.3	18.4	17.9	16.6	21.7	30.8	44.4	22.8	25.1	26.0	12.8	24.8	30.5	35.0	39.6	34.8	22.8	25.3	25.6	25.0	16.2	20.7	35.3	20.4	9.6	31.1	120.8	22.5	10.6	15.4	16.7	8.6	29.1	24.6	11.8	75.7	21.5	40.7	20.2	41.7	18.4	27.1	22.5	43.0	22.7	22.0	18.6	11.6	26.2	29.9	14.7	278.9	21.7	10.0	20.2	21.4	25.5	20.3	21.8	38.2	58.0	16.1	28.6	298.3	17.6	18.3	24.1	16.8	32.2	9.0	22.5	16.0	129.3	16.9	26.9	43.3	157.8	149.9	17.6	16.5	9.4	20.2	10.9	102.1	37.6	27.6	22.2	0.0	15.8	21.8	12.5	13.8	22.1	19.2	12.2	21.6	20.5	16.1	18.5
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306733-76311130	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.3;skeletal muscle: 248.5;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 140.7;U-266/70: 62.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	109.7	5.3	4.3	7.3	4.0	19.9	11.8	3.5	6.3	7.0	2.9	29.0	9.6	9.3	3.2	15.1	13.7	12.8	52.7	4.0	7.0	10.0	130.3	14.1	1.3	6.7	5.4	10.0	12.0	7.9	1.7	16.8	6.2	20.7	26.4	4.0	4.7	13.9	248.5	1.5	26.1	28.0	5.6	2.2	15.5	9.7	5.6	1.3	2.6	154.7	2.1	22.1	4.5	5.6	15.9	9.9	2.0	10.0	46.3	13.9	12.7	21.9	21.6	12.0	12.6	12.6	17.9	0.0	13.1	25.8	26.2	9.2	9.6	6.1	7.4	52.4	3.6	1.7	18.2	16.5	4.8	9.5	10.5	7.1	24.0	10.2	8.2	32.4	0.9	0.0	0.6	140.7	23.7	13.0	0.6	7.4	2.5	24.1	7.2	0.0	3.8	9.9	8.0	17.2	2.6	17.7	12.9	20.2	0.3	5.0	4.9	3.7	3.9	11.6	5.9	29.4	12.5	62.8	17.1	0.0	19.6	7.5	5.4	0.1	2.6	5.7	2.0	3.1	1.1	0.1	2.4	2.4	2.5	0.0	0.5	0.9	0.3	4.4	1.2	0.3	0.8	1.3	4.3	4.0	3.5	6.3	4.0	7.0	6.7	5.4	6.2	5.6	5.6	5.6	0.0	0.0	0.5	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.2	9.1	0.0	7.9	0.0	2.8	1.5	0.1	0.0	0.4	0.0	3.9	1.4	1.0	2.6	5.1	0.0	0.3	0.0	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	3.3	2.9	0.0	7.0	0.5	19.5	0.3	6.6	0.0	0.0	1.1	3.0	0.2	0.0	1.1	0.0	0.8	0.3	0.3	1.4	0.9
STC1	STC	ENSG00000159167	"Stanniocalcin 1"	P52823	8	23841929-23854806	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 64.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 162.2;Collecting duct cells: 97.5;Endometrial ciliated cells: 84.0;Endothelial cells: 242.0;Glandular and luminal cells: 301.5;Theca cells: 214.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 348.4;hTEC/SVTERT24-B: 201.7;U-251 MG: 145.4;U-87 MG: 623.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB018625, HPA023918"	Approved				"Secreted in other tissues"	NA	NA		240000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"			"CAB018625: AB_2197536, HPA023918: AB_1857566"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.44e-5)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.23e-6)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.95e-3)"	44.7	3.1	2.1	2.6	1.4	0.1	26.2	2.0	5.8	49.4	13.8	7.4	1.7	32.4	0.6	7.0	5.9	14.8	25.7	4.1	3.9	17.9	4.0	10.5	0.7	4.5	4.3	2.8	13.7	10.5	28.9	29.1	4.5	9.3	1.9	8.3	10.3	7.3	2.6	3.0	2.9	7.5	3.4	0.2	10.4	0.2	4.7	1.5	64.3	6.4	1.3	44.4	10.2	2.9	1.5	1.3	1.9	0.0	13.0	14.3	0.3	20.6	348.4	6.7	31.5	0.1	0.0	0.1	30.0	6.8	116.6	1.1	0.8	5.1	58.0	2.2	0.4	0.1	0.0	0.0	0.9	0.0	0.5	65.1	0.0	201.7	0.5	96.4	2.8	0.0	0.6	0.5	28.8	0.0	0.0	0.1	8.4	0.0	1.0	0.0	0.3	0.0	11.7	0.0	0.8	0.0	31.4	2.1	2.1	2.3	21.3	0.4	27.0	82.3	3.1	1.6	145.4	0.0	0.1	0.1	623.7	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.4	2.0	5.8	4.1	3.9	4.5	4.3	4.5	3.4	4.7	2.9	162.2	3.2	13.6	0.0	0.2	22.7	2.4	15.7	0.0	3.1	75.3	8.0	3.3	32.9	3.7	97.5	0.0	0.9	0.0	0.8	0.0	37.0	0.1	84.0	42.7	242.0	0.0	0.0	0.2	0.2	6.1	67.9	2.6	301.5	1.3	0.2	23.2	0.0	2.5	8.4	0.3	0.0	0.0	0.3	25.8	0.2	5.0	1.5	17.8	0.0	0.0	0.9	0.0	0.0	0.1	6.7	0.0	0.0	1.2	7.6	0.0	0.1	0.5	2.1	0.0	0.5	7.4	0.0	0.0	0.3	20.6	1.9	2.6	214.5	1.0	9.6
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314723-173328447	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 143.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 278.3;Breast myoepithelial cells: 119.6;Extravillous trophoblasts: 59.5"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 1019.9;T-47d: 940.0;U-138 MG: 382.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA045372	Approved		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		19000000		"Cluster 5: Breast - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	7.4	1.7	0.7	2.4	0.9	0.0	143.6	2.2	3.1	13.2	1.9	4.8	0.6	3.0	0.3	2.0	2.0	6.4	9.9	3.0	1.8	3.6	0.8	11.3	1.1	5.0	6.4	0.7	32.6	3.3	1.7	28.0	3.7	4.8	0.6	7.7	1.0	6.7	4.4	12.8	2.7	21.2	1.3	11.5	3.4	0.7	2.9	0.2	9.1	4.9	0.3	4.7	3.0	3.0	52.5	15.3	2.7	13.0	47.9	20.5	133.8	234.5	239.4	59.1	115.0	74.4	36.7	0.0	33.4	139.8	298.2	21.5	33.8	72.0	102.5	0.1	18.9	0.0	26.7	50.2	311.3	15.8	4.3	43.6	117.9	133.3	7.9	274.4	16.7	42.4	2.4	0.1	1019.9	41.6	0.7	0.7	7.9	23.4	73.2	0.3	36.5	27.4	0.0	3.9	35.6	9.6	10.3	1.1	42.5	10.4	940.0	15.9	151.5	382.8	1.3	229.1	49.2	42.0	24.3	10.5	74.6	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.2	3.1	3.0	1.8	5.0	6.4	3.7	1.3	2.9	3.0	6.9	0.0	0.0	0.0	0.4	5.0	0.2	4.9	0.6	11.1	278.3	119.6	27.1	0.0	0.6	0.0	0.0	37.0	2.4	0.4	0.0	31.6	0.6	9.5	1.0	25.3	7.2	0.0	0.2	13.1	59.5	16.7	0.0	16.1	0.0	0.0	3.6	0.0	5.2	0.0	0.2	0.2	0.0	0.0	4.8	1.0	23.0	0.5	10.6	1.0	0.0	0.9	0.0	0.0	0.1	7.8	0.0	0.4	0.0	0.8	0.0	4.5	0.2	2.4	0.0	2.3	24.6	0.7	0.8	0.5	6.3	21.9	1.0	0.9	0.4	0.5
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154456-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 83.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 140.5;Club cells: 72.6;Prostatic glandular cells: 85.1;Theca cells: 64.4;Urothelial cells: 54.0"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.1;CAPAN-2: 135.2;U-138 MG: 169.2"	"Low region specificity"	"Detected in many"							HPA030985	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	32.9	2.2	1.0	32.9	1.4	0.0	18.5	0.8	2.3	9.6	1.4	18.1	5.2	4.2	0.8	12.6	10.7	16.4	7.2	1.3	1.0	6.6	27.6	14.2	0.3	1.3	0.8	6.0	6.0	0.3	3.7	0.7	1.0	83.8	13.7	0.7	15.1	2.1	1.3	4.6	7.8	26.9	0.8	2.5	13.9	4.2	1.0	0.9	5.0	2.5	4.6	34.5	5.8	1.1	26.9	52.5	3.3	9.8	105.1	89.5	0.9	17.8	20.5	2.4	2.7	38.8	135.2	0.3	0.9	28.9	43.5	5.3	22.0	22.6	5.1	0.0	7.6	0.1	0.5	13.0	4.3	0.0	0.1	59.7	3.7	68.0	37.4	16.6	92.6	7.3	1.2	74.0	29.6	0.4	0.0	0.9	15.7	1.3	23.2	0.1	0.0	0.3	20.8	5.5	0.0	1.2	6.4	0.2	12.1	1.9	29.4	0.4	50.8	169.2	8.0	83.9	22.8	14.0	0.5	0.1	83.4	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.8	2.3	1.3	1.0	1.3	0.8	1.0	0.8	1.0	1.1	1.8	0.0	0.5	2.3	0.3	4.2	41.9	140.5	7.4	0.1	12.8	11.4	0.8	5.7	72.6	1.8	0.0	0.0	0.6	7.0	0.0	3.4	0.4	1.3	4.9	4.5	7.2	0.0	5.3	38.6	0.1	25.2	10.7	4.6	0.0	10.5	1.8	33.1	0.5	0.0	1.7	4.3	24.4	0.8	5.4	1.1	0.9	1.3	7.2	0.0	0.0	10.5	0.0	1.5	1.3	44.4	20.5	1.5	1.3	85.1	2.5	14.7	13.1	0.3	6.6	6.0	26.9	17.1	36.9	12.2	2.3	0.3	0.4	64.4	16.6	54.0
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 127.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Inhibitory neurons: 53.0;Prostatic glandular cells: 102.9"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.5;CAPAN-2: 48.1;U-138 MG: 27.4"	"Low region specificity"	"Detected in all"							"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	20.0	3.7	7.3	11.9	10.4	0.0	13.0	8.3	18.5	9.5	6.9	15.1	6.1	7.1	2.7	6.9	14.3	10.1	15.1	11.2	6.9	6.8	4.0	20.5	0.4	3.1	5.0	17.2	8.1	10.1	19.4	0.2	3.8	127.7	7.6	3.9	11.9	6.9	1.4	4.7	9.1	10.8	5.4	2.7	11.0	1.1	6.4	3.3	7.9	1.6	1.7	15.8	9.0	5.7	3.2	22.5	0.5	6.3	11.5	11.1	0.3	2.8	5.8	0.4	0.8	4.2	48.1	0.0	0.3	7.5	8.8	1.8	4.9	3.5	0.8	0.0	4.7	0.0	0.1	1.1	1.0	0.0	0.1	8.1	0.8	11.5	2.3	9.4	6.1	0.0	0.0	0.4	6.6	0.0	0.0	0.7	9.1	0.0	2.5	0.0	0.0	0.2	10.3	6.6	0.7	2.1	3.5	0.0	0.1	1.0	16.8	0.0	5.1	27.4	6.0	3.8	2.4	0.1	0.0	0.0	11.7	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	10.4	8.3	18.5	11.2	6.9	3.1	5.0	3.8	5.4	6.4	5.7	0.6	0.0	1.1	18.6	0.2	4.8	21.6	20.6	9.1	7.5	16.1	10.3	18.0	18.6	19.4	12.9	2.1	0.0	0.1	15.9	0.0	1.1	0.5	2.8	3.7	2.2	15.7	2.7	68.0	7.4	0.0	27.6	10.7	2.9	0.0	30.4	3.6	5.8	0.0	1.7	53.0	9.8	10.2	0.0	6.2	0.8	15.5	0.7	0.0	2.8	0.0	23.1	0.0	27.6	2.6	11.4	24.0	15.4	0.0	102.9	13.1	10.8	16.0	1.3	0.0	14.7	5.8	3.1	6.2	4.1	5.4	0.0	0.5	9.8	13.8	25.3
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	9.1	6.3	4.3	3.9	3.7	16.9	14.5	7.1	4.6	16.7	10.6	9.5	22.1	3.6	5.3	15.8	7.7	2.3	9.5	7.0	7.5	6.9	189.5	9.1	0.9	14.4	9.4	4.4	27.1	78.9	13.8	11.3	12.8	11.8	6.9	0.7	34.3	7.5	29.9	9.0	10.9	3.1	7.6	1.8	22.5	1.9	7.2	2.2	5.4	12.5	3.1	7.0	7.2	12.7	21.8	25.6	0.0	8.7	12.1	112.9	22.1	6.8	7.4	13.1	11.8	19.5	29.0	0.1	49.9	38.5	94.1	35.9	11.1	22.4	14.9	0.1	35.9	42.1	22.2	38.8	30.0	10.5	7.7	67.3	38.7	78.0	27.7	89.8	11.4	0.0	20.9	4.2	37.6	20.6	0.1	6.2	34.2	33.3	52.7	0.2	14.7	18.5	16.2	54.1	41.9	7.7	18.8	64.1	4.9	4.9	12.7	13.7	49.6	81.2	46.8	17.4	37.4	0.1	0.1	0.2	149.1	26.2	17.2	0.0	2.4	0.4	0.1	2.7	0.0	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.4	0.2	0.0	1.0	4.3	3.7	7.1	4.6	7.0	7.5	14.4	9.4	12.8	7.6	7.2	12.7	9.1	0.0	7.9	2.3	1.0	2.0	7.4	11.9	8.0	0.6	15.5	10.7	6.2	2.8	16.2	0.0	0.0	33.3	0.2	12.2	0.0	8.1	0.2	8.1	1.9	6.2	1.8	29.5	1.3	36.2	4.1	3.6	23.4	5.7	3.8	3.5	1.4	91.6	10.9	0.0	1.0	6.0	8.2	5.9	3.8	0.7	1.8	6.1	0.0	1.9	1.4	0.1	0.0	0.5	0.0	20.8	7.7	7.5	0.1	8.3	11.8	1.5	36.1	0.1	6.6	4.1	3.3	0.6	0.2	19.5	1.4	23.7	0.4	13.1	11.6	8.9
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		1900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	40.6	18.4	32.9	22.3	31.5	46.4	33.1	18.1	34.5	40.4	30.5	33.7	18.1	39.3	18.2	65.6	39.0	25.1	24.0	30.5	23.1	20.0	38.0	26.8	29.8	17.4	22.9	41.2	30.1	43.7	18.0	17.5	18.9	26.0	24.6	11.4	61.1	24.3	111.9	47.1	31.3	34.3	18.6	31.5	32.2	25.4	26.9	68.6	40.9	49.7	29.7	32.2	40.4	22.4	42.4	48.5	14.1	23.5	60.9	55.4	22.2	31.1	31.0	22.6	28.5	24.3	13.8	44.7	35.4	46.2	50.9	74.3	20.1	21.5	19.3	36.7	30.5	70.1	19.2	36.0	53.0	58.9	40.1	56.8	53.2	32.0	90.7	28.2	31.7	59.6	44.2	80.1	24.7	9.8	55.8	20.7	5.4	23.3	18.1	13.8	22.1	41.7	38.2	23.7	3.4	14.2	51.2	33.5	19.2	22.5	12.7	32.4	34.0	40.2	13.8	42.2	25.1	88.0	71.9	22.5	33.4	24.0	26.0	16.6	11.2	20.0	17.8	14.8	14.5	7.9	13.1	19.5	9.6	11.4	14.8	13.3	16.7	20.8	25.5	8.3	14.7	17.1	32.9	31.5	18.1	34.5	30.5	23.1	17.4	22.9	18.9	18.6	26.9	22.4	20.1	16.0	8.2	53.8	22.2	16.4	7.4	9.5	17.6	5.3	16.5	13.2	4.6	18.6	10.5	5.5	14.6	27.3	35.2	27.9	1.9	12.4	4.9	17.5	35.5	12.6	9.1	18.1	63.5	14.5	13.5	20.2	10.7	24.0	29.8	4.7	20.3	32.6	15.7	16.8	56.3	13.0	12.2	22.2	15.2	9.2	27.4	18.7	17.8	57.1	11.0	16.5	36.0	77.4	5.1	12.3	6.7	11.3	14.8	11.2	7.9	3.6	14.2	3.9	26.3	17.1	18.4	21.4	13.5	50.6	22.3	17.4	28.5	1.6	11.8	11.9
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857601-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 84.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 187.7;U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	11.2	7.5	11.5	16.9	14.3	17.3	11.6	11.1	14.3	11.0	84.2	11.5	16.6	10.8	22.5	6.2	12.3	19.8	6.9	17.7	12.4	13.0	9.9	15.1	25.4	12.7	12.2	18.8	14.2	8.4	13.7	10.3	12.5	13.9	14.4	18.8	12.9	7.3	8.2	13.9	15.0	10.2	9.7	22.1	14.9	7.4	13.7	20.8	10.6	6.5	23.4	13.9	7.7	14.3	10.0	14.1	13.9	17.5	14.7	9.2	12.7	24.0	7.7	12.6	15.1	12.4	34.4	44.5	13.6	9.4	13.1	11.9	10.4	28.3	13.4	13.4	16.2	13.0	26.3	11.9	11.7	23.3	13.5	12.1	13.7	16.9	8.8	16.3	15.4	17.7	14.1	8.8	31.0	11.9	17.2	22.9	15.2	20.8	18.9	187.7	26.0	10.9	10.6	22.3	24.3	8.8	16.9	12.3	6.6	9.9	7.6	19.8	16.3	17.1	11.1	11.8	15.7	23.7	20.8	90.6	18.4	24.8	28.0	12.9	1.7	1.4	3.9	1.4	2.6	4.1	4.2	3.3	1.3	4.8	4.5	3.5	3.0	1.8	6.5	5.0	2.2	1.3	11.5	14.3	11.1	14.3	17.7	12.4	12.7	12.2	12.5	9.7	13.7	14.3	55.8	12.8	26.9	123.7	57.1	16.4	14.1	42.4	17.6	39.0	18.7	16.3	8.8	22.8	30.6	33.1	81.3	11.9	62.7	17.3	13.7	10.5	9.8	18.0	19.9	49.3	45.7	14.9	69.9	20.1	6.9	20.2	26.0	14.7	36.8	32.4	32.2	11.2	7.4	30.3	68.1	30.8	46.8	20.4	16.2	8.3	15.2	29.2	8.8	58.1	18.9	19.2	65.9	101.0	87.5	12.7	15.9	7.2	37.1	10.9	19.4	5.1	112.4	61.1	19.7	22.5	18.3	19.9	24.0	7.8	15.5	4.9	48.3	37.0	14.4	12.9
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897548	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	9.0	9.7	8.1	8.1	7.9	23.2	7.9	7.0	8.0	10.1	4.2	9.1	5.9	10.6	5.6	6.6	12.8	6.9	6.3	6.9	5.9	7.1	30.6	12.1	9.5	8.6	8.0	8.7	11.7	6.0	6.1	5.3	7.5	7.6	4.8	4.6	10.7	7.9	17.5	8.3	8.0	9.4	6.9	11.1	8.6	6.9	7.8	10.3	8.8	5.1	8.2	10.9	7.7	7.8	9.6	8.2	12.6	22.1	27.9	17.7	24.8	13.3	15.5	18.5	17.0	10.2	10.0	9.2	2.6	16.1	17.8	8.7	15.1	13.7	12.8	20.3	10.6	15.3	10.3	15.9	18.4	23.0	11.3	13.8	18.6	20.7	9.3	11.7	15.4	15.2	5.2	9.3	15.8	7.9	12.7	12.9	11.3	8.0	15.8	6.7	8.5	6.4	8.8	12.5	2.7	9.1	14.1	9.5	12.9	6.9	8.2	20.3	15.5	14.8	8.4	19.7	16.5	16.8	11.9	9.0	13.0	23.2	11.5	0.0	1.6	0.9	1.0	3.1	0.9	0.9	1.6	1.2	2.0	0.7	0.8	0.6	0.1	0.4	2.9	1.1	2.4	0.8	8.1	7.9	7.0	8.0	6.9	5.9	8.6	8.0	7.5	6.9	7.8	7.8	2.4	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.6	7.3	0.0	1.8	1.8	0.0	1.9	2.4	0.0	24.2	1.7	0.5	0.0	0.0	0.0	2.9	6.9	0.8	0.0	1.6	0.0	1.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	15.4	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	1.2	4.6	0.0	0.0
STIMATE-MUSTN1	TMEM110-MUSTN1	ENSG00000248592	"STIMATE-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 14.9;skeletal muscle: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;Karpas-707: 5.8;PC-3: 6.5"									HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"		Cytosol		"HPA051855: AB_2681639"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	3.6	1.7	0.9	0.5	1.4	1.4	2.6	1.4	2.0	2.9	1.6	1.3	0.0	2.1	0.3	2.1	1.2	0.1	4.4	0.9	0.4	3.1	14.9	2.3	0.1	1.5	1.2	1.6	3.2	0.0	1.4	0.0	1.6	1.4	0.1	0.1	1.6	0.0	9.9	2.0	1.7	0.1	1.9	2.4	2.0	1.4	2.0	0.2	2.1	0.6	0.1	2.5	2.7	2.3	1.8	0.5	0.0	4.0	0.3	0.0	1.1	4.1	0.6	0.1	0.1	0.0	0.5	1.8	0.8	0.0	1.3	1.7	1.0	0.7	0.0	8.8	4.4	2.1	0.0	0.0	0.1	2.8	2.7	0.0	0.2	0.1	0.7	0.0	0.1	2.4	1.6	5.8	0.0	0.6	1.9	0.9	1.4	0.1	6.5	0.8	0.0	1.3	0.0	0.0	0.4	0.7	0.9	0.5	1.9	0.2	0.3	0.9	1.1	0.4	2.2	0.8	2.3	5.0	4.2	0.8	0.9	2.9	1.3	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.9	1.4	1.4	2.0	0.9	0.4	1.5	1.2	1.6	1.9	2.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.9;Late spermatids: 338.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	32.1	44.2	18.8	18.2	15.5	34.1	32.3	24.8	23.5	35.4	24.7	38.7	25.6	33.6	5.5	39.7	34.9	11.8	48.4	18.3	14.7	36.4	45.5	30.5	20.5	19.2	19.4	37.9	34.2	16.1	36.8	12.6	15.2	39.3	7.7	5.7	29.7	16.1	108.2	40.2	37.7	9.6	16.3	48.3	38.1	102.4	17.6	15.0	34.3	27.7	12.9	34.4	35.0	14.9	50.0	25.8	19.9	35.9	18.6	17.0	35.5	24.0	27.7	25.1	25.4	22.5	37.1	31.9	24.8	27.8	11.2	32.3	20.1	41.9	8.2	60.2	37.8	34.8	1.7	26.4	38.1	36.6	53.5	30.5	28.9	19.4	29.2	22.3	25.2	28.1	63.1	51.1	13.9	39.3	31.9	27.7	33.0	19.6	25.1	50.0	20.0	36.1	21.1	39.7	39.8	26.6	0.0	19.7	24.2	11.4	30.3	55.2	33.7	24.6	25.0	45.2	38.7	85.3	38.1	25.7	22.6	48.1	25.5	1.7	3.3	3.9	0.4	5.5	0.3	2.3	0.8	1.4	1.6	0.7	0.7	0.6	9.9	1.4	5.7	0.8	0.6	0.5	18.8	15.5	24.8	23.5	18.3	14.7	19.2	19.4	15.2	16.3	17.6	14.9	24.5	6.4	13.7	12.7	10.5	16.7	7.4	9.5	9.6	25.5	22.0	18.4	13.7	15.7	9.0	23.9	18.8	7.5	20.1	44.4	7.9	9.4	154.9	18.0	18.1	15.7	15.0	27.3	7.9	14.0	5.3	13.2	21.9	17.8	2.5	80.3	15.4	31.6	15.2	18.5	8.5	33.1	6.1	18.3	26.4	338.7	24.5	20.7	16.0	11.2	20.4	21.2	9.2	9.0	6.5	16.7	29.3	20.7	10.2	15.1	27.5	11.0	9.3	21.0	13.1	21.5	23.7	85.5	20.1	14.6	15.5	8.8	16.6	45.2	35.4	12.6
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"	Q8N1F8	2	219597857-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 15.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075"	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	7.6	10.0	12.0	9.5	12.4	19.5	7.1	11.3	13.8	9.2	12.6	9.8	9.2	9.2	15.0	9.6	10.4	9.5	8.0	12.4	10.6	11.2	5.9	9.3	14.0	12.0	11.9	24.5	9.5	7.5	21.5	8.2	12.3	9.9	7.8	12.3	8.1	6.5	5.8	18.4	10.0	8.3	10.0	15.1	8.6	31.2	12.0	19.5	11.1	4.3	11.1	9.0	8.3	11.8	10.1	15.4	16.1	11.0	5.6	9.9	16.5	8.7	7.6	13.9	11.7	14.3	16.7	5.8	8.7	8.4	12.6	24.4	7.7	18.7	10.3	8.7	11.7	15.1	17.2	11.6	7.4	15.9	38.2	9.6	16.5	11.7	5.9	14.2	8.6	9.7	11.4	8.5	7.9	19.7	9.3	19.6	16.2	4.8	8.4	17.5	5.9	4.5	13.8	15.8	10.6	16.8	5.7	13.8	12.0	12.9	8.8	15.3	6.5	15.0	12.6	14.5	8.6	9.4	4.5	10.8	11.4	8.7	9.5	1.5	4.3	5.3	2.6	5.8	2.1	1.7	1.2	2.1	7.7	1.2	1.0	1.0	1.4	3.7	6.5	15.1	2.1	2.6	12.0	12.4	11.3	13.8	12.4	10.6	12.0	11.9	12.3	10.0	12.0	11.8	3.5	6.4	6.7	12.4	3.9	2.3	2.1	6.3	1.2	7.8	5.1	5.5	3.6	1.5	7.8	7.3	18.8	10.0	10.3	14.6	1.9	5.0	14.0	11.9	4.0	4.6	13.1	6.9	10.7	6.5	5.6	5.3	17.3	5.8	12.7	29.7	4.2	3.3	8.4	11.8	8.0	8.8	6.1	8.6	5.7	30.9	25.4	8.9	3.6	8.4	7.0	4.9	4.1	8.5	7.4	4.2	3.3	14.7	2.8	1.7	5.4	2.7	19.9	12.6	13.1	3.2	4.9	18.5	13.8	3.5	2.7	16.1	4.5	5.4	8.8	2.8
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	15.2	24.9	17.6	11.8	17.5	15.0	16.2	16.3	20.5	14.0	19.5	20.0	17.3	13.8	20.8	22.8	18.1	13.0	19.0	16.5	16.8	26.5	43.2	14.3	17.6	17.9	17.5	14.8	30.9	22.7	19.8	9.2	16.9	20.3	13.5	7.9	20.0	10.9	14.4	17.3	17.8	9.9	17.4	21.2	24.2	27.7	18.6	20.5	19.3	8.2	14.5	17.8	14.8	16.5	14.1	18.8	15.7	13.2	40.0	40.0	17.9	17.8	23.6	14.3	14.7	21.2	31.0	8.3	24.4	32.0	23.4	14.5	18.5	30.0	7.8	20.0	19.8	17.7	15.4	19.1	34.9	17.6	20.1	40.1	48.1	20.8	57.4	29.8	17.9	18.7	23.1	21.5	26.8	27.1	19.4	38.0	14.5	25.7	10.3	18.1	17.5	24.9	32.2	16.1	12.3	14.6	5.8	25.5	39.0	11.2	27.4	36.4	13.7	20.6	14.0	16.4	17.4	25.9	12.1	19.5	22.9	18.4	18.3	1.6	7.0	5.3	4.9	3.8	5.5	7.2	6.0	9.2	6.8	6.0	6.1	7.9	4.1	14.5	3.1	5.8	7.3	8.7	17.6	17.5	16.3	20.5	16.5	16.8	17.9	17.5	16.9	17.4	18.6	16.5	11.8	6.4	5.6	3.6	22.4	9.8	18.1	32.6	24.5	7.9	31.8	31.8	9.5	24.3	19.7	7.3	16.7	24.0	23.6	27.6	68.4	40.3	87.2	21.4	13.3	14.0	25.8	36.0	2.2	58.5	25.0	15.8	17.3	12.9	8.2	17.9	12.5	43.7	28.4	13.5	2.7	38.7	16.2	27.1	17.6	70.3	15.2	17.8	21.4	0.0	38.4	22.1	44.3	4.0	6.8	33.3	44.3	13.5	27.6	18.6	58.9	80.2	19.6	19.1	0.0	11.9	19.2	43.1	9.6	28.2	11.2	12.9	22.1	33.6	34.2	20.8
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133583-196176503	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 376.2;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 63.4"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	28.2	8.9	2.1	67.0	2.9	376.2	21.5	3.7	5.3	24.2	3.3	19.1	27.8	5.4	1.8	11.9	5.8	20.4	4.6	4.1	3.3	6.5	8.5	23.6	113.3	3.1	2.0	2.2	12.7	2.1	3.0	16.7	3.2	10.5	17.5	0.4	17.0	5.7	2.4	11.2	40.1	16.8	2.2	56.9	20.1	9.5	4.0	60.9	7.2	3.5	111.1	24.4	5.2	2.9	11.0	7.5	11.2	4.2	47.7	18.1	12.4	25.7	38.4	27.7	28.5	22.8	3.9	122.3	23.1	14.8	7.3	7.4	4.7	11.1	33.4	21.8	12.7	11.6	9.1	2.2	14.2	47.0	118.9	23.1	10.9	34.3	17.7	39.2	11.5	28.5	9.1	111.6	69.4	5.9	61.6	106.0	6.3	19.9	17.2	10.1	67.5	37.4	16.3	25.6	4.2	4.2	6.6	6.4	5.4	17.2	4.3	24.3	14.0	26.8	13.1	19.3	14.7	45.5	78.9	132.1	20.2	15.9	12.1	165.1	74.3	163.1	43.7	81.3	55.4	49.2	77.0	52.8	53.0	58.6	98.6	82.4	236.7	40.8	113.1	37.7	73.8	89.3	2.1	2.9	3.7	5.3	4.1	3.3	3.1	2.0	3.2	2.2	4.0	2.9	23.3	89.8	74.0	48.3	229.3	59.9	27.1	15.1	10.8	0.9	28.9	15.2	2.6	12.8	42.5	11.0	0.0	7.9	267.7	54.0	3.9	6.6	6.8	15.3	14.1	11.3	3.0	68.8	3.4	2.8	24.0	27.2	38.2	26.5	195.1	47.4	5.3	2.4	26.1	0.0	3.1	13.9	18.3	151.1	201.3	3.6	5.6	198.9	58.7	11.2	158.0	0.6	118.4	17.6	0.7	10.9	41.6	4.5	191.8	34.3	80.7	2.5	26.9	0.3	6.6	49.7	19.7	41.1	26.3	16.4	63.4	5.1	342.5	22.6	13.2	53.8
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	71.4	32.4	30.9	49.0	32.6	58.0	60.9	34.3	34.4	99.1	49.4	75.1	83.0	53.9	58.4	167.9	50.7	55.8	49.1	34.2	29.0	77.0	32.4	54.1	67.0	29.0	35.5	44.2	48.0	42.4	31.1	57.5	27.2	49.6	72.3	31.7	70.4	51.2	47.1	154.4	94.4	48.2	28.5	51.5	78.3	36.9	41.3	68.2	55.0	38.8	74.1	86.6	113.9	29.2	161.8	49.4	85.6	79.8	128.6	76.4	121.3	73.8	103.0	100.9	97.7	145.7	212.6	114.1	36.6	92.8	63.1	142.1	80.2	162.3	95.5	286.3	41.2	122.0	59.8	84.2	181.0	124.4	82.8	49.8	253.7	79.3	231.6	106.2	88.2	88.0	45.2	76.6	67.0	70.3	93.5	51.1	76.9	217.3	36.6	116.5	52.5	62.3	98.1	143.2	49.8	71.4	46.7	74.2	103.0	129.7	89.6	119.1	120.0	63.8	46.3	52.8	86.5	74.1	41.7	42.5	99.3	74.0	107.4	5.7	12.7	6.3	5.5	10.9	6.6	6.1	10.2	8.0	10.9	7.9	6.9	5.6	10.9	1.5	13.5	7.1	13.7	6.7	30.9	32.6	34.3	34.4	34.2	29.0	29.0	35.5	27.2	28.5	41.3	29.2	36.2	12.8	27.4	27.7	37.4	70.9	83.6	51.2	20.5	20.3	41.5	33.5	3.0	55.8	55.8	68.0	56.3	39.2	36.9	203.8	25.4	35.8	3.5	74.2	48.7	32.5	42.6	41.4	39.2	55.0	45.9	43.2	65.7	99.6	18.4	49.1	25.0	26.6	28.0	10.1	34.2	86.0	24.4	82.2	57.9	5.9	26.8	58.4	56.9	49.6	47.6	25.5	20.6	35.7	11.1	84.4	96.5	30.5	25.5	60.4	111.8	39.2	51.6	11.0	39.5	47.7	41.0	2.9	21.2	61.9	82.1	20.0	45.5	20.4	59.1	153.3
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492670-241509730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 489.9;tongue: 213.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	53.2	50.6	48.2	37.1	48.9	47.0	52.8	35.8	56.7	59.8	27.8	59.8	36.2	62.9	24.0	62.6	60.5	32.9	69.1	50.4	47.1	56.5	50.0	49.6	36.7	37.5	40.9	59.4	70.3	45.9	65.3	38.7	43.3	55.4	30.5	28.9	48.7	40.2	489.9	53.1	50.5	42.1	30.7	61.6	58.7	48.7	46.4	38.5	71.9	213.8	31.8	60.8	56.7	41.2	75.2	46.9	91.1	114.0	109.9	75.9	140.1	122.3	81.8	90.9	103.4	52.3	64.4	28.5	33.7	163.9	82.3	62.9	130.2	132.9	109.9	107.0	136.4	79.7	98.3	136.6	99.3	48.7	59.0	110.1	93.9	88.3	70.3	111.1	208.7	102.6	125.2	24.6	168.8	78.6	73.0	75.9	127.9	69.5	66.3	121.1	116.2	42.6	79.5	62.4	152.8	70.2	59.4	44.2	77.0	102.7	35.7	85.2	245.7	68.2	83.0	79.1	88.3	50.3	12.1	48.8	66.0	39.6	79.1	17.0	16.3	12.9	17.3	15.5	16.3	15.9	15.9	18.5	15.0	16.9	12.3	11.8	5.8	24.6	19.7	11.8	23.3	12.6	48.2	48.9	35.8	56.7	50.4	47.1	37.5	40.9	43.3	30.7	46.4	41.2	43.6	22.4	41.4	23.2	19.7	25.5	29.0	29.7	19.9	48.7	33.2	39.4	36.3	42.9	24.0	25.8	27.1	82.7	19.8	35.2	27.4	46.0	13.8	18.5	28.4	52.7	35.4	48.6	29.8	34.2	80.7	35.1	36.7	25.4	25.4	40.8	45.7	21.5	45.1	32.0	26.1	40.0	20.3	27.3	25.7	14.4	32.6	20.8	19.6	21.5	47.0	58.9	18.6	16.1	27.5	36.9	74.5	39.9	15.8	37.1	43.4	46.1	16.2	41.1	46.0	41.7	35.3	90.2	54.7	31.7	30.4	52.4	25.4	53.2	44.9	29.9
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98371228-98942827	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 152.7;Oligodendrocytes: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A-431: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	15.1	14.4	5.6	7.9	7.0	3.5	14.1	6.6	7.4	17.4	7.2	13.1	5.5	24.9	14.3	10.2	17.0	14.2	9.1	5.1	6.3	15.6	14.3	11.1	5.5	7.7	6.7	25.0	10.0	16.1	6.4	18.5	7.4	16.5	6.7	12.0	10.7	17.6	11.4	9.6	8.3	17.2	6.3	6.8	8.5	11.4	7.1	5.1	11.9	8.6	5.5	13.6	13.7	7.9	85.3	15.7	16.2	22.0	51.2	25.4	16.4	28.8	25.6	26.3	22.8	11.7	35.7	0.0	25.6	28.7	14.1	33.4	11.4	24.8	42.2	20.5	14.8	22.9	7.2	8.0	17.5	7.7	19.0	17.0	41.9	13.5	36.6	17.2	11.5	13.4	9.8	12.2	19.4	10.7	19.3	9.4	4.9	58.0	6.1	17.1	14.1	7.5	29.9	10.7	4.3	9.6	18.4	21.1	18.2	21.0	17.8	12.3	8.7	17.9	11.5	27.1	16.3	9.8	15.5	6.2	15.9	9.5	29.0	2.0	8.3	4.6	1.3	8.5	1.4	1.8	0.7	1.8	7.9	1.1	1.0	0.6	8.8	2.0	5.4	3.3	0.1	2.8	5.6	7.0	6.6	7.4	5.1	6.3	7.7	6.7	7.4	6.3	7.1	7.9	25.9	38.5	37.4	132.9	6.0	43.7	44.8	25.3	23.3	6.9	29.0	15.5	16.6	31.5	37.7	29.5	14.6	43.6	2.5	11.7	23.5	21.5	118.3	23.7	65.8	31.3	9.1	16.2	34.3	18.9	56.1	39.8	9.7	28.9	17.1	13.3	24.3	23.7	19.2	10.1	33.5	7.8	26.4	17.0	25.1	77.1	91.0	18.6	24.9	152.7	13.8	15.0	3.1	60.3	189.9	24.9	13.1	74.1	6.2	42.1	32.3	25.0	29.0	15.6	39.5	43.8	39.7	16.7	12.6	12.3	40.5	64.7	5.9	47.0	13.8	36.0
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710203-23832513	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"testis: 64.0"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 161.5;Spermatogonia: 75.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"CACO-2: 20.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023194, HPA072896"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA023194: AB_1857590, HPA072896: "	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.1	0.3	0.0	0.4	0.0	0.2	1.1	0.4	0.1	0.2	0.2	0.3	0.1	0.0	0.3	0.2	0.1	0.1	0.3	0.4	0.3	0.3	0.4	0.0	0.6	0.4	0.2	0.4	0.0	0.1	0.0	0.7	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.4	64.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.5	2.3	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.1	0.4	0.3	0.4	0.6	0.4	0.7	0.3	0.4	0.6	0.4	3.2	1.1	2.9	0.3	0.1	0.2	0.5	0.0	2.0	1.0	0.1	0.6	1.5	2.8	0.0	0.0	0.6	0.1	0.3	0.0	0.2	21.1	0.6	0.0	0.4	1.2	0.0	2.9	0.6	0.1	0.6	2.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	4.6	0.4	2.0	0.0	0.0	19.6	3.4	0.5	0.0	2.8	0.0	1.0	0.0	2.5	12.7	0.4	5.3	3.0	0.5	0.3	0.8	0.1	4.3	1.2	0.0	0.6	0.1	161.5	75.0	0.0	0.1	0.5	0.5	0.1	0.5	0.5
STK32C	"MGC23665, PKE, YANK3"	ENSG00000165752	"Serine/threonine kinase 32C"	Q86UX6	10	132207492-132331847	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 278.9;Late spermatids: 83.3;Spermatocytes: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 55.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017894	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA017894: AB_1857591"	"unprognostic (2.11e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.68e-6)"	"unprognostic (2.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.31e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-1)"	11.0	12.5	31.4	7.1	39.6	7.6	8.9	17.8	37.5	8.1	13.5	9.1	5.2	6.9	14.8	5.4	9.4	6.5	7.4	31.3	23.2	15.6	5.0	8.8	10.0	24.6	26.1	6.7	7.4	6.0	12.3	4.9	20.5	6.6	4.7	7.9	5.7	5.2	13.7	7.6	6.8	5.0	23.4	15.1	6.2	54.1	30.9	10.8	6.4	9.1	6.4	8.3	6.5	25.9	69.4	43.5	13.3	33.5	18.4	23.3	2.7	14.1	10.7	17.4	22.2	10.0	46.0	14.8	10.3	16.4	22.0	14.9	18.6	5.5	16.9	8.9	31.1	8.9	46.1	47.1	22.9	7.9	31.1	17.6	20.8	15.7	17.3	22.0	15.6	25.1	15.4	10.2	19.0	21.1	10.4	30.4	8.8	12.6	31.4	12.2	8.2	4.9	23.3	11.7	34.6	27.3	10.2	9.3	20.9	7.9	10.5	19.2	10.6	13.6	14.2	18.2	11.3	19.1	3.8	38.7	31.4	7.4	7.1	55.3	17.9	16.5	5.8	19.6	7.3	6.2	4.7	6.6	25.1	10.2	5.8	4.5	2.4	6.1	17.3	14.5	9.2	7.0	31.4	39.6	17.8	37.5	31.3	23.2	24.6	26.1	20.5	23.4	30.9	25.9	6.6	0.0	7.2	13.4	7.3	5.2	6.8	5.7	4.6	8.4	10.3	11.0	3.7	2.8	6.1	12.9	12.5	3.4	9.3	3.2	19.6	5.4	278.9	25.9	8.2	8.2	19.2	15.8	22.9	8.7	2.3	7.2	6.6	11.8	15.8	6.0	13.6	5.5	14.6	37.0	13.9	7.4	12.2	24.3	28.5	83.3	9.0	14.8	12.4	7.5	14.0	11.0	6.2	9.5	10.0	6.0	5.1	6.8	4.8	11.4	3.8	13.2	13.7	14.6	6.6	10.5	5.6	89.8	20.0	5.9	5.1	1.5	9.3	10.1	7.6	7.3
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 49.3;testis: 51.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.1;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	1.3	8.1	6.7	2.0	6.6	1.3	0.5	8.5	4.9	5.6	49.3	8.3	3.3	12.0	11.3	2.7	42.3	5.1	16.2	6.1	10.1	10.2	0.4	7.1	2.0	14.7	15.6	13.4	6.5	23.1	24.1	0.1	13.3	6.4	1.5	15.6	2.1	11.5	3.9	0.2	3.4	9.3	12.0	1.5	6.0	51.8	12.8	3.8	20.0	6.0	2.2	3.4	1.7	8.3	0.0	3.4	15.4	0.0	0.0	0.0	0.0	3.0	3.1	7.0	6.2	2.2	0.0	23.0	11.5	0.6	8.7	0.0	6.9	2.5	6.0	0.0	18.9	0.0	4.2	5.6	2.5	13.4	0.0	1.1	0.0	0.2	0.0	22.0	0.5	11.2	0.0	21.2	0.3	0.0	0.4	0.0	11.2	0.0	0.0	8.8	2.2	14.3	6.1	0.0	22.9	6.2	0.0	0.0	0.1	4.3	0.0	1.3	0.0	0.0	10.6	0.2	24.3	5.1	21.2	0.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.7	0.0	2.2	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.2	6.7	6.6	8.5	4.9	6.1	10.1	14.7	15.6	13.3	12.0	12.8	8.3	0.1	19.2	14.5	213.8	6.2	0.0	1.3	1.9	0.0	20.7	0.1	0.3	37.8	8.6	27.5	20.2	70.9	0.1	1.4	0.2	3.9	9.5	98.8	220.9	5.5	1.8	9.1	1.7	12.0	4.9	3.3	5.0	6.1	17.8	1.3	29.3	0.4	0.0	0.3	1.7	15.4	1.6	6.1	0.0	0.0	157.0	4.4	0.6	0.0	23.4	0.0	31.0	0.0	117.6	19.7	4.4	0.4	17.0	5.2	0.5	3.6	13.5	155.3	77.4	0.0	0.2	2.7	148.3	26.8	0.2	0.0	0.0	1.3	6.3	3.5	0.0
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101827-2177038	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 118.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 150.1;Early spermatids: 214.3;Horizontal cells: 294.4;Late spermatids: 821.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	9.0	11.3	9.4	6.6	8.3	8.6	7.9	6.7	13.0	7.3	5.1	10.2	7.1	9.7	5.8	15.6	8.6	7.1	10.0	9.5	8.3	6.9	8.9	8.5	6.4	6.2	10.6	8.0	9.3	7.8	9.7	6.2	7.3	8.0	8.2	118.8	8.7	6.3	6.5	11.3	9.3	7.8	5.0	8.3	8.7	18.3	15.4	6.4	8.5	5.7	7.6	8.1	8.9	8.6	23.3	19.4	14.7	25.4	6.7	9.1	17.9	9.3	11.4	12.2	12.5	25.6	17.5	15.9	7.5	11.7	19.0	34.1	17.6	21.4	13.8	6.3	8.4	15.2	7.4	28.1	8.5	13.7	6.8	7.9	18.5	19.5	16.7	11.2	11.7	15.0	14.9	12.8	8.0	10.3	17.4	19.4	27.5	18.4	12.9	14.9	13.2	10.1	11.1	22.9	24.3	11.8	16.6	29.3	15.0	17.0	14.5	13.5	10.0	20.7	14.1	10.5	14.9	11.1	15.5	10.8	11.1	14.7	9.2	0.0	0.3	0.1	0.4	0.2	0.6	0.3	0.6	0.3	0.5	0.4	0.5	0.4	0.7	0.2	0.3	0.4	0.2	0.3	9.4	8.3	6.7	13.0	9.5	8.3	6.2	10.6	7.3	5.0	15.4	8.6	8.8	12.8	9.8	4.9	6.3	11.6	4.4	7.5	13.1	111.8	10.9	9.5	12.2	2.8	9.1	3.7	150.1	7.2	7.5	15.4	1.9	6.4	214.3	15.7	7.8	9.1	6.1	12.0	11.8	6.8	11.5	11.1	11.2	12.7	9.5	8.4	7.9	10.3	5.7	294.4	11.6	7.6	10.2	6.3	4.9	821.8	6.8	5.7	7.2	11.2	4.0	124.7	5.2	9.0	11.2	10.4	9.7	6.0	8.5	6.7	8.8	3.6	10.2	96.7	0.0	10.8	7.2	15.5	14.4	12.4	11.8	5.7	6.0	4.5	10.9	6.6
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672069-218702716	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Respiratory ciliated cells: 38.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	5.6	9.9	1.5	5.4	1.7	2.5	6.6	1.0	3.2	14.1	15.4	9.0	4.4	11.4	13.4	5.1	14.3	10.5	3.5	2.3	1.0	7.3	4.5	7.3	4.5	1.2	2.6	13.4	10.7	9.4	14.8	4.3	0.8	9.6	6.5	11.6	7.3	8.2	3.7	5.0	6.4	8.0	0.3	5.1	8.8	32.0	1.3	3.2	11.8	2.3	4.0	8.2	7.6	1.0	3.7	8.2	17.6	15.0	18.7	14.5	10.9	9.8	7.8	12.2	11.4	10.7	6.0	4.8	13.3	10.3	8.2	7.2	12.2	10.3	10.7	2.8	10.2	4.7	27.1	15.0	9.1	6.7	7.6	15.7	7.5	12.0	8.4	32.3	9.3	6.2	11.1	6.0	10.3	8.5	4.0	8.5	10.7	4.6	5.2	7.3	7.6	5.1	14.9	18.2	14.2	12.3	7.6	12.2	5.0	18.2	12.4	5.3	8.9	16.8	6.1	6.5	6.8	7.5	6.3	2.5	10.4	3.1	7.1	0.0	0.4	0.7	0.3	0.2	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.3	0.0	0.5	0.3	0.3	0.2	0.4	1.5	1.7	1.0	3.2	2.3	1.0	1.2	2.6	0.8	0.3	1.3	1.0	2.1	9.6	6.3	18.3	1.6	1.1	0.9	3.6	2.8	7.4	7.4	5.5	4.0	5.7	3.7	3.7	37.5	1.8	2.9	2.9	0.0	3.7	16.9	17.5	9.0	3.3	2.4	0.8	22.0	2.5	1.5	4.5	10.7	6.3	1.3	12.2	3.3	5.9	2.7	1.7	18.0	4.4	6.1	2.5	1.2	6.0	5.9	2.0	0.0	2.8	2.5	4.9	1.0	8.5	6.2	2.2	5.0	4.9	0.6	1.6	2.5	4.4	38.2	9.1	6.6	3.1	4.0	28.0	8.9	3.7	1.0	0.8	1.5	11.0	4.9	0.9
STK38	"NDR, NDR1"	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547479	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	27.6	11.5	13.2	28.9	13.6	30.6	23.2	15.8	18.1	23.5	15.2	40.4	24.0	21.3	12.5	39.6	21.4	20.7	24.2	14.2	13.4	23.1	24.7	24.9	34.5	14.4	13.4	16.0	12.5	8.3	14.4	21.7	13.6	23.8	36.5	11.3	33.6	16.0	16.1	30.6	41.6	27.4	13.0	34.6	23.2	13.8	14.8	28.0	14.0	16.2	33.8	30.0	28.4	14.2	43.0	31.1	32.1	34.8	63.4	47.9	27.9	46.7	37.6	47.6	47.4	24.0	28.7	57.3	35.3	70.0	39.5	44.7	26.9	19.6	55.7	23.6	23.0	41.1	40.8	21.9	31.2	15.8	21.7	31.9	50.0	36.9	23.6	54.5	30.1	28.7	34.0	32.4	68.5	25.7	25.5	40.8	13.4	50.5	27.3	97.7	38.9	15.3	45.0	52.9	37.4	17.7	57.0	25.9	34.0	35.7	27.8	40.8	29.4	38.4	33.6	30.9	30.7	27.1	51.4	39.9	8.7	60.1	37.8	91.2	45.2	34.6	57.0	49.5	44.1	22.4	46.9	50.4	29.1	16.2	41.1	45.8	59.4	59.3	73.3	14.4	48.7	58.3	13.2	13.6	15.8	18.1	14.2	13.4	14.4	13.4	13.6	13.0	14.8	14.2	29.7	19.2	16.0	27.4	25.7	13.5	9.6	21.5	21.1	3.0	16.0	14.5	15.5	18.6	47.9	7.3	0.0	13.8	59.5	47.1	1.9	18.9	9.0	15.3	16.0	18.4	14.4	16.6	46.5	12.7	17.8	22.2	34.7	20.4	13.3	13.5	12.1	15.0	13.2	5.0	34.2	25.4	22.4	38.2	20.3	5.3	27.1	40.1	17.8	57.1	48.7	7.6	101.0	38.2	36.8	27.8	30.8	30.1	39.6	12.8	32.8	16.6	40.4	7.7	13.1	8.3	14.0	26.5	10.3	31.5	21.2	15.3	45.5	10.1	28.4	27.9
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 49.9;granulocytes: 80.7;monocytes: 33.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	23.9	11.6	6.5	21.6	8.6	17.2	14.0	6.9	11.1	17.2	6.4	28.9	12.9	27.1	7.5	22.7	15.1	25.7	44.9	6.7	8.6	12.9	12.5	12.3	12.4	8.1	7.5	7.0	12.3	26.9	7.2	15.7	8.4	20.2	21.2	6.6	13.8	15.0	8.8	10.8	14.3	33.3	7.6	12.0	18.6	11.2	9.5	17.8	9.2	16.4	14.8	24.6	15.5	6.8	12.0	15.7	40.1	17.7	18.6	12.4	30.8	7.7	11.5	4.8	6.5	19.8	8.5	29.3	17.7	6.4	13.6	21.9	19.0	13.4	7.2	157.8	17.3	18.7	17.5	10.0	15.5	43.7	19.7	14.7	13.3	17.6	21.7	29.3	38.1	36.8	21.2	21.1	9.7	8.3	28.5	46.3	49.6	31.2	25.4	10.6	47.8	22.4	6.8	22.0	6.7	22.3	33.1	19.9	13.3	38.6	9.8	14.0	16.4	15.5	13.9	23.7	20.3	7.7	8.1	29.1	8.0	19.9	6.7	16.3	33.0	60.8	10.0	28.4	7.0	11.6	7.7	9.8	49.9	9.3	9.4	7.6	80.7	11.6	22.4	21.2	10.8	14.7	6.5	8.6	6.9	11.1	6.7	8.6	8.1	7.5	8.4	7.6	9.5	6.8	24.4	19.2	16.2	32.7	20.8	35.4	36.3	88.2	22.2	12.7	16.2	14.7	76.0	10.0	33.7	9.2	2.1	11.0	21.7	33.6	9.8	49.8	23.1	12.5	15.3	26.2	19.2	15.4	57.2	40.1	9.1	19.7	15.3	14.9	17.7	10.9	24.3	14.5	28.8	10.1	37.5	33.8	18.3	36.4	73.7	5.9	6.5	45.7	21.4	37.5	46.2	8.1	14.4	42.3	16.0	70.5	26.3	12.0	22.8	24.8	9.2	16.2	11.9	7.9	19.7	8.6	41.1	12.1	13.4	20.5	32.0	27.8	15.7	9.7	23.0	42.0
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168247595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		80000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	19.4	6.7	20.1	14.0	25.8	5.1	8.4	25.3	25.1	12.0	52.9	26.3	32.0	7.3	14.5	36.3	6.4	18.1	15.8	16.0	18.6	9.0	1.9	7.6	22.2	28.8	25.8	6.6	25.6	13.7	8.2	2.3	31.9	28.7	32.4	27.8	67.9	11.5	2.7	6.3	18.6	11.7	20.8	8.6	31.8	48.5	25.6	29.1	6.9	7.6	23.5	24.8	9.5	37.0	19.1	10.9	40.9	12.9	28.1	37.5	4.0	45.0	33.8	29.6	27.8	0.2	59.9	51.1	12.2	30.5	25.5	46.6	26.7	34.4	37.1	16.2	16.4	21.2	11.8	42.9	52.3	30.5	2.1	29.1	52.8	35.1	36.5	38.5	21.2	41.3	0.5	0.0	67.0	11.4	51.6	13.0	30.3	41.0	24.3	72.1	16.0	4.8	27.9	47.6	65.7	27.0	15.7	2.6	21.8	20.3	8.0	25.9	20.2	36.6	11.1	26.5	32.2	0.1	0.0	41.5	29.7	28.5	25.1	0.0	0.3	0.0	1.1	0.2	0.6	0.2	0.9	1.6	0.5	0.5	0.2	0.8	0.0	1.0	0.1	0.1	1.8	0.2	20.1	25.8	25.3	25.1	16.0	18.6	28.8	25.8	31.9	20.8	25.6	37.0	6.1	3.2	14.0	64.6	6.4	3.8	34.4	6.5	5.7	14.8	5.5	6.5	26.2	18.6	15.2	5.5	16.7	0.1	30.0	47.7	21.5	10.9	29.4	11.9	11.6	5.6	22.8	5.7	159.9	23.1	0.1	9.2	28.1	18.9	0.0	5.8	2.9	0.4	3.5	20.2	142.9	17.3	14.2	6.7	6.7	16.2	10.2	6.7	17.8	64.6	5.5	28.9	12.3	153.3	359.4	36.0	20.1	11.3	9.5	74.8	14.5	7.9	17.5	30.0	6.6	7.7	18.2	25.4	8.1	7.5	4.4	0.3	19.4	15.8	22.4	50.6
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385924	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.7;Late spermatids: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 25.2;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	33.3	15.5	17.4	23.1	17.0	15.2	24.6	16.6	19.9	24.3	14.1	44.8	13.5	23.6	8.1	43.8	24.7	20.4	42.7	17.5	17.6	33.5	45.3	36.4	24.3	24.8	19.0	40.3	45.7	21.8	30.1	13.5	20.6	28.5	12.7	7.5	32.0	23.1	125.2	38.8	23.7	20.0	19.9	35.4	35.5	52.5	20.1	15.6	25.3	39.6	21.4	41.7	26.7	19.8	17.4	7.4	36.6	38.3	25.3	14.7	20.5	17.2	23.1	20.3	21.8	41.3	24.2	73.0	13.8	16.1	21.5	17.1	33.5	7.4	14.9	32.0	26.4	47.7	7.5	53.3	25.1	28.1	60.9	13.3	27.7	15.6	8.2	10.9	12.9	55.2	59.7	25.7	12.9	27.0	29.3	37.1	23.5	31.2	10.2	33.3	24.9	49.1	12.7	19.2	44.6	22.7	13.2	20.5	58.5	23.1	13.9	32.7	21.6	12.7	26.5	37.7	38.3	26.6	16.2	61.3	66.3	24.3	42.8	1.2	3.8	6.8	3.1	8.6	3.6	2.8	2.1	2.2	3.5	2.9	1.2	1.8	25.2	2.1	12.0	3.3	1.3	3.5	17.4	17.0	16.6	19.9	17.5	17.6	24.8	19.0	20.6	19.9	20.1	19.8	10.7	12.8	15.3	11.8	22.0	61.3	54.0	9.4	16.5	11.8	28.3	15.4	25.3	8.6	11.1	11.0	4.2	6.5	15.8	34.8	17.6	21.2	116.7	23.9	11.2	15.2	23.4	7.8	24.8	31.6	10.7	19.2	33.1	36.5	13.3	4.9	14.3	23.7	24.7	10.1	17.3	15.5	12.2	23.3	69.5	236.8	23.0	32.2	30.2	21.5	19.2	4.9	18.6	7.5	12.3	28.5	16.3	33.4	17.0	57.1	6.2	14.9	25.6	10.5	26.3	20.6	18.6	14.9	11.1	28.7	75.4	57.2	17.3	17.6	15.1	51.3
STKLD1	"C9orf96, MGC43306, SGK071"	ENSG00000198870	"Serine/threonine kinase like domain containing 1"	Q8NE28	9	133376366-133406096	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 9.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 33.8;Late spermatids: 66.4;Spermatocytes: 20.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029902	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA029902: AB_10603554"	"unprognostic (6.65e-2)"	"unprognostic (9.43e-3)"	"unprognostic (7.54e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.94e-4)"	"unprognostic (1.92e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.52e-2)"	0.2	0.2	0.3	0.0	0.4	0.1	0.2	0.6	0.6	0.3	0.0	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.2	9.9	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.6	0.3	0.2	0.3	0.2	0.3	0.1	0.2	0.6	0.4	0.0	0.0	4.2	0.5	0.0	1.3	0.0	2.2	3.7	2.1	2.2	1.2	1.5	0.6	0.0	2.1	4.8	0.1	0.1	9.8	0.6	33.8	0.9	1.4	1.1	0.0	0.0	3.5	1.1	1.0	1.1	1.5	0.9	0.0	1.7	0.7	1.3	0.9	1.7	2.9	0.5	0.0	0.8	0.0	66.4	2.1	0.4	0.0	1.0	0.1	1.3	1.0	1.0	3.8	0.2	0.2	1.9	1.6	0.6	0.4	2.8	0.0	2.0	0.0	1.3	0.8	20.5	4.0	0.8	0.0	3.3	1.2	2.5	0.6	0.7
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 951.6;lymphoid tissue: 1343.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 2537.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 424.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 424.6;T-cells: 143.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 3270.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		320000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	56.4	69.1	526.8	103.8	568.0	260.5	60.6	514.2	951.6	57.7	333.6	93.2	70.5	129.8	40.7	115.9	45.2	51.1	56.0	573.2	568.2	77.7	35.8	60.7	253.2	560.1	516.8	172.4	23.2	43.8	103.5	120.1	552.4	31.7	110.6	304.7	43.4	32.7	29.5	56.3	89.1	100.0	537.1	72.8	54.5	387.0	531.7	1343.2	33.6	29.9	246.0	58.9	76.0	791.9	1026.8	226.1	2191.0	882.5	128.9	126.0	225.7	776.3	609.7	1081.9	1037.9	157.2	1018.3	1260.3	426.3	572.0	425.8	304.6	618.6	450.9	1616.1	390.4	310.9	786.0	363.3	547.6	51.9	994.6	529.3	77.0	65.6	439.6	496.8	405.5	833.6	1594.4	1074.4	1203.0	1429.6	268.0	3270.7	1441.5	1350.8	615.1	302.8	1907.9	1709.2	740.7	536.9	91.7	1479.2	1282.3	710.0	348.3	638.4	695.8	500.7	1240.1	406.2	721.8	853.6	634.3	664.8	702.5	1212.0	1535.8	357.7	1904.8	798.2	13.4	4.1	23.5	53.9	8.6	32.2	37.0	47.8	68.2	23.2	45.6	77.8	71.6	1.9	56.3	4.5	424.6	143.3	57.2	526.8	568.0	514.2	951.6	573.2	568.2	560.1	516.8	552.4	537.1	531.7	791.9	257.3	41.7	31.6	32.7	125.1	201.6	148.9	350.0	577.7	454.6	91.0	175.1	77.2	31.5	100.0	174.7	64.6	439.3	261.7	35.1	226.9	148.9	917.2	92.8	100.3	196.3	250.8	505.7	109.5	20.1	604.1	134.9	121.3	141.1	262.0	712.4	109.2	15.4	530.1	195.2	73.0	100.9	567.6	87.3	287.0	2537.2	44.7	130.0	268.6	32.8	32.1	252.4	84.5	38.2	217.4	59.0	69.3	47.0	261.7	63.5	21.0	221.4	59.1	183.6	39.5	68.0	267.6	873.0	260.8	423.9	90.4	130.4	224.9	66.5	177.1	95.7
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102050-17131378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.8;gallbladder: 5.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.0	0.0	0.2	0.1	0.2	0.0	3.0	0.3	0.4	0.8	2.2	0.9	0.1	0.5	0.3	0.0	17.8	5.3	0.0	0.3	0.2	0.0	0.1	2.4	0.0	0.5	0.5	0.0	3.5	0.0	0.5	0.1	0.3	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.3	0.4	0.3	0.2	0.5	0.5	0.3	0.5	0.2	0.6	0.0	0.0	1.3	0.0	0.0	0.0	1.7	2.9	0.0	0.1	5.0	1.4	0.7	2.8	8.3	0.0	0.0	0.0	0.0	1.2	0.0	0.6	1.3	93.8	0.9	0.5	1.8	0.0	0.5	0.2	0.0	0.4	0.0	2.3	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.7	2.0	0.0	0.4	2.8	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.6	0.3	0.4	0.0	0.7	0.0	0.0	72.8	0.0	6.6	1.3	2.7	18.7	23.8	0.0	0.9	0.0	0.3	0.0	1.8	0.6
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STOML1	"FLJ36370, hUNC-24, SLP-1, STORP"	ENSG00000067221	"Stomatin like 1"	Q9UBI4	15	73978926-73994622	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042353	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 65: Brain - Ion transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA042353: AB_10797387"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	11.4	17.3	33.0	6.5	33.7	4.5	10.4	22.0	38.5	9.8	17.1	11.0	5.9	9.1	5.6	9.4	7.3	6.3	23.6	36.8	32.4	8.6	13.2	10.2	5.6	34.6	30.5	8.5	10.1	7.8	16.6	7.5	36.8	9.9	3.6	3.1	8.3	8.8	18.6	9.4	7.9	7.7	26.5	7.9	9.5	13.1	32.6	8.1	13.6	8.9	3.8	11.8	9.2	28.4	5.8	10.8	6.4	8.8	12.7	8.0	5.4	18.3	7.1	9.8	8.3	3.2	31.4	5.8	28.3	14.9	7.3	18.9	6.1	12.9	3.1	19.4	6.6	6.1	10.0	3.6	12.5	4.0	4.6	14.3	9.9	15.4	14.5	8.1	9.3	13.1	14.6	10.9	14.3	8.8	7.6	2.9	3.1	8.9	8.6	4.5	6.5	8.9	20.7	6.3	12.1	7.9	8.4	10.9	11.9	4.0	9.1	4.4	14.3	22.4	7.2	25.8	24.9	10.6	5.8	3.0	20.6	12.1	11.6	1.0	4.1	2.5	5.3	7.7	4.4	4.5	4.3	7.0	6.5	5.6	8.7	9.2	2.1	8.0	18.2	11.5	8.1	5.5	33.0	33.7	22.0	38.5	36.8	32.4	34.6	30.5	36.8	26.5	32.6	28.4	15.2	0.0	4.1	7.2	5.3	3.2	3.7	7.2	1.8	13.1	7.0	4.8	10.8	2.8	5.8	7.3	6.2	13.0	3.5	8.9	1.9	25.1	1.0	2.8	6.2	7.7	10.2	4.2	6.9	19.0	8.6	11.4	12.8	5.4	4.5	8.5	5.0	5.1	10.8	16.8	8.1	7.3	4.1	3.3	2.2	2.6	9.0	3.3	3.6	2.8	2.5	11.9	2.1	7.5	4.1	20.8	4.9	11.7	3.4	6.8	12.6	4.8	2.7	14.0	6.6	7.5	9.7	20.8	7.8	4.7	2.0	5.6	4.1	13.7	5.6	3.3
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	63.6	93.3	45.4	39.1	46.2	66.7	62.0	47.5	49.0	58.4	61.3	75.3	55.6	64.2	49.4	84.7	57.3	33.2	123.4	46.2	46.6	75.4	99.2	43.7	46.6	44.7	45.9	59.4	69.5	71.9	42.3	46.2	45.3	49.0	67.2	23.5	59.3	48.4	171.2	71.0	61.2	54.0	45.9	53.1	75.8	42.8	48.2	55.1	48.6	111.7	59.5	64.5	56.5	45.4	219.6	248.1	130.3	195.7	93.3	111.1	139.5	105.9	153.5	292.6	212.5	283.2	99.6	183.2	72.9	135.2	210.6	91.4	201.3	235.8	193.7	158.1	185.0	112.7	202.6	269.7	272.1	215.8	124.0	141.9	181.1	238.6	283.2	92.2	193.8	183.6	186.5	109.1	144.8	176.0	193.5	377.6	205.3	162.4	155.2	166.6	110.3	197.0	159.5	128.9	120.4	146.3	60.0	158.0	141.7	92.5	109.7	139.1	106.2	99.7	141.1	84.4	190.4	76.1	140.3	173.8	132.7	134.3	137.1	67.8	73.0	42.5	64.7	65.8	77.8	91.4	73.1	74.1	98.0	87.0	69.2	63.8	12.9	98.1	49.3	121.8	115.5	114.4	45.4	46.2	47.5	49.0	46.2	46.6	44.7	45.9	45.3	45.9	48.2	45.4	63.9	41.7	33.1	6.5	66.8	96.4	123.8	172.9	83.6	36.6	104.5	118.7	83.4	108.7	92.5	49.7	8.4	233.6	48.3	116.1	250.5	144.3	77.2	72.7	76.3	66.4	98.8	106.2	7.8	153.4	245.2	74.9	66.3	47.3	84.3	111.3	61.4	111.3	132.7	18.5	8.1	145.9	73.2	41.0	68.3	22.9	75.2	47.9	99.6	5.6	84.5	83.9	56.7	2.5	8.8	137.2	117.5	69.6	126.1	177.6	197.7	290.1	85.8	37.1	52.6	66.5	95.6	73.1	110.0	119.2	114.5	166.4	51.2	153.2	222.2	148.7
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38990859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 34.9"	"Group enriched"	"Detected in some"	19	"Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.4;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"AF22: 17.5"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 23.6"					"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.5	0.0	0.7	1.3	0.1	0.0	0.6	0.0	0.0	34.9	0.0	0.0	1.1	1.8	0.0	0.0	2.1	0.0	4.7	5.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.5	0.0	1.1	1.8	4.7	5.1	5.0	2.0	0.9	1.3	0.0	0.0	1.5	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.4	75.5	0.4	0.3	0.0	0.0	0.1	0.0	1.1	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	109.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1
STON1	"SBLF, stoned-b1"	ENSG00000243244	"Stonin 1"	Q9Y6Q2	2	48529383-48598513	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.0;Muller glia cells: 33.4;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 1.9;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.7;ASC TERT1: 28.6;HSkMC: 36.1;hTERT-RPE1: 17.0;SuSa: 19.6"	"Low region specificity"	"Detected in all"							HPA005715	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA005715: AB_1080113"	"unprognostic (1.61e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.49e-3)"	20.8	5.2	2.3	5.7	2.8	0.5	10.9	10.5	2.0	10.5	10.7	34.5	3.6	27.4	4.6	16.0	17.2	15.6	6.4	1.9	7.1	9.3	2.1	10.9	2.8	33.2	12.5	24.5	1.9	2.1	2.8	18.4	25.9	21.7	8.4	18.1	2.5	19.3	2.2	4.1	7.9	25.1	25.6	7.4	13.0	1.1	4.1	2.5	4.6	6.3	1.4	22.2	10.5	29.2	0.1	0.0	8.6	0.1	23.7	28.6	4.9	1.0	9.2	0.9	2.1	0.1	0.0	0.0	0.3	12.0	4.6	9.0	8.3	0.3	1.7	0.1	2.3	1.4	0.6	0.0	13.5	0.0	0.4	36.1	1.7	2.5	1.0	17.0	16.4	0.8	0.2	0.2	5.7	0.5	0.7	0.3	8.0	0.0	0.1	1.3	1.7	0.0	0.9	6.6	0.3	1.9	0.7	1.5	4.0	19.6	0.7	0.3	8.8	3.0	2.3	0.0	0.7	0.5	0.1	0.0	1.6	0.1	1.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.3	2.8	10.5	2.0	1.9	7.1	33.2	12.5	25.9	25.6	4.1	29.2	16.4	0.0	0.5	0.0	1.1	2.4	15.4	1.1	16.5	3.8	0.8	1.8	2.3	0.0	0.8	5.5	2.1	15.1	0.5	0.6	3.9	0.8	0.4	1.9	42.0	7.7	2.4	0.0	0.0	0.4	1.0	9.9	0.5	2.6	0.0	3.9	11.4	0.2	2.7	13.5	0.0	0.3	0.0	1.3	2.8	0.9	12.2	1.6	0.0	0.0	1.2	33.4	1.0	0.0	0.0	0.4	0.3	10.1	0.2	13.8	0.4	2.0	0.6	2.3	26.3	1.9	15.1	0.3	1.7	1.9	2.4	12.6	1.5	2.6	0.9	14.3
STON1-GTF2A1L	SALF	ENSG00000068781	"STON1-GTF2A1L readthrough"		2	48529925-48776517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 7.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.4;Excitatory neurons: 2.9;Late spermatids: 2.2;Oligodendrocyte precursor cells: 12.1;Spermatocytes: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;ASC TERT1: 2.0;HSkMC: 1.4;hTERT-RPE1: 3.6;SuSa: 7.3"									HPA005715	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA005715: AB_1080113"	"unprognostic (5.66e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-3)"		"unprognostic (8.26e-2)"	"unprognostic (5.08e-2)"		"unprognostic (3.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	2.2	0.3	0.4	0.8	0.6	0.0	0.3	2.9	0.6	1.6	2.0	3.6	0.2	2.1	0.5	1.3	1.3	2.1	0.2	0.4	1.1	0.6	0.0	0.4	0.0	6.7	3.0	1.8	0.0	0.0	0.1	0.7	7.1	0.8	0.9	2.1	0.0	0.9	0.0	0.0	0.4	2.5	4.8	0.5	1.0	0.5	0.8	0.1	0.1	0.0	0.0	2.6	0.4	6.5	0.0	0.0	0.8	0.0	2.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	1.4	0.1	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.9	0.6	0.4	1.1	6.7	3.0	7.1	4.8	0.8	6.5	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	1.9	0.0	0.4	0.0	12.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827531-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;choroid plexus: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;HAP1: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"	No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: AB_2675700, HPA037845: AB_10671369"	"prognostic favorable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	6.3	5.1	26.4	0.5	23.6	0.2	4.2	14.9	33.2	1.9	30.8	1.6	1.1	1.6	7.4	1.4	12.5	0.9	0.4	23.9	22.4	2.8	0.3	1.3	1.2	16.5	24.9	1.1	1.4	6.5	7.2	0.8	17.4	1.2	1.6	0.7	1.6	1.1	1.3	0.9	2.1	0.8	16.3	0.4	3.4	2.5	26.2	6.7	3.1	0.8	1.0	2.5	0.7	20.5	1.8	2.0	4.2	8.6	1.8	0.0	2.5	0.2	0.1	1.2	1.3	1.8	2.6	1.7	2.4	0.0	3.3	0.5	8.1	0.0	0.6	2.0	3.4	0.1	0.4	2.6	0.2	2.3	3.1	0.2	0.1	0.2	0.0	0.2	0.1	4.5	0.4	0.2	0.1	1.8	3.9	2.8	1.4	0.4	1.2	2.8	0.1	0.0	2.6	4.6	1.3	3.9	3.1	0.8	0.6	2.7	1.9	1.8	0.0	0.0	0.2	0.0	1.3	0.7	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	26.4	23.6	14.9	33.2	23.9	22.4	16.5	24.9	17.4	16.3	26.2	20.5	0.3	0.0	0.5	85.2	0.3	1.5	4.5	0.9	1.2	0.7	5.1	4.1	0.5	0.0	5.6	1.8	0.0	1.6	3.1	0.4	3.9	0.1	0.3	67.4	1.7	0.4	0.0	1.7	11.4	0.4	0.5	0.6	0.5	4.2	2.5	0.8	0.0	0.2	0.1	0.0	9.9	2.5	2.0	0.3	0.7	0.7	1.2	0.2	0.0	1.9	0.1	1.9	2.1	6.0	2.1	0.1	0.3	0.0	0.6	1.7	0.8	1.8	42.8	0.4	6.6	1.5	5.0	1.4	8.8	0.4	0.4	1.2	0.7	6.9	5.3	1.8
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155308	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	14.7	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.4	0.2	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRA6	FLJ12541	ENSG00000137868	"Signaling receptor and transporter of retinol STRA6"	Q9BX79	15	74179466-74212267	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040839	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.1	1.0	0.1	0.3	0.0	0.0	0.9	0.0	0.4	24.5	0.4	0.1	0.0	4.3	0.5	1.1	3.6	0.3	0.1	0.1	0.1	4.3	0.0	0.2	0.8	0.1	0.0	0.6	0.1	0.0	5.5	7.6	0.0	5.2	0.0	0.0	0.7	1.4	0.0	0.3	0.2	0.2	0.1	0.1	0.0	3.1	0.3	0.2	0.1	0.1	0.5	1.3	2.4	0.0	0.5	33.7	1.9	0.1	0.0	0.0	6.0	1.0	0.2	0.0	0.0	11.7	94.5	0.0	22.1	0.1	0.7	3.4	1.8	0.0	0.0	0.0	0.2	3.0	1.3	2.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	6.1	0.6	2.9	0.1	0.0	0.4	0.0	0.0	0.0	2.9	17.4	59.2	0.0	3.6	0.0	3.6	0.2	0.1	0.0	0.2	7.3	0.6	1.6	0.1	0.2	0.0	0.6	0.0	142.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	9.7	0.0	0.0	0.2	0.3	1.0	0.0	17.6	0.0	0.0	4.2	0.0	0.0	1.9	0.3	1.7	2.1	43.1	1.3	0.0	0.0	0.1	0.0	12.1	16.1	0.0	1.8	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	2.0	0.0	0.8	0.8	6.8	0.4	1.8	1.9	0.1	0.0	0.0	0.0	0.0	4.7	0.0	4.1	0.0	0.4	0.0	10.3	6.6	0.0	0.0	1.3	4.7	0.5	0.5	0.0	0.0	26.4	0.3	0.1	0.0	1.3
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20 related adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	21.3	28.3	32.2	12.7	32.9	18.3	19.6	31.9	35.8	23.9	30.0	23.0	8.8	20.5	18.2	21.1	23.0	13.4	23.1	32.9	32.6	27.8	23.0	19.0	20.3	34.3	31.8	24.7	17.7	19.1	26.4	13.4	32.6	22.5	11.6	13.9	15.6	14.3	14.6	20.8	19.4	17.2	31.0	32.0	20.5	49.0	32.4	20.1	20.0	10.1	20.4	22.6	20.0	32.8	12.7	37.5	31.9	32.3	30.8	22.8	12.4	23.8	21.6	33.6	29.8	9.9	14.4	19.5	14.4	20.3	16.7	10.5	21.4	23.1	33.0	21.5	20.7	38.4	25.9	23.7	21.8	36.7	26.5	23.9	19.4	38.2	22.1	22.3	37.6	30.0	24.9	20.0	32.2	23.6	43.4	25.0	16.0	10.7	21.2	27.9	50.8	23.8	30.2	24.9	36.0	39.4	16.3	26.3	26.1	32.9	19.7	26.4	30.5	31.7	22.5	25.8	20.0	19.9	22.9	24.3	23.4	21.8	25.7	19.2	9.5	8.8	9.6	6.9	8.8	10.3	8.7	10.7	15.8	7.5	8.5	7.6	10.8	16.8	10.7	13.3	7.3	8.0	32.2	32.9	31.9	35.8	32.9	32.6	34.3	31.8	32.6	31.0	32.4	32.8	6.4	9.6	7.3	48.0	12.5	0.0	0.1	0.5	6.2	2.1	3.6	3.4	0.5	0.0	2.9	9.2	0.0	2.1	9.3	1.2	0.0	7.0	1.1	8.6	9.4	3.7	0.0	3.4	49.1	2.8	0.9	4.7	6.1	7.2	2.5	12.7	0.7	0.1	1.5	1.7	47.5	2.2	2.0	1.3	1.4	2.2	0.6	6.7	0.0	27.2	17.9	1.2	5.2	33.2	71.4	4.8	2.0	1.5	10.2	0.4	1.9	2.0	2.5	3.7	0.0	2.0	4.1	3.1	1.2	4.7	0.4	2.5	9.1	9.3	2.0	0.2
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20 related adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 412.8;Proximal enterocytes: 124.0;Proximal tubular cells: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Uncertain	Aggresome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (4.93e-2)"	29.9	53.2	24.1	8.9	26.3	80.9	16.8	26.2	30.8	10.6	22.4	27.6	37.0	13.2	17.4	17.0	10.4	14.3	38.0	25.3	26.2	73.3	104.9	10.6	14.5	27.7	25.9	14.1	17.6	6.2	17.4	19.7	27.3	11.1	30.3	40.5	13.9	7.7	109.0	8.4	42.9	10.2	26.7	13.7	9.1	15.8	25.6	11.4	17.9	69.5	11.6	9.7	9.3	30.2	12.6	21.5	36.2	47.0	58.5	73.8	25.6	25.6	43.4	34.9	51.6	29.6	11.9	0.1	16.0	40.7	42.4	12.6	35.8	23.9	62.7	14.9	30.1	15.2	9.6	62.9	43.9	18.4	16.7	62.5	21.6	43.7	39.0	63.5	26.5	28.5	33.4	5.3	188.5	6.8	17.2	31.1	49.2	11.7	22.6	22.8	14.5	9.6	29.2	9.9	6.0	29.3	17.6	13.1	76.8	66.0	6.7	34.4	25.7	20.6	16.1	26.6	19.3	21.1	39.0	5.8	35.8	8.2	20.5	5.5	12.9	16.3	9.2	14.4	8.3	28.8	12.2	13.4	17.2	35.8	15.5	15.6	2.6	29.0	13.1	7.7	16.4	15.8	24.1	26.3	26.2	30.8	25.3	26.2	27.7	25.9	27.3	26.7	25.6	30.2	5.0	9.6	4.2	17.0	20.2	2.2	6.8	6.5	11.4	13.8	24.9	10.8	27.8	28.6	6.1	14.7	83.4	51.0	6.3	40.9	39.2	12.4	3.9	7.5	7.4	5.6	16.9	412.8	20.8	15.4	27.6	13.6	6.6	10.2	5.7	12.0	7.9	94.6	19.2	11.8	19.8	22.6	8.2	16.9	5.2	8.1	10.8	13.5	16.0	15.0	14.8	19.6	7.2	26.7	26.0	9.0	35.2	3.8	10.9	10.2	124.0	217.8	5.3	19.1	6.6	21.7	6.6	45.0	46.7	15.2	1.4	27.9	8.9	26.8	25.0	9.1
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882387-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.07e-4)"	"prognostic unfavorable (5.10e-4)"	70.4	70.2	48.1	54.7	52.5	51.8	49.8	44.4	63.7	51.8	41.4	55.5	46.2	52.2	50.5	60.9	44.4	46.9	93.1	54.8	65.3	84.9	80.3	46.8	54.9	49.9	54.5	40.3	72.0	83.9	58.4	64.6	61.6	49.3	52.8	85.5	48.8	48.7	135.9	44.1	44.9	68.8	47.6	40.3	48.5	50.3	59.0	66.5	77.7	114.6	57.2	70.4	41.3	50.9	195.6	226.2	209.7	179.8	182.3	180.6	280.5	227.9	158.2	200.8	186.4	325.9	167.2	215.6	110.6	233.5	199.3	138.0	254.6	251.0	293.2	291.3	206.1	218.6	163.8	144.7	298.8	258.2	102.0	176.9	209.7	224.6	248.6	221.6	237.9	139.6	170.9	63.9	264.3	137.3	215.6	122.6	743.6	124.8	145.8	162.4	289.7	124.5	232.5	197.8	134.8	228.8	184.7	125.5	258.7	415.8	235.5	135.9	201.3	149.0	177.0	160.3	284.7	73.0	106.1	351.5	183.7	140.1	193.9	74.2	73.9	65.8	66.3	87.4	75.1	76.1	67.8	64.2	92.5	66.7	65.8	70.0	33.7	64.3	80.5	56.8	92.2	84.5	48.1	52.5	44.4	63.7	54.8	65.3	49.9	54.5	61.6	47.6	59.0	50.9	111.7	38.5	45.2	19.9	111.2	243.4	177.6	131.5	116.7	90.1	87.8	65.9	104.0	51.5	84.8	66.2	35.5	154.3	121.2	41.5	275.9	171.1	44.3	63.2	82.1	100.3	106.2	103.7	42.8	137.2	201.2	109.7	61.7	78.6	46.3	112.1	71.7	82.1	108.8	60.6	43.4	59.7	128.1	86.2	143.8	86.2	69.9	89.4	128.1	22.5	99.2	207.9	93.7	24.1	33.9	144.2	66.1	102.0	119.5	218.3	56.0	228.5	58.9	100.9	78.9	96.4	139.0	168.1	80.4	115.6	227.9	295.1	111.3	135.2	95.6	192.5
STRBP	"FLJ11307, ILF3L, SPNR"	ENSG00000165209	"Spermatid perinuclear RNA binding protein"	Q96SI9	9	123109500-123268586	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 415.7;Inhibitory neurons: 256.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 157.0;U-698: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020651	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020651: AB_1857616"	"unprognostic (1.92e-2)"	"unprognostic (3.56e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.07e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (1.70e-10)"	"unprognostic (3.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-1)"	3.9	4.4	4.8	11.5	6.1	14.4	12.6	8.8	17.5	9.1	8.6	17.5	15.4	6.2	18.9	16.3	14.8	6.9	5.5	5.1	6.0	11.7	8.1	6.6	29.5	2.6	5.2	3.8	12.1	37.6	15.3	5.5	2.3	9.0	17.0	22.0	15.8	6.9	5.3	5.5	14.0	5.6	2.2	11.0	11.0	37.6	8.1	24.0	17.6	2.9	35.1	7.4	6.7	8.8	24.7	22.7	30.8	16.6	3.9	2.0	40.6	6.3	1.8	9.6	7.1	24.5	28.6	157.0	13.1	4.9	42.7	22.6	36.3	13.1	15.3	23.1	18.3	33.9	23.9	24.2	7.6	70.4	9.0	1.3	16.1	2.6	11.0	4.4	11.9	46.6	71.6	67.7	2.9	38.2	59.0	31.0	40.8	56.0	17.8	94.5	26.4	51.3	22.8	19.4	45.8	16.5	26.3	28.2	23.0	36.0	37.3	45.3	7.0	1.7	14.3	16.9	19.0	80.4	92.9	141.5	8.5	26.9	11.4	3.8	0.4	1.1	1.3	0.2	1.2	8.1	1.2	1.3	0.4	6.3	1.7	1.3	1.2	2.0	0.6	5.1	1.0	0.7	4.8	6.1	8.8	17.5	5.1	6.0	2.6	5.2	2.3	2.2	8.1	8.8	7.1	19.2	28.8	62.7	94.2	8.9	22.9	7.6	14.8	39.5	29.9	16.1	28.0	21.5	26.0	16.5	87.6	18.3	34.5	33.7	17.6	20.8	80.4	81.5	23.5	9.7	32.4	38.9	415.7	19.0	10.0	5.5	15.8	42.4	12.0	16.7	10.8	15.2	9.8	16.8	256.3	25.2	12.2	2.1	14.0	32.4	5.3	8.3	17.8	88.1	8.2	47.1	5.2	100.5	52.1	18.2	25.7	4.9	52.9	25.3	32.5	17.9	92.5	61.6	0.0	5.5	8.8	128.7	34.4	40.0	10.4	12.9	17.9	5.1	29.8	32.2
STRC	DFNB16	ENSG00000242866	Stereocilin	Q7RTU9	15	43599563-43618800	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 9.0;pituitary gland: 4.4;retina: 3.6;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Excitatory neurons: 55.7;Inhibitory neurons: 35.4;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048083	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA048083: AB_2732545"	"unprognostic (8.60e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.99e-4)"	"unprognostic (1.58e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-4)"	0.1	0.6	3.5	0.0	3.8	0.0	0.3	9.0	8.0	0.3	0.3	0.3	0.1	0.1	1.0	0.2	0.4	0.0	0.1	3.8	2.4	0.5	0.6	0.1	0.0	3.8	2.2	0.6	0.2	0.0	4.4	0.0	3.7	1.0	0.0	3.6	0.7	0.0	0.4	0.7	0.4	0.0	1.5	0.3	0.3	5.0	3.2	0.6	1.0	0.0	0.0	0.1	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.8	9.0	8.0	3.8	2.4	3.8	2.2	3.7	1.5	3.2	4.8	0.2	0.0	0.0	10.1	0.0	0.6	0.1	0.2	0.0	2.6	0.6	0.9	0.3	0.0	0.2	0.0	6.2	0.3	0.0	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.0	0.0	55.7	0.2	0.1	0.1	0.0	0.3	0.0	2.0	0.4	0.3	0.1	3.3	35.4	0.2	0.0	0.3	0.2	0.5	0.0	0.1	1.8	6.5	0.0	2.3	0.0	13.0	15.4	0.2	1.3	0.4	0.1	0.2	0.7	0.1	0.3	8.7	0.0	0.2	0.1	4.5	0.9	0.0	0.4	0.7	0.2	0.0	0.1	0.0
STRIP1	"FAM40A, FAR11A, FLJ14743, KIAA1761"	ENSG00000143093	"Striatin interacting protein 1"	Q5VSL9	1	110031577-110074641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060302, HPA060498"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA060302: AB_2684247, HPA060498: AB_2684293"	"unprognostic (2.75e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.23e-2)"	14.9	14.9	13.0	11.7	13.9	22.6	13.9	9.9	14.3	19.2	8.8	16.1	13.1	19.1	15.6	15.2	15.6	10.8	12.7	14.5	13.4	12.3	9.8	12.7	15.6	11.9	12.9	21.5	12.6	21.3	15.7	16.6	14.0	12.9	13.4	11.9	14.1	13.8	14.1	17.5	19.7	18.0	10.1	22.6	13.5	19.4	17.2	16.2	13.6	13.7	15.4	15.4	14.9	12.0	19.7	12.8	34.3	23.4	29.3	19.3	24.7	30.3	26.3	30.9	26.8	13.5	11.2	16.0	16.2	27.0	19.6	18.3	18.4	21.5	21.7	34.2	22.3	26.7	23.1	17.7	16.2	24.3	25.6	20.7	25.3	26.2	28.6	22.7	25.0	21.6	24.1	19.9	30.3	23.3	28.0	25.5	27.9	14.8	17.2	27.0	44.1	14.3	21.4	28.5	44.1	25.4	25.9	32.4	19.5	19.7	16.2	21.9	25.9	23.2	22.1	27.2	20.5	20.3	12.0	16.3	26.5	25.9	34.2	13.9	10.5	14.8	14.9	11.4	13.0	10.7	12.5	15.7	12.2	10.2	14.4	13.0	9.6	16.1	15.5	5.6	12.6	12.8	13.0	13.9	9.9	14.3	14.5	13.4	11.9	12.9	14.0	10.1	17.2	12.0	9.0	3.2	7.8	17.3	16.4	13.8	10.0	7.2	9.6	12.6	8.3	5.7	8.5	4.3	8.2	9.2	18.8	16.1	11.9	15.5	1.9	10.7	47.3	9.1	9.6	13.2	15.0	13.0	15.6	7.2	10.4	10.6	11.7	15.1	7.0	16.2	14.6	9.8	12.9	6.7	17.7	13.0	8.2	11.1	11.6	58.0	9.9	8.9	3.6	7.5	14.3	7.1	17.5	15.1	12.6	12.5	10.2	10.1	11.9	11.5	23.1	3.9	3.0	18.9	6.6	11.4	12.5	11.3	10.2	10.9	12.8	25.9	15.2	13.0	11.5	14.1
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434432-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;choroid plexus: 80.0;skeletal muscle: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.9;Cardiomyocytes: 49.5;Muller glia cells: 62.1;Oligodendrocyte precursor cells: 29.7;Spermatocytes: 79.1;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 41.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 44.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 102.5"	HPA019657	Approved		Approved	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.4	2.3	3.7	1.6	41.0	3.6	0.4	3.9	10.2	0.3	80.0	0.6	0.5	0.4	0.3	1.1	0.2	0.8	9.5	4.4	1.8	4.7	0.5	1.0	2.4	0.8	8.0	0.7	0.9	0.1	8.2	0.9	1.0	1.1	0.9	22.1	1.3	0.1	28.6	0.9	0.9	0.5	2.8	1.2	0.7	14.2	8.9	1.3	0.4	19.4	1.7	0.7	0.4	2.4	15.4	6.5	5.9	9.3	2.3	2.0	25.5	6.1	7.7	10.2	9.8	3.6	8.5	6.4	0.8	2.6	33.2	16.9	6.4	5.5	15.4	37.6	5.3	4.9	11.5	3.7	1.5	3.1	25.0	2.4	1.9	17.3	10.6	16.8	17.8	5.7	21.7	3.8	39.7	0.8	8.2	7.8	5.7	3.3	13.4	5.4	10.9	1.2	3.7	5.7	1.3	1.3	14.2	1.0	3.1	4.4	1.8	7.6	6.4	5.9	5.8	44.7	18.0	3.6	2.5	7.6	39.4	7.9	8.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	3.7	41.0	3.9	10.2	4.4	1.8	0.8	8.0	1.0	2.8	8.9	2.4	0.4	3.2	1.1	54.9	0.8	0.3	0.3	0.3	0.0	10.5	0.5	0.4	49.5	0.0	0.3	0.0	2.1	0.7	0.8	2.1	0.0	0.9	5.7	0.2	0.9	1.1	0.0	9.1	18.6	3.8	3.8	3.2	2.0	0.4	7.6	1.0	0.4	0.2	0.8	1.7	16.7	1.0	0.0	0.3	0.3	9.9	0.6	2.1	1.8	7.5	7.8	62.1	0.0	29.7	1.0	5.0	4.4	0.7	1.4	0.6	0.1	13.7	0.8	3.5	0.0	2.3	0.9	79.1	37.1	0.5	0.1	0.3	1.3	0.5	0.8	0.6
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.7	5.3	9.4	16.7	14.9	8.6	11.9	9.0	8.6	0.6	9.1	8.1	6.2	3.8	21.2	5.3	6.8	21.2	5.5	10.2	8.4	7.5	7.8	7.7	13.0	11.6	7.7	5.6	7.3	2.4	10.1	13.1	5.5	10.7	10.1	10.7	5.0	11.6	11.2	8.6	7.7	9.8	8.1	9.0	8.0	14.2	13.3	6.2	11.5	12.6	8.4	10.1	24.7	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	5.3	16.7	11.9	9.0	5.5	10.2	13.0	11.6	13.1	9.8	14.2	24.7	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
STRN4	"PPP2R6C, ZIN"	ENSG00000090372	"Striatin 4"	Q9NRL3	19	46719511-46746994	"Predicted intracellular proteins, Predicted membrane proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043051, HPA043527, HPA056706"	Supported		Approved	Cytosol		NA	NA		32000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214"	"unprognostic (3.57e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (8.31e-3)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (1.56e-1)"	"unprognostic (9.41e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.74e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-1)"	34.2	25.3	25.5	19.5	25.3	37.6	32.8	15.5	31.1	33.5	19.7	38.0	22.6	37.0	7.9	48.1	32.8	19.6	37.1	32.5	21.4	29.2	23.0	33.8	21.2	19.1	18.8	30.9	36.5	21.3	22.8	20.4	17.6	33.2	12.8	9.7	31.0	19.8	36.1	42.5	30.5	17.7	17.8	42.8	33.8	85.3	24.9	19.4	27.7	15.5	11.6	35.2	34.2	23.5	60.8	79.2	67.5	50.2	19.1	21.1	47.7	51.2	27.4	52.0	45.3	59.7	52.5	30.1	30.2	42.0	42.5	42.2	31.9	49.8	20.3	43.7	66.9	66.3	52.4	51.4	60.8	54.1	69.5	33.8	49.1	33.5	45.5	26.2	46.8	34.9	59.2	38.2	22.1	41.4	60.6	143.4	51.8	63.5	37.1	55.1	41.2	23.3	34.9	107.0	83.5	89.8	71.7	66.1	34.5	29.0	49.7	60.5	64.3	38.8	58.4	26.9	76.4	48.5	74.1	45.0	33.9	33.8	81.9	4.2	6.0	2.8	1.0	9.1	0.3	1.4	0.8	0.7	3.1	2.5	0.4	0.9	9.3	1.4	5.7	2.7	0.3	5.8	25.5	25.3	15.5	31.1	32.5	21.4	19.1	18.8	17.6	17.8	24.9	23.5	28.4	3.2	7.5	6.2	7.7	17.2	10.7	11.6	6.2	14.7	17.7	15.0	12.1	14.3	8.9	7.3	12.5	14.6	10.4	28.3	1.9	12.6	11.4	15.7	17.9	23.9	17.5	11.6	13.7	15.4	18.1	11.4	15.3	18.2	0.0	22.5	20.3	12.3	14.8	30.3	11.1	23.0	10.2	24.1	14.6	19.6	17.7	22.9	10.6	13.1	16.9	7.9	2.1	5.5	12.1	19.8	17.7	19.9	8.0	18.3	15.4	7.4	9.0	7.9	6.6	13.4	14.3	19.8	44.9	16.8	17.3	20.0	8.5	18.6	18.9	17.8
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7147237-7804358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 26.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 41.8;Excitatory neurons: 32.2;Inhibitory neurons: 39.3;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.5;RPMI-8226: 69.8;U-266/70: 110.2;U-698: 47.2"					"Low region specificity"	"Detected in all"			HPA002904	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	18.2	4.6	3.7	4.5	4.8	2.1	5.8	4.0	12.1	5.6	1.3	6.8	2.8	4.3	2.4	3.1	4.8	7.3	6.6	4.2	3.7	4.8	8.7	8.7	4.1	5.8	6.1	4.7	3.0	2.8	1.2	26.6	5.5	5.2	5.9	6.1	3.1	5.6	5.2	4.9	3.2	6.8	1.3	4.7	12.0	2.4	12.1	4.4	3.9	6.6	3.6	9.4	3.9	7.8	11.5	3.7	7.5	3.0	48.5	24.9	37.5	22.3	7.8	5.8	5.3	19.2	11.2	21.4	5.0	15.5	5.0	3.0	5.4	3.9	5.8	3.3	8.6	1.8	12.7	5.7	2.7	3.8	11.5	8.3	0.7	3.8	2.3	4.0	8.8	2.0	1.4	23.5	15.2	2.9	2.2	3.1	3.3	0.2	4.8	3.9	4.8	69.8	14.2	16.0	5.6	4.8	4.7	8.3	3.0	11.8	3.8	1.6	15.8	22.5	2.2	30.0	4.4	110.2	0.8	47.2	5.9	3.0	6.5	0.9	1.7	0.4	0.4	2.0	0.2	0.4	0.2	0.2	0.9	0.7	0.1	0.3	1.3	0.7	1.3	0.3	0.3	0.6	3.7	4.8	4.0	12.1	4.2	3.7	5.8	6.1	5.5	1.3	12.1	7.8	10.2	12.8	2.2	10.4	1.8	0.9	1.8	2.9	0.6	3.5	3.3	1.5	7.5	1.5	8.5	1.8	0.0	41.8	1.6	16.7	0.0	8.6	0.3	4.5	4.5	4.2	3.6	3.2	32.2	19.9	18.9	6.1	5.1	5.2	7.0	6.7	3.6	8.2	7.7	1.7	39.3	4.6	10.2	7.5	1.7	0.4	2.8	2.8	1.8	10.3	4.7	2.6	0.0	19.1	12.1	10.2	6.5	6.8	1.9	7.8	4.6	3.0	7.5	0.8	0.0	17.5	5.7	0.5	1.7	0.4	1.0	94.0	1.0	4.0	4.3	8.9
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3 oligosaccharyltransferase complex catalytic subunit A"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 391.8"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved					NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	38.5	39.2	14.6	44.6	17.7	31.8	55.8	17.9	16.9	84.9	29.8	54.0	42.2	60.8	140.4	30.2	56.3	39.5	38.5	15.0	20.1	45.8	69.0	39.0	32.9	19.4	18.4	68.0	69.0	391.8	29.0	63.8	19.6	56.2	59.5	40.0	80.1	77.2	18.4	31.6	42.1	58.9	17.5	34.4	51.4	44.5	17.5	34.8	83.9	24.4	48.8	50.4	33.3	23.1	113.1	99.5	123.7	173.6	230.1	176.4	133.8	198.5	238.5	158.6	196.6	304.2	294.3	143.6	236.2	297.3	222.4	202.7	173.5	176.2	208.5	114.8	90.0	341.0	63.7	215.1	254.4	208.4	153.6	138.4	125.8	219.5	424.5	186.1	182.2	63.9	147.1	210.6	205.4	82.7	84.4	65.6	78.6	221.8	106.0	98.9	107.1	221.5	173.7	170.1	77.5	66.2	142.9	229.3	72.5	144.9	267.8	148.1	164.5	227.7	82.0	97.6	159.7	66.3	82.4	109.6	87.4	206.3	184.7	96.2	46.7	36.6	56.1	45.4	77.9	42.8	53.7	52.0	65.2	32.1	37.1	44.4	15.7	52.8	41.8	158.3	44.0	47.5	14.6	17.7	17.9	16.9	15.0	20.1	19.4	18.4	19.6	17.5	17.5	23.1	17.4	28.9	25.0	6.8	20.8	16.2	14.3	40.3	12.5	11.6	15.2	9.8	23.3	27.1	29.1	16.5	20.9	45.4	21.7	16.1	1.9	30.1	10.6	22.9	51.0	17.3	15.6	19.6	7.6	27.2	73.4	33.0	26.0	57.0	17.1	29.0	32.2	38.5	30.7	1.7	8.9	37.3	20.3	23.6	31.9	5.4	21.5	17.3	24.9	9.4	12.6	13.2	11.3	11.6	10.9	28.6	12.2	18.8	91.9	19.3	15.6	13.6	23.6	15.1	19.7	23.1	32.8	33.5	13.1	21.9	14.8	45.6	14.6	22.3	26.9	13.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	80.2	126.3	185.5	35.6	186.9	48.9	76.0	183.8	242.7	74.8	173.1	100.3	50.7	67.0	60.3	86.8	65.3	42.1	151.1	187.3	185.3	91.4	100.7	65.0	52.5	188.2	184.2	65.7	93.7	90.6	93.7	23.9	187.9	80.2	32.6	33.2	86.6	53.5	201.8	111.7	63.1	40.1	180.6	70.0	86.2	45.1	193.5	42.3	72.9	125.2	38.2	80.7	69.1	188.0	81.6	107.6	59.4	108.0	123.4	102.5	43.8	112.8	95.1	100.9	90.5	131.0	97.1	83.0	78.2	147.5	69.1	69.7	73.0	137.3	42.9	93.6	318.8	53.4	154.1	104.7	183.7	85.9	96.4	141.1	134.3	118.2	71.4	76.3	106.2	72.3	87.1	119.2	149.3	318.4	90.1	85.4	76.4	107.1	127.5	143.5	46.8	200.6	132.5	72.6	121.1	103.4	89.4	165.8	137.1	35.9	114.1	147.8	108.7	104.3	99.8	94.3	125.9	137.6	150.2	132.3	83.8	73.9	122.0	17.7	13.6	21.7	15.7	12.9	14.5	19.6	13.5	13.8	12.1	21.0	12.8	11.6	13.4	11.2	13.9	20.7	13.2	7.2	185.5	186.9	183.8	242.7	187.3	185.3	188.2	184.2	187.9	180.6	193.5	188.0	96.2	38.5	27.9	24.5	88.9	114.7	107.2	63.9	83.1	93.3	137.1	158.7	1.0	104.4	52.4	130.6	52.1	80.1	101.4	142.7	285.7	139.6	8.6	82.8	69.6	71.6	76.0	68.5	23.2	169.7	93.8	85.7	68.3	65.0	21.0	97.9	80.3	122.1	113.1	84.1	21.1	101.4	85.5	69.4	94.9	16.7	109.0	79.0	117.4	15.0	154.4	184.3	110.2	14.1	24.8	190.2	110.8	112.1	108.6	160.8	165.5	324.1	61.2	83.9	72.3	82.3	129.7	50.4	62.4	107.0	120.5	100.7	96.2	132.5	109.3	118.8
STX10	"hsyn10, SYN10"	ENSG00000104915	"Syntaxin 10"	O60499	19	13144058-13150383	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035303, HPA056439"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA035303: AB_10671932, HPA056439: AB_2683135"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.54e-3)"	"prognostic favorable (8.26e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (2.39e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-2)"	45.3	58.7	42.1	35.6	44.3	72.3	47.1	45.3	52.3	65.5	47.0	57.2	47.7	48.7	17.1	80.7	49.6	29.5	56.1	42.2	41.7	60.9	78.8	66.9	42.5	44.6	43.3	50.7	48.3	27.9	49.1	17.0	43.1	49.9	19.8	11.6	52.0	20.4	35.8	68.2	60.7	20.9	40.7	87.0	60.3	17.7	43.6	35.3	56.6	16.6	28.2	51.4	55.4	48.5	99.9	68.8	51.8	138.1	51.5	52.8	17.2	55.4	49.4	46.1	48.4	31.8	88.3	66.5	80.5	66.8	33.7	76.3	44.9	67.0	26.6	113.4	86.0	60.8	154.4	66.5	38.2	71.4	63.2	54.3	55.3	57.4	37.2	62.8	58.1	85.9	32.9	34.6	31.8	87.2	105.6	125.2	55.2	51.3	112.5	117.3	54.1	96.6	44.4	47.2	60.0	121.3	57.9	66.2	127.6	14.9	45.1	67.9	58.4	75.3	38.7	145.9	77.5	78.1	75.2	57.0	98.0	172.8	59.8	41.5	162.3	120.4	48.1	128.4	40.7	39.9	41.4	48.7	119.1	40.3	36.3	37.3	267.6	32.1	151.5	31.2	51.4	80.7	42.1	44.3	45.3	52.3	42.2	41.7	44.6	43.3	43.1	40.7	43.6	48.5	31.6	16.0	21.6	13.1	29.9	35.4	34.5	52.0	31.3	21.3	43.0	37.5	12.6	30.0	53.6	20.2	6.2	17.7	32.2	54.3	27.4	42.5	1.0	23.9	28.3	31.3	16.3	33.2	16.6	56.1	26.2	27.6	40.8	24.7	53.8	33.7	31.1	18.8	82.4	13.5	11.8	48.0	46.8	86.7	45.8	3.0	25.1	62.0	48.0	7.5	86.1	21.4	48.4	11.1	14.0	57.0	53.8	31.2	25.3	19.9	77.9	28.3	38.2	17.1	26.3	21.2	31.0	9.0	16.2	38.6	43.2	19.4	39.1	23.6	55.5	38.4
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773219-27824443	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	64.2	30.1	38.1	26.6	39.0	10.8	37.0	40.8	45.6	28.8	25.4	30.7	36.3	30.9	62.9	39.2	23.9	39.8	20.9	37.3	41.7	35.2	29.1	50.0	25.6	42.0	45.3	22.1	30.3	46.5	26.6	33.3	43.6	30.7	32.5	43.2	26.9	32.1	21.4	27.0	32.8	35.9	42.2	30.5	65.5	13.4	38.4	17.3	94.7	27.1	22.2	39.1	23.4	44.6	23.2	10.9	28.8	19.0	53.9	65.0	14.8	47.9	70.3	43.1	48.5	13.5	29.5	25.2	49.6	64.6	18.5	19.0	19.2	23.9	42.9	22.2	22.8	14.4	12.0	13.7	42.2	16.1	29.0	61.3	28.7	60.6	34.5	35.3	70.3	14.3	19.1	24.6	47.7	8.5	13.7	12.3	12.1	34.3	15.3	8.7	23.1	15.5	38.1	37.5	32.3	17.6	22.4	19.3	35.2	23.3	13.1	14.0	76.2	21.9	12.5	50.0	16.6	14.5	11.2	14.3	35.1	24.1	31.2	24.6	35.7	13.7	6.1	39.4	10.6	13.6	7.3	9.7	25.2	10.8	8.1	6.8	16.5	9.2	40.6	12.4	7.9	17.4	38.1	39.0	40.8	45.6	37.3	41.7	42.0	45.3	43.6	42.2	38.4	44.6	93.0	54.5	36.3	25.1	43.6	109.4	97.2	30.7	51.2	46.2	42.0	25.7	18.9	30.0	40.8	57.0	31.3	30.0	28.3	82.8	37.2	51.9	2.0	34.7	33.1	71.1	41.3	17.7	70.9	58.4	33.5	53.2	108.6	49.4	22.8	26.7	47.8	20.4	50.6	26.9	65.7	29.5	14.2	91.4	77.7	4.2	36.1	62.3	53.4	56.2	41.3	67.9	36.0	34.7	59.1	68.4	58.6	47.4	33.9	74.9	51.3	69.7	27.4	51.2	39.5	45.7	57.5	20.0	20.1	69.9	99.2	78.0	31.6	54.0	29.9	99.9
STX16	"hsyn16, SYN16"	ENSG00000124222	"Syntaxin 16"	O14662	20	58651253-58679526	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041019, HPA042033"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA041019: AB_10964273, HPA042033: AB_10963935"	"unprognostic (7.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (7.32e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.89e-2)"	39.5	44.5	42.3	34.7	43.6	54.3	42.7	38.8	45.5	60.9	36.8	56.4	26.2	50.1	44.6	40.8	58.9	24.9	38.5	39.1	39.5	47.6	45.9	44.2	46.3	44.4	42.1	58.9	50.0	21.2	68.7	26.4	44.4	52.7	26.0	38.7	43.5	30.0	33.3	53.7	49.3	27.8	39.4	65.3	44.3	36.3	42.5	33.0	49.2	19.5	32.4	55.5	49.5	50.8	37.2	21.4	27.6	26.9	49.7	52.6	38.2	45.1	30.5	45.3	28.0	41.9	53.0	42.5	61.3	32.4	56.7	53.9	25.5	53.6	37.3	20.2	26.9	26.6	63.9	51.3	49.2	38.2	57.8	58.9	80.4	30.5	46.0	84.6	46.4	49.2	31.3	36.8	36.9	86.9	29.8	45.9	11.2	30.1	35.9	27.3	25.8	29.6	34.6	27.3	18.2	27.7	47.7	82.8	83.2	46.4	33.1	50.1	49.5	74.1	36.0	28.6	50.3	75.7	37.7	23.4	54.7	29.2	31.7	18.2	5.8	5.0	4.3	5.3	4.8	2.3	3.9	3.1	3.8	3.7	5.1	4.9	12.6	5.4	3.9	3.9	4.7	4.1	42.3	43.6	38.8	45.5	39.1	39.5	44.4	42.1	44.4	39.4	42.5	50.8	40.2	22.4	46.6	0.0	27.0	26.9	19.3	22.8	29.0	65.2	44.3	41.5	24.3	41.5	31.2	29.5	85.5	24.2	33.7	23.4	5.9	16.6	6.2	32.6	51.2	36.3	46.1	26.5	0.0	13.7	20.6	28.3	38.2	26.1	19.6	54.8	37.1	30.8	22.2	42.1	0.0	25.4	20.3	42.9	35.9	8.9	22.7	37.1	21.4	0.0	44.0	29.5	33.0	0.0	0.0	19.7	22.5	29.0	16.2	20.1	30.0	12.5	45.6	52.8	13.1	32.1	30.4	47.5	20.2	35.2	42.3	17.5	42.6	27.8	26.0	21.5
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906654-99974534	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	9.3	9.4	7.6	9.3	8.3	11.3	12.3	12.9	8.9	9.5	10.2	9.5	8.9	10.8	10.9	12.0	8.0	8.5	8.1	7.6	7.8	9.7	18.3	9.3	9.2	7.6	7.1	10.9	12.1	11.0	7.6	10.7	7.7	12.4	9.8	10.9	12.8	11.3	16.7	17.6	9.4	10.5	6.7	10.5	10.9	7.9	7.9	11.4	13.2	13.0	10.3	7.7	9.8	10.9	12.9	12.4	11.2	13.0	14.0	13.2	22.3	9.7	13.1	10.1	8.4	14.1	15.8	25.2	9.2	9.5	17.7	14.1	9.6	13.6	7.1	21.3	7.7	16.0	16.3	8.3	15.9	22.5	5.3	12.2	15.9	10.9	15.7	11.7	12.0	21.9	22.4	12.5	8.2	15.4	14.5	8.4	10.0	15.3	8.8	10.8	20.3	10.5	13.7	15.5	6.2	11.9	19.1	13.3	10.2	7.0	13.8	6.9	9.1	6.5	9.9	11.1	8.3	18.5	24.4	4.8	9.2	9.5	6.9	18.6	3.6	7.3	6.4	3.9	9.1	6.3	7.7	7.2	4.6	5.1	8.8	8.4	4.0	14.5	8.2	2.8	4.6	4.6	7.6	8.3	12.9	8.9	7.6	7.8	7.6	7.1	7.7	6.7	7.9	10.9	25.1	16.0	32.6	35.6	26.2	10.6	19.2	13.9	34.7	14.9	20.1	20.6	19.1	14.3	19.4	23.9	20.9	24.7	21.5	10.7	29.4	19.0	67.2	13.5	21.6	18.7	25.2	26.9	41.9	19.4	19.5	18.0	28.1	15.6	26.0	24.0	18.5	25.0	10.4	10.1	40.5	15.7	20.3	12.7	10.6	36.7	25.7	17.1	8.8	45.0	24.8	21.8	24.7	48.7	47.4	15.7	18.1	18.0	24.4	30.9	17.8	21.1	19.6	13.5	39.5	19.6	20.2	33.6	18.1	27.3	12.1	27.4	26.6	27.0	16.2	18.3
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 119.9"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	10.6	16.0	8.4	10.9	9.4	12.0	10.9	8.9	10.4	119.9	14.5	12.8	18.1	53.9	8.2	10.7	48.6	14.0	13.0	7.9	9.9	29.2	15.7	10.8	13.2	9.4	8.9	11.3	22.5	16.9	14.6	12.8	10.1	10.6	13.4	8.3	12.1	8.9	16.5	12.0	15.6	15.7	8.2	10.6	18.5	30.5	10.2	9.4	11.3	9.9	12.4	11.0	11.8	9.3	26.6	16.7	19.3	20.0	16.2	23.7	26.1	30.1	26.9	27.6	22.8	35.5	37.3	35.1	69.7	27.1	24.9	13.9	34.6	17.2	27.0	15.1	18.6	22.0	22.3	43.4	24.2	38.6	17.8	22.2	14.7	23.4	16.9	15.4	23.5	27.5	21.7	30.0	19.9	14.0	35.6	27.2	26.0	21.3	36.1	31.4	14.6	28.2	28.2	15.6	24.7	22.0	22.2	14.7	26.4	16.5	21.6	18.3	27.2	16.7	18.4	15.4	32.1	21.6	35.4	40.1	20.4	29.3	21.0	10.6	15.6	10.8	15.1	16.0	18.2	16.7	14.0	13.7	23.8	14.4	11.7	13.4	3.1	16.9	20.6	37.6	14.3	14.0	8.4	9.4	8.9	10.4	7.9	9.9	9.4	8.9	10.1	8.2	10.2	9.3	17.5	32.1	9.0	52.5	15.8	7.9	8.3	20.3	9.6	39.3	14.4	11.6	20.4	18.6	25.3	20.2	20.9	31.0	27.9	33.8	70.5	32.5	80.6	191.1	38.4	14.8	4.9	15.6	40.2	27.9	19.0	18.5	23.9	249.4	8.2	21.6	6.8	10.8	28.1	10.1	48.0	22.8	32.6	13.7	12.4	76.5	14.0	21.3	14.2	48.7	26.5	25.8	16.5	37.7	56.4	36.5	28.8	14.7	20.4	15.7	32.8	25.2	34.5	17.7	6.6	13.1	18.1	94.9	35.7	13.1	9.7	31.7	18.9	27.2	20.0	13.9
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014365-94028597	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.3;intestine: 13.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0"	"Not detected"	"Not detected"							HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.1	0.0	0.3	1.7	0.5	0.0	5.4	0.4	0.6	2.8	3.7	13.0	7.6	0.8	16.3	6.0	1.4	1.8	0.1	0.3	0.2	0.4	0.1	4.0	0.0	0.3	0.6	0.1	6.7	4.6	0.1	0.1	0.2	3.9	13.4	1.2	8.8	0.1	0.1	9.1	8.1	0.3	0.1	0.4	7.3	0.2	0.2	0.2	0.1	0.0	1.2	0.2	2.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	4.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.6	0.3	0.2	0.3	0.6	0.2	0.1	0.2	0.3	0.4	16.0	15.9	1.0	0.2	1.7	2.2	6.4	2.8	3.0	5.6	3.7	0.1	0.0	9.9	0.0	12.5	0.2	0.1	39.4	1.9	4.4	1.9	15.9	2.1	0.2	0.0	0.0	3.9	8.2	0.0	0.1	10.2	19.7	0.0	0.1	0.0	0.0	0.2	0.0	2.4	31.7	10.2	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.5	0.0	1.0	1.6	7.1	38.0	0.7	0.0	1.5	19.2	0.1	16.1	14.8	0.0	1.0	0.5	0.2	0.1	2.7	1.8	0.3	0.3	0.0	15.7	1.6
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 128.5;pituitary gland: 98.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 139.9;U-87 MG: 92.2"	"Group enriched"	"Detected in all"	5	"amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1"	"Group enriched"	"Detected in all"	8	"amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	2.5	6.8	55.0	2.5	70.6	11.9	2.4	28.8	128.5	5.3	13.3	10.8	4.4	3.9	1.5	1.8	3.8	6.8	1.7	76.1	24.5	3.4	2.3	3.4	1.0	16.8	20.1	3.1	10.8	0.9	98.5	2.3	17.8	4.6	2.0	2.5	3.0	1.4	2.1	1.8	4.3	2.7	15.8	2.5	7.8	4.6	23.3	1.2	2.7	0.7	0.6	4.1	4.1	55.3	4.6	21.9	3.4	10.1	4.4	11.7	2.3	14.3	9.5	5.9	3.9	7.4	12.2	5.8	2.1	10.3	32.2	3.7	5.0	9.2	4.4	10.2	3.9	1.8	8.7	4.4	4.9	2.7	5.2	6.8	3.8	41.4	14.4	26.7	10.4	0.9	4.9	6.5	11.4	10.8	1.7	21.1	2.7	8.1	47.8	0.0	2.4	5.7	4.9	3.9	139.9	22.5	4.3	12.1	3.0	4.0	3.9	1.8	39.7	28.9	9.6	22.4	39.0	3.7	2.5	2.7	92.2	2.2	34.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	55.0	70.6	28.8	128.5	76.1	24.5	16.8	20.1	17.8	15.8	23.3	55.3	0.9	0.0	2.8	8.1	0.4	4.2	10.7	6.2	0.6	6.2	4.6	3.4	3.2	4.3	5.9	1.8	4.2	0.4	5.0	1.3	0.0	4.0	0.1	4.5	2.9	1.6	52.7	0.4	60.6	3.6	1.9	2.2	3.1	11.1	15.2	2.2	1.8	0.2	0.7	8.4	16.6	2.8	8.2	1.2	2.1	0.2	1.8	6.1	3.6	5.6	0.1	1.0	6.2	8.5	4.8	29.8	1.2	1.5	1.0	10.5	3.4	0.5	7.4	1.9	0.0	1.9	2.8	1.6	3.8	0.6	2.7	0.7	5.3	1.7	1.5	18.9
STX1B	"STX1B1, STX1B2"	ENSG00000099365	"Syntaxin 1B"	P61266	16	30989256-31010638	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 137.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 36.8;Horizontal cells: 38.7;Inhibitory neurons: 31.1;Late spermatids: 13.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 5.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 137.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 11.1;hTERT-RPE1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079008"	Supported	Approved	Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB079008: , HPA069176: AB_2686098"	"unprognostic (1.43e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.40e-4)"	"unprognostic (3.90e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.57e-2)"	1.5	1.0	7.0	1.1	13.1	0.4	1.7	20.0	137.2	1.7	0.0	2.5	0.5	3.0	3.3	1.2	1.7	0.3	1.6	15.9	5.2	1.3	5.9	0.5	1.7	51.2	5.5	1.7	0.9	0.2	6.5	0.2	42.9	1.7	0.4	10.2	1.0	1.8	0.5	3.3	1.8	1.6	0.0	1.8	0.9	4.6	5.8	0.5	0.7	0.1	1.5	0.7	1.3	52.8	0.1	3.0	4.7	0.7	0.5	0.2	0.1	4.2	6.4	5.1	9.0	0.0	3.4	0.7	0.2	5.6	0.1	0.7	2.1	0.6	6.1	2.6	0.4	0.4	2.7	2.4	0.4	0.2	2.9	1.6	0.1	11.1	1.0	20.4	0.0	1.0	0.5	0.2	5.5	1.3	2.0	0.2	2.3	0.0	0.3	7.1	0.2	0.2	0.4	0.0	6.3	4.0	0.5	0.2	0.0	0.7	0.8	0.1	0.8	3.0	2.4	0.4	0.2	0.3	0.2	0.3	3.3	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	13.1	20.0	137.2	15.9	5.2	51.2	5.5	42.9	0.0	5.8	52.8	0.4	0.0	0.0	7.2	0.6	0.8	0.1	0.2	0.6	10.7	0.4	0.6	1.2	0.0	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.3	6.9	0.1	0.5	0.8	0.0	0.4	36.8	0.4	0.0	0.7	0.0	0.1	0.0	2.5	1.1	5.9	0.6	38.7	31.1	0.2	0.0	0.6	1.1	13.8	0.3	0.3	0.0	4.7	0.7	1.8	0.0	9.0	5.5	0.2	0.0	1.9	0.0	0.2	0.9	2.1	0.0	3.2	0.0	0.8	0.7	4.6	1.3	0.2	0.6	0.8	0.4	0.1	0.3	0.0
STX2	"EPIM, EPM, STX2A, STX2B, STX2C"	ENSG00000111450	"Syntaxin 2"	P32856	12	130789600-130839266	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 152.2;Endometrial ciliated cells: 86.4;Late spermatids: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079007"	Uncertain	Supported	Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Nuclear membrane"	"CAB079007: , HPA069176: AB_2686098"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-3)"	17.7	11.0	11.2	9.1	11.7	6.4	12.0	12.3	13.4	15.1	24.7	21.2	4.2	14.3	9.8	6.0	16.3	9.9	17.0	12.2	12.1	14.4	13.3	17.8	8.6	15.5	12.3	15.3	10.9	5.9	14.6	13.2	14.5	8.4	6.8	16.7	5.0	10.6	6.7	5.1	11.4	17.2	13.0	12.4	11.4	17.0	11.8	6.9	12.4	7.9	6.2	14.5	10.7	16.3	9.6	18.3	26.8	22.4	27.8	63.2	2.8	44.2	35.8	50.8	35.7	5.5	6.6	11.7	6.6	50.5	16.4	2.8	24.4	6.6	54.9	18.7	9.2	6.4	15.9	15.7	30.6	9.2	15.5	23.4	8.3	24.9	20.1	48.2	27.6	12.7	25.7	11.2	46.2	5.6	13.3	10.6	17.9	2.9	28.2	13.7	18.9	7.0	28.7	2.1	24.3	25.4	20.4	1.8	18.1	23.4	6.1	6.4	36.5	30.1	20.3	33.1	19.6	8.1	6.7	7.9	35.0	10.8	24.4	1.0	0.4	0.6	0.5	0.5	0.5	0.5	0.6	0.5	0.3	0.3	0.6	0.6	0.4	0.2	0.2	0.3	0.4	0.2	11.2	11.7	12.3	13.4	12.2	12.1	15.5	12.3	14.5	13.0	11.8	16.3	35.3	22.4	14.8	20.5	6.2	3.4	1.2	2.1	3.4	5.6	2.1	3.0	17.2	11.5	6.9	29.5	0.0	1.8	12.3	0.4	9.8	19.1	152.2	86.4	40.0	22.4	6.7	32.4	33.6	7.4	7.1	26.5	2.6	7.6	1.3	10.9	17.9	19.0	11.5	0.0	17.6	0.7	2.0	11.5	12.3	114.4	28.0	15.1	14.2	23.4	10.3	12.3	6.2	15.1	24.3	14.5	0.1	24.5	10.2	2.0	0.1	17.6	33.9	31.4	13.1	26.1	29.6	42.0	34.2	1.7	1.4	0.8	14.2	11.7	0.6	0.5
STX3	STX3A	ENSG00000166900	"Syntaxin 3"	Q13277	11	59713456-59805882	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 313.2"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 74.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 167.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002191, HPA069176"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nuclear membrane"	"HPA002191: AB_1080165, HPA069176: AB_2686098"	"unprognostic (2.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.07e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-2)"	16.4	24.1	10.1	23.7	11.8	59.2	20.1	18.3	14.6	21.1	11.8	51.0	59.5	29.7	36.7	21.4	15.1	39.1	16.4	10.8	11.2	58.6	15.4	40.7	9.7	11.7	11.9	18.7	24.0	34.1	19.4	50.3	13.4	20.2	56.3	313.2	21.6	24.6	10.9	26.2	44.1	26.4	9.7	23.4	47.5	22.1	12.4	7.4	27.8	17.9	13.8	28.3	18.3	13.1	40.1	23.8	0.9	11.0	20.5	11.5	33.1	21.1	37.7	49.4	61.0	109.4	38.2	11.2	38.9	16.1	85.6	44.0	63.5	22.0	59.4	9.6	12.0	12.7	16.4	34.0	51.1	41.7	116.4	21.0	46.6	38.3	46.2	30.5	39.7	16.6	110.5	23.0	21.5	23.8	0.4	28.9	60.1	63.1	18.2	14.5	40.8	18.6	92.7	94.5	27.0	41.4	9.0	48.0	167.2	79.9	52.1	29.0	54.0	20.8	44.0	28.6	19.3	25.8	49.4	22.8	27.8	27.0	29.0	42.5	6.3	74.1	2.4	1.9	2.5	1.0	3.3	1.6	7.1	3.1	3.0	0.9	60.7	0.5	1.2	1.0	0.0	2.7	10.1	11.8	18.3	14.6	10.8	11.2	11.7	11.9	13.4	9.7	12.4	13.1	17.0	67.3	30.6	2.6	9.5	50.7	69.5	12.8	30.1	373.0	43.5	15.2	10.2	31.5	18.9	11.0	394.0	10.1	5.9	124.6	17.6	40.2	4.8	37.8	9.6	30.2	26.3	4.4	40.4	25.6	15.9	12.8	29.6	68.5	58.2	14.9	20.7	5.6	16.0	72.3	33.0	36.5	18.3	18.9	49.7	7.5	3.7	26.4	37.4	24.4	28.7	48.4	11.3	3.5	25.3	48.9	64.1	7.5	5.8	87.2	34.0	69.5	13.3	400.3	6.6	10.0	15.9	4.6	20.6	29.4	60.1	40.5	17.9	5.6	26.5	87.7
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	38.3	44.0	33.1	34.2	36.2	22.3	33.9	37.4	36.4	36.3	32.3	37.5	38.3	31.4	24.4	35.8	29.8	27.7	39.8	33.2	37.8	33.5	35.8	36.2	31.1	38.0	36.6	30.4	27.7	38.4	23.2	32.3	37.7	29.9	28.6	8.5	29.9	26.5	45.8	44.3	35.9	31.6	36.1	43.7	32.4	14.9	36.2	28.4	29.5	33.8	37.1	38.1	32.6	39.0	51.9	70.6	16.0	36.1	51.1	52.1	33.8	47.7	79.2	47.5	48.7	22.1	53.2	35.4	58.9	80.8	54.4	36.6	15.2	52.6	45.6	60.3	43.8	25.3	48.7	59.7	58.3	29.2	80.1	50.2	36.1	82.1	61.1	58.5	64.3	22.3	29.9	38.6	84.9	80.3	28.0	44.8	33.1	36.9	36.7	24.0	47.1	46.1	45.9	38.7	13.1	24.6	40.6	41.1	17.4	20.7	33.7	38.7	74.4	48.3	21.8	55.8	26.6	41.2	37.0	14.6	73.3	46.4	29.7	21.3	21.7	27.3	17.6	23.8	15.4	12.7	14.7	17.9	18.8	17.5	11.0	14.2	23.0	24.6	21.9	11.1	9.0	11.2	33.1	36.2	37.4	36.4	33.2	37.8	38.0	36.6	37.7	36.1	36.2	39.0	34.9	44.8	22.7	7.8	32.6	65.1	34.6	56.3	31.9	7.4	22.3	20.6	23.6	48.6	35.2	22.0	12.5	31.1	35.9	69.7	29.4	60.6	12.9	22.1	26.6	46.0	25.7	11.1	4.8	67.7	35.7	51.7	43.3	29.0	60.3	42.1	33.9	20.0	89.5	5.0	3.6	39.5	38.7	49.6	149.9	15.7	38.5	83.2	30.2	2.8	51.7	24.1	42.2	3.0	16.0	73.4	58.5	35.3	23.0	61.6	77.7	50.8	31.3	6.9	39.5	40.6	36.4	9.4	6.7	27.0	65.1	33.1	35.4	39.0	47.9	36.2
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		380000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 57: B-cells - Immune response"	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	35.1	17.7	17.6	41.5	20.4	21.6	21.2	20.8	21.1	22.5	11.5	25.1	37.2	27.2	12.1	33.7	22.1	33.5	36.0	19.8	21.0	51.1	18.3	31.5	76.3	23.2	22.2	30.9	14.3	20.5	7.4	42.9	22.4	19.5	29.1	15.9	20.6	25.9	23.1	20.4	37.9	29.2	21.2	45.5	28.3	8.2	18.0	17.7	30.8	22.7	71.8	26.2	16.6	29.3	17.5	17.5	28.7	20.6	56.4	49.9	22.6	33.9	34.7	34.4	49.3	30.9	28.9	87.6	32.7	41.1	51.0	22.8	25.5	31.2	46.6	30.2	30.4	33.1	14.6	33.0	44.6	22.8	24.2	28.6	28.5	35.3	31.6	46.5	37.8	19.2	36.1	30.7	39.8	24.8	10.4	18.2	11.0	25.4	20.2	24.6	22.5	25.5	57.9	20.4	23.5	7.1	15.3	24.9	91.9	42.2	17.0	21.2	66.4	20.1	20.5	44.1	36.6	29.1	18.2	37.2	28.3	17.9	23.2	53.6	51.6	49.1	10.8	58.1	4.4	85.9	8.0	7.7	61.6	106.8	5.7	6.8	83.2	9.5	61.6	73.9	12.8	31.3	17.6	20.4	20.8	21.1	19.8	21.0	23.2	22.2	22.4	21.2	18.0	29.3	37.7	70.5	36.5	34.0	151.6	42.1	23.5	33.8	26.7	26.8	26.7	22.2	51.0	85.8	33.1	42.3	2.1	85.7	111.5	50.8	64.6	56.9	1.2	27.9	33.4	38.3	13.2	57.9	61.3	30.9	54.5	34.1	42.3	28.0	40.6	25.9	43.5	19.4	177.6	37.0	60.6	39.8	38.7	99.4	78.7	2.1	30.7	109.6	133.4	109.6	110.7	25.7	54.6	44.2	77.9	57.6	63.1	46.3	37.3	24.7	113.5	155.0	43.9	16.5	39.5	30.2	38.6	2.7	17.6	36.2	41.2	55.4	24.4	17.9	28.4	24.9
STX8	CARB	ENSG00000170310	"Syntaxin 8"	Q9UNK0	17	9250471-9576591	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 261.6;Late spermatids: 964.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001540	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA001540: AB_1080168"	"unprognostic (8.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	50.7	42.9	51.1	21.7	51.9	42.9	45.6	52.3	72.9	46.8	53.0	59.5	23.1	41.5	64.2	35.6	38.8	28.5	56.2	51.6	51.4	46.3	48.0	35.4	32.8	52.4	51.9	42.6	45.2	42.8	33.7	29.1	53.1	40.2	38.7	32.3	42.8	41.0	64.0	39.7	34.1	42.4	52.7	35.7	43.3	76.2	51.6	43.5	42.8	61.5	39.4	48.6	41.9	54.5	35.1	65.9	54.6	28.9	86.2	107.7	24.6	40.3	69.4	55.6	73.5	22.5	27.6	42.3	34.6	79.7	48.0	37.7	35.5	76.6	86.2	66.6	59.2	26.7	19.0	52.5	117.4	20.3	47.1	87.9	120.9	43.8	65.7	66.5	67.2	44.8	13.2	18.8	62.5	18.5	39.9	41.6	14.2	41.5	34.2	56.2	46.6	25.9	71.8	32.6	7.3	34.7	30.8	16.3	48.2	73.8	21.3	32.3	61.0	42.8	26.6	24.5	54.3	17.5	17.3	16.3	64.1	47.4	39.6	117.0	142.5	159.3	124.3	128.0	113.5	117.0	133.3	139.5	142.6	108.8	85.6	100.7	40.9	167.4	132.6	123.1	198.8	197.8	51.1	51.9	52.3	72.9	51.6	51.4	52.4	51.9	53.1	52.7	51.6	54.5	39.2	32.1	27.0	65.3	37.0	45.8	52.8	83.8	23.3	15.2	32.8	36.2	61.5	31.5	58.5	29.5	12.5	55.9	49.8	34.6	103.7	62.3	261.6	31.4	33.2	33.9	25.0	25.2	79.7	82.8	55.3	49.3	23.0	27.7	54.5	33.5	29.3	38.6	87.1	6.7	63.0	41.2	85.5	46.3	84.0	964.1	46.3	43.6	78.2	89.9	70.4	58.4	107.1	91.0	86.9	69.9	58.1	47.4	23.5	23.8	66.2	93.5	45.0	24.3	13.1	33.9	59.7	58.6	23.8	29.4	44.6	43.4	54.2	20.1	31.2	38.7
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 194.2"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 262.5;Macrophages: 249.1;monocytes: 368.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 248.6;classical monocyte: 471.0;eosinophil: 295.6;intermediate monocyte: 604.8;myeloid DC: 239.7;neutrophil: 356.2;non-classical monocyte: 893.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 239.7;granulocytes: 356.2;monocytes: 893.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 244.8;U-937: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		No	No		870000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.68e-4)"	"prognostic favorable (5.13e-6)"	24.2	22.8	5.2	65.9	6.3	194.2	24.3	4.8	10.9	22.2	9.3	52.5	67.4	8.4	33.2	73.1	27.7	28.4	7.5	5.1	6.2	62.4	49.0	89.6	51.0	8.3	6.6	5.3	86.7	36.1	29.4	36.3	7.9	52.1	37.0	4.2	79.4	22.8	2.9	52.3	63.9	14.6	6.7	162.2	71.9	74.9	8.8	85.3	52.0	3.0	34.6	34.6	34.8	9.3	113.0	39.1	0.9	0.5	0.0	0.9	75.6	14.2	1.5	2.7	7.4	92.5	69.6	29.6	55.4	11.3	49.5	75.5	4.1	67.5	2.7	124.1	46.9	127.8	49.7	55.8	63.6	83.2	244.8	4.4	67.4	13.4	38.0	0.3	58.5	74.7	81.4	98.5	0.0	70.9	41.2	193.2	28.7	72.7	68.0	41.8	0.3	114.7	55.0	128.1	11.5	0.6	34.0	49.6	2.2	35.6	61.9	212.7	61.7	0.4	21.8	1.5	0.8	108.4	58.6	38.8	1.2	224.8	2.7	248.6	471.0	295.6	69.9	604.8	56.7	47.3	52.7	63.8	239.7	52.2	36.6	44.3	356.2	74.7	893.3	91.5	78.9	306.9	5.2	6.3	4.8	10.9	5.1	6.2	8.3	6.6	7.9	6.7	8.8	9.3	2.1	0.0	7.7	0.7	44.1	23.6	48.2	105.1	18.8	6.0	38.0	22.9	0.9	31.5	68.5	35.0	2.1	97.7	56.2	181.4	33.2	100.3	99.9	32.5	5.4	6.7	59.8	38.3	0.6	118.8	123.2	5.7	150.3	47.6	71.8	34.6	16.4	19.6	168.4	0.0	0.4	108.2	105.8	262.5	46.6	233.5	1.8	249.1	14.2	1.0	368.2	0.9	72.1	0.0	0.0	132.8	152.6	1.9	54.7	49.1	171.7	75.9	42.5	4.0	6.6	1.0	8.6	45.7	20.2	35.3	21.3	153.0	47.7	6.0	79.3	68.7
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 41.7;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	1.4	2.0	2.3	1.7	2.3	1.4	1.8	2.2	1.7	2.2	7.8	1.7	2.5	2.8	1.7	1.9	2.8	2.6	1.8	1.5	3.1	4.3	0.9	2.1	1.2	3.2	3.9	2.9	1.5	6.0	2.0	1.8	2.8	3.0	1.7	4.5	1.4	3.5	1.1	1.0	1.4	2.7	3.0	1.1	1.6	2.1	3.2	1.8	3.1	1.0	1.2	1.9	1.3	3.7	5.0	7.3	6.6	5.9	5.5	5.4	2.7	3.8	3.6	4.8	4.7	4.3	2.6	3.4	7.9	3.8	4.2	2.9	8.6	3.8	8.9	5.1	4.9	4.4	4.8	8.9	2.3	2.8	1.3	6.1	1.1	7.0	1.6	2.2	4.9	2.9	7.2	2.6	5.8	2.2	9.3	1.8	4.8	4.2	5.2	3.9	7.7	2.0	8.6	3.0	6.3	4.8	5.8	0.9	3.2	3.5	8.4	1.9	3.8	6.8	5.2	4.2	4.0	2.3	2.3	5.8	4.4	3.6	4.1	1.7	0.4	0.0	0.9	0.3	1.0	0.7	0.8	0.6	0.5	1.1	0.7	0.9	0.1	2.2	0.5	1.1	0.8	0.3	2.3	2.3	2.2	1.7	1.5	3.1	3.2	3.9	2.8	3.0	3.2	3.7	6.6	0.0	9.1	39.5	3.9	0.9	2.4	3.3	4.6	5.6	4.4	3.3	9.6	2.8	5.4	9.2	41.7	1.6	2.1	2.0	9.8	6.0	6.7	16.6	14.4	4.3	6.0	5.2	29.0	2.7	1.9	7.5	6.1	5.8	7.6	6.1	6.1	5.1	2.3	8.4	25.5	1.4	0.0	2.4	1.4	5.3	17.7	2.4	7.2	20.6	2.1	5.9	1.0	84.4	39.3	3.3	2.1	11.7	1.6	2.2	4.9	7.2	17.4	21.6	32.9	8.8	11.4	11.1	7.3	2.8	3.0	0.3	4.8	5.1	3.1	1.2
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 115.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"HEL: 210.2;HMC-1: 219.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	7.0	9.1	7.2	9.5	12.7	34.3	7.8	24.2	13.2	9.5	0.0	14.2	8.0	8.3	7.7	13.7	5.9	9.5	5.9	9.5	6.5	3.6	3.9	6.6	7.8	0.6	0.5	5.5	15.5	115.8	7.7	6.3	0.5	11.4	16.3	20.1	5.5	14.5	7.7	15.4	11.2	10.9	0.0	8.3	8.0	22.2	0.6	9.4	6.3	8.1	9.6	8.5	9.9	8.5	10.8	9.4	4.9	16.5	23.4	48.8	5.4	24.5	36.1	17.8	19.9	8.0	7.0	7.8	5.6	48.8	30.5	12.7	14.1	21.5	21.6	17.1	11.0	210.2	27.2	9.0	26.8	72.7	219.6	35.6	15.0	35.6	72.0	42.1	23.2	12.2	57.8	9.6	35.4	15.7	11.6	18.8	4.0	8.9	21.4	1.7	25.4	3.0	9.7	18.4	10.6	7.6	18.9	13.3	8.2	8.7	3.9	28.0	26.9	25.4	9.2	12.6	22.5	7.9	0.1	9.1	14.0	26.2	18.5	3.8	0.3	9.2	0.9	0.4	0.9	0.3	0.5	1.1	0.4	0.9	0.8	1.3	3.1	0.4	0.5	0.3	0.2	0.3	7.2	12.7	24.2	13.2	9.5	6.5	0.6	0.5	0.5	0.0	0.6	8.5	12.1	16.0	8.8	325.8	5.7	3.6	2.6	1.9	3.4	38.8	6.7	7.7	14.1	11.5	6.7	16.5	31.3	5.2	9.5	18.7	0.0	4.8	39.0	10.1	10.5	10.8	41.1	10.1	441.9	12.9	4.6	10.1	14.3	20.5	44.2	5.1	8.9	4.5	4.7	33.7	300.1	30.3	0.0	7.8	3.1	42.8	7.8	7.8	10.6	97.4	8.5	5.4	6.2	206.1	150.4	11.7	21.4	7.2	5.8	10.4	29.3	1.9	2.2	29.0	13.1	12.7	5.6	13.1	11.5	11.0	6.7	3.8	9.3	5.4	19.3	3.6
STXBP6	"amisyn, HSPC156"	ENSG00000168952	"Syntaxin binding protein 6"	Q8NFX7	14	24809656-25050297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 128.6;Inhibitory neurons: 180.6;Oligodendrocytes: 188.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.6;Daudi: 50.7;HBF TERT88: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003552, HPA074869"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003552: AB_10603343, HPA074869: "	"unprognostic (1.52e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.73e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-3)"	7.3	0.8	18.5	3.8	19.6	0.2	5.0	16.2	27.7	13.5	0.6	11.9	12.3	7.5	38.1	6.0	7.0	11.0	24.7	18.9	21.6	3.6	4.3	26.3	1.6	23.9	23.6	2.8	39.5	23.0	1.0	42.8	17.8	12.7	14.8	2.1	15.0	9.5	4.4	15.0	18.5	5.1	11.4	0.7	9.8	4.4	42.1	7.8	18.0	7.6	5.5	12.3	2.6	19.1	0.1	1.0	2.0	0.5	12.9	22.3	0.2	15.1	40.2	35.5	37.5	48.6	0.3	50.7	0.1	42.6	0.0	0.1	0.0	0.1	64.1	27.2	3.2	12.1	0.4	37.0	9.4	0.9	6.3	3.3	0.0	0.0	0.2	2.0	0.0	1.4	0.5	16.9	34.2	9.7	0.2	0.1	6.6	25.4	0.0	0.0	28.1	0.4	0.0	2.8	2.3	0.1	0.1	7.8	42.6	4.3	0.5	0.7	0.0	6.4	17.2	41.2	2.1	5.1	6.0	2.4	21.8	0.3	24.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	18.5	19.6	16.2	27.7	18.9	21.6	23.9	23.6	17.8	11.4	42.1	19.1	50.3	51.3	7.7	128.6	0.4	67.7	48.4	0.1	20.5	0.6	2.9	3.3	27.4	64.3	3.4	20.2	0.0	1.4	1.7	12.6	0.0	47.9	20.4	38.8	4.9	35.8	40.7	8.6	72.9	98.7	1.5	44.9	20.4	72.8	42.6	0.8	36.8	5.8	20.1	0.0	180.6	64.6	2.0	1.0	11.0	4.6	1.5	2.9	110.3	113.4	2.0	2.7	0.0	113.6	188.1	39.9	49.6	1.2	3.1	73.9	71.8	9.6	0.0	0.5	0.0	16.4	6.5	12.6	19.7	4.1	48.2	4.0	3.2	0.0	51.7	16.4
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
STYX		ENSG00000198252	"Serine/threonine/tyrosine interacting protein"	Q8WUJ0	14	52730166-52774989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.1;Late spermatids: 92.5;Spermatocytes: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040290	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA040290: AB_10963686"	"unprognostic (5.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.84e-3)"	9.4	3.7	3.3	8.8	4.3	5.8	7.6	4.3	4.3	5.6	2.9	6.0	5.7	6.8	4.7	9.1	4.7	5.8	8.7	2.6	3.5	5.8	26.7	5.8	14.0	4.6	4.3	6.8	5.8	4.8	2.2	9.5	4.5	6.3	6.5	3.9	5.7	5.8	11.4	8.1	5.7	6.9	3.8	9.1	6.6	10.9	3.9	9.4	5.6	12.9	12.4	7.4	4.8	5.4	14.4	7.8	10.5	12.7	17.5	24.9	20.0	16.9	12.6	12.1	12.2	11.3	10.3	17.7	14.1	16.0	10.2	11.1	13.1	13.8	21.3	16.0	5.0	9.1	8.3	15.0	14.5	14.5	11.5	17.9	16.4	16.0	16.4	10.9	22.2	15.7	11.0	16.6	16.9	19.9	16.3	9.5	12.7	16.1	15.9	13.6	14.1	10.5	15.8	16.1	2.4	7.0	17.3	11.5	11.4	14.6	28.1	14.5	20.8	21.1	13.4	23.1	10.7	6.1	8.8	10.8	6.8	9.6	18.3	7.7	4.4	3.7	5.6	6.1	7.4	6.1	9.2	7.6	4.8	3.8	10.6	8.2	2.2	4.9	5.8	3.6	10.8	5.6	3.3	4.3	4.3	4.3	2.6	3.5	4.6	4.3	4.5	3.8	3.9	5.4	15.2	6.4	9.2	6.2	18.3	16.6	10.7	10.2	9.6	5.1	14.1	8.0	23.1	8.6	11.4	5.5	6.2	13.8	19.7	7.6	13.7	12.4	117.1	9.1	10.9	16.0	4.8	15.6	7.7	18.2	32.8	11.8	11.2	8.9	20.8	5.9	16.1	54.7	15.4	5.0	7.6	6.1	8.2	21.2	20.4	92.5	9.6	20.2	3.6	10.3	27.6	8.7	15.5	6.6	15.9	14.5	7.9	11.3	16.2	19.6	8.1	12.0	14.6	6.9	26.3	8.7	19.6	73.1	25.7	16.9	19.6	21.1	25.6	5.9	8.2	13.6
STYXL1	"DUSP24, MK-STYX"	ENSG00000127952	"Serine/threonine/tyrosine interacting like 1"	Q9Y6J8	7	75996338-76048004	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050261	Uncertain					NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA050261: AB_2681066"	"unprognostic (6.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.88e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.77e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.22e-4)"	8.7	15.4	21.9	11.5	22.5	15.1	17.4	21.3	26.5	15.3	24.6	15.9	11.2	10.5	20.7	18.9	28.7	9.8	11.5	21.7	19.7	16.8	19.4	11.9	16.1	21.0	20.8	15.2	22.5	16.3	11.9	17.3	22.0	16.5	20.4	13.1	16.2	10.1	10.5	20.4	9.1	14.4	20.2	14.4	14.8	21.9	21.3	13.2	14.8	9.6	21.6	14.2	13.4	23.8	50.3	26.2	20.3	27.2	31.4	33.6	21.1	22.1	31.3	35.1	34.7	30.6	44.2	11.7	10.9	29.4	55.6	21.6	33.3	44.3	50.5	37.4	14.5	14.2	12.2	27.5	44.3	19.9	24.7	33.2	51.0	42.1	104.8	45.0	34.5	17.4	46.4	34.1	31.8	40.8	7.9	84.6	17.1	48.2	62.5	30.1	16.9	31.1	45.2	32.2	26.5	27.6	20.7	46.7	57.6	50.4	51.5	38.0	17.3	29.9	12.6	33.3	31.8	36.6	24.9	39.5	26.7	37.5	47.8	70.8	52.9	50.0	23.8	48.2	26.3	36.3	22.5	26.6	42.1	29.7	19.8	22.2	44.9	49.7	47.0	28.1	41.4	34.1	21.9	22.5	21.3	26.5	21.7	19.7	21.0	20.8	22.0	20.2	21.3	23.8	7.7	22.4	13.2	16.6	10.7	7.4	14.8	24.2	13.1	6.7	17.9	18.5	18.1	10.0	31.4	11.0	0.0	34.8	7.3	24.6	39.2	15.6	91.4	42.7	10.2	11.1	20.3	9.0	18.8	25.6	24.5	9.4	18.3	19.7	10.8	13.9	11.7	18.2	30.9	3.3	11.6	29.1	24.4	21.0	9.6	62.1	11.5	19.7	3.6	11.2	31.1	20.2	9.2	8.0	15.8	23.9	40.3	10.1	23.0	17.0	14.6	25.2	60.7	10.4	6.6	7.6	9.0	39.3	12.6	13.0	9.9	45.0	10.8	9.5	18.8	17.9
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 regulator of transcription"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 1838.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1427.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	142.0	98.7	88.7	130.4	100.7	251.7	122.1	72.7	152.6	109.7	69.4	110.0	88.7	85.4	83.3	108.9	66.0	74.1	113.3	104.3	98.7	129.2	135.3	91.2	159.8	80.7	87.2	68.3	62.0	107.3	88.4	103.2	94.7	73.2	107.1	83.6	76.6	65.4	105.2	69.6	83.7	79.4	86.0	144.9	97.3	71.1	92.6	204.2	69.2	108.9	137.3	124.0	73.2	85.3	199.9	161.8	315.3	295.8	187.5	329.1	197.7	340.3	245.4	300.8	275.4	236.9	307.3	101.2	231.0	236.5	307.3	132.4	266.9	278.9	402.9	420.2	244.1	337.8	365.8	450.5	264.4	594.6	441.4	233.3	235.6	321.0	228.0	166.0	228.9	378.5	399.4	1427.8	269.5	178.6	566.8	942.9	207.8	235.9	326.9	247.8	409.9	645.7	303.0	178.2	170.4	141.1	526.9	244.9	251.9	198.2	272.0	544.9	238.7	324.7	351.5	275.8	261.0	556.0	1035.0	180.5	297.7	634.9	202.4	650.7	135.8	326.2	164.7	142.3	151.4	330.4	215.9	219.8	265.1	214.8	168.2	195.2	163.7	155.2	133.4	390.1	344.6	326.1	88.7	100.7	72.7	152.6	104.3	98.7	80.7	87.2	94.7	86.0	92.6	85.3	298.9	144.2	163.4	27.1	638.2	584.9	588.7	709.9	324.4	118.1	459.2	383.9	196.7	244.5	320.1	310.8	43.8	493.0	613.5	342.1	1009.5	711.4	131.6	319.0	263.7	280.2	281.4	379.5	71.5	327.2	785.0	323.6	227.9	329.9	307.5	188.6	223.1	375.4	500.5	85.8	60.9	362.9	484.2	319.0	721.3	68.1	239.9	422.5	528.3	37.5	587.5	223.7	500.5	64.3	50.4	416.3	516.6	344.6	1838.8	536.0	342.4	921.2	291.9	79.7	203.8	224.0	468.5	447.2	439.9	411.8	565.4	836.8	575.5	357.7	394.6	645.5
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 39.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 19.6;Hofbauer cells: 22.0;Kupffer cells: 32.0;Macrophages: 11.8;Proximal tubular cells: 46.3;Smooth muscle cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 53.3;NB-4: 31.0;U-937: 52.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB022745	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	3.5	0.8	0.0	1.3	0.1	8.1	1.0	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.1	0.2	0.1	0.5	0.7	0.0	0.2	39.9	5.2	2.6	1.9	0.2	0.2	0.1	0.0	3.4	0.0	0.2	0.3	0.1	0.8	0.0	0.6	0.1	0.0	1.0	1.0	0.7	0.1	7.0	7.8	0.1	0.4	0.9	9.3	0.1	0.6	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	8.7	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.2	0.3	0.1	0.4	0.2	8.4	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.5	0.1	3.7	0.0	0.1	1.4	0.0	19.6	0.0	0.5	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	4.3	22.0	0.0	0.0	0.2	8.2	32.0	8.1	0.4	0.0	11.8	0.0	8.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	46.3	1.5	0.0	0.0	0.1	11.2	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.1
SUCO	"C1orf9, CH1, OPT, SLP1"	ENSG00000094975	"SUN domain containing ossification factor"	Q9UBS9	1	172532349-172611833	"Predicted membrane proteins"	Osteogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047251	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		45000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center, Cytosol"		"HPA047251: AB_2679999"	"unprognostic (1.28e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.05e-2)"	9.8	11.9	8.4	9.4	10.3	83.3	14.4	7.9	10.3	13.3	8.6	9.1	10.0	12.1	61.9	8.8	15.7	11.6	9.2	7.5	9.9	12.0	6.9	9.5	9.7	8.2	10.2	17.9	26.1	27.1	13.1	16.9	8.3	13.5	9.4	35.5	14.7	24.5	3.0	12.1	15.2	9.4	9.2	8.9	13.2	24.6	8.9	14.0	17.6	4.6	9.9	12.8	8.0	11.4	30.2	13.1	37.9	34.0	19.1	18.2	42.8	35.9	20.9	22.3	27.0	23.9	31.5	15.0	21.1	20.6	22.9	46.4	16.3	14.0	38.1	8.4	11.8	11.8	8.2	14.7	22.2	19.1	15.9	16.5	14.1	27.6	22.4	69.0	19.7	17.0	7.7	20.8	33.9	7.2	12.8	12.9	34.5	34.6	30.4	12.5	22.0	9.8	34.6	41.6	20.2	26.1	16.6	28.3	31.9	64.8	27.5	20.5	25.9	20.2	21.2	19.5	36.9	30.9	26.5	26.7	19.2	9.9	32.4	6.5	3.5	6.3	4.3	3.2	4.2	4.5	3.9	3.7	2.9	5.2	4.3	4.4	3.2	5.9	3.9	4.2	3.2	2.4	8.4	10.3	7.9	10.3	7.5	9.9	8.2	10.2	8.3	9.2	8.9	11.4	20.9	48.1	30.9	40.5	30.4	26.3	32.4	22.6	59.2	43.0	40.5	31.2	30.1	14.3	39.0	27.6	50.1	38.8	35.6	14.2	3.9	15.0	40.7	30.4	29.4	22.2	26.4	48.6	32.3	32.0	27.3	29.1	29.6	56.9	13.9	25.7	15.0	15.2	13.3	47.1	43.8	30.7	18.3	13.1	17.2	55.8	45.7	22.7	26.6	34.7	18.7	63.5	18.6	82.4	66.3	25.0	7.1	28.2	61.9	38.8	34.0	13.2	37.0	53.8	26.3	29.6	23.0	73.6	36.7	28.9	27.0	49.4	37.4	30.0	11.2	34.7
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376555-118418033	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	10.8	12.3	13.3	12.0	14.2	16.9	18.7	9.6	15.2	16.6	12.1	16.5	14.3	14.9	16.0	19.9	18.1	11.7	12.8	15.8	12.9	16.1	14.0	11.9	14.7	12.7	14.6	15.0	17.3	25.3	11.6	11.5	14.1	16.2	18.3	16.3	19.2	15.7	11.3	20.1	14.1	13.7	10.6	13.7	16.2	16.4	12.2	17.9	21.7	11.9	19.5	14.4	15.2	13.2	29.4	21.9	29.4	29.4	16.1	21.1	31.5	22.5	23.2	25.8	20.4	24.1	18.6	39.8	23.5	21.8	16.0	34.3	35.3	23.8	30.3	35.3	20.9	27.7	18.4	21.6	18.4	30.9	20.5	14.6	25.0	12.8	22.7	33.5	22.2	36.9	30.8	14.1	23.9	20.2	36.7	40.2	30.5	38.8	17.0	32.9	26.4	28.3	23.7	42.7	22.9	22.7	31.9	18.7	19.9	36.7	61.1	24.9	18.7	17.5	16.6	19.7	15.5	26.2	31.4	29.2	19.4	19.4	21.4	1.8	4.3	5.9	5.0	2.8	6.1	8.8	5.4	5.7	4.7	8.4	6.4	4.4	12.6	4.3	2.8	6.8	5.5	3.9	13.3	14.2	9.6	15.2	15.8	12.9	12.7	14.6	14.1	10.6	12.2	13.2	25.5	28.9	15.9	19.6	37.8	64.7	44.7	55.0	46.1	75.4	85.6	63.0	37.5	41.5	37.1	47.8	77.2	34.6	26.9	75.1	80.3	41.5	271.9	87.6	54.4	24.6	37.3	30.3	22.4	19.3	54.5	31.5	36.7	73.2	8.2	37.5	21.0	34.1	25.0	107.7	29.1	60.2	59.0	18.2	36.1	59.4	38.5	20.8	28.4	13.1	30.5	30.0	29.9	30.2	21.6	26.4	52.6	41.0	49.1	60.5	38.3	45.7	61.9	57.3	26.3	42.8	48.5	62.6	53.4	74.1	78.7	49.1	32.9	41.6	56.8	61.9
SUFU	"PRO1280, SUFUH, SUFUXL"	ENSG00000107882	"SUFU negative regulator of hedgehog signaling"	Q9UMX1	10	102503972-102633535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.2;Late spermatids: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008700	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008700: AB_1080125"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.15e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.82e-3)"	6.6	7.2	8.8	7.1	8.5	2.0	6.1	8.9	8.0	8.6	5.5	6.8	3.9	7.4	4.9	9.2	7.1	6.6	6.3	7.8	7.3	6.1	6.2	5.8	7.2	8.3	8.2	8.9	4.1	11.1	4.3	7.4	7.8	8.5	4.4	4.6	7.1	5.2	8.6	14.4	5.7	7.3	6.7	7.4	4.6	11.5	8.0	7.8	3.4	7.3	8.1	8.8	9.2	7.3	8.7	9.1	14.4	20.8	14.5	12.1	7.0	8.8	17.0	12.5	11.3	8.5	6.3	8.9	24.5	9.9	5.0	6.0	17.8	9.8	8.2	5.5	13.8	21.2	5.2	8.0	6.9	7.7	14.6	13.9	7.5	9.3	7.5	22.9	16.3	8.5	4.8	7.9	7.8	7.2	14.8	11.6	4.1	5.6	6.7	15.8	15.5	4.7	8.3	12.8	4.8	7.8	7.0	6.4	8.1	13.1	14.2	5.0	18.1	5.5	7.8	6.0	9.8	6.4	4.5	6.4	6.9	14.9	3.8	2.0	2.0	2.9	1.0	2.4	0.8	0.9	1.2	1.1	1.9	0.8	0.8	1.0	0.4	1.1	2.5	1.1	0.8	1.4	8.8	8.5	8.9	8.0	7.8	7.3	8.3	8.2	7.8	6.7	8.0	7.3	3.3	0.0	3.7	28.7	4.9	3.1	2.1	2.9	6.8	4.2	3.5	3.0	4.0	1.5	4.6	3.7	8.4	7.8	3.1	3.5	1.9	4.4	129.2	4.5	6.2	5.1	1.2	2.5	25.9	3.0	3.5	6.0	4.6	8.5	3.8	3.8	10.8	5.4	12.4	1.7	22.2	2.2	0.0	9.4	6.3	115.9	5.0	8.7	0.0	32.8	7.8	2.7	4.1	17.6	16.8	4.1	1.3	6.8	4.0	2.0	5.7	5.8	5.7	4.8	0.0	3.0	4.5	8.7	5.3	8.9	6.5	7.0	7.1	7.6	3.0	1.3
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40135005-40860763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.4;liver: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.0;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 58.3;Proximal tubular cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.9;LHCN-M2: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavorable (2.53e-4)"	2.4	9.0	1.7	0.9	1.8	0.1	2.3	1.7	2.2	2.2	4.4	4.5	0.7	2.2	1.0	2.1	1.7	2.8	3.9	1.7	2.0	44.4	28.4	0.6	0.8	2.0	2.1	4.1	2.3	4.1	0.9	0.6	1.9	2.0	2.4	2.0	1.4	1.8	10.3	0.9	5.3	2.2	1.8	0.8	1.0	2.8	1.8	0.8	1.8	8.2	1.0	2.0	1.6	1.8	0.8	0.1	4.8	3.4	5.0	11.5	1.8	2.5	4.6	3.2	3.8	2.0	1.0	3.1	1.2	3.5	3.4	0.2	1.4	43.9	5.3	0.0	2.1	2.8	0.3	7.3	6.2	0.4	0.3	14.6	9.7	3.7	2.2	6.9	0.9	1.2	3.9	0.3	26.2	0.0	0.1	0.4	8.1	0.1	3.7	2.9	0.4	0.0	7.4	0.0	0.3	2.7	4.0	1.8	5.8	7.9	0.1	0.7	3.7	14.6	4.2	0.2	1.0	0.3	0.0	0.2	2.8	1.2	3.3	0.0	0.0	0.1	0.2	0.0	0.4	0.5	0.7	0.3	0.0	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.2	1.7	1.8	1.7	2.2	1.7	2.0	2.0	2.1	1.9	1.8	1.8	1.8	0.6	3.2	0.5	76.0	1.9	2.0	2.1	26.0	10.2	1.0	1.3	23.0	5.1	1.5	4.4	1.8	8.4	1.5	0.0	10.1	17.6	1.2	31.0	0.9	2.5	0.7	3.6	0.4	19.8	0.8	2.4	3.5	0.0	1.3	0.0	2.2	0.0	21.1	0.3	0.0	38.5	1.5	0.0	1.3	1.0	16.7	6.2	0.7	3.6	14.0	0.1	5.3	0.0	58.3	22.8	0.6	5.6	3.0	0.1	0.8	13.9	81.6	0.8	4.5	6.6	1.4	15.3	2.7	3.1	3.2	0.6	0.8	0.7	7.4	5.3	0.7
SUGP1	"DKFZp434E2216, F23858, RBP, SF4"	ENSG00000105705	"SURP and G-patch domain containing 1"	Q8IWZ8	19	19276018-19320509	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004890	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA004890: AB_1079935"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"unprognostic (5.21e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.25e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.42e-3)"	5.3	5.5	2.7	4.1	3.1	2.5	5.1	2.4	3.4	4.7	2.5	6.4	4.0	6.3	2.5	6.8	5.0	1.7	8.4	3.3	3.0	4.8	4.1	4.0	3.0	3.0	3.3	4.5	4.3	4.0	4.1	2.7	3.1	4.1	2.4	2.0	5.7	3.0	15.0	5.9	5.7	2.9	2.5	5.5	6.0	14.9	3.0	5.6	4.4	5.6	3.5	5.3	4.7	4.1	13.2	2.7	6.3	8.1	5.8	5.7	15.6	8.1	11.2	11.1	8.9	3.9	9.4	11.1	12.8	10.9	6.7	9.4	6.4	10.3	6.4	7.9	5.2	9.3	3.5	4.0	6.0	8.3	11.9	10.4	5.4	10.0	3.7	6.3	7.4	7.8	14.1	6.9	9.9	8.2	16.1	12.1	14.9	10.2	8.0	15.0	7.1	11.9	8.5	6.0	10.5	12.5	6.3	8.6	15.4	6.9	8.4	13.1	14.7	9.0	9.6	12.8	11.0	11.4	11.8	13.3	11.8	9.1	11.0	6.4	8.9	9.0	9.2	10.8	7.2	7.6	7.9	9.5	9.0	7.4	7.8	8.1	10.2	10.9	13.9	6.9	8.3	9.5	2.7	3.1	2.4	3.4	3.3	3.0	3.0	3.3	3.1	2.5	3.0	4.1	6.4	16.0	14.1	14.4	11.4	4.7	6.5	20.1	12.5	11.5	6.2	6.9	21.5	14.3	16.9	14.7	4.2	18.6	10.7	11.8	17.6	15.1	44.1	9.2	7.6	9.5	9.6	19.0	12.1	14.1	14.3	8.9	13.7	7.2	9.5	11.8	10.4	8.2	14.2	1.7	13.4	10.3	8.2	9.4	7.2	115.2	11.1	10.3	10.6	3.7	17.6	15.2	14.4	10.1	8.6	13.4	13.7	12.4	8.4	3.3	16.5	16.4	10.4	10.2	6.6	8.9	13.7	32.5	17.8	7.1	5.7	16.8	12.0	24.1	11.1	4.4
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 237.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	24.5	36.2	29.0	18.2	30.1	41.7	28.4	30.8	37.6	37.5	28.0	35.9	17.1	30.2	20.5	25.6	35.5	12.7	36.6	34.5	22.7	36.0	31.7	32.9	23.5	21.5	23.5	39.4	23.9	17.0	54.3	14.2	21.7	46.9	16.4	45.1	32.3	16.1	37.7	22.4	31.6	15.6	18.0	37.4	27.0	87.7	24.4	22.7	60.9	24.3	20.2	30.9	32.8	30.6	27.7	25.7	64.6	46.7	29.7	29.2	32.2	33.8	25.4	38.8	33.1	16.9	24.0	54.3	27.3	27.2	45.8	20.1	53.2	20.6	35.2	19.3	47.0	34.3	42.6	22.2	21.4	29.2	33.3	30.4	21.5	23.7	19.3	51.8	20.6	41.8	52.6	38.1	42.6	23.5	34.3	54.5	33.5	32.4	36.1	33.8	33.2	30.6	19.7	27.5	71.5	29.4	29.9	20.7	14.8	49.5	21.6	26.9	22.6	38.0	22.8	44.6	40.2	48.0	39.1	40.0	38.3	45.0	40.9	4.1	1.4	1.3	2.1	1.5	1.1	1.1	1.3	1.2	1.5	1.8	1.2	1.4	1.3	4.4	1.3	1.9	1.3	0.8	29.0	30.1	30.8	37.6	34.5	22.7	21.5	23.5	21.7	18.0	24.4	30.6	24.5	41.7	45.1	69.9	22.9	17.6	22.6	17.9	18.8	91.2	30.0	23.5	34.7	22.8	33.3	27.6	93.8	16.7	57.0	19.2	9.8	16.2	84.9	44.4	44.7	25.2	41.5	35.3	106.5	10.5	10.2	29.1	31.6	40.7	27.1	94.9	21.8	28.5	23.4	106.0	90.3	22.5	26.4	31.4	19.9	132.0	40.4	29.1	12.4	34.7	31.2	44.5	57.7	42.7	45.2	18.7	23.2	37.6	36.1	26.1	14.5	11.3	42.5	108.6	52.6	33.5	22.8	237.7	56.2	17.2	18.8	7.5	29.3	79.8	26.9	23.6
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SULF1	"hSulf-1, KIAA1077, SULF-1"	ENSG00000137573	"Sulfatase 1"	Q8IWU6	8	69466624-69660915	"Predicted intracellular proteins"	Apoptosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 180.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 214.2;Fibroblasts: 52.8;Inhibitory neurons: 63.0;Late spermatids: 101.4;Muller glia cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 315.4;BJ hTERT+: 420.2;fHDF/TERT166: 520.0;U-2197: 126.1;WM-115: 175.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054728	Supported				"Intracellular and membrane"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"HPA054728: AB_2682586"	"unprognostic (2.89e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (8.91e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.69e-2)"	24.1	2.6	8.1	24.4	6.4	0.0	8.0	2.2	2.7	14.5	180.3	36.4	10.0	28.7	14.2	18.3	11.3	30.6	14.2	6.4	7.4	9.9	1.8	9.7	6.3	1.9	18.2	14.2	3.5	1.4	9.7	4.2	5.8	50.8	20.6	60.0	4.3	41.9	2.2	2.6	14.1	72.6	3.4	2.2	4.0	2.2	18.6	2.2	19.9	11.2	4.8	32.1	9.5	3.0	0.0	0.0	57.3	0.0	6.2	27.3	0.4	315.4	420.2	10.9	1.7	0.0	1.2	0.5	0.2	520.0	0.0	0.4	0.8	0.5	2.1	0.0	1.1	0.0	1.0	0.0	1.5	0.1	0.5	35.6	3.7	18.2	6.7	15.2	1.4	0.0	0.0	0.6	8.5	1.3	0.0	0.0	6.5	0.0	0.4	0.0	23.2	0.9	0.0	0.0	1.1	0.0	0.0	0.5	0.0	22.6	76.7	0.0	0.0	29.0	0.8	126.1	0.0	0.1	0.0	0.1	0.1	0.1	175.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.4	2.2	2.7	6.4	7.4	1.9	18.2	5.8	3.4	18.6	3.0	10.6	9.6	6.2	3.9	0.1	0.9	2.7	7.8	26.2	1.8	1.3	13.7	4.3	2.8	13.5	5.5	0.0	0.3	0.0	0.0	0.0	0.3	214.2	1.0	30.5	13.5	1.2	2.7	9.6	0.0	0.0	52.8	0.0	1.0	0.0	0.1	15.4	0.5	0.3	0.0	63.0	0.3	0.0	0.6	1.3	101.4	6.5	0.8	0.0	1.0	0.0	162.8	0.0	3.5	0.6	0.7	0.1	1.9	0.0	1.4	0.0	0.1	5.5	6.5	0.0	5.2	42.4	1.6	1.4	2.5	0.3	0.3	0.3	0.1	0.0	0.4
SULF2	"HSULF-2, KIAA1247, SULF-2"	ENSG00000196562	"Sulfatase 2"	Q8IWU5	20	47656348-47786616	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 205.8;Oligodendrocyte precursor cells: 247.8;Theca cells: 265.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basophil: 27.2;classical monocyte: 19.6;intermediate monocyte: 17.2;myeloid DC: 21.3;neutrophil: 31.5;non-classical monocyte: 9.0;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	84	"dendritic cells: 27.1;granulocytes: 31.5;monocytes: 19.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 338.0;HaCaT: 230.1;HBEC3-KT: 259.4;hTCEpi: 815.1;MCF7: 695.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002325	Approved				"Intracellular and membrane"	NA	NA		340000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA002325: AB_1080126"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (4.39e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.14e-3)"	57.5	12.4	25.8	42.7	30.3	11.5	43.5	21.0	30.7	113.3	20.5	48.0	29.4	152.6	9.8	77.5	73.5	64.3	35.6	45.8	41.4	57.2	38.7	16.5	27.8	56.8	51.1	139.3	9.8	7.1	40.4	26.3	57.1	23.3	43.9	13.6	34.0	22.4	14.7	32.7	26.9	86.5	22.3	15.1	20.6	21.3	30.1	18.2	42.7	22.5	25.1	36.6	62.6	22.6	0.5	20.6	93.4	0.1	19.2	2.3	8.5	16.3	0.0	1.7	2.9	36.7	48.7	3.7	338.0	17.0	5.5	230.1	27.2	259.4	0.7	0.4	20.0	0.0	24.2	82.7	17.4	0.1	4.9	104.1	815.1	1.7	11.2	0.2	18.4	0.0	0.0	151.5	1.9	695.2	0.0	1.4	18.8	0.0	209.0	0.2	0.2	39.8	198.6	1.1	8.2	2.1	32.9	0.3	0.1	122.1	1.3	2.6	17.8	0.0	2.1	0.2	22.5	5.4	1.7	1.6	0.4	0.1	2.8	27.2	19.6	2.2	0.0	17.2	0.2	0.3	0.0	0.1	21.3	0.2	0.0	0.0	31.5	0.1	9.0	27.1	0.0	6.2	25.8	30.3	21.0	30.7	45.8	41.4	56.8	51.1	57.1	22.3	30.1	22.6	62.7	9.6	7.2	2.0	21.9	10.5	7.6	25.4	18.8	8.5	14.0	8.3	8.6	20.0	9.0	16.5	0.0	12.0	34.9	38.4	0.0	5.3	2.7	19.7	205.8	59.2	27.4	7.8	10.3	2.2	10.1	37.0	10.2	30.6	1.3	28.1	62.2	19.0	5.2	35.3	10.8	7.6	16.2	20.6	46.2	6.7	28.9	44.4	10.6	12.2	85.8	8.8	6.2	247.8	1.1	4.9	62.0	76.3	6.2	9.9	3.5	14.1	2.7	6.2	0.0	4.1	13.7	1.2	3.5	24.7	8.4	16.4	11.2	265.0	25.8	12.3
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28603944-28623625	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 135.0;liver: 248.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 321.6;Hepatocytes: 229.6;Kupffer cells: 214.1;Paneth cells: 309.3;Proximal enterocytes: 926.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 257.6;intermediate monocyte: 212.2;myeloid DC: 116.3;neutrophil: 246.7;non-classical monocyte: 122.6"	"Group enriched"	"Detected in all"	33	"dendritic cells: 116.3;granulocytes: 246.7;monocytes: 257.6"	"Group enriched"	"Detected in many"	4	"EFO-21: 171.0;Hep G2: 353.6"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	30.5	100.1	21.0	10.6	21.5	23.7	15.3	21.2	23.5	8.8	31.0	54.0	135.0	7.2	32.3	5.1	14.2	10.9	26.5	22.5	22.7	30.8	248.9	46.6	15.2	22.8	21.7	7.3	17.8	23.4	24.2	12.4	21.8	8.9	41.7	6.0	26.2	20.3	11.3	3.0	104.3	11.1	21.4	66.2	22.2	13.8	22.2	7.6	35.3	4.8	4.2	13.6	5.1	21.7	6.6	1.5	2.7	10.9	0.0	0.0	23.2	0.0	0.2	0.1	0.0	0.9	42.2	0.3	171.0	0.2	1.6	0.4	3.1	12.1	0.3	0.7	30.8	7.2	13.1	353.6	18.3	0.0	12.6	1.1	0.9	0.0	0.0	0.2	2.9	11.9	4.4	4.2	3.0	39.9	0.7	11.0	2.5	1.8	0.1	11.6	1.3	20.5	2.9	2.9	6.9	0.4	0.4	55.7	1.1	14.1	32.8	32.2	22.5	0.5	7.8	0.4	0.0	5.8	5.5	1.6	2.7	63.1	0.0	32.4	257.6	5.0	1.4	212.2	1.2	1.2	1.9	1.4	116.3	0.3	2.9	1.4	246.7	4.3	122.6	8.6	6.3	129.1	21.0	21.5	21.2	23.5	22.5	22.7	22.8	21.7	21.8	21.4	22.2	21.7	7.1	192.3	97.0	25.1	4.6	1.1	8.0	13.2	9.6	21.8	14.4	9.9	14.2	80.1	17.8	16.5	10.4	2.4	3.0	321.6	129.1	13.4	107.8	18.2	5.9	17.0	19.9	20.2	34.4	19.9	1.4	29.2	23.0	5.2	49.9	15.9	43.9	229.6	38.5	8.4	27.5	63.9	14.2	214.1	8.9	34.4	51.3	45.3	1.8	5.6	37.8	67.8	3.1	18.1	3.6	6.2	309.3	34.6	3.6	3.9	926.9	80.9	40.2	3.8	19.7	11.2	15.2	22.8	5.8	9.6	0.3	1.9	9.0	13.1	79.2	6.8
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597050	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 48.2;liver: 50.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 204.8;Paneth cells: 146.1;Proximal enterocytes: 505.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.1;intermediate monocyte: 7.7;myeloid DC: 3.3;neutrophil: 12.4;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.3;granulocytes: 12.4;monocytes: 9.1"	"Cell line enriched"	"Detected in many"	4	"Hep G2: 50.2"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	2.0	2.9	1.2	0.7	1.0	1.2	1.1	2.2	1.4	0.2	0.6	13.6	48.2	0.4	1.3	0.3	1.0	1.0	2.7	1.2	0.6	3.2	50.1	6.9	0.9	0.8	0.6	0.7	2.1	2.9	1.9	1.7	0.9	0.5	13.0	0.7	1.5	1.0	0.9	0.7	45.4	0.7	0.4	4.3	1.1	0.7	0.8	0.4	7.2	0.2	0.6	2.1	0.2	0.7	1.9	1.1	1.0	0.7	0.3	0.4	9.7	1.0	0.0	0.1	0.1	2.0	5.1	0.3	12.2	0.3	0.1	2.9	0.5	0.6	0.2	1.0	0.5	1.5	2.4	50.2	0.7	1.0	1.9	0.3	0.7	0.8	0.2	0.6	0.3	0.8	1.0	2.3	0.4	1.8	0.3	2.6	1.4	0.3	0.3	1.6	0.3	1.0	0.2	1.5	0.6	1.4	0.3	3.9	0.1	1.6	3.2	0.7	0.6	2.5	1.4	1.9	0.8	2.2	1.6	0.4	0.6	0.7	0.8	1.0	9.1	0.1	0.1	7.7	0.0	0.1	0.1	0.1	3.3	0.1	0.1	0.2	12.4	0.2	3.9	0.8	0.3	4.6	1.2	1.0	2.2	1.4	1.2	0.6	0.8	0.6	0.9	0.4	0.8	0.7	0.6	28.9	15.1	2.0	0.5	0.3	0.4	1.9	0.0	0.3	1.9	3.7	2.4	5.7	7.1	3.7	0.0	0.1	0.1	204.8	15.6	7.8	0.2	2.5	0.5	3.8	3.0	0.0	2.8	4.5	0.2	5.4	4.1	0.8	11.4	1.2	7.5	69.5	1.6	0.0	1.8	20.9	0.0	7.6	0.4	1.4	1.5	1.1	0.0	1.0	1.2	4.4	0.0	1.5	0.6	4.2	146.1	1.5	0.1	0.3	505.6	38.2	2.9	0.5	0.0	0.4	0.8	0.7	0.3	0.1	0.1	0.3	0.5	1.6	14.3	0.9
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 237.2"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 129.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 61.3;intermediate monocyte: 53.2;myeloid DC: 33.7;non-classical monocyte: 25.0"	"Group enriched"	"Detected in all"	11	"dendritic cells: 33.7;monocytes: 61.3"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.9;Hep G2: 303.6;Karpas-707: 239.4"									"HPA049500, HPA051051"	Supported					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	15.7	13.7	53.3	21.9	54.0	36.8	15.7	56.3	72.9	15.4	54.3	57.3	237.2	16.8	18.0	14.3	18.0	14.8	11.0	54.0	53.9	34.6	34.5	26.6	30.3	53.8	53.0	10.8	15.9	17.5	23.8	22.4	54.3	20.1	46.4	23.2	25.8	17.8	11.0	25.7	146.6	24.5	52.0	31.8	22.2	9.6	54.3	16.3	20.2	18.9	29.3	13.5	10.5	55.9	32.6	48.8	30.6	21.3	28.4	19.8	46.0	15.8	16.9	16.7	18.9	21.1	166.9	16.9	150.0	16.0	10.9	45.5	38.8	14.0	16.7	19.9	30.6	93.2	61.2	303.6	11.1	14.2	34.9	21.9	20.9	25.4	5.9	34.2	30.6	21.9	19.0	239.4	12.0	55.4	9.6	62.3	19.1	76.2	20.9	38.6	14.8	32.2	29.4	22.0	15.3	24.7	4.8	43.0	7.8	11.4	23.8	22.1	38.3	34.0	17.4	29.4	11.7	28.8	78.1	8.7	17.4	31.7	20.5	1.9	61.3	0.3	4.3	53.2	0.9	3.4	1.1	1.5	33.7	1.7	0.8	0.7	1.6	1.4	25.0	0.5	0.9	20.4	53.3	54.0	56.3	72.9	54.0	53.9	53.8	53.0	54.3	52.0	54.3	55.9	3.3	12.8	12.0	0.0	4.2	2.0	2.2	1.2	0.6	5.3	2.4	1.3	1.8	4.3	7.6	0.0	8.4	5.3	2.8	13.9	0.0	3.3	1.3	0.9	0.9	5.8	1.2	6.1	0.0	4.0	2.3	4.4	2.6	1.3	1.3	1.7	3.9	2.8	1.5	1.7	0.0	13.4	2.0	5.0	3.7	0.5	0.9	2.6	1.8	0.0	4.9	2.6	4.1	0.0	0.0	6.3	25.3	1.9	1.4	4.3	129.1	0.5	2.3	6.7	0.0	1.7	1.7	0.8	0.3	0.9	2.7	3.0	3.8	1.2	26.8	2.1
SULT1A4		ENSG00000213648	"Sulfotransferase family 1A member 4"	P0DMN0	16	29459913-29464966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.0;Club cells: 3.7;Distal enterocytes: 1.6;Proximal enterocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 23.1;myeloid DC: 17.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 17.2;monocytes: 23.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 69.2;Hep G2: 156.6;SK-BR-3: 32.4"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA049500: AB_2680796, HPA051051: AB_2681327"										"unprognostic (4.14e-2)"				"unprognostic (1.04e-1)"				31.7	4.8	1.7	7.3	2.0	3.2	25.0	1.8	4.3	9.0	0.8	46.0	29.0	7.6	0.7	5.7	11.6	3.4	19.8	2.0	1.1	7.8	7.0	21.0	1.6	2.6	1.4	3.7	3.9	2.0	3.8	2.4	2.1	4.4	7.5	0.7	14.6	3.4	6.3	9.1	61.8	1.9	1.1	34.8	15.5	2.3	2.2	1.2	10.4	0.6	2.6	12.8	9.2	2.4	0.6	0.6	6.7	1.3	0.5	1.2	1.5	3.6	0.2	1.0	0.5	2.5	69.2	0.2	22.2	1.2	2.9	13.3	1.4	0.9	0.6	1.5	2.7	0.9	3.0	156.6	1.6	0.0	5.6	0.4	0.0	1.4	0.6	4.0	4.0	0.5	2.9	4.1	0.4	3.0	1.1	19.3	3.2	2.8	1.1	4.2	0.6	1.5	3.9	4.0	0.8	0.8	0.0	32.4	0.1	0.6	0.6	0.3	1.0	3.0	0.5	0.5	1.2	7.5	9.6	3.2	2.3	2.3	0.3	1.6	7.0	0.0	0.8	23.1	0.1	0.7	0.1	0.1	17.2	0.0	0.4	0.0	0.4	0.1	5.3	0.1	0.1	5.1	1.7	2.0	1.8	4.3	2.0	1.1	2.6	1.4	2.1	1.1	2.2	2.4	0.2	6.4	2.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.3;stomach 1: 163.3"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.2	0.6	0.2	0.0	0.9	0.2	0.6	2.4	7.5	2.5	29.2	0.5	15.9	0.3	2.0	6.2	1.1	0.5	0.2	70.3	2.8	2.2	1.8	0.3	0.4	0.2	5.3	5.9	2.9	1.3	0.6	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.2	0.5	163.3	0.1	0.7	0.4	19.4	0.6	0.8	0.7	0.5	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.5	0.2	0.3	0.4	0.6	0.2	0.7	1.2	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860145	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 27.5;liver: 37.2;skin 1: 19.3;vagina: 30.4"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.8;Glandular and luminal cells: 35.1;Hepatocytes: 51.4;Paneth cells: 66.3;Proximal enterocytes: 21.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HHSteC: 71.1;HSkMC: 32.3;hTCEpi: 27.3;HUVEC TERT2: 20.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 7.8"	"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	14.5	0.1	0.0	0.1	0.1	0.1	0.1	0.2	13.5	4.1	0.2	27.5	0.3	1.0	0.8	0.2	0.2	0.0	0.1	0.0	0.3	37.2	2.3	0.0	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.1	0.7	0.1	0.0	6.6	0.4	0.0	19.3	27.3	0.1	0.0	0.0	2.1	0.1	0.1	0.5	0.0	0.0	1.5	0.7	30.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	71.1	0.0	0.0	32.3	27.3	0.0	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	11.9	1.0	8.7	0.0	0.0	0.1	0.0	0.1	1.5	2.8	1.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	65.8	1.3	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.0	35.1	0.0	0.0	2.5	51.4	0.3	0.0	0.0	4.7	0.0	0.8	0.7	0.0	0.3	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	66.3	0.0	0.0	0.0	21.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.4	1.5	0.1	0.0	13.8	0.2
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1072.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	235.6	0.3	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.5	0.6	59.5	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1072.1	0.0	0.2	0.2	0.3	0.1	0.1	36.9	0.0	0.1	0.2	0.1	0.9	1.0	0.1	3.1	0.1	0.3	86.6	0.0	0.0	0.4	24.4	4.2	0.2	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.7	0.4	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SULT4A1	"hBR-STL-1, SULTX3"	ENSG00000130540	"Sulfotransferase family 4A member 1"	Q9BR01	22	43824509-43862513	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 90.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 23.0;Early spermatids: 23.7;Excitatory neurons: 53.1;Horizontal cells: 23.5;Inhibitory neurons: 55.2;Late spermatids: 29.4;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 90.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003129	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003129: AB_1080130"	"unprognostic (2.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.59e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-3)"	"unprognostic (8.34e-3)"	0.0	2.7	22.3	0.3	23.2	0.0	0.0	1.6	90.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.2	21.7	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	2.5	0.0	8.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.8	5.9	0.0	0.0	0.0	0.0	0.0	0.3	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	23.2	1.6	90.2	22.2	21.7	9.6	0.0	8.0	0.0	5.9	25.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	23.0	0.2	0.5	1.4	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	23.7	1.1	1.3	0.4	0.0	0.0	53.1	0.0	0.0	0.4	0.0	3.7	0.0	1.9	0.0	0.0	0.1	23.5	55.2	0.0	0.0	0.0	0.0	29.4	0.0	0.1	0.0	10.3	0.0	4.0	0.0	8.0	6.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	19.5	0.0	0.0	0.2	3.0	5.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0
SUMF1	"FGE, UNQ3037"	ENSG00000144455	"Sulfatase modifying factor 1"	Q8NBK3	3	3700814-4467273	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 116.4;hTERT-RPE1: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038025	Uncertain				"Intracellular and membrane"	NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA038025: AB_10675624"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.99e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.79e-7)"	"unprognostic (5.12e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.86e-2)"	20.7	19.5	10.4	13.1	12.0	10.2	29.2	10.9	12.2	21.3	15.6	23.9	13.3	15.8	26.8	28.7	25.6	19.7	12.5	10.2	12.2	39.3	27.4	23.0	12.6	12.2	11.7	17.4	18.9	46.8	14.5	18.8	11.4	22.1	29.6	3.4	22.8	17.7	4.3	20.3	14.1	20.5	11.4	16.8	23.8	5.1	13.1	10.6	28.4	7.6	13.4	20.0	18.5	13.1	25.0	20.6	11.4	6.3	116.4	61.3	21.9	34.4	53.9	16.2	18.2	9.6	78.9	3.7	20.3	63.0	24.3	13.3	5.0	39.0	25.2	12.0	10.1	5.4	18.9	26.2	30.0	6.1	14.4	56.6	43.2	18.2	5.3	117.9	44.8	8.9	9.1	8.4	45.8	40.2	3.4	9.1	12.0	22.8	23.4	6.3	17.0	16.0	86.6	28.0	2.2	12.6	24.6	56.8	20.4	19.5	75.7	15.6	41.4	32.5	4.2	25.3	21.0	10.4	22.8	1.7	63.2	13.5	24.7	66.1	100.5	35.6	38.9	81.8	35.2	26.6	31.2	32.9	86.6	30.7	39.4	32.0	36.2	42.0	78.2	45.9	16.9	90.2	10.4	12.0	10.9	12.2	10.2	12.2	12.2	11.7	11.4	11.4	13.1	13.1	12.8	19.2	20.1	36.9	13.8	12.7	18.8	32.9	21.1	5.6	29.5	23.2	5.5	18.6	16.7	38.6	6.2	29.8	9.7	16.5	11.7	39.3	26.1	14.2	14.1	13.7	8.4	11.1	53.2	19.1	23.3	25.8	21.4	21.9	17.1	10.4	17.5	18.7	28.2	3.3	57.0	19.7	4.1	37.1	12.0	10.7	16.4	24.3	19.6	62.8	43.9	6.8	11.3	56.8	85.5	14.0	16.4	17.3	11.5	13.7	10.5	23.8	19.4	6.2	6.6	21.2	16.5	4.8	5.1	25.9	11.8	24.4	11.6	11.1	25.6	18.3
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SUMO2	"SMT3B, SMT3H2"	ENSG00000188612	"Small ubiquitin like modifier 2"	P61956	17	75165586-75182959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037314, HPA042123, HPA048064"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"		"CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (6.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (9.80e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (5.23e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.89e-3)"	198.2	205.1	176.2	203.6	186.9	229.8	174.5	214.2	239.9	219.3	168.5	190.1	161.4	205.5	158.5	240.9	186.8	134.0	156.7	185.4	193.4	205.6	185.8	171.5	214.6	175.5	177.3	231.1	161.0	130.6	146.5	130.1	177.5	158.1	143.9	205.9	160.3	122.2	229.4	182.6	169.2	154.8	187.4	174.7	205.3	182.2	187.2	271.9	149.2	152.0	228.6	188.2	205.1	191.5	742.5	299.1	1035.7	534.4	296.8	283.6	486.1	571.2	276.9	384.5	354.5	343.6	396.0	641.8	398.1	327.9	503.0	353.4	470.3	351.7	451.6	373.6	712.4	644.0	282.1	597.4	194.1	856.1	555.7	290.1	195.9	343.9	187.2	615.6	403.8	628.3	540.7	508.7	288.3	317.8	1310.8	734.0	632.8	552.5	445.5	903.2	987.1	539.5	391.9	612.0	633.4	739.0	691.1	566.8	481.4	796.9	614.6	663.0	458.1	557.2	581.7	429.4	931.3	355.4	348.1	986.8	351.2	500.6	457.3	831.1	436.4	781.2	390.9	498.9	408.8	515.7	486.8	456.8	451.6	443.6	444.0	437.1	380.1	452.3	548.3	616.0	701.6	851.5	176.2	186.9	214.2	239.9	185.4	193.4	175.5	177.3	177.5	187.4	187.2	191.5	522.1	163.5	160.6	25.5	453.3	705.4	647.4	717.6	602.2	216.4	492.1	524.1	62.3	337.5	368.2	355.0	50.1	522.8	485.0	278.1	968.5	602.7	281.8	348.6	429.0	458.5	441.9	519.9	35.7	531.7	948.9	451.1	274.2	343.5	349.0	465.0	491.2	273.4	616.3	233.9	33.0	397.9	472.0	676.9	637.0	488.6	604.9	481.5	462.4	21.5	743.4	535.4	517.0	25.1	42.6	666.5	397.3	605.2	443.0	822.3	348.7	847.5	322.6	161.3	571.9	409.5	716.6	872.2	683.2	795.2	742.7	565.2	480.3	476.1	437.0	977.2
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	68.6	58.1	58.5	56.7	64.6	118.8	63.6	50.6	75.5	55.5	55.9	55.2	55.1	52.9	50.3	57.2	52.1	44.6	74.3	64.4	71.8	64.0	59.3	61.7	68.8	53.3	59.0	57.6	49.4	44.7	38.3	49.1	58.3	46.2	45.8	72.0	66.5	47.4	106.6	51.0	58.0	39.8	54.5	61.6	56.3	28.8	68.5	63.7	54.8	73.9	57.5	50.0	53.6	50.9	226.4	88.8	131.7	80.2	105.1	147.9	86.5	152.0	177.2	211.5	173.6	133.6	137.2	78.4	234.6	165.4	122.4	53.0	96.8	123.0	166.3	110.0	106.3	322.7	78.8	123.1	113.3	184.5	172.1	126.0	139.5	123.9	89.9	87.8	109.8	164.6	188.7	215.2	173.8	293.1	220.0	127.7	254.4	223.1	174.9	239.0	8.0	217.1	120.2	111.9	98.8	153.4	136.5	196.2	126.3	48.1	190.6	218.6	172.4	99.1	151.4	151.6	172.8	155.4	234.8	198.7	77.9	265.2	138.6	2.8	123.1	52.0	78.9	130.0	79.7	84.6	74.9	76.5	133.3	77.7	88.7	81.0	14.0	70.6	122.3	162.8	91.2	157.8	58.5	64.6	50.6	75.5	64.4	71.8	53.3	59.0	58.3	54.5	68.5	50.9	83.4	64.1	50.4	5.5	76.5	96.0	121.7	127.9	74.6	72.2	99.4	88.5	59.5	67.2	66.5	95.6	20.9	122.9	98.1	95.6	166.3	121.7	63.1	36.4	51.7	101.4	59.2	113.8	14.3	112.4	107.8	76.7	52.0	37.9	29.8	63.8	92.8	116.6	200.5	62.2	13.3	91.5	81.4	143.4	172.3	114.2	72.1	137.9	97.8	10.3	280.0	132.4	111.2	3.5	6.5	148.7	112.6	72.6	58.2	150.7	129.2	130.2	33.0	60.5	59.2	43.8	68.7	90.7	77.5	82.7	77.9	136.3	78.2	43.2	99.9	145.1
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin like modifier 4"	Q6EEV6	6	149400262-149401278	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.1;Glandular and luminal cells: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	0.5	0.3	1.0	0.3	0.7	0.7	0.3	1.7	1.2	1.1	1.2	0.4	0.2	0.2	0.1	0.6	0.5	0.2	0.8	0.5	0.7	0.8	1.3	1.0	0.5	1.9	0.9	0.9	0.4	0.0	0.8	0.3	1.2	1.0	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.1	1.0	0.6	0.3	0.6	1.5	0.1	0.6	0.0	0.2	0.6	1.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.5	0.2	0.2	0.4	1.0	0.7	0.2	0.6	0.6	0.9	2.2	1.0	0.5	0.2	1.1	0.2	1.0	0.7	1.7	1.2	0.5	0.7	1.9	0.9	1.2	1.0	1.5	1.6	2.0	3.2	1.5	0.0	3.1	2.9	1.8	0.9	0.0	4.3	2.5	1.8	11.1	1.5	0.9	1.8	4.2	0.7	6.4	1.3	0.0	0.7	0.1	4.5	4.0	2.7	1.8	0.8	0.0	0.9	0.4	2.9	2.0	8.4	1.3	7.2	1.4	1.6	1.1	0.0	0.0	0.5	0.0	1.3	4.7	0.9	2.1	5.1	0.0	0.0	3.9	1.7	1.0	0.0	0.0	1.1	1.2	1.2	3.5	3.5	1.0	0.4	1.0	3.9	6.6	1.8	3.6	1.9	0.8	0.5	0.9	0.3	4.3	2.7	0.4	3.9
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 343.8;Late spermatids: 576.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	72.4	26.9	26.1	17.9	25.4	8.3	60.7	43.4	30.7	75.3	29.1	52.3	33.8	73.3	38.5	43.8	66.1	28.2	77.4	25.2	24.3	44.3	28.2	41.7	23.6	23.5	27.2	84.1	34.1	53.0	59.0	47.3	23.1	39.2	30.2	41.4	44.7	34.0	119.2	87.1	42.1	41.5	23.8	38.8	48.1	45.5	24.3	20.0	44.3	99.1	25.1	38.9	57.4	25.3	128.7	34.2	40.2	65.5	43.4	61.6	39.2	31.7	53.4	58.0	59.0	29.1	139.8	30.5	32.2	43.7	113.5	156.8	33.3	55.9	55.9	13.2	33.3	10.0	51.0	27.8	55.3	15.2	24.3	31.0	65.6	46.3	76.4	53.7	42.7	19.0	41.9	22.4	58.6	44.5	10.1	25.2	56.0	44.3	39.0	21.9	22.3	28.7	59.1	40.7	77.2	49.9	40.1	81.4	31.5	64.6	64.6	15.4	32.5	52.8	47.6	55.1	53.2	20.4	25.6	19.0	36.6	12.7	74.4	11.6	9.4	2.5	4.0	8.3	4.2	6.8	7.9	4.6	7.5	5.5	11.0	7.2	0.5	6.6	6.4	1.5	7.3	6.4	26.1	25.4	43.4	30.7	25.2	24.3	23.5	27.2	23.1	23.8	24.3	25.3	107.0	44.8	36.4	63.0	26.5	106.7	96.9	73.2	50.7	72.4	48.0	38.1	103.7	31.5	68.5	40.5	87.6	37.4	14.1	61.9	27.4	41.5	343.8	168.5	40.3	79.9	40.7	31.5	76.5	23.2	23.5	52.6	60.1	143.7	17.1	73.4	62.4	39.1	17.9	112.7	64.5	45.1	59.0	20.0	34.3	576.2	57.2	16.8	42.7	43.1	16.6	24.0	10.3	48.7	49.8	55.8	68.4	42.5	26.4	84.6	37.7	21.9	163.5	67.6	65.7	53.5	73.4	40.9	49.4	36.1	85.7	38.4	22.0	26.1	38.2	137.4
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SUN3	"MGC33329, SUNC1"	ENSG00000164744	"Sad1 and UNC84 domain containing 3"	Q8TAQ9	7	47987148-48029119	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 41.6"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 582.2"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 7.0;U-2 OS: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008344, HPA076890"	Enhanced		Approved	"Golgi apparatus"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA008344: AB_1857656, HPA076890: "	"unprognostic (5.11e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-4)"	"unprognostic (2.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-5)"	"unprognostic (4.88e-1)"	"unprognostic (1.47e-1)"		"unprognostic (2.65e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.58e-1)"	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	3.1	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	1.3	20.6	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.1	1.9	0.0	582.2	0.1	0.0	0.1	0.0	0.0	3.6	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	3.4	0.0	0.0	0.0	0.0	79.3	2.1	0.3	0.0	1.0	0.1	0.0	0.0	1.0	0.4	0.2	0.1	1.5	0.1	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.2	19.1	7.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0
SUN5	"dJ726C3.1, SPAG4L, TSARG4"	ENSG00000167098	"Sad1 and UNC84 domain containing 5"	Q8TC36	20	32983773-33004433	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	449	"testis: 44.8"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 510.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048529	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA048529: AB_2680428"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	510.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.6;Proximal tubular cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		44000	"Cluster 52: Eosinophils - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	19.2	35.2	19.3	9.5	20.2	12.8	18.2	21.0	22.6	16.7	22.2	20.6	19.3	17.6	33.0	21.5	22.9	16.7	29.4	19.6	19.9	40.8	72.3	15.6	8.3	20.7	20.0	22.1	17.4	48.6	16.6	11.5	20.6	25.2	17.1	13.8	20.2	24.5	45.6	10.4	15.6	17.4	20.1	13.6	21.3	8.3	21.7	6.7	18.2	28.8	12.0	21.2	14.3	24.0	10.2	29.8	18.5	30.2	29.6	12.2	40.1	11.5	12.5	15.4	11.1	28.8	22.1	1.2	19.8	14.0	10.6	13.2	13.7	14.5	8.2	45.8	9.0	15.7	19.4	34.9	10.9	0.2	25.9	19.0	5.5	13.1	6.8	23.0	38.9	1.6	28.2	19.0	16.2	25.1	0.4	10.0	9.9	15.6	21.4	13.6	7.7	22.4	17.8	20.4	9.2	12.3	21.1	42.6	17.4	17.2	72.2	14.9	20.6	8.5	10.4	10.8	8.2	22.0	21.3	1.6	13.7	10.2	12.7	11.1	12.6	29.6	0.2	18.7	0.1	2.5	1.2	0.0	16.1	0.3	0.9	0.2	5.1	16.5	16.2	0.5	7.9	11.8	19.3	20.2	21.0	22.6	19.6	19.9	20.7	20.0	20.6	20.1	21.7	24.0	4.5	9.6	10.9	10.7	1.1	1.3	3.8	6.7	6.2	5.1	9.1	6.1	21.7	11.5	12.8	14.7	6.2	29.7	0.9	7.7	17.6	5.6	0.7	7.7	6.7	7.1	6.0	6.5	4.1	6.3	19.1	6.4	6.6	12.4	4.5	6.6	8.9	49.6	10.5	10.1	4.4	6.0	4.1	8.9	4.0	0.9	4.4	4.3	1.8	5.6	10.0	8.5	2.1	5.5	6.2	5.3	7.4	9.1	3.2	3.1	7.9	35.8	6.1	8.4	6.6	8.4	5.4	2.4	1.4	6.8	2.3	30.8	1.6	6.7	7.7	3.0
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351476-21384019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	29.3	24.8	9.7	36.6	11.1	42.3	35.9	18.8	13.9	34.2	8.2	30.6	23.1	41.1	19.5	29.0	32.0	24.1	24.1	9.7	15.6	28.6	22.4	26.3	51.2	11.3	12.0	43.6	22.6	46.2	13.5	32.1	12.0	29.9	35.1	44.4	20.9	32.6	21.8	28.9	25.9	36.6	10.7	32.9	26.3	43.3	12.1	56.8	33.3	24.6	51.8	35.6	20.1	12.3	147.8	136.9	185.5	136.6	85.5	81.7	131.4	130.3	103.2	155.5	145.4	133.9	129.5	311.3	48.5	96.5	99.7	153.9	237.2	118.9	234.0	99.8	100.9	188.7	121.9	195.1	87.0	270.1	134.7	73.4	72.6	131.0	146.3	75.4	107.7	174.2	158.1	129.4	131.3	99.9	253.6	85.8	207.1	136.2	134.1	270.3	210.6	168.0	63.9	160.8	183.8	157.2	209.8	125.3	81.1	118.7	69.2	127.9	91.1	135.0	113.4	85.0	143.3	128.8	230.2	306.7	49.9	158.0	104.9	35.6	18.3	28.2	29.6	23.9	34.7	31.2	27.9	33.2	23.7	27.4	31.3	32.2	15.0	34.0	31.1	22.2	28.4	25.2	9.7	11.1	18.8	13.9	9.7	15.6	11.3	12.0	12.0	10.7	12.1	12.3	41.5	64.1	55.9	24.2	51.6	35.6	44.3	51.5	45.5	48.9	46.3	49.7	64.2	22.8	50.3	53.3	47.9	65.1	73.6	28.4	25.4	71.0	142.5	52.0	124.3	46.9	23.4	74.6	27.4	61.1	63.9	61.1	29.6	61.7	84.2	73.4	29.3	32.0	41.9	55.5	30.1	31.2	40.7	34.9	25.2	96.1	59.7	40.7	17.8	20.6	90.9	53.3	64.9	16.1	25.2	68.9	15.2	59.8	39.5	46.1	16.5	30.4	40.2	41.1	19.7	78.5	69.5	128.9	152.8	45.1	41.5	45.6	56.3	61.6	43.0	35.7
SUPT20H	"bA421P11.4, C13orf19, FAM48A, P38IP, SPT20"	ENSG00000102710	"SPT20 homolog, SAGA complex component"	Q8NEM7	13	37009312-37059713	"Predicted intracellular proteins"	"Autophagy, Gastrulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.7;Spermatocytes: 316.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038906, HPA038907"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA038906: AB_10673482, HPA038907: AB_10697401"	"unprognostic (4.04e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.21e-3)"	10.1	9.1	8.8	12.3	9.9	19.2	10.0	11.3	12.7	13.7	11.0	15.4	7.6	13.4	8.8	10.4	15.2	10.6	12.1	9.0	9.9	10.2	6.5	11.8	13.9	10.2	9.7	13.0	7.5	9.9	9.8	13.6	9.8	11.4	11.3	11.0	8.9	12.5	14.6	9.4	10.6	16.1	9.4	13.4	9.9	56.3	9.7	23.7	9.2	11.4	15.9	13.6	10.6	11.3	13.8	16.7	52.0	29.5	19.2	26.1	21.7	36.4	22.6	40.8	29.4	28.0	26.3	27.3	14.7	29.4	45.3	23.4	32.6	37.7	54.2	38.1	29.5	82.9	11.7	30.6	36.9	33.9	35.4	19.9	23.1	37.0	63.2	24.9	49.3	36.7	27.5	6.9	47.9	20.5	47.6	23.7	32.7	31.9	18.8	38.2	36.3	5.9	30.6	21.5	9.7	26.1	23.4	20.9	26.0	41.3	15.1	29.8	29.8	16.5	14.4	19.4	31.1	11.5	12.3	26.8	18.8	19.9	31.7	18.9	16.1	22.6	18.9	21.1	16.7	12.9	18.0	17.0	15.3	14.1	20.6	19.7	28.1	19.3	20.4	11.9	21.7	15.2	8.8	9.9	11.3	12.7	9.0	9.9	10.2	9.7	9.8	9.4	9.7	11.3	25.9	22.4	29.6	34.9	29.0	13.5	16.1	18.8	19.4	36.0	20.3	22.6	16.4	14.3	28.1	31.3	35.5	32.4	26.4	13.1	21.5	24.7	145.7	48.5	35.6	21.4	31.2	33.9	41.8	14.5	31.0	23.3	25.0	25.3	45.5	60.2	23.2	9.8	19.6	21.9	47.7	20.4	26.4	18.2	16.8	29.4	34.2	22.6	7.2	54.4	33.2	17.3	37.0	45.2	60.1	21.6	14.9	33.4	25.4	19.6	17.9	17.6	40.5	34.4	32.9	20.1	27.8	316.0	74.2	23.3	9.9	26.4	34.5	69.4	19.9	15.7
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	2.4	5.1	3.6	1.2	4.1	1.2	2.4	4.8	5.7	4.4	0.0	3.6	2.2	3.5	4.2	2.9	4.1	2.0	1.8	3.9	4.7	4.3	1.6	2.4	1.7	4.5	3.3	5.2	3.8	3.8	3.2	3.4	3.6	4.4	2.3	4.2	7.2	2.1	1.6	1.4	2.4	2.5	1.8	1.8	2.2	8.9	5.7	2.7	4.4	0.5	1.9	3.2	2.4	5.7	5.2	2.4	12.9	6.8	2.7	7.8	4.3	3.2	4.0	7.2	8.9	4.0	4.0	2.0	3.0	1.5	6.2	2.2	9.0	7.1	13.2	5.0	3.6	1.4	1.9	10.4	6.4	3.9	1.5	4.2	5.7	3.7	10.0	20.5	3.7	7.2	4.7	3.7	6.6	1.5	4.0	8.2	4.6	11.2	1.1	8.8	5.7	2.2	10.2	4.2	6.4	3.1	0.7	0.8	10.2	16.7	3.3	3.8	1.3	6.4	0.1	4.6	7.3	7.2	2.2	12.3	5.0	7.9	6.0	0.1	0.3	0.1	2.9	0.5	5.1	1.2	4.4	3.4	1.4	1.6	5.1	4.3	0.2	2.3	0.7	3.9	1.9	1.6	3.6	4.1	4.8	5.7	3.9	4.7	4.5	3.3	3.6	1.8	5.7	5.7	4.5	3.2	4.8	110.7	11.5	1.8	14.5	10.0	8.6	7.4	5.1	6.7	3.0	2.8	7.2	7.3	6.2	11.7	19.7	1.2	11.7	8.4	142.2	5.4	4.5	5.7	8.4	5.9	286.4	3.2	12.3	7.2	6.6	6.3	3.8	16.0	7.1	3.0	8.7	3.3	405.2	2.3	2.0	2.9	5.0	183.4	7.8	4.5	5.4	124.6	10.5	2.8	20.6	182.9	192.9	4.0	2.1	5.3	14.7	11.3	1.9	10.7	8.3	13.5	13.1	6.8	16.0	26.8	22.0	6.2	1.3	8.2	30.7	7.8	3.7	9.3
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	43.3	46.2	44.7	44.9	46.6	106.1	41.7	38.2	48.3	45.3	35.3	48.1	40.3	49.7	29.6	42.7	46.2	34.6	41.2	42.7	42.6	38.8	52.1	45.4	51.6	40.4	40.6	55.9	49.5	49.3	72.6	38.2	40.7	48.5	30.0	33.0	54.7	36.1	87.2	50.0	51.3	33.7	37.5	46.7	46.9	102.1	45.1	40.2	51.1	35.6	41.4	45.0	40.2	49.1	134.1	209.5	75.2	76.4	70.7	50.4	64.8	115.4	70.5	66.0	73.2	137.9	80.1	159.7	106.4	104.7	55.0	50.8	101.9	73.5	51.6	161.6	100.3	179.2	99.7	84.5	64.0	148.5	117.4	78.9	54.6	83.9	86.2	72.2	64.0	137.3	137.9	80.4	66.2	132.5	108.5	44.5	94.0	109.8	52.3	108.8	111.0	80.5	68.3	214.1	72.7	98.1	134.0	104.6	71.7	63.3	63.6	80.1	137.6	67.1	77.8	84.1	145.5	130.9	240.8	196.0	81.8	84.1	84.7	49.0	22.1	19.0	13.7	11.5	13.9	23.0	9.6	11.5	11.1	16.2	10.6	9.0	46.3	15.3	17.2	42.6	11.4	15.6	44.7	46.6	38.2	48.3	42.7	42.6	40.4	40.6	40.7	37.5	45.1	49.1	45.1	44.8	82.7	26.4	51.9	51.6	26.8	34.1	43.3	47.4	40.2	51.9	58.8	30.0	51.6	44.1	85.5	36.5	79.6	62.6	13.7	37.4	69.9	73.2	57.2	43.8	89.2	40.4	16.6	35.1	45.3	39.1	72.9	92.2	46.2	36.0	32.5	62.5	36.7	48.8	17.6	62.4	26.4	32.2	68.9	79.1	45.1	51.4	40.9	15.0	41.2	28.4	47.4	15.1	23.1	53.5	46.3	41.3	86.5	32.8	58.1	22.9	67.9	57.6	19.7	57.3	38.1	84.4	80.4	41.0	49.6	54.0	72.6	31.0	50.4	31.2
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone and transcription elongation factor"	Q7KZ85	17	28662198-28702679	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	31.2	33.5	24.6	25.4	25.8	65.3	28.3	25.0	26.8	27.0	26.8	36.6	20.0	30.6	26.8	26.5	26.6	24.7	28.8	24.0	29.0	25.6	35.8	28.9	28.4	24.0	25.2	31.2	31.4	30.8	34.3	27.8	24.3	28.7	20.9	29.2	29.1	25.6	54.5	39.2	32.2	27.3	21.6	34.4	31.3	21.4	28.7	34.0	28.9	32.6	30.3	32.1	25.6	25.6	49.4	101.3	49.8	57.1	59.1	39.3	38.2	66.2	70.3	76.3	67.8	94.7	21.5	52.1	33.6	66.5	58.7	57.5	73.6	48.1	78.4	97.6	65.4	72.9	83.2	59.4	49.4	77.2	77.9	54.6	28.4	81.2	53.6	50.3	50.8	50.3	72.9	59.7	55.1	59.1	76.9	33.4	38.7	43.2	32.4	38.7	91.2	42.7	37.6	95.9	37.8	49.9	77.6	120.5	41.6	67.9	74.2	54.2	80.6	59.8	49.4	57.5	85.3	75.4	62.2	74.4	67.5	34.4	50.5	14.7	4.5	4.4	3.7	2.9	3.9	4.5	3.1	4.1	3.7	4.5	3.1	2.8	6.8	4.3	5.0	6.2	3.1	3.1	24.6	25.8	25.0	26.8	24.0	29.0	24.0	25.2	24.3	21.6	28.7	25.6	33.9	38.5	51.0	24.2	36.5	22.4	19.2	16.8	43.3	29.5	27.4	26.0	51.6	22.8	28.4	20.2	56.3	24.4	38.4	29.5	5.9	22.1	5.4	31.0	45.3	32.6	31.0	33.0	21.6	21.3	21.3	32.7	46.4	49.1	50.5	36.6	22.9	33.9	23.7	30.3	19.7	23.1	8.2	23.0	22.4	17.8	25.7	41.8	8.8	16.9	29.9	22.0	30.9	17.6	19.4	31.9	18.7	26.7	55.7	20.0	23.4	10.5	25.7	44.4	32.9	32.4	32.0	19.8	19.1	40.1	24.3	49.8	38.3	42.0	22.9	25.7
SUPT7L	"KIAA0764, SPT7L, STAF65, STAF65gamma"	ENSG00000119760	"SPT7 like, STAGA complex subunit gamma"	O94864	2	27650809-27663840	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039565, HPA063643"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA039565: AB_10795109, HPA063643: AB_2685070"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (7.54e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (5.15e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.75e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.23e-3)"	31.2	35.1	31.9	22.5	32.0	35.7	27.7	32.0	37.5	34.3	38.9	30.9	22.9	31.9	25.0	25.8	32.2	20.4	36.8	31.9	33.3	33.4	37.8	29.6	27.4	31.1	31.9	39.6	31.1	22.8	46.2	27.1	32.0	34.0	25.3	55.5	24.0	22.1	30.2	20.8	32.7	28.1	30.3	41.6	29.8	20.6	31.9	26.2	36.3	27.1	24.2	29.2	29.5	35.4	33.6	28.6	41.2	31.9	36.8	30.1	49.0	32.0	30.9	28.4	30.4	37.2	36.8	29.2	32.9	34.0	40.0	35.8	37.3	35.6	27.6	33.7	36.1	39.8	43.7	42.4	48.1	32.4	37.5	42.3	43.8	42.0	44.0	52.7	37.3	35.3	45.8	34.0	37.3	23.1	28.1	52.9	27.5	33.5	25.0	26.8	44.1	37.4	36.7	31.1	32.5	42.3	28.6	29.6	54.7	52.0	20.5	27.9	28.8	39.2	29.0	19.9	30.8	60.9	47.8	60.4	30.5	39.8	27.3	30.4	14.8	13.6	18.2	15.7	20.7	10.6	14.3	19.0	20.9	17.3	17.2	16.3	3.7	22.9	14.7	14.0	17.6	13.6	31.9	32.0	32.0	37.5	31.9	33.3	31.1	31.9	32.0	30.3	31.9	35.4	15.3	22.4	17.1	33.6	15.9	8.4	13.2	19.9	13.1	18.6	12.7	11.7	21.3	12.8	21.6	22.0	41.7	34.2	25.8	12.1	21.5	18.1	12.5	19.1	18.3	18.5	10.8	11.1	31.2	14.6	29.3	17.7	21.4	14.7	19.6	20.7	15.7	15.6	25.1	15.2	32.7	12.3	12.2	12.3	11.1	3.9	13.7	17.1	3.6	14.0	13.4	19.0	16.5	17.6	33.1	13.9	8.2	15.4	25.5	8.5	10.8	20.6	24.3	24.7	19.7	15.0	16.5	29.4	22.6	15.4	8.7	42.3	19.3	22.1	13.9	11.6
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180234-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	10.1	10.9	7.9	8.7	8.2	24.2	11.5	10.2	10.3	7.7	7.6	11.6	8.9	9.3	7.9	8.8	8.3	6.0	15.8	8.5	8.2	12.9	17.9	6.1	12.0	7.9	7.4	10.6	9.3	16.5	7.5	8.7	7.9	8.0	12.7	11.1	8.9	8.6	25.9	10.6	8.6	9.3	7.2	9.9	8.9	15.8	7.8	11.0	10.9	29.1	12.2	9.5	7.7	8.5	28.9	19.9	17.4	53.5	19.1	16.1	22.7	17.5	27.1	34.7	32.6	51.4	23.8	51.5	14.0	17.6	24.8	32.3	42.2	27.4	33.1	21.5	33.1	22.6	14.9	27.2	48.1	54.3	16.5	20.5	33.7	31.9	72.6	23.6	20.3	32.2	59.6	26.1	19.2	18.7	33.1	33.5	20.8	27.2	106.7	30.1	24.7	22.6	15.6	13.9	24.7	18.7	24.2	49.7	46.7	19.1	15.5	23.5	12.7	13.7	24.7	21.1	34.3	20.5	25.4	47.5	22.6	56.4	8.9	8.9	5.1	4.7	11.1	7.3	12.5	9.0	7.9	9.5	7.1	7.3	8.7	9.6	0.9	7.7	5.4	3.9	8.8	6.2	7.9	8.2	10.2	10.3	8.5	8.2	7.9	7.4	7.9	7.2	7.8	8.5	11.2	6.4	7.4	15.3	21.7	23.8	11.6	16.6	21.6	21.6	10.8	9.5	22.5	5.7	15.1	7.3	4.2	17.8	49.3	11.7	11.7	11.6	13.4	17.2	17.6	10.1	9.0	10.3	29.6	8.6	11.4	12.6	14.8	28.8	7.6	15.1	5.7	12.0	9.6	11.8	28.2	9.0	16.2	6.0	10.0	4.5	6.8	9.4	5.4	15.0	7.2	11.3	19.6	14.1	17.6	8.5	8.1	9.1	37.0	10.8	8.5	14.3	12.6	12.5	6.6	17.2	14.6	38.6	26.6	23.6	22.3	22.4	28.8	16.1	14.1	10.7
SURF1		ENSG00000148290	"SURF1 cytochrome c oxidase assembly factor"	Q15526	9	133351758-133356676	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033946	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB033946: AB_2302648"	"unprognostic (1.87e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (6.92e-9)"	"unprognostic (3.91e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.98e-1)"	41.8	54.3	31.8	9.8	32.9	16.8	39.9	32.3	41.3	33.6	34.2	53.8	18.8	32.8	38.5	34.9	34.5	12.7	70.6	31.0	31.8	59.0	93.1	33.4	16.7	31.9	32.3	31.7	79.4	34.8	41.2	11.9	31.7	42.5	20.8	8.9	42.4	21.4	80.2	41.4	41.1	13.8	32.1	39.9	65.4	33.9	33.8	20.3	43.7	41.2	21.8	45.6	31.8	32.4	9.6	21.8	16.5	23.5	39.7	22.0	35.6	11.5	27.8	18.9	16.5	29.6	32.6	13.0	16.3	18.2	27.6	27.8	20.4	27.6	15.0	23.8	13.3	13.2	31.5	23.4	46.9	21.1	13.5	26.3	47.8	13.2	32.1	23.1	14.9	33.2	13.7	26.3	21.0	42.4	26.7	21.8	18.6	86.9	22.1	18.2	24.7	40.8	31.4	20.4	16.2	45.0	26.2	34.2	30.6	22.4	50.1	15.8	12.2	23.3	14.3	16.1	11.6	32.2	51.9	16.3	22.1	10.3	24.0	10.7	11.6	24.1	6.6	7.8	7.9	23.9	9.8	9.0	10.2	19.3	14.0	7.7	11.1	6.5	7.1	13.4	14.9	5.6	31.8	32.9	32.3	41.3	31.0	31.8	31.9	32.3	31.7	32.1	33.8	32.4	46.2	28.9	29.6	5.2	55.6	46.5	54.9	56.1	43.3	24.4	85.5	97.3	94.6	75.8	44.0	68.0	6.2	93.4	55.7	114.0	137.0	90.4	48.3	54.5	25.2	36.8	53.8	32.2	4.8	101.0	87.5	38.3	41.8	36.9	22.9	44.3	50.3	158.1	101.1	28.6	5.6	74.3	99.7	93.2	83.6	127.1	52.2	60.3	69.4	4.7	96.9	95.2	62.8	4.5	10.4	71.9	102.1	48.2	74.3	56.1	215.0	174.5	45.1	25.3	32.9	41.5	56.6	66.2	94.4	50.4	49.0	80.6	51.5	52.6	79.6	63.4
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356550-133361158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 105.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 448.9;Late spermatids: 992.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	15.3	16.4	13.2	5.4	13.0	5.4	15.3	13.5	15.6	13.8	12.5	16.9	7.6	13.1	6.0	25.8	13.4	3.5	18.9	12.9	12.6	27.7	22.6	12.1	7.1	14.3	13.5	13.2	28.9	5.8	24.2	3.1	13.2	17.7	2.9	4.7	17.0	4.4	21.6	28.3	14.2	2.3	12.6	15.6	20.1	105.8	13.5	6.1	15.5	3.9	4.9	16.5	15.6	13.3	17.4	29.4	12.1	15.1	8.7	6.7	25.4	8.6	7.5	13.5	7.0	40.5	14.0	17.1	12.2	5.8	11.6	46.5	19.2	21.1	6.1	16.7	26.8	13.5	34.7	15.3	17.3	22.6	9.9	8.1	24.5	19.3	28.1	4.8	6.3	20.6	21.9	11.5	9.3	104.3	23.4	15.0	38.1	41.3	56.0	25.7	18.1	40.4	11.8	19.6	44.8	22.7	19.3	31.7	27.0	7.3	33.8	10.6	12.1	20.3	20.7	21.2	31.2	14.3	30.6	18.7	13.0	13.3	20.8	23.7	23.0	18.6	24.3	24.8	32.1	22.3	29.7	28.0	20.3	27.5	27.9	26.6	10.3	21.1	18.6	22.7	42.1	20.8	13.2	13.0	13.5	15.6	12.9	12.6	14.3	13.5	13.2	12.6	13.5	13.3	26.7	12.8	11.5	3.3	23.2	84.1	27.6	53.7	50.7	18.3	31.1	55.1	13.3	35.8	27.3	22.0	2.1	37.8	25.0	30.6	105.7	73.0	448.9	44.4	16.8	20.9	36.5	28.2	3.5	81.6	28.4	19.3	19.9	16.5	9.5	12.9	22.5	23.6	29.7	13.5	2.9	21.5	36.7	25.5	31.7	992.3	26.1	18.7	42.7	0.0	33.1	28.2	34.0	1.0	3.5	63.8	37.4	24.5	19.6	28.8	81.4	78.0	60.2	23.6	65.7	24.4	26.8	169.9	107.3	43.0	88.2	25.6	38.2	52.2	30.1	23.2
SURF4	"ERV29, FLJ22993, MGC102753"	ENSG00000148248	"Surfeit 4"	O15260	9	133361450-133376166	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 325.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064613	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	Yes		65000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA064613: AB_2685299"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.47e-5)"	"prognostic unfavorable (8.11e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.29e-3)"	97.0	106.4	20.3	38.8	22.5	66.5	76.5	22.1	23.4	70.5	27.9	72.1	79.2	78.5	40.6	77.6	71.1	39.0	74.1	21.5	22.3	67.1	223.8	84.2	29.6	23.6	22.2	61.0	150.4	35.4	88.6	55.4	22.2	69.2	37.9	14.0	86.4	39.5	60.1	63.2	82.2	43.4	22.9	59.6	88.5	49.4	25.8	27.8	68.2	23.3	31.4	62.7	59.4	25.9	59.8	96.4	65.3	90.3	134.8	140.2	127.4	184.1	178.4	127.0	124.7	145.9	84.8	41.1	70.6	254.2	122.9	152.7	75.7	94.4	97.0	86.5	46.3	72.1	87.1	156.5	156.2	124.8	94.1	150.4	85.8	109.3	120.2	101.6	118.6	62.9	89.0	109.8	164.5	131.8	60.1	115.4	72.7	162.8	96.2	41.2	89.9	156.5	100.4	56.3	53.8	65.5	136.4	100.4	95.2	61.5	106.6	75.8	127.5	179.4	64.5	137.3	119.6	56.1	86.4	46.4	166.7	66.6	137.5	43.9	40.8	36.2	51.9	32.8	56.9	15.1	36.3	48.4	32.9	12.1	22.0	34.6	28.4	29.4	31.7	38.9	46.9	68.8	20.3	22.5	22.1	23.4	21.5	22.3	23.6	22.2	22.2	22.9	25.8	25.9	53.5	44.8	48.1	18.9	43.0	60.8	65.8	72.5	46.1	21.9	55.5	43.2	42.6	31.5	47.5	35.0	39.6	167.9	80.4	106.9	19.6	95.7	38.6	28.6	72.8	54.8	75.2	31.1	23.2	118.1	254.4	84.8	78.5	67.7	24.7	49.5	47.5	207.3	85.9	33.7	15.6	107.9	30.5	52.3	50.5	19.7	68.3	50.8	40.9	17.8	53.7	53.3	52.5	22.6	23.8	115.1	65.5	53.0	114.8	106.8	151.3	48.5	23.2	26.9	78.9	51.9	80.6	84.4	47.3	46.1	62.4	325.2	90.5	81.8	81.2	84.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040783-112175297	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Kupffer cells: 31.2;NK-cells: 25.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.0;plasmacytoid DC: 44.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 44.2;granulocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.7;HEL: 56.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	7.9	8.9	3.2	8.7	3.8	14.1	4.5	0.1	4.8	5.8	2.2	8.9	7.3	3.3	3.6	2.6	4.1	6.5	5.8	3.3	9.1	12.1	3.4	9.6	8.6	3.0	7.5	1.2	4.0	9.0	4.0	15.3	8.0	4.7	9.4	3.2	5.3	5.3	1.4	1.8	8.6	8.0	3.1	8.2	10.5	4.7	7.3	5.9	4.1	2.1	5.9	12.0	2.2	2.8	2.8	18.7	12.9	0.0	9.4	6.2	41.1	11.8	15.8	16.3	20.8	37.3	24.5	0.3	13.0	20.7	1.1	8.4	4.7	2.1	12.1	50.7	3.9	56.3	13.0	25.7	11.4	14.9	17.4	7.8	1.7	9.0	0.3	11.1	38.9	8.1	31.5	2.3	10.4	3.5	2.1	9.2	4.2	46.1	3.0	12.6	3.0	0.0	3.9	9.7	4.5	10.8	6.5	1.4	0.1	7.1	2.2	16.2	29.7	0.3	6.0	1.8	0.1	0.7	0.7	1.0	11.1	5.8	3.6	6.1	2.4	11.0	2.7	2.9	0.8	0.1	0.7	1.9	1.7	0.3	0.3	1.9	0.9	3.1	5.3	44.2	0.2	2.0	3.2	3.8	0.1	4.8	3.3	9.1	3.0	7.5	8.0	3.1	7.3	2.8	3.1	0.0	4.8	1.6	3.4	0.5	1.7	1.6	0.0	0.3	2.4	1.0	2.0	1.5	4.5	12.9	0.0	9.0	24.3	7.0	0.0	7.0	1.8	6.0	5.4	2.9	4.2	3.0	25.2	7.1	10.5	5.0	8.6	7.8	5.7	4.5	7.1	0.4	16.3	0.0	21.9	4.3	2.0	31.2	6.0	1.8	0.0	21.5	0.0	13.1	19.8	0.3	25.7	38.2	1.2	11.1	3.4	1.9	1.4	2.6	2.7	2.9	5.3	1.4	0.0	4.0	3.9	0.5	0.4	1.8	0.9	8.6	6.1	1.2	6.4	9.5
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 99.8"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000		"Cluster 19: Lung - Lung function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	12.1	9.6	4.9	1.9	2.8	0.2	9.5	1.7	5.8	13.6	2.2	4.8	12.8	9.8	0.5	2.8	15.0	1.8	12.5	1.6	5.3	32.6	2.9	99.8	2.2	22.9	6.9	5.4	4.3	1.5	7.1	3.6	26.5	5.6	1.0	0.1	4.7	5.6	2.2	28.2	34.6	3.4	6.8	3.6	6.3	3.2	13.2	0.8	17.8	1.4	1.3	5.4	11.0	10.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.8	1.7	5.8	1.6	5.3	22.9	6.9	26.5	6.8	13.2	10.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085133	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.3;testis: 77.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 50.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042310	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"			"HPA042310: AB_10796902"	"prognostic favorable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	6.1	1.8	4.5	17.6	3.9	41.3	15.4	4.6	4.3	16.7	4.4	3.8	4.9	19.8	10.0	4.2	35.4	4.2	1.3	4.3	5.6	21.2	27.8	4.1	57.3	6.4	5.7	40.1	1.0	1.3	5.4	2.0	6.5	2.4	2.2	6.4	11.4	3.2	1.2	3.6	18.7	6.1	6.6	36.3	4.5	77.2	5.9	31.8	4.2	0.6	30.5	4.4	6.1	8.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	0.6	0.3	3.4	1.3	150.7	0.6	0.6	0.1	0.3	2.4	0.1	0.0	13.4	0.1	20.7	0.1	2.4	9.5	0.1	4.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	6.2	32.6	0.0	36.8	0.2	78.0	1.8	1.1	4.6	6.5	0.0	82.5	0.0	0.0	0.2	0.2	0.1	1.1	0.0	1.7	19.4	34.6	0.5	0.0	0.0	0.0	0.0	6.6	3.8	9.7	0.0	0.0	0.2	0.6	16.7	79.1	24.0	15.5	27.4	88.7	124.8	43.4	41.1	70.1	214.8	87.7	5.8	11.2	3.0	3.6	182.9	68.3	4.5	3.9	4.6	4.3	4.3	5.6	6.4	5.7	6.5	6.6	5.9	8.0	2.6	0.0	6.7	0.0	32.4	0.6	0.2	0.3	0.0	0.5	24.2	11.0	0.8	17.2	0.2	0.0	4.2	1.0	2.4	0.4	9.8	0.7	3.0	0.4	2.9	3.4	0.0	2.5	0.1	0.2	2.1	9.0	1.1	0.3	3.8	30.8	1.4	66.6	49.4	0.0	0.1	0.4	8.2	10.5	9.2	11.2	5.6	29.1	1.8	17.8	8.3	1.7	2.1	0.5	0.1	0.6	0.1	5.3	17.9	1.4	0.2	59.4	0.7	9.2	0.0	0.1	1.6	3.4	3.9	0.1	0.3	1.4	37.5	34.7	0.7	0.2
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364233	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;esophagus: 51.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.7;Inhibitory neurons: 89.7;Oligodendrocyte precursor cells: 101.6;Squamous epithelial cells: 68.3;Theca cells: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2"	"Lineage enriched"	"Detected in single"	40	"T-cells: 10.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 9.7;RPTEC TERT1: 11.1;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA058296: AB_2683672"	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.4	6.0	28.4	0.8	21.7	0.4	8.7	5.4	63.7	9.5	0.0	1.3	1.0	0.3	25.1	51.1	3.5	0.7	23.0	69.0	26.8	19.5	3.8	2.8	1.6	9.4	10.4	45.3	10.7	14.9	26.0	0.5	15.9	6.0	0.2	12.2	17.0	4.3	3.5	7.8	0.6	0.4	5.0	0.4	11.0	6.6	21.4	3.4	1.0	2.2	15.0	3.6	25.3	16.2	5.9	0.5	0.2	0.0	0.0	0.0	0.1	0.8	0.4	1.0	0.5	5.8	1.8	0.0	1.8	0.2	0.0	9.7	0.2	1.5	0.9	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.0	6.6	0.5	0.0	0.5	3.9	3.8	0.0	0.2	3.0	1.3	0.0	0.2	0.1	11.1	2.8	36.3	0.4	0.0	3.2	0.0	0.8	2.1	0.2	0.0	1.7	6.2	0.0	2.9	0.7	0.1	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.3	0.1	5.5	0.0	6.8	1.7	0.0	0.0	10.2	1.9	0.0	0.2	0.0	0.0	0.9	1.4	28.4	21.7	5.4	63.7	69.0	26.8	9.4	10.4	15.9	5.0	21.4	16.2	0.2	0.0	4.8	6.2	0.0	0.6	8.6	8.4	10.2	17.9	9.7	5.0	9.5	5.7	14.8	16.5	10.4	0.1	0.3	0.1	31.3	0.6	3.1	4.0	0.4	0.6	1.2	0.0	83.7	6.9	0.0	3.8	2.6	6.1	0.0	9.1	0.4	1.8	2.8	21.9	89.7	0.1	2.0	0.6	0.3	3.4	20.5	0.3	5.4	8.4	0.0	1.6	0.0	101.6	2.5	2.6	0.0	12.4	0.1	4.6	0.0	0.3	5.4	6.2	0.0	1.4	2.8	1.3	10.7	68.3	1.7	0.0	1.7	65.5	0.3	25.7
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150043-33218810	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		17000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	4.6	1.4	2.9	0.9	3.0	0.1	1.9	2.2	4.6	6.3	4.4	1.7	0.8	4.6	2.2	1.3	5.2	5.5	1.5	3.1	4.4	1.5	0.5	1.7	2.3	3.4	3.4	3.8	0.6	1.0	0.8	0.2	3.4	1.3	1.2	0.6	0.7	6.3	1.6	1.9	1.9	4.8	3.8	2.5	1.8	2.1	4.7	0.1	3.2	3.3	5.3	1.5	2.4	3.5	0.0	1.1	1.2	0.7	1.7	0.2	0.1	9.6	3.4	31.1	10.5	0.1	0.0	0.0	8.8	2.5	9.5	0.1	13.7	4.5	12.9	0.3	15.3	0.0	2.0	0.0	0.2	0.1	0.1	1.3	2.4	19.9	3.9	15.2	78.5	0.0	0.0	0.1	30.4	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.0	1.0	0.1	0.1	2.5	0.7	1.8	1.9	31.3	0.0	14.4	1.2	4.7	0.0	0.7	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	3.0	2.2	4.6	3.1	4.4	3.4	3.4	3.4	3.8	4.7	3.5	0.1	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	2.2	0.5	0.0	0.0	15.4	0.0	0.1	1.4	0.0	0.9	0.0	0.2	0.4	0.0	0.0	3.3	10.5	0.0	0.0	2.1	2.0	0.3	0.0	0.1	1.8	0.0	0.0	0.5	0.0	61.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	32.9	3.6	29.0	0.1	2.6	0.1	1.0	0.0	0.2	0.1	0.0	0.1
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715144	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.3	19.3	12.0	32.9	12.4	67.2	22.2	26.7	11.6	16.2	13.1	20.9	25.4	13.0	43.1	31.8	21.0	27.5	15.6	13.5	12.8	22.2	12.2	37.1	30.4	24.5	14.5	13.5	22.1	16.6	14.4	17.0	15.3	17.8	19.0	15.6	29.7	16.7	12.3	27.3	32.8	19.7	18.2	33.6	20.9	10.7	14.2	21.7	22.4	11.5	36.2	21.7	18.1	15.5	19.4	4.9	7.0	6.4	14.0	10.2	12.8	10.7	22.6	6.0	5.8	5.9	16.7	22.6	11.8	13.5	4.8	26.4	4.0	22.1	5.6	38.9	3.0	18.4	4.1	9.8	22.6	3.0	45.6	16.6	21.5	10.1	18.7	6.5	12.4	6.9	5.7	19.6	8.4	9.5	4.5	8.1	1.4	11.3	5.0	7.7	6.2	9.1	11.5	9.8	3.0	4.7	8.8	25.4	4.0	5.1	10.4	8.3	19.4	13.8	8.1	8.8	4.4	13.5	3.2	15.7	8.9	10.3	7.4	16.3	11.6	12.3	5.5	10.2	5.5	5.3	4.8	3.4	7.6	5.0	4.6	3.4	33.0	4.1	13.7	4.3	4.6	8.8	12.0	12.4	26.7	11.6	13.5	12.8	24.5	14.5	15.3	18.2	14.2	15.5	45.6	12.8	30.0	22.2	24.6	0.0	36.0	0.0	23.3	16.7	44.2	21.5	14.0	21.5	11.2	18.4	20.9	4.3	32.9	44.3	7.9	26.7	1.0	34.7	13.3	32.8	7.3	13.9	34.6	24.6	1.7	13.1	18.8	28.4	8.8	9.7	17.9	15.9	23.5	15.2	21.1	21.9	0.0	67.4	0.0	5.1	5.3	44.3	0.0	107.7	31.6	4.3	16.5	22.1	28.4	38.7	20.4	6.8	15.1	43.0	74.1	15.2	10.9	23.7	26.3	18.3	19.0	8.4	15.4	19.7	0.0	9.2	21.2	7.6	8.5	54.6
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 39.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 421.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	2.1	1.5	1.4	2.4	1.8	4.7	3.8	8.3	3.5	1.6	1.4	2.9	2.0	2.0	1.5	3.1	2.1	1.7	1.0	1.5	1.2	2.4	3.1	1.3	2.5	1.2	1.4	2.5	1.8	1.9	1.3	3.8	1.2	2.7	3.4	3.4	1.7	2.3	1.4	1.9	2.6	2.3	1.2	1.5	1.8	39.3	1.3	6.1	1.4	1.2	3.1	3.1	1.4	3.1	28.6	20.8	40.8	24.1	7.5	10.7	16.9	14.8	8.1	24.1	34.6	29.5	15.2	22.4	13.4	5.8	22.6	21.3	27.7	16.4	31.6	22.9	15.1	29.4	14.0	21.5	4.3	14.8	16.2	4.1	5.3	24.2	5.4	6.4	19.0	37.4	41.9	15.2	20.3	19.3	31.3	4.4	28.8	26.6	5.9	38.4	28.1	20.7	10.9	11.0	13.8	16.8	23.9	16.6	11.1	23.8	24.6	11.0	11.6	21.4	31.7	22.9	23.1	9.5	36.1	47.9	12.1	14.8	13.5	0.2	0.3	0.2	1.5	1.1	1.9	0.4	1.1	1.7	1.1	0.3	1.8	1.8	0.3	3.0	0.4	1.8	2.0	0.5	1.4	1.8	8.3	3.5	1.5	1.2	1.2	1.4	1.2	1.2	1.3	3.1	2.0	0.0	1.5	4.2	2.6	8.3	10.2	6.7	9.1	7.5	4.0	3.7	2.9	2.8	7.5	1.8	10.4	13.9	1.7	1.1	5.9	4.4	421.0	3.4	5.1	4.3	3.5	16.2	8.0	2.2	25.6	5.1	4.1	4.0	2.5	7.8	1.8	3.0	5.0	11.8	7.9	3.1	6.1	1.6	2.8	104.4	4.7	1.8	1.8	2.8	0.7	4.2	3.1	4.5	4.5	2.1	1.7	2.6	7.1	14.5	1.0	7.4	3.5	10.2	6.6	5.8	6.6	47.5	46.6	8.3	8.8	8.9	3.4	8.7	4.5	10.9
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917844	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 128.2;parathyroid gland: 48.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.9;Excitatory neurons: 63.4;Horizontal cells: 95.9;Inhibitory neurons: 107.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	1.5	8.9	59.2	2.9	64.7	6.0	1.6	30.2	128.2	6.9	0.0	4.5	1.5	8.4	23.4	1.6	4.8	3.3	1.5	65.1	61.6	1.7	0.5	2.0	2.1	68.2	40.2	3.5	1.4	48.4	22.9	1.4	61.2	4.2	1.8	38.6	1.3	3.7	0.5	0.9	3.0	8.0	14.1	1.6	2.5	1.1	48.9	3.8	4.4	0.5	1.7	3.1	3.9	67.5	0.3	0.0	26.0	0.1	2.6	7.4	2.8	11.2	38.8	32.6	46.7	0.8	1.2	0.3	9.9	16.9	34.3	0.6	0.3	2.4	27.9	0.1	6.2	35.2	2.0	2.0	24.5	0.3	0.5	16.7	0.2	52.3	3.9	36.2	2.9	31.7	0.4	35.8	21.8	0.3	34.8	1.7	66.3	0.0	0.2	12.0	16.4	0.7	0.2	0.9	54.2	43.8	0.1	0.4	25.6	24.6	0.4	21.4	0.2	30.1	29.9	1.2	41.3	0.2	0.5	0.2	53.0	0.3	12.3	0.4	0.1	0.0	0.3	0.0	0.3	0.1	0.3	0.2	0.0	0.2	0.1	0.4	0.3	0.3	0.0	0.1	0.6	0.1	59.2	64.7	30.2	128.2	65.1	61.6	68.2	40.2	61.2	14.1	48.9	67.5	0.8	0.0	1.1	12.4	0.3	0.1	1.9	0.7	4.6	111.9	0.7	4.2	0.8	1.5	0.1	0.0	4.2	0.3	0.7	0.3	0.0	0.1	0.6	0.4	4.6	2.4	4.2	2.1	63.4	0.4	0.6	3.3	1.5	1.3	0.0	10.9	7.5	0.1	0.3	95.9	107.2	0.4	0.0	0.0	0.9	0.2	0.0	0.3	0.0	7.5	0.0	22.9	0.0	28.1	15.7	0.2	0.1	5.7	0.5	0.9	0.1	0.1	0.9	16.1	0.0	2.7	4.9	1.3	0.9	0.4	0.4	0.4	2.7	3.0	0.5	0.7
SV2B	"HsT19680, KIAA0735"	ENSG00000185518	"Synaptic vesicle glycoprotein 2B"	Q7L1I2	15	91099950-91302565	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 34.5;retina: 56.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 137.1;Cone photoreceptor cells: 150.1;Excitatory neurons: 455.0;Rod photoreceptor cells: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 2.1;SCLC-21H: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046247	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046247: AB_10963538"	"unprognostic (2.92e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.01e-5)"	"unprognostic (2.66e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.10e-4)"	1.8	1.1	17.2	0.2	17.5	0.1	0.8	7.3	34.5	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.8	22.4	0.0	0.3	0.1	0.2	0.4	8.5	0.0	0.0	1.4	0.1	1.0	0.2	10.7	0.8	0.3	56.3	1.0	0.1	0.6	0.2	0.4	0.2	0.0	0.2	0.3	0.8	1.4	0.6	0.2	1.0	1.2	0.1	0.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.2	17.5	7.3	34.5	22.4	0.0	8.5	0.0	10.7	0.0	1.4	14.8	10.9	0.0	0.0	7.2	0.1	0.4	0.1	0.1	0.0	137.1	0.2	0.5	3.0	1.5	0.0	0.0	150.1	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	3.3	0.0	0.0	455.0	5.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	11.4	0.0	0.0	0.0	0.4	2.0	0.0	0.2	0.0	27.2	0.0	43.4	0.0	5.5	39.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	139.0	0.0	0.5	0.2	8.0	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.2
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083383-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 55.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 85.0;Inhibitory neurons: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	15	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.0	1.2	4.7	0.2	31.4	0.1	0.2	11.1	32.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.0	55.7	0.0	0.0	0.0	0.0	26.1	39.5	0.5	0.1	0.0	0.4	0.0	42.2	0.1	0.1	4.3	0.3	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.5	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	31.4	11.1	32.0	0.0	55.7	26.1	39.5	42.2	9.1	20.2	10.2	0.5	0.0	0.0	5.5	0.1	0.0	0.7	0.4	0.0	5.4	0.7	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	2.5	0.6	0.4	19.8	0.0	85.0	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.7	0.0	0.1	0.0	82.6	0.6	2.0	0.6	0.3	0.8	0.0	0.2	3.6	2.8	0.0	1.0	0.0	3.0	3.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.1	5.6	0.0	0.2	0.4	0.2	0.7	0.0	0.1	0.0	0.2	0.8	0.2	1.5
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817397	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	34.7	15.1	36.4	13.7	37.7	43.1	29.9	39.1	49.9	30.9	33.6	29.3	11.6	24.9	26.2	17.7	27.2	15.2	24.7	37.1	38.4	25.6	19.1	17.4	23.0	38.2	37.3	36.3	12.1	22.1	30.6	20.6	37.5	20.3	15.7	22.6	15.9	15.4	28.0	17.7	19.9	19.2	38.2	22.1	19.0	52.9	37.1	48.3	19.0	23.5	23.5	23.9	24.8	40.3	25.9	12.9	75.2	26.9	30.9	48.3	37.2	21.5	18.1	28.8	29.7	22.8	20.2	29.1	23.5	28.6	22.6	18.3	14.3	23.7	35.2	53.6	23.7	54.5	12.1	43.9	25.6	41.3	35.2	31.2	37.4	16.2	15.4	29.7	29.1	56.0	46.2	14.3	35.3	12.0	41.5	50.8	40.8	23.7	14.5	30.9	55.8	19.2	29.9	25.3	45.5	40.4	26.8	14.9	31.7	76.9	11.3	120.1	22.7	25.4	28.1	19.6	35.6	14.9	19.1	20.7	16.1	27.5	24.4	60.5	40.2	76.5	26.8	40.8	23.5	56.4	46.5	32.3	39.2	59.8	42.8	37.2	70.3	37.3	43.8	33.0	115.7	24.7	36.4	37.7	39.1	49.9	37.1	38.4	38.2	37.3	37.5	38.2	37.1	40.3	46.2	9.6	6.3	0.0	25.0	0.0	33.0	0.0	23.9	6.2	33.1	53.1	0.0	28.6	9.3	20.2	2.1	53.8	20.0	19.5	54.8	51.7	149.0	32.2	34.6	32.3	18.2	135.4	0.0	24.5	66.0	36.6	14.3	18.2	11.4	22.8	42.8	45.6	70.4	6.7	0.0	19.6	0.0	51.8	0.0	61.6	42.9	48.4	0.0	0.0	70.2	33.1	29.9	0.0	0.0	43.1	21.7	53.8	16.9	21.9	20.5	43.2	7.3	15.5	59.2	28.1	28.4	158.0	153.8	21.4	0.0	61.6	21.4	24.1	23.6	31.1
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365248-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.6;placenta: 61.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 20.8"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	38.6	4.2	1.5	2.5	8.6	0.0	23.2	8.9	2.8	10.6	0.9	9.7	1.2	8.6	5.6	3.5	12.4	6.2	6.5	1.1	3.4	3.9	2.9	19.7	3.8	2.7	5.3	3.9	4.7	5.3	0.8	61.7	3.3	1.7	5.1	0.0	4.1	2.1	4.4	11.3	8.7	9.5	1.0	5.2	7.7	1.0	4.3	1.8	7.4	5.5	2.4	9.7	12.1	6.1	0.0	0.1	1.2	0.0	147.1	84.7	0.0	16.3	62.3	1.2	1.9	1.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	12.2	1.0	0.0	0.3	0.1	1.4	0.0	53.8	0.0	2.9	66.7	0.0	12.1	3.2	1.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	7.5	2.0	0.0	10.6	0.0	0.0	0.0	2.3	0.0	1.0	0.0	1.3	2.5	0.0	7.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	8.6	8.9	2.8	1.1	3.4	2.7	5.3	3.3	1.0	4.3	6.1	7.4	0.0	0.5	2.9	0.1	5.7	0.6	0.5	1.2	0.5	0.4	0.9	1.8	5.7	0.1	0.0	0.0	12.2	0.3	0.0	0.0	0.9	0.3	0.5	13.8	2.0	0.0	0.0	16.9	0.2	1.6	92.8	4.1	0.3	0.0	0.0	2.2	0.0	3.0	0.0	50.3	0.0	0.0	0.0	8.2	0.6	42.0	0.6	7.2	13.1	0.0	0.0	0.0	3.0	140.5	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	3.5	7.8	0.4	1.5	0.4	3.3	67.3	1.2	34.1	0.2	0.2
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736959	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 808.1;tongue: 581.5"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 259.3"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 259.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 146.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		210000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	26.4	13.4	3.7	22.7	3.9	37.2	22.6	1.3	8.9	45.8	2.5	314.5	14.8	116.2	24.1	92.1	55.5	52.0	165.0	2.2	2.7	15.4	10.4	22.9	12.6	7.0	4.1	83.3	18.5	31.8	8.5	17.9	4.4	70.3	37.1	10.3	40.6	100.0	808.1	26.9	60.1	107.0	4.4	7.6	77.6	11.7	4.9	19.1	35.0	581.5	10.8	173.2	40.3	5.2	71.4	27.9	12.4	5.4	32.1	84.4	22.1	12.6	24.1	4.3	4.7	34.4	63.1	2.4	43.0	4.9	31.9	146.8	8.6	25.6	5.2	1.4	17.6	0.1	33.6	19.9	21.4	8.0	1.5	72.7	24.5	44.2	19.1	71.9	69.6	14.7	0.1	0.4	6.7	19.9	7.7	4.0	7.0	27.8	15.1	15.5	32.1	0.9	40.2	20.1	18.1	14.1	12.3	1.4	34.3	39.8	12.9	7.9	46.3	21.9	23.4	94.4	34.4	0.6	0.8	0.3	64.5	14.0	65.4	43.4	12.1	58.2	11.1	14.0	10.9	0.6	11.2	7.6	7.3	1.0	17.1	10.9	259.3	14.6	29.6	3.0	4.3	3.7	3.7	3.9	1.3	8.9	2.2	2.7	7.0	4.1	4.4	4.4	4.9	5.2	31.3	48.1	30.5	2.3	3.7	70.2	108.0	41.1	204.9	11.7	36.6	67.1	469.6	18.6	53.5	38.6	25.0	29.7	11.3	39.7	7.9	94.1	4.0	26.3	65.8	61.1	23.9	1.7	8.3	42.3	18.5	68.1	7.7	43.6	10.1	35.7	32.2	11.8	10.4	5.0	43.9	31.3	28.5	7.5	45.7	6.8	109.6	25.3	28.4	146.1	16.7	30.6	13.4	28.1	6.6	63.4	40.2	260.7	3.3	131.8	18.4	10.8	42.2	15.0	46.0	90.6	92.9	6.5	11.1	103.8	60.0	24.8	14.6	27.9	39.2	98.3
SVIP	DKFZp313A2432	ENSG00000198168	"Small VCP interacting protein"	Q8NHG7	11	22813799-22830299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 406.9;Early spermatids: 945.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.2"	"Low region specificity"	"Detected in all"							HPA039807	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039807: AB_10795232"	"unprognostic (1.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.77e-8)"	"unprognostic (2.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.16e-2)"	3.3	8.4	11.6	5.6	14.4	17.5	10.7	13.3	18.5	6.9	9.4	7.7	10.4	7.2	18.2	5.6	8.2	7.2	5.6	12.1	14.7	15.5	4.0	6.7	7.8	15.1	13.1	8.2	13.3	14.0	11.9	2.7	14.9	12.8	8.2	9.2	11.8	8.0	5.5	5.4	11.1	3.6	16.2	8.2	18.6	4.8	15.2	6.2	23.7	4.2	7.2	6.3	3.3	19.0	0.1	4.5	10.0	0.3	1.2	0.4	5.9	4.1	3.0	5.6	4.5	2.9	3.8	0.1	6.3	3.1	6.0	2.6	14.6	4.1	7.3	28.9	11.3	14.5	4.2	7.2	2.9	24.3	20.3	0.6	5.5	0.0	3.6	6.9	21.3	26.3	29.9	31.2	5.6	7.2	26.4	3.2	5.7	24.8	11.5	22.7	10.0	21.8	10.4	12.8	50.2	11.2	0.0	12.3	13.9	2.5	20.8	4.6	14.9	2.4	8.7	34.9	7.0	7.8	0.0	8.4	16.2	0.0	10.4	9.6	1.3	23.3	8.0	0.7	10.6	12.4	12.8	9.1	1.7	12.5	15.8	11.3	4.4	6.6	0.9	24.0	9.6	6.3	11.6	14.4	13.3	18.5	12.1	14.7	15.1	13.1	14.9	16.2	15.2	19.0	68.8	80.1	66.9	4.9	80.1	26.8	69.0	61.6	12.5	48.9	141.2	110.4	157.7	82.9	71.4	161.8	22.9	34.8	89.6	63.8	406.9	89.9	945.7	64.2	9.3	79.4	112.5	187.8	4.8	143.5	7.4	24.9	57.6	80.2	125.4	36.4	79.9	100.7	24.2	26.9	3.8	105.9	111.9	22.1	64.8	319.1	34.8	55.6	55.2	7.5	62.0	67.0	65.9	6.0	62.0	156.5	63.4	47.0	67.1	77.3	100.8	224.4	59.2	79.3	13.1	23.7	32.5	201.7	87.6	28.6	77.4	32.8	89.2	23.2	84.6	92.8
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021068	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 14.3;pituitary gland: 7.4;retina: 13.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 41.7;Early spermatids: 65.4;Excitatory neurons: 70.3;Inhibitory neurons: 75.8;Late spermatids: 121.5"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Karpas-707: 2.8;RPMI-8226: 3.0;SCLC-21H: 1.5;SH-SY5Y: 1.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.0	1.5	11.2	0.1	12.4	0.1	0.0	2.2	14.3	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	1.0	11.3	9.5	0.1	0.2	0.0	0.0	2.9	2.1	0.0	0.7	0.0	7.4	0.0	3.7	0.0	0.1	13.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.7	0.5	6.4	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.5	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	11.2	12.4	2.2	14.3	11.3	9.5	2.9	2.1	3.7	0.4	6.4	6.0	0.2	12.8	9.6	2.6	0.1	0.0	0.7	0.0	0.0	19.7	0.1	0.0	1.3	0.0	5.0	1.8	41.7	1.3	0.0	0.1	0.0	0.1	65.4	0.1	0.1	1.0	16.8	0.0	70.3	0.0	0.3	0.6	0.0	0.2	2.5	0.1	1.1	0.1	0.1	11.8	75.8	0.0	0.0	0.0	0.0	121.5	0.3	1.0	0.0	1.0	0.1	2.1	0.0	4.0	2.8	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.0	21.9	0.0	1.5	0.7	0.7	0.9	0.0	0.0	0.8	0.5	0.1	0.0	0.4
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701362	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.1;salivary gland: 4.0"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 76.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;MOLT-4: 2.0;NTERA-2: 1.9;RT4: 2.0;T-47d: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.0	0.6	0.1	0.5	0.2	0.9	0.2	0.4	0.5	2.5	0.9	0.1	0.2	0.8	0.1	1.8	0.0	0.2	0.5	0.6	2.7	0.0	0.2	0.1	0.8	0.8	0.5	0.5	4.1	0.9	0.6	0.5	0.4	0.3	3.2	4.0	0.8	0.0	0.3	0.2	0.0	0.6	0.1	0.1	0.9	0.7	0.5	0.7	0.0	0.0	0.4	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	2.0	1.1	1.9	0.0	0.0	0.5	0.0	0.1	0.0	2.0	0.1	0.6	0.0	0.4	0.0	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.5	0.6	0.8	0.8	0.5	0.6	0.7	0.7	0.0	0.0	1.9	0.7	0.0	0.1	1.9	2.0	0.0	0.6	1.2	1.4	2.1	0.0	3.1	1.8	0.0	3.7	0.4	0.4	0.0	0.0	0.7	8.2	0.1	0.1	0.0	5.5	1.1	0.0	0.8	0.3	0.0	0.9	76.0	1.2	0.0	0.1	0.1	0.0	1.8	0.1	4.1	0.0	0.2	0.5	0.6	0.1	0.0	0.0	0.1	0.5	0.0	1.0	1.5	0.1	0.0	0.4	0.1	0.2	0.1	0.0	5.6	8.6	0.0	0.0	0.3	2.2	0.7	0.0	0.1	1.9	0.7	0.3	0.5	0.5
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	39.3	10.4	12.8	37.5	13.7	20.9	31.9	13.6	15.9	22.6	17.2	15.0	15.4	17.8	10.4	17.8	16.3	22.0	16.2	12.2	14.1	17.2	10.0	24.9	66.1	16.7	13.6	10.2	15.0	19.4	5.7	39.0	16.7	14.1	12.8	3.9	18.0	15.3	9.8	26.4	20.3	19.7	16.5	59.5	15.9	4.8	14.3	17.3	22.3	14.7	75.3	31.2	17.6	16.5	40.6	22.2	30.8	0.1	62.9	54.6	54.0	43.4	52.6	40.3	44.1	24.7	31.3	161.0	41.6	83.5	57.9	47.7	37.9	24.2	51.6	14.8	15.2	42.6	25.7	12.1	35.2	33.3	76.2	38.4	29.6	29.5	52.3	32.6	124.4	20.2	3.9	0.6	42.4	6.4	10.0	16.1	28.4	10.7	11.3	23.6	28.9	4.7	33.6	106.1	1.5	15.5	41.3	52.6	35.2	42.9	20.9	25.1	143.6	70.3	25.1	59.4	41.2	4.2	12.4	111.5	27.9	36.6	29.3	19.7	5.7	48.6	1.2	13.5	0.5	80.6	1.4	1.1	8.2	84.8	1.2	1.3	1.1	7.9	29.6	2.3	4.2	5.4	12.8	13.7	13.6	15.9	12.2	14.1	16.7	13.6	16.7	16.5	14.3	16.5	154.0	67.3	60.8	33.0	183.7	35.6	68.1	40.1	36.5	3.4	35.1	28.3	17.6	22.8	57.7	20.2	0.0	82.6	9.9	11.3	13.7	47.4	1.6	66.5	18.6	136.0	13.1	9.7	9.0	21.6	128.0	39.1	15.8	71.6	137.8	10.3	53.2	7.2	65.0	26.9	14.5	8.7	18.3	61.9	50.8	2.9	29.8	58.5	28.4	77.8	88.8	9.2	6.2	22.1	22.4	37.0	15.1	34.6	20.7	63.0	22.4	11.7	50.9	2.3	19.7	46.2	35.5	5.5	10.8	17.4	31.3	140.1	15.5	33.4	9.0	78.8
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"		9	128275379-128316123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 142.5"	"Group enriched"	"Detected in all"	9	"Early spermatids: 1180.8;Late spermatids: 1131.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	27.5	26.5	29.0	11.2	31.3	11.0	28.2	31.3	40.8	39.2	32.7	23.5	15.9	27.5	68.8	33.3	31.7	17.8	34.9	28.7	31.9	36.4	42.3	20.6	12.5	30.4	30.8	40.8	21.2	71.4	54.5	17.6	30.4	32.8	12.7	21.1	25.6	37.1	25.2	26.0	18.6	20.3	29.7	18.0	23.0	142.5	30.4	17.1	44.0	25.6	17.7	26.4	31.5	31.6	29.2	51.4	29.7	34.8	79.2	71.8	33.7	50.6	66.7	64.2	42.6	66.6	33.5	27.7	65.7	82.6	39.5	47.8	48.1	67.5	42.6	41.4	35.7	21.0	97.5	52.9	101.9	13.6	18.6	60.8	31.7	107.4	57.8	55.9	62.5	96.8	50.5	42.8	66.5	119.9	29.6	19.6	20.3	67.8	105.3	27.1	41.0	44.4	43.6	15.2	34.0	18.9	63.0	39.8	63.0	32.9	66.2	14.5	39.0	46.4	38.0	90.9	43.3	45.6	75.0	37.0	61.8	20.9	50.7	54.3	14.2	25.8	14.5	8.7	17.0	17.6	14.1	14.4	14.7	20.2	16.7	21.6	9.0	22.2	9.1	21.4	15.6	15.3	29.0	31.3	31.3	40.8	28.7	31.9	30.4	30.8	30.4	29.7	30.4	31.6	33.8	6.4	17.4	5.2	18.0	24.5	35.1	54.0	31.3	13.7	33.6	38.9	36.2	31.5	33.5	36.8	12.5	65.7	13.7	15.7	66.5	25.5	1180.8	30.7	29.1	31.3	25.6	17.2	2.9	38.5	41.1	40.7	19.9	30.7	9.5	27.9	35.7	82.4	33.2	1.7	3.3	27.5	28.5	20.8	13.0	1131.1	43.2	31.5	37.4	2.8	23.8	50.7	20.6	4.5	7.8	29.8	27.1	31.6	17.9	34.9	68.4	84.1	29.5	21.1	32.9	25.7	31.3	93.7	44.3	33.5	21.9	117.0	18.6	32.8	23.4	36.6
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374666-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.4	3.6	1.6	3.9	1.5	5.1	4.0	3.9	2.0	3.7	2.5	4.4	4.5	2.9	3.6	3.6	4.8	3.9	3.1	1.6	1.2	3.7	5.3	3.6	7.1	1.6	1.4	5.3	4.5	2.6	2.0	4.1	1.8	4.0	3.2	0.7	5.1	4.4	3.6	5.0	3.7	2.2	1.3	6.5	4.6	3.6	1.5	4.2	5.0	3.0	4.2	3.4	1.6	2.4	8.1	6.8	3.6	2.2	3.6	3.0	5.3	2.0	2.2	4.6	4.2	7.1	5.5	14.9	10.0	1.9	3.2	5.7	3.4	8.6	0.5	4.8	8.5	6.9	3.0	10.3	3.3	11.3	12.0	4.7	7.4	2.6	1.7	2.7	5.5	6.9	8.4	6.4	2.5	17.6	6.6	15.0	9.0	6.0	9.0	5.5	1.7	16.2	8.6	5.5	7.4	5.5	2.6	8.7	5.5	1.9	11.9	12.9	5.7	3.8	2.7	5.4	4.0	9.5	14.8	10.6	2.1	13.2	3.0	3.2	31.4	7.9	12.5	30.5	12.1	20.9	13.1	13.6	24.3	19.4	16.1	13.9	20.2	16.7	29.5	15.3	13.8	12.3	1.6	1.5	3.9	2.0	1.6	1.2	1.6	1.4	1.8	1.3	1.5	2.4	4.9	3.2	2.0	2.3	10.3	2.7	8.5	16.7	4.0	7.2	9.8	9.3	3.2	2.8	10.6	16.5	8.4	17.8	11.3	10.5	41.1	7.1	10.8	4.5	3.7	6.7	2.4	7.0	1.1	10.7	10.5	4.0	3.1	4.1	1.3	3.7	6.8	13.5	12.1	10.1	1.0	14.2	22.4	9.8	5.4	1.9	11.8	6.5	7.2	0.0	9.6	8.8	19.6	0.0	2.7	6.1	12.2	7.9	3.4	5.6	11.2	17.2	14.6	10.2	6.6	3.2	6.3	10.7	15.0	4.1	3.1	31.7	8.8	13.7	8.9	5.5
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1 RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 38.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.8;Late spermatids: 52.7;Oligodendrocytes: 55.2;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.4;U-266/84: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	3.3	3.2	4.0	2.9	5.8	9.0	4.1	4.5	3.9	3.8	3.7	3.4	4.9	4.3	4.4	2.7	2.9	3.7	3.6	3.2	5.3	4.8	3.3	3.4	2.8	5.2	5.1	6.3	9.2	4.3	2.4	5.6	5.3	4.6	3.3	5.4	6.5	3.1	2.9	3.0	3.8	3.2	4.6	3.0	4.9	38.3	4.7	4.9	5.2	4.5	3.0	3.3	2.8	7.2	2.1	1.8	5.0	2.7	8.1	6.2	4.2	2.1	3.6	2.6	3.9	1.5	1.7	2.1	4.1	1.6	2.6	1.8	3.1	2.8	3.3	5.6	2.1	2.2	1.2	2.0	4.0	0.7	1.8	4.6	2.8	2.8	2.5	4.4	6.3	4.2	4.8	10.2	2.7	0.7	2.5	1.9	5.4	5.5	1.0	1.9	4.5	5.2	2.5	1.3	1.0	7.7	1.7	2.6	7.2	11.7	2.9	1.4	3.0	3.4	2.2	3.2	1.3	18.4	15.2	0.8	3.8	1.3	1.3	14.2	1.9	2.8	1.5	1.8	2.8	2.3	3.1	2.3	1.2	3.3	2.9	2.2	5.6	0.8	4.3	1.1	6.1	1.1	4.0	5.8	4.5	3.9	3.2	5.3	5.2	5.1	5.3	4.6	4.7	7.2	7.1	3.2	1.1	37.2	4.0	1.0	2.0	1.4	2.8	4.3	5.0	3.4	7.3	2.8	3.2	5.5	4.2	3.2	2.2	5.1	0.0	2.9	150.8	5.3	4.4	4.9	0.0	8.2	25.5	2.7	6.8	5.5	4.6	4.9	2.5	4.5	7.9	3.8	3.7	8.4	32.3	3.6	0.0	5.7	1.9	52.7	4.7	3.1	1.8	21.5	3.8	2.6	4.1	31.7	55.2	2.1	7.8	5.7	5.7	2.4	4.4	5.3	2.4	5.4	0.0	4.3	5.7	54.3	11.5	3.0	0.6	6.7	3.6	2.3	2.9	2.3
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719612-16765340	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	15.3	25.1	5.8	11.2	6.5	25.5	12.4	7.1	7.8	13.1	11.8	14.6	17.4	9.2	8.7	11.3	11.1	13.2	9.5	6.8	7.4	16.0	29.4	9.1	10.3	7.1	6.7	10.9	11.8	15.5	7.6	8.7	7.0	12.8	13.0	7.8	10.7	8.0	12.6	10.3	15.6	9.9	6.6	7.1	13.2	6.4	7.7	7.9	11.5	7.6	10.7	10.8	8.3	8.8	29.2	24.1	17.0	32.0	22.6	25.6	7.8	22.7	16.2	18.6	18.4	22.8	23.5	22.6	32.4	22.3	37.9	16.9	21.0	29.7	24.7	14.8	41.9	9.0	25.4	21.9	16.2	15.5	13.4	17.6	13.7	32.2	27.1	21.5	26.0	6.9	19.8	12.2	25.4	34.2	8.4	16.6	19.9	16.1	26.3	9.1	21.5	22.8	27.8	18.9	17.3	21.3	42.2	29.7	23.1	22.0	39.5	13.8	20.6	23.7	12.5	48.7	18.6	13.4	12.2	26.1	23.3	7.7	19.8	7.4	7.2	9.3	9.9	7.9	8.1	9.0	8.4	9.2	7.8	7.0	8.3	8.7	12.0	10.1	11.4	6.5	10.5	6.5	5.8	6.5	7.1	7.8	6.8	7.4	7.1	6.7	7.0	6.6	7.7	8.8	60.4	64.1	75.6	14.4	96.0	64.1	107.0	69.5	37.0	20.2	116.0	78.2	74.3	88.6	92.2	79.1	22.9	66.5	273.8	164.3	111.6	119.6	214.8	219.3	84.7	53.3	106.1	45.9	13.9	132.1	83.3	65.5	72.4	176.3	210.0	38.3	71.4	216.0	49.5	23.5	16.0	107.4	63.1	70.8	241.0	296.2	42.3	171.5	67.6	8.4	55.7	49.4	64.9	11.6	26.9	183.6	159.2	54.5	185.5	80.3	148.3	164.3	169.7	21.5	59.2	56.9	68.1	15.3	21.5	42.0	52.6	150.5	156.6	48.5	118.6	104.4
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 140.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 200.5;Horizontal cells: 95.9;Inhibitory neurons: 129.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 6.4;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	27	"B-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 24.4;PC-3: 25.7;SK-BR-3: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA053057: AB_2682028"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	32.2	38.7	39.1	3.2	42.0	0.0	22.2	44.5	52.4	10.7	4.4	15.4	10.9	5.6	11.5	5.6	20.1	10.3	6.9	42.4	58.6	4.2	52.1	8.8	4.4	24.2	34.0	9.2	140.5	1.5	30.4	2.5	36.6	8.2	19.7	26.1	21.5	11.0	3.8	9.6	12.0	6.9	22.8	1.0	28.2	1.8	50.8	5.4	12.3	7.7	7.8	5.9	8.8	30.2	8.6	5.2	3.6	0.0	0.5	0.6	2.5	3.1	0.0	0.0	0.0	7.9	5.4	0.7	0.5	2.5	1.2	24.4	0.8	5.7	0.0	0.1	11.6	0.0	15.2	8.2	6.2	0.0	0.0	1.9	7.7	0.0	7.2	0.4	3.3	0.6	0.4	1.6	3.5	0.2	0.2	0.0	0.7	7.7	25.7	0.0	0.0	0.0	9.5	2.2	16.3	1.9	6.9	51.4	1.7	2.5	6.8	0.3	5.0	0.3	2.0	0.1	1.5	1.5	0.1	0.5	10.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	39.1	42.0	44.5	52.4	42.4	58.6	24.2	34.0	36.6	22.8	50.8	30.2	39.3	9.6	7.7	16.0	4.3	5.7	2.5	8.3	17.1	46.1	10.9	9.1	2.4	30.0	18.0	11.0	8.4	4.6	0.1	3.6	3.9	5.4	1.4	29.3	3.4	11.8	34.5	0.0	200.5	9.4	0.9	7.9	5.6	20.9	0.0	0.7	10.0	39.1	0.3	95.9	129.6	22.2	2.0	0.8	4.2	0.4	2.1	0.3	1.8	21.5	0.7	2.1	0.0	22.1	5.7	3.9	9.8	0.4	0.1	11.8	16.2	0.1	15.6	7.4	0.0	16.5	4.2	1.3	1.5	3.5	3.3	0.7	0.6	0.1	13.7	4.2
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYCE2	CESC1	ENSG00000161860	"Synaptonemal complex central element protein 2"	Q6PIF2	19	12898786-12919293	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 26.7"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 214.8;Spermatogonia: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 11.6;JURKAT: 10.4;MOLT-4: 11.1;SiHa: 11.7;U-266/70: 12.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042080, HPA062919"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA042080: AB_10794411, HPA062919: AB_2684905"	"unprognostic (3.00e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.39e-4)"	"unprognostic (1.79e-10)"	"unprognostic (7.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-5)"	0.6	0.5	0.4	0.4	0.7	3.2	0.6	1.4	0.9	0.8	0.2	0.8	0.3	0.5	0.5	0.7	0.9	0.3	0.5	0.4	0.2	0.8	1.7	0.5	1.1	0.6	0.5	1.2	0.6	0.1	0.8	0.4	0.7	1.1	0.2	1.4	0.6	0.1	0.4	1.2	0.6	0.1	0.2	0.8	0.7	26.7	0.5	1.8	0.7	0.0	0.7	0.8	0.7	1.6	5.9	1.1	3.0	1.8	0.3	0.8	3.2	1.4	0.6	0.8	0.9	0.2	0.8	4.5	11.6	0.8	1.0	1.2	1.0	0.3	0.9	1.7	0.7	1.3	2.7	0.6	0.1	3.0	4.0	0.8	0.2	0.3	0.6	1.4	0.2	10.4	1.1	1.3	0.5	2.4	11.1	2.0	1.9	0.2	3.3	3.3	1.4	1.1	0.5	0.9	2.1	1.4	11.7	0.6	0.7	0.8	2.3	3.2	0.8	0.8	1.5	4.3	0.4	12.1	1.7	5.1	1.0	4.0	5.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.4	0.7	1.4	0.9	0.4	0.2	0.6	0.5	0.7	0.2	0.5	1.6	0.3	0.0	0.0	4.9	0.6	1.3	0.3	0.9	0.0	0.7	0.4	0.6	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.1	0.0	0.2	34.3	0.4	0.2	0.5	0.0	0.0	1.7	0.4	1.9	0.3	0.0	0.5	0.0	1.8	0.0	0.2	1.0	0.0	1.7	0.0	0.0	0.6	0.8	23.5	3.1	0.3	0.0	0.0	0.0	0.5	0.0	1.5	2.7	0.1	0.1	1.2	0.1	0.3	0.1	0.2	0.2	0.2	26.3	0.4	0.4	214.8	72.2	0.0	0.4	0.3	0.2	0.1	0.3	0.2
SYCN	"FLJ27441, INSSA1, SYL"	ENSG00000179751	Syncollin	Q0VAF6	19	39202825-39204263	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1004	"pancreas: 28361.5"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 4000.5"	"Cancer enriched"	"Detected in single"	842	"pancreatic cancer: 369.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047654	Enhanced				"Intracellular and membrane"	NA	NA		920000		"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA047654: AB_2680112"											"unprognostic (8.02e-2)"							4.5	0.8	0.0	0.4	0.0	0.0	2.5	0.0	0.1	2.6	0.0	0.9	4.0	0.9	0.2	1.5	0.6	0.0	4.5	0.0	0.0	1.0	3.0	0.5	0.6	0.0	0.0	11.2	28361.5	0.0	0.9	1.6	0.0	1.6	0.0	0.0	4.0	0.0	0.8	1.6	1.8	0.0	0.0	1.2	2.2	28.2	0.0	0.0	0.5	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4000.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	1.2	0.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	506.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854863-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 40.2"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 1162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	98	"THP-1: 17.2"	"Region enriched"	"Detected in single"	51	"cerebellum: 14.7"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	56.7	5.3	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1162.6	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYCP3		ENSG00000139351	"Synaptonemal complex protein 3"	Q8IZU3	12	101728648-101739472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 82.9"	"Group enriched"	"Detected in many"	8	"Spermatocytes: 825.7;Spermatogonia: 346.9"	"Cancer enriched"	"Detected in single"	16	"testis cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB032978, HPA039635, HPA043938"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740"	"unprognostic (2.86e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.61e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.15e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.86e-4)"	0.0	0.1	0.3	0.3	0.4	0.2	0.0	0.5	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	82.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.4	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	2.0	9.1	4.5	0.0	0.7	0.4	1.2	2.2	0.9	0.6	1.3	1.5	0.3	1.8	0.0	0.4	3.1	0.6	0.0	0.1	24.1	0.3	1.3	0.9	1.2	0.4	10.1	0.4	0.2	0.7	0.0	0.7	3.8	0.3	0.7	0.2	0.6	0.0	10.7	0.7	0.0	1.0	0.3	31.2	9.0	1.7	0.0	0.0	0.4	0.3	1.0	9.5	1.8	0.3	1.9	1.9	2.0	0.9	1.0	0.3	0.8	1.7	65.7	2.0	0.4	825.7	346.9	0.7	0.3	0.1	2.0	0.2	1.3	0.5
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107401-15114985	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 140.3;Peritubular cells: 42.2;Sertoli cells: 85.5;Syncytiotrophoblasts: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.27e-4)"	23.3	12.6	7.8	5.7	8.0	0.0	17.6	7.4	7.8	27.6	15.7	28.6	3.8	32.9	4.6	6.6	23.2	5.7	20.8	6.9	7.2	16.3	4.9	18.1	3.5	9.7	8.0	23.5	6.0	2.5	6.7	15.4	7.9	18.2	2.5	1.4	6.1	11.5	5.4	8.6	11.7	10.8	7.8	12.9	13.5	4.7	8.5	0.9	12.4	3.8	1.4	23.9	18.8	7.3	11.2	17.4	9.0	23.9	19.9	18.2	7.1	46.9	33.7	44.4	37.5	4.1	7.0	0.0	30.3	46.5	15.2	7.0	7.0	8.1	24.6	0.3	8.0	1.6	34.2	7.6	37.7	0.1	0.1	32.1	5.9	26.6	12.0	26.8	8.2	0.0	0.0	0.1	33.6	5.9	0.0	0.0	14.7	0.3	17.3	0.0	22.4	0.2	11.1	1.8	0.3	17.8	25.9	15.9	31.6	8.7	1.9	1.2	17.5	107.3	32.8	49.6	50.4	0.1	0.3	0.2	29.3	0.1	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	8.0	7.4	7.8	6.9	7.2	9.7	8.0	7.9	7.8	8.5	7.3	18.6	3.2	1.1	3.6	0.2	2.4	0.8	1.2	1.8	0.3	0.9	3.2	4.1	1.5	0.8	1.8	0.0	7.6	0.0	0.0	0.0	4.7	10.0	0.7	13.6	15.2	0.0	0.0	0.0	0.4	140.3	16.2	0.0	0.5	0.0	12.8	20.0	0.3	3.4	1.7	0.0	0.0	0.0	1.0	2.7	19.3	29.5	0.6	14.2	6.5	0.0	20.0	0.0	1.0	0.2	1.7	0.0	42.2	0.0	0.5	0.0	6.1	0.1	0.8	85.5	10.7	30.8	3.1	0.6	0.3	2.6	134.5	0.4	7.5	0.0	0.2
SYDE2	FLJ13815	ENSG00000097096	"Synapse defective Rho GTPase homolog 2"	Q5VT97	1	85156889-85201016	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Cone photoreceptor cells: 54.2;Rod photoreceptor cells: 145.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;SK-BR-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027138, HPA058378"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Golgi apparatus"		"HPA027138: AB_1857686, HPA058378: AB_2683696"	"unprognostic (1.68e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.84e-3)"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.69e-2)"	1.1	0.6	0.8	0.9	0.6	0.5	2.0	0.1	1.2	0.8	4.2	4.5	1.5	1.5	0.7	1.1	0.8	2.2	3.2	1.8	0.5	2.5	3.6	3.3	0.3	0.6	0.6	1.6	1.8	4.3	0.7	2.6	0.3	1.3	1.4	7.6	1.9	1.3	0.4	0.7	1.5	2.2	0.6	0.5	1.8	1.6	0.8	0.4	2.5	1.6	0.3	1.9	0.6	0.3	2.1	0.6	0.6	0.8	2.2	0.6	14.6	2.3	1.4	1.4	2.1	4.0	0.7	0.0	0.8	1.5	2.7	3.9	7.3	1.0	2.1	0.9	2.0	1.9	1.7	1.4	2.6	1.2	0.4	1.0	1.2	1.0	0.9	0.9	0.3	1.3	2.4	0.0	1.0	2.9	1.2	0.2	3.7	1.6	0.9	0.0	3.9	0.5	1.0	5.2	0.1	0.0	1.6	8.0	2.4	3.3	1.8	1.6	0.3	1.7	3.8	0.0	2.3	0.0	0.3	0.8	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.1	1.2	1.8	0.5	0.6	0.6	0.3	0.6	0.8	0.3	3.1	51.3	12.4	9.4	1.1	8.3	8.0	1.7	8.0	6.8	10.0	6.5	24.4	4.3	6.9	1.8	54.2	10.8	0.5	2.5	7.9	1.9	3.1	11.0	2.9	2.1	19.2	3.0	12.6	4.7	4.7	7.8	3.6	5.2	1.3	4.4	3.6	8.4	1.5	0.0	5.2	4.1	2.0	0.3	4.0	1.6	2.1	0.7	19.6	1.9	1.7	9.4	1.0	5.5	0.2	3.6	1.3	2.6	0.7	6.9	8.1	5.8	14.0	145.4	0.0	6.3	5.2	16.6	9.0	8.5	4.5	2.6	3.3	6.6	4.5	4.5
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222276-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: AB_2686301"	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (5.72e-4)"	75.3	56.5	37.8	42.6	38.4	147.6	66.9	39.9	48.4	70.1	39.0	71.6	55.4	59.9	72.2	49.3	63.7	40.7	50.0	36.9	41.6	64.0	48.3	46.4	63.8	39.3	38.4	104.5	59.1	67.8	35.3	57.1	40.3	50.3	59.4	29.5	52.0	51.3	89.1	58.5	57.7	47.0	39.2	55.9	61.9	26.9	38.4	77.6	59.0	57.8	76.8	63.2	60.1	41.4	54.0	22.0	54.9	45.4	85.2	109.0	42.4	56.1	91.0	52.7	47.8	13.7	73.0	46.2	75.6	68.1	39.8	47.3	47.6	43.2	76.4	76.2	39.4	52.8	56.1	41.8	86.6	75.9	54.3	79.4	118.2	54.3	75.2	100.4	76.0	61.8	42.0	74.4	75.2	19.8	77.6	104.0	71.7	78.9	32.4	51.3	46.3	78.9	86.9	28.6	47.8	69.5	49.1	44.5	160.5	47.7	38.3	91.5	61.8	45.9	40.6	87.0	46.8	86.7	83.4	48.6	67.6	77.7	45.2	185.5	82.1	222.9	79.1	98.4	95.7	140.0	102.4	99.9	70.0	125.5	108.4	102.0	337.6	111.3	121.6	67.3	129.2	92.7	37.8	38.4	39.9	48.4	36.9	41.6	39.3	38.4	40.3	39.2	38.4	41.4	160.7	128.2	112.8	6.8	176.0	159.3	123.0	238.5	111.5	74.3	134.9	174.1	108.1	147.3	151.3	189.4	83.4	195.7	203.9	211.7	246.5	158.6	78.7	153.2	125.9	137.4	111.4	117.6	10.6	174.2	130.1	121.1	59.1	166.8	232.4	120.9	154.9	131.3	126.4	58.9	10.2	166.0	181.0	231.5	155.4	32.1	214.6	155.4	108.5	3.7	251.8	95.0	217.3	6.0	12.5	154.5	221.1	164.7	83.0	109.5	322.0	273.4	151.0	90.5	164.3	139.5	142.5	98.2	108.8	88.1	171.3	280.6	176.8	95.9	171.8	147.2
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863194	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.6;Late spermatids: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	18.0	17.3	15.5	29.3	17.0	27.4	18.0	12.5	19.8	24.1	11.9	22.5	22.2	25.3	20.1	19.7	23.5	18.0	17.5	14.9	14.1	19.1	21.4	20.6	34.8	18.9	15.6	23.6	19.1	20.7	32.6	25.0	17.1	23.8	14.1	15.7	24.7	16.4	38.5	25.3	22.8	16.1	11.4	28.5	22.9	41.0	16.6	30.0	24.0	18.9	22.8	20.7	19.9	22.7	57.7	101.0	40.4	29.9	39.0	46.8	67.7	44.5	32.0	45.8	51.0	45.8	51.1	101.6	30.2	51.0	25.7	46.2	55.1	49.9	40.0	79.4	62.2	58.7	68.9	47.5	43.7	64.9	65.6	36.1	29.2	49.3	55.4	31.2	47.6	52.6	79.3	64.4	39.4	54.8	61.0	70.3	34.0	50.0	23.9	64.6	46.4	62.6	31.8	102.7	46.0	57.7	55.1	35.5	36.7	40.3	48.4	89.4	53.5	37.1	58.5	28.8	66.9	84.1	173.1	81.5	42.4	42.8	61.8	1.7	3.0	1.5	2.0	2.5	1.9	2.9	1.8	3.2	2.8	4.8	1.5	1.4	3.4	2.7	5.0	5.8	1.4	2.1	15.5	17.0	12.5	19.8	14.9	14.1	18.9	15.6	17.1	11.4	16.6	22.7	14.7	0.0	7.7	34.9	30.2	20.9	18.7	15.6	18.2	21.6	17.4	15.4	7.0	22.8	12.0	25.8	35.5	35.5	20.9	32.7	54.8	21.6	141.6	24.9	29.9	23.4	36.3	26.5	24.6	17.5	34.5	17.5	41.8	27.7	12.7	35.1	26.0	31.8	18.2	21.9	27.1	38.7	10.2	27.0	25.6	146.4	19.3	24.4	14.2	19.7	47.3	11.3	32.0	29.1	28.4	20.4	25.5	21.1	19.8	21.5	30.8	14.9	15.6	27.4	19.7	17.4	20.4	35.3	34.1	14.4	21.3	57.3	21.2	21.9	38.6	20.6
SYN1	MRX50	ENSG00000008056	"Synapsin I"	P17600	X	47571901-47619857	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 271.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 81.4;basal ganglia: 127.5;cerebral cortex: 271.3;hippocampal formation: 118.3;white matter: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced					NA	NA		48000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 41: Macrophages - Immune response"			"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	3.9	11.0	81.4	3.5	127.5	2.0	0.9	9.0	271.3	1.2	0.0	3.7	0.6	1.3	1.4	0.7	1.9	2.6	15.3	118.3	30.7	2.2	3.0	2.9	0.4	28.5	2.3	2.9	2.2	0.7	35.7	4.4	12.7	2.3	1.8	44.0	1.2	1.7	1.9	1.3	1.8	1.7	0.0	1.1	1.9	2.6	9.9	0.9	0.5	3.8	0.7	4.1	1.6	150.4	0.0	0.0	5.0	0.7	0.2	1.0	0.0	0.9	0.2	1.4	0.4	0.0	0.0	0.0	1.6	0.1	1.6	9.0	0.5	0.0	0.4	0.6	0.1	0.5	0.0	0.0	8.1	0.0	2.1	1.9	0.0	1.5	0.3	0.0	0.1	0.7	0.6	0.3	0.2	0.2	0.3	0.3	17.4	0.0	0.1	0.1	0.1	0.3	0.0	0.0	30.2	7.9	0.0	0.1	0.1	7.2	2.2	0.0	0.2	0.0	0.9	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	127.5	9.0	271.3	118.3	30.7	28.5	2.3	12.7	0.0	9.9	150.4	0.2	0.0	0.0	5.5	0.0	0.9	0.6	0.6	0.6	27.1	0.2	0.1	3.7	1.5	0.1	0.0	10.4	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.4	4.2	0.8	37.3	0.7	0.0	2.7	1.1	0.1	0.0	1.6	3.3	1.5	0.2	28.6	34.1	0.3	2.0	1.6	3.4	1.0	2.8	5.1	0.0	7.5	4.7	6.4	0.0	10.6	5.1	0.6	0.2	3.4	0.0	1.2	0.0	0.1	0.1	7.3	6.6	0.8	2.1	3.6	2.1	0.0	0.6	0.0	0.1	3.2	0.5	0.3
SYN3		ENSG00000185666	"Synapsin III"	O14994	22	32507820-33058381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 25.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.5;Excitatory neurons: 347.7;Inhibitory neurons: 198.6;Late spermatids: 250.7;Oligodendrocyte precursor cells: 75.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 25.0"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Group enriched"	"Detected in many"	11	"B-cells: 3.2;granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 15.0;EFO-21: 12.5;NTERA-2: 7.0;PC-3: 9.0;SCLC-21H: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034566	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034566: AB_10603120"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.77e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.52e-1)"	0.7	0.8	12.4	0.6	0.0	2.5	0.6	0.0	25.0	0.3	0.0	0.7	0.6	0.6	0.6	1.5	0.7	1.0	0.6	6.8	0.0	0.8	0.5	0.8	1.2	3.6	0.0	0.4	1.2	0.4	1.6	2.6	6.4	0.6	0.6	4.1	0.5	0.4	0.5	1.8	1.0	0.6	0.0	1.4	0.8	3.9	0.0	0.7	0.9	0.4	0.6	0.3	0.2	0.0	15.0	0.7	0.4	1.9	0.0	0.4	0.6	0.5	0.1	0.0	0.2	1.4	1.1	0.7	12.5	0.1	6.2	3.6	5.4	0.1	0.0	0.3	1.1	0.7	5.1	3.0	0.0	0.9	0.6	0.2	1.0	0.1	0.0	0.3	0.1	0.3	0.9	0.6	0.0	0.1	0.6	0.5	7.0	0.2	9.0	0.4	0.6	0.6	0.0	1.0	7.4	0.6	1.2	0.1	1.2	3.3	0.2	0.4	0.4	0.7	4.8	1.0	1.0	0.5	0.7	0.6	0.4	0.4	2.8	0.9	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	12.4	0.0	0.0	25.0	6.8	0.0	3.6	0.0	6.4	0.0	0.0	0.0	1.6	0.0	0.0	8.5	1.5	0.4	0.1	0.0	0.0	3.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	54.5	0.1	0.4	0.9	0.0	0.0	347.7	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.3	5.0	198.6	0.0	0.0	0.0	0.5	250.7	1.5	0.1	0.0	12.2	0.0	0.0	0.0	75.9	8.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.6	6.6	0.0	0.9	3.7	9.0	0.0	0.1	1.1	0.0	0.7	0.0	0.0
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32679906-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 106.8;smooth muscle: 54.1;tongue: 73.4"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 121.0;U-138 MG: 113.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	10.5	8.5	6.4	15.6	6.1	0.7	5.4	6.7	6.6	9.7	6.1	11.6	6.5	10.9	4.9	17.9	7.4	9.5	17.3	5.8	7.9	2.4	2.2	10.5	6.4	8.3	8.7	3.7	2.6	4.7	0.7	2.5	7.9	13.1	8.7	0.4	9.6	14.6	106.8	2.5	7.3	54.1	9.0	6.2	9.0	9.7	7.4	1.1	4.5	73.4	1.7	12.3	2.9	8.2	8.7	7.0	11.2	19.3	19.4	30.5	6.6	41.9	81.5	28.7	19.6	1.2	24.8	23.9	13.0	121.0	43.4	5.8	1.0	0.7	16.2	12.4	0.8	26.1	22.6	18.0	16.4	33.0	12.0	46.6	2.9	31.6	1.1	86.1	9.0	17.2	19.6	26.2	24.3	4.2	32.0	8.9	5.9	11.2	9.6	34.5	36.5	12.7	32.6	14.2	18.1	1.7	57.1	17.6	21.7	22.2	16.0	10.4	14.4	113.0	19.4	69.4	18.8	11.4	21.1	30.2	39.0	10.4	98.3	5.9	7.7	6.1	6.1	9.6	8.1	6.9	6.9	6.4	9.7	5.2	6.2	7.0	0.9	9.1	9.5	12.3	7.9	12.0	6.4	6.1	6.7	6.6	5.8	7.9	8.3	8.7	7.9	9.0	7.4	8.2	10.6	9.6	9.8	15.7	15.1	22.0	14.2	14.5	8.0	50.2	20.6	7.0	1.0	20.0	14.1	9.2	39.6	9.4	20.7	8.3	5.9	11.7	11.2	12.9	25.0	13.1	7.3	16.0	12.2	5.4	9.3	17.1	0.5	16.3	22.2	12.4	22.9	19.1	5.4	74.0	13.2	8.4	8.2	17.7	23.2	14.8	41.7	7.3	33.8	7.5	11.4	20.0	34.0	15.1	11.6	7.9	7.9	64.3	5.7	16.0	10.7	10.1	6.0	53.9	19.7	16.6	12.8	32.8	36.0	7.2	22.3	5.1	15.3	9.4	12.6	9.4
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
SYNDIG1L	"capucin, DSPC1, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405894-74426210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	42	"brain: 468.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 468.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 280.7"	"Region enriched"	"Detected in many"	7	"basal ganglia: 125.1"	"HPA042594, HPA048487"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.5	0.1	42.9	0.0	468.2	0.0	0.3	1.2	65.4	0.3	0.5	0.4	0.0	0.3	11.0	0.1	0.2	0.2	0.2	3.4	30.8	0.3	0.1	1.4	0.1	16.7	50.9	0.2	0.2	0.0	0.7	0.0	12.9	0.3	0.2	4.6	0.2	0.2	0.2	0.4	0.5	0.3	19.6	0.2	0.2	0.2	100.2	0.0	0.3	0.0	0.0	0.2	0.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	468.2	1.2	65.4	3.4	30.8	16.7	50.9	12.9	19.6	100.2	7.5	0.1	0.0	2.7	1.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63761899-64226433	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 454.6;Rod photoreceptor cells: 568.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 73.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 73.8;T-cells: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 48.8;SiHa: 29.8;U-698: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.1	6.0	8.8	3.4	9.2	7.9	28.0	21.1	8.7	15.4	89.5	13.3	4.5	18.1	9.9	24.3	14.3	5.5	58.3	9.6	7.6	29.0	19.5	18.4	8.5	7.7	9.6	35.9	37.7	66.6	16.7	9.9	7.5	11.5	4.4	24.8	16.1	3.7	198.5	39.7	11.4	4.6	7.0	10.0	12.4	13.1	11.4	5.5	24.4	96.7	6.1	13.6	19.0	6.9	23.2	8.7	11.0	3.5	11.3	3.2	12.3	1.3	1.6	2.7	4.2	2.8	3.3	48.8	2.3	1.7	2.6	11.0	6.2	3.5	3.2	8.9	3.5	0.4	7.9	0.7	3.0	1.0	0.3	4.4	15.1	3.4	2.2	2.6	7.0	7.5	0.4	4.8	1.8	11.2	6.2	0.3	3.4	5.4	3.3	6.9	14.5	1.8	20.0	13.6	9.9	8.2	29.8	3.8	7.0	5.5	5.0	0.3	7.3	4.2	7.5	1.5	4.5	4.9	3.5	27.5	1.8	0.0	5.7	0.5	0.1	73.8	38.5	0.3	27.6	5.2	24.3	28.0	0.0	5.3	11.8	18.5	30.1	3.9	0.3	1.2	30.1	3.4	8.8	9.2	21.1	8.7	9.6	7.6	7.7	9.6	7.5	7.0	11.4	6.9	414.4	307.7	140.1	8.5	44.9	111.3	138.9	46.4	174.2	27.4	70.3	59.1	261.4	105.8	184.5	202.3	183.5	168.8	226.8	51.0	19.6	108.2	9.4	249.9	71.2	238.8	46.2	10.5	9.5	55.4	65.7	59.6	126.9	365.2	25.9	454.6	73.5	33.3	17.7	6.7	13.9	60.9	59.0	5.7	13.2	14.3	100.9	12.8	48.0	128.4	8.9	107.2	300.7	33.2	6.6	71.7	27.9	53.4	180.3	65.0	35.9	72.2	196.1	568.7	111.7	73.5	167.0	13.0	17.0	104.6	87.5	224.0	222.1	69.5	80.6	80.6
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 70.2;Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 103.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 36.2;Karpas-707: 42.3;REH: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear membrane"		"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	19.1	3.4	5.1	4.3	9.5	13.7	12.6	5.8	6.7	4.0	8.7	2.8	1.5	2.3	1.4	2.0	4.5	2.1	4.3	4.5	5.5	1.1	3.0	4.4	6.0	10.0	8.0	4.0	0.9	0.4	1.7	3.4	7.4	1.6	2.6	11.9	3.2	1.1	2.2	4.3	3.8	2.2	5.6	5.0	2.1	2.7	8.3	2.4	2.9	3.3	6.0	3.2	4.1	12.3	1.2	0.1	0.7	1.1	46.5	36.2	14.3	5.4	9.4	5.1	4.0	7.8	1.3	6.3	0.9	2.6	1.6	0.3	1.1	4.0	2.3	20.9	0.9	4.3	0.9	2.1	6.0	6.6	10.4	10.2	1.4	6.4	3.7	0.4	9.0	1.9	0.3	42.3	3.9	1.5	3.9	7.3	0.1	0.2	2.6	34.8	23.2	13.5	0.6	0.7	1.0	5.1	0.2	0.1	2.5	0.6	2.0	9.6	8.2	3.7	2.2	5.0	0.7	5.0	11.1	5.9	7.4	14.6	28.2	2.2	1.9	0.1	0.7	1.5	0.9	1.2	1.0	0.8	0.8	1.0	1.2	1.0	0.9	0.3	1.6	1.0	0.9	1.0	5.1	9.5	5.8	6.7	4.5	5.5	10.0	8.0	7.4	5.6	8.3	12.3	12.4	9.6	18.3	3.3	19.7	2.3	0.4	0.1	0.6	5.1	1.0	1.3	70.2	0.0	0.7	0.0	62.6	2.2	16.1	4.9	0.0	0.0	3.9	6.5	5.1	14.7	1.2	4.0	2.5	0.4	15.0	22.3	1.1	1.4	12.0	0.2	5.0	6.8	4.3	6.7	3.3	5.0	0.0	17.6	14.8	2.4	13.1	20.3	5.4	3.7	27.8	5.3	9.2	14.1	20.8	0.5	6.2	0.4	20.6	1.9	2.9	0.4	6.6	103.7	6.6	19.1	12.1	0.6	1.1	0.3	1.0	1.9	14.0	0.0	1.9	0.5
SYNE4	"C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4"	ENSG00000181392	"Spectrin repeat containing nuclear envelope family member 4"	Q8N205	19	36003307-36008813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 32.0;Breast myoepithelial cells: 35.9;Cytotrophoblasts: 32.6;Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 32.5;Hep G2: 29.1;MCF7: 34.2;SK-BR-3: 40.1;T-47d: 31.0"	"Region enriched"	"Detected in single"	15	"cerebellum: 6.8"	"Not detected"	"Not detected"			HPA060253	Uncertain					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA060253: AB_2684233"	"unprognostic (8.54e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.36e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (8.64e-9)"	"unprognostic (1.25e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.97e-2)"	0.2	0.2	1.2	0.2	1.0	0.2	5.2	6.7	1.5	2.6	2.5	1.9	3.2	0.7	7.7	1.2	3.9	1.6	0.2	0.7	2.9	8.4	12.0	3.1	0.2	3.7	3.0	0.3	5.4	12.1	12.7	1.6	3.6	10.9	1.4	0.2	9.2	4.0	0.3	1.1	1.3	0.2	1.3	0.3	3.4	0.2	2.5	1.7	8.6	0.0	0.3	0.8	1.3	1.2	0.3	0.3	0.2	0.4	0.1	0.2	4.3	0.0	0.0	0.0	0.1	32.5	3.8	0.3	0.4	0.0	0.2	0.0	0.3	0.4	0.0	1.1	0.5	0.1	0.8	29.1	0.5	0.0	0.2	0.2	0.2	1.1	0.0	0.0	0.2	1.6	0.4	0.4	0.0	34.2	0.5	0.1	0.2	0.3	0.2	0.9	0.0	0.4	2.2	1.0	5.0	0.0	0.0	40.1	0.2	0.2	31.0	0.3	0.0	0.3	0.6	0.5	0.2	0.5	0.7	0.6	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	6.7	1.5	0.7	2.9	3.7	3.0	3.6	1.3	2.5	1.2	0.3	6.4	17.5	0.3	0.7	0.5	14.9	19.9	5.2	0.9	32.0	35.9	0.4	24.3	20.2	29.5	4.2	32.6	0.8	5.4	25.4	21.2	0.0	9.1	1.0	0.8	29.8	0.0	0.6	8.6	24.7	0.7	8.2	10.7	1.3	0.5	0.7	12.5	2.6	0.0	0.9	10.6	26.4	0.6	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.9	11.7	16.9	0.0	0.0	23.9	4.5	24.2	17.3	0.4	0.0	0.3	1.6	0.1	0.4	2.1	0.4	33.9	1.2	0.1	8.8	9.2
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33453689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 34.5;Horizontal cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	135	"amygdala: 11.4;basal ganglia: 11.3;cerebral cortex: 21.0;hippocampal formation: 26.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HMC-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	9.1	8.4	11.4	6.9	11.3	3.4	7.4	0.0	21.0	18.1	6.1	12.4	3.1	18.3	2.4	7.9	19.4	3.0	7.6	26.4	0.0	7.1	3.0	11.7	5.9	0.0	0.1	21.8	5.6	4.4	40.1	3.1	0.0	9.8	2.2	5.8	5.9	3.4	2.1	7.7	11.2	5.9	0.0	11.7	7.9	10.7	0.0	7.8	10.3	2.0	3.6	11.7	12.0	0.0	2.7	1.0	26.1	10.1	5.7	6.0	3.4	7.1	4.6	3.8	3.0	11.9	1.0	8.3	1.6	3.5	3.5	4.0	3.4	3.9	2.5	4.6	2.0	20.8	3.6	0.7	4.9	3.3	22.9	4.1	1.1	7.2	3.3	14.4	2.9	6.5	6.7	3.4	2.8	6.0	5.1	4.2	14.5	1.2	3.0	19.2	0.6	3.1	2.9	2.2	6.7	5.4	2.6	5.0	2.2	6.1	11.1	3.1	0.8	7.8	7.7	3.1	1.5	4.0	1.4	5.9	4.5	3.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	11.3	0.0	21.0	26.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	2.0	28.1	7.4	3.6	2.4	3.1	17.1	23.5	4.6	5.7	1.4	4.3	4.0	3.7	10.4	0.8	7.3	1.4	1.9	2.2	6.3	18.7	21.2	7.2	9.6	4.6	34.5	1.4	1.3	8.8	2.6	3.2	5.1	6.3	10.0	0.8	1.8	38.7	21.1	1.6	6.1	2.8	7.5	1.6	11.5	2.4	3.6	7.5	2.7	4.2	6.2	12.1	6.2	1.5	0.6	13.5	3.8	1.6	1.6	8.5	21.9	7.9	19.7	3.2	9.2	9.3	8.2	9.2	4.3	0.8	12.8	11.8	2.8	1.8
SYNGR1		ENSG00000100321	"Synaptogyrin 1"	O43759	22	39349925-39385575	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"melanoma: 19.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"dendritic cells: 44.7;monocytes: 38.9;T-cells: 30.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029673, CAB034277"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB034277: AB_2255766, HPA029673: AB_10670430"	"unprognostic (2.68e-3)"	"unprognostic (1.84e-3)"	"unprognostic (5.90e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (1.32e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.04e-1)"	9.9	24.6	73.2	4.9	84.9	92.9	14.7	64.7	121.8	36.2	25.3	26.7	5.9	22.1	11.6	37.3	23.5	11.3	57.0	84.7	37.5	26.2	5.3	8.6	7.5	35.1	37.9	72.7	28.0	29.8	15.2	6.5	36.5	29.6	4.3	73.0	45.1	18.0	29.0	51.8	11.8	13.2	6.3	10.6	16.6	19.8	58.4	3.5	11.6	26.4	9.9	25.6	34.9	67.1	5.4	9.6	17.3	31.1	1.7	4.4	7.5	23.2	40.8	29.2	26.9	2.1	0.6	0.2	5.3	6.1	3.3	7.6	11.8	0.5	8.8	0.1	36.6	0.4	0.8	1.0	4.9	1.6	10.5	6.7	1.8	7.9	0.0	20.7	1.4	6.8	11.0	0.7	4.6	12.5	4.8	4.5	3.6	4.8	18.7	14.0	0.0	1.5	0.9	15.0	27.1	5.5	6.1	25.1	23.7	7.1	36.9	27.3	0.5	0.0	19.6	0.3	0.1	6.4	0.2	15.2	0.8	30.2	31.6	0.6	38.9	0.8	30.8	11.8	1.7	5.8	1.1	9.1	44.7	4.2	1.3	15.3	1.7	5.1	0.6	33.1	0.2	18.0	73.2	84.9	64.7	121.8	84.7	37.5	35.1	37.9	36.5	6.3	58.4	67.1	8.9	9.6	1.1	28.4	21.0	30.3	73.6	33.8	39.3	112.9	61.4	73.0	73.6	75.8	31.4	66.2	27.1	25.0	52.5	0.1	15.6	57.2	40.0	14.3	24.4	9.5	0.0	92.9	57.1	12.3	14.4	44.6	1.5	18.5	2.5	49.0	12.1	5.9	14.2	47.1	47.1	0.3	12.2	20.0	13.8	87.9	133.3	11.7	140.5	20.6	10.1	46.8	91.6	39.7	18.7	21.7	1.1	119.2	23.2	36.4	0.1	9.3	7.5	38.6	19.7	46.8	30.6	62.8	14.7	57.1	37.4	13.1	21.2	131.6	0.4	80.2
SYNGR2		ENSG00000108639	"Synaptogyrin 2"	O43760	17	78168581-78173527	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 434.8;monocytes: 836.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 672.3;OE19: 547.9;SK-BR-3: 630.6;T-47d: 502.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014742	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus"		"HPA014742: AB_2669079"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (4.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.78e-2)"	92.9	59.7	50.9	99.4	74.0	112.9	105.5	75.1	63.5	59.2	53.5	118.0	86.4	56.7	22.6	133.8	75.5	70.7	150.1	51.5	61.2	113.0	101.0	158.1	143.9	88.1	70.7	45.3	188.9	52.9	91.2	61.7	86.0	130.7	71.1	2.8	184.8	45.6	369.9	161.4	125.4	33.2	67.3	148.1	141.7	31.8	68.0	68.2	68.7	122.6	112.6	92.0	87.9	92.5	172.5	334.5	9.0	73.9	3.2	1.1	52.5	58.6	60.2	55.0	31.4	200.9	173.6	136.9	123.2	33.5	47.8	245.5	39.9	95.0	16.2	97.2	177.2	47.0	46.9	140.8	76.1	77.3	356.5	3.4	105.1	17.5	47.2	77.9	118.7	50.4	193.9	672.3	5.3	337.4	77.3	79.6	24.4	547.9	140.1	44.3	19.2	391.4	166.7	155.5	53.8	60.2	48.6	630.6	60.3	31.7	502.8	122.2	31.7	1.1	54.2	28.1	77.8	280.7	109.7	79.8	39.7	52.8	9.5	694.4	656.1	237.9	173.6	944.7	202.1	970.0	231.0	200.2	907.6	972.1	204.6	168.6	282.5	219.8	1139.9	530.1	314.6	837.0	50.9	74.0	75.1	63.5	51.5	61.2	88.1	70.7	86.0	67.3	68.0	92.5	56.1	128.2	113.4	3.3	226.6	124.1	136.1	170.9	79.1	3.3	126.5	84.1	63.0	68.6	153.2	171.0	6.2	169.7	63.1	125.2	9.8	313.6	3.6	41.2	9.6	83.5	72.6	70.2	2.4	434.8	59.1	27.9	104.5	89.7	103.0	25.3	56.4	46.9	255.5	5.0	1.2	327.6	193.3	137.9	330.6	4.9	22.1	150.3	74.7	16.9	836.7	5.1	24.7	2.5	31.3	286.5	160.9	17.0	159.2	282.4	77.5	36.2	63.4	3.9	39.5	26.0	46.2	13.4	12.3	120.1	163.4	179.5	58.8	11.4	212.8	216.8
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 122.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.2;Inhibitory neurons: 33.7;Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.0;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.9;HMC-1: 30.3;Karpas-707: 25.8;SK-BR-3: 32.1;U-266/70: 40.2"									"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: AB_2678198"	"unprognostic (8.89e-3)"	"prognostic favorable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	0.3	9.4	83.0	2.9	86.4	0.9	0.3	35.7	106.5	0.5	10.6	5.3	1.3	0.2	0.0	0.5	0.4	0.4	0.9	74.7	110.7	3.8	0.3	1.0	3.2	88.2	95.3	0.6	0.8	7.3	12.3	1.6	122.6	0.8	1.1	9.5	1.1	0.1	0.1	0.6	5.9	0.7	34.3	2.5	2.3	5.6	121.3	0.5	0.4	0.0	3.7	0.4	1.3	70.5	0.9	4.0	3.7	0.5	0.4	0.4	4.5	1.9	3.1	1.5	1.2	6.3	2.9	6.2	1.4	1.4	4.1	3.5	4.1	0.5	0.4	49.9	2.9	0.1	5.9	3.1	2.1	0.0	30.3	0.9	0.2	0.1	1.0	7.2	0.4	1.9	17.9	25.8	0.7	4.7	0.3	0.3	19.0	0.7	1.8	0.0	0.5	4.9	2.4	0.1	8.6	10.7	4.4	32.1	0.4	2.0	4.5	0.4	0.7	0.9	14.5	0.1	0.7	40.2	5.0	7.2	0.6	5.5	0.6	0.0	0.3	0.0	0.3	0.1	0.8	1.2	0.6	1.1	0.3	1.9	0.7	0.3	0.0	2.0	0.3	0.0	0.6	0.4	83.0	86.4	35.7	106.5	74.7	110.7	88.2	95.3	122.6	34.3	121.3	70.5	0.1	0.0	0.6	3.3	5.0	0.3	0.8	0.6	1.2	5.0	0.2	0.3	5.4	0.0	0.6	0.0	2.1	0.5	2.1	0.9	1.9	2.0	0.8	0.0	0.1	0.5	0.0	0.0	24.2	0.5	0.8	1.2	0.5	0.1	1.3	1.4	0.0	0.0	0.3	6.7	33.7	0.5	0.0	0.6	0.4	0.5	0.0	0.5	0.0	1.9	2.7	1.1	2.1	2.5	3.5	1.2	0.0	0.0	2.3	5.5	0.1	0.1	0.9	2.1	0.0	0.1	0.3	3.0	8.6	0.4	0.3	3.1	2.9	0.4	0.3	1.7
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364367-48376377	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 54.4"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 159.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 9.8;SCLC-21H: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.4	0.0	0.4	0.1	0.0	3.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.4	0.5	0.0	1.0	3.9	0.3	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	54.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	9.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.5	3.2	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.1	3.6	0.1	0.3	0.5	0.2	0.0	0.7	1.8	0.7	0.0	2.8	0.0	0.0	24.1	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.8	0.0	0.0	3.2	1.1	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	3.0	1.0	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	32.6	0.0	0.1	0.1	9.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	24.6	0.9	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	6.6	0.0	0.0	159.5	33.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981863-158099176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 116.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 133.4;TIME: 109.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	4.2	5.8	26.1	6.2	69.9	20.0	8.0	58.6	42.0	4.5	1.9	10.6	7.1	7.6	10.5	7.7	5.5	9.4	10.7	22.5	32.4	8.4	4.9	4.5	5.9	98.1	74.7	3.6	8.1	1.5	4.1	3.5	78.9	6.9	10.4	2.3	16.5	5.8	7.2	4.3	6.8	7.7	57.8	4.2	8.5	9.4	58.2	6.5	5.2	9.5	6.5	11.0	4.6	116.2	16.4	56.6	4.5	7.3	3.4	11.2	24.2	29.8	60.4	35.0	41.1	28.7	13.5	0.5	19.8	57.9	133.4	15.4	10.1	18.5	40.1	22.9	9.3	31.8	29.8	30.9	6.5	10.9	32.6	5.9	9.9	53.3	12.4	47.1	61.7	16.4	24.7	6.5	16.1	7.6	14.0	12.2	5.1	51.4	31.2	6.0	19.1	13.4	11.8	18.8	34.8	2.0	22.7	14.2	5.9	17.2	10.9	7.1	109.7	25.8	26.8	61.4	36.5	2.5	7.8	0.4	49.2	17.5	18.4	3.0	0.6	0.5	0.9	0.3	1.9	1.0	1.3	0.8	0.6	2.0	1.1	0.8	4.3	1.0	0.4	0.5	1.2	0.5	26.1	69.9	58.6	42.0	22.5	32.4	98.1	74.7	78.9	57.8	58.2	116.2	17.2	3.2	3.3	5.2	15.4	21.7	19.9	7.5	14.2	2.4	25.4	18.4	13.9	21.5	8.6	18.4	0.0	7.7	12.8	20.0	3.9	59.0	35.5	48.5	13.7	26.4	17.4	5.5	102.1	35.2	5.0	16.6	34.1	114.2	5.1	37.7	7.9	5.2	2.0	0.0	10.1	14.8	10.2	2.2	17.6	56.5	1.2	12.5	10.6	7.5	6.9	1.6	16.5	8.5	502.1	140.2	7.1	6.4	13.5	50.6	13.1	1.7	14.4	0.6	0.0	7.3	18.9	0.9	1.1	11.5	17.2	15.9	17.1	2.2	15.7	36.2
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366499-70417090	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	10.2	10.1	10.3	7.3	10.1	1.3	9.9	9.3	10.0	8.1	13.3	13.7	19.6	9.0	7.9	8.2	7.2	8.4	14.9	8.4	9.3	21.7	20.3	9.5	6.6	10.0	9.8	7.2	7.4	24.9	6.6	9.3	9.8	12.9	15.1	16.4	9.5	11.9	28.7	5.7	16.0	10.7	10.8	9.1	15.5	3.9	10.6	5.1	11.2	29.3	6.4	8.6	6.1	9.7	14.0	9.1	15.3	10.3	11.7	13.4	10.6	10.8	11.1	7.4	8.3	8.7	12.8	0.0	10.0	12.7	7.5	11.6	15.7	11.6	17.5	1.9	8.0	5.2	13.9	11.4	10.3	0.0	1.7	10.5	9.2	9.4	5.3	13.1	16.6	5.8	3.1	2.7	13.4	10.2	7.2	2.1	11.1	13.9	10.9	9.0	22.4	3.9	16.0	20.7	11.1	19.4	14.6	12.0	8.8	9.9	22.7	3.6	18.5	17.7	12.1	6.9	8.7	3.7	15.0	0.0	15.6	1.8	14.9	0.3	3.0	0.1	2.3	3.1	2.7	2.5	2.8	2.7	3.0	2.0	3.8	3.1	0.3	2.3	2.1	1.9	2.3	1.1	10.3	10.1	9.3	10.0	8.4	9.3	10.0	9.8	9.8	10.8	10.6	9.7	36.6	38.5	46.6	0.0	17.8	6.0	28.7	49.4	9.1	44.9	25.9	15.4	89.4	48.6	43.3	75.4	81.3	38.3	13.1	50.1	140.8	49.0	36.9	56.0	26.5	38.4	19.8	5.7	0.0	39.2	31.5	21.7	21.9	85.7	9.5	33.5	37.1	50.4	24.7	30.3	0.0	41.2	44.7	23.6	9.1	9.8	30.4	16.9	14.2	0.0	28.8	37.1	28.8	0.0	0.0	35.7	43.5	41.3	4.2	25.8	87.3	77.0	31.5	88.0	26.3	37.6	27.8	68.9	12.9	12.5	4.8	10.9	17.4	25.0	62.6	30.3
SYNJ2BP-COX16		ENSG00000258644	"SYNJ2BP-COX16 readthrough"		14	70326064-70417074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 4.8;Excitatory neurons: 3.1;Inhibitory neurons: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 10.1;U-2 OS: 10.6"	"Low region specificity"	"Detected in all"							"HPA000866, HPA062659"	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA000866: AB_2276678, HPA062659: AB_2684823"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.41e-2)"	"unprognostic (6.73e-4)"	"unprognostic (6.68e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	2.7	2.8	0.4	1.4	0.6	0.4	2.2	0.7	2.5	2.6	0.5	2.9	1.1	2.6	0.8	1.8	1.8	0.8	4.3	0.5	0.7	3.6	2.3	2.1	1.7	0.6	0.5	2.8	0.7	1.3	1.7	1.0	0.6	1.9	0.7	0.7	1.2	0.5	3.1	1.3	1.3	1.5	0.5	1.9	2.1	11.3	0.5	2.4	1.7	2.4	1.1	2.5	1.8	0.5	5.9	1.6	3.4	1.2	0.0	0.2	2.3	6.2	0.5	2.7	2.4	0.6	7.4	0.0	4.6	0.0	4.9	4.7	0.0	1.1	2.0	0.7	2.0	0.0	1.0	2.5	2.6	0.0	1.2	0.0	1.4	2.3	0.0	4.2	1.9	4.7	0.0	0.5	1.6	0.4	3.6	1.1	1.6	10.1	1.8	4.7	0.7	2.9	1.4	2.3	2.9	4.7	1.1	2.2	3.5	4.2	2.2	2.9	0.0	2.9	10.6	0.0	3.2	0.3	2.6	0.0	5.3	0.0	4.0	1.6	8.9	0.1	11.1	11.2	11.5	14.4	12.1	11.0	12.0	13.6	11.4	10.8	0.0	15.1	5.7	9.2	12.8	7.9	0.4	0.6	0.7	2.5	0.5	0.7	0.6	0.5	0.6	0.5	0.5	0.5	0.6	0.0	0.5	1.0	1.1	0.0	0.1	0.0	1.2	0.3	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.3	1.4	0.0	1.9	0.4	1.6	2.0	0.7	1.8	0.0	4.8	3.1	0.8	0.4	1.1	1.1	2.6	0.0	0.3	0.7	0.7	0.2	0.0	2.7	0.0	0.0	0.8	0.0	0.9	0.6	1.0	0.0	0.0	0.1	0.3	2.1	0.5	0.6	0.3	0.1	0.4	2.4	0.0	0.2	0.6	0.0	0.3	0.0	0.2	0.9	1.0	0.2	1.5	0.0	0.3	0.6	0.2	0.4	0.0
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.8;HeLa: 58.0;WM-115: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	37.2	20.3	51.4	26.5	66.0	0.4	56.7	70.1	58.2	11.8	52.5	594.1	27.1	50.8	12.7	169.6	36.5	19.2	144.2	44.4	75.4	6.9	4.8	23.1	4.2	81.7	66.6	14.1	6.3	8.2	23.2	14.0	81.6	150.6	52.0	40.3	25.6	291.3	624.7	17.0	105.7	160.9	71.6	2.9	158.4	5.2	69.3	3.7	11.2	277.1	4.0	406.3	41.0	79.8	6.6	36.8	8.1	21.9	15.9	0.9	0.5	3.7	5.3	2.1	1.3	5.4	4.9	0.0	5.3	5.3	17.7	4.2	5.5	0.1	1.6	0.5	9.0	0.1	58.0	5.4	9.0	0.0	1.0	0.9	0.3	3.7	0.8	6.0	4.3	0.0	0.2	7.4	5.5	3.7	0.7	0.8	7.2	0.7	11.4	0.0	7.5	5.5	2.1	3.6	3.6	4.2	21.9	3.4	13.5	12.7	0.2	3.6	4.8	4.1	0.4	2.9	8.9	0.1	1.0	0.0	0.4	0.0	124.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	51.4	66.0	70.1	58.2	44.4	75.4	81.7	66.6	81.6	71.6	69.3	79.8	14.8	0.0	1.7	15.3	0.9	2.3	0.7	0.9	2.8	12.6	32.7	103.5	502.5	0.0	1.2	0.0	16.7	1.5	6.6	2.1	0.0	0.5	9.5	1.3	1.0	24.2	3.0	0.0	15.6	1.3	0.7	20.3	5.1	4.2	0.0	1.1	3.6	1.3	0.3	42.1	9.8	0.9	0.0	0.0	5.1	4.5	1.2	2.0	5.4	12.2	0.6	127.8	1.0	2.5	14.0	0.2	2.3	4.1	5.4	2.0	0.6	0.3	3.1	10.2	32.9	19.6	98.5	7.9	11.5	2.1	3.7	0.4	5.9	0.2	0.7	0.9
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.7	0.1	0.7	0.3	3.6	0.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	11.8	0.1	0.1	262.3	0.7	0.5	0.1	0.1	1.2	0.2	0.7	0.6	0.2	0.4	0.0	0.1	0.6	0.5	3.1	0.0	0.4	4.8	0.0	279.2	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.6	0.1	0.2	87.2	0.2	0.0	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.7	0.7	0.8	0.9	0.7	0.5	0.7	0.6	0.5	0.5	0.6	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
SYNPR	"MGC26651, SPO"	ENSG00000163630	Synaptoporin	Q8TBG9	3	63228315-63616924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 123.6;retina: 38.8"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 641.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Region enhanced"	"Detected in all"		"olfactory bulb: 743.6"	"Low region specificity"	"Detected in all"			"HPA051368, HPA061671"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051368: AB_2681456, HPA061671: AB_2684582"			"unprognostic (1.69e-1)"		"unprognostic (3.77e-2)"			"unprognostic (3.14e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.89e-1)"		0.0	0.3	40.0	0.1	123.6	0.0	0.0	52.1	68.7	0.0	5.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.5	42.5	19.0	0.0	0.0	0.0	0.0	21.9	22.8	0.0	0.1	0.0	1.1	0.0	11.2	0.0	0.1	38.8	0.6	0.0	0.0	0.0	0.1	0.0	25.9	0.0	0.5	0.0	41.2	0.0	0.2	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	123.6	52.1	68.7	42.5	19.0	21.9	22.8	11.2	25.9	41.2	40.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	5.3	0.0	72.4	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	641.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	45.0	0.0	8.0	7.6	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0
SYNRG	"AP1GBP1, MGC104959, SYNG"	ENSG00000275066	"Synergin gamma"	Q9UMZ2	17	37514807-37609472	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023554, HPA023555"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA023554: AB_1844892, HPA023555: AB_2058337"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.91e-2)"	"prognostic favorable (3.96e-4)"	8.3	9.1	4.5	12.9	6.6	6.7	7.7	5.6	7.0	8.4	7.1	8.7	6.8	7.6	10.8	9.6	7.5	8.1	5.7	4.1	7.4	9.9	8.5	8.8	21.4	6.7	7.5	8.3	8.8	11.9	11.7	7.7	7.4	8.0	9.5	9.2	9.1	6.7	7.1	8.5	12.1	6.9	6.2	16.6	10.4	13.0	6.8	24.2	9.8	6.0	19.3	8.5	8.4	7.5	7.9	13.1	18.0	12.0	12.0	11.5	7.6	12.3	12.4	13.2	15.1	12.5	11.8	15.5	11.4	11.3	13.5	8.0	15.8	6.5	19.7	14.0	9.1	8.9	8.2	6.0	14.0	14.0	19.2	13.1	14.9	15.5	8.8	12.4	18.3	26.3	18.0	13.3	14.3	6.4	29.4	7.3	7.9	7.3	4.8	19.1	15.3	10.5	12.3	15.4	14.2	13.4	11.5	3.7	10.8	20.5	10.5	11.0	17.4	9.6	12.3	8.0	11.5	14.9	18.5	24.4	10.9	7.1	10.7	12.4	4.0	8.8	12.5	2.9	16.4	10.9	10.9	12.5	3.4	10.9	10.7	10.6	8.3	17.5	3.2	13.2	11.8	4.4	4.5	6.6	5.6	7.0	4.1	7.4	6.7	7.5	7.4	6.2	6.8	7.5	26.9	54.5	38.7	37.5	64.8	8.5	14.6	17.2	19.9	49.8	22.6	21.2	26.3	20.0	25.1	33.1	54.2	18.5	77.0	24.1	17.6	24.7	43.7	26.4	29.7	28.1	42.6	17.9	36.5	21.8	10.6	20.4	26.0	31.8	25.9	23.5	22.9	23.2	21.8	37.0	42.5	22.4	18.3	40.9	24.7	50.1	22.7	27.2	16.0	40.3	30.4	31.2	108.1	55.3	71.3	26.4	19.6	24.0	67.6	17.5	23.5	29.7	23.4	49.5	13.1	29.3	20.2	65.8	23.9	19.0	9.2	26.5	81.8	21.7	17.1	20.8
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187815-49200199	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 259.4;pituitary gland: 106.8;retina: 316.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 529.2;Cone photoreceptor cells: 546.3;Rod photoreceptor cells: 594.4"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 20.3;SCLC-21H: 102.6;SH-SY5Y: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999, HPA079659"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153, HPA079659: "	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.6	40.1	115.7	3.6	132.0	0.8	1.9	26.0	259.4	1.8	0.0	7.4	12.4	1.5	2.0	1.2	1.7	0.8	3.1	144.0	137.9	5.0	0.8	3.0	0.9	89.5	25.8	1.7	7.6	3.3	106.8	0.8	76.2	1.6	3.9	316.3	1.3	1.1	1.9	1.8	13.9	1.9	4.7	2.0	5.3	1.7	86.0	4.2	2.3	1.4	0.7	1.5	2.2	116.9	0.9	3.9	2.9	5.8	3.2	0.5	0.4	0.2	0.1	0.7	0.8	3.6	2.1	3.2	0.5	0.1	4.4	2.9	3.1	0.4	0.7	6.5	3.5	4.9	1.4	1.1	0.1	0.6	10.5	0.4	0.1	0.5	0.7	0.4	0.3	2.7	20.3	7.6	0.6	1.1	1.7	0.4	9.6	2.5	0.8	0.6	0.6	1.5	0.2	0.4	102.6	36.8	1.1	0.4	1.5	0.9	1.9	1.8	0.6	0.6	3.2	1.0	0.4	0.5	6.7	0.8	1.7	1.3	3.2	0.7	0.2	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	1.9	0.2	0.1	0.6	0.1	0.0	115.7	132.0	26.0	259.4	144.0	137.9	89.5	25.8	76.2	4.7	86.0	116.9	7.5	0.0	3.9	24.2	6.3	2.5	2.8	1.0	1.2	529.2	5.8	8.1	1.8	2.8	2.9	9.2	546.3	1.1	1.9	11.3	0.0	0.9	10.3	1.4	3.1	6.5	116.4	0.4	115.1	2.6	0.6	3.7	10.2	3.1	8.8	3.4	6.1	1.2	1.2	122.8	118.4	37.7	10.2	1.9	4.9	12.6	4.1	3.6	3.6	17.8	2.7	54.4	3.1	28.1	33.7	1.2	2.1	3.8	1.5	1.5	16.3	0.9	4.6	594.4	6.6	5.4	7.8	2.4	2.8	3.4	2.6	1.4	3.5	41.3	10.8	1.0
SYPL1	SYPL	ENSG00000008282	"Synaptophysin like 1"	Q16563	7	106090505-106112576	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 633.6;Spermatocytes: 536.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014141	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014141: AB_1857716"	"unprognostic (8.88e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.61e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.25e-9)"	"unprognostic (2.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-1)"	78.7	70.1	35.3	49.2	50.2	51.2	98.3	55.5	63.5	93.6	34.8	83.1	60.4	100.0	88.9	147.2	104.1	70.1	73.3	33.4	41.1	127.2	66.6	66.9	86.0	71.6	50.8	72.1	54.3	125.8	26.3	84.1	69.5	96.8	77.1	13.0	135.8	119.8	149.6	94.0	58.2	109.4	56.2	59.8	81.7	97.6	44.8	56.7	117.4	101.6	121.4	107.5	94.8	82.8	187.1	85.3	44.9	74.4	188.8	142.9	65.0	115.0	128.3	105.8	128.5	58.5	323.6	187.0	150.9	144.2	179.5	154.9	72.4	186.0	174.8	51.6	85.5	82.6	49.5	57.4	148.0	140.7	65.5	107.5	236.7	111.1	142.8	140.9	147.9	69.5	85.5	0.4	212.7	161.3	149.3	167.1	49.8	214.5	112.6	18.4	75.7	97.7	224.4	300.4	22.1	50.1	111.3	266.4	115.6	106.8	81.6	111.0	133.2	210.3	107.3	226.0	132.4	82.1	102.2	193.7	92.6	239.8	121.0	66.9	39.8	44.8	13.6	37.9	28.2	130.3	36.3	27.3	32.5	125.1	53.5	34.3	15.2	71.3	31.2	31.3	33.9	40.9	35.3	50.2	55.5	63.5	33.4	41.1	71.6	50.8	69.5	56.2	44.8	82.8	186.9	54.5	63.4	27.1	238.6	171.7	285.3	326.6	252.6	8.9	111.5	70.4	69.7	181.6	172.9	187.6	16.7	211.6	45.9	51.6	113.5	167.0	633.6	96.6	57.3	153.3	37.8	81.2	8.4	107.5	144.7	125.1	88.7	87.7	91.4	47.9	152.4	96.5	90.5	20.2	7.6	82.7	175.0	83.4	95.3	170.3	95.1	69.4	145.9	16.9	39.4	103.9	15.5	8.5	70.8	130.0	66.2	94.0	23.8	213.6	61.0	221.4	131.2	12.8	157.8	76.3	144.4	536.4	126.3	309.0	173.0	184.0	79.5	113.6	101.1	271.8
SYS1	"C20orf169, dJ453C12.4"	ENSG00000204070	"SYS1 golgi trafficking protein"	Q8N2H4	20	45361937-45376798	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046716	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA046716: AB_2679769"	"unprognostic (8.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.77e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.01e-2)"	19.7	18.4	15.9	16.4	18.4	25.5	18.2	16.9	16.7	19.2	45.1	21.2	11.6	21.6	17.6	16.1	33.0	18.8	16.5	17.3	18.6	23.6	24.9	19.8	26.7	16.7	17.4	25.1	19.2	23.2	16.4	16.0	17.1	14.9	14.5	21.5	26.1	19.6	23.4	12.7	18.1	16.9	16.0	15.3	20.4	8.5	18.4	16.4	29.8	15.8	24.3	19.0	15.6	19.9	16.8	30.4	12.9	22.0	40.2	24.6	20.4	17.3	24.3	25.5	21.8	76.1	32.0	10.5	39.1	28.7	32.8	35.8	25.6	30.5	17.8	15.1	13.9	12.3	16.6	41.5	33.4	23.0	23.9	30.1	44.6	28.0	17.7	25.6	25.6	18.6	19.3	15.3	18.9	36.6	19.0	23.1	13.8	20.2	42.2	3.1	15.0	16.3	30.6	14.5	9.8	11.8	27.5	16.6	34.2	13.3	37.3	14.6	15.1	32.2	21.3	17.9	16.3	18.1	13.0	4.1	22.0	15.5	18.7	51.8	23.4	37.7	33.8	23.4	35.7	26.3	32.5	34.8	26.4	31.3	35.1	30.6	29.7	22.9	25.6	103.9	37.8	30.6	15.9	18.4	16.9	16.7	17.3	18.6	16.7	17.4	17.1	16.0	18.4	19.9	18.5	19.2	28.1	0.0	39.5	29.1	37.6	24.6	19.9	25.3	29.9	25.4	12.7	27.1	17.3	23.9	29.2	28.4	61.1	31.7	17.6	39.6	30.3	48.7	15.8	23.1	16.1	7.6	0.0	57.9	45.2	26.8	9.2	28.5	26.1	15.0	24.7	34.5	60.6	20.2	0.0	22.6	22.4	38.4	15.4	19.9	17.4	30.3	24.9	0.0	24.4	34.3	35.0	0.0	0.0	42.0	28.5	19.2	14.8	36.2	47.5	29.4	58.4	37.1	13.1	21.0	33.2	17.4	13.8	16.6	30.5	52.5	37.2	18.9	17.1	39.4
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 403.3;retina: 197.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	0.5	21.7	113.1	2.2	153.7	0.6	0.7	19.7	403.3	1.4	0.0	4.4	1.5	9.9	0.7	0.7	0.8	1.3	0.2	134.2	2.0	1.9	1.9	0.9	0.3	0.0	0.0	5.2	0.3	0.0	6.4	2.6	3.0	6.6	2.8	197.7	0.2	5.5	0.2	0.2	3.4	25.2	0.0	2.6	1.3	0.7	12.5	0.5	0.3	0.5	0.3	1.6	2.5	146.0	0.0	19.2	14.2	0.0	1.4	4.0	0.0	1.4	1.7	1.0	1.1	1.0	0.5	0.0	2.8	0.2	5.0	0.6	0.3	2.2	1.6	0.3	0.7	1.0	0.5	0.0	3.6	0.0	0.3	1.1	1.4	5.2	39.4	37.1	13.6	0.7	0.7	2.2	31.9	3.1	1.8	0.0	10.3	2.1	5.3	0.0	14.3	0.0	0.0	5.5	18.8	30.9	0.0	2.4	0.3	9.5	6.8	0.0	5.4	2.0	0.7	0.0	6.2	3.4	8.0	0.1	4.5	0.0	29.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	153.7	19.7	403.3	134.2	2.0	0.0	0.0	3.0	0.0	12.5	146.0	2.2	0.0	0.6	124.7	9.0	0.9	0.1	0.0	0.0	1287.6	0.2	3.4	0.6	0.0	1.3	0.0	894.5	5.6	0.1	0.1	0.0	0.0	1.4	0.6	20.2	10.4	96.9	1.3	3753.2	0.2	2.2	5.9	0.0	0.7	0.0	0.7	1.8	0.1	13.9	62.2	2910.4	0.1	0.0	4.7	7.2	2.9	69.3	1.6	1.8	137.7	0.0	337.7	0.0	126.2	105.1	0.1	7.6	4.5	8.5	11.5	0.1	0.1	0.0	905.8	0.0	0.0	6.7	1.5	5.7	0.2	0.6	5.9	0.4	1.8	0.1	0.3
SYT11	"DKFZp781D015, KIAA0080, MGC10881, MGC17226"	ENSG00000132718	"Synaptotagmin 11"	Q9BT88	1	155859567-155885199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 148.8;retina: 68.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 91.1;Bipolar cells: 78.4;Excitatory neurons: 83.5;Horizontal cells: 89.2;Inhibitory neurons: 104.5;Muller glia cells: 135.6;Oligodendrocyte precursor cells: 113.1;Oligodendrocytes: 133.2"	"Cancer enriched"	"Detected in all"	12	"glioma: 117.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 184.0;SCLC-21H: 72.7;SH-SY5Y: 79.2;U-87 MG: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064091	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"			"HPA064091: AB_2685189"	"unprognostic (1.83e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (2.14e-1)"	"unprognostic (8.02e-3)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-3)"	8.0	19.7	94.1	8.8	113.2	3.8	5.0	112.8	126.8	14.0	3.8	13.9	3.4	17.3	11.9	5.4	8.6	11.3	13.4	105.2	106.7	5.1	1.7	7.9	11.1	107.0	108.8	13.4	3.1	1.6	37.1	9.8	107.7	11.8	6.6	68.6	2.4	16.4	2.5	2.4	6.7	19.4	113.2	10.2	6.1	5.7	124.7	3.0	3.5	5.4	9.2	10.6	9.4	148.8	0.1	0.7	47.2	1.1	33.6	17.9	0.2	8.9	24.1	9.3	16.7	0.1	1.3	9.4	3.9	32.2	14.3	0.6	4.0	0.1	13.9	46.0	0.9	9.1	1.3	0.1	9.6	5.1	26.9	11.2	0.0	33.7	0.6	52.5	30.2	0.3	0.1	184.0	12.8	0.1	0.5	2.5	30.8	0.0	0.2	1.9	4.7	0.2	1.5	0.0	72.7	79.2	1.3	0.1	11.1	0.9	0.1	1.3	22.6	17.4	10.8	11.9	11.4	48.7	25.4	18.8	87.2	0.1	13.6	6.1	4.9	0.1	16.9	5.9	4.7	1.9	8.8	11.8	7.0	1.5	0.8	8.8	2.5	7.8	8.5	0.4	17.2	8.3	94.1	113.2	112.8	126.8	105.2	106.7	107.0	108.8	107.7	113.2	124.7	148.8	25.3	0.0	0.0	91.1	3.2	0.5	0.2	0.2	0.6	78.4	0.5	0.9	11.4	0.0	0.1	1.8	22.9	0.1	23.3	0.0	0.0	1.4	0.1	0.9	12.0	20.3	4.8	3.4	83.5	1.0	0.2	9.3	2.0	1.9	12.0	16.0	7.1	0.4	4.7	89.2	104.5	0.1	0.0	9.4	5.2	0.7	2.8	11.2	3.6	23.4	13.6	135.6	19.6	113.1	133.2	1.4	0.0	15.8	5.5	0.4	0.1	1.2	1.0	13.7	19.7	7.7	15.9	2.0	1.0	0.1	1.0	0.0	14.3	2.1	0.0	0.3
SYT12	SRG1	ENSG00000173227	"Synaptotagmin 12"	Q8IV01	11	67006778-67050863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.5;liver: 17.6;parathyroid gland: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 8.8;Basal respiratory cells: 10.9;Excitatory neurons: 39.3;Inhibitory neurons: 21.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 49.8;MCF7: 38.0;SiHa: 44.3;SK-BR-3: 20.9;T-47d: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011006, HPA074255"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA011006: AB_2286996, HPA074255: "	"unprognostic (2.72e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.75e-1)"	"unprognostic (9.86e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.42e-2)"	"unprognostic (9.85e-2)"	0.6	6.9	9.4	0.2	10.9	0.0	4.6	22.5	19.0	0.2	1.7	0.0	0.7	0.1	5.1	0.4	3.8	0.6	0.7	9.9	7.6	0.3	17.6	0.0	0.1	10.3	9.5	0.1	0.3	63.8	5.6	0.8	10.9	1.6	0.0	0.4	1.6	0.8	0.3	0.8	0.3	0.0	4.8	0.0	0.3	1.4	7.9	0.0	0.4	0.0	0.1	1.2	0.2	10.9	0.0	2.0	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	8.1	1.5	3.4	1.3	0.3	1.5	0.2	4.5	0.0	0.0	0.4	0.0	49.8	0.1	0.0	0.0	0.1	0.5	0.3	0.1	0.0	4.6	0.0	0.0	0.1	0.1	0.0	38.0	0.0	0.1	0.9	0.2	1.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	44.3	20.9	0.1	0.1	19.3	0.2	0.0	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.9	22.5	19.0	9.9	7.6	10.3	9.5	10.9	4.8	7.9	10.9	0.2	0.0	0.0	8.8	0.1	1.3	3.8	10.9	0.0	2.2	6.9	6.6	1.2	1.5	3.1	1.8	0.0	0.4	0.1	0.5	0.0	2.9	0.5	0.8	0.3	0.4	0.0	0.0	39.3	0.0	1.5	1.1	0.0	0.5	0.0	0.3	0.0	5.8	0.1	0.0	21.6	0.0	0.0	0.0	1.2	0.2	0.0	0.1	0.0	4.7	0.0	0.1	0.0	3.0	2.3	0.4	0.0	0.4	0.1	1.2	0.2	0.1	1.6	1.2	0.0	1.2	1.6	0.8	1.2	0.0	1.1	1.9	0.5	0.0	0.4	1.3
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1;gallbladder: 20.8;pituitary gland: 16.8"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	7.0	1.5	12.7	0.0	0.2	1.7	30.1	0.0	0.0	12.2	12.5	0.2	0.0	0.0	0.2	20.8	5.2	18.0	11.5	8.9	0.3	0.5	0.0	5.7	1.2	0.0	7.1	0.4	16.8	0.0	5.4	1.8	12.6	11.3	1.9	0.0	0.1	0.2	12.8	0.8	0.0	0.1	11.0	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	5.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	12.7	1.7	30.1	18.0	11.5	5.7	1.2	5.4	0.0	9.0	5.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
SYT15	CHR10SYT	ENSG00000204176	"Synaptotagmin 15"	Q9BQS2	10	46578217-46594173	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 14.6"									"HPA036971, HPA036972, HPA064559"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"	"unprognostic (1.64e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-3)"	3.7	2.3	3.5	3.4	3.8	0.8	3.2	1.9	9.3	4.5	0.0	1.6	1.8	2.9	3.9	3.3	4.5	2.7	4.1	7.6	1.8	2.1	1.4	9.6	5.4	6.9	1.7	2.6	4.8	2.3	0.9	5.1	6.7	2.5	2.1	3.4	3.6	3.5	2.2	11.6	1.5	3.7	0.2	3.5	1.2	1.5	4.3	1.8	2.6	4.1	4.0	2.9	3.4	3.9	2.8	2.9	1.5	0.7	1.7	1.6	2.1	2.9	5.3	2.2	2.5	6.8	5.2	0.6	2.2	2.5	2.1	9.4	0.0	0.8	2.9	1.4	3.2	1.7	2.8	4.5	4.4	3.0	2.1	3.2	0.9	1.4	4.2	2.7	1.2	2.2	0.7	1.7	1.0	4.6	1.5	4.7	1.2	0.5	1.2	1.9	0.0	1.9	3.3	1.3	0.9	1.4	2.4	14.6	1.3	1.4	4.3	1.3	3.8	0.8	3.3	2.0	2.1	2.6	2.9	2.3	1.8	1.9	0.6	0.0	0.6	0.3	0.7	1.4	0.6	0.4	0.6	0.3	0.6	0.2	0.4	0.5	0.0	0.5	1.1	0.4	0.1	0.3	3.5	3.8	1.9	9.3	7.6	1.8	6.9	1.7	6.7	0.2	4.3	3.9	8.0	54.5	49.5	0.7	0.3	6.1	2.2	2.0	0.6	2.2	2.8	1.5	3.6	0.0	3.0	1.8	2.1	1.1	0.6	0.9	1.9	2.0	0.4	0.8	1.2	20.4	1.2	2.7	0.7	5.8	1.4	2.7	0.0	1.0	2.5	1.1	26.4	1.5	0.1	0.0	0.8	1.6	0.0	2.2	3.5	0.6	3.7	0.6	3.6	1.9	0.5	0.6	1.0	1.0	1.1	4.5	0.9	3.8	0.4	5.6	1.1	2.5	1.5	1.8	6.6	3.6	2.7	1.3	1.4	0.5	5.5	1.2	0.8	0.4	1.4	2.4
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.5"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA004199: AB_1080156, HPA076871: AB_2732324"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.0	0.4	7.5	0.0	11.0	0.1	0.1	0.0	16.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.1	12.7	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	1.1	0.4	0.0	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.8	3.8	0.0	0.0	0.0	0.0	0.3	0.2	0.4	10.8	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.6	0.6	0.0	1.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	6.2	17.0	0.3	2.8	0.5	0.7	0.0	1.0	0.0	0.0	0.0	2.7	6.6	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	0.0	16.5	12.7	8.0	0.0	0.0	0.0	0.1	3.8	0.4	0.0	0.0	0.0	8.8	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.3	0.0	0.0	3.7	2.1	0.7	0.0	0.0	0.0	0.3	45.0	0.1	0.4	0.1	0.0	0.0	281.4	0.0	0.6	0.1	3.1	0.3	0.0	3.4	0.0	0.0	0.1	0.0	279.7	0.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	8.4	0.0	0.7	0.0	127.2	13.9	0.1	0.0	0.0	0.3	1.7	0.0	0.2	0.1	0.1	0.0	0.0	0.4	3.8	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710454	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 73.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 23.2;Inhibitory neurons: 22.7;Oligodendrocytes: 7.4"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.5;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported				NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA063655: AB_2685077"	"unprognostic (1.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.17e-3)"	0.2	1.3	2.6	0.2	8.8	0.0	0.1	46.3	73.4	0.2	0.3	0.3	0.2	0.4	0.8	0.0	0.2	0.2	0.3	0.5	16.8	0.0	0.0	0.0	0.1	66.0	17.5	0.6	0.0	0.0	0.0	0.0	68.3	0.1	0.1	5.2	0.2	0.0	0.2	0.1	0.2	0.0	13.9	0.2	0.1	0.5	23.1	0.0	0.0	0.0	0.0	0.2	0.1	20.7	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	8.8	46.3	73.4	0.5	16.8	66.0	17.5	68.3	13.9	23.1	20.7	0.2	0.0	0.0	2.6	0.1	0.5	1.6	1.1	0.0	3.6	0.2	0.1	2.9	0.0	0.5	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.3	0.0	0.0	23.2	0.0	0.1	0.3	0.0	2.0	0.0	0.9	0.0	0.0	0.0	3.3	22.7	0.1	0.0	0.0	0.0	0.5	3.4	0.2	0.0	1.0	0.1	1.2	0.0	1.0	7.4	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.7	5.1	0.0	0.3	0.6	0.3	0.9	0.0	0.6	0.1	0.1	0.1	0.4	2.2
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267892-43277535	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.7;pituitary gland: 30.7;retina: 25.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1"	"Group enriched"	"Detected in some"	5	"glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 245.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		3.7	15.9	21.5	1.4	18.6	0.1	0.0	74.7	42.6	0.0	0.0	1.2	0.8	0.0	0.0	0.1	0.0	0.0	1.3	18.6	50.4	0.1	0.0	0.9	0.0	10.5	15.3	0.5	3.7	0.0	30.7	0.1	39.3	0.6	0.8	25.2	0.1	8.3	0.0	0.0	0.7	0.6	13.5	0.0	3.2	1.6	18.3	0.4	0.3	0.0	0.0	0.0	0.5	10.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	245.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	18.6	74.7	42.6	18.6	50.4	10.5	15.3	39.3	13.5	18.3	10.9	0.0	0.0	1.1	8.8	0.0	0.1	0.0	0.0	0.0	66.8	0.0	0.0	3.6	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	28.7	0.0	50.9	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	0.0	2.5	0.0	7.5	7.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171196-55180289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 72.6;pituitary gland: 59.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	0.2	9.7	40.1	1.9	46.0	0.5	0.1	0.0	72.6	0.8	0.0	2.0	1.3	0.1	0.0	0.2	0.2	0.2	0.2	53.4	58.5	0.1	0.1	0.2	0.2	12.2	20.3	0.0	2.5	0.7	59.3	0.0	22.1	0.1	0.7	4.4	0.0	0.0	0.1	0.8	1.1	0.5	13.3	0.1	1.9	5.4	32.4	0.2	0.1	0.0	0.3	0.1	0.3	39.9	0.2	0.2	0.4	0.4	0.9	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.1	1.7	27.1	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.1	1.1	0.1	60.2	0.7	0.2	0.0	0.1	0.0	0.5	0.5	22.7	3.8	0.0	0.6	0.5	0.0	0.1	95.7	3.8	0.1	0.4	0.3	0.0	0.1	15.9	7.1	0.0	1.1	0.9	0.0	0.5	0.1	0.1	1.4	1.3	1.7	0.1	0.2	1.4	0.9	0.5	0.1	0.3	1.4	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.5	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.1	40.1	46.0	0.0	72.6	53.4	58.5	12.2	20.3	22.1	13.3	32.4	39.9	0.2	0.0	0.0	3.3	1.0	0.6	0.1	1.4	0.0	2.8	0.1	0.6	1.1	0.0	0.4	0.0	4.2	0.0	1.0	0.8	0.0	0.3	15.4	9.1	0.3	0.1	57.6	2.7	20.3	0.4	0.1	0.3	5.6	0.2	0.0	0.7	0.4	0.0	0.2	6.7	11.9	0.8	4.1	0.6	0.0	41.4	0.3	0.1	0.0	3.7	0.1	0.4	0.0	1.5	2.5	0.9	0.1	0.4	0.1	0.1	2.1	0.0	4.0	0.4	0.0	0.0	0.7	8.2	7.6	0.0	0.1	0.0	1.0	0.2	0.6	0.4
SYT7	"IPCA-7, MGC150517, PCANAP7, SYT-VII"	ENSG00000011347	"Synaptotagmin 7"	O43581	11	61513714-61581148	"Predicted intracellular proteins, Predicted membrane proteins"	Exocytosis	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;liver: 86.7;salivary gland: 57.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.2;Enteroendocrine cells: 49.8;Excitatory neurons: 82.1;Hepatocytes: 70.7;Prostatic glandular cells: 36.8;Syncytiotrophoblasts: 66.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 54.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 78.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.0;hTERT-HME1: 89.5;RT4: 37.8;SCLC-21H: 28.4;SK-BR-3: 40.7;T-47d: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012869	Enhanced					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA012869: AB_1857698"	"unprognostic (7.09e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.37e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.47e-1)"	3.8	4.3	17.7	1.2	33.8	0.1	9.2	0.0	78.4	3.1	0.0	5.0	2.3	2.6	1.8	3.5	3.4	1.2	19.0	30.7	1.9	24.7	86.7	1.9	0.3	0.0	1.9	1.3	16.7	5.7	51.6	18.4	0.0	50.8	5.3	8.0	57.0	0.9	3.6	4.2	5.2	1.8	0.0	2.1	3.7	4.0	13.9	0.4	8.0	1.8	0.3	1.9	3.3	38.5	13.4	1.9	0.5	0.2	1.0	14.1	10.4	0.2	35.0	0.6	0.5	3.5	6.9	0.0	0.6	0.2	1.3	6.9	0.9	0.2	0.2	0.2	1.7	0.0	1.7	2.1	0.9	0.1	0.1	0.4	7.8	4.2	89.5	0.2	0.2	0.8	0.1	0.2	0.5	21.6	0.1	0.3	2.4	24.8	14.1	0.0	0.7	1.7	0.0	37.8	28.4	5.2	1.9	40.7	0.3	5.6	39.8	0.0	0.0	8.6	3.1	10.1	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	33.8	0.0	78.4	30.7	1.9	0.0	1.9	0.0	0.0	13.9	38.5	10.6	0.0	0.5	4.2	0.2	0.3	0.4	5.1	0.0	22.6	23.2	16.3	22.3	1.5	5.0	5.5	0.0	45.2	0.6	1.9	5.9	1.2	8.4	0.3	4.3	4.9	49.8	2.7	82.1	1.6	3.4	3.0	0.0	0.5	0.0	5.9	4.6	70.7	4.0	21.9	17.8	30.2	6.1	1.0	0.0	7.6	3.4	0.1	1.8	7.5	0.0	0.6	0.0	6.0	2.5	1.0	4.6	2.2	0.0	36.8	3.5	0.1	1.3	3.5	0.0	2.8	1.4	0.8	3.9	0.9	0.1	66.4	0.2	0.6	2.4	1.7
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;skin 1: 65.5;urinary bladder: 40.5"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047239, HPA052700"	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA047239: , HPA052700: AB_2681920"	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.3	0.1	0.4	0.5	0.0	0.5	29.2	1.0	8.6	0.0	0.0	0.0	0.3	0.6	4.7	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.6	0.0	2.5	0.0	0.0	20.9	2.9	0.0	65.5	2.5	0.0	0.0	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.1	40.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	32.2	0.0	0.0	0.0	0.6	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.2	0.0	5.8	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.1	1.0	0.0	0.3	0.0	2.7	0.0	0.0	13.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.0	3.9	0.0	0.3	184.7	5.6	24.9	520.2	0.0	3.2	192.9	0.6	183.0	39.1	5.5	0.0	28.7	0.7	3.4	0.0	31.1	0.0	15.6	0.1	1.7	0.0	0.0	0.0	9.7	201.8	1.6	12.2	0.6	1.3	0.0	0.0	0.1	7.1	0.0	0.0	1.3	16.2	0.0	14.7	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.0	0.0	0.0	28.3	3.5	0.0	6.2	1.3	18.3	0.0	163.8	0.0	0.0	0.0	7.0	0.0	0.0	132.5	47.2	36.8	0.6	0.1	1.7	31.5
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 232.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 232.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	5.5	1.8	1.5	7.5	1.7	13.9	4.3	2.2	1.6	6.0	23.9	4.2	3.8	3.5	6.4	4.0	14.4	4.8	7.1	2.3	2.7	5.3	2.5	16.8	8.4	3.8	2.9	2.8	1.5	1.8	2.1	1.6	3.4	5.4	2.4	0.4	15.3	5.8	14.9	3.3	9.9	2.8	2.9	19.8	7.1	3.8	2.9	17.4	25.2	8.2	6.0	5.0	3.6	4.6	7.1	1.0	0.1	0.5	0.9	0.9	0.4	3.1	2.0	0.8	2.1	0.6	5.8	0.1	0.5	5.3	2.6	0.8	0.1	0.9	2.9	15.1	0.4	5.8	0.2	0.0	1.7	1.7	23.9	3.1	2.1	6.1	1.0	2.6	1.4	1.1	0.3	5.6	6.8	0.3	0.1	2.0	0.1	1.3	1.0	0.0	5.6	0.7	2.8	0.4	15.6	1.2	1.0	9.7	0.8	0.3	2.0	0.3	8.8	18.9	19.1	0.5	0.6	28.5	7.1	0.6	12.0	8.3	0.6	232.0	16.0	0.8	37.3	3.3	22.0	1.0	14.7	25.3	4.6	0.3	15.7	19.3	35.5	43.1	1.4	1.3	16.4	18.9	1.5	1.7	2.2	1.6	2.3	2.7	3.8	2.9	3.4	2.9	2.9	4.6	2.8	16.0	13.1	2.3	23.5	4.6	2.9	4.4	1.8	0.2	4.4	3.7	4.1	1.5	15.9	14.7	2.1	1.3	334.2	1.0	5.9	0.8	10.8	51.0	3.0	4.2	0.0	4.4	3.4	0.6	0.5	4.8	17.3	37.4	135.4	0.4	3.9	1.9	4.2	0.0	4.8	1.8	4.1	11.5	20.3	18.1	0.0	26.6	10.6	28.1	17.6	0.1	132.8	2.0	2.5	0.6	0.1	0.7	135.2	1.8	2.0	1.9	51.5	0.5	0.0	2.3	2.4	2.1	8.4	2.6	4.4	1.9	230.2	0.9	1.3	3.1
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 68.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 30.1"	"Low region specificity"	"Detected in all"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		3300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	6.9	4.1	6.9	2.2	13.2	2.3	6.0	4.5	5.1	21.7	14.1	9.8	2.1	43.1	3.1	3.9	17.8	4.0	3.2	5.2	13.1	5.6	10.5	4.7	0.7	8.4	9.3	68.3	8.3	1.2	18.8	3.6	7.4	12.7	9.7	1.3	6.1	7.2	2.3	2.0	4.9	32.7	6.1	3.3	7.4	6.8	18.0	0.6	8.8	4.9	1.7	6.1	10.2	7.9	0.3	6.0	1.6	0.0	8.5	4.8	0.1	7.7	4.9	8.0	14.3	0.7	7.6	0.0	2.0	5.4	6.9	6.8	29.5	2.3	8.4	0.0	2.6	0.1	10.8	0.4	2.1	0.0	60.0	1.7	0.5	7.3	0.4	3.1	20.5	0.0	3.0	0.0	3.8	2.0	0.1	0.0	1.2	21.2	0.0	0.0	2.4	0.0	7.0	40.8	14.5	0.6	3.1	11.5	1.7	3.0	7.1	0.6	34.9	4.2	8.8	20.9	1.9	0.1	0.0	0.1	5.2	0.0	4.8	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.8	6.9	13.2	4.5	5.1	5.2	13.1	8.4	9.3	7.4	6.1	18.0	7.9	15.6	28.9	1.7	41.8	0.5	0.1	7.7	3.1	1.2	0.2	19.0	6.6	3.8	18.6	8.0	3.7	0.0	0.4	0.7	29.1	3.9	8.9	1.6	4.3	25.8	13.5	0.0	5.0	0.5	2.3	0.4	20.0	26.5	6.2	3.8	58.1	11.4	38.6	1.3	0.0	1.0	26.9	8.2	1.6	1.9	3.8	72.7	7.2	3.6	8.4	0.5	5.4	0.0	10.6	0.2	7.2	27.1	41.8	0.5	11.9	5.8	2.6	8.1	0.6	52.6	38.1	11.8	2.6	4.4	2.6	0.9	0.0	0.9	18.0	9.6	13.8
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006553-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;stomach 1: 12.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.0	8.2	6.5	0.3	7.2	0.0	2.5	0.0	5.6	5.6	0.1	2.8	2.2	2.2	0.8	3.1	0.4	0.5	1.1	6.7	10.7	1.2	4.4	0.6	0.0	3.4	13.6	0.1	5.8	0.0	0.6	7.4	6.3	0.9	3.2	0.5	2.2	0.4	0.0	0.1	2.4	3.3	2.5	0.0	12.1	0.6	8.6	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	1.2	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	6.2	1.4	0.0	0.0	0.5	2.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.7	0.1	0.0	0.1	0.2	0.2	5.8	0.0	0.0	2.5	8.4	0.0	0.0	2.0	0.0	0.0	0.4	3.2	0.0	0.3	1.2	14.8	19.5	0.0	0.0	0.0	0.1	4.7	0.0	3.3	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	7.2	0.0	5.6	6.7	10.7	3.4	13.6	6.3	2.5	8.6	0.9	0.0	0.0	2.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	4.0	1.5	0.3	0.0	8.7	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.7	3.6	0.1	3.0	0.0	1.4	0.9	3.6	0.6	37.2	4.0	0.0	1.0	0.4	1.3	0.3	0.0	92.0	20.8	6.1	0.0	0.0	0.0	0.6	0.2	0.0	1.0	0.2	0.0	0.0	0.0	1.1	4.9	3.0	2.6	0.3	0.6	0.6	0.1	3.3	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	8.9	0.1	0.0	0.7	1.0
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	52.1	57.4	43.1	50.1	47.1	82.5	45.9	43.9	41.6	48.0	40.2	58.0	44.0	68.9	25.7	66.0	50.3	41.2	65.1	38.5	41.1	48.7	48.6	48.1	56.9	51.4	45.7	59.3	36.7	69.4	28.9	46.3	45.3	46.1	38.5	20.0	38.8	41.0	120.7	48.4	50.3	58.3	44.6	51.7	49.8	22.8	50.0	56.9	44.1	68.8	51.1	59.9	43.0	43.5	126.2	94.6	127.5	89.7	106.1	121.8	42.3	126.4	161.4	145.2	112.6	95.2	108.8	109.9	137.9	168.5	80.1	68.3	115.1	140.0	106.6	189.7	100.1	126.4	96.6	75.9	96.0	124.6	118.9	123.7	113.0	160.0	105.7	102.2	128.0	93.5	115.3	100.3	134.8	121.7	122.2	93.1	90.2	92.0	106.6	123.5	135.8	129.8	98.8	57.8	101.0	105.0	111.0	70.6	161.6	52.4	73.3	80.4	145.2	98.8	116.1	156.8	127.0	55.0	65.2	131.1	111.3	166.3	135.1	37.0	46.4	68.2	44.1	65.2	43.9	58.2	37.7	41.6	36.9	67.4	34.5	37.3	51.2	41.2	78.1	28.4	52.2	65.3	43.1	47.1	43.9	41.6	38.5	41.1	51.4	45.7	45.3	44.6	50.0	43.5	42.5	19.2	23.6	7.5	48.2	45.6	51.6	47.6	39.3	21.4	41.5	32.9	44.3	52.9	28.5	40.5	2.1	56.2	49.4	74.0	70.5	64.4	21.5	31.5	44.5	45.2	47.8	27.8	7.0	53.4	79.8	42.1	31.1	53.5	36.8	31.9	35.7	55.0	72.9	43.7	7.0	47.7	46.8	48.9	45.9	55.4	36.1	47.9	44.4	10.3	78.8	30.4	77.2	7.5	12.0	68.1	47.8	35.7	35.6	63.9	62.5	50.4	18.4	18.5	39.5	31.3	56.3	28.1	20.3	43.9	58.4	84.0	44.5	39.1	49.8	68.3
SZT2	"C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B"	ENSG00000198198	"SZT2 subunit of KICSTOR complex"	Q5T011	1	43389882-43454247	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029012	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Actin filaments"		"HPA029012: AB_10600817"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.47e-7)"	"prognostic unfavorable (2.53e-4)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.28e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.61e-2)"	6.3	5.3	1.3	4.3	2.5	6.0	6.2	3.2	3.1	6.1	0.8	6.7	3.4	7.2	2.6	5.9	7.0	2.7	5.4	1.1	2.1	4.7	4.4	6.4	4.2	2.9	2.3	8.0	6.5	5.6	8.8	2.7	2.5	6.5	3.4	4.0	6.5	3.2	6.6	7.7	7.9	3.6	0.9	7.1	6.4	9.6	3.0	4.4	9.0	3.9	4.1	6.2	5.8	5.0	4.5	4.4	3.7	3.4	9.1	4.5	5.7	3.7	4.4	4.5	4.1	1.5	5.0	4.1	4.1	5.9	3.2	5.1	3.7	6.3	3.9	5.1	3.4	7.5	8.1	2.7	3.4	6.1	6.2	4.8	4.2	7.7	7.5	5.0	5.2	4.7	3.4	6.8	3.2	2.1	4.1	1.6	3.3	2.7	4.5	4.5	5.1	4.9	2.6	6.2	3.8	3.4	7.8	5.9	4.0	4.8	3.2	8.8	6.5	4.8	6.8	6.4	6.5	7.3	2.8	3.4	4.9	3.8	3.1	1.4	0.5	1.4	0.3	0.4	0.8	0.3	0.1	0.1	0.4	0.3	0.4	0.3	1.1	0.3	0.5	0.9	0.4	0.2	1.3	2.5	3.2	3.1	1.1	2.1	2.9	2.3	2.5	0.9	3.0	5.0	8.3	25.6	19.3	19.6	10.5	1.9	3.5	5.1	6.2	16.8	7.7	7.0	4.8	5.7	6.8	5.5	62.6	6.5	9.2	10.0	0.0	6.1	14.2	5.8	10.1	7.6	3.6	5.5	20.4	6.4	5.2	7.0	13.7	6.9	14.5	19.0	12.8	13.1	5.4	13.5	20.2	7.0	4.1	7.0	3.1	15.8	9.3	9.4	5.4	15.9	11.6	5.8	13.4	11.1	29.1	6.8	3.7	6.0	9.5	4.2	10.5	9.2	8.0	22.2	19.7	9.1	7.1	8.1	8.6	4.2	1.8	5.5	11.4	12.6	7.0	3.8
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132644898-132646051	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055614	Approved					NA	NA				"Cluster 4: Stomach - Digestion"					"HPA055614: AB_2682862"											"unprognostic (2.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"				0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR5	PNR	ENSG00000135569	"Trace amine associated receptor 5"	O14804	6	132588673-132589686	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA051703	Uncertain					NA	NA									"HPA051703: AB_2681580"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399778-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"		"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	13.1	14.8	18.2	9.0	20.6	9.7	12.9	17.0	19.8	18.2	10.6	18.9	10.7	16.5	6.2	13.8	15.9	7.4	17.0	17.3	16.1	12.4	16.6	11.0	11.1	18.7	19.3	20.5	15.6	10.0	10.5	8.6	17.7	16.7	5.4	12.2	13.7	10.9	19.9	17.4	13.5	8.7	15.8	15.9	14.7	10.2	18.5	11.9	13.3	10.7	7.8	17.9	14.9	20.6	15.0	15.3	15.2	17.5	15.8	13.2	13.5	12.3	15.1	18.4	17.3	14.2	10.6	22.5	9.4	12.0	10.3	18.0	15.5	18.0	7.2	17.6	24.8	9.9	19.0	14.2	13.7	18.8	18.3	13.5	15.7	13.9	15.1	14.0	13.6	13.5	18.4	15.0	9.3	9.7	14.6	15.6	10.6	23.6	15.4	26.0	21.6	22.6	14.4	15.7	13.5	9.9	17.4	21.5	15.4	9.4	17.6	20.4	11.8	12.8	20.2	9.9	10.1	23.6	16.2	16.4	15.1	13.1	12.8	0.8	5.6	4.1	4.3	4.3	3.4	3.3	2.6	3.5	5.0	3.2	4.1	3.9	0.7	3.3	4.5	2.3	2.8	4.3	18.2	20.6	17.0	19.8	17.3	16.1	18.7	19.3	17.7	15.8	18.5	20.6	6.0	3.2	6.7	17.9	7.0	2.0	2.8	4.0	6.8	55.2	5.9	6.9	7.4	8.6	4.1	3.7	18.8	12.4	4.7	4.9	0.0	6.2	1.6	4.5	7.0	5.4	11.4	6.9	9.1	3.8	7.9	6.2	7.1	4.4	5.1	12.5	2.2	4.7	7.1	28.6	12.6	4.8	0.0	6.0	1.0	3.2	7.8	6.4	5.4	9.4	8.6	12.1	8.2	7.5	18.6	5.4	4.1	9.1	8.4	2.8	7.6	5.4	4.7	18.8	6.6	6.4	7.4	8.2	9.1	5.5	3.3	5.6	8.1	10.3	4.9	1.8
TAB2	"KIAA0733, MAP3K7IP2"	ENSG00000055208	"TGF-beta activated kinase 1 (MAP3K7) binding protein 2"	Q9NYJ8	6	149218641-149411613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065436, HPA070137"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA065436: AB_2732735, HPA070137: AB_2732148"	"unprognostic (1.08e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.49e-1)"	27.6	25.6	55.1	32.9	52.2	48.4	33.3	45.2	58.5	36.4	39.9	47.5	24.1	32.7	27.9	35.7	27.3	26.0	32.3	54.5	84.4	34.5	58.8	31.0	38.8	91.7	73.2	40.9	33.1	41.7	15.3	27.6	67.0	32.8	32.9	20.0	54.8	36.0	69.4	24.6	26.3	37.1	79.7	35.1	27.2	21.3	56.2	47.2	35.7	59.8	37.8	37.5	28.2	71.8	32.0	19.8	51.8	56.0	49.6	42.7	40.1	35.8	65.6	55.4	71.6	30.1	44.9	33.8	44.8	42.8	72.0	31.8	42.3	49.2	86.1	112.0	30.2	55.0	25.8	43.4	49.1	47.8	32.4	51.4	68.8	55.9	73.8	85.1	53.1	33.4	42.1	32.9	57.6	39.8	44.9	27.0	33.0	27.2	22.2	37.7	36.4	21.7	51.9	45.7	39.3	35.7	49.0	81.4	27.6	59.4	50.8	52.1	57.6	42.2	51.8	47.0	63.5	28.9	18.2	50.4	70.8	29.9	44.7	0.0	0.9	0.3	1.4	1.7	1.3	1.9	4.1	2.7	2.1	0.9	2.6	2.3	4.7	4.7	1.4	2.4	4.6	1.2	55.1	52.2	45.2	58.5	54.5	84.4	91.7	73.2	67.0	79.7	56.2	71.8	19.9	67.3	28.3	238.0	27.5	47.0	26.5	17.0	17.1	9.1	29.3	19.4	48.0	11.5	19.5	16.5	2.1	13.1	24.3	42.1	11.7	15.0	40.0	28.5	31.9	22.8	16.3	23.1	82.1	19.8	11.8	26.7	21.9	47.8	28.5	28.0	22.9	41.4	28.9	11.8	83.3	21.5	14.2	43.1	81.7	13.7	29.2	42.4	17.8	188.3	42.8	10.9	21.6	82.9	81.3	26.3	17.2	28.6	23.1	43.7	19.9	19.7	18.5	5.9	19.7	29.9	19.0	16.4	12.4	18.2	42.9	10.7	40.0	12.7	22.2	57.2
TAB3	MAP3K7IP3	ENSG00000157625	"TGF-beta activated kinase 1 (MAP3K7) binding protein 3"	Q8N5C8	X	30827442-30975084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034980, HPA034981"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA034980: AB_10602708, HPA034981: AB_2674394"	"unprognostic (4.39e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.51e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"	8.1	7.6	3.6	8.0	4.5	16.8	8.9	3.9	6.7	8.5	20.6	9.6	7.7	18.0	8.9	16.6	9.7	8.1	8.6	5.3	4.0	14.3	27.1	9.0	8.9	5.2	6.5	12.2	24.9	31.8	6.5	11.6	4.7	14.6	9.5	23.9	9.7	12.6	10.7	9.7	7.9	13.3	3.1	8.5	12.5	15.3	4.4	9.7	10.0	8.9	12.6	7.2	8.3	5.7	40.2	9.5	9.6	9.8	7.3	11.0	10.1	12.2	15.3	8.0	9.1	10.8	33.5	18.1	7.3	14.2	15.5	20.4	14.8	31.0	11.6	31.2	14.2	16.9	10.9	26.4	6.3	18.0	12.7	8.0	18.2	13.8	35.0	13.9	13.5	13.5	19.7	14.4	10.6	19.4	14.4	9.1	11.5	7.2	15.9	9.1	16.8	13.5	13.3	11.6	8.0	11.3	13.6	20.3	26.0	17.8	17.5	7.1	13.0	8.9	13.0	44.8	11.3	18.6	15.3	17.8	13.9	8.3	12.7	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.9	0.2	0.0	0.1	0.1	3.6	4.5	3.9	6.7	5.3	4.0	5.2	6.5	4.7	3.1	4.4	5.7	9.6	12.8	13.2	14.0	10.2	9.1	7.9	7.2	6.8	7.4	10.0	5.3	11.4	20.0	10.5	11.0	12.5	15.1	11.0	12.3	3.9	8.4	1.5	13.0	23.0	8.8	7.2	39.2	23.2	6.9	4.9	5.6	12.8	11.9	14.5	28.6	10.0	26.0	7.7	11.8	22.3	10.8	6.1	16.0	13.7	3.4	10.8	12.6	5.4	20.6	11.5	6.7	3.1	21.6	21.2	9.9	11.2	16.1	7.3	12.6	7.3	11.2	19.6	20.4	0.0	6.3	6.7	3.3	2.2	9.6	10.1	22.4	10.9	24.4	9.8	13.2
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97732084-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 55.6;lymphoid tissue: 46.1"	"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 99.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-266/70: 22.8"	"Region enhanced"	"Detected in all"		"basal ganglia: 560.0"	"Region enriched"	"Detected in all"	10	"basal ganglia: 388.8"	HPA014429	Enhanced				"Secreted to blood"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	2.1	8.6	7.3	10.9	34.2	0.0	2.1	2.0	12.1	0.6	1.9	9.8	8.3	0.8	1.6	0.0	1.0	6.6	1.4	6.1	45.1	7.3	0.3	0.5	0.0	53.2	55.6	0.2	0.6	0.5	1.5	0.0	21.5	1.3	3.6	3.4	6.8	2.1	0.3	1.2	10.3	7.5	16.4	46.1	3.0	0.4	23.9	0.1	7.4	0.0	0.0	1.5	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	34.2	2.0	12.1	6.1	45.1	53.2	55.6	21.5	16.4	23.9	6.4	0.1	0.0	0.0	2.9	0.5	0.4	0.1	0.0	0.0	0.0	0.4	0.6	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	13.2	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.0	99.4	5.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	3.4	0.5	0.0	0.0	0.0	4.2	0.3	9.1	0.0	0.0	0.0	1.1	1.3	0.2	2.1	0.0	0.1	0.0	0.4	0.0	0.5	0.9
TAC3	"LncZBTB39, LncZBTB39-1:2, NK3, NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin precursor 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 431.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 13.9;Extravillous trophoblasts: 19.6;Inhibitory neurons: 40.0;Syncytiotrophoblasts: 18.3"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 14.4;SuSa: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"	NA	NA		130000		"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.1	0.3	15.2	2.5	11.0	1.0	0.1	5.2	16.5	0.1	5.6	3.8	3.0	0.3	0.0	0.1	0.0	0.3	0.1	11.2	25.1	0.1	0.1	0.1	0.2	16.8	7.7	0.2	0.6	0.0	0.7	431.7	7.7	0.2	1.5	6.1	0.0	0.0	0.2	0.5	6.5	4.8	27.3	0.1	13.1	1.8	6.2	0.5	0.1	0.0	0.4	3.1	0.3	9.8	0.0	0.1	0.0	0.4	0.0	0.0	1.2	0.0	1.1	0.3	0.0	1.6	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	14.4	0.3	0.0	0.0	0.0	0.2	1.6	0.5	0.0	0.0	0.0	0.0	0.0	1.5	2.1	0.6	0.0	0.8	0.0	13.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	11.0	5.2	16.5	11.2	25.1	16.8	7.7	7.7	27.3	6.2	9.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	13.9	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.1	1.2	2.7	0.5	0.0	19.6	2.6	0.0	0.1	0.0	4.3	0.7	0.0	2.2	0.0	40.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.5	2.8	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	2.6	1.0	0.0	0.0	18.3	0.0	0.0	1.8	0.0
TACC1		ENSG00000147526	"Transforming acidic coiled-coil containing protein 1"	O75410	8	38728186-38853028	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 554.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 34.8;granulocytes: 31.5;monocytes: 14.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017041, HPA024702, HPA056841"	Approved		Approved	Cytosol		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB017041: , HPA024702: AB_1857723, HPA056841: "	"unprognostic (1.83e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.31e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.18e-1)"	151.8	31.5	32.8	39.5	41.0	68.4	67.7	23.2	36.3	73.8	19.0	76.8	21.5	84.0	14.1	70.5	64.0	47.5	42.4	27.0	25.9	51.6	23.8	67.7	41.9	28.6	34.9	35.9	44.5	29.6	14.1	74.4	27.6	54.8	44.0	15.9	19.1	75.5	20.3	19.4	40.3	90.9	25.6	61.2	38.7	29.2	37.2	27.1	34.4	56.4	34.9	58.6	36.8	49.3	39.4	74.2	53.2	16.6	55.9	38.9	34.8	50.1	64.4	46.8	47.6	34.6	5.9	40.1	29.9	49.5	40.5	36.7	32.0	22.7	96.5	28.8	12.1	155.5	22.8	22.4	65.8	31.4	69.0	71.2	20.6	76.2	24.1	48.5	169.8	47.5	16.4	97.9	143.0	29.2	74.4	17.9	7.6	63.5	35.0	16.7	120.3	7.1	15.9	38.2	3.8	4.2	40.6	41.5	33.9	31.6	19.3	23.9	138.0	56.5	34.3	72.8	40.9	50.5	35.5	35.2	51.4	35.7	69.8	13.7	11.7	15.7	6.0	10.5	6.5	2.0	4.0	5.0	7.6	2.3	3.2	3.6	31.5	3.8	14.3	34.8	3.4	5.8	32.8	41.0	23.2	36.3	27.0	25.9	28.6	34.9	27.6	25.6	37.2	49.3	554.0	218.0	152.9	67.9	66.7	35.2	55.5	9.3	148.0	35.2	14.3	25.1	53.9	191.6	32.7	46.0	62.6	66.2	122.9	30.0	119.3	176.4	4.3	34.9	51.2	251.0	37.8	79.3	109.1	60.2	64.3	147.5	25.0	79.0	115.8	42.1	350.5	39.2	79.0	109.4	73.8	121.2	6.1	90.9	158.7	11.5	168.4	128.8	40.9	203.3	87.1	59.8	51.5	44.2	134.3	47.5	44.2	206.1	73.7	62.4	3.4	23.5	7.7	44.2	190.7	150.0	223.3	42.9	62.3	45.5	18.9	94.0	81.5	43.4	48.7	40.0
TACC2	"AZU-1, ECTACC"	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989163-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 251.7;skeletal muscle: 387.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		32000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	22.1	15.3	18.2	5.3	18.6	0.2	20.9	23.6	22.7	32.3	28.6	91.5	15.3	26.1	9.2	64.2	32.9	12.9	251.7	19.1	18.8	33.9	18.8	68.7	1.0	16.0	16.9	8.8	25.3	36.4	58.7	21.6	14.8	67.7	20.7	7.2	60.7	13.5	387.1	103.3	35.7	22.0	11.8	4.2	49.1	5.8	16.9	5.7	50.7	159.0	5.7	62.4	49.1	17.7	17.8	55.1	26.5	15.2	7.4	7.4	31.7	7.7	20.7	10.5	7.3	22.7	28.9	0.0	7.0	12.3	12.1	58.1	8.5	20.9	10.9	3.0	4.4	0.0	7.7	43.8	11.5	0.0	0.3	3.4	86.0	5.6	36.6	8.6	22.2	0.1	4.5	0.6	10.4	23.5	0.2	9.9	15.7	27.6	24.8	0.3	15.2	8.5	28.9	26.9	17.6	14.2	12.7	52.0	29.5	7.6	10.2	0.4	20.6	4.7	3.5	11.8	14.5	2.4	11.7	0.3	8.7	0.1	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	18.6	23.6	22.7	19.1	18.8	16.0	16.9	14.8	11.8	16.9	17.7	15.5	83.3	94.1	16.3	0.7	33.6	49.7	54.3	33.0	21.6	23.4	14.1	210.1	8.6	70.7	36.8	0.0	53.3	0.4	75.2	1.9	8.2	2.4	88.4	11.0	21.3	30.0	0.0	32.8	14.2	4.4	21.2	38.7	62.8	7.0	0.1	6.1	18.9	6.5	43.7	48.2	38.8	57.0	0.3	4.3	2.6	6.8	1.9	7.2	7.5	0.1	1.1	0.0	80.9	7.6	19.4	47.1	7.5	0.2	49.6	36.5	13.5	84.9	2.7	13.1	27.2	23.7	0.5	8.2	79.5	54.0	228.5	2.6	2.8	41.9	80.5
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600882-63608365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	12.8	18.6	16.6	8.2	17.4	8.3	10.9	18.9	18.4	8.8	17.7	17.8	18.9	11.1	9.7	13.4	9.3	5.5	42.3	16.5	17.5	30.1	69.2	7.7	10.4	17.4	17.4	8.3	12.0	18.2	9.5	8.3	17.3	9.5	16.1	9.4	11.4	9.2	61.5	11.3	16.7	9.7	16.9	11.5	15.1	12.1	17.6	9.9	9.4	55.9	12.2	11.8	9.2	16.7	39.6	61.2	19.4	20.2	16.5	23.5	25.7	28.5	26.8	56.2	44.4	40.5	23.2	32.6	21.2	33.1	38.9	35.8	43.0	41.5	52.6	17.3	58.1	32.0	29.8	72.3	45.5	38.3	21.7	29.0	28.6	48.5	51.1	20.9	29.6	24.2	44.4	24.1	26.6	71.6	44.7	28.7	16.8	42.5	62.9	28.1	47.7	40.8	33.2	27.6	29.5	32.4	19.6	64.0	55.3	25.3	53.3	29.1	26.4	39.9	29.9	27.5	50.7	25.9	27.2	38.7	30.4	26.0	29.6	2.2	9.4	9.0	9.8	8.5	10.7	7.5	13.7	9.7	10.6	9.9	12.4	10.3	1.4	17.8	7.4	7.0	10.2	9.4	16.6	17.4	18.9	18.4	16.5	17.5	17.4	17.4	17.3	16.9	17.6	16.7	9.8	3.2	6.3	2.6	12.0	2.5	8.0	21.1	8.6	8.2	7.8	10.9	54.0	17.2	11.5	14.7	2.1	32.1	8.2	32.9	54.8	29.1	15.3	8.0	11.4	14.2	13.8	17.4	4.0	27.4	28.9	14.1	16.8	6.4	9.5	16.2	8.6	87.9	26.3	6.7	3.9	21.7	12.2	10.7	3.9	46.0	11.8	9.2	10.6	2.8	22.0	15.5	14.4	1.5	3.2	30.0	25.8	11.3	10.7	11.6	81.2	109.7	9.1	13.4	19.7	10.7	14.6	26.8	13.9	18.6	4.3	19.8	10.1	40.7	32.8	7.1
TACR1	"NK1R, NKIR, SPR, TAC1R"	ENSG00000115353	"Tachykinin receptor 1"	P25103	2	75046463-75199520	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 83.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074573	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA074573: AB_2686701"	"unprognostic (5.74e-4)"	"unprognostic (2.41e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.91e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-2)"	6.2	0.3	1.7	0.7	3.6	0.0	5.0	0.0	7.2	4.9	0.0	1.0	0.2	3.0	0.7	1.2	2.9	1.1	0.1	0.6	3.7	0.7	0.0	0.8	1.3	2.2	4.3	0.6	0.1	0.2	0.1	0.5	10.0	1.5	0.5	1.0	1.5	1.0	0.3	4.0	0.7	2.7	0.8	0.0	0.5	0.0	2.5	1.1	0.5	0.3	1.3	2.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.0	7.2	0.6	3.7	2.2	4.3	10.0	0.8	2.5	0.9	7.6	0.0	0.0	1.0	0.0	2.5	0.0	0.0	0.0	1.0	0.3	0.3	1.4	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.8	0.0	0.0	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	83.2	0.2	0.0	0.0	2.6	0.9	0.0	0.0	7.2	2.8	0.0	0.4	0.0	3.5	4.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.2	0.2	0.0	0.0	0.1	1.8	0.1	0.1	0.0	0.0	0.2
TACR3	"NK3R, NKR, TAC3R"	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719985	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;retina: 2.7;urinary bladder: 1.9"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 13.1;Excitatory neurons: 6.7;Extravillous trophoblasts: 4.5;Oligodendrocytes: 10.5;Skeletal myocytes: 11.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"BEWO: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	1.9	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.4	0.3	2.4	1.4	1.5	8.4	1.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.0	4.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575433-58577252	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 989.6;salivary gland: 468.5;skin 1: 438.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 6559.0;Basal respiratory cells: 3141.0;Club cells: 2499.0;Prostatic glandular cells: 3724.1;Squamous epithelial cells: 2716.6;Urothelial cells: 8102.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 4.3;granulocytes: 15.0;monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"A-431: 766.6;CAPAN-2: 1005.9;HaCaT: 1010.0;RT4: 355.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	4.8	1.2	0.2	1.3	0.4	13.5	135.8	0.2	0.4	218.6	1.9	1.1	0.7	19.1	25.3	989.6	27.7	13.0	0.8	0.3	0.3	137.9	4.0	71.2	1.0	0.2	0.3	1.5	81.1	3.5	2.4	17.7	0.2	126.8	0.9	0.0	468.5	97.1	1.9	438.8	1.2	2.0	0.2	1.0	65.7	0.5	0.3	9.2	5.0	0.3	180.0	234.6	375.0	0.6	766.6	0.1	0.0	1.5	0.0	0.0	280.1	0.2	0.0	0.0	0.1	0.7	1005.9	0.1	94.7	64.2	0.1	1010.0	0.0	186.5	0.0	0.7	0.0	0.2	19.7	0.3	0.3	0.1	0.8	0.2	274.5	0.4	11.3	0.0	42.5	0.0	0.2	1.3	0.0	166.3	0.6	1.1	0.5	167.0	1.4	0.2	0.1	0.6	137.0	355.3	0.2	0.3	32.4	264.9	1.0	3.2	173.6	1.5	45.4	1.0	1.7	0.8	1.7	0.4	0.9	0.7	1.0	0.3	0.7	0.0	4.2	15.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.2	0.4	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.6	9.0	346.1	109.2	0.0	3.1	1490.5	6559.0	3141.0	1226.5	0.0	789.8	445.6	0.4	338.8	2499.0	1278.2	0.0	107.1	9.1	2.8	43.0	2165.2	0.0	482.3	48.6	60.4	0.0	0.0	0.1	1263.4	8.1	36.3	143.2	608.7	8.8	0.2	1.4	0.5	8.8	0.0	0.0	8.5	1143.4	0.8	203.4	0.0	0.0	34.8	113.8	0.0	31.3	0.0	0.0	0.0	0.6	1778.0	3.6	0.0	1.4	3724.1	0.2	3.4	1080.4	0.0	0.0	1.3	142.4	0.4	1.1	2716.6	1531.8	78.4	32.8	0.0	1.5	8102.8
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TADA2B	MGC21874	ENSG00000173011	"Transcriptional adaptor 2B"	Q86TJ2	4	7041899-7057952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4;Rod photoreceptor cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035770	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA035770: AB_10603993"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.17e-11)"	"unprognostic (5.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (1.59e-4)"	10.9	16.3	7.7	13.1	8.1	35.4	10.5	9.3	10.4	10.6	8.3	12.7	13.4	11.8	8.1	14.6	12.2	10.2	20.6	11.0	6.5	12.3	15.7	11.7	17.8	8.7	7.0	19.3	30.2	16.7	9.1	10.8	8.6	12.8	10.3	20.2	24.4	13.0	52.0	12.1	13.0	11.6	6.4	15.3	14.6	15.5	8.2	12.0	16.4	42.4	12.6	11.5	9.2	8.3	11.5	17.2	11.8	14.0	12.8	14.5	11.3	16.5	16.9	20.9	12.8	17.0	16.8	15.2	9.6	18.4	27.8	9.2	16.3	8.7	13.4	9.0	12.5	15.5	10.5	12.9	15.6	17.9	24.3	10.5	18.2	13.9	16.1	14.4	9.8	13.9	17.6	23.9	15.8	11.0	21.8	15.3	14.0	15.3	26.4	14.0	24.1	8.0	19.1	15.9	19.2	13.8	14.2	12.6	16.6	9.5	19.0	26.6	15.3	13.2	10.2	16.1	22.9	21.6	19.5	19.7	10.9	9.7	13.7	0.7	1.3	6.9	2.7	1.7	1.9	2.5	1.7	2.6	1.2	1.7	2.3	1.7	4.4	1.5	2.1	1.3	2.0	1.2	7.7	8.1	9.3	10.4	11.0	6.5	8.7	7.0	8.6	6.4	8.2	8.3	7.1	9.6	15.0	7.2	9.0	4.6	2.7	3.3	0.6	27.1	12.4	8.0	12.7	4.3	9.1	7.3	31.3	3.6	14.2	10.6	5.9	4.5	2.9	8.6	9.0	6.4	7.2	2.1	5.0	9.3	2.9	8.0	8.2	8.7	9.5	6.3	4.2	16.7	5.7	40.4	5.2	9.5	4.1	8.8	4.2	4.8	16.8	7.0	7.2	1.9	8.1	10.4	6.2	5.0	3.7	7.9	7.8	12.8	5.1	5.8	8.7	7.6	7.1	38.3	0.0	12.4	5.2	6.1	4.5	3.6	5.8	4.4	10.1	12.5	6.9	5.4
TADA3	"ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L"	ENSG00000171148	"Transcriptional adaptor 3"	O75528	3	9779860-9793011	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042250	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA042250: AB_10794043"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.83e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (5.47e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-3)"	32.5	60.1	51.3	36.9	51.4	34.8	32.5	48.8	57.0	37.9	43.2	44.8	31.4	44.3	23.2	34.2	44.1	32.0	47.2	51.0	54.4	41.6	50.8	34.0	46.3	54.0	53.5	56.8	29.0	35.5	45.0	22.2	50.5	49.6	27.1	18.1	35.5	40.8	59.8	28.6	33.8	32.5	52.4	38.9	39.4	54.5	56.6	32.8	39.3	40.0	37.9	41.6	31.9	48.4	48.0	49.7	78.2	44.2	67.1	61.3	167.6	50.0	83.6	64.3	80.3	50.7	55.1	52.8	59.1	107.7	84.3	28.4	43.9	65.3	29.2	66.0	53.7	118.0	60.6	55.3	95.5	44.6	185.5	62.6	83.3	91.5	65.8	85.0	43.3	75.0	80.6	63.4	80.0	136.0	43.2	44.5	73.5	62.8	47.8	22.2	39.6	67.2	66.3	47.6	30.5	88.5	42.9	23.1	81.5	43.2	80.6	106.2	62.9	88.0	70.4	47.1	70.0	50.3	61.3	92.4	126.0	76.5	74.0	62.8	44.0	126.0	58.2	68.4	30.6	33.8	40.7	48.1	49.6	30.4	35.9	39.2	51.6	53.0	88.9	31.5	54.5	55.2	51.3	51.4	48.8	57.0	51.0	54.4	54.0	53.5	50.5	52.4	56.6	48.4	26.1	12.8	12.8	22.5	37.0	16.8	88.3	66.2	32.5	28.6	43.4	45.7	8.6	41.5	30.2	33.1	14.6	47.3	59.1	80.2	66.5	65.2	93.3	28.7	32.9	24.4	35.5	41.6	9.9	64.2	53.5	34.4	32.1	22.6	47.0	31.9	35.0	43.1	65.0	25.2	10.9	63.0	44.7	50.3	25.4	75.6	36.7	48.8	32.0	6.5	92.8	96.9	146.2	5.0	10.0	67.1	68.2	42.9	31.9	43.1	64.9	70.3	25.2	29.3	72.3	33.9	42.2	86.9	81.2	32.7	16.6	36.8	50.2	41.0	52.7	53.0
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366264-71532374	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	10.9	8.6	10.3	11.4	12.7	12.8	12.3	13.7	11.1	11.1	10.2	10.0	6.6	13.8	12.9	7.5	11.1	7.8	7.0	9.3	14.1	7.5	7.8	9.1	14.1	11.5	11.3	14.4	9.8	12.2	8.4	10.0	10.9	10.0	10.0	27.3	7.7	10.1	10.5	13.3	9.3	10.9	8.2	15.4	10.6	7.2	12.5	14.8	12.7	10.3	12.4	9.2	8.6	16.8	18.6	15.9	18.2	12.4	14.6	23.2	11.0	13.3	12.1	13.7	11.1	12.3	11.3	17.6	11.5	14.9	12.3	17.5	24.1	11.0	17.0	11.2	21.9	20.1	22.1	13.1	11.1	39.7	19.4	14.1	11.3	14.2	27.2	12.8	14.7	13.2	28.2	41.1	14.4	14.5	22.4	25.4	20.9	23.5	20.8	19.8	35.8	21.6	11.1	25.0	9.0	14.5	37.7	13.6	18.7	14.3	9.6	22.9	18.6	16.5	14.2	13.4	9.7	17.5	17.4	21.4	9.0	33.2	12.5	1.6	1.4	0.7	1.4	0.9	1.3	1.0	1.4	1.4	1.5	1.5	1.6	1.8	1.8	1.5	1.6	1.4	1.0	0.7	10.3	12.7	13.7	11.1	9.3	14.1	11.5	11.3	10.9	8.2	12.5	16.8	26.7	32.1	26.7	44.7	21.2	11.9	8.9	10.4	18.2	37.5	12.5	13.3	17.2	10.0	23.9	3.7	81.3	8.6	21.5	7.8	1.9	6.3	2.5	17.0	23.4	24.6	11.4	28.6	54.3	7.0	5.9	17.6	12.2	18.9	23.4	23.9	18.9	12.6	8.8	16.8	52.2	14.6	6.1	16.2	20.0	2.6	22.1	20.4	5.4	47.8	23.9	17.0	29.9	49.3	79.1	7.6	13.3	22.2	18.7	11.2	13.4	5.2	14.8	67.9	0.0	27.4	18.0	9.3	10.7	17.8	17.3	5.7	23.8	25.9	13.6	9.6
TAF10	"TAF2A, TAF2H, TAFII30"	ENSG00000166337	"TATA-box binding protein associated factor 10"	Q12962	11	6606294-6612539	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 361.8;Late spermatids: 1039.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004148, CAB022405"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022405: , HPA004148: AB_1857736"	"unprognostic (1.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.10e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.24e-3)"	"unprognostic (9.03e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.80e-3)"	78.9	140.7	147.5	53.3	150.3	93.0	69.2	149.2	204.1	59.3	142.6	66.2	44.3	63.6	97.5	103.1	61.7	28.3	130.0	147.7	156.2	100.9	151.6	76.7	56.8	157.1	153.2	50.0	152.8	53.2	96.2	31.0	155.9	79.8	54.1	30.8	69.6	42.9	107.5	61.2	68.1	38.7	147.7	125.4	100.1	190.7	149.9	82.0	74.6	50.0	76.3	72.1	58.3	150.9	82.4	138.2	88.7	77.7	140.6	135.1	67.5	61.4	134.6	98.9	98.6	102.0	145.0	45.4	77.2	111.4	137.4	68.6	66.0	99.7	97.3	92.2	95.3	64.2	95.6	122.2	227.7	85.4	98.9	157.8	125.1	77.5	163.0	168.0	110.6	139.5	67.0	80.7	157.4	159.5	122.2	78.5	62.6	130.9	107.6	72.2	46.8	78.5	163.5	108.1	62.2	84.4	82.9	95.0	107.6	129.8	67.1	100.6	64.6	67.2	78.9	97.6	87.9	94.6	70.7	73.4	110.4	44.5	108.2	12.7	9.9	11.8	9.7	15.7	8.8	9.8	9.4	11.1	10.8	11.6	8.8	7.8	27.9	8.7	16.2	23.7	11.4	5.1	147.5	150.3	149.2	204.1	147.7	156.2	157.1	153.2	155.9	147.7	149.9	150.9	106.4	3.2	23.3	6.2	60.1	21.4	56.8	9.4	32.5	23.0	116.3	148.0	51.5	47.1	13.1	36.8	20.9	48.5	130.7	79.7	19.6	18.2	361.8	93.8	90.0	39.3	34.7	45.4	4.4	33.3	55.2	43.0	56.6	86.3	5.1	70.5	26.7	53.8	65.9	23.5	4.4	50.8	2.0	78.4	44.4	1039.1	24.5	91.2	26.6	9.4	36.3	84.7	53.5	2.5	9.9	30.7	68.5	19.2	89.6	85.8	55.5	43.1	14.0	27.1	0.0	36.3	50.0	108.8	33.2	75.0	29.1	53.6	65.0	124.1	44.2	88.7
TAF12	"TAF2J, TAFII20"	ENSG00000120656	"TATA-box binding protein associated factor 12"	Q16514	1	28589323-28643085	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 244.4;Spermatogonia: 196.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008519	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA008519: AB_1080181"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (4.02e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-2)"	18.3	15.4	15.3	16.7	16.3	18.2	16.4	17.2	20.6	19.3	18.6	16.4	13.1	14.6	17.8	19.2	14.9	13.8	20.6	15.2	16.2	17.9	19.2	14.6	24.3	16.1	16.1	16.5	17.7	16.3	14.8	15.7	16.3	12.3	15.0	16.2	14.0	10.3	22.4	19.9	13.2	15.4	15.9	16.2	14.2	22.4	16.2	29.3	13.6	16.8	25.9	17.1	17.4	17.7	39.0	19.3	27.2	18.0	63.7	71.5	16.6	47.0	29.8	29.7	38.6	10.5	33.7	50.3	43.9	43.9	23.0	31.0	45.7	39.8	48.4	29.0	16.7	49.9	20.5	17.6	42.0	39.1	21.1	41.2	42.5	53.2	50.1	31.4	31.3	42.8	43.3	37.3	48.6	38.2	46.0	32.4	37.8	45.2	33.0	46.5	26.8	32.2	42.5	15.7	10.4	25.9	61.6	32.3	70.1	31.8	25.7	46.2	27.9	12.1	21.4	48.8	48.1	43.9	42.6	40.0	28.4	64.8	34.5	105.1	44.7	115.6	38.5	45.6	40.2	40.1	37.7	43.4	39.1	36.1	32.3	40.4	106.4	50.6	49.2	31.0	55.3	41.2	15.3	16.3	17.2	20.6	15.2	16.2	16.1	16.1	16.3	15.9	16.2	17.7	34.4	32.1	16.5	7.8	35.4	29.4	30.8	74.2	32.5	14.8	34.5	43.2	26.6	22.8	32.2	23.9	6.2	69.3	34.9	21.1	58.7	33.6	41.0	22.5	36.5	29.3	7.7	24.2	9.9	39.6	82.3	38.3	14.3	20.1	25.4	13.0	28.2	33.4	79.0	3.3	10.8	21.4	52.9	51.0	33.6	13.1	50.1	43.7	30.2	7.5	68.2	28.0	51.5	9.5	11.5	40.8	29.6	33.4	35.9	34.7	37.6	68.8	19.6	27.3	32.9	31.5	41.5	244.4	196.4	34.2	33.2	117.1	43.3	28.3	23.9	28.6
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076003	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	37.0	17.5	22.5	23.3	24.2	49.7	22.4	23.8	26.3	25.5	14.8	26.4	16.1	21.1	21.9	33.9	12.2	27.3	30.5	19.9	24.7	34.4	32.0	18.3	15.0	25.0	24.5	7.0	17.0	25.7	8.7	33.4	25.7	25.2	27.7	9.2	15.1	17.2	66.9	18.9	17.0	34.9	28.9	12.8	20.9	17.0	27.8	12.9	28.0	48.4	24.3	34.7	9.2	25.6	74.5	19.3	28.7	42.0	80.7	75.2	47.6	172.3	72.5	68.7	69.0	30.6	16.4	28.1	64.2	115.6	40.8	30.7	50.9	62.2	102.8	48.6	11.5	28.5	43.0	31.9	63.8	50.7	41.5	67.5	73.0	115.4	62.3	36.8	59.6	25.8	55.5	26.7	93.9	42.8	26.7	13.6	57.6	34.4	39.2	20.7	51.7	11.5	80.0	63.6	29.8	37.2	84.6	54.2	63.7	50.8	18.5	35.5	78.5	112.7	43.1	80.3	95.5	32.4	88.5	36.9	119.8	26.2	171.2	2.0	2.3	2.0	0.8	1.7	0.7	0.7	0.5	0.8	0.8	0.6	0.5	0.8	4.0	0.2	1.6	1.5	1.3	0.5	22.5	24.2	23.8	26.3	19.9	24.7	25.0	24.5	25.7	28.9	27.8	25.6	46.4	19.2	24.6	1.0	10.3	70.2	10.7	12.3	8.6	5.5	14.7	10.2	63.6	10.0	20.3	7.3	0.0	16.7	21.2	35.6	13.7	16.2	55.2	29.4	24.0	21.4	31.8	9.3	4.5	20.9	30.1	20.9	11.7	48.8	14.5	5.1	25.7	37.9	18.2	6.7	3.8	30.2	18.3	28.3	37.6	6.6	9.3	26.5	14.2	1.9	14.5	13.8	5.2	3.0	3.6	31.8	21.7	12.8	9.8	21.9	25.4	31.1	16.8	7.5	6.6	23.6	20.1	10.8	18.2	10.7	82.3	54.9	13.8	6.8	17.9	29.0
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	3.0	3.4	2.0	4.8	2.1	2.7	3.2	2.3	2.3	3.0	1.6	2.0	2.5	4.1	3.0	2.6	2.8	2.7	1.9	1.7	2.8	2.1	1.8	2.8	6.5	2.4	2.0	6.8	1.9	1.9	2.5	4.4	2.3	3.2	2.6	4.0	2.0	2.7	1.2	2.1	2.4	2.5	2.1	4.4	3.4	6.4	2.1	4.4	5.1	1.3	5.6	5.3	2.5	3.0	13.8	7.3	19.5	6.8	6.6	5.8	17.2	9.1	7.0	10.8	13.2	7.8	14.8	12.6	17.4	3.2	8.6	13.7	13.1	5.6	15.2	8.3	9.9	7.5	6.3	7.5	7.4	18.2	3.3	3.0	6.0	12.1	15.4	5.1	4.5	8.7	23.4	5.6	14.9	5.0	21.6	13.0	39.5	15.8	21.0	13.2	39.1	12.2	4.5	7.3	11.1	23.1	14.0	8.1	10.1	9.9	4.6	9.1	6.1	10.9	10.9	19.4	23.2	6.8	6.6	16.5	9.7	11.7	14.7	1.8	1.5	2.1	3.2	2.5	4.7	5.2	2.8	2.9	1.5	7.4	3.3	4.1	0.3	3.0	2.5	5.3	2.5	1.7	2.0	2.1	2.3	2.3	1.7	2.8	2.4	2.0	2.3	2.1	2.1	3.0	3.1	0.0	1.1	6.5	8.6	8.5	6.4	3.9	6.8	10.2	3.1	3.6	1.5	2.8	1.9	3.7	6.2	7.2	4.6	2.4	1.9	2.9	2.5	3.0	6.1	2.7	1.2	3.8	5.2	0.7	6.7	6.0	4.1	3.0	1.3	7.7	1.1	2.0	4.4	6.7	7.1	3.0	0.0	3.8	1.0	1.3	5.6	4.7	0.0	3.7	2.7	3.8	2.1	8.0	8.0	1.3	1.8	2.2	4.4	8.0	0.9	1.3	2.6	8.5	6.6	4.5	4.3	11.5	12.1	4.9	2.8	5.9	4.7	4.2	3.2	8.8
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	10.0	9.3	2.5	18.2	3.0	16.4	12.6	5.0	6.7	7.7	1.2	9.5	13.7	14.1	9.0	9.5	7.7	15.4	7.1	2.9	3.5	6.8	6.9	8.1	20.6	2.3	0.6	13.8	20.9	5.3	4.9	18.0	2.3	9.9	12.5	8.2	10.1	7.3	8.0	11.4	13.3	9.1	0.5	11.9	11.9	5.5	1.7	10.9	10.1	7.1	13.1	13.8	7.2	7.8	18.2	8.6	17.5	17.9	14.0	47.8	29.2	27.0	11.5	18.4	13.8	28.6	38.8	32.6	34.0	15.6	12.6	44.3	21.5	25.9	21.2	10.6	7.8	34.8	55.6	20.2	16.4	31.9	25.1	19.5	25.8	16.0	35.7	35.0	23.7	22.7	24.2	50.4	22.8	5.0	25.8	66.4	12.1	16.7	9.6	23.3	19.1	30.9	22.7	17.4	10.7	19.5	10.8	38.2	16.5	19.3	32.7	12.4	28.7	26.9	30.5	44.2	28.7	22.9	26.2	32.5	11.2	36.9	10.3	44.2	16.7	28.8	17.3	12.5	17.7	39.1	24.9	19.8	12.0	39.8	28.4	24.1	42.7	18.1	10.8	26.1	18.2	5.2	2.5	3.0	5.0	6.7	2.9	3.5	2.3	0.6	2.3	0.5	1.7	7.8	106.7	89.8	95.5	20.9	246.1	244.2	252.4	66.6	255.0	86.6	129.4	130.9	26.2	134.4	105.3	29.5	39.6	176.0	162.5	94.5	45.0	95.2	19.9	144.9	184.9	121.3	110.2	98.4	41.6	146.3	170.2	147.1	125.4	245.6	104.4	257.2	63.1	54.2	69.3	69.0	38.2	148.0	24.4	103.7	153.6	16.5	128.6	112.0	80.0	24.4	102.1	34.8	89.6	35.2	44.0	110.4	87.5	67.7	162.2	269.2	71.1	101.5	67.7	78.2	72.3	187.4	123.1	49.0	71.5	251.4	203.0	160.9	182.3	119.7	174.1	356.8
TAF1L		ENSG00000122728	"TATA-box binding protein associated factor 1 like"	Q8IZX4	9	32629454-32635669	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"retina: 1.7;testis: 1.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 15.4;Early spermatids: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056605	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"			"HPA056605: AB_2683186"	"unprognostic (7.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.79e-2)"		"unprognostic (4.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.13e-2)"		"unprognostic (1.60e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.86e-2)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	15.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.6	2.1	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
TAF4	"TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135"	ENSG00000130699	"TATA-box binding protein associated factor 4"	O00268	20	61953469-62065810	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008599, CAB031484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"CAB031484: AB_671207, HPA008599: AB_1080183"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.99e-2)"	5.0	5.3	1.7	2.0	1.6	2.8	5.0	3.2	2.0	6.3	0.1	6.1	2.6	6.3	0.5	6.2	5.6	0.9	5.0	1.2	0.5	6.2	7.6	5.0	1.8	1.5	1.0	9.8	6.9	1.2	4.4	1.5	1.1	5.2	0.9	1.6	4.8	1.2	8.8	6.8	6.2	1.1	0.3	6.0	5.8	10.0	1.6	2.7	5.2	1.7	1.1	5.6	5.8	2.0	6.6	6.1	3.6	4.2	1.6	1.2	7.3	3.2	1.4	5.2	2.8	20.5	5.4	5.3	8.1	1.7	3.9	8.4	3.2	3.8	2.2	4.6	4.7	12.3	7.1	9.5	1.7	5.9	10.7	0.9	3.4	2.4	2.4	1.5	2.1	6.5	10.1	4.6	0.9	7.1	16.7	7.2	5.3	4.7	8.6	15.3	8.3	5.7	1.7	6.1	6.1	5.3	9.8	10.2	3.4	2.6	6.3	7.2	2.6	6.7	9.7	6.8	6.0	6.4	6.4	8.5	4.0	3.5	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.7	1.6	3.2	2.0	1.2	0.5	1.5	1.0	1.1	0.3	1.6	2.0	5.6	6.4	14.1	13.1	4.7	7.6	3.2	4.5	4.6	8.8	8.3	4.4	7.3	5.7	4.4	5.5	2.1	5.6	6.1	11.6	0.0	5.7	21.1	7.4	5.8	7.1	3.6	10.8	16.3	3.8	5.0	5.7	8.6	11.3	1.3	7.9	6.4	12.6	5.9	15.2	17.3	9.9	12.2	11.0	5.5	7.0	9.3	7.1	3.6	15.0	10.5	3.9	5.2	17.6	22.1	6.0	10.1	10.5	4.3	8.0	9.8	4.9	7.4	9.1	6.6	5.4	6.2	8.6	13.1	7.6	9.7	8.3	7.5	5.2	9.9	5.6
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26226445-26391685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 65.0;U-266/70: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	1.5	2.0	0.4	2.8	0.4	2.8	2.7	0.3	1.9	1.2	0.0	1.6	0.4	1.4	0.3	1.0	1.3	0.7	0.4	0.3	0.2	1.5	0.1	1.0	3.1	0.9	0.1	3.1	1.2	0.6	0.2	1.7	1.1	0.8	1.4	0.3	1.1	0.8	1.3	1.5	0.8	1.2	0.0	2.5	1.8	4.6	0.2	1.8	1.7	0.7	3.2	1.5	0.6	0.8	4.3	0.7	0.3	1.1	1.6	2.6	2.1	1.3	1.5	0.7	1.3	1.1	2.3	65.0	5.0	0.3	2.5	4.8	3.7	4.0	3.4	15.5	9.9	7.5	1.9	1.0	2.3	20.5	4.4	4.3	1.5	0.5	11.6	0.6	1.4	8.1	10.2	7.9	0.3	4.2	10.7	4.1	3.5	2.5	5.1	0.0	8.1	17.3	1.0	0.3	6.1	2.8	3.9	5.7	2.7	1.6	2.0	3.6	0.9	2.7	1.6	3.7	4.8	26.2	18.0	21.8	1.3	12.8	2.4	0.0	0.3	0.0	0.1	0.5	1.0	2.3	0.7	1.0	1.0	2.0	2.0	1.6	0.0	0.6	0.2	0.3	0.1	0.6	0.4	0.4	0.3	1.9	0.3	0.2	0.9	0.1	1.1	0.0	0.2	0.8	7.2	6.4	7.2	6.2	34.0	80.3	9.5	1.7	49.5	1.5	15.0	17.9	2.8	0.0	2.5	0.0	0.0	18.6	4.1	5.8	17.6	1.2	0.7	28.9	9.7	9.0	0.0	21.7	44.8	2.0	4.3	15.5	36.7	45.0	1.3	5.4	1.1	0.0	2.4	5.0	28.3	7.0	2.0	1.6	17.9	1.6	3.4	5.9	23.2	4.7	2.6	0.2	1.0	7.5	11.7	2.2	2.5	4.1	52.3	13.9	0.8	4.0	1.0	1.2	0.0	17.6	12.1	25.4	24.8	40.8	78.8	9.7	14.5	14.5	6.2	6.7
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367976-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.7;Spermatogonia: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.36e-9)"	"prognostic favorable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	2.2	1.8	2.7	2.8	2.9	4.9	2.3	5.0	3.3	2.5	2.3	3.1	2.9	2.3	1.7	2.4	2.3	1.5	2.0	2.6	2.6	1.7	2.6	1.9	4.4	2.8	2.7	3.0	2.9	1.7	2.1	3.5	2.9	2.0	3.1	3.5	2.0	2.2	3.0	2.5	2.4	2.1	2.7	3.1	2.1	11.2	2.6	7.0	2.0	3.6	4.3	2.2	2.5	3.1	9.7	4.4	10.6	19.2	5.9	4.8	12.4	6.8	7.7	9.6	12.0	8.7	5.0	23.0	3.8	3.6	5.6	9.6	18.1	3.7	12.2	8.5	15.6	10.6	5.0	8.7	2.7	20.6	11.0	2.2	2.7	5.7	6.1	3.9	7.3	10.1	15.4	11.2	6.5	6.4	16.8	26.9	12.9	12.2	5.7	14.2	12.9	7.0	2.7	2.8	7.4	8.2	4.4	3.2	4.1	10.1	3.7	8.5	4.3	5.6	7.1	6.3	12.2	6.3	8.1	14.0	3.1	24.2	3.6	0.2	0.6	0.8	0.4	0.2	0.3	0.1	0.4	0.8	0.3	1.3	1.0	0.5	0.0	0.3	0.3	0.4	1.1	0.2	2.7	2.9	5.0	3.3	2.6	2.6	2.8	2.7	2.9	2.7	2.6	3.1	5.8	6.4	2.6	3.6	6.9	14.4	4.5	1.7	6.2	6.9	3.0	2.7	2.9	1.5	2.5	1.8	6.2	5.6	8.3	2.7	3.9	2.8	19.7	1.8	3.8	5.2	2.4	11.2	4.9	2.2	9.3	5.6	2.0	2.1	8.9	4.1	2.9	2.8	3.8	1.7	5.3	2.9	4.1	2.8	6.3	14.1	1.8	3.6	1.8	3.7	4.9	1.3	4.1	3.5	5.8	1.9	3.3	2.6	14.9	4.3	3.3	1.0	0.7	7.5	0.0	7.2	6.5	48.7	52.3	5.9	14.2	6.8	8.6	3.0	4.0	3.8
TAF6L	PAF65A	ENSG00000162227	"TATA-box binding protein associated factor 6 like"	Q9Y6J9	11	62771357-62787342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067239	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA067239: AB_2685809"	"unprognostic (5.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.45e-3)"	"unprognostic (9.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.61e-3)"	8.6	12.0	6.0	4.3	6.3	5.7	9.1	6.0	8.8	11.2	4.1	8.9	6.7	13.0	6.2	9.9	10.3	3.9	8.1	5.1	5.2	11.8	21.2	7.5	5.3	7.2	6.0	11.0	13.0	5.2	14.9	3.4	6.9	11.1	3.3	4.0	8.5	5.1	17.4	11.8	9.8	4.8	4.8	11.8	9.4	6.7	5.7	5.3	12.7	5.0	3.9	9.6	8.6	5.9	12.6	12.3	15.8	12.6	7.0	5.8	13.1	10.5	7.1	11.6	9.0	6.9	14.3	16.9	21.0	7.5	10.7	16.7	11.2	10.5	3.6	23.3	24.4	8.9	14.4	11.8	10.0	11.4	15.6	7.7	7.6	9.3	6.1	6.0	10.0	17.2	18.9	12.2	7.4	24.5	16.7	31.8	17.1	6.4	15.8	20.4	11.2	21.4	7.9	8.9	16.8	16.7	9.9	10.5	16.2	6.6	18.5	7.9	9.3	11.7	14.6	19.2	11.9	13.3	23.1	19.7	10.4	8.6	10.9	0.7	0.7	0.9	0.6	0.8	0.7	0.8	0.4	0.4	0.9	0.7	0.9	0.6	0.2	1.1	0.3	0.9	0.3	0.2	6.0	6.3	6.0	8.8	5.1	5.2	7.2	6.0	6.9	4.8	5.7	5.9	6.1	3.2	3.0	8.8	9.3	6.1	4.7	1.5	11.4	8.7	6.8	6.0	2.8	12.8	1.8	1.8	0.0	15.0	5.0	9.8	15.6	4.8	6.0	5.3	5.0	5.6	5.3	11.6	3.5	3.1	8.9	5.0	10.2	7.2	0.0	6.9	5.7	12.1	9.8	3.3	5.2	6.9	0.0	10.9	5.5	5.0	5.3	8.0	8.8	2.8	8.9	9.9	13.4	6.0	5.1	3.4	8.5	4.9	11.8	4.6	8.5	18.1	3.2	5.5	0.0	6.8	7.0	3.2	9.6	10.7	6.3	19.4	5.7	9.9	9.4	4.3
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320784	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	58.0	62.9	54.7	53.8	56.1	79.7	76.7	63.6	69.2	57.4	63.0	53.4	44.6	73.8	82.1	48.9	73.6	42.7	103.1	56.4	57.5	63.9	66.6	55.7	79.5	55.2	55.5	104.1	52.8	43.4	62.5	60.9	56.8	67.6	56.4	92.0	56.6	57.0	142.9	56.2	59.5	63.0	60.3	69.8	51.8	76.0	57.0	119.6	60.7	130.8	88.8	51.0	43.8	70.7	82.4	67.4	150.3	110.7	131.2	120.9	93.7	104.9	93.0	145.4	141.4	95.3	90.2	220.1	204.6	107.3	157.5	68.7	95.9	97.4	146.0	96.8	106.6	39.8	80.1	79.8	119.4	55.2	80.2	111.1	141.9	56.8	99.9	114.6	106.5	98.7	85.8	167.3	141.7	103.3	124.7	133.1	54.4	103.7	24.4	156.7	200.7	162.4	107.5	109.0	120.0	137.1	85.6	121.7	118.1	114.5	174.1	178.2	98.5	20.5	69.9	67.6	129.2	45.0	195.3	198.9	89.3	126.8	83.6	183.7	35.9	161.5	53.1	44.5	69.1	58.2	62.6	60.2	50.2	54.7	84.9	72.3	104.2	89.1	55.2	55.5	57.7	70.6	54.7	56.1	63.6	69.2	56.4	57.5	55.2	55.5	56.8	60.3	57.0	70.7	142.3	86.6	68.7	0.0	146.0	120.4	353.0	96.4	67.7	132.7	78.9	72.8	168.4	77.2	92.8	82.8	95.9	94.8	147.4	123.7	82.2	113.7	50.8	92.9	115.7	112.6	84.2	52.6	0.0	76.0	73.3	127.3	70.3	90.8	155.1	70.0	96.0	70.9	51.0	121.1	0.0	110.2	69.2	52.5	92.3	36.8	146.9	86.3	112.1	0.0	94.6	141.4	132.8	0.0	0.0	123.7	150.4	129.1	68.0	243.3	120.0	77.3	107.2	101.4	164.3	175.2	135.8	124.7	141.1	75.7	170.5	141.3	161.5	111.9	106.8	245.9
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SiHa: 47.9"					"Low region specificity"	"Detected in many"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.2	0.1	0.8	0.3	0.1	0.0	1.3	1.6	1.7	0.5	0.1	0.5	2.4	0.1	0.1	0.0	0.1	1.4	0.2	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.1	3.9	0.3	0.3	0.0	0.7	0.1	0.1	0.1	1.7	0.1	0.9	0.1	0.1	0.0	0.0	0.1	31.6	0.5	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.2	0.9	0.0	0.2	0.3	0.2	2.2	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	47.9	0.3	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	1.3	1.4	0.2	0.0	0.4	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	26.1	1.2	5.5	0.2	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.0	0.5	0.4	2.1	0.1	0.0	2.4	0.1	0.0	0.3	0.2	15.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	39.4	25.2	0.0	0.1	1.6	0.1	0.6	0.1	0.1
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	13.7	9.8	5.9	12.8	6.4	21.1	10.8	4.2	6.8	8.5	7.8	9.8	10.5	8.8	6.8	10.1	7.5	8.4	18.0	5.3	5.3	11.3	8.6	9.5	15.6	6.4	5.5	8.0	7.4	16.0	6.6	12.7	5.3	9.0	9.2	8.7	9.5	8.9	16.9	8.5	8.5	10.1	4.4	11.6	10.8	7.9	6.4	23.6	13.9	15.4	15.0	9.8	8.6	7.1	17.2	18.4	14.9	16.7	16.5	15.1	13.6	7.9	13.7	20.4	20.9	31.8	10.0	26.2	16.4	11.5	20.9	12.5	24.5	16.7	15.7	22.6	23.6	33.4	23.3	15.7	20.2	19.5	23.4	20.6	13.0	14.6	18.4	10.0	23.0	31.8	41.7	26.6	11.5	22.7	17.9	29.2	9.3	45.5	8.4	36.1	17.7	20.2	18.0	13.9	15.4	13.7	14.3	11.0	15.7	12.2	16.5	23.6	21.2	18.1	18.8	8.2	16.3	23.0	24.4	55.5	8.3	21.2	10.4	23.0	17.0	27.0	16.0	18.2	11.1	18.2	14.4	12.6	17.8	18.3	14.7	14.4	19.9	10.8	37.4	26.5	13.4	11.0	5.9	6.4	4.2	6.8	5.3	5.3	6.4	5.5	5.3	4.4	6.4	7.1	16.8	19.2	21.1	14.0	17.2	7.0	13.1	14.8	14.2	16.0	14.1	10.4	28.6	10.0	17.4	11.0	31.3	22.1	21.0	12.3	31.3	9.5	12.0	26.5	12.8	16.9	9.0	21.9	7.6	9.9	8.6	11.7	6.6	47.4	19.0	14.2	9.7	9.6	13.5	21.9	8.2	13.3	14.2	21.6	9.5	17.5	14.9	13.1	7.2	13.1	19.3	10.7	33.0	18.6	14.2	8.8	8.3	11.7	19.0	14.4	10.5	16.5	9.8	23.2	13.1	10.6	13.3	15.3	12.9	12.0	8.4	21.5	19.8	19.4	11.1	15.0
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	42.1	43.5	35.5	31.9	38.6	108.2	46.0	35.4	41.4	28.3	34.4	42.5	34.2	31.5	50.4	37.4	31.1	28.8	52.7	39.2	43.0	38.4	55.7	27.7	46.6	37.1	36.4	37.8	40.8	35.5	50.6	38.0	40.5	33.7	47.5	47.2	34.7	27.7	58.0	36.1	33.2	35.9	36.6	35.0	38.0	140.4	37.7	50.9	28.7	41.7	52.3	50.6	30.3	36.1	107.0	109.3	67.7	121.6	114.4	143.5	179.3	100.1	159.8	172.3	227.0	109.7	135.1	135.9	70.2	146.7	322.2	82.2	92.4	208.1	227.4	65.6	111.0	120.4	154.0	157.8	261.3	118.7	168.3	159.4	137.4	117.1	247.7	122.5	143.1	121.4	122.4	119.8	165.9	147.7	126.1	189.5	82.0	42.6	81.6	83.0	119.7	169.0	152.7	120.7	118.1	82.6	108.3	64.3	192.8	111.3	100.9	175.7	103.3	65.9	98.2	78.2	173.1	93.2	118.3	175.6	101.3	145.7	82.8	149.3	107.8	122.5	52.8	101.3	81.2	90.1	79.7	64.2	83.9	75.4	89.6	73.6	16.0	58.7	88.4	47.0	95.5	134.4	35.5	38.6	35.4	41.4	39.2	43.0	37.1	36.4	40.5	36.6	37.7	36.1	67.4	19.2	29.3	0.0	55.2	174.0	151.4	238.7	39.3	24.1	49.9	81.4	69.3	42.9	108.8	23.9	14.6	118.0	45.1	33.8	90.1	67.1	550.8	47.6	44.9	58.6	30.7	93.2	0.0	80.4	166.7	57.3	36.7	38.1	38.6	53.5	34.6	41.9	107.7	20.2	0.0	49.5	146.5	42.8	99.8	924.3	65.3	55.2	99.6	0.0	66.9	35.1	35.0	0.0	0.0	85.1	37.2	34.3	76.5	87.3	47.4	90.2	85.2	43.0	32.9	49.1	95.5	370.7	78.0	60.7	163.2	104.5	50.7	75.0	64.2	149.6
TAF9B	"DN-7, DN7, TAF9L, TAFII31L, TFIID-31"	ENSG00000187325	"TATA-box binding protein associated factor 9b"	Q9HBM6	X	78129748-78139650	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045275, HPA058961"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA045275: AB_10962831, HPA058961: AB_2683863"	"unprognostic (3.62e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.68e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.34e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.62e-1)"	15.7	11.4	12.8	10.4	14.0	12.0	15.6	13.7	17.5	15.5	12.9	14.5	6.5	23.1	14.2	18.2	16.1	13.5	23.1	13.7	15.1	18.2	14.0	11.0	11.5	13.5	12.4	14.4	9.7	22.9	12.0	13.1	13.4	19.8	10.0	33.6	10.1	17.2	15.4	12.3	8.1	30.7	14.5	10.7	11.0	10.4	12.8	17.0	18.9	14.0	10.7	16.5	10.3	18.0	25.6	21.8	52.7	23.3	20.2	20.5	7.9	22.5	20.7	35.6	19.8	30.7	43.3	29.2	31.2	24.5	29.0	19.8	79.5	18.5	36.9	45.7	27.6	16.0	28.7	28.2	20.1	25.4	17.0	26.3	9.8	39.1	26.7	22.5	21.8	28.7	33.4	61.1	32.0	39.1	40.3	19.8	61.9	33.4	40.4	34.3	68.6	26.9	24.6	51.2	33.3	33.1	62.3	26.7	24.7	27.2	43.3	18.2	23.3	27.4	41.6	30.2	27.4	26.2	56.8	21.3	47.6	50.5	39.3	0.8	4.1	1.2	6.6	4.4	12.5	5.6	15.1	11.5	5.2	5.2	15.1	11.3	1.9	14.2	3.3	6.5	17.7	8.7	12.8	14.0	13.7	17.5	13.7	15.1	13.5	12.4	13.4	14.5	12.8	18.0	14.9	9.6	7.8	2.9	6.6	15.6	26.7	6.1	56.3	16.1	12.2	8.8	26.6	10.0	6.2	20.2	8.4	18.1	4.5	1.4	7.9	6.8	1.0	4.7	8.2	16.4	12.6	14.1	4.0	8.6	16.4	12.9	4.1	5.0	2.5	3.0	13.2	5.6	6.9	8.4	4.0	5.4	12.2	3.5	7.9	1.7	10.5	4.9	23.2	3.7	7.6	22.9	2.1	4.5	8.9	3.9	5.0	13.9	14.1	11.7	1.0	17.6	4.1	13.6	19.7	9.3	20.4	5.9	33.5	23.0	8.8	8.5	9.9	3.0	4.4	13.2
TAFA1	"FAM19A1, TAFA-1"	ENSG00000183662	"TAFA chemokine like family member 1"	Q7Z5A9	3	68004247-68545621	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	6	"T-cells: 20.7"	"Cell line enriched"	"Detected in single"	10	"REH: 1.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 12.5;cerebral cortex: 35.6;hippocampal formation: 33.0"	HPA013407	Approved				"Secreted in brain"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA013407: AB_1848386"	"unprognostic (5.19e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-4)"	"unprognostic (5.77e-2)"	0.2	1.1	4.1	0.3	7.3	0.0	0.0	0.0	13.9	0.0	1.6	0.2	1.3	0.2	1.1	0.1	0.0	0.7	0.1	13.9	9.1	0.3	0.3	0.1	0.6	12.4	1.0	0.0	0.0	0.0	0.4	0.0	15.4	1.4	0.1	0.3	0.1	3.8	0.1	0.0	0.2	0.3	0.4	0.4	0.1	0.2	8.6	0.0	0.1	0.2	0.2	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	20.7	0.0	15.9	0.0	16.6	11.1	0.0	0.0	11.9	15.9	0.4	3.7	0.0	0.1	8.4	3.3	4.1	7.3	0.0	13.9	13.9	9.1	12.4	1.0	15.4	0.4	8.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TAFA3	"FAM19A3, TAFA-3"	ENSG00000184599	"TAFA chemokine like family member 3"	Q7Z5A8	1	112720419-112727235	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 15.5;retina: 51.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.3;BJ hTERT+: 4.7;HEL: 1.8;U-87 MG: 1.7"	"Region enriched"	"Detected in single"	21	"olfactory bulb: 3.5"	"Low region specificity"	"Detected in all"			HPA055927	Approved				"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055927: AB_2682972"	"unprognostic (9.96e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.63e-4)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.14e-6)"	"unprognostic (2.10e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	0.3	15.5	1.3	0.1	0.7	0.0	0.2	1.2	0.7	0.1	0.4	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.5	0.6	0.1	0.0	0.0	0.4	1.9	3.0	0.6	0.0	0.0	0.3	0.1	1.0	0.3	0.0	51.2	0.1	0.2	0.0	0.2	0.0	0.1	0.9	0.0	0.0	8.0	2.6	0.1	0.3	0.0	0.0	0.1	0.2	0.8	1.3	0.2	0.1	0.0	0.0	0.3	0.3	0.1	4.7	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.8	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	1.7	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	1.2	0.7	0.5	0.6	1.9	3.0	1.0	0.9	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TAFA5	"FAM19A5, TAFA-5"	ENSG00000219438	"TAFA chemokine like family member 5"	Q7Z5A7	22	48489553-48850912	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Fibroblasts: 1.1"	"Cancer enhanced"	"Detected in all"		"glioma: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.3;HEK 293: 13.6;Hep G2: 32.1;NTERA-2: 12.7;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025629	Approved				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB025629: "	"unprognostic (2.86e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.94e-2)"	2.7	1.3	50.3	0.8	40.6	0.0	2.0	37.0	51.8	19.7	15.0	8.4	1.0	8.1	4.7	0.9	5.2	2.0	2.5	53.9	43.0	2.4	2.7	2.1	0.4	55.2	85.9	12.1	2.4	4.3	7.0	0.1	51.1	6.8	0.2	3.6	4.9	3.2	1.5	5.4	3.3	0.7	41.5	0.3	2.9	3.3	49.6	1.2	0.8	1.7	0.1	4.0	4.9	28.2	0.0	1.3	2.5	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	17.3	0.1	0.1	1.3	0.0	0.0	0.0	13.6	0.0	0.2	32.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.3	12.7	0.6	0.0	0.6	0.0	7.4	0.0	0.0	7.2	0.2	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	40.6	37.0	51.8	53.9	43.0	55.2	85.9	51.1	41.5	49.6	28.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2404.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		270000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	401.9	154.7	103.7	356.0	103.2	437.3	355.4	106.3	115.0	266.6	94.9	337.4	314.3	220.5	94.9	494.0	231.9	282.6	351.1	101.1	152.7	307.9	254.4	687.7	321.1	141.7	117.6	170.9	284.7	81.0	100.0	378.2	122.9	208.5	307.9	46.1	388.7	205.2	83.4	418.2	356.3	254.4	125.2	479.7	698.8	127.0	125.9	309.6	210.2	139.6	386.4	436.1	350.0	114.9	1382.3	723.7	22.3	8.3	266.8	646.6	835.4	760.0	872.6	1635.2	799.8	786.6	1049.3	862.0	628.0	954.9	495.0	1054.3	378.1	1039.9	978.8	974.3	355.5	1140.7	651.8	50.0	322.7	808.2	1221.4	667.4	776.9	1030.4	504.3	1134.7	1029.0	260.3	494.8	578.9	586.1	563.0	378.1	601.2	619.3	947.6	1457.7	2.9	391.7	1275.3	376.6	527.7	340.7	325.6	900.7	1435.1	410.3	1190.6	756.5	814.2	1147.3	955.1	1134.4	876.9	2078.0	230.8	110.6	525.0	1238.3	541.3	603.8	1458.4	742.0	3160.6	558.9	449.7	499.9	866.5	620.0	544.6	1177.7	680.2	321.6	360.3	3746.8	817.6	356.9	1966.4	756.1	2257.9	103.7	103.2	106.3	115.0	101.1	152.7	141.7	117.6	122.9	125.2	125.9	114.9	617.1	179.5	130.5	0.3	507.8	549.1	330.6	454.3	307.9	31.6	257.0	201.8	12.8	121.5	221.4	183.9	18.8	497.4	567.6	371.0	74.3	1273.4	54.3	289.4	145.9	509.6	317.8	197.6	0.1	1206.9	2404.5	405.2	545.3	242.7	418.8	32.0	265.2	64.1	443.7	3.3	0.6	445.5	284.8	285.9	952.4	85.9	118.7	651.5	334.4	16.9	911.4	66.3	186.4	0.5	1.6	877.4	263.2	63.9	393.4	337.5	324.2	208.2	275.9	25.6	184.1	358.3	324.3	14.3	20.7	494.1	572.5	230.4	393.6	136.7	271.7	405.9
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998739-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7"	"Cancer enriched"	"Detected in many"	4	"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA		9000000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	0.3	33.5	291.3	1.5	313.2	0.0	0.1	250.3	442.4	0.0	172.3	11.4	0.6	0.0	0.0	0.2	0.0	0.2	0.6	318.0	310.2	4.5	0.3	0.5	0.2	300.5	235.8	0.3	5.6	0.0	100.9	0.0	292.8	0.5	2.3	74.3	0.2	0.2	0.2	0.6	2.4	1.1	212.3	0.1	3.3	0.3	254.2	1.3	0.4	0.0	0.2	0.2	1.1	309.3	0.0	0.0	104.1	0.2	0.0	0.0	0.1	2.6	1.9	0.1	0.1	0.4	0.2	0.0	3.8	0.0	0.1	0.7	0.1	7.2	1.4	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.0	0.1	0.0	4.0	0.0	9.0	15.1	2.8	0.0	41.6	0.0	55.5	94.5	0.0	0.1	0.0	2.1	0.1	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.3	313.2	250.3	442.4	318.0	310.2	300.5	235.8	292.8	212.3	254.2	309.3	0.1	0.0	0.0	16.6	0.0	0.8	1.2	1.0	0.0	104.3	0.2	0.3	0.7	0.0	1.8	5.5	8.4	0.0	0.1	0.0	0.0	0.1	2.6	0.2	0.0	1.1	5.3	0.0	78.1	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	297.8	49.3	0.0	30.5	0.0	0.0	0.9	0.0	0.4	0.0	15.0	0.0	16.3	0.0	32.2	18.8	2.3	0.0	0.0	0.0	1.1	0.0	31.9	12.8	50.7	0.0	0.4	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.9
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663124	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 13.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3"	"Group enriched"	"Detected in some"	4	"renal cancer: 1.6;testis cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 6.9;naive B-cell: 7.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HAP1: 2.9;K-562: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.2	0.4	0.1	0.5	0.0	0.1	0.3	0.9	0.2	1.3	0.1	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.5	0.5	3.0	0.2	0.1	0.2	0.5	0.6	0.3	0.1	0.0	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	13.7	0.1	0.1	0.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	2.4	0.3	0.1	0.1	0.7	0.0	0.4	1.5	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.0	0.1	0.0	0.4	0.0	2.9	0.0	0.1	0.4	0.3	0.7	0.0	0.0	0.1	0.3	1.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	8.2	0.2	0.2	0.2	0.5	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.1	0.1	0.0	0.2	1.3	0.3	0.2	0.4	0.4	0.6	0.6	1.2	0.0	0.1	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.4	0.5	0.3	0.9	0.5	0.5	0.5	0.6	0.6	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.2	0.0	0.0	0.0	4.2	0.0	0.1	0.0	7.9	0.1	0.1	0.0	0.2	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	2.3	0.0	1.0	0.0	0.8	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TAMALIN	GRASP	ENSG00000161835	"Trafficking regulator and scaffold protein tamalin"	Q7Z6J2	12	52006946-52015889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040664, HPA062028"	Approved		Approved	"Nuclear bodies,Vesicles"		No	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles	"Nuclear bodies"	"HPA040664: AB_10794066, HPA062028: AB_2684664"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.77e-2)"	31.9	6.3	9.8	4.1	14.9	23.8	26.9	3.2	21.5	17.6	0.4	9.4	2.2	22.0	1.6	7.1	22.2	9.6	24.2	10.5	3.7	12.2	4.2	46.8	3.8	5.0	4.9	14.9	5.7	2.8	6.2	8.9	4.8	13.0	1.9	0.1	6.5	3.1	10.6	10.7	9.8	6.0	4.1	18.2	8.6	2.6	7.6	3.7	16.3	8.4	2.3	12.5	17.1	7.1	0.0	0.0	4.4	0.2	1.9	3.6	1.0	0.2	1.1	0.0	1.1	0.0	0.0	0.0	10.0	0.0	0.4	0.1	1.3	0.0	0.4	0.2	1.3	0.3	0.0	6.2	7.4	0.3	3.3	7.2	0.0	0.3	0.0	0.0	37.4	1.0	1.6	0.0	0.9	0.2	3.1	10.5	4.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	1.1	1.6	0.0	0.2	7.5	2.7	0.0	0.3	27.4	0.0	2.5	0.2	0.0	0.2	0.0	0.1	0.6	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.8	14.9	3.2	21.5	10.5	3.7	5.0	4.9	4.8	4.1	7.6	7.1	243.8	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.2	114.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	8.3	7.4	5.8	5.6	6.2	4.3	8.0	6.4	8.5	8.0	2.6	6.5	4.9	7.2	9.7	9.0	6.9	4.1	8.0	5.3	6.9	6.7	5.5	5.0	7.1	3.9	4.1	11.0	5.6	5.8	5.6	4.1	4.0	5.2	4.9	6.3	6.8	4.5	9.2	10.1	6.2	6.2	2.8	6.5	6.0	5.7	5.4	6.5	6.0	5.2	7.8	8.4	8.2	6.2	6.2	11.3	13.5	9.4	14.3	18.0	24.9	9.3	6.6	13.9	13.8	13.6	9.9	23.4	13.3	9.8	6.2	7.4	22.9	13.9	17.9	8.8	21.6	14.0	10.6	15.9	16.7	25.8	7.1	10.3	20.3	13.1	14.6	9.1	21.8	18.3	20.8	7.0	18.0	17.8	14.6	19.2	10.9	9.6	23.8	14.4	7.7	20.7	21.6	14.8	6.2	5.4	8.1	10.3	16.6	15.1	13.5	11.6	5.7	7.2	8.3	21.8	13.5	5.4	14.2	12.1	8.8	21.8	6.7	1.9	4.5	7.1	5.7	3.2	7.6	7.5	9.1	5.8	7.8	7.1	8.4	8.8	0.2	6.9	6.7	5.8	7.7	4.8	5.8	6.2	6.4	8.5	5.3	6.9	3.9	4.1	4.0	2.8	5.4	6.2	9.4	6.4	7.0	24.5	11.4	4.2	8.1	15.7	5.7	11.5	5.5	8.3	8.9	0.0	8.7	3.7	12.5	12.2	8.6	3.3	9.8	10.1	2.2	5.4	9.2	7.6	3.0	9.4	34.5	9.3	11.0	7.2	6.6	4.4	2.5	10.5	5.7	5.8	9.2	10.1	34.7	8.1	12.2	6.4	6.4	1.5	7.8	6.8	3.6	14.0	5.9	11.0	10.3	34.7	32.0	7.9	3.4	6.4	7.1	6.7	4.2	10.3	11.8	14.7	0.0	8.6	8.7	7.4	12.4	6.6	4.1	7.0	9.5	10.8	7.3	5.9
TANC1	"KIAA1728, ROLSB"	ENSG00000115183	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1"	Q9C0D5	2	158968640-159232659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 212.0;Microglial cells: 159.3;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 223.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036750	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA036750: AB_10670241"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.91e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	9.1	5.9	9.7	3.9	14.0	0.2	7.8	15.8	7.5	10.2	8.1	9.2	6.4	10.9	2.0	12.7	5.8	7.5	22.1	13.0	15.8	6.6	4.4	12.6	3.3	18.4	13.6	6.3	5.9	5.9	3.5	13.4	18.1	7.8	7.0	12.0	7.1	4.4	2.7	20.5	6.5	12.9	11.9	5.0	5.9	1.9	21.1	3.6	10.8	4.3	4.8	8.6	6.8	20.0	8.7	7.4	18.4	14.3	16.7	7.1	9.0	6.6	13.9	6.6	10.4	8.0	9.5	0.0	22.6	21.2	5.0	18.7	5.9	26.1	8.4	0.0	13.7	5.6	11.8	1.5	19.7	0.7	14.3	11.0	21.3	12.4	23.1	30.1	35.8	8.5	1.4	39.8	11.1	3.9	5.5	0.0	2.4	9.8	6.7	0.7	10.0	12.9	15.2	34.9	2.8	18.9	14.5	6.6	34.9	11.4	7.2	5.6	33.8	14.7	8.6	3.1	6.1	19.7	14.5	0.0	8.2	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	14.0	15.8	7.5	13.0	15.8	18.4	13.6	18.1	11.9	21.1	20.0	42.1	28.9	17.1	34.9	0.2	48.9	13.5	21.7	46.7	30.1	19.3	16.9	64.7	15.7	23.5	11.0	6.2	2.9	0.9	18.9	3.9	13.3	1.1	11.1	12.1	48.3	0.0	4.2	9.9	12.5	3.8	16.0	33.1	11.7	17.2	47.6	35.3	8.7	2.0	212.0	54.7	16.6	10.2	2.8	10.3	1.7	10.5	1.7	24.9	159.3	0.6	48.6	1.0	193.5	223.7	13.4	22.7	4.9	1.6	14.4	10.5	4.9	12.5	4.9	13.1	11.6	27.5	0.5	2.1	38.6	42.1	2.1	2.5	14.6	14.9	17.3
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"			"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 597.7;Granulosa cells: 195.7;Inhibitory neurons: 394.9;Oligodendrocyte precursor cells: 641.4;Oligodendrocytes: 329.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 11.2;basal ganglia: 27.6;cerebral cortex: 22.3;hippocampal formation: 15.9;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	5.8	6.4	11.2	2.9	27.6	12.0	5.6	0.0	22.3	6.8	0.0	4.2	2.0	5.1	8.3	6.1	4.2	5.4	5.1	15.9	2.8	6.3	2.2	12.5	1.5	1.6	0.0	4.4	4.2	30.5	10.4	4.1	4.3	6.1	2.0	6.4	7.3	5.3	2.2	11.1	2.5	7.0	1.3	2.5	3.8	18.4	1.1	3.4	3.7	2.5	1.7	8.3	7.0	17.5	28.2	25.9	15.8	2.7	7.9	19.0	30.5	17.6	17.3	17.0	21.0	1.5	8.0	0.0	5.3	30.3	21.6	3.8	25.6	51.6	38.2	10.9	11.8	41.0	38.9	1.5	6.9	11.2	0.0	29.3	29.5	19.9	56.9	18.8	5.5	10.4	5.2	0.0	24.6	21.4	7.4	1.8	1.8	4.9	16.8	5.7	31.7	2.1	15.1	38.4	26.5	29.2	9.8	18.3	7.2	27.3	8.4	2.9	28.0	41.3	21.4	2.7	21.7	0.0	0.0	0.0	15.2	2.9	15.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.3	0.9	0.0	0.4	0.0	0.0	11.2	27.6	0.0	22.3	15.9	2.8	1.6	0.0	4.3	1.3	1.1	17.5	13.2	16.0	59.4	79.0	2.3	25.1	13.0	25.3	6.8	63.1	11.6	8.5	3.9	10.0	19.2	27.6	16.7	8.0	9.4	3.4	1.9	10.9	17.5	15.4	12.6	12.3	4.2	3.8	597.7	14.0	35.0	8.5	7.7	19.7	0.0	195.7	24.3	1.3	7.3	8.4	394.9	3.3	20.3	9.7	10.9	10.4	5.6	16.7	10.6	151.8	11.2	3.9	14.4	641.4	329.8	29.4	2.8	3.4	2.9	10.6	0.3	1.7	10.2	7.1	19.7	62.9	6.9	23.0	20.4	10.8	15.9	16.4	9.9	8.8	2.2	11.8
TANGO2	"C22orf25, DKFZp761P1121"	ENSG00000183597	"Transport and golgi organization 2 homolog"	Q6ICL3	22	20017014-20067164	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 111.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003080	Approved					NA	NA		200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA003080: AB_1078350"	"unprognostic (4.05e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (3.01e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.95e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.62e-2)"	17.0	26.7	20.9	13.8	19.2	50.5	13.4	19.1	23.8	10.9	15.9	14.9	9.8	13.0	9.2	11.5	10.9	10.9	78.9	21.8	22.4	21.3	20.0	19.2	17.7	24.7	26.6	7.9	15.4	27.7	19.7	11.6	30.2	17.1	11.3	6.4	12.2	12.2	27.7	12.8	16.2	12.0	20.6	34.0	21.2	7.5	25.7	12.4	24.3	29.0	11.7	15.1	9.7	20.5	15.6	14.2	4.8	9.6	33.6	10.9	8.7	15.7	20.8	14.5	12.8	10.0	12.1	6.2	11.1	42.4	20.2	18.9	11.2	17.5	9.2	36.8	11.4	16.9	11.9	12.0	24.6	15.7	29.1	15.6	12.9	21.0	11.6	14.5	21.6	10.4	44.0	13.1	20.8	17.7	10.3	10.7	2.3	37.7	9.5	9.5	12.9	4.0	11.7	19.9	8.4	4.7	16.1	27.7	35.3	10.3	7.0	14.3	14.7	19.0	14.4	25.2	11.0	6.7	4.1	6.4	25.9	12.9	13.6	76.3	44.1	77.8	14.9	53.4	16.2	20.5	15.9	19.2	41.6	15.7	10.0	13.1	55.8	31.3	70.1	14.3	28.7	39.6	20.9	19.2	19.1	23.8	21.8	22.4	24.7	26.6	30.2	20.6	25.7	20.5	5.8	16.0	5.8	10.7	11.9	3.8	3.9	4.2	2.2	4.9	3.9	3.4	17.1	10.0	4.6	7.3	4.2	10.6	10.2	11.5	19.6	11.5	5.5	2.7	3.4	5.7	6.6	111.4	20.6	9.7	17.4	5.9	9.2	4.9	15.2	4.5	6.4	6.4	39.4	10.1	13.3	7.0	8.2	21.6	7.1	15.9	5.0	24.0	19.6	15.9	24.8	7.6	19.6	3.0	30.9	11.6	9.2	4.9	7.2	4.8	13.8	7.7	6.1	2.9	19.7	3.0	6.6	4.8	3.1	5.3	4.5	11.5	9.7	13.0	6.3	3.5
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843531-69085182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	5.1	3.0	2.8	4.5	3.8	3.4	4.6	3.5	3.4	4.8	4.9	3.9	2.4	4.3	1.9	3.6	3.8	2.8	3.2	2.6	3.6	5.7	12.9	3.6	4.9	2.7	3.1	4.2	3.2	6.0	2.5	3.4	2.8	4.0	3.1	4.2	3.2	4.2	8.8	4.2	3.1	4.8	2.4	4.5	4.1	4.3	3.5	4.7	3.3	5.7	4.6	5.5	4.2	3.9	7.1	14.3	4.6	9.9	7.6	8.6	3.3	9.5	7.7	11.5	9.3	9.1	5.7	15.8	5.1	13.2	6.0	5.8	10.6	12.8	14.0	3.8	6.3	3.0	5.4	8.5	6.3	8.0	7.2	6.6	6.7	16.3	14.7	4.7	11.2	7.6	10.6	2.7	10.7	7.1	8.3	6.4	10.2	6.9	7.6	8.9	6.8	17.8	8.4	3.9	4.8	5.6	23.3	1.3	6.3	5.5	4.6	8.9	6.5	10.9	3.9	11.2	6.8	4.9	4.5	10.7	6.9	3.0	7.4	0.0	3.8	2.0	3.4	6.6	3.5	2.7	3.3	3.5	4.8	2.4	2.0	3.3	0.2	2.0	6.2	1.3	4.9	3.1	2.8	3.8	3.5	3.4	2.6	3.6	2.7	3.1	2.8	2.4	3.5	3.9	5.1	0.0	4.2	23.5	5.4	5.2	9.5	5.0	2.8	8.8	1.5	1.8	3.8	5.7	2.2	7.3	10.4	5.6	3.1	2.1	0.0	2.2	110.2	1.5	3.5	4.8	0.0	7.8	45.4	3.3	2.7	4.0	6.1	3.0	1.3	3.7	3.9	12.3	4.7	5.0	57.4	1.8	4.1	7.6	3.5	50.5	5.6	4.2	5.4	25.3	3.5	3.3	4.1	38.7	51.3	2.7	4.4	3.4	2.9	3.7	1.1	6.0	0.5	10.5	0.0	3.9	3.4	5.7	4.7	4.0	3.0	2.5	7.0	3.2	2.2	9.2
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236230	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601"	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	42.9	36.2	20.9	46.2	23.6	84.2	57.7	22.1	24.7	30.5	25.3	32.4	28.0	30.7	27.0	29.8	35.0	43.0	27.1	20.1	24.1	29.1	66.5	39.7	52.8	24.0	25.5	30.8	22.9	27.8	19.7	36.9	23.5	24.6	35.8	32.1	26.6	24.7	52.3	26.7	29.1	32.5	21.4	43.2	30.2	22.3	21.9	42.1	36.4	43.3	51.4	49.0	25.0	25.1	39.2	24.5	31.7	36.3	91.3	124.9	45.2	58.0	86.4	39.3	57.7	30.8	50.5	53.1	38.7	67.6	28.2	27.5	19.2	43.4	59.5	126.6	20.5	29.8	22.5	79.1	72.4	51.1	32.2	98.3	66.6	59.6	46.6	73.5	101.7	32.0	30.5	68.7	77.7	29.3	31.4	50.7	18.2	40.9	21.5	17.9	45.5	35.2	86.3	62.1	26.4	30.7	37.4	40.6	60.4	43.2	17.5	64.9	108.2	50.4	29.3	25.7	34.0	46.6	46.1	80.9	66.9	40.3	40.8	122.2	71.4	97.1	36.0	78.5	55.9	63.8	58.8	53.1	66.5	66.7	39.9	39.6	189.4	42.4	94.0	43.4	100.7	55.0	20.9	23.6	22.1	24.7	20.1	24.1	24.0	25.5	23.5	21.4	21.9	25.1	34.7	57.7	79.6	82.3	108.9	59.9	106.3	82.7	21.6	32.7	73.0	71.5	27.3	42.9	69.2	46.0	12.5	43.1	54.8	50.4	60.7	58.8	18.0	47.2	42.3	46.7	47.4	63.8	49.9	40.5	82.9	67.8	28.5	52.4	59.5	17.0	28.2	58.1	45.6	21.9	60.9	29.3	71.2	71.5	194.0	10.0	52.8	106.8	72.9	120.9	177.7	33.5	40.2	63.3	87.4	56.0	43.9	26.4	57.1	81.8	34.4	46.5	66.2	37.4	26.3	52.1	40.3	54.3	33.9	29.3	60.9	134.9	109.3	33.0	32.2	158.4
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390363-29551903	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	13.7	9.1	12.0	9.8	16.0	10.5	10.3	13.8	13.1	11.8	1.2	9.5	5.2	10.8	8.5	10.3	7.9	9.6	13.2	13.3	12.8	10.2	8.6	9.8	9.9	16.4	14.5	10.3	7.8	19.4	8.0	11.7	14.9	9.0	8.5	20.9	7.8	10.0	11.4	10.4	7.3	11.7	13.2	10.4	8.1	11.7	13.9	13.2	14.5	15.2	9.5	12.1	8.7	20.4	19.3	35.0	32.1	13.4	24.1	29.8	11.3	20.0	23.9	20.3	21.1	20.7	7.9	13.8	15.8	35.9	20.7	16.3	30.4	15.7	36.4	20.7	18.2	21.0	21.3	12.2	16.6	26.5	16.7	19.4	19.6	29.0	30.6	21.3	27.3	14.0	20.7	12.0	26.7	14.2	18.5	9.5	12.0	12.9	8.6	15.1	41.2	8.8	19.1	31.5	16.1	18.7	34.6	34.4	21.1	32.6	23.6	21.6	33.6	28.0	19.7	23.7	27.5	9.3	18.6	14.0	20.3	14.8	24.3	0.6	0.5	0.5	0.6	0.6	0.5	0.5	0.6	0.7	0.5	0.6	0.7	0.7	1.7	0.5	0.6	1.4	0.4	0.3	12.0	16.0	13.8	13.1	13.3	12.8	16.4	14.5	14.9	13.2	13.9	20.4	96.9	48.1	45.8	105.8	35.9	44.5	27.4	27.0	52.9	56.6	35.5	23.2	90.2	30.0	37.7	46.0	98.0	18.7	40.5	29.3	15.6	27.3	11.8	45.0	72.0	55.4	37.7	18.7	162.3	24.3	16.0	58.0	31.6	80.1	28.5	44.3	52.1	29.5	30.1	52.2	160.5	23.7	24.4	65.6	60.4	19.8	39.7	67.3	40.9	92.8	55.8	37.1	29.9	142.2	220.8	38.9	24.0	54.2	34.2	40.4	17.6	22.1	31.0	54.7	26.3	66.1	52.1	59.1	33.2	49.5	45.9	37.6	43.1	43.0	21.1	41.6
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973868-29992261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	31.4	36.0	23.4	14.7	21.2	12.7	30.8	18.0	26.1	24.8	11.9	21.8	17.3	25.9	11.1	20.8	22.6	12.0	32.6	23.0	18.9	22.7	17.6	34.0	14.4	21.0	20.0	24.1	19.5	17.4	29.4	19.4	18.9	22.5	8.5	14.3	20.5	13.3	23.4	22.4	24.4	13.3	15.3	33.8	21.8	34.8	20.8	13.2	25.4	12.7	10.5	22.4	21.6	19.0	22.2	41.8	22.4	35.1	25.8	17.1	34.2	40.0	21.1	26.4	24.4	33.6	28.7	23.8	32.8	28.8	18.0	33.9	20.4	20.0	14.1	37.5	43.3	25.8	46.2	34.8	18.7	25.5	47.5	20.0	17.1	28.1	11.2	18.5	44.7	22.4	23.5	23.6	25.8	41.0	29.8	36.0	21.5	16.4	27.6	54.2	32.5	22.2	16.6	20.5	26.1	20.8	22.8	30.2	12.1	14.4	37.5	28.5	62.9	45.0	20.7	32.4	23.6	34.2	23.7	22.1	27.6	28.8	33.7	0.3	0.7	0.4	0.7	0.7	0.8	0.5	0.7	0.6	0.4	0.6	0.4	0.3	1.2	0.5	0.4	0.8	0.9	0.6	23.4	21.2	18.0	26.1	23.0	18.9	21.0	20.0	18.9	15.3	20.8	19.0	52.0	9.6	11.5	21.9	6.3	10.7	4.6	7.5	7.4	14.6	10.5	5.7	9.8	7.2	9.1	9.2	39.6	7.8	7.6	27.0	1.9	8.5	3.9	8.7	9.5	35.3	13.1	3.4	7.9	12.0	6.2	9.7	14.3	8.9	3.8	16.0	47.2	11.8	9.8	10.1	10.7	16.8	12.2	11.2	11.1	4.4	12.5	8.2	7.2	7.5	9.0	8.4	11.3	9.0	12.7	16.1	14.8	12.8	5.9	7.4	27.2	8.0	10.0	21.4	6.6	8.7	8.7	19.7	21.6	9.1	9.7	12.0	9.2	16.0	14.7	7.4
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 400.6;Rod photoreceptor cells: 323.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA		520000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	15.4	18.2	33.9	24.9	35.7	41.9	17.1	36.8	38.5	12.7	27.9	23.8	27.1	16.8	12.7	18.2	10.5	19.5	18.5	33.0	38.1	16.2	18.4	23.2	33.8	34.2	35.3	19.3	11.7	15.5	18.7	14.3	33.5	29.0	24.6	48.3	15.2	16.0	21.8	20.3	28.8	17.7	33.6	26.0	25.2	10.7	41.2	31.6	21.1	13.0	33.0	20.6	13.3	42.6	25.7	17.2	12.7	11.1	30.6	37.0	14.5	26.2	29.8	14.9	19.3	8.9	38.5	77.4	8.4	34.9	21.5	22.5	11.2	23.5	23.3	28.3	9.2	91.7	9.0	11.7	35.6	95.2	123.5	25.3	27.7	46.9	68.4	31.3	48.3	45.5	54.3	9.0	27.8	18.2	50.0	62.0	4.7	11.7	9.2	29.1	17.2	8.3	14.1	43.8	2.3	12.5	24.1	10.9	33.6	5.5	22.0	70.0	75.9	25.5	4.5	24.2	22.6	8.7	8.9	60.6	35.8	64.1	35.2	122.3	39.4	91.5	60.9	53.8	58.1	47.9	46.0	53.4	52.4	44.9	40.3	52.9	86.2	86.9	95.4	48.8	46.6	46.0	33.9	35.7	36.8	38.5	33.0	38.1	34.2	35.3	33.5	33.6	41.2	42.6	43.2	35.3	98.9	203.4	110.7	35.2	46.7	30.4	38.1	69.9	52.3	39.6	57.6	52.9	36.7	46.0	212.7	36.1	138.5	116.3	70.5	40.3	18.6	17.5	30.6	36.2	25.1	65.2	117.0	59.1	93.5	37.8	75.4	39.2	167.6	31.6	29.6	57.7	78.5	40.4	156.2	80.7	22.4	104.3	103.0	10.3	38.8	160.5	35.6	133.0	156.9	48.4	217.3	400.6	202.2	91.0	111.7	47.8	84.9	44.4	105.2	37.4	20.7	323.8	46.0	29.9	55.2	101.4	53.3	48.3	31.4	43.8	103.5	66.4	69.3	53.7
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5"	"Low region specificity"	"Detected in all"							HPA007066	Approved					NA	NA		20000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	47.3	73.1	2.4	28.5	4.8	25.0	43.1	1.9	2.8	40.1	1.2	66.7	52.3	38.2	13.3	57.3	43.8	10.5	63.7	2.9	1.8	67.4	107.5	82.1	21.2	2.7	3.2	33.3	48.2	14.9	38.8	18.7	2.0	64.3	19.6	4.1	61.9	17.2	26.7	54.0	81.9	23.1	1.9	129.0	52.1	16.2	2.0	24.4	59.1	6.5	36.7	45.0	43.4	2.4	3.3	1.2	6.3	26.1	20.3	25.6	92.9	18.5	88.1	42.5	57.1	0.1	168.7	48.1	38.1	41.3	92.2	2.9	0.3	30.3	15.8	125.5	4.1	19.1	9.9	24.8	0.2	20.4	63.0	51.7	20.6	0.8	8.2	37.8	0.4	16.0	1.5	140.8	14.7	19.6	51.9	44.1	0.5	0.0	6.3	2.8	0.4	1.3	35.5	1.2	8.6	0.6	0.6	2.4	23.7	3.7	1.4	0.9	45.5	89.4	18.6	1.3	2.0	140.5	117.4	46.2	58.6	38.8	58.8	159.7	87.9	172.1	137.3	121.6	117.0	97.1	99.7	114.3	90.0	86.0	76.2	109.9	151.3	159.6	139.0	102.9	85.9	150.5	2.4	4.8	1.9	2.8	2.9	1.8	2.7	3.2	2.0	1.9	2.0	2.4	116.8	125.0	102.1	22.5	186.6	77.0	93.3	148.2	66.6	34.7	82.0	64.1	73.9	84.4	105.8	71.7	33.3	46.9	223.7	259.6	13.7	256.4	1.9	64.0	52.4	99.1	84.6	58.0	25.9	282.9	85.9	63.9	105.5	78.4	91.9	65.9	75.0	143.7	119.7	20.2	15.0	174.6	83.4	124.3	128.0	9.2	33.2	131.9	119.2	30.9	229.3	34.7	195.7	23.6	8.7	215.5	172.4	32.0	194.9	130.4	283.2	33.1	113.3	30.4	32.9	39.3	57.6	1.2	0.6	53.6	56.3	49.1	163.7	66.4	162.3	141.0
TAPBPL	"FLJ10143, TAPBP-R, TAPBPR"	ENSG00000139192	"TAP binding protein like"	Q9BX59	12	6451690-6466517	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 94.2;Proximal enterocytes: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 64.2;HDLM-2: 37.6;Karpas-707: 44.9;RPMI-8226: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039545	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA039545: AB_10673360"	"prognostic favorable (1.98e-4)"	"unprognostic (3.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.64e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.04e-5)"	"unprognostic (3.53e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.28e-2)"	"prognostic favorable (7.86e-4)"	11.4	11.7	3.8	12.1	4.9	12.5	12.0	4.3	5.2	12.0	7.2	21.3	32.8	11.7	5.9	9.9	17.4	21.5	15.8	3.6	4.1	14.6	19.6	17.4	17.3	5.8	4.4	10.4	9.3	13.3	10.8	8.2	4.5	11.8	11.2	0.8	34.3	20.0	9.3	8.6	28.1	7.3	4.6	16.8	23.8	2.1	4.0	16.1	22.1	3.7	7.1	13.9	10.1	4.9	6.5	4.7	0.1	2.8	9.5	13.7	13.2	4.3	11.5	5.4	7.9	5.4	64.2	5.6	2.4	5.6	3.1	7.6	0.0	1.1	1.0	37.6	0.0	5.8	3.6	6.0	12.0	5.3	15.0	19.9	3.7	9.9	1.5	3.5	7.6	3.7	0.0	44.9	1.4	13.9	10.5	2.7	0.8	0.4	1.1	10.9	3.4	36.4	4.3	18.0	0.6	0.1	15.8	9.3	1.2	0.1	0.4	11.5	7.2	5.8	2.3	1.6	7.7	7.4	2.0	3.2	10.8	5.3	6.5	126.0	102.3	72.9	89.9	124.9	56.7	40.7	45.7	57.5	76.7	38.5	28.9	52.5	74.6	104.5	102.6	60.6	33.7	124.6	3.8	4.9	4.3	5.2	3.6	4.1	5.8	4.4	4.5	4.6	4.0	4.9	21.4	19.2	13.1	7.8	26.7	8.3	18.6	47.1	14.2	4.0	14.2	11.3	6.1	27.1	35.1	35.0	10.4	19.2	28.4	49.8	0.0	27.7	0.3	7.0	7.7	15.1	9.0	8.2	1.1	53.8	18.7	24.3	18.3	10.9	13.3	5.1	14.3	11.9	31.8	0.0	1.4	32.6	26.4	16.9	17.7	0.4	15.5	22.5	16.0	2.8	21.3	7.6	34.0	4.0	3.1	34.3	63.2	8.6	94.2	16.1	82.3	12.6	16.0	1.9	6.6	8.8	9.6	0.5	0.2	8.8	8.0	13.8	26.3	3.4	33.7	22.5
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Late spermatids: 163.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042567	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Cytosol"	"HPA042567: AB_2678055"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	7.4	15.1	17.5	6.0	18.6	25.7	10.0	17.3	22.3	8.2	15.1	8.9	6.4	10.0	9.2	6.1	9.5	6.7	9.1	17.1	17.0	12.4	30.5	11.9	9.6	18.6	17.4	8.1	8.1	13.0	8.5	6.8	18.4	7.4	8.2	24.7	7.6	6.4	35.5	7.7	7.5	9.3	17.4	8.5	7.9	11.1	17.5	12.2	11.5	19.9	8.1	7.6	6.9	19.5	4.9	3.6	6.0	7.0	8.9	6.8	2.5	7.8	6.0	7.4	8.1	4.9	8.5	31.7	8.3	5.0	10.8	4.0	5.2	4.0	9.3	2.9	6.3	6.2	5.0	5.2	8.4	12.6	6.2	4.2	7.7	7.3	5.3	9.1	3.8	19.3	9.7	14.5	7.2	3.5	18.7	10.1	4.0	9.3	8.4	45.0	8.4	5.8	12.0	5.1	10.0	8.0	7.4	6.2	9.5	4.1	11.5	12.3	7.1	6.2	4.1	4.2	10.3	13.9	12.2	24.2	12.4	30.9	7.3	1.1	0.3	0.0	0.2	0.2	0.0	1.0	0.7	0.4	0.5	2.5	0.9	0.7	0.6	0.3	0.3	0.8	0.5	0.3	17.5	18.6	17.3	22.3	17.1	17.0	18.6	17.4	18.4	17.4	17.5	19.5	12.0	32.1	62.6	47.3	20.2	9.1	6.3	4.2	4.0	24.5	15.0	9.9	14.3	10.0	8.7	7.3	114.7	4.2	16.2	11.1	3.9	6.7	79.0	14.2	12.6	12.8	14.4	16.6	42.6	8.2	3.1	10.2	8.6	12.0	2.5	17.5	8.6	46.0	4.2	70.7	43.6	9.8	4.1	10.3	18.9	163.1	9.9	11.1	16.0	45.0	6.5	33.1	8.2	60.8	68.2	9.5	9.4	15.1	8.9	7.1	10.7	8.7	14.4	62.4	6.6	17.0	11.5	33.3	5.7	7.1	8.0	7.0	10.8	16.5	9.0	6.6
TARBP1	"TRM3, TRMT3, TRP-185"	ENSG00000059588	"TAR (HIV-1) RNA binding protein 1"	Q13395	1	234391313-234479179	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 209.4;Inhibitory neurons: 161.5;Oligodendrocyte precursor cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020810, HPA024632"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"CAB020810: , HPA024632: AB_1857770"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.14e-10)"	"unprognostic (5.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.27e-2)"	4.8	5.2	3.9	7.4	4.0	11.1	9.1	5.5	5.0	4.9	0.1	6.1	6.5	4.9	7.6	6.3	7.6	5.7	3.8	3.7	2.9	5.6	3.9	6.2	10.3	0.4	0.8	2.7	7.7	6.1	6.3	8.3	1.1	7.4	9.0	7.3	9.3	4.5	6.3	7.9	5.8	4.6	0.7	7.5	8.3	4.8	4.3	6.7	6.2	7.1	11.4	3.7	4.2	4.1	18.9	12.9	8.3	9.7	13.6	18.5	17.2	7.9	5.9	10.1	7.4	6.2	12.0	16.3	8.2	6.0	8.7	12.1	9.7	9.9	9.7	16.0	14.9	9.0	14.0	9.1	4.3	39.7	7.6	7.7	8.9	7.3	4.1	7.8	10.5	21.6	11.5	10.2	7.1	3.9	16.5	19.4	17.7	20.1	5.3	28.7	4.9	16.0	6.8	10.8	8.9	10.6	10.8	14.0	12.1	5.5	9.0	39.9	7.1	9.3	1.2	10.4	16.1	27.0	19.0	7.2	6.0	18.3	14.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	0.3	0.0	1.1	0.0	0.0	3.9	4.0	5.5	5.0	3.7	2.9	0.4	0.8	1.1	0.7	4.3	4.1	12.4	41.7	22.7	53.8	14.6	6.2	4.1	7.4	7.4	35.1	18.4	18.9	5.8	5.7	13.3	7.3	37.5	20.1	23.3	7.2	1.9	4.7	21.5	13.8	13.6	11.1	11.5	16.4	209.4	5.7	17.6	10.1	16.3	9.9	3.8	13.2	12.1	7.7	9.0	57.2	161.5	12.2	10.2	6.6	9.2	3.6	5.6	11.4	10.6	39.4	8.0	7.7	10.3	115.1	72.3	8.8	6.5	6.0	6.3	6.5	5.8	4.3	27.9	17.1	0.0	12.7	7.8	4.1	8.6	11.5	8.2	11.9	12.8	12.8	19.6	4.8
TARBP2	Trbp	ENSG00000139546	"TARBP2 subunit of RISC loading complex"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	9.2	13.1	9.8	9.2	10.0	6.8	8.9	13.4	11.3	8.9	9.5	9.5	9.0	8.5	7.9	13.1	11.7	6.7	9.7	9.6	10.1	18.6	20.6	10.1	10.5	10.0	10.0	8.0	18.7	8.5	8.5	13.8	9.9	11.3	5.5	6.7	11.0	5.1	9.8	9.8	9.5	6.1	9.9	15.2	12.4	13.1	10.8	10.3	12.0	7.1	9.0	10.4	8.9	10.5	25.5	69.1	26.8	29.6	15.3	20.8	35.0	22.6	19.2	34.1	20.3	61.2	33.5	24.5	44.6	24.9	22.2	20.0	32.8	34.1	19.9	30.5	54.1	28.6	26.6	43.9	33.3	48.0	31.9	24.3	21.0	35.2	16.5	23.2	41.2	36.6	37.1	38.3	24.9	102.9	32.5	62.9	53.0	19.7	37.1	23.9	14.4	31.6	22.6	26.4	34.8	24.8	11.8	28.7	58.9	19.1	40.4	63.7	22.1	31.2	29.8	11.9	27.4	19.7	39.6	26.1	34.8	24.2	35.6	2.1	11.5	5.7	13.9	11.9	13.3	10.9	13.3	12.8	14.9	15.3	13.7	13.6	0.7	13.1	7.7	13.3	11.7	12.5	9.8	10.0	13.4	11.3	9.6	10.1	10.0	10.0	9.9	9.9	10.8	10.5	5.2	0.0	8.2	4.6	10.7	6.4	10.5	15.3	17.1	9.3	12.0	10.0	6.0	15.7	11.2	9.2	10.4	46.5	7.2	9.8	21.5	20.7	10.7	7.9	8.8	11.6	5.4	9.4	2.3	26.2	48.9	9.3	13.7	7.2	10.8	10.5	12.1	18.4	25.6	1.7	3.1	10.8	18.3	9.3	4.7	23.8	5.6	7.9	14.2	1.0	12.2	10.2	10.3	4.5	6.2	16.8	9.9	4.1	15.6	11.2	11.3	28.6	7.1	14.2	0.0	4.0	10.0	11.6	13.0	14.4	4.7	32.2	9.0	9.9	14.8	10.1
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11030528	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	NA		29000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	83.4	80.1	71.9	87.1	80.6	69.7	83.3	84.7	79.0	93.9	78.1	94.5	77.4	90.9	78.8	111.1	84.1	58.7	93.0	69.4	78.5	93.8	105.5	91.6	106.5	75.5	77.2	103.5	77.2	86.7	89.1	82.7	76.4	90.1	94.5	119.9	86.6	78.8	138.9	96.1	94.5	81.2	74.8	97.4	82.4	68.2	74.7	115.1	96.6	102.9	122.9	87.6	95.8	86.0	244.7	164.4	270.4	143.5	143.9	118.2	160.3	164.7	142.3	263.6	195.5	187.9	175.6	316.3	118.1	180.6	154.3	169.2	333.1	187.6	336.0	175.1	153.8	241.2	275.2	257.9	119.4	290.5	158.9	99.5	211.4	184.5	147.9	143.8	188.6	126.7	319.0	176.4	221.7	195.0	215.6	228.6	221.0	232.2	141.7	256.9	214.4	206.2	186.0	179.1	187.9	150.8	221.3	173.7	128.8	197.1	173.8	200.9	174.8	173.8	207.8	146.3	236.9	133.3	176.2	336.3	116.2	288.2	192.0	38.0	38.0	33.7	46.7	48.6	57.4	55.2	46.9	45.4	61.7	39.6	46.3	50.5	15.4	67.2	50.0	43.1	54.3	36.4	71.9	80.6	84.7	79.0	69.4	78.5	75.5	77.2	76.4	74.8	74.7	86.0	35.5	32.1	74.4	29.4	57.6	114.6	89.9	40.8	52.3	37.6	52.0	38.6	68.0	31.5	57.0	29.5	29.2	63.2	46.3	54.2	33.2	50.8	9.7	50.7	50.0	54.9	66.3	63.5	29.5	54.2	84.5	45.2	34.7	61.7	42.3	45.8	40.0	51.7	50.1	37.0	29.8	50.1	38.7	45.9	46.3	12.3	47.2	37.8	35.6	23.4	54.3	36.2	35.0	37.2	57.2	52.9	36.1	51.6	48.8	71.7	43.2	43.9	54.4	38.8	32.9	42.8	56.9	64.9	32.8	52.4	114.5	73.5	41.3	23.6	52.6	71.3
TARM1		ENSG00000248385	"T cell-interacting, activating receptor on myeloid cells 1"	B6A8C7	19	54069895-54081365	"Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"bone marrow: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051022, HPA054401"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"					"HPA051022: AB_2681315, HPA054401: AB_2682476"														"unprognostic (1.56e-1)"				0.0	0.1	0.4	0.0	0.2	6.9	0.0	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.2	0.4	0.2	0.6	0.5	0.3	0.1	0.3	0.2	0.4	0.1	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TARS1	TARS	ENSG00000113407	"Threonyl-tRNA synthetase 1"	P26639	5	33440696-33468091	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		580000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	29.0	32.2	13.7	33.8	16.2	45.0	26.8	20.0	20.1	24.0	17.1	42.6	30.7	24.7	35.8	40.9	17.4	19.9	38.7	13.8	17.9	32.4	68.6	24.1	29.9	22.4	18.5	17.9	68.1	33.8	9.9	37.1	18.3	27.6	42.8	40.7	36.8	26.4	38.4	19.1	29.8	37.2	18.4	21.7	40.0	18.7	18.3	31.7	37.6	28.4	40.1	42.9	10.8	22.6	253.0	136.1	132.7	189.5	80.2	129.9	230.1	237.5	172.9	152.5	163.7	176.6	128.7	96.0	84.8	176.5	271.8	151.1	261.1	207.1	267.4	158.9	140.5	151.1	332.9	108.5	256.7	225.6	141.0	133.7	287.7	217.5	273.9	102.4	144.3	191.8	236.3	204.6	191.5	105.7	166.3	104.7	159.2	181.5	168.4	137.1	237.9	123.4	170.8	119.8	81.0	102.7	245.6	175.8	195.5	103.8	85.9	236.3	123.0	132.8	211.9	102.5	196.3	135.4	258.4	132.6	156.2	302.6	148.3	34.2	22.0	22.6	27.4	24.5	27.6	28.7	25.2	26.6	32.6	23.9	21.5	27.5	2.6	46.2	18.3	18.3	24.2	20.6	13.7	16.2	20.0	20.1	13.8	17.9	22.4	18.5	18.3	18.4	18.3	22.6	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	36.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	42.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	52.1	2.6	0.0	0.0	0.0
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	9.8	16.5	11.8	10.6	11.4	10.0	10.3	11.2	12.5	9.5	10.9	10.3	8.9	8.9	13.0	13.4	11.7	7.7	20.3	11.3	11.5	14.3	25.3	8.6	14.7	12.0	11.5	11.7	8.4	17.7	9.3	8.9	12.7	8.7	11.3	14.7	9.7	9.3	31.9	11.8	9.6	10.0	10.4	12.5	12.0	11.0	11.9	12.6	11.2	31.1	15.4	9.6	9.4	12.8	33.5	27.4	18.1	27.4	19.9	18.2	34.1	15.9	17.2	30.7	30.8	22.4	30.3	48.0	34.2	12.0	21.1	33.8	44.2	36.8	23.5	29.2	38.4	22.7	25.2	22.7	19.7	31.4	33.4	16.2	30.2	23.4	31.6	19.9	20.1	26.4	40.3	32.6	21.8	40.4	27.0	26.0	22.3	46.0	40.2	27.5	23.0	59.8	20.9	15.7	25.5	29.8	24.1	52.5	38.7	25.4	42.3	48.9	11.9	17.8	18.8	14.9	27.2	31.2	39.6	36.2	26.6	36.3	17.6	30.5	15.4	30.5	21.0	27.0	21.3	28.7	20.5	21.2	25.0	25.3	19.6	20.7	2.4	33.2	29.3	16.7	31.4	18.3	11.8	11.4	11.2	12.5	11.3	11.5	12.0	11.5	12.7	10.4	11.9	12.8	6.3	3.2	12.8	6.2	13.2	3.3	5.6	10.4	5.2	15.3	6.2	4.6	22.3	11.5	11.9	7.3	20.9	24.5	8.8	8.2	11.7	11.5	1.6	9.6	12.8	7.4	4.2	11.1	9.3	9.8	14.3	8.4	13.3	11.7	22.2	11.0	6.8	22.6	13.2	15.2	9.1	12.6	6.1	7.7	5.2	2.5	8.4	8.8	3.6	2.8	12.5	7.6	9.2	6.0	9.9	11.9	3.5	7.2	9.9	4.5	8.5	8.8	9.4	16.8	6.6	10.3	8.3	18.2	12.3	7.4	4.0	14.1	10.6	15.8	12.6	4.8
TARS3	"FLJ25005, TARSL2, ThrRS-L"	ENSG00000185418	"Threonyl-tRNA synthetase 3"	A2RTX5	15	101653596-101724473	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.8;skeletal muscle: 38.5;tongue: 36.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;B-cells: 9.5;Cardiomyocytes: 41.0;dendritic cells: 27.6;Plasma cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Enhanced		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	4.9	4.2	16.1	4.1	24.8	3.1	4.6	20.1	21.1	6.4	9.0	7.9	3.8	4.3	3.5	3.8	5.2	3.4	15.2	14.7	18.4	5.2	3.6	3.7	4.7	20.0	19.8	6.9	6.4	7.5	6.3	1.9	20.2	5.7	3.7	6.2	4.9	5.9	38.5	3.3	6.2	4.2	17.5	4.4	5.7	3.5	19.1	4.2	6.2	36.7	4.7	6.9	4.6	33.8	2.5	4.6	7.9	4.3	8.4	6.4	3.9	8.6	5.8	6.5	4.0	6.8	2.2	3.3	3.3	10.3	5.3	7.6	13.8	4.9	6.0	3.8	22.0	8.1	2.9	5.5	3.9	3.8	1.7	4.5	4.6	3.2	3.7	7.7	4.7	7.0	8.0	6.9	6.6	4.3	2.0	7.4	9.5	12.5	3.3	4.1	12.0	8.6	5.7	2.7	12.5	8.2	11.5	4.5	5.1	14.5	2.9	8.0	6.4	3.2	7.4	6.4	2.8	9.6	11.5	4.1	8.2	6.6	5.9	0.8	1.0	1.5	2.7	1.5	2.7	4.9	5.0	4.3	0.7	7.5	4.9	2.6	0.2	7.9	0.7	1.7	0.9	1.1	16.1	24.8	20.1	21.1	14.7	18.4	20.0	19.8	20.2	17.5	19.1	33.8	7.7	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	3.3	27.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	5.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	7.3	0.0	0.0	0.0
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555307-6579755	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"testis: 4.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.1;Late spermatids: 18.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;Hep G2: 1.6;LHCN-M2: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034579, HPA034580"	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.1	0.3	0.2	0.1	0.3	0.6	0.1	0.2	0.5	0.2	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.8	0.0	0.2	0.5	0.1	0.1	0.3	0.6	0.2	4.3	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.2	0.4	0.5	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.8	1.9	0.0	0.1	0.0	0.0	1.5	0.0	0.1
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331280-1335314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 12.1;salivary gland: 7.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 2.9;Cardiomyocytes: 3.8;Muller glia cells: 1.3;Plasma cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	17	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 20: HeLa - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.3	0.3	0.5	1.3	0.7	0.5	0.3	1.0	0.7	0.4	0.0	1.0	1.5	0.3	12.1	1.2	0.4	0.1	1.3	0.4	0.1	0.5	1.0	0.4	1.3	0.5	0.3	0.4	0.2	0.0	1.5	0.2	0.4	0.3	0.1	0.0	7.9	0.1	1.1	0.3	1.9	0.0	0.3	3.6	0.7	0.7	0.4	0.2	0.6	0.0	0.9	0.3	0.6	1.1	0.6	0.5	0.1	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.3	1.2	0.7	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.6	0.4	0.1	1.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	2.5	0.0	0.3	0.1	0.2	0.3	0.2	1.4	0.4	0.2	0.3	0.0	0.1	0.9	0.1	0.2	0.9	0.8	0.1	0.8	0.1	0.1	0.2	0.0	0.7	0.3	1.5	1.5	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.0	0.7	0.4	0.1	0.5	0.3	0.4	0.3	0.4	1.1	0.4	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0
TAS2R1	"T2R1, TRB7"	ENSG00000169777	"Taste 2 receptor member 1"	Q9NYW7	5	9627347-9712378	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 7.5"	"Group enriched"	"Detected in some"	36	"Early spermatids: 46.0;Late spermatids: 70.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA051879	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA051879: AB_2681649"										"unprognostic (2.19e-1)"								0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.1	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	70.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA043862, HPA054366"	Uncertain					NA	NA									"HPA043862: AB_2678703, HPA054366: AB_2682464"			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R39		ENSG00000236398	"Taste 2 receptor member 39"	P59534	7	143183419-143184435	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	90	"brain: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060680	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"					"HPA060680: AB_2684341"																		0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.0	0.0	6.6	3.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.0	2.4	2.0	0.9	3.2	6.6	3.6	5.2	2.8	3.6	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R41	T2R59	ENSG00000221855	"Taste 2 receptor member 41"	P59536	7	143477873-143478796	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057063	Uncertain					NA	NA									"HPA057063: AB_2683324"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R42	"hT2R55, T2R24, T2R55, TAS2R55"	ENSG00000186136	"Taste 2 receptor member 42"	Q7RTR8	12	11185993-11186937	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036149	Uncertain		Approved	"Nucleoplasm,Actin filaments,Focal adhesion sites"		NA	NA							"Nucleoplasm, Actin filaments"	"Focal adhesion sites"	"HPA036149: AB_10672080"														"unprognostic (2.45e-2)"	"unprognostic (4.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R60	T2R60	ENSG00000185899	"Taste 2 receptor member 60"	P59551	7	143443453-143444409	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030416	Uncertain					NA	NA									"HPA030416: AB_10603344"						"unprognostic (1.78e-2)"								"unprognostic (7.98e-2)"				0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TASOR	"C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1"	ENSG00000163946	"Transcription activation suppressor"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	9.5	8.4	4.0	15.4	8.4	11.8	11.4	8.7	5.3	12.0	1.7	11.7	10.0	12.3	7.4	11.1	13.1	11.7	6.2	2.2	3.6	10.2	7.9	11.3	20.7	5.1	5.6	14.2	12.4	21.1	4.4	9.4	6.0	9.3	12.4	9.9	8.9	9.4	2.6	7.1	11.3	12.3	5.9	14.7	12.8	29.2	4.5	21.3	18.8	6.9	19.3	12.5	3.8	12.0	49.2	19.2	29.2	23.0	15.5	26.7	14.6	21.4	22.0	20.1	21.1	15.8	35.8	77.3	7.9	21.6	33.9	19.1	29.3	25.1	29.2	38.3	14.8	30.4	27.3	7.1	10.9	32.2	46.1	12.9	20.6	19.6	35.1	23.7	26.5	28.8	29.8	43.3	26.0	17.3	39.8	6.4	16.3	25.9	29.0	20.9	28.9	25.9	19.0	35.5	19.3	23.9	46.9	18.5	23.2	16.6	30.6	36.7	28.6	25.9	23.7	23.8	33.1	39.2	58.5	38.6	30.1	46.7	35.0	0.6	0.8	1.1	1.2	0.6	0.7	0.7	1.0	1.2	1.0	1.1	1.1	1.2	0.2	0.9	0.7	0.7	1.0	0.6	4.0	8.4	8.7	5.3	2.2	3.6	5.1	5.6	6.0	5.9	4.5	12.0	25.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	14.5	12.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	9.2	2.1	0.0	0.0	0.0
TASOR2	"bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006"	ENSG00000108021	"Transcription activation suppressor family member 2"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	9.5	8.6	3.1	12.0	4.4	14.3	12.5	19.5	8.0	13.2	9.8	10.9	6.6	13.0	15.3	9.7	10.7	10.2	9.3	2.3	9.0	8.9	10.8	8.1	17.2	2.5	5.1	12.7	10.9	14.5	10.7	12.6	3.5	9.9	11.9	14.1	9.5	10.9	12.1	8.9	9.2	13.3	1.2	10.0	10.3	24.6	4.6	14.9	16.4	14.4	17.0	17.5	8.0	10.5	38.2	31.7	19.9	34.0	25.1	29.7	28.0	31.7	20.1	26.7	33.6	33.7	22.0	77.2	19.8	31.4	16.9	29.3	57.5	32.5	43.0	15.2	38.7	36.1	24.7	22.8	25.0	26.9	20.7	22.9	35.6	43.5	36.8	17.9	31.4	29.4	59.1	17.6	30.2	25.7	35.0	9.5	24.3	24.6	20.3	25.8	27.7	27.1	16.0	34.1	24.4	27.5	31.5	28.3	22.2	22.3	37.2	20.9	31.6	33.6	36.2	65.5	43.7	21.3	21.9	67.8	16.6	26.1	18.1	1.0	1.2	0.2	1.2	1.2	1.1	1.0	0.9	1.1	0.7	1.8	0.9	1.5	0.9	4.3	0.4	1.1	1.3	0.5	3.1	4.4	19.5	8.0	2.3	9.0	2.5	5.1	3.5	1.2	4.6	10.5	19.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	11.7	18.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	10.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	7.3	2.7	0.0	0.0	0.0
TASP1	"C20orf13, dJ585I14.2, FLJ20212"	ENSG00000089123	"Taspase 1"	Q9H6P5	20	13389392-13638932	"Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 136.1;Inhibitory neurons: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030824, HPA030825"	Uncertain		Approved	"Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA030824: AB_10600327, HPA030825: AB_10601575"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.44e-3)"	"unprognostic (9.85e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.67e-2)"	7.0	4.5	1.0	4.3	1.7	4.9	6.8	1.5	2.9	6.5	3.9	5.2	3.7	6.8	6.0	4.8	8.1	4.5	5.7	1.2	2.7	5.4	4.5	6.0	5.7	1.3	1.7	5.6	5.9	8.7	7.4	6.5	1.0	5.2	5.7	6.4	6.0	4.6	2.9	5.5	4.6	5.1	0.5	5.6	5.6	6.1	2.3	12.5	7.8	4.3	5.2	5.6	6.2	2.9	13.1	7.7	3.1	3.7	3.6	5.6	6.0	5.3	7.6	6.1	7.1	16.0	13.3	5.9	3.6	7.0	6.7	17.2	4.9	18.4	7.1	3.5	5.8	11.8	4.7	20.3	7.4	16.0	4.1	6.3	12.1	6.2	15.0	3.7	6.1	10.4	10.7	0.2	5.4	15.8	30.7	8.7	4.2	11.7	3.5	4.8	12.7	9.1	8.5	9.8	8.3	5.7	8.2	15.8	10.2	4.4	8.3	5.8	5.9	5.7	4.0	5.9	7.6	11.3	16.7	4.2	3.2	3.6	5.5	2.3	4.5	4.9	12.7	6.5	9.0	12.1	12.8	10.0	5.0	9.8	18.6	14.4	2.5	14.8	6.5	19.5	13.3	7.1	1.0	1.7	1.5	2.9	1.2	2.7	1.3	1.7	1.0	0.5	2.3	2.9	10.7	6.4	7.7	31.3	19.6	14.1	13.2	11.1	24.5	14.9	10.0	8.8	6.4	17.2	8.8	5.5	10.4	12.0	13.8	3.9	7.9	12.1	20.1	15.7	10.6	6.6	3.6	7.8	136.1	6.0	12.3	15.9	13.3	9.5	15.2	5.2	3.6	6.4	4.7	11.8	131.0	9.9	4.1	3.0	4.7	4.8	3.4	5.8	10.6	35.6	2.9	6.6	11.3	50.3	49.6	8.6	11.4	3.4	13.3	8.0	5.3	12.2	23.5	17.0	6.6	23.7	17.0	29.3	9.3	18.0	12.1	7.0	12.7	10.2	7.7	8.9
TATDN1	CDA11	ENSG00000147687	"TatD DNase domain containing 1"	Q6P1N9	8	124488485-124539458	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023634, HPA053045"	Uncertain		Supported	Nucleoplasm		NA	NA		660000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA023634: AB_1857779, HPA053045: AB_2682024"	"unprognostic (2.19e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.12e-2)"	23.4	18.7	16.0	15.8	16.8	16.9	39.1	16.8	21.9	20.1	13.0	21.2	18.1	23.5	21.0	16.4	23.5	14.6	23.1	16.1	17.1	28.1	25.2	14.8	19.8	17.0	16.9	39.5	44.8	24.4	8.9	13.6	18.5	17.2	22.4	13.7	27.7	15.0	52.2	20.4	18.1	19.7	17.1	12.2	22.7	12.3	16.4	27.1	36.9	43.9	20.0	21.0	17.3	19.4	65.5	45.1	42.5	30.2	36.8	69.9	31.9	35.5	38.1	43.3	40.0	44.7	69.1	49.7	77.4	38.6	33.6	53.7	52.0	51.9	71.6	64.0	34.3	45.6	36.5	39.1	70.2	35.5	17.0	52.5	80.5	63.5	132.4	48.3	35.3	48.4	38.1	31.4	59.1	198.4	52.8	21.6	42.7	132.8	58.8	35.4	31.7	55.7	61.3	45.5	35.7	49.2	39.2	80.3	87.2	39.3	52.7	38.1	28.4	30.8	82.7	57.3	96.7	40.0	65.3	62.1	57.9	61.4	27.1	29.3	11.0	4.3	12.8	9.1	19.1	17.2	19.5	16.2	15.6	16.6	27.7	24.8	2.1	17.7	6.6	14.0	22.5	14.8	16.0	16.8	16.8	21.9	16.1	17.1	17.0	16.9	18.5	17.1	16.4	19.4	39.8	16.0	27.1	25.5	37.0	64.7	100.9	129.4	75.7	19.3	79.5	131.4	23.9	21.5	55.6	27.6	14.6	66.6	26.7	17.8	107.6	55.2	7.0	40.1	43.0	31.9	16.2	23.8	36.6	62.0	62.5	42.7	29.6	44.4	20.8	76.5	26.7	40.2	54.6	16.8	35.2	41.6	65.1	36.7	43.6	6.7	49.7	36.3	48.0	30.0	51.6	24.8	37.0	20.1	48.6	40.8	34.3	34.6	34.1	94.2	57.8	128.9	33.8	19.2	19.7	64.7	57.5	34.6	45.1	54.0	58.2	59.7	38.9	68.6	60.7	82.6
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	15.5	15.8	19.8	14.8	20.9	34.4	15.4	18.0	21.4	19.9	17.0	15.5	12.7	17.4	15.5	19.9	15.6	10.3	16.2	20.8	17.3	17.8	14.0	17.3	21.6	17.6	17.2	24.7	19.9	17.9	17.8	9.8	17.3	20.9	14.7	9.0	17.7	12.3	15.0	20.7	18.8	13.5	17.4	23.9	16.7	8.6	19.5	32.5	20.8	10.9	22.1	16.6	18.4	18.3	19.4	32.1	16.9	14.3	21.2	22.9	73.3	23.2	22.5	28.8	18.8	23.6	17.0	45.6	17.0	32.1	30.7	14.3	29.1	20.9	22.5	29.5	36.5	24.3	30.8	24.9	13.7	34.6	24.8	17.6	22.9	40.2	13.6	18.8	23.6	28.3	27.9	40.7	26.4	37.2	45.4	29.6	23.9	25.2	31.9	24.8	18.0	26.5	18.2	26.8	18.7	22.6	19.4	21.8	10.9	15.6	22.2	32.4	18.8	33.1	21.6	28.1	41.6	25.5	43.6	80.6	30.0	35.6	23.1	1.3	0.6	0.5	1.6	1.0	1.6	0.8	1.4	1.3	0.5	1.4	1.4	2.1	0.5	0.9	0.5	1.3	1.7	0.9	19.8	20.9	18.0	21.4	20.8	17.3	17.6	17.2	17.3	17.4	19.5	18.3	6.3	6.4	11.0	4.9	8.2	12.6	4.6	4.8	9.1	4.4	9.4	6.3	6.9	7.2	4.3	11.0	6.2	3.8	9.3	12.7	1.9	5.1	2.0	4.1	7.0	7.9	16.8	6.1	8.8	9.2	4.0	6.8	5.1	5.9	5.1	9.1	7.9	10.2	10.3	5.0	5.9	8.7	2.0	15.6	21.0	1.8	7.2	9.1	14.2	6.5	9.0	5.2	18.6	4.5	5.0	8.6	3.1	7.5	8.8	9.3	8.0	5.4	2.4	2.8	6.6	5.8	4.7	2.1	5.6	6.4	12.4	2.5	10.7	8.7	10.8	7.1
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816830	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"	13.0	11.3	10.1	10.4	12.4	12.2	10.0	10.1	12.7	6.5	9.3	8.3	6.1	7.1	13.3	7.3	7.7	7.4	19.3	10.6	12.4	16.6	10.3	8.0	12.2	12.2	10.5	8.6	9.4	18.2	8.2	7.3	12.4	6.9	7.7	17.7	8.5	6.9	29.9	6.3	7.2	7.7	10.5	11.1	11.1	10.0	10.4	11.2	11.7	24.1	10.3	8.2	5.5	15.8	12.2	11.9	10.3	15.1	16.7	26.0	23.5	12.9	14.3	10.8	13.1	3.1	17.2	27.4	12.3	12.4	6.0	7.6	13.0	18.2	11.5	17.1	17.0	13.4	10.3	6.3	19.0	33.3	16.3	20.6	12.8	14.3	37.3	11.2	16.1	37.7	28.2	21.7	11.7	5.9	28.4	10.9	13.9	14.9	7.6	16.0	19.3	49.4	11.3	6.3	21.6	18.5	14.5	25.1	30.6	19.2	26.6	19.6	10.1	7.9	10.3	16.4	13.0	19.4	32.9	44.9	20.6	26.8	12.0	26.1	37.2	60.2	12.7	59.3	11.5	39.7	15.8	15.4	45.6	31.0	12.5	14.9	42.8	13.8	64.4	74.6	16.1	22.9	10.1	12.4	10.1	12.7	10.6	12.4	12.2	10.5	12.4	10.5	10.4	15.8	9.1	6.4	16.2	17.3	18.5	4.5	8.1	14.2	3.4	16.1	8.5	8.3	36.6	8.6	8.0	3.7	18.8	14.3	39.7	3.4	41.1	18.1	12.2	10.8	7.6	8.9	10.2	6.5	35.1	16.5	17.5	10.0	6.1	7.8	7.0	10.8	5.3	7.0	18.8	15.2	43.9	5.1	12.2	27.6	8.3	4.0	5.3	20.4	14.2	17.8	31.0	17.8	8.2	23.1	53.6	12.0	6.2	4.9	9.3	6.2	7.3	26.4	12.5	29.6	6.6	8.8	9.2	24.2	17.9	6.6	4.4	9.3	11.1	11.0	5.2	7.0
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	57.0	107.0	58.0	54.9	61.1	106.6	78.7	62.5	67.6	64.7	71.5	72.3	63.4	63.5	88.2	113.6	78.4	73.1	128.1	56.4	65.7	102.2	80.4	69.5	57.5	61.2	59.9	55.3	69.9	125.2	44.7	104.2	61.3	83.3	79.6	124.3	91.6	79.7	94.4	57.1	67.9	66.0	59.6	66.2	76.3	77.2	63.6	76.7	98.6	89.2	67.8	101.5	52.4	64.5	180.9	98.2	98.1	93.4	151.9	109.9	66.5	131.5	160.9	96.6	120.1	79.8	142.8	38.3	120.9	193.5	166.1	125.0	92.8	86.1	149.8	72.3	48.2	103.6	98.5	160.2	143.0	152.7	117.9	93.7	175.2	112.4	127.9	115.7	105.5	65.3	117.3	113.9	197.5	66.5	67.4	150.1	110.7	234.6	91.0	55.6	105.3	79.1	136.7	200.8	64.9	105.4	184.5	237.8	280.6	187.1	111.1	226.5	114.6	90.5	140.1	113.8	87.8	207.6	154.1	71.2	106.1	283.6	212.3	155.3	81.3	211.8	68.6	100.4	84.4	70.8	81.7	81.2	59.6	62.3	74.5	75.2	163.7	63.4	114.8	55.0	117.1	85.8	58.0	61.1	62.5	67.6	56.4	65.7	61.2	59.9	61.3	59.6	63.6	64.5	111.3	214.7	199.3	58.1	122.8	183.3	269.4	220.7	100.7	375.3	161.6	98.2	595.7	134.4	268.4	128.8	95.9	154.7	178.2	209.3	412.8	211.5	124.3	342.9	128.2	142.9	140.0	160.4	107.4	262.9	105.6	156.7	118.3	245.9	148.8	101.3	78.9	106.3	123.1	159.9	107.0	162.1	242.1	144.7	107.3	94.2	116.8	191.4	113.8	86.2	260.0	189.8	141.1	82.0	105.7	301.4	166.1	148.6	157.4	291.0	146.0	323.4	546.6	147.6	105.2	126.6	202.7	221.8	137.5	121.7	191.9	621.4	166.1	197.0	140.3	393.3
TAX1BP3	TIP-1	ENSG00000213977	"Tax1 binding protein 3"	O14907	17	3662895-3668679	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 395.9;Ductal cells: 351.0;Exocrine glandular cells: 385.9;Pancreatic endocrine cells: 505.8;Paneth cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 164.3;granulocytes: 217.8;monocytes: 78.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046410, HPA063078"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Actin filaments"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	"Vesicles, Actin filaments"	"HPA046410: AB_2679656, HPA063078: AB_2684937"	"unprognostic (6.15e-2)"	"unprognostic (6.46e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.80e-2)"	"unprognostic (5.45e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (5.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-1)"	107.3	131.8	62.7	49.2	78.5	16.5	94.4	67.9	67.3	192.9	48.2	108.5	108.8	128.1	33.6	258.5	84.4	90.9	194.8	57.3	58.8	115.0	39.7	94.9	39.3	72.5	73.3	95.9	80.4	23.5	30.9	53.2	69.9	91.7	77.4	3.7	109.7	105.6	28.7	120.4	119.6	70.3	66.2	52.3	136.5	51.2	65.2	44.6	63.6	33.4	49.0	102.8	160.1	80.6	183.1	319.1	68.4	38.5	219.2	175.6	81.3	223.6	184.5	234.0	136.7	135.9	144.5	19.1	159.1	290.8	77.2	282.6	39.1	205.3	90.8	50.7	64.4	25.9	75.8	106.6	191.1	4.3	37.7	267.6	322.5	145.1	68.9	165.3	266.0	50.1	9.6	14.4	280.1	169.4	52.2	15.1	65.9	116.7	112.6	50.0	41.8	16.3	248.6	141.2	14.7	43.2	276.2	116.2	39.4	67.5	125.3	23.2	269.6	195.3	75.2	154.9	230.2	5.7	2.6	5.5	117.4	30.0	190.3	217.8	65.4	120.4	26.9	78.9	22.2	29.2	25.0	26.6	58.7	25.3	17.3	22.7	73.8	20.0	73.6	164.3	36.7	53.3	62.7	78.5	67.9	67.3	57.3	58.8	72.5	73.3	69.9	66.2	65.2	80.6	51.5	60.9	25.8	0.0	19.0	95.3	79.7	229.3	99.6	1.6	51.0	28.2	41.5	92.9	107.6	99.3	0.0	124.7	68.5	395.9	88.0	351.0	16.2	12.8	27.3	77.0	24.6	21.4	0.0	385.9	145.3	72.6	43.8	16.1	26.6	21.2	75.3	11.1	69.8	5.0	0.0	120.0	71.2	35.2	73.2	10.5	174.6	64.0	113.8	0.0	85.5	19.8	26.8	0.0	0.0	505.8	362.8	209.9	5.8	89.0	279.2	185.3	26.8	2.6	39.5	44.1	78.6	8.6	12.8	94.5	76.0	155.6	16.1	92.0	103.0	107.9
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411524-154421726	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	19.0	13.8	37.2	8.5	38.1	41.4	17.2	38.1	44.4	18.1	37.0	18.3	9.7	15.1	7.6	21.7	16.6	8.7	43.5	37.0	37.0	22.3	21.9	21.4	17.9	39.3	37.6	18.5	21.3	12.1	14.5	6.6	38.5	17.9	11.7	8.4	13.6	10.2	47.0	18.7	22.9	12.3	37.7	39.2	17.4	4.5	37.9	14.1	18.5	65.6	16.0	18.4	18.4	39.4	24.5	28.6	9.3	11.7	18.3	13.4	18.4	6.9	21.0	15.3	17.1	8.5	29.6	28.2	43.6	16.4	36.6	28.4	17.2	16.6	12.3	25.5	19.6	5.5	20.0	16.4	25.8	12.3	11.8	15.4	35.6	11.7	31.7	12.9	25.6	30.9	12.1	34.9	18.1	17.6	29.0	33.2	2.4	24.9	27.9	21.4	16.2	40.1	24.2	9.0	11.8	17.9	5.3	17.9	26.6	11.1	10.5	16.0	15.5	10.4	11.9	25.5	15.2	55.9	30.6	66.2	13.7	36.6	13.3	5.8	11.1	17.5	12.4	10.4	11.5	12.5	16.6	15.5	14.5	18.7	14.1	12.0	9.9	12.7	7.8	7.9	15.4	9.4	37.2	38.1	38.1	44.4	37.0	37.0	39.3	37.6	38.5	37.7	37.9	39.4	36.2	6.4	11.8	37.2	29.3	10.8	7.9	10.5	14.8	21.6	11.1	15.6	21.1	14.3	13.0	9.2	18.8	5.0	29.7	13.6	5.9	14.7	1.1	6.5	9.6	18.5	6.1	9.7	22.4	16.5	10.1	12.4	23.4	9.6	18.4	19.2	15.0	7.9	24.4	10.1	28.4	15.9	12.2	19.9	16.5	2.0	11.5	20.4	14.2	14.0	21.7	14.2	15.5	23.1	39.7	13.4	12.2	9.1	17.2	8.3	19.6	5.9	8.0	25.6	13.1	12.4	11.3	10.4	3.8	16.8	11.2	2.9	25.6	9.2	15.8	6.7
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30326947	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	22.6	17.0	6.9	10.2	8.2	8.2	23.7	5.8	10.2	29.6	9.3	18.3	8.6	14.7	4.6	44.1	14.9	12.7	11.2	7.5	9.3	21.3	17.9	23.7	17.2	7.4	8.1	21.1	10.8	24.5	19.5	17.5	7.0	21.3	5.5	10.8	23.2	12.9	5.6	45.3	17.3	6.8	6.2	24.2	17.3	21.6	9.7	18.4	19.0	6.9	10.4	19.9	39.9	6.4	18.9	7.1	2.9	9.0	8.4	10.8	23.9	10.7	14.9	11.8	18.7	8.4	7.2	9.5	10.2	17.8	16.2	18.3	4.3	9.9	6.2	7.2	12.4	2.6	6.4	6.0	21.9	3.7	12.9	14.0	15.5	23.4	4.0	12.3	5.5	20.5	5.1	8.8	8.9	22.1	26.9	7.9	1.9	33.9	9.5	12.3	12.4	8.8	11.6	17.9	4.9	3.8	11.0	15.7	24.5	7.8	13.8	2.3	10.8	22.9	10.4	13.1	5.8	8.8	4.2	8.3	15.6	5.6	13.1	37.5	14.9	37.9	26.6	30.1	29.3	13.4	30.9	27.2	21.7	20.7	40.7	34.0	10.6	24.3	45.5	37.5	28.8	28.4	6.9	8.2	5.8	10.2	7.5	9.3	7.4	8.1	7.0	6.2	9.7	6.4	27.8	6.4	3.4	24.8	18.2	49.2	40.2	40.3	32.5	7.8	18.4	12.4	2.7	14.3	23.6	5.5	18.8	57.6	19.5	26.8	23.5	20.1	10.7	8.8	5.4	14.4	10.7	3.0	3.0	10.2	80.6	18.3	19.4	16.4	9.5	20.1	11.0	8.6	27.5	1.7	3.5	14.2	18.3	12.9	46.0	6.9	21.8	15.9	26.6	10.3	78.1	28.1	28.8	2.5	1.0	18.7	18.7	9.1	12.3	24.3	14.9	20.5	6.6	39.3	39.5	7.4	17.1	33.2	13.5	27.6	37.1	116.3	28.0	20.2	11.0	28.3
TBC1D10B	"DKFZP434P1750, EPI64B, FLJ13130, Rab27A-GAPbeta"	ENSG00000169221	"TBC1 domain family member 10B"	Q4KMP7	16	30357102-30370494	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048894	Uncertain					NA	NA		250000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA048894: AB_2680549"	"unprognostic (2.55e-1)"	"unprognostic (1.33e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (8.94e-5)"	"unprognostic (1.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	17.4	18.1	13.3	11.7	14.1	12.6	15.6	13.1	14.7	17.9	2.9	16.3	12.0	19.1	3.6	18.1	15.5	8.4	15.7	14.3	11.0	12.6	8.0	15.1	11.1	17.2	13.4	16.0	12.8	10.6	11.6	9.4	13.5	13.4	5.3	4.6	14.0	11.0	36.0	21.5	15.1	8.9	13.7	17.1	13.7	42.8	13.9	14.3	12.7	17.8	9.5	15.7	16.1	19.4	30.6	40.2	16.6	32.7	21.4	20.1	37.5	31.8	25.1	34.8	32.2	29.0	23.0	37.0	32.7	23.7	22.9	25.9	22.2	23.7	12.7	37.2	56.8	19.6	28.1	31.1	30.9	27.2	38.9	26.5	23.3	41.8	23.9	15.4	32.7	33.5	38.9	38.7	23.3	47.6	39.5	19.8	9.4	22.7	29.1	50.4	26.5	36.7	18.7	23.0	34.8	24.8	18.0	29.7	13.0	11.1	31.8	32.9	34.3	39.4	19.4	25.9	30.0	27.0	30.6	29.7	35.0	37.8	25.8	0.3	0.9	1.7	1.2	0.4	0.6	0.9	0.6	1.2	0.9	0.5	0.2	0.2	1.3	0.9	0.8	0.8	0.6	1.0	13.3	14.1	13.1	14.7	14.3	11.0	17.2	13.4	13.5	13.7	13.9	19.4	13.8	0.0	10.2	10.4	9.3	18.1	6.4	8.3	7.4	18.8	14.5	13.5	6.8	7.2	7.7	11.0	0.0	12.4	12.2	20.4	3.9	8.6	14.8	10.6	11.2	12.2	15.0	8.2	9.6	10.9	12.5	9.8	9.2	12.5	5.1	17.6	10.8	6.6	17.3	11.8	8.8	11.9	10.2	16.4	16.1	34.2	10.2	18.3	7.2	7.5	14.4	13.8	14.4	4.0	19.8	14.1	9.5	12.0	10.5	8.5	19.0	7.1	5.6	13.6	0.0	9.7	10.6	17.1	14.0	10.5	17.5	11.2	10.6	18.4	13.6	9.8
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TBC1D12	KIAA0608	ENSG00000108239	"TBC1 domain family member 12"	O60347	10	94402541-94536332	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 110.5;Oligodendrocytes: 397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038277, HPA038645"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear speckles"		"HPA038277: AB_10672584, HPA038645: AB_10672650"	"unprognostic (7.23e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.79e-5)"	"unprognostic (7.83e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-1)"	5.8	3.6	13.5	3.1	26.5	1.1	5.6	28.3	16.0	4.6	8.2	6.1	4.5	4.1	2.8	3.3	3.8	3.6	3.8	12.4	17.8	4.0	3.7	4.7	2.5	40.2	26.7	3.9	4.6	13.3	2.6	5.7	35.8	4.1	6.8	7.0	3.2	4.3	4.1	4.9	5.1	4.3	25.1	4.9	3.6	8.4	23.0	1.3	3.3	4.1	2.6	4.6	4.1	46.1	7.3	3.2	4.1	6.1	5.6	6.8	5.4	4.6	9.5	5.1	4.7	12.8	3.1	0.0	2.7	6.8	4.9	4.0	4.9	3.4	6.5	0.0	5.7	2.3	2.9	4.1	4.2	0.0	1.8	4.6	4.3	5.3	6.9	8.6	5.5	0.0	3.4	7.4	8.2	4.0	0.0	0.0	1.3	5.2	3.3	0.0	5.3	3.9	4.6	3.2	1.7	4.1	4.6	4.0	3.9	3.7	8.6	4.4	5.4	3.5	4.8	5.7	3.7	5.1	5.3	0.0	3.5	0.0	1.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	26.5	28.3	16.0	12.4	17.8	40.2	26.7	35.8	25.1	23.0	46.1	11.0	9.6	5.3	34.9	7.6	19.5	6.5	2.9	10.8	17.5	10.6	9.1	6.5	4.3	4.3	9.2	10.4	19.4	0.6	18.1	0.0	5.8	22.6	7.6	9.5	13.7	8.4	5.2	46.8	5.1	13.4	23.8	13.7	10.3	5.7	3.5	8.9	4.8	19.1	8.4	66.7	8.7	4.1	23.6	25.9	9.2	8.4	20.9	16.0	110.5	11.7	8.9	1.0	60.8	397.2	7.6	13.2	10.5	12.0	11.7	11.7	5.9	4.0	28.0	13.1	11.7	12.0	64.3	13.5	11.4	19.2	24.4	1.5	6.3	11.8	10.3
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787253-128810430	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 55.5;Oligodendrocytes: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No		9300	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	13.5	21.6	32.3	9.1	30.8	14.7	13.4	23.2	32.3	13.8	19.9	15.3	12.3	13.9	14.0	11.8	14.5	8.6	18.7	30.9	28.1	27.8	16.6	11.2	10.8	29.8	28.9	18.7	17.5	28.4	15.4	9.9	29.6	17.3	8.3	7.1	18.6	13.8	20.7	12.2	15.9	12.9	25.6	19.3	17.0	7.2	29.9	10.9	17.8	13.6	10.9	14.1	10.9	30.0	9.5	22.5	23.1	23.2	29.3	14.1	22.5	22.4	19.0	22.7	14.7	24.6	12.5	15.9	15.2	26.6	22.6	25.1	14.2	17.8	13.3	12.6	16.1	17.0	27.4	22.7	18.1	25.9	33.3	19.8	20.7	19.7	11.8	20.1	29.6	16.6	26.7	10.5	27.4	20.5	15.8	15.2	22.0	26.3	33.5	17.7	21.4	36.1	16.7	12.3	23.2	16.3	31.1	19.7	13.4	22.3	21.0	24.1	23.7	28.3	17.7	23.2	18.4	13.3	18.5	15.5	20.7	15.4	20.8	23.0	2.7	4.8	4.2	2.7	4.4	4.7	3.3	4.2	3.0	3.2	2.9	5.0	2.0	3.4	2.1	8.3	2.6	3.6	32.3	30.8	23.2	32.3	30.9	28.1	29.8	28.9	29.6	25.6	29.9	30.0	6.9	3.2	9.0	9.4	7.2	2.3	2.6	3.4	4.6	10.1	9.6	9.1	12.1	2.8	4.2	16.5	10.4	5.2	6.6	8.8	9.8	6.1	1.5	4.2	6.7	9.4	5.4	7.8	11.2	9.9	4.7	6.4	9.7	5.9	8.2	10.9	16.1	14.8	17.6	6.7	10.5	4.7	4.1	8.5	2.5	2.9	9.3	6.7	0.0	5.6	55.5	6.5	9.2	11.1	36.6	8.5	5.2	7.5	5.4	3.5	15.9	26.0	4.8	5.8	6.6	5.6	4.9	5.1	8.6	5.7	3.1	2.5	6.5	9.7	6.8	2.1
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	28.4	25.9	9.9	15.7	13.2	42.2	25.4	11.8	17.0	21.0	8.4	15.5	15.5	21.3	13.0	16.3	15.1	21.6	15.3	9.4	11.1	22.6	30.6	21.4	22.5	13.2	12.4	22.3	23.8	23.0	14.3	23.4	13.2	17.8	14.9	14.1	22.6	13.0	43.4	18.1	17.8	18.3	11.3	21.8	17.2	18.5	10.5	24.9	27.9	25.5	19.8	17.8	14.9	18.5	21.0	20.3	17.1	18.4	35.2	38.8	25.6	20.8	58.5	30.6	39.7	13.9	18.4	26.9	14.0	21.6	21.9	13.7	22.3	15.7	32.6	23.1	18.0	23.5	17.0	12.3	29.9	33.1	17.1	35.0	20.5	23.1	39.3	39.7	26.9	25.7	27.9	16.0	25.4	15.3	24.9	25.3	37.4	19.2	17.4	17.9	19.1	29.3	23.3	18.6	18.9	17.3	29.5	25.9	26.2	23.7	26.5	23.1	25.3	23.9	10.6	26.5	14.4	38.1	36.1	35.5	14.3	22.6	21.8	2.6	5.7	7.8	6.1	5.5	6.8	4.3	7.5	5.8	5.1	4.2	9.5	8.6	11.7	5.7	8.1	2.8	10.8	5.4	9.9	13.2	11.8	17.0	9.4	11.1	13.2	12.4	13.2	11.3	10.5	18.5	83.4	48.1	69.3	42.4	34.7	58.6	33.6	23.8	25.6	33.7	30.2	25.5	24.8	24.3	38.5	18.4	10.4	20.4	43.1	18.3	13.7	29.3	160.8	38.1	40.4	53.3	13.8	27.8	60.3	25.5	15.5	44.5	17.3	82.0	34.1	30.8	79.2	35.6	24.0	52.2	57.7	22.0	20.3	54.2	41.8	26.7	34.8	46.0	32.0	35.6	27.5	29.9	16.5	45.2	85.7	25.1	11.0	32.7	33.9	39.9	21.5	39.8	49.8	25.6	19.7	58.2	35.7	76.9	24.5	18.1	68.5	38.3	39.2	38.8	15.0	37.1
TBC1D16	"FLJ20748, MGC25062"	ENSG00000167291	"TBC1 domain family member 16"	Q8TBP0	17	79932343-80035872	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 307.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.3"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 179.1;SK-MEL-30: 192.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024482, HPA065839"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Intermediate filaments"		"HPA024482: AB_1857790, HPA065839: AB_2685566"	"unprognostic (4.53e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.99e-3)"	37.3	8.1	17.6	8.7	24.8	0.9	18.4	24.4	14.6	10.4	5.3	8.0	7.9	12.4	11.5	10.1	12.9	9.5	10.7	10.6	15.2	27.7	7.4	9.0	7.8	18.0	22.7	11.7	15.7	12.9	7.0	7.5	16.0	17.7	5.9	7.6	29.4	10.8	5.1	17.3	9.0	10.5	13.0	7.3	8.4	4.1	38.9	4.0	10.1	6.7	3.5	8.6	6.2	17.4	30.3	28.2	43.1	50.8	179.1	93.7	8.2	17.3	17.1	10.7	12.0	53.6	10.3	0.1	11.9	29.2	20.3	9.4	45.8	16.2	8.2	1.5	21.5	0.0	13.3	25.1	30.5	0.6	4.1	106.1	28.1	23.2	16.7	17.1	45.9	19.8	7.2	19.6	20.2	18.4	8.1	2.7	51.8	39.3	15.4	25.4	27.2	17.5	12.6	36.5	43.8	56.8	15.4	42.5	192.4	26.7	27.9	13.6	31.3	37.1	26.1	29.5	15.3	59.9	11.4	3.3	15.9	11.2	47.8	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.2	17.6	24.8	24.4	14.6	10.6	15.2	18.0	22.7	16.0	13.0	38.9	17.4	5.7	0.0	7.9	15.7	1.7	5.5	5.2	4.3	2.8	8.5	12.3	7.5	8.1	17.2	5.5	7.3	10.4	6.1	0.3	3.1	9.8	15.1	0.9	15.3	22.7	10.4	31.8	3.6	7.3	22.1	1.5	17.5	9.7	26.0	7.6	23.8	14.6	17.9	3.2	307.9	8.9	6.3	14.2	58.4	3.1	2.2	5.9	6.4	76.5	37.5	0.9	23.1	2.1	14.6	4.9	17.4	4.8	7.9	0.4	12.5	3.5	13.5	8.2	7.0	6.6	19.3	10.3	0.3	4.3	5.8	4.5	1.9	2.7	7.6	7.0	5.9
TBC1D17	FLJ12168	ENSG00000104946	"TBC1 domain family member 17"	Q9HA65	19	49877425-49888750	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068119	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA068119: AB_2685958"	"unprognostic (5.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.33e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.18e-4)"	"unprognostic (6.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.52e-2)"	29.8	26.4	31.7	9.6	34.9	6.5	26.6	32.8	41.1	22.7	17.6	32.2	14.1	30.2	12.5	17.7	24.3	10.6	35.9	31.2	28.5	20.4	28.3	15.8	10.3	38.8	32.6	30.6	27.6	18.1	21.1	13.2	34.6	20.6	5.8	13.2	28.0	17.7	124.2	38.2	19.0	12.3	29.3	15.4	27.8	10.3	32.4	12.3	20.6	39.4	7.1	30.9	20.1	41.2	12.4	25.3	7.9	11.5	36.0	24.5	18.2	14.2	48.0	15.5	25.0	13.8	18.0	7.3	13.8	26.6	26.5	13.7	7.0	19.3	8.4	22.3	18.3	8.7	20.6	15.3	30.4	4.5	12.8	29.0	19.7	14.7	11.5	27.9	14.6	11.5	9.9	41.9	13.7	14.3	5.9	9.4	13.4	13.5	20.4	8.9	11.1	20.1	21.3	22.9	14.5	16.0	18.6	20.0	12.3	10.2	18.5	6.9	17.8	34.2	11.5	12.8	7.3	26.4	37.0	5.3	35.6	5.1	13.2	13.8	3.9	8.5	7.9	3.9	7.1	8.1	7.2	8.3	3.7	10.9	7.1	6.0	5.1	10.8	3.7	4.9	4.4	6.0	31.7	34.9	32.8	41.1	31.2	28.5	38.8	32.6	34.6	29.3	32.4	41.2	18.1	12.8	12.2	19.2	14.9	14.5	16.3	27.1	17.6	32.0	22.4	23.2	7.8	25.8	15.9	20.2	39.6	49.5	15.3	21.3	25.4	16.1	2.8	16.9	12.3	14.4	48.7	12.2	6.9	18.9	17.6	17.7	23.4	23.7	4.5	12.7	21.8	27.7	13.6	48.8	8.9	28.7	28.5	13.1	26.5	5.0	27.4	12.9	14.2	5.6	22.0	23.9	15.5	11.6	16.0	12.2	19.1	31.2	16.2	15.1	31.7	22.5	7.5	52.6	13.1	18.1	17.7	10.5	13.1	10.8	12.9	66.4	17.2	16.1	16.2	10.5
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26756223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	3.4	5.8	5.2	2.5	4.5	1.6	4.3	5.3	5.1	7.4	10.7	4.4	1.8	7.6	7.0	2.9	7.7	7.5	5.7	4.2	6.2	17.3	2.9	4.3	2.2	7.1	6.2	8.8	3.0	14.6	5.0	3.8	7.0	5.2	3.0	9.2	3.2	6.3	3.1	2.2	1.7	8.7	4.8	2.8	3.1	4.9	5.7	17.4	7.8	5.0	2.6	4.8	3.0	6.0	2.4	1.9	8.5	5.3	11.5	18.5	2.4	11.1	8.2	4.9	4.8	4.1	5.8	5.6	9.5	15.0	15.2	1.0	4.8	5.6	4.7	1.7	2.2	1.4	6.6	1.2	6.3	3.2	1.4	9.3	4.5	9.4	5.7	19.7	6.7	7.2	5.3	0.0	77.1	0.1	6.3	3.5	3.9	3.2	9.2	4.7	8.4	0.6	18.9	2.5	8.4	3.2	5.3	1.2	5.5	6.9	2.1	1.2	6.5	6.2	1.7	4.7	2.8	1.2	3.1	2.6	22.1	1.7	6.4	1.1	0.5	1.8	4.2	0.6	5.1	1.6	3.2	4.7	0.9	2.0	2.4	2.9	0.0	4.5	0.6	1.7	1.7	1.3	5.2	4.5	5.3	5.1	4.2	6.2	7.1	6.2	7.0	4.8	5.7	6.0	6.0	3.2	4.1	66.9	8.2	3.6	5.3	7.6	7.4	7.4	5.7	5.3	6.4	1.5	2.5	20.2	14.6	4.0	18.1	1.0	5.9	4.8	11.1	15.7	18.9	6.8	9.5	2.1	106.6	3.1	2.2	9.3	6.1	9.0	8.9	9.3	7.1	1.9	1.6	5.0	95.3	2.1	10.2	2.4	2.7	3.1	9.0	2.4	10.6	42.2	0.8	7.4	13.4	102.5	72.4	2.6	0.4	9.1	5.5	1.9	0.6	19.2	17.4	19.3	0.0	9.5	11.1	25.6	8.9	3.1	4.5	1.9	14.4	13.1	1.6	2.3
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98199011-98255649	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.0;HaCaT: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	8.8	5.3	11.1	5.7	16.0	13.1	7.8	12.3	26.0	10.8	8.5	8.6	12.6	4.4	1.5	37.4	5.5	4.0	3.7	10.6	12.9	6.4	19.8	32.0	3.8	14.9	14.9	2.9	3.0	3.5	4.4	7.2	16.4	12.0	4.4	3.4	14.7	6.1	4.3	24.3	10.1	2.8	11.4	9.4	7.0	3.4	23.3	3.0	8.1	1.4	4.9	11.7	17.3	23.9	77.0	10.8	0.5	2.5	8.2	15.9	24.3	33.2	18.4	23.8	19.6	6.9	32.8	1.3	24.7	19.6	5.2	98.1	0.7	36.8	8.3	2.6	1.4	0.7	38.0	5.4	37.6	1.7	2.9	21.7	59.8	23.6	58.7	41.5	8.6	2.1	2.4	1.0	19.0	9.9	0.4	4.6	1.6	7.4	6.2	1.2	4.8	0.2	36.0	46.7	0.9	1.4	11.3	24.4	3.4	1.7	8.1	2.6	51.7	28.8	8.6	4.8	13.6	1.6	1.5	0.6	29.0	2.9	3.2	2.1	27.5	8.4	2.5	15.3	1.8	1.2	3.8	2.2	10.0	0.8	1.6	1.9	11.9	1.2	12.3	1.3	5.5	10.8	11.1	16.0	12.3	26.0	10.6	12.9	14.9	14.9	16.4	11.4	23.3	23.9	2.9	57.7	12.5	5.2	2.4	8.3	18.5	30.4	21.6	3.3	2.7	5.6	0.7	4.3	23.3	3.7	0.0	21.5	0.9	16.2	3.9	3.3	1.8	4.6	3.7	5.0	7.7	0.4	4.6	3.2	10.9	2.4	6.1	10.3	0.0	0.6	1.1	6.1	32.0	1.7	5.4	12.6	18.3	16.2	1.8	1.2	1.8	18.3	3.6	4.7	7.5	4.4	3.1	12.1	64.9	14.4	10.7	0.7	1.7	9.2	16.4	3.2	10.8	2.4	0.0	1.8	3.4	2.1	3.0	29.8	10.9	17.4	2.4	0.7	5.7	17.1
TBC1D20	"C20orf140, dJ852M4.2"	ENSG00000125875	"TBC1 domain family member 20"	Q96BZ9	20	423596-462566	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043613	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA043613: AB_10963930"	"unprognostic (2.16e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	16.8	21.5	21.7	7.6	24.2	7.0	16.0	22.6	22.4	18.4	17.0	19.1	8.6	17.4	15.6	18.9	16.1	11.8	16.6	20.4	21.6	14.4	13.4	18.1	10.6	23.1	23.6	17.3	14.7	21.2	17.8	17.5	22.2	17.7	11.8	7.7	16.9	18.8	20.4	20.0	14.5	20.4	22.3	16.1	15.4	9.9	23.0	14.6	15.0	23.6	12.9	19.6	16.8	23.4	18.5	12.6	18.2	15.9	75.9	39.3	16.3	19.8	39.1	27.7	29.4	11.8	9.6	8.4	4.6	43.7	35.2	18.1	18.8	20.2	26.8	4.9	4.9	13.4	4.0	27.3	45.7	13.1	7.1	35.2	38.3	15.4	14.4	29.9	17.7	14.4	14.8	17.7	30.7	4.5	12.1	15.5	10.6	23.7	11.0	12.0	17.2	10.4	18.7	12.0	15.8	12.8	22.2	39.9	53.5	20.0	14.1	27.9	19.9	25.0	8.9	22.2	14.3	9.7	19.0	7.7	13.4	14.0	15.9	3.0	0.6	0.7	1.8	0.5	1.2	0.8	1.2	2.1	0.6	0.7	1.1	1.8	1.5	0.9	0.4	0.6	0.8	0.7	21.7	24.2	22.6	22.4	20.4	21.6	23.1	23.6	22.2	22.3	23.0	23.4	23.0	12.8	13.6	16.3	22.6	18.5	13.6	11.3	23.3	29.3	22.4	14.4	16.8	24.3	11.1	14.7	12.5	16.5	28.9	29.6	11.7	23.8	48.9	21.3	26.9	20.7	16.1	48.6	16.2	30.3	25.1	23.0	17.9	16.2	11.4	14.4	25.4	19.7	19.7	26.9	19.2	17.9	8.2	17.6	16.4	147.2	29.5	18.6	14.2	14.0	13.2	21.4	43.3	11.6	15.2	22.5	20.7	35.3	30.0	21.2	19.4	17.0	17.1	19.4	19.7	22.1	18.3	33.1	34.7	15.3	18.9	50.9	24.0	19.6	15.7	27.9
TBC1D21	"MGC34741, MgcRabGAP"	ENSG00000167139	"TBC1 domain family member 21"	Q8IYX1	15	73873564-73889214	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	238	"testis: 49.7"	"Group enriched"	"Detected in some"	112	"Early spermatids: 401.0;Late spermatids: 1080.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043319	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA043319: AB_10966214"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1080.9	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 252.9;Oligodendrocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001173	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212"	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"	13.4	12.3	10.5	14.4	9.9	10.4	11.8	9.0	10.5	11.8	7.9	12.5	14.9	10.5	6.8	18.1	12.1	9.3	12.9	10.4	9.2	13.3	11.0	12.7	19.4	11.3	11.5	9.8	14.7	12.0	11.2	12.0	10.7	9.3	9.5	4.9	14.1	7.8	17.9	17.6	15.0	7.6	9.8	19.1	14.8	7.3	11.0	14.7	12.3	11.3	18.4	11.0	12.3	11.4	19.1	13.0	8.1	9.9	11.6	16.1	9.9	12.8	17.2	14.3	15.3	14.8	14.5	16.6	13.9	19.5	8.9	20.7	7.0	20.0	9.9	7.2	19.6	9.5	11.1	28.6	17.7	20.9	7.4	18.9	23.0	9.8	13.6	17.2	23.7	10.4	6.2	17.4	13.1	9.8	9.3	10.7	8.0	17.9	14.6	11.8	9.5	17.9	16.7	9.7	6.6	12.3	11.8	4.5	20.1	10.0	10.5	13.7	19.5	10.9	15.3	11.5	8.2	11.5	3.9	10.5	27.0	10.6	6.9	2.5	10.7	6.3	6.4	15.5	6.0	11.6	5.9	6.1	12.5	13.0	3.9	4.3	15.5	5.5	18.6	6.1	10.2	6.6	10.5	9.9	9.0	10.5	10.4	9.2	11.3	11.5	10.7	9.8	11.0	11.4	20.3	25.6	18.3	81.0	47.0	6.4	12.1	21.1	21.6	18.6	9.9	7.9	8.6	14.3	20.2	7.3	18.8	24.4	22.7	27.9	11.7	25.8	13.9	20.1	14.2	19.0	3.6	13.5	82.0	23.5	19.6	12.2	39.3	14.5	17.1	13.3	23.2	7.9	33.1	21.9	94.2	16.2	18.3	23.0	16.7	3.5	9.9	32.7	10.6	252.9	39.4	13.7	29.9	76.9	113.2	30.2	25.2	11.7	28.8	10.5	39.4	19.8	15.0	27.3	13.1	12.3	11.8	7.9	10.5	18.5	8.0	29.0	22.7	12.7	18.4	11.8
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	5.8	12.1	8.3	5.1	8.4	18.3	5.7	8.3	8.2	7.9	8.8	6.5	7.9	6.4	7.4	14.1	8.2	5.9	7.4	8.3	8.0	8.6	6.1	8.0	5.8	7.7	8.1	9.4	12.8	10.7	6.7	6.0	7.9	8.2	7.7	7.7	11.8	5.5	15.0	15.2	8.5	6.7	7.1	7.2	7.5	10.0	8.5	13.5	7.7	7.8	7.1	7.5	9.3	8.1	13.2	5.5	9.9	10.9	9.1	9.1	14.2	7.2	15.0	13.2	16.2	12.6	8.5	12.3	7.4	9.2	17.9	8.9	12.7	11.6	14.8	19.9	10.4	19.5	9.0	17.2	13.0	11.1	15.9	7.8	16.6	13.0	15.4	12.6	18.9	20.4	22.5	3.1	9.6	11.9	16.6	8.4	13.0	15.0	5.1	10.7	9.1	9.6	13.6	9.5	13.0	8.4	7.9	11.2	14.3	13.3	8.2	19.7	18.4	8.0	12.2	5.5	9.6	11.1	12.4	80.8	5.5	16.5	12.6	1.4	2.6	4.4	2.3	3.5	2.7	1.7	2.6	2.3	4.0	2.0	2.8	2.4	1.1	3.0	1.5	1.1	1.9	2.6	8.3	8.4	8.3	8.2	8.3	8.0	7.7	8.1	7.9	7.1	8.5	8.1	4.1	3.2	5.6	17.9	6.3	8.2	8.5	7.5	8.0	5.0	6.0	3.7	5.8	7.2	10.1	1.8	4.2	6.3	4.6	15.1	3.9	12.3	5.6	10.6	3.6	4.9	1.8	10.5	20.3	15.4	9.2	4.2	3.1	8.1	5.7	5.0	3.6	3.9	5.8	0.0	22.0	4.9	10.2	4.4	7.8	5.0	3.1	4.1	1.8	6.5	6.0	3.6	6.2	14.1	24.1	15.0	6.8	1.2	5.6	10.0	11.2	9.0	15.8	4.5	0.0	4.2	3.6	6.5	6.4	10.8	15.9	6.7	6.6	3.2	6.3	11.2
TBC1D23	FLJ11046	ENSG00000036054	"TBC1 domain family member 23"	Q9NUY8	3	100260992-100325251	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038151, HPA038152"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038151: AB_10672405, HPA038152: AB_10672620"	"unprognostic (9.23e-3)"	"unprognostic (6.01e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.87e-3)"	"unprognostic (6.16e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.32e-1)"	15.1	17.4	4.8	12.7	7.0	23.0	14.8	10.8	6.7	13.5	5.0	15.1	17.9	14.3	10.2	16.2	9.3	13.9	14.3	5.9	6.4	17.1	22.7	12.6	12.5	6.6	5.4	16.2	18.2	17.9	5.1	21.6	7.1	11.7	15.5	16.8	15.2	9.9	17.2	13.5	18.4	14.1	7.0	12.5	15.2	17.1	6.7	14.4	14.1	15.3	15.5	15.6	8.2	10.9	72.9	15.0	17.4	9.8	34.4	44.3	17.5	40.4	45.7	46.6	53.6	28.6	13.3	18.3	20.6	46.9	26.0	25.5	64.5	29.4	72.4	9.0	15.1	49.9	16.6	19.3	33.9	23.2	39.1	35.9	23.7	23.3	38.1	39.0	25.2	14.1	41.0	26.8	30.1	16.3	17.9	11.4	20.3	26.2	27.8	14.8	37.9	21.6	27.3	16.3	24.8	13.5	23.4	18.4	29.8	22.7	19.6	22.0	24.1	32.9	30.9	15.5	26.9	25.6	28.1	31.8	42.1	21.2	27.4	27.8	17.8	22.7	12.2	20.5	12.4	12.0	11.7	10.7	18.7	12.7	10.3	10.9	10.2	21.8	24.8	8.2	17.4	17.4	4.8	7.0	10.8	6.7	5.9	6.4	6.6	5.4	7.1	7.0	6.7	10.9	24.0	41.7	12.6	19.6	24.5	31.5	18.6	14.8	16.5	18.6	17.9	11.7	26.1	11.5	20.5	12.9	14.6	20.1	19.1	24.8	31.3	26.8	46.8	17.5	28.4	22.5	7.2	54.1	50.9	29.5	19.3	31.9	13.7	31.7	29.8	19.0	13.9	19.0	13.9	35.3	42.4	17.5	18.3	17.1	20.2	44.2	20.5	21.9	24.9	48.7	14.0	18.7	12.3	41.7	56.4	36.1	16.9	14.3	34.5	22.3	21.1	19.9	19.3	30.2	13.1	27.6	25.9	20.8	15.2	20.4	38.8	65.8	21.1	21.8	14.3	30.2
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 34.7"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	3.8	3.3	7.5	1.8	8.1	2.5	2.8	3.6	10.5	2.1	0.0	2.0	2.2	1.4	2.8	1.0	2.3	1.9	3.0	8.3	3.7	4.3	3.7	3.9	1.8	2.9	2.9	1.0	10.6	1.9	2.6	2.1	3.1	2.5	0.9	4.2	16.5	3.5	3.4	1.2	1.6	1.7	1.9	2.0	2.2	1.2	4.4	0.9	3.1	1.7	1.2	1.8	0.9	2.8	3.4	6.7	4.5	9.2	5.1	5.1	3.8	6.2	3.3	4.0	3.5	6.2	2.9	8.6	5.2	4.9	1.9	6.3	7.1	2.0	2.9	9.3	8.0	8.0	9.5	5.5	3.1	5.9	3.2	1.9	2.8	3.5	1.4	2.8	5.1	3.3	9.9	4.8	3.8	6.4	4.1	11.9	4.0	3.2	4.3	20.9	8.5	6.1	2.9	2.3	34.7	8.5	3.8	15.3	2.6	1.6	4.8	5.2	5.4	7.8	8.4	7.9	6.2	3.2	3.0	11.0	3.4	8.5	7.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	7.5	8.1	3.6	10.5	8.3	3.7	2.9	2.9	3.1	1.9	4.4	2.8	4.7	28.9	26.7	15.7	1.9	0.5	3.0	1.4	1.8	19.0	17.8	10.8	6.9	10.0	6.9	5.5	43.8	1.5	5.6	2.4	33.2	5.0	0.2	2.8	10.0	5.4	11.4	6.5	29.6	6.1	1.0	5.8	5.6	4.0	3.8	6.0	10.4	17.3	3.5	26.9	34.0	2.6	6.1	5.1	3.3	1.0	9.0	3.0	1.8	6.5	3.6	13.8	6.2	25.1	9.7	5.0	2.8	6.0	1.7	3.1	1.8	3.9	3.6	25.5	0.0	11.2	3.7	8.8	5.9	1.4	1.4	0.3	2.9	3.4	4.7	1.6
TBC1D25	OATL1	ENSG00000068354	"TBC1 domain family member 25"	Q3MII6	X	48539714-48562609	"Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029197	Approved	Approved				NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA029197: AB_2672945"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"	7.6	8.3	8.0	4.9	8.8	8.9	7.2	9.4	8.6	7.2	4.6	7.9	4.2	7.2	3.2	7.4	6.9	4.8	10.8	8.1	7.5	5.6	6.8	7.2	6.3	7.1	6.9	7.3	8.4	7.8	7.7	4.5	7.5	6.8	4.2	5.8	5.9	5.3	9.3	9.9	6.3	6.3	5.6	9.1	6.4	8.2	7.6	6.9	6.6	7.4	5.0	7.1	7.1	7.5	7.6	7.5	2.8	8.6	10.4	10.0	3.9	5.1	9.6	9.0	9.4	4.9	6.8	7.8	3.7	13.0	12.3	6.9	12.8	13.7	8.1	14.6	8.4	4.0	11.7	4.5	11.5	5.2	10.1	10.7	13.7	12.3	14.9	11.3	9.8	8.3	3.1	11.7	11.0	6.6	9.6	9.7	4.3	3.6	13.5	4.9	4.9	10.5	8.3	3.8	7.9	5.4	7.8	7.0	6.8	12.6	7.7	1.7	9.2	5.9	8.7	18.1	5.9	11.5	6.0	5.7	9.8	6.5	5.7	1.6	2.0	5.4	6.6	2.6	5.1	4.3	4.5	5.6	2.2	4.8	4.7	4.9	4.3	4.5	2.1	2.5	4.2	4.5	8.0	8.8	9.4	8.6	8.1	7.5	7.1	6.9	7.5	5.6	7.6	7.5	5.7	19.2	9.3	6.5	11.2	17.3	9.4	11.1	10.8	9.5	5.7	5.2	7.4	5.7	5.9	1.8	14.6	7.1	13.0	7.5	11.7	6.8	16.2	5.7	4.9	6.1	15.6	4.0	8.1	14.0	7.5	6.2	3.6	8.2	5.7	4.6	8.6	4.5	5.5	13.5	9.0	3.4	10.2	4.4	9.3	36.9	5.6	6.5	7.2	3.7	4.5	4.9	22.6	5.5	8.0	11.6	3.2	4.9	8.6	8.2	4.0	4.9	5.0	7.0	26.3	4.7	6.1	9.5	11.8	8.4	14.9	14.6	13.6	6.0	3.9	8.6
TBC1D26	MGC51025	ENSG00000214946	"TBC1 domain family member 26"	Q86UD7	17	15732247-15749192	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.5"	"Group enriched"	"Detected in some"	79	"Early spermatids: 171.9;Late spermatids: 145.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.4"									HPA050460	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA050460: AB_2681136"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-1)"		"unprognostic (7.90e-2)"	"unprognostic (3.22e-1)"			"unprognostic (1.16e-1)"		"unprognostic (3.20e-1)"			"unprognostic (5.15e-9)"	"unprognostic (9.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.16e-2)"	0.0	0.0	2.3	0.0	2.4	0.0	0.1	1.7	2.9	0.4	1.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	1.8	0.1	0.0	0.1	0.0	1.9	1.8	0.3	0.0	0.0	0.2	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.7	0.0	0.0	17.5	1.8	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.7	2.9	2.5	1.8	1.9	1.8	1.9	1.7	1.8	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	145.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D2B	KIAA1055	ENSG00000167202	"TBC1 domain family member 2B"	Q9UPU7	15	77984036-78077724	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7;Theca cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041833, HPA048174, HPA052663"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906"	"unprognostic (3.13e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.19e-2)"	23.1	15.4	4.8	20.4	5.1	22.5	17.3	4.6	5.0	25.1	9.3	15.8	12.9	23.3	11.7	11.4	20.8	28.2	10.2	4.1	6.6	7.7	16.3	33.9	23.1	9.7	5.5	46.1	18.3	17.1	5.9	25.0	6.0	11.5	17.4	4.5	8.7	14.3	5.1	13.4	16.0	21.2	6.3	25.5	12.9	12.6	6.7	23.8	12.1	10.8	19.3	19.1	14.9	6.6	12.0	9.4	11.1	10.5	76.2	60.4	19.3	27.1	40.7	24.9	27.3	12.0	4.8	18.5	10.6	23.0	13.8	17.1	24.4	29.9	18.9	35.2	18.8	11.8	9.1	8.2	36.1	30.1	17.3	59.2	20.4	16.5	11.0	36.8	28.6	23.5	6.2	12.5	32.5	13.2	11.2	19.7	8.8	9.3	9.0	16.8	50.9	4.1	12.7	45.1	5.9	16.0	25.3	17.0	31.9	10.2	5.6	31.1	35.5	27.1	17.8	8.6	14.5	20.9	23.8	9.7	9.3	39.8	14.6	0.0	0.8	0.3	1.4	0.6	0.8	0.0	0.9	1.6	0.5	0.1	0.7	0.6	1.4	1.4	0.2	1.2	0.5	0.6	4.8	5.1	4.6	5.0	4.1	6.6	9.7	5.5	6.0	6.3	6.7	6.6	13.9	3.2	17.3	26.4	6.4	9.3	7.3	13.9	1.8	10.7	5.3	4.3	3.3	14.3	9.7	5.5	6.2	20.6	24.0	12.8	0.0	8.8	10.0	7.1	33.7	16.1	7.3	4.4	23.3	10.0	6.9	28.0	17.3	6.3	9.5	6.3	21.4	90.7	19.0	15.2	20.3	19.7	10.2	31.9	29.3	10.3	42.6	21.5	14.2	45.9	23.7	6.2	6.2	12.5	10.4	15.3	13.4	42.2	9.5	6.3	15.3	4.3	10.9	8.9	26.3	19.4	18.2	6.0	7.1	4.5	9.9	28.5	26.0	79.0	15.7	8.1
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"		"GTPase activation"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;REH: 5.0;U-138 MG: 6.6;U-266/70: 10.3;U-266/84: 4.3;U-698: 5.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.9	1.9	0.8	0.0	0.9	0.2	0.7	0.8	5.2	1.7	0.8	1.1	0.0	2.3	0.0	2.3	0.7	1.0	0.8	0.9	0.6	1.6	2.0	1.1	1.3	0.9	0.8	1.5	1.2	1.0	2.1	0.0	0.9	2.0	1.4	2.9	1.4	0.1	0.9	2.3	4.1	0.0	0.6	1.5	1.1	3.7	0.8	0.0	1.3	0.0	2.1	1.7	1.8	0.7	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	10.3	4.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.8	5.2	0.9	0.6	0.9	0.8	0.9	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64759484-64881033	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1;pancreas: 12.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.9;Inhibitory neurons: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.9;OE19: 11.9;RPMI-8226: 12.6;RT4: 12.8;SCLC-21H: 26.5;SK-BR-3: 16.7;T-47d: 14.5"									"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.5	1.1	2.0	1.0	2.7	0.3	2.3	4.9	10.1	3.0	1.4	1.4	1.8	1.4	1.8	0.6	1.5	1.8	0.6	5.3	1.7	2.2	1.2	2.3	0.4	6.8	1.8	0.9	12.0	2.4	6.4	0.6	6.9	3.0	1.5	2.2	6.8	2.7	0.3	0.8	1.6	0.9	2.0	1.9	3.9	1.9	2.0	0.3	1.5	0.3	0.3	3.3	1.3	3.8	5.1	1.0	0.5	0.3	0.1	0.6	0.7	0.0	0.0	0.1	0.0	4.3	1.8	0.1	0.9	0.1	0.3	0.1	5.3	0.2	0.0	0.0	3.8	0.3	1.4	0.1	0.0	4.0	0.8	0.3	0.1	0.0	0.0	0.6	3.8	1.2	0.0	2.0	0.3	25.9	0.0	0.6	1.1	11.9	5.2	0.2	0.1	12.6	0.9	12.8	26.5	1.8	1.4	16.7	0.3	0.3	14.5	1.4	4.2	0.0	0.9	0.9	2.5	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	2.7	4.9	10.1	5.3	1.7	6.8	1.8	6.9	2.0	2.0	3.8	5.1	0.0	6.3	4.9	0.6	0.9	4.6	0.9	0.0	9.3	7.2	3.8	0.6	5.7	4.5	3.7	8.4	0.7	1.5	2.5	9.8	3.9	14.2	2.2	0.8	6.5	0.0	0.0	30.9	4.9	0.3	0.7	3.6	4.2	8.9	0.8	1.8	0.3	1.6	0.0	42.8	6.4	6.1	4.0	6.2	1.9	0.3	3.0	5.4	12.2	1.2	2.6	0.0	1.5	2.0	2.7	4.9	0.0	0.6	9.1	3.9	2.3	1.8	0.6	0.0	0.6	1.0	3.7	3.0	0.3	1.4	0.1	0.8	0.4	4.4	8.7
TBC1D31	"Gm85, MGC21654, WDR67"	ENSG00000156787	"TBC1 domain family member 31"	Q96DN5	8	123041968-123152153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.9;Excitatory neurons: 23.4;Inhibitory neurons: 32.0;NK-cells: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023710	Approved		Approved	Centrosome		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA023710: AB_1858819"	"unprognostic (1.39e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.21e-2)"	"unprognostic (3.18e-5)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.33e-1)"	3.9	2.5	5.8	6.0	7.8	7.4	2.0	20.6	6.6	1.7	5.2	4.2	5.4	2.4	1.4	2.5	4.2	2.2	2.7	7.3	4.1	2.8	3.1	2.5	7.2	4.3	5.5	1.7	3.8	2.9	3.5	1.9	5.1	2.3	3.5	4.9	2.4	1.7	4.4	2.9	4.8	2.7	4.4	5.8	3.4	5.1	6.0	14.4	3.1	2.5	6.1	2.2	1.7	7.3	30.6	19.5	15.4	12.9	5.1	5.5	10.9	17.5	6.4	14.0	12.7	17.9	11.4	11.2	21.5	4.7	9.5	21.1	14.3	7.2	19.7	31.3	31.6	28.8	13.5	8.3	7.7	11.9	20.3	4.4	4.2	11.6	11.9	4.1	10.2	31.0	24.0	23.1	10.2	50.5	37.2	8.1	12.8	26.5	29.8	21.2	14.5	16.8	9.4	11.1	16.8	14.7	31.5	83.2	9.7	9.8	15.8	9.2	8.8	12.8	31.9	11.9	22.1	34.5	58.1	15.1	13.2	20.1	19.0	9.1	10.0	10.6	17.4	12.6	26.6	9.2	10.6	14.3	8.8	8.4	10.8	12.3	5.8	20.5	11.2	7.9	11.6	15.6	5.8	7.8	20.6	6.6	7.3	4.1	4.3	5.5	5.1	4.4	6.0	7.3	2.7	0.0	3.4	19.9	3.7	0.5	1.0	2.4	1.2	2.7	1.0	1.3	14.0	0.0	1.4	1.8	6.2	1.6	10.4	2.4	0.0	1.8	4.9	3.4	3.2	2.4	3.0	12.8	23.4	1.1	2.6	2.6	2.6	1.2	7.6	4.2	1.1	1.8	3.9	0.0	32.0	2.0	0.0	6.6	1.9	2.9	1.5	3.8	1.8	14.0	4.6	1.3	24.7	11.1	13.4	1.0	0.6	1.5	5.8	0.7	1.2	2.2	3.7	5.9	0.0	2.4	2.3	10.9	2.7	4.1	1.3	0.1	12.5	2.5	3.5	0.6
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 7.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.2;Excitatory neurons: 124.1;Inhibitory neurons: 87.4;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 102.6;Rod photoreceptor cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	1.2	2.4	0.8	0.9	1.5	0.8	1.7	0.6	1.4	1.8	0.9	1.1	1.8	1.7	0.8	1.0	1.6	1.9	0.7	0.8	1.6	1.4	0.4	0.9	1.0	1.1	1.4	1.8	1.3	2.3	1.5	2.9	1.2	1.6	0.7	7.4	0.8	0.9	0.2	1.2	1.4	0.8	0.6	1.0	1.3	3.6	1.8	1.6	2.4	0.5	1.1	1.0	0.9	2.5	1.7	2.0	3.4	4.4	2.8	4.5	1.8	1.9	2.9	3.2	4.6	0.1	1.3	3.4	3.2	2.0	4.7	1.5	1.6	1.6	4.0	22.7	2.2	3.9	0.7	0.7	1.2	2.1	1.5	1.7	1.2	2.8	2.1	3.8	0.7	3.9	2.2	0.0	2.5	1.0	2.3	1.3	1.9	1.1	0.7	2.1	1.6	0.3	1.6	0.8	6.5	3.5	2.2	1.4	1.0	1.8	2.1	1.6	0.4	2.1	2.1	0.6	2.2	1.6	0.0	1.3	3.0	1.1	3.3	6.1	0.9	1.3	1.8	0.5	1.3	2.5	1.4	1.3	0.7	4.5	2.6	2.0	0.8	2.6	0.9	8.2	1.6	0.3	0.8	1.5	0.6	1.4	0.8	1.6	1.1	1.4	1.2	0.6	1.8	2.5	3.9	3.2	8.4	68.2	6.4	6.1	3.7	3.1	9.6	26.2	6.1	5.0	3.1	4.3	10.1	7.3	43.8	4.4	8.7	3.4	0.0	2.4	9.8	8.8	9.5	3.5	5.4	1.7	124.1	2.2	1.7	6.2	10.2	4.7	3.8	26.7	2.9	1.1	1.4	13.5	87.4	6.0	4.1	1.6	2.9	3.5	2.5	2.8	1.8	36.5	1.5	6.7	3.1	105.6	102.6	1.0	3.9	1.9	1.8	2.3	8.0	1.5	20.3	110.4	0.0	6.6	5.3	21.5	7.9	3.4	5.1	2.3	4.9	4.8	4.8	2.3
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.8"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.6;HeLa: 8.7;T-47d: 5.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	2.4	4.0	3.6	1.3	2.9	0.9	2.5	4.2	4.0	3.7	1.9	3.6	1.4	2.2	0.2	5.8	3.2	0.6	2.1	4.8	3.0	3.6	4.2	3.1	1.0	4.6	2.2	4.0	3.6	0.4	5.0	0.5	5.8	5.0	0.5	2.4	4.3	1.0	3.7	6.0	4.3	0.5	1.0	4.9	3.1	13.8	3.9	0.8	3.2	0.3	0.6	4.2	5.0	1.3	1.1	1.8	1.1	1.3	1.1	1.3	3.6	0.9	0.5	1.0	1.5	0.4	8.6	0.2	0.7	0.5	0.4	3.8	0.5	0.8	0.3	1.5	2.8	0.6	8.7	0.5	0.6	0.2	1.0	1.1	1.7	1.1	0.2	2.4	0.7	0.9	0.5	0.8	0.3	0.1	0.8	3.4	0.4	0.3	0.4	1.1	0.3	0.1	1.1	1.1	0.7	0.9	0.8	0.5	0.6	1.4	5.9	0.8	2.0	0.4	0.3	2.9	0.4	1.2	1.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	2.9	4.2	4.0	4.8	3.0	4.6	2.2	5.8	1.0	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Cell type enriched"	"Detected in single"	9	"Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CAPAN-2: 34.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		1.1	1.5	1.5	0.4	1.7	1.8	1.2	1.9	2.7	1.1	1.7	1.3	0.5	2.1	0.0	2.2	2.3	0.7	0.9	1.6	1.6	4.0	2.1	1.3	0.7	2.0	1.4	1.8	1.6	0.0	1.9	0.2	2.0	2.5	0.0	1.5	1.7	0.1	1.3	2.2	2.1	0.2	0.8	2.3	1.3	7.0	1.5	1.5	1.2	0.0	0.6	1.6	2.1	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	7.7	0.1	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.3	0.0	1.2	0.0	0.0	3.3	6.9	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.9	2.7	1.6	1.6	2.0	1.4	2.0	0.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.8;Cholangiocytes: 2.8;Cone photoreceptor cells: 6.2;Pancreatic endocrine cells: 4.1;Rod photoreceptor cells: 1.9;Syncytiotrophoblasts: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.7;HaCaT: 7.0;HeLa: 9.6;RPMI-8226: 4.2;RT4: 4.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		1.7	3.2	0.6	0.0	0.6	0.0	1.7	1.1	3.7	2.5	0.6	2.4	1.4	1.6	0.1	4.1	2.0	0.2	1.5	0.7	0.4	2.5	3.4	2.2	0.3	0.8	0.4	3.0	2.7	0.4	3.2	0.7	0.7	4.1	0.7	2.3	3.2	0.0	2.0	3.9	4.7	0.1	0.5	4.2	2.4	7.3	0.5	0.0	2.1	0.0	0.5	3.5	3.4	0.7	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	0.0	1.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	4.2	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.4	0.9	0.0	2.9	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.1	3.7	0.7	0.4	0.8	0.4	0.7	0.5	0.5	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.8	2.8	1.3	0.0	6.2	0.8	0.1	0.0	0.0	1.0	0.6	0.5	0.1	0.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.8	0.0	0.0	0.7	0.6	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HHSteC: 4.1;HL-60: 1.0"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.4	0.8	0.0	0.0	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	1.1	0.3	1.2	0.4	0.0	0.0	2.8	0.9	0.6	0.7	0.2	0.0	0.6	1.7	0.0	0.7	0.0	0.3	1.3	0.0	0.3	0.5	0.0	0.4	1.0	0.8	0.0	0.0	1.1	0.5	3.3	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3G		ENSG00000260287	"TBC1 domain family member 3G"	Q6DHY5	17	36323884-36334759	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 1.3"									"HPA046969, HPA047745, HPA052553"	Supported		Approved	Vesicles		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"					"unprognostic (4.41e-1)"					"unprognostic (1.17e-2)"				"unprognostic (5.01e-2)"				0.4	0.8	0.2	0.0	0.2	0.0	0.5	0.2	0.9	0.8	0.2	0.5	0.1	0.9	0.0	1.2	1.5	0.0	0.5	0.2	0.2	2.8	1.2	0.6	0.0	0.2	0.2	0.9	0.6	0.0	0.9	0.0	0.2	1.4	0.0	0.0	0.6	0.0	0.5	1.0	0.6	0.0	0.2	1.5	0.4	26.1	0.2	0.0	0.4	0.0	0.0	1.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3H		ENSG00000274226	"TBC1 domain family member 3H"	P0C7X1	17	36377531-36388423	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"CAPAN-2: 5.9"									"HPA046969, HPA047745, HPA052553"	Approved		Approved	Vesicles		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.3	1.3	0.0	1.3	0.1	0.1	1.3	1.5	0.6	1.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.2	1.3	1.3	1.1	0.5	0.3	0.0	1.3	1.3	0.2	0.0	0.0	0.5	0.0	1.4	0.6	0.0	0.1	0.2	0.0	0.1	0.4	0.3	0.0	1.3	0.6	0.1	4.7	1.3	0.0	0.2	0.0	0.0	0.5	0.5	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	1.3	1.5	1.3	1.3	1.3	1.3	1.4	1.3	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3I		ENSG00000274933	"TBC1 domain family member 3I"	A0A087WXS9	17	36253456-36264553	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.0"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 38.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"CAPAN-2: 5.3"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.1	0.8	0.0	1.0	0.0	0.1	1.1	1.5	0.3	0.7	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.2	1.0	1.0	0.2	0.3	0.1	0.1	1.0	0.8	0.2	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.6	0.3	0.1	7.0	0.9	0.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.1	1.5	1.0	1.0	1.0	0.8	1.0	0.6	0.9	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"T-47d: 1.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.3	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Gastric mucus-secreting cells: 5.1;Glandular and luminal cells: 2.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.1;hTERT-RPE1: 42.8;NB-4: 38.0"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	12.9	26.7	9.5	9.7	8.8	5.7	12.3	12.6	25.1	23.0	10.8	18.2	10.9	9.8	11.4	33.8	19.1	6.1	12.6	9.3	7.6	22.9	29.8	17.8	10.1	8.8	7.5	17.4	17.6	3.5	29.0	4.7	9.2	31.0	6.6	46.9	19.8	7.2	17.5	36.3	20.3	4.4	6.4	30.3	17.0	26.1	8.5	9.8	16.4	7.6	4.8	20.6	28.0	11.8	12.8	16.7	6.6	10.0	12.3	11.1	39.1	5.7	3.8	5.1	5.9	9.3	0.2	4.3	0.2	7.3	4.5	20.5	6.1	5.4	3.4	12.6	15.5	0.0	31.9	4.0	8.6	1.7	15.4	9.4	13.0	6.6	3.7	42.8	7.0	8.0	3.4	14.6	8.4	6.8	7.6	38.0	6.3	9.6	3.7	5.0	7.7	0.0	16.1	17.2	9.0	12.5	0.0	6.6	7.7	15.3	9.6	2.7	15.7	0.0	8.6	6.7	8.0	10.2	4.8	0.0	10.2	5.3	5.8	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	1.0	0.2	0.2	0.0	0.1	0.1	9.5	8.8	12.6	25.1	9.3	7.6	8.8	7.5	9.2	6.4	8.5	11.8	0.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.6	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.3	0.2	0.0	0.4	5.0	1.1	0.9	0.2	0.0	0.0	1.1	0.0	0.1	0.3	5.1	2.2	0.0	0.9	0.0	0.3	0.1	0.0	1.0	0.3	0.0	0.3	0.0	0.6	0.3	0.4	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.5	1.3	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.7	0.0	0.3	0.6	0.4	0.5	0.0
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75283503-75482169	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 157.7;Microglial cells: 307.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 25.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 84.7;HUVEC TERT2: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	14.8	70.6	13.2	15.7	12.5	3.4	20.1	12.5	15.1	10.0	7.1	8.7	4.6	8.5	18.4	9.4	10.7	14.1	33.8	10.5	13.8	25.2	11.7	11.9	34.2	15.9	12.0	44.8	15.0	22.1	5.3	20.7	16.7	12.3	10.4	1.6	27.6	4.3	82.8	21.4	10.3	10.2	12.0	21.0	11.0	5.3	20.0	10.7	24.3	54.9	32.6	8.4	9.2	10.5	12.9	14.9	9.2	0.6	21.3	22.8	12.0	11.0	5.8	8.7	9.6	84.7	15.5	2.7	2.4	15.7	4.2	12.0	23.4	11.0	9.0	42.6	24.3	41.5	19.8	25.9	5.4	20.0	0.5	25.0	19.7	9.7	22.4	14.9	61.6	46.0	12.0	1.3	10.0	6.2	29.4	3.6	12.9	24.7	8.8	26.4	8.7	15.2	8.5	9.3	16.9	5.2	4.8	14.6	8.0	4.8	5.0	0.7	26.2	9.8	12.1	5.2	13.0	0.7	0.1	0.3	17.4	18.5	14.7	5.0	0.4	0.0	0.7	0.1	0.0	0.6	11.2	2.5	0.6	0.5	10.4	4.9	0.5	0.5	0.1	9.9	25.0	2.3	13.2	12.5	12.5	15.1	10.5	13.8	15.9	12.0	16.7	12.0	20.0	10.5	17.8	6.4	29.1	32.3	2.6	36.2	10.0	2.0	19.9	1.6	33.1	41.1	81.4	10.0	6.1	14.7	0.0	10.8	32.4	8.0	15.6	12.3	25.5	14.3	17.7	32.6	21.0	5.0	78.0	7.4	9.7	17.3	7.1	8.7	5.1	81.5	26.0	19.4	26.6	1.7	157.7	10.7	24.4	24.8	25.8	5.2	3.7	12.9	21.4	307.3	33.6	0.4	1.0	40.7	5.1	4.9	2.9	7.2	2.1	16.4	3.4	10.8	3.9	0.6	6.6	24.8	21.6	2.4	7.7	24.2	44.2	4.9	25.2	8.1	15.5	10.6
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TBC1D7	"dJ257A7.3, FLJ32666"	ENSG00000145979	"TBC1 domain family member 7"	Q9P0N9	6	13266542-13328583	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"melanoma: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 320.4;U-266/84: 174.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034748	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"			"HPA034748: AB_10671232"	"unprognostic (9.53e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-3)"	"unprognostic (5.54e-2)"	"unprognostic (9.30e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.78e-2)"	9.4	12.0	14.3	9.7	15.9	26.5	11.5	13.0	26.3	10.8	9.9	15.2	14.5	8.4	20.0	17.1	6.6	10.3	31.7	14.3	12.9	21.4	17.5	11.0	13.9	11.8	11.6	7.7	10.2	12.4	10.7	14.4	13.4	12.4	16.5	11.5	12.2	7.0	16.2	13.8	10.8	10.1	10.7	12.3	9.8	14.0	12.7	16.9	8.0	14.5	15.6	10.0	11.4	15.8	26.2	25.5	36.0	36.8	27.5	15.7	24.9	11.5	13.3	24.0	26.8	51.8	23.0	18.1	75.0	19.3	55.8	20.8	24.5	29.0	21.9	28.4	29.1	50.3	16.5	45.8	63.6	32.7	73.6	21.4	40.6	29.7	19.3	24.0	40.5	57.2	57.3	23.7	30.8	42.8	42.2	78.5	24.4	32.4	24.6	61.7	15.7	77.7	54.1	35.1	69.4	30.8	28.4	55.4	320.4	71.3	53.6	19.1	29.4	24.6	30.8	13.6	16.2	55.8	174.2	86.2	23.1	34.1	51.1	28.2	21.6	27.0	11.6	20.0	7.6	15.4	9.9	10.5	43.3	14.5	9.1	11.1	42.2	21.4	13.7	42.2	14.6	10.4	14.3	15.9	13.0	26.3	14.3	12.9	11.8	11.6	13.4	10.7	12.7	15.8	11.0	12.8	13.9	3.9	16.2	7.5	9.9	37.2	11.4	6.5	15.7	20.6	30.6	15.7	28.8	16.5	4.2	41.0	15.0	12.9	33.2	16.4	8.1	15.2	12.7	12.4	9.0	57.4	8.4	14.3	23.3	9.9	15.8	15.7	9.5	14.4	12.1	15.2	24.2	10.1	9.5	18.3	50.8	12.9	23.0	5.8	4.4	31.3	10.6	4.7	13.9	8.9	13.4	6.6	7.3	22.2	18.3	5.3	21.9	11.6	13.1	56.1	16.4	8.0	13.1	5.6	20.2	14.7	34.3	21.7	8.9	46.9	11.3	14.4	16.4	13.4
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007228-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 30.1;non-classical monocyte: 38.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 38.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.9;ASC TERT1: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	17.3	6.3	4.7	8.9	4.4	12.7	21.8	8.7	5.0	14.4	8.3	9.0	7.1	10.6	7.8	15.4	19.9	18.1	38.6	5.1	6.3	17.0	24.8	23.2	7.2	6.8	5.3	8.4	34.3	17.5	13.0	3.1	6.7	44.0	6.0	6.5	19.0	30.3	83.7	28.1	28.7	6.9	4.3	14.5	27.2	18.1	5.9	6.4	9.6	79.7	6.8	13.1	17.5	4.1	5.1	30.1	2.6	8.6	82.9	57.8	24.4	3.1	51.8	2.1	2.6	10.8	8.0	2.6	27.1	2.3	42.5	15.5	5.0	23.5	1.4	1.5	4.6	1.5	11.1	37.7	5.7	0.3	26.0	27.4	21.8	2.8	21.6	1.7	30.2	4.5	0.7	2.6	2.7	13.3	2.8	15.8	6.7	3.6	32.3	6.4	7.5	0.6	17.0	32.3	18.7	9.2	4.2	7.4	10.8	4.0	2.1	23.1	26.0	1.3	4.5	4.4	2.1	5.0	0.4	0.2	10.9	7.7	8.0	0.0	9.7	0.4	0.2	30.1	0.3	0.4	0.3	0.2	5.0	1.5	0.6	0.4	0.3	0.0	38.2	7.2	0.2	4.1	4.7	4.4	8.7	5.0	5.1	6.3	6.8	5.3	6.7	4.3	5.9	4.1	4.3	3.2	4.6	10.7	2.8	4.1	38.3	7.2	23.9	6.4	15.0	3.9	12.2	18.6	14.4	5.5	4.2	4.6	4.8	1.1	0.0	8.2	6.0	42.6	4.7	9.8	3.0	0.8	43.5	3.0	2.8	4.3	31.6	23.7	7.0	0.9	11.7	5.6	3.7	1.7	42.8	2.2	10.2	13.8	17.7	10.9	3.1	27.7	5.4	22.5	28.1	1.0	0.0	23.6	6.5	2.6	2.4	1.9	1.4	35.0	4.8	1.2	31.9	3.7	6.6	24.7	4.3	3.6	4.0	29.8	6.3	3.4	1.6	2.7	1.1	29.7
TBC1D8B	"FLJ20298, GRAMD8B, RP11-321G1.1"	ENSG00000133138	"TBC1 domain family member 8B"	Q0IIM8	X	106802673-106876150	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 230.8;Alveolar cells type 2: 234.5;Club cells: 92.9;granulocytes: 113.0;Respiratory ciliated cells: 108.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023883, HPA027527"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA023883: AB_1857794, HPA027527: AB_2199395"	"unprognostic (6.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.15e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.16e-2)"	4.5	19.6	5.8	4.2	11.5	5.2	4.6	15.3	19.6	6.9	15.0	6.3	7.8	5.4	10.0	3.0	3.9	7.0	3.4	8.0	5.1	8.4	12.0	4.5	2.7	2.0	1.5	6.4	9.0	8.6	6.4	4.5	3.6	6.8	7.3	9.6	7.7	6.4	3.1	4.1	9.5	5.1	0.5	3.2	11.0	8.5	5.9	1.6	8.8	1.6	2.0	4.5	2.5	24.4	14.7	4.6	1.8	7.1	21.9	30.9	7.9	16.3	16.9	2.8	8.5	8.1	12.6	5.1	12.9	16.6	11.6	7.6	5.9	8.2	7.2	2.5	6.5	7.1	6.4	7.7	5.7	1.8	2.6	13.7	6.5	6.0	2.9	17.2	7.9	4.1	2.4	8.3	10.0	7.4	4.6	2.7	9.2	21.6	7.3	2.0	3.9	2.1	7.9	10.7	3.3	2.7	13.4	9.7	6.0	9.1	11.0	2.2	10.0	10.4	11.2	13.9	6.0	7.6	8.4	1.3	20.2	1.5	13.1	2.1	0.8	0.4	0.7	0.4	0.5	0.7	0.6	0.5	0.2	1.4	0.4	0.5	1.9	0.5	0.4	1.0	0.2	0.1	5.8	11.5	15.3	19.6	8.0	5.1	2.0	1.5	3.6	0.5	5.9	24.4	7.0	230.8	234.5	1.0	2.2	2.4	7.8	8.4	7.4	4.1	6.9	3.3	2.6	4.3	92.9	7.3	4.2	2.8	0.6	9.5	7.9	8.8	0.9	4.9	12.5	19.2	4.8	1.3	8.3	9.3	3.0	25.2	21.9	6.8	113.0	4.8	3.3	13.5	1.7	0.0	7.5	15.1	6.1	2.2	0.4	2.2	9.0	12.7	3.6	14.0	1.0	1.8	1.0	13.6	25.4	6.1	9.2	8.6	0.2	8.0	14.0	12.1	108.3	3.6	0.0	8.3	5.7	3.6	3.2	3.5	1.4	2.6	9.4	31.4	10.1	10.3
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907897	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (8.22e-2)"	54.9	61.8	53.9	20.8	62.2	22.8	46.3	58.1	51.1	39.3	38.6	34.1	22.8	38.9	12.0	43.9	34.2	23.8	30.9	51.4	50.1	44.8	55.0	31.7	23.9	60.5	59.8	39.0	46.4	27.0	29.2	17.2	61.6	33.6	12.1	9.1	37.0	25.0	45.9	44.4	34.4	21.1	63.4	39.5	35.5	20.5	57.2	13.1	36.3	18.7	15.3	35.1	35.7	65.9	42.7	64.0	27.4	62.4	69.9	49.0	66.8	51.0	47.2	50.1	48.4	43.8	41.9	29.3	60.2	57.8	56.6	39.6	28.3	115.9	9.8	98.0	39.1	26.0	47.3	27.9	41.5	35.1	85.0	50.6	42.6	39.2	18.9	22.6	48.4	55.3	17.7	28.1	39.5	104.2	22.7	24.5	20.3	17.4	36.5	38.7	22.1	27.8	35.1	66.8	40.1	30.4	48.2	54.5	54.9	11.0	45.0	48.8	57.2	71.2	31.9	34.8	45.2	16.8	23.3	22.7	68.0	41.7	51.7	5.0	7.8	5.5	6.1	9.2	4.8	6.3	4.2	4.9	9.3	5.1	3.9	3.5	0.9	4.2	9.2	9.5	4.0	7.1	53.9	62.2	58.1	51.1	51.4	50.1	60.5	59.8	61.6	63.4	57.2	65.9	24.9	22.4	19.2	20.2	19.7	16.6	10.2	14.6	15.4	27.8	23.9	21.6	9.5	12.8	14.0	27.6	8.4	19.8	20.4	28.4	13.7	21.1	2.4	18.2	20.2	21.0	18.0	17.5	32.1	18.0	23.6	21.1	21.9	27.0	11.4	30.0	24.3	35.2	30.7	62.2	23.6	23.9	10.2	33.5	15.7	8.2	32.3	28.6	16.0	15.9	21.4	17.8	24.7	14.6	27.0	25.2	24.3	28.6	16.4	15.3	24.4	22.6	13.3	18.0	26.3	26.7	16.4	11.1	18.5	25.0	15.6	14.1	17.9	57.1	20.5	13.7
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	152.9	255.7	134.2	112.1	136.7	156.5	146.4	137.9	177.2	149.1	137.7	152.0	105.3	131.3	246.2	170.6	142.3	89.0	153.9	134.8	152.7	189.9	286.7	114.4	146.2	144.7	151.8	194.1	131.7	162.1	150.7	122.9	150.4	127.7	106.2	108.8	124.4	100.0	147.1	98.1	104.6	104.7	138.3	108.7	153.0	79.3	145.4	155.0	130.2	108.1	140.7	133.1	136.9	140.9	427.1	286.2	526.4	515.1	227.5	322.7	285.1	352.9	303.2	377.9	432.6	389.5	456.0	654.1	627.0	200.5	562.2	258.0	328.1	453.9	372.7	306.6	524.8	310.9	286.4	426.5	331.7	271.8	248.1	326.4	350.4	270.0	401.0	372.1	329.6	532.2	331.9	396.4	346.7	367.4	575.7	650.3	320.5	122.1	265.0	383.6	434.5	703.6	373.7	358.0	501.1	324.3	339.3	236.6	668.0	455.3	337.2	679.0	307.2	192.2	214.2	341.5	563.3	323.0	339.3	580.9	438.0	463.3	391.1	73.3	138.4	77.5	135.4	153.6	153.5	218.6	160.9	162.4	172.5	196.0	150.8	194.9	82.2	132.7	168.3	253.7	241.6	156.8	134.2	136.7	137.9	177.2	134.8	152.7	144.7	151.8	150.4	138.3	145.4	140.9	177.5	153.8	141.9	53.2	234.6	210.9	264.5	447.5	140.0	167.4	310.9	371.0	88.5	275.9	217.0	303.5	58.4	453.9	195.5	231.4	718.1	377.4	46.5	458.4	263.1	185.2	253.5	189.1	71.2	388.5	374.1	216.1	151.4	238.8	159.0	394.1	297.0	1298.8	411.2	148.0	73.9	300.7	252.3	495.5	401.4	42.7	306.6	226.3	225.9	40.3	394.9	231.3	254.3	66.9	126.8	476.2	283.1	258.8	182.6	406.3	256.6	1037.0	360.8	133.3	236.7	214.8	223.0	236.5	119.0	261.6	226.0	563.8	203.7	505.0	303.6	303.3
TBCB	"CG22, CKAP1, CKAPI"	ENSG00000105254	"Tubulin folding cofactor B"	Q99426	19	36114289-36125947	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 448.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041428, HPA041722"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA041428: AB_10794517, HPA041722: AB_10804007"	"unprognostic (3.88e-3)"	"unprognostic (3.05e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.15e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.02e-1)"	83.7	83.8	332.0	49.9	365.5	52.8	77.9	365.7	448.6	95.6	289.2	102.5	34.9	117.6	33.0	83.3	88.7	31.0	109.5	332.5	357.6	92.0	57.5	73.3	52.1	368.9	354.4	89.6	44.8	47.5	116.3	36.6	370.0	67.4	29.8	62.3	51.6	46.8	87.8	58.7	66.6	48.0	356.8	76.1	69.7	89.4	359.9	53.3	58.8	49.5	42.3	99.7	82.0	412.4	119.8	361.0	122.7	89.0	84.2	83.4	54.8	95.6	72.6	158.0	111.5	161.0	62.0	99.4	167.4	144.9	114.3	59.0	99.8	102.6	84.0	231.4	127.9	85.5	89.4	224.9	104.7	96.6	166.8	97.6	74.7	123.9	76.4	105.7	102.5	139.7	39.7	141.1	125.3	189.2	152.6	117.5	83.0	137.8	139.8	135.2	69.5	93.2	137.9	108.3	139.6	153.0	89.3	112.2	102.9	109.2	58.7	120.2	106.5	156.9	166.9	91.3	181.4	70.9	182.3	113.1	140.7	99.2	87.5	310.8	240.3	318.5	286.0	335.8	190.5	258.8	260.4	249.5	265.2	246.6	155.9	195.5	103.8	246.1	409.3	280.2	386.5	358.2	332.0	365.5	365.7	448.6	332.5	357.6	368.9	354.4	370.0	356.8	359.9	412.4	110.6	60.9	29.7	13.1	76.9	66.9	89.8	170.1	56.9	61.3	73.5	98.9	53.5	58.6	90.9	138.0	12.5	136.7	111.5	64.8	180.0	147.2	143.5	88.7	85.6	100.9	107.2	52.4	14.0	111.8	212.5	93.0	53.0	80.5	83.7	99.4	80.7	33.7	160.5	72.3	14.9	58.4	160.7	70.9	154.0	274.0	90.1	95.8	129.9	13.1	239.2	127.8	142.2	11.6	68.3	129.8	95.3	101.2	53.3	61.7	63.1	188.4	115.8	85.6	65.7	75.6	195.8	108.3	156.9	71.7	67.6	82.6	114.3	88.2	56.7	78.5
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
TBCD		ENSG00000141556	"Tubulin folding cofactor D"	Q9BTW9	17	82752065-82945914	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, GTPase activation"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 204.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045200	Approved					NA	NA		6200	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA045200: AB_10969134"	"unprognostic (4.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (3.41e-3)"	"unprognostic (9.03e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	34.3	23.9	17.6	22.2	19.0	23.2	31.7	12.1	17.6	32.7	17.9	22.9	15.5	27.1	24.7	28.9	26.8	33.0	39.3	18.3	14.4	26.6	25.7	26.3	24.0	16.9	15.2	25.7	28.4	26.3	26.5	27.5	17.1	28.1	14.8	11.3	70.0	18.7	25.1	23.3	23.3	21.6	11.1	34.6	30.6	24.5	14.7	51.7	36.7	18.5	21.1	26.1	26.6	16.9	63.1	61.9	63.9	89.8	36.9	40.5	65.3	37.0	24.1	40.5	28.2	34.9	16.6	36.7	34.3	44.3	52.0	64.8	144.6	36.0	34.5	46.7	56.7	85.8	52.8	46.1	23.9	30.8	60.9	33.8	26.2	30.5	13.6	28.4	122.6	68.5	47.2	14.9	35.1	70.9	204.4	19.4	30.1	32.2	45.0	107.9	71.7	23.1	28.5	59.2	61.5	70.9	40.0	70.0	24.6	39.7	52.7	18.7	52.8	75.9	56.8	48.2	60.4	21.1	17.2	40.7	47.3	37.7	29.5	21.3	17.7	9.6	23.4	41.3	28.6	1.3	21.0	24.7	15.4	1.1	8.6	10.4	3.7	18.2	51.7	3.0	16.8	16.9	17.6	19.0	12.1	17.6	18.3	14.4	16.9	15.2	17.1	11.1	14.7	16.9	50.3	19.2	43.2	31.0	9.1	6.8	10.7	9.3	8.6	15.6	16.0	13.8	7.0	11.5	15.7	12.9	12.5	31.8	14.8	11.1	11.7	12.0	11.5	17.8	11.7	34.3	16.2	24.4	48.5	15.2	27.9	18.3	27.5	27.5	38.1	30.5	16.1	26.4	25.7	13.5	43.9	11.4	32.6	15.7	7.0	20.8	15.2	14.2	19.6	31.9	10.8	7.5	17.5	19.6	45.4	9.7	4.7	18.8	16.7	9.9	6.0	16.0	14.9	13.8	6.6	15.7	10.6	15.9	21.8	15.8	10.1	49.7	29.3	21.0	15.3	12.1
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000284770	"Tubulin folding cofactor E"	Q15813	1	235367360-235452443	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 16.4"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA026552, HPA026557"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 1: K-562 - Erythropoiesis"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA026552: AB_1857797, HPA026557: AB_1857798"																		2.8	4.1	2.1	2.4	2.0	2.1	2.5	2.9	4.1	2.7	1.9	3.8	2.7	2.5	0.6	3.5	1.8	2.3	5.1	1.9	2.0	3.6	5.5	1.9	2.2	2.2	2.0	2.0	1.6	3.0		3.2	2.1	2.6	3.3	4.5	3.3	1.9	7.9	2.1	1.3	2.0	1.9	1.9	3.7	1.7	2.1	2.1	6.8	1.6	2.8	2.7		2.1	14.5	26.9	12.6	7.9	14.1	15.8	11.2	20.3	9.9	21.6	26.9	23.0	11.1	14.7	36.6	8.7	14.4	7.6	18.6	12.6	16.5	24.8	28.2	15.7	11.4	17.8	20.4	25.0	10.8	17.1	11.7	17.1	17.8	7.9	10.9	18.2	60.5	6.5	21.4	7.6	9.2	10.6	23.8	40.3	2.3	14.1	26.7	30.4	21.2	11.4	10.5	6.5	15.4	8.3	16.9	12.0	21.7	14.0	12.8	13.9	8.7	18.0	17.8	9.8	29.1	16.8	11.4	14.8	20.8	0.3	0.8	0.6	0.5	1.7	0.5	0.1	0.5	0.4	0.9	0.4	0.1	0.3	0.1	0.3	0.7	0.2	0.3	0.4	2.1	2.0	2.9	4.1	1.9	2.0	2.2	2.0	2.1	1.9	2.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000285053	"Tubulin folding cofactor E"	Q15813	1	235328570-235448952	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA026552, HPA026557"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA026552: AB_1857797, HPA026557: AB_1857798"																		0.9	0.7	1.1	1.3	0.8	1.3	0.8	2.4	1.7	0.8	0.1	1.0	0.8	1.5	0.5	0.6	0.7	0.6	1.1	1.0	1.3	1.2	0.7	0.8	1.5	1.9	1.1	1.9	1.6	0.8		1.3	2.2	1.2	0.9	1.9	0.7	0.8	3.5	0.8	1.4	0.7	0.5	1.0	1.2	1.6	1.4	2.4	1.0	2.4	1.2	0.9		1.7	8.4	2.5	8.9	5.7	1.5	2.4	5.9	3.7	1.9	6.3	3.3	2.2	6.6	4.4	9.0	1.5	3.8	3.9	3.4	3.2	4.5	6.3	6.7	2.2	3.5	2.8	0.6	5.6	5.2	0.8	1.0	3.4	3.9	1.3	2.3	5.2	6.2	2.3	3.9	4.2	8.1	2.0	10.0	4.8	1.9	5.2	3.8	2.0	2.2	2.7	9.3	8.5	3.6	6.4	4.0	1.3	9.5	10.8	3.5	4.6	7.8	4.5	5.2	5.6	6.5	5.8	6.2	2.5	6.0	3.0	2.5	2.4	2.3	2.9	2.4	1.8	2.0	2.4	2.6	1.3	2.4	2.1	0.5	1.8	2.5	1.8	2.7	2.1	1.1	0.8	2.4	1.7	1.0	1.3	1.9	1.1	2.2	0.5	1.4	1.7	10.1	0.0	5.9	17.9	8.9	3.1	5.2	8.2	5.2	9.2	6.9	9.4	0.0	4.3	7.0	7.3	4.2	0.0	8.6	4.3	0.0	3.5	10.9	3.4	12.3	5.9	3.5	6.9	22.4	1.6	0.0	5.5	9.7	4.3	3.8	7.7	2.2	5.9	0.0	6.7	26.1	5.3	4.1	4.7	2.7	6.2	10.8	6.6	8.8	10.3	8.9	8.9	11.3	11.6	22.0	3.1	4.1	7.5	6.6	2.9	5.2	1.4	5.7	13.1	0.0	5.9	7.6	14.0	8.8	7.5	2.8	0.0	8.8	8.5	8.3	3.9
TBCEL	"LRRC35, MGC10233"	ENSG00000154114	"Tubulin folding cofactor E like"	Q5QJ74	11	121024072-121090775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 104.0;Oligodendrocytes: 39.4;Plasma cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA038593, HPA038594"	Approved		Uncertain	Cytosol		NA	NA		22000	"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"	"unprognostic (9.06e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.02e-1)"	7.4	7.6	10.7	5.9	14.2	5.6	9.0	14.4	11.5	7.2	15.0	7.4	5.4	8.5	9.6	5.7	6.2	7.7	9.8	8.5	11.0	8.3	15.1	9.6	7.5	10.5	10.5	9.2	6.3	16.5	7.9	10.8	9.8	9.0	5.9	8.3	7.2	12.3	6.1	5.1	5.8	9.6	10.2	8.4	6.0	14.8	14.2	7.2	10.3	8.2	7.4	6.6	4.7	13.6	6.2	5.8	9.8	8.5	17.5	16.5	7.5	11.5	14.2	8.7	12.7	6.0	9.7	7.6	17.3	14.3	8.4	1.6	10.8	3.8	11.4	9.1	8.0	13.2	4.5	6.0	21.6	9.4	8.8	18.2	12.8	8.4	9.1	8.8	14.4	4.3	3.9	14.3	12.3	4.2	3.9	7.8	5.8	0.2	5.6	3.3	14.3	3.5	11.7	3.8	5.2	12.0	11.3	11.7	7.9	8.3	11.3	7.9	18.9	19.2	4.2	7.8	6.4	5.5	4.3	4.0	2.7	0.1	7.3	0.0	0.2	0.1	0.3	0.3	0.4	0.1	0.4	0.4	0.2	0.2	0.4	0.3	0.1	0.6	0.2	0.4	0.2	0.2	10.7	14.2	14.4	11.5	8.5	11.0	10.5	10.5	9.8	10.2	14.2	13.6	9.4	6.4	11.3	15.7	7.8	2.9	1.8	2.0	2.8	9.0	4.4	2.9	10.3	7.2	1.7	7.3	14.6	1.7	3.4	2.0	1.9	4.7	11.3	9.3	8.2	8.0	3.6	104.0	34.1	2.6	1.9	7.0	1.5	3.7	1.3	6.7	13.2	20.7	3.1	8.4	32.9	2.5	4.1	6.7	2.8	5.8	9.3	4.3	10.6	20.6	10.1	5.5	6.2	36.2	39.4	3.3	1.0	9.8	42.7	2.7	2.0	4.3	8.4	9.2	0.0	14.8	6.0	14.9	6.0	3.7	1.7	1.4	3.7	6.8	2.3	1.2
TBCEL-TECTA		ENSG00000285509	"TBCEL-TECTA readthrough"		11	121024125-121113108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.3"									"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol		NA	NA					"Cluster 36: HEL - Hemostasis"		Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"																		0.1	0.0	0.4	0.1	0.6	0.0	0.1	0.3	0.6	0.2	0.5	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.4	1.1	0.3	0.1	0.2	0.0	0.7	0.6	0.2	0.6	0.4		0.2	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	1.1	0.1	0.0	0.0	0.0	0.1		0.6	0.1	0.2	0.5	0.1	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.3	0.4	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.2	0.0	0.2	0.7	0.9	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.6	0.4	1.1	0.7	0.6	0.7	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106316683	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Excitatory neurons: 196.6;Inhibitory neurons: 221.1;Microglial cells: 128.4;Oligodendrocyte precursor cells: 147.2;Oligodendrocytes: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 44.0;BJ hTERT+ SV40 Large T+ RasG12V: 81.7;HBF TERT88: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	7.4	5.2	5.6	3.0	5.3	1.3	3.4	11.0	6.1	4.5	8.3	3.2	2.3	4.3	6.0	4.2	5.3	5.6	2.8	6.1	7.0	6.3	4.4	4.1	3.0	5.2	5.3	6.4	5.8	4.8	3.9	5.5	6.0	4.7	3.1	7.6	3.6	6.0	1.6	4.1	3.3	4.7	3.5	3.6	3.5	6.1	6.9	4.7	5.5	4.3	2.6	5.2	3.0	10.1	1.4	5.9	9.0	2.7	36.7	19.1	1.1	8.1	8.9	44.0	81.7	10.9	6.4	2.3	13.0	28.0	7.0	5.4	5.7	8.1	59.3	5.1	1.8	14.1	4.5	10.3	9.7	2.7	6.3	20.9	5.9	4.1	7.1	14.5	11.1	6.0	7.2	3.8	10.2	7.7	5.2	3.7	2.0	14.4	2.0	4.1	3.7	6.8	11.1	9.0	4.4	4.1	8.2	4.0	5.6	7.6	4.8	8.5	8.3	7.7	4.3	2.4	4.4	2.5	6.1	6.8	10.1	5.6	5.0	14.1	5.1	5.1	4.7	5.7	5.6	4.8	4.9	6.4	4.8	7.9	5.6	5.2	0.4	5.2	3.8	4.4	5.5	4.0	5.6	5.3	11.0	6.1	6.1	7.0	5.2	5.3	6.0	3.5	6.9	10.1	7.7	19.2	25.2	134.8	13.9	2.3	6.4	9.0	17.1	20.7	8.2	6.9	8.2	5.7	15.5	14.7	20.9	11.5	9.0	3.5	3.9	4.3	45.7	10.2	15.9	8.9	5.4	9.2	196.6	0.9	6.6	12.5	15.3	21.1	11.4	21.5	8.6	4.6	6.8	11.8	221.1	5.7	10.2	6.2	1.6	28.2	11.1	7.7	5.4	128.4	4.6	8.1	10.3	147.2	188.8	2.2	8.0	12.8	10.4	4.3	4.8	8.0	11.9	15.3	0.0	10.6	9.6	14.5	8.2	14.2	2.4	7.4	10.6	13.9	5.5	4.5
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.6	15.3	6.0	10.1	6.1	16.9	11.4	5.6	6.9	10.6	5.3	10.5	15.1	11.0	6.7	11.3	9.5	10.1	9.4	5.8	5.6	11.8	17.4	12.9	14.6	6.5	6.9	9.6	7.5	11.6	9.8	13.7	6.1	10.6	8.5	6.3	10.2	9.0	18.4	8.6	11.4	10.8	5.3	13.4	10.2	23.5	6.7	6.8	8.5	14.9	12.9	16.0	10.2	7.1	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.0	6.1	5.6	6.9	5.8	5.6	6.5	6.9	6.1	5.3	6.7	7.1	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TBKBP1	"KIAA0775, ProSAPiP2"	ENSG00000198933	"TBK1 binding protein 1"	A7MCY6	17	47694081-47712050	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062347, HPA064856"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA062347: AB_2684744, HPA064856: AB_2685371"	"unprognostic (2.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (8.14e-6)"	"unprognostic (5.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.59e-5)"	13.9	10.9	25.2	8.5	22.3	6.7	12.0	11.4	29.9	17.1	6.3	15.3	3.1	14.0	2.1	11.3	14.2	8.1	16.4	27.3	19.3	12.9	3.4	12.3	6.0	18.4	19.8	21.4	9.6	10.1	11.6	9.5	18.2	13.4	2.2	10.4	15.9	9.3	35.5	7.4	7.8	7.9	11.6	18.4	10.5	14.2	24.4	3.2	11.7	22.3	3.4	14.9	12.3	18.5	0.5	10.0	18.3	19.4	9.2	9.3	11.9	10.1	10.6	4.9	5.8	62.8	1.5	0.3	9.9	12.6	8.7	1.1	14.4	2.6	2.9	12.3	32.6	26.8	9.8	10.7	21.2	5.1	5.7	18.8	6.5	1.1	1.8	15.2	17.4	7.3	23.5	0.0	2.8	2.8	3.3	25.2	25.5	0.5	7.0	12.0	5.7	10.5	6.1	0.8	15.8	29.5	4.8	1.2	5.2	17.2	11.0	11.4	20.2	15.1	17.8	18.4	1.2	6.8	0.7	12.4	8.8	9.6	3.9	0.0	0.2	0.4	1.0	0.1	0.5	0.0	0.3	0.8	0.2	0.2	0.1	0.3	2.2	0.9	0.0	0.2	0.2	0.1	25.2	22.3	11.4	29.9	27.3	19.3	18.4	19.8	18.2	11.6	24.4	18.5	15.5	0.0	1.1	13.4	2.4	4.0	3.2	0.9	1.8	13.7	2.8	3.4	3.7	1.5	1.1	3.7	2.1	0.1	6.3	0.0	1.9	1.1	6.9	0.7	3.5	9.7	5.3	3.2	6.9	1.8	0.2	3.9	2.6	1.2	0.0	4.2	10.4	1.1	3.2	28.6	12.1	0.5	4.1	2.9	4.0	6.6	8.7	2.2	1.8	5.6	1.1	4.7	5.2	9.5	1.2	0.9	0.0	8.6	2.2	5.5	0.0	5.0	0.8	3.7	0.0	1.5	2.7	3.8	5.3	2.0	3.0	0.3	3.9	1.3	0.1	2.2
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"TBL1X receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	18.8	20.3	7.2	24.4	12.7	30.2	21.7	13.9	11.8	24.9	8.5	31.0	24.6	16.9	9.2	21.2	22.4	23.2	32.6	16.0	3.3	22.3	24.5	19.6	31.3	8.1	8.5	20.9	12.1	27.3	2.9	21.0	4.9	25.6	24.4	42.7	16.1	14.8	12.9	17.1	18.7	19.4	8.6	22.9	22.3	19.1	8.4	45.5	47.1	25.3	36.3	25.3	10.3	15.0	96.8	41.2	61.1	39.7	56.2	65.8	44.2	26.1	52.3	30.3	36.3	48.9	76.2	98.9	132.9	43.6	58.4	61.2	42.9	63.2	58.7	97.5	14.5	56.2	66.8	30.3	49.7	91.0	29.6	95.3	35.9	37.3	90.6	53.8	48.5	68.5	44.8	189.9	42.8	31.0	81.7	14.0	38.1	59.8	32.2	53.9	72.6	124.6	33.1	119.5	24.8	38.7	43.3	35.9	49.8	37.3	113.0	74.3	60.5	48.9	35.3	28.8	65.6	89.8	117.6	280.7	32.9	66.2	56.1	14.3	3.7	3.8	5.6	6.2	5.9	7.5	6.9	7.3	4.6	7.3	5.9	7.4	12.9	7.4	5.5	12.4	8.3	5.3	7.2	12.7	13.9	11.8	16.0	3.3	8.1	8.5	4.9	8.6	8.4	15.0	55.1	73.7	60.7	128.0	56.5	91.5	55.1	90.6	62.0	113.6	69.2	42.2	101.9	47.1	80.3	104.8	125.1	28.9	70.0	84.7	29.4	52.2	7.4	90.9	59.0	65.5	85.3	60.4	228.9	43.8	35.1	81.8	44.4	134.5	25.3	65.9	48.5	66.6	37.8	116.1	167.6	72.6	59.0	91.1	75.0	9.0	64.0	69.4	65.8	184.6	55.8	47.6	41.2	241.8	269.4	66.7	43.7	73.0	75.1	144.9	41.5	67.3	83.9	81.6	46.0	76.3	54.4	12.9	61.4	88.1	111.8	27.5	66.0	41.6	84.6	83.6
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7101970	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.9;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-698: 12.3"									"HPA050857, HPA060073"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA050857: , HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	0.3	0.0	0.1	0.0	1.3	0.0	0.3	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.8	0.3	0.4	0.2	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.4	0.1	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.2	3.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.3	0.0	0.0	0.0	1.1
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972053-1982929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 113.8;Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	3.6	3.5	1.8	3.2	2.2	2.1	3.9	4.5	2.7	3.4	1.0	3.4	2.4	3.8	0.6	4.9	3.0	1.4	4.7	2.3	2.3	3.3	3.1	2.8	2.3	3.3	2.0	3.7	5.9	2.8	2.4	1.2	3.4	2.8	1.0	1.5	4.8	1.1	10.6	5.4	3.5	1.4	1.7	3.0	3.7	6.8	1.8	2.0	3.1	3.1	1.5	3.3	3.5	2.7	7.1	13.4	3.6	7.2	3.5	2.8	11.8	6.4	4.2	5.4	4.4	17.3	13.3	9.4	14.6	4.9	4.9	18.8	5.9	7.5	2.8	6.9	8.5	5.9	7.1	6.6	4.0	10.3	5.4	2.8	5.5	6.7	3.9	4.3	6.8	5.6	12.1	6.7	3.2	11.3	13.2	5.8	8.6	6.2	5.4	23.1	6.7	15.7	2.6	2.7	8.4	6.5	5.8	14.6	6.0	3.5	11.1	6.9	10.8	7.4	8.8	6.6	12.6	12.1	5.6	15.0	4.5	6.5	8.7	4.5	9.4	5.5	10.6	11.0	9.3	6.4	7.6	10.4	10.4	6.9	9.7	7.4	2.2	14.5	11.8	5.3	9.2	8.5	1.8	2.2	4.5	2.7	2.3	2.3	3.3	2.0	3.4	1.7	1.8	2.7	9.1	3.2	12.2	2.3	11.9	13.0	15.8	21.9	12.0	13.0	12.6	10.4	16.4	7.2	16.4	18.4	8.4	26.4	10.7	23.4	7.9	25.4	113.8	7.4	8.5	11.2	13.8	18.5	2.0	22.5	26.0	10.5	20.4	9.7	14.7	14.5	7.1	12.7	19.6	10.1	2.1	16.1	18.3	8.9	6.6	72.1	14.9	8.5	7.2	0.0	24.1	13.6	9.2	2.0	2.0	24.0	22.0	10.9	13.5	15.6	31.9	16.9	8.8	9.8	26.3	11.1	24.7	21.8	20.8	13.7	18.3	22.4	11.1	11.6	24.2	14.4
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	10.2	10.5	9.4	9.6	9.6	15.6	10.4	10.8	15.1	10.5	9.1	11.8	8.5	12.6	8.1	11.3	11.7	8.2	9.9	10.1	11.5	11.0	11.5	9.7	14.0	10.2	10.2	12.8	11.7	9.3	9.3	10.8	10.2	10.5	8.5	8.9	10.3	7.6	12.8	10.7	11.9	9.6	8.7	14.9	11.7	34.5	9.7	11.9	10.5	10.6	12.2	10.6	10.8	12.3	12.9	14.0	24.4	31.2	12.5	14.2	23.0	20.5	15.6	19.9	21.1	28.9	12.7	27.1	16.4	16.7	28.6	18.9	31.6	16.8	21.2	31.5	23.2	27.6	16.6	26.1	18.1	32.7	23.1	13.8	19.2	22.9	25.8	16.3	15.9	37.2	49.7	16.5	18.3	19.3	32.8	31.8	24.5	27.3	11.0	28.6	20.0	23.8	14.5	6.5	10.4	24.9	24.1	17.8	16.0	20.7	12.4	40.7	17.6	13.5	19.1	22.2	32.0	24.4	35.1	42.3	18.5	27.0	21.9	67.4	30.8	39.8	37.8	32.2	44.4	52.9	36.7	38.6	30.2	49.9	47.3	40.0	44.4	35.0	45.4	42.6	37.2	21.8	9.4	9.6	10.8	15.1	10.1	11.5	10.2	10.2	10.2	8.7	9.7	12.3	8.4	9.6	6.9	6.8	16.5	5.5	5.3	11.6	20.5	7.5	8.3	7.4	9.9	15.7	10.0	12.9	8.4	15.8	10.5	6.2	3.9	6.6	26.9	7.8	9.3	9.5	7.2	17.5	13.7	4.7	13.5	9.2	7.7	10.7	1.3	13.0	13.2	8.0	10.1	0.0	12.8	7.5	22.4	14.0	5.3	7.7	10.8	9.8	1.8	10.3	8.5	5.4	6.2	11.1	16.2	6.6	7.9	10.5	18.7	8.5	8.2	8.9	7.2	6.7	13.1	6.6	11.1	88.1	17.4	18.3	6.7	13.5	11.1	10.1	8.0	6.7
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 126.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	12.1	11.7	16.9	12.0	18.9	37.5	10.5	19.0	23.0	10.4	12.7	11.7	13.3	12.3	8.1	11.7	13.1	11.8	11.9	19.3	19.4	9.2	13.7	9.7	21.3	14.2	12.9	12.5	8.1	10.4	11.7	14.8	14.2	12.2	14.3	15.0	9.1	12.3	6.4	9.0	12.9	11.1	11.7	12.6	11.7	126.7	20.0	19.8	16.8	9.2	16.9	15.1	9.8	16.5	16.5	19.6	43.9	28.5	32.6	33.3	24.5	29.9	31.5	39.1	51.1	23.0	13.0	49.8	20.2	24.1	43.8	21.2	28.0	32.3	46.8	38.3	35.9	87.8	11.5	25.5	33.0	46.4	32.8	20.8	32.2	43.8	47.1	30.7	37.6	43.3	129.3	33.4	28.1	37.0	39.2	27.8	49.2	23.6	25.1	26.7	26.4	19.5	23.2	14.3	56.5	56.2	17.7	23.2	37.8	36.9	10.5	18.5	34.4	22.5	32.4	50.0	33.6	27.2	31.5	32.8	37.7	30.0	27.4	133.1	31.7	81.8	62.7	33.3	69.8	67.6	53.1	67.1	29.8	60.2	50.6	59.5	74.8	52.5	38.3	35.4	60.5	64.0	16.9	18.9	19.0	23.0	19.3	19.4	14.2	12.9	14.2	11.7	20.0	16.5	35.6	6.4	12.2	10.7	43.2	70.7	27.0	46.7	46.1	22.8	29.8	34.2	12.8	28.6	21.1	7.3	18.8	40.7	59.1	16.8	29.4	29.1	407.5	20.6	17.1	40.8	71.0	51.4	35.3	25.2	69.7	30.8	36.7	14.8	40.0	13.5	22.9	11.2	24.4	15.2	25.2	26.5	48.8	14.8	43.2	75.1	21.1	38.3	32.0	22.5	21.3	23.3	42.2	27.2	27.7	31.4	24.2	18.4	35.2	39.7	17.9	28.4	28.2	12.3	19.7	27.3	35.1	557.4	72.8	36.7	65.8	244.9	50.0	11.0	24.3	37.6
TBPL2	"TBP2, TRF3"	ENSG00000182521	"TATA-box binding protein like 2"	Q6SJ96	14	55413541-55456726	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;skeletal muscle: 1.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Smooth muscle cells: 2.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;HMC-1: 2.7;U-2 OS: 2.5;U-937: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056241	Uncertain					NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA056241: AB_2683076"					"unprognostic (3.42e-1)"	"unprognostic (1.16e-1)"				"unprognostic (1.50e-1)"			"unprognostic (3.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"		0.2	0.5	0.6	0.8	0.7	0.5	0.0	1.7	1.2	0.4	0.4	0.2	0.9	0.7	0.0	0.2	0.2	0.1	0.0	0.6	0.4	0.2	0.2	0.4	0.3	1.5	0.6	0.1	0.2	0.1	0.0	0.2	0.8	0.3	0.2	0.1	0.6	0.1	1.7	1.3	0.6	0.0	0.2	0.5	0.5	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	2.0	0.5	0.0	0.6	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.2	0.3	0.4	1.6	0.0	0.2	0.5	0.1	0.0	0.0	5.7	0.0	0.4	0.6	0.0	0.0	0.0	2.7	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.3	1.9	0.0	1.4	0.3	1.0	0.4	0.0	0.5	0.5	0.0	0.4	0.0	0.8	0.7	0.5	0.0	0.1	0.2	0.0	0.8	0.7	0.0	0.2	2.5	0.2	0.4	1.7	0.9	0.2	0.3	4.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.7	1.7	1.2	0.6	0.4	1.5	0.6	0.8	0.2	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.3	2.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
TBR1		ENSG00000136535	"T-box brain transcription factor 1"	Q16650	2	161416297-161425870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"brain: 29.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 32.3;Late spermatids: 65.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	196	"amygdala: 9.2;basal ganglia: 27.4;cerebral cortex: 29.1;hippocampal formation: 13.0;white matter: 19.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 44.6;basal ganglia: 28.3;cerebral cortex: 70.8;hippocampal formation: 45.7;white matter: 43.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 66.9"	"HPA051256, HPA078644, HPA078657"	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388"	"unprognostic (3.08e-2)"	"unprognostic (5.45e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.43e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.14e-1)"			"unprognostic (1.39e-9)"	"unprognostic (5.72e-2)"	"unprognostic (1.72e-1)"		"unprognostic (5.37e-2)"	0.0	0.0	9.2	0.0	27.4	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	27.4	0.0	29.1	13.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	32.3	0.2	0.3	0.4	0.0	0.0	9.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	65.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.3	0.2	0.5	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	24.5	29.5	19.3	23.0	21.8	23.0	24.0	22.8	21.4	22.9	23.5	36.1	29.4	23.1	7.9	35.8	21.2	11.9	56.5	19.7	21.6	29.6	43.3	19.0	25.5	22.4	21.1	24.0	21.3	21.9	17.4	19.5	23.0	24.5	18.7	6.6	24.1	15.6	83.0	32.4	28.6	15.6	21.4	28.5	26.2	34.4	22.0	21.9	18.9	66.2	17.9	29.3	25.5	23.2	49.4	113.1	35.7	77.3	31.5	28.9	70.2	39.2	35.9	74.6	61.5	123.8	67.5	93.8	58.7	39.9	103.3	125.6	82.6	89.3	37.6	49.0	77.8	64.5	73.6	84.4	51.6	74.5	63.4	39.7	81.7	71.2	50.7	26.7	46.6	79.3	181.1	46.0	46.2	84.5	75.9	168.0	111.0	110.6	88.6	65.9	45.3	136.2	44.1	50.4	69.9	65.6	40.4	218.8	77.6	45.6	97.7	120.4	36.4	54.6	65.7	33.9	64.8	81.0	87.6	137.5	50.1	104.9	125.7	17.3	23.8	20.6	31.1	44.3	29.5	27.9	25.6	30.0	35.9	20.9	34.5	33.3	1.9	18.1	39.5	13.6	27.2	33.0	19.3	21.8	22.8	21.4	19.7	21.6	22.4	21.1	23.0	21.4	22.0	23.2	13.3	3.2	16.3	9.4	21.0	35.1	33.2	39.8	15.4	15.1	17.0	15.0	28.0	15.7	24.1	20.2	0.0	61.5	18.4	32.9	43.0	31.1	24.6	12.5	13.8	14.2	22.2	14.3	6.5	18.3	72.5	17.9	24.5	16.9	14.0	25.4	10.4	31.8	34.5	11.8	7.1	32.5	36.7	12.3	17.8	19.6	16.4	18.0	17.8	3.7	34.6	14.7	14.4	4.5	8.4	29.5	28.0	11.7	17.9	33.8	33.5	47.4	11.2	14.2	13.1	17.1	25.5	72.4	33.0	17.0	29.3	47.9	19.2	44.7	53.3	30.2
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box transcription factor 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"intestine: 9.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5"					"Low region specificity"	"Detected in single"			"HPA047881, HPA076197"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA047881: AB_2680199, HPA076197: "	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.4	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.4	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.0	0.0	103.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	20.4	0.0	0.0	0.2	42.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.1
TBX15	TBX14	ENSG00000092607	"T-box transcription factor 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 46.8;skeletal muscle: 132.2;tongue: 114.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.2;Fibroblasts: 11.1;Hepatocytes: 15.3;Melanocytes: 7.2;Skeletal myocytes: 13.1;Smooth muscle cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 52.6;ASC TERT1: 22.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.4;fHDF/TERT166: 28.2;HSkMC: 37.9;RH-30: 29.1;U-2197: 27.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"spinal cord: 3.3"	"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	29.8	0.1	0.8	0.0	1.0	0.0	16.1	0.7	1.3	0.1	2.1	0.1	0.0	0.2	0.1	1.9	0.4	0.5	3.1	0.7	0.6	1.0	46.8	0.6	2.7	0.6	0.7	0.1	0.1	0.5	1.5	0.1	0.7	1.4	0.0	0.2	6.9	0.0	132.2	9.4	0.1	0.1	0.5	0.0	0.1	0.7	0.9	0.3	1.9	114.7	1.3	0.4	0.3	0.7	1.4	0.0	0.0	0.0	52.6	22.1	0.0	4.7	6.4	12.3	20.4	0.0	0.0	0.0	2.6	28.2	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	1.4	0.0	0.1	0.4	0.0	37.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	14.1	0.0	0.0	0.2	2.3	0.0	0.2	0.0	29.1	0.4	3.0	1.4	0.6	0.0	1.6	0.0	0.6	0.6	0.0	0.6	0.0	6.6	4.0	27.3	0.2	0.4	0.2	0.0	13.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.7	1.3	0.7	0.6	0.6	0.7	0.7	0.5	0.9	0.7	3.2	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.2	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	15.3	0.1	0.0	0.2	0.0	0.0	0.0	4.0	1.1	0.0	0.1	7.2	1.9	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.1	12.5	0.2	0.4	0.0	2.0	0.0	0.3	0.1	0.0	0.0
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box transcription factor 19"	O60806	1	168280877-168314426	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"pituitary gland: 50.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 5.5;HDLM-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.8	0.8	1.0	0.8	1.2	0.7	1.8	0.8	1.3	2.9	1.0	2.5	0.8	5.0	0.8	1.6	2.7	1.2	1.1	1.1	2.0	1.8	1.1	2.4	1.7	1.5	1.1	3.7	1.1	0.5	50.2	0.6	1.2	2.2	1.0	0.4	1.8	1.0	0.8	2.5	1.6	2.1	1.0	2.3	1.1	1.0	1.5	1.6	1.3	0.8	1.1	1.5	2.1	1.2	1.0	0.0	0.8	3.1	1.4	0.6	1.0	1.6	0.9	0.5	0.8	1.4	1.0	0.8	1.7	0.6	0.8	5.5	0.4	0.4	0.8	5.1	0.7	0.1	1.1	0.4	1.5	1.6	2.0	1.2	1.4	0.2	0.8	1.3	0.7	0.3	1.1	1.3	0.7	0.2	0.8	1.3	0.2	3.3	0.5	1.3	0.4	0.3	1.2	0.4	1.1	1.6	0.9	0.7	1.0	1.3	0.2	1.3	1.2	0.5	1.3	1.1	1.7	1.0	0.8	0.6	0.1	0.4	1.6	0.2	0.7	0.4	1.1	0.5	0.5	0.4	0.8	0.7	0.7	0.5	0.5	0.5	1.0	0.9	1.0	2.4	0.8	0.6	1.0	1.2	0.8	1.3	1.1	2.0	1.5	1.1	1.2	1.0	1.5	1.2	1.4	0.0	0.5	2.3	1.4	2.7	1.3	1.2	2.2	0.0	3.1	3.0	0.4	0.0	0.6	0.0	0.0	0.1	6.1	2.6	0.0	0.6	0.6	3.2	1.8	2.5	1.2	0.8	0.7	0.4	0.4	2.5	0.0	5.6	4.5	1.8	0.4	0.7	1.3	0.0	0.5	0.9	2.0	2.8	8.9	0.7	3.4	4.2	0.0	6.5	3.9	0.4	6.2	0.5	3.1	1.9	0.6	2.6	1.1	4.3	0.7	0.6	1.2	0.0	0.0	0.7	0.9	1.0	1.1	1.9	3.3	0.1	1.6	0.9	0.9	2.7
TBX2		ENSG00000121068	"T-box transcription factor 2"	Q13207	17	61399843-61409466	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 62.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.1;Collecting duct cells: 95.6;Muller glia cells: 139.8;Sertoli cells: 170.9;Smooth muscle cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 129.3;MCF7: 78.5;SH-SY5Y: 65.4;SK-MEL-30: 49.3;WM-115: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	21.1	3.7	2.9	2.6	3.4	0.0	16.1	2.7	4.6	14.5	1.7	9.8	4.9	22.0	14.1	7.1	15.7	4.5	19.9	2.2	3.2	31.7	4.9	62.8	1.0	3.8	4.1	10.2	3.6	2.1	6.2	24.7	3.8	16.3	1.8	6.3	4.2	27.5	8.1	5.6	11.4	4.6	2.3	13.7	11.5	5.4	3.9	0.8	15.9	5.8	0.5	31.2	13.0	2.2	0.5	1.9	0.0	129.3	4.2	4.4	15.6	22.4	21.2	1.0	0.2	3.6	0.4	0.0	1.6	3.3	2.5	0.0	2.4	0.0	0.4	0.0	8.8	2.2	0.0	6.4	14.0	0.4	2.1	8.0	0.2	23.4	1.3	0.3	0.0	0.0	0.5	0.0	1.4	78.5	0.0	0.4	0.1	0.0	9.4	0.0	5.3	0.2	0.0	31.0	0.3	65.4	0.0	0.0	49.3	0.2	1.6	2.5	0.0	2.9	0.0	7.3	4.7	0.1	0.3	0.0	17.6	0.0	43.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.4	2.7	4.6	2.2	3.2	3.8	4.1	3.8	2.3	3.9	2.2	12.7	0.0	0.6	2.3	0.1	0.6	0.3	0.0	0.0	134.1	0.4	1.1	11.1	0.0	0.0	95.6	22.9	0.4	0.5	0.0	1.9	0.1	0.8	1.4	45.7	12.2	0.0	0.0	0.1	0.0	0.4	13.7	0.5	1.6	0.0	0.1	12.1	0.0	0.9	1.7	0.0	0.0	0.0	1.0	1.8	1.1	39.4	1.1	1.8	5.6	0.0	139.8	0.0	0.0	0.1	0.0	0.0	47.4	0.0	0.5	0.0	25.1	0.0	13.4	170.9	0.8	104.0	0.4	0.7	0.1	0.3	0.3	0.9	1.1	0.0	0.2
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.1;lung: 3.3;lymphoid tissue: 11.7"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 92.8;NK-cells: 119.4;Plasma cells: 22.8;T-cells: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 16.3"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.2"	"CAB009524, CAB030043"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	0.9	0.4	0.3	1.9	0.3	11.1	0.4	0.3	0.3	0.4	0.4	0.5	0.9	0.3	0.4	0.3	0.4	0.8	0.3	0.2	0.3	0.5	1.2	3.3	7.5	0.4	0.3	0.2	0.2	0.0	0.2	0.2	0.3	0.4	0.5	0.0	0.6	0.2	0.5	0.2	1.6	0.4	0.3	11.7	1.2	0.4	0.3	1.0	0.7	0.2	2.2	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	3.6	2.0	3.1	8.9	0.0	0.5	0.4	7.8	0.2	14.3	0.0	0.1	0.1	2.4	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.3	0.3	0.3	1.1	0.0	0.6	0.0	7.6	0.0	0.0	0.0	0.6	0.0	0.6	0.9	1.3	1.5	0.0	0.0	0.0	0.1	92.8	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.3	0.1	0.0	0.0	0.2	1.1	0.2	2.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	1.9	0.0	1.9	0.8	0.0	119.4	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.1	0.0	45.6	0.0	0.0	0.0
TBX4		ENSG00000121075	"T-box transcription factor 4"	P57082	17	61452404-61485110	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 32.3;placenta: 21.0;prostate: 9.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 6.2;Late spermatids: 14.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;Hep G2: 1.2;OE19: 1.2;THP-1: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB032413, HPA044457"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	32.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	21.0	0.1	9.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	2.9	0.3	0.2	0.2	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.1	0.0	5.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBX5	HOS	ENSG00000089225	"T-box transcription factor 5"	Q99593	12	114353911-114408442	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.1;lung: 20.8;placenta: 28.7"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 104.7"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 18.9;BJ hTERT+: 41.5;BJ hTERT+ SV40 Large T+: 9.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HAP1: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	3.4	0.0	0.1	0.0	0.0	0.0	4.4	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	88.1	0.9	0.0	0.0	0.0	20.8	0.6	0.3	0.1	0.0	0.0	1.3	0.0	28.7	0.3	3.4	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.9	41.5	9.2	12.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	16.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.2	2.9	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.0	4.5	0.1	0.1	104.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1"	"Group enriched"	"Detected in all"	22	"dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA031257, HPA031258, HPA031259"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		890000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"		"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.2	10.8	5.3	28.1	5.1	24.8	8.2	5.4	5.9	5.4	5.8	10.1	10.3	3.2	2.0	5.4	4.9	21.2	3.3	4.5	6.8	5.8	12.8	23.9	12.4	10.0	6.6	2.9	3.6	2.9	2.3	14.2	8.8	6.4	13.0	1.6	9.0	4.0	1.0	1.3	11.9	12.6	8.9	57.8	11.2	1.4	9.7	15.1	1.8	3.3	8.3	13.9	2.1	14.7	0.2	5.4	0.3	0.1	1.2	3.9	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	12.1	0.0	0.3	0.0	0.0	0.0	0.0	9.4	0.7	17.8	0.0	0.0	1.6	6.2	15.3	2.1	0.0	0.0	0.9	1.1	2.3	0.1	0.6	2.2	0.6	0.2	2.4	76.7	0.2	18.0	23.7	2.6	0.0	1.2	21.0	0.0	0.2	1.1	0.2	0.0	0.8	0.0	0.0	14.4	2.0	0.6	0.2	1.4	1.0	4.6	0.9	0.3	0.4	60.8	1.7	324.3	322.4	333.6	7.3	466.0	11.9	8.3	13.5	3.7	129.0	4.5	2.3	1.3	271.1	11.9	423.1	22.6	13.9	216.7	5.3	5.1	5.4	5.9	4.5	6.8	10.0	6.6	8.8	8.9	9.7	14.7	3.9	3.2	10.8	8.1	9.9	0.4	1.2	0.5	2.8	1.0	3.0	3.0	1.1	5.7	1.7	1.8	6.2	0.6	16.4	0.8	9.8	5.2	0.4	1.0	0.6	5.0	1.8	12.8	1.2	9.5	0.5	2.9	7.1	3.8	71.0	0.5	16.8	8.6	88.8	3.3	1.8	1.9	12.2	193.6	19.5	0.7	0.3	132.9	3.6	191.1	63.7	4.9	26.8	3.0	5.9	4.4	7.9	0.0	16.4	5.8	0.2	6.3	1.0	4.1	19.7	1.3	1.7	0.5	0.7	26.2	0.6	0.5	13.4	0.3	2.7	1.2
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779746-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 103.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 84.6"	"Group enriched"	"Detected in many"	47	"NK-cells: 39.2;T-cells: 84.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	14.3	2.3	0.1	14.2	0.7	5.1	27.7	0.2	0.5	9.5	1.4	16.5	12.1	11.4	5.1	21.6	11.8	25.2	8.5	0.2	0.3	6.9	2.9	14.4	22.0	3.1	0.5	6.5	103.0	19.8	6.9	1.5	1.6	17.2	15.2	0.5	46.5	7.8	3.1	13.7	14.5	5.8	1.4	11.1	24.9	5.9	0.7	11.5	12.5	1.2	24.5	18.4	13.9	0.7	9.2	1.5	0.0	0.0	1.6	0.0	12.2	0.0	0.2	0.0	0.0	6.5	19.1	6.0	0.4	0.1	0.2	1.0	9.0	9.0	0.0	0.1	4.7	0.0	2.4	0.0	0.0	0.0	0.0	0.2	9.3	0.0	0.5	0.0	0.0	0.5	0.1	4.7	0.0	16.3	0.0	0.0	1.3	63.8	0.0	0.1	0.0	0.0	4.3	37.3	7.0	0.0	0.8	43.9	0.0	2.4	22.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	38.4	0.1	84.6	0.7	42.0	49.0	0.1	0.2	33.6	28.7	1.3	39.2	0.2	0.2	14.8	22.5	0.1	0.7	0.2	0.5	0.2	0.3	3.1	0.5	1.6	1.4	0.7	0.7	10.0	41.7	79.6	0.7	12.4	53.4	31.3	38.1	33.6	0.4	94.3	34.3	0.9	48.6	73.1	25.8	0.0	1.0	39.6	50.2	1.9	73.3	18.5	51.4	13.6	10.9	31.8	1.7	14.4	211.7	3.6	21.2	124.4	118.6	7.0	2.5	5.7	0.6	0.3	0.0	1.8	58.5	48.8	3.0	12.7	32.7	56.8	4.0	60.5	10.3	3.1	3.5	53.5	0.5	1.6	91.7	40.0	12.8	15.6	49.1	13.6	7.5	81.0	0.1	0.0	13.2	4.5	33.8	11.8	45.4	82.5	5.5	111.0	0.1	51.7	86.8
TCAF1	"FAM115A, KIAA0738"	ENSG00000198420	"TRPM8 channel associated factor 1"	Q9Y4C2	7	143851375-143902198	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011732	Approved		Approved	"Nuclear bodies,Vesicles,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	"Nuclear bodies, Vesicles"	"HPA011732: AB_2668526"	"unprognostic (1.57e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.95e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-1)"	29.0	46.5	22.7	12.9	51.4	4.7	21.7	15.1	30.3	27.5	2.7	18.8	12.2	32.2	15.2	15.1	22.2	19.3	23.7	29.4	42.7	14.8	29.3	19.0	8.4	15.4	13.4	39.9	19.4	35.1	27.2	81.1	19.8	36.2	20.3	28.0	15.8	19.8	17.5	16.9	15.8	30.6	11.5	11.7	21.7	9.4	31.0	17.1	26.8	55.7	9.0	14.8	13.4	20.1	47.2	29.0	90.1	93.7	57.9	55.7	55.1	54.3	64.9	42.4	56.3	60.5	33.0	0.2	25.2	63.3	54.5	29.7	34.8	35.7	46.5	25.7	26.0	25.7	15.7	54.0	39.7	0.3	16.2	58.2	31.5	50.0	18.4	66.8	53.4	32.2	43.2	4.5	83.2	70.7	42.3	15.9	27.6	52.0	17.4	26.0	60.7	6.2	33.7	37.5	25.6	153.1	55.5	34.2	25.7	63.7	51.5	4.0	48.8	44.6	28.5	42.2	32.7	14.0	19.2	0.4	81.9	7.6	62.3	0.4	1.5	0.9	4.7	1.8	3.3	1.6	2.8	3.1	2.9	1.6	2.4	3.0	0.4	4.4	3.1	1.4	2.3	2.5	22.7	51.4	15.1	30.3	29.4	42.7	15.4	13.4	19.8	11.5	31.0	20.1	36.3	44.8	37.1	30.3	7.3	0.0	15.0	0.0	16.5	47.7	29.4	38.6	43.0	31.5	14.9	3.7	25.0	251.7	15.2	18.7	0.0	30.9	2.4	27.6	62.7	35.1	19.4	22.1	71.2	35.6	43.7	54.6	20.9	40.5	7.6	167.5	34.6	83.6	32.9	30.3	63.1	29.3	0.0	10.5	0.0	3.5	53.1	12.2	0.0	29.0	10.8	27.5	20.6	57.3	43.7	49.9	15.4	56.4	8.4	27.3	20.1	8.9	8.0	26.7	13.1	72.1	53.3	13.3	11.7	14.1	0.0	521.5	10.4	377.5	23.5	24.3
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	2.1	1.9	1.5	4.0	1.5	4.1	5.8	4.6	3.4	4.0	0.0	1.2	1.0	1.7	0.8	9.2	1.9	2.2	1.2	1.5	1.9	2.6	4.5	3.7	4.2	2.2	2.5	2.6	2.0	2.1	2.6	5.2	2.5	2.8	1.1	3.2	3.7	1.2	0.7	4.3	2.4	1.5	0.7	2.8	2.0	1.6	1.7	3.3	1.3	0.7	3.4	2.8	5.9	3.2	5.5	0.3	0.1	0.2	1.0	1.0	2.0	1.5	3.1	0.7	2.2	0.1	0.3	0.2	2.1	1.3	0.5	0.8	0.1	3.0	2.3	10.6	0.5	0.8	0.6	0.1	1.2	0.3	0.4	2.9	1.3	0.3	0.9	2.1	11.6	0.7	3.0	5.1	4.3	0.8	0.6	0.8	0.2	5.0	2.7	0.4	2.1	2.4	0.0	1.9	0.1	0.1	0.5	4.3	0.2	0.8	1.9	0.2	18.5	1.3	0.9	5.5	0.4	7.7	2.6	0.1	13.8	0.4	3.2	5.7	0.2	0.2	2.9	0.2	3.1	1.9	4.8	3.1	0.2	1.8	4.2	3.3	0.9	2.2	0.2	0.7	5.6	1.2	1.5	1.5	4.6	3.4	1.5	1.9	2.2	2.5	2.5	0.7	1.7	3.2	0.5	0.0	1.8	0.0	4.5	0.0	1.3	0.0	3.4	0.7	5.6	3.4	0.4	0.0	1.8	0.0	0.0	16.2	5.6	0.2	0.0	0.9	1.0	0.8	1.4	3.5	0.0	0.4	3.7	0.4	4.9	2.4	2.6	1.3	2.5	0.3	0.7	12.3	2.0	0.0	3.6	0.2	0.0	1.6	0.0	1.1	1.8	1.8	0.0	0.0	0.4	2.1	7.2	1.5	0.1	1.3	0.1	0.7	5.0	2.1	2.1	0.4	0.0	0.1	0.0	2.3	1.1	3.5	2.0	4.9	0.0	15.7	9.1	0.8	0.4	1.1
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.5	0.3	0.8	0.4	0.0	0.3	0.5	0.5	0.0	0.7	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39665349-39666554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	47	"heart muscle: 5162.1;skeletal muscle: 15829.0;tongue: 5831.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 2473.2"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;SK-BR-3: 8.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.8"	"Low region specificity"	"Detected in some"			"CAB004591, HPA026477"	Enhanced					NA	NA		36000	"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.55e-4)"	4.1	4.2	13.0	0.8	16.2	2.9	5.7	13.7	16.1	3.0	11.4	3.2	0.7	2.2	0.0	188.9	2.5	1.8	5162.1	12.1	13.0	3.1	3.4	8.4	3.3	13.2	14.3	3.5	2.7	0.9	5.3	0.9	13.2	107.1	0.1	1.1	137.6	1.6	15829.0	5.5	2.5	0.8	12.2	3.2	2.6	3.5	14.1	1.0	5.0	5831.4	0.9	1.7	3.0	13.0	0.1	2.5	1.7	2.2	0.2	0.3	0.6	0.4	0.2	0.4	0.5	0.9	1.5	1.0	1.6	0.3	1.7	0.9	0.3	0.0	0.0	0.9	2.6	0.7	2.0	0.4	0.1	0.6	0.3	0.7	0.3	1.0	0.1	1.0	0.2	1.1	1.6	0.3	0.0	1.1	0.7	5.3	1.0	0.9	0.6	0.7	1.5	0.7	0.8	0.2	1.0	1.7	1.3	8.4	1.1	0.9	0.6	1.1	1.1	0.8	1.0	1.4	0.5	3.7	2.0	0.5	0.6	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	13.0	16.2	13.7	16.1	12.1	13.0	13.2	14.3	13.2	12.2	14.1	13.0	3.3	0.0	0.0	8.1	0.7	1.7	0.5	0.3	0.0	1.5	1.5	0.9	2473.2	5.7	0.3	1.8	0.0	0.1	0.3	0.4	1.9	0.3	0.4	0.9	0.5	29.0	3.0	1.3	2.2	0.0	0.0	68.5	1.5	0.6	0.0	0.8	2.2	0.0	0.4	10.1	2.7	1.1	0.0	0.6	2.0	0.1	0.3	2.9	1.8	1.0	0.1	0.8	0.0	1.0	2.6	0.5	0.6	0.4	0.9	0.7	0.5	0.3	0.6	1.7	6.6	336.9	25.4	1.0	1.2	0.0	2.0	0.4	1.9	0.5	1.2	0.7
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	52.7	46.0	44.1	56.5	47.5	81.2	62.2	44.7	58.3	55.3	42.5	49.7	47.1	55.6	45.8	53.9	52.4	42.6	35.9	42.0	46.0	59.8	90.4	46.7	98.3	47.2	44.6	61.9	68.4	80.0	28.2	49.3	47.0	59.0	50.7	49.0	56.5	54.2	42.0	49.8	46.9	52.4	47.5	49.5	52.2	36.8	44.2	72.4	124.2	41.7	112.6	54.6	41.4	55.1	161.3	157.9	138.1	145.7	99.3	121.8	100.9	122.1	147.3	143.5	160.2	91.4	131.0	392.5	136.9	147.0	152.5	120.9	182.3	116.6	212.9	225.0	88.5	293.6	71.5	139.5	309.7	116.8	122.7	88.5	308.1	137.4	606.2	121.3	128.2	132.9	191.1	334.0	135.5	75.6	245.8	83.3	229.1	265.0	47.1	185.1	48.2	72.5	204.0	107.0	129.9	95.5	101.9	91.0	356.3	132.2	129.6	132.6	110.6	106.1	96.3	120.6	114.5	201.1	134.4	260.9	184.9	133.2	152.1	82.3	64.1	78.7	103.9	63.1	98.3	213.8	107.0	96.7	81.8	174.1	93.9	99.3	23.1	97.5	60.6	116.7	153.0	73.5	44.1	47.5	44.7	58.3	42.0	46.0	47.2	44.6	47.0	47.5	44.2	55.1	94.7	89.8	106.2	24.2	253.2	135.5	128.3	98.9	257.2	77.0	129.2	124.3	23.9	82.9	109.4	99.3	89.6	115.5	143.8	61.0	168.3	121.0	86.4	126.9	145.4	92.5	87.2	330.7	17.7	109.9	125.1	118.8	111.6	124.4	98.7	75.7	66.4	160.7	87.7	57.2	20.1	96.6	118.0	89.5	134.2	191.0	134.8	124.2	117.4	17.8	132.5	166.0	170.0	22.1	29.7	121.1	71.6	132.8	341.1	146.0	72.2	207.6	110.6	104.5	78.9	102.6	130.4	94.9	103.1	237.2	150.6	112.1	154.8	108.5	88.1	148.6
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Centrosome	"HPA043836: AB_2678694"	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	32.9	31.0	63.0	9.7	62.9	8.5	32.1	58.0	105.9	45.8	32.9	43.7	6.2	42.7	13.2	14.2	42.0	16.7	40.1	63.4	61.6	39.7	56.9	23.9	12.8	70.5	61.8	55.8	19.3	31.0	57.7	17.5	71.8	39.2	3.2	12.1	22.2	25.3	41.6	24.7	21.6	14.0	54.2	30.7	25.8	91.9	62.5	15.4	38.5	14.0	6.0	38.2	31.6	62.8	17.1	18.7	29.7	50.2	26.5	15.8	11.5	16.8	20.0	31.4	15.0	11.4	30.5	19.4	38.6	21.8	18.0	45.8	12.3	15.5	6.1	12.0	21.8	7.2	37.3	29.1	38.8	8.3	9.9	24.9	13.4	8.1	10.3	43.9	21.6	24.4	12.8	35.5	9.7	41.5	34.4	41.5	18.4	22.8	44.7	32.1	21.7	51.0	17.1	12.2	28.5	48.4	18.0	12.0	46.3	9.8	34.0	21.3	30.7	56.2	28.3	31.5	10.2	40.2	28.4	10.7	50.1	9.4	11.5	1.6	1.0	3.2	2.2	1.2	0.9	7.5	1.9	1.6	1.3	2.8	3.3	2.1	0.5	2.6	1.9	2.1	3.9	1.0	63.0	62.9	58.0	105.9	63.4	61.6	70.5	61.8	71.8	54.2	62.5	62.8	43.3	0.0	3.1	20.5	34.5	22.6	38.3	17.6	38.7	54.1	44.9	64.0	31.0	30.0	11.5	71.7	27.1	27.6	13.6	0.6	107.6	35.6	123.6	30.8	44.3	40.7	19.1	5.7	21.9	16.0	13.4	43.9	13.7	21.0	2.5	62.8	47.5	47.6	17.4	65.6	19.0	2.8	16.2	16.8	23.7	173.1	51.9	20.5	62.2	7.5	18.4	123.3	10.3	8.5	17.0	24.3	2.1	49.2	14.7	31.2	11.6	115.6	16.1	37.1	26.3	43.2	48.9	126.1	39.0	13.2	20.2	20.8	18.7	42.3	3.6	25.9
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23380909-23424748	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 513.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 214.8;Hepatocytes: 205.9;Intestinal goblet cells: 376.2;Proximal tubular cells: 260.9;Undifferentiated cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 8.4;naive CD4 T-cell: 13.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.3;Hep G2: 55.1;OE19: 28.7;SiHa: 18.2;T-47d: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	17.5	95.6	4.7	4.6	4.3	0.6	19.6	4.1	4.7	35.7	7.8	87.1	15.8	17.0	7.3	40.5	28.3	11.6	71.6	4.0	4.4	64.9	160.7	20.4	2.4	6.0	4.9	81.9	229.4	16.3	14.9	3.9	5.4	59.9	39.8	3.2	100.3	14.5	513.3	53.4	35.2	9.2	5.2	10.6	75.9	4.7	4.1	1.8	41.2	173.1	4.5	36.2	38.7	5.1	0.0	0.1	0.5	0.5	2.5	15.3	9.0	6.4	4.1	3.2	1.9	4.1	0.5	0.2	0.7	7.9	1.0	9.1	0.5	0.1	2.8	0.0	0.1	0.0	6.9	55.1	1.9	0.8	0.0	10.1	2.8	2.9	0.0	7.1	0.4	0.1	0.0	0.0	1.1	1.5	0.4	6.1	0.0	28.7	1.8	0.1	0.0	0.2	0.0	0.1	0.5	0.1	18.2	0.8	0.8	1.5	28.4	2.8	0.4	0.0	0.2	0.7	0.0	0.5	5.3	0.0	0.5	0.5	0.6	0.0	0.2	0.0	0.4	0.7	0.4	0.0	8.4	1.1	2.9	0.0	13.6	6.1	0.0	0.2	0.2	0.9	0.8	2.3	4.7	4.3	4.1	4.7	4.0	4.4	6.0	4.9	5.4	5.2	4.1	5.1	10.5	125.0	109.5	4.2	1.9	27.4	53.4	30.9	30.7	2.3	46.3	42.4	109.8	100.1	57.2	42.3	2.1	3.3	1.9	158.0	199.6	37.7	6.1	7.7	6.6	13.4	55.9	5.7	2.8	97.9	33.9	45.2	69.3	20.8	9.5	214.8	8.2	205.9	1.5	25.2	4.5	376.2	6.1	7.6	65.4	17.9	17.1	8.4	24.9	3.7	3.2	6.8	3.1	2.0	1.3	25.5	143.0	15.4	0.5	38.8	154.3	260.9	29.4	1.4	19.7	90.1	24.0	0.7	2.6	61.1	54.8	2.2	8.4	52.0	223.5	73.9
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCEAL3	"MGC15737, WEX8"	ENSG00000196507	"Transcription elongation factor A like 3"	Q969E4	X	103607451-103629690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 165.3;Peritubular cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045564, HPA058982"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (2.55e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.05e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (7.19e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.64e-1)"	43.0	61.9	109.1	15.2	111.0	14.9	42.9	108.8	137.0	101.4	111.0	74.0	11.8	171.1	32.4	25.5	120.6	21.2	66.0	104.8	124.0	55.7	9.8	47.5	10.3	117.0	122.9	163.1	34.0	47.7	108.6	17.8	118.0	97.6	9.5	45.9	34.7	70.0	21.5	33.6	32.2	43.1	112.1	43.7	57.5	34.3	116.7	7.0	50.7	10.7	8.0	126.7	68.3	117.5	81.5	8.6	21.5	17.6	72.6	36.8	0.7	118.4	56.4	53.1	70.0	0.0	7.8	0.0	14.3	87.1	94.5	31.3	15.5	46.6	38.9	0.1	3.9	6.0	35.4	0.2	69.8	0.0	25.6	47.9	14.3	37.6	53.9	75.3	36.0	27.6	0.0	23.1	73.6	68.4	3.9	0.6	9.2	0.0	21.9	28.5	13.5	0.3	25.6	16.2	32.7	26.3	5.3	6.9	29.5	10.5	32.4	18.9	47.1	27.6	14.1	56.9	37.5	24.2	12.0	0.1	68.6	0.1	61.9	5.7	8.3	5.1	13.2	4.7	14.3	9.3	11.4	10.4	9.6	10.5	11.1	13.7	1.4	20.0	0.5	12.2	15.9	6.3	109.1	111.0	108.8	137.0	104.8	124.0	117.0	122.9	118.0	112.1	116.7	117.5	39.1	16.0	47.9	6.2	15.9	25.9	91.4	37.8	20.5	57.0	69.8	73.4	50.2	40.0	39.4	75.4	18.8	3.1	19.9	5.1	142.8	41.3	3.3	61.1	165.3	46.2	43.4	6.3	10.0	39.0	3.3	56.3	19.4	40.6	95.8	55.5	58.2	3.8	63.5	18.5	13.8	32.1	36.7	35.1	32.9	17.2	157.2	31.3	16.0	4.7	29.7	137.8	17.5	9.0	12.3	25.3	9.6	256.1	33.0	78.9	0.7	30.6	62.4	35.6	26.3	26.0	62.4	4.4	1.9	10.2	16.9	2.7	21.1	32.9	6.2	45.6
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276750	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.0;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"							"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	0.9	10.5	56.5	0.9	54.9	0.0	2.1	55.4	67.3	6.2	35.5	2.2	0.6	5.6	6.8	0.3	2.4	0.8	2.7	52.9	55.2	0.3	0.1	0.3	0.0	50.8	52.6	5.2	0.9	0.0	62.2	0.0	49.5	3.3	0.7	23.5	1.1	4.1	0.1	0.4	1.2	3.3	44.9	0.0	1.0	60.0	50.3	0.6	2.3	0.7	0.0	1.5	3.8	55.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	54.9	55.4	67.3	52.9	55.2	50.8	52.6	49.5	44.9	50.3	55.4	0.1	0.0	0.0	2.9	0.0	0.1	0.5	0.0	1.8	43.4	0.3	9.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.3	7.5	0.6	0.0	0.0	7.0	0.0	0.4	7.6	0.0	0.2	0.0	16.5	0.0	0.0	0.3	1.7	7.7	0.0	0.0	0.0	1.7	22.1	8.4	0.7	0.0	2.8	0.0	75.5	0.0	7.1	2.8	0.0	0.0	35.7	0.0	0.2	0.0	0.3	0.0	6.8	0.0	6.9	1.4	7.6	1.9	0.1	0.3	0.4	0.1	0.2	0.0	0.2
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 73.4;testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982"	Supported		Uncertain	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.6	10.7	27.3	0.2	24.3	0.0	0.6	23.1	41.4	1.5	3.6	1.7	0.2	3.6	1.4	0.0	5.7	0.1	0.5	23.8	35.4	1.0	0.0	0.1	0.0	27.3	32.9	8.5	0.4	1.8	73.4	0.0	26.3	0.8	0.2	16.7	1.8	0.6	0.0	0.3	0.7	0.7	19.2	0.0	0.8	26.8	26.0	0.0	0.5	0.2	0.0	0.0	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.3	24.3	23.1	41.4	23.8	35.4	27.3	32.9	26.3	19.2	26.0	22.5	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	40.4	0.0	0.1	4.6	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	10.4	0.0	0.0	0.0	0.3	6.7	2.5	0.1	1.8	1.0	0.0	1.9	0.0	4.5	1.7	0.4	0.0	0.7	0.0	0.5	0.0	0.0	0.0	4.3	0.0	1.4	0.9	1.9	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330229-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9"	"Low region specificity"	"Detected in many"							"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA051507: AB_2681512, HPA065080: AB_2685419"	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	7.7	27.9	72.4	4.3	73.0	0.0	9.1	75.1	126.3	26.3	40.5	18.6	4.0	48.2	18.3	5.5	17.0	11.9	14.0	72.1	84.5	5.0	2.4	6.1	2.3	80.8	77.5	29.0	1.2	1.1	37.4	2.1	82.3	12.3	7.8	23.5	3.5	13.2	3.7	1.8	8.3	29.9	74.5	5.8	6.5	3.1	77.2	5.1	3.8	9.9	1.4	9.7	15.6	96.0	0.0	0.0	83.8	0.0	36.3	55.5	15.0	12.0	61.9	26.4	75.1	0.0	0.0	0.0	0.0	12.9	115.3	0.0	0.0	1.8	45.5	0.0	0.8	0.3	0.0	0.0	18.2	0.0	0.1	46.6	0.0	83.8	0.1	0.0	27.6	0.0	0.5	0.2	72.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	53.1	0.3	0.0	0.0	210.1	56.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	38.8	1.4	0.6	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	72.4	73.0	75.1	126.3	72.1	84.5	80.8	77.5	82.3	74.5	77.2	96.0	4.8	0.0	1.3	5.9	0.0	2.5	5.3	0.3	1.2	36.4	0.9	19.2	13.6	0.0	0.7	3.7	4.2	1.4	0.1	0.0	5.9	0.2	0.2	1.0	42.9	5.2	0.0	0.0	21.2	0.0	0.7	55.2	0.0	0.7	0.0	19.2	1.8	0.0	0.7	48.8	26.5	0.0	0.0	0.0	4.0	1.8	43.8	0.6	8.8	4.7	0.0	88.3	0.0	19.6	46.5	0.3	0.0	39.1	0.1	1.1	0.0	2.1	0.0	12.9	13.1	48.3	38.7	3.0	1.5	0.8	3.1	0.3	0.5	5.1	0.0	0.8
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059115	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA059115: AB_2683909"	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	42.9	62.6	51.9	36.3	53.1	29.3	60.0	55.0	69.6	67.2	53.8	47.9	30.5	58.3	131.1	38.8	45.3	57.1	93.1	53.1	54.6	69.4	42.7	43.9	47.6	53.4	52.2	69.4	40.9	71.0	56.5	62.2	53.9	59.2	49.5	33.2	61.5	56.1	18.8	39.3	40.4	63.2	55.1	45.8	42.0	42.9	53.4	71.9	71.3	32.0	45.7	57.3	36.5	55.9	49.2	26.4	110.9	51.8	161.9	269.3	53.2	104.9	154.7	90.6	141.0	20.6	94.5	25.8	68.2	120.7	157.7	32.1	19.6	120.0	116.5	0.4	61.5	111.2	34.5	30.8	98.8	114.4	105.6	184.9	68.0	79.5	0.0	190.3	123.9	75.3	135.0	23.8	223.6	0.0	98.2	43.9	123.2	4.4	52.7	37.1	152.8	7.6	124.7	36.4	57.7	75.4	58.3	18.1	130.8	105.7	33.9	38.0	83.1	53.5	71.0	164.4	35.2	26.2	49.8	1.1	86.7	61.0	87.6	73.7	31.9	20.0	66.3	29.3	76.6	62.4	78.1	71.4	58.2	52.6	84.5	73.5	3.0	120.6	23.2	101.3	109.5	54.5	51.9	53.1	55.0	69.6	53.1	54.6	53.4	52.2	53.9	55.1	53.4	55.9	72.3	51.3	66.7	6.8	32.7	60.8	83.9	169.4	68.9	52.3	70.5	69.2	76.6	104.4	89.4	97.5	10.4	188.8	48.5	27.5	273.9	137.8	6.8	46.2	71.8	85.0	78.5	33.2	10.3	109.4	176.3	93.9	29.6	49.7	69.6	76.2	169.6	102.5	98.7	50.5	10.0	133.7	81.4	90.6	81.1	17.2	125.9	52.4	120.9	10.3	71.4	110.4	104.0	7.1	11.3	68.2	49.2	121.9	27.2	51.3	73.5	276.2	60.1	37.5	85.5	80.6	77.4	5.6	4.0	47.6	59.5	134.9	45.1	68.1	78.7	79.5
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1165.9;Distal tubular cells: 360.0;Extravillous trophoblasts: 456.2;Syncytiotrophoblasts: 780.1;Theca cells: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	93.9	178.7	62.9	49.8	65.5	13.8	71.7	69.0	116.6	82.8	86.4	67.6	24.8	101.5	185.0	51.1	71.6	82.0	78.7	65.6	68.0	96.7	34.7	81.2	23.4	67.8	68.7	272.5	46.5	107.0	82.9	219.3	69.4	86.0	55.9	45.4	45.5	105.4	14.4	36.4	38.3	97.5	66.6	55.4	76.2	72.4	67.6	36.0	120.0	31.5	25.6	115.9	60.8	74.4	130.5	64.1	195.0	100.8	412.6	397.8	146.6	267.7	355.5	185.7	300.7	122.0	135.2	0.5	387.2	219.4	342.5	77.2	33.8	169.8	247.8	0.6	73.6	133.2	156.0	79.6	282.8	0.2	0.3	275.6	162.1	248.5	245.0	323.5	312.7	55.2	119.9	9.7	445.4	0.2	66.2	0.8	121.8	0.1	120.4	0.3	389.7	0.7	227.4	239.7	88.3	106.2	168.8	5.4	188.5	209.0	27.0	7.3	258.1	165.0	71.9	502.2	75.9	0.1	7.8	1.1	400.9	0.2	134.4	1.2	1.6	0.0	0.3	1.0	0.0	2.4	1.9	0.7	1.3	1.6	4.0	3.5	0.0	1.6	0.1	23.6	1.2	1.4	62.9	65.5	69.0	116.6	65.6	68.0	67.8	68.7	69.4	66.6	67.6	74.4	121.4	173.1	70.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	81.5	125.3	0.0	0.0	47.0	233.6	0.0	1165.9	2.1	0.0	360.0	250.1	0.0	100.6	149.7	85.3	0.0	0.0	0.0	139.8	456.2	130.2	0.0	115.6	11.4	268.5	0.0	0.0	141.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	120.8	0.0	0.0	0.9	0.0	0.0	298.6	10.2	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	780.1	4.9	323.7	0.0	0.0
TCEANC	MGC17403	ENSG00000176896	"Transcription elongation factor A N-terminal and central domain containing"	Q8N8B7	X	13653189-13681964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000337, HPA001013"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA000337: , HPA001013: AB_1079371"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.29e-3)"	"unprognostic (4.03e-2)"	"unprognostic (4.29e-6)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.11e-4)"	1.5	1.2	1.3	1.0	1.4	4.5	2.5	2.0	1.8	1.5	1.2	1.2	1.1	1.5	3.0	0.8	1.8	1.0	1.5	1.4	1.4	1.5	1.7	1.7	2.7	1.5	1.4	2.5	1.5	1.2	1.3	1.2	1.5	1.5	1.5	2.8	1.8	1.2	1.7	1.5	1.4	1.5	1.3	2.5	1.2	1.0	1.6	2.9	2.0	1.5	2.0	1.1	1.1	1.9	0.4	1.1	1.2	2.1	2.5	3.0	0.4	0.3	1.0	1.0	0.4	0.4	0.8	1.3	1.1	0.8	0.6	0.6	1.1	0.6	0.2	1.4	1.5	0.7	0.6	0.6	1.4	1.1	1.3	2.6	1.0	0.6	4.2	1.5	0.3	1.3	1.4	2.2	1.4	0.9	1.8	1.1	1.6	0.6	0.3	1.4	1.1	2.8	0.5	0.7	1.2	1.1	1.1	1.2	1.6	1.5	1.2	1.0	0.5	0.9	0.4	0.8	0.1	1.8	1.1	1.0	1.2	0.6	0.4	7.2	1.6	4.2	2.6	1.4	3.0	3.5	2.8	3.5	1.3	3.6	3.4	3.1	2.1	1.6	1.5	2.3	3.7	1.9	1.3	1.4	2.0	1.8	1.4	1.4	1.5	1.4	1.5	1.3	1.6	1.9	2.9	0.0	1.1	1.6	3.8	0.3	1.0	1.2	1.8	3.5	2.3	2.0	2.6	1.5	2.3	3.7	2.1	2.2	7.3	1.3	3.9	1.5	0.0	2.2	2.6	1.5	2.4	19.0	1.7	0.9	0.8	1.8	1.1	2.0	5.1	2.1	1.8	3.9	2.0	1.7	2.2	2.5	2.0	2.8	2.0	0.2	3.4	1.8	0.0	2.8	3.1	4.9	6.2	0.5	2.5	0.5	1.8	2.2	7.3	1.2	2.7	3.2	2.0	2.3	0.0	1.7	2.6	1.1	1.2	0.9	0.3	3.3	4.8	2.1	1.3	0.9
TCEANC2	"C1orf83, FLJ32112"	ENSG00000116205	"Transcription elongation factor A N-terminal and central domain containing 2"	Q96MN5	1	54053584-54112519	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.4;Spermatocytes: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046918	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046918: AB_2679864"	"unprognostic (2.80e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.73e-5)"	"unprognostic (8.64e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.57e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.08e-1)"	2.0	2.3	5.8	2.9	5.6	2.8	2.2	4.7	5.8	2.2	4.9	2.6	2.6	2.1	2.3	2.9	2.1	1.5	2.6	5.0	5.1	2.4	2.2	1.9	3.9	5.7	5.5	1.8	2.1	2.3	2.1	2.3	5.7	2.3	3.1	2.1	2.0	1.5	3.8	2.5	2.6	1.8	5.5	3.7	2.4	7.1	6.1	5.1	2.1	3.1	3.7	2.7	2.3	6.6	4.3	1.9	4.6	3.9	3.3	5.2	4.9	4.5	3.6	4.8	4.2	1.2	2.6	3.2	3.8	1.6	4.4	4.1	6.6	3.6	6.5	7.6	2.7	6.3	4.3	2.0	1.9	4.2	5.3	3.7	3.0	4.0	2.4	2.4	7.1	8.6	5.7	3.4	4.3	1.6	9.3	3.4	11.4	4.4	2.9	9.2	9.4	5.6	1.6	2.8	4.2	4.4	2.4	4.8	5.8	7.2	4.6	7.6	4.1	4.9	2.7	4.6	5.5	8.1	12.9	5.2	4.1	5.9	6.0	3.3	3.2	4.2	1.6	4.0	1.9	2.8	2.2	2.5	3.5	3.3	2.5	2.9	3.5	4.8	3.4	3.0	1.7	1.5	5.8	5.6	4.7	5.8	5.0	5.1	5.7	5.5	5.7	5.5	6.1	6.6	4.0	9.6	11.2	12.7	6.7	0.6	1.5	2.3	1.2	3.2	3.8	3.0	8.4	5.7	5.9	11.0	12.5	6.1	4.7	2.7	1.9	4.0	36.4	9.8	4.7	5.5	3.6	7.6	6.3	1.8	5.7	3.6	5.6	3.7	2.5	4.4	3.9	4.4	4.8	8.4	7.8	4.2	2.0	9.6	1.0	23.5	3.1	5.3	1.8	6.5	12.3	2.5	9.2	5.5	16.7	3.6	3.7	3.0	5.7	2.4	4.3	3.5	16.8	3.3	0.0	4.2	3.6	29.4	12.5	5.5	1.0	4.0	5.6	4.2	4.5	1.6
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204"	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	11.6	8.6	6.6	15.5	6.1	28.1	12.0	7.9	10.0	11.6	4.1	12.2	10.5	13.3	6.4	13.1	12.5	7.3	10.0	6.4	5.2	9.2	6.7	10.5	17.7	5.5	5.1	13.7	9.0	8.9	11.3	12.4	5.5	10.4	10.8	16.9	10.9	8.4	23.7	13.2	11.2	10.4	4.2	12.0	11.7	10.3	5.3	19.0	10.0	13.6	17.1	12.4	12.3	8.8	51.7	37.6	56.6	39.1	15.2	23.9	72.0	38.0	30.6	42.1	48.8	61.0	53.8	89.0	27.8	31.7	30.0	44.6	70.1	48.1	63.8	52.6	56.3	58.1	43.4	37.4	16.3	87.8	43.5	16.8	28.0	40.8	43.7	23.0	37.3	73.5	69.4	31.9	32.2	36.8	76.8	49.3	56.3	29.2	42.3	74.3	66.9	58.7	26.3	40.2	36.8	45.6	42.7	44.6	28.3	34.1	47.5	43.9	42.2	36.3	42.1	31.0	60.2	32.4	38.3	116.8	33.7	73.0	41.3	0.9	5.7	2.5	5.7	8.8	6.9	5.5	6.6	7.2	9.7	5.5	6.8	6.8	0.5	9.5	11.9	4.9	6.5	5.3	6.6	6.1	7.9	10.0	6.4	5.2	5.5	5.1	5.5	4.2	5.3	8.8	35.8	54.5	49.8	50.6	49.5	44.9	49.5	35.6	54.7	54.1	32.4	33.1	35.6	14.3	39.9	23.9	62.6	48.6	42.9	20.8	1.9	31.9	3.2	23.8	62.1	37.6	28.2	77.0	100.9	33.4	60.7	43.3	56.6	44.1	37.9	57.4	21.4	17.6	30.8	35.3	91.0	36.9	24.4	28.9	30.4	7.4	28.6	36.5	24.9	42.2	33.1	20.8	35.0	73.4	76.3	44.9	25.3	24.5	61.9	60.7	13.8	7.6	33.8	38.4	19.7	53.2	51.1	73.3	60.8	66.6	45.7	43.9	42.8	43.7	47.5	62.2
TCF12	"bHLHb20, HEB, HsT17266, HTF4, p64"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: AB_2685564"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	26.1	21.5	29.2	23.4	45.5	21.2	29.5	37.1	34.0	75.6	17.2	26.7	28.4	47.9	24.3	26.6	46.3	37.1	21.8	30.5	32.6	28.4	25.0	28.9	26.0	43.1	39.3	43.3	19.7	44.0	11.5	33.4	38.3	32.0	30.3	29.4	23.3	28.3	20.5	21.3	28.4	44.1	34.5	25.0	25.5	27.4	35.5	133.0	29.0	26.6	28.1	31.2	22.4	55.7	25.4	50.8	204.5	70.6	90.0	79.0	36.1	52.2	89.6	45.1	58.9	34.0	20.3	35.5	42.3	78.3	33.4	30.4	84.3	37.3	56.7	47.5	29.8	71.7	52.7	40.4	62.4	46.1	36.1	69.4	66.2	42.9	112.2	60.1	81.0	163.0	81.7	46.8	61.8	9.5	109.4	25.0	57.5	26.4	20.9	143.2	234.9	33.9	61.5	53.1	43.6	121.2	58.7	21.0	52.0	65.3	33.6	93.9	63.2	75.5	57.5	32.2	78.2	24.6	49.7	59.4	40.8	86.3	90.9	27.4	13.8	11.3	17.4	17.9	14.3	13.4	14.0	16.5	20.0	14.7	16.2	14.8	1.5	16.8	26.3	8.4	23.0	14.1	29.2	45.5	37.1	34.0	30.5	32.6	43.1	39.3	38.3	34.5	35.5	55.7	35.5	54.5	19.6	212.9	37.7	26.6	20.6	14.2	44.9	13.8	24.0	20.4	19.3	14.3	21.2	16.5	35.5	10.4	20.6	17.0	13.7	16.0	23.7	25.9	148.0	38.2	9.0	34.9	117.7	11.8	15.5	42.3	52.0	33.3	23.4	26.9	25.7	18.2	27.5	13.5	319.8	16.8	10.2	38.1	30.0	19.9	25.7	33.0	14.2	440.3	17.4	29.0	18.6	618.3	1512.7	15.9	18.4	34.6	29.1	23.4	20.0	15.3	15.9	23.3	46.0	39.9	36.5	22.2	15.0	33.6	33.8	13.0	28.4	16.5	20.1	18.2
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.8;skeletal muscle: 13.2;tongue: 9.1"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	7.0	0.6	1.3	0.1	1.2	0.0	4.6	1.2	1.4	0.2	0.9	1.6	0.1	0.8	0.0	0.3	0.4	0.1	27.8	1.1	1.2	1.5	0.2	0.6	0.1	1.3	1.3	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.2	0.2	0.5	0.2	1.3	0.0	0.6	2.0	1.3	0.0	0.5	9.1	0.0	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.2	1.4	1.1	1.2	1.3	1.3	1.4	1.3	1.3	1.2	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0;Inhibitory neurons: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	7.1	6.5	4.2	1.7	3.1	1.6	7.5	0.0	2.9	10.2	0.0	9.1	1.6	9.0	0.2	16.3	6.9	1.0	4.9	3.7	2.4	7.6	7.4	7.1	1.6	0.9	1.0	7.6	8.2	1.2	7.4	1.2	1.1	6.9	1.3	0.9	9.9	1.0	5.7	14.3	10.0	1.4	0.0	7.3	8.0	15.3	1.8	2.3	9.6	1.3	1.6	7.8	11.0	2.1	6.6	2.3	3.2	2.1	1.0	2.1	5.5	4.2	2.8	2.1	3.5	5.0	2.5	10.9	3.6	1.1	3.1	5.4	3.9	3.3	1.2	8.5	3.9	3.4	2.2	1.6	1.5	6.0	4.7	1.2	2.9	3.0	3.0	0.9	1.0	3.1	4.1	3.9	1.6	3.0	9.4	1.8	3.4	2.2	3.1	4.7	2.0	5.7	0.5	5.2	6.2	2.0	2.7	2.0	2.7	2.0	1.2	4.8	3.9	3.8	8.9	3.9	1.9	7.0	6.2	4.5	2.3	4.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.1	0.0	2.9	3.7	2.4	0.9	1.0	1.1	0.0	1.8	2.1	10.0	0.0	9.6	23.5	9.1	22.6	11.3	19.4	12.0	25.1	11.5	6.9	7.3	17.2	10.1	9.2	18.8	6.3	11.0	16.6	0.0	10.8	127.0	14.2	9.9	9.3	16.8	9.9	54.0	7.5	5.5	8.1	10.7	22.2	1.3	10.0	8.9	12.6	6.2	10.1	63.5	13.8	12.2	12.4	13.3	36.2	12.5	9.4	7.2	22.5	12.0	5.6	6.2	29.7	55.0	13.3	13.5	6.4	8.7	20.9	13.0	6.0	13.4	12.6	6.6	5.8	8.5	19.1	13.4	19.5	22.9	4.5	13.0	4.3	17.9	14.6
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889113-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	8.9	10.7	0.1	11.0	0.0	0.0	0.3	0.4	1.7	3.3	2.7	24.6	23.4	9.4	13.1	19.4	3.5	20.2	22.6	1.6	0.0	38.3	5.1	58.5	0.3	0.2	0.0	88.3	10.4	1.3	3.5	137.2	0.1	37.0	21.2	0.0	0.1	42.2	1.1	0.1	26.7	14.3	0.0	100.4	21.0	3.4	0.1	0.1	0.3	0.7	0.0	40.3	8.5	0.1	0.0	1.3	0.0	0.2	0.2	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	51.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.7	1.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	5.5	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.0	1.9	123.8	0.5	0.0	0.0	0.5	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	102.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.9	0.1	0.3	0.0	0.0	0.0	0.0	118.3	0.3	20.8	0.3	0.4	1.4	0.0	5.7	0.1	14.5	0.0	0.4
TCF25	"KIAA1049, Nulp1"	ENSG00000141002	"Transcription factor 25"	Q9BQ70	16	89873570-89913627	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041699, HPA041786"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"			"HPA041699: AB_10960254, HPA041786: AB_10960526"	"unprognostic (1.33e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (6.67e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.08e-1)"	71.9	91.2	48.2	51.1	53.7	98.7	71.0	45.6	58.4	72.2	34.6	77.4	61.4	77.4	42.3	69.3	69.0	55.0	73.4	50.7	52.1	65.8	78.4	68.3	63.8	48.2	44.8	85.3	85.9	65.4	85.7	53.3	52.4	70.6	37.2	22.9	72.8	53.7	83.8	71.8	70.9	46.1	35.2	78.0	84.9	76.9	48.8	45.0	77.7	41.4	44.4	73.3	65.4	48.1	51.1	72.9	80.6	107.8	65.4	70.1	89.7	122.4	91.9	91.9	42.9	46.9	75.4	120.2	95.0	88.2	30.7	50.3	45.7	53.8	36.5	50.6	96.7	61.2	71.0	94.4	109.7	72.1	78.7	84.8	55.3	56.6	61.1	90.4	83.1	46.7	113.6	72.4	95.4	166.8	78.4	138.9	52.1	77.3	40.4	122.4	77.2	68.2	78.1	69.0	71.7	42.7	184.5	70.5	67.9	33.6	66.0	75.1	126.6	75.0	81.6	42.7	51.8	91.0	34.7	68.7	72.0	83.0	98.8	124.5	131.5	107.5	97.8	107.4	72.3	74.9	71.2	76.3	91.5	93.2	60.1	63.0	222.6	78.2	102.9	145.3	67.2	81.0	48.2	53.7	45.6	58.4	50.7	52.1	48.2	44.8	52.4	35.2	48.8	48.1	160.7	160.3	154.7	64.3	170.9	102.3	155.7	145.6	124.7	360.0	135.7	142.0	90.7	107.2	148.7	165.5	277.3	249.1	277.8	194.9	148.7	110.8	271.7	165.3	209.1	143.3	148.2	85.0	65.2	152.3	329.5	149.4	181.5	203.1	172.8	153.1	126.7	157.7	156.4	464.4	69.7	233.2	120.1	154.6	161.0	383.9	173.4	160.2	186.7	45.0	195.6	150.8	307.9	38.7	54.7	117.2	179.7	184.3	236.4	175.1	192.8	179.1	162.7	279.4	157.8	119.1	152.1	192.7	74.6	114.9	104.0	538.8	193.8	185.4	185.6	199.4
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114681-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 604.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;T-cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 28.8;memory CD4 T-cell: 49.7;memory CD8 T-cell: 29.0;naive CD4 T-cell: 97.2;naive CD8 T-cell: 62.3;NK-cell: 43.0"	"Group enriched"	"Detected in many"	20	"NK-cells: 43.0;T-cells: 97.2"	"Cell line enriched"	"Detected in many"	6	"MOLT-4: 1324.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	4.1	5.3	2.0	56.4	1.8	16.4	4.0	1.8	1.9	3.2	21.3	5.8	16.0	3.9	41.5	3.5	43.1	6.2	2.4	3.1	1.5	4.0	5.8	5.6	94.4	5.9	2.7	1.8	9.4	2.1	6.4	3.5	2.2	5.0	6.8	1.5	8.0	3.5	1.4	4.3	20.4	1.8	3.8	34.6	11.0	3.4	2.1	604.3	6.3	1.0	70.0	9.8	2.0	2.6	0.2	7.8	8.2	29.2	3.9	16.2	11.4	2.2	4.4	0.7	0.8	61.6	19.3	0.4	14.0	13.4	32.3	1.0	13.1	3.1	0.6	3.0	12.2	0.2	7.4	46.4	0.4	0.4	1.6	1.1	0.1	12.6	0.7	5.7	1.8	218.2	7.9	0.3	1.3	0.7	1324.2	1.4	9.0	19.2	10.4	1.6	0.0	1.4	3.0	1.4	3.4	25.1	6.0	1.8	1.6	6.4	1.6	7.3	1.9	81.2	0.5	37.0	2.8	1.3	0.1	0.4	42.7	0.5	4.1	2.2	0.3	3.2	12.3	0.2	28.8	3.5	49.7	29.0	0.2	1.4	97.2	62.3	1.9	43.0	0.2	0.5	6.5	21.8	2.0	1.8	1.8	1.9	3.1	1.5	5.9	2.7	2.2	3.8	2.1	2.6	6.0	3.2	1.9	4.6	27.3	15.7	27.9	6.9	2.8	28.6	14.5	14.9	3.1	10.0	2.9	3.7	73.0	21.6	47.4	18.4	0.0	6.1	3.8	57.6	30.4	9.6	12.6	5.3	2.4	9.9	30.5	11.7	6.6	35.8	20.3	12.1	6.8	3.0	7.1	10.1	2.0	17.0	6.1	9.7	20.0	2.3	6.2	8.7	10.6	1.0	17.1	12.4	41.2	3.5	4.1	23.6	18.5	4.5	9.3	24.6	50.8	1.4	2.5	58.4	0.0	61.4	16.1	4.0	11.0	3.3	11.4	30.0	108.3	8.6	24.1	14.9
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841005-62861822	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.6;Oligodendrocytes: 32.4;Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055223, HPA076419"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA055223: AB_2682745, HPA076419: "	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	7.0	4.3	48.1	4.9	56.0	4.8	7.4	48.4	73.3	7.3	35.4	7.7	3.7	6.5	7.4	6.9	6.6	5.8	6.6	42.7	44.4	5.6	5.5	4.1	6.1	51.4	54.7	9.5	5.6	9.9	4.8	5.7	52.3	5.4	4.3	8.9	5.8	6.9	5.7	13.6	4.9	6.3	53.8	5.0	4.8	74.0	49.2	11.8	18.3	7.2	6.1	7.1	5.4	62.4	23.4	6.9	14.9	17.6	31.1	31.3	13.3	14.9	20.1	28.5	15.6	16.9	14.1	11.8	16.7	13.2	15.1	25.0	15.1	16.8	24.7	8.3	12.7	9.9	20.9	25.3	12.2	14.4	11.4	11.6	24.2	8.1	16.4	12.1	12.9	17.9	11.1	4.4	13.3	28.1	63.4	18.0	9.8	19.2	21.7	34.8	25.9	16.8	7.6	6.8	21.3	11.5	26.2	10.4	41.3	10.5	17.9	26.5	14.1	22.4	14.6	19.7	17.7	11.0	8.0	9.9	13.6	17.6	12.7	0.1	0.3	0.6	0.6	0.3	0.4	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.5	0.2	0.3	0.4	0.4	0.1	48.1	56.0	48.4	73.3	42.7	44.4	51.4	54.7	52.3	53.8	49.2	62.4	8.9	0.0	1.5	4.9	3.3	10.5	1.6	1.6	0.6	10.2	4.6	5.0	4.7	5.7	1.3	7.3	6.2	0.6	3.7	1.3	1.9	1.4	23.6	2.7	6.9	6.6	2.4	1.7	10.6	1.2	0.9	5.2	1.5	2.7	0.0	7.8	3.3	3.8	1.0	8.4	7.4	2.5	2.0	4.0	6.2	9.4	7.8	2.4	3.6	3.7	2.1	12.8	1.0	10.1	32.4	1.0	1.8	7.2	0.9	1.5	1.2	2.2	1.8	6.9	0.0	4.8	4.1	64.6	8.9	2.1	14.2	0.3	2.5	5.8	2.3	1.3
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0"	"Low region specificity"	"Detected in many"							HPA028375	Approved					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	41.4	0.2	0.0	0.0	2.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	6.4	0.1	0.5	2.8	0.5	1.2	2.5	2.0	0.0	0.3	1.8	0.0	0.6	0.0	0.3	0.0	0.0	0.2	1.4	0.2	3.5	1.8	0.0	0.5	0.2	7.5	0.9	0.0	0.8	0.0	0.1	2.5	0.0	0.6	0.0	0.5	0.5	0.0	26.2	9.5	0.2	0.3	21.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.7	0.0	0.0	3.2	1.4	22.6	29.1	1.0	2.4	5.2	0.8	0.1	0.0	0.1
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084141-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"SK-BR-3: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"		NA	NA					"Cluster 8: SK-BR-3 - Unknown function"		"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038638, HPA061543"	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: AB_2684556"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	6.5	7.3	9.7	8.9	10.6	6.8	6.6	10.9	11.3	10.1	8.1	10.4	7.3	9.1	7.5	15.4	7.6	5.9	8.1	9.4	10.5	7.8	5.6	7.3	11.7	10.4	10.5	8.9	10.9	7.4	6.4	7.6	10.5	8.6	6.8	9.2	10.5	7.9	9.1	27.4	8.2	7.6	9.2	11.8	8.2	9.3	10.7	10.4	8.6	7.0	11.6	9.3	13.8	11.0	27.6	24.0	12.7	15.3	11.0	11.9	17.3	25.6	13.4	21.8	12.1	15.2	9.4	38.2	7.2	14.9	11.8	22.5	14.0	16.0	19.5	20.7	13.8	27.6	15.3	15.0	13.3	38.0	20.4	9.8	19.1	22.9	17.1	13.7	19.7	23.8	30.5	7.5	18.2	18.9	35.0	38.4	15.3	6.6	24.2	31.7	24.9	32.4	9.9	24.2	18.8	19.8	18.5	19.8	18.2	9.0	17.9	27.2	21.8	22.2	15.5	14.3	32.7	21.8	29.5	27.0	23.5	31.0	23.7	0.0	2.7	2.3	3.6	1.7	2.6	2.0	3.2	4.5	2.1	1.3	3.2	2.5	2.7	5.9	3.7	1.5	4.7	3.1	9.7	10.6	10.9	11.3	9.4	10.5	10.4	10.5	10.5	9.2	10.7	11.0	11.7	19.2	21.4	18.9	10.4	9.8	7.7	9.5	8.0	28.9	11.3	11.4	13.2	17.2	12.0	7.3	18.8	11.2	14.3	12.8	9.8	20.7	32.5	23.0	19.1	15.2	14.8	15.4	8.3	15.1	8.4	11.4	10.2	13.2	13.3	15.7	7.9	7.4	11.6	25.2	12.3	10.7	10.2	13.0	7.8	47.6	11.1	11.4	7.2	1.9	14.3	13.9	35.0	10.1	19.4	18.8	14.4	27.8	15.0	9.1	14.2	6.6	33.6	24.0	13.1	19.6	12.6	25.1	33.2	14.8	24.7	7.0	15.9	30.9	12.2	30.7
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153482-40155310	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.5;Alveolar cells type 2: 882.5;Collecting duct cells: 200.5;Distal tubular cells: 193.7;Ductal cells: 331.6;Glandular and luminal cells: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 48.5;AF22: 134.4;BJ: 51.5;BJ hTERT+: 134.4;EFO-21: 87.5;HeLa: 94.8;RPTEC TERT1: 67.2;SuSa: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	91.5	24.2	6.2	42.9	7.4	0.0	64.0	6.0	10.8	134.1	10.6	68.7	30.9	67.7	18.3	22.3	20.3	105.2	130.8	6.5	6.5	252.6	210.0	165.4	18.0	6.5	6.6	44.6	51.5	70.3	18.9	165.1	6.9	67.7	71.1	4.5	176.0	28.3	37.7	13.2	101.4	43.5	6.9	83.3	56.1	4.8	8.6	3.8	53.9	47.9	4.1	255.3	26.2	7.8	0.0	48.5	134.4	0.0	0.0	0.0	0.3	51.5	134.4	0.2	0.6	0.7	0.0	0.0	87.5	1.0	0.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	94.8	21.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.2	67.2	0.1	0.1	0.2	0.2	4.6	0.0	50.4	0.0	0.0	43.6	0.0	1.2	0.4	0.8	1.2	1.7	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.4	6.0	10.8	6.5	6.5	6.5	6.6	6.9	6.9	8.6	7.8	209.5	99.3	882.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	124.9	62.0	0.0	0.0	77.4	200.5	0.0	12.3	1.5	0.0	193.7	331.6	0.0	152.6	90.7	103.2	0.0	0.0	0.0	111.2	26.5	13.5	0.0	397.4	26.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.1	0.0	0.0	2.5	8.7	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	4.5	8.1	22.7	0.0	0.0
TCIRG1	"a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7"	ENSG00000110719	"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3"	Q13488	11	68039025-68050895	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 289.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 135.5;Kupffer cells: 115.2;Macrophages: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 131.9;RPMI-8226: 138.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038742	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria		"HPA038742: AB_10795138"	"unprognostic (5.35e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.50e-11)"	"unprognostic (2.48e-3)"	"unprognostic (7.88e-3)"	"unprognostic (2.50e-1)"	"prognostic favorable (9.45e-6)"	56.8	112.5	7.1	46.1	7.1	97.7	47.2	9.2	14.5	85.1	11.4	66.6	44.2	58.0	18.6	45.3	61.4	11.7	27.9	6.6	7.2	35.5	61.7	113.9	30.9	10.9	9.3	49.1	289.2	4.4	20.3	14.1	12.0	72.2	8.0	0.3	57.9	16.1	10.5	25.9	87.0	12.1	9.1	194.8	59.2	6.7	18.1	12.1	52.5	3.9	13.4	56.1	60.7	10.8	31.8	57.2	0.8	0.2	25.1	19.7	39.0	61.5	29.4	17.2	16.3	1.3	92.0	2.7	32.9	21.9	26.2	39.0	3.7	23.5	3.6	82.1	1.9	22.0	80.6	18.9	23.4	16.3	131.9	22.8	13.5	21.2	1.4	0.0	11.8	1.2	11.6	8.4	5.7	10.7	0.8	97.8	3.5	44.6	14.4	26.8	0.9	138.6	16.2	17.6	3.0	0.7	26.0	33.4	16.8	6.1	36.3	41.1	42.3	33.2	25.9	93.3	11.4	1.3	1.2	4.8	74.0	26.7	16.2	21.7	65.5	72.8	15.7	109.0	12.7	11.3	11.7	16.9	49.0	7.5	6.6	7.2	150.0	32.1	144.3	33.8	12.1	47.8	7.1	7.1	9.2	14.5	6.6	7.2	10.9	9.3	12.0	9.1	18.1	10.8	40.6	28.9	59.8	0.3	37.1	6.2	13.2	36.2	7.4	0.7	14.9	8.9	1.6	18.6	57.1	7.3	0.0	21.7	60.6	74.2	0.0	30.4	0.4	13.3	16.7	22.1	23.9	15.2	0.3	67.0	54.1	24.9	135.5	21.5	50.0	29.5	21.0	17.8	105.1	0.0	0.6	32.4	18.3	115.2	22.8	0.6	5.9	132.3	5.4	8.4	74.9	0.7	45.3	0.5	0.1	51.8	85.4	13.2	59.1	10.6	45.5	2.0	47.9	1.0	39.5	7.7	26.0	0.1	2.9	10.4	5.3	26.5	46.5	9.0	36.2	19.0
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 267.6"	"Group enriched"	"Detected in some"	4	"B-cells: 282.5;dendritic cells: 210.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	142	"Daudi: 459.4;REH: 599.4;U-698: 616.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	1.0	0.1	0.1	34.4	0.1	20.3	0.2	0.1	0.1	0.1	0.0	2.4	0.8	0.8	0.6	0.5	0.1	3.6	0.6	0.1	0.1	0.4	0.4	1.0	267.6	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.2	0.3	2.0	0.0	4.0	0.0	0.1	0.4	14.2	0.3	0.0	56.7	3.4	7.7	0.1	19.1	1.1	0.0	216.0	2.7	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	459.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	599.4	0.3	0.8	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.1	1.0	1.0	0.2	2.8	0.6	0.2	0.5	3.9	616.2	0.2	0.1	0.1	4.6	1.4	1.8	0.5	0.5	1.3	874.7	0.9	0.4	2.2	2160.3	1.5	0.5	3.3	1.3	1.6	1099.9	1.2	92.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	1.3	0.0	282.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	210.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.9	0.6	2.8	0.0	0.0	2.7	0.0	3.1	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	28.7	60.2	0.0	0.0	0.0	2.7	0.0	0.3	0.0
TCL1B	TML1	ENSG00000213231	"TCL1 family AKT coactivator B"	O95988	14	95686426-95692628	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.5"	"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 72.7"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	24	"naive B-cell: 11.7;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	24	"B-cells: 11.7;dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	7	"U-698: 511.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.0	0.1	0.4	0.7	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.2	0.6	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	2.5	0.4	0.2	0.0	0.0	2.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.5	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	2.5	0.6	0.4	0.0	0.0	1.3	0.0	0.2	0.2	0.4	511.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	0.3	0.0	6.2	0.0	0.3	0.1	0.7	0.1	0.2	0.1	0.2	0.6	0.4	0.5	0.1	0.4	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	9.0	0.0	0.0	72.7	0.0	0.1	0.0	0.1
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357629-150400308	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	13.0	10.8	44.2	14.5	43.8	13.9	13.5	43.4	104.8	15.4	40.1	20.4	7.3	16.7	7.4	16.6	14.8	6.5	14.9	43.3	42.2	14.8	9.5	12.5	18.3	44.3	43.6	15.7	14.8	9.9	11.0	10.3	44.5	15.7	8.7	9.6	12.1	10.8	21.4	16.6	15.3	11.7	40.9	18.8	14.3	14.5	45.0	20.5	12.6	9.7	16.2	19.7	14.1	48.9	78.3	85.0	42.7	80.3	16.2	21.4	115.1	59.4	24.5	81.1	80.9	211.5	59.3	113.1	53.2	21.9	92.6	88.2	93.0	107.4	57.4	59.9	100.8	54.9	55.6	80.8	17.4	91.5	40.7	18.0	24.8	94.1	71.4	20.1	36.1	59.2	80.2	32.8	27.7	70.7	100.4	67.4	128.8	35.3	80.4	91.4	67.4	64.8	19.5	54.3	58.0	59.7	68.5	111.0	55.2	66.8	49.7	36.1	35.0	59.3	73.5	71.8	113.4	40.6	55.6	123.4	46.6	78.2	54.1	1.6	2.2	1.1	3.8	2.0	4.8	4.6	3.6	3.8	2.1	4.2	3.1	3.4	1.4	8.3	2.1	2.2	2.4	3.2	44.2	43.8	43.4	104.8	43.3	42.2	44.3	43.6	44.5	40.9	45.0	48.9	18.5	9.6	22.4	7.8	41.7	40.0	21.1	14.5	15.9	25.4	13.6	12.7	17.9	11.5	10.4	11.0	41.7	21.7	29.7	24.0	5.9	19.6	8.4	13.2	17.3	24.4	18.7	23.3	7.4	23.4	41.0	20.1	18.3	17.6	23.5	29.1	12.8	10.0	28.8	21.9	6.4	18.8	16.2	27.9	53.3	6.8	19.0	40.0	12.4	2.8	27.8	9.7	33.0	3.0	8.9	15.2	8.4	15.8	26.1	37.8	15.1	6.3	10.1	25.6	26.3	20.3	17.7	27.6	34.1	22.7	39.1	8.9	26.3	20.1	32.0	19.3
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789703	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 586.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavorable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	114.1	92.9	110.5	90.8	117.0	181.5	106.0	119.2	179.4	88.3	118.1	103.6	71.7	97.8	84.9	103.8	93.2	69.2	114.8	117.4	120.5	105.8	98.0	89.5	105.7	117.3	118.1	122.8	96.0	98.2	57.0	83.5	120.9	81.0	108.1	76.8	92.2	72.6	171.8	101.3	84.7	99.7	122.2	82.2	92.3	174.0	118.0	98.2	77.1	125.4	128.3	101.9	84.8	141.4	236.3	284.1	296.9	405.2	260.5	209.0	456.5	344.6	170.4	423.3	320.9	571.4	170.9	579.5	233.4	275.2	494.7	339.0	793.5	350.2	601.5	301.8	380.6	606.7	292.7	545.9	199.1	496.7	308.9	204.3	215.0	417.5	392.0	241.8	381.7	498.8	856.1	262.8	399.4	201.5	620.2	590.4	321.6	305.0	310.3	447.8	219.7	474.7	345.1	170.7	365.8	237.7	323.3	452.3	161.3	386.2	212.6	464.2	264.0	203.9	310.0	467.0	717.6	238.5	531.7	638.4	293.8	571.8	329.1	92.0	73.8	93.6	84.3	99.1	110.1	95.8	92.6	91.7	90.4	74.2	94.4	92.4	34.4	101.1	131.5	55.4	105.0	114.2	110.5	117.0	119.2	179.4	117.4	120.5	117.3	118.1	120.9	122.2	118.0	141.4	122.4	51.3	38.8	12.4	95.4	171.7	304.4	153.2	75.7	39.1	95.2	75.2	68.2	81.5	108.6	27.6	29.2	161.7	80.7	93.8	115.4	191.9	427.4	113.4	140.1	106.4	104.4	119.5	22.8	134.6	288.7	98.6	64.2	122.2	104.6	109.8	51.0	43.8	118.7	30.3	24.3	84.6	120.1	65.7	134.4	586.4	86.0	91.5	108.5	22.5	99.9	73.3	77.2	18.1	25.3	151.1	75.7	92.2	93.0	235.2	84.0	152.3	127.1	53.1	72.3	111.9	247.2	307.3	237.1	93.4	148.0	240.4	116.6	100.6	133.8	249.3
TCP10L	PRED77	ENSG00000242220	"T-complex 10 like"	Q8TDR4	21	32497967-32587373	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 203.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1153.7;Late spermatids: 1940.5;Spermatocytes: 455.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;hTERT-RPE1: 2.0;SCLC-21H: 1.4;THP-1: 1.8"									HPA044709	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA044709: AB_10961410"	"unprognostic (2.31e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.41e-5)"	"unprognostic (4.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-3)"	0.7	0.8	1.3	0.0	1.5	1.4	0.8	3.4	4.1	2.0	0.9	1.1	0.3	0.9	1.9	0.5	1.8	0.4	2.1	1.4	0.9	1.4	18.5	0.6	0.2	1.1	0.7	1.4	0.6	0.2	1.4	0.4	0.6	1.6	0.4	1.9	0.7	0.5	0.7	0.9	0.5	0.0	0.3	0.8	0.6	203.6	1.0	0.4	1.0	0.3	0.4	0.7	1.0	2.0	0.0	0.2	0.3	0.1	0.4	0.2	0.2	0.1	0.4	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	2.2	0.2	0.2	0.2	0.2	0.1	0.4	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.6	0.3	0.8	0.1	0.1	0.0	0.1	0.2	0.3	0.4	0.1	1.4	0.0	0.0	0.0	0.4	0.5	0.3	1.8	0.6	0.4	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.3	1.5	3.4	4.1	1.4	0.9	1.1	0.7	0.6	0.3	1.0	2.0	1.1	0.0	0.5	2.0	0.3	1.1	0.5	1.2	0.0	1.1	0.8	0.9	2.5	1.5	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.6	1153.7	1.9	0.4	0.9	0.0	0.0	2.9	0.2	0.2	0.8	0.0	0.5	4.5	0.7	0.7	23.0	0.3	0.0	1.7	0.8	2.0	0.8	0.3	1940.5	16.8	1.2	0.0	0.0	0.0	3.8	0.0	0.5	1.6	0.2	0.1	10.1	0.0	0.7	0.0	1.5	1.6	1.1	26.3	0.4	0.6	455.0	9.2	0.0	1.4	0.3	0.1	0.1	0.4	0.2
TCP10L2	bA517H2.3	ENSG00000166984	"T-complex 10 like 2, pseudogene"	B9ZVM9	6	167146414-167196913	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.7;Late spermatids: 10.8;Spermatocytes: 39.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB034197, HPA044709"	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB034197: AB_2202388, HPA044709: AB_10961410"			"unprognostic (5.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"		"unprognostic (2.52e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.40e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	39.5	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0
TCP11	"D6S230E, FPPR, KIAA0229"	ENSG00000124678	"T-complex 11"	Q8WWU5	6	35118071-35148610	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	338	"testis: 340.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1921.3;Late spermatids: 6899.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.6;WM-115: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048311	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA048311: AB_2680351"	"unprognostic (1.35e-1)"	"prognostic favorable (5.02e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.43e-4)"	"unprognostic (8.09e-7)"	"unprognostic (4.06e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.98e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.54e-4)"	"unprognostic (9.41e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-1)"	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.7	0.1	1.0	0.1	0.2	0.0	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.0	0.2	340.8	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.1	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1921.3	0.3	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	6899.4	30.1	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	29.0	0.0	0.1	0.0	0.1	3.6	0.0	13.1	0.0	0.1	375.1	26.2	0.0	0.1	0.0	0.0	0.2	0.0	0.2
TCP11L1	FLJ11336	ENSG00000176148	"T-complex 11 like 1"	Q9NUJ3	11	33039417-33105943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005769	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Golgi apparatus"	"HPA005769: AB_2202398"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.99e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.50e-3)"	6.3	5.0	5.6	5.5	7.9	7.4	4.5	0.7	7.3	4.8	0.0	6.9	6.1	5.0	3.3	4.9	4.0	8.1	4.7	9.6	7.4	5.9	4.0	4.6	4.9	4.9	8.9	5.3	5.7	4.0	5.0	7.0	8.3	5.0	7.2	6.0	4.9	7.0	3.0	5.4	8.9	8.7	1.0	5.4	4.2	5.6	3.1	7.6	3.2	4.1	5.7	5.8	4.5	7.5	11.9	21.3	10.7	10.2	18.3	20.3	7.2	16.9	14.4	12.8	17.3	11.0	5.6	12.3	4.6	33.1	19.0	18.7	14.5	13.2	18.2	16.1	13.0	8.3	23.1	8.1	12.0	8.2	10.8	16.4	16.2	13.2	25.0	14.6	12.8	17.4	5.2	14.3	32.4	17.6	8.1	3.2	8.0	8.8	8.2	9.4	22.4	2.2	11.6	4.6	9.1	18.3	43.3	27.5	7.9	13.5	7.0	3.4	20.0	22.7	32.5	25.7	18.1	17.5	19.7	13.9	16.5	4.0	18.1	18.6	6.1	8.8	3.4	3.9	3.4	2.1	1.8	3.8	5.9	2.8	1.8	2.4	3.6	4.8	1.1	11.1	5.9	3.5	5.6	7.9	0.7	7.3	9.6	7.4	4.9	8.9	8.3	1.0	3.1	7.5	4.9	9.6	1.1	12.7	5.0	2.3	10.7	4.2	12.0	5.6	1.7	2.0	3.1	2.8	1.8	0.0	4.2	3.8	4.6	3.5	1.9	4.6	11.6	1.8	4.4	4.5	1.8	2.1	22.5	4.0	19.2	6.3	3.1	2.3	4.5	2.4	4.2	1.6	6.8	8.4	23.7	1.2	2.0	5.7	5.2	6.3	1.8	6.9	0.0	18.7	20.2	1.6	8.2	23.1	29.6	5.7	1.6	2.6	11.6	8.9	13.3	5.0	0.7	5.7	0.0	7.0	6.4	10.4	5.4	6.1	2.6	4.7	6.7	2.8	1.4	3.9
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347003	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 98.8;choroid plexus: 79.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.0"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	11.5	8.8	16.4	7.9	43.0	30.3	10.3	32.6	24.5	9.2	79.4	7.7	7.5	10.0	4.2	22.9	13.1	9.5	22.6	12.9	22.4	6.7	6.5	16.7	10.2	46.6	33.2	9.0	6.0	10.2	4.8	14.5	43.3	6.7	9.0	10.3	12.1	6.5	17.9	13.9	9.8	8.2	28.4	11.7	12.1	10.6	30.8	13.6	11.6	23.0	16.8	8.5	9.3	98.8	3.3	8.1	1.1	2.3	10.6	12.2	5.0	2.1	10.2	1.3	3.2	1.3	4.3	1.1	3.2	8.1	3.0	15.2	1.0	4.5	2.3	1.7	3.3	0.7	3.4	5.1	10.4	0.3	2.1	15.4	10.2	1.6	7.6	25.1	7.5	5.9	2.0	1.5	1.9	2.4	2.0	1.7	1.4	4.4	5.0	1.0	0.3	3.8	10.1	15.2	5.0	3.6	5.5	1.7	6.0	8.4	4.6	0.3	5.7	1.9	1.6	2.9	0.5	10.0	0.8	3.8	5.3	0.3	1.0	29.6	6.9	11.0	4.8	3.1	3.6	12.4	9.9	5.4	1.7	10.6	12.2	8.3	67.0	4.3	5.3	1.2	12.3	3.8	16.4	43.0	32.6	24.5	12.9	22.4	46.6	33.2	43.3	28.4	30.8	98.8	12.6	12.8	14.4	15.0	23.1	1.1	3.4	4.4	5.7	8.1	3.5	5.5	10.5	0.0	8.6	3.7	22.9	1.5	13.4	4.2	1.9	3.6	6.3	28.6	7.3	12.1	4.2	33.7	7.7	2.6	0.8	10.5	11.2	20.5	2.5	4.3	6.1	1.5	1.2	21.9	23.9	5.0	2.0	3.1	2.0	4.5	5.9	5.2	3.6	12.2	8.0	3.1	10.3	9.0	111.0	3.7	4.8	2.6	9.9	4.0	5.9	1.2	16.7	13.4	13.1	11.8	7.2	4.3	3.0	6.3	2.6	15.1	12.4	8.0	1.2	8.7
TCP11X1		ENSG00000268235	"T-complex 11 family, X-linked 1"		X	102215301-102229532	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Uncertain					NA	NA									"HPA048311: AB_2680351"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCP11X2		ENSG00000215029	"T-complex 11 family, X-linked 2"		X	102456862-102471842	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"Early spermatids: 4.6;Late spermatids: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Supported					NA	NA						"Cluster 25: Spermatids - Spermatogenesis"			"HPA048311: AB_2680351"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	21.7	48.0	49.1	13.1	52.3	12.3	21.5	50.1	52.9	23.2	47.0	24.7	18.9	23.1	60.6	15.6	26.1	16.6	22.6	48.4	50.6	51.0	41.9	23.5	15.8	51.6	51.6	27.1	24.1	39.8	48.8	14.5	52.3	34.5	28.8	14.0	21.8	25.1	19.6	14.2	23.1	21.8	48.8	25.9	23.3	15.7	52.1	20.1	45.3	13.8	16.0	25.4	15.9	51.5	12.8	15.5	9.8	14.8	42.5	18.5	12.9	26.0	19.2	25.8	21.6	9.1	13.6	15.2	18.6	61.5	29.6	14.4	19.3	26.2	21.0	22.9	13.4	25.4	19.6	11.9	25.8	10.9	31.9	40.2	26.8	28.7	22.9	24.7	27.0	12.0	9.4	33.8	63.8	11.7	13.4	9.8	8.0	24.1	35.5	8.1	10.6	36.0	44.5	16.7	26.3	8.7	30.9	33.8	28.6	19.7	28.8	10.2	24.5	19.3	11.9	40.4	9.8	18.4	26.1	10.4	45.4	19.3	27.2	20.4	17.8	23.2	19.1	34.2	11.1	12.0	12.0	14.7	10.1	13.7	14.9	15.5	20.1	23.0	47.5	15.6	17.8	22.4	49.1	52.3	50.1	52.9	48.4	50.6	51.6	51.6	52.3	48.8	52.1	51.5	15.5	25.6	15.6	8.8	19.3	2.7	10.0	10.3	14.2	10.2	19.9	18.0	14.1	20.0	12.9	27.6	12.5	25.9	20.5	34.0	46.9	15.3	8.0	15.5	15.0	14.7	17.5	9.0	12.3	11.6	11.5	17.6	53.5	17.0	5.7	7.1	11.4	31.8	24.8	10.1	11.0	19.1	20.3	18.6	6.0	14.3	15.5	19.2	14.2	11.2	15.5	26.3	26.8	11.1	16.8	15.1	28.6	16.1	13.2	13.4	34.9	50.3	22.8	11.3	6.6	13.7	16.6	8.2	6.1	10.4	4.5	20.0	21.6	22.1	16.6	7.9
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66779047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.9;liver: 7.1"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 55.7;granulocytes: 25.9;Inhibitory neurons: 21.6;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 14.6;HUVEC TERT2: 13.4;THP-1: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028420	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.1	0.3	2.5	0.4	2.2	4.4	1.0	2.8	2.2	1.1	6.6	0.8	0.2	0.4	0.1	0.3	8.9	0.3	3.0	2.3	2.7	3.3	7.1	2.5	0.0	6.3	5.5	0.0	0.2	0.0	0.7	5.7	5.0	0.6	0.3	0.9	0.5	0.6	0.7	0.5	0.5	0.4	4.6	0.2	0.4	0.0	3.5	0.1	0.5	0.2	0.1	0.7	0.7	4.9	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	13.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.2	2.8	2.2	2.3	2.7	6.3	5.5	5.0	4.6	3.5	4.9	7.5	0.0	3.2	2.9	0.3	1.3	0.0	4.5	0.0	0.3	0.1	0.0	0.6	0.0	11.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	55.7	0.5	12.5	0.0	0.8	13.2	0.0	0.0	0.5	0.0	0.5	25.9	0.0	0.7	3.5	2.7	0.0	21.6	0.0	0.0	0.6	0.8	0.1	0.0	3.0	0.0	1.9	0.3	6.1	0.0	0.5	0.5	0.0	0.0	0.4	1.2	0.5	0.0	0.0	104.2	0.6	0.0	0.4	1.3	0.0	0.1	0.0	0.6	0.0	3.1	0.1	0.0	0.1
TCTEX1D4		ENSG00000188396	"Tctex1 domain containing 4"	Q5JR98	1	44805893-44807351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 21.6;fallopian tube: 10.2"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 94.5;Respiratory ciliated cells: 129.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 7.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.7;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062652	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA062652: AB_2684818"	"unprognostic (3.12e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.58e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.83e-3)"	1.1	2.0	0.7	1.2	1.0	2.4	0.4	1.1	2.1	1.1	21.6	0.4	0.4	1.3	2.2	0.7	10.2	1.8	0.6	0.9	1.4	0.6	0.6	2.8	0.3	5.1	4.0	0.4	0.9	0.4	0.8	0.1	3.0	0.3	0.1	0.0	1.1	0.3	0.4	0.6	0.5	0.1	2.6	0.4	1.0	0.4	3.9	0.0	0.9	0.2	0.0	0.4	0.3	3.0	0.5	0.9	0.3	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.4	0.7	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	1.1	0.0	0.1	0.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.5	0.9	0.0	0.0	1.8	0.1	0.7	0.2	0.3	0.7	0.4	0.0	0.2	0.2	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.2	0.7	1.0	1.1	2.1	0.9	1.4	5.1	4.0	3.0	2.6	3.9	3.0	0.2	0.0	0.5	0.0	0.3	0.3	0.4	11.4	0.0	0.0	0.6	0.8	0.2	1.5	10.6	1.8	0.0	0.2	0.1	0.9	0.0	1.2	0.0	94.5	0.9	0.4	0.0	0.0	0.0	4.0	0.2	0.4	0.0	1.5	0.0	0.2	0.0	1.2	0.8	0.0	0.0	1.7	10.2	1.2	0.9	0.1	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	2.4	0.0	0.0	0.4	2.3	1.3	129.4	0.0	0.0	0.8	3.8	0.1	0.6	0.0	0.0	0.3	0.3	0.5	0.6	0.5
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110663431	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 98.9;Respiratory ciliated cells: 203.7;Spermatocytes: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments,Microtubules"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"	"Nucleoplasm, Vesicles, Microtubules"	"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.8	14.0	5.6	2.0	5.3	1.0	8.4	9.3	7.5	10.1	18.2	7.1	1.5	9.0	10.7	4.5	15.3	5.6	17.0	5.7	4.5	19.0	9.1	8.3	2.5	4.5	5.0	12.8	10.8	15.2	26.2	4.0	4.4	10.0	0.9	3.0	9.5	6.1	10.3	5.3	4.0	3.6	3.6	4.6	6.9	21.1	5.2	1.3	17.6	1.9	0.8	7.7	7.0	7.0	11.6	11.7	6.7	17.6	24.9	18.0	4.3	6.3	16.2	5.9	4.4	1.2	2.7	2.0	6.9	18.6	7.2	6.1	4.7	4.6	5.0	4.7	8.7	0.3	4.1	3.6	8.6	1.2	1.3	14.8	7.8	7.7	7.9	34.7	3.3	3.0	7.4	2.5	9.7	9.4	0.9	2.2	4.1	3.5	16.7	2.4	2.9	14.6	16.8	1.8	5.5	11.7	13.1	1.6	5.3	5.5	22.7	16.0	4.0	8.2	2.4	3.5	6.0	4.2	2.6	2.6	11.1	1.3	9.3	0.0	2.0	0.0	0.8	3.6	2.2	4.9	1.5	2.5	3.4	9.1	2.2	1.6	6.4	1.0	1.9	4.3	0.5	2.0	5.6	5.3	9.3	7.5	5.7	4.5	4.5	5.0	4.4	3.6	5.2	7.0	6.5	3.2	18.8	25.5	24.0	13.8	28.4	38.4	18.2	10.7	22.8	19.3	13.0	24.3	26.0	16.5	31.3	30.9	5.8	1.0	9.8	24.3	82.7	98.9	29.0	11.5	18.0	1.3	15.0	4.7	8.5	30.5	8.2	9.8	3.8	27.1	9.3	6.9	11.8	3.3	12.1	4.8	32.6	3.8	12.4	18.7	17.1	7.0	23.2	7.5	1.7	30.5	0.0	12.5	9.3	4.2	2.4	28.6	9.6	20.0	0.4	42.5	203.7	34.1	6.6	16.2	18.3	96.9	30.1	8.5	11.2	18.3	4.2	38.1	4.7	16.6
TCTN2	"C12orf38, FLJ12975, JBTS24, MKS8, TECT2"	ENSG00000168778	"Tectonic family member 2"	Q96GX1	12	123671110-123708399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039900	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus, Vesicles"		"HPA039900: AB_10673366"	"unprognostic (3.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-3)"	"unprognostic (3.14e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.68e-1)"	5.3	4.4	5.5	2.6	6.4	1.9	7.2	5.8	5.3	10.0	30.4	5.7	2.1	11.0	11.0	3.4	28.5	6.4	4.8	4.9	9.5	10.0	1.4	8.3	3.3	8.4	11.5	14.7	6.9	14.1	16.3	4.6	6.5	9.6	4.0	17.6	9.1	8.6	1.7	8.3	3.8	6.0	7.1	4.1	5.4	11.1	8.7	2.5	12.4	2.1	3.0	5.2	6.7	4.1	14.9	15.1	10.7	15.6	15.0	16.5	13.1	5.4	10.9	11.5	8.7	7.9	14.5	0.5	9.2	8.9	10.0	19.6	6.2	4.9	11.2	2.5	7.6	1.2	10.6	7.2	5.0	3.7	4.8	8.0	8.8	16.3	4.8	34.9	15.7	5.1	7.1	0.3	7.1	7.9	4.5	7.4	6.8	5.9	9.1	4.0	10.8	1.5	13.7	11.1	6.5	8.3	18.2	6.0	8.4	11.0	25.5	5.6	9.8	16.0	8.2	14.7	7.1	4.3	8.9	1.4	20.9	0.4	9.7	1.7	0.2	1.2	1.9	0.6	2.7	1.9	2.2	2.0	0.4	2.1	2.4	2.4	0.3	0.8	0.5	2.5	1.4	0.2	5.5	6.4	5.8	5.3	4.9	9.5	8.4	11.5	6.5	7.1	8.7	4.1	2.7	3.2	5.3	6.5	1.8	4.1	2.3	2.6	1.2	4.4	4.8	2.3	3.8	5.7	3.9	7.3	12.5	2.8	2.1	1.2	0.0	2.9	6.1	27.6	5.0	1.7	1.2	2.5	10.4	2.1	3.0	4.6	2.6	4.3	3.8	5.0	2.9	0.4	1.3	0.0	14.4	1.8	2.0	0.3	1.2	2.8	2.5	1.0	5.4	2.8	1.4	4.6	1.0	2.5	1.3	2.0	0.8	4.9	1.1	1.4	0.2	1.9	32.1	14.5	0.0	6.0	2.7	11.5	10.9	0.6	2.3	1.1	2.4	2.3	3.0	1.0
TCTN3	"C10orf61, DKFZP564D116, JBTS18, TECT3"	ENSG00000119977	"Tectonic family member 3"	Q6NUS6	10	95659823-95694143	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026987	Approved		Approved	Microtubules	"Intracellular and membrane"	NA	NA		4400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA026987: AB_10600911"	"unprognostic (1.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.78e-2)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.59e-1)"	21.3	25.3	8.6	15.7	9.0	5.1	25.2	9.1	11.3	26.3	24.0	22.1	17.6	24.8	65.0	17.0	35.4	22.7	18.4	8.8	9.8	32.5	26.8	19.4	14.3	9.7	9.5	30.6	27.1	69.9	22.8	26.9	9.5	25.6	25.6	22.2	25.4	27.7	9.5	20.5	15.4	26.8	9.2	17.3	19.1	19.4	9.6	14.0	70.6	11.5	18.0	23.9	18.6	9.2	34.0	54.1	44.1	89.3	93.6	74.6	25.7	45.3	94.8	46.9	55.3	35.4	57.3	31.3	40.1	60.4	49.8	46.7	43.9	54.5	56.5	33.6	36.4	10.9	21.6	49.2	46.9	37.4	22.8	65.2	49.2	46.6	72.4	88.0	80.7	27.7	21.0	40.3	63.4	32.5	23.4	27.9	12.1	49.7	38.1	25.3	33.9	38.3	67.8	23.3	11.5	24.5	37.7	18.5	52.6	40.8	71.0	35.1	37.9	35.6	24.9	23.9	49.5	18.9	37.9	20.7	57.5	47.1	19.0	6.8	14.2	4.9	25.8	21.9	32.0	28.3	23.1	25.2	45.2	19.4	24.2	20.0	1.6	26.8	24.3	23.6	22.2	21.3	8.6	9.0	9.1	11.3	8.8	9.8	9.7	9.5	9.5	9.2	9.6	9.2	14.8	19.2	16.2	16.6	29.3	14.4	23.7	33.8	31.3	24.0	18.2	15.0	8.5	27.1	20.3	31.3	37.5	50.3	18.8	20.2	7.9	27.2	18.6	25.5	25.7	20.4	13.8	11.6	17.3	20.3	44.2	27.3	11.7	18.3	8.2	29.8	21.4	16.8	28.5	25.2	17.7	12.5	26.4	14.1	59.1	14.1	20.8	18.7	16.0	16.9	14.8	36.7	15.5	20.6	13.7	14.1	12.7	25.2	35.9	19.8	16.2	16.1	27.5	44.4	13.1	23.9	19.8	39.8	34.1	15.3	11.5	31.5	23.0	34.2	23.7	14.6
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 797.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.3	1.6	0.3	16.8	0.5	0.0	0.1	0.2	1.2	0.2	0.2	1.2	3.5	0.4	0.6	0.7	0.3	1.9	0.0	0.5	0.3	0.6	797.8	3.2	3.1	0.2	1.1	0.1	0.3	0.1	4.0	0.6	0.2	0.2	1.4	0.0	0.4	0.2	0.2	0.0	5.9	2.5	0.3	1.9	1.6	0.4	0.3	0.2	0.2	0.0	2.6	7.6	0.1	0.7	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	1.2	0.5	0.3	0.2	1.1	0.2	0.3	0.3	0.7	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
TDRD1	CT41.1	ENSG00000095627	"Tudor domain containing 1"	Q9BXT4	10	114179270-114232304	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 17.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.1;Late spermatids: 5.3;Spermatocytes: 25.6;Spermatogonia: 25.5"	"Cancer enriched"	"Detected in some"	5	"prostate cancer: 4.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 51.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037729	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA037729: AB_10670527"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.15e-2)"		"unprognostic (6.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.60e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.68e-1)"	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.2	2.0	0.2	0.0	0.2	0.3	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	17.5	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.3	0.3	0.2	0.1	0.3	0.4	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.9	3.5	2.8	0.0	0.0	0.0	0.3	2.7	0.3	0.0	0.2	7.1	0.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.3	5.3	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.7	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.5	0.5	25.6	25.5	0.0	0.0	0.1	0.1	0.7	0.1	0.0
TDRD15		ENSG00000218819	"Tudor domain containing 15"	B5MCY1	2	21123968-21144368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 5.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Late spermatids: 12.1;Sertoli cells: 6.6;Spermatocytes: 34.5;Spermatogonia: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.5;U-266/70: 7.5;U-266/84: 3.0"									"HPA051770, HPA054675"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA051770: AB_2681601, HPA054675: AB_2682569"							"unprognostic (4.20e-3)"								"unprognostic (1.46e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	2.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	12.1	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	34.5	8.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TDRD5	"FLJ34823, TUDOR3"	ENSG00000162782	"Tudor domain containing 5"	Q8NAT2	1	179591613-179691272	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 6.5;testis: 21.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 36.1;Late spermatids: 12.1;Spermatocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.7;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.3;U-266/84: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA029418	Enhanced					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA029418: AB_10603035"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-4)"	"unprognostic (3.96e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.41e-4)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.31e-1)"	0.2	0.3	0.8	0.1	1.4	0.3	3.6	0.0	0.8	0.1	0.0	0.6	0.5	0.0	6.5	0.5	0.9	0.2	0.0	0.7	0.4	1.8	0.0	0.1	0.0	0.9	0.9	0.0	0.2	0.3	2.3	0.2	1.0	0.6	0.7	0.3	0.8	0.3	0.0	0.3	0.4	0.0	0.6	0.0	0.3	21.9	1.1	0.1	0.8	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.7	10.3	0.2	0.0	0.0	1.5	0.0	0.0	14.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.8	0.7	0.4	0.9	0.9	1.0	0.6	1.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	3.5	1.8	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	36.1	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.1
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 224.8;Spermatocytes: 82.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.7	3.3	3.0	5.1	0.2	0.8	7.8	5.4	1.2	1.8	1.0	0.7	0.9	3.4	0.6	0.8	2.2	1.6	4.1	2.6	2.1	2.5	0.7	4.0	3.9	3.2	1.1	1.1	0.4	3.0	1.6	4.1	2.0	0.3	8.9	1.3	0.6	2.3	3.5	0.7	0.4	2.7	2.5	0.8	30.3	3.7	0.0	5.6	0.1	0.1	1.1	0.8	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.1	7.8	5.4	4.1	2.6	3.9	3.2	4.1	2.7	3.7	4.0	0.8	9.6	0.5	3.9	0.0	0.5	0.4	0.1	1.2	11.3	0.4	0.8	3.4	0.0	3.8	7.3	6.2	0.0	0.0	0.0	1.9	0.3	224.8	1.0	2.2	1.2	4.2	0.0	13.6	0.2	0.0	1.0	0.0	0.7	0.0	0.4	0.7	3.0	0.1	5.0	14.7	0.3	0.0	0.3	0.0	33.8	4.1	0.5	3.6	6.5	0.0	1.1	0.0	14.6	17.8	0.1	0.0	4.5	0.0	0.6	0.4	0.4	0.2	7.5	13.1	3.0	0.5	82.7	34.7	0.0	1.6	0.0	0.0	1.4	0.5	0.2
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97412096-97496125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 63.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.7;Microglial cells: 33.7;Rod photoreceptor cells: 44.4;Spermatocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 56.5;HDLM-2: 55.6;THP-1: 54.4"	"Low region specificity"	"Detected in all"							"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	7.3	6.2	11.9	8.0	13.6	11.1	6.7	13.0	12.5	6.7	10.4	14.4	15.8	6.9	6.4	8.9	8.8	10.2	6.5	11.0	13.1	6.9	8.1	9.7	8.1	14.2	12.3	7.4	5.7	9.8	5.9	8.9	14.4	6.1	13.9	63.1	7.5	7.3	4.7	5.4	13.7	9.8	14.6	9.0	8.5	36.9	12.3	11.0	7.9	5.4	8.4	8.2	6.7	15.4	17.1	11.7	0.0	4.0	8.7	11.2	9.8	10.6	26.7	35.8	39.9	15.2	14.1	1.1	5.1	15.1	56.5	12.8	9.8	5.4	9.6	55.6	8.3	7.8	5.5	11.1	7.9	17.6	18.0	3.8	10.7	11.9	1.2	10.7	15.7	8.2	4.4	0.8	9.5	10.2	8.8	8.6	1.7	20.1	6.2	3.8	5.9	0.2	8.8	11.4	1.8	4.8	14.8	6.5	41.6	6.2	3.9	54.4	16.1	4.5	4.4	11.4	8.2	5.5	6.9	1.0	10.6	9.4	11.8	1.7	2.2	7.2	1.1	4.3	1.6	3.0	1.5	1.1	3.2	2.5	1.2	1.9	4.2	1.2	4.2	0.7	1.1	1.2	11.9	13.6	13.0	12.5	11.0	13.1	14.2	12.3	14.4	14.6	12.3	15.4	7.0	0.0	3.0	10.4	5.7	1.7	2.6	2.2	2.8	8.2	2.7	2.4	6.4	1.5	4.0	3.7	18.8	1.7	3.0	14.2	5.9	4.4	44.7	11.1	5.2	6.0	6.0	1.7	18.5	4.9	2.2	4.3	10.2	8.0	0.0	5.4	2.9	2.5	4.8	5.0	19.0	7.9	2.0	6.4	1.8	23.9	4.4	7.3	1.8	33.7	10.8	8.6	1.0	21.1	29.9	6.1	7.6	3.8	4.3	2.2	8.9	2.8	12.9	44.4	6.6	3.7	4.2	36.4	15.7	4.4	2.3	0.7	4.7	2.6	7.2	4.3
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.1;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.5	3.1	5.1	4.4	5.1	1.4	4.5	7.9	5.8	2.1	2.3	3.2	2.2	1.6	6.0	1.8	2.0	1.9	3.5	5.5	6.0	4.0	3.6	4.4	5.9	7.4	5.8	0.9	3.0	30.1	4.6	3.6	8.2	6.0	4.0	9.6	7.0	5.7	4.2	2.2	2.2	2.8	4.7	6.3	2.9	22.2	6.0	10.0	7.3	4.9	5.4	2.6	1.7	5.4	10.8	9.4	8.1	18.8	0.5	0.8	7.7	1.8	1.0	5.6	3.7	6.1	15.1	12.6	16.3	0.7	13.1	6.4	11.9	12.5	8.5	32.5	8.3	12.6	2.6	4.2	3.4	2.4	2.0	1.0	4.8	11.8	5.0	1.6	5.9	24.3	9.8	11.0	1.8	29.3	20.3	3.9	6.2	16.0	16.0	2.5	5.0	26.2	9.6	5.3	11.7	19.2	13.2	10.5	12.4	14.5	22.9	9.4	2.4	2.6	4.6	8.2	10.2	22.2	29.4	14.1	12.0	10.1	3.6	5.2	0.9	2.0	8.2	4.3	12.5	3.9	7.6	8.3	2.0	3.6	5.6	6.9	0.6	7.7	8.0	5.3	9.9	4.1	5.1	5.1	7.9	5.8	5.5	6.0	7.4	5.8	8.2	4.7	6.0	5.4	1.0	3.2	8.3	2.3	2.5	0.3	2.1	1.5	0.6	3.4	4.4	1.1	4.8	0.0	2.2	7.3	4.2	2.7	2.4	0.7	1.9	3.1	23.9	1.5	0.2	1.7	0.0	2.1	6.6	2.5	2.9	0.5	2.6	1.2	4.5	4.6	1.4	1.6	5.4	6.7	5.9	0.9	2.0	2.6	1.3	60.4	0.3	2.3	1.8	2.8	2.2	1.8	0.0	6.0	8.3	1.9	0.3	2.2	1.9	1.6	0.1	1.4	1.4	3.5	13.1	1.9	1.0	43.2	27.4	0.4	0.1	2.5	2.9	0.6	0.9	1.8
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489803-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 151.3;Early spermatids: 80.7;Syncytiotrophoblasts: 272.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 56.1;HBEC3-KT: 27.6;hTERT-RPE1: 23.7;SuSa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008462	Approved		Supported	Vesicles,Cytosol		NA	NA		52000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	8.7	10.4	12.4	2.2	13.6	0.2	8.7	12.8	14.4	13.3	23.0	6.8	2.1	10.0	9.8	3.9	18.5	10.7	4.6	12.5	14.7	26.9	15.9	9.8	4.4	14.2	13.5	19.5	8.9	16.1	16.7	36.4	13.2	14.7	2.6	16.9	6.5	8.6	1.7	3.3	4.9	5.1	12.4	4.0	6.1	14.0	15.5	4.8	24.6	2.6	5.1	9.9	7.7	10.8	9.9	9.8	16.7	0.0	0.0	0.0	56.1	5.6	3.5	5.3	4.6	0.0	0.0	0.0	2.3	1.8	5.3	2.1	0.0	27.6	6.6	0.0	0.7	0.1	0.0	14.8	6.4	0.0	4.1	6.4	21.4	0.0	10.0	23.7	0.8	0.1	1.2	0.0	5.7	0.0	0.1	0.1	20.0	0.0	2.1	0.0	0.0	0.0	17.0	14.5	5.0	8.1	0.0	17.2	4.5	27.4	5.7	0.0	0.3	0.3	1.7	0.0	0.5	0.0	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.6	12.8	14.4	12.5	14.7	14.2	13.5	13.2	12.4	15.5	10.8	20.4	22.4	15.4	41.8	1.0	23.5	28.6	7.3	39.3	17.8	15.8	10.8	4.4	12.8	10.5	18.4	2.1	151.3	0.4	0.5	43.0	10.2	80.7	19.5	10.7	21.2	7.8	0.0	33.3	4.8	61.2	12.2	0.5	7.3	0.0	9.7	7.9	21.0	12.7	10.1	39.9	1.6	16.2	1.9	5.8	16.1	7.2	7.4	8.8	53.4	0.2	9.2	0.0	16.6	4.5	2.9	1.0	6.4	2.5	34.3	0.0	20.7	28.4	12.4	19.7	9.0	10.5	21.5	11.0	7.1	7.0	272.1	0.9	1.7	0.7	14.7
TEAD3	"ETFR-1, TEAD5, TEF-5"	ENSG00000007866	"TEA domain transcription factor 3"	Q99594	6	35473597-35497079	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7;Cytotrophoblasts: 56.4;Extravillous trophoblasts: 70.3;Syncytiotrophoblasts: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA028906	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA028906: AB_10603347"	"unprognostic (1.77e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.01e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.92e-2)"	17.8	6.3	2.4	12.8	2.3	0.2	17.6	2.0	2.6	41.4	4.4	85.8	18.6	79.3	8.5	37.4	50.8	19.9	22.9	2.1	2.0	14.6	12.4	24.2	2.5	4.2	3.0	28.4	10.7	19.5	7.2	34.5	2.4	36.3	16.6	8.2	24.5	42.4	33.2	45.5	26.5	50.3	2.3	9.2	33.4	5.8	2.7	3.6	14.0	11.3	6.6	59.6	38.3	1.7	22.9	3.8	32.4	16.6	14.3	28.2	93.7	30.6	69.2	30.5	31.4	52.6	12.9	0.0	14.6	32.2	12.5	24.6	5.3	17.6	18.6	0.4	5.2	0.1	14.3	36.4	29.7	3.0	0.7	35.7	27.6	27.1	18.7	27.2	1.8	2.2	8.1	0.5	32.3	52.3	1.2	7.7	7.5	21.3	3.7	0.5	12.0	2.1	8.6	42.8	0.6	6.6	9.3	19.9	7.3	39.8	30.6	13.0	2.2	25.8	24.4	9.7	2.4	4.0	4.2	0.1	4.6	0.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.3	2.0	2.6	2.1	2.0	4.2	3.0	2.4	2.3	2.7	1.7	2.1	22.4	10.2	7.8	0.3	18.9	27.6	7.8	18.8	3.1	18.2	16.8	14.9	10.0	12.6	7.3	66.7	56.4	0.3	23.6	3.9	5.7	0.4	8.2	16.9	2.2	3.6	0.0	0.1	7.0	70.3	14.6	9.7	7.9	0.0	5.4	2.2	10.8	5.9	1.7	0.1	13.4	10.2	0.0	2.2	0.7	23.0	1.1	0.0	2.8	1.0	4.0	0.0	5.0	0.2	13.3	12.3	30.5	0.3	26.6	17.7	4.3	10.6	14.5	32.9	17.2	26.8	2.3	4.3	12.6	24.9	159.5	0.9	1.6	15.8	34.3
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 127.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	17.4	5.2	4.2	7.1	3.6	0.4	12.0	5.6	5.5	10.4	4.0	8.1	4.8	9.7	1.0	7.8	8.3	4.5	20.0	3.5	3.9	33.7	4.6	26.0	1.6	5.3	4.8	4.5	51.1	1.6	3.4	10.9	6.1	8.5	4.1	0.5	8.0	5.0	127.3	16.4	8.4	8.9	4.0	9.0	8.1	3.7	6.4	1.6	23.6	46.7	2.4	11.3	7.1	3.6	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.6	5.6	5.5	3.5	3.9	5.3	4.8	6.1	4.0	6.4	3.6	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269838	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 20.7;eosinophil: 13.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	0.9	1.7	0.1	2.1	0.2	6.1	1.4	0.1	0.4	1.2	1.0	1.3	1.6	1.1	4.2	3.4	1.9	1.1	1.3	0.0	0.4	1.1	2.5	2.0	3.1	1.1	0.3	0.4	0.8	1.2	0.6	1.1	1.1	0.5	1.3	1.8	2.3	1.0	0.6	3.6	1.5	0.8	0.3	1.7	1.1	1.2	0.7	2.0	1.3	0.5	3.3	1.0	1.6	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	2.2	1.3	2.7	0.0	2.2	1.9	2.0	0.0	0.1	0.6	1.1	0.0	1.8	0.1	0.8	13.5	1.0	0.1	0.0	2.2	20.3	0.0	0.3	1.7	0.0	1.4	0.0	0.6	7.5	0.5	4.1	1.0	1.3	4.9	0.4	1.4	0.8	3.1	2.7	0.0	3.4	0.9	0.0	0.2	0.6	0.3	0.5	1.1	0.7	4.2	0.0	0.0	0.0	2.8	0.0	20.3	15.4	2.6	0.0	3.0	0.1	20.7	0.6	13.3	0.1	0.7	0.3	1.0	0.2	0.5	1.5	0.7	0.5	0.5	0.5	3.6	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.0	0.4	1.1	0.3	1.1	0.3	0.7	0.2	0.6	6.4	6.8	0.7	6.8	2.5	1.7	0.2	2.8	0.9	1.7	1.1	1.8	7.2	2.6	0.0	0.0	1.5	3.3	2.1	0.0	1.7	6.4	13.9	1.5	1.2	3.0	12.6	6.7	1.1	0.1	0.8	0.0	25.1	19.6	0.7	0.0	2.9	4.9	0.0	1.6	1.4	4.1	4.6	1.8	2.6	0.0	5.9	1.8	10.3	1.7	6.6	0.0	0.5	0.2	1.0	0.6	0.4	15.4	1.3	3.0	2.0	0.2	3.1	6.6	1.8	0.8	0.7	1.4	9.8	3.0	0.8	3.4	0.3	2.1	1.6
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252232	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 84.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Rod photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	8.4	7.0	11.7	10.4	12.3	6.1	8.0	6.5	12.5	6.4	4.7	8.5	9.2	6.8	3.0	9.8	6.9	5.7	9.9	12.7	12.9	7.7	9.2	13.3	11.8	11.8	11.2	5.7	84.9	3.1	16.7	8.6	12.7	11.6	5.0	10.2	18.9	3.8	9.1	5.9	10.8	4.7	8.5	18.6	18.3	4.6	11.5	9.5	9.6	5.0	6.7	6.8	6.6	8.2	4.4	6.1	8.4	18.3	7.2	4.3	6.2	9.1	5.0	7.1	8.7	5.8	5.4	3.6	14.4	10.6	8.8	2.8	5.7	4.2	3.0	8.8	8.0	5.3	9.4	5.3	8.5	6.5	9.9	7.5	3.4	6.9	5.3	6.6	25.2	15.1	3.6	15.0	5.4	7.2	9.4	6.8	3.3	8.6	5.9	7.8	8.5	17.7	5.4	4.8	15.0	16.9	5.4	14.9	8.5	6.1	4.8	9.2	26.0	6.7	11.5	17.4	7.6	17.6	9.8	1.9	14.0	5.6	12.5	2.5	2.9	0.9	2.2	3.2	1.3	1.8	2.9	1.7	1.8	1.6	4.8	4.2	3.5	1.0	4.9	2.4	3.0	2.3	11.7	12.3	6.5	12.5	12.7	12.9	11.8	11.2	12.7	8.5	11.5	8.2	32.2	9.6	18.4	18.3	12.3	2.3	2.2	3.7	1.8	37.1	7.0	5.8	11.2	7.2	7.0	5.5	106.3	6.0	10.9	16.0	1.9	6.4	2.1	6.9	5.5	22.9	29.3	2.1	21.1	13.4	9.8	7.2	35.7	8.1	8.2	11.0	21.0	8.5	13.7	32.0	17.8	22.9	10.2	20.5	4.0	2.2	7.2	14.2	1.8	16.9	19.5	11.4	14.4	10.1	10.1	11.9	10.3	3.4	17.4	4.1	10.8	3.6	7.7	66.7	0.0	7.5	7.4	5.5	4.5	7.1	1.8	3.4	16.0	9.0	10.0	2.9
TECPR2	KIAA0329	ENSG00000196663	"Tectonin beta-propeller repeat containing 2"	O15040	14	102362941-102502477	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Excitatory neurons: 59.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000658	Enhanced		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli, Centrosome"	"HPA000658: AB_1079191"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.76e-3)"	"unprognostic (3.78e-2)"	"prognostic favorable (6.53e-9)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-3)"	5.4	5.1	12.4	5.4	18.8	5.7	5.4	12.1	13.9	6.0	5.6	8.3	3.8	7.9	6.7	4.9	6.4	4.5	7.5	12.9	10.5	4.4	4.1	5.1	2.7	13.0	14.7	5.9	4.5	9.0	7.2	5.7	12.2	6.4	3.2	9.7	10.1	7.2	11.1	5.6	4.7	8.7	10.4	5.7	5.4	10.9	15.4	5.5	5.7	7.8	2.9	7.2	5.0	21.5	4.7	9.4	8.9	7.4	18.0	13.6	4.9	10.4	12.0	10.3	8.6	2.0	3.4	3.5	6.4	10.9	7.6	8.4	6.2	7.8	8.6	13.0	4.1	4.2	4.9	4.1	8.5	2.3	3.9	9.0	6.8	9.3	6.1	9.7	10.2	3.9	2.1	7.8	9.6	8.9	2.1	2.5	3.4	4.9	9.7	5.0	6.2	1.1	5.2	7.8	7.1	6.6	9.0	2.3	5.7	5.7	10.5	3.1	10.6	7.9	2.0	21.4	4.4	8.0	5.1	0.7	7.6	6.1	8.3	0.3	0.5	0.9	0.2	0.3	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	7.3	0.1	0.1	0.1	0.4	0.4	12.4	18.8	12.1	13.9	12.9	10.5	13.0	14.7	12.2	10.4	15.4	21.5	9.1	9.6	6.9	57.5	3.5	2.0	3.1	4.7	8.0	17.0	10.1	8.0	13.0	4.3	5.6	3.7	50.1	7.1	5.7	7.2	5.9	8.2	31.2	7.4	10.3	8.7	4.2	5.7	59.1	7.1	5.7	8.4	5.6	6.3	0.0	8.6	8.2	6.1	4.9	13.5	34.4	3.8	10.2	4.7	3.4	27.9	14.3	12.7	3.6	26.2	8.5	21.6	5.2	28.6	150.4	6.8	2.5	18.8	8.0	4.0	5.9	6.0	7.0	44.7	19.7	9.1	8.3	24.6	15.0	7.7	1.6	6.0	4.6	8.4	4.6	3.2
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1013.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	102.7	162.6	189.0	43.1	201.7	74.2	100.4	220.8	237.5	156.8	216.5	78.5	106.1	53.2	103.2	373.2	87.1	49.7	78.4	180.1	200.0	112.2	133.9	67.8	55.7	209.6	191.2	80.9	105.5	306.1	78.7	68.0	212.2	85.7	59.3	82.8	222.3	83.5	366.3	263.5	95.9	36.7	207.6	75.4	81.7	182.7	199.9	65.8	92.7	209.6	85.3	51.6	185.9	230.2	220.5	162.1	149.5	169.6	214.7	97.2	156.9	62.8	175.2	196.3	242.9	225.3	246.2	113.8	127.4	134.2	152.4	328.8	158.1	254.3	84.0	192.3	165.9	193.7	225.4	254.6	129.7	139.5	143.7	144.9	201.8	174.3	96.1	98.4	93.7	169.2	128.9	391.5	104.0	289.3	170.1	248.3	155.6	556.1	227.6	154.4	96.1	521.1	275.1	115.8	183.2	113.0	103.1	278.4	139.6	77.2	151.3	274.4	55.2	160.5	66.8	141.0	212.6	118.4	119.8	122.7	163.8	212.6	162.2	55.6	72.7	52.5	137.8	106.4	148.8	100.1	180.1	159.1	124.2	99.1	207.1	164.5	32.7	183.7	83.9	137.1	290.1	170.9	189.0	201.7	220.8	237.5	180.1	200.0	209.6	191.2	212.2	207.6	199.9	230.2	60.4	73.7	71.1	47.7	87.6	169.5	227.5	297.9	125.7	90.8	161.1	155.6	52.9	120.1	221.5	165.5	123.0	509.5	88.1	159.2	56.7	166.2	443.9	102.2	40.1	64.7	100.0	80.1	15.3	225.1	525.5	81.8	89.7	64.2	36.1	90.1	73.2	143.1	188.0	112.7	19.2	144.0	199.4	113.8	99.3	1013.1	72.7	77.8	163.7	18.7	61.6	577.9	103.0	12.5	46.5	104.8	128.2	60.2	206.1	110.2	343.2	202.9	213.1	177.5	65.7	68.4	286.7	215.0	134.2	255.3	239.7	486.2	117.7	116.0	216.2	196.5
TECTA	"DFNA12, DFNA8, DFNB21"	ENSG00000109927	"Tectorin alpha"	O75443	11	121101243-121191490	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.2;Cone photoreceptor cells: 4.2;Early spermatids: 5.6;Excitatory neurons: 9.9;Hepatic stellate cells: 8.9;Inhibitory neurons: 7.2;Oligodendrocyte precursor cells: 5.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018870	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018870: AB_1857879"	"unprognostic (1.12e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-6)"	"unprognostic (1.22e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.19e-2)"	0.3	0.5	1.6	0.2	2.1	0.2	0.3	1.0	1.6	0.3	1.5	0.5	0.1	0.3	0.6	0.1	0.3	0.3	1.1	1.3	2.0	0.5	0.4	0.4	0.1	1.5	1.4	0.7	0.3	0.8	1.3	0.2	1.5	0.5	0.1	1.1	0.3	0.5	0.8	0.1	0.2	0.2	0.9	0.3	0.3	0.9	1.6	0.2	0.7	0.4	0.1	0.3	0.2	1.9	0.0	0.0	1.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	1.7	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.0	1.6	1.3	2.0	1.5	1.4	1.5	0.9	1.6	1.9	0.5	3.2	0.5	5.2	0.1	0.0	0.1	0.0	0.0	1.8	0.2	0.3	1.9	1.5	0.6	0.0	4.2	0.0	0.2	0.0	0.0	0.2	5.6	0.6	0.3	0.5	0.0	0.0	9.9	0.4	0.1	0.4	0.0	0.3	0.0	0.6	8.9	0.6	0.1	0.0	7.2	0.0	0.0	0.3	0.0	2.7	0.3	0.2	0.0	1.0	0.2	0.9	0.0	5.0	2.8	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.7	0.0	1.9	0.4	0.9	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 66.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	1.6	5.2	4.9	5.5	6.8	4.7	4.1	7.8	4.3	0.5	5.5	5.1	3.8	1.0	6.8	4.6	1.8	4.3	5.8	3.0	4.0	5.4	4.9	5.4	7.0	3.5	2.5	3.0	1.0	5.3	1.6	4.2	4.2	1.6	0.5	4.3	2.3	2.3	8.2	5.4	1.0	3.1	6.8	5.9	4.9	3.6	4.5	5.7	0.5	3.1	3.9	4.5	5.3	17.2	38.9	9.2	13.5	0.8	1.5	24.5	13.4	5.0	15.9	14.7	14.0	31.2	25.6	27.2	2.2	6.2	43.5	3.2	14.0	3.0	29.0	16.0	6.5	22.8	13.3	0.6	12.9	17.9	0.3	4.6	10.6	3.5	2.0	6.4	23.2	10.5	31.2	2.5	66.7	26.9	29.6	11.9	14.6	41.8	21.9	13.8	17.9	4.5	14.3	25.7	15.5	13.7	15.8	9.8	2.0	26.0	12.6	7.8	10.9	18.4	33.4	22.4	17.8	8.2	15.7	13.9	14.8	18.0	0.0	0.5	0.6	0.5	0.9	0.4	0.1	0.8	1.4	0.7	0.3	0.6	0.1	0.1	0.0	0.8	2.4	0.6	0.2	5.2	5.5	4.1	7.8	5.8	3.0	7.0	3.5	4.2	3.1	3.6	5.3	4.8	3.2	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.9	5.3	0.0	0.0	0.6	1.8	0.0	8.0	10.1	0.0	3.9	11.6	0.0	12.0	3.0	4.0	0.0	0.0	0.0	12.7	26.6	3.4	0.0	7.2	0.0	8.1	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	14.7	0.0	0.0	4.7	0.0	0.0	2.0	3.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.0	4.2	2.5	0.0	0.0
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460086-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.0;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.8;Extravillous trophoblasts: 12.5;Granulosa cells: 6.7;Hofbauer cells: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"		"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavorable (2.43e-5)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.3	0.8	0.8	1.7	0.9	4.0	0.4	0.4	1.4	0.7	0.2	1.0	1.5	0.4	0.0	2.3	0.3	0.1	0.8	0.8	0.6	0.6	0.8	0.5	2.2	0.7	0.6	0.4	0.6	0.2	0.8	0.9	0.8	0.6	0.7	0.2	0.6	0.2	0.3	0.9	1.4	0.3	0.4	1.2	0.8	5.0	0.9	2.2	0.4	0.0	1.4	0.4	0.8	0.6	10.2	31.3	17.7	20.8	0.3	1.2	17.7	7.9	4.7	12.5	12.1	21.9	8.2	14.0	12.6	3.4	6.8	15.3	12.9	8.0	3.0	15.6	17.4	12.7	23.2	22.9	0.4	12.3	16.3	1.1	1.0	11.0	3.0	1.0	5.8	22.8	21.9	5.2	4.4	19.7	21.6	23.2	39.2	9.7	11.5	52.0	15.1	31.3	2.7	4.4	16.6	27.2	9.1	9.5	7.1	4.7	14.0	14.2	2.2	13.2	19.2	12.8	18.2	11.4	20.1	28.3	6.7	12.3	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.1	0.8	0.9	0.4	1.4	0.8	0.6	0.7	0.6	0.8	0.4	0.9	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.0	0.0	0.0	0.0	12.8	0.5	0.0	1.9	2.9	0.0	1.2	1.1	0.6	0.0	0.0	0.0	1.3	12.5	1.7	0.0	1.0	0.0	6.7	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.9	0.4	2.7	0.0	0.0
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906238	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	4.9	6.0	4.4	5.9	4.6	2.2	6.7	5.7	6.0	4.0	5.5	5.7	5.6	4.9	4.1	5.2	4.8	4.1	8.9	4.6	4.4	9.6	8.8	4.0	7.3	4.5	4.4	4.8	3.3	6.6	3.2	6.8	4.6	5.0	6.6	6.9	5.4	4.8	6.8	5.3	4.6	5.1	4.3	5.7	5.1	4.2	4.6	5.4	5.4	11.7	6.7	5.4	2.9	5.1	12.8	19.2	10.7	14.9	12.7	12.4	10.1	13.1	9.5	23.7	21.4	15.6	7.2	17.4	12.7	8.1	15.5	21.6	18.6	9.1	22.4	5.5	23.9	8.8	15.1	15.5	8.5	18.7	11.2	7.9	11.7	13.4	6.9	7.2	11.9	12.4	19.1	14.3	13.9	11.7	16.0	24.3	8.9	19.6	12.1	10.5	22.9	17.6	19.2	14.4	16.3	7.5	9.8	11.7	15.4	10.9	23.7	14.1	7.8	10.9	14.7	11.2	13.8	7.9	14.0	16.2	7.3	13.8	13.2	2.6	7.7	6.5	6.4	12.2	8.8	9.8	8.2	6.5	8.1	6.3	9.9	9.2	2.3	8.6	9.9	7.0	10.0	7.1	4.4	4.6	5.7	6.0	4.6	4.4	4.5	4.4	4.6	4.3	4.6	5.1	10.1	16.0	10.6	13.7	11.3	4.1	8.0	22.6	9.1	17.8	6.8	6.9	5.8	11.5	13.6	9.2	8.4	26.0	11.5	5.4	25.4	13.4	10.4	12.6	15.3	9.6	5.4	6.9	27.1	8.5	17.3	10.2	5.1	7.8	5.1	17.2	10.4	10.1	20.4	16.8	27.3	7.4	22.4	7.8	3.0	6.3	8.1	9.6	7.2	21.5	14.0	15.0	16.5	27.2	32.2	12.5	5.6	7.5	7.1	5.2	9.4	17.7	17.8	19.4	19.7	11.0	11.6	27.7	17.8	8.7	4.3	17.8	10.0	18.9	7.9	4.7
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TEKT1		ENSG00000167858	"Tektin 1"	Q969V4	17	6789133-6831761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 50.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 412.2;Endometrial ciliated cells: 173.1;Late spermatids: 146.2;Respiratory ciliated cells: 288.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 7.8"	"HPA044444, HPA062285"	Approved					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA044444: AB_10961038, HPA062285: AB_2684737"	"unprognostic (7.28e-3)"	"unprognostic (7.24e-3)"		"prognostic favorable (6.08e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.91e-1)"		"unprognostic (4.22e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.63e-6)"	"unprognostic (6.28e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.13e-1)"	0.0	0.0	1.6	0.0	1.8	0.5	0.0	1.2	1.2	1.5	9.5	0.0	0.0	1.2	0.3	0.9	50.4	0.9	0.5	1.8	2.2	0.0	0.2	4.6	0.3	5.9	6.5	0.3	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.1	4.8	0.1	0.1	9.9	2.0	0.1	0.3	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	1.2	1.2	1.8	2.2	5.9	6.5	4.2	4.8	2.0	4.0	0.1	0.0	1.5	2.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.5	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	412.2	173.1	1.5	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	18.3	0.0	0.0	146.2	2.8	0.3	0.0	0.0	0.0	1.0	0.0	1.5	1.1	0.0	0.0	0.7	0.0	0.2	0.0	0.1	288.1	0.0	0.0	0.0	5.3	38.2	3.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
TEKT2	TEKTB1	ENSG00000092850	"Tektin 2"	Q9UIF3	1	36084094-36088275	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 62.8;testis: 71.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 523.7;Late spermatids: 306.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	8	"NB-4: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA027248, HPA027461"	Approved		Approved	Microtubules		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules		"HPA027248: AB_1857884, HPA027461: AB_10600912"	"unprognostic (1.02e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-3)"	"unprognostic (5.28e-4)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (9.78e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.68e-2)"	0.2	0.5	2.2	0.1	2.4	1.5	0.9	1.9	2.6	3.5	12.2	0.6	0.1	1.5	0.1	0.2	62.8	0.1	0.1	2.3	3.0	3.1	0.1	6.3	0.1	4.6	6.3	0.5	2.4	0.7	4.3	0.0	3.7	0.7	0.0	0.1	0.4	0.5	0.0	0.2	0.2	0.3	4.4	0.0	0.4	71.2	3.1	1.1	2.7	0.0	0.0	0.1	0.3	3.3	0.0	0.0	4.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	37.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.2	2.4	1.9	2.6	2.3	3.0	4.6	6.3	3.7	4.4	3.1	3.3	0.2	0.0	0.0	0.0	0.2	0.1	0.6	9.4	0.0	0.0	0.8	0.6	0.6	0.0	8.0	1.8	0.0	0.2	0.0	0.0	0.0	0.9	523.7	81.2	0.8	0.4	1.8	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.1	12.2	0.0	0.0	306.1	5.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.1	0.0	3.8	0.0	0.4	0.0	2.5	84.7	0.1	0.0	0.0	2.6	27.6	4.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5
TEKT3	FLJ32828	ENSG00000125409	"Tektin 3"	Q9BXF9	17	15303811-15341632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 31.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 413.1;Late spermatids: 408.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SuSa: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027293, HPA044354, HPA073565"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA027293: , HPA044354: AB_10962623, HPA073565: "	"unprognostic (1.85e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.73e-2)"	"unprognostic (5.38e-4)"	"unprognostic (4.59e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.63e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-4)"	"unprognostic (1.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-3)"	"unprognostic (7.85e-2)"	0.3	0.2	0.7	0.3	0.6	0.1	0.5	1.4	0.9	1.2	0.6	0.3	0.3	0.5	0.6	0.1	4.9	0.4	0.2	0.4	0.4	0.3	0.2	0.8	0.1	0.9	1.0	0.9	0.7	0.2	1.0	0.3	0.5	0.4	0.2	0.6	0.5	0.1	0.1	0.7	0.4	0.2	0.5	0.2	0.2	31.0	0.4	0.1	0.7	0.0	0.1	0.2	0.4	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.1	1.5	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.7	0.6	1.4	0.9	0.4	0.4	0.9	1.0	0.5	0.5	0.4	1.1	0.7	3.2	0.5	0.7	0.1	0.3	0.1	0.7	0.0	0.7	0.5	0.5	0.7	1.5	4.7	0.0	0.0	0.3	0.2	0.5	0.0	0.1	413.1	16.3	1.7	0.7	1.8	0.0	1.2	0.0	0.5	3.9	0.0	0.5	0.0	0.7	0.4	0.1	3.8	0.0	1.1	0.0	0.0	0.0	1.4	408.9	11.1	0.3	0.0	1.0	0.0	1.7	0.0	2.0	0.8	0.0	0.1	6.4	0.0	0.2	0.7	0.1	39.1	0.2	6.6	3.2	1.4	25.9	2.6	0.0	0.1	0.0	0.1	3.4	0.0	0.2
TEKT4	MGC27019	ENSG00000163060	"Tektin 4"	Q8WW24	2	94871430-94876823	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 2.7"	"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 2.9"	"HPA048600, HPA053929, HPA069872"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Intermediate filaments"		"HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: "	"unprognostic (1.49e-2)"	"unprognostic (4.00e-1)"		"prognostic favorable (1.29e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-3)"	"unprognostic (5.45e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.56e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.7	1.6	0.5	0.3	0.1	0.2	3.6	0.0	1.5	2.9	0.4	1.5	0.1	1.9	0.0	0.0	0.7	0.6	0.5	7.2	4.7	1.8	0.0	0.5	0.1	0.3	1.9	1.9	137.1	49.0	1.3	1.3	0.0	0.0	1.3	0.4	0.5	1.1	0.0	0.9	1.3	0.1	1.8	1.5	0.2	0.0	0.9	0.2	0.0	1.6	0.5	129.3	2.8	0.8	0.0	1.0	2.6	0.0	0.0	2.0	2.3	0.8	0.0	1.2	0.0	0.4	0.0	8.3	51.6	0.0	6.6	0.6	0.9	12.4	2.4	0.0	1.3	0.5	0.5	0.0	0.2	0.4
TELO2	"hCLK2, KIAA0683, TEL2"	ENSG00000100726	"Telomere maintenance 2"	Q9Y4R8	16	1493344-1510457	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041348, HPA041473"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Cytosol"		"HPA041348: AB_10794514, HPA041473: AB_10795593"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.15e-3)"	12.3	13.2	7.3	7.6	7.2	11.3	13.4	8.8	11.0	15.2	5.7	12.6	8.9	14.1	1.1	14.4	15.1	3.7	13.2	6.9	6.4	13.6	14.8	11.6	8.1	10.2	7.6	14.4	12.2	4.3	12.5	4.8	7.6	15.8	1.4	1.8	11.4	4.8	17.0	14.4	14.4	2.4	6.4	18.6	11.9	10.0	7.6	5.8	13.2	4.9	3.1	13.6	13.9	8.3	19.7	28.8	8.8	16.8	3.4	3.6	33.9	30.5	5.7	14.4	10.4	37.0	18.3	28.8	25.8	4.9	7.1	20.5	6.3	11.6	2.7	16.9	55.1	16.5	36.7	21.8	5.7	21.0	23.9	7.0	4.3	13.4	2.8	4.9	8.6	24.6	43.2	10.1	5.8	66.3	24.9	56.1	28.2	6.9	23.9	73.5	12.3	29.4	5.4	18.3	36.8	20.6	26.5	24.8	9.8	3.3	23.2	25.3	13.8	31.2	21.7	30.5	25.8	18.2	12.6	53.3	9.9	29.3	26.7	0.0	5.7	2.9	4.1	7.2	3.9	4.1	2.9	3.4	6.9	6.0	3.1	2.5	0.5	3.4	10.7	4.3	2.7	4.7	7.3	7.2	8.8	11.0	6.9	6.4	10.2	7.6	7.6	6.4	7.6	8.3	15.8	0.0	2.7	18.9	15.2	6.9	7.8	10.4	10.2	13.7	12.7	9.8	1.6	11.5	6.3	9.2	12.5	25.5	9.1	19.4	5.9	8.2	2.0	8.4	11.0	9.6	2.4	10.8	5.3	7.2	20.2	11.4	15.8	9.2	2.5	21.2	8.9	12.3	19.6	18.5	6.4	17.2	8.2	11.8	7.0	1.9	7.5	8.6	8.8	10.3	13.3	17.3	8.2	8.5	7.0	6.9	5.5	14.7	8.7	8.8	13.7	6.3	5.1	20.1	13.1	9.9	11.4	9.8	8.2	10.3	6.5	22.0	9.6	19.0	23.5	5.1
TENM1	"ODZ1, ODZ3, TEN-M1, TEN1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins, Transporters"	"Stress response, Transcription, Transcription regulation"	"Neuropeptide, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Group enriched"	"Detected in many"	11	"Excitatory neurons: 126.0;Inhibitory neurons: 463.2;Oligodendrocyte precursor cells: 434.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 23.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;MOLT-4: 5.9;RPTEC TERT1: 2.0;SCLC-21H: 1.9;U-138 MG: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	2.6	1.6	4.8	0.2	4.9	2.1	1.1	23.1	3.7	0.2	0.0	1.8	0.1	1.9	1.2	0.2	1.7	0.7	0.4	4.4	5.8	1.3	8.0	1.4	0.6	2.2	3.6	0.1	0.1	0.1	4.7	0.0	4.0	4.6	0.2	2.5	1.4	0.9	1.0	1.3	1.2	0.6	2.3	0.6	0.8	0.4	4.2	8.1	1.7	0.8	0.4	0.5	0.3	1.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.6	0.0	0.0	5.9	0.0	0.3	0.0	0.8	0.0	0.0	0.0	2.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.4	0.0	0.0	3.2	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	4.8	4.9	23.1	3.7	4.4	5.8	2.2	3.6	4.0	2.3	4.2	1.9	0.7	0.0	0.0	29.0	0.2	3.3	0.1	0.0	1.8	10.2	0.6	0.3	1.6	1.5	0.0	1.8	0.0	0.0	3.4	0.1	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.7	126.0	0.0	0.0	6.8	0.0	0.2	7.6	2.2	0.4	22.9	0.0	6.7	463.2	0.0	0.0	1.0	0.8	0.4	5.0	0.3	3.6	5.6	0.6	0.7	2.1	434.8	7.7	0.0	0.0	0.0	3.0	13.7	0.0	4.0	0.0	0.6	0.0	0.6	1.8	0.0	3.4	0.1	1.8	0.0	2.2	0.0	0.0	0.3
TENM2	"KIAA1127, ODZ2, Ten-M2, TEN2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 9.8;heart muscle: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No		11000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.1	0.5	2.9	0.0	4.7	0.0	1.9	0.0	9.8	1.3	0.0	0.2	0.4	0.0	0.5	1.9	0.1	0.4	35.1	6.0	1.2	0.8	1.3	0.2	0.0	0.6	0.1	0.7	0.1	0.0	0.7	0.0	1.6	2.2	0.1	4.1	0.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.1	1.3	4.3	2.2	0.4	0.5	1.0	0.1	2.0	0.0	0.1	0.0	13.4	0.0	0.0	0.4	0.0	1.9	0.0	0.7	1.8	0.0	0.0	0.0	0.0	66.1	1.7	0.0	0.0	43.0	0.8	43.3	0.0	0.0	0.2	0.0	2.0	0.0	0.0	3.0	7.4	0.3	5.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	9.8	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.1	2.4	3.8	0.1	0.0	74.6	64.0	0.1	50.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.7	0.0	9.8	6.0	1.2	0.6	0.1	1.6	0.0	4.3	0.0	0.5	0.0	0.0	512.9	0.0	14.8	1.1	20.3	33.6	15.5	0.3	13.0	144.0	0.0	1.4	0.0	18.8	0.0	0.0	1.0	0.0	3.4	23.5	0.1	0.3	1.7	0.0	0.0	706.2	0.2	0.0	2.2	0.0	0.2	1.3	1.6	0.4	5.1	0.1	121.1	965.9	0.7	0.0	0.0	1.2	18.2	4.4	0.2	1.8	36.5	0.0	2.3	0.0	21.6	12.8	0.0	0.0	61.7	0.0	1.4	0.3	0.0	0.6	1.8	0.0	0.4	1.5	1.2	1.1	1.4	1.7	0.0	0.1	0.0	0.4	0.1
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 13.1"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.0	5.1	12.0	1.6	18.4	0.0	2.0	0.0	12.3	1.5	0.0	4.3	0.8	2.9	0.6	0.8	1.0	2.4	1.4	21.8	8.1	0.9	0.3	0.8	0.8	2.8	7.3	3.8	1.2	5.1	4.5	13.1	0.0	3.7	0.8	3.9	0.6	3.6	2.1	0.4	0.9	2.3	0.8	2.2	0.7	2.1	7.4	2.8	6.1	4.3	1.2	1.6	1.4	2.0	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	18.4	0.0	12.3	21.8	8.1	2.8	7.3	0.0	0.8	7.4	2.0	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
TENM4	"KIAA1302, ODZ4, Ten-M4, TEN4"	ENSG00000149256	"Teneurin transmembrane protein 4"	Q6N022	11	78652829-79441030	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;ovary: 16.6;parathyroid gland: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Early spermatids: 96.8;Excitatory neurons: 337.4;Inhibitory neurons: 297.7;Microglial cells: 117.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 9.1;hTERT-RPE1: 9.5;PC-3: 10.8;REH: 10.4;SH-SY5Y: 17.4"	"Low region specificity"	"Detected in all"							"HPA019521, HPA065961"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019521: AB_2670171, HPA065961: AB_2685588"	"unprognostic (2.81e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.40e-3)"	"unprognostic (5.64e-2)"	"unprognostic (7.07e-2)"	"unprognostic (9.81e-3)"	1.9	1.4	7.5	1.0	13.4	0.0	0.7	0.3	12.6	2.5	0.0	0.5	0.1	1.3	0.2	2.0	2.1	0.4	0.4	9.0	7.5	1.5	0.0	0.4	0.5	10.9	9.2	16.6	0.3	14.0	7.1	0.1	7.9	0.4	0.3	2.6	0.5	0.2	0.4	3.3	0.3	1.0	13.0	0.3	0.5	1.6	11.8	1.9	5.8	1.0	1.2	0.5	1.5	17.8	0.0	0.0	3.4	0.0	3.7	5.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.7	0.0	2.1	5.0	5.3	0.0	4.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	9.1	2.3	2.5	4.5	9.5	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.0	1.8	0.3	10.8	10.4	0.0	0.0	6.4	1.1	7.1	17.4	0.0	0.0	0.0	6.2	0.0	0.1	0.5	0.1	1.2	0.1	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	13.4	0.3	12.6	9.0	7.5	10.9	9.2	7.9	13.0	11.8	17.8	0.1	0.0	0.0	134.5	0.2	0.9	0.8	3.4	17.1	7.5	0.1	0.0	1.9	4.3	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	96.8	1.1	1.7	0.3	0.0	0.0	337.4	0.0	0.2	2.6	0.0	0.8	1.3	0.8	0.0	0.0	0.1	0.0	297.7	0.0	0.0	0.6	0.4	56.6	5.3	0.7	0.0	117.1	0.4	13.9	0.0	58.3	21.3	0.0	0.0	1.9	0.0	0.4	0.0	0.4	7.0	1.0	0.0	25.1	2.8	4.8	1.0	7.3	2.0	0.1	0.1	0.3	0.0	0.6
TENT4A	"LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Terminal nucleotidyltransferase 4A"	Q5XG87	5	6713432-6757044	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.1	8.1	8.4	9.5	8.6	27.6	11.0	16.6	10.1	12.5	5.7	10.0	8.7	11.1	6.4	10.7	11.5	10.0	8.5	8.7	8.1	9.6	20.5	12.8	13.0	6.5	6.5	15.6	12.0	10.0	11.1	9.1	7.0	11.1	7.2	12.5	8.2	8.8	9.3	15.7	12.4	12.2	6.0	13.7	9.6	10.1	7.9	14.6	10.2	12.1	10.4	10.1	11.8	8.9	31.7	20.9	25.4	31.6	17.7	15.6	37.0	21.0	25.7	25.1	28.2	21.9	17.3	23.1	16.1	25.5	28.5	22.9	20.7	16.4	23.1	26.1	14.0	12.0	72.5	12.4	11.0	18.0	17.3	10.7	13.8	28.7	18.4	18.6	15.0	16.9	16.3	29.8	20.8	17.6	24.4	25.3	13.6	9.7	16.6	21.8	21.2	6.0	10.5	17.5	25.1	19.3	50.7	24.1	14.5	13.4	14.5	9.9	13.6	30.6	32.7	27.2	29.8	28.6	12.6	20.4	19.6	16.4	19.2	0.0	0.2	0.2	0.6	0.1	0.6	0.5	0.4	0.4	0.3	0.4	0.5	0.5	0.1	0.1	0.2	1.1	0.6	0.2	8.4	8.6	16.6	10.1	8.7	8.1	6.5	6.5	7.0	6.0	7.9	8.9	19.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	13.4	13.2	0.0	0.0	0.0	5.5	0.0	5.3	12.3	0.0	1.9	4.9	0.0	10.7	15.4	4.8	0.0	0.0	0.0	4.4	4.0	4.0	0.0	14.0	0.0	14.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	5.6	4.8	10.7	0.0	0.0
TENT4B	"PAPD5, TRF4-2, TUT3"	ENSG00000121274	"Terminal nucleotidyltransferase 4B"	Q8NDF8	16	50152911-50235310	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042968, HPA048225"	Uncertain		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042968: AB_2678244, HPA048225: AB_2680319"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	6.1	6.4	2.4	1.7	2.3	7.1	4.6	3.9	2.6	7.3	3.0	6.9	4.6	6.9	2.3	5.4	6.5	2.0	3.7	2.7	3.0	4.2	8.9	5.0	2.3	2.2	2.4	6.8	4.3	3.9	4.8	2.8	2.2	5.3	1.9	1.4	4.7	1.7	5.4	5.5	5.9	2.5	2.2	4.6	5.5	5.7	3.1	1.7	4.7	2.1	1.9	7.2	6.4	2.7	5.5	1.9	0.6	3.3	3.8	2.0	4.3	3.9	2.3	3.5	1.6	3.4	2.3	6.5	5.6	2.7	1.4	3.6	3.9	2.0	3.1	3.8	4.5	3.6	1.6	5.4	3.8	2.4	4.9	1.9	2.6	2.3	3.3	2.3	1.8	2.1	4.2	1.5	4.1	1.5	3.5	4.6	4.2	1.5	4.5	4.9	4.8	6.9	1.7	0.5	4.0	2.2	4.9	2.7	2.3	1.5	1.5	0.9	3.0	2.1	4.1	4.0	1.9	4.9	3.7	6.9	1.7	2.7	2.7	0.0	0.4	0.0	0.4	0.2	0.1	0.3	0.2	0.5	0.2	0.2	0.3	0.5	0.7	0.2	0.2	0.4	0.1	0.1	2.4	2.3	3.9	2.6	2.7	3.0	2.2	2.4	2.2	2.2	3.1	2.7	17.9	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	17.8	16.3	0.0	0.0	0.0	14.7	0.0	18.1	82.8	0.0	3.9	10.9	0.0	44.3	24.4	6.1	0.0	0.0	0.0	14.9	11.5	6.7	0.0	31.5	0.0	13.5	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	22.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	18.3	14.9	17.3	0.0	0.0
TENT5A	"C6orf37, FAM46A, FLJ20037"	ENSG00000112773	"Terminal nucleotidyltransferase 5A"	Q96IP4	6	81491439-81752774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 225.9;salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	13.5	21.3	4.3	7.9	4.6	225.9	12.2	9.0	5.8	21.3	9.9	17.2	16.4	10.2	19.7	4.4	12.0	32.3	21.7	4.0	14.0	6.4	35.9	9.1	5.2	7.8	7.1	23.6	8.3	9.4	17.4	18.7	6.1	9.9	16.9	8.7	104.4	24.8	2.1	18.7	22.2	11.1	5.0	9.9	37.8	3.7	6.7	2.9	8.8	5.1	4.3	16.6	8.8	5.3	3.5	5.0	3.3	0.2	67.9	29.8	6.2	27.0	19.2	15.7	23.5	51.0	2.6	0.3	1.0	81.9	10.0	2.9	2.4	4.2	11.5	0.0	6.2	0.1	86.1	8.0	21.2	95.6	7.1	13.2	2.4	12.3	2.1	51.2	2.0	0.8	1.4	0.0	10.6	14.7	0.0	67.2	0.9	29.2	3.8	0.0	28.8	0.1	2.1	6.2	3.3	4.4	12.1	5.2	8.3	9.9	1.2	162.0	4.5	17.9	3.8	7.6	7.6	0.4	0.3	0.3	25.3	72.7	7.8	37.3	29.9	46.3	11.5	29.6	6.8	18.2	4.3	5.7	24.2	21.0	8.1	8.0	13.8	16.9	47.3	8.5	5.6	14.0	4.3	4.6	9.0	5.8	4.0	14.0	7.8	7.1	6.1	5.0	6.7	5.3	22.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	40.8	44.2	0.0	0.0	0.0	5.5	0.0	39.9	43.1	0.0	3.9	30.5	0.0	73.1	70.6	2.9	0.0	0.0	0.0	23.4	115.4	32.7	0.0	176.7	0.0	40.9	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	26.7	0.0	0.0	5.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	162.0	9.4	12.6	0.0	0.0
TENT5C	"FAM46C, FLJ20202"	ENSG00000183508	"Terminal nucleotidyltransferase 5C"	Q5VWP2	1	117606048-117628389	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 89.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.3"	"Group enriched"	"Detected in many"	17	"B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054049	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favorable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	2.8	2.4	0.9	17.0	1.0	89.1	11.6	1.1	1.6	10.9	27.4	23.8	16.0	3.2	19.1	3.6	4.8	7.8	6.9	1.4	0.9	7.5	10.3	10.5	18.8	1.6	1.6	9.0	46.8	11.2	2.6	3.8	1.1	6.6	24.8	0.1	25.8	4.1	29.4	1.2	13.0	2.9	1.9	21.7	30.2	43.5	1.0	6.2	14.3	10.9	37.3	14.1	1.9	1.3	0.2	0.1	0.1	1.3	0.1	0.0	1.3	0.6	26.9	0.5	0.2	1.7	0.2	4.9	0.3	0.8	0.3	0.3	0.1	0.5	0.2	17.6	1.6	37.9	0.2	0.0	0.1	22.4	46.8	0.0	0.1	0.4	0.0	0.1	0.1	10.0	5.2	296.2	0.0	3.8	0.1	22.8	3.8	4.5	2.4	0.1	0.1	185.5	0.3	3.7	2.2	0.2	1.7	2.4	1.8	0.6	1.9	0.2	0.5	0.3	2.1	0.1	0.4	81.7	72.8	1.9	1.7	8.1	2.4	29.3	0.0	15.9	3.4	0.0	3.1	13.3	3.3	4.4	0.1	10.4	0.4	1.9	1.6	1.1	0.0	0.3	13.7	2.9	0.9	1.0	1.1	1.6	1.4	0.9	1.6	1.6	1.1	1.9	1.0	1.3	17.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	34.0	43.2	0.0	0.0	0.0	1.8	0.0	1.9	104.5	0.0	11.7	0.8	0.0	8.3	5.4	2.9	0.0	0.0	0.0	5.2	2.2	3.2	0.0	13.7	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	47.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.2	48.4	1.0	0.0	0.0
TENT5D	"CT1.26, CT112, FAM46D, MGC26999"	ENSG00000174016	"Terminal nucleotidyltransferase 5D"	Q8NEK8	X	80335504-80445311	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059362	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"				"HPA059362: AB_2683991"	"unprognostic (3.49e-1)"			"unprognostic (1.14e-2)"					"unprognostic (4.36e-1)"	"unprognostic (1.59e-1)"		"unprognostic (4.64e-1)"		"unprognostic (4.28e-2)"	"unprognostic (8.21e-3)"	"unprognostic (2.95e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TEPP		ENSG00000159648	"Testis, prostate and placenta expressed"	Q6URK8	16	57976435-57988116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 14.2"	"Group enriched"	"Detected in many"	12	"Early spermatids: 317.5;Late spermatids: 440.1"	"Group enriched"	"Detected in some"	4	"thyroid cancer: 3.2;urothelial cancer: 1.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062092	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA062092: AB_2684679"	"unprognostic (4.86e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.59e-1)"	0.1	0.4	0.3	0.0	0.3	0.0	0.2	0.1	0.4	0.5	0.1	0.1	0.0	0.2	0.2	0.4	0.3	0.0	0.4	0.3	0.4	0.2	0.0	0.5	0.0	0.3	0.3	0.4	0.2	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.3	0.4	0.0	0.2	0.1	0.0	0.1	0.1	0.0	14.2	0.4	0.1	2.2	0.0	0.1	0.8	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.9	0.0	1.1	0.8	0.0	0.2	1.1	1.7	0.0	0.1	0.0	0.1	0.6	0.4	0.3	0.3	0.1	0.4	0.3	0.4	0.3	0.3	0.2	0.1	0.4	0.2	0.5	12.8	5.9	0.0	0.2	0.1	8.2	24.4	2.2	0.1	1.0	8.6	30.4	1.5	8.7	1.8	0.0	2.7	0.5	0.0	0.0	0.0	317.5	0.4	0.1	1.4	0.0	0.0	0.2	0.6	4.1	1.4	0.0	0.2	2.5	0.2	2.5	0.0	0.5	0.0	0.1	0.0	4.1	0.0	0.6	440.1	3.7	0.3	1.8	0.0	0.0	0.8	0.0	0.5	0.1	0.1	0.0	0.4	0.0	1.6	0.0	0.0	3.0	1.1	0.0	0.2	3.1	2.7	3.3	0.3	0.0	1.1	1.7	2.9	0.0	3.6
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647773-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	56.3	93.4	151.5	41.2	152.0	89.7	51.9	146.3	186.2	52.7	112.3	48.3	27.2	51.6	57.6	37.6	50.7	36.7	67.0	146.2	189.9	46.7	42.9	51.8	68.2	142.8	154.1	72.8	38.2	71.8	144.4	27.5	155.3	48.0	26.9	168.6	38.3	44.8	58.3	48.0	41.8	39.1	146.0	57.7	37.7	55.0	174.0	71.9	55.2	47.3	61.9	44.5	46.4	156.5	25.1	23.2	51.2	39.7	56.9	59.2	16.0	74.6	63.9	62.0	45.8	25.7	26.9	127.2	97.0	50.6	30.6	35.6	51.1	21.3	52.5	48.1	74.1	64.9	36.6	59.1	74.4	88.6	88.7	50.7	59.3	49.8	76.8	68.2	42.2	82.6	77.2	52.2	71.9	73.7	107.2	112.5	25.9	32.4	53.3	119.9	33.0	106.0	46.4	22.7	123.9	74.7	96.8	22.4	61.8	18.5	51.7	86.0	46.6	59.1	31.3	51.4	57.9	216.2	202.5	179.2	62.2	59.6	57.1	56.4	21.9	101.3	28.7	19.8	35.8	46.8	44.2	47.9	21.0	65.7	53.9	33.8	33.2	39.7	31.2	20.3	48.6	19.8	151.5	152.0	146.3	186.2	146.2	189.9	142.8	154.1	155.3	146.0	174.0	156.5	109.1	48.1	69.3	30.7	160.8	195.5	114.3	82.5	163.4	388.8	73.6	77.0	95.2	68.6	74.2	93.8	93.8	76.8	172.7	33.4	135.0	81.7	7.8	68.5	81.8	102.3	97.8	421.4	46.7	51.1	38.9	115.7	39.3	74.6	124.9	81.4	84.3	58.1	60.7	282.7	54.5	50.1	120.1	70.8	138.5	23.6	115.5	89.3	120.9	18.7	96.6	320.2	125.7	38.2	68.2	46.3	46.9	130.5	162.8	101.7	45.1	74.7	66.9	176.2	138.1	79.0	106.2	255.1	116.2	94.3	194.4	122.3	215.0	140.7	32.2	116.4
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295068	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	213.2	438.0	3.2	0.0	173.9	31.7	59.4	0.3	0.1	3.0	0.2	429.4	0.1	0.1	1.0	929.2	29.1	0.0	1.7	0.1	0.0	0.4	0.1	0.5	1.2	0.0	22.9	560.1	6.8	1.3	1.5	1.8	2.9	0.2	252.2	0.4	0.2	9.4	2.9	0.1	1.3	2.1	0.0	5.4	23.9	0.5	0.2	2.1	0.1	0.0	0.2	0.0	0.1	0.3	799.9	0.0	0.0	0.0	0.0	0.9	0.5	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210506-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 197.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 386.6;Glandular and luminal cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA		34000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	29.3	7.2	2.7	54.4	2.7	44.1	32.2	3.4	3.6	29.0	10.0	134.7	41.1	105.9	21.7	58.2	45.2	37.4	14.7	2.3	2.9	19.3	10.1	41.0	49.6	6.4	3.5	7.3	20.8	15.3	5.7	25.6	3.4	55.2	69.0	13.4	34.2	197.1	5.1	23.2	47.5	147.6	3.2	30.0	52.1	39.9	4.3	33.5	66.4	8.9	51.3	87.1	41.1	3.0	115.9	24.0	27.0	0.2	11.7	29.7	62.3	58.9	28.9	10.9	10.6	60.4	126.2	0.0	230.0	41.7	1.3	116.9	14.4	87.3	26.4	57.3	46.0	11.5	53.1	30.5	69.9	53.6	0.2	66.4	263.6	37.7	95.0	74.9	31.1	0.0	11.9	39.5	3.0	24.4	0.2	0.7	17.8	134.0	67.4	0.2	0.4	46.0	110.9	44.0	12.4	113.4	85.5	267.1	68.2	77.6	0.3	21.5	52.3	0.6	1.5	86.2	0.7	92.6	48.9	1.3	7.4	27.2	89.3	274.7	79.2	221.5	150.2	132.1	144.7	104.6	113.4	137.6	86.9	95.5	111.0	127.6	41.6	205.1	170.5	20.7	130.4	162.8	2.7	2.7	3.4	3.6	2.3	2.9	6.4	3.5	3.4	3.2	4.3	3.0	40.8	243.6	47.0	0.0	60.4	200.4	196.2	64.8	60.3	2.2	62.2	57.0	16.1	47.1	81.7	36.8	12.5	23.2	121.3	140.8	21.5	110.7	386.6	176.7	29.9	49.0	50.6	17.7	0.1	112.3	78.1	23.6	84.1	283.9	18.9	54.1	25.7	11.9	15.4	1.7	0.1	100.7	34.6	58.0	119.0	112.5	1.8	78.0	28.4	10.3	77.6	24.7	201.8	0.0	0.3	196.8	112.1	0.4	76.3	102.4	65.3	13.6	68.1	13.9	6.6	9.0	42.3	19.1	10.6	55.9	122.7	29.1	79.2	8.8	79.7	135.9
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 329.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 261.1"	"Lineage enriched"	"Detected in all"	5	"monocytes: 261.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA053200: AB_2682079"	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	8.1	46.5	17.4	10.3	36.8	118.8	8.9	16.4	25.4	4.3	15.7	3.8	7.2	3.9	121.9	3.3	4.0	36.1	71.5	26.5	15.0	26.5	4.9	10.2	8.0	17.8	15.0	5.3	102.4	9.4	26.7	10.2	18.2	9.8	2.8	0.5	329.9	19.7	5.1	9.7	7.3	2.8	14.8	11.9	138.4	31.1	15.5	7.4	10.7	8.1	10.3	29.3	5.3	18.9	0.2	97.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	4.3	13.8	4.7	0.0	0.2	0.6	8.1	0.0	0.0	37.5	19.2	115.5	9.8	78.1	0.0	49.2	398.5	0.1	0.0	0.0	0.0	0.0	0.0	18.5	54.0	0.9	0.0	2.2	95.5	675.1	9.0	288.1	0.0	0.4	0.0	52.4	56.5	15.0	17.0	6.1	0.1	0.1	3.6	0.9	0.0	53.9	0.0	0.0	1.7	0.2	0.4	17.0	38.2	0.0	0.1	221.8	0.5	0.0	51.0	51.5	7.0	67.9	0.4	5.5	2.4	9.1	35.8	13.1	0.3	3.8	12.6	11.6	261.1	2.6	3.5	19.0	17.4	36.8	16.4	25.4	26.5	15.0	17.8	15.0	18.2	14.8	15.5	18.9	35.6	0.0	0.0	5.9	16.2	2.7	0.3	0.4	1.8	0.8	5.5	67.1	58.3	183.0	0.9	12.9	0.0	0.4	21.1	0.2	74.3	159.5	106.5	1.3	0.7	43.6	1.8	222.9	26.1	481.2	0.6	7.9	316.0	3.2	71.1	1.2	1.8	0.5	48.0	0.0	2.0	1.5	0.0	17.9	6.1	319.3	3.1	30.6	72.9	8.4	41.0	0.2	25.7	2.5	1.5	215.6	0.9	3.4	25.8	3.5	0.2	6.1	0.0	1.5	144.7	1.9	68.4	63.0	20.3	0.5	2.0	1.2	28.3	66.7	2.3	1.3
TESK2		ENSG00000070759	"Testis associated actin remodelling kinase 2"	Q96S53	1	45343883-45491163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 222.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;RT4: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	3.8	2.1	7.1	2.8	10.6	10.2	6.6	10.3	8.3	6.4	4.8	5.3	8.6	3.2	3.7	7.1	3.0	2.6	2.4	7.3	8.0	2.5	6.9	3.9	3.9	10.8	10.1	9.8	3.6	3.4	2.4	3.5	10.3	15.5	7.0	2.8	8.4	2.6	8.3	12.7	10.8	2.9	8.5	5.3	4.5	9.6	9.9	4.2	3.4	4.7	5.2	4.7	7.4	15.1	1.9	0.0	0.9	0.1	3.5	1.8	14.6	0.7	4.9	2.1	3.6	4.3	1.7	6.2	0.6	1.8	5.4	2.3	3.9	3.1	1.6	4.4	4.9	4.2	2.0	3.2	1.9	1.4	11.1	1.9	3.2	2.4	3.4	3.2	1.7	8.1	0.8	12.4	1.4	0.7	3.6	2.9	3.8	1.8	1.8	5.2	0.1	1.5	1.9	14.7	0.4	1.6	3.8	7.3	14.1	8.6	11.3	1.8	0.0	0.2	2.1	1.3	1.3	8.0	5.0	1.2	1.1	0.0	1.0	12.8	4.6	13.3	2.7	3.4	1.9	8.0	2.5	1.8	2.4	6.6	4.1	2.3	19.0	1.5	8.0	1.3	1.9	3.4	7.1	10.6	10.3	8.3	7.3	8.0	10.8	10.1	10.3	8.5	9.9	15.1	3.9	0.0	2.8	54.2	10.7	7.8	7.1	2.8	14.2	2.4	11.9	9.4	1.3	4.3	3.4	0.0	14.6	8.3	4.2	13.9	0.0	1.3	23.7	4.6	1.8	3.2	4.2	5.0	10.2	2.7	2.8	3.7	7.7	8.9	7.0	2.4	2.2	6.3	6.8	0.0	6.7	6.9	4.1	5.5	4.4	7.8	2.8	6.0	3.6	15.9	4.6	1.1	4.1	18.6	222.9	1.1	7.3	1.9	9.8	10.6	14.9	1.2	2.0	3.1	6.6	2.6	6.1	22.0	13.6	12.6	8.5	14.8	4.7	1.8	4.9	8.0
TESPA1	"ITPRID3, KIAA0748"	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948015-54984762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.3;lymphoid tissue: 75.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 202.7;granulocytes: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 247.1;HMC-1: 187.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058823, HPA079222"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058823: AB_2683828, HPA079222: "	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.3	0.5	19.6	13.9	37.6	14.5	1.7	12.0	81.3	1.9	11.9	3.7	3.0	2.3	4.8	1.9	1.3	4.8	1.0	36.6	13.2	0.8	0.9	5.8	36.4	11.6	12.2	6.9	0.9	0.7	0.6	0.5	12.1	1.5	4.8	1.0	1.4	1.1	1.4	1.0	7.5	2.1	11.4	13.5	3.9	0.9	16.1	75.2	1.1	0.6	36.4	4.0	1.1	44.2	0.2	0.4	0.6	0.4	0.7	0.7	3.2	0.0	0.7	0.2	0.3	0.0	0.4	17.5	0.2	0.7	0.6	0.4	0.7	0.4	0.3	20.0	0.6	247.1	0.8	0.3	0.6	13.6	187.7	0.5	0.4	0.4	0.7	0.5	0.0	41.5	1.0	16.3	0.4	0.4	39.1	1.5	0.5	0.2	0.2	9.3	0.3	2.7	0.6	0.9	0.5	0.2	0.6	0.1	0.5	0.7	0.2	3.6	0.3	0.4	0.4	0.2	0.2	11.1	0.4	12.0	1.7	4.0	0.4	43.1	1.4	1.6	38.3	1.3	43.5	17.9	126.0	57.5	16.0	15.0	175.8	98.8	3.1	57.2	1.5	5.6	92.6	64.5	19.6	37.6	12.0	81.3	36.6	13.2	11.6	12.2	12.1	11.4	16.1	44.2	0.7	0.0	4.3	10.1	9.9	0.5	0.0	0.0	0.0	0.0	0.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	32.4	202.7	0.0	0.0	1.3	0.0	0.1	120.1	0.0	0.4	0.5	0.1	0.0	2.5	0.0	0.0	1.3	1.6	0.0	0.9	4.6	1.8	2.8	3.3	0.0	25.7	7.1	5.1	0.0	0.0	1.2	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.3	0.0	37.0	0.8	0.1	0.0
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 55.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	4.3	3.1	2.9	10.1	4.4	22.4	5.4	2.5	2.7	6.3	5.8	5.2	6.1	7.2	6.0	7.7	4.9	5.0	3.3	2.1	4.6	4.1	4.2	5.4	5.6	5.3	4.4	4.3	3.7	4.6	1.8	10.2	5.3	4.4	5.9	6.6	4.7	3.3	2.8	11.0	6.0	5.7	2.9	7.2	5.3	1.3	4.1	5.4	4.2	5.2	7.0	5.5	4.5	5.6	5.1	3.1	10.9	11.1	2.1	3.7	4.2	3.1	4.8	4.8	4.7	3.1	6.4	0.5	4.0	4.0	2.1	4.9	9.3	6.1	5.3	6.7	2.9	7.0	6.5	1.6	4.9	15.5	11.8	3.8	7.9	4.5	5.6	8.6	6.4	4.1	7.7	13.6	4.4	3.1	2.5	4.7	2.5	6.2	2.2	8.4	4.7	1.0	4.7	9.4	7.5	5.9	4.2	9.1	0.8	5.9	4.5	11.8	9.1	7.8	6.7	2.1	5.3	9.5	6.8	6.8	4.8	3.8	7.2	30.1	13.6	14.7	3.9	10.4	1.6	5.3	2.3	2.2	10.2	6.3	1.9	2.9	55.5	5.9	13.6	8.9	3.1	3.3	2.9	4.4	2.5	2.7	2.1	4.6	5.3	4.4	5.3	2.9	4.1	5.6	24.5	25.6	29.1	58.8	28.3	14.4	11.0	14.2	12.5	22.8	15.6	13.6	27.9	5.7	23.9	9.2	16.7	23.1	34.1	19.0	7.9	7.0	0.4	22.1	38.3	20.3	23.3	10.9	48.4	7.5	5.7	18.0	21.4	33.2	27.8	15.5	13.6	8.5	14.5	35.3	89.7	15.8	32.6	48.8	93.3	0.9	8.1	98.3	5.4	90.9	48.1	5.8	34.0	112.6	128.3	8.2	18.7	7.2	22.5	12.1	16.3	2.8	22.3	24.3	13.1	47.0	21.7	0.2	1.3	28.4	35.9	34.2	18.9	24.7	14.0	27.5
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73984910-74108176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;skin 1: 16.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.2	1.6	3.7	5.2	2.4	19.7	3.0	6.3	13.7	2.5	0.0	4.1	5.4	2.0	1.4	7.6	1.9	2.5	1.2	9.3	1.7	1.6	3.9	4.1	3.7	2.0	1.5	1.5	2.6	2.0	1.5	4.6	2.2	2.5	4.3	3.6	4.2	1.1	1.2	16.2	6.0	2.1	0.6	3.8	4.3	1.6	2.7	5.8	2.3	1.3	4.1	3.4	4.0	5.8	9.0	8.0	14.5	8.9	1.2	1.3	26.4	1.8	2.4	3.4	2.7	16.6	8.1	14.9	3.5	2.4	1.6	9.4	13.0	5.2	3.6	6.7	5.2	19.2	7.0	5.6	5.1	20.2	11.3	2.0	13.3	4.2	9.9	4.3	5.3	10.3	13.4	4.8	2.0	14.6	10.0	13.0	8.1	7.7	2.7	15.4	9.1	5.2	3.8	16.5	18.1	15.5	4.0	10.3	4.9	5.7	6.6	16.1	6.7	3.7	15.4	1.8	6.8	4.2	2.0	12.7	2.4	13.9	4.9	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.2	3.7	2.4	6.3	13.7	9.3	1.7	2.0	1.5	2.2	0.6	2.7	5.8	4.2	6.4	9.0	31.3	6.4	49.5	3.5	4.2	14.8	16.3	8.0	5.8	2.9	2.8	8.0	1.8	20.9	7.0	7.3	10.5	0.0	3.5	4.7	18.8	11.9	6.6	6.0	24.8	88.5	4.4	30.1	3.4	13.7	29.6	2.5	6.2	3.6	6.1	10.1	10.1	45.7	8.0	8.2	26.9	23.2	0.8	0.6	26.9	10.6	54.4	27.1	1.5	2.1	41.7	86.7	6.2	7.7	3.0	4.8	6.2	10.3	1.5	11.9	8.6	0.0	3.8	7.7	0.5	2.6	24.4	68.2	2.5	5.5	2.3	6.9	7.0
TEX101	"CT131, MGC4766, SGRG, SPATA44, TES101RP"	ENSG00000131126	"Testis expressed 101"	Q9BY14	19	43401496-43418597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 117.7"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 909.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 21.5"	"Immune cell enriched"	"Detected in single"	557	"basophil: 55.7"	"Lineage enriched"	"Detected in single"	557	"granulocytes: 55.7"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA041915, HPA042513"	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA041915: AB_10795268, HPA042513: AB_10795507"	"unprognostic (2.50e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.64e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.78e-4)"		"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.67e-7)"	"unprognostic (8.83e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.04e-2)"	0.1	0.4	0.3	0.3	0.3	0.1	0.2	0.3	21.5	0.5	0.2	0.5	0.4	0.4	0.2	1.3	0.3	0.2	0.5	2.6	0.2	0.2	0.5	0.2	0.2	4.3	0.2	0.5	1.6	0.1	0.0	0.2	2.0	0.3	0.5	0.0	1.1	0.2	0.6	1.5	0.5	0.3	1.1	0.1	0.2	117.7	0.3	1.0	0.1	0.0	1.3	0.1	1.0	0.4	0.2	0.0	0.3	0.1	0.2	0.6	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.4	0.3	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.4	0.1	0.5	0.1	0.2	0.3	0.4	0.0	0.2	0.2	0.4	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.7	0.0	0.2	0.5	0.0	0.2	0.0	0.1	0.2	0.6	0.1	0.0	1.3	0.1	0.2	0.1	0.1	0.3	0.2	0.3	0.1	0.2	0.1	0.1	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	21.5	2.6	0.2	4.3	0.2	2.0	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.2	0.0	0.0	31.5	6.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	909.7	151.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX11	"MZIP4, Spo22, TGC1, TSGA3, ZIP4"	ENSG00000120498	"Testis expressed 11"	Q8IYF3	X	70528940-70908711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 58.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 20.1;Early spermatids: 14.7;Exocrine glandular cells: 9.7;Late spermatids: 28.0;Paneth cells: 12.5;Spermatocytes: 46.5;Spermatogonia: 30.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3;testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002950	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA002950: AB_1080249"	"unprognostic (6.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.87e-3)"	"unprognostic (7.77e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	3.9	1.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	58.8	0.0	0.0	0.2	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.5	11.6	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	14.7	0.1	0.0	0.2	1.2	0.0	2.6	9.7	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.8	0.0	0.0	0.3	28.0	0.6	0.1	0.0	0.0	0.6	0.0	0.0	2.0	1.9	0.5	12.5	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	46.5	30.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0
TEX12		ENSG00000150783	"Testis expressed 12"	Q9BXU0	11	112167372-112172556	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"retina: 8.6;testis: 20.7"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 211.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038289, HPA038290"	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA038289: AB_10672742, HPA038290: AB_2675934"	"unprognostic (1.49e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.20e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.16e-3)"	0.3	0.0	0.1	0.1	0.1	0.4	0.4	0.5	0.3	0.2	0.1	0.3	0.6	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	8.6	0.2	0.1	0.9	0.7	0.4	0.2	0.0	0.2	0.2	20.7	0.2	0.1	0.1	0.7	0.2	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.3	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.7	0.1	0.4	0.2	0.2	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.2	0.1	0.0	0.0	1.4	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.0	4.2	0.1	0.3	0.3	0.0	0.2	2.0	0.0	0.1	0.1	0.0	0.0	1.7	0.2	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.4	0.3	0.0	2.2	0.1	0.0	0.0	1.9	5.1	0.9	0.3	0.0	1.0	0.6	0.3	0.0	0.5	0.2	0.1	0.1	0.7	0.1	0.2	0.3	0.1	0.0	0.4	6.6	0.2	0.4	211.7	36.1	0.0	0.4	0.0	0.3	0.2	0.2	0.3
TEX13A		ENSG00000268629	"Testis expressed 13A"	Q9BXU3	X	105218929-105220694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	107	"testis: 10.6"	"Group enriched"	"Detected in some"	37	"Early spermatids: 90.8;Late spermatids: 159.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072257	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA072257: AB_2732198"															"unprognostic (3.70e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TEX19	FLJ35767	ENSG00000182459	"Testis expressed 19"	Q8NA77	17	82359247-82363775	"Predicted intracellular proteins"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	207	"testis: 30.9"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 244.5;Spermatogonia: 180.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.2;HMC-1: 22.7;JURKAT: 10.8;MOLT-4: 20.0;U-266/70: 29.3;U-937: 11.0"					"Not detected"	"Not detected"			HPA054577	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA054577: AB_2682528"	"unprognostic (3.58e-2)"	"unprognostic (5.43e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.51e-5)"	"unprognostic (4.14e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.44e-1)"		"unprognostic (3.59e-1)"	"unprognostic (1.67e-15)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.3	3.8	0.1	0.0	0.1	0.1	2.3	0.1	28.2	5.3	0.0	0.1	1.1	1.9	0.1	0.1	0.0	2.8	0.1	0.0	1.4	0.0	0.1	22.7	0.0	0.0	0.0	0.1	0.4	0.0	10.8	1.2	0.4	0.0	1.4	20.0	1.0	0.5	1.1	0.3	1.4	0.3	5.2	0.1	0.1	0.1	0.5	0.2	8.9	1.4	0.9	0.7	0.6	0.0	0.1	0.8	2.0	0.1	29.3	1.5	2.6	0.0	11.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	244.5	180.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX2	"HT008, KIAA1738, TMEM96"	ENSG00000136478	"Testis expressed 2"	Q8IWB9	17	64147227-64263260	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020648, HPA057116"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA020648: AB_1857908, HPA057116: AB_2683341"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.90e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.53e-3)"	"unprognostic (5.59e-3)"	16.6	24.2	38.4	7.3	46.9	18.7	19.6	38.3	39.3	17.8	31.1	13.6	10.2	14.7	11.4	17.3	13.4	16.7	27.2	37.6	46.2	18.5	33.2	14.9	6.3	43.5	46.4	15.7	29.4	31.5	11.2	9.9	43.3	16.3	13.5	23.0	19.4	17.0	45.0	15.5	10.2	14.6	40.4	12.7	13.2	53.5	44.9	8.9	40.2	41.9	6.8	10.5	11.1	44.2	32.6	15.2	9.5	19.5	44.7	26.3	11.5	44.1	49.7	39.2	27.0	14.2	7.8	11.3	11.0	55.9	24.3	15.5	17.0	53.3	44.7	16.6	11.6	76.3	9.9	27.0	16.7	22.5	12.2	19.3	29.0	26.7	54.3	27.5	19.1	18.8	21.3	13.6	29.8	36.1	20.5	10.4	5.4	25.3	26.9	12.6	85.8	16.1	22.7	14.9	14.4	24.0	21.9	55.9	24.3	52.2	26.4	19.0	22.6	36.5	21.1	28.5	25.8	14.0	20.1	7.2	14.5	21.0	33.6	0.0	3.1	0.9	1.5	1.0	1.7	0.3	1.7	1.8	2.9	0.6	1.7	1.7	0.3	3.3	2.0	20.6	1.3	1.8	38.4	46.9	38.3	39.3	37.6	46.2	43.5	46.4	43.3	40.4	44.9	44.2	8.1	3.2	8.1	27.4	3.4	8.8	6.8	5.1	16.5	4.2	17.6	13.7	33.3	8.6	6.2	12.9	6.2	2.5	14.7	10.7	1.9	4.7	53.5	6.0	10.5	8.8	12.1	15.4	41.6	8.3	2.0	7.4	16.3	4.2	3.8	12.2	8.6	30.4	12.0	10.1	35.6	11.3	6.1	11.5	3.7	52.9	6.5	9.2	7.2	17.8	2.9	7.2	1.0	33.2	39.3	6.5	4.6	12.8	10.1	7.1	7.1	8.3	8.2	17.3	0.0	12.6	7.4	22.5	8.8	14.6	8.9	1.4	3.6	9.4	10.9	5.4
TEX22		ENSG00000226174	"Testis expressed 22"	C9J3V5	14	105398538-105450106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 290.6;Late spermatids: 614.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;U-266/70: 2.3;U-937: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065576	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA065576: AB_2685513"	"unprognostic (3.99e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.42e-4)"	"unprognostic (8.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.91e-3)"	0.2	0.0	0.7	0.2	0.8	0.4	0.3	1.1	0.7	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.6	0.5	0.6	0.1	0.1	0.5	0.9	0.8	0.6	0.3	0.2	0.1	0.1	0.8	0.4	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.7	0.7	0.2	5.0	0.7	1.0	0.3	0.0	0.2	0.1	0.2	1.2	0.2	0.3	0.3	1.4	0.4	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.0	0.2	0.2	0.0	0.0	3.2	0.2	0.1	0.5	0.0	0.1	0.2	0.8	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.9	0.0	1.0	0.1	0.1	0.1	0.0	0.1	0.8	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.3	0.0	2.3	0.3	0.3	0.1	1.7	1.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.8	1.1	0.7	0.6	0.5	0.9	0.8	0.8	0.7	0.7	1.2	0.3	0.0	0.0	6.2	1.1	0.4	0.4	0.2	0.6	0.1	1.0	0.9	0.4	0.0	0.1	0.0	0.0	0.2	0.3	0.2	1.9	0.6	290.6	1.3	0.5	0.4	0.0	0.8	3.2	0.6	0.1	0.4	0.0	0.4	4.5	2.2	0.0	0.1	1.0	0.0	4.8	0.2	0.0	1.9	0.3	614.3	4.1	1.0	1.8	1.0	1.2	0.3	0.0	6.6	5.8	0.6	0.1	2.2	0.3	0.5	0.8	0.5	0.4	0.2	6.6	0.9	0.6	54.2	3.0	0.4	0.1	0.1	0.6	0.4	0.2	0.2
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985942-70994873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	39.5	38.8	30.8	21.5	34.8	20.0	29.7	33.1	31.2	32.2	39.1	28.3	25.0	25.4	45.5	27.5	35.3	22.7	36.0	29.3	32.7	41.1	38.8	30.4	22.0	38.5	34.5	39.6	47.5	66.1	29.2	25.0	33.5	31.6	32.7	43.9	36.0	34.3	56.4	20.9	25.6	34.0	32.9	23.5	30.0	36.9	33.4	25.7	46.1	54.3	27.0	26.2	21.6	33.4	61.9	57.1	39.4	50.3	116.4	58.9	44.7	69.8	65.6	79.1	49.6	67.5	49.8	50.2	25.9	122.5	74.7	45.6	75.3	82.7	113.8	38.4	62.8	60.1	28.7	71.8	68.3	70.7	48.7	53.7	54.3	76.2	51.6	43.4	81.5	51.3	75.7	32.4	93.6	48.2	61.2	39.3	26.2	98.7	66.4	43.1	120.7	43.1	57.7	53.1	64.0	33.8	72.3	70.9	46.0	26.2	46.3	41.3	66.1	96.8	83.6	52.4	93.8	25.3	23.9	58.4	84.4	91.7	83.2	8.7	3.8	7.7	3.4	3.9	2.9	1.8	3.7	4.6	2.9	2.7	4.1	3.3	2.8	2.6	3.9	3.1	3.3	2.1	30.8	34.8	33.1	31.2	29.3	32.7	38.5	34.5	33.5	32.9	33.4	33.4	14.7	3.2	14.7	9.4	11.3	8.3	10.7	8.2	5.7	14.7	20.6	14.9	22.9	20.0	8.4	23.9	37.5	16.4	9.0	21.8	7.9	24.9	15.7	10.8	11.9	15.5	8.4	17.4	8.0	23.8	17.4	16.3	12.2	13.3	2.5	17.1	16.4	35.2	19.5	8.4	7.5	18.2	8.2	18.3	6.4	28.5	15.8	11.9	19.6	6.5	13.0	28.1	14.4	15.1	12.6	21.1	14.9	18.4	7.4	12.9	24.4	18.3	5.5	72.9	0.0	16.7	15.0	45.3	11.2	12.8	7.5	17.9	8.7	14.4	18.9	7.7
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264, ER-phagy receptor"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 374.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	34.7	73.4	43.5	23.1	46.5	22.3	35.6	48.7	51.7	39.0	53.1	41.5	39.0	34.2	41.2	41.1	44.0	39.7	41.4	43.8	47.2	67.6	65.3	29.8	33.5	47.2	45.5	31.3	54.3	88.5	26.2	29.4	46.4	45.1	34.5	20.4	58.7	46.9	34.2	69.3	37.6	26.3	46.3	40.9	46.7	111.5	45.9	29.1	48.7	29.6	26.3	35.9	34.9	48.4	36.5	65.5	11.6	59.3	116.8	56.4	23.5	31.0	72.0	50.1	50.1	35.2	84.2	51.6	21.9	44.1	84.2	34.7	32.7	61.6	23.7	42.0	51.9	49.6	40.2	47.8	104.0	31.5	53.6	74.8	96.9	56.3	57.1	45.3	36.9	39.0	26.6	87.7	51.9	42.1	50.9	73.3	12.6	59.8	72.7	24.3	15.3	98.7	79.7	50.1	16.5	26.8	37.4	101.5	48.0	15.7	49.6	66.0	27.3	49.8	20.8	53.0	41.2	61.0	71.3	26.4	61.5	65.9	50.9	99.2	110.1	69.3	119.7	115.6	120.3	98.6	122.6	113.6	104.6	102.4	100.9	103.1	23.5	76.1	115.6	92.4	159.9	139.9	43.5	46.5	48.7	51.7	43.8	47.2	47.2	45.5	46.4	46.3	45.9	48.4	63.6	35.3	21.9	12.4	36.7	34.8	46.7	123.9	45.5	33.5	69.9	68.2	24.4	65.8	68.2	99.3	58.4	142.9	52.3	70.3	62.6	83.1	57.7	44.9	31.8	54.8	32.9	24.8	6.5	75.7	88.9	41.4	29.0	48.2	16.5	45.3	38.9	63.1	105.4	42.1	9.1	56.5	118.0	48.3	45.5	61.2	51.0	47.8	65.8	8.4	56.1	62.6	89.6	7.5	12.3	59.6	76.4	48.9	36.0	45.6	137.6	126.7	49.7	55.4	26.3	30.8	30.7	374.8	111.7	46.3	35.4	76.3	61.9	110.4	86.0	49.9
TEX30	C13orf27	ENSG00000151287	"Testis expressed 30"	Q5JUR7	13	102765888-102773811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 71.3;liver: 40.1;testis: 122.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 384.7;Spermatocytes: 958.6;Spermatogonia: 283.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 364.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 364.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 295.3;THP-1: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053545	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053545: AB_2682181"	"unprognostic (5.26e-2)"	"prognostic favorable (2.09e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (1.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	8.4	6.0	8.5	6.7	7.8	14.4	7.7	8.6	12.3	7.3	8.0	5.6	5.5	10.4	71.3	8.4	6.1	4.9	9.1	7.7	7.9	19.2	40.1	5.9	11.8	7.7	8.2	7.2	5.6	4.3	7.2	14.9	7.7	4.6	4.5	7.5	5.2	13.1	9.7	7.5	5.4	7.3	7.8	6.5	5.7	122.8	9.1	16.1	5.5	9.3	7.4	6.8	6.4	8.5	44.0	16.1	39.0	30.8	23.3	16.8	0.4	59.0	14.9	39.9	35.6	41.2	43.0	25.6	25.0	22.4	52.5	23.8	35.3	21.0	53.9	53.8	21.3	44.2	34.9	0.4	15.7	92.5	86.0	8.9	13.6	33.2	20.8	14.4	30.8	64.9	27.6	0.0	47.6	24.5	61.0	295.3	14.1	63.4	38.3	37.8	18.0	18.4	61.7	18.5	51.2	22.1	33.3	42.9	37.8	23.0	30.0	188.3	12.0	27.3	21.2	44.0	63.7	23.9	30.3	0.1	46.9	54.0	45.9	364.5	7.6	79.4	10.6	9.4	15.2	12.9	11.6	13.6	8.8	11.8	13.1	11.2	3.9	28.5	9.7	17.8	18.8	8.8	8.5	7.8	8.6	12.3	7.7	7.9	7.7	8.2	7.7	7.8	9.1	8.5	12.4	0.0	3.7	1.6	15.0	23.7	16.2	35.3	12.0	7.4	12.1	21.5	12.2	7.2	14.3	12.9	4.2	110.9	10.9	3.4	37.2	16.0	384.7	11.1	10.2	15.5	3.0	34.1	5.1	9.7	113.9	15.7	5.1	6.7	27.3	11.3	13.6	39.5	46.6	6.7	6.3	4.9	22.4	5.3	18.9	79.2	30.4	11.7	28.4	4.7	17.7	8.0	14.4	5.0	4.6	9.7	2.2	18.8	15.8	16.0	8.1	100.8	11.2	5.9	92.1	15.4	29.7	958.6	283.2	16.9	19.9	142.3	20.2	5.0	8.3	10.9
TEX33	"C22orf33, EAN57, MGC35206"	ENSG00000185264	"Testis expressed 33"	O43247	22	36991120-37007851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	442	"testis: 91.4"	"Group enriched"	"Detected in some"	43	"Early spermatids: 873.2;Late spermatids: 258.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005998	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA005998: AB_1078352"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	873.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	258.2	4.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	12.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX35	"C1orf49, DKFZP564J047, TSC24"	ENSG00000240021	"Testis expressed 35"	Q5T0J7	1	178513109-178548602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 117.9"	"Group enriched"	"Detected in some"	137	"Early spermatids: 1312.2;Late spermatids: 2214.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039190	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA039190: AB_10794425"	"unprognostic (2.20e-1)"	"unprognostic (1.77e-2)"				"unprognostic (1.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-1)"	"unprognostic (5.41e-2)"	0.3	0.2	2.3	0.3	2.5	2.2	0.6	8.7	2.7	0.2	0.0	0.3	1.6	0.5	1.4	0.4	0.2	0.3	0.6	1.3	1.6	0.2	0.2	0.4	0.6	0.7	0.5	0.6	0.4	0.4	0.0	0.5	1.0	0.5	0.6	2.0	0.3	0.2	0.3	2.2	0.4	0.3	0.0	0.7	1.6	117.9	1.4	0.3	0.5	0.3	0.4	0.3	0.1	3.4	0.2	0.1	0.1	0.5	0.3	0.9	2.8	0.1	0.2	0.2	0.1	0.0	0.3	0.4	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	1.1	0.4	0.0	0.1	0.2	0.1	0.0	0.2	0.7	0.3	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.5	0.9	0.0	0.1	0.3	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.7	0.4	0.3	0.5	0.1	0.7	0.6	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.3	2.5	8.7	2.7	1.3	1.6	0.7	0.5	1.0	0.0	1.4	3.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1312.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2214.6	8.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	11.5	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TEX37	"C2orf51, FLJ25369, TSC21"	ENSG00000172073	"Testis expressed 37"	Q96LM6	2	88524649-88529585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	640	"testis: 85.0"	"Group enriched"	"Detected in some"	229	"Early spermatids: 846.6;Late spermatids: 3191.0"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"BEWO: 50.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043987, HPA070239"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA043987: AB_10961125, HPA070239: "										"unprognostic (1.08e-3)"					"unprognostic (2.24e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	50.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	846.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3191.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	8.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TEX44	"C2orf57, MGC35154"	ENSG00000177673	"Testis expressed 44"	Q53QW1	2	231592864-231594276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	923	"testis: 152.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049917, HPA056433"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"					"HPA049917: AB_2680951, HPA056433: AB_2683131"					"unprognostic (5.42e-2)"					"unprognostic (3.90e-1)"					"unprognostic (6.21e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	152.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX55	"C3orf30, FLJ32859, TSCPA"	ENSG00000163424	"Testis expressed 55"	Q96M34	3	119146151-119160042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	168	"testis: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA062468, HPA068480"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Vesicles		"HPA062468: AB_2684772, HPA068480: "				"unprognostic (4.06e-3)"				"unprognostic (3.67e-2)"									"unprognostic (2.66e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4"	"Group enriched"	"Detected in many"	12	"B-cells: 14.4;granulocytes: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.8	6.1	4.1	4.6	3.9	3.4	10.1	7.4	3.9	8.8	17.0	3.6	11.6	5.2	8.4	4.4	28.0	5.2	1.1	3.2	4.2	10.8	1.5	4.4	6.0	9.4	8.6	5.4	5.4	14.2	9.9	1.6	4.5	4.5	4.8	18.0	10.5	3.4	1.2	5.6	8.0	2.2	5.3	3.2	12.2	16.4	6.6	3.7	17.4	1.5	10.6	2.7	1.6	5.7	7.8	7.1	15.3	13.7	3.7	10.8	2.0	1.7	6.3	4.8	5.7	1.7	6.9	15.5	7.0	1.2	8.2	6.6	6.6	7.4	5.5	1.7	7.8	9.1	6.7	5.2	1.1	3.3	1.3	5.9	13.3	5.4	4.1	6.9	0.2	11.1	5.2	1.4	2.6	4.5	6.5	1.2	7.2	13.2	3.0	2.6	7.1	5.5	15.9	4.4	24.3	9.8	8.7	4.9	5.5	11.2	14.6	3.0	0.7	20.3	5.8	6.5	6.4	2.1	16.5	11.7	8.0	1.7	3.9	4.3	0.1	0.1	0.4	0.6	0.1	14.4	0.4	0.3	0.2	11.4	0.2	0.8	0.3	0.4	0.4	0.4	0.6	0.7	4.1	3.9	7.4	3.9	3.2	4.2	9.4	8.6	4.5	5.3	6.6	5.7	1.5	6.4	7.5	38.8	21.0	4.2	7.3	13.2	20.5	6.4	11.3	11.7	0.8	5.7	23.5	11.0	12.5	1.8	0.3	2.3	21.5	15.6	89.1	86.2	5.1	3.2	7.7	5.9	14.3	7.0	0.5	5.0	17.3	4.8	1.3	5.1	1.8	0.4	1.3	1.7	20.4	3.7	16.2	0.0	2.1	40.9	4.7	2.7	3.6	4.7	1.2	6.8	1.0	14.6	15.1	4.5	5.4	3.8	15.8	3.7	12.3	21.7	125.6	37.5	0.0	4.6	6.0	74.6	36.6	6.9	2.3	0.3	1.0	6.2	6.7	4.9
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7525.8;retina: 2433.0"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000	"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	80.9	1.2	186.3	1.0	412.5	2.4	13.3	591.8	274.2	2.0	58.9	2.3	0.9	1.7	1.4	11.0	1.4	1.9	12.1	173.7	287.7	3.4	7525.8	1.9	1.3	786.9	385.4	2.1	4.6	2.2	4.4	1.3	628.2	5.4	1.2	2433.0	55.8	1.8	2.1	4.2	1.6	1.5	484.9	2.9	1.9	14.3	398.1	1.2	2.2	2.7	3.0	1.2	2.8	862.1	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	186.3	412.5	591.8	274.2	173.7	287.7	786.9	385.4	628.2	484.9	398.1	862.1	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385345-58399220	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 631.4;Late spermatids: 933.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	16.5	20.1	5.7	21.6	6.1	38.1	17.3	10.8	8.4	11.4	6.8	20.0	21.0	13.7	9.5	14.7	12.6	10.7	18.5	5.5	7.3	21.5	22.6	10.9	27.7	5.8	6.1	17.8	13.9	16.2	6.3	20.4	6.5	14.5	17.3	9.8	17.3	11.4	17.7	9.0	17.8	11.6	7.0	17.3	16.1	33.0	6.4	24.9	19.6	16.1	23.0	16.7	7.5	8.8	85.7	47.7	52.8	54.7	15.3	19.4	59.8	37.9	37.3	46.8	51.1	170.0	88.6	170.1	53.9	17.6	34.8	65.2	97.6	53.5	73.4	73.4	85.7	64.1	33.4	64.5	23.3	164.7	49.4	19.2	24.4	57.0	51.6	22.2	41.1	49.9	153.4	74.8	33.2	46.4	130.2	65.1	100.0	39.2	49.9	102.9	113.0	76.0	28.3	57.0	69.8	48.1	75.1	103.7	97.0	42.9	112.8	47.9	32.0	34.4	109.5	39.5	102.5	75.6	125.8	214.2	44.1	125.1	26.4	1.0	9.5	4.0	8.3	9.5	10.8	12.8	10.0	8.8	12.1	12.5	12.4	10.1	7.1	15.0	8.3	14.7	9.0	6.9	5.7	6.1	10.8	8.4	5.5	7.3	5.8	6.1	6.5	7.0	6.4	8.8	46.4	54.5	27.9	6.2	52.5	50.1	44.0	52.4	59.2	25.1	48.6	62.9	35.0	38.6	51.0	20.2	16.7	98.1	56.8	17.1	88.0	41.0	631.4	36.8	44.5	39.5	15.5	46.7	10.1	44.7	77.4	38.8	25.0	41.2	29.7	34.1	26.0	64.1	44.0	38.7	11.5	37.5	18.3	21.9	19.3	933.1	41.3	32.3	23.2	2.8	36.3	38.2	48.4	10.6	11.7	35.2	23.0	30.9	35.8	47.3	14.1	72.0	31.4	21.4	26.3	74.8	40.5	55.3	63.9	48.6	54.7	52.5	38.3	69.1	48.1	31.8
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.3;retina: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.4	0.0	0.0	0.0	0.0	8.2	3.5	0.1	0.1	0.0	0.1	0.0	0.0	33.3	3.9	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	3.9	9.0	0.0	0.0	0.0	0.6	0.2	10.2	0.0	0.0	14.8	6.4	0.7	0.0	8.6	0.0	0.0	0.6	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.1	3.9	9.0	10.2	0.6	1.1	0.2	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.1;Proximal enterocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	6.2	4.2	3.7	6.9	3.8	1.9	5.8	5.3	5.4	9.0	1.7	5.4	6.4	7.8	1.0	8.1	6.9	3.8	3.2	3.5	3.2	3.6	5.3	3.9	6.8	3.9	3.7	10.0	12.0	3.3	4.3	3.7	3.9	5.7	1.9	0.7	7.6	3.1	7.5	10.5	6.8	2.5	3.5	7.3	5.0	1.7	3.7	8.3	4.6	3.1	3.9	6.4	8.4	5.1	14.9	15.4	12.9	19.2	5.4	14.1	21.7	5.7	14.6	9.6	10.5	8.1	23.0	51.0	14.5	5.5	4.5	22.0	23.6	19.4	3.0	29.8	17.4	15.6	13.0	21.1	7.5	27.8	8.8	13.3	12.2	10.4	29.0	4.5	6.4	16.7	29.1	13.1	3.8	23.9	39.2	46.4	29.8	14.7	20.2	34.3	28.8	53.7	3.7	11.2	27.0	20.0	19.2	19.7	18.9	2.0	10.0	21.9	4.2	13.1	10.4	46.2	15.1	21.3	19.3	43.6	8.8	27.2	9.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.7	3.8	5.3	5.4	3.5	3.2	3.9	3.7	3.9	3.5	3.7	5.1	7.0	3.2	0.0	2.3	11.6	21.5	9.8	5.7	30.1	4.2	8.1	6.6	2.2	7.2	2.1	27.6	0.0	7.7	5.3	5.3	7.9	4.1	0.1	2.4	9.6	5.4	7.8	22.7	3.0	5.7	11.7	7.6	10.7	3.1	0.0	6.9	3.6	3.4	4.2	0.0	3.9	12.4	8.2	4.0	7.4	0.1	11.8	3.7	3.6	1.0	4.7	2.2	5.2	1.5	3.6	2.9	5.3	5.3	7.2	11.1	40.0	5.7	1.4	3.4	6.6	6.9	7.1	0.9	0.9	22.1	22.3	2.2	7.3	7.5	20.2	4.3
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155256134-155314493	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	4.9	17.3	1.9	3.1	2.8	1.5	5.2	2.9	4.1	6.2	0.6	7.2	5.0	5.0	3.9	9.4	4.8	2.8	10.8	2.8	1.7	6.8	15.0	4.6	5.6	0.8	1.3	6.1	7.1	3.8	7.3	2.1	1.1	5.6	4.8	5.2	6.7	3.1	17.3	7.9	6.4	3.9	1.1	8.5	6.9	11.3	1.9	3.9	7.2	5.5	4.9	7.0	6.9	2.6	7.3	3.5	7.9	12.5	5.9	11.8	6.5	8.9	8.4	8.9	11.9	5.8	6.3	11.6	5.4	3.5	6.5	11.8	5.6	8.8	15.1	11.1	7.3	5.2	4.2	33.2	16.4	6.9	3.8	11.7	3.8	13.3	11.8	10.9	10.6	9.0	13.5	3.1	11.4	4.5	5.2	10.0	8.3	7.3	9.4	6.5	4.7	11.3	9.7	4.9	5.9	14.4	2.4	8.2	8.1	10.6	5.1	9.6	4.2	3.6	7.6	8.5	9.3	5.2	7.0	7.0	12.5	11.8	9.2	5.9	2.8	4.5	4.1	5.0	6.4	7.5	6.3	5.7	6.5	7.0	7.9	6.2	2.5	6.7	5.2	5.3	7.8	3.6	1.9	2.8	2.9	4.1	2.8	1.7	0.8	1.3	1.1	1.1	1.9	2.6	5.9	22.4	12.0	25.8	16.5	6.2	14.1	31.7	16.5	16.2	9.6	10.2	21.6	8.6	14.6	12.9	22.9	19.6	8.9	4.8	31.3	20.9	239.4	7.4	6.2	5.1	6.0	19.1	41.9	17.8	19.0	9.0	11.2	5.1	27.8	10.7	4.2	24.3	14.9	30.3	47.4	8.9	24.4	10.7	5.1	24.6	5.0	9.9	3.6	44.0	13.3	13.4	9.2	42.3	46.3	13.8	8.5	8.6	9.3	8.0	5.9	21.4	11.5	21.6	13.1	7.1	11.6	35.1	17.2	17.1	11.4	7.3	14.2	28.6	13.7	9.6
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540561-246566261	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	11.6	23.5	3.6	9.4	3.7	24.2	12.1	6.2	5.0	8.5	6.3	12.6	11.4	7.2	9.5	10.9	8.6	7.1	14.0	3.4	3.9	21.2	37.8	6.3	13.3	3.4	3.5	6.9	15.6	10.8	6.3	9.1	3.5	8.8	12.9	5.0	11.3	7.5	22.7	9.3	9.1	8.0	3.8	7.0	10.1	8.7	3.9	9.3	13.6	24.3	13.2	13.3	6.1	4.1	33.9	31.9	12.1	21.5	14.8	21.1	42.2	24.2	24.8	26.9	24.6	39.0	31.6	59.8	36.9	24.7	17.4	28.5	29.3	25.7	36.8	23.4	11.3	30.3	18.1	34.5	24.2	54.1	26.3	21.0	30.2	23.1	25.8	14.8	21.2	20.9	89.2	19.8	23.4	15.7	27.5	24.1	53.8	58.6	32.1	27.2	23.9	72.9	24.5	36.7	26.7	53.8	23.4	41.9	82.2	13.3	30.6	51.3	15.6	18.7	22.7	26.6	63.8	57.1	102.9	47.6	23.0	52.6	23.9	0.3	5.4	1.5	9.1	5.7	11.5	11.9	8.0	9.7	12.9	12.0	10.3	8.9	1.2	14.8	9.8	11.1	12.3	5.3	3.6	3.7	6.2	5.0	3.4	3.9	3.4	3.5	3.5	3.8	3.9	4.1	11.9	6.4	9.4	4.2	17.2	53.3	13.7	27.9	31.9	3.2	12.4	11.9	16.5	14.3	18.4	16.5	10.4	24.4	13.1	7.6	29.4	13.8	1.5	17.6	12.9	13.2	11.4	8.6	8.1	15.5	28.1	10.2	18.8	22.4	14.0	7.5	5.7	33.9	11.9	0.0	7.2	14.3	6.1	9.3	7.7	3.4	6.5	7.3	5.4	1.9	6.9	6.6	7.2	6.0	5.5	11.0	10.3	4.5	12.7	17.2	7.8	39.2	15.4	3.4	13.1	14.4	12.2	13.2	21.6	21.3	44.9	21.1	10.9	17.7	19.8	10.4
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 986.1;Late spermatids: 397.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	18.8	15.1	7.8	9.2	8.9	50.3	18.9	21.2	12.7	12.1	8.2	14.8	22.7	15.3	15.9	13.7	14.7	19.4	26.0	9.0	7.0	29.5	17.3	11.8	10.5	12.5	10.6	23.3	12.4	16.7	13.0	28.4	12.4	19.4	14.0	13.2	12.3	13.7	28.5	11.9	21.3	14.4	7.4	9.5	12.4	69.9	8.2	169.7	21.6	21.3	10.6	11.2	10.2	10.0	32.8	14.7	61.6	49.4	20.3	21.9	134.0	16.3	18.8	25.5	40.2	19.2	32.2	115.8	73.7	18.7	44.6	19.5	15.8	31.2	35.8	46.9	28.5	140.4	21.5	26.0	19.6	43.1	47.8	20.6	22.8	27.8	26.9	23.5	18.3	216.4	53.5	6.8	44.3	25.4	423.3	16.1	49.6	17.2	20.0	222.7	42.2	27.0	29.4	16.5	26.9	25.0	54.5	19.5	29.0	45.3	46.7	21.9	12.0	24.2	21.9	19.8	20.7	20.7	20.5	366.5	19.4	11.4	11.6	69.3	4.0	48.0	28.0	6.9	10.9	14.7	12.8	14.9	9.8	18.7	18.6	22.2	4.4	37.4	10.0	33.7	12.8	12.5	7.8	8.9	21.2	12.7	9.0	7.0	12.5	10.6	12.4	7.4	8.2	10.0	29.7	32.1	30.6	64.0	24.2	25.1	52.1	30.4	43.3	33.0	45.1	36.8	87.6	45.8	30.7	47.8	33.3	235.4	98.5	23.1	93.9	36.8	986.1	63.9	51.1	26.8	38.6	171.9	194.6	26.4	125.2	44.0	15.8	35.8	33.5	84.8	27.8	39.8	27.8	37.0	166.7	27.1	40.7	13.5	15.4	397.5	77.0	27.0	5.4	51.5	14.9	26.1	128.8	61.9	116.6	27.2	25.7	75.2	25.2	36.3	87.5	98.4	43.1	34.5	26.3	96.7	38.6	75.4	75.6	31.3	20.0	99.2	42.9	72.4	42.0	36.0
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043410	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 12.5;monocytes: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	23.6	27.8	16.8	27.3	24.1	22.9	25.8	26.9	24.1	23.3	23.6	10.8	24.7	21.1	15.6	26.2	18.5	17.2	25.7	29.4	15.1	12.6	29.2	11.8	37.2	30.9	25.8	12.4	25.1	18.4	20.8	28.7	17.2	11.5	14.8	13.4	28.3	17.0	20.5	14.7	24.7	27.5	22.5	16.8	5.9	32.2	10.7	20.0	14.0	13.2	25.0	20.5	25.6	32.8	41.5	14.6	44.6	48.6	45.1	12.5	40.6	55.8	49.7	38.2	23.3	26.8	10.2	18.0	65.7	48.6	25.5	25.4	40.2	44.8	24.4	11.8	8.3	39.6	26.2	69.0	10.0	28.3	38.5	32.3	64.4	50.1	47.8	26.3	8.4	19.8	55.9	49.2	20.6	7.5	17.2	36.3	11.0	34.1	11.9	22.2	26.6	43.1	18.0	12.4	12.4	44.8	19.0	17.9	52.5	27.6	15.0	48.5	47.1	48.7	48.0	27.3	30.1	29.7	8.0	56.1	14.0	33.2	0.0	4.8	1.8	0.6	4.7	1.1	0.5	0.9	0.5	2.2	1.0	0.6	0.5	12.5	0.4	6.3	0.5	1.3	2.6	27.8	27.3	25.8	26.9	25.7	29.4	37.2	30.9	28.7	27.5	32.2	25.6	13.8	16.0	8.8	13.7	9.8	19.8	19.7	11.2	30.1	6.8	10.9	9.4	8.1	15.7	11.8	20.2	4.2	16.0	4.4	14.3	9.8	17.7	0.7	10.9	15.3	17.5	12.5	5.2	7.5	15.8	9.4	20.2	14.3	14.8	5.7	12.0	10.8	15.0	22.3	18.5	7.2	8.2	0.0	21.7	29.4	2.2	27.4	20.5	8.8	11.2	15.5	12.0	4.1	6.0	7.7	21.4	13.7	24.5	12.9	20.2	10.6	12.1	7.0	5.6	13.1	18.5	14.3	2.2	0.8	18.9	22.0	37.1	8.6	13.9	7.5	19.6
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366535	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"stomach 1: 7973.0"	"Group enriched"	"Detected in many"	9	"Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"MCF7: 13512.4;OE19: 5337.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		950000		"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	2.3	0.3	0.0	20.3	0.0	0.0	26.7	0.0	0.0	9.7	0.0	114.7	34.8	0.2	0.0	18.3	0.9	167.2	0.6	0.0	0.0	0.9	0.8	1.3	0.2	0.0	0.0	0.2	10.7	0.0	0.2	1.1	0.0	25.0	108.4	0.0	32.4	0.7	0.2	0.1	68.4	4.8	0.0	3.1	7973.0	0.1	0.0	0.2	5.3	0.0	0.2	30.6	2.2	0.0	0.0	42.7	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	16.2	5.7	0.0	1.1	0.0	1.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13512.4	4.6	0.5	5.5	5337.9	223.4	1.7	0.0	0.2	0.0	1.4	0.3	0.2	0.0	5.0	0.0	1.3	5.0	0.1	0.0	0.0	3.5	0.1	0.0	3.6	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	18.7	0.0	6.1	5.9	0.0	0.0	432.7	197.2	0.0	564.7	12.1	35.0	0.0	0.1	3.1	601.9	0.0	245.7	0.0	1.8	0.2	3.5	430.2	0.0	0.0	821.8	3.1	5.1	12908.9	2.9	13.4	0.0	0.0	1.6	0.2	0.0	0.0	1395.6	111.9	0.0	0.0	0.0	0.0	9.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14603.3	500.9	0.0	40.6	432.4	78.0	0.0	2.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	8.9	0.0	80.0	232.6
TFF2	SML1	ENSG00000160181	"Trefoil factor 2"	Q03403	21	42346357-42350997	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 6852.1"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 2057.4;Gastric mucus-secreting cells: 7217.7"	"Group enriched"	"Detected in many"	11	"pancreatic cancer: 320.9;stomach cancer: 244.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.4;Karpas-707: 20.0;OE19: 55.4;PC-3: 145.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025834, HPA036705"	Enhanced				"Secreted to digestive system"	NA	NA		890000		"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB025834: , HPA036705: AB_2675263"	"unprognostic (3.95e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"			"prognostic unfavorable (1.99e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.55e-2)"		"unprognostic (1.27e-9)"	"unprognostic (1.99e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.26e-3)"	1.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	6.5	1424.4	0.1	0.0	3.4	1.2	105.4	0.2	0.0	0.0	0.3	4.0	1.0	0.0	0.0	0.0	0.0	17.2	0.0	0.2	1.0	0.0	0.1	4.2	0.0	2.9	0.0	0.1	0.1	0.5	0.2	0.0	2.7	6852.1	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.2	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	2.9	0.0	2.6	55.4	145.2	1.1	0.0	8.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.1	0.0	0.0	2.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	3.6	0.5	0.2	2057.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	104.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	93.8	0.2	1.3	7217.7	0.0	0.0	0.5	0.0	6.1	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	2.9	5.4	0.0	0.6	0.0	0.0	0.0	0.0	833.8	5.5	0.0	11.7	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.1	11.8
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"Trafficking from ER to golgi regulator"	Q92734	3	100709295-100748964	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No		320000	"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	62.2	73.0	40.7	37.2	40.4	37.4	52.4	43.5	46.4	53.9	46.7	63.8	89.8	52.0	78.5	85.7	51.2	56.4	82.6	41.3	45.4	71.9	113.9	55.6	29.4	44.2	43.2	48.2	66.7	89.0	64.1	79.2	44.4	47.9	69.6	40.9	60.6	61.3	75.5	58.9	76.6	66.5	43.2	42.6	54.4	47.7	42.3	40.6	64.1	58.2	54.9	61.6	57.3	44.4	203.8	107.5	126.7	79.0	160.1	176.4	163.9	141.1	190.4	182.5	213.0	136.0	96.1	24.7	103.3	180.4	141.3	143.1	143.4	161.5	216.2	123.8	87.4	99.7	69.3	130.0	183.3	70.2	51.8	149.3	216.6	108.4	190.8	165.1	165.5	44.5	73.1	63.5	191.9	143.9	63.3	56.7	122.5	193.8	169.3	55.5	77.8	89.0	226.5	125.9	96.4	93.1	95.0	118.2	175.8	103.4	141.7	103.1	113.1	103.0	130.8	48.4	104.4	56.2	65.8	92.1	171.2	79.7	130.7	84.3	43.6	42.8	30.8	45.2	37.4	37.4	31.6	34.5	43.1	35.9	29.4	29.7	26.1	43.1	44.8	29.3	41.0	37.0	40.7	40.4	43.5	46.4	41.3	45.4	44.2	43.2	44.4	43.2	42.3	44.4	67.9	60.9	36.9	46.4	43.3	136.6	105.9	183.6	69.4	46.8	58.0	50.2	83.5	48.6	93.1	36.8	25.0	211.6	43.1	111.8	137.0	190.3	101.5	70.8	70.4	70.2	52.6	27.1	54.8	107.7	201.5	97.8	47.4	79.0	76.8	62.9	53.9	68.4	86.2	57.2	59.2	128.5	122.1	27.3	84.9	45.5	70.8	43.6	64.0	38.4	98.5	88.0	28.8	49.3	55.0	130.5	91.0	74.1	75.8	133.5	202.5	106.4	63.9	60.3	39.5	81.3	87.2	79.2	51.5	68.0	118.9	284.4	43.2	90.0	97.2	123.0
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 272.3;placenta: 191.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2284.2;Hepatic stellate cells: 872.4;Syncytiotrophoblasts: 879.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 22.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.3;neutrophil: 1.3;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 386.2;HUVEC TERT2: 742.5;LHCN-M2: 459.9;TIME: 451.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	NA	NA	58100000	87000000	"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	67.5	12.6	2.6	20.5	3.4	8.2	52.3	4.9	5.8	41.5	7.4	23.3	52.5	25.7	18.5	33.3	35.6	57.6	38.5	4.1	2.2	56.3	272.3	126.7	33.3	6.8	2.5	26.5	25.0	7.1	6.1	191.2	3.9	15.7	27.4	4.5	15.0	12.8	26.8	19.8	41.8	30.7	3.7	20.7	19.2	6.9	3.6	11.1	36.2	42.8	17.7	52.9	29.8	3.2	38.9	24.7	29.3	0.8	224.3	267.7	0.7	66.0	156.3	42.7	65.1	22.6	192.6	0.7	27.3	52.7	74.7	2.1	15.9	3.6	110.3	1.9	7.6	12.3	73.8	197.3	386.2	0.9	0.4	123.1	5.1	232.8	61.9	93.4	742.5	0.7	31.2	0.7	459.9	35.4	4.6	0.7	22.9	0.8	68.8	0.3	40.2	0.3	72.9	1.4	0.3	0.5	56.7	2.1	3.5	95.8	0.7	0.2	451.4	30.6	29.0	61.4	13.5	1.1	1.7	0.4	239.4	0.6	35.4	3.3	0.2	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.2	0.5	0.2	0.2	1.3	0.5	0.1	2.7	0.1	2.3	2.6	3.4	4.9	5.8	4.1	2.2	6.8	2.5	3.9	3.7	3.6	3.2	99.2	35.3	335.5	1.3	4.4	20.8	2.9	33.5	4.6	0.6	16.1	9.1	7.0	173.0	102.5	38.6	0.0	59.5	4.8	0.5	13.7	140.0	41.5	7.3	74.2	287.1	105.0	43.1	0.7	273.1	2284.2	283.0	12.2	5.3	13.9	1.5	872.4	382.1	50.2	1.7	0.2	11.3	158.7	63.7	41.3	15.2	171.8	21.9	26.6	13.1	33.7	33.1	1.0	0.0	0.1	157.6	34.1	70.0	9.5	8.0	36.6	109.4	45.2	1.1	216.9	141.2	127.8	2.7	0.5	10.2	18.5	879.2	8.1	30.6	18.5	16.7
TFPI2	"PP5, REF1, TFPI-2"	ENSG00000105825	"Tissue factor pathway inhibitor 2"	P48307	7	93885396-93890753	"Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"placenta: 954.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1476.3;Glandular and luminal cells: 575.6;Prostatic glandular cells: 412.6;Syncytiotrophoblasts: 2184.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 65.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 3001.0;hTEC/SVTERT24-B: 1373.4;U-138 MG: 1245.9;U-2197: 1050.8;U-87 MG: 2051.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 29.7"	"CAB010142, HPA049158, HPA070525"	Enhanced				"Secreted to extracellular matrix"	NA	NA		51000		"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB010142: AB_628166, HPA049158: AB_2680659, HPA070525: "	"prognostic favorable (8.33e-7)"	"unprognostic (2.20e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (5.19e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.86e-2)"	"unprognostic (7.54e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.91e-2)"	51.3	28.3	0.6	36.5	0.7	0.3	30.0	0.5	1.6	2.7	1.2	3.5	1.3	32.1	5.5	2.2	19.1	15.6	7.8	0.6	4.0	20.5	21.2	11.3	3.0	5.0	0.7	46.7	76.6	0.1	9.7	954.6	0.7	7.1	2.0	51.7	4.0	5.5	2.6	1.0	1.4	9.6	0.6	4.1	5.1	0.7	1.4	6.9	0.8	1.4	1.2	26.6	1.0	0.9	1.4	179.6	42.0	1.9	99.8	15.4	0.5	178.3	33.5	20.6	15.0	0.3	1.6	0.0	3001.0	47.0	43.9	18.6	1.1	216.1	24.6	2.8	1.3	0.1	10.2	0.7	545.7	0.0	0.9	9.1	10.7	1373.4	90.1	200.0	449.0	0.0	0.4	2.2	210.1	0.3	0.4	0.7	10.8	0.0	45.7	0.5	0.0	0.2	52.1	5.4	1.6	110.2	0.0	12.7	1.2	29.9	1.5	2.9	680.3	1245.9	13.2	1050.8	1.8	0.1	4.4	14.6	2051.0	0.3	140.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.7	0.5	1.6	0.6	4.0	5.0	0.7	0.7	0.6	1.4	0.9	141.3	3.2	3.9	0.0	1.2	0.6	311.3	77.9	0.6	17.5	37.2	7.9	0.5	21.5	122.9	318.2	39.6	16.1	0.6	0.0	0.0	1476.3	0.0	280.3	38.3	122.3	0.0	2.7	0.0	41.9	214.2	137.2	0.0	575.6	0.0	0.1	108.1	1.4	16.2	3.3	0.0	0.5	12.2	4.1	4.0	0.1	1.5	5.2	3.6	2.8	17.1	22.4	0.0	0.0	0.0	39.4	0.0	0.0	0.2	412.6	0.0	1.7	27.4	161.3	0.0	7.0	35.5	0.4	3.6	1.1	1.4	2184.1	4.9	0.7	0.0	35.0
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107020-54115657	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA034958: AB_10603036, HPA058534: AB_2683745"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	12.1	15.8	27.4	8.9	25.2	10.4	12.8	23.1	41.3	11.7	18.6	15.7	9.7	11.7	4.3	10.0	9.9	7.2	16.1	26.5	24.7	12.0	10.5	12.3	10.7	24.1	25.0	9.5	8.7	9.2	10.9	8.4	24.3	22.2	4.1	5.0	13.1	5.4	19.4	13.2	12.2	6.1	20.9	19.1	14.1	9.1	24.0	13.5	11.2	10.6	6.4	12.3	9.4	28.0	23.5	28.5	18.2	12.9	6.7	9.5	11.8	25.1	15.5	23.9	24.5	17.8	23.6	20.5	20.2	12.8	12.5	11.2	10.8	19.6	7.8	43.5	52.2	30.7	27.5	20.8	39.6	16.1	34.7	11.2	9.5	18.8	15.7	11.5	18.7	30.8	19.3	45.8	9.2	30.2	34.3	47.2	11.0	34.1	19.8	30.6	10.0	15.4	10.0	35.9	19.2	17.4	9.2	38.4	45.1	5.6	14.0	48.9	37.8	52.4	19.3	7.5	36.9	33.8	48.2	18.5	20.7	40.4	34.4	10.5	9.2	6.4	15.4	10.7	14.6	9.4	19.4	20.1	19.0	9.3	16.2	17.2	6.5	21.4	3.9	43.3	26.0	11.2	27.4	25.2	23.1	41.3	26.5	24.7	24.1	25.0	24.3	20.9	24.0	28.0	25.3	16.0	7.2	5.2	12.2	17.0	9.8	25.5	12.0	10.9	31.4	32.3	2.5	12.8	28.6	22.0	2.1	22.4	30.3	22.5	15.6	21.0	9.6	27.1	8.2	29.5	15.6	7.8	5.0	27.6	29.1	11.3	11.2	13.3	15.2	20.8	37.9	9.6	135.7	0.0	4.1	35.7	32.6	28.1	41.0	5.5	12.2	43.5	39.2	1.0	49.7	17.8	25.7	2.5	3.6	55.9	18.4	17.0	13.1	31.9	23.0	24.8	46.4	12.4	6.6	7.8	16.5	11.0	16.0	5.8	17.3	26.1	22.8	41.1	16.1	13.0
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	685	"thyroid gland: 9329.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 5.5;Cardiomyocytes: 3.0;Early spermatids: 2.3;Late spermatids: 2.2;Microglial cells: 1.9;Proximal tubular cells: 4.0"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HSkMC: 2.4;Karpas-707: 5.6;PC-3: 2.8;U-266/70: 2.0;U-266/84: 1.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.1"	"Low region specificity"	"Detected in some"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	1.6	3.2	3.0	0.5	0.4	7.8	1.4	0.2	1.9	1.2	1.5	1.8	0.0	1.8	1.0	2.0	0.4	8.6	13.6	1.7	0.2	2.9	3.6	4.2	12.0	0.4	0.5	1.2	8.0	2.7	1.2	0.2	0.5	3.6	0.1	0.1	3.9	1.8	2.8	6.3	1.7	0.1	0.2	1.9	2.2	2.9	0.5	0.4	9329.0	0.0	0.6	0.6	1.7	0.5	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	1.7	0.6	0.0	0.5	0.0	0.7	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.2	0.1	1.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.0	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.1	3.0	0.4	0.2	1.9	1.7	0.2	0.4	0.5	0.5	0.2	0.5	0.5	0.3	0.0	0.6	0.3	0.2	0.0	5.5	0.1	0.0	0.0	0.1	0.1	3.0	0.0	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.3	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.4	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	1.9	0.7	0.3	0.0	0.5	0.1	0.1	0.0	0.4	0.1	0.5	0.0	4.0	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.0	0.6	0.0	0.2	1.1	0.0	1.2
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574054-94596242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 75.2;U-698: 97.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	10.4	9.4	5.3	8.2	5.5	6.0	12.4	5.6	8.2	10.4	6.3	8.0	10.2	8.0	11.8	6.9	9.2	6.8	5.4	4.9	5.6	10.9	30.0	7.1	12.9	5.6	5.4	12.1	10.0	8.1	8.4	10.1	5.9	7.9	9.5	6.9	7.7	7.6	4.1	7.5	9.2	6.7	5.6	9.2	9.1	6.0	5.3	14.1	13.3	4.3	11.0	9.1	6.4	6.6	16.7	7.2	11.6	10.6	17.2	13.5	14.1	15.3	14.9	14.2	13.4	18.9	15.9	26.0	14.8	10.9	8.8	10.4	20.1	11.9	14.9	20.3	7.7	20.7	8.1	18.1	21.0	75.2	13.8	14.9	9.5	8.0	22.8	11.1	13.2	18.9	21.3	8.9	13.3	10.8	20.6	38.4	15.2	26.8	8.3	17.1	11.4	15.9	18.3	7.4	15.9	8.9	11.6	24.2	43.5	19.1	10.2	39.8	12.2	5.6	14.5	8.6	12.6	20.0	11.4	97.5	14.9	26.5	15.5	14.7	5.5	10.8	9.6	6.6	14.9	9.5	11.6	10.7	8.7	7.1	16.8	12.5	1.6	12.1	8.3	7.6	13.8	6.9	5.3	5.5	5.6	8.2	4.9	5.6	5.6	5.4	5.9	5.6	5.3	6.6	7.4	12.8	6.8	8.1	12.8	2.4	9.2	15.9	6.8	4.3	7.8	7.9	5.2	8.6	11.9	7.3	2.1	15.7	12.5	5.8	9.8	11.9	1.2	10.4	8.9	7.0	5.4	3.4	7.7	9.1	17.7	12.9	6.1	6.0	11.4	7.7	7.9	21.4	11.2	1.7	6.7	7.7	8.2	8.8	7.2	1.0	14.3	7.5	8.8	8.4	11.1	7.0	7.2	12.1	10.4	8.9	6.6	8.2	10.7	10.9	10.0	17.6	15.9	4.7	26.3	6.7	8.1	11.9	12.3	8.5	3.7	10.4	11.0	9.2	9.1	9.7
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447284-70554193	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3;Pancreatic endocrine cells: 74.5;Urothelial cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 11.3;eosinophil: 23.8;neutrophil: 23.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"A-431: 72.5;CAPAN-2: 82.5;HBEC3-KT: 72.3;OE19: 54.6;RPTEC TERT1: 72.6;U-87 MG: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.2	0.5	9.2	5.0	16.8	1.6	6.9	15.0	12.2	6.1	5.2	10.7	8.5	1.3	2.9	25.5	6.1	14.1	0.7	10.4	11.7	13.4	4.5	3.9	4.1	21.0	15.8	0.1	7.5	3.0	0.5	1.9	18.5	2.4	7.9	7.4	6.4	1.2	0.1	12.2	10.0	1.4	16.6	5.8	8.5	2.5	13.2	1.0	8.1	0.3	9.0	10.0	12.8	27.3	72.5	11.3	0.1	0.2	0.0	0.0	0.0	11.0	0.0	0.3	0.1	0.2	82.5	0.0	43.2	0.4	11.2	37.1	0.6	72.3	0.1	0.1	1.6	0.0	1.8	6.0	0.0	0.9	0.1	0.0	29.1	0.1	27.8	3.4	0.0	5.6	0.0	0.4	0.0	2.6	0.1	1.4	1.1	54.6	22.9	0.0	0.5	19.8	72.6	27.2	0.6	0.1	5.8	0.0	0.1	0.2	9.8	0.7	0.6	0.3	4.9	0.1	15.7	0.4	0.6	0.1	69.0	2.4	25.6	11.3	0.8	23.8	1.7	0.2	4.4	0.0	1.0	1.0	1.0	0.0	0.5	0.4	23.8	0.3	0.0	0.0	0.0	0.7	9.2	16.8	15.0	12.2	10.4	11.7	21.0	15.8	18.5	16.6	13.2	27.3	0.4	6.4	2.7	0.3	0.2	16.2	12.3	16.9	10.8	1.4	9.8	12.1	2.3	24.3	21.8	25.8	0.0	0.0	2.2	19.8	1.9	37.3	21.3	8.1	0.7	1.7	1.2	0.0	0.8	10.0	0.0	0.6	13.7	10.5	5.7	0.0	0.0	3.0	3.9	0.0	3.6	6.2	12.2	3.2	2.4	1.9	0.3	4.1	0.0	6.5	18.2	7.9	2.1	59.3	36.1	74.5	9.0	0.0	0.7	16.8	21.1	6.6	20.4	0.7	0.0	0.1	1.1	0.6	0.2	12.2	24.9	0.0	1.9	0.0	5.6	63.6
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"		19	41301587-41353922	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000		"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	39.8	28.6	10.8	39.7	10.7	82.9	25.4	11.8	9.4	53.2	9.5	31.0	14.4	45.9	7.4	52.2	27.7	18.1	35.8	9.5	15.5	35.8	14.7	63.4	34.0	24.5	14.9	17.4	14.3	11.5	18.0	32.1	17.6	31.6	8.4	0.6	21.2	19.8	8.1	29.3	37.8	21.8	18.4	88.9	20.1	8.1	19.4	16.7	20.2	8.3	25.7	44.1	45.3	17.7	57.7	87.6	3.4	0.3	41.7	35.3	10.0	81.9	64.4	25.2	15.4	40.4	30.1	57.0	88.6	110.5	26.8	30.1	17.8	54.6	11.1	76.6	17.9	199.0	18.0	50.4	47.7	54.9	119.6	45.0	17.5	50.5	32.7	138.7	135.2	21.1	108.0	116.8	27.9	42.1	43.1	79.6	9.4	12.0	52.7	44.4	13.1	85.4	46.8	20.3	0.3	6.5	23.9	0.1	15.1	32.5	1.9	36.3	170.3	96.4	77.2	20.7	91.2	74.4	31.7	36.3	90.3	106.4	16.4	1.1	0.8	3.9	0.7	1.2	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.3	2.4	0.3	0.8	0.9	0.3	0.9	10.8	10.7	11.8	9.4	9.5	15.5	24.5	14.9	17.6	18.4	19.4	17.7	55.0	0.0	0.0	3.3	120.6	44.4	36.5	64.8	38.7	0.2	14.4	9.7	2.3	4.3	17.2	16.5	0.0	5.4	438.3	1.4	0.0	12.8	1.0	5.7	18.2	63.1	0.0	28.0	1.6	17.1	452.1	34.3	14.3	5.0	64.9	20.0	71.4	2.7	141.2	0.0	2.1	1.4	22.4	136.1	158.6	1.8	12.2	188.8	23.2	30.0	105.8	0.3	223.5	0.0	0.6	45.1	16.4	18.0	156.5	32.9	0.4	9.0	9.7	0.7	39.5	13.9	78.6	3.1	8.0	40.3	18.9	55.7	221.9	4.1	0.8	31.1
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028988-136063818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 457.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.8;Kupffer cells: 292.9;Langerhans cells: 251.2;Macrophages: 198.9;Pancreatic endocrine cells: 590.1;Smooth muscle cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 77.3"	"Group enriched"	"Detected in many"	32	"classical monocyte: 252.3;intermediate monocyte: 149.1;myeloid DC: 156.9;non-classical monocyte: 121.4;plasmacytoid DC: 324.5"	"Group enriched"	"Detected in all"	46	"dendritic cells: 324.5;monocytes: 252.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2857.3;GAMG: 2417.8;HSkMC: 2675.6;hTCEpi: 1915.6;LHCN-M2: 2269.4;U-2197: 1916.3;U-87 MG: 3667.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	133.2	55.3	9.5	164.0	10.4	25.9	112.2	10.0	25.5	51.8	51.9	92.8	48.2	59.7	41.6	28.7	59.7	146.1	95.5	10.4	11.5	124.0	132.1	89.7	66.2	15.8	11.9	25.4	22.4	18.4	77.6	457.6	15.7	69.5	84.4	2.8	68.3	58.9	34.8	314.1	65.3	291.0	12.2	121.1	67.4	7.6	77.3	57.7	40.4	41.7	44.4	138.9	39.0	14.0	102.2	405.6	0.8	3.8	1104.3	354.4	1.5	295.1	42.9	209.9	125.1	186.4	1276.3	0.1	181.6	2857.3	2417.8	498.0	1.0	981.4	208.0	2.3	0.1	0.1	451.6	501.3	718.9	0.7	3.9	2675.6	1915.6	77.9	93.1	827.5	188.1	0.2	0.2	3.8	2269.4	4.8	0.7	0.7	13.1	5.1	0.9	0.4	24.3	3.4	96.7	8.8	1.3	0.7	473.7	15.5	3.9	452.8	3.7	110.9	745.6	1419.3	59.8	1916.3	1139.6	0.3	0.7	1.9	3667.3	0.9	1077.5	1.6	252.3	1.0	0.9	149.1	1.0	1.0	1.0	2.0	156.9	0.4	0.3	1.0	5.3	6.2	121.4	324.5	0.5	108.5	9.5	10.4	10.0	25.5	10.4	11.5	15.8	11.9	15.7	12.2	77.3	14.0	12.4	3.2	21.4	0.0	6.3	119.4	4.8	141.8	4.6	0.4	1.9	5.5	8.9	4.3	21.8	1.8	0.0	9.9	146.5	1.3	0.0	67.5	2.4	2.3	57.9	16.4	3.5	8.8	0.4	112.6	8.5	113.5	0.5	1.7	5.1	0.0	21.0	25.7	251.8	1.7	0.0	7.8	6.1	292.9	251.2	1.9	10.2	198.9	49.8	4.7	151.1	0.3	6.2	0.0	0.0	590.1	0.0	2.2	1.9	1.0	0.1	2.7	8.5	0.2	26.3	156.8	326.1	0.2	0.9	1.9	55.7	19.4	8.5	10.8	0.9	2.5
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	15.9	9.9	9.8	18.2	9.3	33.7	15.4	13.2	8.9	19.4	11.8	18.8	11.7	20.6	8.8	15.0	8.5	21.7	8.2	6.8	11.3	22.6	14.8	16.3	13.8	18.4	14.5	13.0	8.3	8.5	7.6	48.8	20.0	17.1	13.4	4.7	8.3	16.8	8.7	6.2	9.3	33.0	18.0	16.5	18.4	18.3	17.5	11.2	11.2	13.2	13.6	22.5	8.4	27.9	13.7	19.5	115.5	36.1	26.2	19.3	17.4	44.1	47.8	40.7	44.9	19.9	9.3	29.7	13.4	34.6	32.1	30.4	39.6	34.1	54.0	77.1	12.3	43.9	20.7	17.8	43.2	27.2	102.8	40.2	35.4	62.8	29.5	25.2	7.4	10.9	62.4	12.1	55.4	20.3	4.0	31.0	24.7	12.2	11.5	11.0	253.1	12.5	9.9	3.8	31.1	36.2	34.3	150.2	46.4	47.3	28.1	36.6	13.6	29.8	25.5	129.3	27.3	12.1	13.4	20.0	62.5	45.9	26.2	16.2	2.4	9.5	7.8	1.6	6.7	1.6	3.3	5.8	2.0	1.2	3.2	6.2	4.9	4.3	2.0	1.4	2.4	2.2	9.8	9.3	13.2	8.9	6.8	11.3	18.4	14.5	20.0	18.0	17.5	27.9	13.5	6.4	8.8	18.9	18.9	23.6	7.4	19.9	44.3	8.0	18.9	11.7	7.6	4.3	12.8	60.7	0.0	23.0	37.3	5.0	0.0	18.8	128.4	6.4	22.7	17.6	9.6	7.4	14.2	31.2	6.7	36.0	9.2	9.3	29.9	19.5	6.4	12.7	49.4	0.0	8.6	7.3	8.2	32.4	52.5	101.7	9.6	39.7	35.6	116.2	24.3	3.1	35.0	45.8	21.1	33.8	4.2	13.5	11.9	18.4	3.6	13.8	5.0	2.0	32.9	21.8	20.9	11.0	12.7	25.6	16.2	19.4	25.4	7.6	8.3	11.5
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.9;Hepatic stellate cells: 322.7;Leydig cells: 146.3;Skeletal myocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 35.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 16.6;T-cells: 35.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 227.2;ASC TERT1: 108.4;RT4: 57.1;U-2197: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		50000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	66.3	35.2	6.9	9.2	6.8	5.0	62.1	7.6	8.0	56.6	20.4	28.8	8.2	33.9	24.2	28.5	36.6	20.0	16.2	7.6	6.7	28.2	16.6	27.3	7.2	6.0	10.1	81.5	12.3	5.9	7.1	58.5	7.8	16.4	12.5	1.5	35.0	32.7	12.8	25.0	19.7	27.4	7.9	40.0	18.1	11.0	8.0	7.7	13.2	29.4	4.2	47.3	28.6	7.8	9.9	9.4	14.1	2.4	227.2	108.4	44.6	7.1	35.3	8.1	9.9	4.4	1.4	0.1	1.7	13.0	6.4	1.4	3.6	1.0	6.2	34.1	7.6	0.0	11.1	41.2	5.0	0.3	0.1	26.3	4.7	17.8	4.0	1.3	4.2	0.0	23.6	0.7	2.4	0.2	0.1	0.1	5.9	4.6	3.2	0.5	4.8	2.1	3.2	57.1	0.7	0.0	3.4	0.2	20.4	5.8	1.2	3.7	12.7	13.5	3.5	78.0	1.7	34.8	3.3	0.0	2.8	1.9	1.7	1.2	0.0	0.0	35.2	0.2	19.4	0.0	8.7	19.2	0.0	0.0	2.7	12.7	0.6	16.6	1.4	1.2	4.5	8.1	6.9	6.8	7.6	8.0	7.6	6.7	6.0	10.1	7.8	7.9	8.0	7.8	77.6	9.6	9.7	58.8	3.1	37.6	10.0	2.3	44.3	0.3	38.2	60.1	20.7	30.0	4.2	31.3	2.1	27.5	66.7	0.5	3.9	2.0	54.3	11.2	32.8	90.5	24.0	10.7	7.7	5.1	12.0	143.9	5.1	8.1	2.5	20.5	322.7	21.0	11.8	0.0	34.0	1.9	8.2	23.2	29.4	29.8	146.3	5.2	35.6	82.4	0.7	1.2	62.8	7.5	0.9	3.3	0.4	74.4	21.3	8.5	1.4	20.9	8.3	0.2	13.1	187.2	36.5	0.8	2.2	17.2	34.1	58.0	36.9	92.2	3.7	8.0
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7914830-7919097	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"pituitary gland: 106.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.3;Late spermatids: 8.6;Plasma cells: 9.2;Proximal tubular cells: 8.9;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;REH: 4.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA074356	Enhanced		Approved	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA074356: AB_2686681"	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.0	0.3	0.3	0.1	0.2	0.3	0.0	1.2	1.0	1.1	0.0	0.3	2.0	1.3	0.1	0.0	0.9	0.1	0.8	0.4	0.2	0.8	1.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	106.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.2	0.2	0.4	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.4	0.1	0.2	0.8	0.0	0.0	0.8	0.1	0.0	0.0	1.5	0.5	0.2	0.6	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.7	0.0	0.7	0.5	0.2	0.2	0.1	1.5	4.3	0.0	1.1	0.0	0.1	0.4	0.8	0.1	0.0	0.3	0.0	0.4	0.6	0.1	0.9	1.4	1.4	0.3	0.6	0.6	0.4	0.1	0.3	0.4	0.6	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.2	1.2	1.0	0.4	0.2	0.6	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.0	2.0	2.4	1.5	2.9	0.3	0.0	1.6	1.6	2.3	1.8	0.0	0.6	0.0	0.0	0.1	1.8	0.1	3.9	0.3	0.5	1.4	3.7	0.2	0.0	0.0	7.3	0.2	0.8	0.8	0.0	0.5	0.0	0.2	1.4	2.9	0.3	0.0	3.3	0.2	0.0	0.3	0.4	8.6	1.2	0.6	5.4	1.9	0.1	3.4	0.0	0.5	1.8	0.3	0.0	1.2	9.2	4.3	0.5	8.9	0.3	2.4	13.1	0.2	3.5	0.4	1.9	0.0	1.4	0.4	4.4	0.1	0.2	0.4
TGFBRAP1	"TRAP-1, TRAP1, VPS3"	ENSG00000135966	"Transforming growth factor beta receptor associated protein 1"	Q8WUH2	2	105264391-105329735	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037672, HPA038397"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA037672: AB_2675597, HPA038397: AB_10669782"	"unprognostic (1.66e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-2)"	9.6	8.1	6.5	8.0	6.3	22.7	8.1	6.1	7.2	6.6	7.7	8.1	7.2	7.8	5.4	8.3	7.0	5.9	6.6	6.8	5.4	6.7	5.0	7.4	9.4	5.8	6.4	7.6	9.9	11.4	5.1	10.4	5.9	8.3	8.2	6.2	8.3	9.3	11.8	11.1	8.0	8.9	5.6	8.5	13.5	2.5	6.5	9.1	10.9	7.7	8.3	7.8	6.6	7.2	22.5	17.5	12.5	15.5	13.3	10.5	25.4	16.0	21.8	26.6	25.3	25.9	13.6	22.7	16.9	18.2	27.1	13.5	22.4	38.1	21.9	24.3	23.8	30.7	13.8	20.7	12.1	28.6	22.4	12.7	22.5	22.2	19.6	14.1	28.7	19.5	28.0	10.9	32.6	14.9	20.4	18.3	15.9	15.4	14.5	22.9	19.8	33.0	16.4	27.3	24.7	16.5	13.2	26.1	25.8	9.0	13.1	17.5	20.8	16.7	25.4	14.1	16.4	11.3	14.8	24.7	11.9	19.6	35.3	0.4	0.8	1.1	1.8	0.7	1.5	0.6	1.2	1.0	0.6	1.0	0.7	1.1	0.3	0.9	0.5	1.0	0.9	0.7	6.5	6.3	6.1	7.2	6.8	5.4	5.8	6.4	5.9	5.6	6.5	7.2	13.7	6.4	9.5	10.4	8.1	8.0	3.5	5.6	9.1	12.4	8.8	9.3	5.9	5.7	7.1	5.5	16.7	12.4	8.9	7.5	1.9	5.4	0.1	5.2	7.0	10.6	11.3	11.3	17.0	10.8	4.8	8.5	9.7	8.3	2.5	10.8	13.9	6.7	12.9	15.2	14.8	8.2	8.2	13.8	4.4	0.5	7.5	9.9	3.6	17.8	9.5	9.0	11.3	8.5	13.5	8.3	5.2	8.2	7.6	7.7	5.8	7.3	2.7	7.2	26.3	15.8	8.1	0.4	1.2	11.5	13.1	7.4	8.8	11.1	9.2	3.1
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like X-linked"	Q8IUE1	X	89921908-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	88	"testis: 8.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 74.1;Late spermatids: 45.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.9;U-2 OS: 12.4;U-266/84: 21.4"									HPA034543	Supported		Approved	Nucleoplasm		No	No				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.4	0.3	0.0	1.1	21.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 713.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	25.7	1.3	0.6	0.9	0.8	0.7	2.2	3.7	2.0	78.7	0.8	1.4	0.8	1.0	1.6	713.5	4.4	0.6	5.1	0.5	0.6	2.5	1.7	5.3	1.5	1.5	0.9	3.0	3.2	0.2	3.3	1.2	1.4	4.1	0.9	1.7	89.7	4.4	1.1	73.2	1.9	0.5	0.4	2.6	1.8	2.9	0.9	1.3	2.7	0.3	40.4	1.3	144.2	0.9	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.7	2.0	0.5	0.6	1.5	0.9	1.4	0.4	0.9	0.9	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341079	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"esophagus: 1838.1"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	295	"neutrophil: 30.3"	"Lineage enriched"	"Detected in single"	303	"granulocytes: 30.3"	"Cell line enriched"	"Detected in single"	14	"EFO-21: 5.2"									HPA004728	Approved					NA	NA		14000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.6	0.3	0.2	0.2	0.0	1.4	3.9	0.0	0.1	54.3	0.0	0.3	0.0	0.2	0.8	1838.1	1.4	2.2	0.4	0.2	0.0	0.2	0.8	0.5	0.0	0.1	0.3	0.3	1.1	0.0	1.6	0.1	0.1	0.6	0.8	0.0	229.3	0.0	0.4	83.1	0.4	0.0	0.1	0.4	2.2	2.0	0.0	0.1	0.1	0.0	142.9	0.3	31.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.9	4.0	0.1	0.1	46.2	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.3	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.2	0.5	22.5	8.2	0.0	0.0	0.1	0.3	0.2
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	377	"prostate: 434.4"	"Cell type enriched"	"Detected in some"	20	"Prostatic glandular cells: 226.6"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	1.1	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	434.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	4.2	0.7	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	5.7	0.8	0.6	0.4	0.0	0.0	0.2	0.0	0.3	1.3	0.0	1.5	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	11.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.4	0.0	226.6	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.3	0.0	0.4	1.0	0.2	0.1	0.2	2.4
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380901-2432753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	HPA059196	Uncertain					NA	NA									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773446-55826445	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA025024: AB_1854330, HPA029824: AB_2673212"	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	5.9	4.0	1.8	5.0	1.4	7.2	5.5	3.8	2.3	5.0	2.5	4.9	3.1	5.9	4.1	5.7	5.8	4.1	3.5	1.5	1.5	5.5	4.0	4.5	8.5	1.2	1.3	6.0	4.0	6.8	4.0	4.2	1.3	4.5	4.6	2.5	4.9	5.7	7.4	6.4	5.5	4.6	1.1	5.7	4.5	4.9	1.6	9.5	5.4	2.6	8.5	7.3	5.1	1.9	12.0	9.0	10.2	12.7	9.7	8.2	10.3	10.9	11.6	11.9	12.3	8.5	10.7	27.7	7.0	8.5	8.5	10.8	24.3	14.7	16.3	17.2	8.7	31.6	10.6	5.1	13.1	16.8	9.4	9.7	10.1	11.4	22.7	5.2	9.5	16.0	24.8	9.9	9.6	9.4	36.0	10.6	35.0	16.8	3.6	26.4	7.1	8.2	10.6	12.0	10.6	13.3	19.4	8.0	10.4	10.5	10.9	9.7	9.7	8.4	10.6	9.8	10.4	8.5	6.3	32.1	8.5	13.6	11.3	5.0	2.7	4.3	5.1	2.8	6.0	4.6	4.8	4.7	2.4	4.8	5.2	5.2	3.4	3.3	3.9	5.2	4.2	2.6	1.8	1.4	3.8	2.3	1.5	1.5	1.2	1.3	1.3	1.1	1.6	1.9	29.8	48.1	35.2	15.7	41.6	37.0	36.8	25.7	35.3	30.6	21.8	34.7	15.5	20.0	37.9	51.5	22.9	29.6	30.4	10.8	3.9	20.3	3.7	28.2	42.6	27.2	10.7	49.2	28.9	25.2	26.7	32.4	23.4	27.6	50.0	24.3	20.7	17.2	20.3	21.9	30.0	23.3	16.2	16.8	12.2	4.6	29.5	22.2	7.2	12.2	26.1	27.7	29.9	34.7	19.9	22.2	12.1	23.0	32.7	42.3	10.9	17.7	25.5	29.5	26.3	40.5	25.7	88.2	78.3	33.5	26.1	22.4	41.2	35.2	22.5	31.9
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171815	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"adrenal gland: 196.6;brain: 270.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	5	"midbrain: 192.4;pons: 270.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"PC-3: 60.8;SK-BR-3: 21.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 178.8"	"Region enriched"	"Detected in many"	20	"midbrain: 594.4"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	3.3	196.6	1.9	0.1	3.0	0.0	0.0	0.2	1.3	0.6	0.2	0.1	0.0	0.5	0.1	0.7	0.2	0.4	0.1	1.3	46.5	0.4	0.4	0.0	0.0	13.9	192.4	0.7	0.2	0.0	1.7	0.1	270.9	0.3	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.8	0.2	0.3	0.5	14.6	0.0	0.0	0.0	0.0	1.4	1.5	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	60.8	0.0	0.0	0.0	0.1	0.1	1.1	0.2	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.2	1.3	1.3	46.5	13.9	192.4	270.9	0.8	14.6	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.4	9.0	0.4	0.0	0.0	0.1	0.0	12.4	0.4	0.0	0.3	0.0	0.0	1.1	0.2	0.5	0.0	0.3	0.1	0.0	0.0	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	2.2	0.1	0.3	0.2	0.2
THADA	"ARMC13, FLJ21877, GITA, KIAA1767"	ENSG00000115970	"THADA armadillo repeat containing"	Q6YHU6	2	43230851-43596038	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.7;Excitatory neurons: 77.5;Inhibitory neurons: 77.2;Microglial cells: 89.9;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA035191, HPA035192"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA035191: AB_10670290, HPA035192: AB_2674512"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (8.27e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.14e-1)"	11.0	9.3	7.0	7.5	8.3	8.9	11.1	7.1	7.3	12.1	14.8	9.1	4.2	11.0	10.2	9.9	11.1	6.1	9.0	6.9	7.3	9.6	17.3	9.8	14.3	8.3	8.2	11.5	11.5	12.4	11.1	6.1	7.9	13.0	6.1	8.3	10.2	6.9	10.1	13.8	9.4	7.3	7.3	11.7	9.1	10.2	8.1	10.2	13.5	6.1	9.8	10.5	11.0	9.3	19.2	22.6	10.0	0.3	26.6	22.8	14.4	12.6	10.3	11.6	9.8	13.3	11.3	17.5	21.0	15.0	15.8	17.4	15.7	21.6	19.9	14.6	15.5	12.5	8.6	17.7	9.3	19.5	9.7	15.0	19.1	24.5	31.8	12.2	16.1	6.5	22.6	9.1	14.2	24.2	19.4	21.7	20.2	27.4	12.7	8.9	18.1	13.3	18.4	16.9	13.2	20.5	11.9	11.5	11.3	11.6	11.8	10.1	13.6	19.0	14.0	14.7	22.9	23.0	15.2	19.6	15.4	19.1	15.7	17.2	2.6	1.2	3.4	4.0	3.7	3.6	3.7	4.2	4.2	3.6	3.4	4.0	1.8	5.4	2.9	3.2	4.5	2.2	7.0	8.3	7.1	7.3	6.9	7.3	8.3	8.2	7.9	7.3	8.1	9.3	11.7	19.2	14.4	74.7	15.4	8.5	16.5	8.9	23.3	11.9	11.8	11.0	8.5	18.6	12.0	14.7	16.7	7.9	9.6	5.1	1.9	8.8	20.9	19.5	17.0	10.3	7.3	12.4	77.5	9.6	5.4	12.5	15.3	11.2	6.3	19.7	11.4	17.8	9.7	3.3	77.2	5.4	4.1	9.7	7.4	11.1	9.9	12.9	3.6	89.9	7.9	5.3	10.3	73.9	111.0	6.4	7.2	8.6	11.5	11.3	2.5	7.4	22.6	24.9	0.0	16.2	9.1	20.7	14.1	11.0	4.4	4.8	16.5	20.3	6.3	7.4
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892433	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 40.4"									"HPA041416, HPA073220"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041416: AB_10795592, HPA073220: "	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	1.7	2.2	4.6	1.3	5.2	0.1	1.9	6.1	7.3	2.4	2.4	2.2	2.3	2.1	1.8	1.9	3.2	1.5	4.7	3.9	5.2	3.0	2.1	1.8	1.0	5.1	5.4	3.7	1.9	5.1	1.7	1.8	5.2	3.0	1.9	10.8	1.8	3.1	2.3	1.3	1.2	2.0	5.0	0.9	2.9	3.4	6.3	0.9	3.6	2.3	0.9	2.6	1.4	5.9	7.3	12.6	7.7	9.8	4.1	5.0	0.1	13.5	6.1	11.4	13.5	2.0	9.5	0.0	8.2	3.8	14.3	11.3	16.2	3.7	10.2	0.0	8.3	2.6	6.2	0.9	2.0	0.7	5.2	1.6	5.1	6.5	6.2	7.9	5.8	0.0	0.9	0.0	8.3	5.7	0.0	2.9	11.2	5.2	5.3	0.0	9.9	0.3	5.1	5.9	8.6	8.9	9.3	3.9	6.5	7.5	4.6	6.3	4.3	7.9	5.6	40.4	9.6	3.4	4.3	0.0	5.0	0.9	11.6	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.4	4.2	0.0	0.2	0.1	4.6	5.2	6.1	7.3	3.9	5.2	5.1	5.4	5.2	5.0	6.3	5.9	3.5	0.0	0.5	0.0	0.5	1.8	4.1	2.4	1.2	17.5	2.0	2.0	6.1	1.5	2.0	11.0	0.0	0.2	0.0	2.5	9.8	3.0	12.6	5.5	1.9	2.7	3.0	0.4	3.0	1.1	0.3	2.4	1.1	1.1	0.0	2.1	1.4	1.8	1.3	1.7	4.0	1.5	8.2	0.6	1.0	7.8	2.5	0.7	0.0	0.0	0.1	5.2	0.0	1.0	4.7	0.8	5.3	4.9	1.2	2.2	0.6	6.8	5.4	4.6	0.0	1.5	2.9	19.3	2.7	2.6	1.4	0.1	0.2	1.8	2.9	4.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76381132	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 241.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008758, HPA077077"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA008758: AB_1855714, HPA077077: "	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	25.7	21.9	13.8	20.1	14.2	33.4	29.7	13.6	16.3	21.4	13.2	24.1	19.9	24.2	21.1	11.2	19.0	16.7	17.2	14.4	13.8	19.6	19.5	21.8	33.0	13.1	14.2	20.3	41.6	14.2	9.5	26.2	13.1	17.1	25.7	37.2	15.6	19.0	31.7	14.5	20.0	22.0	13.9	26.0	21.5	18.1	14.2	30.6	22.1	32.9	28.7	20.4	15.0	13.6	37.7	29.3	54.6	31.1	36.4	51.5	33.4	38.0	38.9	46.4	40.8	58.9	38.9	100.8	57.1	36.2	40.7	36.5	67.4	44.6	73.9	78.3	21.5	72.2	20.2	27.4	40.2	92.3	34.9	37.1	57.8	41.3	76.9	28.1	40.7	70.5	85.3	55.3	42.0	40.4	81.4	51.9	22.7	98.5	31.8	60.3	124.7	105.0	27.1	38.8	53.1	35.6	36.7	40.1	20.5	36.5	40.6	35.8	36.7	55.4	91.7	114.2	33.9	49.9	56.6	241.7	13.3	50.8	30.6	0.7	1.5	1.7	4.5	1.6	5.2	3.3	4.7	5.0	2.1	3.6	3.4	4.4	0.5	5.6	1.5	0.9	4.7	1.7	13.8	14.2	13.6	16.3	14.4	13.8	13.1	14.2	13.1	13.9	14.2	13.6	42.4	25.6	25.3	0.0	13.6	0.0	0.0	0.0	0.0	0.0	29.6	24.0	0.0	0.0	6.2	11.0	0.0	14.2	31.6	0.0	13.7	10.9	0.0	13.6	34.7	9.8	0.0	0.0	0.0	26.4	21.5	11.3	0.0	19.3	7.6	24.5	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	14.1	0.0	0.0	7.6	0.0	0.0	16.3	5.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	16.3	13.4	34.4	0.0	0.0
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71664301-71680644	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 367.4;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	16.1	26.1	5.7	9.1	7.1	14.8	4.2	11.6	9.2	4.8	3.1	4.1	5.7	6.3	17.0	6.5	4.6	8.6	5.2	5.5	6.3	5.6	4.4	4.7	7.9	6.7	6.0	8.6	3.8	3.4	11.1	6.8	6.6	4.7	5.7	11.3	4.7	4.1	5.0	5.7	4.3	4.4	6.9	5.1	6.4	18.2	5.7	5.4	4.6	5.7	7.1	28.2	4.1	10.8	3.9	4.9	11.2	8.6	8.2	7.2	5.6	6.0	5.5	5.7	4.8	5.1	5.1	2.7	4.0	4.0	6.9	6.8	10.9	3.4	7.4	11.5	6.0	7.8	8.6	8.0	7.4	4.8	3.4	5.1	15.1	5.4	12.0	11.9	9.0	13.2	5.7	5.6	7.9	1.3	3.9	4.7	5.7	7.9	8.2	5.5	3.8	13.3	7.1	6.0	7.9	12.4	6.6	3.8	5.8	7.8	7.1	5.4	4.0	5.9	2.8	5.1	4.1	6.9	9.4	6.2	3.4	5.7	3.6	1.4	2.2	2.2	3.7	3.0	6.0	4.1	5.1	3.6	3.0	4.8	8.1	5.5	1.9	6.4	3.7	1.4	5.5	2.1	5.7	7.1	11.6	9.2	5.5	6.3	6.7	6.0	6.6	6.9	5.7	10.8	15.1	0.0	11.0	11.1	36.2	19.6	27.7	13.7	20.5	11.5	9.9	13.6	12.4	4.3	7.9	3.7	4.2	4.0	24.4	8.1	9.8	7.7	367.4	12.2	13.5	10.6	5.4	3.4	14.8	5.4	7.3	47.1	12.8	20.2	58.3	9.4	6.1	4.3	12.3	13.5	20.8	8.1	2.0	11.3	93.2	183.7	11.5	75.2	78.2	5.6	9.9	10.2	9.2	14.1	24.3	7.0	9.4	5.7	44.3	16.7	15.6	19.2	10.5	7.5	0.0	22.2	64.1	26.1	7.2	44.8	29.5	3.0	20.0	6.7	9.5	25.7
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	17.4	24.7	22.1	6.5	22.3	9.6	17.9	23.1	25.8	23.4	18.9	20.1	7.9	18.8	8.3	15.7	19.4	7.7	28.4	20.9	21.3	27.0	29.0	14.1	11.5	23.7	21.8	22.3	24.0	14.0	19.7	7.4	22.2	22.9	4.5	5.1	16.5	9.9	22.8	17.0	15.1	7.0	21.0	21.6	19.2	16.8	21.9	9.7	19.9	13.4	8.6	18.9	18.2	25.0	13.6	12.8	11.2	16.3	18.2	16.3	10.8	12.0	15.6	31.2	19.4	17.1	8.4	11.9	15.7	13.2	11.6	10.5	17.9	10.7	10.8	20.6	30.1	13.7	18.5	15.5	22.8	9.8	13.6	15.3	13.4	19.7	17.2	19.0	13.6	20.5	14.1	14.9	11.7	9.7	17.2	22.2	9.7	15.8	21.7	16.2	13.6	17.3	14.3	3.2	14.7	16.7	14.6	19.9	28.6	9.3	12.8	17.4	12.4	16.5	9.9	11.4	19.0	16.7	19.3	15.9	13.9	20.9	9.5	16.6	19.4	15.2	25.2	16.2	25.7	22.1	25.0	26.8	24.4	31.0	27.3	23.1	12.0	24.7	12.9	22.2	27.1	20.9	22.1	22.3	23.1	25.8	20.9	21.3	23.7	21.8	22.2	21.0	21.9	25.0	12.1	0.0	7.5	5.5	10.8	14.0	12.0	13.2	9.1	11.1	10.4	14.2	7.2	10.0	6.9	9.2	6.2	16.0	9.7	10.7	19.6	10.5	6.5	9.2	11.8	12.8	7.7	11.0	4.6	10.4	17.5	15.8	5.6	9.0	5.7	17.6	11.7	11.6	15.5	5.0	5.8	10.4	10.2	10.9	15.9	4.7	18.6	7.1	10.6	2.8	19.2	12.2	12.3	5.0	7.9	9.8	13.1	23.3	18.1	21.5	21.1	19.3	12.3	8.8	13.1	13.8	15.8	18.2	18.0	8.7	14.8	16.4	9.3	17.7	13.0	15.6
THAP4	"CGI-36, Nb(III)"	ENSG00000176946	"THAP domain containing 4"	Q8WY91	2	241584405-241637158	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"		"DNA-binding, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044982, HPA053448"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear speckles"		"HPA044982: AB_10959786, HPA053448: AB_2682154"	"unprognostic (3.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.07e-1)"	34.3	31.8	60.3	19.0	60.4	28.1	35.6	57.7	78.5	34.5	60.2	51.1	42.1	30.9	28.7	53.1	29.0	25.0	106.5	58.9	60.7	96.7	54.0	29.3	22.0	60.0	61.4	33.2	48.4	107.0	37.7	16.1	60.3	43.7	27.1	9.0	42.1	24.1	118.8	46.8	34.9	17.3	56.3	26.5	52.0	40.8	62.7	23.4	31.9	91.6	19.0	41.5	38.9	59.8	47.6	53.4	31.5	58.9	41.5	43.1	53.7	32.1	42.5	46.6	41.4	48.6	41.1	40.5	16.4	50.1	53.8	53.4	63.8	71.4	17.6	33.3	76.9	42.5	35.7	138.7	55.0	48.6	28.5	44.8	55.4	50.2	69.2	32.5	43.9	62.4	76.9	13.1	36.4	84.5	51.1	110.1	57.1	43.9	45.2	55.9	44.1	52.6	100.2	57.0	76.4	50.1	24.7	76.9	65.1	19.4	38.7	52.3	40.0	55.5	36.6	50.7	58.3	32.4	19.9	42.6	40.2	40.4	40.9	31.0	15.7	40.3	27.4	18.0	29.4	21.6	30.3	25.5	16.4	25.0	28.6	23.3	10.2	22.7	24.1	23.2	53.6	16.1	60.3	60.4	57.7	78.5	58.9	60.7	60.0	61.4	60.3	56.3	62.7	59.8	16.6	19.2	21.7	15.7	16.4	20.0	42.1	31.9	21.1	9.9	21.2	17.1	55.9	35.8	28.3	40.5	4.2	23.4	13.2	64.6	223.0	48.0	17.7	37.5	19.6	17.7	28.8	21.5	12.2	27.8	24.6	19.9	35.2	58.9	7.0	16.6	13.6	38.0	17.7	8.4	12.8	52.3	32.6	11.4	10.6	7.7	18.0	14.2	12.4	7.5	15.3	11.1	22.6	11.1	11.5	27.6	44.2	19.5	21.3	38.1	79.0	90.0	21.3	6.8	32.9	16.3	23.3	25.3	29.1	40.0	25.9	27.5	15.1	17.5	60.2	53.4
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 398.3;Late spermatids: 537.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	8.9	13.2	9.8	11.3	11.2	4.7	12.8	13.1	14.3	12.1	9.2	9.2	9.8	12.8	12.6	7.7	9.9	7.8	13.8	9.4	10.8	15.9	19.7	10.3	14.6	11.2	10.4	17.4	9.9	18.0	10.6	10.0	10.5	13.1	8.2	17.8	9.9	11.4	13.0	8.3	9.8	8.6	10.8	12.7	10.2	26.7	10.8	13.1	22.3	15.3	13.3	7.8	5.9	14.9	19.4	14.8	18.6	42.3	11.8	16.7	9.7	17.5	19.8	19.0	20.1	7.5	15.9	23.4	31.0	12.1	24.8	8.0	19.3	13.8	24.5	30.5	15.2	17.6	14.4	7.1	25.1	31.7	22.4	10.4	26.1	11.6	27.4	20.2	11.8	26.3	27.9	49.3	19.4	19.5	48.6	13.7	21.9	11.5	14.4	15.0	26.6	54.8	11.6	11.2	21.8	38.2	25.0	29.2	35.1	14.5	12.2	11.9	11.8	35.7	19.7	28.3	21.8	57.0	52.6	43.0	19.8	19.1	33.0	19.2	8.0	15.0	11.7	10.6	15.2	17.8	13.2	11.1	8.0	19.5	17.2	14.6	25.7	11.2	15.5	12.7	11.9	8.3	9.8	11.2	13.1	14.3	9.4	10.8	11.2	10.4	10.5	10.8	10.8	14.9	30.6	16.0	20.9	9.4	31.0	12.2	12.0	9.0	9.1	40.9	23.6	20.4	30.1	32.9	12.6	25.8	8.4	13.2	26.6	14.7	46.9	15.5	398.3	14.9	18.9	20.7	15.7	39.5	12.9	16.9	9.3	21.3	7.7	12.1	32.2	18.6	21.8	26.5	9.6	47.1	15.1	16.3	12.2	15.2	19.8	537.3	28.3	15.0	35.6	6.5	16.1	49.5	15.5	12.5	21.6	13.6	15.6	28.2	20.8	14.9	16.6	32.8	23.7	40.7	26.3	24.4	21.8	44.6	25.9	8.4	18.0	14.4	22.5	18.0	12.4	8.1
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	9.8	11.3	6.8	12.6	12.3	12.6	15.3	14.4	10.0	10.2	8.9	9.9	12.4	16.5	12.7	9.4	10.6	9.1	14.6	7.9	11.5	9.8	12.5	9.4	15.7	11.7	9.6	14.8	8.5	12.4	9.4	9.6	11.0	13.5	11.7	21.7	13.3	10.2	15.3	16.7	13.2	10.7	7.2	12.5	11.0	23.5	10.8	9.2	15.5	13.6	12.1	9.2	8.5	21.0	8.5	6.2	13.4	9.2	14.8	14.9	6.9	19.8	10.1	10.5	10.8	7.3	20.7	11.5	10.0	6.6	11.8	8.8	12.4	8.8	12.8	14.1	8.5	8.8	10.5	9.3	20.0	12.8	9.5	12.3	16.9	11.7	18.3	16.5	5.9	14.8	16.2	25.0	11.3	10.4	11.1	8.2	6.8	12.2	5.8	11.0	14.5	8.5	9.9	6.5	10.0	10.3	9.6	12.6	11.8	11.0	14.1	10.2	6.8	17.5	11.6	20.8	9.8	22.4	12.3	11.5	11.9	9.5	14.9	17.2	8.4	12.7	9.0	7.4	12.2	8.6	10.9	8.6	7.0	10.2	12.2	9.5	18.2	6.9	8.3	5.7	13.3	6.6	6.8	12.3	14.4	10.0	7.9	11.5	11.7	9.6	11.0	7.2	10.8	21.0	11.0	12.8	11.0	21.9	19.8	8.3	14.7	12.7	14.8	20.2	13.0	10.5	17.0	18.6	11.5	22.0	31.3	10.8	13.5	8.9	15.6	8.3	131.8	13.1	13.5	8.5	12.6	12.6	11.0	6.4	8.8	16.0	8.6	8.4	10.8	18.0	9.3	9.8	7.2	16.8	15.6	12.8	6.1	14.0	6.5	23.0	14.0	9.6	7.2	13.1	11.5	13.3	8.2	18.6	35.9	8.0	11.5	11.3	17.5	11.4	16.7	15.7	20.6	18.9	0.0	10.0	13.7	56.0	16.6	12.2	6.8	7.7	18.1	15.5	7.5	7.7
THAP7	MGC10963	ENSG00000184436	"THAP domain containing 7"	Q9BT49	22	20999104-21002196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.9;Spermatogonia: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 106.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003083	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Vesicles"	"HPA003083: AB_1080264"	"unprognostic (6.48e-2)"	"unprognostic (2.13e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-3)"	16.1	26.9	13.7	5.6	12.9	4.8	18.1	13.7	19.6	23.0	16.0	23.1	7.9	20.4	4.8	15.4	20.9	5.8	19.4	12.6	13.2	20.8	37.8	13.4	8.8	14.1	14.9	21.9	26.9	9.8	39.5	4.2	14.4	29.1	2.5	2.7	19.0	9.2	39.7	19.1	19.0	3.5	13.3	24.2	23.2	35.5	13.9	7.6	20.9	14.4	3.7	21.5	16.6	13.2	23.5	25.0	6.9	11.8	6.0	7.5	14.2	12.1	11.6	15.9	14.7	11.5	13.5	17.2	11.9	7.6	8.4	16.4	6.1	12.1	2.4	17.1	36.4	21.6	18.7	14.9	18.5	22.2	13.4	7.2	15.0	14.0	12.9	7.0	8.4	13.1	106.2	19.8	8.8	29.3	24.4	13.7	9.6	16.0	24.7	19.0	13.6	10.4	8.4	11.8	13.5	11.7	15.1	19.5	21.5	3.2	22.4	14.6	5.5	25.4	19.5	15.4	12.8	27.6	17.4	14.1	27.6	14.3	22.4	1.9	22.1	8.8	27.2	23.9	36.1	50.0	32.8	27.4	21.3	36.9	45.2	36.3	1.9	24.0	25.3	31.6	30.7	24.9	13.7	12.9	13.7	19.6	12.6	13.2	14.1	14.9	14.4	13.3	13.9	13.2	18.7	16.0	25.7	6.2	33.3	19.1	20.3	24.5	14.8	31.5	25.0	30.4	14.8	37.1	18.3	25.8	14.6	31.2	23.8	22.4	64.6	28.2	30.0	16.6	15.7	20.3	22.2	16.2	5.8	38.2	30.1	25.8	20.4	10.6	21.5	21.0	18.5	35.3	27.8	13.5	5.8	22.8	30.5	15.8	11.5	44.0	41.7	14.2	40.9	1.0	27.5	52.0	45.3	3.5	7.2	23.9	19.7	32.4	28.6	31.4	38.4	57.4	22.6	27.1	39.5	22.8	43.5	162.9	119.4	16.7	16.3	29.6	28.8	31.1	21.7	13.2
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034984-36054739	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.8;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	3.3	3.2	9.1	2.5	9.8	0.9	2.7	9.4	9.6	5.0	6.3	9.5	3.7	4.7	3.4	3.7	3.8	3.5	3.5	8.3	9.7	4.1	4.6	2.8	3.1	10.1	9.8	3.5	2.8	3.7	3.4	2.8	10.2	3.6	2.4	4.6	3.0	4.3	10.2	5.2	3.5	4.4	8.9	3.4	3.6	9.7	9.7	4.0	3.1	3.3	2.2	6.6	4.0	11.2	3.3	8.2	4.4	3.7	11.6	8.0	2.8	2.7	4.8	5.5	7.8	3.6	2.3	4.5	9.7	4.5	5.7	1.5	2.5	3.3	2.1	3.2	1.6	2.8	3.0	4.3	12.7	1.6	2.7	6.2	5.0	3.8	2.6	6.2	2.6	8.2	2.4	5.3	5.8	5.5	4.1	3.4	3.9	5.6	3.1	3.9	1.4	4.2	4.5	2.9	8.1	6.1	4.6	3.9	3.3	5.7	4.1	2.2	2.3	7.3	4.5	4.5	2.2	5.2	4.5	3.3	8.0	2.6	4.7	7.1	6.5	7.9	5.2	7.6	5.9	4.1	5.5	5.4	4.7	3.0	4.1	6.1	2.7	6.2	6.6	4.5	5.8	4.1	9.1	9.8	9.4	9.6	8.3	9.7	10.1	9.8	10.2	8.9	9.7	11.2	1.4	3.2	3.7	3.6	3.4	1.1	1.2	3.2	2.8	2.2	3.0	2.4	3.7	5.7	2.9	7.3	2.1	10.2	3.5	2.1	1.9	5.7	3.0	1.5	3.9	2.5	6.6	1.3	2.7	0.5	5.5	3.8	4.1	2.7	5.7	8.8	3.9	3.5	15.8	3.3	3.3	1.3	12.2	4.4	0.8	6.1	1.8	3.2	1.8	1.9	4.4	5.2	8.2	4.5	5.5	2.6	2.7	4.1	2.5	1.2	5.3	11.7	1.2	3.0	0.0	1.7	2.9	18.8	21.5	2.3	2.3	10.5	2.5	5.8	2.2	1.0
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 40.5;Late spermatids: 52.9;Oligodendrocytes: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	1.3	1.6	3.0	1.0	3.6	2.0	3.2	3.3	4.5	2.0	2.6	1.5	1.5	2.5	3.6	1.3	1.7	1.3	2.7	3.1	3.3	3.0	3.2	1.6	1.8	3.4	3.2	3.2	2.5	3.2	2.7	2.1	3.6	2.4	1.6	4.3	2.0	1.9	5.2	1.7	1.5	1.4	3.2	1.4	1.4	6.7	3.1	2.5	4.1	6.8	1.7	1.5	1.6	5.8	1.1	1.5	5.7	3.2	1.7	2.0	4.0	1.1	1.8	1.1	1.0	2.3	2.0	6.3	2.0	1.5	2.1	1.4	4.6	1.8	1.3	2.4	1.7	2.7	2.2	2.9	2.0	2.5	2.1	2.1	2.9	0.5	2.8	1.7	1.7	5.1	2.4	4.2	1.4	1.5	6.1	3.0	4.6	2.2	0.8	5.5	2.4	3.7	2.0	1.3	4.8	3.3	2.2	3.0	4.1	4.7	1.8	2.2	1.1	1.4	1.6	1.1	0.8	2.7	1.3	6.0	1.7	1.5	2.2	0.0	0.9	0.1	0.5	1.4	0.7	1.3	0.4	0.5	1.0	1.1	1.2	1.0	0.0	0.6	1.0	0.6	0.2	0.5	3.0	3.6	3.3	4.5	3.1	3.3	3.4	3.2	3.6	3.2	3.1	5.8	3.2	3.2	3.6	8.5	2.8	0.8	2.8	2.3	2.2	2.8	2.4	2.3	5.0	0.0	2.2	1.8	6.2	3.2	3.6	1.3	0.0	1.6	40.5	4.0	2.8	2.0	3.0	2.5	4.6	2.5	2.0	2.3	5.6	4.2	1.3	4.2	1.4	1.3	1.3	0.0	4.7	1.7	2.0	0.8	1.3	52.9	1.8	2.6	0.0	3.7	1.3	4.0	2.1	7.5	20.8	0.9	0.7	0.0	2.3	1.8	1.1	2.5	1.9	4.7	6.6	4.6	2.8	6.1	5.2	2.6	1.7	3.3	2.0	1.4	1.5	2.0
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	1300000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	65.4	11.4	2.0	19.6	1.8	15.5	25.5	1.6	3.2	16.7	3.4	16.5	5.5	12.6	3.1	36.8	27.5	26.5	31.0	2.4	3.0	19.7	9.7	56.7	14.5	4.1	2.7	6.9	13.2	9.9	20.4	28.5	2.8	8.0	5.9	0.2	10.8	4.6	40.7	71.4	20.0	15.6	3.0	43.6	30.8	7.6	8.5	5.1	35.5	17.5	8.0	20.8	21.0	2.4	11.5	9.9	0.3	0.0	24.3	1.4	0.2	0.2	0.0	0.0	0.0	0.0	39.2	0.0	33.5	3.4	1.7	33.1	0.0	1.8	0.0	0.0	0.1	0.1	1.0	0.0	4.7	0.0	0.2	1.1	42.6	0.7	2.8	23.0	11.0	0.0	4.2	0.0	0.9	0.8	0.0	4.2	0.1	29.8	1.6	0.0	0.0	4.9	0.2	16.2	0.7	0.0	9.4	1.2	17.4	2.9	0.0	24.8	21.7	0.1	0.6	3.2	0.0	0.0	0.0	0.0	2.0	5.8	0.8	0.0	4.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	24.6	2.0	8.7	10.8	0.0	2.0	2.0	1.8	1.6	3.2	2.4	3.0	4.1	2.7	2.8	3.0	8.5	2.4	254.3	22.4	21.4	0.0	2.0	34.3	10.4	9.5	23.3	0.1	3.9	5.3	16.8	1.5	21.3	0.0	0.0	3.2	16.9	0.0	0.0	1.8	0.9	1.9	1.8	200.6	0.0	2.7	0.3	0.2	37.1	46.1	2.6	7.2	7.6	0.2	65.3	0.8	14.9	0.0	0.7	0.4	4.1	32.4	138.1	4.9	130.8	130.9	16.0	1.0	8.1	0.0	0.0	0.0	0.0	9.0	0.0	259.2	2.3	4.5	0.0	0.3	2.5	0.0	6.6	51.4	39.0	0.2	1.0	237.3	98.6	42.4	3.2	2.8	0.1	58.2
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		21000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	52.9	7.9	5.5	14.8	15.4	0.0	36.2	10.9	7.7	63.1	0.2	20.4	2.5	50.0	0.7	12.0	34.7	50.4	44.2	6.5	13.1	8.3	8.2	19.8	3.3	17.1	18.2	33.2	5.6	1.7	9.5	2.2	21.4	9.7	2.4	0.1	8.2	2.5	3.4	41.1	9.2	21.3	11.3	3.3	5.4	2.3	15.0	0.6	17.0	1.8	1.2	29.1	30.8	19.3	0.2	0.0	2.5	1.1	250.2	200.3	0.0	76.8	88.6	96.3	117.8	0.4	0.0	0.1	0.1	76.1	0.2	0.1	2.4	3.2	22.5	0.0	0.0	0.0	0.0	0.0	73.1	0.3	0.0	113.2	0.0	127.2	0.0	0.2	0.0	0.0	0.0	0.1	3.7	0.0	0.1	1.7	16.3	0.0	0.6	0.0	0.1	1.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.0	46.1	0.4	107.6	9.3	0.1	0.7	0.0	30.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	15.4	10.9	7.7	6.5	13.1	17.1	18.2	21.4	11.3	15.0	19.3	3.5	6.4	0.0	6.8	0.0	86.8	1.6	0.1	1.8	0.4	2.2	1.8	5.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	3.1	71.1	4.6	0.0	0.0	1.2	0.0	0.0	127.7	1.1	1.4	0.0	0.0	15.4	0.0	0.3	0.0	1.7	0.0	0.0	0.0	69.8	0.3	8.1	1.2	56.9	6.5	0.0	0.2	0.0	40.7	55.8	0.5	0.0	16.1	0.0	1.9	0.0	4.4	0.0	0.2	0.0	1.0	33.7	0.0	0.4	1.2	42.3	0.1	2.1	5.5	0.0	0.9
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	29	"Early spermatids: 297.1;Late spermatids: 1075.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9400000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	16.7	9.3	4.5	8.9	5.1	9.1	16.3	3.0	5.3	24.9	7.9	25.0	5.4	33.6	21.0	14.1	24.4	16.7	23.2	4.9	5.4	16.4	14.5	15.6	5.7	4.8	6.7	24.9	19.1	10.8	15.9	8.8	4.5	20.0	10.7	4.7	13.3	15.5	5.8	18.8	14.1	28.6	3.3	11.0	14.5	14.9	6.4	4.4	23.6	8.0	6.2	18.8	19.4	4.2	3.3	7.8	28.3	28.9	15.1	17.5	1.7	13.3	19.6	6.1	10.9	1.0	24.0	2.2	14.7	29.4	1.8	7.9	0.8	5.0	4.5	5.3	1.9	1.9	9.8	1.1	16.3	1.6	3.9	30.3	17.2	8.9	12.2	76.2	11.0	4.9	1.7	4.6	5.5	12.0	1.3	3.0	6.5	6.9	3.9	26.2	1.2	5.3	12.7	8.2	41.7	23.8	3.4	6.5	6.8	40.7	19.1	4.1	8.5	20.1	4.6	3.8	4.7	11.1	1.4	0.5	18.2	1.7	1.7	0.0	1.6	0.6	0.6	0.8	0.4	0.5	0.9	0.7	1.3	0.2	1.0	0.3	0.7	0.3	0.2	0.2	1.7	0.8	4.5	5.1	3.0	5.3	4.9	5.4	4.8	6.7	4.5	3.3	6.4	4.2	4.0	0.0	14.3	7.2	1.4	7.9	2.6	3.1	4.6	2.5	6.6	6.1	1.7	5.7	2.8	0.0	0.0	1.7	3.5	3.3	1.9	4.9	297.1	5.3	10.3	5.6	4.8	0.8	11.2	2.5	1.8	22.6	5.6	5.0	0.0	7.5	2.9	5.4	9.9	8.4	6.3	4.3	6.1	3.8	8.6	1075.2	23.3	3.7	10.6	0.0	1.9	1.5	1.0	0.0	3.2	3.7	2.9	10.1	1.4	2.3	2.7	3.8	2.6	3.7	0.0	11.8	8.1	20.8	4.8	3.7	5.3	1.4	2.2	2.4	3.4	2.2
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 216.7;heart muscle: 167.9;smooth muscle: 251.4;tongue: 214.6"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	216.7	1.2	15.4	5.2	19.6	10.6	26.8	13.8	13.0	2.1	5.0	58.1	2.2	26.8	1.6	6.0	2.5	10.4	167.9	12.2	24.5	0.7	0.3	1.3	1.1	22.3	25.3	4.1	22.8	35.7	14.3	0.2	19.9	9.0	8.7	7.5	46.5	5.7	77.2	2.9	3.3	251.4	21.7	0.3	8.6	8.7	28.0	3.6	27.0	214.6	4.0	3.5	5.8	20.0	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	19.6	13.8	13.0	12.2	24.5	22.3	25.3	19.9	21.7	28.0	20.0	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530606-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.3;Late spermatids: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA066627, HPA068093"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA066627: , HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.5	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.1	0.0	1.3	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0
THEM4	CTMP	ENSG00000159445	"Thioesterase superfamily member 4"	Q5T1C6	1	151870866-151909637	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 30.3"	"Low region specificity"	"Detected in all"							HPA028161	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028161: AB_10603454"	"unprognostic (2.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.15e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-3)"	4.6	8.2	2.9	5.5	4.1	3.1	4.8	4.8	4.0	4.6	4.4	3.7	4.1	5.2	6.9	3.2	4.2	3.6	6.8	2.6	3.9	10.0	7.9	3.6	6.0	4.1	3.6	4.4	8.9	8.4	6.0	2.5	4.5	4.3	4.4	15.9	4.1	6.1	10.4	3.4	4.6	3.2	2.3	4.9	4.7	6.1	4.1	3.1	5.8	3.0	6.2	5.2	3.1	5.9	5.4	5.9	1.1	5.2	5.2	3.9	5.2	4.7	3.7	3.7	3.7	5.7	4.0	10.5	7.2	4.3	2.8	5.6	2.5	12.1	5.0	11.8	3.5	16.5	9.4	5.5	4.2	16.0	8.0	7.5	5.6	4.5	5.3	5.2	7.8	0.4	19.4	9.4	7.3	7.4	0.3	5.2	18.6	5.4	10.9	0.2	1.0	2.5	5.6	4.9	6.3	11.2	2.8	5.0	30.3	10.3	9.8	9.4	9.3	0.8	4.8	4.0	2.2	18.5	21.2	7.5	7.8	11.8	24.9	2.6	0.8	2.3	7.2	2.4	10.5	3.9	14.4	7.1	2.4	2.1	14.9	10.5	1.1	7.9	0.8	6.8	22.2	3.3	2.9	4.1	4.8	4.0	2.6	3.9	4.1	3.6	4.5	2.3	4.1	5.9	9.6	6.4	15.1	11.4	20.5	5.6	8.0	9.6	17.6	36.4	17.3	19.3	19.1	12.8	9.9	14.7	104.3	29.7	32.6	4.6	41.1	19.1	39.8	19.0	12.8	13.5	18.1	22.1	18.1	19.5	21.5	16.1	13.7	36.6	23.5	22.4	23.9	17.6	12.8	13.5	21.6	7.4	20.3	5.1	12.3	30.4	16.8	8.7	21.4	5.6	10.4	25.5	26.8	30.2	24.9	15.1	9.2	16.1	18.5	6.3	13.6	27.8	4.9	73.3	13.1	21.2	9.7	37.4	24.5	11.7	4.4	10.3	37.9	31.6	12.2	5.5
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727223-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4;RT4: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	14.3	17.2	15.8	4.4	13.9	5.3	15.6	14.4	18.3	9.6	12.0	13.3	11.5	6.9	3.5	21.0	9.4	7.3	16.6	16.1	15.4	21.6	47.0	10.6	6.5	20.7	17.2	4.4	23.1	15.7	12.5	8.3	16.7	12.5	5.1	1.4	16.3	10.3	12.4	16.6	11.6	3.5	15.0	11.0	15.6	3.7	15.9	6.8	14.2	7.2	4.1	17.2	11.5	14.2	28.5	23.1	3.5	23.9	10.9	3.8	16.6	14.3	11.8	21.5	14.9	14.2	41.5	11.9	31.8	5.4	8.0	64.4	10.2	31.0	3.5	9.9	28.2	9.1	12.3	28.9	11.9	5.3	9.2	5.5	10.9	4.2	6.0	4.3	18.4	16.6	4.3	5.9	3.7	82.4	21.7	1.3	5.4	53.0	74.5	24.9	2.4	27.4	25.9	114.0	53.1	20.8	21.9	64.7	18.6	3.2	31.9	4.3	10.7	9.2	6.7	26.8	2.5	3.8	5.6	5.2	9.5	25.7	11.6	7.2	4.9	2.6	10.9	9.2	16.6	5.1	11.6	14.1	4.7	6.7	13.6	12.9	0.7	11.1	9.0	3.6	11.6	9.1	15.8	13.9	14.4	18.3	16.1	15.4	20.7	17.2	16.7	15.0	15.9	14.2	35.4	9.6	5.8	6.2	6.7	3.6	7.5	5.7	2.8	10.4	24.7	25.3	7.4	11.5	7.8	18.4	6.2	18.3	11.5	16.6	5.9	13.7	3.3	5.5	3.0	14.6	31.8	11.6	11.3	11.6	10.1	4.8	7.7	9.0	0.0	6.6	19.2	20.8	11.4	16.8	7.8	13.5	6.1	3.1	1.4	15.7	2.8	3.9	5.4	2.8	2.3	13.5	16.5	11.6	7.3	9.4	9.0	4.1	3.7	10.7	29.0	16.2	2.4	11.3	0.0	6.1	4.3	2.7	5.7	18.4	7.7	3.4	10.3	8.2	22.4	25.1
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 215.5;lymphoid tissue: 126.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	30.7	10.6	10.8	72.8	13.1	215.5	12.7	13.6	14.4	7.2	12.3	14.7	10.1	5.7	3.9	8.0	10.2	23.6	6.6	11.2	16.6	9.2	19.1	45.8	47.9	22.2	14.3	3.3	5.4	2.7	4.9	18.8	19.1	5.4	10.1	0.9	11.1	3.9	3.4	4.5	28.2	15.5	15.4	126.0	12.2	22.4	17.8	16.0	11.0	4.5	29.9	26.9	6.4	24.6	9.1	0.3	3.4	0.5	11.4	15.6	1.5	1.9	20.0	28.7	40.2	1.3	2.4	12.8	1.2	6.6	15.9	1.3	5.2	1.2	4.6	1.7	1.2	18.0	0.4	2.3	22.3	23.0	27.8	7.9	0.3	14.8	0.1	1.5	11.1	1.0	24.7	135.9	2.1	6.1	0.9	20.1	11.8	0.3	1.8	4.1	12.8	23.2	8.6	0.3	0.2	5.0	0.1	0.8	26.2	2.1	0.3	20.2	6.9	1.7	0.2	5.6	0.3	98.4	6.1	0.8	32.3	62.1	0.5	41.7	403.3	341.0	71.9	441.4	66.1	41.5	53.1	60.2	309.6	21.8	45.6	48.2	498.1	61.9	454.6	125.2	56.4	380.7	10.8	13.1	13.6	14.4	11.2	16.6	22.2	14.3	19.1	15.4	17.8	24.6	2.2	3.2	20.0	0.3	42.6	3.2	1.1	2.7	0.6	0.4	1.0	0.6	0.7	2.8	8.7	0.0	0.0	0.8	87.5	0.3	0.0	0.9	2.3	4.5	1.8	6.8	10.7	6.1	6.2	8.3	1.3	1.8	1.1	6.4	13.3	7.1	3.6	1.3	62.6	0.0	0.7	0.2	36.7	135.9	59.9	5.2	0.6	125.4	17.8	6.5	144.8	0.1	54.6	0.5	14.7	8.7	0.0	0.4	57.3	3.0	0.0	0.4	3.2	0.2	0.0	21.9	2.1	1.8	2.9	0.1	1.1	2.5	21.2	3.0	0.8	5.0
THG1L	"FLJ11601, FLJ20546, hTHG1, ICF45, IHG-1"	ENSG00000113272	"TRNA-histidine guanylyltransferase 1 like"	Q9NWX6	5	157731420-157741449	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035877, HPA035878"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"HPA035877: AB_10669979, HPA035878: AB_10672993"	"unprognostic (4.30e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.74e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.69e-1)"	3.8	4.9	2.3	4.0	2.5	5.9	5.3	2.7	2.7	5.2	2.2	6.9	5.5	6.8	5.9	5.0	6.4	4.7	3.4	2.2	2.7	3.5	5.1	3.0	5.4	2.6	2.4	7.6	4.7	3.1	3.2	4.3	2.6	4.0	7.7	3.4	3.1	5.3	3.9	5.4	4.9	5.7	2.1	4.1	5.4	4.9	2.6	5.3	6.7	2.8	6.0	6.4	4.6	3.0	8.8	15.4	7.2	13.8	6.7	19.6	5.5	6.8	12.6	13.7	18.1	21.4	8.7	21.8	5.7	6.0	8.3	9.1	9.0	13.1	15.2	8.9	12.0	7.7	10.2	9.1	7.6	16.6	8.0	17.8	15.4	12.1	16.6	13.0	5.1	3.4	13.8	6.9	8.2	12.1	2.0	11.3	6.9	3.9	14.8	3.3	13.8	12.6	8.5	11.0	9.1	12.8	5.5	8.2	11.3	5.2	13.9	9.5	5.8	10.9	7.2	9.2	18.5	6.0	7.1	14.0	4.8	15.9	6.9	3.9	7.8	0.1	3.3	8.7	3.9	5.7	4.3	3.4	7.0	4.6	6.3	5.3	0.7	6.7	8.7	4.5	5.0	3.9	2.3	2.5	2.7	2.7	2.2	2.7	2.6	2.4	2.6	2.1	2.6	3.0	6.0	3.2	8.6	1.3	14.7	20.6	27.7	27.1	27.9	2.6	14.2	15.4	6.2	11.5	11.5	3.7	4.2	17.6	10.2	6.9	9.8	17.1	19.2	8.8	20.8	9.0	7.2	23.5	1.8	26.4	12.8	15.4	12.2	7.2	2.5	17.3	6.8	8.6	19.1	0.0	1.4	14.3	8.2	15.7	17.9	8.6	14.3	16.2	5.4	1.9	21.2	2.0	7.2	0.5	1.9	12.1	19.6	15.4	13.7	21.2	9.7	14.7	5.8	4.6	6.6	17.1	12.4	19.8	8.9	24.0	15.3	13.8	11.2	38.0	24.1	28.4
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016612-25026664	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Early spermatids: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	1.7	6.0	4.0	1.8	4.2	0.6	3.6	3.2	4.5	4.1	2.9	2.7	2.6	3.6	4.9	1.9	5.6	2.0	3.7	4.1	4.2	9.7	21.4	1.5	2.8	3.9	3.5	7.3	3.0	5.3	3.7	1.7	4.2	2.9	3.0	4.1	3.4	2.6	4.6	2.2	2.4	2.2	3.9	2.2	2.7	5.9	4.1	3.3	8.3	5.9	2.7	1.8	1.5	4.3	7.1	8.1	5.0	10.0	5.0	6.2	1.3	3.4	1.3	3.7	2.4	5.3	8.8	32.7	10.6	1.6	4.0	3.8	7.2	6.4	3.8	4.5	3.9	12.0	2.2	3.4	5.6	0.0	2.0	3.9	11.6	2.7	5.7	6.4	2.5	13.3	10.4	3.8	8.0	11.1	6.6	2.3	9.2	12.3	3.9	3.5	1.3	14.2	10.6	1.6	8.3	4.7	6.8	6.0	12.3	2.6	6.0	0.6	2.5	4.4	3.9	5.9	3.2	2.7	3.8	0.0	7.3	6.6	3.5	0.1	0.4	0.0	2.9	0.5	5.1	5.0	4.1	3.8	2.2	3.8	9.5	6.3	0.6	10.8	0.7	3.7	2.0	3.1	4.0	4.2	3.2	4.5	4.1	4.2	3.9	3.5	4.2	3.9	4.1	4.3	1.3	3.2	3.2	2.6	3.4	0.6	3.1	5.6	2.8	4.2	2.1	2.9	8.5	1.5	6.1	3.7	0.0	6.1	0.8	0.6	15.6	3.3	29.9	5.1	3.9	1.8	1.2	2.5	4.0	1.3	3.9	2.7	1.5	2.5	0.0	7.8	2.2	9.8	2.1	3.3	5.1	1.8	2.0	0.9	0.8	5.5	2.1	0.6	0.0	4.7	1.5	6.8	0.0	2.0	5.4	1.1	1.0	1.5	0.9	1.8	2.3	11.0	8.7	4.5	0.0	4.3	1.9	8.2	13.6	2.6	1.0	1.0	2.8	11.8	3.5	1.1
THNSL2	"FLJ10916, SOFAT, TSH2"	ENSG00000144115	"Threonine synthase like 2"	Q86YJ6	2	88170295-88186636	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Proximal tubular cells: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 31.6;MCF7: 12.2;SK-MEL-30: 12.6;SuSa: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035395	Approved				"Secreted - unknown location"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035395: AB_10601600"	"unprognostic (1.51e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.24e-2)"	13.9	22.6	14.9	2.4	16.9	0.9	16.4	15.1	15.6	14.8	15.0	18.0	5.6	11.2	22.6	6.5	19.2	7.7	17.8	13.8	18.1	28.5	50.0	7.2	1.9	16.7	16.2	14.9	14.2	32.3	29.1	8.6	16.0	22.3	3.7	7.3	12.9	13.5	50.1	9.3	12.6	6.3	16.1	7.5	13.5	13.0	16.7	1.1	21.9	35.8	1.8	12.5	9.9	16.3	0.3	0.0	0.0	0.0	2.7	0.9	1.5	4.6	5.0	6.4	8.3	6.6	7.7	0.0	2.2	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.1	0.0	0.0	0.0	31.6	0.0	0.6	5.1	10.3	1.9	0.0	0.5	0.0	0.0	0.0	0.0	4.7	12.2	0.0	0.1	6.2	7.1	0.6	0.0	0.0	0.0	5.2	0.5	0.3	0.0	5.4	0.4	12.6	15.0	8.8	2.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.3	0.3	0.4	0.2	0.4	0.1	0.2	0.4	0.7	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	14.9	16.9	15.1	15.6	13.8	18.1	16.7	16.2	16.0	16.1	16.7	16.3	2.8	3.2	9.3	13.1	3.1	6.6	8.6	8.3	9.6	12.8	23.2	20.2	17.3	20.0	2.9	14.7	0.0	42.5	0.4	9.2	58.7	14.8	1.3	14.5	8.9	3.6	2.4	6.1	2.8	3.0	15.7	13.8	6.6	8.4	0.0	8.1	7.9	43.6	4.6	13.5	3.0	6.8	4.1	10.7	4.6	4.2	9.0	2.8	14.2	5.6	11.3	43.5	3.1	4.0	16.7	5.4	8.9	9.8	1.7	6.3	13.4	87.2	5.2	7.3	0.0	8.9	6.4	3.7	11.4	3.7	5.1	23.9	1.7	13.8	6.2	5.6
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	6.0	5.2	8.7	8.1	9.7	7.5	5.8	10.0	12.2	5.5	9.8	6.6	6.3	4.7	4.5	6.5	4.1	4.6	4.6	8.8	8.8	7.5	9.9	4.6	12.3	9.4	9.0	4.7	3.9	6.7	3.7	6.4	9.9	5.1	5.5	5.8	6.9	4.1	6.2	6.3	5.9	5.7	8.8	6.3	5.3	16.8	9.5	12.8	4.7	6.2	11.6	9.5	3.8	10.7	27.0	15.8	32.4	26.1	20.8	15.4	40.2	15.4	14.5	29.8	31.1	30.8	16.1	37.2	11.9	20.0	46.0	17.1	43.0	24.4	36.9	12.3	19.1	22.2	18.4	21.0	16.0	50.5	20.2	10.6	14.4	33.3	21.8	13.6	33.3	34.5	52.3	17.4	27.3	20.5	38.1	29.6	31.5	34.2	21.1	53.3	30.3	33.4	17.2	26.1	21.2	16.6	39.0	19.9	25.3	36.7	14.0	37.1	16.6	26.6	29.9	21.8	48.3	15.9	26.4	54.7	22.2	36.0	22.8	13.4	7.3	6.4	9.8	10.7	14.8	13.3	11.7	12.4	11.9	11.5	13.5	13.4	0.7	11.2	9.4	7.2	12.8	6.6	8.7	9.7	10.0	12.2	8.8	8.8	9.4	9.0	9.9	8.8	9.5	10.7	20.4	19.2	11.7	48.3	21.0	12.9	15.6	16.8	23.9	30.8	13.1	14.1	9.6	2.8	17.9	11.0	20.9	24.7	23.2	6.0	15.6	16.5	67.1	15.0	23.6	16.7	9.5	21.0	45.3	8.2	16.7	19.9	9.2	21.9	27.3	32.4	8.2	10.3	16.1	28.6	51.6	8.7	10.2	6.9	11.1	11.6	19.3	15.0	3.6	32.8	14.3	12.9	10.3	41.7	74.6	12.7	7.0	17.0	15.6	16.7	9.2	10.2	10.5	27.6	6.6	21.6	22.9	73.4	30.5	13.8	9.1	18.7	22.3	17.7	13.4	12.9
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	22.8	26.1	26.2	22.7	28.2	25.1	26.3	29.0	43.8	28.6	33.3	28.5	23.0	27.1	38.1	26.3	26.6	19.6	21.0	25.9	28.1	22.5	26.0	27.3	32.7	27.9	26.8	32.1	27.8	23.9	21.8	23.4	28.8	26.8	22.8	34.9	22.4	19.2	23.5	29.6	28.1	22.6	26.3	30.8	24.1	15.1	28.0	38.2	26.0	17.7	27.4	24.6	25.8	30.5	59.6	48.6	61.1	66.1	44.0	42.0	32.8	39.6	38.9	42.8	56.9	34.3	59.4	60.5	44.3	43.6	41.2	44.1	74.6	29.6	72.3	58.1	67.5	84.8	69.1	46.8	40.8	99.5	58.0	83.5	36.1	49.1	56.2	37.3	40.2	90.6	129.3	53.5	43.9	62.6	86.0	96.3	34.0	79.7	47.5	86.3	38.2	50.0	67.6	66.4	46.9	41.5	111.0	30.2	39.3	48.6	30.3	60.0	41.8	38.4	19.8	55.2	67.8	37.1	58.0	51.7	34.3	86.8	43.2	9.8	8.3	9.2	11.1	10.9	12.9	10.7	12.1	12.1	7.9	11.5	13.1	12.6	4.7	11.0	12.2	13.3	10.2	7.9	26.2	28.2	29.0	43.8	25.9	28.1	27.9	26.8	28.8	26.3	28.0	30.5	65.8	137.8	151.4	68.2	81.2	83.4	67.7	69.3	80.8	67.5	45.3	45.3	53.6	20.0	89.0	64.4	158.4	42.3	69.5	65.9	11.7	55.0	5.7	54.9	102.4	68.4	67.5	88.5	64.8	50.9	36.4	68.2	46.9	70.8	80.4	90.4	59.6	37.9	38.9	53.8	72.7	55.9	46.8	44.6	58.1	9.0	93.2	61.9	30.2	75.9	82.4	41.2	69.0	96.5	119.9	47.3	36.3	91.4	66.4	76.2	55.1	28.9	77.5	108.9	124.9	81.0	98.1	69.0	35.8	55.7	77.0	43.6	76.2	84.2	57.9	73.8
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	12.0	14.5	22.0	11.4	15.9	35.1	21.4	23.0	40.6	23.1	19.1	27.0	12.5	13.4	63.2	82.9	15.1	8.0	9.3	40.2	14.9	16.3	22.2	11.9	29.1	15.5	13.3	18.8	15.3	10.0	15.9	17.4	15.9	14.6	21.1	12.1	22.5	14.9	12.6	26.5	16.2	12.2	13.2	17.7	17.5	51.3	15.4	39.2	20.5	17.6	45.5	17.4	33.5	15.9	82.1	44.7	47.0	102.7	44.1	39.3	168.0	48.4	44.6	104.5	120.4	63.5	65.2	105.6	68.3	27.9	112.6	69.2	71.6	206.0	109.7	73.5	103.3	57.3	46.2	70.7	14.6	94.6	49.2	33.3	85.9	90.0	45.2	23.3	58.3	98.0	88.1	46.5	66.9	98.7	64.0	57.9	40.1	82.3	160.3	110.7	59.3	110.4	75.2	60.7	89.5	51.4	100.0	48.5	52.5	67.4	55.3	86.1	45.1	35.9	40.8	55.6	88.2	23.2	44.1	64.4	26.7	90.1	28.5	16.5	26.9	15.1	39.3	33.5	48.4	49.6	81.7	48.9	43.1	70.6	99.7	62.4	3.9	42.3	31.5	39.8	133.6	59.1	22.0	15.9	23.0	40.6	40.2	14.9	15.5	13.3	15.9	13.2	15.4	15.9	14.9	12.8	8.6	2.0	35.8	44.5	34.1	64.5	132.1	12.3	17.7	18.0	4.0	10.0	24.4	25.8	10.4	40.8	25.1	8.1	41.1	25.1	187.0	50.2	18.4	16.1	16.8	63.9	5.2	19.2	84.3	15.2	26.5	44.9	12.0	18.8	13.9	20.3	24.6	6.7	3.7	16.3	26.4	13.2	14.9	122.0	14.6	14.3	8.8	1.9	15.4	8.9	27.8	4.5	2.0	21.9	11.6	19.2	55.9	18.4	10.4	46.8	15.8	12.0	19.7	10.6	22.8	107.9	48.3	226.5	40.9	20.0	33.3	25.0	27.7	31.1
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	17.0	16.9	8.6	16.1	9.1	23.5	15.3	9.6	11.2	16.1	9.7	17.9	18.8	20.3	6.0	19.3	13.9	10.5	15.8	8.6	9.2	22.2	21.3	17.5	20.8	11.6	9.1	11.6	12.9	10.8	17.4	18.2	11.8	21.1	10.1	2.1	15.2	12.2	25.9	24.9	19.2	12.5	9.2	22.7	15.6	10.4	10.2	19.6	15.7	8.4	16.1	17.1	16.5	9.5	37.3	59.6	42.0	45.0	21.1	23.9	74.4	11.3	25.7	25.7	37.8	39.6	42.8	70.0	36.0	18.9	19.1	49.9	46.3	35.6	14.0	62.3	59.9	38.0	58.6	58.7	35.9	56.2	80.0	24.3	42.6	31.4	76.9	32.4	24.1	39.7	56.1	36.5	12.8	87.0	32.0	103.3	76.2	21.4	25.3	84.7	31.6	82.4	27.1	18.6	86.4	41.0	31.8	49.9	21.7	18.1	35.9	60.0	20.1	26.8	61.1	30.6	41.3	26.3	24.3	85.5	7.0	38.1	27.3	2.4	61.3	13.6	35.2	62.2	36.2	37.8	32.6	34.7	88.6	43.2	37.1	39.1	4.4	38.8	35.7	74.3	38.0	45.4	8.6	9.1	9.6	11.2	8.6	9.2	11.6	9.1	11.8	9.2	10.2	9.5	11.0	19.2	7.4	1.6	24.7	68.2	84.9	59.0	30.7	3.7	22.1	20.8	3.3	14.3	18.9	18.4	2.1	107.8	23.3	23.2	35.2	33.1	5.4	17.9	19.0	17.9	25.8	30.3	1.9	23.5	121.1	24.6	15.3	25.8	12.0	15.6	6.4	10.3	51.8	3.3	1.7	32.3	44.7	19.4	37.3	3.2	14.9	23.4	24.9	2.8	39.6	3.2	15.5	0.5	4.2	21.5	28.0	12.0	19.7	109.4	32.1	32.0	8.7	2.4	6.6	23.4	31.9	5.3	23.3	23.3	44.9	77.2	20.4	20.9	42.2	46.8
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863868	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 1032.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	54.7	63.5	57.1	43.2	60.0	80.1	75.1	58.1	85.1	54.4	52.0	69.9	64.2	50.5	53.2	73.1	43.0	48.6	88.0	61.5	59.1	67.8	73.5	40.9	68.1	58.4	59.1	44.4	62.3	52.1	33.5	53.5	57.1	43.8	69.1	64.5	50.5	49.5	103.5	64.2	53.7	59.6	57.3	38.2	49.1	47.6	57.8	72.3	44.4	104.0	68.0	60.8	50.3	61.1	141.2	83.5	95.6	23.9	125.1	172.5	89.6	120.2	126.9	139.2	140.1	101.6	151.5	168.3	49.1	155.1	139.2	79.3	107.5	190.4	194.1	169.6	75.5	150.2	102.8	117.2	130.1	212.6	69.6	123.9	157.2	118.4	213.1	137.6	155.1	110.0	116.8	158.6	170.2	1032.4	186.4	186.9	120.4	304.8	65.5	132.3	89.7	227.4	245.4	128.0	47.3	107.8	105.0	147.6	171.6	93.9	93.6	289.6	113.6	100.8	105.9	125.1	216.3	101.3	162.3	204.1	125.3	268.3	133.5	73.1	40.4	33.1	38.7	47.7	54.0	46.7	47.9	53.2	59.0	31.5	40.5	43.4	23.4	55.6	41.9	54.0	61.7	35.6	57.1	60.0	58.1	85.1	61.5	59.1	58.4	59.1	57.1	57.3	57.8	61.1	82.6	89.8	45.0	14.4	59.2	61.6	91.2	179.9	70.6	53.5	70.9	121.3	143.8	81.5	102.9	84.6	18.8	180.3	66.0	62.1	207.4	145.2	84.7	100.7	75.6	57.8	55.2	159.7	26.8	126.9	166.1	65.4	47.4	73.8	54.4	74.3	44.6	78.1	111.6	48.8	26.4	106.3	101.7	75.6	58.9	89.7	88.9	70.2	67.6	14.0	173.1	82.5	93.7	12.5	18.9	127.6	86.7	71.5	53.3	96.6	108.8	241.2	102.1	73.1	52.6	66.9	83.4	244.9	54.5	116.6	71.6	213.4	68.0	80.7	133.2	95.7
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785503-2815807	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 136.6;Paneth cells: 160.6;Proximal enterocytes: 312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		2000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	13.4	19.6	31.8	11.8	31.6	19.6	15.3	29.8	48.4	15.3	25.4	21.3	22.6	18.7	6.3	31.0	17.6	3.3	38.0	33.2	28.7	22.7	73.0	13.7	11.6	33.7	31.7	18.8	17.5	6.0	32.0	7.8	30.7	37.6	7.0	9.3	15.7	5.2	40.6	20.0	21.5	6.1	26.9	23.0	16.1	70.2	28.6	13.8	17.9	11.0	8.3	18.7	15.9	30.4	91.4	66.3	25.1	54.6	12.8	12.5	89.9	55.4	20.4	53.8	43.4	78.4	28.3	81.3	26.4	21.7	37.7	72.4	37.8	45.6	22.5	0.3	79.7	28.9	75.9	94.4	13.7	56.3	43.1	13.9	16.0	44.8	20.0	15.5	31.0	54.0	68.2	38.7	23.1	70.5	63.1	105.0	74.7	27.2	90.2	51.7	33.8	77.5	22.8	51.9	68.5	54.6	48.5	42.9	27.6	13.1	41.8	53.8	35.5	41.2	35.5	88.6	95.4	67.1	60.7	55.7	46.0	93.3	50.1	9.3	2.5	1.2	3.7	2.9	3.0	3.8	2.7	5.2	3.6	5.3	3.4	3.0	1.0	3.0	6.0	7.0	7.6	2.5	31.8	31.6	29.8	48.4	33.2	28.7	33.7	31.7	30.7	26.9	28.6	30.4	5.1	3.2	10.6	15.0	12.0	6.8	10.3	15.6	11.4	20.3	12.6	10.8	9.0	5.7	9.7	11.0	35.5	27.6	8.7	136.6	9.8	18.7	17.6	11.1	8.3	7.4	40.8	13.7	12.1	15.1	55.9	11.1	9.2	10.1	5.7	23.1	7.1	85.9	23.0	6.7	10.5	59.9	6.1	9.8	6.0	23.4	11.5	9.1	3.6	3.7	8.3	13.5	4.1	4.0	7.1	21.3	160.6	6.0	17.2	16.6	312.2	10.8	9.7	32.4	13.1	10.6	15.0	55.6	19.2	13.4	5.8	33.8	8.0	15.9	48.2	8.4
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3"	ENSG00000126351	"Thyroid hormone receptor alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 236.7"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.41e-3)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (6.05e-8)"	"unprognostic (3.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.88e-3)"	40.7	43.7	199.1	12.0	236.7	23.0	38.9	159.3	218.3	67.5	108.5	67.2	31.1	49.9	22.0	19.1	57.7	25.8	63.8	189.7	181.8	34.1	10.2	32.2	9.7	162.4	172.1	90.7	31.3	29.9	50.0	17.1	149.4	34.5	18.8	35.4	27.3	35.5	90.7	50.2	36.2	34.6	166.5	13.9	48.0	18.7	183.6	12.8	32.6	52.8	6.3	45.0	45.9	179.9	4.9	37.6	11.5	28.9	77.4	28.2	4.2	19.3	23.0	19.6	18.2	31.5	27.2	5.6	31.3	37.6	8.7	11.4	22.6	11.7	10.6	2.1	21.6	10.4	44.5	13.4	26.0	16.9	11.2	45.1	9.5	18.4	7.1	45.4	26.6	16.7	21.2	5.2	16.5	7.1	22.8	27.4	10.6	24.6	11.8	32.1	22.7	27.6	6.4	3.3	19.5	17.7	14.8	23.3	33.7	17.5	27.3	19.5	18.7	19.4	18.9	17.7	5.9	11.9	9.0	3.4	12.0	19.1	10.6	0.2	0.3	1.9	2.0	0.1	0.8	0.2	0.8	1.2	0.3	0.4	1.4	1.7	1.1	2.1	0.3	0.6	1.0	0.7	199.1	236.7	159.3	218.3	189.7	181.8	162.4	172.1	149.4	166.5	183.6	179.9	32.2	19.2	7.3	27.1	6.2	10.6	28.1	3.3	31.3	76.4	19.6	21.2	45.4	38.6	2.7	33.1	20.9	0.8	16.5	37.9	50.9	12.3	1.1	20.5	29.5	20.8	25.1	17.9	19.1	14.8	1.4	36.8	29.0	12.1	14.0	23.1	24.7	13.8	11.6	62.2	24.2	22.6	6.1	10.6	5.1	2.7	51.6	8.6	19.6	8.4	5.1	95.2	37.0	15.6	26.5	6.9	14.6	49.7	3.9	17.2	58.8	29.9	7.5	22.5	19.7	84.7	44.4	0.3	27.3	14.6	10.4	0.3	18.1	16.3	39.9	13.8
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224432-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		59000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	41.9	40.6	24.0	45.9	24.7	44.6	43.7	28.5	26.3	36.6	31.2	40.2	33.9	39.5	34.9	40.6	39.3	29.6	47.2	24.3	26.2	32.3	45.8	37.4	57.1	25.6	24.6	45.3	35.6	52.0	30.0	40.1	26.7	50.4	38.7	40.9	38.8	31.3	115.3	38.2	35.1	42.1	24.1	48.0	37.8	34.3	25.0	63.1	46.0	64.0	60.8	37.1	36.2	28.1	100.7	63.9	110.1	94.9	88.0	69.7	90.9	104.6	107.4	107.2	109.8	74.7	91.5	187.5	38.5	113.8	73.8	89.1	125.2	106.9	131.3	97.4	70.1	157.7	94.3	85.6	94.6	157.2	102.5	105.7	65.7	107.1	86.7	75.2	118.4	107.5	127.8	93.5	77.6	57.8	180.4	92.7	130.5	64.2	50.4	163.6	133.4	99.4	77.0	125.4	69.6	83.9	117.5	77.0	92.7	108.7	73.1	69.3	122.4	89.2	100.4	82.5	111.6	56.7	80.7	162.4	82.2	109.2	92.7	85.8	36.9	64.7	51.5	43.9	46.0	53.6	43.9	46.5	42.4	61.0	46.4	43.1	80.8	51.2	48.6	46.7	40.7	47.3	24.0	24.7	28.5	26.3	24.3	26.2	25.6	24.6	26.7	24.1	25.0	28.1	101.0	115.4	101.7	32.3	136.1	56.7	94.5	126.9	78.0	98.0	76.4	65.5	113.7	75.8	106.2	47.8	31.3	150.7	151.9	64.3	97.8	155.7	9.7	92.1	114.7	96.2	72.4	114.9	65.6	104.1	147.2	98.3	58.6	106.0	92.9	120.5	80.7	78.8	101.6	87.5	63.2	70.1	89.5	77.1	71.7	12.0	80.2	89.9	72.9	53.4	155.5	129.4	196.7	47.7	53.4	111.5	61.9	83.5	119.7	125.2	51.6	76.0	87.6	93.2	92.1	114.6	116.5	145.9	118.4	89.6	68.5	144.1	129.0	141.0	87.1	86.4
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7"	"Group enriched"	"Detected in some"	5	"basophil: 7.2;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	15	"B-cells: 2.2;granulocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"K-562: 45.6;RT4: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	11.1	4.9	7.7	1.7	15.1	1.0	10.0	0.0	17.6	2.8	0.0	11.7	2.5	7.0	1.8	6.4	3.8	2.2	7.7	18.5	2.0	12.1	20.1	5.0	1.5	0.0	0.0	2.3	9.0	7.3	15.7	4.4	0.0	7.5	8.4	20.1	6.2	7.7	23.6	6.8	3.9	7.0	0.0	5.7	8.3	0.7	1.4	3.6	4.4	27.0	1.4	8.9	4.2	6.7	10.3	3.1	0.6	0.1	17.4	8.8	6.7	0.5	2.1	1.5	3.2	6.7	9.7	0.1	2.5	6.8	1.1	15.4	10.8	3.9	1.0	0.0	6.4	0.0	2.5	8.9	0.5	0.0	0.0	16.0	7.3	0.2	1.2	3.5	0.0	0.0	45.6	0.0	1.5	0.6	0.0	0.0	6.5	0.6	3.4	0.0	0.0	0.0	10.0	32.7	1.7	0.6	16.5	8.9	0.2	4.6	9.7	0.0	0.9	3.9	3.0	0.0	1.9	0.1	0.5	0.0	2.7	0.1	0.3	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	7.7	15.1	0.0	17.6	18.5	2.0	0.0	0.0	0.0	0.0	1.4	6.7	3.0	3.2	11.4	199.2	3.3	9.9	29.5	13.2	1.8	17.9	24.5	18.7	11.6	8.6	14.1	23.9	164.7	12.4	0.0	39.9	1.9	2.4	2.3	3.4	0.5	6.0	25.2	3.8	688.0	12.5	23.2	13.7	16.3	5.7	0.0	0.3	7.5	37.7	1.7	0.0	631.3	8.1	10.2	11.3	11.7	2.4	0.6	4.6	1.8	97.4	0.2	11.7	0.0	329.2	32.4	10.3	17.5	2.2	0.1	40.1	4.8	8.1	10.3	21.8	6.6	12.0	7.5	0.3	0.7	5.1	23.9	5.5	1.0	0.4	9.8	81.3
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 210.0;liver: 408.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 128.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040642	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	210.0	5.9	0.1	0.4	0.1	0.0	95.3	2.7	0.3	0.1	0.0	2.6	0.0	0.1	0.4	0.3	1.0	3.4	18.6	0.2	0.0	4.6	408.9	0.1	0.7	0.0	0.2	0.1	3.6	15.5	0.1	0.0	0.4	0.1	0.2	1.5	48.9	2.3	8.2	33.7	4.6	0.5	0.0	0.1	0.7	0.1	0.0	0.2	5.7	3.3	0.0	0.8	1.1	0.1	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.3	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	2.3	21.1	11.2	0.1	4.3	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.6	0.1	0.4	0.0	2.7	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	2.9	128.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52416373	"Disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.0;Astrocytes: 25.5;Basal respiratory cells: 16.5;Endothelial cells: 29.9;Hepatic stellate cells: 17.2;Microglial cells: 17.8;Spermatocytes: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;HBEC3-KT: 19.9;hTCEpi: 19.0;hTERT-HME1: 19.5;HUVEC TERT2: 40.6;LHCN-M2: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"	No	No		1400000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	10.0	2.0	7.9	1.0	7.4	0.2	8.7	5.5	8.5	5.3	4.5	2.8	0.7	5.2	2.8	3.1	5.1	3.3	9.0	8.2	5.5	3.0	2.2	11.5	2.1	6.0	5.4	2.1	1.4	1.4	3.4	11.3	5.8	4.1	1.4	6.8	3.9	1.9	4.5	6.3	2.7	4.7	5.6	5.9	2.1	2.1	6.4	1.4	5.0	10.4	1.6	3.8	4.5	5.9	0.9	3.9	0.5	3.5	3.1	10.3	0.8	8.4	4.1	3.2	5.1	0.1	0.7	0.3	1.0	19.9	3.1	4.4	0.0	19.9	4.9	9.3	2.9	0.5	0.0	0.0	1.9	2.1	0.6	4.1	19.0	15.4	19.5	1.8	40.6	1.2	0.0	0.3	18.6	0.0	0.7	0.4	0.3	0.2	0.9	0.6	4.3	0.0	4.5	0.2	0.1	0.7	0.2	0.1	0.8	0.2	0.4	0.3	9.6	1.0	1.7	0.0	6.3	0.6	0.1	0.1	1.8	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.4	5.5	8.5	8.2	5.5	6.0	5.4	5.8	5.6	6.4	5.9	22.0	0.0	1.1	25.5	0.9	1.5	1.1	16.5	0.6	8.0	1.5	3.0	3.1	0.0	1.8	1.8	2.1	5.4	3.6	0.3	3.9	0.3	1.4	0.8	1.0	29.9	0.0	0.0	3.5	0.6	1.8	6.4	1.1	0.7	0.0	1.5	17.2	2.0	3.1	0.0	3.1	0.3	0.0	1.6	1.6	0.6	3.4	0.6	5.4	17.8	0.4	1.2	1.0	3.0	0.9	0.4	0.2	3.8	0.6	1.8	0.4	0.8	1.3	3.2	6.6	4.4	2.3	18.5	10.1	1.0	1.6	3.4	0.9	0.6	0.3	0.4
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370365-11832198	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 7.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Bipolar cells: 183.8;Horizontal cells: 208.6;Inhibitory neurons: 494.3;Oligodendrocyte precursor cells: 262.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	54	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.3;HUVEC TERT2: 6.7;REH: 7.1;SH-SY5Y: 10.2;THP-1: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"	NA	NA		6100000	"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	2.4	0.7	2.9	0.7	2.3	0.0	2.1	3.2	4.4	3.3	0.0	1.0	0.3	2.8	0.8	0.5	2.1	2.6	0.7	4.2	3.5	7.5	0.6	1.1	0.3	2.8	4.9	2.5	0.4	1.2	1.6	4.1	2.5	3.4	0.7	5.0	0.5	2.1	0.2	0.5	0.5	2.4	3.4	0.9	0.5	0.8	4.8	0.2	1.9	1.2	0.2	1.8	1.7	2.4	0.0	10.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	7.1	0.0	0.0	0.3	0.1	0.7	10.2	0.0	0.3	0.0	1.6	0.1	19.2	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	3.2	4.4	4.2	3.5	2.8	4.9	2.5	3.4	4.8	2.4	46.9	22.4	8.2	150.5	0.0	2.7	1.4	0.0	1.2	183.8	0.8	0.5	1.5	21.5	2.8	55.2	112.6	23.5	0.1	0.4	7.9	7.0	1.2	4.9	22.4	42.6	41.7	0.0	56.6	2.2	4.3	8.1	0.5	18.8	0.0	6.1	28.2	1.3	2.2	208.6	494.3	0.8	0.0	1.5	2.9	0.5	24.2	0.5	12.4	105.9	0.0	20.7	0.0	262.4	5.4	5.5	6.8	1.5	0.1	7.7	0.1	8.8	0.1	9.3	0.0	10.6	5.0	1.6	1.1	0.6	2.4	51.9	0.8	21.5	1.2	1.1
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677718	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;retina: 19.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 25.0;Horizontal cells: 90.9;Inhibitory neurons: 153.4;Rod photoreceptor cells: 32.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Daudi: 11.0;SCLC-21H: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	1.9	0.0	0.8	0.0	1.2	0.0	0.7	0.6	1.2	0.2	0.1	0.1	0.0	0.2	4.1	0.3	0.9	0.2	0.5	1.2	2.3	0.9	0.1	0.1	0.0	8.2	3.3	0.0	0.0	0.3	0.6	0.2	8.9	0.7	0.0	19.7	0.4	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	1.6	0.8	0.7	0.1	0.0	0.2	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.2	1.2	2.3	8.2	3.3	8.9	0.6	1.6	1.6	1.1	0.0	0.0	2.6	0.0	0.1	0.7	0.0	13.6	1.6	0.1	0.9	0.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	1.9	0.0	3.7	0.5	0.2	0.8	0.0	0.0	9.5	0.0	0.0	0.2	0.0	1.4	0.0	1.7	1.8	0.0	0.0	90.9	153.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	8.4	0.0	1.8	0.0	1.5	7.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	32.2	6.6	0.3	3.3	0.5	0.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	13.6	17.6	29.3	10.4	41.7	8.2	11.0	27.5	33.0	9.4	28.5	11.5	14.2	12.1	15.1	8.5	14.9	9.7	14.8	30.1	27.0	14.4	11.3	9.5	10.6	28.4	27.5	12.6	11.4	19.8	11.1	6.7	27.7	16.0	10.6	13.2	17.3	14.0	23.6	6.9	9.8	11.8	27.9	10.7	10.7	20.1	27.9	11.0	11.5	20.7	10.2	10.2	7.3	29.3	3.9	24.1	11.4	12.4	26.3	14.6	6.3	11.2	9.7	10.7	10.5	4.9	15.9	7.2	9.5	13.1	12.1	11.8	12.1	13.8	7.8	15.9	13.7	10.2	16.9	13.3	13.0	9.1	8.7	20.6	10.2	16.4	12.0	22.9	13.0	11.6	7.7	15.9	15.7	11.6	14.6	3.7	4.1	20.9	20.1	9.9	7.9	13.4	18.9	7.6	22.1	10.6	10.8	22.0	6.6	6.6	14.9	4.4	10.9	7.0	7.4	14.5	6.5	18.9	12.2	4.4	7.3	4.2	10.9	13.7	16.0	8.7	9.8	12.0	9.8	10.2	7.2	7.6	14.7	15.3	11.7	10.2	1.7	8.3	16.1	18.7	6.4	10.9	29.3	41.7	27.5	33.0	30.1	27.0	28.4	27.5	27.7	27.9	27.9	29.3	8.1	6.4	7.5	16.6	14.5	0.0	7.8	0.0	6.8	27.4	12.0	10.7	0.1	8.6	3.7	7.3	8.4	11.0	9.2	7.2	54.8	14.5	21.9	6.7	9.2	6.2	6.1	3.4	11.8	12.4	5.1	9.9	9.2	6.7	23.5	7.7	7.1	10.8	18.4	8.4	23.1	7.5	0.0	7.9	0.0	23.0	11.5	9.8	0.0	4.7	9.9	33.4	14.4	15.1	37.0	8.2	9.6	7.5	11.3	9.3	15.2	38.9	2.9	11.6	13.1	13.2	7.7	57.5	8.3	9.5	0.0	6.7	9.3	14.2	7.7	5.9
THUMPD1	"FLJ20274, Tan1"	ENSG00000066654	"THUMP domain containing 1"	Q9NXG2	16	20702816-20742084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027851	Approved		Approved	Cytosol		NA	NA		9300000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027851: AB_10670036"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.48e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.45e-1)"	"prognostic favorable (8.52e-8)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-2)"	16.0	16.4	10.9	14.4	11.4	21.2	38.3	12.4	14.2	23.0	12.3	23.0	13.3	25.3	28.3	15.2	21.8	15.6	11.4	11.3	12.8	22.8	17.0	16.6	21.0	10.6	10.9	23.5	18.9	30.5	13.8	17.6	10.4	33.4	18.5	20.6	19.6	22.8	17.1	15.7	17.6	24.4	11.2	18.3	23.3	16.4	12.9	20.7	20.2	20.3	20.7	20.0	19.2	12.0	22.4	22.8	41.9	23.7	35.7	31.3	25.2	22.0	22.8	20.7	20.4	17.6	23.2	53.9	42.0	25.0	19.5	21.3	27.7	29.6	32.5	32.0	16.0	49.0	20.5	43.3	23.6	79.2	100.2	25.5	40.0	22.5	25.3	23.8	24.1	24.0	95.7	41.5	23.9	25.3	38.7	32.3	35.3	20.5	14.2	51.6	38.0	43.8	24.4	17.9	31.8	21.7	18.2	32.1	23.4	25.5	22.4	28.4	23.1	28.9	17.1	19.8	21.9	42.6	43.2	38.5	21.9	22.7	24.6	13.3	6.4	19.3	15.3	7.4	19.5	10.7	15.6	15.0	6.4	9.7	19.7	17.7	2.9	14.3	8.3	5.5	12.4	9.4	10.9	11.4	12.4	14.2	11.3	12.8	10.6	10.9	10.4	11.2	12.9	12.0	55.6	41.7	48.5	16.3	66.6	48.4	37.5	27.1	57.5	37.0	62.7	48.8	30.3	42.9	38.2	31.3	20.9	61.0	81.6	35.6	39.2	29.8	5.9	66.2	64.3	47.9	36.5	23.5	25.6	34.4	35.3	45.5	26.5	97.0	72.1	42.7	42.1	45.2	30.0	35.3	24.7	38.3	26.4	34.8	35.2	8.9	41.0	34.3	33.8	20.6	45.5	45.1	55.6	21.1	32.6	27.5	33.8	67.7	41.3	52.0	32.2	49.7	39.8	37.0	46.0	50.9	50.7	44.1	66.3	46.6	55.4	73.1	72.5	25.5	44.9	35.6
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	2.4	2.0	2.6	0.5	2.5	1.7	2.1	2.9	3.0	1.9	2.6	1.9	0.5	1.7	0.2	3.5	1.5	0.5	3.3	2.6	2.6	2.4	2.3	2.2	1.4	2.6	2.8	3.2	2.2	0.5	2.3	0.4	2.6	2.0	0.7	0.4	2.1	0.4	6.0	2.5	2.0	0.4	2.4	2.5	2.2	0.9	2.6	2.0	2.1	4.0	1.5	2.1	2.4	2.8	4.9	4.7	1.0	6.5	2.3	3.3	2.7	1.3	2.5	3.0	3.1	5.0	4.5	7.8	2.7	1.6	7.6	2.0	9.7	4.4	3.2	13.1	10.8	4.7	3.0	5.7	4.1	6.3	2.4	3.9	3.2	3.1	1.0	2.9	4.9	1.5	5.9	1.8	6.1	2.3	3.3	5.0	0.0	13.0	2.9	3.4	4.2	5.4	2.9	2.6	5.7	3.1	1.3	5.6	3.2	0.4	1.8	3.9	2.5	4.0	2.5	1.1	3.6	2.4	3.1	5.1	2.0	11.4	3.2	0.0	0.6	0.0	0.1	0.4	0.6	0.7	0.4	0.1	0.5	0.3	0.6	0.4	0.1	0.4	0.1	0.9	0.1	0.6	2.6	2.5	2.9	3.0	2.6	2.6	2.6	2.8	2.6	2.4	2.6	2.8	17.4	25.6	20.6	26.8	17.8	14.3	29.0	19.5	15.9	26.8	14.4	29.8	23.7	8.6	20.3	14.7	18.8	11.5	23.0	7.2	19.6	16.6	4.5	7.5	16.9	13.7	9.6	23.8	42.2	13.7	13.6	18.4	17.9	10.9	7.0	19.2	10.0	9.9	11.3	6.7	41.6	8.1	8.2	10.9	7.7	4.0	28.0	10.0	5.4	45.0	11.8	12.1	15.5	45.2	30.3	16.7	17.1	25.6	8.2	23.7	10.3	16.4	10.9	21.1	6.6	20.5	16.0	9.1	19.7	16.9	13.5	6.8	12.6	22.2	13.5	22.7
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362971-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	14.5	15.5	10.1	15.0	11.5	33.0	18.0	12.7	11.0	18.1	14.0	19.1	16.8	16.3	16.7	20.9	14.7	13.6	24.6	9.9	11.7	20.0	23.4	14.2	18.8	11.2	10.6	14.7	15.5	25.8	12.1	15.1	12.0	19.5	19.0	22.0	15.9	17.9	26.9	13.6	14.3	14.4	11.6	14.3	14.1	59.4	10.9	18.3	23.1	26.4	17.7	16.4	9.6	15.2	40.0	53.0	36.4	18.7	46.5	44.4	146.3	47.2	38.3	47.1	35.8	40.2	41.0	41.0	35.8	43.5	74.1	26.0	66.4	48.3	47.9	45.6	39.1	51.0	51.2	35.3	44.8	66.0	35.3	36.2	53.7	55.7	58.1	38.0	31.5	65.1	80.2	58.2	62.9	55.3	78.9	27.2	69.3	44.0	50.1	49.4	62.7	57.9	29.7	60.4	15.5	48.9	39.6	27.5	43.5	37.2	45.2	42.1	22.8	45.0	38.9	54.9	53.1	73.1	186.7	129.2	55.0	60.5	65.7	19.1	17.8	17.6	20.5	23.4	26.2	17.2	17.6	21.9	20.8	20.0	28.0	21.5	3.6	17.7	29.0	20.5	18.4	14.1	10.1	11.5	12.7	11.0	9.9	11.7	11.2	10.6	12.0	11.6	10.9	15.2	14.9	25.6	21.8	10.1	14.0	10.7	29.3	42.6	16.5	21.6	19.5	23.2	45.3	17.2	34.6	22.0	16.7	34.7	13.1	10.0	52.8	39.2	270.0	19.2	26.8	14.9	3.0	9.7	9.7	29.4	28.4	22.3	12.2	20.9	28.4	21.9	13.2	25.3	27.4	38.7	13.2	15.5	38.7	14.8	6.8	145.3	20.5	18.0	12.4	9.4	20.2	31.4	18.6	18.1	12.5	28.2	9.8	25.9	16.2	32.6	10.9	32.6	20.1	35.2	6.6	28.5	24.5	183.5	52.9	18.9	12.9	27.5	18.4	49.2	20.0	20.9
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: AB_2676183"	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	42.3	40.5	74.2	22.0	75.4	43.3	45.1	74.4	104.9	39.8	68.5	53.9	30.2	43.1	75.8	28.1	47.6	31.1	51.7	75.9	76.2	40.1	57.5	28.3	40.5	72.2	71.3	62.9	32.8	27.9	50.8	22.2	73.2	50.1	44.9	41.3	29.6	54.2	32.3	28.1	36.3	42.3	72.5	36.6	39.4	42.6	74.9	77.1	52.1	38.0	44.5	44.3	33.1	76.6	32.0	19.5	69.8	56.0	65.9	74.7	41.0	26.9	59.2	62.0	58.1	106.8	76.3	60.0	88.6	37.8	66.6	48.9	106.8	82.0	60.5	61.5	30.3	165.5	25.7	97.6	94.3	133.0	52.4	56.9	43.2	73.9	48.2	80.6	98.9	199.0	78.1	28.0	56.5	17.7	155.1	242.8	81.0	127.0	71.0	72.3	51.8	50.6	86.4	55.4	66.4	53.7	55.8	13.6	33.1	50.3	78.2	66.5	52.7	26.6	41.3	24.4	41.7	31.4	35.0	126.9	39.5	170.6	31.5	185.4	89.8	330.3	145.2	108.4	175.6	122.1	152.3	146.8	99.1	96.4	175.4	200.0	47.2	139.1	104.4	131.3	199.8	160.0	74.2	75.4	74.4	104.9	75.9	76.2	72.2	71.3	73.2	72.5	74.9	76.6	41.9	32.1	28.8	8.1	31.1	23.8	42.2	107.4	28.5	28.6	37.5	65.4	52.1	47.1	57.7	36.8	14.6	52.7	33.5	25.5	86.1	48.2	28.2	44.7	33.8	36.9	57.6	40.8	15.3	55.6	52.9	42.3	20.4	23.4	40.5	65.5	37.1	47.9	53.0	28.6	12.0	47.9	75.3	22.2	23.7	16.0	50.4	32.7	40.9	8.4	43.1	65.7	44.3	11.1	11.1	53.2	33.0	48.5	29.8	13.4	49.3	93.3	73.1	23.9	46.0	34.0	51.3	79.1	94.9	31.4	20.6	13.8	44.1	72.7	52.7	31.6
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIAM2	STEF	ENSG00000146426	"TIAM Rac1 associated GEF 2"	Q8IVF5	6	154832697-155257723	"Metabolic proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.4;non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 36.9"	"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.4	1.2	2.8	0.9	7.1	0.4	1.2	5.4	11.8	1.1	0.0	1.2	8.3	0.8	0.6	0.6	0.8	2.2	2.2	6.1	0.0	0.3	0.3	0.5	1.2	0.4	1.0	0.3	1.3	0.1	1.4	0.5	0.0	2.0	0.8	3.3	1.3	2.7	2.5	0.6	7.9	1.1	0.4	0.7	3.0	13.3	0.8	0.6	5.5	1.7	2.0	2.0	0.7	6.1	8.3	1.5	65.7	6.1	2.9	7.9	0.4	3.2	2.2	3.3	5.5	0.7	4.8	1.1	3.1	6.3	0.9	0.5	2.4	0.0	2.3	27.8	3.3	0.0	1.1	1.9	1.8	0.2	1.7	5.4	0.2	1.1	0.2	2.5	4.7	0.5	0.2	0.1	7.5	0.5	0.7	0.7	4.1	0.1	1.3	8.4	43.3	0.3	0.2	0.2	1.1	14.5	0.1	0.3	0.2	11.9	0.3	0.6	1.5	0.2	15.5	0.4	1.5	0.2	3.6	0.2	0.0	0.3	3.9	0.0	0.0	2.1	0.0	2.0	0.0	2.0	0.1	0.1	0.3	0.7	0.0	0.0	6.4	0.4	9.5	0.0	1.2	0.1	2.8	7.1	5.4	11.8	6.1	0.0	0.4	1.0	0.0	0.4	0.8	6.1	2.9	3.2	2.6	8.8	9.6	3.1	22.5	2.8	1.8	14.3	3.3	5.3	8.3	7.2	2.1	1.8	81.3	1.8	4.3	2.2	0.0	5.3	141.5	8.3	4.9	2.7	0.0	3.6	74.2	3.1	2.6	4.4	6.1	12.1	19.7	6.8	11.0	1.5	1.9	23.5	31.4	3.9	6.1	2.2	2.2	347.4	9.9	5.2	12.4	4.7	9.8	7.6	4.1	28.6	5.1	5.9	5.8	7.9	13.3	9.6	23.9	1.0	3.3	23.9	0.0	7.0	4.3	6.7	7.3	2.1	2.6	0.4	5.0	5.3	3.9	11.6
TICAM1	"MGC35334, PRVTIRB, TICAM-1, TRIF"	ENSG00000127666	"Toll like receptor adaptor molecule 1"	Q8IUC6	19	4815932-4831712	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.9;Paneth cells: 146.3;Urothelial cells: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042460, HPA055421"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA042460: AB_10806240, HPA055421: "	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.60e-3)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.86e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.48e-2)"	12.8	6.4	4.5	6.7	5.0	15.0	11.2	3.1	7.5	14.0	2.3	13.1	14.4	9.3	1.1	45.6	9.4	7.0	10.3	4.7	4.9	13.9	20.1	16.5	6.9	5.1	5.1	7.3	10.3	2.9	6.1	4.4	4.7	9.4	3.2	0.4	13.5	3.3	19.7	21.5	14.5	3.3	4.6	11.9	15.7	1.8	5.1	2.6	8.2	4.1	4.4	10.1	17.4	4.5	34.9	6.7	0.1	5.8	4.9	6.2	3.1	11.2	11.4	8.8	9.8	6.9	12.2	23.5	6.2	12.9	8.8	23.1	3.2	11.8	3.4	25.4	6.2	5.9	13.7	6.7	13.5	2.1	14.7	10.1	14.4	11.0	8.0	6.8	9.2	8.1	12.9	4.9	4.8	13.0	6.0	1.2	1.0	6.2	26.5	13.2	1.4	15.4	8.0	10.7	4.6	8.5	6.9	20.4	11.4	0.0	9.2	4.9	18.5	10.7	7.3	27.4	17.1	19.6	18.5	16.7	12.5	8.1	8.4	6.8	4.1	1.8	1.7	5.4	1.5	3.4	1.7	2.0	3.6	2.8	1.1	0.7	1.2	1.2	7.1	2.5	2.1	5.1	4.5	5.0	3.1	7.5	4.7	4.9	5.1	5.1	4.7	4.6	5.1	4.5	10.5	6.4	9.6	3.9	12.4	69.3	67.0	20.0	23.9	0.9	19.4	13.6	2.5	21.5	18.5	5.5	0.0	6.3	3.7	156.9	7.9	29.9	0.1	27.0	7.6	14.4	29.2	4.2	3.9	17.5	11.7	11.0	42.3	56.2	10.8	4.6	11.7	13.4	12.8	1.7	3.2	39.2	10.2	14.0	52.6	0.3	3.7	22.1	14.2	1.9	17.7	0.8	7.2	3.0	1.4	51.8	146.3	5.3	18.6	57.5	55.8	9.2	16.3	0.2	6.6	4.6	5.8	0.3	1.4	27.3	71.2	3.4	9.8	3.4	26.2	134.3
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274537-112285904	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 86.6;Syncytiotrophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 137.4;U-698: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	6.4	6.3	2.0	19.9	1.8	40.6	13.7	4.3	2.1	7.7	4.3	7.0	6.7	5.6	2.1	15.6	6.8	7.5	10.7	2.3	2.4	5.2	11.3	10.2	32.2	2.3	2.1	9.3	41.3	11.5	2.1	14.2	2.5	6.7	6.9	2.8	34.8	3.7	3.8	9.3	8.8	5.3	2.1	11.7	10.3	2.1	2.3	15.4	21.1	6.4	34.6	11.6	7.7	2.3	21.9	5.5	7.9	13.4	9.5	7.7	15.9	17.0	32.0	10.6	18.1	2.8	19.1	66.3	13.5	6.8	15.5	6.3	10.9	13.0	22.1	54.1	6.4	6.6	12.4	6.2	6.4	21.2	8.8	10.4	7.0	11.4	12.3	18.0	17.0	18.1	6.8	137.4	14.3	11.0	37.3	11.5	1.6	13.4	7.0	63.7	19.9	44.7	23.6	14.7	18.1	18.6	13.7	28.2	6.6	3.4	12.2	29.9	12.7	16.7	19.8	14.2	13.6	85.3	84.8	123.8	15.7	13.8	12.6	6.8	7.2	4.0	11.1	5.2	18.1	38.2	20.4	19.4	13.2	40.4	9.0	11.6	21.4	17.4	6.8	12.3	33.9	11.3	2.0	1.8	4.3	2.1	2.3	2.4	2.3	2.1	2.5	2.1	2.3	2.3	35.7	19.2	27.4	0.0	44.8	21.3	15.7	27.8	43.9	1.4	31.6	30.9	15.4	12.8	15.7	12.9	0.0	47.9	23.4	4.4	19.6	16.5	0.1	10.0	9.6	31.8	9.0	7.6	1.4	24.4	20.9	22.3	14.8	21.0	3.8	5.4	6.4	10.7	17.8	0.0	0.6	8.4	28.5	13.0	29.7	1.4	9.0	13.1	33.8	2.8	7.1	12.5	11.3	0.5	0.1	11.4	8.0	10.9	86.6	29.2	11.0	9.5	8.8	0.6	6.6	27.2	10.5	2.5	3.8	39.2	26.0	79.4	35.9	5.7	7.0	15.1
TIFAB		ENSG00000255833	"TIFA inhibitor"	Q6ZNK6	5	135444226-135452351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"myeloid DC: 4.5;plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 13.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049372	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA049372: AB_2680733"	"unprognostic (1.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.87e-1)"	"unprognostic (3.25e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.01e-2)"	0.1	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.9	1.0	0.1	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.5	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.9	1.0	0.2	0.0	2.6	0.7	0.3	0.0	1.9	0.0	0.0	4.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	17.6	9.2	0.0	2.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4360028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814"	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	3.8	5.4	1.4	1.9	1.6	1.9	2.9	1.9	3.0	1.8	1.8	3.7	0.7	2.8	1.2	3.7	2.3	1.4	5.0	2.2	1.6	4.2	3.1	3.7	2.0	1.9	2.0	1.1	2.0	0.9	5.3	1.4	2.1	2.8	1.7	2.3	3.0	1.7	5.8	2.5	3.6	2.1	2.1	5.3	3.3	3.5	1.9	1.7	2.3	2.0	1.9	3.5	2.4	2.3	4.1	9.9	4.8	7.7	10.9	6.3	47.3	9.3	8.0	5.3	7.3	5.7	3.8	4.1	0.7	5.8	5.2	5.7	5.8	7.6	7.0	3.8	2.9	0.1	4.7	7.8	14.3	2.1	0.5	8.1	12.9	5.9	6.8	3.2	14.5	3.4	0.3	2.2	9.2	7.7	2.2	0.8	8.6	5.5	1.7	3.0	6.4	1.0	6.7	5.0	0.2	2.8	7.9	3.2	10.1	22.0	0.8	1.6	10.5	8.2	5.9	5.6	3.8	1.4	2.1	6.9	5.4	0.8	5.7	0.5	1.7	0.2	0.7	3.5	0.5	0.9	0.7	0.8	1.9	1.3	0.6	0.7	1.5	0.8	3.4	1.6	1.4	0.6	1.4	1.6	1.9	3.0	2.2	1.6	1.9	2.0	2.1	2.1	1.9	2.3	10.7	0.0	1.7	0.0	14.7	0.0	13.8	0.0	5.7	4.2	6.2	7.5	10.5	1.5	0.0	5.5	18.8	27.4	16.9	5.0	15.6	15.6	28.0	4.7	5.9	9.4	7.3	1.3	0.0	13.9	28.5	6.6	11.7	4.8	0.0	4.5	5.0	5.6	59.3	1.7	0.0	1.5	0.0	20.4	0.0	27.8	3.7	30.6	0.0	0.0	34.9	11.5	7.2	0.0	0.0	17.5	2.6	4.5	16.3	9.5	2.9	11.7	0.0	3.3	6.6	5.7	8.3	19.9	22.3	8.1	0.0	34.3	11.8	10.8	2.3	15.6
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232543883-232550557	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies"	"HPA041717: AB_2677636"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	1.8	2.3	6.3	2.3	5.3	6.5	2.7	13.4	7.8	3.2	5.4	2.8	1.9	2.6	2.9	2.8	3.8	1.9	2.4	5.0	4.5	7.4	2.7	2.5	3.4	3.2	2.4	5.7	2.9	1.6	5.0	2.0	4.1	4.4	2.1	10.4	2.7	1.7	4.0	4.2	3.6	1.3	1.5	6.1	3.3	5.2	4.5	3.3	4.7	1.4	2.2	2.8	3.0	9.7	3.1	2.3	4.7	7.5	1.7	2.3	3.6	2.1	1.2	2.6	2.9	2.8	3.6	5.0	1.5	1.6	2.8	3.2	4.1	1.3	3.8	3.0	3.9	4.5	7.7	3.5	1.1	3.6	2.9	2.6	1.2	2.6	1.6	2.5	1.5	6.5	3.6	5.0	2.1	5.3	4.9	8.3	2.8	1.9	2.7	4.7	6.3	2.3	1.5	3.5	6.1	6.0	2.2	2.1	2.3	3.3	3.1	3.9	2.5	4.3	4.5	2.7	2.1	4.8	3.4	4.5	2.5	3.6	2.6	1.6	1.7	1.8	1.9	1.4	1.9	1.7	2.0	1.5	1.1	2.1	3.1	2.5	2.3	1.8	1.5	1.2	1.6	0.7	6.3	5.3	13.4	7.8	5.0	4.5	3.2	2.4	4.1	1.5	4.5	9.7	2.4	9.6	3.9	4.2	5.3	1.3	4.5	2.3	1.8	4.9	2.5	2.2	2.0	1.5	2.9	3.7	8.4	2.2	3.1	1.7	0.0	3.6	4.2	1.0	3.6	1.7	1.2	6.5	4.5	1.5	1.3	3.1	7.7	1.5	0.0	6.4	1.4	0.7	1.4	6.7	5.7	1.5	2.0	1.6	1.7	0.7	4.7	2.4	1.8	1.0	2.8	7.5	5.2	5.0	8.1	2.0	2.4	1.9	5.6	2.6	3.5	1.4	1.7	7.0	6.6	3.7	2.0	3.9	5.7	3.7	2.0	1.4	4.1	4.0	3.0	2.9
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111533-89114901	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 25.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.9;Hepatocytes: 21.0;Syncytiotrophoblasts: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.02e-4)"	2.8	1.9	1.9	3.2	1.9	2.5	10.4	4.7	2.1	3.9	3.9	3.4	6.8	2.4	4.0	2.7	1.7	2.8	1.6	1.7	2.4	5.4	25.4	3.1	4.5	2.0	2.5	2.1	3.6	7.1	3.5	8.6	2.1	3.8	4.1	13.2	10.7	2.5	1.9	2.4	4.8	1.9	1.8	3.5	4.4	3.7	2.4	5.5	5.6	3.1	4.5	3.0	2.7	2.3	15.2	7.0	7.5	9.0	8.1	6.2	3.3	9.0	11.0	8.5	7.1	14.1	14.4	7.3	4.7	3.6	6.1	4.7	8.2	13.8	11.4	12.7	2.6	8.6	7.7	6.8	24.0	4.0	5.9	15.4	13.4	3.4	12.2	7.9	3.2	9.6	11.1	12.3	10.6	5.8	7.6	4.6	9.0	16.2	2.3	11.5	13.1	10.0	7.4	28.7	35.6	7.2	8.8	27.8	11.5	9.9	9.8	8.1	2.5	10.9	10.1	3.5	6.9	19.7	6.4	5.5	9.6	7.0	9.4	11.7	1.3	0.1	1.9	1.9	0.9	1.2	0.9	1.4	1.5	1.0	0.9	1.4	0.0	2.2	1.0	0.2	1.0	0.9	1.9	1.9	4.7	2.1	1.7	2.4	2.0	2.5	2.1	1.8	2.4	2.3	1.9	0.0	0.5	1.3	1.8	0.3	5.9	1.7	7.4	4.5	4.9	3.3	3.5	7.2	5.5	3.7	10.4	15.9	1.3	1.2	1.9	2.7	1.4	6.3	3.0	2.6	2.4	1.7	1.3	5.7	10.5	1.7	4.6	6.3	0.0	2.8	2.2	21.0	4.9	0.0	1.9	2.9	0.0	2.4	1.1	0.8	1.5	3.5	0.0	0.0	4.3	2.7	1.0	1.5	2.3	3.8	1.9	1.2	2.4	2.3	8.3	10.2	1.5	7.2	0.0	1.5	2.7	2.3	8.0	3.6	0.4	39.0	2.5	2.1	3.2	1.6
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779730	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 22.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 107.6;Rod photoreceptor cells: 30.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.2	0.3	0.6	0.2	0.7	0.0	0.4	0.6	0.7	0.8	1.3	0.2	0.3	0.7	1.2	0.1	2.0	0.2	0.3	0.5	0.9	0.7	0.1	0.4	0.1	1.1	1.2	0.5	0.2	1.5	1.2	0.1	0.8	0.4	0.2	22.1	0.7	0.3	0.4	0.4	0.2	0.2	1.0	0.2	0.3	4.9	0.8	0.3	0.7	0.8	0.1	0.2	0.1	0.8	0.4	0.4	2.0	0.8	0.1	0.2	0.2	0.0	0.4	0.2	0.4	0.3	0.9	0.7	0.1	0.1	0.9	0.4	0.8	0.3	0.3	0.7	0.1	1.0	0.6	0.2	0.1	0.4	0.2	0.0	0.3	0.3	0.2	0.4	0.1	1.5	0.3	3.1	0.2	0.2	2.0	0.2	0.9	0.3	0.3	0.3	0.4	0.0	1.3	0.1	0.9	1.0	0.1	0.2	1.9	0.9	0.5	0.1	0.0	0.2	0.4	0.3	0.4	4.5	9.4	0.4	0.6	1.1	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.8	0.4	0.0	1.5	8.5	0.6	0.0	0.4	0.6	0.6	7.9	0.8	0.8	0.1	0.0	0.3	1.8	12.5	0.2	0.8	0.2	0.0	0.7	107.6	6.9	0.6	0.7	1.2	0.4	6.5	1.1	0.2	0.4	1.1	1.4	0.0	0.2	0.0	0.1	0.5	1.7	6.3	0.4	0.0	0.3	0.0	14.0	0.3	0.5	0.0	5.6	0.0	14.1	0.0	5.5	2.1	0.4	1.1	0.4	0.0	0.4	0.4	2.0	9.3	30.3	0.0	1.0	0.5	8.3	3.2	0.0	0.0	0.3	0.6	0.1	0.4	0.3
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150000654	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	2.6	3.6	2.1	1.7	2.4	1.3	4.7	2.7	2.4	2.5	2.6	2.8	2.2	2.4	5.1	1.7	3.1	2.3	2.0	2.0	2.3	3.6	2.8	2.4	1.9	2.2	2.3	3.9	3.2	11.2	2.6	2.6	2.2	4.1	2.5	3.5	3.1	3.0	1.4	2.7	2.0	2.6	2.1	2.1	2.9	4.0	2.2	2.3	3.0	2.2	2.0	2.4	1.7	2.5	2.1	5.7	3.8	8.2	10.7	8.8	5.9	6.0	6.3	4.6	4.6	3.7	3.7	1.0	5.3	7.1	5.7	3.7	3.4	4.4	5.4	4.7	2.8	1.8	3.1	2.0	9.5	2.6	4.4	9.0	8.3	5.9	7.7	5.4	3.6	4.1	2.5	4.7	5.8	5.0	3.4	1.2	1.5	2.7	4.8	3.9	4.3	2.7	4.4	3.0	2.9	3.8	4.2	6.7	9.1	4.6	7.5	4.5	4.9	3.7	2.8	4.1	4.5	3.5	1.4	2.7	5.9	2.8	5.9	0.0	2.2	1.2	1.5	2.3	1.3	1.4	2.0	1.5	1.9	1.7	4.2	2.6	0.0	3.4	1.3	1.0	2.2	1.5	2.1	2.4	2.7	2.4	2.0	2.3	2.2	2.3	2.2	2.1	2.2	2.5	3.1	12.8	2.7	1.3	2.2	2.2	6.6	2.9	2.2	6.2	5.4	3.7	5.4	4.3	4.7	3.7	0.0	5.2	2.6	2.0	7.9	5.1	1.2	2.9	3.5	2.7	3.0	0.4	1.4	4.7	2.7	3.5	7.1	3.6	3.8	4.6	3.3	1.8	4.2	3.3	1.6	2.6	6.1	1.9	1.9	2.1	4.4	2.6	3.6	2.8	4.8	6.3	1.0	4.5	5.6	4.3	1.9	3.4	3.8	5.7	3.1	7.9	3.6	6.3	0.0	2.1	3.8	20.0	8.7	2.6	1.1	3.6	2.2	6.8	2.0	4.9
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298808-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	2.9	3.3	5.1	1.8	5.1	0.6	4.7	6.0	6.1	5.1	7.0	4.9	1.8	5.5	4.5	1.9	5.1	2.6	5.3	4.9	5.6	6.0	3.1	2.8	3.4	5.2	5.6	10.6	2.8	6.5	8.2	3.2	5.5	5.6	1.9	5.1	2.7	5.0	4.2	2.1	2.8	3.5	5.0	4.8	2.7	8.5	5.2	3.7	6.7	5.3	3.0	4.1	3.4	5.7	0.9	1.9	5.5	3.0	2.4	3.6	4.2	2.7	1.6	4.0	3.7	0.2	1.7	2.0	4.5	2.0	3.3	0.5	1.8	0.7	5.0	0.2	2.7	5.9	1.7	0.1	2.8	1.0	7.5	3.9	1.3	3.7	1.1	4.7	3.1	1.4	2.9	3.5	3.4	1.2	1.9	9.0	6.3	0.6	5.1	10.2	1.3	8.3	2.2	0.5	7.1	2.6	6.8	0.9	2.7	4.8	3.2	3.3	1.2	2.6	6.2	2.7	1.6	7.5	8.3	6.5	1.5	3.4	2.9	0.5	0.6	3.4	1.5	0.5	2.7	0.6	1.2	2.3	0.5	2.5	2.4	1.7	2.1	2.0	1.7	0.5	1.4	0.7	5.1	5.1	6.0	6.1	4.9	5.6	5.2	5.6	5.5	5.0	5.2	5.7	1.7	9.6	4.5	11.4	4.9	0.8	3.2	2.1	4.0	6.1	2.4	2.4	9.9	4.3	4.4	0.0	4.2	1.5	1.6	0.6	3.9	2.8	4.7	2.3	3.8	2.3	1.2	2.5	14.6	1.4	1.1	2.6	4.6	1.7	1.3	5.9	0.4	0.6	0.9	5.0	12.7	1.0	4.1	0.6	0.8	2.0	2.8	1.1	5.4	2.8	0.9	3.4	4.1	20.6	12.1	1.1	0.1	4.5	2.0	2.3	1.0	0.9	2.9	2.2	6.6	3.1	3.6	11.6	10.5	2.1	0.6	1.4	2.9	3.8	0.6	1.5
TIMD4	TIM4	ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919292-156963226	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 55.3;testis: 144.0"	"Group enriched"	"Detected in some"	23	"Early spermatids: 1336.2;Late spermatids: 1946.7"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.6;naive CD8 T-cell: 1.6;T-reg: 4.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.0"	"Group enriched"	"Detected in some"	18	"U-266/70: 96.7;U-266/84: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015625, CAB026027"	Approved		Approved	"Plasma membrane"		NA	NA		32000000	"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	14.9	0.4	0.4	6.9	0.3	16.1	0.4	0.3	1.4	0.1	1.8	1.1	0.4	0.0	1.3	0.1	0.1	1.3	0.7	0.5	0.4	3.4	16.3	1.6	55.3	0.5	0.4	0.0	0.2	0.1	0.0	5.0	0.5	0.3	0.8	0.0	0.2	0.0	0.1	0.3	1.7	1.0	0.3	8.0	0.2	144.0	0.5	22.4	1.1	0.0	17.4	4.8	0.1	0.5	0.1	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	96.7	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.3	2.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	4.0	0.7	0.4	0.3	0.3	1.4	0.5	0.4	0.5	0.4	0.5	0.3	0.5	0.5	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.4	5.9	0.1	1336.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.7	0.3	46.4	0.0	0.3	0.0	0.0	69.4	1.9	1946.7	14.9	1.9	0.0	2.8	0.0	0.0	1.0	0.0	0.3	0.0	0.0	10.9	6.5	0.0	0.0	0.8	0.0	0.0	13.1	0.0	0.1	16.6	8.1	0.0	0.0	0.3	1.7	0.1	0.1	0.0
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528464-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria		NA	NA		16000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	40.5	41.6	55.1	28.5	56.9	34.8	42.5	56.3	68.3	24.8	53.2	35.5	27.0	27.2	43.8	44.1	25.1	20.3	60.9	56.7	57.4	50.7	77.6	27.9	45.8	55.8	55.6	25.5	33.6	45.1	29.2	21.7	56.1	31.0	35.9	15.1	28.0	30.2	77.8	33.7	27.8	27.5	58.5	37.9	35.3	35.6	56.1	38.5	29.7	67.7	50.1	33.7	27.2	58.0	115.6	171.9	79.1	76.0	67.6	57.2	99.7	96.6	77.0	151.1	85.9	127.6	97.9	218.1	108.0	86.5	131.4	86.3	114.0	112.6	136.4	74.8	84.9	139.4	67.0	167.5	71.3	183.3	148.0	54.2	89.6	146.1	101.4	40.0	95.2	142.8	157.1	96.7	112.7	241.1	99.4	243.5	83.4	99.9	184.4	163.5	167.0	190.3	77.6	78.2	64.0	82.2	101.5	198.6	128.6	77.7	150.1	69.3	60.2	86.0	160.5	150.6	188.1	133.2	192.6	176.1	79.2	91.3	146.2	30.9	88.3	20.9	71.5	84.2	81.6	187.6	86.4	79.0	146.4	179.0	118.0	103.6	4.9	67.3	81.3	146.6	84.0	145.1	55.1	56.9	56.3	68.3	56.7	57.4	55.8	55.6	56.1	58.5	56.1	58.0	53.2	12.8	11.0	3.9	66.4	122.9	42.9	94.5	54.1	16.9	103.1	142.2	124.1	78.6	45.6	44.1	4.2	68.0	52.5	78.2	211.3	84.1	134.7	36.7	28.1	55.8	27.0	56.8	3.2	125.6	88.2	42.0	24.5	39.1	52.6	30.1	40.4	212.3	125.9	8.4	3.9	61.0	48.8	71.7	100.3	284.7	46.3	52.9	81.8	3.7	103.2	55.0	56.7	3.0	5.6	85.3	63.5	51.1	51.5	102.4	120.3	227.3	23.2	15.5	13.1	50.5	71.3	85.9	52.8	78.1	129.7	39.5	42.2	37.7	92.6	52.4
TIMM10B	"FXC1, TIM10B, Tim9b"	ENSG00000132286	"Translocase of inner mitochondrial membrane 10B"	Q9Y5J6	11	6481501-6484681	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052265	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA052265: AB_2681778"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.19e-10)"	"unprognostic (9.92e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.42e-1)"	16.5	24.0	12.1	14.2	13.3	16.9	18.1	14.4	16.8	18.5	11.4	22.6	17.0	21.6	21.9	17.0	19.4	14.8	16.1	11.5	15.6	27.5	20.3	17.7	17.2	18.7	18.2	21.6	24.5	28.9	19.2	17.3	18.4	21.9	18.6	18.2	18.2	20.1	12.4	15.5	17.6	18.8	13.3	18.4	22.7	12.9	14.6	13.9	26.6	11.3	16.8	20.6	15.8	16.9	21.7	11.8	25.6	24.4	30.6	31.1	17.8	21.2	29.4	26.3	30.1	21.7	43.5	21.8	14.8	24.7	32.7	28.5	23.8	32.3	25.4	22.0	23.3	28.6	23.8	25.0	34.3	39.6	31.1	30.9	36.0	16.8	26.4	16.9	19.7	29.1	51.5	40.2	25.3	17.2	38.7	20.9	39.5	33.8	21.1	28.8	17.2	21.4	32.8	30.4	27.2	29.5	25.0	36.1	35.9	16.7	23.1	28.4	20.7	28.4	20.2	22.9	14.8	36.3	39.9	33.3	27.4	29.2	31.0	17.2	28.9	25.8	36.5	29.8	38.5	36.0	32.6	34.8	26.7	37.9	45.2	39.6	6.5	36.0	25.2	32.9	28.6	39.6	12.1	13.3	14.4	16.8	11.5	15.6	18.7	18.2	18.4	13.3	14.6	16.9	18.7	19.2	24.1	3.9	28.5	29.1	44.8	32.2	19.4	26.2	24.1	19.3	21.0	0.0	28.2	18.4	25.0	29.5	28.0	23.3	58.7	24.4	19.8	17.1	17.7	16.9	31.0	12.6	8.6	29.7	29.5	22.6	10.2	20.6	31.1	21.1	0.0	0.0	29.3	11.8	9.9	34.5	30.5	0.0	18.9	10.9	18.3	19.1	23.2	5.6	28.7	21.8	44.3	7.5	11.7	29.3	26.9	21.1	21.6	41.7	25.0	34.0	35.8	31.2	26.3	14.9	24.1	49.0	35.2	24.0	31.1	40.2	22.5	33.3	27.2	63.7
TIMM13	"Tim13, TIMM13B"	ENSG00000099800	"Translocase of inner mitochondrial membrane 13"	Q9Y5L4	19	2425625-2427586	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048985	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoli fibrillar center"	"HPA048985: AB_2680589"	"unprognostic (5.47e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.15e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (8.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.91e-2)"	"prognostic favorable (3.88e-5)"	"unprognostic (4.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.47e-2)"	59.3	129.0	52.4	26.6	53.7	34.5	50.1	55.2	74.7	46.3	54.0	68.2	51.1	40.9	11.4	105.8	43.9	15.8	91.2	51.9	54.0	96.9	142.8	42.5	26.6	54.8	55.8	54.0	97.6	32.4	49.8	24.9	54.2	64.7	16.4	6.0	51.1	12.1	87.4	75.8	52.0	11.7	53.6	64.9	67.4	58.3	58.1	31.0	54.2	42.4	15.6	48.1	56.9	53.7	132.4	135.2	48.3	95.8	26.7	26.7	66.3	75.2	26.2	54.3	39.6	196.5	65.2	79.0	26.2	25.1	39.7	95.5	75.2	102.2	15.0	73.2	265.8	66.4	140.2	151.9	76.2	129.1	68.8	62.7	54.3	59.5	40.5	36.9	65.6	102.2	136.4	114.8	22.0	54.7	153.1	176.2	135.5	106.9	196.1	113.8	38.8	212.2	53.5	111.4	178.8	164.4	34.1	137.0	89.6	21.5	91.5	141.0	62.4	63.6	71.3	120.1	152.9	179.5	100.4	85.5	65.4	175.3	98.7	40.2	162.0	51.3	62.5	158.5	77.6	98.8	71.0	65.8	149.5	92.3	87.7	76.3	10.5	99.8	95.8	334.7	78.1	124.3	52.4	53.7	55.2	74.7	51.9	54.0	54.8	55.8	54.2	53.6	58.1	53.7	75.4	51.3	77.8	9.8	88.9	233.0	146.9	266.3	97.9	40.9	249.6	291.6	147.5	144.4	136.6	130.6	4.2	330.2	118.6	325.8	420.7	251.8	67.5	85.9	146.9	116.9	192.0	103.2	10.1	385.7	435.1	126.9	126.9	101.1	61.6	230.5	99.2	411.8	317.2	26.9	13.5	348.1	189.2	162.7	140.3	121.4	128.6	104.0	225.9	4.7	150.2	91.2	90.6	8.0	15.3	325.5	214.8	98.9	91.0	221.9	359.7	638.8	84.2	43.7	52.6	105.7	156.2	106.0	144.8	195.2	276.2	284.2	60.4	454.8	425.6	189.3
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955503-201970664	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	31.4	48.3	29.3	35.4	30.6	36.8	29.3	31.2	35.8	27.4	34.9	35.2	31.4	25.7	41.1	31.9	20.9	19.0	72.2	31.3	32.5	42.2	80.6	23.7	30.9	30.2	30.6	18.5	23.4	55.8	24.8	31.3	31.0	25.0	38.0	33.3	23.0	28.4	86.1	20.9	23.9	35.3	30.5	24.9	29.1	19.7	30.7	30.3	38.2	94.9	35.8	42.8	23.2	29.4	89.1	88.9	78.5	94.9	64.5	67.2	132.5	138.4	98.0	110.5	98.4	104.8	89.7	122.5	49.7	118.6	81.1	69.2	145.3	82.4	118.3	90.4	90.7	67.7	119.1	99.7	66.7	145.5	69.5	78.0	89.8	113.2	93.9	79.5	117.4	75.4	173.1	66.7	131.7	56.9	78.9	78.3	99.6	88.3	47.0	76.5	91.4	152.6	136.2	83.1	118.0	83.2	84.6	213.5	130.7	98.7	118.5	97.0	95.2	73.6	78.7	86.7	146.4	99.9	115.9	102.3	78.4	109.2	84.2	18.5	32.0	29.2	21.7	44.5	28.6	30.3	23.5	28.1	50.1	23.6	22.4	26.2	7.7	29.7	46.7	33.6	37.0	32.2	29.3	30.6	31.2	35.8	31.3	32.5	30.2	30.6	31.0	30.5	30.7	29.4	31.7	38.5	37.2	9.4	54.7	92.2	100.2	123.3	34.1	24.1	43.2	36.2	129.5	37.1	73.0	38.6	35.5	115.2	44.2	38.8	137.0	94.5	69.7	40.1	55.2	46.0	34.0	36.6	18.1	86.0	187.0	55.9	40.2	48.1	55.2	37.9	32.9	168.0	114.8	35.3	17.4	58.1	81.4	44.0	177.7	32.0	33.5	52.8	53.4	4.7	80.4	49.4	26.8	6.6	14.9	109.4	30.4	38.4	98.6	85.0	37.2	131.8	55.8	31.7	26.3	46.6	75.3	42.6	61.5	60.6	98.9	265.6	46.2	62.9	58.3	118.1
TIMM17B	"DXS9822, JM3"	ENSG00000126768	"Translocase of inner mitochondrial membrane 17B"	O60830	X	48893447-48898143	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029093	Approved		Approved	Microtubules,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Mitochondria	"HPA029093: AB_10600913"	"unprognostic (7.87e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (8.44e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.67e-2)"	"prognostic favorable (7.88e-4)"	24.0	42.0	49.8	18.8	51.1	28.2	25.9	50.6	60.6	29.2	47.0	40.3	25.5	27.7	21.0	38.2	29.1	17.6	75.3	50.1	49.6	47.5	48.7	28.1	27.8	49.5	48.9	27.3	33.4	47.6	45.1	23.0	48.9	36.4	19.4	26.2	25.3	27.7	99.1	35.4	32.2	18.0	50.5	37.9	40.5	18.7	50.6	40.7	30.4	83.2	26.8	35.5	28.7	53.1	71.0	127.8	78.7	78.1	24.2	19.3	65.4	31.3	47.7	81.1	52.9	113.3	93.4	51.8	47.4	27.2	131.1	52.5	125.1	68.3	30.4	111.2	140.1	37.6	69.2	101.4	68.3	56.5	35.0	24.9	67.3	60.9	80.8	40.3	37.6	90.1	56.5	118.2	37.8	183.5	89.4	136.7	102.8	93.2	118.3	62.1	51.0	187.8	80.9	41.1	77.6	69.7	48.6	77.0	47.0	98.5	168.7	97.4	26.2	37.1	72.4	89.8	54.9	107.8	137.1	64.3	51.4	100.3	44.6	178.2	123.4	179.9	67.2	123.9	77.4	113.4	67.1	76.3	121.1	113.4	64.8	59.7	139.6	75.7	104.8	127.6	74.4	124.3	49.8	51.1	50.6	60.6	50.1	49.6	49.5	48.9	48.9	50.5	50.6	53.1	23.8	25.6	34.9	4.9	56.5	30.2	52.4	99.0	21.1	40.4	52.9	62.2	40.0	41.5	59.4	73.5	16.7	94.4	45.0	40.2	185.9	94.5	5.6	42.4	25.5	24.6	81.5	48.8	4.3	73.1	94.3	31.0	34.1	37.8	52.0	50.3	24.7	56.0	99.6	35.3	5.6	68.3	91.6	37.6	49.8	7.4	23.9	48.9	44.4	3.7	85.9	48.7	55.6	2.5	9.1	89.9	92.7	23.0	103.7	63.3	102.4	160.0	56.6	43.8	32.9	21.2	45.0	29.0	39.9	52.0	34.4	79.6	48.2	52.7	59.8	61.2
TIMM21	"C18orf55, HSPC154, TIM21"	ENSG00000075336	"Translocase of inner mitochondrial membrane 21"	Q9BVV7	18	74148523-74160531	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010587, HPA051543"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA010587: AB_1851244, HPA051543: AB_2681528"	"unprognostic (4.88e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (9.22e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.55e-3)"	"prognostic favorable (1.38e-9)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.66e-2)"	13.8	14.6	22.7	10.1	23.8	8.1	10.6	25.7	29.6	9.7	23.0	16.2	12.2	10.4	11.9	13.3	9.5	5.6	48.7	22.8	23.2	21.0	22.3	7.4	9.9	22.9	22.5	11.9	9.6	18.0	11.4	10.0	23.0	12.2	13.5	14.8	10.2	9.9	50.8	11.1	11.5	9.5	22.6	13.8	12.4	7.0	23.1	7.7	12.4	47.9	10.1	12.6	10.2	24.3	25.6	26.6	24.4	30.2	19.7	17.4	35.9	38.5	12.8	22.8	19.2	19.5	18.3	34.2	12.1	15.0	19.1	41.6	34.0	32.8	38.1	21.7	19.6	14.7	46.2	53.9	10.0	55.6	23.7	16.2	19.4	29.0	19.9	18.6	17.5	19.0	30.2	23.2	27.9	25.6	29.6	45.6	23.5	15.3	48.6	27.5	28.2	42.6	30.2	35.5	25.9	14.2	14.5	35.9	23.8	19.1	24.9	28.6	12.6	53.3	37.9	17.5	40.3	7.3	60.3	37.2	26.0	59.7	38.0	8.7	9.8	6.3	12.7	15.6	15.2	16.0	12.2	10.7	13.2	12.3	15.3	17.6	1.2	17.1	18.2	15.7	10.0	8.8	22.7	23.8	25.7	29.6	22.8	23.2	22.9	22.5	23.0	22.6	23.1	24.3	8.0	12.8	17.8	8.1	12.1	8.0	9.3	30.2	21.6	17.1	9.0	12.6	165.5	14.3	16.7	5.5	6.2	29.4	10.2	9.4	54.8	13.2	3.1	7.3	13.5	13.1	14.4	16.2	8.6	9.4	28.3	19.0	14.8	6.7	9.5	12.6	11.7	20.2	18.8	16.8	11.1	11.5	8.2	11.7	3.5	1.5	11.5	8.5	1.8	6.5	13.4	20.0	9.2	8.5	9.2	9.1	6.2	12.4	25.7	10.5	12.5	34.5	15.0	20.1	6.6	15.0	16.5	12.8	12.7	20.2	8.0	16.4	7.5	12.9	18.2	7.7
TIMM22	"TEX4, TIM22"	ENSG00000177370	"Translocase of inner mitochondrial membrane 22"	Q9Y584	17	997129-1003671	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	40	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045138	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA045138: AB_10962055"	"unprognostic (2.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-3)"	7.7	9.9	6.6	3.9	7.0	6.8	7.5	9.7	8.6	6.8	8.4	8.5	2.8	7.5	8.8	8.8	6.4	1.6	15.2	6.4	6.8	9.3	6.3	6.2	3.8	7.4	6.8	7.3	7.0	10.3	9.0	6.9	8.1	7.0	4.4	4.5	7.2	1.8	12.3	8.5	6.2	5.2	7.4	7.3	8.4	6.9	7.4	6.2	6.6	12.2	6.0	7.9	6.7	8.3	3.9	0.2	13.0	12.6	19.0	8.8	4.0	12.8	8.5	10.6	13.1	8.4	4.8	4.7	2.5	21.2	9.1	3.6	26.0	14.2	21.0	0.0	0.0	9.5	1.8	0.1	18.6	5.6	1.5	11.3	9.0	13.4	20.6	10.6	17.2	0.3	1.8	13.1	12.9	0.0	17.2	6.6	9.0	11.5	17.0	8.9	6.5	6.5	17.1	0.2	4.6	10.7	4.9	5.3	10.3	12.3	8.1	10.0	18.7	12.5	9.5	10.2	15.7	2.9	0.0	4.2	10.2	8.6	12.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.0	9.7	8.6	6.4	6.8	7.4	6.8	8.1	7.4	7.4	8.3	20.2	3.2	15.9	2.0	21.7	43.6	10.7	31.5	17.1	26.4	21.4	18.5	25.3	18.6	17.8	7.3	33.3	62.8	16.3	11.8	37.2	36.2	5.9	14.9	21.2	28.2	20.4	16.8	6.9	28.2	60.8	26.9	17.3	15.8	3.8	27.1	13.9	12.1	40.4	26.9	7.1	11.9	30.5	9.7	18.9	9.7	20.2	14.6	16.0	7.5	26.9	19.1	24.7	4.0	2.8	29.0	8.6	21.4	13.2	17.0	14.2	26.7	10.2	43.7	13.1	17.4	21.4	42.7	47.2	19.5	54.1	61.6	19.0	42.7	16.8	12.9
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972489-46003742	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	39.0	50.1	47.1	35.5	48.7	66.4	38.3	50.3	62.9	28.2	55.6	40.1	56.5	26.8	61.9	43.1	28.0	31.7	84.9	49.1	51.6	59.5	74.2	26.6	36.4	50.7	51.5	20.6	32.2	50.5	35.0	35.2	52.3	34.6	39.9	42.9	32.5	36.9	128.5	35.7	37.7	37.6	49.9	25.6	32.8	80.6	50.5	40.0	43.3	134.5	45.4	53.0	27.1	49.0	162.6	167.5	108.7	110.3	88.5	82.4	106.1	130.6	156.1	155.6	164.0	212.8	125.4	144.1	105.7	138.6	111.3	136.1	168.0	139.9	153.3	108.0	165.6	92.1	120.8	231.7	142.2	173.1	98.7	99.4	122.3	133.4	188.0	64.7	146.1	123.0	166.0	78.8	138.7	162.7	155.5	239.0	131.7	119.0	51.8	118.6	105.0	105.5	177.6	111.8	127.3	117.0	72.8	159.4	132.8	83.8	168.7	102.1	108.1	74.8	130.6	96.8	188.9	83.6	148.9	203.2	139.3	246.7	63.9	54.8	98.1	54.3	73.1	131.1	75.7	82.1	70.0	79.1	111.2	79.8	62.5	69.5	22.8	79.1	118.6	92.2	85.8	129.5	47.1	48.7	50.3	62.9	49.1	51.6	50.7	51.5	52.3	49.9	50.5	49.0	13.3	9.6	22.2	10.7	19.4	21.9	18.1	32.7	15.9	14.3	16.0	11.9	97.5	30.0	24.4	12.9	8.4	42.1	17.0	16.1	45.0	40.4	101.5	26.6	20.8	18.3	10.2	43.3	19.1	30.1	47.7	24.8	20.9	23.8	27.8	14.2	13.2	27.3	34.5	0.0	18.6	16.5	36.7	16.0	15.8	35.0	17.7	18.9	23.2	12.2	29.3	23.0	20.6	14.6	19.6	36.7	14.7	11.7	36.0	20.3	22.3	61.0	26.9	10.4	6.6	13.1	26.0	148.7	48.4	38.7	21.6	35.6	16.6	17.0	25.6	22.4
TIMM29	"C19orf52, TIM29"	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928811-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	8.4	11.7	4.6	5.4	4.5	10.1	8.4	3.7	6.1	10.4	3.5	11.0	8.0	11.0	1.1	14.9	9.0	3.1	13.5	4.9	3.8	11.5	12.2	8.1	6.0	5.8	4.3	7.9	9.9	3.3	10.7	4.6	4.2	10.1	2.0	1.1	10.1	3.8	23.5	13.9	9.7	2.1	3.8	10.7	11.0	13.0	4.2	5.3	7.5	5.9	2.8	10.5	11.4	4.7	21.3	8.0	6.2	10.4	5.3	5.1	16.7	14.3	7.6	10.7	9.9	14.7	7.0	18.0	24.7	7.0	5.8	20.1	3.3	8.9	1.8	21.3	25.0	20.7	8.4	10.0	8.4	15.8	15.5	4.5	8.6	7.5	3.2	4.3	6.5	15.7	23.1	15.4	4.1	19.0	17.4	29.1	21.8	6.6	34.0	23.4	8.7	22.3	4.7	8.6	15.6	15.8	16.9	9.1	18.3	2.3	13.1	16.7	10.7	17.1	10.0	21.6	23.1	49.7	52.8	19.8	10.6	19.3	14.8	3.7	8.7	9.8	5.3	9.3	8.9	17.9	10.6	11.7	5.8	15.0	10.1	8.3	1.7	11.3	7.4	11.0	12.8	3.8	4.6	4.5	3.7	6.1	4.9	3.8	5.8	4.3	4.2	3.8	4.2	4.7	6.9	3.2	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.6	8.4	0.0	0.0	1.3	16.5	0.0	36.0	13.8	0.0	19.6	21.6	0.0	9.6	10.9	4.9	0.0	0.0	0.0	10.5	31.4	5.2	0.0	9.2	1.3	10.5	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	2.4	0.0	0.0	22.1	0.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	35.7	5.5	14.7	0.0	0.0
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943667	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA		9100	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	15.2	25.1	16.1	11.2	15.2	8.4	13.0	15.9	22.8	20.2	16.3	27.6	16.9	18.3	7.0	20.9	13.9	6.8	52.3	15.8	15.4	20.0	34.6	10.7	11.1	15.4	15.2	16.2	17.6	13.5	14.4	8.3	15.6	17.5	8.2	4.2	14.0	11.6	62.1	15.7	14.3	10.2	16.6	19.4	20.8	11.0	17.6	7.7	13.8	49.2	8.1	20.1	15.3	16.2	64.5	37.2	24.4	52.0	28.6	28.6	33.3	34.9	26.6	43.8	39.6	82.5	18.1	98.5	45.5	27.5	37.3	46.6	75.7	38.4	21.7	45.5	98.7	53.6	31.4	70.1	72.4	66.3	21.9	31.6	60.1	37.0	53.5	19.4	30.4	53.3	97.2	55.7	20.7	58.5	59.2	53.7	61.3	61.8	116.8	60.4	35.6	68.8	24.9	42.0	46.2	28.3	39.0	50.5	112.8	19.3	29.7	64.4	19.6	30.1	40.2	69.7	72.5	70.4	84.8	99.5	24.2	92.7	48.6	14.3	12.9	4.1	11.3	14.1	10.4	8.6	11.0	10.9	16.4	7.9	9.9	10.6	1.1	10.3	8.7	12.5	9.8	9.5	16.1	15.2	15.9	22.8	15.8	15.4	15.4	15.2	15.6	16.6	17.6	16.2	20.0	35.3	16.4	13.7	31.8	27.9	33.7	41.9	14.2	53.0	43.8	37.6	36.1	32.9	21.5	29.5	41.7	38.5	25.6	48.4	66.5	47.8	11.7	24.8	42.1	22.2	40.1	28.2	13.5	42.9	43.2	25.4	19.4	31.6	33.0	26.4	20.3	62.2	34.9	52.2	13.9	45.5	26.4	21.7	11.1	13.7	36.7	17.2	21.4	1.9	22.9	23.5	44.3	11.1	10.9	42.1	29.0	29.3	25.8	31.8	45.9	75.1	12.4	63.6	32.9	25.0	33.7	38.7	33.9	18.7	19.9	32.6	20.2	29.5	64.6	30.9
TIMM50	"TIM50, TIM50L"	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.5;Late spermatids: 662.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	37.3	37.2	31.2	30.4	33.7	45.4	29.7	34.3	44.2	27.7	31.5	32.2	30.4	33.2	11.2	35.8	27.9	18.5	75.7	35.0	35.0	32.9	43.9	25.7	27.7	35.0	32.8	27.4	35.3	36.2	22.7	25.2	33.0	27.4	15.4	8.9	32.0	17.5	127.0	26.6	29.6	23.0	30.6	26.2	31.8	80.5	32.9	21.6	31.7	76.6	18.2	30.9	26.1	33.1	147.2	365.3	59.6	155.1	43.8	33.4	116.8	115.8	54.2	119.6	97.4	262.6	96.6	156.5	126.0	67.9	71.9	81.6	100.9	114.8	56.4	148.7	170.8	140.3	94.5	197.3	81.5	282.8	106.6	51.9	73.2	97.2	78.7	33.9	76.4	184.5	237.8	91.3	77.2	202.9	178.4	110.5	113.7	159.2	123.3	190.8	112.5	119.3	88.1	195.5	166.3	99.4	133.6	190.0	251.8	35.7	89.1	168.0	86.4	154.7	165.6	140.1	262.7	96.1	181.1	232.8	117.9	146.7	179.2	42.5	53.7	13.4	36.3	58.5	34.9	41.8	34.1	40.0	60.5	46.4	41.4	35.7	5.9	45.2	58.1	47.0	47.8	62.1	31.2	33.7	34.3	44.2	35.0	35.0	35.0	32.8	33.0	30.6	32.9	33.1	20.0	22.4	26.0	4.6	19.3	26.0	43.6	57.4	18.8	10.4	23.8	28.7	47.6	24.3	37.6	25.8	12.5	83.8	14.7	27.4	66.5	56.3	185.5	19.8	24.2	28.6	23.4	29.6	8.7	51.8	84.4	30.9	25.0	21.5	39.3	29.5	19.2	31.3	67.1	28.6	9.3	27.5	48.8	18.8	27.7	662.8	23.3	22.3	30.2	3.7	22.1	17.4	21.6	6.6	4.9	50.9	22.2	21.1	34.6	68.0	35.7	66.0	22.1	11.4	6.6	27.2	55.7	111.5	46.5	32.3	26.7	94.5	19.9	34.1	48.1	47.6
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345661-101348742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.2;Hepatocytes: 68.3;Suprabasal keratinocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria		NA	NA		59000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	5.1	5.6	4.3	6.5	4.4	6.9	7.6	5.1	5.2	4.4	4.8	7.2	6.6	4.2	4.7	7.0	5.6	3.6	10.9	4.5	5.3	9.2	25.3	3.1	8.2	4.5	5.5	5.9	5.2	6.7	1.9	6.3	4.5	6.5	7.5	5.0	6.0	3.7	10.0	6.5	6.3	4.8	5.0	4.5	4.2	3.2	5.2	6.8	6.5	14.0	8.7	6.5	3.1	4.3	31.5	30.0	17.1	33.8	13.3	15.0	20.3	23.5	11.4	20.0	40.6	26.4	21.3	38.0	29.7	17.8	36.5	27.7	46.2	24.5	33.3	17.7	29.9	62.8	44.7	46.5	12.7	39.9	217.8	15.0	21.5	30.0	18.8	9.6	19.7	15.9	51.0	40.8	26.8	50.7	18.3	39.1	55.3	46.4	49.3	30.2	31.1	44.9	18.3	21.1	22.7	20.9	28.6	22.8	22.5	18.8	19.1	19.3	14.2	27.5	31.5	40.6	26.1	18.7	50.8	45.9	14.6	53.8	22.2	1.2	3.8	0.2	4.9	5.8	7.0	12.1	6.8	7.2	4.6	11.9	10.3	8.4	0.4	5.2	3.1	11.7	3.8	4.3	4.3	4.4	5.1	5.2	4.5	5.3	4.5	5.5	4.5	5.0	5.2	4.3	7.0	3.2	4.4	1.3	10.7	102.2	39.6	27.6	31.9	7.6	11.2	16.8	25.8	5.7	14.1	11.0	6.2	38.4	8.7	7.5	39.2	13.5	0.7	9.0	10.8	10.2	8.4	27.4	2.8	10.9	47.6	13.0	7.1	7.3	16.5	9.3	5.3	68.3	21.1	3.3	2.8	8.6	22.4	7.2	13.9	0.5	6.5	7.5	14.2	1.9	5.0	5.4	3.1	1.0	0.7	15.4	6.7	2.6	13.8	36.2	8.0	39.9	9.1	8.5	0.0	9.6	16.7	2.9	10.9	27.7	88.5	36.7	6.9	12.4	18.0	27.8
TIMM8B	"DDP2, FLJ21744, MGC102866, MGC117373, TIM8B"	ENSG00000150779	"Translocase of inner mitochondrial membrane 8 homolog B"	Q9Y5J9	11	112084800-112086798	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 577.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041173	Approved					NA	NA		11000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA041173: AB_10796340"	"unprognostic (1.36e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.44e-2)"	35.2	55.8	35.0	23.3	36.1	34.9	30.9	37.5	49.0	27.3	36.4	31.2	19.0	22.0	25.2	65.7	19.6	9.0	137.9	35.8	36.3	38.0	51.2	21.2	21.2	36.3	35.6	18.2	21.9	24.1	22.1	17.5	35.6	25.1	23.7	15.6	28.3	17.7	106.5	34.6	23.3	20.1	36.3	27.6	27.8	31.9	36.4	29.6	21.4	97.9	22.5	27.2	32.3	36.5	43.4	56.0	105.5	89.6	45.0	27.7	50.6	43.8	29.3	55.4	54.6	198.2	53.4	19.3	96.0	53.5	46.9	57.9	82.6	61.5	29.0	55.0	116.0	86.7	77.4	125.6	70.1	98.8	45.3	53.5	28.3	59.4	20.6	20.6	84.9	84.4	74.5	86.2	52.5	114.8	75.9	113.9	52.3	126.0	97.4	65.5	49.5	121.6	107.5	118.6	85.1	61.9	71.6	100.9	33.5	47.5	123.5	75.1	62.5	58.6	77.8	48.6	54.1	30.7	73.5	137.7	21.0	97.6	55.9	100.8	146.8	157.0	54.5	156.2	52.6	91.1	55.8	53.0	157.2	85.8	64.7	54.4	80.3	93.2	133.4	213.2	91.1	113.6	35.0	36.1	37.5	49.0	35.8	36.3	36.3	35.6	35.6	36.3	36.4	36.5	83.5	54.5	41.1	6.8	66.3	82.7	69.3	247.1	66.6	44.6	136.2	167.3	577.5	178.7	142.1	101.2	31.3	222.2	78.9	257.3	360.0	229.6	96.1	103.4	141.4	94.0	142.7	118.9	7.7	227.3	184.5	100.0	95.3	124.8	60.9	90.5	110.3	444.8	297.2	33.7	8.8	166.9	185.1	138.9	76.3	181.0	98.8	115.3	168.9	2.8	185.5	125.6	116.4	4.5	12.0	220.0	210.3	88.8	106.0	107.4	195.8	515.8	96.2	69.0	72.3	63.4	132.8	193.9	158.9	224.2	148.6	129.7	54.8	185.9	208.6	94.0
TIMM9	TIM9A	ENSG00000100575	"Translocase of inner mitochondrial membrane 9"	Q9Y5J7	14	58408495-58427531	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002932	Approved		Supported	Mitochondria		NA	NA		78000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA002932: AB_1080287"	"prognostic favorable (8.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (9.89e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.41e-1)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.77e-2)"	42.4	35.8	22.6	18.1	25.1	21.3	40.5	26.9	39.7	37.1	25.7	45.1	23.0	33.6	35.6	29.9	36.1	24.0	34.9	24.0	24.7	46.4	31.8	24.0	28.4	23.8	24.6	48.3	75.7	21.2	27.7	22.3	24.3	32.2	18.0	28.2	35.8	20.5	66.1	33.2	26.8	26.8	24.2	26.1	37.1	22.4	23.3	18.8	30.2	23.6	25.1	39.2	31.4	28.0	71.0	56.7	45.8	46.6	53.0	99.6	63.0	67.6	38.3	55.0	48.7	60.3	74.3	100.4	73.1	38.8	45.2	48.0	63.9	67.0	76.3	68.0	38.5	53.0	36.2	68.8	129.1	78.5	45.6	77.1	86.5	51.4	100.4	80.2	54.4	47.2	82.0	57.8	53.9	120.3	75.5	101.0	38.2	106.2	98.8	63.3	73.8	58.9	70.3	63.1	60.3	34.3	44.6	109.7	126.7	55.2	78.0	45.1	57.4	63.0	87.0	41.4	73.8	40.4	43.1	91.8	50.0	79.1	76.8	8.8	14.8	4.0	14.3	17.0	26.3	28.5	22.5	21.4	21.4	22.3	28.5	27.3	1.6	27.8	19.2	23.2	25.2	12.5	22.6	25.1	26.9	39.7	24.0	24.7	23.8	24.6	24.3	24.2	23.3	28.0	26.8	32.1	20.0	12.7	40.5	35.3	46.4	47.6	38.7	15.9	44.2	55.2	20.7	32.9	26.0	14.7	22.9	80.1	30.7	12.2	72.4	39.1	36.7	21.4	38.5	33.6	25.2	35.3	14.2	54.1	92.9	32.2	25.5	21.9	36.8	36.6	39.7	33.0	61.2	5.0	15.4	43.2	24.4	47.9	29.9	32.7	74.3	30.0	33.8	3.7	47.6	31.6	39.1	8.5	12.2	38.2	30.5	51.6	33.8	57.3	35.3	117.7	15.0	24.0	19.7	49.7	32.3	78.8	22.1	39.2	39.6	73.5	29.9	56.9	53.4	42.8
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498547-119525090	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	10.5	12.0	13.4	10.7	14.3	6.3	13.1	14.2	15.4	15.0	13.2	11.3	8.9	9.3	17.9	15.9	12.8	14.4	44.0	12.7	13.9	17.8	14.2	11.0	17.7	14.3	13.6	10.9	11.1	23.1	7.1	17.1	13.9	13.0	13.7	4.2	14.6	19.7	27.3	15.8	7.7	12.1	14.0	9.9	8.5	10.6	14.1	11.4	19.1	49.2	14.8	14.2	7.0	14.6	26.9	24.5	12.4	10.4	45.5	30.6	27.0	7.7	25.3	21.7	24.7	16.7	16.0	19.5	13.7	27.1	15.1	12.2	30.8	24.8	35.0	16.4	10.9	14.4	10.7	18.8	23.9	11.3	9.1	28.0	37.4	18.4	22.4	13.9	31.5	18.5	19.8	18.1	40.3	33.2	12.0	23.7	16.2	22.4	30.1	10.0	8.4	25.4	32.0	13.1	15.8	29.4	7.8	11.8	28.0	16.2	19.5	30.4	16.1	12.2	9.3	11.3	13.8	12.1	11.8	28.3	20.7	28.5	19.6	11.1	17.6	21.3	10.8	17.6	12.5	16.2	10.4	12.0	17.4	17.6	12.2	10.9	4.3	13.1	20.9	15.1	20.7	22.1	13.4	14.3	14.2	15.4	12.7	13.9	14.3	13.6	13.9	14.0	14.1	14.6	61.2	25.6	39.3	18.6	24.0	37.5	50.4	110.2	31.3	25.0	44.8	55.0	165.3	41.5	63.7	40.5	14.6	157.5	28.9	44.0	150.6	73.2	12.2	39.9	41.1	56.0	28.8	43.1	17.4	62.7	112.7	48.2	29.0	31.1	41.2	34.1	31.8	52.4	86.3	21.9	23.9	43.5	87.5	32.7	40.4	10.0	47.2	39.4	44.4	15.0	65.7	73.6	18.6	22.6	35.6	52.7	40.9	54.5	30.2	43.5	50.5	146.5	63.0	35.4	72.3	43.9	52.5	111.1	58.2	45.9	42.1	177.5	29.7	48.0	45.7	46.7
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582408-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 2277.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 2325.3;Hepatic stellate cells: 2681.5;Langerhans cells: 2307.7;Leydig cells: 1776.0;Macrophages: 1705.0;Peritubular cells: 1561.7;Smooth muscle cells: 2043.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3225.4;ASC TERT1: 4323.2;fHDF/TERT166: 2762.5;HSkMC: 2960.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	127000000	520000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	1043.9	895.8	110.6	1713.4	110.5	122.2	253.0	114.1	329.6	630.5	160.0	228.0	68.3	342.1	237.4	130.8	570.2	1220.1	995.3	113.5	119.9	469.6	458.6	1221.2	150.4	132.9	125.2	820.8	170.1	224.1	510.7	589.3	130.1	749.1	204.0	25.9	518.6	412.7	61.8	132.4	180.0	741.1	118.9	239.9	208.9	267.7	286.5	80.3	340.0	78.9	119.7	2277.2	303.3	115.6	194.7	295.9	150.4	1850.9	3225.4	4323.2	36.4	2079.0	1728.4	632.5	514.0	118.9	360.1	1.8	269.6	2762.5	355.3	187.2	82.9	896.0	394.8	387.0	193.8	204.1	191.7	174.9	2097.2	136.6	2440.9	2960.8	227.7	1951.9	410.1	743.6	292.1	0.7	315.8	142.9	1088.6	343.1	2.5	518.0	166.8	229.8	647.9	2.5	318.3	173.8	1038.8	120.4	2.5	8.6	1243.6	8.2	276.9	277.6	15.3	257.6	284.8	943.7	1012.1	1108.3	206.3	58.8	135.0	7.4	2688.9	322.6	634.2	331.9	488.4	8.3	139.4	853.2	137.8	21.9	224.6	122.9	511.4	10.1	73.0	65.4	504.5	88.4	817.9	15.0	104.0	431.4	110.6	110.5	114.1	329.6	113.5	119.9	132.9	125.2	130.1	118.9	286.5	115.6	145.9	109.0	170.1	6.2	57.5	231.2	591.5	937.3	132.6	25.4	147.8	133.2	22.5	374.6	355.5	132.4	0.0	25.2	59.3	53.6	0.0	538.6	21.6	34.7	511.9	772.1	277.2	102.7	0.4	411.3	280.1	2325.3	53.5	66.7	491.4	163.7	2681.5	345.1	329.7	0.0	0.4	73.0	297.0	741.4	2307.7	86.9	1776.0	1705.0	512.3	6.5	289.0	141.7	73.2	8.5	0.6	802.1	42.4	1561.7	257.4	741.4	1.1	12.9	109.1	8.4	690.2	304.1	2043.5	52.8	10.6	25.8	174.7	45.0	126.5	231.9	50.5	513.7
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1235.1;Sertoli cells: 427.3;Syncytiotrophoblasts: 1946.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 87.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 322.7;CAPAN-2: 178.9;EFO-21: 403.6;HaCaT: 181.4;HBEC3-KT: 211.9;HUVEC TERT2: 173.4;TIME: 376.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		370000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	173.7	40.8	19.0	18.5	17.7	0.9	150.5	17.9	19.9	86.8	16.4	83.2	26.7	101.8	10.7	31.0	82.4	23.9	230.7	15.2	17.9	177.7	22.7	85.7	8.5	19.6	18.3	38.8	31.0	13.2	25.3	183.6	19.8	71.2	16.5	1.0	63.8	40.6	46.6	37.0	51.6	36.5	16.4	119.6	66.4	6.2	21.2	3.8	115.1	30.6	5.3	88.4	70.2	17.1	96.6	0.2	0.0	0.5	0.8	0.2	322.7	14.9	1.9	0.7	0.4	44.5	178.9	0.2	403.6	13.4	7.0	181.4	0.2	211.9	0.1	0.7	0.1	0.1	7.3	11.5	4.5	0.1	0.5	0.2	37.9	0.0	7.6	0.1	173.4	0.1	2.4	0.4	0.0	0.0	0.7	0.6	0.9	52.6	6.1	0.4	0.1	0.4	57.0	72.6	0.4	0.5	38.0	125.6	4.2	18.8	7.5	0.3	376.6	0.3	91.6	0.7	2.8	0.4	0.5	1.6	0.2	0.2	3.3	2.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.0	19.0	17.7	17.9	19.9	15.2	17.9	19.6	18.3	19.8	16.4	21.2	17.1	345.4	9.6	5.8	0.7	2.7	11.0	121.5	244.1	8.0	0.0	32.0	73.0	46.7	37.1	28.6	132.4	0.0	1235.1	2.6	158.9	1.9	378.7	1.4	8.4	3.2	161.4	11.4	13.5	0.1	92.2	223.5	35.0	50.0	14.4	14.7	49.7	306.6	4.4	89.3	0.0	1.1	35.5	14.2	8.8	10.3	0.7	7.5	4.2	23.2	13.1	2.0	0.2	0.0	0.5	0.0	344.6	115.3	4.1	0.2	131.4	45.2	80.9	9.1	0.4	427.3	9.5	357.4	0.3	0.8	4.9	6.5	1946.1	3.8	2.7	59.7	219.4
TIPIN	FLJ20516	ENSG00000075131	"TIMELESS interacting protein"	Q9BVW5	15	66336191-66386746	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 98.0;Langerhans cells: 93.7;Spermatocytes: 120.6;Suprabasal keratinocytes: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039704, HPA058799"	Enhanced					NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039704: AB_10795258, HPA058799: AB_2683824"	"unprognostic (3.47e-1)"	"prognostic favorable (4.15e-4)"	"unprognostic (3.49e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.18e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.91e-1)"	"unprognostic (2.89e-3)"	4.2	4.4	3.3	7.1	3.3	12.6	5.9	5.4	4.6	3.9	2.0	4.8	2.8	4.7	1.8	4.9	5.5	2.6	3.1	3.2	3.1	4.0	4.9	3.5	9.5	3.2	3.9	6.4	4.7	5.2	3.2	3.8	3.1	3.5	5.3	8.1	3.3	3.2	4.0	3.9	3.0	4.4	2.9	3.7	3.8	20.5	3.2	7.8	4.4	4.8	10.8	3.6	3.3	3.7	28.6	33.9	36.9	17.7	6.4	13.6	30.2	39.1	16.0	54.8	48.0	49.9	32.1	58.5	27.8	14.9	31.9	44.8	94.2	34.1	51.7	39.0	52.4	51.7	33.0	28.0	12.9	54.4	17.1	17.5	11.1	51.2	41.2	7.8	23.0	47.6	43.6	27.4	47.8	32.7	50.3	35.2	37.7	66.7	26.7	50.1	54.9	58.0	19.0	32.5	35.0	21.9	27.5	17.4	25.3	26.8	26.6	32.9	15.3	38.9	42.6	33.7	73.4	16.4	91.2	92.7	26.0	98.8	40.3	0.4	2.1	1.4	2.7	4.3	3.2	2.3	2.0	2.4	3.8	4.3	3.0	3.4	0.4	4.5	2.7	2.9	1.9	1.9	3.3	3.3	5.4	4.6	3.2	3.1	3.2	3.9	3.1	2.9	3.2	3.7	7.8	6.4	7.0	14.0	15.7	98.0	72.4	24.3	5.7	11.8	7.1	9.0	2.7	28.6	11.5	9.2	10.4	35.9	7.8	5.4	86.1	11.8	63.3	8.3	8.6	18.4	4.8	15.6	7.8	8.6	41.2	16.5	5.1	4.8	8.2	11.8	14.6	13.7	21.4	8.4	11.1	7.1	14.2	27.4	93.7	31.4	19.0	13.2	56.9	1.0	12.3	9.2	15.5	10.1	9.6	7.3	7.0	18.0	8.7	41.2	3.8	63.5	6.8	14.7	32.9	51.9	29.0	120.6	62.5	6.6	108.8	19.4	21.0	9.3	10.1	34.1
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178962-168202109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: AB_2682435"	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	16.3	14.9	15.5	19.6	16.3	33.8	21.0	15.0	20.1	17.7	12.8	22.2	19.0	23.2	16.8	20.1	14.3	16.8	23.7	16.8	17.0	17.8	22.5	14.9	22.2	14.0	13.4	17.4	15.9	27.4	13.6	17.5	14.4	18.4	22.0	14.7	12.0	17.3	24.4	16.3	18.5	22.7	13.4	16.3	15.4	18.2	15.1	30.1	17.4	23.0	19.9	18.7	13.6	15.7	69.4	31.0	45.9	41.6	36.7	53.1	27.5	50.5	53.0	54.6	48.4	48.3	50.1	49.0	68.2	48.7	40.1	81.8	34.5	49.3	52.6	47.2	36.4	47.3	29.2	22.9	64.5	94.7	62.0	43.2	62.8	47.4	62.7	36.0	58.1	75.4	69.0	66.3	47.7	25.4	84.9	49.0	37.0	96.7	54.2	41.1	47.0	66.4	49.7	33.9	29.6	66.1	39.3	54.6	102.2	51.6	59.9	96.3	53.4	45.6	52.4	43.6	69.7	72.2	80.5	108.1	29.8	61.4	53.4	71.6	26.7	36.8	22.0	32.1	22.1	27.3	25.7	23.8	31.6	27.6	22.8	22.4	34.5	29.6	33.9	23.4	36.0	28.2	15.5	16.3	15.0	20.1	16.8	17.0	14.0	13.4	14.4	13.4	15.1	15.7	52.1	25.6	20.4	9.4	39.7	48.2	42.1	70.4	50.1	27.3	31.3	36.2	46.3	22.8	40.7	22.0	16.7	44.2	49.0	37.1	29.4	68.5	53.4	36.0	50.1	43.4	24.0	32.6	41.6	88.9	62.8	47.3	24.5	30.8	40.0	35.2	36.0	33.5	65.1	52.2	37.9	33.9	44.7	26.6	41.1	15.4	37.6	42.6	30.2	19.7	61.0	43.9	51.5	22.1	21.3	69.7	27.7	38.0	37.1	43.3	35.9	77.2	36.1	20.8	26.3	35.4	51.1	151.5	51.6	56.0	41.8	29.0	48.0	84.5	38.5	37.5
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	24.4	32.1	25.5	17.3	36.6	18.5	24.4	28.2	32.8	31.8	23.5	30.1	20.3	31.1	10.1	16.7	28.8	13.4	24.8	26.3	29.3	21.8	25.9	21.7	20.6	34.0	33.3	37.2	33.2	13.2	24.5	14.9	31.2	31.3	9.2	11.3	24.0	14.5	44.1	19.7	25.9	15.1	25.7	32.2	26.0	20.3	35.1	17.1	30.4	16.7	14.9	28.7	23.5	49.4	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	25.5	36.6	28.2	32.8	26.3	29.3	34.0	33.3	31.2	25.7	35.1	49.4	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69274615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 237.5"	"Low region specificity"	"Detected in all"							"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	44.4	14.9	35.1	11.6	45.3	12.0	30.2	44.5	42.6	16.9	25.7	39.0	54.4	19.8	13.1	45.8	23.8	24.4	35.8	38.0	45.4	44.7	64.8	47.6	9.7	52.6	39.9	37.0	21.9	57.9	5.3	18.4	52.6	24.8	35.1	122.0	37.1	21.9	14.1	35.0	49.6	16.1	55.0	5.7	58.3	32.1	39.9	32.5	44.9	15.1	23.1	55.3	22.3	66.3	237.5	6.4	24.4	25.8	92.9	90.3	108.5	37.3	26.7	54.9	29.0	31.8	106.6	33.0	37.0	20.3	31.4	158.3	33.2	79.3	75.9	115.3	20.7	34.5	22.5	165.2	28.9	13.8	59.1	71.3	65.2	43.1	32.4	19.6	143.6	9.9	19.7	24.7	34.3	36.0	5.5	2.3	49.5	194.5	50.0	23.1	26.9	2.9	192.0	194.2	8.3	14.9	13.3	111.2	3.4	55.7	37.0	7.9	196.3	44.3	48.3	32.4	38.6	23.0	5.2	0.9	48.0	19.6	16.1	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.8	0.1	35.1	45.3	44.5	42.6	38.0	45.4	52.6	39.9	52.6	55.0	39.9	66.3	2.9	44.8	22.8	76.4	2.3	65.1	79.1	26.3	4.6	212.4	4.6	1.3	38.5	40.0	33.1	3.7	35.5	27.9	2.7	74.4	0.0	32.5	3.5	7.1	1.7	36.4	11.5	10.5	10.1	24.3	25.6	15.5	64.2	9.9	5.7	0.2	27.5	104.9	5.6	18.5	13.4	45.0	36.7	14.6	28.9	6.7	29.2	8.2	28.4	22.5	9.0	111.1	1.0	21.6	82.5	44.2	65.8	13.9	5.2	115.4	73.4	1.9	51.3	267.6	0.0	4.9	13.1	19.6	18.0	40.6	64.1	43.2	3.2	0.2	50.3	244.5
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708362-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.0;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 238.7;Early spermatids: 405.1;Paneth cells: 140.4;Proximal enterocytes: 130.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.2;MAIT T-cell: 3.9;memory CD4 T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.2;T-reg: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.0;CAPAN-2: 41.1;MCF7: 20.3;OE19: 37.4;SK-BR-3: 25.7;T-47d: 52.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.2	4.7	0.1	0.1	4.0	0.1	0.4	6.3	7.4	34.1	43.0	1.5	2.4	25.5	13.7	6.2	0.0	0.4	0.1	5.8	7.1	5.2	0.4	0.2	0.4	0.1	6.4	7.5	1.7	1.6	0.2	4.0	13.2	0.1	20.8	5.3	0.7	7.3	37.4	0.5	0.0	0.5	27.0	2.5	0.0	0.2	6.9	0.0	2.6	4.1	6.0	0.3	0.3	8.3	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	13.0	41.1	8.2	1.3	0.0	0.1	10.4	0.6	0.0	0.0	0.5	0.2	0.0	0.7	2.9	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.3	0.0	20.3	0.0	0.3	0.9	37.4	0.2	0.1	0.0	6.2	1.4	6.8	0.2	0.2	1.6	25.7	0.0	3.3	52.2	0.2	0.0	0.1	1.0	0.1	0.0	1.7	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	3.9	0.4	3.1	2.4	0.0	0.6	3.3	1.2	0.0	0.0	0.0	0.0	3.8	1.2	0.2	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.3	0.1	9.6	13.7	0.3	1.9	0.0	7.0	21.0	0.0	0.0	20.3	6.3	0.9	34.3	42.1	31.3	0.0	32.1	0.8	238.7	19.6	21.1	405.1	31.2	1.1	0.5	12.5	0.0	0.9	23.6	4.2	0.6	52.5	13.2	4.5	0.1	0.0	7.3	2.7	0.0	0.9	50.9	24.4	0.3	0.3	36.5	1.8	0.8	3.6	0.0	0.1	0.0	0.0	0.5	1.4	21.8	140.4	1.2	0.2	6.5	130.4	8.0	86.1	0.0	0.0	0.0	3.4	4.3	4.8	8.0	0.1	40.2	4.3	0.0	62.1	25.6
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174091-78187233	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 34.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"white matter: 3.6"	"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	3.7	2.7	2.5	20.4	3.4	77.9	5.9	3.6	3.4	5.9	1.3	24.4	18.0	3.0	0.2	27.2	4.9	3.4	2.8	2.7	2.4	11.0	9.2	9.1	34.8	3.4	3.3	1.3	5.6	0.6	0.6	14.8	3.3	3.4	15.7	0.1	6.3	1.5	5.5	14.2	18.3	10.1	2.6	12.4	17.9	3.1	3.8	25.1	2.0	1.6	30.6	5.5	9.0	4.4	443.9	357.7	68.2	92.5	7.6	28.0	47.3	207.6	113.2	323.1	442.3	324.2	178.7	144.1	72.9	131.7	133.9	204.2	63.4	187.1	158.0	51.2	230.4	252.5	119.9	213.3	2.2	107.1	162.9	13.8	7.1	166.1	22.5	22.3	137.9	49.4	156.7	311.9	130.8	352.0	56.0	68.6	36.7	259.1	240.9	152.6	276.4	324.1	90.6	138.5	33.6	94.2	162.0	481.2	59.7	59.4	303.9	156.1	57.8	302.3	305.7	219.9	292.1	132.5	71.4	181.9	149.0	71.9	142.1	0.0	1.1	0.0	1.8	2.1	0.7	5.8	7.9	4.0	3.4	1.7	0.4	2.2	1.8	10.8	1.7	1.1	34.0	5.5	2.5	3.4	3.6	3.4	2.7	2.4	3.4	3.3	3.3	2.6	3.8	4.4	1.6	0.0	2.7	0.0	17.1	28.4	13.3	17.8	2.2	0.0	10.6	9.4	0.9	2.8	8.3	12.9	0.0	92.8	3.6	35.0	7.9	7.7	3.0	9.2	3.3	10.6	5.4	108.6	0.3	11.2	210.4	15.7	19.4	7.0	0.0	15.9	7.5	10.5	65.2	0.0	0.2	32.7	8.2	15.5	19.1	6.8	0.6	10.9	3.6	0.0	5.7	0.0	3.1	0.0	1.0	9.6	7.5	0.7	53.6	4.9	3.1	17.5	5.8	0.0	0.0	1.7	20.1	3.8	16.8	24.7	11.2	51.0	8.7	1.7	60.8	24.0
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041162: AB_10961178"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.18e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.05e-2)"	48.1	30.2	24.2	11.8	27.6	8.5	25.6	24.7	25.7	20.0	19.7	15.0	10.9	16.2	29.3	12.3	19.0	21.1	19.2	24.1	25.6	25.1	37.3	18.7	11.7	26.5	27.8	26.8	24.4	38.0	22.4	15.1	27.6	19.2	12.7	11.7	22.6	19.9	11.5	12.7	13.5	18.9	27.5	23.0	15.7	33.9	25.8	13.0	25.6	14.6	9.9	17.8	15.4	28.3	13.3	26.5	12.1	14.5	64.3	52.2	0.7	22.0	22.3	15.1	16.8	6.5	26.4	0.1	23.8	63.9	19.0	11.8	5.3	17.7	10.4	8.5	6.2	4.1	17.2	12.9	45.1	5.6	9.2	39.4	15.3	18.5	26.1	62.5	19.9	13.1	6.8	28.1	37.9	4.1	5.5	14.9	5.9	5.1	15.4	7.0	21.0	28.1	44.1	12.5	4.4	8.9	63.2	6.1	26.9	6.6	9.6	16.3	29.7	30.8	15.9	26.3	7.6	30.3	12.2	11.6	38.9	5.7	18.4	5.6	9.4	6.0	1.8	5.1	1.2	0.1	1.3	1.0	8.7	1.7	0.6	0.9	8.5	2.7	4.3	1.8	1.2	2.5	24.2	27.6	24.7	25.7	24.1	25.6	26.5	27.8	27.6	27.5	25.8	28.3	25.0	22.4	9.3	19.6	7.3	5.7	5.1	5.8	12.5	15.5	15.4	11.4	8.0	17.2	7.5	22.0	22.9	10.0	7.6	6.0	9.8	15.7	25.2	15.2	23.2	14.4	9.6	10.3	10.1	22.4	6.0	19.9	11.7	13.0	24.8	20.6	31.1	48.9	21.7	21.9	12.0	6.5	2.0	55.6	10.1	40.5	23.3	23.6	10.6	10.3	22.6	18.4	12.3	14.6	19.4	28.9	3.3	19.2	12.4	4.3	14.4	45.9	9.0	20.5	0.0	14.4	10.6	48.9	11.1	9.6	3.8	2.9	8.6	22.2	7.6	4.2
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 127.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 166.9;Spermatogonia: 491.5"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.3;medulla oblongata: 1.7"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cell line enriched"	"Detected in some"	163	"THP-1: 495.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.3	0.1	0.3	0.4	0.4	0.9	0.2	0.2	4.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	0.3	0.3	0.3	0.2	1.0	0.4	1.7	0.2	0.1	0.0	0.0	0.9	0.3	0.6	0.1	0.0	2.2	0.0	0.0	0.3	0.2	0.1	0.1	0.5	0.7	0.0	127.1	0.5	0.4	0.1	0.5	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	495.2	0.0	0.0	0.0	0.1	0.2	0.0	3.0	2.7	0.0	0.0	0.4	1.6	0.1	60.9	24.4	0.4	3.5	0.1	2.9	2.2	0.0	0.1	6.0	5.4	1.0	7.8	0.3	0.2	3.5	5.8	0.3	0.4	0.2	4.3	0.3	0.3	1.7	0.2	0.6	0.5	0.5	0.5	0.2	0.0	0.0	0.7	0.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	44.8	0.0	0.1	0.7	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	25.2	0.4	0.0	0.0	0.3	3.7	22.5	4.1	1.9	0.0	1.0	0.6	6.0	20.6	1.0	0.1	0.0	0.0	1.9	1.3	0.0	0.0	0.1	0.0	1.0	26.3	1.4	1.6	166.9	491.5	0.1	0.1	0.0	4.1	0.1	0.0	0.0
TLCD1		ENSG00000160606	"TLC domain containing 1"	Q96CP7	17	28724348-28727935	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 36.4;Syncytiotrophoblasts: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 21.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 116.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042366	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA042366: AB_10794419"	"unprognostic (1.23e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.47e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.05e-5)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.93e-2)"	2.6	5.4	14.5	3.2	14.9	1.4	5.2	16.6	21.5	4.4	13.1	8.1	8.1	1.8	13.8	13.1	14.5	2.3	2.3	14.7	14.9	25.9	15.0	7.4	3.2	14.7	15.7	1.1	11.9	3.4	3.9	4.5	14.1	6.5	8.2	1.6	12.9	3.7	0.8	20.6	4.0	1.0	14.7	1.3	8.8	13.1	15.1	4.5	5.3	0.1	9.8	13.8	5.7	13.9	12.4	55.8	14.9	12.7	10.2	18.5	34.6	10.1	17.8	4.7	6.7	31.1	21.3	3.9	15.3	12.1	21.4	19.4	16.6	31.6	7.2	3.1	15.8	6.6	33.4	38.2	10.9	14.0	1.0	12.5	25.4	17.1	30.0	7.3	4.1	1.2	24.3	0.6	8.1	43.5	1.6	5.9	17.0	42.4	10.0	4.6	6.3	23.7	38.9	22.2	28.1	5.6	20.6	116.2	11.3	22.1	57.1	4.9	4.2	4.8	16.2	8.9	16.4	4.0	4.9	9.0	9.1	8.0	16.2	1.9	0.9	0.2	0.2	1.1	0.5	1.4	0.5	0.3	0.9	0.6	0.2	0.3	0.6	0.4	0.7	21.7	0.4	0.4	14.5	14.9	16.6	21.5	14.7	14.9	14.7	15.7	14.1	14.7	15.1	13.9	2.1	0.0	8.4	4.2	2.5	2.4	11.8	23.9	2.2	0.2	19.0	17.1	0.9	7.2	16.6	12.9	0.0	18.3	1.0	7.8	0.0	9.0	17.0	24.1	4.6	1.7	4.8	1.3	0.0	8.3	36.4	4.2	7.1	23.6	0.0	0.9	1.1	18.6	3.5	1.7	0.0	8.8	14.2	0.8	3.7	15.6	1.2	1.5	3.6	0.0	2.1	5.3	0.0	1.0	0.0	10.5	4.5	0.4	1.8	23.7	8.5	6.9	31.0	0.7	0.0	2.0	8.8	20.2	7.2	8.4	2.0	32.3	2.2	3.0	8.0	23.1
TLCD2		ENSG00000185561	"TLC domain containing 2"	A6NGC4	17	1702816-1710377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 129.3;Distal enterocytes: 112.4;Proximal enterocytes: 68.9;Skeletal myocytes: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 3.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.0;HaCaT: 8.4;SiHa: 11.2;T-47d: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 14.2"	HPA046063	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoli	"HPA046063: AB_2679520"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.94e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (3.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.44e-2)"	10.3	9.4	0.6	1.8	0.7	2.1	4.7	1.6	0.9	3.0	2.3	7.3	6.0	1.8	1.2	4.7	2.7	1.8	2.1	0.6	0.5	1.8	7.0	3.9	0.7	1.0	0.7	2.5	1.2	1.0	1.1	1.5	1.0	1.9	5.3	10.5	2.9	0.9	1.7	2.4	6.9	1.2	0.7	1.3	4.7	0.6	1.0	0.1	1.6	0.8	0.8	3.1	3.5	1.6	1.0	1.1	1.1	3.5	8.1	9.0	0.3	1.9	1.8	1.0	0.7	6.9	3.1	0.1	1.9	3.1	1.0	8.4	1.5	0.9	0.7	0.2	0.7	0.9	2.4	0.3	2.3	0.1	2.4	7.6	3.2	1.2	2.2	2.9	0.7	0.1	0.8	0.4	0.9	1.9	0.1	0.4	0.1	3.4	0.6	0.1	5.3	0.2	0.7	2.7	0.2	0.4	11.2	1.0	1.6	1.5	9.4	0.8	2.6	0.5	2.3	2.1	0.5	0.1	0.1	0.1	0.6	0.3	1.0	3.4	0.2	0.4	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.4	0.2	0.2	1.6	0.3	0.1	0.2	0.1	0.1	0.6	0.7	1.6	0.9	0.6	0.5	1.0	0.7	1.0	0.7	1.0	1.6	19.0	51.3	55.5	0.3	1.6	0.0	8.2	0.0	4.0	7.9	5.8	9.5	2.7	17.2	18.0	11.0	129.3	4.9	2.0	112.4	0.0	7.3	1.1	12.9	10.4	14.1	9.0	11.2	0.5	9.6	2.6	14.9	20.9	13.3	15.8	3.9	18.9	24.2	5.5	0.0	0.4	24.6	0.0	6.5	0.0	1.8	13.4	10.7	0.0	3.7	1.4	11.7	0.0	0.0	0.1	13.5	40.1	5.7	3.3	6.3	68.9	1.1	19.9	57.8	6.6	124.2	17.8	0.6	0.8	9.1	0.3	4.0	5.1	5.4	35.7	13.0
TLDC2	"C20orf118, dJ132F21.2"	ENSG00000101342	"TBC/LysM-associated domain containing 2"	A0PJX2	20	36876121-36894235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.2;granulocytes: 15.2;Intestinal goblet cells: 4.9;Paneth cells: 11.5;Proximal enterocytes: 20.4;Undifferentiated cells: 7.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 34.7"	"Region enriched"	"Detected in many"	4	"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			HPA047468	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047468: AB_2680059"	"unprognostic (9.06e-3)"	"unprognostic (3.35e-4)"	"unprognostic (4.60e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.97e-5)"	"unprognostic (7.25e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.87e-2)"	10.0	2.6	0.6	4.7	0.9	1.6	6.5	0.1	0.8	6.3	2.7	11.7	18.2	2.7	0.4	3.2	8.0	2.7	7.0	0.4	1.0	5.9	2.3	11.1	2.8	1.5	1.0	5.1	4.3	0.0	2.8	0.2	1.4	3.8	12.3	1.3	4.1	0.2	2.0	4.7	17.1	0.7	0.9	7.9	3.6	3.0	1.7	0.0	4.1	0.0	0.1	5.5	5.6	2.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	1.6	0.5	0.4	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.1	0.3	1.3	0.6	4.0	0.0	0.4	34.7	0.1	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.0	6.2	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.6	0.3	0.2	0.1	0.0	0.0	0.2	0.1	4.6	0.5	0.0	0.2	0.6	0.2	0.1	0.2	0.1	0.8	0.6	0.5	0.1	0.0	0.8	0.7	0.4	0.4	0.5	0.6	0.9	0.1	0.8	0.4	1.0	1.5	1.0	1.4	0.9	1.7	2.1	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.7	2.8	0.0	0.0	0.0	0.0	0.4	10.2	0.0	0.5	0.3	0.3	0.1	0.1	3.6	0.8	0.3	0.0	0.0	0.5	1.1	0.3	15.2	0.3	0.0	0.0	0.3	0.0	0.3	4.9	0.0	0.0	0.5	0.4	0.0	0.3	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.5	11.5	0.0	0.1	0.0	20.4	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.4	0.1	7.3	0.0
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"TLE family member 1, transcriptional corepressor"	Q04724	9	81583683-81689547	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB011482: AB_443210, HPA071396: AB_2686392"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (4.09e-1)"	44.9	40.1	36.1	11.8	31.8	40.0	39.0	23.1	35.5	57.4	11.7	39.3	7.7	50.1	27.1	20.3	43.0	27.3	19.3	41.2	22.1	21.4	80.7	23.5	12.7	20.7	32.3	42.0	59.9	6.3	19.1	19.3	20.2	31.0	21.6	11.1	47.5	17.4	90.7	31.8	30.2	33.3	20.1	44.7	38.2	25.8	27.6	6.6	24.9	22.5	13.5	30.2	35.5	23.3	69.9	50.6	49.7	0.2	50.3	28.3	99.6	3.9	12.4	8.6	11.3	8.8	26.2	0.0	43.1	27.6	69.0	40.9	1.0	22.3	8.3	0.2	40.0	0.0	12.0	74.8	24.5	0.0	1.3	12.4	47.2	26.2	57.1	22.6	35.1	20.0	0.3	22.4	25.8	74.2	9.8	0.4	88.6	48.0	26.1	66.9	35.2	4.9	46.1	38.2	25.2	31.0	4.8	39.6	22.2	53.3	27.9	31.4	27.6	21.7	22.5	10.5	30.8	0.5	0.3	1.6	28.0	0.2	41.0	8.4	0.0	4.6	2.1	0.0	2.9	6.6	0.2	0.9	0.6	5.8	0.0	0.2	0.0	4.3	0.1	1.7	0.0	0.6	36.1	31.8	23.1	35.5	41.2	22.1	20.7	32.3	20.2	20.1	27.6	23.3	66.6	0.0	6.5	121.5	52.4	54.6	22.3	9.8	18.8	36.6	33.5	18.4	5.7	41.5	15.8	14.7	16.7	67.2	63.5	49.5	15.6	40.8	1.7	85.9	76.2	38.2	28.8	13.9	36.5	23.8	71.9	27.5	23.9	205.8	0.0	30.1	27.1	65.3	7.8	16.8	23.5	24.0	36.7	6.4	20.5	3.6	22.7	9.6	46.2	46.9	8.1	39.5	68.0	22.6	14.5	54.8	41.0	34.3	35.1	40.5	12.2	3.0	17.1	6.0	118.3	12.8	47.4	2.2	102.4	29.3	43.8	50.8	18.6	71.4	48.6	69.4
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"TLE family member 2, transcriptional corepressor"	Q04725	19	2997639-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.4;RT4: 35.2;T-47d: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	35.6	31.5	19.4	5.2	20.6	1.6	34.2	67.6	21.2	45.0	10.5	52.4	12.5	62.6	5.2	13.5	62.2	9.0	75.6	13.4	18.9	52.0	17.1	42.5	5.5	22.0	21.5	29.3	36.7	20.4	25.9	9.3	27.2	55.5	6.6	8.7	85.5	28.0	66.4	21.9	18.4	11.1	18.5	46.9	30.2	23.0	27.9	4.9	72.5	30.9	2.1	67.4	25.7	22.2	0.5	2.8	0.2	44.4	6.7	1.1	9.5	0.4	0.0	2.1	1.1	14.0	5.1	0.2	5.9	3.2	1.3	7.6	7.7	2.7	0.5	1.2	2.1	0.0	3.4	0.6	8.6	0.0	0.4	9.6	1.2	4.9	0.1	2.6	18.0	12.6	16.2	0.2	0.3	15.0	0.4	0.2	0.1	1.3	2.9	3.9	2.2	4.4	5.5	35.2	2.3	11.1	3.0	22.0	1.1	0.9	25.1	0.1	11.7	14.0	14.4	0.8	0.5	0.5	0.5	3.0	0.3	3.3	2.8	0.0	0.0	0.1	1.1	0.0	0.9	1.7	0.7	0.4	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.0	0.2	0.3	19.4	20.6	67.6	21.2	13.4	18.9	22.0	21.5	27.2	18.5	27.9	22.2	27.1	19.2	17.6	1.6	0.7	3.6	34.2	8.3	11.4	36.9	27.0	16.5	24.9	12.8	7.0	36.8	2.1	1.8	2.8	21.7	1.9	11.3	6.5	1.8	9.6	10.3	13.8	0.4	10.3	2.7	4.4	14.8	8.2	6.0	0.0	7.2	16.1	4.0	0.7	1.7	29.3	14.9	8.2	0.3	3.1	18.8	11.8	1.1	5.4	3.7	0.1	19.2	2.1	10.6	14.6	2.7	9.8	15.1	0.3	28.2	1.3	1.1	10.0	4.4	0.0	1.5	11.2	1.2	5.8	4.6	2.3	6.7	2.3	0.7	26.5	32.5
TLE3	"ESG, ESG3, GRG3, HsT18976, KIAA1547"	ENSG00000140332	"TLE family member 3, transcriptional corepressor"	Q04726	15	70047790-70098176	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.1"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 49.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054116	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA054116: AB_2682386"	"unprognostic (5.57e-2)"	"prognostic favorable (2.09e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.74e-1)"	16.1	6.4	9.2	18.3	11.5	65.1	15.2	10.7	10.9	17.4	2.9	20.6	17.3	10.8	3.0	31.1	10.1	5.8	9.9	12.3	15.3	16.4	13.3	20.3	17.7	15.1	13.9	14.0	14.9	5.8	10.3	12.6	11.8	23.2	6.4	4.9	19.1	10.1	8.3	29.4	21.8	6.9	13.4	23.1	15.7	22.1	15.1	13.5	13.5	2.9	18.9	9.8	19.4	12.2	7.8	24.2	13.3	23.6	12.1	9.9	80.3	1.5	4.1	3.1	2.5	34.0	22.8	22.0	32.8	2.1	4.8	14.3	32.3	11.5	1.6	30.9	45.9	36.9	50.8	6.6	11.5	11.4	51.1	20.5	6.3	9.1	8.2	19.7	15.5	47.9	26.1	96.0	4.5	20.9	41.2	28.3	14.2	7.4	24.9	36.8	13.6	24.7	7.1	41.7	19.5	28.7	66.2	29.7	28.7	14.5	33.6	24.9	11.7	9.5	18.7	29.6	16.4	84.6	57.2	35.3	13.3	37.3	25.1	2.6	4.5	2.5	1.9	4.8	1.8	9.9	2.6	2.5	2.9	4.9	2.5	3.3	49.1	2.8	5.2	8.7	1.6	1.7	9.2	11.5	10.7	10.9	12.3	15.3	15.1	13.9	11.8	13.4	15.1	12.2	27.5	12.8	27.7	16.0	49.2	115.1	47.8	19.5	59.2	19.9	45.5	28.4	8.1	4.3	18.9	62.5	31.3	25.3	38.2	55.2	7.9	11.6	45.5	17.2	5.0	27.6	28.8	15.2	6.1	5.6	64.4	25.0	17.9	32.1	53.2	25.5	23.9	21.5	37.3	0.0	5.0	30.3	10.2	41.5	78.2	76.9	14.0	51.5	35.6	13.1	35.8	32.6	1.0	9.5	0.4	11.0	31.7	18.4	47.2	39.9	41.0	13.2	8.1	4.4	0.0	39.8	24.7	5.8	28.0	67.7	132.8	82.4	37.6	0.7	43.9	31.5
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	7.7	10.2	5.9	10.7	8.3	11.1	12.3	4.1	10.5	12.7	5.1	13.0	9.4	10.6	5.4	9.4	9.5	9.6	7.0	10.1	4.6	13.0	14.8	8.4	15.0	3.5	7.3	14.0	10.4	18.0	6.2	15.2	3.4	11.8	12.3	15.8	9.2	14.6	16.3	8.5	11.8	11.7	4.4	13.2	13.5	17.7	10.6	13.8	17.6	5.5	15.7	11.7	8.3	7.6	16.6	15.6	22.0	17.3	15.4	15.3	24.7	22.5	31.9	21.8	18.2	21.8	25.9	34.2	18.7	33.4	23.6	13.7	28.5	24.6	23.8	42.1	14.9	39.1	18.5	28.0	16.5	50.3	19.0	16.7	24.6	43.4	28.4	23.0	24.3	21.2	42.3	27.4	13.2	20.3	43.8	15.5	20.6	15.5	8.9	31.9	26.9	34.7	17.7	30.9	25.0	19.7	24.7	16.7	16.1	14.9	13.8	17.0	33.2	19.3	24.0	12.7	17.8	24.5	43.0	59.7	23.9	20.1	19.9	11.1	3.1	5.7	5.2	2.6	7.3	8.3	8.3	5.7	3.0	8.3	9.3	6.2	4.2	8.1	5.3	4.4	8.5	5.2	5.9	8.3	4.1	10.5	10.1	4.6	3.5	7.3	3.4	4.4	10.6	7.6	34.2	51.3	27.8	135.8	76.7	41.3	33.2	27.1	30.7	34.8	45.9	28.4	32.1	37.1	29.2	51.5	60.5	82.7	42.6	55.8	88.0	29.2	58.1	29.5	33.9	34.5	23.9	33.7	196.2	32.7	52.7	30.3	37.8	38.4	27.3	39.5	27.5	40.0	27.4	45.4	161.0	36.7	36.7	29.0	30.4	32.0	43.2	54.7	37.4	74.0	29.1	26.6	49.4	84.9	92.0	35.6	36.5	44.8	66.3	51.0	33.4	58.0	30.7	77.5	0.0	41.6	29.6	31.1	54.9	24.5	39.1	174.9	66.4	59.2	33.9	43.0
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732195	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		1300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	125.7	62.7	31.1	84.7	42.1	79.2	79.4	39.3	31.1	80.0	43.1	196.2	36.5	151.8	25.3	78.0	102.9	53.2	81.2	26.2	34.9	47.3	42.3	91.8	63.1	50.8	41.9	66.0	33.1	41.6	36.7	70.4	49.7	72.6	41.4	7.7	42.5	111.4	70.9	46.7	77.9	145.4	41.5	89.7	91.8	23.3	44.9	61.1	49.0	55.8	52.7	147.7	66.3	44.6	63.4	103.8	62.7	86.9	210.8	158.7	71.4	171.2	186.8	162.9	146.4	86.3	27.4	76.5	55.5	319.0	103.0	33.3	74.2	106.9	118.3	172.8	48.0	173.0	132.1	77.4	130.6	105.8	276.2	193.4	50.2	240.1	112.7	223.7	253.4	64.7	60.2	76.0	218.5	27.8	71.5	27.8	51.3	28.4	78.8	95.0	36.6	44.8	81.4	49.8	14.1	59.6	83.7	46.3	53.4	56.5	39.3	72.6	308.5	257.8	99.6	80.0	140.6	26.2	27.6	51.7	199.9	55.9	238.4	6.0	5.9	7.3	5.4	6.1	4.4	2.6	3.1	4.1	4.3	2.3	1.4	3.1	10.0	4.1	8.1	5.4	2.3	6.9	31.1	42.1	39.3	31.1	26.2	34.9	50.8	41.9	49.7	41.5	44.9	44.6	123.2	109.0	66.9	11.4	99.8	40.1	69.4	43.5	42.7	11.7	40.3	61.3	134.1	31.5	55.7	53.3	10.4	44.3	186.3	43.8	23.5	94.3	47.2	36.0	156.9	106.8	34.1	127.0	7.7	61.9	82.6	103.9	51.0	73.0	206.6	72.0	93.9	54.7	112.4	15.2	7.6	29.0	26.4	196.9	91.0	26.4	99.4	323.4	23.2	21.5	174.1	33.0	288.4	4.5	9.1	107.7	33.2	128.6	61.4	58.4	40.6	62.8	34.3	17.6	203.8	126.5	267.9	32.0	28.5	47.4	26.6	58.8	143.8	89.4	28.9	46.4
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 38.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.7;Inhibitory neurons: 127.2;Microglial cells: 139.6;Oligodendrocyte precursor cells: 108.6;Oligodendrocytes: 93.6;Skeletal myocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.3;hTERT-HME1: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		46000000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587"	"prognostic favorable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.81e-6)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	19.0	4.1	14.2	2.2	15.6	3.8	10.4	3.2	16.9	8.0	20.2	9.3	4.7	3.7	2.1	2.1	4.3	1.9	12.1	18.3	8.2	38.4	4.8	2.4	0.5	7.6	8.2	4.6	4.7	2.4	5.5	1.2	6.2	2.3	7.3	7.7	7.8	2.1	26.1	3.6	5.1	2.9	11.2	1.3	5.5	5.4	7.0	3.1	13.0	12.2	0.5	4.1	4.2	13.8	1.8	5.6	8.0	9.4	59.3	5.6	9.0	13.7	10.8	12.4	12.2	15.1	1.9	4.8	6.2	24.0	20.5	2.4	10.3	2.2	10.8	15.2	1.0	0.6	22.8	10.1	2.0	1.6	0.4	10.3	5.6	16.6	48.9	7.1	0.5	5.7	0.6	0.2	21.0	7.5	0.7	0.6	14.2	26.3	4.1	5.8	20.3	5.8	6.5	11.6	1.9	9.3	10.6	1.1	3.5	17.1	2.9	3.6	3.9	22.2	30.0	36.3	35.6	0.3	0.9	3.1	10.1	3.4	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	15.6	3.2	16.9	18.3	8.2	7.6	8.2	6.2	11.2	7.0	13.8	11.5	0.0	3.2	50.6	1.1	2.4	1.8	0.7	1.2	18.6	16.5	10.2	41.1	5.7	0.9	27.6	37.5	1.2	0.7	39.0	11.7	3.5	4.3	10.9	14.3	9.0	2.4	37.7	153.7	3.9	29.7	21.5	40.8	17.4	0.0	9.3	3.3	12.6	4.9	48.8	127.2	20.0	6.1	6.2	3.1	5.2	11.8	5.5	0.0	139.6	0.8	11.1	1.0	108.6	93.6	3.7	21.0	15.8	0.7	1.5	14.6	35.1	0.1	48.3	0.0	135.6	12.3	6.7	24.5	3.1	1.6	1.4	1.3	25.8	37.7	1.7
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186069155-186088073	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.7;Early spermatids: 70.2"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 10.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 5.5;memory CD8 T-cell: 5.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 20.0;BJ hTERT+ SV40 Large T+ RasG12V: 30.2;CAPAN-2: 48.4;HDLM-2: 19.3;HSkMC: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025658: "	"unprognostic (2.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.83e-1)"	7.3	5.5	0.8	3.3	0.8	0.3	6.7	1.3	1.1	5.4	1.7	11.7	18.2	6.1	3.3	9.0	10.1	11.3	3.3	0.9	1.6	11.8	14.7	11.5	0.9	3.0	1.2	8.8	5.8	4.1	0.5	17.3	2.7	7.6	12.5	1.6	10.5	10.9	1.0	3.3	16.8	8.3	2.2	5.2	10.9	5.4	1.1	2.5	7.5	3.3	2.0	8.4	2.7	2.5	3.5	0.9	0.5	0.0	19.3	20.0	1.6	0.1	14.4	8.8	30.2	0.0	48.4	0.1	2.0	2.1	17.2	4.9	0.0	10.3	1.5	19.3	0.2	3.1	0.7	0.0	8.6	3.2	1.2	20.0	3.9	11.8	0.5	5.3	4.2	3.3	0.0	0.0	5.1	0.0	3.7	0.0	1.5	0.0	0.6	4.6	0.0	0.2	8.2	5.0	0.0	0.1	2.6	2.1	4.0	0.2	0.6	0.0	3.0	1.5	1.0	0.0	2.1	0.0	0.0	0.0	4.1	2.0	3.4	0.5	0.0	0.0	5.5	0.0	3.1	0.0	1.2	5.9	2.0	0.0	0.8	2.7	0.2	0.6	0.0	0.0	0.1	0.9	0.8	0.8	1.3	1.1	0.9	1.6	3.0	1.2	2.7	2.2	1.1	2.5	12.9	19.2	7.8	0.3	0.8	3.8	5.2	8.1	9.1	0.1	4.0	3.4	1.4	12.8	13.2	14.7	0.0	20.5	2.0	33.7	0.0	10.3	70.2	8.5	5.4	5.8	1.2	4.4	0.1	10.1	4.2	10.8	8.6	19.7	2.5	5.0	6.1	7.9	2.6	0.0	0.0	6.4	4.1	0.6	5.0	6.4	8.4	3.6	0.0	10.3	0.0	4.8	4.1	0.5	0.0	5.8	8.4	3.8	0.5	2.2	20.7	4.9	7.5	0.6	0.0	6.7	3.3	0.1	0.4	7.3	1.0	19.6	1.3	3.1	4.6	5.2
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867072-12890361	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 6.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.1;dendritic cells: 24.1;Hofbauer cells: 24.6;Macrophages: 20.2;Microglial cells: 14.0;monocytes: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 20.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 16.3;U-266/70: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059613	Supported					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA059613: AB_2684083"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.34e-1)"	1.1	1.6	1.3	4.3	1.2	0.6	4.1	1.6	1.3	1.3	1.0	1.9	1.8	0.9	0.5	0.6	0.8	2.9	0.7	1.1	1.5	0.6	0.6	4.6	4.3	3.5	2.5	0.7	0.3	0.9	0.2	6.4	3.5	0.8	2.3	0.1	1.4	1.0	0.1	0.1	1.8	2.0	3.4	3.8	1.7	0.5	2.7	3.8	0.4	0.3	5.6	2.5	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.3	0.0	3.1	0.0	0.3	0.0	0.4	10.0	4.5	0.0	11.6	0.0	8.7	0.0	0.0	4.9	7.2	0.0	0.0	0.5	0.1	9.7	20.7	0.0	3.3	1.3	1.2	1.6	1.3	1.1	1.5	3.5	2.5	3.5	3.4	2.7	6.1	0.2	0.0	3.9	0.0	10.1	1.3	1.3	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.6	0.0	2.1	0.3	24.1	0.0	0.0	0.0	0.0	0.3	0.2	1.3	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.5	1.3	0.0	0.7	0.2	24.6	0.0	0.1	0.0	0.0	6.2	8.1	0.7	0.6	20.2	1.8	14.0	11.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	5.7	0.9	0.0	0.0	2.2	0.7	0.0	4.5	0.5	0.0	0.1	0.1	1.0	0.3	2.5	0.1	0.0	1.6
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.7;lymphoid tissue: 16.8"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 49.8;Macrophages: 21.1;monocytes: 39.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	74	"classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	78	"dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001608	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	3.6	0.5	0.2	16.8	0.2	5.7	0.9	0.2	0.3	0.7	0.5	1.7	0.8	0.4	0.1	0.9	0.6	2.5	0.8	0.1	0.3	0.5	2.2	10.7	6.1	1.1	0.7	0.4	0.6	0.3	0.1	4.3	0.8	0.3	1.8	0.0	0.3	0.2	0.2	0.2	1.5	3.8	0.5	13.3	0.8	0.4	0.4	1.7	0.4	1.3	1.9	3.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	14.9	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.0	27.6	0.0	15.6	0.0	0.0	3.8	0.2	0.2	0.2	0.3	0.1	0.3	1.1	0.7	0.8	0.5	0.4	0.9	0.0	0.0	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.7	5.3	0.0	0.0	0.0	0.0	49.8	5.1	0.0	0.0	21.1	0.0	0.0	39.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"brain: 9.0"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Group enriched"	"Detected in many"	6	"cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	2.3	0.6	1.0	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA046058: AB_2679519, HPA055621: AB_2682865"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	30.9	36.3	25.4	16.5	26.0	23.2	35.8	27.3	36.5	29.4	27.6	27.7	20.5	30.3	45.3	21.4	29.9	26.0	45.4	25.2	27.0	38.8	29.3	27.4	26.5	26.7	27.0	36.4	21.8	41.6	20.4	35.7	26.8	33.3	28.5	26.2	30.1	22.5	40.9	19.8	25.0	29.3	27.1	23.9	24.4	34.9	25.9	25.1	40.6	35.3	20.3	30.1	20.7	28.4	31.3	15.0	22.8	18.2	68.1	66.2	29.2	54.5	55.2	26.4	35.0	9.7	39.0	25.3	70.9	45.9	52.7	34.8	29.2	39.7	40.5	41.3	34.4	28.2	23.0	21.8	66.7	40.9	48.0	74.2	67.0	30.5	38.0	64.4	50.5	33.6	32.7	47.7	64.7	10.1	20.9	32.0	24.9	27.5	21.4	17.9	43.1	31.5	78.4	24.3	25.4	30.9	32.5	64.1	102.6	30.5	35.1	43.2	45.3	35.3	17.8	19.8	41.9	40.0	39.4	30.8	61.3	39.4	31.8	52.8	18.7	44.9	16.1	23.7	16.6	24.2	18.6	19.7	18.6	20.1	17.2	19.9	12.2	23.3	26.8	36.4	24.3	19.4	25.4	26.0	27.3	36.5	25.2	27.0	26.7	27.0	26.8	27.1	25.9	28.4	49.5	41.7	40.2	32.3	49.0	78.3	91.9	205.2	59.2	60.3	67.7	56.6	40.5	48.6	99.9	79.1	60.5	51.2	47.4	46.5	39.2	50.3	6.5	43.3	34.7	59.2	43.9	42.1	42.3	45.3	60.0	84.3	29.0	42.2	61.5	37.6	80.7	54.2	50.3	69.0	46.9	41.3	158.7	58.7	53.8	9.9	79.9	48.1	90.7	43.1	54.1	99.2	63.8	50.3	63.4	54.2	60.4	53.0	51.4	110.0	45.9	67.6	100.0	70.1	39.5	75.3	60.0	172.1	72.5	58.6	76.4	53.5	47.3	42.0	43.0	110.1
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: AB_2679957, HPA050547: AB_2681168"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	20.2	24.4	15.6	15.9	17.3	13.1	19.8	18.2	22.2	19.7	24.4	15.7	18.0	18.4	26.5	16.5	17.4	23.1	19.5	17.5	18.6	32.9	29.8	20.6	17.7	16.5	17.4	22.0	13.9	23.6	15.9	33.8	17.6	22.2	16.3	17.1	17.8	22.1	15.6	18.5	16.2	17.8	17.2	22.3	19.6	27.6	18.0	11.8	26.4	17.6	15.2	20.0	16.6	19.7	35.7	56.5	25.7	35.7	58.8	39.0	35.4	73.8	44.9	54.6	49.1	43.4	30.0	12.5	56.7	54.9	61.5	37.8	27.5	44.5	59.0	15.0	21.7	28.6	32.3	47.3	51.8	8.6	35.3	47.9	42.8	43.1	20.9	40.0	71.1	21.2	32.2	35.7	73.5	22.1	21.3	28.9	32.6	53.2	22.0	17.8	33.2	21.0	62.2	27.9	8.6	16.9	28.2	19.5	37.8	45.1	48.1	17.9	64.6	44.0	33.0	64.9	37.7	24.9	59.1	21.9	33.6	19.4	31.6	64.5	28.5	27.3	29.7	34.2	33.3	24.9	35.1	33.0	30.4	26.2	33.1	32.0	7.9	33.0	29.8	60.5	41.8	35.3	15.6	17.3	18.2	22.2	17.5	18.6	16.5	17.4	17.6	17.2	18.0	19.7	30.4	12.8	14.7	3.9	13.8	35.1	56.9	64.3	20.5	25.1	22.5	25.1	17.7	32.9	44.5	51.5	20.9	91.3	28.2	12.9	29.4	59.9	62.2	24.1	33.3	36.0	10.3	5.9	7.6	38.4	98.2	38.6	17.3	25.8	22.2	44.3	58.2	38.4	218.5	23.5	9.2	12.6	40.7	33.6	33.9	46.6	36.1	40.6	26.6	7.5	70.8	45.4	15.5	6.0	5.4	74.9	19.4	24.8	14.5	52.5	35.1	61.4	29.4	34.0	0.0	25.4	26.5	60.8	58.1	16.3	15.5	79.9	17.8	39.3	16.7	48.5
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377692	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 5463.1;Endothelial cells: 1843.0;Pancreatic endocrine cells: 2557.3;Prostatic glandular cells: 2717.0;Urothelial cells: 4902.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 703.8;hTERT-RPE1: 925.5;HUVEC TERT2: 633.3;LHCN-M2: 687.7;OE19: 672.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	365.9	71.3	41.9	50.5	43.1	2.6	192.8	44.1	68.2	82.6	65.6	61.6	38.3	74.9	58.2	210.9	74.7	237.6	181.7	42.2	45.2	155.1	92.6	229.8	25.2	45.1	43.9	49.7	211.7	19.9	20.2	194.6	47.7	79.9	59.9	6.0	180.9	32.0	50.2	63.5	62.2	94.6	45.4	120.5	129.7	19.5	53.5	17.0	72.5	64.2	60.2	150.9	115.5	45.9	367.9	401.9	0.0	1.0	108.4	422.2	0.6	115.2	455.5	23.9	8.8	159.7	703.8	0.1	351.3	23.5	545.5	434.0	1.9	80.0	22.9	0.9	0.0	3.9	391.8	521.8	39.4	0.0	0.5	40.0	19.1	169.7	81.5	925.5	633.3	0.0	0.3	0.8	687.7	0.5	0.0	0.7	1.5	672.9	170.7	0.2	0.9	0.8	449.3	54.8	0.2	0.5	46.8	25.1	4.4	6.0	0.8	1.7	404.7	233.6	38.9	4.8	244.3	0.5	0.7	1.1	337.4	0.4	62.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	43.1	44.1	68.2	42.2	45.2	45.1	43.9	47.7	45.4	53.5	45.9	1131.0	576.9	342.3	0.3	7.5	278.0	5463.1	668.3	272.6	0.1	956.5	363.1	24.0	274.5	984.3	57.0	0.0	0.8	17.0	176.6	0.0	1383.5	5.2	514.1	168.0	1843.0	39.2	15.6	0.0	1600.9	0.9	297.2	147.8	1807.5	31.5	0.2	1263.6	21.8	1.9	0.0	0.0	15.9	382.5	27.8	222.1	11.3	255.7	35.6	300.6	30.9	26.4	0.0	0.0	0.0	0.3	2557.3	251.8	176.0	11.1	2717.0	0.3	1.2	238.5	0.0	322.1	37.7	311.0	6.6	1.4	925.8	253.7	1.4	44.1	44.2	46.6	4902.9
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.9"	"Group enriched"	"Detected in many"	4	"Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2"					"Low region specificity"	"Detected in many"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	21.3	5.2	9.4	4.9	9.6	0.1	16.3	9.2	11.5	8.3	10.4	3.4	3.9	7.6	4.7	3.4	6.4	10.6	8.4	9.1	10.3	19.1	7.9	9.2	6.6	12.2	9.6	3.2	9.8	6.8	3.1	17.4	11.5	4.0	3.3	1.1	4.0	6.5	5.9	2.4	3.6	14.9	10.0	33.9	3.4	1.9	12.1	2.1	12.7	5.7	5.0	6.7	2.5	10.4	0.1	94.8	3.5	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	1.2	0.0	194.9	0.0	38.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.3	0.1	0.7	0.0	0.0	0.0	24.7	65.9	0.0	0.0	0.0	6.2	0.7	0.0	0.2	47.2	0.0	0.0	0.1	2.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	1.5	0.1	0.1	8.4	0.1	1.2	0.0	0.5	0.1	0.1	0.5	0.0	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.4	9.6	9.2	11.5	9.1	10.3	12.2	9.6	11.5	10.0	12.1	10.4	226.1	0.0	4.4	0.3	1.6	3.2	0.2	0.0	0.6	0.2	41.4	23.9	2.8	4.3	0.0	1.8	0.0	0.0	1.0	0.0	9.8	35.2	0.4	0.7	1.1	188.9	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.9	1.3	0.3	151.0	1.1	0.1	0.0	0.1	0.0	0.0	9.1	3.0	1.8	2.1	1.2	1.8	33.7	0.6	0.4	0.0	0.5	0.6	0.9	0.0	6.8	2.5	1.3	0.0	35.8	0.7	0.0	0.0	1.5	2.5	0.2	0.5	0.2	2.8	0.0	1.1	5.2	0.0	0.6
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 266.6"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.2	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.4	3.1	266.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.3	0.0	0.0	0.0	0.3	144.5	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107572-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 195.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"			"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	6.5	3.9	5.4	5.2	6.0	5.3	4.6	7.7	8.8	3.3	6.3	2.6	2.0	2.8	2.1	3.1	2.8	3.7	9.6	5.2	5.6	1.9	2.3	10.7	5.7	6.8	6.0	1.7	1.2	1.8	0.9	7.8	6.6	2.1	2.6	2.8	2.9	1.3	47.3	1.8	2.6	3.9	6.9	6.2	2.1	3.6	5.4	2.2	10.4	21.8	3.0	3.8	1.5	7.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.3	5.6	0.0	0.2	0.0	0.3	0.1	1.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.3	23.2	0.0	0.0	49.6	1.6	0.1	0.2	0.0	0.0	0.1	0.3	27.7	36.4	0.9	0.0	0.4	0.0	0.0	3.0	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.4	1.2	0.3	0.2	0.0	1.9	0.5	0.0	14.9	68.3	0.6	0.9	0.1	0.3	2.1	0.0	17.0	0.1	3.4	0.1	76.6	31.7	195.8	5.0	13.4	0.0	0.3	0.5	0.8	18.9	0.9	0.1	0.8	118.1	5.0	6.4	2.6	0.0	11.8	5.4	6.0	7.7	8.8	5.2	5.6	6.8	6.0	6.6	6.9	5.4	7.6	30.5	0.0	6.0	2.9	0.9	2.4	0.1	0.4	0.6	1.6	0.5	1.8	1.2	1.5	0.8	0.0	0.0	0.3	7.5	0.0	0.0	0.2	13.1	0.6	0.2	16.7	0.0	4.4	18.7	2.0	0.4	1.5	0.0	0.3	44.4	0.0	7.9	0.1	50.9	0.0	22.4	0.0	0.0	37.8	46.4	7.4	0.9	45.9	3.6	46.9	19.4	0.5	16.5	2.0	1.9	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.4	1.3	0.0	1.4	0.6	13.1	7.5	0.1	1.7	0.3	4.2	0.1	0.0	0.1
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 75.5;liver: 33.7"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	1.0	0.4	2.2	75.5	0.6	0.2	0.1	0.3	0.5	0.5	0.2	0.7	3.3	33.7	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.0	0.0	0.1	0.3	0.0	0.1	68.8	0.3	0.1	0.1	2.4	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.7	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 246.0"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 38.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	63.4	246.0	27.8	2.6	28.5	4.1	29.1	32.8	33.9	17.4	64.1	7.8	9.4	3.4	17.0	39.6	12.8	7.0	47.3	30.0	29.7	18.9	86.4	10.1	3.4	34.0	32.0	36.5	69.9	36.3	19.5	3.9	32.5	41.1	3.9	6.0	46.9	6.0	7.1	68.2	8.3	1.9	30.1	5.1	35.6	11.5	32.6	5.6	15.5	3.7	8.4	5.5	22.1	35.1	7.7	10.9	27.3	35.1	8.1	1.3	15.4	1.8	4.5	2.7	3.0	26.0	35.8	16.3	26.9	2.2	1.0	13.3	11.6	21.2	1.9	16.7	5.0	10.2	2.7	54.5	18.8	4.2	10.6	3.7	5.0	14.6	3.9	12.6	3.9	28.7	5.8	13.9	0.8	69.2	8.3	18.6	12.6	18.4	11.2	22.4	1.2	39.9	86.2	12.6	27.2	30.5	1.2	28.2	6.1	19.5	143.9	11.4	3.1	0.4	3.4	3.8	2.3	27.1	18.1	8.4	2.5	5.9	1.0	1.1	1.6	3.4	9.1	1.5	7.0	12.4	5.6	7.8	1.5	11.9	11.8	9.0	1.1	12.5	0.9	38.1	5.6	4.9	27.8	28.5	32.8	33.9	30.0	29.7	34.0	32.0	32.5	30.1	32.6	35.1	4.0	9.6	43.7	23.5	12.7	1.9	6.2	33.6	5.7	19.2	52.2	38.5	99.4	52.9	36.6	44.1	10.4	72.9	16.3	23.3	17.6	27.1	28.8	17.9	2.6	5.7	59.4	13.7	11.6	27.7	4.6	4.3	31.1	16.5	7.0	482.7	5.0	220.6	15.6	25.2	15.3	21.8	52.9	6.3	2.7	59.3	9.9	5.8	12.4	2.8	9.4	204.7	7.2	17.1	36.5	21.7	23.7	2.2	12.9	31.3	29.0	77.5	37.9	23.6	13.1	1.6	21.8	13.3	17.9	18.0	7.0	82.1	8.3	204.8	19.0	10.4
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189149-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	28.0	35.2	7.5	10.5	7.6	3.7	25.6	7.9	7.9	29.2	18.2	23.9	12.7	31.1	31.3	25.4	27.9	17.5	21.7	7.4	7.7	25.1	34.6	26.7	7.7	8.8	9.4	24.8	46.8	36.6	20.0	18.1	8.4	23.4	15.5	5.9	35.6	21.3	19.5	24.2	21.4	18.1	8.5	19.4	29.4	20.2	8.3	8.3	30.7	11.1	12.4	23.8	23.6	8.4	22.0	45.1	17.7	18.0	59.4	40.4	22.4	37.6	55.4	53.7	60.5	19.1	49.0	12.5	25.2	50.3	30.7	50.5	14.9	29.7	39.3	18.4	15.4	9.4	21.3	56.2	41.8	18.5	22.8	41.3	56.1	36.9	50.5	42.3	32.3	7.9	11.2	30.7	43.6	51.2	12.1	15.7	8.4	62.1	39.2	15.6	22.1	24.7	42.5	37.9	16.3	18.6	39.0	44.3	24.5	16.8	28.8	14.1	26.0	47.5	21.2	23.1	28.1	31.0	25.5	7.4	18.1	11.5	39.5	33.4	20.5	25.0	14.1	18.1	15.3	15.0	14.6	12.6	23.4	16.3	13.0	12.9	28.3	23.1	18.5	39.2	17.2	13.5	7.5	7.6	7.9	7.9	7.4	7.7	8.8	9.4	8.4	8.5	8.3	8.4	5.5	16.0	5.3	8.8	11.2	3.3	6.1	7.3	18.8	4.4	6.1	5.0	1.5	7.2	7.6	1.8	14.6	9.8	5.0	4.0	0.0	8.2	13.9	5.2	7.4	8.7	1.8	5.5	6.6	4.9	10.4	14.9	13.7	6.3	2.5	5.3	5.0	4.8	4.1	0.0	7.1	3.5	6.1	2.5	4.5	6.2	5.3	5.6	1.8	4.7	5.3	5.4	4.1	9.0	7.3	5.3	6.1	4.5	54.3	7.7	3.5	3.0	30.0	7.6	6.6	10.1	7.4	7.0	5.4	19.5	4.7	11.9	9.1	5.7	4.1	3.8
TM9SF2	P76	ENSG00000125304	"Transmembrane 9 superfamily member 2"	Q99805	13	99446311-99564048	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005657	Supported					NA	NA		2100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA005657: AB_1080303"	"unprognostic (9.77e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.21e-7)"	"unprognostic (6.49e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.21e-1)"	66.6	67.2	34.4	66.7	37.4	64.6	90.6	35.9	41.4	100.2	62.5	115.8	119.4	63.6	119.0	56.1	76.6	73.6	51.0	35.8	40.3	108.4	169.4	78.6	62.1	35.9	35.1	53.2	90.2	126.8	41.5	98.2	36.6	97.8	123.7	41.9	109.6	73.2	36.3	56.6	119.3	65.7	39.8	62.4	104.1	59.6	36.9	49.7	121.2	48.3	71.3	90.0	44.4	44.9	187.3	56.7	75.8	107.8	223.2	134.8	108.2	124.1	154.5	86.6	134.8	93.1	234.7	72.1	100.0	150.1	88.4	183.1	81.1	108.7	117.8	80.8	57.8	89.6	90.9	100.2	118.0	235.8	100.0	106.2	132.4	75.1	76.8	133.2	110.4	72.8	90.7	70.0	103.0	62.8	59.1	91.9	66.3	335.7	70.0	49.3	61.0	78.7	178.9	137.3	71.7	87.5	71.7	285.6	94.8	145.5	174.0	280.5	109.1	69.6	50.7	70.5	77.8	96.6	120.8	29.0	163.8	120.0	103.0	192.4	156.4	174.9	57.7	180.5	72.8	86.9	68.4	65.3	139.6	60.1	62.8	58.4	251.3	76.0	182.1	159.6	109.6	178.1	34.4	37.4	35.9	41.4	35.8	40.3	35.9	35.1	36.6	39.8	36.9	44.9	68.9	83.3	76.3	29.0	72.5	40.9	57.3	132.8	48.9	20.6	82.9	40.5	44.0	70.1	170.7	86.5	18.8	99.3	94.5	141.1	11.7	98.6	149.2	101.0	75.6	65.4	83.0	47.9	36.6	102.7	122.8	74.6	89.2	93.9	54.5	35.2	87.4	172.9	116.0	21.9	44.4	167.9	128.1	137.6	57.2	41.8	50.1	100.7	72.9	44.0	97.4	42.7	42.2	34.2	44.8	83.4	116.7	52.3	143.1	69.0	123.5	70.8	187.7	25.3	19.7	44.1	104.1	109.7	56.3	69.8	52.1	171.4	53.2	43.2	119.4	104.0
TM9SF3	SMBP	ENSG00000077147	"Transmembrane 9 superfamily member 3"	Q9HD45	10	96518110-96587452	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039609	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		240000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"HPA039609: AB_10673535"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.18e-2)"	57.0	53.4	28.5	54.6	33.0	36.7	58.4	33.2	34.8	65.3	34.9	111.8	116.9	62.5	69.2	57.5	46.0	89.9	39.7	27.7	34.4	68.0	75.0	43.2	42.0	33.8	31.2	62.9	73.3	70.1	22.5	67.8	35.2	91.7	94.5	43.4	83.2	56.4	26.6	38.5	112.4	50.8	35.7	41.8	183.5	34.6	30.7	44.7	87.4	41.1	44.9	72.8	34.8	43.6	146.8	97.2	106.5	149.3	151.4	112.4	127.7	197.8	146.7	84.0	67.5	116.4	281.6	107.3	107.0	175.8	105.5	135.3	97.6	108.1	156.8	121.3	83.6	95.3	81.8	92.0	114.5	197.7	107.2	105.0	108.6	118.6	203.7	253.2	94.7	96.4	97.0	119.9	132.2	66.4	77.1	76.2	68.9	237.9	59.6	94.6	134.4	84.8	120.1	106.8	49.6	110.3	104.1	98.6	103.0	126.2	171.0	73.7	165.3	103.5	87.1	104.6	183.1	123.7	152.3	98.4	140.9	134.9	73.5	5.7	2.2	3.8	3.5	2.3	4.0	2.1	3.6	3.9	2.7	1.5	2.7	3.6	2.4	3.9	2.4	7.1	4.0	1.3	28.5	33.0	33.2	34.8	27.7	34.4	33.8	31.2	35.2	35.7	30.7	43.6	115.7	51.3	43.0	43.1	53.2	116.8	118.8	63.2	51.8	57.8	103.1	73.0	65.0	121.5	88.2	141.6	56.3	77.5	89.5	238.7	21.5	80.7	27.6	93.0	162.0	99.8	123.9	68.8	59.9	146.1	97.6	98.7	212.0	192.2	40.6	75.0	78.9	126.9	60.0	58.9	64.0	368.3	69.2	85.6	125.3	12.8	93.2	73.5	103.2	49.6	56.8	58.1	54.6	69.9	79.2	132.1	140.6	82.4	88.9	196.1	141.5	59.3	65.9	54.7	65.7	89.2	121.0	45.8	38.4	73.2	120.6	140.9	63.0	74.5	246.7	156.2
TM9SF4	"dJ836N17.2, KIAA0255"	ENSG00000101337	"Transmembrane 9 superfamily member 4"	Q92544	20	32109714-32167258	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064099	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA064099: AB_2685190"	"unprognostic (3.10e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.37e-6)"	"unprognostic (3.85e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	23.4	21.1	16.7	23.4	16.9	16.3	22.6	14.8	19.5	26.5	20.7	32.1	29.6	25.0	30.4	30.3	34.8	22.1	24.4	17.6	17.9	26.6	33.7	24.4	18.9	15.3	15.8	28.7	30.5	52.6	17.0	39.6	16.3	28.0	37.2	17.7	30.7	26.8	23.3	32.0	29.0	31.8	14.0	23.6	29.8	18.0	18.9	21.0	24.7	24.3	24.2	27.9	22.9	16.2	59.0	41.1	46.1	53.2	88.7	71.9	59.1	47.8	71.9	65.6	63.7	122.2	71.1	41.0	88.2	78.2	102.4	94.8	52.4	101.9	56.4	23.5	29.4	94.4	34.6	93.1	78.3	45.9	52.0	76.2	76.3	49.7	79.6	80.3	59.1	48.3	60.4	74.5	51.8	62.5	46.5	36.4	41.2	71.2	50.0	43.9	65.1	51.4	57.2	41.3	39.0	45.7	88.6	57.7	51.4	61.0	72.4	52.0	48.5	119.2	36.7	63.7	59.1	74.9	65.9	38.2	94.4	149.6	54.6	24.0	48.4	9.9	20.0	50.5	24.8	16.5	17.7	22.9	41.8	13.1	19.4	16.4	11.7	18.8	67.8	13.7	19.1	34.6	16.7	16.9	14.8	19.5	17.6	17.9	15.3	15.8	16.3	14.0	18.9	16.2	16.4	25.6	25.2	33.0	16.2	7.0	17.4	27.1	17.6	12.2	15.7	16.1	16.0	14.3	36.5	9.2	16.7	29.4	11.9	25.2	1.9	19.0	53.5	18.0	25.2	18.4	13.9	12.4	31.2	18.5	21.7	20.4	23.4	24.9	8.2	19.3	16.8	26.2	24.0	8.4	37.1	31.7	20.3	19.1	10.5	57.5	16.8	22.5	7.2	24.4	25.2	14.0	10.3	28.6	34.8	19.8	25.7	10.9	23.1	22.1	29.8	14.0	32.8	12.3	6.6	19.9	25.8	26.5	9.7	21.8	11.4	37.6	16.8	23.4	27.5	21.9
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.4	11.9	4.4	17.9	4.6	12.5	18.0	5.4	6.7	10.8	5.1	13.0	11.0	15.8	6.9	14.3	11.4	9.9	9.2	4.4	5.1	12.1	13.5	8.9	22.0	4.8	4.7	16.8	14.8	9.5	5.3	14.0	5.0	11.8	11.8	5.7	14.4	9.9	9.6	14.4	10.1	13.0	4.9	16.1	12.8	26.7	4.5	19.1	11.6	7.6	20.0	13.9	10.8	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.4	4.6	5.4	6.7	4.4	5.1	4.8	4.7	5.0	4.9	4.5	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274197-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 573.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	231.0	120.9	118.0	84.1	135.0	96.1	165.5	124.8	123.6	146.8	112.1	143.1	152.6	119.7	92.9	333.4	97.3	135.5	123.3	109.4	131.2	123.5	170.8	175.1	55.4	194.5	144.0	93.5	240.3	125.6	50.2	172.7	150.7	97.6	140.7	15.2	155.1	89.5	219.1	185.3	174.6	127.1	139.8	65.9	212.3	25.4	134.1	41.9	158.0	185.2	106.8	172.9	215.1	144.2	183.9	66.4	3.5	47.1	404.3	170.6	188.7	175.5	217.9	103.4	117.7	169.8	449.0	40.6	123.3	263.0	194.6	305.3	59.8	399.9	100.4	151.0	23.5	264.6	41.8	205.6	183.3	2.4	252.4	161.1	370.7	210.4	265.6	108.4	111.8	6.7	169.0	75.0	182.9	6.1	2.8	46.5	2.5	382.3	60.4	5.7	28.3	33.1	142.1	573.4	2.2	3.1	58.0	214.7	122.8	36.6	56.3	39.8	168.4	182.4	50.1	84.9	64.8	35.9	45.2	17.7	179.9	41.0	105.5	352.9	136.4	298.5	107.9	172.7	91.8	77.1	98.0	89.1	93.3	61.9	64.3	70.2	167.1	66.7	221.9	25.9	116.1	190.1	118.0	135.0	124.8	123.6	109.4	131.2	194.5	144.0	150.7	139.8	134.1	144.2	47.6	73.7	25.6	20.9	37.2	81.7	96.9	85.0	51.2	2.0	28.8	26.0	26.4	78.6	66.9	69.9	0.0	139.1	51.8	266.8	13.7	175.5	0.6	45.6	42.6	50.8	22.7	66.3	2.4	281.2	146.8	61.9	110.6	78.4	50.0	16.1	28.9	50.4	104.9	0.0	2.5	67.9	52.9	45.1	50.2	2.8	54.0	69.6	46.2	14.0	22.0	22.9	48.4	5.0	35.2	294.3	177.3	59.5	30.3	151.8	204.4	37.7	34.8	1.9	13.1	35.7	45.0	1.4	12.5	86.5	101.2	282.1	41.3	9.9	69.1	299.8
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1803.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2394.6;Late spermatids: 2375.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017378: AB_2669604"	"prognostic unfavorable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favorable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	333.4	364.8	332.1	276.3	361.6	315.4	416.8	347.5	376.4	413.7	528.2	493.6	475.8	252.3	640.9	406.3	431.1	360.3	215.5	301.1	358.3	1144.5	1803.2	423.3	292.3	374.4	346.9	281.2	574.2	577.5	133.7	303.1	378.7	383.2	494.4	305.0	479.8	409.3	232.1	231.4	536.1	294.7	351.9	267.8	549.8	247.9	366.9	313.0	596.4	232.3	332.3	406.2	216.5	395.2	609.6	516.6	413.3	381.1	1169.3	645.1	513.6	450.2	854.0	572.0	519.7	837.6	1703.8	380.3	746.9	882.6	598.6	648.1	363.7	659.4	619.2	551.7	390.3	606.2	367.8	414.0	707.7	701.9	959.4	657.5	1511.3	640.9	925.8	809.3	481.6	461.0	556.2	1526.5	662.5	589.5	362.1	424.2	432.1	730.6	392.2	302.8	413.0	651.0	871.5	909.9	319.0	208.7	603.5	786.1	511.2	530.7	989.4	731.6	456.8	522.6	393.9	355.8	396.9	654.2	717.8	326.8	730.9	324.3	260.8	896.4	749.8	795.5	559.9	721.8	587.8	403.6	501.1	558.5	585.5	356.6	438.9	501.8	1242.0	463.8	769.5	587.0	544.8	1813.1	332.1	361.6	347.5	376.4	301.1	358.3	374.4	346.9	378.7	351.9	366.9	395.2	428.2	477.5	455.5	80.6	314.2	261.0	535.0	836.9	222.5	245.8	526.8	337.6	221.0	571.9	766.5	544.4	114.7	406.9	366.7	995.8	131.0	927.3	1504.8	340.5	240.0	321.9	294.9	232.7	43.9	816.9	913.0	336.0	325.7	501.9	257.7	194.5	358.7	2394.6	618.9	180.0	57.3	612.6	598.1	570.6	292.8	2375.1	288.6	458.2	247.3	58.1	540.3	467.7	285.3	94.5	115.5	846.7	651.3	287.3	589.8	550.0	1585.8	809.6	874.1	154.8	170.9	191.7	361.1	458.1	214.7	272.7	235.0	891.0	315.9	372.8	552.2	654.4
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331088-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	30	"parathyroid gland: 83.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.1	0.2	0.7	0.4	0.7	0.8	0.4	2.4	0.9	0.3	0.3	0.4	0.6	0.4	1.6	0.1	0.9	0.6	0.2	0.6	0.2	0.2	0.3	0.1	0.4	0.7	1.0	0.4	0.2	83.6	0.1	0.2	2.7	0.4	0.1	0.7	0.6	0.5	0.2	0.4	0.4	0.1	0.5	0.3	0.2	0.7	0.5	0.1	0.8	0.1	0.1	0.1	0.8	0.7	0.3	0.3	0.1	0.9	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.6	0.8	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.9	0.2	1.0	0.0	0.3	0.3	0.4	0.5	0.3	0.3	0.2	0.3	1.5	0.0	0.2	0.3	0.6	0.2	0.3	0.6	0.2	0.7	0.3	0.1	0.5	0.6	0.4	0.2	1.5	0.6	0.5	0.3	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.7	0.7	2.4	0.9	0.6	0.2	0.7	1.0	2.7	0.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.6	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMC4		ENSG00000167608	"Transmembrane channel like 4"		19	54160108-54173250	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"pancreas: 45.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 160.1;Paneth cells: 119.7;Proximal enterocytes: 228.6;Respiratory ciliated cells: 155.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 17.3;T-47d: 30.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA048635	Approved		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA048635: AB_2680470"	"unprognostic (7.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"prognostic favorable (1.54e-8)"	"unprognostic (6.70e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.79e-2)"	2.3	0.4	0.2	0.4	0.2	0.0	12.5	0.3	0.7	8.7	0.0	38.6	33.1	3.2	0.0	14.8	16.8	8.4	5.7	0.3	0.2	25.5	2.6	11.9	0.1	0.5	0.8	1.1	45.6	4.5	21.0	0.7	0.7	21.6	12.0	0.0	42.1	4.9	1.4	5.4	37.2	0.4	0.2	0.2	31.9	0.5	0.2	0.0	31.3	0.1	0.5	18.9	9.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	17.3	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.7	0.3	0.2	0.5	0.8	0.7	0.2	0.2	0.1	1.5	28.9	30.0	0.7	1.5	2.4	26.9	78.6	24.5	0.3	42.5	19.8	1.7	51.5	94.4	46.0	0.0	22.7	3.7	160.1	13.7	78.2	0.0	59.7	6.6	2.2	41.6	0.0	0.6	64.1	6.1	1.8	102.4	56.2	5.7	0.5	1.1	0.6	3.9	0.0	0.6	92.7	57.0	1.3	3.0	0.1	1.2	3.2	1.8	0.0	2.1	0.1	4.1	1.0	0.7	50.7	119.7	0.7	2.4	22.0	228.6	29.0	155.7	0.5	26.3	0.9	13.6	0.4	1.9	22.0	1.7	23.4	2.8	2.1	77.1	43.1
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.4;stomach 1: 46.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 69.7;OE19: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.6	0.1	0.2	3.1	0.4	1.5	12.7	0.5	0.3	8.9	5.6	21.6	45.4	2.1	17.5	1.2	5.1	25.5	0.1	0.3	0.0	0.3	0.6	18.9	0.2	0.2	0.2	0.1	2.3	6.0	0.1	3.2	0.2	12.2	22.7	0.2	22.8	0.2	0.1	1.8	53.4	1.1	0.0	0.1	46.0	3.8	0.2	0.1	0.7	0.0	1.1	3.2	0.5	0.2	6.9	10.8	0.0	0.3	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.1	69.7	0.0	0.3	0.0	0.2	4.4	1.1	0.0	0.0	0.1	0.1	0.0	1.8	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.1	0.0	0.2	2.5	41.5	3.1	0.0	0.0	2.6	0.1	0.3	0.7	0.2	0.1	2.1	0.0	1.1	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.1	157.0	162.5	0.0	1.8	0.8	22.9	46.6	2.8	0.3	57.4	17.9	0.9	102.9	282.4	22.0	2.1	39.0	1.0	173.7	0.0	121.1	32.8	107.0	6.9	2.9	38.9	8.0	1.9	166.3	3.4	3.3	188.1	88.4	5.7	11.0	0.7	0.6	2.7	3.3	2.0	101.5	26.4	0.0	1.1	32.6	0.3	1.8	1.8	0.0	1.0	0.2	0.0	0.5	0.9	302.2	180.9	0.7	0.5	103.1	374.3	2.0	624.7	1.9	0.0	0.4	9.5	1.3	1.1	2.2	1.7	16.3	1.3	1.5	125.1	55.9
TMC6	"EVER1, EVIN1, LAK-4P, TNRC6C-AS1"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78107397-78132407	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 110.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 108.7;SK-BR-3: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	29.5	6.8	19.2	45.4	50.5	72.7	25.2	43.4	33.5	11.3	5.2	23.5	21.7	7.6	1.0	25.4	14.1	9.7	35.9	19.3	26.4	20.6	9.1	40.3	69.7	59.3	49.7	3.8	14.6	3.1	5.6	8.8	55.9	20.2	6.6	0.6	29.3	7.9	3.5	17.9	50.6	3.5	35.8	110.5	14.6	2.6	48.4	26.3	12.9	1.8	32.4	14.6	18.4	81.9	17.9	14.0	7.5	6.0	0.0	0.0	15.2	0.0	0.0	0.2	0.2	25.2	19.2	19.7	23.7	0.0	6.3	31.0	1.0	5.9	0.0	2.0	11.3	41.3	4.2	31.0	1.9	38.3	67.0	1.1	16.2	0.0	1.3	0.2	14.7	9.2	108.7	73.3	0.0	36.1	18.9	65.4	5.9	32.9	4.9	8.4	0.6	58.9	11.4	65.1	1.9	4.9	5.7	121.0	33.2	9.7	68.7	57.6	5.2	0.0	8.7	0.1	0.3	57.6	27.3	13.2	0.0	60.4	1.0	17.7	11.6	23.2	56.2	38.3	49.0	28.5	41.7	46.2	18.6	21.7	36.5	39.6	15.3	35.8	63.5	5.7	38.0	33.5	19.2	50.5	43.4	33.5	19.3	26.4	59.3	49.7	55.9	35.8	48.4	81.9	43.8	41.7	29.6	8.1	69.5	11.1	21.0	22.3	7.4	3.2	17.4	6.5	14.7	10.0	41.5	16.5	0.0	1.2	79.8	25.0	0.0	41.2	0.3	5.1	1.6	19.7	9.1	28.4	0.2	23.1	26.4	4.6	10.2	8.0	40.5	0.7	23.6	2.2	67.0	1.7	0.2	14.0	40.7	66.2	29.9	1.2	9.6	44.7	14.2	20.6	62.0	7.5	85.5	1.5	50.8	40.5	53.7	1.2	62.6	31.5	20.3	2.0	20.3	1.8	13.1	4.6	13.5	0.5	2.2	8.4	10.2	3.7	83.7	2.5	30.3	37.4
TMC7	FLJ21240	ENSG00000170537	"Transmembrane channel like 7"	Q7Z402	16	18983934-19063942	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;testis: 9.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 172.0;Late spermatids: 44.6;Oligodendrocytes: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029465	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA029465: AB_10600914"	"unprognostic (1.80e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.60e-5)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (7.60e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (9.20e-4)"	2.1	0.2	6.0	1.0	15.8	0.3	1.7	12.4	10.6	0.5	0.4	3.8	2.5	0.7	0.6	0.4	0.4	1.4	1.4	7.0	9.0	0.6	0.3	2.9	0.3	13.8	13.2	0.2	0.4	0.4	0.3	4.3	12.6	1.5	4.5	1.1	0.4	0.9	0.9	1.1	2.7	1.1	7.5	0.6	3.1	9.6	15.0	0.2	0.8	0.9	0.2	8.1	0.8	23.9	1.9	3.5	1.0	1.9	0.2	1.6	4.8	0.6	1.0	0.7	1.5	1.2	8.5	0.2	7.9	0.7	1.8	6.8	2.9	2.8	0.9	0.1	2.0	0.1	3.6	5.5	0.2	0.2	0.1	0.3	4.1	6.5	7.2	2.2	2.6	3.8	2.2	0.2	2.8	3.9	0.3	0.3	3.1	11.1	5.1	0.2	3.1	0.2	1.3	8.7	0.6	1.9	2.1	5.4	0.6	4.9	1.7	0.6	2.3	1.1	1.8	1.3	3.3	0.4	0.9	0.2	5.4	0.3	1.0	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.3	0.1	0.2	0.1	0.0	6.0	15.8	12.4	10.6	7.0	9.0	13.8	13.2	12.6	7.5	15.0	23.9	12.6	3.2	6.2	3.9	0.1	0.4	4.4	3.2	0.0	0.6	1.3	0.4	0.7	1.5	2.0	0.0	0.0	0.2	0.0	13.4	0.0	4.1	172.0	1.4	0.4	4.9	1.2	2.7	7.5	11.0	2.3	0.6	9.2	2.4	0.0	1.2	4.6	0.2	0.2	0.0	12.1	6.0	4.1	0.0	1.2	44.6	1.2	0.6	0.0	6.5	0.2	0.3	2.1	6.6	96.5	14.0	8.0	0.4	0.1	2.3	3.6	0.3	0.9	2.7	0.0	1.6	2.2	6.9	12.1	1.9	1.0	0.3	0.4	0.1	7.6	17.3
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMCC1	KIAA0779	ENSG00000172765	"Transmembrane and coiled-coil domain family 1"	O94876	3	129647792-129893606	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Alveolar cells type 1: 54.5;Astrocytes: 119.1;Excitatory neurons: 206.7;Inhibitory neurons: 201.5;Microglial cells: 127.4;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053894	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA053894: AB_2682295"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (7.75e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (6.82e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	7.5	6.8	12.9	4.8	13.1	3.2	7.3	23.5	14.8	9.8	1.1	6.7	4.1	7.8	6.7	7.6	6.9	8.6	8.2	10.8	12.1	6.7	34.5	6.7	5.0	10.1	13.1	8.0	4.8	7.8	6.5	9.8	9.9	7.5	5.1	15.2	5.5	6.2	30.1	7.7	4.4	6.8	10.0	6.8	4.0	13.5	16.9	8.3	6.8	21.1	5.5	7.8	6.9	14.5	10.6	11.3	8.8	7.2	12.9	9.1	8.9	4.1	5.4	3.6	3.7	7.3	5.7	6.5	11.4	7.9	4.2	9.6	5.0	8.2	2.6	8.6	1.6	4.3	3.4	26.7	4.4	3.2	2.6	5.3	15.1	2.8	6.7	7.7	11.0	3.9	2.2	4.7	8.2	11.6	5.7	1.9	6.7	7.7	3.6	5.2	7.4	5.5	8.4	12.9	8.2	5.7	14.0	4.8	4.1	8.5	9.2	3.5	9.6	5.7	9.2	5.3	8.5	6.9	5.1	4.8	4.2	3.8	3.0	0.6	0.9	2.1	1.1	0.9	1.2	0.7	0.9	0.9	0.5	1.1	1.1	1.4	9.6	0.8	2.0	1.4	1.9	0.8	12.9	13.1	23.5	14.8	10.8	12.1	10.1	13.1	9.9	10.0	16.9	14.5	14.1	54.5	7.4	119.1	9.4	6.6	12.6	9.9	12.5	37.1	17.4	12.1	23.0	7.2	16.0	22.0	31.3	10.6	8.3	9.0	7.9	15.8	9.6	30.5	14.6	13.2	12.6	4.6	206.7	8.1	20.7	10.9	10.2	38.3	3.8	12.0	9.7	36.8	9.9	35.3	201.5	12.2	10.2	18.6	6.6	10.5	13.1	13.5	1.8	127.4	6.8	27.0	12.3	181.0	209.2	24.9	22.8	8.6	14.5	20.4	4.7	13.1	19.6	29.5	6.6	18.1	12.2	33.5	19.4	15.8	7.0	23.9	8.9	9.6	8.3	25.2
TMCC2	"FLJ38497, HUCEP11"	ENSG00000133069	"Transmembrane and coiled-coil domain family 2"	O75069	1	205227946-205285632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 88.1;brain: 47.3"	"Cell type enriched"	"Detected in many"	8	"Erythroid cells: 622.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014254	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA014254: AB_1851326"	"unprognostic (2.59e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.18e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.99e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.43e-3)"	1.4	2.6	15.2	0.4	24.2	88.1	0.9	18.7	47.3	1.8	0.0	2.5	0.3	1.6	0.0	0.7	2.0	0.3	3.6	25.2	16.1	1.4	0.7	3.1	0.3	38.5	26.1	3.1	0.5	3.1	5.0	5.3	41.0	1.0	0.1	8.5	0.9	0.3	3.5	1.7	0.9	0.5	17.3	16.0	0.9	2.0	25.5	0.7	1.3	1.5	0.2	1.2	1.6	33.6	1.9	0.9	1.7	3.8	0.7	0.2	0.9	2.4	1.0	2.3	1.8	0.3	0.2	1.8	0.4	0.6	6.3	3.2	1.1	0.5	0.7	5.7	4.2	7.5	0.5	0.1	0.3	0.3	3.5	0.4	0.1	1.2	0.0	2.0	0.3	1.7	4.0	2.4	0.9	0.1	0.0	0.9	4.1	0.0	5.2	2.8	4.3	9.1	0.4	0.1	32.0	4.3	0.2	0.0	8.0	1.5	0.7	0.4	0.8	1.5	2.5	3.9	2.7	4.9	2.1	1.2	1.3	0.6	9.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	15.2	24.2	18.7	47.3	25.2	16.1	38.5	26.1	41.0	17.3	25.5	33.6	1.9	0.0	0.0	6.2	0.4	1.0	0.4	1.2	0.0	34.4	0.2	0.0	4.6	0.0	0.3	1.8	10.4	0.1	0.3	0.0	0.0	1.6	1.5	3.7	0.8	2.5	3.5	622.1	7.9	0.0	0.2	1.0	0.0	1.9	0.0	7.4	3.9	0.0	0.9	40.4	10.1	0.1	0.0	0.6	6.1	0.8	1.2	13.1	3.6	2.8	7.8	17.7	0.0	2.5	73.0	0.2	0.0	0.4	0.8	0.1	0.0	0.2	0.9	43.2	0.0	1.8	2.8	1.1	4.8	0.4	0.9	0.0	0.7	0.8	0.1	0.1
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567122-94650557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.2;Distal enterocytes: 98.3;Microglial cells: 70.3;Oligodendrocytes: 119.8;Paneth cells: 70.1;Urothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 46.9;neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 31.3;Karpas-707: 41.9;U-266/84: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	11.7	4.5	13.6	9.4	25.8	10.0	9.6	23.1	16.5	11.6	3.9	22.5	14.9	7.7	3.1	6.1	5.7	5.3	2.3	13.2	19.6	8.1	4.1	5.3	4.4	26.9	25.9	4.7	3.2	4.6	3.4	17.8	26.7	8.3	16.4	0.9	2.8	5.4	18.4	6.1	21.0	7.9	20.8	12.2	7.3	2.0	24.8	4.0	13.3	7.0	6.3	7.5	4.8	36.3	7.8	0.4	1.9	0.0	0.7	2.7	13.6	0.0	0.0	0.5	1.9	0.0	1.7	0.2	0.1	0.0	6.8	19.1	10.7	12.9	2.6	3.5	2.6	5.1	0.8	0.0	0.5	0.0	10.2	1.7	1.7	7.2	10.1	11.3	31.3	0.0	0.2	41.9	1.0	0.4	0.0	0.4	1.0	2.7	6.5	0.0	0.6	5.1	2.0	16.4	0.2	0.8	0.2	8.0	0.4	8.8	0.0	0.4	19.0	0.0	0.2	0.1	3.4	19.4	30.1	0.3	3.9	1.6	1.7	16.4	4.3	46.9	3.3	6.0	0.3	5.4	1.2	1.9	2.5	3.1	0.0	2.2	69.7	3.3	7.8	2.8	0.0	3.1	13.6	25.8	23.1	16.5	13.2	19.6	26.9	25.9	26.7	20.8	24.8	36.3	81.2	0.0	2.7	2.9	5.7	20.6	32.7	3.2	9.6	4.4	2.1	1.3	2.0	4.3	3.2	7.3	0.0	16.0	16.3	98.3	0.0	1.9	5.8	24.5	3.6	31.9	12.0	0.0	0.6	3.8	3.2	4.8	10.2	39.8	0.0	17.1	31.8	0.6	4.1	0.0	15.0	13.0	0.0	15.0	9.2	8.3	1.8	20.3	3.6	70.3	19.0	0.1	11.3	11.6	119.8	12.9	70.1	1.2	7.8	16.8	48.1	8.9	3.0	0.3	6.6	19.7	6.1	0.0	2.2	30.4	16.2	7.1	7.7	2.5	8.2	83.3
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113491021-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 20.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA039561: AB_2676573, HPA048126: AB_2680276"	"unprognostic (7.89e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (4.10e-4)"	24.2	26.9	20.5	18.6	18.3	76.7	22.7	29.8	21.5	31.1	49.2	23.1	21.0	33.1	20.0	14.4	25.2	27.7	28.2	17.3	16.3	24.2	14.3	24.3	16.3	19.4	18.8	25.2	40.7	35.1	23.1	30.1	19.4	22.1	22.0	18.1	38.7	21.6	19.1	13.4	22.7	29.6	19.6	19.8	44.3	16.1	19.6	12.4	10.7	15.2	13.1	19.6	18.9	21.2	97.8	32.6	46.3	32.0	93.1	136.4	25.0	105.0	99.6	45.1	45.3	35.7	41.9	23.1	25.9	115.7	61.7	38.5	24.8	38.0	70.0	48.0	25.1	20.9	52.2	36.0	87.9	34.3	41.7	112.0	88.5	33.9	68.9	116.7	74.5	14.3	30.3	31.6	79.6	17.5	18.0	20.6	23.2	46.5	50.9	22.4	28.0	16.7	74.3	12.6	40.4	33.5	32.3	70.3	33.6	65.3	41.5	64.6	117.4	50.3	53.5	36.9	44.8	39.2	23.9	14.8	167.2	17.8	24.6	3.1	8.3	8.5	1.3	5.6	1.5	3.1	1.5	2.0	6.0	1.8	1.7	1.7	20.2	5.0	11.3	1.3	1.5	2.7	20.5	18.3	29.8	21.5	17.3	16.3	19.4	18.8	19.4	19.6	19.6	21.2	34.3	12.8	15.1	21.5	12.5	9.8	37.2	25.8	21.6	16.4	39.2	17.5	20.3	24.3	27.8	25.8	14.6	21.6	13.5	37.1	5.9	46.8	14.6	28.2	39.2	31.3	34.2	23.5	42.9	37.4	53.8	35.0	39.3	28.6	26.6	18.4	35.0	12.4	19.1	21.9	41.0	69.2	12.2	31.3	18.8	37.1	36.7	24.5	17.8	12.2	31.4	25.9	17.5	24.6	31.9	52.6	28.2	47.8	19.2	64.0	20.0	11.2	45.2	19.0	6.6	26.2	31.9	17.6	12.2	15.9	7.1	13.0	11.8	34.4	17.7	31.3
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682240-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	7.9	8.9	1.4	5.3	2.4	4.7	9.5	1.3	1.4	8.7	6.5	7.9	17.3	9.8	21.0	8.4	10.3	6.4	4.8	1.6	1.7	9.2	5.4	6.1	6.9	1.9	2.2	7.2	10.8	34.6	3.6	3.1	1.7	13.2	6.1	0.3	17.0	10.6	2.3	5.7	9.6	5.6	1.7	9.5	11.7	1.7	2.0	3.7	11.5	2.4	5.0	9.4	7.9	1.5	9.3	5.6	0.0	0.3	7.5	5.2	6.2	6.8	20.9	13.1	7.3	4.6	42.5	16.2	9.9	19.7	5.8	6.9	1.7	6.8	2.7	13.8	1.7	6.1	6.6	2.3	6.1	0.0	8.1	5.4	7.6	4.4	2.5	4.8	6.3	0.3	1.2	10.7	5.8	7.9	0.0	3.6	0.6	12.6	7.9	3.1	17.5	10.0	11.2	7.2	0.0	0.7	9.0	12.3	13.9	0.9	10.6	10.4	4.0	10.0	4.6	7.2	4.7	1.2	0.6	4.6	11.4	13.8	6.5	0.1	3.8	2.1	4.7	6.7	4.7	4.2	5.0	5.0	7.4	4.9	3.7	3.2	0.3	4.2	4.1	0.2	3.9	3.6	1.4	2.4	1.3	1.4	1.6	1.7	1.9	2.2	1.7	1.7	2.0	1.5	5.8	12.8	11.0	8.8	9.9	2.8	9.6	6.3	4.6	0.2	17.0	15.4	8.0	2.8	12.0	11.0	0.0	9.3	6.0	12.3	9.8	13.2	0.3	10.6	8.1	5.2	6.0	6.5	2.4	16.9	18.6	7.7	15.8	16.5	3.8	7.7	5.3	5.1	9.1	0.0	5.0	15.9	12.2	7.1	3.3	0.5	6.2	6.7	10.6	11.2	9.5	3.0	5.2	3.0	0.4	11.0	7.5	5.7	6.9	11.4	4.5	7.9	18.8	0.5	0.0	6.1	7.7	0.3	2.1	7.9	2.6	7.3	8.2	5.7	14.2	7.9
TMCO5A	"MGC35118, TMCO5"	ENSG00000166069	"Transmembrane and coiled-coil domains 5A"	Q8N6Q1	15	37921939-37967724	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"testis: 90.7"	"Group enriched"	"Detected in some"	104	"Early spermatids: 1153.9;Late spermatids: 3910.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA056530, HPA064017"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA056530: AB_2683167, HPA064017: "										"unprognostic (2.60e-1)"	"unprognostic (1.69e-4)"							0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	90.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1153.9	0.2	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3910.6	13.4	1.1	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.1	0.0	6.6	0.0	0.0	24.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639435-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	6.6	10.5	5.7	3.9	5.7	2.9	6.6	5.5	5.8	6.1	5.5	4.9	2.9	4.8	3.4	7.2	6.9	2.9	3.1	5.5	5.8	6.7	13.3	3.6	4.6	6.0	5.9	7.1	6.6	4.0	4.9	5.6	5.9	4.8	2.5	0.7	9.8	2.9	3.6	5.2	4.8	3.0	6.3	7.2	5.2	10.4	5.9	7.7	5.3	2.6	4.0	5.4	5.6	7.0	3.9	7.5	5.0	7.4	4.9	5.2	18.1	3.0	3.4	3.8	4.1	11.6	7.2	15.6	7.8	2.3	4.4	7.7	4.2	8.8	2.0	5.5	13.7	11.9	3.7	8.3	6.5	6.7	4.4	8.6	2.3	4.6	7.7	2.9	8.9	12.6	5.1	5.0	4.7	7.5	15.3	15.5	5.7	9.2	11.3	13.1	10.3	15.5	4.6	3.5	8.6	3.7	8.6	16.6	8.0	3.4	13.6	7.9	4.2	0.1	3.7	1.4	1.3	8.4	5.7	7.4	2.4	10.7	4.6	11.6	6.5	5.7	5.2	9.1	5.7	7.8	6.9	5.1	6.9	6.1	9.5	3.9	12.7	4.4	10.3	1.9	8.2	4.1	5.7	5.7	5.5	5.8	5.5	5.8	6.0	5.9	5.9	6.3	5.9	7.0	4.0	6.4	2.0	1.3	7.5	1.9	7.3	3.4	6.8	5.2	4.6	4.3	0.6	5.7	2.4	11.0	6.2	7.7	4.2	3.9	0.0	3.8	4.1	2.2	4.0	6.3	7.3	10.3	3.8	2.4	7.4	4.6	6.6	2.5	0.0	4.6	10.0	9.7	4.8	0.0	3.3	5.0	4.1	5.1	2.7	1.5	4.1	4.1	1.8	9.4	6.6	3.3	16.5	1.0	3.9	4.5	5.2	4.9	7.3	7.4	6.2	2.4	6.2	4.3	6.6	3.9	3.4	19.2	15.8	10.3	2.3	6.3	8.2	7.7	7.7	6.9
TMED1	"Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L"	ENSG00000099203	"Transmembrane p24 trafficking protein 1"	Q13445	19	10832067-10836318	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018507	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA018507: AB_1858063"	"unprognostic (6.98e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (8.66e-5)"	"unprognostic (9.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.45e-2)"	23.6	31.2	13.4	15.4	15.3	21.6	25.1	15.6	17.3	30.0	24.9	19.5	18.9	25.0	16.3	19.9	24.8	18.8	42.3	13.0	16.9	37.8	51.9	19.6	14.3	16.6	15.1	34.4	34.5	24.4	35.9	21.4	15.5	26.5	8.1	4.4	24.2	14.8	64.4	19.1	17.4	10.6	15.2	22.3	26.2	20.2	14.5	10.2	28.7	34.9	7.0	22.3	21.0	17.4	40.4	63.3	26.7	43.6	26.2	28.5	27.8	63.3	53.0	59.0	82.3	59.2	57.2	29.1	146.5	46.0	30.8	32.2	18.8	33.4	23.6	44.2	38.5	41.5	49.8	48.5	35.4	35.2	91.4	42.2	35.1	34.9	24.9	25.8	37.4	22.3	30.3	80.6	25.3	63.9	25.4	38.0	41.3	23.6	60.5	27.8	22.9	44.6	35.0	33.3	29.5	29.0	37.6	37.0	33.9	11.2	43.8	38.5	41.5	75.1	34.4	80.3	71.6	48.9	56.6	27.8	58.1	63.5	41.6	12.3	94.6	44.3	59.3	94.0	40.9	50.9	39.9	48.6	81.1	42.2	36.6	40.5	35.7	122.8	103.0	59.9	38.9	66.0	13.4	15.3	15.6	17.3	13.0	16.9	16.6	15.1	15.5	15.2	14.5	17.4	20.2	9.6	15.3	4.6	16.5	18.5	24.4	53.9	12.0	10.2	31.8	32.0	0.2	41.5	33.0	53.3	8.4	111.5	24.5	22.7	41.1	54.4	5.5	30.9	26.7	26.4	23.5	30.7	1.0	44.2	94.0	38.1	15.8	21.7	27.3	43.7	24.3	43.9	52.5	5.0	1.2	21.1	46.8	20.2	16.6	6.3	22.4	20.0	42.7	1.0	25.0	40.3	28.8	4.0	3.2	41.7	35.5	20.3	24.4	35.4	37.7	57.4	42.9	18.0	32.9	28.9	27.1	21.7	30.9	14.8	17.5	146.3	15.1	62.3	28.8	23.3
TMED10	"p23, P24(DELTA), p24d1, p24delta1, TMP21"	ENSG00000170348	"Transmembrane p24 trafficking protein 10"	P49755	14	75131469-75176612	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034442, CAB037251, HPA047139, HPA050539"	Enhanced		Supported	"Golgi apparatus"		NA	NA		220000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.51e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.17e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.06e-2)"	68.0	70.3	51.8	55.2	55.8	18.0	93.2	52.6	60.7	137.9	61.2	77.0	62.3	92.6	133.1	59.9	100.6	69.2	82.3	49.5	66.1	62.7	126.9	68.0	61.0	65.8	54.3	99.7	131.9	91.4	53.6	76.3	63.2	91.0	82.3	48.8	130.7	85.9	73.7	56.0	58.8	78.9	57.5	54.6	78.3	40.0	58.2	73.7	146.0	61.0	65.9	66.9	59.7	69.6	93.3	52.2	85.5	142.5	197.5	183.7	110.9	96.5	159.5	99.5	111.2	51.8	161.2	82.5	80.6	167.5	56.8	90.8	80.4	140.6	160.5	43.7	36.2	50.5	31.1	79.2	167.1	101.7	50.2	135.1	221.5	77.0	220.1	196.0	176.9	91.7	44.6	177.8	145.0	104.6	71.0	80.7	51.9	145.2	55.8	70.6	55.3	116.6	119.7	94.8	82.9	87.1	89.0	147.0	175.9	81.0	138.3	163.3	122.3	97.0	62.9	65.9	50.7	98.9	99.3	91.3	177.0	88.3	95.8	107.4	46.4	28.9	60.8	39.4	93.8	39.7	58.7	59.3	62.9	30.3	51.9	55.9	20.4	101.8	42.6	70.9	38.2	91.4	51.8	55.8	52.6	60.7	49.5	66.1	65.8	54.3	63.2	57.5	58.2	69.6	80.8	64.1	106.3	32.0	141.8	114.2	180.4	488.1	107.0	55.6	182.5	130.6	155.3	187.3	279.9	200.5	27.1	181.0	186.7	186.2	62.6	319.1	14.5	147.7	177.5	107.3	140.7	75.5	26.9	385.7	609.9	164.4	145.8	172.0	100.1	170.9	123.1	339.7	255.0	77.4	30.0	276.2	272.6	159.4	166.3	31.5	179.3	151.6	297.1	38.4	129.5	137.9	130.7	50.8	84.2	225.8	148.9	209.9	538.8	218.7	120.3	138.9	304.8	63.1	78.9	112.7	132.2	317.7	116.5	151.7	135.1	309.2	122.1	145.8	161.9	207.7
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584533-123598582	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	106.0	97.1	40.7	92.6	43.5	122.1	136.1	44.2	50.8	155.6	59.5	132.5	123.7	102.5	203.3	111.9	102.3	96.1	116.5	40.5	45.3	102.8	271.1	85.4	72.7	46.6	46.6	101.5	229.1	99.3	65.0	125.4	46.9	140.5	140.7	56.9	227.6	102.2	131.0	74.8	110.5	102.1	46.0	63.2	133.8	58.5	44.2	69.1	197.6	112.1	95.2	118.6	71.4	53.8	237.7	204.9	133.4	232.2	295.7	260.2	317.5	401.2	318.5	246.8	194.2	209.9	198.9	199.3	210.7	398.7	169.4	228.1	181.8	214.5	257.3	155.2	169.3	217.3	114.0	267.6	559.5	296.9	178.1	220.5	349.2	212.6	286.0	352.7	234.7	133.5	223.1	132.9	255.6	175.1	159.8	242.7	192.9	201.0	206.6	164.8	216.8	235.7	303.9	349.1	166.5	143.1	267.3	263.6	273.7	160.0	450.2	237.2	226.2	210.1	132.4	204.9	227.5	292.3	290.7	167.6	248.3	192.9	254.2	249.7	143.2	145.9	157.0	147.5	198.8	111.8	137.0	148.4	158.6	102.5	110.3	129.4	111.1	148.5	141.3	242.5	140.1	142.2	40.7	43.5	44.2	50.8	40.5	45.3	46.6	46.6	46.9	46.0	44.2	53.8	97.1	48.1	71.5	9.1	148.8	417.4	290.3	348.5	207.1	50.1	258.8	98.0	167.2	213.1	233.2	154.5	20.9	281.5	166.9	169.6	117.4	325.1	12.2	89.2	136.5	142.0	170.7	76.3	20.0	249.6	678.6	242.7	156.5	136.8	92.6	88.4	143.5	538.8	215.8	48.8	20.3	352.4	321.4	141.7	414.3	13.9	181.4	128.5	378.8	17.8	129.8	124.1	195.7	19.6	27.5	224.9	158.5	153.4	521.0	486.3	178.1	163.0	142.1	54.7	164.3	112.6	193.5	165.9	150.6	289.8	498.8	451.9	154.3	125.0	263.9	389.2
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311112-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 409.4"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavorable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	25.9	26.2	19.6	23.1	19.2	37.0	66.4	21.5	20.5	56.6	30.6	49.9	25.4	38.3	138.7	132.3	38.7	37.8	41.9	20.8	31.9	34.7	12.4	30.9	26.0	22.4	22.0	30.9	246.7	54.9	89.6	42.4	26.5	60.0	55.4	11.3	409.4	54.6	4.6	106.8	26.6	37.3	21.6	32.4	73.1	35.0	22.6	23.1	76.3	7.2	37.8	48.7	75.1	25.1	68.1	169.0	31.9	63.6	220.3	167.5	69.0	153.0	206.7	103.3	126.9	141.4	123.3	31.5	117.3	236.0	135.9	124.5	95.7	98.5	53.0	62.7	145.6	104.5	143.0	110.3	131.5	112.2	200.4	126.5	144.4	59.6	86.9	123.5	120.8	105.9	47.1	0.6	101.4	144.3	32.1	106.0	45.7	251.6	92.2	39.1	47.4	158.9	94.2	51.4	99.4	48.8	80.6	162.1	159.3	103.5	141.5	81.7	98.5	85.2	75.7	2.2	111.4	61.7	78.8	44.1	109.8	180.7	103.1	74.9	69.8	95.1	58.1	85.3	62.7	75.5	57.2	63.9	106.7	63.6	71.4	69.1	6.0	61.4	95.7	109.1	73.1	92.2	19.6	19.2	21.5	20.5	20.8	31.9	22.4	22.0	26.5	21.6	22.6	25.1	9.9	28.9	43.6	6.8	41.2	95.8	109.4	125.6	64.9	14.9	153.8	132.8	16.9	55.8	108.5	57.0	8.4	167.8	40.7	67.7	23.5	143.4	48.9	31.6	39.6	31.7	83.9	33.7	10.0	250.5	294.5	68.1	54.6	70.4	47.0	44.0	65.7	6.4	100.5	13.5	10.2	219.3	87.5	52.7	54.4	118.6	49.7	49.2	85.4	9.4	60.0	38.0	44.3	17.1	12.9	173.3	79.9	27.4	71.1	165.2	43.9	28.9	37.7	17.0	19.7	25.6	57.0	51.1	60.3	104.7	121.8	172.4	30.4	64.6	126.4	200.1
TMED4	"HNLF, p24a3, p24alpha3"	ENSG00000158604	"Transmembrane p24 trafficking protein 4"	Q7Z7H5	7	44577894-44582287	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014650	Approved				"Intracellular and membrane"	NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014650: AB_1858066"	"unprognostic (7.34e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.09e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.65e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (6.61e-2)"	35.2	51.7	40.5	32.2	48.3	49.5	42.9	44.8	43.2	48.9	53.2	46.5	87.9	51.2	78.6	37.3	53.9	37.2	65.0	40.9	48.5	88.3	49.0	42.1	37.1	47.8	45.3	72.0	73.0	139.4	68.3	61.9	47.9	57.5	48.1	92.0	67.3	65.1	61.5	40.5	92.8	44.3	44.1	38.5	51.7	31.4	44.0	38.3	114.0	41.6	38.1	42.3	40.5	56.7	47.2	57.0	80.0	90.8	70.7	41.8	68.6	55.7	68.8	56.4	70.1	62.2	114.1	44.5	90.9	60.0	120.8	74.9	42.5	46.7	67.9	59.3	69.0	39.5	100.4	59.6	63.7	63.8	72.8	54.5	69.7	59.7	48.4	103.8	50.7	68.9	62.8	96.4	67.6	42.4	61.8	86.2	51.5	73.1	57.5	52.6	37.2	87.4	81.7	76.6	64.0	91.3	59.4	132.7	64.4	90.7	103.8	64.1	47.3	41.3	61.0	47.8	88.1	143.9	140.0	53.6	84.6	67.5	148.8	95.3	60.2	87.2	85.3	63.3	103.4	67.4	85.0	82.2	55.1	54.5	69.5	77.8	58.5	82.8	71.3	120.7	79.2	56.6	40.5	48.3	44.8	43.2	40.9	48.5	47.8	45.3	47.9	44.1	44.0	56.7	41.4	118.6	74.0	11.8	70.3	56.2	53.5	61.0	44.9	150.5	83.2	77.2	69.8	62.9	66.0	154.5	75.0	176.0	83.5	79.7	41.1	79.4	54.9	79.3	61.7	36.8	62.9	49.2	25.5	60.6	57.4	75.2	45.9	92.9	41.1	89.9	36.4	55.5	70.7	112.7	30.2	75.0	63.1	45.9	55.0	100.4	78.3	50.4	40.9	12.2	56.9	115.7	41.2	25.1	31.0	79.0	78.6	81.3	142.7	75.6	267.7	140.9	69.4	135.9	59.2	87.1	65.8	51.8	60.8	47.0	56.8	159.9	74.1	60.3	79.6	76.3
TMED5	"CGI-100, p24g2, p24gamma2"	ENSG00000117500	"Transmembrane p24 trafficking protein 5"	Q9Y3A6	1	93149742-93180516	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050289	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA050289: AB_2681074"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.37e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.38e-1)"	19.1	18.5	5.4	18.8	6.4	31.1	9.2	7.4	6.7	9.6	15.6	15.2	16.7	6.6	12.9	9.2	6.0	15.2	12.5	5.4	8.3	27.7	51.9	18.5	16.0	7.6	6.3	6.8	14.1	11.6	5.4	16.6	7.9	11.1	13.7	4.9	13.5	8.0	19.8	4.8	15.5	8.6	7.5	13.6	14.7	8.1	8.4	10.2	16.2	18.7	13.6	18.3	6.1	9.2	46.5	19.4	21.0	21.4	60.4	36.2	46.5	36.2	35.5	28.4	41.9	33.1	35.5	22.5	36.1	31.2	60.5	24.6	24.3	22.0	32.2	25.7	30.5	21.0	19.9	34.9	36.0	24.8	30.7	43.0	31.9	44.3	40.3	32.5	34.4	18.1	35.6	62.3	28.0	7.5	27.4	19.4	13.9	25.1	26.1	20.6	35.8	36.5	36.2	25.9	12.3	14.1	43.6	39.4	41.0	17.4	18.6	20.9	34.4	30.1	29.6	38.4	37.6	42.5	57.8	27.4	20.1	23.3	13.6	56.7	32.4	45.4	22.0	32.6	26.4	24.2	22.5	25.9	26.6	17.9	16.9	20.0	15.8	16.2	36.0	18.2	27.7	28.9	5.4	6.4	7.4	6.7	5.4	8.3	7.6	6.3	7.9	7.5	8.4	9.2	39.0	73.7	45.9	21.2	66.6	71.8	81.7	39.3	55.2	5.8	33.2	22.9	42.3	34.3	37.7	58.8	20.9	36.1	61.1	52.5	11.7	34.3	97.8	32.5	33.2	33.1	20.4	20.4	16.6	40.8	87.3	59.4	50.4	52.3	40.5	18.9	18.9	116.1	68.1	8.4	19.2	32.9	26.4	74.9	91.7	143.6	23.6	78.6	33.8	22.5	57.9	13.2	46.4	32.2	42.0	37.2	48.8	16.1	163.4	101.9	53.6	66.2	29.2	8.5	59.2	52.1	49.1	32.1	15.0	53.7	64.8	85.4	64.5	19.7	35.5	115.8
TMED6	"MGC23911, p24g5, p24gamma5"	ENSG00000157315	"Transmembrane p24 trafficking protein 6"	Q8WW62	16	69343250-69351786	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 298.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.3;Exocrine glandular cells: 36.6;Pancreatic endocrine cells: 12.8;Paneth cells: 10.6;Proximal tubular cells: 19.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.5;OE19: 7.4"									HPA012532	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA012532: AB_1858065"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-3)"	"prognostic favorable (7.74e-5)"	"unprognostic (9.84e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.52e-3)"	0.5	0.6	0.1	0.7	0.3	1.1	0.6	0.8	0.7	2.5	0.1	4.3	12.5	0.9	18.1	0.4	22.5	0.7	0.4	0.3	0.0	16.1	5.5	1.9	1.3	0.1	0.1	0.6	298.9	0.1	0.2	0.4	0.1	0.7	7.8	1.0	0.5	2.4	0.3	1.0	7.7	0.5	0.1	0.9	61.2	0.4	0.2	0.2	0.5	0.0	0.6	0.3	0.2	0.4	0.6	1.6	1.4	1.0	0.1	0.0	0.9	2.0	0.1	0.0	0.3	2.2	0.8	4.2	0.7	0.0	0.6	1.1	0.2	0.2	0.4	0.6	1.7	2.1	0.6	15.5	0.1	2.7	0.9	0.2	0.8	0.1	0.3	0.8	0.1	1.9	1.4	0.5	0.3	1.6	1.1	2.9	1.9	7.4	1.4	2.3	1.2	1.6	0.4	1.7	3.2	1.3	2.7	0.9	1.0	0.5	0.5	1.7	1.9	2.2	1.3	0.8	1.4	1.4	1.3	4.5	1.2	2.2	0.7	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.7	0.3	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.5	1.3	0.5	0.0	0.1	0.1	0.6	0.5	0.5	0.3	0.2	1.5	0.1	1.8	2.1	0.1	0.0	5.0	0.0	6.6	0.1	28.3	0.7	0.4	8.4	3.2	1.4	36.6	0.0	0.1	9.7	5.0	1.3	0.1	0.4	4.7	0.3	0.0	0.8	2.6	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	1.0	12.8	10.6	0.0	0.3	0.3	8.0	19.1	0.4	0.6	0.0	0.5	0.2	0.1	0.1	0.6	0.0	0.1	0.5	0.1	7.0	0.2
TMED7	"CGI-109, FLJ90481, p24g3, p24gamma3"	ENSG00000134970	"Transmembrane p24 trafficking protein 7"	Q9Y3B3	5	115613210-115632992	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008960, CAB025883"	Supported					NA	NA		13000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB025883: , HPA008960: AB_1080280"	"unprognostic (1.40e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.15e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.22e-1)"	35.0	41.2	23.1	29.5	31.9	31.8	37.8	31.2	32.7	50.5	37.8	42.1	36.9	41.2	70.2	32.4	38.6	33.5	43.5	21.9	24.6	54.2	80.2	30.5	23.4	39.8	27.2	31.0	35.2	53.6	28.0	43.8	28.1	48.7	42.3	19.2	43.4	44.3	22.0	18.9	38.3	45.0	33.3	25.9	41.5	18.9	28.5	19.5	79.8	24.9	24.1	37.6	22.6	44.8	63.6	42.4	43.8	54.7	112.3	84.4	68.1	109.8	116.4	79.7	129.8	36.3	110.1	33.1	105.7	115.1	99.5	49.6	41.3	128.0	125.7	76.0	34.4	30.5	39.2	76.8	119.8	31.9	59.0	78.2	60.5	76.1	95.8	100.4	78.5	22.3	29.6	44.5	87.1	30.1	24.0	28.5	30.8	37.7	35.5	25.9	65.1	63.8	98.6	44.6	33.3	39.8	90.0	52.3	68.1	41.7	63.0	41.8	80.1	109.0	46.3	79.2	66.3	29.3	24.0	33.5	88.7	52.2	61.8	25.5	23.8	20.2	14.9	23.1	15.3	10.4	11.5	13.3	19.3	9.1	11.1	12.0	16.3	14.2	18.5	13.3	11.5	20.7	23.1	31.9	31.2	32.7	21.9	24.6	39.8	27.2	28.1	33.3	28.5	44.8	37.8	38.5	29.8	0.0	26.9	45.6	30.1	35.3	15.4	31.5	47.4	21.5	42.4	61.5	29.3	46.0	10.4	44.2	30.6	63.8	13.7	37.4	28.7	34.5	48.9	30.6	87.3	9.1	0.0	28.3	103.6	51.8	34.1	45.6	10.1	20.4	44.3	114.2	50.1	30.3	0.0	85.8	24.4	51.6	55.5	20.1	46.9	38.4	51.6	0.0	36.8	52.6	19.6	0.0	0.0	37.4	39.9	53.4	13.9	60.5	50.0	42.2	36.9	25.8	39.5	42.9	43.1	39.2	18.0	25.3	44.0	82.8	23.6	33.9	46.9	55.6
TMED7-TICAM2		ENSG00000251201	"TMED7-TICAM2 readthrough"		5	115578642-115626161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 2.9;Excitatory neurons: 4.8;Inhibitory neurons: 5.1;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA008960	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008960: AB_1080280"	"unprognostic (7.37e-6)"	"unprognostic (5.18e-4)"	"unprognostic (2.84e-2)"	"unprognostic (8.53e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.47e-3)"	"unprognostic (6.56e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.42e-2)"	1.9	2.6	1.2	2.9	1.3	1.0	1.6	1.5	2.6	3.2	0.7	1.9	1.8	1.7	1.8	1.2	1.6	1.7	0.8	1.0	1.3	2.1	2.5	2.0	1.8	1.7	1.5	1.3	1.5	1.7	0.4	4.1	1.7	2.0	1.9	2.8	1.3	3.0	0.4	0.4	2.0	2.6	1.6	2.6	2.3	0.9	1.5	1.9	2.0	1.0	2.7	2.6	0.4	2.0	4.1	2.9	2.7	10.9	16.2	30.7	10.2	19.0	14.9	11.2	19.9	2.5	9.6	1.1	8.4	21.4	7.7	8.1	1.8	11.4	22.1	9.4	2.1	0.7	1.5	0.3	12.1	2.2	5.5	15.1	9.9	12.5	12.8	19.6	7.0	1.6	1.4	3.3	13.7	4.6	1.7	0.5	0.4	9.6	4.4	1.4	4.6	1.3	9.2	2.2	2.1	3.1	8.8	0.9	15.6	11.1	1.5	3.1	11.8	10.4	11.3	9.8	16.8	5.7	4.5	1.2	11.1	3.1	8.2	1.8	3.4	1.3	0.5	3.9	1.1	0.4	0.4	0.6	3.4	0.3	0.4	0.4	1.1	0.6	3.1	0.5	0.8	1.3	1.2	1.3	1.5	2.6	1.0	1.3	1.7	1.5	1.7	1.6	1.5	2.0	0.0	3.2	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	4.7	1.1	0.0	0.0	5.5	13.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2
TMED8	FAM15B	ENSG00000100580	"Transmembrane p24 trafficking protein family member 8"	Q6PL24	14	77335029-77377094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 62.7;Cone photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001205	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA001205: AB_2204460"	"unprognostic (1.07e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.77e-1)"	5.5	8.3	8.2	8.6	9.6	7.7	5.7	4.7	8.4	5.9	4.1	4.4	3.3	6.7	5.1	3.6	5.4	4.1	3.4	7.5	16.6	10.4	3.4	4.6	17.5	7.9	10.5	7.3	5.6	11.1	9.2	4.4	11.2	5.9	4.8	24.2	4.4	5.9	2.3	4.9	5.5	5.6	6.9	8.0	6.2	6.8	12.8	9.8	10.9	2.4	19.5	4.7	3.5	5.9	14.7	12.0	13.9	12.4	8.5	7.6	11.8	9.2	6.0	9.4	10.1	7.5	8.1	58.7	7.5	7.5	7.7	10.0	10.4	10.5	14.6	18.6	6.3	19.6	9.5	7.9	5.9	9.6	51.8	8.0	7.4	12.3	11.0	9.5	13.5	47.7	10.1	15.4	9.5	14.4	15.2	14.2	6.9	10.7	12.0	12.2	12.7	4.7	9.9	9.0	17.2	10.4	15.9	9.4	11.8	10.6	15.2	15.9	9.7	9.7	6.2	17.5	10.7	12.3	25.2	28.9	11.1	17.7	14.3	2.3	0.7	2.2	0.3	0.9	0.4	2.1	0.5	0.4	0.6	2.1	0.3	0.5	1.0	0.5	0.8	1.0	0.7	0.5	8.2	9.6	4.7	8.4	7.5	16.6	7.9	10.5	11.2	6.9	12.8	5.9	6.6	3.2	7.8	62.7	33.9	6.6	4.9	7.7	2.8	33.4	12.5	8.3	16.8	8.6	5.3	22.0	108.4	10.5	7.9	6.5	5.9	6.4	4.8	9.8	15.5	10.4	44.3	15.4	44.7	4.7	10.0	8.4	7.1	9.0	0.0	9.1	8.9	9.8	7.8	28.6	40.7	6.3	10.2	24.8	7.7	6.9	14.6	19.8	5.4	21.5	16.8	14.9	6.2	39.7	24.2	6.8	3.3	14.3	19.9	7.5	3.2	22.2	20.9	39.3	13.1	7.1	8.4	6.8	15.7	8.2	8.9	4.1	10.3	19.8	6.7	4.3
TMED9	"HSGP25L2G, p24a2, p24alpha2"	ENSG00000184840	"Transmembrane p24 trafficking protein 9"	Q9BVK6	5	177592203-177597242	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 915.2;Syncytiotrophoblasts: 773.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014650	Approved					NA	NA		36000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014650: AB_1858066"	"unprognostic (5.75e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.37e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (2.88e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.65e-2)"	86.5	106.7	29.8	38.3	30.0	37.7	74.4	29.8	34.0	74.9	42.0	87.5	31.8	76.6	65.6	135.7	60.7	25.7	99.1	29.9	30.7	97.3	229.5	100.6	29.7	32.4	31.2	62.4	253.7	40.8	82.1	59.1	30.8	87.0	45.5	15.7	139.2	34.4	55.7	83.8	75.6	39.4	31.0	102.1	114.0	54.0	32.3	24.4	87.8	16.8	36.4	84.8	82.5	30.6	100.4	115.9	51.0	163.3	131.5	93.0	224.1	181.5	139.1	91.0	125.3	178.5	142.5	57.5	214.3	171.2	179.5	79.9	49.6	244.8	91.1	275.7	73.6	47.8	93.2	151.2	132.7	130.9	170.4	88.1	125.6	95.8	106.7	122.9	137.4	51.7	55.9	100.0	99.3	243.9	31.3	96.4	57.0	89.9	112.7	53.3	66.9	147.8	109.3	86.0	26.6	38.4	89.7	104.1	99.9	80.4	104.7	131.0	121.0	112.2	83.2	93.0	140.5	171.4	109.9	56.7	149.1	165.9	146.5	78.9	98.3	77.2	85.5	94.5	85.3	65.9	68.3	67.0	91.9	63.5	58.0	53.8	39.1	76.8	89.0	201.4	74.8	131.9	29.8	30.0	29.8	34.0	29.9	30.7	32.4	31.2	30.8	31.0	32.3	30.6	115.6	67.3	69.5	10.1	127.3	145.0	193.4	601.4	48.9	67.4	118.6	94.0	48.0	147.3	235.8	128.8	31.3	525.6	167.8	172.8	29.4	428.6	7.1	51.0	108.4	145.1	112.3	78.9	9.3	354.1	915.2	175.9	79.0	89.8	113.4	141.8	115.6	118.4	384.5	60.6	9.6	323.1	238.0	79.5	139.2	13.5	135.2	121.2	256.1	15.9	189.2	105.4	147.2	17.6	10.3	320.0	155.7	98.2	370.3	229.6	84.2	71.7	94.5	73.7	65.7	83.4	160.3	89.1	175.7	59.9	138.5	773.2	104.7	157.7	182.7	203.6
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473149-100577636	"Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 28.9"	"Cell type enhanced"	"Detected in single"		"Endometrial stromal cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BEWO: 14.8;NTERA-2: 29.8;REH: 20.4;SCLC-21H: 25.4;SH-SY5Y: 16.9"	"Low region specificity"	"Detected in all"							HPA051501	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA051501: AB_2681509"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	0.0	0.0	6.1	0.0	16.2	0.0	0.0	10.3	10.7	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.0	9.3	0.0	0.0	0.0	0.1	13.8	12.7	0.3	0.0	0.0	0.2	0.3	13.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	8.4	0.1	0.1	4.0	13.6	0.2	0.8	0.1	0.0	0.0	0.1	28.9	0.0	0.0	12.0	0.6	0.1	0.4	14.8	0.9	0.2	0.6	0.8	0.8	0.1	0.0	2.7	0.4	0.2	0.0	4.6	0.0	0.7	0.0	6.7	0.0	0.3	0.7	0.6	0.0	0.0	0.4	0.0	0.7	0.2	0.5	1.9	5.3	0.2	0.0	0.9	0.1	7.7	0.0	29.8	0.0	0.4	20.4	10.3	0.0	0.5	0.0	25.4	16.9	0.1	0.0	0.4	6.8	0.0	0.1	2.7	2.3	3.9	0.1	0.9	4.6	3.5	4.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	16.2	10.3	10.7	9.0	9.3	13.8	12.7	13.2	8.4	13.6	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192194933	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.3;prostate: 36.6;seminal vesicle: 13.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 416.1;Inhibitory neurons: 382.0;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 1337.5"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 36.9;LHCN-M2: 107.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	0.3	2.3	30.2	0.1	25.8	0.0	0.3	16.0	26.6	0.1	5.8	0.9	0.6	0.0	8.1	1.2	0.1	1.7	1.8	28.5	26.9	0.0	0.0	0.1	0.0	21.5	23.5	0.2	0.0	0.0	0.3	0.0	22.4	36.6	1.5	3.3	0.1	13.3	0.3	0.2	0.6	0.1	16.6	0.0	0.9	0.7	26.3	0.0	0.2	0.6	0.1	0.8	0.5	33.3	0.0	0.9	36.9	0.0	5.6	5.8	0.1	0.1	0.7	1.8	2.2	0.0	0.0	0.0	0.0	10.3	4.5	0.0	2.3	0.0	7.1	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.0	15.6	0.0	2.0	10.8	9.0	0.1	0.0	0.0	0.0	107.1	0.0	0.0	0.1	2.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.2	2.8	0.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	25.8	16.0	26.6	28.5	26.9	21.5	23.5	22.4	16.6	26.3	33.3	0.1	0.0	0.0	11.8	0.0	0.1	0.1	0.0	0.0	16.6	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	416.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.6	382.0	0.5	0.0	0.0	0.7	2.3	26.4	0.0	0.0	11.2	0.0	0.6	0.0	210.6	1337.5	0.0	0.0	8.6	0.0	5.7	0.1	0.0	0.0	1.6	6.6	24.6	0.6	1.2	2.6	0.3	0.3	0.0	0.4	0.0	0.0	0.1
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 192.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.8;Endothelial cells: 25.5;Fibroblasts: 40.7;Leydig cells: 40.7;Peritubular cells: 52.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.9;ASC TERT1: 19.5;HHSteC: 44.8;HSkMC: 20.6;U-87 MG: 13.9;WM-115: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	40.8	5.0	5.4	3.2	5.5	0.0	27.6	4.3	9.0	15.8	6.0	14.5	6.7	3.6	36.6	6.5	8.0	7.3	18.7	5.1	7.0	1.9	7.0	192.5	1.2	5.5	7.0	26.5	2.3	0.8	11.2	54.1	6.0	10.3	11.6	0.4	8.0	24.7	9.7	4.6	13.2	5.5	4.6	6.9	30.2	2.7	8.1	1.1	7.5	14.1	0.6	11.1	8.2	4.7	0.0	0.0	5.9	0.0	28.9	19.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	44.8	0.0	0.0	20.6	0.0	1.4	0.1	0.2	0.0	0.3	1.0	0.1	0.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	1.9	3.9	0.0	0.8	0.0	0.1	13.9	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.5	4.3	9.0	5.1	7.0	5.5	7.0	6.0	4.6	8.1	4.7	57.8	0.0	3.6	2.3	0.1	2.5	0.3	0.0	1.2	0.7	0.4	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	4.0	25.5	0.0	0.0	0.1	0.0	0.0	40.7	1.5	0.2	1.3	0.1	7.1	15.2	0.1	0.0	1.6	0.0	0.0	0.0	4.9	0.5	40.7	0.2	7.2	1.9	0.0	0.0	0.0	17.1	0.0	0.1	0.0	52.6	0.0	0.1	0.0	3.4	0.0	0.1	32.9	10.3	15.1	0.1	0.2	0.7	2.6	0.1	0.5	0.3	0.0	0.3
TMEM102	"CBAP, FLJ36878"	ENSG00000181284	"Transmembrane protein 102"	Q8N9M5	17	7435435-7437679	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 69.0;Pancreatic endocrine cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;HMC-1: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024433	Uncertain		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA024433: AB_1858071"	"unprognostic (2.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.10e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.42e-3)"	2.6	8.1	0.4	1.5	0.6	1.5	3.4	0.7	0.3	3.2	0.2	5.9	2.8	1.8	1.0	10.2	1.7	1.0	2.0	0.3	0.3	5.2	4.4	3.1	2.5	0.7	0.6	0.5	5.4	1.6	1.0	0.8	0.6	2.3	1.0	0.2	6.2	0.7	3.6	8.8	6.0	0.3	0.5	6.4	4.4	6.7	0.6	1.5	3.8	0.1	1.8	2.6	4.6	0.6	5.3	3.7	0.4	0.0	1.3	0.6	2.9	1.1	1.4	0.7	1.5	2.0	5.5	5.3	4.8	0.5	0.7	10.6	0.9	5.8	0.1	4.8	6.5	4.9	2.2	1.9	0.6	2.9	11.9	0.4	5.4	0.4	1.0	1.8	2.4	4.5	1.9	0.3	0.0	3.2	3.3	5.2	0.2	5.1	3.0	5.4	0.4	1.9	5.0	3.4	0.2	3.4	0.6	4.7	1.4	0.9	2.5	1.2	3.2	0.2	0.3	0.6	0.1	1.0	1.4	0.7	1.6	2.5	2.4	0.0	0.4	3.8	0.7	0.9	0.4	0.8	0.8	0.9	0.5	0.8	0.6	0.6	0.0	1.0	1.0	0.5	0.7	0.4	0.4	0.6	0.7	0.3	0.3	0.3	0.7	0.6	0.6	0.5	0.6	0.6	2.4	0.0	0.0	0.0	8.8	3.7	5.6	5.2	8.6	0.0	4.0	3.4	1.1	7.2	4.2	1.8	0.0	9.1	6.5	18.2	7.9	21.6	16.8	7.1	1.1	3.0	1.2	2.5	0.1	21.9	7.9	0.4	9.7	11.0	0.0	4.5	2.2	3.6	7.1	1.7	0.1	8.2	6.1	7.2	10.6	69.0	0.9	4.5	1.8	0.0	11.6	1.6	8.2	0.0	0.5	32.5	15.3	0.7	5.9	2.9	15.2	9.0	2.4	0.6	0.0	0.4	1.4	1.1	2.7	5.7	7.1	5.1	8.1	0.6	7.6	13.1
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776499-74839753	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	6.5	10.7	7.0	5.6	9.1	8.4	5.3	9.2	7.9	3.9	5.6	5.0	3.5	4.7	3.8	6.6	4.2	3.4	7.2	6.5	6.8	7.7	14.9	7.8	4.5	10.4	9.3	3.8	8.1	8.1	9.9	5.0	9.8	5.5	2.9	2.0	7.5	3.8	5.4	5.2	5.3	4.2	8.2	7.0	6.1	8.4	9.3	4.2	7.8	3.8	4.4	5.1	4.2	10.8	10.8	26.0	13.4	15.4	18.9	11.7	8.1	18.2	18.1	22.8	25.1	21.1	11.2	5.6	5.8	20.9	23.4	12.0	13.8	10.2	12.0	4.2	19.5	14.1	10.5	15.0	13.8	23.5	12.6	9.3	10.9	23.1	5.0	6.8	16.5	13.6	8.4	8.5	15.6	10.3	14.1	9.3	7.5	14.2	20.6	8.7	21.3	9.4	9.9	9.3	11.4	15.1	10.1	12.9	13.6	10.0	16.5	35.8	13.2	48.0	12.1	18.4	24.0	5.9	5.5	6.5	18.5	24.0	18.6	1.4	5.0	3.7	4.7	4.1	2.4	3.3	4.5	4.4	5.3	0.8	3.7	2.6	2.1	2.8	4.6	5.5	5.0	3.6	7.0	9.1	9.2	7.9	6.5	6.8	10.4	9.3	9.8	8.2	9.3	10.8	2.3	6.4	5.8	7.8	2.2	2.5	1.1	3.4	0.6	2.7	5.6	3.3	49.5	8.6	4.6	5.5	2.1	4.1	5.2	6.0	0.0	5.0	3.0	3.3	2.7	4.8	8.3	1.7	5.6	5.6	4.3	4.6	5.6	6.4	1.3	3.2	2.9	14.2	13.3	0.0	4.4	4.7	4.1	7.3	3.8	3.5	2.8	9.5	0.0	4.7	4.7	4.1	3.1	4.0	11.1	6.2	3.4	2.2	8.2	2.5	3.4	1.9	2.0	3.1	0.0	3.3	4.2	4.4	3.8	2.8	2.3	3.8	4.3	2.5	3.6	1.6
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211270-12243367	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	9.9	26.1	6.0	7.1	8.5	7.2	10.9	10.7	9.1	13.1	7.6	12.6	8.6	14.7	12.2	10.3	11.2	9.1	11.4	6.3	7.0	17.8	18.8	7.7	7.9	7.4	7.4	12.0	10.1	12.7	9.9	14.0	8.1	14.6	11.5	14.6	13.1	13.9	14.7	9.0	10.2	12.7	10.5	8.4	8.9	7.0	7.4	6.7	16.0	12.2	6.8	10.7	10.2	14.5	13.9	26.3	14.8	24.2	26.3	21.3	11.5	19.7	33.3	12.6	12.7	8.6	42.1	3.7	21.2	23.5	30.0	14.6	11.9	12.5	10.5	7.2	11.5	5.5	14.5	8.3	20.8	20.5	8.6	22.1	14.1	9.9	19.2	57.5	16.0	10.2	16.1	11.1	14.9	4.4	3.9	8.6	17.4	17.5	13.9	11.1	10.9	10.1	23.5	12.4	15.4	21.4	18.8	15.4	16.7	20.0	13.9	10.0	18.9	14.0	20.3	14.1	16.2	15.0	28.6	5.9	19.6	6.7	35.2	11.6	4.3	5.3	9.1	5.2	12.8	6.1	10.6	10.6	2.9	7.8	17.3	13.2	2.8	14.4	7.9	0.9	10.3	6.8	6.0	8.5	10.7	9.1	6.3	7.0	7.4	7.4	8.1	10.5	7.4	14.5	45.0	73.7	40.3	41.1	34.3	36.8	42.6	38.5	62.6	55.0	46.0	30.4	46.0	38.6	49.3	66.2	45.9	54.0	18.9	53.6	17.6	115.4	5.0	29.2	56.3	34.6	57.6	24.4	60.1	58.7	36.0	65.8	36.7	37.8	14.5	53.8	41.7	85.1	33.3	65.6	78.6	37.9	57.0	29.2	23.9	4.3	49.0	23.9	37.4	28.1	19.1	95.2	39.1	66.9	82.3	75.3	53.4	60.9	39.9	85.0	57.1	67.7	47.4	51.8	32.9	49.5	41.6	40.1	31.6	56.4	43.3	135.6	41.1	70.7	47.2	81.9
TMEM106C	MGC5576	ENSG00000134291	"Transmembrane protein 106C"	Q9BVX2	12	47963569-47968878	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 876.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047204	Enhanced					NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047204: AB_2679982"	"unprognostic (1.63e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.27e-8)"	"unprognostic (1.05e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.62e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.83e-1)"	28.1	41.9	37.4	36.3	37.5	48.2	66.6	38.2	46.1	52.0	56.7	138.2	113.2	35.8	135.8	42.0	48.5	45.5	58.9	39.7	42.4	80.9	44.7	39.4	38.4	36.4	36.3	55.5	66.5	146.2	62.9	73.4	37.1	41.0	145.3	121.7	59.7	51.7	26.5	37.4	120.1	55.3	35.5	78.1	53.5	40.0	43.4	55.9	49.3	34.3	46.8	28.9	32.8	33.7	243.9	166.4	151.7	167.7	68.5	50.0	143.2	133.6	191.0	238.5	203.8	250.2	243.3	212.2	182.9	147.6	221.8	162.1	239.2	146.1	226.6	203.8	229.1	163.7	217.2	101.7	52.4	172.6	117.9	34.4	98.4	217.8	114.2	163.4	154.2	224.0	113.4	235.6	169.6	174.4	248.2	75.5	27.0	258.7	226.5	217.9	195.9	180.9	127.2	183.2	100.9	120.5	206.8	138.5	142.4	78.4	503.5	136.9	38.3	99.8	168.9	145.0	240.9	130.8	228.9	240.1	127.3	876.5	97.9	39.3	8.8	23.9	44.4	8.6	54.9	36.9	42.8	46.5	12.5	30.8	39.7	44.0	7.6	19.6	10.4	1.9	66.4	41.0	37.4	37.5	38.2	46.1	39.7	42.4	36.4	36.3	37.1	35.5	43.4	33.7	14.5	32.1	20.7	6.8	26.5	47.9	39.2	45.8	36.5	30.2	54.9	78.7	39.1	61.5	21.9	35.0	18.8	75.3	17.7	244.8	86.1	63.8	2.8	35.7	5.7	17.3	36.0	49.2	14.1	45.1	32.8	45.4	37.2	18.6	10.8	86.3	55.0	19.6	54.3	30.3	13.0	150.8	101.7	16.4	20.7	6.8	32.6	21.5	21.4	8.4	10.1	268.4	27.8	4.5	1.2	35.5	208.3	41.3	72.5	22.6	385.7	82.2	11.5	47.2	13.1	46.4	36.9	52.8	36.0	55.4	40.9	14.9	31.5	35.0	220.5	39.4
TMEM107	"JBTS29, MGC10744, MKS13"	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8172457-8176399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 110.8;Respiratory ciliated cells: 164.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	9.6	13.4	11.1	6.6	12.0	15.0	9.8	12.2	13.3	10.6	19.3	9.0	3.5	11.3	20.7	10.5	27.0	7.2	9.2	11.9	12.8	14.7	4.4	11.3	7.4	13.0	12.6	7.8	11.2	16.9	23.5	6.8	12.2	7.3	5.0	29.6	10.7	6.5	1.6	12.0	7.6	6.6	12.1	13.7	8.0	17.1	12.3	8.9	16.1	1.8	7.6	8.4	9.6	12.5	45.0	16.9	21.8	11.3	12.2	17.8	4.8	11.1	8.2	8.2	10.9	2.0	26.6	10.5	14.6	9.7	7.4	30.5	8.3	16.9	13.6	18.1	11.5	7.6	29.0	4.7	4.9	2.6	8.3	7.9	11.2	20.7	9.4	18.4	13.1	17.7	5.9	23.5	18.0	12.2	6.8	7.7	2.2	6.3	7.2	13.1	6.5	19.1	15.8	3.5	7.3	10.7	13.5	2.4	9.1	5.1	8.1	8.8	10.6	4.8	9.6	7.6	6.1	9.5	5.5	4.9	27.3	10.0	8.7	21.0	22.1	51.6	28.2	27.9	24.3	45.4	27.6	30.3	19.7	59.2	30.9	32.2	20.0	26.4	56.8	31.6	24.8	21.0	11.1	12.0	12.2	13.3	11.9	12.8	13.0	12.6	12.2	12.1	12.3	12.5	30.8	9.6	9.8	2.9	38.1	19.2	19.5	35.2	11.4	17.3	31.1	43.3	7.9	35.8	25.1	33.1	45.9	17.3	30.0	12.9	13.7	21.7	12.2	99.9	22.9	25.1	9.1	15.4	5.1	11.1	21.3	18.2	48.9	26.9	36.7	12.7	27.1	24.0	45.5	11.8	3.6	14.1	16.2	45.6	31.6	10.1	12.8	55.9	33.8	3.7	22.0	37.7	28.8	1.5	1.7	11.0	12.7	15.1	110.8	16.3	26.0	21.7	164.3	63.2	0.0	15.3	16.8	69.4	50.3	13.0	28.6	13.3	34.8	13.2	17.6	11.1
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397775	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.2;skeletal muscle: 23.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		55000		"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	1.4	11.3	6.3	1.5	9.6	0.2	1.5	3.4	10.0	2.0	3.2	1.5	0.4	2.4	0.6	9.6	1.7	0.8	6.8	9.6	2.9	0.4	0.1	11.0	1.7	0.0	4.1	0.3	0.3	3.0	2.2	2.4	4.0	1.0	1.3	35.2	1.3	2.0	23.1	1.4	1.6	5.5	0.0	1.3	1.3	13.9	7.9	1.3	3.1	7.0	2.3	8.3	0.8	0.8	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.7	1.0	1.8	8.5	0.0	0.0	0.0	0.0	24.2	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	13.8	0.7	0.1	0.3	3.8	0.0	0.0	0.0	4.8	0.1	1.1	0.0	21.0	92.6	0.0	0.1	0.3	5.5	0.2	0.0	0.0	0.1	0.1	0.0	3.4	1.3	0.0	0.7	1.8	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.6	3.4	10.0	9.6	2.9	0.0	4.1	4.0	0.0	7.9	0.8	0.6	3.2	4.6	209.9	0.0	2.4	0.5	0.2	0.0	10.4	1.3	2.8	1.7	1.5	5.0	0.0	102.2	1.8	0.0	0.0	0.0	0.0	80.6	1.0	0.6	1.3	0.0	0.0	357.3	0.4	8.6	4.6	4.1	0.2	1.3	5.5	0.4	0.0	0.3	1.7	475.3	0.0	0.0	0.0	0.8	38.2	0.9	0.1	0.0	33.7	0.0	5.7	0.0	480.0	22.2	0.3	0.0	0.7	1.2	0.2	0.0	0.0	0.0	57.6	0.0	6.8	3.3	17.2	11.2	0.0	1.6	1.1	1.0	4.9	0.0	0.4
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60914158-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	83.0	46.4	22.2	44.4	23.2	27.0	71.9	23.3	25.5	85.4	42.1	75.1	26.2	97.7	26.7	93.8	73.7	35.7	84.0	19.8	23.2	47.3	32.1	71.8	48.0	26.7	24.5	81.5	46.1	67.3	41.1	46.8	25.4	52.4	27.0	14.3	81.8	60.8	99.4	69.7	47.8	70.0	25.9	58.1	58.2	14.4	25.5	41.4	57.3	77.0	50.3	70.4	79.9	24.7	111.5	103.5	63.3	102.1	169.4	77.7	51.5	107.3	100.4	118.5	99.8	94.5	115.7	131.5	190.4	130.1	69.9	143.5	73.2	48.8	72.5	102.5	97.0	96.2	44.3	21.1	50.2	188.4	77.0	54.1	61.6	92.9	46.8	41.9	148.1	104.8	48.4	330.4	85.4	217.2	139.9	80.8	104.6	62.8	111.4	132.3	123.9	183.0	56.6	63.6	25.3	44.4	86.2	196.8	102.7	44.8	110.4	35.8	143.7	136.9	65.9	174.4	95.8	108.7	89.5	69.9	121.2	82.0	159.7	39.0	76.0	56.4	188.7	69.5	193.3	116.5	108.4	161.4	227.4	140.4	97.4	124.8	8.2	121.1	52.4	470.0	91.1	139.4	22.2	23.2	23.3	25.5	19.8	23.2	26.7	24.5	25.4	25.9	25.5	24.7	118.2	70.5	23.2	5.5	60.2	50.7	43.8	30.9	63.7	13.4	39.5	45.3	34.6	25.8	23.9	25.8	0.0	120.7	83.4	6.8	25.4	76.6	20.7	18.7	25.9	91.2	7.2	33.0	5.3	80.2	116.4	75.9	10.7	27.9	50.7	22.2	71.0	18.9	66.8	30.3	3.8	10.1	22.4	21.3	69.1	11.1	89.5	43.4	51.6	11.2	45.4	30.2	68.0	3.5	5.1	53.1	14.7	97.4	38.4	36.5	10.6	17.1	18.7	34.8	39.5	45.0	67.6	5.9	7.2	55.1	50.6	53.2	52.7	25.8	16.8	33.9
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197954-21214176	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	17.6	11.7	18.9	12.4	19.3	37.7	10.8	21.1	25.1	10.6	18.4	13.9	12.5	11.8	18.6	14.2	9.4	9.0	21.3	19.1	19.9	9.9	9.9	11.8	13.8	20.3	19.3	12.2	30.4	14.9	1.3	17.1	19.8	12.2	10.0	10.9	23.7	9.1	81.3	16.8	14.2	9.8	18.7	11.5	13.2	7.7	19.8	15.8	12.6	54.1	9.8	15.6	1.9	19.8	25.3	27.5	22.7	22.1	33.9	24.1	31.2	38.9	17.7	35.8	31.3	74.5	13.5	27.4	29.7	36.3	29.0	35.0	30.0	35.8	17.9	23.2	46.5	19.8	27.0	32.1	36.8	25.1	22.0	26.5	27.7	36.4	26.2	17.2	22.8	19.3	23.0	9.5	26.9	39.9	37.8	46.6	30.5	68.8	15.3	27.2	49.8	19.6	25.2	21.3	13.8	24.0	17.6	19.0	36.9	87.2	18.4	24.8	21.4	25.1	29.7	42.5	49.3	9.6	13.2	69.3	24.9	31.9	22.6	31.2	70.6	76.2	33.1	58.9	29.6	49.4	33.1	31.8	47.1	47.4	37.0	31.8	58.4	40.8	67.9	38.8	40.3	68.1	18.9	19.3	21.1	25.1	19.1	19.9	20.3	19.3	19.8	18.7	19.8	19.8	35.0	48.1	21.8	5.5	26.0	84.9	61.9	77.7	35.3	32.9	40.2	39.9	49.9	22.8	49.1	36.8	18.8	80.7	36.6	49.4	50.9	55.3	20.7	23.9	23.6	36.8	31.9	51.3	4.4	40.5	80.9	33.9	20.9	29.1	27.3	23.1	32.2	28.1	54.3	23.5	5.1	67.4	73.2	25.3	34.5	16.3	35.8	26.3	40.9	8.4	48.6	31.6	33.0	6.0	8.0	47.4	60.6	57.6	19.9	63.6	55.0	55.9	33.0	39.9	32.9	25.7	42.0	40.4	38.4	34.7	92.6	90.8	28.7	31.3	49.6	80.2
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354750-50359521	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	29.4	34.3	23.5	12.0	24.4	11.7	28.6	24.6	26.5	25.2	26.9	29.5	23.4	33.3	17.6	27.2	26.3	15.6	31.9	23.3	23.1	28.9	32.3	26.6	11.3	25.7	24.1	25.4	29.9	32.0	20.3	22.8	24.7	30.7	12.8	6.7	29.1	20.6	27.1	42.6	27.1	17.0	23.2	24.3	31.2	17.0	24.4	10.8	34.6	18.2	9.6	28.0	25.6	24.0	26.6	31.9	20.4	33.6	56.9	45.2	26.4	40.3	59.3	50.2	38.3	24.0	30.4	12.9	33.1	53.1	46.2	27.8	24.7	32.7	14.1	23.9	42.9	19.5	27.8	32.9	79.7	21.4	27.2	68.4	41.6	41.5	30.1	43.3	38.6	15.7	21.3	21.7	37.9	24.5	14.8	33.8	36.4	17.4	49.9	7.2	16.3	28.8	38.3	24.7	22.7	48.7	24.5	26.9	34.5	17.8	22.3	22.4	40.4	45.3	22.8	48.1	42.9	32.0	19.9	7.3	41.6	23.3	30.5	52.5	27.9	41.4	26.5	25.1	17.5	18.2	17.5	21.2	23.2	18.5	18.7	18.2	37.9	27.3	24.5	26.1	24.1	23.8	23.5	24.4	24.6	26.5	23.3	23.1	25.7	24.1	24.7	23.2	24.4	24.0	24.0	16.0	12.4	4.2	14.3	30.2	19.7	26.1	29.6	17.1	25.3	24.9	7.0	25.8	15.8	11.0	6.2	58.8	15.9	39.9	3.9	44.7	1.1	17.9	17.2	22.9	15.7	18.5	2.9	26.5	42.2	31.5	20.4	16.3	11.4	23.6	26.0	19.5	36.3	18.5	3.7	26.6	28.5	11.4	12.4	1.2	29.2	15.5	10.6	2.8	20.4	25.7	13.4	6.6	4.4	35.6	32.5	25.2	18.8	33.8	43.9	26.9	14.3	15.1	26.3	19.3	26.5	17.0	8.0	17.5	34.9	92.8	14.3	36.4	24.9	25.6
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 59.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 19.3"	"Cell line enhanced"	"Detected in many"		"RT4: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.8	8.8	7.0	2.2	7.8	1.2	11.4	9.2	8.4	6.0	27.5	4.2	11.1	2.7	7.1	4.2	4.9	6.8	26.3	6.4	6.5	30.8	12.3	8.5	4.5	7.2	7.5	5.2	4.2	59.7	6.5	2.9	7.2	3.9	3.7	7.0	13.3	5.9	6.6	11.1	6.3	2.1	6.9	3.4	10.2	27.1	7.5	5.4	6.3	5.8	6.8	7.4	3.2	8.5	6.2	6.4	8.9	9.7	8.3	6.6	6.0	5.1	7.5	6.1	6.6	4.6	5.1	6.9	2.9	3.5	7.6	5.9	4.8	5.1	5.4	17.1	4.1	4.4	5.4	5.1	13.2	1.6	0.7	7.8	8.5	7.7	13.5	6.7	2.2	13.2	8.7	5.0	6.5	9.4	2.3	14.2	10.6	14.5	3.9	7.0	3.8	12.2	18.9	33.1	8.1	5.6	5.3	4.4	8.3	11.7	16.0	22.9	1.6	5.8	1.8	5.1	2.2	6.5	12.1	6.6	7.9	5.5	8.0	1.1	2.6	4.5	8.1	4.5	6.8	2.9	18.5	15.6	2.9	3.6	9.6	10.8	0.4	2.4	3.5	4.2	19.3	4.0	7.0	7.8	9.2	8.4	6.4	6.5	7.2	7.5	7.2	6.9	7.5	8.5	4.0	3.2	18.5	17.3	6.2	5.5	6.2	8.8	7.4	11.2	14.0	12.8	21.7	7.2	10.1	29.5	16.7	18.6	10.2	5.7	23.5	4.2	67.8	7.0	4.3	3.5	0.0	3.4	28.3	4.0	5.9	5.9	7.7	3.7	5.7	7.0	2.2	5.4	5.1	10.1	25.6	4.6	24.4	4.1	4.5	33.5	9.3	3.9	7.2	7.5	3.6	13.4	11.3	13.0	33.3	2.7	3.2	4.9	5.5	4.2	20.9	10.3	18.6	17.3	6.6	6.5	6.6	123.5	37.4	6.2	5.4	40.1	17.4	7.0	6.0	7.6
TMEM117	DKFZp434K2435	ENSG00000139173	"Transmembrane protein 117"	Q9H0C3	12	43835967-44389762	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 65.6;Excitatory neurons: 220.2;Inhibitory neurons: 190.3;Microglial cells: 80.6;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046223	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046223: AB_10960636"	"unprognostic (1.37e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.07e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.80e-1)"	1.8	1.9	0.9	1.2	1.4	0.1	2.7	1.5	2.1	3.8	8.8	3.4	6.0	4.0	2.6	5.8	2.3	3.5	4.2	1.3	1.3	2.2	2.1	1.1	1.4	2.4	1.5	2.5	3.7	4.1	1.7	3.0	2.8	3.5	3.5	2.3	2.1	5.2	3.3	4.0	4.2	4.0	1.4	0.7	2.1	2.4	1.3	0.9	2.3	3.3	2.3	4.1	3.8	2.6	1.2	0.4	4.0	6.7	4.5	9.6	0.1	12.6	6.2	2.3	2.7	10.0	4.3	4.5	0.9	9.0	0.6	6.4	2.6	2.8	1.7	1.9	7.4	1.2	2.5	4.0	1.3	1.8	4.7	5.0	9.9	1.3	0.7	9.2	0.4	0.5	2.2	1.9	4.4	1.1	0.0	1.1	0.8	0.0	2.4	3.0	4.5	1.8	4.5	2.7	0.6	6.1	4.8	1.5	10.2	1.6	0.3	4.7	1.5	3.4	1.1	1.8	3.3	3.4	3.9	2.6	1.7	2.0	1.2	0.0	0.0	0.0	1.2	0.0	1.7	1.0	0.3	1.2	0.0	0.9	0.5	0.6	0.0	0.4	0.0	0.1	0.2	0.4	0.9	1.4	1.5	2.1	1.3	1.3	2.4	1.5	2.8	1.4	1.3	2.6	3.2	0.0	1.3	65.6	8.4	6.5	4.8	3.4	9.6	3.9	2.4	2.8	5.4	2.8	2.5	7.3	4.2	15.0	2.8	6.9	3.9	2.8	25.8	3.9	5.5	2.1	0.0	1.7	220.2	3.0	2.7	3.8	18.3	6.0	2.5	6.0	4.2	2.7	5.6	5.0	190.3	4.2	12.2	3.8	2.5	9.5	6.2	2.1	12.4	80.6	0.1	3.4	3.1	123.1	152.4	2.5	19.2	6.4	11.2	2.1	13.8	1.3	2.7	5.2	0.0	2.2	3.8	1.4	5.5	17.7	12.1	11.5	5.1	2.3	5.0	4.9
TMEM119	OBIF	ENSG00000183160	"Transmembrane protein 119"	Q4V9L6	12	108589851-108598320	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biomineralization, Differentiation, Osteogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.3;Fibroblasts: 30.5;Late spermatids: 9.3;Melanocytes: 8.8;Microglial cells: 15.0;Peritubular cells: 24.0;Smooth muscle cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 559.2;ASC TERT1: 152.6;BJ hTERT+: 168.0;fHDF/TERT166: 81.9;HSkMC: 238.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051870, HPA052650"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051870: AB_2681645, HPA052650: AB_2681901"	"unprognostic (4.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.29e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	29.6	8.0	7.6	16.2	8.9	3.0	27.1	8.5	9.2	61.0	5.3	12.6	15.1	18.9	14.1	6.9	11.9	35.8	9.4	7.7	9.3	6.0	0.9	37.6	47.8	17.2	12.1	1.4	7.5	5.6	6.1	6.6	14.9	12.7	15.1	0.9	6.8	26.0	1.6	13.9	23.1	11.2	13.4	11.4	10.5	5.9	16.4	5.1	21.7	1.7	27.2	32.2	18.4	21.9	0.1	0.3	1.3	0.7	559.2	152.6	0.8	11.8	168.0	0.4	3.0	0.2	0.6	0.3	0.4	81.9	0.3	0.2	0.1	0.2	0.1	0.5	0.0	0.3	0.6	1.0	7.2	0.3	1.2	238.4	0.3	7.0	0.1	0.7	0.1	0.2	0.5	0.5	0.5	0.7	0.3	1.6	0.1	0.0	0.9	0.6	0.9	0.8	0.1	0.7	0.2	39.5	0.0	0.3	0.3	4.5	0.2	1.8	1.2	13.1	0.4	11.2	0.5	2.6	3.1	0.6	6.8	0.5	0.1	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.4	0.3	0.3	1.4	0.2	0.4	0.2	0.1	0.1	7.6	8.9	8.5	9.2	7.7	9.3	17.2	12.1	14.9	13.4	16.4	21.9	1.3	0.0	0.0	0.0	0.2	3.8	0.1	0.0	0.6	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	8.3	0.2	5.8	1.3	0.0	0.0	0.0	0.0	0.2	30.5	0.0	0.2	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	1.9	4.4	9.3	4.1	1.1	8.8	15.0	1.6	0.0	0.0	0.0	0.0	0.1	1.1	24.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.1	0.1	0.0	3.7	0.3	0.7	0.5	0.0	0.1
TMEM120B		ENSG00000188735	"Transmembrane protein 120B"	A0PK00	12	121712752-121783001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 93.1;NK-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014066	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"HPA014066: AB_1845296"	"unprognostic (8.80e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.72e-2)"	7.6	10.9	6.7	2.6	17.1	7.7	6.9	18.2	8.9	27.1	4.3	6.9	3.5	13.7	2.3	4.4	18.6	2.1	7.7	9.8	3.3	11.4	7.9	6.5	3.0	5.2	1.5	8.6	16.7	4.4	19.9	1.7	5.5	9.0	2.0	4.2	11.0	2.7	13.9	5.5	5.3	5.5	1.0	6.7	8.8	5.6	5.1	1.3	13.8	4.9	1.7	6.7	11.7	3.0	5.4	17.3	4.1	11.7	5.0	6.6	8.5	7.0	7.8	6.4	5.2	11.0	5.6	5.6	4.3	7.0	6.3	8.9	9.6	8.1	3.4	3.4	9.7	7.9	6.1	7.1	6.8	5.5	5.9	6.1	7.2	7.3	5.2	11.0	4.0	12.2	7.2	3.8	3.9	8.1	9.6	7.6	7.7	3.4	10.9	11.4	16.9	7.4	3.4	5.7	15.6	11.1	7.2	5.4	6.1	7.4	12.8	4.4	5.3	8.7	10.0	5.5	6.1	9.5	3.8	3.9	10.9	7.0	8.8	1.0	0.3	0.3	0.7	0.3	0.5	0.6	0.7	0.5	0.4	1.1	0.5	0.5	0.7	0.6	0.3	0.9	0.6	0.3	6.7	17.1	18.2	8.9	9.8	3.3	5.2	1.5	5.5	1.0	5.1	3.0	3.3	25.6	12.2	12.1	14.0	6.5	5.3	6.5	4.6	35.4	9.2	5.5	5.9	8.6	9.9	11.0	22.9	6.4	45.9	36.7	7.9	7.8	19.7	30.6	12.6	4.8	6.6	16.6	29.8	12.3	6.9	9.1	8.2	42.9	4.5	29.8	1.8	4.6	5.7	13.5	40.7	4.9	4.1	4.7	93.1	39.9	6.5	17.6	1.8	10.3	32.1	3.6	76.2	7.1	6.6	30.3	33.6	6.4	19.8	7.2	29.4	7.0	15.7	20.6	6.6	10.3	8.6	8.4	7.5	2.9	7.0	11.4	28.0	16.8	5.4	10.0
TMEM121	"hole, MGC4659, TMEM121A"	ENSG00000184986	"Transmembrane protein 121"	Q9BTD3	14	105526583-105530202	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 31.2;Muller glia cells: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4"	"Low region specificity"	"Detected in all"							HPA049857	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA049857: AB_2680917"	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.48e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.90e-2)"	2.0	1.0	4.8	0.5	5.0	0.2	2.4	2.9	6.4	4.6	0.4	2.4	0.2	4.3	0.1	1.0	4.6	0.1	2.3	5.7	3.1	2.6	2.6	1.7	0.3	5.8	4.8	2.4	2.4	0.6	5.1	0.2	3.8	3.7	0.0	0.0	1.4	0.4	0.3	1.5	1.8	0.2	2.6	3.4	1.8	1.2	3.3	0.1	2.6	0.0	0.0	2.1	2.1	3.9	0.0	4.0	0.4	3.6	0.0	0.2	0.7	2.4	0.5	0.4	0.0	0.0	1.3	1.2	8.1	0.0	0.7	0.4	0.4	0.1	0.0	0.5	1.9	0.0	0.4	1.4	0.6	0.0	1.4	0.2	0.0	0.1	0.0	0.2	0.4	0.5	0.1	0.0	0.2	8.1	0.2	0.0	1.2	0.1	10.2	6.7	0.0	0.1	0.1	0.0	5.3	2.0	0.4	0.0	2.0	0.0	2.4	0.3	1.4	1.1	2.1	0.2	0.4	0.6	0.0	0.0	0.1	0.5	5.4	0.0	0.0	0.0	0.6	0.0	1.0	2.1	1.2	0.6	0.2	0.6	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.2	4.8	5.0	2.9	6.4	5.7	3.1	5.8	4.8	3.8	2.6	3.3	3.9	10.6	0.0	0.5	2.3	2.8	4.6	2.6	0.1	2.2	5.1	8.9	10.8	1.5	1.5	0.7	5.5	0.0	0.2	0.7	0.0	0.0	1.0	1.7	5.4	5.5	9.5	0.0	3.4	5.7	0.2	2.2	4.6	1.1	1.4	0.0	31.2	10.8	2.3	0.4	10.1	4.8	0.0	0.0	0.6	4.8	2.2	4.4	0.4	7.2	2.8	0.0	14.4	1.0	12.1	11.5	0.0	0.0	6.4	0.5	1.8	0.0	0.1	1.6	1.6	0.0	4.0	3.2	0.7	3.1	0.4	2.6	0.3	3.2	1.8	0.2	0.6
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116297-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hofbauer cells: 2.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8"	"Low region specificity"	"Detected in all"							HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	0.3	0.6	6.4	0.9	7.5	1.0	0.7	3.5	7.6	0.2	1.5	0.2	0.2	0.3	0.9	0.3	0.3	0.2	1.2	8.7	3.9	0.3	0.1	0.3	0.1	3.8	3.3	0.2	1.1	0.1	1.6	0.7	3.3	6.6	0.2	1.3	0.4	0.2	1.3	0.5	0.2	0.3	3.6	0.7	0.2	1.9	4.9	0.1	0.1	0.4	0.1	0.3	0.2	5.1	0.0	0.0	6.0	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.1	0.0	0.1	0.2	3.0	0.0	0.3	0.1	14.2	2.1	0.0	0.0	0.3	0.8	0.0	11.9	0.6	0.6	0.2	0.2	0.0	0.2	0.4	0.9	0.0	9.8	0.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	7.5	3.5	7.6	8.7	3.9	3.8	3.3	3.3	3.6	4.9	5.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	1.3	0.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	16.1	16.7	29.2	13.0	29.4	6.5	19.3	28.9	38.9	18.2	25.9	21.4	19.6	19.3	30.7	14.3	15.8	17.3	24.7	30.4	31.7	15.3	17.2	15.8	18.7	29.7	30.0	16.4	15.9	11.0	20.8	13.3	30.9	17.0	17.6	18.6	15.7	14.1	16.2	13.8	19.8	21.4	30.1	16.5	17.6	10.9	30.2	16.0	16.8	20.1	17.5	18.6	14.8	32.3	37.9	29.8	33.1	16.0	60.2	49.6	10.6	33.1	36.1	25.6	38.1	84.8	37.1	39.9	72.2	27.1	28.6	45.0	53.2	33.0	23.8	56.5	49.7	30.1	49.1	36.1	35.6	75.4	34.7	37.9	38.3	38.6	47.0	41.1	38.6	49.5	72.5	31.2	58.8	47.9	29.4	91.3	36.1	129.6	50.1	25.0	25.4	33.6	49.5	42.1	30.8	19.1	31.2	24.9	31.9	42.5	50.1	45.4	20.5	38.2	26.5	96.9	35.4	14.6	91.1	47.7	19.4	60.4	20.6	21.5	15.6	7.9	19.0	18.2	24.8	18.3	23.4	23.5	20.1	17.7	23.3	23.4	5.9	23.4	14.5	18.4	25.9	15.9	29.2	29.4	28.9	38.9	30.4	31.7	29.7	30.0	30.9	30.1	30.2	32.3	44.9	22.4	40.7	16.6	34.6	26.1	32.2	80.8	22.8	32.5	36.8	31.1	87.3	54.3	57.2	40.5	14.6	41.0	54.2	33.6	168.3	76.0	5.4	27.2	39.2	46.1	34.6	34.5	19.3	49.0	54.5	45.1	15.8	25.8	42.5	27.8	42.5	43.6	84.1	23.5	20.1	41.3	81.4	47.4	44.6	8.3	66.5	43.5	72.9	9.4	48.8	79.0	80.3	20.6	29.7	51.5	52.8	88.4	22.4	35.3	56.5	162.9	51.3	31.2	39.5	30.0	43.8	34.4	46.8	23.1	36.9	25.2	49.7	45.4	52.0	45.4
TMEM128	MGC13159	ENSG00000132406	"Transmembrane protein 128"	Q5BJH2	4	4235542-4248223	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044809	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044809: AB_10963539"	"unprognostic (4.97e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	22.5	27.2	21.7	15.4	24.0	8.4	33.0	24.0	34.8	25.3	21.9	23.1	20.7	27.3	47.0	20.4	29.2	16.9	22.9	21.1	23.8	33.5	19.7	25.0	23.3	25.2	23.5	36.6	21.4	44.7	17.8	26.9	24.9	26.8	24.9	16.2	22.0	25.5	14.4	22.5	19.4	16.4	24.6	22.2	23.7	25.3	23.2	23.6	37.2	15.3	23.2	17.9	18.4	29.1	15.7	12.0	43.7	33.3	34.8	29.0	31.1	33.2	37.2	34.8	33.0	13.5	60.9	9.1	17.0	29.6	33.0	13.3	21.1	22.5	33.0	25.0	13.1	17.1	8.8	19.0	48.9	41.4	30.0	40.6	38.7	13.5	27.0	31.1	20.9	29.9	24.7	17.9	40.7	17.1	34.0	55.3	36.3	22.8	23.4	13.2	17.5	19.7	52.9	24.4	24.5	39.6	13.5	12.9	41.2	28.6	44.4	40.5	20.5	32.8	13.8	30.9	35.0	49.8	43.9	30.6	34.2	28.6	40.7	25.7	36.5	42.8	36.3	50.4	45.8	38.1	43.9	36.2	38.1	34.3	59.0	49.9	17.4	45.6	45.0	61.5	36.7	37.9	21.7	24.0	24.0	34.8	21.1	23.8	25.2	23.5	24.9	24.6	23.2	29.1	20.7	12.8	22.7	8.8	13.8	17.8	20.3	63.5	12.0	9.9	25.5	22.0	9.1	24.3	30.5	31.3	2.1	45.3	17.3	24.2	29.4	28.7	25.9	16.3	19.6	18.6	17.3	15.2	11.1	23.7	44.4	23.1	7.1	14.6	15.8	14.3	27.8	18.2	30.2	13.5	12.3	23.2	28.5	23.5	14.0	8.9	40.7	14.9	39.2	10.3	25.2	26.4	23.7	14.1	24.5	18.2	33.9	37.6	5.7	24.0	24.9	38.3	32.6	11.7	46.0	18.9	20.3	76.7	34.4	12.8	25.1	43.8	16.3	17.0	17.7	20.6
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Uncertain		Supported	"Golgi apparatus"		NA	NA		9400	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	0.5	37.1	63.7	1.5	64.2	0.6	1.2	0.0	116.6	3.2	0.0	3.9	0.8	1.1	9.4	1.6	1.0	1.8	0.6	67.3	141.0	3.4	0.1	6.2	2.3	11.6	8.2	0.9	0.8	2.7	100.3	0.5	17.0	2.4	1.2	17.9	0.4	6.7	2.0	0.4	1.5	0.8	7.2	0.7	1.4	37.4	55.7	1.8	0.5	0.1	0.3	0.9	4.9	42.4	0.0	0.6	0.0	0.0	0.2	0.0	0.3	2.9	6.7	0.5	0.4	0.1	0.1	0.1	6.4	1.7	6.9	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	11.0	0.3	0.2	0.1	0.4	0.3	0.5	0.1	0.2	3.8	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.4	7.8	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.4	0.4	0.2	0.8	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	1.6	0.3	0.2	0.2	0.1	0.1	63.7	64.2	0.0	116.6	67.3	141.0	11.6	8.2	17.0	7.2	55.7	42.4	0.1	0.0	0.0	2.6	0.0	0.4	0.4	0.1	0.0	51.2	0.3	0.4	1.0	1.5	2.0	1.8	2.1	0.1	1.5	0.1	0.0	0.0	1.6	0.1	0.2	0.5	0.0	0.0	43.8	0.2	0.1	2.1	0.0	0.2	0.0	0.5	0.7	0.0	0.1	0.0	53.9	0.0	2.0	0.0	1.2	2.7	0.9	0.3	0.0	3.7	0.0	1.7	0.0	11.6	4.2	0.0	0.0	6.8	0.0	0.3	0.2	0.1	0.3	4.3	0.0	0.6	0.8	0.6	0.6	0.0	0.3	0.3	0.2	0.0	0.1	0.2
TMEM131	"CC28, KIAA0257, PRO1048, RW1, YR-23"	ENSG00000075568	"Transmembrane protein 131"	Q92545	2	97756333-97995948	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017678, HPA017682"	Approved		Uncertain	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Intermediate filaments"		"HPA017678: AB_1858086, HPA017682: AB_1858087"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.18e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.10e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.77e-1)"	12.1	12.2	7.2	20.7	7.5	17.5	10.6	7.2	7.6	18.8	9.3	25.8	18.5	16.3	8.5	14.3	15.3	15.8	13.0	7.4	5.5	12.1	13.5	12.4	25.4	6.1	7.5	16.3	19.0	27.5	11.1	18.3	6.1	16.6	23.2	11.4	13.4	11.5	24.4	24.1	19.4	16.5	6.6	18.4	26.2	14.7	10.3	18.4	12.8	22.3	23.1	14.1	10.4	8.6	26.1	15.7	28.8	21.0	29.6	35.8	31.4	37.8	36.5	18.9	22.7	20.3	36.8	41.3	20.4	39.3	32.2	18.4	30.5	50.5	28.0	29.4	19.8	30.0	10.6	29.3	33.4	28.2	38.6	34.4	20.2	33.7	34.7	32.0	23.5	19.8	18.1	42.8	58.2	15.7	20.6	17.9	15.8	20.2	33.4	29.7	18.3	18.3	19.3	30.7	32.3	15.7	24.4	16.7	23.2	30.7	14.0	25.8	28.1	49.1	22.4	23.9	14.7	18.1	26.8	20.6	38.5	24.3	33.9	3.7	1.3	3.6	1.7	1.6	1.9	2.1	1.5	1.7	1.7	1.9	1.7	2.3	0.9	2.5	1.6	2.4	1.0	1.0	7.2	7.5	7.2	7.6	7.4	5.5	6.1	7.5	6.1	6.6	10.3	8.6	29.4	16.0	27.9	90.1	41.2	19.8	17.7	16.3	24.5	28.3	17.3	16.0	34.7	15.7	23.4	20.2	22.9	15.4	33.1	62.2	3.9	9.7	14.4	88.9	33.9	19.3	30.1	23.5	113.1	24.0	12.7	23.5	60.1	86.8	23.5	21.3	22.9	26.0	24.5	25.2	99.7	45.6	10.2	29.2	18.5	20.1	20.8	35.8	12.4	87.1	47.0	14.1	9.2	92.5	129.8	18.1	40.1	19.2	36.3	17.9	27.4	7.0	38.2	19.3	13.1	31.9	24.9	21.2	26.0	25.0	25.6	13.5	22.4	28.0	36.6	16.0
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.4;lymphoid tissue: 48.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	9.8	1.7	1.6	20.9	4.0	49.4	7.2	1.0	2.7	5.6	1.0	6.4	2.3	6.3	9.4	6.7	5.0	4.9	8.7	1.5	1.6	3.5	20.7	6.6	47.8	1.9	1.4	4.6	31.2	1.1	3.9	3.9	1.9	5.9	4.6	0.4	8.1	4.8	24.5	6.9	10.9	6.9	1.0	24.6	6.1	4.4	2.0	48.3	4.1	6.2	45.4	6.1	6.0	2.8	5.8	3.7	15.7	16.5	9.1	7.9	0.3	8.3	4.0	5.6	7.1	25.8	3.7	105.2	2.0	11.1	6.2	5.7	12.1	14.3	8.5	9.7	8.7	20.6	7.0	6.7	5.9	22.9	1.2	7.3	8.7	7.4	6.9	6.3	14.4	19.1	19.7	0.4	5.7	10.7	99.9	16.6	14.0	0.2	5.4	34.3	15.2	6.8	3.8	2.4	11.7	9.1	6.5	14.2	8.6	8.0	5.5	16.6	11.6	7.5	13.2	9.1	6.9	11.2	12.1	122.4	2.2	13.5	6.2	11.8	19.4	21.1	12.3	36.8	16.7	28.2	15.5	11.7	20.9	27.3	25.8	17.5	21.0	24.3	31.6	2.1	20.9	17.6	1.6	4.0	1.0	2.7	1.5	1.6	1.9	1.4	1.9	1.0	2.0	2.8	13.6	6.4	9.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	5.5	4.3	0.0	0.0	1.8	0.0	0.0	0.5	13.2	0.0	1.9	2.0	0.0	1.3	8.2	3.2	0.0	0.0	0.0	9.3	0.2	3.7	0.0	1.1	5.1	5.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	16.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	4.8	0.0	0.0	1.5	5.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	7.2	5.1	0.0	0.0
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM132B	"KIAA1786, KIAA1906"	ENSG00000139364	"Transmembrane protein 132B"	Q14DG7	12	125186836-125662377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 13.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 165.5;Excitatory neurons: 431.6;Inhibitory neurons: 481.5;Oligodendrocyte precursor cells: 268.9"	"Cancer enriched"	"Detected in single"	7	"glioma: 3.3"	"Group enriched"	"Detected in many"	4	"amygdala: 5.0;basal ganglia: 9.0;cerebral cortex: 13.1;hippocampal formation: 9.6;white matter: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.1;HSkMC: 6.6;NTERA-2: 7.7;RPMI-8226: 3.5;U-138 MG: 11.8;U-937: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035661, HPA035662"	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035661: AB_10669774, HPA035662: AB_2674726"	"unprognostic (3.38e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-3)"	0.1	0.1	5.0	0.1	9.0	0.0	0.1	0.0	13.1	0.6	0.0	0.9	0.1	0.5	0.7	0.4	0.2	0.2	1.1	9.6	1.3	0.1	0.0	0.0	0.1	0.2	2.0	0.1	0.1	0.0	1.0	0.1	0.3	0.4	0.2	1.0	2.2	0.3	1.2	1.7	0.3	0.1	0.0	0.0	0.3	0.5	0.5	0.0	1.9	0.3	0.2	0.3	0.6	6.2	0.0	0.0	3.1	0.0	2.2	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	11.8	0.0	0.0	0.0	0.0	0.2	0.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	9.0	0.0	13.1	9.6	1.3	0.2	2.0	0.3	0.0	0.5	6.2	0.0	0.0	0.0	165.5	0.0	1.1	0.9	0.5	1.2	5.4	0.5	0.4	3.0	0.0	0.5	0.0	6.2	0.0	0.1	0.2	0.0	0.0	27.1	0.5	11.8	0.4	0.0	0.0	431.6	0.0	0.0	0.8	0.0	1.0	0.0	1.4	0.0	0.0	0.2	1.7	481.5	0.5	0.0	0.0	0.5	41.0	0.3	0.2	1.8	13.1	0.0	0.4	0.0	268.9	18.9	0.0	0.0	4.5	0.0	0.7	0.1	0.1	0.3	0.5	0.0	1.4	0.2	1.2	4.6	1.3	3.3	0.0	0.2	28.4	0.0	0.4
TMEM132D	"KIAA1944, MOLT, PPP1R153"	ENSG00000151952	"Transmembrane protein 132D"	Q14C87	12	129071725-129904025	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 5.5"	"Group enriched"	"Detected in some"	60	"Excitatory neurons: 448.6;Inhibitory neurons: 523.0;Oligodendrocyte precursor cells: 573.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;MOLT-4: 4.6;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010739	Approved					NA	NA		110000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA010739: AB_2204753"			"unprognostic (1.69e-1)"		"unprognostic (1.21e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.39e-1)"		"unprognostic (1.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.31e-4)"		0.0	0.1	0.9	0.1	5.5	0.1	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.6	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.5	0.0	4.9	2.5	1.0	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	1.8	0.0	448.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	523.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.4	0.0	0.2	0.0	573.0	7.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	12.6	24.3	22.5	8.6	23.2	4.7	14.8	21.2	29.9	15.6	19.9	14.0	8.3	9.6	11.0	55.5	10.2	6.5	46.8	21.6	22.2	25.2	33.9	11.2	11.9	22.8	22.6	8.6	42.9	7.9	8.7	5.3	22.4	25.7	4.5	2.8	20.6	7.3	57.4	57.5	14.5	4.4	22.7	16.2	22.4	26.5	22.9	6.6	13.5	26.0	8.8	15.9	25.4	22.5	12.3	4.6	6.5	14.0	4.3	7.3	7.2	2.5	4.6	2.9	1.2	5.8	14.3	11.7	27.2	6.2	9.2	10.0	2.9	10.7	1.8	11.3	4.9	2.2	4.5	5.9	6.6	2.3	3.2	7.3	13.4	2.3	7.7	12.7	3.0	7.9	3.0	6.6	6.3	29.0	13.3	8.6	11.0	20.4	16.3	6.5	3.8	38.5	11.3	12.5	6.0	13.3	9.1	14.2	28.6	4.4	34.5	2.3	5.8	10.4	9.0	12.5	3.3	27.8	19.4	8.2	15.6	3.0	8.5	58.2	54.3	98.5	71.4	132.7	78.8	203.7	84.2	80.6	66.6	195.7	85.6	80.6	25.7	90.2	176.0	87.3	123.9	73.3	22.5	23.2	21.2	29.9	21.6	22.2	22.8	22.6	22.4	22.7	22.9	22.5	43.3	16.0	41.5	11.8	83.0	90.0	87.7	177.7	99.0	29.3	139.9	173.4	53.4	60.1	93.5	68.0	10.4	69.5	46.5	64.7	133.1	95.0	50.2	53.0	35.3	36.6	71.4	22.3	9.4	126.0	147.9	31.3	120.3	73.4	23.4	52.5	29.3	69.6	84.0	11.8	8.2	100.3	97.6	43.6	49.3	46.2	20.8	49.0	110.3	2.8	61.2	39.5	63.8	9.5	14.1	189.9	81.7	24.8	47.2	142.6	150.8	148.9	75.0	29.5	6.6	24.4	45.9	105.8	80.1	185.1	180.1	72.8	53.3	37.6	73.5	152.2
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87328824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 88.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056685: AB_2683208, HPA069473: AB_2686139"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	26.1	14.9	4.2	5.6	6.0	3.7	14.2	2.8	5.2	5.6	5.8	10.5	15.6	6.4	4.7	4.4	6.0	8.3	6.7	4.9	5.2	12.0	24.7	6.5	5.9	5.0	5.8	7.3	6.2	9.4	5.4	10.2	5.6	10.7	8.5	7.0	10.0	6.4	8.4	3.9	14.5	6.9	2.5	5.8	7.4	10.2	4.3	6.6	10.1	7.5	4.8	5.5	4.4	6.7	8.8	15.7	9.8	13.7	31.3	28.6	9.2	6.5	16.7	7.6	17.0	27.1	39.9	24.2	17.1	8.9	19.9	8.3	13.3	14.9	8.5	22.7	7.5	18.5	14.0	88.5	17.6	10.8	9.2	34.8	9.2	11.0	7.6	10.2	19.5	26.4	19.3	35.9	9.0	5.9	28.3	10.8	11.5	47.2	11.7	12.5	7.5	19.2	17.5	28.1	4.8	11.0	9.6	30.0	13.6	18.8	42.0	9.6	10.3	7.9	10.3	30.6	4.6	13.4	28.2	28.2	6.0	11.5	15.7	0.9	4.8	1.4	7.5	5.1	6.7	4.7	4.7	8.1	5.6	3.4	5.3	5.1	1.5	7.2	2.2	5.7	5.4	4.1	4.2	6.0	2.8	5.2	4.9	5.2	5.0	5.8	5.6	2.5	4.3	6.7	14.4	9.6	7.5	121.8	7.1	4.2	4.0	4.6	8.6	5.6	12.7	7.1	6.3	5.7	6.8	1.8	4.2	2.6	7.7	10.5	5.9	2.8	2.8	5.8	11.0	8.1	3.6	3.8	99.6	3.2	8.6	11.0	8.6	4.2	9.5	11.5	7.9	16.2	4.9	1.7	93.7	6.8	10.2	7.8	6.0	7.7	7.2	5.4	5.4	48.7	4.1	5.0	9.2	123.1	202.4	3.1	10.9	7.2	10.3	6.1	21.8	10.6	8.7	4.2	32.9	5.7	8.4	2.2	3.8	4.8	4.8	1.5	8.3	24.6	8.7	3.8
TMEM138	"HSPC196, JBTS16"	ENSG00000149483	"Transmembrane protein 138"	Q9NPI0	11	61362344-61369509	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042373	Approved		Approved	Microtubules		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA042373: AB_10793880"	"unprognostic (1.30e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (2.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.46e-1)"	13.8	40.6	8.4	11.5	8.5	18.1	14.3	10.3	9.7	16.3	10.0	13.4	10.8	17.5	25.9	10.8	17.3	11.6	9.1	8.7	9.1	17.9	22.2	15.3	18.0	9.0	11.0	23.7	13.9	18.4	12.6	14.9	8.6	17.1	18.7	50.7	11.1	13.8	6.8	18.6	15.9	18.6	9.0	18.4	13.5	12.5	8.9	14.0	13.5	8.5	22.8	17.8	13.3	9.5	16.3	35.5	14.0	20.3	48.9	20.1	16.5	24.9	30.7	36.2	32.8	17.7	24.6	14.0	21.0	29.7	56.5	30.2	26.0	31.0	39.8	18.0	14.4	10.1	28.7	21.0	35.0	21.8	26.3	32.4	47.7	60.5	39.4	13.5	31.4	16.7	29.8	23.0	60.1	45.4	17.3	21.6	22.8	28.2	34.5	11.9	10.3	30.4	32.3	39.6	14.9	11.1	31.7	30.4	34.2	12.8	47.3	19.0	18.7	45.2	18.7	31.5	24.7	24.0	24.6	13.6	23.7	26.5	24.0	41.7	26.0	26.5	23.1	26.6	25.3	26.1	21.7	22.3	15.9	24.1	24.0	21.4	5.3	27.8	18.2	28.0	30.2	24.1	8.4	8.5	10.3	9.7	8.7	9.1	9.0	11.0	8.6	9.0	8.9	9.5	12.6	16.0	23.2	16.0	23.1	19.9	16.1	49.8	25.0	28.9	15.7	17.1	4.2	4.3	26.2	20.2	81.3	54.8	27.3	13.9	15.6	17.1	21.7	22.0	16.6	18.7	9.6	22.1	12.5	16.0	39.9	20.5	9.2	7.0	37.3	17.8	13.6	16.3	45.7	15.2	12.1	11.6	16.2	15.6	10.7	7.6	31.7	35.6	37.4	3.7	25.5	25.9	36.0	10.1	8.1	18.6	11.5	28.6	18.1	22.1	26.7	20.8	59.6	194.1	0.0	15.3	14.3	24.9	16.2	16.3	20.5	27.5	23.3	56.9	14.3	12.9
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791344-136793317	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 580.8;Distal tubular cells: 626.1;Intestinal goblet cells: 547.5;Paneth cells: 682.0;Proximal enterocytes: 633.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 228.2;T-47d: 221.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	32.7	44.1	37.9	23.3	40.1	40.2	48.7	43.8	42.6	36.4	39.7	120.5	48.4	25.2	63.6	109.6	48.2	27.9	74.0	36.8	41.3	116.8	134.7	39.3	21.1	42.1	40.2	33.4	74.0	83.0	62.2	41.9	44.4	132.3	112.2	12.2	61.5	28.5	38.1	68.7	60.6	22.4	40.0	38.7	76.2	33.1	41.1	29.8	66.3	35.8	26.4	39.2	49.5	44.1	55.0	35.9	34.9	21.1	42.2	34.1	69.9	30.8	47.4	35.9	29.0	47.9	47.5	53.4	44.1	32.5	32.0	78.2	14.0	87.8	11.6	38.7	27.5	30.4	18.0	52.3	60.8	31.1	35.5	33.1	146.4	26.7	79.0	42.3	54.6	67.4	28.9	26.7	48.2	102.0	42.0	21.2	16.7	228.2	43.8	34.6	37.6	156.1	82.1	28.4	55.3	25.7	32.9	125.7	35.1	27.1	221.4	28.9	38.5	24.6	19.9	46.3	19.5	17.0	29.7	28.2	39.9	44.2	37.2	19.5	29.5	20.4	23.1	44.2	20.6	18.2	15.1	16.0	24.1	23.0	20.6	19.5	7.3	29.9	37.4	90.6	16.4	29.1	37.9	40.1	43.8	42.6	36.8	41.3	42.1	40.2	44.4	40.0	41.1	44.1	62.0	57.7	79.0	6.5	39.6	40.7	99.3	120.5	55.2	13.8	128.7	152.9	42.3	124.4	100.9	117.7	8.4	182.4	64.0	580.8	626.1	179.2	48.4	80.1	50.4	48.5	206.9	53.6	8.2	78.5	141.7	59.1	76.5	148.2	41.8	67.5	56.0	171.7	148.5	5.0	6.4	547.5	109.9	61.6	29.8	134.9	37.6	53.7	85.4	2.8	85.7	61.1	78.2	2.5	11.7	90.1	682.0	29.7	34.8	193.7	633.0	459.2	60.9	30.0	46.0	32.4	46.9	57.2	53.5	156.7	62.8	274.3	42.7	65.1	460.1	125.9
TMEM143	FLJ10922	ENSG00000161558	"Transmembrane protein 143"	Q96AN5	19	48332356-48364059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 43.6;skeletal muscle: 95.5;tongue: 61.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014476, HPA058645"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA014476: AB_1858092, HPA058645: "	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (5.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-1)"	6.5	9.0	5.2	2.6	6.0	2.7	5.2	5.3	6.8	4.9	4.3	7.2	4.5	4.3	2.5	4.6	4.5	3.2	43.6	5.2	5.4	10.4	18.1	4.3	3.7	5.5	5.5	4.7	5.7	3.7	5.1	2.7	5.5	5.3	2.7	3.3	5.6	2.6	95.5	5.8	6.8	2.2	4.7	7.7	6.8	4.2	5.7	6.2	6.4	61.2	2.3	6.2	4.3	5.9	4.6	7.4	2.3	4.2	4.5	6.3	4.7	4.2	2.5	2.9	3.7	6.3	5.9	8.6	7.5	2.8	1.4	5.2	2.3	3.0	1.6	10.6	5.2	5.2	6.3	10.1	3.6	4.1	4.8	5.8	3.7	1.5	3.7	3.3	2.4	12.9	3.8	12.5	3.1	2.6	5.9	14.8	2.9	8.7	2.5	8.6	1.4	14.2	3.9	3.4	8.6	8.5	2.5	3.1	2.1	2.6	4.4	2.9	2.9	3.5	3.9	2.6	1.6	24.3	8.2	6.5	2.9	5.4	2.8	1.9	1.2	1.4	2.2	0.7	2.7	2.1	1.7	2.1	1.5	1.5	2.6	1.5	1.0	3.4	1.2	0.6	1.3	1.3	5.2	6.0	5.3	6.8	5.2	5.4	5.5	5.5	5.5	4.7	5.7	5.9	2.3	3.2	1.1	8.1	3.7	0.3	3.0	3.4	2.8	3.3	3.2	1.8	27.0	0.0	2.0	1.8	8.4	9.5	2.8	3.7	13.7	3.5	0.7	2.0	1.4	2.2	3.0	4.8	9.8	2.4	6.1	3.3	5.6	1.3	1.3	4.6	1.4	7.5	5.5	0.0	8.7	4.4	4.1	2.1	1.0	1.3	2.5	2.6	8.8	6.5	2.5	3.9	2.1	5.5	9.9	1.2	7.1	1.2	7.6	0.9	8.5	14.6	5.3	6.7	0.0	2.5	3.1	8.7	5.5	3.1	1.0	3.7	3.6	3.4	4.3	1.2
TMEM145	FLJ90805	ENSG00000167619	"Transmembrane protein 145"	Q8NBT3	19	42313309-42325064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 67.8;pituitary gland: 18.3;retina: 28.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 64.5;Cone photoreceptor cells: 29.2;Excitatory neurons: 26.5;Horizontal cells: 69.0;Inhibitory neurons: 54.3;Rod photoreceptor cells: 33.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 6.8;neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7;PC-3: 11.6;SCLC-21H: 26.2;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060462	Enhanced	Approved	Approved	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA060462: AB_2684285"	"unprognostic (9.56e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.20e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.31e-2)"	1.0	4.3	17.7	0.7	21.0	2.0	0.7	67.8	37.3	0.2	0.1	0.8	1.2	0.6	1.0	0.5	0.6	0.8	0.9	16.5	15.6	0.5	0.7	0.3	1.1	17.8	20.0	0.6	2.5	1.8	18.3	0.2	18.2	0.5	0.6	28.8	0.5	0.5	1.8	2.3	0.6	0.6	10.7	0.9	1.2	4.2	19.2	0.4	0.7	0.8	0.5	0.6	0.2	21.0	0.7	3.2	2.4	7.3	0.2	0.2	1.0	0.3	0.1	1.1	3.0	0.6	0.9	1.9	0.3	1.2	0.7	0.3	1.7	0.6	1.5	8.5	2.0	3.5	3.5	3.1	0.2	2.0	13.7	0.7	0.6	0.4	0.8	0.2	1.4	1.0	1.9	6.6	0.1	0.7	0.5	2.5	1.7	2.4	11.6	0.3	0.8	6.2	0.1	1.3	26.2	12.7	1.2	0.9	1.7	0.2	2.3	2.1	0.5	2.0	2.3	1.6	0.9	1.4	4.2	1.9	0.9	1.4	6.1	6.8	0.9	1.0	0.6	0.8	0.3	1.2	0.6	0.4	0.3	1.2	0.6	0.9	14.2	0.8	0.8	0.8	0.5	1.2	17.7	21.0	67.8	37.3	16.5	15.6	17.8	20.0	18.2	10.7	19.2	21.0	0.5	0.0	0.0	16.3	0.1	0.3	0.4	0.0	0.0	64.5	0.7	0.9	0.5	0.0	0.0	0.0	29.2	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	26.5	0.2	0.1	0.1	0.0	0.2	1.3	0.1	1.1	0.0	0.4	69.0	54.3	0.0	0.0	0.6	0.3	0.2	0.0	0.2	5.4	1.0	0.0	10.3	2.1	15.1	5.7	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	33.0	0.0	1.4	0.3	9.5	17.9	0.0	0.1	0.0	0.1	1.4	0.1	0.1
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671113-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 253.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	20.7	46.8	51.9	13.6	52.7	10.3	24.9	52.7	78.4	25.8	72.6	25.3	38.3	27.7	36.4	36.2	31.3	25.0	16.5	53.3	62.6	51.5	106.4	18.0	19.7	55.1	50.5	39.8	36.2	22.2	24.2	16.1	55.8	36.4	25.9	31.4	21.7	21.6	4.4	13.9	35.4	26.4	52.5	13.7	40.8	17.2	55.0	15.5	28.6	8.5	23.9	24.4	26.2	55.4	253.4	37.5	27.3	77.6	73.1	56.0	23.1	50.0	68.0	45.2	69.5	57.8	63.5	30.8	54.2	63.1	94.9	93.9	61.3	83.7	75.3	125.0	50.1	45.6	57.4	95.7	24.0	23.6	54.7	50.5	57.8	49.5	11.1	59.5	61.7	38.9	9.8	85.4	54.1	51.3	46.4	26.9	16.2	165.9	64.7	36.0	38.8	24.5	88.5	48.1	141.4	68.5	55.6	44.2	97.1	33.9	68.0	44.8	45.8	62.0	83.3	24.5	81.3	40.9	37.1	46.6	87.4	14.8	50.7	23.3	0.5	16.4	38.4	0.1	24.8	54.6	48.7	40.4	19.4	36.0	36.9	39.4	2.1	11.0	0.1	35.2	66.5	30.3	51.9	52.7	52.7	78.4	53.3	62.6	55.1	50.5	55.8	52.5	55.0	55.4	28.6	25.6	17.6	13.1	23.4	48.4	61.9	183.5	56.9	20.4	71.3	72.4	17.4	54.3	90.1	51.5	8.4	56.1	27.5	22.6	64.6	108.1	1.4	31.2	33.3	37.3	33.5	32.8	50.3	140.9	150.8	62.4	50.0	26.3	25.4	46.5	38.6	138.7	47.0	5.0	45.7	53.1	77.3	7.0	56.6	2.5	43.5	10.9	88.9	16.9	4.9	27.1	16.5	15.1	15.5	74.7	25.2	50.0	18.6	48.5	77.4	152.7	85.5	13.2	6.6	38.6	60.7	4.3	41.2	139.5	38.2	15.5	30.9	22.0	51.7	69.3
TMEM150A	"FLJ90024, TM6P1, TMEM150, TTN1"	ENSG00000168890	"Transmembrane protein 150A"	Q86TG1	2	85598547-85603196	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HHSteC: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019015	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA019015: AB_2204758"	"unprognostic (2.80e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.09e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.54e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.87e-3)"	18.7	16.3	10.0	5.2	10.8	1.2	17.0	9.8	11.1	16.3	11.1	21.0	6.5	17.7	6.3	11.0	17.1	10.4	15.5	9.7	10.3	32.8	38.5	19.3	6.0	11.9	10.7	17.1	37.9	8.0	11.7	22.4	10.9	17.4	4.1	1.4	14.9	10.2	53.7	9.3	12.9	11.5	10.6	9.7	20.6	24.4	11.3	2.5	14.9	27.2	4.2	22.2	13.1	10.1	2.7	5.1	6.3	9.3	52.9	23.7	15.3	5.2	9.1	4.3	2.0	23.6	7.1	0.8	19.8	15.3	8.0	2.2	6.8	13.7	2.0	1.2	6.7	1.5	3.0	39.9	49.6	0.4	4.7	28.5	18.4	7.0	9.9	20.6	15.2	1.0	14.0	1.5	17.5	11.9	0.4	6.9	11.5	10.8	5.1	4.1	0.6	15.8	13.4	10.6	1.0	3.9	5.4	35.4	13.5	5.9	8.7	6.2	12.6	5.2	4.4	4.5	1.8	10.6	2.8	5.2	8.5	6.0	2.3	0.0	15.2	7.2	5.5	17.9	6.5	5.3	6.2	5.6	12.8	8.1	6.9	4.2	0.7	8.4	15.1	7.6	1.5	6.0	10.0	10.8	9.8	11.1	9.7	10.3	11.9	10.7	10.9	10.6	11.3	10.1	24.1	9.6	14.9	10.7	9.0	4.5	15.3	16.0	10.2	6.8	15.3	12.7	5.2	12.8	16.2	14.7	0.0	133.5	10.4	3.5	29.4	16.9	137.5	5.0	9.0	14.9	3.0	1.7	3.9	14.4	18.2	14.3	5.6	6.0	10.2	5.2	15.7	19.7	37.9	3.3	5.0	5.2	16.2	10.3	13.1	64.8	19.9	14.6	10.6	9.4	15.2	6.5	7.2	5.5	5.9	12.8	7.0	24.5	5.9	20.3	16.4	85.0	8.3	3.4	13.1	14.6	11.7	2.4	5.6	7.9	3.7	146.0	7.0	9.2	7.0	13.1
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 134.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	13.1	43.1	12.9	4.6	15.3	1.9	22.0	9.7	16.8	15.1	6.3	7.7	7.4	4.9	134.9	3.6	7.4	6.5	12.7	15.7	12.7	17.3	13.9	6.2	14.7	12.9	15.9	31.5	3.4	5.4	8.4	9.8	14.7	12.6	4.3	4.5	17.0	7.6	6.9	4.3	6.9	6.9	12.0	14.3	5.0	3.2	12.2	9.1	11.4	9.7	12.8	5.0	5.2	12.5	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.9	15.3	9.7	16.8	15.7	12.7	12.9	15.9	14.7	12.0	12.2	12.5	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291894-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 112.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 70.1"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	3.1	1.4	41.3	0.0	68.0	0.0	0.0	73.5	60.8	0.0	3.8	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.8	45.2	44.0	0.1	0.2	0.1	0.0	86.0	68.1	0.2	1.1	0.3	9.7	0.0	69.6	0.1	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	61.8	0.0	5.4	0.3	70.6	0.0	0.0	0.0	0.0	0.0	0.1	112.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.0	1.1	0.0	3.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	15.3	3.5	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	68.0	73.5	60.8	45.2	44.0	86.0	68.1	69.6	61.8	70.6	112.9	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.7	4.3	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	7.7	0.0	11.6	0.4	0.0	1.0	9.2	0.1	0.0	0.0	0.0	0.0	0.1	15.2	11.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	2.5	0.0	2.0	70.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270450-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 53.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 27.0;Inhibitory neurons: 31.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055167	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055167: AB_2682723"	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	0.1	2.9	12.4	0.4	20.9	0.2	0.2	47.4	53.7	0.3	0.0	0.9	0.5	0.2	0.0	0.2	0.3	0.0	0.6	34.8	2.9	0.2	0.2	0.1	0.2	8.4	4.3	0.3	0.4	0.0	3.9	0.0	11.3	0.3	0.3	2.8	0.3	0.0	0.2	0.2	0.7	0.1	1.5	0.3	0.5	0.8	12.9	0.1	0.3	0.0	0.0	0.1	0.4	15.7	0.0	0.1	6.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	0.7	4.9	0.1	0.2	0.5	0.0	0.1	0.0	0.1	28.6	5.9	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.9	47.4	53.7	34.8	2.9	8.4	4.3	11.3	1.5	12.9	15.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	5.3	0.1	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	31.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.8	0.0	0.4	0.0	4.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618628-152680012	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.3;skin 1: 58.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 477.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	3.1	0.5	0.3	17.2	0.7	18.6	4.3	0.6	1.7	5.7	0.5	3.1	2.6	1.6	0.7	58.3	1.4	5.1	0.8	0.4	0.7	0.6	5.9	5.1	14.3	0.8	0.6	0.2	1.0	0.3	0.8	3.8	1.1	2.0	2.6	0.2	6.9	2.3	0.4	58.5	3.6	1.8	0.7	12.4	5.9	0.2	1.0	6.2	3.6	1.9	26.4	11.6	7.9	1.0	32.1	0.1	0.3	0.1	0.5	8.7	14.1	8.0	29.1	8.5	16.2	0.4	4.2	32.5	3.3	7.6	9.3	22.8	0.0	63.0	15.5	0.1	0.1	1.8	0.5	0.0	8.9	25.7	71.1	8.3	29.7	27.1	23.4	0.0	21.4	19.7	0.1	55.6	0.7	2.3	10.1	8.0	1.6	0.1	7.8	1.2	0.1	0.2	47.5	19.4	0.1	1.2	2.2	6.2	1.0	8.4	1.0	17.8	8.6	1.2	5.1	0.7	11.1	69.7	26.0	18.1	11.7	56.6	6.6	403.7	37.8	305.7	4.9	38.2	9.2	51.6	10.9	7.9	19.6	45.1	10.7	7.4	477.5	0.8	43.7	2.5	22.5	17.2	0.3	0.7	0.6	1.7	0.4	0.7	0.8	0.6	1.1	0.7	1.0	1.0	6.5	12.8	19.3	0.0	108.6	74.2	9.0	23.6	20.5	0.1	8.8	4.8	1.7	0.0	20.9	22.0	2.1	25.0	9.8	0.9	0.0	6.4	0.1	31.9	13.4	6.7	1.2	6.6	0.5	3.7	14.5	5.2	8.2	75.0	101.2	0.1	0.7	4.6	4.5	3.3	0.3	0.7	14.2	9.8	15.7	0.2	0.6	28.2	5.4	15.9	82.1	0.1	5.2	3.5	0.1	21.5	7.1	0.0	45.7	5.4	0.0	0.3	60.5	0.7	0.0	3.0	3.6	0.1	0.5	119.2	194.4	25.9	28.6	0.5	2.6	27.2
TMEM158	"p40BBp, RIS1"	ENSG00000249992	"Transmembrane protein 158"	Q8WZ71	3	45224466-45226287	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;endometrium 1: 69.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 24.5;Breast myoepithelial cells: 24.5;Endometrial stromal cells: 61.0;Muller glia cells: 87.4"	"Cancer enhanced"	"Detected in many"		"glioma: 38.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 336.1;GAMG: 111.9;U-138 MG: 138.9;U-87 MG: 455.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 95.5"	"Low region specificity"	"Detected in all"			HPA074974	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA074974: AB_2732274"	"unprognostic (3.84e-1)"	"unprognostic (9.83e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.31e-2)"	"unprognostic (4.67e-3)"	"unprognostic (6.23e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.84e-3)"	"prognostic favorable (6.43e-5)"	"prognostic unfavorable (5.42e-9)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.49e-3)"	2.6	9.2	20.3	3.8	33.3	1.9	1.6	7.5	23.0	8.6	8.5	8.1	0.7	69.5	2.2	18.2	3.9	6.4	0.7	22.4	23.9	3.6	0.7	1.6	0.5	10.6	22.5	1.4	1.9	0.2	12.2	0.8	10.4	13.2	1.9	1.5	1.4	22.7	2.0	2.4	1.9	17.0	15.2	0.4	1.9	2.5	27.4	0.2	0.7	0.7	1.1	8.7	2.8	13.8	12.9	2.1	4.4	0.8	7.7	18.3	3.7	31.6	336.1	17.0	27.5	0.7	0.8	0.1	1.6	10.5	111.9	17.2	5.1	1.4	50.2	0.8	2.0	0.0	6.1	0.1	10.7	2.5	6.1	24.6	0.6	33.7	2.7	39.2	1.8	0.0	80.3	0.9	30.4	0.5	0.0	22.3	37.8	0.3	46.5	0.0	1.0	4.9	6.7	11.9	6.1	1.4	12.2	0.4	2.1	3.4	0.3	4.3	5.1	138.9	10.4	88.4	110.2	0.0	0.1	0.0	455.3	12.6	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	33.3	7.5	23.0	22.4	23.9	10.6	22.5	10.4	15.2	27.4	13.8	1.6	0.0	0.5	1.6	0.4	24.5	6.1	2.1	2.8	4.4	13.1	24.5	1.0	1.5	0.8	9.2	0.0	0.1	0.5	0.6	0.0	2.9	0.2	10.8	61.0	1.3	7.7	0.0	8.7	0.4	0.1	9.3	0.5	4.2	0.0	0.7	2.5	2.7	5.1	1.7	5.7	0.6	2.0	0.8	16.4	0.7	8.4	6.4	0.0	1.9	1.4	87.4	0.0	6.0	1.2	1.0	0.5	0.0	0.0	1.7	0.0	0.2	0.4	2.9	0.0	4.9	8.3	0.3	0.5	1.0	10.5	0.3	0.6	16.7	0.7	4.2
TMEM159	promethin	ENSG00000011638	"Transmembrane protein 159"	Q96B96	16	21158377-21180616	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 128.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.2;Basal squamous epithelial cells: 176.4;Squamous epithelial cells: 127.5;Suprabasal keratinocytes: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 67.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018033, HPA063509"	Approved		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"HPA018033: AB_2204762, HPA063509: AB_2685026"	"unprognostic (7.62e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.68e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (8.11e-5)"	"unprognostic (8.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.57e-2)"	40.2	33.0	3.8	5.4	8.0	3.2	27.0	6.0	4.0	47.4	2.3	42.6	4.3	28.6	7.9	61.9	26.3	20.1	91.6	3.4	3.3	16.5	2.5	19.9	11.7	2.7	3.3	40.8	12.4	14.1	3.2	4.0	3.9	22.1	12.0	5.7	36.8	10.4	128.5	96.0	17.9	17.8	2.4	7.1	21.1	10.5	5.4	5.0	15.4	100.6	16.7	47.9	57.3	2.8	14.3	7.1	7.6	28.7	67.9	44.1	3.4	7.4	27.6	2.9	4.9	5.6	21.4	20.2	7.9	21.6	12.9	23.1	11.7	13.0	3.4	7.7	4.5	9.1	1.9	11.1	15.4	7.2	24.2	17.3	58.8	15.4	48.1	12.2	15.0	10.8	6.9	6.1	5.8	25.2	5.6	6.7	7.0	14.1	3.5	28.9	4.2	7.3	38.1	41.1	1.2	1.1	18.2	25.8	9.8	13.5	46.0	6.5	10.6	5.4	5.4	25.6	1.9	0.5	1.7	7.2	22.2	6.4	5.3	19.5	8.8	7.0	9.7	6.9	9.8	12.2	12.7	8.2	5.4	9.6	9.9	9.6	3.9	7.3	10.3	14.3	14.8	6.6	3.8	8.0	6.0	4.0	3.4	3.3	2.7	3.3	3.9	2.4	5.4	2.8	17.3	9.6	20.9	0.0	12.9	121.2	38.5	31.9	176.4	1.0	53.3	55.2	59.4	15.7	31.8	22.0	0.0	4.8	9.1	34.5	7.9	19.7	0.8	11.4	12.8	13.7	14.5	11.8	1.9	21.3	2.1	44.3	19.4	19.3	15.8	14.0	17.5	0.2	10.2	1.7	0.8	30.6	12.2	15.7	39.0	2.2	67.4	13.8	30.2	4.7	22.7	44.7	7.2	1.0	0.1	24.7	41.8	37.2	3.8	45.3	23.1	21.1	11.2	1.5	32.9	26.5	35.7	2.0	9.9	127.5	150.2	1.9	14.8	5.1	29.9	66.6
TMEM160	FLJ20512	ENSG00000130748	"Transmembrane protein 160"	Q9NX00	19	47045909-47048624	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 168.4;NB-4: 231.7;PC-3: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055904	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA055904: AB_2682965"	"unprognostic (2.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.37e-2)"	15.1	18.0	33.8	5.3	26.5	5.6	13.8	14.3	40.0	14.6	14.1	13.9	3.7	16.2	1.0	20.1	12.4	0.5	23.0	33.7	18.3	24.2	25.5	15.3	4.2	29.4	23.3	9.1	18.0	2.3	12.4	1.9	28.8	10.9	1.3	1.7	15.6	1.4	28.6	18.6	13.8	1.3	17.0	19.6	16.6	11.4	24.6	2.3	19.2	2.5	2.2	14.8	12.7	28.0	37.5	12.9	7.6	9.7	2.1	2.2	17.8	19.5	3.3	6.3	6.7	6.2	12.9	36.7	33.4	2.3	5.4	26.7	5.1	4.4	3.5	31.6	168.4	37.5	11.1	11.0	1.3	26.0	55.0	2.0	2.6	3.7	1.4	4.6	4.6	23.2	34.3	10.6	3.2	9.9	30.5	231.7	19.3	12.2	104.7	54.9	17.3	22.5	5.9	6.0	20.2	35.8	22.3	15.8	22.6	10.7	8.3	17.1	21.2	6.0	32.9	13.1	20.1	46.8	48.5	28.6	8.9	26.8	8.8	28.3	41.0	62.9	27.9	30.9	18.9	41.6	44.3	51.0	25.8	50.0	42.7	28.0	3.3	22.3	28.1	45.4	46.2	15.6	33.8	26.5	14.3	40.0	33.7	18.3	29.4	23.3	28.8	17.0	24.6	28.0	52.1	9.6	12.9	7.8	74.8	57.9	63.9	93.0	38.7	47.9	80.7	78.7	21.0	77.2	48.6	119.5	18.8	28.3	98.6	200.5	158.5	122.0	95.4	45.7	33.3	49.1	104.0	46.7	17.1	179.7	95.5	49.4	58.1	45.6	57.3	60.2	56.7	96.1	152.9	20.2	18.1	120.2	95.6	138.2	99.8	255.3	48.7	89.7	94.3	4.7	194.0	106.6	161.7	11.6	13.8	155.9	164.3	52.6	87.1	61.7	207.7	247.6	33.1	31.7	32.9	38.0	63.9	32.8	33.7	66.5	81.8	14.2	87.5	61.1	120.8	84.8
TMEM161A	"FLJ20422, FLJ39645"	ENSG00000064545	"Transmembrane protein 161A"	Q9NX61	19	19119169-19138513	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043365	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA043365: AB_10796793"	"unprognostic (4.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.15e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.18e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.89e-3)"	13.0	22.5	4.5	4.4	4.6	5.4	13.6	4.8	6.9	19.8	7.1	15.8	3.5	21.7	1.5	14.8	17.6	5.4	17.7	4.3	4.3	15.3	25.9	12.3	4.8	6.9	4.6	17.7	15.7	13.7	8.2	3.3	5.4	14.3	3.7	2.5	14.9	7.1	50.7	16.9	11.2	6.3	4.4	10.4	14.7	6.3	5.4	5.8	19.5	13.2	4.8	14.3	15.9	5.9	28.9	19.3	12.6	20.1	24.8	17.1	12.8	13.4	12.8	16.4	20.1	17.5	30.8	26.4	57.9	9.4	11.3	23.9	20.6	29.3	11.4	9.9	47.6	10.0	10.6	24.0	30.9	9.1	14.7	26.9	23.9	15.6	25.9	14.9	17.9	30.5	31.6	27.2	12.5	33.8	19.5	24.7	9.9	37.1	19.6	33.4	9.4	44.8	13.0	13.0	13.0	13.6	20.2	20.1	15.7	9.1	17.1	24.0	7.6	13.3	5.3	34.4	21.1	27.8	14.9	16.1	13.9	22.5	20.7	1.3	6.1	1.4	8.2	5.3	6.7	4.3	7.5	6.2	8.4	5.6	8.8	6.3	1.1	5.4	7.1	19.4	11.4	4.1	4.5	4.6	4.8	6.9	4.3	4.3	6.9	4.6	5.4	4.4	5.4	5.9	15.7	6.4	18.3	5.5	9.5	6.1	15.1	27.1	14.8	15.7	13.4	15.4	8.7	20.0	18.3	11.0	10.4	19.8	14.8	6.5	7.9	20.5	1.2	8.8	14.1	11.3	5.4	6.7	10.9	12.9	15.1	14.6	14.8	9.5	15.9	15.1	9.7	25.3	16.3	16.8	11.4	10.0	10.2	9.5	4.1	1.5	11.8	7.5	12.4	5.6	6.8	15.8	8.2	4.5	8.4	11.9	7.5	17.7	13.6	14.9	12.5	29.1	11.8	14.5	13.1	13.5	14.3	8.7	8.4	12.4	8.7	12.3	11.4	33.8	19.3	10.0
TMEM161B	MGC33214	ENSG00000164180	"Transmembrane protein 161B"	Q8NDZ6	5	88189633-88269476	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 82.1;HMC-1: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044562	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA044562: AB_10794291"	"unprognostic (2.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-3)"	"unprognostic (9.35e-2)"	4.6	5.8	5.0	5.8	4.7	6.2	16.0	7.3	6.3	6.5	3.0	9.7	12.4	6.4	14.2	7.8	7.1	5.6	4.8	4.3	3.8	9.7	11.9	10.1	9.1	3.1	3.1	11.2	14.0	23.0	4.8	8.1	3.2	12.3	11.3	18.2	14.1	8.9	6.4	15.6	11.5	5.8	3.0	6.4	22.9	12.5	4.0	8.6	20.9	7.0	9.5	7.4	6.0	5.6	11.8	8.0	8.7	9.5	5.4	10.3	18.6	10.3	15.4	14.6	21.2	8.9	30.2	18.2	5.2	7.7	26.6	12.3	10.2	13.3	18.4	16.4	10.7	82.1	10.3	5.9	14.0	15.9	85.2	9.2	19.1	12.4	18.3	10.4	6.5	11.9	40.5	16.0	12.7	5.5	11.6	13.9	5.6	8.7	14.3	9.7	10.1	19.9	13.0	16.4	11.1	9.3	5.9	16.3	24.5	7.7	9.8	14.5	5.4	9.5	8.7	13.7	18.9	19.6	33.3	14.9	23.3	15.7	13.4	1.5	1.4	1.0	2.9	2.8	2.9	2.2	2.4	2.1	0.8	2.1	2.4	1.9	0.8	2.9	1.1	2.6	2.1	1.2	5.0	4.7	7.3	6.3	4.3	3.8	3.1	3.1	3.2	3.0	4.0	5.6	9.8	28.9	16.4	37.2	19.2	7.8	8.0	12.0	5.7	15.8	13.6	9.7	16.3	11.5	15.0	9.2	16.7	9.3	17.9	14.7	3.9	8.8	3.6	10.2	11.4	7.7	14.3	10.3	43.4	9.7	4.1	9.8	12.2	14.0	16.5	14.4	15.0	23.1	5.3	6.7	46.3	13.7	6.1	11.8	5.5	3.1	10.5	8.2	0.0	28.1	7.1	15.6	22.6	59.3	55.0	11.3	6.6	12.8	13.1	9.4	11.3	6.4	9.4	22.2	6.6	8.9	8.9	35.8	12.6	9.3	7.1	15.1	15.8	11.3	14.3	7.5
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;pancreas: 27.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 36.9;Excitatory neurons: 62.2;Exocrine glandular cells: 30.8;Oligodendrocyte precursor cells: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.3;RPTEC TERT1: 67.3;SCLC-21H: 30.2;U-937: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007224: AB_2667780"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favorable (3.15e-4)"	3.4	8.5	13.5	5.1	13.4	0.3	1.4	18.8	13.3	0.2	5.4	1.0	0.6	0.4	0.3	0.1	2.8	9.3	6.7	12.9	15.2	1.6	0.4	14.5	10.4	18.3	20.7	0.9	27.8	0.8	13.9	3.7	15.4	0.2	0.5	4.0	3.0	0.2	0.3	0.1	1.0	0.4	16.5	1.6	7.3	6.5	28.3	2.0	0.9	0.5	16.4	12.2	0.1	23.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.2	20.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	3.5	6.7	0.1	0.1	0.3	0.0	0.6	0.1	0.0	5.2	1.1	2.3	0.0	0.1	0.1	67.3	10.0	30.2	1.1	0.0	0.0	1.6	0.1	0.0	0.0	7.0	0.0	0.4	0.0	1.5	1.6	0.0	0.0	0.0	12.6	1.3	0.0	0.0	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.2	13.5	13.4	18.8	13.3	12.9	15.2	18.3	20.7	15.4	16.5	28.3	23.0	19.3	3.2	36.9	2.6	6.7	0.0	0.0	0.0	0.0	2.7	0.2	5.1	5.4	7.2	0.0	0.0	0.0	0.1	0.9	0.1	0.0	8.5	4.8	0.3	0.2	3.5	0.0	0.4	62.2	30.8	0.4	0.7	20.9	1.0	0.0	0.6	0.4	0.3	5.0	1.7	23.5	0.4	0.0	1.3	0.0	3.8	0.0	2.7	0.0	14.0	2.6	1.0	5.2	219.7	13.0	12.6	0.1	0.4	0.3	0.0	0.0	0.3	0.0	5.7	0.0	0.5	0.4	2.1	1.6	0.0	0.4	0.1	0.7	1.9	0.1	2.5
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Distal enterocytes: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 59.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 59.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	16.9	10.3	11.4	9.6	11.8	19.0	12.3	6.8	9.7	5.5	14.3	18.8	21.5	5.3	6.0	13.8	8.1	5.1	22.7	9.0	12.1	11.1	2.0	17.9	6.7	13.5	13.0	13.8	25.4	8.3	9.6	5.2	11.2	8.9	21.2	3.6	9.8	14.4	27.5	20.3	19.2	6.9	8.2	8.4	14.0	1.9	12.3	12.6	13.8	19.3	8.0	5.8	6.8	8.6	10.8	24.3	19.5	12.8	23.7	17.3	11.9	5.3	12.4	11.0	7.1	19.1	16.6	8.6	35.2	8.3	27.1	15.6	17.1	27.9	10.8	23.9	11.7	58.5	13.0	8.1	13.9	26.1	80.1	24.0	48.4	19.9	27.2	30.2	21.8	15.2	18.4	10.2	19.7	21.6	27.4	33.1	17.5	36.9	17.3	12.4	15.1	7.2	17.5	11.3	18.2	20.3	34.0	33.1	15.9	18.1	9.6	25.7	49.0	9.3	6.8	11.0	7.7	5.9	7.9	6.9	24.3	32.0	25.3	59.7	3.3	14.2	0.6	2.9	1.6	0.2	0.7	0.6	2.7	0.6	0.4	0.5	16.3	2.3	1.8	0.5	1.0	1.8	11.4	11.8	6.8	9.7	9.0	12.1	13.5	13.0	11.2	8.2	12.3	8.6	2.9	3.2	36.1	84.5	3.7	4.8	3.7	4.7	4.6	1.2	11.7	9.1	21.3	11.5	6.9	16.5	2.1	2.7	3.5	53.0	3.9	4.6	0.5	6.7	3.8	6.0	27.6	14.5	22.9	11.4	6.3	3.1	7.7	10.7	3.8	4.3	6.4	1.7	13.6	0.0	31.4	12.7	10.2	25.1	9.4	1.3	1.8	12.5	1.8	24.4	28.1	1.0	4.1	34.2	7.6	13.5	15.0	1.5	1.6	9.0	31.9	3.3	5.4	1.3	0.0	6.4	4.1	0.2	0.3	10.4	8.0	2.7	5.2	3.8	21.2	12.3
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 1021.6;Urothelial cells: 601.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	53.4	61.3	39.2	42.6	75.1	11.3	35.2	62.0	70.8	45.9	36.0	32.4	32.0	34.0	31.1	55.8	31.6	46.0	37.3	40.8	51.1	41.6	19.3	52.7	32.6	84.8	72.0	22.3	40.1	32.3	24.0	60.5	78.9	37.8	33.3	15.0	40.4	30.6	17.1	26.2	27.9	40.0	54.5	37.0	39.2	13.7	65.8	24.0	37.8	17.2	42.5	78.8	42.7	117.4	74.6	30.4	47.1	50.2	143.5	105.4	50.0	138.6	212.7	98.0	106.7	34.2	108.3	76.9	98.3	85.9	56.2	53.8	50.0	56.8	98.9	43.8	46.4	66.0	50.1	66.6	89.1	92.1	75.1	109.1	72.7	55.9	37.3	82.4	113.2	25.6	112.8	47.8	116.5	54.5	73.0	76.5	51.7	97.8	70.6	52.0	35.5	42.1	148.6	70.2	48.3	64.7	69.8	261.0	85.8	46.3	41.2	65.3	98.3	83.1	49.6	37.0	102.5	44.4	38.5	48.3	98.9	77.2	67.9	23.7	40.4	26.0	15.2	35.7	17.0	19.0	14.3	17.8	36.5	11.5	12.1	14.4	28.6	18.1	35.9	28.4	18.3	30.2	39.2	75.1	62.0	70.8	40.8	51.1	84.8	72.0	78.9	54.5	65.8	117.4	119.6	54.5	52.4	42.7	87.9	245.1	277.8	295.0	147.4	50.6	85.8	42.7	32.2	71.4	214.9	79.1	81.3	112.5	97.7	42.4	17.6	171.1	32.1	123.6	99.1	108.0	50.4	79.1	58.2	163.5	157.2	110.4	76.0	173.8	21.0	57.6	113.8	18.4	105.7	28.6	71.5	69.4	77.3	97.9	145.7	24.7	58.7	109.5	88.9	59.0	117.5	53.2	123.6	71.4	1021.6	248.0	48.6	63.6	117.1	239.3	51.3	50.0	125.2	91.9	98.6	92.2	129.0	37.8	24.6	169.4	268.8	80.6	81.6	90.6	61.6	601.6
TMEM168	DKFZp564C012,FLJ13576	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762377-112790423	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	12.9	10.6	6.0	12.5	7.6	6.7	15.6	7.5	7.1	11.6	9.5	22.4	13.7	13.2	17.9	14.1	10.7	12.2	13.9	5.8	6.8	12.8	8.4	12.1	11.3	8.1	6.6	12.1	6.7	28.6	8.3	14.4	8.2	16.3	24.6	20.2	20.6	13.4	9.4	26.7	14.8	15.3	7.8	12.3	12.6	10.2	6.7	13.5	17.7	9.4	11.2	10.9	12.9	10.1	16.0	13.2	12.2	10.9	20.4	41.5	17.2	17.3	16.2	6.4	5.6	17.0	16.4	16.9	11.4	17.2	14.6	16.8	12.5	15.1	16.5	26.8	12.9	14.7	16.8	9.7	13.7	16.4	17.9	20.3	38.6	7.3	10.9	6.0	18.9	13.6	19.9	15.0	23.3	25.2	14.2	10.3	9.9	16.7	10.2	9.5	6.1	24.9	16.0	29.9	9.2	18.2	23.3	30.6	14.0	14.9	17.5	14.4	27.0	30.5	15.5	14.5	22.6	25.4	23.1	18.9	19.7	14.7	40.0	21.2	14.9	11.6	12.1	12.6	14.4	10.9	12.9	11.8	16.0	13.2	18.6	13.0	8.4	13.5	13.2	11.1	13.0	9.5	6.0	7.6	7.5	7.1	5.8	6.8	8.1	6.6	8.2	7.8	6.7	10.1	17.4	12.8	22.3	43.1	18.6	31.1	19.1	12.0	27.3	31.5	16.4	14.4	18.1	10.0	18.9	33.1	27.1	35.5	14.3	16.9	0.0	5.9	2.9	9.2	22.1	17.3	20.5	14.1	29.9	9.1	8.9	17.6	18.3	11.8	12.0	19.2	18.5	12.6	8.9	16.8	32.6	34.8	16.2	13.5	9.3	1.9	18.3	10.9	24.9	41.2	10.8	16.3	15.5	70.9	71.5	6.1	17.0	14.7	10.2	21.6	15.5	6.0	7.1	29.6	6.6	19.4	16.7	18.1	13.3	24.8	26.0	14.2	13.8	21.1	30.5	14.5
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 3.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"							"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	0.5	1.0	1.4	1.0	3.0	0.3	0.2	1.5	2.6	0.7	0.0	0.4	0.7	0.3	0.7	0.2	1.0	0.8	0.4	2.3	2.1	1.8	1.7	0.6	1.0	2.6	2.1	0.3	0.3	0.1	0.8	0.1	2.8	0.4	0.3	3.4	0.2	0.3	0.3	0.5	0.6	0.4	1.0	1.0	0.2	0.3	1.7	1.0	2.6	0.3	0.7	0.2	0.1	2.8	0.0	0.3	7.3	0.1	1.0	0.0	0.0	0.3	0.2	0.2	0.8	0.3	2.4	0.0	5.8	0.3	0.4	0.1	0.9	0.0	0.2	1.4	0.3	2.9	0.1	1.4	1.9	0.1	0.5	0.6	0.6	0.5	0.7	1.8	0.0	0.9	0.0	0.3	6.3	0.8	0.2	0.1	4.1	0.0	0.0	1.4	2.0	0.0	12.3	0.0	9.9	14.5	0.3	0.1	5.7	4.0	0.5	1.0	0.0	0.2	0.4	0.0	0.4	1.7	2.2	0.4	1.9	0.2	1.4	0.8	1.0	0.1	1.2	1.0	0.9	1.5	2.0	1.4	0.0	1.4	2.1	0.9	2.3	0.3	3.2	0.1	3.7	0.7	1.4	3.0	1.5	2.6	2.3	2.1	2.6	2.1	2.8	1.0	1.7	2.8	0.3	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	14.4	0.1	0.5	0.8	4.3	0.0	5.5	22.9	0.1	0.3	0.0	0.0	0.6	0.0	0.4	0.4	0.2	4.9	0.0	13.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	1.4	0.8	0.4	0.0	13.9	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	3.7	0.2	2.2	3.1	11.1	9.3	0.1	0.6	0.4	0.3	0.1	0.3	2.8	0.1	11.6	0.0	3.6	0.4	0.0	0.7	0.0	0.0	0.0	0.8	0.1	0.2	0.1
TMEM17	FLJ34583	ENSG00000186889	"Transmembrane protein 17"	Q86X19	2	62500218-62511894	"Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 25.4;Spermatocytes: 39.2;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018100	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Actin filaments"		"HPA018100: AB_2240686"	"unprognostic (8.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.87e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.49e-6)"	2.4	5.0	4.1	0.5	4.3	0.8	2.4	2.6	4.2	1.8	4.8	1.4	1.0	2.3	1.6	2.6	4.3	2.9	2.2	4.4	9.5	4.3	2.3	1.8	1.0	4.5	5.5	3.1	3.2	6.1	4.3	1.7	5.5	2.5	0.9	4.0	2.2	2.0	1.8	2.4	0.8	1.6	3.5	0.8	1.3	4.8	8.5	1.4	4.6	1.8	0.9	1.5	1.3	3.4	3.3	4.6	4.7	1.8	2.4	3.1	3.0	2.5	2.3	2.0	2.1	0.3	6.1	0.0	3.2	3.3	6.7	3.2	2.1	1.4	1.5	3.2	1.4	1.5	1.8	0.3	3.5	2.3	1.8	2.8	3.9	1.7	3.9	3.4	2.5	0.3	1.4	0.2	5.3	0.9	0.4	0.5	2.3	3.0	2.3	0.2	0.6	0.2	4.3	1.0	1.2	4.0	2.6	0.9	9.1	1.6	1.5	3.0	1.7	4.0	2.2	4.8	2.6	0.4	0.0	0.0	5.8	0.4	8.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.3	0.1	1.9	0.0	0.4	4.1	4.3	2.6	4.2	4.4	9.5	4.5	5.5	5.5	3.5	8.5	3.4	2.9	3.2	4.1	2.6	0.4	5.0	2.3	10.7	9.1	7.1	3.0	2.8	2.6	4.3	7.5	5.5	8.4	2.3	1.5	0.1	0.0	5.3	4.8	11.4	2.1	2.7	1.2	1.7	2.8	8.5	2.2	4.2	1.1	1.7	1.3	2.8	3.9	2.5	2.6	10.1	3.9	0.9	6.1	0.6	1.5	2.8	4.7	1.4	3.6	1.0	0.9	9.9	0.0	0.0	2.9	7.9	0.3	3.8	1.4	1.0	0.4	2.5	25.4	4.8	6.6	2.4	1.8	39.2	21.7	5.5	2.8	0.4	0.3	5.4	1.1	1.5
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11537749-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.2;Excitatory neurons: 57.3;Inhibitory neurons: 52.3;Kupffer cells: 36.8;Macrophages: 31.5;monocytes: 45.8;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 22.1;U-937: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	7.0	2.8	8.1	4.3	9.0	25.2	2.3	8.6	10.7	1.6	2.2	2.3	0.7	2.4	3.1	1.3	1.6	1.7	2.1	10.2	6.9	3.7	8.7	3.8	1.7	8.4	7.7	2.2	1.9	2.9	2.7	2.5	9.1	1.9	1.1	9.5	1.5	2.0	6.2	0.9	1.2	2.9	6.8	3.9	1.5	3.4	7.7	1.9	2.6	7.3	1.2	1.5	0.9	7.4	0.9	1.5	8.8	7.9	1.6	0.1	1.8	0.8	2.0	1.2	1.4	0.5	0.5	7.3	4.0	0.5	2.3	0.0	10.0	0.6	3.1	2.1	5.3	4.1	1.0	1.2	0.5	6.6	4.1	0.6	0.1	1.3	0.0	2.0	0.8	6.7	0.2	0.1	1.8	1.3	8.0	11.3	2.5	0.8	1.2	4.1	8.4	1.2	0.9	1.8	6.0	5.1	0.5	2.9	3.3	12.4	2.9	22.1	0.1	1.6	1.9	3.2	2.1	6.3	13.4	6.4	1.4	16.6	2.2	0.9	0.8	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.1	8.1	9.0	8.6	10.7	10.2	6.9	8.4	7.7	9.1	6.8	7.7	7.4	2.7	3.2	2.0	39.2	2.9	1.8	0.6	0.2	0.6	13.2	2.2	1.8	6.5	1.5	1.5	0.0	4.2	2.1	11.8	0.5	5.9	0.6	0.5	1.9	1.8	2.3	1.8	0.8	57.3	1.4	0.3	2.3	0.5	2.1	1.3	5.1	2.2	8.4	7.0	25.2	52.3	0.3	0.0	36.8	13.2	0.4	0.9	31.5	0.0	21.5	45.8	13.7	2.1	31.7	27.1	0.9	0.3	1.5	0.5	1.1	0.0	5.4	0.1	8.3	6.6	4.1	3.7	7.5	4.8	0.2	0.9	1.9	1.4	1.7	0.8	0.5
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120569-73131809	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 35.6;kidney: 10.8;lymphoid tissue: 14.3;stomach 1: 25.4;thyroid gland: 31.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 28.6;Distal enterocytes: 106.0;Gastric mucus-secreting cells: 29.6;Ionocytes: 40.7;Paneth cells: 63.4;Proximal enterocytes: 41.9;Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 24.1;memory CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	89	"T-cells: 24.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.0;LHCN-M2: 66.1;RPTEC TERT1: 51.5;WM-115: 177.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 3.7"	HPA042308	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.1	0.1	2.0	3.1	3.5	0.0	1.6	1.8	2.8	0.3	1.3	35.6	27.7	0.0	0.7	4.8	0.4	0.8	0.0	2.1	2.5	10.8	2.1	0.2	0.4	1.9	2.9	0.1	0.8	0.9	0.1	0.5	2.2	0.1	33.1	0.1	0.5	3.8	0.7	1.0	19.8	1.2	1.5	14.3	25.4	0.6	2.9	0.5	31.1	0.6	3.0	0.7	0.2	3.7	23.4	1.0	0.0	0.2	7.3	10.3	0.0	7.1	35.0	13.6	23.1	0.7	10.7	0.0	15.0	9.4	2.7	17.3	0.3	1.1	11.2	0.0	3.7	0.0	0.2	0.0	2.7	0.0	1.1	2.2	0.9	18.9	1.6	5.3	8.7	0.0	0.0	0.3	66.1	2.3	0.0	0.1	1.9	0.3	1.4	0.0	0.0	12.5	51.5	0.3	0.1	0.0	5.4	0.2	0.1	3.9	1.2	0.1	0.0	0.2	1.2	19.8	0.4	0.0	0.0	0.0	18.1	0.0	177.2	0.0	0.0	0.0	1.6	0.0	24.1	0.0	0.9	8.2	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.8	2.0	3.5	1.8	2.8	2.1	2.5	1.9	2.9	2.2	1.5	2.9	3.7	0.2	0.0	0.0	0.0	0.6	1.8	0.6	25.4	1.2	0.0	6.8	0.4	0.3	28.6	9.2	7.3	0.0	0.2	0.0	106.0	15.6	6.9	0.0	0.2	0.1	0.9	2.4	0.0	0.3	9.9	0.4	1.4	29.6	0.5	0.0	0.0	0.7	1.5	1.3	0.0	0.3	21.2	40.7	0.0	0.4	0.0	0.0	0.1	1.8	1.9	0.0	0.0	5.2	1.0	9.7	10.4	63.4	0.0	0.1	0.8	41.9	8.9	4.4	0.0	0.0	0.0	0.4	0.2	1.7	6.5	1.7	0.5	1.0	0.0	51.4	1.0
TMEM174	"FLJ31268, MGC13034"	ENSG00000164325	"Transmembrane protein 174"	Q8WUU8	5	73173193-73175143	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	309	"kidney: 153.2"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 160.6"	"Cancer enriched"	"Detected in single"	126	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA037975	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA037975: AB_10672732"					"unprognostic (8.11e-2)"								"prognostic favorable (3.30e-6)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805118	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 377.7;liver: 1170.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1043.9;Paneth cells: 779.4;Proximal enterocytes: 1294.5;Proximal tubular cells: 1103.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 146.5;intermediate monocyte: 98.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 146.5"	"Cell line enriched"	"Detected in some"	31	"HSkMC: 730.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	76.6	33.1	46.5	124.8	48.0	6.8	49.3	49.2	50.8	45.7	39.1	143.9	113.2	18.6	17.9	28.5	48.9	129.8	90.9	43.6	56.2	377.7	1170.6	58.5	85.6	64.0	56.2	104.7	29.8	3.9	11.6	66.6	58.2	26.5	151.3	20.6	24.2	15.9	6.4	20.6	203.1	50.2	61.3	51.0	48.7	6.1	49.9	15.5	21.3	17.4	66.0	98.0	54.5	63.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.5	14.2	0.2	0.6	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.3	730.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	2.7	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	146.5	12.6	0.3	98.4	0.4	2.1	0.1	0.2	30.9	0.0	0.2	0.0	1.8	0.3	46.0	2.4	0.4	53.3	46.5	48.0	49.2	50.8	43.6	56.2	64.0	56.2	58.2	61.3	49.9	63.9	15.8	0.0	5.2	3.9	9.8	7.4	0.4	0.9	5.2	56.2	40.6	63.8	24.9	118.7	10.9	200.5	4.2	0.6	2.0	348.5	152.6	64.6	0.3	4.9	14.8	20.5	74.1	6.6	0.0	27.2	0.6	185.3	17.9	2.5	29.0	29.9	23.2	1043.9	52.2	0.0	0.2	237.7	73.2	56.9	26.2	1.5	60.3	109.4	5.4	1.9	313.0	80.8	1.0	1.0	0.0	56.0	779.4	7.5	0.9	1.8	1294.5	1103.9	10.6	5.3	0.0	5.7	32.8	0.9	1.6	2.9	8.4	1.4	6.4	0.1	262.4	2.7
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1656.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	120.9	49.5	48.5	190.8	50.1	13.5	77.8	50.7	65.8	74.5	43.0	251.8	167.7	25.9	25.7	50.4	81.5	197.3	208.5	45.4	58.0	356.5	1656.5	95.6	177.5	69.2	60.1	143.1	53.6	7.3	22.7	115.0	64.5	48.9	244.9	34.1	42.5	28.3	11.0	34.7	286.6	99.0	65.0	87.0	94.5	11.1	52.2	26.1	33.6	36.1	93.7	158.6	92.4	73.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	48.5	50.1	50.7	65.8	45.4	58.0	69.2	60.1	64.5	65.0	52.2	73.2	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TMEM177	MGC10993	ENSG00000144120	"Transmembrane protein 177"	Q53S58	2	119679167-119686507	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 66.5;Proximal tubular cells: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036689, HPA053816"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA036689: AB_2675253, HPA053816: AB_2682272"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.05e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	3.2	8.0	6.6	4.8	7.1	1.0	6.8	7.4	7.7	5.3	3.3	10.9	16.1	6.6	9.0	5.7	10.6	3.9	8.2	6.8	4.6	13.4	25.7	3.3	5.1	4.2	6.2	7.9	5.5	8.2	12.5	3.2	4.5	5.9	9.1	7.2	6.9	5.9	12.2	6.7	13.7	5.2	3.9	4.0	6.3	7.7	6.6	4.7	5.6	7.0	5.2	5.2	4.9	6.6	22.9	19.9	17.2	16.7	4.6	4.5	8.9	8.4	10.4	24.3	18.3	50.4	12.6	37.9	20.1	7.4	19.9	13.7	27.9	28.7	14.0	18.0	51.4	19.5	11.8	56.7	10.1	12.5	13.9	12.4	20.1	19.2	12.5	9.3	15.7	22.3	30.7	4.9	13.3	19.0	21.8	24.3	44.0	16.7	29.2	19.6	16.8	22.4	24.4	11.8	33.8	19.3	10.9	23.2	26.9	15.9	17.7	21.1	12.8	12.0	28.7	9.2	16.7	4.9	3.8	23.3	4.5	15.2	22.0	0.0	2.6	2.6	8.2	2.1	8.5	6.6	6.9	8.4	4.9	8.7	16.2	10.3	0.8	7.2	1.4	5.8	7.9	5.5	6.6	7.1	7.4	7.7	6.8	4.6	4.2	6.2	4.5	3.9	6.6	6.6	2.6	3.2	0.0	3.3	3.6	2.9	12.1	13.9	1.8	13.3	8.2	9.7	13.0	11.5	10.7	5.5	14.6	11.9	2.1	8.9	66.5	16.0	2.2	4.0	6.8	5.0	2.4	3.4	4.1	14.3	9.7	5.4	5.6	2.8	0.0	10.1	1.4	30.5	6.3	11.8	4.1	7.2	8.2	1.2	1.1	2.1	7.5	1.5	14.2	0.0	4.7	9.4	5.2	5.5	2.0	12.3	6.5	12.4	3.4	9.2	22.8	47.2	5.4	21.8	0.0	2.6	6.1	6.5	6.6	5.1	2.0	2.1	4.1	21.5	14.1	4.5
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074064-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.3	1.4	3.7	0.6	5.4	0.0	0.5	0.2	7.4	0.3	0.0	0.8	0.0	0.8	0.4	0.7	0.3	0.3	11.3	7.0	5.0	1.3	0.0	0.3	1.4	1.5	5.9	0.1	0.9	11.9	4.2	0.0	5.6	2.3	0.3	5.5	1.2	0.5	4.6	0.2	0.4	1.0	0.6	0.7	0.3	0.5	5.2	1.4	8.5	12.2	3.1	0.5	0.2	1.9	0.0	0.1	0.0	0.0	0.5	0.2	1.5	0.1	2.3	0.7	0.8	0.0	0.0	1.9	2.0	0.1	0.5	0.0	6.0	0.0	1.9	5.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.9	2.6	8.2	2.4	6.4	3.9	0.1	0.2	0.9	1.2	0.8	0.0	0.0	0.1	0.9	2.7	0.0	0.0	0.0	0.0	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.2	7.4	7.0	5.0	1.5	5.9	5.6	0.6	5.2	1.9	1.3	0.0	0.0	175.0	0.0	0.5	0.7	0.9	0.6	25.5	1.4	0.5	48.7	0.0	1.3	1.8	2.1	0.0	0.0	0.0	1.9	0.1	1.3	0.2	0.1	1.2	0.0	0.0	584.8	0.4	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	30.3	566.2	0.0	2.0	0.0	0.0	1.6	0.0	0.1	1.8	24.4	0.0	4.2	0.0	306.1	81.3	0.8	0.0	0.7	0.0	2.2	0.0	3.4	0.2	1.8	0.0	3.9	0.8	1.4	0.7	2.9	0.1	0.3	0.3	0.2	0.1	2.0
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	663877-677406	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.5	19.9	9.3	6.3	9.1	8.8	18.5	8.8	11.7	14.8	7.6	12.3	8.9	17.7	9.7	14.8	15.8	8.5	11.6	9.6	10.0	13.2	10.1	11.0	8.4	9.8	9.4	28.3	25.2	12.4	9.7	9.9	9.8	9.5	6.2	12.0	14.3	7.0	27.3	15.4	10.1	9.5	9.4	9.2	13.3	12.2	10.2	7.0	12.8	12.2	6.4	13.6	13.1	10.4	17.4	14.1	20.3	21.7	23.9	35.4	19.0	23.8	19.0	20.2	19.5	1.9	27.6	25.1	44.5	31.1	10.7	24.0	7.2	26.3	17.8	37.1	16.6	14.4	7.6	28.7	25.9	13.5	11.9	24.6	26.4	35.1	26.7	18.2	5.9	39.1	14.7	14.7	30.5	48.1	32.7	32.1	13.8	15.1	21.4	17.8	9.9	17.8	21.0	16.3	14.4	24.9	13.1	22.7	25.4	9.5	16.2	25.6	19.5	19.0	25.5	12.6	36.7	19.3	34.4	21.8	20.7	14.4	13.1	3.8	16.1	6.9	11.8	15.7	11.3	18.4	13.5	9.5	16.6	14.8	14.8	14.4	1.0	18.5	18.4	22.3	17.1	13.1	9.3	9.1	8.8	11.7	9.6	10.0	9.8	9.4	9.8	9.4	10.2	10.4	49.2	22.4	32.8	4.6	39.4	35.9	29.7	46.0	61.5	19.8	68.3	108.2	28.3	31.5	39.2	27.6	8.4	72.5	28.1	26.0	31.3	34.1	14.2	37.5	53.7	41.0	19.8	37.9	4.1	46.3	62.1	47.1	27.0	53.1	29.8	77.6	38.2	37.4	49.1	20.2	3.9	39.4	36.7	37.4	31.5	13.1	63.3	31.2	40.9	2.8	36.4	49.8	20.6	4.5	10.2	36.6	50.7	51.1	43.1	40.1	51.0	45.8	32.1	33.7	19.7	31.8	48.8	93.3	68.1	72.6	43.2	81.1	30.0	63.5	41.7	40.4
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040189	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	"Golgi apparatus"	"HPA040189: AB_10793959"	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	14.6	12.4	16.6	12.2	17.0	9.1	18.7	9.7	17.5	27.3	8.3	22.7	24.6	15.2	9.0	13.1	12.7	16.5	10.3	17.6	17.5	7.9	14.9	13.3	9.4	13.3	15.1	10.3	34.3	13.4	11.8	15.0	14.1	20.0	24.8	10.5	52.3	20.9	10.2	16.1	28.5	17.4	12.9	14.3	35.7	21.3	22.3	6.3	21.3	8.7	8.2	20.6	13.4	14.9	22.1	12.6	17.5	27.0	45.1	41.1	33.4	49.1	28.6	25.1	28.4	21.5	26.5	9.3	24.7	41.0	53.5	32.0	26.1	32.4	39.6	13.7	18.7	17.3	18.9	45.6	36.8	21.9	15.8	34.3	31.2	27.9	37.6	37.6	40.7	13.1	33.4	11.3	41.4	13.3	9.7	27.1	13.6	43.8	15.9	9.3	20.1	10.6	23.9	17.1	51.3	35.3	36.0	33.3	24.2	23.9	12.7	30.4	39.1	25.7	17.4	43.1	43.0	6.6	4.9	10.0	31.0	26.8	25.1	5.7	1.1	3.0	2.2	1.1	1.7	0.4	1.2	1.8	0.8	0.4	1.1	1.5	0.7	2.0	1.9	1.0	1.3	0.8	16.6	17.0	9.7	17.5	17.6	17.5	13.3	15.1	14.1	12.9	22.3	14.9	26.7	12.8	33.1	19.9	9.4	20.4	15.6	20.5	17.6	15.6	30.0	18.8	14.2	27.1	23.1	16.5	18.8	8.8	46.0	47.2	3.9	23.3	4.2	16.8	27.7	27.5	44.3	21.5	61.1	32.7	12.5	16.6	49.5	40.5	11.4	36.8	21.0	22.5	10.2	20.2	66.3	35.9	18.3	15.3	16.4	6.7	13.1	14.7	14.2	28.1	13.3	6.0	51.5	43.2	61.7	35.3	25.7	17.7	26.6	37.5	39.4	4.6	25.8	14.6	6.6	12.7	17.8	13.1	22.7	23.6	21.0	5.2	27.0	24.2	30.5	37.1
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 94.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053790, HPA071312"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.3	0.1	1.4	0.1	0.7	3.0	0.1	1.0	20.6	0.2	12.1	24.4	1.1	0.3	94.6	7.0	3.6	0.4	0.0	0.2	6.2	24.4	2.2	0.2	0.2	0.0	0.2	22.9	5.2	11.4	1.7	0.1	11.3	6.6	0.1	22.5	4.5	4.9	37.0	23.6	0.3	0.0	0.1	12.6	3.7	0.2	0.6	0.6	0.6	4.3	12.8	41.0	0.1	23.7	15.0	0.1	0.0	0.0	0.1	5.0	0.8	0.3	0.9	0.1	20.9	25.4	0.5	7.6	0.3	7.5	17.0	0.0	9.7	0.3	0.2	0.9	0.1	15.3	9.7	0.2	0.0	0.0	0.0	8.9	0.3	8.0	0.4	0.1	6.3	0.2	0.1	0.0	34.2	0.2	0.1	0.7	13.5	19.3	0.5	0.0	10.9	7.3	37.9	40.8	0.1	6.4	58.4	0.1	0.5	53.7	0.1	0.0	0.0	8.2	9.7	1.1	0.1	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	2.9	3.2	4.4	0.0	1.6	4.0	5.8	7.2	2.2	1.1	12.1	5.5	7.5	11.5	18.2	9.2	0.0	7.1	1.4	65.9	1.9	13.2	0.0	19.3	3.4	1.4	7.2	0.0	0.3	11.0	8.7	1.7	23.4	31.7	1.3	0.5	0.0	14.2	0.8	0.0	0.1	40.4	14.2	0.6	2.6	0.0	0.0	1.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.1	41.7	0.0	4.6	10.4	60.5	5.1	28.0	0.6	0.0	1.8	3.0	0.0	0.1	15.4	9.2	16.8	1.2	0.1	19.4	16.0
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273010	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 86.8;Oligodendrocytes: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	28.6	21.9	49.5	14.0	52.3	5.8	24.9	54.5	59.6	18.6	22.1	21.0	16.9	19.4	7.2	17.3	17.1	14.5	35.7	49.6	48.2	25.9	11.4	35.9	8.4	56.8	56.0	16.2	18.4	18.9	34.3	38.4	54.8	18.8	10.8	15.2	22.6	14.4	28.7	16.0	17.6	14.0	52.9	22.0	22.4	7.5	56.7	6.2	26.1	17.4	8.2	18.4	16.5	66.9	55.8	47.5	27.5	21.9	53.6	42.6	63.4	58.8	82.9	46.9	41.5	35.1	25.2	10.6	44.9	87.6	42.4	67.2	24.9	57.8	31.6	37.9	45.0	20.9	34.0	29.5	56.3	16.6	28.0	36.1	50.2	55.4	61.5	48.5	59.5	15.9	13.5	36.2	41.5	31.6	10.6	14.1	22.4	41.2	43.4	18.1	24.8	10.6	34.8	60.6	59.3	10.5	44.2	63.6	32.0	31.7	35.2	12.0	89.2	47.7	48.4	42.5	36.2	74.5	197.9	8.5	69.2	12.1	42.0	14.2	3.3	4.7	5.3	2.3	4.6	1.4	2.9	4.0	4.5	1.1	2.1	2.5	10.9	6.2	1.6	7.0	1.0	3.2	49.5	52.3	54.5	59.6	49.6	48.2	56.8	56.0	54.8	52.9	56.7	66.9	43.4	6.4	14.8	86.8	7.5	12.4	19.8	22.3	17.6	16.4	15.9	10.5	17.1	8.6	18.7	14.7	2.1	35.0	17.8	12.5	3.9	17.3	5.6	17.4	15.5	34.6	25.9	4.6	42.6	22.2	48.3	17.4	13.3	33.8	2.5	15.3	18.2	4.4	14.7	15.2	40.7	19.7	12.2	8.5	19.7	2.4	11.8	8.4	14.2	22.5	12.2	44.4	23.7	42.3	93.1	28.3	9.8	13.5	35.6	32.9	11.1	4.3	15.9	9.0	19.7	15.3	27.0	3.3	6.1	5.3	9.7	78.4	9.3	10.2	10.1	37.0
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617386-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 131.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	14.0	20.7	7.8	12.4	10.0	7.9	12.8	10.0	15.9	16.1	10.3	14.8	17.2	14.2	11.2	12.9	13.6	13.4	14.3	10.6	8.9	20.3	20.4	12.7	11.4	8.1	8.7	16.5	15.4	131.7	7.1	19.6	8.7	16.7	16.4	16.2	17.3	16.7	14.7	11.8	16.9	14.3	9.2	11.2	15.3	12.0	9.9	12.6	32.6	16.4	13.8	14.5	7.6	11.2	17.4	27.3	33.7	25.6	45.0	44.6	22.3	32.6	37.5	23.7	26.9	22.7	32.7	16.3	15.7	25.1	23.2	20.5	28.4	24.6	25.8	36.4	16.2	21.1	19.8	16.2	36.3	28.8	29.8	33.2	33.0	26.3	26.9	34.9	30.7	18.4	27.2	44.1	33.6	27.0	24.8	10.2	21.7	40.4	15.7	24.3	11.6	28.2	26.3	32.6	25.8	33.4	18.3	27.0	28.5	25.8	26.8	17.5	31.5	29.2	15.7	24.3	21.0	47.9	68.0	21.5	34.9	17.0	32.7	20.5	12.9	14.7	15.3	16.5	19.4	10.4	13.9	13.9	15.8	12.1	13.0	12.4	10.0	14.6	17.9	10.8	14.3	11.0	7.8	10.0	10.0	15.9	10.6	8.9	8.1	8.7	8.7	9.2	9.9	11.2	8.3	9.6	9.3	7.8	9.5	4.6	8.0	6.3	6.8	8.6	8.3	5.7	19.8	8.6	11.5	5.5	12.5	14.3	12.5	9.8	1.9	12.8	34.6	8.0	11.1	10.0	5.4	8.2	10.4	12.7	12.0	10.6	7.7	9.9	21.5	7.3	8.2	11.8	10.4	11.8	12.7	7.7	6.1	11.9	5.1	13.7	10.8	9.1	5.4	6.5	6.4	8.5	7.2	8.5	14.1	8.6	6.7	14.7	9.0	7.8	9.7	5.8	5.2	6.5	6.6	9.5	8.8	6.5	5.4	10.6	3.4	8.6	12.0	10.6	11.3	7.0
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	15.0	13.8	5.7	8.0	6.6	6.8	13.1	6.8	9.0	14.6	19.7	12.9	7.1	15.0	17.3	15.5	14.4	11.3	30.1	6.7	6.4	10.6	8.9	9.9	10.7	6.0	6.1	30.9	9.5	16.4	8.1	26.8	6.1	13.9	9.4	10.6	12.9	16.8	13.6	20.0	9.1	16.6	6.4	16.8	9.7	17.0	6.9	10.7	9.9	15.9	11.0	12.8	15.1	6.1	18.0	17.7	20.0	12.4	27.0	17.8	8.2	16.9	20.8	16.6	24.2	10.9	29.9	21.4	37.7	19.0	22.8	22.1	23.1	16.4	17.0	14.3	17.3	12.1	19.6	11.8	19.9	18.5	12.8	17.4	27.6	16.9	10.8	19.8	14.6	16.6	5.1	13.1	12.4	29.5	13.1	13.6	14.9	9.5	19.8	12.1	29.8	12.3	20.1	22.8	6.9	9.9	12.5	21.2	23.1	17.9	11.7	10.4	17.6	13.5	11.8	24.7	21.9	12.7	12.0	30.8	22.6	21.9	18.6	2.2	5.1	12.9	9.9	3.1	8.4	5.2	6.9	10.0	7.5	5.0	9.5	8.9	7.1	14.9	2.7	5.6	9.6	6.4	5.7	6.6	6.8	9.0	6.7	6.4	6.0	6.1	6.1	6.4	6.9	6.1	13.5	6.4	2.6	5.9	7.6	11.1	12.1	19.8	6.2	17.4	13.5	12.1	12.3	2.8	9.8	14.7	6.2	29.1	13.1	9.6	3.9	4.4	0.6	22.6	10.5	12.1	13.1	6.5	12.1	9.3	10.7	15.4	2.0	11.2	5.7	22.7	23.9	7.2	11.2	18.5	12.3	5.9	18.3	11.7	12.0	3.2	22.7	11.4	14.2	6.5	16.1	12.2	17.5	10.6	8.2	12.7	9.3	23.7	4.1	8.6	8.3	6.8	17.5	9.2	46.0	9.4	14.1	11.7	16.8	11.0	20.0	17.2	9.8	24.3	5.1	17.7
TMEM185B	"FAM11B, FLJ20979"	ENSG00000226479	"Transmembrane protein 185B"	Q9H7F4	2	120217479-120223400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.44e-4)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.71e-7)"	"unprognostic (3.09e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	11.8	7.9	7.6	7.6	8.8	5.7	9.8	8.3	7.4	7.4	7.7	8.5	6.1	10.4	5.2	9.9	9.6	6.5	11.9	7.3	7.8	9.3	6.8	8.7	6.9	8.7	8.6	5.5	9.0	25.9	6.3	7.3	8.5	9.3	5.9	4.5	9.9	7.0	10.8	7.9	8.0	9.1	8.5	7.2	8.1	13.1	8.3	7.4	10.2	7.8	7.8	9.4	8.1	9.4	29.5	11.2	9.0	18.8	20.2	24.9	16.7	23.1	21.1	19.3	16.5	34.8	27.7	0.0	16.7	20.9	22.1	18.1	8.8	17.2	24.2	13.5	15.4	13.5	9.7	7.3	22.7	0.0	26.3	20.7	24.9	20.8	24.7	18.1	15.7	14.7	13.1	14.9	17.3	23.2	13.9	19.6	13.0	13.1	23.7	9.7	0.0	9.1	17.9	22.0	13.5	12.8	19.1	27.5	18.2	10.2	9.5	21.4	20.2	10.2	22.7	20.9	8.6	10.1	15.5	12.8	12.4	15.2	27.9	0.1	0.6	0.9	0.9	0.9	1.0	0.3	0.7	0.5	0.6	0.4	0.7	0.7	1.5	1.4	0.7	0.5	0.8	0.3	7.6	8.8	8.3	7.4	7.3	7.8	8.7	8.6	8.5	8.5	8.3	9.4	12.2	16.0	2.6	4.9	9.4	8.4	36.0	7.3	14.8	2.7	8.2	5.7	8.6	5.7	4.3	7.3	6.2	9.4	4.7	4.6	1.9	18.0	12.6	4.1	5.7	11.1	1.2	3.4	2.0	12.3	29.3	12.1	12.2	7.4	7.0	5.4	7.5	4.5	15.4	1.7	1.8	4.5	2.0	7.2	4.7	6.1	4.7	8.4	7.2	3.7	5.4	7.5	5.2	5.5	6.1	13.4	6.7	2.2	6.9	16.2	5.0	3.9	6.0	3.8	0.0	17.1	8.8	18.5	9.3	10.4	4.4	14.5	7.9	4.1	4.6	14.2
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797642	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.8;Late spermatids: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: AB_2685041"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	7.0	11.2	8.6	6.2	9.0	2.2	10.0	8.8	10.5	6.5	9.2	10.8	9.6	7.5	12.5	9.6	9.3	4.6	13.2	8.5	8.9	12.3	16.3	5.8	8.6	8.6	8.7	8.5	8.9	12.4	9.5	7.2	8.8	7.5	11.2	5.0	8.3	7.2	18.5	8.3	9.7	7.5	8.6	9.9	9.5	7.8	8.9	7.9	7.6	21.3	10.7	7.5	6.5	9.2	10.4	16.1	11.8	15.1	19.8	10.5	11.2	11.8	12.1	15.2	12.5	15.9	17.1	31.9	9.8	8.7	10.4	19.8	21.2	16.8	17.3	18.7	20.4	13.4	22.3	34.1	22.0	15.1	10.3	12.7	27.8	16.7	24.4	12.5	14.0	25.9	23.3	17.1	9.0	28.3	11.7	14.7	15.0	22.0	13.9	24.4	15.5	35.3	16.3	8.8	18.1	17.3	16.2	22.7	14.3	12.0	27.1	12.0	8.9	10.8	15.1	27.0	9.9	15.6	17.6	15.5	16.8	27.1	8.8	9.9	8.7	6.8	7.5	8.6	10.0	13.1	8.1	8.8	9.1	11.5	13.7	10.9	4.1	9.1	13.3	7.0	11.7	7.4	8.6	9.0	8.8	10.5	8.5	8.9	8.6	8.7	8.8	8.6	8.9	9.2	3.4	6.4	6.7	2.6	6.7	8.2	7.1	16.1	5.7	6.9	7.3	6.6	2.7	10.0	13.1	11.0	0.0	23.4	4.4	7.8	21.5	15.1	44.8	4.8	6.0	5.6	13.8	8.2	1.9	11.2	13.3	5.7	6.1	5.0	7.0	9.6	6.1	12.8	13.2	13.5	1.5	9.4	12.2	4.9	4.7	106.9	9.3	2.5	7.2	1.0	9.9	10.8	11.3	1.5	1.9	9.9	6.7	6.4	5.1	9.8	14.8	21.9	9.3	5.6	13.1	6.6	5.3	21.3	11.9	9.5	9.5	15.1	5.0	11.0	16.0	5.8
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972754-153983194	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	6.9	9.1	5.5	4.8	6.5	2.7	6.5	6.3	6.5	6.7	8.9	6.2	5.0	5.8	7.0	5.1	7.4	4.2	6.2	5.5	6.0	5.6	8.3	4.8	7.7	6.8	6.3	7.1	12.4	5.6	6.8	3.6	6.3	6.7	3.2	2.7	10.7	6.2	6.4	8.5	6.8	4.4	6.7	7.0	6.4	3.9	6.1	5.4	5.0	3.2	4.6	5.9	5.6	8.0	11.9	13.1	2.9	11.6	12.1	10.0	1.8	4.7	2.9	1.4	4.7	2.8	20.7	1.8	27.5	5.2	7.7	11.3	3.9	7.4	1.1	15.8	6.4	3.2	8.3	4.8	10.4	1.9	3.5	12.8	12.1	4.0	7.6	7.4	4.2	7.4	2.9	15.0	6.7	14.7	6.8	2.6	2.1	14.2	18.4	6.5	2.0	20.1	9.2	3.9	4.4	4.1	8.2	6.9	5.8	3.2	11.9	4.0	7.3	2.4	2.6	10.1	2.9	10.9	7.7	2.5	6.9	7.7	1.7	31.5	15.2	19.6	21.5	11.7	21.8	14.6	25.9	23.1	11.4	18.8	31.6	19.5	14.1	17.0	11.4	30.6	29.3	17.7	5.5	6.5	6.3	6.5	5.5	6.0	6.8	6.3	6.3	6.7	6.1	8.0	6.7	0.0	6.3	3.9	4.7	2.8	6.1	11.7	5.2	4.8	9.4	9.8	5.2	12.8	5.1	7.3	6.2	13.3	8.5	5.9	1.9	10.1	0.3	9.4	5.4	7.0	2.4	4.0	1.5	8.7	10.8	6.8	3.6	7.9	3.8	9.0	7.9	16.1	12.4	1.7	1.8	8.2	12.2	7.0	3.3	0.6	14.6	7.1	10.6	0.0	7.0	14.6	5.2	0.5	3.7	9.9	3.8	14.3	3.6	5.9	12.0	8.7	6.5	6.0	6.6	7.8	5.5	1.7	9.4	4.3	4.7	9.9	6.9	14.7	8.1	3.8
TMEM19	FLJ10936	ENSG00000139291	"Transmembrane protein 19"	Q96HH6	12	71686082-71705047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016830	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"			"HPA016830: AB_1858107"	"unprognostic (8.22e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.45e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.00e-1)"	11.4	10.9	8.0	16.9	9.5	8.1	20.6	9.9	8.8	13.3	12.4	27.2	34.4	8.1	9.8	31.1	12.2	11.0	15.7	8.3	10.5	38.3	24.7	16.2	18.7	10.5	9.8	4.2	16.2	15.2	6.9	9.4	10.4	7.5	20.3	13.8	12.5	13.0	25.2	21.7	30.1	14.8	10.8	18.2	14.7	7.1	9.1	20.1	13.6	21.9	30.9	19.4	16.6	12.3	35.9	45.5	30.8	18.2	47.7	22.0	18.6	28.4	33.8	32.7	28.5	22.2	32.3	66.2	38.0	54.4	27.2	45.9	27.1	30.6	43.8	48.5	32.4	38.4	29.4	25.1	13.1	40.9	37.1	20.0	33.7	41.8	13.6	26.1	35.6	58.4	23.0	37.9	49.9	17.4	39.7	11.9	17.3	22.3	30.1	29.8	45.4	37.8	30.0	82.1	33.7	26.8	49.6	25.5	12.9	23.5	38.2	12.1	35.1	45.8	22.2	20.1	25.9	73.9	101.4	47.7	19.4	11.7	50.0	26.0	27.1	10.4	33.2	34.3	25.7	102.3	26.1	28.2	47.6	118.6	25.2	30.3	2.3	28.8	31.3	134.5	29.8	33.7	8.0	9.5	9.9	8.8	8.3	10.5	10.5	9.8	10.4	10.8	9.1	12.3	12.8	22.4	16.3	9.8	44.7	19.1	18.8	32.7	14.8	12.9	11.7	5.8	22.4	12.8	20.1	25.8	12.5	13.6	37.9	21.9	11.7	15.8	16.4	7.4	6.0	14.9	19.9	9.9	7.2	21.6	25.1	11.8	6.6	7.5	15.8	7.4	16.4	31.1	25.9	15.2	9.2	14.5	34.6	32.1	33.7	75.3	7.5	24.2	23.2	5.6	21.4	11.0	22.6	9.5	12.2	22.1	20.2	13.5	54.8	6.9	51.2	46.1	30.6	8.8	6.6	7.5	9.0	4.4	8.4	43.8	46.5	4.8	12.4	7.7	27.4	16.6
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719315-19773617	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.4;retina: 21.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 4.8;ASC TERT1: 4.5"					"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.3	1.3	2.6	0.0	4.4	0.0	0.0	0.0	4.1	0.4	0.0	0.1	0.0	1.4	0.4	0.0	0.3	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	3.6	6.7	0.0	1.1	0.0	3.7	0.0	3.3	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	4.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	4.1	2.7	10.4	3.6	6.7	3.3	1.9	7.1	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	116.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	90.9	0.4	0.0	0.0	45.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	3.3	23.9	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.9	0.0	2.6	0.0	127.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TMEM198	"MGC99813, TMEM198A"	ENSG00000188760	"Transmembrane protein 198"	Q66K66	2	219543663-219550595	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 19.2;Horizontal cells: 21.9;Muller glia cells: 10.9;Proximal enterocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.0;SH-SY5Y: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042385, HPA062897"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA042385: AB_2677972, HPA062897: "	"unprognostic (2.59e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.89e-4)"	"unprognostic (6.39e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	3.2	8.2	10.8	1.4	9.7	0.1	3.0	12.1	19.4	4.6	2.3	2.7	8.9	5.2	1.0	2.0	3.6	1.8	4.4	21.0	8.4	4.0	4.3	3.2	0.7	7.7	7.4	14.7	12.0	3.1	18.3	1.1	6.0	4.2	0.6	2.5	3.8	1.8	2.8	1.5	4.4	1.6	7.4	2.2	4.6	5.9	8.5	0.5	4.0	2.0	0.7	3.8	2.0	8.8	0.6	0.1	5.6	9.6	1.1	1.0	4.9	2.8	1.5	2.3	2.0	12.5	1.6	2.6	2.7	1.8	5.8	3.5	2.0	1.4	0.4	8.7	2.4	2.0	2.9	10.4	1.6	0.7	4.7	2.4	0.8	1.1	2.7	2.5	0.0	1.8	7.8	8.1	1.4	1.2	0.1	0.6	7.3	1.0	0.9	0.2	3.4	2.9	1.4	1.4	20.0	17.4	0.7	2.0	5.0	1.0	0.2	4.0	0.1	2.5	1.0	2.3	1.2	7.7	2.4	2.7	2.3	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	10.8	9.7	12.1	19.4	21.0	8.4	7.7	7.4	6.0	7.4	8.5	8.8	0.3	0.0	1.1	2.0	0.8	0.1	1.4	1.4	1.2	9.3	3.5	4.3	1.8	4.3	0.6	0.0	2.1	1.0	0.4	0.4	1.9	3.9	0.8	0.3	2.6	0.4	19.2	0.0	4.9	7.9	0.9	3.9	1.5	0.6	0.0	1.6	0.0	1.6	0.3	21.9	4.8	2.4	2.0	0.3	0.9	1.4	2.8	0.0	1.8	0.0	0.6	10.9	0.0	3.0	1.2	1.5	4.0	4.9	1.1	0.8	12.4	1.8	0.6	7.4	0.0	1.6	2.8	8.4	4.2	0.4	0.1	2.9	0.4	5.5	0.5	0.4
TMEM199	"C17orf32, MGC45714, VMA12, VPH2"	ENSG00000244045	"Transmembrane protein 199"	Q8N511	17	28357642-28363683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027051	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA027051: AB_10600915"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (9.98e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-3)"	"unprognostic (5.95e-2)"	8.3	11.9	9.2	10.3	10.4	13.3	8.6	10.1	13.0	9.1	9.6	9.0	7.4	9.5	9.6	10.6	8.0	6.2	9.3	9.5	10.5	12.9	14.4	8.5	12.7	10.2	10.1	8.0	8.9	15.5	11.7	9.5	10.1	9.8	7.9	13.9	9.5	6.8	7.2	11.6	9.0	6.2	9.5	13.2	8.9	7.8	10.4	12.8	10.8	7.5	11.2	8.8	8.8	12.0	12.2	20.4	19.6	16.7	7.9	6.8	16.5	14.8	9.5	20.6	18.5	48.9	9.6	17.6	14.8	11.0	26.4	20.6	21.8	13.9	18.0	32.8	19.6	13.0	17.7	23.6	15.9	18.7	22.0	9.7	12.6	19.6	13.0	12.2	10.2	16.1	21.6	21.8	15.4	24.1	21.3	25.6	16.2	21.0	13.9	17.2	24.4	16.3	15.5	20.2	24.8	26.0	17.8	45.6	27.1	20.1	28.7	16.9	14.0	17.4	13.5	15.0	25.3	29.3	38.9	16.2	21.6	11.4	22.2	28.5	24.2	20.0	15.1	25.2	16.6	17.1	13.1	13.4	20.0	16.0	16.4	14.5	18.9	15.6	23.0	14.0	14.9	19.1	9.2	10.4	10.1	13.0	9.5	10.5	10.2	10.1	10.1	9.5	10.4	12.0	12.4	32.1	8.6	8.8	21.0	5.7	10.5	34.3	15.4	13.8	14.3	14.4	5.6	12.8	23.5	9.2	8.4	40.2	15.5	21.1	43.0	40.2	3.7	12.0	11.4	14.6	15.6	12.2	11.0	31.4	38.1	10.6	7.7	10.9	7.6	11.9	17.5	26.8	51.3	11.8	10.5	15.7	32.6	22.9	9.5	4.5	11.5	22.4	21.4	6.5	45.0	19.1	25.7	7.5	13.7	35.4	19.4	6.4	15.1	13.1	20.3	54.0	15.1	14.0	13.1	8.6	14.2	26.5	35.4	14.0	8.8	48.4	15.2	14.7	13.0	11.4
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130366017-130443067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.5;Distal enterocytes: 23.3;Endometrial stromal cells: 18.6;Enteroendocrine cells: 24.6;Granulosa cells: 49.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 40.8;hTEC/SVTERT24-B: 67.1;hTERT-RPE1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	5.7	17.1	1.7	3.9	2.5	0.1	5.9	0.1	2.2	11.1	0.0	11.1	7.3	39.3	5.3	1.2	12.9	6.4	0.6	4.5	2.7	13.6	0.4	6.8	3.8	0.9	4.6	15.6	1.5	0.8	5.3	3.3	1.5	2.7	22.3	11.2	1.6	1.4	0.6	2.0	8.3	18.7	0.8	1.0	6.3	2.7	3.8	4.7	5.6	0.4	3.4	5.6	3.5	0.8	0.1	0.1	0.2	0.0	11.7	14.6	0.1	10.6	13.0	11.1	19.6	16.6	0.0	0.0	0.0	22.3	2.5	2.5	1.0	0.0	40.8	15.5	0.0	0.0	0.0	0.8	5.3	0.3	0.0	16.7	0.0	67.1	13.3	33.5	0.4	0.3	0.0	1.5	5.2	0.0	0.0	0.1	8.4	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	13.4	12.5	4.0	1.1	1.9	8.2	0.0	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	1.7	2.5	0.1	2.2	4.5	2.7	0.9	4.6	1.5	0.8	3.8	0.8	0.5	0.0	0.5	1.3	0.2	2.0	0.1	0.1	1.2	26.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.4	23.3	0.0	0.0	2.0	5.2	18.6	0.8	24.6	2.7	7.1	0.0	1.7	3.6	2.0	0.7	0.0	49.9	0.0	0.0	0.2	13.5	4.3	1.6	0.0	0.0	0.9	1.8	5.9	0.3	1.8	1.9	0.0	0.5	0.0	1.0	0.3	0.1	6.0	10.5	3.3	0.0	4.6	9.9	0.0	2.1	0.0	0.8	8.4	3.3	2.6	0.1	1.4	0.5	5.8	11.3	4.0	0.1
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119429-29123903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 8.8;Fibroblasts: 6.1;Leydig cells: 12.8;Melanocytes: 8.8;Peritubular cells: 15.1;Sertoli cells: 6.6;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.2;BJ hTERT+ SV40 Large T+: 26.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.5;fHDF/TERT166: 29.0;HBF TERT88: 25.3"	"Low region specificity"	"Detected in all"							HPA055254	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA055254: AB_2682760"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	16.8	4.4	2.0	4.0	6.3	0.0	11.8	6.9	3.3	47.2	6.6	29.5	2.3	60.6	7.8	5.6	21.5	7.3	7.0	1.9	2.4	9.4	8.4	10.5	1.2	2.2	2.1	33.3	2.5	26.1	3.6	6.5	2.2	24.6	4.1	0.3	4.1	39.7	2.2	5.8	9.2	35.1	2.0	6.4	6.4	13.3	2.6	1.0	5.0	2.6	1.3	20.9	24.3	2.1	21.0	0.0	3.4	0.0	28.2	23.4	1.1	14.4	22.6	26.7	29.5	1.1	2.3	0.0	3.5	29.0	9.8	0.4	2.3	0.0	25.3	0.1	0.9	0.1	5.7	1.8	19.6	0.0	0.1	12.5	2.7	20.1	3.9	1.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.3	1.9	0.0	5.8	0.0	0.0	0.0	0.3	0.1	0.0	1.7	20.7	0.0	0.1	9.5	0.0	0.0	0.0	9.4	0.4	19.9	0.4	0.0	0.0	0.0	11.6	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.3	6.9	3.3	1.9	2.4	2.2	2.1	2.2	2.0	2.6	2.1	2.0	3.2	0.6	0.7	0.2	1.9	0.4	0.2	2.8	0.8	0.6	1.8	1.0	1.5	0.7	0.0	2.1	0.1	0.2	0.1	0.0	0.0	0.1	1.0	8.8	1.3	0.0	0.0	0.3	0.0	0.5	6.1	0.0	0.6	0.0	0.0	1.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	1.2	2.4	12.8	0.1	8.8	1.9	0.1	0.1	0.0	0.0	0.1	0.0	0.1	15.1	0.0	0.3	0.0	5.9	0.4	1.9	6.6	1.1	9.5	0.3	0.6	0.2	0.6	0.5	0.4	0.0	0.0	0.3
TMEM200C	TTMA	ENSG00000206432	"Transmembrane protein 200C"	A6NKL6	18	5882072-5895955	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.7;salivary gland: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.3;Cone photoreceptor cells: 6.2;Inhibitory neurons: 8.0;Oligodendrocyte precursor cells: 17.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;NTERA-2: 4.7;PC-3: 22.0;U-2 OS: 10.9;U-251 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047253, HPA050490"	Uncertain		Approved	Microtubules		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA047253: AB_2680001, HPA050490: AB_2681144"	"unprognostic (6.57e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.82e-4)"	"unprognostic (2.48e-10)"	"unprognostic (2.94e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.38e-2)"	0.2	3.9	2.2	0.3	2.2	0.0	0.6	0.3	2.2	0.7	0.0	0.5	0.1	0.5	1.1	0.2	0.5	0.4	2.1	1.0	2.5	1.6	1.0	0.1	0.4	2.2	7.7	0.7	0.0	0.1	2.3	0.0	2.6	0.7	0.0	0.8	5.5	0.2	0.0	0.2	0.6	0.1	2.5	0.6	0.4	0.9	2.6	0.1	0.1	0.0	0.3	0.4	0.1	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	22.0	1.3	0.0	0.0	0.0	0.0	1.1	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.9	0.0	3.9	0.0	0.0	0.0	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	0.3	2.2	1.0	2.5	2.2	7.7	2.6	2.5	2.6	0.9	0.1	0.0	1.1	0.3	0.0	0.1	0.0	0.0	0.0	9.3	0.5	2.0	2.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	2.0	3.4	0.1	0.7	0.0	0.0	1.6	0.0	0.1	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.0	0.0	0.4	1.1	1.2	0.2	0.0	1.0	0.0	0.8	0.0	17.6	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.0	1.4	0.3	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.1
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM204	"C16orf30, CLP24, FLJ20898"	ENSG00000131634	"Transmembrane protein 204"	Q9BSN7	16	1528688-1555580	"Predicted membrane proteins, Transporters"	"Stress response"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 208.2;Endothelial cells: 95.9;Hepatic stellate cells: 133.2;Peritubular cells: 67.4;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 156.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 156.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ: 16.5;BJ hTERT+: 21.2;fHDF/TERT166: 14.2;HHSteC: 36.9;HSkMC: 14.8;TIME: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014028	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014028: AB_2204906"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (8.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.62e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-2)"	48.6	20.9	15.1	7.8	13.4	0.5	43.3	13.2	16.3	36.8	11.0	28.4	6.5	35.9	4.0	12.1	26.9	12.9	70.4	11.8	12.2	45.9	17.2	71.5	16.4	13.8	14.3	17.5	15.8	7.4	14.6	12.8	15.1	28.3	2.8	0.5	16.8	14.4	18.0	18.9	25.3	11.2	12.1	24.2	22.1	8.2	16.1	7.9	49.0	16.1	5.4	28.8	20.7	11.7	0.1	0.1	0.9	0.1	7.5	12.5	0.2	16.5	21.2	2.5	2.6	0.6	0.1	0.1	0.1	14.2	0.0	0.3	0.0	0.0	1.1	0.1	0.1	0.0	0.8	0.2	36.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.5	0.3	0.5	0.1	1.8	0.4	0.0	0.0	12.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	4.4	0.3	0.7	0.0	24.5	0.9	45.2	0.6	80.0	55.0	1.8	1.3	156.6	82.2	2.8	34.1	0.8	0.6	38.1	41.1	15.1	13.4	13.2	16.3	11.8	12.2	13.8	14.3	15.1	12.1	16.1	11.7	208.2	0.0	3.7	0.7	4.5	5.7	7.1	17.1	1.2	0.2	3.4	4.4	8.3	0.0	1.6	0.0	0.0	0.5	6.5	0.0	0.0	0.3	0.8	1.9	33.6	95.9	0.0	5.7	0.7	0.2	0.2	31.8	0.0	0.8	0.0	2.3	133.2	1.1	0.4	0.0	0.6	0.0	2.0	3.8	5.7	1.3	23.6	5.6	7.2	30.0	1.4	0.2	12.3	0.0	0.6	0.0	0.0	67.4	0.5	1.1	0.0	0.1	0.2	0.8	118.3	3.3	43.0	0.0	0.2	0.7	3.1	0.4	15.3	17.2	0.0	5.1
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 405.8;Hepatocytes: 520.1;Late spermatids: 662.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	70.3	177.5	111.5	36.8	113.2	55.2	76.0	110.7	142.9	92.8	135.4	73.8	62.3	69.5	92.6	53.7	85.2	61.1	119.7	117.2	122.4	139.2	276.9	73.9	38.9	112.8	113.1	86.8	155.0	210.0	97.4	53.6	114.0	93.2	36.4	25.9	92.4	78.7	122.2	74.3	57.2	42.2	113.6	62.6	86.3	78.8	113.6	39.3	132.1	66.0	34.1	92.4	64.0	122.7	95.5	229.7	28.5	96.2	54.1	64.5	52.6	35.2	80.9	75.9	59.4	70.0	29.5	84.7	209.3	71.6	74.5	95.6	40.5	106.6	50.5	100.7	39.2	23.0	76.5	117.7	135.9	38.9	69.8	61.3	106.7	48.7	81.0	78.5	92.3	79.9	70.4	349.8	47.0	238.8	58.6	108.9	49.9	123.0	174.5	54.3	43.4	225.9	186.9	169.0	50.2	76.7	37.3	151.1	88.1	33.1	132.2	111.3	54.0	94.3	36.2	104.4	80.2	207.0	225.3	51.5	90.4	172.2	74.0	31.8	336.5	36.7	67.2	150.0	67.9	112.7	54.7	58.5	208.2	95.8	43.9	52.2	52.6	55.8	91.0	150.9	73.7	175.8	111.5	113.2	110.7	142.9	117.2	122.4	112.8	113.1	114.0	113.6	113.6	122.7	80.5	67.3	70.5	40.1	44.1	51.5	135.9	281.3	62.0	32.5	113.3	134.4	68.5	175.8	202.3	152.6	12.5	123.7	27.7	53.7	60.7	159.2	405.8	63.2	65.8	72.4	117.6	14.5	30.8	162.7	83.0	76.4	26.0	97.0	29.2	45.4	69.3	520.1	94.4	26.9	27.3	81.4	136.3	67.5	50.0	662.3	80.8	61.2	96.0	5.6	62.1	91.9	19.6	17.6	22.2	97.7	68.6	68.1	70.7	136.7	104.1	224.6	69.3	33.1	46.0	76.3	70.9	38.1	15.6	46.4	54.0	96.7	29.8	101.6	79.3	130.9
TMEM207		ENSG00000198398	"Transmembrane protein 207"	Q6UWW9	3	190428655-190449901	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"kidney: 17.8"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 68.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014332	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"HPA014332: AB_2204907"															"unprognostic (4.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM208	HSPC171	ENSG00000168701	"Transmembrane protein 208"	Q9BTX3	16	67227103-67229278	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041868, HPA041949"	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041868: AB_10962347, HPA041949: AB_10959903"	"unprognostic (9.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.42e-2)"	35.5	83.8	41.8	31.7	41.9	22.5	40.3	44.0	50.1	34.7	50.3	42.9	45.8	29.2	57.5	41.0	32.7	27.8	26.6	41.8	44.8	52.9	124.7	34.9	28.0	43.8	44.6	25.2	65.3	67.6	62.6	32.7	43.9	34.1	41.7	13.8	44.9	31.1	26.5	32.9	39.1	28.1	43.4	38.2	47.4	30.4	43.8	26.5	41.3	19.0	32.1	36.9	28.7	44.9	64.6	82.1	40.0	48.6	124.3	59.3	73.4	66.3	83.3	72.1	61.4	106.4	80.1	63.4	76.1	93.8	64.6	86.2	64.4	89.8	45.6	27.9	90.1	34.9	64.0	110.1	128.6	56.2	91.6	79.9	112.7	95.1	82.1	51.5	54.3	57.6	61.2	81.4	85.7	128.0	56.2	82.5	67.2	105.5	56.1	61.0	48.7	186.2	97.4	42.9	66.2	67.6	119.1	50.2	54.8	27.2	65.0	70.7	33.8	54.5	35.9	78.3	74.0	122.7	127.9	131.8	96.0	54.1	79.8	79.2	108.5	59.4	74.0	102.7	66.5	70.7	68.7	63.9	85.1	58.5	56.1	61.6	69.7	53.3	81.3	168.5	74.2	93.9	41.8	41.9	44.0	50.1	41.8	44.8	43.8	44.6	43.9	43.4	43.8	44.9	51.7	25.6	36.9	8.1	71.8	51.7	79.5	131.0	48.9	44.7	92.1	96.9	29.8	102.9	111.1	57.0	33.3	98.9	69.2	81.8	60.7	158.8	19.8	57.6	54.3	49.5	76.8	31.6	7.8	202.0	142.9	66.7	50.0	64.1	53.3	47.1	43.5	209.6	120.5	26.9	9.3	119.0	140.4	54.7	53.6	7.4	62.1	59.4	88.9	6.5	90.2	102.6	55.6	9.0	12.3	129.7	107.8	41.8	197.3	137.6	145.4	162.7	109.7	55.5	26.3	43.6	100.6	68.4	58.4	62.7	51.9	143.7	52.4	65.9	95.4	128.0
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164713-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	8.9	15.3	4.1	8.4	6.2	9.6	10.6	7.2	6.5	7.4	13.0	11.0	8.8	10.8	9.5	5.5	9.6	6.4	6.2	4.0	5.2	8.6	10.4	9.2	11.9	6.1	6.1	10.2	8.5	15.1	4.4	9.5	6.4	8.3	11.2	13.3	7.9	8.4	5.2	7.2	10.7	9.0	5.9	10.5	7.6	15.0	5.4	14.2	16.2	7.7	12.1	7.6	4.3	9.6	23.4	21.8	29.3	36.7	16.8	17.2	21.4	20.8	20.9	18.3	24.7	23.0	39.2	34.6	15.1	13.3	34.5	34.2	34.7	24.2	33.0	42.7	20.0	17.9	34.0	16.5	29.6	38.2	17.2	18.9	24.6	37.0	36.8	11.4	14.5	35.1	58.9	38.2	23.2	30.2	73.2	23.6	44.1	20.9	19.4	38.9	33.1	57.4	19.1	29.3	26.2	40.0	47.5	75.8	31.3	22.7	23.7	25.6	11.4	33.0	13.1	35.4	50.6	51.7	81.6	70.4	54.7	43.4	53.0	16.1	12.2	13.8	22.0	18.3	23.0	18.3	22.3	20.2	12.0	17.3	25.6	22.3	1.8	19.5	16.8	14.9	24.6	15.1	4.1	6.2	7.2	6.5	4.0	5.2	6.1	6.1	6.4	5.9	5.4	9.6	12.3	3.2	12.3	11.4	15.3	4.7	4.0	8.2	6.8	13.6	8.8	5.2	8.6	10.0	9.8	9.2	4.2	8.9	15.2	7.2	1.9	6.4	33.5	9.6	8.0	9.5	13.8	25.9	10.4	9.1	9.3	7.5	7.7	10.4	10.1	10.0	9.7	9.4	7.9	5.0	13.0	11.9	8.2	13.1	4.4	8.5	6.5	7.8	7.2	15.0	7.7	18.1	8.2	10.6	20.9	7.6	11.6	5.3	11.0	5.3	13.4	4.9	9.8	14.6	0.0	9.0	5.9	16.6	16.0	6.4	5.4	6.6	13.1	12.1	9.5	3.7
TMEM210		ENSG00000185863	"Transmembrane protein 210"	A6NLX4	9	137170858-137172056	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 14.8"	"Group enriched"	"Detected in some"	68	"Early spermatids: 900.5;Late spermatids: 1815.1"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 3.2"	"Cell line enriched"	"Detected in some"	8	"RPMI-8226: 13.5"	"Not detected"	"Not detected"							HPA066907	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA066907: AB_2685747"	"unprognostic (5.17e-2)"		"unprognostic (5.04e-2)"	"unprognostic (2.87e-5)"						"unprognostic (4.18e-2)"		"unprognostic (3.63e-2)"		"unprognostic (3.14e-2)"	"unprognostic (8.00e-2)"			0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	900.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.7	1815.1	12.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	1.1	0.0	0.0	0.0	0.0	19.7	0.0	0.1	9.1	4.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 2.6;salivary gland: 5.8;stomach 1: 3.2"	"Cell type enriched"	"Detected in some"	19	"Ionocytes: 36.7"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 4.8;endometrial cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066784	Uncertain					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA066784: AB_2685722"	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.3	0.2	2.6	0.0	0.3	0.0	0.6	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	5.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.3	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 76.0;salivary gland: 52.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054059	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.1	0.5	0.2	0.5	1.1	4.7	0.6	0.7	2.8	0.4	0.1	1.3	0.2	0.6	0.3	0.1	0.2	0.0	0.6	0.1	76.0	0.1	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.1	0.3	52.3	1.2	0.1	5.3	0.3	0.1	0.0	0.2	0.4	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	2.1	0.2	0.2	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	1.1	2.0	0.2	0.2	0.1	0.1	0.5	0.5	0.6	0.7	0.6	0.1	0.2	0.1	0.4	0.0	0.5	1.0	0.1	3.2	9.9	0.0	0.1	0.0	0.9	3.0	0.0	0.4	14.1	7.9	0.4	0.0	4.4	53.3	0.0	0.0	0.2	0.0	144.8	0.0	0.0	0.9	0.4	0.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	1.3	1.3	0.1	0.0	0.0	0.1	1.7	0.4	0.0	2.0	0.0	0.8	0.0	0.0	0.1	26.6	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.9	3.5	1.3	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.2	0.6
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	17.7	18.1	4.8	9.5	5.5	5.3	14.0	5.3	6.5	15.5	5.3	13.5	8.4	16.6	6.9	11.6	14.8	7.4	10.2	4.6	5.4	12.7	12.9	12.0	10.5	6.0	5.5	15.0	14.5	10.3	15.2	5.9	5.8	13.0	6.0	6.5	10.9	6.8	9.2	8.9	11.8	8.3	5.7	16.6	13.2	5.6	5.1	8.4	10.9	5.7	7.0	13.8	13.2	6.3	12.5	24.0	14.9	18.2	13.5	18.6	9.0	12.2	9.2	9.3	12.0	2.5	35.9	15.6	29.9	7.5	14.2	14.2	9.4	11.6	12.2	22.0	13.5	35.1	6.1	10.0	13.3	11.1	12.6	14.7	15.2	16.5	19.6	14.9	13.7	19.1	14.4	19.4	16.2	6.4	2.9	23.3	12.2	34.0	22.6	16.3	18.0	12.0	8.3	12.3	12.9	19.4	16.6	6.6	9.1	8.7	31.3	15.7	17.6	11.4	10.3	13.4	13.5	11.1	10.1	12.9	9.1	22.9	20.3	43.7	40.1	17.4	21.6	31.6	18.7	29.6	20.5	20.5	47.4	23.9	17.2	20.4	15.7	32.5	30.9	41.1	20.5	27.0	4.8	5.5	5.3	6.5	4.6	5.4	6.0	5.5	5.8	5.7	5.1	6.3	21.0	19.2	13.4	7.8	17.8	12.1	19.6	34.6	19.4	7.0	22.1	24.6	8.1	15.7	16.6	14.7	0.0	28.0	18.1	5.7	27.4	20.5	3.4	23.1	22.4	15.8	10.8	14.5	4.4	16.2	18.4	21.1	8.6	10.6	3.8	22.2	18.5	15.1	42.2	23.5	7.4	11.7	20.3	21.0	17.5	1.9	10.2	21.9	17.8	14.0	26.0	26.0	18.6	9.5	11.2	13.1	3.9	16.6	15.8	9.4	8.5	19.7	29.4	12.4	26.3	16.7	18.3	16.6	13.8	18.0	14.2	9.7	14.5	27.0	13.7	16.6
TMEM219	IGFBP-3R	ENSG00000149932	"Transmembrane protein 219"	Q86XT9	16	29940885-29973050	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 637.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059185	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA059185: AB_2683941"	"unprognostic (4.13e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-3)"	119.7	181.1	246.7	50.2	256.4	79.4	117.6	241.4	280.2	103.6	249.0	130.4	121.9	85.0	164.7	119.1	130.0	89.8	130.4	234.5	239.8	173.7	194.7	125.0	75.3	252.4	244.6	107.9	161.6	109.3	105.2	55.9	243.8	139.5	88.2	39.7	175.9	97.7	101.4	121.4	127.7	65.6	252.5	138.3	170.6	140.6	251.1	62.5	114.0	89.3	73.4	110.7	100.6	247.5	58.8	70.2	60.1	77.8	157.0	161.8	68.5	59.7	123.2	87.7	113.3	34.4	168.4	46.3	111.2	151.1	63.9	34.0	35.5	82.0	43.3	81.6	68.0	44.3	53.3	114.2	181.1	29.8	108.5	146.5	124.0	63.0	55.2	166.7	142.6	126.2	30.9	95.4	115.5	63.8	41.1	98.2	34.8	119.3	45.4	81.8	37.6	107.5	158.8	38.4	33.8	67.1	20.5	40.7	110.7	81.0	66.6	109.7	79.5	69.9	41.7	36.0	28.3	74.0	24.2	39.5	93.9	99.0	59.2	471.8	333.2	450.9	146.6	253.1	151.0	213.7	205.9	154.2	274.5	206.2	191.3	149.2	154.9	132.7	187.3	298.5	246.2	328.3	246.7	256.4	241.4	280.2	234.5	239.8	252.4	244.6	243.8	252.5	251.1	247.5	174.0	70.5	122.2	16.0	82.3	67.0	134.0	207.4	84.8	23.7	239.3	258.4	73.2	167.3	158.1	176.6	10.4	80.4	85.6	309.2	252.4	183.3	181.0	107.8	67.0	143.2	180.4	39.3	10.8	238.7	225.3	97.1	87.7	97.1	142.5	84.1	213.5	165.7	269.2	16.8	13.4	273.1	154.6	260.8	149.8	524.8	86.6	189.8	167.2	6.5	192.0	119.6	114.4	12.5	23.8	213.7	333.7	100.4	95.8	136.2	637.1	371.1	183.7	30.7	52.6	54.8	92.5	101.1	117.5	119.1	78.6	71.1	89.4	118.7	227.9	215.0
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448668	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 7.9;retina: 9.4"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 14.6;Muller glia cells: 49.2;Rod photoreceptor cells: 24.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;PC-3: 6.8;REH: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"		"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	0.6	4.2	3.6	0.2	3.6	0.1	1.2	3.2	4.4	0.8	2.7	0.7	0.1	0.6	0.7	0.5	2.7	0.2	0.6	3.7	3.2	0.6	0.4	0.3	0.2	3.6	3.1	7.9	2.2	5.4	1.7	0.1	3.1	1.3	0.0	9.4	0.8	1.0	0.2	0.4	0.4	0.1	3.4	0.4	0.4	0.5	3.8	0.5	0.7	0.1	0.1	0.4	1.0	3.4	0.5	1.5	0.6	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.4	0.2	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	1.0	0.3	6.8	3.9	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.2	4.4	3.7	3.2	3.6	3.1	3.1	3.4	3.8	3.4	0.5	0.0	0.5	1.0	0.1	0.0	0.1	0.0	0.0	1.3	0.3	0.3	0.3	1.5	0.0	0.0	14.6	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	2.0	0.0	0.0	2.2	0.0	0.2	0.0	0.2	3.3	0.0	3.7	1.7	3.9	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	49.2	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.5	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792006	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	13.1	20.9	10.4	9.4	12.0	6.4	12.8	12.4	13.4	13.2	11.6	15.7	11.0	12.9	9.7	13.3	11.7	5.5	27.9	10.4	10.5	17.3	22.5	11.1	12.0	11.6	10.2	11.4	19.8	8.0	13.2	7.1	11.8	14.8	7.4	5.2	15.3	7.2	16.1	13.3	14.4	5.3	10.0	16.6	15.4	6.7	10.4	7.3	13.8	8.5	7.0	12.2	11.1	12.1	29.2	24.4	14.3	19.6	11.8	13.5	19.5	15.3	13.4	16.9	14.1	21.5	34.9	21.6	36.8	11.1	22.5	43.3	17.3	18.9	9.6	34.7	32.5	16.1	26.9	25.9	20.6	20.0	18.4	14.4	18.8	11.2	13.9	20.3	13.9	28.2	24.8	15.8	12.6	42.3	20.3	44.3	28.2	30.2	29.2	24.7	17.3	48.8	26.8	18.3	24.3	32.0	16.0	32.3	43.0	14.5	48.1	18.4	13.9	20.2	24.4	18.7	18.5	32.1	27.5	25.1	24.0	17.8	21.5	21.0	41.3	25.0	71.3	46.2	68.8	77.6	69.8	69.9	46.8	81.8	74.9	73.0	19.0	66.2	29.8	75.6	66.8	41.5	10.4	12.0	12.4	13.4	10.4	10.5	11.6	10.2	11.8	10.0	10.4	12.1	31.9	12.8	5.6	4.2	24.1	13.5	15.3	39.7	8.6	17.9	27.6	45.0	18.8	52.9	25.2	20.2	12.5	49.4	22.8	30.2	62.6	37.2	2.6	29.1	26.9	28.9	20.5	18.5	6.1	44.3	42.9	22.0	15.3	22.3	19.7	22.4	31.8	36.0	37.6	6.7	8.0	32.6	38.7	20.1	13.6	3.4	32.6	16.2	19.6	4.7	16.2	16.5	35.0	6.0	5.7	36.1	19.3	26.4	25.4	22.4	32.1	52.3	39.6	18.0	19.7	22.3	17.9	6.9	19.7	21.3	13.9	14.2	24.3	34.2	43.4	17.1
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030921-124033067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.6;intestine: 8.4;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 130.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056391	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.0	1.0	7.5	0.0	11.0	0.0	0.0	9.8	9.0	0.1	2.5	0.1	8.4	0.1	0.4	0.0	0.6	0.0	0.2	7.7	9.6	0.0	0.0	0.0	0.0	9.1	12.6	0.2	0.0	0.8	0.9	0.1	9.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	3.9	0.1	7.9	0.1	1.8	5.3	10.2	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	130.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	9.8	9.0	7.7	9.6	9.1	12.6	9.0	7.9	10.2	11.7	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.2	0.0	2.0	11.4	0.0	2.5	0.0	0.0	0.1	10.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.2	0.7	0.2
TMEM229B	"C14orf83, FLJ33387"	ENSG00000198133	"Transmembrane protein 229B"	Q8NBD8	14	67447084-67533739	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Late spermatids: 25.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 19.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 12.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 12.9;MCF7: 13.6;SK-MEL-30: 11.6;U-937: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046562	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA046562: AB_10960265"	"prognostic favorable (5.38e-4)"	"unprognostic (6.55e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.21e-5)"	"unprognostic (7.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.79e-5)"	1.5	15.3	10.1	5.6	8.7	1.8	3.7	21.2	15.8	10.8	0.0	4.3	15.7	1.4	10.9	1.3	2.0	4.1	1.3	10.9	10.7	2.0	1.1	3.5	9.1	25.8	10.9	1.1	5.0	12.5	6.9	0.8	27.6	2.7	3.3	5.4	4.0	10.4	0.5	1.4	14.2	3.2	10.4	9.8	4.2	6.1	15.4	11.8	8.3	0.9	6.1	5.0	1.5	11.5	3.2	0.4	0.0	0.8	0.3	0.0	1.2	0.5	0.7	0.8	3.3	0.0	10.1	12.9	0.1	0.3	2.8	0.0	0.2	0.7	0.1	4.2	1.0	7.8	0.0	0.0	1.0	8.5	1.5	0.2	0.4	0.1	0.0	0.2	0.0	0.8	0.1	0.5	0.0	13.6	5.2	3.2	0.1	6.7	0.6	4.7	0.1	1.9	0.1	6.7	1.9	0.4	0.0	4.9	11.6	0.5	10.3	8.1	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.6	34.5	7.0	5.8	5.7	9.1	9.9	6.5	9.5	1.3	5.9	8.0	2.7	0.9	5.0	6.5	0.1	5.5	6.9	1.5	2.5	5.8	10.1	8.7	21.2	15.8	10.9	10.7	25.8	10.9	27.6	10.4	15.4	11.5	1.2	0.0	0.5	1.3	2.6	0.3	0.3	3.6	0.0	4.8	3.5	2.5	1.8	2.8	2.5	0.0	14.6	0.1	8.3	3.6	0.0	2.0	12.6	2.3	0.3	1.4	2.4	0.4	7.1	3.6	0.0	0.6	1.1	0.3	0.0	11.0	2.9	0.2	1.8	0.0	10.6	5.3	0.0	6.2	1.0	25.7	0.0	2.6	7.2	3.7	5.5	0.3	15.5	19.1	6.1	0.5	5.7	0.7	0.4	0.4	11.3	2.2	2.4	4.1	0.0	0.2	0.7	0.7	0.3	0.1	0.1	0.1	4.1	4.9	3.9	1.1
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	140.5	120.1	89.7	60.4	98.6	60.4	88.4	101.9	110.7	108.3	113.6	83.9	62.3	88.9	120.4	57.3	87.1	97.7	101.4	88.2	100.2	145.7	197.8	75.8	81.0	98.9	95.1	97.4	95.1	99.3	89.5	72.5	99.1	105.5	88.7	107.4	78.9	83.1	107.1	34.4	70.2	88.9	95.3	71.8	87.6	49.7	96.0	85.6	135.5	148.3	76.6	93.3	56.6	111.8	157.2	108.1	139.1	105.2	307.1	271.6	105.6	124.0	185.4	119.9	131.4	86.0	152.4	74.8	99.5	180.7	136.6	127.1	104.5	185.2	172.3	83.6	119.6	132.6	31.5	266.3	196.3	154.9	52.8	189.3	202.4	92.2	183.3	167.0	160.1	163.6	126.1	200.3	199.2	44.7	156.9	143.8	106.3	298.8	152.4	100.4	93.2	161.5	182.5	79.4	116.8	141.7	74.6	154.8	270.0	149.0	123.9	145.6	135.7	154.7	90.5	150.1	135.2	133.2	284.3	147.5	62.5	132.2	166.3	128.9	175.4	116.7	136.5	187.1	166.3	170.7	145.8	145.3	163.8	153.1	150.8	148.6	55.7	153.9	180.6	161.2	147.6	349.2	89.7	98.6	101.9	110.7	88.2	100.2	98.9	95.1	99.1	95.3	96.0	111.8	126.6	57.7	64.6	15.3	123.4	70.4	126.7	148.7	65.4	89.6	151.7	133.7	51.3	111.5	95.1	154.5	64.6	173.4	127.8	55.0	502.9	146.6	200.3	77.1	103.2	109.5	95.8	103.7	20.2	111.2	208.8	141.6	59.1	64.1	114.1	82.8	126.7	147.5	212.8	62.2	27.7	123.1	126.1	162.9	172.9	89.5	212.2	121.9	199.3	14.0	215.6	113.9	151.4	13.0	49.6	100.2	130.0	220.4	161.7	129.6	102.0	363.2	81.9	113.3	85.5	100.4	128.0	99.4	97.5	68.1	60.5	148.0	118.2	184.2	125.6	152.1
TMEM231	"ALYE870, FLJ22167, JBTS20, MKS11, PRO1886"	ENSG00000205084	"Transmembrane protein 231"	Q9H6L2	16	75536741-75556268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 48.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 121.2;Respiratory ciliated cells: 132.2;Rod photoreceptor cells: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042081	Enhanced		Approved	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA042081: AB_10795391"	"unprognostic (4.29e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	2.4	3.3	5.1	1.4	5.1	1.4	2.5	5.0	5.2	3.6	11.9	2.5	2.4	4.2	3.6	1.7	48.5	3.2	6.0	5.3	6.5	2.9	1.1	4.6	1.6	8.8	10.3	4.7	3.1	7.0	4.9	2.2	7.1	3.5	1.9	5.2	1.5	3.5	1.0	2.3	2.6	5.5	8.5	1.5	1.9	4.5	7.3	0.9	5.8	1.2	1.0	2.6	1.7	5.1	4.0	2.6	7.1	12.0	6.8	16.6	3.8	5.0	6.3	6.1	7.3	1.4	7.0	5.0	6.7	6.9	5.1	10.3	0.8	5.3	3.9	0.9	2.9	0.3	3.6	1.6	5.9	2.9	2.1	3.7	7.0	6.2	15.1	11.0	3.3	4.5	4.8	0.2	1.8	11.5	1.8	5.2	4.0	0.8	2.1	0.9	1.0	11.5	7.4	1.6	5.7	3.8	8.8	2.5	4.4	2.3	2.3	3.0	5.1	4.7	3.7	3.0	2.6	9.1	8.4	1.6	11.9	1.3	4.6	1.8	0.3	0.2	0.6	0.4	1.5	2.2	0.7	1.2	1.0	1.0	0.6	1.0	2.5	0.4	0.2	1.3	0.2	0.6	5.1	5.1	5.0	5.2	5.3	6.5	8.8	10.3	7.1	8.5	7.3	5.1	6.4	3.2	6.3	9.4	3.0	1.0	4.7	5.5	1.8	18.3	5.3	6.1	5.2	1.5	14.0	7.3	52.1	1.1	1.1	3.7	0.0	3.0	17.6	121.2	8.1	6.3	3.0	1.7	11.6	2.3	1.2	5.2	3.6	10.6	1.3	6.1	4.2	1.5	0.9	13.5	11.4	5.0	18.3	1.2	0.8	5.3	1.8	1.5	0.0	1.0	2.8	6.0	0.0	9.5	7.6	1.5	3.8	3.8	2.0	5.0	16.8	2.1	132.2	33.1	0.0	6.6	6.1	15.3	9.8	1.8	1.0	0.3	2.3	6.0	4.2	2.5
TMEM232	FLJ43080	ENSG00000186952	"Transmembrane protein 232"	C9JQI7	5	110289233-110738956	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.4;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 154.8;Early spermatids: 130.7;Endometrial ciliated cells: 80.5;Excitatory neurons: 258.9;Inhibitory neurons: 175.0;Respiratory ciliated cells: 114.0;Spermatocytes: 83.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049386	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA049386: AB_2680739"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-4)"	"unprognostic (8.96e-2)"	0.6	1.2	2.7	0.2	2.4	0.1	1.1	1.1	1.8	1.1	8.3	0.4	0.5	0.8	1.7	0.6	14.4	1.8	0.7	1.8	2.3	3.7	0.7	1.7	0.4	6.6	7.9	0.7	0.4	2.1	1.3	0.4	6.0	0.9	0.4	3.6	0.6	0.7	0.0	0.4	0.3	0.4	5.1	0.2	0.9	16.9	2.8	0.4	3.8	0.3	0.3	0.3	0.1	5.3	0.4	0.1	1.0	0.3	0.8	1.5	0.2	0.0	0.0	0.2	0.2	0.2	0.1	0.5	0.3	0.0	1.6	0.3	0.2	0.8	0.2	1.0	0.1	0.1	0.0	0.0	0.7	0.3	0.1	0.4	0.1	0.2	0.4	1.4	0.0	1.2	0.3	0.3	0.5	0.1	0.5	0.3	0.1	0.1	0.0	0.2	0.1	0.2	1.0	0.0	0.8	1.0	0.1	0.0	0.9	1.6	0.4	0.1	0.0	1.1	0.1	0.0	0.0	2.5	0.9	0.4	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.4	1.1	1.8	1.8	2.3	6.6	7.9	6.0	5.1	2.8	5.3	0.6	0.0	5.4	154.8	0.4	0.4	0.9	4.8	1.2	5.0	1.2	0.8	2.4	1.5	11.7	7.3	27.1	0.3	0.0	0.4	9.8	1.3	130.7	80.5	1.4	0.7	1.2	0.8	258.9	0.5	0.1	0.8	0.0	2.3	0.0	0.7	1.1	0.6	0.1	3.3	175.0	0.6	8.2	1.3	0.0	68.0	1.2	0.7	0.0	32.8	0.0	4.5	0.0	54.8	66.1	0.2	0.1	0.7	0.5	0.7	0.4	5.5	114.0	16.9	0.0	1.6	1.8	83.9	4.3	0.1	0.4	0.3	0.2	1.6	0.3	0.6
TMEM233	"DSPB2, IFITMD2"	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593774-119643075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 66.6;tongue: 21.2"	"Group enriched"	"Detected in some"	5	"granulocytes: 79.1;Skeletal myocytes: 77.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.7	0.6	4.6	0.1	6.6	0.0	0.4	1.1	9.0	0.4	1.3	0.2	0.2	0.3	0.2	0.3	0.2	0.5	1.2	4.4	2.5	1.3	0.6	0.9	0.2	1.8	1.4	0.9	0.2	1.3	0.8	0.1	1.8	0.6	0.2	0.2	0.5	0.3	66.6	0.1	0.3	0.4	1.4	0.2	0.3	0.2	3.4	0.9	14.3	21.2	0.2	1.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.7	0.0	22.2	0.0	9.0	0.1	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.6	1.1	9.0	4.4	2.5	1.8	1.4	1.8	1.4	3.4	4.4	12.0	3.2	1.1	0.7	0.0	0.0	0.4	0.0	0.0	2.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.9	9.5	0.3	0.1	13.3	0.0	0.0	5.4	8.5	0.0	3.6	0.0	0.4	79.1	5.5	15.4	0.1	0.1	8.4	3.7	0.0	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.5	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	77.8	2.2	3.1	1.0	0.2	0.1	0.1	0.9	9.2	0.0	0.2
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA015049	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	6.5	7.4	5.7	2.6	5.8	2.8	6.8	5.0	6.4	7.9	7.4	6.4	2.2	7.6	9.4	9.0	7.3	3.4	9.2	5.7	6.1	9.7	6.3	6.4	3.5	5.9	6.7	9.9	5.8	6.9	12.3	5.9	6.0	8.5	4.1	6.1	7.2	7.0	3.0	4.8	5.2	4.4	5.2	7.5	5.6	9.0	5.8	3.1	12.3	1.7	3.5	6.6	7.6	5.4	10.0	7.5	4.2	4.4	12.0	9.4	4.4	14.6	10.5	7.3	5.5	5.4	9.8	3.1	16.1	13.5	5.7	8.0	5.4	10.5	6.2	6.4	5.9	6.1	11.9	6.2	8.7	7.4	4.0	11.9	10.5	7.6	5.5	12.8	10.7	3.3	5.9	1.9	12.4	3.0	2.9	6.2	7.6	2.5	5.7	4.0	3.3	3.6	16.3	5.1	5.3	5.4	10.6	5.7	5.0	13.6	2.8	2.3	12.9	2.6	4.1	10.3	10.6	3.1	1.8	1.3	8.0	2.6	9.8	25.9	11.9	19.1	5.8	13.3	9.3	6.9	4.6	6.6	11.4	6.9	3.3	4.2	35.8	10.8	9.3	8.6	3.1	6.7	5.7	5.8	5.0	6.4	5.7	6.1	5.9	6.7	6.0	5.2	5.8	5.4	7.5	9.6	1.5	10.4	8.3	2.7	6.6	14.5	5.2	5.3	9.0	9.1	3.6	4.3	11.4	23.9	2.1	26.0	5.0	17.4	1.9	20.9	27.8	17.9	9.1	7.5	6.0	7.4	10.8	15.5	23.0	9.1	16.3	10.0	3.8	10.8	6.4	5.6	19.3	1.7	7.8	11.8	10.2	8.3	3.2	55.6	9.3	8.2	14.2	8.4	11.4	8.6	9.2	3.5	2.8	18.4	12.2	7.9	5.1	5.6	12.5	11.0	23.7	13.5	6.6	5.7	9.2	31.8	15.0	5.9	3.1	21.3	6.9	15.2	9.9	8.0
TMEM235		ENSG00000204278	"Transmembrane protein 235"	A6NFC5	17	78231310-78240987	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 107.8"	"Cell type enriched"	"Detected in some"	23	"Oligodendrocytes: 107.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053939	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA053939: AB_2682316"					"unprognostic (1.47e-1)"	"unprognostic (6.91e-3)"								"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"			0.0	0.0	41.5	0.0	73.7	0.0	0.0	46.9	59.8	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.4	42.8	0.0	0.0	0.0	0.0	65.0	60.2	0.0	0.0	0.0	0.3	0.0	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	59.6	0.3	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	73.7	46.9	59.8	40.4	42.8	65.0	60.2	52.2	38.7	59.6	107.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	107.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752201-17800868	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"MOLT-4: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.7	0.6	0.3	1.7	0.3	0.5	0.4	0.8	0.5	0.5	0.4	14.1	21.8	0.3	0.2	0.3	0.2	0.4	0.3	0.3	0.1	0.2	0.1	0.7	0.3	0.1	0.0	0.3	0.5	0.1	0.0	1.5	0.2	0.1	14.0	0.3	0.1	0.2	0.3	0.3	33.5	1.0	0.0	0.3	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.2	0.0	0.2	0.9	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.2	10.3	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.8	0.5	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.7	0.2	0.0	0.5	0.0	0.2	0.1	0.5	0.0	0.0	0.3	7.3	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.1	81.1	0.0	0.1	1.1	0.1	0.1	0.2	23.4	0.4	0.4	0.9	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.0	7.2	0.0	0.4	28.8	0.0	4.8	0.8	1.1	0.0	5.9	0.0	3.7	0.0	0.1	0.0	0.0	0.6	0.7	48.1	0.0	0.0	0.4	96.5	0.0	0.0	0.9	0.0	0.7	0.3	0.4	0.1	0.2	0.0	0.3	0.4	0.2	19.0	0.6
TMEM237	"ALS2CR4, JBTS14"	ENSG00000155755	"Transmembrane protein 237"	Q96Q45	2	201620184-201643570	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 89.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052596, HPA054732"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA052596: AB_2681879, HPA054732: AB_2682587"	"unprognostic (1.70e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.06e-1)"	"unprognostic (8.30e-6)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.96e-6)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	4.1	15.1	6.3	1.7	6.5	2.3	11.0	7.1	7.8	5.0	6.0	3.0	0.8	6.0	4.6	6.0	5.8	4.1	7.7	6.8	6.7	5.4	1.9	5.1	2.3	6.9	6.9	8.4	1.9	5.0	3.0	5.2	7.2	7.8	3.7	89.3	5.1	4.8	7.7	18.5	1.8	5.8	7.1	1.4	2.2	3.0	6.4	7.0	4.6	9.2	3.1	4.1	3.4	6.8	3.7	7.2	32.3	16.4	7.8	10.1	3.1	22.6	9.9	14.7	28.4	5.9	5.3	3.7	6.9	21.9	12.7	6.8	5.6	24.4	27.1	6.9	20.6	10.7	21.4	19.4	15.1	10.4	2.1	9.0	5.0	20.4	5.1	24.8	25.5	23.4	7.8	13.0	29.8	5.2	29.7	16.3	32.7	1.9	23.8	43.9	30.8	7.6	12.2	9.7	33.7	47.4	21.4	8.4	12.6	20.3	12.5	18.7	6.8	26.8	7.3	8.6	9.5	6.0	14.9	11.4	22.7	9.7	17.0	0.0	0.0	0.0	1.0	1.1	0.9	0.7	1.0	1.6	1.3	0.1	1.1	1.4	0.0	0.9	0.7	0.3	1.8	0.5	6.3	6.5	7.1	7.8	6.8	6.7	6.9	6.9	7.2	7.1	6.4	6.8	6.8	6.4	9.6	12.4	1.6	71.2	81.7	46.7	50.7	33.3	17.1	41.4	20.2	2.8	18.9	18.4	41.7	21.0	3.1	0.6	13.7	11.1	8.9	16.3	10.9	11.6	4.8	8.6	16.5	7.6	26.8	25.8	3.1	7.7	5.1	19.9	10.4	2.7	9.4	32.0	15.3	4.5	18.3	2.2	12.2	7.0	21.8	2.9	12.4	4.7	5.7	38.5	0.0	14.1	10.8	6.5	1.9	21.4	3.0	36.9	0.7	3.9	19.8	160.3	6.6	33.2	20.6	33.3	22.0	30.0	45.3	15.1	4.2	39.8	5.3	29.2
TMEM240	"C1orf70, SCA21"	ENSG00000205090	"Transmembrane protein 240"	Q5SV17	1	1534778-1540624	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.5;Excitatory neurons: 15.5;Inhibitory neurons: 15.1;Oligodendrocyte precursor cells: 8.0;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5;SCLC-21H: 9.3;SH-SY5Y: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066721	Supported					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA066721: AB_2732750"	"unprognostic (2.24e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.52e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (9.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (9.50e-4)"	"unprognostic (2.64e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.93e-1)"	4.1	3.5	10.9	0.6	12.2	0.1	3.9	17.1	22.8	14.8	2.5	17.4	0.4	15.1	0.9	2.9	10.6	1.0	8.2	13.1	7.6	3.6	1.2	4.2	0.4	7.1	8.1	16.1	1.3	1.4	15.1	1.6	7.3	9.5	0.5	1.3	2.5	3.3	3.8	2.7	4.9	2.1	5.4	4.0	5.7	3.0	8.5	0.3	5.3	1.2	0.2	10.8	8.6	9.6	0.9	1.0	5.7	0.7	0.8	3.8	1.4	3.8	2.1	3.5	2.0	0.0	0.4	0.7	0.7	1.9	0.2	2.2	0.0	0.2	0.5	3.5	8.5	0.5	3.6	1.3	7.5	0.0	0.8	5.2	1.8	1.4	0.3	4.3	3.5	0.6	1.1	0.3	0.0	0.2	0.6	0.9	3.9	0.1	1.2	3.3	1.1	0.7	0.4	0.0	9.3	11.2	1.4	0.4	4.0	0.1	0.6	0.0	1.9	0.5	1.7	0.7	1.7	1.6	0.4	0.4	1.9	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	17.1	22.8	13.1	7.6	7.1	8.1	7.3	5.4	8.5	9.6	0.7	0.0	0.0	6.5	0.2	0.0	0.3	0.0	1.2	3.1	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.2	1.6	0.4	0.0	0.0	15.5	0.0	0.1	0.8	0.0	0.2	0.0	1.6	0.7	0.0	0.1	3.3	15.1	0.6	0.0	0.0	0.0	0.0	1.2	0.2	0.0	1.0	0.0	4.5	1.0	8.0	4.4	0.1	0.2	2.2	0.3	0.2	0.1	0.1	0.0	0.5	6.6	0.2	0.9	0.1	0.5	0.1	0.0	0.0	0.2	1.4	0.3	0.1
TMEM241	"C18orf45, FLJ44259, MGC11386"	ENSG00000134490	"Transmembrane protein 241"	Q24JQ0	18	23197144-23437961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.8;Oligodendrocyte precursor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029489, HPA059922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Vesicles	"HPA029489: AB_2673067, HPA059922: AB_2684164"	"unprognostic (1.44e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.15e-4)"	"unprognostic (7.07e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.53e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.93e-1)"	"prognostic unfavorable (5.80e-4)"	2.1	0.6	0.7	1.8	0.9	1.1	2.3	0.0	1.7	1.8	0.7	1.7	1.5	2.0	1.6	1.7	1.7	1.6	1.5	1.5	0.2	1.1	1.7	1.4	1.4	0.1	0.1	1.6	1.3	2.4	1.1	2.3	0.0	0.9	2.2	0.3	1.2	0.9	1.0	0.8	1.1	2.9	0.0	1.5	1.4	0.6	0.2	1.0	2.2	0.9	1.5	1.6	1.0	1.1	3.2	4.5	1.2	4.1	5.5	5.3	3.5	1.6	1.9	1.9	3.8	1.3	7.6	13.1	3.4	2.7	6.6	6.0	2.9	7.8	5.3	1.4	1.5	2.4	4.5	3.7	3.3	2.7	2.1	5.3	6.5	6.3	6.6	4.1	6.6	6.3	5.5	4.1	5.3	4.6	2.6	0.5	1.8	10.6	2.9	1.9	5.8	11.2	2.6	1.9	4.6	4.3	7.1	3.2	4.2	4.3	4.0	0.8	3.0	10.3	2.4	3.6	3.9	8.4	8.1	5.3	5.1	8.4	7.2	1.2	0.5	0.0	0.9	2.2	1.3	1.3	0.2	0.9	2.0	2.2	0.8	1.2	0.0	6.0	0.8	0.7	1.2	1.1	0.7	0.9	0.0	1.7	1.5	0.2	0.1	0.1	0.0	0.0	0.2	1.1	3.7	0.0	6.9	4.9	3.5	2.8	3.3	3.9	4.0	1.0	16.1	7.9	1.4	1.5	5.2	3.7	4.2	8.3	4.7	1.8	0.0	2.3	0.0	2.4	4.6	2.5	1.2	3.8	70.8	2.2	8.7	3.9	7.1	3.2	2.5	4.2	3.3	3.8	3.1	10.1	16.0	4.0	6.1	0.6	2.9	0.3	1.8	2.4	1.8	11.2	1.4	1.0	5.2	21.6	9.9	3.0	3.1	1.2	5.7	4.6	2.0	3.3	8.3	1.3	0.0	4.2	3.0	1.4	5.5	6.2	4.4	4.7	2.1	4.2	2.3	2.9
TMEM242	"BM033, C6orf35"	ENSG00000215712	"Transmembrane protein 242"	Q9NWH2	6	157289025-157323601	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025764	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025764: AB_1845742"	"unprognostic (5.42e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	6.7	9.2	9.2	5.0	9.9	11.0	6.4	9.6	10.6	7.5	8.4	7.3	5.9	7.6	8.0	6.0	5.8	5.0	14.1	10.0	9.1	8.2	10.2	5.4	5.4	8.8	8.4	6.5	5.5	10.7	6.2	6.1	9.0	6.5	6.2	9.5	6.8	5.4	12.1	6.1	5.7	7.9	8.3	5.2	6.5	4.7	9.4	6.0	7.4	11.9	5.8	7.2	6.9	9.3	5.1	4.0	8.3	8.8	15.4	10.0	6.2	9.7	9.1	9.7	10.7	5.3	4.9	7.7	12.5	10.6	13.3	9.0	8.7	8.7	9.9	11.1	14.3	10.9	9.1	10.8	16.0	11.3	8.3	10.2	9.3	6.9	14.1	13.4	11.8	10.3	17.1	10.1	8.7	5.2	6.6	14.9	5.6	3.2	7.8	3.8	5.4	11.1	13.9	4.5	10.9	5.7	8.7	5.8	11.8	7.6	5.9	11.9	9.9	6.7	7.6	14.5	13.0	9.7	10.5	7.3	13.7	13.0	11.2	15.0	19.5	12.4	13.9	16.8	13.4	18.5	14.0	13.9	18.6	19.5	12.1	13.8	3.0	17.1	11.6	29.8	16.7	12.1	9.2	9.9	9.6	10.6	10.0	9.1	8.8	8.4	9.0	8.3	9.4	9.3	28.8	12.8	10.0	7.5	21.6	27.5	18.8	62.2	25.6	25.1	20.3	25.4	51.8	20.0	27.1	22.0	4.2	51.2	28.0	19.6	33.2	49.1	11.7	25.8	32.8	28.0	9.6	40.0	23.0	39.1	53.2	27.5	13.3	28.6	15.8	16.9	25.4	28.5	36.5	38.7	28.3	21.8	32.6	17.3	26.7	6.8	21.1	17.7	42.7	14.0	21.7	26.9	27.8	15.1	22.0	39.6	26.9	26.7	23.7	17.9	32.0	38.2	29.7	30.5	59.2	22.8	36.0	34.7	37.1	24.4	24.3	41.6	24.8	24.6	24.6	16.8
TMEM243	"C7orf23, MGC4175, MM-TRAG"	ENSG00000135185	"Transmembrane protein 243"	Q9BU79	7	87196160-87220587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 150.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014918	Uncertain					NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA014918: AB_2067447"	"unprognostic (5.14e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.32e-2)"	"prognostic favorable (9.13e-4)"	28.6	16.4	16.3	31.0	17.0	28.5	26.7	16.8	20.1	31.9	20.2	19.3	24.8	21.9	38.7	18.2	27.9	22.6	16.2	16.2	16.5	36.6	8.6	52.6	68.1	16.9	16.8	35.4	35.1	20.3	22.4	32.6	16.7	24.9	17.3	5.8	32.0	24.1	5.2	21.0	38.8	16.0	17.8	44.2	27.4	10.9	17.3	27.4	69.8	8.1	80.3	23.0	27.1	18.1	35.7	21.1	20.7	25.8	48.5	54.0	49.7	28.5	42.9	20.9	38.2	29.7	42.1	76.1	61.1	28.7	37.9	33.4	19.8	28.6	27.7	32.5	52.7	1.2	38.5	63.2	38.0	27.7	5.7	36.0	28.3	16.1	32.2	40.0	31.6	39.3	3.6	39.8	28.7	58.7	34.9	4.5	23.4	4.1	28.9	68.0	62.0	105.1	61.0	27.3	22.7	20.4	21.2	43.4	33.0	35.7	16.2	4.9	17.0	35.2	30.9	90.2	25.1	56.1	52.2	150.0	32.2	25.3	21.0	53.3	34.8	23.9	45.3	38.3	65.6	181.9	81.6	57.4	61.5	170.8	135.6	95.5	15.7	67.7	25.6	129.4	79.7	38.8	16.3	17.0	16.8	20.1	16.2	16.5	16.9	16.8	16.7	17.8	17.3	18.1	45.0	25.6	109.4	6.5	192.9	42.7	44.0	55.7	31.9	6.1	40.0	42.4	1.0	34.3	32.9	22.0	39.6	111.8	102.2	8.1	52.8	26.2	139.6	41.6	21.3	41.6	7.3	13.9	14.8	42.5	43.8	44.7	21.9	18.9	2.5	25.6	32.9	3.4	48.9	11.8	13.9	23.5	14.2	66.5	62.4	23.0	83.0	45.6	51.6	22.5	43.7	8.8	50.4	6.6	6.1	24.3	24.5	59.0	144.9	51.4	34.6	70.0	34.6	12.2	46.0	24.6	19.8	16.8	43.2	23.6	38.1	33.5	85.1	29.3	39.7	43.7
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015135-109119947	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	29.2	47.6	18.1	12.4	19.4	7.3	20.2	16.8	19.4	21.0	32.6	22.9	12.6	27.3	26.1	23.1	29.2	19.2	43.1	19.6	21.4	45.9	25.2	28.7	15.1	17.3	19.6	45.3	24.6	65.1	11.3	29.1	17.8	25.5	16.9	27.7	26.2	33.9	35.4	14.2	15.9	34.2	20.6	17.9	17.8	16.8	22.0	17.0	74.2	39.2	11.6	18.9	11.9	18.4	32.3	42.2	30.5	10.3	69.9	39.9	67.0	45.4	35.0	47.9	37.6	56.9	62.9	28.9	45.3	34.7	46.4	49.5	39.1	29.2	56.2	37.8	16.8	36.0	32.2	33.7	30.5	27.5	27.2	42.9	29.2	46.7	42.8	51.5	40.7	31.5	24.4	31.2	55.1	21.2	36.8	12.6	33.9	43.2	37.5	20.8	60.3	18.0	50.8	31.0	16.8	16.4	30.0	29.6	30.2	44.9	39.6	15.4	44.9	37.0	27.7	34.9	52.4	20.6	56.9	9.2	51.5	14.5	54.9	4.4	1.6	1.5	2.4	1.1	2.9	1.5	4.0	3.4	1.6	2.1	5.2	3.6	0.6	3.3	2.4	2.2	4.3	1.8	18.1	19.4	16.8	19.4	19.6	21.4	17.3	19.6	17.8	20.6	22.0	18.4	55.0	115.4	93.1	36.6	22.4	25.2	18.8	27.4	27.3	43.8	34.4	23.0	135.6	74.4	33.8	86.5	106.3	50.7	20.1	27.0	3.9	22.7	6.7	31.6	24.8	51.8	31.2	70.5	71.4	31.1	17.7	31.3	25.5	56.4	31.6	62.8	74.3	98.3	18.0	63.9	62.0	31.1	10.2	28.4	14.3	7.8	41.0	18.9	23.2	46.9	18.3	52.6	16.5	60.8	75.8	30.0	35.6	51.1	19.7	23.1	55.3	33.7	45.6	32.4	46.0	40.7	37.9	27.4	43.8	21.0	28.4	15.1	28.2	81.4	35.6	21.7
TMEM247		ENSG00000284701	"Transmembrane protein 247"	A6NEH6	2	46479565-46484425	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 443.1;Late spermatids: 400.3"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"U-266/84: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079482	Enhanced					NA	NA					"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA079482: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	443.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	400.3	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TMEM248	"C7orf42, FLJ10099, FLJ13090"	ENSG00000106609	"Transmembrane protein 248"	Q9NWD8	7	66921225-66958551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016495	Uncertain		Approved	Vesicles		NA	NA		1600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA016495: AB_1848643"	"unprognostic (6.74e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (6.67e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.57e-2)"	31.8	39.7	29.2	27.5	30.8	17.8	34.8	25.3	29.0	46.6	57.5	40.8	42.4	44.3	40.6	26.6	45.0	38.6	32.4	32.2	36.1	36.3	49.4	38.7	36.5	27.3	31.0	50.0	40.3	50.0	31.7	34.5	31.0	43.1	41.1	39.0	39.6	40.9	23.1	29.5	37.4	39.2	26.3	34.2	43.6	32.6	40.1	29.5	46.1	21.4	35.0	34.0	32.4	28.0	46.4	53.3	44.2	63.4	98.2	75.0	38.7	55.7	95.1	51.8	55.9	38.9	59.2	46.7	66.3	75.5	70.8	40.8	38.3	45.9	64.0	43.1	28.2	34.2	36.9	45.4	63.5	57.6	45.5	68.0	52.4	43.6	36.1	75.4	68.5	36.1	66.6	30.6	83.4	28.1	54.3	70.5	65.9	47.5	36.1	39.3	51.4	79.3	70.3	35.1	30.7	65.6	49.1	89.0	50.6	65.6	44.8	52.1	63.9	72.4	35.4	48.0	61.9	37.2	45.4	52.1	60.6	62.9	70.5	2.3	4.0	7.7	6.0	4.3	7.2	8.3	6.5	6.4	3.2	8.1	6.3	6.8	5.8	7.3	2.7	8.3	4.7	1.9	29.2	30.8	25.3	29.0	32.2	36.1	27.3	31.0	31.0	26.3	40.1	28.0	55.1	51.3	42.7	14.7	66.2	64.5	53.5	23.6	46.7	18.5	60.6	44.2	25.0	51.5	25.2	53.3	6.2	48.3	75.2	100.8	11.7	37.0	106.2	37.8	34.5	51.7	27.6	45.9	25.8	47.2	81.2	60.9	55.5	35.0	28.5	44.8	58.2	109.9	52.7	18.5	26.4	82.6	16.2	65.7	76.5	172.3	63.6	53.0	49.8	20.6	46.2	96.7	62.8	24.1	27.7	60.2	62.3	65.8	76.5	108.8	64.4	34.3	36.9	12.7	32.9	40.3	47.7	111.5	57.9	42.2	73.9	88.1	64.4	46.4	60.3	98.7
TMEM249	C8orfK29	ENSG00000261587	"Transmembrane protein 249"	Q2WGJ8	8	144352219-144354914	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 27.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 32.4;Late spermatids: 30.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078901	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA078901: "	"unprognostic (2.23e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.13e-7)"	"unprognostic (6.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.46e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	27.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.2	0.0	0.0	0.2	0.3	0.4	0.0	0.1	0.4	0.0	0.2	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.4	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	32.4	0.1	0.2	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	3.3	1.6	0.3	0.0	0.0	0.0	30.4	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.1	0.0	0.4	0.0
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	6.9	25.3	35.0	3.8	36.0	2.2	14.6	33.9	44.3	14.9	32.2	16.0	46.0	15.3	25.7	11.1	13.7	8.9	8.9	37.5	36.7	18.6	23.1	9.9	4.8	32.1	30.3	23.4	17.6	23.3	29.5	6.0	32.0	15.7	3.7	22.3	21.0	18.3	18.5	8.7	35.2	10.8	31.5	5.3	13.3	6.5	35.1	5.1	15.9	9.9	5.3	14.4	11.6	35.1	3.4	0.7	5.8	9.5	6.0	0.9	5.6	5.2	9.9	4.9	9.8	27.1	18.8	0.3	20.1	5.3	10.9	14.8	0.0	18.3	4.4	11.9	11.1	0.5	5.4	6.0	16.0	0.3	0.5	7.3	10.9	5.3	0.9	35.9	7.2	13.7	2.6	11.7	4.9	4.1	6.0	0.5	4.9	0.1	12.8	8.1	4.2	12.3	25.3	0.3	17.0	11.5	5.1	33.7	0.1	8.7	43.8	0.6	2.5	2.1	10.6	0.4	1.6	11.7	8.3	3.1	0.4	0.2	0.2	0.7	0.2	0.2	5.1	0.2	7.1	4.0	7.3	2.9	0.5	2.6	10.0	5.4	0.4	7.4	0.2	3.4	6.0	3.5	35.0	36.0	33.9	44.3	37.5	36.7	32.1	30.3	32.0	31.5	35.1	35.1	5.1	6.4	3.9	11.1	6.2	5.7	10.7	14.7	13.1	27.7	27.7	30.6	6.1	14.3	9.3	16.5	29.2	37.1	4.8	0.9	11.7	16.6	2.8	4.1	5.0	6.4	11.4	5.2	20.1	6.4	16.9	8.7	2.6	5.5	8.9	18.0	3.6	9.6	2.9	11.8	22.0	7.8	10.2	0.0	1.9	5.5	23.3	1.1	7.2	2.8	3.4	28.8	5.2	8.5	6.5	5.0	5.5	23.3	5.5	5.5	149.1	25.6	7.4	41.1	0.0	12.1	7.5	3.9	5.2	4.0	3.7	16.3	4.7	15.3	15.0	5.7
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118875	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066070	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA066070: AB_2685608"	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	14.9	14.0	18.6	11.6	18.6	4.3	13.5	14.1	20.2	12.8	10.0	20.0	16.7	14.3	7.3	29.1	12.2	6.9	17.4	19.5	12.0	16.3	21.7	13.1	11.4	15.6	13.8	13.2	13.2	8.2	11.9	10.4	16.4	14.7	8.0	2.9	14.0	8.5	28.5	20.8	17.1	7.7	13.3	16.8	15.6	13.0	16.7	8.7	11.0	10.4	8.9	19.5	15.0	16.0	24.9	46.2	17.7	26.5	24.7	22.4	54.9	29.2	20.7	17.3	12.3	26.4	35.5	18.3	33.3	31.5	27.6	62.2	12.6	20.6	5.4	78.8	24.1	15.4	48.3	18.7	34.2	28.2	19.2	20.2	38.8	18.8	19.6	22.3	27.9	18.0	35.1	18.9	15.3	57.3	34.6	22.7	39.2	43.4	49.6	14.0	24.5	30.5	19.0	17.9	30.4	23.1	31.5	21.6	26.4	10.4	19.7	42.1	31.6	30.2	13.3	39.8	32.9	11.0	11.3	10.9	30.4	19.9	29.0	4.3	2.9	1.8	6.2	4.2	4.5	1.8	4.7	5.2	3.0	1.3	2.2	4.1	3.4	3.5	4.2	1.9	2.6	2.1	18.6	18.6	14.1	20.2	19.5	12.0	15.6	13.8	16.4	13.3	16.7	16.0	11.9	6.4	7.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	12.9	11.9	0.0	0.0	1.3	14.7	0.0	17.1	15.2	0.0	3.9	13.1	0.0	9.8	12.6	6.0	0.0	0.0	0.0	10.6	21.3	5.1	0.0	7.0	2.5	14.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	1.3	0.0	0.0	13.2	1.5	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	7.8	5.5	11.5	0.0	0.0
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93188463	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 113.5;Hofbauer cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Golgi apparatus"	"HPA048559: AB_2680441"	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	16.6	22.9	7.3	6.4	7.8	2.7	16.9	7.9	10.0	15.5	8.2	22.9	10.3	14.2	16.5	13.1	14.7	6.7	25.6	7.6	7.6	33.2	17.2	17.1	8.0	7.7	7.8	14.2	21.2	10.3	19.8	6.9	7.8	25.7	12.5	20.7	19.6	9.2	30.6	13.7	18.1	6.8	7.4	15.9	21.8	8.4	8.1	8.6	17.6	12.4	6.9	17.2	12.8	9.0	11.0	12.1	15.3	16.1	17.2	7.3	9.4	7.9	8.2	12.7	16.2	7.8	11.1	12.1	12.9	7.9	15.9	15.9	17.8	12.6	17.7	9.3	13.4	10.9	8.8	18.3	15.2	16.0	14.7	9.3	14.6	10.0	16.2	6.8	12.2	13.5	9.3	12.0	11.6	52.5	10.2	12.8	8.3	28.0	11.6	4.7	16.0	11.3	16.6	23.6	12.9	13.4	11.7	6.0	36.9	12.4	17.7	11.4	5.0	6.1	10.8	14.6	9.4	9.3	16.0	11.8	11.4	6.1	9.1	6.8	9.7	13.6	3.9	9.4	2.9	4.7	4.6	4.4	8.0	5.5	5.2	5.9	10.5	5.3	13.0	7.3	4.1	4.2	7.3	7.8	7.9	10.0	7.6	7.6	7.7	7.8	7.8	7.4	8.1	9.0	13.4	3.2	14.4	5.2	22.4	23.2	37.9	33.6	13.1	14.8	41.1	39.1	22.5	32.9	22.0	31.3	27.1	36.6	16.5	44.8	113.5	30.3	1.8	33.1	16.3	11.9	15.0	11.3	5.9	26.6	21.1	16.6	20.9	35.7	17.2	15.2	8.9	19.2	110.1	13.5	7.8	36.1	26.4	28.4	20.0	2.3	11.8	39.6	32.0	2.8	16.2	34.8	12.3	5.0	13.8	17.7	23.8	10.9	13.1	43.3	31.7	69.6	17.2	30.6	39.5	13.9	23.2	4.5	17.8	18.1	31.1	27.4	16.1	17.6	30.9	36.4
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540883	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 22.0;kidney: 35.7"	"Group enriched"	"Detected in some"	5	"Proximal enterocytes: 21.6;Proximal tubular cells: 20.6"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Immune cell enriched"	"Detected in single"	8	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.2;RPTEC TERT1: 2.2;SK-BR-3: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079457	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA079457: "	"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	1.1	2.9	0.1	1.1	0.0	0.0	0.6	1.2	0.0	1.5	0.0	8.4	1.6	5.5	0.0	6.0	3.3	1.3	4.5	0.0	0.0	35.7	1.6	0.3	0.3	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.1	2.8	0.2	1.3	0.2	0.0	1.3	0.5	22.0	0.0	0.1	0.5	2.0	0.1	0.4	0.0	0.4	0.2	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0
TMEM253	"C14orf176, C14orf95, NCRNA00220"	ENSG00000232070	"Transmembrane protein 253"	P0C7T8	14	21098811-21103724	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 97.3"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 201.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052329, HPA065092"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"			"HPA052329: AB_2681791, HPA065092: AB_2685420"	"unprognostic (7.48e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	0.7	2.4	0.7	0.8	0.8	0.1	0.6	0.9	1.6	0.7	0.8	15.0	97.3	0.4	1.6	1.5	0.5	0.9	0.4	0.8	0.8	1.0	1.1	0.5	0.1	0.8	0.9	0.5	1.3	0.4	0.6	0.4	0.8	0.7	12.8	0.2	6.9	1.3	0.1	1.3	88.8	0.8	0.8	0.5	0.7	0.4	0.8	0.4	5.7	0.0	0.3	0.5	1.0	0.8	0.1	0.4	0.7	0.9	0.7	0.0	1.7	0.4	0.7	0.1	0.4	0.9	0.5	1.5	0.2	0.0	0.0	1.7	0.3	1.4	0.0	0.9	0.1	0.7	1.4	1.0	0.0	0.0	0.0	0.2	1.0	0.2	0.9	0.6	0.1	0.5	0.5	0.0	0.3	0.0	0.0	0.1	0.6	1.6	0.0	0.3	0.2	0.8	0.7	0.6	0.3	0.6	0.5	0.3	0.8	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.9	1.6	0.8	0.8	0.8	0.9	0.8	0.8	0.8	0.8	0.0	0.0	0.0	2.0	0.5	0.8	1.0	1.3	2.2	0.9	0.7	1.3	0.2	1.5	0.3	0.0	0.0	1.1	0.1	45.3	0.0	0.3	0.1	0.0	0.2	0.4	3.6	0.0	0.1	0.0	0.2	0.2	2.0	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.2	11.2	0.0	0.3	0.3	0.0	0.0	0.2	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	8.8	0.0	0.1	0.2	201.8	0.7	0.1	0.5	0.0	0.4	0.4	0.0	0.3	1.6	0.6	1.0	0.1	0.2	23.4	0.8
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	15.2	11.9	7.9	11.1	8.3	9.4	26.5	7.3	8.3	16.0	7.0	22.6	16.3	10.7	62.1	39.5	28.0	14.0	5.7	8.0	7.0	14.8	52.8	9.4	10.4	8.0	8.7	13.0	19.0	16.5	4.4	15.6	8.5	43.1	22.3	11.2	16.6	14.2	4.4	72.3	15.4	10.4	8.3	7.8	15.0	15.5	7.5	15.4	14.8	2.9	14.6	12.4	22.7	9.3	14.4	13.8	20.0	17.2	27.1	29.7	33.4	13.5	9.3	9.0	9.7	10.6	43.5	11.0	22.1	16.9	9.3	15.2	8.9	11.5	10.0	17.5	16.5	3.0	3.8	14.3	11.2	12.8	13.0	20.3	48.6	8.9	7.3	20.6	7.7	9.1	7.9	22.9	9.4	29.8	10.7	9.9	11.0	12.6	43.2	13.2	2.8	9.7	13.5	11.9	8.0	12.1	12.6	31.4	13.3	14.8	45.1	9.1	12.1	7.8	12.8	12.0	8.0	15.8	24.7	0.8	17.8	13.6	6.6	57.3	25.0	13.0	18.1	28.6	22.3	21.3	20.2	18.8	20.7	14.3	33.8	22.6	2.8	17.5	31.5	23.1	27.2	20.5	7.9	8.3	7.3	8.3	8.0	7.0	8.0	8.7	8.5	8.3	7.5	9.3	4.6	9.6	9.6	17.6	7.3	8.2	5.9	9.7	5.2	7.9	22.6	17.5	4.4	12.8	13.7	9.2	16.7	40.9	3.8	9.0	21.5	15.7	10.5	37.6	10.0	5.4	8.4	5.9	17.2	8.7	37.2	7.6	11.2	10.5	5.7	12.9	5.7	33.4	19.4	16.8	16.4	23.7	8.2	10.3	5.8	7.5	9.3	8.5	3.6	4.7	15.2	15.7	12.3	8.5	14.8	10.3	15.3	11.7	5.2	15.6	19.6	23.1	40.2	13.3	13.1	2.6	7.1	36.8	8.7	20.9	24.0	22.7	6.9	11.2	18.1	8.4
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;ovary: 19.6"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	4.7	3.3	7.4	1.8	5.8	0.7	3.2	4.8	9.2	11.9	1.7	2.6	0.7	1.9	1.6	2.8	3.8	1.1	1.3	3.8	27.4	1.4	0.6	3.0	3.6	22.7	48.7	19.6	0.4	1.4	3.8	0.2	33.0	1.4	2.3	1.5	1.2	1.8	1.4	2.6	2.3	0.9	19.9	1.7	1.8	0.2	36.8	8.1	0.4	2.7	3.8	1.9	8.5	11.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.2	0.0	0.1	0.3	0.0	2.9	0.0	1.9	0.7	0.7	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.3	0.4	0.0	0.0	0.1	9.5	0.0	0.0	0.1	0.0	17.1	0.0	0.0	5.1	0.1	0.5	0.0	27.7	0.3	0.0	0.3	0.0	0.0	11.8	0.0	5.1	0.0	5.2	3.7	29.7	0.0	0.0	0.0	0.3	0.0	2.8	0.1	1.4	0.2	0.2	1.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	7.4	5.8	4.8	9.2	3.8	27.4	22.7	48.7	33.0	19.9	36.8	11.5	0.1	3.2	0.0	1.6	0.0	0.4	0.1	0.1	0.6	1.9	0.2	1.3	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	4.4	0.0	0.4	0.0	0.3	0.4	0.0	1.3	0.0	4.3	0.0	0.0	1.0	0.7	1.6	0.6	1.6	5.4	1.9	3.7	0.3	0.0	32.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	14.6	0.6	0.1	0.1	0.0	1.3	0.1	0.4	0.0	0.0	0.0
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TMEM258	"C11orf10, Kud, Kuduk"	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	116.4	158.4	125.5	66.1	128.7	128.4	120.8	130.8	162.2	142.2	123.0	112.4	80.9	116.0	350.1	122.8	123.1	59.3	170.8	122.6	128.7	123.5	160.6	110.0	83.0	130.0	125.6	154.9	300.3	80.5	128.9	80.4	130.3	105.5	107.6	44.0	183.9	88.7	146.7	95.3	99.8	81.5	131.1	124.4	142.8	79.1	126.8	111.7	109.1	120.6	108.9	107.5	111.7	140.1	144.3	254.9	194.9	173.3	329.0	308.4	117.1	113.9	177.1	104.5	124.8	223.5	265.5	103.9	205.9	272.1	196.1	154.8	186.7	222.7	149.1	141.7	168.6	86.8	258.3	347.6	310.7	186.9	96.3	272.5	339.6	137.1	364.8	267.9	210.9	207.4	221.7	394.5	185.4	501.1	131.2	318.8	267.1	315.6	172.9	142.1	144.6	673.0	241.5	243.7	169.3	173.1	103.8	221.7	211.5	179.6	244.5	347.3	108.0	129.2	111.7	166.1	78.3	248.6	201.7	173.6	183.8	112.6	135.7	507.9	225.6	287.6	169.5	200.4	216.5	233.2	198.8	190.1	177.8	187.1	167.1	166.7	182.4	151.7	204.4	496.4	236.8	244.9	125.5	128.7	130.8	162.2	122.6	128.7	130.0	125.6	130.3	131.1	126.8	140.1	211.3	102.5	224.1	6.8	323.6	228.9	220.5	794.5	170.8	41.3	525.1	608.3	491.3	403.2	445.9	318.2	18.8	409.5	279.8	306.2	295.4	534.8	234.4	369.2	304.7	254.8	311.1	197.7	7.4	654.4	667.7	314.8	210.5	305.6	226.7	261.8	335.2	572.9	461.4	37.0	8.2	631.5	441.5	401.7	396.9	142.8	335.5	265.7	569.2	3.7	430.0	418.6	270.8	6.0	25.8	469.4	432.6	214.4	821.3	296.6	392.2	553.8	470.9	73.9	170.9	192.3	248.5	399.4	433.8	297.4	279.0	508.0	245.2	135.3	442.1	274.9
TMEM259	"ASBABP1, C19orf6, MBRL, MGC4022"	ENSG00000182087	"Transmembrane protein 259"	Q4ZIN3	19	1009648-1021179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042669, HPA054801"	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA042669: AB_10794916, HPA054801: AB_2682604"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.12e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (8.92e-6)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.10e-3)"	114.9	119.8	59.6	68.7	62.3	82.4	112.4	59.9	74.5	111.8	71.3	117.4	66.8	108.0	22.3	114.7	110.9	48.0	129.9	57.0	61.3	119.3	162.6	128.5	75.2	72.1	65.6	106.5	127.3	83.2	154.2	50.3	63.7	126.3	33.9	39.1	109.2	45.6	112.7	128.6	135.7	35.2	58.9	191.5	115.5	101.2	66.1	71.9	133.2	48.2	47.8	103.3	113.1	75.5	125.0	78.3	53.6	61.3	64.7	62.2	94.4	101.1	89.5	83.7	89.9	73.2	68.6	84.8	98.5	78.9	39.4	138.9	54.4	102.0	36.9	108.5	88.0	50.4	102.9	81.2	114.6	98.1	122.5	83.7	102.2	67.5	83.6	79.5	73.7	85.6	85.5	168.2	56.8	54.9	106.5	89.9	78.3	63.1	60.2	120.8	40.6	110.1	66.3	115.1	73.7	77.8	64.9	82.2	73.9	43.0	80.9	125.3	87.0	83.0	47.2	118.5	108.2	240.2	95.7	96.2	98.3	79.3	84.6	0.6	1.7	1.0	2.2	1.4	1.6	1.6	1.3	2.2	2.5	1.3	1.3	1.6	1.1	1.2	2.3	2.9	1.4	1.6	59.6	62.3	59.9	74.5	57.0	61.3	72.1	65.6	63.7	58.9	66.1	75.5	73.6	32.1	49.9	64.6	70.1	62.3	54.5	26.0	51.2	118.5	50.3	44.7	14.1	30.0	27.6	66.2	98.0	59.2	90.0	114.1	11.7	28.4	18.3	46.5	56.4	50.4	40.2	21.0	36.3	34.3	51.4	49.6	122.3	63.5	15.2	89.4	40.7	52.0	51.1	104.3	40.8	78.4	18.3	30.0	58.1	11.4	42.6	55.2	44.4	36.5	28.7	65.9	26.8	35.2	58.4	42.9	75.8	34.3	89.1	63.7	56.2	20.7	26.3	170.2	32.9	48.5	51.2	45.4	38.5	53.8	64.9	82.4	69.3	126.4	62.6	66.3
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 39.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 66.7;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	4.6	4.3	4.5	4.0	5.4	2.1	5.5	4.7	4.9	39.8	12.4	5.8	5.2	6.2	7.8	3.4	7.4	5.9	2.5	4.4	4.5	6.8	5.6	4.4	4.7	4.6	4.4	9.3	4.5	7.3	3.7	5.7	4.5	5.2	5.8	6.9	3.8	4.5	2.2	5.6	5.7	3.9	4.4	4.0	5.5	5.2	4.5	5.8	8.4	2.2	3.8	4.7	3.6	7.3	8.0	5.5	4.2	8.9	14.5	11.9	8.2	8.4	9.2	5.4	6.4	2.6	5.8	6.5	8.0	6.2	6.1	9.1	9.7	6.1	8.4	8.1	4.9	4.2	2.7	3.6	10.2	5.9	9.6	14.6	10.7	3.0	10.3	9.8	7.1	4.9	5.2	6.8	7.1	5.3	3.1	2.2	3.9	13.0	8.6	4.3	6.7	2.2	9.0	11.7	8.8	4.3	9.4	6.7	5.5	7.8	8.6	9.0	10.0	10.9	4.1	8.2	4.2	4.1	3.5	3.8	6.8	4.3	5.5	0.0	1.1	1.2	1.3	0.8	0.9	0.7	0.8	0.7	0.9	0.7	1.2	0.8	0.5	2.5	0.7	1.9	1.3	0.8	4.5	5.4	4.7	4.9	4.4	4.5	4.6	4.4	4.5	4.4	4.5	7.3	12.2	19.2	17.2	39.8	13.0	5.4	7.1	5.9	5.7	14.6	8.0	7.7	3.7	2.8	8.5	22.0	4.2	10.2	9.8	9.4	1.9	8.1	88.5	22.8	17.6	8.3	18.0	7.6	66.7	3.8	7.7	10.4	9.2	29.1	12.0	20.0	8.9	13.3	6.5	6.7	62.8	10.0	6.1	12.8	5.0	31.5	15.2	8.7	1.8	39.4	11.1	5.2	14.4	69.9	106.0	5.6	7.6	10.9	9.3	9.3	9.5	4.8	14.2	16.4	0.0	7.0	8.0	9.3	11.0	10.0	5.5	11.1	8.9	14.5	12.1	8.0
TMEM263	"C12orf23, MGC17943"	ENSG00000151135	"Transmembrane protein 263"	Q8WUH6	12	106955719-106978778	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014453, HPA042339"	Uncertain		Approved	Vesicles		NA	NA		14000	"Cluster 40: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA014453: , HPA042339: AB_10795503"	"unprognostic (2.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (7.84e-4)"	"unprognostic (4.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.53e-1)"	20.6	27.1	14.5	20.4	15.6	7.4	22.3	14.2	18.2	41.6	21.8	17.8	17.3	28.3	33.4	9.5	16.2	30.4	28.6	15.5	22.1	29.4	44.6	15.3	21.1	13.2	17.1	29.3	23.4	20.7	37.5	43.2	16.5	28.5	19.2	16.8	21.0	21.6	11.5	8.6	15.3	29.9	13.3	16.4	30.9	19.4	21.4	31.0	33.6	14.2	19.7	22.1	13.9	13.5	32.7	28.2	54.1	37.4	125.8	141.6	23.5	123.1	114.0	59.0	74.6	30.1	14.0	3.2	37.5	174.3	33.3	14.9	34.4	48.6	80.9	61.5	38.0	45.5	41.0	65.0	65.1	2.4	28.3	98.6	23.1	63.9	53.8	137.3	73.4	35.1	22.1	12.1	83.6	26.7	35.4	21.4	17.7	21.1	60.3	77.1	41.3	7.9	60.7	27.3	28.2	38.6	67.3	31.2	51.2	41.9	36.5	13.7	86.7	50.6	30.7	66.9	31.6	50.8	31.5	30.3	39.2	7.7	79.4	11.7	1.4	1.6	15.8	1.6	18.3	15.7	15.2	13.7	4.3	16.8	26.8	24.9	1.0	19.8	0.6	14.8	17.4	13.9	14.5	15.6	14.2	18.2	15.5	22.1	13.2	17.1	16.5	13.3	21.4	13.5	31.6	9.6	23.6	12.1	33.5	0.0	52.0	0.0	53.5	24.4	47.7	25.8	55.4	22.8	11.2	23.9	31.3	40.4	54.3	12.4	92.0	19.2	34.8	19.9	75.7	26.4	28.8	10.9	15.4	33.0	72.6	61.5	50.0	32.4	29.9	33.7	33.2	44.4	13.5	11.8	16.5	65.1	0.0	6.7	0.0	37.2	47.2	10.4	0.0	22.5	9.6	34.1	22.6	24.1	8.4	17.3	13.2	43.6	68.3	48.6	23.0	47.7	12.4	21.0	26.3	39.1	41.7	51.2	22.5	12.7	0.0	36.0	36.3	30.6	16.4	44.2
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.4;skeletal muscle: 5.8;tongue: 2.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.0	0.0	0.1	8.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.5	0.0	0.5	0.1	0.6	0.8	0.0	1.1	0.0	1.2	0.9	0.7	0.1	0.0	1.1	0.0	0.0	5.8	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.4	0.3	0.0	2.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	8.4	1.7	1.2	0.9	0.6	0.8	0.7	0.5	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	7.3	7.7	11.0	6.9	12.7	3.6	7.5	2.9	16.6	6.5	6.4	6.9	3.4	6.8	6.3	4.3	4.7	3.7	3.3	14.4	6.1	3.3	5.3	5.2	9.5	4.4	5.3	8.5	4.7	14.1	4.1	4.8	5.3	12.2	5.4	4.5	8.9	6.5	4.6	4.2	6.3	6.8	5.3	13.3	7.2	3.9	6.5	8.6	6.2	4.3	9.4	6.3	5.1	11.3	4.7	7.1	3.8	8.2	10.1	7.6	2.9	4.3	7.9	6.0	6.1	5.1	2.0	19.5	3.5	4.8	17.0	8.1	7.4	3.7	5.2	9.9	4.6	6.5	5.8	4.0	17.9	13.6	3.0	6.7	6.5	7.8	8.4	7.7	4.1	24.9	12.3	51.5	4.4	13.6	15.4	4.5	9.8	6.0	7.8	17.4	4.5	17.7	3.5	3.4	12.5	8.4	14.4	18.8	41.3	2.4	25.2	12.2	2.5	6.0	6.8	2.3	8.3	27.8	27.5	20.7	3.1	11.4	11.0	0.3	1.3	0.2	0.6	1.0	0.2	1.3	0.7	0.4	0.7	2.2	0.9	0.8	1.0	0.8	1.0	4.7	0.1	0.5	11.0	12.7	2.9	16.6	14.4	6.1	4.4	5.3	5.3	5.3	6.5	11.3	1.7	0.0	10.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	5.2	0.0	0.0	1.3	0.0	0.0	4.7	3.0	0.0	0.0	1.4	0.0	5.0	8.9	0.5	0.0	0.0	0.0	4.6	1.2	1.3	0.0	8.8	0.0	9.6	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	19.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	1.9	4.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.8	1.1	9.7	0.0	0.0
TMEM273	"C10orf128, Em:AC084727.5"	ENSG00000204161	"Transmembrane protein 273"	Q5T292	10	49154725-49188585	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 37.8;dendritic cells: 10.1;Hofbauer cells: 82.9;Macrophages: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 269.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 214.8;HEL: 51.7;K-562: 101.4;U-266/84: 38.3;U-87 MG: 102.2;U-937: 91.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058166	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA058166: AB_2683627"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (9.13e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (2.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.24e-1)"	31.5	3.0	15.1	17.2	22.1	4.0	27.5	23.0	27.1	15.1	13.4	12.8	8.8	13.7	6.1	8.4	12.8	18.3	28.0	15.2	18.2	6.0	9.5	27.1	22.2	25.0	22.8	3.9	4.0	14.4	3.3	10.9	25.0	8.2	14.2	1.1	9.8	7.8	8.5	7.3	24.3	20.9	18.9	29.8	8.9	1.9	20.5	7.8	10.2	16.5	23.4	14.4	12.7	30.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	214.8	0.0	51.7	0.0	0.0	0.0	0.5	21.9	0.0	0.0	0.0	0.0	0.0	1.4	0.2	101.4	6.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.1	0.0	38.3	0.1	102.2	91.6	0.0	24.9	4.2	269.0	22.9	1.4	36.5	35.9	13.8	22.0	19.8	18.5	0.7	6.1	19.4	0.2	0.7	0.6	11.2	11.5	15.1	22.1	23.0	27.1	15.2	18.2	25.0	22.8	25.0	18.9	20.5	30.7	37.8	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.8	0.0	0.8	10.1	0.0	0.0	0.1	0.0	1.1	0.2	9.4	0.0	0.0	0.0	0.0	0.7	0.5	0.0	2.0	0.0	0.0	0.0	0.0	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	5.6	0.0	0.0	0.0
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284948	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	62.9	57.0	60.3	59.1	70.2	53.7	54.0	65.2	67.5	61.3	72.8	64.7	43.9	62.0	50.2	58.1	47.4	60.0	45.3	67.2	73.5	77.3	99.6	91.7	53.5	63.3	64.5	47.6	70.8	96.2	47.6	48.5	64.6	64.7	70.8	57.0	55.2	58.6	29.2	38.3	46.4	79.1	73.5	62.1	59.4	28.8	69.5	47.6	84.5	40.4	60.9	66.4	34.8	82.1	54.2	60.6	91.5	77.6	228.2	212.0	76.3	217.9	171.3	82.3	128.2	56.3	129.1	61.9	148.3	194.8	82.7	62.4	41.5	120.4	211.5	84.9	63.8	60.4	55.1	56.7	129.2	73.7	104.6	197.2	116.5	116.9	63.7	175.2	262.4	59.1	59.4	107.8	158.4	37.2	27.1	54.2	32.7	46.1	46.7	44.4	65.6	78.5	315.3	131.1	64.9	62.9	111.9	52.8	74.9	105.8	58.6	224.8	234.5	103.8	116.9	65.6	153.3	90.3	136.1	27.9	81.7	137.2	165.7	44.5	85.8	59.0	37.1	84.7	44.8	27.1	37.3	36.7	78.6	22.6	34.8	34.5	138.3	42.5	87.5	33.2	53.0	61.5	60.3	70.2	65.2	67.5	67.2	73.5	63.3	64.5	64.6	73.5	69.5	82.1	73.2	163.5	132.5	7.5	38.8	71.2	33.7	67.6	42.1	24.5	53.1	27.6	43.8	40.0	96.1	66.2	45.9	39.6	51.0	67.6	11.7	51.0	11.1	46.7	57.0	68.0	36.2	20.8	15.8	111.2	52.1	65.7	43.3	76.0	39.8	31.4	66.0	79.1	54.3	20.2	14.5	44.3	54.9	89.3	79.1	9.5	45.4	57.8	48.0	10.3	62.4	40.7	35.0	17.1	15.6	101.6	38.5	62.4	55.8	80.9	31.1	33.2	95.2	24.0	32.9	56.1	77.2	45.0	21.2	41.8	78.3	94.4	43.3	62.5	28.8	65.9
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TMEM33	"FLJ10525, Pom33"	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935129-41960803	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	12.4	16.1	8.0	19.4	10.5	14.9	16.0	13.1	11.4	11.4	16.0	18.7	21.1	11.1	25.5	21.2	12.3	17.2	10.5	9.6	12.8	24.2	39.9	15.1	17.0	15.5	13.5	10.5	18.2	30.1	11.0	20.0	14.7	17.2	21.3	13.0	17.9	11.8	8.4	11.9	16.9	11.3	14.1	13.9	19.1	9.9	12.1	14.9	23.8	12.4	20.1	21.8	10.8	18.8	36.9	42.4	36.7	51.3	46.7	31.8	44.9	49.5	53.9	41.5	47.5	52.4	123.4	64.8	74.7	41.5	85.5	57.4	124.4	65.0	56.1	17.1	26.2	80.7	49.7	45.9	54.4	108.7	67.6	33.4	69.0	52.5	78.3	26.5	32.7	37.3	86.8	24.7	57.4	32.6	96.5	67.9	67.2	58.1	50.0	42.7	57.8	51.6	58.2	53.5	40.8	58.4	40.5	38.0	62.4	35.3	42.9	37.4	53.0	48.3	65.0	48.9	89.5	44.5	76.9	77.4	51.7	88.4	71.2	41.2	32.1	21.7	14.9	31.0	17.6	13.0	15.3	14.2	22.9	12.0	13.6	15.0	43.2	16.5	35.2	17.9	19.0	16.4	8.0	10.5	13.1	11.4	9.6	12.8	15.5	13.5	14.7	14.1	12.1	18.8	25.1	60.9	34.3	20.9	25.0	73.3	35.7	42.4	24.5	19.2	36.9	16.4	18.0	27.1	40.5	55.2	16.7	56.3	35.2	58.9	23.5	44.6	2.9	26.9	31.2	25.9	35.0	25.0	33.6	38.1	49.3	30.5	36.2	33.4	38.7	23.1	24.7	84.4	57.3	28.6	32.8	40.4	34.6	67.5	51.0	4.7	20.2	55.7	56.9	11.2	55.9	33.9	16.5	32.6	40.3	54.1	47.4	23.3	32.5	73.7	41.6	41.1	29.7	20.4	26.3	26.5	55.6	31.0	28.7	47.5	66.9	133.1	28.3	39.7	43.0	64.5
TMEM35A	"FLJ14084, NACHO, TMEM35, TUF-1"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078879-101096367	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.9;intestine: 36.8;seminal vesicle: 50.9"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 37.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.5	6.9	20.8	1.3	20.4	0.0	0.8	18.5	28.5	4.6	2.5	36.8	3.4	7.8	3.6	11.2	4.1	3.4	0.5	28.4	71.9	0.5	0.0	2.3	0.1	21.8	21.3	7.9	0.2	12.7	2.2	0.1	36.8	22.3	9.6	10.2	0.5	50.9	0.8	0.6	7.2	10.3	15.6	0.8	5.2	1.4	47.5	0.2	0.8	2.5	0.3	9.7	4.4	13.5	0.0	0.0	5.4	0.0	3.9	10.1	0.0	1.1	0.7	0.4	0.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	3.4	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	3.5	0.0	1.9	0.0	7.5	52.5	0.0	0.0	0.1	6.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	13.2	0.0	0.0	0.0	1.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	20.4	18.5	28.5	28.4	71.9	21.8	21.3	36.8	15.6	47.5	13.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	7.4	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.2	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	37.5	0.0	0.0
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 13.4;Club cells: 6.2;granulocytes: 8.8;Respiratory ciliated cells: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 115.3;CAPAN-2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 5: Breast - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	48.9	36.0	12.6	25.1	12.5	13.6	40.1	12.4	18.5	41.6	16.9	27.4	16.6	36.2	39.0	15.4	41.3	41.0	32.3	12.4	13.1	36.8	40.1	44.2	40.0	13.8	12.8	32.5	29.6	29.8	21.8	63.4	13.7	30.4	26.6	2.2	25.8	34.8	8.6	13.3	27.6	30.1	13.7	32.5	24.4	22.6	13.4	29.7	44.7	20.4	30.9	36.2	33.3	14.4	25.8	19.5	4.2	7.3	115.3	67.1	9.3	27.7	46.2	19.1	25.8	19.4	113.1	12.6	42.1	28.4	30.3	27.2	8.1	23.4	15.0	49.2	12.9	27.2	9.0	23.1	63.2	18.0	27.5	67.7	21.3	17.4	36.6	39.1	38.3	26.8	17.5	36.2	34.2	16.2	13.3	18.6	20.2	0.0	13.6	17.7	37.3	4.0	53.6	24.9	11.1	3.5	42.4	0.6	39.5	21.3	10.3	27.9	39.4	25.6	24.0	22.7	15.8	20.9	12.7	8.9	25.7	29.4	22.2	161.3	101.2	112.4	188.7	118.6	202.9	108.9	205.0	208.3	71.3	89.9	177.7	179.9	31.4	165.4	100.4	159.5	232.4	182.9	12.6	12.5	12.4	18.5	12.4	13.1	13.8	12.8	13.7	13.7	13.4	14.4	0.6	22.4	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	6.2	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.3	0.7	2.1	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.3	8.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	15.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438504	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.1;liver: 100.0;parathyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 57.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0"	"Low region specificity"	"Detected in all"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	53.1	11.1	2.1	6.6	2.0	0.7	25.6	1.8	3.6	21.9	2.5	37.3	53.5	6.4	4.8	6.8	3.4	23.2	4.8	1.5	1.8	101.1	100.0	15.4	10.2	2.5	2.1	12.7	13.3	124.7	1.0	14.9	2.3	3.9	19.0	23.6	7.0	7.6	2.4	10.5	76.1	4.8	2.5	25.7	18.1	5.1	3.7	3.0	31.1	4.2	4.9	7.0	5.6	3.2	0.0	7.3	0.7	0.3	4.3	0.4	1.0	0.2	0.1	0.0	0.1	11.4	6.4	0.0	26.9	3.4	0.6	1.7	3.0	0.0	0.0	0.0	2.9	1.0	4.0	74.7	5.9	0.0	0.1	9.7	0.0	0.0	0.0	0.2	5.9	0.0	0.2	10.9	0.0	0.7	0.0	0.8	5.4	0.1	0.2	0.0	0.1	9.9	60.0	4.9	0.9	0.4	0.3	2.9	0.0	5.0	1.2	1.7	3.8	0.0	10.4	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.1	2.0	1.8	3.6	1.5	1.8	2.5	2.1	2.3	2.5	3.7	3.2	12.2	25.6	9.6	0.0	3.2	2.0	0.3	11.1	0.0	2.4	1.8	1.5	2.1	82.9	13.6	18.4	0.0	64.9	0.1	179.9	50.9	36.1	0.3	7.7	98.8	15.1	9.1	5.3	0.0	52.3	3.8	17.9	11.7	10.3	1.3	16.4	61.8	184.5	64.6	6.7	0.0	22.0	14.2	65.5	5.0	1.9	49.7	19.5	1.8	0.0	0.6	146.8	0.0	0.0	0.6	15.3	68.1	3.8	0.0	0.1	575.7	188.1	7.6	17.4	0.0	0.9	14.8	0.0	0.8	1.0	2.8	104.1	2.4	45.3	23.3	2.3
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661139-16690023	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 581.3;tongue: 260.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Cone photoreceptor cells: 85.5;Excitatory neurons: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 36.9;eosinophil: 12.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.1;OE19: 15.2;U-266/70: 15.6;U-698: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	2.1	4.1	10.5	1.3	15.4	5.8	2.3	13.3	15.9	1.9	52.4	2.9	1.9	1.3	18.0	9.2	3.4	0.9	26.1	10.8	16.1	5.7	7.6	4.5	1.5	10.7	14.3	2.4	2.1	4.4	7.4	0.6	11.2	7.0	2.7	10.0	9.3	5.0	581.3	1.8	2.0	1.4	10.2	1.6	14.7	3.9	16.0	2.9	2.5	260.0	2.3	1.7	1.3	11.3	4.1	0.8	1.0	6.1	3.3	0.3	0.5	1.4	0.8	0.9	1.9	1.3	5.8	16.1	2.4	0.3	5.3	3.3	8.1	1.7	0.9	1.1	2.4	0.0	2.5	1.3	0.9	0.1	0.2	1.4	6.2	1.1	0.7	4.6	0.4	2.9	0.1	1.5	0.6	6.3	0.2	1.7	1.5	15.2	9.4	8.5	1.4	4.4	5.8	3.0	9.9	6.9	4.4	0.5	2.1	0.5	3.0	1.3	0.0	1.2	2.8	3.7	0.7	15.6	12.2	27.1	1.4	9.6	1.2	36.9	4.2	12.3	0.0	1.6	0.0	4.6	0.5	0.1	0.4	6.0	0.1	0.1	2.4	3.5	1.0	0.8	0.8	1.0	10.5	15.4	13.3	15.9	10.8	16.1	10.7	14.3	11.2	10.2	16.0	11.3	2.8	3.2	1.5	18.3	2.3	1.1	3.5	6.7	3.4	30.7	3.9	2.2	25.9	1.5	3.0	0.0	85.5	0.1	0.6	1.7	1.9	3.6	0.1	1.4	0.6	4.5	4.2	0.0	31.0	2.5	0.1	3.0	17.3	1.4	0.0	2.2	9.7	9.2	0.4	13.5	24.0	7.6	14.2	4.3	1.2	0.9	10.5	0.9	3.6	3.7	0.9	13.9	0.0	7.5	3.1	10.8	1.1	22.6	2.9	3.4	0.4	1.2	1.8	9.5	0.0	25.4	3.9	0.9	1.3	3.3	0.3	0.1	0.6	2.1	2.7	1.3
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694541-105776629	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.4;tongue: 62.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 267.0;Late spermatids: 488.4;Spermatocytes: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	7.6	14.0	6.2	7.1	11.6	19.1	4.7	19.5	9.2	7.6	6.3	12.5	6.4	8.3	17.3	7.2	7.2	6.8	30.7	7.4	12.9	29.2	15.3	5.7	8.1	8.3	8.4	18.3	4.9	9.2	5.8	4.6	10.6	8.0	11.8	10.4	4.0	6.8	77.4	6.0	10.7	8.1	5.9	6.3	6.7	28.6	9.0	4.9	28.8	62.1	5.1	5.0	4.0	19.6	16.7	25.6	19.6	30.9	110.5	24.3	40.8	23.4	15.3	22.6	23.3	40.0	22.5	38.4	11.8	8.5	36.4	11.6	28.4	13.5	24.4	29.0	37.8	15.8	16.2	24.7	15.1	48.1	32.7	23.0	11.8	15.5	21.6	7.1	9.1	26.6	84.3	33.2	14.0	46.4	33.6	14.5	15.1	48.7	27.1	22.3	61.4	18.4	10.3	13.2	34.1	8.3	24.2	39.4	17.9	13.0	49.2	33.5	4.9	20.5	20.2	78.9	24.7	40.7	109.8	19.1	38.2	52.2	41.7	15.6	20.2	53.8	13.2	29.6	17.7	56.6	18.3	15.8	23.3	56.6	38.9	24.9	3.1	28.2	26.8	51.7	18.0	24.2	6.2	11.6	19.5	9.2	7.4	12.9	8.3	8.4	10.6	5.9	9.0	19.6	9.2	0.0	2.7	7.5	27.8	30.3	24.9	6.2	15.9	12.9	8.9	3.9	55.5	15.7	8.4	25.8	29.2	12.0	16.4	19.1	66.5	8.9	267.0	2.2	7.2	9.9	31.8	7.2	12.4	6.9	19.0	24.2	9.2	3.0	15.8	11.3	3.6	24.4	30.9	11.8	28.6	12.9	18.3	7.9	33.2	488.4	85.1	21.4	32.0	6.5	18.3	30.6	3.1	65.4	30.6	6.3	12.2	44.8	20.2	55.1	10.9	47.0	7.6	12.3	118.3	18.2	58.1	157.8	47.6	13.0	32.7	21.2	13.8	39.7	19.0	20.2
TMEM39A	"FLJ10902, SUSR2"	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119428949-119468830	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	12.4	10.5	2.2	14.4	4.3	12.9	10.2	4.1	3.5	19.5	10.9	9.0	10.0	13.2	10.9	9.0	11.7	12.6	11.1	2.2	3.1	6.4	13.0	12.4	10.0	4.0	3.4	13.1	28.4	12.8	15.4	18.1	4.3	9.1	9.3	5.0	13.3	14.3	7.2	8.8	8.0	9.7	3.1	9.2	9.8	7.8	4.7	12.1	16.6	11.9	13.6	14.4	10.5	6.2	28.3	15.1	24.1	17.4	56.1	54.2	24.1	26.4	54.3	37.2	50.0	26.1	21.2	12.0	27.4	28.7	37.9	28.7	29.3	12.1	38.0	12.6	11.2	15.5	13.5	25.4	37.9	27.1	23.4	29.7	20.5	25.9	61.5	37.5	23.6	18.5	16.1	35.5	19.6	14.1	13.7	7.0	20.5	29.8	31.5	16.5	11.3	25.7	9.2	10.7	10.7	15.8	26.6	15.2	33.4	17.3	14.8	23.8	18.5	20.2	17.2	13.8	17.3	39.5	12.5	28.5	27.6	18.2	26.8	12.7	10.9	7.3	11.7	5.8	11.9	7.7	7.1	9.6	12.3	9.0	5.6	6.1	3.8	11.9	4.6	17.3	8.9	9.4	2.2	4.3	4.1	3.5	2.2	3.1	4.0	3.4	4.3	3.1	4.7	6.2	8.5	9.6	15.8	9.8	14.3	22.8	16.0	21.8	8.6	4.7	14.6	10.8	10.8	7.2	16.2	7.3	6.2	26.5	24.7	7.4	5.9	11.6	22.8	8.2	26.3	10.8	10.8	9.0	12.4	14.2	57.6	28.9	13.3	17.9	1.3	13.5	7.9	12.0	13.3	1.7	14.0	18.3	6.1	15.0	54.9	6.8	17.1	17.8	10.6	12.2	31.0	3.9	9.2	25.1	21.8	10.2	6.6	13.2	57.8	20.6	8.0	3.0	14.9	6.4	6.6	15.9	25.2	26.1	18.5	9.6	21.7	59.8	17.4	9.4	11.1	20.4
TMEM39B	FLJ10315	ENSG00000121775	"Transmembrane protein 39B"	Q9GZU3	1	32072031-32102866	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040191, HPA040224"	Approved		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA040191: AB_10805706, HPA040224: AB_10795274"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (2.82e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (5.11e-9)"	"unprognostic (2.20e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.10e-1)"	6.3	4.5	0.8	3.7	0.6	3.8	5.5	0.4	2.6	7.9	0.2	5.8	3.3	8.9	5.5	4.5	5.7	4.4	4.3	0.8	1.1	3.9	5.1	4.7	5.8	1.0	0.8	7.2	3.5	3.6	5.1	5.0	1.0	4.6	3.5	0.6	4.4	5.6	5.2	6.2	4.6	5.8	0.6	5.1	4.5	2.5	1.1	8.4	5.0	3.4	5.4	6.4	5.6	0.8	11.4	3.4	4.6	11.7	13.3	7.7	6.3	9.1	15.7	12.2	11.8	6.9	16.6	13.7	15.5	7.7	7.7	13.1	3.4	14.6	4.0	7.0	10.9	8.2	7.9	3.6	14.8	14.1	9.0	10.7	5.9	18.3	12.7	7.0	8.7	7.9	11.5	11.5	10.4	7.5	11.1	3.9	14.6	13.1	8.7	18.0	15.1	17.0	5.8	6.9	10.6	6.3	12.9	7.7	11.4	2.0	6.2	6.7	10.5	20.5	13.3	7.3	12.0	6.1	7.8	13.0	12.4	12.7	15.4	3.7	22.1	8.4	7.8	18.9	10.6	17.7	11.8	9.7	22.8	16.1	15.2	12.6	6.2	7.7	15.0	33.9	13.8	13.9	0.8	0.6	0.4	2.6	0.8	1.1	1.0	0.8	1.0	0.6	1.1	0.8	12.3	9.6	1.1	4.9	15.3	11.1	14.6	16.2	19.4	8.4	9.7	10.3	2.7	10.0	9.2	3.7	18.8	33.4	17.6	4.7	1.9	8.3	6.7	4.9	10.9	22.0	5.4	6.5	15.8	16.0	22.0	14.1	5.1	7.0	15.2	9.8	14.6	7.0	15.5	6.7	12.3	8.2	12.2	13.5	13.9	2.2	12.2	13.7	10.6	8.4	16.9	4.9	4.1	7.1	12.2	6.3	3.4	13.9	11.4	7.1	6.0	4.4	4.6	5.8	6.6	10.8	17.0	17.4	22.2	14.7	10.2	40.8	8.5	12.6	9.6	7.5
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733528-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 219.8;skin 1: 64.7;vagina: 80.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 104.7;Cytotrophoblasts: 128.3;Macrophages: 121.3;Squamous epithelial cells: 116.5;Suprabasal keratinocytes: 201.9;Syncytiotrophoblasts: 656.6;Urothelial cells: 157.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3;urothelial cancer: 12.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 244.9;hTCEpi: 56.1;hTERT-HME1: 68.0;RT4: 36.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044165, HPA073122"	Enhanced		Approved	Cytosol		NA	NA		2500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA044165: AB_10961279, HPA073122: "	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.1	0.1	0.4	0.0	0.4	3.3	3.2	0.5	0.6	42.1	0.3	0.0	0.1	0.1	1.3	219.8	3.1	0.1	4.2	0.5	0.3	0.2	0.3	2.1	0.1	0.4	0.3	0.1	0.1	3.2	0.2	15.9	0.3	3.7	0.0	0.1	27.3	2.5	1.3	64.7	0.0	0.1	0.1	1.8	0.2	0.8	0.4	1.5	0.1	0.6	25.9	15.2	80.1	0.3	26.6	0.1	0.0	0.1	0.0	0.0	22.4	0.2	1.1	1.3	1.4	1.0	4.1	0.1	0.2	0.0	0.6	7.6	0.0	244.9	5.1	0.2	0.0	1.9	0.2	0.8	0.0	0.0	0.0	0.0	56.1	0.0	68.0	0.4	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	0.0	0.2	4.3	0.0	1.6	0.0	1.6	36.0	0.2	0.2	0.1	31.3	0.0	4.6	2.8	0.7	0.0	0.0	1.6	0.0	2.1	0.3	0.1	0.4	0.1	0.0	0.0	1.6	0.9	1.1	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.0	0.0	0.0	0.8	0.0	32.9	0.4	0.4	0.5	0.6	0.5	0.3	0.4	0.3	0.3	0.1	0.4	0.3	0.1	0.0	0.0	0.3	0.3	64.2	104.7	71.7	17.6	0.0	1.5	5.6	4.7	0.0	39.4	1.8	0.0	128.3	0.0	0.1	0.0	0.5	0.8	2.9	0.0	1.8	0.0	0.0	0.3	0.0	14.7	1.8	0.0	0.1	0.0	0.0	2.2	0.7	10.8	0.0	0.3	0.0	12.2	4.8	7.3	2.0	0.3	121.3	10.6	0.0	2.6	0.0	2.1	0.0	0.2	2.2	0.0	0.0	0.0	53.5	0.0	0.0	55.0	0.0	0.0	0.1	3.6	0.7	6.8	116.5	201.9	656.6	1.0	0.2	0.0	157.9
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	9.0	27.2	9.6	5.4	9.3	11.0	10.2	9.7	11.0	10.0	8.9	7.9	26.4	8.7	11.2	23.6	9.2	7.6	9.9	9.0	9.4	14.7	20.5	10.6	7.4	9.4	11.6	14.1	9.7	8.7	5.7	8.4	9.2	10.2	8.9	7.5	12.0	8.3	9.8	19.9	24.1	7.4	9.8	12.5	10.3	9.3	12.1	7.8	7.0	16.4	12.6	10.8	14.6	10.9	43.6	15.4	10.1	12.5	15.6	16.8	29.6	16.3	14.3	20.2	14.6	40.5	16.7	13.4	30.5	15.3	28.5	29.4	28.1	17.5	20.4	22.6	25.8	23.3	8.6	41.2	17.5	25.3	12.5	15.7	25.6	18.3	20.9	12.7	15.6	16.8	42.1	32.4	13.0	16.8	15.6	14.5	16.8	34.1	24.1	15.5	15.6	24.6	17.4	31.4	10.1	13.1	14.1	35.8	25.7	14.4	42.8	19.6	11.4	11.9	15.0	25.2	34.5	47.2	78.0	26.5	18.2	15.1	14.6	14.0	8.2	7.2	16.3	9.4	21.0	17.5	16.7	18.1	9.3	15.6	18.2	19.8	2.8	12.2	12.2	21.7	15.3	9.2	9.6	9.3	9.7	11.0	9.0	9.4	9.4	11.6	9.2	9.8	12.1	10.9	12.1	9.6	30.5	7.2	16.7	53.0	42.8	29.5	50.7	22.4	38.2	20.6	12.6	24.3	24.9	20.2	18.8	27.5	18.3	23.3	7.9	33.4	0.7	17.7	14.5	19.8	18.6	16.4	8.1	56.0	23.5	18.0	36.2	38.0	8.8	50.2	17.2	40.9	19.6	16.8	9.8	28.3	16.2	14.2	17.3	2.8	14.3	12.5	8.8	2.8	65.9	11.4	11.3	20.1	7.6	50.3	17.0	13.5	20.9	64.2	200.8	23.2	9.6	28.6	19.7	16.8	16.5	22.1	14.3	113.0	84.7	46.0	18.5	82.6	45.6	93.4
TMEM41B	KIAA0033	ENSG00000166471	"Transmembrane protein 41B"	Q5BJD5	11	9280654-9314636	"Predicted membrane proteins, Transporters"	"Autophagy, Host-virus interaction, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014946	Uncertain		Approved	Peroxisomes		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Peroxisomes		"HPA014946: AB_2205037"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (6.18e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.18e-2)"	6.0	7.6	9.9	7.2	11.0	11.1	8.8	12.5	15.1	5.3	8.9	11.6	17.6	5.4	9.9	8.0	4.9	7.4	8.8	9.5	11.5	11.6	18.8	14.7	8.9	12.8	12.2	4.7	9.6	10.2	3.0	11.4	12.0	11.7	9.5	8.3	9.7	6.1	5.1	9.7	17.1	3.3	12.8	6.8	12.1	8.1	11.6	9.2	15.7	5.0	7.9	7.8	3.4	15.9	34.1	25.5	17.3	18.4	17.8	25.0	47.6	31.5	24.6	14.3	26.3	17.9	108.8	13.2	26.2	18.8	28.5	42.0	19.8	16.4	18.4	20.9	19.4	12.0	21.3	21.1	24.5	11.5	14.2	20.1	23.5	14.5	17.5	18.0	13.0	16.2	25.5	32.8	29.3	11.2	16.0	12.6	50.1	18.8	17.3	12.1	23.9	18.7	25.6	32.2	5.6	20.7	26.1	23.7	26.4	22.5	20.4	15.8	17.9	16.7	21.1	28.9	17.3	9.3	17.6	22.5	18.4	8.0	14.6	9.9	1.4	5.5	5.5	1.7	6.7	7.0	4.1	6.9	1.7	5.3	8.2	10.4	3.5	9.5	1.7	8.5	4.1	3.4	9.9	11.0	12.5	15.1	9.5	11.5	12.8	12.2	12.0	12.8	11.6	15.9	21.6	48.1	77.1	32.3	27.9	76.0	57.8	48.5	42.7	36.7	36.4	21.0	21.3	34.3	44.3	31.3	66.7	44.6	34.8	58.0	7.9	30.6	1.3	48.5	31.5	20.1	39.8	29.0	47.3	39.4	60.5	29.0	22.4	89.2	17.1	24.8	21.4	55.4	22.7	20.2	52.1	42.3	36.7	18.9	44.6	2.0	18.0	24.7	19.6	26.2	23.4	24.0	22.6	37.2	69.3	57.9	40.3	13.9	26.6	58.4	56.0	17.2	34.2	38.4	19.7	37.9	25.4	50.9	44.6	47.0	63.6	56.1	28.3	31.3	33.8	77.0
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861904-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Nucleoli	"HPA052569: AB_2681871"	"prognostic favorable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	14.8	21.8	15.4	2.2	16.5	2.1	13.6	16.2	18.0	16.9	14.8	11.4	2.4	12.3	11.3	11.4	12.9	3.5	15.1	15.4	16.5	19.7	22.8	11.5	4.7	15.8	16.2	18.5	14.1	7.3	25.8	3.8	16.2	17.5	3.5	4.3	11.7	5.1	20.7	13.2	10.1	3.8	16.4	14.2	13.6	26.4	16.2	9.4	20.2	8.8	4.2	13.6	14.1	17.0	6.0	6.1	1.8	3.5	22.4	17.7	0.2	4.9	7.0	5.9	6.0	1.4	11.9	4.1	9.3	9.8	2.6	4.1	0.4	7.5	6.1	6.3	0.1	2.6	8.1	6.7	23.7	3.0	0.2	18.4	19.3	6.2	13.7	12.7	10.3	10.3	0.1	8.4	9.2	4.8	2.7	5.0	3.3	7.4	2.4	2.1	1.0	1.0	13.3	2.4	1.9	2.3	5.9	2.0	2.5	5.7	4.4	5.2	6.8	5.2	0.6	7.6	5.5	2.8	2.2	1.2	10.4	3.6	2.4	5.8	9.0	4.7	7.6	8.7	8.4	15.4	11.6	7.2	11.5	13.0	15.7	12.7	1.7	10.7	11.9	12.6	10.0	9.7	15.4	16.5	16.2	18.0	15.4	16.5	15.8	16.2	16.2	16.4	16.2	17.0	8.0	22.4	7.7	0.0	14.0	6.1	14.4	31.5	19.4	8.9	17.5	21.2	11.3	18.6	13.0	33.1	2.1	22.5	15.1	4.5	13.7	19.9	70.0	16.0	14.0	10.5	12.0	12.0	0.0	10.2	14.0	18.3	7.1	13.0	3.8	24.7	13.2	18.5	22.7	18.5	0.0	10.2	24.4	10.6	6.0	85.6	27.4	11.7	7.2	0.0	11.2	21.5	10.3	0.0	0.0	14.3	9.3	19.5	6.2	19.1	11.7	21.7	19.9	15.8	6.6	15.4	9.0	33.8	19.9	13.0	8.9	9.7	12.8	29.2	10.7	9.4
TMEM43	"ARVD5, DKFZp586G1919, LUMA, MGC3222"	ENSG00000170876	"Transmembrane protein 43"	Q9BTV4	3	14125015-14143680	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA019198	Approved					NA	NA		34000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA019198: AB_1858118"	"unprognostic (3.65e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.66e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	75.4	34.3	23.1	36.8	23.8	21.0	61.3	23.0	25.3	66.8	23.5	56.7	23.5	89.1	31.0	69.5	63.9	47.1	64.7	23.2	25.0	27.7	19.6	58.1	30.2	27.5	25.1	82.6	27.3	25.6	30.6	57.6	25.9	43.3	29.4	15.9	37.9	65.2	60.8	108.7	40.0	82.5	23.6	31.2	34.8	15.2	25.5	26.0	47.0	45.8	33.7	56.1	66.4	25.2	41.5	45.7	44.1	58.3	173.4	180.6	104.6	80.1	164.8	129.9	93.0	37.5	54.1	19.5	55.7	201.3	64.3	88.3	47.1	70.9	92.9	48.7	38.0	35.3	45.6	53.8	109.3	51.4	40.4	136.0	173.6	107.9	133.0	103.6	94.8	36.2	56.1	47.8	76.6	54.3	23.4	43.2	48.4	62.8	75.3	32.2	46.8	78.2	59.4	70.4	12.9	35.5	101.0	59.3	66.5	37.3	37.5	74.3	86.4	118.7	63.7	120.6	76.0	32.1	54.3	25.1	89.3	68.4	108.7	81.3	51.5	100.3	68.7	45.5	64.0	36.8	66.8	62.7	67.4	31.6	44.5	49.0	157.2	79.9	49.2	42.6	65.7	69.7	23.1	23.8	23.0	25.3	23.2	25.0	27.5	25.1	25.9	23.6	25.5	25.2	44.2	137.8	46.8	17.9	16.8	43.7	32.2	31.0	39.9	6.2	19.9	29.7	13.4	15.7	52.9	18.4	14.6	31.2	43.2	9.3	0.0	34.9	0.6	17.3	58.1	37.4	4.9	22.5	24.1	10.0	65.6	68.0	20.9	34.4	28.4	16.1	23.6	8.9	17.8	6.7	20.6	8.3	8.2	16.1	33.5	3.9	43.2	19.8	30.2	15.9	26.8	8.4	16.5	30.2	23.9	22.4	9.7	70.7	15.6	35.8	8.8	9.0	16.2	8.6	32.9	43.6	39.3	5.6	12.0	44.1	45.5	37.5	32.1	17.6	11.5	30.2
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.2;Hepatic stellate cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.7;NK-cell: 8.1"	"Group enriched"	"Detected in many"	10	"granulocytes: 3.7;NK-cells: 8.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	10.3	2.9	9.8	2.3	11.7	5.2	8.9	7.8	12.4	6.9	7.1	11.0	2.7	5.6	13.7	5.6	5.4	4.5	9.6	10.3	10.1	6.0	3.4	11.3	3.0	9.9	9.7	4.9	3.5	0.9	2.6	7.4	10.0	5.2	7.2	0.6	7.7	2.2	3.2	3.6	6.8	3.2	8.8	9.3	4.9	2.2	10.5	2.0	5.6	2.3	1.6	5.3	5.9	9.2	11.1	9.1	13.4	14.2	4.8	16.2	11.8	8.2	15.3	6.8	10.8	5.0	21.8	2.0	38.9	10.0	20.3	12.6	4.5	6.4	4.6	18.1	6.3	12.4	10.6	3.8	8.7	3.9	18.9	10.0	6.8	15.4	6.8	32.8	28.2	12.1	3.4	0.5	22.9	10.1	5.9	9.9	6.9	11.1	14.8	11.5	8.4	0.3	7.2	6.3	3.7	7.7	6.1	1.9	12.6	5.6	9.0	8.5	33.7	20.8	7.6	6.4	11.2	1.5	1.2	4.0	31.4	15.0	10.4	3.7	0.2	0.2	0.4	0.1	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.2	0.4	8.1	0.3	0.4	0.0	0.0	9.8	11.7	7.8	12.4	10.3	10.1	9.9	9.7	10.0	8.8	10.5	9.2	22.0	0.0	2.3	3.3	2.1	0.5	3.3	4.9	1.8	0.9	2.8	2.3	1.7	1.5	6.0	5.5	2.1	9.5	1.7	31.2	0.0	5.7	0.6	2.3	3.7	23.8	6.0	4.0	12.7	4.9	4.0	6.0	22.4	2.0	17.7	10.6	53.2	0.6	3.5	0.0	5.4	25.2	6.1	1.3	3.4	0.3	3.1	1.5	1.8	12.2	0.1	0.5	2.1	2.5	1.5	14.9	21.0	1.9	1.3	6.0	3.9	0.4	7.5	0.6	6.6	1.8	3.6	0.5	6.5	2.4	0.6	8.8	1.9	6.0	21.0	6.3
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skin 1: 475.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	19.4	18.1	1.4	11.7	3.3	2.0	42.8	1.7	2.5	38.4	2.3	10.3	3.6	18.3	3.2	16.5	20.9	18.9	21.9	1.5	1.8	3.7	99.0	13.1	2.6	1.9	1.9	11.9	23.3	2.7	22.9	40.9	1.8	9.1	6.6	1.7	26.9	6.3	3.2	475.1	6.4	25.4	1.7	5.0	7.0	13.3	1.9	1.6	9.1	2.5	50.7	19.5	79.5	2.1	28.6	2.0	2.7	9.6	406.9	118.3	0.3	66.9	62.0	9.4	84.8	2.5	0.6	0.0	32.6	44.1	24.6	31.9	2.4	13.0	23.4	7.2	8.4	23.9	9.3	8.0	25.7	0.4	1.5	125.4	7.4	17.1	25.4	39.0	3.5	0.0	0.6	3.2	22.6	0.3	0.1	0.7	3.2	0.0	16.8	0.0	23.3	0.4	0.6	1.0	2.9	19.4	16.4	8.5	7.3	18.2	0.8	13.6	9.3	62.9	44.3	0.5	15.2	53.8	32.9	0.1	49.7	1.9	42.6	0.0	0.9	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.6	1.4	3.3	1.7	2.5	1.5	1.8	1.9	1.9	1.8	1.7	1.9	2.1	1.6	60.9	61.4	0.7	3.0	94.6	5.4	425.3	9.6	3.2	19.1	8.9	2.5	1.5	841.5	0.0	0.0	2.6	0.4	0.2	0.0	7.5	207.3	3.0	79.1	8.9	1.2	1.3	0.8	14.9	46.3	56.3	2.0	2.0	65.0	10.7	15.0	137.1	5.8	8.4	2.4	2.0	63.1	6.5	25.4	25.4	16.1	6.6	23.2	13.1	1.1	3.5	0.0	16.1	11.8	6.5	2.6	27.8	26.8	3.1	0.3	0.2	121.0	0.9	6.6	22.8	56.6	1.5	3.3	5.4	254.9	7.5	6.4	26.7	0.1	4.4
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815848-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.5;intestine: 136.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 11.7;T-cells: 3.6"	"Group enriched"	"Detected in some"	5	"OE19: 333.1;RT4: 133.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.7	0.6	1.5	8.3	1.6	1.1	13.2	1.9	1.8	14.9	7.6	95.1	136.4	1.1	13.6	66.5	21.7	24.1	0.1	2.1	2.0	20.6	24.7	6.0	0.9	1.5	2.8	0.2	1.2	12.4	4.2	1.4	1.5	3.6	94.6	0.4	15.4	8.2	0.3	25.4	127.4	2.8	0.9	0.8	24.3	0.3	2.0	0.4	6.5	0.0	15.0	30.8	27.3	1.4	0.1	0.1	0.1	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	39.1	16.8	0.2	7.0	0.0	0.2	22.3	0.0	0.0	0.0	0.1	0.5	0.3	2.1	40.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.2	0.1	0.0	13.3	0.2	1.5	0.2	333.1	49.2	0.3	0.1	2.6	21.0	133.1	4.1	0.6	0.2	10.8	0.1	0.1	37.1	0.2	0.3	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.1	0.3	0.1	1.2	0.5	0.1	0.2	0.1	0.2	0.2	3.0	0.8	0.0	0.4	3.6	0.6	11.7	0.5	0.1	0.3	0.5	0.9	1.5	1.6	1.9	1.8	2.1	2.0	1.5	2.8	1.5	0.9	2.0	1.4	0.1	19.2	12.5	0.3	1.1	3.3	16.4	29.1	0.0	0.1	6.7	2.5	0.8	18.6	68.8	46.0	0.0	3.8	0.0	325.6	13.7	26.9	0.4	27.7	2.9	1.0	55.4	0.0	0.8	8.6	0.8	0.8	17.9	29.5	2.5	0.3	0.4	8.4	0.5	0.0	0.4	49.3	20.3	0.6	0.4	0.3	0.3	2.9	3.6	2.8	0.1	0.1	0.0	0.0	0.3	50.2	221.6	0.0	0.0	23.8	288.7	1.4	133.9	0.2	0.0	0.7	3.6	0.1	0.2	4.4	20.9	0.4	1.8	0.1	122.2	162.0
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627075-34657285	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	40.0	20.8	34.8	8.5	38.3	0.0	18.8	27.1	39.5	46.7	41.6	25.9	8.6	45.7	33.4	34.6	35.1	28.6	36.1	30.8	35.8	27.7	24.8	21.9	6.2	36.5	38.7	21.7	11.3	5.6	6.6	1.2	33.7	32.9	14.9	17.8	29.6	45.6	23.8	6.3	11.5	51.0	37.8	7.5	13.8	4.9	39.5	3.1	20.2	31.1	4.2	36.2	20.1	33.4	0.0	1.7	50.7	21.4	43.8	33.1	0.0	112.6	0.3	21.8	18.7	0.1	0.0	0.0	9.2	348.1	0.0	0.1	14.5	4.0	32.0	0.0	9.9	0.0	13.2	0.0	25.3	0.0	0.0	30.0	0.1	8.9	9.7	38.9	24.8	0.0	0.0	0.0	41.6	0.9	0.0	0.0	6.0	0.6	0.3	0.0	25.3	0.0	83.6	33.0	0.5	0.0	0.1	1.3	0.0	5.4	0.2	0.0	0.9	44.0	4.4	74.4	4.8	0.0	0.0	0.0	18.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	38.3	27.1	39.5	30.8	35.8	36.5	38.7	33.7	37.8	39.5	33.4	110.7	19.2	0.6	85.5	0.1	8.2	15.9	0.9	1.8	8.3	10.8	12.7	27.7	10.0	1.5	16.5	6.2	0.0	0.6	0.0	7.9	0.8	0.4	7.6	4.6	29.8	0.0	0.0	4.3	5.3	0.2	48.3	1.1	6.2	2.5	0.7	46.4	17.5	0.1	30.3	25.6	0.0	0.0	0.8	11.7	3.8	74.3	1.2	65.8	13.1	0.0	148.0	0.0	5.0	2.2	3.0	0.0	92.9	0.1	14.3	0.0	13.4	2.0	7.3	92.1	84.7	67.1	0.3	2.1	1.9	5.3	0.1	0.7	0.8	0.0	12.1
TMEM50B	C21orf4	ENSG00000142188	"Transmembrane protein 50B"	P56557	21	33432485-33479974	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034199, HPA068995"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center"		"CAB034199: AB_2205160, HPA068995: AB_2686066"	"unprognostic (3.22e-1)"	"unprognostic (5.93e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.58e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.32e-3)"	23.4	26.9	17.3	15.5	13.4	9.3	26.4	13.8	20.3	25.3	22.8	20.8	22.4	22.1	55.1	19.9	27.4	29.5	24.7	13.4	15.5	36.0	15.6	24.2	15.4	14.9	20.7	33.6	12.3	35.1	15.0	17.0	16.1	30.8	19.9	28.2	15.8	48.8	19.9	14.5	21.2	22.1	15.0	16.0	23.2	16.0	22.6	13.8	89.3	22.1	15.1	29.7	15.7	14.3	25.7	5.7	10.4	15.5	55.7	40.4	5.4	20.5	27.4	16.8	10.8	6.3	22.9	14.2	21.6	20.3	21.2	10.6	14.2	14.4	12.2	17.3	11.9	28.5	4.0	13.9	25.4	20.7	17.6	20.3	14.0	13.0	10.2	28.4	20.7	15.4	20.1	28.9	21.8	15.9	15.6	21.9	4.6	45.5	5.3	7.9	19.6	25.0	30.4	17.8	8.9	12.1	23.7	29.2	24.5	6.1	34.0	26.7	18.0	11.2	9.1	15.5	8.3	29.4	49.7	18.9	10.5	31.4	19.9	14.7	18.3	43.6	18.1	19.6	18.5	13.4	22.0	20.8	24.8	17.0	24.8	22.7	3.6	19.6	23.3	26.5	35.4	21.2	17.3	13.4	13.8	20.3	13.4	15.5	14.9	20.7	16.1	15.0	22.6	14.3	69.7	28.9	59.4	29.7	44.5	74.1	94.0	55.2	48.9	53.0	61.5	46.0	46.7	55.8	49.3	82.8	108.4	33.9	50.5	46.7	27.4	37.9	58.1	52.6	42.6	60.7	21.6	43.1	23.9	31.0	46.4	62.0	39.8	38.4	29.8	36.1	94.2	55.4	37.9	43.7	46.2	53.1	61.1	33.6	74.1	39.2	71.4	35.4	83.6	33.7	29.7	72.7	50.4	26.2	44.8	28.0	38.2	119.6	57.8	128.9	68.3	56.5	83.6	86.1	98.6	45.0	52.2	190.4	114.0	37.8	93.6	41.3	55.2	22.9	46.5	126.7
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220478	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.0;Exocrine glandular cells: 74.1;Pancreatic endocrine cells: 71.0;Urothelial cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	5.0	20.5	8.1	8.8	8.1	0.8	5.5	18.1	10.6	16.0	7.4	19.8	22.8	5.3	7.3	17.6	11.3	21.2	5.8	8.0	7.4	36.0	4.0	14.2	4.8	9.4	8.6	21.3	45.1	12.9	7.0	10.8	8.5	15.7	10.7	0.4	10.4	15.3	1.7	8.4	20.1	7.9	8.2	7.0	30.2	2.6	8.8	2.2	4.8	3.0	5.0	30.3	18.1	9.1	42.7	22.4	12.5	3.0	2.1	4.5	0.0	4.8	20.1	14.5	19.6	29.6	46.8	0.0	15.4	3.2	20.7	40.2	4.3	15.7	8.2	0.1	11.1	1.0	1.2	29.8	17.8	0.0	39.7	1.4	13.7	18.9	20.6	9.3	13.6	1.7	6.5	0.1	7.5	14.7	0.0	0.1	2.3	33.7	8.4	5.9	8.0	7.4	37.0	43.3	1.9	37.0	4.0	16.2	40.6	7.5	2.3	4.5	9.5	15.0	13.2	6.6	15.2	0.4	0.6	0.1	14.8	0.6	18.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	8.1	8.1	18.1	10.6	8.0	7.4	9.4	8.6	8.5	8.2	8.8	9.1	2.7	0.0	2.6	19.9	1.5	18.2	53.8	9.4	15.4	0.1	9.7	6.7	3.0	34.3	10.7	49.7	0.0	6.3	0.1	20.3	5.9	87.0	0.5	10.0	1.9	10.5	19.2	0.0	0.7	74.1	0.9	10.3	26.0	15.7	0.0	0.3	8.6	0.4	48.1	0.0	8.1	18.7	57.0	31.4	19.2	0.4	2.8	22.1	14.2	23.4	13.1	0.0	0.0	11.6	0.4	71.0	27.2	13.9	0.3	53.7	14.3	12.1	11.7	0.1	32.9	1.6	30.3	0.5	3.6	20.7	21.2	1.4	1.1	1.0	15.4	117.9
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"kidney: 175.8"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 712.1"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 95.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.1	0.6	0.8	0.9	3.4	0.3	0.8	0.9	0.1	0.9	0.1	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.7	0.7	175.8	0.2	0.7	0.2	1.3	0.8	0.0	0.3	0.1	0.0	6.0	1.2	0.1	0.1	0.1	1.9	0.0	0.0	0.4	0.2	0.4	1.0	0.1	0.4	0.3	1.2	0.1	0.2	0.0	0.2	0.2	0.0	1.6	2.3	0.1	0.0	0.1	0.0	0.0	1.1	2.2	0.0	0.1	0.0	95.9	0.1	0.0	0.1	0.7	4.9	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	7.0	8.9	0.0	3.0	5.0	1.4	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	4.7	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.9	0.8	0.9	0.7	0.7	1.3	0.8	1.2	1.0	1.2	1.6	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	12.9	0.0	44.7	0.0	0.1	712.1	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.8	0.0	2.5	3.2	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.2	0.0	0.0	0.8	1.1	0.1	0.3	4.2	1.8	2.8	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	19.4	0.1	0.0	0.0	0.1
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 59.5"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 999.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 99.4"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 99.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	12.8	12.0	5.7	4.4	9.2	6.7	12.1	6.8	8.3	6.8	6.3	14.2	16.4	8.9	6.8	6.0	7.0	6.2	13.9	5.7	7.2	18.3	59.5	10.5	4.0	8.5	8.5	10.6	8.3	6.3	10.1	3.9	8.5	7.2	6.9	7.1	7.2	3.3	7.6	6.6	14.6	4.2	5.8	6.3	10.1	34.9	8.8	3.3	7.9	3.7	2.1	7.5	6.1	15.4	12.9	14.7	13.0	9.6	16.6	12.5	15.6	3.8	11.1	7.2	10.5	4.7	39.9	4.1	11.8	3.6	27.4	11.5	3.6	7.8	3.8	6.5	9.2	4.7	6.0	22.7	16.5	3.7	16.6	14.8	11.9	14.4	3.1	7.9	4.0	9.1	2.0	5.1	4.3	7.7	4.5	11.2	7.6	9.9	8.5	6.8	1.8	40.0	21.6	13.4	9.0	8.7	4.1	15.7	21.3	9.3	4.8	9.9	1.7	5.3	8.8	7.5	4.7	3.7	4.7	2.3	13.6	9.6	6.3	14.1	12.9	6.3	7.3	23.1	6.3	13.9	7.4	6.3	6.6	14.8	3.5	4.5	1.4	7.8	16.2	99.4	8.1	7.6	5.7	9.2	6.8	8.3	5.7	7.2	8.5	8.5	8.5	5.8	8.8	15.4	10.9	6.4	12.0	8.1	3.5	1.7	9.5	24.2	1.8	6.9	9.0	7.6	35.5	10.0	20.4	20.2	4.2	14.5	9.5	53.1	45.0	18.6	188.3	14.0	4.6	8.5	14.4	10.1	2.9	25.7	15.5	6.9	8.2	5.7	6.3	8.6	10.0	93.0	34.3	18.5	3.6	22.6	44.7	12.6	0.7	999.9	9.0	14.0	8.8	1.9	3.8	17.1	5.2	3.0	4.8	17.5	51.3	12.4	2.6	8.9	74.3	45.9	32.8	13.8	26.3	3.7	10.6	15.6	13.2	3.9	2.3	9.3	3.7	8.3	18.0	12.7
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1231.3;Intestinal goblet cells: 357.2;Paneth cells: 800.1;Proximal enterocytes: 418.6;Undifferentiated cells: 355.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 198.9;OE19: 242.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060864, HPA061992"	Approved		Approved	Vesicles		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA060864: , HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	19.2	15.6	68.2	39.9	64.2	0.0	24.6	61.3	98.4	59.0	52.8	268.0	116.0	40.4	26.6	145.3	25.5	62.0	18.7	64.1	70.0	44.3	14.9	26.8	4.6	70.5	68.8	20.3	31.8	49.5	22.6	18.4	64.8	58.2	113.2	4.2	54.0	22.9	6.9	116.0	123.1	21.3	67.8	13.2	108.0	11.9	65.5	2.4	47.8	4.9	13.0	51.1	78.6	66.4	133.3	33.9	0.0	32.0	59.1	35.4	119.9	20.0	29.2	43.1	55.2	84.7	198.9	0.0	57.1	24.8	55.2	80.0	28.6	107.4	12.8	158.3	6.4	0.2	11.3	4.5	42.9	0.4	2.0	30.5	96.2	66.1	18.1	29.1	19.3	13.0	18.7	0.1	22.7	135.6	0.1	2.6	10.3	242.7	60.8	17.7	52.2	0.6	16.2	159.8	1.8	17.1	14.4	82.1	44.0	19.3	89.3	24.2	39.9	42.3	47.5	95.9	40.8	5.2	12.4	15.8	30.1	3.3	61.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.2	64.2	61.3	98.4	64.1	70.0	70.5	68.8	64.8	67.8	65.5	66.4	6.4	19.2	27.6	3.9	6.6	20.4	92.3	36.9	20.5	8.2	82.0	61.0	4.7	97.2	36.9	47.8	4.2	42.8	1.3	1231.3	27.4	150.2	43.4	7.5	16.1	12.3	60.7	0.0	3.3	202.4	149.1	22.9	160.0	14.3	5.7	11.8	18.9	3.7	8.4	0.0	2.9	357.2	12.2	1.0	6.5	32.3	19.9	3.7	14.2	0.0	3.1	33.7	0.0	3.5	2.6	166.3	800.1	24.5	1.6	160.9	418.6	84.9	14.0	10.3	6.6	8.5	20.6	10.9	8.8	65.0	63.6	64.3	3.3	2.4	355.8	193.3
TMEM59	"C1orf8, HSPC001"	ENSG00000116209	"Transmembrane protein 59"	Q9BXS4	1	54026681-54053504	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075447	Approved					NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA075447: "	"unprognostic (2.63e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.49e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.38e-2)"	257.6	359.7	181.9	164.6	220.8	259.7	341.4	240.3	253.8	343.6	379.5	488.3	364.1	208.7	415.5	241.8	403.2	299.3	275.7	178.4	202.0	473.7	505.7	264.0	162.6	240.6	205.0	225.4	586.1	532.5	170.2	325.8	239.1	350.2	485.3	254.2	550.3	279.9	194.5	194.7	369.1	219.8	235.7	188.7	433.0	174.9	204.6	186.9	341.3	247.6	189.2	289.2	202.6	286.8	188.9	122.3	142.8	185.2	844.1	371.1	182.8	347.9	499.1	211.5	276.0	99.1	391.9	96.7	322.6	595.6	257.7	281.1	166.2	237.5	221.9	237.7	177.4	133.5	266.6	166.1	317.8	165.7	268.7	408.3	411.2	207.5	219.2	566.9	246.6	127.8	158.9	326.3	245.1	91.6	97.9	137.3	201.0	528.3	226.3	94.0	251.6	403.2	257.6	248.0	208.2	173.3	381.5	386.0	398.3	266.2	184.9	348.4	259.3	259.8	90.7	193.3	187.8	289.0	338.7	114.5	349.4	275.4	222.3	1183.5	654.6	831.5	439.7	532.9	461.8	449.3	465.9	480.4	520.9	405.2	430.3	426.4	1196.5	430.4	595.9	527.1	576.1	1153.8	181.9	220.8	240.3	253.8	178.4	202.0	240.6	205.0	239.1	235.7	204.6	286.8	355.3	233.9	181.3	49.6	221.3	404.2	637.0	1214.2	237.3	150.2	409.0	325.1	155.1	479.0	991.8	437.7	118.9	477.7	244.5	905.2	160.4	527.8	357.1	348.5	201.9	279.5	408.2	277.0	44.3	352.5	528.7	410.6	226.8	217.2	155.2	89.5	334.4	413.2	320.2	132.9	42.1	672.8	1131.1	302.9	290.3	183.1	432.7	225.4	690.1	27.2	209.3	473.5	190.5	60.3	176.6	329.3	1064.8	354.0	692.8	583.2	1015.8	468.8	977.4	183.6	368.1	198.6	350.4	488.9	210.1	245.5	414.3	687.1	227.2	185.8	534.9	750.4
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 282.6;pituitary gland: 82.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	1.9	16.8	205.4	1.3	228.2	0.0	1.6	90.2	282.6	2.7	29.6	8.4	0.5	2.6	0.4	2.3	1.4	1.9	10.4	238.3	265.6	3.1	0.5	1.3	0.2	133.0	121.9	0.6	3.2	3.9	82.1	0.9	119.1	1.8	0.8	21.2	1.2	1.3	2.9	0.7	3.5	2.2	100.3	0.5	2.6	2.4	177.3	0.1	5.8	0.2	0.1	0.7	2.3	166.3	0.0	1.0	0.3	36.0	42.6	2.0	0.0	3.9	0.7	1.4	0.8	0.1	1.8	0.1	25.3	2.3	3.6	0.5	10.7	0.1	1.2	0.2	1.7	0.0	0.5	27.3	6.5	0.0	0.5	15.8	0.0	0.5	1.2	23.3	0.0	1.5	0.0	0.3	1.0	1.6	0.2	0.0	3.3	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.6	21.0	2.5	0.0	0.0	0.3	0.3	0.0	0.4	0.8	8.4	0.3	2.4	5.3	2.1	0.3	1.4	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	205.4	228.2	90.2	282.6	238.3	265.6	133.0	121.9	119.1	100.3	177.3	166.3	0.2	0.0	0.0	35.9	0.0	0.0	0.2	1.9	0.0	92.2	0.1	2.5	0.5	0.0	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.5	1.7	0.4	11.7	0.4	0.0	0.0	110.7	0.0	0.1	4.1	0.0	0.3	0.0	0.3	0.0	0.0	0.2	50.5	88.0	0.0	0.0	0.0	0.3	1.6	0.3	0.1	0.0	18.7	0.6	67.9	0.0	42.3	18.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	27.5	0.0	1.2	4.1	3.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798434	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved					NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA062625: AB_2684811"	"prognostic favorable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	15.9	23.9	17.5	17.6	17.4	10.6	29.6	18.4	21.4	21.7	19.5	24.9	17.7	16.6	29.7	15.3	18.9	18.6	17.1	17.4	19.3	30.4	35.5	18.9	29.2	18.0	17.5	23.3	18.2	39.8	17.5	23.5	18.2	17.4	24.3	14.1	21.2	19.9	22.9	16.5	17.0	19.6	18.9	20.4	16.4	24.1	17.8	20.4	25.8	20.3	27.7	16.9	13.1	19.1	45.7	30.3	46.2	54.4	61.6	54.5	21.2	41.8	79.9	44.2	69.9	28.4	56.8	35.1	10.0	39.4	150.6	46.8	44.0	24.6	49.7	27.5	41.9	19.0	26.9	39.9	43.4	26.9	33.9	39.9	35.1	32.8	39.6	42.8	31.9	32.0	45.7	68.2	70.4	49.3	20.4	68.7	32.3	55.3	39.4	24.1	36.6	50.7	52.9	33.9	23.2	37.4	31.4	43.7	66.0	48.7	52.8	49.0	21.2	55.6	38.7	49.2	31.4	27.6	46.6	51.1	42.3	55.8	50.2	208.6	51.3	100.2	29.2	58.7	32.4	88.9	51.0	36.9	40.3	72.5	42.9	36.6	52.7	32.3	54.7	52.6	79.4	41.2	17.5	17.4	18.4	21.4	17.4	19.3	18.0	17.5	18.2	18.9	17.8	19.1	16.5	9.6	11.5	2.9	33.5	30.0	34.6	61.7	25.6	7.6	37.5	42.4	8.0	20.0	29.0	44.1	8.4	56.4	17.6	22.0	52.8	28.4	9.4	17.7	13.7	20.1	9.1	14.5	6.1	29.8	40.2	26.9	11.7	14.5	24.7	21.1	24.7	26.3	70.8	13.5	6.5	30.6	61.1	43.5	38.9	10.9	45.7	39.1	28.4	7.5	42.6	21.5	21.6	3.0	7.9	27.6	31.4	35.3	15.4	35.4	30.3	50.5	31.4	12.4	52.6	12.6	50.5	49.8	40.3	31.0	33.4	43.9	20.8	16.4	23.6	39.3
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980628-54992288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 23.7;parathyroid gland: 13.6;pituitary gland: 47.6;salivary gland: 19.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Enteroendocrine cells: 48.4;Intestinal goblet cells: 64.4;Ionocytes: 248.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 20.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA030614	Uncertain					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favorable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.4	6.1	0.7	0.3	0.8	0.0	3.1	3.4	0.7	0.7	1.3	5.8	1.9	0.1	0.1	3.2	2.0	0.3	0.0	0.6	1.8	23.7	0.1	1.0	0.0	3.2	1.2	0.1	3.6	13.6	47.6	0.1	3.2	2.9	1.8	0.2	19.5	4.8	0.2	3.2	4.3	1.0	0.8	0.3	3.6	0.4	1.0	0.3	0.5	0.1	0.0	2.1	1.1	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	20.5	2.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	3.4	0.7	0.6	1.8	3.2	1.2	3.2	0.8	1.0	0.4	0.1	0.0	3.1	0.0	0.4	0.9	6.7	8.2	1.8	2.6	10.5	11.6	0.0	0.0	5.7	7.3	2.1	0.1	0.0	4.7	49.0	4.7	0.1	5.5	1.1	0.2	48.4	0.0	0.4	3.4	0.2	0.3	0.0	11.4	0.0	0.1	0.0	0.0	0.1	0.0	0.3	64.4	248.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.5	0.1	3.7	7.4	0.7	0.0	3.5	1.3	0.2	10.5	0.9	0.0	1.2	0.8	0.3	1.6	5.3	2.4	0.3	0.1	0.1	2.7	4.1
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 61.0;U-266/84: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	7.1	4.6	4.8	6.0	5.0	9.0	22.9	8.2	6.7	8.1	3.6	13.1	13.1	5.4	12.3	6.2	7.5	7.9	5.1	5.3	4.8	7.6	10.3	8.8	7.2	4.5	4.5	3.2	8.1	13.7	4.6	10.3	5.0	6.1	14.4	8.9	13.6	7.1	9.4	5.2	11.7	6.5	5.0	6.1	10.2	2.0	5.4	4.0	8.5	6.6	8.0	7.6	5.4	5.6	14.9	7.9	3.5	6.8	4.3	5.5	36.4	13.9	17.6	24.1	33.3	12.5	28.5	15.0	7.9	13.2	21.7	27.6	14.8	10.9	8.7	17.7	6.8	12.2	15.4	9.5	9.4	12.7	10.5	3.9	13.0	10.6	7.4	6.8	13.6	3.7	10.9	12.7	2.8	3.5	0.0	3.0	1.2	61.0	3.2	7.5	3.7	7.9	12.9	18.6	22.2	9.6	10.9	27.2	6.7	3.9	14.6	12.9	8.0	11.9	4.9	8.5	22.7	10.6	67.1	10.7	11.0	14.0	10.4	0.5	0.7	1.1	0.8	0.3	1.0	0.7	1.1	1.0	0.7	0.8	0.7	0.9	0.2	1.6	0.4	1.7	2.0	0.4	4.8	5.0	8.2	6.7	5.3	4.8	4.5	4.5	5.0	5.0	5.4	5.6	7.7	16.0	4.6	12.1	18.8	2.3	4.1	2.8	5.7	5.6	12.3	6.3	2.6	8.6	5.0	12.9	10.4	21.9	7.0	12.5	5.9	12.9	1.6	9.6	3.7	5.6	4.2	9.1	36.3	14.8	25.2	4.8	11.2	13.9	5.1	7.0	6.1	7.3	7.5	1.7	33.4	11.4	6.1	6.5	4.8	3.7	2.5	7.1	5.4	18.7	6.4	7.8	6.2	29.1	34.5	12.2	8.1	1.2	16.5	2.7	12.8	3.4	6.1	9.9	6.6	4.1	5.2	2.2	1.0	8.6	2.8	34.1	7.4	3.8	11.0	4.8
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.7;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.2	9.6	9.2	0.6	5.9	0.8	3.3	28.7	10.5	2.6	0.0	4.5	1.2	0.1	4.5	6.4	0.2	0.2	0.9	5.6	24.6	0.5	0.1	0.5	0.3	4.5	8.3	0.1	4.8	1.5	41.9	0.7	16.9	0.2	3.0	2.4	2.7	0.0	0.5	9.7	2.7	0.6	4.2	3.3	1.9	11.3	18.2	0.1	2.2	0.4	0.3	0.0	7.1	4.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	18.5	3.4	0.0	3.0	2.5	3.8	1.5	0.0	1.2	1.4	0.3	1.8	0.0	0.0	3.2	0.1	0.0	7.5	0.0	0.2	0.0	0.0	8.7	0.0	24.1	0.0	9.3	2.6	0.1	0.8	0.0	0.0	0.0	1.2	12.7	0.3	0.0	32.5	4.9	0.4	29.1	0.0	0.6	2.8	1.6	0.0	0.0	5.9	0.0	0.0	1.9	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.1	9.2	5.9	28.7	10.5	5.6	24.6	4.5	8.3	16.9	4.2	18.2	4.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	3.3	2.2	0.8	0.7	0.0	1.7	0.0	2.1	0.0	1.5	3.8	1.9	0.0	9.5	0.3	0.4	0.1	19.2	0.0	25.8	0.2	0.1	0.3	0.0	2.4	0.0	0.2	0.0	0.0	2.7	3.3	22.2	3.0	4.1	0.0	0.0	6.2	0.0	0.2	0.0	3.7	0.6	0.3	0.0	16.1	1.1	0.2	7.0	0.4	0.1	0.0	0.5	0.2	0.1	0.6	0.0	0.0	0.3	0.6	0.1	2.4	0.0	0.0	0.2	0.7	0.7	0.1
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"choroid plexus: 42.5;epididymis: 144.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 62.0;Hepatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	17.1	12.0	5.2	9.3	9.3	3.4	8.4	7.1	7.1	15.4	42.5	10.5	9.6	10.9	144.9	10.5	8.8	10.4	7.2	4.9	6.8	13.6	20.8	9.5	12.9	9.4	7.4	16.3	15.3	6.8	4.7	10.3	7.8	11.4	5.5	1.0	17.8	17.3	8.9	6.4	9.8	16.3	7.5	8.9	7.1	12.2	7.4	5.1	22.9	7.1	12.1	10.6	7.8	14.5	26.5	20.3	10.0	5.4	45.7	33.0	5.5	19.2	18.2	14.8	16.3	5.7	17.8	17.2	7.5	11.8	6.4	9.0	26.9	13.0	19.5	34.8	9.8	32.1	7.3	12.8	16.1	1.9	5.1	43.4	14.0	6.1	13.8	17.1	15.1	4.1	14.8	36.9	25.1	35.3	0.1	4.6	1.5	13.6	10.6	3.8	22.1	8.7	29.2	50.6	7.1	20.0	12.6	10.9	23.5	13.3	10.9	1.5	15.1	14.9	13.1	10.8	15.8	24.3	0.4	18.8	13.4	3.9	20.0	2.7	0.1	0.1	1.5	0.3	1.9	3.1	1.6	1.7	0.3	2.0	0.7	1.1	0.0	3.2	0.4	0.2	0.8	0.9	5.2	9.3	7.1	7.1	4.9	6.8	9.4	7.4	7.8	7.5	7.4	14.5	16.7	9.6	12.5	5.2	15.7	24.1	12.7	5.4	62.0	0.7	7.3	11.4	20.4	7.2	3.7	22.0	0.0	25.3	18.6	2.5	1.9	3.9	3.7	3.3	9.6	9.0	7.8	18.7	9.9	10.2	6.2	18.1	6.1	4.6	14.0	13.5	6.1	51.7	4.0	1.7	14.1	4.5	8.2	9.7	11.6	3.2	46.9	11.1	24.9	9.4	1.9	4.0	4.1	8.0	46.8	8.8	2.4	21.4	12.6	19.7	16.7	30.6	3.7	0.0	0.0	10.5	11.9	3.4	2.2	17.4	23.4	15.7	13.3	23.7	7.2	8.6
TMEM65		ENSG00000164983	"Transmembrane protein 65"	Q6PI78	8	124306189-124372701	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.6;Horizontal cells: 99.3;Inhibitory neurons: 139.8;Microglial cells: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025020	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA025020: AB_2205178"	"prognostic unfavorable (2.17e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.95e-2)"	"unprognostic (8.26e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.78e-1)"	3.7	3.1	5.1	4.9	5.1	3.5	5.1	5.2	5.4	5.5	3.4	4.0	15.4	4.8	2.2	5.6	3.0	4.7	11.9	4.9	5.0	4.7	2.7	3.6	4.5	3.8	5.8	4.2	4.8	6.6	2.1	3.3	4.8	2.8	4.5	2.7	8.6	2.0	13.9	10.1	5.5	3.7	3.7	4.7	2.8	1.7	6.2	3.7	5.3	12.4	4.5	3.2	5.3	4.6	7.9	5.4	11.2	4.0	3.4	6.1	0.9	4.5	4.4	6.9	7.9	0.9	3.1	7.4	4.4	8.0	5.3	3.6	5.8	4.3	8.2	23.2	5.9	5.0	4.6	1.6	9.5	3.4	4.8	4.4	8.1	10.0	7.9	9.4	15.8	3.6	2.3	6.2	8.5	6.1	2.4	1.3	3.0	3.5	7.5	1.4	10.6	4.5	7.3	3.4	9.1	5.4	16.6	41.9	7.8	5.7	3.7	4.3	10.3	5.8	13.9	19.4	7.7	4.2	3.3	3.0	8.2	24.6	8.4	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.4	0.1	0.2	0.3	0.0	5.1	5.1	5.2	5.4	4.9	5.0	3.8	5.8	4.8	3.7	6.2	4.6	14.0	12.8	3.9	34.3	15.1	13.4	9.4	3.0	11.4	6.0	14.0	11.8	37.2	15.7	4.8	7.3	0.0	0.6	10.0	17.0	23.5	10.9	3.9	12.1	12.9	14.0	1.2	6.3	72.6	7.8	1.6	13.0	5.6	9.7	1.3	31.2	23.9	4.7	8.9	99.3	139.8	3.7	4.1	19.1	10.5	1.0	9.9	19.8	8.8	70.3	9.3	4.4	14.4	52.3	45.0	9.8	4.7	11.7	10.2	7.8	5.3	19.2	5.8	2.3	6.6	25.9	8.9	3.3	4.5	31.9	12.5	0.7	14.8	7.5	5.2	11.6
TMEM68	FLJ32370	ENSG00000167904	"Transmembrane protein 68"	Q96MH6	8	55696424-55773407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018216, HPA019173"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA018216: AB_2205185, HPA019173: AB_1858129"	"unprognostic (4.43e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.63e-1)"	8.9	12.9	5.8	8.2	6.5	10.9	13.1	13.2	8.4	10.3	14.5	13.9	12.7	10.5	14.3	13.0	22.0	10.8	6.0	6.6	5.8	17.4	12.8	10.2	9.5	5.2	5.5	13.4	10.6	17.6	5.7	11.9	4.7	13.3	14.5	11.4	12.5	10.2	5.0	14.3	12.8	9.5	4.6	8.3	11.1	8.3	5.6	11.0	16.5	5.3	9.2	11.8	7.6	10.0	22.3	13.4	21.5	13.1	17.0	20.3	38.5	19.6	14.6	18.2	17.1	18.3	41.3	24.0	21.8	12.7	22.5	27.0	17.0	25.5	20.2	33.3	19.2	29.0	12.4	19.5	19.1	12.7	15.7	14.1	38.1	18.4	43.2	26.0	16.3	24.9	29.2	23.6	26.3	11.8	31.8	17.0	24.1	46.1	6.5	22.6	8.9	15.7	29.9	16.9	18.0	16.2	12.6	20.3	39.9	27.7	30.2	16.0	13.2	13.8	17.6	23.6	16.2	20.1	27.4	31.4	18.7	20.6	21.1	35.0	7.6	5.9	7.8	5.0	11.1	10.0	9.1	8.1	8.3	9.7	7.5	10.9	8.4	9.4	9.3	7.6	7.4	4.4	5.8	6.5	13.2	8.4	6.6	5.8	5.2	5.5	4.7	4.6	5.6	10.0	10.5	12.8	12.7	10.7	13.4	34.2	28.0	38.4	19.9	18.2	14.2	12.1	5.2	15.7	30.4	25.8	14.6	32.9	14.6	15.3	13.7	16.4	2.3	42.0	10.4	11.1	15.0	20.0	17.0	8.0	21.1	12.2	13.3	10.4	5.7	12.6	11.4	12.5	13.2	21.9	21.6	26.5	40.7	12.6	11.0	1.2	13.1	9.0	7.2	20.6	13.0	17.2	9.2	26.7	16.9	15.8	21.6	13.9	14.6	26.9	17.4	22.0	66.7	15.3	26.3	9.2	10.8	16.2	15.3	17.5	35.5	22.2	11.7	15.3	15.8	29.3
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45688181-45694436	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favorable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	17.4	19.5	12.0	17.2	12.4	9.4	21.0	13.2	14.4	14.6	15.6	19.0	22.7	15.6	26.7	21.5	17.1	15.8	31.8	12.4	12.9	16.3	19.4	12.1	26.9	12.6	13.0	23.5	14.0	31.9	5.9	19.7	13.0	19.1	22.9	16.6	21.2	15.4	23.9	21.2	17.0	13.9	12.4	16.2	15.2	13.3	13.0	21.2	21.1	25.4	27.7	26.0	8.7	13.3	50.1	13.2	33.9	25.9	25.1	32.6	81.6	31.6	37.1	52.5	50.7	34.2	24.8	59.8	20.4	30.9	38.1	64.9	26.5	77.2	56.3	40.1	31.6	126.2	30.6	38.2	45.3	59.6	58.2	38.8	75.5	50.7	32.6	34.3	44.7	57.8	75.5	37.4	32.4	17.9	32.9	41.3	77.8	30.0	33.4	51.1	29.2	59.9	56.7	57.2	36.8	34.6	32.8	88.8	56.2	61.2	47.0	59.1	32.5	23.9	40.0	49.8	38.9	29.9	41.6	44.8	32.5	43.0	36.5	12.2	25.0	10.2	9.0	25.8	11.7	16.6	12.8	10.5	22.1	15.5	14.5	11.4	9.6	9.2	34.6	12.5	12.8	13.6	12.0	12.4	13.2	14.4	12.4	12.9	12.6	13.0	13.0	12.4	13.0	13.3	10.8	0.0	14.9	9.8	22.4	20.1	22.8	49.2	37.5	11.0	19.1	21.7	9.1	12.8	26.8	18.4	0.0	61.4	7.7	16.7	43.0	22.7	1.9	13.4	12.6	14.3	24.0	32.4	9.1	17.8	36.1	17.1	35.7	11.6	6.3	12.1	14.6	14.4	37.7	6.7	9.7	21.3	34.6	38.9	11.9	4.4	18.6	21.8	17.8	2.8	23.9	14.5	14.4	9.5	14.6	14.8	16.1	12.8	16.3	22.7	31.0	39.0	18.8	9.8	13.1	10.8	13.0	21.7	16.9	53.5	26.0	59.7	13.7	16.3	25.0	22.4
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911316-44937010	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 51.2;kidney: 74.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"RPMI-8226: 44.0;U-937: 26.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039894, HPA062907"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favorable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.7	0.5	0.0	51.2	6.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	1.5	74.4	0.1	0.0	0.0	1.7	1.5	0.0	9.1	0.5	0.2	0.0	1.4	0.0	7.7	0.2	2.4	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	2.8	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	3.5	1.5	1.7	1.5	1.4	0.2	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	0.0	21.1	33.2	0.1	5.5	0.7	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	5.8	2.0	17.5	1.0	16.2	0.2	4.9	10.3	19.4	1.9	8.8	4.0	18.2	2.0	0.8	4.0	7.4	3.9	11.2	13.5	16.6	4.5	4.7	27.6	2.0	19.8	13.2	1.0	2.0	7.1	10.1	17.2	18.2	3.1	1.8	3.9	6.3	15.7	5.1	9.8	23.1	2.0	10.8	2.8	4.1	4.1	17.8	0.3	4.1	2.2	1.2	1.2	2.0	11.5	0.0	4.4	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.6	0.1	0.9	0.0	2.7	0.3	3.4	0.4	0.1	0.0	4.2	1.1	0.0	9.2	0.0	0.0	1.2	0.0	0.9	0.0	0.1	0.1	0.1	0.6	16.8	7.1	0.0	0.0	0.1	0.0	3.0	1.2	0.3	0.0	0.2	0.0	0.7	0.6	0.5	1.9	0.1	0.0	0.1	0.9	0.0	0.0	1.7	0.0	2.9	0.0	0.1	2.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	16.2	10.3	19.4	13.5	16.6	19.8	13.2	18.2	10.8	17.8	11.5	3.7	0.0	0.0	0.7	0.1	0.3	0.7	0.9	0.6	10.5	2.2	1.0	2.3	0.0	0.2	0.0	0.0	0.2	0.2	1.0	0.0	0.5	1.0	0.2	0.1	3.3	15.6	0.0	9.7	0.2	1.8	0.8	2.6	0.1	0.0	0.5	4.6	0.8	0.0	18.5	16.3	9.9	2.0	0.6	0.7	0.7	0.0	1.4	1.8	1.9	1.0	0.5	0.0	0.0	1.1	0.9	15.6	0.0	0.1	0.7	21.1	0.6	1.2	4.0	19.7	0.4	13.3	0.2	2.7	0.2	0.9	1.4	0.2	0.3	3.9	0.3
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 132.4;skin 1: 89.9;vagina: 59.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 24.1;Squamous epithelial cells: 59.9;Suprabasal keratinocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.2;SK-BR-3: 26.7;T-47d: 28.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoli fibrillar center"		"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	2.1	2.8	5.5	1.5	6.3	2.9	4.5	6.2	7.5	34.5	5.1	2.4	2.6	2.4	2.6	132.4	2.5	1.8	1.8	5.2	5.7	2.4	3.6	1.9	2.9	6.2	6.2	2.4	2.1	6.0	3.7	1.6	6.0	28.4	1.3	1.7	23.5	2.6	2.9	89.9	2.7	1.2	5.8	3.8	2.9	2.0	6.1	3.6	2.2	0.7	10.9	6.9	59.4	7.8	12.5	7.2	2.4	4.7	1.8	1.8	5.9	3.5	1.4	6.2	2.4	8.5	3.4	2.2	7.6	0.9	2.2	10.8	2.8	5.1	2.7	8.3	3.9	2.3	3.3	2.5	3.3	2.6	3.3	1.7	30.2	4.6	4.7	4.4	1.4	8.2	10.5	14.8	2.9	14.1	7.3	4.0	3.6	9.0	5.7	8.5	2.3	5.0	1.3	3.0	4.3	4.7	4.3	26.7	7.0	2.9	28.3	7.4	3.4	11.5	3.8	4.2	9.5	11.3	13.0	5.2	8.0	6.0	8.8	0.0	2.0	3.0	1.7	0.7	1.8	1.7	1.5	1.8	1.6	2.2	2.0	2.4	3.7	1.7	1.3	2.0	2.1	1.7	5.5	6.3	6.2	7.5	5.2	5.7	6.2	6.2	6.0	5.8	6.1	7.8	1.8	3.2	1.5	8.8	3.9	13.3	1.4	24.1	9.1	3.0	10.0	6.5	1.2	2.8	14.3	1.8	2.1	7.7	3.6	2.4	1.9	2.5	0.1	3.7	2.4	2.0	3.0	0.8	1.8	3.3	1.8	2.1	1.5	6.7	0.0	3.1	2.2	2.4	3.4	8.4	2.2	2.9	10.2	2.5	1.8	0.3	1.5	1.4	5.4	3.7	4.4	1.5	1.0	2.5	5.8	4.5	2.1	0.7	1.6	10.7	4.3	1.6	4.2	2.2	0.0	1.0	1.9	1.3	2.1	59.9	33.1	7.4	3.2	2.9	3.1	6.4
TMEM80	FLJ38216	ENSG00000177042	"Transmembrane protein 80"	Q96HE8	11	695428-705028	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.2;Spermatogonia: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059592, HPA067046"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus"		"HPA059592: AB_2684076, HPA067046: AB_2685769"	"unprognostic (1.48e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.23e-3)"	21.0	23.0	18.4	14.7	18.2	6.5	23.8	19.5	22.0	30.5	17.3	30.2	23.7	27.8	24.8	42.5	30.1	8.4	15.3	19.3	16.5	36.0	20.2	17.5	21.2	21.2	18.1	29.7	29.7	17.8	34.3	8.7	19.0	29.9	17.5	9.1	31.5	19.4	19.7	31.0	31.1	12.7	18.9	34.3	30.8	24.8	19.0	19.7	47.6	11.8	21.3	27.8	30.6	19.9	37.8	17.5	11.0	14.3	23.6	11.1	19.0	8.5	4.7	8.9	9.6	23.9	42.0	16.0	7.3	13.2	15.8	26.8	16.2	9.7	6.3	11.0	41.7	9.7	19.0	14.5	13.9	12.8	16.8	25.7	19.9	4.0	6.2	17.5	10.5	18.9	12.1	17.7	11.4	12.2	16.8	8.7	10.4	29.9	8.4	12.2	7.6	31.5	12.7	5.7	31.1	9.8	12.8	23.5	12.3	7.3	18.2	11.9	15.0	14.9	7.8	3.4	6.4	8.4	3.2	14.8	15.6	15.9	6.5	8.3	26.5	35.4	21.0	25.9	18.4	26.7	15.7	16.0	21.8	30.1	22.3	20.0	12.8	21.4	32.0	22.0	21.4	20.7	18.4	18.2	19.5	22.0	19.3	16.5	21.2	18.1	19.0	18.9	19.0	19.9	15.1	6.4	20.7	13.7	24.0	15.3	15.9	25.6	17.6	22.7	31.7	36.8	19.3	15.7	20.2	20.2	8.4	33.9	19.4	15.4	11.7	13.0	9.2	17.1	15.8	14.4	12.1	8.6	13.9	17.1	9.8	20.8	9.7	19.9	7.0	15.9	12.8	6.2	17.6	55.5	13.1	22.7	28.5	13.2	13.6	9.5	42.6	12.7	12.4	11.2	19.7	23.2	26.8	16.6	16.7	10.6	10.3	28.6	11.5	12.3	22.1	8.1	19.4	9.1	32.9	23.4	21.2	82.2	87.2	13.7	17.2	15.2	16.7	21.6	19.5	12.3
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742499-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.4;kidney: 11.5;liver: 52.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"CACO-2: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	24.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	52.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	1.6	0.0	42.8	7.9	0.0	0.0	0.0	0.0	0.0	2.4	2.7	0.0	0.2	2.9	0.0	1.5	0.1	0.0	0.0	0.4	49.3	0.1	0.0	0.0	9.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	60.2	0.0	0.0	0.0	173.6	53.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	12.5	0.0
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 17.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.6;Theca cells: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	2.8	2.7	2.6	2.2	2.2	0.3	3.2	2.1	2.8	2.3	3.8	1.5	1.4	2.2	1.0	2.3	2.6	4.0	2.9	2.1	2.6	9.5	2.6	3.5	4.7	3.1	2.7	7.1	3.4	5.4	2.2	4.3	2.5	1.6	1.8	5.7	2.7	1.4	2.9	17.6	2.0	1.9	2.7	4.9	2.1	2.3	4.0	1.6	2.1	2.5	2.5	2.3	3.6	4.5	0.0	0.2	0.6	3.1	2.7	0.0	0.1	0.6	0.5	0.5	0.5	0.0	0.4	0.0	1.2	0.6	3.0	0.3	0.2	0.1	0.3	0.2	1.9	0.2	0.1	0.0	2.1	0.0	2.8	3.8	1.2	0.1	0.2	0.7	1.7	1.8	0.6	0.0	1.3	1.7	0.0	0.0	0.2	0.5	1.6	0.0	5.1	0.0	17.5	3.8	1.0	1.3	1.0	3.2	1.4	1.1	3.9	0.4	1.9	0.5	0.2	0.1	0.1	3.2	2.7	0.0	1.1	0.0	1.1	0.0	1.9	0.1	0.2	1.4	0.5	0.0	0.2	0.4	3.4	0.1	0.4	0.8	0.0	0.1	0.5	2.0	0.5	0.8	2.6	2.2	2.1	2.8	2.1	2.6	3.1	2.7	2.5	2.7	4.0	4.5	1.9	0.0	0.0	0.3	0.0	0.1	0.8	0.4	0.0	5.2	3.5	1.8	2.2	0.0	0.7	11.0	8.4	0.5	1.4	0.6	7.9	7.8	12.2	1.1	1.9	2.1	3.5	0.0	0.5	8.0	0.3	1.7	1.1	1.0	0.0	3.0	3.9	1.6	40.6	0.0	0.8	0.8	0.0	12.7	0.8	12.1	2.1	8.3	0.0	3.7	2.3	2.6	0.0	2.0	0.1	7.4	0.1	1.9	0.4	0.6	0.0	8.3	0.4	4.8	6.6	0.4	1.2	7.8	2.6	0.2	0.3	2.3	0.7	17.4	0.2	0.4
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.0;liver: 16.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.6	2.4	5.1	6.9	0.9	4.7	6.8	1.4	3.8	1.8	9.7	1.5	0.1	1.0	1.8	11.0	0.8	4.6	3.9	1.3	16.9	1.2	1.7	4.4	3.7	1.2	0.6	0.5	2.9	0.6	4.3	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.2	0.3	3.4	3.6	4.1	3.0	4.2	1.6	2.3	0.4	1.2	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.6	5.1	4.7	6.8	4.6	3.9	4.4	3.7	4.3	3.4	4.2	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
TMEM87A	DKFZP564G2022	ENSG00000103978	"Transmembrane protein 87A"	Q8NBN3	15	42210447-42273584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018104, HPA018189"	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA018104: AB_1858135, HPA018189: AB_2205198"	"unprognostic (7.07e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.63e-1)"	31.8	26.3	23.7	26.1	37.7	88.2	97.7	32.0	29.5	40.2	17.7	56.5	26.6	38.6	49.3	48.2	45.3	32.4	19.7	23.5	26.3	27.1	24.5	72.8	25.4	36.7	29.4	35.4	34.9	47.9	14.2	42.7	38.7	79.8	60.9	26.1	64.7	36.6	24.9	50.2	26.9	38.0	32.5	23.1	38.6	33.0	28.8	24.8	75.9	22.2	30.9	42.0	34.3	59.1	41.0	20.5	30.5	27.0	58.5	50.3	47.7	55.1	82.0	53.5	52.0	29.8	87.5	17.4	52.9	59.9	60.5	104.0	28.3	51.2	42.8	46.8	25.0	35.6	51.5	33.5	63.4	65.6	48.3	52.3	112.1	39.5	65.3	50.6	41.9	30.1	39.4	67.4	51.7	26.3	21.3	38.8	25.7	60.8	29.3	33.5	46.6	36.8	34.5	127.4	33.7	41.2	53.1	70.1	49.9	24.0	27.4	62.4	41.3	104.4	25.5	68.1	82.6	46.8	95.0	36.5	40.1	47.9	66.8	58.3	26.9	31.2	29.0	32.3	33.3	27.6	35.6	34.0	24.4	24.4	33.6	33.5	15.2	42.4	34.7	22.4	42.2	26.0	23.7	37.7	32.0	29.5	23.5	26.3	36.7	29.4	38.7	32.5	28.8	59.1	66.2	125.0	264.0	46.0	48.9	68.6	90.2	78.8	58.1	31.2	148.7	105.9	13.9	45.8	98.0	49.7	50.1	78.1	57.5	77.7	1.9	63.7	5.6	57.0	67.0	54.6	32.2	34.5	41.7	64.2	72.7	64.0	50.0	124.7	59.5	42.9	51.0	34.4	41.6	20.2	48.2	74.1	67.1	39.2	37.0	7.9	41.0	41.3	62.2	45.0	60.1	61.8	52.5	74.4	177.5	56.1	62.4	53.8	47.6	118.5	36.6	15.5	86.4	63.0	85.5	77.0	59.0	59.4	61.4	79.1	65.5	110.4	54.8	53.3	76.9	105.6
TMEM87B	FLJ14681	ENSG00000153214	"Transmembrane protein 87B"	Q96K49	2	112055269-112119318	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035183	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus, Vesicles"		"HPA035183: AB_10600829"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.28e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.32e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.25e-3)"	10.5	12.2	6.8	14.7	6.6	7.9	20.1	6.1	8.0	12.9	6.9	28.4	28.6	11.0	18.5	10.5	8.4	12.1	5.0	5.9	7.1	7.9	7.4	11.7	15.4	7.5	10.0	6.0	11.3	12.9	9.2	15.1	8.0	30.7	27.8	6.9	15.4	15.9	3.1	13.7	30.5	13.4	7.1	15.5	22.8	5.0	8.3	9.7	15.0	4.2	14.6	17.1	9.0	6.9	21.7	6.4	5.9	25.8	24.9	32.6	21.4	35.5	46.8	21.9	26.7	16.6	28.6	20.9	18.2	47.3	30.2	34.9	3.8	21.6	28.7	12.8	4.1	27.5	4.6	15.2	24.7	19.6	28.9	22.3	25.9	28.0	22.0	21.4	23.6	9.6	16.9	13.1	31.8	13.7	9.3	10.8	4.8	35.0	16.4	7.6	8.9	17.0	20.3	30.2	4.6	6.4	15.4	38.6	34.6	15.5	20.4	14.7	26.6	22.3	6.8	17.6	7.8	10.6	18.1	12.9	25.9	10.1	16.3	5.4	3.0	2.6	3.2	5.2	5.6	5.9	6.9	4.4	2.7	4.9	6.2	3.6	1.8	3.5	6.7	2.7	7.4	3.6	6.8	6.6	6.1	8.0	5.9	7.1	7.5	10.0	8.0	7.1	8.3	6.9	18.3	28.9	13.9	18.9	23.3	12.2	14.5	20.9	39.9	5.0	32.9	14.4	4.6	20.0	21.6	18.4	2.1	15.9	12.3	59.5	0.0	42.9	18.7	14.4	26.5	19.9	17.4	6.3	18.4	89.3	25.5	17.5	46.4	24.9	13.3	14.5	35.7	10.1	21.7	6.7	16.4	53.6	12.2	37.7	10.9	24.5	9.9	22.7	3.6	30.0	20.9	4.0	6.2	21.6	23.1	69.7	47.1	3.0	21.6	28.9	44.9	4.7	17.9	7.9	0.0	5.4	17.2	4.9	5.6	29.9	12.8	29.1	20.5	11.8	38.2	23.9
TMEM88	"FLJ20025, MGC71744"	ENSG00000167874	"Transmembrane protein 88"	Q6PEY1	17	7855066-7856099	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.5"	"Group enriched"	"Detected in many"	7	"Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Group enriched"	"Detected in many"	6	"AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052991	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052991: AB_2682006"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (3.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.68e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.72e-1)"	63.2	22.3	11.2	7.9	11.0	6.9	29.5	12.4	24.4	20.0	14.3	18.1	5.7	24.1	3.6	6.4	26.4	12.7	98.5	11.3	11.6	37.7	5.9	14.1	3.6	12.6	11.6	8.5	10.8	7.4	21.4	23.7	12.0	19.3	2.7	2.4	9.3	6.3	35.4	3.8	15.4	10.1	11.0	15.9	18.2	4.9	12.9	2.5	39.6	36.8	0.8	19.1	14.0	10.9	0.2	0.8	8.1	65.2	0.0	0.3	3.9	0.4	0.2	0.1	0.2	1.9	0.3	0.4	0.3	0.7	0.4	0.5	0.6	0.4	0.1	0.0	0.1	0.5	1.2	1.1	42.3	0.6	2.6	1.0	1.8	1.2	0.3	0.6	51.4	0.9	1.2	0.1	0.8	5.0	0.5	1.2	26.5	0.3	0.0	0.3	0.2	0.1	0.6	1.6	0.7	3.7	0.5	0.8	2.0	2.2	1.4	0.2	5.2	0.4	1.6	2.2	0.5	0.2	0.1	0.4	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	11.0	12.4	24.4	11.3	11.6	12.6	11.6	12.0	11.0	12.9	10.9	177.3	6.4	2.2	2.0	6.2	4.1	4.0	1.4	2.2	4.7	7.9	5.2	5.9	0.0	2.4	1.8	4.2	3.1	3.1	2.0	0.0	2.2	3.0	3.1	2.0	142.1	6.6	0.0	0.6	2.2	1.0	19.2	4.6	6.7	4.5	1.8	109.9	2.4	2.6	3.3	0.9	2.5	0.0	7.3	9.3	8.6	0.9	9.9	0.0	5.6	0.2	0.6	0.0	0.0	0.1	4.0	5.7	0.0	1.0	6.5	2.4	0.6	1.5	1.4	0.0	11.3	6.5	1.7	1.8	2.7	3.1	5.2	2.5	0.8	1.5	3.2
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"brain: 437.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"				"HPA065743: AB_2685552"	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	95.5	0.1	285.1	0.0	0.0	192.8	193.1	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	82.8	125.8	1.0	0.0	0.1	0.0	312.3	232.8	0.1	0.0	0.0	0.0	0.0	199.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	129.9	0.0	0.0	2.2	242.8	0.0	0.0	0.0	0.0	0.3	0.1	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	285.1	192.8	193.1	82.8	125.8	312.3	232.8	199.0	129.9	242.8	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM89		ENSG00000183396	"Transmembrane protein 89"	A2RUT3	3	48620759-48621769	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 24.8"	"Group enriched"	"Detected in some"	16	"Early spermatids: 329.4;Late spermatids: 228.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA053577	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA053577: AB_2682196"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.31e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.86e-2)"	0.1	0.0	0.1	0.0	0.1	1.7	0.1	0.1	0.4	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.5	24.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.3	0.0	0.4	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.9	0.4	0.1	0.2	0.1	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	329.4	0.0	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	228.6	2.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	17.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0
TMEM8B	"C9orf127, FP588, LINC00950, NAG-5, NGX6, NGX6a"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 36.1;Granulosa cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 51.2"	"Lineage enriched"	"Detected in many"	24	"dendritic cells: 51.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	10.4	21.1	19.9	3.1	16.0	1.8	12.3	11.5	20.7	21.7	3.6	19.9	5.1	20.1	6.2	5.7	20.8	6.7	15.9	20.3	13.9	15.8	6.4	10.2	3.6	14.2	15.3	33.6	11.8	17.8	30.6	4.5	13.9	23.9	5.5	7.7	18.1	14.2	12.8	9.3	9.5	6.9	12.7	8.5	17.7	19.1	18.5	5.2	22.7	9.6	2.6	19.3	15.7	12.4	3.1	3.4	11.7	9.2	12.9	10.7	1.4	2.8	5.5	3.1	3.8	1.4	0.8	2.5	6.5	7.7	9.1	1.2	3.1	4.7	2.5	1.9	5.2	0.7	2.5	3.4	9.1	0.2	0.2	10.1	6.1	3.2	3.4	10.0	1.8	11.5	1.2	6.9	5.5	1.2	6.6	1.4	1.6	2.7	4.6	7.2	2.4	6.2	3.3	1.5	2.8	8.1	4.3	1.8	4.1	3.8	3.2	1.1	2.9	7.3	2.2	7.2	1.1	8.6	2.8	2.8	6.7	1.2	4.6	0.7	2.1	0.2	0.5	0.1	0.3	0.6	0.4	0.4	8.2	0.5	0.4	0.4	0.9	0.7	0.1	51.2	0.2	1.3	19.9	16.0	11.5	20.7	20.3	13.9	14.2	15.3	13.9	12.7	18.5	12.4	4.4	12.8	12.2	18.9	3.3	4.5	9.1	8.1	8.0	4.1	12.1	11.4	11.7	10.0	9.1	14.7	2.1	34.1	36.1	8.2	1.9	5.7	25.4	7.7	8.4	3.2	6.7	0.8	12.4	4.0	9.2	9.2	11.2	6.3	1.3	47.3	1.8	4.0	3.2	1.7	13.0	7.0	12.2	1.3	11.2	14.0	14.6	5.3	10.6	10.3	3.6	9.1	2.1	12.1	7.2	3.6	8.0	19.5	2.6	9.0	3.0	4.5	7.5	5.3	6.6	7.1	8.7	8.6	5.2	1.9	1.6	13.0	3.6	8.1	7.8	10.0
TMEM91	"DSPC3, FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 212.0;Late spermatids: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 193.3"	"Group enriched"	"Detected in all"	8	"granulocytes: 193.3;monocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 20.1;HSkMC: 20.5;TIME: 19.8"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	24.0	12.8	32.3	6.9	43.1	36.2	19.7	19.5	35.2	39.1	27.7	26.6	3.5	18.6	10.2	22.6	30.2	8.2	16.4	29.3	49.0	20.3	9.6	23.3	6.5	29.2	33.3	20.1	17.7	4.1	26.2	9.4	28.4	23.0	3.9	9.2	11.4	8.6	5.4	66.3	14.3	8.7	23.3	37.5	12.3	37.8	52.7	5.7	20.5	7.3	7.6	29.8	31.3	24.2	3.3	7.0	5.4	2.7	6.4	13.6	5.0	2.6	3.4	1.3	2.1	0.5	2.9	1.5	2.4	3.0	2.1	0.9	1.3	2.4	3.0	2.3	3.6	20.1	5.7	11.1	12.3	3.4	5.2	20.5	12.6	4.0	9.8	14.8	9.2	3.7	3.8	6.2	2.1	6.3	2.5	6.6	2.3	0.9	4.2	4.2	1.2	1.4	3.4	1.6	1.4	3.3	5.0	1.0	4.1	3.8	1.3	9.9	19.8	3.1	3.0	2.9	2.7	3.8	0.6	1.1	6.5	4.6	1.2	36.8	51.9	4.0	5.9	12.3	7.4	0.7	3.4	3.1	9.5	1.4	8.0	3.9	193.3	1.5	9.1	14.6	4.7	41.2	32.3	43.1	19.5	35.2	29.3	49.0	29.2	33.3	28.4	23.3	52.7	24.2	20.2	3.2	22.4	23.8	3.5	17.8	22.9	59.8	7.4	8.3	10.7	15.9	5.3	2.8	25.0	7.3	6.2	2.7	10.6	0.7	1.9	5.3	212.0	12.0	12.1	13.7	14.4	4.8	11.7	3.2	84.3	21.7	1.1	4.8	34.2	13.0	20.0	3.8	15.7	8.4	18.9	1.6	10.2	67.6	8.4	451.5	14.0	51.6	8.8	7.5	30.7	4.1	20.6	5.0	5.8	3.8	18.5	7.2	1.7	6.5	2.3	2.5	13.5	6.4	6.6	4.8	8.6	4.9	9.0	9.7	21.3	8.6	7.8	3.7	1.7	10.4
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.0;stomach 1: 23.0"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 285.4;Urothelial cells: 88.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.5;CACO-2: 14.1;CAPAN-2: 10.6;EFO-21: 21.4;OE19: 16.8;SuSa: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.0	0.4	0.9	0.4	0.4	0.3	0.2	0.5	2.1	0.1	2.2	16.0	0.8	0.0	0.7	0.6	4.4	0.1	0.3	0.3	1.0	8.3	2.6	0.1	0.8	0.4	2.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.0	2.7	0.0	0.0	0.2	19.0	0.3	0.4	0.2	23.0	0.2	0.6	0.0	0.0	0.0	0.1	1.5	1.4	0.4	0.7	7.5	0.1	0.0	0.0	0.1	1.5	0.2	0.1	0.0	0.0	14.1	10.6	0.0	21.4	0.2	2.8	0.1	0.1	1.6	0.0	3.6	0.2	0.1	0.7	0.9	0.2	0.0	0.1	0.2	1.4	0.0	0.4	1.6	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	3.1	16.8	3.5	0.2	0.0	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.2	0.5	0.0	0.3	2.0	0.0	0.1	0.0	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.5	0.3	0.3	0.8	0.4	0.5	0.4	0.6	0.4	0.1	3.2	21.7	0.0	0.0	0.5	15.8	26.5	1.8	0.0	9.7	0.0	0.3	18.6	16.1	7.3	0.0	0.1	0.0	5.9	0.0	7.9	0.1	2.3	2.1	1.2	5.4	0.0	0.0	19.6	2.8	0.8	34.1	19.5	0.0	0.0	2.2	15.6	0.4	0.0	0.0	24.4	0.0	0.6	0.7	0.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	45.1	14.8	0.0	0.2	19.1	285.4	0.0	3.5	0.0	0.0	0.0	1.5	0.1	1.6	0.2	1.0	0.0	0.3	0.0	19.8	88.3
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319200-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.4;pancreas: 322.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 341.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	4.3	26.0	5.2	7.3	6.3	6.7	11.7	6.6	9.0	5.7	6.5	14.3	16.4	6.7	4.7	7.4	13.1	10.2	3.4	6.3	5.4	7.1	113.4	17.4	7.1	14.9	14.2	18.1	322.0	6.5	1.6	6.8	14.9	10.8	12.6	6.3	3.7	3.3	15.5	9.8	11.2	5.7	5.0	4.6	38.8	58.0	7.4	7.6	4.2	9.1	8.2	26.6	5.2	6.8	46.1	120.4	214.8	105.5	28.0	40.2	70.5	44.1	27.9	67.9	90.3	341.0	34.3	126.3	46.4	17.0	140.1	48.7	137.1	75.0	52.7	60.3	102.1	47.8	56.9	143.0	25.7	76.9	36.4	84.0	10.0	66.4	27.5	8.3	21.1	80.1	101.3	92.1	22.7	81.8	120.0	72.4	95.6	187.7	30.6	94.8	236.5	112.8	85.6	210.6	154.1	67.0	70.0	55.1	36.3	118.2	97.0	35.8	13.8	72.8	56.8	62.9	81.7	74.3	159.0	115.9	14.6	54.7	44.3	0.7	2.2	2.2	7.8	2.7	9.2	11.1	6.4	9.4	16.1	5.5	10.4	9.8	1.0	9.5	1.0	9.3	6.6	5.2	5.2	6.3	6.6	9.0	6.3	5.4	14.9	14.2	14.9	5.0	7.4	6.8	4.2	9.6	61.5	3.3	7.7	14.5	6.0	32.8	18.8	11.3	22.5	21.5	9.0	121.5	19.1	14.7	16.7	34.2	5.0	6.1	15.6	23.3	22.3	7.5	14.3	7.1	38.8	40.3	2.9	196.4	84.0	14.4	49.5	11.4	1.3	212.9	6.4	226.9	22.0	3.3	4.5	16.2	26.4	6.7	34.7	49.1	13.4	9.9	16.0	0.0	11.4	8.2	4.1	4.0	1.0	47.7	3.5	11.3	15.3	13.9	4.0	6.3	12.2	9.1	6.6	10.4	12.4	91.3	65.5	22.7	11.2	10.7	6.4	65.1	29.4	7.9
TMEM98	DKFZP564K1964	ENSG00000006042	"Transmembrane protein 98"	Q9Y2Y6	17	32927910-32945106	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 277.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040473, HPA053385"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040473: AB_10794876, HPA053385: AB_2682134"	"unprognostic (1.55e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.36e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.14e-4)"	"prognostic favorable (7.10e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	56.3	50.6	48.9	17.3	84.1	4.7	44.5	75.3	64.1	68.6	161.9	90.0	102.5	100.4	74.2	27.9	96.5	93.9	44.3	51.2	56.9	36.5	27.5	58.1	5.7	72.8	77.4	191.9	88.5	53.7	23.9	28.2	69.7	80.7	96.3	15.7	50.1	23.9	5.3	24.6	118.4	62.3	51.9	19.6	101.6	20.7	75.0	4.4	47.7	14.6	7.7	50.7	42.6	109.3	7.4	27.2	115.5	0.2	154.7	138.0	1.1	114.2	153.2	59.2	126.5	277.6	8.1	1.6	1.7	144.0	2.1	0.9	74.2	30.1	34.5	24.7	92.0	4.6	0.1	124.5	71.5	0.3	1.7	116.3	29.7	74.7	12.1	31.6	154.8	40.7	78.1	0.3	162.9	0.2	0.1	0.7	77.0	83.1	42.0	0.2	108.4	0.5	13.6	49.0	9.8	158.3	2.7	0.0	89.8	72.6	36.5	0.2	128.2	83.8	78.1	1.0	0.2	9.2	3.8	0.1	42.9	0.1	46.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.0	0.1	48.9	84.1	75.3	64.1	51.2	56.9	72.8	77.4	69.7	51.9	75.0	109.3	7.6	41.7	24.8	6.2	0.6	25.1	76.1	111.5	27.3	1.4	32.4	104.5	14.1	72.9	61.0	46.0	0.0	8.1	0.7	109.2	5.9	81.0	18.2	14.7	48.5	7.8	97.9	2.7	0.6	66.4	7.3	127.2	40.8	12.1	3.8	87.8	29.6	13.0	5.7	0.0	0.3	145.7	40.7	0.6	15.9	14.9	120.5	2.0	44.4	1.9	0.0	106.3	0.0	3.0	173.0	88.2	97.9	151.6	0.2	68.1	250.9	37.2	54.6	4.8	65.7	22.1	55.5	40.7	27.7	17.1	12.6	7.1	2.4	132.6	166.6	68.6
TMEM9B	C11orf15	ENSG00000175348	"TMEM9 domain family member B"	Q9NQ34	11	8947202-8965011	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037784	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA037784: AB_10671886"	"unprognostic (3.18e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.06e-1)"	"prognostic favorable (4.26e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.51e-3)"	"unprognostic (9.56e-2)"	34.2	40.0	67.6	33.8	70.5	78.0	47.9	70.1	80.8	37.0	62.3	63.6	54.6	22.2	59.0	62.4	31.4	39.5	53.3	65.1	69.3	60.2	39.8	50.7	40.5	70.6	69.5	24.1	41.4	63.9	38.5	45.2	71.5	34.2	67.0	42.3	51.4	26.0	47.4	45.5	54.8	22.2	70.8	41.7	59.3	27.5	72.0	35.6	75.0	42.9	43.3	47.3	35.9	75.2	63.0	42.4	23.7	46.0	117.1	65.9	41.1	78.4	69.3	45.2	46.3	32.4	96.7	39.1	40.3	81.6	53.2	81.9	22.3	57.5	47.3	72.7	45.0	26.2	36.8	31.0	66.3	53.2	79.5	61.1	94.6	27.9	56.0	61.7	54.5	26.4	21.0	58.0	87.2	43.9	16.6	33.9	7.4	90.1	49.5	18.8	30.4	31.6	67.7	72.4	26.4	22.5	44.8	92.3	40.6	29.7	55.7	35.1	59.4	55.0	24.9	93.7	48.6	24.1	44.7	27.8	69.0	35.0	47.5	178.7	104.5	151.8	98.5	134.7	101.7	103.2	94.3	109.8	112.6	89.3	77.7	109.0	50.5	93.3	150.2	80.7	136.8	159.8	67.6	70.5	70.1	80.8	65.1	69.3	70.6	69.5	71.5	70.8	72.0	75.2	61.5	41.7	52.0	17.9	65.7	65.0	65.5	155.5	58.6	61.0	67.5	35.9	28.6	70.1	104.1	95.6	20.9	104.8	69.6	124.0	70.5	84.5	16.4	29.2	28.0	49.3	31.2	111.6	21.9	80.7	112.9	48.0	34.7	43.8	88.1	21.1	55.0	30.5	109.3	43.7	23.2	78.8	213.6	79.0	109.8	13.4	38.2	70.1	60.5	15.9	58.1	82.6	77.2	24.1	33.8	70.9	103.9	28.6	53.6	59.2	114.7	45.7	53.2	49.2	19.7	41.6	26.2	56.4	58.2	83.7	87.4	160.8	66.8	40.3	82.8	80.6
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 508.1;Late spermatids: 544.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	10.3	10.6	4.4	14.0	5.2	26.2	14.1	6.2	5.5	13.3	12.3	12.5	12.9	14.8	14.1	11.5	12.9	14.1	9.2	4.3	5.3	12.6	11.0	12.0	16.0	5.3	5.1	12.6	13.6	15.6	9.9	16.5	5.2	14.5	14.2	12.5	17.4	10.3	9.8	9.7	14.8	11.6	5.1	12.8	14.0	19.4	5.4	9.6	20.9	8.3	14.8	13.5	7.9	6.1	19.5	8.3	7.8	7.9	20.7	26.4	17.5	24.6	23.6	16.1	19.2	11.9	14.1	7.4	3.9	25.1	11.3	10.5	10.2	10.8	26.4	14.3	7.6	14.4	11.0	14.1	18.5	16.3	19.7	15.6	17.0	21.4	19.3	17.1	17.5	6.0	8.8	11.8	21.2	11.1	9.5	14.1	6.8	12.3	4.4	7.8	9.9	10.4	21.0	15.4	5.4	8.3	20.2	14.2	15.4	10.4	10.7	19.4	23.1	15.8	6.7	27.9	14.8	13.2	13.6	7.2	24.1	16.6	13.1	4.8	2.4	5.1	3.1	2.0	2.1	2.6	2.8	2.7	2.1	3.1	2.9	2.6	5.3	2.7	3.4	2.4	3.1	1.6	4.4	5.2	6.2	5.5	4.3	5.3	5.3	5.1	5.2	5.1	5.4	6.1	49.2	64.1	78.9	21.9	84.7	37.5	37.6	41.7	39.3	43.4	46.2	35.8	36.9	38.6	86.4	42.3	37.5	39.6	108.4	48.8	15.6	52.4	508.1	150.4	92.8	43.1	55.6	45.0	32.2	56.2	58.7	70.0	54.6	86.2	74.7	51.7	29.3	19.7	28.4	35.3	38.4	61.6	38.7	31.8	54.4	544.8	51.0	55.1	35.6	32.8	66.7	41.5	59.8	36.2	40.9	50.6	40.8	62.1	129.3	64.8	49.4	25.1	200.5	52.1	32.9	62.8	56.8	116.2	39.3	30.6	39.5	80.6	94.5	54.5	38.5	85.7
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMIGD2	"CD28H, IGPR-1, MGC23244"	ENSG00000167664	"Transmembrane and immunoglobulin domain containing 2"	Q96BF3	19	4292232-4302431	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 35.3"	"Group enriched"	"Detected in some"	4	"dendritic cells: 49.9;NK-cells: 104.0;T-cells: 45.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 114.3"	"Group enriched"	"Detected in many"	38	"dendritic cells: 109.4;NK-cells: 89.8;T-cells: 114.3"	"Group enriched"	"Detected in some"	4	"BEWO: 12.4;HEL: 30.0;MOLT-4: 27.2"					"Low region specificity"	"Detected in single"			HPA011081	Approved					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA011081: AB_1079372"	"unprognostic (1.08e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.78e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.10e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.12e-4)"	"unprognostic (8.89e-4)"	0.3	0.2	1.5	4.2	1.5	4.8	0.2	1.4	1.7	0.2	0.7	1.4	1.4	0.5	0.0	0.5	0.4	0.7	0.1	1.5	1.8	0.2	0.8	0.9	6.4	1.9	1.7	0.0	0.1	0.0	0.1	0.4	1.7	0.3	0.5	0.1	0.2	0.1	0.1	0.1	4.1	0.1	1.5	6.4	0.7	0.6	1.8	35.3	0.2	0.1	3.4	0.6	0.3	1.7	0.0	0.1	0.3	0.3	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	27.2	0.0	0.1	0.0	0.0	5.2	1.4	0.0	0.0	0.2	0.1	3.3	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.8	9.0	0.1	114.3	0.2	15.0	22.5	0.4	0.3	82.9	43.2	2.7	89.8	0.5	109.4	1.3	23.3	1.5	1.5	1.4	1.7	1.5	1.8	1.9	1.7	1.7	1.5	1.8	1.7	0.3	0.0	0.6	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.5	0.0	0.0	0.0	1.8	49.9	0.1	0.0	0.1	0.0	0.2	0.3	0.2	0.0	14.9	0.2	0.0	0.5	1.2	7.1	0.2	1.3	0.4	1.4	0.6	0.3	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	1.7	1.8	3.7	1.6	0.0	104.0	0.0	0.1	0.0	0.0	0.4	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.1	0.8	45.4	0.0	0.0	0.2
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155489011-155719098	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	11.7	10.2	7.1	6.6	7.4	8.4	11.3	9.0	8.0	11.3	8.1	11.6	11.8	9.4	10.4	10.3	9.9	8.0	25.3	6.7	7.7	16.7	18.8	5.6	7.0	8.5	8.2	12.0	9.5	18.9	5.4	8.4	8.5	6.6	12.5	10.9	12.7	9.7	32.0	5.9	11.2	12.3	8.3	8.7	9.1	2.9	7.3	8.9	10.5	33.4	7.6	8.2	6.6	9.8	25.0	11.9	9.8	28.6	11.8	18.1	0.0	9.9	14.6	12.3	32.4	8.7	13.9	0.0	38.9	17.6	28.2	13.4	21.2	9.7	13.9	10.3	14.3	11.3	19.5	10.2	16.4	10.5	7.6	19.5	20.0	13.6	20.8	18.2	19.5	15.5	15.8	9.0	20.5	9.3	12.8	11.8	3.0	21.6	0.1	12.7	15.5	9.4	15.0	8.5	9.2	13.7	9.3	0.5	11.2	10.5	10.6	11.9	16.5	10.3	9.7	20.4	12.4	11.0	12.6	9.6	12.4	16.4	9.6	3.4	12.6	14.7	4.6	14.9	3.5	8.1	5.0	3.9	13.1	10.6	6.5	5.7	18.2	6.2	21.5	6.1	5.5	5.8	7.1	7.4	9.0	8.0	6.7	7.7	8.5	8.2	8.5	8.3	7.3	9.8	6.7	0.0	2.3	27.1	10.1	5.2	12.1	14.4	9.6	4.0	5.2	7.5	7.2	7.2	9.7	9.2	0.0	8.8	6.5	7.9	23.5	10.7	0.0	6.8	7.4	6.2	6.1	14.3	22.2	7.6	6.8	10.2	9.2	7.3	10.1	8.1	4.2	12.0	12.4	0.0	29.5	7.3	4.1	16.1	10.4	0.5	8.4	12.1	12.4	51.5	13.1	7.6	10.3	47.7	25.5	8.5	7.3	5.7	5.6	4.3	17.4	17.0	9.5	5.4	0.0	5.9	9.5	0.3	2.5	7.6	4.1	6.7	8.0	10.5	6.5	11.0
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601743	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 250.0;tongue: 255.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.0;Erythroid cells: 138.9;Horizontal cells: 102.6"	"Group enriched"	"Detected in many"	4	"glioma: 21.6;ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.0;HDLM-2: 155.7;K-562: 53.3;SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"							HPA051202	Enhanced					NA	NA		9400	"Cluster 40: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	18.8	65.1	16.8	4.5	19.9	24.2	15.8	25.0	22.0	46.4	16.3	34.8	4.2	54.3	5.6	17.4	27.4	7.4	144.2	18.0	25.7	9.2	28.5	15.5	2.6	20.1	12.1	51.3	23.0	13.9	31.6	2.6	17.3	17.1	6.3	9.2	10.4	9.1	250.0	7.5	12.2	36.3	17.8	3.5	18.4	2.8	12.6	1.0	21.9	255.8	2.4	38.3	25.4	22.6	5.4	1.4	0.0	0.7	6.3	0.6	1.9	1.0	9.1	0.1	0.2	1.2	1.6	0.1	38.0	0.1	8.5	0.4	1.6	0.0	0.0	155.7	5.6	7.4	8.8	0.6	0.2	0.1	12.5	0.5	0.0	0.4	0.0	0.1	0.7	0.2	53.3	0.1	0.1	2.3	0.0	1.0	2.0	1.5	0.6	0.0	5.1	0.1	0.0	1.1	0.6	157.4	4.8	0.1	2.7	2.1	2.0	7.7	0.8	0.0	5.7	4.3	1.1	19.1	4.1	0.2	7.0	5.1	8.4	0.8	0.3	0.5	1.2	0.3	1.1	1.2	1.0	0.7	0.5	2.0	0.6	0.7	0.0	0.7	0.4	0.1	2.2	1.1	16.8	19.9	25.0	22.0	18.0	25.7	20.1	12.1	17.3	17.8	12.6	22.6	4.7	6.4	4.2	2.3	1.9	2.3	1.0	0.0	0.0	1.1	1.6	1.3	60.0	4.3	0.0	0.0	6.2	0.2	1.1	0.0	0.0	0.3	0.8	10.2	14.5	13.0	3.0	138.9	27.6	6.5	0.4	12.8	4.6	27.7	10.8	0.1	27.5	20.2	0.9	102.6	19.3	0.4	0.0	13.7	4.2	0.6	10.2	6.5	17.8	6.5	0.1	2.2	0.0	31.2	5.9	4.7	0.0	6.8	0.4	2.1	0.0	0.2	0.0	1.3	19.7	8.8	23.9	2.6	6.8	0.2	1.0	0.1	3.2	0.1	0.1	0.9
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751597-51816363	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.9;Excitatory neurons: 147.3;Horizontal cells: 87.5;Inhibitory neurons: 125.9;Oligodendrocyte precursor cells: 98.0;Oligodendrocytes: 94.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 13.1;monocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	6.1	5.2	30.0	5.6	43.1	0.7	4.2	9.8	63.0	8.8	0.0	12.2	2.2	5.2	3.3	3.9	6.9	4.4	6.3	48.3	17.9	2.5	1.3	3.7	4.4	16.8	12.7	5.4	2.3	4.3	6.0	2.0	21.3	4.3	4.1	15.7	3.1	8.3	2.0	3.7	5.8	5.8	9.5	3.8	3.7	2.2	18.1	4.8	4.0	3.7	4.0	4.7	7.6	27.3	1.2	0.7	2.4	5.7	11.3	12.1	0.4	6.5	2.2	4.8	5.2	0.1	0.6	5.3	0.2	5.1	5.0	3.4	10.2	5.8	1.5	0.1	5.0	0.0	1.0	0.1	1.9	2.1	0.4	7.1	7.7	0.7	1.4	6.4	1.0	13.6	0.0	0.1	6.0	0.9	4.4	0.7	1.6	0.0	1.2	3.4	1.4	0.1	0.8	1.7	37.0	9.1	6.0	0.0	1.7	3.0	1.4	0.3	2.4	12.9	1.0	8.3	4.7	0.0	0.0	0.0	4.1	14.2	6.0	0.2	5.9	8.6	2.3	2.4	0.9	2.7	1.3	1.0	1.6	1.6	1.6	0.7	13.1	1.3	10.6	1.3	0.5	1.2	30.0	43.1	9.8	63.0	48.3	17.9	16.8	12.7	21.3	9.5	18.1	27.3	13.8	0.0	4.1	101.9	7.4	4.8	3.6	1.2	3.4	26.3	3.0	3.0	7.9	0.0	1.7	11.0	22.9	0.1	1.8	0.1	7.9	3.3	30.8	0.9	4.3	13.5	23.4	0.8	147.3	1.8	0.1	12.2	1.1	0.5	0.0	3.0	12.8	0.4	4.9	87.5	125.9	0.7	2.0	7.9	4.4	19.6	11.1	9.1	1.8	53.4	29.8	12.6	3.1	98.0	94.1	2.2	0.2	5.7	2.6	1.9	1.8	1.2	2.8	19.7	6.6	13.1	5.8	6.6	4.9	6.3	7.5	0.3	6.5	1.3	0.5	1.8
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		1200000	"Cluster 42: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	12.2	7.4	4.8	13.6	4.9	9.7	9.4	4.2	5.3	11.4	6.7	15.4	15.5	9.9	10.3	43.4	13.2	11.8	6.9	4.2	3.7	13.5	13.7	21.7	12.8	5.0	5.2	6.9	8.0	7.3	3.4	21.9	4.9	7.5	15.4	3.6	12.8	9.8	3.4	15.0	16.0	9.6	4.9	13.7	16.9	3.4	5.8	12.6	9.6	6.4	19.5	16.4	18.7	5.0	59.4	56.0	22.3	5.8	21.6	35.9	25.8	26.1	35.5	26.7	23.8	21.8	42.4	13.9	21.7	28.0	18.9	82.3	20.7	58.5	33.9	23.8	9.1	20.6	62.6	17.9	24.0	26.6	22.1	24.2	55.7	21.5	66.2	32.9	47.7	20.0	22.3	20.6	32.6	43.9	17.8	17.7	12.4	36.3	10.3	21.0	26.7	37.8	43.5	41.5	5.4	14.6	43.5	28.9	15.6	29.7	19.7	21.0	53.8	33.9	22.6	27.8	31.3	12.5	39.5	15.6	21.7	48.0	20.4	47.6	27.9	41.4	22.7	34.7	20.2	20.4	19.8	20.3	20.6	23.8	16.7	15.7	45.5	18.8	39.3	29.0	26.0	16.7	4.8	4.9	4.2	5.3	4.2	3.7	5.0	5.2	4.9	4.9	5.8	5.0	147.9	397.4	68.2	23.8	43.5	106.9	91.4	66.3	70.6	8.3	38.8	27.3	45.8	30.0	112.7	42.3	14.6	56.1	63.3	117.4	41.1	85.8	38.9	67.5	87.6	131.6	18.6	50.9	29.4	71.6	66.3	84.1	71.9	91.3	143.0	28.8	101.4	52.9	53.9	15.2	25.5	52.0	36.7	51.7	74.1	99.3	45.1	88.4	32.0	33.7	67.5	19.2	60.8	17.1	17.1	152.6	79.0	44.4	44.1	160.3	65.5	56.5	82.2	12.6	13.1	35.2	58.0	14.5	13.9	137.0	132.1	51.3	74.3	57.4	59.9	215.9
TMOD4	Sk-Tmod	ENSG00000163157	"Tropomodulin 4"	Q9NZQ9	1	151169986-151176284	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	68	"skeletal muscle: 1225.0;tongue: 534.1"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.6;U-266/84: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028203	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA028203: AB_10600830"																		0.9	0.9	1.6	2.9	1.6	2.3	1.6	1.5	2.5	0.8	2.2	2.0	1.0	2.0	2.5	12.9	1.8	2.2	0.7	1.7	1.4	0.8	0.2	2.4	5.8	1.5	1.7	1.7	0.4	0.6	0.1	1.3	1.5	10.1	2.4	1.0	8.1	1.8	1225.0	4.1	2.0	1.5	1.4	3.5	1.7	1.4	1.5	2.7	0.5	534.1	7.1	1.2	0.2	1.4	0.9	1.5	2.1	0.5	1.3	0.2	1.8	0.8	0.3	0.8	0.1	0.7	0.8	1.2	0.9	1.2	0.4	0.7	1.5	0.4	0.3	2.9	4.4	2.1	3.4	0.0	0.6	1.9	5.0	0.2	0.6	0.9	2.5	2.4	0.6	4.5	1.2	2.8	0.4	2.4	0.8	8.6	1.3	0.6	2.3	3.6	0.8	0.4	0.3	1.2	1.7	1.4	0.4	0.0	0.2	0.5	0.7	4.0	0.5	0.1	1.0	1.7	1.0	3.4	6.4	1.0	0.6	4.3	0.6	0.0	0.1	0.1	0.5	0.0	0.2	0.4	0.5	0.1	0.0	0.4	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.2	1.6	1.6	1.5	2.5	1.7	1.4	1.5	1.7	1.5	1.4	1.5	1.4	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33097146	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	0.6	0.5	0.8	1.4	0.7	5.5	0.6	0.7	1.2	0.6	4.3	1.0	1.2	0.5	0.6	0.6	0.9	0.6	0.4	1.5	0.5	1.0	0.6	1.1	1.1	1.4	1.4	0.6	0.7	1.9	0.3	1.2	1.6	0.5	1.2	2.8	0.7	0.6	0.2	1.1	1.1	0.8	0.2	1.5	1.3	0.3	1.7	0.5	1.0	0.3	1.3	0.8	0.4	0.2	1.4	1.9	1.0	1.7	1.2	1.0	27.2	0.6	1.0	1.6	0.9	2.7	3.8	0.8	1.2	1.7	0.9	1.4	1.7	1.5	2.6	4.2	0.6	3.4	1.9	2.1	0.9	3.0	4.7	1.1	1.2	2.0	1.4	0.8	1.9	1.7	2.6	2.9	1.2	1.3	1.2	1.3	1.0	0.4	1.1	1.5	0.6	1.9	1.5	1.9	0.2	0.6	0.9	2.6	0.6	1.3	1.4	4.2	2.7	2.4	3.0	1.3	2.6	2.3	1.6	0.4	3.0	2.2	1.7	0.0	1.1	0.3	0.1	2.4	0.6	0.3	0.2	0.0	1.0	0.1	0.0	0.0	1.9	0.0	1.1	0.2	0.2	0.4	0.8	0.7	0.7	1.2	1.5	0.5	1.4	1.4	1.6	0.2	1.7	0.2	0.3	0.0	1.3	0.0	0.8	0.8	0.1	0.0	0.0	1.2	0.4	0.4	0.4	0.0	0.2	0.0	0.0	1.1	1.9	1.4	0.0	0.4	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.8	1.7	0.3	0.0	1.1	0.0	0.4	0.4	0.6	0.9	1.7	0.0	0.2	2.0	1.3	1.2	0.0	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.5	1.4	0.4	1.0	0.2	1.4	0.3	0.4	2.2	0.0	0.2	0.7	0.0	0.0	1.5	0.9	0.4	0.6	0.5	0.6	0.2
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 86.1;lymphoid tissue: 28.4;vagina: 41.7"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	19.9	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.4	12.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	28.4	0.3	41.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.3	0.2	0.3	0.9	0.4	1.1	0.1	0.3	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
TMPRSS11D	"ASP, HAT"	ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884002	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"cervix: 51.6;esophagus: 71.8;lymphoid tissue: 34.4;salivary gland: 21.0;vagina: 76.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 24.4;Club cells: 13.8;Inhibitory neurons: 3.9;Oligodendrocyte precursor cells: 5.0;Urothelial cells: 12.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077704	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA077704: "	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.3	2.6	51.6	1.0	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	2.6	2.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	21.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.9	0.2	0.0	0.0	34.4	0.6	76.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.3	2.6	1.1	1.1	2.6	2.0	2.7	0.7	0.9	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.1	24.4	0.6	0.0	0.0	0.0	0.3	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.0	1.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	12.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447463-68497604	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3"	"Cell type enriched"	"Detected in some"	14	"Ionocytes: 476.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043816, HPA051062"	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA043816: , HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	89.5	0.0	0.0	0.0	0.0	18.2	220.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.0	0.0	56.7	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	24.5	6.5	156.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	12.9	0.7	0.0	0.0	0.5	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	476.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.2	6.6	0.3	1.1	0.7	0.0	0.0	32.6
TMPRSS11F	"FLJ16046, HATL4"	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129869	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.2;skin 1: 9.3;vagina: 4.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 6.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026911	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.1	1.0	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	4.1	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.9	0.0	0.3	0.0	0.1	0.0	0.5
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	512	"intestine: 979.8"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.9	1.7	0.0	0.0	0.2	979.8	0.2	0.0	0.1	0.0	0.1	0.1	0.7	0.6	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	21.8	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.9	1.7	0.7	0.6	0.2	0.6	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.7;intestine: 43.5;urinary bladder: 74.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"	"Immune cell enriched"	"Detected in single"	7	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.2	0.0	0.1	6.1	0.1	0.8	0.3	1.8	0.3	16.6	0.3	43.5	25.4	2.1	3.2	108.7	1.0	14.3	0.2	0.1	0.0	21.1	0.2	1.4	0.2	0.1	0.0	0.1	0.3	0.0	0.2	0.1	0.2	7.8	42.9	0.4	6.5	0.2	0.2	4.1	22.4	1.5	0.0	0.2	31.4	1.1	0.2	1.1	0.2	0.1	14.9	74.6	16.7	0.3	18.5	0.1	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	103.7	0.1	3.5	0.0	0.1	39.2	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	3.4	0.3	0.0	1.3	0.3	4.5	0.1	141.6	0.0	0.1	0.1	0.2	70.6	95.9	0.1	0.1	0.0	8.4	0.1	0.2	0.5	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.8	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.0	1.7	0.0	0.4	1.1	35.2	101.7	38.1	0.0	0.0	0.0	0.7	0.0	103.5	11.0	0.0	0.2	0.0	187.9	0.0	1.5	3.0	45.3	4.6	0.8	4.2	0.0	0.2	7.3	3.0	0.5	53.5	66.4	5.7	0.0	0.0	0.1	0.2	0.0	0.2	55.3	34.6	0.3	0.3	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	52.6	67.5	0.0	2.7	17.5	55.2	2.4	69.4	0.0	0.0	0.0	4.7	0.0	0.1	119.2	6.3	0.3	0.5	0.0	71.2	258.6
TMPRSS7		ENSG00000176040	"Transmembrane serine protease 7"	Q7RTY8	3	112034843-112081269	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 4.3;Early spermatids: 6.0;Excitatory neurons: 4.0;Respiratory ciliated cells: 8.1;Urothelial cells: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA040630	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA040630: AB_10796124"	"unprognostic (4.02e-2)"	"unprognostic (9.87e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.64e-3)"		"unprognostic (6.63e-2)"		"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.06e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.2	1.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.5	4.3	0.6	0.0	0.0	0.5	0.0	0.3	0.0	1.9	0.0	0.0	0.6	0.0	1.6	0.0	0.2	6.0	1.3	0.1	0.4	0.0	0.0	4.0	0.2	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.7	2.2	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.4	2.2	0.0	0.0	1.6	2.6	0.0	8.1	0.0	0.0	0.3	0.5	0.7	0.2	0.0	0.9	0.8	0.4	0.1	0.2	3.0
TMPRSS9		ENSG00000178297	"Transmembrane serine protease 9"	Q7Z410	19	2360238-2426239	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 4.1;lymphoid tissue: 2.4;testis: 3.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 23.4;Erythroid cells: 48.6;Granulosa cells: 22.1;Late spermatids: 59.9;Theca cells: 41.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.5;melanoma: 1.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;SK-BR-3: 1.2;U-266/70: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051483	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA051483: AB_2681501"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.44e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.73e-2)"	0.1	0.7	1.5	0.1	0.5	0.8	0.4	0.7	1.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.0	4.1	0.0	0.1	0.6	0.4	0.2	0.7	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.2	0.0	0.6	0.5	0.1	0.0	0.1	2.4	0.1	3.7	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.2	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.4	0.0	0.3	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.7	0.1	0.3	0.3	0.3	0.3	2.2	0.5	0.4	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.5	0.7	1.3	0.4	0.2	0.6	0.4	0.7	0.1	0.6	0.3	0.2	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.0	0.7	0.2	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	23.4	0.2	0.5	0.1	0.0	48.6	2.4	0.0	0.1	0.5	0.0	0.9	0.0	22.1	0.7	4.8	0.2	0.0	2.1	0.0	0.0	0.0	0.3	59.9	0.9	0.4	0.0	0.0	0.1	0.1	0.0	2.5	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	11.0	3.5	0.0	0.0	0.5	0.1	41.0	0.0	0.0
TMSB15B	MGC39900	ENSG00000158427	"Thymosin beta 15B"	P0CG35	X	103918896-103966712	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 75.3;REH: 58.7"									HPA064607	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA064607: AB_2685298"	"unprognostic (7.47e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.58e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.68e-2)"	"unprognostic (9.33e-4)"	"unprognostic (1.16e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-3)"	4.7	1.7	2.9	2.9	2.7	5.5	7.3	7.5	4.1	12.1	0.4	6.4	2.6	11.1	5.6	2.4	7.2	3.8	2.6	2.6	2.9	2.7	0.7	3.2	5.0	2.5	3.0	15.9	1.6	7.1	3.1	2.3	2.8	6.4	4.3	5.3	2.7	4.8	0.6	3.8	4.0	7.9	2.6	2.4	4.1	1.7	3.4	8.3	2.3	1.5	6.1	5.3	7.8	2.9	0.0	4.1	75.3	32.7	7.3	7.4	2.1	7.0	7.7	20.2	34.0	5.8	2.4	7.1	5.2	8.1	9.2	0.3	1.1	1.3	20.4	2.8	29.5	11.0	0.1	0.3	5.8	1.6	1.2	5.5	6.1	11.9	3.4	10.7	34.6	7.3	5.1	23.3	24.5	1.3	24.6	0.3	12.4	0.1	8.9	58.7	20.3	3.0	14.3	8.1	17.0	26.4	1.0	0.3	10.1	22.1	3.5	6.2	41.8	10.0	11.4	9.0	11.8	2.9	1.6	29.6	12.4	1.4	2.5	3.3	1.0	2.6	2.5	1.6	1.7	10.7	2.9	1.8	2.3	9.5	6.0	3.9	0.8	4.5	0.6	11.4	7.7	1.7	2.9	2.7	7.5	4.1	2.6	2.9	2.5	3.0	2.8	2.6	3.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4 X-linked"	P62328	X	12975110-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 30742.3;Langerhans cells: 57681.0;monocytes: 48133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033806	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	6173.6	4217.0	3255.7	5088.7	3773.0	8722.4	4452.0	3539.2	4521.9	3685.7	2999.1	4327.1	1776.8	3731.3	2877.9	2069.6	2709.3	4129.3	2652.4	3319.4	3573.5	3300.1	2360.4	6225.5	10448.1	4064.7	3620.0	2592.1	1852.6	483.2	1053.7	2450.2	4203.0	2335.6	3793.9	273.3	1886.8	2441.9	816.5	1962.4	3671.2	3340.7	4219.2	7935.5	4690.0	486.8	3591.8	6377.6	1648.7	1475.0	7233.8	5168.6	2907.2	4467.6	5980.6	4886.3	9387.7	14881.1	11264.5	12247.2	23.0	3083.9	8032.6	2344.3	4005.4	1016.1	4865.3	1417.1	2900.6	9443.7	4198.0	2564.2	1411.5	2072.7	3135.4	8343.4	80.9	1771.0	2621.8	12.9	2619.8	6994.8	14038.1	5755.3	2911.9	2781.9	2412.7	5704.5	14335.9	3714.1	230.0	22.0	8424.8	2121.5	8390.5	15083.5	3384.1	2853.1	3337.3	6352.0	3321.0	5858.5	14234.5	1720.4	994.2	422.9	4461.8	207.4	583.3	6898.2	5536.5	6961.4	11607.2	3383.5	1647.5	19441.4	3123.6	4432.5	3490.6	2774.8	5183.2	2860.5	2499.5	42940.3	34738.5	50992.6	21474.2	33907.1	18326.4	18757.1	23777.1	23343.2	31253.2	16919.4	19802.1	20330.2	35862.9	18444.5	37523.3	12797.6	34088.1	86809.5	3255.7	3773.0	3539.2	4521.9	3319.4	3573.5	4064.7	3620.0	4203.0	4219.2	3591.8	4467.6	6885.8	5253.2	4939.6	35.9	6293.8	8836.3	2708.7	10515.3	296.5	332.9	2318.3	1124.2	106.9	3484.4	8003.6	6882.2	22.9	283.0	9136.2	9016.2	2181.5	17304.6	142.1	2613.2	4698.0	9239.4	1765.0	1339.1	54.3	23029.4	511.7	4800.1	2728.9	5047.4	4380.4	4646.7	6638.0	1088.5	30742.3	62.2	81.0	4883.9	14806.8	20982.2	57681.0	343.6	3932.0	17648.1	6349.9	212.7	48133.8	86.7	20882.8	19.6	102.1	25113.5	5826.4	6035.9	2541.8	3272.5	6888.7	835.1	2596.4	99.4	5732.4	1018.2	5450.7	58.2	126.3	933.7	9528.5	454.8	12719.6	3874.8	3140.6	9064.0
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane O-mannosyltransferase targeting cadherins 1"	Q8IUR5	12	29500840-29784759	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Astrocytes: 64.6;Excitatory neurons: 186.0;Inhibitory neurons: 200.5;Skeletal myocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 83.0;HSkMC: 56.9;hTERT-HME1: 103.8;LHCN-M2: 58.8;RH-30: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	36.7	14.1	14.5	5.2	21.0	0.2	16.8	6.7	13.5	11.9	13.3	11.9	3.1	9.0	3.0	6.8	14.3	7.1	16.5	20.0	25.0	14.7	2.4	8.7	2.7	11.4	24.0	9.3	2.6	28.0	10.7	2.8	15.8	6.9	5.9	2.6	4.5	8.8	18.5	4.0	6.4	13.2	7.9	42.4	8.3	2.4	25.1	6.9	4.7	31.2	2.1	12.1	8.2	6.3	0.0	0.0	15.3	0.0	47.7	31.6	0.1	14.7	33.1	4.3	3.4	0.0	0.2	0.1	7.4	10.0	17.6	0.0	0.5	0.2	0.2	0.3	4.6	0.0	41.5	0.7	83.0	2.1	0.0	56.9	5.6	40.3	103.8	12.2	2.2	0.0	0.0	2.2	58.8	0.0	0.0	0.0	11.1	0.2	20.8	0.0	122.4	2.1	0.0	0.3	1.2	1.2	1.7	0.0	4.1	5.4	0.0	0.8	6.2	3.7	2.4	2.3	12.5	19.6	0.0	0.0	27.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.5	21.0	6.7	13.5	20.0	25.0	11.4	24.0	15.8	7.9	25.1	6.3	105.0	3.2	0.6	64.6	0.9	3.3	1.0	6.1	11.4	12.1	1.3	10.4	32.3	0.0	2.4	3.7	0.0	0.1	0.0	0.0	0.0	0.1	29.6	7.7	16.2	57.9	0.0	0.0	186.0	0.0	0.0	17.5	2.0	7.0	0.0	4.3	54.7	5.4	0.5	0.0	200.5	0.2	0.0	17.7	4.2	7.5	8.1	4.9	10.6	30.9	0.5	0.5	0.0	9.5	5.7	0.0	0.0	18.4	0.3	4.0	0.1	0.7	6.0	1.3	46.0	60.3	24.9	2.4	1.7	1.3	2.0	1.9	1.0	21.9	0.0	0.4
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane O-mannosyltransferase targeting cadherins 2"	Q8N394	12	82686880-83134870	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 60.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 2152.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.0;WM-115: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	3.7	0.8	11.4	4.7	39.8	2.1	4.6	21.4	25.1	4.8	0.0	11.7	2.8	5.4	4.4	9.8	10.0	7.8	2.0	11.2	19.1	6.6	1.2	6.4	1.8	28.3	29.9	1.9	4.5	2.8	3.5	3.4	26.7	6.1	5.7	5.5	6.9	11.2	1.2	5.2	4.7	6.8	11.7	1.3	10.2	3.0	26.8	1.5	6.4	1.7	2.2	7.5	7.3	60.8	1.7	6.4	32.0	0.2	4.3	3.9	2.9	2.1	0.7	1.7	0.3	0.3	3.4	0.0	0.5	11.9	1.2	2.8	9.7	4.9	0.5	7.5	5.8	0.0	5.2	0.2	0.4	2.2	1.0	1.1	4.3	0.2	1.6	3.4	2.7	3.5	0.0	4.2	0.4	3.4	1.6	8.8	1.1	6.0	5.3	0.0	1.3	0.6	2.9	14.1	8.3	15.1	2.9	4.6	21.0	5.4	4.9	0.5	1.7	5.3	1.8	7.2	2.7	7.8	5.7	1.2	1.2	3.8	80.2	0.0	0.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	11.4	39.8	21.4	25.1	11.2	19.1	28.3	29.9	26.7	11.7	26.8	60.8	10.7	9.6	8.9	333.3	2.0	14.4	15.5	12.0	18.2	38.1	8.9	5.5	1.8	11.5	18.4	14.7	8.4	13.6	3.1	3.6	0.0	5.4	12.9	13.5	7.5	10.3	2.4	0.8	117.1	8.2	1.7	9.8	12.8	13.1	0.0	0.2	2.5	1.4	1.9	8.4	377.0	9.8	2.0	6.6	9.6	5.0	5.9	6.2	32.0	86.2	9.3	13.9	1.0	38.7	2152.4	9.4	3.3	1.2	7.3	11.9	2.7	2.1	17.0	1.6	6.6	0.8	2.2	0.6	2.2	16.2	11.5	4.1	2.8	1.0	5.9	14.5
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane O-mannosyltransferase targeting cadherins 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	5.9	4.4	3.6	3.8	3.8	1.7	6.7	5.8	4.7	5.6	2.1	4.5	5.4	6.4	5.2	9.1	3.9	5.7	3.8	3.9	4.6	8.1	9.0	5.2	2.9	3.4	3.9	5.3	3.2	6.2	2.8	10.2	4.1	7.4	4.7	7.9	3.8	6.3	1.7	12.5	4.4	9.2	3.2	3.9	3.8	4.1	3.6	4.0	6.3	4.3	4.5	6.8	4.7	4.1	13.2	14.0	12.6	11.9	28.8	25.4	22.5	28.1	26.6	15.8	16.9	20.3	9.2	4.1	5.0	25.8	9.6	28.9	13.5	22.4	26.5	2.4	10.2	4.0	9.5	9.3	15.0	4.3	2.5	21.7	12.0	30.5	12.0	16.2	24.9	3.4	8.9	1.4	17.8	7.9	3.0	5.5	9.7	5.0	7.3	2.6	27.4	4.1	13.7	21.3	10.7	10.6	22.8	16.1	7.3	13.3	25.9	4.3	26.4	21.8	12.0	19.4	13.7	4.5	6.3	4.7	6.8	5.0	16.5	7.4	1.3	2.3	1.8	1.1	2.2	2.3	2.0	1.4	0.9	1.8	2.4	2.0	1.3	1.2	1.6	0.9	1.7	0.7	3.6	3.8	5.8	4.7	3.9	4.6	3.4	3.9	4.1	3.2	3.6	4.1	15.9	12.8	8.2	19.6	6.9	34.2	24.4	29.1	24.5	12.5	11.4	8.1	11.1	5.7	20.0	7.3	27.1	29.6	3.5	6.7	3.9	14.5	26.8	23.7	22.2	16.9	3.6	9.5	51.6	10.8	18.2	23.8	8.6	21.9	9.5	12.4	15.7	19.2	8.2	13.5	46.8	5.9	75.3	5.9	6.0	18.2	20.2	3.7	8.8	20.6	2.8	8.3	2.1	28.1	42.4	12.4	4.9	19.5	4.6	18.0	7.3	13.9	34.9	23.4	19.7	17.1	22.3	12.0	8.7	32.6	40.5	17.8	5.2	14.1	7.1	14.4
TMTC4	"FLJ14624, FLJ22153"	ENSG00000125247	"Transmembrane O-mannosyltransferase targeting cadherins 4"	Q5T4D3	13	100603625-100675093	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 139.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016489, HPA057056"	Approved		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA016489: AB_1858157, HPA057056: "	"unprognostic (1.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	5.2	4.2	13.4	5.9	22.9	3.1	6.5	18.9	34.0	6.9	11.5	8.4	9.9	9.6	8.0	5.1	14.3	5.7	4.0	14.0	16.0	12.5	11.3	4.3	4.8	21.6	19.4	6.1	10.5	10.7	3.3	5.0	21.9	8.7	8.5	10.0	8.7	6.0	13.6	7.4	8.6	7.0	17.9	4.3	9.2	11.8	19.1	7.1	8.1	8.7	5.7	7.7	4.6	32.2	10.4	7.7	42.2	21.2	5.7	10.5	44.6	5.5	5.0	5.0	4.1	8.1	17.5	29.6	18.4	5.0	12.0	6.8	13.5	7.8	6.6	16.9	9.3	12.6	15.4	13.0	7.1	15.7	0.4	14.7	11.1	2.2	8.8	14.8	23.5	16.1	9.5	3.7	5.7	9.2	12.5	9.0	11.3	27.8	7.8	13.9	7.7	6.8	19.8	7.4	21.1	21.9	11.1	19.7	5.3	26.0	14.6	44.6	36.6	4.8	8.2	4.1	9.7	9.5	9.1	5.8	22.4	9.9	13.5	0.0	1.1	0.1	1.3	1.2	1.1	1.0	1.3	2.1	3.3	1.2	1.5	0.5	0.0	0.7	1.8	2.3	2.1	0.8	13.4	22.9	18.9	34.0	14.0	16.0	21.6	19.4	21.9	17.9	19.1	32.2	4.7	6.4	3.9	18.9	4.5	3.1	7.2	4.2	3.4	19.0	10.7	4.1	11.3	18.6	6.2	5.5	8.4	11.6	5.6	7.7	1.9	11.6	5.8	12.2	9.7	8.4	10.7	5.0	11.1	18.7	19.8	6.2	6.1	14.4	0.0	12.8	39.7	15.3	4.3	26.9	19.4	10.1	2.0	6.9	2.5	6.2	4.1	3.7	3.6	9.4	3.3	8.2	5.2	15.1	139.6	13.0	7.4	6.8	3.6	10.9	10.5	14.2	6.8	8.6	6.6	4.2	5.8	9.7	32.3	7.9	5.8	3.1	4.1	5.3	11.7	5.3
TMUB1	"C7orf21, HOPS, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081085-151083493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	33.1	53.3	26.8	25.6	24.7	23.0	34.3	25.6	38.6	34.0	19.4	52.7	47.2	33.6	8.6	54.2	32.8	14.9	50.4	24.9	24.6	56.3	131.3	41.6	26.3	29.6	25.9	37.0	93.5	20.3	68.8	20.4	27.0	51.2	8.3	5.2	44.1	14.9	84.5	47.0	56.7	9.0	24.2	53.6	66.8	25.9	29.4	17.9	51.3	20.0	12.1	40.8	38.9	23.7	88.3	77.5	18.0	93.2	11.6	14.2	67.2	35.3	29.3	30.8	34.3	67.5	104.6	58.6	73.9	17.4	39.9	58.6	20.0	31.2	6.8	108.0	74.4	24.8	74.8	104.7	29.5	31.3	84.8	22.0	25.4	25.8	6.9	23.4	22.9	59.3	159.4	77.4	14.0	141.2	104.5	134.5	77.2	51.7	48.3	64.8	22.7	108.5	32.2	67.4	65.6	73.2	28.6	43.6	47.9	10.6	34.0	42.9	28.3	39.0	28.5	49.3	59.1	121.2	72.5	41.4	89.8	58.2	50.4	4.2	3.1	23.8	5.7	4.3	5.0	5.3	8.7	6.4	3.2	11.2	8.7	4.8	5.3	3.7	2.6	4.8	12.1	2.4	26.8	24.7	25.6	38.6	24.9	24.6	29.6	25.9	27.0	24.2	29.4	23.7	24.0	6.4	3.2	7.5	51.2	26.4	25.9	26.0	31.9	15.2	45.7	34.8	9.9	28.6	15.9	22.0	14.6	93.1	50.2	136.7	35.2	73.1	11.9	15.8	11.7	21.5	41.3	23.2	4.5	109.6	60.2	18.3	52.0	29.3	15.9	23.3	25.4	51.4	44.2	20.2	5.3	85.9	46.8	30.4	61.2	5.1	12.5	32.4	32.0	6.5	44.8	28.9	70.0	2.5	7.2	96.3	109.7	16.6	67.8	39.3	191.0	37.9	6.4	16.0	39.5	9.3	21.8	22.3	15.6	39.5	36.9	94.5	52.8	25.4	84.0	37.9
TMUB2	MGC3123	ENSG00000168591	"Transmembrane and ubiquitin like domain containing 2"	Q71RG4	17	44186970-44191929	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043137	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Vesicles, Cytosol"		"HPA043137: AB_10794388"	"unprognostic (4.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.78e-3)"	32.2	35.7	34.1	22.9	34.4	43.9	32.5	34.9	38.1	37.3	32.5	39.1	24.5	32.5	21.9	37.3	33.9	25.2	33.1	34.2	32.8	36.9	35.8	31.5	26.3	33.6	33.8	35.2	36.9	27.5	32.9	25.9	32.9	42.0	21.9	16.8	36.1	26.3	32.7	32.4	36.5	21.7	32.2	52.8	36.7	46.8	34.2	23.2	42.7	20.0	20.5	35.3	34.3	34.3	22.8	43.0	27.6	25.1	41.6	32.8	21.6	29.5	31.6	53.7	54.4	22.7	41.5	15.8	31.1	36.1	40.5	42.3	19.3	28.0	33.4	38.7	39.7	16.5	40.9	35.1	43.8	18.7	35.5	40.1	39.8	36.9	22.9	45.1	37.8	25.8	19.2	45.4	35.7	15.9	26.0	23.8	9.1	19.0	35.7	23.2	33.3	25.5	33.8	25.2	21.8	22.2	15.5	14.4	29.4	27.6	42.2	23.0	31.8	44.4	27.0	31.1	26.7	33.5	26.1	15.4	34.0	15.7	30.4	84.1	30.0	57.3	17.1	26.7	14.5	16.6	14.3	16.5	19.1	23.8	13.4	15.3	65.4	13.9	29.0	23.1	18.1	20.4	34.1	34.4	34.9	38.1	34.2	32.8	33.6	33.8	32.9	32.2	34.2	34.3	24.8	35.3	25.9	21.2	40.8	13.0	21.2	27.0	25.6	30.8	29.8	25.3	16.7	22.8	27.2	22.0	31.3	46.3	24.9	42.5	3.9	21.0	51.0	13.9	16.8	20.4	33.5	25.7	15.8	18.8	29.6	22.0	23.0	25.1	22.1	25.6	18.9	13.9	42.6	21.9	16.4	27.1	12.2	37.9	25.9	28.4	21.8	30.9	14.2	16.9	31.5	29.1	25.7	14.6	12.2	25.8	33.2	24.0	18.8	20.5	39.6	10.7	18.9	27.9	26.3	14.6	19.6	81.5	37.1	17.2	14.9	96.7	27.6	30.0	27.0	23.4
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257655	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		26000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	11.0	8.8	5.8	10.8	6.3	10.7	11.3	6.7	8.7	7.8	7.4	12.3	10.6	8.1	10.8	9.1	6.6	8.5	4.8	5.4	6.6	10.2	12.6	9.3	12.4	6.5	6.8	6.6	9.1	9.4	5.5	13.2	7.0	7.9	12.2	6.8	8.3	9.2	5.2	9.8	9.3	9.9	6.9	10.7	10.4	5.0	7.0	11.6	11.4	4.4	10.5	13.0	6.6	7.0	27.0	23.8	33.8	18.4	26.0	20.3	35.5	33.5	26.8	33.2	42.2	24.9	49.0	38.8	30.0	22.6	15.6	26.1	60.3	21.5	60.4	38.6	19.6	28.4	19.4	24.7	22.4	66.2	27.4	24.4	19.5	22.2	16.3	24.0	29.7	31.2	23.6	25.9	32.1	32.6	29.7	35.5	38.3	42.2	28.5	30.9	60.9	23.4	32.2	34.8	21.1	15.5	26.6	17.8	24.6	22.2	25.8	28.6	19.0	34.9	32.2	24.8	30.9	22.4	23.9	31.4	15.4	36.6	33.5	10.5	12.2	6.2	8.6	14.7	10.6	7.7	8.8	9.0	13.6	6.3	8.5	10.1	4.3	11.5	11.0	15.7	11.0	12.4	5.8	6.3	6.7	8.7	5.4	6.6	6.5	6.8	7.0	6.9	7.0	7.0	43.0	38.5	29.1	24.5	55.9	108.6	63.1	80.5	71.2	13.7	40.7	20.8	9.2	44.3	55.7	35.0	12.5	73.9	82.6	38.2	9.8	62.1	2.5	22.0	42.2	47.5	17.4	81.2	8.9	67.6	149.3	48.4	32.1	28.0	43.6	24.4	43.2	44.0	73.2	10.1	11.2	29.2	63.1	61.1	84.3	4.3	24.8	65.7	55.2	18.7	70.0	27.0	46.4	22.1	25.2	50.3	44.0	28.6	79.2	58.4	29.3	32.4	42.2	32.6	59.2	37.3	49.4	59.5	68.7	79.0	97.3	57.7	62.5	58.7	46.5	59.5
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"	NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.7	16.2	11.7	24.1	13.0	14.1	19.2	14.2	15.4	15.0	9.9	12.7	18.2	16.6	20.4	14.1	13.8	16.5	20.8	13.5	13.2	14.6	16.2	19.5	27.9	11.1	11.2	13.0	11.9	15.9	9.6	19.8	12.1	17.7	16.3	26.0	10.6	13.0	11.0	16.7	18.8	21.0	11.4	22.6	14.0	11.4	12.1	23.3	17.7	21.0	22.7	20.1	11.2	11.5	11.1	17.4	32.9	25.9	66.6	70.7	24.5	85.7	91.0	61.0	67.7	8.4	31.9	31.4	16.6	125.4	25.9	40.8	21.9	42.9	92.8	30.3	19.6	28.8	27.4	14.7	70.6	62.0	45.7	56.5	27.1	66.2	59.2	61.8	78.4	27.0	18.9	42.5	73.1	6.9	33.3	19.6	13.9	9.1	28.2	30.7	65.5	38.5	51.7	24.2	31.5	24.5	42.0	26.7	31.8	32.4	17.6	52.1	76.4	108.4	30.0	24.7	63.6	28.4	30.4	29.4	65.5	50.1	81.3	2.2	2.9	2.4	3.8	4.7	5.5	3.1	3.9	3.6	4.7	2.1	4.3	4.4	0.7	4.9	3.3	6.4	4.4	2.7	11.7	13.0	14.2	15.4	13.5	13.2	11.1	11.2	12.1	11.4	12.1	11.5	31.4	28.9	27.8	36.2	25.0	20.3	17.2	17.6	12.0	29.1	21.0	15.6	25.1	10.0	18.8	16.5	18.8	15.0	44.3	10.6	1.9	15.2	8.9	18.7	38.5	27.3	18.0	17.0	77.9	10.2	20.8	34.5	13.3	25.6	20.3	24.2	34.2	26.6	18.6	26.9	45.6	13.8	14.2	23.3	26.8	3.3	24.2	23.9	24.9	32.8	18.2	20.5	20.6	49.8	53.1	15.4	15.4	16.6	29.8	19.4	17.5	8.0	28.8	32.5	39.5	23.6	32.0	23.8	28.3	21.7	24.3	12.4	23.3	22.9	9.4	16.6
TMX4	"DJ971N18.2, KIAA1162, PDIA14, TXNDC13"	ENSG00000125827	"Thioredoxin related transmembrane protein 4"	Q9H1E5	20	7977346-8019805	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 690.2;Late spermatids: 1524.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000399, HPA015752"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA000399: AB_1858471, HPA015752: AB_1858470"	"unprognostic (3.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.14e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.96e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.16e-1)"	"prognostic favorable (2.60e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	19.5	38.8	19.8	18.5	20.5	30.7	19.8	17.1	27.5	41.7	29.2	24.4	13.4	29.3	33.5	15.1	29.4	19.8	59.4	20.7	55.8	29.7	28.8	19.4	15.0	29.0	24.9	35.8	15.1	38.0	28.9	12.1	23.9	26.6	12.9	37.8	37.2	42.3	30.3	8.1	14.3	26.7	20.6	17.6	17.5	64.9	43.5	15.3	26.4	32.5	14.7	17.9	13.7	18.4	10.4	14.5	14.0	15.9	30.4	33.5	4.2	25.7	34.0	15.4	11.0	10.0	24.0	27.3	20.2	24.9	22.6	9.5	10.1	15.2	16.0	14.0	12.9	13.1	5.7	16.0	28.6	48.5	19.0	20.5	19.1	13.4	31.0	36.9	18.1	19.5	16.3	65.4	17.3	6.7	1.5	30.3	12.0	14.9	16.5	17.5	50.4	27.6	21.8	5.7	28.1	35.2	42.2	1.9	24.6	8.8	17.7	23.4	26.1	41.4	12.1	15.9	25.2	69.3	21.6	51.6	20.1	23.8	29.7	81.5	28.0	78.2	39.0	16.4	37.9	35.8	39.1	55.8	32.9	27.5	23.4	32.0	164.1	41.8	18.0	11.2	55.1	52.7	19.8	20.5	17.1	27.5	20.7	55.8	29.0	24.9	23.9	20.6	43.5	18.4	52.7	35.3	29.2	22.2	66.4	16.4	65.1	23.7	22.2	57.9	38.6	52.6	257.5	40.0	20.8	58.8	58.4	19.5	91.5	21.9	21.5	31.0	690.2	266.2	44.4	49.7	55.8	51.1	85.8	32.7	5.2	80.3	38.7	29.4	60.3	34.5	45.7	53.3	24.7	92.5	68.6	21.1	40.7	33.8	40.3	1524.7	77.0	55.1	46.2	20.6	37.5	85.7	64.9	38.7	38.4	24.7	20.4	56.1	72.9	45.3	31.1	23.8	29.4	99.0	32.9	136.4	43.1	178.7	39.7	30.9	15.6	8.2	99.2	28.2	24.6	30.4
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019575-115118257	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 376.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.3;Basal prostatic cells: 72.1;Basal respiratory cells: 150.6;Basal squamous epithelial cells: 126.3;Prostatic glandular cells: 69.2;Smooth muscle cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 798.5;hTEC/SVTERT24-B: 634.4;U-138 MG: 526.0;U-251 MG: 484.5;U-87 MG: 711.8;WM-115: 1253.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	840000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	61.0	4.7	16.4	170.4	28.5	0.9	41.2	14.0	9.8	43.6	3.0	174.3	16.7	106.8	12.2	23.9	25.5	14.1	32.6	15.6	34.3	82.0	7.7	54.2	39.8	20.3	43.8	5.3	4.8	2.3	7.2	4.0	28.0	39.1	28.3	4.8	19.8	33.3	6.2	25.9	56.5	376.2	15.0	40.8	62.4	4.8	65.4	17.1	13.3	3.2	22.6	96.7	15.9	20.5	25.1	6.0	6.9	1.3	37.5	10.1	0.1	205.7	798.5	425.4	203.6	5.3	55.3	0.0	32.8	291.7	6.9	89.9	0.0	12.0	241.3	0.4	2.2	0.0	4.8	0.0	0.7	0.4	3.9	6.2	1.7	634.4	289.9	42.9	0.1	0.0	0.0	5.2	11.4	0.0	0.1	0.3	65.2	0.9	85.3	0.2	451.9	0.1	373.3	0.1	0.6	5.9	91.4	0.2	19.3	140.9	1.0	1.4	0.1	526.0	88.4	94.2	484.5	14.3	0.4	0.4	711.8	0.6	1253.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.4	28.5	14.0	9.8	15.6	34.3	20.3	43.8	28.0	15.0	65.4	20.5	0.7	12.8	43.5	160.3	0.4	12.1	72.1	150.6	126.3	0.1	9.3	33.3	1.4	0.0	14.8	1.8	0.0	1.1	0.3	0.0	0.0	25.8	15.4	6.7	47.8	11.1	0.0	0.0	7.0	4.5	0.6	19.0	0.0	24.9	2.5	0.5	6.1	0.0	1.2	0.0	0.9	0.0	0.0	0.6	4.7	18.4	3.4	0.9	5.4	1.9	0.1	1.3	0.0	4.0	0.8	3.9	0.0	0.4	0.3	69.2	0.0	0.3	3.5	0.2	0.0	1.3	58.9	0.4	0.2	4.8	4.5	1.0	2.6	0.1	0.1	5.8
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 68.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6"	"Group enriched"	"Detected in some"	8	"HDLM-2: 103.7;NB-4: 214.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100		"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	1.4	0.5	0.0	3.3	0.0	12.7	0.5	0.0	0.1	0.1	0.0	0.9	0.0	1.5	0.0	0.7	0.3	0.6	2.6	0.1	0.0	1.2	0.6	3.6	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	1.5	2.4	0.2	0.1	6.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.8	0.0	0.0	0.0	0.0	103.7	0.0	19.4	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	10.1	0.0	23.2	39.5	36.6	7.2	17.2	13.9	7.6	7.0	5.0	5.2	20.8	2.0	68.0	4.3	13.6	14.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	3.0	0.0	90.7	8.4	1.2	12.1	4.6	0.2	17.4	20.4	2.0	2.8	4.0	0.0	2.1	0.9	60.8	0.5	0.0	7.4	0.1	15.5	5.9	10.7	0.0	0.0	0.0	3.3	1.7	2.0	1.5	30.5	12.6	0.0	1.8	0.1	36.5	0.0	0.0	0.4	10.2	14.1	72.7	0.0	0.3	108.3	5.4	1.9	3.4	0.1	2.1	0.0	0.1	14.3	0.0	0.0	10.4	1.7	0.0	0.1	3.0	0.2	0.0	0.6	4.0	0.0	0.0	1.3	4.1	1.1	100.0	0.0	0.4	0.3
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 166.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavorable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	36.1	30.4	32.4	19.3	31.1	8.1	30.3	28.5	32.0	22.0	38.6	19.9	17.7	21.7	14.9	39.6	19.2	28.9	46.7	30.9	29.1	35.9	54.8	40.9	17.0	30.3	30.1	17.4	37.6	23.0	17.5	44.7	29.4	20.5	16.9	26.3	23.9	20.5	23.3	29.0	17.7	30.9	28.9	50.2	25.4	17.2	35.7	22.0	24.0	23.8	19.5	35.1	23.4	28.9	43.3	61.3	40.2	28.4	34.3	30.1	39.0	50.4	62.4	60.6	47.6	166.1	25.8	8.7	34.4	67.0	29.4	49.1	22.3	86.9	46.5	24.0	28.0	7.7	66.0	24.2	45.9	13.5	12.5	38.9	99.7	47.7	37.0	56.9	71.7	17.4	20.0	12.8	28.8	25.8	25.6	7.4	9.3	36.4	22.3	11.3	50.8	15.5	89.5	45.9	29.3	31.7	62.3	102.5	25.8	55.8	42.9	11.4	76.4	44.2	43.7	34.4	39.3	20.8	18.7	9.3	34.3	9.0	28.5	1.7	7.2	9.5	6.5	7.0	7.7	5.3	4.7	5.9	9.3	3.9	4.5	5.5	2.5	9.1	8.7	4.5	4.3	5.0	32.4	31.1	28.5	32.0	30.9	29.1	30.3	30.1	29.4	28.9	35.7	28.9	66.6	38.5	12.9	5.5	4.6	24.6	47.5	32.0	12.5	25.6	18.2	11.9	21.8	20.0	17.5	22.0	16.7	31.5	6.2	14.3	23.5	60.5	40.1	23.0	13.9	62.4	17.4	7.4	11.7	82.5	34.9	13.5	12.8	30.2	7.0	14.0	60.3	29.5	11.0	11.8	7.5	11.0	10.2	12.5	12.1	6.9	7.8	7.0	0.0	9.4	30.1	10.0	4.1	7.1	7.2	112.9	15.1	7.9	7.1	46.9	13.6	16.9	20.2	9.8	13.1	10.9	22.3	5.4	5.6	15.9	28.4	69.2	5.0	18.1	9.7	43.0
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380046	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"urinary bladder: 196.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 443.9;Fibroblasts: 302.3;Langerhans cells: 137.4;Melanocytes: 74.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"neutrophil: 183.0"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 183.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.5;HHSteC: 40.3;hTEC/SVTERT24-B: 54.9;SH-SY5Y: 21.6;U-2197: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Uncertain				"Secreted to blood"	NA	NA		100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB032719: AB_2204650, HPA050884: AB_2681261"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (9.16e-5)"	15.6	0.5	1.9	27.6	2.2	7.6	11.1	1.5	2.8	9.2	1.2	6.3	0.7	2.0	0.3	2.2	2.2	19.8	15.4	1.7	2.2	0.4	1.2	11.0	0.6	1.6	2.2	0.5	1.2	0.3	0.4	1.8	1.9	3.2	2.8	0.0	3.4	0.9	1.7	2.7	2.2	7.2	1.6	3.0	4.0	10.6	2.6	1.4	1.6	2.8	0.5	196.0	1.6	2.3	0.0	0.0	0.0	0.0	3.8	15.5	0.0	2.5	67.5	2.5	12.4	0.0	0.0	0.0	0.8	1.1	1.4	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.3	0.0	40.3	0.0	0.0	19.5	0.0	54.9	3.8	2.3	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.3	0.0	15.5	0.0	1.1	0.0	0.0	0.0	0.0	21.6	0.5	0.0	0.0	0.4	0.0	0.0	0.0	2.2	4.4	44.3	0.8	0.0	0.0	0.0	4.8	0.7	3.3	0.0	8.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	183.0	0.0	2.1	0.0	0.0	2.5	1.9	2.2	1.5	2.8	1.7	2.2	1.6	2.2	1.9	1.6	2.6	2.3	4.5	3.2	1.7	1.3	1.1	64.7	0.9	11.1	0.0	0.0	1.5	1.4	2.2	0.0	1.5	0.0	0.0	0.1	0.3	0.1	0.0	2.8	443.9	2.9	2.7	7.3	0.0	0.8	0.7	0.0	0.9	302.3	0.5	10.6	2.5	0.0	1.4	0.0	1.4	0.0	0.4	0.0	0.0	6.9	137.4	38.5	2.5	49.6	74.7	1.9	5.9	0.0	0.0	13.6	7.1	1.5	0.0	0.4	1.4	3.0	0.0	0.2	0.2	0.0	0.0	40.6	45.5	10.7	1.9	1.0	53.0	1.8	6.0	0.3	0.0	3.8
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 155.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	72.4	5.1	4.2	62.3	4.1	65.5	19.3	8.9	7.0	15.9	31.2	17.8	16.1	13.3	17.1	25.3	10.5	16.6	8.5	3.9	4.0	16.4	10.1	19.1	117.8	4.9	4.1	3.5	16.8	14.8	1.6	52.5	4.8	18.9	19.0	2.4	11.2	14.4	3.3	31.6	31.3	15.5	1.7	61.1	28.6	17.5	5.1	100.0	25.3	5.6	115.9	43.6	17.8	6.6	27.7	19.0	10.0	16.1	20.5	17.2	91.2	15.0	40.4	11.1	23.0	10.2	31.6	51.0	4.7	16.7	17.6	38.4	8.3	45.4	15.7	56.6	17.9	81.4	41.1	17.6	9.9	99.6	86.4	19.1	42.0	33.7	15.9	21.2	15.4	99.9	32.0	155.2	15.5	10.7	84.5	128.9	15.0	16.0	8.9	25.6	44.1	75.8	44.5	54.8	5.1	7.8	56.6	10.9	5.5	32.1	9.4	111.4	8.1	20.2	7.8	14.1	17.9	76.0	90.0	103.3	23.3	104.8	11.9	491.9	96.1	305.0	111.0	105.1	217.3	267.2	221.9	164.7	133.6	243.5	260.8	169.7	54.6	111.4	86.7	63.8	188.4	213.0	4.2	4.1	8.9	7.0	3.9	4.0	4.9	4.1	4.8	1.7	5.1	6.6	8.9	9.6	18.7	1.6	174.9	160.5	80.9	81.9	123.5	0.2	14.4	10.8	10.3	12.8	38.3	18.4	0.0	142.6	83.6	2.7	17.6	55.4	4.4	11.8	7.8	23.2	1.2	34.5	0.8	101.0	158.8	30.1	17.9	9.5	211.8	0.7	6.4	1.9	48.9	0.0	2.3	9.9	20.3	59.4	323.4	1.4	2.1	126.0	37.4	24.4	196.6	4.3	111.2	1.0	6.8	125.7	2.7	1.9	45.6	63.9	0.9	19.8	47.2	0.4	46.0	4.0	32.9	1.1	18.0	93.1	119.2	292.7	139.0	35.2	4.3	103.6
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TNFRSF10B	"CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB"	ENSG00000120889	"TNF receptor superfamily member 10b"	O14763	8	23020133-23069031	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 81.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023625	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023625: AB_1847860"	"unprognostic (8.43e-3)"	"unprognostic (7.43e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.52e-2)"	20.7	21.8	4.4	17.1	4.0	13.9	16.8	3.7	4.2	10.7	19.5	14.7	22.0	11.1	6.8	10.4	13.5	23.9	14.0	4.8	3.9	15.1	34.7	22.9	14.9	4.7	4.8	17.8	21.9	19.6	6.5	13.6	4.4	12.2	21.7	1.1	13.2	10.7	10.6	6.9	25.0	16.2	4.8	17.4	14.1	5.1	5.9	8.3	16.8	4.8	16.7	31.1	9.5	4.7	39.0	98.4	144.6	46.5	71.7	93.7	143.0	91.2	123.5	50.7	77.6	40.9	39.1	23.1	59.1	52.4	88.4	37.2	39.3	179.7	90.4	22.9	31.2	0.0	43.6	85.4	238.0	9.6	37.5	136.1	164.6	110.5	121.1	131.9	160.4	27.5	16.1	0.2	104.5	12.3	0.8	14.3	37.0	52.6	34.6	21.0	53.5	14.8	100.2	62.7	0.2	24.2	46.4	14.0	51.1	101.6	23.1	9.9	145.3	71.8	36.4	23.2	66.6	27.4	4.7	10.8	74.6	17.8	106.6	3.8	17.8	0.6	1.9	12.6	3.0	4.0	2.4	2.0	15.8	1.9	4.7	1.9	3.6	1.2	17.5	0.0	1.6	7.8	4.4	4.0	3.7	4.2	4.8	3.9	4.7	4.8	4.4	4.8	5.9	4.7	41.8	12.8	35.6	8.1	17.6	31.6	35.0	55.9	34.7	0.8	31.7	26.7	3.7	12.8	36.4	12.9	0.0	4.2	10.4	28.4	3.9	29.1	1.3	42.2	16.8	39.4	0.0	4.0	3.3	26.5	8.8	18.8	60.6	81.9	9.5	17.1	18.9	27.1	9.8	0.0	1.1	20.8	14.2	21.3	69.6	2.3	7.2	33.1	19.6	38.4	15.5	2.6	1.0	15.1	0.6	50.7	22.6	6.8	5.1	37.7	36.4	9.2	18.7	0.3	0.0	15.4	14.3	0.3	2.1	25.3	18.2	4.2	14.3	21.0	26.0	53.1
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102921-23117445	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 23.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.9;Endothelial cells: 5.3;Gastric mucus-secreting cells: 13.7;granulocytes: 8.8;Proximal enterocytes: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 3195.8"	"Lineage enriched"	"Detected in many"	120	"granulocytes: 3195.8"	"Group enriched"	"Detected in many"	5	"BEWO: 108.8;HUVEC TERT2: 91.2"									CAB025635	Enhanced					NA	NA	14600000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB025635: "	"unprognostic (2.63e-1)"	"unprognostic (4.49e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.74e-3)"	"unprognostic (4.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.54e-2)"	8.3	1.8	1.2	23.8	1.0	21.0	1.0	0.9	2.4	4.1	1.7	2.8	2.0	1.1	0.7	2.2	4.7	12.7	1.6	0.7	1.0	2.6	2.6	7.5	1.6	1.6	1.2	0.5	2.5	1.8	1.1	8.3	1.6	1.8	3.0	0.1	1.1	1.5	0.5	0.4	2.4	3.1	1.4	18.4	2.6	0.8	1.6	2.9	3.6	7.2	1.3	6.9	0.4	1.3	0.7	3.6	1.3	3.4	0.0	0.7	108.8	4.4	0.0	0.3	0.4	0.0	4.1	0.2	1.4	3.9	0.3	0.6	0.2	0.4	0.2	4.4	1.1	0.4	1.1	1.2	11.2	0.5	2.0	12.1	0.8	2.0	0.8	1.6	91.2	0.2	0.0	0.0	0.8	3.2	0.0	2.6	4.2	0.2	0.1	0.2	0.1	0.0	19.4	0.4	0.0	0.2	0.2	0.2	1.0	9.7	14.7	0.6	18.0	1.0	2.3	3.3	0.3	3.4	1.3	0.0	4.9	0.9	1.7	57.8	26.7	511.0	0.1	14.4	0.3	1.4	0.5	0.1	6.0	0.4	0.6	0.3	3195.8	1.4	21.5	0.4	0.4	9.2	1.2	1.0	0.9	2.4	0.7	1.0	1.6	1.2	1.6	1.4	1.6	1.3	1.0	6.4	7.9	0.3	0.2	0.3	0.3	1.5	0.6	0.0	0.1	0.0	0.4	2.8	4.7	3.7	0.0	1.1	0.0	0.3	0.0	0.4	1.0	0.5	0.1	5.3	1.8	0.0	0.1	0.4	0.9	0.8	13.7	0.2	8.8	0.0	1.8	0.0	2.4	0.0	0.0	0.5	0.0	1.6	0.6	0.4	0.0	2.5	0.0	1.0	1.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.2	0.0	1.8	0.1	0.0	0.4	0.3	0.6	1.5	0.2	0.1	1.1	0.9	0.3	0.4	0.4
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118951885	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 29.9;thyroid gland: 101.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 134.3;Collecting duct cells: 73.5;Ductal cells: 32.7;Proximal tubular cells: 117.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	40	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	40	"dendritic cells: 3.9"	"Group enriched"	"Detected in many"	4	"BJ: 546.7;BJ hTERT+: 2013.0"	"Low region specificity"	"Detected in all"							CAB034939	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (3.88e-4)"	3.3	3.3	2.6	5.3	3.1	0.0	2.6	2.6	4.1	1.1	3.5	2.5	1.4	10.2	0.5	0.4	1.4	5.8	9.4	2.5	2.7	29.9	14.2	9.4	7.0	5.0	3.0	0.3	1.8	0.5	1.8	4.9	3.3	1.6	3.5	0.3	1.4	1.0	0.4	0.5	2.2	2.6	3.1	2.6	1.2	0.1	3.0	1.3	101.8	0.8	2.9	10.7	0.3	3.8	0.0	0.9	8.6	0.0	27.5	5.3	0.0	546.7	2013.0	25.9	7.2	6.3	1.1	0.0	143.7	302.4	0.0	5.6	0.0	0.0	13.2	0.1	0.0	0.0	23.1	0.0	3.6	0.0	0.0	2.9	0.0	26.7	0.0	10.9	0.3	0.0	0.0	0.0	73.8	13.6	0.0	0.1	0.9	2.6	3.3	0.0	1.0	0.0	23.6	0.0	1.3	0.0	4.8	0.2	0.0	0.3	0.0	0.1	1.2	16.9	8.6	10.1	1.2	0.6	0.0	0.1	2.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.6	3.1	2.6	4.1	2.5	2.7	5.0	3.0	3.3	3.1	3.0	3.8	2.1	3.2	0.0	7.2	0.7	2.2	0.6	1.4	0.0	0.2	134.3	4.1	3.8	22.8	1.0	73.5	0.0	0.0	0.2	2.5	9.8	32.7	0.1	0.6	1.4	7.4	9.5	0.0	0.8	1.3	0.2	9.4	0.0	1.7	0.0	0.0	4.6	2.0	0.5	0.0	0.3	9.2	2.0	0.3	3.9	0.3	0.3	1.1	0.0	0.0	8.3	1.2	0.0	3.0	0.3	9.2	0.8	0.0	0.0	6.8	1.1	117.3	0.1	0.1	0.0	0.4	4.3	0.1	0.3	0.0	1.1	0.0	0.4	0.0	2.8	0.3
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 612.4;Basal prostatic cells: 1315.6;Basal respiratory cells: 622.2;Ductal cells: 938.2;Exocrine glandular cells: 698.4;Pancreatic endocrine cells: 1232.3;Prostatic glandular cells: 757.9;Urothelial cells: 695.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 139.6;neutrophil: 102.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 139.6"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 699.6"									HPA007853	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		370000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	42.0	45.9	5.3	27.0	5.2	8.3	24.4	6.1	9.9	12.5	9.4	26.5	37.5	34.8	1.2	17.6	19.0	55.2	108.3	5.6	8.8	133.5	61.0	72.6	2.4	8.2	7.9	8.2	116.3	56.1	59.3	33.0	7.0	33.4	4.5	4.8	48.4	17.1	58.5	18.1	21.6	32.5	7.4	6.7	42.6	5.4	10.4	5.2	37.0	9.3	3.1	73.8	13.9	7.0	217.6	155.6	17.7	31.9	31.0	71.3	109.1	444.3	277.5	316.2	205.5	70.1	336.0	1.5	566.2	270.4	401.3	224.2	4.2	283.4	132.2	8.3	11.2	1.5	52.4	58.4	205.1	3.7	15.2	65.2	196.7	345.1	433.5	298.1	100.9	0.6	24.5	2.4	362.7	394.0	0.6	28.3	85.5	88.7	369.6	1.9	207.1	7.8	355.8	37.6	19.9	7.3	314.7	127.9	255.8	57.7	69.4	5.8	192.2	601.9	303.2	423.8	699.6	6.6	2.9	3.1	190.0	18.9	488.8	12.2	11.4	139.6	6.1	7.3	7.9	0.2	2.8	4.9	14.6	0.2	1.4	2.7	102.9	8.0	4.7	0.6	3.4	4.0	5.3	5.2	6.1	9.9	5.6	8.8	8.2	7.9	7.0	7.4	10.4	7.0	16.9	102.5	37.7	0.3	6.9	612.4	1315.6	622.2	113.3	1.5	139.0	46.7	63.9	195.9	238.7	182.1	2.1	134.6	10.0	74.2	64.6	938.2	1.3	170.5	29.4	47.5	27.3	1.3	0.2	698.4	169.5	155.1	33.1	173.1	59.1	3.0	24.3	20.7	39.7	0.0	0.5	19.9	152.5	5.6	121.4	0.8	6.2	23.0	112.1	1.9	10.8	23.3	4.1	0.0	0.1	1232.3	155.3	6.8	5.3	757.9	52.9	118.0	118.4	5.9	6.6	190.5	228.6	10.9	9.4	35.5	359.7	189.1	25.3	1.3	50.0	695.6
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.9;lymphoid tissue: 33.0;skeletal muscle: 62.9"	"Group enriched"	"Detected in some"	4	"B-cells: 117.3;Plasma cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	41	"memory B-cell: 130.9;naive B-cell: 51.8"	"Lineage enriched"	"Detected in many"	59	"B-cells: 130.9"	"Group enriched"	"Detected in some"	9	"Karpas-707: 167.2;RPMI-8226: 106.7;U-266/70: 72.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.4	0.1	0.3	8.9	0.4	1.1	0.7	0.0	0.5	0.3	0.0	3.4	4.1	0.1	0.0	1.3	0.4	0.5	5.3	0.1	0.3	0.3	0.3	0.8	17.3	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.4	2.5	0.3	2.1	0.3	62.9	0.0	18.9	0.1	0.2	33.0	5.2	0.1	0.4	2.0	0.5	0.0	21.6	2.6	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.2	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	13.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	130.9	0.0	0.0	0.0	51.8	0.0	0.1	0.5	0.0	0.0	0.0	2.2	2.7	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.3	0.9	0.2	0.4	1.2	0.0	0.0	0.0	0.0	117.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.4	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.5	32.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	143.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.0	6.2	0.0	0.0	0.0
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922032-41926806	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 33.8;lymphoid tissue: 58.1"	"Cell type enriched"	"Detected in some"	10	"B-cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"memory B-cell: 22.5;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	40	"B-cells: 29.1"	"Group enriched"	"Detected in some"	6	"REH: 21.0;U-698: 10.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003246, CAB008380"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"			"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favorable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"	0.8	0.8	2.1	17.7	1.3	6.0	0.5	1.6	1.9	0.2	0.6	2.1	1.2	0.3	0.3	1.5	0.4	1.0	0.4	1.9	2.0	0.8	0.3	1.0	39.0	3.6	2.1	0.1	0.1	0.1	0.2	0.3	2.2	0.5	1.1	0.4	1.7	0.1	2.3	3.3	33.8	0.1	2.7	58.1	2.5	0.7	2.1	3.4	1.1	0.5	54.6	1.8	0.5	2.0	0.3	0.2	1.1	2.3	0.0	0.0	0.4	0.2	0.1	0.2	0.8	0.9	0.5	1.9	0.4	0.2	0.2	0.4	0.7	0.0	0.3	0.4	2.3	0.2	0.4	0.2	0.1	1.7	0.4	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.4	1.9	0.2	0.7	1.6	1.8	0.7	0.1	0.1	21.0	2.4	1.6	0.0	0.2	1.3	0.3	0.1	0.4	0.3	0.2	0.4	2.2	0.2	0.5	2.5	0.9	0.3	2.0	1.1	10.9	0.1	1.8	0.5	0.7	0.1	0.2	0.2	0.2	0.3	22.5	0.3	0.2	0.1	29.1	0.4	0.4	0.3	0.3	0.3	0.4	0.2	1.1	2.1	1.3	1.6	1.9	1.9	2.0	3.6	2.1	2.2	2.7	2.1	2.0	0.1	0.0	1.1	0.0	194.5	0.1	0.4	0.0	1.2	1.0	1.6	1.3	1.4	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	2.6	0.5	0.3	1.2	0.4	0.0	0.0	0.2	0.7	0.5	4.3	0.0	1.5	0.0	0.2	0.1	8.4	0.1	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.0	6.5	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.0	0.3	0.1	0.2	0.0	0.4	0.0	0.5	0.4	1.5	1.4	0.3	0.0	0.1	3.4	0.2	0.4	0.2
TNFRSF14	"ATAR, CD270, HVEA, HVEM, LIGHTR, TR2"	ENSG00000157873	"TNF receptor superfamily member 14"	Q92956	1	2555639-2565382	"Cancer-related genes, CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 16.2"	"Low region specificity"	"Detected in all"							"HPA006404, CAB026150, CAB030007"	Approved					NA	NA		110000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348"	"prognostic favorable (4.39e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (6.83e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (7.79e-6)"	37.0	71.8	2.4	6.2	2.2	5.0	34.8	2.2	6.6	52.5	3.9	57.6	16.9	32.9	1.2	26.4	39.9	4.4	23.8	2.7	2.4	57.1	61.8	58.0	10.0	2.6	2.3	33.0	20.4	3.9	24.4	2.8	2.4	50.4	5.5	0.6	35.3	2.3	6.5	22.2	67.5	1.2	2.1	100.7	45.9	7.5	2.7	2.8	29.4	1.0	4.0	33.6	37.3	2.6	0.6	0.3	0.3	8.7	2.3	9.1	2.7	2.5	8.5	4.9	6.5	0.7	6.3	2.4	0.5	7.7	2.8	4.4	0.0	3.2	0.7	11.4	0.0	6.1	0.8	1.0	9.1	3.3	6.8	4.4	2.6	2.6	0.6	4.3	5.8	0.4	1.9	11.9	4.5	0.0	4.4	0.3	0.1	2.4	4.4	2.8	0.0	0.6	0.4	3.7	0.1	0.2	0.0	0.4	16.2	0.0	1.5	0.7	5.9	0.3	1.8	0.8	0.4	8.1	2.2	1.2	0.5	2.7	1.5	2.2	31.4	5.5	40.2	68.2	23.3	42.4	47.2	27.0	23.2	50.1	51.3	39.4	78.4	12.8	50.9	33.2	62.8	39.3	2.4	2.2	2.2	6.6	2.7	2.4	2.6	2.3	2.4	2.1	2.7	2.6	63.7	19.2	38.0	5.5	97.6	16.4	31.2	50.3	23.3	1.5	36.0	33.8	8.3	47.1	51.5	35.0	0.0	1.2	90.9	94.7	3.9	16.8	0.3	19.9	18.4	52.7	36.1	18.7	8.8	32.9	1.5	27.1	77.5	25.8	53.2	8.3	41.4	20.0	88.8	0.0	0.9	78.4	22.4	80.1	59.3	2.6	20.8	91.3	46.2	17.8	106.1	15.9	131.8	2.5	1.3	24.6	115.8	13.9	70.4	29.8	219.6	35.5	34.7	0.7	19.7	9.0	22.0	0.1	0.4	15.6	13.4	1.2	84.4	16.0	101.4	44.3
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206592	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 189.0;dendritic cells: 72.2;Langerhans cells: 86.4;Melanocytes: 49.8;Plasma cells: 55.3;Suprabasal keratinocytes: 150.6;T-cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cell: 184.5;T-reg: 71.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 184.5;T-cells: 71.8"	"Group enriched"	"Detected in some"	12	"RPMI-8226: 225.6;SCLC-21H: 152.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008025	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.9	0.6	1.1	7.3	1.3	2.9	2.4	2.5	3.1	11.1	0.7	6.0	7.2	1.4	0.0	6.3	1.4	0.9	0.5	1.0	0.6	2.8	0.9	4.6	5.5	1.3	0.6	0.3	0.3	9.4	4.9	0.3	1.3	2.8	1.5	0.0	5.6	0.6	0.8	38.5	7.1	0.3	0.6	9.0	5.2	0.9	0.9	1.9	1.4	0.0	3.8	2.0	3.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.2	0.1	0.5	16.1	0.1	0.1	225.6	0.3	0.0	152.8	0.2	0.0	0.6	0.0	0.0	8.2	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.3	0.2	0.6	0.1	0.0	0.2	0.2	0.0	6.8	0.1	12.6	4.6	28.9	4.4	0.1	11.5	0.9	1.5	0.8	184.5	0.1	0.3	71.8	6.7	1.1	1.3	2.5	3.1	1.0	0.6	1.3	0.6	1.3	0.6	0.9	1.2	11.2	0.0	1.3	0.3	23.5	189.0	12.5	15.5	16.5	0.0	5.0	3.0	2.9	0.0	3.2	0.0	0.0	0.0	72.2	0.3	0.0	0.8	0.0	1.2	1.2	4.1	3.5	0.0	2.0	0.6	1.3	4.7	1.1	2.9	45.7	0.0	0.7	0.0	0.8	0.0	0.3	0.2	20.3	0.3	86.4	0.0	0.0	5.4	49.8	0.0	12.7	0.0	21.6	0.5	0.3	0.4	0.0	0.0	55.3	10.1	0.1	0.1	0.8	0.0	0.0	6.2	2.2	0.0	0.0	0.3	150.6	0.0	75.7	0.0	0.8	7.0
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 507.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	NA	NA	17700	570000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (2.19e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.14e-2)"	"prognostic favorable (8.22e-4)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.74e-1)"	166.5	133.3	33.7	76.7	34.4	42.4	120.0	35.3	38.6	105.0	47.8	114.1	101.5	111.8	23.0	105.6	106.7	88.8	80.6	32.4	40.3	94.5	176.5	130.7	38.1	45.7	40.4	90.6	57.3	53.7	57.3	82.4	39.6	86.9	56.4	3.5	76.0	46.3	91.0	103.7	109.5	97.5	40.4	111.3	84.4	22.6	39.7	39.2	97.4	63.1	36.1	113.2	113.2	37.4	40.2	296.4	40.9	60.2	277.7	282.0	75.7	82.2	143.0	108.2	93.9	34.7	153.6	3.7	28.9	179.3	85.6	107.1	12.9	96.4	74.1	0.8	25.3	20.3	79.2	82.2	245.5	104.4	66.9	291.8	94.4	90.2	131.4	250.4	134.1	42.0	33.7	29.8	126.3	57.1	34.0	100.0	102.1	146.1	87.6	27.9	66.6	32.4	83.7	70.7	0.1	2.1	117.8	60.9	62.5	103.6	16.4	111.4	146.0	84.6	71.7	64.7	78.4	0.1	10.6	12.8	100.5	95.9	107.0	17.1	165.8	93.5	62.2	130.4	60.0	0.5	25.1	51.0	123.7	0.4	22.3	34.0	507.2	9.7	111.5	31.6	26.2	117.3	33.7	34.4	35.3	38.6	32.4	40.3	45.7	40.4	39.6	40.4	39.7	37.4	102.0	51.3	37.1	15.3	4.8	123.0	115.8	127.3	81.4	0.4	50.1	35.9	9.3	67.2	70.8	27.6	0.0	62.0	35.5	204.0	15.6	98.7	1.2	25.5	66.5	111.8	33.6	30.1	4.6	119.4	120.2	109.3	43.8	42.3	7.6	27.6	159.2	145.0	176.4	0.0	1.3	56.8	32.6	146.7	113.4	5.4	102.2	102.4	71.2	32.8	127.1	15.9	104.0	11.1	0.9	116.6	239.4	65.8	4.2	141.2	227.5	96.9	30.8	0.7	124.9	64.1	89.4	1.3	1.1	57.0	134.7	148.6	31.2	21.5	57.4	140.1
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	8100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	45.6	5.4	3.9	68.4	3.8	52.1	34.7	4.8	17.9	14.3	5.6	12.8	16.8	11.6	0.4	5.5	14.6	15.6	10.9	3.7	9.0	7.5	15.7	32.0	32.1	18.3	7.2	6.3	5.9	2.3	4.5	35.8	10.6	6.4	10.8	0.8	6.5	2.6	10.7	7.8	23.9	16.8	9.0	53.3	16.4	2.2	8.9	12.7	7.6	6.3	21.3	28.9	8.8	14.1	0.0	0.3	4.1	0.0	9.6	13.5	8.9	1.1	2.0	4.0	4.3	1.8	34.0	0.2	0.6	3.9	5.6	0.0	0.8	0.0	2.2	14.5	0.0	0.0	0.2	0.0	25.2	0.3	3.8	14.8	0.0	13.0	0.0	7.2	19.6	0.2	45.7	6.4	1.5	0.0	0.0	8.1	0.2	4.9	1.4	1.2	0.4	25.9	0.0	0.8	0.0	0.1	0.6	0.4	1.4	6.4	0.0	51.8	7.8	5.3	0.2	27.0	0.0	1.9	0.0	0.0	30.8	37.0	1.4	0.6	127.1	18.2	48.4	260.5	26.5	13.5	34.4	40.5	71.7	8.4	9.8	15.5	138.0	13.4	387.1	15.1	70.9	150.4	3.9	3.8	4.8	17.9	3.7	9.0	18.3	7.2	10.6	9.0	8.9	14.1	99.4	9.6	15.9	0.7	42.8	16.8	3.9	1.0	1.2	0.2	3.2	4.1	3.6	5.7	6.5	3.7	0.0	0.9	268.7	12.8	0.0	0.5	0.6	1.7	5.1	46.0	0.0	7.4	0.2	0.6	6.3	13.2	12.8	4.9	2.5	1.4	31.1	17.0	72.6	0.0	0.2	3.0	0.0	200.5	288.0	1.2	2.1	230.2	16.0	30.9	175.3	0.3	109.2	0.0	0.1	0.7	4.2	0.4	72.5	8.0	25.8	0.4	1.5	1.2	32.9	6.8	9.8	0.0	0.9	0.7	10.5	30.1	138.4	1.9	4.8	8.8
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNFRSF4	"ACT35, CD134, OX40, TXGP1L"	ENSG00000186827	"TNF receptor superfamily member 4"	P43489	1	1211340-1214153	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 112.3;Endothelial cells: 58.0;granulocytes: 67.4;Ionocytes: 40.7;Langerhans cells: 128.1;T-cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 9.7;memory CD4 T-cell: 26.6;NK-cell: 14.7;T-reg: 35.3"	"Group enriched"	"Detected in many"	17	"granulocytes: 9.7;NK-cells: 14.7;T-cells: 35.3"	"Group enriched"	"Detected in some"	10	"MOLT-4: 6.2;NB-4: 12.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			CAB016128	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB016128: AB_626897"	"unprognostic (2.24e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.50e-6)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.91e-2)"	10.2	0.5	0.5	6.2	0.1	0.6	6.7	0.6	0.9	1.9	0.2	3.3	1.7	1.1	0.0	1.0	1.2	0.5	10.3	0.5	0.2	4.1	0.7	6.3	6.5	0.3	0.2	0.8	1.2	0.2	1.6	1.8	0.3	3.7	0.2	0.0	1.8	0.7	2.1	1.1	5.2	0.2	0.3	13.3	2.6	0.3	0.5	1.8	4.6	0.4	1.5	1.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	12.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.3	0.4	0.0	3.0	0.0	26.6	2.8	0.0	0.0	2.3	0.1	0.3	14.7	0.0	1.1	35.3	2.8	0.5	0.1	0.6	0.9	0.5	0.2	0.3	0.2	0.3	0.3	0.5	0.4	112.3	0.0	0.0	0.3	11.1	9.1	0.3	0.9	0.0	0.3	1.0	2.4	1.7	0.0	0.1	0.0	0.0	0.0	25.6	0.0	0.0	0.9	0.0	0.6	3.8	58.0	0.0	2.7	0.7	0.2	0.4	7.7	0.0	0.6	67.4	0.0	13.9	0.4	1.9	0.0	0.1	0.3	40.7	1.9	128.1	0.0	0.3	9.6	10.6	1.0	18.4	0.0	8.2	1.5	0.1	0.0	0.0	0.4	26.2	0.4	0.0	0.2	0.1	0.2	0.0	17.8	2.0	0.0	0.2	0.1	8.4	0.1	43.6	2.5	0.1	0.2
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696652-63698684	"Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 51.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 21.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 21.6"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 28.3;RPTEC TERT1: 110.7;TIME: 69.0"									HPA047154	Approved				"Secreted to blood"	NA	NA	406000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA047154: AB_2679959"																		30.9	5.1	14.4	14.3	11.9	0.2	24.7	11.5	18.2	7.8	7.4	13.7	0.0	8.0	0.0	11.7	9.6	0.5	7.7	11.4	14.7	16.6	5.5	51.2	1.2	17.0	12.9	7.3	8.3	0.0	15.4	0.0	16.8	10.6	0.1	0.0	10.2	0.0	7.1	13.8	16.1	0.9	15.0	39.3	9.8	6.8	18.7	0.0	12.3	0.0	3.4	16.0	9.6	11.4	0.0	0.5	0.0	0.0	0.0	0.2	1.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.8	0.0	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	69.0	0.0	1.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	1.3	21.6	0.1	0.1	14.4	11.9	11.5	18.2	11.4	14.7	17.0	12.9	16.8	15.0	18.7	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	5.3	0.0	0.1	3.1	2.3	0.6	3.5	0.0	0.6	0.2	0.1	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.9	0.0	0.2	0.3	0.0	0.9	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.2	0.2	0.1	0.0	0.3	0.1	0.9	0.9	0.7	0.5	0.1	1.4	2.5	1.4	0.7	1.0	0.1	1.2	1.1	0.9	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.3	0.0	0.6	0.0	0.2	0.2	0.1	0.2	0.1	0.7	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523475	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 732.8;Exocrine glandular cells: 424.6;Proximal tubular cells: 556.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 265.4;classical monocyte: 133.4;intermediate monocyte: 203.5;neutrophil: 257.1;non-classical monocyte: 213.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 265.4;monocytes: 213.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 73.1;CAPAN-2: 53.7;HaCaT: 51.5;HMC-1: 244.5;RPTEC TERT1: 122.1"	"Low region specificity"	"Detected in all"							HPA054938	Uncertain				"Secreted to blood"	NA	NA	67400	18000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	51.0	49.9	9.5	55.4	9.8	14.8	84.5	9.8	17.0	37.3	17.3	76.8	100.3	47.1	19.6	66.4	39.1	45.3	31.7	9.0	9.9	145.1	209.0	177.2	54.7	12.0	10.2	27.1	22.2	77.7	10.4	167.9	11.0	86.7	91.4	1.4	127.9	42.7	20.7	54.6	95.2	26.3	11.0	70.9	47.3	4.8	10.3	34.2	29.3	61.7	46.8	70.3	62.4	10.6	12.4	0.6	0.1	0.2	8.2	6.6	73.1	0.0	0.5	3.7	5.9	0.3	53.7	7.9	34.7	0.0	3.2	51.5	0.3	6.3	0.7	19.6	0.2	0.2	1.5	1.1	0.4	14.7	244.5	8.2	8.0	1.3	0.2	0.0	25.6	1.6	0.3	8.7	0.0	0.1	1.9	19.4	0.3	0.2	0.5	2.9	0.2	3.5	122.1	4.6	0.3	0.5	27.2	1.0	0.6	0.4	15.3	8.0	1.1	0.1	0.2	0.1	0.7	9.3	1.1	9.5	0.6	8.0	0.2	265.4	133.4	14.7	10.9	203.5	15.0	16.7	30.4	16.8	49.1	18.2	21.6	8.5	257.1	49.3	213.2	2.9	36.8	73.6	9.5	9.8	9.8	17.0	9.0	9.9	12.0	10.2	11.0	11.0	10.3	10.6	326.5	70.5	114.4	0.0	26.2	22.0	169.5	398.4	69.4	0.3	146.5	97.3	7.9	84.4	281.1	66.2	0.0	6.6	20.7	294.2	45.0	732.8	4.5	60.5	18.2	247.5	48.3	9.7	0.1	424.6	189.4	69.2	44.9	121.0	257.0	2.4	186.7	75.2	23.5	1.7	0.1	111.3	175.0	79.8	23.7	3.8	18.3	70.5	7.2	52.5	160.3	18.7	52.5	0.0	0.1	244.0	216.4	4.9	23.2	82.7	317.0	556.7	114.5	1.5	0.0	6.5	22.3	0.1	0.3	103.1	25.6	10.9	51.8	19.7	74.3	170.1
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.5;liver: 5.2;lymphoid tissue: 15.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 10.8;Breast myoepithelial cells: 5.1;Ductal cells: 6.2;Early spermatids: 8.0;Late spermatids: 15.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"NK-cell: 13.6"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 13.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 2.1;NTERA-2: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	NA	NA	17200		"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 35: Glandular cells - Unknown function"			"CAB009193: , HPA045142: AB_2679231"	"unprognostic (3.97e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.94e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.74e-2)"	0.2	0.0	0.0	4.8	0.0	0.2	4.5	0.0	0.1	0.8	0.2	0.9	0.4	0.1	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.1	5.2	0.1	15.2	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	1.1	0.0	0.1	1.9	0.0	0.0	0.6	0.5	1.3	0.1	1.5	0.0	0.1	5.0	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.0	0.0	10.8	5.1	0.4	1.5	0.2	0.0	0.0	0.0	2.3	0.0	0.0	6.2	8.0	0.5	0.1	0.1	1.2	0.0	0.2	0.2	0.0	0.2	0.0	0.7	0.0	0.3	0.0	1.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	15.3	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	3.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.3	0.0	1.8	0.0	0.0	0.0
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7549058-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.7;BJ hTERT+: 18.4;HDLM-2: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	853000	130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA035984: , HPA052967: AB_2682000"	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	41.6	28.5	57.4	9.8	55.3	3.1	36.6	49.4	66.5	37.6	48.9	68.2	9.7	38.2	7.0	13.9	37.7	15.6	39.6	54.8	50.4	32.9	16.5	37.7	15.8	55.7	54.2	42.7	23.2	11.1	18.0	11.2	53.2	39.4	5.7	2.9	26.1	27.2	16.9	15.8	26.7	13.3	52.8	38.4	38.8	5.6	57.0	4.8	22.9	9.3	5.5	47.1	30.1	52.1	0.0	0.5	0.7	0.0	14.9	17.7	4.0	6.9	18.4	7.7	5.7	0.1	2.5	0.0	5.8	16.3	0.8	1.4	1.4	0.6	1.6	20.3	2.0	0.9	0.4	2.3	12.8	0.0	0.0	15.0	2.6	2.8	0.3	3.0	12.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.6	0.1	7.5	0.1	0.0	0.1	11.6	0.0	0.0	7.9	2.5	0.0	12.6	0.1	1.4	0.6	16.1	15.1	1.1	0.1	8.8	0.0	0.0	0.0	2.4	0.0	10.5	2.6	3.5	11.6	5.1	5.9	6.0	2.9	4.3	3.1	2.2	1.8	4.1	4.2	2.0	2.8	1.5	2.5	4.0	1.1	57.4	55.3	49.4	66.5	54.8	50.4	55.7	54.2	53.2	52.8	57.0	52.1	115.9	9.6	12.2	0.0	20.4	6.1	11.1	1.5	6.8	6.7	21.7	41.7	4.3	17.2	3.4	16.5	0.0	1.6	38.3	2.5	7.9	15.2	0.4	4.1	15.2	33.9	1.2	3.2	0.0	12.1	0.8	42.7	4.6	8.5	34.3	6.8	48.5	3.4	44.3	20.2	0.0	3.4	0.0	59.7	26.8	1.2	50.7	62.1	19.6	0.0	28.6	46.6	40.2	0.0	0.0	8.1	1.7	50.4	3.6	6.7	0.4	39.6	0.6	2.6	59.2	34.4	56.7	0.2	1.1	2.1	7.5	0.8	38.7	9.4	4.1	6.0
TNFSF12-TNFSF13	TWE-PRIL	ENSG00000248871	"TNFSF12-TNFSF13 readthrough"		17	7549099-7561601	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 9.1;choroid plexus: 5.7"	"Group enriched"	"Detected in some"	17	"Alveolar cells type 2: 3.7;Club cells: 3.7;granulocytes: 3.8;Macrophages: 4.5;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;fHDF/TERT166: 1.3;HUVEC TERT2: 1.1;U-138 MG: 1.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in all"							"HPA004863, HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.23e-2)"	4.0	1.3	4.7	0.7	4.7	0.7	1.8	4.5	9.1	0.7	5.7	1.4	0.2	0.4	0.0	0.3	0.4	0.1	2.3	4.5	5.0	2.3	0.7	4.6	1.0	5.1	5.1	0.4	0.5	0.1	0.4	0.2	4.7	0.7	0.0	0.1	0.6	0.2	0.7	0.8	0.8	0.3	4.6	3.1	0.7	0.1	5.0	0.2	0.4	0.0	0.5	1.1	0.3	4.8	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	1.7	0.6	0.9	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.4	2.4	7.2	0.2	4.5	0.3	0.7	0.5	0.3	1.8	1.5	0.3	0.1	0.3	0.2	0.2	0.9	1.0	1.4	4.7	4.7	4.5	9.1	4.5	5.0	5.1	5.1	4.7	4.6	5.0	4.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 141.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 438.1;intermediate monocyte: 420.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	35000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	27.7	31.6	39.5	37.7	43.7	48.4	29.5	39.7	47.3	33.5	66.7	45.9	74.7	13.3	19.2	12.5	31.8	54.1	18.0	35.3	37.6	55.6	16.2	100.7	33.1	44.8	43.3	24.8	41.1	18.0	19.7	14.7	41.1	22.6	41.9	13.0	141.9	32.1	5.3	10.5	39.5	24.8	40.0	30.6	54.0	4.6	44.8	14.1	27.0	10.1	24.5	26.0	15.5	38.8	20.8	8.3	2.8	5.5	3.2	1.7	3.4	3.7	2.7	1.5	1.3	4.6	12.8	9.1	43.6	3.8	5.2	13.1	0.1	3.6	1.6	16.2	7.0	5.9	18.2	9.7	6.7	5.1	5.9	3.6	3.6	1.0	5.7	8.8	4.7	6.5	4.6	3.5	1.3	3.1	2.3	16.6	2.7	20.3	6.0	16.5	3.4	39.9	110.6	13.5	5.1	4.9	7.2	18.8	2.5	4.1	25.2	12.4	2.4	4.8	5.8	2.1	8.1	0.8	2.8	2.4	1.9	44.1	9.5	75.2	438.1	158.9	0.9	420.9	0.8	13.7	0.5	0.7	283.5	25.0	2.4	1.5	56.9	7.9	265.4	130.8	0.9	257.1	39.5	43.7	39.7	47.3	35.3	37.6	44.8	43.3	41.1	40.0	44.8	38.8	0.2	6.4	10.4	0.0	2.1	0.0	0.2	0.2	8.0	0.1	0.4	0.1	0.0	0.0	2.0	1.8	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.2	0.1	0.0	1.2	5.9	0.0	0.2	0.0	2.9	11.2	0.4	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	19.5	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.7	0.3	1.5	0.2	0.0	0.1	0.2	0.0	0.0	2.6	0.0	0.0	0.8	0.1	0.6	0.2
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.5;Kupffer cells: 141.1;Langerhans cells: 246.7;Macrophages: 170.4;monocytes: 509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 505.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9"	"Cell line enriched"	"Detected in some"	7	"U-937: 167.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	790000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	8.2	5.3	2.8	25.9	2.6	20.1	4.7	2.7	4.1	2.2	5.8	5.5	10.7	1.4	1.5	4.8	2.4	12.4	3.8	2.7	3.1	1.5	5.3	10.9	20.9	6.3	3.0	1.1	1.5	0.7	1.0	9.0	4.2	1.7	8.4	0.4	3.3	1.2	1.4	1.9	6.4	5.0	4.6	15.9	5.0	1.2	3.5	5.3	3.0	1.6	17.7	11.1	2.1	5.2	0.1	0.4	0.1	0.1	0.7	0.8	0.2	0.3	0.8	0.6	2.1	0.1	1.7	0.3	0.2	0.2	0.3	0.1	0.0	0.1	0.1	11.6	0.0	0.9	0.4	0.0	0.4	10.2	0.3	2.0	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.6	1.2	0.0	0.1	5.3	0.1	1.1	0.0	0.0	0.2	0.0	0.6	0.3	1.3	0.3	0.0	0.0	0.4	0.2	0.1	22.3	0.2	0.3	0.0	0.0	0.4	10.0	0.3	0.1	10.3	167.0	1.7	12.6	350.9	100.1	5.4	272.3	31.5	4.4	21.5	4.4	206.4	7.1	9.9	3.4	505.4	5.0	234.1	77.8	19.4	165.8	2.8	2.6	2.7	4.1	2.7	3.1	6.3	3.0	4.2	4.6	3.5	5.2	3.1	16.0	12.9	6.2	7.0	7.1	0.7	1.3	1.2	0.9	2.4	3.2	0.6	10.0	4.2	5.5	0.0	0.5	40.6	0.6	1.9	2.3	1.2	0.4	0.7	3.6	1.2	14.5	18.1	32.5	1.1	29.6	3.1	0.5	5.1	0.9	3.9	2.8	87.5	0.0	11.2	0.9	0.0	141.1	246.7	0.6	5.3	170.4	8.8	15.0	509.4	0.2	5.2	55.3	5.1	1.7	0.5	1.9	1.5	2.7	2.2	1.3	2.0	0.3	6.6	1.4	4.1	0.1	0.7	0.5	4.7	1.1	10.5	1.2	1.8	3.1
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 29.0;liver: 107.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 26.3;dendritic cells: 40.5;granulocytes: 26.1;Macrophages: 20.0;NK-cells: 26.8;T-cells: 43.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 199.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 199.7;T-cells: 61.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 16.9;NB-4: 4.9;THP-1: 3.1;U-937: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA012700	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	41000		"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	29.0	1.7	2.2	3.1	1.3	1.9	2.7	0.8	6.4	2.1	1.3	2.7	1.8	0.9	0.3	1.8	9.7	1.2	3.8	1.0	1.2	1.3	107.9	4.9	2.5	1.3	1.7	5.1	4.5	0.0	1.1	0.2	1.7	2.0	1.3	0.2	2.2	0.2	0.5	0.6	5.9	1.2	0.9	3.2	2.3	0.6	3.1	1.1	2.8	0.6	2.0	4.1	2.3	1.7	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.0	0.0	0.2	1.1	0.0	0.5	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.4	0.0	140.9	17.6	115.3	41.8	4.0	61.2	0.4	17.7	34.5	6.9	1.9	2.8	15.0	199.7	30.7	0.5	0.7	15.9	12.8	2.2	1.3	0.8	6.4	1.0	1.2	1.3	1.7	1.7	0.9	3.1	1.7	0.7	9.6	26.3	0.0	1.6	2.9	0.7	0.9	0.0	0.0	1.1	0.8	0.8	15.7	8.2	0.0	0.0	0.1	40.5	0.0	0.0	4.1	1.2	4.8	2.6	0.9	0.0	0.4	0.1	3.8	0.2	12.4	1.1	18.1	26.1	0.2	1.8	15.8	12.8	0.0	0.1	0.2	0.0	3.4	12.3	0.0	0.3	20.0	3.6	1.0	5.8	0.0	26.8	0.0	0.1	6.0	0.0	0.0	4.8	0.6	0.0	0.4	2.8	0.0	0.0	1.4	1.0	0.2	0.3	0.3	3.3	0.0	43.7	0.0	0.0	0.4
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784652-114806039	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	0.8	0.7	0.1	2.5	0.2	0.1	0.9	0.1	0.5	1.5	0.1	2.3	9.5	1.0	0.9	1.2	0.9	1.9	0.0	0.1	0.2	4.5	0.2	4.1	0.8	0.3	0.1	0.1	0.1	0.8	0.1	4.4	0.2	4.1	2.0	0.0	4.8	1.9	0.1	0.6	3.5	2.0	0.0	0.5	2.9	0.1	0.2	0.6	0.9	0.0	1.0	4.7	0.7	0.4	0.5	4.4	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.2	3.0	1.6	0.0	0.0	0.5	13.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	16.7	0.0	0.0	0.9	0.4	0.6	0.0	0.0	0.3	16.0	0.0	0.0	0.1	0.0	0.1	16.5	0.1	0.0	0.0	0.7	0.0	5.6	1.2	0.0	7.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.4	0.2	12.8	12.1	0.0	0.1	0.5	7.7	25.6	14.8	0.3	3.7	3.7	0.6	1.5	4.9	7.3	0.0	0.7	0.4	8.0	0.0	4.9	0.7	15.7	2.9	0.3	0.0	0.0	0.1	2.0	0.2	1.2	8.2	28.9	0.0	0.0	0.0	0.0	2.3	0.0	0.7	2.4	2.0	0.3	5.1	0.1	0.0	5.0	0.0	0.0	5.3	0.1	0.0	0.0	0.1	1.3	0.5	0.4	1.2	4.9	8.9	9.3	1.0	0.3	0.0	0.4	3.0	0.0	0.0	13.7	0.6	0.3	1.0	0.1	7.4	6.5
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183731-173207331	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Granulosa cells: 37.0;Macrophages: 26.4;monocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 42.0;HHSteC: 17.3;HUVEC TERT2: 81.2;LHCN-M2: 67.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059579	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	1.2	2.0	1.1	2.3	1.2	0.6	0.6	1.8	1.5	1.0	0.1	1.0	0.3	0.8	0.5	0.6	0.9	1.1	1.0	1.1	0.9	0.8	0.9	1.2	2.2	1.2	1.2	1.1	1.1	0.5	1.5	0.5	1.2	1.4	1.2	1.4	0.4	0.6	0.2	0.3	0.8	0.8	0.8	1.7	0.7	4.0	1.1	3.7	0.4	0.2	1.9	1.5	0.8	1.2	0.1	0.0	0.4	1.2	2.7	14.1	0.2	4.1	0.9	0.2	0.3	0.2	0.1	0.2	0.7	42.0	0.2	0.1	0.1	0.1	0.3	0.7	0.1	0.1	0.4	1.6	17.3	0.3	0.2	6.2	0.3	2.1	0.3	1.3	81.2	1.5	0.1	0.5	67.5	0.0	0.7	0.4	0.3	0.1	0.6	2.0	0.1	0.6	0.6	0.1	0.1	0.6	0.3	0.2	0.9	1.3	0.0	0.7	0.6	0.1	0.1	0.4	0.2	0.9	1.4	0.3	0.2	7.7	4.4	0.0	0.1	0.1	0.5	0.0	0.3	0.5	0.2	0.4	0.3	0.5	0.4	0.4	0.7	1.7	0.0	1.2	0.4	2.8	1.1	1.2	1.8	1.5	1.1	0.9	1.2	1.2	1.2	0.8	1.1	1.2	0.2	0.0	0.5	8.5	0.8	0.8	0.3	0.4	0.6	0.4	0.2	0.0	1.5	1.5	0.1	1.8	0.0	0.2	2.2	0.9	0.0	0.1	5.8	0.2	0.4	1.0	0.0	0.8	3.6	0.0	0.2	3.7	0.0	0.1	0.0	37.0	0.0	1.2	0.5	0.0	5.2	0.0	0.0	0.6	2.3	2.2	0.3	26.4	1.8	0.0	8.2	1.3	2.1	2.5	4.0	0.3	0.1	1.9	0.4	0.4	0.0	0.2	0.8	0.5	0.0	0.6	3.7	0.3	0.2	0.0	0.6	0.0	2.4	0.7	0.1	0.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Human disease related genes, Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 265.5;Proximal enterocytes: 257.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 406.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476"	"prognostic favorable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	120.0	49.7	34.1	79.6	33.4	128.0	90.7	35.3	40.8	60.1	33.3	72.7	73.2	37.6	22.4	89.3	37.9	54.3	96.3	31.5	36.5	83.3	107.9	91.7	69.4	40.5	37.4	41.8	71.6	42.8	27.2	28.7	39.0	47.9	52.4	17.4	53.1	39.2	211.2	60.4	90.8	32.6	37.6	101.2	63.5	14.6	37.1	43.4	45.9	130.7	83.3	84.4	69.3	35.3	117.7	81.3	15.4	55.7	58.4	58.6	39.4	54.7	174.5	48.6	91.1	78.4	155.5	95.8	182.3	74.2	285.3	68.3	25.2	406.4	59.4	167.8	34.6	37.8	44.4	51.1	111.4	43.6	168.3	84.3	74.5	80.3	166.2	134.1	69.1	37.2	24.6	94.2	122.7	43.7	48.2	60.0	13.9	41.1	43.4	39.0	118.4	131.4	152.3	85.0	21.7	49.9	42.4	131.5	57.2	41.6	67.5	54.5	107.8	162.7	53.0	28.7	79.2	184.6	102.2	43.4	177.0	63.7	39.6	18.2	12.1	36.0	11.9	11.1	14.0	12.7	13.9	12.0	9.2	16.8	7.1	7.9	41.3	12.4	10.8	12.8	21.2	10.4	34.1	33.4	35.3	40.8	31.5	36.5	40.5	37.4	39.0	37.6	37.1	35.3	31.1	57.7	45.4	4.9	73.1	29.7	50.4	119.9	27.3	14.3	33.3	24.9	48.8	54.3	72.2	27.6	4.2	18.3	53.7	233.7	72.4	218.0	3.3	39.8	18.0	75.1	37.3	52.4	6.5	139.1	31.3	38.9	92.8	64.8	48.2	105.2	42.1	62.7	39.0	18.5	6.4	69.0	46.8	49.6	113.1	6.9	27.1	64.9	26.6	8.4	238.3	20.3	68.0	5.5	9.4	265.5	173.9	23.7	63.6	179.1	257.5	56.4	49.1	15.0	32.9	69.2	45.7	2.2	13.9	30.2	28.6	48.2	60.7	12.2	77.1	158.6
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.4;urinary bladder: 4.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.7;Distal enterocytes: 19.1;Early spermatids: 13.8;Late spermatids: 46.2;T-cells: 17.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 6.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;hTEC/SVTERT24-B: 8.0;U-138 MG: 30.9;U-266/70: 8.8;U-266/84: 9.3;U-87 MG: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043063	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	0.7	0.1	0.6	6.4	0.6	1.0	0.1	0.4	0.9	1.3	0.0	0.5	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.9	0.5	0.2	0.4	1.6	2.6	1.9	0.4	0.1	0.2	0.0	0.0	0.0	2.2	0.1	0.4	0.9	0.7	0.0	0.5	0.2	0.9	0.5	0.1	0.9	0.7	0.6	0.4	1.9	0.1	0.0	3.2	4.2	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.3	0.1	0.4	0.5	0.1	0.1	1.1	0.1	0.1	0.2	2.8	4.6	0.0	0.0	0.7	0.9	7.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	8.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	30.9	0.6	2.5	0.1	8.8	9.3	0.2	6.3	0.3	1.0	0.6	0.1	0.0	2.5	0.0	1.8	0.0	1.1	6.2	0.0	0.1	0.5	2.8	0.3	0.0	0.1	0.0	0.7	0.6	0.6	0.6	0.4	0.9	0.9	0.5	1.9	0.4	2.2	0.1	0.4	0.8	0.2	3.2	21.7	0.7	1.8	0.1	0.2	5.7	0.0	0.0	0.4	0.1	0.6	0.0	4.9	0.0	6.2	0.0	2.4	19.1	0.0	0.2	13.8	0.0	0.1	1.4	0.0	0.0	1.5	1.1	0.0	0.3	2.0	0.2	7.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	4.1	0.8	2.7	46.2	0.3	9.5	0.0	0.0	0.1	0.3	2.1	0.5	0.1	0.7	3.7	0.0	2.4	0.1	0.0	0.1	1.7	1.3	0.0	0.7	1.1	0.4	0.4	0.0	0.4	0.0	17.8	0.0	9.8	0.1
TNK1	KOS1	ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 13.1;Distal enterocytes: 13.9;Gastric mucus-secreting cells: 16.8;Proximal enterocytes: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 9.1;HBEC3-KT: 6.0;hTCEpi: 6.6;T-47d: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"	"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.6	0.9	0.3	1.2	0.5	0.2	5.6	1.9	0.4	3.8	0.4	7.3	3.7	2.4	0.8	7.1	3.1	1.0	1.6	0.2	0.3	5.2	5.1	2.6	1.5	0.0	0.0	3.3	7.8	3.0	3.0	0.2	0.0	7.0	2.3	1.3	8.1	1.4	0.5	8.8	7.7	0.5	0.0	3.1	7.6	1.9	0.2	0.5	4.8	0.1	1.7	4.2	5.6	0.3	5.7	0.9	0.1	0.4	0.0	0.0	3.7	0.2	0.0	0.3	0.4	2.9	2.6	0.0	2.2	0.3	0.1	9.1	0.0	6.0	0.1	0.6	1.3	0.0	3.5	1.6	0.3	0.0	0.2	0.1	6.6	0.0	1.0	0.1	0.0	2.4	0.7	0.0	0.0	4.4	0.6	0.0	0.7	4.9	0.7	0.2	0.1	0.6	4.1	2.6	0.1	0.4	3.1	4.5	0.8	0.2	7.4	0.1	1.5	0.2	0.7	0.2	0.0	0.4	0.9	0.1	0.1	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.6	0.5	0.6	0.4	0.0	0.4	1.1	1.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.5	1.9	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	2.6	6.4	3.4	0.0	2.9	2.5	2.6	5.1	13.1	1.8	9.1	7.4	1.1	2.8	3.5	1.8	0.0	0.2	0.3	13.9	0.0	5.2	1.5	2.8	1.0	1.5	3.0	0.4	0.5	6.9	0.6	1.0	16.8	4.6	0.0	0.1	1.1	2.9	0.1	0.0	0.4	7.0	2.0	0.0	0.5	1.5	1.2	0.4	0.0	0.0	0.4	0.2	2.1	0.0	0.1	8.5	8.0	0.4	0.4	3.9	11.6	1.6	1.9	2.9	0.0	0.8	1.8	1.5	0.6	11.0	2.4	0.7	2.4	0.1	7.2	2.2
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041954, HPA069561"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Vesicles	"HPA041954: AB_10794164, HPA069561: "	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	14.2	10.0	77.1	24.7	64.1	72.2	15.0	40.0	102.9	18.0	11.8	18.5	9.4	13.8	11.1	19.1	17.1	10.5	18.4	75.6	51.4	7.7	10.5	14.1	30.0	77.5	59.8	13.4	12.1	6.1	36.4	12.7	70.1	21.1	6.3	9.3	26.3	11.8	54.8	62.3	16.1	9.2	45.5	27.0	19.7	12.0	57.0	16.0	10.0	16.7	20.1	19.4	19.3	60.6	93.4	16.3	15.4	13.4	15.3	11.5	80.0	17.7	16.7	11.7	9.4	15.6	79.3	25.9	55.1	24.2	17.4	34.1	14.9	22.2	3.5	61.8	15.4	22.0	36.2	10.4	7.9	13.5	10.2	7.8	30.7	11.7	17.9	26.7	13.3	9.2	11.3	30.6	9.4	67.1	5.3	39.7	12.3	24.6	29.1	13.8	15.6	26.0	7.2	51.2	16.2	16.5	9.5	37.6	21.3	11.3	71.4	11.9	18.9	19.1	13.0	11.4	48.6	70.8	9.2	17.0	22.1	38.0	15.4	1.4	1.2	0.3	0.9	1.5	0.4	1.3	0.8	0.4	0.5	2.5	0.5	0.5	2.7	0.4	1.4	1.5	0.1	0.7	77.1	64.1	40.0	102.9	75.6	51.4	77.5	59.8	70.1	45.5	57.0	60.6	9.3	6.4	7.7	44.4	14.6	6.9	8.1	6.0	4.6	30.6	13.0	12.6	16.1	7.2	8.9	0.0	50.1	13.4	11.0	18.0	1.9	4.0	1.0	4.1	5.4	11.1	6.1	12.8	42.7	5.3	3.3	4.6	14.3	4.1	1.3	4.5	11.7	19.2	8.1	99.3	45.3	2.3	6.1	16.0	11.7	1.2	6.5	13.7	5.4	20.6	16.2	5.9	21.6	245.3	25.1	29.5	9.6	6.4	10.7	8.2	0.9	1.6	7.6	20.3	0.0	4.8	5.7	6.4	11.2	11.0	10.5	4.2	12.5	1.7	6.4	19.0
TNKS	"ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555912-9782346	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	7.3	9.3	14.2	6.5	20.5	12.2	9.9	18.5	15.8	12.1	6.9	7.5	6.0	10.5	17.5	5.9	8.2	6.2	7.0	13.4	16.8	6.1	7.5	6.6	8.5	21.5	18.5	13.1	7.5	12.5	12.6	7.9	22.2	7.8	6.8	21.0	7.1	7.7	18.4	11.4	7.8	7.1	14.7	6.5	7.2	20.3	18.3	10.5	9.7	11.8	8.6	7.9	6.9	32.2	8.8	11.5	28.8	17.4	17.8	23.7	10.7	13.4	15.1	10.7	12.0	6.9	6.9	18.9	5.4	13.2	14.3	9.2	16.5	12.5	15.4	4.9	8.6	13.3	10.7	15.6	16.0	6.9	7.9	16.9	14.8	11.1	21.6	17.3	14.6	14.5	12.7	19.6	19.9	5.8	17.5	10.4	18.9	9.7	6.7	13.9	17.8	5.5	12.8	17.8	29.1	21.4	10.5	9.9	19.3	17.3	6.6	10.2	19.7	17.4	10.6	11.9	10.0	6.7	11.8	13.3	18.7	9.5	17.1	2.4	1.1	0.9	2.0	1.1	1.0	1.9	1.6	1.9	1.4	3.2	1.8	2.2	3.5	1.5	1.4	1.8	0.8	0.7	14.2	20.5	18.5	15.8	13.4	16.8	21.5	18.5	22.2	14.7	18.3	32.2	19.7	16.0	11.7	130.9	23.1	11.5	12.8	11.4	12.0	34.1	15.8	13.6	17.0	15.7	12.0	9.2	14.6	11.2	14.9	9.2	1.9	12.4	149.9	19.9	30.6	15.5	13.8	14.5	203.2	8.5	10.9	20.3	19.9	20.9	10.1	33.7	18.9	18.0	7.1	42.1	230.6	10.8	16.2	9.4	8.5	76.3	16.8	10.3	12.4	92.8	8.4	15.1	5.2	313.1	285.7	13.4	12.8	18.0	20.7	12.8	17.2	6.9	28.1	37.0	0.0	28.7	16.6	37.7	15.4	12.9	15.5	12.3	18.1	39.5	12.2	12.8
TNKS1BP1	"FLJ45975, KIAA1741, TAB182"	ENSG00000149115	"Tankyrase 1 binding protein 1"	Q9C0C2	11	57299638-57324952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037929, HPA037930"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		180000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA037929: AB_10672613, HPA037930: AB_2675745"	"unprognostic (7.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-1)"	"unprognostic (9.17e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (2.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.07e-1)"	62.7	27.3	11.8	17.3	10.2	3.3	41.9	4.6	9.4	43.3	18.0	23.6	28.8	40.3	30.3	55.4	35.3	28.1	23.3	11.3	9.2	14.7	31.6	40.3	6.6	9.6	8.8	32.2	30.9	18.9	17.1	29.5	7.2	33.6	16.2	3.3	44.2	40.2	67.2	83.0	26.6	29.4	4.9	18.1	52.8	10.1	11.0	22.3	25.0	29.9	14.3	38.5	45.6	6.7	89.5	58.7	41.2	33.6	127.8	97.1	31.0	61.5	113.8	46.3	42.5	26.1	59.5	2.0	38.5	101.2	49.6	151.7	31.4	105.3	30.1	34.2	10.4	11.5	38.2	12.2	86.6	14.4	4.3	96.8	123.5	70.9	54.6	57.5	60.0	12.4	13.2	9.3	65.3	45.4	11.0	14.7	45.8	46.5	45.9	16.9	57.2	25.9	53.5	116.6	14.6	22.6	81.5	121.5	44.3	29.0	182.2	11.9	115.1	47.3	45.8	56.6	35.2	15.0	4.1	11.3	107.0	4.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.8	10.2	4.6	9.4	11.3	9.2	9.6	8.8	7.2	4.9	11.0	6.7	38.1	12.8	35.4	12.7	1.9	83.6	28.0	61.9	40.9	4.8	24.8	23.9	7.9	38.6	39.0	44.1	2.1	16.8	1.3	27.3	0.0	31.8	1.8	18.5	25.4	25.9	18.0	7.4	7.2	22.3	3.2	31.2	49.5	38.4	2.5	3.7	19.6	46.0	3.9	8.4	4.8	25.8	18.3	1.5	25.4	2.9	48.1	3.8	17.8	1.9	0.7	4.0	0.0	4.5	2.4	38.8	14.3	49.2	0.6	41.2	18.2	2.4	15.4	1.3	32.9	41.2	26.9	1.5	3.0	68.9	88.2	24.5	2.3	23.4	14.5	36.8
TNMD	"BRICD4, ChM1L, myodulin, TEM, tendin"	ENSG00000000005	Tenomodulin	Q9H2S6	X	100584936-100599885	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 21.1;breast: 12.9;seminal vesicle: 26.1"	"Cell type enriched"	"Detected in some"	7	"Adipocytes: 73.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HAP1: 6.9;NTERA-2: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034961, HPA055634"	Uncertain					NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA034961: AB_10670285, HPA055634: AB_2682868"	"unprognostic (3.60e-2)"		"unprognostic (9.84e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.77e-3)"		"unprognostic (2.42e-1)"			"unprognostic (2.15e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.40e-2)"	"unprognostic (9.60e-4)"	"unprognostic (6.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.48e-1)"	21.1	0.2	0.2	0.6	0.1	0.0	12.9	0.0	0.2	0.5	1.1	0.8	0.1	0.3	0.2	0.3	0.3	0.5	1.0	0.2	0.5	0.8	0.0	0.0	0.1	0.5	0.5	2.1	0.1	0.0	0.0	2.4	0.3	1.3	0.5	0.0	0.5	26.1	3.3	3.2	0.5	0.7	0.1	0.2	0.1	0.1	0.4	0.4	0.2	5.8	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.5	0.5	0.5	0.3	0.1	0.4	0.1	73.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	3.9	0.0	0.0	0.0	0.1	5.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.7	0.5	9.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.7	3.2	0.0	0.1	0.0	1.0	0.0	0.3	0.7	0.6	0.0
TNN	TNW	ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067833-175148075	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 12.0;breast: 4.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.1;Fibroblasts: 7.5;Hepatic stellate cells: 2.5;Langerhans cells: 2.5;Smooth muscle cells: 10.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NB-4: 3.6;THP-1: 11.1;U-266/70: 2.7;U-937: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		34000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	12.0	0.2	0.0	0.1	0.1	0.0	4.9	0.0	0.1	0.1	0.1	0.3	0.8	0.0	0.0	0.1	0.0	1.7	0.3	0.2	0.0	0.4	1.3	0.4	0.1	0.0	0.1	0.0	0.3	0.8	2.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	3.1	0.4	0.4	0.1	0.4	0.4	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	6.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.1	7.5	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	10.4	0.4	1.4	0.0	1.8	0.1	0.1	0.0	0.0	0.1
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Cluster 13: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	8.4	10.9	0.7	0.8	0.8	0.7	19.1	2.7	1.1	7.7	7.3	4.0	1.1	2.8	41.7	387.3	2.8	3.3	8734.3	1.2	0.7	19.2	4.0	78.5	3.9	0.8	0.9	2.4	6.8	1.6	17.6	5.2	1.0	170.1	4.1	0.4	120.8	2.2	21081.1	18.9	3.3	0.8	0.8	2.8	5.7	10.6	0.8	4.3	14.4	12403.9	1.6	5.3	5.4	0.7	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.7	0.8	2.7	1.1	1.2	0.7	0.8	0.9	1.0	0.8	0.8	0.7	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
TNNC2	"CFAP85, FAP85"	ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	109	"skeletal muscle: 30416.4;tongue: 8088.6"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.2;head and neck cancer: 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 6.1"	"Low region specificity"	"Detected in some"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		560000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	6.6	5.5	4.8	0.4	5.7	1.1	8.3	5.2	6.9	2.2	4.4	5.3	2.5	4.2	1.0	128.5	3.0	2.2	4.0	4.8	4.5	1.7	2.5	3.2	0.5	4.4	4.5	6.5	2.2	1.2	3.1	0.2	4.5	44.3	2.2	1.3	176.3	1.3	30416.4	10.1	7.8	1.0	4.1	1.8	2.4	4.6	4.8	6.7	5.1	8088.6	0.7	2.5	3.0	5.5	0.1	0.0	0.2	0.4	1.6	1.0	1.7	0.1	0.4	0.0	0.1	0.2	1.1	0.4	1.1	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	10.0	0.4	0.3	0.2	14.8	0.2	0.1	0.7	0.3	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.4	0.1	11.3	0.5	1.6	0.1	0.4	0.5	1.3	0.4	0.5	0.2	0.3	0.9	0.2	1.5	0.4	0.2	1.4	0.1	0.2	0.0	0.6	1.3	0.1	1.1	0.6	5.3	1.3	0.2	0.3	4.6	0.0	0.3	2.0	0.3	0.8	0.8	3.9	8.7	4.8	5.7	5.2	6.9	4.8	4.5	4.4	4.5	4.5	4.1	4.8	5.5	0.9	3.2	0.6	0.3	3.1	0.8	0.5	2.0	0.0	4.2	3.1	1.7	0.5	2.8	3.6	3.7	0.0	2.4	0.5	171.7	3.9	1.5	6.9	37.1	1.0	3.8	22.9	0.0	1.9	5.1	0.4	7.2	0.5	2.3	0.0	13.9	0.0	1.1	0.3	0.0	0.7	108.2	14.2	0.3	1.1	47.0	1.2	22.4	0.0	0.0	2.1	1.4	1.0	0.0	0.6	3.3	92.9	3.0	0.5	0.7	338.7	1.0	4.3	2.4	0.0	1165.3	9.5	2.5	5.5	0.1	8.4	0.1	4.7	7.2	37.0	0.7
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	40	"skeletal muscle: 12562.8;tongue: 3158.3"	"Group enriched"	"Detected in some"	17	"Cardiomyocytes: 74.7;Skeletal myocytes: 176.2"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 491.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA		74000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.3	0.4	0.0	0.1	0.0	0.1	1.6	0.1	0.1	0.3	0.0	0.9	2.1	1.2	0.4	194.2	0.4	1.2	97.4	0.0	0.2	10.8	1.9	1.1	0.3	0.1	0.0	0.5	1.5	0.0	0.3	0.1	0.1	85.8	0.0	0.0	56.6	0.0	12562.8	2.1	2.5	0.1	0.0	0.3	1.3	0.5	0.1	1.6	1.4	3158.3	0.4	0.2	1.5	0.1	0.9	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.8	0.3	0.0	0.0	491.6	0.9	0.0	0.8	0.3	0.0	0.1	0.1	0.1	4.9	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	74.7	0.0	0.0	0.0	0.0	0.4	0.0	0.7	5.9	0.0	3.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	3.6	0.0	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	176.2	2.2	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.9	0.1
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838981-1841680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	25	"skeletal muscle: 7969.8;tongue: 2622.3"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 86.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 35.7;hTCEpi: 101.2"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 5.1"	"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	3.0	1.8	0.3	1.1	0.3	6.1	7.9	0.3	0.6	1.0	0.4	1.2	0.3	0.8	0.3	66.9	0.9	5.6	1.7	0.3	0.4	0.7	1.6	7.8	1.6	0.4	0.4	0.7	8.8	0.0	0.9	3.0	0.4	14.0	0.2	0.0	216.1	3.2	7969.8	55.2	2.7	0.2	0.4	5.8	1.1	0.7	0.5	1.9	2.8	2622.3	1.0	27.4	3.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	35.7	1.0	0.2	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	8.1	101.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	3.1	0.0	0.1	1.2	2.4	0.0	1.0	0.0	1.0	0.0	0.7	0.0	0.0	12.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	13.8	5.8	53.3	0.1	12.5	0.1	3.8	0.0	0.0	8.0	4.8	0.0	0.0	39.7	0.4	17.6	86.4	0.0	2.5	0.3	0.3	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.4	0.5	0.6	1.2	3.2	4.4	0.0	9.1	25.1	2.6	1.8	15.4	0.0	0.5	23.7	5.6	21.5	3.0	0.0	0.0	33.8	15.7	0.1	0.0	1.4	0.0	1.4	0.2	2.0	0.0	0.0	0.0	0.6	449.4	2.4	1.1	0.1	10.8	0.4	0.4	0.3	39.6	0.0	0.0	0.0	2.0	18.8	10.7	0.0	0.3	25.9	0.0	0.0	16.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	4.2	0.1	0.0	0.2	13.2	0.0	0.0	598.7	2.4	0.0	0.6	2.7	6.5	87.2	1.9	4.3	0.0	0.9
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	622	"heart muscle: 10813.5"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.3	0.0	0.5	0.0	17.3	0.2	0.4	0.7	0.7	0.7	0.0	0.3	0.1	0.8	6.2	0.9	10813.5	0.6	0.2	1.0	1.1	7.3	1.6	0.5	2.8	1.4	2.3	0.2	0.6	1.0	1.3	2.4	0.0	0.2	1.3	0.0	6.5	1.2	0.6	0.0	0.6	0.4	0.7	3.7	0.3	0.1	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.4	0.6	0.2	0.5	2.8	1.3	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	205	"heart muscle: 10670.6"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	4.9	12.4	0.6	13.9	0.1	11.9	11.7	20.4	2.3	11.7	1.3	0.3	3.2	0.8	7.8	1.9	3.8	10670.6	16.8	11.6	51.9	2.3	22.0	2.7	11.6	11.6	1.3	5.0	0.0	4.5	10.3	11.6	6.1	0.1	0.4	3.6	0.7	16.5	21.7	1.6	0.1	11.6	0.7	2.0	1.7	11.6	2.1	2.0	9.4	0.5	19.3	5.0	15.8	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.9	11.7	20.4	16.8	11.6	11.6	11.6	11.6	11.6	11.6	15.8	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
TNNT3	"AMCD2B, DA2B, DKFZp779M2348, FSSV"	ENSG00000130595	"Troponin T3, fast skeletal type"	P45378	11	1919703-1938706	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	43	"skeletal muscle: 13906.8;tongue: 4507.7"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 542.6"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 28.8;urothelial cancer: 19.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	21	"HSkMC: 24.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.1"	"Low region specificity"	"Detected in single"			"CAB002451, HPA037810, HPA056909"	Enhanced					NA	NA		470000	"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273"	"unprognostic (1.01e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (2.17e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.53e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.42e-5)"	"unprognostic (2.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.90e-2)"	31.2	2.4	0.2	1.4	0.4	1.5	20.0	0.1	0.4	16.3	0.1	5.8	0.2	6.6	2.8	62.5	14.4	1.9	185.3	0.2	0.1	0.8	1.4	3.7	1.4	0.1	0.1	1.7	2.2	0.3	2.5	41.3	0.1	20.7	0.5	0.0	216.0	3.1	13906.8	8.8	3.0	1.3	0.1	2.8	3.3	5.2	0.1	5.4	7.6	4507.7	2.0	20.3	12.0	0.2	0.0	0.0	0.0	0.0	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	33.1	0.0	1.9	0.0	0.8	2.9	3.9	5.9	2.2	0.0	0.4	0.3	17.8	0.0	10.1	0.0	0.0	24.5	1.5	0.0	0.0	0.1	0.3	2.4	0.3	33.9	0.0	0.0	0.1	0.0	6.7	42.0	0.0	0.1	0.0	3.0	0.0	0.0	2.7	0.0	0.0	0.0	6.1	0.0	2.3	2.5	110.9	2.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	94.8	0.3	0.2	0.0	0.0	42.5	0.0	0.0	542.6	11.2	0.1	0.6	2.9	3.4	18.3	2.0	0.7	0.0	17.1
TNP1		ENSG00000118245	"Transition protein 1"	P09430	2	216859458-216860064	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1160	"testis: 5953.3"	"Group enriched"	"Detected in some"	205	"Early spermatids: 41424.6;Late spermatids: 136509.6"	"Group enriched"	"Detected in some"	58	"liver cancer: 6.0;testis cancer: 4.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044387	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA044387: AB_2678923"															"unprognostic (1.67e-1)"			0.9	0.8	1.4	0.4	4.9	0.0	4.0	1.4	1.4	1.0	0.0	0.9	0.8	0.6	0.0	0.8	0.6	0.0	0.8	1.6	0.0	1.1	2.0	0.6	0.1	0.0	0.0	0.8	1.3	0.0	0.8	0.0	0.0	5.1	0.0	0.0	0.8	0.0	2.3	1.4	1.6	0.0	0.0	0.6	1.0	5953.3	1.0	0.0	2.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.9	1.4	1.4	1.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41424.6	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136509.6	410.1	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	246.7	0.0	0.0	0.0	0.0	0.0	0.0	249.8	0.0	0.1	433.2	234.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.5	23.0	10.6	28.8	14.6	31.7	25.0	14.0	10.0	20.2	23.0	24.5	20.5	24.0	33.8	23.1	20.6	27.7	20.8	10.5	17.1	30.5	28.4	17.3	29.9	18.2	13.4	22.4	31.5	39.8	15.6	36.8	16.5	23.4	29.9	65.0	20.9	28.1	25.0	11.6	20.9	28.2	15.1	20.6	30.7	37.3	13.1	35.6	36.8	27.0	32.3	33.3	14.0	21.5	94.8	123.7	154.5	104.8	133.3	144.5	110.4	112.3	145.6	112.2	113.6	111.4	87.1	117.5	78.5	173.0	140.4	71.6	126.3	108.8	160.8	66.6	71.9	76.2	144.8	55.9	103.9	78.4	55.1	110.8	80.2	151.0	184.8	78.2	248.6	52.9	113.4	54.8	298.1	50.3	87.2	37.3	99.3	39.8	90.9	83.1	150.5	74.1	73.4	109.5	87.5	73.6	160.6	60.3	135.8	99.8	71.2	61.9	225.1	79.5	113.8	116.8	136.7	53.2	95.8	155.8	69.9	91.3	154.4	8.2	8.2	6.9	11.9	11.0	16.5	10.3	10.9	9.3	10.3	10.8	11.6	11.9	8.4	14.1	14.0	5.0	8.3	10.5	10.6	14.6	14.0	10.0	10.5	17.1	18.2	13.4	16.5	15.1	13.1	21.5	42.3	12.8	25.0	45.7	49.0	59.1	40.9	29.7	60.3	105.0	38.7	24.0	53.8	30.0	28.7	27.6	98.0	81.9	44.9	39.8	17.6	39.0	105.4	38.6	46.1	64.8	53.2	27.1	142.2	41.5	50.0	52.8	53.0	46.7	22.1	62.8	50.7	38.1	42.7	89.2	77.8	46.3	28.5	40.0	42.2	60.9	46.6	42.1	24.9	50.6	47.4	143.1	26.8	79.9	84.7	58.9	24.9	60.2	42.9	57.0	33.9	36.1	27.6	187.9	26.3	72.5	48.8	58.5	76.3	42.0	53.3	131.3	36.9	40.2	37.2	60.2
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	28.3	33.0	50.3	21.7	54.4	26.8	24.8	36.7	57.3	30.9	28.2	28.4	17.3	33.3	25.5	31.3	30.3	20.5	26.6	54.6	44.1	22.5	18.4	23.0	23.4	51.3	45.4	40.3	20.6	32.3	33.6	20.9	50.9	26.6	19.8	33.0	22.2	23.9	25.7	48.1	23.4	28.1	39.5	26.3	23.5	32.7	51.5	27.8	26.8	20.1	23.9	28.6	27.6	51.2	54.4	40.5	61.0	78.3	36.3	47.6	39.5	61.0	40.1	86.5	60.6	55.9	28.5	36.6	46.5	51.7	24.1	70.5	109.2	60.3	47.9	45.6	87.6	56.5	72.1	68.4	40.9	100.6	52.0	42.9	46.8	57.5	60.4	55.8	41.0	72.7	89.4	33.9	48.5	93.4	84.8	68.8	71.0	39.8	120.8	80.7	47.6	67.0	51.2	38.9	148.6	73.8	49.6	62.2	30.7	41.2	43.5	35.2	41.5	131.5	34.9	71.3	91.2	66.8	70.4	62.3	39.2	89.9	47.9	0.2	0.2	0.1	0.6	0.3	0.9	0.4	0.4	0.5	0.4	0.4	0.8	1.0	0.8	0.1	0.4	1.5	0.2	0.2	50.3	54.4	36.7	57.3	54.6	44.1	51.3	45.4	50.9	39.5	51.5	51.2	13.2	6.4	17.9	24.2	10.7	31.0	8.9	10.6	14.8	42.4	22.8	17.1	17.6	11.5	10.0	22.0	100.1	10.9	11.0	14.1	5.9	9.7	12.2	16.2	20.6	17.0	22.9	14.9	22.3	8.5	6.6	18.0	10.2	12.9	3.8	20.7	19.2	17.8	10.5	57.2	26.6	17.7	8.2	13.0	14.9	19.5	31.1	8.7	8.8	22.5	11.1	24.6	6.2	19.6	24.7	15.2	9.1	32.4	8.7	19.3	11.9	16.7	11.3	33.6	6.6	23.8	15.3	23.8	11.3	21.9	41.5	14.5	9.5	16.5	16.6	9.3
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	16.1	16.9	17.1	19.3	17.7	34.3	15.7	19.0	18.7	14.1	16.3	18.4	16.4	15.6	17.8	21.1	16.2	13.0	15.6	17.3	19.9	19.1	22.9	16.0	23.4	17.0	17.6	20.5	15.1	21.1	10.0	14.8	19.3	16.6	20.1	16.5	15.5	18.0	32.6	18.1	16.6	19.5	17.2	17.7	19.7	26.4	19.0	30.1	22.8	27.0	28.8	18.6	15.1	17.6	59.1	65.3	49.7	84.3	47.3	40.5	42.3	51.8	45.0	47.4	55.5	53.7	52.9	73.3	23.6	55.7	89.7	42.3	101.6	49.8	67.6	61.3	45.0	54.0	52.2	42.2	45.0	99.8	44.2	38.1	49.7	57.9	51.4	41.4	59.9	59.5	124.7	51.3	61.2	43.7	86.9	73.4	142.6	64.4	59.7	61.0	46.3	60.0	48.0	54.6	61.5	48.7	55.2	25.7	58.3	71.4	29.0	61.3	45.2	59.7	29.4	71.1	71.5	65.3	54.6	99.3	86.3	100.5	106.1	26.7	14.1	22.0	16.4	17.3	14.6	16.1	13.3	14.8	16.1	15.5	13.0	15.2	15.5	14.5	23.9	7.7	15.1	11.7	17.1	17.7	19.0	18.7	17.3	19.9	17.0	17.6	19.3	17.2	19.0	17.6	20.4	16.0	16.7	30.7	31.4	6.8	15.6	5.7	27.3	23.4	20.3	13.8	21.4	20.0	11.6	18.4	22.9	24.7	26.9	20.4	7.9	23.2	41.4	19.1	17.7	18.8	11.5	38.5	45.8	24.8	37.2	17.4	22.4	27.7	10.8	30.5	19.6	27.9	27.8	37.0	46.8	22.2	2.0	25.7	9.5	25.4	16.8	24.9	8.8	31.9	44.4	13.6	17.5	37.7	47.5	30.3	17.7	17.7	28.5	17.6	21.7	18.7	13.1	21.7	13.1	18.5	19.4	76.3	31.8	32.5	8.2	35.0	23.5	33.1	24.8	30.4
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743616	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 31.3;retina: 16.2"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.9;U-937: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		58000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	0.0	1.4	30.7	0.2	24.3	0.1	0.0	15.2	26.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.3	27.7	0.0	0.4	0.5	0.2	23.3	16.4	0.0	0.4	0.0	2.7	0.0	20.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.2	0.3	0.4	18.2	0.1	0.1	0.0	0.3	0.0	0.0	30.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.7	24.3	15.2	26.3	31.3	27.7	23.3	16.4	20.3	20.8	18.2	30.5	0.0	0.0	0.0	20.2	2.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	226.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	580.5	179.6	0.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	3.7	0.0	1.8	0.0	2288.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.8	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	30.4	18.3	10.8	29.0	8.9	51.8	30.1	16.2	14.2	40.8	2.2	56.3	25.3	57.6	16.4	26.0	43.5	22.4	22.1	10.3	0.5	22.9	19.8	32.0	16.1	6.2	1.7	46.0	29.5	35.0	22.2	30.6	1.6	36.1	22.6	12.2	28.8	34.3	24.0	33.2	29.0	36.4	1.3	25.2	33.8	22.6	5.1	17.2	32.6	11.1	14.6	40.8	31.9	3.2	72.8	63.4	51.5	43.4	42.9	50.6	133.8	50.4	47.3	27.4	29.0	26.3	62.4	49.3	48.3	74.7	60.8	79.7	30.2	60.5	23.0	21.6	19.2	31.4	56.6	43.1	37.1	104.3	111.2	51.2	70.0	54.8	63.2	39.5	31.3	43.6	45.4	27.2	35.3	120.0	24.6	127.2	4.5	47.5	48.0	27.0	25.7	37.3	22.3	91.3	22.3	53.4	38.8	102.5	37.0	23.1	106.9	106.1	78.7	78.3	109.6	47.0	36.7	38.6	44.1	46.2	44.1	72.6	94.1	14.2	3.8	3.6	1.7	1.5	1.2	2.2	1.2	1.0	1.4	2.3	0.9	1.7	20.8	3.2	2.1	5.4	1.9	0.2	10.8	8.9	16.2	14.2	10.3	0.5	6.2	1.7	1.6	1.3	5.1	3.2	25.6	9.6	29.0	59.7	7.4	9.3	3.7	9.8	13.6	51.7	15.8	25.9	7.5	14.3	12.4	14.7	2.1	14.5	20.4	33.6	1.9	5.0	14.4	22.2	29.7	17.3	31.3	9.7	40.9	6.6	3.8	17.8	19.4	36.2	14.0	48.3	29.6	25.4	11.2	50.5	45.6	30.4	8.2	41.8	12.4	18.8	18.3	22.8	5.4	71.2	25.9	31.0	11.3	32.6	20.3	9.0	10.6	19.9	12.1	6.5	7.4	5.4	11.1	4.0	19.7	18.4	21.2	0.4	2.1	12.5	8.8	10.0	12.3	18.6	25.1	3.8
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing adaptor 6A"	Q8NDV7	16	24610209-24827632	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.2	21.0	5.0	6.4	3.6	6.0	14.9	10.8	7.1	17.8	6.1	17.8	5.5	23.5	11.5	11.3	17.7	6.4	11.1	3.4	6.6	10.3	13.0	12.8	7.1	6.1	4.8	20.6	19.2	13.2	22.8	6.6	6.1	14.6	6.4	7.0	14.9	8.0	14.0	13.1	15.3	8.1	2.2	9.9	15.2	6.6	7.0	8.6	17.8	6.9	7.4	13.0	13.4	7.4	10.1	13.8	16.0	8.7	13.6	17.7	9.1	16.9	13.6	12.0	13.1	10.2	8.2	10.2	7.1	17.0	12.4	11.2	20.1	14.2	18.0	10.4	10.4	10.2	16.7	14.1	11.7	10.5	6.9	18.0	7.3	15.8	10.2	14.8	16.7	6.6	15.7	6.2	15.8	11.9	8.8	6.9	23.1	4.9	6.8	17.1	12.4	9.1	9.1	9.3	7.7	10.8	11.8	7.2	6.6	12.1	8.4	6.8	15.5	15.3	10.5	7.6	12.0	13.7	11.6	16.5	14.3	6.4	11.3	0.5	0.5	0.4	0.5	0.3	0.4	1.1	0.5	0.5	0.2	1.0	0.7	0.5	0.3	0.6	0.3	1.0	0.5	0.3	5.0	3.6	10.8	7.1	3.4	6.6	6.1	4.8	6.1	2.2	7.0	7.4	51.2	38.5	60.0	289.3	45.5	34.9	17.8	21.9	39.9	97.1	42.8	41.0	75.3	51.5	32.3	46.0	118.9	22.4	49.9	38.3	17.6	23.6	17.2	38.7	65.5	45.5	55.9	34.9	283.8	24.5	15.1	50.5	33.6	42.8	39.3	76.5	60.3	115.3	21.2	176.7	414.6	36.3	22.4	56.2	26.5	11.3	69.0	28.7	30.2	138.7	36.1	42.0	50.4	265.4	234.2	28.5	36.1	81.3	44.7	26.0	42.8	19.2	29.8	81.7	19.7	52.8	60.9	41.2	30.6	38.1	28.7	8.2	39.0	36.5	35.8	17.4
TNRC6B	KIAA1093	ENSG00000100354	"Trinucleotide repeat containing adaptor 6B"	Q9UPQ9	22	40044817-40335808	"Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 484.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003180	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA003180: AB_1079196"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.85e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.81e-1)"	4.0	3.6	4.5	4.9	6.2	19.5	3.9	22.0	7.6	4.4	13.2	4.2	3.2	4.0	5.8	3.5	3.7	4.4	4.7	3.6	1.1	3.9	5.4	4.9	5.3	3.7	3.5	4.2	3.9	4.7	5.5	3.6	4.2	3.7	3.5	12.7	4.0	2.8	6.4	5.5	5.2	3.7	1.1	5.6	4.3	14.9	3.9	9.2	5.0	5.1	5.9	3.6	4.2	15.7	6.3	9.3	9.4	9.8	6.1	4.3	5.1	4.2	7.7	6.5	7.9	4.2	4.3	11.9	7.4	5.1	7.6	4.3	11.8	8.6	6.8	13.0	9.3	8.8	9.3	5.3	3.0	10.2	12.5	4.8	4.0	10.2	5.1	3.1	9.0	6.7	7.4	10.8	6.1	6.8	6.3	3.2	12.2	4.8	6.7	7.7	9.0	6.0	6.1	10.6	11.4	2.7	10.2	3.6	5.2	8.5	5.1	3.7	10.3	5.7	20.7	5.8	4.0	8.5	8.2	7.8	3.7	5.1	6.8	228.9	32.8	66.2	48.0	19.2	42.4	100.7	50.5	44.5	16.3	134.6	52.8	53.6	484.5	34.7	29.6	104.9	29.5	12.5	4.5	6.2	22.0	7.6	3.6	1.1	3.7	3.5	4.2	1.1	3.9	15.7	114.0	38.5	54.9	260.8	178.8	74.8	70.2	60.8	92.8	248.7	103.4	85.9	153.6	125.8	56.0	69.9	458.7	36.4	171.1	77.8	70.5	59.8	82.5	142.2	91.0	104.4	141.0	203.1	334.1	59.3	20.7	108.4	61.2	85.0	65.9	78.1	120.7	109.7	39.0	341.6	371.8	76.7	65.1	115.9	80.1	72.4	111.9	71.4	65.8	235.2	117.2	127.2	168.9	255.9	304.0	54.4	76.4	127.9	117.8	79.8	93.0	69.0	91.3	356.9	52.6	175.5	95.1	87.7	88.3	56.6	82.1	7.5	149.0	82.6	83.7	59.1
TNRC6C	"FLJ20015, KIAA1582"	ENSG00000078687	"Trinucleotide repeat containing adaptor 6C"	Q9HCJ0	17	77959240-78108835	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 237.7;Oligodendrocyte precursor cells: 175.4;Oligodendrocytes: 144.9;Rod photoreceptor cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022007, HPA062051"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA022007: AB_2670877, HPA062051: AB_2684670"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (6.56e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.70e-2)"	5.2	3.1	9.3	4.5	10.5	3.1	5.2	18.8	11.9	5.3	0.0	4.7	2.0	5.9	4.3	2.7	5.6	4.1	6.1	10.1	8.1	2.9	3.5	3.6	5.8	8.2	7.2	7.3	4.0	3.8	7.4	1.9	6.3	5.1	2.7	25.0	5.6	4.0	10.8	3.0	4.0	4.8	2.5	5.1	3.7	8.3	7.1	17.7	4.3	7.6	5.0	4.5	4.1	18.3	4.2	4.0	7.1	7.7	3.0	2.2	0.0	6.3	5.3	4.4	3.6	4.2	1.2	0.0	2.6	4.9	3.1	0.3	5.2	0.2	2.7	3.4	5.5	15.0	1.5	4.7	2.7	3.6	7.3	1.9	2.0	1.7	4.1	2.0	9.4	14.6	2.5	7.4	4.6	5.8	34.5	1.7	3.7	1.8	3.0	4.5	14.2	2.8	1.0	6.0	8.7	16.0	7.6	9.2	3.0	3.4	6.9	5.1	7.0	9.8	3.2	5.1	7.9	5.5	0.9	4.3	2.8	5.3	7.2	15.9	0.2	1.2	1.5	0.1	1.6	0.9	1.6	1.6	0.1	0.9	1.8	2.1	0.9	2.4	0.0	0.6	0.8	0.4	9.3	10.5	18.8	11.9	10.1	8.1	8.2	7.2	6.3	2.5	7.1	18.3	43.9	28.9	27.8	63.6	24.7	22.0	9.5	4.7	26.7	123.2	28.4	17.5	30.1	30.0	7.6	9.2	237.7	0.1	36.2	8.8	1.9	7.5	9.7	12.6	26.3	25.3	39.8	21.0	125.8	6.0	0.7	36.5	8.6	13.6	22.8	13.0	40.7	21.3	2.1	74.0	112.6	8.7	8.2	10.5	14.8	7.9	51.3	6.6	16.0	33.7	7.3	33.1	41.2	175.4	144.9	9.0	5.3	42.9	15.8	11.8	6.5	5.2	5.9	138.1	0.0	35.9	27.4	36.7	20.1	12.2	14.2	0.3	47.9	14.4	7.9	5.1
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218033982	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	248.2	60.3	51.6	42.9	98.0	42.3	100.9	71.7	45.5	99.5	45.1	373.4	23.4	253.7	44.3	117.8	136.2	80.4	170.4	34.0	53.4	74.6	39.6	117.2	11.5	82.3	79.2	110.4	55.2	33.2	15.4	54.5	106.4	126.1	41.7	7.7	52.9	225.0	171.6	47.8	78.9	178.0	72.2	70.1	115.2	23.5	80.9	21.5	65.8	207.2	7.5	228.4	82.6	82.9	0.3	0.4	8.9	0.1	135.1	74.1	0.8	22.9	7.8	1.3	0.9	10.0	0.1	0.0	13.1	66.6	1.5	1.7	1.4	1.3	0.7	9.4	0.8	19.8	5.7	2.6	9.8	0.1	2.3	35.2	0.0	24.4	0.2	43.6	32.2	0.1	0.6	2.6	18.8	4.4	0.1	1.4	0.9	0.2	0.4	75.4	16.8	1.0	4.8	0.2	2.1	10.1	3.9	9.7	2.0	6.1	3.1	8.5	63.2	16.6	29.5	17.5	4.9	1.1	0.1	0.1	9.8	2.7	1.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.8	51.6	98.0	71.7	45.5	34.0	53.4	82.3	79.2	106.4	72.2	80.9	82.9	93.3	173.1	85.9	29.7	1.1	16.2	48.6	29.5	42.1	4.8	7.2	21.2	339.0	38.6	27.5	14.7	0.0	8.7	0.5	0.1	7.9	36.1	2.2	3.0	29.5	76.6	0.0	143.1	3.9	19.1	1.5	52.4	1.1	3.8	30.4	8.8	71.7	38.5	13.0	42.1	5.3	0.0	6.1	15.3	19.3	11.9	169.6	16.7	10.6	32.8	1.3	14.1	0.0	15.6	52.0	17.0	0.0	504.0	0.4	12.1	0.0	26.1	22.3	1.3	368.1	29.7	183.5	1.1	1.9	5.7	11.8	1.9	4.1	20.7	0.2	17.3
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.3;Hepatic stellate cells: 93.1;Leydig cells: 141.7;Peritubular cells: 114.0;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 114.2;ASC TERT1: 78.1;HHSteC: 59.9;HSkMC: 86.2;hTERT-RPE1: 61.9;TIME: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	156.3	66.9	59.3	14.8	66.2	0.3	121.6	46.4	57.8	121.2	33.3	79.0	14.4	98.8	14.0	28.3	121.0	32.5	99.6	43.7	49.2	67.3	66.5	83.4	15.8	58.0	63.5	104.1	34.6	17.0	43.3	33.1	54.0	66.3	11.5	6.0	35.7	41.1	69.0	42.1	56.7	28.5	50.8	79.5	58.2	15.9	58.3	7.2	80.6	58.8	6.4	82.6	81.1	57.9	2.0	21.2	2.7	2.2	114.2	78.1	0.7	11.8	27.1	6.2	3.2	1.4	5.7	0.1	25.3	32.1	2.6	1.5	0.1	7.8	2.4	0.5	0.8	0.4	25.5	11.3	59.9	0.3	0.5	86.2	0.3	7.9	4.7	61.9	36.3	0.4	0.6	0.3	24.9	5.1	0.2	0.4	1.9	1.4	5.8	0.7	6.6	0.3	8.2	0.4	1.2	2.7	4.4	2.4	8.8	1.6	26.1	0.7	52.1	12.9	14.8	4.7	2.0	0.6	0.3	0.1	20.4	0.3	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.3	66.2	46.4	57.8	43.7	49.2	58.0	63.5	54.0	50.8	58.3	57.9	109.3	3.2	25.7	33.3	0.5	0.0	6.8	0.0	5.2	21.1	15.1	13.0	7.9	10.0	2.5	5.5	0.0	0.5	0.9	0.4	3.9	5.8	2.8	4.4	41.1	69.6	1.2	2.7	3.1	4.4	0.4	40.5	2.0	14.5	0.0	7.7	93.1	37.5	2.4	30.3	7.8	3.9	0.0	4.4	0.0	7.2	141.7	2.9	0.0	31.9	0.1	29.6	0.0	46.3	35.6	2.4	9.0	114.0	1.8	4.5	2.1	2.6	1.5	11.3	151.2	51.3	64.7	4.2	4.4	1.3	0.0	0.8	1.4	2.6	1.8	2.1
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 4.0;intermediate monocyte: 3.2;memory B-cell: 2.3;myeloid DC: 2.6;naive B-cell: 1.9;non-classical monocyte: 3.2;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	7	"B-cells: 2.3;dendritic cells: 3.7;monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A549: 266.7;LHCN-M2: 170.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		8100	"Cluster 14: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	30.4	35.3	57.3	23.8	59.0	6.3	20.9	57.3	51.6	26.2	59.2	19.3	18.7	24.6	6.5	6.4	21.9	21.3	23.8	55.2	64.7	59.7	51.6	40.7	36.7	81.4	63.3	38.3	57.0	30.8	10.5	56.7	73.2	16.3	16.9	9.1	48.5	16.0	22.0	14.4	23.9	16.6	63.2	42.0	30.3	9.4	73.9	8.3	29.8	15.0	19.4	16.2	16.6	63.6	26.5	266.7	15.9	27.7	35.6	28.8	50.6	23.6	133.8	22.7	34.7	60.5	34.7	13.4	40.9	86.4	84.8	49.4	25.9	38.6	20.6	0.2	1.6	37.4	37.3	32.3	36.8	0.1	0.4	28.7	16.3	13.0	20.7	147.3	18.1	0.0	0.1	80.6	170.0	16.4	0.1	0.8	15.4	38.1	31.5	12.1	38.7	44.5	77.5	53.0	1.5	32.3	46.5	9.3	26.9	79.6	35.2	27.6	72.6	35.0	27.1	0.4	36.5	51.7	72.4	30.6	8.7	26.0	129.6	0.2	4.0	0.0	0.0	3.2	0.1	2.3	0.0	0.0	2.6	1.9	0.0	0.0	0.5	0.0	3.2	3.7	0.0	1.4	57.3	59.0	57.3	51.6	55.2	64.7	81.4	63.3	73.2	63.2	73.9	63.6	8.5	67.3	15.8	90.8	10.9	4.8	6.5	26.3	14.2	1.6	8.5	10.3	23.9	35.8	18.8	31.3	0.0	27.7	7.1	41.3	1.9	15.5	11.8	19.8	11.0	12.4	15.0	6.3	2.4	18.4	59.2	14.9	18.3	23.2	0.0	11.4	31.4	40.3	77.4	0.0	6.4	14.0	10.2	41.3	8.4	18.5	6.2	28.9	16.0	76.8	23.1	35.2	1.0	150.8	3.7	23.8	9.9	15.4	5.3	10.5	33.6	14.1	11.1	1.4	26.3	45.5	21.8	2.2	3.0	1.5	3.3	30.0	3.5	20.1	17.0	3.2
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 253.3"	"Low region specificity"	"Detected in all"							HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	42.6	210.2	32.6	22.3	34.9	70.2	65.3	31.6	40.8	55.3	59.3	47.4	56.1	23.9	26.5	77.7	54.6	47.6	44.7	29.8	39.4	67.9	168.6	36.8	18.9	37.3	48.2	63.4	207.9	81.4	50.1	13.8	38.6	72.3	57.5	101.8	99.8	92.2	178.6	133.5	48.1	29.4	31.8	17.8	87.5	26.0	33.4	17.7	95.4	109.9	21.0	81.9	70.9	40.2	44.1	88.7	28.1	11.5	51.4	25.4	22.0	31.9	79.2	20.5	25.0	36.0	54.6	40.0	60.6	43.9	20.7	61.0	19.5	54.1	21.1	20.4	29.3	4.8	100.7	60.5	72.0	21.5	18.9	54.5	65.5	23.9	120.0	27.3	9.9	12.2	17.0	33.7	43.4	119.0	16.1	19.4	10.2	109.4	33.9	14.0	35.6	47.6	80.9	89.4	16.6	40.4	55.1	158.9	19.9	42.5	253.3	27.1	13.2	23.3	16.7	26.7	15.8	51.9	57.7	18.5	19.2	10.2	9.1	417.7	53.5	285.6	245.8	107.3	269.9	40.7	222.7	192.5	119.1	31.9	192.1	233.6	130.7	28.8	152.5	38.5	206.0	169.0	32.6	34.9	31.6	40.8	29.8	39.4	37.3	48.2	38.6	31.8	33.4	40.2	101.6	115.4	118.3	71.8	53.1	283.2	232.9	119.8	284.0	125.3	180.6	179.6	115.5	210.1	81.8	68.0	56.3	20.8	124.8	183.3	103.7	42.6	97.9	143.7	51.7	40.7	203.4	18.1	11.5	54.1	2.0	83.5	123.3	176.2	63.9	19.7	33.2	205.6	35.4	18.5	14.1	223.2	48.8	27.6	249.2	40.4	26.4	89.9	71.2	5.6	29.1	118.3	20.6	16.6	34.1	41.8	186.7	59.8	41.3	187.2	126.2	60.4	87.8	62.7	164.3	137.3	123.8	36.9	12.1	153.8	230.7	10.9	154.7	77.4	167.6	287.2
TOB2	"APRO5, bK223H9, TOB4, TOBL, TROB2"	ENSG00000183864	"Transducer of ERBB2, 2"	Q14106	22	41433494-41446801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016603, HPA054112"	Approved		Approved	Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA016603: AB_2669400, HPA054112: AB_2682385"	"unprognostic (1.21e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (3.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (1.50e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.13e-2)"	46.1	31.3	39.3	15.6	56.3	9.7	25.5	78.1	40.1	26.5	18.5	30.1	22.4	25.0	11.8	26.6	38.4	28.8	41.2	39.3	43.8	24.6	27.1	20.7	18.5	61.7	42.9	38.0	29.0	35.6	22.8	22.0	44.0	26.6	15.5	55.0	17.2	19.4	86.5	27.1	23.9	20.1	39.5	20.6	30.5	13.6	52.0	19.6	36.1	68.1	19.7	23.3	21.0	71.9	36.8	16.6	28.5	19.4	65.4	45.5	27.5	23.9	36.7	29.8	26.2	21.9	17.0	22.4	23.5	34.8	11.6	31.4	26.7	13.4	27.1	23.0	34.2	12.3	23.9	33.4	44.8	33.5	15.9	42.1	22.5	35.6	15.4	30.1	30.2	7.6	18.9	24.5	24.6	40.8	13.9	19.2	24.4	48.1	17.6	29.7	19.2	19.4	21.3	25.3	13.1	8.8	60.0	32.2	44.6	17.7	17.9	16.5	37.9	29.3	27.1	23.0	22.7	22.9	10.7	12.2	17.8	14.2	19.7	3.9	5.9	4.1	7.5	8.0	7.1	10.0	6.2	6.3	5.3	7.5	3.2	4.7	3.8	3.8	8.4	8.0	5.5	6.1	39.3	56.3	78.1	40.1	39.3	43.8	61.7	42.9	44.0	39.5	52.0	71.9	48.5	48.1	59.6	48.6	61.4	126.8	66.6	24.3	105.3	56.0	83.1	56.9	59.8	58.6	31.7	47.8	64.6	34.7	56.9	76.9	23.5	29.7	41.1	88.6	59.3	45.3	54.3	16.8	12.2	19.1	37.3	54.1	42.3	116.9	34.1	13.7	52.5	29.7	19.6	25.2	15.1	67.7	10.2	22.0	117.9	61.6	66.8	51.4	53.4	14.0	34.6	58.3	18.6	10.1	43.6	32.3	60.0	82.0	26.2	73.6	103.6	29.2	45.9	105.2	52.6	97.4	60.9	23.8	28.9	88.7	136.7	63.3	57.4	19.6	61.9	92.2
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45340052-45343973	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 36.6;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	4.8	5.1	4.9	5.9	4.9	8.0	5.5	4.8	6.1	3.7	4.8	6.8	6.7	6.7	8.4	3.7	5.4	3.5	3.7	4.7	5.4	4.7	5.5	5.1	7.9	5.1	5.0	6.2	4.8	7.5	3.2	6.8	5.1	5.0	8.2	4.1	5.3	5.0	3.0	3.9	5.0	6.5	5.0	5.8	5.6	11.8	5.4	9.0	7.1	2.4	8.3	5.5	3.3	5.1	15.8	9.1	16.5	15.7	7.6	5.9	23.9	15.6	12.9	26.6	24.7	16.7	9.6	29.9	12.1	16.2	23.4	15.9	21.0	22.5	21.3	19.6	17.3	36.0	21.9	15.6	7.3	23.7	17.2	8.8	4.8	28.4	17.8	9.4	19.5	22.5	28.4	19.6	18.9	14.6	34.8	18.4	31.1	20.6	14.2	24.9	24.5	13.6	11.5	28.7	13.9	13.4	14.5	36.3	27.5	25.7	9.8	33.2	14.6	12.6	23.3	19.1	29.7	15.0	19.4	19.9	14.8	26.5	14.7	20.0	5.8	6.2	7.3	6.9	8.4	5.9	6.3	7.3	6.0	8.4	6.4	7.0	0.6	4.1	6.1	5.2	8.6	5.1	4.9	4.9	4.8	6.1	4.7	5.4	5.1	5.0	5.1	5.0	5.4	5.1	6.5	6.4	4.8	2.3	12.4	1.8	6.3	8.8	4.6	10.7	4.5	5.0	1.8	7.2	8.1	7.3	12.5	36.6	9.2	9.2	7.9	5.4	13.9	2.1	6.2	9.0	3.0	14.1	2.5	6.2	13.8	6.6	4.6	3.4	11.4	10.5	8.6	5.0	9.3	8.4	2.7	7.3	8.2	3.5	2.6	9.4	6.8	6.2	3.6	1.9	12.3	13.1	9.2	2.0	2.1	3.4	10.7	6.4	7.0	6.5	8.8	7.9	4.7	18.3	13.1	8.0	7.1	51.7	18.9	3.8	1.4	22.7	9.0	10.2	6.9	4.6
TOGARAM1	"crescerin, Crescerin-1, FAM179B, KIAA0423"	ENSG00000198718	"TOG array regulator of axonemal microtubules 1"	Q9Y4F4	14	44962190-45074431	"Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 4.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050849, HPA053559"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA050849: AB_2681257, HPA053559: AB_2682190"	"unprognostic (2.91e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.63e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.60e-1)"	4.5	6.6	9.6	2.9	13.4	3.9	5.2	10.1	13.0	6.7	9.6	4.5	2.7	6.0	5.2	4.6	10.4	4.7	8.3	11.2	8.9	7.9	4.6	3.9	3.9	7.2	8.0	7.6	6.3	8.5	7.1	5.8	8.7	5.5	3.7	16.8	4.8	6.4	12.4	4.2	3.8	5.4	7.5	4.3	4.3	6.5	9.3	8.4	9.0	12.1	3.9	5.4	4.3	19.9	3.5	5.7	5.3	1.4	12.2	14.2	3.8	4.9	10.4	9.1	10.8	2.3	3.7	3.3	5.6	7.9	4.9	6.4	9.8	3.3	10.0	3.0	3.6	2.7	2.8	2.7	8.6	4.6	2.7	8.3	5.6	5.2	8.8	10.8	7.4	1.8	1.9	3.7	9.2	5.0	5.9	2.5	1.8	5.2	4.3	2.9	12.9	2.2	8.6	12.0	5.5	2.1	5.8	8.4	9.1	5.5	6.2	3.6	5.5	6.1	4.9	7.8	3.7	3.8	3.0	3.7	3.5	0.9	5.2	4.8	0.4	1.0	0.4	0.4	0.5	0.4	0.6	0.4	0.6	0.6	0.5	0.3	0.0	0.8	0.4	0.7	0.6	0.3	9.6	13.4	10.1	13.0	11.2	8.9	7.2	8.0	8.7	7.5	9.3	19.9	15.8	16.0	14.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.2	10.9	0.0	0.0	20.4	16.5	0.0	11.9	13.2	0.0	1.9	10.2	0.0	65.7	28.6	6.6	0.0	0.0	0.0	5.6	8.1	8.8	0.0	16.0	10.1	30.1	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	3.8	0.0	0.0	10.4	38.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.9	6.3	34.4	0.0	0.0
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29052230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3"	"Low region specificity"	"Detected in many"							"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.1	1.2	4.5	0.6	11.5	1.9	0.2	10.6	2.3	0.5	25.2	0.3	0.5	0.6	0.1	0.4	20.1	0.3	2.8	4.5	7.6	0.1	0.2	2.8	0.8	19.2	34.9	0.5	0.3	0.0	1.1	0.3	17.3	0.2	0.2	0.2	0.2	0.1	1.2	0.3	0.4	0.5	12.5	2.0	1.0	1.3	10.6	0.2	0.1	3.0	0.7	0.2	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.0	0.6	0.1	0.2	0.6	2.3	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.3	0.3	0.0	0.3	1.3	1.0	0.4	0.1	0.0	0.3	0.6	0.3	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.5	4.5	11.5	10.6	2.3	4.5	7.6	19.2	34.9	17.3	12.5	10.6	5.3	0.3	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	65.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.2	30.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.6	0.5	0.0	0.0
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 498.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	Cytosol		NA	NA		140000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	26.8	35.4	58.2	12.4	73.5	13.6	25.8	27.5	80.9	35.9	17.6	26.3	25.5	23.5	11.5	93.4	22.4	18.4	31.3	85.0	39.4	43.1	113.3	26.6	14.2	39.9	39.1	24.6	58.2	18.9	54.2	12.1	39.8	31.4	8.2	11.4	31.6	20.5	76.2	75.9	23.4	11.1	32.9	28.8	31.9	73.4	42.7	13.2	24.7	22.7	14.2	33.5	48.8	56.5	31.4	32.6	16.3	18.6	34.0	21.2	14.2	27.2	24.5	31.3	27.7	35.4	19.5	14.6	25.6	25.3	47.9	27.7	14.7	33.4	8.5	30.1	30.1	11.9	6.9	54.2	48.4	22.8	29.0	32.1	38.5	18.6	17.9	17.1	19.7	21.7	19.9	38.5	26.1	26.3	29.1	27.9	20.0	33.9	42.1	21.8	16.6	14.6	20.9	41.3	43.5	25.5	24.4	29.4	30.7	8.3	23.3	25.7	36.0	33.8	14.4	14.4	16.0	38.8	37.8	18.3	53.2	14.9	27.0	45.4	126.6	139.6	33.4	114.0	27.8	38.8	35.3	31.5	99.9	50.0	27.4	26.1	179.1	44.5	108.8	52.4	48.8	77.3	58.2	73.5	27.5	80.9	85.0	39.4	39.9	39.1	39.8	32.9	42.7	56.5	19.5	9.6	19.3	15.0	27.8	66.9	43.9	71.7	23.3	42.6	30.3	24.6	22.8	58.6	30.9	23.9	8.4	49.2	28.0	50.8	70.5	66.3	173.6	11.7	14.8	24.9	51.6	45.0	35.1	69.2	41.1	27.6	19.4	15.8	38.1	20.7	37.9	112.2	92.1	74.0	17.0	30.8	48.8	38.4	33.1	498.2	21.8	48.3	71.2	16.9	50.6	38.1	19.6	10.6	15.0	76.3	53.7	30.9	33.4	55.7	66.6	110.1	15.4	20.6	6.6	18.5	24.5	100.7	39.6	76.3	98.9	104.4	22.0	27.4	29.3	74.0
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347992	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 213.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	34.7	47.8	20.8	17.0	19.4	60.8	32.1	19.9	25.8	43.6	23.6	22.7	29.1	26.6	12.7	76.5	26.8	24.9	43.2	19.8	26.6	32.7	49.0	37.1	15.3	30.2	24.5	21.5	20.2	48.5	37.4	27.7	32.9	23.2	9.8	5.9	60.6	11.7	213.8	74.9	28.4	10.8	19.6	23.9	20.8	25.9	24.8	13.1	26.5	68.6	12.7	19.5	45.0	22.1	15.8	15.3	8.8	14.3	58.3	34.9	42.3	15.5	43.8	28.4	31.1	21.5	14.3	6.2	28.0	45.4	18.3	7.3	8.6	15.6	9.9	18.7	21.3	5.3	17.1	43.8	58.6	10.8	23.6	49.8	19.2	39.6	13.3	18.5	19.8	11.6	10.3	15.3	14.1	13.8	8.2	27.5	7.0	18.9	8.6	14.9	12.3	13.2	10.9	11.3	14.9	12.1	34.1	34.8	34.5	7.3	18.0	16.7	22.0	34.0	29.4	27.3	7.7	18.0	12.4	16.7	45.7	10.5	11.4	18.6	100.9	44.5	19.3	60.7	15.6	13.6	29.5	18.4	48.0	11.0	22.6	15.7	129.1	15.1	66.2	25.9	48.2	63.3	20.8	19.4	19.9	25.8	19.8	26.6	30.2	24.5	32.9	19.6	24.8	22.1	10.1	22.4	36.9	8.8	12.7	12.7	10.3	29.5	7.4	11.1	19.1	11.0	23.2	15.7	33.0	12.9	12.5	64.6	13.8	41.6	27.4	40.9	29.9	32.0	17.8	14.2	16.2	9.7	9.3	38.9	57.1	22.6	15.3	48.0	22.8	10.4	16.1	34.0	60.8	11.8	15.2	18.1	50.8	33.5	35.2	21.4	11.5	45.2	19.6	7.5	34.0	19.5	9.2	6.6	13.2	34.2	21.5	12.8	5.7	11.9	55.3	34.9	24.2	8.2	6.6	16.6	15.4	23.5	5.6	17.3	21.9	170.2	18.2	13.4	15.2	10.7
TOM1L1	SRCASM	ENSG00000141198	"Target of myb1 like 1 membrane trafficking protein"	O75674	17	54899387-54961956	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Late spermatids: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022916	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA022916: AB_1858181"	"unprognostic (1.50e-1)"	"unprognostic (7.70e-3)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (6.26e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.87e-2)"	"prognostic favorable (3.81e-6)"	"unprognostic (7.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.62e-2)"	7.8	16.5	5.7	7.1	6.8	1.4	32.9	7.7	6.9	36.5	19.8	33.6	106.9	12.6	45.1	21.1	35.0	19.0	8.0	4.9	6.2	78.7	108.2	17.1	5.2	4.8	5.9	4.8	42.4	64.9	12.9	6.8	4.1	32.9	36.4	19.1	32.8	20.1	2.7	20.6	60.9	8.5	6.4	4.2	54.7	15.4	6.2	7.9	57.5	3.4	12.0	12.1	12.1	6.0	48.6	50.3	8.8	59.6	0.2	0.5	0.6	25.2	39.9	24.0	33.8	33.1	48.3	0.2	62.2	22.7	36.5	31.4	47.9	52.6	36.0	1.2	59.7	72.3	43.5	52.4	50.2	0.4	0.2	21.3	83.8	22.5	124.2	44.0	14.5	14.3	30.9	0.4	23.7	45.1	2.1	0.7	21.1	90.1	36.1	0.6	39.2	29.2	108.5	61.2	42.2	48.5	24.8	41.5	60.1	41.9	102.7	7.0	17.8	13.3	1.9	31.7	45.3	0.9	37.1	1.1	22.4	0.2	28.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	5.7	6.8	7.7	6.9	4.9	6.2	4.8	5.9	4.1	6.4	6.2	6.0	1.1	22.4	21.6	15.3	1.9	15.8	17.2	21.3	19.4	14.3	30.4	26.7	4.9	27.1	20.6	36.8	22.9	8.9	0.8	37.4	103.7	60.8	82.5	29.4	6.0	0.9	18.7	3.8	57.0	44.9	3.7	4.2	36.7	29.7	1.3	16.4	1.8	43.2	3.1	15.2	28.6	55.2	8.2	1.3	1.2	184.0	2.8	3.1	12.4	7.5	3.2	12.7	0.0	40.7	20.2	52.0	30.4	3.0	0.7	26.0	86.1	93.2	20.1	19.0	6.6	4.9	6.5	2.5	6.6	28.0	17.8	3.1	1.2	21.5	42.8	18.5
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 180.5;Cone photoreceptor cells: 158.4;Oligodendrocytes: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		73000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	20.7	30.5	64.0	9.5	62.7	6.1	20.3	52.7	70.0	31.9	21.3	44.2	14.0	33.2	11.0	64.4	26.6	13.0	141.0	66.0	56.4	31.3	13.9	23.2	7.7	91.5	80.3	32.9	19.7	40.3	42.2	9.0	95.3	37.3	13.8	50.2	21.3	28.7	67.1	59.7	20.9	23.3	49.7	16.6	34.9	39.4	74.6	8.8	48.5	55.4	12.9	31.4	35.1	72.7	27.1	29.0	8.2	6.2	19.1	19.3	14.2	43.3	20.1	22.9	19.3	28.2	17.6	5.0	52.9	40.8	13.3	104.3	6.8	24.1	14.0	7.2	12.7	8.0	28.0	6.0	12.2	2.0	5.2	22.9	16.6	20.5	15.2	19.6	23.3	7.3	3.0	6.9	30.3	27.1	3.6	4.6	1.5	34.4	19.5	4.7	20.7	12.0	32.4	48.1	8.7	8.4	19.5	25.2	15.3	55.9	13.4	3.6	31.8	21.9	6.5	46.0	16.8	6.1	5.1	2.3	26.4	2.7	55.2	10.0	3.3	4.8	2.8	1.0	2.0	1.6	2.6	2.4	1.6	2.2	4.3	3.2	12.8	1.4	3.3	1.9	1.3	1.7	64.0	62.7	52.7	70.0	66.0	56.4	91.5	80.3	95.3	49.7	74.6	72.7	10.1	32.1	17.0	180.5	9.5	10.8	14.6	13.9	7.4	74.5	20.9	14.1	73.7	15.7	16.6	11.0	158.4	8.5	10.2	43.3	5.9	12.2	30.8	14.1	9.4	12.4	20.4	4.8	63.2	8.7	17.4	12.7	13.3	15.7	2.5	28.1	16.4	13.4	9.2	95.9	74.2	19.2	18.3	8.5	7.6	64.2	26.4	6.4	12.4	35.6	11.8	28.1	10.3	66.9	123.2	16.1	41.0	25.6	8.4	39.1	22.4	11.1	22.9	78.3	19.7	18.0	13.0	16.7	12.1	37.2	17.2	32.2	10.0	30.8	15.4	64.5
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109341-235128837	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	71.5	83.5	80.0	39.2	89.0	96.6	130.8	63.0	111.9	82.9	63.4	64.3	61.0	83.5	91.6	67.8	95.6	48.3	86.4	91.7	79.9	100.4	88.3	60.2	53.7	76.9	71.5	119.5	103.1	111.6	54.3	68.2	81.2	80.5	67.9	51.3	125.1	70.1	83.0	82.5	54.5	59.3	81.7	47.2	69.4	32.8	84.1	57.1	142.9	82.4	56.6	66.4	56.7	83.3	198.7	102.4	131.6	111.6	101.4	202.6	203.5	138.8	119.3	127.9	92.5	133.1	135.6	239.3	180.1	121.0	36.1	154.0	147.8	135.0	166.9	57.9	314.8	146.2	126.2	253.9	169.2	331.3	84.2	182.3	180.8	128.6	175.4	173.0	140.7	92.2	312.1	85.9	141.9	58.2	141.9	149.4	296.6	131.2	54.9	170.9	100.3	312.6	144.5	140.2	172.5	402.8	108.0	149.2	306.7	53.6	230.9	358.6	125.6	111.5	67.5	143.0	299.6	201.2	203.1	172.4	131.2	155.4	193.1	37.7	18.8	6.5	19.4	19.7	23.6	23.0	24.8	24.3	22.7	18.2	30.1	24.2	5.6	15.8	22.9	30.6	23.7	21.5	80.0	89.0	63.0	111.9	91.7	79.9	76.9	71.5	81.2	81.7	84.1	83.3	167.2	137.8	163.5	25.1	201.9	267.4	254.9	158.5	251.6	49.9	299.2	307.0	137.8	160.2	151.3	49.7	29.2	171.3	195.5	98.3	160.4	161.6	318.4	180.2	254.3	156.8	160.5	127.0	69.0	211.2	462.5	139.9	121.3	216.9	157.7	146.4	129.9	160.1	159.9	50.5	61.1	273.4	99.7	197.7	164.6	354.0	155.0	175.7	149.4	28.1	187.5	145.4	116.4	26.2	55.8	220.1	172.3	153.4	176.7	340.4	247.0	223.5	99.7	60.9	105.2	201.4	207.5	186.5	71.1	273.3	286.1	199.5	179.5	196.1	272.6	333.4
TOMM20L	UNQ9438	ENSG00000196860	"Translocase of outer mitochondrial membrane 20 like"	Q6UXN7	14	58395928-58408702	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 10.9"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 154.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076397	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA076397: "	"unprognostic (1.72e-1)"	"unprognostic (2.34e-4)"	"unprognostic (8.13e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.57e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	0.3	0.1	0.2	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.1	1.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.4	0.3	0.4	0.2	0.3	0.0	0.2	0.3	0.1	0.1	0.2	0.4	10.9	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.4	0.1	0.2	0.1	0.4	0.5	0.2	0.1	0.1	0.1	1.0	0.7	0.1	0.1	0.2	0.3	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	154.1	0.8	0.2	0.1	0.0	0.0	2.5	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.0	0.0	28.6	0.9	0.2	0.0	0.0	0.0	0.8	0.0	4.5	2.1	0.1	0.3	0.7	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.4	0.1	27.6	1.6	0.0	0.4	0.0	0.1	0.2	0.2	0.2
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681957-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003037	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	19.6	21.1	27.6	19.0	28.5	30.4	17.2	29.0	29.7	16.6	29.4	22.6	24.5	15.5	19.2	28.4	20.5	11.5	29.1	27.7	28.7	23.9	28.5	12.7	25.3	28.6	28.2	19.1	21.1	22.5	9.9	15.7	28.9	15.1	27.6	8.6	21.4	12.5	34.6	22.1	19.4	19.4	28.0	17.0	20.3	17.0	29.6	27.0	17.1	31.0	30.5	23.8	17.8	28.3	61.7	35.5	53.4	56.9	38.6	35.7	57.5	49.7	34.3	71.1	53.1	65.0	35.8	62.0	39.9	48.9	48.7	49.7	81.8	75.2	56.7	53.8	89.9	83.4	25.2	63.0	50.2	223.2	56.7	49.0	52.6	64.1	41.6	37.0	52.9	59.5	64.4	48.2	48.1	47.9	67.7	103.3	82.0	80.8	71.5	73.9	69.2	58.8	47.7	44.3	62.4	41.3	58.1	72.7	59.1	36.1	50.5	73.1	54.3	43.4	81.8	40.1	76.2	65.9	85.7	94.3	54.3	76.0	60.6	12.9	50.9	16.6	35.4	51.1	44.9	48.7	37.8	37.5	66.4	37.8	38.0	41.4	5.0	42.7	43.1	58.0	48.7	72.8	27.6	28.5	29.0	29.7	27.7	28.7	28.6	28.2	28.9	28.0	29.6	28.3	62.4	25.6	30.4	4.2	123.3	167.0	134.8	158.7	109.8	30.1	79.5	67.7	70.2	82.9	68.0	71.7	16.7	180.0	89.7	74.8	223.0	135.3	139.6	50.5	58.8	77.1	105.1	98.8	7.3	133.2	232.1	70.4	65.7	50.6	74.3	100.3	69.9	101.4	163.9	28.6	8.4	133.5	99.7	120.2	130.7	143.2	55.3	93.3	113.8	4.7	153.2	76.1	105.0	4.5	8.7	116.2	85.2	54.5	130.3	153.4	116.2	245.9	35.2	33.7	72.3	73.3	76.9	130.1	148.2	185.5	210.3	135.6	102.6	100.9	189.7	158.7
TOMM34	"HTOM34P, TOM34"	ENSG00000025772	"Translocase of outer mitochondrial membrane 34"	Q15785	20	44942130-44960397	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 119.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.3;monocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018845, HPA056875"	Enhanced		Supported	Vesicles,Mitochondria,Cytosol		NA	NA		26000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Vesicles, Mitochondria"	"HPA018845: AB_1858184, HPA056875: AB_2683264"	"unprognostic (4.96e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (4.47e-5)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (2.55e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (5.79e-3)"	13.4	46.0	31.4	13.6	40.3	20.1	14.6	24.3	51.7	14.5	28.3	14.6	11.8	14.8	49.0	19.5	49.1	13.6	16.0	54.6	32.6	28.6	18.8	14.0	15.2	29.0	26.1	26.4	18.0	24.4	26.6	29.6	28.0	18.8	18.4	9.0	15.7	16.9	18.0	14.6	13.7	15.4	24.7	14.9	15.8	119.4	33.6	18.3	16.5	15.2	22.0	26.2	12.7	35.7	133.6	46.0	40.1	85.6	36.3	35.6	90.2	75.6	109.6	92.8	67.1	187.4	48.6	90.9	63.5	59.6	94.2	82.1	98.8	164.0	107.3	16.1	46.2	71.7	58.2	133.7	46.2	47.5	42.3	38.7	45.2	129.8	230.8	80.9	95.8	36.6	82.6	36.4	89.3	88.2	50.2	65.4	47.1	70.7	172.8	43.1	42.2	98.9	76.1	73.7	68.3	40.4	103.5	71.0	91.8	30.7	53.5	40.8	57.2	121.5	80.0	58.9	114.8	31.2	40.1	75.4	110.9	55.8	48.2	15.9	16.9	15.3	14.8	17.5	15.4	25.4	15.3	15.7	39.7	28.6	17.1	13.7	4.6	14.8	18.8	21.1	19.3	17.3	31.4	40.3	24.3	51.7	54.6	32.6	29.0	26.1	28.0	24.7	33.6	35.7	7.3	6.4	11.5	3.6	15.0	13.8	84.6	17.2	14.8	3.1	14.1	11.2	10.3	5.7	15.5	12.9	4.2	128.3	8.7	7.7	31.3	38.4	18.5	17.5	7.2	13.0	12.0	17.2	6.8	30.7	38.0	14.8	16.8	14.8	9.5	28.2	6.4	9.1	22.7	3.3	4.8	9.3	8.2	5.9	47.2	32.9	6.8	10.3	7.2	5.6	176.9	17.4	7.2	3.5	2.7	46.2	9.5	6.4	16.9	69.1	6.9	22.5	44.3	4.2	0.0	5.6	13.6	43.0	56.2	15.7	11.1	56.5	8.8	24.0	13.6	55.9
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA		45000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	34.6	59.7	31.3	25.1	30.1	32.9	29.0	33.6	37.2	25.2	28.0	34.7	28.4	25.0	14.1	51.8	25.3	10.8	46.1	30.7	33.5	33.5	50.8	28.4	23.6	32.6	33.5	24.9	26.6	31.4	25.3	20.0	33.6	24.7	23.0	18.0	24.1	17.4	64.0	34.4	26.1	16.4	30.2	26.4	29.3	22.0	35.0	25.2	22.3	34.4	22.6	29.9	29.5	32.2	147.6	244.6	87.6	121.3	32.2	28.4	110.3	103.3	57.1	192.1	136.6	268.8	99.5	215.3	107.7	68.8	108.7	155.2	228.9	149.1	87.0	84.0	206.1	145.3	93.5	214.7	68.0	187.6	125.1	45.2	83.4	149.3	94.1	36.0	67.3	102.4	232.6	73.3	76.4	184.2	205.4	137.1	153.6	209.6	149.1	206.1	99.2	125.3	89.6	201.8	135.2	86.4	109.9	229.4	75.2	48.4	77.1	188.2	55.9	132.0	133.6	93.1	273.7	78.3	176.0	212.9	98.2	197.0	142.1	0.7	3.6	3.7	2.8	4.6	3.2	5.8	2.8	4.1	4.6	2.4	4.9	5.4	0.7	3.2	4.3	4.6	3.5	1.4	31.3	30.1	33.6	37.2	30.7	33.5	32.6	33.5	33.6	30.2	35.0	32.2	26.2	16.0	7.3	8.8	34.9	87.4	73.7	17.1	35.9	68.2	32.7	30.9	15.7	25.8	14.3	31.3	29.2	104.5	28.9	78.8	39.2	48.1	11.3	22.7	41.0	31.0	29.3	52.4	11.3	38.6	169.9	38.6	40.2	29.5	19.1	57.8	12.5	24.2	100.1	70.7	16.9	59.4	28.5	21.0	44.9	7.2	26.8	35.0	39.2	4.7	31.9	46.6	27.8	5.5	12.8	53.6	32.4	24.5	47.9	139.0	34.5	39.5	4.9	60.2	19.7	49.1	47.8	46.2	64.5	60.5	89.4	72.9	26.7	105.9	132.1	75.5
TOMM40L	"FLJ12770, TOMM40B"	ENSG00000158882	"Translocase of outer mitochondrial membrane 40 like"	Q969M1	1	161225939-161230746	"Predicted intracellular proteins"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051304	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA051304: AB_2681432"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.46e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-2)"	"prognostic favorable (7.80e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.14e-1)"	8.5	7.1	11.4	7.2	12.2	14.9	6.7	10.4	17.0	5.3	7.1	11.8	13.9	7.5	2.7	10.1	5.3	4.0	24.3	11.7	9.6	9.9	17.5	7.7	6.7	11.1	11.0	3.6	3.8	15.0	5.8	6.0	11.1	6.4	10.7	11.1	5.8	8.8	23.2	7.2	11.9	8.5	10.5	7.8	8.0	2.2	12.8	7.2	5.7	51.4	7.5	8.6	6.1	11.7	7.6	7.2	11.8	12.9	19.2	10.1	9.1	11.2	13.7	21.6	18.6	41.7	9.8	22.5	13.4	14.9	8.0	9.9	22.6	22.3	12.4	18.9	15.5	21.2	10.5	21.0	8.5	40.8	34.0	11.0	14.0	24.0	12.9	11.0	24.8	23.4	30.0	18.7	15.3	12.3	16.5	6.0	12.9	17.2	20.4	18.7	8.6	21.3	16.2	16.2	28.2	11.8	10.7	30.1	9.9	12.6	23.0	30.9	19.1	11.2	7.7	9.7	16.5	16.5	15.0	16.1	11.6	24.6	11.8	2.5	1.6	1.4	1.0	1.9	1.4	0.8	0.7	1.3	3.0	0.5	0.7	1.7	0.7	1.9	1.5	3.4	1.6	1.5	11.4	12.2	10.4	17.0	11.7	9.6	11.1	11.0	11.1	10.5	12.8	11.7	4.1	0.0	3.3	2.3	3.5	0.5	1.4	1.6	3.4	6.0	2.9	2.3	4.0	1.5	1.7	1.8	6.2	2.4	2.8	8.7	7.9	4.0	4.1	0.7	2.3	4.1	7.7	3.4	5.3	7.8	3.2	3.3	3.6	1.3	3.8	2.2	1.4	7.4	9.7	5.0	5.9	2.6	4.1	5.0	2.7	1.9	2.1	14.8	0.0	1.9	5.6	2.4	4.1	2.0	1.6	4.6	4.1	0.7	4.6	1.1	11.4	5.1	1.2	9.7	0.0	2.2	5.2	0.9	1.8	5.2	1.7	0.8	3.8	3.6	7.0	1.4
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592604	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048712	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	90.0	92.6	69.9	62.8	72.2	66.4	71.9	71.1	84.8	62.2	68.9	84.2	74.0	64.9	62.0	89.1	58.7	47.2	83.9	71.3	75.9	114.5	87.5	57.0	83.0	70.7	73.5	63.7	90.3	52.4	66.3	39.2	77.0	58.9	60.2	40.2	70.1	46.0	129.4	63.3	62.2	55.9	72.9	75.5	72.7	65.2	70.7	72.0	65.2	89.6	78.8	79.8	65.2	70.7	353.2	400.4	234.3	211.2	265.7	258.9	128.9	262.5	169.4	252.1	268.6	431.4	142.2	240.3	208.4	253.7	254.4	119.0	212.0	316.2	262.6	338.5	329.0	212.1	535.7	630.0	216.1	350.6	133.7	224.9	170.4	277.4	273.5	118.7	293.5	264.1	524.9	261.5	261.1	282.3	297.2	306.9	407.7	296.2	249.0	247.9	195.2	353.3	294.0	218.7	202.4	184.7	134.9	181.6	201.5	198.2	127.0	405.4	198.8	173.3	369.7	273.9	411.8	97.5	312.3	407.8	211.4	300.9	272.0	77.3	155.2	74.5	202.0	177.4	252.1	309.9	246.7	227.8	196.8	260.6	251.9	232.8	17.8	216.5	154.3	218.4	221.2	279.7	69.9	72.2	71.1	84.8	71.3	75.9	70.7	73.5	77.0	72.9	70.7	70.7	31.7	28.9	33.4	16.0	95.5	112.3	49.9	72.8	138.3	5.0	51.2	66.5	20.8	47.1	54.3	46.0	12.5	24.5	41.6	36.5	80.3	55.6	218.3	43.3	49.1	49.8	18.1	120.5	14.2	127.2	55.6	45.9	122.9	46.2	46.2	22.1	50.0	159.2	66.6	1.7	14.9	50.8	52.9	52.7	48.6	181.2	35.1	55.0	62.2	6.5	58.3	10.5	32.0	6.6	11.0	109.2	32.6	31.2	178.3	67.7	75.3	215.0	51.7	8.8	0.0	40.5	42.2	87.4	24.2	235.4	146.3	25.2	73.3	20.8	53.6	55.9
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 18.7;Astrocytes: 31.0;Club cells: 10.5;Excitatory neurons: 16.5;granulocytes: 8.8;Inhibitory neurons: 15.5;Microglial cells: 10.3;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 26.3;Respiratory ciliated cells: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004801	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA004801: AB_1859553"																		176.9	267.7	240.1	136.8	246.2	228.0	219.9	246.7	320.8	158.4	254.4	158.2	101.8	139.7	270.3	234.0	162.9	96.2	285.9	245.2	248.1	271.8	232.2	143.6	207.5	243.9	242.9	179.0	208.3	193.3	143.2	141.2	245.5	177.6	177.1	128.8	166.1	120.3	272.4	196.4	134.8	132.3	250.1	200.3	170.2	133.9	245.5	192.6	161.4	232.8	260.9	166.5	153.9	254.2	647.0	319.0	372.7	382.2	337.6	398.5	391.6	312.2	324.8	390.3	380.4	559.4	295.3	289.3	373.3	370.1	445.4	201.2	597.3	523.3	505.9	409.8	619.8	525.5	382.4	928.6	264.9	708.7	328.6	362.0	529.4	431.8	366.2	277.1	480.4	407.1	1335.5	350.4	481.7	766.0	519.4	1124.8	329.7	2247.1	312.6	373.3	234.1	865.3	540.1	329.3	327.6	458.7	213.0	369.5	548.5	389.7	451.6	1411.8	342.8	272.0	340.9	274.2	478.8	318.6	751.6	1314.8	155.9	586.7	362.7	119.3	439.5	259.3	291.7	448.3	283.7	419.2	294.4	291.2	454.1	380.7	329.3	324.1	55.9	230.6	475.3	474.6	303.3	674.5	240.1	246.2	246.7	320.8	245.2	248.1	243.9	242.9	245.5	250.1	245.5	254.2	0.0	3.2	18.7	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.3	0.0	0.0	0.0	12.1	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401089	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	29.7	23.1	21.8	19.5	38.7	16.6	31.5	20.6	24.4	19.8	19.1	27.7	29.3	24.5	21.3	28.9	20.4	16.1	38.8	23.6	23.0	36.8	61.7	15.9	22.2	21.3	18.6	30.8	26.8	27.2	14.8	23.4	21.9	26.4	29.8	45.4	21.9	26.9	66.4	19.8	24.4	26.7	17.9	19.2	21.5	19.6	22.9	29.6	30.1	76.1	25.9	27.3	17.8	19.5	70.2	48.3	39.8	57.9	55.4	60.0	52.0	57.9	49.6	52.2	53.8	68.7	39.0	83.2	49.9	49.7	46.6	67.4	73.1	53.4	76.7	31.6	33.7	95.2	30.3	67.3	34.6	117.2	41.8	53.7	48.6	46.5	75.6	46.5	38.8	40.1	69.2	65.6	63.3	51.9	79.6	47.5	55.2	107.4	101.2	72.0	80.9	89.0	42.6	52.2	72.2	60.1	42.3	67.0	77.9	38.2	87.1	65.8	35.2	45.5	60.3	25.8	44.0	71.1	108.8	139.1	44.1	70.0	35.2	1.1	1.0	1.2	1.9	1.1	2.3	2.0	2.3	2.0	1.4	1.4	2.3	2.5	0.2	2.7	1.3	1.4	1.0	0.8	21.8	38.7	20.6	24.4	23.6	23.0	21.3	18.6	21.9	17.9	22.9	19.5	24.2	6.4	25.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	30.0	20.2	0.0	0.0	11.2	14.7	0.0	26.8	11.5	0.0	11.7	19.0	0.0	13.8	34.9	10.0	0.0	0.0	0.0	20.1	33.2	12.9	0.0	25.4	7.6	27.1	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	48.6	10.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	16.3	6.3	32.9	0.0	0.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444440	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.0	2.1	0.4	2.5	0.4	8.5	1.3	0.4	1.3	1.7	0.0	3.4	3.5	1.6	0.2	3.9	1.4	0.6	1.4	0.3	0.3	1.4	1.7	1.3	2.3	1.3	0.6	1.7	1.5	0.4	0.9	1.5	1.1	1.6	0.8	0.1	1.5	0.8	0.5	3.3	4.4	0.6	0.1	3.9	2.2	3.8	0.8	2.3	2.4	0.1	1.4	2.3	2.1	0.3	21.2	18.6	13.7	21.7	1.0	1.7	33.0	17.6	3.4	10.4	8.1	15.0	17.9	19.6	17.5	2.7	4.9	14.2	13.4	10.7	2.3	20.2	26.6	46.5	26.1	15.9	0.6	14.3	28.1	1.7	1.5	10.9	2.1	2.6	5.0	26.5	53.0	14.3	4.2	43.4	35.5	24.5	19.4	20.4	26.7	42.6	8.9	20.3	5.9	22.6	22.9	13.0	18.4	12.3	7.8	5.2	17.6	13.2	5.9	12.7	52.3	14.5	21.7	5.0	9.9	12.0	12.3	30.2	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.3	0.3	1.3	0.6	1.1	0.1	0.8	0.3	2.5	6.4	22.4	1.6	2.9	8.9	5.2	1.0	1.2	3.1	3.5	2.9	2.3	8.6	3.7	1.8	2.1	4.1	1.3	20.2	0.0	0.9	0.4	4.3	2.7	4.3	2.4	7.2	2.4	1.0	5.3	3.8	11.7	6.1	2.5	8.5	2.9	11.4	4.5	1.7	1.0	14.6	0.0	0.9	16.7	0.7	0.3	3.0	14.2	1.9	1.2	1.1	1.0	0.5	0.8	1.2	7.1	1.2	4.0	3.9	76.5	7.7	4.1	3.0	6.6	6.4	2.8	4.6	7.8	3.4	11.2	1.2	3.1	3.3	15.9	3.9
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 197.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	14.0	17.4	7.3	9.4	6.1	48.2	13.7	2.5	7.8	23.2	4.0	12.6	7.6	11.7	4.8	18.4	13.4	9.2	7.6	8.5	5.8	14.4	30.3	10.5	12.0	7.0	4.7	32.1	18.9	10.1	9.2	7.4	7.1	13.2	9.7	2.0	14.2	8.1	7.3	22.6	11.6	7.8	2.9	12.6	12.9	23.4	5.4	21.4	21.9	3.4	11.4	17.8	19.1	6.4	25.5	38.3	15.8	59.4	22.0	24.5	28.1	11.6	14.8	20.5	21.1	48.4	35.8	74.2	42.6	16.2	14.7	26.8	33.8	21.3	17.6	29.5	52.4	65.6	21.5	49.5	24.8	44.4	68.4	25.1	22.3	17.4	24.8	17.7	25.0	21.1	80.5	28.2	18.3	106.3	197.8	87.9	27.6	54.9	65.4	24.7	20.7	112.2	15.3	40.4	28.1	34.1	33.2	29.3	61.7	19.3	19.3	72.5	16.5	14.3	57.7	16.4	30.2	15.2	17.0	38.0	24.1	64.9	17.4	31.4	10.5	0.5	6.2	6.3	6.3	28.9	11.3	8.6	35.3	14.4	24.2	18.8	0.7	0.4	1.2	30.9	3.2	9.2	7.3	6.1	2.5	7.8	8.5	5.8	7.0	4.7	7.1	2.9	5.4	6.4	11.4	6.4	8.6	3.3	11.9	23.7	32.3	13.1	14.2	1.2	15.3	11.6	3.3	10.0	10.5	9.2	0.0	11.7	7.3	6.7	7.9	11.4	29.3	3.9	10.9	7.7	4.9	41.3	2.5	9.3	23.6	8.9	5.6	5.8	7.0	24.7	6.4	12.1	11.1	3.3	3.5	11.3	2.0	8.8	24.9	11.1	8.7	9.4	21.4	0.0	9.3	1.4	2.1	1.5	2.9	7.1	11.2	4.5	6.1	29.7	2.8	15.8	3.1	0.2	6.6	13.5	10.0	31.3	36.4	17.8	23.9	10.1	8.6	21.4	20.8	22.8
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	27.1	25.5	15.3	38.9	17.6	49.1	34.7	25.2	16.5	36.2	12.0	30.1	28.8	42.9	25.5	34.1	29.7	26.2	38.5	15.3	16.0	32.1	27.7	28.0	50.4	13.5	16.2	40.6	28.8	53.2	11.7	34.4	15.1	38.7	33.3	112.3	27.1	34.2	29.9	32.4	28.6	34.2	16.4	36.4	32.1	19.5	14.6	82.5	45.8	36.7	46.6	43.7	18.5	25.3	57.6	58.6	125.9	155.3	41.1	51.7	50.1	54.4	69.6	49.4	53.9	30.1	44.6	176.9	37.1	79.2	30.5	47.7	105.6	60.5	82.5	85.5	56.7	268.5	71.2	50.6	28.9	212.8	137.4	37.1	29.7	55.3	48.2	49.8	81.7	118.6	92.0	84.3	64.4	64.0	138.5	52.5	95.9	38.5	44.1	569.9	71.0	82.6	43.9	199.5	63.2	109.7	81.1	57.4	49.9	72.2	59.7	187.1	78.7	68.3	52.6	55.2	58.9	129.6	78.6	185.1	44.9	155.6	46.5	3.2	1.4	2.8	3.0	1.7	3.3	2.0	2.9	3.1	2.2	2.5	3.3	3.0	1.0	3.9	2.6	2.8	2.3	1.1	15.3	17.6	25.2	16.5	15.3	16.0	13.5	16.2	15.1	16.4	14.6	25.3	36.4	64.1	62.7	65.3	47.3	39.1	47.9	30.9	31.3	62.4	44.4	31.9	121.5	34.3	36.1	25.8	56.3	47.8	65.8	29.9	13.7	34.3	3.6	48.0	58.8	36.6	59.3	65.6	77.8	33.4	24.5	40.2	28.5	45.1	34.1	71.4	25.0	35.1	26.2	60.6	89.8	32.3	20.3	40.7	50.1	6.0	39.1	45.3	23.2	43.1	49.8	51.3	68.0	76.4	113.0	35.5	22.2	33.4	46.0	56.2	20.6	25.6	39.2	95.7	32.9	56.5	51.0	94.9	44.0	57.9	37.6	46.7	53.7	48.4	39.2	64.3
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	9.4	8.0	1.9	3.3	1.8	5.7	8.6	3.1	2.6	8.6	2.1	7.8	2.3	8.4	1.6	8.6	8.5	2.1	6.0	1.8	1.8	7.0	11.2	7.7	3.6	1.7	1.6	7.5	7.7	2.6	8.9	2.5	1.7	7.7	2.4	2.1	8.1	1.7	10.0	11.3	8.2	2.6	1.4	11.4	7.6	11.7	2.0	4.2	6.7	2.5	3.3	8.5	7.8	2.0	9.3	14.2	9.4	11.1	3.8	4.6	10.9	9.4	4.9	14.2	12.8	22.4	3.4	13.7	6.0	6.5	6.6	11.7	12.6	6.7	11.5	11.6	11.4	13.1	15.2	7.9	4.3	5.8	11.9	2.9	4.6	15.0	8.7	2.9	7.3	11.5	11.3	5.7	6.1	6.4	15.2	5.9	8.7	13.8	6.8	17.4	22.6	14.8	3.2	8.1	7.7	13.6	12.6	8.3	8.4	24.5	16.1	6.5	6.5	10.6	8.1	18.2	15.4	5.8	13.7	10.4	6.6	8.0	10.5	1.1	3.1	3.4	1.8	2.7	1.3	0.7	1.3	1.6	1.3	0.8	1.1	1.2	4.2	2.2	1.5	1.2	1.2	2.0	1.9	1.8	3.1	2.6	1.8	1.8	1.7	1.6	1.7	1.4	2.0	2.0	5.3	6.4	4.8	6.5	9.7	2.0	4.5	4.5	6.8	20.8	6.2	3.9	3.1	5.7	7.4	11.0	39.6	7.4	11.8	4.6	3.9	4.2	7.2	5.0	8.7	6.2	0.0	9.9	16.4	3.7	6.9	6.3	6.6	6.3	5.1	12.1	6.4	7.0	5.4	21.9	17.2	4.2	4.1	12.4	6.3	7.9	8.1	11.6	1.8	12.2	13.9	6.4	15.5	11.6	11.2	3.6	2.8	6.4	12.0	5.8	3.8	2.1	6.5	22.2	13.1	9.3	6.6	26.7	25.5	5.2	3.4	4.4	9.0	13.1	5.9	5.0
TOPAZ1	"C3orf77, FLJ36157"	ENSG00000173769	"Testis and ovary specific PAZ domain containing 1"	Q8N9V7	3	44241886-44332098	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 3.5"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 122.4;Spermatogonia: 75.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047431, HPA051034"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA047431: AB_2680045, HPA051034: AB_2681318"														"unprognostic (1.68e-1)"	"unprognostic (8.88e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	122.4	75.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TOPBP1	"Dpb11, KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 104.1;Spermatocytes: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	7.7	4.9	3.6	13.0	4.3	33.1	10.7	5.0	4.6	6.5	3.1	9.3	8.3	8.1	5.0	8.9	5.9	6.9	6.1	4.6	3.3	5.5	7.4	7.3	19.7	3.7	3.2	7.3	7.6	6.0	3.6	12.0	3.7	6.6	11.5	8.2	7.1	5.5	6.9	11.8	9.2	8.7	3.5	10.4	8.7	22.4	3.7	29.1	7.4	7.6	18.6	8.3	7.0	4.5	44.4	27.2	43.1	35.1	8.0	10.5	32.3	33.9	26.9	41.0	52.4	37.9	27.5	80.5	29.1	24.7	49.3	50.2	62.8	22.6	62.7	48.9	28.2	75.4	38.3	23.4	7.7	81.5	57.1	12.5	13.7	40.2	23.9	15.4	28.5	46.3	47.6	55.7	32.6	30.3	79.9	43.1	35.7	50.4	23.0	53.3	53.8	58.4	14.6	30.1	40.9	45.2	41.9	22.6	35.4	41.7	37.7	74.6	19.9	43.0	38.9	43.9	37.7	33.4	53.4	150.6	25.4	42.7	38.4	1.8	0.7	2.2	0.7	0.9	1.0	0.9	0.7	0.7	0.7	0.5	0.7	0.7	0.9	1.0	0.5	1.0	1.5	0.4	3.6	4.3	5.0	4.6	4.6	3.3	3.7	3.2	3.7	3.5	3.7	4.5	17.1	22.4	21.9	10.7	22.8	12.4	8.8	7.8	20.5	15.2	14.2	14.2	10.1	12.8	19.7	11.0	2.1	20.0	33.9	11.9	9.8	12.3	69.4	8.8	16.8	16.0	7.2	42.7	24.3	13.3	19.6	14.9	16.3	13.1	7.6	34.3	7.5	9.5	11.2	3.3	19.6	13.9	6.1	16.7	8.0	104.1	10.2	18.2	8.8	11.2	27.4	10.4	28.8	16.6	13.0	14.7	11.6	9.8	37.5	10.2	6.1	6.1	8.7	9.3	13.1	20.9	12.2	81.3	43.6	22.0	11.5	14.0	23.3	17.7	14.8	10.5
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase"	Q9NS56	9	32540544-32552586	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 67.6"	"Cell line enhanced"	"Detected in all"		"HEL: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	9.8	9.8	5.4	8.4	6.3	25.2	12.4	10.5	8.5	10.3	7.3	9.2	8.3	11.4	10.0	9.9	7.6	8.7	6.8	5.4	6.6	13.2	16.2	9.3	9.3	6.1	6.1	15.3	8.6	14.0	6.9	10.0	6.2	11.2	9.3	11.5	7.6	9.3	7.2	9.6	8.8	11.2	5.9	10.5	8.9	14.8	6.6	14.5	14.1	10.4	10.1	10.3	7.2	8.3	16.6	15.1	20.4	17.9	24.4	21.8	12.9	20.7	19.5	16.9	19.5	9.5	8.3	26.8	11.7	20.8	14.8	10.9	24.2	23.5	23.6	22.5	13.3	90.8	25.2	11.9	15.1	26.1	24.0	17.9	25.8	24.4	17.1	20.9	20.8	20.1	16.1	13.6	27.9	8.9	23.5	47.6	27.2	12.3	15.2	23.9	18.1	12.2	22.5	17.2	10.1	16.1	20.7	11.2	13.8	22.9	11.3	14.7	22.0	18.4	18.6	9.6	15.5	9.5	16.2	28.5	17.0	14.8	8.4	38.8	10.0	21.3	9.6	9.8	10.3	9.4	10.4	11.4	10.2	10.8	13.9	13.8	67.6	15.0	13.6	8.2	13.5	7.3	5.4	6.3	10.5	8.5	5.4	6.6	6.1	6.1	6.2	5.9	6.6	8.3	69.2	54.5	32.0	10.7	49.1	47.2	45.3	33.7	61.5	46.8	32.7	28.6	18.4	25.8	37.0	25.8	37.5	31.9	63.4	26.3	19.6	25.1	169.9	36.2	38.1	48.8	45.9	66.5	14.5	18.4	16.9	42.0	25.0	45.5	41.8	43.6	26.4	24.3	17.7	55.5	15.5	22.9	44.7	19.1	35.3	21.8	33.2	31.8	19.6	7.5	30.4	43.5	36.0	13.0	22.4	21.1	24.3	32.7	39.5	39.0	24.3	22.7	22.3	42.0	19.7	54.0	48.2	54.4	53.7	39.0	47.6	50.8	55.4	43.1	24.0	49.8
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812942-129824244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		20000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: AB_2681382"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	21.2	24.2	14.3	20.7	14.8	34.5	19.6	14.7	17.7	18.6	14.2	20.7	16.6	20.3	19.9	14.3	17.2	20.6	16.8	15.7	15.9	20.5	35.9	19.4	22.9	13.6	14.0	17.2	19.5	19.4	14.3	23.5	14.0	21.3	22.3	9.8	17.0	23.1	16.4	17.8	18.8	25.4	14.1	18.8	18.1	9.2	15.4	26.3	23.8	14.9	19.0	28.6	15.6	14.8	33.7	49.5	35.9	41.5	53.1	51.3	47.4	76.7	94.5	67.0	57.2	32.3	48.2	41.0	44.0	99.7	46.0	77.2	34.7	50.8	54.7	65.7	32.9	36.9	49.8	32.3	66.9	82.1	65.5	69.8	50.7	63.5	45.6	61.5	73.2	65.3	66.5	32.3	74.6	84.3	58.9	79.3	53.8	39.2	55.6	30.5	56.5	41.9	54.9	42.4	27.0	47.6	79.3	30.7	43.3	40.1	61.6	63.4	65.1	66.1	37.7	49.6	59.6	36.6	87.0	37.7	49.0	46.9	54.3	95.5	72.8	141.3	57.4	68.5	48.1	45.5	48.4	52.1	61.4	33.5	40.9	42.4	72.7	68.6	58.3	56.5	59.1	78.9	14.3	14.8	14.7	17.7	15.7	15.9	13.6	14.0	14.0	14.1	15.4	14.8	25.0	9.6	11.8	5.5	17.5	17.6	16.6	39.5	12.0	11.2	16.5	15.9	9.9	18.6	24.4	14.7	2.1	47.9	39.3	18.7	15.6	42.1	0.7	12.5	18.8	24.2	19.2	30.5	6.3	49.9	65.7	25.0	13.7	15.0	22.2	23.4	16.1	22.7	45.2	21.9	6.4	17.8	26.4	19.1	22.4	1.3	12.8	27.9	14.2	3.7	47.6	18.5	35.0	9.5	6.6	40.1	18.9	15.4	23.7	24.7	21.0	17.0	14.9	9.2	32.9	15.2	24.3	7.3	10.1	9.3	18.5	53.4	25.5	23.4	15.4	19.6
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	12.5	19.5	9.4	8.3	9.0	41.5	10.6	9.7	9.4	8.7	13.8	9.5	16.3	8.9	19.4	15.2	8.2	10.8	10.5	11.9	13.0	12.0	41.5	14.3	7.1	10.2	12.7	14.0	14.4	16.8	10.7	21.8	10.8	8.9	8.5	9.8	8.9	12.7	19.7	14.6	19.8	11.4	8.9	9.8	12.0	9.4	11.2	8.2	10.5	15.7	10.1	10.3	9.8	9.9	25.3	23.3	19.0	40.2	45.5	24.1	78.1	32.7	39.6	26.0	25.5	36.6	40.5	21.0	39.7	35.3	14.0	35.9	34.4	34.7	33.5	23.4	18.9	25.4	40.8	32.1	35.7	27.4	27.3	41.4	26.2	34.4	37.1	22.7	37.5	19.4	51.3	21.5	31.2	15.0	20.1	19.9	47.8	27.4	6.2	21.8	27.3	30.4	20.0	43.0	16.3	41.8	36.4	41.9	33.3	37.9	40.0	19.5	48.9	37.8	34.2	20.2	25.3	34.1	47.8	41.5	20.2	19.2	35.4	21.5	6.1	7.7	6.3	8.3	6.0	6.8	6.1	5.5	4.2	5.9	6.6	6.5	12.7	5.0	8.3	9.0	5.6	2.6	9.4	9.0	9.7	9.4	11.9	13.0	10.2	12.7	10.8	8.9	11.2	9.9	48.4	153.8	59.0	27.7	22.6	250.7	70.3	37.0	62.0	28.5	52.5	27.7	37.0	125.8	57.9	77.3	37.5	109.6	39.5	67.9	25.4	65.2	30.9	77.1	71.0	50.2	22.0	36.0	52.5	63.8	187.8	51.9	36.2	117.2	19.0	45.7	45.3	237.1	43.0	32.0	43.2	52.5	44.7	53.1	118.6	19.2	58.4	39.2	48.0	29.0	49.8	46.6	41.2	30.7	38.3	85.8	43.1	85.4	30.2	67.3	215.2	44.6	41.3	34.8	52.6	47.4	43.7	27.5	31.4	66.1	249.6	180.3	41.9	69.9	51.0	118.1
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803157-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA		140000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	11.1	10.0	8.6	13.1	8.4	14.3	8.7	12.0	8.7	8.4	9.5	20.3	11.3	9.1	7.0	10.3	7.7	13.3	8.9	8.2	9.2	8.6	18.5	11.7	11.0	8.8	8.6	7.5	12.6	11.7	7.3	14.2	8.7	11.0	22.6	5.9	10.3	9.2	10.6	11.8	14.1	12.6	8.6	9.3	11.9	10.2	9.5	10.7	10.7	9.9	9.4	15.8	8.5	8.4	11.7	26.5	10.9	29.0	53.2	39.4	25.0	40.8	26.7	27.6	27.2	22.0	26.1	8.3	25.2	40.7	43.0	46.4	11.9	16.9	28.2	30.4	12.3	7.2	21.5	15.8	22.8	13.8	31.1	22.6	29.3	39.6	19.4	20.4	24.9	21.5	25.6	18.8	26.2	32.9	19.2	21.8	22.9	54.8	20.1	7.8	18.9	25.3	21.3	12.1	15.0	17.2	26.0	30.4	16.6	19.5	43.7	13.5	22.7	51.9	24.5	62.4	35.7	13.6	53.9	7.0	28.6	17.9	36.0	8.7	13.3	20.2	12.6	16.0	13.0	4.0	10.0	11.2	6.9	4.7	7.3	7.3	16.4	8.8	10.1	4.2	10.5	9.9	8.6	8.4	12.0	8.7	8.2	9.2	8.8	8.6	8.7	8.6	9.5	8.4	9.5	9.6	2.4	6.5	11.7	6.5	5.9	7.3	12.5	2.7	6.9	5.6	5.5	5.7	6.1	5.5	4.2	10.8	16.1	15.3	0.0	9.7	13.3	5.0	6.7	8.2	19.2	3.4	13.9	13.7	17.7	10.5	17.9	5.7	4.5	4.0	9.7	13.3	12.0	6.7	15.6	16.2	4.1	5.4	5.0	15.1	4.4	12.1	3.6	4.7	12.3	4.7	16.5	14.6	10.5	12.6	6.7	5.7	14.5	10.1	10.7	3.7	9.4	2.7	19.7	6.8	13.0	22.7	5.4	10.4	5.4	15.2	12.2	4.6	10.5	11.2
TOR2A	"FLJ14771, TORP1"	ENSG00000160404	"Torsin family 2 member A"	"Q5JU69, Q8N2E6"	9	127731524-127735313	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 69.1;Theca cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071229	Approved		Uncertain	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA071229: AB_2732175"	"unprognostic (1.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.82e-2)"	6.8	10.7	9.6	6.8	9.3	26.9	6.7	9.4	13.2	7.9	9.5	12.2	11.2	6.7	3.4	11.4	7.0	4.9	5.4	9.2	9.1	10.2	14.0	8.7	7.7	9.4	9.2	8.2	13.6	3.1	10.0	7.9	8.9	8.1	5.4	2.9	8.7	3.6	3.3	9.5	12.8	2.7	8.6	20.8	11.8	20.4	9.7	8.4	8.7	2.2	4.5	7.1	7.1	9.1	7.4	11.5	9.7	12.2	4.7	4.6	13.0	5.1	6.3	8.0	6.3	7.9	12.6	13.6	7.5	4.4	6.0	23.2	3.0	6.4	2.2	21.1	11.0	5.2	10.6	9.7	7.7	11.0	27.0	7.4	11.8	7.4	3.9	4.0	11.5	16.2	16.2	37.3	4.7	43.4	14.3	34.7	8.7	24.0	9.9	23.4	4.5	30.9	8.3	6.9	21.0	8.3	4.7	16.6	5.3	5.3	37.0	21.4	7.2	5.2	6.0	9.1	6.0	23.4	21.8	5.6	6.4	17.8	5.0	26.5	68.5	96.5	32.8	80.2	26.1	12.1	18.9	32.5	71.6	18.0	14.0	25.2	44.0	26.9	78.3	16.2	32.2	41.5	9.6	9.3	9.4	13.2	9.2	9.1	9.4	9.2	8.9	8.6	9.7	9.1	5.3	3.2	5.1	6.2	12.4	1.5	4.4	16.6	1.2	13.7	8.7	5.8	0.6	15.7	9.6	3.7	0.0	37.9	16.0	26.4	1.9	19.1	69.1	7.0	5.7	8.5	22.8	34.1	5.5	27.4	38.9	10.1	8.2	10.8	5.7	11.7	15.0	7.5	56.9	8.4	4.6	20.4	20.3	33.9	8.3	10.7	11.5	26.2	3.6	2.8	25.2	11.7	30.9	6.0	3.7	15.5	28.7	11.3	21.1	6.0	33.9	8.7	7.7	14.6	0.0	2.5	4.2	30.6	10.9	7.5	1.4	51.9	15.0	114.6	18.3	4.9
TOR3A	"ADIR, ADIR2, FLJ22345"	ENSG00000186283	"Torsin family 3 member A"	Q9H497	1	179082070-179098023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 112.6;Plasma cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 281.7;U-266/84: 322.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028766	Approved				"Intracellular and membrane"	NA	Yes		24000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA028766: AB_10602251"	"unprognostic (5.55e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.82e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (4.78e-8)"	"unprognostic (4.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	17.0	15.5	16.9	30.8	17.9	39.7	19.5	16.4	18.6	16.7	19.3	26.1	23.3	16.1	12.8	15.8	17.8	18.1	12.8	17.2	19.4	17.0	27.8	20.4	46.4	18.3	17.2	14.8	23.4	22.5	16.9	15.3	17.2	17.9	26.0	9.5	23.9	17.0	24.4	17.8	23.1	18.8	17.6	37.4	26.5	4.3	19.9	26.7	18.6	13.9	44.8	23.3	13.5	19.3	56.8	65.5	18.6	52.6	38.2	29.9	57.1	41.4	50.0	48.0	34.8	29.8	86.4	90.0	70.2	41.1	28.9	68.5	53.7	34.6	25.3	70.8	49.4	98.3	38.5	45.9	62.9	109.6	80.6	33.1	31.0	35.3	31.9	19.2	35.5	34.8	123.9	164.3	33.8	121.4	66.3	60.5	38.6	68.0	36.4	49.4	33.9	88.4	30.5	76.8	37.8	49.3	61.9	96.9	25.5	32.5	71.5	80.1	22.0	36.2	25.6	59.9	54.3	281.7	322.8	77.4	25.1	77.3	26.5	5.2	71.3	19.3	33.6	56.5	41.4	97.8	29.9	37.7	85.7	73.1	22.7	27.6	14.1	31.5	59.4	93.1	43.3	53.3	16.9	17.9	16.4	18.6	17.2	19.4	18.3	17.2	17.2	17.6	19.9	19.3	24.8	3.2	11.7	4.9	65.2	17.0	14.0	19.2	10.8	3.7	14.8	11.3	11.5	25.8	11.1	11.0	10.4	30.1	32.5	18.6	3.9	34.0	1.1	10.6	16.8	19.3	14.4	18.3	4.4	44.5	57.5	19.8	20.9	11.1	10.8	14.3	13.9	10.7	57.4	0.0	4.6	18.9	32.6	22.0	112.6	1.1	17.1	36.4	16.0	5.6	50.6	17.1	16.5	3.0	4.0	18.9	17.9	18.8	153.7	19.5	15.1	10.3	13.4	9.6	6.6	18.9	17.3	0.8	5.3	12.7	15.8	10.9	24.8	21.2	27.0	12.3
TOR4A	"C9orf167, FLJ20245"	ENSG00000198113	"Torsin family 4 member A"	Q9NXH8	9	137277726-137282641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.6;Undifferentiated cells: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 45.4;TIME: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044913	Enhanced		Approved	Nucleoplasm		NA	NA		260000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044913: AB_10965030"	"unprognostic (1.95e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.99e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.56e-1)"	4.4	2.9	2.2	4.9	1.9	2.8	2.4	1.9	1.9	4.8	2.0	12.4	9.6	3.6	0.8	7.5	4.2	5.2	13.0	1.6	1.8	11.7	2.9	10.9	4.1	2.8	2.3	5.1	3.8	1.9	1.9	1.9	2.5	2.3	4.3	0.0	1.6	2.5	1.4	1.7	11.0	1.3	2.6	15.4	12.5	0.6	3.2	0.8	4.2	0.7	3.0	3.8	3.8	2.3	16.7	21.6	0.2	0.6	0.2	1.7	1.7	27.0	18.5	12.3	6.5	2.7	30.8	1.6	37.4	9.7	0.9	34.0	0.1	9.0	4.2	1.4	1.4	18.2	15.4	14.8	25.9	8.0	45.4	0.9	9.3	2.5	4.8	13.9	16.8	0.1	27.8	2.1	2.1	1.8	0.0	22.0	2.6	18.0	23.9	4.4	5.8	11.3	14.7	0.1	0.8	0.2	19.7	0.1	0.5	0.5	1.6	24.7	41.7	0.6	14.6	2.9	4.6	0.2	1.2	10.5	4.6	7.3	6.0	0.5	0.7	1.3	0.1	0.7	0.2	0.2	0.1	0.0	0.5	0.4	0.0	0.0	0.4	0.2	1.2	0.0	0.2	0.3	2.2	1.9	1.9	1.9	1.6	1.8	2.8	2.3	2.5	2.6	3.2	2.3	10.5	0.0	5.9	0.0	6.2	2.7	3.0	4.9	2.2	0.1	1.9	4.6	8.1	22.8	6.3	12.9	0.0	0.2	4.1	45.6	0.0	10.4	0.1	4.6	2.4	8.4	7.2	5.2	0.0	2.2	0.2	1.9	21.4	9.6	10.2	0.0	27.8	1.0	15.0	0.0	0.0	24.7	2.0	22.0	17.7	0.1	2.5	16.2	0.0	2.8	16.1	0.7	15.5	0.0	0.0	22.9	29.4	4.1	2.4	1.7	17.9	0.6	7.5	0.6	19.7	1.5	3.1	0.0	0.7	2.2	2.4	0.0	2.9	4.3	34.7	15.4
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805412-59119147	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 52.4"	"Group enriched"	"Detected in many"	5	"Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 36.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6"	"Cell line enhanced"	"Detected in many"		"JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	0.7	1.0	7.1	5.8	9.3	2.9	1.0	0.1	10.7	1.8	0.0	11.4	9.5	1.3	0.4	3.3	0.8	4.6	0.7	6.4	8.0	3.0	1.1	4.6	18.2	2.0	4.4	5.7	1.4	2.4	1.8	1.3	2.2	2.0	8.6	6.0	1.6	1.0	0.1	0.5	10.3	2.5	0.0	5.5	7.9	6.3	5.8	52.4	1.1	0.6	18.9	2.0	1.4	4.9	0.9	0.2	15.7	0.0	1.6	3.5	0.0	3.3	7.5	1.8	0.3	0.0	0.0	0.0	0.0	14.4	0.8	1.2	3.9	0.0	0.4	0.5	1.5	0.0	2.8	0.0	12.7	2.8	0.7	1.9	0.5	2.3	2.9	1.0	25.9	75.9	0.0	0.0	1.2	0.0	149.1	0.0	2.7	0.2	0.4	3.1	10.7	0.1	0.4	0.4	14.3	43.8	0.0	0.1	0.0	3.6	0.0	0.0	0.2	3.9	1.8	12.9	4.4	0.0	0.0	9.9	0.5	0.1	2.8	21.5	0.2	3.2	12.1	0.0	5.5	5.4	8.6	18.2	1.4	1.3	3.3	9.7	0.3	18.4	0.0	0.0	36.6	5.6	7.1	9.3	0.1	10.7	6.4	8.0	2.0	4.4	2.2	0.0	5.8	4.9	0.6	9.6	31.6	316.3	12.3	1.3	0.1	0.1	1.2	18.4	0.2	0.9	1.8	1.5	2.5	1.8	0.0	3.9	23.2	3.7	0.0	0.9	2.0	1.9	2.7	1.8	46.0	4.2	198.3	0.7	0.2	2.7	6.1	0.8	16.5	0.0	0.4	0.7	3.7	0.0	155.0	34.8	2.0	0.6	9.6	2.2	0.9	2.8	0.0	47.8	0.6	14.3	34.0	455.4	5.0	2.6	9.6	0.4	22.4	0.1	4.0	1.3	10.4	2.2	0.0	0.2	0.6	1.0	0.7	0.5	1.3	0.8	35.0	0.0	10.3	0.1
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914852-44069616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 92.0;U-266/70: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049900: AB_2680942, HPA058396: AB_2683704"	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	10.0	4.0	11.2	6.2	8.2	1.8	6.8	4.9	18.4	10.2	2.3	7.6	1.3	6.2	1.1	12.8	3.6	2.9	3.6	8.3	35.7	5.1	5.2	36.4	13.3	12.3	18.8	3.1	2.0	10.1	24.6	2.6	15.9	16.7	2.4	1.9	3.8	2.7	1.5	5.1	10.2	1.6	5.8	5.7	9.7	20.8	25.9	50.2	7.4	6.4	8.1	17.6	8.9	10.6	9.9	12.5	4.9	0.9	4.7	13.3	0.1	11.5	5.3	8.1	8.9	0.0	4.0	0.0	16.8	16.6	35.2	5.1	3.2	0.3	8.4	15.5	2.7	0.0	1.1	0.0	92.0	0.1	19.4	31.0	14.0	27.0	1.6	25.8	9.4	9.5	0.0	14.5	4.6	11.3	3.2	4.5	3.0	0.3	42.2	0.0	10.1	15.4	0.0	1.2	4.3	35.8	2.4	0.0	18.0	0.5	0.0	9.2	11.3	0.0	7.5	0.3	0.1	57.4	13.5	9.0	16.9	0.1	27.0	0.0	0.2	6.5	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.7	1.1	0.0	2.6	1.2	0.1	11.2	8.2	4.9	18.4	8.3	35.7	12.3	18.8	15.9	5.8	25.9	10.6	8.0	0.0	0.6	3.9	3.4	1.0	1.0	0.7	0.0	0.8	0.2	0.1	0.8	1.5	0.1	0.0	0.0	0.0	7.3	0.3	0.0	0.1	22.3	0.3	8.9	8.9	0.0	0.0	20.5	0.2	0.1	6.7	1.5	0.3	0.0	10.7	34.2	0.5	1.5	3.3	76.9	0.6	0.0	2.9	3.6	17.3	1.8	1.2	1.8	3.7	0.2	4.6	1.0	45.2	0.5	0.1	2.2	0.7	12.1	0.5	0.0	0.1	0.0	0.1	0.0	0.4	8.7	1.3	1.8	0.2	1.3	0.3	10.5	0.1	1.8	0.3
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.7	14.6	17.3	14.1	17.6	21.4	16.3	17.9	20.1	18.0	14.8	18.5	12.6	15.4	15.1	21.1	14.7	12.2	21.9	17.5	17.7	15.0	15.7	15.9	15.1	17.1	18.7	15.9	15.8	20.4	13.6	15.5	17.5	14.7	15.2	16.1	14.8	17.4	55.5	21.5	14.8	19.7	16.8	13.7	16.9	14.3	18.3	26.1	17.1	25.8	21.3	17.4	16.0	19.5	27.1	27.4	22.7	21.5	32.1	30.6	30.3	25.3	49.6	52.7	50.3	27.0	31.6	16.2	17.5	41.5	42.0	31.5	37.4	38.8	66.8	28.6	15.1	18.1	17.7	37.8	41.5	33.6	28.7	40.0	39.8	41.7	39.4	35.9	38.0	30.1	22.6	27.4	37.9	22.8	33.4	19.3	12.8	39.5	43.2	29.7	23.7	18.6	24.5	33.4	20.9	21.5	25.0	26.3	21.3	29.8	24.8	12.6	25.0	27.2	24.9	24.1	22.5	35.1	41.7	36.9	12.8	16.4	28.7	40.9	27.4	40.0	23.1	29.2	25.0	24.0	20.5	22.2	26.0	24.9	21.3	24.4	48.6	29.2	27.5	33.7	31.7	28.9	17.3	17.6	17.9	20.1	17.5	17.7	17.1	18.7	17.5	16.8	18.3	19.5	60.0	67.3	64.0	0.0	43.3	87.3	63.9	81.3	58.1	75.0	50.4	42.0	51.8	42.9	64.4	46.0	29.2	73.5	69.3	51.0	62.6	47.3	76.1	42.6	46.9	53.4	68.9	48.8	0.0	51.4	64.1	48.4	40.8	50.4	61.4	41.4	37.9	43.1	43.8	42.1	0.0	45.4	52.9	41.3	61.6	36.5	48.7	46.1	39.2	0.0	55.3	40.4	46.4	0.0	0.0	51.4	51.9	44.0	44.4	59.0	91.4	64.0	57.4	54.5	32.9	54.1	58.6	131.9	66.8	50.5	88.8	265.8	62.0	55.5	43.8	70.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	Apoptosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.5;lymphoid tissue: 29.5;skin 1: 20.4;vagina: 13.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 45.5;Basal respiratory cells: 42.4;Basal squamous epithelial cells: 179.2;Endometrial ciliated cells: 38.7;Respiratory ciliated cells: 27.3;Squamous epithelial cells: 72.1;Suprabasal keratinocytes: 32.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044300, HPA048797"	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA044300: AB_2678888, HPA048797: AB_2680524"	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.0	0.6	0.9	0.0	0.8	0.0	1.3	1.1	1.3	5.6	0.6	0.1	0.0	0.1	2.5	24.5	2.7	0.0	0.0	0.8	0.6	0.8	0.1	0.2	0.0	1.0	1.0	0.0	0.2	0.0	1.8	0.0	0.9	2.0	0.0	0.5	3.9	0.8	0.1	20.4	0.1	0.0	0.5	0.0	0.0	1.6	1.0	29.5	0.0	0.0	1.1	0.0	13.6	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.1	1.3	0.8	0.6	1.0	1.0	0.9	0.5	1.0	0.8	0.2	0.0	0.5	1.0	0.0	45.5	11.4	42.4	179.2	0.7	1.5	23.9	0.3	0.0	5.3	0.0	0.0	0.1	0.0	0.3	7.9	0.0	0.9	38.7	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	1.8	1.1	0.0	0.4	1.8	1.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.2	27.3	0.4	0.0	0.6	1.6	0.2	0.3	72.1	32.7	0.3	0.3	0.0	0.3	2.6
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779893-223845954	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	11.7	8.5	35.3	12.2	37.2	49.8	9.5	34.7	39.4	11.4	35.6	9.9	8.5	12.6	10.0	16.8	10.1	18.4	12.2	33.0	34.4	9.7	14.9	18.4	12.8	34.9	35.8	13.8	12.0	15.8	7.1	8.9	33.2	8.9	9.9	38.0	12.4	8.1	13.0	13.0	10.0	11.1	33.5	9.3	12.4	11.2	37.4	15.8	20.7	11.2	13.1	16.6	11.7	35.8	32.8	16.2	42.9	27.3	15.0	14.5	27.3	20.6	29.3	29.4	25.1	33.6	19.2	0.0	17.5	17.3	21.3	21.9	33.9	12.3	39.3	62.9	33.2	43.1	15.2	11.5	30.3	36.0	28.9	17.5	13.3	27.2	27.7	22.1	17.7	23.6	55.7	31.7	24.8	9.5	27.5	22.2	37.0	19.7	15.6	36.0	44.7	3.7	26.5	20.4	36.9	47.6	22.8	27.9	29.9	27.9	15.8	48.6	20.7	30.0	21.1	32.7	39.2	15.4	17.3	26.4	18.1	23.9	35.0	4.8	1.2	0.8	0.9	1.3	1.2	0.9	1.1	1.8	1.3	0.8	1.1	0.8	1.4	3.3	1.0	0.8	0.8	1.0	35.3	37.2	34.7	39.4	33.0	34.4	34.9	35.8	33.2	33.5	37.4	35.8	18.2	48.1	22.7	76.4	23.7	17.2	41.6	7.2	21.1	8.1	12.6	8.0	20.3	18.6	28.3	7.3	52.1	10.3	24.2	13.0	1.9	20.4	1.1	45.0	42.2	19.1	14.9	54.3	1.7	10.7	5.9	22.6	21.9	152.0	48.8	14.1	8.6	10.7	9.8	0.0	5.3	8.7	14.2	14.1	44.4	2.4	10.5	41.7	8.8	23.4	9.6	10.0	7.2	27.2	29.0	21.4	7.3	8.6	27.4	30.9	6.7	5.5	15.6	45.5	0.0	41.2	26.3	12.3	20.1	21.1	11.6	4.8	38.8	31.4	10.2	40.6
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 461.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: AB_2684113, HPA061276: AB_2684461"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	77.8	18.6	41.1	20.4	17.8	29.6	63.7	40.5	27.5	32.8	19.7	43.4	20.2	36.0	4.9	24.5	45.5	24.7	71.7	24.7	27.6	27.9	10.5	45.7	12.7	16.9	30.2	20.0	37.7	5.6	20.3	23.9	24.1	47.8	27.5	2.2	42.7	11.7	15.0	30.3	38.8	32.8	19.5	61.2	29.9	16.2	18.3	9.1	41.0	10.3	12.3	29.2	32.0	13.4	0.0	82.0	27.3	38.2	28.0	2.2	0.5	23.9	46.3	8.5	10.7	5.1	0.5	14.3	20.5	6.9	21.7	14.5	14.6	0.5	2.8	28.0	12.3	1.3	0.8	0.0	52.5	0.8	101.1	118.0	1.9	11.5	4.9	2.0	29.6	31.6	2.2	0.1	11.3	73.0	1.4	133.9	48.9	53.4	26.9	60.3	16.1	7.2	0.0	5.2	357.9	13.0	44.2	96.8	0.1	33.9	209.9	7.5	6.8	55.8	39.3	87.3	0.1	0.5	0.5	0.3	0.1	7.8	16.1	0.0	5.9	0.0	5.2	5.8	7.0	8.0	1.0	5.1	4.7	8.4	0.0	1.7	41.2	8.1	21.2	25.3	0.9	4.8	41.1	17.8	40.5	27.5	24.7	27.6	16.9	30.2	24.1	19.5	18.3	13.4	52.2	22.4	30.9	0.3	13.2	10.8	36.9	12.9	13.6	1.7	29.5	22.7	10.3	24.3	23.7	42.3	0.0	57.8	8.7	31.0	1.9	32.0	96.5	9.0	6.3	45.1	36.0	3.2	2.7	21.3	22.0	15.0	23.0	9.7	0.0	7.8	76.8	1.6	35.7	0.0	10.2	30.1	38.7	7.5	20.3	461.2	12.2	9.3	10.6	5.6	11.5	0.8	0.0	0.0	0.5	28.5	16.0	7.5	2.1	28.6	17.7	0.1	14.5	0.8	13.1	1.4	22.4	3.4	6.3	4.4	4.4	68.3	8.7	5.1	54.0	45.7
TP53I3	PIG3	ENSG00000115129	"Tumor protein p53 inducible protein 3"	Q53FA7	2	24077433-24085861	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.8;Late spermatids: 213.9;Proximal enterocytes: 200.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"T-47d: 599.7"					"Low region specificity"	"Detected in all"			"CAB017479, HPA022012, HPA028742"	Enhanced		Supported	Vesicles		NA	NA		250000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456"	"unprognostic (3.66e-2)"	"unprognostic (1.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.57e-3)"	20.2	24.6	8.6	16.1	9.8	20.0	17.2	8.4	9.6	29.6	11.2	54.4	51.5	17.3	4.5	119.2	16.5	26.3	15.4	7.5	9.0	46.8	15.2	29.9	7.2	9.4	11.1	8.2	40.1	7.0	11.7	10.6	8.5	15.0	40.8	2.0	25.3	11.2	6.2	8.0	69.1	16.9	7.7	11.9	25.3	38.4	13.0	14.2	23.6	5.9	10.1	22.3	63.8	9.7	27.5	86.8	50.6	21.1	38.8	85.3	37.2	27.3	32.3	22.6	31.1	22.1	48.4	3.5	15.0	44.0	6.1	8.0	13.1	46.5	13.8	21.6	2.0	8.7	33.3	57.5	25.2	4.1	15.3	92.3	72.3	60.2	14.7	46.1	102.0	16.3	7.3	23.4	95.5	18.1	5.0	0.6	39.2	30.8	36.0	10.1	45.7	0.9	38.1	41.4	7.2	32.9	35.1	7.8	6.1	40.5	599.7	5.6	80.6	26.9	63.8	18.5	13.7	10.6	7.4	3.0	8.9	0.4	7.0	11.8	19.1	16.9	0.2	12.6	0.2	4.9	0.2	0.6	16.0	5.5	0.1	0.4	4.1	0.3	5.6	7.1	0.5	6.1	8.6	9.8	8.4	9.6	7.5	9.0	9.4	11.1	8.5	7.7	13.0	9.7	19.2	28.9	38.4	3.9	6.8	4.7	24.7	69.7	6.8	0.8	25.8	33.0	9.0	50.1	51.9	42.3	0.0	41.9	1.1	175.8	109.5	93.5	127.8	50.4	47.4	20.3	79.4	7.2	0.4	134.7	31.9	30.6	83.6	68.2	12.7	85.8	23.9	12.9	45.0	0.0	0.4	63.9	57.0	22.9	11.1	213.9	7.8	20.9	14.2	4.7	23.9	9.5	0.0	5.0	0.3	91.1	138.5	9.1	8.0	11.4	200.9	104.7	19.2	1.9	19.7	14.1	36.8	56.6	14.3	38.8	7.0	28.9	3.4	16.2	75.2	49.9
TP53INP1	"DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B"	ENSG00000164938	"Tumor protein p53 inducible nuclear protein 1"	Q96A56	8	94925972-94949378	"Predicted intracellular proteins"	"Apoptosis, Autophagy, Transcription, Transcription regulation"	"Activator, Antioxidant"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 175.6;Plasma cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 54.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 79.7;U-266/70: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005856	Uncertain		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA005856: AB_10600832"	"unprognostic (1.39e-2)"	"unprognostic (4.47e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (5.45e-5)"	11.2	10.6	6.4	23.1	7.9	42.1	12.7	6.0	7.6	11.8	9.7	16.5	17.2	12.7	12.6	10.9	14.7	10.9	10.9	5.5	6.5	11.5	101.9	25.3	36.0	8.5	6.8	9.0	60.4	10.1	7.1	14.4	7.0	22.5	20.2	17.6	17.9	9.2	9.2	13.1	35.5	12.2	7.0	40.6	25.6	28.6	8.0	29.3	10.2	8.6	41.1	13.3	8.7	8.8	0.5	2.5	24.1	9.3	29.4	27.6	24.8	5.8	13.5	2.6	6.2	2.2	0.6	5.3	12.4	11.2	2.3	4.2	0.0	9.5	5.8	0.3	3.0	3.4	5.3	14.8	19.7	0.0	16.8	45.4	22.2	6.9	2.8	22.4	39.8	2.6	1.8	79.7	12.4	1.7	4.0	1.5	2.3	0.1	0.7	3.4	1.9	29.4	6.3	26.5	3.3	19.5	3.6	2.0	5.2	38.5	11.8	3.3	27.6	4.8	5.8	0.0	0.9	85.4	18.9	2.3	8.4	0.0	0.0	54.6	3.7	11.7	1.4	3.6	1.3	11.5	4.0	2.7	1.4	9.7	0.8	0.6	16.9	5.2	2.3	1.4	6.6	2.5	6.4	7.9	6.0	7.6	5.5	6.5	8.5	6.8	7.0	7.0	8.0	8.8	18.5	35.3	35.7	10.7	70.0	4.6	3.0	17.9	8.0	5.2	27.4	11.6	13.2	75.8	27.9	11.0	27.1	6.1	10.1	27.5	3.9	9.3	17.3	39.9	18.1	14.2	83.9	6.7	0.9	21.3	1.5	11.4	11.2	35.9	4.5	18.8	29.3	175.6	12.5	1.7	2.9	20.9	20.3	44.2	5.6	43.3	7.2	12.6	16.0	16.9	17.7	5.3	3.1	12.1	11.0	18.0	32.2	10.1	233.2	18.1	21.6	9.6	66.4	19.8	6.6	11.0	12.7	18.9	5.6	10.8	6.5	5.7	17.9	26.8	4.8	8.7
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk, TPRKB"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689444	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 212.4;SK-MEL-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	6.5	7.7	6.0	7.3	5.3	6.3	8.9	4.7	6.1	6.9	2.6	6.5	4.8	7.0	4.6	8.8	6.3	5.7	5.1	5.0	6.1	6.8	7.0	5.7	11.2	5.1	5.3	6.2	5.4	7.4	6.2	6.0	5.0	7.9	6.0	6.4	7.1	6.1	6.7	9.6	5.9	6.8	4.8	7.0	7.0	12.1	6.9	13.2	8.0	5.3	11.9	10.6	6.8	6.5	12.7	8.7	17.9	15.9	18.5	15.1	16.6	17.7	16.3	22.7	16.4	24.7	8.0	32.2	26.1	14.6	20.3	19.6	23.1	20.3	19.6	7.9	12.0	31.0	8.4	22.4	24.3	20.2	212.4	20.3	24.2	15.8	15.4	10.6	15.3	12.7	21.5	13.1	19.6	19.1	31.0	35.5	14.6	18.1	29.8	17.9	16.2	19.1	15.2	14.1	21.6	11.5	21.3	42.1	90.7	9.3	15.4	21.8	15.7	26.3	15.5	17.5	19.8	14.5	19.6	24.7	15.2	15.2	12.6	36.6	16.1	28.4	16.9	15.8	19.5	19.9	18.2	19.4	16.7	19.3	19.9	17.1	2.7	22.5	14.6	25.4	25.5	17.4	6.0	5.3	4.7	6.1	5.0	6.1	5.1	5.3	5.0	4.8	6.9	6.5	12.6	9.6	13.1	5.2	14.3	50.7	54.8	45.9	39.9	9.4	22.8	21.2	7.0	18.6	27.7	9.2	12.5	42.6	23.9	10.4	27.4	28.9	214.7	13.3	25.6	17.5	13.1	16.2	5.0	23.8	73.6	29.1	23.4	14.2	22.9	14.6	11.0	12.2	25.8	15.2	4.7	16.5	32.6	14.4	28.5	49.9	22.1	13.1	37.4	4.7	17.9	8.1	21.6	6.0	6.0	34.7	4.9	16.1	8.4	62.6	15.5	31.1	18.0	10.4	6.6	8.8	26.1	87.6	15.6	35.2	61.8	88.7	19.4	26.8	13.1	59.9
TP53TG5	"C20orf10, CLG01, dJ453C12.5"	ENSG00000124251	"TP53 target 5"	Q9Y2B4	20	45372557-45407889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041979, HPA058510, HPA077455"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA041979: AB_2677778, HPA058510: , HPA077455: "	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-3)"	"unprognostic (3.10e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.72e-5)"	"unprognostic (2.09e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.41e-1)"	0.1	0.1	1.1	0.2	1.8	0.7	0.1	0.9	2.6	0.1	1.4	0.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	1.1	1.5	0.1	0.1	0.2	0.4	1.8	1.5	0.1	0.1	0.0	0.2	0.1	2.0	0.1	0.0	0.8	0.2	0.0	0.2	0.2	0.2	0.0	0.7	0.2	0.2	17.8	1.7	0.0	0.2	0.0	0.0	0.2	0.1	3.5	0.3	0.7	0.4	1.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.3	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.3	0.4	1.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.1	0.0	0.5	0.4	0.3	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.4	0.4	0.3	1.0	0.4	0.2	0.1	1.1	0.1	0.6	1.4	0.4	0.9	0.2	0.3	0.4	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.8	0.9	2.6	1.1	1.5	1.8	1.5	2.0	0.7	1.7	3.5	0.1	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.0	0.8	0.5	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	671.5	0.5	0.2	0.3	0.0	0.0	7.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.5	0.0	0.0	1.1	254.4	4.7	0.1	0.0	1.9	0.0	0.1	0.0	2.5	157.5	0.0	1.2	4.5	0.0	0.2	0.2	0.1	0.3	1.0	0.0	0.4	1.2	2.1	1.8	0.0	1.1	0.0	0.1	0.0	0.3	0.9
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652516-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.7	0.7	0.5	0.5	0.8	4.2	0.5	1.4	8.0	0.2	0.0	0.1	0.1	3.7	6.7	0.0	0.1	0.8	0.7	0.1	0.2	0.9	1.0	2.4	2.9	0.1	0.8	0.1	0.3	0.0	1.4	2.6	0.1	0.2	2.9	0.3	0.2	6.6	0.2	0.0	1.4	0.7	0.3	0.7	0.7	1.6	0.2	0.0	1.4	0.1	2.9	1.0	2.6	0.1	0.3	7.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	4.0	2.6	2.0	0.0	0.9	4.3	2.7	0.9	0.0	0.8	8.7	0.2	3.9	2.6	0.0	0.0	2.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.8	1.9	15.0	2.0	0.5	0.0	0.1	0.0	11.6	0.1	0.3	3.8	18.0	8.4	0.4	0.0	0.8	0.0	10.9	9.2	0.0	2.9	7.5	0.0	5.8	3.3	0.7	18.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	4.2	0.5	0.8	0.7	2.4	2.9	1.4	1.4	0.7	1.0	0.0	0.0	1.5	0.0	1.2	3.1	3.8	13.0	16.5	0.5	0.2	2.5	1.5	0.0	7.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	21.8	31.0	0.3	0.3	2.4	3.2	0.1	0.2	0.4	0.4	0.0	0.7	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.5	2.0	0.0	1.3	15.7	0.6	0.1	1.8	0.0	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	6.8	0.2	0.0	0.1	35.8	0.1	0.0	0.0	2.6	0.1	0.4	1.6	2.3	0.3	0.4	0.1	0.3	0.2
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82367420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		310000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	19.9	2.5	1.6	3.3	20.6	0.5	17.3	0.4	5.7	24.2	0.6	8.5	3.5	15.8	2.6	26.3	14.9	6.9	9.1	0.2	4.2	10.7	1.5	7.5	1.9	8.2	11.4	6.0	8.3	4.2	14.2	6.2	9.3	15.3	3.0	0.2	20.1	7.0	2.9	15.9	8.0	6.7	3.1	9.9	9.0	3.6	3.6	4.2	15.7	1.9	3.0	35.1	20.2	3.6	17.1	27.6	8.7	21.2	35.2	40.4	17.6	84.9	94.6	16.7	22.0	3.9	26.9	0.0	9.6	39.5	51.9	37.3	10.3	44.6	13.9	0.0	14.5	11.9	13.1	0.8	29.1	0.9	9.2	25.8	115.2	98.5	34.1	12.9	4.5	0.7	2.3	0.2	3.9	37.8	0.0	0.0	12.5	8.8	22.3	0.0	19.4	0.2	24.4	25.8	4.4	16.9	20.9	28.3	0.0	16.2	49.4	3.5	10.8	15.1	15.8	33.5	19.2	0.1	0.0	0.0	71.3	1.3	17.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	20.6	0.4	5.7	0.2	4.2	8.2	11.4	9.3	3.1	3.6	3.6	16.4	12.8	6.5	2.3	0.2	67.9	78.2	120.3	68.3	1.1	44.6	24.0	2.1	21.5	62.4	55.2	0.0	42.7	0.4	9.0	0.0	35.8	8.6	29.2	38.7	25.4	1.2	0.0	21.3	45.4	82.5	48.0	14.8	68.0	0.0	3.8	11.0	0.2	3.6	1.7	0.9	20.2	75.3	0.6	11.5	6.5	12.8	2.3	17.8	7.5	0.1	2.1	0.0	2.0	3.2	38.2	17.8	6.0	0.0	51.9	1.9	0.7	29.9	0.3	32.9	55.6	47.0	13.7	11.8	25.2	31.3	65.9	3.5	9.7	10.8	78.8
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 174.3;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 148.6;hTERT-RPE1: 121.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	27.7	48.8	37.7	18.2	54.3	12.5	29.1	70.2	40.5	36.9	48.5	30.4	19.4	30.6	19.3	38.4	35.5	21.7	68.0	34.7	33.4	50.9	27.8	29.5	17.0	43.5	48.3	41.5	52.0	30.8	37.9	18.8	46.6	28.7	19.5	11.5	36.1	27.3	36.7	22.2	31.4	18.6	35.4	28.6	19.1	14.5	44.0	8.5	55.5	24.8	18.2	25.3	26.4	45.9	15.3	45.0	5.1	6.5	38.5	43.3	14.9	21.2	148.6	10.9	13.1	33.5	50.7	34.5	30.9	21.6	35.7	18.8	11.9	37.6	14.7	4.1	9.2	12.9	23.5	18.7	49.9	4.5	28.1	41.5	18.6	21.3	37.2	121.7	16.9	9.8	15.0	11.9	13.5	18.3	1.3	68.3	8.4	18.6	22.3	2.5	6.2	67.3	34.9	54.4	6.5	9.8	17.0	43.2	17.1	10.3	13.9	41.4	7.1	16.0	7.8	22.3	13.3	20.0	13.1	29.6	47.2	10.9	12.3	6.9	14.6	1.3	1.8	2.4	2.0	3.4	2.4	2.3	9.9	5.2	3.3	2.1	0.5	8.5	0.3	5.0	1.2	4.7	37.7	54.3	70.2	40.5	34.7	33.4	43.5	48.3	46.6	35.4	44.0	45.9	8.3	9.6	19.6	174.3	9.0	4.6	6.0	15.4	2.8	19.6	17.0	11.2	34.4	12.8	24.4	27.6	16.7	7.2	3.1	35.9	1.9	13.2	13.2	15.0	21.8	8.1	28.8	9.0	24.5	18.7	3.2	20.2	23.0	19.1	31.1	7.7	15.7	18.3	21.5	50.5	26.6	26.8	14.2	17.9	4.7	11.3	21.5	23.7	7.2	79.6	13.7	17.2	3.1	25.1	61.7	11.5	20.3	21.4	4.6	15.9	29.0	19.7	27.9	13.7	0.0	49.8	18.5	3.6	3.3	10.6	4.0	6.6	5.9	13.2	20.3	22.2
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048932-69136316	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.5;Melanocytes: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	5.8	3.8	2.2	4.8	2.9	4.4	5.2	4.8	3.1	8.9	0.2	11.7	7.6	8.9	3.2	4.6	8.5	3.8	3.9	2.2	1.3	7.5	11.1	4.5	5.8	0.7	0.2	5.8	3.6	2.7	4.2	3.0	0.8	7.2	3.9	4.4	4.1	5.7	4.2	10.0	7.2	4.8	0.1	6.3	4.7	3.2	1.5	3.0	4.3	1.4	4.2	6.3	5.9	3.2	4.6	8.8	3.5	4.9	2.7	3.0	10.5	3.6	3.9	4.7	2.4	8.5	12.4	3.5	5.0	6.9	3.2	9.6	3.2	5.8	2.0	2.7	3.3	7.7	13.7	1.9	3.2	6.5	8.5	4.0	3.2	2.2	2.8	2.4	4.9	8.4	4.7	16.7	2.7	6.9	4.4	9.4	2.4	11.5	3.1	4.6	3.3	6.8	5.1	8.0	2.8	3.6	5.9	11.4	17.0	4.3	7.0	9.1	5.2	3.5	4.5	6.4	4.0	6.8	2.9	4.0	7.7	5.5	8.3	2.9	10.2	2.6	0.9	9.9	0.8	2.4	1.8	2.1	7.7	1.8	1.8	1.9	7.0	6.2	11.7	3.1	2.7	4.4	2.2	2.9	4.8	3.1	2.2	1.3	0.7	0.2	0.8	0.1	1.5	3.2	4.5	9.6	1.5	10.1	6.7	4.0	2.7	3.0	2.2	1.8	2.8	2.5	3.1	5.7	2.3	12.9	2.1	2.6	6.1	4.4	17.6	7.2	17.7	2.1	5.6	4.2	0.0	8.2	30.5	8.6	4.8	4.0	8.6	3.4	2.5	7.3	5.3	18.4	11.9	0.0	22.4	2.6	2.0	12.6	5.5	2.7	6.2	10.2	35.6	4.7	7.7	2.5	3.1	26.2	4.5	4.8	2.6	6.8	8.3	1.5	8.8	9.1	0.8	4.9	6.6	5.1	5.7	2.2	4.4	1.9	3.4	1.9	3.6	3.2	3.6	2.1
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 187.6"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 50.5"	"Group enriched"	"Detected in many"	5	"B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 252.6;SK-BR-3: 572.5"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		310000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	5.4	9.2	34.9	28.4	40.2	8.9	75.9	34.2	69.4	19.6	36.6	117.7	98.9	9.9	56.2	34.9	15.3	31.1	11.7	42.9	35.4	46.5	30.7	19.8	44.0	33.2	37.1	2.4	41.8	27.4	34.3	22.9	36.3	104.8	129.7	187.6	80.7	18.3	8.6	46.9	100.3	10.4	32.8	16.0	84.1	5.2	53.3	15.5	64.5	9.8	56.2	20.9	20.2	48.1	131.8	34.9	1.6	23.0	0.0	0.0	51.7	8.6	12.9	34.7	17.1	18.0	37.4	189.9	45.2	0.8	25.5	52.5	52.7	36.3	24.6	23.8	44.2	26.8	46.9	29.4	0.2	8.6	0.7	0.0	25.2	0.1	12.2	21.6	2.0	128.9	0.4	252.6	0.1	43.6	42.6	39.4	11.7	148.8	86.0	0.3	0.7	122.0	60.7	31.6	64.9	44.1	40.1	572.5	110.7	51.0	55.9	34.2	2.1	0.0	35.2	0.6	30.8	94.1	87.1	155.2	22.5	0.2	2.6	0.6	0.1	5.5	12.7	0.1	22.0	50.5	12.4	11.1	2.5	44.7	8.1	9.3	0.5	15.1	0.1	5.2	9.1	8.3	34.9	40.2	34.2	69.4	42.9	35.4	33.2	37.1	36.3	32.8	53.3	48.1	17.3	44.8	67.8	10.4	133.6	80.7	89.6	83.4	51.2	171.1	105.6	54.2	22.2	82.9	78.1	66.2	118.9	98.9	28.6	230.9	170.2	112.8	20.6	25.2	8.4	26.2	169.9	11.6	85.4	79.6	116.9	6.7	97.3	72.8	1.3	15.3	25.7	40.6	13.1	32.0	53.9	331.9	476.0	14.6	24.2	13.0	1.2	10.8	104.9	37.5	91.2	50.3	60.8	69.9	181.0	79.7	317.5	1.5	270.5	214.4	132.3	135.3	21.4	232.2	0.0	49.6	8.3	1.6	18.2	91.4	124.6	231.2	51.3	0.3	247.1	135.4
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TPD52L2	"D54, hD54, TPD54"	ENSG00000101150	"TPD52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 187.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047489	Approved		Approved	Vesicles,Cytosol		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA047489: AB_2680067"	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	85.1	84.6	75.8	52.8	76.8	98.9	68.9	76.0	88.1	74.1	74.0	79.7	38.3	72.6	31.4	109.6	68.0	42.6	85.7	76.8	81.6	66.2	51.4	60.8	43.2	80.8	77.4	60.7	45.5	38.3	58.9	65.9	79.5	66.3	35.2	24.6	50.3	60.9	70.2	70.8	52.6	72.1	78.0	71.4	54.5	40.2	83.5	35.7	49.8	53.4	41.7	83.6	71.5	81.4	175.2	87.9	54.5	66.9	122.4	193.8	80.4	196.7	173.0	343.1	145.0	326.9	194.9	70.0	211.3	200.0	204.2	168.4	111.5	269.0	198.7	39.5	46.4	66.9	112.6	199.6	129.9	85.0	66.3	140.3	296.6	138.5	221.3	121.6	160.1	74.0	140.4	101.0	137.0	96.3	83.5	109.4	78.7	172.6	308.1	114.0	59.5	113.3	135.8	76.0	82.3	92.2	230.9	177.5	165.3	80.3	120.6	171.5	170.1	273.4	79.1	160.9	145.4	63.2	108.6	85.0	256.8	79.0	86.6	66.9	73.0	47.1	29.4	55.1	36.8	33.5	32.3	34.2	47.6	31.4	32.4	29.8	137.3	47.5	48.1	24.0	38.8	74.6	75.8	76.8	76.0	88.1	76.8	81.6	80.8	77.4	79.5	78.0	83.5	81.4	37.5	16.0	23.4	36.2	26.6	44.1	28.3	58.8	33.0	18.9	28.0	31.1	45.4	20.0	31.3	22.0	6.2	77.2	28.6	27.8	39.2	50.5	7.8	21.7	38.4	36.7	18.6	26.9	19.6	32.1	104.0	37.7	23.9	31.9	38.7	25.8	28.9	14.5	187.3	8.4	21.7	27.2	20.3	47.4	33.0	12.1	42.0	52.3	28.4	7.5	50.6	32.5	27.8	13.6	32.3	74.8	25.1	65.1	29.4	51.7	37.5	36.6	26.5	19.7	46.0	18.9	65.6	13.9	25.6	37.2	42.3	108.8	25.0	42.3	27.9	44.4
TPGS2	"C18orf10, DKFZP586M1523, HsT3006"	ENSG00000134779	"Tubulin polyglutamylase complex subunit 2"	Q68CL5	18	36777647-36829216	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 499.2;Late spermatids: 1012.6;Spermatocytes: 318.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 266.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040596, HPA040617"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA040596: AB_10796458, HPA040617: AB_10794037"	"unprognostic (6.51e-3)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.93e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.03e-2)"	"unprognostic (5.28e-2)"	44.8	52.7	65.8	29.5	70.4	70.2	40.2	68.8	71.3	44.8	169.7	40.1	27.2	37.4	32.5	56.8	54.7	43.5	58.9	71.4	82.7	46.2	27.2	48.6	38.8	80.9	89.1	67.6	35.2	41.1	23.0	35.4	92.2	34.2	41.0	58.4	32.6	34.8	16.4	46.4	34.5	48.4	65.3	24.9	31.9	202.9	68.6	101.3	49.6	22.1	64.6	54.1	37.7	69.9	142.4	109.6	208.8	183.2	102.3	111.0	87.6	152.7	207.6	210.6	252.9	53.2	99.6	138.8	104.0	307.5	133.5	138.1	173.9	215.3	246.9	182.2	59.0	97.2	186.5	145.8	104.9	126.5	83.1	148.9	110.0	188.0	96.6	202.5	253.6	142.1	143.1	100.0	279.9	84.0	202.2	74.0	126.8	62.8	70.9	149.4	192.8	169.6	235.3	136.8	146.5	160.3	229.8	59.4	67.6	181.4	114.1	120.6	143.0	210.6	78.1	30.3	123.6	126.5	129.4	164.4	170.3	101.3	120.9	266.1	44.0	89.5	44.2	50.3	44.4	44.7	51.4	46.2	45.1	31.5	38.5	43.5	13.5	52.3	61.0	35.8	94.3	52.8	65.8	70.4	68.8	71.3	71.4	82.7	80.9	89.1	92.2	65.3	68.6	69.9	26.2	44.8	34.7	9.4	23.7	28.9	39.3	87.8	25.6	21.5	38.2	42.5	19.7	54.3	64.1	25.8	8.4	81.2	25.6	13.9	72.4	123.2	499.2	68.8	27.1	32.0	19.8	125.8	27.1	77.2	144.5	41.3	25.0	50.7	19.0	41.6	36.8	21.7	85.8	8.4	30.9	24.5	69.2	29.9	32.4	1012.6	36.7	27.2	32.0	13.1	58.9	35.7	43.3	11.1	23.0	92.4	23.9	49.2	29.2	18.9	34.6	47.8	77.5	22.8	32.9	21.2	39.5	318.9	131.1	48.4	39.9	31.3	27.3	76.5	43.2	43.2
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.0;intestine: 19.3;stomach 1: 15.0"	"Cell type enriched"	"Detected in many"	30	"Enteroendocrine cells: 1466.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 3.4;midbrain: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.6	0.1	0.2	1.2	0.3	1.1	1.3	0.3	0.3	0.6	4.7	9.0	10.2	0.9	0.9	0.2	0.9	0.1	0.3	0.4	3.4	0.5	0.2	0.8	0.5	0.2	9.0	0.7	0.5	0.1	3.0	0.2	1.1	1.4	19.3	1.8	0.5	0.1	0.4	1.4	11.2	0.2	0.2	0.7	15.0	0.9	0.4	0.3	0.5	0.1	0.7	0.4	0.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.0	0.7	0.3	1.1	0.0	1.5	0.3	0.0	0.6	0.0	0.2	0.1	0.2	0.8	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.4	3.4	0.2	9.0	1.1	0.2	0.4	0.3	1.4	0.0	0.0	1.0	1.1	0.4	0.4	0.5	0.0	14.9	1.9	1.0	0.8	0.0	0.1	5.5	2.1	0.2	0.6	1.7	0.0	0.2	0.8	0.1	0.6	0.7	1466.7	0.4	0.5	0.6	0.0	1.2	2.0	0.2	0.0	5.6	0.4	0.2	0.2	1.7	0.4	48.2	0.0	0.3	1.4	0.8	0.9	0.5	0.0	0.0	0.1	1.4	1.0	0.0	0.6	0.4	13.4	1.2	0.3	2.3	1.5	0.3	0.9	5.6	6.6	1.3	1.3	2.8	3.7	0.0	1.4	0.0	1.2	0.0	2.7	0.4
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938845-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	716	"brain: 325.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.0;Inhibitory neurons: 3.2;Late spermatids: 7.4;Spermatogonia: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 325.8;pons: 141.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	31	"midbrain: 106.7;pons and medulla: 34.9"	"Group enriched"	"Detected in some"	5	"midbrain: 49.9;pons: 49.6"	CAB078198	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 34: Spermatids - Unknown function"			"CAB078198: AB_2665804"	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	45.3	325.8	0.0	0.2	0.0	0.4	0.0	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	1.0	0.4	45.3	325.8	141.5	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.2	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2470.8;tongue: 2005.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	340.4	588.6	446.2	269.7	480.2	334.8	274.5	476.5	541.9	314.1	446.9	425.6	421.0	240.5	220.2	764.4	248.2	216.8	819.8	481.0	462.0	609.0	536.1	308.6	253.9	459.2	460.4	269.9	238.1	496.4	236.8	287.2	467.2	272.1	435.3	625.0	377.6	273.3	2470.8	410.1	404.5	301.5	429.7	291.4	329.0	239.8	503.5	200.3	269.1	2005.8	410.4	363.8	440.6	454.4	1556.8	1350.5	706.1	1094.6	666.5	696.6	1236.3	1097.5	1184.9	1999.1	2407.5	1409.9	823.0	903.4	212.7	1069.7	1042.4	748.8	1671.0	1812.3	2189.4	1196.4	1265.1	1172.0	924.4	926.2	496.8	1351.5	924.0	764.0	739.7	1537.8	1305.0	2816.1	1233.3	451.0	615.0	336.5	1554.5	1130.0	709.6	1119.5	1741.0	1302.3	855.9	413.5	1156.1	930.7	1261.4	1061.1	497.2	830.0	953.3	977.8	542.7	1452.6	224.4	1003.2	778.2	1068.0	914.6	703.1	1631.7	653.4	285.7	1327.8	2153.1	821.2	784.9	1708.8	2304.1	2375.2	824.6	2402.3	845.7	863.3	820.0	808.0	2656.1	800.9	570.5	703.0	934.3	1387.7	2165.7	482.0	1106.3	4679.5	446.2	480.2	476.5	541.9	481.0	462.0	459.2	460.4	467.2	429.7	503.5	454.4	311.5	134.6	204.2	34.6	290.6	684.8	553.8	1756.4	414.9	284.6	294.3	303.3	552.5	391.7	673.0	389.9	110.5	1017.0	278.2	850.3	1508.5	1361.5	203.0	280.8	307.0	352.0	425.5	243.3	38.4	786.5	1824.0	386.5	408.3	343.9	362.8	364.8	276.6	547.3	937.3	297.8	33.7	567.2	1151.5	386.7	750.4	683.5	279.0	482.8	674.1	18.7	1129.8	739.6	312.0	17.1	26.7	1081.5	889.4	263.3	427.9	556.2	1595.9	1642.7	401.2	298.0	197.2	270.5	551.3	14.9	79.0	690.4	615.9	1530.4	352.9	869.2	827.0	652.5
TPK1	"HTPK1, PP20"	ENSG00000196511	"Thiamin pyrophosphokinase 1"	Q9H3S4	7	144451941-144836395	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 14.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.0;Excitatory neurons: 82.6;Inhibitory neurons: 76.3;Late spermatids: 95.8;Microglial cells: 110.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 70.6;CACO-2: 17.2;EFO-21: 21.2;TIME: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021545, HPA021849"	Approved		Approved	Vesicles		NA	NA		210000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA021545: AB_1858209, HPA021849: AB_1858210"	"unprognostic (4.05e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.22e-3)"	4.3	3.4	2.9	5.9	3.2	2.7	4.2	2.1	4.1	2.7	3.3	6.4	14.3	2.2	1.5	1.9	2.0	3.6	3.4	2.8	5.2	3.9	4.5	5.2	5.8	3.1	3.0	2.3	2.0	1.8	1.5	5.2	3.0	1.8	6.1	2.4	3.6	2.6	1.6	1.4	7.5	3.6	2.9	8.1	2.2	3.4	4.3	2.8	3.1	2.9	5.0	4.1	1.6	3.9	0.7	0.7	0.7	70.6	0.5	0.7	5.8	0.3	0.3	0.2	0.2	17.2	2.8	1.3	21.2	1.2	1.4	0.0	1.4	0.8	0.6	4.3	1.0	0.3	0.2	0.3	1.8	5.5	1.7	1.4	1.4	0.8	1.0	2.0	13.6	2.8	1.5	3.2	0.3	2.1	1.6	8.2	1.8	2.1	5.9	0.7	1.6	2.5	10.9	6.3	0.7	0.2	1.1	0.2	1.3	1.3	1.0	10.4	16.3	0.7	1.8	1.3	0.9	1.6	4.2	1.7	2.5	13.8	0.7	0.4	10.2	0.3	5.0	7.4	5.2	6.7	5.5	4.6	13.2	7.2	6.5	5.4	4.7	5.8	10.8	3.1	7.7	5.6	2.9	3.2	2.1	4.1	2.8	5.2	3.1	3.0	3.0	2.9	4.3	3.9	8.5	9.6	2.8	43.1	23.8	2.3	2.6	3.0	0.6	3.9	4.4	2.9	5.9	8.6	1.3	3.7	8.4	41.2	8.3	20.1	19.6	4.3	83.0	5.3	2.3	8.9	1.2	2.1	82.6	6.7	14.3	6.3	7.1	8.6	7.6	6.5	6.1	5.2	17.0	1.7	76.3	5.0	0.0	18.9	19.2	95.8	5.0	17.9	8.8	110.5	15.7	3.4	17.5	55.8	38.4	9.8	15.9	1.2	9.9	1.8	20.4	8.6	3.2	5.4	0.0	3.6	2.9	14.9	10.5	2.1	1.7	32.0	12.1	4.0	8.1	4.1
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690056	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 39012.3;tongue: 16773.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	812	"plasmacytoid DC: 398.6"	"Lineage enriched"	"Detected in single"	920	"dendritic cells: 398.6"	"Cell line enhanced"	"Detected in many"		"BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1"									"HPA047089, HPA053624"	Approved					NA	NA		140000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	331.1	285.0	88.0	411.0	89.8	16.7	260.8	92.5	117.3	651.3	127.3	3498.4	217.7	1928.1	201.9	1018.0	849.7	442.4	788.5	84.8	81.1	144.0	41.0	283.1	62.2	86.1	79.2	388.4	73.7	24.1	82.6	142.3	80.5	1219.0	238.0	8.0	393.6	1988.7	39012.3	148.5	636.2	2340.8	78.6	140.1	1252.6	82.9	83.3	26.3	138.9	16773.7	21.2	1630.1	454.9	79.8	375.4	291.2	213.9	33.6	335.4	893.3	129.3	2309.6	934.4	983.0	667.9	12.2	24.2	0.4	213.0	1289.0	144.6	9.2	3.7	291.2	457.0	716.2	10.8	9.1	1054.1	11.8	540.2	2.3	102.7	1067.7	44.9	738.8	0.4	1399.1	235.7	25.3	5.6	0.8	1052.1	15.3	2.7	29.1	269.6	1.5	17.0	18.5	391.5	3.0	31.1	7.2	3.8	13.3	470.0	7.9	18.2	273.8	6.8	27.7	30.0	16.5	585.7	11.6	730.6	0.6	2.7	2.9	34.0	6.5	29.2	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.4	0.2	0.0	398.6	0.0	2.1	88.0	89.8	92.5	117.3	84.8	81.1	86.1	79.2	80.5	78.6	83.3	79.8	110.0	3.2	4.1	10.4	5.9	57.1	81.2	274.1	24.5	0.8	29.9	1066.2	619.5	4.3	42.1	7.3	0.0	12.1	116.7	1.4	0.0	21.4	4.3	20.3	488.3	80.3	2.4	4.0	2.5	5.7	104.8	332.6	99.4	18.7	2.5	142.0	181.3	1.4	32.4	1.7	4.6	1.9	48.8	3.1	77.9	32.4	283.0	24.2	67.6	9.4	6.5	11.7	1.0	3.0	0.4	8.4	0.1	2072.1	2.9	169.8	0.4	1.3	23.5	0.9	2222.0	594.8	2341.4	2.5	27.3	6.7	42.8	14.6	16.0	106.7	2.8	28.7
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	13	"skeletal muscle: 8905.8;tongue: 6106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	140.7	103.2	95.0	233.2	104.1	590.1	97.1	83.3	116.2	94.9	73.3	199.0	163.5	69.6	73.4	287.4	100.6	136.1	318.5	104.8	101.5	81.5	114.4	178.7	287.3	96.6	101.4	45.4	265.9	91.7	19.6	141.1	101.6	122.3	201.5	60.3	101.5	56.0	8905.8	103.0	167.8	111.6	94.6	208.9	152.8	64.8	93.8	203.0	88.8	6106.5	287.2	183.2	29.7	98.2	529.4	332.8	306.1	225.4	262.1	341.1	317.9	439.0	419.1	597.9	437.7	596.1	513.9	414.6	366.9	500.2	206.4	472.1	320.0	468.7	485.8	315.7	171.9	537.6	234.1	311.7	200.9	728.2	627.5	260.0	246.2	515.8	355.1	224.9	929.4	269.0	411.8	429.7	710.0	342.2	582.0	683.1	714.2	775.9	515.9	510.0	233.2	574.9	405.6	387.4	234.4	409.4	360.0	443.7	419.2	303.9	645.0	788.9	758.8	558.8	353.9	497.3	711.1	332.4	623.0	516.2	490.7	514.7	860.0	932.1	743.2	1729.3	547.2	945.6	480.1	395.2	464.0	504.4	792.6	324.5	347.2	442.6	824.3	386.4	1104.4	392.9	551.5	2029.4	95.0	104.1	83.3	116.2	104.8	101.5	96.6	101.4	101.6	94.6	93.8	98.2	346.0	621.8	343.2	17.6	318.6	149.5	227.6	169.5	127.5	84.2	135.4	88.4	85.0	125.8	275.6	97.5	31.3	127.3	475.7	494.5	105.7	292.1	72.3	353.7	191.1	395.7	141.0	189.8	65.7	347.0	331.0	170.4	245.6	474.2	531.3	119.5	200.3	110.6	559.1	304.5	50.5	291.2	93.6	355.6	504.7	182.3	46.6	648.3	152.9	31.9	704.0	54.5	466.5	12.5	30.6	530.4	363.9	29.7	218.2	204.8	220.1	179.8	230.8	62.8	19.7	155.1	128.5	38.6	67.6	223.6	143.3	101.9	422.6	119.2	302.1	324.6
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103002	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 2111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		370000000	"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	324.1	109.9	24.7	186.3	26.3	33.8	269.0	42.1	40.4	342.4	23.4	255.0	64.6	455.0	10.6	401.8	310.0	144.8	189.6	23.2	27.0	168.1	54.1	374.1	78.2	30.7	28.7	293.8	77.9	23.6	93.4	170.7	31.9	212.1	39.2	3.6	267.2	140.4	50.3	241.4	153.8	190.4	29.1	244.1	201.4	66.2	36.6	32.4	119.4	19.3	68.5	287.5	333.8	27.8	614.5	275.2	194.7	190.9	701.3	728.2	725.6	1082.9	470.3	356.4	357.7	325.5	473.5	31.1	724.2	492.9	383.9	331.6	72.9	386.7	141.6	503.8	138.8	305.4	270.2	232.3	357.0	52.3	728.3	715.2	94.0	327.6	331.1	353.2	427.2	115.7	46.2	217.9	360.8	290.2	152.4	233.0	227.1	461.2	380.4	201.4	413.2	143.4	87.3	387.9	75.3	315.3	670.4	155.5	298.8	90.6	5.3	60.8	1237.2	954.1	166.8	2111.0	875.3	82.4	167.3	142.5	651.4	144.5	337.0	130.8	81.4	5.9	96.0	93.9	71.4	59.6	69.0	84.3	96.6	53.0	18.6	47.2	82.1	75.2	50.4	76.8	151.0	158.4	24.7	26.3	42.1	40.4	23.2	27.0	30.7	28.7	31.9	29.1	36.6	27.8	389.4	400.6	156.6	9.4	148.6	431.1	1297.2	175.2	273.8	45.9	194.3	189.4	49.1	120.1	297.0	242.8	10.4	263.5	205.6	298.4	13.7	717.1	67.3	159.0	506.6	425.5	94.0	33.4	23.8	571.6	852.9	345.1	303.7	305.0	249.6	170.8	288.8	4.2	336.8	5.0	19.0	215.8	101.7	112.0	368.8	54.8	173.1	433.2	142.3	26.2	249.5	7.5	132.8	13.6	48.5	1017.2	258.8	547.2	310.9	900.2	61.2	29.0	133.1	11.7	335.2	170.0	516.6	29.5	10.1	328.2	343.8	568.9	192.0	222.3	162.7	1025.0
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155077	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 76.4;liver: 68.8;thyroid gland: 76.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Proximal tubular cells: 307.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA		39000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.8	16.4	9.2	12.9	12.2	10.0	10.0	10.5	12.2	7.7	9.6	34.5	34.5	6.9	17.5	10.3	7.0	10.4	12.2	10.4	9.7	76.4	68.8	9.3	10.0	9.8	9.7	4.5	11.6	18.0	7.5	5.6	9.9	10.8	35.1	13.1	12.1	6.6	13.2	10.3	28.9	10.5	9.3	11.0	12.2	6.7	9.9	9.2	76.9	11.7	10.1	15.9	7.4	9.8	24.5	7.3	7.9	19.9	12.9	24.9	19.5	27.7	30.8	23.3	36.2	17.1	5.9	3.1	20.3	37.0	18.0	12.0	11.3	20.0	38.6	16.2	16.2	20.0	12.0	25.2	14.1	9.3	17.4	14.5	21.2	26.0	16.5	15.1	32.9	13.5	40.6	5.6	17.2	11.1	9.6	12.7	13.2	33.9	20.7	11.9	19.6	13.8	27.2	24.8	13.0	10.0	18.3	31.9	36.9	19.9	22.9	9.0	14.0	53.1	10.3	28.0	40.0	8.1	38.9	8.0	19.0	12.3	54.5	8.7	22.1	7.2	11.6	46.7	14.9	2.7	9.2	11.1	32.3	2.6	8.1	11.2	2.2	10.4	40.7	6.5	16.2	17.2	9.2	12.2	10.5	12.2	10.4	9.7	9.8	9.7	9.9	9.3	9.9	9.8	13.9	16.0	15.5	4.6	12.6	42.7	41.3	23.0	13.6	15.3	20.9	15.0	22.9	25.8	15.8	35.0	22.9	20.7	20.5	144.6	115.4	52.7	1.2	38.4	15.3	14.3	24.0	18.1	18.7	37.4	25.3	11.3	14.8	39.4	22.9	4.3	17.5	86.5	44.9	6.7	13.2	34.8	22.4	48.5	60.9	2.8	4.1	41.1	24.9	9.4	32.6	33.5	29.9	11.1	10.2	76.8	106.6	10.1	9.7	38.8	80.8	307.6	12.2	19.5	0.0	9.3	13.9	0.7	7.7	19.5	34.5	17.5	21.1	9.5	50.7	78.9
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374066-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	70	"thyroid gland: 1588.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.5;Early spermatids: 4.2;Endothelial cells: 12.6;Late spermatids: 7.5;Peritubular cells: 3.8"	"Cancer enriched"	"Detected in some"	364	"thyroid cancer: 188.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.9;RPMI-8226: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007987, CAB009587"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB009587: , HPA007987: AB_1080270"	"unprognostic (1.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.98e-3)"	"unprognostic (7.10e-3)"	13.1	0.3	0.1	0.4	0.0	0.1	11.0	0.0	0.6	0.1	0.0	4.6	0.6	0.6	0.0	2.0	0.7	3.0	11.5	0.1	0.2	0.2	0.6	0.8	1.4	0.2	0.1	0.3	2.3	0.3	0.6	0.0	0.1	0.6	0.9	0.2	3.4	0.0	6.0	1.8	3.8	0.6	0.1	22.8	2.8	1.2	0.2	0.0	1588.2	5.6	0.4	2.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.4	24.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.0	0.2	12.6	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	1.1	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.8	0.3	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.1
TPP1	"CLN2, LPIC, SCAR7, TPP-1"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612768-6619448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		9500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	74.7	145.9	71.0	74.6	81.0	111.7	44.3	80.3	81.4	53.8	120.1	59.1	59.9	74.0	43.1	39.5	47.1	65.1	56.3	70.6	78.4	71.6	92.7	81.5	77.7	85.2	82.6	49.7	36.2	54.2	63.6	94.2	81.0	38.9	59.7	48.5	42.5	57.5	31.4	39.5	73.3	92.0	74.7	135.0	48.4	20.0	83.3	47.4	45.7	39.0	60.9	68.4	42.8	90.4	26.1	48.1	25.9	50.5	309.9	160.1	21.8	50.9	220.7	36.9	62.0	20.1	122.5	37.4	32.6	136.6	220.2	85.8	48.3	68.7	57.9	37.3	27.6	32.2	23.8	54.9	210.9	45.8	182.6	231.8	104.5	45.9	102.6	240.4	158.8	32.9	59.8	124.6	110.4	30.2	16.6	52.4	18.0	61.5	57.1	36.1	21.6	77.0	62.8	38.2	4.5	20.4	52.6	44.6	91.0	76.5	30.8	79.7	188.0	119.7	33.1	101.1	19.8	92.3	95.3	14.0	139.8	101.7	64.5	67.0	167.1	38.2	39.9	171.2	30.0	35.1	31.4	41.0	185.9	37.0	20.1	27.2	27.5	29.1	125.1	93.1	60.3	138.8	71.0	81.0	80.3	81.4	70.6	78.4	85.2	82.6	81.0	74.7	83.3	90.4	32.0	25.6	37.3	31.6	53.0	23.7	28.4	29.8	13.1	24.8	21.1	23.9	41.8	50.1	26.8	16.5	12.5	35.4	71.0	55.2	5.9	42.2	11.8	13.3	30.2	40.7	16.7	37.5	12.5	13.4	45.3	40.3	16.3	24.8	62.2	25.6	75.7	81.0	261.6	15.2	12.4	31.3	26.4	376.5	126.5	11.2	27.1	219.8	90.7	15.9	156.0	37.9	49.4	8.0	21.9	17.4	44.1	26.4	26.4	23.5	99.7	51.6	14.5	23.8	6.6	19.0	20.3	0.8	1.1	27.6	20.0	88.0	42.2	24.6	32.5	26.5
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693352	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 185.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.8	6.6	100.8	0.7	136.7	0.2	2.5	55.3	120.4	1.8	0.0	12.8	5.2	3.3	0.5	11.0	10.4	1.7	9.8	112.3	69.9	4.4	2.7	10.2	0.3	110.3	102.3	1.8	6.0	2.1	19.5	2.2	107.7	2.3	1.8	6.3	5.7	3.6	10.5	8.2	9.5	3.6	47.5	2.6	4.9	2.2	124.6	0.4	6.9	5.3	1.4	6.8	2.7	185.2	0.2	7.4	0.3	5.4	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.5	0.0	1.9	2.9	2.9	0.0	0.0	1.5	2.5	0.2	3.6	0.2	0.8	0.2	0.3	0.0	0.7	0.0	0.1	0.2	0.0	0.1	0.1	2.7	0.0	0.2	0.2	0.5	0.2	0.8	0.7	0.3	0.1	1.0	0.2	1.0	13.2	1.6	0.8	0.3	3.6	0.3	0.7	0.2	0.1	0.2	2.7	0.0	0.2	1.0	0.2	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	100.8	136.7	55.3	120.4	112.3	69.9	110.3	102.3	107.7	47.5	124.6	185.2	1.6	38.5	10.0	6.8	0.7	4.1	1.4	0.6	9.6	21.3	3.1	2.4	18.4	2.8	5.3	1.8	0.0	0.0	1.1	5.7	1.9	2.4	9.1	26.6	0.9	2.0	10.2	0.0	45.2	0.7	0.3	3.3	3.1	5.8	4.5	0.1	2.2	4.3	3.3	42.1	32.6	6.5	0.0	0.0	2.2	7.2	0.3	1.2	1.8	4.7	0.1	0.9	0.0	6.6	104.7	0.7	5.2	0.4	3.3	0.8	10.3	1.1	13.5	2.4	0.0	1.5	4.2	2.2	0.8	6.7	3.1	0.0	4.8	0.1	4.8	4.1
TPPP2	"C14orf8, CT152, p18, p25beta"	ENSG00000179636	"Tubulin polymerization promoting protein family member 2"	P59282	14	21024109-21036276	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 254.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 9161.6"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004120	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA004120: AB_2303582"	"unprognostic (2.91e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.54e-1)"		"unprognostic (1.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.63e-4)"		"unprognostic (3.83e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.64e-4)"	"unprognostic (2.51e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.21e-1)"	0.1	0.4	0.8	0.1	0.9	0.0	0.5	0.8	1.1	0.2	1.3	0.1	0.1	0.2	3.4	0.0	0.2	0.3	0.6	0.8	0.8	0.9	13.3	0.1	0.0	0.9	0.8	0.8	0.2	0.2	0.1	0.0	0.9	0.4	0.3	0.3	1.4	0.2	3.2	0.1	0.3	0.0	0.9	0.1	0.1	254.8	0.9	0.0	0.1	4.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.8	1.1	0.8	0.8	0.9	0.8	0.9	0.9	0.9	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	1897.4	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9161.6	47.5	2.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	52.0	30.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TPRA1	"FLJ32197, GPR175, TMEM227, TPRA40"	ENSG00000163870	"Transmembrane protein adipocyte associated 1"	Q86W33	3	127571232-127598267	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 179.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019784	Approved		Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA019784: AB_2670266"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.91e-3)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.28e-2)"	23.9	29.7	22.4	11.7	23.3	26.5	24.5	23.4	26.2	35.8	25.9	25.8	16.9	28.8	12.5	26.4	28.1	16.5	24.7	22.3	23.3	26.8	37.0	24.9	13.9	22.9	23.4	27.8	26.7	29.0	21.7	20.8	23.0	28.8	11.3	8.0	26.4	16.2	26.8	42.9	21.2	17.2	22.7	25.0	25.8	16.3	24.2	11.5	27.0	19.8	13.0	28.5	28.8	22.7	40.0	31.2	12.9	27.3	51.4	28.6	42.1	20.5	34.2	24.7	22.2	22.1	30.9	36.7	37.6	38.4	77.2	43.6	22.6	34.8	12.9	20.0	15.0	21.4	46.0	20.7	56.6	13.3	44.7	28.8	28.8	16.4	42.8	51.2	18.0	24.5	14.0	36.7	30.4	39.8	18.5	43.4	19.3	25.5	23.4	31.9	17.0	37.0	29.6	19.1	24.6	9.5	37.7	57.7	35.1	10.4	27.3	42.3	28.7	29.6	13.1	60.0	13.2	25.0	21.0	34.4	31.9	38.8	22.4	3.8	12.9	11.5	6.4	9.4	8.6	6.6	7.4	9.5	12.7	6.4	5.6	6.8	7.0	6.6	8.4	9.7	7.2	6.5	22.4	23.3	23.4	26.2	22.3	23.3	22.9	23.4	23.0	22.7	24.2	22.7	15.7	22.4	7.0	13.1	11.7	50.0	20.5	18.8	24.5	7.8	16.3	17.9	11.8	11.5	16.5	25.8	4.2	56.9	8.4	18.2	5.9	29.1	2.7	23.5	18.0	22.8	17.4	46.5	9.3	19.6	43.3	22.9	17.9	27.5	17.8	13.9	21.8	21.7	32.9	5.0	9.7	18.7	18.3	16.0	179.7	2.4	33.5	32.0	30.2	5.6	52.3	11.2	20.6	6.6	8.1	31.4	17.6	19.5	17.9	37.5	37.5	13.1	12.4	8.9	13.1	13.2	18.3	8.4	17.9	19.1	54.4	68.1	12.6	12.7	20.7	23.5
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.6;vagina: 32.3"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.6	1.9	0.5	1.8	0.6	0.0	23.3	0.6	0.7	23.3	3.5	0.5	0.3	3.0	2.8	50.6	8.4	2.9	2.0	0.4	0.7	0.4	9.0	4.4	0.9	2.2	0.7	2.2	0.6	0.1	0.2	1.2	1.0	1.2	0.3	0.4	6.1	1.3	9.1	25.1	0.7	3.0	0.6	0.7	0.5	4.8	3.6	1.5	1.3	0.4	9.0	1.0	32.3	2.0	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.5	0.6	0.6	0.7	0.4	0.7	2.2	0.7	1.0	0.6	3.6	2.0	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TPRKB	"CGI-121, CGI121"	ENSG00000144034	"TP53RK binding protein"	Q9Y3C4	2	73729104-73737400	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035712	Approved		Supported	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA035712: AB_10669674"	"unprognostic (1.11e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.21e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.10e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.68e-3)"	"unprognostic (5.66e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.03e-2)"	22.7	23.1	11.8	22.3	12.3	70.2	42.7	14.5	17.2	32.7	12.6	36.5	38.7	30.2	35.8	31.0	54.9	20.2	34.0	12.0	12.5	35.5	39.2	17.3	37.0	12.7	12.2	36.1	26.7	18.5	12.7	22.6	12.7	25.0	33.9	16.1	31.1	19.0	68.1	25.7	35.5	29.1	12.7	22.3	24.9	51.8	12.1	37.0	21.3	50.9	33.7	26.3	25.2	13.1	106.1	73.3	73.4	85.5	27.2	37.6	62.2	73.5	40.0	72.2	54.2	110.8	66.0	67.0	54.0	38.2	130.7	62.6	60.6	77.6	116.0	53.4	79.2	135.7	49.8	90.6	26.6	198.3	72.8	27.2	43.6	76.4	76.3	37.4	76.9	114.7	119.8	105.1	75.5	56.4	142.5	130.6	94.9	130.5	93.9	83.6	211.6	93.8	67.2	89.8	69.1	83.1	53.1	79.5	105.6	59.8	58.7	78.6	48.5	62.4	104.7	113.6	182.6	69.1	127.6	176.9	55.9	131.2	78.4	32.5	18.2	29.1	16.5	28.5	26.4	23.9	23.6	22.3	22.1	20.9	27.0	25.5	13.1	24.6	21.5	30.1	25.4	15.8	11.8	12.3	14.5	17.2	12.0	12.5	12.7	12.2	12.7	12.7	12.1	13.1	56.3	32.1	39.8	7.2	43.1	53.2	66.8	123.0	38.7	15.0	51.8	94.9	63.5	50.1	70.6	22.0	4.2	81.3	39.7	64.0	88.0	95.4	138.9	50.2	42.7	81.9	33.6	62.1	8.6	184.9	107.9	45.1	17.9	43.4	48.7	51.3	148.2	44.3	86.7	8.4	8.7	71.2	71.2	55.6	60.0	28.9	59.0	52.1	33.8	2.8	65.0	36.6	64.9	10.1	8.3	110.7	76.9	52.3	35.6	47.8	103.4	154.9	54.4	21.8	52.6	61.7	46.2	259.3	87.8	44.8	53.0	45.6	42.8	53.9	85.4	58.2
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;pancreas: 91.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 177.7;Proximal enterocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 61.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 23.6"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.7	5.1	24.3	4.4	37.8	2.7	4.8	29.9	33.1	5.2	15.1	25.4	22.0	4.7	0.9	20.5	5.1	3.2	10.7	23.5	23.7	19.1	24.3	8.1	2.4	33.1	32.4	6.4	91.4	2.5	6.0	3.3	28.2	8.0	6.9	1.7	11.8	3.4	6.2	15.6	26.0	1.5	20.8	5.0	29.3	9.3	31.9	2.0	5.5	3.1	1.5	7.8	6.9	56.4	10.2	11.4	3.8	17.0	5.2	5.5	30.1	7.0	4.3	7.0	3.9	38.5	12.1	18.6	10.1	3.6	9.2	30.4	7.9	3.9	0.9	11.9	11.1	8.7	17.5	25.5	7.9	13.5	10.8	4.7	7.5	6.2	4.3	4.6	4.5	8.2	16.1	6.4	2.1	61.9	8.9	29.0	13.5	55.5	14.8	26.3	9.1	28.4	15.9	21.0	24.4	8.9	10.8	49.6	13.0	2.9	57.8	21.0	5.0	12.7	6.0	20.1	15.1	5.3	11.0	9.7	9.1	12.1	7.2	0.0	0.8	0.0	0.3	0.8	0.1	0.3	0.3	0.5	0.6	0.3	0.1	0.3	0.0	0.8	0.4	0.6	0.6	0.2	24.3	37.8	29.9	33.1	23.5	23.7	33.1	32.4	28.2	20.8	31.9	56.4	4.6	19.2	5.5	6.2	3.5	1.8	1.3	2.6	2.2	19.3	13.2	9.5	7.6	15.7	2.6	16.5	6.2	5.4	8.4	177.7	7.9	8.0	3.1	7.6	4.1	2.9	9.0	7.4	3.3	45.4	1.3	3.0	15.3	9.6	1.3	8.7	3.9	19.5	3.6	11.8	3.8	46.0	6.1	2.8	1.6	5.3	3.4	5.2	5.4	1.0	2.8	12.4	1.0	2.5	30.4	15.3	39.7	4.5	1.9	3.3	95.9	20.0	2.3	7.3	6.6	3.2	4.5	2.7	4.4	5.8	2.8	1.9	4.5	10.3	36.7	1.7
TPRX1	FLJ40321	ENSG00000178928	"Tetrapeptide repeat homeobox 1"	Q8N7U7	19	47801243-47819051	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 1.1;testis: 1.2"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 1.9;Spermatocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044922	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044922: AB_10962509"															"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	96.6	2.9	0.3	23.6	0.5	2.4	47.2	0.3	0.9	53.7	0.9	83.0	71.6	73.3	6.0	64.3	26.6	129.7	14.7	0.4	0.4	13.9	12.2	128.5	21.3	0.4	0.3	3.2	18.9	2.3	3.5	1.2	0.6	65.9	34.6	0.0	60.2	22.5	10.1	122.7	148.7	17.9	0.4	5.9	104.0	8.9	0.4	14.2	4.7	13.0	13.2	113.5	52.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.9	0.4	0.4	0.4	0.3	0.6	0.4	0.4	0.3	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2"	P20231	16	1227272-1230184	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	25	"granulocytes: 8966.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	50	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 297.5"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		16000000	"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	95.1	2.5	0.3	20.2	0.6	4.3	47.8	0.3	0.9	53.2	1.0	77.8	35.5	71.8	9.8	64.6	30.4	103.9	15.0	0.5	0.5	15.5	12.2	127.8	26.2	0.5	0.4	3.5	18.9	1.5	3.9	1.3	0.5	67.0	19.8	0.0	64.5	13.3	10.0	122.5	146.1	22.0	0.5	5.2	102.1	9.9	0.5	4.9	4.7	10.4	9.9	118.6	53.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.2	0.4	297.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	4.7	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.9	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.3	0.1	38.5	275.3	0.0	2.8	0.0	4.4	0.0	0.0	0.0	1.5	0.0	1.5	0.0	16.7	0.0	0.0	0.1	0.6	0.7	0.0	2.4	0.6	0.0	0.0	3.2	0.0	18.9	0.0	0.0	0.2	6.0	2.0	0.0	8966.1	0.0	0.0	0.0	3.8	0.0	0.1	0.7	0.0	0.0	0.0	1.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.8	5.4	0.7	0.1	3.6	0.0	0.0	0.4	1.1	0.0	0.7	0.0	0.0	0.1	345.1	0.0	1.0	6.1
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1259008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.2"	"Cell type enriched"	"Detected in some"	19	"granulocytes: 202.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	29	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	49	"HEL: 28.2;HMC-1: 40.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	8.0	0.5	1.2	1.9	1.3	1.6	4.5	1.3	2.7	5.1	1.0	7.8	3.8	8.5	1.9	8.1	3.2	13.8	1.1	1.4	1.1	1.2	0.7	17.8	5.4	1.4	1.3	0.3	1.5	0.1	0.4	0.1	1.5	5.5	0.8	0.1	4.8	1.2	1.4	9.5	13.4	5.4	1.1	0.4	21.2	1.3	1.4	1.2	0.3	1.0	2.3	13.3	5.0	1.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.2	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	2.7	1.4	1.1	1.4	1.3	1.5	1.1	1.4	1.2	0.0	3.2	7.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.2	0.0	0.0	202.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 14.7"	"Cell type enriched"	"Detected in some"	6	"Intestinal goblet cells: 278.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HMC-1: 23.2;MCF7: 7.9"	"Not detected"	"Not detected"							HPA060458	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA060458: AB_2684283"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	0.7	1.0	0.4	1.4	1.6	0.0	3.2	0.0	0.4	0.7	0.0	14.7	14.1	1.3	0.1	0.8	0.7	1.0	0.3	0.2	0.4	1.2	0.4	0.8	0.0	0.1	0.1	2.1	0.2	0.0	3.1	0.0	0.3	1.1	9.0	0.1	0.3	0.2	0.2	1.2	9.3	0.3	0.1	0.0	1.1	1.6	0.5	0.0	0.1	0.0	0.0	1.8	0.8	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.4	0.2	0.4	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.0	0.0	0.4	0.0	0.0	0.0	278.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.3	0.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	4.7	0.0
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205317-66420543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 76.5;Excitatory neurons: 101.9;Inhibitory neurons: 107.1;Spermatocytes: 97.1"	"Cancer enhanced"	"Detected in all"		"glioma: 36.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 52.2;neutrophil: 35.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: AB_2732672"	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavorable (8.16e-6)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.73e-5)"	16.9	15.8	22.1	10.8	20.5	6.0	13.4	18.4	21.6	35.4	12.3	11.1	3.2	21.8	14.3	10.8	11.2	38.1	8.5	19.4	36.7	23.1	46.0	11.5	5.9	37.2	25.0	13.5	7.8	11.0	19.5	26.4	24.7	15.1	8.0	5.2	6.8	16.4	2.7	8.2	8.7	16.2	22.9	12.0	10.9	23.0	33.8	2.1	11.3	5.6	5.3	36.8	22.1	22.5	12.1	6.5	16.5	22.4	52.7	42.0	5.7	22.3	49.8	25.7	37.1	21.9	6.6	1.4	17.7	45.1	38.9	8.9	16.2	24.8	33.3	3.5	9.3	2.3	15.1	16.5	62.3	1.8	1.9	59.5	19.0	50.2	22.1	27.8	32.7	2.9	1.0	10.2	40.2	6.2	0.1	3.1	15.5	0.4	9.6	7.8	14.6	11.4	27.3	11.5	10.4	44.5	27.8	2.1	62.2	32.4	8.6	4.7	62.3	33.1	21.3	24.2	40.6	9.2	13.3	4.7	29.6	6.8	48.2	52.2	2.3	23.9	0.8	0.1	0.8	6.1	0.5	0.6	0.3	14.0	2.2	4.1	35.2	8.8	0.0	0.0	0.0	1.9	22.1	20.5	18.4	21.6	19.4	36.7	37.2	25.0	24.7	22.9	33.8	22.5	33.8	0.0	8.9	38.8	11.5	10.8	7.7	24.4	33.6	8.5	4.0	13.3	1.6	5.7	9.6	31.3	2.1	1.8	3.8	0.2	9.8	23.0	11.2	13.3	76.5	17.9	7.7	1.3	101.9	47.6	4.3	58.5	12.2	9.7	4.5	12.2	10.0	34.1	16.2	6.7	107.1	0.8	8.2	8.9	8.9	11.6	48.1	6.2	14.2	32.8	15.8	5.0	1.0	61.3	38.8	23.7	0.1	37.2	7.1	5.3	0.0	3.2	19.5	3.6	6.6	16.4	21.6	97.1	41.3	15.1	7.5	3.8	2.8	12.6	0.7	7.7
TPST2	TANGO13B	ENSG00000128294	"Tyrosylprotein sulfotransferase 2"	O60704	22	26521996-26596717	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 398.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.0;NK-cells: 263.7;Plasma cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021054	Enhanced				"Intracellular and membrane"	NA	NA		88000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA021054: AB_1858221"	"unprognostic (2.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.08e-5)"	"unprognostic (8.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (9.68e-2)"	"unprognostic (9.21e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	24.4	31.0	24.4	15.2	20.8	23.1	21.8	19.1	29.9	17.4	26.9	11.5	13.6	18.0	111.6	18.7	17.0	12.2	27.5	23.4	22.9	24.9	74.9	45.7	19.1	22.0	24.2	9.2	398.8	5.3	9.9	41.8	20.8	16.0	8.8	3.3	10.9	17.8	38.5	18.4	13.4	12.1	23.1	36.4	11.7	20.6	34.2	10.7	38.8	22.6	17.0	17.1	17.3	20.7	12.8	9.1	11.7	6.0	24.4	18.7	16.4	27.9	49.9	22.2	20.3	6.2	6.5	21.4	7.3	50.4	11.6	19.5	8.8	19.2	12.7	8.8	16.9	51.8	5.6	13.1	10.2	6.0	158.7	20.1	30.3	22.5	7.7	22.5	41.6	9.6	52.6	65.2	17.2	14.3	24.3	40.7	15.4	10.0	9.1	22.5	15.8	60.2	6.7	14.3	8.8	6.1	12.9	11.2	16.0	17.0	5.2	24.7	33.2	27.3	61.2	22.5	27.3	20.9	31.5	20.6	20.7	23.1	25.3	490.4	77.0	111.9	249.2	86.3	70.5	23.6	57.0	187.2	48.3	25.6	27.8	163.6	163.0	354.9	94.3	115.3	71.9	240.7	24.4	20.8	19.1	29.9	23.4	22.9	22.0	24.2	20.8	23.1	34.2	20.7	37.3	16.0	12.6	13.7	30.8	38.1	82.5	29.9	14.2	9.0	10.8	13.1	15.5	47.1	14.4	22.0	6.2	171.0	120.8	6.7	27.4	12.9	15.2	31.1	14.8	66.1	0.0	64.6	23.4	65.1	49.8	10.7	5.1	39.5	53.7	13.9	113.6	79.3	123.9	6.7	20.3	9.3	12.2	55.9	48.6	4.5	5.3	70.1	28.4	47.8	32.4	1.9	263.7	5.0	1.9	53.1	8.7	4.1	183.7	36.4	16.5	7.6	18.6	5.3	6.6	9.9	15.3	2.9	13.2	15.1	35.9	143.0	64.4	42.0	11.8	83.7
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341284	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol		NA	NA		1500000	"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB008364: AB_591904, HPA039437: AB_2676508"	"prognostic favorable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.31e-5)"	"unprognostic (6.51e-2)"	5808.9	3790.0	1970.1	2971.0	2089.0	7021.6	4788.5	2017.1	2885.0	4815.0	2151.1	3979.7	3896.8	3466.6	5086.2	4739.6	3764.4	3768.2	4538.7	1920.3	2182.7	4819.1	6862.2	3615.7	5627.2	2141.5	2042.0	6982.0	10645.5	2467.5	2595.3	4390.6	2185.5	3646.9	3385.7	1026.8	8474.6	2254.8	23236.6	3472.5	3896.8	2786.2	2206.2	3281.4	3544.7	821.0	1977.3	3910.4	4425.0	13885.5	4621.3	4859.8	4376.0	2225.8	1905.1	1684.0	2793.7	1836.1	8042.9	11121.9	3311.0	3946.8	6100.9	2460.2	2560.6	3800.8	4814.7	4011.0	3236.5	4125.5	1627.8	3232.7	2281.2	5785.6	3386.6	1869.7	2010.7	3227.6	1369.1	4278.1	8106.1	4451.8	4843.1	9204.7	11563.7	1572.6	9416.5	7957.8	5168.0	3360.7	2443.5	1080.9	5091.4	3449.9	5437.0	10564.3	3194.8	6358.1	1773.3	3370.4	2645.5	3062.6	6392.2	3916.9	1185.4	3165.1	1308.7	4147.6	6396.8	2827.9	2383.4	12710.0	3402.5	1129.5	1605.0	1855.4	2470.9	2644.9	2873.7	3842.4	3013.5	3486.9	899.6	1195.3	1271.4	617.3	1006.6	978.8	1830.5	1337.9	1874.2	1366.7	1138.9	1036.9	1944.6	1636.5	546.5	1513.4	929.3	1454.0	1812.0	3204.4	1970.1	2089.0	2017.1	2885.0	1920.3	2182.7	2141.5	2042.0	2185.5	2206.2	1977.3	2225.8	4176.2	1593.0	3381.6	39.5	4868.3	3494.9	6406.7	2737.1	4501.1	371.9	5018.7	4187.9	2795.4	3154.1	2226.0	763.2	160.6	4470.7	5693.8	3799.1	3144.1	2527.2	1185.2	3111.2	5482.8	3928.3	2068.2	3074.8	44.9	5125.2	6375.7	3310.5	2398.6	5369.5	1842.3	4305.3	5062.0	4784.7	4614.9	213.7	39.1	5716.8	852.4	5939.9	3637.5	1381.9	6800.4	6005.9	1773.4	87.1	6495.9	2240.9	5186.5	25.1	50.5	5271.4	5556.8	3870.4	4453.2	6953.8	11028.2	9311.2	1156.1	656.2	2530.9	5300.1	3028.9	443.5	687.3	5411.6	3479.1	5749.6	5238.7	4437.6	5420.4	9158.8
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 107.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
TPTEP2-CSNK1E		ENSG00000283900	"TPTEP2-CSNK1E readthrough"		22	38291918-38398522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.4;B-cells: 1.8;Breast glandular cells: 1.9;Collecting duct cells: 9.2;Endometrial ciliated cells: 2.0"					"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.0;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"AF22: 5.2;Karpas-707: 9.1;U-266/70: 6.4"									HPA026288	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA026288: AB_1847276"																		2.9	0.5	0.9	0.7	2.0	2.4	2.8	1.0	1.8	2.5	0.7	1.2	0.3	2.5	0.8	1.0	2.8	0.9	2.1	1.1	2.0	1.1	0.7	1.9	0.5	1.3	1.2	1.0	0.6	2.3	1.5	1.1	1.1	1.2	0.3	2.2	1.6	0.6	1.5	1.7	0.9	0.9	1.2	0.9	0.9	1.3	1.4	0.3	1.8	0.9	1.3	1.3	1.4	2.5	0.7	0.0	5.2	0.5	0.8	1.2	0.7	1.5	4.7	0.7	0.7	0.0	0.4	0.0	0.8	1.2	0.7	0.7	0.5	0.7	0.8	3.5	1.4	0.6	2.6	0.2	0.8	1.4	1.1	0.9	2.2	0.2	0.2	3.5	1.5	0.3	0.5	9.1	0.3	0.2	0.0	0.4	0.6	0.0	0.0	1.2	0.8	2.3	0.7	0.0	0.9	0.3	0.2	0.1	1.9	1.5	0.1	0.5	4.3	0.0	0.7	0.1	0.0	6.4	4.8	1.8	1.7	0.5	0.6	0.4	0.2	4.0	0.0	0.0	0.0	0.7	0.3	0.0	0.3	0.3	0.0	0.0	1.1	0.7	0.0	3.5	0.7	0.1	0.9	2.0	1.0	1.8	1.1	2.0	1.3	1.2	1.1	1.2	1.4	2.5	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.0	9.2	0.0	0.0	0.8	0.0	0.0	0.9	0.0	2.0	1.0	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRA2A	"AWMS1, htra-2-alpha"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	35.1	39.1	55.7	37.0	58.2	113.4	32.1	57.4	75.7	47.1	57.9	38.7	26.4	42.8	43.9	47.3	42.7	21.3	30.4	55.3	57.8	45.9	34.9	33.5	47.6	57.2	56.5	53.1	32.6	25.6	40.4	32.9	57.6	41.3	39.2	42.0	33.2	22.1	23.1	42.8	36.8	41.0	56.6	52.8	33.0	30.9	56.8	46.1	35.9	21.3	53.6	37.9	42.9	64.9	57.2	61.2	94.1	148.4	49.1	30.9	60.4	71.4	33.6	70.5	57.4	51.2	76.4	107.4	39.9	53.7	82.3	92.1	115.6	66.9	88.4	64.6	65.7	65.9	67.9	81.8	52.0	78.0	59.2	37.1	44.9	53.1	66.1	62.7	80.9	46.7	129.5	51.0	79.7	55.6	96.5	128.7	84.5	69.5	62.5	106.1	74.8	64.3	81.8	81.0	80.7	65.8	66.0	75.8	49.8	69.1	59.6	85.5	73.8	55.4	79.0	51.0	83.4	56.6	76.1	86.9	47.7	103.8	75.3	16.8	17.1	23.6	24.6	28.8	21.6	17.6	23.3	23.1	20.6	16.1	19.6	23.7	25.4	19.1	27.0	30.0	25.2	10.2	55.7	58.2	57.4	75.7	55.3	57.8	57.2	56.5	57.6	56.6	56.8	64.9	110.6	60.9	72.2	112.3	141.9	104.4	95.6	61.7	94.4	54.5	118.5	74.8	42.5	60.1	60.8	88.3	52.1	83.2	153.3	84.9	25.4	54.8	62.1	155.7	137.1	74.8	118.5	77.5	113.1	43.9	84.6	91.5	89.2	166.7	86.7	62.5	84.6	71.4	54.8	37.0	115.4	100.3	48.8	89.5	125.4	23.7	65.0	88.9	56.9	107.7	71.5	48.1	70.0	203.1	245.1	59.2	92.0	67.7	125.4	97.7	59.7	41.8	71.3	101.8	72.3	119.2	88.2	99.8	65.0	138.6	113.1	117.9	130.4	49.1	112.6	92.1
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185913-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	19.8	20.7	7.1	27.7	6.9	60.9	18.5	10.1	10.6	23.0	5.9	24.1	18.3	16.8	3.8	40.4	18.8	11.0	21.8	7.0	6.2	26.8	40.8	26.0	32.8	8.5	6.7	18.8	72.7	7.6	21.9	8.4	6.6	29.1	6.3	3.2	29.0	9.6	29.3	23.6	30.7	5.3	6.7	36.9	27.5	20.8	7.2	16.6	24.8	5.0	15.7	22.6	27.0	6.8	62.8	40.9	14.5	24.7	7.8	9.0	35.9	21.4	14.0	17.6	14.9	26.2	29.6	38.3	20.5	10.1	13.7	38.6	18.8	38.1	3.5	27.1	87.1	22.5	71.2	46.0	30.5	45.4	42.7	14.6	22.9	12.9	17.7	10.3	17.9	37.3	27.8	61.7	7.6	70.5	32.5	51.2	21.3	21.3	38.0	87.6	19.7	83.0	13.4	61.5	16.8	28.0	18.4	66.2	31.3	6.1	28.0	47.0	19.4	14.6	36.2	19.2	24.4	73.9	14.1	46.7	18.0	31.5	23.5	16.9	30.5	51.4	21.2	26.5	20.3	13.6	19.1	19.5	32.5	6.7	12.6	15.3	40.6	32.1	16.7	68.7	29.5	22.4	7.1	6.9	10.1	10.6	7.0	6.2	8.5	6.7	6.6	6.7	7.2	6.8	22.2	9.6	19.3	12.1	80.3	42.1	57.4	48.9	33.6	32.6	38.8	30.1	12.0	17.2	31.8	33.1	18.8	25.5	151.7	66.2	27.4	52.3	20.7	17.1	25.1	27.2	18.0	17.4	11.6	62.9	54.5	27.2	77.5	32.4	27.3	31.6	12.8	24.0	46.4	43.7	12.9	55.3	46.8	46.9	59.4	8.8	32.3	69.6	42.7	9.4	111.4	22.5	117.4	14.1	15.3	80.6	67.7	32.4	133.1	125.9	55.0	28.9	19.7	32.8	19.7	20.5	23.7	49.9	31.5	34.3	45.6	30.6	84.3	31.2	71.0	92.5
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 42.7;lymphoid tissue: 11.4;ovary: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 575.5;Granulosa cells: 108.7;Late spermatids: 326.8;Undifferentiated cells: 141.9"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 14.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 71.9"	"Lineage enriched"	"Detected in many"	18	"T-cells: 71.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 41.7;HDLM-2: 35.1;HSkMC: 22.3;hTEC/SVTERT24-B: 17.8;SiHa: 17.8"									HPA045817	Approved				"Intracellular and membrane"	NA	NA		18000	"Cluster 32: T-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	2.5	0.4	2.1	8.9	2.1	3.7	2.2	0.3	3.4	0.3	0.3	40.0	4.2	0.2	0.7	0.3	0.8	0.5	0.3	1.9	1.5	0.6	1.0	2.8	11.4	0.3	2.7	26.7	0.1	2.1	0.3	0.9	0.3	0.2	42.7	0.0	0.5	0.1	0.1	1.0	10.7	2.8	0.4	3.8	1.1	0.4	3.8	8.1	0.4	0.6	7.8	0.7	0.4	1.6	1.3	1.1	0.4	0.2	12.4	13.4	41.7	2.0	3.3	5.8	10.8	0.5	4.7	0.0	0.5	6.5	10.8	0.0	2.8	0.6	8.6	35.1	0.7	0.0	8.4	0.0	1.5	0.1	0.0	22.3	0.0	17.8	8.1	1.3	0.0	0.3	0.0	0.1	0.8	0.0	0.1	0.1	1.1	2.3	0.9	0.3	0.7	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.2	0.3	0.0	0.2	0.3	5.8	0.8	0.0	2.1	4.0	0.0	0.1	5.3	3.5	0.0	0.0	0.3	0.0	8.5	0.3	10.5	0.7	33.6	12.4	1.8	3.9	71.9	46.1	1.3	3.9	0.2	1.6	23.5	13.2	2.1	2.1	0.3	3.4	1.9	1.5	0.3	2.7	0.3	0.4	3.8	1.6	9.0	3.2	11.0	0.0	7.8	1.0	0.6	0.6	0.0	1.1	1.4	0.4	85.4	0.0	0.9	0.0	0.0	9.4	4.6	51.1	0.0	0.1	575.5	4.3	0.6	7.5	12.7	0.8	10.6	0.9	41.5	6.1	2.6	1.9	2.5	108.7	2.2	0.1	2.6	0.0	0.7	67.9	0.0	1.3	6.6	326.8	5.0	4.6	3.6	3.7	12.6	0.0	3.1	1.0	0.7	0.6	73.8	2.6	5.4	0.5	17.4	1.2	1.7	0.1	6.6	0.9	7.3	3.5	5.6	0.4	0.6	4.4	29.7	0.2	141.9	0.5
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47997385	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.5;Cholangiocytes: 15.7;Fibroblasts: 6.6;Hepatocytes: 11.3;Microglial cells: 7.5;Proximal tubular cells: 22.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 6.7;U-2197: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		41000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	2.3	0.9	0.1	0.6	0.2	0.0	2.7	1.0	0.3	2.8	0.5	2.9	0.4	1.5	0.8	1.3	1.9	1.6	7.0	0.1	0.0	16.6	4.2	1.7	0.0	0.1	0.2	0.8	2.6	0.0	1.5	0.4	0.2	3.6	0.7	0.0	1.6	3.3	0.6	1.6	1.6	0.9	0.1	1.2	1.6	0.9	0.1	0.4	1.0	0.6	0.1	3.8	2.6	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	6.7	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	1.6	0.0	0.5	0.3	0.3	0.8	1.4	0.6	2.8	0.0	0.6	2.9	7.5	15.7	0.1	1.8	0.0	0.0	0.0	0.0	5.9	3.8	0.1	0.1	0.5	1.9	0.0	0.0	0.3	2.2	0.0	6.6	0.0	0.1	0.0	0.0	1.4	11.3	0.1	0.0	0.3	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	7.5	0.0	0.0	0.0	0.5	0.7	1.3	0.0	2.2	0.1	0.4	0.0	22.8	0.0	0.0	0.0	0.3	4.1	0.0	4.0	0.1	0.3	0.0	0.2	0.1	0.0	0.2
TRADD	Hs.89862	ENSG00000102871	"TNFRSF1A associated via death domain"	Q15628	16	67154185-67159909	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004602, HPA071341"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB004602: AB_2209061, HPA071341: AB_2732178"	"unprognostic (2.66e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (1.40e-4)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.83e-1)"	15.4	19.4	9.5	12.8	10.5	4.9	15.6	10.9	10.2	17.8	10.8	17.4	8.4	14.2	3.7	26.9	16.6	4.1	11.2	9.9	8.8	22.2	18.4	17.6	12.4	13.2	10.0	10.5	17.8	7.0	12.1	6.7	12.4	21.2	5.6	1.1	23.8	6.2	6.3	22.5	19.2	4.9	11.3	29.9	19.1	5.0	10.1	7.4	18.1	2.1	10.6	18.2	17.9	12.0	17.3	14.0	0.2	4.8	12.6	10.0	16.8	12.6	9.5	6.0	9.3	8.2	13.0	9.0	21.8	11.0	12.6	29.0	2.0	11.4	4.9	26.1	12.8	5.7	6.4	9.0	15.7	7.3	13.7	10.5	16.0	8.0	3.1	15.3	11.8	8.7	8.4	13.1	9.1	15.5	8.8	14.5	0.2	16.0	42.2	17.1	6.6	36.4	10.4	10.9	2.2	8.1	28.6	6.4	9.0	4.7	11.0	10.3	13.2	7.5	8.2	13.3	9.5	26.3	9.4	10.6	19.9	6.5	9.4	51.9	42.4	95.1	54.4	56.2	84.2	72.0	166.0	96.2	54.2	71.8	46.7	38.5	75.7	40.7	78.6	76.4	82.1	49.5	9.5	10.5	10.9	10.2	9.9	8.8	13.2	10.0	12.4	11.3	10.1	12.0	24.0	3.2	8.6	3.9	37.7	17.3	22.9	60.2	12.5	0.9	29.8	25.0	3.5	30.0	32.8	5.5	0.0	32.0	47.9	24.9	31.3	70.0	1.4	31.0	18.1	20.5	19.2	9.9	1.8	38.1	41.5	22.3	44.9	27.6	8.9	25.9	17.2	19.2	47.0	0.0	2.4	28.2	38.7	37.7	35.0	2.9	30.1	28.6	56.9	0.0	163.4	5.0	48.4	1.0	8.3	62.0	35.7	30.5	52.5	57.7	28.1	80.3	40.7	2.1	26.3	16.0	21.9	2.2	7.6	29.7	25.7	30.5	46.7	23.3	23.8	42.1
TRAF1	EBI6	ENSG00000056558	"TNF receptor associated factor 1"	Q13077	9	120902393-120929173	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Langerhans cells: 319.7;monocytes: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Group enriched"	"Detected in many"	6	"HDLM-2: 92.5;WM-115: 113.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001852, CAB009593"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB009593: , HPA001852: AB_1080344"	"unprognostic (1.45e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.19e-5)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.42e-5)"	"unprognostic (1.85e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.87e-3)"	7.0	9.9	8.0	20.8	11.1	8.9	6.7	7.7	9.4	8.6	7.0	8.8	3.5	6.2	4.6	5.7	9.6	7.5	9.0	7.7	8.0	9.5	6.3	9.4	33.5	9.4	9.2	12.1	4.8	2.9	12.4	2.8	8.5	11.8	4.1	10.8	5.2	5.6	2.6	7.4	10.9	3.6	7.2	14.9	8.0	3.1	10.6	15.0	9.1	1.8	23.1	14.8	7.4	14.0	3.2	2.0	0.4	0.1	3.7	9.1	0.0	0.8	5.0	1.4	2.7	0.2	1.7	6.1	1.0	1.0	14.7	1.1	0.5	0.3	1.9	92.5	0.0	0.5	1.5	0.4	2.6	0.2	6.9	4.6	4.8	5.8	4.2	1.8	0.9	1.7	0.2	12.6	0.9	0.3	0.2	2.6	1.2	1.4	0.2	1.5	1.5	12.2	0.5	0.2	1.1	0.1	0.8	0.3	0.3	2.7	0.7	1.1	0.9	1.2	0.8	4.9	16.1	9.3	3.5	3.2	3.0	0.5	113.0	0.0	0.3	0.0	3.8	0.4	6.7	0.3	9.7	8.2	0.4	0.1	3.1	4.5	0.0	1.7	0.3	2.8	12.9	2.1	8.0	11.1	7.7	9.4	7.7	8.0	9.4	9.2	8.5	7.2	10.6	14.0	1.6	6.4	0.0	9.8	9.6	9.7	6.2	1.0	2.8	2.0	2.2	2.4	2.5	4.3	4.0	3.7	18.8	0.0	19.0	0.5	1.9	24.3	0.6	0.8	2.5	5.0	1.8	2.7	1.4	2.0	0.1	7.1	3.1	1.0	36.8	1.3	1.4	1.4	2.7	0.0	2.1	1.1	0.0	3.7	319.7	0.8	1.8	26.0	7.2	3.7	316.7	1.4	4.1	2.5	8.3	15.6	0.3	1.9	10.7	6.7	0.6	1.5	0.3	5.9	0.0	3.6	4.1	1.9	0.4	1.6	10.4	0.0	36.7	3.0	0.8	1.8
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	8.3	7.9	14.9	13.8	16.9	16.1	9.1	20.0	18.8	10.6	13.2	11.1	9.9	8.3	4.1	15.3	8.3	6.0	11.0	15.6	14.3	10.3	15.1	9.6	20.2	17.9	15.7	7.3	8.0	4.8	10.1	8.3	18.2	12.5	5.5	4.2	11.5	8.3	8.5	12.1	12.0	6.2	14.9	16.8	9.6	17.8	15.7	17.8	14.1	5.1	14.7	11.0	11.5	18.1	25.4	76.3	20.2	18.0	5.6	8.8	39.5	20.5	11.1	29.2	19.8	47.5	44.5	31.2	25.8	12.8	39.3	65.0	27.9	33.3	11.8	47.9	22.8	23.6	76.2	30.0	8.3	23.5	23.4	6.6	9.9	23.7	13.4	10.9	13.9	28.5	40.5	34.5	13.2	36.6	38.3	33.6	33.1	57.4	33.9	35.8	31.1	42.7	18.0	19.6	32.9	15.4	25.6	58.9	23.7	22.5	42.4	27.2	15.7	37.8	24.2	24.6	34.8	14.3	25.2	31.2	13.3	19.2	28.5	2.0	4.8	9.1	12.3	5.8	17.8	15.2	13.4	15.6	6.5	12.3	10.7	13.2	4.2	14.0	12.0	14.8	24.0	8.3	14.9	16.9	20.0	18.8	15.6	14.3	17.9	15.7	18.2	14.9	15.7	18.1	7.9	0.0	6.4	7.5	12.5	11.9	14.1	18.1	4.0	6.9	8.3	7.0	7.5	12.8	8.7	5.5	0.0	19.4	7.4	23.3	3.9	19.2	3.2	4.4	4.3	11.0	11.4	9.0	5.6	12.8	28.9	6.9	9.7	6.1	10.2	11.8	4.2	4.1	13.3	18.5	4.5	16.1	6.1	2.2	8.7	4.1	3.4	6.2	14.2	2.8	32.7	4.5	11.3	2.5	5.7	20.8	6.2	7.9	11.3	20.0	15.6	6.3	5.6	9.8	19.7	4.1	7.4	17.5	23.8	5.3	12.8	17.8	13.9	6.5	15.4	10.0
TRAF3	"CAP-1, CD40bp, CRAF1, LAP1, RNF118"	ENSG00000131323	"TNF receptor associated factor 3"	Q13114	14	102777449-102911500	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002933	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA002933: AB_1080352"	"unprognostic (4.06e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.49e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (1.31e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.12e-1)"	6.6	4.2	8.3	18.8	8.7	20.5	4.8	6.3	14.5	3.9	7.6	7.9	7.7	5.8	2.3	6.6	6.8	6.2	6.3	15.6	12.1	5.4	6.4	7.3	20.9	9.8	9.9	3.3	4.5	7.2	8.4	3.9	9.5	5.0	6.3	4.4	4.8	5.7	5.6	6.8	10.7	6.4	8.1	12.0	6.7	10.7	12.8	9.4	6.1	3.3	15.9	8.8	4.7	8.0	25.3	26.4	14.8	9.7	7.5	11.4	23.4	19.1	19.0	19.1	16.7	13.3	36.7	18.6	22.5	19.2	25.8	14.9	20.4	20.4	19.1	50.2	13.9	18.2	11.7	10.3	12.0	21.4	54.5	11.4	13.9	13.1	18.3	10.9	13.9	27.8	18.2	57.4	11.8	23.6	46.2	12.6	8.0	10.7	19.2	25.5	19.8	11.7	16.8	29.3	38.3	13.8	19.8	14.1	13.0	6.6	13.1	24.2	29.9	18.0	14.8	48.0	27.8	42.2	51.7	36.0	20.5	10.8	21.8	3.3	5.1	1.8	2.9	4.0	2.4	10.0	4.2	2.6	3.6	9.5	3.0	2.1	3.8	2.4	2.5	5.9	3.8	5.0	8.3	8.7	6.3	14.5	15.6	12.1	9.8	9.9	9.5	8.1	12.8	8.0	4.2	6.4	8.9	54.5	43.3	12.2	20.4	20.0	18.2	42.6	9.1	6.9	8.0	10.0	13.8	0.0	6.2	5.3	12.8	14.9	3.9	15.8	9.7	20.2	13.5	8.6	17.4	2.1	108.3	17.8	11.7	11.2	8.6	12.2	8.2	3.5	1.4	5.3	12.9	15.2	63.1	15.8	10.2	8.7	29.5	7.6	1.8	20.3	17.8	23.4	18.1	5.4	8.2	63.8	43.6	22.6	5.9	6.4	42.1	28.8	16.9	8.3	19.2	11.0	0.0	12.2	8.4	14.2	33.2	12.7	12.6	3.4	21.9	1.5	11.3	24.9
TRAF3IP1	"DKFZP434F124, FAP116, IFT54, MIP-T3, MIPT3"	ENSG00000204104	"TRAF3 interacting protein 1"	Q8TDR0	2	238320441-238400897	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 75.3;Endometrial ciliated cells: 150.3;Late spermatids: 75.1;Respiratory ciliated cells: 105.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037857, HPA037858"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037857: AB_2675706, HPA037858: AB_10671724"	"unprognostic (1.25e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (9.04e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.78e-3)"	"unprognostic (7.48e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.07e-1)"	7.1	5.0	7.9	4.2	7.7	2.0	6.7	7.1	9.3	7.1	10.5	10.2	5.2	8.4	12.3	6.5	19.3	5.7	5.3	7.4	8.6	6.9	5.6	6.7	4.7	9.9	10.0	7.2	5.4	12.2	5.9	4.9	9.0	7.1	6.0	6.7	6.4	8.1	11.3	5.6	4.9	7.4	9.4	4.9	5.9	14.2	8.5	4.0	10.7	7.5	5.3	7.0	6.2	7.3	8.6	10.4	9.4	11.4	9.2	11.4	6.9	6.9	10.4	8.9	8.3	3.7	6.6	0.2	3.6	9.9	10.3	8.5	10.5	7.9	13.7	5.2	10.7	2.2	9.2	12.7	9.7	10.4	5.8	8.8	12.3	11.3	9.1	8.3	9.1	7.6	10.5	1.9	9.6	10.8	8.3	5.7	10.5	6.8	5.4	13.0	17.1	3.4	12.1	4.0	12.8	6.9	11.7	9.0	9.0	5.7	7.6	7.8	10.4	10.8	8.4	11.0	9.1	4.9	2.8	3.3	10.6	3.7	7.3	0.2	0.2	0.1	0.3	0.1	0.6	0.3	0.3	0.4	0.1	0.2	0.3	0.3	0.3	2.0	1.5	0.4	0.0	0.2	7.9	7.7	7.1	9.3	7.4	8.6	9.9	10.0	9.0	9.4	8.5	7.3	10.9	32.1	18.1	20.5	5.0	7.9	7.8	5.2	9.6	20.3	15.6	11.0	14.6	2.8	21.7	1.8	37.5	7.1	7.4	10.5	0.0	8.1	75.3	150.3	25.2	10.4	10.7	6.1	37.9	9.1	6.0	11.6	9.2	24.5	6.3	16.0	8.2	16.0	4.5	47.1	36.9	9.9	8.2	2.5	6.0	75.1	11.1	4.9	3.6	15.0	3.2	14.5	4.1	16.1	18.1	8.4	7.1	17.0	4.2	7.0	7.8	8.2	105.3	37.8	6.6	17.9	12.4	48.1	44.1	9.1	8.0	3.7	5.1	18.1	11.4	5.9
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111555381-111606906	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	19.7	16.3	24.8	19.5	24.8	32.4	19.9	24.3	29.4	24.9	23.7	34.0	28.6	36.2	47.2	26.5	34.7	14.2	8.3	24.4	26.0	9.3	8.6	17.5	16.3	27.2	28.2	13.9	21.6	13.6	9.3	14.2	25.6	19.2	26.4	5.9	25.3	30.8	11.4	35.0	25.1	22.1	21.7	6.8	35.5	3.0	28.7	21.0	14.8	14.8	22.5	26.5	18.1	22.9	32.2	11.0	6.8	15.7	35.9	39.0	15.6	39.8	62.2	9.9	14.1	8.7	14.1	6.2	13.2	33.5	35.5	58.2	8.0	86.2	18.4	43.2	11.6	12.7	10.6	11.9	13.9	6.9	22.6	47.1	57.5	29.9	110.1	24.9	20.0	15.2	13.6	1.9	13.2	22.0	51.2	19.4	9.0	30.6	8.8	53.3	12.4	2.7	29.5	52.4	27.3	6.9	12.1	71.8	47.8	12.7	31.6	18.0	9.2	19.2	7.6	149.7	35.5	0.8	12.4	16.8	45.8	10.8	50.1	25.8	2.5	5.3	3.8	0.8	12.7	6.4	7.6	5.6	2.6	8.6	7.6	7.4	3.5	5.7	0.3	0.8	17.9	3.1	24.8	24.8	24.3	29.4	24.4	26.0	27.2	28.2	25.6	21.7	28.7	22.9	24.7	3.2	13.8	26.1	10.8	30.1	61.5	46.3	11.4	7.5	8.3	8.6	4.9	7.2	21.6	3.7	12.5	19.3	3.8	30.0	5.9	35.4	0.1	20.9	14.5	18.3	13.2	5.2	5.9	31.9	28.8	14.4	18.3	32.7	20.2	7.7	3.9	5.5	6.0	6.7	10.8	16.9	16.2	1.3	10.7	0.5	7.2	5.8	12.4	7.5	6.2	14.2	8.2	19.6	6.6	20.2	26.3	7.5	4.5	42.9	18.5	5.9	18.3	5.5	0.0	14.7	10.5	0.8	2.1	16.2	24.6	20.9	7.9	4.6	21.9	45.0
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 130.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 133.8;dendritic cells: 124.7;NK-cells: 407.8;T-cells: 162.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 115.2;JURKAT: 64.2;Karpas-707: 46.2;MOLT-4: 60.9;NB-4: 68.7;THP-1: 64.1;U-266/70: 68.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040796: AB_10794861"	"prognostic favorable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"	3.6	2.3	1.9	51.6	2.0	31.8	4.1	1.8	4.2	3.5	1.4	8.2	7.4	2.8	2.7	3.4	2.0	10.5	1.7	2.0	2.0	4.2	5.7	10.8	99.7	3.0	2.6	2.1	0.9	0.7	0.8	2.0	3.0	3.4	10.4	0.3	5.6	2.8	1.1	2.4	30.6	3.8	2.3	60.1	13.4	3.8	3.0	130.5	3.0	1.9	90.5	11.7	2.2	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	115.2	0.0	11.0	0.0	0.0	0.2	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	64.2	0.1	46.2	0.0	0.0	60.9	68.7	0.2	0.0	0.0	7.1	0.0	20.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	64.1	0.0	0.0	0.1	0.0	0.1	68.1	25.6	4.7	0.0	31.9	0.1	456.2	155.3	169.6	296.7	171.1	317.7	300.5	410.4	343.1	164.1	287.8	459.3	365.0	41.2	345.1	209.8	121.6	587.1	414.3	1.9	2.0	1.8	4.2	2.0	2.0	3.0	2.6	3.0	2.3	3.0	3.7	1.6	3.2	9.6	0.3	133.8	2.3	4.8	1.2	1.2	1.7	1.5	1.9	0.7	2.8	0.2	0.0	0.0	0.5	124.7	0.4	11.7	0.1	11.3	14.8	0.9	2.1	0.0	22.9	0.4	0.2	0.3	1.4	2.0	48.0	58.2	0.0	6.1	3.8	22.3	0.0	0.4	0.4	0.0	24.7	12.6	9.0	0.3	40.8	10.6	39.4	69.8	0.2	407.8	0.0	0.7	0.0	0.1	0.0	64.1	2.4	0.4	12.8	0.9	0.4	0.0	0.7	1.2	8.0	0.6	2.6	2.3	0.4	162.8	0.0	0.6	1.8
TRAF4	"CART1, MLN62, RNF83"	ENSG00000076604	"TNF receptor associated factor 4"	Q9BUZ4	17	28744005-28750956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 54.0"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 54.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009055, HPA021904, HPA052377"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804"	"unprognostic (1.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.58e-3)"	10.7	19.4	16.1	11.2	17.8	31.2	19.3	15.6	19.1	10.9	18.4	28.4	47.1	9.1	4.1	28.6	14.4	20.3	5.2	15.5	15.5	45.0	60.1	22.7	18.8	18.6	17.7	12.2	32.1	4.0	14.5	16.4	17.0	31.4	22.2	3.6	46.8	6.9	1.8	15.4	38.7	5.1	15.6	19.0	35.9	15.1	16.3	13.6	29.1	0.8	20.1	36.7	11.8	23.9	41.2	62.7	85.3	41.6	12.0	13.9	131.2	27.3	22.8	28.2	37.2	50.2	50.0	62.5	38.8	29.9	19.0	61.0	39.1	61.5	11.6	20.3	58.5	22.5	111.7	58.3	45.9	10.9	25.0	26.5	59.2	33.2	39.7	25.5	22.2	29.1	60.1	5.4	26.1	67.3	34.6	22.7	65.9	80.2	14.4	52.1	38.8	30.6	80.8	115.7	53.2	61.3	42.0	181.7	84.3	73.4	69.5	17.2	15.0	17.8	37.4	20.3	39.2	8.2	21.3	80.1	14.0	17.8	81.9	5.7	0.5	1.9	1.0	1.1	2.6	9.7	1.8	1.9	2.9	9.3	1.3	1.3	0.2	1.8	0.9	54.0	1.0	1.8	16.1	17.8	15.6	19.1	15.5	15.5	18.6	17.7	17.0	15.6	16.3	23.9	9.3	22.4	28.3	28.4	59.2	137.5	185.0	58.2	122.3	3.4	134.8	100.1	0.4	44.3	66.7	20.2	6.2	107.9	88.3	121.3	43.0	78.5	53.4	102.8	22.8	20.7	84.1	4.8	0.9	109.2	136.8	20.4	83.1	133.7	7.0	10.1	8.9	38.1	13.9	8.4	1.6	81.6	61.1	2.2	71.9	12.1	3.7	16.0	39.2	3.7	7.3	23.0	5.2	37.7	19.8	128.0	125.7	1.5	36.6	219.0	155.7	33.8	68.7	2.3	0.0	9.8	34.9	5.8	22.6	57.7	78.6	124.4	31.5	14.5	93.5	346.4
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	8.6	3.3	3.6	17.0	4.6	4.1	6.0	1.5	3.2	10.8	26.3	14.0	5.0	17.3	7.4	5.6	17.8	8.1	3.5	3.6	2.2	5.0	1.8	5.7	29.7	2.7	2.7	6.2	21.3	1.6	2.9	5.4	2.8	9.0	9.5	0.7	7.5	10.8	1.5	2.8	17.4	20.0	2.2	16.7	9.3	6.9	3.1	13.5	3.0	2.6	27.2	13.5	6.5	2.4	6.2	4.5	7.9	7.1	6.8	4.9	2.8	8.6	10.3	12.2	10.8	2.2	11.9	18.8	4.8	13.6	6.2	1.2	15.1	1.4	6.1	36.3	5.4	0.9	7.1	0.0	9.9	3.0	13.3	5.8	2.7	6.6	2.0	18.4	8.6	16.3	7.6	8.7	3.4	4.8	8.3	3.4	9.5	9.7	3.8	12.6	11.0	17.6	9.3	4.3	14.0	14.6	6.4	0.3	18.3	29.2	4.4	0.3	5.4	7.9	6.1	2.7	9.8	2.4	3.8	20.0	2.1	0.0	3.0	13.8	0.3	0.4	9.2	0.3	17.3	22.2	11.6	12.5	1.5	19.6	10.2	10.2	0.7	21.3	0.5	1.1	17.7	7.4	3.6	4.6	1.5	3.2	3.6	2.2	2.7	2.7	2.8	2.2	3.1	2.4	15.2	12.8	7.2	3.3	75.9	3.7	4.0	2.7	9.6	2.5	13.9	13.7	2.5	0.0	6.8	11.0	0.0	9.5	31.0	3.6	0.0	0.9	55.0	5.3	23.6	9.0	14.8	4.6	13.4	9.8	2.2	16.9	16.8	8.1	15.2	5.3	6.1	0.3	10.0	0.0	14.1	11.4	4.1	4.8	12.6	47.9	14.3	17.3	8.8	20.6	16.3	1.0	32.0	7.5	2.8	7.1	11.4	27.4	11.3	3.4	1.8	0.8	8.6	0.7	13.1	7.3	29.1	3.8	2.7	4.4	4.0	1.4	41.6	5.0	14.3	2.6
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36483769-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	6.5	5.1	4.3	5.3	5.2	23.3	5.8	4.6	5.8	6.1	4.7	5.7	6.0	6.4	5.7	6.4	6.2	5.7	7.5	4.8	4.4	6.7	7.9	7.9	6.3	4.7	4.5	7.9	7.2	6.0	4.0	6.2	4.5	5.0	6.3	5.4	5.9	5.4	7.0	6.4	7.6	7.5	3.7	8.4	5.7	7.8	4.8	9.5	9.6	8.0	7.1	5.5	6.2	6.5	5.1	6.3	12.0	6.8	11.0	7.9	5.1	7.5	8.0	6.8	8.8	5.6	3.3	6.7	4.5	8.0	7.8	9.4	9.6	7.6	11.2	11.0	11.1	6.4	5.0	5.0	7.1	7.2	7.5	7.5	10.5	3.6	11.1	6.6	9.7	8.7	9.7	7.1	8.7	6.2	11.6	4.0	6.5	5.8	5.7	7.5	16.2	3.8	8.2	10.4	1.9	10.4	7.5	7.1	5.3	8.0	8.3	6.9	7.7	9.6	8.5	8.9	9.2	8.2	7.4	7.1	5.4	5.0	7.3	59.5	12.4	34.6	17.8	17.9	17.4	17.1	15.0	17.5	12.3	13.6	14.5	19.0	17.5	16.2	13.7	7.2	13.2	14.5	4.3	5.2	4.6	5.8	4.8	4.4	4.7	4.5	4.5	3.7	4.8	6.5	9.1	9.6	5.1	13.1	12.1	12.7	13.8	6.5	6.8	2.7	5.3	3.6	7.0	7.2	4.0	3.7	6.2	6.6	12.3	8.1	5.9	8.7	7.3	6.3	6.3	12.1	4.2	7.4	29.0	7.2	6.2	6.5	6.6	10.4	19.0	5.5	19.2	6.0	7.2	8.4	24.0	5.8	8.2	8.5	13.6	3.4	2.5	7.8	7.2	17.8	9.1	4.6	8.2	11.1	29.1	7.9	8.2	4.1	10.8	10.4	10.0	5.5	3.1	2.9	13.1	6.6	9.5	15.2	9.3	8.0	12.5	6.4	10.9	4.4	3.9	11.6
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	29.1	29.4	16.5	24.4	15.1	35.0	28.2	18.2	23.0	32.1	17.0	38.0	40.0	31.2	11.6	54.6	30.4	22.2	21.3	17.9	14.6	28.1	51.5	33.2	22.9	17.8	15.3	23.5	37.4	14.6	32.1	20.6	14.8	27.0	17.4	8.5	34.7	16.5	30.4	47.7	35.2	18.8	14.2	34.5	35.6	14.8	17.7	19.1	25.6	9.9	18.6	34.5	34.8	14.3	57.7	72.2	40.3	72.5	40.8	76.5	47.4	43.4	53.9	49.9	44.6	88.2	72.1	36.6	50.2	55.4	31.8	65.9	38.1	76.8	18.8	58.3	48.8	52.4	98.5	68.3	53.8	56.3	72.7	76.2	62.8	48.1	62.6	41.0	97.4	70.6	57.1	47.9	48.2	131.1	58.3	65.2	79.7	78.7	34.8	107.4	66.7	74.2	40.2	30.4	80.9	67.2	36.3	68.5	48.6	20.9	78.1	68.2	74.3	60.2	83.9	56.7	48.2	69.2	55.0	48.4	34.4	35.9	47.8	4.0	9.1	7.3	4.5	12.4	4.3	5.5	4.4	4.7	11.2	3.9	3.1	3.8	6.2	2.9	8.9	5.3	6.5	5.3	16.5	15.1	18.2	23.0	17.9	14.6	17.8	15.3	14.8	14.2	17.7	14.3	18.9	0.0	9.2	12.4	18.2	28.8	21.1	34.2	22.8	15.9	31.6	27.9	4.9	21.5	20.8	14.7	6.2	23.5	17.4	56.4	17.6	39.0	5.0	23.6	34.6	26.5	34.0	33.6	8.9	59.0	36.3	19.0	38.7	27.9	9.5	22.1	26.0	32.3	42.2	37.0	8.2	38.7	34.6	41.8	21.3	13.1	24.8	26.8	10.6	8.4	33.9	12.6	6.2	6.6	4.9	53.0	43.6	22.2	24.0	33.8	80.0	29.2	19.7	10.9	6.6	11.9	18.3	8.5	25.3	50.7	32.5	26.7	16.0	29.0	42.5	38.5
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125538-112153604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 117.6;Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	17.1	14.6	15.9	30.4	21.5	30.1	20.3	21.2	18.9	21.2	24.7	40.6	16.7	16.8	15.6	32.0	15.4	17.7	22.3	15.1	17.3	15.7	13.5	26.3	37.1	22.4	20.0	18.7	11.8	15.7	11.7	19.0	23.0	22.0	20.6	18.7	19.0	19.8	12.9	35.9	20.3	25.9	20.5	31.3	17.2	29.1	20.1	32.6	13.8	11.4	40.4	29.9	21.7	30.2	23.8	26.2	41.8	40.8	28.8	27.3	22.1	27.2	38.8	36.5	29.4	29.5	21.9	27.4	22.6	28.9	15.7	49.0	42.0	26.3	24.2	47.3	40.1	44.4	37.7	16.3	50.0	27.1	67.7	34.4	43.5	27.1	35.7	37.2	32.6	16.6	50.1	16.9	23.6	41.2	31.5	39.0	35.4	27.8	31.8	43.8	25.6	46.8	24.3	89.5	36.4	27.3	57.4	55.7	15.1	30.8	35.8	38.7	22.1	17.2	12.2	17.1	14.3	40.3	36.2	29.3	18.5	21.6	19.1	323.7	96.1	226.1	45.1	86.8	30.1	56.7	43.1	40.3	50.1	60.2	39.4	36.6	188.2	70.8	93.1	33.5	63.7	101.2	15.9	21.5	21.2	18.9	15.1	17.3	22.4	20.0	23.0	20.5	20.1	30.2	10.7	19.2	13.1	6.8	12.4	12.2	7.4	18.5	30.7	7.0	14.7	11.8	10.9	5.7	18.9	12.9	25.0	20.1	8.5	15.4	5.9	21.3	1.7	9.0	14.3	11.3	15.6	9.0	8.4	20.8	15.6	15.1	15.3	7.5	12.0	10.0	7.9	5.7	14.8	15.2	12.2	10.3	30.5	11.9	9.9	3.7	11.8	14.0	7.2	7.5	117.6	9.9	19.6	10.6	28.6	25.8	15.5	12.8	8.7	22.7	13.0	6.3	10.2	10.9	0.0	5.6	8.8	75.6	36.0	22.0	15.2	26.4	14.0	10.0	9.4	14.4
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828601-49856574	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.8"	"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	1.5	1.0	1.6	1.8	2.5	6.8	1.9	0.7	1.8	2.0	0.4	2.3	1.5	1.7	1.4	2.9	1.8	1.0	0.9	1.6	0.9	0.8	0.8	0.9	4.6	0.6	0.6	2.1	1.0	0.8	1.2	1.6	0.7	1.4	2.9	2.3	1.2	0.9	2.0	4.2	2.0	2.1	0.6	1.9	1.2	7.9	1.3	5.3	1.4	1.2	4.4	1.3	1.9	0.9	10.4	12.4	17.4	17.6	1.6	2.4	14.4	12.4	5.8	25.3	24.0	15.2	11.6	25.5	8.5	7.1	17.7	13.4	18.5	14.0	18.8	14.7	12.2	19.2	16.3	13.6	0.7	15.8	15.4	1.6	2.0	20.4	10.7	3.0	6.7	22.3	14.0	17.8	11.4	15.1	26.5	20.1	14.0	12.3	20.3	14.4	11.7	14.8	4.6	14.2	8.4	14.4	13.6	11.3	8.8	12.4	10.2	22.4	5.2	16.1	19.0	22.5	24.4	13.0	33.7	27.3	8.1	21.2	14.6	0.0	0.6	0.3	0.9	0.3	0.9	2.9	0.5	2.1	0.6	1.5	0.7	1.1	0.1	1.2	1.3	0.7	0.3	0.6	1.6	2.5	0.7	1.8	1.6	0.9	0.6	0.6	0.7	0.6	1.3	0.9	0.6	3.2	0.6	1.0	1.8	1.1	0.6	1.5	2.2	2.8	1.2	1.4	2.6	0.0	0.3	3.7	0.0	4.2	1.2	1.8	0.0	2.0	4.3	0.6	0.9	0.8	0.0	3.8	1.4	1.0	8.2	2.0	1.5	0.9	0.0	5.7	1.1	0.7	3.5	0.0	0.9	2.0	0.0	0.8	0.4	4.8	2.5	0.7	1.8	1.0	1.8	1.7	0.0	0.5	0.6	1.1	0.3	1.2	4.3	0.8	0.9	0.3	0.5	3.3	0.0	1.4	1.7	15.6	9.1	2.3	0.3	1.0	1.2	1.2	4.6	0.2
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225890	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.0;Cardiomyocytes: 262.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	26.0	13.1	23.0	17.1	26.2	18.2	18.0	28.5	27.7	13.7	27.8	27.1	34.5	12.2	10.4	29.3	19.8	26.9	168.9	24.2	19.5	20.1	15.3	24.1	22.8	24.4	30.3	8.5	13.1	32.2	17.7	15.3	21.6	15.4	25.4	96.7	44.1	13.1	262.4	45.1	42.0	16.8	19.1	22.2	61.0	12.1	26.0	17.9	31.4	202.6	22.6	33.8	18.4	21.4	22.2	19.2	37.9	16.4	25.6	24.9	48.9	29.5	33.5	19.0	20.6	12.8	30.7	43.9	15.1	75.2	20.4	10.7	26.5	68.8	20.6	39.6	18.8	30.4	19.9	35.6	12.8	34.6	22.9	21.4	28.9	41.9	38.0	28.1	38.6	11.6	15.7	34.4	24.4	9.2	3.7	18.1	16.4	60.4	14.8	16.1	14.1	36.8	26.3	165.3	23.8	27.9	11.3	16.3	16.2	31.4	14.6	29.3	39.6	16.6	19.2	99.0	17.4	25.7	23.0	38.9	18.2	30.2	16.4	0.9	1.3	0.5	0.6	2.4	0.5	2.4	0.9	0.7	1.5	3.6	0.3	0.9	0.6	1.0	1.4	2.5	0.4	0.7	23.0	26.2	28.5	27.7	24.2	19.5	24.4	30.3	21.6	19.1	26.0	21.4	27.4	32.1	32.4	173.0	23.9	38.0	16.3	32.1	30.1	22.7	18.5	17.7	262.0	24.3	38.1	14.7	100.1	23.0	13.9	61.4	1.9	10.8	1.1	53.3	21.8	23.9	22.8	6.5	62.0	12.3	18.3	14.0	81.1	70.0	10.8	11.5	6.8	10.3	15.7	33.7	81.3	39.5	26.4	15.7	33.4	3.0	1.8	23.3	24.9	97.4	17.9	27.8	4.1	105.1	64.8	24.2	37.1	2.6	5.4	18.5	97.9	10.2	80.6	139.9	32.9	15.9	29.9	1.0	3.9	27.5	43.2	15.7	7.5	4.6	35.6	27.0
TRAK2	"ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98"	ENSG00000115993	"Trafficking kinesin protein 2"	O60296	2	201377207-201451500	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 157.8;Erythroid cells: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015827, HPA062163"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA015827: AB_1858238, HPA062163: AB_2684702"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.48e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.82e-3)"	24.1	20.3	53.2	16.4	63.7	52.2	14.8	61.2	60.9	16.1	55.6	22.4	13.4	14.3	13.0	16.7	13.9	18.7	70.9	47.3	54.0	23.7	14.1	20.7	17.3	92.9	67.6	9.7	15.4	26.6	12.4	23.7	86.8	12.8	22.8	20.1	26.4	15.2	14.8	8.1	16.1	20.4	99.9	18.1	12.2	7.8	69.7	12.4	34.9	26.8	13.6	15.7	9.0	102.2	11.6	15.5	9.4	34.3	61.6	87.4	10.6	39.2	32.8	27.4	31.9	24.4	9.8	7.1	16.3	50.6	26.4	11.2	20.0	12.9	43.5	21.4	13.0	15.5	25.6	15.9	33.8	12.3	18.4	48.4	10.8	28.8	22.2	27.5	40.4	11.0	12.4	26.9	55.8	16.6	9.6	6.9	10.6	11.3	32.7	12.1	24.9	10.6	21.9	15.6	18.6	24.0	21.0	15.5	63.6	13.6	12.4	12.4	50.2	44.2	16.6	31.0	25.7	16.2	30.2	8.3	37.2	18.2	24.4	2.6	5.5	6.2	7.8	7.0	7.3	9.3	10.1	6.7	4.3	14.2	6.9	7.3	3.4	11.1	6.5	2.3	12.6	6.0	53.2	63.7	61.2	60.9	47.3	54.0	92.9	67.6	86.8	99.9	69.7	102.2	34.0	16.0	29.8	37.5	17.8	8.3	3.4	6.3	11.4	45.4	14.4	8.8	157.8	22.8	13.4	9.2	73.0	10.3	9.3	27.9	7.9	13.9	1.9	12.7	20.9	21.0	29.5	181.0	92.3	14.7	4.8	16.9	10.7	25.7	19.6	10.3	15.0	14.3	10.6	77.4	75.6	20.6	10.2	12.9	7.7	3.8	8.1	13.2	26.6	22.5	14.2	5.1	12.3	47.7	57.0	10.7	14.5	12.8	16.8	5.7	21.7	8.9	14.9	22.1	13.1	23.2	23.3	9.4	12.8	16.2	4.1	5.6	16.6	18.7	24.5	7.2
TRAM1	"TRAM, TRAMP"	ENSG00000067167	"Translocation associated membrane protein 1"	Q15629	8	70573218-70608416	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023929	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA023929: AB_1858239"	"unprognostic (3.85e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (8.34e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.85e-2)"	93.2	82.8	26.6	95.9	28.9	102.3	115.8	27.6	42.1	139.2	47.7	85.4	91.7	93.4	148.5	65.2	78.5	117.7	59.8	24.8	31.1	120.7	190.2	146.3	103.5	32.5	27.9	73.4	175.5	117.3	38.8	146.8	32.4	87.2	79.7	33.3	193.9	86.0	26.7	49.2	93.6	96.7	29.1	90.0	94.7	61.0	29.1	98.6	170.7	54.9	114.3	120.2	47.7	34.5	171.1	172.5	73.6	45.2	352.6	367.8	105.2	302.9	301.7	231.7	279.1	109.9	275.8	169.1	58.5	259.6	91.3	219.3	67.6	262.1	221.8	112.2	76.1	118.5	54.6	125.7	515.4	91.3	66.3	441.5	249.6	114.2	410.8	238.5	196.7	85.0	77.8	430.3	288.6	47.2	210.4	65.7	48.3	132.3	81.0	100.9	55.3	113.8	610.5	160.4	53.4	54.2	195.0	389.0	180.5	103.1	144.1	102.0	195.3	141.0	117.5	162.4	102.0	338.7	140.1	85.5	160.3	92.9	105.0	150.1	97.3	64.9	120.8	107.7	153.5	107.9	132.1	137.6	114.3	87.9	119.6	125.2	28.2	130.7	113.7	190.4	146.8	232.7	26.6	28.9	27.6	42.1	24.8	31.1	32.5	27.9	32.4	29.1	29.1	34.5	138.3	275.7	132.0	19.6	166.4	85.5	85.2	214.0	69.4	23.7	114.2	62.4	43.0	131.5	209.3	178.4	14.6	154.3	200.5	69.3	68.4	174.5	142.8	77.9	140.7	134.3	44.2	59.7	27.4	247.7	236.7	177.0	70.8	186.6	72.4	59.0	137.8	202.9	182.7	23.5	26.1	95.5	156.6	134.9	251.0	222.2	127.4	123.7	202.7	29.0	132.1	65.6	128.8	34.2	40.3	290.5	51.0	94.4	670.6	199.6	78.0	147.0	110.2	32.9	124.9	76.4	99.5	134.8	56.8	72.3	88.5	194.3	154.2	78.2	65.5	130.6
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1"	"Low region specificity"	"Detected in all"							HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	1.2	2.4	4.7	0.5	6.0	0.0	4.2	5.4	7.0	2.5	2.9	1.2	0.4	1.9	6.0	0.8	3.9	1.7	1.0	4.9	6.1	6.9	0.1	1.6	0.5	5.7	5.5	2.2	2.9	2.4	3.2	0.6	6.1	4.3	1.1	5.5	1.4	2.5	0.3	2.4	0.6	2.0	5.5	0.6	1.9	3.6	6.0	0.2	4.9	0.6	0.4	1.1	0.8	6.5	1.4	0.9	4.2	2.1	0.0	0.0	0.0	0.6	0.4	0.9	2.5	0.1	5.0	0.0	0.5	1.1	5.4	0.1	2.0	2.3	3.4	0.0	0.1	1.2	1.2	0.5	1.2	1.3	0.0	4.5	1.9	1.1	0.0	3.5	0.0	0.0	0.0	2.6	7.0	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.5	0.0	0.7	0.3	2.4	9.0	0.0	3.6	4.5	2.2	6.2	1.3	3.0	11.0	4.8	0.1	1.7	9.1	2.1	0.0	4.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	6.0	5.4	7.0	4.9	6.1	5.7	5.5	6.1	5.5	6.0	6.5	0.6	0.0	1.5	2.6	0.5	0.9	0.3	0.3	1.8	6.8	2.8	2.0	0.7	0.0	1.6	1.8	4.2	1.9	0.0	0.0	1.9	2.3	0.3	0.5	2.2	2.0	0.0	0.0	3.0	0.7	0.4	2.5	0.0	0.5	0.0	1.5	0.0	0.0	0.3	5.0	3.8	0.3	2.0	0.0	0.4	0.1	0.9	0.1	3.6	0.0	0.0	3.3	0.0	8.0	13.5	0.6	0.0	1.9	0.0	0.9	0.0	2.1	2.3	3.1	0.0	1.7	0.8	1.9	6.2	1.5	1.4	0.3	0.1	1.8	0.1	0.1
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497408-52577060	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 122.0;Plasma cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	19.5	4.9	3.4	14.8	4.7	5.3	13.8	3.0	4.3	14.9	7.8	12.5	14.0	13.1	11.5	5.6	13.5	17.3	10.4	3.0	3.3	7.4	16.2	14.1	7.5	4.3	3.5	12.4	7.0	2.8	3.9	35.8	3.6	6.0	14.7	3.9	6.4	5.8	3.6	11.5	12.6	17.5	3.3	19.2	9.5	13.3	4.4	4.5	12.4	5.9	13.3	13.3	9.6	3.3	45.4	19.8	22.7	22.6	250.1	265.8	39.8	130.0	130.8	106.7	98.2	43.2	9.2	11.0	21.4	253.4	76.0	10.0	14.9	81.3	133.6	24.8	8.0	24.1	20.5	54.9	71.3	6.2	13.1	97.4	8.0	93.5	41.2	155.1	124.1	9.1	15.1	78.4	154.5	16.2	8.9	17.7	10.4	17.9	8.8	10.9	59.8	91.0	25.3	7.5	5.5	8.7	29.9	13.2	31.6	47.7	20.6	12.9	198.8	177.6	38.4	65.0	72.1	53.4	97.7	31.1	64.7	16.1	110.8	0.1	1.0	1.0	0.9	1.1	0.5	1.2	0.7	0.5	1.1	0.8	0.3	0.6	0.2	0.7	2.1	0.5	0.2	0.7	3.4	4.7	3.0	4.3	3.0	3.3	4.3	3.5	3.6	3.3	4.4	3.3	12.8	6.4	3.2	6.8	15.9	8.2	2.8	8.5	3.4	3.1	4.0	5.1	9.9	4.3	4.1	7.3	25.0	36.2	6.6	7.8	3.9	3.6	38.3	4.0	28.9	17.9	9.0	8.6	12.0	3.2	30.8	26.2	6.1	5.0	2.5	34.0	19.6	36.1	15.7	5.0	9.2	19.6	6.1	12.0	6.9	122.0	20.8	5.7	26.6	13.1	4.3	1.8	8.2	3.5	3.1	6.2	1.7	23.3	69.5	2.8	7.0	3.1	4.9	12.7	13.1	16.2	15.7	23.4	8.6	1.2	4.1	20.7	6.0	14.3	5.7	1.5
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826819-36945057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 45.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 115.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 115.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 67.9;HMC-1: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035508	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	7.4	4.6	1.7	14.0	2.5	10.0	6.4	5.2	7.5	24.6	0.0	14.8	11.1	18.0	5.2	3.2	45.0	9.6	6.2	1.8	2.3	3.4	9.9	8.8	18.7	1.9	0.5	15.6	2.4	3.2	6.7	5.2	1.8	16.5	13.4	1.4	6.8	6.3	1.1	2.3	16.7	8.8	3.4	13.1	8.2	2.4	3.3	17.5	6.2	2.5	20.8	16.6	10.0	0.7	1.4	1.7	0.4	0.0	4.5	17.9	0.0	1.4	9.1	3.9	8.0	0.0	7.2	67.9	2.8	5.3	13.5	0.5	0.2	1.0	0.7	3.7	0.1	11.6	4.8	0.0	5.5	3.1	26.1	5.7	3.5	3.1	0.2	1.1	5.4	7.6	9.5	9.9	2.4	0.1	8.9	1.3	0.5	0.0	1.9	2.5	0.3	1.4	1.5	3.3	0.6	0.0	7.2	1.9	0.7	0.8	1.2	3.8	3.7	3.4	1.3	0.2	1.2	9.3	2.2	15.8	0.6	2.6	0.4	7.3	2.0	11.5	14.9	2.9	10.7	10.9	12.3	15.3	1.4	17.5	11.0	10.6	115.1	8.5	3.9	0.2	11.6	3.0	1.7	2.5	5.2	7.5	1.8	2.3	1.9	0.5	1.8	3.4	3.3	0.7	5.4	16.0	7.8	18.3	18.8	0.8	1.3	1.7	6.8	4.4	1.6	2.3	3.6	1.5	4.0	3.7	2.1	1.3	16.5	40.9	0.0	3.1	0.4	6.1	15.1	5.5	5.4	12.6	56.5	1.8	1.6	7.1	18.8	8.8	6.3	73.0	5.7	17.7	5.0	0.0	91.8	16.7	0.0	6.6	0.8	0.0	4.4	7.4	5.4	52.5	8.7	1.6	26.8	23.6	13.2	3.2	16.9	6.0	21.9	1.6	16.7	0.9	5.2	0.7	0.0	2.6	5.2	0.3	0.3	2.6	0.9	0.7	21.8	3.7	4.0	1.5
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717553	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	46.4	50.6	32.5	32.7	35.6	35.6	45.7	28.9	37.6	54.0	22.7	50.0	39.7	42.5	18.5	72.2	59.0	33.3	88.1	34.5	34.2	59.9	121.5	33.3	47.6	33.1	32.2	58.8	76.2	39.9	35.3	33.3	33.5	41.6	36.9	22.3	46.1	26.5	193.9	67.7	36.7	30.3	26.8	39.9	49.5	40.1	36.7	27.5	33.3	138.9	36.4	48.9	50.4	32.5	113.4	277.6	56.7	150.2	61.1	62.1	167.6	67.6	60.7	152.2	95.3	347.9	156.5	361.1	123.7	65.1	41.1	207.3	223.0	167.7	67.1	139.3	241.8	105.9	225.1	246.0	105.3	192.0	69.4	74.2	114.6	121.1	188.2	55.0	106.1	122.5	338.4	120.8	50.5	367.8	138.6	141.5	106.0	133.8	140.1	314.1	118.9	500.6	112.8	83.0	268.4	102.2	70.0	254.5	135.8	46.5	184.5	137.2	60.2	63.7	112.9	112.5	99.5	135.5	161.1	289.2	39.7	152.1	88.8	0.1	24.0	0.8	24.7	38.9	47.3	42.1	36.0	31.5	54.9	30.7	42.1	35.9	2.6	31.9	29.8	8.4	33.4	33.0	32.5	35.6	28.9	37.6	34.5	34.2	33.1	32.2	33.5	26.8	36.7	32.5	20.4	22.4	17.5	16.3	21.3	25.4	44.3	63.2	38.1	29.3	32.4	36.8	2.1	45.8	39.8	31.3	10.4	112.6	5.9	28.7	88.0	67.7	24.1	30.6	21.1	21.3	35.5	42.1	31.6	53.8	56.2	23.7	36.2	28.1	16.5	41.5	12.8	48.8	46.1	47.1	31.1	37.5	59.0	14.5	14.8	13.0	16.4	14.7	12.4	12.2	26.3	20.2	12.3	11.6	16.2	31.9	14.5	21.4	37.9	45.9	14.1	140.9	30.1	22.2	19.7	29.9	29.4	37.2	70.9	70.7	28.1	67.2	15.1	58.9	74.9	42.8
TRAPPC1	"BET5, MUM2"	ENSG00000170043	"Trafficking protein particle complex 1"	Q9Y5R8	17	7930345-7932123	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052398	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA052398: AB_2681813"	"unprognostic (1.07e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.64e-1)"	111.7	145.2	130.1	91.9	128.2	100.6	100.8	133.8	142.5	99.3	124.8	119.5	83.0	129.8	124.8	156.7	94.0	74.4	169.6	129.1	139.2	158.7	123.6	132.4	140.5	136.4	134.0	79.7	101.1	109.4	124.3	114.6	134.1	93.7	87.9	67.5	103.7	65.8	139.1	110.1	121.9	102.4	127.5	170.7	118.0	72.6	145.6	166.0	101.4	94.4	153.0	108.9	104.6	134.2	178.9	306.2	161.1	186.5	262.9	258.9	101.5	221.7	233.9	206.2	233.3	172.3	104.1	192.0	164.7	337.5	203.1	159.6	173.8	282.3	235.9	279.3	278.6	93.4	165.5	193.6	196.0	114.3	243.0	302.5	197.9	218.6	162.2	262.2	240.4	174.3	74.9	130.4	314.4	166.7	246.3	157.9	101.2	130.4	138.6	122.7	137.7	165.5	392.3	131.0	68.4	165.7	150.6	78.3	166.5	217.3	163.8	124.2	271.5	146.6	105.3	138.0	179.9	139.6	130.9	100.2	294.5	132.4	176.5	315.1	235.5	427.0	190.0	225.2	157.4	243.2	189.5	196.8	270.7	215.8	158.4	177.2	244.3	192.5	235.5	293.0	288.7	304.6	130.1	128.2	133.8	142.5	129.1	139.2	136.4	134.0	134.1	127.5	145.6	134.2	90.4	67.3	46.7	11.4	160.1	54.0	81.2	257.4	78.0	32.8	120.1	158.7	13.0	131.5	124.3	240.9	8.4	375.1	182.9	135.1	340.4	280.8	33.6	60.5	76.3	97.5	118.1	105.2	10.1	259.0	427.6	84.2	67.2	74.1	102.1	78.0	153.8	136.1	362.8	45.4	9.9	155.1	193.3	210.5	135.3	72.6	115.5	195.9	149.4	8.4	374.8	97.8	303.8	6.0	15.5	256.6	162.0	83.5	120.1	62.9	200.0	530.3	87.6	33.7	39.5	31.8	117.1	67.8	69.3	139.5	72.6	271.4	169.7	113.0	144.3	100.2
TRAPPC10	"EHOC-1, TMEM1, TRS130"	ENSG00000160218	"Trafficking protein particle complex 10"	P48553	21	44012309-44106552	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.2;Oligodendrocytes: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"basophil: 9.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050423	Supported					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA050423: AB_2681123"	"unprognostic (1.82e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.76e-1)"	5.6	4.3	2.8	7.3	5.7	17.4	4.6	4.1	4.7	4.9	3.5	7.0	5.3	5.1	7.8	5.6	5.3	5.4	4.8	3.1	4.2	7.0	6.1	5.8	10.0	4.6	4.8	3.6	5.0	7.5	3.4	6.0	5.5	3.8	7.4	6.1	5.3	4.1	6.2	5.5	6.7	5.3	3.5	7.5	6.8	7.6	4.8	10.1	7.0	5.6	11.9	5.3	4.2	10.5	12.1	5.8	8.7	6.0	15.7	8.0	8.7	10.8	10.7	10.9	11.5	12.8	6.8	15.1	3.6	10.5	20.7	5.6	8.5	11.7	16.0	9.8	8.2	20.7	6.2	4.8	7.2	14.0	12.1	6.3	12.4	14.0	11.0	8.3	12.3	9.3	15.4	15.7	18.4	8.6	8.0	6.7	10.1	8.8	8.8	8.9	5.7	12.4	6.1	8.2	12.4	7.2	9.8	10.8	10.1	4.5	5.9	11.9	12.9	11.2	7.6	12.8	10.5	14.8	14.3	10.8	6.9	13.2	8.7	9.7	0.4	0.9	0.6	0.6	0.1	0.3	0.7	0.6	0.3	0.5	0.3	0.5	0.8	0.4	0.7	0.7	0.0	0.2	2.8	5.7	4.1	4.7	3.1	4.2	4.6	4.8	5.5	3.5	4.8	10.5	17.1	0.0	3.6	26.1	28.9	16.6	12.5	6.9	4.6	29.2	12.0	9.4	10.0	4.3	5.5	12.9	39.6	4.2	81.2	25.1	9.8	1.8	14.3	19.7	20.2	10.6	8.3	4.2	35.8	2.2	4.3	9.5	10.2	29.8	8.2	11.7	10.4	11.1	7.5	18.5	33.3	11.0	10.2	9.4	19.1	33.8	7.8	17.6	12.4	32.8	10.3	11.3	65.9	24.6	132.9	4.8	15.7	7.2	28.0	13.1	7.9	12.4	12.0	39.4	0.0	17.4	13.1	25.4	20.6	5.5	23.3	7.7	37.0	23.1	11.5	19.5
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC13	"C5orf44, FLJ13611, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65625004-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.0	11.5	7.8	8.9	8.4	8.0	12.8	9.1	9.9	10.6	7.0	10.8	9.3	10.8	9.1	12.4	8.9	9.3	16.8	8.3	9.4	20.0	14.7	10.5	10.8	8.7	8.8	7.6	7.3	22.7	8.8	10.4	8.8	18.7	13.3	16.6	9.1	10.9	13.4	5.8	9.1	12.9	9.1	9.9	10.0	10.6	8.7	16.6	17.3	16.8	10.8	12.1	7.0	10.4	20.7	13.6	21.0	38.2	15.8	20.2	20.7	23.8	21.2	29.1	31.2	11.8	28.7	21.3	25.5	19.5	31.0	18.8	24.0	25.0	33.9	14.6	17.8	13.4	15.3	11.1	21.7	16.6	19.3	14.5	19.2	22.7	28.8	17.5	25.8	30.0	16.2	19.1	26.3	21.9	27.3	6.4	9.5	11.9	7.4	23.7	26.9	24.0	20.8	23.2	25.4	19.2	29.3	17.4	22.2	11.6	25.7	20.8	17.8	10.2	14.0	22.6	24.4	12.6	26.3	34.0	21.3	28.9	19.8	17.6	8.3	3.6	8.4	9.3	11.0	5.8	8.1	7.0	9.0	4.7	7.9	7.9	3.1	8.9	13.4	6.7	9.3	9.1	7.8	8.4	9.1	9.9	8.3	9.4	8.7	8.8	8.8	9.1	8.7	10.4	10.4	19.2	10.5	27.1	7.4	5.7	6.8	17.3	6.2	13.3	8.5	5.5	7.1	12.8	13.1	7.3	10.4	12.1	13.0	7.6	15.6	12.9	24.6	7.9	7.6	11.9	15.5	12.0	54.7	10.8	9.6	9.1	11.2	7.6	3.8	9.8	8.2	11.2	12.4	13.5	44.2	8.9	26.4	13.9	7.7	10.2	7.5	9.6	7.2	28.1	11.1	14.8	11.3	46.3	66.5	10.3	6.3	13.2	8.9	11.8	11.0	25.2	13.4	16.2	6.6	8.7	8.3	16.4	8.6	9.1	6.8	15.2	12.0	10.2	8.7	11.9
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	P0DI81	X	13712244-13734635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.0	5.7	12.5	6.7	13.4	7.6	6.8	13.1	14.2	10.0	10.7	10.9	6.0	11.0	6.3	8.4	9.4	5.5	5.3	13.3	13.9	7.4	8.2	7.5	12.7	12.1	11.2	11.2	9.2	5.2	7.7	5.3	12.5	8.3	6.4	10.2	7.3	5.1	4.4	7.4	9.6	8.8	10.2	10.3	9.7	3.2	14.9	9.0	7.8	2.7	11.8	8.9	9.9	11.8	9.1	6.2	10.5	26.1	8.0	5.9	3.7	8.5	7.8	6.7	6.9	5.8	11.0	14.8	13.2	6.9	8.8	11.0	13.8	12.4	8.6	15.3	20.4	11.3	16.0	5.2	6.4	15.9	20.8	8.0	7.0	14.7	17.1	13.4	6.3	11.1	15.0	26.3	7.3	16.0	16.0	21.7	10.6	7.2	11.4	15.3	14.3	14.6	10.8	5.5	10.6	13.6	14.5	12.1	11.0	16.3	13.5	10.6	7.9	6.7	6.2	11.4	5.5	13.3	13.8	19.6	6.0	10.5	6.4	19.3	6.0	11.0	18.1	8.4	18.2	13.2	14.3	17.8	5.5	12.8	11.8	16.6	11.7	22.9	6.9	13.0	18.7	11.1	12.5	13.4	13.1	14.2	13.3	13.9	12.1	11.2	12.5	10.2	14.9	11.8	8.9	9.6	6.5	7.8	22.0	15.2	10.0	14.8	9.6	16.5	16.5	13.6	11.0	15.7	14.6	9.2	12.5	14.1	49.8	14.6	21.5	10.0	17.7	17.3	11.0	9.3	12.1	12.4	20.7	13.4	19.9	11.5	14.8	21.2	9.5	16.9	16.8	12.2	11.6	20.2	20.2	14.0	8.2	12.9	14.4	6.1	12.8	13.6	8.8	10.3	12.0	8.8	44.3	31.7	17.3	15.7	18.6	11.3	17.6	9.8	15.4	23.8	8.5	14.5	6.6	8.6	18.5	4.3	4.0	11.3	17.6	17.9	28.8	16.6	13.2	12.5
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	55.4	134.3	55.1	30.9	56.7	36.9	51.5	57.4	69.8	49.1	55.2	46.0	25.3	46.7	60.3	53.8	44.1	19.9	66.4	57.8	61.9	53.5	46.5	42.7	31.1	57.5	57.9	55.8	48.8	58.1	45.3	20.4	59.1	39.2	23.8	25.6	48.0	20.5	96.8	58.5	39.1	18.1	60.0	52.7	62.8	122.0	56.9	50.0	41.8	70.7	27.2	48.5	47.3	65.4	69.9	47.9	79.6	60.8	58.5	73.9	81.5	61.5	69.4	92.6	35.4	133.6	89.6	53.4	105.8	78.6	97.7	73.3	109.5	88.5	67.0	46.9	65.7	35.3	46.1	172.7	86.3	101.4	27.5	72.2	54.7	125.4	63.1	52.4	75.7	118.7	108.2	41.4	64.3	216.2	136.1	311.7	80.3	133.4	88.6	128.9	65.9	55.4	73.1	79.6	85.8	42.2	207.6	63.5	59.0	43.6	162.5	106.3	60.3	61.1	66.7	81.1	71.2	57.9	106.6	254.5	73.3	148.0	74.5	39.2	136.3	40.8	113.0	114.5	115.0	154.2	129.8	124.1	135.1	137.9	120.8	103.5	23.9	94.6	114.8	162.5	178.0	162.9	55.1	56.7	57.4	69.8	57.8	61.9	57.5	57.9	59.1	60.0	56.9	65.4	66.2	57.7	82.0	2.3	58.7	51.9	57.4	115.4	43.3	34.9	80.1	106.3	121.1	92.9	81.1	53.3	10.4	93.8	58.2	75.3	240.7	134.7	219.1	60.9	53.4	60.7	62.1	42.1	4.0	154.8	141.5	79.2	72.9	50.5	36.1	55.9	62.8	123.9	226.7	15.2	5.1	78.5	75.3	91.0	69.6	403.2	74.0	68.4	81.8	1.9	134.4	87.3	79.3	2.5	13.0	137.4	76.3	58.3	92.6	45.3	122.5	271.7	93.5	39.5	59.2	44.1	94.7	210.7	123.1	86.0	64.9	77.6	61.2	64.6	86.8	62.5
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	43.7	74.7	42.5	31.2	43.0	28.8	46.6	47.0	50.7	38.5	53.7	57.0	33.6	41.1	60.7	61.6	37.0	32.6	51.1	43.1	44.9	55.3	51.2	36.4	38.3	48.0	45.1	28.2	46.0	54.4	47.0	37.8	47.2	39.2	42.5	39.9	46.4	45.4	48.9	51.5	38.5	49.9	48.3	41.6	48.2	53.1	46.3	51.3	59.9	44.6	54.4	46.2	41.2	48.9	95.7	65.6	44.9	70.2	114.2	91.4	87.9	85.2	109.0	100.0	97.0	55.9	90.0	40.4	79.0	95.0	79.6	68.8	69.9	114.1	113.8	79.8	103.7	75.8	77.2	81.7	132.6	80.0	76.7	78.3	98.5	93.8	91.5	103.6	126.7	101.2	93.2	67.0	122.0	71.4	95.6	74.6	60.5	79.5	93.7	65.8	63.8	90.9	128.4	76.1	67.8	49.7	69.2	78.5	140.1	115.2	50.2	59.6	95.6	59.1	66.7	116.0	116.3	80.1	87.0	67.3	100.7	88.7	60.5	161.9	130.2	148.7	85.0	142.5	89.4	93.6	100.4	90.4	132.6	89.0	96.0	86.9	134.3	95.8	116.3	109.4	135.4	155.3	42.5	43.0	47.0	50.7	43.1	44.9	48.0	45.1	47.2	48.3	46.3	48.9	41.9	25.6	27.6	12.1	45.6	101.1	111.5	152.1	52.3	41.8	97.8	78.5	57.8	55.8	75.7	38.6	16.7	145.7	43.0	55.1	170.2	157.0	286.1	51.8	38.3	59.1	48.3	63.3	15.4	188.5	146.0	52.1	29.0	55.6	45.7	40.5	33.2	49.8	145.0	53.8	16.9	51.2	132.2	56.1	74.7	131.0	42.9	60.6	96.0	10.3	104.4	68.0	61.8	8.5	17.9	178.4	72.1	51.9	80.7	196.9	73.3	115.9	49.2	30.7	32.9	37.4	69.2	172.5	89.4	63.4	123.6	191.4	50.4	50.3	54.3	134.1
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018763-119025454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA039752: AB_2676664, HPA041371: AB_2677439"	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.8	37.8	14.6	4.3	14.8	8.2	20.2	15.3	18.6	17.9	15.5	22.9	8.4	17.9	11.8	21.3	18.0	5.2	27.2	14.4	16.7	36.8	26.1	19.5	8.1	15.6	15.0	15.5	25.5	13.5	29.2	5.6	15.0	20.8	6.1	9.2	18.9	12.3	38.3	19.6	23.6	4.0	15.3	22.1	22.6	31.5	14.7	16.9	17.6	18.2	6.1	19.3	16.0	16.2	15.5	14.1	16.9	20.2	25.2	19.3	8.7	59.6	44.3	45.6	40.0	35.1	6.4	18.6	40.3	27.2	23.6	14.5	32.0	25.9	32.9	31.5	15.3	28.5	14.2	40.0	33.4	25.3	14.8	25.1	29.2	40.1	30.1	23.5	42.3	20.7	34.7	7.3	28.8	38.6	30.0	24.9	13.7	30.0	44.4	26.3	13.1	25.9	34.7	20.2	7.4	16.2	10.5	13.1	15.4	19.8	58.5	21.5	24.9	10.5	18.8	13.1	19.7	9.2	18.9	45.9	11.8	20.1	18.5	68.3	37.0	77.0	50.8	45.8	53.5	59.1	59.6	59.8	37.2	55.5	54.7	59.6	32.6	54.6	58.3	52.4	96.4	61.2	14.6	14.8	15.3	18.6	14.4	16.7	15.6	15.0	15.0	15.3	14.7	16.2	50.3	38.5	34.4	7.5	38.8	51.4	59.1	166.1	37.5	60.1	38.4	38.7	30.8	41.5	83.4	71.7	14.6	90.7	61.1	30.4	140.8	107.6	41.9	46.0	39.1	47.7	67.6	45.3	9.0	76.2	56.5	45.1	15.3	33.2	62.1	335.0	46.1	21.8	80.4	38.7	11.7	33.5	152.5	27.3	30.7	16.4	44.4	33.1	30.2	10.3	76.3	88.5	41.2	10.1	15.0	103.4	44.3	60.9	26.9	51.1	83.0	206.1	89.0	61.2	46.0	21.6	82.2	78.2	67.0	28.7	59.0	87.3	52.7	49.1	36.8	52.4
TRAPPC5	"MGC52424, TRS31"	ENSG00000181029	"Trafficking protein particle complex 5"	Q8IUR0	19	7680833-7687703	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 57.5;Gastric mucus-secreting cells: 86.2;Plasma cells: 76.9;Squamous epithelial cells: 80.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 314.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042221, HPA049064"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA042221: AB_2677907, HPA049064: AB_2680618"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.86e-8)"	"unprognostic (3.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-1)"	58.9	86.8	65.7	25.6	68.7	62.7	58.4	67.1	112.6	55.6	60.6	53.0	27.6	52.1	8.1	85.6	44.7	13.8	105.1	69.4	74.7	75.7	99.7	35.9	23.4	64.5	68.9	50.1	67.1	19.9	58.4	19.1	70.5	71.1	8.4	9.0	64.8	17.2	112.4	90.6	48.5	11.5	64.3	60.6	57.5	181.4	65.9	16.8	56.0	27.3	12.2	55.5	56.2	64.4	61.0	129.4	20.7	56.9	16.3	24.1	62.1	47.1	33.8	45.3	46.1	76.9	41.2	62.9	92.0	32.7	25.8	55.2	13.0	47.2	8.9	48.3	199.2	23.7	86.7	163.7	56.8	42.1	45.3	40.0	61.9	34.6	15.8	15.4	57.6	64.3	34.3	89.3	22.3	190.7	72.3	148.8	66.1	27.1	314.1	46.6	28.8	91.1	50.7	142.8	54.1	47.0	40.1	74.6	69.1	7.1	60.1	44.3	58.8	54.2	44.9	103.3	47.7	80.8	44.2	44.3	75.3	51.2	74.2	207.5	373.4	151.4	116.7	394.1	112.3	313.7	145.0	129.3	442.0	289.2	141.7	124.7	518.4	97.4	365.5	188.8	222.5	329.3	65.7	68.7	67.1	112.6	69.4	74.7	64.5	68.9	70.5	64.3	65.9	64.4	1.8	3.2	3.6	15.3	36.1	1.9	1.2	2.4	57.5	5.1	6.3	4.2	1.0	1.5	5.1	5.5	2.1	3.5	1.2	26.7	0.0	26.9	13.3	3.8	4.8	5.6	11.4	41.0	13.5	19.3	5.3	14.3	86.2	3.7	1.3	2.0	8.2	13.4	9.9	8.4	16.4	15.7	0.0	18.8	3.3	44.4	1.5	52.2	1.8	11.2	17.0	1.5	4.1	11.6	22.8	19.8	26.3	3.4	76.9	1.9	28.0	9.2	2.6	4.8	0.0	1.4	8.4	5.0	1.2	80.1	1.7	3.4	18.0	2.7	14.1	1.5
TRAPPC6A	"HSPC289, MGC2650, TRS33"	ENSG00000007255	"Trafficking protein particle complex 6A"	O75865	19	45162928-45178237	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 246.5;Proximal tubular cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 164.5;U-266/70: 135.3"	"Low region specificity"	"Detected in all"							HPA043043	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043043: AB_10794650"	"unprognostic (2.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.23e-6)"	"unprognostic (3.85e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-2)"	27.3	32.7	25.4	14.1	28.9	48.7	31.0	27.9	35.1	20.5	19.9	33.1	18.3	21.6	19.5	25.4	29.1	15.9	21.4	24.3	25.5	57.5	59.8	18.6	34.2	30.0	27.2	23.0	28.9	17.1	20.5	12.7	29.2	39.1	11.5	4.6	30.7	16.8	35.2	56.0	28.1	7.0	27.0	42.4	32.2	24.8	26.6	20.6	38.4	15.8	17.4	23.7	24.5	33.2	7.6	42.1	9.4	18.7	15.7	11.3	18.3	2.3	8.2	2.6	5.8	12.6	38.2	76.1	40.0	4.8	22.0	15.8	3.3	6.8	1.1	42.5	30.8	28.0	3.5	14.0	33.0	12.3	28.2	27.8	37.9	2.0	12.8	10.4	8.9	48.8	27.6	57.7	4.1	104.0	30.5	42.0	11.9	164.5	21.0	52.8	10.2	93.9	27.2	26.6	44.2	18.3	16.4	77.9	29.1	16.0	45.1	39.3	3.5	6.3	6.8	4.4	2.7	135.3	43.0	57.0	14.4	25.6	10.5	25.7	59.5	30.5	78.2	60.3	94.8	92.1	105.5	81.8	91.2	93.7	110.4	95.1	4.8	113.6	62.8	87.6	112.7	86.2	25.4	28.9	27.9	35.1	24.3	25.5	30.0	27.2	29.2	27.0	26.6	33.2	28.8	44.8	51.7	5.2	61.6	58.1	64.3	149.3	55.2	13.6	66.6	71.4	17.9	68.6	71.5	58.8	2.1	122.7	63.4	41.7	246.5	53.4	15.1	56.8	26.9	33.7	83.8	23.8	2.7	42.1	43.7	24.8	29.6	65.2	40.6	63.9	42.1	113.7	72.0	13.5	2.3	84.6	148.5	56.6	67.3	94.0	19.3	45.3	108.5	5.6	114.2	54.9	60.8	4.5	10.7	24.4	73.8	10.5	39.9	35.1	61.8	303.6	62.0	13.6	13.1	23.9	34.4	14.2	68.9	43.0	83.5	88.5	72.1	72.7	81.8	71.6
TRAPPC6B		ENSG00000182400	"Trafficking protein particle complex 6B"	Q86SZ2	14	39147811-39170532	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047928	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA047928: AB_2680214"	"unprognostic (3.89e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.18e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	12.7	15.8	17.0	11.2	19.1	4.8	14.6	18.5	21.9	11.7	14.3	12.9	10.9	12.1	12.2	15.0	9.6	9.5	13.7	20.0	16.8	13.9	24.4	10.4	12.2	13.8	13.7	10.2	10.9	13.9	12.6	12.9	15.9	12.9	10.4	24.6	10.4	13.2	16.6	11.4	10.3	11.8	14.0	12.9	11.0	12.9	14.6	13.5	15.9	18.6	12.2	12.8	12.0	15.6	17.5	7.7	13.0	12.6	18.1	20.4	10.3	22.0	19.4	19.6	19.2	12.7	32.6	10.9	15.2	20.5	9.7	13.4	19.2	14.0	23.8	19.9	9.4	14.9	10.6	37.3	25.8	21.1	19.8	19.4	23.2	16.9	22.4	31.1	17.3	19.8	16.7	22.4	20.5	21.6	15.7	15.2	11.1	13.5	29.7	12.2	24.0	10.7	21.4	34.0	12.7	10.3	26.2	15.9	24.7	13.5	30.2	13.2	24.8	18.0	9.1	15.4	12.1	20.8	30.7	15.9	8.9	12.1	17.4	8.7	3.2	5.6	2.9	6.8	2.6	3.3	4.0	3.3	4.8	2.1	3.4	3.4	3.3	7.7	7.1	4.8	3.6	2.4	17.0	19.1	18.5	21.9	20.0	16.8	13.8	13.7	15.9	14.0	14.6	15.6	20.0	22.4	19.4	24.2	20.3	22.6	19.7	17.9	25.6	25.3	18.2	12.6	24.0	10.0	15.6	18.4	35.5	14.2	28.7	12.4	54.8	14.3	38.8	12.1	17.6	17.5	16.6	27.6	47.0	17.4	13.1	22.0	18.8	18.4	29.2	15.5	23.6	22.8	15.7	23.5	50.6	9.6	26.4	15.0	21.3	16.0	16.1	23.0	17.8	13.1	18.2	16.0	27.8	31.2	45.0	22.2	12.6	17.7	21.4	19.2	11.3	20.7	10.8	39.4	26.3	15.5	21.1	58.9	31.3	29.7	25.1	22.6	22.3	26.8	10.1	30.1
TRAPPC8	"GSG1, HsT2706, KIAA1012, TRS85"	ENSG00000153339	"Trafficking protein particle complex 8"	Q9Y2L5	18	31829197-31953136	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041107	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Microtubules	"HPA041107: AB_10793869"	"unprognostic (4.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (1.85e-9)"	"unprognostic (3.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.92e-1)"	10.5	9.9	5.4	10.1	6.1	10.2	9.8	8.5	6.7	9.3	11.3	9.9	10.2	8.5	5.9	11.5	9.6	7.6	10.5	5.8	5.6	12.7	18.1	8.9	13.0	6.3	5.2	9.0	9.8	14.6	7.1	9.7	5.8	8.3	10.9	20.9	10.4	8.7	16.9	13.6	11.9	9.4	5.0	10.7	10.0	30.2	5.5	16.3	12.4	12.4	13.4	9.2	9.7	8.7	12.3	10.2	11.9	9.0	17.3	16.3	13.0	16.0	16.9	14.7	14.4	7.0	9.1	17.6	12.6	15.5	13.4	18.4	17.2	9.1	20.2	19.8	8.0	14.4	9.5	8.7	13.5	42.4	16.1	14.9	12.1	13.8	19.6	16.4	17.0	14.6	21.2	15.7	15.0	8.4	18.2	14.5	11.9	36.1	8.7	19.0	14.1	18.5	14.4	19.1	9.0	10.6	20.5	12.2	14.3	18.7	13.5	18.3	20.8	15.5	7.8	5.7	9.9	19.6	23.5	25.9	15.0	18.2	16.3	8.7	1.6	1.7	1.0	1.5	2.2	1.3	1.4	1.2	1.6	1.4	1.2	1.3	2.3	1.9	1.5	1.2	1.7	0.7	5.4	6.1	8.5	6.7	5.8	5.6	6.3	5.2	5.8	5.0	5.5	8.7	16.9	28.9	15.1	44.1	26.3	18.0	8.7	10.0	31.9	12.2	14.3	9.7	21.6	21.5	14.6	11.0	29.2	11.2	19.9	27.3	1.9	11.0	35.3	23.4	14.9	16.1	12.6	20.0	68.1	9.4	9.6	14.8	32.6	17.4	3.8	11.1	19.6	34.2	16.6	11.8	71.6	14.7	8.2	24.0	13.3	42.4	15.5	22.3	10.6	43.1	23.4	11.0	23.7	55.3	82.8	14.2	10.1	9.4	18.7	16.1	26.2	15.5	25.8	24.7	13.1	14.8	14.3	88.8	47.4	21.8	27.1	20.5	16.6	11.6	13.7	15.5
TRARG1	"BEC-1, DSPB1, IFITMD3, LOST1, TUSC5"	ENSG00000184811	"Trafficking regulator of GLUT4 (SLC2A4) 1"	Q8IXB3	17	1279662-1300978	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"adipose tissue: 101.4;breast: 68.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	294	"ASC diff: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050825	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA050825: AB_2681252"	"unprognostic (5.84e-2)"	"unprognostic (7.21e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.10e-1)"	101.4	1.1	0.0	1.2	0.0	0.0	68.7	0.0	0.4	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.1	0.6	1.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	1.2	2.1	2.3	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.0	0.6	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17137336-17202054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399"	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	1.8	1.5	1.4	1.3	2.3	1.5	1.8	4.5	1.6	1.7	1.9	1.2	0.8	2.7	4.6	1.2	2.0	2.0	1.4	1.5	1.1	2.1	0.7	1.4	2.2	2.5	2.0	3.0	1.5	2.6	1.3	1.5	3.2	1.3	1.0	5.8	1.5	0.9	1.2	1.6	1.3	1.1	1.6	1.3	1.5	1.2	1.5	3.3	3.7	0.2	1.9	1.1	1.5	1.4	3.6	1.3	7.7	1.3	2.3	1.1	0.0	4.0	2.0	4.0	4.0	3.2	3.5	2.1	0.5	1.5	5.7	1.9	3.7	2.0	2.6	5.4	1.6	2.4	3.3	1.8	0.6	2.8	3.1	2.0	1.6	1.7	1.6	2.6	2.6	6.1	3.8	2.7	4.6	0.8	14.6	0.9	4.1	1.1	1.3	2.6	5.3	1.3	0.7	2.4	1.7	2.3	0.0	1.7	2.1	3.3	2.9	2.3	0.9	1.9	5.1	4.7	3.0	3.1	4.1	7.0	2.5	3.2	1.9	4.9	2.5	1.2	2.2	1.7	4.2	3.4	3.8	2.8	3.2	3.5	4.9	3.4	1.6	2.6	0.9	7.0	1.3	2.0	1.4	2.3	4.5	1.6	1.5	1.1	2.5	2.0	3.2	1.6	1.5	1.4	6.5	6.4	4.8	29.4	9.1	3.3	2.1	3.5	4.6	12.2	2.6	2.8	5.5	2.8	6.1	3.7	4.2	2.1	7.1	2.1	5.9	4.4	6.7	8.1	5.9	6.2	0.0	6.9	21.8	4.9	2.5	5.8	5.6	5.9	12.7	10.2	4.2	1.7	5.1	16.8	23.2	1.2	4.1	5.0	7.0	6.7	6.5	5.8	0.0	8.4	5.4	12.1	7.2	23.6	14.9	2.5	1.7	6.4	10.2	1.1	2.5	5.0	7.5	17.3	0.0	7.7	7.6	12.5	6.1	4.8	3.1	1.8	10.4	7.6	3.1	1.2
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 66.3"	"Group enriched"	"Detected in some"	5	"Late spermatids: 315.7;Proximal enterocytes: 186.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		12000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.7	0.2	1.6	0.3	3.7	0.0	0.4	0.6	3.8	0.3	0.0	1.6	60.0	0.4	0.6	1.6	0.3	2.6	1.0	1.1	2.7	13.4	6.1	0.2	0.1	2.1	2.0	0.2	1.8	0.0	0.3	0.1	1.9	0.5	1.3	0.0	0.2	0.0	0.0	0.1	66.3	0.1	0.6	0.1	1.7	1.8	2.5	0.0	0.4	0.0	0.0	0.4	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.6	3.8	1.1	2.7	2.1	2.0	1.9	0.6	2.5	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.3	1.5	0.0	1.8	0.0	0.1	0.0	2.3	7.9	0.2	45.6	0.8	1.6	0.1	3.0	0.0	0.1	2.5	0.0	0.3	4.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	7.0	0.0	0.0	0.4	315.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	5.3	0.9	6.3	1.9	0.1	0.3	186.3	32.8	0.0	0.0	0.0	0.3	0.2	1.7	0.8	2.1	0.0	0.0	0.1	0.0	3.7	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.8;lung: 30.1"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 1014.1"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	4	"hTCEpi: 74.6;THP-1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Secreted in brain"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	10.7	13.2	28.1	3.5	31.1	0.2	9.8	33.7	61.5	6.5	29.1	3.5	0.9	1.6	2.3	0.6	7.4	9.7	2.1	27.5	32.3	1.3	2.3	30.1	2.6	44.5	34.4	2.4	3.9	7.4	3.9	10.7	42.7	2.0	4.3	1.9	6.0	3.1	0.4	0.5	1.4	4.5	46.7	0.5	2.5	0.7	43.5	1.8	1.7	0.0	0.4	4.5	0.6	69.8	0.0	0.3	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.2	74.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	42.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	28.1	31.1	33.7	61.5	27.5	32.3	44.5	34.4	42.7	46.7	43.5	69.8	1.8	6.4	7.5	0.0	0.7	0.8	0.2	79.8	0.0	0.3	1.8	58.8	0.1	1.5	9.6	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	10.4	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	2.5	0.0	2.2	0.2	1014.1	0.0	0.0	0.0	2.0	34.7	5.2	1.0	0.6	120.5	0.0	12.2	8.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	1.0	6.6	0.1	1.0	0.0	0.0	0.0	0.1	7.3	0.8	0.0	0.0	0.1
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	7	"Macrophages: 75.6;monocytes: 28.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 92.4"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 92.4"	"Cell line enriched"	"Detected in single"	170	"HEL: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		43000000	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	0.9	1.0	1.7	2.7	2.1	8.7	0.5	2.2	4.5	0.3	1.3	0.3	0.0	0.1	0.4	0.1	0.4	0.9	0.3	1.9	2.5	0.2	0.3	2.1	5.4	3.3	2.4	0.1	0.4	0.2	0.4	0.5	2.8	0.2	0.9	0.2	0.4	0.3	0.1	0.3	0.4	0.2	2.5	7.3	0.2	0.1	3.6	4.1	0.3	0.5	4.8	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	1.7	2.8	0.2	1.8	0.4	0.2	0.1	0.0	0.7	0.3	0.5	0.0	10.7	0.0	0.3	0.9	0.0	110.6	1.7	2.1	2.2	4.5	1.9	2.5	3.3	2.4	2.8	2.5	3.6	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.0	75.6	0.0	6.5	28.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		9.9	14.3	32.7	16.5	33.4	28.7	12.2	33.2	42.1	13.8	39.8	12.4	11.1	7.7	11.4	19.2	15.5	13.8	10.7	33.0	32.7	12.2	12.8	13.8	26.6	33.0	34.2	7.4	13.1	11.3	20.6	8.4	34.3	16.6	9.9	1.9	36.5	15.4	9.7	26.4	12.0	7.0	33.8	25.0	13.7	4.0	33.5	18.1	8.4	13.8	18.1	13.1	10.4	33.7	19.2	18.1	13.3	10.3	18.1	17.5	0.0	6.7	29.5	46.9	67.5	0.3	21.8	23.8	11.7	24.4	44.8	21.4	0.9	27.2	6.7	19.9	1.6	13.5	58.1	0.5	20.1	12.8	9.3	16.2	2.5	25.9	9.8	9.8	20.4	16.9	0.0	32.6	20.7	0.4	17.3	8.6	0.1	11.0	11.2	14.4	4.9	43.2	13.4	3.8	0.1	8.1	21.8	29.6	15.4	0.9	0.8	20.3	22.2	8.5	9.2	21.8	14.2	26.4	16.9	10.4	21.5	25.4	7.5	7.7	142.3	11.0	32.6	119.2	18.7	86.8	43.0	31.4	125.9	87.5	40.3	33.8	82.2	30.9	94.6	99.1	43.3	78.6	32.7	33.4	33.2	42.1	33.0	32.7	33.0	34.2	34.3	33.8	33.5	33.7	0.0	0.0	0.5	6.8	2.1	9.1	0.0	53.6	0.6	0.0	0.0	0.0	6.3	0.0	24.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.7	2.3	0.0	0.0	4.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	40.7	0.0	22.6	0.0	0.0	2.0	24.9	5.6	0.0	0.0	0.0	1.0	5.9	0.0	1.1	0.0	3.9	0.0	0.0	0.0	29.9	0.0	0.0	0.0	4.2	0.0	0.0	2.7	13.9	0.0	2.6	0.0	1.5	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 24.5"	"Cell type enhanced"	"Detected in single"		"Suprabasal keratinocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"basophil: 1.7;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;U-698: 7.3;U-937: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054060	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	0.9	0.5	0.4	0.6	0.4	0.7	0.8	0.5	1.1	3.2	5.0	0.6	0.2	1.2	0.6	2.9	1.2	0.7	1.0	0.7	0.2	1.4	0.6	1.1	1.4	0.5	0.3	0.9	0.8	0.2	0.7	0.9	0.5	1.3	0.2	0.0	1.9	2.4	0.3	24.5	1.1	0.5	0.3	2.4	0.7	1.0	0.4	0.5	1.3	0.1	1.1	0.6	3.2	0.4	2.1	2.6	0.2	0.9	0.3	0.5	0.2	0.6	0.5	0.5	1.4	0.7	0.5	0.2	1.3	0.5	0.1	2.2	0.9	1.4	0.0	2.3	5.4	0.2	0.5	0.3	0.2	0.6	1.4	0.6	1.3	0.6	0.5	0.3	0.2	0.4	0.3	2.5	0.1	2.5	1.5	1.6	0.8	0.4	1.7	3.5	0.7	1.7	0.2	0.7	0.6	0.3	0.2	0.2	0.8	0.0	0.4	0.7	0.0	0.9	1.6	2.0	0.8	2.8	2.1	7.3	0.2	7.0	1.1	1.7	0.0	2.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.5	1.1	0.7	0.2	0.5	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.7	0.1	0.1	0.0	0.1
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974688-129977935	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 68.7;cervix: 26.0;endometrium 1: 18.7;retina: 35.2"	"Cell type enriched"	"Detected in some"	10	"Muller glia cells: 234.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3"	"Group enriched"	"Detected in many"	6	"hypothalamus: 68.7;medulla oblongata: 59.4;pons: 38.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.0"	"Group enriched"	"Detected in many"	5	"hypothalamus: 175.6;olfactory bulb: 148.0"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 5: Muller glia cells - Visual perception"			"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.2	0.0	4.9	0.1	0.9	3.7	1.9	2.2	0.8	26.0	0.1	0.0	0.1	18.7	0.0	0.0	2.5	0.0	0.5	2.3	68.7	0.5	0.0	0.6	0.0	59.4	9.1	3.8	0.0	0.0	0.2	0.2	38.2	0.1	0.0	35.2	0.5	0.1	0.1	0.4	0.0	0.3	2.8	0.1	0.0	1.2	3.7	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.9	2.2	0.8	2.3	68.7	59.4	9.1	38.2	2.8	3.7	0.7	0.3	0.0	0.0	0.3	0.2	0.8	0.7	0.0	0.0	10.4	1.6	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	9.0	0.8	0.7	0.0	0.0	0.2	0.0	0.1	0.2	0.0	22.5	0.0	0.1	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	11.5	2.7	0.0	2.0	0.0	0.0	0.0	234.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.7	1.6	0.0	0.1	0.1	0.2	0.1	0.0	4.3
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086585-109121565	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055162	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	5.2	3.4	1.4	0.9	1.2	1.2	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443964-120446384	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	21.8	24.6	16.6	18.9	16.8	32.9	28.4	17.1	23.0	16.6	18.0	24.6	19.2	14.1	20.8	22.9	17.2	15.4	19.4	16.8	17.5	21.1	66.4	16.8	24.8	16.9	16.7	12.1	52.5	14.7	12.3	29.1	17.1	20.1	30.5	8.8	25.3	15.3	60.4	27.0	18.5	20.9	17.2	16.3	19.6	13.2	16.9	25.7	15.7	39.1	27.5	24.1	15.6	18.2	56.2	75.1	67.4	46.3	57.5	88.1	161.0	71.8	51.2	62.5	51.6	63.2	30.4	110.0	59.6	59.2	25.0	37.4	79.3	118.6	65.8	49.1	88.5	66.9	48.7	167.9	85.4	113.6	49.6	91.6	146.7	61.4	87.0	62.3	131.1	59.8	109.3	27.7	92.1	70.3	86.0	152.7	96.5	67.9	60.4	70.4	63.5	114.4	81.1	62.0	66.3	43.2	82.7	28.1	64.6	105.7	93.9	65.6	74.8	40.0	60.7	40.7	44.1	70.6	120.6	118.5	61.5	86.9	71.2	26.7	47.1	18.2	41.0	52.7	48.8	35.1	39.2	39.0	59.1	31.8	48.3	43.1	4.0	49.6	36.5	53.1	37.3	45.0	16.6	16.8	17.1	23.0	16.8	17.5	16.9	16.7	17.1	17.2	16.9	18.2	25.8	3.2	15.2	3.6	30.5	51.2	28.5	108.2	44.3	10.6	35.9	44.1	12.1	45.8	36.0	7.3	6.2	128.5	29.4	16.9	66.5	48.4	8.3	22.4	27.7	34.3	22.1	23.7	3.9	50.4	91.2	23.1	15.3	16.4	17.2	34.9	24.3	63.3	52.0	3.3	2.9	22.6	40.7	23.3	27.6	5.7	16.4	19.1	39.2	1.0	48.0	15.4	44.3	3.0	4.7	43.2	20.7	18.4	19.8	37.7	30.1	49.4	25.4	9.5	19.7	18.9	27.3	34.5	31.4	45.6	71.3	75.4	28.3	47.0	39.5	28.9
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 104.3;Muller glia cells: 100.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 48.8"	"Group enriched"	"Detected in many"	8	"B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	43.3	63.1	29.1	38.9	29.9	16.8	38.3	36.1	35.2	21.7	30.5	27.0	17.8	44.4	43.4	15.5	23.4	28.8	51.0	31.6	37.7	92.3	21.0	39.8	72.7	31.4	30.8	97.8	26.2	18.0	20.0	46.6	29.7	33.0	13.4	137.8	20.4	25.6	14.3	16.9	25.2	34.2	29.7	79.7	41.8	28.5	32.4	39.3	23.9	19.5	69.6	48.4	19.5	28.0	0.2	0.4	138.8	183.5	48.9	44.7	0.2	7.9	7.5	4.9	7.9	0.9	15.3	16.3	5.5	16.9	0.8	2.3	10.3	16.1	4.2	18.3	28.9	185.7	0.4	2.7	60.7	10.7	68.0	41.7	16.0	20.3	5.6	48.9	22.1	23.8	258.0	0.3	7.9	1.7	24.4	44.8	66.1	7.0	18.0	0.0	46.2	6.7	31.9	23.4	118.9	56.6	1.1	7.4	189.3	41.4	0.2	1.1	13.9	65.3	32.0	0.6	17.8	0.1	0.2	22.9	35.2	36.3	246.7	1.7	0.2	3.2	12.7	0.0	15.8	9.6	26.1	13.8	1.2	12.2	15.0	9.2	0.5	19.3	0.2	0.1	48.8	8.9	29.1	29.9	36.1	35.2	31.6	37.7	31.4	30.8	29.7	29.7	32.4	28.0	52.2	3.2	8.3	25.5	12.5	6.1	9.1	26.9	19.4	55.0	7.9	8.6	17.1	12.8	15.6	16.5	31.3	2.6	17.5	0.7	7.9	17.2	4.3	9.7	11.6	43.9	0.0	22.1	13.5	104.3	0.2	11.3	20.9	15.9	34.2	77.3	59.6	6.7	5.8	20.2	6.9	0.4	28.5	5.1	8.2	14.3	77.3	3.8	30.2	13.1	3.0	100.3	26.8	59.8	2.7	45.3	0.2	74.4	21.0	11.6	0.3	1.0	17.9	66.7	52.6	9.9	41.2	1.0	6.0	5.7	5.4	0.8	27.1	30.5	0.8	32.5
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 53.1;Hepatocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 630.3;hTCEpi: 401.9;hTERT-HME1: 461.8;SK-MEL-30: 615.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	8.0	16.4	5.6	4.0	5.4	16.1	7.8	6.0	6.7	4.4	6.5	4.4	1.3	2.9	3.0	20.5	2.2	2.6	4.0	5.1	6.5	9.9	80.5	15.4	6.5	5.5	5.5	3.2	17.3	13.3	15.2	8.4	5.6	7.8	2.2	2.7	10.4	3.0	1.8	13.6	5.3	1.8	4.4	12.1	10.2	1.4	6.7	5.6	38.2	0.5	5.9	4.8	5.3	4.4	80.9	41.6	5.1	11.9	13.7	17.9	33.7	23.9	65.8	23.0	47.5	86.7	40.0	35.3	22.2	22.5	102.3	62.6	22.6	107.7	21.4	12.4	16.2	27.5	8.9	144.2	630.3	71.5	12.7	73.3	401.9	43.5	461.8	16.2	45.1	86.1	97.3	155.2	2.3	77.3	4.2	87.0	11.8	122.8	133.0	15.2	7.1	77.1	27.0	33.3	14.7	23.0	5.6	192.2	615.5	7.2	55.7	185.6	24.6	11.7	20.6	0.3	36.2	52.3	73.9	63.5	10.5	61.4	43.6	5.1	6.4	1.4	13.2	4.9	9.4	21.0	12.3	15.3	6.7	13.8	13.7	9.8	4.4	10.2	2.6	2.8	9.7	7.8	5.6	5.4	6.0	6.7	5.1	6.5	5.5	5.5	5.6	4.4	6.7	4.4	7.9	3.2	1.5	0.3	9.3	6.8	10.9	20.3	3.4	6.8	12.7	8.3	1.6	11.5	8.5	1.8	4.2	14.1	4.0	3.4	0.0	53.1	0.0	0.2	1.6	15.8	1.2	5.7	2.2	22.7	6.4	3.9	0.0	2.6	5.1	0.5	6.8	38.4	6.4	0.0	3.1	8.8	6.1	3.3	4.4	0.0	1.8	3.0	7.2	0.0	4.2	1.0	14.4	1.0	0.6	24.0	1.9	1.5	10.0	12.2	0.0	0.1	2.9	7.0	6.6	6.5	6.9	2.4	3.1	4.0	5.4	7.1	5.7	3.5	2.2	6.7
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.8;kidney: 2.0;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406835	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	10.2	12.1	12.7	8.9	16.0	30.7	10.4	23.9	15.2	14.7	10.1	13.6	7.7	11.5	4.5	20.7	12.7	6.1	8.7	14.4	11.6	12.2	10.2	11.8	12.2	11.6	9.9	11.9	11.9	6.7	9.8	5.6	10.8	15.4	7.1	2.0	17.1	7.0	5.0	17.1	14.6	4.6	8.6	24.1	12.9	14.9	13.2	10.1	11.0	3.1	8.7	11.7	15.6	11.0	28.3	26.3	13.8	19.1	10.2	8.4	65.1	18.1	12.1	20.5	16.4	32.2	24.0	21.1	19.7	12.2	13.5	45.1	16.8	17.4	8.6	23.6	40.5	17.5	26.7	17.6	27.6	22.2	25.6	11.3	27.2	21.3	10.6	10.5	10.2	33.9	40.7	26.4	10.7	18.2	27.1	35.1	35.3	23.9	22.9	26.3	12.5	25.8	13.4	34.0	22.9	42.0	15.1	42.2	24.7	5.6	29.9	36.8	11.6	13.0	18.3	30.6	37.9	26.9	19.3	18.9	16.1	17.7	20.9	5.2	4.5	5.6	5.5	5.3	5.9	3.7	6.4	7.1	4.4	3.5	3.6	5.1	6.2	6.2	7.5	3.5	6.4	3.9	12.7	16.0	23.9	15.2	14.4	11.6	11.6	9.9	10.8	8.6	13.2	11.0	7.8	3.2	5.8	1.6	12.1	15.8	16.3	7.4	10.8	12.1	13.3	10.7	3.6	12.8	10.4	1.8	2.1	15.7	21.6	28.1	17.6	14.8	154.2	11.2	10.2	10.1	14.4	12.6	9.8	11.0	15.5	8.5	23.4	17.1	5.7	13.4	8.9	5.7	11.8	5.0	4.7	21.7	4.1	12.6	9.3	16.5	9.6	11.0	5.4	2.8	22.0	10.3	30.9	3.0	3.2	18.3	21.1	7.5	12.8	17.4	17.8	9.9	7.3	1.6	6.6	8.4	9.1	7.3	12.4	15.8	19.5	57.3	18.9	14.9	17.6	30.1
TRIM13	"DLEU5, Leu5, RFP2, RNF77"	ENSG00000204977	"Tripartite motif containing 13"	O60858	13	49995888-50020481	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 576.8;Spermatocytes: 211.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000367	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA000367: AB_1856196"	"unprognostic (1.14e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.07e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.55e-2)"	18.0	13.7	12.8	14.7	18.1	65.2	21.0	21.7	14.7	17.0	10.1	18.1	12.7	16.6	14.9	26.6	17.2	12.6	16.6	11.8	14.3	22.0	14.3	20.8	20.2	15.2	14.2	19.3	15.5	20.2	15.7	14.9	15.4	20.1	20.1	15.8	19.0	13.1	24.9	27.0	18.7	14.0	13.6	20.9	15.3	79.0	15.1	24.1	15.9	24.3	23.2	15.5	18.9	24.3	10.6	12.0	41.3	32.1	22.7	35.3	18.7	17.0	24.5	13.5	9.4	16.6	23.7	38.9	5.2	18.6	12.2	16.2	18.4	22.5	16.6	15.1	16.2	38.7	9.9	18.9	25.3	37.5	21.7	25.9	32.5	12.4	20.6	34.0	30.3	32.9	21.0	12.0	27.0	9.6	31.5	58.5	37.5	24.3	9.0	37.7	1.9	11.7	28.8	17.2	16.5	26.9	15.4	15.8	24.8	29.1	17.9	46.9	28.5	13.9	12.8	11.5	9.7	8.6	7.8	28.6	6.2	16.9	19.2	24.8	17.7	28.4	19.0	15.8	24.1	46.4	25.5	25.2	22.7	45.4	22.3	20.9	35.0	27.0	23.5	34.8	30.0	14.4	12.8	18.1	21.7	14.7	11.8	14.3	15.2	14.2	15.4	13.6	15.1	24.3	34.2	25.6	29.1	20.9	47.7	27.5	37.0	48.8	21.1	24.5	24.8	19.2	20.1	22.8	39.8	27.6	20.9	33.4	31.7	24.2	19.6	25.4	576.8	21.3	25.3	29.8	44.9	20.6	30.6	20.1	16.5	26.2	15.8	15.3	38.7	34.1	20.3	15.1	18.3	11.8	29.6	27.5	30.5	21.3	62.3	83.6	25.7	24.3	17.8	35.6	27.1	14.5	28.8	45.8	57.5	20.3	22.7	29.7	13.8	34.5	21.5	32.8	51.8	54.3	19.7	25.2	29.9	211.2	25.2	29.9	33.4	32.2	29.0	21.3	28.6	31.1
TRIM14	KIAA0129	ENSG00000106785	"Tripartite motif containing 14"	Q14142	9	98069275-98119222	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 75.0;Kupffer cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053217	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"HPA053217: AB_2682082"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.55e-3)"	"unprognostic (4.57e-2)"	6.4	5.3	9.0	18.4	7.6	12.1	10.0	4.7	7.7	5.8	4.7	18.9	29.5	4.3	1.8	19.5	6.3	9.6	1.6	7.7	7.3	11.4	22.3	14.9	25.6	14.1	8.1	2.9	3.1	13.5	5.1	5.0	8.4	9.4	16.8	2.7	10.6	5.6	1.0	9.9	30.4	8.8	9.4	26.8	11.6	7.8	9.7	32.7	2.9	1.0	21.8	12.7	9.1	8.9	25.5	12.9	0.6	11.3	0.0	3.9	8.3	14.8	28.1	79.3	67.8	24.8	14.9	33.5	11.8	16.1	47.2	28.6	24.9	16.5	24.1	43.3	20.0	9.9	20.3	24.6	17.1	53.1	10.7	2.4	8.0	11.6	14.8	10.6	10.1	37.4	39.6	15.5	7.3	32.6	42.2	16.7	14.2	56.3	39.5	27.4	1.4	17.2	6.3	15.6	4.0	3.3	20.8	43.2	14.3	2.8	11.4	30.4	7.1	3.3	8.5	1.2	20.5	6.7	8.3	11.1	9.1	41.1	11.4	1.0	14.4	2.1	15.1	28.4	16.1	8.3	17.1	15.7	15.8	5.6	13.1	11.4	4.0	13.0	59.0	15.3	23.1	17.2	9.0	7.6	4.7	7.7	7.7	7.3	14.1	8.1	8.4	9.4	9.7	8.9	2.1	3.2	8.8	3.3	15.3	2.8	14.3	11.8	15.4	35.1	8.7	8.3	1.0	7.2	14.2	5.5	75.0	5.0	28.8	40.0	3.9	4.9	8.8	4.8	8.9	4.1	12.6	5.9	7.0	13.6	16.9	3.2	13.3	5.4	1.3	12.0	7.5	22.4	15.4	3.3	5.4	15.3	10.2	80.6	2.4	9.9	0.3	32.6	1.8	2.8	16.5	1.9	30.9	12.1	0.9	15.0	13.5	1.5	8.5	19.1	38.1	21.1	17.0	4.4	0.0	1.4	2.0	16.3	3.8	17.3	3.3	3.3	21.3	5.8	19.4	21.1
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 145.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 153.4;Squamous epithelial cells: 95.5;Urothelial cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"T-reg: 45.1"	"Lineage enriched"	"Detected in many"	12	"T-cells: 45.1"	"Cell line enhanced"	"Detected in all"		"A549: 283.8;HaCaT: 229.0;HeLa: 203.8;OE19: 364.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (6.71e-4)"	18.3	32.7	14.1	7.8	16.2	17.4	13.4	17.7	21.5	44.9	10.3	14.1	22.8	6.1	4.9	145.9	8.8	16.3	23.1	13.5	15.8	8.5	5.9	14.5	9.7	16.9	16.0	7.3	6.0	3.6	4.4	34.5	17.2	10.2	11.2	3.6	38.0	11.7	28.1	44.9	12.5	9.0	15.8	6.0	31.7	12.7	17.2	10.1	18.7	27.2	37.3	35.7	70.2	22.1	91.5	283.8	8.6	19.4	40.4	46.1	9.6	14.8	51.9	17.9	25.0	17.2	115.6	9.8	54.7	64.7	106.9	229.0	25.6	65.7	12.0	120.0	16.4	4.5	203.8	9.5	67.1	5.4	9.6	25.7	40.9	39.3	22.3	49.6	38.8	11.4	5.7	45.8	49.2	32.2	20.2	11.7	13.1	364.2	17.0	8.7	71.8	6.9	92.4	116.0	6.4	17.7	64.7	72.2	22.1	49.7	10.9	12.6	61.0	22.5	26.3	10.9	51.3	11.1	12.9	1.0	34.6	12.6	58.3	0.4	3.8	1.0	1.2	1.1	0.8	0.5	4.9	1.5	2.6	0.6	1.3	2.6	0.6	0.9	0.5	0.4	45.1	2.3	14.1	16.2	17.7	21.5	13.5	15.8	16.9	16.0	17.2	15.8	17.2	22.1	34.9	38.5	2.6	14.0	5.3	30.8	59.0	55.6	10.2	7.2	11.8	5.7	12.5	10.0	73.5	11.0	18.8	13.6	2.8	9.9	0.0	49.1	1.1	16.5	9.9	28.7	4.2	9.0	9.6	17.3	8.4	9.6	34.7	25.7	4.5	12.4	3.6	3.2	4.0	3.3	14.0	21.7	28.5	2.9	8.6	3.9	7.2	2.9	7.2	11.2	13.0	6.6	4.1	18.6	19.2	153.4	26.9	4.5	3.7	29.5	4.3	6.2	33.5	8.4	6.6	5.8	14.0	10.3	12.1	95.5	77.6	4.7	5.9	60.9	18.4	111.9
TRIM17	"RBCC, RNF16, terf"	ENSG00000162931	"Tripartite motif containing 17"	Q9Y577	1	228407935-228416861	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 42.0"	"Group enriched"	"Detected in some"	27	"Early spermatids: 291.1;Late spermatids: 87.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HEL: 2.1;NTERA-2: 1.9;SH-SY5Y: 2.3;T-47d: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA054908	Approved		Approved	Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA054908: AB_2682638"	"prognostic favorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.96e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-1)"	2.1	1.2	3.2	0.3	6.3	0.2	2.9	10.2	4.9	3.0	1.1	0.6	0.2	2.0	0.4	1.9	3.9	0.4	1.7	4.8	1.4	3.0	0.2	1.5	0.6	1.3	0.9	3.2	0.6	1.6	2.1	0.3	0.8	4.1	0.0	0.2	4.6	0.7	0.1	2.2	1.0	0.2	0.0	6.4	1.0	42.0	2.6	0.0	3.1	0.0	0.2	1.6	3.2	1.0	0.1	0.4	0.2	0.2	0.0	0.0	4.4	0.3	0.0	0.0	0.0	1.0	0.5	0.0	1.0	0.0	0.1	1.1	0.0	0.0	0.1	0.1	0.4	2.1	0.7	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.1	0.2	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	2.3	0.0	0.2	0.0	0.4	5.6	0.1	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.2	6.3	10.2	4.9	4.8	1.4	1.3	0.9	0.8	0.0	2.6	1.0	0.0	0.0	0.5	0.3	0.1	0.3	1.7	0.1	2.8	1.0	0.6	0.9	1.5	0.0	1.5	1.8	0.0	0.0	0.9	0.1	0.0	0.7	291.1	1.2	1.3	0.3	0.0	0.0	7.0	0.0	0.0	1.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	87.9	1.2	0.1	0.0	1.0	0.0	0.5	1.0	0.5	0.9	0.6	0.0	0.4	0.1	0.7	0.0	0.0	2.4	0.0	0.0	0.1	0.3	2.5	1.8	0.2	0.3	0.8	0.9	0.0	0.0	0.6
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152163-153339319	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 116.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 47.0;SK-MEL-30: 46.8"									"HPA035853, HPA035854"	Supported		Uncertain	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	5.8	11.8	29.5	4.8	64.4	0.1	11.8	38.6	46.2	23.6	0.0	21.6	17.4	9.9	8.0	10.7	15.2	12.6	8.4	48.0	34.8	24.2	7.9	7.2	2.2	40.1	33.2	12.8	12.7	1.0	21.6	2.5	56.3	13.1	19.3	19.4	42.9	13.4	2.1	7.1	17.3	7.0	35.3	10.6	27.4	1.9	37.9	2.9	50.6	3.0	3.9	12.0	11.5	116.2	10.2	0.2	47.0	24.2	22.0	27.2	0.5	12.7	15.4	3.6	4.5	4.1	0.2	0.1	7.7	21.7	8.5	6.4	24.7	4.7	3.2	0.0	5.4	0.1	4.6	0.5	24.7	0.1	0.1	13.5	2.3	5.4	4.7	12.9	3.4	0.4	0.2	0.0	4.9	0.4	2.4	0.1	37.4	27.5	8.8	1.0	9.4	0.0	37.0	11.8	14.5	27.3	4.4	2.7	46.8	6.9	1.7	0.5	2.8	12.7	3.0	10.8	3.9	0.0	0.0	0.1	20.9	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	29.5	64.4	38.6	46.2	48.0	34.8	40.1	33.2	56.3	35.3	37.9	116.2	11.2	6.4	33.7	189.0	2.6	7.0	15.3	40.2	9.1	67.7	40.5	29.1	39.6	17.2	82.1	58.8	29.2	2.0	0.7	59.4	101.8	9.6	3.3	113.3	16.3	17.3	62.3	0.4	266.4	26.1	0.5	22.0	80.0	95.6	1.3	4.8	21.0	12.4	1.4	111.0	211.2	64.1	54.9	0.8	7.7	2.4	29.5	2.2	64.0	21.5	3.2	86.9	0.0	237.2	1132.8	22.5	41.4	32.7	1.5	17.8	62.9	14.7	106.0	23.4	26.3	14.7	16.2	0.4	1.3	5.0	4.0	0.7	2.8	8.7	90.8	33.7
TRIM21	"RNF81, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004566, HPA005673"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favorable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.26e-6)"	"unprognostic (9.12e-3)"	14.1	13.0	6.1	21.6	6.0	27.7	11.9	5.9	8.0	11.9	7.2	17.1	20.3	12.5	13.0	12.0	14.6	12.9	13.1	5.5	6.8	16.3	17.6	23.5	23.8	8.2	6.3	20.6	11.7	6.8	7.1	14.4	7.0	11.3	18.4	2.4	19.5	12.9	5.5	11.4	19.2	17.9	7.8	32.5	15.5	3.5	7.8	21.8	10.0	8.2	23.2	16.7	10.9	7.2	13.5	15.5	7.7	7.3	15.5	23.1	10.7	16.8	31.7	64.6	71.4	7.2	37.6	20.5	7.5	25.0	66.5	18.4	13.6	25.7	20.1	34.5	14.6	31.6	8.5	6.5	34.3	37.3	29.6	22.7	14.9	13.0	9.2	23.3	40.3	17.3	10.1	21.6	21.9	11.9	19.8	26.5	6.6	14.9	8.0	13.8	10.0	10.9	25.6	12.0	0.1	3.3	13.8	14.9	19.1	12.0	5.3	24.5	36.7	15.6	12.3	8.3	6.1	11.4	9.5	13.0	14.0	29.2	11.5	105.2	132.4	311.9	89.3	139.6	78.6	50.2	76.6	81.1	109.5	57.9	67.6	71.7	354.0	78.0	130.9	36.7	100.1	175.2	6.1	6.0	5.9	8.0	5.5	6.8	8.2	6.3	7.0	7.8	7.8	7.2	8.9	9.6	6.3	0.0	6.4	2.0	6.1	7.5	11.4	0.4	2.7	3.2	2.3	12.8	9.8	5.5	0.0	6.8	11.0	12.8	7.9	11.3	0.1	3.7	4.5	7.8	2.4	8.2	0.2	8.5	9.6	5.7	10.2	5.7	12.6	8.1	9.7	8.7	9.6	1.7	0.1	7.3	0.0	11.9	2.2	1.3	4.4	9.6	1.8	1.9	20.7	2.6	22.6	1.0	0.1	9.7	4.7	7.2	4.0	4.3	10.0	4.9	7.9	0.0	13.1	4.7	5.3	0.3	0.8	4.7	1.7	9.0	10.5	4.5	6.0	3.8
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 135.9;dendritic cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	54.0	21.3	13.1	101.3	18.8	90.3	50.7	16.3	23.7	42.7	25.5	36.0	25.2	50.6	70.2	37.1	49.3	78.6	22.6	14.7	16.5	21.2	72.5	83.4	139.0	17.9	16.7	60.3	17.2	8.0	12.6	21.5	16.7	43.3	53.4	11.0	65.4	52.6	13.4	18.1	53.4	52.1	17.7	143.1	39.5	15.4	12.8	101.2	21.7	40.6	120.7	61.6	22.6	29.3	2.8	1.2	13.9	2.4	88.6	174.6	5.0	53.3	93.9	89.8	209.9	1.7	8.6	111.9	13.0	80.2	20.6	10.5	34.0	56.4	10.7	2.0	0.0	6.4	5.6	1.4	107.8	18.2	11.4	190.6	54.3	18.7	9.6	124.5	128.7	1.0	2.3	4.7	111.6	1.5	54.1	16.9	40.3	0.5	4.9	62.6	3.4	2.3	51.1	14.9	1.4	2.7	4.5	4.5	2.1	56.8	4.5	17.9	153.6	56.4	29.8	2.5	2.4	4.9	4.4	11.2	67.7	28.9	7.2	108.7	118.5	79.6	109.0	143.3	145.9	149.4	118.4	117.2	138.7	158.2	106.5	102.7	103.1	61.3	181.1	177.0	197.9	181.9	13.1	18.8	16.3	23.7	14.7	16.5	17.9	16.7	16.7	17.7	12.8	29.3	54.4	67.3	57.7	2.0	135.9	12.6	17.0	42.5	56.3	0.5	17.7	14.0	6.0	7.2	60.5	29.5	0.0	1.5	113.9	4.7	5.9	11.2	0.3	16.1	27.0	40.5	4.2	16.8	4.9	8.0	4.7	36.2	20.9	23.8	17.7	5.4	33.5	4.3	18.7	1.7	0.3	9.0	30.5	87.1	46.6	2.0	36.1	67.8	5.4	52.5	59.0	6.4	83.4	1.0	0.5	5.4	6.3	30.1	18.8	9.9	4.4	3.3	52.5	1.0	13.1	35.1	24.4	0.6	0.3	14.1	8.7	2.3	89.3	13.0	5.0	18.8
TRIM23	"ARD1, ARFD1, RNF46"	ENSG00000113595	"Tripartite motif containing 23"	P36406	5	65589690-65625975	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039605	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"			"HPA039605: AB_10673146"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.70e-1)"	8.1	10.8	12.3	6.0	13.8	7.7	8.2	18.1	17.7	9.1	5.2	6.1	3.9	9.2	6.0	7.4	7.0	5.3	11.0	14.5	12.0	8.8	10.8	5.7	7.5	10.8	10.2	13.2	5.4	8.4	4.7	7.1	12.9	11.4	4.3	14.6	5.5	7.6	13.2	6.2	4.6	7.8	12.7	7.6	4.4	10.4	12.0	8.6	10.6	17.5	6.7	6.3	5.2	19.3	8.5	11.8	12.6	18.2	17.9	17.9	9.1	16.7	15.2	13.3	16.4	12.2	8.2	6.7	18.8	11.0	13.8	7.3	11.7	9.4	20.1	6.7	15.0	5.8	15.7	6.6	16.8	3.8	7.2	14.0	8.1	14.9	13.5	12.7	6.4	8.0	6.4	9.2	16.5	7.8	7.4	4.0	6.6	1.5	4.7	6.6	21.9	9.7	7.3	8.6	7.5	10.2	15.9	4.4	13.2	10.3	10.3	4.6	11.0	10.5	11.4	13.2	12.3	11.3	12.2	8.8	12.1	6.6	10.4	19.9	3.5	8.9	4.7	2.8	5.9	3.9	5.1	4.0	3.2	4.7	8.0	6.1	9.2	5.1	4.4	3.5	6.4	3.9	12.3	13.8	18.1	17.7	14.5	12.0	10.8	10.2	12.9	12.7	12.0	19.3	13.8	19.2	7.8	28.1	13.1	6.9	2.3	4.4	7.4	28.2	7.0	7.1	22.3	10.0	6.8	5.5	16.7	3.8	12.5	4.7	5.9	4.9	7.0	9.4	21.3	11.1	6.6	21.0	49.1	3.1	2.6	17.1	5.6	7.6	3.8	19.7	13.9	13.0	3.9	45.4	49.3	4.4	2.0	10.0	3.5	4.2	20.8	7.4	10.6	24.4	6.8	27.2	8.2	39.7	49.7	5.8	4.3	17.0	11.4	9.1	6.0	10.1	11.8	24.8	32.9	16.0	12.9	27.2	16.9	5.0	6.3	7.0	13.1	16.0	3.8	6.9
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56836387-56914080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 23.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	16.3	20.7	9.8	19.8	10.4	47.7	13.1	9.5	23.2	14.5	11.1	19.7	19.4	12.1	8.5	20.4	18.2	9.7	11.1	9.0	11.3	11.9	29.8	25.0	17.3	10.3	9.9	14.3	16.7	13.0	10.3	9.5	10.3	9.3	17.3	11.8	15.3	7.4	12.6	29.2	20.2	12.4	11.4	41.6	17.0	9.1	12.1	18.5	10.8	7.6	19.7	12.1	14.6	9.0	77.2	37.4	9.0	30.7	66.6	55.8	0.1	29.6	59.6	69.4	59.3	36.7	41.1	74.6	59.8	28.6	75.4	44.5	44.5	39.9	38.5	64.1	35.0	48.1	29.0	41.0	57.0	58.2	33.2	25.1	65.7	36.2	76.4	32.9	46.7	50.2	12.0	43.8	35.8	51.3	65.6	41.9	5.8	63.3	71.5	46.3	30.2	47.4	40.5	59.7	17.5	16.3	23.3	37.1	69.7	5.8	50.3	46.8	31.3	32.2	23.1	50.1	31.2	24.7	51.1	12.1	31.2	39.4	13.0	4.8	3.0	1.2	1.0	2.5	1.3	2.2	0.9	1.0	3.1	1.7	0.7	1.0	23.5	1.1	1.8	2.2	2.0	1.1	9.8	10.4	9.5	23.2	9.0	11.3	10.3	9.9	10.3	11.4	12.1	9.0	27.3	35.3	19.8	7.5	12.7	18.5	8.5	10.5	13.1	9.9	12.6	11.9	7.5	20.0	16.6	9.2	29.2	5.4	15.1	54.8	0.0	19.1	3.5	44.9	20.0	32.7	18.6	11.1	4.1	21.6	10.7	16.0	32.6	72.5	3.8	23.0	32.2	30.9	14.8	3.3	8.2	28.7	6.1	27.5	24.6	2.1	9.6	29.3	14.2	8.4	28.3	5.7	11.3	12.1	0.3	32.2	54.2	9.4	17.7	21.6	20.0	8.0	18.5	22.2	6.6	13.1	9.2	0.4	0.3	24.5	30.5	15.9	11.5	45.3	25.7	25.4
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	15.6	16.5	3.6	6.9	4.4	4.5	16.3	4.5	7.1	15.8	3.7	17.9	5.6	16.8	2.9	28.9	16.4	4.9	12.5	3.3	4.9	18.1	26.1	16.8	6.6	4.7	4.0	12.5	15.5	4.2	14.1	2.9	4.3	18.2	2.3	4.2	21.0	3.2	14.5	20.8	19.8	1.1	3.6	18.0	17.6	11.5	4.8	3.9	17.6	1.3	6.6	17.8	17.4	4.9	15.7	8.3	0.0	23.8	8.1	4.6	7.8	9.7	5.4	11.4	11.6	0.0	0.9	38.2	13.0	12.4	17.0	17.6	0.0	16.8	3.5	0.0	13.0	6.1	2.5	16.7	7.1	13.3	5.4	4.6	5.7	11.9	7.1	0.0	7.6	18.4	2.8	0.0	0.0	0.0	19.1	17.8	0.0	0.0	6.7	16.9	15.1	5.3	9.8	14.5	0.5	11.0	18.5	0.9	5.2	5.0	8.0	2.3	16.5	8.7	5.8	0.0	0.2	15.1	31.2	18.1	0.0	21.3	15.0	0.5	1.5	0.1	1.8	1.9	1.2	1.0	1.2	1.5	1.2	1.4	0.7	1.0	0.5	0.7	1.6	0.5	1.6	1.3	3.6	4.4	4.5	7.1	3.3	4.9	4.7	4.0	4.3	3.6	4.8	4.9	13.5	28.9	21.7	18.3	23.8	30.1	22.4	13.1	34.7	20.1	22.0	18.0	13.5	18.6	15.7	12.9	16.7	18.6	31.1	21.8	11.7	16.1	0.5	25.7	15.1	16.2	22.3	1.7	16.5	15.9	14.4	12.7	17.9	34.7	5.1	12.2	9.3	52.9	13.8	13.5	25.1	15.4	6.1	17.3	25.7	1.6	7.5	21.0	17.8	18.7	24.0	12.1	21.6	18.1	26.9	13.6	15.7	12.0	26.3	20.2	17.1	15.8	24.4	19.7	6.6	10.7	12.1	5.0	13.4	42.0	34.0	17.6	28.7	9.4	17.2	22.3
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923988	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	23.8	28.1	1.8	7.2	1.7	1.1	23.3	1.1	2.6	33.0	2.2	23.0	8.7	24.5	0.0	20.5	31.0	0.5	24.3	1.6	1.3	32.7	59.5	26.8	2.2	2.2	2.1	30.8	53.0	0.6	33.8	4.5	1.8	35.1	0.6	0.1	25.8	6.5	21.2	17.6	26.8	2.3	1.5	45.8	27.3	14.4	2.0	0.9	26.3	0.0	1.0	28.7	22.6	2.0	2.4	8.2	1.2	21.7	2.8	6.2	0.3	16.1	0.8	5.1	6.2	6.1	1.7	1.6	1.1	4.8	1.3	17.5	4.0	9.2	0.5	1.3	2.6	20.3	2.5	9.3	4.3	2.0	5.7	0.1	1.0	4.1	1.3	0.6	4.5	5.8	2.1	12.1	1.3	4.9	11.1	0.9	0.0	3.4	13.5	20.1	4.6	49.7	3.9	2.3	4.9	18.7	19.9	11.6	4.1	0.6	11.6	12.2	13.1	6.3	9.3	14.7	5.1	31.7	2.7	17.9	6.8	24.8	20.0	5.2	4.4	2.5	7.0	12.5	11.3	7.0	10.6	5.5	8.5	1.8	4.1	7.6	2.7	6.4	7.0	5.6	5.2	9.9	1.8	1.7	1.1	2.6	1.6	1.3	2.2	2.1	1.8	1.5	2.0	2.0	21.4	16.0	24.8	11.8	32.2	28.4	41.9	27.4	33.6	11.7	32.2	24.6	18.3	24.3	24.0	29.5	16.7	46.4	25.4	15.9	21.5	39.5	12.9	27.1	27.0	32.0	27.6	24.6	13.5	43.4	55.5	25.5	26.5	27.2	21.5	36.9	27.8	42.1	41.1	8.4	13.4	38.5	26.4	28.3	23.5	6.8	23.9	29.0	8.8	16.9	46.5	10.4	29.9	19.1	19.7	48.9	18.7	18.4	51.2	53.3	19.3	27.6	23.9	13.6	19.7	14.8	31.0	8.0	16.1	25.8	19.6	45.6	28.9	43.7	28.3	30.9
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544064-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 2817.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	103.1	111.0	83.5	103.8	85.9	217.5	104.4	91.1	100.1	152.9	77.5	159.9	90.8	163.3	42.8	132.6	142.8	73.6	114.7	83.1	80.1	122.1	104.6	103.5	142.5	85.5	83.4	228.1	183.7	89.4	98.7	108.9	89.1	128.8	57.8	39.4	108.4	108.8	172.4	143.3	117.7	94.6	86.0	137.4	136.7	215.5	82.8	186.6	117.9	77.0	109.2	147.7	115.1	97.2	481.6	1080.4	491.9	365.1	218.9	186.5	616.5	321.5	291.1	311.4	237.0	732.8	375.0	562.5	196.1	270.7	492.8	317.7	590.5	480.5	163.6	281.3	2817.1	1012.8	407.6	537.7	254.4	640.9	577.5	252.4	248.2	385.9	274.9	220.1	301.3	597.7	507.1	259.4	284.8	705.0	756.5	640.8	372.8	443.6	637.5	761.9	340.9	550.2	260.8	730.6	517.1	403.4	343.9	359.3	170.7	131.9	273.2	493.1	272.4	643.1	273.2	148.6	562.5	397.7	665.7	604.7	293.0	432.9	418.6	1.9	9.7	8.2	12.8	11.1	17.2	15.9	18.0	17.4	13.7	19.1	22.8	20.5	4.3	24.9	7.9	21.2	12.4	10.1	83.5	85.9	91.1	100.1	83.1	80.1	85.5	83.4	89.1	86.0	82.8	97.2	60.8	12.8	18.6	18.3	51.0	64.2	60.2	34.7	47.3	61.8	86.6	87.5	9.5	51.5	29.0	33.1	27.1	61.2	72.4	88.3	23.5	44.8	96.9	70.7	53.3	49.7	64.6	46.7	10.3	56.3	61.6	48.3	65.7	80.2	21.6	136.3	35.7	31.9	46.9	55.5	12.6	79.4	14.2	36.5	70.7	110.6	65.9	48.3	28.4	6.5	32.8	49.8	19.6	10.6	18.2	56.3	50.0	41.3	43.5	52.1	47.3	36.3	28.7	34.1	59.2	69.3	61.6	158.7	83.1	58.0	60.7	56.1	54.5	80.9	94.1	45.6
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111286-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 600.1;skin 1: 551.2;vagina: 269.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 4.0"	"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	2.5	1.0	0.1	0.4	0.2	0.4	41.7	0.0	0.4	133.8	1.6	3.0	1.7	2.6	4.8	600.1	17.4	3.5	0.4	0.3	0.0	1.7	1.8	3.7	0.0	1.8	0.6	0.4	1.0	0.0	8.1	30.7	1.8	31.4	2.6	0.3	131.5	23.7	2.2	551.2	1.0	1.5	2.6	0.3	1.4	2.7	0.0	19.9	0.4	0.2	107.2	55.8	269.1	0.6	34.4	2.5	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.2	0.1	0.8	25.6	0.2	3.9	0.2	0.5	399.9	0.0	107.5	0.0	0.1	0.0	0.2	25.4	0.4	0.0	0.2	0.5	0.0	476.0	0.0	2.6	0.0	0.0	0.0	0.2	0.7	0.0	4.4	0.0	0.0	0.1	11.4	0.1	0.0	0.3	0.0	0.3	190.5	1.3	5.9	268.3	35.2	0.1	0.2	1.9	0.0	0.4	0.1	2.1	0.2	0.1	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.0	1.8	0.6	1.8	2.6	0.0	0.6	0.5	0.0	1.5	3.3	0.2	272.0	106.1	76.4	250.4	0.0	9.5	58.8	1.2	1.5	39.2	0.0	0.0	41.0	0.2	11.3	0.0	5.0	28.1	8.7	0.8	3.4	2.4	0.0	0.5	4.3	7.1	5.6	1.1	3.6	1.3	0.0	0.0	0.4	5.0	0.0	0.1	2.1	12.2	0.0	30.3	150.3	0.6	1.4	23.2	1.0	0.0	0.0	0.0	0.0	0.1	57.1	11.3	0.0	0.0	66.0	0.2	0.6	64.6	0.0	0.0	0.1	4.9	0.8	2.6	552.9	460.6	24.8	2.4	0.1	3.7	159.3
TRIM3	"BERP, HAC1, RNF22, RNF97"	ENSG00000110171	"Tripartite motif containing 3"	O75382	11	6448613-6474459	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043396, HPA048233"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA043396: AB_2678460, HPA048233: AB_2680321"	"unprognostic (1.24e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (4.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	9.5	4.6	6.4	4.6	6.2	1.3	10.3	11.6	7.5	11.2	0.0	13.0	17.8	13.5	1.8	4.8	10.1	4.1	8.0	5.8	3.4	6.3	6.3	9.7	2.4	8.5	3.1	8.7	6.4	2.7	5.9	3.9	9.4	9.5	4.8	4.8	9.0	5.4	11.5	8.4	15.7	5.6	2.2	5.7	10.1	3.8	5.9	1.5	6.8	4.8	1.6	11.2	9.3	6.1	7.2	12.4	4.9	8.3	8.1	7.8	6.7	10.3	6.1	7.8	8.6	7.6	5.0	3.9	3.6	7.9	9.1	5.0	5.1	7.7	3.0	4.8	7.6	1.2	13.5	5.3	5.2	0.4	4.1	6.7	3.7	6.1	3.2	3.3	8.0	2.9	1.7	4.7	7.8	15.2	0.3	1.0	3.5	15.2	10.7	2.4	4.2	4.9	1.9	3.8	5.1	7.8	5.7	54.9	6.6	2.5	20.8	1.3	13.4	20.3	9.5	15.0	6.9	5.5	3.6	0.8	11.0	1.7	7.6	0.0	1.0	0.6	0.5	1.0	0.4	0.1	0.4	0.4	1.2	0.1	0.1	0.6	0.0	0.6	0.2	0.2	0.5	0.5	6.4	6.2	11.6	7.5	5.8	3.4	8.5	3.1	9.4	2.2	5.9	6.1	8.5	6.4	0.0	9.8	2.4	4.8	2.8	2.8	3.4	8.8	8.5	6.0	2.2	2.8	2.7	0.0	10.4	1.8	3.5	16.0	0.0	3.1	3.9	2.8	4.4	6.5	4.8	0.4	13.2	3.5	2.2	6.9	5.6	7.3	1.3	3.6	4.6	2.5	4.7	8.4	12.2	11.4	4.1	0.8	6.5	5.6	5.9	3.5	7.2	11.2	3.4	2.2	3.1	5.0	10.2	3.1	5.4	5.3	2.5	3.2	28.7	3.1	8.4	9.6	13.1	5.0	11.3	3.1	6.0	3.7	5.4	0.8	3.4	3.3	6.6	2.3
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.1;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.4	12.1	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687305-116701300	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	6.7	7.2	4.6	5.4	4.5	1.0	6.8	16.4	5.4	10.1	15.2	6.0	5.9	10.6	6.5	7.4	13.1	6.4	7.9	4.7	6.1	5.2	3.8	5.5	8.1	3.6	2.8	10.1	6.2	8.6	3.5	6.1	3.9	6.9	6.2	7.2	5.2	7.3	18.6	4.6	7.2	10.7	2.1	6.2	5.4	5.2	4.5	7.5	6.3	12.5	7.4	7.6	5.7	3.4	10.9	24.5	14.3	15.7	28.3	20.1	10.8	19.9	21.7	22.1	18.4	16.4	11.7	11.3	8.6	30.7	16.5	22.8	17.5	22.4	20.0	9.9	8.5	6.1	15.4	10.2	14.7	4.1	19.1	17.4	19.7	21.0	12.3	24.4	14.6	12.4	8.6	9.3	26.3	13.9	11.0	0.1	13.0	26.2	14.6	12.7	38.2	7.4	9.0	25.1	14.2	7.2	15.7	10.8	11.4	14.3	29.8	4.0	18.2	20.4	16.2	15.3	15.2	15.1	4.3	17.7	17.0	2.7	20.5	0.0	1.7	0.0	10.9	3.3	8.4	7.3	9.5	8.7	2.3	5.1	9.6	9.8	0.3	7.0	3.0	4.3	20.9	6.0	4.6	4.5	16.4	5.4	4.7	6.1	3.6	2.8	3.9	2.1	4.5	3.4	2.5	6.4	0.6	5.5	4.3	4.2	6.3	9.3	5.7	11.7	3.1	3.7	7.6	7.2	7.3	9.2	0.0	6.7	2.1	1.7	1.9	8.5	3.5	7.1	10.7	3.6	4.2	0.4	7.6	8.0	3.6	6.1	3.6	2.3	2.5	4.5	2.9	4.1	7.2	1.7	10.1	4.0	8.2	2.4	4.7	2.1	5.3	2.2	1.8	1.9	0.8	4.0	3.1	6.6	5.1	5.0	2.6	12.0	3.1	2.8	10.6	3.1	10.8	4.8	0.0	6.0	6.6	17.7	13.1	5.6	3.7	7.4	4.7	5.0	5.3	4.8
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392790-114511203	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	9.3	8.1	10.1	10.7	11.3	25.4	13.5	18.3	16.9	12.5	8.2	9.5	8.8	15.2	29.8	11.7	9.1	10.9	8.9	11.5	9.9	13.5	12.2	10.9	13.3	8.0	9.1	14.4	12.2	15.3	7.3	16.0	8.2	12.6	10.1	18.8	10.7	11.0	8.8	14.8	8.9	11.8	8.1	12.7	11.2	25.3	9.5	17.8	14.2	10.7	12.8	11.5	9.8	11.3	30.9	16.3	30.1	22.6	12.5	13.1	51.0	15.4	16.3	20.9	22.1	18.5	12.8	32.8	15.5	18.1	13.6	17.4	27.6	18.0	28.6	24.9	16.4	31.6	21.7	21.6	13.8	40.3	25.3	12.5	12.9	24.9	25.2	16.0	17.8	27.3	40.1	22.5	20.2	115.4	40.9	17.0	40.7	11.7	16.3	34.8	45.9	10.8	14.9	47.7	20.8	21.9	29.2	34.7	27.4	19.3	15.8	21.7	20.1	14.5	23.4	33.8	21.7	15.7	15.6	33.4	20.4	23.0	42.0	13.2	1.2	6.1	2.5	1.5	2.2	3.0	2.6	2.7	1.5	1.4	2.0	3.1	3.6	4.1	2.4	3.0	1.6	0.8	10.1	11.3	18.3	16.9	11.5	9.9	8.0	9.1	8.2	8.1	9.5	11.3	31.0	19.2	33.3	70.5	35.4	52.8	28.9	28.6	25.6	75.6	35.9	23.9	29.2	30.0	32.3	55.2	98.0	64.9	53.9	33.3	1.9	21.0	237.3	50.4	37.5	33.2	52.1	37.9	120.7	23.6	34.0	28.7	30.1	90.0	37.4	55.6	40.7	44.3	29.6	26.9	108.5	30.4	30.5	50.3	47.9	97.9	49.0	37.2	19.6	79.6	42.9	31.5	54.6	116.6	101.8	31.4	34.9	36.9	31.6	47.3	26.6	17.3	31.4	58.3	32.9	38.3	32.5	60.0	31.9	31.2	55.4	87.7	42.8	48.1	31.2	55.3
TRIM35	"HLS5, KIAA1098, MAIR"	ENSG00000104228	"Tripartite motif containing 35"	Q9UPQ4	8	27284886-27311272	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA019647: AB_1858291"	"unprognostic (7.67e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.61e-2)"	"unprognostic (9.64e-3)"	"unprognostic (9.35e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (8.79e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.59e-7)"	"unprognostic (1.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.92e-1)"	9.4	6.1	6.5	5.9	8.2	7.2	8.4	8.1	9.2	8.9	13.7	7.9	5.5	8.8	4.5	10.7	7.4	3.6	5.5	8.9	6.8	6.3	11.9	5.9	6.9	10.0	7.7	6.1	5.9	4.6	4.2	5.3	9.7	7.3	3.9	4.1	16.3	9.0	5.0	32.2	6.2	7.2	6.7	6.2	5.9	6.4	9.8	8.1	4.6	4.6	7.0	8.2	10.4	11.7	17.4	12.3	7.0	9.0	68.4	16.9	16.1	10.3	8.1	9.4	10.0	17.6	3.4	15.3	10.3	11.5	8.3	17.0	10.1	19.9	7.1	8.7	7.6	15.1	10.3	15.1	17.8	8.3	12.4	24.6	44.2	13.3	26.1	5.0	9.4	14.5	10.8	16.4	7.7	9.0	27.8	11.3	12.3	11.1	9.8	13.8	9.0	13.3	6.4	13.5	11.9	11.4	8.6	8.1	14.3	6.7	5.2	13.2	10.9	8.5	17.7	27.1	10.2	7.5	8.5	11.1	12.1	12.0	8.5	11.9	3.0	4.0	8.6	3.0	9.7	5.3	11.2	9.7	3.8	3.8	7.5	11.2	1.1	8.9	3.4	6.4	14.5	5.3	6.5	8.2	8.1	9.2	8.9	6.8	10.0	7.7	9.7	6.7	9.8	11.7	9.4	3.2	4.5	5.2	4.4	20.9	6.0	4.6	40.9	3.5	3.6	2.7	5.0	8.6	3.8	12.9	6.2	3.5	3.2	3.6	0.0	3.7	1.0	4.0	3.7	6.7	2.4	8.6	8.3	5.1	2.8	6.6	6.1	4.6	5.7	3.8	23.9	20.3	2.9	5.0	5.3	2.7	6.1	8.9	6.2	0.6	12.8	6.9	7.2	3.7	5.2	3.5	3.1	4.5	16.8	4.7	2.0	10.9	4.8	3.6	4.5	6.1	0.9	3.5	0.0	3.4	5.5	1.3	3.9	15.0	22.3	1.5	6.9	2.4	3.5	2.5
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 129.2;Excitatory neurons: 96.7;Inhibitory neurons: 105.2;Late spermatids: 88.8;Spermatocytes: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 30.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 30.4;T-cells: 8.3"	"Cell line enriched"	"Detected in all"	4	"MCF7: 242.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	8.8	12.3	16.2	9.5	19.3	6.8	8.2	24.8	31.4	7.9	5.2	9.0	6.7	8.8	10.7	8.4	9.7	8.9	11.5	19.5	13.8	7.6	8.2	8.9	9.0	21.4	15.2	6.1	7.7	8.6	10.3	9.4	23.0	9.4	7.0	32.9	5.8	9.2	11.1	7.4	6.2	10.8	9.4	8.6	6.5	62.3	18.2	12.1	13.3	12.7	8.4	9.0	6.5	18.7	21.4	33.3	21.9	27.5	20.5	19.0	35.3	24.0	36.9	25.3	41.4	19.6	14.4	21.1	36.1	25.3	43.3	19.0	31.5	17.7	40.5	41.8	30.4	32.6	28.9	27.1	36.1	16.8	15.8	15.4	16.1	32.5	40.8	25.8	33.0	19.1	25.4	29.7	24.9	242.4	34.0	9.5	31.5	28.9	22.0	15.0	57.1	13.7	24.0	29.7	51.7	29.9	24.8	10.2	23.2	26.4	30.4	7.8	25.9	39.5	47.6	36.5	27.6	30.5	48.5	18.5	26.8	17.5	18.7	30.4	3.7	4.5	7.2	2.7	6.7	3.6	4.7	4.6	4.0	3.9	4.0	5.4	5.3	3.4	2.8	3.0	8.3	3.1	16.2	19.3	24.8	31.4	19.5	13.8	21.4	15.2	23.0	9.4	18.2	18.7	10.3	9.6	11.0	44.4	13.2	7.9	6.0	6.5	15.4	19.7	13.2	12.2	24.1	7.2	15.6	9.2	33.3	15.1	7.8	12.0	3.9	10.3	129.2	30.8	13.8	13.7	12.0	12.8	96.7	5.6	10.6	14.0	11.7	13.5	10.8	18.0	12.1	18.9	8.7	45.4	105.2	7.2	16.2	9.1	6.9	88.8	9.9	9.3	12.4	18.7	7.2	19.9	5.2	36.2	43.5	10.2	11.3	17.7	15.1	9.9	3.3	9.7	29.1	38.8	13.1	10.9	17.3	133.1	45.0	14.0	6.3	17.8	14.7	19.7	9.1	6.8
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991231	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	7.1	6.0	1.8	10.8	1.8	13.0	6.1	1.6	2.4	7.3	3.4	5.8	6.6	7.3	9.6	7.8	7.4	6.6	3.7	1.7	1.9	9.9	5.6	9.3	13.6	3.0	2.1	4.6	3.2	2.9	2.0	6.3	2.7	7.0	7.3	0.4	6.1	6.2	7.6	5.2	8.9	6.1	2.4	14.3	5.8	2.1	2.7	7.7	5.5	3.0	14.6	7.0	7.0	2.7	4.8	2.6	0.4	5.6	13.0	17.3	4.6	5.9	11.7	11.2	18.5	2.0	5.0	10.5	9.4	7.3	10.8	7.3	3.6	5.8	6.6	10.7	2.3	4.8	4.6	2.0	17.2	5.7	9.4	17.4	4.2	6.9	2.5	9.2	9.8	5.0	3.2	5.7	13.5	2.3	5.5	6.4	1.8	0.0	3.5	8.3	5.4	11.2	13.3	9.3	0.1	0.1	4.4	9.1	16.2	0.6	1.3	7.3	10.1	2.0	3.4	3.5	4.0	6.5	5.1	11.7	5.4	6.9	12.6	12.1	10.2	4.7	6.9	12.5	6.6	13.1	5.8	6.2	9.8	15.1	5.4	6.0	11.4	6.5	11.7	9.0	7.9	7.1	1.8	1.8	1.6	2.4	1.7	1.9	3.0	2.1	2.7	2.4	2.7	2.7	37.6	25.6	47.1	0.3	120.2	14.9	56.9	16.1	24.5	0.6	20.1	12.8	6.0	18.6	32.4	46.0	0.0	23.5	88.5	48.3	17.6	28.5	1.1	48.4	28.1	39.9	18.1	10.3	0.1	14.9	23.5	25.5	24.5	69.4	35.5	52.4	35.0	17.5	32.6	0.0	0.1	33.3	16.2	94.0	32.7	2.8	19.9	81.3	10.6	34.7	113.2	0.2	107.1	0.0	0.2	20.4	47.4	18.8	34.3	39.7	48.3	69.5	22.7	1.1	6.6	23.1	28.2	0.3	0.5	42.7	9.2	21.2	53.1	23.0	25.6	94.7
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	10.0	8.7	0.8	1.7	1.0	3.1	10.2	1.3	1.1	11.4	1.5	13.6	1.6	12.1	2.2	13.1	11.7	1.3	8.7	0.9	0.9	9.8	11.6	9.7	1.6	1.3	1.0	11.5	12.2	2.1	14.8	1.6	1.0	10.8	1.5	1.5	10.2	2.0	14.3	9.3	11.9	1.8	0.8	14.3	11.0	20.7	1.1	1.7	11.6	1.4	2.1	12.9	9.5	1.1	3.2	0.1	2.6	4.8	1.2	1.2	2.7	1.4	1.8	2.1	1.9	3.8	0.4	4.1	2.8	2.7	1.3	1.0	3.1	2.2	2.2	3.2	3.4	3.2	0.5	1.4	2.7	4.8	3.5	1.4	1.8	2.7	2.9	3.2	1.3	3.4	4.9	3.2	2.7	2.9	1.0	1.0	3.6	1.3	2.2	2.2	0.5	3.1	2.2	3.0	5.7	2.8	1.1	2.3	2.8	2.5	3.1	1.2	1.2	2.3	1.8	2.8	4.9	5.7	7.6	4.2	1.3	1.7	3.6	1.0	0.9	4.1	2.7	1.3	2.4	1.8	1.9	2.0	0.9	1.6	2.2	2.2	4.5	2.6	1.4	0.7	1.7	1.4	0.8	1.0	1.3	1.1	0.9	0.9	1.3	1.0	1.0	0.8	1.1	1.1	5.9	3.2	7.2	0.7	14.2	3.7	5.6	2.6	6.8	6.0	7.5	5.2	5.6	2.8	3.5	1.8	6.2	4.7	11.9	5.5	7.9	4.6	4.6	11.2	4.1	4.8	5.4	3.6	0.9	6.1	5.7	4.1	15.3	13.1	5.7	4.2	5.7	3.7	3.3	3.3	1.1	7.3	4.1	7.2	5.0	7.8	2.8	7.3	3.6	1.0	4.3	6.9	8.2	0.5	0.9	6.8	10.0	4.5	10.9	3.7	7.5	4.0	7.2	7.6	0.0	3.8	5.8	19.1	10.0	5.3	4.1	10.0	15.3	3.5	4.4	5.3
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Club cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051120	Uncertain		Approved	Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919531	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	18.7	21.5	11.0	17.1	11.5	9.3	26.8	15.5	12.6	18.9	15.4	17.3	17.5	23.7	19.8	15.3	22.9	15.2	10.0	10.5	11.9	20.6	22.9	18.5	22.4	11.2	11.9	41.3	23.8	25.5	16.2	19.9	10.9	23.0	19.2	21.5	19.0	20.2	7.5	21.8	18.6	19.9	10.7	21.5	20.1	16.0	12.0	20.9	24.5	11.8	23.8	17.3	17.3	13.3	20.8	26.2	14.4	12.0	37.0	34.6	6.3	34.6	41.3	28.0	32.4	13.1	20.1	30.3	0.1	28.8	24.2	24.3	19.0	21.2	28.4	31.2	1.4	25.3	13.1	20.8	52.4	35.9	29.4	36.9	44.3	21.6	54.7	37.8	24.6	14.9	37.1	45.3	23.9	26.4	26.8	32.2	10.9	31.0	21.0	15.0	20.6	34.6	31.6	26.4	16.8	11.9	26.4	39.4	42.3	20.7	18.2	20.2	30.6	30.7	27.6	59.5	33.6	37.7	44.4	24.0	20.1	39.7	41.7	38.2	28.4	23.6	28.5	28.6	32.8	26.2	29.4	32.6	24.9	25.3	40.7	30.4	11.7	22.3	26.1	18.5	32.8	28.0	11.0	11.5	15.5	12.6	10.5	11.9	11.2	11.9	10.9	10.7	12.0	13.3	17.8	25.6	20.1	19.2	32.3	25.1	24.8	17.7	25.0	21.6	21.8	18.0	6.1	18.6	14.2	22.0	18.8	16.4	28.1	10.1	9.8	15.9	7.4	12.5	25.4	18.8	9.0	16.8	18.3	12.8	6.7	20.1	19.4	11.4	27.3	19.0	22.5	20.4	14.3	6.7	20.7	10.4	16.2	21.4	14.8	13.1	31.1	21.2	23.2	12.2	27.0	35.9	32.0	23.1	22.5	14.9	10.4	27.4	20.1	26.6	17.8	19.0	16.5	22.1	0.0	21.8	20.4	22.4	9.4	18.0	23.0	16.3	29.8	52.5	13.5	23.6
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235808	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 77.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (2.68e-2)"	7.9	9.6	52.7	7.5	57.8	8.1	5.8	48.3	50.8	6.9	31.3	6.6	8.4	7.6	5.8	10.1	6.4	3.2	9.4	42.2	44.1	9.5	12.2	6.2	4.9	57.3	57.3	6.0	9.9	11.7	10.9	4.1	53.2	6.8	2.7	7.0	7.6	5.6	26.1	9.8	7.2	3.5	54.5	8.2	8.8	13.2	53.8	10.1	11.7	12.7	5.2	6.8	6.7	54.7	9.3	24.0	8.7	14.6	10.1	10.0	20.6	13.3	7.2	9.6	9.0	20.4	13.8	16.0	21.4	9.1	18.0	17.3	9.1	31.9	5.2	77.8	29.2	17.8	24.9	11.7	9.7	13.3	11.8	8.8	16.1	12.0	4.2	9.3	5.6	23.8	22.7	18.8	5.3	33.8	20.0	14.7	8.3	7.0	11.3	18.7	13.2	20.9	5.5	14.7	13.5	12.7	12.3	14.3	18.7	3.8	28.7	14.8	11.7	13.1	8.9	8.0	10.3	41.2	28.1	21.9	13.7	15.3	11.3	0.2	0.3	0.6	0.6	0.3	0.9	0.5	0.6	1.1	0.4	0.6	0.6	0.8	1.0	0.6	0.7	0.7	0.9	0.4	52.7	57.8	48.3	50.8	42.2	44.1	57.3	57.3	53.2	54.5	53.8	54.7	9.1	3.2	12.4	11.4	10.1	8.0	9.5	7.5	8.0	19.1	10.5	8.9	13.2	12.8	10.0	11.0	18.8	14.6	13.6	12.3	11.7	8.5	8.0	15.8	12.9	10.4	12.7	5.9	5.2	12.1	10.0	7.5	16.8	12.4	2.5	12.3	10.4	21.0	8.8	28.6	5.3	13.1	12.2	15.1	7.3	4.0	5.3	10.1	8.8	5.6	11.8	15.0	14.4	1.5	5.8	9.9	12.3	11.7	11.1	9.5	16.0	8.0	24.1	30.4	0.0	24.4	10.7	33.2	23.7	12.3	11.2	13.0	13.6	10.2	12.6	8.3
TRIM43	TRIM43A	ENSG00000144015	"Tripartite motif containing 43"	Q96BQ3	2	95592001-95599778	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.4;Spermatogonia: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042223, HPA042772"	Uncertain					NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA042223: AB_10962361, HPA042772: AB_10964436"				"unprognostic (7.17e-3)"						"unprognostic (1.42e-1)"					"unprognostic (9.27e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM43B		ENSG00000144010	"Tripartite motif containing 43B"	A6NCK2	2	95477164-95484731	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042223, HPA042772"	Uncertain					NA	NA									"HPA042223: AB_10962361, HPA042772: AB_10964436"										"unprognostic (3.93e-1)"					"unprognostic (1.24e-1)"			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM44	"DIPB, MC7"	ENSG00000166326	"Tripartite motif containing 44"	Q96DX7	11	35662775-35818007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049053, HPA057633"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Plasma membrane"	"HPA049053: AB_2680613, HPA057633: AB_2683484"	"unprognostic (2.73e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-1)"	12.6	10.7	16.9	12.3	16.4	6.0	11.1	18.5	21.9	10.9	8.3	13.5	10.6	10.9	10.2	9.1	11.1	11.6	11.6	16.6	17.0	18.0	14.4	11.9	12.8	16.0	16.7	10.3	15.5	11.1	7.9	13.3	16.1	10.4	11.1	27.0	9.4	11.4	11.5	8.3	12.0	12.2	17.8	14.1	11.3	6.7	17.3	12.1	14.9	9.8	13.2	11.1	8.6	19.0	20.1	16.9	26.4	12.3	19.6	29.6	0.1	18.5	21.9	22.7	20.6	19.7	13.3	26.7	17.1	24.3	25.7	15.4	9.1	21.1	25.4	17.6	17.4	28.7	23.0	11.4	26.0	22.7	23.7	22.4	23.2	13.3	36.0	25.1	24.3	9.2	45.4	9.3	24.1	12.1	24.1	11.1	14.9	4.2	14.5	16.6	68.4	14.5	21.0	26.9	18.1	15.5	27.7	19.6	21.0	14.3	29.5	19.0	27.4	28.9	23.8	16.6	21.2	15.7	15.0	0.1	23.9	23.7	22.2	0.2	0.9	0.3	0.9	1.2	0.8	1.1	0.9	0.9	0.8	1.5	1.1	1.2	0.0	1.2	1.5	1.8	0.3	0.5	16.9	16.4	18.5	21.9	16.6	17.0	16.0	16.7	16.1	17.8	17.3	19.0	67.5	60.9	72.6	78.4	68.5	26.8	57.9	19.8	74.0	221.5	45.3	38.2	58.9	55.8	45.6	25.8	204.3	55.4	72.1	70.3	33.2	62.8	18.8	78.0	74.0	62.4	51.4	39.3	151.7	71.1	25.9	49.4	74.9	54.4	58.9	107.1	49.2	53.3	42.7	84.1	134.5	57.6	16.2	65.7	37.8	13.4	36.1	70.3	19.6	84.3	76.9	72.2	72.1	121.7	171.0	53.3	50.4	37.2	59.6	90.3	50.9	75.6	48.4	173.4	98.6	71.9	52.1	88.2	81.5	46.1	26.7	52.1	47.0	58.5	54.5	59.9
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cardiomyocytes: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: AB_2682445"	"prognostic favorable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.27e-2)"	2.9	7.1	3.9	1.2	3.6	2.1	5.4	2.9	3.9	7.3	3.1	6.2	3.7	8.7	6.6	2.2	10.0	2.9	12.6	3.4	3.1	6.7	1.7	2.4	0.9	3.3	3.2	9.1	11.4	5.6	10.5	2.0	3.0	10.7	2.1	3.6	4.7	5.7	29.1	5.8	3.1	4.9	3.2	3.2	5.7	7.6	3.7	0.8	12.0	10.5	0.6	8.1	5.3	3.8	4.3	3.6	16.0	7.5	1.3	3.6	11.9	4.8	2.0	3.3	3.3	1.8	3.9	0.1	3.5	2.2	3.5	3.9	3.7	3.9	4.4	2.5	3.8	2.6	13.9	2.1	2.3	2.4	3.6	4.6	3.8	5.5	3.9	6.2	4.1	4.7	3.2	3.2	3.1	19.3	1.4	2.7	8.7	2.5	3.5	6.1	31.4	0.9	4.5	3.9	11.9	3.1	3.9	3.6	3.1	15.0	6.2	3.1	1.4	4.6	6.6	2.8	4.3	8.7	3.5	0.3	6.0	2.2	12.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	3.9	3.6	2.9	3.9	3.4	3.1	3.3	3.2	3.0	3.2	3.7	3.8	1.1	9.6	2.7	4.9	0.1	1.1	1.8	1.5	1.2	1.4	5.0	3.4	12.2	4.3	2.2	1.8	4.2	2.7	0.1	0.3	1.9	1.9	5.7	2.8	2.6	1.5	1.8	2.5	2.5	3.2	1.2	2.1	3.6	2.8	0.0	4.0	2.2	0.2	0.8	1.7	1.9	1.6	0.0	0.3	0.3	2.7	1.8	0.4	0.0	3.7	0.0	1.4	0.0	3.5	2.3	2.1	0.0	1.9	0.6	0.5	0.4	0.4	1.9	1.4	0.0	3.1	2.1	6.1	5.3	1.3	1.6	1.1	0.4	5.5	1.6	1.3
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	0.6	0.4	8.3	0.5	9.2	0.3	0.5	8.4	10.1	1.1	4.0	0.8	0.3	3.1	3.3	0.4	2.3	0.4	0.3	9.4	7.6	0.6	0.1	0.5	0.5	7.3	6.3	0.3	0.5	0.1	4.9	0.1	7.5	1.1	0.1	1.1	0.4	0.8	0.1	0.3	0.7	0.9	6.2	1.0	1.0	1.9	7.9	1.1	0.3	0.0	0.2	0.5	0.9	8.8	1.7	2.2	1.5	0.1	0.3	1.3	0.1	1.6	1.7	1.9	2.2	0.0	0.8	0.7	1.1	2.0	0.4	1.8	0.0	0.7	0.6	3.9	0.7	1.3	2.6	0.1	0.8	0.4	4.1	1.4	0.4	2.0	0.7	4.5	2.5	4.1	0.0	3.2	1.0	1.1	2.4	0.2	5.7	0.2	2.3	4.1	0.1	0.8	0.3	0.0	3.9	9.3	0.7	0.5	1.2	0.6	2.8	3.4	3.7	3.8	1.2	0.2	0.8	3.2	1.2	0.7	4.0	0.6	1.1	0.4	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.1	8.3	9.2	8.4	10.1	9.4	7.6	7.3	6.3	7.5	6.2	7.9	8.8	0.2	0.0	0.0	1.0	0.3	0.4	0.8	0.2	0.0	6.9	2.9	1.8	1.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.7	6.5	2.9	0.4	0.7	1.8	0.8	13.1	0.2	0.0	0.8	1.5	3.9	0.0	0.1	0.4	0.0	0.8	0.0	9.7	0.0	0.0	0.0	1.0	7.5	0.3	0.2	0.0	0.0	2.6	0.6	2.1	3.0	9.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.6	0.0	1.4	0.9	1.3	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.8
TRIM47	"GOA, RNF100"	ENSG00000132481	"Tripartite motif containing 47"	Q96LD4	17	75874164-75878581	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 48.4;RPTEC TERT1: 36.0;U-266/70: 39.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014933	Uncertain		Supported	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA014933: AB_10603219"	"prognostic favorable (6.54e-4)"	"unprognostic (8.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.08e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.69e-5)"	"unprognostic (3.94e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.98e-2)"	20.6	10.3	43.4	6.5	45.1	0.3	17.7	39.9	68.1	20.4	38.8	31.9	9.0	29.2	3.9	19.1	17.6	7.6	26.7	41.7	42.3	39.2	17.8	18.9	4.3	50.1	46.8	7.2	18.0	5.8	8.8	2.6	43.1	16.8	4.5	0.8	24.4	4.9	6.8	19.9	19.6	6.1	41.5	28.9	17.4	7.4	53.0	1.8	12.8	4.5	4.3	31.4	21.4	45.7	20.6	14.8	0.1	0.1	3.2	3.4	0.5	0.8	1.6	1.1	0.9	2.8	10.2	0.0	12.9	0.7	10.1	23.4	3.7	5.5	0.1	13.2	9.4	0.1	10.2	28.3	5.3	0.1	0.1	2.8	1.5	2.3	2.0	1.0	10.1	1.6	2.2	30.3	0.6	3.5	2.0	0.3	1.6	7.9	29.1	1.5	1.8	48.4	36.0	0.7	5.8	0.4	6.1	29.1	8.4	0.8	3.5	0.6	15.6	18.0	11.3	1.8	7.1	39.2	12.1	2.5	7.8	0.0	1.7	0.0	0.0	1.4	1.7	0.0	4.6	2.4	4.0	2.2	0.1	2.1	2.6	1.7	0.0	2.2	0.0	1.2	5.4	0.6	43.4	45.1	39.9	68.1	41.7	42.3	50.1	46.8	43.1	41.5	53.0	45.7	34.3	16.0	5.4	26.4	5.2	18.0	39.8	34.8	34.1	6.0	20.8	23.4	4.8	40.0	13.8	16.5	0.0	0.5	2.6	30.2	19.6	67.5	0.5	13.6	17.7	39.6	8.4	1.3	1.9	76.6	1.4	33.7	22.4	12.6	22.2	17.1	43.5	11.4	63.5	0.0	1.4	12.5	57.0	9.1	14.5	1.0	34.2	8.2	42.7	8.4	2.6	10.3	0.0	5.5	5.8	105.2	4.7	19.2	12.5	57.0	42.0	66.3	16.7	0.9	32.9	14.5	36.4	1.0	2.2	22.1	15.9	0.8	7.9	2.0	11.8	19.2
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663195-5938619	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	8.8	10.9	2.1	8.1	2.3	3.8	8.0	2.0	2.4	11.8	7.2	7.2	7.4	11.7	18.4	7.7	9.4	6.9	5.7	2.0	3.3	9.0	12.8	11.8	8.4	4.0	3.5	11.4	13.3	4.2	3.8	9.6	3.4	8.5	7.7	1.9	14.0	9.1	1.9	5.5	8.5	11.3	3.0	10.4	7.8	8.3	3.5	9.4	9.6	4.0	8.9	8.2	8.6	2.9	7.7	15.4	19.2	12.4	24.0	22.5	5.4	18.0	35.0	37.3	50.0	13.8	13.5	5.5	13.3	18.8	27.6	13.0	18.4	25.8	14.9	9.6	5.1	15.2	10.4	9.5	20.2	11.5	15.3	15.4	22.7	10.5	31.3	22.9	52.8	8.9	16.9	12.2	32.1	4.2	7.7	5.3	7.7	11.7	8.1	14.3	4.7	1.5	23.7	14.4	0.5	1.1	11.8	18.4	6.8	20.7	9.3	6.6	43.3	13.9	20.2	3.6	4.2	9.4	7.9	1.9	10.9	6.8	15.4	10.7	7.6	11.6	3.6	7.8	3.0	3.1	2.8	2.8	9.4	2.6	1.8	3.7	7.7	4.1	8.0	7.0	2.2	4.1	2.1	2.3	2.0	2.4	2.0	3.3	4.0	3.5	3.4	3.0	3.5	2.9	14.2	6.4	14.0	4.9	8.7	5.2	9.5	9.7	9.6	0.2	8.3	6.5	4.9	2.8	13.4	11.0	0.0	7.8	16.4	5.5	5.9	10.6	5.0	8.6	12.6	14.8	1.2	8.4	3.0	8.8	10.5	12.4	6.1	12.5	0.0	11.9	15.4	13.9	6.4	0.0	1.4	9.7	4.1	12.2	7.1	3.8	7.8	10.8	3.6	19.7	10.8	7.0	14.4	3.0	1.0	8.1	4.9	7.5	6.7	10.1	7.4	6.3	3.7	0.1	19.7	6.5	10.9	5.2	3.3	7.0	5.4	7.8	7.5	20.6	7.5	9.9
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312536-73328082	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 29.1;parathyroid gland: 33.3;stomach 1: 48.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"Hep G2: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	6.8	0.3	0.1	0.0	0.1	0.1	0.2	29.1	33.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	0.1	0.4	48.7	8.7	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.2	4.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	112	"basophil: 11.2"	"Lineage enriched"	"Detected in single"	112	"granulocytes: 11.2"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 61.3"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"		"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM51GP		ENSG00000220948	"Tripartite motif-containing 51G, pseudogene"		11	48975324-48983826	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.1"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA					"Cluster 33: SK-MEL-30 - Melanocyte processes"		Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (2.95e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM52	RNF102	ENSG00000183718	"Tripartite motif containing 52"	Q96A61	5	181254417-181261139	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA054565, HPA056819"	Approved		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Intermediate filaments"	"HPA054565: AB_2682525, HPA056819: AB_2683245"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (2.96e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (4.07e-4)"	9.3	10.0	10.8	8.6	10.9	8.7	9.0	14.0	14.4	14.2	11.0	12.2	8.1	10.1	9.1	7.0	12.3	5.5	11.0	10.9	10.8	13.7	11.6	12.1	14.2	11.4	10.5	16.0	15.6	9.2	18.9	5.9	11.6	15.2	6.6	21.5	11.5	7.0	6.7	10.0	13.1	5.3	9.6	18.7	11.0	11.6	11.4	10.8	17.3	3.9	9.7	12.0	10.8	11.7	4.3	4.9	7.8	10.0	13.8	8.7	6.9	4.6	4.1	4.4	3.8	7.1	7.7	9.3	4.9	5.0	12.0	7.8	4.2	6.2	5.1	16.0	8.9	3.6	21.4	6.0	3.3	11.0	7.9	8.7	5.1	4.7	2.7	7.2	5.3	13.5	3.8	21.3	4.6	8.1	6.1	10.0	2.7	4.8	6.3	7.1	4.2	6.4	3.7	5.6	8.8	7.1	6.6	4.7	4.4	6.8	8.8	7.4	6.5	8.8	4.6	4.2	4.4	15.5	8.1	6.3	10.0	9.5	3.5	5.8	2.2	5.2	7.1	1.9	7.9	4.9	7.5	7.8	1.8	3.5	9.2	7.5	2.3	5.1	1.9	2.4	5.5	3.3	10.8	10.9	14.0	14.4	10.9	10.8	11.4	10.5	11.6	9.6	11.4	11.7	11.9	19.2	23.6	6.5	20.5	8.8	6.5	3.1	8.0	27.8	6.7	6.7	9.4	8.6	15.0	7.3	39.6	3.7	28.1	7.2	3.9	3.5	27.2	10.3	14.4	14.0	9.0	8.6	9.5	2.5	1.1	12.6	6.6	11.8	17.7	21.2	7.9	3.5	4.2	28.6	10.5	8.3	2.0	6.0	9.7	5.4	12.8	10.3	5.4	9.4	12.5	17.3	35.0	6.6	8.1	2.3	8.1	9.4	24.9	4.5	8.1	3.4	11.6	42.9	0.0	20.3	13.3	25.2	11.0	5.5	6.1	4.2	25.9	19.0	7.8	4.1
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175485	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 61.8;liver: 37.9;skeletal muscle: 29.6;tongue: 33.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 426.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	1.4	0.0	0.1	0.1	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.1	0.1	3.5	0.8	5.3	0.1	61.8	0.0	0.0	4.8	37.9	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.4	0.0	0.3	0.7	0.1	0.0	1.3	0.2	29.6	0.4	0.1	0.1	0.0	0.1	0.0	7.3	0.0	0.2	0.3	33.7	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	7.2	0.1	0.3	0.1	0.0	0.4	0.5	0.6	0.0	60.5	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.2	426.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	1.5	27.6	0.0	2.4	0.0	0.0	0.1	0.0	91.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.6	0.0	0.1	2.8	0.0	0.0	0.1	0.0	108.9	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	64.7	0.2	1.2	0.0	0.0	0.2	0.0	0.1	3.8	0.0	3.5	0.0	0.0	0.7	30.4	0.1	0.0	1.5	0.0	0.0	1.3	0.0	6.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	7.4	15.4	0.0	6.6	31.0	2.9	23.8	1.2	0.0	0.0	3.8	0.3	0.0	0.0	0.3
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085481-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	13.6	11.3	12.9	14.4	13.9	6.7	12.9	11.7	12.2	14.8	12.6	11.8	11.7	13.5	13.4	12.4	14.8	7.5	9.9	10.4	11.5	12.9	10.8	17.7	15.4	17.0	13.8	19.0	10.1	9.6	8.6	8.9	14.0	14.8	9.7	2.0	14.0	13.0	11.9	15.7	14.7	8.5	12.7	21.4	12.4	3.8	14.2	12.9	12.7	6.7	12.4	12.6	13.4	16.8	16.4	20.1	8.5	10.9	19.1	19.7	10.2	13.4	11.7	21.2	19.6	9.6	23.0	19.2	14.0	11.1	29.3	18.4	3.5	12.3	14.2	19.2	5.5	12.2	28.9	7.1	17.1	21.6	26.4	12.6	17.3	13.8	22.4	20.7	11.2	12.2	21.6	23.7	14.8	22.4	18.3	24.0	8.5	8.8	16.7	16.8	13.9	12.7	11.1	16.9	0.4	0.3	14.8	40.8	11.6	10.8	9.3	14.0	21.6	29.4	26.1	22.4	14.4	11.7	12.4	14.7	14.6	17.2	23.6	1.7	1.2	1.2	1.8	0.8	1.4	1.1	1.4	1.2	0.4	1.6	1.3	1.7	3.9	4.1	1.2	1.1	0.7	0.6	12.9	13.9	11.7	12.2	10.4	11.5	17.0	13.8	14.0	12.7	14.2	16.8	62.5	73.7	82.7	3.3	45.7	5.2	82.2	6.7	28.5	3.1	30.4	27.2	21.7	108.7	32.8	51.5	2.1	41.6	45.4	51.9	3.9	61.4	2.1	60.8	53.7	80.6	29.1	43.5	0.1	48.1	25.7	40.0	33.1	42.5	15.2	129.9	114.5	48.1	19.3	10.1	0.1	40.9	4.1	48.7	4.5	5.2	132.3	33.3	1.8	8.4	60.0	20.4	141.1	2.5	3.6	56.9	45.4	94.4	24.9	79.9	76.5	11.4	51.0	4.0	65.7	76.7	38.9	5.4	7.2	15.9	3.3	29.8	44.3	64.5	41.1	60.5
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857187-247880138	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 32.2;thyroid gland: 15.2"	"Cell type enriched"	"Detected in many"	23	"Erythroid cells: 456.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023637	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.5	0.6	0.7	0.6	0.5	32.2	0.5	0.1	1.0	0.4	0.0	1.1	0.1	0.2	0.1	0.1	1.3	0.3	0.2	0.6	2.9	0.2	0.2	1.3	0.2	3.2	4.1	0.0	0.2	0.1	0.2	5.8	4.3	1.5	0.9	0.6	0.3	0.2	0.2	0.9	0.3	0.6	1.3	2.4	0.4	2.7	3.1	0.3	15.2	1.6	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.7	18.3	0.0	0.0	0.0	1.3	40.7	0.0	0.0	0.0	5.5	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.4	21.8	0.1	0.0	0.0	0.2	0.3	2.7	0.0	37.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	4.7	0.0	0.0	29.0	0.0	0.0	6.3	0.0	0.0	0.0	13.0	42.1	0.7	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.6	0.7	0.5	0.1	1.0	0.6	2.9	3.2	4.1	4.3	1.3	3.1	0.9	0.6	3.2	3.0	0.3	1.7	1.0	1.4	0.0	0.6	3.4	1.1	0.3	0.5	0.0	5.6	1.8	12.5	3.3	0.4	0.8	0.0	0.1	4.3	2.5	0.7	1.7	1.2	456.4	3.7	0.0	4.6	3.0	0.0	2.1	8.2	0.4	1.8	0.1	2.4	0.0	1.8	0.4	0.0	3.2	1.4	1.2	0.9	19.4	1.8	0.0	1.0	2.7	2.1	0.5	0.3	0.2	0.7	0.7	0.3	4.0	0.0	0.2	3.7	3.7	0.0	0.9	0.7	2.8	9.7	0.1	0.9	4.9	1.7	0.3	0.8	0.8
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.4"	"Cell type enriched"	"Detected in many"	12	"Oligodendrocytes: 391.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	0.7	0.8	9.0	5.1	38.8	17.6	2.1	18.0	20.4	1.4	0.0	2.7	2.8	3.0	0.9	4.9	2.0	2.7	0.8	12.3	15.2	1.2	1.0	2.0	12.1	19.4	23.6	1.3	1.5	1.8	1.2	2.0	19.9	2.0	2.6	1.4	1.7	1.0	1.2	5.4	2.9	2.8	9.3	5.1	2.5	8.7	24.6	13.6	2.0	0.1	12.1	3.1	2.2	68.4	20.4	15.8	19.8	1.3	7.8	10.6	26.0	31.5	27.3	38.5	36.9	1.9	34.8	54.5	22.9	23.7	12.1	34.1	0.0	12.9	50.7	49.1	19.2	2.0	5.4	2.4	10.9	24.3	3.2	9.0	3.8	18.7	13.4	23.6	27.1	8.0	25.8	22.6	36.7	21.9	15.0	1.9	52.5	13.2	26.1	20.7	17.2	24.6	13.8	6.6	13.0	2.8	9.0	26.3	0.7	26.5	31.2	22.4	20.9	2.8	8.9	4.5	3.1	37.0	14.5	13.4	3.4	31.0	3.1	29.1	2.8	5.4	10.9	3.1	12.7	10.4	17.9	15.0	4.5	9.3	12.0	14.5	2.2	12.4	1.5	6.7	22.0	3.7	9.0	38.8	18.0	20.4	12.3	15.2	19.4	23.6	19.9	9.3	24.6	68.4	0.6	0.0	6.5	0.3	7.8	4.8	4.7	2.1	3.4	0.4	2.8	1.8	2.5	2.8	1.4	1.8	6.2	7.2	6.1	1.2	0.0	2.0	31.2	1.9	2.1	2.5	10.8	29.5	0.4	2.0	11.7	2.1	5.1	2.9	1.3	10.1	2.2	0.1	2.9	0.0	0.5	2.9	2.0	2.2	2.3	12.5	0.3	1.8	3.6	0.0	2.1	0.5	3.1	0.0	391.8	1.9	2.8	0.7	6.4	3.3	1.2	2.3	2.1	1.7	0.0	2.4	2.7	14.0	15.1	5.6	4.4	2.5	10.9	2.7	4.8	3.6
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.9"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 74.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	2.8	3.8	0.4	1.7	0.4	2.0	3.2	0.2	0.4	2.2	0.8	2.1	0.5	3.2	4.8	4.3	3.2	2.3	0.9	0.4	0.6	20.9	0.8	2.1	0.6	0.9	0.6	4.3	1.3	1.3	0.9	5.4	0.6	2.5	1.7	0.2	10.5	3.6	0.8	1.0	1.1	5.2	0.6	3.7	1.0	9.3	0.8	1.3	3.8	0.6	1.3	2.6	2.8	0.7	0.7	16.2	1.1	0.0	2.0	2.9	18.7	4.4	3.3	4.3	4.2	0.4	3.6	0.0	2.5	4.5	12.1	2.9	7.5	6.7	6.1	0.6	5.0	2.0	1.6	0.1	0.7	6.6	8.7	5.1	6.4	6.2	4.3	6.4	3.8	0.1	8.0	0.2	1.8	0.2	0.0	0.9	22.2	2.6	5.7	7.7	0.0	0.1	0.9	6.6	0.1	0.2	0.0	8.4	0.8	36.7	3.2	1.1	19.2	4.0	21.3	0.1	4.7	0.2	0.1	0.0	3.7	0.0	3.5	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.1	0.4	0.4	0.2	0.4	0.4	0.6	0.9	0.6	0.6	0.6	0.8	0.7	1.2	0.0	4.8	0.0	0.1	0.5	0.6	0.5	1.8	0.0	3.1	1.8	0.4	0.0	0.8	1.8	0.0	12.5	0.0	0.2	3.9	1.2	1.2	0.7	1.7	1.5	0.0	2.1	0.0	0.2	15.5	2.1	0.0	1.0	0.0	4.1	0.0	0.5	3.1	0.0	0.0	0.3	2.0	3.5	0.3	0.8	0.9	1.1	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.4	0.3	74.4	1.1	0.0	0.0	0.5	0.7	10.8	3.3	1.8	0.4	5.7	0.4	4.1	0.2	0.3
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165016458-165041749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 1.5;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 14.2"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.2	0.3	0.2	0.3	0.0	0.4	0.5	0.9	0.7	0.0	0.1	0.0	0.0	5.1	0.6	0.0	0.0	0.0	3.0	0.8	0.9	0.7	0.0	0.0	0.2	0.0	10.6	0.3	0.0	1.5	0.0	0.2	0.0	1.1	0.5	0.0	0.3	0.0	0.0	1.3	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.7	0.3	0.0	0.1	0.8	0.5	0.0	0.0	0.3	9.6	8.2	0.0	0.3	5.6	0.7	0.2	0.0	0.1
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2"	"Not detected"	"Not detected"							HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.1	3.6	1.9	2.2	2.2	3.7	1.3	2.2	2.3	2.9	0.3	1.3	1.9	1.5	2.1	1.0	3.5	2.9	3.0	1.8	3.1	1.0	1.1	2.2	3.2	2.4	2.6	5.0	1.4	1.1	1.0	1.7	2.3	1.8	1.4	2.7	0.9	2.0	0.9	1.1	1.4	2.2	1.7	2.1	1.3	8.9	2.5	2.6	5.6	1.4	2.9	2.3	0.2	2.7	0.9	0.8	2.0	2.1	1.1	1.1	1.2	4.2	1.3	0.9	0.8	0.7	1.4	0.9	1.1	5.3	1.0	1.0	1.4	1.5	0.9	1.6	0.8	1.6	1.5	0.9	15.1	1.6	1.4	9.0	1.3	3.7	1.4	8.5	0.8	1.3	1.8	3.6	0.8	1.0	1.4	1.0	6.5	1.0	0.7	1.4	1.1	1.2	0.6	2.6	1.7	1.1	1.0	1.5	1.2	10.2	0.5	1.6	0.9	2.7	1.8	0.9	1.7	17.2	8.2	2.3	1.0	0.9	1.9	5.4	1.4	0.1	2.9	1.2	3.3	3.5	1.8	3.3	1.5	5.8	4.4	3.6	0.3	8.0	1.1	4.1	0.8	1.4	1.9	2.2	2.2	2.3	1.8	3.1	2.4	2.6	2.3	1.7	2.5	2.7	0.2	0.0	3.3	1.0	3.8	0.3	1.2	0.4	0.0	1.1	0.1	0.1	2.3	0.0	0.2	3.7	4.2	0.3	2.3	0.0	0.0	0.3	34.5	0.4	2.1	0.9	0.0	1.3	1.9	0.7	0.0	1.6	0.5	0.1	0.0	4.8	0.0	0.4	1.1	1.7	1.4	0.0	0.0	0.6	0.7	14.0	1.2	0.9	0.0	0.0	1.7	2.7	1.0	3.5	4.3	0.1	0.1	1.5	6.4	0.6	0.0	3.7	0.1	0.4	0.0	1.5	1.3	50.1	3.7	0.2	0.0	0.3	2.2	2.8	0.0	0.6
TRIM64	"C11orf28, TRIM64A"	ENSG00000204450	"Tripartite motif containing 64"	A6NGJ6	11	89968502-89974072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"placenta: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	266	"basophil: 26.5"	"Lineage enriched"	"Detected in single"	266	"granulocytes: 26.5"	"Not detected"	"Not detected"											HPA045370	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"					"HPA045370: AB_2679298"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM64B		ENSG00000189253	"Tripartite motif containing 64B"	A6NI03	11	89869282-89876017	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	17	"placenta: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	332	"basophil: 33.2"	"Lineage enriched"	"Detected in single"	332	"granulocytes: 33.2"	"Not detected"	"Not detected"											HPA045370	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"		"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA045370: AB_2679298"															"unprognostic (2.08e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM64C		ENSG00000214891	"Tripartite motif containing 64C"	A6NLI5	11	49053714-49059112	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045370	Uncertain					NA	NA									"HPA045370: AB_2679298"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75896951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	13.0	7.8	12.5	8.5	15.2	7.4	10.7	15.3	13.5	15.5	11.0	14.1	8.8	14.7	6.8	14.2	13.1	7.1	10.3	11.5	13.2	11.2	8.4	12.9	10.5	15.0	14.6	14.1	15.7	7.4	11.8	5.4	14.8	11.7	7.9	7.2	12.6	8.1	13.2	14.6	13.5	8.3	13.8	16.6	11.3	3.9	14.5	6.5	12.2	6.9	8.2	14.6	14.0	17.0	19.8	20.2	7.8	22.2	13.5	19.2	4.0	8.3	8.9	11.1	9.4	9.1	17.0	21.4	6.5	7.2	15.6	13.7	16.8	18.6	6.8	11.1	28.9	16.9	20.4	12.5	13.4	17.2	18.9	12.0	14.4	8.9	16.0	9.3	29.2	27.2	29.3	19.5	8.7	20.6	38.0	33.7	17.7	20.0	19.5	31.3	11.2	30.9	11.2	8.2	16.1	14.9	11.4	21.3	22.7	9.7	21.2	24.2	14.5	26.6	13.5	13.3	16.9	17.9	7.4	6.2	16.2	32.2	11.8	1.4	1.1	1.8	1.9	1.0	2.2	1.4	1.4	1.9	0.9	2.0	1.5	1.5	1.1	1.9	0.6	1.3	1.3	0.6	12.5	15.2	15.3	13.5	11.5	13.2	15.0	14.6	14.8	13.8	14.5	17.0	8.4	6.4	4.8	13.1	7.5	2.9	5.7	2.4	3.4	19.0	3.7	3.0	4.3	5.7	3.4	9.2	12.5	0.9	9.0	3.6	1.9	3.2	0.4	2.8	9.2	8.2	0.0	9.5	4.5	3.4	3.6	6.6	7.1	4.0	7.0	8.6	5.7	3.8	8.9	5.0	5.9	6.6	6.1	5.4	9.3	0.5	13.7	6.9	8.8	3.7	4.9	6.3	3.1	6.6	9.3	5.3	2.9	9.4	5.8	5.1	4.8	5.9	1.8	12.9	0.0	9.3	5.2	0.8	2.9	6.7	3.7	0.5	8.5	6.4	5.9	2.8
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	4.4	5.9	4.5	4.0	5.6	2.8	4.6	2.8	4.6	3.9	5.2	4.4	3.5	3.8	8.2	5.2	4.2	3.0	2.4	3.0	5.1	4.9	10.9	3.6	5.3	4.1	5.4	3.6	8.9	3.1	9.5	1.5	4.0	4.2	4.6	3.6	4.3	3.3	3.6	11.9	5.5	3.5	3.3	5.7	5.4	17.3	5.4	4.5	6.2	3.1	5.2	4.2	4.2	3.6	5.3	4.9	2.9	10.2	6.0	4.5	3.6	3.2	3.7	2.2	2.9	6.5	9.9	5.2	2.2	2.9	2.1	7.2	3.1	2.8	2.7	6.1	2.4	5.0	9.2	3.6	2.5	4.5	3.9	7.1	2.8	1.9	6.6	2.4	2.9	13.1	2.7	5.5	2.9	5.8	2.1	3.4	1.8	2.7	4.6	3.0	2.2	2.1	3.1	6.7	2.1	2.0	4.6	3.2	2.2	2.8	4.2	1.0	2.3	4.2	3.8	2.5	2.8	2.3	3.7	6.4	2.8	4.6	2.4	0.0	0.5	0.6	0.7	0.1	0.4	0.6	0.7	0.9	0.7	0.8	0.7	1.1	0.3	0.8	1.3	1.3	0.6	0.3	4.5	5.6	2.8	4.6	3.0	5.1	4.1	5.4	4.0	3.3	5.4	3.6	3.0	3.2	5.6	47.7	4.0	1.8	2.3	3.6	2.2	8.0	5.1	5.6	1.9	4.3	5.1	5.5	12.5	3.6	3.1	4.5	0.0	3.4	46.0	5.0	4.0	3.2	6.0	5.7	14.2	3.2	1.8	2.6	5.1	3.7	1.3	6.7	5.0	9.8	2.6	11.8	17.1	4.2	0.0	5.2	2.2	27.3	1.8	3.8	0.0	13.1	5.9	4.3	3.1	9.5	22.6	3.9	3.9	2.2	3.1	1.6	8.3	2.4	5.4	9.0	13.1	6.5	2.5	14.6	7.2	3.8	1.1	1.4	3.3	8.0	4.4	1.0
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 8.5;retina: 3.5"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 69.0;Inhibitory neurons: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.0	0.2	1.0	0.0	0.8	0.0	0.0	8.5	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.0	0.0	0.0	0.0	3.5	1.5	0.0	0.0	0.0	0.5	0.1	2.7	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	8.5	2.2	1.4	1.5	3.5	1.5	2.7	1.7	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	24.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.5	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608231	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	5.1	6.5	6.6	3.7	7.0	2.1	6.4	7.2	7.2	9.6	6.3	7.1	6.6	6.5	7.2	5.0	7.6	5.1	7.2	6.6	7.0	9.7	7.4	6.6	5.2	6.6	6.9	10.1	6.2	8.9	6.3	6.2	6.8	10.7	6.2	5.8	8.3	8.1	5.9	4.8	6.0	6.0	6.8	6.8	8.0	6.5	7.3	6.5	9.6	6.6	5.8	7.0	5.3	7.2	10.2	11.2	4.5	8.2	7.2	11.6	0.0	10.9	8.0	9.9	8.9	1.4	10.3	6.9	6.5	5.6	9.3	11.6	4.5	7.7	8.4	17.2	8.8	8.4	2.9	0.0	8.3	13.7	11.4	9.1	11.1	5.7	8.6	10.2	12.6	6.3	8.0	3.7	8.9	2.4	11.3	3.7	5.4	7.1	9.2	9.0	6.4	0.3	6.3	4.4	2.4	4.3	0.0	11.0	7.1	9.0	4.8	6.8	10.3	13.1	8.8	13.3	5.0	13.7	15.9	9.9	8.9	6.0	12.5	8.6	2.5	8.9	7.9	4.8	8.8	8.5	8.8	8.9	5.6	7.6	11.1	9.0	0.3	5.7	5.5	3.8	8.7	7.4	6.6	7.0	7.2	7.2	6.6	7.0	6.6	6.9	6.8	6.8	7.3	7.2	3.2	0.0	3.6	2.9	2.8	0.8	1.4	2.7	3.4	3.3	2.6	2.4	5.4	2.8	5.9	5.5	2.1	6.1	2.7	5.3	5.9	3.2	0.9	2.6	2.2	3.4	6.7	1.3	1.7	3.3	2.7	2.9	4.6	2.8	3.8	5.9	3.6	6.0	2.2	0.0	1.6	5.2	6.1	2.1	0.6	0.4	1.8	2.0	0.0	1.9	2.7	4.1	5.2	3.5	3.0	3.3	1.9	1.9	1.8	2.0	2.4	2.5	2.4	2.8	6.6	2.0	2.6	2.9	6.6	2.0	1.0	4.4	2.8	3.9	4.7	0.6
TRIM69	"RNF36, Trif, TRIMLESS"	ENSG00000185880	"Tripartite motif containing 69"	Q86WT6	15	44728988-44767829	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.2;Late spermatids: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028894	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028894: AB_10603136"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.49e-2)"	0.8	0.8	5.2	0.4	5.2	0.2	0.8	4.7	7.1	0.9	4.5	1.2	0.4	0.6	0.4	0.7	0.8	0.5	2.8	5.0	5.1	1.6	1.5	1.3	0.9	5.2	5.0	0.8	0.4	0.3	1.5	0.2	5.1	0.8	0.5	0.6	0.8	0.2	5.9	1.0	1.3	0.6	5.0	2.4	0.7	35.0	5.0	0.5	0.6	6.0	1.2	0.7	0.8	5.4	0.1	0.1	0.2	0.6	0.2	0.7	0.0	0.1	0.3	0.8	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.7	0.0	0.2	0.1	0.0	0.7	0.0	0.1	0.9	0.6	0.1	0.1	1.1	0.2	0.7	0.0	2.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.2	8.2	2.3	1.4	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.8	0.9	0.0	0.0	0.2	0.6	0.1	0.0	0.2	0.0	4.2	0.1	5.2	5.2	4.7	7.1	5.0	5.1	5.2	5.0	5.1	5.0	5.0	5.4	41.8	6.4	5.1	9.4	22.1	21.3	21.3	8.0	12.0	10.8	9.3	9.1	60.2	8.6	11.0	9.2	4.2	6.1	20.4	16.5	41.1	42.1	213.2	9.0	12.2	22.2	4.2	5.7	16.0	16.0	4.2	17.8	13.7	10.6	14.0	10.5	11.4	5.1	36.3	23.5	9.8	7.5	8.2	25.4	39.7	93.9	9.3	22.6	12.4	1.0	52.7	21.2	20.6	9.5	1.7	14.8	13.4	11.7	21.9	11.4	18.6	27.0	8.8	4.2	6.6	27.0	19.7	78.8	1.7	25.0	41.2	1.5	25.6	5.1	7.0	52.5
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 193.3;tongue: 51.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.8;Cardiomyocytes: 40.1;Squamous epithelial cells: 39.6;Suprabasal keratinocytes: 28.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HDLM-2: 35.0;PC-3: 18.8;TIME: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	2.1	1.5	1.2	0.4	1.0	0.4	2.1	10.5	3.0	5.5	0.4	1.9	0.3	1.3	3.1	27.0	2.2	0.2	8.5	0.9	1.7	3.9	0.6	2.6	0.4	3.1	2.9	1.5	4.8	2.7	5.5	0.3	2.8	2.8	0.5	1.6	7.3	0.6	193.3	28.7	1.3	0.6	1.3	1.4	2.2	1.3	2.0	0.4	6.3	51.0	2.1	2.2	9.5	1.3	9.0	4.4	0.1	0.5	0.7	0.8	0.2	1.9	0.0	0.7	1.8	0.4	12.0	0.6	6.1	2.6	3.7	16.4	4.8	13.8	0.2	35.0	1.8	0.9	12.2	0.2	2.2	0.0	2.0	0.1	10.5	0.4	6.7	2.7	3.9	1.6	0.5	2.0	0.4	1.3	0.5	0.3	0.0	14.5	18.8	0.4	6.0	1.4	4.9	0.0	0.4	1.1	4.2	0.2	6.5	0.2	1.0	0.4	16.0	0.2	3.4	0.6	6.3	2.8	0.4	1.0	0.5	0.7	1.5	0.0	1.7	0.0	0.4	0.7	0.7	0.1	0.4	0.4	0.3	0.2	0.7	0.5	0.0	0.1	0.5	0.2	0.9	0.3	1.2	1.0	10.5	3.0	0.9	1.7	3.1	2.9	2.8	1.3	2.0	1.3	7.3	0.0	1.1	0.0	1.0	17.8	4.3	11.1	12.0	6.2	0.8	1.5	40.1	0.0	6.3	3.7	0.0	0.1	0.8	5.9	5.9	0.7	0.9	0.2	0.3	4.6	0.0	0.0	1.3	2.4	0.7	4.8	11.2	0.7	0.0	0.1	5.7	0.4	1.1	0.0	3.9	3.3	2.0	6.0	2.8	0.0	0.9	2.9	1.8	0.0	5.7	0.6	1.0	2.0	0.1	5.0	6.5	1.5	0.1	2.5	0.0	1.5	2.9	2.9	13.1	17.3	5.8	1.5	0.4	39.6	28.4	0.0	1.4	0.1	3.4	5.3
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.8	0.9	0.8	0.1	0.1	0.1	0.0	0.8	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214091-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 151.8;tongue: 43.0"	"Cell type enriched"	"Detected in many"	5	"Skeletal myocytes: 45.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9"	"Region enriched"	"Detected in many"	7	"cerebellum: 9.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	0.2	0.2	0.9	0.2	0.8	0.8	0.2	9.3	1.0	0.1	0.5	0.2	0.2	0.2	0.3	1.0	0.1	0.2	0.8	0.7	0.4	0.1	0.1	0.2	0.3	1.0	0.5	0.2	0.3	0.1	0.0	0.2	1.3	1.9	0.1	0.8	2.5	0.1	151.8	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.5	0.1	0.2	43.0	0.2	0.1	0.0	1.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.2	7.2	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.8	12.6	0.1	0.1	0.5	0.2	0.2	0.2	0.3	29.7	4.1	0.0	0.2	2.6	0.2	0.1	0.3	0.1	0.3	0.2	2.6	0.1	0.2	0.2	0.2	0.1	17.9	1.7	0.2	0.2	0.4	0.2	1.9	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.6	0.4	0.3	1.5	0.6	0.4	0.6	0.2	0.1	0.9	0.8	9.3	1.0	0.7	0.4	1.0	0.5	1.3	0.1	0.5	1.2	4.7	3.2	3.8	0.0	0.8	0.1	3.1	0.0	0.0	1.0	3.1	8.0	3.0	0.0	2.5	0.0	2.1	0.3	2.4	0.0	0.0	0.0	0.3	1.5	4.7	1.5	0.0	0.0	0.2	0.0	0.3	2.5	0.0	4.0	1.3	0.8	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.2	0.3	0.0	0.0	3.1	0.0	0.0	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.1	0.1	0.0	0.9	0.0	45.6	2.2	0.1	0.2	0.8	0.3	0.1	2.2	1.2	0.9	1.5
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 41.9;Horizontal cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 6.0;Hep G2: 10.5"									"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA047843: AB_2680176, HPA051845: AB_2681635"	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	2.8	3.7	1.0	1.3	1.7	2.5	3.5	4.7	2.1	5.0	0.7	2.1	3.6	2.9	0.5	1.4	6.4	1.1	2.0	1.0	1.4	4.2	5.6	1.9	2.3	1.1	1.0	4.3	6.0	1.3	3.6	0.4	1.1	4.5	0.2	0.9	2.1	1.6	2.6	2.4	3.3	0.2	0.8	3.2	21.6	11.3	1.3	1.1	4.6	0.4	0.4	2.2	3.1	1.8	1.0	3.2	1.3	1.9	0.0	0.6	0.5	0.4	0.1	0.0	0.7	0.0	1.5	1.8	0.3	0.2	0.2	1.1	0.3	0.0	0.1	4.1	6.0	1.1	2.8	10.5	0.6	0.6	4.2	1.7	0.0	0.2	0.3	0.9	0.0	2.5	0.6	4.9	0.0	0.7	1.7	2.1	0.1	0.3	1.0	2.8	0.2	0.9	0.3	0.0	1.6	1.2	2.0	0.7	1.9	0.5	0.5	1.9	1.2	0.9	1.4	1.3	0.8	2.3	1.4	1.8	1.2	2.6	1.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.3	0.3	0.0	0.2	0.3	0.2	1.0	1.7	4.7	2.1	1.0	1.4	1.1	1.0	1.1	0.8	1.3	1.8	3.8	0.0	0.5	0.0	15.5	0.9	3.2	3.1	4.6	21.9	5.1	4.2	2.5	1.5	3.3	5.5	18.8	2.1	8.7	1.6	5.9	1.8	5.9	9.2	13.4	2.8	4.9	3.4	0.1	4.7	0.7	4.7	16.8	5.6	0.0	41.9	2.9	3.0	3.0	32.0	0.1	3.2	4.1	2.4	1.2	11.4	6.5	3.1	1.8	0.0	2.5	5.8	9.2	0.0	0.1	2.9	4.0	3.8	11.2	3.3	10.0	4.7	5.4	14.5	0.0	14.6	4.1	9.1	2.5	3.3	2.0	1.1	6.8	14.2	3.4	2.6
TRIM77	TRIM77P	ENSG00000214414	"Tripartite motif containing 77"	I1YAP6	11	89710299-89717872	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039896	Uncertain					NA	NA									"HPA039896: AB_2676732"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102644479-102658318	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	80.1	47.6	67.2	21.5	68.1	26.0	58.4	62.9	55.0	63.0	35.8	50.9	17.8	53.5	9.3	42.0	55.6	22.0	67.8	55.0	56.5	77.9	62.2	70.3	18.3	72.4	72.7	45.2	80.4	36.6	43.5	21.3	64.7	55.5	9.5	18.1	69.1	21.9	80.8	48.3	43.8	17.1	60.4	42.8	61.9	20.1	84.4	18.7	67.4	38.8	11.8	62.9	49.9	54.2	96.4	18.7	16.3	28.7	17.2	40.6	21.1	34.4	59.3	32.1	24.6	30.7	93.0	30.7	102.9	57.5	11.4	32.7	12.2	40.4	21.3	34.4	23.4	78.3	12.9	67.4	55.8	15.5	28.3	47.0	21.9	64.8	32.9	83.4	40.6	13.6	17.3	33.4	24.3	45.5	27.8	57.7	12.7	25.6	38.0	18.6	49.2	16.6	37.4	48.0	12.3	26.2	18.8	17.2	42.6	16.9	58.4	28.2	94.8	40.9	22.4	23.3	68.8	49.0	28.5	16.3	65.5	39.2	9.7	14.0	5.2	2.7	6.8	4.6	6.5	8.9	7.3	5.4	4.5	7.4	6.4	5.7	17.9	6.0	5.7	12.4	7.5	4.5	67.2	68.1	62.9	55.0	55.0	56.5	72.4	72.7	64.7	60.4	84.4	54.2	46.0	57.7	71.2	33.6	29.5	31.5	12.6	21.2	21.6	33.4	53.9	45.3	38.0	38.6	33.6	88.3	8.4	13.0	52.8	15.4	41.1	63.2	1.1	91.5	61.7	30.1	21.6	2.5	8.9	44.9	2.6	38.9	20.4	81.6	8.8	32.2	31.8	33.3	25.4	28.6	13.6	32.8	18.3	40.5	24.1	1.7	31.1	43.5	17.8	13.1	58.1	26.1	24.7	18.1	17.6	65.0	16.4	34.3	18.6	30.5	32.0	53.0	38.5	15.1	13.1	35.7	38.4	2.4	5.1	19.8	22.9	10.9	26.6	38.9	21.4	30.1
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143342-14532128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 215.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	35.3	20.5	31.7	11.6	33.3	5.5	31.8	32.2	38.6	23.4	34.5	36.6	6.8	38.9	15.5	14.5	21.2	18.8	31.9	37.2	33.6	24.9	22.1	25.7	10.2	28.1	28.1	52.8	20.6	9.1	28.9	11.6	26.6	28.2	13.6	10.2	17.4	11.1	20.9	18.7	27.8	19.2	26.4	38.9	22.9	17.2	31.4	13.3	17.0	17.4	10.6	27.1	20.5	27.2	43.7	15.9	37.2	18.0	78.6	101.0	41.3	40.4	49.2	32.6	36.9	10.3	17.4	10.4	28.0	56.6	79.6	13.0	6.5	19.4	66.6	25.8	8.0	5.5	46.1	13.2	40.0	13.9	14.8	47.6	19.9	114.4	36.4	30.3	28.8	6.8	1.4	6.8	78.7	8.3	0.1	9.5	9.3	4.8	13.7	9.9	22.9	34.2	31.6	20.5	17.1	67.5	34.3	9.0	18.9	47.1	5.3	2.0	66.4	61.4	38.3	44.7	48.4	0.3	2.2	12.9	215.1	8.8	14.8	0.1	0.5	0.0	0.0	0.7	0.1	0.7	0.0	0.0	0.5	1.8	0.0	0.0	0.0	1.6	0.6	1.1	0.3	0.1	31.7	33.3	32.2	38.6	37.2	33.6	28.1	28.1	26.6	26.4	31.4	27.2	33.0	19.2	25.9	205.7	16.6	16.4	13.0	15.6	17.1	30.5	21.9	15.0	19.3	10.0	21.0	11.0	14.6	9.7	5.6	24.8	0.0	21.2	2.9	11.7	24.8	28.7	18.0	6.5	400.9	14.2	22.0	38.9	7.7	34.2	17.7	17.2	14.6	17.1	14.2	28.6	443.4	20.6	14.2	15.4	22.1	6.6	78.6	20.2	5.4	308.2	12.1	7.3	2.1	476.5	80.4	38.5	14.9	42.9	29.2	52.8	9.2	5.4	18.3	2.7	6.6	27.5	20.0	3.5	6.2	7.2	13.8	8.2	3.8	11.7	19.4	20.3
TRIOBP	"DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara"	ENSG00000100106	"TRIO and F-actin binding protein"	Q9H2D6	22	37697048-37776556	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003747, HPA019769"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA003747: AB_1858328, HPA019769: AB_1858329"	"unprognostic (2.94e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.67e-2)"	56.3	46.5	15.4	27.3	16.6	25.7	50.8	14.7	14.9	73.1	22.1	70.6	23.9	71.8	12.8	78.5	66.1	27.8	74.6	12.8	13.2	37.2	21.6	51.6	17.4	20.0	17.2	55.7	32.7	31.1	16.9	44.2	16.5	45.3	17.0	4.8	44.3	33.3	24.3	32.0	38.0	31.0	16.6	53.1	53.6	26.1	16.9	16.7	48.2	14.3	12.5	66.5	65.7	17.3	65.9	53.1	33.2	26.4	73.1	118.1	47.5	113.0	111.9	57.7	42.1	11.8	44.8	24.5	30.4	69.6	31.6	52.7	9.2	63.7	18.1	39.6	29.1	6.8	41.6	22.4	75.5	32.1	28.9	47.1	29.8	52.0	24.5	125.3	71.9	20.6	6.4	34.6	45.5	39.3	14.4	23.1	20.2	65.4	63.2	25.1	23.9	17.2	41.0	52.8	16.2	25.4	50.9	46.5	59.7	32.8	25.4	23.0	151.9	87.2	38.6	60.6	27.0	30.4	9.1	15.4	82.7	13.0	104.3	7.7	7.6	12.2	1.8	7.5	0.6	1.3	1.5	1.8	4.1	2.4	1.2	1.8	18.2	1.9	12.5	1.9	2.5	2.0	15.4	16.6	14.7	14.9	12.8	13.2	20.0	17.2	16.5	16.6	16.9	17.3	102.0	19.2	29.7	17.9	10.7	6.2	48.3	18.3	18.8	22.8	40.1	45.1	65.2	62.9	23.3	58.8	2.1	105.7	14.7	63.8	15.6	42.7	30.3	32.6	107.0	91.6	22.9	28.2	4.7	51.6	34.2	65.5	58.1	34.2	6.3	128.1	124.6	17.1	42.7	16.8	4.6	52.1	6.1	56.0	7.5	10.6	113.1	31.2	14.2	27.2	32.0	29.6	8.2	7.5	14.0	62.8	46.9	92.2	9.5	41.9	24.8	15.8	23.9	7.3	52.6	17.7	31.8	49.8	23.4	57.2	6.1	116.0	12.7	22.5	40.6	57.9
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751530	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 362.8"	"Cell type enhanced"	"Detected in many"		"monocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 26.4"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		24000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	110.7	60.3	15.5	25.5	15.6	8.6	92.3	15.3	17.8	123.9	18.6	112.1	30.5	66.5	17.5	253.3	80.1	27.6	125.7	14.6	16.7	81.7	27.0	115.4	14.5	17.5	16.5	99.4	44.7	18.6	22.4	48.6	16.0	80.4	19.9	16.9	85.4	45.0	362.8	57.8	56.0	26.4	15.8	40.0	58.6	29.9	17.5	9.6	75.5	177.3	21.9	86.7	147.4	14.8	83.5	49.7	17.1	25.8	64.7	67.9	61.1	52.5	60.0	58.8	51.1	67.8	46.7	1.8	69.2	44.6	47.6	60.2	38.8	76.5	34.7	52.5	15.5	27.0	48.4	52.3	53.4	1.4	8.3	79.0	50.9	52.5	39.8	77.2	61.2	3.7	40.2	22.1	43.7	28.3	7.5	18.7	36.3	51.9	41.7	12.2	35.1	24.5	50.0	40.9	0.1	19.6	69.1	30.7	20.0	39.4	32.2	14.7	120.5	39.3	70.4	103.8	56.4	23.1	13.4	8.4	63.6	7.9	26.2	0.0	0.8	0.0	0.6	0.1	0.9	1.5	0.3	1.1	5.2	1.7	0.3	0.2	0.1	2.5	0.1	26.4	0.0	0.5	15.5	15.6	15.3	17.8	14.6	16.7	17.5	16.5	16.0	15.8	17.5	14.8	43.0	28.9	19.8	6.5	5.6	85.4	104.9	76.9	43.9	14.7	28.3	16.6	8.7	20.0	66.9	16.5	37.5	9.9	16.5	39.1	5.9	45.0	16.4	30.3	32.1	43.1	7.7	4.4	0.1	38.0	37.9	66.3	10.7	55.7	29.7	8.8	38.9	3.7	9.6	0.0	0.2	16.3	24.4	6.7	90.4	13.6	55.9	19.6	37.4	3.7	196.9	12.5	0.0	5.5	0.4	91.5	24.7	36.1	9.0	116.6	25.8	23.8	24.8	18.5	32.9	26.4	46.4	5.7	6.9	51.3	83.3	14.2	7.4	24.5	25.9	120.7
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRIP12	"KIAA0045, TRIPC, ULF"	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763837-229923239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	48.2	32.3	20.2	47.1	26.7	53.9	33.6	20.2	31.4	34.8	15.7	40.8	25.6	30.8	33.4	47.6	28.1	33.9	41.5	16.0	25.4	41.3	42.8	33.3	48.2	20.7	20.8	32.7	29.3	45.0	24.8	44.6	22.1	39.9	33.9	34.8	30.2	33.0	81.7	29.3	27.6	38.2	17.9	41.1	39.1	127.7	21.5	60.3	44.5	59.0	56.3	46.3	26.5	30.0	97.1	100.7	96.2	79.0	94.9	106.2	88.3	144.5	103.0	106.9	118.7	80.5	75.3	37.8	96.2	135.6	129.5	76.3	140.5	105.9	159.3	132.4	52.9	264.1	84.4	78.3	76.4	195.8	163.2	88.1	80.3	174.9	108.5	74.9	145.1	88.2	188.2	38.2	122.5	72.5	105.3	68.5	77.0	50.3	47.7	94.8	189.8	33.6	75.7	156.4	94.4	67.5	1.6	51.9	97.7	85.1	48.2	118.3	188.8	133.9	94.7	84.9	115.5	66.4	79.3	119.0	103.8	77.0	116.6	34.0	14.2	23.6	12.9	16.2	13.1	9.6	12.0	12.7	13.4	8.9	9.5	9.7	36.0	13.9	18.7	12.6	19.5	9.8	20.2	26.7	20.2	31.4	16.0	25.4	20.7	20.8	22.1	17.9	21.5	30.0	78.3	89.8	51.2	85.8	43.4	31.0	32.8	36.3	25.6	31.2	41.2	29.8	91.0	34.3	52.8	31.3	52.1	27.0	60.8	57.3	15.6	37.5	119.5	63.5	65.2	59.3	18.6	40.2	147.6	45.1	25.1	43.7	56.6	73.5	39.2	53.1	50.0	54.3	35.1	42.1	130.3	32.5	30.5	89.6	32.2	102.1	34.8	70.8	26.6	122.7	63.9	25.8	56.7	127.2	251.3	57.8	35.0	45.5	52.1	44.7	25.7	34.5	73.1	32.1	19.7	57.5	45.0	137.2	59.3	43.1	36.2	42.4	47.0	60.2	31.9	54.5
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892884-919357	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 115.4;Late spermatids: 206.9;Respiratory ciliated cells: 79.9;Spermatocytes: 86.4;Spermatogonia: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.4	0.7	2.0	4.4	2.1	6.0	2.7	0.9	1.8	1.5	1.0	3.8	3.5	1.8	0.6	4.6	6.7	0.7	0.4	1.6	1.5	1.1	0.8	1.3	7.1	1.3	2.0	2.0	1.3	0.2	1.6	3.3	1.4	0.8	5.7	0.5	1.0	0.4	0.6	2.3	3.6	3.5	1.1	1.9	1.7	29.9	1.9	9.3	0.5	0.3	8.4	1.9	1.7	1.2	67.5	73.9	46.6	69.6	4.3	10.1	51.8	68.6	33.1	103.4	96.7	72.2	43.4	59.1	48.7	39.5	90.1	48.7	100.3	47.6	129.1	91.0	83.7	40.6	136.4	52.3	1.1	67.3	23.9	4.7	3.6	87.0	37.3	10.7	51.5	45.9	61.7	50.2	71.7	45.7	67.6	60.6	53.0	37.7	69.4	38.8	87.3	113.0	29.3	34.2	47.9	49.0	103.1	38.2	20.8	40.2	71.3	32.0	26.4	55.6	70.4	46.5	79.0	31.9	68.9	64.6	34.2	79.3	63.1	0.0	0.0	0.0	0.4	0.0	0.2	1.1	0.6	0.7	0.1	1.2	0.2	0.1	0.0	1.6	0.1	1.0	2.1	0.4	2.0	2.1	0.9	1.8	1.6	1.5	1.3	2.0	1.4	1.1	1.9	1.2	0.7	0.0	1.1	0.3	4.3	3.4	3.5	7.3	4.0	0.9	2.2	1.8	0.3	0.0	5.0	0.0	0.0	8.6	0.7	2.2	0.0	3.0	115.4	29.3	2.1	2.5	4.2	14.3	1.3	2.0	25.2	3.4	1.5	3.8	5.7	9.8	2.2	0.4	7.3	3.3	0.5	3.0	4.1	1.3	4.2	206.9	2.1	1.7	0.0	0.0	1.1	0.7	0.0	0.0	0.4	2.2	1.8	2.2	18.1	2.8	0.5	1.2	79.9	0.9	6.6	2.5	5.2	86.4	70.1	7.6	1.4	3.4	3.2	2.7	5.1	3.3
TRIP4	"ASC-1, HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: AB_2681211"	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	14.9	12.4	13.6	13.3	14.7	15.3	17.1	14.1	20.6	13.0	14.9	17.1	17.1	13.2	11.6	19.4	14.1	11.0	15.5	13.7	14.0	27.5	14.3	15.0	16.4	14.4	14.2	13.1	16.6	20.0	13.0	16.9	14.8	12.7	19.2	16.8	13.3	12.1	8.9	18.0	17.9	16.5	14.2	16.6	15.6	12.0	14.5	19.8	25.6	9.2	18.7	17.7	14.7	15.6	18.6	27.1	23.3	16.7	18.9	24.6	21.8	19.3	24.7	32.7	31.5	22.8	40.5	13.3	6.3	29.4	26.6	25.7	38.3	22.0	30.9	27.0	10.9	19.4	19.2	24.1	33.5	21.2	35.1	30.9	28.2	25.9	27.0	18.7	28.9	19.2	22.7	16.2	30.4	21.2	13.5	21.3	13.7	32.7	14.4	20.4	17.7	22.2	31.6	35.1	12.6	19.8	17.3	20.7	35.3	43.5	26.2	31.3	25.7	23.2	15.8	15.6	27.7	13.5	25.9	13.5	19.2	21.4	29.6	70.1	22.2	54.3	20.8	29.1	17.7	16.0	19.7	21.2	20.5	16.3	16.6	17.3	30.9	21.2	42.4	16.2	23.3	16.9	13.6	14.7	14.1	20.6	13.7	14.0	14.4	14.2	14.8	14.2	14.5	15.6	12.7	22.4	13.2	15.3	10.0	8.4	9.6	23.3	2.2	11.1	7.6	7.1	10.3	7.2	18.1	12.9	12.5	22.2	20.1	15.3	13.7	25.2	20.4	21.7	10.7	13.2	11.4	9.9	32.5	27.1	26.8	10.2	10.2	16.2	19.6	12.3	10.0	4.4	21.7	15.2	25.8	8.2	24.4	12.9	7.6	3.7	11.8	15.3	14.2	22.5	27.5	10.0	27.8	18.1	30.9	33.6	10.5	12.8	6.5	6.0	13.5	44.6	26.7	17.3	6.6	9.0	15.0	19.3	21.4	5.4	6.3	24.2	14.4	12.1	8.1	7.8
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867387-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		21000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	42.2	43.0	34.3	15.7	39.5	15.7	42.6	36.2	41.6	59.4	40.4	45.2	9.7	74.6	16.2	63.7	49.5	37.0	39.1	32.6	36.2	55.8	41.1	33.8	14.6	40.6	36.9	50.6	39.8	46.4	16.8	27.4	35.9	42.9	8.4	5.4	46.8	56.7	10.2	55.1	21.5	27.5	36.9	20.0	27.6	18.4	38.4	16.6	50.5	5.8	12.1	47.2	52.5	37.0	128.1	63.4	26.8	126.1	37.8	44.9	131.2	82.3	79.8	101.2	94.8	55.8	143.9	5.5	81.3	87.7	128.3	94.2	38.0	149.2	27.3	19.1	58.5	0.5	117.9	0.8	99.3	66.5	7.1	81.1	94.0	67.8	108.2	64.2	52.8	19.1	83.3	1.0	90.5	286.9	1.3	99.5	92.4	52.3	50.4	47.9	27.0	12.7	65.5	42.8	9.7	1.7	67.5	192.3	78.1	43.8	20.3	77.5	86.5	149.5	145.8	167.5	186.7	1.0	2.1	0.8	92.9	7.8	230.5	0.0	1.2	0.2	0.1	2.1	0.4	2.5	0.9	0.7	1.9	2.4	1.1	0.6	0.0	0.0	3.8	5.2	0.9	0.4	34.3	39.5	36.2	41.6	32.6	36.2	40.6	36.9	35.9	36.9	38.4	37.0	24.5	48.1	38.8	14.4	8.0	131.9	151.5	144.1	78.0	0.9	48.3	55.8	13.9	38.6	87.0	60.7	0.0	113.0	12.0	9.5	80.3	106.9	1.1	22.7	46.1	26.3	4.9	6.7	0.3	84.3	90.4	54.6	40.8	44.8	8.2	55.3	23.9	28.8	44.0	1.7	0.4	12.8	34.6	8.0	59.3	2.8	65.9	17.5	37.4	5.6	20.3	94.8	0.0	4.0	6.5	95.0	13.1	72.6	16.0	72.9	3.6	130.0	34.3	4.6	72.3	50.9	104.0	4.7	4.5	68.2	98.3	132.8	7.1	58.3	18.8	155.6
TRIR	"C19orf43, fSAP18, MGC2803, TERCIR"	ENSG00000123144	"Telomerase RNA component interacting RNase"	Q9BQ61	19	12730640-12734684	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 390.7;Exocrine glandular cells: 381.0;Extravillous trophoblasts: 514.9;Proximal tubular cells: 510.1;Syncytiotrophoblasts: 579.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059965	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA059965: AB_2684182"	"unprognostic (5.57e-2)"	"unprognostic (2.73e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-2)"	171.6	146.4	162.7	76.7	168.5	133.5	161.3	163.0	211.3	168.9	153.2	191.4	78.2	164.6	108.6	170.1	141.8	45.6	169.1	156.0	169.9	164.8	261.8	132.8	98.7	167.8	158.5	166.4	152.3	76.3	131.9	71.9	160.5	144.9	68.6	53.5	137.9	61.4	167.0	162.4	155.4	66.2	165.4	178.7	163.3	99.6	170.5	104.7	124.6	73.5	107.6	163.1	152.4	163.7	276.7	148.0	185.0	135.2	146.5	156.5	174.3	230.8	144.4	175.7	171.6	195.9	94.1	221.0	294.2	142.8	143.0	188.6	185.5	150.3	143.1	250.9	353.8	147.8	177.6	327.5	140.0	214.8	265.8	158.9	182.6	134.4	108.6	151.1	171.0	156.5	208.3	88.4	168.0	612.7	350.0	504.5	200.8	161.7	416.8	302.3	141.1	222.1	209.2	192.7	203.9	268.2	158.0	159.4	277.4	122.8	138.6	311.5	175.5	212.9	164.4	323.0	296.0	292.2	341.3	248.1	173.7	257.0	147.3	22.5	22.9	85.3	25.0	22.0	28.2	66.5	31.4	31.1	21.5	48.6	29.5	26.1	45.3	23.7	20.2	29.1	37.7	13.8	162.7	168.5	163.0	211.3	156.0	169.9	167.8	158.5	160.5	165.4	170.5	163.7	264.0	70.5	76.0	0.0	93.5	0.0	0.0	0.0	0.0	0.0	262.4	287.0	0.0	0.0	34.0	183.9	0.0	390.7	254.9	0.0	272.0	313.9	0.0	162.2	165.6	95.0	0.0	0.0	0.0	381.0	514.9	92.1	0.0	153.6	25.2	177.4	0.0	0.0	359.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.0	0.0	247.6	0.0	0.0	0.0	0.0	351.9	0.0	0.0	29.7	0.0	0.0	510.1	30.6	0.0	0.0	0.0	113.7	0.0	0.0	0.0	0.0	579.3	113.6	162.0	0.0	0.0
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39838110-39883511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.0	9.9	13.1	7.0	13.1	5.6	12.9	14.7	16.1	15.6	12.8	13.6	6.3	14.7	15.3	18.5	13.1	6.0	15.2	13.1	14.0	15.3	13.0	9.2	8.4	12.1	12.1	14.3	21.5	9.7	16.7	11.8	12.6	19.9	10.5	14.7	13.6	10.9	9.5	21.6	11.1	10.0	12.0	12.6	12.0	11.9	13.9	11.8	16.8	4.4	9.9	15.3	16.8	14.3	20.5	9.4	23.0	18.4	10.6	16.5	29.8	11.1	17.3	22.0	21.8	20.0	20.6	11.5	17.4	11.3	12.2	18.9	29.4	22.7	29.7	17.0	15.6	25.6	22.8	13.5	21.8	21.0	14.4	13.3	21.3	25.0	26.9	25.9	18.0	27.1	31.7	14.1	13.8	11.5	14.3	30.7	31.6	17.4	6.2	21.1	21.6	23.3	21.1	27.3	21.9	16.6	15.2	10.3	17.7	23.0	12.5	37.5	11.0	12.8	18.2	21.1	21.3	19.4	13.2	22.5	14.2	24.6	12.1	0.0	5.4	0.6	2.0	3.9	3.7	2.9	1.8	2.2	10.4	2.2	1.9	2.7	0.2	2.0	5.3	10.1	2.3	2.4	13.1	13.1	14.7	16.1	13.1	14.0	12.1	12.1	12.6	12.0	13.9	14.3	4.9	22.4	7.8	16.6	8.0	14.8	17.1	14.4	10.2	4.6	7.8	9.1	10.8	5.7	11.7	7.3	2.1	34.1	10.3	2.9	7.9	12.2	5.9	13.5	10.8	6.2	10.2	13.3	31.3	9.3	32.8	9.6	3.1	6.1	2.5	9.4	8.9	7.0	8.2	15.2	26.6	8.8	16.2	5.9	5.1	3.1	9.6	7.3	5.4	26.2	12.3	4.9	3.1	34.7	31.3	9.5	5.8	11.3	3.3	8.8	4.5	9.2	25.7	7.3	0.0	8.8	6.9	24.9	16.2	13.2	17.0	16.6	6.1	10.7	9.0	11.2
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922516	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021281: AB_2670649, HPA052197: AB_2681758"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favorable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	7.5	9.4	7.4	11.3	8.5	16.4	13.6	8.1	7.8	9.0	9.3	7.2	7.0	9.1	11.8	7.8	10.4	7.5	6.6	6.8	8.2	9.9	11.3	9.2	14.6	7.8	7.7	9.0	9.7	11.6	7.8	7.5	8.2	9.5	8.1	5.5	9.6	7.7	7.3	10.3	9.3	6.4	8.0	11.9	9.3	12.0	7.5	13.8	18.4	7.8	14.0	7.1	6.5	10.2	19.4	12.1	6.5	8.0	8.1	6.7	11.2	9.7	11.0	15.3	11.6	16.9	14.0	12.1	6.4	9.7	17.1	18.0	10.6	7.6	11.8	14.6	8.4	10.0	14.8	15.3	16.7	19.4	15.8	11.7	17.0	8.5	6.9	9.2	6.9	9.5	16.0	15.3	10.7	28.1	8.3	13.3	9.1	20.7	13.4	9.8	14.5	8.7	14.5	15.5	11.5	10.1	7.1	15.4	16.6	5.5	6.8	10.5	10.6	8.4	8.5	17.7	15.0	16.3	12.6	6.1	9.0	9.8	7.7	44.4	21.1	49.4	20.4	23.4	25.4	19.4	30.8	24.6	22.6	28.8	39.7	27.9	32.4	22.9	16.1	13.1	35.1	20.1	7.4	8.5	8.1	7.8	6.8	8.2	7.8	7.7	8.2	8.0	7.5	10.2	7.5	12.8	5.3	0.0	16.7	0.0	14.6	0.0	10.2	9.1	7.3	7.6	0.0	4.3	6.8	5.5	0.0	8.9	17.5	3.5	7.9	9.1	30.6	9.3	5.4	4.9	2.4	6.9	0.0	9.6	6.9	6.0	9.2	7.1	0.0	4.1	5.3	7.3	10.8	6.7	0.0	5.6	0.0	10.7	0.0	18.3	5.0	9.7	0.0	0.0	10.7	12.1	8.2	0.0	0.0	10.3	5.7	7.2	12.0	6.1	4.9	9.9	5.8	4.9	6.6	8.6	5.2	16.7	13.3	7.8	0.0	18.3	14.6	6.6	3.9	8.1
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	5.6	6.9	7.3	5.7	8.1	6.0	6.2	10.7	8.0	8.3	5.8	8.3	4.4	7.1	4.4	5.5	7.6	4.1	4.9	6.8	7.3	6.9	6.4	4.9	7.4	7.9	7.6	9.5	7.9	3.9	6.7	3.8	7.1	8.3	3.5	7.3	6.1	4.2	4.4	10.7	7.1	4.0	6.6	8.1	6.7	3.4	7.6	4.0	7.6	2.1	4.2	7.6	7.1	9.8	4.7	5.6	7.0	6.2	4.2	3.3	3.1	4.4	3.3	4.5	3.9	3.3	4.1	8.7	3.3	3.4	2.7	5.3	3.3	5.5	4.1	3.7	5.6	7.8	14.8	3.5	7.6	8.0	5.2	3.8	5.5	4.3	7.4	5.3	4.7	10.4	6.2	3.6	3.4	3.3	8.1	6.2	6.2	5.0	6.7	8.1	2.4	4.6	4.3	4.2	9.4	9.0	3.7	4.7	4.1	4.4	5.0	5.7	4.8	3.6	5.1	5.9	4.0	4.2	6.1	6.9	2.1	6.1	7.3	3.4	2.7	1.5	3.1	2.4	3.8	3.3	2.8	3.1	1.2	4.3	3.3	3.0	2.8	2.4	1.7	2.3	1.9	1.5	7.3	8.1	10.7	8.0	6.8	7.3	7.9	7.6	7.1	6.6	7.6	9.8	13.2	3.2	8.9	30.3	20.3	7.4	11.4	8.9	15.9	16.2	13.5	16.5	7.4	14.3	8.4	3.7	6.2	16.1	11.0	7.9	11.7	11.3	2.1	7.1	14.1	12.8	13.8	13.7	25.4	12.5	8.6	14.0	13.7	9.1	14.5	17.3	13.6	8.1	8.2	16.8	27.5	14.0	8.2	10.4	9.5	0.9	14.6	12.2	10.6	19.7	15.5	15.9	25.7	37.2	45.7	10.0	6.7	23.7	9.1	14.2	11.4	9.0	7.8	13.5	26.3	13.0	11.1	4.2	5.3	9.7	7.5	12.2	16.4	12.3	10.9	9.4
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMT112	"HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2"	ENSG00000173113	"TRNA methyltransferase subunit 11-2"	Q9UI30	11	64316460-64317559	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039901, HPA040006"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoplasm	"HPA039901: AB_10796334, HPA040006: AB_10793859"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (6.08e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.28e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-2)"	159.1	273.6	158.4	109.5	159.8	149.7	152.5	161.3	182.3	182.2	172.7	143.8	68.5	173.0	140.7	167.7	167.5	90.9	138.0	157.3	175.5	176.0	164.7	129.6	170.8	165.9	169.2	238.2	145.5	109.9	182.0	112.2	170.3	137.7	65.4	64.3	116.5	96.4	159.4	146.6	110.0	105.6	163.0	146.8	129.4	130.7	169.0	152.3	142.0	81.8	153.4	145.8	150.3	177.6	411.4	590.3	203.2	298.9	238.0	195.8	199.9	195.3	245.2	231.2	188.3	308.0	401.7	320.5	575.6	204.5	353.1	338.8	367.8	430.1	157.7	373.0	340.1	359.7	503.6	708.9	264.3	282.2	225.2	227.1	401.0	205.5	409.7	241.4	239.7	218.3	298.2	394.5	220.0	1070.4	414.0	527.9	543.0	279.2	511.0	249.6	233.0	451.3	270.6	416.8	133.3	599.3	278.1	322.8	571.4	178.1	503.8	249.7	197.0	241.7	297.2	408.7	365.7	338.7	591.5	512.8	330.2	276.3	255.4	780.9	377.7	573.3	428.7	331.8	444.1	956.3	559.0	481.0	404.8	808.8	617.8	534.8	459.0	392.8	303.5	671.5	551.1	883.6	158.4	159.8	161.3	182.3	157.3	175.5	165.9	169.2	170.3	163.0	169.0	177.6	234.8	160.3	164.3	8.1	269.6	349.9	421.7	465.9	299.9	89.4	219.5	323.8	137.4	135.8	255.8	274.0	22.9	561.1	239.3	96.1	491.0	232.1	71.3	270.9	200.4	236.0	154.4	251.8	10.0	224.4	469.8	249.8	96.8	257.8	217.4	251.8	189.5	196.0	395.2	52.2	10.9	160.6	205.4	174.6	312.3	63.1	299.5	179.1	336.2	12.2	321.2	177.2	247.2	9.0	24.5	221.2	126.4	218.6	296.7	304.4	111.0	610.2	305.0	88.1	216.9	196.2	246.6	230.6	531.2	276.6	396.4	412.1	261.6	258.2	155.3	386.8
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.1"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	6.0	5.8	5.0	5.4	5.1	3.1	8.7	4.3	6.7	6.5	5.5	5.7	4.6	6.5	6.1	5.6	7.6	4.4	5.9	6.5	4.8	7.6	6.0	5.9	6.5	3.6	3.9	5.0	5.1	8.6	4.7	5.4	4.1	6.9	6.5	8.1	7.7	6.1	9.7	5.3	5.0	8.2	3.4	5.5	5.7	6.4	5.5	8.3	8.8	10.0	6.7	6.7	4.3	4.9	14.8	12.6	10.3	8.1	19.0	9.7	2.5	9.1	10.6	13.1	11.2	7.7	10.0	14.9	12.3	9.4	8.5	10.1	14.7	14.9	15.4	14.8	11.2	14.4	12.8	2.6	14.8	0.0	11.2	12.1	19.6	12.9	16.2	3.8	11.1	15.4	20.4	10.1	8.2	73.1	17.2	6.1	0.0	33.9	11.5	5.4	6.9	9.9	12.1	15.7	17.3	13.8	13.4	49.5	19.5	8.7	14.1	6.1	8.9	9.1	23.8	6.8	10.4	10.4	15.6	5.8	8.2	5.0	7.5	0.4	3.5	3.8	2.3	2.9	3.0	2.1	3.2	2.5	2.8	2.8	3.9	3.9	1.3	3.1	3.3	0.8	2.1	2.4	5.0	5.1	4.3	6.7	6.5	4.8	3.6	3.9	4.1	3.4	5.5	4.9	4.9	9.6	7.5	2.0	11.2	5.2	6.1	3.5	7.4	5.6	5.5	4.7	3.9	7.2	2.2	3.7	16.7	7.3	8.4	4.2	5.9	5.6	18.6	6.3	4.9	5.7	3.0	1.7	1.5	6.2	5.4	4.5	6.6	3.6	9.5	7.7	4.2	5.4	5.1	8.4	1.8	4.4	4.1	4.1	2.5	21.0	4.1	5.2	5.4	1.0	8.1	4.0	9.2	1.0	1.2	4.3	3.9	6.0	8.4	4.8	3.9	8.2	7.6	8.2	0.0	8.2	6.5	14.2	5.8	4.7	4.3	4.9	6.3	7.9	4.9	4.6
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150498	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	8.8	8.7	6.9	12.2	9.8	5.2	14.5	9.6	9.6	11.2	6.7	9.3	11.2	13.9	11.8	8.5	9.2	7.2	8.0	6.5	9.7	8.8	8.7	7.8	18.2	8.5	9.0	13.5	11.5	12.9	6.8	10.7	8.7	10.4	11.3	21.7	9.1	8.1	13.1	14.7	10.7	10.1	7.0	14.1	10.0	9.4	8.5	11.3	12.0	6.2	14.6	9.5	10.3	14.9	17.5	10.0	16.5	11.5	8.7	16.9	18.0	18.0	7.1	13.4	11.1	11.9	7.0	28.7	21.8	14.4	8.9	15.4	30.6	14.0	23.1	29.0	24.2	17.2	23.1	11.6	15.7	30.0	15.4	11.9	15.5	25.5	33.3	8.4	12.4	21.0	36.6	17.9	13.6	6.7	24.6	15.6	23.0	16.7	19.9	26.0	25.0	15.7	11.1	13.6	10.7	17.9	16.6	15.8	21.6	16.1	9.3	26.1	13.0	17.8	11.9	15.1	24.3	22.8	20.0	34.0	20.1	23.5	7.0	0.2	5.8	3.1	10.5	6.1	13.0	19.9	11.3	10.6	7.0	18.7	16.8	14.0	2.5	7.9	5.1	12.8	8.6	5.6	6.9	9.8	9.6	9.6	6.5	9.7	8.5	9.0	8.7	7.0	8.5	14.9	13.1	25.6	17.0	34.0	29.0	9.7	14.2	14.2	19.9	38.9	10.7	7.9	11.1	12.8	22.2	14.7	29.2	14.2	18.9	8.0	13.7	10.5	20.9	14.3	21.0	15.7	20.4	11.3	23.1	6.1	10.2	13.7	11.7	8.0	21.5	18.7	17.9	11.4	7.6	28.6	32.1	9.9	18.3	10.1	7.0	6.0	24.8	10.3	10.6	25.3	14.7	16.6	41.2	33.7	97.4	8.5	9.6	18.4	9.0	12.6	13.0	10.7	20.4	44.7	19.7	16.0	13.4	47.6	21.9	12.2	11.9	7.3	21.5	15.8	13.6	10.0
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118101-185157072	"Metabolic proteins, Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.0;Spermatocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	6.8	8.6	7.8	8.4	9.1	5.7	7.6	9.7	9.7	7.9	9.1	7.7	8.5	7.3	9.4	6.9	10.6	7.0	12.1	7.6	8.4	13.1	14.5	7.4	10.8	8.7	8.2	11.4	5.0	12.1	7.0	8.2	8.9	7.6	7.2	8.9	5.6	8.1	20.8	4.8	7.0	6.9	9.1	10.6	7.2	27.7	8.2	10.2	10.4	18.7	11.9	7.0	5.5	12.3	12.4	22.3	15.1	11.3	21.8	20.0	21.5	11.7	10.5	15.7	16.4	20.4	23.1	13.5	28.5	8.1	24.0	15.6	25.7	15.3	15.4	16.1	11.2	13.0	15.9	20.9	15.2	19.3	20.6	9.6	20.3	16.1	16.1	16.6	17.5	17.9	34.5	18.0	18.9	10.5	14.7	11.2	24.9	25.3	4.6	17.1	21.7	21.6	15.2	13.5	13.4	12.0	22.8	22.0	16.2	34.2	22.4	10.7	16.9	14.3	11.4	9.9	15.8	28.7	41.5	21.3	9.4	16.8	14.0	24.0	10.6	21.9	7.5	14.7	8.1	12.3	9.9	9.3	13.3	18.1	12.3	9.7	12.3	12.8	19.2	5.5	14.2	9.2	7.8	9.1	9.7	9.7	7.6	8.4	8.7	8.2	8.9	9.1	8.2	12.3	8.2	12.8	15.6	24.2	18.0	2.7	8.1	11.6	7.4	8.7	6.9	6.5	29.5	11.5	15.1	16.5	8.4	16.3	10.0	8.9	27.4	12.2	73.0	22.4	8.9	11.7	6.1	29.0	19.8	6.0	9.9	12.0	10.7	8.2	8.8	14.5	11.0	25.0	13.0	3.3	19.6	9.2	12.2	17.5	6.2	25.0	12.5	13.7	1.8	20.6	16.3	9.6	6.2	18.6	36.8	7.6	10.9	12.0	10.7	5.9	9.6	23.9	44.2	8.6	0.0	11.0	9.6	103.8	32.0	9.7	2.4	11.4	10.7	13.6	8.3	5.3
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111875-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 131.7;Late spermatids: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 84.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	15.7	24.0	11.2	7.6	11.4	8.2	16.8	11.4	16.8	17.7	12.0	15.3	8.7	14.7	4.4	16.3	16.0	6.4	13.8	11.3	10.6	18.0	31.4	12.9	13.1	12.2	10.9	15.5	24.2	5.8	21.8	5.5	11.9	20.7	2.7	2.4	19.1	5.6	15.6	17.1	16.3	3.6	11.1	28.1	17.2	22.8	11.7	10.2	18.7	4.8	5.2	15.3	13.8	12.9	13.8	15.4	6.1	9.9	6.0	4.4	20.9	12.3	6.4	9.7	8.8	18.5	11.7	18.7	10.2	5.9	7.4	21.0	4.5	7.2	1.4	20.3	52.2	22.7	23.3	17.0	15.8	34.9	21.2	8.2	9.0	10.3	3.8	6.7	9.9	15.4	84.5	13.1	6.8	21.7	19.5	21.6	11.2	16.2	19.9	22.8	10.6	7.4	5.7	15.1	16.0	12.2	7.9	18.9	21.5	2.6	13.6	28.7	9.3	11.5	15.4	9.3	10.6	44.3	21.6	14.6	15.2	14.7	11.9	10.2	12.2	7.4	9.8	15.3	14.4	9.7	10.3	11.7	14.3	6.3	11.1	11.1	1.5	10.6	13.5	12.7	8.4	12.3	11.2	11.4	11.4	16.8	11.3	10.6	12.2	10.9	11.9	11.1	11.7	12.9	10.8	12.8	13.8	13.4	13.4	9.8	10.2	13.9	9.6	12.5	15.9	18.0	7.4	14.3	14.1	11.0	8.4	25.0	18.3	17.0	13.7	12.3	131.7	8.9	9.5	10.9	18.6	14.5	6.9	13.0	18.9	10.8	15.8	6.6	25.4	15.8	8.9	18.6	25.0	15.2	7.4	13.4	14.2	18.9	8.9	206.4	17.7	13.7	7.2	4.7	16.9	22.7	12.3	3.5	9.0	13.0	13.4	14.3	18.1	12.1	14.4	10.5	11.9	12.8	6.6	11.8	11.2	16.4	13.7	10.4	11.2	28.5	16.6	19.2	20.0	9.7
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	5.4	6.4	3.3	7.1	3.3	7.8	6.3	3.7	4.0	6.8	5.6	7.8	6.1	4.7	4.0	8.2	5.3	5.4	9.1	3.3	3.8	8.7	6.2	6.5	10.3	4.3	3.9	6.7	6.4	14.7	5.8	3.9	4.7	6.6	9.2	2.4	9.9	5.3	15.0	6.9	9.2	5.0	3.4	10.6	8.7	2.5	4.0	14.7	8.6	14.4	11.3	5.2	6.1	3.3	22.4	18.9	3.8	8.9	8.7	4.5	11.6	11.4	15.4	12.6	18.7	20.6	17.5	19.9	22.3	10.6	25.6	13.7	17.5	16.0	15.7	17.2	10.9	12.6	15.6	9.9	7.6	22.5	19.6	5.8	9.3	18.2	8.4	8.8	24.8	21.2	13.0	18.3	11.7	22.5	28.5	11.6	5.2	27.7	14.0	22.8	18.2	19.1	9.2	12.8	5.5	7.4	19.4	14.0	11.7	10.4	9.1	10.8	14.5	15.7	9.4	14.8	10.3	11.5	18.7	18.1	12.2	25.3	12.4	14.9	10.0	18.8	15.8	8.0	17.0	18.7	18.6	15.8	9.3	20.4	21.8	18.3	5.7	18.7	9.5	10.0	16.8	14.8	3.3	3.3	3.7	4.0	3.3	3.8	4.3	3.9	4.7	3.4	4.0	3.3	3.0	6.4	6.3	22.2	10.5	2.3	5.5	4.1	6.2	0.8	3.0	1.5	10.3	1.5	5.0	14.7	2.1	6.1	5.7	5.4	7.9	4.0	0.1	3.3	1.9	4.0	6.7	5.7	17.2	3.4	3.0	3.4	6.1	2.9	13.3	6.9	3.6	4.1	3.6	1.7	18.5	6.8	2.0	5.3	0.6	0.8	3.4	3.4	1.8	18.7	5.6	4.8	14.4	9.5	11.6	5.3	4.8	3.8	4.2	3.8	5.5	5.7	6.0	1.8	0.0	5.3	3.0	0.2	3.8	6.2	1.6	5.1	8.7	4.4	6.1	5.3
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	5.8	3.5	2.0	3.9	2.5	7.1	6.9	2.6	2.8	5.1	0.7	4.9	3.6	6.2	4.4	6.6	5.4	3.4	4.6	2.2	0.9	3.2	4.2	4.2	5.0	0.9	0.6	7.6	4.5	4.2	3.2	4.9	1.2	4.8	3.2	3.7	5.5	3.8	5.9	9.0	3.6	4.4	0.6	4.0	5.3	4.9	1.3	3.7	4.5	2.6	5.2	5.0	5.6	2.6	5.2	5.1	6.4	7.5	6.5	6.3	15.2	5.9	4.2	7.6	6.7	6.8	7.0	6.9	3.1	2.3	6.4	4.1	9.3	5.4	6.7	3.7	5.9	6.9	8.9	5.1	6.0	11.4	4.9	3.9	7.7	5.8	6.3	6.4	8.1	4.8	10.2	7.2	5.0	3.2	9.5	8.3	7.4	6.5	8.5	6.9	6.9	4.9	6.6	6.0	6.9	4.7	3.8	3.4	5.5	7.2	2.9	4.7	5.2	4.6	2.5	4.4	9.3	8.4	6.0	6.2	5.1	10.7	4.7	0.1	0.3	0.0	0.6	0.3	0.3	0.2	0.5	0.6	0.5	0.5	0.7	0.2	0.0	0.2	0.6	0.4	0.0	0.1	2.0	2.5	2.6	2.8	2.2	0.9	0.9	0.6	1.2	0.6	1.3	2.6	4.4	9.6	7.3	12.7	4.9	6.8	4.2	3.1	2.8	7.8	6.8	5.1	3.3	7.2	3.2	7.3	25.0	10.2	4.1	2.6	5.9	5.0	3.8	16.2	13.0	4.7	1.8	1.7	21.3	4.5	6.2	7.5	14.8	25.6	5.1	18.8	5.0	3.8	4.6	3.3	18.4	2.0	2.0	3.1	2.4	2.8	5.9	3.7	1.8	8.4	4.1	2.6	3.1	8.5	12.3	4.5	7.2	3.8	5.3	5.3	3.0	2.7	8.1	10.8	0.0	6.3	6.5	9.2	5.8	8.2	5.8	16.3	5.2	4.8	3.8	7.6
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971441-60981170	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	7.3	5.5	3.5	4.4	3.8	4.8	9.8	6.0	4.1	6.5	3.1	6.7	5.7	7.0	7.8	7.6	7.4	5.1	4.2	3.4	4.6	6.9	6.8	5.0	6.0	2.5	3.4	9.9	6.7	10.5	3.5	7.0	2.8	6.9	6.0	5.2	7.6	4.8	7.5	6.7	4.5	7.0	3.1	4.7	5.8	17.3	4.0	6.1	7.2	7.2	5.8	6.7	3.9	3.8	49.7	12.5	17.9	25.0	15.5	23.6	19.4	18.2	14.0	19.1	15.2	9.8	28.7	25.2	19.9	13.3	14.3	22.3	22.9	26.4	25.0	25.3	11.5	18.6	8.1	10.2	25.1	33.2	9.9	18.3	25.1	17.4	25.4	17.0	17.0	21.6	24.5	8.8	28.3	18.7	17.1	16.8	16.4	19.4	20.3	5.4	41.5	21.4	16.3	16.7	22.1	21.6	20.2	20.1	16.6	15.4	33.5	19.7	16.1	22.1	26.7	15.7	17.5	5.3	10.8	11.6	15.6	7.2	21.0	0.1	3.2	0.7	2.4	5.5	3.3	4.9	3.4	3.5	3.0	4.1	3.8	3.4	0.3	1.4	5.9	5.2	4.5	2.5	3.5	3.8	6.0	4.1	3.4	4.6	2.5	3.4	2.8	3.1	4.0	3.8	7.0	6.4	10.9	3.9	4.5	6.4	19.5	15.9	9.6	5.7	6.3	10.0	8.0	1.5	19.6	11.0	4.2	12.8	5.7	3.2	1.9	7.7	221.8	8.2	17.4	9.2	5.4	10.7	5.4	7.5	12.4	12.4	9.7	8.1	6.3	12.1	8.6	7.0	10.9	3.3	6.7	8.3	8.2	6.2	7.6	50.2	11.1	6.0	7.2	3.7	4.1	12.2	1.0	9.0	6.3	8.2	4.8	7.5	4.7	8.2	3.9	11.1	14.9	5.4	13.1	14.7	9.5	23.3	12.6	11.1	4.3	19.2	5.2	14.4	7.6	10.6
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937228-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	7.4	9.7	5.1	7.3	5.3	13.8	5.9	5.9	6.3	5.9	4.5	5.8	3.4	6.6	6.0	9.1	5.7	3.5	7.7	5.4	5.2	8.0	5.5	4.9	9.3	5.8	5.1	5.6	7.3	6.8	8.4	5.1	5.8	5.2	5.5	3.7	6.1	9.9	20.2	7.8	5.9	5.6	4.9	6.6	5.8	11.5	4.8	8.8	5.9	7.3	9.0	11.0	6.4	5.1	55.5	27.8	17.1	25.9	10.4	11.8	21.4	24.7	12.5	24.5	20.6	36.5	22.2	62.1	13.1	15.1	33.8	39.9	36.3	41.8	40.3	13.3	25.5	50.6	12.0	32.2	19.8	47.8	13.3	13.6	21.8	44.4	33.4	8.6	10.0	25.6	32.3	18.0	28.8	14.4	50.6	26.2	39.5	36.9	33.9	33.4	33.6	36.1	18.3	31.3	33.9	51.1	29.2	39.3	45.0	16.2	20.2	24.4	8.8	28.5	27.1	26.8	52.1	31.6	64.1	74.6	13.3	37.9	29.3	2.1	7.8	6.3	9.1	9.1	10.9	8.6	9.9	11.5	18.0	8.1	10.1	11.1	0.7	15.6	8.3	7.5	12.5	7.2	5.1	5.3	5.9	6.3	5.4	5.2	5.8	5.1	5.8	4.9	4.8	5.1	11.7	6.4	20.3	2.0	20.0	21.4	26.1	35.8	25.0	19.8	12.6	14.9	25.9	15.7	31.3	29.5	10.4	26.2	12.4	6.3	35.2	26.3	3.9	18.2	14.8	17.8	13.8	10.7	6.4	30.7	26.8	19.7	12.8	16.2	34.9	25.5	5.0	19.1	17.6	26.9	4.9	8.6	26.4	15.0	47.5	6.5	11.5	35.0	17.8	11.2	13.6	13.2	20.6	4.5	4.0	22.4	7.3	7.2	17.5	33.8	3.8	22.7	30.8	11.0	13.1	26.7	28.7	70.4	103.6	17.4	24.0	29.3	21.0	18.7	12.6	20.6
TRMT61B	FLJ20628	ENSG00000171103	"TRNA methyltransferase 61B"	Q9BVS5	2	28849821-28870309	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026747, HPA026751"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA026747: AB_1848782, HPA026751: AB_1848784"	"unprognostic (1.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.36e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (9.61e-5)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.34e-1)"	8.8	13.1	9.8	8.5	9.9	9.2	13.1	12.1	17.0	9.4	12.0	8.4	14.1	10.1	14.0	8.6	8.1	7.2	15.2	9.8	9.9	14.4	12.6	6.6	11.0	9.7	9.8	9.4	7.0	15.1	9.0	8.9	10.0	10.6	9.3	9.4	8.7	7.9	13.8	8.7	14.1	10.3	9.8	8.7	9.2	7.4	9.7	10.2	9.1	16.6	9.1	10.7	7.5	10.6	28.5	16.7	16.7	29.6	22.3	19.0	20.1	16.5	20.3	20.6	19.2	19.3	15.0	29.9	14.8	14.5	24.7	21.7	23.5	20.1	21.3	22.6	15.8	9.1	13.6	25.7	25.2	19.4	10.0	19.5	22.0	16.4	22.2	15.2	20.0	19.1	18.9	11.2	17.2	11.3	17.3	29.6	31.0	33.6	26.7	12.7	26.9	26.1	18.2	18.2	28.1	29.8	17.8	27.8	28.5	13.9	14.2	6.7	15.8	13.7	23.1	13.6	21.0	13.7	24.2	46.6	18.1	28.9	18.8	0.0	8.0	3.5	11.2	8.5	13.8	14.5	12.4	12.0	7.8	14.1	13.7	9.9	1.1	17.7	7.1	8.3	14.7	7.4	9.8	9.9	12.1	17.0	9.8	9.9	9.7	9.8	10.0	9.8	9.7	10.6	10.2	16.0	8.7	18.3	17.7	18.1	11.0	23.7	17.1	10.8	9.9	10.2	2.8	11.5	14.7	9.2	6.2	22.1	11.8	4.5	15.6	14.5	9.3	9.4	11.8	8.5	4.8	10.9	38.0	10.2	13.8	10.8	21.4	7.7	9.5	15.8	7.5	11.5	9.2	6.7	34.8	9.8	20.3	7.3	8.2	3.6	8.7	7.0	7.2	7.5	11.0	10.3	8.2	36.2	32.2	10.3	8.5	10.5	13.5	7.6	23.6	30.3	15.0	21.6	6.6	12.2	10.6	24.1	9.7	15.3	15.8	8.8	12.4	15.9	12.1	7.3
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 118.6;choroid plexus: 375.5"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.9;Collecting duct cells: 14.7;Distal tubular cells: 11.7;Endometrial ciliated cells: 35.1;Glandular and luminal cells: 18.7;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 118.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.0;BJ: 8.7;fHDF/TERT166: 11.9;RPTEC TERT1: 4.0;SCLC-21H: 4.3;U-266/84: 4.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 31.1"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	1.3	0.4	6.1	0.6	6.8	0.3	2.3	118.6	7.9	1.7	375.5	1.6	0.7	1.0	0.9	0.9	2.0	1.6	6.3	25.2	6.3	3.5	2.2	1.7	0.4	5.4	7.2	0.3	2.2	1.6	1.4	0.4	11.5	1.2	1.2	24.5	2.6	1.0	3.2	3.2	1.2	0.4	4.8	1.5	1.1	1.2	17.5	0.2	33.7	1.6	0.3	0.9	0.8	5.0	0.1	0.0	6.0	0.0	0.0	0.0	1.4	8.7	2.0	1.2	0.6	0.0	0.1	0.1	0.4	11.9	1.1	0.2	0.1	0.2	1.2	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.2	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.7	0.1	0.0	1.0	0.0	0.1	4.0	0.1	4.3	0.1	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.8	0.8	0.1	0.2	4.4	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	6.1	6.8	118.6	7.9	25.2	6.3	5.4	7.2	11.5	4.8	17.5	5.0	6.2	6.4	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	6.7	0.0	0.0	9.9	14.7	0.0	1.0	0.2	0.0	11.7	2.3	0.0	35.1	6.4	2.1	0.0	0.0	0.0	1.1	0.2	1.8	0.0	18.7	1.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	14.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0
TRMU	"FLJ10140, MTO2, MTU1, TRMT"	ENSG00000100416	"TRNA mitochondrial 2-thiouridylase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	4.2	7.5	7.7	2.3	7.8	2.9	4.0	8.3	9.6	4.3	8.3	4.5	4.7	3.6	7.5	5.6	3.4	2.6	11.2	7.6	8.5	9.1	8.8	3.5	5.0	8.5	8.6	4.0	10.2	8.0	5.3	4.1	8.5	4.4	4.1	2.8	5.5	4.7	6.9	4.8	4.0	3.9	7.9	4.2	4.3	2.3	8.5	3.0	4.6	8.4	4.3	4.2	4.1	7.8	17.8	16.0	6.6	15.1	12.2	8.6	16.6	18.1	12.6	24.9	19.2	22.7	4.5	11.5	12.5	16.2	10.9	15.3	28.5	16.0	21.1	7.5	38.4	13.6	25.0	27.1	10.4	26.5	9.0	8.2	17.6	25.8	8.1	10.3	16.2	5.8	19.3	2.7	15.3	19.1	10.4	21.5	25.5	10.6	27.5	12.2	14.4	21.2	12.5	12.1	15.9	19.0	16.0	18.5	31.7	8.2	10.7	10.9	11.9	11.1	19.8	15.8	20.7	6.5	7.8	12.6	15.7	19.1	22.8	0.0	6.2	3.8	9.4	9.0	8.3	5.4	8.2	8.9	7.1	5.5	7.3	6.9	1.3	8.0	9.8	5.8	11.0	5.9	7.7	7.8	8.3	9.6	7.6	8.5	8.5	8.6	8.5	7.9	8.5	7.8	12.7	9.6	6.1	22.9	13.2	6.2	10.8	16.8	7.4	26.4	10.6	11.8	14.7	10.0	10.7	11.0	16.7	24.9	16.1	14.1	27.4	20.1	1.6	6.3	10.2	14.5	12.5	14.3	19.4	19.6	21.0	11.9	21.9	6.6	9.5	26.8	13.9	16.8	15.9	13.5	18.0	12.3	10.2	9.9	4.0	3.3	15.2	8.8	8.8	5.6	14.9	11.9	20.6	10.1	14.6	19.5	9.9	17.0	13.8	14.2	15.3	27.9	10.2	26.4	6.6	7.6	14.4	18.5	12.9	9.6	9.7	15.3	13.1	21.0	19.3	9.9
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	5.8	4.7	8.2	3.9	8.5	4.1	5.2	10.1	10.5	5.2	7.7	5.8	2.7	4.2	5.5	5.2	5.0	2.5	5.4	7.9	8.5	5.3	3.3	5.2	5.9	8.4	8.2	5.8	5.6	5.7	4.0	4.1	8.5	4.3	4.4	7.2	4.8	5.1	4.0	6.9	4.7	3.7	8.1	5.3	5.1	2.9	8.2	8.5	3.8	3.4	7.0	5.0	4.6	9.2	5.1	3.0	8.6	6.0	7.7	14.6	4.1	6.7	13.5	12.1	10.9	4.7	7.8	7.7	2.6	7.4	5.7	3.8	9.4	10.7	12.1	6.8	10.6	5.8	10.1	3.2	7.1	4.5	4.8	15.7	9.2	9.5	7.4	8.5	17.4	7.8	6.8	6.1	12.0	3.5	7.7	5.2	6.1	5.5	6.5	5.5	6.0	5.4	13.3	5.1	5.0	6.5	8.0	6.9	7.7	9.1	7.7	5.4	5.0	3.1	3.0	5.0	6.1	7.9	10.6	4.8	7.6	9.7	9.1	5.4	2.7	7.3	4.2	4.5	4.2	3.6	4.5	5.3	3.3	4.1	5.3	3.4	1.6	9.7	2.8	2.2	3.3	2.2	8.2	8.5	10.1	10.5	7.9	8.5	8.4	8.2	8.5	8.1	8.2	9.2	30.3	35.3	36.6	15.0	29.2	17.6	20.0	33.8	17.6	35.1	22.3	23.0	19.9	21.5	39.9	18.4	35.5	30.6	37.1	13.4	17.6	37.4	11.1	41.0	20.4	23.8	10.3	32.2	29.7	32.8	52.8	23.0	14.8	28.0	35.4	28.1	25.4	10.8	33.1	23.5	28.2	13.9	36.7	30.1	23.2	5.0	28.9	27.6	14.2	6.5	35.1	25.5	39.1	17.6	29.9	40.8	12.2	22.6	37.5	22.2	23.4	19.5	84.7	35.4	32.9	22.0	55.0	21.9	25.3	36.3	20.5	68.4	31.8	23.1	14.8	28.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0;lymphoid tissue: 36.7;testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Erythroid cells: 75.6;Late spermatids: 70.2;Spermatocytes: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.6"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	1.3	1.5	0.2	7.3	0.3	51.0	1.4	0.2	0.7	2.8	0.2	6.7	9.0	1.2	0.5	13.5	0.7	0.8	0.8	0.2	0.2	0.9	1.6	2.4	11.2	0.4	0.2	0.8	0.8	0.7	0.4	5.1	0.3	0.9	9.2	0.6	2.5	0.4	0.3	7.7	7.6	2.8	0.1	7.0	5.4	29.1	0.5	36.7	0.8	0.3	14.5	1.9	5.3	0.3	95.9	73.9	92.4	69.7	2.8	6.2	71.2	45.4	43.4	129.5	73.1	163.7	73.5	64.6	21.9	33.7	70.7	74.6	70.4	44.0	75.7	51.9	101.8	90.9	120.4	53.7	1.9	66.5	93.8	1.5	6.0	86.9	59.8	21.1	75.1	68.0	57.2	108.9	52.7	123.0	122.9	101.8	43.4	269.3	110.2	62.5	78.6	83.9	31.7	35.0	59.9	41.0	56.0	107.4	32.7	53.6	88.2	50.1	25.0	33.5	91.2	69.4	124.8	58.3	68.8	83.0	32.3	73.8	38.4	0.2	0.0	0.1	0.1	0.0	0.2	1.4	2.1	2.3	0.3	1.4	0.1	0.5	0.0	2.0	0.1	0.0	8.6	0.5	0.2	0.3	0.2	0.7	0.2	0.2	0.4	0.2	0.3	0.1	0.5	0.3	0.1	0.0	0.0	0.0	4.6	3.8	1.5	2.8	1.2	0.6	2.1	2.8	0.5	0.0	1.8	0.0	0.0	14.1	1.0	3.7	0.0	0.7	71.5	1.9	1.3	1.9	1.2	75.6	0.0	0.7	23.6	3.3	10.2	2.7	0.0	16.0	5.7	1.1	15.7	0.0	0.0	7.9	10.2	6.7	3.7	70.2	1.8	4.0	1.8	0.0	0.9	0.0	6.2	0.0	0.0	0.8	1.8	0.4	17.0	1.1	0.7	0.1	0.2	0.4	0.0	0.7	3.5	29.1	9.3	15.6	2.0	4.0	2.5	0.9	12.7	3.6
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724034-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 93.7;Excitatory neurons: 144.6;Granulosa cells: 91.8;Inhibitory neurons: 184.4;Microglial cells: 49.6;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 164.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	5.2	4.7	7.3	1.9	7.9	0.3	4.7	10.9	7.5	9.1	5.8	7.6	1.2	11.1	5.2	3.6	8.6	5.4	10.1	7.9	7.0	3.2	0.8	3.3	1.9	7.1	5.6	14.2	1.4	6.5	10.3	3.5	7.7	7.0	2.5	22.8	2.9	7.8	1.2	3.6	3.9	10.6	6.1	2.8	3.2	4.8	6.1	1.5	5.1	3.6	1.0	6.3	6.9	7.9	4.2	5.7	10.8	1.2	9.7	23.9	4.8	6.8	10.5	8.4	12.2	1.7	1.1	0.0	2.1	7.0	14.2	0.3	3.0	3.2	12.2	1.0	4.1	6.8	2.6	2.9	4.0	0.4	0.0	11.4	3.2	7.9	9.4	14.2	4.9	0.0	0.2	0.0	12.1	2.6	0.4	0.5	6.0	0.1	3.1	0.0	5.0	0.0	5.9	0.1	6.7	4.8	8.1	0.0	1.5	9.9	3.3	0.1	4.3	10.1	1.6	14.0	9.1	3.9	1.8	2.1	7.7	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.9	10.9	7.5	7.9	7.0	7.1	5.6	7.7	6.1	6.1	7.9	6.2	3.2	0.5	93.7	2.9	2.9	1.6	1.2	7.4	17.9	0.9	1.8	12.0	1.5	0.6	5.5	16.7	0.2	0.3	0.0	0.0	0.3	3.6	0.5	10.8	4.6	1.8	0.4	144.6	0.2	0.2	13.2	0.0	0.9	0.0	91.8	3.6	0.0	0.1	13.5	184.4	0.0	0.0	0.0	1.6	2.9	8.4	0.5	1.8	49.6	0.1	7.7	0.0	154.8	164.8	0.1	0.0	10.9	1.5	0.9	0.0	0.7	3.0	16.0	0.0	10.4	12.0	9.8	2.8	0.7	1.1	0.3	2.2	1.7	0.0	0.3
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092807	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051197: AB_2681384, HPA065061: AB_2685416"	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	54.2	60.9	40.6	37.4	49.5	69.3	50.5	43.6	47.4	45.6	41.3	42.6	36.4	41.7	32.1	45.8	41.3	34.1	46.4	40.7	44.2	43.0	61.9	55.9	42.2	50.0	46.4	40.4	64.2	42.4	62.1	47.8	50.7	46.6	36.1	29.7	48.2	36.1	80.5	46.1	46.9	37.6	43.3	60.4	51.9	35.7	50.0	41.6	47.3	39.7	38.9	41.9	41.4	63.0	53.7	64.4	56.3	58.2	85.2	81.6	86.0	85.2	99.8	95.7	109.6	141.6	78.3	50.0	79.5	99.1	97.4	70.0	51.6	121.5	73.7	26.7	40.2	127.5	54.8	131.0	85.0	74.9	83.8	91.4	75.4	71.7	61.0	100.0	107.9	101.1	61.2	58.3	77.0	40.6	91.1	84.0	44.3	49.2	86.9	56.4	80.9	51.2	82.3	68.9	49.6	50.1	91.9	153.2	59.3	66.6	55.6	59.9	106.7	117.9	53.2	64.8	51.6	52.9	30.6	41.5	128.2	36.6	61.7	30.6	30.5	50.6	24.0	32.4	25.5	17.4	19.9	25.7	40.2	15.3	17.2	18.7	48.5	25.9	38.2	17.4	24.7	27.0	40.6	49.5	43.6	47.4	40.7	44.2	50.0	46.4	50.7	43.3	50.0	63.0	24.2	19.2	14.1	49.0	29.9	15.2	15.2	20.6	21.6	25.7	24.1	19.9	13.1	12.8	19.1	20.2	79.2	52.6	37.0	34.9	3.9	30.1	14.8	16.0	21.9	25.1	20.4	21.5	44.6	27.3	43.8	23.9	48.4	24.9	19.7	43.4	21.0	23.4	37.2	67.3	56.3	24.6	28.5	25.6	22.2	8.5	25.4	23.7	12.4	40.3	27.9	28.5	23.7	59.3	138.0	36.2	24.1	23.0	45.8	23.6	30.4	11.4	18.0	29.2	39.5	18.3	24.0	23.2	27.3	19.1	15.8	68.4	32.2	30.3	24.0	24.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.3;placenta: 20.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	4.3	0.5	1.2	0.7	1.5	0.2	3.3	0.6	1.3	3.4	5.8	2.8	1.2	4.8	1.6	5.7	5.4	2.3	0.5	1.5	1.9	1.4	0.1	13.3	1.1	1.8	3.4	1.2	0.7	0.9	0.2	20.8	1.2	2.2	1.6	0.3	0.9	5.4	0.4	1.9	1.2	4.0	1.6	2.2	1.6	0.6	2.0	0.2	9.4	1.0	0.8	1.8	2.0	1.2	0.0	4.9	0.2	0.0	8.8	2.1	0.0	3.2	4.9	0.7	0.1	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	1.2	1.5	0.6	1.3	1.5	1.9	1.8	3.4	1.2	1.6	2.0	1.2	3.4	0.0	2.6	2.0	0.0	2.3	1.9	0.0	0.0	1.4	0.4	2.9	0.7	0.0	10.5	3.7	0.0	1.3	0.0	0.1	0.0	0.0	1.0	3.0	4.0	1.6	0.0	0.0	19.3	0.2	0.0	3.1	0.0	8.0	0.0	0.1	0.0	0.0	0.3	0.0	47.2	0.0	0.0	0.0	5.3	0.5	6.2	1.8	1.8	12.2	0.1	0.0	0.0	2.0	0.3	0.0	5.1	0.7	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.3	20.2	0.1	0.7	0.1	3.4	0.4	0.1	2.1	0.0	1.5
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136212745-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain					NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.1	0.9	0.6	0.4	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 9.4;skin 1: 4.1"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 627.4;Melanocytes: 158.3"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	112	"SK-MEL-30: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.4	0.1	0.0	0.0	4.1	0.0	0.0	0.5	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.1	0.2	0.2	0.4	0.3	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	627.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	50.5	0.1	0.1	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	13.5	0.8	0.0	0.0	0.0	1.0	6.3	0.0	0.0	158.3	0.0	0.0	11.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	22.2	0.0	0.1	0.1	10.1	4.4	1.8	1.0	1.0	0.0	0.0	0.0	0.1
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.4	3.1	15.5	5.7	14.3	7.6	60.8	10.5	14.7	10.9	10.1	5.9	0.9	9.9	3.4	14.2	5.5	10.0	3.8	17.0	13.5	5.4	2.1	4.7	4.9	32.5	31.5	5.2	1.1	5.3	2.6	2.8	24.2	9.4	2.7	4.1	12.0	8.4	2.6	10.6	2.1	10.6	18.4	4.2	2.7	12.5	27.5	2.4	5.7	3.3	4.0	5.1	14.1	16.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	15.5	14.3	10.5	14.7	17.0	13.5	32.5	31.5	24.2	18.4	27.5	16.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 173.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	27.6	38.8	33.1	14.1	34.9	8.4	27.5	36.3	36.2	26.3	33.8	35.2	22.2	23.1	21.4	35.2	26.3	15.4	88.3	31.7	34.6	52.0	46.5	20.3	16.3	35.0	34.0	26.0	51.3	19.2	35.2	10.9	33.7	36.0	18.4	12.7	38.9	28.4	173.8	27.4	30.3	12.0	34.1	30.8	41.9	51.1	36.7	21.1	33.5	116.1	17.6	30.0	25.8	34.3	25.1	24.5	26.5	43.0	32.0	23.5	32.2	16.4	31.6	28.7	24.0	16.1	37.1	24.7	63.6	27.4	22.2	34.1	11.8	35.7	10.1	23.8	14.2	12.7	23.8	28.0	46.4	16.2	21.4	17.7	20.7	31.6	28.1	52.7	20.4	49.0	22.3	27.1	24.2	59.4	30.3	33.7	16.8	33.3	26.1	39.3	19.5	71.4	74.4	29.1	23.0	33.4	13.2	32.1	47.5	18.0	37.1	25.8	23.9	19.4	14.9	37.9	16.4	53.0	14.3	16.3	46.7	8.3	32.1	11.0	16.9	28.5	18.8	31.2	15.0	38.0	18.5	19.9	24.4	39.9	20.1	23.3	15.8	26.1	27.4	59.0	25.2	12.0	33.1	34.9	36.3	36.2	31.7	34.6	35.0	34.0	33.7	34.1	36.7	34.3	17.1	9.6	23.1	9.8	31.4	13.3	18.7	32.7	28.5	8.9	40.4	45.3	42.5	32.9	25.5	27.6	0.0	44.4	17.0	66.3	95.9	41.4	147.5	41.3	20.1	17.5	26.9	14.9	2.8	58.4	46.7	19.8	41.8	27.5	24.6	10.0	21.0	30.0	25.5	10.1	4.9	111.3	30.5	18.9	12.8	82.1	19.9	15.0	37.4	2.8	27.2	32.1	15.5	7.5	6.8	46.6	60.5	17.0	47.1	24.0	92.0	82.9	48.2	11.6	6.6	22.4	29.3	59.6	13.4	42.8	18.5	36.0	21.8	20.2	40.3	22.6
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415571-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	17.1	20.5	6.2	18.3	8.0	22.8	10.4	5.7	7.6	7.9	3.9	7.0	6.6	7.6	1.8	5.3	7.3	8.5	11.2	6.1	9.8	4.7	4.0	30.2	24.6	10.6	15.4	7.8	6.3	8.9	1.6	20.1	17.2	6.0	6.2	1.0	4.5	2.6	3.9	6.5	10.7	11.8	7.1	23.7	5.9	2.0	7.3	15.7	6.2	5.5	16.2	10.7	7.2	8.0	0.3	1.6	0.0	0.0	25.6	78.8	4.9	8.3	9.4	9.1	8.9	0.3	0.3	9.6	2.2	108.4	7.8	0.2	0.2	0.0	5.1	43.0	0.7	10.7	0.0	26.1	30.0	14.8	89.0	35.2	0.0	54.0	0.7	4.1	3.8	12.9	37.2	26.0	43.4	0.5	19.1	20.5	0.1	0.1	0.2	11.3	0.3	4.3	40.6	1.1	1.2	0.1	0.0	0.0	94.7	41.0	0.0	12.7	84.9	0.2	0.3	0.3	1.1	0.1	0.3	5.1	8.2	21.6	12.6	60.8	26.6	35.8	63.4	52.8	55.5	19.2	46.0	59.3	58.7	20.3	25.7	44.8	6.8	63.2	49.4	51.3	49.9	43.1	6.2	8.0	5.7	7.6	6.1	9.8	10.6	15.4	17.2	7.1	7.3	8.0	15.8	0.0	5.3	1.0	11.1	2.8	0.1	0.0	0.0	0.6	0.5	0.4	1.1	1.5	0.6	0.0	0.0	2.2	29.3	0.0	0.0	0.2	0.3	0.4	0.1	12.3	0.0	6.7	3.3	3.6	2.3	11.0	1.1	0.1	50.0	16.7	8.9	0.4	50.6	0.0	2.6	0.0	0.0	19.5	18.2	0.0	1.8	28.7	28.4	4.7	39.4	0.3	49.4	0.5	0.5	4.7	0.1	4.5	15.1	0.0	0.0	0.1	0.8	0.6	26.3	7.9	23.6	1.3	5.9	0.4	1.7	16.1	26.8	2.8	0.0	0.1
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783087-109833406	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 50.8;salivary gland: 19.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 17.1;Cholangiocytes: 20.0;Cytotrophoblasts: 20.0;Kupffer cells: 19.6;Respiratory ciliated cells: 28.2;Syncytiotrophoblasts: 21.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"hippocampal formation: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;BJ hTERT+: 9.5;EFO-21: 7.2;HaCaT: 14.2;HUVEC TERT2: 8.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.0	0.8	0.2	0.9	0.3	0.1	1.9	0.7	0.5	2.0	50.8	0.4	0.7	0.6	0.4	10.3	4.7	1.4	0.8	4.2	0.2	14.7	8.6	2.2	0.8	0.5	0.4	0.3	4.4	0.3	2.1	5.2	0.3	6.8	0.3	0.0	19.2	0.8	0.1	7.5	0.4	0.7	0.2	2.8	0.7	0.8	0.8	0.1	0.9	0.0	0.9	1.8	2.2	0.4	2.4	0.2	0.0	0.0	2.0	1.2	7.9	4.2	9.5	1.2	0.3	0.0	6.4	0.0	7.2	5.8	0.0	14.2	1.0	0.0	0.4	0.0	1.8	0.0	0.1	3.7	0.6	0.0	0.0	3.4	2.0	2.7	0.0	0.6	8.7	0.0	0.5	0.0	0.4	5.3	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.0	0.3	0.6	2.6	3.5	1.1	0.2	4.5	0.0	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.5	4.2	0.2	0.5	0.4	0.3	0.2	0.8	0.4	0.1	0.0	0.0	0.0	0.7	3.3	8.1	17.1	7.4	0.0	5.1	5.5	1.0	20.0	12.0	11.0	0.0	20.0	0.4	0.0	3.9	2.5	0.2	3.2	1.0	1.4	0.0	0.0	0.3	9.3	5.3	1.2	2.0	1.2	0.0	0.9	0.7	7.7	4.0	0.0	0.4	0.0	6.1	19.6	0.7	0.2	0.9	2.6	7.2	1.9	0.8	0.0	0.0	1.0	0.3	2.0	0.0	0.0	0.0	4.6	0.0	12.5	28.2	0.0	0.0	0.1	1.1	0.3	1.1	4.5	3.8	21.1	0.3	0.2	0.0	3.3
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933746	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.1;kidney: 4.4"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063175	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	4.4	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.1	0.5	0.5	0.6	0.6	0.6	0.5	0.7	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871208-142885745	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.3;prostate: 23.5;salivary gland: 69.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Collecting duct cells: 27.6;Cytotrophoblasts: 17.0;Ductal cells: 80.1;Early spermatids: 25.9;Late spermatids: 37.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 18.0;RT4: 30.7;SK-BR-3: 23.5;T-47d: 52.8"	"Low region specificity"	"Detected in single"							HPA062864	Approved					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.0	0.0	0.5	0.0	0.6	0.1	4.2	0.6	1.1	0.5	0.6	0.1	8.1	0.1	0.3	2.7	0.2	8.2	0.1	0.5	0.6	5.2	0.9	0.2	0.0	0.6	0.6	0.0	38.3	1.5	0.5	11.9	0.8	23.5	0.0	0.0	69.3	1.6	0.0	6.4	2.2	0.0	0.6	0.0	4.5	1.2	0.6	0.0	1.8	0.0	0.2	0.4	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.9	0.1	0.0	23.5	0.6	0.9	52.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.1	0.5	0.6	0.6	0.6	0.8	0.6	0.6	0.6	0.0	3.2	0.0	0.0	0.0	0.5	1.1	0.2	5.2	0.6	2.4	2.0	1.9	18.6	1.4	27.6	0.0	17.0	0.1	0.1	0.0	80.1	25.9	0.7	0.2	0.2	0.0	0.0	0.1	3.3	0.8	0.2	3.6	1.6	0.0	0.0	0.4	0.0	1.6	3.3	0.1	0.3	0.0	0.0	0.0	37.3	0.9	0.2	0.0	0.0	2.0	0.7	0.0	0.0	6.8	8.9	0.1	0.0	0.0	10.6	0.1	0.3	0.7	0.2	0.0	1.0	0.3	0.3	0.4	4.3	1.8	6.0	0.0	0.0	0.2	3.1
TRUB1	PUS4	ENSG00000165832	"TruB pseudouridine synthase family member 1"	Q8WWH5	10	114938195-114977676	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 62.2;Theca cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037914, HPA057552"	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA037914: AB_10672399, HPA057552: AB_2683465"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.20e-3)"	"unprognostic (9.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	7.4	29.3	6.3	7.5	7.4	4.2	11.3	5.1	9.0	9.8	7.3	9.5	8.9	12.8	9.3	8.3	9.7	7.7	21.5	7.6	7.1	16.0	12.9	6.6	10.0	5.8	6.0	16.8	6.8	15.8	4.9	7.5	6.1	11.7	10.4	6.7	9.3	9.9	7.5	6.5	8.2	11.1	5.6	9.3	8.7	17.9	7.0	11.5	12.3	9.7	10.1	7.8	4.8	6.4	25.5	19.6	18.8	47.0	13.3	17.7	25.3	21.4	24.1	28.4	32.0	16.1	25.5	31.4	24.2	16.9	12.4	21.3	25.6	26.5	41.8	23.9	27.5	14.4	9.2	28.8	22.8	27.2	20.7	18.2	35.8	20.2	39.6	30.1	16.2	24.9	15.1	12.5	34.1	12.3	25.7	21.6	17.8	17.0	19.1	25.4	47.5	19.2	37.4	12.7	17.5	19.3	18.0	26.4	47.7	20.0	21.1	16.6	14.5	13.0	13.0	20.8	26.5	23.6	20.4	26.3	18.3	34.2	11.9	4.0	2.6	0.9	4.4	4.0	6.5	7.3	4.7	4.7	4.8	5.9	6.2	5.8	0.2	8.1	7.3	4.3	6.2	4.6	6.3	7.4	5.1	9.0	7.6	7.1	5.8	6.0	6.1	5.6	7.0	6.4	6.9	12.8	8.4	8.8	11.2	5.6	4.7	15.3	6.2	13.9	11.9	8.1	13.6	4.3	12.0	9.2	2.1	9.1	10.5	7.1	21.5	7.6	62.2	11.1	12.8	6.6	7.7	9.0	23.0	4.9	6.6	11.2	6.6	12.0	10.2	26.7	12.1	20.2	7.6	25.2	22.0	8.2	6.1	7.3	4.2	9.6	8.4	5.0	3.6	8.4	5.4	10.4	9.2	31.2	16.7	7.0	3.6	10.1	12.7	4.2	6.2	27.9	9.8	5.6	6.6	8.4	9.3	14.5	23.3	15.9	7.0	6.2	8.0	74.1	12.9	5.8
TRUB2	CLONE24922	ENSG00000167112	"TruB pseudouridine synthase family member 2"	O95900	9	128305159-128322447	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021211	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021211: AB_1858375"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.81e-3)"	"prognostic favorable (5.57e-10)"	"unprognostic (8.74e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	3.7	8.5	8.7	3.6	9.0	4.2	4.7	8.9	9.3	3.3	8.7	4.5	5.0	3.3	2.9	6.3	4.1	2.7	8.7	8.5	8.1	6.5	12.9	2.4	4.5	9.3	9.3	3.8	5.2	7.2	6.8	2.7	9.8	3.6	4.2	3.6	4.8	3.4	7.2	5.4	4.3	3.2	7.7	3.6	4.6	3.1	9.5	3.5	4.7	9.8	4.3	4.0	3.5	9.9	6.6	14.9	6.7	9.2	10.7	7.9	7.1	7.1	8.5	11.6	9.5	11.1	8.3	14.7	6.0	9.7	11.0	17.5	15.4	12.4	7.8	7.1	10.2	6.9	12.8	10.4	8.2	12.7	8.9	10.0	13.7	11.4	10.7	7.2	12.0	12.8	26.2	6.4	9.3	19.7	17.1	14.7	9.2	22.2	19.0	13.3	10.9	21.0	10.7	5.9	14.4	10.6	13.2	14.6	9.5	5.2	19.1	8.7	8.1	9.4	7.5	11.2	8.6	7.5	16.4	11.9	9.9	9.9	10.5	3.6	3.6	1.1	5.0	3.8	5.7	6.3	4.8	5.7	5.5	5.3	5.5	5.7	1.8	6.5	2.0	3.8	6.2	3.8	8.7	9.0	8.9	9.3	8.5	8.1	9.3	9.3	9.8	7.7	9.5	9.9	10.9	25.6	10.3	1.6	17.1	9.6	13.7	43.0	15.4	21.3	14.6	15.7	49.9	24.3	27.0	35.0	16.7	51.6	10.9	19.8	64.6	39.0	12.9	15.1	20.7	16.4	19.1	16.2	5.0	35.4	45.9	15.4	27.0	15.9	8.2	22.0	17.2	50.7	31.0	3.3	5.2	26.4	34.6	9.0	4.1	16.4	20.8	12.4	12.4	3.7	16.8	15.4	18.6	3.0	10.5	27.2	19.1	18.0	17.8	14.9	34.0	78.6	16.9	16.7	0.0	17.2	16.3	15.8	19.2	22.1	10.5	28.0	13.9	46.1	35.3	11.1
TSBP1	"C6orf10, TSBP"	ENSG00000204296	"Testis expressed basic protein 1"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	61	"testis: 35.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA047479, HPA057426"	Approved		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Cytosol		"HPA047479: , HPA057426: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	11.8	14.5	6.1	5.2	6.0	9.0	12.2	8.3	6.8	13.7	3.6	13.4	5.1	12.0	6.5	10.1	11.8	5.4	14.0	6.0	5.1	13.1	10.9	11.4	6.3	4.5	5.2	18.2	12.8	7.4	16.2	9.3	4.9	13.1	7.1	8.3	11.4	5.4	14.9	15.8	12.6	7.9	1.1	14.9	12.2	22.8	4.5	6.7	17.3	14.6	8.6	11.4	12.7	4.4	8.3	9.7	13.0	10.7	13.0	12.2	24.2	10.3	17.6	11.5	11.0	16.5	9.5	19.4	4.7	20.9	17.0	21.0	15.4	11.0	11.3	9.4	8.2	6.1	19.9	13.6	15.6	9.4	8.0	13.6	8.2	14.3	17.4	11.1	13.0	16.9	11.1	10.2	12.9	15.4	8.3	7.8	17.8	12.1	7.8	9.9	24.5	11.0	5.0	10.7	6.4	10.0	12.7	7.9	6.2	15.2	14.4	5.5	13.8	18.1	10.8	11.4	7.7	5.7	13.8	18.5	10.3	5.2	8.2	2.1	2.3	2.8	3.2	3.8	3.5	0.9	1.7	2.9	1.7	1.2	2.9	2.6	0.9	3.0	1.8	0.9	3.1	1.5	6.1	6.0	8.3	6.8	6.0	5.1	4.5	5.2	4.9	1.1	4.5	4.4	14.7	22.4	27.2	35.3	10.8	7.5	6.2	5.1	9.6	26.6	11.2	9.5	29.2	7.2	10.3	11.0	37.5	15.1	13.5	7.1	13.7	11.7	45.9	18.0	22.2	12.7	16.8	15.8	53.6	7.2	24.0	14.0	14.3	25.8	8.8	27.4	9.7	5.9	9.2	25.2	59.0	10.0	10.2	7.7	7.9	133.1	15.5	12.8	12.4	19.7	10.8	9.7	7.2	30.7	47.8	12.5	7.9	11.3	12.4	9.0	8.9	7.3	16.2	24.4	19.7	19.5	15.4	22.4	20.0	11.8	8.7	21.1	11.9	23.2	10.6	11.0
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047967-2089491	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	12.6	10.0	3.8	10.2	4.6	10.9	12.6	4.5	6.1	16.7	0.9	15.3	12.4	17.4	7.3	12.0	16.0	10.9	12.6	5.9	1.3	9.6	9.0	12.0	7.7	3.1	1.5	18.4	14.8	14.7	16.5	9.2	2.7	12.4	9.1	17.7	21.3	15.6	31.1	14.4	12.8	11.4	0.1	11.4	15.7	16.2	2.6	11.7	18.6	14.5	7.8	14.0	12.8	12.5	13.5	21.4	28.9	32.5	33.7	28.1	24.3	31.7	21.7	23.4	19.7	25.7	25.4	20.5	27.6	26.2	11.0	22.0	17.5	23.1	17.3	15.5	28.5	19.2	39.6	10.7	23.0	24.0	22.4	33.5	14.3	18.9	13.9	27.9	22.3	14.4	19.0	17.7	21.0	27.0	28.9	7.1	29.8	10.1	21.2	45.3	31.6	25.7	9.4	12.1	22.1	41.3	45.2	29.4	15.3	28.2	26.8	17.5	35.5	24.5	16.5	22.0	16.5	39.0	42.7	40.8	10.2	9.7	29.6	3.2	2.7	2.8	3.1	2.1	2.8	1.8	1.9	1.7	2.5	1.8	1.3	2.1	3.5	1.6	1.7	0.6	1.4	2.2	3.8	4.6	4.5	6.1	5.9	1.3	3.1	1.5	2.7	0.1	2.6	12.5	23.8	25.6	18.9	43.8	16.8	9.2	8.1	10.1	14.8	53.8	23.7	20.2	41.8	21.5	15.3	20.2	93.8	13.0	17.3	34.5	3.9	15.2	13.1	47.8	26.3	25.6	32.5	17.4	22.8	14.1	8.0	19.7	44.9	62.1	8.8	49.0	32.2	38.7	11.4	45.4	22.4	26.6	8.2	17.6	9.9	29.3	28.3	13.8	8.8	15.9	12.1	19.0	36.0	18.6	25.7	21.4	17.5	25.9	14.4	9.4	25.4	8.9	17.8	64.7	13.1	17.2	20.4	18.3	37.7	12.9	9.8	9.3	18.8	31.6	28.9	10.6
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	20.9	11.8	8.1	10.7	8.9	34.9	13.2	9.9	15.2	18.9	3.3	14.9	6.0	23.4	14.4	23.8	15.4	22.6	21.5	9.1	9.0	15.9	29.6	15.0	10.3	8.5	8.8	15.2	11.4	10.8	9.8	16.9	9.0	11.4	12.4	16.7	10.6	7.3	17.0	11.1	11.9	26.3	6.1	13.8	16.3	17.8	6.6	11.8	12.9	14.4	9.9	20.6	23.3	11.1	45.7	6.2	19.6	18.8	25.1	12.2	56.4	44.6	16.9	32.1	39.5	25.0	22.4	14.9	25.1	33.7	65.7	18.9	19.8	16.2	63.7	11.8	11.1	16.0	11.6	12.7	28.5	9.8	10.6	22.6	12.4	20.9	31.4	19.4	20.4	7.1	27.7	23.9	22.6	16.1	10.5	12.1	25.1	13.6	12.3	11.0	35.8	17.7	20.7	26.6	11.3	10.1	20.5	10.8	45.8	23.5	10.3	13.0	33.0	21.1	21.9	25.3	41.6	31.9	6.6	20.6	14.3	29.2	12.7	0.5	1.7	2.0	1.1	1.6	1.8	1.1	1.4	1.2	1.1	1.4	1.1	1.1	2.2	2.0	2.9	1.2	0.6	1.5	8.1	8.9	9.9	15.2	9.1	9.0	8.5	8.8	9.0	6.1	6.6	11.1	97.4	64.1	30.8	160.3	52.5	148.9	81.5	12.6	111.0	18.6	65.1	28.4	46.9	20.0	18.2	12.9	29.2	28.6	53.7	77.6	17.6	13.8	23.2	85.5	107.6	48.3	31.6	10.3	78.7	13.8	33.0	59.6	50.0	166.6	65.4	10.9	29.3	40.1	18.4	16.8	70.9	45.4	22.4	24.1	94.9	29.6	18.6	58.9	42.7	86.2	20.2	31.8	16.5	59.3	86.5	26.0	82.2	15.1	37.3	42.6	16.0	10.6	10.8	21.3	13.1	79.0	48.9	51.6	29.3	77.0	108.3	54.9	48.7	17.9	34.8	83.5
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 1234.8;dendritic cells: 1146.4;Plasma cells: 2348.5;T-cells: 1479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 380.5;ASC TERT1: 259.7;HHSteC: 628.0;hTCEpi: 572.7;Karpas-707: 364.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: AB_2666504"	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	536.4	240.5	90.3	394.8	93.5	433.3	447.3	101.0	105.0	396.4	104.1	290.2	87.2	269.3	72.0	300.4	369.8	167.1	331.9	81.3	102.9	194.9	177.4	522.6	281.0	99.6	97.2	371.1	113.8	55.7	136.2	163.8	98.9	404.4	183.6	22.5	333.4	160.5	729.3	493.6	426.3	178.7	92.8	408.2	390.4	43.8	99.3	203.2	313.0	187.8	338.2	508.2	486.9	91.3	10.9	18.2	9.3	25.7	380.5	259.7	3.7	16.9	14.1	7.8	8.6	0.1	35.8	23.4	40.1	13.7	5.5	53.5	19.1	54.2	3.3	7.0	9.0	11.5	76.9	1.0	628.0	2.5	37.7	238.8	572.7	6.1	158.7	78.8	29.3	2.5	3.6	364.1	67.2	37.8	0.7	40.5	16.3	11.5	11.7	1.2	23.5	51.3	26.1	7.3	2.4	20.3	16.6	89.2	128.8	16.9	17.0	52.4	44.1	23.6	7.1	4.8	3.4	79.6	37.8	11.2	12.0	46.7	6.7	668.9	417.2	1653.1	649.7	524.1	484.2	584.0	740.6	641.5	399.5	559.6	686.3	643.0	2396.6	968.4	851.8	81.4	1080.9	1624.1	90.3	93.5	101.0	105.0	81.3	102.9	99.6	97.2	98.9	92.8	99.3	91.3	423.5	64.1	164.7	10.4	1234.8	110.0	82.8	129.7	435.4	52.0	97.0	47.5	31.8	70.1	106.9	47.8	0.0	3.2	1146.4	26.2	232.8	28.3	28.8	24.2	40.9	171.7	64.2	481.5	13.1	22.2	140.5	454.2	200.3	29.7	353.2	15.3	247.0	95.6	121.3	62.2	12.9	32.9	83.4	396.3	191.8	41.2	230.5	539.1	437.6	16.9	126.0	8.9	234.8	37.7	23.7	22.7	19.6	319.7	2348.5	106.5	58.6	48.6	61.0	19.1	433.9	245.4	248.3	24.1	15.3	182.6	79.1	9.9	1479.6	89.6	33.0	42.2
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479232	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 601.0;choroid plexus: 224.0"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 778.8"	"Cancer enhanced"	"Detected in all"		"glioma: 118.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 198.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	37.1	52.7	437.1	33.6	601.0	72.0	36.1	524.6	456.9	43.4	224.0	47.5	23.5	40.5	10.1	73.0	36.8	14.4	59.7	384.9	457.3	64.1	30.0	42.6	40.6	527.5	563.9	44.1	37.3	18.5	52.1	22.7	484.3	55.7	10.7	21.9	97.6	22.2	26.2	58.8	44.4	14.0	485.2	95.2	38.6	36.7	538.9	31.2	34.5	28.7	23.2	37.8	46.8	565.4	42.0	30.8	10.3	33.7	34.2	40.5	19.9	30.5	49.6	28.3	25.8	16.9	25.0	36.8	36.1	24.4	66.0	31.2	12.2	26.7	9.9	65.6	25.2	34.2	34.5	14.6	54.4	44.1	86.3	45.7	24.0	32.4	32.2	33.0	58.3	29.0	75.2	64.2	22.9	74.3	55.6	198.4	14.0	35.7	42.6	89.7	8.1	51.6	23.2	22.3	8.8	25.1	41.4	78.8	65.5	16.7	22.5	63.1	50.2	38.4	39.1	95.0	22.8	40.9	42.6	27.1	35.7	66.4	47.8	9.7	18.7	30.0	19.0	20.2	14.9	11.9	16.3	17.9	12.7	11.8	15.2	16.2	56.1	18.8	20.5	13.3	25.0	18.2	437.1	601.0	524.6	456.9	384.9	457.3	527.5	563.9	484.3	485.2	538.9	565.4	16.7	12.8	8.9	123.4	50.8	32.8	35.9	50.7	37.5	15.4	47.3	61.3	17.7	44.3	32.5	40.5	6.2	30.7	69.3	60.3	137.0	63.5	1.7	14.0	25.5	26.1	33.6	60.6	3.8	33.9	35.3	29.8	21.4	19.9	15.9	36.1	42.1	11.1	79.9	18.5	4.6	32.1	38.7	57.7	67.1	5.2	45.7	56.7	55.2	14.0	77.2	778.8	116.4	50.8	162.6	60.6	52.7	39.9	31.8	59.2	62.8	21.0	13.7	18.2	46.0	16.1	34.5	1.7	5.4	32.8	33.8	79.1	78.2	28.9	31.7	80.3
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	16.4	17.9	21.4	14.8	23.0	19.8	17.8	22.2	27.9	17.1	15.4	20.6	11.6	17.4	28.1	15.1	14.7	12.3	21.9	21.1	22.6	14.7	15.3	16.6	19.1	23.1	20.4	11.6	17.3	15.9	11.8	17.5	22.5	17.2	13.6	21.7	15.2	15.2	36.2	14.1	11.5	17.8	19.9	14.7	15.3	14.6	22.3	28.1	21.0	22.8	18.7	16.4	12.3	29.7	83.3	28.2	39.2	41.6	30.1	31.7	96.6	40.1	77.9	64.1	61.7	30.0	35.8	54.3	40.2	50.4	41.0	38.8	44.2	38.7	69.6	78.1	23.4	28.2	19.7	34.7	60.1	103.4	32.3	21.1	67.2	29.7	60.9	25.4	38.1	95.5	55.9	144.0	59.7	43.4	97.8	46.5	72.6	107.6	30.7	60.3	65.0	113.0	37.6	26.6	35.2	52.3	54.0	39.0	102.7	41.2	51.1	57.8	20.0	39.5	83.9	26.5	61.9	190.4	141.7	87.1	36.7	52.5	86.1	33.5	16.7	24.7	33.7	27.5	30.2	24.8	32.3	35.3	35.9	18.1	24.4	33.7	3.1	54.3	25.4	31.8	39.8	35.0	21.4	23.0	22.2	27.9	21.1	22.6	23.1	20.4	22.5	19.9	22.3	29.7	15.5	48.1	8.1	22.2	26.1	11.1	12.4	17.3	16.5	8.7	18.4	13.7	32.0	10.0	17.1	12.9	4.2	42.5	31.4	3.4	54.8	33.0	1.6	6.7	13.1	15.9	6.7	22.7	30.9	41.8	48.9	20.0	14.3	11.7	32.3	18.0	18.2	34.0	31.7	3.3	32.7	8.4	10.2	13.1	29.1	2.5	21.8	16.6	33.8	13.1	21.6	19.8	64.9	42.7	91.7	35.9	4.5	19.5	45.7	13.3	5.4	71.4	6.9	12.5	13.1	11.3	24.9	46.0	44.6	23.1	13.2	22.6	34.8	19.1	9.8	10.5
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	28.5	68.2	2.2	1.3	1.8	1.3	29.5	2.4	2.4	38.8	1.8	34.7	1.1	37.1	1.9	41.0	37.8	1.5	26.3	2.1	1.7	39.1	41.3	31.5	1.3	2.2	1.7	47.9	43.0	1.8	36.0	1.3	2.0	36.2	1.3	2.0	34.0	1.9	26.7	40.5	27.7	1.2	1.3	44.1	34.3	45.0	1.7	0.5	30.9	1.8	0.7	38.9	34.2	2.2	3.3	1.7	2.5	3.1	1.3	2.0	3.9	0.6	1.0	0.9	1.7	2.1	1.1	1.1	0.0	0.9	2.5	2.5	2.6	2.3	1.4	1.1	6.2	1.0	1.1	2.0	0.5	1.1	1.1	1.9	1.1	2.0	1.3	0.9	1.3	0.0	1.7	0.9	2.4	1.4	0.4	0.2	1.5	2.9	1.1	1.4	2.6	0.7	3.4	2.4	0.1	1.7	0.0	3.5	3.0	2.5	2.6	3.1	1.1	0.2	2.8	2.7	3.4	1.4	1.9	0.9	2.6	1.3	1.2	5.0	0.6	1.9	0.2	0.5	0.4	0.1	0.3	0.1	0.3	0.4	0.4	0.2	4.8	0.0	0.3	0.4	0.0	0.2	2.2	1.8	2.4	2.4	2.1	1.7	2.2	1.7	2.0	1.3	1.7	2.2	33.1	12.8	27.7	6.8	28.2	73.5	92.0	137.7	67.2	35.4	62.9	60.8	11.8	52.9	60.9	44.1	29.2	102.5	45.4	58.8	95.9	68.7	24.0	39.4	37.0	32.5	76.8	13.7	3.8	59.7	98.2	47.5	19.9	35.3	26.6	47.7	35.7	40.6	57.8	16.8	4.9	103.7	122.1	37.0	53.6	17.2	67.7	45.0	46.2	1.0	51.8	81.9	18.6	6.0	5.9	50.4	55.9	66.5	27.6	79.8	57.8	110.5	70.0	48.9	59.2	38.7	60.8	40.1	77.2	56.7	70.2	111.0	32.8	100.3	66.5	62.3
TSEN54	"SEN54, SEN54L"	ENSG00000182173	"TRNA splicing endonuclease subunit 54"	Q7Z6J9	17	75515944-75524735	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 78.4;granulocytes: 81.7;NK-cells: 87.6;T-cells: 70.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024543, HPA053097"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024543: , HPA053097: AB_2682043"	"unprognostic (3.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.60e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (2.33e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (2.62e-5)"	"unprognostic (7.26e-3)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.78e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.54e-4)"	11.1	14.9	2.8	1.3	4.2	2.1	12.7	5.2	3.2	14.1	2.3	19.2	2.9	11.8	0.2	23.2	15.5	3.1	8.3	2.6	3.2	27.2	18.2	17.8	2.9	5.0	4.1	12.4	29.9	4.1	18.3	1.7	3.5	20.0	2.1	0.4	17.4	3.4	9.5	24.3	22.5	2.3	4.1	25.4	20.4	14.2	3.5	5.1	18.1	1.8	2.5	15.1	17.0	4.6	21.8	25.3	2.6	7.2	2.7	2.7	14.7	6.1	6.6	14.4	13.0	35.4	3.9	32.5	9.1	3.6	12.3	11.9	14.3	11.1	7.5	7.7	33.9	26.2	4.7	23.9	11.8	7.5	36.0	2.7	13.7	6.2	5.8	2.0	14.0	20.7	31.5	6.0	2.8	36.6	46.7	19.1	9.0	31.7	30.5	26.4	23.6	25.1	8.4	9.5	19.0	17.0	13.2	30.8	14.3	8.5	11.9	17.3	3.0	6.2	20.7	13.7	12.5	22.6	14.1	19.0	6.1	32.7	6.4	20.0	4.1	14.4	82.1	9.7	56.1	11.5	34.1	62.4	10.8	7.2	26.5	50.0	0.2	47.7	9.8	26.2	21.2	27.1	2.8	4.2	5.2	3.2	2.6	3.2	5.0	4.1	3.5	4.1	3.5	4.6	9.8	9.6	9.6	15.7	13.3	26.4	10.7	19.0	17.6	15.4	11.3	11.9	2.6	20.0	11.6	9.2	4.2	13.6	78.4	25.4	11.7	17.8	6.1	7.7	6.9	10.8	18.7	14.9	14.7	17.2	18.2	8.1	29.0	7.0	81.7	10.2	8.6	8.6	13.2	32.0	15.0	16.9	24.4	4.7	11.1	4.6	4.7	9.2	16.0	5.6	12.5	15.4	87.6	14.1	23.9	14.5	13.8	7.5	29.2	22.3	23.1	13.1	5.0	7.7	13.1	5.9	7.4	15.0	33.8	21.3	24.3	7.5	70.4	14.6	22.6	8.7
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18526951	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	40.4	55.6	41.1	32.2	42.2	60.8	56.6	43.1	50.8	44.8	45.7	49.5	42.8	40.2	56.3	56.7	49.3	36.5	68.2	42.1	44.5	70.1	62.3	43.9	42.9	42.4	42.3	44.6	45.4	61.5	36.5	61.4	42.4	43.1	59.0	43.6	46.4	41.1	77.1	47.2	43.4	42.9	43.9	34.0	45.4	55.5	41.8	45.9	52.4	83.0	57.4	46.9	42.2	46.5	51.3	79.1	73.7	51.1	82.2	85.4	63.7	77.1	103.0	92.2	90.3	54.3	27.5	65.5	49.2	86.4	103.7	77.0	74.0	70.3	102.0	95.4	87.7	41.1	38.6	79.7	106.3	64.6	69.8	75.0	139.9	48.6	131.6	102.2	76.8	68.4	66.9	55.2	112.7	85.7	45.7	66.8	45.1	115.6	81.5	37.0	72.5	54.7	63.6	68.8	52.2	88.6	75.7	61.6	101.1	77.1	59.7	64.8	43.1	63.0	38.0	126.4	59.4	37.2	76.0	56.9	64.5	34.2	80.5	187.8	69.8	155.7	50.4	81.6	52.4	78.5	48.0	54.0	66.1	69.2	51.5	54.9	123.6	57.9	114.3	54.5	84.4	91.1	41.1	42.2	43.1	50.8	42.1	44.5	42.4	42.3	42.4	43.9	41.8	46.5	63.0	64.1	57.5	22.9	44.4	42.6	81.5	159.2	26.7	41.0	39.2	42.2	68.0	42.9	90.4	44.1	25.0	191.9	34.2	85.5	125.2	112.4	48.0	58.4	36.0	54.4	61.6	74.5	29.1	101.3	107.7	48.6	32.6	48.9	44.9	46.2	47.2	36.0	79.6	37.0	28.4	65.0	156.6	45.2	33.6	21.2	56.2	51.6	56.9	26.2	82.3	86.1	54.6	32.2	32.8	132.7	76.2	43.2	47.0	103.0	72.2	126.8	113.4	43.3	46.0	44.7	81.2	177.6	153.7	32.8	48.4	296.1	38.1	91.5	47.8	97.4
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668643-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	103	"testis: 14.0"	"Group enriched"	"Detected in some"	18	"Early spermatids: 86.4;Late spermatids: 224.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022968	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA022968: AB_2671013"					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	3.9	0.0	0.3	1.7	0.1	0.0	0.0	1.2	0.3	0.1	0.1	0.0	1.9	0.0	8.4	0.1	0.3	0.0	0.0	0.0	86.4	0.3	0.3	1.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.4	0.0	0.4	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.9	2.2	224.1	0.6	0.8	0.0	0.0	0.1	0.6	1.0	0.5	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	6.0	1.5	0.0	0.0	0.3	1.6	0.6	0.0	0.4	0.7	0.6	0.1	0.0	0.0
TSHB		ENSG00000134200	"Thyroid stimulating hormone subunit beta"	P01222	1	115029826-115034302	"Human disease related genes, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2634	"pituitary gland: 1757.6"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 25: Spermatids - Spermatogenesis"			"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.6	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.3	0.0	0.3	0.0	1757.6	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.3	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSHR	LGR3	ENSG00000165409	"Thyroid stimulating hormone receptor"	P16473	14	80954989-81146306	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"thyroid gland: 273.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 5.5;Excitatory neurons: 7.0;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 9.5;Plasma cells: 11.7;Skeletal myocytes: 4.1"	"Cancer enriched"	"Detected in some"	116	"thyroid cancer: 100.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"naive B-cell: 1.7;T-reg: 6.9"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 58.4;MOLT-4: 23.8;SCLC-21H: 23.0;U-266/70: 11.3"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	CAB000473	Approved				"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB000473: AB_2303782"	"unprognostic (3.36e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.17e-6)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.11e-3)"	"unprognostic (5.08e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	0.5	0.6	1.6	0.8	1.8	1.2	0.8	4.0	2.3	0.2	0.2	0.5	0.3	0.6	0.5	0.2	0.8	0.5	0.3	1.3	0.5	0.3	0.4	0.2	1.9	0.8	0.3	0.3	0.4	0.3	0.2	0.4	0.5	0.5	0.3	2.3	0.6	0.2	0.8	1.1	0.4	0.2	0.1	0.8	0.5	0.7	1.2	20.8	273.9	0.2	0.8	0.3	0.1	1.8	0.4	0.2	0.7	0.4	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.4	0.5	0.7	0.2	0.1	0.5	0.3	0.3	0.0	0.1	0.3	0.1	0.3	0.8	0.4	0.0	0.2	0.4	0.3	0.1	0.1	0.3	0.1	0.0	58.4	0.3	0.7	0.1	0.4	23.8	0.5	0.4	0.1	0.2	0.8	0.2	0.9	0.0	0.5	23.0	0.4	0.2	0.2	0.3	0.5	0.3	0.1	0.2	0.7	0.5	0.6	0.3	11.3	6.3	0.6	0.3	0.3	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.3	0.1	1.7	0.2	0.1	0.9	0.1	0.2	0.5	6.9	0.1	1.6	1.8	4.0	2.3	1.3	0.5	0.8	0.3	0.5	0.1	1.2	1.8	0.2	0.0	0.5	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.1	0.2	0.3	1.8	0.0	7.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	6.5	0.0	0.1	0.0	6.6	9.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.6	0.0	4.1	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TSHZ1	"NY-CO-33, SDCCAG33, TSH1"	ENSG00000179981	"Teashirt zinc finger homeobox 1"	Q6ZSZ6	18	75210755-75289950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 84.9;Peritubular cells: 187.3;Theca cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.4"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 115.6"	"Low region specificity"	"Detected in all"			HPA006982	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006982: AB_1079886"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.12e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.42e-3)"	12.0	7.7	16.3	7.1	14.1	3.3	12.1	23.5	21.0	17.4	6.3	18.1	13.8	11.4	9.3	10.0	15.9	10.4	10.9	17.0	10.4	12.1	8.2	8.0	7.3	18.8	11.5	35.4	7.2	9.2	9.7	29.7	19.3	8.9	9.3	7.9	12.5	11.1	9.2	10.6	13.7	9.3	20.1	9.4	8.8	6.3	15.5	12.3	8.2	6.4	5.3	10.9	11.0	14.1	5.4	7.0	2.2	12.8	18.8	8.9	2.2	24.2	22.6	4.0	7.4	3.2	12.9	10.8	3.0	21.9	4.5	4.8	2.9	6.9	1.4	44.4	23.2	8.3	14.5	4.3	4.9	20.0	9.4	9.1	7.2	3.3	6.5	6.2	10.1	12.5	4.7	19.1	6.6	5.2	14.3	11.4	0.9	6.3	7.6	12.9	6.6	12.9	7.6	3.9	15.9	12.1	6.8	8.8	6.8	0.8	2.0	10.4	7.6	8.7	5.9	6.0	3.9	6.2	15.9	8.7	8.6	16.6	8.1	0.0	0.5	0.5	2.1	0.2	1.4	0.4	1.0	1.8	0.8	0.6	1.5	2.2	0.3	1.5	0.2	0.8	0.4	0.7	16.3	14.1	23.5	21.0	17.0	10.4	18.8	11.5	19.3	20.1	15.5	14.1	60.2	12.8	14.0	34.3	7.1	17.0	5.6	4.8	27.9	40.8	12.2	12.6	24.4	25.8	7.9	3.7	2.1	4.6	25.6	25.4	3.9	7.5	1.2	12.5	33.9	34.4	16.9	6.9	24.9	10.0	2.2	28.8	4.6	18.2	7.0	22.5	21.0	20.5	6.4	11.8	27.7	15.0	10.2	10.8	30.9	5.9	64.7	14.3	8.8	30.0	11.2	17.9	24.7	84.9	21.3	2.9	14.7	187.3	10.6	7.3	29.7	18.4	9.1	12.1	26.3	21.3	12.2	1.4	4.8	33.1	13.2	3.6	18.2	83.2	17.9	5.4
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972358-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7"	"Low region specificity"	"Detected in all"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	21.5	14.8	3.4	4.5	4.7	0.2	10.6	2.9	4.3	9.0	0.0	7.3	2.3	6.8	16.5	8.2	8.7	12.4	3.7	5.7	8.9	3.3	12.6	2.9	3.9	5.9	8.2	18.4	3.5	5.4	2.7	1.3	5.5	5.4	2.0	1.7	12.9	13.6	1.6	5.9	2.8	8.8	10.3	5.1	6.1	4.8	8.1	2.0	5.3	2.6	3.4	7.6	5.7	7.5	0.0	0.0	1.8	26.7	11.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	5.2	1.4	0.0	23.6	0.0	0.3	0.0	0.6	4.1	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.7	4.4	15.3	0.1	0.0	0.7	0.0	0.0	0.0	0.1	2.6	13.7	0.0	0.1	0.3	0.0	2.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.4	3.0	0.2	0.6	0.1	0.0	0.1	2.4	0.5	3.4	4.7	2.9	4.3	5.7	8.9	5.9	8.2	5.5	10.3	8.1	7.5	171.4	0.0	0.6	32.7	7.0	45.4	19.9	43.8	37.0	6.7	24.4	161.5	2.8	54.3	41.6	36.8	2.1	1.3	1.3	0.1	0.0	52.2	11.1	32.7	144.4	125.7	6.6	0.0	188.2	9.8	0.5	93.3	3.1	68.9	1.3	395.6	11.7	92.1	1.2	0.0	58.1	1.9	18.3	1.3	16.6	20.3	468.2	2.8	12.4	104.9	1.9	39.0	1.0	23.6	4.9	6.8	2.7	803.8	16.0	27.5	0.8	0.4	19.9	1.9	39.5	10.9	48.2	2.6	1.8	43.9	40.5	0.8	24.2	396.9	2.6	8.2
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
TSKS	"PPP1R161, TSSKS"	ENSG00000126467	"Testis specific serine kinase substrate"	Q9UJT2	19	49739753-49763306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"testis: 120.0"	"Group enriched"	"Detected in some"	46	"Early spermatids: 887.3;Late spermatids: 1022.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.1;testis cancer: 2.2"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"NB-4: 11.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA045729	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA045729: AB_10963430"	"unprognostic (3.56e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.51e-8)"	"unprognostic (7.89e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-2)"	1.1	0.1	0.2	0.1	0.2	0.5	0.9	0.8	0.3	0.8	0.1	0.2	0.0	0.9	0.0	0.3	1.0	0.3	1.5	0.2	0.2	0.1	0.2	0.4	0.4	0.1	0.2	0.3	0.2	0.0	0.0	0.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	1.8	0.2	0.1	0.1	0.5	0.2	120.0	0.2	0.3	0.7	0.0	0.1	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	11.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.8	0.0	0.4	0.0	0.0	0.0	1.0	0.7	0.7	0.2	0.2	0.2	0.8	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.1	2.0	0.0	0.0	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	887.3	1.0	0.5	0.7	0.0	0.8	0.4	0.0	8.6	1.9	0.0	0.1	0.0	0.2	0.4	0.0	2.5	0.0	0.3	0.0	0.0	1.3	0.4	1022.9	9.6	1.5	0.0	1.0	0.2	1.2	1.0	0.5	0.5	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.3	20.5	8.4	0.7	1.4	6.7	0.5	0.2	0.0	0.1
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798153	"Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 237.3"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 506.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 168.0;ASC diff: 282.5;OE19: 188.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted to blood"	NA	NA		6200000	"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	96.5	12.1	4.2	8.3	4.5	2.1	80.4	6.5	5.8	147.1	27.8	23.5	37.1	46.4	20.6	62.8	67.7	14.9	34.8	6.5	2.7	41.5	237.3	15.0	2.4	4.4	3.1	47.0	16.8	6.4	14.8	30.3	5.0	44.0	14.4	4.1	33.9	24.6	9.5	60.0	32.3	41.1	1.9	6.9	28.2	9.1	3.9	4.7	37.6	5.7	5.6	41.6	99.6	4.4	3.7	168.0	19.1	18.4	282.5	36.1	34.6	5.9	32.2	12.6	12.0	22.2	48.0	0.3	32.7	21.1	53.7	68.6	10.9	42.7	3.9	35.7	5.9	8.3	43.5	63.1	53.6	3.0	11.9	37.3	46.0	22.5	18.2	24.0	15.7	6.4	19.9	1.4	11.7	81.9	0.5	6.5	24.5	188.9	7.4	5.9	18.3	28.7	29.7	29.7	16.8	28.5	32.7	25.7	15.4	15.8	34.5	2.7	4.9	35.4	28.2	86.8	14.2	1.1	0.6	1.4	16.6	8.9	6.4	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	4.2	4.5	6.5	5.8	6.5	2.7	4.4	3.1	5.0	1.9	3.9	4.4	6.2	0.0	0.5	1.0	0.5	17.3	12.1	25.8	27.9	3.5	13.6	13.2	3.2	11.5	12.1	1.8	0.0	50.0	0.1	33.2	0.0	6.7	0.2	8.1	35.6	5.8	7.8	13.5	0.5	21.7	71.8	33.0	14.8	10.6	1.3	38.7	9.7	506.3	9.9	0.0	0.1	12.4	26.4	9.1	6.4	2.0	37.3	0.8	5.4	1.9	1.6	9.2	0.0	0.0	0.0	21.3	21.2	45.1	0.1	14.6	28.6	21.9	3.0	0.6	0.0	1.0	11.3	0.4	2.0	22.3	22.6	43.8	1.6	8.6	13.8	20.1
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	16.2	16.9	20.9	13.5	21.9	47.8	25.4	22.7	28.4	17.4	18.9	23.3	16.9	15.8	17.9	16.6	14.2	13.2	19.5	21.0	23.6	24.4	22.9	14.3	19.1	21.3	22.4	16.7	18.4	21.7	13.1	10.8	22.3	14.5	18.8	16.6	14.9	17.2	31.6	19.3	14.6	14.2	21.4	14.7	15.0	26.2	22.0	24.1	17.2	31.0	18.2	15.6	12.8	23.8	56.2	24.8	38.4	34.1	35.0	27.8	21.1	45.6	43.2	50.3	48.4	71.1	32.3	81.7	51.9	45.4	30.1	27.0	55.0	46.6	69.8	43.2	44.3	48.0	33.0	68.3	40.0	69.3	32.5	24.2	51.3	56.3	38.7	23.0	43.2	40.0	72.9	39.4	47.4	30.5	38.2	77.5	46.6	32.8	47.2	67.6	43.1	59.3	63.7	36.0	48.9	30.6	31.4	46.6	61.2	29.2	29.3	54.1	30.8	36.2	56.4	22.9	45.1	33.8	97.0	85.4	40.3	46.8	45.6	27.6	29.8	28.6	22.5	27.9	26.9	27.4	23.4	19.8	27.4	21.0	26.5	22.9	9.3	26.9	24.3	20.1	25.6	28.8	20.9	21.9	22.7	28.4	21.0	23.6	21.3	22.4	22.3	21.4	22.0	23.8	34.7	32.1	24.4	15.0	37.5	39.1	34.4	49.1	23.3	32.1	38.2	27.6	34.7	42.9	36.9	42.3	22.9	34.9	34.3	22.3	43.0	64.4	80.0	24.9	29.7	42.7	19.9	34.7	19.8	60.0	33.3	32.5	15.8	23.9	40.0	36.0	58.5	44.4	35.2	16.8	19.8	27.7	57.0	35.6	34.9	19.8	36.4	29.8	67.6	15.0	45.4	88.7	44.3	29.1	33.5	45.4	22.2	31.2	25.4	34.7	24.4	58.7	33.0	29.5	26.3	39.9	81.8	152.8	96.6	36.7	43.9	28.5	36.8	38.5	37.9	28.8
TSNARE1	FLJ31164	ENSG00000171045	"T-SNARE domain containing 1"	Q96NA8	8	142212080-142403182	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.7;Inhibitory neurons: 23.0;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 24.5"					"Low region specificity"	"Detected in all"			HPA074249	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA074249: "	"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.33e-4)"	10.1	9.5	10.8	6.6	10.6	4.2	12.0	5.0	19.0	16.3	4.8	11.3	11.6	13.8	2.9	10.4	15.0	5.9	9.1	9.9	7.3	13.6	10.0	9.9	6.7	12.0	8.4	20.4	28.5	7.0	12.9	3.3	9.2	13.7	2.8	4.0	13.4	6.4	11.0	27.3	12.9	3.8	5.9	12.6	13.3	13.4	8.9	6.2	16.3	4.6	4.4	11.8	12.1	14.1	6.6	6.4	4.2	5.3	3.2	2.9	13.2	1.9	3.1	1.9	1.9	2.1	7.0	3.5	10.7	1.5	3.2	5.9	1.9	6.6	0.8	4.0	6.4	4.2	1.7	7.2	8.5	9.5	9.6	5.6	6.2	0.0	4.3	3.9	2.1	18.4	8.4	0.3	1.3	8.7	8.1	8.8	4.2	6.4	15.8	0.0	2.2	6.2	3.6	8.0	17.5	10.6	8.9	7.1	12.8	2.0	4.7	8.2	5.1	3.1	8.5	5.6	4.3	0.5	2.8	5.6	5.7	24.5	3.2	1.6	0.5	0.1	0.9	2.3	0.6	0.3	0.5	0.2	0.6	0.4	0.2	0.3	0.0	0.5	2.0	0.0	0.6	0.6	10.8	10.6	5.0	19.0	9.9	7.3	12.0	8.4	9.2	5.9	8.9	14.1	1.9	0.0	1.1	12.1	2.3	4.5	2.2	0.8	6.8	2.6	1.8	1.8	4.6	2.8	0.5	1.8	2.1	0.3	1.6	1.6	3.9	1.6	2.4	1.9	1.0	1.5	1.8	2.5	26.7	1.8	1.8	1.5	4.1	1.4	0.0	1.2	1.1	1.3	1.9	0.0	23.0	2.1	0.0	2.6	2.9	5.3	0.9	1.7	3.6	12.2	1.5	3.1	2.1	21.1	24.6	1.6	0.2	1.5	1.6	1.3	1.6	1.4	2.3	1.3	0.0	2.3	1.7	5.0	3.7	3.5	7.5	0.3	3.1	0.7	0.9	1.5
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185962	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 593.8;kidney: 244.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	57	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	57	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.9	4.3	0.5	53.2	0.7	0.0	6.2	1.7	1.1	78.2	1.4	523.3	25.4	17.7	34.7	5.5	122.4	28.9	0.9	0.5	0.5	244.3	3.9	32.1	0.4	1.2	0.6	0.4	3.1	72.0	17.3	1.1	1.1	194.7	593.8	0.0	101.0	65.9	0.8	2.5	96.7	20.8	1.0	0.7	213.1	27.3	0.6	1.9	121.9	0.1	4.9	104.9	9.9	1.8	129.6	2.0	0.0	0.0	0.2	0.0	1.8	0.1	2.7	0.1	0.0	0.0	216.7	0.0	40.2	0.3	0.2	151.4	0.0	111.2	0.1	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.2	0.0	173.6	0.7	60.9	3.6	0.3	1.3	0.0	0.0	1.6	4.9	0.0	0.5	0.1	257.9	8.1	0.1	0.1	1.6	628.4	308.2	1.9	0.0	0.3	13.0	0.5	0.5	9.0	0.1	1.4	0.0	0.7	0.4	0.7	1.5	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.5	0.7	1.7	1.1	0.5	0.5	1.2	0.6	1.1	1.0	0.6	1.8	2.5	25.6	29.5	0.3	7.4	1.0	194.4	499.9	4.0	0.0	14.5	11.0	0.7	11.5	723.5	579.4	0.0	0.3	0.2	1983.8	46.9	61.3	141.3	268.3	14.1	4.5	201.8	0.0	1.2	525.1	0.1	6.0	223.3	144.3	11.4	0.0	1.4	3.6	0.3	0.0	1.3	648.1	242.1	0.3	0.3	838.1	5.0	5.3	5.4	1.0	1.6	0.0	0.0	0.5	1.6	484.4	1127.7	1.9	0.7	211.7	505.4	477.8	1817.6	0.0	0.0	0.4	54.1	4.7	2.6	2.9	1.3	0.0	7.4	0.0	275.9	517.0
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753755-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 303.4;Alveolar cells type 1: 496.8;Cytotrophoblasts: 293.7;Intestinal goblet cells: 404.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 99.6;plasmacytoid DC: 231.7"	"Group enriched"	"Detected in many"	42	"B-cells: 99.6;dendritic cells: 231.7"	"Cell line enhanced"	"Detected in many"		"OE19: 484.5;SCLC-21H: 215.3;SK-BR-3: 314.0;T-47d: 587.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	65.6	81.1	32.1	29.1	37.2	26.1	76.3	20.5	95.8	60.7	17.0	83.5	88.9	20.0	36.9	19.7	19.9	55.5	23.9	36.2	67.1	7.8	47.4	185.5	56.2	24.1	28.3	3.1	95.8	14.1	83.6	67.1	28.7	51.1	99.9	19.4	168.0	35.8	9.3	16.6	77.3	20.3	19.8	26.3	108.0	8.9	27.1	20.4	35.1	13.7	47.2	41.0	16.1	29.3	47.4	38.6	47.8	50.9	6.0	0.2	13.2	99.0	16.1	2.6	4.9	137.4	70.9	1.4	24.7	35.8	12.3	71.2	56.2	83.2	21.6	1.4	60.3	20.3	15.3	14.8	13.3	1.9	4.0	5.6	35.4	5.2	5.9	27.4	30.1	20.7	67.0	0.4	2.9	135.4	2.8	2.6	33.4	484.5	46.5	54.0	0.2	48.5	153.1	90.1	215.3	32.5	18.0	314.0	4.8	68.1	587.9	5.2	2.9	1.4	17.0	1.5	33.1	28.4	0.8	1.0	44.2	0.8	69.1	0.6	0.0	0.2	0.0	0.0	0.1	47.9	0.1	0.0	1.1	99.6	0.0	0.1	3.9	3.6	0.1	231.7	0.0	5.6	32.1	37.2	20.5	95.8	36.2	67.1	24.1	28.3	28.7	19.8	27.1	29.3	303.4	496.8	82.5	10.1	94.0	42.6	84.9	96.0	31.9	78.2	141.7	46.7	19.1	41.5	137.6	29.5	8.4	293.7	131.6	95.4	7.9	68.0	1.6	27.8	6.5	97.9	107.7	60.2	79.3	203.9	109.3	22.5	89.2	67.1	9.5	1.0	7.5	26.3	40.8	15.2	56.8	404.6	122.1	18.9	22.6	2.5	0.6	9.4	32.0	9.4	61.3	3.5	2.1	23.6	7.6	109.1	88.8	0.7	49.9	127.4	99.8	0.9	63.2	8.1	32.9	2.2	22.0	1.7	19.5	39.4	39.6	201.1	8.9	6.1	125.3	173.6
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451465-69507666	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	70.1	5.3	22.8	15.3	37.6	1.0	61.0	35.0	34.1	16.4	14.9	62.5	38.8	32.6	8.5	10.8	24.6	27.4	16.9	23.6	25.4	25.9	4.6	34.4	8.7	36.9	33.4	3.4	20.0	3.2	6.6	28.1	33.7	34.5	39.4	3.1	26.6	24.7	17.9	10.6	38.8	31.3	30.0	26.7	75.3	9.5	34.5	3.6	14.5	5.6	7.5	46.0	14.9	62.4	51.3	103.9	2.1	0.3	2.3	0.0	12.0	0.2	1.9	2.6	6.8	45.1	154.7	0.0	211.3	2.3	9.2	101.2	7.2	11.5	3.0	42.1	20.4	2.9	3.5	10.0	1.1	0.1	1.8	2.2	3.1	1.4	1.5	7.5	39.4	20.5	1.1	0.0	1.2	168.0	0.6	0.9	2.6	153.2	266.8	4.0	2.1	2.0	29.7	92.9	34.5	13.2	0.6	134.8	17.9	17.3	59.3	2.2	34.5	0.2	0.8	0.1	17.5	1.2	6.1	1.0	1.1	0.1	0.2	0.0	0.0	0.0	2.3	0.0	19.5	0.0	3.1	2.8	3.3	0.0	1.0	0.2	0.0	0.1	0.0	0.2	1.1	0.5	22.8	37.6	35.0	34.1	23.6	25.4	36.9	33.4	33.7	30.0	34.5	62.4	108.8	32.1	6.9	4.9	1.5	3.6	10.9	59.6	2.2	2.9	45.1	15.6	1.7	31.5	29.5	29.5	6.2	2.0	1.6	125.8	3.9	125.2	27.9	25.5	3.8	48.4	40.2	8.0	1.7	189.3	11.9	8.2	71.4	36.6	1.3	2.5	10.4	0.1	25.3	1.7	1.0	106.7	36.7	8.5	16.1	6.6	0.6	9.8	28.4	15.0	15.6	44.7	0.0	11.1	75.3	193.4	120.9	0.0	0.2	50.4	68.3	1.8	27.6	1.5	13.1	39.7	26.8	4.3	18.5	2.9	3.1	3.0	3.9	7.5	66.3	29.6
TSPAN16	"TM-8, TM4-B, TM4SF16"	ENSG00000130167	"Tetraspanin 16"	Q9UKR8	19	11296139-11326996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 134.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 4868.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 16.6;eosinophil: 19.1;neutrophil: 37.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 37.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA076551	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA076551: "	"unprognostic (1.06e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.06e-3)"		"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.69e-4)"	"unprognostic (8.81e-8)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.67e-1)"	0.0	0.0	0.2	0.2	0.1	5.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	134.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.6	2.2	19.1	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	37.4	0.0	0.4	0.0	0.0	0.3	0.2	0.1	0.3	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	892.5	0.0	0.1	1.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	4868.3	15.5	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	20.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN17	"FBX23, FBXO23, TM4SF17"	ENSG00000048140	"Tetraspanin 17"	Q96FV3	5	176647387-176659054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030447	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA030447: AB_2673484"	"unprognostic (1.70e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.46e-1)"	13.3	40.5	23.0	16.3	24.3	58.2	12.9	18.6	26.2	14.1	21.3	18.0	15.9	12.1	8.4	24.5	13.0	14.7	28.3	24.5	20.1	30.2	20.6	17.7	17.6	18.7	20.0	11.4	26.3	18.2	23.5	12.3	20.6	17.5	13.9	20.8	15.9	10.4	41.6	17.1	17.9	13.3	19.4	22.0	21.1	20.9	21.5	7.0	14.1	25.8	15.2	18.4	13.9	20.6	48.9	48.3	31.8	58.2	43.0	36.8	49.4	35.8	52.0	51.7	51.3	15.0	54.6	21.8	63.5	62.0	106.9	36.4	15.9	83.2	31.6	161.0	33.5	8.3	20.9	17.7	39.1	17.7	29.3	44.0	46.2	41.3	24.9	35.2	71.6	16.6	41.8	22.8	53.1	80.2	3.8	7.8	25.6	47.3	52.5	18.8	27.0	12.1	48.3	35.5	47.9	33.9	38.8	44.6	49.6	26.4	36.7	22.4	56.2	55.9	57.5	42.5	45.8	12.9	17.9	9.7	61.1	37.6	33.3	0.0	2.4	0.6	3.8	2.4	3.1	1.1	2.9	6.2	2.4	1.8	1.9	2.7	0.3	3.0	3.9	0.6	7.5	2.8	23.0	24.3	18.6	26.2	24.5	20.1	18.7	20.0	20.6	19.4	21.5	20.6	11.3	12.8	9.8	5.5	8.0	2.9	11.3	10.7	10.2	23.7	11.5	4.8	16.0	17.2	10.2	11.0	12.5	1.0	11.4	31.1	5.9	37.2	0.8	10.3	6.7	14.1	14.4	51.1	9.5	56.7	18.8	10.5	20.9	12.1	0.0	25.7	10.8	13.5	15.2	1.7	4.2	18.3	14.2	12.4	4.1	1.3	6.8	9.7	7.2	6.5	12.9	7.1	16.5	2.0	3.5	46.6	21.5	7.2	6.6	17.5	29.1	14.6	6.2	24.8	0.0	4.7	11.7	1.9	2.5	12.0	5.4	1.2	14.2	41.1	25.0	13.5
TSPAN19		ENSG00000231738	"Tetraspanin 19"	P0C672	12	85014311-85036277	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"retina: 4.3;testis: 4.5"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 382.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.5;SK-BR-3: 1.7;U-266/70: 1.6"					"Low region specificity"	"Detected in many"			HPA057066	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA057066: AB_2683325"				"unprognostic (1.94e-1)"	"unprognostic (9.81e-4)"	"unprognostic (8.57e-2)"		"unprognostic (8.37e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.09e-3)"		"unprognostic (2.22e-1)"	"unprognostic (3.78e-2)"		0.1	0.3	0.7	0.3	0.6	1.1	0.0	2.3	1.1	0.2	1.3	0.2	0.4	0.3	0.9	0.1	0.9	0.3	0.1	0.4	0.6	0.4	0.0	2.7	0.3	1.0	0.3	0.2	0.8	0.1	2.0	0.1	0.9	0.5	0.1	4.3	0.0	0.0	0.9	1.3	0.2	0.0	0.2	0.3	0.1	4.5	0.6	0.0	1.8	0.5	0.2	0.1	0.0	1.2	0.3	0.0	0.6	0.2	0.3	0.5	0.8	0.4	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.5	0.0	0.3	0.3	0.9	0.6	0.7	0.4	0.4	0.4	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	1.1	0.0	1.7	0.4	0.2	0.4	0.0	0.5	1.0	0.3	0.5	0.3	1.6	0.0	0.2	1.3	0.0	0.5	0.3	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.2	1.4	0.2	0.1	0.2	0.0	0.0	0.7	0.6	2.3	1.1	0.4	0.6	1.0	0.3	0.9	0.2	0.6	1.2	0.1	3.2	2.0	0.7	0.0	0.1	0.0	18.2	0.0	3.5	0.1	0.1	1.1	0.0	30.3	0.0	8.4	0.0	0.0	0.0	0.0	0.0	72.7	0.6	0.0	0.5	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	14.2	0.0	0.3	6.9	0.0	0.1	0.0	1.0	0.0	5.1	0.0	0.0	3.1	0.0	0.0	0.4	0.1	0.6	0.0	0.1	382.1	9.1	6.6	0.4	5.2	7.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089503	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.4;intestine: 55.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 109.0;neutrophil: 109.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 109.8;NK-cells: 86.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9"	"Region enhanced"	"Detected in all"		"white matter: 842.5"	"Low region specificity"	"Detected in many"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	7.2	1.8	3.5	10.1	1.9	20.8	4.5	0.9	1.4	10.7	1.3	55.4	5.4	47.4	7.5	14.6	22.2	7.4	7.4	1.0	3.6	8.4	0.8	6.5	1.4	5.4	4.1	2.9	2.9	10.2	2.1	3.0	5.7	15.4	12.0	2.0	3.0	28.3	2.8	2.0	11.0	42.7	2.1	3.8	13.8	1.1	5.7	2.7	2.7	5.2	1.1	24.7	8.0	1.2	15.1	0.3	1.2	0.0	0.0	0.2	0.1	2.1	1.0	2.4	3.8	3.1	9.5	0.0	58.8	3.5	3.3	2.2	1.9	0.0	2.7	3.1	1.2	0.5	1.1	0.0	0.2	0.1	0.0	0.0	0.4	0.7	0.0	16.9	0.1	11.1	0.0	0.9	0.0	0.8	8.2	1.3	13.8	3.2	1.6	0.1	0.8	0.0	0.4	5.8	3.0	4.5	3.5	1.6	0.2	8.2	0.3	0.6	0.2	0.2	5.7	0.4	14.1	12.5	0.4	0.1	0.1	26.9	6.9	109.0	9.1	55.8	17.4	0.2	5.6	0.6	20.5	22.6	4.1	0.3	3.4	17.0	109.8	86.2	0.1	3.8	3.3	13.1	3.5	1.9	0.9	1.4	1.0	3.6	5.4	4.1	5.7	2.1	5.7	1.2	18.7	0.0	0.6	0.3	1.4	8.0	23.2	10.9	1.8	2.5	1.5	7.6	9.6	0.0	4.4	11.0	0.0	1.4	19.9	0.1	0.0	35.3	12.2	14.3	0.9	16.3	39.4	3.0	2.8	2.4	4.3	4.0	0.5	16.3	0.0	2.0	6.4	0.0	0.7	0.0	5.4	1.3	4.1	0.6	3.7	4.6	0.6	3.0	3.6	2.8	2.7	0.0	40.2	1.5	0.2	10.9	0.0	3.0	3.3	30.0	0.0	1.3	10.7	0.4	6.6	1.4	16.2	0.1	0.9	0.2	2.7	0.3	17.2	0.1	1.4	21.6
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750219	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	24.5	29.7	9.0	11.2	10.8	5.5	23.1	10.8	15.6	26.2	11.8	20.5	16.4	26.2	13.2	20.4	25.8	20.9	26.7	9.5	10.3	26.7	20.9	22.8	11.8	11.2	10.2	25.6	25.2	32.7	24.4	12.5	11.0	22.1	10.7	29.7	25.6	13.5	21.0	18.6	18.5	8.4	11.1	20.8	23.0	8.0	9.9	9.8	30.2	21.2	8.7	21.0	20.1	13.0	9.5	23.4	21.1	5.4	44.3	24.0	13.5	15.8	11.7	4.6	5.1	16.7	46.4	7.6	32.7	29.0	9.4	17.5	5.7	26.7	10.7	23.1	15.4	10.7	18.7	6.6	45.2	10.6	17.9	29.6	30.2	13.7	30.3	22.1	14.6	4.6	7.5	19.9	19.6	19.4	9.2	5.9	4.3	18.3	7.0	10.5	139.8	20.0	15.7	19.0	6.6	16.7	15.6	21.3	10.5	4.5	41.1	15.8	27.6	11.3	9.5	5.6	7.4	28.9	8.1	4.1	32.7	6.3	19.2	25.4	26.3	16.4	35.8	28.6	34.8	31.1	28.5	30.7	27.6	31.0	28.3	26.2	5.8	35.4	42.0	58.3	22.1	33.0	9.0	10.8	10.8	15.6	9.5	10.3	11.2	10.2	11.0	11.1	9.9	13.0	37.1	48.1	32.4	8.1	23.8	11.2	46.4	37.4	22.2	43.2	32.0	27.4	5.1	20.0	31.4	31.3	41.7	20.9	29.8	19.9	9.8	37.6	1.2	18.5	32.5	26.7	26.5	8.2	9.1	39.0	15.2	31.7	11.7	20.4	45.0	28.9	22.1	21.6	22.4	21.9	9.1	21.6	32.6	18.0	16.4	1.8	25.7	24.2	32.0	8.4	21.6	62.7	35.0	11.1	13.3	37.6	20.3	17.3	18.4	30.5	30.6	18.1	27.9	60.4	19.7	22.3	31.9	9.2	7.7	16.1	12.6	24.5	20.4	35.3	19.4	31.8
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318204	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	0.5	0.5	0.2	1.6	0.2	19.9	0.3	0.5	0.2	1.1	0.0	0.5	0.3	0.7	0.2	0.4	0.5	1.4	11.4	0.2	0.3	0.2	0.4	2.0	5.5	0.5	0.3	0.5	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.9	0.5	0.3	0.6	0.5	0.0	0.1	3.5	0.9	0.2	0.2	0.9	0.2	0.2	2.4	0.7	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	15.0	0.0	0.1	0.6	6.6	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.9	0.0	40.5	31.8	4.2	25.8	40.9	16.5	2.4	9.1	22.7	32.2	1.1	7.2	27.1	17.3	58.6	46.0	1.6	13.2	21.7	0.2	0.2	0.5	0.2	0.2	0.3	0.5	0.3	0.3	0.1	0.2	0.5	0.5	0.0	6.7	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.2	0.1	15.9	0.0	0.6	0.0	0.0	0.1	44.6	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	20.6	0.0	0.0	0.3	1.3	0.5	0.0	30.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	6.5	19.6	4.1	0.9	13.6	1.8	1.0	14.4	0.2	87.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	21.9	0.0	0.0	0.1
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144707-129169699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	3.2	4.4	8.2	9.1	8.0	3.9	3.0	6.9	7.2	2.0	5.4	6.4	3.6	1.5	10.9	3.9	2.1	3.1	8.6	6.8	11.9	64.8	28.2	5.0	16.3	10.8	13.4	2.4	21.2	11.1	19.9	3.8	12.2	7.4	3.4	1.3	18.8	7.0	13.0	7.6	12.3	2.2	11.0	16.9	6.2	11.4	14.1	6.7	8.4	4.4	14.4	7.9	3.8	10.0	1.5	4.3	1.0	23.2	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.7	2.1	18.4	1.8	0.4	12.9	1.7	12.3	4.0	0.5	18.7	14.0	38.2	0.8	8.2	0.9	5.5	0.8	0.9	3.8	0.2	1.2	0.0	0.5	9.4	0.4	2.6	0.0	4.6	11.5	0.1	8.5	0.8	4.5	3.9	0.5	0.4	1.4	5.0	5.8	6.9	2.3	0.7	13.6	5.3	4.7	2.4	0.1	0.1	1.8	1.9	0.6	48.8	5.8	8.1	0.4	18.4	2.7	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.4	8.2	8.0	6.9	7.2	6.8	11.9	10.8	13.4	12.2	11.0	14.1	10.0	0.9	0.0	0.6	3.3	27.8	2.5	0.7	0.8	0.6	3.5	10.5	9.8	6.2	0.0	0.2	5.5	4.2	0.1	7.6	0.7	13.7	2.2	2.5	2.7	0.5	1.4	3.5	5.2	3.6	8.7	0.2	6.7	0.0	1.6	0.0	1.4	0.4	15.8	8.4	0.0	1.7	0.6	0.0	23.6	84.0	4.2	2.8	32.0	1.8	3.7	44.8	8.4	0.0	3.5	0.1	2.4	1.1	32.7	1.3	1.9	1.0	59.2	2.2	1.7	0.0	11.3	1.0	0.8	4.1	0.4	3.0	0.1	2.2	8.4	0.4	1.3
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627108-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 121.7;RT4: 153.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	29.6	18.2	7.2	4.9	7.5	0.6	34.2	7.2	8.9	26.9	26.8	40.0	19.7	20.5	14.8	46.8	39.5	16.7	8.6	7.4	9.0	36.5	70.2	11.3	3.0	8.7	9.3	53.4	20.2	34.7	36.9	20.0	8.2	18.9	33.1	6.2	52.6	10.3	4.6	9.7	18.5	7.2	8.9	8.7	14.8	74.9	9.6	4.2	19.3	5.3	6.8	32.2	24.1	12.0	24.8	23.0	80.6	42.2	28.7	16.6	30.4	12.9	17.3	20.3	47.6	54.9	37.7	0.0	53.3	12.2	16.9	19.9	0.3	19.7	25.8	0.1	33.3	3.8	14.9	62.0	17.1	0.1	2.5	30.2	9.3	19.5	6.6	34.4	49.3	0.0	0.0	0.1	21.7	19.8	0.1	0.3	121.7	35.4	18.4	0.0	35.5	0.0	33.0	153.5	4.7	20.3	11.6	10.0	18.5	61.9	16.6	3.3	12.7	16.0	24.4	24.3	8.6	0.1	0.2	0.3	13.4	0.0	11.5	0.3	0.0	0.1	0.3	0.0	1.1	0.1	0.8	0.3	0.0	0.1	2.1	1.2	0.3	0.1	0.1	0.1	0.0	0.3	7.2	7.5	7.2	8.9	7.4	9.0	8.7	9.3	8.2	8.9	9.6	12.0	147.0	3.2	10.1	14.4	2.3	7.1	41.0	75.7	29.0	0.6	72.5	46.1	8.2	50.1	89.4	93.8	0.0	28.7	1.1	94.9	23.5	80.3	422.5	54.0	21.4	37.4	33.6	4.8	0.9	12.6	40.7	25.6	21.9	19.2	0.0	684.8	47.5	104.0	4.5	0.0	0.8	47.9	193.3	10.2	3.1	1708.3	32.9	3.1	10.6	1.0	1.0	48.2	0.0	9.5	0.4	18.7	55.5	35.7	0.3	33.0	43.5	43.8	193.9	1.9	19.7	17.1	43.1	20.9	32.4	23.3	5.4	13.5	2.5	49.4	94.3	89.7
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 542.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2"	"Low region specificity"	"Detected in all"							"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	56.1	125.6	355.5	17.2	433.8	1.3	33.5	369.5	542.1	42.6	271.3	68.1	36.3	43.8	37.6	33.6	36.5	25.8	70.3	413.7	334.3	56.2	45.0	67.4	41.1	290.3	298.8	19.6	19.8	13.9	28.0	25.1	283.6	18.8	64.6	286.9	12.5	26.8	153.9	19.4	34.0	51.1	291.7	96.3	14.5	4.8	331.7	15.7	51.3	232.3	28.9	29.7	16.9	384.6	0.1	0.0	2.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.8	1.6	0.0	109.5	14.9	0.5	0.0	67.2	0.0	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.0	380.9	0.0	0.4	1.7	0.4	239.7	0.0	11.2	0.1	0.0	14.6	4.6	0.0	11.0	1.4	129.0	14.4	0.0	0.0	4.3	6.5	0.0	0.3	0.0	0.1	3.1	0.1	1.0	163.2	54.8	0.0	5.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	355.5	433.8	369.5	542.1	413.7	334.3	290.3	298.8	283.6	291.7	331.7	384.6	116.1	12.8	23.8	274.9	1.1	10.6	2.7	6.3	6.2	92.0	1.0	3.8	34.1	1.5	4.6	11.0	43.8	0.4	0.2	69.1	23.5	0.4	0.0	2.1	1.6	153.3	18.7	5.3	215.6	0.6	0.4	14.0	4.6	5.6	10.1	108.1	407.3	4.8	45.1	97.6	249.8	23.5	0.0	15.0	10.0	1.9	0.6	1.5	14.2	46.9	0.0	102.3	0.0	353.4	50.6	0.9	21.9	3.0	1.5	2.4	40.3	9.8	1.2	107.4	59.2	26.5	11.7	0.6	3.3	9.9	6.5	0.8	2.6	27.0	35.7	0.9
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 951.1;stomach 1: 631.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 2160.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	11.1	9.7	1.9	126.9	5.2	0.0	17.0	6.1	7.1	28.6	1.6	951.1	916.0	12.5	11.7	5.5	13.4	208.2	5.5	1.8	3.4	57.6	53.2	23.0	4.6	12.4	4.9	41.8	60.0	0.4	2.5	2.0	10.5	163.9	862.0	0.3	76.4	10.8	63.7	13.6	848.3	39.2	8.5	0.3	631.0	5.8	4.4	1.1	6.5	12.4	3.8	11.0	4.0	14.6	0.0	0.7	0.0	0.0	5.2	0.8	2.8	0.0	0.0	0.0	0.0	48.8	3.1	0.0	0.2	0.0	0.6	6.5	0.0	0.0	0.0	0.2	0.1	0.0	52.2	3.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.3	0.0	0.2	3.0	0.3	2160.7	173.3	0.2	0.0	4.9	34.1	41.0	4.1	7.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	6.1	7.1	1.8	3.4	12.4	4.9	10.5	8.5	4.4	14.6	0.8	0.0	2.2	0.0	6.1	20.8	32.5	14.0	0.6	0.3	8.5	1.8	0.3	346.0	76.7	44.1	0.0	1.2	0.0	1688.5	127.2	943.3	34.5	3.7	4.5	3.8	174.1	0.0	0.1	654.9	0.6	37.3	645.3	44.8	4.5	0.0	2.2	26.0	0.2	0.0	0.1	886.7	16.2	2.2	29.1	17.9	44.1	2.6	64.0	0.0	7.8	10.3	0.0	0.5	14.3	325.0	2225.8	32.0	2.2	376.2	3546.1	2.5	30.2	0.6	0.0	7.7	23.6	0.5	1.0	2.7	13.5	1.1	5.8	10.7	1583.9	46.0
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497893-44711572	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Early spermatids: 3.3;Excitatory neurons: 1.1;Oligodendrocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.7;U-2 OS: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	1.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 690.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 516.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	249.3	164.5	42.3	65.3	46.3	488.7	204.3	50.9	61.1	217.3	45.8	189.7	73.6	91.8	8.7	690.1	108.5	39.4	174.7	39.9	51.0	120.5	81.9	181.5	44.3	61.9	48.8	72.3	93.4	22.4	50.8	30.5	57.4	126.6	33.9	4.2	244.9	28.9	84.0	388.0	116.9	26.6	58.0	206.9	216.9	21.4	59.5	22.2	77.4	27.5	39.9	135.7	355.5	69.0	300.0	143.3	10.2	134.4	54.7	175.3	10.8	216.6	107.0	109.4	115.7	28.8	222.4	0.3	147.8	175.7	52.2	242.2	27.9	171.7	13.9	49.5	111.4	28.9	150.4	10.1	193.4	66.4	145.0	137.5	276.4	65.9	58.2	125.8	262.9	0.2	24.0	53.6	114.2	244.5	1.1	188.5	11.6	154.0	355.7	67.0	0.0	516.2	139.3	173.8	14.0	65.4	103.9	200.4	263.5	0.1	76.3	256.6	269.7	132.6	96.9	135.5	92.9	21.7	4.1	2.7	170.0	218.3	171.4	656.8	1678.5	931.0	314.7	1051.6	247.7	199.2	429.9	309.2	1170.2	266.9	325.9	264.3	1052.3	365.0	713.1	209.0	539.5	1585.6	42.3	46.3	50.9	61.1	39.9	51.0	61.9	48.8	57.4	58.0	59.5	69.0	225.5	160.3	140.0	3.6	88.9	366.8	392.3	1429.2	554.3	2.8	269.3	360.2	92.1	323.1	555.7	206.0	2.1	10.0	140.3	680.7	369.8	578.5	2.4	170.8	143.6	220.4	194.9	239.9	0.3	586.4	284.9	205.1	440.9	309.5	268.6	124.3	187.1	110.5	758.5	3.3	0.8	636.8	478.1	644.7	524.7	11.7	82.6	611.6	723.9	10.3	776.9	180.5	207.0	6.0	20.1	1442.1	705.9	157.6	76.3	526.2	471.9	180.7	283.2	19.4	105.2	108.2	197.8	2.8	4.5	1067.4	536.0	20.0	180.0	30.5	664.1	786.1
TSPOAP1	"BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1"	ENSG00000005379	"TSPO associated protein 1"	O95153	17	58301228-58328795	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.0;Breast glandular cells: 7.1;Breast myoepithelial cells: 8.1;Collecting duct cells: 7.3;dendritic cells: 22.3;Endometrial ciliated cells: 9.3;Respiratory ciliated cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 127.5;HL-60: 52.6;NB-4: 52.6;REH: 99.9;THP-1: 33.0;U-266/70: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024662, HPA025244"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA024662: AB_2066340, HPA025244: AB_1845509"	"unprognostic (2.03e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.23e-4)"	"unprognostic (1.24e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.15e-7)"	"unprognostic (1.62e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-2)"	9.7	28.6	71.0	5.6	66.2	40.6	18.4	45.1	92.0	47.3	45.7	35.7	4.0	38.4	6.5	11.0	62.5	5.8	18.1	68.9	47.9	36.6	16.6	18.0	10.8	45.0	49.0	65.9	33.2	14.4	69.9	1.7	44.8	49.1	3.5	17.9	27.7	16.2	8.9	11.8	19.1	6.3	40.2	25.3	26.4	3.7	56.9	13.2	44.9	3.2	5.0	25.0	22.6	52.8	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.8	0.0	2.8	2.6	0.5	0.0	0.4	0.0	0.0	0.1	127.5	1.1	0.7	1.7	0.0	0.2	52.6	5.1	0.0	0.6	0.0	0.0	12.5	0.0	17.8	2.0	9.3	0.0	0.0	18.1	52.6	0.8	0.0	0.1	99.9	0.0	13.7	0.3	0.1	7.2	4.9	0.2	0.2	0.0	0.1	0.2	33.0	0.0	0.0	1.1	0.2	0.1	36.4	7.2	9.5	0.1	1.6	0.0	0.2	0.0	0.0	1.7	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.3	71.0	66.2	45.1	92.0	68.9	47.9	45.0	49.0	44.8	40.2	56.9	52.8	0.6	9.6	9.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.1	8.1	0.0	0.0	4.3	7.3	0.0	0.0	22.3	0.0	1.9	0.9	0.0	9.3	3.1	0.2	0.0	0.0	0.0	0.2	0.7	1.0	0.0	3.7	1.3	4.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.8	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	4.0	0.1	0.0	0.0
TSPY1	"CT78, TSPY"	ENSG00000258992	"Testis specific protein Y-linked 1"	Q01534	Y	9466955-9469749	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	74	"testis: 7.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	366	"U-266/70: 248.7;U-266/84: 249.2"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (2.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	248.7	249.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY10		ENSG00000236424	"Testis specific protein Y-linked 10"	P0CW01	Y	9527880-9530682	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.6"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 10.3"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 63.8"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (5.36e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	63.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY2	TSPYQ1	ENSG00000168757	"Testis specific protein Y-linked 2"	A6NKD2	Y	6246223-6249019	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 7.5"	"Group enriched"	"Detected in some"	34	"Spermatocytes: 7.7;Spermatogonia: 27.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	656	"U-266/70: 107.3;U-266/84: 119.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (3.69e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.3	119.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY3	CT78	ENSG00000228927	"Testis specific protein Y-linked 3"	P0CV98	Y	9398421-9401223	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.0"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"U-266/70: 148.5;U-266/84: 145.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	148.5	145.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY4		ENSG00000233803	"Testis specific protein Y-linked 4"	P0CV99	Y	9337464-9340284	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	138	"testis: 32.7"	"Cell type enriched"	"Detected in single"	11	"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	591	"U-266/70: 1954.4;U-266/84: 2232.7"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.4	1954.4	2232.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY8		ENSG00000229549	"Testis specific protein Y-linked 8"	P0CW00	Y	9357797-9360599	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 2.0;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	266	"U-266/84: 291.5"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	1.0	291.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY9P	TSPY9	ENSG00000238074	"Testis specific protein Y-linked 9, pseudogene"		Y	9487313-9489893	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	50	"testis: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	625	"U-266/70: 678.1;U-266/84: 699.0"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA					"Cluster 29: U-266 - Adaptive immune response"		Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	678.1	699.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116267760-116279930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	26.5	73.8	51.1	17.1	56.4	34.4	23.4	35.2	78.2	22.5	25.5	30.8	24.4	28.4	33.0	34.0	31.4	20.5	43.3	64.9	38.1	50.4	40.9	21.4	21.4	25.9	22.2	34.9	33.3	63.9	40.1	16.0	26.0	42.0	17.7	26.1	30.2	33.9	114.9	29.4	30.0	24.3	17.1	29.5	35.5	28.9	34.6	22.3	39.6	91.9	25.6	31.4	22.7	44.5	22.2	21.5	27.3	50.3	47.2	30.9	22.7	35.2	34.7	31.3	35.8	27.7	15.9	47.3	43.0	40.8	28.2	38.5	21.6	59.8	33.2	19.4	56.0	19.1	29.9	50.8	29.8	31.9	11.2	36.2	46.0	32.5	31.2	32.9	30.3	20.7	34.3	36.1	44.2	48.9	21.5	18.9	13.6	21.3	19.8	19.1	23.5	26.3	54.9	42.9	23.7	23.6	29.2	38.8	18.0	30.6	51.0	39.1	37.3	21.2	18.7	17.2	38.7	19.8	22.7	25.2	35.1	20.3	14.1	121.0	30.1	51.5	40.5	51.0	61.4	46.4	52.4	45.4	26.1	52.2	51.1	50.0	24.1	33.2	57.7	44.9	44.8	34.0	51.1	56.4	35.2	78.2	64.9	38.1	25.9	22.2	26.0	17.1	34.6	44.5	29.4	35.3	45.9	15.7	65.2	166.1	100.6	37.6	70.6	81.0	91.7	47.5	100.0	61.5	40.5	104.8	27.1	54.8	54.2	49.3	154.6	40.8	33.0	40.5	42.0	40.4	74.6	49.7	65.4	43.9	25.5	63.1	41.3	34.9	31.7	67.5	73.9	81.3	42.4	38.7	50.5	59.3	46.8	82.1	116.0	20.2	75.5	40.2	87.2	22.5	38.3	82.6	42.2	15.6	20.2	48.8	52.5	95.5	24.1	77.0	60.3	218.9	41.4	58.1	131.5	87.6	63.5	61.9	39.8	55.5	162.0	59.7	69.1	101.3	70.2	75.8
TSPYL2	"CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX"	ENSG00000184205	"TSPY like 2"	Q9H2G4	X	53082367-53088540	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 367.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 190.0;T-cells: 224.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044133	Approved					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"			"HPA044133: AB_10965838"	"unprognostic (3.29e-2)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (3.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (6.74e-8)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.16e-7)"	"unprognostic (6.50e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.10e-2)"	73.3	148.7	92.9	23.8	100.7	67.3	65.8	92.1	110.7	137.9	39.1	112.4	9.2	121.1	59.2	31.2	125.4	31.2	94.9	93.1	121.0	48.0	39.7	75.4	33.7	69.0	83.5	367.4	70.0	22.6	311.8	10.7	82.7	131.8	11.4	35.3	42.7	55.6	99.3	48.4	77.8	30.0	58.5	85.5	86.7	163.1	118.9	20.2	87.2	26.8	22.3	120.4	81.8	85.5	4.3	13.8	14.0	57.7	10.5	12.7	19.9	29.9	31.6	19.3	18.7	20.4	9.5	32.2	5.5	15.9	14.7	12.5	11.6	11.8	17.5	8.1	25.1	8.1	60.9	26.7	30.9	13.3	9.9	24.8	21.3	26.2	44.2	11.6	14.0	11.1	6.4	29.1	10.7	19.4	18.9	15.8	21.1	6.4	25.5	14.8	17.5	23.8	3.4	23.7	17.0	10.3	23.6	8.6	16.3	63.9	13.0	4.0	20.4	8.8	14.7	114.4	5.7	31.2	20.9	29.6	14.8	21.6	18.5	4.8	0.1	2.2	7.4	0.7	9.3	6.0	10.6	6.0	0.2	7.7	14.1	10.4	1.2	7.4	1.3	15.2	8.4	5.8	92.9	100.7	92.1	110.7	93.1	121.0	69.0	83.5	82.7	58.5	118.9	85.5	45.4	9.6	43.5	17.3	98.0	40.8	80.8	20.3	63.7	100.1	48.8	60.7	33.3	10.0	30.3	18.4	45.9	5.0	190.0	9.2	1.9	8.8	11.1	28.1	47.0	38.9	72.7	5.2	43.4	6.0	15.8	64.3	40.2	61.2	64.6	36.7	27.8	5.8	6.2	30.3	65.0	18.7	14.2	11.4	79.0	11.9	39.1	51.7	44.4	9.4	5.1	53.0	11.3	13.6	9.4	5.1	12.0	51.9	141.4	44.9	4.2	1.4	19.1	34.3	59.2	76.4	75.4	59.7	94.2	17.7	36.4	16.4	224.7	29.6	12.0	31.0
TSPYL4	"dJ486I3.2, KIAA0721"	ENSG00000187189	"TSPY like 4"	Q9UJ04	6	116249964-116254075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA044863	Approved					NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA044863: AB_10962578"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.41e-3)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (5.13e-7)"	"unprognostic (3.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.38e-2)"	8.2	35.4	57.5	7.5	61.8	10.4	14.0	56.2	109.7	17.1	15.5	12.3	5.8	21.5	18.0	11.6	21.0	10.6	20.4	62.8	72.8	14.9	9.0	10.2	10.3	44.9	55.9	25.4	12.2	28.7	28.4	10.7	60.0	22.4	8.1	30.1	9.6	18.5	5.1	10.5	9.3	15.4	43.1	11.0	15.3	14.8	69.5	17.7	14.3	7.8	9.2	11.8	11.9	48.5	6.2	3.4	47.6	39.7	19.2	16.4	8.9	24.3	16.4	30.6	18.2	9.6	5.9	5.0	9.0	37.5	16.1	13.6	20.7	21.6	45.8	20.7	7.0	10.1	18.8	22.7	15.1	19.1	6.4	16.0	10.0	23.7	12.0	23.9	21.0	28.0	15.7	16.4	25.7	19.2	36.9	11.7	11.5	2.1	8.1	20.9	2.6	4.9	9.2	9.0	55.9	37.6	21.6	9.0	4.3	16.9	16.3	10.5	24.4	25.4	21.3	14.6	14.1	6.6	8.2	0.8	11.7	12.5	16.2	0.5	2.1	2.5	3.2	1.8	3.8	2.4	3.9	3.3	1.9	3.0	4.1	3.1	2.8	3.8	2.8	3.1	3.6	4.0	57.5	61.8	56.2	109.7	62.8	72.8	44.9	55.9	60.0	43.1	69.5	48.5	7.0	3.2	7.7	11.8	9.2	4.8	11.9	4.9	30.1	21.4	11.8	13.2	44.2	11.5	7.2	11.0	20.9	3.3	13.0	3.2	19.6	5.4	20.3	30.8	31.9	11.5	31.7	6.1	16.2	7.4	2.0	13.3	8.6	25.8	11.4	27.5	11.7	3.7	3.6	40.4	16.8	5.8	6.1	6.8	3.5	6.7	10.2	8.8	5.4	7.5	5.9	20.7	6.2	4.5	8.5	7.1	2.5	10.9	7.3	7.0	0.7	6.4	27.5	28.7	0.0	14.8	16.8	20.1	3.6	14.1	5.3	3.4	11.9	18.9	4.5	8.0
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273488-97277928	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Group enriched"	"Detected in many"	8	"Early spermatids: 172.9;Late spermatids: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favorable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	6.0	8.6	11.1	4.3	12.6	1.2	12.1	6.7	11.4	11.4	0.8	9.7	1.8	15.2	15.5	4.5	12.4	6.6	12.4	10.0	17.6	10.0	1.7	7.2	6.2	10.3	8.6	25.2	8.7	8.1	11.8	4.3	12.5	15.3	3.2	11.3	9.7	18.3	12.9	4.1	4.1	14.3	7.6	7.3	8.4	44.7	14.4	7.4	8.3	10.5	7.3	9.7	4.6	8.7	0.0	15.9	0.0	0.0	0.4	0.4	0.1	12.4	0.0	12.2	7.9	0.0	0.5	0.0	16.8	14.8	0.0	4.4	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	19.4	0.0	17.2	0.0	0.0	0.2	34.9	30.5	0.0	0.5	23.4	0.0	0.0	0.0	0.0	0.2	23.1	0.0	0.1	10.2	0.1	60.8	47.1	0.0	4.1	0.0	8.2	0.0	1.9	0.0	0.0	26.2	0.1	0.0	14.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.0	11.1	12.6	6.7	11.4	10.0	17.6	10.3	8.6	12.5	7.6	14.4	8.7	7.5	6.4	4.1	0.0	5.5	2.3	4.5	0.7	6.8	12.5	9.9	8.8	16.3	2.8	2.1	9.2	20.9	0.2	2.6	0.0	5.9	5.8	172.9	6.4	13.7	9.8	2.4	3.4	0.0	3.5	0.1	12.1	10.2	2.6	0.0	19.2	6.4	0.8	6.3	8.4	0.0	0.3	2.0	5.0	5.9	419.0	24.5	4.6	7.2	0.0	2.2	13.1	0.0	0.0	0.0	3.7	0.0	21.1	0.8	7.8	0.0	1.4	4.1	12.2	6.6	12.4	9.3	35.5	31.0	5.6	1.6	0.1	1.3	9.9	0.3	4.1
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253178-54256229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 21.5"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 33.9;Spermatogonia: 22.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	69	"K-562: 8.3"									"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: AB_2674288, HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.3	0.3	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	33.9	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSR1	FLJ10534	ENSG00000167721	"TSR1 ribosome maturation factor"	Q2NL82	17	2322396-2336657	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Approved	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA024434: AB_1858413, HPA053087: AB_2682040"	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	18.2	10.9	11.7	17.2	12.1	15.5	17.3	11.2	12.2	10.5	11.5	13.0	9.4	14.8	12.2	20.1	12.3	10.8	17.2	11.5	11.4	12.3	14.8	10.1	15.9	11.7	11.8	15.2	19.9	16.1	8.3	14.6	11.9	13.4	14.6	14.0	12.8	13.9	49.4	19.6	9.4	18.4	12.6	11.0	11.8	18.1	12.4	15.3	11.8	30.7	19.2	22.2	11.8	12.1	80.2	85.1	39.6	77.6	31.6	36.9	80.4	65.5	36.3	39.8	30.6	138.2	33.4	85.5	54.6	52.2	36.4	70.3	86.5	76.8	50.7	39.1	97.3	63.9	66.4	65.5	44.0	59.4	42.3	37.4	48.1	76.6	87.2	43.5	39.5	45.5	84.1	46.5	49.1	49.8	56.6	29.3	94.0	60.0	50.6	59.6	55.1	57.6	49.1	52.5	27.7	61.7	57.6	43.4	45.7	37.6	40.4	26.0	43.9	54.6	43.3	65.7	122.8	33.3	45.7	49.7	53.5	67.3	67.3	1.9	7.1	1.5	8.3	10.5	11.0	7.1	6.8	7.7	11.5	8.7	7.4	9.0	1.3	6.5	11.5	4.8	9.1	6.3	11.7	12.1	11.2	12.2	11.5	11.4	11.7	11.8	11.9	12.6	12.4	12.1	13.5	32.1	29.3	7.2	21.5	34.4	42.8	18.1	31.3	16.2	18.3	13.7	17.6	12.8	30.7	14.7	18.8	29.9	17.3	7.8	3.9	27.7	68.2	18.0	32.6	20.8	10.3	30.5	7.7	16.5	39.7	24.0	18.3	24.8	43.1	24.4	12.5	13.2	16.0	18.5	6.7	12.0	10.2	12.4	10.2	73.6	13.1	14.4	16.0	3.7	18.2	12.6	10.3	3.0	6.4	23.3	5.8	12.0	23.2	35.8	4.8	11.4	21.9	19.7	19.7	36.4	27.7	29.7	47.7	42.2	41.2	24.2	16.1	25.4	15.7	33.1
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TSR3	"C16orf42, MGC24381"	ENSG00000007520	"TSR3 ribosome maturation factor"	Q9UJK0	16	1349240-1351878	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040760, HPA046265"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA040760: AB_2677122, HPA046265: AB_10963942"	"unprognostic (4.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-1)"	44.0	47.6	47.7	18.9	50.4	17.4	40.4	47.9	54.6	35.5	43.3	60.7	25.6	38.6	11.1	51.2	33.5	12.6	72.8	46.1	44.5	51.8	58.3	34.4	20.4	52.7	50.0	32.2	57.2	18.5	35.0	15.2	46.8	42.6	9.0	8.3	42.6	19.8	86.8	46.5	38.3	11.6	48.7	43.0	49.1	30.5	49.6	15.9	35.0	27.9	11.7	48.9	38.1	47.7	60.0	65.2	26.6	35.7	30.8	37.3	44.7	54.3	23.8	38.1	35.3	72.7	59.6	37.8	70.8	36.7	40.5	61.6	24.2	45.2	13.1	73.8	110.8	16.7	56.3	58.2	56.0	36.2	31.8	39.5	63.8	34.3	33.0	29.5	41.7	60.2	54.1	32.6	31.8	107.4	53.6	61.1	44.6	34.4	78.0	93.5	32.3	103.0	33.5	23.7	41.9	53.9	41.9	52.3	73.0	20.8	50.3	44.8	45.9	63.0	67.3	54.2	67.4	67.8	49.2	51.3	31.9	43.5	43.6	13.8	4.0	12.0	4.7	3.6	5.9	7.4	5.9	4.4	3.4	10.0	6.2	5.7	10.4	2.6	3.9	5.2	4.8	1.7	47.7	50.4	47.9	54.6	46.1	44.5	52.7	50.0	46.8	48.7	49.6	47.7	45.2	19.2	16.2	3.3	33.7	28.2	44.9	7.4	18.8	27.1	54.3	48.9	9.4	44.3	12.1	25.8	12.5	48.6	37.8	43.1	103.7	36.5	3.5	30.7	30.9	30.7	24.0	32.4	4.3	46.6	48.7	28.5	18.3	26.9	8.2	45.0	33.9	54.1	48.8	18.5	5.2	35.3	10.2	42.4	26.7	4.9	28.0	38.0	48.0	1.9	34.6	53.9	49.4	3.5	9.2	38.5	32.6	32.0	47.3	53.8	41.5	125.6	11.1	33.6	6.6	27.7	40.4	15.7	39.7	50.3	41.5	29.8	34.7	38.4	35.7	49.2
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: AB_2683811"	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	34.9	26.0	25.2	16.5	27.1	42.5	30.9	26.5	32.5	33.5	22.4	44.4	17.6	43.1	6.4	33.5	36.7	16.0	38.7	24.8	25.1	35.0	46.8	31.8	21.2	26.8	26.5	31.1	28.4	9.6	31.3	11.9	25.6	39.6	6.0	5.9	25.1	19.3	62.3	39.3	29.2	13.1	25.7	39.1	31.5	72.7	27.6	17.1	29.7	16.6	10.5	39.6	29.4	28.0	48.1	62.4	18.9	29.8	15.4	11.1	35.8	31.9	21.8	38.0	26.1	46.8	60.2	34.9	27.6	24.8	42.6	46.6	21.5	37.5	7.1	40.7	66.7	20.3	34.7	47.3	43.0	35.9	40.5	27.3	51.9	24.2	22.7	16.2	27.2	33.7	47.0	37.5	18.0	64.7	41.9	61.9	54.4	35.7	74.3	46.6	17.2	30.6	19.0	42.0	48.7	49.2	28.3	59.8	38.5	9.7	31.4	40.8	36.1	49.4	26.0	47.3	37.2	73.8	70.3	29.1	42.9	35.4	53.1	105.4	64.9	69.6	64.2	58.7	68.9	64.1	63.6	66.6	67.3	87.2	56.6	53.3	64.0	70.5	65.5	65.0	74.9	57.6	25.2	27.1	26.5	32.5	24.8	25.1	26.8	26.5	25.6	25.7	27.6	28.0	56.4	19.2	17.8	8.1	33.8	67.3	56.3	59.0	18.2	35.3	36.0	36.2	20.5	31.5	34.0	12.9	12.5	50.9	44.3	72.7	50.9	55.0	88.1	31.6	31.9	42.4	57.3	52.8	4.0	50.5	45.9	32.4	29.6	31.6	17.2	33.4	37.5	32.0	39.0	28.6	4.1	44.9	63.1	29.8	34.9	178.8	44.4	32.3	32.0	6.5	53.4	43.7	57.7	5.5	6.8	62.3	53.9	33.8	27.9	71.9	58.2	46.7	20.9	40.6	39.5	43.3	45.6	129.3	73.1	27.9	82.3	82.1	38.2	38.9	46.9	55.8
TSSK1B	"FKSG81, SPOGA4, STK22D, TSSK1"	ENSG00000212122	"Testis specific serine kinase 1B"	Q9BXA7	5	113432553-113434989	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	224	"testis: 53.6"	"Group enriched"	"Detected in some"	108	"Early spermatids: 490.9;Late spermatids: 1056.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027827	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA027827: AB_10603138"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	490.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1056.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205696-24208362	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 38.1"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 253.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	1.0	1.1	0.7	2.0	0.4	3.4	1.0	1.0	0.3	1.4	0.0	1.4	1.6	1.1	0.3	1.3	1.2	1.6	0.7	0.6	0.1	0.8	0.6	1.0	2.7	0.3	0.3	1.1	1.5	0.0	0.9	0.4	0.3	0.9	0.0	3.1	1.5	0.0	1.3	4.2	1.7	0.0	0.2	1.7	1.2	38.1	0.3	0.0	1.4	0.0	0.0	1.1	1.1	0.3	0.6	2.3	2.2	0.8	0.0	0.0	2.4	0.9	0.0	0.0	0.0	1.3	2.2	1.8	0.5	0.1	0.4	2.1	0.0	0.1	0.0	0.9	1.7	2.0	3.4	1.7	0.0	1.0	2.1	0.0	0.0	0.0	0.3	1.9	0.0	2.1	0.8	1.2	0.0	2.2	2.1	1.1	0.4	0.5	1.8	1.8	0.8	1.5	0.0	3.0	1.2	1.2	1.7	1.4	0.4	0.9	1.0	1.0	0.9	1.6	1.0	2.1	0.7	2.3	3.0	2.6	0.5	1.6	0.5	0.0	0.2	0.4	0.4	0.2	0.1	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.5	0.1	0.3	0.1	0.1	0.7	0.4	1.0	0.3	0.6	0.1	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	253.7	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	26.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.3	0.1	0.8	0.0	0.0	0.2	0.1	6.8	0.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 177.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"OE19: 264.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		560000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	51.4	154.1	31.3	20.9	40.5	27.1	37.3	38.2	36.0	34.1	31.3	190.7	147.7	18.9	2.9	96.7	25.7	75.9	69.9	29.1	33.1	100.8	561.2	22.7	8.1	34.4	35.2	26.9	63.6	9.4	12.4	7.9	34.4	26.4	80.3	1.3	39.8	18.2	52.9	33.8	114.2	13.2	35.4	16.9	88.4	8.1	35.8	4.3	17.1	34.9	16.2	30.0	56.7	39.0	42.6	86.1	10.8	36.8	25.9	10.6	21.4	23.0	18.6	12.6	18.3	25.4	25.7	11.1	18.8	17.0	11.9	35.1	7.9	22.3	2.7	33.6	50.0	11.5	15.5	49.7	64.9	16.4	26.4	20.1	23.9	9.1	7.6	17.5	31.1	5.9	14.2	18.2	6.0	90.8	0.5	49.9	18.7	264.4	39.3	37.0	11.7	19.7	35.9	36.7	6.4	17.1	24.2	41.4	31.7	10.2	43.4	39.3	25.1	14.0	27.2	24.2	7.4	14.0	15.4	3.4	5.3	46.4	8.5	10.9	17.7	8.0	0.8	4.7	1.7	2.8	0.8	0.6	25.0	1.7	0.4	0.2	21.8	3.7	1.5	1.7	2.1	8.1	31.3	40.5	38.2	36.0	29.1	33.1	34.4	35.2	34.4	35.4	35.8	39.0	13.9	28.9	74.8	10.1	7.8	1.3	9.5	20.4	12.0	1.3	32.7	16.6	39.2	170.1	23.7	20.2	0.0	11.6	2.5	565.8	46.9	45.3	1.9	53.3	30.2	13.4	34.3	35.3	0.3	44.0	6.4	14.6	126.9	74.3	14.0	60.9	39.3	414.9	15.1	1.7	0.5	162.8	8.2	28.9	6.8	3.5	13.1	23.2	1.8	1.0	18.6	27.3	3.1	3.5	7.4	36.8	463.4	7.9	24.5	10.5	278.5	254.5	19.2	0.8	0.0	10.7	11.5	2.4	0.5	39.8	2.4	11.4	5.0	57.5	217.4	17.3
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038977	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 684.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 6.6"	"Low region specificity"	"Detected in all"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA		57000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	33.8	72.1	28.3	25.8	31.4	48.3	73.6	19.8	40.3	31.4	34.6	60.3	40.4	10.4	101.5	91.3	69.2	18.9	55.4	28.2	28.0	125.3	74.7	47.4	52.8	21.2	23.4	55.1	93.5	167.2	119.2	13.2	23.2	98.6	40.8	11.4	175.7	43.5	38.7	79.6	50.5	8.5	20.8	39.7	61.3	35.6	27.3	59.5	140.0	18.6	51.2	29.9	46.4	24.9	119.8	1.6	0.3	0.6	0.0	0.0	2.1	0.2	0.0	0.2	0.0	11.1	112.5	25.0	67.9	0.0	0.0	107.2	0.1	46.4	0.0	98.4	84.9	13.3	43.2	0.0	12.2	43.7	0.9	0.6	28.2	0.0	4.8	0.1	15.6	100.8	0.4	130.8	12.8	205.3	118.6	0.6	0.7	215.1	0.3	38.7	0.0	184.8	98.0	32.8	67.5	37.2	0.0	284.0	0.9	54.0	274.9	0.6	0.5	0.0	41.5	0.6	4.8	315.4	243.2	26.3	0.3	0.2	0.4	438.2	24.2	357.7	226.5	72.0	218.8	530.9	296.2	252.0	72.6	506.1	333.3	282.1	337.5	306.5	104.8	203.9	410.8	220.6	28.3	31.4	19.8	40.3	28.2	28.0	21.2	23.4	23.2	20.8	27.3	24.9	6.5	253.2	228.8	1.0	170.3	86.3	307.5	331.1	160.5	16.2	443.9	457.1	68.4	223.1	259.0	367.8	27.1	271.5	101.2	478.1	684.8	169.7	16.3	336.9	29.2	14.0	218.5	29.0	5.8	151.5	112.7	35.8	59.1	201.2	124.7	88.7	10.8	149.3	72.3	3.3	1.9	418.1	402.8	18.7	116.2	25.1	8.4	40.7	151.2	1.9	178.3	73.0	206.0	1.0	0.7	131.5	383.6	9.8	110.5	386.2	426.6	665.8	615.1	31.8	19.7	99.5	37.7	73.3	44.4	199.6	135.8	151.0	149.3	31.7	267.0	384.9
TSTD2	"C9orf97, PP4189"	ENSG00000136925	"Thiosulfate sulfurtransferase like domain containing 2"	Q5T7W7	9	97600080-97633368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022537, HPA024241, HPA064304"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238"	"unprognostic (7.24e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.21e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	5.9	5.6	3.4	5.3	4.2	2.5	8.1	4.0	5.1	8.5	3.5	7.0	4.7	8.2	7.4	6.1	7.3	7.1	9.9	3.2	4.1	8.0	9.5	7.3	6.5	3.7	4.3	7.3	10.3	10.1	4.6	7.6	4.1	7.6	7.3	10.3	6.7	8.2	9.1	6.0	4.3	8.6	4.2	6.1	6.2	8.0	4.2	8.9	10.4	12.9	8.1	7.5	3.8	5.5	13.6	10.7	17.3	11.3	11.1	9.2	15.1	8.7	10.7	12.0	12.3	10.9	4.7	14.4	4.1	11.6	14.5	19.0	15.3	9.3	13.3	10.0	6.7	10.1	12.6	8.8	14.4	15.0	13.3	12.3	15.4	11.8	21.0	11.2	9.5	15.0	18.0	10.7	10.6	7.6	17.7	8.2	13.5	17.8	10.6	14.5	24.9	7.7	8.9	6.6	12.3	9.7	11.3	8.0	10.4	13.4	6.1	8.3	9.8	11.1	10.1	12.5	10.0	15.8	21.2	7.5	8.8	7.3	7.7	4.3	2.9	3.9	4.4	5.0	7.3	4.1	4.3	5.4	4.8	4.5	4.8	4.7	1.0	8.6	4.0	2.0	2.6	3.9	3.4	4.2	4.0	5.1	3.2	4.1	3.7	4.3	4.1	4.2	4.2	5.5	11.4	19.2	15.3	23.8	11.7	1.7	4.3	5.7	7.4	27.8	11.1	9.9	17.5	11.5	16.9	1.8	25.0	7.6	12.3	11.1	17.6	8.7	17.9	11.3	17.2	7.8	19.2	12.4	26.0	7.5	3.9	11.3	10.2	10.6	20.8	8.5	5.0	13.4	5.3	21.9	31.5	5.3	4.1	5.4	3.1	9.6	8.1	5.9	5.4	15.0	6.5	13.0	7.2	36.7	36.4	9.2	6.5	10.5	9.5	5.2	4.5	8.9	16.2	23.9	19.7	13.9	9.4	18.8	24.8	7.6	4.1	10.9	9.3	7.6	6.3	3.8
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTBK2	"KIAA0847, SCA11"	ENSG00000128881	"Tau tubulin kinase 2"	Q6IQ55	15	42738730-42920809	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.8;Inhibitory neurons: 185.1;Late spermatids: 146.2;Oligodendrocytes: 125.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018113, HPA049866"	Approved		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Intermediate filaments"		"HPA018113: AB_1858421, HPA049866: AB_2680923"	"unprognostic (2.15e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.26e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	5.3	4.2	7.7	3.0	9.9	5.2	4.4	11.3	20.0	6.0	2.1	6.7	1.6	5.3	3.9	2.6	5.5	3.7	7.2	6.9	13.9	3.4	3.1	4.8	3.4	17.4	9.1	6.4	2.5	4.6	5.6	4.0	18.9	4.7	3.0	17.7	3.2	3.8	10.4	3.1	3.9	5.0	6.3	4.3	3.4	33.4	16.9	5.2	3.8	6.3	3.1	5.3	4.7	13.8	5.7	3.8	8.4	4.2	6.5	6.6	1.8	4.6	7.4	4.5	6.9	4.3	1.3	3.3	6.1	4.7	9.2	3.9	8.1	6.7	6.8	13.0	3.6	4.8	6.9	1.6	5.0	6.7	7.8	4.7	6.5	3.9	21.1	9.9	5.2	5.1	7.0	4.9	4.5	0.9	4.1	4.3	2.3	1.7	3.8	7.2	9.1	1.7	5.8	4.0	6.6	6.5	12.6	0.9	2.5	5.8	2.6	8.7	5.8	5.1	4.7	5.7	6.0	7.1	11.3	5.5	3.9	5.8	3.0	0.1	0.5	0.2	0.2	0.3	0.5	0.3	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.1	7.7	9.9	11.3	20.0	6.9	13.9	17.4	9.1	18.9	6.3	16.9	13.8	16.2	6.4	11.8	75.7	11.5	10.7	12.1	11.8	26.2	36.3	9.6	7.6	17.6	12.8	10.0	9.2	37.5	4.1	9.1	3.9	0.0	5.7	80.5	24.9	11.7	17.0	14.3	17.4	153.8	4.3	3.2	15.5	4.6	4.6	19.0	16.2	17.5	9.8	7.4	45.4	185.1	5.1	2.0	16.0	25.9	146.2	16.8	16.4	12.4	69.3	16.9	16.5	6.2	97.5	125.6	7.5	2.6	20.3	6.6	12.4	5.5	5.5	40.5	39.4	13.1	24.6	16.3	34.5	10.1	12.5	9.2	3.1	13.4	11.3	5.3	7.4
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036557, HPA057502"	Approved		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA036557: AB_10670112, HPA057502: AB_2683450"	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	37.0	46.5	77.6	35.6	79.7	26.2	39.4	84.2	111.7	31.5	71.2	44.5	27.3	32.2	58.1	37.4	32.2	26.2	59.9	79.4	83.1	49.5	45.5	33.0	47.8	90.6	85.4	32.6	27.4	45.1	29.8	35.5	88.7	33.4	45.4	42.9	39.4	37.2	91.2	34.8	30.9	41.8	80.3	36.6	34.6	33.8	83.8	48.7	35.7	77.0	55.9	35.7	27.6	84.1	83.2	85.1	62.2	104.4	71.9	51.6	70.5	90.8	80.4	97.7	115.6	120.2	94.0	84.5	172.7	78.2	132.9	63.9	83.5	124.7	156.6	157.7	88.4	75.9	63.0	87.3	102.0	127.2	61.2	48.7	81.0	86.5	71.8	71.8	118.8	74.2	73.6	81.7	112.3	65.0	92.8	99.8	70.7	67.3	85.8	88.4	87.0	93.6	124.2	76.8	51.2	57.7	63.1	74.4	175.1	58.3	117.6	121.5	84.4	64.8	55.8	58.5	141.9	58.4	114.8	82.3	89.6	143.3	85.9	109.8	72.8	105.7	57.6	80.9	73.4	92.6	68.3	68.0	73.5	86.0	62.5	69.1	103.0	87.7	80.6	65.4	90.2	113.1	77.6	79.7	84.2	111.7	79.4	83.1	90.6	85.4	88.7	80.3	83.8	84.1	48.6	67.3	50.8	20.9	55.0	47.0	33.6	89.2	28.5	38.4	40.4	47.0	237.0	40.0	67.4	46.0	20.9	108.7	36.0	58.0	162.4	114.2	115.3	62.8	46.5	61.3	35.3	89.2	54.0	106.5	77.9	57.4	23.4	54.8	83.4	41.3	52.1	72.8	90.0	35.3	47.6	51.4	83.4	48.1	34.7	39.9	46.9	52.4	28.4	23.4	70.1	99.1	68.0	43.7	57.0	98.5	54.7	63.9	42.9	37.6	53.7	144.9	89.4	50.2	59.2	55.7	59.2	142.9	101.5	37.8	47.3	99.9	50.8	53.6	53.7	21.9
TTC12	"FLJ13859, FLJ20535, TPARM"	ENSG00000149292	"Tetratricopeptide repeat domain 12"	Q9H892	11	113314579-113383544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 158.8;Late spermatids: 210.5;Respiratory ciliated cells: 62.0;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 26.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038542, HPA038543, HPA061364"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.14e-4)"	"prognostic favorable (2.48e-5)"	"unprognostic (2.11e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.33e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (5.95e-5)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-2)"	4.1	8.3	4.5	3.7	4.5	2.0	11.0	4.7	4.7	6.8	15.7	5.4	3.8	6.8	12.1	4.3	17.7	5.3	7.5	3.4	5.5	9.3	5.7	5.7	6.5	7.4	6.7	8.7	5.5	24.4	12.6	4.6	5.3	10.3	6.6	11.3	7.8	11.6	4.0	5.8	4.9	4.1	5.2	4.9	5.3	51.9	5.8	4.5	16.2	6.6	7.7	5.7	4.7	5.9	5.6	3.7	8.3	9.0	6.0	7.3	4.9	5.0	9.4	6.5	6.3	4.2	15.8	3.0	7.3	0.2	5.3	12.0	0.0	24.2	9.8	3.4	4.0	1.2	11.8	6.5	12.0	0.0	2.0	8.1	9.7	0.0	14.3	12.8	4.7	0.0	5.1	2.0	12.0	7.3	0.0	1.1	5.3	19.4	6.3	0.0	1.3	5.4	12.1	4.2	7.2	10.0	26.4	9.3	5.3	11.3	16.9	3.4	1.7	1.2	5.9	5.2	9.0	1.7	3.0	0.1	5.6	0.5	0.0	0.0	1.0	1.5	1.7	1.0	2.6	2.3	2.2	1.8	2.0	3.3	2.5	2.5	1.5	1.4	0.9	1.6	0.9	1.2	4.5	4.5	4.7	4.7	3.4	5.5	7.4	6.7	5.3	5.2	5.8	5.9	2.3	0.0	5.4	31.6	6.6	1.3	4.9	9.0	5.2	7.5	4.0	4.1	7.5	7.2	14.4	5.5	2.1	6.8	4.2	3.0	5.9	6.3	158.8	24.6	3.7	2.4	4.8	1.7	10.9	4.9	2.0	3.8	2.0	4.8	2.5	5.2	0.4	2.7	2.6	1.7	3.1	3.3	4.1	1.0	1.3	210.5	3.4	1.7	1.8	9.4	1.6	6.0	5.2	7.1	11.7	3.8	3.5	3.8	4.9	2.5	3.9	8.9	62.0	9.1	6.6	3.6	4.3	84.7	7.5	3.6	1.7	2.7	3.8	4.9	4.6	2.6
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 42.7;Excitatory neurons: 70.9;Inhibitory neurons: 76.7;Microglial cells: 56.2;Oligodendrocyte precursor cells: 41.7;Oligodendrocytes: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	7.8	5.1	7.4	11.7	9.4	11.6	7.0	7.9	7.9	7.1	4.8	11.2	8.0	5.9	6.5	6.0	6.5	6.1	6.5	7.3	9.2	6.4	7.9	9.9	19.6	7.3	6.7	5.6	10.5	6.8	9.2	7.5	7.5	6.3	15.9	11.8	6.7	5.1	11.4	9.8	12.2	6.1	7.7	20.3	12.2	2.9	8.4	10.2	6.8	6.2	14.8	6.5	6.7	9.5	12.4	12.4	12.0	23.5	11.0	7.1	24.5	17.7	13.9	9.8	11.0	18.4	13.2	22.7	15.9	10.8	9.7	19.4	8.0	6.6	6.5	25.6	23.3	6.8	13.7	12.5	11.6	14.1	6.0	6.3	11.4	9.2	8.5	9.8	17.5	9.7	7.3	12.9	9.1	6.5	7.5	13.5	13.5	41.1	15.2	12.0	17.2	31.9	10.2	8.5	16.5	14.2	13.5	13.8	24.2	5.2	14.8	18.1	9.0	11.5	1.6	15.7	31.9	15.8	27.9	6.8	11.3	8.8	19.2	5.7	5.5	4.9	6.6	4.1	4.5	2.8	4.5	5.3	7.7	2.2	3.5	4.4	1.9	7.9	5.3	4.9	3.9	4.2	7.4	9.4	7.9	7.9	7.3	9.2	7.3	6.7	7.5	7.7	8.4	9.5	7.2	6.4	7.4	42.7	18.9	3.3	1.0	1.8	1.2	6.1	3.4	2.4	3.0	1.5	4.0	1.8	6.2	4.3	21.8	6.6	1.9	5.6	1.7	1.7	2.4	5.4	6.1	11.6	70.9	8.6	5.1	5.2	14.3	3.0	9.5	4.6	1.8	5.0	5.0	11.8	76.7	11.3	8.2	7.8	6.6	2.3	2.8	8.9	1.8	56.2	7.2	4.5	17.5	41.7	70.6	4.1	8.7	6.8	13.6	1.9	2.6	1.2	1.3	10.8	6.6	5.5	4.9	3.1	3.5	3.8	2.7	1.6	16.9	2.1	9.4	1.6
TTC14	"FLJ00166, KIAA1980"	ENSG00000163728	"Tetratricopeptide repeat domain 14"	Q96N46	3	180602163-180617828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009295	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009295: AB_1858425"	"unprognostic (2.72e-1)"	"unprognostic (4.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-3)"	25.9	23.3	18.2	28.5	20.1	30.7	27.7	13.7	22.7	40.6	27.9	33.7	23.4	35.2	43.7	17.9	38.7	19.5	25.0	20.2	16.2	36.8	21.6	28.0	41.3	17.8	16.2	56.1	35.3	27.3	57.9	21.5	17.1	36.3	22.0	68.6	22.0	23.8	13.7	22.2	31.2	19.7	15.9	33.4	28.0	20.5	16.6	24.1	49.4	7.2	28.9	29.6	32.4	25.2	18.6	15.2	22.7	12.9	29.6	25.9	21.4	26.1	21.0	18.8	30.8	20.3	24.3	27.9	27.4	18.9	43.0	26.2	21.3	13.9	25.4	52.0	21.5	26.5	37.0	46.2	21.8	28.7	23.3	32.9	26.3	18.9	9.4	31.1	15.2	35.2	11.3	5.4	21.1	5.4	21.9	2.1	16.1	23.0	29.6	25.5	14.0	29.9	10.6	14.0	19.4	18.8	24.8	12.5	25.8	22.7	47.0	26.9	24.3	37.6	19.3	17.4	48.7	40.2	66.2	62.0	18.4	35.1	16.7	23.8	9.4	10.6	10.6	10.4	12.7	14.7	11.0	10.6	7.1	10.7	13.3	10.9	7.5	13.9	14.6	17.6	10.7	6.3	18.2	20.1	13.7	22.7	20.2	16.2	17.8	16.2	17.1	15.9	16.6	25.2	33.8	9.6	35.6	135.2	82.1	17.7	33.5	33.6	23.9	98.2	25.8	15.9	14.0	41.5	38.9	66.2	116.7	33.4	114.3	27.8	3.9	28.4	6.2	19.0	41.7	38.7	39.0	41.8	173.1	32.7	19.6	41.8	30.5	19.6	59.6	112.6	45.0	30.4	24.5	80.8	169.9	24.8	30.5	31.7	23.0	11.0	92.6	37.5	30.2	111.5	61.0	49.8	121.5	120.1	160.0	31.9	38.9	81.3	61.5	23.9	42.7	9.4	40.7	123.5	85.5	47.1	40.2	59.6	29.9	16.8	15.3	24.6	68.8	72.2	23.4	23.1
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358920-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	20.7	18.7	11.0	16.1	11.3	15.5	28.6	16.7	12.2	22.0	22.0	21.2	21.6	26.9	25.0	14.2	28.4	22.3	13.5	11.1	12.2	19.4	38.6	24.2	20.2	11.9	12.5	40.9	49.5	27.7	12.3	29.2	11.7	25.4	22.9	25.1	40.7	21.4	16.4	19.5	25.5	23.0	11.0	23.4	27.4	24.8	12.4	24.6	36.9	20.0	22.4	18.8	15.6	13.0	15.0	30.4	31.3	49.3	77.2	63.6	22.1	35.6	47.6	29.3	35.1	21.1	21.7	31.6	34.9	35.9	33.7	31.1	22.3	23.5	35.2	24.5	29.0	24.2	19.5	20.8	95.3	36.6	29.9	59.5	69.8	21.3	68.4	66.2	29.5	22.7	35.5	26.2	29.8	18.1	27.1	20.3	46.8	58.0	25.0	25.1	33.3	36.9	37.2	21.4	16.7	39.7	27.7	73.1	44.6	31.4	68.6	40.8	39.6	41.7	18.4	47.1	52.1	51.1	44.5	29.8	26.9	21.6	45.3	20.0	21.7	19.0	14.9	22.4	15.9	16.4	16.2	14.5	16.9	14.8	16.3	15.1	18.5	16.5	20.8	17.6	16.1	18.0	11.0	11.3	16.7	12.2	11.1	12.2	11.9	12.5	11.7	11.0	12.4	13.0	43.0	64.1	62.7	159.6	53.3	42.1	35.0	36.4	30.7	44.1	40.3	35.7	20.5	31.5	51.9	22.0	60.5	32.6	43.8	30.7	3.9	23.1	52.6	35.8	44.5	40.9	22.3	44.0	204.6	43.4	28.8	44.4	40.2	48.6	36.6	56.2	40.0	57.5	26.2	47.1	203.2	42.1	34.6	48.0	32.3	18.4	57.2	37.1	28.4	181.8	47.8	24.8	37.0	192.0	200.6	29.7	31.5	36.5	48.9	50.1	47.7	15.5	54.3	47.3	52.6	45.5	36.2	51.8	35.0	34.6	43.2	30.8	45.6	33.5	35.8	42.7
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999784-16045015	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	6.6	11.4	8.1	3.8	7.8	11.2	7.5	19.4	11.6	6.9	8.4	8.0	10.3	6.9	5.2	6.8	5.8	5.2	8.6	8.8	9.6	8.7	7.7	6.6	4.6	7.9	7.4	6.9	12.4	11.2	8.0	5.8	7.9	6.8	5.7	9.9	9.1	4.2	8.8	9.5	9.8	3.8	6.3	4.5	8.4	3.6	8.0	3.9	10.6	4.4	3.3	6.3	6.7	10.5	7.0	4.1	7.6	12.1	6.4	5.6	4.0	3.1	4.6	3.1	3.8	6.5	12.8	8.9	9.8	4.3	4.6	9.1	9.9	8.3	3.8	12.5	10.2	8.2	9.2	6.3	9.1	9.3	11.6	5.6	7.0	2.6	11.4	9.6	7.1	12.4	4.6	7.7	6.8	7.6	7.5	6.8	10.0	11.8	3.0	7.8	8.0	8.2	11.6	10.5	6.6	5.5	7.6	9.8	16.6	24.6	6.9	4.6	13.1	4.2	1.2	6.1	7.5	4.8	1.5	4.2	9.8	9.8	9.5	5.2	0.7	1.8	0.7	0.7	1.2	0.9	0.9	1.2	0.7	1.1	1.0	1.3	0.7	0.6	0.7	1.1	1.0	0.4	8.1	7.8	19.4	11.6	8.8	9.6	7.9	7.4	7.9	6.3	8.0	10.5	51.0	41.7	38.6	69.5	60.8	105.3	83.5	30.8	70.6	147.8	65.1	47.9	34.8	42.9	35.4	46.0	143.9	75.7	62.8	59.7	70.5	50.0	59.4	49.4	41.5	60.3	45.6	32.4	115.1	41.2	41.9	34.2	43.8	67.9	31.1	46.8	42.8	36.0	25.6	129.5	100.9	52.3	26.4	25.8	76.7	7.2	41.0	46.5	55.2	35.6	34.8	73.9	70.0	54.3	57.8	47.7	57.9	33.4	34.5	89.1	75.4	47.1	26.5	180.4	46.0	56.5	40.2	30.2	31.1	56.9	116.8	65.5	68.9	69.9	63.3	72.7
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035510: AB_2674659, HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.1	0.1	0.6	0.4	0.6	0.1	0.2	0.4	1.1	0.2	1.8	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.1	0.5	0.6	0.1	0.1	0.2	0.3	0.7	0.9	0.3	1.1	0.2	0.1	0.1	0.6	0.2	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.0	0.5	0.2	0.1	21.2	0.5	0.2	0.2	0.1	0.3	0.1	0.1	0.6	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.3	0.2	0.2	0.2	0.0	0.4	0.2	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.8	0.3	0.0	0.8	0.0	0.2	0.0	0.1	0.7	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.1	0.5	0.6	0.7	0.9	0.6	0.5	0.5	0.6	3.7	0.0	3.0	20.2	10.4	0.6	4.4	4.0	0.6	5.3	2.6	2.4	6.4	4.3	5.4	1.8	8.4	1.7	1.8	2.5	0.0	2.1	82.3	24.0	3.6	3.0	4.2	0.4	15.0	1.8	1.7	2.1	4.1	5.2	1.3	3.2	5.0	1.3	1.6	5.0	13.3	2.5	0.0	2.2	0.9	84.7	7.2	1.6	3.6	4.7	2.6	3.4	0.0	5.0	3.2	1.7	2.0	6.0	3.7	2.1	2.3	1.2	56.0	15.3	6.6	7.8	2.7	59.8	3.4	0.1	0.6	3.7	1.3	2.1	2.4	2.3
TTC21B	"FAP60, FLA17, FLJ11457, IFT139B, JBTS11, NPHP12, THM1"	ENSG00000123607	"Tetratricopeptide repeat domain 21B"	Q7Z4L5	2	165857475-165953851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 67.8;Excitatory neurons: 81.2;Inhibitory neurons: 85.5;Oligodendrocyte precursor cells: 77.9;Oligodendrocytes: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035495, HPA073293"	Supported		Approved	Cytosol		NA	No			"Cluster 38: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035495: AB_10672866, HPA073293: "	"unprognostic (1.63e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.84e-2)"	5.5	4.1	3.1	3.1	3.4	2.1	5.3	6.5	4.3	6.8	2.6	5.1	2.6	6.3	2.8	3.0	7.3	2.8	5.2	3.2	3.2	5.2	4.0	4.7	4.1	3.3	3.5	8.0	5.0	4.3	4.6	4.7	3.5	6.1	4.0	7.5	4.6	4.2	9.1	4.7	4.2	4.1	3.2	4.0	4.3	4.4	3.1	5.0	4.3	9.2	3.3	4.7	6.0	3.9	4.1	2.1	11.8	6.2	11.0	7.0	3.6	8.2	5.9	4.9	5.8	4.4	2.5	8.9	3.8	3.2	4.7	5.0	8.2	4.8	6.9	6.4	4.9	6.5	4.4	13.6	6.2	6.7	0.0	4.0	2.9	5.9	5.2	8.4	7.0	5.6	9.6	6.1	9.0	2.4	7.0	7.8	6.9	4.6	6.9	9.5	9.1	3.9	6.2	8.2	9.6	6.9	4.7	1.7	8.6	6.3	2.5	7.2	3.9	12.0	5.1	6.5	5.4	3.5	4.5	5.8	5.2	5.4	7.2	3.2	0.5	0.6	0.8	0.6	1.1	1.2	1.0	0.8	0.9	1.0	1.0	1.3	0.2	1.4	1.0	0.4	1.1	0.5	3.1	3.4	6.5	4.3	3.2	3.2	3.3	3.5	3.5	3.2	3.1	3.9	11.1	3.2	9.8	32.7	12.9	9.2	8.3	5.3	22.8	21.6	7.2	6.9	12.5	4.3	9.4	5.5	33.3	3.8	20.2	4.6	0.0	3.3	2.4	67.8	15.3	8.2	7.2	13.7	81.2	1.8	4.6	11.3	11.2	21.6	6.3	12.8	10.8	8.4	13.1	15.2	85.5	7.7	6.1	8.1	4.9	3.2	10.5	7.2	10.6	44.0	5.7	9.9	9.2	77.9	58.9	1.1	6.5	12.8	14.5	6.3	4.0	7.2	34.7	22.7	6.6	15.9	10.7	7.1	12.1	8.5	3.8	2.9	12.5	8.5	5.8	4.7
TTC22	FLJ20619	ENSG00000006555	"Tetratricopeptide repeat domain 22"	Q5TAA0	1	54779712-54801323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.6;vagina: 48.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 72.4;Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 27.1;Paneth cells: 36.9;Proximal enterocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;CAPAN-2: 10.7;HaCaT: 12.3;hTCEpi: 6.9;OE19: 14.7;RPMI-8226: 8.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035072	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA035072: AB_10602252"	"prognostic favorable (2.06e-4)"	"unprognostic (8.52e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.08e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.21e-1)"	0.4	0.9	1.0	2.4	3.2	1.4	2.6	0.7	1.9	21.7	2.6	14.5	15.7	1.5	2.7	109.6	3.4	2.7	0.2	1.0	2.4	9.3	6.1	2.1	1.6	0.7	0.7	0.4	9.4	16.5	6.1	0.2	0.7	6.3	11.2	0.2	17.5	1.7	0.6	25.0	17.4	0.7	0.5	2.0	13.1	0.7	2.2	2.3	4.1	0.0	7.2	3.7	48.1	0.7	9.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	10.7	0.1	0.4	0.0	0.0	12.3	0.0	3.6	0.0	4.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.1	0.1	14.7	1.1	0.1	0.1	8.1	0.5	2.2	0.3	0.2	0.7	0.1	0.0	0.2	0.4	0.2	0.1	0.1	0.0	0.2	0.1	0.8	2.2	0.1	0.1	0.1	0.0	1.0	0.0	2.5	3.4	0.0	2.0	0.7	1.6	3.7	0.0	0.5	1.4	1.7	1.3	1.6	0.0	0.0	2.7	0.5	1.0	3.2	0.7	1.9	1.0	2.4	0.7	0.7	0.7	0.5	2.2	0.7	0.0	0.0	3.1	0.0	1.8	1.3	5.9	3.2	3.4	0.0	3.9	3.6	2.7	15.7	4.5	3.7	0.0	0.3	5.9	72.4	7.9	5.0	2.7	3.3	0.4	0.3	2.4	2.7	0.3	9.1	0.4	0.5	23.0	3.2	0.0	0.0	0.4	2.2	0.0	0.0	0.1	27.1	4.1	0.0	0.3	1.1	0.3	0.4	1.8	0.0	0.0	0.0	7.2	0.0	0.1	10.5	36.9	0.0	1.0	6.0	51.7	8.9	5.7	0.0	0.0	0.0	0.4	0.4	0.9	19.7	4.5	0.0	4.1	0.1	15.4	13.9
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favorable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	8.3	10.1	5.3	4.3	6.6	1.1	8.0	5.1	6.3	11.6	6.6	17.1	3.5	11.2	6.9	9.8	10.0	8.8	10.6	4.5	6.2	8.9	8.1	6.6	3.1	6.7	5.8	14.9	8.0	8.9	5.3	9.4	6.5	10.7	7.8	7.2	6.7	9.2	8.1	8.4	6.8	10.0	5.7	5.2	9.1	13.0	6.0	3.7	12.7	7.6	3.3	13.2	10.1	8.1	9.9	9.8	15.3	17.8	18.0	20.2	6.4	12.0	14.8	12.6	14.2	8.8	17.0	2.4	23.7	13.7	11.4	19.0	5.0	12.0	13.7	3.3	16.3	10.7	17.1	7.0	10.4	2.4	0.7	14.5	10.5	9.9	9.5	13.7	21.6	4.8	8.3	1.4	11.8	6.0	8.6	2.7	8.4	2.7	7.0	2.7	19.9	3.8	10.0	13.2	6.7	3.0	15.8	6.4	14.7	15.4	10.7	10.9	14.3	16.0	9.4	10.7	15.5	8.1	12.4	3.3	14.3	0.8	9.6	1.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.5	0.5	0.1	0.5	0.1	0.0	5.3	6.6	5.1	6.3	4.5	6.2	6.7	5.8	6.5	5.7	6.0	8.1	5.9	3.2	7.0	27.1	0.6	2.4	4.6	4.4	4.6	1.7	4.6	4.3	9.5	4.3	5.2	5.5	0.0	4.6	0.1	4.3	5.9	6.0	12.5	3.3	10.6	7.0	0.0	0.8	3.3	6.2	4.6	7.4	10.2	4.5	1.3	13.5	9.3	5.3	4.0	8.4	3.5	5.7	6.1	3.8	1.7	8.5	9.0	2.5	1.8	15.9	0.6	11.5	0.0	6.6	13.2	3.9	2.6	10.1	0.1	3.1	3.8	5.5	4.0	5.4	6.6	6.5	5.5	18.0	9.2	7.9	4.0	1.9	0.4	10.9	6.7	2.6
TTC23L	FLJ25439	ENSG00000205838	"Tetratricopeptide repeat domain 23 like"	Q6PF05	5	34838833-34899456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 24.7"	"Group enriched"	"Detected in some"	12	"Early spermatids: 373.9;Late spermatids: 218.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037807	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 34: Spermatids - Unknown function"			"HPA037807: AB_10672466"	"unprognostic (7.87e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-3)"	"unprognostic (8.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.16e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.53e-3)"	"unprognostic (4.69e-4)"	0.0	0.9	0.9	0.1	1.3	0.0	0.7	0.8	1.1	0.4	3.6	0.0	0.0	0.4	0.7	0.0	3.6	0.2	0.1	0.8	1.8	0.3	0.1	0.3	0.2	2.2	2.1	0.1	0.7	0.8	0.9	0.1	1.6	0.2	0.0	1.2	0.4	0.6	0.0	0.6	0.1	0.1	2.2	0.0	0.2	24.7	1.4	0.2	0.5	0.0	0.1	0.1	0.0	2.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.8	1.1	0.8	1.8	2.2	2.1	1.6	2.2	1.4	2.3	0.0	0.0	1.1	14.7	0.0	0.0	0.2	0.5	0.0	0.0	5.4	0.5	0.4	0.0	2.7	0.0	10.4	0.2	0.1	0.0	0.0	0.1	373.9	8.1	0.3	0.4	0.0	0.0	13.1	0.0	0.1	0.4	0.0	0.3	1.3	0.1	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	218.7	3.1	0.0	0.0	1.9	0.0	0.7	0.0	4.5	15.3	0.0	0.0	3.0	0.0	0.0	0.0	0.1	23.3	0.5	0.0	0.1	0.1	11.0	2.0	0.0	0.0	0.4	0.0	0.3	0.1	0.1
TTC25	DKFZP434H0115	ENSG00000204815	"Tetratricopeptide repeat domain 25"	Q96NG3	17	41930617-41966503	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 17.0;testis: 44.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 227.2;Endometrial ciliated cells: 65.3;Late spermatids: 43.5;Respiratory ciliated cells: 79.4;Spermatocytes: 98.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.0;U-87 MG: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023908	Enhanced		Uncertain	Vesicles,Centrosome		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	Vesicles	"HPA023908: AB_2241243"	"unprognostic (3.08e-3)"	"unprognostic (4.51e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.76e-1)"	"unprognostic (2.71e-1)"	0.6	0.6	1.8	0.0	1.8	2.7	0.8	1.6	1.8	2.6	6.8	1.1	0.1	1.5	1.3	0.1	17.0	0.5	0.7	1.8	2.4	2.0	0.4	2.8	0.1	3.1	3.3	1.3	0.7	1.9	5.6	0.3	2.4	0.9	0.1	1.7	0.3	0.4	0.5	0.4	0.3	0.5	2.2	0.2	0.5	44.9	2.6	0.3	2.0	0.2	0.0	0.8	0.5	1.7	0.1	1.2	1.4	1.4	0.3	0.3	0.2	0.0	0.6	0.2	0.3	0.2	1.0	0.1	0.5	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.3	0.0	0.4	0.0	0.7	0.2	0.2	0.6	0.0	0.8	0.0	0.7	0.1	0.8	0.2	0.8	0.8	0.1	0.4	0.0	0.1	0.0	0.1	1.0	1.3	0.1	3.0	2.0	0.1	0.4	1.1	0.4	0.5	0.3	0.0	0.1	0.6	0.5	0.3	1.0	0.9	0.1	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.8	1.6	1.8	1.8	2.4	3.1	3.3	2.4	2.2	2.6	1.7	0.4	3.2	4.8	2.9	0.0	0.0	0.5	0.0	0.0	2.7	0.5	1.1	1.6	1.5	14.9	3.7	8.4	0.5	0.0	0.3	1.9	2.3	227.2	65.3	2.6	0.9	0.0	18.7	5.2	0.8	0.7	3.0	0.5	3.1	3.8	0.6	0.7	0.2	0.4	3.3	4.6	0.2	0.0	0.0	0.0	43.5	3.4	0.4	0.0	1.0	0.2	2.8	0.0	1.0	0.7	0.4	0.1	1.9	0.0	0.2	0.0	3.4	79.4	5.2	13.1	4.1	0.6	98.4	3.5	0.0	0.0	0.1	0.2	1.5	0.2	0.3
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.4;Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 82.5;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036338	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036338: AB_10673351"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	2.0	3.1	2.2	1.6	2.2	2.5	3.6	2.4	2.1	3.6	9.0	1.6	0.7	4.2	3.6	1.9	14.1	2.9	1.6	1.9	2.4	4.6	1.1	3.3	1.9	3.1	4.0	4.8	1.7	8.2	3.7	2.5	2.5	2.7	1.6	4.7	1.8	3.4	1.1	1.9	1.0	2.9	2.9	1.7	1.5	12.2	3.0	2.4	4.8	1.6	2.0	2.5	1.9	2.4	13.2	9.8	8.5	10.1	10.3	11.9	4.2	6.3	6.5	10.1	10.3	6.3	9.3	2.9	10.3	4.9	16.5	6.4	9.5	7.4	14.6	8.3	8.2	3.5	7.5	5.5	5.2	10.3	2.4	6.8	6.5	15.1	6.8	6.3	7.5	6.8	8.1	1.8	8.1	12.9	17.6	12.0	8.4	3.9	8.6	6.1	10.0	4.6	8.8	3.9	12.4	8.9	15.5	6.5	8.9	2.5	7.9	5.5	5.3	9.4	8.1	8.6	11.8	4.0	5.6	2.2	16.3	5.0	11.2	0.6	0.1	0.4	0.6	0.1	0.3	1.2	0.4	0.4	0.4	0.7	0.7	0.5	1.8	0.5	0.5	0.9	0.3	0.3	2.2	2.2	2.4	2.1	1.9	2.4	3.1	4.0	2.5	2.9	3.0	2.4	2.3	0.0	4.1	13.7	2.3	1.1	2.3	5.5	1.8	6.8	3.3	2.3	2.6	5.7	13.4	5.5	12.5	1.4	0.4	0.7	0.0	5.3	45.4	52.6	8.0	2.3	1.2	6.5	26.9	2.8	3.3	5.9	1.1	11.5	5.7	7.4	4.6	1.8	2.2	0.0	20.3	1.0	12.2	0.8	1.2	17.7	4.1	1.9	3.6	7.5	1.6	4.2	1.0	9.0	6.5	2.2	2.7	5.3	0.3	0.9	0.1	5.5	82.5	18.3	0.0	5.0	4.1	57.5	11.1	2.0	1.7	0.4	1.4	11.0	0.9	0.8
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	7.9	8.2	3.4	8.1	4.4	7.5	12.2	3.9	4.1	7.7	3.6	7.3	5.7	9.1	8.9	9.2	9.6	5.4	8.6	3.2	6.2	7.3	7.9	6.3	9.4	3.8	3.3	11.7	8.3	10.8	4.4	8.3	4.1	6.9	8.6	5.2	8.9	5.6	9.9	8.4	5.9	9.3	3.4	8.6	6.7	12.5	4.6	7.5	9.9	8.4	11.3	9.5	7.1	8.2	43.0	20.6	13.9	10.5	11.5	23.1	6.7	17.5	14.2	26.3	22.9	31.6	25.3	37.3	15.2	26.3	27.3	21.2	22.4	27.4	38.1	17.9	27.4	42.0	10.3	43.7	21.9	40.7	21.3	15.3	24.5	32.0	34.5	12.9	24.4	9.2	59.5	10.7	23.6	17.0	32.4	14.0	25.3	18.9	21.3	21.2	29.9	32.1	20.2	24.8	11.4	16.6	14.3	13.1	16.7	16.1	16.2	9.6	20.6	16.4	18.2	19.8	30.3	15.0	4.1	41.8	17.8	31.2	17.9	0.0	4.7	0.0	9.1	10.0	10.1	9.9	10.1	9.1	10.5	9.7	12.6	9.8	0.2	9.3	7.1	4.9	9.6	5.9	3.4	4.4	3.9	4.1	3.2	6.2	3.8	3.3	4.1	3.4	4.6	8.2	6.8	9.6	10.4	19.9	10.1	5.6	9.2	7.2	8.0	5.1	6.3	4.3	8.2	4.3	8.8	0.0	4.2	13.4	4.8	2.2	7.9	10.1	18.2	5.6	6.7	8.0	7.3	6.3	27.6	9.5	12.7	8.8	7.7	5.2	12.0	12.0	3.9	4.9	7.6	3.3	33.7	4.5	2.0	8.1	4.6	2.7	8.4	4.0	5.4	27.2	6.5	5.5	1.0	32.2	66.7	5.1	4.7	7.2	6.5	7.0	2.2	4.8	12.4	6.0	6.6	9.7	6.4	28.3	11.3	7.4	5.7	6.4	8.2	9.9	7.9	6.8
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706617-146945882	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 20.0;testis: 71.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.1	0.0	1.1	0.0	0.8	0.0	0.1	0.5	0.5	0.5	4.6	0.0	0.0	0.2	2.2	0.0	20.0	0.0	0.0	0.9	1.3	0.2	0.0	2.0	0.0	3.8	4.2	0.0	0.0	0.7	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	71.8	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	1.4	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.5	0.5	0.9	1.3	3.8	4.2	2.9	3.4	1.1	2.1	0.2	0.0	1.8	7.8	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	697.9	48.9	0.3	0.7	0.0	0.0	5.3	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	2.0	0.0	0.0	445.9	7.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	4.9	0.0	0.1	0.0	0.1	97.7	0.0	0.0	0.0	1.4	157.6	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	45.8	29.3	28.1	27.1	25.0	26.4	43.1	36.3	35.3	59.3	45.7	34.6	24.7	38.9	58.6	27.9	34.9	35.4	28.0	38.9	15.5	37.7	31.7	24.4	29.4	10.0	11.1	60.6	42.9	39.1	35.6	29.0	11.8	51.2	36.3	63.0	50.0	41.4	27.7	30.7	30.3	34.6	6.7	27.3	40.9	27.4	15.3	38.0	64.8	30.6	29.2	30.6	9.4	21.4	72.9	25.4	115.3	22.2	108.9	156.8	40.0	77.5	96.0	34.2	46.1	34.0	35.8	62.3	26.6	130.9	32.1	23.3	35.3	47.9	48.2	66.3	25.0	125.6	38.0	44.1	39.6	70.9	39.1	81.9	28.8	35.0	31.0	68.8	51.6	54.1	77.3	71.1	65.2	56.0	69.4	18.8	33.3	48.0	42.6	91.6	55.3	33.2	39.4	55.3	87.7	67.6	97.2	55.2	49.1	26.5	62.2	27.3	68.3	49.2	19.5	61.2	30.4	71.1	55.1	60.6	80.7	69.9	37.9	4.8	6.2	6.8	11.5	6.4	17.1	13.0	13.3	15.8	10.8	15.1	23.2	14.4	1.0	12.8	8.6	17.3	10.0	4.8	28.1	25.0	36.3	35.3	38.9	15.5	10.0	11.1	11.8	6.7	15.3	21.4	78.3	125.0	142.7	161.3	144.8	65.9	94.8	102.7	86.0	347.7	175.8	140.1	134.7	68.6	118.2	75.4	227.2	50.1	129.5	67.8	166.3	91.1	192.7	115.0	217.4	78.9	190.2	65.4	424.5	75.3	93.5	171.0	131.5	132.0	64.6	256.8	99.6	94.4	61.4	329.7	396.0	163.1	99.7	95.2	83.7	192.4	210.0	86.8	211.7	111.5	87.4	196.5	93.7	321.7	261.9	73.3	96.5	261.1	167.6	121.4	72.8	96.1	108.6	233.9	52.6	245.8	127.9	400.0	258.4	91.7	62.8	52.7	109.7	204.1	148.1	103.9
TTC30A	"FAP259, FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612999-177618742	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.1;Respiratory ciliated cells: 29.0;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.1	1.8	1.9	1.2	2.1	0.4	4.2	1.9	1.9	2.9	4.0	2.6	1.7	3.2	7.9	1.6	6.3	2.2	3.4	1.8	2.2	5.0	2.9	2.5	1.2	2.4	2.6	2.5	3.3	5.6	2.1	0.9	2.6	2.9	2.5	8.2	3.2	2.8	1.5	1.1	1.7	2.7	2.6	1.2	2.8	9.9	2.2	1.7	7.2	1.2	1.3	1.2	0.6	2.6	5.1	2.9	2.8	0.0	5.7	4.7	2.1	2.4	7.1	4.3	4.5	0.9	3.6	1.1	4.6	4.3	5.8	4.2	1.9	5.4	4.7	0.3	1.6	1.0	1.4	1.3	2.3	1.2	1.1	2.9	3.5	2.4	0.9	4.1	2.0	2.5	0.7	0.5	3.0	2.6	4.0	2.4	1.6	1.8	1.0	2.5	7.5	0.5	5.4	1.3	9.2	6.2	2.2	4.2	2.6	6.6	2.4	1.3	1.8	2.6	1.5	2.9	2.0	1.9	1.9	0.3	6.6	0.1	2.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.5	0.2	0.1	0.0	0.3	0.1	0.2	0.2	1.9	2.1	1.9	1.9	1.8	2.2	2.4	2.6	2.6	2.6	2.2	2.6	2.3	9.6	3.1	1.6	1.2	0.8	0.8	3.6	1.8	3.0	3.8	2.4	3.6	2.8	4.7	7.3	2.1	1.0	0.4	5.0	1.9	5.5	50.1	10.8	3.1	2.0	7.2	0.4	1.2	4.0	0.7	3.2	1.5	1.6	0.0	2.8	3.6	3.8	0.8	16.8	1.6	2.5	8.2	0.6	0.4	10.9	2.1	0.8	1.8	0.0	0.3	10.6	0.0	0.5	1.0	2.9	1.0	2.2	1.2	1.1	1.7	4.7	29.0	11.7	0.0	4.1	2.1	51.7	4.3	2.8	0.4	0.3	0.9	4.1	1.9	0.3
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177552796	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.3;Spermatocytes: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	1.7	1.6	1.7	1.8	1.8	0.8	5.3	1.8	1.8	3.4	3.3	3.3	2.6	3.3	6.8	2.0	10.3	2.1	1.7	1.6	1.7	4.9	2.5	3.2	2.2	2.3	2.6	3.4	2.4	5.1	1.6	1.7	2.1	2.8	3.0	5.2	3.7	3.2	0.4	2.4	2.9	2.5	2.5	2.3	3.9	7.0	2.0	3.2	8.2	0.5	2.4	1.9	0.8	2.6	2.5	3.7	4.7	0.9	4.1	4.8	3.2	1.4	4.5	3.9	4.1	2.1	6.1	0.9	3.9	2.8	4.5	6.0	5.7	6.2	3.7	1.4	2.8	1.7	2.2	1.8	3.5	2.2	2.9	4.0	5.7	3.8	2.9	4.7	3.1	4.5	2.3	0.8	2.3	4.2	4.4	3.4	2.2	3.3	0.9	3.4	4.1	1.0	5.9	2.7	11.4	6.2	1.8	4.1	2.9	6.4	4.2	4.2	2.7	2.1	1.1	2.8	1.2	2.1	2.6	0.3	4.9	0.9	3.7	2.7	1.4	1.2	0.6	1.3	0.4	0.5	0.4	0.7	1.6	1.4	0.8	0.8	0.8	0.9	1.0	1.1	0.4	0.7	1.7	1.8	1.8	1.8	1.6	1.7	2.3	2.6	2.1	2.5	2.0	2.6	1.8	3.2	4.6	1.3	2.8	0.6	0.6	5.0	2.8	2.2	3.1	2.8	1.4	5.7	7.9	0.0	2.1	2.5	0.4	4.8	5.9	4.8	10.8	12.8	3.7	2.5	1.2	1.3	0.7	2.7	1.1	3.3	5.1	1.9	1.3	3.2	2.5	2.8	1.2	5.0	0.8	2.4	6.1	1.3	0.6	6.6	1.5	1.3	1.8	1.9	1.4	7.2	4.1	1.5	1.1	2.6	0.5	2.2	4.1	0.6	2.6	5.3	43.3	11.5	0.0	2.7	1.8	24.5	3.7	2.3	0.9	0.5	1.3	5.4	1.8	0.2
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (2.49e-4)"	6.4	4.8	3.5	8.4	3.9	9.0	4.8	3.4	4.3	5.4	3.8	7.9	11.1	5.9	4.5	6.1	5.9	5.9	5.7	3.3	3.6	6.0	18.7	6.8	9.8	4.3	3.8	6.3	7.9	9.2	3.2	9.2	3.9	5.2	8.2	4.8	4.7	4.5	3.7	8.8	9.9	7.4	3.8	8.2	7.5	3.2	3.8	9.7	4.8	3.9	10.6	5.7	4.6	4.5	16.0	13.1	11.7	6.3	7.3	17.0	12.9	11.2	11.4	16.2	11.9	11.3	13.0	20.6	6.4	9.5	14.2	11.8	9.5	10.5	11.0	23.0	8.3	22.4	12.9	24.9	11.0	10.1	21.5	11.5	13.7	14.0	9.8	14.3	11.0	12.0	15.0	11.5	12.0	13.7	17.4	9.2	7.6	12.2	7.9	13.7	24.0	11.5	11.5	11.8	5.6	16.5	7.9	12.4	10.2	7.4	9.7	6.2	17.6	12.5	18.7	9.5	12.6	13.6	10.8	14.1	13.5	12.5	11.4	4.9	8.3	6.1	6.5	8.1	7.2	7.0	4.9	6.2	8.1	4.7	4.6	5.4	0.8	6.6	8.7	4.4	7.3	7.4	3.5	3.9	3.4	4.3	3.3	3.6	4.3	3.8	3.9	3.8	3.8	4.5	5.4	16.0	9.2	7.2	10.8	2.8	4.1	5.2	4.6	11.1	5.2	5.0	3.5	14.3	7.8	9.2	39.6	8.3	9.8	7.8	1.9	5.8	4.6	3.8	8.0	6.7	6.1	13.3	3.0	5.5	5.3	6.0	7.1	5.9	19.0	8.8	4.6	20.8	8.3	5.0	3.4	5.9	6.1	7.9	3.5	5.0	6.2	7.5	3.6	10.3	13.2	9.2	19.6	2.5	4.4	5.9	9.4	5.7	9.6	3.1	13.9	6.0	4.3	23.6	6.6	7.3	5.3	8.3	10.0	4.2	3.3	8.1	9.8	8.2	6.5	3.8
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896631-19901983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.8	8.7	12.3	10.5	34.7	16.6	13.6	17.2	12.3	8.6	11.7	12.2	13.9	26.0	7.4	11.9	6.7	7.1	8.8	9.1	11.4	12.3	10.0	15.5	10.6	10.0	16.5	8.6	8.2	11.3	8.5	11.3	16.0	10.2	33.0	11.1	9.3	22.5	13.8	13.1	8.0	9.5	15.6	11.4	12.5	9.7	19.7	12.4	7.7	10.1	11.3	11.2	14.2	22.5	14.4	12.8	9.6	5.6	12.3	2.7	4.8	8.0	7.7	5.0	7.3	25.6	14.5	2.7	5.1	9.6	14.6	5.6	15.4	4.9	21.3	23.3	14.8	20.4	12.8	12.1	14.2	25.5	11.7	9.6	8.6	20.4	6.5	7.5	23.3	27.1	28.5	6.4	6.8	10.7	21.7	9.6	8.4	24.1	12.6	8.5	24.1	21.6	8.6	20.6	19.1	16.1	8.5	18.2	14.1	11.9	5.5	5.6	11.6	12.4	11.5	6.6	29.8	27.3	24.0	17.9	13.9	6.7	9.2	7.6	23.1	7.3	5.7	8.7	12.2	11.6	7.8	7.2	11.9	15.8	12.2	28.0	6.7	6.9	5.0	15.6	4.9	8.7	10.5	13.6	17.2	8.8	9.1	10.6	10.0	11.3	9.5	9.7	14.2	23.2	9.6	14.4	8.5	24.7	18.9	33.4	36.0	34.7	66.9	27.4	39.0	15.8	15.7	26.4	12.9	14.6	14.6	13.7	10.0	45.0	12.2	27.2	25.8	6.1	16.2	28.3	34.0	7.1	24.8	8.7	19.6	14.8	13.2	8.8	7.2	7.5	24.1	9.1	42.1	8.6	19.9	32.6	8.8	8.9	7.2	19.9	17.4	7.2	5.6	14.6	67.8	11.3	9.5	22.0	14.6	12.9	9.8	12.3	15.8	13.7	28.5	48.7	39.2	13.1	21.1	21.3	113.2	38.7	22.4	26.1	9.6	21.6	9.0	11.7	26.7
TTC33	OSRF	ENSG00000113638	"Tetratricopeptide repeat domain 33"	Q6PID6	5	40512333-40755963	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038252, HPA038253"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA038252: AB_10674551, HPA038253: AB_10671739"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.28e-3)"	6.9	5.9	6.6	3.3	7.2	0.8	5.7	10.0	9.7	5.8	5.3	6.3	4.3	6.2	4.7	4.2	5.6	4.6	6.3	7.5	6.6	7.5	7.7	5.1	4.3	6.3	6.5	6.7	4.8	8.9	4.4	4.1	6.3	5.9	4.2	11.6	5.3	5.6	15.5	3.8	4.8	5.0	5.6	4.6	5.2	4.5	7.3	6.7	6.0	14.8	4.1	5.4	5.2	6.9	3.6	3.2	6.1	6.8	5.0	7.1	2.9	4.7	5.6	4.8	5.1	1.7	3.5	11.0	2.8	4.3	5.2	1.6	5.2	2.7	8.5	10.3	4.9	2.4	13.5	4.3	5.5	6.5	3.1	4.4	5.6	4.8	5.0	8.4	7.2	7.3	5.8	8.3	6.4	1.0	12.5	9.3	1.9	2.8	3.5	11.1	11.5	7.9	8.2	2.1	4.5	6.2	11.0	6.4	8.1	5.0	4.3	8.7	5.5	5.5	4.6	4.3	4.6	6.0	6.7	5.8	5.1	10.1	4.9	7.1	1.8	3.2	2.0	4.4	2.2	2.1	2.3	2.1	1.9	2.2	2.5	2.2	2.5	2.3	6.6	1.0	2.2	1.9	6.6	7.2	10.0	9.7	7.5	6.6	6.3	6.5	6.3	5.6	7.3	6.9	12.9	16.0	7.4	9.8	13.1	14.4	5.6	8.6	11.4	12.3	8.6	6.0	18.2	7.2	6.2	7.3	6.2	5.9	8.8	6.9	19.6	8.2	22.4	9.1	11.5	11.0	3.0	9.5	23.7	6.3	4.2	12.6	6.1	6.8	12.7	8.9	13.9	9.4	5.1	5.0	27.5	8.0	10.2	7.5	15.4	8.4	14.0	7.5	10.6	15.9	14.3	19.2	2.1	23.6	35.1	8.0	8.4	13.9	11.8	6.8	6.8	12.6	13.7	23.5	13.1	9.9	13.4	28.1	22.1	6.3	18.3	2.6	14.6	5.0	6.2	4.5
TTC34		ENSG00000215912	"Tetratricopeptide repeat domain 34"	A8MYJ7	1	2635976-2801717	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.8;Late spermatids: 27.4;Respiratory ciliated cells: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA066832	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA066832: AB_2685731"	"unprognostic (1.45e-4)"	"unprognostic (5.00e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.69e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.68e-4)"	0.3	0.3	0.4	0.1	0.4	0.0	0.6	0.4	0.2	0.7	0.7	0.1	0.0	0.5	0.2	0.0	2.1	0.0	0.2	0.4	0.3	0.6	0.1	0.5	0.1	1.5	2.2	0.9	0.3	0.1	0.8	0.0	0.8	0.6	0.0	0.1	0.3	0.1	0.0	0.1	0.4	0.0	1.2	0.5	0.2	5.7	0.4	0.0	1.7	0.0	0.1	0.4	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.2	0.4	0.3	1.5	2.2	0.8	1.2	0.4	0.5	0.3	6.4	0.0	2.9	0.6	0.0	0.5	0.3	0.0	3.3	0.4	2.8	6.0	4.3	1.0	0.0	0.0	0.1	0.3	0.2	0.0	0.7	22.8	1.1	0.4	0.4	0.0	0.0	0.9	0.6	0.0	0.5	0.0	0.1	4.5	3.0	0.7	0.0	0.3	0.0	0.8	0.6	2.0	1.3	0.4	27.4	0.6	0.3	1.8	1.0	1.1	2.1	1.0	0.5	0.1	0.6	0.1	0.0	0.0	0.3	0.3	0.4	6.9	3.5	0.0	1.0	0.5	2.1	0.7	0.0	0.1	0.0	0.6	1.0	0.6	0.0
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 171.5"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.0	1.3	0.8	0.1	0.8	0.0	11.1	0.8	0.7	0.3	0.7	0.5	5.9	0.4	18.5	0.5	0.5	0.1	1.0	0.3	0.6	8.9	171.5	0.3	0.1	1.1	0.7	0.6	1.2	0.0	1.6	0.1	0.6	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.1	0.0	0.6	0.2	0.7	0.8	0.6	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.8	0.8	0.7	0.3	0.6	1.1	0.7	0.6	0.6	0.6	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95461755-95554977	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037905	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	23.6	24.2	10.6	17.9	13.1	10.5	25.7	21.4	15.4	23.8	14.8	20.2	21.4	22.8	19.7	19.9	16.9	18.4	24.3	12.3	11.7	27.5	23.2	17.1	20.5	15.0	12.2	22.6	26.7	46.1	20.2	25.9	15.9	27.2	22.1	21.8	20.7	21.4	34.5	32.7	19.2	22.2	12.7	19.4	26.2	7.8	13.3	25.8	26.2	30.9	21.5	17.0	16.7	18.5	33.1	34.6	43.0	14.9	70.3	94.9	38.2	61.8	49.6	39.3	58.6	37.1	23.6	58.0	39.7	59.0	41.0	31.7	54.5	74.5	65.4	34.0	44.6	39.1	68.8	24.6	60.1	25.7	27.1	63.6	37.3	50.1	69.5	60.3	63.0	19.0	31.2	37.1	75.1	19.0	33.5	20.6	24.3	15.1	28.2	28.1	60.0	61.5	43.2	25.7	53.5	41.8	50.8	24.8	57.0	35.7	38.8	21.7	87.4	53.3	30.5	42.5	47.9	35.4	48.3	53.0	54.0	36.9	70.0	6.1	6.4	2.4	10.1	7.8	12.2	10.3	9.8	8.5	8.1	10.0	10.0	10.6	0.2	9.3	8.0	16.2	9.7	4.4	10.6	13.1	21.4	15.4	12.3	11.7	15.0	12.2	15.9	12.7	13.3	18.5	51.4	76.9	56.1	68.6	38.5	19.5	20.4	26.5	8.6	57.8	33.2	31.8	84.9	25.8	40.9	27.6	50.1	32.5	52.0	22.4	15.6	41.5	2.4	44.8	70.9	39.9	32.5	20.2	146.8	40.5	41.8	43.4	42.8	57.3	41.1	64.6	32.9	36.0	26.9	58.9	130.6	34.3	16.2	28.8	16.7	4.3	62.4	32.2	8.8	68.4	55.4	21.0	41.2	99.5	145.0	38.1	20.2	64.7	41.1	19.0	32.2	30.7	38.2	33.6	39.5	55.1	39.5	10.5	10.0	30.9	32.8	19.8	34.8	52.3	34.2	18.2
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 233.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 134.2;NK-cells: 182.3;Proximal enterocytes: 144.5;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 90.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.9;NK-cells: 38.0;T-cells: 90.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029302, HPA075893"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA029302: AB_10601704, HPA075893: "	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favorable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	24.7	23.6	9.5	10.2	11.6	46.9	25.7	10.3	10.7	16.8	12.8	42.1	79.4	13.8	6.4	12.5	17.2	15.5	23.2	9.7	11.0	64.4	233.6	15.6	10.7	13.3	12.3	26.0	35.5	7.6	13.2	7.8	11.9	23.6	31.9	4.7	27.0	7.3	20.6	12.2	80.9	10.3	10.3	22.8	29.1	6.8	12.2	2.5	15.2	12.3	5.9	16.9	13.5	11.3	12.0	13.2	16.4	34.5	15.2	13.1	15.7	17.2	11.5	18.7	14.6	21.8	8.5	0.1	10.8	17.9	7.4	10.8	16.8	13.9	6.8	27.0	36.9	15.6	28.4	76.0	21.0	9.0	59.8	22.6	7.3	8.5	9.7	12.9	15.9	0.2	11.9	19.4	12.2	12.1	0.3	28.2	12.5	22.6	13.1	0.0	8.0	8.0	12.6	13.8	2.9	22.8	23.7	16.3	13.3	7.5	26.1	18.0	18.5	13.0	14.1	10.3	11.0	14.7	9.2	1.7	8.8	13.7	13.8	29.9	11.9	22.5	90.5	11.4	9.7	2.3	8.5	41.0	10.8	1.7	3.5	36.9	7.6	38.0	8.7	4.3	4.5	42.5	9.5	11.6	10.3	10.7	9.7	11.0	13.3	12.3	11.9	10.3	12.2	11.3	9.2	0.0	7.5	13.7	6.5	3.3	5.9	4.3	3.4	2.6	10.2	6.7	9.2	38.6	4.3	9.2	6.2	10.4	69.1	69.0	23.5	10.4	0.3	7.4	9.6	8.9	20.9	10.5	0.3	10.2	9.3	7.5	11.7	6.9	17.2	13.3	9.7	134.2	13.4	5.0	1.8	37.8	4.1	14.9	4.3	0.9	7.5	9.6	5.4	9.4	12.8	9.3	182.3	5.5	5.6	9.7	51.6	13.9	16.2	8.6	144.5	149.6	5.3	5.4	6.6	7.4	5.9	1.8	3.7	5.3	8.2	6.4	29.2	22.7	51.7	4.6
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 59.5"	"Group enriched"	"Detected in many"	9	"Early spermatids: 425.0;Late spermatids: 616.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	2.2	8.2	3.5	3.3	3.5	1.7	35.9	3.0	9.6	14.1	0.0	29.5	6.1	1.0	15.9	18.4	7.5	14.9	15.3	1.0	11.4	26.6	2.8	9.1	1.4	7.4	5.3	0.3	13.5	13.5	11.0	0.3	14.0	20.5	35.2	4.6	11.5	4.2	4.1	10.5	8.1	1.6	2.2	0.3	29.4	59.5	7.7	0.5	10.1	1.7	2.0	8.0	9.4	3.7	6.4	3.4	0.7	0.3	0.4	0.7	28.2	0.3	0.2	0.2	0.2	18.2	2.8	0.1	9.6	0.4	0.4	0.2	3.8	0.2	0.1	70.6	9.7	0.5	1.8	3.2	1.1	0.0	0.7	0.1	1.6	0.1	0.0	0.8	1.4	0.2	0.4	0.1	0.2	52.4	0.6	0.2	4.8	33.8	0.6	0.1	0.2	4.3	28.6	9.1	22.1	1.6	0.5	153.7	1.8	2.0	111.7	0.8	0.8	0.4	2.5	0.5	0.5	5.4	7.1	0.2	2.1	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	31.7	0.0	0.3	3.5	3.5	3.0	9.6	1.0	11.4	7.4	5.3	14.0	2.2	7.7	3.7	0.4	3.2	25.2	1.3	1.1	1.5	5.3	1.7	0.0	2.5	30.8	15.1	13.0	5.7	6.4	9.2	0.0	0.5	15.3	29.3	11.7	38.9	425.0	5.4	3.0	1.9	41.4	9.7	9.7	52.7	4.8	0.9	21.9	9.5	3.8	0.5	0.4	0.6	2.0	0.0	10.2	56.0	6.1	0.3	1.3	616.8	2.5	0.9	0.0	1.0	2.6	1.7	0.0	0.0	0.9	30.5	13.7	2.6	0.4	12.0	2.7	24.4	9.3	7.3	6.6	1.8	1.3	22.8	6.5	4.8	6.5	3.4	1.7	0.5	20.7	14.6
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 143.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.8;Hepatocytes: 169.3;Late spermatids: 320.0;Rod photoreceptor cells: 241.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.9"	"Lineage enriched"	"Detected in all"	4	"T-cells: 115.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA065705: AB_2685538, HPA065713: AB_2685542"	"prognostic favorable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	21.1	30.5	6.7	12.3	6.4	36.3	18.9	3.2	26.2	20.1	10.8	10.9	9.1	15.6	7.4	16.0	18.6	23.6	7.2	19.9	4.5	6.1	94.2	15.1	19.0	1.6	2.5	10.2	15.8	1.9	20.1	2.7	0.6	20.0	7.4	143.2	25.2	5.4	10.2	56.1	13.4	8.3	2.1	13.2	12.8	33.3	3.6	15.4	7.1	1.6	21.3	13.3	19.6	5.3	12.6	10.4	6.1	3.7	38.3	39.8	22.9	16.4	39.0	13.9	13.5	1.3	6.8	19.7	16.8	30.4	11.1	15.8	12.3	16.5	10.9	28.7	13.1	6.6	50.6	26.3	7.7	31.4	15.3	33.4	21.8	8.4	11.7	26.9	1.1	14.6	0.1	0.2	8.7	10.7	4.9	10.0	14.5	5.5	25.1	28.1	9.5	7.8	14.7	19.7	15.9	12.4	34.5	10.6	11.4	6.5	8.2	10.6	8.3	11.8	9.6	8.7	8.7	0.4	0.1	32.0	16.0	32.9	8.3	2.4	5.4	0.2	32.8	6.1	84.0	16.4	71.7	40.3	7.8	10.0	30.0	25.0	1.5	18.5	5.2	27.8	115.9	13.1	6.7	6.4	3.2	26.2	19.9	4.5	1.6	2.5	0.6	2.1	3.6	5.3	6.9	0.0	3.4	13.7	23.0	46.0	17.1	10.1	30.1	14.7	28.6	24.1	3.0	64.3	5.0	7.3	45.9	0.7	52.0	2.0	0.0	14.2	149.8	72.9	34.9	7.0	4.2	20.6	114.3	11.5	15.2	16.5	15.8	30.0	2.5	11.5	4.6	169.3	12.6	13.5	80.3	9.4	18.3	26.6	44.5	320.0	11.1	21.5	14.2	20.6	18.9	27.8	38.1	41.7	2.3	8.9	1.5	7.9	7.1	20.8	11.4	1.3	16.7	241.5	0.0	5.2	6.7	42.4	8.0	26.8	86.1	0.5	95.9	9.2	9.0	20.1
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305960	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA045008: AB_10960209, HPA054198: AB_2682414"	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	2.1	2.8	2.8	1.8	2.8	2.9	3.8	2.2	3.1	3.1	4.8	2.2	2.1	3.1	3.2	2.2	5.7	2.2	1.8	2.6	3.1	3.5	1.4	2.5	3.2	2.1	2.7	3.0	1.9	6.1	2.1	2.4	2.1	3.8	2.3	2.6	2.3	3.0	0.7	3.4	1.6	2.9	2.1	2.4	2.4	2.5	4.3	2.6	4.9	2.3	3.1	2.3	1.7	2.2	3.4	5.4	6.5	0.7	4.7	6.8	3.5	4.3	5.0	6.4	6.6	2.4	7.6	7.2	2.7	4.5	3.3	2.8	6.4	3.0	9.8	6.3	2.4	5.9	2.2	4.3	4.8	11.0	3.5	4.2	6.7	5.6	7.2	5.8	6.3	5.1	4.3	3.5	6.3	4.6	6.5	4.6	5.5	5.6	5.2	3.4	4.8	5.2	5.6	3.5	2.2	4.3	4.9	5.1	3.0	2.6	4.0	5.3	6.6	2.5	4.1	3.4	2.3	5.0	4.7	8.9	2.0	4.6	6.0	1.3	2.0	2.9	2.7	2.0	2.3	2.7	2.0	2.2	2.2	3.0	2.1	2.5	0.8	3.0	2.9	1.6	2.7	2.0	2.8	2.8	2.2	3.1	2.6	3.1	2.1	2.7	2.1	2.1	4.3	2.2	13.9	12.8	7.2	6.5	15.2	6.4	9.4	21.5	13.6	15.5	9.4	12.8	4.3	12.8	9.8	18.4	16.7	20.4	12.2	2.3	11.7	10.6	1.6	27.7	13.4	12.3	9.0	6.7	18.2	6.5	12.4	12.5	8.6	7.9	12.0	16.0	10.8	6.4	15.4	5.0	12.4	6.9	18.3	11.2	6.8	3.4	10.2	10.5	7.2	6.5	11.5	12.4	19.6	11.6	8.7	6.4	5.0	9.8	7.8	4.6	8.6	13.1	32.8	19.4	6.6	14.1	11.6	26.6	36.1	8.8	8.7	4.7	12.7	14.6	8.3	5.3
TTC7A	"KIAA1140, TTC7"	ENSG00000068724	"Tetratricopeptide repeat domain 7A"	Q9ULT0	2	46916157-47076137	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 168.0;Microglial cells: 77.8;Oligodendrocytes: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 90.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036781, HPA036782"	Enhanced					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036781: AB_10673665, HPA036782: AB_10671711"	"unprognostic (2.51e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.51e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (3.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-2)"	8.7	16.8	2.5	6.9	4.1	18.4	6.6	3.7	3.3	6.3	10.1	6.7	12.9	4.1	1.9	14.0	5.0	3.8	3.7	2.6	3.7	6.2	5.7	12.5	10.4	6.6	4.5	4.3	16.1	4.6	4.5	5.7	5.6	4.9	5.7	4.0	12.9	4.3	1.9	12.7	12.5	2.7	3.8	10.6	10.3	40.8	4.2	29.1	10.4	0.8	14.6	4.8	8.8	5.6	39.9	14.6	4.6	1.3	6.9	8.5	19.2	10.7	14.2	6.9	6.4	22.6	23.2	26.5	10.2	19.9	8.0	16.4	6.4	13.5	5.6	51.9	5.3	2.7	11.6	24.1	2.9	10.8	10.4	3.4	15.9	8.6	10.6	8.1	5.6	10.2	10.4	17.5	3.9	14.8	54.5	11.4	5.1	42.5	3.7	90.0	7.8	47.6	6.5	10.0	5.8	5.4	19.8	39.8	3.5	8.5	7.5	22.7	14.1	7.8	6.0	5.9	9.0	10.7	4.3	13.5	5.7	13.0	4.4	0.0	1.5	0.0	0.3	0.8	0.3	1.2	0.9	0.3	0.7	1.1	0.6	0.2	0.3	0.2	0.3	1.6	0.3	0.4	2.5	4.1	3.7	3.3	2.6	3.7	6.6	4.5	5.6	3.8	4.2	5.6	2.4	22.4	12.4	32.0	22.0	6.5	4.8	5.1	9.1	1.9	4.7	2.7	4.3	11.5	5.4	7.3	0.0	8.0	16.7	29.1	3.9	5.1	52.9	27.9	10.9	5.0	6.7	7.4	24.2	7.5	11.2	8.4	13.3	15.4	8.2	4.7	1.8	9.2	16.4	0.0	18.8	9.4	0.0	29.5	15.7	168.0	4.7	24.6	5.4	77.8	18.6	22.6	1.0	17.6	86.8	22.2	11.8	6.8	22.9	3.1	38.7	4.6	12.4	3.7	0.0	8.0	5.2	6.1	6.8	12.2	5.5	4.0	11.5	2.9	7.6	4.5
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Excitatory neurons: 116.7;Inhibitory neurons: 132.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 5.6;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA058363: AB_2683692, HPA059577: AB_2684069"	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	23.7	11.6	42.9	9.1	43.4	10.2	18.1	47.1	57.2	20.1	0.7	37.9	5.0	24.2	6.1	15.5	18.0	9.2	33.2	51.0	18.7	16.9	17.6	18.5	4.1	35.7	32.2	15.8	24.7	15.7	18.2	18.4	38.7	16.1	4.4	14.4	12.8	13.9	60.9	9.3	11.0	17.6	14.6	15.4	22.4	4.2	45.2	3.5	9.5	27.9	2.7	25.4	13.1	39.6	19.4	17.2	20.0	14.8	18.2	21.5	65.5	15.5	13.2	20.2	21.7	4.5	5.1	0.2	23.6	17.4	23.9	0.4	13.1	10.8	19.6	35.3	14.1	43.6	8.9	4.1	18.3	1.0	72.8	16.1	7.1	10.9	13.2	18.5	29.4	16.9	24.7	35.3	19.7	20.5	0.5	17.2	11.4	1.1	14.8	37.8	33.0	6.6	6.6	14.4	30.5	20.9	15.4	6.3	33.3	12.7	9.0	13.3	33.7	20.6	16.1	15.2	25.4	12.0	6.3	0.2	29.6	4.1	20.6	5.6	0.2	8.0	0.1	0.5	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	1.0	0.3	0.1	0.5	0.9	0.5	42.9	43.4	47.1	57.2	51.0	18.7	35.7	32.2	38.7	14.6	45.2	39.6	13.1	3.2	1.1	88.8	0.5	2.8	2.1	1.1	0.6	13.4	2.7	2.8	21.6	2.8	0.4	5.5	16.7	13.1	0.6	0.1	1.9	2.3	5.9	1.3	5.2	7.9	1.2	2.5	116.7	2.4	7.4	7.3	0.5	2.0	7.6	20.0	10.8	9.9	8.1	30.3	132.8	0.1	4.1	5.6	4.3	3.2	6.8	7.2	12.4	36.5	2.7	6.0	0.0	69.9	70.7	0.8	0.1	7.2	0.4	3.0	0.3	4.0	5.5	17.8	26.3	9.9	9.2	1.7	1.6	0.7	2.0	30.1	1.1	2.1	0.0	1.2
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"brain: 110.8;choroid plexus: 32.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.1;Excitatory neurons: 39.3;Horizontal cells: 18.5;Inhibitory neurons: 19.7;Oligodendrocyte precursor cells: 27.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	0.0	0.6	73.9	0.3	74.7	0.0	0.0	49.7	110.8	0.0	32.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.2	60.6	0.2	0.0	0.0	0.0	45.1	46.3	0.0	0.0	0.0	0.9	0.0	46.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.1	43.0	0.0	0.2	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.1	69.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	26.8	1.4	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	73.9	74.7	49.7	110.8	84.2	60.6	45.1	46.3	46.4	43.0	60.4	69.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	39.1	0.2	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.8	0.2	0.2	1.8	0.0	39.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	18.5	19.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	4.7	0.0	1.7	0.0	27.2	5.0	0.1	1.2	0.7	0.0	0.1	0.0	0.0	1.2	8.4	0.0	0.0	0.1	7.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1
TTC9C	MGC29649	ENSG00000162222	"Tetratricopeptide repeat domain 9C"	Q8N5M4	11	62728069-62740293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055169	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA055169: AB_2682724"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.67e-7)"	"prognostic favorable (4.15e-5)"	"unprognostic (7.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-2)"	12.9	14.1	17.0	18.2	17.5	5.6	14.8	18.9	21.7	13.7	15.9	16.0	20.4	15.3	17.3	14.4	18.4	15.1	11.3	18.2	17.7	15.0	13.4	12.4	25.9	18.7	17.6	26.2	13.3	9.4	11.9	19.3	19.1	12.1	15.5	9.9	14.9	14.2	16.2	19.9	15.4	15.6	17.4	19.7	15.4	14.0	17.8	25.1	19.3	13.7	23.9	15.9	11.5	18.4	47.4	39.4	32.8	31.5	46.6	54.3	24.4	48.7	49.7	57.1	47.6	35.0	45.0	35.7	88.1	33.5	50.7	41.2	49.8	14.8	44.9	93.0	24.8	39.3	57.1	43.0	51.1	26.9	41.1	35.8	31.4	46.3	47.1	42.5	43.3	42.0	29.3	34.3	54.2	33.9	42.5	55.2	27.4	38.5	31.5	32.5	42.3	54.0	36.6	18.0	28.3	23.3	41.3	35.3	57.1	29.1	46.5	24.8	36.9	56.5	33.3	64.0	34.1	36.4	58.6	40.1	31.3	20.2	30.5	70.1	39.1	40.5	22.4	36.4	17.6	42.3	24.1	22.9	33.9	37.9	23.6	21.7	25.1	29.9	24.3	33.9	39.5	24.7	17.0	17.5	18.9	21.7	18.2	17.7	18.7	17.6	19.1	17.4	17.8	18.4	14.5	16.0	10.9	7.8	27.0	29.6	13.3	14.2	25.0	17.5	13.8	13.8	9.3	10.0	17.3	18.4	8.4	35.0	21.8	17.0	27.4	24.0	23.3	14.0	14.4	19.6	6.0	14.1	18.0	14.9	41.9	18.5	7.7	10.9	8.2	22.6	13.6	9.9	38.5	28.6	13.5	15.8	18.3	27.1	20.6	20.4	28.3	18.8	16.0	4.7	40.5	13.5	35.0	7.5	9.8	19.7	15.3	27.4	22.4	21.3	25.9	27.0	18.2	16.0	32.9	10.2	17.0	32.4	31.8	21.2	33.2	23.8	21.5	19.6	17.7	19.6
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	8.0	5.0	7.0	6.2	7.7	16.7	9.6	9.0	8.3	7.4	6.7	9.6	4.7	8.5	9.0	6.4	7.3	5.3	13.3	6.9	7.3	6.6	4.2	7.0	10.5	7.0	7.1	8.6	6.6	7.0	5.0	6.5	7.1	7.9	6.6	8.6	6.1	7.4	13.6	7.1	6.5	7.1	6.8	7.9	6.5	9.6	7.1	18.9	10.4	10.3	10.0	7.9	6.9	8.3	12.5	11.5	16.4	14.8	9.0	11.5	14.7	14.1	10.7	16.2	12.0	11.8	13.2	20.9	11.5	10.6	18.3	29.7	18.5	10.8	17.1	13.9	12.6	9.6	17.2	9.5	9.1	25.6	14.9	7.1	12.0	13.8	10.5	13.1	14.0	34.1	19.3	17.5	12.7	19.0	59.8	15.5	30.0	22.3	16.8	37.1	22.8	24.9	13.1	10.1	14.4	24.8	19.8	14.4	10.7	15.3	17.9	13.7	13.2	25.0	15.8	21.8	16.8	8.2	24.8	25.0	14.7	20.6	25.1	17.0	5.8	12.0	6.6	6.0	8.6	13.6	8.4	7.8	3.6	12.2	9.3	7.0	20.9	8.2	7.4	11.2	9.6	3.3	7.0	7.7	9.0	8.3	6.9	7.3	7.0	7.1	7.1	6.8	7.1	8.3	26.8	25.6	21.6	12.7	35.4	9.8	21.9	26.9	7.4	27.2	11.8	15.5	40.1	25.8	18.3	18.4	60.5	23.8	33.2	14.8	19.6	28.5	22.9	26.2	21.4	29.5	12.1	68.0	12.4	21.2	22.8	17.5	15.3	16.8	22.8	28.8	27.5	8.3	18.7	30.3	10.6	15.4	20.3	22.0	12.1	6.8	23.6	17.4	1.8	14.0	30.1	20.3	41.2	9.5	19.2	25.3	18.6	25.9	14.3	22.8	16.5	19.3	29.2	55.0	26.3	21.9	24.1	47.4	61.8	7.5	8.5	25.2	28.2	16.8	19.7	24.5
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060326-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005776, HPA070762"	Approved		Supported	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA005776: AB_1080416, HPA070762: AB_2686307"	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	3.8	4.7	2.6	6.4	3.9	5.4	4.2	2.8	3.7	3.3	3.6	5.0	4.3	3.0	1.7	5.2	2.6	2.8	3.1	2.4	2.8	2.6	1.4	2.6	7.3	5.4	3.5	2.7	3.5	3.9	2.3	2.7	3.6	2.5	5.4	2.5	3.3	2.5	4.7	4.9	4.0	4.0	3.0	4.3	3.9	4.2	3.8	8.9	3.6	2.3	7.9	3.3	3.6	4.7	27.7	10.0	19.8	28.0	7.7	6.7	24.6	14.5	6.7	20.8	18.3	14.1	4.8	33.4	21.8	9.6	23.2	28.1	35.2	18.7	32.0	25.9	24.8	28.5	19.5	18.2	5.5	42.1	31.5	7.7	7.0	15.4	28.4	5.2	14.4	26.0	22.3	29.6	15.9	42.4	28.1	26.0	30.9	26.3	20.0	40.0	72.7	14.6	12.7	12.4	16.8	7.0	21.7	21.4	8.4	14.9	11.7	17.0	14.6	13.1	27.6	31.0	31.8	13.5	12.5	40.6	8.8	31.2	53.7	0.9	2.3	1.5	1.2	2.8	1.2	1.5	1.4	2.0	2.6	1.5	1.4	1.7	0.4	2.6	1.6	1.4	2.7	1.0	2.6	3.9	2.8	3.7	2.4	2.8	5.4	3.5	3.6	3.0	3.8	4.7	4.4	6.4	6.4	6.8	13.4	13.3	17.1	8.5	12.0	5.7	7.6	6.3	7.3	5.7	7.3	12.9	8.4	9.7	8.9	10.6	5.9	6.6	6.9	8.9	15.6	6.9	4.9	30.3	8.1	8.0	7.6	11.0	8.6	12.3	9.5	24.7	5.7	3.0	11.4	11.8	4.7	8.3	0.0	8.6	12.1	7.0	6.5	14.5	7.2	10.3	22.1	3.3	14.4	2.5	13.5	9.3	5.1	4.1	16.0	22.7	6.2	3.8	5.1	7.2	0.0	18.4	8.5	9.2	12.4	19.4	14.3	3.8	12.3	12.2	13.5	17.9
TTI1	"KIAA0406, smg-10"	ENSG00000101407	"TELO2 interacting protein 1"	O43156	20	37983007-38033461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034230, HPA068338"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	Nucleoplasm	"CAB034230: AB_1564322, HPA068338: AB_2685975"	"unprognostic (7.14e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (1.11e-1)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	6.8	9.5	7.4	9.1	7.7	8.7	8.9	7.5	8.0	8.5	8.1	7.7	6.2	9.7	9.8	7.3	10.0	6.0	8.2	7.3	8.0	8.5	12.0	7.5	11.8	7.4	7.2	11.8	13.9	11.0	10.0	10.9	7.5	9.4	10.6	10.0	10.1	11.1	16.0	8.0	7.5	10.0	6.8	9.3	8.7	11.0	7.6	13.8	12.1	10.2	12.8	9.0	7.4	10.3	21.7	31.6	34.3	13.1	13.7	19.0	36.7	24.1	14.1	35.2	29.8	74.3	27.5	35.5	24.5	13.8	39.1	33.7	38.8	50.5	34.5	14.3	15.2	48.9	31.3	38.6	15.5	39.4	22.0	14.6	32.6	35.0	21.1	13.5	26.5	37.1	52.3	23.6	26.9	22.3	53.7	27.3	33.7	33.7	32.9	34.7	55.2	41.6	13.4	23.0	31.1	27.7	36.9	64.5	8.6	35.1	36.6	18.8	17.6	47.0	31.2	25.3	24.9	20.4	19.1	39.5	27.5	25.5	24.8	13.8	8.2	15.0	9.3	9.5	10.4	7.9	7.1	9.2	10.8	7.7	10.5	8.5	5.1	9.6	6.1	5.2	9.9	7.9	7.4	7.7	7.5	8.0	7.3	8.0	7.4	7.2	7.5	6.8	7.6	10.3	6.1	9.6	11.6	16.3	9.2	3.1	3.6	5.1	4.0	8.5	5.0	5.0	12.3	7.2	8.3	3.7	10.4	15.1	5.9	3.4	1.9	5.7	8.9	5.1	6.8	6.9	3.0	9.9	15.9	3.2	10.7	7.0	5.1	5.2	2.5	16.8	3.3	8.4	5.5	8.4	14.6	4.4	4.1	1.6	2.0	3.9	6.5	5.0	3.6	14.0	7.5	5.9	6.2	15.6	25.4	3.9	5.3	6.8	10.5	6.0	3.9	5.0	15.8	9.1	0.0	5.3	5.5	14.5	12.9	4.2	3.0	14.4	8.9	8.2	6.3	4.4
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513185	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	5.6	6.9	5.0	6.7	5.5	7.9	6.4	6.6	6.2	6.6	5.5	6.1	5.6	6.2	6.5	6.4	6.5	4.7	7.5	4.9	5.5	6.8	7.4	4.6	10.8	5.4	5.4	5.8	4.7	9.6	5.7	5.8	5.6	6.1	6.0	5.5	6.1	5.1	9.1	6.5	5.5	6.1	5.4	7.6	5.5	12.9	5.5	10.6	6.6	6.9	11.4	6.7	6.0	5.8	8.2	15.1	19.6	19.5	14.8	9.7	8.1	12.2	13.7	20.0	19.6	12.4	6.9	23.3	17.8	9.1	17.8	14.2	31.2	14.3	17.6	10.6	10.0	14.5	8.4	12.9	15.9	13.1	13.4	8.2	17.9	14.9	13.3	12.1	17.7	30.2	21.7	17.9	14.1	16.8	39.0	13.2	25.9	23.0	10.4	26.0	15.6	11.1	11.2	8.9	23.5	12.3	11.8	10.9	14.8	17.7	11.2	10.4	10.7	12.4	10.9	13.0	12.0	9.6	10.0	34.2	12.1	13.0	13.5	19.9	20.9	35.8	24.2	24.5	23.6	18.6	21.1	23.3	19.4	22.9	24.1	21.5	23.0	23.3	27.5	14.0	25.2	19.8	5.0	5.5	6.6	6.2	4.9	5.5	5.4	5.4	5.6	5.4	5.5	5.8	5.6	6.4	4.8	5.9	8.3	5.4	7.8	7.7	8.0	6.3	3.9	3.4	0.7	1.5	8.7	7.3	20.9	9.9	5.0	3.5	3.9	9.4	21.9	7.4	9.3	7.0	3.0	15.4	4.7	9.2	9.5	6.1	3.6	7.2	3.8	8.1	3.6	5.5	9.3	6.7	5.0	6.2	6.1	5.5	3.1	4.2	6.8	5.4	5.4	3.7	10.8	6.1	5.2	3.5	5.7	6.3	2.2	7.5	5.2	7.5	5.6	7.7	8.5	11.5	6.6	6.2	5.5	40.4	10.5	5.0	8.1	8.8	6.0	7.7	5.6	4.9
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039516-43089419	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 39.9;Spermatogonia: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Mitochondria	"HPA048392: AB_2680384"	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.2	9.9	2.7	10.0	2.2	4.6	10.0	12.1	4.9	6.9	5.2	1.8	5.8	8.1	3.8	9.8	3.9	8.5	11.0	10.1	5.3	1.7	3.8	3.8	7.6	8.3	5.4	3.6	5.9	9.7	2.7	8.3	4.9	3.1	11.3	4.7	3.8	3.4	4.8	3.1	4.0	7.8	3.2	4.0	13.5	10.7	5.6	7.0	3.7	3.4	4.6	4.8	8.8	0.9	0.8	17.5	12.3	18.8	17.1	0.5	5.8	6.5	3.3	5.6	0.0	2.6	1.0	3.5	10.6	1.8	0.6	1.5	1.5	3.4	1.4	2.7	1.7	0.6	1.6	13.3	4.5	2.2	13.5	21.8	2.0	5.4	14.3	10.7	14.2	0.5	10.8	12.3	5.5	4.3	7.4	2.2	4.6	1.2	9.3	9.2	0.2	6.1	1.5	4.0	8.2	4.6	2.4	16.0	9.1	6.3	7.4	10.1	3.4	2.3	7.7	0.8	3.6	0.7	0.5	9.1	8.2	6.2	4.7	5.5	6.7	10.6	5.9	11.2	2.7	9.8	12.3	9.8	4.5	8.4	10.5	1.2	10.5	4.8	6.5	6.4	5.7	9.9	10.0	10.0	12.1	11.0	10.1	7.6	8.3	8.3	7.8	10.7	8.8	3.8	0.0	2.7	3.9	1.5	2.3	2.4	5.9	2.8	5.1	6.2	7.2	5.0	1.5	5.6	1.8	6.2	2.7	3.4	1.1	15.6	7.3	39.9	12.8	6.6	4.1	0.0	2.1	8.8	4.9	1.3	5.9	3.6	4.1	1.3	9.2	5.7	0.3	4.9	5.0	9.0	3.0	16.2	4.0	2.2	18.2	4.1	2.4	8.8	3.7	4.4	6.4	7.2	4.0	3.8	4.5	6.6	6.0	0.5	2.4	0.6	7.2	20.0	11.5	6.6	5.6	3.7	10.7	32.6	4.8	2.7	0.7	5.9	5.5	1.8	2.2
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173880-1197936	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 13.1;fallopian tube: 10.7;testis: 41.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 244.1;Late spermatids: 768.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.5;endometrial cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"SCLC-21H: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.3	0.0	0.6	0.1	0.4	0.0	1.1	0.2	0.4	1.7	13.1	0.2	0.1	0.2	0.4	0.3	10.7	0.3	0.2	0.8	0.9	0.4	0.0	2.8	0.1	2.6	3.7	0.0	0.3	0.0	2.1	1.5	1.8	0.3	0.1	0.0	0.3	0.1	0.4	0.2	0.2	0.0	2.0	0.1	0.5	41.9	0.9	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.4	0.8	0.9	2.6	3.7	1.8	2.0	0.9	0.6	14.4	0.0	0.5	0.0	0.3	1.8	0.7	3.0	0.0	0.1	1.4	1.0	0.8	1.5	3.4	0.0	2.1	0.0	0.9	0.9	0.0	0.5	244.1	52.2	0.6	2.1	0.0	0.0	0.2	1.3	1.0	0.3	3.6	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.1	768.4	5.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	1.0	4.5	0.0	1.5	0.4	0.1	72.5	0.1	6.6	0.9	1.0	9.3	2.1	1.0	2.0	0.1	0.9	0.0	3.6	1.3
TTLL11	"bA244O19.1, C9orf20"	ENSG00000175764	"Tubulin tyrosine ligase like 11"	Q8NHH1	9	121821928-122093606	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 201.7;Inhibitory neurons: 157.5;Oligodendrocytes: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021828	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021828: AB_2670841"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.61e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.53e-2)"	3.8	5.5	7.7	2.7	11.4	1.3	3.6	7.7	18.0	4.2	0.0	10.3	2.6	5.2	3.0	7.0	4.9	3.4	5.1	3.3	7.6	2.8	5.4	3.8	2.4	9.2	8.8	4.3	4.9	4.3	2.9	4.4	9.1	4.4	4.0	6.0	4.7	5.2	24.3	4.2	3.2	9.3	8.4	3.2	4.2	12.1	8.1	2.7	3.5	8.7	2.6	5.7	4.2	19.0	2.4	1.2	3.9	5.3	5.4	6.5	1.6	4.5	5.5	7.7	4.4	3.6	1.4	5.4	1.4	9.3	2.5	5.8	6.8	5.4	4.7	3.7	5.6	2.6	5.2	3.7	6.2	4.7	2.9	4.7	7.6	3.1	4.9	2.9	2.8	4.6	8.1	5.3	2.7	3.8	3.3	3.8	2.1	8.2	8.3	3.4	6.8	8.4	4.0	1.9	8.2	3.4	2.7	5.0	3.6	2.1	4.0	4.0	3.2	3.6	0.7	6.5	6.1	5.8	7.9	2.3	3.3	5.2	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	7.7	11.4	7.7	18.0	3.3	7.6	9.2	8.8	9.1	8.4	8.1	19.0	2.1	0.0	1.5	18.3	1.6	2.5	0.9	0.8	6.2	3.0	2.2	2.4	1.4	1.5	0.4	1.8	10.4	1.7	1.2	1.1	1.9	1.9	22.3	2.8	2.7	1.5	1.2	3.4	201.7	1.8	0.7	2.2	1.1	1.3	1.3	1.0	0.7	1.8	1.6	6.7	157.5	1.6	0.0	0.9	1.2	23.1	3.7	0.9	3.6	22.5	0.9	2.4	2.1	58.8	412.6	1.9	0.1	3.0	2.2	0.8	0.5	2.0	1.8	2.6	0.0	5.5	2.6	13.3	2.5	4.2	4.1	1.0	1.8	2.7	1.0	0.9
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TTLL13P	"FLJ46079, MGC33417, TTLL13"	ENSG00000213471	"Tubulin tyrosine ligase like 13, pseudogene"	A6NNM8	15	90249530-90265482	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"testis: 8.9"	"Cell type enhanced"	"Detected in single"		"Inhibitory neurons: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041305	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA041305: AB_2732492"	"unprognostic (6.23e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.49e-4)"	"unprognostic (6.09e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.61e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.88e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTLL3	"DKFZP434B103, HOTTL"	ENSG00000214021	"Tubulin tyrosine ligase like 3"	Q9Y4R7	3	9808086-9855138	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 63.9"					"Low region specificity"	"Detected in all"			HPA051413	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA051413: AB_2681476"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.96e-1)"	"unprognostic (4.04e-4)"	"unprognostic (3.14e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (6.45e-6)"	"unprognostic (1.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (9.51e-6)"	32.2	23.7	24.3	12.4	25.6	30.9	27.5	22.1	30.7	54.5	29.3	31.3	11.5	29.0	16.5	15.9	37.3	25.3	25.6	22.8	25.3	25.2	9.9	24.8	23.0	28.7	28.0	63.0	17.5	11.0	37.5	12.7	26.7	39.7	13.1	8.5	20.1	30.4	11.8	41.0	22.8	20.4	25.6	29.4	19.4	40.8	26.5	13.2	27.2	12.6	15.1	30.8	40.0	30.9	2.0	5.1	10.9	2.1	19.2	36.4	63.9	6.7	6.5	3.6	4.9	8.7	7.7	11.7	5.8	12.5	3.6	3.0	6.9	1.3	2.2	13.6	19.7	14.2	17.6	8.9	6.6	12.9	24.1	23.6	9.2	6.9	2.7	20.8	6.2	17.6	14.0	28.0	8.0	7.0	2.3	20.3	1.4	1.3	2.9	6.7	4.4	5.2	5.4	14.9	5.1	4.6	3.4	1.8	5.8	5.3	4.9	8.9	20.2	9.6	12.4	9.2	3.2	17.8	8.6	16.8	8.0	18.9	3.4	5.9	2.1	6.6	2.3	5.9	1.1	2.8	1.6	1.2	2.7	2.7	1.8	1.5	8.5	2.3	3.5	3.0	2.9	0.9	24.3	25.6	22.1	30.7	22.8	25.3	28.7	28.0	26.7	25.6	26.5	30.9	11.7	12.8	9.1	0.0	5.6	5.2	5.1	6.7	9.1	11.1	6.0	6.5	3.3	1.5	8.5	9.2	25.0	5.4	12.0	11.7	0.0	4.3	29.1	16.5	14.2	10.1	12.0	1.7	0.0	6.7	5.4	14.9	27.0	10.5	8.2	13.6	9.3	1.6	5.3	6.7	0.0	11.9	2.0	14.4	5.7	17.8	22.7	9.2	10.6	0.0	7.9	9.4	11.3	0.0	0.0	7.4	8.2	12.4	4.0	6.6	3.0	2.2	28.7	13.8	13.1	11.6	8.8	15.1	6.7	4.1	4.7	5.1	7.5	9.5	8.5	7.3
TTLL4	KIAA0173	ENSG00000135912	"Tubulin tyrosine ligase like 4"	Q14679	2	218710835-218755416	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 39.4;Muller glia cells: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027091, HPA050252"	Approved		Approved	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA027091: AB_10601828, HPA050252: AB_2681064"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (3.83e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (6.63e-12)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.29e-3)"	3.9	7.2	7.1	8.4	9.9	5.8	6.4	7.5	9.6	5.4	20.1	5.5	5.6	4.7	3.5	6.9	7.3	4.2	4.6	7.2	8.4	4.4	5.9	6.9	6.2	9.7	11.2	4.5	7.1	5.2	6.7	8.0	10.1	6.6	6.4	15.2	6.8	3.7	5.6	8.6	5.8	5.2	7.2	5.7	8.9	25.5	9.6	5.7	3.9	2.9	8.9	5.2	6.3	10.6	18.4	12.3	32.3	16.4	8.1	6.3	43.5	12.2	9.8	19.8	16.8	52.6	21.4	14.4	10.1	9.5	18.9	19.0	34.3	16.9	23.0	16.3	27.3	18.5	19.0	50.2	11.5	23.6	13.1	10.4	10.1	17.7	19.9	8.5	19.0	16.0	53.8	22.2	11.0	10.7	13.1	15.3	36.4	13.5	8.1	29.4	14.6	18.9	19.7	14.5	12.9	12.7	9.3	13.7	23.9	48.9	11.1	12.0	7.6	17.6	17.9	11.3	11.7	11.2	10.1	32.4	9.2	14.5	23.4	0.1	12.6	0.8	3.1	6.0	2.9	3.9	2.3	2.3	7.3	3.5	1.5	1.4	14.5	2.1	8.8	4.3	1.3	5.1	7.1	9.9	7.5	9.6	7.2	8.4	9.7	11.2	10.1	7.2	9.6	10.6	1.6	3.2	5.8	28.4	3.1	4.6	12.3	3.2	4.6	6.6	4.5	5.1	3.5	5.7	4.2	7.3	27.1	6.8	3.0	2.4	0.0	6.0	39.4	7.8	3.1	3.7	5.4	6.5	3.9	3.9	8.0	4.8	10.2	5.3	1.3	4.2	1.8	2.6	7.8	3.3	4.8	4.7	4.1	5.5	2.9	16.1	3.1	9.4	3.6	15.9	10.4	72.7	5.2	11.1	20.8	5.8	2.5	1.5	2.8	15.2	2.9	1.8	7.5	12.7	0.0	3.3	3.1	18.3	12.7	4.2	4.1	5.7	2.5	2.1	5.1	11.4
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2;Early spermatids: 111.0;Excitatory neurons: 134.3;Inhibitory neurons: 114.2;Oligodendrocytes: 242.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.5	5.5	3.7	6.0	6.0	11.7	7.1	7.1	7.2	7.3	15.0	6.2	4.7	8.0	7.2	7.8	11.6	6.5	5.8	3.8	6.6	6.2	4.1	6.5	5.1	10.5	6.4	7.1	4.9	11.1	5.4	7.5	10.6	6.9	7.3	23.9	6.5	6.9	4.7	7.1	4.5	8.6	6.4	4.1	5.9	57.4	6.4	10.1	7.8	5.8	7.5	6.1	6.4	12.0	22.8	16.2	13.9	14.5	10.9	16.8	12.9	13.1	15.9	15.4	19.9	10.3	20.8	6.4	7.2	13.9	11.3	21.3	12.3	21.7	29.3	7.6	7.3	12.5	16.8	11.3	9.3	9.2	11.5	13.1	10.6	19.4	21.5	16.8	33.8	17.5	7.2	10.5	15.7	32.1	15.6	12.6	9.9	18.0	16.6	9.5	19.6	8.8	15.0	22.2	18.4	11.6	27.5	20.2	6.8	11.0	27.6	9.8	38.1	20.5	18.0	18.5	12.2	8.8	13.5	14.6	20.7	10.4	13.9	11.6	2.0	1.7	2.6	2.0	2.4	2.3	2.5	2.7	3.2	1.8	2.9	2.7	2.4	2.3	2.5	3.4	2.2	1.4	3.7	6.0	7.1	7.2	3.8	6.6	10.5	6.4	10.6	6.4	6.4	12.0	7.1	3.2	10.1	71.8	6.1	5.0	5.5	5.4	8.0	10.9	17.3	11.6	8.7	17.2	10.2	11.0	127.2	8.1	8.5	7.6	3.9	7.1	111.0	37.4	11.9	10.7	7.7	5.0	134.3	5.3	13.2	9.3	8.6	10.8	12.6	11.7	19.6	7.4	5.6	0.0	114.2	6.5	16.2	5.8	5.1	93.1	12.5	6.6	5.4	82.4	8.5	10.0	6.2	78.4	242.9	6.1	11.9	11.7	7.6	6.2	6.0	2.4	40.1	80.1	13.1	9.5	6.0	37.7	16.4	9.0	6.3	6.0	8.3	9.1	8.0	4.6
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 49.7;Late spermatids: 176.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules	Vesicles	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.6	0.1	0.6	0.0	0.1	0.5	1.0	0.2	1.6	2.8	1.3	0.1	0.0	0.0	3.6	0.5	0.0	0.7	0.6	2.5	0.0	0.6	0.0	0.8	0.9	0.0	0.6	0.0	0.4	0.0	0.6	0.1	3.9	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.6	0.0	0.2	18.9	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.0	0.7	0.6	0.8	0.9	0.6	0.6	0.8	0.6	0.1	3.2	2.6	5.2	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.6	0.0	3.8	1.8	0.0	0.0	0.0	7.4	1.9	0.3	49.7	2.6	0.1	0.5	4.2	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	1.0	2.6	0.0	0.0	0.0	176.1	1.2	0.1	0.0	0.0	0.0	0.4	0.0	13.0	0.7	0.0	2.2	0.0	0.0	0.4	4.1	3.2	23.8	0.7	0.0	0.0	0.0	11.2	0.4	0.0	0.0	0.0	0.0	0.4	3.5	0.1
TTLL7	FLJ23033	ENSG00000137941	"Tubulin tyrosine ligase like 7"	Q6ZT98	1	83865024-83999150	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 57.1"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1558.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.4;RH-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052249	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA052249: AB_2681773"	"unprognostic (9.68e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.93e-4)"	"unprognostic (4.34e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.04e-3)"	4.2	1.5	17.9	1.3	34.5	0.0	1.4	16.5	23.5	2.3	0.2	4.0	1.7	4.4	1.4	3.2	5.8	4.0	3.8	16.5	19.0	0.8	1.1	3.0	0.1	18.9	22.7	1.3	4.4	1.4	7.7	0.0	23.1	5.4	2.2	8.2	2.7	2.7	3.4	0.7	1.8	7.5	11.7	0.4	3.7	5.0	20.8	0.1	1.6	1.7	0.2	5.3	2.5	57.1	3.4	0.2	2.5	4.5	2.1	5.0	0.0	7.1	2.8	2.5	4.7	0.0	0.5	0.0	2.1	6.6	10.2	0.1	5.0	2.5	3.8	28.4	3.6	4.1	5.5	0.1	1.1	0.2	0.5	1.5	0.2	3.9	0.1	7.4	2.8	0.1	0.0	10.3	10.3	0.0	0.0	0.0	2.0	0.0	3.5	0.0	22.1	0.0	0.4	1.8	13.9	8.9	3.8	2.2	2.3	4.6	3.1	0.2	0.4	3.8	1.5	0.6	7.7	3.5	6.6	0.2	5.2	0.0	5.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	34.5	16.5	23.5	16.5	19.0	18.9	22.7	23.1	11.7	20.8	57.1	3.9	67.3	7.5	12.4	3.9	3.2	18.8	2.1	0.6	138.6	6.9	4.8	16.8	17.2	7.7	7.3	73.0	0.7	0.9	1.8	1.9	18.2	211.6	36.3	6.8	6.1	27.6	0.0	230.3	7.6	0.2	14.2	10.2	1.7	25.3	2.7	3.9	2.4	0.5	95.9	216.6	5.3	4.1	0.3	7.7	38.6	10.8	2.6	17.8	16.9	0.6	19.1	2.1	113.6	1558.6	4.3	4.7	84.7	12.5	22.5	0.4	13.8	30.8	118.4	19.7	68.0	44.9	68.2	45.7	2.7	2.0	0.7	3.0	1.1	1.3	26.5
TTLL8		ENSG00000138892	"Tubulin tyrosine ligase like 8"	A6PVC2	22	50015123-50056935	"Predicted intracellular proteins"		Ligase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	39	"testis: 4.2"	"Group enriched"	"Detected in some"	42	"Cardiomyocytes: 1.8;Early spermatids: 4.6;Late spermatids: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA016882	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA016882: AB_10603223"								"unprognostic (1.81e-1)"		"unprognostic (1.08e-2)"				"unprognostic (8.18e-2)"	"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"		Ligase	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.4;choroid plexus: 10.3;epididymis: 2.6;fallopian tube: 6.2;testis: 5.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 20.8;Early spermatids: 39.3;Endometrial ciliated cells: 25.8;Late spermatids: 69.8;Oligodendrocytes: 28.0;Respiratory ciliated cells: 50.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Microtubules"		"HPA041772: AB_10959904, HPA055676: AB_2682881"	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.1	0.1	2.0	0.0	2.1	0.0	0.2	2.2	2.2	0.9	10.3	0.0	0.0	0.1	2.6	0.0	6.2	0.1	0.0	2.5	2.3	0.7	0.0	1.1	0.1	3.8	4.4	0.1	0.2	0.6	0.9	0.0	3.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	3.0	0.2	0.0	5.0	2.4	0.0	0.6	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	2.2	2.2	2.5	2.3	3.8	4.4	3.0	3.0	2.4	2.6	0.2	12.8	20.8	13.1	0.1	0.1	1.1	1.1	0.0	1.8	0.4	0.6	0.9	0.0	8.1	0.0	4.2	0.1	0.1	0.0	0.0	0.2	39.3	25.8	0.7	1.1	0.0	0.0	5.6	0.0	0.0	1.6	0.0	0.8	7.6	0.8	0.4	0.1	0.0	5.0	7.8	0.2	2.0	0.6	0.5	69.8	1.5	3.5	0.0	1.0	0.8	0.4	0.0	15.1	28.0	0.1	0.0	1.2	0.0	0.5	0.0	0.2	50.2	0.8	0.0	0.8	0.7	13.8	1.2	0.0	0.1	0.0	2.7	0.4	0.0	0.4
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 167.2;skeletal muscle: 920.6;tongue: 369.5"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.6	0.4	2.7	0.5	2.4	4.3	0.5	2.8	4.9	0.3	0.0	0.4	0.4	0.4	0.2	2.7	0.3	0.7	167.2	1.9	3.4	0.2	0.3	1.2	1.4	11.2	4.4	0.7	1.7	0.0	0.8	0.5	6.6	2.7	0.0	1.9	7.0	0.0	920.6	0.8	0.6	0.0	3.2	0.7	0.4	1.6	4.8	0.7	0.6	369.5	0.4	0.2	0.3	5.3	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	2.7	2.4	2.8	4.9	1.9	3.4	11.2	4.4	6.6	3.2	4.8	5.3	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475874-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 28.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 91.0;HSkMC: 78.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: AB_2685686"	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	8.2	4.4	5.4	5.7	5.5	9.0	5.2	4.7	5.4	6.1	7.1	3.6	3.5	5.0	4.7	5.5	4.9	4.0	2.8	6.3	7.3	4.1	28.7	3.3	8.4	5.2	6.3	4.1	6.4	7.2	7.0	2.8	8.1	4.6	4.0	2.9	5.0	4.3	2.7	12.5	4.0	5.4	3.2	4.6	4.0	3.0	5.2	6.2	7.6	1.7	7.9	5.0	5.3	4.3	21.1	10.8	8.2	14.6	91.0	35.3	8.2	22.4	31.1	21.3	18.1	40.1	12.5	13.1	18.8	20.9	38.8	20.4	10.5	35.2	22.9	13.6	4.8	6.2	11.6	11.8	25.2	9.3	14.1	78.5	22.6	20.9	35.0	10.1	7.3	11.0	8.0	13.4	17.2	24.2	9.1	5.9	9.8	11.4	18.0	2.8	8.8	7.1	8.3	15.0	18.2	8.6	31.1	13.5	14.0	10.1	14.8	6.0	7.5	47.2	18.8	14.2	19.5	19.8	14.5	14.0	22.8	6.6	14.1	0.6	1.1	1.8	4.0	2.2	4.4	3.6	3.6	4.2	1.1	3.8	3.0	4.7	2.6	5.7	2.3	2.0	3.8	2.3	5.4	5.5	4.7	5.4	6.3	7.3	5.2	6.3	8.1	3.2	5.2	4.3	3.9	9.6	11.4	6.2	15.7	6.4	17.2	9.5	1.8	24.4	8.0	5.8	5.3	18.6	10.3	22.0	25.0	7.4	19.8	8.7	1.9	10.2	4.9	8.4	30.5	7.5	9.5	38.9	8.3	9.4	8.6	13.8	2.6	9.3	9.5	8.3	8.2	60.7	4.9	18.5	9.1	5.3	2.0	17.6	6.5	10.3	18.6	6.9	3.6	2.8	8.4	11.5	30.9	8.5	7.1	13.3	9.3	11.3	8.6	14.3	11.0	4.7	8.4	20.3	6.6	16.3	10.1	9.6	11.4	6.1	20.0	10.9	17.9	12.3	9.5	10.9
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"choroid plexus: 142023.1"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 23659.3"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Group enriched"	"Detected in all"	7	"cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1381.8"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	99000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	4.2	0.6	148.5	0.5	56.7	9.6	0.4	621.7	83.7	2.0	142023.1	6.0	14.9	1.3	0.9	2.2	0.8	51.2	2.9	1730.9	37.3	18.4	21288.1	0.8	2.4	106.5	86.0	1.1	1785.1	186.8	6.0	2.7	27.1	1.6	4.5	80.1	1.8	0.4	1.1	15.6	6.8	0.3	12.3	3.8	49.8	2.3	688.2	1.1	1.3	0.0	0.1	2.3	0.6	133.9	1.6	0.4	0.6	0.5	0.8	0.1	1.0	0.8	0.3	0.0	0.0	160.1	0.0	2.9	39.6	0.5	0.6	0.4	0.0	0.3	0.0	5.9	0.8	5.2	1.8	249.0	0.4	11.2	1.0	0.1	0.1	0.1	0.0	0.7	0.0	0.3	2.8	0.4	0.0	0.5	0.4	0.7	0.6	4.5	0.3	0.3	7.4	0.2	0.3	1.6	0.9	1.1	5.8	0.0	0.2	1.7	0.6	0.2	1.7	2.4	57.0	0.5	4.3	1.0	2.6	17.6	0.7	4.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	148.5	56.7	621.7	83.7	1730.9	37.3	106.5	86.0	27.1	12.3	688.2	133.9	0.0	0.0	0.0	0.0	15.1	0.5	0.0	0.0	0.0	144.8	0.0	0.0	1.8	779.2	0.0	5.5	162.6	0.3	0.0	1.5	5.9	3.1	6.8	0.5	0.5	14.1	356.2	192.5	0.0	2.0	3.6	0.7	13.3	0.0	0.0	0.2	192.4	23659.3	2.4	26.9	0.1	19.6	0.0	313.7	0.0	8.7	0.3	1.2	0.0	0.0	0.0	24.9	0.0	0.0	0.0	130.5	5.2	0.0	0.0	0.2	1.3	26.9	0.0	56.0	0.0	0.0	0.3	3.3	1.1	0.0	0.1	4.0	10.9	0.0	1.7	0.0
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436904	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 80.9;choroid plexus: 35.6;testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005725, HPA023617, HPA050655"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	0.9	0.9	64.3	0.0	67.9	0.0	3.5	64.0	80.9	4.0	35.6	10.0	0.2	1.6	0.0	1.1	10.4	0.2	3.6	57.6	59.7	1.2	0.7	0.2	0.0	69.4	66.5	1.5	19.4	0.0	17.7	0.0	63.5	3.5	0.0	3.2	3.6	0.4	3.3	5.9	2.6	0.0	67.6	1.4	2.5	53.4	69.3	0.0	0.3	0.0	0.0	1.7	4.2	66.8	0.1	0.0	7.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.3	67.9	64.0	80.9	57.6	59.7	69.4	66.5	63.5	67.6	69.3	66.8	0.4	3.2	0.6	257.6	0.4	0.8	1.2	0.6	0.0	138.6	44.3	42.2	1.3	4.3	3.0	0.0	20.9	0.9	1.3	0.2	0.0	30.4	3.9	0.3	0.9	2.8	1.2	0.0	26.4	0.6	0.7	1.5	0.0	0.7	0.0	13.7	0.7	0.1	0.3	10.1	3.3	0.0	0.0	0.0	1.5	4.8	1.8	0.3	23.2	19.7	0.3	653.4	0.0	48.2	97.5	2.2	0.0	0.7	0.1	1.9	0.4	0.7	2.8	155.3	6.6	2.3	7.8	2.2	5.1	0.0	0.9	4.2	0.6	0.5	0.3	1.9
TTYH3	KIAA1691	ENSG00000136295	"Tweety family member 3"	Q9C0H2	7	2631986-2664802	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.0;Kupffer cells: 85.0;Melanocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 10.0;non-classical monocyte: 8.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.0"	"Cell line enhanced"	"Detected in all"		"U-2 OS: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053520	Uncertain					NA	NA		55000	"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"			"HPA053520: AB_2682176"	"unprognostic (2.53e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (2.53e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (7.90e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.85e-2)"	25.6	29.4	31.6	30.7	32.7	11.8	16.3	43.3	39.3	19.0	1.8	15.8	19.9	18.7	1.9	7.7	16.7	18.3	12.4	24.1	8.9	43.3	37.4	25.6	19.4	11.4	18.4	15.0	9.6	4.6	14.2	23.8	9.0	20.9	6.7	5.3	25.4	7.3	3.9	12.0	27.7	10.6	4.7	40.8	13.3	14.4	33.8	11.7	21.6	1.7	7.3	14.6	11.4	10.7	43.8	84.9	88.0	123.7	24.2	21.7	98.5	69.4	61.8	29.8	34.9	35.3	30.9	3.6	82.4	66.1	78.8	19.3	12.7	31.5	8.4	5.9	42.9	21.8	17.9	98.7	32.3	4.5	13.2	52.0	15.1	32.0	8.3	55.5	99.4	21.6	6.7	4.7	20.1	25.5	16.1	47.0	112.7	61.7	32.9	66.3	63.7	4.1	47.0	47.0	36.8	185.1	42.8	8.2	40.3	58.1	22.3	117.5	117.9	69.3	205.4	40.9	78.6	8.0	5.3	12.1	50.0	16.1	152.7	0.0	4.9	1.5	0.2	10.0	0.2	0.3	0.1	0.1	2.2	0.3	0.3	0.0	0.5	0.3	8.4	1.0	0.2	3.4	31.6	32.7	43.3	39.3	24.1	8.9	11.4	18.4	9.0	4.7	33.8	10.7	8.6	0.0	4.2	38.5	4.8	6.5	1.8	12.9	2.2	9.0	10.2	7.1	2.7	18.6	8.8	9.2	4.2	1.8	2.9	9.6	3.9	20.3	0.5	2.8	12.8	21.0	7.8	1.7	22.4	5.2	28.8	9.0	7.1	6.0	2.5	19.4	15.4	21.1	135.0	30.3	25.4	20.5	8.2	85.0	32.6	5.2	8.1	52.4	56.9	17.8	30.7	4.0	2.1	8.5	6.1	20.2	2.7	3.8	1.5	5.0	28.3	32.2	3.8	2.2	6.6	2.2	8.0	1.7	2.3	1.2	3.7	2.5	3.8	4.9	11.2	3.1
TUB	rd5	ENSG00000166402	"TUB bipartite transcription factor"	P50607	11	8019244-8106243	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1;retina: 82.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 41.7;Excitatory neurons: 34.6;Horizontal cells: 30.3;Inhibitory neurons: 23.2;Oligodendrocyte precursor cells: 23.1;Rod photoreceptor cells: 55.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.8;HEK 293: 33.7;HeLa: 54.3;SCLC-21H: 51.0;SH-SY5Y: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017997, HPA049019"	Enhanced		Approved	"Nucleoli,Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Centriolar satellite"	Nucleoli	"HPA017997: AB_1858449, HPA049019: AB_2680601"	"unprognostic (2.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.35e-5)"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-2)"	7.1	17.3	25.5	2.5	26.2	0.2	6.6	14.4	25.1	26.5	2.5	8.1	2.0	24.4	10.3	3.2	19.8	4.7	12.6	35.9	31.4	11.4	0.9	3.9	1.9	18.6	79.1	18.2	4.6	13.7	31.7	4.3	30.8	8.6	2.3	82.6	5.3	8.1	2.9	6.4	3.9	11.3	18.0	1.7	3.7	5.0	27.5	2.5	10.8	8.2	0.9	11.0	13.9	16.4	0.0	9.8	14.2	16.7	13.2	4.3	0.0	9.4	2.5	9.9	13.2	0.0	0.1	0.0	0.8	13.2	4.6	0.1	26.8	2.0	9.2	0.0	33.7	0.0	54.3	6.1	2.2	0.0	0.4	6.8	2.4	4.7	0.0	0.8	0.9	15.7	0.0	0.1	4.8	1.4	0.1	0.1	9.4	0.0	0.1	12.6	0.2	0.0	0.0	0.5	51.0	38.1	6.9	0.1	2.6	6.3	1.4	0.2	0.0	5.4	12.5	0.9	3.9	0.1	0.0	0.0	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	26.2	14.4	25.1	35.9	31.4	18.6	79.1	30.8	18.0	27.5	16.4	0.5	0.0	0.0	15.0	0.0	0.8	2.0	0.1	1.2	15.5	0.8	1.9	3.5	1.5	0.7	0.0	41.7	0.2	0.1	0.0	5.9	0.1	4.2	4.4	14.1	0.5	1.8	0.0	34.6	0.0	0.4	6.8	0.0	0.4	1.3	10.1	1.4	0.2	0.2	30.3	23.2	0.0	0.0	0.0	0.7	4.9	14.6	0.2	1.8	8.4	0.0	12.6	0.0	23.1	1.9	0.0	0.0	14.7	0.1	1.5	0.0	10.2	5.1	55.6	0.0	6.8	1.5	1.6	1.4	0.2	0.9	0.0	0.5	0.5	0.0	0.4
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184686-49189080	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1313.3"	"Cell type enhanced"	"Detected in all"		"Ductal cells: 1162.0;Respiratory ciliated cells: 1173.3;Smooth muscle cells: 1005.3"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1660.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 3100.7;SCLC-21H: 1983.9"	"Low region specificity"	"Detected in all"							"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	150.3	133.5	803.3	166.9	990.4	152.0	179.7	1083.4	882.6	185.8	692.7	466.4	54.4	406.3	166.6	140.0	342.0	193.1	156.5	784.4	1066.9	64.9	21.1	214.3	71.7	1209.8	1002.4	172.8	53.5	79.1	163.4	123.9	1136.6	173.4	126.5	259.7	104.7	267.3	37.4	107.9	125.9	865.4	1083.5	84.7	135.6	69.0	987.8	162.7	39.7	94.1	55.9	210.1	117.1	1313.3	3.2	154.4	3100.7	419.3	263.1	613.9	10.5	286.4	325.6	163.2	390.4	9.4	54.8	120.7	322.4	824.7	304.0	6.4	388.0	97.3	120.3	97.0	138.1	41.5	27.6	34.4	54.1	70.2	3.2	359.5	33.8	325.0	31.8	627.1	945.9	237.2	45.0	124.5	888.7	70.3	276.5	59.2	335.0	3.6	112.5	225.4	232.3	14.1	718.9	13.8	1983.9	1150.3	79.1	4.5	106.0	449.9	210.4	97.3	929.1	178.6	108.5	21.2	80.5	41.5	126.9	234.2	93.8	117.2	191.6	503.5	260.5	824.7	159.0	554.9	118.1	158.2	140.0	146.7	314.0	166.9	134.2	125.2	1660.9	89.9	812.8	101.1	172.8	495.5	803.3	990.4	1083.4	882.6	784.4	1066.9	1209.8	1002.4	1136.6	1083.5	987.8	1313.3	296.9	230.8	181.5	49.9	220.8	87.2	250.6	179.3	59.7	233.0	140.0	291.6	187.9	25.8	148.1	64.4	77.2	10.5	202.9	4.5	25.4	1162.0	10.0	414.9	413.6	334.2	785.8	48.0	78.2	16.2	12.8	391.5	63.2	102.4	547.9	695.0	165.6	2.8	452.0	249.0	60.6	15.5	329.6	80.7	277.6	20.7	193.6	204.2	183.2	37.5	616.6	788.9	77.2	73.4	432.6	333.3	12.8	142.6	32.5	60.4	1.5	73.3	1173.3	349.6	164.3	542.7	1005.3	15.4	31.2	20.9	99.3	15.9	266.5	40.6	12.4	95.7
TUBA1B	K-ALPHA-1	ENSG00000123416	"Tubulin alpha 1b"	P68363	12	49127782-49131397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 2143.3;Extravillous trophoblasts: 2555.5;Hofbauer cells: 2114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011513, HPA039247, HPA043684, HPA063394"	Enhanced		Supported	Microtubules		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules		"CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (5.49e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (2.98e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.85e-12)"	"unprognostic (1.60e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.55e-3)"	531.9	319.3	1071.9	650.0	1115.9	1491.9	453.7	941.8	1318.4	306.5	841.2	598.4	279.4	460.5	403.7	550.9	369.1	305.6	509.3	1108.8	1139.4	310.3	233.9	511.3	750.8	1176.0	1108.8	325.9	179.9	262.6	322.2	582.9	1162.2	247.8	665.1	652.9	304.6	394.1	243.9	404.3	352.5	1004.6	993.4	435.8	355.7	322.7	1127.4	1557.3	267.3	242.0	882.3	639.5	339.4	1076.7	3063.5	3381.9	3587.5	2051.4	910.0	1321.7	1939.2	2635.0	2642.5	5018.6	4034.6	4300.0	3144.6	3430.1	1854.8	3732.5	2047.5	1864.3	3993.2	3609.1	4586.7	1938.3	2103.5	2445.9	1822.2	2219.9	251.5	3705.8	1863.3	793.6	540.2	3930.9	1298.9	1697.4	4353.5	3121.3	2788.0	2182.3	4142.7	3362.1	4985.5	2943.8	2504.9	7570.8	3944.4	3980.1	3023.6	2137.4	2377.1	2008.1	2250.7	1921.9	2211.7	1697.3	803.9	1804.3	2403.1	3624.8	2321.3	2393.9	2752.4	2404.5	3470.2	1196.5	1876.2	3685.5	1668.2	2924.3	2303.6	197.9	240.0	411.5	241.8	1022.1	266.7	268.9	230.1	225.3	632.4	239.6	241.0	192.4	271.6	230.9	1107.4	632.0	293.2	731.1	1071.9	1115.9	941.8	1318.4	1108.8	1139.4	1176.0	1108.8	1162.2	993.4	1127.4	1076.7	702.9	198.7	231.8	36.6	445.8	584.0	653.7	875.4	288.5	426.4	267.9	391.8	0.8	90.1	373.4	187.6	492.1	1143.1	514.2	482.6	361.9	814.5	272.5	189.3	218.3	643.9	303.7	2143.3	201.8	630.1	2555.5	603.4	237.0	203.9	542.8	1069.6	353.4	106.3	2114.8	498.0	99.1	508.1	512.7	361.8	1353.1	204.8	326.8	729.8	473.2	68.4	1248.5	455.7	228.6	34.7	82.7	703.3	298.4	236.6	595.9	373.5	240.0	245.1	287.7	970.8	263.0	321.5	957.4	161.6	488.9	560.6	449.8	304.4	480.3	172.4	551.2	539.1
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274600	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 479.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 98.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 4114.3"	"Low region specificity"	"Detected in all"							"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules		NA	Yes		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (8.48e-8)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	92.6	57.8	12.4	110.5	12.1	148.8	54.7	13.9	18.0	101.0	41.9	158.2	106.9	59.6	62.7	479.4	50.8	92.1	55.3	12.8	16.4	113.5	69.3	74.1	78.6	15.7	14.1	38.3	52.6	22.5	28.0	109.9	15.5	43.7	156.5	2.5	139.0	46.4	45.3	166.1	117.6	129.8	15.7	42.1	115.2	26.3	22.6	103.3	56.3	42.5	170.7	222.5	168.8	15.4	1295.3	987.5	211.7	363.9	220.5	368.4	816.3	1010.1	1126.1	1742.1	927.3	966.9	947.0	578.9	1053.2	1194.2	1047.3	580.5	1246.0	1412.1	1150.2	564.1	449.7	703.4	406.7	943.7	165.2	550.9	498.4	269.8	663.0	1485.6	619.9	550.6	1139.5	320.6	1026.8	308.3	1521.8	811.1	306.5	535.8	639.6	4114.3	1928.6	344.0	414.5	319.7	770.3	602.8	169.8	9.1	875.5	574.4	386.0	828.3	559.4	426.0	835.1	819.3	911.5	821.9	1717.4	101.6	306.5	565.2	431.6	536.1	725.9	98.8	14.6	29.9	12.3	17.3	19.7	10.5	13.1	11.7	27.0	7.4	7.0	7.9	12.2	13.6	13.1	21.6	17.6	20.8	12.4	12.1	13.9	18.0	12.8	16.4	15.7	14.1	15.5	15.7	22.6	15.4	94.3	118.6	136.1	2.6	54.9	194.5	354.2	317.7	306.7	1.3	61.3	75.8	0.9	45.8	150.9	58.8	0.0	291.9	50.1	432.7	70.5	285.8	7.9	107.7	65.8	83.0	77.5	155.5	2.1	559.2	1118.2	109.7	153.4	204.4	67.2	110.8	39.3	55.9	276.8	0.0	1.9	190.5	101.7	65.6	121.7	8.4	68.0	163.3	46.2	2.8	265.5	2.8	6.2	1.0	1.4	465.6	330.2	40.6	71.0	206.3	234.1	137.1	51.9	0.6	39.5	84.3	258.2	9.0	65.5	530.8	183.1	161.6	77.6	46.1	187.9	293.4
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 404.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	404.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
TUBA3D	H2-ALPHA	ENSG00000075886	"Tubulin alpha 3d"	P0DPH8	2	131476119-131482934	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 86.2;testis: 220.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 358.9;Late spermatids: 119.6;Spermatocytes: 667.9;Spermatogonia: 326.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"							"CAB004972, HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules		"CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic favorable (4.65e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (4.75e-9)"	"unprognostic (4.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.96e-4)"	"unprognostic (2.28e-1)"	0.1	0.1	0.4	0.2	0.3	0.4	0.6	1.6	0.4	2.8	0.0	0.1	0.1	4.8	6.8	0.2	4.0	0.2	86.2	0.6	0.2	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	10.1	0.0	0.3	0.3	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.2	220.2	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	0.9	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.1	0.6	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.5	0.5	1.1	0.7	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.4	0.5	0.3	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.6	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.9	0.4	1.1	1.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	119.6	12.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	4.8	0.0	0.0	0.0	0.0	52.6	0.0	0.1	667.9	326.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUBA3E		ENSG00000152086	"Tubulin alpha 3e"	Q6PEY2	2	130191745-130198439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"heart muscle: 53.3;testis: 175.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 259.8;Late spermatids: 109.4;Spermatocytes: 415.4;Spermatogonia: 172.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 4.2;U-2 OS: 2.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.02e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.65e-7)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.94e-3)"	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	1.7	0.0	0.0	0.0	3.9	0.4	0.0	2.5	0.0	53.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	175.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.4	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.1	415.4	172.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219278170	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 360.2;tongue: 210.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 265.9;HBEC3-KT: 439.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		130000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	14.3	41.4	33.6	34.1	47.5	107.1	16.4	22.3	133.1	27.7	8.1	32.9	18.6	9.8	10.1	84.8	12.6	13.5	97.7	42.6	32.3	31.9	29.5	26.7	56.7	46.3	27.3	12.9	18.2	34.6	23.1	5.0	31.4	19.7	27.8	39.2	46.9	22.4	360.2	161.4	35.5	12.8	3.9	56.8	30.6	32.4	14.9	16.9	12.3	210.3	63.4	22.6	57.3	54.0	106.0	90.0	0.0	0.3	9.1	6.9	0.3	16.2	49.7	2.8	1.9	20.4	106.7	144.2	172.2	11.7	172.7	265.9	49.3	439.9	3.9	81.7	0.7	184.2	154.5	15.4	7.3	60.9	60.8	6.7	158.0	23.7	49.2	27.4	17.3	2.4	20.5	91.3	100.6	4.3	0.3	107.9	32.3	83.2	107.4	6.5	139.0	84.5	129.7	7.5	85.8	1.5	213.2	18.7	0.7	1.8	8.0	50.9	12.3	49.8	27.4	58.4	56.7	38.0	48.8	171.4	183.3	116.4	2.5	141.7	63.3	170.2	107.1	45.7	110.1	124.9	150.3	142.8	20.9	95.5	140.2	138.4	331.2	82.0	71.9	3.8	143.8	270.9	33.6	47.5	22.3	133.1	42.6	32.3	46.3	27.3	31.4	3.9	14.9	54.0	55.3	44.8	47.1	16.3	160.6	181.8	201.2	235.3	68.9	123.3	42.3	51.6	60.9	28.6	62.0	49.7	77.2	0.7	311.6	87.3	140.8	199.3	423.0	9.8	3.3	36.5	107.9	56.2	34.8	205.6	0.5	11.5	40.8	26.1	15.8	0.1	36.0	33.0	6.0	67.3	22.5	141.9	48.8	15.3	54.9	823.0	16.8	159.5	78.2	9.4	27.8	38.6	50.4	10.6	10.6	613.5	51.2	7.5	202.3	46.7	87.5	137.5	11.1	72.9	0.0	21.1	408.5	5.7	5.0	130.6	244.5	2.5	290.1	1.4	58.9	113.0
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110100-18146683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 5.0;NK-cells: 10.4"	"Group enriched"	"Detected in many"	5	"NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3"	"Group enriched"	"Detected in all"	4	"cerebellum: 54.7;olfactory bulb: 53.9"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		NA	NA		80000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	7.3	1.9	9.0	1.0	11.8	4.7	7.2	24.3	16.3	2.5	0.8	2.0	0.8	2.7	6.3	4.3	4.8	1.0	128.9	15.0	2.8	2.3	4.3	2.4	3.5	0.6	9.0	2.3	4.4	2.7	14.5	0.6	0.8	2.5	0.5	2.8	4.4	0.6	332.2	4.4	2.6	0.7	1.5	4.2	4.7	52.3	11.5	0.8	6.5	154.7	1.0	2.0	2.2	12.5	0.6	1.1	1.2	1.4	1.8	0.5	0.4	0.6	0.3	1.4	0.8	0.9	1.1	0.9	2.2	0.7	0.4	0.6	2.2	0.4	0.3	0.8	1.6	2.2	1.7	0.9	1.0	1.0	1.0	0.7	0.8	0.8	0.6	0.5	2.0	0.9	0.6	0.9	0.6	3.4	1.0	30.2	1.0	0.5	0.5	0.9	0.5	0.2	0.7	1.1	10.9	1.1	0.6	1.9	1.0	0.5	0.6	4.8	36.3	0.9	1.0	1.0	0.4	2.2	1.3	0.7	0.9	1.4	0.6	2.8	0.7	2.7	0.5	0.6	0.7	0.4	0.4	0.3	0.4	0.6	0.7	0.4	5.0	10.4	0.4	1.0	0.8	17.1	9.0	11.8	24.3	16.3	15.0	2.8	0.6	9.0	0.8	1.5	11.5	12.5	0.2	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	4.7	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.3	16.4	0.2	0.1	0.4	0.0	0.0	8.1	1.1	0.0	0.3	0.0	0.2	2.5	0.1	0.7	0.0	0.1	3.3	5.6	0.0	0.0	0.3	0.0	22.9	0.3	0.1	0.0	0.0	0.2	0.1	1.0	3.5	1.7	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.2	6.6	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393101-5404828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 28.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 19.8;Proximal enterocytes: 19.7"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 13.3;JURKAT: 7.7;K-562: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045900, HPA063394"	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.1	0.0	0.4	0.5	0.3	0.1	0.4	0.4	0.6	0.1	1.4	11.9	24.3	0.0	0.0	0.3	0.2	0.1	0.7	0.3	0.4	5.8	0.0	0.2	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.1	10.8	0.0	0.8	0.0	0.1	0.3	28.3	0.3	0.6	0.0	0.2	1.0	0.8	0.3	0.0	1.4	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	13.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	0.4	0.8	0.5	0.9	0.6	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	19.7	4.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.4	0.1
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153497-3157544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 364.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;monocytes: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in all"		"AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	58.8	17.8	266.1	19.3	251.1	67.5	47.8	130.1	287.5	32.7	10.0	78.0	24.2	50.8	28.0	90.6	23.5	21.5	29.4	248.3	364.3	31.1	67.0	16.4	11.0	292.6	212.2	15.5	39.4	2.2	56.3	23.9	334.3	17.5	8.2	49.9	52.2	15.6	22.3	151.4	34.9	41.7	131.6	7.7	41.0	9.5	204.4	6.4	10.0	11.8	9.6	23.6	51.2	169.4	55.9	45.3	241.1	53.6	30.6	34.0	14.5	119.8	44.7	80.6	115.7	247.6	18.4	27.4	72.9	115.5	80.2	26.0	86.6	26.8	28.0	134.1	57.7	9.4	11.4	77.0	31.6	1.5	8.4	35.1	31.1	85.1	5.3	28.9	37.3	10.6	33.7	8.8	74.2	25.1	14.9	2.8	207.2	16.0	58.3	12.4	22.6	18.9	28.0	27.4	57.6	52.9	30.5	8.5	179.7	365.5	19.1	2.0	76.0	53.9	56.7	117.3	65.8	3.2	4.6	18.8	19.7	7.0	280.1	0.0	1.1	0.0	2.2	1.6	2.4	3.2	2.1	3.1	0.5	0.6	1.0	2.0	0.3	0.4	1.3	0.2	3.2	1.2	266.1	251.1	130.1	287.5	248.3	364.3	292.6	212.2	334.3	131.6	204.4	169.4	125.3	16.0	13.1	43.1	31.6	311.4	63.3	87.0	132.6	105.6	32.0	134.6	20.4	42.9	62.7	12.9	16.7	6.0	53.4	87.0	217.2	54.0	60.9	46.7	29.6	40.6	73.1	322.3	59.9	182.4	50.4	96.2	185.0	57.9	34.9	10.1	12.5	55.6	50.8	516.5	73.0	103.9	73.2	6.3	164.4	32.9	20.8	36.7	129.9	24.4	72.7	261.0	0.0	18.1	23.0	103.4	181.8	15.4	15.8	34.9	126.3	40.4	50.3	86.2	6.6	95.6	87.9	32.4	14.9	140.6	368.5	6.2	58.9	6.4	60.0	54.7
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 313.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8"					"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		89000000	"Cluster 24: B-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.7	24.8	99.4	12.1	93.3	3.4	2.1	100.5	127.6	3.3	0.0	18.4	3.7	9.7	0.2	3.6	2.3	8.8	5.5	88.6	313.3	13.3	0.9	4.1	7.1	208.8	132.7	3.9	3.2	0.4	55.1	1.8	266.2	3.0	2.6	24.8	10.6	0.4	0.6	5.2	8.0	12.7	74.2	1.3	7.2	38.0	183.4	1.0	2.5	0.3	5.2	7.3	5.3	82.5	30.1	421.3	152.6	173.9	17.9	170.8	6.8	181.0	31.0	105.8	48.2	57.2	53.5	89.6	93.6	136.8	74.3	112.1	148.9	26.7	26.3	22.7	15.5	0.7	32.5	383.7	6.0	0.0	67.6	98.4	7.9	161.9	14.0	136.8	88.4	5.9	9.2	2.5	122.3	288.6	1.2	31.5	274.3	11.2	237.3	0.1	54.1	9.5	131.8	8.1	424.9	433.8	251.2	4.4	137.1	27.5	15.0	1.9	110.9	142.8	156.9	197.3	185.3	1.4	19.6	35.2	150.2	11.5	260.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	99.4	93.3	100.5	127.6	88.6	313.3	208.8	132.7	266.2	74.2	183.4	82.5	0.4	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.4	1.8	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	28.7	8.2	0.5	2.6	3.8	4.9	0.0	37.9	21.4	0.7	6.1	27.0	0.7	0.0	0.0	0.0	0.0	0.2	5.0	45.1	0.1	0.0	0.0	0.0	16.8	0.3	0.2	0.0	9.4	0.0	0.3	0.0	16.1	9.2	49.2	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.1	0.2	0.4	3.0	0.0	1.0	0.1	0.0	0.2	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	134.5	112.6	162.0	97.2	163.4	423.9	94.4	149.4	182.7	88.1	482.7	198.3	142.0	107.7	209.1	343.3	507.2	106.0	435.8	174.0	185.2	122.5	140.1	130.5	95.5	184.1	233.6	72.9	123.8	87.8	118.0	86.3	213.9	120.2	111.9	261.8	177.9	121.5	202.5	240.0	166.4	119.8	162.9	85.6	161.4	765.7	192.6	162.9	115.7	96.6	119.7	188.3	139.4	133.9	706.2	1032.5	431.7	314.2	213.2	223.6	600.5	643.7	536.0	872.4	598.6	1101.0	840.2	429.0	480.2	631.2	848.2	1305.1	539.5	1039.2	330.2	307.9	458.5	311.2	789.6	877.8	134.5	370.0	331.5	145.0	291.5	667.5	183.1	215.7	631.7	300.6	443.0	239.7	731.2	1936.4	337.4	504.2	457.8	1234.8	1778.1	423.5	822.2	394.2	666.8	647.8	301.5	323.6	853.9	485.8	173.2	244.2	699.0	397.6	495.6	618.1	685.0	710.0	863.6	92.4	274.9	475.1	503.6	286.9	549.8	95.7	30.0	43.2	40.5	30.1	38.2	32.6	31.3	34.4	34.9	30.8	19.7	26.7	56.4	24.4	30.5	36.3	44.7	32.6	162.0	163.4	149.4	182.7	174.0	185.2	184.1	233.6	213.9	162.9	192.6	133.9	478.5	221.2	146.3	21.5	315.8	326.2	945.7	458.7	327.2	508.1	286.9	389.5	91.9	143.0	284.1	143.5	300.3	346.6	640.9	744.1	221.1	348.6	2190.0	1191.6	224.8	203.9	391.5	419.9	30.1	446.8	545.5	247.8	274.7	415.0	189.2	200.9	142.5	139.2	265.9	244.0	24.3	503.6	323.5	59.9	214.9	2907.1	254.2	299.3	138.7	22.5	224.0	299.3	49.4	15.6	19.7	477.4	697.2	153.1	264.0	475.1	540.7	345.5	1558.7	763.3	111.7	261.8	416.0	1717.5	740.9	419.1	297.6	321.1	362.9	89.8	487.3	592.7
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
TUBB8B	TUBB8P12	ENSG00000173213	"Tubulin beta 8B"	A6NNZ2	18	47390-49557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA							Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.42e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859479-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	4.4	4.4	5.8	4.9	6.9	3.9	7.0	9.2	7.4	7.5	5.0	7.5	3.8	5.5	9.1	10.6	6.5	4.6	6.0	5.9	6.3	6.2	5.9	5.1	6.7	6.7	6.9	9.0	7.8	5.9	6.9	4.2	7.0	7.8	4.7	5.6	7.0	6.2	6.5	6.8	4.8	4.3	6.3	5.8	6.4	5.5	6.2	8.2	7.3	7.7	8.3	6.4	8.3	8.9	11.7	15.8	12.2	12.8	6.8	4.9	9.7	9.1	5.3	11.7	9.5	17.0	7.5	10.5	15.0	2.1	7.9	9.7	17.4	5.4	11.1	6.1	21.2	12.6	12.4	20.4	3.6	7.6	6.4	2.7	8.3	10.1	3.5	4.0	9.4	10.3	27.5	7.1	4.0	83.1	15.6	8.5	10.8	13.0	6.9	16.1	17.9	16.2	5.0	4.8	11.3	6.8	6.4	4.9	6.5	14.5	11.8	7.2	3.0	8.4	18.3	5.9	9.8	8.3	13.7	16.2	4.0	8.3	7.5	6.5	8.4	16.3	11.4	5.8	13.2	11.7	14.0	12.1	5.9	8.9	18.1	14.8	8.8	10.1	6.5	9.9	16.7	7.1	5.8	6.9	9.2	7.4	5.9	6.3	6.7	6.9	7.0	6.3	6.2	8.9	8.3	12.8	36.1	10.7	16.9	15.7	14.4	9.1	10.8	7.6	10.9	11.3	5.3	5.7	17.6	3.7	6.2	6.3	9.4	3.2	11.7	5.7	1.7	9.2	8.5	9.4	10.3	13.9	9.2	4.8	7.4	9.6	4.1	16.3	11.4	9.9	8.9	3.8	4.0	3.3	9.5	5.5	8.2	4.7	7.1	0.8	5.6	6.9	7.2	9.4	6.0	10.3	13.4	8.5	18.4	3.7	7.5	8.2	10.9	12.5	3.6	3.6	9.4	8.6	6.6	13.3	9.6	14.7	24.2	10.6	16.9	4.0	16.2	2.6	4.9	6.8
TUBE1	"dJ142L7.2, FLJ22589, TUBE"	ENSG00000074935	"Tubulin epsilon 1"	Q9UJT0	6	112070663-112087529	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 199.6;Spermatocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 48.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032073, HPA032074"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA032073: AB_10601773, HPA032074: AB_10601216"	"unprognostic (4.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-3)"	12.3	9.0	9.8	5.0	10.1	4.1	11.0	11.7	16.8	15.6	9.9	11.8	5.0	17.0	8.3	6.8	16.4	8.8	17.5	9.7	10.0	12.3	40.1	7.9	7.3	10.4	10.2	15.2	10.9	7.5	14.4	9.1	10.4	11.0	6.2	10.1	6.7	8.4	5.8	11.3	7.6	10.3	10.2	6.9	11.7	27.1	10.1	4.8	10.6	4.8	5.4	12.6	10.4	11.4	2.1	2.8	7.6	24.0	17.5	9.2	6.3	8.6	13.7	5.9	11.6	4.2	4.2	8.0	5.4	3.6	9.2	6.4	8.7	3.8	12.2	4.1	7.8	2.8	2.0	6.1	25.0	15.4	10.1	10.0	25.1	8.1	20.9	8.5	7.4	22.8	15.6	10.8	4.8	1.7	8.8	20.5	7.6	12.1	5.2	10.3	4.7	5.2	9.0	2.0	11.5	10.1	7.0	6.0	26.4	6.6	4.8	36.5	4.3	5.3	4.9	48.2	9.2	3.2	1.1	8.7	7.7	18.2	13.8	0.0	0.4	1.1	1.1	0.5	3.3	1.5	2.4	1.5	0.8	1.1	3.2	2.7	0.3	1.8	0.8	0.6	2.5	0.9	9.8	10.1	11.7	16.8	9.7	10.0	10.4	10.2	10.4	10.2	10.1	11.4	27.6	6.4	16.7	25.8	13.4	24.6	17.8	12.3	15.4	23.0	15.0	13.3	17.5	11.5	13.5	22.0	35.5	4.1	9.8	6.8	15.6	12.5	199.6	12.1	12.0	16.7	6.1	19.1	58.2	18.0	12.3	18.8	7.7	7.7	16.5	11.5	18.5	71.9	7.2	13.5	68.3	11.4	4.1	6.7	10.2	49.8	15.5	6.2	7.2	21.5	4.6	11.8	9.2	31.7	82.0	12.6	9.0	19.9	10.9	13.2	12.7	25.6	14.6	28.0	19.7	13.3	13.4	97.0	27.0	12.7	12.5	3.3	14.8	35.0	8.0	14.8
TUBG1	"TUBG, TUBGCP1"	ENSG00000131462	"Tubulin gamma 1"	P23258	17	42609641-42615238	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 173.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 670.6;Erythroid cells: 286.9;Late spermatids: 560.5;Spermatocytes: 347.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004608	Enhanced					NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"			"CAB004608: AB_628417"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.08e-8)"	"unprognostic (2.62e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.48e-5)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.97e-2)"	23.0	30.4	17.7	20.4	18.4	51.7	19.0	17.8	25.4	17.6	21.1	24.0	16.6	20.7	13.4	35.6	16.3	10.1	43.6	18.5	19.8	24.8	27.1	19.1	18.0	20.3	18.0	12.5	48.7	29.9	20.2	21.0	20.0	19.7	14.9	10.5	19.1	18.3	60.7	29.0	18.1	27.2	15.9	19.3	29.8	173.8	21.4	27.6	14.8	36.3	20.6	21.7	19.9	19.7	117.8	288.8	112.1	124.0	70.5	47.8	97.7	133.4	87.2	205.6	158.8	177.4	76.9	80.2	92.8	105.9	178.5	171.9	124.2	178.0	149.7	225.9	142.6	64.1	168.5	299.3	34.6	73.8	87.6	38.1	54.0	251.1	75.8	50.6	131.9	119.0	119.7	77.2	155.9	326.7	176.3	66.2	59.3	176.7	139.1	81.8	164.2	130.5	91.7	136.6	158.9	74.5	78.0	76.9	63.6	113.9	233.6	70.2	88.5	197.9	131.0	169.2	207.0	111.2	169.0	126.2	108.6	70.6	144.2	1.7	13.1	3.1	10.6	25.1	11.6	14.9	9.8	11.4	15.7	15.0	10.4	10.5	0.4	12.7	27.4	44.1	13.5	10.4	17.7	18.4	17.8	25.4	18.5	19.8	20.3	18.0	20.0	15.9	21.4	19.7	14.9	16.0	4.2	3.9	12.8	17.6	16.3	49.4	12.0	14.1	14.6	16.5	18.8	14.3	24.1	7.3	4.2	45.8	7.0	10.2	39.2	35.2	670.6	15.1	13.7	20.1	9.6	286.9	7.2	54.4	78.6	15.7	15.8	10.7	2.5	16.9	15.7	15.9	40.2	20.2	6.4	13.7	38.7	6.3	10.8	560.5	22.7	9.7	17.8	8.4	26.4	17.7	10.3	4.0	3.8	42.3	6.2	21.8	41.5	15.2	15.1	76.6	18.1	10.9	59.2	7.1	43.5	347.8	128.0	27.3	28.6	20.1	8.5	15.0	14.0	15.6
TUBG2		ENSG00000037042	"Tubulin gamma 2"	Q9NRH3	17	42659284-42667006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							CAB011495	Approved		Supported	"Centriolar satellite"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Centriolar satellite"		"CAB011495: AB_443396"	"unprognostic (2.60e-1)"	"unprognostic (5.85e-3)"	"unprognostic (6.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (4.68e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.61e-3)"	20.7	38.8	87.1	6.4	94.1	3.0	21.3	78.1	109.1	38.5	67.3	34.2	6.1	28.2	14.6	13.8	28.6	10.9	24.3	87.8	81.6	35.1	18.1	18.6	7.8	90.0	84.4	28.2	76.0	18.2	43.8	9.6	88.1	33.7	5.4	13.9	17.0	22.9	8.8	13.5	14.4	14.3	76.4	17.0	30.5	19.1	94.3	5.8	23.7	9.0	5.5	33.1	31.4	99.3	10.2	20.2	9.9	14.6	38.4	20.8	6.4	17.7	19.8	13.8	13.7	11.4	7.0	5.0	10.6	25.6	14.8	36.8	0.0	16.1	11.3	9.9	11.5	3.8	29.0	23.3	16.6	0.0	13.0	22.7	16.1	15.7	17.5	24.0	10.1	11.4	1.1	10.8	27.3	20.9	9.8	8.2	3.5	10.1	5.1	7.5	6.2	11.3	15.0	10.4	11.2	7.6	11.3	18.0	12.1	17.7	34.7	4.8	11.7	43.9	3.1	11.0	10.3	56.5	10.8	1.5	15.6	0.0	26.3	0.0	0.9	0.2	3.0	0.5	1.4	1.2	3.3	1.1	0.9	0.5	3.5	2.3	0.2	1.0	0.1	4.5	1.6	1.8	87.1	94.1	78.1	109.1	87.8	81.6	90.0	84.4	88.1	76.4	94.3	99.3	6.9	3.2	4.2	22.9	3.6	5.5	15.9	7.8	36.5	17.6	9.6	13.7	11.3	4.3	5.6	3.7	4.2	5.5	3.0	0.5	17.6	5.1	7.7	1.8	7.9	7.3	1.2	24.4	44.9	9.1	4.2	13.4	14.3	1.9	11.4	6.7	9.3	3.7	3.6	20.2	33.1	1.7	2.0	2.5	3.7	11.1	17.4	2.8	16.0	10.3	3.1	7.8	1.0	19.6	25.8	5.1	0.4	21.4	9.7	5.2	0.1	24.3	7.1	5.4	13.1	10.3	11.4	5.1	5.0	9.4	4.0	2.5	3.9	7.9	0.5	7.3
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278635-133312337	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.0	22.2	14.4	20.9	15.4	35.0	13.4	13.5	19.3	15.7	18.2	18.2	22.1	16.0	10.5	17.3	30.3	14.9	20.4	14.8	14.1	19.3	16.4	17.3	20.9	17.1	15.2	26.8	28.3	26.0	3.5	15.8	17.5	17.8	13.3	11.8	28.2	17.1	33.2	22.5	22.1	14.9	13.0	21.9	20.4	21.7	15.0	20.7	19.0	24.4	14.4	15.9	5.8	14.5	64.2	84.2	30.7	35.6	28.3	29.8	42.9	47.5	66.5	50.0	49.5	97.0	45.9	42.1	27.7	48.6	21.6	47.2	35.8	32.3	22.8	50.5	75.7	24.6	46.7	52.3	35.5	63.4	57.0	31.3	29.9	46.5	58.0	55.3	33.3	29.9	36.4	45.6	41.2	79.9	41.4	56.3	30.4	37.2	64.6	32.7	32.9	19.5	32.7	40.8	20.6	43.0	33.0	40.1	36.1	17.9	23.6	38.3	45.6	30.9	27.6	38.0	47.9	43.7	25.9	53.8	102.3	27.3	19.8	6.4	22.5	15.9	15.3	23.2	14.8	11.4	13.3	14.6	27.6	12.3	14.0	15.4	13.8	27.7	25.8	11.7	18.3	19.0	14.4	15.4	13.5	19.3	14.8	14.1	17.1	15.2	17.5	13.0	15.0	14.5	29.1	48.1	38.5	18.9	36.7	13.9	27.4	30.2	23.3	45.7	25.9	25.3	33.9	22.8	38.8	40.5	31.3	41.4	40.1	34.8	23.5	34.5	25.9	78.0	41.6	26.4	29.3	28.0	17.5	37.1	32.9	35.9	38.7	37.1	39.9	49.5	28.9	27.5	44.4	38.7	15.9	36.2	8.2	42.7	25.5	28.6	33.8	51.6	14.2	15.9	75.0	39.3	62.8	9.5	20.1	37.3	33.5	35.3	37.2	28.6	37.3	53.4	112.2	74.8	32.9	39.9	32.1	74.3	65.3	29.0	13.8	42.5	35.7	50.4	36.0	30.3
TUBGCP3	"GCP3, SPBC98, Spc98p"	ENSG00000126216	"Tubulin gamma complex associated protein 3"	Q96CW5	13	112485011-112588205	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043913	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA043913: AB_10963220"	"unprognostic (6.12e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.89e-2)"	"unprognostic (8.70e-3)"	"unprognostic (1.62e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.38e-2)"	12.8	10.0	4.8	12.1	6.3	31.2	10.9	6.0	5.2	12.5	5.1	10.7	8.7	13.1	6.5	10.7	11.7	8.9	9.4	4.3	5.6	8.7	14.7	10.6	14.9	5.9	5.1	17.9	10.4	8.7	7.8	9.7	5.9	8.2	10.0	11.7	10.4	8.4	12.1	14.1	11.2	12.5	4.6	14.9	9.6	16.8	5.8	19.1	10.6	8.9	13.3	11.0	11.8	8.8	48.1	20.5	29.6	17.5	12.0	15.0	25.5	21.6	22.8	29.1	25.7	22.4	40.5	34.2	12.0	20.5	29.1	31.2	27.8	24.4	38.2	26.9	34.1	35.8	28.3	18.6	12.4	102.6	32.2	11.7	18.4	19.0	34.1	11.9	23.3	33.0	19.7	23.2	21.9	19.6	41.3	34.9	17.5	51.0	20.7	48.6	26.6	23.0	12.4	19.8	27.4	25.1	26.0	34.2	14.5	17.4	20.7	79.8	18.6	16.6	51.8	19.5	27.1	23.8	18.7	47.7	28.1	68.7	34.4	19.0	33.8	50.0	10.9	28.3	13.4	17.5	11.8	13.7	37.4	11.2	17.9	11.4	31.6	19.0	25.0	19.9	16.2	18.7	4.8	6.3	6.0	5.2	4.3	5.6	5.9	5.1	5.9	4.6	5.8	8.8	14.9	9.6	8.7	25.8	16.6	11.6	5.5	4.9	14.8	18.6	7.6	6.7	9.6	7.2	9.2	9.2	16.7	8.8	18.5	7.5	0.0	6.7	22.9	5.8	12.2	11.9	8.4	23.5	45.9	6.2	11.6	12.0	16.3	7.1	7.0	13.3	12.8	14.7	14.6	28.6	44.4	7.4	2.0	22.5	13.0	24.6	14.9	20.0	19.6	34.7	19.0	11.5	14.4	42.3	49.3	8.6	4.0	10.9	18.5	4.3	7.4	9.7	3.9	16.4	26.3	13.0	11.5	25.0	31.4	12.2	8.2	4.1	13.3	12.0	8.4	3.9
TUBGCP4	"76P, FLJ14797"	ENSG00000137822	"Tubulin gamma complex associated protein 4"	Q9UGJ1	15	43369221-43409771	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 55.5;Rod photoreceptor cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043212	Approved		Supported	Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome		"HPA043212: AB_10796690"	"unprognostic (1.34e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-1)"	3.9	4.3	5.1	3.7	6.9	4.8	5.1	8.4	8.4	5.3	6.4	5.0	4.8	4.5	3.5	5.8	4.5	2.9	4.9	5.6	5.6	4.7	5.9	3.9	4.6	5.6	5.7	5.2	6.1	8.3	5.2	3.7	5.9	5.1	5.2	11.1	5.1	3.7	9.7	4.6	5.2	4.9	5.4	4.4	4.9	4.1	5.7	6.1	4.5	9.8	5.5	4.6	5.1	6.4	18.2	5.6	13.3	13.7	12.9	13.9	10.3	10.2	7.3	13.9	14.0	18.0	11.1	11.3	15.2	8.8	19.5	29.4	28.3	18.2	16.3	19.0	26.9	29.5	30.2	15.9	10.7	20.4	17.6	7.6	17.9	14.4	20.0	11.0	11.5	18.5	28.4	9.6	10.4	6.3	16.4	15.7	6.3	29.6	22.1	22.0	17.5	15.9	9.2	17.1	35.5	12.1	12.4	23.8	4.1	8.4	14.1	15.8	9.5	13.2	13.5	18.3	22.7	9.9	12.5	19.6	12.1	29.0	15.1	0.1	2.5	13.8	3.7	2.9	2.7	3.6	2.8	2.6	5.3	3.2	2.0	2.9	0.3	5.3	1.6	2.8	3.2	2.4	5.1	6.9	8.4	8.4	5.6	5.6	5.6	5.7	5.9	5.4	5.7	6.4	6.5	19.2	14.5	12.1	14.9	11.0	16.3	4.5	5.2	30.9	8.8	7.4	1.7	18.6	10.8	16.5	22.9	16.1	6.5	8.5	7.9	12.2	28.7	9.4	15.3	8.8	14.4	15.4	17.3	9.9	14.7	10.4	5.6	10.4	11.4	15.9	10.0	11.4	6.9	55.5	13.8	10.6	8.2	7.6	5.6	43.6	15.2	6.1	3.6	4.7	7.7	13.1	22.6	17.1	9.2	11.0	9.4	12.4	5.8	20.1	12.7	6.1	9.5	57.1	6.6	19.1	10.2	25.0	14.5	9.2	8.9	11.5	9.8	11.2	17.7	16.9
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: AB_2676942"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	8.4	9.1	3.5	6.5	4.2	9.0	9.7	3.8	6.6	9.7	1.8	7.3	6.3	9.7	5.7	8.0	6.7	6.0	9.1	3.3	4.7	8.2	9.3	7.0	8.4	4.8	4.1	7.4	10.6	8.4	8.0	6.9	5.1	9.6	7.3	9.8	6.7	7.7	10.7	10.0	6.3	8.7	3.3	7.2	7.8	13.4	4.3	8.9	11.2	10.2	8.7	7.6	7.6	6.5	20.3	20.8	23.9	14.4	18.3	11.9	13.8	24.3	26.6	26.2	22.7	16.1	9.3	16.0	10.3	22.3	13.8	19.8	16.0	18.8	21.8	23.6	6.6	26.9	21.2	8.8	6.4	27.7	11.6	19.4	7.2	17.5	16.2	8.6	16.1	26.4	19.8	23.6	16.9	13.1	18.8	12.1	14.2	19.8	18.8	22.9	26.1	3.2	15.3	30.6	8.3	14.0	19.7	14.2	12.7	11.8	22.2	13.4	13.9	18.4	11.7	14.0	36.6	18.3	19.8	40.0	23.8	18.3	17.3	0.2	1.4	0.6	2.6	2.1	2.7	2.2	4.0	4.4	2.3	4.2	3.5	4.7	1.5	3.9	2.1	2.5	3.7	1.7	3.5	4.2	3.8	6.6	3.3	4.7	4.8	4.1	5.1	3.3	4.3	6.5	7.4	16.0	17.7	16.0	11.0	3.3	3.2	4.2	9.1	27.6	5.2	5.0	13.2	7.2	6.3	5.5	14.6	8.3	11.6	3.0	5.9	6.5	7.8	12.5	13.4	6.4	4.2	3.8	21.4	4.6	7.2	10.4	6.1	6.2	6.3	31.4	5.7	10.2	7.9	10.1	29.7	4.7	4.1	5.2	2.9	13.4	11.1	6.2	3.6	12.2	5.1	11.6	7.2	15.6	26.2	6.6	5.0	12.8	7.9	2.3	2.9	7.1	9.0	18.9	0.0	13.6	10.6	35.0	36.7	8.6	2.7	3.4	9.6	14.1	4.6	2.0
TUBGCP6	"DJ402G11.6, GCP6, KIAA1669"	ENSG00000128159	"Tubulin gamma complex associated protein 6"	Q96RT7	22	50217689-50245023	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043928	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA043928: AB_10960352"	"unprognostic (4.26e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.90e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.53e-2)"	"prognostic favorable (3.18e-5)"	11.1	14.9	10.3	12.3	10.0	13.2	12.2	13.2	14.9	16.6	9.9	12.7	9.8	15.2	6.7	10.1	15.6	10.2	11.3	9.0	8.0	15.1	12.7	11.9	16.4	9.6	7.8	18.3	23.4	12.2	22.2	8.1	7.6	16.4	4.6	5.9	15.9	8.9	14.9	12.9	16.4	6.1	5.7	17.1	15.9	12.4	8.2	15.5	19.7	7.0	10.1	12.7	10.7	11.6	8.0	7.0	12.6	15.2	9.8	9.2	8.6	8.9	5.8	6.2	7.5	5.1	6.6	7.0	6.4	9.1	5.6	9.1	6.3	9.4	2.9	7.2	19.8	6.9	32.7	6.6	6.7	14.6	13.0	13.2	8.4	8.0	6.6	10.5	9.3	14.8	7.2	18.5	5.8	8.3	11.1	12.3	4.2	3.7	4.6	13.4	7.0	14.6	5.2	9.9	4.6	9.1	7.0	12.8	3.7	5.2	6.9	8.3	9.7	9.2	6.6	8.1	6.5	19.4	4.0	8.6	8.0	6.4	6.2	0.7	0.9	0.7	2.2	0.8	1.6	1.0	1.6	2.4	1.0	1.1	1.4	1.7	1.0	1.1	0.7	1.5	2.4	1.2	10.3	10.0	13.2	14.9	9.0	8.0	9.6	7.8	7.6	5.7	8.2	11.6	8.4	9.6	17.2	22.9	10.8	6.4	2.8	6.8	5.2	9.3	9.4	11.0	8.1	7.2	8.3	11.0	16.7	4.6	12.5	8.2	3.9	4.2	2.0	7.2	7.4	6.4	9.0	7.0	13.9	3.6	3.2	8.4	17.9	9.3	6.3	11.5	5.3	7.1	4.4	6.7	12.0	8.1	6.1	9.8	6.2	3.8	9.6	8.6	7.2	9.4	4.6	3.2	9.2	6.6	10.0	4.6	4.9	6.8	11.5	3.9	10.1	2.6	13.2	11.0	6.6	7.8	7.0	10.8	10.0	6.2	5.5	3.4	12.4	10.4	7.7	3.1
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846348	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		610000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	69.7	114.6	69.6	67.1	74.2	75.1	65.8	78.9	78.1	59.4	93.3	101.5	104.4	64.9	34.7	105.2	73.6	46.6	177.8	68.1	75.3	107.3	145.1	58.3	69.2	73.1	77.4	61.4	114.2	117.1	55.4	47.6	74.1	57.7	86.1	35.8	88.9	59.7	224.4	76.0	83.9	53.6	72.9	66.2	106.1	73.3	77.0	59.9	62.7	221.5	79.3	67.1	62.9	74.3	176.2	323.1	102.4	216.2	144.9	131.4	208.7	125.8	144.4	194.9	183.0	351.3	189.4	390.5	228.5	126.4	112.4	337.6	244.2	242.9	116.2	155.4	370.8	151.7	254.8	433.6	171.7	273.8	134.8	169.9	188.1	211.9	208.7	126.8	235.2	213.0	339.0	150.3	144.4	355.0	262.3	266.3	231.8	213.9	196.9	361.8	187.3	569.6	169.3	168.4	178.8	219.6	110.0	388.5	180.2	84.6	231.5	217.6	150.1	115.9	136.4	146.7	196.6	229.8	253.6	172.2	148.6	336.8	157.1	94.6	155.8	72.3	103.1	153.6	115.3	100.6	97.2	108.7	199.3	98.8	91.7	95.3	32.4	97.2	119.2	123.1	140.1	185.6	69.6	74.2	78.9	78.1	68.1	75.3	73.1	77.4	74.1	72.9	77.0	74.3	108.2	70.5	76.7	29.4	144.6	168.1	262.5	322.0	158.2	102.4	165.1	139.2	134.4	190.1	182.6	176.6	87.6	333.1	113.2	260.0	334.6	230.2	381.8	116.1	92.5	111.3	148.5	148.1	17.5	289.8	299.2	111.2	153.4	79.6	105.9	170.6	108.5	247.1	253.8	74.0	19.9	230.5	217.7	167.5	146.4	669.0	109.3	128.6	138.7	14.0	167.5	140.6	88.6	28.6	30.3	199.7	215.3	111.7	264.9	245.3	330.7	451.9	237.3	116.3	85.5	105.5	129.1	205.7	177.4	230.1	156.0	287.0	120.2	288.2	418.7	277.6
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 111.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.2;Glandular and luminal cells: 76.8;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.2;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 41.7"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	5.6	6.8	4.7	2.8	4.2	6.7	10.1	5.0	5.3	25.4	3.4	11.6	7.5	5.3	6.3	48.1	5.1	5.9	4.9	3.8	5.9	14.1	7.0	8.4	0.9	4.0	4.0	7.4	17.2	11.4	7.2	13.3	5.2	9.6	13.0	2.1	18.3	9.2	2.5	111.5	10.8	6.2	3.3	1.5	12.8	5.4	6.2	2.2	5.7	2.7	6.2	12.4	26.8	3.5	40.7	13.7	10.0	11.5	2.3	1.9	63.1	10.7	9.5	41.3	39.6	43.6	31.5	3.5	64.6	12.5	19.5	46.4	17.6	16.2	30.1	27.0	8.7	2.2	23.0	6.7	32.2	0.8	4.7	6.5	18.9	32.5	71.6	24.5	3.4	5.0	3.6	26.8	12.8	16.8	2.0	0.5	11.7	29.6	11.4	0.1	28.1	14.2	34.7	61.8	19.5	8.0	68.2	45.8	8.0	29.4	36.5	2.1	8.6	7.4	51.7	46.2	71.7	6.6	13.7	0.5	6.3	0.9	4.7	5.2	0.6	0.7	0.3	0.1	0.7	0.6	1.0	0.5	0.9	0.2	0.8	0.3	2.5	0.1	0.3	0.1	3.5	0.5	4.7	4.2	5.0	5.3	3.8	5.9	4.0	4.0	5.2	3.3	6.2	3.5	2.1	25.6	2.0	1.6	3.8	69.2	35.2	14.7	35.9	2.5	28.8	20.2	9.8	8.6	19.0	14.7	0.0	28.1	6.6	59.5	13.7	18.2	2.7	43.2	8.9	2.7	32.2	2.7	4.4	15.2	13.9	7.0	46.9	76.8	4.5	9.0	1.1	10.5	4.0	0.0	9.3	39.1	20.3	0.0	12.7	3.2	2.5	6.5	8.8	1.0	2.0	2.1	0.0	8.5	1.8	47.4	34.6	5.3	7.7	21.7	15.4	11.2	15.9	0.5	6.6	4.1	5.5	0.6	3.5	39.6	66.5	56.8	5.8	10.9	35.7	35.6
TULP3	TUBL3	ENSG00000078246	"TUB like protein 3"	O75386	12	2877223-2941138	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	21.0	17.1	13.6	7.5	14.2	2.6	18.3	19.2	16.1	33.3	15.8	21.6	5.4	23.2	11.7	17.8	24.3	12.1	17.7	13.8	13.2	17.3	9.0	13.5	6.1	16.3	14.8	37.7	9.6	13.3	12.3	13.7	13.8	15.4	8.2	12.7	13.0	13.9	10.4	25.7	10.5	18.2	14.5	9.4	15.5	13.0	14.4	9.4	15.5	9.7	8.1	16.7	24.1	17.1	22.6	18.8	35.0	29.1	34.3	51.0	32.9	34.5	57.5	36.4	40.2	24.0	20.4	16.7	5.1	51.2	31.2	18.5	21.1	22.2	42.0	21.7	15.4	10.0	23.4	15.5	44.3	10.8	11.1	30.1	25.7	55.3	74.9	44.6	28.6	20.8	9.7	15.1	31.0	20.3	16.1	9.4	47.4	17.8	13.7	16.8	34.2	6.3	22.9	18.7	8.8	23.4	30.1	17.8	19.9	63.4	22.2	10.5	23.0	26.6	32.0	54.7	33.9	4.7	6.0	14.3	26.9	5.9	41.5	0.0	0.9	0.3	2.1	0.8	3.5	1.6	1.7	2.2	0.7	1.8	2.0	2.8	0.4	2.7	0.5	1.6	3.3	1.0	13.6	14.2	19.2	16.1	13.8	13.2	16.3	14.8	13.8	14.5	14.4	17.1	12.9	6.4	10.5	70.5	6.2	20.3	16.9	14.8	26.2	6.1	9.9	12.2	8.0	18.6	15.9	1.8	2.1	9.4	6.0	4.6	23.5	17.3	5.8	35.1	33.5	15.2	3.6	6.1	6.0	7.3	10.6	31.7	6.6	14.6	0.0	11.5	24.3	5.5	5.3	40.4	10.8	4.0	14.2	2.5	8.6	3.6	40.7	5.4	19.6	14.0	6.7	50.7	12.3	10.1	34.9	11.1	2.4	24.8	8.3	23.3	3.2	21.9	47.4	10.0	39.5	22.3	26.3	38.0	50.8	22.2	20.2	11.6	6.5	13.3	6.4	13.2
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	16.1	10.6	8.5	2.8	8.5	1.7	14.8	7.0	9.3	13.6	9.5	14.3	5.3	18.3	6.2	9.1	15.9	2.8	12.2	8.7	8.9	13.1	10.9	9.8	1.6	9.6	10.5	13.2	9.8	5.6	9.0	3.8	8.2	11.7	3.7	2.8	10.8	6.1	8.3	13.1	9.1	5.5	9.0	6.8	11.5	21.8	8.6	3.2	11.9	4.7	2.0	12.7	10.7	10.4	10.0	2.1	2.1	0.0	7.0	5.8	0.1	7.5	0.0	2.8	3.4	0.1	3.5	0.0	2.2	8.9	7.6	0.0	5.3	9.4	1.7	0.0	10.3	38.6	11.2	0.0	3.4	0.0	0.0	7.1	13.0	3.1	7.3	0.0	3.1	0.0	0.0	0.1	3.3	5.0	0.0	0.1	1.8	8.0	9.5	0.0	1.4	0.1	3.9	4.6	0.7	16.8	9.3	7.6	8.2	4.1	6.7	10.8	6.6	0.0	13.6	0.1	0.0	0.0	0.0	0.0	8.8	2.6	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.5	8.5	7.0	9.3	8.7	8.9	9.6	10.5	8.2	9.0	8.6	10.4	46.5	12.8	6.4	2.3	2.1	60.8	46.1	14.7	47.3	24.8	45.4	55.0	12.2	20.0	5.9	16.5	4.2	29.5	2.4	14.8	66.5	7.9	85.7	11.0	26.6	24.4	13.1	4.8	7.3	12.4	13.8	33.0	7.1	17.2	0.0	15.7	22.9	18.5	9.7	21.9	7.6	11.8	10.2	4.8	13.0	16.2	30.7	5.2	28.4	3.7	1.2	42.9	0.0	4.0	9.3	8.1	9.5	21.8	0.5	45.5	8.1	23.1	3.5	14.3	32.9	52.8	36.9	164.0	12.8	16.8	37.8	29.0	1.3	16.3	14.3	19.8
TUSC3	"MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	23.3	68.8	18.7	8.4	18.4	0.1	28.3	22.3	17.1	25.0	46.6	14.5	9.3	31.9	100.8	11.8	57.6	16.7	34.9	17.1	48.2	25.2	6.9	18.4	6.8	8.9	11.6	73.6	35.0	54.0	69.6	80.5	8.9	46.4	15.5	40.9	12.1	29.7	4.5	8.2	8.2	32.5	7.7	5.3	10.8	23.2	21.0	7.5	9.5	5.7	5.6	34.0	13.0	8.0	52.1	38.4	104.3	96.7	125.2	126.7	0.2	74.9	168.8	85.2	139.3	0.1	0.1	0.7	24.5	105.9	92.4	39.3	37.5	76.1	116.0	0.1	49.8	0.0	30.1	6.0	51.9	0.2	5.6	111.8	22.8	121.0	43.1	113.7	6.9	15.9	70.9	15.6	123.2	41.2	20.6	0.4	49.2	0.0	33.5	24.8	88.7	0.3	108.3	127.1	40.7	74.6	0.0	40.6	56.5	76.2	49.8	0.2	29.0	71.9	71.3	31.3	36.5	0.0	10.0	0.4	1.2	0.0	102.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.4	22.3	17.1	17.1	48.2	8.9	11.6	8.9	7.7	21.0	8.0	88.6	0.0	10.3	13.4	0.6	9.9	61.1	123.5	63.7	50.4	40.0	52.1	47.5	18.6	47.0	79.1	8.4	472.9	0.9	2.1	17.6	179.0	11.5	100.8	48.6	36.2	95.7	0.0	141.0	12.2	321.8	53.4	7.7	35.0	1.3	39.3	7.5	0.0	41.8	32.0	155.3	26.3	95.6	0.0	6.3	7.6	34.8	1.5	24.9	24.4	1.6	35.9	0.0	61.3	3.9	23.8	4.1	23.0	2.6	63.8	0.0	23.7	172.4	28.1	39.5	2.0	49.7	60.9	47.4	26.2	4.1	783.8	1.6	46.6	7.8	51.4
TUT4	"KIAA0191, PAPD3, TENT3A, ZCCHC11"	ENSG00000134744	"Terminal uridylyl transferase 4"	Q5TAX3	1	52408282-52553487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	22.5	34.4	28.4	18.3	28.6	26.6	21.4	44.7	36.2	34.1	28.6	26.3	8.7	27.4	23.7	19.3	30.8	15.4	27.1	26.8	35.3	22.9	31.3	22.1	34.2	28.5	29.4	46.3	31.2	29.5	41.5	21.2	28.5	26.1	11.2	84.9	20.7	16.5	60.0	35.1	30.9	15.9	26.4	35.0	22.3	46.9	33.4	32.5	31.4	30.0	29.4	23.1	26.5	33.5	24.4	22.7	55.3	37.3	21.1	27.1	36.4	20.0	31.0	30.3	34.9	23.6	12.5	50.6	23.0	30.0	49.1	19.7	41.6	22.6	38.7	39.7	36.5	53.7	30.0	49.7	35.0	59.4	29.1	31.9	49.4	32.6	40.0	38.6	21.4	35.7	44.7	25.6	25.7	0.3	60.1	42.7	39.8	12.5	27.5	51.3	55.3	39.3	33.4	20.0	28.7	26.8	31.8	14.1	32.9	62.3	19.4	31.5	18.1	23.2	30.6	21.1	26.2	52.7	74.0	71.8	15.5	32.0	17.0	83.7	9.7	34.8	26.1	4.0	19.3	49.0	27.3	21.6	5.1	50.2	33.1	22.0	37.6	25.3	3.7	61.9	23.3	5.1	28.4	28.6	44.7	36.2	26.8	35.3	28.5	29.4	28.5	26.4	33.4	33.5	52.2	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	36.1	41.4	0.0	0.0	0.0	47.8	0.0	53.6	64.9	0.0	15.6	28.5	0.0	59.5	96.1	14.3	0.0	0.0	0.0	17.0	19.1	18.8	0.0	46.7	0.0	70.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	9.8	0.0	0.0	0.0	0.0	19.6	0.0	0.0	30.2	0.0	0.0	22.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	36.9	28.2	57.3	0.0	0.0
TUT7	"FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6"	ENSG00000083223	"Terminal uridylyl transferase 7"	Q5VYS8	9	86287733-86354454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 114.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.6;monocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	12.5	9.4	4.8	16.0	6.4	22.6	18.7	5.9	10.0	12.8	10.9	12.1	11.0	9.1	8.9	24.7	8.8	11.3	8.2	5.1	7.9	7.5	38.4	16.5	19.1	9.0	6.3	8.7	13.1	8.7	8.2	14.3	7.8	20.8	11.8	7.7	14.2	7.2	13.6	33.7	12.3	7.8	5.1	20.6	13.6	11.6	9.2	15.1	8.6	9.3	19.2	13.4	16.0	9.0	16.2	17.2	9.8	14.3	22.4	36.0	12.2	21.6	20.5	9.1	10.6	7.8	13.7	22.8	18.9	14.0	9.5	27.3	11.8	12.0	13.5	27.1	6.0	16.5	18.4	13.7	19.3	19.1	21.8	23.5	22.7	14.5	16.2	13.7	15.0	12.3	15.9	24.0	24.6	14.9	16.0	11.0	7.5	25.1	11.1	8.0	17.5	10.1	15.3	31.4	7.2	5.7	13.1	15.5	7.4	11.6	6.4	7.8	24.8	8.7	10.5	15.7	14.8	27.4	23.3	16.5	20.7	10.8	11.8	35.4	19.4	20.5	15.0	24.7	12.5	11.6	8.2	10.7	11.9	12.2	9.5	10.1	114.6	12.8	47.8	5.5	8.8	8.9	4.8	6.4	5.9	10.0	5.1	7.9	9.0	6.3	7.8	5.1	9.2	9.0	28.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	34.2	16.4	0.0	0.0	0.0	9.2	0.0	22.4	36.6	0.0	5.9	29.6	0.0	80.3	61.1	7.2	0.0	0.0	0.0	17.9	17.4	5.6	0.0	206.7	0.0	36.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	12.4	0.0	0.0	0.0	0.0	27.8	0.0	0.0	13.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	92.5	14.8	30.9	0.0	0.0
TVP23A	"FAM18A, YDR084C"	ENSG00000166676	"Trans-golgi network vesicle protein 23 homolog A"	A6NH52	16	10760919-10818794	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.7"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 29.0;Granulosa cells: 92.1;Inhibitory neurons: 28.4;Langerhans cells: 47.6;monocytes: 29.1;Oligodendrocyte precursor cells: 23.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;NTERA-2: 1.3;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060582	Uncertain		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA060582: AB_2684326"	"unprognostic (6.70e-4)"	"unprognostic (1.64e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.39e-5)"	"unprognostic (4.96e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.42e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.78e-7)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.87e-4)"	1.0	1.2	4.5	1.1	4.8	1.8	0.6	3.0	5.7	1.6	1.0	0.8	0.8	0.9	0.5	0.6	1.5	0.9	1.4	4.4	4.4	1.0	1.1	0.9	2.0	3.3	3.8	3.6	1.0	0.0	2.2	0.1	3.8	2.0	0.2	2.2	0.7	0.9	0.5	0.7	1.3	0.6	2.8	1.7	0.8	1.0	4.3	0.8	0.9	0.0	0.6	0.7	0.8	3.6	0.1	0.4	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.2	0.1	0.6	0.3	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.3	1.3	0.1	0.0	0.6	0.1	0.2	0.0	0.4	0.2	2.1	0.1	0.2	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.3	0.1	1.0	0.1	0.3	0.3	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.6	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	4.5	4.8	3.0	5.7	4.4	4.4	3.3	3.8	3.8	2.8	4.3	3.6	0.2	0.0	1.8	5.2	0.8	1.1	0.0	0.1	0.6	6.4	0.1	0.4	0.6	0.0	0.1	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.7	0.6	0.4	0.4	0.0	0.0	29.0	0.6	0.6	3.3	0.0	0.3	0.0	92.1	0.0	0.2	0.8	1.7	28.4	0.0	0.0	1.0	47.6	0.3	2.8	4.5	1.8	1.9	29.1	4.7	0.0	23.6	1.1	0.3	0.0	1.5	0.2	0.0	0.0	1.3	0.2	1.3	0.0	0.2	3.6	2.2	3.1	0.1	1.0	1.4	0.5	0.1	0.1	0.1
TVP23B	"CGI-148, FAM18B, FAM18B1, YDR084C"	ENSG00000171928	"Trans-golgi network vesicle protein 23 homolog B"	Q9NYZ1	17	18781111-18806714	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019585, HPA065603"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: AB_2685517"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.13e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.54e-1)"	"unprognostic (5.27e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.55e-2)"	26.4	43.2	11.1	20.0	11.7	19.9	30.3	12.8	15.1	38.2	23.3	25.8	29.9	26.5	40.4	52.3	34.5	30.4	22.8	10.6	13.5	31.0	44.0	20.8	25.4	12.3	13.0	30.1	33.6	47.8	32.7	29.6	13.0	33.5	31.2	32.1	34.3	24.4	17.3	19.3	23.8	21.7	13.1	17.4	40.5	34.9	12.4	20.4	46.9	16.2	31.4	32.7	34.2	13.3	55.0	63.8	23.6	26.2	68.8	60.9	56.1	93.5	75.0	42.8	54.6	37.6	38.7	17.9	33.9	60.3	42.6	74.1	19.2	40.2	63.2	44.3	39.7	17.0	47.1	46.3	48.0	13.0	35.6	31.6	95.7	46.0	67.7	78.7	36.0	12.6	14.0	13.1	62.9	27.6	17.2	18.3	11.0	99.2	25.6	17.4	52.1	23.1	52.7	36.0	13.4	29.9	49.8	32.4	60.4	129.0	46.9	19.7	41.6	32.7	28.1	69.8	57.5	25.9	31.7	9.5	50.2	22.2	68.2	54.4	20.4	44.6	29.7	27.4	40.5	32.1	33.0	32.1	17.3	26.9	34.8	34.8	24.2	32.3	27.1	27.9	26.3	32.1	11.1	11.7	12.8	15.1	10.6	13.5	12.3	13.0	13.0	13.1	12.4	13.3	10.0	12.8	13.2	9.4	29.4	25.2	28.1	70.4	54.7	8.6	16.5	9.7	4.2	10.0	42.4	9.2	10.4	13.3	15.7	8.5	11.7	13.9	8.6	21.7	16.1	12.9	6.1	17.2	8.1	11.6	30.3	19.1	40.2	16.2	22.2	7.1	11.0	10.3	10.0	1.7	8.8	14.6	44.7	10.3	10.7	4.2	16.8	16.0	26.6	11.2	9.1	9.1	17.5	14.1	12.8	16.5	10.7	17.0	62.1	28.5	12.0	14.0	60.0	11.1	13.1	9.0	17.0	50.8	43.0	65.5	30.5	26.1	23.7	8.9	8.6	32.4
TVP23C	"FAM18B2, MGC8763"	ENSG00000175106	"Trans-golgi network vesicle protein 23 homolog C"	Q96ET8	17	15502264-15563595	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA019585, HPA065603"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: AB_2685517"	"unprognostic (2.87e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.09e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.45e-2)"	3.8	6.6	4.2	2.3	3.5	10.9	4.5	6.9	3.9	7.4	8.0	3.3	2.1	4.6	3.3	5.9	4.2	2.4	4.1	3.1	4.7	6.4	3.9	4.6	2.8	5.5	5.2	8.8	5.2	3.7	10.1	4.0	3.9	6.4	2.1	4.1	6.0	2.0	3.0	4.5	3.8	2.2	3.0	4.7	3.8	5.2	5.2	1.9	6.8	1.5	2.4	3.9	5.7	6.5	8.3	7.3	2.7	3.9	3.5	1.8	4.2	6.9	11.6	12.1	14.2	9.3	3.3	0.0	3.7	5.8	6.6	3.5	8.4	5.2	8.6	5.2	4.5	5.5	6.7	13.2	3.2	2.0	5.0	2.4	2.0	12.2	7.2	10.2	11.1	2.9	6.7	3.5	5.3	2.7	3.5	5.6	3.0	3.3	2.5	0.6	0.3	0.4	3.3	4.8	0.9	2.3	8.7	1.0	1.8	11.3	4.8	1.1	7.9	2.0	2.8	2.9	2.2	2.2	2.1	0.0	2.3	0.0	1.8	11.3	1.8	8.4	3.3	4.1	4.5	6.4	4.5	5.0	3.0	4.6	5.5	5.1	2.9	5.0	2.9	3.3	4.7	4.3	4.2	3.5	6.9	3.9	3.1	4.7	5.5	5.2	3.9	3.0	5.2	6.5	3.5	3.2	8.2	0.0	2.9	4.0	5.4	4.3	4.6	5.9	4.2	2.7	17.2	0.0	7.0	0.0	14.6	5.9	5.5	3.8	1.9	2.9	1.3	6.6	4.4	5.8	1.8	3.0	0.0	0.6	11.7	5.6	6.6	6.5	2.5	6.2	1.8	0.7	3.2	6.7	0.0	4.0	6.1	1.9	3.3	0.9	3.4	2.3	1.8	0.0	2.4	2.6	4.1	0.0	0.0	1.6	2.9	2.2	9.2	5.2	4.3	0.8	4.3	10.5	0.0	3.3	5.6	10.0	7.9	5.5	2.8	5.5	4.7	7.2	4.9	7.0
TWF1	"A6, PTK9"	ENSG00000151239	"Twinfilin actin binding protein 1"	Q12792	12	43793723-43806328	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018116	Approved		Supported	Cytosol		NA	NA		75000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA018116: AB_1855899"	"unprognostic (3.06e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.51e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.62e-1)"	45.2	40.2	27.9	39.0	33.0	46.2	49.4	30.6	38.9	54.8	27.2	65.9	68.7	39.9	48.5	93.8	45.3	48.7	13.1	26.5	32.5	51.2	53.9	24.9	30.5	32.5	30.9	27.1	39.0	39.9	23.9	35.0	32.6	46.0	65.7	32.5	42.5	73.5	5.8	36.7	67.8	46.6	31.8	20.2	46.1	20.1	30.8	24.4	73.1	11.7	34.2	74.6	38.0	37.2	121.3	88.5	45.1	55.5	115.8	132.5	109.3	165.3	136.1	131.7	99.2	143.3	165.2	32.5	150.0	159.6	77.3	79.8	62.6	118.2	186.1	11.3	72.5	30.2	68.6	67.7	93.9	35.0	37.6	91.0	94.4	136.8	152.0	167.5	117.0	16.1	33.4	35.9	207.4	64.8	16.8	24.1	27.5	0.0	142.7	14.1	51.1	36.8	175.9	149.1	33.3	50.0	138.2	123.7	121.7	62.8	116.2	34.4	113.0	161.5	107.1	130.8	139.8	31.1	32.9	44.4	148.8	89.0	62.6	10.2	2.6	5.7	5.1	4.1	5.9	6.1	6.0	6.6	4.1	3.0	5.9	6.7	4.4	12.1	4.4	2.7	6.6	3.2	27.9	33.0	30.6	38.9	26.5	32.5	32.5	30.9	32.6	31.8	30.8	37.2	40.7	12.8	33.8	6.2	24.7	41.7	33.3	32.6	42.1	22.7	43.9	30.6	6.0	30.0	40.3	35.0	20.9	41.5	36.2	92.8	41.1	50.9	20.6	70.9	40.3	32.0	44.9	7.8	10.1	79.7	58.0	32.4	53.0	53.6	5.1	27.7	24.3	28.7	26.9	20.2	10.3	45.2	48.8	30.0	20.9	10.8	26.8	24.7	35.6	8.4	17.7	33.5	14.4	10.1	15.7	74.9	77.4	32.0	34.0	57.5	66.3	68.7	53.5	32.9	26.3	25.4	41.7	11.7	22.1	95.0	51.1	85.0	25.8	39.6	61.8	74.9
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228612-52246788	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 183.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 205.0;monocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Uncertain	"Plasma membrane"		NA	NA		5900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA053874: AB_2682287"	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	50.3	32.0	16.6	28.1	16.4	28.3	39.0	12.9	26.5	35.7	13.2	32.4	21.8	35.4	0.6	44.5	27.9	17.2	94.8	17.3	15.4	31.2	29.3	34.9	33.3	15.5	13.7	29.5	17.3	6.8	18.3	15.8	16.0	29.1	4.8	0.9	36.7	18.7	183.4	32.4	33.6	14.1	15.4	54.8	24.5	14.2	14.7	21.3	23.8	4.3	15.1	36.2	36.4	18.0	24.9	59.8	10.7	28.6	29.1	47.5	35.7	56.0	55.9	49.1	43.4	32.3	51.6	89.9	36.5	27.1	39.2	37.5	11.9	60.0	4.2	52.4	34.0	89.6	38.0	78.9	49.1	54.3	139.6	46.4	28.8	50.4	12.8	21.9	82.9	50.1	21.0	36.0	20.7	21.7	65.0	117.1	30.4	15.2	171.9	27.0	22.0	92.0	22.3	38.4	13.6	59.7	19.7	74.7	109.2	4.2	19.3	40.5	105.9	55.1	68.4	50.4	47.4	37.4	35.9	45.6	125.9	143.8	73.7	97.5	167.8	143.4	107.7	169.1	95.0	109.1	112.4	114.6	159.7	83.1	86.5	108.9	242.0	93.7	181.6	150.6	141.9	149.6	16.6	16.4	12.9	26.5	17.3	15.4	15.5	13.7	16.0	15.4	14.7	18.0	44.3	6.4	7.8	2.0	50.7	17.2	29.5	59.2	12.5	14.0	29.9	28.2	28.8	27.1	23.7	12.9	0.0	42.4	77.0	64.4	37.2	86.8	3.1	34.2	27.5	35.9	22.1	17.7	7.5	100.8	84.3	34.0	18.8	86.3	40.6	28.4	31.1	13.3	205.0	6.7	4.2	20.2	30.5	108.8	56.7	2.7	35.1	111.8	33.8	3.7	202.4	14.9	97.9	3.5	3.5	103.2	55.7	33.8	25.2	20.3	65.5	25.4	12.2	5.1	52.6	16.1	38.6	1.7	25.1	27.2	15.3	22.6	64.4	53.7	23.9	31.3
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994403	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	4.9	7.0	3.7	5.5	3.7	3.0	7.5	3.6	3.5	3.8	3.2	4.4	3.3	4.6	5.3	5.5	6.6	2.6	5.0	3.4	3.6	5.9	6.0	2.1	6.1	3.9	4.0	5.1	5.2	4.8	2.4	3.8	3.8	4.0	4.8	1.6	4.0	3.4	11.6	5.5	3.8	4.5	3.7	4.6	3.9	8.3	4.0	8.1	4.1	12.6	8.3	6.6	3.5	3.5	15.5	32.0	12.5	39.7	11.1	7.2	14.7	11.4	14.8	17.3	16.6	52.6	13.1	55.4	21.1	7.0	10.4	25.0	52.2	27.7	21.1	25.5	31.0	42.1	17.4	40.2	19.1	54.8	16.7	14.9	30.7	25.5	77.6	15.8	10.6	26.3	45.9	15.0	12.3	21.2	37.0	18.8	35.8	28.2	25.9	35.5	27.5	33.2	10.7	15.4	20.1	38.5	12.0	16.0	37.8	13.8	20.9	16.0	12.4	8.6	17.4	10.6	32.5	28.0	31.3	46.0	10.6	47.8	9.8	1.2	0.6	0.1	1.2	0.5	3.7	2.4	1.8	2.7	1.2	2.1	2.0	2.2	0.0	2.5	0.8	1.3	0.4	1.4	3.7	3.7	3.6	3.5	3.4	3.6	3.9	4.0	3.8	3.7	4.0	3.5	3.5	0.0	2.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	6.8	6.6	0.0	0.0	3.1	1.8	0.0	4.2	1.9	0.0	3.9	5.4	0.0	2.3	7.2	2.0	0.0	0.0	0.0	3.0	3.7	1.3	0.0	2.8	1.3	7.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.6	1.1	9.1	0.0	0.0
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.2;Peritubular cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		3500000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	23.7	19.5	7.7	16.7	9.6	8.2	17.5	9.2	12.2	40.6	12.7	22.1	11.1	51.3	45.8	26.1	30.5	36.3	18.6	7.4	9.2	36.3	10.0	19.7	11.8	10.5	9.4	32.3	9.7	33.2	9.8	24.8	10.4	43.0	22.4	5.7	11.1	64.6	5.7	12.9	12.5	80.1	9.7	13.6	14.9	11.8	8.9	7.0	34.9	16.5	14.9	34.7	16.2	11.0	57.3	19.9	57.6	28.6	111.2	99.7	26.6	107.2	132.4	57.6	81.9	21.2	73.5	8.2	52.7	142.5	37.4	19.5	57.1	42.4	105.3	22.0	15.4	14.7	15.9	10.8	98.7	10.8	29.4	102.0	34.1	48.3	23.3	78.7	90.8	7.8	22.7	14.6	149.2	17.0	11.9	13.2	18.9	33.6	16.1	20.7	58.7	5.0	65.7	75.2	7.4	20.0	83.3	23.1	22.9	23.9	26.1	25.0	75.6	104.9	52.4	99.5	67.5	21.2	20.1	15.1	64.5	14.9	37.9	8.3	2.7	4.0	4.3	1.5	2.8	2.1	2.0	4.5	5.5	1.6	2.3	4.8	1.2	2.9	0.5	5.3	1.0	2.1	7.7	9.6	9.2	12.2	7.4	9.2	10.5	9.4	10.4	9.7	8.9	11.0	9.0	25.6	18.4	13.1	8.1	39.6	21.3	18.5	51.2	4.8	18.5	11.6	7.8	10.0	21.0	75.4	0.0	6.3	12.1	12.1	1.9	9.1	141.2	13.3	38.6	18.1	6.0	9.9	28.0	7.6	18.3	61.9	10.2	23.4	6.3	31.6	17.2	7.5	16.0	3.3	31.0	8.2	57.0	9.4	30.1	30.7	37.6	12.2	23.2	17.8	15.3	16.1	7.2	29.1	31.6	9.2	10.7	95.2	17.8	46.3	1.3	12.6	12.4	5.0	72.3	28.9	56.6	24.6	9.6	26.6	26.9	4.7	10.1	20.4	12.2	27.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179675-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	26.1	35.8	20.6	20.7	22.0	16.5	20.3	20.6	21.3	30.7	27.5	32.2	16.9	35.4	22.7	30.7	30.5	18.7	22.2	20.4	22.8	30.0	45.6	23.1	22.0	25.3	23.6	29.0	29.2	32.5	31.7	16.7	22.1	30.1	17.9	12.6	23.2	21.7	21.8	31.3	24.4	27.8	21.5	28.5	26.5	29.4	23.9	19.3	27.0	14.5	27.0	28.6	24.3	22.7	45.1	37.7	38.5	43.5	48.8	63.8	31.1	62.7	49.6	59.3	56.6	42.4	47.4	51.1	24.9	61.2	19.5	49.5	53.0	41.2	53.7	58.8	41.0	80.8	57.6	55.8	51.7	59.4	61.4	64.3	54.2	62.8	29.6	43.6	47.6	60.8	33.5	51.3	49.2	25.0	43.8	38.1	56.1	32.0	34.3	50.8	58.3	45.1	40.6	56.4	40.1	41.3	65.1	40.8	68.5	46.9	37.8	35.6	49.9	62.3	53.5	83.3	81.1	75.8	63.0	45.7	64.5	79.5	58.9	11.0	8.8	4.6	12.9	9.8	11.0	6.8	8.8	9.7	6.9	7.4	7.6	8.3	1.4	14.2	13.3	14.3	7.0	10.6	20.6	22.0	20.6	21.3	20.4	22.8	25.3	23.6	22.1	21.5	23.9	22.7	26.2	22.4	21.4	13.4	13.4	8.8	11.3	14.1	17.1	16.0	26.4	24.6	9.5	11.5	16.8	14.7	39.6	10.8	18.9	15.0	1.9	17.4	14.4	26.9	44.7	23.6	26.3	12.4	9.7	16.4	14.3	27.7	23.9	27.4	13.3	20.2	16.1	32.2	18.2	26.9	9.6	18.1	12.2	11.0	10.0	16.8	23.9	15.9	5.4	7.5	20.9	13.3	10.3	9.5	12.9	22.4	7.2	20.7	19.8	12.4	8.3	12.7	24.1	26.1	13.1	33.6	25.8	34.3	23.8	21.2	12.1	6.8	15.5	23.2	14.7	7.7
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139291998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 82.0;skeletal muscle: 300.0;tongue: 189.1"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 260.7;Late spermatids: 67.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.0;HSkMC: 3.0;REH: 2.6;RPMI-8226: 3.8;U-698: 7.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	1.1	1.5	0.7	2.5	0.5	0.2	2.2	0.4	0.8	0.9	0.3	1.3	0.6	2.8	0.6	4.4	1.8	2.2	82.0	1.2	1.5	0.1	0.3	1.2	3.1	1.1	1.1	11.4	0.2	2.8	1.2	0.6	1.8	3.0	0.9	0.3	2.4	0.3	300.0	0.6	1.5	2.2	2.0	2.2	0.9	3.8	0.8	7.7	0.3	189.1	3.5	1.1	0.6	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.3	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.2	0.2	0.5	0.6	0.1	0.0	0.3	2.6	1.1	3.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.9	0.0	0.0	0.0	0.1	0.8	1.4	7.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.8	0.1	0.3	0.0	0.8	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.4	0.8	1.2	1.5	1.1	1.1	1.8	2.0	0.8	1.9	2.0	0.0	0.0	4.9	5.9	0.5	0.3	0.6	0.0	0.1	2.0	0.5	260.7	0.0	1.6	1.8	0.0	0.1	0.7	0.0	0.0	0.0	38.5	4.3	0.3	4.9	0.0	2.7	8.7	0.0	0.0	11.4	0.5	0.4	0.0	0.2	0.7	0.4	1.7	0.0	17.4	0.0	0.0	6.6	6.0	67.2	0.6	4.1	5.4	12.2	0.6	6.5	2.1	2.5	4.0	0.0	0.0	2.2	7.4	0.1	0.0	0.0	17.8	0.1	0.0	25.8	2.2	3.8	1.2	0.3	0.4	0.0	2.0	5.9	0.0	0.1
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786432-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	14.4	15.9	4.6	8.0	5.3	14.0	10.1	7.8	6.3	6.9	6.7	6.3	8.3	9.8	6.6	6.1	9.1	6.3	5.7	4.1	5.6	7.5	8.0	7.7	12.6	3.9	4.6	16.5	8.5	11.6	6.9	5.8	4.1	6.5	6.0	14.6	7.0	8.7	5.9	6.1	6.5	7.5	4.0	7.7	6.8	6.0	4.6	9.2	10.4	6.0	11.5	7.9	4.6	6.4	27.7	16.9	15.9	28.3	28.4	15.5	8.4	10.8	10.4	12.1	11.8	23.7	16.1	57.6	26.7	6.1	34.8	17.5	54.9	35.4	21.6	17.7	66.7	20.7	23.5	15.3	12.1	31.1	14.2	9.2	17.1	28.2	50.6	16.4	15.5	23.4	40.3	16.6	9.5	16.5	28.6	17.9	47.6	18.3	19.4	19.5	21.7	47.7	9.7	13.6	25.8	18.7	25.0	23.6	19.8	27.1	28.7	12.7	7.6	7.6	10.0	26.9	18.9	17.4	28.4	57.6	9.6	20.1	7.8	0.6	1.9	1.0	3.1	1.5	4.0	3.7	3.4	3.7	2.1	4.0	4.0	4.4	0.7	2.9	1.7	2.1	3.8	2.1	4.6	5.3	7.8	6.3	4.1	5.6	3.9	4.6	4.1	4.0	4.6	6.4	26.3	16.0	24.8	17.6	32.0	41.0	60.2	13.6	23.3	35.9	27.0	29.1	13.3	17.2	23.3	9.2	6.2	14.2	37.7	9.0	21.5	19.3	4.4	33.5	27.3	15.6	14.4	19.8	32.5	16.7	13.2	35.8	9.7	27.2	13.3	13.1	13.2	16.1	9.0	28.6	39.7	15.0	8.2	7.7	11.1	2.2	27.1	12.2	17.8	11.2	9.0	17.7	12.3	16.1	28.3	15.6	7.7	21.1	17.0	43.6	12.3	20.5	16.3	23.0	6.6	42.3	25.8	17.1	37.7	19.1	34.8	21.9	32.9	16.3	16.2	33.0
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467046-36481640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No		84000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	60.3	182.3	89.8	45.5	92.4	64.7	58.0	94.6	98.2	57.4	92.4	65.3	84.0	50.0	51.7	79.8	64.1	49.4	122.3	87.9	90.7	91.5	149.5	44.7	59.2	92.9	91.3	75.8	59.2	99.1	43.4	47.3	91.9	59.3	63.6	43.0	59.5	52.5	159.4	60.5	64.3	48.3	91.2	65.7	76.1	48.8	97.0	50.9	67.7	180.1	59.9	59.0	54.0	91.7	52.8	80.4	75.4	126.8	115.2	125.0	81.3	70.8	108.1	114.8	128.7	87.9	52.1	133.3	64.2	116.8	54.5	76.1	151.7	127.4	66.1	93.6	131.8	147.7	91.7	125.4	94.6	189.6	125.8	162.3	98.9	101.9	79.3	99.5	118.2	78.4	157.7	104.1	106.1	80.3	87.5	128.2	60.0	170.3	95.3	75.3	79.5	92.6	116.4	84.8	99.9	98.3	70.2	148.1	125.3	61.3	103.6	165.9	83.7	120.5	95.0	69.8	65.9	81.4	64.2	128.6	111.0	109.5	74.1	30.2	173.5	32.3	102.5	194.3	108.9	140.4	101.2	109.0	223.4	133.8	116.4	108.6	59.3	145.4	170.1	167.1	110.9	224.3	89.8	92.4	94.6	98.2	87.9	90.7	92.9	91.3	91.9	91.2	97.0	91.7	68.9	60.9	53.0	12.1	66.4	83.5	87.7	154.0	108.1	105.6	124.3	137.7	105.4	88.6	82.5	69.9	39.6	213.2	62.8	128.5	303.3	93.0	19.6	45.7	70.6	73.7	89.5	114.0	8.3	106.2	275.8	74.0	75.4	57.2	69.1	148.0	81.0	122.7	173.4	116.1	10.3	132.4	95.6	100.5	80.7	36.8	56.5	80.7	78.2	8.4	91.9	168.9	77.2	9.0	13.5	82.5	104.3	50.8	79.5	52.7	252.2	213.7	49.0	59.4	19.7	61.1	67.1	49.1	42.4	124.5	89.8	207.1	62.4	287.0	179.6	87.1
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679083-11742857	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Plasma cells: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	15.7	14.2	4.5	22.5	5.6	55.4	16.6	7.7	5.9	20.8	16.6	30.0	38.5	15.1	23.6	13.1	16.2	17.3	13.7	5.0	4.9	25.7	44.3	34.9	25.3	4.8	4.8	16.6	26.5	45.1	12.6	17.0	4.8	24.4	29.8	15.3	34.8	14.9	30.1	12.0	32.0	15.6	4.6	22.4	36.1	8.5	4.9	20.6	34.4	14.9	27.9	25.3	11.8	5.0	26.1	17.7	8.2	11.2	21.6	18.0	14.4	25.3	34.5	22.7	29.1	8.8	40.5	65.2	41.6	32.0	30.9	22.9	10.2	21.4	18.5	29.4	13.5	13.9	19.4	43.8	31.7	20.6	27.1	13.7	23.6	25.4	39.9	17.6	28.9	14.6	21.5	81.8	20.2	23.7	16.1	7.9	10.7	18.6	9.1	20.5	16.5	141.9	26.0	13.7	11.5	10.9	49.6	38.2	27.3	9.1	23.4	28.1	30.1	10.5	12.0	49.8	14.7	110.5	64.8	39.5	22.3	25.7	17.9	3.5	2.4	7.7	1.8	1.7	4.5	3.8	3.3	4.1	2.6	4.6	3.2	2.1	0.7	5.6	2.2	2.0	6.8	2.8	4.5	5.6	7.7	5.9	5.0	4.9	4.8	4.8	4.8	4.6	4.9	5.0	16.2	44.8	46.2	21.9	49.2	14.7	24.8	12.9	23.3	16.2	16.1	18.0	9.1	18.6	24.6	18.4	50.1	21.1	27.2	45.8	15.6	20.4	3.1	19.9	14.6	15.2	24.5	6.5	23.0	39.7	29.8	14.0	45.3	28.5	15.2	13.0	15.7	39.3	30.3	23.5	25.5	44.0	8.2	18.1	26.9	1.4	20.2	29.2	23.2	18.7	21.2	16.4	15.5	22.1	18.6	26.1	21.0	13.2	307.9	28.0	37.1	15.2	15.9	23.4	6.6	13.8	16.2	11.6	13.1	17.5	11.8	25.0	25.2	11.3	27.7	32.1
TXNDC15	"2310047H23Rik, C5orf14, FLJ22625"	ENSG00000113621	"Thioredoxin domain containing 15"	Q96J42	5	134874371-134901635	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015483	Approved		Approved	"Golgi apparatus"		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA015483: AB_1845722"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.36e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.50e-1)"	34.1	44.7	20.3	34.9	23.2	8.9	33.9	22.8	23.2	42.5	39.1	37.3	23.7	35.0	56.1	22.3	29.5	32.5	35.8	20.8	24.2	29.0	33.7	30.5	25.4	25.9	21.6	31.4	49.7	43.7	42.9	37.1	21.6	38.2	26.2	36.5	46.8	44.0	41.9	19.1	21.7	43.7	21.5	35.9	32.3	18.8	21.8	20.3	59.9	30.4	31.1	35.9	24.7	23.8	28.8	77.8	47.8	76.9	75.8	102.7	5.5	117.7	135.1	42.3	93.7	56.8	38.5	38.1	64.3	108.6	78.8	21.0	33.0	48.6	38.6	81.5	36.6	20.0	46.7	46.1	58.7	13.6	51.2	61.7	39.6	56.0	35.2	70.6	65.8	18.0	10.1	106.8	65.6	36.5	20.8	30.7	21.4	31.3	31.7	30.0	58.1	117.7	35.5	29.4	27.7	35.6	70.3	19.4	63.9	22.7	27.3	19.8	83.0	62.5	35.3	62.0	42.7	70.7	120.3	31.8	93.0	28.5	41.3	32.7	34.3	19.8	31.0	33.7	32.7	32.3	25.2	32.8	31.0	23.8	20.8	24.5	9.3	29.5	33.8	30.1	29.8	32.7	20.3	23.2	22.8	23.2	20.8	24.2	25.9	21.6	21.6	21.5	21.8	23.8	47.8	60.9	31.9	11.8	49.9	25.4	30.5	41.5	22.8	37.6	25.1	29.0	36.4	27.1	36.3	23.9	20.9	32.4	31.9	10.0	13.7	33.5	4.2	12.1	49.4	38.7	12.6	6.7	13.7	33.1	54.3	65.7	12.8	19.2	30.4	33.1	45.3	29.7	33.9	63.9	19.7	17.0	44.7	31.3	32.3	6.7	63.3	27.3	69.4	19.7	39.2	43.0	29.9	19.6	20.1	19.2	14.0	45.5	203.2	25.1	17.4	28.3	26.7	36.6	46.0	45.2	44.1	36.5	61.6	17.4	23.4	30.0	36.3	45.1	13.3	21.5
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430596-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 69.8;Glandular and luminal cells: 124.9;Inhibitory neurons: 88.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	6.2	4.0	4.6	3.5	4.6	5.1	6.9	10.1	6.0	9.3	0.6	5.8	4.1	6.9	14.6	3.7	4.1	5.2	3.7	4.9	4.3	5.0	7.4	4.4	4.5	3.9	4.0	10.3	6.4	7.0	3.8	5.8	4.3	26.7	5.9	9.1	4.0	13.0	2.0	4.6	4.8	4.3	4.0	10.2	6.3	7.1	4.1	5.9	4.0	4.0	3.9	3.4	3.8	6.7	8.3	0.8	8.9	5.0	6.5	4.7	7.0	2.7	3.6	4.5	8.7	3.0	6.6	13.5	8.9	2.2	2.8	7.7	10.3	3.7	6.9	5.7	13.5	6.2	6.2	2.8	4.7	7.4	2.9	8.8	3.4	5.8	4.2	4.0	5.1	5.8	8.0	20.4	3.9	4.0	9.3	5.1	9.9	5.5	4.9	18.4	16.9	12.4	5.7	8.4	29.0	10.0	13.2	13.5	3.9	7.5	8.6	5.4	2.7	6.0	3.0	6.9	4.6	5.6	8.0	13.5	1.7	7.7	3.5	1.3	3.0	1.2	1.3	2.4	1.3	0.5	1.3	0.9	2.6	0.3	0.6	0.6	1.7	0.6	2.9	1.0	2.4	1.0	4.6	4.6	10.1	6.0	4.9	4.3	3.9	4.0	4.3	4.0	4.1	6.7	9.1	9.6	6.4	23.2	6.1	6.6	6.0	2.5	9.6	42.3	26.6	19.0	10.1	8.6	5.0	7.3	8.4	2.3	15.1	8.8	1.9	5.2	4.0	69.8	9.6	7.4	18.5	21.8	61.0	3.9	1.6	7.2	13.3	124.9	2.5	13.9	15.4	14.1	3.3	10.1	88.8	17.9	0.0	18.8	8.6	4.2	27.7	13.0	1.8	24.4	5.9	7.3	7.2	45.8	51.5	1.3	8.5	52.3	11.3	19.0	5.9	2.8	4.4	44.8	0.0	11.1	11.2	12.0	9.5	8.1	8.4	1.1	7.7	5.7	10.9	4.5
TXNDC17	"MGC14353, TRP14, TXNL5"	ENSG00000129235	"Thioredoxin domain containing 17"	Q9BRA2	17	6640985-6644541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 182.9"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 785.8;Proximal tubular cells: 814.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022931	Approved					NA	NA		820000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022931: AB_1858479"	"unprognostic (8.94e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.97e-2)"	"unprognostic (5.02e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.88e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.86e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.09e-2)"	"unprognostic (9.01e-2)"	25.9	45.3	16.7	22.6	17.3	21.8	28.0	17.7	24.0	35.5	18.5	54.1	56.8	20.4	40.3	182.9	16.1	27.0	31.3	17.8	18.5	62.3	69.8	23.2	22.1	17.3	17.3	13.3	40.4	24.5	27.6	15.0	17.5	32.2	44.7	7.4	47.5	14.6	21.7	27.7	38.8	20.4	18.2	41.9	54.5	15.5	17.2	25.8	20.7	10.1	27.0	68.7	58.5	18.7	130.8	154.4	62.1	134.1	38.1	54.4	29.1	65.4	56.4	59.2	57.0	84.8	44.0	27.8	62.4	50.6	62.3	200.0	67.6	223.5	73.2	93.0	109.3	33.1	138.6	153.3	43.3	54.1	70.7	55.1	83.6	72.7	72.3	58.2	79.8	88.2	45.1	13.3	83.1	91.8	55.1	69.7	90.3	91.9	123.9	53.2	41.4	69.5	126.7	253.3	28.8	74.9	65.9	66.7	54.6	42.1	63.3	48.2	59.8	48.8	61.7	55.7	117.2	20.0	47.8	43.1	98.9	56.9	57.1	77.2	105.0	93.6	35.3	117.3	37.2	54.9	41.7	42.4	115.8	47.5	32.2	37.8	180.9	35.5	120.9	109.3	66.9	56.7	16.7	17.3	17.7	24.0	17.8	18.5	17.3	17.3	17.5	18.2	17.2	18.7	91.8	93.0	157.2	3.9	66.9	189.3	185.3	785.8	330.6	18.1	141.5	162.6	110.3	175.8	236.4	125.0	2.1	180.7	76.6	560.2	389.4	326.8	362.5	110.0	81.6	99.6	135.1	70.7	3.9	451.8	291.6	84.9	181.0	126.9	50.0	92.2	88.2	371.7	245.0	40.4	3.6	316.4	221.8	114.9	83.7	303.2	74.9	118.9	113.8	1.9	170.2	86.8	80.3	4.0	5.3	534.5	378.6	67.0	112.5	169.9	420.3	814.9	142.9	26.8	26.3	58.5	103.9	34.6	116.4	500.1	143.3	104.9	67.7	151.0	332.1	300.0
TXNDC2	SPTRX1	ENSG00000168454	"Thioredoxin domain containing 2"	Q86VQ3	18	9885726-9889275	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	311	"testis: 105.2"	"Group enriched"	"Detected in some"	98	"Early spermatids: 307.9;Late spermatids: 125.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.5;U-2 OS: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016414, HPA018817"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB016414: , HPA018817: AB_2241329"	"unprognostic (1.21e-2)"	"unprognostic (3.55e-3)"		"unprognostic (6.31e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.25e-1)"	"unprognostic (6.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.17e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.18e-2)"	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	105.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.2	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.6	0.0	0.8	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.4	0.2	1.1	0.5	0.3	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.9	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	125.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910788	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	42	"Plasma cells: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 13.0;naive B-cell: 6.9;plasmacytoid DC: 26.7"	"Group enriched"	"Detected in many"	21	"B-cells: 13.0;dendritic cells: 26.7"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 2833.2;U-266/84: 6053.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	97.4	74.8	21.1	173.0	23.4	61.8	163.4	22.0	22.5	132.2	52.7	266.2	263.5	80.5	85.8	78.2	63.9	98.6	63.3	19.8	23.2	63.1	133.3	90.9	194.2	25.0	24.7	96.4	154.6	68.6	42.5	134.0	23.2	73.2	213.6	4.4	219.3	93.6	25.1	32.9	193.9	121.9	24.9	250.6	287.6	28.3	26.4	54.1	69.6	29.2	263.8	190.9	57.0	25.9	166.1	159.0	111.5	365.9	911.2	388.1	175.9	361.5	349.7	246.2	265.2	238.8	119.0	176.1	620.7	557.2	273.6	127.3	195.5	178.6	280.3	148.8	166.6	267.6	128.3	435.9	268.5	307.2	255.0	266.7	256.8	236.6	259.2	542.1	1334.0	109.7	170.5	1216.5	171.7	147.7	75.2	185.7	142.8	260.5	340.6	128.0	160.4	2833.2	201.1	149.6	168.7	90.5	462.4	280.2	209.4	514.9	143.5	133.9	369.7	280.5	194.2	243.0	386.5	1408.7	6053.9	305.0	144.7	191.7	392.2	0.0	0.4	0.0	0.9	0.7	0.7	13.0	0.2	0.7	1.0	6.9	0.2	0.4	0.0	0.0	0.1	26.7	0.9	0.5	21.1	23.4	22.0	22.5	19.8	23.2	25.0	24.7	23.2	24.9	26.4	25.9	1.3	0.0	4.8	0.0	14.6	0.9	0.2	0.4	3.4	0.0	1.8	1.3	0.2	0.0	2.0	0.0	0.0	0.9	5.6	1.2	0.0	9.0	0.1	1.1	6.9	3.2	4.9	11.2	0.0	10.7	1.9	4.1	6.1	2.3	1.3	0.6	3.9	4.9	1.5	0.0	0.0	15.9	0.0	0.8	0.7	0.0	0.0	1.3	3.6	0.0	1.8	0.1	0.0	0.0	0.0	9.5	1.5	0.4	677.7	0.4	3.2	0.5	1.7	0.5	6.6	0.5	4.2	0.1	0.1	3.9	0.1	1.2	2.0	0.2	5.8	0.2
TXNDC9	APACD	ENSG00000115514	"Thioredoxin domain containing 9"	O14530	2	99318982-99340702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031844, HPA031845, HPA031846"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916"	"unprognostic (3.63e-3)"	"unprognostic (4.26e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (2.06e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	18.7	17.9	10.0	21.3	10.8	17.5	28.7	11.0	13.2	19.3	10.4	24.6	18.4	16.6	25.9	26.1	18.1	18.6	28.6	10.8	11.7	28.8	27.2	20.1	29.2	11.6	11.5	10.7	10.9	15.4	11.3	23.5	11.9	19.6	26.3	11.0	15.1	16.1	18.2	19.0	17.6	24.4	11.8	18.6	18.5	17.8	10.9	26.1	24.8	16.2	34.0	24.9	14.1	12.5	78.3	27.6	55.0	27.7	55.8	57.8	65.8	83.1	79.5	88.5	85.0	71.1	55.5	58.0	66.9	72.6	77.0	52.7	55.2	88.2	102.6	44.0	53.5	60.4	34.5	77.0	54.2	71.8	44.2	53.0	76.7	74.3	53.8	46.1	101.9	32.1	73.0	51.1	103.7	41.5	43.4	63.6	43.4	46.4	68.7	32.5	53.0	56.4	123.9	62.6	37.1	31.5	41.7	56.2	93.7	69.8	64.3	60.9	69.4	65.1	62.7	40.6	62.6	21.2	37.1	65.6	51.9	76.8	58.6	110.6	54.1	61.1	56.7	60.5	70.2	69.1	66.6	64.4	60.3	57.6	61.9	62.5	53.5	77.7	82.6	60.9	91.2	87.0	10.0	10.8	11.0	13.2	10.8	11.7	11.6	11.5	11.9	11.8	10.9	12.5	46.6	9.6	13.4	8.8	33.4	35.2	29.7	137.1	25.0	11.3	21.5	26.3	27.6	25.8	67.0	36.8	8.4	75.7	31.3	26.2	84.1	79.8	75.7	37.3	29.9	46.2	20.9	47.8	13.3	69.4	82.5	29.2	22.4	25.5	17.7	21.0	38.2	24.4	56.9	13.5	12.8	25.7	91.6	25.4	31.3	21.1	27.7	30.2	26.6	4.7	55.5	26.9	44.3	12.5	16.7	84.5	21.6	23.3	31.8	24.0	21.9	121.5	72.8	19.8	26.3	17.8	89.3	52.8	42.7	29.4	38.9	81.3	35.1	40.1	26.6	21.9
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996579	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2550.5;NK-cells: 2028.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	1542.7	466.8	130.3	566.5	159.9	404.7	1396.7	137.1	158.5	846.0	133.8	965.4	223.3	811.8	381.2	428.7	730.3	395.0	745.2	120.3	136.6	532.6	204.0	841.9	800.8	182.0	144.9	382.9	580.5	634.0	192.3	594.0	185.4	352.4	487.5	14.5	567.0	554.5	1446.1	1060.4	810.7	658.7	157.1	946.4	713.4	106.4	159.2	373.7	556.6	2306.2	1068.8	740.9	638.7	217.3	56.5	0.2	13.0	0.9	291.6	951.8	29.7	66.0	131.3	58.5	79.7	35.3	74.6	15.8	379.6	18.1	9.7	15.0	13.0	124.8	154.8	74.2	7.1	45.7	20.2	32.6	13.8	189.7	91.7	1276.5	664.0	119.0	206.7	781.9	23.2	61.8	184.8	121.2	30.2	76.5	31.9	180.2	36.3	112.5	48.5	28.5	107.8	498.3	151.6	122.8	61.7	99.9	283.1	80.5	239.0	26.2	29.1	266.6	56.5	160.1	10.0	304.2	108.7	169.3	170.7	13.8	39.3	86.6	86.3	1059.6	571.2	1219.2	792.2	551.3	729.8	519.3	668.8	710.4	334.4	542.4	650.2	708.5	1246.6	637.1	496.3	154.8	674.5	1684.4	130.3	159.9	137.1	158.5	120.3	136.6	182.0	144.9	185.4	157.1	159.2	217.3	2550.5	227.6	328.5	26.4	1360.4	70.7	236.9	129.8	413.8	6.5	167.4	111.2	526.0	185.8	184.4	272.2	29.2	5.0	1004.6	578.0	450.0	79.7	8.3	179.8	594.5	740.2	164.2	270.8	0.2	53.8	4.1	666.5	160.5	464.2	377.4	53.6	349.8	114.8	231.9	6.7	0.5	320.9	136.3	845.1	184.9	35.5	654.5	730.8	108.5	36.5	892.0	3.6	2028.9	45.2	55.8	225.7	459.4	447.2	639.6	370.7	79.0	169.3	155.8	3.7	1196.5	452.4	398.7	7.6	63.7	160.1	72.2	10.9	1142.8	303.9	186.9	516.2
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597209-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1100000	"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	38.3	55.9	45.4	38.6	47.5	83.0	49.1	49.1	63.6	42.5	40.1	41.7	42.1	38.3	66.9	54.2	35.2	40.0	80.0	50.0	50.9	51.7	80.7	30.6	41.2	47.7	47.2	47.1	62.2	51.4	38.2	48.1	49.5	40.5	43.4	77.9	48.5	39.3	149.0	36.5	40.6	43.4	46.2	32.2	46.7	41.9	47.5	48.0	197.9	146.8	49.9	51.8	35.1	54.0	77.7	74.8	99.2	102.8	83.2	121.6	70.2	90.2	91.8	113.4	95.4	67.0	74.2	83.4	78.1	98.4	82.3	93.7	94.4	81.3	116.9	85.7	43.1	114.9	58.3	127.1	98.3	168.9	71.7	92.9	82.4	107.4	97.4	118.8	93.0	62.9	85.5	136.0	116.0	74.4	98.1	109.8	71.9	53.5	79.6	78.2	66.8	145.9	133.0	118.6	81.6	74.5	51.3	70.9	88.1	78.3	77.5	89.1	74.3	118.7	62.9	41.9	89.5	130.8	151.1	130.5	77.2	127.0	89.1	98.5	63.1	48.3	26.9	55.8	37.2	38.9	33.0	35.8	54.8	35.4	32.0	32.9	48.3	43.3	54.9	47.0	42.9	61.5	45.4	47.5	49.1	63.6	50.0	50.9	47.7	47.2	49.5	46.2	47.5	54.0	89.7	57.7	45.9	25.5	80.0	134.3	123.1	177.1	75.7	82.7	89.3	110.4	110.1	67.2	108.3	29.5	139.7	242.3	82.7	72.2	109.5	150.5	246.9	88.0	90.0	84.2	75.9	153.8	43.8	128.3	130.9	86.1	52.0	90.3	53.2	167.5	52.8	78.0	150.1	57.2	43.6	111.6	77.3	97.3	97.0	294.1	77.6	90.5	65.8	15.9	121.8	86.0	78.2	26.2	55.6	139.5	83.7	83.8	88.9	121.2	110.0	144.7	75.1	97.1	65.7	73.0	167.1	204.1	108.0	93.9	126.0	358.6	72.4	171.0	109.7	123.1
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
TXNRD3	"TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126571779-126655124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	4.9	4.0	2.4	2.2	2.4	1.1	6.1	3.4	1.9	4.7	3.1	2.4	1.3	5.1	5.9	4.8	3.6	3.6	3.1	1.8	3.3	5.7	8.7	4.2	1.1	2.8	3.0	6.7	6.3	8.2	1.7	2.9	2.8	3.8	3.0	1.9	3.7	4.1	5.6	3.2	1.4	4.9	3.0	2.6	3.6	20.4	3.0	4.6	6.1	5.8	1.4	3.2	1.9	2.8	16.0	3.8	4.9	8.3	8.7	13.1	2.7	6.7	5.8	5.4	7.4	7.6	8.7	0.0	8.5	9.7	3.4	6.4	6.3	7.1	6.4	0.0	5.1	1.5	3.7	5.9	7.8	6.4	0.6	13.1	5.9	1.8	12.1	7.0	3.8	5.2	3.7	0.0	9.0	12.2	1.4	3.4	7.3	4.3	3.4	0.5	4.2	2.6	6.0	8.0	8.9	5.1	19.9	5.7	10.3	3.7	8.0	2.6	6.9	6.8	1.8	9.3	3.3	4.0	1.9	0.0	3.5	2.2	5.6	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	2.4	2.4	3.4	1.9	1.8	3.3	2.8	3.0	2.8	3.0	3.0	2.8	1.3	3.2	7.2	14.4	0.4	1.0	5.7	1.6	6.2	2.0	2.9	2.4	4.1	4.3	3.0	3.7	2.1	9.4	0.1	0.5	3.9	5.1	18.2	1.5	4.0	1.7	4.2	3.0	7.5	3.8	5.4	5.3	4.1	1.0	5.7	6.1	2.9	8.0	2.9	0.0	5.8	2.4	0.0	0.8	0.7	4.0	4.7	1.0	0.0	3.7	0.0	3.2	0.0	11.1	4.7	3.8	0.3	8.6	0.1	5.5	0.1	4.5	3.3	0.9	0.0	5.7	2.8	71.5	18.2	6.1	0.6	7.3	0.6	6.6	1.5	3.2
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380572	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 206.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	53.0	60.5	69.9	37.0	71.9	82.6	52.5	70.7	82.3	55.8	72.2	51.5	29.4	44.8	22.6	46.2	49.0	26.2	65.0	69.6	68.8	77.3	111.2	72.6	51.5	75.1	71.4	56.4	65.1	28.6	66.2	20.1	71.5	64.5	25.7	25.2	50.8	20.6	41.3	51.1	73.9	23.5	70.2	140.8	54.6	16.6	71.8	54.4	60.2	33.7	51.8	49.3	46.0	76.4	29.1	41.1	24.1	38.0	31.9	44.2	23.5	38.9	39.1	48.1	52.2	31.5	18.7	44.5	44.5	43.4	32.8	28.4	29.4	45.5	24.2	78.0	45.5	81.4	90.5	80.2	49.4	34.4	89.4	43.2	31.3	54.5	32.2	29.9	46.5	56.6	35.0	116.1	42.3	90.1	50.7	206.9	7.7	28.4	71.8	49.9	21.1	45.1	40.0	90.1	22.4	28.0	37.6	38.6	28.1	18.4	21.5	57.2	41.1	61.7	22.7	74.1	45.9	97.2	81.4	40.2	32.4	70.8	36.6	9.8	20.8	27.2	12.8	15.2	7.9	7.5	7.6	11.6	23.5	8.0	5.0	7.1	33.0	8.6	15.7	13.0	10.1	13.0	69.9	71.9	70.7	82.3	69.6	68.8	75.1	71.4	71.5	70.2	71.8	76.4	18.6	12.8	17.9	13.1	17.5	6.6	5.4	7.6	13.1	9.2	10.3	11.0	25.7	11.5	11.1	9.2	4.2	7.0	23.2	14.6	52.8	7.6	2.1	10.2	12.6	12.8	4.8	8.6	10.4	11.1	9.7	11.1	27.0	12.0	19.6	17.1	15.4	27.1	14.6	0.0	9.2	8.7	8.2	28.2	14.6	8.8	7.5	30.8	16.0	12.2	25.3	8.7	17.5	11.1	11.1	11.8	12.9	9.8	19.5	5.9	12.1	29.0	11.2	11.0	0.0	10.5	12.6	1.5	4.5	8.8	7.2	6.7	19.4	13.6	11.1	6.3
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		11000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	46.8	19.5	6.1	77.7	6.0	22.0	37.9	7.1	7.9	32.2	12.7	20.4	26.1	7.8	0.5	58.5	30.0	7.2	26.7	6.4	8.6	38.2	82.0	63.4	31.5	22.1	18.3	4.0	13.8	4.5	8.8	15.4	15.9	21.0	3.6	0.0	40.0	5.6	10.7	24.5	32.5	9.1	10.9	86.1	31.2	3.0	18.0	15.6	25.4	1.6	15.3	22.9	27.0	12.2	27.0	2.5	0.4	0.8	1.8	2.2	5.1	3.7	0.5	6.1	17.4	0.1	40.0	1.8	4.1	5.8	1.3	21.0	0.2	1.0	0.0	9.0	16.5	1.8	3.9	3.5	95.2	1.3	26.9	4.7	4.6	5.4	0.0	0.1	0.1	0.5	2.8	68.6	0.9	1.9	1.5	9.9	0.6	1.9	9.1	5.7	0.4	35.1	0.3	1.2	0.7	5.6	22.9	17.3	6.5	0.2	4.2	13.8	6.7	0.8	4.7	1.5	1.5	68.6	15.9	5.7	1.9	1.5	1.6	19.5	135.8	74.9	2.0	98.4	1.2	6.7	2.9	1.2	39.5	6.9	1.6	1.3	114.1	9.5	77.1	9.3	3.1	10.1	6.1	6.0	7.1	7.9	6.4	8.6	22.1	18.3	15.9	10.9	18.0	12.2	122.6	12.8	29.0	0.3	122.9	58.5	57.4	169.9	53.5	3.4	101.5	90.8	3.2	50.1	88.6	33.1	4.2	17.2	65.8	154.8	29.4	340.2	2.2	55.7	56.0	55.7	16.8	19.6	0.3	643.9	300.8	81.9	38.7	59.2	53.4	3.0	38.2	93.0	477.4	0.0	0.4	50.2	24.4	371.8	409.4	8.7	5.0	561.7	113.8	4.7	2174.6	2.9	71.1	0.5	0.2	364.0	86.4	1.9	102.1	109.8	214.5	105.1	78.0	6.6	26.3	93.3	62.4	1.5	8.0	71.7	56.7	33.5	62.5	3.7	51.1	76.0
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.5;lymphoid tissue: 113.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.7;T-cells: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002784, HPA074922"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	4.5	3.1	4.3	24.2	7.5	88.5	6.7	4.1	6.5	4.8	2.7	22.9	10.5	5.1	1.3	14.8	5.6	3.8	2.2	5.0	4.9	6.5	11.8	4.9	36.1	4.9	5.2	2.1	3.6	1.8	1.6	22.3	4.4	3.1	27.1	4.2	3.9	2.0	0.4	6.2	14.8	12.7	4.8	10.6	8.8	34.3	6.1	113.6	2.1	0.4	44.5	8.4	5.5	10.3	102.7	156.6	320.4	154.9	35.1	57.9	159.9	238.9	141.1	251.7	299.9	132.8	80.1	160.0	91.5	129.9	143.2	45.1	225.3	89.7	216.1	152.3	244.9	273.1	135.8	229.4	8.2	564.8	286.5	51.5	20.7	159.6	49.6	48.4	214.4	334.0	222.0	249.6	321.8	118.1	687.7	311.4	114.7	124.3	114.0	446.8	287.0	191.3	95.6	88.9	106.0	175.7	201.4	91.6	61.1	197.3	63.5	253.5	85.0	289.7	569.5	267.3	474.2	305.9	405.2	367.3	75.2	240.6	339.2	0.0	0.0	1.3	1.1	0.1	0.0	1.1	2.8	2.2	1.8	0.0	0.0	0.6	0.7	6.7	0.1	0.3	14.1	2.9	4.3	7.5	4.1	6.5	5.0	4.9	4.9	5.2	4.4	4.8	6.1	10.3	2.1	0.0	2.3	1.6	15.7	14.4	15.9	13.0	27.9	0.5	7.8	11.7	3.6	2.8	6.7	0.0	0.0	105.8	14.5	15.5	1.9	2.3	34.4	5.6	8.4	12.5	1.2	189.3	0.4	0.8	115.3	28.3	14.3	7.4	7.0	76.2	6.8	4.3	71.4	0.0	0.6	20.9	10.2	15.6	19.4	31.9	6.2	10.7	10.6	1.0	3.9	45.0	5.2	0.5	15.6	1.5	8.9	3.8	112.7	5.0	13.8	36.6	1.0	2.4	13.1	1.3	32.6	180.8	30.7	48.0	7.2	27.0	21.3	10.5	54.9	18.7
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177875-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"skin 1: 31.6"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 184.9"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	995	"SK-MEL-30: 426.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.3	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.5	5.2	0.3	0.0	184.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.0	0.0	0.1	0.0	0.0	0.0
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583589	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;ovary: 49.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		17000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	21.5	3.5	18.2	1.4	30.3	0.8	5.2	17.7	27.1	2.1	0.0	2.3	1.6	4.6	3.5	13.1	11.5	2.5	2.2	27.7	10.7	11.3	0.8	3.3	1.3	20.9	22.6	49.7	9.8	0.9	0.9	5.7	18.6	2.6	0.9	2.6	1.9	6.1	0.9	13.8	2.4	4.4	14.4	5.5	3.2	18.8	15.7	0.4	1.1	1.8	3.7	2.1	4.1	32.0	10.3	6.7	20.7	22.7	18.9	12.8	69.2	14.6	9.3	14.2	13.1	37.7	3.4	0.4	18.3	11.9	19.9	23.7	23.3	3.6	6.5	5.8	15.5	3.2	20.2	18.1	13.3	5.2	0.4	4.1	7.3	10.9	3.6	5.8	10.6	9.8	19.1	4.3	7.9	9.8	2.4	1.0	47.7	16.0	6.7	31.9	18.6	3.8	1.2	19.7	24.6	7.0	13.7	21.6	16.3	29.8	17.8	6.0	8.4	28.0	12.2	21.0	22.5	1.7	3.5	3.1	17.2	33.8	17.2	1.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.5	0.3	0.1	0.3	0.1	0.1	18.2	30.3	17.7	27.1	27.7	10.7	20.9	22.6	18.6	14.4	15.7	32.0	3.4	3.2	1.1	17.6	0.9	6.8	8.5	0.4	0.6	2.7	2.2	2.2	2.9	2.8	0.7	3.7	6.2	2.9	1.1	1.3	0.0	3.9	3.6	1.1	13.0	5.4	1.8	0.0	42.4	3.6	10.2	10.5	8.6	1.9	0.0	7.6	9.7	0.4	1.2	0.0	4.6	0.9	0.0	1.9	1.3	5.1	44.4	0.9	8.8	1.0	0.1	8.3	1.0	29.1	46.8	4.6	0.1	47.0	0.3	6.4	1.2	1.2	0.5	4.0	0.0	3.9	4.3	4.0	6.5	4.2	10.9	18.9	0.7	5.8	2.3	5.7
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710285	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 44.8;heart muscle: 59.9;skin 1: 145.0"	"Cell type enriched"	"Detected in some"	17	"Melanocytes: 2486.6"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"SK-MEL-30: 1395.0"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 4.6;thalamus: 1.8"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		51000		"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.3	0.0	0.1	0.6	0.4	0.2	4.9	0.3	0.9	0.0	44.8	2.2	5.0	0.0	1.2	10.0	0.2	4.5	59.9	2.6	0.0	16.2	0.0	3.7	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	5.3	2.7	1.3	0.0	4.8	145.0	4.7	1.8	0.1	0.0	2.1	1.1	0.3	0.0	0.0	7.5	0.0	1.1	0.4	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	1395.0	0.1	19.5	1.5	0.0	0.0	0.7	0.0	0.9	0.0	0.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.9	2.6	0.0	1.2	1.1	2.1	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	92.3	0.1	0.0	0.0	11.7	0.0	0.0	44.3	0.0	0.0	3.7	2.1	0.0	0.0	0.0	144.8	0.3	2.5	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	17.5	4.7	0.3	0.0	2486.6	0.0	0.0	15.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	1.4	0.7	0.7	0.0	16.8	0.0	0.5	0.0	0.0	0.2
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin like peroxisomal matrix peptidase 1"	Q2T9J0	10	70137981-70146700	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 27.5;PC-3: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	5.7	6.0	1.4	1.9	1.3	0.9	5.4	1.7	1.8	5.8	1.1	4.9	3.3	4.1	0.6	11.8	4.5	0.6	2.9	1.0	0.9	5.2	6.4	2.8	1.8	2.1	0.7	4.2	6.2	1.3	3.4	1.3	0.8	5.7	0.6	0.2	5.7	1.5	3.2	11.4	5.0	0.3	0.6	5.4	3.9	14.2	0.9	1.2	4.6	0.5	0.9	4.8	6.5	1.4	16.0	10.2	0.8	6.2	1.0	0.9	3.7	2.2	1.4	2.0	1.8	6.2	9.6	13.8	6.0	0.5	0.6	27.5	1.0	3.9	0.4	8.9	9.5	0.7	2.9	3.3	2.4	1.2	0.1	2.0	7.6	1.7	3.1	1.2	1.4	4.9	0.1	4.3	0.8	6.3	5.3	5.6	3.3	3.5	41.7	8.9	2.6	6.2	0.9	2.6	7.4	3.8	6.7	14.8	6.1	0.2	9.4	1.1	2.6	2.5	1.7	4.8	8.7	14.9	9.9	7.0	2.9	6.2	1.8	0.0	0.8	0.7	3.8	1.2	2.4	3.0	2.2	2.8	0.9	3.3	3.0	2.6	0.3	2.0	0.7	0.7	2.6	1.4	1.4	1.3	1.7	1.8	1.0	0.9	2.1	0.7	0.8	0.6	0.9	1.4	6.1	9.6	5.3	4.9	12.6	14.3	14.5	13.3	14.8	6.9	14.8	16.9	4.2	27.1	7.8	11.0	0.0	35.2	15.5	14.6	17.6	7.8	120.7	5.5	6.8	6.3	14.3	5.0	6.7	9.5	9.8	7.5	5.1	6.3	13.4	9.3	6.8	16.5	12.1	0.0	6.0	12.1	16.2	10.7	6.6	227.4	9.3	8.2	12.4	6.5	6.1	7.0	12.3	11.6	5.5	5.5	11.6	7.9	7.5	14.5	19.2	16.5	3.9	4.4	6.6	6.9	6.1	124.7	12.5	22.4	18.5	16.7	14.0	10.6	21.0	8.8
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.8;Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	7.7	10.8	5.5	8.1	5.9	9.1	10.0	6.6	7.6	13.0	8.8	9.0	9.5	9.2	9.7	6.6	10.1	7.1	7.9	5.6	6.4	8.8	12.0	7.2	9.8	6.4	5.8	12.2	7.3	13.1	6.9	8.4	6.1	9.8	10.7	9.0	7.1	9.5	15.6	7.9	7.8	9.2	5.6	7.7	7.7	8.1	5.7	10.4	12.8	8.4	9.4	8.5	8.7	7.3	16.3	20.5	12.1	24.9	17.4	12.0	13.8	16.8	12.9	12.9	12.0	23.3	20.2	28.1	25.2	15.4	18.6	18.4	24.9	20.3	18.4	22.1	24.1	11.9	17.1	15.6	17.7	27.7	15.1	12.4	20.3	17.5	27.0	10.6	13.0	20.9	32.3	16.0	15.6	15.7	18.1	23.4	21.1	27.2	18.8	19.7	16.6	34.8	17.4	16.4	18.2	18.3	20.4	38.4	17.6	22.7	26.6	19.6	14.0	15.0	10.8	11.8	23.3	16.1	25.7	33.2	12.1	25.9	20.8	2.4	7.4	3.9	8.5	7.7	11.2	8.3	8.8	9.5	8.8	9.8	10.8	11.7	1.8	11.1	10.0	6.7	6.8	6.2	5.5	5.9	6.6	7.6	5.6	6.4	6.4	5.8	6.1	5.6	5.7	7.3	10.0	6.4	15.3	39.2	18.2	10.5	5.3	10.0	17.1	12.0	11.4	11.7	9.5	10.0	7.6	11.0	4.2	18.6	11.7	7.8	0.0	7.8	7.3	10.9	18.0	8.8	4.8	12.6	57.8	6.9	13.1	11.0	12.8	10.9	34.2	9.1	6.1	14.2	7.7	3.3	53.4	12.3	12.2	7.1	11.2	4.5	8.4	10.3	8.8	43.1	10.0	6.8	10.3	50.3	58.7	7.1	4.0	8.2	18.0	6.2	4.9	2.4	9.6	11.5	19.7	11.2	10.4	23.9	23.4	15.6	16.9	15.2	17.1	10.2	11.4	3.3
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"	Q6NUM6	7	72558744-72828200	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Excitatory neurons: 47.4;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.3	1.8	2.4	1.3	2.3	2.9	2.5	2.0	2.6	4.1	6.9	1.8	1.0	2.4	2.9	2.0	2.3	0.9	1.5	2.5	2.3	1.8	4.5	1.6	1.7	1.8	1.4	5.3	2.0	1.7	2.1	1.8	1.9	2.6	2.4	2.5	1.8	2.7	3.4	2.6	1.7	1.3	1.5	1.9	2.0	2.9	1.8	2.4	3.4	1.1	2.5	2.6	3.1	3.1	2.4	2.5	1.0	2.0	1.5	0.5	1.1	1.2	0.5	1.0	1.1	8.0	4.1	7.4	0.7	0.8	1.0	1.1	1.9	0.8	1.2	8.0	2.3	0.7	1.2	4.7	0.8	7.6	2.0	3.6	0.5	1.2	0.8	0.6	0.7	1.6	10.3	7.5	1.0	1.0	2.5	3.8	1.8	3.1	4.5	1.4	5.4	2.7	1.1	0.8	1.7	0.9	1.5	8.2	4.5	3.1	2.1	2.6	3.1	1.8	4.1	9.4	1.4	6.5	8.4	8.2	0.5	2.1	9.5	3.0	1.9	3.3	1.5	0.8	1.3	4.7	0.9	0.9	0.7	2.3	1.1	1.4	2.2	1.2	0.8	2.9	1.0	0.6	2.4	2.3	2.0	2.6	2.5	2.3	1.8	1.4	1.9	1.5	1.8	3.1	3.5	0.0	2.0	21.9	7.2	0.0	1.8	0.0	2.2	4.3	3.4	3.4	5.3	2.8	0.6	0.0	10.4	4.8	5.4	2.1	0.0	2.9	4.9	3.6	7.6	3.2	0.0	3.2	47.4	0.7	1.7	3.3	4.6	5.3	1.3	2.0	1.8	2.7	3.1	1.7	27.7	2.9	0.0	1.0	0.0	1.1	0.9	3.0	0.0	15.0	3.2	0.9	2.1	23.1	41.4	0.8	2.3	0.7	5.8	2.2	2.0	0.7	1.5	8.0	0.0	6.9	5.2	5.6	5.2	5.4	0.0	1.9	5.1	5.4	2.2	1.1
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	12.9	15.4	10.8	11.7	11.8	13.1	17.0	11.3	12.7	13.4	10.2	15.2	8.9	16.0	12.2	11.6	14.7	9.2	20.3	10.5	12.5	17.4	13.8	10.6	14.6	11.2	12.1	26.6	11.7	21.5	11.7	12.7	11.8	15.1	11.1	14.6	14.0	13.6	10.6	9.9	8.9	17.9	11.5	11.0	11.5	11.9	11.6	12.7	19.2	14.4	16.4	15.2	11.1	13.2	19.6	16.1	27.3	19.5	30.3	32.9	41.4	32.9	30.0	30.7	26.9	34.3	16.2	51.0	29.4	28.6	45.1	15.6	31.5	37.9	38.3	31.9	27.1	40.2	49.4	67.0	19.9	81.2	24.9	25.1	37.7	39.2	37.6	24.7	27.7	34.8	70.8	38.0	39.9	16.6	39.8	27.1	72.8	29.2	37.2	37.2	56.8	23.0	26.6	25.2	21.1	18.0	15.7	42.4	53.7	29.5	23.2	29.3	18.2	13.6	37.0	37.0	40.2	21.9	42.7	35.4	30.3	29.0	39.9	9.1	6.4	1.8	10.6	8.8	10.0	10.7	9.2	9.7	9.9	9.8	13.2	14.2	0.5	15.4	6.9	9.6	9.4	5.8	10.8	11.8	11.3	12.7	10.5	12.5	11.2	12.1	11.8	11.5	11.6	13.2	30.6	16.0	23.9	17.6	34.1	25.6	40.5	32.7	58.1	34.5	32.4	42.3	29.9	20.0	28.6	16.5	4.2	44.5	21.2	7.4	78.2	36.2	19.8	28.9	38.8	31.7	13.8	18.5	28.0	59.4	51.1	34.7	15.8	29.0	21.0	32.8	21.8	29.2	33.1	50.5	22.7	19.5	22.4	30.9	22.6	19.6	43.5	26.2	21.4	14.0	39.5	27.6	37.0	30.2	24.5	32.5	8.4	61.3	35.6	45.7	12.2	64.4	18.4	22.5	13.1	44.2	36.0	34.3	45.3	44.1	22.7	22.3	29.2	55.7	25.9	31.2
TYW5	"C2orf60, FLJ37953"	ENSG00000162971	"TRNA-yW synthesizing protein 5"	A2RUC4	2	199928913-199955736	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028294, HPA045803"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA028294: AB_2672549, HPA045803: AB_10964878"	"unprognostic (3.44e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.30e-3)"	"unprognostic (9.54e-2)"	"unprognostic (6.98e-3)"	"unprognostic (2.87e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.42e-3)"	1.0	2.1	2.7	1.4	2.9	3.6	2.1	4.4	3.9	1.0	2.7	1.3	1.8	1.5	1.9	0.9	1.2	1.0	0.9	2.9	2.6	1.6	2.5	1.4	2.3	2.5	2.5	1.7	1.0	1.6	0.5	1.1	2.6	1.4	1.5	7.0	1.7	1.1	1.8	3.7	2.1	1.1	2.2	2.5	1.6	1.1	2.7	1.2	1.7	0.9	1.5	1.0	0.5	4.0	1.3	1.6	2.0	1.7	1.5	1.8	2.3	1.9	1.2	1.5	1.3	1.8	1.6	1.1	1.2	1.3	1.7	1.7	3.1	1.5	2.2	2.0	1.3	2.1	2.7	2.3	3.6	2.4	1.5	1.9	3.5	0.9	3.1	3.5	1.3	1.5	1.7	1.4	0.9	1.9	1.7	3.9	2.4	1.5	2.6	1.5	1.7	1.3	2.8	1.7	1.7	1.3	1.4	2.8	4.2	3.7	1.4	2.7	1.5	1.4	1.2	1.6	1.5	2.4	2.2	1.0	2.3	2.2	1.6	0.5	0.3	0.6	0.3	0.3	0.3	0.3	0.4	0.4	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.2	0.4	0.1	2.7	2.9	4.4	3.9	2.9	2.6	2.5	2.5	2.6	2.2	2.7	4.0	6.4	6.4	15.5	17.6	8.4	8.3	14.7	9.7	3.4	24.4	4.5	3.7	5.6	4.3	9.6	12.9	123.0	10.4	8.2	6.0	3.9	8.5	2.6	5.4	5.7	7.8	2.4	7.8	17.7	6.2	9.3	8.7	6.6	5.2	6.3	17.1	10.0	8.9	6.0	8.4	15.8	6.7	12.2	8.5	13.9	1.1	6.2	5.7	7.2	14.0	12.1	39.0	14.4	13.0	27.0	10.0	6.7	5.7	5.5	16.5	20.1	10.6	8.5	33.7	6.6	9.7	10.5	10.5	12.4	5.2	6.0	8.3	9.4	12.3	10.3	17.0
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
U2AF1L4	"MGC33901, U2AF1L3, U2af26"	ENSG00000161265	"U2 small nuclear RNA auxiliary factor 1 like 4"	Q8WU68	19	35742464-35745445	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052083, HPA061644"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052083: AB_2681720, HPA061644: AB_2684574"	"prognostic favorable (2.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.58e-5)"	"unprognostic (3.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (8.58e-5)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.05e-4)"	2.6	3.7	8.9	1.5	9.9	1.7	2.2	8.6	12.6	3.5	7.1	5.5	1.6	3.5	0.0	2.3	3.9	0.5	11.4	9.5	9.9	4.3	2.4	2.4	0.4	9.8	9.3	4.4	2.2	5.4	5.4	1.8	9.6	3.7	0.6	4.6	1.8	3.0	9.1	1.5	2.6	2.1	8.8	2.5	3.5	8.5	9.2	2.6	2.8	6.9	0.9	4.1	2.5	9.9	4.1	13.7	2.2	3.3	0.4	1.6	3.0	3.3	3.4	8.3	8.2	5.1	3.3	1.7	6.6	7.7	7.7	1.9	6.7	5.4	5.1	10.7	1.5	2.3	3.4	5.9	10.2	2.6	5.5	2.0	2.1	3.4	2.0	3.0	1.6	5.2	4.4	4.6	5.5	8.5	8.0	2.5	3.1	8.9	2.7	2.2	3.0	0.0	1.9	0.6	4.5	4.1	5.0	3.7	1.2	4.4	3.7	4.9	2.9	5.3	2.2	1.4	5.5	5.4	7.0	3.5	4.1	5.9	6.6	0.0	2.0	1.7	2.9	4.0	2.9	8.4	5.7	5.5	2.4	6.8	8.1	7.8	2.3	0.9	2.7	9.0	10.2	3.3	8.9	9.9	8.6	12.6	9.5	9.9	9.8	9.3	9.6	8.8	9.2	9.9	12.0	19.2	25.4	7.8	40.9	10.3	14.3	34.7	10.2	26.9	19.8	18.9	4.7	8.6	16.5	9.2	14.6	14.9	35.2	20.1	27.4	11.1	13.9	6.5	8.9	11.9	12.6	7.8	6.5	12.6	9.4	13.6	12.2	7.8	36.6	10.3	10.4	18.3	19.2	20.2	7.1	13.4	48.8	18.5	36.3	15.6	15.5	18.4	30.2	1.9	27.9	12.3	30.9	4.5	7.7	9.5	22.5	12.4	38.4	12.0	23.6	26.6	12.7	29.3	13.1	15.2	16.7	36.7	16.0	9.3	8.8	29.6	39.1	12.6	10.7	12.7
U2AF1L5		ENSG00000275895	"U2 small nuclear RNA auxiliary factor 1 like 5"	P0DN76	21	6484623-6499261	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.0;Club cells: 14.2;granulocytes: 30.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Uncertain	Nucleoplasm		NA	NA		28000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (6.54e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.20e-2)"	48.0	41.4	34.1	50.7	33.1	71.5	47.4	33.0	42.7	40.8	29.2	45.3	44.2	43.2	54.4	39.6	47.4	26.1	39.8	33.3	34.7	47.7	44.4	32.0	55.4	35.1	32.9	58.1	47.6	34.9	41.7	52.8	35.0	34.2	54.1	48.7	31.8	31.0	40.1	41.5	36.4	47.5	35.4	52.3	34.3	39.6	33.7	86.5	49.4	39.0	80.9	55.6	19.9	36.2	195.0	186.6	156.9	128.0	107.5	76.0	80.6	118.0	103.5	164.3	88.2	83.2	88.6	571.9	105.2	149.3	191.6	143.2	275.3	223.6	195.6	143.0	266.8	226.8	170.8	311.9	178.1	401.0	125.5	61.1	64.6	91.6	121.6	77.5	179.7	58.4	479.7	186.2	150.5	85.4	216.3	131.2	212.7	250.6	76.2	277.6	91.4	108.7	167.9	274.8	164.7	124.3	70.3	139.5	91.0	63.8	78.1	222.5	234.7	121.5	217.1	51.1	86.7	184.5	212.6	538.1	105.0	260.3	176.3	175.4	197.4	182.8	147.0	189.1	162.2	210.7	176.6	172.2	207.3	236.6	188.1	165.4	348.0	169.9	127.9	297.9	246.3	235.8	34.1	33.1	33.0	42.7	33.3	34.7	35.1	32.9	35.0	35.4	33.7	36.2	2.6	12.8	18.0	0.0	0.8	0.0	4.2	0.0	0.0	0.2	4.7	2.7	0.0	2.8	14.2	0.0	0.0	1.4	3.2	0.4	1.9	4.8	0.7	2.8	3.1	2.9	2.4	0.0	0.0	7.1	1.9	7.5	0.0	3.6	30.3	3.8	1.4	1.2	1.1	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.3	2.9	0.0	0.0	2.9	0.5	1.0	0.0	0.0	6.4	2.1	1.2	0.9	3.8	1.5	1.7	10.2	0.4	0.0	1.8	1.5	1.9	2.0	0.0	0.0	2.1	2.0	3.9	1.4	2.0
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060725	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	22.1	18.2	16.6	19.3	17.1	57.6	23.4	21.9	25.1	25.0	15.9	21.3	12.9	22.6	20.8	21.5	23.9	12.3	18.1	16.2	16.8	23.2	24.3	18.8	29.9	16.4	16.1	31.7	25.2	22.5	21.5	17.8	16.6	19.8	20.1	51.8	18.5	14.5	27.4	21.9	22.0	17.5	15.1	25.7	19.9	20.4	16.2	31.3	22.5	17.7	26.1	20.9	21.9	20.8	165.4	54.2	59.7	40.1	30.9	28.3	103.9	72.8	46.4	82.2	61.2	72.7	49.7	189.2	76.0	47.5	157.0	58.2	124.0	66.1	93.2	51.8	88.0	205.1	49.9	58.3	31.7	202.1	75.3	34.4	32.0	64.3	81.9	36.4	45.4	118.5	129.5	59.1	39.0	46.3	100.4	86.8	96.7	52.8	50.4	101.9	116.2	79.0	40.8	102.8	76.5	44.5	146.1	48.2	87.1	61.2	85.3	84.8	49.5	44.1	52.2	35.1	118.0	69.4	97.5	319.8	34.9	72.1	63.1	40.2	32.7	33.3	40.9	31.7	35.1	60.1	37.1	37.0	27.0	60.7	42.4	36.6	33.3	35.5	48.2	53.9	40.5	21.6	16.6	17.1	21.9	25.1	16.2	16.8	16.4	16.1	16.6	15.1	16.2	20.8	124.4	118.6	129.4	116.2	94.8	60.8	85.7	140.5	68.9	124.2	64.4	90.3	123.8	52.9	115.6	62.5	66.7	78.9	109.9	50.0	52.8	77.2	35.1	91.5	129.4	96.4	55.2	126.0	71.7	79.8	83.7	103.8	58.1	99.1	98.1	165.5	62.8	58.5	61.3	92.5	80.7	74.7	85.5	60.2	54.6	22.0	108.7	78.4	51.6	63.7	115.9	98.1	110.2	104.5	145.8	89.6	55.7	79.7	108.7	81.9	48.0	60.6	100.2	125.4	78.9	122.8	139.4	243.6	235.6	76.9	64.8	79.1	98.6	111.6	80.7	78.4
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 244.5;BJ hTERT+: 148.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	37.7	17.9	10.5	7.8	13.1	1.0	33.0	11.0	12.9	25.1	24.2	14.6	22.2	22.1	21.5	28.9	21.6	32.2	28.0	9.4	11.8	30.8	17.3	30.7	8.0	13.3	12.8	31.2	12.7	12.5	11.5	28.6	13.0	21.6	15.4	11.9	25.3	18.4	142.0	19.4	22.3	16.0	12.1	30.0	15.9	16.1	14.2	4.6	35.6	106.0	6.7	13.2	25.4	14.7	42.7	34.8	15.2	20.2	29.9	127.9	0.1	244.5	148.4	62.7	53.8	58.5	61.5	29.2	65.6	61.4	18.4	48.1	34.4	19.4	78.3	0.1	15.3	16.4	27.9	12.3	38.8	0.4	6.0	60.8	10.7	37.1	28.1	103.3	67.7	6.9	4.1	0.1	78.7	14.0	0.1	2.6	12.7	19.3	18.0	0.0	109.6	0.2	30.3	14.4	4.0	7.6	46.5	7.1	48.9	30.3	13.4	4.9	130.5	3.6	24.8	20.6	39.1	2.3	8.8	0.2	31.4	4.4	27.4	0.1	0.9	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.8	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	10.5	13.1	11.0	12.9	9.4	11.8	13.3	12.8	13.0	12.1	14.2	14.7	293.0	6.4	6.4	31.6	5.4	11.3	14.6	13.7	10.2	6.3	22.2	33.3	175.1	18.6	19.2	49.7	4.2	1.0	2.1	66.5	3.9	49.0	21.0	75.3	46.3	177.4	9.1	3.0	0.9	48.7	1.9	81.6	33.6	53.0	15.2	34.9	47.5	18.8	9.6	25.2	0.7	33.1	6.1	24.3	8.6	15.2	125.2	15.8	30.2	184.6	9.5	49.4	2.1	6.0	62.0	78.8	35.7	141.1	0.8	21.8	45.3	5.0	61.9	4.2	52.6	53.5	96.2	46.4	35.2	16.4	13.1	1.0	2.9	62.7	24.2	10.9
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077517-137084539	"Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 21.7;Horizontal cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	11.6	14.1	13.5	5.5	18.7	3.1	9.5	14.3	16.4	15.0	15.8	8.1	5.7	6.7	5.1	6.0	7.6	5.3	11.0	14.4	14.0	14.0	2.8	12.5	7.9	16.6	15.8	3.8	9.6	7.9	15.4	6.3	15.8	13.0	3.6	2.9	11.0	5.6	2.7	10.1	10.8	3.5	12.6	22.0	10.2	3.2	19.0	2.4	14.1	2.7	5.9	10.0	9.1	24.1	0.8	5.8	0.0	15.7	26.4	12.1	4.5	8.1	21.1	22.4	15.4	11.7	2.6	3.7	4.7	8.3	40.6	12.1	29.6	2.0	4.6	10.0	2.7	7.9	9.5	11.3	58.5	0.1	31.5	8.9	2.1	12.7	10.4	10.4	17.7	7.3	2.4	18.0	15.2	13.5	0.8	8.1	2.6	28.3	8.3	12.8	0.2	11.3	8.9	1.1	9.3	5.8	2.0	44.3	18.7	3.7	23.9	21.8	14.1	40.2	8.6	28.3	3.9	19.6	30.1	7.9	34.9	8.6	11.7	0.1	1.0	0.0	0.2	0.5	0.8	0.5	0.1	0.3	0.5	0.2	0.2	0.3	0.1	0.0	0.0	0.3	0.5	0.4	13.5	18.7	14.3	16.4	14.4	14.0	16.6	15.8	15.8	12.6	19.0	24.1	2.4	0.0	8.4	16.0	6.9	6.1	0.6	2.0	4.0	6.8	4.8	3.9	4.0	5.7	1.5	0.0	2.1	0.4	7.1	2.1	11.7	1.4	0.2	2.2	4.9	3.1	1.8	0.4	3.3	0.9	5.0	4.0	1.1	3.4	4.5	0.8	7.1	0.7	21.7	20.2	5.1	1.8	6.1	10.9	9.9	0.2	2.5	11.2	8.8	6.5	9.1	4.7	3.1	6.6	18.4	0.8	1.9	3.8	5.6	2.0	0.5	3.4	1.1	5.1	0.0	3.0	16.5	0.6	1.5	3.5	4.4	1.4	4.5	1.0	3.1	0.2
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA2	"FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	91.3	36.8	35.9	37.1	37.1	54.9	67.7	44.6	53.1	52.4	35.1	41.6	27.4	55.3	34.8	43.6	47.9	35.7	43.3	36.4	39.3	36.5	36.0	45.3	57.2	36.9	39.1	51.7	40.4	40.8	38.5	60.6	36.5	33.6	35.1	47.2	34.4	34.3	109.4	54.5	37.0	43.0	36.9	32.4	38.6	91.8	38.3	68.5	41.8	57.8	54.8	45.7	46.1	40.7	122.9	175.7	176.2	73.4	93.5	75.8	72.0	93.5	80.0	118.2	130.9	151.7	72.7	227.4	140.3	76.7	73.4	48.8	188.8	72.9	165.4	164.0	126.7	241.6	84.6	152.9	120.3	194.6	100.7	55.3	90.8	83.8	146.2	79.2	94.2	96.2	244.0	125.4	105.0	122.7	151.1	107.4	132.3	190.4	59.9	118.1	121.3	101.9	83.9	126.1	149.0	146.1	85.8	77.3	133.2	113.9	55.7	234.4	61.2	131.9	92.1	85.3	169.6	130.7	200.8	223.1	83.5	146.4	118.8	8.8	4.8	8.1	7.3	4.9	9.9	8.5	9.5	11.1	5.8	8.2	11.5	9.3	0.6	8.0	6.4	10.2	8.0	3.8	35.9	37.1	44.6	53.1	36.4	39.3	36.9	39.1	36.5	36.9	38.3	40.7	58.9	25.6	35.3	25.5	62.1	87.1	72.5	36.4	59.7	90.6	36.3	33.1	36.2	31.5	32.7	18.4	41.7	75.4	53.3	15.9	33.2	49.8	22.1	29.7	47.8	55.9	46.0	60.3	50.8	42.0	95.9	56.4	44.4	36.2	38.7	52.5	25.0	25.0	46.7	47.1	48.9	32.8	24.4	34.9	45.4	23.9	43.5	40.4	76.5	33.7	51.9	50.2	41.2	41.7	56.7	39.6	23.9	53.0	74.5	93.5	19.0	32.0	29.7	42.0	269.5	69.0	206.5	223.9	198.3	57.9	92.9	92.8	58.6	49.9	45.4	73.6
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 383.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	34.3	32.3	83.7	39.4	225.9	39.1	43.4	138.0	136.2	32.1	32.1	34.5	28.8	35.8	41.0	33.9	27.5	29.7	66.6	109.7	198.7	33.9	31.2	32.2	49.6	240.4	162.7	30.0	19.3	45.6	22.9	41.7	245.4	36.6	35.8	62.0	44.9	32.2	41.5	45.0	30.3	39.8	131.0	38.9	26.4	23.7	197.1	44.8	27.1	34.7	49.8	39.4	26.6	383.0	76.6	31.4	75.8	47.1	69.0	90.9	56.1	65.9	74.4	70.4	70.2	39.2	52.2	55.2	18.6	72.5	71.3	42.1	59.1	76.5	80.2	105.0	38.5	77.0	57.7	39.6	53.8	77.1	62.4	72.0	49.8	67.9	54.9	86.7	92.3	45.2	31.9	45.6	94.0	26.8	49.5	49.7	67.5	95.4	26.9	39.6	55.9	53.0	113.2	94.6	32.8	46.2	70.3	51.0	58.4	80.9	34.3	73.3	71.4	53.0	46.9	70.6	93.3	53.2	91.8	67.3	54.5	84.3	69.7	87.9	45.7	71.0	24.3	54.0	28.1	33.6	32.2	30.3	40.1	29.7	29.6	30.5	40.9	39.8	57.1	20.1	40.8	53.0	83.7	225.9	138.0	136.2	109.7	198.7	240.4	162.7	245.4	131.0	197.1	383.0	21.9	35.3	31.4	35.9	35.5	33.8	29.2	66.2	31.9	22.9	21.6	17.9	68.5	14.3	44.5	35.0	39.6	74.5	19.8	15.8	19.6	37.1	15.2	25.1	21.2	26.9	18.6	30.7	44.6	23.6	57.2	28.3	22.4	25.6	42.4	26.0	22.9	17.2	34.1	33.7	62.8	16.3	97.6	37.1	49.6	10.3	40.4	39.6	30.2	44.0	60.6	29.1	24.7	53.3	76.7	31.5	11.7	38.0	28.3	23.7	16.7	36.9	47.3	48.9	26.3	22.2	31.0	34.2	32.1	34.9	42.8	56.8	34.0	24.3	17.5	32.5
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132679794	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017235, HPA076042"	Supported		Enhanced	Vesicles,Cytosol		NA	NA		43000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA017235: AB_1858507, HPA076042: "	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	18.3	29.2	15.6	18.6	17.5	21.5	23.0	15.2	16.3	18.0	30.9	21.5	24.0	17.2	30.4	17.2	16.6	16.9	23.8	16.7	15.8	31.3	31.8	17.7	22.4	12.6	13.6	16.9	52.1	31.0	22.3	25.8	14.1	24.8	22.6	25.2	48.0	20.2	31.4	22.0	24.8	17.7	13.8	21.1	26.7	17.0	14.2	19.7	31.8	24.4	24.9	17.2	11.8	16.5	67.2	24.4	42.1	35.3	28.4	31.9	44.5	57.1	57.2	34.4	39.6	44.9	24.2	52.1	41.1	40.8	23.3	39.6	41.6	43.6	49.5	51.3	18.1	63.6	39.6	50.1	27.9	79.6	36.7	28.0	24.8	32.8	48.7	31.8	38.6	28.6	41.0	76.2	38.0	59.4	44.1	29.2	38.6	56.3	22.9	38.6	37.0	99.8	31.0	50.9	40.2	35.8	33.5	32.0	51.3	37.8	40.0	39.5	35.9	36.7	36.2	17.8	29.8	71.7	51.8	98.3	40.9	28.1	33.5	8.3	7.1	7.0	12.4	8.2	14.6	15.1	13.8	19.1	15.9	10.2	16.1	16.3	1.6	26.0	9.5	19.2	15.5	10.5	15.6	17.5	15.2	16.3	16.7	15.8	12.6	13.6	14.1	13.8	14.2	16.5	23.1	35.3	25.9	37.2	24.0	17.2	18.9	26.4	21.1	22.1	26.1	13.1	36.9	22.8	24.4	7.3	14.6	63.0	28.4	8.3	68.4	30.3	124.8	17.7	22.2	20.5	21.6	10.9	37.6	44.9	48.0	24.8	28.5	17.4	24.1	16.8	13.2	22.8	22.6	21.9	35.6	22.6	34.6	10.3	11.4	418.2	16.8	13.9	17.8	16.9	21.6	26.1	16.5	37.7	28.4	23.2	16.7	27.1	85.4	23.1	35.4	43.1	20.8	23.6	32.9	23.5	28.2	49.4	23.1	15.9	18.5	99.7	20.4	29.7	18.3	18.1
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 11928.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	1161.5	955.0	823.8	793.2	845.7	2181.5	1115.4	815.0	1021.1	1262.7	808.6	984.4	531.1	938.2	966.2	1196.8	984.5	610.9	989.3	803.8	848.5	931.1	927.4	888.7	1469.5	861.9	825.6	1622.0	1664.8	844.0	758.0	720.8	858.2	917.0	789.6	235.6	1061.1	615.4	1629.9	1444.0	916.6	712.9	883.0	1239.2	989.5	755.3	853.4	1487.1	748.6	1196.7	1674.0	995.3	1107.5	875.5	1680.6	1304.1	961.2	1612.8	2437.7	2298.9	2376.3	1260.7	1738.5	2044.2	1618.9	2381.2	1521.6	2403.4	1268.0	2092.8	803.0	1103.3	1881.9	2242.7	1918.7	650.0	2938.0	1320.1	1942.1	2733.4	1770.8	2898.3	1616.2	2684.2	3008.4	1406.4	2024.7	1778.7	2083.2	1508.8	2131.5	3231.7	1769.8	2786.9	2336.4	2584.2	2162.6	3166.1	2800.9	1899.3	958.6	2769.6	2001.7	2497.0	1246.1	1505.9	914.3	2187.0	2300.9	1424.6	970.6	3681.4	1562.7	1017.6	850.0	2172.8	2271.9	1973.0	2863.7	2412.2	1386.0	3245.8	1412.8	962.6	2155.2	1163.1	1761.2	1764.2	2401.7	3126.7	2616.4	2119.8	2320.3	3025.4	2946.4	2445.0	1168.8	1864.5	1629.2	2469.2	2250.9	4829.5	823.8	845.7	815.0	1021.1	803.8	848.5	861.9	825.6	858.2	883.0	853.4	875.5	831.5	464.8	673.1	15.0	2198.0	1898.4	2027.9	1544.8	1365.8	117.9	1444.5	1279.9	332.3	1109.5	886.1	654.7	68.8	2020.5	1806.7	1264.6	1571.0	1437.7	3146.5	772.1	1337.9	1108.6	1106.6	2241.7	10.8	2271.5	2803.3	1060.1	672.2	1194.9	805.8	1061.9	1385.3	1919.9	2574.7	104.3	12.4	1812.7	710.1	3200.4	2894.6	11928.8	1875.2	2003.3	1250.4	8.4	3379.8	599.1	2276.1	11.1	23.1	1799.4	1853.6	1034.7	1202.4	2110.3	1645.1	2688.2	510.4	219.1	696.8	1483.1	2041.1	629.9	674.5	1939.2	2239.4	2282.9	1892.0	1285.6	1783.6	2426.6
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701155	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	6.7	6.6	5.9	9.9	8.0	17.1	8.3	7.5	7.5	10.6	4.9	7.1	8.1	6.8	6.2	11.4	5.7	8.0	5.3	5.6	7.9	6.3	10.7	7.8	12.4	9.7	8.0	7.7	6.2	7.9	12.0	9.8	10.0	7.7	8.4	14.4	6.7	5.5	5.2	8.4	8.6	8.7	8.4	10.2	9.4	10.0	8.7	10.4	7.9	6.5	13.6	10.2	10.6	16.0	34.4	18.8	30.5	24.0	14.8	17.4	20.6	69.5	27.1	31.1	36.2	19.8	45.1	43.4	24.2	28.7	31.8	19.8	31.9	34.6	46.6	50.0	8.9	27.8	30.7	18.7	12.6	49.3	20.4	12.5	10.9	40.3	24.3	21.2	27.8	21.9	67.2	25.0	37.2	13.0	51.5	11.2	18.0	24.3	22.6	30.0	62.6	16.1	25.3	38.3	14.9	18.8	39.2	27.5	13.0	25.3	18.4	13.0	40.6	28.6	31.9	23.6	30.8	17.8	15.0	43.0	50.9	13.5	28.1	6.4	1.8	2.9	2.4	2.3	2.7	3.0	2.8	3.2	2.2	3.0	2.0	2.4	1.3	5.7	2.6	3.1	2.5	1.4	5.9	8.0	7.5	7.5	5.6	7.9	9.7	8.0	10.0	8.4	8.7	16.0	34.6	25.6	21.7	54.5	46.5	70.1	65.2	43.0	37.5	45.8	30.8	17.0	13.5	10.0	34.6	16.5	54.2	29.2	45.0	34.7	3.9	24.6	2.3	28.6	24.8	39.0	32.3	23.8	66.3	17.1	17.8	26.6	39.8	45.3	31.0	62.3	20.0	20.9	23.2	33.7	78.1	27.0	28.5	29.9	54.0	5.8	21.5	31.4	24.9	37.5	34.6	14.6	26.8	77.9	115.7	53.3	36.6	19.9	44.8	87.0	21.2	15.9	34.9	39.9	19.7	28.0	24.0	57.7	43.9	30.9	46.2	58.8	37.6	40.4	22.8	149.0
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805209-49813953	"Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		370000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	21.6	21.4	10.1	32.7	10.6	40.2	20.7	10.4	12.1	25.6	10.4	29.0	43.4	22.5	15.6	18.7	23.8	27.7	17.9	9.8	10.5	25.6	23.0	35.4	51.2	13.7	11.1	32.8	17.2	2.9	14.1	19.4	12.1	34.8	26.1	1.2	42.3	22.4	9.1	20.5	48.6	20.6	12.3	65.6	27.5	5.8	12.2	39.8	31.8	10.3	33.6	23.1	23.3	13.8	11.6	0.1	0.9	0.3	30.2	31.7	3.5	6.1	27.0	42.7	56.7	0.0	23.9	0.4	4.8	22.4	18.3	6.2	0.1	10.9	3.7	29.9	0.1	55.7	0.6	3.5	22.3	5.3	103.7	49.0	0.7	16.9	1.0	29.6	21.7	2.0	0.1	3.4	10.0	0.3	11.6	13.7	0.1	0.0	1.2	14.6	1.0	1.9	8.8	22.3	0.0	0.9	7.4	10.7	3.8	0.6	1.1	36.8	9.7	8.3	1.1	3.7	2.4	0.1	0.2	0.3	23.2	19.8	2.0	20.7	22.5	38.5	16.4	32.9	14.3	17.1	15.0	14.5	21.3	18.1	13.4	12.4	6.8	17.1	27.6	7.6	15.9	22.0	10.1	10.6	10.4	12.1	9.8	10.5	13.7	11.1	12.1	12.3	12.2	13.8	17.3	32.1	20.3	11.4	28.0	3.8	6.3	10.5	6.8	0.2	9.2	9.1	6.9	17.2	16.6	12.9	0.0	5.2	15.5	28.7	0.0	9.5	6.9	5.8	3.0	13.5	9.5	8.0	0.2	7.8	3.5	11.8	52.5	6.5	83.0	13.2	16.1	7.6	21.6	0.0	0.1	21.7	8.2	20.1	6.4	34.1	11.1	32.5	0.0	15.0	16.8	2.4	19.6	1.0	0.1	5.2	21.7	11.3	14.1	4.4	51.8	5.6	12.8	1.2	6.6	5.8	8.1	0.9	0.3	7.3	4.7	2.9	17.7	6.9	20.2	6.6
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961373	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 301.3;tongue: 171.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 290.9;Late spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 246.4;K-562: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		87000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	23.1	20.7	42.2	14.7	44.8	82.5	20.7	43.0	43.0	23.8	41.4	38.6	24.3	22.0	12.9	37.4	22.8	12.0	72.0	40.4	42.2	23.5	24.9	19.8	15.7	43.2	42.7	20.9	17.1	27.1	23.5	22.8	41.8	24.7	18.4	15.2	27.8	20.6	301.3	53.2	23.3	16.3	43.7	21.0	23.0	43.1	44.0	17.7	18.0	171.0	16.5	28.3	27.0	41.0	37.4	42.7	29.7	43.4	22.0	25.6	55.7	32.0	27.1	38.9	31.2	59.7	46.3	44.8	30.1	26.4	46.1	124.4	41.9	37.0	17.5	246.4	39.6	37.4	79.0	33.8	22.9	49.2	34.4	24.2	47.7	24.6	23.8	26.0	32.8	41.4	316.6	35.5	31.2	76.9	40.4	50.5	70.5	87.4	71.8	45.1	55.8	59.3	28.0	23.7	46.0	50.6	46.3	41.4	33.5	26.3	34.9	52.5	26.8	22.0	33.0	26.5	40.2	20.5	41.1	53.9	40.7	43.9	30.6	6.5	17.6	8.7	4.8	28.4	5.1	4.9	5.4	3.2	15.6	2.8	2.8	3.3	3.7	4.0	33.4	1.6	4.5	7.0	42.2	44.8	43.0	43.0	40.4	42.2	43.2	42.7	41.8	43.7	44.0	41.0	42.8	16.0	10.0	18.6	14.5	40.7	38.8	41.8	43.3	38.3	29.6	36.2	85.7	11.5	24.5	27.6	31.3	148.6	20.7	45.5	93.9	16.3	101.6	82.9	33.7	27.5	16.8	290.9	17.3	22.9	32.7	22.5	21.9	21.3	7.0	28.6	20.3	32.7	75.2	13.5	23.6	37.4	28.5	34.3	30.3	197.4	19.6	41.8	35.6	9.4	46.0	60.7	13.4	9.0	14.1	22.6	42.3	22.6	24.6	23.1	47.9	35.6	96.0	44.1	19.7	42.8	27.4	57.7	54.9	73.2	64.8	60.5	16.5	25.7	55.6	39.4
UBAC2	"FLJ30548, PHGDHL1, RP11-178C10.1"	ENSG00000134882	"UBA domain containing 2"	Q8NBM4	13	99200774-99386504	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013448	Approved		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA013448: AB_1855301"	"unprognostic (7.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.26e-2)"	15.3	13.3	9.0	18.2	9.3	19.6	20.0	7.3	9.2	21.3	9.9	21.5	30.7	19.9	17.9	28.6	27.6	22.6	27.3	10.1	8.4	21.9	27.7	16.9	25.4	10.9	9.6	19.1	17.4	30.0	2.7	29.4	8.8	18.4	22.9	7.6	25.8	17.3	39.0	30.6	23.3	19.7	11.6	20.8	17.7	26.2	12.6	29.3	30.0	38.9	27.3	23.9	8.6	8.8	51.8	26.8	22.4	33.9	52.2	62.8	56.3	25.9	73.3	40.3	36.4	29.2	108.7	19.9	43.8	34.8	27.0	49.2	28.8	41.1	22.0	33.8	33.7	37.2	16.9	22.5	48.7	48.2	28.1	45.9	54.9	24.6	71.0	54.6	38.8	39.6	31.1	13.3	31.6	14.3	32.1	15.3	32.6	104.0	27.0	27.6	24.9	15.2	32.7	29.6	25.2	40.3	21.0	67.8	41.4	39.4	41.5	148.7	30.3	21.9	19.0	20.1	29.5	16.3	12.0	6.6	42.9	71.9	38.3	64.6	53.7	41.9	61.3	57.3	87.3	48.1	53.8	62.6	46.2	55.2	73.6	74.5	48.8	84.6	57.5	57.3	40.2	88.1	9.0	9.3	7.3	9.2	10.1	8.4	10.9	9.6	8.8	11.6	12.6	8.8	28.7	6.4	19.1	58.8	45.3	27.1	26.0	41.7	40.5	27.3	31.2	24.3	23.8	21.5	29.4	23.9	27.1	111.6	48.5	37.3	23.5	44.1	26.0	24.5	21.7	26.4	8.4	31.3	110.9	34.9	84.6	31.6	19.4	21.9	22.2	34.3	17.9	29.1	48.5	32.0	103.0	30.1	40.7	39.1	121.4	22.0	35.1	88.4	30.2	81.5	35.7	48.8	69.0	82.0	73.3	29.0	32.6	50.8	11.7	48.7	48.0	22.6	31.6	21.2	32.9	24.7	32.1	66.2	35.1	31.7	33.1	132.4	66.0	54.4	39.1	34.4
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 110.3;Late spermatids: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	25.5	28.4	21.7	11.1	20.0	26.2	24.6	23.9	39.5	29.9	7.4	44.3	14.2	38.6	2.6	32.8	32.0	6.2	39.8	23.3	16.4	39.2	70.6	29.9	8.7	16.2	14.2	29.2	30.1	5.1	25.0	10.6	14.5	39.6	2.3	4.8	23.7	9.5	51.1	31.4	25.5	6.8	10.6	29.3	34.9	29.1	16.8	5.5	35.4	8.6	4.4	33.5	27.5	24.2	13.5	38.2	8.9	14.2	6.0	7.6	39.4	19.7	8.2	7.6	11.0	18.6	15.5	19.8	21.6	6.3	5.7	36.5	5.7	20.4	2.1	42.4	57.4	18.7	42.8	29.6	12.1	11.8	30.8	10.8	14.9	11.6	5.7	8.7	8.3	15.0	28.7	20.4	3.0	66.0	19.5	63.6	33.3	12.0	33.4	27.9	11.1	65.6	6.7	19.0	25.7	23.7	23.5	35.9	33.1	5.1	23.2	18.9	24.4	15.2	17.2	61.5	13.0	38.8	34.2	22.9	6.2	15.8	8.1	0.9	1.6	8.7	1.6	2.5	1.0	1.3	1.3	1.7	1.9	1.2	1.3	1.4	2.7	1.1	3.3	1.2	1.7	1.3	21.7	20.0	23.9	39.5	23.3	16.4	16.2	14.2	14.5	10.6	16.8	24.2	12.0	9.6	8.2	3.3	14.3	110.3	55.8	32.7	29.6	9.7	23.7	20.6	4.2	15.7	17.9	18.4	4.2	65.8	15.1	26.4	31.3	21.1	37.6	29.1	16.2	16.8	84.6	26.1	6.2	23.6	60.1	16.2	43.3	28.7	10.8	13.6	16.1	32.4	23.6	10.1	6.1	34.4	28.5	14.7	25.9	129.1	16.1	14.5	21.4	1.9	19.4	13.0	23.7	3.5	8.1	22.4	19.0	19.9	22.2	37.6	24.4	57.0	7.3	11.5	46.0	15.2	25.1	18.6	14.6	20.2	102.9	107.8	15.9	14.0	22.0	33.1
UBALD2	"FAM100B, MGC29814"	ENSG00000185262	"UBA like domain containing 2"	Q8IYN6	17	76265348-76271298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 229.1"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 205.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.8;neutrophil: 29.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 29.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 324.7;Karpas-707: 401.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023046	Uncertain					NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA023046: AB_1848359"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.45e-3)"	43.9	19.4	36.1	54.4	38.0	229.1	43.6	36.5	48.8	33.1	32.4	53.6	80.0	24.5	8.0	97.9	29.4	14.8	44.5	32.5	53.6	39.1	35.2	72.0	45.0	68.4	42.9	17.7	43.6	26.6	22.1	21.9	47.0	33.3	17.9	6.9	59.5	10.9	172.4	63.0	81.5	8.9	35.8	75.1	51.5	23.0	45.2	38.8	34.2	25.9	25.5	33.1	49.6	44.1	118.6	26.2	23.7	18.9	29.2	27.5	56.0	42.7	32.8	17.9	20.3	30.8	127.9	31.2	44.0	12.5	19.7	43.3	12.1	24.1	14.1	324.7	30.5	34.5	31.4	29.0	20.1	40.9	162.8	24.9	31.8	19.1	50.3	21.0	57.4	99.6	55.5	401.9	23.3	61.3	193.2	99.4	21.8	71.4	48.1	93.9	49.6	87.3	33.8	66.6	60.3	57.4	30.1	41.2	217.0	25.8	29.8	106.3	42.3	35.8	52.1	60.3	68.9	177.7	149.2	67.8	41.6	34.0	99.8	7.8	1.8	3.3	2.3	1.5	1.9	2.7	3.9	2.4	0.7	2.1	4.6	3.7	29.2	1.4	1.1	3.9	2.8	0.6	36.1	38.0	36.5	48.8	32.5	53.6	68.4	42.9	47.0	35.8	45.2	44.1	81.6	22.4	17.6	5.2	99.8	71.9	84.5	15.5	18.8	12.8	95.5	78.2	18.0	67.2	16.6	23.9	14.6	9.0	115.3	117.2	15.6	31.4	25.5	126.6	43.1	53.1	36.3	59.8	5.1	30.8	18.6	23.5	42.8	181.6	22.2	21.6	29.6	34.3	29.2	11.8	5.8	84.5	10.2	60.5	55.6	8.2	19.9	87.9	49.8	8.4	27.5	31.3	50.4	6.0	8.7	44.7	80.6	20.3	106.6	93.2	119.3	22.4	30.2	18.7	19.7	25.5	28.8	5.1	4.5	38.7	106.3	27.9	100.9	30.6	72.4	205.6
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	40.7	55.5	46.4	24.5	47.1	131.5	35.8	48.0	53.4	45.0	46.4	38.5	22.3	34.0	25.5	69.7	33.9	30.4	38.2	45.6	48.2	34.8	53.1	42.5	23.8	48.5	48.5	40.9	28.0	34.4	25.6	29.3	49.4	30.4	24.8	44.8	29.6	30.6	110.0	39.5	26.3	35.2	46.3	28.2	33.6	47.8	49.9	31.6	25.6	71.7	32.7	38.0	45.8	48.2	56.7	31.7	35.2	38.4	63.6	39.3	29.8	44.4	61.6	48.4	65.6	34.3	23.0	39.3	19.5	66.5	41.1	28.3	49.2	69.5	46.4	57.1	22.3	35.1	65.4	35.5	57.8	39.3	44.8	48.7	113.0	57.5	75.0	73.4	54.4	37.9	27.4	38.0	45.7	23.7	36.5	55.0	38.2	38.8	45.9	32.6	24.8	22.8	104.2	36.9	19.9	28.1	49.0	50.2	22.5	31.1	24.6	38.5	39.2	24.7	38.0	37.4	41.5	18.9	25.3	41.0	49.5	31.5	74.2	26.8	50.9	66.6	38.0	45.2	65.8	26.8	38.1	40.0	47.1	23.2	36.3	29.8	120.2	50.1	41.0	26.7	52.9	55.0	46.4	47.1	48.0	53.4	45.6	48.2	48.5	48.5	49.4	46.3	49.9	48.2	21.6	67.3	26.0	44.4	22.4	46.9	66.3	20.4	45.5	15.8	27.9	23.1	13.1	20.0	33.5	7.3	25.0	33.2	21.6	25.8	19.6	34.8	77.5	56.9	37.2	21.4	16.1	50.7	33.1	40.1	35.4	31.2	44.4	90.0	25.9	15.4	17.5	25.3	22.0	6.7	42.9	18.5	30.5	21.4	39.8	62.9	29.2	38.2	24.9	26.2	23.1	26.0	13.4	38.7	35.4	44.3	23.0	42.5	25.0	47.9	22.5	21.0	22.5	10.9	19.7	44.0	32.5	51.0	22.9	54.6	59.0	89.6	28.6	20.8	18.8	70.9
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	12.2	25.7	12.5	8.2	12.9	17.2	12.8	17.3	13.4	15.5	5.3	13.8	8.7	13.0	8.8	19.1	11.4	6.6	15.3	9.5	13.7	14.9	11.1	13.2	10.4	9.4	9.5	15.2	15.4	9.3	11.0	11.8	9.7	14.3	12.1	9.9	13.1	6.7	37.8	22.2	10.8	10.3	6.8	10.9	14.0	32.5	13.6	13.9	15.8	20.5	12.1	12.5	15.2	12.9	40.5	36.5	25.9	32.9	25.2	22.0	31.2	31.8	19.6	32.1	31.0	49.9	21.0	46.8	9.8	26.7	24.7	23.1	43.9	34.9	35.5	34.8	21.5	26.2	47.2	55.0	20.5	59.6	40.3	20.4	28.8	40.8	28.2	16.7	26.3	28.3	36.5	37.6	29.4	26.9	44.6	100.4	27.7	22.6	28.5	34.1	16.0	29.9	31.2	30.1	26.5	18.4	37.6	30.3	9.4	25.8	26.9	26.3	30.9	19.0	25.5	22.8	35.7	14.5	32.3	49.3	20.9	22.5	48.3	1.6	2.7	3.0	2.2	3.1	4.7	2.7	2.7	3.2	3.1	1.4	2.4	3.3	1.6	4.5	7.2	4.1	3.3	2.3	12.5	12.9	17.3	13.4	9.5	13.7	9.4	9.5	9.7	6.8	13.6	12.9	23.8	54.5	23.1	56.8	15.0	28.2	23.8	21.0	27.3	28.7	25.3	26.2	59.9	8.6	32.4	12.9	60.5	44.4	24.7	28.1	3.9	20.0	102.8	52.5	30.3	28.6	25.1	20.8	46.8	19.8	36.3	23.7	32.6	68.8	14.5	36.2	11.7	14.0	16.6	16.8	48.3	30.4	14.2	17.0	21.4	85.0	30.4	17.1	26.6	33.7	19.0	12.5	16.5	50.8	46.3	27.0	26.8	24.5	28.4	24.9	12.3	15.9	24.1	27.0	26.3	27.4	22.6	81.0	70.4	25.9	31.1	72.9	22.3	68.4	29.6	23.7
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		67000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	54.1	49.3	30.7	60.9	31.3	62.8	50.0	29.2	40.4	52.2	32.5	53.2	34.2	59.8	48.6	55.0	54.6	44.8	62.7	32.0	31.2	39.8	36.6	54.5	60.7	26.3	27.6	60.5	37.9	60.4	49.4	70.6	26.3	45.7	40.8	46.0	48.0	47.1	83.1	60.2	40.6	55.2	20.4	53.6	45.9	64.5	27.2	59.5	53.6	49.1	65.9	54.0	50.9	35.0	189.3	184.8	167.4	136.5	121.0	138.0	148.1	212.1	154.9	187.6	131.6	197.9	143.6	235.3	213.2	178.9	94.6	160.8	224.3	158.4	167.7	208.1	199.7	255.7	184.6	162.7	113.7	269.6	144.0	130.5	68.3	173.8	114.8	117.9	153.1	92.0	235.0	111.5	152.6	212.6	207.8	101.1	320.4	140.1	170.9	148.9	135.5	207.8	120.7	220.5	173.1	209.3	245.1	227.2	91.4	186.8	226.6	180.6	245.9	117.0	123.8	145.1	205.7	239.1	278.4	313.2	125.7	144.8	179.0	15.1	28.2	20.4	23.1	35.9	25.4	20.9	21.8	21.2	34.9	26.4	24.6	27.7	24.5	36.4	41.3	16.3	21.5	29.6	30.7	31.3	29.2	40.4	32.0	31.2	26.3	27.6	26.3	20.4	27.2	35.0	29.2	25.6	38.5	22.9	31.7	18.4	18.7	21.5	22.2	18.4	21.5	21.5	39.0	17.2	32.3	18.4	8.4	51.3	32.7	16.7	17.6	28.4	80.6	34.3	43.8	26.8	23.4	34.9	26.7	27.1	39.5	29.0	21.9	35.7	24.7	32.3	23.2	19.1	36.1	15.2	25.3	21.7	26.4	22.6	30.2	147.1	21.5	32.4	19.6	26.2	24.5	13.7	24.7	29.1	29.1	30.9	10.4	22.6	20.6	25.1	12.5	15.9	29.7	20.4	13.1	31.1	51.6	42.2	48.8	31.7	20.5	77.8	23.5	35.6	22.0	21.9
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UBB	"FLJ25987, MGC8385"	ENSG00000170315	"Ubiquitin B"	P0CG47	17	16380798-16382745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013048, HPA041344, HPA049132"	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"CAB013048: AB_2533002, HPA041344: AB_2677422, HPA049132: AB_2680646"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.86e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	942.4	1676.7	1564.8	674.6	1589.2	2376.9	770.4	1662.2	2231.7	812.8	1565.4	1065.5	1179.6	788.9	1367.0	656.3	656.8	813.0	1668.3	1644.2	1719.8	1593.6	2982.1	1046.3	1002.7	1672.3	1765.4	726.2	1305.1	1677.7	1373.8	1012.3	1713.9	808.0	1097.8	566.0	1294.6	861.8	2656.6	692.3	1134.0	932.4	1670.6	1078.8	1245.6	1591.8	1597.4	1226.8	1181.5	2162.1	993.0	974.7	689.1	1980.8	1646.5	3022.4	1559.8	1912.1	1530.0	963.9	1131.3	1609.5	2166.2	2855.8	2453.4	2916.5	1270.4	1662.3	2631.3	1916.6	1678.5	1295.4	0.8	1054.2	3076.0	2126.4	2231.3	1649.8	1653.1	2183.7	1022.3	6.6	2162.4	1468.9	1010.2	2183.4	848.2	1486.0	1582.3	1562.2	1888.9	1530.9	1743.0	3858.5	2354.7	2086.6	1288.4	4642.0	1177.2	2185.1	1984.7	1484.1	2312.8	1911.4	1179.0	1757.0	2109.6	1239.7	1454.4	3025.5	1392.6	1936.0	1152.7	1417.8	867.8	1087.6	2507.7	845.7	1238.7	1366.4	1688.3	1757.9	1356.3	5348.4	1684.4	3262.9	2632.2	2121.6	2131.1	3065.4	2048.1	2372.7	1501.1	2872.4	1787.4	2146.5	981.5	3290.2	1875.7	2799.7	2592.8	7841.1	1564.8	1589.2	1662.2	2231.7	1644.2	1719.8	1672.3	1765.4	1713.9	1670.6	1597.4	1980.8	1607.0	1003.2	1168.4	46.7	786.3	979.5	1548.2	1890.9	796.2	426.2	763.6	1161.1	370.3	948.0	1262.5	551.8	120.9	1661.1	1082.7	1377.9	1829.3	1114.8	3648.2	961.6	510.0	870.9	922.4	4506.0	29.1	880.2	996.8	1202.3	1270.6	799.9	1800.7	412.4	669.3	1509.8	1168.9	233.9	37.3	1351.2	1310.2	589.0	1180.7	2126.9	592.4	826.6	1812.5	50.6	1001.9	912.0	1051.5	30.7	133.6	751.3	1879.5	775.2	700.4	974.6	1970.0	3101.7	2080.6	506.8	880.9	714.4	3554.9	3297.7	1090.7	739.1	1112.3	1815.4	1231.6	935.0	993.8	1036.2
UBC		ENSG00000150991	"Ubiquitin C"	P0CG48	12	124911604-124917368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000362, CAB005419, HPA041344, HPA049132"	Supported					NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"			"CAB000362: AB_2301097, CAB005419: AB_2180553, HPA041344: AB_2677422, HPA049132: AB_2680646"	"unprognostic (7.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.35e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (6.69e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.81e-2)"	1262.3	939.6	1151.9	699.3	1221.6	2805.5	941.4	1314.4	1635.4	1055.3	1295.5	931.6	571.9	960.0	987.6	1641.4	1095.1	1356.3	1277.9	1143.2	1267.5	983.6	1652.7	1070.8	833.5	1278.5	1215.6	819.4	921.7	653.3	512.9	826.4	1231.8	709.8	1060.9	974.0	1114.7	1136.4	3463.2	933.2	836.0	1278.4	1259.5	799.3	813.0	1257.7	1239.5	767.6	912.2	3177.8	993.4	1144.9	1183.7	1600.9	1407.8	1259.6	1043.5	863.8	2845.1	1769.8	692.9	1750.1	2130.8	1259.1	1229.6	1129.7	1747.7	1272.9	1410.4	2133.4	2042.1	1026.2	2048.8	3325.1	1075.2	1480.4	760.1	971.1	831.8	2017.2	2199.3	1404.5	844.9	2035.2	2538.3	1500.0	2283.6	1644.8	1630.2	510.6	897.8	1259.9	1467.1	1270.4	1300.6	1641.0	966.5	835.3	1520.0	781.7	970.6	1182.5	1719.0	2164.3	1216.6	891.7	1691.7	1928.1	1622.1	619.9	1653.3	931.5	2019.6	2766.8	792.8	1496.9	1103.8	1460.9	1819.8	1608.8	1490.2	779.7	1805.4	335.0	532.6	606.0	431.8	517.4	412.7	315.8	375.2	450.0	310.2	295.5	292.5	350.7	989.3	401.3	653.5	432.6	499.4	1022.5	1151.9	1221.6	1314.4	1635.4	1143.2	1267.5	1278.5	1215.6	1231.8	1259.5	1239.5	1600.9	2304.5	1451.9	1227.6	128.0	1287.0	1219.8	3858.3	4028.1	1915.7	618.9	843.1	1183.4	915.2	683.4	2496.6	660.3	333.6	841.0	1282.5	1499.3	892.1	1475.7	4437.0	1595.5	1062.5	1370.6	747.6	340.1	42.3	1128.2	1268.9	1662.4	1305.8	2615.6	911.9	698.7	637.9	442.9	1295.9	518.2	49.3	1067.2	1564.5	654.8	1858.6	4032.6	786.9	1668.6	1220.2	124.6	1728.7	1784.0	520.1	31.7	106.2	1334.3	1613.6	830.1	2420.4	1775.3	1850.8	1023.9	1700.8	1215.7	611.4	1695.6	2149.7	1135.2	429.9	1523.5	1048.6	1754.1	1980.7	752.4	845.9	2349.3
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334979-58370751	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.7;tongue: 65.3"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 112.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	13.0	11.8	5.3	16.7	5.7	32.4	7.8	6.6	8.1	8.9	4.4	11.4	7.0	12.6	7.5	11.6	7.1	9.5	33.3	6.1	6.2	8.1	8.3	8.9	13.8	6.6	6.4	8.4	5.5	8.9	3.9	8.9	6.6	9.5	12.0	5.4	5.5	6.7	138.7	5.9	8.3	13.6	6.4	13.4	6.4	4.5	6.3	7.8	8.4	65.3	11.4	15.1	5.6	6.7	19.1	10.2	18.8	24.4	37.5	30.0	12.1	12.4	21.2	13.9	20.3	20.9	16.4	0.0	19.0	18.6	10.3	17.1	36.6	18.0	19.5	19.8	21.2	4.9	3.7	12.2	24.4	15.3	11.8	34.8	19.9	14.4	26.8	18.7	28.1	13.1	10.0	7.8	19.1	6.1	16.5	17.1	23.0	11.7	15.7	13.8	16.9	10.6	21.2	11.2	14.0	18.8	24.2	40.3	20.6	28.5	14.8	10.2	22.8	5.3	18.6	18.2	13.7	19.7	16.4	16.8	16.7	31.3	6.2	10.1	38.5	17.8	6.2	27.1	7.2	8.9	7.3	7.9	20.0	9.8	7.5	6.2	112.3	8.2	23.4	8.3	9.8	23.4	5.3	5.7	6.6	8.1	6.1	6.2	6.6	6.4	6.6	6.4	6.3	6.7	41.6	12.8	11.2	5.5	54.3	194.4	94.1	60.6	46.1	23.7	45.6	45.5	92.4	17.2	39.0	27.6	18.8	29.9	41.7	27.4	76.3	62.3	5.0	32.6	46.9	42.5	41.7	12.0	18.5	42.0	50.4	51.9	38.7	51.2	22.9	19.6	27.5	15.6	73.7	16.8	17.1	40.1	69.2	90.6	104.0	3.0	33.2	147.7	53.4	4.7	94.6	17.9	22.6	12.5	21.2	81.2	52.7	32.4	26.4	108.4	16.1	54.3	33.6	16.1	6.6	51.4	59.1	33.5	19.9	47.1	190.2	149.0	42.8	14.9	28.5	118.2
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628434	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	78.4	59.9	75.8	66.9	82.0	106.9	72.6	79.3	84.2	84.2	63.0	106.8	46.5	72.8	102.6	89.0	95.0	49.8	93.7	77.9	85.8	80.1	82.6	77.0	83.5	78.7	80.4	64.3	66.5	72.8	62.3	65.5	80.0	57.0	92.8	77.2	61.0	72.3	190.3	77.9	70.4	74.3	81.9	79.3	70.2	135.6	80.1	128.0	61.3	127.3	140.2	79.7	72.8	86.4	175.9	113.9	194.3	137.0	127.9	161.7	125.4	179.6	165.5	204.7	238.6	292.0	160.6	247.8	229.1	185.7	254.0	108.8	192.6	300.2	272.5	162.4	113.7	140.1	115.0	172.1	249.9	136.9	119.7	129.9	152.0	204.9	301.8	177.4	221.8	159.5	125.0	203.1	192.9	175.5	215.3	197.2	108.1	60.4	124.0	162.7	198.1	179.6	220.4	202.0	177.5	117.0	157.1	198.7	309.4	413.4	125.2	121.6	148.9	156.4	87.6	132.5	223.5	146.0	260.0	343.8	112.3	223.2	128.0	44.1	57.0	115.9	57.7	53.7	62.1	89.2	82.1	80.9	63.3	90.7	102.5	90.3	90.7	65.1	66.2	106.1	110.8	58.0	75.8	82.0	79.3	84.2	77.9	85.8	78.7	80.4	80.0	81.9	80.1	86.4	137.1	32.1	69.8	35.9	215.4	171.8	182.3	204.8	112.7	76.3	124.8	146.9	96.4	124.4	96.5	68.0	81.3	181.4	205.8	158.0	215.2	208.4	637.0	457.2	94.2	131.0	123.4	148.8	62.0	178.4	228.0	104.8	77.5	230.9	138.8	119.4	109.9	80.6	178.0	94.2	54.4	120.8	142.4	136.4	203.4	550.0	104.4	150.8	152.9	49.6	189.5	170.7	234.8	38.2	65.7	228.7	127.1	93.6	237.3	234.8	123.8	200.9	63.9	105.1	118.3	102.2	171.2	459.7	152.5	149.4	203.7	249.6	217.1	111.7	160.4	247.1
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	182.7	171.7	85.7	172.0	92.6	478.3	141.9	101.1	120.6	127.1	93.4	154.9	154.0	125.3	113.8	173.4	125.9	142.5	149.4	92.1	103.9	172.2	251.4	175.3	189.6	102.5	96.0	131.5	154.2	133.5	98.4	159.0	99.8	106.8	144.4	129.0	116.7	102.1	243.6	136.4	158.3	129.9	101.4	149.5	144.4	127.0	95.6	198.5	159.2	197.9	197.0	185.6	128.0	113.7	301.6	169.1	275.4	223.4	286.2	408.0	235.9	301.2	395.1	260.1	243.6	257.4	416.4	319.3	190.6	304.4	336.8	168.6	294.7	400.8	352.5	299.6	149.8	292.0	165.8	209.6	300.3	415.5	240.4	314.0	247.9	288.6	398.9	334.3	343.4	258.7	372.9	316.4	350.9	243.1	613.4	235.1	200.2	341.0	167.1	318.4	269.9	231.5	261.5	283.7	275.6	232.1	183.5	464.8	349.6	318.2	193.0	241.0	318.4	270.0	231.1	179.2	276.3	277.9	389.8	491.3	288.2	227.2	297.0	614.9	253.7	394.0	163.5	256.0	216.3	165.9	203.4	194.4	217.6	139.2	205.8	190.5	817.2	215.7	271.9	149.8	229.6	422.1	85.7	92.6	101.1	120.6	92.1	103.9	102.5	96.0	99.8	101.4	95.6	113.7	303.4	166.7	193.1	98.9	291.7	844.0	693.9	408.2	233.9	133.7	251.5	166.9	229.8	193.0	242.3	139.8	125.1	311.5	317.4	336.1	547.8	361.0	779.4	257.1	246.7	344.0	240.8	348.7	159.7	382.2	561.6	286.0	202.3	371.3	224.9	154.8	193.1	235.7	392.9	122.8	145.8	283.8	303.2	403.0	825.6	635.1	164.7	415.1	357.5	111.5	399.4	160.0	280.2	104.5	185.0	454.4	347.2	149.0	296.4	612.3	335.8	428.8	242.4	170.6	105.2	270.6	531.9	217.2	180.7	258.2	813.3	638.4	382.5	172.3	268.2	784.3
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926436-43956136	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 32.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 30.2"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	5.8	8.3	11.7	2.4	12.2	2.2	5.0	14.2	17.6	4.6	9.8	6.5	2.4	4.5	5.7	5.2	4.5	3.4	10.9	12.3	11.2	6.9	10.7	4.4	2.7	12.0	11.7	5.1	10.0	4.6	5.1	2.8	11.9	5.7	2.9	6.9	5.6	4.4	32.5	4.9	3.9	4.4	11.8	4.7	4.6	3.0	11.5	2.7	4.9	27.8	2.7	5.3	5.2	12.7	4.9	4.0	2.4	11.0	11.0	4.5	1.8	2.3	5.8	2.9	3.7	2.1	5.6	4.6	6.3	6.3	8.1	5.3	3.1	2.5	4.4	10.5	5.4	5.0	5.8	5.4	4.1	10.9	9.8	3.4	5.2	3.3	5.0	4.2	3.6	5.5	5.6	9.2	4.0	3.0	6.5	6.1	5.4	5.9	5.1	4.0	3.3	7.1	6.2	5.9	8.8	30.2	5.0	9.7	3.8	4.4	4.9	3.3	3.2	1.9	6.0	4.1	6.9	13.5	10.8	2.2	5.7	14.2	10.9	10.2	14.5	17.5	11.1	23.8	11.4	12.8	13.5	12.5	15.1	12.7	16.2	13.4	1.4	9.9	28.7	13.0	12.6	8.8	11.7	12.2	14.2	17.6	12.3	11.2	12.0	11.7	11.9	11.8	11.5	12.7	14.9	0.0	6.5	8.8	10.4	6.2	9.1	9.4	4.0	9.6	24.3	24.3	24.6	14.3	10.0	16.5	2.1	11.9	11.9	8.4	54.8	18.7	6.2	8.9	7.2	12.9	18.7	9.9	14.2	28.4	20.3	14.9	8.2	8.7	4.5	11.1	12.5	25.4	27.4	11.8	13.5	8.0	8.2	11.6	14.1	10.7	12.2	12.5	16.0	8.4	18.4	18.8	5.2	20.1	12.1	14.1	7.6	21.8	11.2	12.1	15.5	52.0	5.5	11.6	6.6	23.0	10.5	15.6	9.6	10.8	11.2	7.7	8.8	16.5	8.4	12.3
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805955-23891640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	68.6	54.9	84.5	67.1	91.0	123.2	89.5	91.5	121.1	74.7	83.9	76.9	50.6	66.6	68.3	80.9	63.5	61.8	62.6	82.4	94.1	69.3	71.2	71.2	102.4	92.5	88.7	79.3	53.9	103.7	34.4	96.1	93.8	71.3	79.0	73.1	64.6	73.6	89.4	63.8	51.4	77.5	93.2	73.8	60.9	51.7	87.2	98.5	61.4	94.9	108.1	92.5	65.1	101.8	199.3	101.7	202.1	99.1	129.2	170.3	151.5	141.0	256.8	172.7	234.0	80.1	235.8	182.6	121.2	166.3	146.8	65.6	232.5	208.6	228.2	202.2	201.4	235.5	75.8	97.3	177.0	260.2	138.8	172.6	162.8	230.4	324.9	207.1	278.6	118.9	177.2	210.8	136.0	86.7	188.6	235.8	268.0	117.8	255.3	201.6	80.7	531.0	262.0	129.3	54.3	176.0	146.7	131.5	215.5	202.5	146.4	329.1	183.1	132.2	144.2	85.9	109.5	154.9	99.8	363.6	152.2	231.9	110.9	1.7	4.2	3.7	1.8	4.7	2.9	3.0	2.4	1.8	3.8	2.8	3.2	2.0	1.5	4.3	2.8	4.0	2.0	2.1	84.5	91.0	91.5	121.1	82.4	94.1	92.5	88.7	93.8	93.2	87.2	101.8	30.7	44.8	28.9	66.3	52.7	72.3	62.6	89.0	59.2	31.3	37.9	24.9	68.2	31.5	59.5	18.4	4.2	97.3	27.9	56.7	56.7	90.4	25.6	37.0	28.7	58.4	46.3	41.0	47.1	78.0	99.4	43.2	25.5	32.7	40.6	40.2	43.5	22.5	98.8	20.2	50.6	37.9	150.5	69.4	156.5	55.3	40.7	61.5	97.8	127.4	98.9	81.6	36.0	90.5	102.8	71.8	61.9	48.5	40.8	78.0	21.5	43.4	60.1	27.7	52.6	47.1	63.0	35.4	59.5	61.7	90.2	72.1	35.7	27.6	52.2	72.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591794	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0"	"Group enriched"	"Detected in all"	6	"B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	23.9	8.9	14.3	10.6	17.2	7.0	18.3	14.5	28.1	22.9	9.4	18.2	4.6	18.2	25.7	17.4	13.7	15.4	19.9	20.2	16.8	17.1	13.4	17.8	16.4	13.2	12.8	16.2	7.0	13.5	12.0	7.4	14.4	14.7	4.8	16.6	11.9	13.3	16.0	16.8	8.3	18.9	12.6	14.3	11.6	15.1	13.7	18.1	13.9	12.4	12.6	16.2	17.8	28.4	36.7	12.9	33.3	0.6	29.0	32.1	30.3	22.6	38.2	20.8	29.0	3.6	29.2	31.7	15.1	19.9	28.5	3.5	24.5	35.2	26.5	0.2	24.6	0.0	15.3	4.3	20.8	0.0	24.5	25.6	36.2	30.0	50.0	21.1	20.2	24.5	1.9	32.4	19.0	5.9	16.8	7.2	23.7	20.7	18.6	34.9	13.0	36.8	20.4	0.8	8.5	17.7	24.8	14.4	0.4	23.8	30.7	20.9	17.8	20.4	29.1	13.8	25.7	31.2	10.9	49.4	19.2	14.2	5.8	0.1	41.7	0.2	0.7	50.3	0.9	35.1	1.4	0.6	57.6	40.1	9.1	3.5	1.1	2.5	54.4	74.0	0.7	15.7	14.3	17.2	14.5	28.1	20.2	16.8	13.2	12.8	14.4	12.6	13.7	28.4	13.3	22.4	9.8	159.3	48.4	25.6	12.2	77.2	34.7	24.0	31.3	27.1	38.2	15.7	28.1	31.3	16.7	34.8	24.2	0.9	68.4	12.0	24.2	9.6	30.8	24.6	1.8	8.2	652.7	29.2	43.1	42.1	5.6	18.8	0.0	38.5	14.6	41.4	47.7	32.0	399.4	1.1	67.1	47.3	73.9	16.0	39.4	49.2	78.2	402.8	40.5	14.8	1.0	513.2	845.2	13.9	1.2	53.0	32.8	64.6	0.0	152.7	17.3	3.6	32.9	14.9	67.3	36.3	91.0	44.1	42.3	38.6	4.6	15.1	0.7	8.6
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 654.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA030445"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"			"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.08e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	61.6	45.8	57.8	40.1	60.8	48.3	58.1	59.9	71.5	56.2	51.4	51.4	46.7	51.6	55.8	46.7	58.3	71.4	54.2	74.3	59.7	71.8	58.3	39.9	39.6	56.6	57.8	52.5	56.5	79.4	35.3	48.6	58.0	40.0	54.4	68.4	54.6	39.6	175.1	57.0	42.5	42.9	62.3	40.3	59.2	56.8	58.8	67.9	73.7	88.6	48.4	61.6	46.9	64.1	104.8	46.6	654.4	22.8	189.8	243.1	104.0	137.1	171.9	112.8	139.2	51.0	124.0	51.4	117.1	188.5	94.5	43.8	400.7	140.5	202.1	125.9	120.3	177.2	59.0	142.5	91.6	83.5	81.3	96.7	127.9	99.3	94.8	114.6	150.9	105.4	91.9	93.3	280.7	57.5	152.6	77.7	125.6	71.2	217.6	147.0	66.8	122.1	193.2	91.1	113.4	126.3	59.7	62.8	58.1	178.3	33.7	121.5	140.1	218.2	143.2	129.4	162.0	81.1	55.0	143.7	215.7	32.6	124.3	29.1	28.2	53.7	17.6	25.4	21.3	15.0	13.6	22.7	18.4	9.5	14.3	15.7	25.6	18.5	36.3	60.0	5.9	20.5	57.8	60.8	59.9	71.5	74.3	59.7	56.6	57.8	58.0	62.3	58.8	64.1	69.3	9.6	24.2	100.9	50.3	102.9	83.7	111.2	70.6	151.8	84.4	74.4	37.7	108.7	63.7	55.2	29.2	31.9	84.8	56.4	229.0	95.8	36.9	54.3	51.6	59.8	59.8	108.8	115.4	101.9	83.4	81.2	60.6	57.8	23.5	61.8	72.1	55.9	85.3	75.7	67.7	39.4	91.6	71.4	63.9	79.7	62.7	76.3	129.9	71.2	62.4	103.9	79.3	160.9	158.3	113.7	41.6	36.1	87.7	74.8	58.9	172.6	51.8	73.3	26.3	56.4	81.7	83.1	191.6	77.3	122.3	36.0	55.4	57.9	50.9	103.4
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 282.2;monocytes: 215.5;NK-cells: 193.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA037444	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	26.7	29.7	33.0	25.5	33.7	41.8	22.8	35.9	40.6	27.7	32.5	29.6	24.7	23.1	53.0	43.1	18.8	28.7	56.7	33.4	38.0	28.2	44.2	22.6	32.1	37.5	37.7	12.6	70.5	41.8	21.0	39.9	38.7	25.4	33.7	16.0	25.2	30.3	60.7	18.8	26.9	35.6	35.5	23.7	26.5	26.0	36.1	34.5	35.4	69.1	33.1	40.7	23.5	38.3	42.9	23.9	53.6	55.1	69.2	83.0	74.8	38.9	55.5	43.3	44.4	26.0	26.4	22.0	13.7	88.7	93.7	35.1	62.3	84.9	67.9	33.7	22.7	31.6	28.5	86.6	86.2	13.1	70.1	48.1	137.7	57.9	87.1	40.1	78.1	100.8	94.2	13.7	80.1	64.0	35.1	55.9	59.8	60.9	33.8	41.8	35.0	39.1	66.3	17.8	36.0	53.0	45.2	36.2	77.0	89.4	31.0	52.8	49.7	47.6	41.7	54.9	43.1	17.1	14.3	43.6	57.1	38.4	35.8	112.4	50.0	63.8	66.3	68.2	26.2	26.2	44.8	40.4	45.0	25.4	40.7	41.4	37.3	102.3	78.5	56.4	51.6	63.6	33.0	33.7	35.9	40.6	33.4	38.0	37.5	37.7	38.7	35.5	36.1	38.3	17.6	6.4	18.4	0.0	26.4	32.5	24.1	33.0	11.4	24.2	37.7	24.9	48.1	30.0	21.6	27.6	8.4	84.9	87.3	38.6	56.7	49.7	23.6	15.0	23.9	27.1	41.8	102.5	0.0	79.4	282.2	24.9	15.8	13.8	21.5	13.1	22.1	41.7	152.7	26.9	0.0	58.1	32.6	72.2	105.7	61.3	25.7	67.6	35.6	0.0	215.5	28.3	193.6	0.0	0.0	71.8	31.9	30.9	25.7	46.0	49.7	62.2	23.4	21.7	39.5	14.8	31.4	123.5	79.4	19.0	40.3	65.7	36.2	16.0	35.5	34.6
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 210.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 286.0;Late spermatids: 248.3;Suprabasal keratinocytes: 239.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	21.0	19.1	15.8	25.4	21.4	31.5	20.1	21.0	24.3	25.2	11.6	39.7	22.5	22.7	14.7	52.2	16.3	16.0	37.9	16.1	18.7	27.0	30.3	15.6	38.8	21.5	19.2	15.6	18.4	21.5	9.7	18.9	21.7	22.6	24.2	17.5	21.0	20.8	210.2	28.0	23.6	27.2	20.3	20.7	21.8	23.2	21.0	24.9	16.1	84.1	46.4	24.5	32.1	26.5	54.5	57.8	52.7	38.9	42.2	44.3	74.9	51.7	41.4	48.2	42.1	40.0	27.0	84.5	52.8	51.2	39.4	57.2	66.3	48.1	77.2	44.8	53.9	31.7	28.6	45.9	41.3	46.5	57.4	38.0	70.3	45.8	66.1	33.8	65.6	55.8	56.5	88.9	40.1	24.3	59.4	42.5	58.2	40.1	29.6	76.1	27.9	78.1	56.4	35.1	22.7	42.3	48.9	41.8	41.6	77.4	41.1	29.9	49.6	48.1	36.8	57.0	58.7	34.3	43.8	118.9	36.9	42.8	37.7	13.3	15.8	39.0	22.2	16.8	29.9	34.1	28.3	29.1	20.2	24.4	28.3	28.9	28.1	32.5	18.6	14.8	28.9	21.8	15.8	21.4	21.0	24.3	16.1	18.7	21.5	19.2	21.7	20.3	21.0	26.5	28.3	22.4	14.4	31.3	70.6	286.0	36.5	47.8	111.5	18.8	47.0	31.0	67.6	27.1	32.2	25.8	6.2	47.0	47.8	41.4	82.2	30.9	139.5	36.7	25.7	35.5	38.4	26.5	47.9	26.7	59.6	31.1	32.6	39.9	21.0	13.9	31.1	62.3	48.1	15.2	46.3	38.3	44.7	36.5	81.1	248.3	19.6	35.7	67.6	30.9	43.1	28.7	36.0	36.2	84.4	43.0	30.4	21.1	154.3	65.7	40.4	75.6	35.4	17.1	6.6	25.9	43.5	70.8	50.8	85.3	239.7	66.8	58.2	13.8	30.1	54.0
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44801826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 211.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	26.7	20.9	21.1	13.4	22.8	25.9	17.5	21.9	24.7	13.5	20.0	22.2	13.3	20.2	8.4	16.1	16.3	12.1	34.7	21.3	21.8	24.4	27.6	16.9	16.2	22.4	22.3	13.7	26.7	20.5	8.2	14.2	22.6	14.8	14.1	20.7	12.6	21.3	61.3	15.3	16.6	20.4	22.1	19.7	21.6	12.2	22.0	22.9	16.9	51.8	14.9	21.2	12.5	24.2	51.9	11.5	34.9	44.3	46.2	20.6	31.3	37.0	27.5	29.5	31.7	40.5	6.7	66.4	33.4	35.8	38.6	20.5	49.4	43.5	27.2	61.9	51.1	107.3	7.0	33.6	35.5	79.2	19.4	33.3	50.0	39.5	39.5	14.7	47.0	71.3	99.8	47.9	43.0	24.6	89.2	13.3	86.7	35.4	44.2	73.2	31.1	61.2	41.4	28.3	39.3	72.5	49.6	18.2	52.3	30.5	17.6	68.5	37.3	31.1	21.2	28.5	58.5	73.8	144.7	64.1	29.3	96.1	36.3	3.2	16.1	8.5	20.8	16.8	22.8	16.0	19.0	21.5	17.3	16.2	20.1	21.3	4.9	20.8	20.1	24.6	21.1	17.4	21.1	22.8	21.9	24.7	21.3	21.8	22.4	22.3	22.6	22.1	22.0	24.2	54.6	57.7	115.4	70.8	48.3	47.7	38.4	32.0	39.3	58.8	37.3	34.0	70.6	28.6	48.4	53.3	66.7	40.7	53.3	29.8	25.4	32.9	63.4	36.8	68.5	54.1	30.0	37.4	56.3	40.7	26.3	41.3	26.0	49.7	43.6	66.6	37.1	69.7	35.3	32.0	57.5	31.2	26.4	42.2	37.4	211.1	41.3	42.9	28.4	32.8	43.2	39.5	49.4	73.9	56.7	43.2	21.5	50.4	53.6	55.6	27.4	36.7	43.0	102.2	26.3	59.3	42.8	42.9	49.4	44.9	56.0	35.8	49.4	75.6	46.0	40.9
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952960	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 365.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA		21000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	46.8	64.7	43.0	29.1	44.2	42.3	34.4	46.4	49.1	44.7	58.7	42.3	23.4	44.3	37.6	49.9	44.6	44.6	98.2	42.1	45.4	42.1	44.2	38.8	31.8	48.7	43.4	41.7	84.3	49.2	29.4	52.5	45.0	36.1	26.0	42.0	39.3	41.5	69.3	31.2	24.4	49.2	41.8	28.6	34.6	36.4	45.8	37.4	45.0	60.6	39.8	40.1	33.7	47.8	82.6	43.8	58.5	56.1	126.1	107.5	86.5	72.0	97.8	45.8	51.1	22.9	92.5	34.0	87.4	76.6	123.8	62.5	46.2	81.6	59.5	40.9	22.6	11.5	63.5	28.6	98.3	23.6	36.8	146.7	106.9	61.3	99.7	106.3	89.7	36.3	27.5	104.1	71.5	29.9	31.1	26.1	80.0	60.5	49.8	24.4	27.8	77.2	95.9	106.5	20.3	59.6	68.3	164.7	43.8	166.0	17.1	27.2	89.1	51.7	24.2	72.2	76.5	83.5	65.6	58.5	102.1	28.9	49.7	2.2	1.4	3.4	2.8	1.2	3.8	2.3	2.8	2.6	1.3	4.5	3.6	3.8	4.8	0.9	1.5	2.3	4.4	1.3	43.0	44.2	46.4	49.1	42.1	45.4	48.7	43.4	45.0	41.8	45.8	47.8	69.9	41.7	51.8	87.1	43.1	145.8	187.5	65.7	59.7	65.1	83.7	49.4	102.9	44.3	69.3	71.7	60.5	116.3	56.7	38.6	41.1	66.0	93.5	225.7	91.2	81.4	59.1	100.0	97.1	70.9	67.1	65.2	43.8	365.8	14.7	53.9	45.3	73.1	41.8	43.7	116.9	35.3	54.9	40.3	69.8	44.0	44.1	52.0	48.0	89.0	26.2	87.4	51.5	113.1	108.5	118.3	33.6	78.6	60.5	227.6	27.6	49.7	95.3	35.6	13.1	65.9	69.0	46.5	22.5	78.6	153.7	200.4	49.2	79.7	26.6	274.3
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021, CAB079920"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		130000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	62.5	76.3	42.5	60.3	44.0	81.6	62.0	46.1	49.3	64.7	37.1	63.8	45.1	72.7	48.7	74.2	67.3	34.3	68.2	45.2	45.2	63.4	40.8	53.1	76.0	39.3	42.3	93.1	49.1	72.0	61.6	58.1	40.2	53.4	47.3	31.7	56.4	46.7	58.0	68.0	61.1	53.8	42.2	71.9	52.9	47.6	47.1	110.3	53.2	57.0	89.3	66.6	63.1	42.1	121.3	161.1	269.0	157.7	112.7	135.8	114.4	170.0	121.7	154.3	152.9	191.8	190.1	208.2	137.7	148.1	140.7	142.4	193.2	159.2	197.9	151.2	133.4	130.6	136.6	188.4	178.6	194.9	148.0	127.1	100.7	152.1	180.0	149.0	170.0	169.9	190.3	124.3	148.0	254.4	349.6	193.0	219.0	136.0	118.5	434.0	170.9	238.4	145.7	106.6	150.3	159.8	149.3	164.1	177.7	152.8	167.5	234.4	139.4	149.2	172.6	134.0	155.5	132.1	170.4	423.4	85.3	142.9	164.7	278.7	214.3	327.1	165.9	256.6	200.9	297.8	167.8	170.3	214.7	241.1	148.2	149.6	149.5	202.6	249.5	186.3	196.5	260.9	42.5	44.0	46.1	49.3	45.2	45.2	39.3	42.3	40.2	42.2	47.1	42.1	109.5	51.3	67.0	16.3	172.8	178.6	186.4	275.6	97.3	64.6	101.9	105.7	89.1	84.4	140.9	62.5	50.1	312.8	153.9	77.4	105.7	211.9	64.4	66.6	100.6	118.3	102.3	127.4	17.2	148.2	293.1	134.4	55.5	104.6	109.5	149.7	94.2	43.7	213.5	47.1	16.8	97.1	162.8	104.8	182.1	37.8	129.8	124.8	128.1	15.9	220.2	104.7	209.1	16.6	26.7	212.3	91.8	107.6	144.1	294.8	90.4	117.7	65.7	63.1	78.9	82.1	185.4	139.6	145.7	158.4	206.7	418.1	144.7	134.9	134.7	304.5
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352722	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 498.7;Late spermatids: 1426.6;Plasma cells: 1003.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 294.1;Karpas-707: 247.4;U-266/70: 274.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	25.9	23.2	14.9	52.3	15.9	119.3	31.4	16.8	18.8	33.3	15.0	48.9	55.0	27.8	28.6	23.2	20.9	26.6	14.7	15.2	16.5	22.0	26.9	29.9	90.5	16.9	17.8	23.7	32.0	21.8	12.9	33.3	17.1	42.3	49.6	19.4	44.7	21.2	12.0	14.3	45.9	30.2	16.9	43.7	49.1	24.6	16.2	57.8	31.9	15.6	97.1	36.7	14.5	18.3	38.8	13.4	36.3	46.5	37.0	47.8	0.2	60.4	53.4	36.7	40.0	21.9	23.7	294.1	32.9	63.0	30.6	15.3	23.9	35.1	59.4	41.6	37.0	53.6	16.1	36.0	98.2	68.2	33.4	36.7	34.4	30.8	52.1	48.9	83.1	34.7	43.9	247.4	43.4	23.8	28.5	52.1	12.5	27.3	19.0	110.1	46.5	143.6	46.2	26.9	18.3	36.7	25.6	55.7	56.9	52.2	22.0	149.3	56.1	20.2	19.1	36.3	47.0	274.1	146.1	80.0	40.3	48.3	34.4	24.6	13.5	24.7	6.2	22.0	7.2	37.5	8.2	7.6	12.4	29.6	7.6	7.0	30.7	12.8	37.4	45.5	13.0	13.3	14.9	15.9	16.8	18.8	15.2	16.5	16.9	17.8	17.1	16.9	16.2	18.3	65.3	16.0	33.9	18.6	185.6	24.9	60.0	39.1	31.3	34.6	39.5	29.5	9.7	30.0	38.5	20.2	29.2	89.7	136.8	71.0	50.9	60.5	498.7	35.6	50.3	104.6	77.3	34.7	26.9	101.4	91.8	60.0	72.9	50.2	25.3	27.1	99.2	45.5	75.8	23.5	28.9	80.3	42.7	107.7	53.0	1426.6	54.7	105.5	72.9	23.4	65.4	18.6	30.9	26.2	31.0	112.0	74.3	47.8	1003.3	99.5	72.4	49.2	33.4	16.0	32.9	54.3	61.1	22.5	20.5	54.4	34.7	129.4	52.3	32.6	65.0	123.7
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698109-39782792	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		390000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	29.9	19.4	13.5	23.4	17.5	21.4	21.7	20.9	24.5	16.0	9.2	35.8	31.2	17.8	17.7	26.2	12.7	12.9	18.4	18.3	14.9	26.7	45.4	16.4	20.1	12.9	14.0	13.6	13.2	20.4	15.8	24.4	13.1	19.8	24.2	21.0	16.9	14.9	37.3	22.6	24.8	17.2	7.8	18.0	31.8	16.5	14.2	22.4	23.8	25.6	18.0	20.2	17.2	16.0	91.3	90.7	49.3	45.6	29.8	28.7	82.8	122.8	26.4	32.8	34.0	138.0	91.1	114.3	105.2	35.0	79.8	39.0	95.4	54.7	51.9	76.1	70.0	145.7	88.9	121.6	38.4	159.0	79.6	27.1	60.2	46.0	49.0	35.2	43.3	49.3	152.9	39.6	33.9	86.6	111.5	89.9	67.7	54.4	69.8	66.3	144.0	44.2	46.0	123.9	103.9	47.4	91.7	34.5	58.9	54.1	44.4	58.2	116.9	49.9	105.7	60.0	114.5	55.3	174.0	121.4	26.9	101.4	59.5	19.6	18.1	24.8	14.4	16.9	13.4	20.7	15.0	13.8	19.7	14.7	11.2	12.6	15.1	14.0	25.4	27.6	16.0	10.5	13.5	17.5	20.9	24.5	18.3	14.9	12.9	14.0	13.1	7.8	14.2	16.0	63.2	57.7	63.1	69.2	53.0	122.9	65.5	74.3	59.7	62.2	65.3	52.5	72.3	52.9	66.7	49.7	29.2	84.5	76.5	143.7	66.5	83.5	144.9	72.0	82.3	65.6	59.7	85.8	115.9	89.4	168.7	59.2	68.3	90.9	34.8	40.1	63.5	113.6	80.2	104.3	113.8	74.5	65.1	77.1	91.8	202.4	65.3	76.5	56.9	89.0	104.0	87.1	56.7	87.0	118.2	139.6	94.3	56.4	55.5	111.4	75.3	98.0	60.7	42.9	39.5	61.8	121.1	145.2	55.1	74.3	137.9	147.5	61.3	54.8	74.1	107.0
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 544.4"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		5800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	41.5	46.0	63.7	37.1	64.8	54.4	33.9	65.0	72.0	35.5	54.4	45.5	39.6	35.0	41.0	49.1	38.5	34.0	51.5	65.4	65.3	40.1	40.9	33.9	48.8	67.8	64.7	33.9	30.3	43.2	31.2	42.7	66.8	39.1	45.6	28.1	33.9	36.8	63.5	36.2	40.7	48.6	62.3	37.6	37.5	28.5	66.7	51.9	36.4	53.1	52.5	46.8	32.3	65.5	121.9	68.9	98.3	77.4	105.1	93.1	56.6	100.0	113.6	125.8	118.7	79.0	57.0	114.2	49.0	133.5	94.7	101.4	132.1	108.6	124.3	114.4	142.9	132.1	63.3	94.8	70.0	190.9	91.0	82.7	93.1	91.2	65.7	90.6	143.4	69.4	544.4	59.3	137.9	89.6	100.0	137.6	72.8	134.8	71.6	80.5	147.6	31.2	118.8	96.2	88.0	65.4	79.9	99.1	95.6	89.4	61.7	104.0	103.8	88.6	113.5	75.5	103.6	57.3	99.7	103.7	120.0	87.5	86.0	84.4	87.8	105.7	84.9	102.2	79.7	77.3	79.9	91.6	109.2	73.6	69.0	82.9	73.2	81.2	89.0	106.3	106.1	141.1	63.7	64.8	65.0	72.0	65.4	65.3	67.8	64.7	66.8	62.3	66.7	65.5	102.6	109.0	83.9	26.1	110.7	125.5	171.6	318.5	51.2	54.5	76.9	72.8	64.9	101.5	180.3	71.7	16.7	312.1	159.0	215.1	197.6	288.2	79.9	133.1	104.6	125.9	126.0	173.0	25.6	385.0	406.5	102.6	60.1	124.9	129.3	79.3	109.6	159.8	298.5	69.0	24.3	153.1	193.3	126.9	159.7	61.1	87.3	140.9	126.3	19.7	257.9	98.4	200.8	22.6	30.4	432.1	222.1	103.8	98.4	186.7	213.5	257.2	173.9	45.5	105.2	81.0	205.4	202.8	121.2	87.6	129.7	372.1	130.1	133.7	154.0	208.4
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"	A0A1B0GUS4	13	30422488-30429758	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 46.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.5	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.4	0.4	0.0	0.3	0.2	0.8	0.2	0.2	0.5	0.1	0.2	0.2	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.2	0.4	0.7	0.2	0.4	0.0	0.2	0.2	46.5	0.0	0.2	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.4	0.2	0.3	0.2	0.7	0.2	0.6	0.2	0.3	0.3	0.4	0.2	0.3	0.4	0.4	0.3	0.3	0.4	0.7	0.2	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	70.7	60.4	84.4	92.3	84.8	85.5	51.1	80.0	95.2	54.2	70.7	46.3	47.6	44.1	68.5	42.7	66.1	66.6	35.2	80.2	88.0	51.5	121.1	91.1	119.9	93.6	88.1	61.5	24.3	39.9	36.8	53.1	86.2	47.0	43.6	23.6	103.3	49.2	14.3	36.1	57.6	67.3	96.2	126.4	55.6	17.1	94.6	113.4	37.4	29.3	86.7	76.0	44.4	86.1	55.6	26.2	85.8	29.0	179.2	222.3	9.7	30.2	178.8	261.3	337.0	9.8	140.9	169.3	110.3	92.5	223.3	43.7	38.0	99.4	55.4	163.9	1.5	169.2	0.0	38.0	330.7	38.8	54.3	238.9	22.9	122.8	33.6	96.2	83.9	173.2	7.9	118.5	47.8	67.6	280.1	92.2	23.3	0.5	33.3	243.1	52.9	118.4	71.0	58.5	2.1	45.2	60.3	5.4	139.9	15.3	68.3	20.3	30.9	56.3	19.6	43.6	10.2	162.1	176.6	3.4	161.0	98.8	12.3	508.1	534.8	487.8	359.2	638.4	394.1	379.2	368.2	377.9	401.3	310.9	315.1	331.1	838.8	486.9	556.7	256.3	513.7	1060.5	84.4	84.8	80.0	95.2	80.2	88.0	93.6	88.1	86.2	96.2	94.6	86.1	94.6	28.9	22.2	2.9	53.5	23.3	26.2	75.7	26.2	12.4	31.9	38.7	6.0	24.3	38.2	12.9	4.2	4.2	59.3	16.4	64.6	95.4	4.9	16.6	83.4	65.5	23.9	53.0	2.0	65.2	38.1	43.8	23.0	16.4	53.9	41.3	53.2	35.3	165.3	13.5	4.8	38.6	48.8	77.4	36.9	10.9	48.1	73.1	8.8	9.4	79.0	54.0	97.9	3.5	2.0	37.3	48.1	33.4	51.4	52.8	47.7	32.3	33.3	4.4	26.3	15.4	33.8	2.4	9.8	25.6	27.7	3.4	68.8	26.9	22.7	33.3
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93441947	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2532.0;Late spermatids: 8141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	52.4	48.6	46.4	62.1	49.9	69.9	41.6	40.3	51.6	35.8	26.8	55.9	42.5	44.0	38.3	60.4	37.3	33.5	57.6	50.8	53.2	54.4	45.5	38.2	80.0	45.2	43.9	31.3	30.6	40.4	32.6	49.5	52.2	46.0	44.0	50.3	36.0	34.5	83.0	41.3	42.3	42.7	44.3	42.9	41.0	186.9	44.3	79.4	29.0	70.3	73.8	76.4	38.6	44.4	190.3	133.2	221.1	142.6	82.9	81.4	154.5	259.4	135.6	201.0	167.3	239.8	80.0	380.2	57.3	151.1	133.8	147.7	245.2	188.7	189.7	323.3	128.4	258.0	66.6	214.2	106.4	311.9	165.1	86.3	75.2	120.8	148.9	143.1	157.3	146.9	292.8	58.0	210.9	155.3	310.4	286.2	288.9	165.9	189.4	237.3	179.9	186.6	170.1	280.9	214.9	195.6	136.1	158.5	130.0	118.7	207.5	188.0	165.8	135.7	114.6	124.1	189.9	99.5	289.4	324.0	53.5	162.5	170.2	133.7	89.5	101.3	99.3	123.3	116.8	174.0	124.8	124.1	119.6	144.7	109.3	104.9	27.7	106.0	141.7	89.6	198.6	202.5	46.4	49.9	40.3	51.6	50.8	53.2	45.2	43.9	52.2	44.3	44.3	44.4	87.5	38.5	45.8	24.8	151.4	322.2	231.3	219.1	92.2	72.1	84.3	60.5	74.6	60.1	112.2	90.1	27.1	236.0	104.3	76.3	191.7	141.4	2532.0	79.7	79.0	95.3	74.7	75.9	44.6	99.0	226.0	100.9	49.5	96.5	93.8	68.3	55.3	55.3	165.6	87.5	49.0	78.6	187.2	67.8	216.3	8141.3	93.8	97.0	147.7	33.7	152.9	111.9	79.3	38.7	42.1	135.5	83.8	86.1	113.3	218.2	61.2	171.3	88.9	57.6	46.0	101.9	146.2	338.4	227.6	142.2	322.5	284.7	128.2	86.4	94.9	260.3
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389456-76453152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.7;Inhibitory neurons: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	9.1	9.7	12.9	10.1	14.0	21.2	9.7	8.0	24.9	12.8	1.4	10.7	9.4	11.5	7.0	12.8	11.0	6.5	20.3	15.4	11.7	8.4	10.5	8.7	13.1	21.7	9.0	15.1	17.4	10.9	18.2	9.1	21.7	11.6	5.3	10.5	12.9	8.7	28.3	16.1	10.6	7.1	4.4	13.9	11.0	16.6	11.6	12.0	16.1	13.4	8.6	10.8	12.5	14.5	25.8	29.2	29.1	35.5	17.7	11.3	25.2	11.8	12.8	18.9	18.3	25.6	12.7	36.4	8.3	14.8	29.7	25.2	34.2	20.4	13.2	10.5	42.2	36.9	20.6	42.9	14.7	22.6	22.0	11.4	16.2	18.1	15.3	16.2	25.7	19.9	31.5	31.4	9.6	21.3	44.7	26.0	27.0	15.5	38.9	43.3	37.6	40.2	8.5	22.1	43.0	38.5	17.4	43.9	23.6	26.3	25.4	16.1	15.4	21.9	20.5	18.8	19.9	25.8	9.2	30.8	24.1	18.8	14.6	0.0	0.7	1.0	1.4	0.3	0.8	0.9	0.9	0.7	0.4	1.6	0.7	1.1	0.1	0.5	0.4	1.5	0.9	0.8	12.9	14.0	8.0	24.9	15.4	11.7	21.7	9.0	21.7	4.4	11.6	14.5	7.9	3.2	7.7	24.8	19.6	8.7	6.1	7.2	13.1	45.8	9.7	9.1	23.2	5.7	7.3	7.3	41.7	6.4	15.2	6.5	0.0	6.0	1.8	8.6	13.7	8.3	23.4	33.2	54.7	9.4	7.4	8.3	17.9	10.1	7.0	18.9	7.1	8.5	8.1	45.4	63.0	9.3	2.0	5.3	11.0	1.8	9.6	11.6	5.4	19.7	10.0	7.3	18.6	27.2	24.7	7.2	5.7	7.9	22.9	9.8	5.2	3.3	5.6	23.8	6.6	12.2	10.9	19.6	23.2	12.9	12.4	5.2	14.7	13.3	8.7	6.2
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	25.4	23.1	36.1	19.0	37.0	32.2	22.4	34.5	43.3	21.2	35.2	24.3	18.7	21.8	27.2	27.4	23.7	19.9	25.9	37.3	38.0	28.8	31.6	25.0	29.5	36.0	36.0	23.1	31.8	28.3	31.3	23.9	37.5	21.2	28.2	25.9	22.5	20.9	26.3	26.7	25.5	24.4	35.5	32.3	26.8	34.6	38.2	29.8	23.0	25.8	35.2	25.7	22.2	36.2	39.0	33.0	45.6	35.0	45.8	46.9	39.4	38.0	57.0	47.3	38.0	37.3	40.4	47.5	53.3	52.8	39.5	33.0	54.3	43.6	40.5	48.7	34.3	37.8	29.6	36.4	57.5	62.1	58.3	45.5	56.7	38.5	44.1	51.3	61.8	43.3	32.4	57.1	61.3	60.4	38.1	45.6	62.5	92.3	55.5	43.4	31.8	50.3	52.4	40.6	46.2	64.6	38.1	70.6	64.5	77.5	43.3	93.2	43.3	30.5	34.1	36.5	41.2	69.3	55.2	62.1	34.2	43.2	47.1	3.9	1.3	2.9	2.1	1.6	2.0	1.4	2.0	2.7	1.2	1.5	2.2	2.5	2.0	2.3	1.3	2.4	3.1	0.8	36.1	37.0	34.5	43.3	37.3	38.0	36.0	36.0	37.5	35.5	38.2	36.2	40.8	32.1	26.5	9.8	24.7	16.2	18.0	15.9	15.4	41.2	27.3	32.5	29.4	27.1	18.4	16.5	4.2	19.8	45.2	33.4	11.7	14.5	4.5	24.8	20.9	32.8	33.6	12.0	12.2	21.0	18.2	23.3	14.3	24.9	10.8	31.9	35.3	38.3	27.5	60.6	11.7	29.2	22.4	48.0	19.7	7.3	17.7	27.9	14.2	10.3	30.9	42.8	39.1	7.1	11.7	26.2	18.5	19.2	22.1	29.5	29.6	19.7	29.0	23.1	13.1	20.1	21.2	34.1	29.2	18.1	19.0	19.6	26.5	36.3	25.7	31.4
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407788	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.9;testis: 158.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 341.4;dendritic cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	16.3	17.6	17.1	21.8	17.3	115.9	11.0	15.7	23.7	16.8	10.9	18.5	11.4	17.2	5.5	37.1	15.1	13.1	24.8	25.2	23.8	13.0	11.5	16.2	35.7	17.0	16.5	14.8	7.7	6.8	28.8	13.6	22.2	15.1	9.3	9.4	12.0	6.2	15.5	12.0	16.2	15.0	16.7	25.7	17.6	158.3	18.9	47.8	10.3	5.7	30.9	16.2	17.8	21.3	532.9	279.4	241.3	193.8	15.3	21.6	42.9	419.3	126.1	253.2	229.1	191.1	183.6	508.6	169.5	106.4	304.5	152.9	243.6	109.5	111.4	402.0	810.5	305.8	162.8	62.5	45.1	370.0	286.0	23.8	30.2	186.7	179.1	55.0	100.6	272.7	310.0	347.0	161.3	139.5	503.2	191.3	605.3	147.2	470.6	437.4	185.5	185.8	69.2	111.5	609.3	330.0	534.5	131.2	248.6	72.6	93.8	198.1	155.9	151.9	432.8	130.7	1013.5	277.1	734.4	617.0	159.2	257.5	562.7	0.5	0.8	1.3	0.7	0.6	0.5	2.5	1.0	1.0	0.6	0.6	1.0	0.5	2.4	0.2	0.4	1.3	0.4	0.1	17.1	17.3	15.7	23.7	25.2	23.8	17.0	16.5	22.2	16.7	18.9	21.3	308.0	0.0	3.4	5.9	161.3	162.6	151.2	31.5	81.4	59.3	235.9	341.4	3.1	8.6	9.9	20.2	54.2	87.8	432.7	59.2	15.6	42.8	127.5	89.3	68.2	72.5	92.6	166.5	8.7	30.5	247.9	99.3	44.9	68.0	18.4	200.9	31.8	10.6	65.5	32.0	11.0	69.1	38.7	26.8	125.3	52.2	17.4	131.7	74.7	3.7	36.7	91.1	21.6	7.5	13.5	82.3	44.1	12.4	100.6	82.9	20.4	18.4	9.7	75.7	13.1	125.2	186.7	196.9	174.0	74.1	115.9	59.8	233.3	64.6	55.8	121.1
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	7.5	6.2	5.3	7.5	5.3	11.4	7.0	6.3	7.2	5.9	1.1	5.2	4.5	5.1	5.5	8.7	4.7	8.1	8.3	6.1	3.0	11.2	12.6	7.3	7.1	2.8	2.1	5.4	6.7	8.6	4.6	7.3	3.4	6.0	5.9	10.4	5.7	5.2	8.5	5.5	4.7	6.3	1.6	6.7	5.5	9.5	3.3	7.0	9.1	10.0	7.1	9.7	6.2	4.2	10.3	7.0	8.2	8.0	13.0	14.4	6.8	10.8	12.6	10.6	10.8	5.9	11.1	4.8	8.6	11.7	15.7	10.0	11.2	11.7	16.7	7.7	7.2	10.3	6.5	9.0	8.9	5.6	12.9	10.6	12.2	12.4	21.9	8.5	13.4	5.6	5.1	9.7	16.1	8.7	11.8	6.4	6.2	14.3	13.0	3.8	7.5	4.1	19.7	11.6	5.6	6.5	8.5	26.4	13.2	8.4	13.4	10.0	11.8	12.2	9.4	9.7	8.2	8.7	9.5	3.6	11.2	8.2	11.2	23.8	13.1	17.4	4.7	12.8	5.8	6.8	4.8	3.6	9.1	6.8	4.3	5.0	33.1	7.0	14.4	11.9	6.1	6.9	5.3	5.3	6.3	7.2	6.1	3.0	2.8	2.1	3.4	1.6	3.3	4.2	28.7	16.0	14.0	40.1	30.3	55.3	26.4	32.1	19.4	35.5	26.7	14.7	24.3	37.1	22.9	53.3	16.7	18.4	35.0	14.2	50.9	23.2	154.5	18.3	21.0	35.3	23.3	26.5	117.0	17.4	20.0	24.9	13.3	26.9	21.0	16.8	26.0	28.7	39.9	42.1	91.8	12.1	22.4	50.3	107.9	56.8	20.5	45.7	42.7	104.9	67.0	28.8	21.6	66.9	67.7	20.9	12.4	18.8	21.3	34.1	14.7	76.1	19.2	32.2	19.7	27.3	39.9	39.4	30.4	20.9	64.5	55.1	31.0	30.6	12.9	40.9
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908407-48929056	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	33.5	45.9	37.4	37.8	40.6	33.4	36.0	37.7	44.5	41.2	32.8	37.6	34.6	39.8	60.3	45.3	44.4	34.6	33.8	40.0	40.7	40.2	33.1	34.9	44.9	39.2	37.9	36.2	34.5	46.8	31.4	42.6	42.6	39.1	40.4	38.4	38.5	47.0	29.9	43.9	35.7	49.3	35.7	41.9	35.8	28.0	40.7	45.2	50.2	28.8	59.3	45.8	39.1	57.8	101.2	122.4	45.1	43.0	111.8	107.7	61.6	107.6	131.1	126.1	120.7	153.8	84.8	81.6	150.5	133.1	158.0	64.0	57.1	100.7	159.7	271.7	61.8	73.9	80.3	96.8	128.8	53.0	76.3	92.4	109.5	103.1	132.3	134.7	94.0	38.1	55.2	103.0	137.4	160.8	57.5	52.4	42.1	122.4	105.7	45.7	114.6	46.6	98.7	97.6	46.4	70.1	73.2	38.8	76.5	100.7	107.7	41.4	111.2	187.2	89.9	62.0	89.4	77.8	79.5	47.6	91.8	38.2	83.2	5.2	7.7	5.7	8.3	9.9	6.8	6.2	7.3	8.4	5.4	8.6	6.9	7.6	7.3	5.4	9.5	6.8	8.2	6.4	37.4	40.6	37.7	44.5	40.0	40.7	39.2	37.9	42.6	35.7	40.7	57.8	36.6	25.6	19.2	17.9	32.7	52.8	50.3	47.1	27.3	56.4	40.6	32.9	37.9	21.5	25.8	36.8	41.7	34.2	40.0	42.1	21.5	44.2	1.6	48.8	40.8	44.0	48.6	23.4	22.5	54.7	32.7	35.1	20.9	59.5	6.3	37.6	37.5	25.8	24.8	43.7	20.8	35.9	20.3	28.1	54.0	5.1	28.0	35.6	30.2	12.2	48.6	31.6	26.8	13.6	52.7	75.8	25.6	29.0	23.7	89.5	34.7	27.5	42.1	34.4	32.9	25.8	39.3	21.6	26.0	35.9	57.0	42.8	30.7	50.4	30.8	66.7
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	13.8	16.5	14.4	10.7	16.1	9.2	13.7	13.3	15.6	14.4	16.5	17.8	12.9	14.1	13.4	18.6	16.2	12.1	26.2	14.4	12.4	16.7	16.0	13.6	12.6	13.7	14.6	15.8	14.3	22.6	13.6	13.1	14.8	15.4	18.1	14.9	14.4	14.1	34.0	19.2	15.8	14.7	12.5	15.8	16.5	12.9	16.1	12.6	18.2	29.7	13.5	17.0	14.5	20.3	17.1	26.4	20.4	14.8	33.9	27.1	17.9	22.1	25.1	26.2	17.4	28.0	17.1	10.6	16.0	36.3	22.5	21.5	20.9	28.3	25.1	23.4	14.7	20.3	17.6	25.5	21.7	16.7	16.2	31.0	25.8	25.4	30.2	39.5	28.7	24.8	22.7	9.7	30.2	26.6	11.5	24.2	21.0	19.1	31.6	18.8	19.2	20.9	22.4	30.2	19.1	34.9	25.8	34.6	17.3	23.7	35.3	17.6	26.5	32.3	9.2	16.8	16.0	21.8	19.4	18.6	32.1	13.7	27.4	22.9	12.9	12.8	12.6	14.5	12.4	13.6	12.1	9.0	12.4	10.0	10.0	13.3	16.1	13.1	12.0	11.4	16.2	10.7	14.4	16.1	13.3	15.6	14.4	12.4	13.7	14.6	14.8	12.5	16.1	20.3	11.9	12.8	15.1	34.0	9.7	5.1	11.8	13.9	6.8	19.3	14.4	12.8	35.4	11.5	17.1	16.5	33.3	17.9	12.8	21.0	11.7	17.7	15.7	12.6	12.5	14.2	9.0	13.0	24.5	15.3	11.5	11.1	18.8	12.2	9.5	20.0	11.7	18.8	12.5	21.9	23.6	15.9	18.3	19.2	6.1	32.0	12.5	14.2	10.6	13.1	17.7	13.6	32.0	21.1	38.3	25.3	13.7	9.8	15.6	17.2	19.6	19.9	18.4	25.0	6.6	9.4	13.0	10.4	13.2	13.4	7.2	23.7	10.7	17.7	16.8	18.4
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138916-157269370	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	25.7	17.4	12.0	21.5	13.2	16.2	21.7	17.5	14.1	18.4	18.8	22.3	20.0	19.4	13.4	28.3	18.5	19.1	28.5	13.2	14.1	20.3	22.9	19.0	20.9	14.6	13.4	20.0	22.4	36.2	11.1	17.5	14.9	19.9	23.2	20.2	22.7	22.7	65.6	20.8	20.8	29.2	12.7	18.0	20.9	26.2	14.8	18.6	17.3	58.5	22.8	28.1	17.0	15.0	68.8	53.3	33.5	67.3	58.8	61.3	37.1	74.0	63.4	61.1	61.3	48.3	55.7	36.8	64.0	82.1	79.6	42.4	52.6	68.3	72.0	67.6	48.3	37.6	35.6	35.0	58.4	56.9	52.8	54.8	61.6	68.0	55.9	46.4	72.2	30.3	55.7	39.9	87.6	59.8	56.2	35.9	53.3	61.1	63.6	31.9	37.7	75.9	63.2	74.1	53.5	55.2	72.8	61.9	54.5	37.2	32.0	39.3	65.3	76.6	16.5	190.0	93.3	39.7	42.9	37.0	87.7	83.0	89.5	0.3	1.8	1.1	2.2	2.3	3.0	1.1	2.4	2.4	2.0	1.2	2.2	2.7	0.6	2.1	2.5	1.8	2.8	1.5	12.0	13.2	17.5	14.1	13.2	14.1	14.6	13.4	14.9	12.7	14.8	15.0	23.8	22.4	19.7	52.2	14.2	27.5	17.3	19.0	17.6	34.7	22.4	16.9	33.7	22.8	14.2	25.8	66.7	14.9	25.3	27.3	9.8	20.3	11.6	21.6	27.4	23.4	24.5	14.9	98.9	17.7	17.4	19.6	27.0	24.5	9.5	23.0	23.6	48.3	15.4	32.0	100.7	21.8	12.2	27.6	15.2	10.1	15.5	20.6	5.4	52.5	22.0	9.9	26.8	81.4	96.2	27.5	13.4	25.6	17.5	31.5	20.6	19.1	19.8	39.9	0.0	23.1	21.4	26.6	27.3	37.5	33.2	15.1	20.9	22.3	26.2	28.1
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892390-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.7;Inhibitory neurons: 74.5;Oligodendrocyte precursor cells: 78.9;Oligodendrocytes: 70.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Approved		Approved	"Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	1.6	2.4	0.8	1.4	1.4	0.8	1.5	0.4	2.1	1.7	0.2	1.7	2.1	1.7	1.2	1.7	5.0	1.3	1.4	1.0	1.4	2.1	1.2	1.1	1.6	0.8	1.9	2.1	2.3	1.9	2.4	1.1	1.2	1.2	1.7	3.3	1.9	1.4	2.7	1.3	1.4	1.6	1.6	1.6	1.7	1.1	1.3	2.1	2.7	2.5	1.8	2.1	1.9	1.3	2.9	4.0	3.8	3.5	3.0	4.9	3.0	3.0	3.7	3.8	6.5	5.7	1.5	13.2	4.6	1.8	6.6	3.0	7.5	3.7	6.0	5.6	17.0	7.6	2.0	6.2	4.1	6.5	3.6	3.9	5.2	4.2	5.0	2.8	5.0	7.0	11.1	5.8	3.3	3.3	4.1	8.3	4.8	10.4	6.3	6.1	8.6	5.2	7.2	3.8	6.8	4.2	1.7	4.4	2.8	5.1	2.8	4.7	1.5	1.6	4.6	3.6	7.5	6.4	13.8	4.4	2.8	12.0	3.5	0.0	0.7	0.2	3.3	2.0	4.3	4.7	3.5	2.6	2.2	3.2	3.7	5.5	0.0	1.0	0.9	1.7	4.0	2.2	0.8	1.4	0.4	2.1	1.0	1.4	0.8	1.9	1.2	1.6	1.3	1.3	4.7	6.4	6.4	35.9	8.1	6.2	5.2	6.7	6.2	11.0	2.7	2.7	3.1	2.8	5.1	7.3	35.5	7.4	10.0	1.5	1.9	5.4	2.1	15.7	6.2	5.8	7.7	2.1	95.7	4.7	4.7	5.1	2.0	2.8	1.3	6.8	4.2	2.7	5.2	6.7	74.5	5.2	8.2	4.6	3.4	1.1	6.8	3.1	7.2	36.5	2.7	3.9	3.1	78.9	70.9	3.6	5.9	4.1	4.8	3.6	3.6	5.5	31.9	14.9	6.6	11.1	4.3	7.3	14.7	4.8	6.8	3.0	5.8	8.4	6.7	3.7
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359600-118399211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	18.6	14.1	15.9	20.3	17.8	17.7	18.0	25.5	20.5	16.1	15.7	17.4	19.1	18.9	18.6	15.0	15.5	15.6	19.7	15.1	20.2	18.0	27.6	17.0	22.5	18.9	18.1	19.1	19.5	19.0	9.5	17.5	20.2	19.0	20.7	18.4	16.1	14.9	22.1	24.0	20.5	18.1	16.5	19.7	23.9	17.7	19.7	21.3	18.4	15.9	21.6	14.7	12.7	24.4	18.8	17.9	22.4	22.5	38.0	34.9	22.3	27.1	28.1	19.7	24.0	49.7	44.9	39.3	51.0	34.4	26.5	40.3	31.9	25.7	32.6	22.3	14.8	64.5	15.4	25.7	32.6	36.8	47.3	35.4	18.2	40.4	39.3	26.3	33.3	33.9	37.2	35.9	28.7	35.4	31.5	36.5	20.9	37.7	22.7	20.0	32.5	40.2	21.6	43.1	20.3	21.1	39.2	33.5	12.3	24.2	44.8	16.6	34.6	29.0	19.0	25.1	22.8	10.5	13.8	36.4	16.1	41.6	30.4	14.2	9.5	9.7	7.5	10.5	5.8	5.1	5.6	5.4	9.8	3.5	6.0	5.4	9.6	6.5	12.8	5.7	7.0	4.8	15.9	17.8	25.5	20.5	15.1	20.2	18.9	18.1	20.2	16.5	19.7	24.4	28.7	12.8	31.9	45.7	27.5	26.8	22.0	20.4	25.6	19.5	26.3	18.0	18.2	10.0	27.8	14.7	18.8	20.3	30.6	25.5	5.9	19.8	18.0	23.7	35.3	20.9	18.6	26.9	46.2	28.5	19.8	24.2	41.8	31.7	10.8	25.7	19.2	44.6	21.9	16.8	56.3	20.1	30.5	27.9	23.1	15.2	17.1	33.2	24.9	36.5	32.4	20.5	24.7	55.8	80.9	27.0	18.3	21.4	42.0	23.1	29.0	11.5	37.5	16.8	19.7	23.4	23.6	35.3	22.0	30.3	39.2	24.8	31.0	26.0	20.3	26.1
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.9;Inhibitory neurons: 101.1;Oligodendrocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	13.5	22.2	13.0	12.9	18.4	20.1	13.4	19.6	16.7	15.8	9.3	24.3	16.2	19.4	12.6	22.8	14.6	12.3	23.2	13.6	13.9	13.6	13.9	11.2	12.4	19.1	15.1	23.3	26.9	21.1	15.2	20.0	20.7	14.1	13.4	19.3	15.0	12.8	41.8	25.3	15.9	17.4	10.4	12.2	20.4	9.5	16.6	17.1	21.0	27.5	14.2	17.3	16.7	28.7	37.9	24.5	28.8	31.6	37.5	49.0	22.5	24.4	31.1	24.0	24.3	26.6	43.2	32.4	29.2	43.6	18.6	27.5	37.2	28.2	28.1	33.8	20.8	35.1	41.5	30.2	27.4	36.6	23.9	40.4	24.7	32.1	26.8	43.9	35.0	23.3	61.7	42.4	22.0	19.6	24.1	16.7	38.2	24.2	19.9	23.6	28.1	34.8	23.0	17.0	35.0	26.7	38.8	26.8	49.5	30.4	21.1	26.0	30.4	21.1	32.0	26.5	20.2	18.8	27.7	37.1	30.9	41.4	28.4	3.4	4.9	2.4	3.0	3.7	5.1	3.6	5.0	5.0	4.1	3.2	4.5	3.6	5.5	1.8	2.8	1.8	6.4	3.6	13.0	18.4	19.6	16.7	13.6	13.9	19.1	15.1	20.7	10.4	16.6	28.7	13.5	22.4	24.0	65.6	17.7	17.6	14.6	13.0	21.6	14.7	18.6	13.2	42.2	15.7	12.9	9.2	25.0	33.1	12.3	12.0	9.8	12.8	3.0	22.4	23.3	15.4	16.3	33.4	99.9	14.8	13.5	18.5	14.8	24.6	6.3	27.9	17.2	16.4	16.5	16.8	101.1	16.2	16.2	22.1	10.9	4.8	11.1	16.1	5.4	46.9	22.9	10.5	19.6	82.4	185.2	19.5	19.5	8.6	24.3	19.3	25.5	10.3	12.9	33.5	19.7	15.2	16.4	8.5	15.0	35.8	22.4	20.5	18.3	21.1	18.6	18.5
UBL3	"DKFZP434K151, FLJ32018, HCG-1, PNSC1"	ENSG00000122042	"Ubiquitin like 3"	O95164	13	29764371-29850617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 350.5;Late spermatids: 316.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053772, HPA058781"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA053772: AB_2682258, HPA058781: AB_2683818"	"unprognostic (2.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (8.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.84e-1)"	23.3	20.7	39.6	17.8	49.6	22.2	29.3	58.0	47.1	38.3	25.9	28.6	27.7	42.4	25.6	42.9	27.1	31.5	20.5	38.5	52.3	35.1	41.7	36.9	19.3	51.5	54.8	30.7	55.8	30.0	17.1	22.6	49.0	22.5	27.7	47.2	29.2	22.7	29.7	24.1	29.0	30.7	53.8	25.2	72.8	22.4	47.3	21.5	40.4	35.5	19.0	19.5	23.6	61.3	12.5	7.8	23.9	14.5	33.0	31.7	25.3	101.2	59.2	42.5	34.0	18.6	27.7	10.9	22.3	101.3	19.7	12.2	11.0	15.1	121.0	17.3	13.5	11.5	9.9	15.0	10.4	17.0	14.8	18.8	48.2	22.4	14.3	36.7	15.5	12.9	5.8	7.7	18.1	84.5	12.8	14.3	14.3	29.3	11.1	14.5	30.8	12.5	28.2	14.7	27.8	13.9	14.3	49.0	106.8	50.6	26.4	28.6	13.4	54.7	13.6	30.3	13.8	17.7	7.4	8.2	19.4	14.4	37.0	10.4	11.2	10.0	10.7	11.4	5.0	2.9	13.5	10.5	10.9	4.1	7.6	9.5	11.2	6.9	13.0	5.1	34.7	9.1	39.6	49.6	58.0	47.1	38.5	52.3	51.5	54.8	49.0	53.8	47.3	61.3	60.7	192.3	46.2	58.4	47.0	77.0	99.6	30.6	57.5	166.8	47.3	29.6	35.6	70.1	63.3	36.8	77.2	17.2	55.2	81.8	92.0	36.7	350.5	113.7	66.4	44.0	60.6	8.6	77.2	37.3	87.9	73.0	154.5	103.6	14.5	16.4	35.0	58.0	39.1	95.9	95.1	58.8	42.7	60.0	92.1	316.1	34.8	69.4	97.8	91.8	56.6	174.9	38.1	97.0	214.1	60.9	34.8	33.1	58.3	65.9	45.1	50.8	80.4	67.9	19.7	91.0	49.6	72.5	24.5	55.2	80.0	29.6	56.8	76.5	43.8	104.0
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486615	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003617	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	18.3	29.6	31.2	11.3	32.5	11.2	17.1	28.8	38.3	21.2	25.8	27.1	17.7	19.0	18.0	29.1	17.9	11.4	47.8	32.4	30.0	20.0	28.1	17.7	16.1	31.0	29.7	15.8	36.9	20.9	16.0	13.5	31.7	20.9	12.4	6.4	27.8	20.2	97.9	24.8	19.5	11.9	30.4	18.9	23.1	4.5	32.0	17.3	15.8	72.1	17.0	25.8	21.5	34.0	84.8	50.9	15.3	42.1	31.3	31.3	51.0	35.0	26.3	37.2	39.5	50.3	32.6	64.1	107.8	33.7	31.5	31.5	76.9	40.4	20.2	42.6	46.5	46.3	46.6	29.6	38.9	55.8	48.1	24.0	45.9	24.8	42.8	36.1	27.0	46.5	51.9	31.4	30.1	66.2	49.9	52.3	17.8	74.4	82.0	44.5	44.5	68.4	31.0	34.2	29.3	44.2	19.4	66.7	59.0	18.2	30.8	40.3	27.3	37.6	42.5	61.1	77.9	60.8	67.8	115.8	39.6	92.4	44.5	94.7	22.0	22.1	33.2	18.9	46.4	20.4	31.2	35.5	21.7	16.3	26.5	30.0	7.1	34.1	16.7	12.7	34.0	41.9	31.2	32.5	28.8	38.3	32.4	30.0	31.0	29.7	31.7	30.4	32.0	34.0	17.6	3.2	6.7	3.9	12.3	9.6	11.7	13.2	4.0	19.4	16.7	24.5	32.5	15.7	9.2	16.5	4.2	32.5	25.2	21.8	43.0	25.3	0.3	5.7	11.9	14.2	8.5	29.0	8.7	32.2	47.4	14.5	9.2	7.7	9.5	16.8	13.2	18.9	24.2	18.5	6.3	17.2	14.2	13.8	10.2	1.0	12.5	31.7	28.4	1.9	20.3	17.2	38.1	5.5	4.9	30.2	11.4	18.8	19.5	16.7	24.6	25.1	4.7	11.4	0.0	13.2	24.9	0.1	5.7	21.9	12.1	13.0	16.2	7.2	17.4	7.8
UBL4B	FLJ25690	ENSG00000186150	"Ubiquitin like 4B"	Q8N7F7	1	110112443-110113947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"testis: 104.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6512.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031364	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA031364: AB_10604000"	"unprognostic (2.92e-1)"	"unprognostic (3.48e-2)"		"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.65e-2)"		"unprognostic (5.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.87e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.20e-9)"	"unprognostic (3.29e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.90e-2)"	0.3	0.0	0.9	0.0	0.8	0.0	0.6	0.4	1.1	0.1	2.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.1	0.5	1.6	0.1	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	104.9	2.4	0.0	0.0	0.7	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.4	1.1	0.6	1.2	0.5	1.6	0.4	0.3	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1490.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6512.1	29.2	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.5	0.0	51.6	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 175.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: AB_2677732"	"unprognostic (4.21e-2)"	"prognostic favorable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	33.8	38.4	27.0	13.5	28.9	15.9	32.9	26.7	35.0	34.0	23.9	48.1	15.0	36.8	15.4	37.8	30.3	10.6	67.9	29.4	26.9	38.1	32.0	29.7	21.4	28.2	27.3	31.1	44.7	25.0	30.3	15.6	29.2	36.4	16.5	13.1	34.2	16.3	114.6	54.3	36.9	18.4	25.5	48.2	43.5	55.8	25.9	27.3	37.0	37.8	29.6	38.7	33.1	29.0	18.7	20.3	31.6	42.3	32.4	42.1	21.8	29.8	36.0	37.6	46.6	24.7	26.4	27.2	31.1	35.9	48.6	29.4	88.4	40.4	36.5	36.0	55.6	35.8	32.2	45.3	31.7	22.4	29.1	32.9	35.5	32.1	43.0	32.3	32.0	60.8	30.9	39.3	39.3	26.2	28.1	35.3	75.7	31.2	24.6	29.4	25.0	60.5	32.6	21.2	31.1	61.8	28.8	26.8	40.1	44.1	28.6	36.7	18.8	34.6	20.4	17.4	37.5	39.8	82.1	30.5	22.7	40.3	30.6	32.9	51.6	59.7	35.1	58.5	33.7	50.5	35.3	37.1	70.6	55.3	33.9	40.6	65.3	55.5	55.5	151.5	65.6	52.1	27.0	28.9	26.7	35.0	29.4	26.9	28.2	27.3	29.2	25.5	25.9	29.0	17.3	32.1	18.2	3.9	35.4	15.8	24.1	35.6	26.7	5.8	24.9	23.9	29.9	18.6	20.0	14.7	8.4	71.1	36.8	25.5	58.7	37.3	75.3	12.7	13.0	20.7	23.4	45.8	5.7	34.7	66.9	20.7	22.4	13.5	19.0	21.5	22.5	16.3	41.9	5.0	3.8	26.9	20.3	38.3	31.4	175.8	24.5	31.4	21.4	5.6	82.6	18.2	23.7	4.0	4.5	29.5	27.6	21.1	51.6	19.5	48.9	44.6	16.1	9.0	19.7	13.5	50.5	59.2	31.1	29.8	25.1	68.4	23.0	19.6	28.0	25.2
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882401	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 14.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.7	12.3	8.3	14.5	7.9	48.9	12.9	10.5	8.3	14.9	12.4	13.9	14.7	12.4	6.5	25.0	11.9	11.8	20.8	9.1	5.9	10.5	13.6	13.5	15.4	6.6	6.9	13.3	14.1	12.2	10.1	11.5	5.8	11.6	14.3	20.1	15.7	9.6	22.9	15.8	14.6	13.8	6.2	21.5	12.7	37.4	8.0	22.5	11.4	19.5	15.5	11.6	16.5	8.0	21.0	26.0	29.5	29.3	25.3	23.6	23.7	25.7	24.5	29.6	28.4	21.7	24.4	39.2	23.1	25.3	32.1	27.2	38.2	23.6	25.0	38.4	19.0	32.2	35.0	17.1	24.3	39.4	33.6	15.8	30.6	34.4	36.7	22.5	39.3	38.3	53.6	32.5	22.0	30.1	43.6	18.0	25.1	21.8	19.3	67.5	36.6	37.5	15.5	24.0	39.9	22.0	44.7	36.4	22.3	21.8	36.0	34.6	39.7	31.3	29.5	102.5	32.4	30.4	34.7	77.5	18.5	24.5	53.9	1.7	1.2	0.9	1.4	1.1	1.0	0.9	1.0	1.3	0.8	1.0	1.1	0.7	14.2	1.0	0.9	1.7	0.9	0.9	8.3	7.9	10.5	8.3	9.1	5.9	6.6	6.9	5.8	6.2	8.0	8.0	31.2	9.6	15.9	17.3	31.9	18.0	22.0	7.5	30.1	59.9	23.6	20.3	25.5	22.8	9.8	9.2	110.5	28.1	51.3	41.1	7.9	16.7	46.2	39.2	36.8	36.4	30.9	32.4	17.9	18.2	23.3	22.9	29.6	29.8	7.6	27.9	28.5	31.0	23.2	50.5	16.8	27.4	8.2	33.2	21.5	57.8	29.2	37.0	26.6	30.0	28.9	27.9	61.8	19.6	20.3	27.7	33.4	22.6	44.0	33.4	27.4	13.3	16.4	100.8	13.1	26.8	21.8	153.8	128.4	30.9	22.3	29.1	40.4	35.2	26.8	27.3
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.7;Late spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"basophil: 8.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	3.4	4.6	4.2	2.4	2.9	5.9	4.7	12.2	5.9	5.6	2.0	4.2	2.4	4.7	6.8	4.3	5.3	2.7	3.8	3.4	5.0	3.4	4.4	3.6	2.6	1.8	1.7	6.2	6.6	4.0	8.4	3.0	1.1	4.6	3.3	13.5	5.0	3.0	7.3	9.7	3.8	3.0	0.1	3.5	3.9	14.5	2.5	3.3	5.8	4.8	2.5	4.1	5.1	8.0	3.3	3.1	4.9	6.1	3.8	3.5	3.7	1.8	2.7	1.6	2.0	3.7	3.2	5.5	3.4	2.3	4.2	3.0	6.3	1.5	2.9	2.8	3.7	4.2	5.8	4.1	2.2	8.2	3.1	2.4	4.3	2.2	3.4	3.0	3.3	2.9	9.9	4.1	2.1	5.0	5.9	9.4	6.9	3.3	2.2	3.4	4.6	3.9	2.3	2.4	8.0	5.8	5.7	3.9	2.7	4.5	2.5	5.4	3.7	2.0	2.3	3.1	2.4	4.8	5.8	9.5	3.4	4.9	3.0	8.5	0.6	0.0	0.3	0.2	0.2	0.5	0.3	0.3	0.2	0.6	0.4	0.3	0.5	1.9	0.2	0.7	0.2	0.1	4.2	2.9	12.2	5.9	3.4	5.0	1.8	1.7	1.1	0.1	2.5	8.0	21.0	6.4	23.6	58.1	11.7	23.3	18.6	9.9	15.4	54.0	23.2	13.6	27.2	21.5	15.0	22.0	93.8	9.0	21.8	16.5	7.9	8.0	140.7	58.3	38.2	17.7	23.4	24.8	97.5	6.9	8.9	20.2	14.3	68.8	11.4	28.7	17.5	22.6	7.1	45.4	95.1	16.7	10.2	11.5	17.9	178.6	22.4	15.4	8.8	53.4	19.0	23.6	16.5	79.4	84.9	9.2	14.0	21.4	16.2	41.5	15.7	11.0	36.5	58.2	19.7	37.6	22.8	44.6	31.6	20.9	28.8	14.6	14.3	27.2	13.5	28.4
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	4.5	4.4	4.3	2.7	5.1	6.9	4.5	5.5	5.1	4.8	2.4	6.2	2.8	5.9	2.7	4.4	4.8	2.6	3.8	4.5	3.8	4.4	3.5	3.7	3.7	3.8	3.7	5.0	6.1	5.4	4.4	3.4	3.5	5.2	2.9	3.8	4.8	4.4	11.2	7.6	4.2	4.1	3.2	4.3	4.7	4.8	3.9	3.8	3.8	6.8	3.0	5.6	4.2	6.1	6.1	6.1	4.8	3.1	6.3	3.5	2.6	4.9	4.7	6.1	6.0	5.8	5.2	4.8	2.0	4.2	7.0	8.5	3.2	7.8	3.6	1.4	2.7	7.9	2.1	5.4	5.0	3.9	2.9	4.5	5.6	4.9	6.2	5.0	3.9	3.7	6.7	4.4	3.5	4.5	7.0	5.0	3.7	6.3	3.7	4.7	5.8	3.3	3.8	6.7	5.9	5.7	3.4	18.8	4.0	3.7	8.1	2.5	4.3	4.0	2.7	4.6	4.4	5.9	9.4	4.2	2.1	3.5	3.0	7.9	5.1	9.4	4.4	5.1	5.0	6.3	5.2	3.6	5.5	4.8	5.3	5.1	8.1	5.2	5.3	3.7	5.6	4.6	4.3	5.1	5.5	5.1	4.5	3.8	3.8	3.7	3.5	3.2	3.9	6.1	2.4	12.8	6.0	6.8	3.6	1.9	4.1	3.4	0.6	6.6	2.8	2.0	1.1	1.5	3.1	0.0	6.2	6.9	1.9	5.6	0.0	4.0	1.4	2.5	2.5	3.6	10.2	0.4	9.6	4.2	4.4	3.5	5.1	2.7	2.5	4.5	4.6	4.3	4.9	6.7	8.5	4.9	6.1	5.0	3.2	1.9	6.8	3.5	3.6	3.7	6.6	4.5	4.1	4.5	10.4	3.9	3.4	3.8	2.3	5.8	4.7	5.2	2.7	5.2	6.6	5.2	2.8	10.2	5.2	1.6	2.4	10.1	3.1	3.8	5.3	5.9
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659968-83707958	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	50.1	49.8	43.0	43.6	46.4	84.9	42.3	42.2	46.7	40.7	30.6	44.2	39.3	43.1	38.8	50.8	36.9	37.0	63.0	50.1	50.2	55.2	74.0	39.0	51.1	46.7	47.2	36.1	50.5	72.2	28.6	50.4	50.7	45.4	41.3	55.8	34.5	46.8	125.8	42.4	39.6	47.1	43.6	37.7	42.4	42.0	46.3	69.4	45.3	72.9	65.1	53.3	35.2	57.0	154.5	137.8	101.9	77.9	83.4	89.3	164.0	140.8	125.4	147.7	111.3	56.8	105.5	153.9	86.6	120.0	137.0	172.0	141.8	101.7	152.7	79.7	66.0	95.1	97.9	90.3	111.7	116.6	98.3	74.7	127.1	124.1	172.4	92.8	112.8	72.6	102.7	105.7	124.6	91.0	160.8	66.6	132.6	147.5	126.3	117.6	113.7	80.4	98.7	65.0	90.4	101.2	130.9	131.7	102.0	100.2	64.6	84.2	111.8	92.2	84.9	154.2	143.6	146.1	222.0	74.7	139.4	85.1	114.1	34.9	21.2	22.6	19.8	31.4	19.3	19.0	16.9	18.2	24.2	19.6	16.9	18.5	22.7	31.8	30.7	10.5	24.2	20.5	43.0	46.4	42.2	46.7	50.1	50.2	46.7	47.2	50.7	43.6	46.3	57.0	39.5	35.3	42.2	29.4	53.9	103.2	66.2	43.0	42.7	58.4	41.2	28.3	76.7	31.5	46.8	22.0	20.9	59.9	38.9	49.9	19.6	55.1	37.9	47.7	50.9	42.8	51.4	51.8	61.9	53.5	86.9	42.2	32.1	74.9	50.1	33.6	25.7	73.4	52.1	75.7	58.7	41.5	42.7	51.2	87.5	18.3	24.5	52.4	42.7	41.2	46.5	31.0	39.1	33.2	67.9	70.4	36.5	27.8	56.2	68.8	48.9	39.6	33.4	34.1	39.5	33.4	42.9	74.1	50.5	45.2	92.5	164.3	47.7	28.9	41.1	84.0
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563627-56567868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.8	20.2	24.9	14.9	26.8	11.1	12.1	19.7	30.6	15.9	12.7	15.7	11.2	16.6	15.9	18.7	17.5	14.5	21.6	27.4	25.5	13.5	19.4	13.8	18.4	20.2	20.4	25.7	10.5	23.6	16.3	15.8	22.1	20.2	12.1	22.2	14.4	20.0	28.0	13.6	12.4	18.4	21.3	14.9	13.1	4.4	22.6	18.9	20.7	22.8	18.6	18.6	11.1	25.5	36.3	26.5	25.9	30.6	58.3	37.0	16.3	28.6	33.9	21.0	23.2	14.9	16.6	27.6	30.5	34.0	32.9	20.7	50.0	31.9	25.3	43.0	30.1	11.2	34.2	15.9	30.6	22.1	23.7	34.7	39.6	28.3	24.6	30.3	18.7	17.6	13.3	29.5	33.6	16.9	28.5	19.2	21.7	11.6	31.1	25.3	33.7	26.3	42.8	27.9	31.9	29.9	41.3	18.1	17.4	45.2	30.4	16.1	21.2	22.2	22.5	32.4	17.5	11.1	14.8	18.9	24.9	23.1	19.3	50.0	23.6	24.1	15.1	31.1	17.1	7.8	22.9	17.7	17.8	8.6	30.3	18.9	20.4	20.9	34.2	6.5	23.5	20.3	24.9	26.8	19.7	30.6	27.4	25.5	20.2	20.4	22.1	21.3	22.6	25.5	13.9	22.4	17.2	0.0	30.5	31.2	41.6	27.4	20.5	42.3	14.5	11.3	37.6	15.7	25.0	18.4	18.8	28.8	15.4	12.1	17.6	20.0	0.1	11.8	22.7	18.9	34.2	18.3	0.0	16.6	26.7	27.9	13.7	15.7	12.7	14.2	18.2	20.3	24.7	42.1	0.0	20.3	18.3	30.7	25.3	1.6	24.8	21.1	17.8	0.0	35.9	22.3	42.2	0.0	0.0	18.9	12.7	36.5	23.5	32.0	20.7	16.4	27.5	35.8	13.1	25.4	29.8	0.3	1.5	32.7	30.4	40.0	28.7	12.2	19.3	35.6
UBQLN3	TUP-1	ENSG00000175520	"Ubiquilin 3"	Q9H347	11	5507300-5509958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	396	"testis: 158.8"	"Group enriched"	"Detected in some"	70	"Early spermatids: 709.6;Late spermatids: 1878.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020547, HPA062018"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA020547: AB_1858577, HPA062018: AB_2684661"															"unprognostic (3.79e-3)"			0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	158.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.4	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	709.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1878.4	9.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	18.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3"	Q6ZT12	2	169827454-170084131	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.2;tongue: 87.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	14.2	12.4	4.4	7.7	5.8	7.4	9.2	5.9	8.5	10.9	2.8	8.8	8.1	10.1	6.9	12.8	8.4	9.3	29.4	8.0	3.3	15.2	21.0	8.8	7.2	2.4	2.7	10.2	11.9	21.5	2.1	8.7	3.3	13.1	8.5	21.2	11.5	10.3	71.2	9.2	7.5	11.1	3.2	8.8	9.3	9.7	3.4	9.5	17.9	87.1	7.3	11.0	2.3	8.4	14.8	12.4	12.9	17.1	25.0	19.7	10.8	26.1	15.0	14.7	11.8	19.1	9.1	16.7	22.2	20.5	12.0	19.0	15.5	13.2	18.2	17.4	13.4	61.1	12.6	20.3	12.4	20.4	18.9	11.9	12.1	19.3	12.9	11.7	14.8	8.3	32.4	17.6	25.6	14.0	13.3	10.0	10.1	14.9	10.2	12.6	21.1	17.8	10.5	20.5	25.1	13.7	18.4	16.7	10.6	10.2	10.9	11.4	18.9	22.1	9.0	17.5	16.7	14.2	11.9	15.1	18.2	11.8	12.5	0.0	0.6	0.5	0.9	0.6	1.3	0.6	0.5	0.8	0.9	0.3	0.9	1.2	0.6	0.8	0.5	0.7	1.0	0.4	4.4	5.8	5.9	8.5	8.0	3.3	2.4	2.7	3.3	3.2	3.4	8.4	19.0	44.8	26.9	162.6	16.3	25.9	12.4	14.8	20.5	46.3	15.8	8.9	109.7	17.2	20.0	12.9	81.3	19.7	22.9	17.1	3.9	8.7	7.6	16.8	21.9	26.4	16.7	24.4	305.1	11.0	8.4	22.2	23.4	22.0	16.5	22.7	30.4	39.0	10.2	63.9	302.0	11.3	22.4	20.9	18.7	10.2	25.7	18.7	16.0	110.5	18.7	61.7	14.4	232.2	288.0	10.7	15.0	19.2	21.3	20.9	15.3	10.0	13.4	51.5	26.3	29.0	21.8	12.4	8.6	22.9	29.0	23.0	18.1	17.3	13.2	17.2
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074510-19210266	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 271.0;Suprabasal keratinocytes: 252.9;Urothelial cells: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		15000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	56.2	62.8	48.2	23.0	46.0	79.8	49.8	38.7	48.4	57.4	47.6	69.6	20.9	61.7	35.7	55.4	52.3	29.6	58.7	45.8	46.0	74.7	82.7	71.9	25.7	51.5	46.4	75.3	53.5	35.5	70.7	27.5	54.9	67.2	22.7	44.6	48.0	27.0	129.1	161.9	59.7	26.0	35.2	62.8	70.6	105.3	45.9	34.6	56.5	45.0	25.7	90.0	59.2	44.7	61.4	60.7	53.5	39.7	97.6	50.0	46.2	46.5	48.8	49.5	44.7	97.2	51.3	36.6	42.3	61.7	43.3	40.8	42.3	46.3	46.0	30.6	37.5	83.8	63.3	64.1	68.6	51.9	53.4	45.0	57.9	100.8	96.3	48.1	54.9	63.7	58.5	32.9	47.6	43.6	24.7	62.9	43.5	124.3	33.6	34.0	41.7	31.0	44.7	35.2	37.7	37.4	55.0	31.1	39.9	48.6	21.7	40.4	85.9	57.4	36.1	69.0	52.8	38.8	25.2	41.5	39.3	79.3	50.3	39.8	28.7	4.7	4.9	5.9	4.2	7.4	4.4	2.9	14.2	4.0	3.9	3.7	15.4	4.4	2.1	6.5	3.4	8.3	48.2	46.0	38.7	48.4	45.8	46.0	51.5	46.4	54.9	35.2	45.9	44.7	28.1	35.3	37.6	85.5	30.3	271.0	124.6	28.9	28.5	57.5	22.1	23.9	19.1	37.1	30.4	31.3	152.2	24.7	34.2	31.6	13.7	41.3	21.4	39.8	32.0	30.8	17.5	48.4	58.9	40.9	17.0	32.2	44.9	50.4	19.6	32.9	31.1	94.1	63.2	79.1	61.8	29.2	12.2	43.0	48.7	28.7	30.7	46.4	49.8	34.7	64.4	28.8	21.6	51.8	44.5	61.0	16.7	35.7	26.4	59.1	57.9	135.6	39.1	48.5	19.7	28.3	30.1	44.8	21.0	28.0	252.9	33.9	32.7	34.5	20.1	236.5
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7"	Q8N806	14	93207241-93229215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 300.9;Late spermatids: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	12.7	10.4	16.9	13.2	19.1	21.1	19.1	16.3	20.2	17.6	17.7	16.9	11.8	14.4	14.0	13.0	14.4	13.1	22.0	18.8	15.9	16.6	15.1	12.7	22.2	15.3	16.1	17.6	22.9	25.7	8.9	10.3	16.0	14.6	18.3	24.3	12.7	15.3	17.5	15.7	13.2	15.3	17.1	14.1	14.2	19.0	17.3	34.0	16.8	25.9	27.3	13.6	10.9	18.8	26.1	33.0	52.2	44.2	24.2	24.0	18.6	54.0	38.6	57.1	43.9	23.5	28.2	60.9	42.6	28.3	26.0	30.7	55.8	30.1	60.7	46.4	29.2	45.7	33.1	23.7	11.2	65.7	47.5	15.5	20.7	33.8	21.2	21.7	33.1	54.8	41.5	60.5	57.7	77.3	104.5	35.7	24.1	69.4	61.9	81.9	92.9	33.6	20.6	42.0	65.3	45.4	39.5	32.1	16.3	31.1	58.4	44.6	24.0	43.1	23.0	37.0	56.3	69.0	103.4	61.1	37.0	49.8	38.7	34.5	11.3	18.2	17.8	14.2	19.5	26.4	16.4	16.4	11.4	20.4	13.6	15.1	16.6	18.1	18.3	15.0	26.7	13.4	16.9	19.1	16.3	20.2	18.8	15.9	15.3	16.1	16.0	17.1	17.3	18.8	13.8	16.0	6.4	9.4	16.1	19.9	8.3	8.0	6.8	6.1	11.6	11.0	19.7	11.5	8.5	11.0	10.4	12.3	15.1	15.6	11.7	9.9	300.9	8.2	8.5	11.0	5.4	20.2	16.3	12.9	15.2	12.0	9.7	9.1	5.1	8.8	12.8	11.3	14.0	3.3	12.7	8.4	12.2	10.7	10.9	372.2	9.3	9.0	14.2	7.5	9.3	13.5	13.4	10.6	13.9	8.9	5.4	12.4	26.0	4.7	10.3	9.3	5.5	13.9	6.6	11.2	10.1	38.7	23.2	10.7	13.5	6.6	12.4	6.2	12.4	6.0
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498924-97571206	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.4;neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	18.8	11.1	14.9	5.7	15.2	8.8	14.7	16.8	17.0	16.5	12.6	10.3	1.8	13.5	4.0	9.5	13.6	7.0	35.1	13.5	15.8	29.2	18.6	29.8	3.1	17.7	17.1	8.7	9.6	3.6	15.9	3.8	16.2	13.4	0.6	6.0	11.2	7.5	34.2	49.5	5.5	3.6	16.1	11.0	9.4	60.3	18.9	1.6	14.6	11.2	1.1	12.4	16.3	14.6	18.1	17.7	4.6	23.0	18.9	17.8	5.4	20.3	29.4	21.3	16.3	12.0	15.4	2.2	24.1	13.8	13.4	21.4	4.6	27.2	3.0	5.6	9.1	2.2	5.5	15.2	27.2	2.0	5.9	24.6	9.0	23.3	5.7	32.8	34.3	4.7	1.2	3.3	13.9	8.6	0.9	18.5	7.5	3.4	32.1	1.8	8.1	2.1	16.7	6.7	1.5	4.8	9.2	5.6	27.1	4.0	20.8	13.6	37.5	26.9	16.4	28.4	26.8	4.2	5.1	0.9	22.7	12.3	14.3	1.0	2.6	6.4	0.1	0.7	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.6	0.0	0.7	0.9	0.3	0.5	14.9	15.2	16.8	17.0	13.5	15.8	17.7	17.1	16.2	16.1	18.9	14.6	5.0	41.7	28.6	13.1	1.1	26.0	8.8	32.2	19.4	3.8	10.0	4.8	15.5	8.6	21.2	7.3	4.2	3.5	0.6	1.5	11.7	18.9	53.5	8.2	8.7	23.8	0.0	0.4	5.6	12.8	12.8	11.6	2.6	4.0	0.0	0.8	7.9	7.0	25.8	6.7	5.9	0.2	10.2	10.1	18.9	33.8	12.8	10.3	10.6	12.2	8.4	16.5	2.1	2.0	14.5	22.1	0.1	9.4	3.0	14.0	0.0	10.4	19.1	18.6	13.1	8.5	10.3	7.5	7.9	8.2	29.7	2.9	1.9	1.5	0.4	7.6
UBTD2	"DC-UbP, MGC30022"	ENSG00000168246	"Ubiquitin domain containing 2"	Q8WUN7	5	172209646-172283764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.1;Late spermatids: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035891, HPA035892"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035891: AB_2674846, HPA035892: AB_10670670"	"unprognostic (2.89e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.92e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.52e-1)"	13.5	11.4	7.6	8.7	9.0	1.6	17.5	24.7	9.5	24.6	8.7	15.0	18.4	21.0	9.3	10.6	12.0	16.1	10.3	7.9	8.4	15.6	15.7	13.2	9.2	8.4	8.2	21.1	12.5	11.1	7.0	17.1	8.3	13.4	15.8	9.2	11.9	12.7	9.8	9.9	22.1	17.9	7.9	7.2	12.2	35.4	7.8	12.0	11.5	15.7	10.2	14.5	11.3	8.3	21.9	16.7	78.1	61.0	48.1	42.9	38.0	27.8	33.2	29.9	43.8	36.5	15.9	18.7	23.5	43.6	51.4	15.1	41.7	30.3	40.1	18.0	30.3	5.7	17.6	28.4	32.6	13.3	10.3	33.1	37.1	31.9	25.7	25.8	36.5	28.8	2.3	7.5	28.6	23.8	23.7	27.8	33.4	19.0	21.1	43.5	38.0	7.2	36.3	23.0	22.9	57.9	30.1	27.0	28.4	39.9	23.3	21.7	26.6	39.6	29.2	21.0	23.9	6.8	19.9	17.8	13.9	18.2	31.0	0.0	0.3	0.0	0.2	0.4	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.2	0.7	0.5	0.1	7.6	9.0	24.7	9.5	7.9	8.4	8.4	8.2	8.3	7.9	7.8	8.3	15.2	6.4	4.8	14.0	3.7	22.0	25.7	12.8	15.9	8.4	22.2	12.1	5.5	11.5	11.9	9.2	0.0	9.8	5.6	22.8	17.6	14.5	76.1	9.7	28.3	12.3	8.9	0.0	14.9	12.0	21.7	31.4	8.6	23.6	0.0	14.2	13.9	15.1	6.8	25.2	22.5	12.2	14.2	6.5	44.5	130.9	24.8	9.8	14.2	9.4	5.8	16.2	1.0	25.6	19.8	21.6	9.8	21.1	2.9	29.8	20.5	17.2	6.8	3.4	6.6	16.7	19.6	5.8	9.7	17.0	18.8	8.1	4.0	11.9	13.7	39.6
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor"	P17480	17	44205033-44221626	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	34.8	36.5	36.2	44.8	33.7	54.9	35.4	38.2	37.1	50.6	30.1	49.4	33.6	50.8	27.5	41.8	41.9	32.5	38.8	35.5	32.7	38.1	36.1	32.3	67.6	34.0	34.5	41.6	41.4	38.2	33.8	29.2	32.2	41.6	28.2	23.1	37.7	40.8	63.7	47.4	42.5	36.3	31.6	49.8	34.7	20.8	34.9	73.6	46.4	36.6	51.7	45.1	41.8	35.0	69.1	104.3	77.3	93.2	49.6	56.5	72.3	70.6	46.7	70.1	52.0	50.7	54.8	250.0	69.3	65.3	51.9	63.6	99.1	59.2	57.9	145.3	109.5	100.5	73.8	83.7	32.5	192.1	85.7	56.9	52.2	44.6	65.6	67.2	58.9	108.8	117.4	75.9	58.9	113.7	188.3	75.0	73.7	46.6	81.6	184.0	104.3	112.0	40.4	54.5	119.5	90.3	70.4	62.2	54.2	47.9	89.9	120.8	75.5	109.9	133.1	65.1	95.0	66.6	61.7	151.1	64.8	86.0	100.1	9.6	5.7	6.1	15.5	6.3	16.7	11.7	10.8	16.2	6.7	14.1	12.2	13.1	9.7	15.7	11.6	12.7	10.0	11.3	36.2	33.7	38.2	37.1	35.5	32.7	34.0	34.5	32.2	31.6	34.9	35.0	41.4	41.7	42.1	14.7	57.5	20.5	19.6	17.9	57.5	88.8	31.0	29.6	44.5	35.8	32.2	38.6	79.2	30.9	60.3	41.7	35.2	27.2	2.3	39.3	57.7	42.7	47.3	61.2	8.5	40.8	40.7	38.9	23.9	48.1	31.7	43.1	32.5	26.5	25.9	26.9	8.2	32.5	12.2	18.4	13.3	3.6	36.7	27.4	23.2	8.4	38.1	33.9	54.6	3.5	10.6	28.1	30.7	50.8	42.2	17.4	26.7	25.4	26.5	57.6	52.6	48.5	45.9	5.3	44.0	52.1	24.3	32.7	53.1	40.2	32.8	11.8
UBXN1	"2B28, LOC51035, SAKS1, UBXD10"	ENSG00000162191	"UBX domain protein 1"	Q04323	11	62676498-62679117	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012669, HPA076932"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	Nucleoplasm	"HPA012669: AB_1853149, HPA076932: "	"unprognostic (1.76e-3)"	"unprognostic (8.72e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.94e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.42e-1)"	138.3	103.0	88.9	67.1	94.0	63.7	121.3	91.5	102.9	133.5	86.1	130.6	71.9	113.2	44.3	99.6	112.4	54.4	106.4	85.8	88.5	95.1	72.8	81.9	108.0	96.5	90.1	147.8	120.3	58.9	75.8	52.2	93.9	89.4	37.9	28.0	79.0	56.1	284.3	128.6	93.3	48.3	91.2	111.7	116.6	113.5	91.1	107.6	96.8	105.3	82.2	113.2	103.8	94.7	86.2	137.7	101.3	142.5	137.7	147.0	87.7	73.4	136.6	139.4	94.6	99.0	109.7	135.7	131.3	100.1	123.7	119.2	81.6	128.3	64.5	124.3	99.5	95.6	118.9	136.4	269.1	150.7	102.6	191.7	195.1	123.5	188.5	149.4	132.1	170.3	148.0	86.4	88.5	196.6	117.8	280.3	5.2	67.4	88.9	86.6	107.9	135.3	114.1	85.8	98.6	165.5	68.8	108.3	330.0	43.2	150.5	188.0	128.6	111.8	84.0	113.4	84.6	109.0	89.3	123.8	129.7	64.9	103.7	158.0	320.2	160.7	273.9	346.7	350.2	534.6	415.2	323.7	346.2	533.5	494.7	365.8	173.5	303.8	440.6	276.8	562.3	559.0	88.9	94.0	91.5	102.9	85.8	88.5	96.5	90.1	93.9	91.2	91.1	94.7	183.1	93.0	116.4	16.6	222.8	264.0	176.5	240.7	142.3	61.7	202.9	190.2	86.4	137.2	160.7	75.4	45.9	172.9	194.1	162.0	156.5	191.1	184.1	91.2	119.0	194.9	126.2	144.9	9.2	184.7	195.2	124.1	78.0	81.4	162.7	146.6	180.2	77.0	216.3	30.3	9.1	156.5	187.2	325.2	352.2	245.8	208.8	196.2	183.2	8.4	307.5	153.5	244.1	7.5	17.8	203.8	235.9	143.3	93.0	192.7	335.9	259.7	132.7	57.4	197.2	171.3	300.3	257.6	220.6	130.2	302.8	324.7	226.9	147.0	161.4	235.0
UBXN10	"FLJ25429, UBXD3"	ENSG00000162543	"UBX domain protein 10"	Q96LJ8	1	20186096-20196050	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 117.5;Endometrial ciliated cells: 72.6;Late spermatids: 146.8;Respiratory ciliated cells: 117.8;Spermatocytes: 48.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;HMC-1: 7.1;K-562: 8.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028555, HPA028564"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028555: AB_10600417, HPA028564: AB_10601897"	"unprognostic (3.00e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.31e-2)"	"prognostic favorable (2.02e-4)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.60e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	0.6	1.3	2.5	0.5	2.8	2.0	2.9	2.1	2.9	7.1	15.3	9.7	0.8	6.2	4.7	4.1	49.7	2.0	3.5	3.3	3.3	2.1	5.9	5.3	0.3	5.2	5.6	0.4	1.5	4.8	3.0	1.0	4.5	2.4	4.8	2.2	0.9	2.7	0.2	0.5	2.0	3.4	4.8	0.1	2.3	14.1	3.7	0.3	5.4	0.2	0.5	2.6	0.3	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	1.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	8.5	0.0	0.0	0.0	0.3	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.6	0.4	5.6	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	2.7	0.4	0.7	0.9	0.8	0.1	0.5	0.8	0.4	4.1	0.0	0.0	0.4	0.5	2.5	2.8	2.1	2.9	3.3	3.3	5.2	5.6	4.5	4.8	3.7	4.3	0.1	0.0	6.1	0.7	0.2	0.1	0.0	5.5	0.0	0.5	1.2	1.5	5.3	1.5	13.0	3.7	0.0	0.1	0.4	5.1	5.9	3.7	117.5	72.6	2.0	0.8	1.2	2.1	1.8	1.7	0.6	2.0	0.0	7.4	13.9	0.4	1.1	4.2	0.9	0.0	1.6	10.6	10.2	1.2	0.0	146.8	2.8	0.8	0.0	0.0	0.6	1.9	0.0	0.0	0.1	1.4	1.4	1.2	0.0	0.1	0.6	2.9	117.8	3.1	0.0	0.4	4.1	48.9	2.2	0.0	0.0	0.3	1.2	0.0	3.2	0.3
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 48.4;monocytes: 93.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	10.5	10.8	23.2	9.5	25.2	19.3	10.6	17.8	35.1	11.6	45.1	8.4	3.4	9.5	14.7	6.2	31.2	5.1	11.0	26.8	23.9	19.1	7.8	17.7	8.0	25.3	27.9	13.4	11.1	8.0	31.3	4.3	22.0	11.5	2.7	15.0	9.4	6.5	5.6	7.6	8.0	4.1	24.3	21.8	8.8	48.4	25.0	6.8	25.1	3.4	3.9	8.5	7.5	20.1	26.4	11.7	5.7	11.6	4.1	3.1	19.7	5.7	8.8	15.6	11.3	4.6	22.8	15.3	8.5	3.6	10.3	14.0	3.5	9.3	3.9	7.7	13.6	2.6	18.1	11.5	7.2	11.2	5.0	4.7	9.9	26.3	6.7	4.9	4.3	11.1	10.2	10.3	5.4	11.8	6.4	5.4	11.5	7.4	8.8	13.1	4.2	13.8	8.7	3.8	26.9	6.3	14.1	13.1	10.2	2.9	10.3	10.7	4.2	8.9	13.4	13.4	8.7	9.7	29.8	17.7	11.0	15.4	7.5	2.2	93.2	4.6	9.0	82.6	11.4	12.7	13.6	10.8	48.4	16.2	15.2	9.7	6.8	6.1	72.2	7.5	12.5	41.7	23.2	25.2	17.8	35.1	26.8	23.9	25.3	27.9	22.0	24.3	25.0	20.1	4.3	0.0	1.1	5.5	18.8	21.4	15.7	23.4	5.2	11.9	13.2	15.5	1.3	5.7	16.2	23.9	22.9	9.9	10.0	5.5	13.7	14.7	131.1	78.6	9.2	5.1	9.0	6.7	7.0	8.7	20.8	10.0	17.9	8.3	10.2	11.9	6.1	3.0	20.9	23.5	5.1	5.9	18.3	62.4	35.3	327.4	12.8	59.9	10.6	2.8	41.9	24.2	12.3	2.0	1.6	7.6	2.5	10.1	9.5	9.8	1.2	26.7	121.2	54.9	19.7	6.6	11.5	26.1	24.0	5.1	13.4	7.3	23.7	8.7	8.3	12.1
UBXN2A	UBXD4	ENSG00000173960	"UBX domain protein 2A"	P68543	2	23927285-24004909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065482, HPA069096"	Supported		Approved	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Centrosome		"HPA065482: AB_2685495, HPA069096: AB_2686084"	"unprognostic (5.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (9.26e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.75e-2)"	6.1	3.7	3.5	3.4	4.1	5.0	5.0	5.9	3.6	3.1	2.6	4.9	5.7	5.1	3.9	5.1	3.5	3.7	7.8	2.9	3.9	4.1	5.7	4.6	3.9	4.2	4.5	3.9	3.0	7.4	1.5	5.3	4.2	3.8	4.1	5.6	4.5	4.7	10.9	4.8	5.4	6.9	3.9	3.0	2.9	3.2	3.9	4.5	3.9	7.9	4.3	4.0	2.4	5.8	14.8	9.6	13.1	8.8	14.8	12.9	6.6	14.8	9.9	14.1	9.8	7.2	6.5	12.7	4.5	9.5	9.9	6.2	12.7	10.5	12.5	25.7	12.0	14.9	6.4	10.9	10.9	9.5	6.4	15.8	8.3	12.4	9.4	10.0	8.5	9.6	17.0	12.3	12.4	11.2	12.6	6.0	10.4	9.5	6.8	16.9	32.7	5.6	5.9	11.3	6.5	15.6	14.2	6.9	18.6	9.2	4.1	5.3	14.2	10.1	10.5	9.3	9.6	17.7	20.3	18.0	7.9	8.7	10.4	4.8	2.1	2.5	3.2	1.2	3.5	3.7	3.3	3.1	1.7	2.9	3.6	3.3	1.9	4.7	1.6	4.1	2.7	1.6	3.5	4.1	5.9	3.6	2.9	3.9	4.2	4.5	4.2	3.9	3.9	5.8	26.9	25.6	19.2	27.1	29.3	25.5	26.9	13.6	35.9	17.1	29.7	35.2	54.9	15.7	13.6	16.5	43.8	33.9	38.9	23.1	17.6	27.4	2.3	28.9	38.7	23.5	4.2	19.6	22.0	27.2	34.4	33.4	26.5	30.6	17.7	25.2	25.4	16.3	15.6	42.1	35.5	18.3	18.3	15.4	17.5	2.9	26.4	28.2	35.6	13.1	26.7	25.6	27.8	26.7	53.6	38.4	29.9	26.7	28.7	32.8	32.3	17.7	14.7	28.4	32.9	27.6	34.7	25.0	15.6	27.5	31.3	37.4	29.0	10.2	19.5	36.3
UBXN2B	p37	ENSG00000215114	"UBX domain protein 2B"	Q14CS0	8	58411359-58451501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.8;monocytes: 12.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045278	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA045278: AB_10963578"	"unprognostic (1.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.42e-2)"	7.9	9.1	10.3	12.0	11.4	15.4	11.0	14.0	12.5	6.6	9.2	8.7	7.7	8.1	10.8	5.8	8.5	8.6	9.8	11.9	9.0	15.7	18.8	9.7	9.1	11.2	8.9	9.0	8.8	16.1	7.9	7.6	11.2	9.5	9.2	13.4	12.9	8.5	9.0	6.4	7.8	9.8	9.6	10.1	8.2	9.5	9.8	11.9	14.2	11.0	9.4	8.9	4.3	12.8	11.1	20.2	16.9	20.9	3.0	1.5	11.7	6.7	12.3	8.2	10.6	8.8	20.4	13.0	13.4	8.3	22.2	9.9	25.1	12.1	11.5	10.0	12.7	16.2	17.0	11.0	12.6	14.5	15.1	5.4	19.0	3.8	18.9	19.5	10.2	19.7	11.4	23.8	7.4	11.3	26.0	16.0	22.1	38.6	4.8	14.5	7.5	8.9	26.4	16.8	6.2	25.4	11.6	11.7	19.7	16.5	23.7	17.3	2.3	6.3	13.4	13.7	14.0	12.4	13.3	18.0	20.6	13.6	8.5	15.8	11.9	18.0	4.3	11.0	4.2	3.4	4.1	3.6	5.9	3.3	4.9	4.3	42.8	5.4	12.9	2.9	5.3	5.3	10.3	11.4	14.0	12.5	11.9	9.0	11.2	8.9	11.2	9.6	9.8	12.8	4.0	9.6	8.7	27.7	11.4	5.7	10.6	10.3	4.0	16.0	13.7	11.7	18.4	10.0	9.0	11.0	22.9	15.9	10.4	15.9	9.8	11.2	35.8	8.6	9.3	4.7	12.0	13.5	55.3	11.1	17.6	9.5	10.7	11.8	23.5	13.3	4.6	17.1	23.0	11.8	62.4	9.6	14.2	32.4	12.4	61.8	10.5	27.5	8.8	21.5	26.0	13.6	15.5	43.2	41.4	10.8	8.2	14.7	8.4	10.4	15.5	29.7	8.9	25.6	0.0	13.9	8.5	20.4	17.8	9.3	6.7	8.6	10.9	8.6	9.1	10.4
UBXN4	"KIAA0242, UBXD2, UBXDC1"	ENSG00000144224	"UBX domain protein 4"	Q92575	2	135741734-135785056	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036325	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036325: AB_10669788"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.14e-3)"	51.9	55.6	33.3	58.4	38.3	65.4	57.4	37.4	38.0	62.3	44.7	57.1	69.8	56.0	71.1	44.4	49.0	57.2	44.3	31.5	33.8	64.2	93.8	47.2	59.5	40.2	36.8	52.6	73.4	83.5	19.6	63.0	40.1	64.6	60.2	85.6	71.8	47.8	55.1	56.0	67.9	43.9	35.9	55.7	64.6	57.7	33.7	76.6	76.1	52.7	59.8	60.5	25.1	47.6	136.2	34.6	85.1	66.2	106.9	107.0	95.5	106.6	106.3	87.0	77.4	65.3	91.8	84.0	149.4	105.1	46.6	98.3	50.7	68.4	103.5	115.5	62.8	80.5	60.7	98.6	99.4	85.2	70.7	81.6	66.6	86.7	85.8	118.2	110.5	66.2	74.4	116.1	95.3	64.1	109.9	61.3	64.3	70.6	70.9	87.9	100.5	146.5	112.2	97.7	77.4	50.2	97.2	64.1	64.4	77.1	68.0	78.2	101.8	78.4	40.1	82.5	58.4	108.7	72.2	76.2	99.0	59.3	75.5	62.9	35.8	59.1	46.5	42.3	42.6	45.9	42.5	42.5	35.8	42.6	41.4	41.0	73.7	48.4	52.2	56.6	52.3	35.9	33.3	38.3	37.4	38.0	31.5	33.8	40.2	36.8	40.1	35.9	33.7	47.6	178.1	208.3	171.4	56.2	177.4	175.1	283.0	318.5	160.5	172.3	164.1	153.3	150.8	134.4	264.1	126.9	223.1	238.2	140.8	168.9	90.1	254.6	863.9	209.3	223.1	151.7	186.6	129.8	85.2	195.8	214.0	197.4	129.5	240.6	176.9	151.5	113.2	225.7	138.8	97.6	78.4	246.9	183.1	88.6	125.2	325.1	172.7	139.9	92.5	60.9	158.8	162.2	122.6	71.9	105.3	190.7	166.7	143.7	300.3	344.1	183.0	156.8	286.7	349.8	105.2	159.3	173.9	446.1	248.4	176.1	183.6	379.4	171.6	271.6	186.0	303.7
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457794	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	99.7	188.7	60.5	35.0	60.9	85.8	89.4	53.3	91.6	94.9	64.0	93.6	49.2	94.5	21.1	89.7	89.1	33.7	116.1	72.3	53.1	118.4	122.2	72.0	35.2	64.0	64.8	115.2	100.3	64.7	146.1	34.8	64.1	93.8	14.1	23.8	86.1	50.7	216.6	113.8	67.7	23.2	52.9	77.8	88.5	174.8	55.1	26.9	111.8	84.3	18.1	91.8	85.3	57.5	71.7	49.4	23.3	50.6	57.7	70.6	35.1	71.3	84.3	50.9	54.1	30.8	58.8	31.8	63.5	70.8	26.3	40.8	18.2	54.8	18.6	56.3	39.4	26.4	53.5	41.4	94.5	33.6	51.1	65.2	70.4	40.1	38.7	62.3	62.9	42.7	55.6	83.6	38.3	45.4	67.2	56.8	37.6	27.4	42.9	30.4	33.3	76.0	48.3	43.9	67.1	97.3	40.1	40.9	116.7	10.8	48.5	54.4	76.8	67.4	51.4	145.0	47.7	186.6	80.7	33.2	128.7	62.5	61.4	6.4	6.6	10.4	3.8	8.0	6.2	5.3	4.5	5.2	6.7	6.0	5.3	4.2	6.7	2.7	4.9	10.2	5.5	4.9	60.5	60.9	53.3	91.6	72.3	53.1	64.0	64.8	64.1	52.9	55.1	57.5	26.7	41.7	30.1	13.7	25.1	37.2	44.9	26.7	15.9	37.2	36.3	25.1	47.2	64.3	21.2	44.1	27.1	54.5	31.9	105.0	80.3	58.1	297.0	29.1	35.6	30.5	46.8	172.0	14.4	65.0	43.1	39.0	28.5	32.2	34.3	50.0	47.5	61.6	54.8	13.5	11.9	66.2	20.3	52.8	35.9	1342.0	100.0	37.5	53.4	1.9	49.0	60.1	25.7	5.5	10.3	65.6	90.1	73.0	16.4	50.9	136.9	112.2	21.4	35.2	72.3	38.8	29.5	139.9	68.9	20.4	41.1	79.6	18.5	41.4	58.4	48.5
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	6.5	7.5	5.3	7.5	7.5	21.7	8.2	17.5	7.1	8.3	7.4	6.9	5.5	10.1	8.1	6.6	8.4	5.7	4.9	5.4	9.3	6.8	6.4	6.7	9.0	6.3	7.3	12.8	7.4	10.8	7.3	9.5	6.9	7.3	6.8	18.1	6.6	6.7	5.0	10.7	6.3	7.9	5.8	8.9	6.6	11.9	7.6	13.9	8.1	7.0	8.7	6.2	7.0	10.9	25.2	7.7	29.8	15.8	15.2	26.6	13.0	20.3	13.4	11.4	10.4	19.9	10.5	23.0	41.6	13.7	15.4	20.0	22.5	12.0	21.2	9.5	13.8	36.9	16.5	11.3	11.6	18.8	11.5	16.0	13.5	16.0	20.0	20.4	18.7	17.2	17.8	15.5	13.5	10.8	19.6	9.9	17.3	10.2	9.7	22.7	22.3	15.8	9.4	10.9	20.0	15.4	32.6	9.0	15.7	23.7	24.2	15.7	23.5	13.0	11.6	11.8	21.7	21.6	31.3	33.5	12.0	21.0	9.9	9.9	4.7	7.0	4.4	3.7	4.0	6.9	3.8	2.9	5.0	5.9	6.5	5.9	8.4	6.2	5.4	2.2	6.6	2.5	5.3	7.5	17.5	7.1	5.4	9.3	6.3	7.3	6.9	5.8	7.6	10.9	27.1	44.8	18.8	29.7	31.4	47.3	14.3	16.2	40.5	38.0	22.2	16.0	16.8	12.8	21.1	20.2	70.9	18.0	32.9	14.8	5.9	10.8	38.3	47.8	46.3	27.8	46.5	34.0	35.3	10.0	10.5	30.7	18.8	35.1	8.8	46.0	21.8	12.0	12.5	32.0	41.3	15.9	12.2	25.4	41.0	24.7	29.8	24.7	23.2	27.2	28.4	21.5	33.0	36.7	47.8	12.2	11.8	28.2	34.3	31.7	13.3	11.7	30.5	46.5	32.9	37.3	25.6	34.7	23.8	38.6	54.7	18.9	29.8	33.2	15.8	25.3
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30729131-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 167.4;Granulosa cells: 191.2;Hepatocytes: 65.7;Late spermatids: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	10.2	17.3	17.0	7.1	12.0	8.8	14.1	12.2	16.1	10.4	0.0	12.5	13.1	10.4	49.9	10.7	13.2	13.5	4.9	13.3	5.4	22.1	44.1	8.7	8.1	10.3	4.2	79.9	33.0	20.5	2.8	15.6	10.6	16.3	16.3	11.6	8.5	18.6	3.7	16.9	12.1	10.8	1.7	11.1	12.4	37.1	9.2	14.3	25.9	5.4	9.7	10.4	3.3	12.7	16.4	17.0	11.7	12.2	17.9	25.2	14.3	29.5	17.2	15.2	19.6	27.6	6.1	26.8	23.2	24.5	25.9	14.8	3.1	16.8	24.6	23.9	27.2	77.0	14.0	33.0	27.3	18.1	41.8	20.2	17.4	25.6	12.7	13.6	14.1	12.8	71.9	21.8	35.5	16.1	18.6	14.6	22.9	52.2	12.9	21.4	10.9	18.3	27.7	22.4	6.4	17.7	8.3	26.0	52.1	14.1	16.8	30.4	17.3	17.0	7.8	8.2	28.3	8.8	29.2	19.7	15.0	29.0	25.5	0.0	4.6	0.6	6.2	4.9	5.4	4.7	3.3	5.8	5.2	1.9	3.0	5.5	0.8	2.8	2.4	6.5	3.2	2.7	17.0	12.0	12.2	16.1	13.3	5.4	10.3	4.2	10.6	1.7	9.2	12.7	20.5	3.2	8.2	5.5	5.2	0.0	5.4	0.0	8.0	2.5	7.5	7.6	4.3	17.2	3.1	14.7	20.9	23.8	10.7	7.5	7.9	9.7	167.4	9.1	18.6	12.4	8.5	12.8	5.4	5.3	20.2	22.8	9.7	11.3	14.0	191.2	21.4	65.7	22.0	11.8	7.8	9.7	0.0	16.7	0.0	180.4	14.3	8.9	0.0	6.5	11.6	8.1	12.3	4.5	16.3	3.1	6.0	9.8	6.7	4.9	6.9	25.4	0.7	2.2	6.6	8.7	10.4	16.1	24.2	13.0	0.0	15.2	6.6	27.1	11.8	4.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		700000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	20.7	56.9	20.6	20.2	24.2	33.5	34.2	20.3	25.2	15.3	17.2	35.4	21.6	12.4	63.2	58.0	13.0	17.7	29.3	21.7	20.5	32.2	50.9	15.0	21.3	18.6	18.9	7.4	30.9	23.9	22.9	24.6	18.5	19.5	39.5	9.7	27.2	18.2	53.9	48.6	19.9	25.1	18.9	15.9	25.1	43.3	20.5	25.7	44.4	40.6	34.6	44.3	26.6	21.0	196.0	31.9	26.9	18.8	49.9	58.6	78.6	72.3	70.3	90.7	100.5	177.5	92.1	100.4	50.2	75.7	70.2	105.8	64.1	175.3	137.1	53.8	55.9	62.2	50.7	114.9	71.6	150.4	45.7	52.6	118.7	71.7	114.2	38.4	90.1	79.6	70.0	27.9	138.9	70.2	62.4	100.2	40.3	229.0	95.1	49.5	42.9	66.3	108.4	77.9	81.0	23.8	40.8	78.3	34.5	58.2	45.7	42.0	70.8	39.6	47.9	42.7	98.2	39.5	45.5	117.1	80.4	161.3	29.0	57.6	68.7	49.3	29.9	134.4	39.6	51.5	54.1	43.0	99.5	51.5	53.0	49.5	15.6	62.7	117.9	134.9	71.8	50.1	20.6	24.2	20.3	25.2	21.7	20.5	18.6	18.9	18.5	18.9	20.5	21.0	18.2	9.6	23.4	9.1	20.3	76.3	80.4	197.5	35.9	9.3	48.8	66.2	27.2	28.6	88.2	46.0	2.1	105.2	32.9	39.0	92.0	146.2	198.2	35.4	17.4	26.6	24.0	24.4	22.5	143.1	163.6	25.1	23.9	36.2	24.1	19.3	13.9	45.7	88.0	16.8	22.3	54.6	81.4	28.8	28.8	43.5	16.8	32.8	26.6	18.7	33.3	17.3	22.6	22.6	24.9	153.1	44.3	11.7	33.3	133.1	40.4	119.6	48.0	8.9	19.7	24.5	73.5	159.3	36.8	64.8	79.1	169.0	22.1	47.6	60.8	96.2
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		18000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	19.9	19.0	11.0	22.5	12.1	24.6	22.7	20.3	15.8	13.6	5.5	23.3	24.7	14.8	17.5	32.2	11.3	15.5	30.5	13.3	12.3	27.2	37.9	15.9	29.1	11.8	11.5	16.4	33.1	20.3	9.7	23.1	12.8	21.4	24.0	37.7	26.0	16.0	39.7	21.3	24.2	18.1	12.9	18.0	17.8	13.4	10.7	24.8	19.2	36.8	32.6	19.1	14.3	14.1	136.6	74.0	61.7	65.5	37.1	37.8	76.4	80.1	40.4	74.8	65.8	71.4	94.9	104.7	72.5	44.4	43.2	85.5	84.1	99.5	100.9	110.0	61.9	126.0	97.5	97.3	57.6	198.5	67.8	33.9	44.5	106.1	91.2	33.6	76.4	100.3	285.1	86.2	67.3	105.9	146.2	70.1	57.7	89.1	46.9	84.5	68.3	216.4	70.8	81.0	61.2	76.7	72.7	97.3	110.4	64.9	82.2	95.8	49.9	71.9	21.4	70.0	125.0	62.8	105.2	117.5	40.2	119.5	123.6	60.9	31.7	41.6	53.3	40.1	59.5	43.8	48.0	51.2	39.0	37.4	51.0	57.1	19.5	75.2	45.0	41.3	51.3	44.8	11.0	12.1	20.3	15.8	13.3	12.3	11.8	11.5	12.8	12.9	10.7	14.1	33.9	9.6	30.2	12.7	28.6	24.3	13.5	27.9	18.8	20.6	19.4	16.6	79.5	21.5	28.5	27.6	43.8	35.8	45.7	18.9	45.0	26.3	2.8	13.0	15.4	21.4	10.8	39.7	35.4	28.3	34.5	22.8	20.9	16.0	56.3	21.4	17.9	24.6	28.0	25.2	33.2	20.2	16.2	18.8	20.7	3.8	14.9	25.0	17.8	19.7	23.4	27.4	75.2	18.1	29.6	25.3	10.6	17.3	58.5	21.8	30.2	39.9	21.1	43.5	19.7	19.6	34.9	22.1	16.8	32.7	30.0	25.2	34.5	31.9	23.2	12.4
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531264	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	21.5	25.3	40.3	10.2	41.2	16.4	20.4	40.5	45.2	21.2	37.0	26.0	11.8	20.2	18.7	21.2	19.9	12.2	28.1	38.1	39.2	29.3	52.7	17.2	15.1	41.6	41.4	22.2	29.8	22.6	24.2	14.3	40.0	26.9	9.3	13.5	25.6	17.3	43.9	19.1	18.0	11.2	40.7	20.9	24.9	20.4	42.1	17.5	23.4	26.8	11.5	20.9	17.2	40.9	13.9	30.0	33.9	43.8	23.6	16.7	28.9	22.0	32.1	37.0	28.0	30.1	12.4	15.0	12.9	26.4	28.9	26.3	31.9	28.0	15.8	27.7	29.8	14.0	46.3	19.2	33.6	23.2	19.9	18.8	25.8	29.9	21.6	22.4	23.0	36.3	17.9	11.2	27.6	55.2	31.9	11.8	40.4	27.0	29.6	30.1	52.5	25.1	24.1	13.0	45.7	28.9	31.8	23.9	34.3	15.4	46.6	13.5	17.1	40.9	20.7	25.7	21.7	22.7	31.3	19.4	20.3	16.0	29.1	2.1	5.5	9.0	7.3	7.2	9.8	7.4	8.5	6.4	5.2	8.0	11.3	5.6	3.6	7.0	2.6	5.9	12.0	5.6	40.3	41.2	40.5	45.2	38.1	39.2	41.6	41.4	40.0	40.7	42.1	40.9	13.6	16.0	5.0	7.8	12.4	14.3	10.3	9.9	12.5	18.0	16.2	20.1	14.0	4.3	6.2	14.7	8.4	33.8	12.0	20.4	29.4	22.7	21.9	9.0	10.2	14.3	12.1	3.0	4.7	26.2	17.5	15.7	6.6	9.2	2.5	16.2	13.2	20.5	26.4	26.9	6.1	11.6	16.2	10.0	13.4	33.3	17.7	14.0	16.0	4.7	20.4	22.0	9.2	2.0	6.0	18.6	12.3	19.9	8.0	14.3	21.1	31.6	3.1	13.1	19.7	12.4	17.2	32.8	33.4	11.8	12.5	25.7	10.0	14.9	14.8	8.5
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	41.9	47.3	21.2	17.4	23.2	24.7	44.0	32.0	33.2	53.7	24.4	46.9	33.5	41.9	7.2	50.4	49.8	11.9	57.1	20.4	21.2	55.1	55.6	40.6	21.2	23.9	21.5	74.9	46.3	17.2	52.3	17.9	23.7	49.4	8.7	55.9	43.4	17.6	61.1	43.0	51.8	9.6	19.4	64.7	37.2	25.7	22.7	15.9	59.0	36.6	11.0	40.1	54.0	31.4	29.2	30.3	25.5	34.2	18.4	15.6	40.9	22.8	15.4	46.2	23.0	72.8	22.0	29.3	37.5	14.9	31.6	46.7	20.0	31.4	9.2	12.3	33.6	22.2	67.8	108.1	20.3	38.2	40.8	21.9	27.6	18.5	15.1	18.3	21.5	28.4	32.1	30.3	14.6	37.4	45.1	66.3	18.9	23.0	70.0	45.4	19.2	51.0	19.1	41.4	60.3	35.3	32.9	31.8	36.2	12.7	33.4	34.1	24.2	48.7	18.2	32.1	30.1	31.5	18.1	13.6	25.0	27.1	18.8	8.0	11.4	9.9	18.3	19.7	21.0	31.0	17.8	15.8	13.3	17.1	10.1	12.4	1.8	8.5	22.2	7.6	20.8	12.1	21.2	23.2	32.0	33.2	20.4	21.2	23.9	21.5	23.7	19.4	22.7	31.4	31.7	25.6	8.3	17.0	24.1	18.9	21.4	29.9	14.8	30.7	13.5	17.3	20.3	18.6	17.7	9.2	83.4	31.2	16.8	24.7	23.5	19.4	2.4	18.2	17.0	19.4	21.5	5.5	7.8	11.1	23.6	17.5	25.0	22.7	13.3	21.1	13.6	12.4	17.6	20.2	9.7	21.2	32.6	11.4	16.4	3.7	17.7	14.5	10.6	4.7	17.0	18.5	12.3	10.1	12.2	17.5	27.4	20.7	21.4	17.8	38.7	16.1	11.3	148.0	26.3	16.2	30.1	12.7	12.4	22.5	19.0	33.4	22.0	28.4	24.3	19.2
UCMA	"C10orf49, GRP"	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221766-13234374	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;ovary: 1.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;basal ganglia: 2.2;cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"	NA	NA		20000		"Cluster 10: Brain - Neuronal signaling"		"Cluster 52: Non-specific - Transcription"			"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.2	0.2	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 7.8;Excitatory neurons: 6.5;Inhibitory neurons: 5.5;Oligodendrocytes: 6.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 19.4"	"Low region specificity"	"Detected in many"							CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	133000		"Cluster 40: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.5	5.1	8.6	0.6	8.2	1.1	1.5	8.4	13.5	3.3	4.2	2.4	0.3	2.4	0.5	0.9	3.0	0.8	4.2	8.0	7.3	2.0	5.9	1.9	0.7	9.7	18.2	2.9	2.3	0.0	4.3	1.0	14.9	3.0	0.0	0.9	0.9	0.3	4.8	1.3	1.9	0.4	7.1	2.9	1.3	2.8	8.4	0.6	1.7	0.4	0.2	2.8	1.7	10.1	1.2	2.7	0.4	0.7	1.2	1.0	5.1	0.4	1.0	0.4	0.4	0.2	2.1	1.1	0.6	0.4	1.2	0.4	0.4	0.3	0.0	3.4	4.4	2.4	2.0	2.2	2.9	0.2	2.6	1.5	2.0	0.2	2.4	2.6	0.0	2.0	2.4	1.9	0.1	2.0	1.3	7.2	4.4	0.1	2.8	3.5	2.3	1.5	0.1	0.5	0.7	2.3	1.1	0.1	6.4	0.3	1.1	3.2	0.2	0.8	4.8	1.4	1.9	19.4	2.3	0.7	3.7	5.7	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	8.6	8.2	8.4	13.5	8.0	7.3	9.7	18.2	14.9	7.1	8.4	10.1	0.8	0.0	0.5	7.8	1.1	0.5	0.3	0.3	0.0	2.3	1.8	1.0	0.4	4.3	0.2	0.0	0.0	0.6	3.2	0.5	0.0	0.7	0.6	0.5	0.9	0.8	0.0	2.7	6.5	3.8	0.6	0.7	0.0	0.5	0.0	1.2	1.1	1.1	0.7	1.7	5.5	0.3	2.0	1.3	2.4	0.4	1.5	0.9	0.0	3.7	0.9	1.8	0.0	2.5	6.0	0.6	1.1	0.7	0.1	0.7	1.1	0.5	0.5	3.5	0.0	1.5	1.2	1.1	0.6	0.0	0.0	0.8	0.8	0.4	0.5	0.1
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561718-48563781	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 13.1;vagina: 4.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 2.9;Basal respiratory cells: 1.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.8;hTCEpi: 27.3;hTEC/SVTERT24-B: 21.5;SiHa: 19.1;U-251 MG: 20.7;WM-115: 55.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	98600			"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	0.1	0.0	0.2	0.3	0.1	0.1	0.4	0.3	0.4	2.3	0.1	0.2	0.1	1.2	0.7	3.4	0.2	0.4	0.3	0.2	0.4	1.4	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.3	0.2	0.3	3.1	0.0	0.0	1.6	0.4	0.3	13.1	0.2	0.2	0.2	0.7	0.2	1.4	0.3	0.0	0.0	0.0	0.1	0.5	4.5	0.2	0.0	3.1	0.5	0.1	1.8	1.1	2.6	9.7	12.1	5.9	4.4	0.0	0.0	0.0	0.4	2.3	7.0	1.9	0.0	11.6	3.2	9.2	0.2	0.2	18.8	1.5	2.0	0.0	0.5	1.3	27.3	21.5	4.3	4.1	0.0	0.2	0.0	0.2	0.9	0.0	0.0	1.8	0.8	0.0	0.2	0.2	0.3	0.0	1.8	0.0	0.0	0.0	19.1	0.0	14.5	1.7	0.3	0.4	0.0	2.6	1.8	0.3	20.7	0.1	0.3	0.0	8.8	0.1	55.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5364966-5374692	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.8;pancreas: 5.8;stomach 1: 3.4"	"Cell type enriched"	"Detected in some"	29	"Enteroendocrine cells: 242.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.4"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 1.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 5.1"					HPA038281	Uncertain				"Secreted to blood"	NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.0	0.8	1.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	2.3	8.8	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	1.9	0.5	0.0	5.8	0.0	2.7	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.8	1.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	242.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.3	0.6	2.9	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974672-73982843	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 278.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	70.9	20.5	12.2	142.9	14.6	132.8	37.6	12.9	24.1	41.3	22.1	33.2	53.4	17.4	7.6	17.7	175.7	42.3	14.1	12.1	15.9	34.9	26.2	69.3	278.1	19.7	19.8	4.9	12.6	8.1	13.8	27.3	19.8	19.7	44.8	6.9	42.7	23.0	99.1	9.2	56.6	30.4	17.6	183.1	55.2	14.5	22.4	217.3	45.1	141.7	240.2	73.6	4.9	26.1	0.9	78.7	20.2	43.5	9.5	0.0	11.6	14.1	9.3	54.9	14.8	153.1	59.0	360.2	165.1	19.5	5.5	3.5	13.3	0.0	28.6	97.1	5.6	241.5	26.4	28.3	32.2	123.9	77.5	8.9	0.0	43.9	0.0	11.0	5.7	144.6	101.5	119.0	9.5	147.5	108.5	55.8	12.8	9.0	21.7	99.7	120.7	202.0	150.4	211.0	23.6	32.3	68.2	395.6	26.6	55.9	123.3	79.3	10.0	0.2	59.7	14.4	21.5	48.4	24.4	293.8	7.2	45.0	0.4	809.1	1116.7	1465.3	1462.8	1945.8	925.0	1914.8	1176.3	1233.5	1228.7	1851.8	1092.9	1143.1	154.2	1816.8	1692.3	3009.5	2589.5	2966.6	12.2	14.6	12.9	24.1	12.1	15.9	19.7	19.8	19.8	17.6	22.4	26.1	4.7	3.2	27.6	0.3	287.4	3.4	2.7	20.2	0.6	0.9	30.9	19.8	5.2	5.7	43.9	92.0	8.4	8.3	404.4	6.2	7.9	1.9	18.7	122.1	10.5	8.9	297.3	695.6	0.0	7.5	12.1	9.9	46.4	102.4	86.2	12.4	9.7	5.0	442.2	0.0	0.1	31.5	89.5	326.6	146.2	46.0	0.9	232.3	26.6	1.9	533.6	4.3	509.8	1.0	1.0	1.8	45.9	0.4	117.9	12.8	4.5	2.7	137.6	8.1	6.6	6.1	11.2	15.2	14.5	1.9	4.5	11.2	189.9	13.5	21.7	43.4
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	10.1	8.4	5.3	8.8	7.9	4.5	11.8	6.5	6.7	11.5	6.3	13.4	11.1	8.8	8.7	10.7	8.8	9.4	9.2	5.7	6.4	12.3	9.0	9.0	7.0	8.1	7.1	8.0	7.2	9.9	4.2	9.4	8.5	10.4	14.1	9.7	7.5	9.5	11.0	14.8	10.0	11.0	6.6	6.9	9.8	5.3	7.0	7.6	10.9	10.5	8.6	10.2	6.9	11.1	16.2	19.6	8.9	8.6	28.2	25.1	8.3	17.5	24.3	22.7	21.6	8.1	4.6	5.0	9.4	20.7	19.8	24.8	8.2	18.1	25.8	14.6	10.7	7.5	8.8	9.1	12.7	11.5	10.4	17.4	18.3	11.2	15.5	15.9	21.2	0.4	5.7	4.7	29.3	12.3	0.3	3.7	2.4	24.9	19.8	1.8	20.7	6.2	26.9	25.4	3.7	7.9	19.1	23.8	15.1	11.0	19.1	6.8	16.2	20.7	11.1	34.0	17.2	0.9	11.3	1.1	17.7	8.7	21.3	4.6	4.9	3.1	4.2	5.1	4.0	2.6	3.1	3.5	3.4	2.7	1.8	2.6	6.5	5.2	4.2	4.2	2.3	2.4	5.3	7.9	6.5	6.7	5.7	6.4	8.1	7.1	8.5	6.6	7.0	11.1	10.3	16.0	19.3	18.9	4.5	6.2	6.3	9.9	8.6	9.3	11.2	6.3	10.1	5.7	12.4	23.9	10.4	8.4	9.4	27.3	3.9	10.8	3.3	13.6	12.4	11.6	9.1	4.8	14.7	13.3	7.4	8.7	10.7	12.9	6.3	11.6	13.6	13.5	12.5	15.2	14.4	15.4	18.3	18.6	10.3	2.0	8.1	11.0	7.2	20.6	11.9	13.3	11.3	25.1	34.3	14.5	10.3	18.4	3.4	8.3	12.8	12.8	23.9	11.1	13.1	10.2	8.7	7.1	7.2	10.1	9.2	7.7	6.6	11.7	15.7	7.6
UFC1	HSPC155	ENSG00000143222	"Ubiquitin-fold modifier conjugating enzyme 1"	Q9Y3C8	1	161152776-161158856	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 703.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027481, HPA028722"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		62000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA027481: AB_10599850, HPA028722: AB_10601674"	"unprognostic (2.16e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.62e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.22e-2)"	85.3	112.1	135.3	76.1	139.3	134.5	134.0	137.6	167.5	100.4	138.9	114.5	112.6	91.7	170.6	100.2	209.3	103.2	111.9	135.4	149.2	129.5	115.4	87.8	107.6	136.4	139.0	140.7	164.7	148.0	102.4	92.9	143.0	106.5	141.9	85.1	126.0	112.2	101.0	110.5	103.1	108.4	139.6	79.1	116.3	56.3	137.6	110.4	108.9	108.3	128.6	125.9	76.8	142.3	140.7	119.8	107.8	129.9	137.5	226.7	223.5	124.7	154.0	122.7	111.8	165.0	268.6	183.2	232.8	180.7	77.3	65.7	89.1	127.2	96.1	154.4	238.6	109.4	163.0	200.9	139.8	233.4	271.9	190.4	202.6	152.5	104.6	207.4	227.9	189.4	183.0	123.8	159.8	161.3	126.1	234.9	198.9	387.9	128.5	152.6	80.8	258.6	248.4	158.2	112.9	196.2	108.1	324.2	163.8	176.8	148.2	482.1	165.6	90.5	92.2	90.7	196.1	233.3	322.2	177.5	140.7	164.8	119.7	137.3	156.7	104.5	174.7	164.1	212.8	209.3	185.0	188.2	192.4	164.1	161.9	175.4	28.4	208.3	121.6	206.4	274.4	268.1	135.3	139.3	137.6	167.5	135.4	149.2	136.4	139.0	143.0	139.6	137.6	142.3	107.0	70.5	85.3	18.3	151.9	99.8	173.3	244.6	106.4	57.4	174.2	177.5	117.6	147.3	171.6	104.8	41.7	253.8	170.8	150.8	440.3	224.2	131.0	421.2	96.6	123.3	204.5	124.7	8.7	380.8	386.9	99.2	111.6	113.2	119.7	143.1	116.7	106.2	244.7	47.1	7.7	240.0	205.4	150.7	138.5	392.3	105.0	132.0	131.6	9.4	229.3	161.8	195.7	11.1	13.3	265.5	189.1	91.0	182.6	148.0	243.5	380.9	703.0	72.0	65.7	86.3	106.7	96.6	42.4	125.2	120.9	431.9	155.1	124.4	193.7	218.6
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	17.0	20.6	9.8	18.9	13.1	17.9	21.4	11.9	15.4	20.8	7.8	18.7	22.7	19.0	23.4	20.7	16.8	18.0	23.7	9.2	12.1	21.3	29.7	15.4	22.1	13.8	11.4	22.4	25.2	24.9	10.0	18.1	15.3	24.4	19.5	31.6	23.5	17.9	21.1	20.3	22.8	17.1	12.4	17.9	21.8	14.2	10.8	20.8	28.1	21.4	21.8	20.1	11.2	19.5	16.9	8.8	18.3	30.7	25.8	39.2	27.2	23.3	23.6	14.6	13.6	11.0	19.2	40.7	28.9	23.5	16.2	32.0	15.0	22.0	21.3	21.9	13.6	17.9	13.3	20.2	34.3	34.0	25.6	28.2	20.1	17.4	47.9	27.1	24.2	25.7	24.1	43.7	27.9	16.3	12.5	21.0	6.6	14.5	9.9	15.6	21.4	32.6	26.5	30.5	12.9	12.5	19.2	22.4	21.5	16.2	54.4	28.7	24.0	20.3	11.0	20.8	24.7	25.7	14.2	30.9	31.2	22.5	19.0	8.7	7.9	8.9	8.7	10.1	10.0	9.6	9.2	9.4	10.2	8.6	11.4	9.3	1.6	13.1	10.4	10.7	11.1	7.2	9.8	13.1	11.9	15.4	9.2	12.1	13.8	11.4	15.3	12.4	10.8	19.5	42.8	57.7	50.2	54.2	53.9	19.5	34.4	52.2	36.5	48.8	33.3	33.8	60.4	31.5	64.9	46.0	45.9	64.1	57.2	31.6	19.6	42.0	61.0	64.3	60.8	35.1	19.8	30.7	26.5	50.7	34.3	45.2	32.1	62.2	30.9	43.0	32.5	69.5	35.4	43.7	33.0	48.9	36.7	33.2	13.9	44.1	50.1	37.5	14.2	30.9	42.5	34.9	39.1	58.3	103.1	40.4	29.9	50.4	72.7	29.8	46.1	30.7	76.1	74.9	19.7	49.0	44.2	85.3	37.8	37.6	19.2	91.0	46.5	59.5	35.9	29.8
UFM1	"bA131P10.1, C13orf20"	ENSG00000120686	"Ubiquitin fold modifier 1"	P61960	13	38349849-38363619	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039758	Approved					NA	NA		240000	"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA039758: AB_10697555"	"unprognostic (8.08e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (9.67e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.90e-1)"	41.9	43.1	35.6	47.8	38.1	100.1	47.4	35.6	44.0	43.5	40.5	39.7	48.5	58.4	64.8	29.9	37.1	42.2	35.8	37.6	42.1	45.3	52.9	41.6	52.3	39.1	37.5	50.3	67.0	32.7	37.2	53.1	39.4	49.9	50.6	32.1	58.5	50.3	24.8	42.8	47.8	39.2	40.1	46.9	52.3	19.8	36.9	31.9	52.1	26.2	48.5	41.7	35.8	44.5	31.3	18.1	47.4	46.2	81.8	97.4	43.3	94.1	72.8	47.7	50.3	56.2	63.1	50.9	29.1	81.8	94.5	51.6	44.9	57.4	67.6	71.4	27.5	42.5	33.9	50.0	107.8	63.3	59.1	81.6	84.3	46.4	127.6	69.9	47.7	39.6	28.5	68.5	68.6	35.6	42.8	52.5	48.9	94.4	45.8	48.9	84.8	50.6	60.2	40.6	17.9	40.6	32.4	54.8	80.8	64.9	40.0	49.1	56.5	55.1	33.5	88.1	53.1	64.7	43.9	67.6	116.6	32.2	84.5	71.5	30.6	41.1	30.7	42.0	37.3	40.1	31.2	28.7	26.7	37.6	30.4	31.8	15.5	39.6	40.3	45.0	32.4	34.7	35.6	38.1	35.6	44.0	37.6	42.1	39.1	37.5	39.4	40.1	36.9	44.5	92.1	80.1	73.3	20.9	141.6	136.9	151.7	147.8	108.1	24.0	102.7	64.4	66.3	64.3	115.3	62.5	20.9	87.2	112.7	84.8	99.7	91.5	38.6	126.8	113.4	78.8	31.7	52.6	29.0	102.3	140.2	121.5	92.8	148.1	115.3	53.4	68.9	119.6	97.6	6.7	34.9	113.5	107.8	94.3	148.3	13.3	59.0	102.0	94.3	43.1	92.3	26.7	62.8	26.2	58.9	161.9	102.2	40.3	330.9	215.8	95.2	136.5	141.2	22.3	19.7	87.3	88.1	56.6	44.9	110.2	173.3	140.4	93.0	45.2	80.8	220.3
UFSP1	UFSP	ENSG00000176125	"UFM1 specific peptidase 1 (inactive)"	Q6NVU6	7	100888721-100889715	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 7.9;Proximal tubular cells: 7.4;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027099	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027099: AB_2214069"	"unprognostic (8.56e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.71e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	2.0	2.7	1.2	0.9	1.3	0.6	1.6	1.9	1.7	1.5	0.2	1.8	1.0	2.4	1.3	1.9	1.8	0.1	1.6	0.9	1.2	2.1	3.1	1.0	0.6	1.4	1.5	0.9	3.1	1.0	2.3	0.4	1.4	1.8	0.5	0.3	1.7	1.0	3.7	1.1	1.5	0.8	1.2	1.6	1.9	0.7	1.1	0.8	1.4	1.2	0.4	2.1	1.1	1.5	2.9	3.7	0.8	3.8	3.6	2.1	2.3	2.2	0.7	0.9	0.6	1.5	2.0	0.7	1.7	1.8	1.4	5.6	1.1	1.3	0.5	2.6	8.2	2.4	3.2	1.8	3.6	1.0	1.1	2.4	1.6	1.2	4.6	1.0	0.3	1.4	3.7	1.7	1.4	7.3	2.4	6.0	2.8	3.0	5.1	1.2	1.1	5.8	1.6	1.3	2.6	4.3	4.4	5.6	2.7	1.1	1.4	0.9	0.9	2.4	2.5	2.6	1.7	1.7	2.2	0.2	0.8	2.0	2.8	0.0	2.4	1.5	3.1	2.1	3.5	1.0	2.6	1.7	2.9	3.9	2.9	3.6	0.4	3.0	2.2	4.4	1.2	1.7	1.2	1.3	1.9	1.7	0.9	1.2	1.4	1.5	1.4	1.2	1.1	1.5	0.7	0.0	0.0	0.0	0.8	0.6	2.3	1.3	1.8	0.4	1.4	1.3	0.8	1.5	0.7	1.8	0.0	2.4	0.8	2.5	7.9	2.2	0.3	2.2	3.6	0.8	3.0	0.8	0.3	2.1	1.2	1.2	1.1	1.2	0.0	0.6	1.8	4.7	1.9	0.0	0.3	2.2	0.0	0.8	0.7	0.4	1.8	0.6	0.0	1.0	0.5	2.5	0.0	1.0	0.2	1.8	5.0	1.9	1.3	3.2	1.6	7.4	0.7	1.0	6.6	1.5	1.5	0.2	0.3	2.4	1.0	1.6	0.8	4.4	2.5	2.2
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.2	24.9	19.9	9.5	21.7	5.7	24.3	25.2	24.1	21.6	29.6	19.5	13.0	19.9	28.1	25.8	17.7	15.6	32.1	20.4	21.9	37.3	24.1	17.1	11.9	20.4	20.2	31.4	19.7	23.8	10.0	14.0	20.9	19.8	15.3	56.4	20.3	19.2	48.5	21.6	12.0	20.2	20.7	14.5	17.5	21.0	21.3	14.3	25.9	40.6	16.1	16.2	10.1	25.3	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	19.9	21.7	25.2	24.1	20.4	21.9	20.4	20.2	20.9	20.7	21.3	25.3	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.9"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 294.5;Urothelial cells: 534.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.7"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 195.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	39.1	65.6	9.5	34.6	9.6	112.9	25.2	11.1	10.9	23.1	10.4	20.5	23.8	16.3	7.3	40.8	15.7	42.6	14.4	9.7	13.1	29.7	32.5	33.7	41.8	11.0	12.4	12.0	16.6	5.5	12.5	27.6	10.3	13.8	17.8	12.2	14.1	7.7	9.0	32.8	31.7	21.4	10.2	35.5	47.9	7.9	11.6	20.5	9.9	7.7	46.8	72.3	28.5	13.7	93.4	9.8	15.7	10.5	33.2	39.7	8.3	57.0	59.7	65.3	87.9	19.8	70.0	21.9	44.1	38.0	142.9	46.6	18.4	24.7	69.6	8.9	10.7	8.9	14.3	9.8	23.7	9.8	13.8	39.6	18.9	62.4	89.1	151.0	20.3	10.8	49.4	41.5	195.7	15.9	10.7	10.9	17.9	31.4	10.1	12.4	111.5	7.1	151.0	35.2	7.6	12.0	25.3	21.1	66.1	92.2	113.6	10.1	96.6	30.0	15.2	84.8	41.1	7.7	30.3	10.2	37.0	6.1	41.6	0.1	0.3	0.2	1.2	0.7	2.0	4.2	2.2	1.6	1.9	5.3	2.0	2.0	1.2	1.4	1.0	109.7	3.6	1.4	9.5	9.6	11.1	10.9	9.7	13.1	11.0	12.4	10.3	10.2	11.6	13.7	128.0	41.7	51.1	17.6	66.6	75.7	151.6	90.6	76.8	29.8	71.8	37.8	11.8	47.1	130.7	29.5	62.6	7.3	262.4	69.8	17.6	108.2	20.6	125.0	83.4	116.1	18.5	26.5	40.4	50.6	12.8	64.6	121.8	294.5	10.8	18.3	90.7	20.6	21.4	18.5	41.9	55.1	36.7	34.0	109.2	5.9	49.0	49.1	58.7	24.4	44.4	8.4	9.2	25.1	12.8	72.2	65.1	38.4	33.3	216.6	42.6	77.2	143.9	16.5	13.1	153.2	74.9	1.8	8.7	99.7	122.2	3.4	41.4	30.5	22.1	534.7
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		4000000	"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	8.1	8.5	4.2	13.7	4.6	21.8	7.6	4.8	6.5	9.1	5.0	12.4	9.0	7.3	19.9	8.0	6.5	6.5	8.0	4.3	4.6	8.2	14.9	8.4	12.3	4.7	4.4	5.1	14.8	8.7	6.5	8.7	5.0	8.7	10.0	9.7	8.6	6.2	13.2	8.8	10.2	6.2	4.0	9.4	10.7	6.4	4.8	11.7	10.4	13.0	12.6	7.5	6.6	5.6	34.8	11.8	22.0	47.6	28.0	22.3	34.3	39.4	16.7	12.7	11.3	26.0	24.9	49.4	15.4	28.3	11.3	25.3	16.8	16.8	25.5	31.5	8.2	43.4	14.9	82.3	28.0	58.6	25.9	16.3	13.0	25.4	23.0	25.0	29.8	19.8	28.4	25.6	26.9	24.4	23.5	33.5	39.5	24.0	12.4	19.2	21.3	20.9	23.8	25.2	11.7	17.4	27.3	36.0	24.4	22.5	14.4	40.2	43.1	34.6	24.4	20.1	28.4	27.3	40.4	22.3	29.3	31.4	32.6	3.8	2.5	2.5	2.3	2.5	2.3	1.6	1.9	2.1	1.9	3.3	1.6	2.3	3.7	1.9	2.5	3.1	1.6	1.4	4.2	4.6	4.8	6.5	4.3	4.6	4.7	4.4	5.0	4.0	4.8	5.6	14.6	35.3	24.7	24.8	14.3	8.2	6.4	11.1	5.7	19.8	11.2	7.1	16.7	12.8	20.7	3.7	22.9	10.5	22.1	21.5	1.9	14.0	9.2	18.4	27.7	16.5	22.8	31.5	40.6	19.5	20.1	16.6	21.9	22.2	11.4	20.8	17.9	39.7	16.6	20.2	37.6	21.9	8.2	25.4	16.4	2.3	14.9	20.0	14.2	32.8	26.0	7.5	15.5	31.2	46.5	19.4	10.4	13.5	31.5	13.3	25.3	8.4	12.7	20.2	6.6	18.5	13.3	10.0	8.5	9.4	10.7	10.8	18.9	16.0	22.8	10.1
UGGT2	"FLJ10873, FLJ11485, HUGT2, MGC117360, MGC150689, MGC87276, UGCGL2"	ENSG00000102595	"UDP-glucose glycoprotein glucosyltransferase 2"	Q9NYU1	13	95801580-96053482	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 112.0;Excitatory neurons: 215.1;Inhibitory neurons: 169.6;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 207.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.9;eosinophil: 2.6;intermediate monocyte: 6.2;myeloid DC: 3.6;non-classical monocyte: 6.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047955	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047955: AB_2680222"	"unprognostic (5.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (9.99e-4)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.21e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.61e-2)"	11.8	6.9	5.1	5.1	6.3	3.8	9.3	1.1	9.1	8.2	6.3	6.9	5.4	10.3	16.0	4.0	7.8	6.0	8.7	5.7	4.3	7.5	8.3	6.7	3.0	3.6	2.9	7.8	10.7	7.6	8.8	11.2	3.5	7.4	6.2	7.8	8.0	7.3	4.0	4.8	4.6	10.0	2.8	3.8	7.8	12.0	3.5	1.2	11.4	4.3	2.6	8.2	6.0	8.1	20.3	9.6	19.8	10.2	32.5	34.4	16.0	32.5	25.2	15.6	26.6	14.6	17.2	7.0	11.8	22.0	11.4	12.4	7.0	7.0	22.9	0.2	8.6	9.0	19.1	9.6	19.0	25.4	20.9	20.6	7.4	5.9	18.7	28.8	14.2	0.1	5.8	11.5	22.1	6.0	0.2	10.9	8.4	15.1	5.8	0.1	14.4	10.5	13.6	19.4	4.1	15.3	18.6	18.4	13.2	26.9	16.4	12.1	23.1	15.7	10.2	17.6	17.1	16.1	8.3	8.8	40.9	13.3	21.2	0.4	5.9	2.6	0.1	6.2	0.0	1.2	0.1	0.1	3.6	0.4	0.1	0.1	0.4	1.1	6.0	0.3	0.0	1.9	5.1	6.3	1.1	9.1	5.7	4.3	3.6	2.9	3.5	2.8	3.5	8.1	22.2	16.0	19.9	112.0	3.9	4.0	10.3	10.6	10.2	19.5	11.0	13.1	13.1	7.2	16.3	14.7	31.3	18.3	0.5	5.8	0.0	13.9	44.7	13.2	34.3	17.7	4.8	7.8	215.1	18.9	17.3	32.4	12.2	20.9	18.3	22.4	12.8	8.6	7.5	18.5	169.6	7.1	8.2	7.1	11.9	15.4	22.1	8.5	3.6	76.8	6.8	11.8	0.0	209.1	207.3	18.6	5.2	16.6	9.8	9.9	4.0	5.6	15.1	17.1	32.9	28.2	32.3	38.1	26.3	8.0	3.1	13.8	1.6	19.5	7.8	7.5
UGP2	"SVUGP2, UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840952-63891562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 858.6;tongue: 756.1"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 849.9;Hepatocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 417.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		13000000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	267.3	72.0	79.8	65.8	89.3	40.1	119.7	72.7	109.8	65.9	78.8	177.9	66.0	75.2	50.6	97.5	68.9	60.7	232.5	87.9	81.4	105.4	858.6	65.4	65.7	77.7	77.0	47.0	74.4	113.3	49.8	137.8	77.6	57.4	159.3	36.8	92.9	66.2	498.0	59.1	67.6	78.5	73.2	50.8	69.5	38.3	83.3	106.2	64.5	756.1	73.7	88.4	63.7	91.8	122.3	77.6	63.1	42.0	176.1	222.4	220.6	129.1	116.1	82.7	89.4	170.0	104.5	149.5	48.3	165.6	79.9	57.4	73.4	102.6	137.0	99.2	35.7	86.5	50.4	117.9	87.0	79.1	73.9	148.1	175.8	76.1	80.3	108.4	119.4	38.9	48.2	58.1	327.8	56.7	104.6	75.2	122.9	207.7	50.1	80.4	117.9	84.5	147.4	77.7	36.5	29.6	103.3	149.8	64.3	162.6	51.7	59.2	144.3	84.4	125.9	113.8	90.5	101.3	51.4	174.9	99.2	122.7	225.7	417.1	33.0	53.1	48.0	40.7	51.8	33.0	53.6	50.1	27.9	31.8	57.6	53.6	45.4	70.0	39.5	29.7	127.2	62.0	79.8	89.3	72.7	109.8	87.9	81.4	77.7	77.0	77.6	73.2	83.3	91.8	73.4	28.9	54.0	107.4	65.3	75.8	87.8	245.9	34.7	49.6	360.6	87.1	264.3	104.4	171.6	47.8	64.6	414.3	81.1	849.9	242.6	140.6	91.5	53.0	106.3	69.8	44.5	56.0	86.1	103.6	445.5	159.3	79.0	49.5	67.8	42.4	63.5	559.4	120.9	87.5	78.4	179.8	144.5	102.4	90.2	86.1	79.2	89.1	96.0	62.8	139.7	58.8	154.5	37.2	79.3	91.6	313.9	77.5	60.7	81.2	176.2	284.4	139.3	57.3	72.3	50.5	129.2	84.9	54.9	50.9	57.8	472.8	143.1	90.6	189.5	109.1
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 71.3;liver: 143.3;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 1194.0"	"Not detected"	"Not detected"							"CAB009819, HPA054065, HPA056023"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: "		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	1.8	0.0	1.8	5.8	0.1	2.6	16.1	0.0	3.5	0.0	0.0	0.0	71.3	143.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	1.3	0.0	2.6	3.6	0.0	11.1	2.6	0.0	0.0	0.0	17.4	0.4	0.0	1.2	0.5	0.0	5.8	88.8	5.5	0.0	4.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	53.8	1.6	0.0	80.2	0.1	0.8	294.5	0.1	4.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.3	0.0	31.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	1194.0	0.0	0.1	0.2	0.1	3.2	149.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.2	12.5	0.0	0.0	0.0	0.3	0.0	2.9	1.8	0.0	0.0	0.0	0.4	0.0	0.0	52.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.5	0.0	0.0	0.4	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.5	1.8	0.1	0.0	0.0	0.0	0.0	1.2	0.2	17.3	1.1	0.0	0.0	0.0	0.1	3.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	P0DTE4	4	69588417-69653249	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 3.6;kidney: 2.3;liver: 3.6;pituitary gland: 5.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 107.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;lung cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA017261, HPA045108"	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	"P0DTE4, P0DTE5"	4	69588417-69639642	"Enzymes, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 6.3;liver: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"					"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 233.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	233.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214748	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 239.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 13.7;Cholangiocytes: 7.2"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"basophil: 4.7;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.7"	"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 5: Breast - Unknown function"		"Cluster 35: Glandular cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.0	0.1	0.0	0.1	239.4	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.9	0.0	0.5	11.4	0.0	0.0	0.0	3.6	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646597-68670652	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 77.7;liver: 291.2"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.7;Hepatocytes: 142.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	21.6	5.1	0.0	0.0	0.0	0.1	77.7	0.0	0.0	0.0	0.0	291.2	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.1	17.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	4.4	0.9	0.1	168.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	24.2	3.0	0.2	0.0	0.2	0.0	2.7	0.1	3.6	0.1	0.1	0.0	0.0	0.0	0.0	2.9	142.8	0.0	0.0	0.1	3.3	0.0	3.2	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.1	0.6	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.9
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 460.0;liver: 136.2"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"memory B-cell: 2.8;naive B-cell: 8.8"	"Lineage enriched"	"Detected in single"	61	"B-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7"									HPA045108	Supported					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.3	0.0	0.0	38.8	0.0	0.0	0.7	0.0	0.0	1.5	0.0	365.7	364.3	1.4	1.5	0.1	0.2	0.6	0.0	0.0	0.0	0.2	136.2	0.2	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	125.8	0.0	0.2	0.7	0.0	0.0	460.0	9.1	0.1	0.6	0.8	0.0	0.1	0.4	0.0	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	130.1	0.0	0.0	0.0	11.1	0.1	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.3	0.1	35.1	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	100.6	0.2
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280475-69295050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"breast: 198.5"	"Cell type enriched"	"Detected in single"	16	"Cholangiocytes: 10.0"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	10	"Daudi: 2.9;NB-4: 2.7"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	198.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	107	"liver: 1273.7"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 883.5"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RH-30: 4.6"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	1.3	1273.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	11.7	883.5	0.1	0.0	0.1	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1299.8;liver: 1612.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.0	0.0	3.8	68.7	8.9	24.2	0.2	49.9	10.4	0.0	0.0	0.0	1299.8	1612.1	0.4	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.1	0.0	0.3	6.9	0.0	3.6	27.5	0.0	0.3	66.6	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951006-36001028	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 51.1;liver: 58.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 28.2"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	58.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.0	0.1	0.3	0.0	0.7	0.1	0.2	3.0	0.0	6.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	49.7	0.0	0.0	0.0	0.0	3.9	0.0	125.9	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	72.1	0.1	0.0	0.3	0.7	0.0	2.6	0.0	24.5	0.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.4	0.0	0.0	3.8	87.0	0.0	0.2	6.6	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.5	0.0	1.8	0.1
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	4.3	4.4	2.8	4.3	2.8	14.2	3.6	7.1	3.2	2.7	4.6	3.1	3.2	3.3	2.4	3.2	2.8	2.5	6.8	2.4	3.4	3.7	3.9	4.2	4.9	3.5	3.7	3.3	8.0	8.5	3.0	5.3	3.9	3.6	3.9	7.5	5.9	2.9	14.3	3.1	3.6	3.9	3.5	4.4	4.0	12.0	3.5	5.8	6.0	7.5	4.2	3.5	2.4	3.8	12.9	9.1	7.9	25.9	4.1	3.0	14.3	7.4	5.0	7.1	10.0	18.2	3.4	19.4	7.9	7.7	12.3	9.6	29.2	4.2	9.6	10.0	9.4	17.2	8.7	15.2	16.7	15.7	10.3	6.8	12.0	5.7	12.0	6.6	9.1	16.6	29.3	7.5	3.1	12.3	12.2	10.2	3.6	9.3	6.3	7.3	12.7	11.8	9.6	11.8	9.5	9.7	18.7	9.7	24.7	8.1	18.5	20.3	5.6	3.5	12.7	5.5	8.2	11.1	18.6	12.0	1.9	21.5	8.8	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.4	1.3	0.1	0.1	0.2	2.8	2.8	7.1	3.2	2.4	3.4	3.5	3.7	3.9	3.5	3.5	3.8	5.1	16.0	6.3	16.0	5.0	1.0	3.0	3.9	5.7	10.1	5.2	2.9	16.8	4.3	9.1	0.0	20.9	6.9	3.7	3.0	1.9	5.4	10.0	5.8	4.9	6.3	9.5	6.7	20.8	5.8	3.8	4.9	10.2	11.5	1.3	14.3	15.0	6.0	15.6	5.0	39.3	4.9	10.2	19.0	6.0	18.2	5.6	11.9	0.0	22.5	9.4	4.6	4.1	25.6	14.1	7.2	3.3	2.6	11.4	9.9	4.1	3.9	5.1	10.8	13.1	7.5	5.4	16.4	10.8	8.3	2.8	4.9	3.9	4.0	3.8	8.5
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142874	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	8.7	10.9	6.2	10.2	7.7	32.9	8.8	11.0	11.5	7.2	9.9	8.3	8.4	7.5	7.0	7.0	6.3	8.9	7.9	13.2	6.2	12.3	24.6	7.7	9.2	4.9	5.4	7.5	3.8	13.6	5.2	9.0	4.8	9.0	7.9	14.6	6.4	8.0	19.8	5.9	7.1	8.8	4.6	9.2	6.0	14.0	3.7	8.4	10.9	14.6	7.0	10.1	5.2	9.2	18.6	19.7	10.8	11.2	16.4	23.1	21.6	28.3	28.4	22.4	16.3	14.8	6.2	16.0	7.2	29.1	13.1	6.9	20.4	9.7	21.5	42.7	10.0	10.7	14.1	17.3	15.1	20.4	16.8	13.1	8.0	27.0	18.6	20.7	16.0	11.0	8.6	16.2	22.1	10.3	13.1	17.5	18.7	6.3	17.7	14.7	19.2	15.7	11.4	32.2	18.3	11.4	21.4	24.5	8.5	9.2	21.9	23.0	12.7	24.6	13.2	21.5	20.1	19.1	35.2	22.3	12.4	15.1	15.2	21.6	11.4	7.8	3.6	12.3	5.3	5.5	4.0	4.1	12.8	4.5	3.4	4.2	33.9	5.9	10.9	7.6	5.2	5.4	6.2	7.7	11.0	11.5	13.2	6.2	4.9	5.4	4.8	4.6	3.7	9.2	10.6	28.9	8.7	27.1	18.2	12.7	17.2	5.0	19.9	11.9	9.3	7.5	15.7	1.5	12.6	9.2	4.2	4.7	15.0	10.9	5.9	6.0	35.1	15.7	23.7	8.6	5.4	9.4	75.2	5.9	8.9	24.7	7.7	9.9	24.1	6.3	5.3	18.5	11.2	15.2	54.2	2.1	4.1	23.3	21.4	5.3	7.2	29.5	10.6	45.0	25.7	8.3	8.2	37.2	29.5	5.9	7.4	7.9	12.5	18.5	8.9	14.9	21.8	12.0	0.0	23.3	15.1	24.1	19.1	14.9	11.6	10.9	15.7	8.3	5.7	11.9
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 64.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 64.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	28.2	24.6	15.8	14.0	15.9	60.2	27.2	22.3	19.1	31.1	19.1	32.5	9.5	29.4	11.2	18.8	26.6	10.8	27.1	15.1	15.4	21.9	18.6	26.4	22.8	14.0	14.4	35.8	27.2	9.1	19.6	12.7	14.4	23.0	12.4	15.0	17.1	13.3	32.6	23.8	23.3	18.9	12.6	31.4	22.5	62.3	14.9	27.6	23.5	12.0	22.0	29.2	23.8	17.6	27.6	26.6	26.9	33.1	25.8	22.7	38.3	28.1	31.4	35.5	37.0	30.6	30.7	79.1	33.8	23.3	37.8	21.1	27.9	62.7	41.8	91.4	25.4	35.4	30.9	25.7	28.5	43.8	22.7	15.9	29.0	27.0	74.0	26.9	41.6	47.1	30.9	26.1	26.6	25.7	43.1	29.4	19.6	22.2	16.2	39.5	38.8	46.1	38.0	17.4	29.1	23.2	62.3	20.1	30.4	28.3	17.5	24.2	31.6	20.1	20.3	17.7	37.6	39.1	49.8	50.8	19.6	43.2	22.1	15.8	11.8	33.0	9.0	7.0	9.4	11.8	10.3	8.9	7.4	13.9	10.0	8.3	64.5	14.5	4.5	9.5	14.7	6.5	15.8	15.9	22.3	19.1	15.1	15.4	14.0	14.4	14.4	12.6	14.9	17.6	24.8	12.8	21.0	36.9	31.3	10.5	18.0	11.8	23.3	19.3	10.9	11.8	20.6	8.6	17.3	9.2	14.6	13.9	22.5	7.8	7.9	13.7	27.4	19.4	23.1	17.0	13.1	47.8	59.5	12.9	12.7	17.1	12.2	22.8	18.3	20.6	13.2	8.8	9.9	16.8	53.3	7.9	8.2	14.8	14.1	13.2	15.5	19.8	1.8	44.0	18.0	8.9	19.6	43.7	51.1	17.0	9.1	12.4	24.2	12.9	8.1	8.9	19.2	33.7	13.1	17.7	18.8	132.1	73.8	13.2	11.9	6.8	23.0	35.4	8.7	13.9
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149963943-149973715	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;lung: 1.7;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 4.4;cerebral cortex: 1.9;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.2	0.1	0.1	0.2	0.1	0.3	0.0	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.6	0.2	0.4	0.1	1.7	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.2	2.1	1.0	1.6	0.0	3.3	6.8	3.2	3.0	0.9	0.6	2.0	0.2	3.1	3.5	0.7	16.5	6.9	0.7	29.3	1.4	2.7	17.1	3.8	0.3	0.6	0.0	18.0	0.1	1.2	9.1	6.8	13.6	2.5	0.0	1.1	26.1	3.3	0.0	3.5	2.7	4.3	0.0	0.5	1.4	2.3	0.0	1.3	0.5	0.0	0.4	1.0	0.4	4.4	2.0	0.0	1.3	2.9	6.4	0.3	1.6	0.0	1.4	0.0	0.5	0.7	2.3	8.7	5.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.1	4.4	1.9	1.6	0.2	0.1	0.2	0.5	0.1	0.1	0.2	1.6	6.4	2.2	0.0	0.5	0.1	0.5	0.0	0.6	0.0	1.0	3.0	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.6	0.0	1.6	0.0	0.7	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	1.6	1.3	0.2	0.2	2.5	0.6	0.0	0.7	0.2	0.3	0.1
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942014-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 12.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 66.7;U-2197: 47.4"									"CAB018974, HPA066741"	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"CAB018974: , HPA066741: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	1.5	0.7	1.3	0.6	1.6	1.8	0.7	1.6	2.6	0.9	0.7	0.2	0.2	0.1	0.1	6.1	0.2	0.5	2.0	3.0	1.0	2.1	0.5	3.4	0.3	1.8	1.2	0.0	0.4	0.6	0.5	1.6	1.8	0.2	0.1	0.2	0.7	0.1	0.3	0.5	0.2	0.7	0.8	0.2	0.3	1.5	1.1	0.7	1.2	0.7	0.8	1.4	1.6	1.7	19.9	1.8	0.5	6.1	1.1	5.6	3.3	20.1	11.8	20.6	16.8	7.4	11.0	0.0	29.9	23.0	29.6	13.9	7.6	18.4	11.8	9.1	3.9	1.1	2.8	0.0	7.1	0.0	1.5	2.7	13.9	18.3	8.0	16.7	11.9	16.6	2.5	0.0	15.4	13.9	1.8	0.0	0.0	3.6	10.2	3.0	4.5	0.0	29.0	5.7	0.6	0.0	66.7	1.4	1.9	3.2	1.8	8.5	18.8	13.5	17.1	47.4	23.5	0.0	0.1	0.9	19.2	10.7	9.9	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.8	1.5	0.0	0.0	0.3	1.8	0.0	0.4	0.0	0.0	1.7	0.5	1.3	1.6	1.6	2.6	3.0	1.0	1.8	1.2	1.8	0.8	1.1	1.7	28.9	0.0	1.3	0.0	1.2	3.7	6.5	17.9	7.4	0.0	1.3	4.4	0.3	0.0	9.4	1.8	0.0	0.0	12.1	0.5	0.0	7.5	7.0	0.3	0.5	9.1	0.0	0.0	3.0	8.8	0.5	3.0	1.1	0.2	0.0	0.1	7.1	0.2	2.2	0.0	0.7	0.3	2.0	0.8	2.1	8.0	0.0	3.1	1.8	0.0	0.0	0.4	4.1	0.5	0.3	4.5	0.0	0.0	1.4	1.4	0.0	0.1	1.4	0.0	0.0	1.0	4.2	3.1	7.0	11.8	2.8	0.0	11.0	0.6	0.4	5.2
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150061053-150069121	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5;testis: 6.3"	"Cell type enhanced"	"Detected in single"		"Gastric mucus-secreting cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: AB_2684920"	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	1.3	1.2	1.6	0.7	1.8	0.7	1.0	1.6	2.4	0.5	0.4	0.8	1.1	1.0	0.9	1.5	2.0	1.3	0.7	1.7	1.4	1.7	1.0	1.5	0.5	0.9	0.9	0.8	0.7	0.9	0.1	0.9	0.9	0.7	0.8	0.8	0.4	0.5	6.5	1.1	0.5	0.5	0.2	0.6	1.9	6.3	1.3	0.5	4.9	0.4	0.9	1.0	0.5	1.9	6.2	2.0	6.5	7.3	1.6	11.9	2.3	6.1	2.6	7.2	8.0	11.0	5.1	0.2	11.8	9.9	10.9	8.3	17.7	20.5	7.7	3.7	7.8	0.6	2.9	0.5	2.5	0.1	1.1	10.2	3.5	15.0	8.1	6.9	9.7	0.2	0.5	0.8	6.3	7.0	0.3	0.5	3.1	2.6	14.8	6.2	5.9	0.3	17.5	12.4	1.2	0.5	12.2	8.2	3.0	3.4	2.5	1.7	5.6	1.2	9.8	20.5	13.3	0.3	0.2	4.1	9.6	3.7	5.1	0.8	0.2	0.2	2.2	0.2	2.9	0.8	1.5	2.4	0.2	0.5	0.8	1.2	1.0	0.6	0.2	0.3	2.3	0.4	1.6	1.8	1.6	2.4	1.7	1.4	0.9	0.9	0.9	0.2	1.3	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0
ULK2	"ATG1B, KIAA0623, Unc51.2"	ENSG00000083290	"Unc-51 like autophagy activating kinase 2"	Q8IYT8	17	19770829-19867936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.0;Inhibitory neurons: 76.9;Late spermatids: 70.1;Oligodendrocytes: 94.6;Spermatocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;non-classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"SuSa: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037021	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB037021: AB_1841237"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.38e-2)"	10.5	6.9	14.3	4.6	19.8	3.0	7.8	16.9	14.9	10.0	9.7	10.8	3.0	9.3	6.4	6.3	10.8	7.4	8.3	14.9	12.1	6.5	3.4	8.4	4.8	22.1	18.8	11.4	7.5	13.3	5.3	8.1	20.7	8.0	4.2	9.4	5.9	9.8	15.2	7.5	4.7	9.5	18.3	7.1	7.5	33.8	16.6	3.9	6.4	14.7	3.7	9.0	8.5	26.5	12.7	13.1	18.0	2.4	10.2	19.3	0.0	10.3	12.8	10.6	9.8	0.2	2.6	0.0	5.4	13.4	12.0	5.8	0.0	2.1	9.9	10.6	13.2	0.3	5.2	0.0	13.1	0.0	6.3	12.5	15.6	5.4	4.4	9.3	7.6	0.0	0.0	0.0	8.1	3.4	0.0	0.5	2.7	0.2	3.3	0.8	0.0	0.0	7.3	5.3	4.6	18.7	16.4	2.0	5.2	43.7	12.6	4.5	12.0	0.0	1.5	3.7	6.3	0.0	0.0	0.0	1.6	0.0	3.8	0.0	0.9	0.2	0.2	4.0	0.1	0.0	0.5	0.5	0.8	0.0	0.8	0.5	0.2	0.2	3.4	0.0	0.1	0.3	14.3	19.8	16.9	14.9	14.9	12.1	22.1	18.8	20.7	18.3	16.6	26.5	8.9	19.2	14.1	32.3	1.8	7.4	4.7	3.2	6.8	16.1	9.5	8.1	10.9	4.3	6.1	7.3	8.4	7.7	4.4	1.4	3.9	3.1	34.2	19.6	15.3	5.3	2.4	6.7	62.0	3.4	2.8	12.0	6.6	11.3	0.0	18.0	3.6	1.7	8.5	15.2	76.9	3.9	4.1	20.5	5.1	70.1	14.0	9.1	8.8	41.2	12.3	6.1	7.2	35.2	94.6	2.5	2.4	12.4	2.1	7.5	1.0	5.4	10.0	12.7	13.1	11.5	12.7	58.2	22.1	8.6	9.7	2.9	4.7	6.6	2.9	3.8
ULK3	"DKFZP434C131, FLJ90566"	ENSG00000140474	"Unc-51 like kinase 3"	Q6PHR2	15	74836118-74843346	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 89.7;Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040474	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA040474: AB_2677003"	"unprognostic (3.67e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	7.1	15.2	29.5	6.4	31.5	2.2	6.1	28.1	32.2	13.6	23.0	12.1	5.0	4.4	3.5	35.7	5.5	4.5	15.9	29.4	27.3	17.6	13.8	8.3	5.8	34.0	26.6	5.7	12.0	16.2	12.5	3.5	35.8	9.9	9.4	15.4	11.5	3.1	21.0	24.7	15.7	4.4	26.1	13.1	10.6	7.1	27.8	6.3	7.6	19.0	7.8	9.4	15.4	30.4	6.7	17.7	7.4	14.4	9.3	6.7	6.0	5.1	7.3	10.1	11.1	7.0	15.4	13.0	8.8	6.2	10.8	4.7	23.1	7.6	4.4	26.1	26.1	30.3	25.0	7.4	14.8	10.3	22.5	9.4	14.0	8.2	7.1	3.5	15.8	16.8	10.3	11.9	7.0	9.4	7.3	6.6	10.0	10.6	8.7	18.6	10.3	23.0	6.0	7.4	16.7	22.3	8.6	9.8	25.6	9.1	11.0	26.8	9.4	16.0	8.9	12.7	10.3	20.7	19.7	9.3	7.4	29.5	12.4	5.2	3.5	1.4	10.9	7.3	8.7	3.3	6.4	9.0	3.7	2.8	7.1	4.8	0.8	5.8	6.1	4.0	9.2	5.1	29.5	31.5	28.1	32.2	29.4	27.3	34.0	26.6	35.8	26.1	27.8	30.4	16.5	9.6	15.3	37.2	11.4	10.1	7.5	6.0	10.2	89.7	18.1	13.6	17.1	14.3	6.7	12.9	16.7	9.2	23.3	46.4	19.6	11.0	1.0	8.9	8.8	10.7	11.4	14.1	64.7	11.7	2.5	9.2	23.4	11.9	21.0	6.2	13.2	13.3	16.1	89.2	56.5	17.5	4.1	7.9	8.2	2.2	13.1	11.2	5.4	18.7	13.2	18.4	29.9	16.6	15.3	12.3	17.9	11.7	8.6	10.4	68.5	16.5	8.0	54.5	0.0	12.9	8.8	9.5	17.3	19.7	21.7	5.7	19.7	12.3	27.9	8.9
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962130	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	2.7	3.1	1.6	2.9	2.1	8.5	2.5	0.4	1.7	8.5	16.9	1.6	1.2	6.6	4.5	1.5	9.0	1.9	8.6	2.3	2.5	3.9	2.1	3.5	3.0	6.9	7.6	2.1	2.0	8.0	2.9	2.7	3.9	2.2	1.7	6.0	1.7	2.4	0.4	2.1	2.0	3.5	5.6	2.0	2.4	23.4	2.5	3.0	4.9	0.4	2.7	1.9	3.7	2.1	8.3	2.9	2.8	3.8	1.1	1.7	4.8	2.7	2.7	3.2	3.0	1.0	2.3	9.5	1.6	6.3	3.5	4.1	3.7	2.1	2.9	1.5	1.0	2.1	5.7	3.3	4.1	6.5	1.8	1.6	2.3	16.1	3.2	4.4	2.2	6.4	2.1	7.5	2.3	6.4	8.1	4.9	3.4	2.1	3.4	1.7	9.1	4.5	7.2	7.6	1.6	10.3	3.1	1.3	2.8	1.8	3.1	2.0	6.6	2.0	2.4	14.2	2.5	4.5	9.0	3.9	11.5	6.3	2.5	3.7	3.7	4.0	5.0	4.3	4.1	3.7	5.3	4.5	3.3	4.7	4.0	5.7	6.6	1.8	2.3	3.3	7.7	3.0	1.6	2.1	0.4	1.7	2.3	2.5	6.9	7.6	3.9	5.6	2.5	2.1	6.4	9.6	6.9	84.9	11.2	2.0	3.0	4.0	5.2	5.6	5.7	4.6	14.8	4.3	5.1	3.7	54.2	3.1	9.9	2.0	0.0	3.4	352.3	45.3	27.4	6.0	1.8	2.1	108.6	2.4	4.1	8.7	10.2	7.5	1.3	49.6	1.8	6.6	7.3	11.8	99.2	1.2	2.0	3.1	4.0	405.2	6.5	6.9	0.0	80.6	5.9	10.4	3.1	49.8	62.0	3.0	0.7	4.1	5.1	0.9	1.1	5.9	47.3	26.7	6.6	4.4	10.5	38.9	9.6	3.3	3.7	4.2	10.8	3.6	1.9	1.2
UMAD1	"RPA3-AS1, RPA3OS"	ENSG00000219545	"UBAP1-MVB12-associated (UMA) domain containing 1"	C9J7I0	7	7640711-7968020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.7;Inhibitory neurons: 114.3;Microglial cells: 79.6;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044806	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044806: AB_10961141"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.08e-3)"	"unprognostic (9.24e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.73e-8)"	"unprognostic (6.66e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.58e-1)"	9.2	16.5	5.5	11.2	5.8	9.5	10.3	5.6	6.2	10.1	7.0	12.8	15.4	10.3	11.4	8.9	10.2	10.7	13.7	4.9	8.3	17.2	14.3	12.0	15.7	6.9	7.3	13.6	36.1	29.7	10.3	9.2	7.5	18.9	11.6	11.5	20.6	11.7	11.3	7.0	16.6	9.8	6.1	10.3	23.0	5.8	7.0	18.4	24.6	10.5	13.4	12.3	8.4	7.1	24.7	17.9	9.0	10.5	12.7	14.9	10.3	14.9	17.2	11.5	17.4	7.6	17.9	13.4	15.4	9.4	46.3	15.7	10.4	15.0	14.3	10.1	8.1	7.3	12.4	8.9	14.2	13.6	16.3	14.2	18.6	16.6	12.7	13.5	7.1	17.2	15.1	40.0	15.4	19.9	12.4	7.4	16.2	16.5	14.8	13.6	21.3	21.3	20.9	11.1	3.6	14.8	21.0	26.7	21.6	26.5	20.8	16.3	7.8	11.7	27.2	23.3	15.2	28.6	34.2	15.5	26.4	19.2	36.8	51.8	16.0	43.5	19.3	21.5	23.9	28.8	27.2	24.2	13.8	26.0	31.8	23.8	46.1	18.5	24.1	16.3	38.7	17.9	5.5	5.8	5.6	6.2	4.9	8.3	6.9	7.3	7.5	6.1	7.0	7.1	12.1	25.6	11.9	58.8	22.8	0.0	27.7	0.0	12.0	6.5	13.8	12.3	10.9	11.5	9.9	14.7	14.6	16.7	7.7	7.6	39.2	8.4	7.1	9.7	7.6	7.1	6.1	6.7	96.7	14.5	23.6	11.4	33.1	10.6	15.2	3.8	6.4	9.5	16.8	15.2	114.3	13.3	0.0	13.2	0.0	3.7	13.4	12.9	0.0	79.6	8.9	11.4	16.5	80.9	119.3	10.4	9.0	7.9	28.4	19.3	16.8	34.2	9.5	9.8	26.3	12.0	9.6	4.8	5.0	12.6	0.0	21.2	17.0	7.6	7.7	21.2
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333051-20356301	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	693	"kidney: 2277.8"	"Group enriched"	"Detected in some"	146	"Collecting duct cells: 248.3;Distal tubular cells: 950.9"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	NA	NA	55000000	66000000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2277.8	0.8	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	248.3	0.0	0.0	0.0	0.0	950.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UMODL1		ENSG00000177398	"Uromodulin like 1"	Q5DID0	21	42062959-42143453	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;fallopian tube: 1.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Early spermatids: 4.3;Endometrial ciliated cells: 3.9;Ionocytes: 2.0;Late spermatids: 2.4;Spermatocytes: 2.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.9"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067245	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA067245: AB_2685810"	"unprognostic (4.70e-3)"	"unprognostic (3.75e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.72e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.47e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.82e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-4)"	"unprognostic (2.68e-1)"	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	3.9	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	2.0	0.0	0.0	2.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730433-124749273	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA		9200	"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	1.3	1.4	2.5	1.2	2.5	1.3	1.8	2.8	2.9	1.0	1.1	2.3	2.0	1.3	1.0	2.0	1.8	0.7	0.8	2.6	1.8	1.8	2.6	0.9	1.4	2.8	2.1	1.9	2.1	1.5	0.8	0.7	2.3	1.4	1.6	1.8	1.3	0.7	3.1	2.3	2.1	1.1	2.0	2.6	1.8	0.9	2.3	1.8	1.1	0.7	1.7	0.8	1.0	3.5	1.4	4.4	5.1	2.1	2.9	3.4	5.4	7.9	2.4	3.1	2.6	3.8	2.1	4.0	8.2	3.0	7.9	9.0	7.1	2.4	5.0	4.4	4.2	8.2	3.0	2.7	2.6	8.7	6.0	3.8	2.3	1.8	3.9	1.9	1.2	8.2	3.7	1.9	2.3	3.5	10.8	1.7	12.1	3.9	2.7	7.4	6.0	3.3	2.4	2.5	4.0	2.6	11.3	4.2	4.3	3.7	4.1	3.1	15.4	2.5	5.2	7.4	3.2	8.0	12.5	12.1	2.8	3.4	2.6	5.9	10.3	5.5	14.0	11.3	12.4	17.0	9.2	12.1	14.6	24.3	13.9	10.8	0.7	12.8	9.3	11.0	12.4	11.9	2.5	2.5	2.8	2.9	2.6	1.8	2.8	2.1	2.3	2.0	2.3	3.5	9.6	6.4	11.5	6.5	11.2	15.8	24.5	41.3	18.8	8.3	8.9	12.3	6.2	20.0	22.8	9.2	4.2	66.8	13.2	9.0	29.4	29.8	3.2	10.9	18.2	15.2	9.6	16.2	11.0	30.5	35.0	12.7	14.3	12.1	12.0	22.8	7.9	31.4	22.0	5.0	12.0	10.3	20.3	7.0	5.9	4.4	13.7	8.3	3.6	10.3	18.0	11.0	13.4	15.6	12.2	23.4	8.6	13.9	10.4	14.6	14.0	25.9	22.1	9.1	13.1	13.3	17.1	23.2	32.1	20.6	19.0	109.2	11.0	29.5	17.8	21.1
UNC119	"HRG4, POC7, POC7A"	ENSG00000109103	"Unc-119 lipid binding chaperone"	Q13432	17	28546708-28552631	"Disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	20	"retina: 1168.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 671.1;Cone photoreceptor cells: 856.9;Muller glia cells: 301.5;Rod photoreceptor cells: 2038.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041912	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA041912: AB_10795267"	"unprognostic (8.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.95e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.76e-3)"	"prognostic favorable (8.09e-5)"	"unprognostic (2.65e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (9.82e-4)"	"unprognostic (1.71e-3)"	17.7	29.3	48.1	23.6	47.8	55.9	20.7	44.0	59.2	25.9	54.7	19.9	12.0	21.3	17.8	25.3	19.1	14.3	24.5	49.7	49.5	36.6	32.9	21.1	29.7	49.3	45.9	21.3	24.5	22.2	28.8	11.0	49.7	29.8	10.9	1168.7	26.7	20.1	6.1	32.6	26.0	13.7	43.9	55.5	20.3	53.1	51.4	17.5	23.1	6.2	29.6	22.9	25.9	45.6	24.9	30.7	30.0	42.0	31.1	30.2	14.7	20.0	27.4	35.7	33.4	42.7	8.1	20.2	21.2	30.9	24.5	39.7	25.6	29.8	19.0	37.6	47.8	14.0	15.5	13.2	21.3	20.9	42.1	27.8	40.4	25.7	12.7	33.4	28.9	21.5	14.6	16.3	22.1	39.1	20.8	20.8	29.3	21.0	21.9	32.8	49.2	9.0	27.2	27.2	11.7	41.1	28.8	46.4	31.1	34.5	36.7	35.7	22.1	20.4	38.5	33.3	19.8	18.6	20.7	4.6	33.7	33.5	19.1	21.6	48.7	120.2	8.9	122.1	8.9	29.1	16.9	13.7	82.3	42.6	18.7	13.4	131.5	18.2	212.4	93.4	16.5	36.3	48.1	47.8	44.0	59.2	49.7	49.5	49.3	45.9	49.7	43.9	51.4	45.6	10.4	0.0	5.4	5.2	34.5	13.4	16.3	38.8	34.1	671.1	25.2	33.8	12.6	18.6	17.9	12.9	856.9	25.3	48.7	22.9	33.2	20.4	3.0	5.5	8.4	24.0	25.3	4.8	8.8	18.3	9.0	13.6	11.2	7.8	12.7	14.1	8.9	13.8	34.6	146.4	11.3	14.3	34.6	41.0	89.8	6.6	14.6	44.6	19.6	4.7	56.8	301.5	59.8	4.5	1.2	17.8	16.4	21.4	19.6	22.1	23.8	20.6	6.7	2038.5	46.0	6.6	15.8	1.5	16.6	20.6	14.3	20.0	25.3	14.1	13.7	18.9
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710458-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077812	Enhanced					NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	14.6	34.8	21.6	10.6	20.9	12.2	17.8	18.6	18.2	16.1	28.1	14.1	9.3	20.0	15.7	11.9	47.1	9.9	11.3	19.8	26.7	29.7	10.8	15.4	11.1	26.6	26.2	35.7	18.4	40.2	26.0	11.4	22.0	18.8	13.1	20.1	13.0	24.8	7.9	15.1	13.1	18.9	25.3	14.6	17.0	18.4	30.1	22.3	31.3	11.2	15.7	11.3	10.0	19.2	27.0	25.8	52.3	45.0	51.2	37.8	44.3	32.7	38.0	36.5	16.3	31.1	10.9	27.1	12.7	36.8	17.5	28.1	55.9	36.6	37.4	21.2	28.3	12.5	19.5	19.4	34.6	34.9	19.1	29.9	37.1	27.2	41.6	58.7	41.7	40.3	31.1	2.9	31.1	23.7	32.2	28.5	64.8	30.6	31.5	38.0	34.8	14.0	43.3	55.7	31.4	39.5	78.5	15.3	27.5	36.7	60.2	23.6	26.2	33.7	22.9	14.6	22.3	21.1	19.7	16.6	40.1	17.4	37.4	0.0	0.4	0.5	1.3	0.2	0.7	0.6	1.1	1.4	0.5	0.7	1.5	1.2	0.8	1.1	2.7	1.0	1.2	0.6	21.6	20.9	18.6	18.2	19.8	26.7	26.6	26.2	22.0	25.3	30.1	19.2	10.1	3.2	7.5	7.8	3.4	2.9	7.6	5.8	6.8	8.1	11.9	11.7	4.6	7.2	5.9	18.4	10.4	11.4	6.3	7.0	15.6	7.1	17.2	30.7	9.6	9.9	14.3	8.2	6.8	7.7	5.3	7.3	1.1	7.2	2.5	8.3	6.1	6.0	3.0	8.4	8.6	5.3	4.1	3.8	1.4	4.0	13.1	3.3	5.4	7.5	3.3	12.8	1.0	4.5	4.7	8.6	4.5	16.1	3.5	11.4	4.8	14.0	33.0	10.4	13.1	7.6	7.3	15.6	13.6	6.3	3.3	5.2	5.9	9.0	8.0	8.1
UNC13B	"hmunc13, Munc13-2, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	12.6	12.8	10.5	5.6	13.3	1.0	10.3	6.6	14.5	12.5	15.7	22.2	11.6	10.1	7.7	17.5	10.4	11.5	13.6	11.4	7.2	21.8	12.8	38.9	1.8	8.3	9.5	7.3	21.3	15.0	11.5	6.0	7.8	22.6	25.0	41.2	17.8	23.3	24.2	12.3	13.4	11.9	7.3	4.7	17.9	15.6	10.6	3.0	12.2	10.4	5.0	10.2	12.7	9.0	9.8	12.8	13.9	22.6	26.3	14.6	11.8	15.7	7.1	11.4	15.3	10.7	4.5	0.0	7.0	20.6	20.1	4.7	35.4	18.2	14.5	0.0	11.3	5.9	36.6	13.9	12.7	2.2	6.4	11.6	14.0	18.0	18.5	18.2	37.3	15.8	13.5	8.1	13.5	7.5	2.1	0.2	12.6	30.2	13.3	0.1	8.6	3.4	15.5	12.6	14.9	15.7	11.0	6.8	11.4	23.0	11.6	7.5	34.5	7.8	7.2	12.3	12.2	12.7	16.2	0.0	8.5	18.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	13.3	6.6	14.5	11.4	7.2	8.3	9.5	7.8	7.3	10.6	9.0	6.7	57.7	80.7	28.7	0.8	3.1	1.1	2.1	3.4	42.3	7.3	4.4	11.4	18.6	16.7	9.2	95.9	3.7	0.1	24.4	3.9	6.0	6.9	8.2	5.1	8.5	24.6	1.7	60.4	12.2	2.1	4.8	16.3	13.9	2.5	8.7	5.7	12.5	4.9	6.7	17.7	31.9	0.0	2.4	3.0	12.3	2.1	3.7	7.2	73.1	0.1	5.7	0.0	42.3	36.7	7.8	11.9	3.0	4.2	11.7	10.5	7.8	10.0	40.8	6.6	8.4	6.5	8.7	7.5	14.3	7.4	2.9	1.0	5.7	19.5	5.7
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844552	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.9;lymphoid tissue: 66.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.0"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		1500000	"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	7.7	7.3	5.6	23.5	6.8	58.9	7.8	5.8	7.3	18.6	5.0	10.7	8.0	8.6	2.0	23.6	13.8	6.5	14.3	5.0	5.6	6.6	12.6	38.1	25.9	7.9	6.5	19.3	8.8	0.5	11.6	9.0	7.5	8.1	4.5	5.5	7.7	5.1	8.5	6.0	18.5	4.9	6.2	66.2	13.8	6.1	8.2	20.7	5.9	1.5	17.6	10.7	19.6	8.7	44.0	18.7	0.4	0.3	0.5	1.0	47.6	0.1	0.0	0.0	0.1	41.4	97.0	3.4	46.4	0.0	7.5	15.4	0.0	2.2	0.0	0.4	0.5	245.7	136.3	24.2	3.9	94.1	245.9	0.6	2.0	0.5	2.1	2.3	17.9	42.5	87.1	1.1	0.0	71.2	100.9	50.8	0.9	69.9	1.7	32.8	1.0	1.5	1.6	17.7	0.3	66.7	19.2	189.7	0.9	0.5	47.1	56.5	48.1	0.8	65.9	0.5	0.5	1.3	5.9	4.0	0.6	31.3	0.2	59.1	16.0	31.2	19.3	16.9	17.4	6.7	11.4	13.6	12.3	3.6	8.8	11.9	40.1	14.7	25.6	7.2	10.8	18.1	5.6	6.8	5.8	7.3	5.0	5.6	7.9	6.5	7.5	6.2	8.2	8.7	3.8	44.8	8.3	6.8	16.6	1.1	1.7	1.0	0.6	12.0	4.9	2.4	68.3	7.2	4.4	3.7	20.9	4.7	27.0	40.9	0.0	7.2	5.3	1.3	3.3	6.6	6.0	14.9	1.2	6.0	11.6	2.2	2.0	2.3	45.0	9.9	7.9	1.2	58.5	5.0	1.5	3.6	2.0	21.6	8.2	0.5	2.8	22.2	1.8	5.6	22.5	4.5	61.8	3.0	7.9	47.3	30.7	1.5	27.4	1.6	5.5	0.7	1.6	16.2	0.0	4.5	2.6	1.2	1.4	1.5	1.4	25.9	30.9	2.0	6.3	2.3
UNC45A	"GC-UNC45, SMAP-1"	ENSG00000140553	"Unc-45 myosin chaperone A"	Q9H3U1	15	90930180-90954093	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039228	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"	Cytosol	"HPA039228: AB_2676402"	"unprognostic (1.46e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (7.46e-7)"	"unprognostic (9.30e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-2)"	25.0	25.3	7.7	16.7	8.2	17.3	23.2	8.6	9.1	32.0	10.0	41.2	16.4	38.1	11.0	31.4	28.4	17.3	15.9	7.8	7.7	18.9	13.0	20.2	18.9	8.9	11.6	26.1	22.3	33.2	17.5	19.6	9.5	25.2	13.4	5.6	25.8	34.1	9.6	37.7	23.5	28.0	8.3	19.7	28.5	13.1	9.6	18.0	19.5	10.6	17.3	39.3	29.4	8.0	38.2	76.3	30.9	27.2	83.0	38.0	27.3	42.4	36.2	56.5	45.1	61.3	49.4	44.7	55.5	53.8	32.5	82.1	52.9	54.4	26.6	49.8	75.9	86.2	77.0	44.4	46.8	21.5	56.2	47.3	65.8	55.7	40.5	54.2	77.5	35.1	38.6	35.8	43.3	62.2	28.1	18.6	41.8	69.5	38.0	54.8	46.9	48.1	38.4	89.2	43.1	39.4	57.1	55.9	54.3	36.8	50.8	44.3	77.0	48.0	34.1	40.4	45.0	33.6	50.5	21.1	46.6	49.7	49.8	11.5	8.3	5.0	11.8	7.3	11.3	7.9	9.6	9.1	10.4	6.3	7.8	7.4	1.6	9.8	11.6	9.1	9.3	9.8	7.7	8.2	8.6	9.1	7.8	7.7	8.9	11.6	9.5	8.3	9.6	8.0	21.7	22.4	22.4	9.4	23.2	16.3	24.8	26.1	30.1	27.2	17.2	19.6	12.7	35.8	23.8	18.4	18.8	53.6	17.5	26.9	13.7	33.6	26.7	12.8	20.3	25.3	37.0	25.2	19.1	18.2	22.7	23.7	26.5	22.1	29.2	30.9	18.9	13.4	28.2	18.5	18.4	15.9	26.4	12.2	14.0	29.0	29.5	20.7	19.6	9.4	28.8	21.5	27.8	7.1	11.0	23.3	26.0	51.6	20.6	16.8	22.0	19.6	11.7	35.1	32.9	15.2	33.9	24.8	6.4	33.9	18.8	46.2	21.4	26.0	22.7	20.3
UNC50	"GMH1, UNCL, URP"	ENSG00000115446	"Unc-50 inner nuclear membrane RNA binding protein"	Q53HI1	2	98608579-98618515	"Predicted membrane proteins"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 215.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027009	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA027009: AB_1858620"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.38e-1)"	"unprognostic (7.12e-3)"	"unprognostic (4.82e-3)"	36.6	49.1	46.3	34.2	48.2	36.8	45.8	48.8	57.3	38.1	53.6	35.0	37.9	46.3	69.2	30.9	42.7	36.2	38.7	46.2	48.3	52.5	46.9	38.6	41.4	48.5	46.6	44.2	42.0	82.4	41.4	52.2	49.1	41.3	43.2	60.0	56.0	45.4	31.6	39.9	34.4	38.7	49.0	39.3	45.5	48.9	47.2	36.6	64.1	35.9	42.6	37.8	30.5	54.3	55.2	35.6	65.2	44.3	95.7	82.6	73.0	51.2	71.8	61.9	54.2	54.5	64.0	16.6	75.2	44.1	94.0	52.0	45.9	41.5	50.9	56.4	46.2	37.5	47.3	89.4	103.0	71.7	56.7	54.6	92.5	33.1	60.4	71.5	55.1	43.3	61.2	50.2	63.5	39.2	31.7	80.3	49.6	46.1	41.7	20.1	47.3	58.8	68.9	48.6	24.2	35.6	35.9	47.3	86.5	75.8	40.7	91.9	42.7	67.4	41.3	34.5	35.0	76.1	63.2	44.2	63.6	51.7	60.1	61.6	54.3	66.7	50.6	54.9	43.9	52.8	42.2	47.9	54.9	48.1	46.2	52.9	45.3	58.5	51.4	51.3	37.4	44.2	46.3	48.2	48.8	57.3	46.2	48.3	48.5	46.6	49.1	49.0	47.2	54.3	45.3	25.6	31.0	13.7	35.7	47.2	51.2	139.4	42.7	36.7	46.7	40.8	39.5	38.6	85.8	35.0	16.7	118.6	41.2	27.4	33.2	52.3	47.7	38.3	35.3	48.3	21.6	19.1	21.2	53.2	77.1	58.9	19.4	30.7	27.3	23.7	47.2	33.9	73.2	33.7	24.1	34.1	85.5	31.3	33.3	29.9	54.7	33.0	44.4	19.7	41.7	84.6	48.4	19.1	25.8	40.7	33.0	74.9	51.0	75.7	29.0	46.6	73.8	49.8	46.0	45.0	58.9	215.1	58.7	34.6	49.7	152.6	29.2	39.1	30.1	44.6
UNC5B	"p53RDL1, UNC5H2"	ENSG00000107731	"Unc-5 netrin receptor B"	Q8IZJ1	10	71212570-71302864	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 112.7;Muller glia cells: 54.1;Oligodendrocytes: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.2;HHSteC: 146.3;hTCEpi: 132.1;SH-SY5Y: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076687	Approved					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA076687: "	"unprognostic (3.98e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (8.82e-3)"	"unprognostic (6.79e-3)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (7.70e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.25e-1)"	3.2	10.2	17.5	4.0	28.4	0.1	2.3	26.8	19.2	6.0	15.4	7.2	2.6	5.9	6.0	18.6	7.4	8.8	15.6	15.1	17.3	7.9	2.4	9.5	3.5	34.1	28.8	3.6	4.3	2.2	5.8	5.0	25.3	9.8	4.9	7.8	5.3	27.0	2.6	8.0	5.2	4.4	19.1	7.8	8.7	5.6	32.3	2.9	3.7	4.1	2.9	9.0	12.2	48.3	0.0	0.2	0.8	3.9	11.6	18.9	0.3	6.6	19.3	0.2	0.6	3.8	17.9	0.0	6.7	41.6	0.4	46.2	1.4	2.7	0.0	0.1	4.3	10.7	0.7	0.2	146.3	0.2	1.1	16.4	132.1	1.6	8.4	1.7	2.8	0.2	0.4	0.1	0.2	1.5	0.0	0.0	10.3	9.6	0.3	0.0	4.5	0.1	0.1	20.5	20.3	123.7	1.4	1.6	1.0	18.2	1.9	0.6	8.0	1.4	5.9	2.5	2.7	0.0	0.0	0.0	42.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	28.4	26.8	19.2	15.1	17.3	34.1	28.8	25.3	19.1	32.3	48.3	18.6	0.0	3.3	5.5	0.0	3.1	19.3	21.8	2.8	13.1	1.6	3.0	7.6	0.0	11.3	5.5	0.0	0.4	0.0	34.3	0.0	5.7	0.4	12.7	4.8	22.7	3.0	0.0	8.9	1.6	0.4	6.5	12.2	25.8	22.9	27.0	7.5	0.0	1.2	112.7	11.3	6.3	32.6	8.5	2.4	1.0	0.6	5.9	1.8	29.0	0.6	54.1	0.0	11.6	89.0	12.1	20.1	0.7	0.0	14.7	8.1	0.2	14.4	3.5	0.0	2.7	12.7	0.8	5.4	20.3	4.3	0.3	0.8	0.7	4.7	44.8
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026895-41039221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 44.8;RPTEC TERT1: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	1.2	1.0	1.3	1.0	1.6	0.9	1.6	1.3	1.7	1.5	1.2	3.1	37.1	1.1	0.3	1.3	1.9	9.2	1.2	1.3	1.3	58.6	52.8	2.1	1.0	1.7	1.4	1.5	36.2	0.3	0.8	0.4	1.6	1.5	1.3	0.8	1.7	0.6	0.7	1.9	29.4	0.4	1.4	3.3	23.6	2.2	1.5	2.7	1.6	0.2	0.7	1.1	1.1	2.3	0.5	0.2	0.6	0.9	0.2	0.1	0.6	0.0	0.1	0.0	0.0	7.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.2	0.1	1.1	1.3	0.6	0.0	3.8	0.1	0.3	0.2	0.1	0.6	0.0	0.4	0.1	0.0	2.8	0.5	0.4	0.0	0.1	0.9	2.3	0.2	44.8	0.2	0.9	0.1	0.5	13.0	0.0	0.6	0.6	0.0	0.0	1.3	0.7	0.1	0.2	0.2	0.0	0.4	0.3	0.1	4.3	2.3	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	1.6	1.3	1.7	1.3	1.3	1.7	1.4	1.6	1.4	1.5	2.3	0.3	3.2	1.1	4.2	1.3	0.8	0.6	0.4	0.6	0.6	1.0	1.0	0.8	30.0	0.3	22.0	4.2	0.4	1.8	2.3	3.9	25.7	2.4	0.6	0.3	0.4	1.2	0.4	0.3	68.6	0.8	0.5	36.7	1.6	0.0	0.3	1.4	30.0	0.3	1.7	0.2	5.0	0.0	0.8	0.3	0.4	0.3	0.8	1.8	0.0	0.8	0.2	2.1	0.0	3.5	19.8	3.1	0.7	0.3	0.6	37.3	41.8	0.9	0.3	0.0	0.3	0.4	0.9	0.8	0.5	0.1	0.8	1.0	0.1	5.4	0.4
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235475-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.8;intestine: 6.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 638.7;Inhibitory neurons: 768.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4;renal cancer: 1.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.8;thalamus: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;HeLa: 2.9;NTERA-2: 8.6;SH-SY5Y: 2.9;SuSa: 2.8;U-251 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.0	1.7	1.7	0.0	2.4	0.0	0.0	0.0	3.1	2.3	0.0	0.3	6.0	1.7	0.0	0.0	0.1	0.0	0.0	2.4	19.8	2.1	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.1	3.3	0.0	0.0	4.8	0.5	4.9	0.0	0.2	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	7.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.5	0.2	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	0.0	3.1	2.4	19.8	0.4	1.6	0.0	0.0	7.0	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.1	0.1	0.0	0.0	638.7	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	40.4	768.3	0.7	0.0	0.0	0.0	4.4	0.0	0.0	0.0	42.2	0.0	1.8	0.0	43.2	10.2	0.0	0.0	0.0	0.0	1.8	2.0	0.6	0.0	2.6	0.0	0.0	0.7	0.7	1.2	0.1	0.1	0.0	0.0	0.0	2.6	0.0
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316014	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 5.1;intestine: 9.6;liver: 14.1;skin 1: 19.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.2	9.6	0.2	0.5	5.1	1.1	0.8	0.0	0.0	0.0	1.1	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	19.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	6.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991100-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	18.7	17.7	4.9	19.9	5.6	19.9	15.4	5.0	7.5	19.0	6.4	20.2	22.5	7.7	0.8	20.5	15.7	9.8	7.3	4.9	5.0	16.4	15.3	29.5	29.5	10.7	6.5	6.2	17.1	2.6	6.7	6.4	8.1	16.4	3.1	0.1	27.9	8.8	3.5	16.3	35.8	3.1	7.9	76.7	20.6	1.7	6.8	3.5	14.8	1.5	7.3	20.6	15.0	10.2	18.9	34.1	2.5	13.8	7.2	2.7	28.2	8.3	7.7	13.0	11.8	2.8	128.9	40.9	30.8	4.0	11.0	44.9	1.0	7.0	0.4	14.1	9.3	4.2	11.1	6.4	11.2	30.0	22.7	6.0	7.6	3.8	1.5	5.0	2.6	6.4	3.0	19.3	2.0	18.7	0.2	23.9	6.2	46.8	16.7	24.5	0.0	368.2	11.8	10.7	3.9	5.5	14.0	95.6	19.3	1.0	35.4	39.0	9.2	8.6	12.2	12.8	0.8	13.2	18.8	7.0	16.0	30.7	10.5	0.1	3.8	6.6	0.1	7.2	0.2	2.5	0.2	0.2	5.1	2.7	0.0	0.0	3.2	2.1	7.7	14.8	0.0	1.2	4.9	5.6	5.0	7.5	4.9	5.0	10.7	6.5	8.1	7.9	6.8	10.2	12.5	9.6	9.1	4.6	45.3	4.0	21.9	12.5	9.1	0.0	16.4	13.1	1.8	40.0	21.0	16.5	0.0	10.3	63.3	23.2	1.9	36.8	0.8	32.0	5.9	10.0	4.2	3.0	1.1	23.4	47.8	8.0	20.9	17.2	7.0	9.3	10.0	5.4	96.2	5.0	0.1	17.2	14.2	78.3	28.4	0.1	4.4	85.3	23.2	13.1	57.5	4.7	8.2	0.0	0.7	49.7	25.6	4.1	33.8	27.0	31.7	6.9	57.3	0.5	0.0	8.3	9.8	0.2	1.1	12.9	6.5	7.3	10.5	2.1	23.1	37.7
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
UNK	"KIAA1753, ZC3H5, ZC3HDC5"	ENSG00000132478	"Unk zinc finger"	Q9C0B0	17	75784806-75825799	"Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.3;Spermatocytes: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023636, HPA027962"	Uncertain		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"		"HPA023636: AB_10601774, HPA027962: AB_10611522"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.04e-3)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.73e-2)"	"unprognostic (9.78e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-2)"	12.0	11.7	8.5	8.6	9.1	8.4	13.6	9.5	9.6	20.9	9.6	12.7	6.8	18.2	4.0	13.7	17.5	5.3	10.5	7.4	7.8	15.1	12.8	10.1	10.6	9.4	8.8	22.1	14.8	9.8	20.1	5.8	8.1	16.0	3.4	5.6	14.2	6.4	9.1	18.4	14.1	4.7	7.4	21.2	11.4	9.3	10.0	10.1	16.9	4.2	5.2	14.0	15.3	13.0	9.3	14.7	16.0	13.6	5.0	4.6	13.0	6.1	6.6	6.7	8.2	5.4	10.5	19.8	5.2	6.6	11.1	8.4	8.1	7.3	3.1	10.3	26.6	12.4	12.8	11.6	6.7	9.6	15.2	9.1	4.4	5.8	6.2	7.6	8.9	14.0	6.5	9.6	5.4	18.6	21.4	13.2	6.9	6.5	9.6	22.4	16.0	10.1	6.3	9.8	14.7	28.8	7.9	11.0	22.0	8.0	13.4	14.7	6.5	15.9	8.6	7.1	7.9	16.4	5.1	11.0	11.5	6.1	10.0	0.0	0.2	0.1	0.5	0.1	0.4	0.2	0.2	0.3	0.1	0.7	0.4	0.4	0.0	0.2	0.2	0.4	0.3	0.4	8.5	9.1	9.5	9.6	7.4	7.8	9.4	8.8	8.1	7.4	10.0	13.0	12.7	16.0	17.0	33.6	25.4	15.2	17.3	19.3	10.2	26.4	16.5	14.7	11.2	11.5	21.3	3.7	14.6	9.1	18.9	11.4	3.9	15.3	130.3	14.7	11.8	13.3	16.8	10.9	15.4	22.9	15.8	14.1	15.8	9.1	19.0	15.6	7.9	6.0	14.3	21.9	21.1	13.3	38.7	10.8	14.3	22.6	19.0	10.1	26.6	28.1	10.8	22.5	18.6	27.2	26.0	21.3	12.7	10.5	24.4	12.9	7.0	6.1	24.0	24.4	19.7	15.1	15.5	120.5	73.5	13.0	21.9	17.2	19.1	10.5	14.0	13.9
UNKL	"C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L"	ENSG00000059145	"Unk like zinc finger"	Q9H9P5	16	1363205-1414751	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055801, HPA073949"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA055801: AB_2682926, HPA073949: AB_2686647"	"unprognostic (5.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	6.9	7.5	4.5	4.0	3.1	5.6	7.3	9.0	8.3	7.5	0.5	6.5	4.1	8.9	0.7	4.4	8.4	1.8	4.4	4.6	3.5	3.9	4.3	5.3	4.3	8.8	5.4	10.7	4.2	2.0	5.1	3.0	8.9	7.0	1.4	2.6	6.9	3.0	11.5	7.6	7.4	1.7	2.2	8.2	5.6	6.6	6.3	5.4	7.9	2.3	2.8	7.3	6.2	5.2	4.7	12.3	2.8	7.2	2.1	2.6	21.5	12.0	3.6	3.2	2.8	10.1	10.7	1.8	24.4	4.1	5.5	8.6	3.6	1.3	2.2	22.0	10.4	3.7	14.8	8.3	1.6	2.1	7.5	3.4	1.6	5.1	2.1	3.8	5.7	5.4	10.6	6.5	1.5	7.4	5.5	6.0	7.8	2.0	13.4	14.7	3.2	13.7	2.0	1.3	9.4	5.6	7.1	4.4	1.3	2.0	7.1	3.4	6.9	7.1	10.9	6.1	5.1	14.2	8.0	8.4	5.7	4.2	8.3	3.5	1.1	2.7	2.1	0.4	1.0	0.7	0.7	0.5	0.4	0.9	1.5	0.7	4.1	1.4	0.4	1.8	0.9	0.7	4.5	3.1	9.0	8.3	4.6	3.5	8.8	5.4	8.9	2.2	6.3	5.2	7.6	6.4	7.5	18.3	16.0	5.5	6.2	5.0	3.4	30.0	8.1	9.5	2.7	7.2	8.3	5.5	14.6	12.8	16.2	5.3	1.9	5.4	5.7	4.9	6.4	8.9	3.6	6.1	13.3	3.0	6.6	8.7	6.6	7.0	5.1	20.6	12.5	6.8	4.1	6.7	15.7	6.5	6.1	7.3	3.8	20.8	16.4	6.2	7.2	9.4	13.9	16.6	23.7	13.0	17.2	7.3	11.3	15.4	17.1	22.7	11.5	2.0	8.0	37.3	6.6	12.5	8.3	14.2	20.0	4.5	8.2	20.5	11.8	9.4	4.9	11.7
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 216.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 146.5;Proximal tubular cells: 68.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	14	"basophil: 2.1;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	7	"CACO-2: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		1400000	"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.2	0.2	0.2	0.2	0.6	2.0	0.1	0.7	1.8	0.2	0.2	0.2	1.2	0.2	0.2	0.1	0.3	0.1	1.9	0.2	0.0	25.7	216.0	0.8	0.2	0.1	0.1	0.2	0.1	0.0	0.4	0.0	0.4	0.3	0.1	1.1	0.1	0.1	0.5	0.9	0.4	0.1	0.0	0.8	0.2	3.0	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.7	1.8	0.2	0.0	0.1	0.1	0.4	0.0	0.4	0.1	0.8	0.0	2.0	0.3	0.6	0.6	1.3	0.1	0.0	4.0	0.3	0.3	2.4	4.3	0.0	1.8	10.4	0.1	0.1	0.0	11.7	0.1	1.2	0.2	0.6	1.9	2.4	5.3	0.7	0.4	0.1	1.4	0.0	0.5	0.0	0.6	3.6	146.5	0.1	0.0	1.2	0.0	0.0	5.1	2.7	1.4	0.3	1.0	0.0	0.0	21.3	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.7	1.2	0.0	68.5	0.0	1.8	0.0	2.7	3.7	12.8	6.8	0.0	1.1	0.3	0.9	0.2	0.1	1.1
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1 RNA helicase and ATPase"	Q92900	19	18831959-18868230	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		19000	"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favorable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.7	21.2	11.6	22.2	13.2	26.1	21.2	13.9	14.3	23.4	8.9	23.2	21.6	24.4	8.1	24.1	20.6	17.7	17.5	11.8	11.6	16.3	17.3	21.6	25.8	15.8	12.7	22.5	42.2	35.1	18.6	22.3	11.4	21.1	10.7	10.1	36.7	22.3	31.3	29.3	21.7	13.8	13.3	24.8	23.8	30.9	12.6	27.0	23.0	19.6	16.5	23.5	23.1	15.3	61.2	39.8	27.4	32.8	41.5	27.1	89.7	50.6	31.1	48.0	37.4	76.9	54.0	54.5	65.4	32.0	25.5	60.0	38.7	55.2	18.2	29.2	76.5	59.9	37.2	49.8	35.7	67.2	34.7	30.3	39.3	37.4	40.3	27.5	30.8	46.6	76.6	51.4	25.8	66.5	78.5	42.2	45.7	42.2	96.0	62.1	44.2	51.4	21.1	54.3	57.8	44.6	46.4	52.2	27.3	21.8	31.4	42.7	43.9	42.6	29.6	52.8	57.3	33.0	27.4	83.7	30.3	64.0	48.0	0.0	0.6	1.1	0.2	0.3	0.2	0.1	0.3	0.0	0.4	0.3	0.2	0.1	1.7	1.0	0.8	0.2	0.2	0.3	11.6	13.2	13.9	14.3	11.8	11.6	15.8	12.7	11.4	13.3	12.6	15.3	24.2	22.4	13.6	10.1	14.8	15.7	13.3	10.0	10.2	30.8	24.7	24.5	14.5	12.8	11.0	27.6	14.6	16.4	18.7	32.5	0.0	11.1	13.5	46.5	27.8	19.4	21.6	8.8	9.9	9.8	13.7	15.8	29.0	65.9	0.0	24.4	13.9	24.1	14.4	37.0	9.5	27.4	10.2	19.1	12.2	7.9	14.6	19.5	12.4	10.3	11.8	19.5	13.4	9.0	11.4	16.6	16.6	19.2	18.9	22.2	17.5	10.5	29.0	18.5	13.1	15.6	15.0	26.8	18.4	20.1	18.6	20.5	16.5	20.5	22.8	27.2
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281601-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	17.5	20.0	13.7	15.1	14.6	18.0	16.4	19.6	19.7	17.6	10.2	17.4	18.1	18.7	8.3	13.3	18.4	11.7	12.9	12.9	16.9	14.5	10.3	12.1	17.0	16.4	14.6	15.5	19.7	13.7	17.1	11.2	17.3	16.4	11.1	11.6	16.5	14.5	23.8	15.6	15.9	11.3	13.2	16.3	16.7	46.3	14.3	17.9	30.2	7.5	10.8	15.4	14.3	17.5	55.9	15.9	35.3	31.7	16.4	28.1	22.3	42.0	30.0	26.4	29.1	24.4	19.4	54.0	11.9	19.6	17.8	29.3	17.2	14.1	32.6	39.8	33.7	47.0	50.9	27.1	28.3	81.7	20.3	19.1	28.1	17.8	20.5	27.7	21.2	14.0	29.0	24.7	26.6	16.7	33.8	22.1	46.7	36.8	15.9	43.2	19.8	31.7	23.4	17.5	39.1	43.3	33.6	51.3	31.3	23.6	37.6	72.7	27.5	27.8	46.0	15.5	26.6	53.4	39.3	74.5	51.7	46.7	23.3	3.0	5.6	4.8	6.8	4.7	5.2	13.2	7.0	7.2	6.5	9.7	7.1	6.7	0.9	11.9	6.1	16.9	10.8	4.3	13.7	14.6	19.6	19.7	12.9	16.9	16.4	14.6	17.3	13.2	14.3	17.5	104.8	67.3	61.5	88.5	64.2	68.7	57.8	57.2	76.8	85.3	80.6	84.3	22.8	52.9	60.8	58.8	83.4	65.0	75.3	32.1	103.7	54.3	205.8	148.7	101.2	78.1	57.5	51.9	84.7	71.2	45.2	69.7	42.8	65.4	55.6	57.7	63.9	72.6	45.7	79.1	114.7	50.5	79.3	44.9	46.1	96.8	100.6	53.8	55.2	59.0	51.1	74.2	83.4	188.5	130.9	52.6	34.0	87.6	81.1	59.1	36.0	69.8	96.0	72.3	85.5	77.5	56.4	480.3	172.4	82.4	71.9	40.5	64.3	111.8	62.2	46.7
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.2;urinary bladder: 205.7;vagina: 52.4"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.3	0.1	0.3	0.5	0.4	31.8	0.2	0.1	0.0	0.0	0.0	43.2	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.2	6.8	0.0	0.1	4.2	0.2	0.1	20.7	0.1	0.0	0.1	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	205.7	52.4	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.3	0.2	0.3	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205143	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 33.8;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 147.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA031799, HPA031800"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	10.2	0.0	0.4	0.1	1.6	0.2	0.2	0.3	0.6	4.8	0.0	0.0	0.1	0.5	0.0	3.5	7.9	8.0	1.8	0.4	0.0	10.2	0.1	1.2	0.0	0.1	0.0	0.0	6.5	0.0	0.2	7.6	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	33.8	0.6	0.0	3.7	0.0	0.2	17.0	88.8	1.4	0.3	0.1	17.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	40.6	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	36.5	147.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.3	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	1.5	0.0	0.2	0.3	0.6	32.2	0.0	0.5	0.2	0.4	0.5	24.3	198.3	0.0	0.0	3.5	0.4	0.1	0.0	15.6	3.5	25.1	9.4	0.9	0.0	0.0	1.9	0.7	11.1	4.0	11.2	80.9	2.5	0.5	0.0	0.5	0.5	1.7	1.2	0.2	24.4	0.3	3.1	1.5	0.0	1.1	1.8	0.0	1.1	0.2	0.0	0.5	0.5	0.8	0.2	0.0	0.4	0.9	0.2	10.9	27.8	1.2	0.0	0.5	4.6	0.2	0.5	0.3	0.0	1.5	0.7	0.1	0.0	46.3
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"urinary bladder: 70.1"	"Group enriched"	"Detected in some"	7	"Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 144.4;RT4: 160.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.2	70.1	2.4	0.2	4.0	0.4	0.1	0.4	0.0	0.1	26.2	0.0	0.0	0.0	0.1	0.2	9.0	0.0	0.2	0.4	0.2	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	144.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	160.9	0.0	0.1	0.3	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.9	0.0	0.4	0.6	1.0	0.0	0.0	3.2	0.0	0.0	10.5	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.5	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	9.6	0.1	0.4	0.0	6.9
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 120.6;esophagus: 64.8;lung: 50.0;urinary bladder: 42.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	120.6	0.7	0.1	0.1	0.4	0.1	1.4	0.0	0.4	8.0	1.0	1.2	0.0	0.7	0.2	64.8	10.0	0.1	10.6	0.0	0.2	0.6	1.0	50.0	0.1	0.1	0.2	6.9	1.3	0.0	1.7	0.0	0.2	2.7	0.0	0.2	8.3	0.0	0.5	4.1	0.9	0.0	0.0	2.1	2.9	4.2	0.7	0.0	1.4	0.0	1.8	42.2	12.1	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.2	0.0	0.7	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
UPK3BL1	"UPK3BL, UPLP"	ENSG00000267368	"Uroplakin 3B like 1"	B0FP48	7	102637025-102642791	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 272.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.7;Club cells: 3.1;granulocytes: 7.6;Respiratory ciliated cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 113.0"									HPA011403	Supported					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA011403: AB_2668503"	"unprognostic (4.63e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.93e-2)"	40.4	36.9	25.6	9.2	26.3	23.4	38.3	26.9	33.2	86.7	32.3	45.1	9.9	44.3	4.4	272.8	50.2	2.8	50.0	27.5	32.9	82.2	59.4	48.3	21.5	30.4	31.0	45.8	53.4	6.9	56.2	4.8	30.5	74.1	4.0	5.6	94.6	55.5	34.7	52.8	62.5	2.4	25.1	98.8	46.6	22.2	25.2	18.2	81.1	12.6	93.6	98.7	172.8	32.5	17.9	13.5	8.6	3.6	3.6	0.5	11.8	0.0	1.9	1.8	4.7	2.0	9.3	2.6	2.9	2.2	2.8	113.0	2.6	12.8	1.6	15.9	19.8	2.6	7.5	4.3	1.0	4.6	4.3	7.1	16.0	0.0	3.0	15.1	16.1	0.2	6.9	8.9	5.7	40.3	7.3	37.8	3.8	15.4	4.2	7.1	4.8	14.7	16.4	13.9	5.9	13.3	23.4	5.9	6.4	7.0	1.7	6.8	5.3	32.2	14.1	11.6	6.8	9.8	4.8	1.6	6.9	10.5	5.4	15.8	3.9	6.7	6.1	3.6	3.1	3.5	3.4	3.4	5.4	3.0	4.4	3.5	5.0	6.2	1.4	4.9	6.0	4.1	25.6	26.3	26.9	33.2	27.5	32.9	30.4	31.0	30.5	25.1	25.2	32.5	0.6	9.6	13.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.1	0.0	0.0	0.2	0.7	0.0	0.0	2.2	0.0	0.1	0.4	1.3	0.0	0.0	0.0	0.7	0.1	0.6	0.0	0.2	7.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	1.8	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.3	0.0	0.0
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 67.3;lymphoid tissue: 76.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA011403	Approved					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"		"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011403: AB_2668503"																		11.0	5.4	11.4	16.0	11.0	45.2	11.3	12.1	13.1	6.1	10.2	10.2	12.4	10.2	8.5	67.3	11.4	9.6	6.2	10.7	9.3	5.6	7.4	11.2	28.2	11.5	9.6	8.3	10.5	9.7		8.3	10.1	12.6	10.6	6.9	13.8	22.5	23.1	22.0	12.0	7.0	5.6	25.0	8.7	3.9	9.4	18.4	29.3	6.5	76.8	17.9		12.6	10.8	16.2	6.9	12.3	3.3	1.1	23.7	19.3	24.2	24.1	29.4	5.6	17.8	12.1	9.5	7.6	2.6	34.1	0.8	9.1	6.6	13.4	19.9	4.3	32.1	9.9	13.9	10.7	12.9	11.4	13.3	6.9	6.4	5.4	10.9	15.7	11.5	27.7	8.7	43.9	12.0	17.9	2.8	5.2	3.4	9.3	3.7	18.0	13.4	41.6	8.8	9.5	10.9	5.2	9.9	11.9	5.7	10.1	5.1	12.7	5.6	8.2	8.0	27.1	9.5	7.7	3.5	19.1	9.4	0.1	2.5	2.0	4.8	1.3	1.9	3.0	2.0	1.7	1.0	3.0	3.4	1.8	4.1	0.7	1.4	5.8	2.0	1.1	11.4	11.0	12.1	13.1	10.7	9.3	11.5	9.6	10.1	5.6	9.4	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108736	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 62.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 362.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.4	9.4	3.8	7.5	4.4	12.5	10.0	3.0	5.8	16.8	2.0	9.8	4.3	3.9	0.8	66.9	5.7	5.9	8.9	3.1	3.9	39.8	11.9	18.8	3.7	4.2	2.8	1.9	4.6	5.0	7.4	3.8	3.7	4.9	5.3	0.5	14.2	1.1	3.7	3.1	6.5	3.4	1.3	20.3	4.1	2.2	4.4	1.2	8.0	0.9	6.6	9.1	31.2	3.7	19.5	26.0	2.4	5.2	8.9	4.0	29.7	7.9	15.5	14.5	17.5	10.8	9.9	0.0	2.5	9.7	89.9	13.9	5.2	46.1	9.4	4.1	4.5	0.8	4.8	4.6	7.4	0.9	1.3	5.0	21.8	6.4	362.8	5.9	9.1	0.4	1.5	13.5	7.6	2.3	0.0	2.9	9.4	4.2	20.7	0.0	4.8	6.0	33.7	11.5	2.3	1.6	10.2	3.0	63.4	29.3	2.4	0.9	12.4	29.6	22.9	7.3	22.6	21.4	34.7	3.7	29.6	3.0	77.8	11.5	16.0	12.2	11.8	12.1	8.9	0.2	7.8	8.7	6.5	0.6	8.1	8.1	6.2	5.4	14.8	0.5	8.4	10.9	3.8	4.4	3.0	5.8	3.1	3.9	4.2	2.8	3.7	1.3	4.4	3.7	107.4	19.2	58.5	5.2	19.1	46.8	26.3	104.4	19.4	27.6	9.0	16.1	11.6	24.3	51.0	11.0	33.3	15.1	122.9	250.1	70.5	50.5	1.0	42.1	22.4	108.1	13.1	4.4	16.5	40.5	260.3	34.1	5.1	91.1	25.9	3.8	72.5	17.5	110.0	16.8	29.4	35.0	85.5	130.5	118.1	2.4	5.3	199.5	87.2	1.0	61.4	13.3	71.1	4.0	3.6	117.9	260.8	2.2	30.3	30.4	42.8	23.3	11.9	29.2	6.6	21.1	32.2	0.3	9.5	42.9	29.8	78.7	71.0	1.5	29.1	34.9
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75156388-75304885	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	6.2	10.9	7.2	6.3	7.4	13.4	7.9	7.4	8.7	8.1	8.1	7.6	10.9	5.9	8.9	7.9	7.2	6.1	9.3	7.1	8.2	11.4	8.6	7.6	8.9	7.2	8.3	6.1	6.5	14.0	7.0	5.8	7.9	9.2	7.9	6.4	8.7	6.0	8.9	5.6	8.1	6.5	7.4	7.3	10.3	1.9	8.1	8.9	10.2	10.8	8.2	6.9	4.7	8.1	11.6	7.6	8.9	8.1	9.4	9.9	8.4	8.0	9.2	8.4	9.6	7.2	7.7	16.3	6.6	8.5	15.1	4.8	20.7	6.8	13.9	14.3	8.0	10.2	7.8	9.1	9.0	20.2	20.1	7.5	5.0	11.2	6.1	13.4	15.1	13.1	12.1	15.7	22.6	4.8	22.7	12.4	17.8	8.6	13.0	10.7	22.8	8.1	21.9	6.4	0.6	9.2	11.0	11.4	11.4	15.7	5.3	12.6	12.6	10.6	6.3	19.4	6.8	10.7	36.5	15.8	11.2	21.9	6.9	6.9	7.3	9.2	7.7	10.6	9.0	8.2	7.6	8.0	10.9	7.0	9.4	8.3	1.4	14.4	17.9	5.2	13.5	7.1	7.2	7.4	7.4	8.7	7.1	8.2	7.2	8.3	7.9	7.4	8.1	8.1	8.5	6.4	5.0	8.1	8.0	6.2	8.7	10.0	3.4	8.5	5.3	3.8	6.6	5.7	11.2	9.2	0.0	8.4	8.1	5.3	27.4	8.8	2.0	4.8	4.1	8.6	6.0	4.6	8.8	6.0	15.1	5.2	5.1	4.1	24.1	5.2	11.7	6.0	11.6	10.1	8.8	5.3	22.4	16.1	8.8	1.8	4.4	10.8	14.2	3.7	7.8	9.4	13.4	13.0	8.4	5.6	3.2	3.4	9.8	5.5	8.4	15.4	6.1	7.2	6.6	4.8	7.1	0.7	2.4	4.2	6.0	12.2	12.1	6.5	7.2	7.4
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Inhibitory neurons: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	19.4	30.0	22.0	13.8	24.3	4.6	16.5	21.9	27.7	20.1	20.9	26.0	18.9	18.6	22.9	18.8	20.6	12.6	55.3	22.4	23.0	28.6	27.1	15.8	17.9	24.1	23.5	19.8	15.9	37.2	23.9	14.9	26.6	19.7	25.8	29.5	18.7	18.4	106.8	16.3	19.3	18.5	19.9	19.7	23.0	17.6	22.9	21.2	22.3	105.7	21.9	20.1	18.0	22.8	20.2	28.6	33.5	32.2	34.1	38.4	4.8	38.5	43.3	70.7	48.1	97.7	39.4	66.6	68.5	26.1	60.7	53.5	60.0	70.0	52.6	19.0	24.2	89.2	41.3	80.3	22.7	54.2	25.6	37.6	72.3	37.9	48.8	51.2	24.6	53.5	39.9	23.9	50.0	26.8	58.6	29.2	25.4	42.0	61.5	31.4	50.0	37.9	67.6	26.2	46.4	28.7	32.9	148.9	34.0	28.1	23.9	34.6	23.5	46.2	28.8	25.9	34.6	30.1	37.2	26.5	79.7	31.1	36.8	28.6	10.2	14.2	14.8	14.3	18.3	12.3	13.7	14.7	16.0	15.7	16.7	14.7	0.3	22.3	10.2	14.4	14.2	12.6	22.0	24.3	21.9	27.7	22.4	23.0	24.1	23.5	26.6	19.9	22.9	22.8	7.0	0.0	7.8	51.6	7.0	6.4	9.3	18.1	6.8	20.7	7.8	5.8	44.0	10.0	11.8	16.5	8.4	22.9	5.3	13.9	60.7	18.2	15.1	10.5	8.5	10.5	12.0	5.2	64.6	13.1	15.7	9.2	7.7	6.9	8.2	17.5	6.1	14.2	11.6	18.5	68.9	9.1	18.3	6.6	3.9	8.6	10.5	5.8	14.2	33.7	13.2	16.7	10.3	44.2	50.3	19.1	6.6	12.0	5.0	8.4	10.9	19.4	14.8	22.8	6.6	9.6	11.9	24.6	18.2	6.2	5.3	17.4	6.2	19.7	13.2	9.6
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 911.7;Late spermatids: 1207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	38.9	69.6	100.5	37.3	102.8	45.3	45.3	103.3	140.9	48.4	97.6	43.3	34.3	61.5	58.4	59.2	40.0	20.8	267.2	100.1	106.6	66.9	83.3	33.9	35.6	102.5	102.2	33.4	61.2	46.8	78.0	29.3	102.9	55.4	44.0	104.3	53.0	28.6	228.8	42.9	28.5	52.4	102.4	43.2	49.5	104.1	104.4	45.7	42.9	197.9	40.8	46.1	42.8	107.9	207.7	144.2	162.8	139.4	130.9	129.8	125.5	116.4	117.3	167.7	162.6	233.9	84.5	84.4	180.3	143.5	244.1	109.0	111.7	164.5	138.6	108.0	187.7	163.3	87.3	327.6	215.9	153.8	127.2	136.2	257.4	131.7	204.7	91.0	120.4	158.9	178.4	165.9	190.4	220.9	149.0	315.9	97.3	158.4	167.6	106.5	130.7	279.9	116.2	191.5	273.1	97.1	127.9	191.7	165.6	84.1	168.3	382.2	110.5	178.0	151.1	115.9	242.0	126.8	193.1	146.6	53.7	229.7	211.0	32.7	88.5	18.2	76.1	141.6	93.6	152.4	95.0	87.6	108.6	116.1	98.7	88.0	8.4	81.6	120.9	133.2	110.7	123.8	100.5	102.8	103.3	140.9	100.1	106.6	102.5	102.2	102.9	102.4	104.4	107.9	18.5	28.9	29.3	8.1	54.2	58.5	96.8	193.0	61.5	108.7	96.0	100.3	911.7	74.4	119.8	77.3	50.1	134.7	34.0	112.4	391.3	103.4	342.3	46.6	78.7	54.1	99.7	105.0	8.9	179.7	124.4	88.5	90.7	39.1	59.5	90.0	41.4	166.1	218.8	70.7	10.2	94.5	154.6	67.8	55.6	1207.0	78.6	64.8	83.6	3.7	63.6	79.1	46.4	9.0	10.0	95.6	64.2	83.8	88.3	122.1	44.6	257.2	87.1	123.8	0.0	32.9	269.4	155.9	96.0	103.3	76.3	95.4	43.5	159.3	102.3	118.5
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673686	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 209.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA046851: AB_2679839"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	7.5	12.2	7.4	3.7	7.5	5.7	7.5	8.2	9.7	7.6	9.3	9.9	8.1	6.5	1.7	12.3	6.1	1.2	10.2	7.1	7.1	10.7	11.9	4.7	4.2	7.6	7.3	6.5	9.0	3.5	6.7	2.2	7.7	9.4	1.9	3.9	11.5	3.3	15.7	9.0	8.3	1.5	7.0	7.4	9.6	3.4	7.4	2.4	6.3	5.0	1.6	6.3	8.1	8.1	26.9	52.9	7.7	12.0	4.7	4.6	6.5	10.4	3.5	7.7	7.6	31.4	22.8	17.4	21.1	3.6	10.4	26.1	7.4	12.3	2.4	8.8	27.4	9.8	28.7	20.3	6.3	16.0	7.6	4.4	10.3	6.8	7.6	4.8	6.0	8.1	21.3	12.2	4.3	82.4	15.7	39.2	8.6	10.6	29.8	17.9	11.7	31.1	6.1	13.2	15.5	15.7	11.5	41.7	16.2	2.4	39.7	14.9	7.9	16.8	19.7	17.6	23.6	18.7	11.0	18.3	13.8	13.7	12.3	14.6	25.0	20.1	21.3	19.1	20.4	30.8	21.1	19.0	20.0	29.9	19.2	15.3	11.0	19.6	17.2	26.7	25.8	20.0	7.4	7.5	8.2	9.7	7.1	7.1	7.6	7.3	7.7	7.0	7.4	8.1	49.0	44.8	25.0	3.6	32.3	0.0	42.2	0.0	47.3	21.8	77.5	86.4	35.8	70.1	16.1	64.4	16.7	53.1	22.9	65.2	140.8	56.6	1.7	50.3	40.6	32.9	35.2	32.2	2.4	78.4	53.1	32.4	54.6	41.1	5.1	28.0	44.6	125.4	54.8	18.5	4.2	75.2	0.0	39.7	0.0	3.7	48.4	29.2	0.0	7.5	47.2	59.7	66.9	5.0	5.2	67.4	66.9	36.1	38.4	85.1	209.3	170.6	12.4	37.0	39.5	28.3	31.8	4.2	32.0	91.0	0.0	29.0	25.3	35.1	79.0	57.0
UQCRB	"QCR7, QP-C, UQBP, UQCR6"	ENSG00000156467	"Ubiquinol-cytochrome c reductase binding protein"	P14927	8	96222947-96235546	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1306.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 5409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043060	Approved					NA	NA		2200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043060: AB_10806376"	"unprognostic (5.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.66e-3)"	198.8	242.2	204.1	128.7	208.6	179.4	146.7	213.8	353.3	180.1	217.8	255.3	172.0	147.7	184.8	148.6	151.3	80.1	926.1	199.4	222.2	284.0	223.6	119.8	150.0	211.4	210.0	243.0	185.4	252.5	198.1	97.6	214.9	137.6	155.9	235.7	206.4	100.3	1306.1	107.0	155.6	129.1	217.9	128.9	193.1	67.8	209.8	145.1	121.1	822.2	160.0	176.0	153.5	216.3	338.9	150.1	202.0	126.9	280.8	287.7	129.6	267.9	202.2	147.6	158.0	132.3	157.2	146.2	395.7	218.5	153.0	162.1	187.1	252.1	193.2	221.6	136.6	483.3	312.6	235.6	208.9	269.5	197.0	337.3	217.3	170.1	258.8	469.7	214.5	246.7	258.2	244.2	225.2	206.1	432.6	406.1	117.8	705.2	227.7	190.4	131.0	274.3	290.5	258.5	182.1	181.3	163.0	60.8	434.5	268.5	250.1	440.2	260.0	92.7	144.4	165.8	288.6	211.2	172.2	344.5	153.2	353.9	104.4	134.4	143.7	141.5	123.0	240.0	152.2	211.3	194.1	156.2	162.1	165.5	235.4	224.3	102.5	130.5	290.1	139.4	241.3	224.4	204.1	208.6	213.8	353.3	199.4	222.2	211.4	210.0	214.9	217.9	209.8	216.3	361.3	445.5	566.8	40.8	601.2	302.2	509.6	1261.7	333.5	299.0	330.1	403.9	5409.1	859.3	687.3	332.9	116.7	637.3	578.6	812.3	2484.8	893.3	1127.8	663.6	588.1	474.6	730.7	467.4	42.9	926.7	513.3	508.6	372.6	525.9	587.0	399.0	732.5	1069.1	1143.8	126.2	50.7	1074.2	608.3	1670.2	624.3	290.2	863.9	661.6	820.0	22.5	1280.8	555.2	748.7	19.1	27.9	791.9	949.4	720.7	415.0	378.9	1166.7	2205.9	482.9	436.7	539.0	745.3	650.7	358.2	245.9	444.4	291.1	598.4	675.0	401.5	1078.0	588.9
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 766.7;tongue: 882.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 662.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		250000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	66.0	58.2	93.7	46.9	97.1	62.4	55.0	117.3	110.1	50.7	127.2	156.9	156.3	35.5	50.4	78.9	66.2	33.9	387.7	96.7	115.0	131.3	149.0	42.1	42.8	111.0	101.7	36.1	87.4	192.2	30.6	56.0	114.6	51.8	129.6	52.9	105.9	77.5	766.7	78.6	125.4	62.8	99.3	41.0	103.3	52.1	111.6	72.7	48.4	882.7	58.0	63.5	40.0	101.4	118.2	169.6	136.7	145.0	147.5	117.0	225.2	129.4	206.1	196.5	178.9	272.8	107.1	193.4	94.4	143.2	274.1	123.6	171.6	280.9	91.7	138.3	173.8	214.7	186.7	317.1	186.9	164.4	152.2	150.9	293.6	183.2	274.6	167.5	172.5	173.7	110.5	107.1	152.5	192.0	156.7	241.6	157.6	229.6	324.2	103.4	138.1	273.5	235.8	178.7	84.4	107.5	182.8	218.7	211.8	92.0	163.1	178.0	112.5	107.7	153.7	179.5	272.4	124.8	121.4	136.5	192.7	233.9	319.0	251.3	643.7	325.4	204.7	665.7	193.7	260.0	203.5	206.1	593.3	227.7	177.1	175.2	158.2	194.4	608.0	235.0	258.1	988.2	93.7	97.1	117.3	110.1	96.7	115.0	111.0	101.7	114.6	99.3	111.6	101.4	31.5	57.7	50.4	17.3	59.0	117.6	164.6	339.4	103.6	41.9	59.3	46.1	662.2	140.2	139.2	121.4	29.2	334.4	28.0	550.2	365.9	163.7	155.0	64.0	41.6	53.4	144.5	80.6	16.9	166.3	311.1	78.2	167.7	61.5	82.4	72.5	49.6	188.0	238.2	40.4	22.0	319.6	223.8	118.1	85.4	331.9	58.4	107.7	119.2	12.2	129.1	67.1	51.5	14.6	12.5	163.5	333.3	70.7	117.6	78.4	553.4	398.4	104.7	65.0	59.2	61.2	153.0	110.3	74.7	173.0	105.4	336.7	50.8	172.1	416.8	153.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21953288-21983660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 722.2;tongue: 933.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	158.8	117.7	69.0	103.1	71.2	127.7	108.4	75.5	90.0	90.8	113.9	259.8	292.5	98.2	72.7	157.4	109.7	99.5	559.4	72.4	73.7	240.0	245.1	75.4	120.0	74.1	69.5	114.5	89.7	257.2	39.8	96.5	72.7	95.6	262.8	142.3	133.8	104.3	722.2	85.4	233.6	121.2	65.8	80.9	153.2	55.8	76.5	131.3	107.9	933.2	149.3	153.6	59.8	73.3	173.9	193.1	116.5	66.4	154.3	186.8	169.1	163.8	160.6	177.5	174.5	347.9	177.7	338.9	144.3	170.4	129.8	324.6	222.3	212.7	193.7	151.4	178.4	185.9	166.1	494.3	164.6	249.1	501.2	232.3	229.4	130.3	186.2	169.4	248.1	224.1	217.9	159.1	177.2	230.6	288.6	175.0	124.6	261.1	148.8	310.9	263.6	390.0	285.8	214.6	154.4	114.9	237.2	318.6	190.3	151.6	354.4	264.1	179.3	103.3	98.1	104.0	148.0	126.3	87.2	302.7	188.7	239.8	126.4	80.1	128.7	71.4	80.0	147.8	103.3	96.0	98.3	89.3	153.9	77.9	106.8	97.6	45.9	101.8	148.1	67.6	134.8	157.3	69.0	71.2	75.5	90.0	72.4	73.7	74.1	69.5	72.7	65.8	76.5	73.3	105.5	64.1	52.5	81.9	81.1	90.6	190.8	444.0	74.6	109.1	91.7	79.6	556.2	84.4	194.9	71.7	87.6	238.3	82.6	233.4	455.9	124.5	88.0	72.0	55.7	91.3	113.8	92.4	65.0	109.6	157.6	89.0	144.3	65.8	92.6	99.6	84.3	122.3	195.5	69.0	74.0	224.4	238.0	145.1	100.6	89.9	68.3	104.6	131.6	27.2	162.1	108.0	91.6	60.3	50.7	97.2	214.0	97.0	72.9	114.4	378.0	306.9	110.2	152.6	78.9	94.1	109.5	68.9	56.7	132.0	88.4	278.3	91.3	170.2	358.7	204.3
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205320-29213151	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 231.6;tongue: 285.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1474.9;Distal tubular cells: 1035.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	28.7	50.1	25.6	17.4	26.7	52.8	24.7	29.4	31.1	18.3	33.6	49.0	43.2	19.2	23.1	33.2	19.3	13.2	138.3	27.2	28.4	62.5	50.9	17.6	17.2	27.0	27.4	15.4	29.4	47.3	19.9	17.3	26.1	18.8	52.6	26.6	26.7	21.9	231.6	27.9	34.0	24.8	26.4	21.1	39.3	25.9	29.3	26.0	16.8	285.9	25.9	25.7	20.3	26.0	63.0	103.7	37.7	34.1	60.6	45.9	41.8	47.8	49.7	64.7	71.1	63.3	37.7	56.7	49.2	54.4	52.7	64.8	83.4	56.9	77.6	38.7	83.2	80.2	39.2	58.1	51.3	77.2	67.5	55.5	60.4	44.2	66.9	38.0	52.4	69.0	58.0	34.5	70.2	58.0	54.5	57.6	39.6	132.2	39.7	48.9	50.3	43.1	80.9	74.4	45.8	22.4	43.5	84.9	58.2	42.0	39.6	63.4	33.4	43.5	66.4	30.2	50.4	16.4	33.3	52.5	38.4	66.4	31.7	51.4	90.7	43.8	50.0	90.9	50.3	54.8	53.2	51.9	106.6	48.0	56.1	53.6	27.3	49.2	78.3	59.3	68.4	166.2	25.6	26.7	29.4	31.1	27.2	28.4	27.0	27.4	26.1	26.4	29.3	26.0	69.7	54.5	46.6	16.6	104.9	147.6	279.7	466.7	105.9	71.8	119.5	128.4	1474.9	161.5	201.4	114.0	16.7	282.0	116.8	321.6	1035.0	245.2	258.4	106.1	66.8	106.8	160.0	147.9	18.1	235.1	271.7	126.7	139.7	88.5	90.7	114.2	83.9	272.1	266.1	52.2	19.2	293.6	317.3	160.6	109.6	146.0	92.2	136.6	165.4	13.1	206.6	124.6	132.8	19.6	15.8	205.0	225.8	81.6	159.4	257.3	338.6	758.4	132.4	84.1	98.6	107.5	131.0	348.8	80.5	203.9	160.3	381.9	109.5	209.1	407.4	372.1
UQCRH	"QCR6, UQCR8"	ENSG00000173660	"Ubiquinol-cytochrome c reductase hinge protein"	P07919	1	46303698-46316776	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042574	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA042574: AB_10960998"	"unprognostic (2.24e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.04e-1)"	216.1	159.7	403.2	200.3	408.4	414.5	241.5	420.6	533.0	176.6	423.5	433.1	396.6	153.6	215.7	292.8	121.1	134.9	1012.8	410.2	421.1	363.4	261.5	121.6	257.5	417.7	404.1	227.8	215.9	403.4	144.7	142.4	411.3	147.8	418.4	436.6	278.5	177.2	932.8	172.0	291.0	146.8	408.8	143.2	256.0	77.7	420.4	312.4	138.0	1033.3	349.6	237.6	188.9	408.4	766.7	456.4	514.3	945.2	529.0	720.3	1070.8	501.7	311.3	435.2	372.5	883.1	416.1	750.2	653.2	474.0	777.9	537.8	742.2	778.7	650.8	563.1	1262.1	1854.5	1320.9	1215.3	313.6	1832.0	508.1	810.8	466.3	706.7	363.4	643.0	622.6	907.5	1803.3	814.1	675.1	613.9	830.6	1884.9	3043.4	950.6	917.8	858.9	840.5	2386.6	974.1	1679.4	1008.3	1180.4	806.7	1519.3	1628.1	1346.7	507.4	2232.3	541.3	410.8	528.9	589.2	935.7	546.9	1230.5	1185.4	593.1	1432.2	625.9	171.5	372.6	249.0	214.4	332.7	281.9	544.6	307.8	283.6	481.5	433.1	346.2	313.0	69.3	221.4	297.8	318.2	340.7	620.8	403.2	408.4	420.6	533.0	410.2	421.1	417.7	404.1	411.3	408.8	420.4	408.4	249.6	105.8	148.5	26.4	523.3	457.8	703.8	1298.7	544.7	269.7	669.2	942.3	1897.2	479.0	505.3	393.6	166.8	651.5	273.8	761.5	2099.3	479.4	65.2	239.0	321.1	293.0	502.5	453.8	49.7	350.6	816.2	285.8	452.1	341.1	283.6	432.7	355.6	612.9	724.5	102.6	53.9	1148.6	612.3	711.1	410.1	69.1	308.8	516.2	489.2	12.2	606.2	408.1	365.6	22.1	22.2	419.9	789.0	284.4	703.3	710.0	944.4	1521.9	213.3	454.0	328.7	358.3	372.6	184.3	337.8	935.4	526.9	650.2	318.0	396.5	1298.2	866.4
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 16.6"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 444.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA042574	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	3.6	2.2	1.3	0.3	1.3	1.1	2.8	3.0	1.6	3.2	0.8	4.4	0.3	2.3	0.7	4.6	2.7	0.3	16.6	1.3	1.1	5.8	3.4	2.4	0.3	1.6	1.3	3.8	3.0	0.1	2.7	0.1	1.6	2.6	0.2	2.9	3.3	0.1	10.4	3.1	3.3	0.2	0.7	2.8	3.5	1.7	1.5	0.3	2.4	0.1	0.2	3.0	3.2	2.3	0.2	0.1	0.8	0.8	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.6	0.1	0.3	0.6	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.3	0.0	0.4	0.2	0.5	0.0	0.5	0.1	0.4	0.4	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.5	0.4	0.2	0.5	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.3	0.2	0.5	0.2	0.3	0.2	0.5	0.2	1.8	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	1.6	0.4	0.2	0.4	0.2	0.2	1.3	1.3	3.0	1.6	1.3	1.1	1.6	1.3	1.6	0.7	1.5	2.3	1.4	0.0	1.1	6.2	12.3	0.0	39.0	0.0	1.8	3.8	3.1	6.2	444.8	24.3	0.6	9.2	6.2	21.4	4.1	6.1	23.5	1.1	3.0	4.0	6.7	10.7	7.3	6.6	5.3	0.7	21.5	13.9	1.5	4.6	2.5	9.7	17.9	23.1	20.6	1.7	5.4	12.6	0.0	48.3	0.0	3.6	11.1	11.9	0.0	0.0	12.9	3.0	16.5	1.0	2.9	0.6	6.1	12.4	7.8	31.9	11.5	10.3	0.0	6.9	6.6	33.2	12.7	6.2	12.5	5.5	0.0	23.5	5.4	3.9	15.4	31.1
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866630-132868847	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1301.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3312.4;Hepatocytes: 5039.2;Proximal tubular cells: 3336.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	226.5	378.7	277.6	91.8	283.7	132.6	189.2	309.6	391.9	151.7	293.2	313.0	220.8	147.9	211.2	332.4	138.6	78.3	1301.6	283.6	315.5	460.7	1036.6	149.0	69.1	291.2	285.6	120.0	269.4	318.5	222.8	89.0	294.9	272.9	232.2	187.4	253.8	122.2	1024.7	182.3	244.5	98.5	286.6	151.8	372.3	128.9	294.7	130.3	167.3	873.5	92.3	219.9	193.3	302.3	300.9	391.1	246.7	599.9	364.2	292.2	209.3	216.3	310.6	341.7	424.9	556.4	353.8	126.5	433.4	291.5	424.5	302.7	229.5	536.6	300.7	222.9	466.0	169.4	606.3	459.9	312.7	188.8	276.2	314.0	366.5	247.4	341.6	229.6	274.1	258.3	219.2	398.6	369.7	547.5	450.5	442.1	175.3	568.1	367.0	288.4	271.7	541.7	460.9	573.4	410.7	335.8	269.1	302.7	493.9	170.4	451.9	422.5	168.3	316.0	392.1	257.2	438.7	423.1	616.3	236.6	417.9	350.0	320.6	474.1	528.3	355.5	245.6	431.0	251.8	317.2	280.3	280.2	472.0	260.6	273.5	263.6	258.8	322.9	410.0	516.7	326.1	658.2	277.6	283.7	309.6	391.9	283.6	315.5	291.2	285.6	294.9	286.6	294.7	302.3	252.0	250.0	349.3	17.6	258.1	348.3	334.0	1046.6	235.6	97.8	575.5	657.7	3312.4	993.7	556.9	787.2	120.9	720.4	200.6	1678.3	1813.7	685.6	470.0	424.1	308.5	288.4	549.3	319.4	13.9	947.7	484.1	330.2	438.3	467.5	294.5	277.0	333.8	5039.2	771.4	72.3	17.0	1047.6	807.7	421.1	448.6	1116.6	282.4	301.6	715.1	11.2	394.7	459.2	260.6	13.6	23.5	705.7	1460.8	288.9	416.2	537.1	2476.1	3336.0	512.5	271.5	184.1	217.8	388.7	308.1	174.7	570.1	514.0	562.7	205.0	235.9	1205.6	500.2
URAD	PRHOXNB	ENSG00000183463	"Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase"	A6NGE7	13	27977717-27988693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine metabolism"	"Decarboxylase, Lyase"		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	14	"intestine: 25.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 44.4;Intestinal goblet cells: 110.6;Paneth cells: 43.3;Proximal enterocytes: 196.3;Undifferentiated cells: 54.7"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 2.6;CACO-2: 2.4"									HPA038972	Uncertain					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA038972: AB_10671869"			"unprognostic (2.00e-1)"											"unprognostic (1.05e-1)"	"unprognostic (5.21e-2)"			0.2	0.0	0.0	1.7	0.0	0.0	0.2	0.7	0.1	0.0	0.0	25.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	17.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	44.4	3.9	0.1	0.3	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	110.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	43.3	0.0	0.0	0.0	196.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	54.7	0.0
URB1	"C21orf108, KIAA0539, NPA1"	ENSG00000142207	"URB1 ribosome biogenesis homolog"	O60287	21	32311018-32393012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018334	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli fibrillar center"		"HPA018334: AB_1856088"	"unprognostic (1.58e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.57e-1)"	"unprognostic (4.65e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.78e-2)"	5.3	7.5	4.7	4.0	4.5	3.2	4.9	3.8	5.0	6.5	14.4	4.7	2.3	11.2	4.2	6.9	8.0	2.5	6.3	5.9	4.6	3.4	5.2	3.7	4.1	6.9	5.4	7.6	5.9	5.6	4.5	3.4	6.8	9.9	2.8	2.1	7.2	8.0	8.8	7.1	3.4	5.5	4.5	3.5	4.3	6.6	5.1	3.8	4.1	4.3	3.9	8.7	6.6	6.1	12.7	16.0	7.0	14.6	14.1	11.2	11.3	12.9	6.4	9.6	7.4	22.3	7.1	12.7	7.0	12.7	10.5	7.8	19.9	30.5	9.9	9.9	12.1	43.6	14.7	11.8	10.2	24.5	9.3	18.2	10.4	21.9	23.6	7.1	10.4	14.6	39.7	12.1	14.2	12.8	15.9	8.7	23.4	15.1	14.7	18.7	16.4	15.3	6.5	12.0	15.8	14.1	15.1	12.5	14.0	5.2	11.0	9.3	12.1	23.6	14.1	9.8	14.6	17.0	17.7	20.0	10.7	22.0	12.2	0.9	0.3	0.0	0.4	0.3	0.8	0.6	0.5	0.5	0.3	0.5	0.6	0.6	0.3	0.8	0.1	0.3	0.5	0.3	4.7	4.5	3.8	5.0	5.9	4.6	6.9	5.4	6.8	4.5	5.1	6.1	8.1	3.2	10.5	14.7	8.5	9.7	14.5	11.3	25.6	7.2	9.6	8.6	9.4	2.8	17.2	1.8	4.2	5.9	5.9	2.4	0.0	4.8	9.4	35.0	38.0	7.6	7.8	8.0	27.6	6.0	3.9	8.7	7.7	22.1	0.0	45.4	4.6	8.5	4.0	15.2	29.0	4.7	6.1	2.7	3.1	6.0	5.6	3.4	5.4	15.0	3.0	3.9	3.1	26.2	27.5	4.5	4.3	7.5	4.2	20.9	0.8	2.4	18.6	5.6	6.6	18.1	8.8	12.8	15.4	16.2	11.4	4.2	5.5	13.2	7.1	14.6
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
URGCP	"DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4"	ENSG00000106608	"Upregulator of cell proliferation"	Q8TCY9	7	43875894-43926411	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019879, HPA020134, HPA029468"	Approved		Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.23e-3)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.69e-3)"	15.9	35.6	25.1	9.9	24.6	10.3	15.0	24.5	25.9	19.7	24.1	22.6	24.3	17.7	14.7	17.8	19.5	11.1	25.2	24.5	22.5	24.3	29.6	14.2	10.8	20.7	20.0	20.7	19.1	22.1	27.4	11.9	21.3	21.6	19.0	20.1	15.6	16.1	34.9	18.6	22.8	18.7	19.2	18.5	17.4	9.7	23.4	10.4	18.7	31.6	10.6	20.4	16.6	23.8	28.2	25.1	10.1	32.1	26.3	24.0	9.6	33.2	58.4	35.2	35.6	21.1	21.8	16.5	16.9	31.7	53.5	44.3	28.0	23.8	34.3	31.6	17.3	11.5	25.2	19.0	28.0	17.7	20.3	18.5	28.5	27.8	27.0	23.1	17.7	18.9	28.6	13.1	23.7	21.0	18.6	14.6	19.1	33.1	25.8	24.9	14.6	22.2	33.7	27.7	25.8	44.4	34.4	49.6	15.4	16.5	25.0	21.0	19.5	20.3	9.4	22.8	26.1	34.1	53.6	20.7	23.2	26.7	38.6	4.5	4.7	6.2	8.8	7.4	9.4	5.8	9.2	11.7	10.2	4.9	9.9	8.8	0.5	2.8	8.3	1.6	10.6	6.6	25.1	24.6	24.5	25.9	24.5	22.5	20.7	20.0	21.3	19.2	23.4	23.8	10.1	3.2	9.2	14.7	12.2	11.1	13.4	7.9	9.1	25.9	17.7	17.8	23.8	12.8	7.3	12.9	8.4	6.3	8.9	41.0	17.6	13.0	1.2	16.3	14.3	10.2	8.4	6.3	28.6	13.2	11.8	13.5	23.9	23.2	7.0	21.1	12.5	27.3	6.5	16.8	25.1	12.5	10.2	5.0	10.2	3.4	18.3	7.5	12.4	6.5	4.8	12.2	7.2	7.5	17.6	15.7	23.4	18.8	4.2	14.1	37.9	26.4	8.7	20.4	6.6	13.8	12.6	8.8	8.3	9.1	14.8	3.4	10.8	15.2	16.2	15.0
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371361-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	20.1	23.8	35.5	16.3	40.3	26.2	20.0	37.7	37.8	21.2	28.1	22.0	20.2	21.2	15.1	22.0	18.8	11.2	31.1	33.8	35.9	26.8	24.6	17.6	21.7	40.3	41.2	19.5	30.0	18.9	17.9	14.7	38.0	22.7	16.5	12.4	17.2	14.1	25.2	20.9	20.8	16.8	35.7	28.0	23.2	12.5	38.6	23.6	19.3	25.5	20.7	21.9	18.7	42.4	17.9	36.6	34.5	21.6	31.2	29.9	29.9	17.8	27.8	40.1	27.4	28.5	32.7	41.6	14.2	37.8	26.0	63.8	40.3	38.7	20.7	27.7	27.5	37.2	53.4	32.9	28.7	40.8	30.9	40.5	33.3	31.4	28.2	30.6	49.0	44.7	43.9	26.2	29.5	39.9	54.7	54.9	39.5	71.5	41.0	44.5	41.8	48.6	33.5	16.3	27.6	37.6	31.5	51.3	41.4	18.5	50.7	32.2	32.1	31.6	30.0	30.3	30.0	25.2	54.2	39.8	31.4	33.6	38.7	6.1	14.1	10.0	14.5	18.3	12.2	11.7	12.7	13.6	16.8	12.3	12.4	13.5	3.5	12.2	17.6	12.2	15.7	12.6	35.5	40.3	37.7	37.8	33.8	35.9	40.3	41.2	38.0	35.7	38.6	42.4	49.9	16.0	24.5	13.7	36.8	22.7	32.9	60.0	16.5	19.2	37.1	32.9	22.4	25.8	26.1	27.6	14.6	84.1	37.1	57.3	70.5	69.2	2.5	21.5	31.6	47.4	22.2	53.0	12.6	112.2	85.1	32.1	35.7	19.8	37.4	34.6	38.9	23.1	81.6	10.1	13.3	53.3	28.5	42.6	27.7	4.2	31.1	31.6	53.4	4.7	70.5	32.2	59.8	15.1	38.7	89.5	49.3	31.2	29.4	38.4	90.4	51.4	17.4	14.4	19.7	26.3	32.6	24.1	27.1	29.4	23.9	71.7	37.4	48.1	66.7	31.7
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	336	"liver: 116.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 62.2"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000		"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	116.6	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	3.3	62.2	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	51.7	120.1	72.0	25.5	73.9	199.0	48.2	72.0	79.3	40.8	77.2	49.3	29.2	46.9	54.7	34.2	49.2	30.8	70.6	73.1	74.5	58.0	100.9	34.8	35.2	72.1	73.4	51.1	45.1	115.0	42.6	39.4	73.6	35.1	30.1	24.7	61.4	44.2	75.9	31.7	30.7	54.7	72.9	37.8	38.5	44.8	73.6	44.0	54.0	83.8	36.1	40.3	32.7	73.8	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	72.0	73.9	72.0	79.3	73.1	74.5	72.1	73.4	73.6	72.9	73.6	73.8	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823258	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	27.9	41.3	54.1	13.4	55.3	67.5	26.9	40.6	64.5	15.9	33.0	29.9	20.9	21.4	56.9	24.9	19.3	15.6	73.2	56.3	45.8	40.7	59.7	20.5	18.8	41.6	48.1	22.5	32.9	30.0	29.9	11.3	43.5	27.4	16.5	26.2	29.6	19.1	83.8	23.0	24.2	18.1	40.2	28.0	29.6	31.2	51.8	18.6	32.5	80.0	19.1	27.3	17.0	47.8	45.5	56.3	29.8	74.9	38.5	42.2	51.9	51.4	94.5	39.0	34.6	22.9	54.0	58.4	24.7	72.9	24.3	23.5	18.5	43.1	31.3	78.1	39.9	125.3	27.9	40.1	67.3	50.7	29.7	59.3	20.7	25.8	66.0	47.5	34.4	48.5	24.4	54.1	63.5	65.2	51.2	72.8	37.7	31.8	54.0	33.1	34.1	37.3	53.9	28.2	26.2	46.8	51.6	41.8	80.7	30.8	40.4	59.1	33.8	52.3	19.6	38.1	48.2	50.7	36.8	40.6	75.6	23.1	26.3	4.9	31.9	4.6	30.1	33.1	33.9	30.1	29.3	38.6	53.5	37.5	38.1	29.6	2.1	53.6	31.9	25.3	29.8	38.1	54.1	55.3	40.6	64.5	56.3	45.8	41.6	48.1	43.5	40.2	51.8	47.8	19.0	19.2	23.1	20.5	34.3	9.3	12.0	31.8	9.6	49.3	36.2	39.5	70.5	40.0	28.6	36.8	45.9	60.8	36.3	19.1	101.8	59.7	57.0	11.2	25.5	22.2	14.5	231.5	23.9	59.6	47.4	33.3	23.9	16.9	11.4	112.3	28.2	53.4	79.3	47.1	25.2	25.6	40.7	47.8	20.8	123.7	35.8	31.6	62.2	9.4	58.7	77.0	69.0	13.6	29.6	42.7	15.8	40.6	46.9	27.3	52.9	142.6	20.4	42.3	6.6	22.8	36.7	55.7	100.9	28.5	12.8	20.0	37.8	55.0	38.8	21.3
USB1	"C16orf57, FLJ13154, HVSL1, Mpn1"	ENSG00000103005	"U6 snRNA biogenesis phosphodiesterase 1"	Q9BQ65	16	57999546-58021618	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041791, HPA059854"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA041791: AB_10793933, HPA059854: AB_2684143"	"unprognostic (2.79e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (6.69e-7)"	"unprognostic (4.30e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.04e-2)"	21.5	27.5	24.0	27.6	23.4	30.9	14.8	22.4	26.2	15.6	20.9	22.8	14.3	19.0	16.3	17.4	15.7	14.7	27.7	23.6	25.8	19.0	29.9	20.5	20.2	26.5	24.9	11.8	17.6	14.7	13.4	16.6	26.3	17.2	18.6	6.7	14.1	18.4	15.6	15.2	18.1	24.8	23.8	25.7	19.4	20.2	25.7	18.4	19.1	13.0	20.8	28.1	15.4	23.5	53.2	109.2	36.5	69.7	46.4	32.5	57.6	43.9	58.2	68.6	48.3	70.9	31.0	32.5	56.6	65.3	61.0	38.6	58.2	93.6	97.6	31.9	32.9	40.5	43.0	103.8	52.7	54.2	114.1	46.6	54.7	87.2	50.8	45.4	76.1	69.7	55.4	15.4	58.2	56.0	50.1	62.3	60.6	47.7	88.5	49.3	32.9	53.8	49.1	63.4	17.6	41.6	114.8	29.8	27.6	57.6	14.8	54.5	82.6	40.2	59.0	43.3	60.5	23.4	37.3	58.9	48.3	51.1	50.0	112.3	58.4	86.8	57.1	67.8	37.4	19.5	33.2	43.7	54.8	13.4	20.3	36.7	162.2	45.5	95.5	23.8	45.1	32.4	24.0	23.4	22.4	26.2	23.6	25.8	26.5	24.9	26.3	23.8	25.7	23.5	12.9	0.0	9.2	6.2	12.2	18.1	17.7	22.8	13.1	3.2	15.2	13.0	13.0	14.3	12.4	9.2	4.2	29.3	33.2	30.2	11.7	39.5	1.3	9.5	10.7	13.5	12.6	9.0	10.4	46.2	55.3	13.3	14.3	9.7	16.5	6.3	17.5	13.0	42.0	6.7	6.2	15.9	28.5	19.8	16.4	1.4	8.1	26.5	14.2	5.6	37.2	11.5	48.4	2.5	5.2	49.7	20.0	11.7	16.4	14.7	18.3	16.2	9.7	3.6	6.6	7.7	15.3	12.6	22.5	10.9	13.1	20.5	24.3	13.0	10.2	15.2
USE1	"D12, MDS032, p31, SLT1"	ENSG00000053501	"Unconventional SNARE in the ER 1"	Q9NZ43	19	17215346-17219829	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026851, HPA047562"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA026851: AB_10602903, HPA047562: AB_2680089"	"unprognostic (3.03e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.31e-2)"	33.2	40.2	48.0	20.2	50.0	28.8	30.5	48.1	57.9	30.7	45.2	30.5	17.4	24.5	19.0	25.9	24.0	20.2	47.1	48.4	49.0	31.6	42.0	25.7	28.2	49.8	49.0	31.9	43.2	14.2	22.1	15.6	49.3	26.8	10.9	11.8	38.4	14.9	56.0	28.2	25.4	14.9	48.2	39.7	31.7	19.6	48.0	25.2	24.6	36.2	18.3	29.3	24.4	53.8	34.5	20.1	10.9	45.4	36.4	34.4	37.7	24.5	28.3	27.0	33.7	26.4	40.4	23.0	55.5	33.6	9.5	19.6	9.7	33.4	9.3	49.5	44.2	42.5	37.6	28.3	74.4	47.9	37.7	47.2	17.6	23.4	46.3	30.7	18.1	55.8	27.6	77.8	28.5	41.3	46.2	35.2	21.2	26.6	70.1	36.2	12.1	89.6	31.4	27.5	29.4	25.9	27.1	39.1	42.5	10.9	25.2	74.5	26.6	17.8	17.2	32.5	30.9	87.4	86.7	30.9	47.9	76.2	30.2	43.9	58.1	18.0	54.3	51.6	61.8	139.4	80.9	65.8	71.5	128.9	115.6	86.4	10.5	54.4	38.8	87.0	85.0	66.6	48.0	50.0	48.1	57.9	48.4	49.0	49.8	49.0	49.3	48.2	48.0	53.8	34.0	32.1	27.2	6.8	48.8	45.2	53.0	48.5	44.3	24.5	48.4	58.8	45.0	30.0	30.0	16.5	18.8	45.0	32.4	47.2	72.4	37.4	39.5	20.3	35.0	28.4	13.8	19.6	9.2	62.0	35.1	37.3	32.6	24.9	48.9	35.3	34.6	48.4	40.7	11.8	8.1	35.0	26.4	39.0	29.2	137.4	48.1	29.9	21.4	3.7	33.5	41.5	28.8	17.1	12.1	31.2	53.7	26.7	34.1	38.5	51.2	118.2	22.7	34.7	39.5	39.2	62.9	20.7	25.5	29.5	34.8	75.7	36.8	42.4	31.8	38.9
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.3	18.2	26.3	18.9	26.2	17.5	13.9	26.2	27.2	14.8	25.7	18.4	18.5	14.3	14.2	13.8	16.8	14.6	18.4	26.5	26.6	15.7	21.0	18.4	27.8	26.0	25.5	16.7	11.4	20.5	11.4	18.1	26.4	15.1	18.3	17.0	14.0	18.2	32.7	15.3	19.6	18.1	26.0	30.5	14.9	7.6	28.2	36.0	12.9	29.4	32.7	20.7	13.7	26.9	17.2	25.5	29.9	35.0	39.4	22.3	39.9	14.0	30.3	42.9	33.3	17.9	21.2	22.1	29.0	23.5	18.6	21.0	35.6	22.3	24.0	20.6	21.2	19.1	20.9	18.9	23.0	26.7	25.4	18.3	22.0	31.1	25.1	27.3	40.7	36.8	31.7	23.1	27.2	20.1	41.5	29.2	61.8	37.0	32.9	35.6	23.3	26.9	21.0	26.8	16.9	32.3	25.5	32.8	18.1	42.9	27.5	85.5	24.0	21.5	13.5	13.2	23.1	19.5	26.6	34.3	18.3	25.9	16.7	2.5	2.6	1.4	1.9	2.1	1.1	1.5	1.1	1.3	2.6	1.7	1.2	1.2	4.1	0.9	2.1	2.7	1.3	1.3	26.3	26.2	26.2	27.2	26.5	26.6	26.0	25.5	26.4	26.0	28.2	26.9	13.1	6.4	6.9	3.6	18.0	2.3	0.6	3.1	9.1	3.3	2.7	3.9	1.0	0.0	3.2	3.7	2.1	2.2	14.5	7.1	1.9	2.1	0.4	5.5	8.1	6.0	3.0	5.0	6.3	1.3	4.4	4.6	14.8	5.6	11.4	4.0	1.1	0.4	3.1	5.0	5.4	3.4	6.1	2.1	3.5	0.2	0.3	12.4	5.4	4.7	4.7	1.6	4.1	4.0	5.8	2.3	7.1	0.0	20.0	1.6	7.3	3.1	7.9	3.5	6.6	3.3	4.9	0.5	0.4	8.5	1.8	3.4	9.3	7.7	4.9	1.9
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	7.1	4.9	5.6	3.0	5.9	10.2	6.7	8.8	8.0	5.5	7.5	7.5	2.8	5.3	7.8	6.8	6.2	2.4	7.0	6.2	5.3	8.2	16.4	5.9	5.3	5.4	5.4	5.8	8.5	6.0	6.7	2.8	5.6	5.9	3.9	5.6	6.4	2.7	18.7	7.4	8.3	2.4	5.2	8.7	7.5	4.8	5.3	6.7	6.2	8.5	4.6	6.0	6.1	6.8	4.6	3.4	4.1	3.9	9.8	3.7	2.8	1.8	2.9	1.7	1.6	3.2	1.9	8.0	3.2	4.6	2.8	2.8	4.5	3.6	3.3	2.7	1.9	5.7	2.2	5.3	2.9	10.5	6.2	5.5	6.4	3.2	3.6	2.6	4.2	5.9	2.7	4.1	3.7	6.4	5.9	5.8	3.0	6.1	3.4	2.5	3.2	3.2	6.3	6.3	1.9	3.0	4.3	2.4	5.5	2.8	3.3	7.7	5.7	2.7	6.0	1.5	2.6	4.8	2.9	9.2	3.1	4.3	2.0	2.2	1.0	1.7	1.3	1.3	1.0	1.0	0.9	1.0	0.8	2.3	1.1	1.2	3.2	1.2	1.8	2.3	0.5	0.7	5.6	5.9	8.8	8.0	6.2	5.3	5.4	5.4	5.6	5.2	5.3	6.8	27.1	22.4	15.1	0.0	30.1	0.0	11.2	0.0	15.9	19.5	19.7	12.6	0.0	14.3	6.2	25.8	14.6	8.1	42.7	13.1	25.4	8.4	6.7	28.3	18.6	15.6	6.1	17.0	0.0	11.8	4.2	13.3	18.3	22.8	5.1	6.7	20.3	46.3	7.8	13.5	0.0	10.2	0.0	22.6	0.0	10.9	13.1	17.0	0.0	0.0	16.4	12.4	29.9	0.0	0.0	12.5	12.4	13.9	17.5	18.4	23.6	29.2	12.4	18.8	6.6	27.6	13.8	13.1	6.0	15.8	0.0	14.5	20.0	12.2	10.9	19.5
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916083-74923256	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 7.8;skin 1: 2.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.2;Late spermatids: 17.9;Muller glia cells: 11.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.8;hTCEpi: 1.6;K-562: 1.3;MCF7: 2.0;OE19: 1.9"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 9.9"	"Not detected"	"Not detected"			HPA024360	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	0.9	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.3	0.0	0.0	0.1	0.8	1.9	7.8	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.8	0.2	0.5	0.0	0.0	0.0	1.8	0.6	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	1.7	0.6	0.0	0.2	0.0	0.0	0.1	0.2	0.4	1.6	0.3	0.3	0.0	0.1	0.0	0.1
USHBP1	"AIEBP, FLJ38709, MCC2"	ENSG00000130307	"USH1 protein network component harmonin binding protein 1"	Q8N6Y0	19	17249171-17282786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 41.5;Endothelial cells: 28.3;Hepatic stellate cells: 21.4;Ionocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.9;HeLa: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052471	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052471: AB_2681843"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.12e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.88e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.88e-1)"	8.8	1.9	5.0	1.6	4.9	2.9	8.2	7.2	5.2	2.9	4.1	1.9	1.9	3.6	1.1	1.3	3.1	1.7	12.6	5.0	4.1	4.5	1.2	6.9	2.6	4.6	4.5	1.4	4.8	0.8	1.2	5.6	5.1	2.3	0.5	1.1	2.0	0.9	6.2	2.1	2.2	1.3	3.3	3.5	1.7	1.0	5.1	0.5	4.5	4.8	0.5	2.8	2.3	4.6	0.6	0.9	1.7	0.4	0.0	0.0	10.9	0.3	0.0	0.0	0.0	1.9	0.9	2.9	3.4	0.0	0.1	1.2	0.1	0.2	0.0	0.7	1.3	0.7	5.0	1.1	0.0	2.4	2.4	0.3	0.0	0.2	0.2	0.6	3.2	1.1	1.4	1.5	0.0	0.1	0.4	2.4	1.3	0.3	2.7	1.4	0.2	0.7	0.0	1.3	1.1	0.7	0.7	0.7	0.2	0.9	1.3	0.9	1.9	1.8	0.5	1.5	1.0	2.6	0.9	2.8	0.6	1.5	0.6	2.0	0.4	0.7	0.7	0.3	0.6	0.6	0.6	0.7	0.1	1.0	0.9	0.8	1.6	0.7	0.2	0.8	0.8	0.5	5.0	4.9	7.2	5.2	5.0	4.1	4.6	4.5	5.1	3.3	5.1	4.6	41.5	3.2	0.5	0.7	0.0	0.5	0.9	0.1	0.6	0.3	0.5	0.1	6.7	0.0	0.7	0.0	0.0	1.1	3.1	0.2	0.0	0.1	0.7	0.7	0.8	28.3	0.0	0.0	0.4	0.6	0.9	0.9	0.0	1.5	1.3	0.1	21.4	0.3	0.1	0.0	0.5	0.2	20.3	0.6	1.2	0.2	0.6	0.3	5.4	6.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	1.3	0.1	1.7	0.0	2.2	1.5	0.2	0.4	0.2	1.0	4.5	0.7	0.3	0.0	0.8
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724577-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		170000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	35.0	38.7	13.1	32.3	14.7	13.0	39.0	15.6	19.0	44.3	26.1	33.9	35.6	32.3	64.2	50.1	30.1	32.0	57.4	14.9	16.1	38.7	76.8	30.4	32.5	16.7	14.4	56.9	57.5	37.7	31.5	43.7	16.4	39.9	36.9	39.2	54.7	37.5	219.2	36.2	33.7	35.7	14.9	26.3	40.8	43.1	15.6	30.7	53.4	138.7	39.7	40.2	27.6	19.2	46.8	36.0	49.5	66.7	118.6	155.8	45.5	106.2	129.4	57.2	69.2	36.2	70.4	60.6	64.0	98.0	49.2	52.8	74.9	66.5	85.6	67.2	29.3	41.8	31.4	76.3	93.0	55.8	46.2	89.2	80.6	59.8	116.4	110.6	87.1	41.7	73.7	67.9	85.8	30.9	55.4	29.5	67.9	98.2	21.3	36.3	47.2	49.2	85.5	53.1	39.4	38.3	39.1	82.4	67.3	73.6	60.6	45.1	67.4	52.2	32.2	95.8	40.7	63.6	36.6	29.5	77.6	33.1	63.2	21.9	13.1	11.9	16.4	18.7	22.2	9.8	13.6	15.7	16.8	11.2	13.9	13.8	8.1	22.2	26.9	13.4	15.1	13.7	13.1	14.7	15.6	19.0	14.9	16.1	16.7	14.4	16.4	14.9	15.6	19.2	34.5	60.9	84.5	59.1	43.2	38.0	52.8	59.6	51.2	33.3	35.0	28.4	126.9	28.6	71.7	25.8	43.8	47.9	32.6	32.0	35.2	38.4	11.1	35.7	57.5	36.4	40.1	20.8	70.9	48.6	49.0	62.7	61.2	55.0	48.8	126.2	32.9	62.0	42.8	26.9	68.7	63.7	40.7	38.0	35.1	10.9	78.6	41.3	28.4	60.9	54.8	32.8	45.3	77.4	113.7	48.5	33.4	68.4	106.9	78.2	44.3	50.4	66.4	51.2	39.5	54.0	50.5	73.8	68.2	58.7	40.3	90.6	37.8	36.3	41.9	63.8
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066156-27171811	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	20.4	13.6	21.0	20.9	22.0	75.7	15.3	21.6	26.7	13.1	15.5	35.6	18.2	13.2	15.1	17.0	13.5	17.9	14.4	23.7	22.2	24.8	34.9	23.6	29.4	18.9	24.8	14.7	15.3	16.5	13.8	17.7	19.5	14.0	25.5	38.0	10.2	12.1	13.1	24.0	24.3	18.6	21.0	17.2	17.7	15.5	22.2	12.2	16.1	15.9	26.4	21.8	13.5	21.8	24.9	15.3	28.6	14.9	18.8	23.8	10.2	34.1	23.9	18.5	13.7	27.7	37.8	35.1	16.6	27.0	44.9	15.0	18.9	19.8	39.4	57.0	16.1	54.3	19.2	19.6	23.6	31.8	36.5	14.9	28.3	21.0	23.9	23.4	43.3	23.8	18.4	16.5	38.9	14.4	19.6	42.0	20.5	31.5	26.7	22.1	36.5	8.3	36.3	17.3	31.5	19.0	29.3	24.2	28.2	35.5	11.4	30.4	51.6	19.3	18.6	41.6	31.4	12.6	15.0	24.6	32.4	18.5	22.0	0.0	0.5	2.2	0.5	0.5	0.9	1.2	0.9	0.8	0.6	1.6	0.6	0.6	0.5	0.9	0.8	1.1	1.4	0.4	21.0	22.0	21.6	26.7	23.7	22.2	18.9	24.8	19.5	21.0	22.2	21.8	54.2	28.9	29.9	19.6	42.1	91.6	29.4	7.0	34.7	23.8	30.6	24.0	23.4	17.2	9.1	23.9	39.6	15.4	26.5	47.0	29.4	12.8	19.2	29.1	26.4	42.0	20.9	60.6	37.0	16.3	7.0	34.2	23.9	68.9	13.3	15.7	21.4	23.3	14.0	28.6	29.0	27.5	10.2	20.8	153.8	10.7	7.8	47.8	39.2	42.2	33.6	13.8	9.2	43.7	65.0	24.4	37.4	6.4	37.1	34.0	34.3	21.3	12.2	32.1	32.9	114.7	42.8	2.7	12.9	23.1	79.0	10.9	27.2	9.3	24.1	40.6
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP17L1	USP17L1P	ENSG00000230549	"Ubiquitin specific peptidase 17 like family member 1"	Q7RTZ2	8	7332387-7333979	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.2	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L10		ENSG00000231396	"Ubiquitin specific peptidase 17 like family member 10"	C9JJH3	4	9210657-9212249	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17 like family member 11"	C9JVI0	4	9215405-9216997	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"brain: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	3.2	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	2.4	1.4	3.4	2.4	1.0	3.6	0.2	2.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L12		ENSG00000227551	"Ubiquitin specific peptidase 17 like family member 12"	C9JPN9	4	9220152-9221744	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L13		ENSG00000232399	"Ubiquitin specific peptidase 17 like family member 13"	C9JLJ4	4	9224896-9226488	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17 like family member 15"	C9J2P7	4	9234385-9236046	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	87	"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	7.1	0.0	3.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	3.8	0.0	0.0	0.0	0.0	10.4	0.9	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	3.5	0.0	7.6	6.8	3.8	10.4	0.9	12.3	0.9	12.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17 like family member 17"	D6RBQ6	4	9243879-9245471	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L18		ENSG00000250844	"Ubiquitin specific peptidase 17 like family member 18"	D6R9N7	4	9248630-9250222	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L19		ENSG00000248920	"Ubiquitin specific peptidase 17 like family member 19"	D6RCP7	4	9253378-9254970	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L2	DUB3	ENSG00000223443	"Ubiquitin specific peptidase 17 like family member 2"	Q6R6M4	8	12137168-12139077	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"															"unprognostic (2.01e-1)"			0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.6	0.2	0.5	0.0	0.2	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L20		ENSG00000250745	"Ubiquitin specific peptidase 17 like family member 20"	D6RJB6	4	9258124-9259716	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"brain: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA045642: AB_2679403"																		0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.0	1.2	1.0	1.7	0.7	0.7	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L21		ENSG00000249811	"Ubiquitin specific peptidase 17 like family member 21"	D6R901	4	9262872-9264464	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17 like family member 22"	D6RA61	4	9267619-9269211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	1.2	0.8	0.6	1.3	0.1	1.8	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17 like family member 24"	Q0WX57	4	9325165-9326757	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17 like family member 25"	Q0WX57	4	9329911-9331503	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17 like family member 26"	Q0WX57	4	9334658-9336250	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17 like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17 like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17 like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L3	"USP17B, USP17F"	ENSG00000225327	"Ubiquitin specific peptidase 17 like family member 3"	A6NCW0	8	7976393-7977985	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17 like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L4		ENSG00000236125	"Ubiquitin specific peptidase 17 like family member 4"	A6NCW7	8	7337115-7338707	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17 like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L7		ENSG00000226430	"Ubiquitin specific peptidase 17 like family member 7"	P0C7H9	8	12132417-12134099	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"															"unprognostic (5.31e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L8		ENSG00000237038	"Ubiquitin specific peptidase 17 like family member 8"	P0C7I0	8	7971661-7973253	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18150170-18177397	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	10.8	5.0	3.6	5.1	3.8	8.1	8.3	3.3	4.5	4.0	4.0	5.0	6.0	3.2	7.8	4.0	7.3	6.6	4.4	3.7	3.9	5.9	23.6	7.9	9.2	5.1	3.9	2.9	4.2	3.6	5.7	5.7	4.2	5.3	4.4	0.7	14.0	2.5	3.8	3.4	6.7	4.0	7.0	11.0	7.2	9.7	4.1	15.0	7.3	5.5	6.5	4.0	3.6	3.7	14.4	14.6	4.2	18.2	18.2	13.5	18.4	7.3	17.5	181.8	196.2	2.2	20.1	0.2	10.8	4.0	57.5	4.9	21.6	6.4	6.2	64.4	29.4	28.3	1.9	27.0	2.1	6.9	25.7	6.0	2.5	12.8	0.0	1.0	40.8	20.6	1.4	1.7	1.8	24.9	33.4	16.7	12.7	15.6	11.0	13.1	28.4	0.0	3.6	12.4	15.2	11.9	8.8	15.0	71.9	16.3	9.9	6.6	66.7	1.3	3.5	4.1	7.5	3.4	45.4	0.2	16.3	17.1	10.5	3.2	3.9	8.3	8.5	11.0	10.7	5.3	7.2	11.1	1.8	3.4	8.2	9.6	0.7	13.3	8.6	3.3	13.1	5.3	3.6	3.8	3.3	4.5	3.7	3.9	5.1	3.9	4.2	7.0	4.1	3.7	9.7	9.6	4.8	0.7	2.5	1.7	4.5	5.7	2.2	0.2	8.4	8.3	1.4	8.6	6.9	0.0	0.0	4.6	3.0	6.2	46.9	5.9	1.6	20.1	2.5	8.4	3.0	1.3	0.5	11.1	31.9	7.1	4.1	6.3	0.0	8.5	11.0	5.5	8.7	0.0	0.6	3.5	6.1	6.3	0.8	1.7	3.7	3.8	3.6	0.0	1.6	5.1	8.2	2.0	0.3	13.4	3.2	7.2	2.3	2.5	5.4	8.0	12.2	0.3	6.6	8.0	2.5	10.9	1.0	4.0	1.0	1.5	5.0	5.5	2.8	2.9
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 168.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 460.0;Late spermatids: 1094.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 14.5;U-266/70: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	7.0	13.4	11.9	1.6	22.6	1.9	4.1	18.8	19.0	6.0	32.7	10.2	13.9	5.2	5.7	9.8	11.6	2.3	73.5	18.6	9.4	53.4	18.9	3.4	0.1	12.0	13.1	6.2	18.1	24.2	18.9	1.3	7.7	4.1	6.0	76.2	7.6	3.0	168.3	12.8	17.4	6.8	8.2	0.6	6.2	86.5	15.1	0.6	3.8	62.8	0.6	4.5	4.8	17.5	6.0	0.5	0.9	3.2	0.1	0.2	1.3	0.7	0.4	0.0	0.6	6.1	0.8	10.2	1.8	1.1	1.4	1.0	7.9	2.9	0.2	7.2	1.0	2.8	4.4	12.5	2.7	0.0	2.8	0.9	0.6	0.7	2.0	1.3	0.6	7.6	14.5	0.8	1.7	4.1	0.0	0.6	1.6	2.0	1.3	0.1	2.1	1.5	4.6	0.3	11.9	3.6	3.4	2.6	0.7	1.7	8.8	6.2	0.0	0.0	1.5	0.8	1.0	56.9	13.5	0.2	0.1	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	22.6	18.8	19.0	18.6	9.4	12.0	13.1	7.7	8.2	15.1	17.5	0.6	3.2	2.7	10.7	0.6	2.4	5.3	1.5	1.2	75.2	3.3	2.4	85.2	7.2	6.1	5.5	95.9	0.5	1.6	25.5	113.5	3.1	460.0	39.0	3.0	3.6	0.0	0.4	15.7	1.6	0.9	7.4	2.0	8.4	0.0	2.0	2.2	23.0	17.2	10.1	11.6	2.0	0.0	1.3	2.9	1094.1	6.5	2.1	0.0	1.9	0.0	49.7	0.0	8.0	12.5	1.2	11.8	7.2	0.1	1.1	41.3	41.6	35.0	140.0	19.7	43.3	24.0	50.5	16.5	12.9	4.0	1.4	1.3	0.5	2.6	2.9
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999596-21043760	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	40.7	66.8	91.2	40.3	93.7	53.0	42.5	72.0	90.5	55.3	44.8	48.8	33.6	63.7	48.2	40.7	57.3	40.0	79.8	93.1	112.3	49.5	44.1	46.3	48.3	71.7	78.1	75.6	48.0	68.2	65.2	39.3	85.8	50.2	35.2	57.1	36.3	48.2	108.6	40.3	39.5	54.0	72.4	45.1	49.8	29.3	120.3	63.9	57.0	81.2	50.2	42.3	35.4	68.4	106.9	189.7	179.9	155.5	102.7	105.9	85.9	120.2	91.8	105.6	89.3	220.0	46.9	145.4	112.5	185.2	71.3	111.7	176.7	143.1	157.1	70.0	122.8	120.8	121.5	107.9	121.3	134.2	101.0	117.4	83.9	119.9	125.1	119.8	134.1	93.3	139.7	51.4	151.6	109.5	189.8	63.7	93.1	125.5	61.9	206.2	284.5	99.2	97.7	153.9	86.3	177.8	154.9	63.5	124.9	488.4	106.4	78.0	171.0	107.4	140.8	111.3	164.1	55.0	79.6	476.2	109.0	70.3	169.4	5.5	9.6	10.0	7.9	7.6	7.9	8.0	8.1	7.8	9.2	9.9	10.7	10.2	9.9	7.1	9.7	7.6	6.1	6.0	91.2	93.7	72.0	90.5	93.1	112.3	71.7	78.1	85.8	72.4	120.3	68.4	46.6	41.7	48.8	31.6	47.9	33.0	43.8	33.8	38.7	97.6	80.3	63.8	23.8	45.8	41.5	60.7	93.8	51.4	36.6	59.3	23.5	51.6	36.0	59.3	75.3	56.1	88.2	43.7	53.1	59.0	37.5	51.0	57.6	68.7	30.4	86.5	76.8	68.5	38.1	117.8	66.0	48.8	30.5	53.8	36.1	51.2	51.0	31.7	35.6	43.1	42.2	55.4	28.8	38.7	50.6	69.6	40.3	71.8	36.6	62.2	33.4	48.9	37.4	59.1	13.1	58.6	52.2	15.9	19.7	49.6	29.1	65.8	33.4	77.9	53.3	53.5
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215364	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 552.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	16.6	8.2	13.4	14.2	13.3	56.7	13.4	25.3	13.6	9.4	13.2	12.0	8.3	10.7	9.2	9.4	9.9	9.0	12.7	12.6	14.7	15.7	15.3	10.6	22.1	13.5	13.1	16.5	11.4	20.3	12.8	9.6	14.6	10.2	13.3	17.2	12.8	9.6	47.9	13.6	12.6	9.8	12.8	18.6	12.3	8.4	13.6	21.9	9.2	36.6	20.9	10.4	9.2	14.2	32.5	17.4	21.3	11.6	27.2	23.5	24.6	14.0	17.5	19.6	20.3	25.0	11.1	25.9	15.1	26.1	40.1	25.6	28.5	23.6	30.5	27.2	17.4	51.5	40.2	29.6	16.1	36.0	38.6	21.0	20.6	30.0	33.7	19.0	18.2	25.7	48.5	10.6	26.6	7.6	21.9	19.1	31.4	15.5	21.0	22.3	27.1	11.3	34.6	21.4	18.7	13.1	23.8	16.8	21.1	32.3	11.7	17.5	24.7	17.9	17.3	21.7	22.6	13.2	10.6	33.2	16.9	29.4	16.3	5.4	1.3	1.7	2.8	1.1	1.7	3.0	2.2	2.2	1.2	3.4	1.9	2.5	1.4	2.3	1.5	6.9	1.3	0.7	13.4	13.3	25.3	13.6	12.6	14.7	13.5	13.1	14.6	12.8	13.6	14.2	20.4	16.0	20.0	92.4	27.7	14.9	8.4	5.6	9.1	14.0	13.4	10.2	37.7	10.0	13.0	12.9	73.0	4.2	42.6	11.1	0.0	10.3	0.7	11.9	15.1	16.1	17.3	37.4	84.5	10.2	7.8	11.9	21.4	15.0	12.7	18.2	12.1	11.9	9.7	38.7	100.4	16.2	8.2	19.2	18.8	2.5	11.8	18.6	10.6	87.1	19.6	7.0	15.5	552.4	115.2	11.8	11.4	7.9	18.1	12.7	8.3	5.9	10.0	16.9	6.6	18.0	13.5	7.7	7.1	13.9	17.2	1.5	21.8	9.8	16.0	12.1
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	25.8	12.9	13.4	16.8	20.1	26.9	17.6	12.6	17.2	18.1	12.3	15.3	12.6	26.8	18.7	21.4	16.8	12.4	28.1	16.2	4.2	21.4	20.2	24.0	20.1	4.7	4.3	14.1	15.9	14.3	7.6	29.4	4.8	17.9	16.1	9.5	17.5	24.6	120.9	13.1	13.3	36.4	4.4	19.5	13.1	54.5	4.9	25.6	15.5	75.1	19.3	15.5	17.3	11.9	31.2	23.1	21.5	3.2	38.7	57.5	25.3	22.0	21.8	16.0	20.1	20.5	17.4	33.6	31.5	34.9	24.3	16.4	16.7	29.1	22.0	33.5	19.1	27.5	23.5	15.8	64.3	36.6	12.1	37.6	34.7	25.8	74.0	41.7	57.0	30.0	35.9	61.4	29.1	13.0	42.1	7.1	26.6	12.5	20.3	31.8	20.0	25.8	43.5	8.3	4.7	12.8	31.4	26.2	20.9	25.9	14.0	21.3	54.6	24.8	16.0	26.2	12.5	17.7	11.9	26.8	16.0	16.1	18.6	0.0	1.4	1.9	1.8	1.4	2.0	1.6	1.5	3.2	1.2	1.1	1.4	2.1	2.9	1.1	1.3	1.3	2.2	0.8	13.4	20.1	12.6	17.2	16.2	4.2	4.7	4.3	4.8	4.4	4.9	11.9	30.4	57.7	29.5	47.3	21.7	17.1	18.8	9.7	15.9	6.2	17.4	11.8	55.7	15.7	24.2	22.0	4.2	39.0	21.4	20.3	5.9	9.4	166.7	24.0	19.0	19.7	9.6	21.5	148.0	13.4	8.4	19.4	17.9	34.6	6.3	14.4	17.9	18.0	13.3	5.0	98.4	12.8	8.2	24.2	16.0	192.8	19.0	24.2	16.0	86.2	23.7	4.0	23.7	150.3	72.4	13.4	8.4	12.8	15.9	22.0	11.9	15.1	23.4	6.7	19.7	26.1	17.2	11.2	5.8	22.7	19.2	33.1	26.9	18.5	11.6	20.4
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	5.8	6.7	3.2	9.5	4.3	5.8	10.4	20.1	9.5	21.1	0.6	10.4	9.6	11.5	11.3	9.6	9.8	7.7	62.7	4.6	1.8	9.9	11.3	7.5	15.6	2.1	1.7	14.1	8.2	15.5	7.4	8.0	3.4	11.3	11.7	27.1	12.0	14.2	68.3	7.0	10.4	13.1	1.2	13.8	9.2	9.2	1.9	9.0	10.1	66.5	15.5	9.8	8.4	5.3	18.3	20.2	26.7	35.4	21.3	20.9	18.8	13.2	18.0	17.5	29.7	30.2	25.6	24.2	29.3	18.0	40.1	35.1	37.9	24.8	24.1	27.1	17.2	12.9	13.8	16.3	13.0	16.8	12.4	12.6	18.5	20.2	23.8	25.4	32.0	11.9	22.7	15.3	18.5	9.3	12.9	27.1	32.0	33.6	14.4	31.3	37.1	29.4	19.3	17.8	11.6	12.6	31.4	10.7	10.1	82.7	25.8	5.8	17.1	19.2	28.3	17.8	13.8	10.4	15.9	20.1	1.9	32.1	12.8	0.2	5.0	3.4	23.2	3.7	12.1	15.5	5.7	16.8	6.4	12.3	3.8	13.1	1.4	28.6	6.4	1.9	9.2	10.3	3.2	4.3	20.1	9.5	4.6	1.8	2.1	1.7	3.4	1.2	1.9	5.3	7.3	9.6	8.8	18.3	17.8	1.7	7.3	9.9	13.6	18.7	9.7	9.8	152.2	5.7	9.9	5.5	18.8	4.4	32.1	3.3	5.9	6.7	1.7	6.6	11.6	7.9	4.9	2.5	57.0	3.9	4.7	12.2	11.7	8.7	1.3	18.9	7.5	8.8	4.4	5.0	34.1	9.6	4.1	6.5	2.5	2.0	6.8	7.4	1.8	10.3	8.2	10.3	73.2	29.1	21.3	3.5	5.3	13.9	21.7	7.1	7.3	7.1	14.6	21.5	6.6	10.3	11.0	15.8	11.4	7.7	2.0	1.1	18.6	9.0	8.9	5.8
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.9"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 1.8;Early spermatids: 2.2;Spermatocytes: 5.1;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.0	0.9	0.0	0.5	1.8	0.0	2.1	0.6	0.0	1.0	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.5	1.0	1.0	0.1	0.1	0.2	0.4	1.9	0.9	0.3	1.3	0.0	0.0	0.2	0.8	0.1	0.1	0.6	0.7	0.0	0.3	1.4	0.0	0.0	0.8	0.2	0.4	4.9	0.8	0.0	0.3	0.0	0.1	0.3	0.0	2.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.6	0.5	0.2	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.2	0.0	1.3	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	1.1	0.3	0.1	0.6	0.1	0.2	0.9	0.5	2.1	0.6	1.0	1.0	1.9	0.9	0.8	0.8	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2
USP30	"FLJ40511, MGC10702"	ENSG00000135093	"Ubiquitin specific peptidase 30"	Q70CQ3	12	109023089-109088023	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 52.7;Oligodendrocytes: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016952	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016952: AB_1858680"	"unprognostic (2.34e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-3)"	8.4	8.8	2.9	7.3	6.0	10.7	6.5	4.2	5.4	6.6	1.9	10.2	11.4	7.8	4.7	5.6	8.0	5.9	6.8	3.3	6.9	9.1	16.3	6.8	8.8	5.2	4.3	12.4	8.6	14.4	4.2	5.1	5.5	6.8	8.4	10.7	7.7	6.7	10.0	6.6	11.1	6.2	3.0	7.9	6.5	13.8	5.0	6.3	8.2	8.7	4.5	4.3	3.3	14.1	5.3	4.1	10.7	9.2	7.3	8.3	5.9	5.9	7.8	6.8	5.9	4.9	3.9	13.6	4.8	5.9	6.1	5.6	9.4	6.3	7.7	16.0	11.7	4.2	3.8	7.1	7.8	8.7	4.6	10.1	7.4	5.9	6.0	17.5	8.0	13.8	6.8	6.1	5.9	6.3	13.8	5.0	3.2	6.3	11.3	14.7	7.6	8.1	5.4	6.4	9.7	8.6	8.0	5.6	6.3	7.8	14.5	6.8	5.5	5.9	3.3	5.9	3.7	16.0	14.4	19.3	6.5	5.0	6.9	14.0	8.4	16.2	17.5	14.0	20.2	17.3	14.7	16.8	5.6	17.0	15.2	14.1	5.1	23.3	11.7	15.2	14.4	7.4	2.9	6.0	4.2	5.4	3.3	6.9	5.2	4.3	5.5	3.0	5.0	14.1	3.9	0.0	4.6	10.7	2.5	2.0	2.2	4.1	6.2	9.1	4.8	4.1	8.6	10.0	5.6	5.5	8.4	5.7	3.4	14.3	0.0	4.7	27.3	3.6	3.8	3.6	6.7	5.7	18.8	5.7	4.2	4.4	1.5	3.2	0.0	11.8	4.2	18.3	5.7	6.7	22.7	8.4	0.0	3.5	1.4	52.7	3.7	2.2	1.8	7.5	3.5	6.9	4.1	16.6	41.8	5.3	5.6	3.8	6.7	1.9	13.3	7.3	5.2	14.9	13.1	5.2	3.5	26.1	5.6	4.7	3.3	7.3	3.4	5.0	9.9	2.7
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	5.5	2.9	7.5	2.0	23.4	4.3	6.7	18.9	13.0	12.9	0.7	4.2	1.7	11.0	3.8	6.0	5.3	1.9	9.2	10.0	10.5	3.6	5.6	6.1	1.8	22.3	20.3	2.2	4.3	5.5	5.7	3.9	21.3	7.5	2.3	3.2	4.6	4.1	8.9	11.2	2.6	7.5	11.3	1.6	2.6	11.8	20.6	2.6	3.0	8.4	2.5	7.5	7.9	31.2	12.0	12.4	3.5	4.9	6.2	4.8	3.3	4.1	3.7	5.1	6.1	7.9	7.1	4.0	4.2	5.1	8.3	15.2	8.7	15.9	8.4	2.9	3.5	1.6	7.4	16.7	7.8	4.2	4.3	4.1	13.5	9.5	21.8	1.9	9.3	3.9	4.9	12.0	7.1	8.0	2.0	3.5	6.9	3.9	3.8	9.9	9.8	7.9	7.7	17.5	9.3	6.0	6.3	12.4	3.6	3.9	5.0	9.2	5.5	10.3	7.6	5.3	11.2	3.9	7.0	4.2	7.4	5.5	4.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	7.5	23.4	18.9	13.0	10.0	10.5	22.3	20.3	21.3	11.3	20.6	31.2	25.9	6.4	3.7	11.1	2.2	66.8	62.7	35.5	44.9	13.7	7.6	19.8	13.6	7.2	10.9	5.5	2.1	13.8	3.6	2.7	0.0	7.0	4.8	20.6	12.8	17.6	4.8	8.2	59.2	8.6	7.5	6.9	2.0	13.2	1.3	23.7	7.5	27.7	4.7	0.0	49.6	3.5	12.2	3.5	10.8	10.4	7.8	5.0	7.2	32.8	3.1	4.0	3.1	31.7	198.7	7.9	2.0	4.5	2.8	32.0	1.5	11.6	17.6	8.1	19.7	8.8	11.2	24.2	57.1	17.4	26.6	7.5	2.9	4.4	6.4	23.9
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60177327-60422470	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 59.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 59.2;granulocytes: 29.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 171.4"					"Low region specificity"	"Detected in all"			HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	16.1	21.8	13.6	15.0	27.8	32.1	14.1	23.2	23.6	12.4	25.2	13.0	9.5	10.3	6.8	21.7	10.7	11.8	17.4	14.3	22.8	20.2	26.6	20.7	10.5	22.2	25.0	10.0	12.5	19.2	11.9	13.2	24.8	10.8	11.4	58.8	12.9	11.2	40.8	21.0	10.5	13.7	18.1	18.5	12.2	102.1	22.3	14.4	20.6	29.2	11.6	13.1	14.7	44.4	32.6	38.2	19.0	30.8	44.8	45.3	17.2	26.4	41.9	34.5	45.8	18.6	20.0	19.4	21.5	50.0	56.1	16.3	33.1	36.9	61.5	16.8	13.9	39.7	31.8	19.5	44.1	31.7	33.6	39.6	24.6	49.9	45.2	33.5	38.6	24.4	42.9	17.1	41.1	171.4	32.3	21.3	21.7	29.6	18.8	15.8	51.6	11.5	33.1	24.5	13.1	19.1	22.9	6.0	33.8	32.1	27.4	41.3	32.6	49.7	54.9	33.1	23.5	16.2	37.4	19.6	24.6	23.6	33.4	14.5	4.3	16.5	2.0	3.7	1.4	3.0	1.4	1.7	8.5	2.2	1.0	1.9	29.4	1.3	4.6	59.2	2.6	2.1	13.6	27.8	23.2	23.6	14.3	22.8	22.2	25.0	24.8	18.1	22.3	44.4	8.0	6.4	16.4	58.8	12.5	26.9	13.3	5.8	11.4	17.3	9.2	7.6	8.2	10.0	10.1	5.5	241.8	5.1	12.6	8.5	3.9	11.3	95.0	9.0	9.9	9.8	8.3	44.2	92.3	7.5	8.4	12.6	15.8	11.6	11.4	18.5	12.5	12.0	18.5	13.5	113.1	5.6	6.1	29.7	41.3	33.3	13.1	25.1	5.4	101.2	28.0	10.4	24.7	70.4	268.9	9.6	11.4	5.7	8.3	10.3	7.4	4.6	7.0	136.4	26.3	11.9	9.1	92.7	14.9	11.2	21.9	4.9	10.9	8.5	5.5	8.2
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61471087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	32.2	36.0	49.9	21.7	53.9	37.7	35.6	57.7	58.3	36.1	59.9	47.0	14.8	38.4	54.4	35.8	33.3	21.1	33.7	49.7	53.5	43.3	34.8	36.4	44.1	52.1	51.8	43.4	32.4	35.1	45.0	17.4	52.3	38.6	26.8	77.5	27.2	32.4	53.9	41.4	40.8	27.9	50.3	45.8	36.3	45.1	54.5	47.8	32.2	36.8	45.1	36.9	32.8	56.8	43.6	29.9	38.9	40.3	71.8	48.1	32.4	26.3	37.1	23.0	21.7	43.0	16.3	102.2	27.0	56.9	24.3	23.4	30.9	34.4	42.6	36.7	24.4	61.6	29.5	69.6	60.2	46.1	37.8	52.9	43.6	41.9	62.1	55.7	49.0	28.8	42.7	32.2	51.5	40.6	30.6	66.6	26.3	43.9	23.9	32.4	46.5	27.7	67.9	52.2	31.9	34.0	40.5	30.1	48.3	49.4	16.0	33.2	43.6	36.1	48.2	21.5	34.7	37.0	19.7	103.6	33.8	42.5	31.7	2.1	1.2	1.6	3.8	1.1	3.5	2.6	2.6	2.9	1.0	3.1	2.9	3.9	1.8	3.1	2.8	3.2	2.5	1.4	49.9	53.9	57.7	58.3	49.7	53.5	52.1	51.8	52.3	50.3	54.5	56.8	64.5	64.1	68.3	193.6	82.8	61.1	54.2	40.3	46.7	139.7	54.0	46.6	46.0	48.6	54.6	33.1	250.2	33.5	87.3	46.0	9.8	41.4	133.5	59.9	66.9	59.3	48.6	53.2	256.6	33.6	23.8	53.0	73.9	70.6	32.3	78.0	31.8	38.9	21.6	107.7	240.4	37.8	59.0	45.4	48.6	138.0	56.8	56.0	40.9	212.7	55.2	60.0	87.6	232.2	310.0	49.9	41.1	67.0	69.9	79.9	38.3	23.4	44.1	178.1	26.3	78.2	63.9	95.8	115.9	53.1	61.4	53.4	70.5	74.7	35.6	69.9
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78215232	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 39.1;Granulosa cells: 30.8;Late spermatids: 121.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	6.1	19.8	8.0	3.6	7.4	2.5	5.1	5.1	8.0	9.2	7.4	7.6	3.5	6.7	3.2	6.0	6.4	3.5	10.2	8.3	7.1	6.2	16.8	7.0	3.3	9.0	8.2	7.4	5.9	12.4	13.4	4.7	9.4	5.9	1.9	2.1	3.9	3.2	4.1	3.0	4.5	4.7	3.9	4.9	4.6	4.5	8.3	6.2	8.7	4.0	2.6	6.6	7.7	6.4	2.2	3.3	5.7	6.1	9.7	8.7	3.9	5.0	5.8	5.8	4.0	8.4	4.7	1.7	5.0	9.5	6.2	5.8	3.8	7.8	3.4	12.8	2.0	2.9	9.8	5.0	7.4	1.8	8.3	7.4	5.1	12.1	3.5	11.4	7.2	6.5	4.1	4.2	4.6	2.0	4.7	7.6	1.7	6.2	5.3	2.9	5.2	2.0	4.5	4.1	2.8	5.9	3.9	5.1	1.9	8.1	4.3	1.6	8.9	10.6	5.9	12.8	2.7	5.7	2.0	2.7	3.1	2.0	6.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	7.4	5.1	8.0	8.3	7.1	9.0	8.2	9.4	3.9	8.3	6.4	1.3	0.0	1.8	5.9	1.2	0.8	0.2	0.7	3.4	0.8	1.0	0.6	3.5	0.0	0.3	0.0	6.2	0.7	1.0	1.2	0.0	1.1	39.1	1.3	2.7	1.9	0.0	0.4	5.2	2.0	1.6	2.0	5.1	1.2	0.0	30.8	1.4	2.7	1.6	0.0	4.8	0.9	0.0	0.6	0.8	121.6	1.5	1.4	1.8	2.8	2.7	0.4	0.0	3.5	2.8	2.0	0.1	3.0	0.8	0.3	0.8	1.0	0.5	0.6	6.6	0.7	1.3	1.2	2.4	4.1	1.0	0.3	2.9	2.1	1.3	0.2
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	43.9	37.9	20.0	21.5	21.9	46.6	32.9	29.3	23.9	32.6	27.5	31.2	13.4	26.8	22.9	25.0	34.2	18.7	30.2	21.4	20.6	34.4	30.3	36.1	20.6	22.6	21.3	67.4	44.5	18.1	50.3	26.0	21.5	36.2	15.8	26.3	24.9	13.1	30.3	40.4	26.6	16.3	19.4	30.7	31.2	22.2	21.2	15.1	31.6	11.7	20.5	29.3	29.8	30.1	42.7	50.3	14.6	26.9	30.5	33.7	27.8	34.1	34.5	32.1	21.5	49.2	21.0	54.0	16.9	30.6	34.8	30.6	34.5	25.4	57.0	13.0	52.1	49.4	81.0	51.9	31.3	54.7	26.0	29.5	41.0	45.8	101.6	24.7	28.3	24.1	40.0	55.3	26.8	32.6	50.1	55.1	22.6	31.6	39.9	38.1	31.8	36.3	20.2	44.1	42.8	25.8	24.5	112.5	63.7	31.3	29.2	34.4	24.3	75.2	35.3	44.3	61.1	40.7	17.4	66.1	29.6	41.9	24.0	10.1	3.0	2.4	5.5	4.2	6.5	5.1	5.2	4.8	1.8	4.7	5.7	5.6	4.3	4.5	2.7	9.7	3.8	1.9	20.0	21.9	29.3	23.9	21.4	20.6	22.6	21.3	21.5	19.4	21.2	30.1	27.4	12.8	37.4	23.5	55.9	51.7	28.4	8.2	40.9	33.2	18.1	16.9	14.1	18.6	18.8	14.7	33.3	8.3	66.3	14.4	5.9	10.2	20.7	22.3	24.0	28.4	18.5	14.7	19.0	9.6	11.3	26.6	25.0	42.7	20.3	12.8	12.1	16.5	43.3	26.9	22.5	18.6	10.2	24.5	72.8	8.5	11.8	49.4	30.2	10.3	14.9	13.2	16.5	13.6	19.8	13.2	8.4	12.4	57.1	32.4	7.3	5.0	11.1	32.1	6.6	22.1	23.1	18.4	16.5	24.4	43.3	12.9	73.6	13.1	18.6	22.2
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568351	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.4;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	2.7	4.1	3.5	4.4	4.7	11.8	4.7	8.5	4.9	3.6	1.9	3.0	2.9	4.2	7.5	3.9	3.3	3.5	2.3	3.3	4.0	2.9	3.8	3.0	6.0	3.8	4.0	5.9	3.0	4.0	1.4	4.0	4.0	3.6	3.5	9.1	3.9	3.0	2.9	3.9	3.3	3.2	2.5	3.8	3.4	12.7	3.4	6.3	5.0	4.2	4.9	3.6	2.2	8.3	9.6	6.9	14.2	11.0	3.6	4.4	12.1	7.1	5.1	12.2	13.6	13.1	7.4	8.7	7.5	5.6	9.3	8.9	15.7	8.0	13.4	12.0	8.3	23.5	13.6	8.7	4.1	15.6	11.3	2.4	4.7	12.9	9.2	4.5	5.3	15.0	17.3	16.2	7.8	7.2	20.1	10.6	12.2	6.2	5.9	16.0	21.3	8.0	4.2	11.2	15.5	8.4	11.5	5.6	7.2	13.6	6.4	10.8	6.8	13.7	12.0	7.7	9.5	11.0	10.4	17.6	7.4	11.2	9.5	4.2	2.0	3.8	3.1	2.3	3.2	2.5	2.6	2.7	2.1	3.2	4.0	2.6	1.6	3.2	2.2	2.9	3.6	1.2	3.5	4.7	8.5	4.9	3.3	4.0	3.8	4.0	4.0	2.5	3.4	8.3	12.8	0.0	11.0	34.3	16.5	19.5	7.0	7.1	22.2	14.7	14.4	10.2	4.9	4.3	9.6	7.3	27.1	8.4	13.4	5.5	0.0	5.8	119.4	13.3	11.8	14.2	10.3	16.6	47.4	2.3	6.6	13.2	9.2	16.4	5.1	16.2	12.5	11.0	7.8	15.2	40.0	8.9	4.1	8.5	22.9	145.5	9.9	17.2	21.4	27.2	10.2	9.1	10.3	35.2	60.5	4.9	7.4	9.8	14.6	12.1	7.1	4.2	11.1	19.9	6.6	12.7	21.6	60.8	31.4	13.6	20.6	7.3	19.7	10.9	7.6	7.1
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	6.5	4.4	2.5	6.2	4.3	21.6	4.6	4.3	2.9	6.2	4.3	8.0	7.9	5.5	2.3	7.0	4.3	5.2	6.8	2.2	2.4	7.0	13.2	6.3	6.4	5.9	3.8	3.7	8.2	7.7	3.3	8.1	4.9	5.5	5.7	4.5	5.8	5.6	36.6	5.9	7.2	5.7	4.9	7.4	6.3	6.8	3.2	9.3	7.4	21.3	5.8	6.8	3.9	6.8	8.5	7.9	6.6	11.3	8.4	8.2	5.1	13.0	12.5	11.8	10.1	23.1	11.7	10.5	9.2	11.5	7.8	6.5	15.9	13.5	10.2	26.0	10.5	9.7	8.5	4.7	11.3	19.4	9.4	10.2	11.1	12.0	9.5	8.3	12.2	11.9	21.5	31.5	7.9	13.3	25.6	3.7	6.1	17.7	15.3	16.7	10.2	10.1	7.2	9.2	13.8	12.3	10.5	17.3	10.9	4.9	10.8	7.6	14.6	10.8	9.1	9.6	14.1	35.7	65.3	18.6	10.9	14.4	9.3	13.4	4.5	9.7	5.7	4.6	7.0	4.6	4.9	4.9	6.6	4.5	4.8	4.2	4.3	10.1	4.9	2.7	7.9	4.3	2.5	4.3	4.3	2.9	2.2	2.4	5.9	3.8	4.9	4.9	3.2	6.8	21.5	22.4	19.8	13.7	19.5	53.5	21.0	6.2	25.6	7.4	20.8	13.7	18.4	10.0	12.2	0.0	12.5	12.8	22.2	35.5	1.9	8.3	36.4	20.7	26.1	15.3	30.6	31.5	19.6	7.7	7.1	13.4	26.0	52.1	3.8	9.9	17.9	38.4	10.6	8.4	15.9	20.2	4.1	17.0	16.6	20.3	6.8	21.9	12.4	9.4	10.1	15.1	12.3	18.6	22.8	10.2	13.4	9.4	38.6	16.8	17.0	18.5	10.9	8.9	13.1	15.0	14.1	11.3	4.7	31.5	59.1	26.7	23.2	11.0	17.6	45.4
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649283	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	22.6	16.1	18.1	19.8	18.7	40.8	21.3	19.0	20.6	22.2	22.7	24.2	17.1	23.5	26.1	22.7	19.5	12.7	22.7	17.9	19.5	21.7	18.5	21.4	26.5	18.9	18.4	20.1	17.2	21.8	14.3	26.9	18.9	18.7	22.7	22.0	19.0	21.2	55.2	23.8	19.5	21.3	18.9	20.9	20.6	15.6	18.8	41.0	19.8	42.6	32.2	24.7	20.6	19.8	71.0	70.0	70.0	77.5	49.7	38.7	79.5	59.2	54.6	84.1	74.5	113.9	49.8	83.0	53.4	54.6	62.3	50.6	135.7	62.5	105.8	83.9	86.4	103.4	39.1	100.6	49.0	127.4	67.5	27.9	49.3	65.1	57.8	39.3	68.1	85.3	129.8	47.2	62.8	81.4	125.2	94.8	92.8	84.9	64.2	114.1	150.0	63.1	45.0	53.8	65.1	53.7	36.4	58.9	51.4	56.7	39.5	60.5	43.9	51.7	65.0	62.7	97.2	42.0	83.0	87.7	44.9	130.5	63.6	51.1	35.8	44.5	40.2	42.4	46.6	34.7	41.8	41.7	40.6	37.0	40.4	37.0	23.1	40.4	41.6	32.0	53.4	43.6	18.1	18.7	19.0	20.6	17.9	19.5	18.9	18.4	18.9	18.9	18.8	19.8	18.4	19.2	25.2	19.9	17.5	20.5	16.7	17.9	22.2	8.5	14.1	14.0	17.3	11.5	19.9	12.9	8.4	54.1	17.8	14.8	21.5	21.1	26.1	9.8	15.4	17.1	12.1	18.3	13.9	18.8	31.8	17.1	9.7	11.7	17.1	16.3	17.5	14.2	25.6	5.0	18.2	13.4	24.4	11.9	14.7	13.0	19.3	17.6	19.6	17.8	26.4	15.3	12.3	16.1	33.1	19.2	8.5	18.8	14.0	16.0	11.2	14.6	15.6	11.6	0.0	13.0	17.7	19.5	17.1	15.5	16.2	35.7	21.3	12.7	15.7	16.3
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277144-49340712	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.8;Late spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	25.2	20.3	24.2	26.5	26.3	53.7	24.9	24.5	28.2	27.7	27.1	25.4	18.3	24.4	21.6	26.0	22.4	18.3	26.5	23.7	23.4	21.8	20.2	29.5	30.9	23.9	24.4	24.5	19.0	24.1	16.4	23.3	23.9	23.7	23.4	26.9	21.0	21.7	31.6	31.4	22.5	24.0	22.4	33.7	20.2	28.0	24.8	37.0	23.0	28.8	33.7	25.8	25.0	24.5	14.2	15.8	21.6	28.8	38.7	40.1	14.7	36.4	32.9	46.7	41.3	16.8	34.8	27.1	14.4	53.9	27.4	18.9	28.6	52.6	42.5	42.1	8.4	60.3	31.9	19.6	57.0	32.5	34.0	42.8	23.3	51.0	41.5	34.3	55.0	29.9	21.6	41.6	42.1	24.5	38.3	55.8	18.7	17.7	26.9	15.6	13.3	23.9	37.5	29.2	17.5	24.0	27.2	19.3	14.0	21.6	13.5	51.2	50.1	31.1	17.2	39.6	22.5	33.6	17.3	38.6	28.6	50.1	36.5	70.1	83.6	94.8	48.1	69.2	53.7	51.0	50.2	48.9	74.6	41.4	47.7	42.2	179.2	72.4	81.2	28.4	59.7	78.0	24.2	26.3	24.5	28.2	23.7	23.4	23.9	24.4	23.9	22.4	24.8	24.5	24.3	41.7	25.1	28.1	24.7	18.7	17.9	17.2	22.2	17.5	10.9	10.3	17.9	10.0	23.2	20.2	20.9	22.7	27.9	13.6	21.5	16.5	131.8	17.3	18.3	22.1	10.7	31.6	30.8	13.6	14.3	17.9	27.5	21.1	33.6	21.4	17.5	14.6	24.0	11.8	26.4	13.8	16.2	38.6	21.0	104.9	15.5	34.2	16.0	16.9	36.0	13.9	23.7	25.6	20.2	18.9	7.6	19.2	29.2	17.6	14.5	13.4	28.6	20.5	13.1	18.4	17.0	35.3	14.5	17.9	18.5	24.2	29.4	17.0	13.9	14.5
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 79.3;Oligodendrocytes: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	11.8	12.0	10.4	7.5	17.0	3.4	13.9	12.8	11.4	10.0	16.5	9.4	10.5	10.6	24.0	10.4	11.5	11.6	8.2	10.2	12.0	14.2	13.2	12.5	7.2	19.4	14.2	15.9	14.0	16.8	8.5	12.4	19.0	13.5	9.5	14.2	12.9	10.4	9.6	19.7	10.1	8.5	12.3	9.9	13.1	14.7	16.2	10.1	16.4	7.6	7.8	9.6	7.5	25.4	17.3	19.9	17.6	12.0	25.2	23.0	15.7	16.4	12.4	14.7	16.0	14.3	20.2	0.4	4.7	26.4	38.6	30.3	13.3	29.7	20.6	0.0	9.0	13.3	17.4	24.3	22.3	5.8	8.9	22.2	21.1	22.2	30.9	26.2	17.3	8.1	22.0	3.2	21.4	14.0	6.2	8.5	7.9	17.8	16.0	0.0	36.3	8.1	17.9	27.6	9.6	10.3	13.5	13.5	16.9	12.9	15.4	12.9	17.3	20.9	13.1	8.9	20.6	6.0	4.9	0.8	27.1	10.2	18.6	0.0	1.0	0.0	0.5	1.1	0.2	0.4	0.5	0.4	1.5	0.7	0.7	0.7	0.1	0.5	0.9	1.9	0.8	0.5	10.4	17.0	12.8	11.4	10.2	12.0	19.4	14.2	19.0	12.3	16.2	25.4	11.8	32.1	35.5	79.3	7.9	7.4	9.1	13.6	15.4	18.1	17.0	14.7	10.7	10.0	19.9	16.5	25.0	21.2	6.7	9.9	7.9	9.4	8.4	19.8	18.3	11.1	15.0	5.7	25.9	12.6	10.6	11.9	21.4	21.3	9.5	23.4	12.8	25.4	8.2	23.5	38.2	10.9	4.1	11.6	3.6	10.7	6.8	9.1	3.6	40.3	5.9	11.9	4.1	48.2	127.7	10.5	12.6	8.2	10.9	12.9	13.9	14.6	21.0	19.4	13.1	17.5	10.6	30.2	20.9	17.2	10.5	15.7	5.5	21.1	12.1	10.0
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762, HPA027763"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: "	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.3	0.2	2.6	0.6	3.4	0.7	1.9	0.8	4.1	2.9	2.9	3.5	4.2	1.9	1.0	6.5	4.2	1.2	0.0	3.3	1.4	4.0	9.1	3.2	0.1	2.5	4.6	0.1	5.0	1.1	3.5	8.3	2.5	9.8	3.2	1.4	4.3	2.2	0.0	2.2	3.5	0.2	2.1	0.3	2.1	3.2	2.3	0.3	1.7	0.0	0.7	1.1	2.4	2.5	5.6	1.4	0.0	0.5	0.0	0.0	11.7	0.1	0.2	0.6	1.6	2.8	4.5	0.0	1.8	0.2	2.5	6.8	0.6	5.3	0.6	3.6	1.8	0.3	3.0	1.0	0.1	0.5	0.0	0.0	6.8	0.3	2.8	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.9	4.6	0.7	4.8	0.3	3.6	0.0	0.8	4.1	3.0	0.7	0.0	2.4	8.1	1.0	3.7	9.9	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.4	0.8	4.1	3.3	1.4	2.5	4.6	2.5	2.1	2.3	2.5	0.0	3.2	3.1	1.6	0.3	4.7	7.8	4.6	5.2	0.5	7.0	2.4	0.6	4.3	7.4	11.0	6.2	26.2	0.6	14.3	1.9	4.4	1.1	37.9	4.2	0.5	2.4	3.2	35.5	4.7	23.7	0.8	7.7	52.5	0.0	0.9	0.4	15.6	2.7	0.0	4.0	8.3	2.0	0.9	0.3	1.1	0.0	0.6	5.4	0.0	0.3	8.4	0.0	73.4	1.2	11.3	3.5	0.0	0.2	10.6	8.7	1.8	30.2	1.5	0.0	0.0	1.0	1.5	0.3	12.3	3.3	73.2	0.7	0.0	9.7	11.8
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590960-52659301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 150.8;Early spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.4	8.6	30.4	3.3	31.2	2.9	6.4	27.4	31.5	7.6	22.4	3.9	4.4	6.5	5.4	11.5	7.0	5.3	28.6	30.8	33.3	9.9	2.9	3.9	3.7	27.9	33.9	11.0	5.2	10.4	4.6	5.3	26.7	6.9	4.0	11.5	8.3	6.7	14.5	7.5	4.2	5.0	30.4	3.3	6.0	12.3	32.5	3.4	9.3	12.5	5.5	6.0	7.4	26.8	8.1	5.7	18.0	13.3	19.1	23.8	19.8	13.0	10.5	9.5	7.9	11.5	6.2	5.4	14.9	13.0	13.4	4.7	31.6	15.1	17.2	4.7	11.1	8.4	5.3	12.8	19.1	11.2	9.4	20.4	13.9	9.7	9.1	18.4	14.2	7.4	8.3	7.4	20.3	7.4	4.8	5.9	13.3	9.0	6.8	12.0	13.1	1.1	20.3	14.8	10.8	12.9	6.4	21.5	12.9	17.1	7.9	8.2	13.3	9.2	20.1	10.9	19.9	7.5	3.7	4.2	14.2	6.7	11.6	0.7	0.4	0.1	0.7	0.4	0.5	0.4	1.2	0.6	0.9	0.4	0.2	0.2	0.1	0.4	0.3	1.4	0.4	0.3	30.4	31.2	27.4	31.5	30.8	33.3	27.9	33.9	26.7	30.4	32.5	26.8	10.0	6.4	7.2	24.2	6.4	5.4	11.2	15.2	26.2	150.8	13.7	11.7	44.9	14.3	16.4	14.7	4.2	12.1	10.7	5.2	21.5	10.8	229.8	18.4	34.9	12.5	4.2	6.7	32.6	12.0	12.5	17.8	17.3	15.6	0.0	22.9	13.6	6.8	5.8	35.3	24.3	5.9	10.2	8.4	4.6	34.1	28.9	7.9	8.8	21.5	12.9	30.0	5.2	30.2	12.6	12.5	9.9	36.1	9.5	21.1	3.9	17.1	23.8	8.7	6.6	16.2	15.9	3.2	14.4	25.9	8.2	7.7	8.0	18.3	7.1	17.7
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11961887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	15.7	14.3	11.9	11.4	15.8	19.0	15.1	17.3	12.8	14.3	10.2	19.8	10.3	17.2	15.6	16.1	13.5	12.3	23.5	12.5	14.1	13.2	23.3	16.2	13.3	14.1	12.8	15.9	16.9	22.2	13.8	16.7	15.0	16.6	12.3	25.7	14.1	15.4	59.8	18.0	14.1	17.8	14.1	11.8	16.6	15.0	12.7	19.1	14.9	33.6	13.8	16.7	14.2	20.6	26.8	15.7	30.3	13.1	21.8	23.2	12.6	31.6	22.3	20.1	22.1	16.5	22.2	29.6	13.3	28.0	23.7	17.8	23.7	15.3	30.3	27.5	20.4	18.6	30.3	12.6	21.5	25.0	23.9	22.3	22.5	12.3	29.0	26.1	21.8	21.7	35.8	23.7	25.4	10.6	21.7	14.3	7.9	28.1	12.7	21.4	30.3	9.4	24.6	29.1	9.8	21.0	25.8	19.6	19.3	18.4	14.4	20.6	24.9	27.8	16.2	22.3	19.6	7.9	18.1	25.9	19.9	15.2	20.3	14.7	5.9	11.9	11.0	7.4	14.5	7.4	10.3	11.4	7.9	6.7	13.1	11.4	2.8	18.5	11.5	4.8	8.3	7.9	11.9	15.8	17.3	12.8	12.5	14.1	14.1	12.8	15.0	14.1	12.7	20.6	41.1	70.5	63.1	116.5	46.9	71.0	68.8	28.8	45.5	67.5	41.1	30.9	222.5	40.0	56.0	23.9	47.9	69.6	57.2	30.4	25.4	39.5	40.1	49.8	63.0	44.8	59.3	34.3	122.7	38.9	33.2	69.7	44.4	134.5	54.3	52.6	32.5	53.9	28.0	63.9	136.5	32.9	24.4	27.7	39.7	30.0	44.1	41.8	24.9	96.5	40.5	79.7	68.0	171.4	315.9	44.8	31.5	50.0	55.2	65.5	29.7	21.9	48.2	52.4	52.6	85.0	68.2	92.8	55.1	46.6	87.9	125.7	65.0	41.8	35.0	58.9
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	25.8	47.5	18.7	26.6	24.5	43.5	26.4	31.0	26.4	26.9	21.6	24.4	21.7	25.3	20.4	23.0	22.3	18.9	21.6	19.3	20.4	18.2	23.8	23.1	35.1	20.1	20.4	31.1	24.6	25.2	26.9	27.3	21.7	23.5	26.0	57.0	31.2	18.6	23.1	29.5	28.7	22.9	18.5	36.0	32.5	20.6	20.8	26.9	28.6	19.5	34.5	23.1	24.6	36.0	43.9	20.5	47.0	34.0	40.1	49.0	46.4	54.0	36.5	35.3	46.6	19.1	43.2	49.1	35.6	48.8	27.5	39.2	59.0	43.4	53.6	48.3	42.1	104.3	75.7	34.5	35.5	53.0	53.7	39.8	36.6	36.1	39.7	48.1	106.1	36.2	83.8	133.2	44.0	21.9	44.2	68.5	29.7	44.5	36.8	61.3	47.2	57.3	40.7	36.2	57.1	35.6	50.4	45.7	122.7	62.3	23.4	63.0	76.1	37.7	30.9	46.7	31.8	105.6	81.7	48.1	36.3	64.5	56.6	82.1	19.5	35.0	12.2	9.4	13.9	28.6	17.8	17.9	21.1	29.8	20.5	13.1	16.8	12.2	10.9	15.3	21.4	12.6	18.7	24.5	31.0	26.4	19.3	20.4	20.1	20.4	21.7	18.5	20.8	36.0	37.9	54.5	42.1	32.0	55.4	22.2	25.1	30.3	33.0	86.5	22.2	24.5	65.3	21.5	24.4	20.2	62.6	61.4	48.3	17.8	25.4	28.5	71.4	33.3	48.5	32.5	21.7	88.1	66.4	20.0	56.3	42.0	33.1	41.4	49.9	200.4	27.5	22.1	29.2	50.5	74.2	31.3	32.6	22.6	28.1	47.7	34.8	34.4	58.7	52.5	55.9	30.7	36.0	54.3	112.3	23.8	16.4	51.6	150.1	20.7	24.1	20.2	27.3	69.2	32.9	51.7	39.8	52.7	47.4	35.1	25.7	32.6	41.8	54.8	31.6	21.6
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 48.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in all"		"REH: 46.7;U-698: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.9	2.8	4.3	2.6	3.2	5.3	2.6	6.0	3.8	3.4	0.4	2.6	1.7	2.9	1.6	1.9	2.6	1.6	2.0	3.3	3.7	2.0	1.6	2.7	2.6	2.7	3.9	3.1	2.0	1.5	2.7	1.4	2.5	2.3	1.5	9.3	2.0	1.6	2.9	3.0	1.7	1.6	0.7	2.5	1.8	4.8	4.1	6.7	7.0	1.0	2.5	2.5	2.6	3.8	6.0	1.8	23.6	11.6	2.8	3.0	9.7	2.3	2.2	3.4	4.3	7.5	1.4	24.5	2.5	2.9	4.9	2.6	14.7	2.2	5.1	6.1	11.0	8.8	10.3	2.7	2.0	6.9	5.2	3.1	1.7	5.0	3.1	3.1	2.2	24.9	18.7	6.4	2.6	3.5	26.7	10.5	6.5	6.4	2.2	46.7	11.3	5.4	1.4	4.1	15.8	6.5	3.1	1.1	1.3	5.5	3.5	6.1	6.1	8.1	8.0	2.6	3.1	12.2	11.4	63.9	1.0	6.9	1.5	5.1	0.4	0.6	0.3	0.4	0.2	0.6	0.2	0.3	0.1	0.4	0.4	0.3	1.0	0.4	0.5	0.3	0.2	0.2	4.3	3.2	6.0	3.8	3.3	3.7	2.7	3.9	2.5	0.7	4.1	3.8	2.4	0.0	9.7	20.2	2.0	5.0	3.0	3.9	1.2	27.5	3.6	3.3	4.6	4.3	6.5	5.5	43.8	2.9	4.5	1.4	1.9	1.9	6.5	4.1	5.0	2.8	0.0	8.2	42.8	2.0	1.6	4.3	3.1	4.6	1.3	4.8	1.4	2.1	2.0	15.2	48.6	1.9	4.1	3.1	4.6	7.2	3.7	3.1	3.6	14.0	5.0	2.8	2.1	56.3	31.8	2.6	1.9	6.0	3.0	4.5	2.1	1.1	7.1	10.9	6.6	6.2	3.4	13.3	14.3	2.7	6.3	5.7	2.4	5.1	2.2	4.6
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
USP50		ENSG00000170236	"Ubiquitin specific peptidase 50"	Q70EL3	15	50494018-50546708	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 107.8;Late spermatids: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039470	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA039470: AB_10672964"	"unprognostic (7.05e-3)"	"unprognostic (2.38e-1)"		"unprognostic (2.01e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.49e-4)"	"unprognostic (3.03e-1)"	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	107.8	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	3.2	0.0	0.0	0.0	0.0	58.0	0.3	0.2	0.0	2.8	0.0	0.0	0.0	3.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	3.8	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 51.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.7;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	1.4	3.1	2.5	0.9	2.7	0.5	1.7	2.8	2.8	1.9	4.2	0.8	0.4	3.1	51.7	0.6	5.5	0.8	2.1	2.2	4.2	3.7	1.2	1.5	1.1	2.2	3.1	6.5	1.1	5.6	1.4	2.4	2.4	2.4	0.8	3.1	0.8	2.5	0.4	1.1	0.7	1.9	2.5	1.8	0.8	2.3	3.8	2.4	5.3	1.1	1.2	0.9	0.7	2.5	0.0	0.6	3.9	1.1	1.9	1.0	0.0	0.6	0.3	0.7	0.9	1.2	0.5	0.0	4.6	0.8	0.8	0.2	1.0	0.4	1.2	1.3	0.0	1.0	0.2	0.0	0.8	2.5	0.2	3.9	0.0	0.4	0.0	0.3	0.2	3.0	3.1	3.0	0.6	2.6	2.4	1.3	4.8	0.0	0.2	3.4	0.7	1.5	0.9	0.1	0.0	0.7	1.1	0.1	3.7	7.0	0.9	1.3	0.2	1.5	2.1	0.4	0.1	4.7	2.0	0.9	1.0	1.4	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	2.7	2.8	2.8	2.2	4.2	2.2	3.1	2.4	2.5	3.8	2.5	5.1	3.2	5.5	3.3	2.6	0.9	2.2	0.9	2.2	23.7	3.8	7.4	6.9	1.5	2.0	3.7	6.2	4.3	1.2	0.2	9.8	1.5	0.3	9.0	9.2	6.0	3.6	5.0	2.7	0.0	2.2	8.1	0.0	2.1	1.3	7.9	6.4	0.7	7.6	6.7	5.0	0.5	0.0	5.6	2.5	1.0	4.1	4.7	5.4	1.9	0.3	32.9	3.1	3.5	3.7	0.2	0.3	8.2	1.0	1.0	0.0	13.1	11.2	16.4	0.0	7.1	5.0	11.4	12.5	1.0	0.4	2.7	3.1	13.0	0.4	0.5
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 586.8;Microglial cells: 269.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 327.9;SK-MEL-30: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	37.8	14.4	5.6	5.7	5.8	0.9	25.3	6.1	6.2	18.5	11.8	16.3	5.7	13.1	13.1	17.0	30.6	10.2	24.0	4.9	7.3	19.9	7.3	29.4	12.4	9.4	8.1	9.4	24.6	8.1	10.3	10.5	7.3	9.2	16.1	3.4	12.7	11.5	33.5	11.7	9.7	10.2	6.5	7.2	15.1	7.8	8.6	5.4	10.5	51.7	8.0	12.7	12.0	5.5	11.4	6.8	2.4	0.0	60.5	60.4	13.6	70.6	327.9	6.2	8.1	7.4	10.4	46.1	2.5	21.1	12.1	5.5	5.5	5.3	16.1	6.1	4.5	3.1	5.2	2.6	47.2	3.9	0.7	20.3	15.0	21.9	31.0	11.7	29.8	3.0	7.3	1.7	8.4	2.5	2.9	5.2	6.7	7.0	3.8	0.9	11.4	9.2	16.4	7.2	3.8	3.0	3.9	27.5	102.4	13.3	7.0	2.7	32.3	2.0	7.0	26.3	6.4	3.3	5.2	7.8	31.4	1.7	7.9	1.3	0.0	0.0	0.4	0.0	0.5	0.7	1.0	0.8	0.1	0.7	1.9	1.0	0.2	0.9	0.0	0.3	0.9	0.3	5.6	5.8	6.1	6.2	4.9	7.3	9.4	8.1	7.3	6.5	8.6	5.5	27.6	35.3	44.5	80.6	18.5	61.8	73.6	21.2	48.3	17.8	74.1	46.6	99.0	32.9	33.9	119.5	29.2	48.4	15.1	207.8	45.0	33.4	5.6	167.2	45.9	35.7	34.6	4.8	32.4	62.7	17.3	86.0	41.8	586.8	70.8	19.8	23.9	30.5	9.3	25.2	32.5	80.4	52.9	21.3	76.4	7.3	19.0	36.5	14.2	269.8	45.6	25.0	12.3	11.6	11.9	110.6	214.5	10.9	18.6	138.6	46.0	20.1	27.3	31.5	6.6	91.8	32.9	18.0	4.0	62.6	42.3	49.8	26.8	14.8	62.6	124.8
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625994	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 134.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	4.6	3.1	61.5	5.5	103.5	2.1	16.3	85.5	72.4	14.5	32.2	15.0	4.9	9.3	13.2	13.9	12.0	5.6	7.0	60.5	71.9	5.2	1.5	17.9	2.8	99.8	97.5	6.8	10.8	8.9	2.9	2.8	94.0	12.1	19.7	14.8	16.8	7.6	49.7	15.2	6.7	7.1	70.4	2.9	20.7	9.1	85.0	8.4	40.7	17.0	7.1	6.6	4.9	134.8	10.0	8.4	15.9	13.7	4.4	4.8	4.7	4.7	11.2	7.9	8.6	8.1	16.7	6.6	6.5	3.7	6.1	14.2	10.7	4.3	10.2	2.8	8.6	5.0	6.3	8.0	4.1	5.6	2.3	3.9	3.8	9.0	10.9	20.6	3.4	5.7	7.5	3.0	6.3	5.6	4.5	6.8	8.0	33.4	30.2	7.0	11.9	3.0	8.7	7.6	4.8	5.4	10.1	11.7	15.8	10.2	15.8	5.8	4.9	3.5	11.2	6.6	6.8	2.4	4.3	4.1	8.3	5.3	3.1	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.5	0.4	0.4	0.3	0.7	0.4	0.0	0.3	0.5	0.4	0.6	0.4	61.5	103.5	85.5	72.4	60.5	71.9	99.8	97.5	94.0	70.4	85.0	134.8	5.9	48.1	34.3	33.0	1.7	2.7	8.5	11.0	4.0	7.7	15.3	8.4	7.2	5.7	18.9	12.9	16.7	1.0	1.2	19.6	0.0	4.7	2.4	25.8	12.9	6.3	10.3	2.1	23.1	8.0	1.0	7.6	40.2	44.3	3.8	3.5	2.5	3.0	1.4	5.0	33.4	23.4	2.0	1.3	1.4	2.2	3.4	1.8	8.8	76.8	0.8	12.5	0.0	116.1	476.0	12.2	9.7	10.9	2.3	52.6	10.5	1.9	21.7	12.2	6.6	19.6	3.8	9.2	6.0	7.7	4.0	1.4	3.0	2.9	11.2	15.2
USP6NL	"KIAA0019, RN-tre, RNTRE, TRE2NL, USP6NL-IT1"	ENSG00000148429	"USP6 N-terminal like"	Q92738	10	11453946-11611754	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 145.2;Oligodendrocyte precursor cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.0;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039196	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"			"HPA039196: AB_10795031"	"unprognostic (1.64e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.54e-2)"	5.4	6.8	4.8	7.3	5.2	8.6	5.5	6.5	4.3	6.5	6.0	5.8	5.5	5.9	7.7	22.9	8.9	5.7	4.5	4.8	6.0	5.6	16.3	6.5	14.9	7.5	6.3	7.5	5.1	5.4	4.6	6.8	7.5	4.7	7.4	13.0	6.9	5.2	1.7	8.1	5.8	5.7	6.9	13.6	7.3	24.6	6.4	7.4	5.2	2.2	18.5	5.6	9.7	7.5	26.9	11.6	24.5	10.7	6.1	7.4	11.9	7.3	6.3	8.2	11.3	14.3	24.8	33.5	7.0	6.3	6.7	14.6	11.2	7.9	12.0	0.1	8.7	14.3	6.6	25.5	7.3	4.2	2.0	4.2	11.6	9.5	5.6	9.5	19.8	11.5	22.6	0.8	7.0	18.6	11.6	3.1	12.5	25.0	6.0	22.2	6.4	4.3	11.6	7.9	7.8	13.7	7.9	24.0	25.3	10.2	17.8	4.4	10.8	4.2	15.4	10.9	7.1	0.0	0.9	22.0	7.1	5.1	11.5	0.8	0.5	0.8	0.0	0.9	0.1	4.0	0.1	0.1	0.7	3.4	0.1	0.1	0.3	0.5	0.6	0.6	0.0	0.3	4.8	5.2	6.5	4.3	4.8	6.0	7.5	6.3	7.5	6.9	6.4	7.5	12.0	3.2	17.5	23.2	37.7	6.8	20.6	7.8	13.6	6.0	9.6	6.6	7.8	2.8	12.4	1.8	29.2	7.6	0.5	8.2	7.9	10.8	17.4	32.5	9.7	11.1	13.8	14.3	16.0	10.6	7.5	6.8	20.4	33.2	0.0	11.8	5.7	14.1	8.6	6.7	24.3	14.0	8.2	16.3	8.7	15.4	4.7	12.7	12.4	145.2	7.5	11.2	3.1	68.3	29.4	16.1	6.8	4.9	20.0	20.8	4.2	9.0	15.6	14.6	0.0	5.2	9.1	21.5	7.2	20.1	9.9	7.3	3.9	7.7	7.1	48.3
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892097-8975328	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	22.3	16.1	17.6	27.0	19.8	54.6	20.5	20.5	20.7	20.1	15.1	33.1	21.8	21.5	10.1	29.6	19.0	19.9	23.8	21.4	18.1	19.5	25.1	19.3	39.9	16.9	20.1	19.8	26.7	34.8	13.9	23.7	17.5	20.7	32.5	21.7	18.7	18.7	45.2	25.4	25.9	25.7	18.7	24.2	25.5	58.8	18.8	51.1	22.8	41.0	44.9	26.3	17.7	20.8	39.9	73.5	62.2	46.9	34.9	42.9	42.9	53.6	44.7	48.1	40.4	66.6	46.7	94.6	33.8	61.0	27.7	48.8	95.2	61.9	79.6	63.1	38.1	78.4	49.5	132.9	49.0	87.6	48.8	37.3	37.7	52.6	61.0	37.0	69.7	139.8	77.7	101.5	49.6	75.4	130.8	16.9	43.9	49.8	41.4	114.5	69.7	86.2	33.4	77.9	58.8	35.5	59.4	55.3	28.7	62.3	55.0	39.4	60.4	52.1	54.1	80.3	40.4	49.1	134.3	145.1	48.5	49.6	43.5	5.2	2.1	2.8	4.5	2.2	5.7	4.0	4.1	5.3	2.2	4.9	4.9	4.3	3.4	2.8	6.1	6.5	5.1	1.1	17.6	19.8	20.5	20.7	21.4	18.1	16.9	20.1	17.5	18.7	18.8	20.8	40.4	35.3	54.5	22.2	38.0	46.5	23.1	17.9	22.8	51.1	29.7	28.8	74.3	21.5	36.4	29.5	25.0	21.9	51.4	39.8	5.9	22.5	282.4	38.5	50.9	35.8	42.2	46.5	31.4	33.4	14.5	34.4	31.1	57.6	26.6	47.8	25.0	37.5	19.8	43.7	34.9	49.3	10.2	29.2	31.0	112.2	25.4	43.8	19.6	21.5	36.3	29.2	24.7	24.1	30.2	35.6	39.0	34.6	46.8	34.1	31.3	13.7	37.8	44.2	6.6	58.4	39.4	33.8	39.4	41.3	50.0	21.1	40.4	47.6	54.8	35.0
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9 X-linked"	Q93008	X	41085445-41236579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA		24000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	16.4	16.8	11.9	14.3	13.9	18.2	14.2	12.7	12.8	15.3	14.3	14.8	13.6	15.4	14.9	14.1	16.0	13.0	15.3	14.3	13.2	17.8	33.9	14.4	15.8	12.2	13.1	13.4	16.0	30.0	10.2	18.4	13.8	12.3	13.7	22.0	11.5	15.3	39.1	13.8	14.3	16.3	12.5	13.3	13.8	17.5	12.8	18.8	19.5	28.4	16.2	15.0	12.6	16.4	38.6	44.2	39.1	40.2	33.0	32.7	8.8	21.5	28.8	23.8	27.5	21.1	16.9	25.7	11.5	48.5	71.3	25.3	67.1	39.7	39.7	32.0	50.5	29.3	41.3	19.9	27.6	26.4	21.0	29.3	17.9	56.4	53.4	35.5	37.2	17.1	36.0	20.3	38.6	29.1	18.8	12.7	42.6	14.1	24.7	20.3	51.8	16.9	24.7	30.7	22.2	20.8	89.0	26.7	26.0	69.8	24.3	16.2	40.2	36.6	27.6	34.6	24.0	19.1	22.3	30.9	26.4	12.1	18.5	1.7	2.3	3.0	2.5	1.9	3.6	2.8	3.0	2.7	2.6	2.1	3.0	2.8	6.4	2.5	2.5	2.1	2.8	1.5	11.9	13.9	12.7	12.8	14.3	13.2	12.2	13.1	13.8	12.5	12.8	16.4	38.1	41.7	35.1	48.0	42.6	48.3	30.8	29.6	55.2	38.1	41.3	29.5	83.5	54.3	37.9	27.6	37.5	39.6	46.3	58.5	7.9	28.4	14.9	85.5	56.9	43.6	26.9	41.0	84.9	26.5	25.4	41.4	41.8	136.9	25.9	58.3	45.7	62.8	32.6	37.0	86.0	39.1	18.3	47.8	42.1	15.4	33.2	55.5	33.8	67.5	44.6	31.3	30.9	74.9	108.0	32.6	40.1	49.2	38.8	35.6	47.7	21.5	35.8	31.2	32.9	70.6	48.3	86.4	82.9	55.2	55.3	46.7	42.4	45.8	38.0	40.2
USPL1	"bA121O19.1, C13orf22, D13S106E"	ENSG00000132952	"Ubiquitin specific peptidase like 1"	Q5W0Q7	13	30617693-30660770	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 135.8;Late spermatids: 306.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039342, HPA040172"	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039342: AB_10795105, HPA040172: AB_10796447"	"unprognostic (5.74e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.32e-3)"	11.9	9.9	8.0	8.5	8.5	24.1	11.3	11.0	12.0	10.3	7.9	10.7	6.3	10.9	7.1	7.3	10.0	6.2	8.0	8.5	8.1	12.0	15.6	11.8	12.9	8.0	8.0	13.2	12.1	4.7	8.9	8.2	8.2	10.9	6.5	15.6	9.0	6.6	9.4	9.7	13.7	6.3	8.4	18.6	10.0	19.4	8.4	9.3	10.9	8.3	11.5	10.6	9.6	11.2	4.5	6.5	14.7	9.5	7.5	9.0	6.2	10.1	7.9	9.8	7.9	9.1	11.5	10.1	5.0	8.6	12.8	9.1	16.2	6.1	14.4	8.5	6.6	12.6	10.4	8.0	6.7	12.1	9.6	6.8	10.7	7.2	10.1	14.2	14.2	10.9	12.4	6.6	10.8	3.9	17.3	25.3	12.6	15.0	4.2	15.3	11.3	9.5	7.9	3.0	13.0	11.7	5.5	6.4	9.5	11.3	7.1	15.1	9.0	6.8	6.7	9.2	7.9	6.7	6.3	14.5	3.9	8.7	13.6	3.1	3.8	3.7	3.5	2.8	5.0	5.3	3.4	3.7	3.5	5.7	4.7	4.3	1.8	4.5	2.3	2.6	4.2	3.1	8.0	8.5	11.0	12.0	8.5	8.1	8.0	8.0	8.2	8.4	8.4	11.2	17.6	16.0	9.8	17.3	30.2	4.5	6.6	4.5	17.1	10.1	9.0	8.4	18.2	5.7	7.4	7.3	16.7	4.3	18.6	6.3	3.9	5.1	135.8	9.3	19.6	13.9	14.3	9.5	19.6	4.5	5.9	13.7	13.7	12.1	1.3	9.4	11.0	6.9	7.0	15.2	23.0	11.7	6.1	10.1	15.4	306.1	6.8	18.2	3.6	19.7	6.9	8.9	10.3	21.6	26.8	5.5	5.6	5.3	24.2	8.5	5.7	3.5	6.4	12.0	6.6	13.1	12.6	16.4	8.8	15.5	3.8	3.1	18.2	10.1	8.8	5.0
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.2	6.3	3.0	7.4	0.2	6.2	10.0	7.9	7.6	7.5	9.2	1.7	6.8	5.6	4.6	9.2	6.0	4.3	5.8	16.0	3.6	1.3	5.2	3.9	28.2	17.2	11.6	13.1	4.6	1.9	4.6	14.1	6.3	2.7	6.8	3.2	4.8	1.7	6.7	5.7	8.8	13.5	6.5	5.0	6.7	22.7	6.5	27.5	5.8	3.7	8.8	7.7	15.6	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	6.3	7.4	10.0	7.9	5.8	16.0	28.2	17.2	14.1	13.5	22.7	15.6	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
UTF1		ENSG00000171794	"Undifferentiated embryonic cell transcription factor 1"	Q5T230	10	133230217-133231558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.9"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 42.1;Spermatogonia: 40.0"	"Cancer enriched"	"Detected in single"	243	"testis cancer: 49.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"NTERA-2: 5.5;RPMI-8226: 2.0"									CAB022384	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB022384: "					"unprognostic (9.19e-2)"					"unprognostic (1.95e-1)"	"unprognostic (8.57e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-1)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.0	42.1	1.1	0.3	7.0	0.0	0.0	4.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	40.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11 small subunit processome component"	Q9Y3A2	1	38009258-38024820	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 111.4;tongue: 85.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	15.4	18.7	11.0	15.4	11.9	16.7	13.6	11.9	15.9	11.4	10.6	18.4	11.3	15.9	13.4	18.4	12.3	12.9	19.9	11.7	11.6	12.3	17.0	11.4	14.9	12.9	12.3	11.0	15.6	12.0	7.3	14.8	12.4	13.7	13.3	7.0	14.1	12.8	111.4	14.6	9.9	19.7	12.0	10.7	14.0	15.1	11.9	13.5	11.0	85.5	17.5	19.7	11.0	14.7	37.6	22.9	38.5	36.8	27.8	37.8	34.6	41.5	39.4	55.4	50.4	32.8	44.9	62.6	37.9	34.2	27.2	31.6	44.2	37.2	68.8	47.3	39.9	72.6	27.9	28.8	37.9	72.7	45.3	35.3	23.7	61.4	53.3	34.1	44.6	47.6	84.1	32.5	63.5	26.6	56.9	75.4	92.1	41.9	29.1	49.7	80.8	57.3	36.5	36.2	49.8	41.5	36.1	30.7	67.8	40.1	28.1	44.5	33.2	36.8	45.0	40.8	80.0	31.0	65.8	52.6	49.3	79.3	46.5	18.1	27.6	15.2	23.1	30.6	24.3	15.0	18.3	19.3	27.6	17.5	16.3	20.3	8.3	32.2	36.5	26.3	23.4	20.5	11.0	11.9	11.9	15.9	11.7	11.6	12.9	12.3	12.4	12.0	11.9	14.7	37.9	35.3	43.6	0.0	5.7	0.0	0.0	0.0	0.0	0.0	29.8	27.6	0.0	0.0	21.1	25.8	0.0	54.2	23.6	0.0	39.2	60.2	0.0	23.6	43.5	31.4	0.0	0.0	0.0	67.4	51.7	23.4	0.0	24.8	25.2	19.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	19.1	0.0	0.0	0.0	0.0	72.6	0.0	0.0	3.5	0.0	0.0	49.4	25.5	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	77.8	10.5	39.1	0.0	0.0
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023, CAB079950"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	11.5	7.8	5.9	11.9	7.7	9.8	13.2	6.2	8.1	10.5	5.6	10.1	7.2	11.2	11.1	11.6	10.7	7.6	7.8	5.9	7.6	9.0	8.2	7.5	13.7	6.7	7.0	12.7	16.1	9.5	5.2	10.1	6.6	8.2	11.9	5.1	8.6	8.3	12.5	10.0	8.2	11.7	5.8	9.5	10.1	2.2	7.0	12.7	9.2	6.3	17.1	14.2	9.8	7.1	34.7	38.0	19.9	52.9	32.7	33.2	33.5	37.6	28.5	37.0	29.4	39.0	33.5	81.6	73.7	27.3	40.2	43.4	80.6	40.8	45.1	27.2	40.1	46.6	32.9	29.8	36.9	66.7	34.5	40.9	35.1	50.2	52.6	23.7	29.5	29.9	47.3	25.0	32.1	57.1	48.4	50.6	41.6	65.5	42.1	37.5	30.1	56.0	25.4	26.1	20.8	54.7	21.3	38.9	45.2	26.1	21.0	38.4	25.8	16.2	21.2	45.8	73.2	30.8	38.4	71.1	24.4	81.2	37.4	29.2	9.4	5.0	13.9	16.8	16.1	12.3	11.5	13.1	13.8	14.1	14.4	13.5	1.1	18.5	15.4	11.0	17.6	8.8	5.9	7.7	6.2	8.1	5.9	7.6	6.7	7.0	6.6	5.8	7.0	7.1	10.1	12.8	15.6	3.6	11.2	8.4	17.0	11.1	17.6	5.3	10.2	13.2	10.5	11.5	20.6	0.0	4.2	24.1	16.8	7.2	13.7	16.8	0.2	12.7	24.0	10.1	7.7	12.2	7.8	12.6	20.0	11.9	9.7	15.7	14.0	10.6	6.8	5.1	13.6	1.7	7.2	10.4	12.2	9.5	5.5	0.5	6.2	11.1	5.4	3.7	17.8	6.5	16.5	3.5	8.4	13.0	9.7	7.2	14.7	12.2	4.9	9.1	8.1	5.2	13.1	17.9	13.2	1.3	2.2	18.9	8.0	40.6	13.1	13.1	13.8	11.4
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9"									"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	5.7	5.2	3.8	0.0	3.5	0.0	5.2	3.6	4.4	5.9	4.0	6.1	0.3	7.1	0.0	4.4	5.9	0.0	6.2	3.4	3.5	5.9	7.7	4.7	0.6	3.3	3.9	5.5	6.8	1.2	5.5	0.0	3.3	5.3	0.0	2.2	6.6	0.0	6.7	3.7	5.6	0.2	3.3	5.1	5.9	3.2	3.7	1.8	6.1	2.4	0.0	5.5	5.1	3.8	0.0	0.0	1.2	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.2	1.3	5.7	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.5	3.6	4.4	3.4	3.5	3.3	3.9	3.3	3.3	3.7	3.8	9.9	6.4	17.5	8.5	8.2	5.9	5.6	10.8	9.6	13.9	13.7	7.9	23.8	12.8	15.8	16.5	4.2	10.1	5.1	21.2	0.0	7.3	0.4	9.1	13.9	13.9	18.6	19.9	8.9	7.6	9.6	13.9	5.1	12.4	11.4	14.4	14.6	33.6	9.3	25.2	9.0	14.7	8.2	13.5	3.9	0.8	10.5	8.1	8.8	5.6	8.2	14.1	10.3	6.6	10.7	7.7	11.3	14.3	8.4	12.7	9.9	6.4	14.8	11.6	6.6	20.2	12.6	7.2	13.3	14.0	8.4	7.0	7.2	9.4	14.1	6.7
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18 small subunit processome component"	Q9Y5J1	17	51260546-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.6;Late spermatids: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	17.9	20.1	12.6	24.9	13.7	40.0	25.8	19.1	15.7	18.8	14.2	17.5	17.8	15.7	15.8	21.0	17.5	12.8	10.2	13.2	13.8	21.8	22.3	17.3	33.1	13.0	12.3	23.8	21.3	23.3	20.4	26.3	13.6	16.2	18.7	17.5	17.4	14.2	24.4	32.3	16.5	12.9	13.0	24.5	18.1	58.7	13.2	27.7	24.4	16.2	34.4	24.8	18.0	15.6	90.5	87.7	54.6	50.3	35.1	52.2	142.2	48.9	40.2	83.5	79.7	55.4	49.3	113.5	67.8	36.6	89.0	48.1	89.7	52.0	123.3	74.8	117.0	119.4	52.6	97.3	48.0	127.9	56.4	33.9	39.5	71.1	57.0	42.1	50.7	55.6	98.7	50.6	63.5	56.1	115.6	86.9	78.5	127.5	91.8	103.2	124.2	89.4	61.3	59.1	60.7	76.9	56.7	66.6	114.7	67.4	82.3	64.4	44.7	85.3	71.8	71.1	102.9	97.4	192.5	131.5	53.0	87.6	62.4	19.0	48.2	27.9	40.2	46.9	49.9	54.1	50.7	49.2	55.9	52.4	53.6	51.1	8.2	40.0	49.0	35.0	56.8	56.2	12.6	13.7	19.1	15.7	13.2	13.8	13.0	12.3	13.6	13.0	13.2	15.6	20.6	16.0	23.4	11.8	37.4	60.2	62.9	40.6	33.0	15.6	19.6	17.9	4.4	20.0	25.2	14.7	14.6	66.7	27.4	11.4	39.2	38.4	190.6	26.3	27.3	25.1	16.1	20.8	18.5	46.9	71.2	24.5	14.3	24.1	31.7	19.6	8.9	17.1	62.8	10.1	18.0	20.7	34.6	37.7	26.1	182.0	26.8	33.3	23.2	15.0	42.2	21.3	25.7	17.6	24.6	34.2	16.3	22.2	24.2	50.2	13.8	37.5	38.8	11.8	13.1	24.8	35.7	140.2	104.5	27.7	52.7	79.6	30.4	30.8	25.3	48.1
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23 small subunit processome component"	Q9BRU9	8	116766505-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavorable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	11.8	7.9	5.6	10.1	6.6	33.2	9.6	8.1	6.7	7.8	4.3	7.1	6.2	9.6	6.5	7.2	8.1	7.9	7.1	5.7	6.0	6.8	7.4	7.8	15.4	5.6	5.5	13.7	9.7	8.1	4.8	9.6	5.7	8.1	5.6	9.6	9.0	6.4	8.6	8.0	7.8	7.4	6.1	10.3	7.7	6.8	5.4	8.2	12.3	6.2	8.9	7.9	5.9	9.0	22.0	22.7	12.9	11.3	17.9	21.3	9.8	21.9	13.3	14.1	15.6	23.8	14.2	34.4	20.5	10.5	14.1	16.1	18.2	12.8	17.4	33.5	35.3	42.5	18.3	16.2	19.1	21.2	19.7	18.6	13.8	15.7	19.1	9.2	15.4	25.9	27.7	22.6	14.1	38.3	50.2	12.4	11.8	35.9	44.1	28.1	14.2	29.7	8.9	19.8	22.7	18.3	14.2	53.8	21.5	6.5	25.8	14.6	16.4	14.7	20.3	35.7	30.9	30.8	48.9	39.7	18.8	27.4	17.4	49.7	24.6	32.6	39.5	26.6	34.2	43.1	35.2	31.2	22.1	41.6	47.7	33.2	24.6	28.1	37.0	36.1	43.6	26.4	5.6	6.6	8.1	6.7	5.7	6.0	5.6	5.5	5.7	6.1	5.4	9.0	33.6	41.7	33.1	36.2	31.0	21.9	27.0	17.4	31.9	23.2	16.7	29.2	23.4	27.1	23.4	7.3	6.2	28.3	24.8	9.9	27.4	17.3	13.9	18.0	37.0	28.7	12.0	12.4	62.6	20.7	17.9	32.9	21.9	20.6	41.8	24.3	25.0	13.8	16.6	16.8	62.2	16.6	14.2	12.6	10.5	4.8	28.9	18.5	10.6	15.9	24.0	27.4	20.6	42.3	43.0	12.4	9.4	28.6	32.0	28.7	9.0	16.2	19.2	22.4	13.1	39.5	26.4	44.0	20.3	26.6	16.2	19.8	29.5	28.8	16.6	19.1
UTP25	"C1orf107, DEF, DIEXF, MGC29875"	ENSG00000117597	"UTP25 small subunit processor component"	Q68CQ4	1	209827972-209857565	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 11.0;Endometrial stromal cells: 11.4;Glandular and luminal cells: 13.1;Granulosa cells: 10.7;Pancreatic endocrine cells: 11.2;Proximal tubular cells: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026640	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA026640: AB_2067139"	"unprognostic (3.11e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (7.01e-2)"	3.6	2.9	2.9	4.0	3.1	2.9	6.5	1.2	3.2	3.6	1.5	3.4	2.8	4.2	3.4	3.2	4.5	2.6	2.4	2.9	2.5	3.5	4.4	2.5	4.9	1.5	2.3	7.1	3.5	3.6	1.5	3.2	2.2	3.0	3.8	2.3	3.0	3.2	2.6	4.6	3.0	3.9	1.8	3.9	3.3	2.0	2.4	3.5	4.2	2.8	4.7	4.1	3.2	3.0	9.5	9.6	3.5	6.3	7.4	6.9	10.2	11.9	14.4	8.4	7.7	6.1	10.3	11.5	6.9	12.7	10.2	10.2	10.6	7.3	11.5	8.3	10.3	6.1	6.6	4.2	5.2	9.0	6.1	6.8	10.2	13.8	12.8	7.3	7.0	6.1	15.6	7.3	8.8	4.8	8.1	5.1	15.3	8.7	7.0	6.4	11.2	14.7	6.1	8.7	8.2	10.0	6.1	15.5	12.3	9.3	6.4	7.1	8.3	17.7	8.2	11.5	13.1	8.0	9.4	11.0	7.7	6.7	7.2	4.1	2.3	0.7	3.7	3.0	5.1	5.3	4.0	3.6	3.1	4.5	5.0	4.5	0.2	4.9	4.1	2.1	3.2	2.5	2.9	3.1	1.2	3.2	2.9	2.5	1.5	2.3	2.2	1.8	2.4	3.0	8.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	9.9	10.0	0.0	0.0	0.0	11.0	0.0	6.8	6.7	0.0	7.9	10.2	0.0	10.6	11.4	4.0	0.0	0.0	0.0	9.1	7.8	3.1	0.0	13.1	0.0	10.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.2	0.0	0.0	1.4	0.0	0.0	10.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	4.0	3.2	6.6	0.0	0.0
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3 small subunit processome component"	Q9NQZ2	4	70688532-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	22.4	22.7	8.9	25.5	9.5	19.1	18.7	9.4	11.3	14.0	10.0	16.9	16.3	16.1	15.0	20.6	16.3	14.6	17.0	9.9	9.8	21.0	27.1	18.6	33.0	9.1	9.3	15.7	14.9	16.3	9.4	16.3	9.1	15.1	16.4	12.0	15.9	13.7	15.9	18.8	21.5	20.2	8.7	34.5	17.8	11.4	9.6	32.1	16.0	13.1	31.5	22.1	12.3	10.0	33.7	32.3	42.4	35.4	58.9	44.3	36.3	68.4	43.9	38.4	37.0	42.4	43.7	147.4	42.1	58.9	43.8	27.7	62.7	93.7	55.4	45.9	35.9	56.1	43.0	45.9	63.9	85.9	47.9	60.4	55.2	47.0	46.0	42.3	52.2	42.3	65.3	48.2	62.8	69.7	79.9	47.8	29.6	68.9	46.7	33.8	58.3	60.5	69.7	53.7	35.5	48.4	29.1	65.4	44.5	46.1	36.1	34.2	58.5	38.8	65.9	37.3	44.3	69.6	55.4	104.8	47.3	41.4	34.8	8.4	10.7	5.6	6.4	12.6	6.8	7.0	5.3	7.4	13.4	6.1	7.7	6.7	0.8	6.8	11.3	13.5	7.3	5.5	8.9	9.5	9.4	11.3	9.9	9.8	9.1	9.3	9.1	8.7	9.6	10.0	19.2	57.7	54.2	4.9	23.7	22.9	44.3	42.2	24.5	19.4	12.3	14.4	20.6	14.3	50.5	12.9	6.2	26.7	30.0	11.8	19.6	29.3	1.1	22.8	29.3	26.7	15.0	16.8	6.2	29.8	14.6	23.6	21.9	25.1	29.2	16.7	16.8	25.1	21.9	16.8	5.9	14.7	30.5	37.8	24.2	2.2	17.4	24.2	12.4	5.6	27.9	26.8	30.9	2.5	8.9	22.6	9.5	25.2	18.5	23.0	15.9	27.9	45.7	22.3	13.1	30.8	48.8	11.5	9.5	23.0	25.6	21.6	24.6	22.2	15.6	29.9
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4 small subunit processome component"	Q969X6	16	69131291-69231130	"Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 100.0;Spermatogonia: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 398.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: AB_2678542"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavorable (9.05e-5)"	"prognostic unfavorable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favorable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	25.4	17.4	7.7	17.5	8.6	27.1	21.0	7.3	10.1	16.3	7.3	21.1	10.8	20.6	9.9	23.0	19.5	12.7	19.2	10.3	7.5	31.7	19.1	16.3	19.1	6.1	6.9	18.3	24.1	16.6	14.2	15.5	6.6	16.1	17.6	11.4	15.7	14.4	61.7	20.2	13.9	22.7	5.9	14.0	19.1	31.4	8.0	17.6	23.2	26.3	23.3	28.8	16.8	7.3	79.6	95.6	56.9	79.8	48.5	42.9	94.5	83.7	57.2	152.1	112.8	188.1	68.8	166.4	68.0	57.7	63.1	106.0	130.8	102.7	167.4	33.2	74.6	82.2	58.6	99.7	58.6	96.5	52.7	41.0	55.2	143.0	129.5	40.7	68.6	88.8	169.4	22.9	90.0	96.2	105.4	50.5	139.1	80.3	66.7	174.3	85.3	163.4	63.6	77.7	96.4	67.1	178.3	45.3	48.3	63.3	80.2	53.4	48.2	83.3	83.6	73.4	119.2	59.5	116.1	398.1	56.5	76.5	87.4	4.5	18.6	3.5	26.7	26.1	38.5	30.6	30.0	26.9	25.6	20.1	34.7	31.6	1.7	35.0	19.4	21.6	31.5	30.2	7.7	8.6	7.3	10.1	10.3	7.5	6.1	6.9	6.6	5.9	8.0	7.3	12.1	6.4	11.4	0.0	14.6	0.0	30.0	0.0	28.5	5.7	12.4	11.6	0.0	5.7	9.9	5.5	8.4	18.9	7.4	1.7	9.8	27.4	17.9	7.0	13.2	12.1	0.0	12.4	0.0	25.4	22.1	14.8	10.2	9.0	2.5	12.0	9.3	7.9	16.7	6.7	0.0	6.4	0.0	8.9	0.0	7.6	15.8	9.8	0.0	0.0	8.2	7.6	11.3	0.0	0.0	24.4	5.4	14.7	13.4	26.7	4.5	100.0	5.8	5.7	6.6	26.7	12.8	30.1	49.5	25.1	0.0	12.9	11.0	16.5	10.0	22.6
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6 small subunit processome component"	Q9NYH9	17	31860904-31901708	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	17.7	14.3	24.2	7.8	24.3	9.5	15.8	24.9	39.8	21.5	25.4	17.0	4.4	15.3	12.9	17.7	17.1	4.3	17.2	24.2	24.1	21.1	24.4	14.5	11.4	24.0	24.3	20.5	19.1	5.1	19.7	6.4	24.0	22.3	6.4	10.2	13.1	5.7	16.2	17.4	17.1	6.9	23.6	25.7	15.1	18.7	24.5	9.1	18.0	6.3	12.5	16.7	17.0	24.7	14.4	9.0	12.3	7.4	11.9	8.0	15.3	11.8	6.7	17.6	13.6	32.8	7.8	20.9	14.0	11.3	16.7	18.6	16.7	14.1	16.0	4.6	26.4	13.1	21.2	31.6	14.1	19.8	13.5	13.2	15.1	16.7	12.5	16.3	11.4	13.2	23.1	11.9	13.8	11.6	19.4	56.4	16.9	17.2	14.6	20.6	17.8	21.4	19.0	12.9	8.4	12.8	12.5	9.3	22.7	19.4	22.7	39.0	11.5	27.8	20.5	14.3	24.3	13.0	25.9	31.8	18.9	14.4	15.4	15.5	10.6	7.4	7.1	11.3	7.0	12.6	7.7	7.7	14.7	15.2	6.6	7.7	13.7	5.9	11.1	21.3	8.1	7.8	24.2	24.3	24.9	39.8	24.2	24.1	24.0	24.3	24.0	23.6	24.5	24.7	22.5	19.2	24.3	17.9	32.7	25.7	30.7	29.1	12.5	16.7	13.5	16.3	15.6	14.3	31.7	5.5	8.4	42.4	34.3	10.6	9.8	29.7	35.6	23.4	29.0	21.1	5.4	29.5	23.0	24.0	50.3	26.2	16.3	33.5	36.2	20.5	12.1	15.6	35.8	11.8	21.4	16.3	20.3	21.0	17.6	5.4	18.6	29.4	8.8	18.7	43.4	16.4	7.2	17.6	16.2	26.3	8.4	17.0	17.4	31.9	12.7	18.5	30.3	16.4	6.6	28.2	23.7	102.9	66.2	17.2	26.0	38.3	19.9	21.0	16.7	31.2
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		4200	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	52.6	17.4	26.8	25.8	40.5	56.6	40.5	32.7	18.3	40.4	35.6	33.8	17.0	29.8	16.8	27.9	43.5	31.2	24.8	18.4	67.9	30.9	25.3	49.3	34.9	48.6	52.1	37.2	52.1	69.4	7.9	45.8	49.7	39.7	31.7	11.0	26.0	26.1	14.0	27.5	22.3	25.9	40.0	71.5	27.2	59.2	48.8	43.2	68.4	38.9	35.8	25.2	16.0	31.0	27.2	22.6	39.3	51.0	66.5	60.5	23.4	39.0	37.8	31.1	45.2	86.1	9.8	8.4	33.6	88.4	36.6	15.6	219.4	32.9	44.6	90.6	25.5	32.2	24.9	51.6	26.3	36.1	0.7	35.5	6.8	46.2	24.1	29.3	157.0	25.1	2.0	22.7	44.1	18.1	28.7	15.5	15.9	16.6	23.9	25.7	70.2	0.8	35.9	0.7	49.7	0.9	60.8	8.4	23.5	59.5	33.3	48.2	203.6	29.8	37.0	15.5	37.6	17.7	25.3	1.3	18.2	21.5	49.5	41.2	40.9	23.2	39.5	120.8	28.3	25.7	24.9	33.0	17.2	35.7	21.8	22.8	34.5	37.6	173.9	50.4	22.2	13.9	26.8	40.5	32.7	18.3	18.4	67.9	48.6	52.1	49.7	40.0	48.8	31.0	267.0	410.3	138.7	148.2	101.2	29.4	31.7	17.2	40.9	6.5	47.4	32.1	56.0	28.6	111.0	31.3	0.0	94.4	175.1	10.9	0.0	25.3	527.1	61.2	51.5	171.8	31.2	19.8	61.2	32.0	6.9	51.6	76.5	87.5	29.7	22.8	83.6	15.6	22.3	60.6	161.4	16.9	8.2	109.7	45.9	332.1	23.9	97.6	39.2	425.3	79.8	29.1	171.0	68.9	4.1	28.1	9.3	33.4	70.3	25.4	3.6	7.1	87.3	4.3	144.7	151.0	157.8	6.6	6.6	33.7	45.5	129.3	108.0	32.0	22.3	19.2
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.3;granulocytes: 41.2;monocytes: 17.9;NK-cells: 88.6;T-cells: 18.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 43.0;pons: 27.0;white matter: 25.2"	"Immune cell enriched"	"Detected in many"	5	"T-reg: 45.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 45.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 22.6;HEL: 7.1;HMC-1: 5.7;THP-1: 26.2"	"Region enriched"	"Detected in single"	19	"pons and medulla: 6.1"	"Region enriched"	"Detected in some"	12	"spinal cord: 79.7"	HPA017000	Uncertain				"Secreted to blood"	NA	NA	2590000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	0.5	3.7	0.1	0.5	0.1	2.9	0.1	1.5	0.5	0.3	0.0	0.7	0.6	0.1	0.0	0.1	0.4	0.5	0.0	0.2	4.6	0.3	0.1	0.5	1.8	43.0	6.2	0.3	0.0	0.0	0.0	0.0	27.0	1.4	1.2	0.9	0.0	0.0	0.3	0.3	0.5	1.2	4.0	1.1	0.2	0.0	0.9	0.9	0.1	0.0	0.3	0.2	0.1	25.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.1	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.5	0.1	0.6	5.0	0.0	6.7	0.0	4.4	4.5	0.8	0.0	0.4	1.3	0.1	6.1	0.0	0.0	45.2	1.7	0.1	0.1	1.5	0.5	0.2	4.6	43.0	6.2	27.0	4.0	0.9	25.2	0.1	0.0	1.9	0.0	5.1	1.5	0.1	0.1	1.8	3.2	0.0	0.0	0.1	0.0	0.7	1.8	0.0	0.0	15.3	2.7	0.0	0.0	0.0	0.0	0.1	0.3	1.2	1.7	0.4	0.0	0.0	0.6	1.1	0.1	41.2	0.0	0.0	0.0	0.1	5.0	0.5	3.7	0.0	0.0	1.3	0.0	0.0	5.5	0.0	1.0	17.9	0.8	88.6	0.5	0.2	0.1	4.7	0.0	4.3	1.2	3.0	0.6	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.8	0.4	0.1	18.2	0.0	8.0	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.8;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.3"	"Region enriched"	"Detected in some"	9	"pons and medulla: 11.3"	"Region enriched"	"Detected in single"	46	"spinal cord: 6.0"	HPA026992	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.0	1.2	0.8	0.8	0.5	0.5	1.2	4.1	1.4	0.2	0.0	0.5	5.3	0.7	0.5	0.7	1.0	1.2	0.7	0.7	0.5	0.6	3.2	0.5	1.0	0.7	0.4	1.0	0.5	0.2	0.0	0.4	1.1	0.6	0.4	14.9	0.6	0.2	0.5	1.1	3.2	0.5	0.1	0.6	1.6	2.3	0.6	0.1	0.5	0.0	0.3	0.4	0.1	0.9	0.4	1.0	1.3	0.6	0.3	1.6	0.4	1.0	0.5	0.3	0.2	0.7	0.5	0.7	0.5	0.4	2.6	0.5	0.4	0.0	1.6	0.6	0.5	0.6	1.4	2.9	0.3	0.8	0.4	0.6	0.2	0.2	0.3	0.9	0.3	0.6	0.4	0.6	0.5	0.6	0.2	0.5	0.7	1.3	3.3	0.9	1.5	0.2	0.2	1.6	0.7	0.5	0.6	0.7	0.4	0.5	0.5	0.5	1.4	0.7	0.4	1.3	0.4	1.1	0.6	0.6	0.9	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	4.1	1.4	0.7	0.5	0.7	0.4	1.1	0.1	0.6	0.9	0.2	3.2	1.1	0.7	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.3	1.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.1	0.0	0.7	1.6	0.0	0.2	0.1	1.5	0.0	0.0	0.1	0.2	2.6	2.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2"	"Low region specificity"	"Detected in all"							"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	3.6	3.5	0.9	2.4	1.5	6.8	3.5	2.0	2.2	0.0	1.6	2.9	2.5	0.0	9.4	4.1	0.0	3.5	2.9	0.9	1.2	3.1	4.1	4.2	2.1	2.1	1.1	0.0	3.4	2.9	4.0	3.4	2.1	8.1	6.2	4.5	4.3	6.2	5.7	5.1	6.3	0.0	1.3	3.4	2.9	3.8	1.4	0.0	3.8	5.2	6.0	3.6	0.0	3.2	0.0	2.5	0.0	0.0	0.0	0.0	8.7	4.5	7.7	5.0	7.5	0.0	0.0	12.4	0.0	5.1	0.0	0.0	0.0	0.0	6.9	6.9	0.0	20.6	0.0	0.0	6.4	0.0	0.0	7.8	7.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	5.5	0.0	7.1	0.1	0.0	0.0	0.0	0.0	3.1	5.6	5.4	8.3	4.9	0.0	0.0	0.0	14.9	8.5	0.0	4.4	5.9	8.7	0.0	0.0	3.1	13.5	16.4	20.2	0.8	0.0	0.0	1.8	1.7	3.8	2.6	1.9	3.7	2.9	2.6	2.1	1.8	3.2	3.6	2.7	3.9	5.8	2.2	2.9	3.2	1.1	0.9	1.5	2.0	2.2	0.9	1.2	2.1	1.1	2.1	1.3	1.4	3.2	0.0	16.0	25.3	58.4	35.4	11.3	18.4	8.2	44.3	35.2	0.0	0.0	6.1	5.7	10.7	18.4	64.6	10.0	8.0	3.0	0.0	4.8	0.4	0.0	0.0	9.0	1.8	19.6	66.7	0.0	3.7	9.3	37.8	0.0	16.4	0.0	12.5	2.1	3.0	37.0	65.2	3.3	2.0	14.2	14.5	2.0	10.8	12.7	8.8	54.4	18.1	12.8	25.7	57.8	65.8	1.5	2.2	11.7	23.2	14.0	2.9	2.6	10.7	37.4	0.0	4.7	5.0	4.0	6.8	33.2	15.3	13.3	25.1	0.0	2.9	21.3
UVRAG	VPS38	ENSG00000198382	"UV radiation resistance associated"	Q9P2Y5	11	75815210-76144232	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 144.6;Microglial cells: 178.9;Oligodendrocytes: 361.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016932	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"			"HPA016932: AB_1858707"	"unprognostic (3.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.03e-1)"	32.1	12.8	11.4	17.9	16.9	33.9	20.7	12.1	15.4	13.7	35.9	14.5	10.6	13.3	14.3	10.1	13.3	15.3	10.7	11.4	12.8	11.6	15.3	15.4	26.5	15.0	15.9	12.4	8.2	21.3	7.3	18.2	16.9	10.5	12.4	19.2	8.0	11.4	14.5	11.8	10.6	14.9	16.0	21.4	12.7	7.9	13.9	25.2	12.9	14.7	25.4	13.1	8.9	25.2	10.3	14.4	11.2	9.7	27.2	20.2	16.3	15.0	27.5	17.4	13.8	19.7	18.9	49.5	30.5	20.5	30.7	10.8	19.5	17.5	19.9	27.2	7.8	18.3	12.2	16.8	24.2	30.6	19.1	17.4	14.6	23.8	42.6	13.1	51.0	22.0	19.6	29.7	16.5	24.1	20.9	19.6	11.1	32.1	15.7	17.3	28.5	40.9	14.8	35.0	15.3	10.8	16.6	16.7	13.2	17.1	20.9	27.4	45.3	16.8	12.7	62.4	10.3	18.4	23.3	51.0	7.6	16.0	21.3	5.8	9.9	8.4	7.0	8.8	6.4	23.4	6.1	6.9	16.8	26.6	8.2	6.6	13.9	8.1	11.4	24.0	6.3	4.7	11.4	16.9	12.1	15.4	11.4	12.8	15.0	15.9	16.9	16.0	13.9	25.2	97.3	12.8	21.3	53.8	97.0	9.2	9.4	9.8	26.7	52.2	17.5	19.4	16.1	10.0	11.3	7.3	68.8	37.6	41.6	9.5	7.9	11.5	6.2	13.6	28.1	36.5	5.4	24.6	144.6	8.7	10.3	24.7	34.1	18.5	10.8	16.0	20.0	9.2	17.3	53.8	124.6	10.0	8.2	22.0	50.8	2.6	21.5	46.3	8.8	178.9	45.8	19.0	34.0	89.0	361.8	10.5	11.4	16.1	40.4	12.1	10.8	11.0	6.5	53.1	13.1	27.2	28.6	13.5	19.1	19.4	12.6	32.8	28.1	25.1	10.1	9.1
UVSSA	KIAA1530	ENSG00000163945	"UV stimulated scaffold protein A"	Q2YD98	4	1345691-1395989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050824, HPA053496"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA050824: AB_2681251, HPA053496: AB_2682170"	"unprognostic (6.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.85e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.76e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (6.87e-4)"	4.2	4.3	3.5	5.5	4.1	8.0	4.4	3.4	5.1	4.5	5.5	4.7	5.5	5.0	6.0	4.2	6.4	3.4	2.9	3.3	3.1	3.2	3.9	6.0	3.8	5.7	3.9	5.5	6.7	2.6	9.3	2.8	4.7	4.1	3.5	4.7	5.7	2.7	4.6	9.2	5.3	2.5	3.0	5.6	5.5	9.4	5.4	3.8	7.1	1.5	3.4	4.7	4.5	7.5	3.7	4.1	6.1	5.7	7.0	9.0	4.6	3.4	2.9	3.0	2.6	3.4	7.5	2.7	6.5	3.4	7.9	4.4	3.8	3.9	2.6	3.7	1.6	6.4	7.9	4.0	2.7	3.9	7.6	2.6	7.8	3.4	4.4	3.4	5.0	4.6	6.2	8.9	3.7	2.1	5.8	8.1	6.0	2.9	5.2	5.0	3.1	3.4	2.7	5.4	4.4	5.8	2.6	3.0	3.8	5.3	8.0	2.2	9.5	11.4	2.8	4.2	5.9	13.4	9.0	6.1	8.5	4.4	6.9	0.1	0.6	0.9	0.6	0.5	0.3	0.4	0.5	0.5	1.0	0.4	0.4	0.3	1.0	3.3	0.8	0.8	0.2	0.5	3.5	4.1	3.4	5.1	3.3	3.1	5.7	3.9	4.7	3.0	5.4	7.5	20.7	6.4	26.2	16.3	11.5	5.5	5.2	3.4	5.7	18.2	13.7	10.7	3.6	7.2	8.8	16.5	41.7	3.4	17.1	10.3	3.9	8.0	7.6	23.7	23.1	9.1	6.0	7.4	6.9	8.5	2.9	10.3	21.9	20.1	8.8	16.7	5.3	12.5	6.8	30.3	9.3	10.9	8.2	10.8	6.3	7.3	5.3	13.4	5.4	14.0	7.6	9.0	7.2	5.5	16.5	10.1	6.7	3.8	12.6	5.0	10.7	4.8	23.6	25.3	0.0	13.1	11.4	23.2	9.4	8.0	6.1	3.7	12.0	12.8	6.5	4.5
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093308-106194301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 323.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		24000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	16.3	17.6	20.4	25.0	18.7	40.4	15.3	30.4	29.3	19.6	20.6	21.7	15.5	24.3	33.1	24.1	29.2	19.6	29.3	25.9	20.3	60.0	15.7	46.0	27.9	15.0	23.0	24.4	15.8	37.3	16.3	54.6	19.3	23.2	24.0	10.5	14.6	25.9	31.9	14.0	14.3	21.4	18.5	25.0	26.2	31.9	31.0	22.2	30.0	28.6	30.4	29.5	18.3	23.7	66.5	48.8	50.9	39.0	88.4	65.2	110.2	71.4	66.9	49.9	61.5	96.9	110.4	12.0	87.0	74.1	111.2	32.8	22.6	58.2	54.5	64.2	40.5	37.0	21.4	110.6	34.9	30.5	39.0	42.8	63.8	50.3	33.5	57.5	52.5	22.8	22.1	28.5	103.6	46.8	34.3	66.8	60.1	64.2	65.4	70.3	38.6	34.3	323.0	60.9	16.7	19.0	51.5	45.7	44.3	67.7	17.0	93.7	48.0	55.1	58.5	45.4	45.4	34.4	51.4	17.9	55.0	70.1	103.8	11.3	24.7	28.5	23.1	20.8	25.7	15.3	64.3	41.4	19.1	30.5	68.8	49.1	6.1	37.5	16.0	13.5	130.4	44.3	20.4	18.7	30.4	29.3	25.9	20.3	15.0	23.0	19.3	18.5	31.0	23.7	15.4	89.8	88.8	18.9	22.1	16.8	26.8	117.3	14.8	9.9	11.6	10.5	18.7	17.2	61.6	86.5	4.2	71.2	17.7	20.5	50.9	46.9	80.2	41.5	19.3	25.5	6.6	12.0	49.8	25.0	74.1	34.2	16.8	40.6	29.8	13.1	10.8	15.0	33.2	8.4	37.5	15.6	34.6	20.1	12.5	18.5	15.2	33.9	14.2	33.7	56.2	10.8	18.6	24.1	11.7	30.4	16.2	12.8	10.2	35.7	9.6	17.5	38.8	7.9	19.7	19.0	35.1	17.0	81.6	22.6	13.2	24.6	33.7	51.6	18.0	19.8
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"VAC14 component of PIKFYVE complex"	Q08AM6	16	70687439-70801160	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	17.3	25.0	20.6	14.5	19.3	11.3	17.1	19.5	24.7	16.2	18.0	16.7	12.1	16.9	8.6	19.0	15.1	10.2	20.3	20.8	20.5	26.3	27.1	16.9	24.7	21.5	20.0	14.3	23.7	17.5	16.6	10.9	21.4	17.5	8.3	6.8	17.4	10.7	24.3	23.0	17.9	11.5	19.2	22.5	20.7	16.2	21.6	15.5	21.4	12.0	13.9	18.1	14.9	21.6	25.9	25.3	21.0	23.6	29.9	20.3	32.0	18.5	29.0	34.6	15.5	31.6	41.0	33.3	23.3	22.5	39.9	32.3	27.8	30.1	16.3	10.0	28.2	16.9	18.6	39.5	76.8	29.1	33.7	36.0	30.9	50.7	45.1	20.7	33.0	29.2	30.1	14.6	30.1	37.3	27.1	48.5	36.9	20.4	22.7	32.3	14.9	48.6	16.7	17.4	24.9	26.7	60.9	18.5	43.0	15.2	27.4	27.0	26.7	45.7	25.9	29.2	20.4	20.4	27.5	62.9	76.1	25.1	21.3	0.8	2.7	4.4	1.5	3.6	1.4	2.5	2.2	3.1	5.6	3.9	2.0	1.8	1.0	2.4	3.6	3.1	1.3	1.1	20.6	19.3	19.5	24.7	20.8	20.5	21.5	20.0	21.4	19.2	21.6	21.6	5.1	3.2	4.2	15.0	10.1	4.2	7.8	7.0	9.6	8.4	8.4	7.4	12.6	12.8	8.0	3.7	2.1	16.7	4.0	11.5	5.9	19.2	20.4	14.2	5.4	8.2	9.1	5.7	11.7	22.5	29.2	5.9	11.7	6.7	5.7	11.6	16.4	15.9	42.9	10.1	13.8	10.0	14.2	18.3	13.5	74.4	6.2	15.6	10.6	10.3	19.2	6.8	8.2	8.5	16.3	20.8	10.8	3.4	15.8	8.9	13.7	15.0	14.6	7.7	6.6	5.9	7.9	4.8	13.5	10.3	9.1	19.6	6.5	8.7	12.6	7.1
VAMP1	"SYB1, VAMP-1"	ENSG00000139190	"Vesicle associated membrane protein 1"	P23763	12	6462237-6470677	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 192.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.0;Excitatory neurons: 22.6;Inhibitory neurons: 25.0;Oligodendrocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002779, CAB016119, CAB079000"	Approved	Supported				NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB002779: , CAB016119: AB_628309, CAB079000: "	"unprognostic (2.33e-1)"	"unprognostic (6.72e-3)"	"prognostic unfavorable (6.37e-5)"	"unprognostic (8.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.22e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.04e-11)"	"unprognostic (1.47e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.65e-2)"	11.7	18.9	45.3	21.9	60.6	63.4	11.5	102.1	179.8	19.6	30.6	35.4	6.9	20.9	7.0	12.5	22.4	6.4	11.5	40.1	85.4	16.1	18.6	15.2	39.7	192.8	89.2	12.7	10.4	2.7	12.8	3.3	163.5	24.1	11.9	35.7	14.5	9.9	10.0	8.9	33.0	10.3	93.3	42.2	17.5	11.4	106.3	12.8	30.8	3.5	35.9	21.4	18.5	93.9	3.0	11.0	5.8	8.1	16.7	19.1	7.1	5.4	10.5	5.7	16.0	3.9	9.5	30.8	1.1	13.5	5.8	8.9	7.2	3.0	8.3	24.3	15.5	4.9	40.1	4.0	7.6	11.6	11.8	13.7	1.4	7.4	4.2	19.5	5.2	13.4	1.9	8.9	13.0	3.4	15.6	13.9	27.4	1.4	4.7	17.5	9.2	5.6	3.5	4.4	1.2	2.3	10.5	6.0	4.5	30.9	2.0	4.6	6.5	2.8	8.5	5.8	3.9	7.6	3.1	200.3	10.2	24.4	2.3	9.0	1.0	14.1	5.9	0.4	4.8	4.8	4.9	5.7	1.1	1.0	5.1	4.4	5.1	2.2	0.5	2.2	6.8	2.3	45.3	60.6	102.1	179.8	40.1	85.4	192.8	89.2	163.5	93.3	106.3	93.9	2.8	6.4	2.0	11.1	10.3	1.1	3.3	1.6	9.1	20.0	2.2	5.0	1.9	1.5	1.9	0.0	6.2	0.3	17.8	4.1	1.9	0.2	0.9	3.3	1.2	2.9	4.8	1.3	22.6	0.5	0.7	3.5	5.1	1.6	10.8	2.6	2.2	3.1	1.7	1.7	25.0	2.1	8.2	3.8	2.6	0.5	3.7	3.6	0.0	6.5	6.0	6.4	10.3	6.6	26.8	0.6	2.8	4.9	12.2	1.8	0.6	0.4	4.9	6.8	6.6	4.7	4.2	2.7	4.3	3.0	0.9	0.1	14.8	2.9	1.6	0.9
VAMP4		ENSG00000117533	"Vesicle associated membrane protein 4"	O75379	1	171700160-171742074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050418	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA050418: AB_2681121"	"unprognostic (9.38e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (5.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.15e-1)"	10.9	12.0	11.2	8.6	11.3	5.2	8.8	14.1	13.5	8.9	8.0	8.2	7.9	8.5	7.4	8.4	7.7	8.1	7.7	11.5	13.8	8.1	8.2	10.3	10.9	13.4	13.6	7.0	9.9	12.7	15.2	10.1	13.6	7.3	7.1	10.0	10.5	7.0	6.3	10.0	8.1	7.4	13.3	10.1	8.5	11.7	14.3	7.1	11.4	6.1	8.4	7.3	8.3	12.8	9.5	3.3	8.1	6.6	12.1	14.0	5.2	16.8	13.7	4.1	5.2	2.6	12.2	6.1	14.9	13.5	6.2	6.2	3.3	5.8	5.9	10.9	5.4	5.0	4.1	2.2	7.3	4.4	4.1	6.9	10.0	5.2	9.6	11.9	7.6	8.1	12.4	7.1	8.9	3.1	10.6	6.2	3.9	18.1	12.9	8.7	6.3	15.6	8.6	3.0	5.1	9.6	8.6	8.8	7.3	8.9	12.0	8.1	8.9	12.7	4.3	18.3	16.2	25.8	23.4	8.4	19.6	3.9	10.4	11.0	8.8	11.9	8.6	7.6	11.9	8.2	11.3	9.9	4.5	6.6	7.8	8.6	3.4	9.5	7.8	6.4	11.3	8.8	11.2	11.3	14.1	13.5	11.5	13.8	13.4	13.6	13.6	13.3	14.3	12.8	22.3	22.4	9.3	18.3	21.4	15.4	13.8	18.0	26.7	12.3	12.9	9.7	11.6	10.0	14.8	3.7	22.9	10.8	18.2	9.7	15.6	7.5	35.1	7.8	8.4	20.3	10.2	30.9	23.5	7.7	13.4	20.4	6.6	8.9	24.7	8.9	18.2	11.8	14.8	10.1	24.1	12.3	16.2	15.4	12.1	38.6	9.3	20.1	12.4	19.7	17.1	17.0	25.7	18.6	23.0	10.0	14.9	13.2	20.8	19.7	13.4	13.7	11.4	9.4	19.7	15.2	15.0	42.7	20.2	16.1	17.3	13.4	23.1	8.5	7.4	17.5
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881345-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	29.4	24.3	17.8	24.1	20.6	37.1	23.8	22.3	24.9	23.2	18.3	22.9	23.4	21.4	15.5	22.6	16.5	22.2	19.6	18.1	21.4	39.2	47.9	24.8	26.4	20.7	20.5	17.9	14.3	32.3	8.7	40.5	21.5	21.4	24.4	10.3	17.3	20.1	21.9	20.1	27.5	28.2	20.4	21.8	18.4	14.9	19.9	29.9	24.4	24.1	28.6	25.6	15.9	23.0	72.9	31.3	21.0	43.6	57.0	54.3	56.3	55.3	49.1	49.0	98.4	33.8	46.5	100.6	100.0	66.9	55.5	25.5	47.6	38.9	64.5	42.3	41.6	41.8	43.1	24.3	63.6	86.9	62.8	50.9	37.9	54.8	49.8	42.8	55.4	43.5	91.1	54.2	56.0	36.5	34.1	48.8	15.0	54.1	45.3	25.5	41.2	75.3	65.6	36.2	16.0	46.0	32.7	32.6	49.6	54.8	31.9	71.8	58.4	44.8	46.7	65.0	79.6	123.8	167.8	138.9	39.2	104.4	51.0	86.8	25.3	39.6	15.1	27.0	19.1	12.3	17.7	18.6	26.4	13.2	16.2	17.5	21.9	22.7	26.7	15.0	22.0	22.4	17.8	20.6	22.3	24.9	18.1	21.4	20.7	20.5	21.5	20.4	19.9	23.0	17.8	3.2	9.2	11.1	21.2	19.6	14.7	11.8	20.5	7.6	16.6	9.5	12.3	5.7	12.5	7.3	6.2	48.4	24.9	14.1	41.1	28.0	6.9	13.8	14.5	19.8	13.2	31.4	14.2	26.0	49.7	19.6	12.2	13.7	31.1	22.5	20.3	25.1	31.1	6.7	14.6	12.8	10.2	30.8	49.0	6.9	17.7	35.9	19.6	7.5	32.5	10.4	29.9	8.0	19.2	29.9	13.5	19.5	15.2	17.5	25.3	52.9	10.5	4.6	26.3	10.8	18.9	45.4	26.3	20.3	19.5	69.8	21.6	25.3	15.3	20.1
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 873.4;NB-4: 1362.5;U-937: 912.8"	"Low region specificity"	"Detected in all"							"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		220000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	74.0	34.7	26.9	148.4	28.2	299.7	225.1	28.7	53.8	121.8	51.6	250.6	229.9	30.6	144.5	303.1	166.1	119.2	24.6	26.5	29.9	280.1	247.4	266.5	212.4	35.6	31.6	10.4	182.5	270.3	33.7	265.7	34.3	107.7	300.9	4.4	322.5	90.4	24.3	210.2	252.1	71.4	31.9	175.9	228.4	23.4	35.5	173.5	126.0	27.3	311.7	198.0	150.0	36.5	255.0	33.2	2.6	2.3	2.4	1.4	241.6	0.7	0.3	0.2	0.3	191.2	225.2	56.8	174.4	1.2	17.9	175.2	2.4	451.6	0.6	232.3	173.7	290.3	104.4	220.7	3.3	873.4	287.1	2.3	317.5	0.3	72.3	1.2	58.2	1.2	214.9	11.6	103.8	363.9	0.8	1362.5	3.2	315.9	26.0	5.2	8.9	381.7	516.9	384.3	8.4	2.9	120.9	628.3	19.4	126.3	231.4	665.4	113.9	0.3	15.3	2.9	2.7	3.0	151.1	340.0	2.6	912.8	1.1	601.3	868.6	328.4	469.3	740.3	455.6	519.3	537.0	463.3	787.3	508.3	423.2	442.0	52.4	556.3	460.0	2135.6	665.3	1536.0	26.9	28.2	28.7	53.8	26.5	29.9	35.6	31.6	34.3	31.9	35.5	36.5	39.4	371.8	283.2	1.3	147.7	259.1	303.3	800.9	164.4	1.2	289.7	251.7	6.3	356.0	662.1	366.0	0.0	980.8	447.1	832.3	765.0	630.7	28.0	231.3	22.8	46.1	129.1	147.4	0.1	730.0	460.4	35.6	188.6	212.9	269.4	3.3	163.1	314.8	1191.1	0.0	0.1	391.8	545.3	1000.4	488.7	49.1	9.3	537.2	352.2	2.8	686.1	7.9	375.9	0.0	0.5	865.5	843.2	7.5	103.0	302.7	1184.0	1046.8	600.5	2.0	46.0	21.4	56.5	48.0	8.3	239.8	329.7	877.8	219.5	13.8	299.4	602.0
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
VANGL2	"KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1"	ENSG00000162738	"VANGL planar cell polarity protein 2"	Q9ULK5	1	160400564-160428670	"Disease related genes, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Intestinal goblet cells: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.3;AN3-CA: 26.4;NTERA-2: 43.1;SH-SY5Y: 28.9;SuSa: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027043	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA027043: AB_10601709"	"unprognostic (4.32e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.84e-3)"	"unprognostic (9.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-2)"	1.6	1.5	8.3	2.5	7.9	0.2	5.7	9.1	6.8	10.1	5.3	7.2	5.2	7.1	6.3	13.1	6.1	3.1	4.9	8.5	11.5	3.9	0.4	5.7	4.8	12.8	14.7	8.3	6.1	5.5	4.4	6.1	11.2	10.7	5.6	4.3	13.3	8.2	1.9	37.6	5.4	3.7	12.8	2.0	4.9	1.9	13.5	8.3	8.2	1.3	7.0	6.1	14.0	11.2	1.2	1.6	106.3	26.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	10.0	0.1	13.5	0.0	0.2	6.2	17.8	0.9	0.0	0.0	1.3	5.4	0.0	0.0	0.1	0.0	0.0	0.2	3.7	0.0	0.0	0.3	0.0	4.1	8.4	0.0	0.7	0.0	7.2	0.3	43.1	0.5	0.0	14.5	5.6	0.1	0.0	0.2	9.8	28.9	0.0	0.0	9.6	36.7	0.0	1.4	0.0	0.0	16.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.9	9.1	6.8	8.5	11.5	12.8	14.7	11.2	12.8	13.5	11.2	1.3	0.0	0.5	14.0	0.0	15.8	2.8	7.1	6.2	4.3	11.0	9.5	3.8	4.3	4.3	0.0	33.3	0.0	1.3	1.9	0.0	3.9	1.2	1.9	7.8	2.6	16.8	0.0	0.8	1.6	0.0	5.0	3.1	4.1	0.0	5.0	2.5	0.0	0.1	10.1	2.5	18.4	8.2	0.0	0.4	1.4	3.7	0.2	7.2	0.0	0.0	4.3	0.0	13.0	3.5	4.3	2.2	7.2	0.1	7.1	1.3	0.4	3.9	0.4	0.0	3.5	3.7	0.5	3.0	13.1	17.0	0.0	0.2	1.5	6.4	5.6
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914016-9960021	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		580000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	33.1	67.1	21.5	24.2	26.8	97.1	29.5	30.7	28.1	30.2	21.5	38.6	31.2	32.9	24.8	47.5	29.3	31.9	37.5	23.2	24.9	32.6	36.6	33.9	25.7	34.9	26.3	39.1	40.9	36.2	17.7	29.8	34.5	24.5	35.4	20.1	32.6	22.0	69.7	32.3	30.6	27.4	27.8	26.7	38.9	29.1	25.5	30.0	35.2	38.4	26.3	36.5	32.2	30.7	58.1	34.4	40.7	26.7	46.9	50.5	56.8	69.9	57.9	62.3	67.9	46.6	55.9	56.5	63.6	61.5	53.9	39.7	39.8	66.7	70.7	35.6	49.8	92.4	33.8	72.3	110.8	126.3	169.7	47.8	66.3	59.0	69.6	48.7	64.0	45.4	94.6	57.3	55.2	31.2	97.4	72.9	26.2	197.6	54.3	50.4	55.2	77.5	60.9	57.3	57.2	31.2	81.1	48.7	53.2	37.2	45.7	64.2	68.9	100.7	75.3	105.6	86.3	101.9	89.2	66.6	57.0	53.5	70.8	131.3	143.3	251.0	69.8	127.9	82.9	100.0	72.1	75.4	118.1	94.4	78.1	72.1	226.2	90.8	109.5	84.6	98.9	183.9	21.5	26.8	30.7	28.1	23.2	24.9	34.9	26.3	34.5	27.8	25.5	30.7	173.6	128.2	178.8	63.0	160.0	673.4	358.4	356.5	278.3	113.9	248.2	179.3	218.3	167.3	229.4	207.8	62.6	296.9	148.0	427.2	457.8	291.8	10.5	235.9	182.2	232.4	144.6	188.1	91.4	361.3	321.6	221.4	156.0	255.8	225.2	220.2	211.3	141.1	287.8	136.3	93.2	180.6	390.6	288.2	459.8	21.7	182.0	285.9	279.3	63.7	350.4	124.3	108.1	102.1	150.4	310.2	262.7	216.3	146.6	335.4	255.9	390.4	265.5	79.5	190.7	204.8	371.4	231.3	201.4	267.3	622.5	452.6	190.2	253.6	201.0	390.8
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389229-58451101	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		240000	"Cluster 32: T-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	15.7	36.4	32.1	11.2	30.4	4.2	14.2	29.6	30.1	13.7	20.3	24.2	19.6	16.4	10.3	19.3	14.9	9.7	29.4	28.8	33.5	24.8	35.0	14.1	9.6	34.6	34.0	17.9	18.9	27.9	21.0	9.2	36.2	17.8	9.9	14.3	16.2	12.3	46.4	13.0	18.2	11.6	36.4	15.0	19.0	8.8	37.0	12.2	23.3	39.6	6.7	18.1	12.9	31.5	31.0	30.4	33.6	18.0	30.3	12.5	29.5	27.0	11.2	41.0	20.1	123.0	29.0	27.2	37.7	18.3	32.3	57.6	27.1	38.9	24.6	12.8	20.2	16.5	32.2	38.9	30.2	15.5	19.8	28.9	44.4	22.8	18.7	19.8	20.5	26.7	39.5	14.9	20.0	96.7	24.5	30.6	17.7	60.2	40.0	24.2	31.3	18.0	31.6	40.7	47.1	32.6	44.7	117.0	48.0	18.4	48.0	23.2	28.6	65.8	31.9	33.3	36.9	19.9	23.1	31.4	55.7	16.8	33.8	2.1	2.3	3.1	3.9	2.4	4.5	2.8	4.6	3.2	2.3	2.3	3.3	4.8	3.7	3.7	3.0	2.3	2.7	2.6	32.1	30.4	29.6	30.1	28.8	33.5	34.6	34.0	36.2	36.4	37.0	31.5	22.5	44.8	26.8	31.6	18.7	11.7	13.5	17.2	23.9	29.7	23.6	21.1	46.5	24.3	16.6	31.3	29.2	34.8	20.7	28.6	35.2	35.1	5.0	18.2	20.9	23.2	21.7	18.7	34.3	30.5	50.3	24.0	20.4	16.0	9.5	23.3	15.7	40.3	16.1	35.3	34.7	23.4	22.4	18.5	10.0	6.1	18.6	17.3	14.2	40.3	22.8	34.3	20.6	35.2	43.7	37.5	22.4	25.2	14.0	17.7	38.9	42.9	19.1	29.7	13.1	22.2	26.0	22.0	29.4	18.2	10.5	44.5	20.5	37.4	27.6	16.6
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30914205-30926459	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	10.2	14.4	1.3	2.1	1.5	1.9	9.7	1.5	1.6	12.5	0.4	10.5	1.2	10.4	1.5	22.5	10.1	0.2	11.1	1.4	1.3	12.5	18.9	10.5	3.1	1.3	1.6	15.3	14.0	2.3	17.1	0.9	1.4	10.2	2.2	1.4	10.9	1.1	20.9	10.1	12.8	0.7	1.2	13.4	11.7	11.8	1.3	4.1	15.0	0.2	2.3	10.5	13.2	1.3	13.8	9.6	5.5	23.1	4.9	4.4	0.7	2.2	1.9	2.5	1.6	12.6	8.9	11.9	7.5	3.0	9.4	0.0	21.3	0.0	2.4	4.6	15.7	13.2	10.2	0.9	6.7	2.3	0.3	6.2	8.1	5.9	1.3	0.9	1.3	19.5	0.1	10.5	5.4	0.0	4.6	0.0	1.7	0.0	1.2	9.1	0.0	10.3	18.3	0.0	8.5	0.2	0.2	6.6	5.4	5.0	16.3	7.4	2.2	14.2	1.4	1.0	0.1	10.0	17.1	18.8	0.0	0.6	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.2	0.1	1.3	1.5	1.5	1.6	1.4	1.3	1.3	1.6	1.4	1.2	1.3	1.3	3.0	6.4	12.5	14.7	8.0	4.0	4.9	4.7	4.0	6.6	6.4	3.7	11.6	8.6	5.5	9.2	0.0	8.7	4.1	10.1	1.9	6.7	1.5	7.7	5.2	3.9	13.1	3.4	8.3	7.1	9.6	4.8	11.7	8.6	12.7	12.9	7.5	22.5	9.2	8.4	9.1	8.4	2.0	6.9	3.5	1.6	4.1	5.1	1.8	3.7	7.9	2.8	4.1	8.0	7.2	8.9	4.7	4.1	12.3	2.3	12.4	12.5	8.9	6.0	0.0	2.9	3.7	10.4	8.0	9.0	4.1	3.4	4.8	6.9	10.9	3.8
VASH1	KIAA1036	ENSG00000071246	"Vasohibin 1"	Q7L8A9	14	76761468-76783015	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"	"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 67.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 139.7;Early spermatids: 72.8;Late spermatids: 95.3;Microglial cells: 53.4;Rod photoreceptor cells: 98.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 46.1;HEL: 35.1;HUVEC TERT2: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000653	Uncertain				"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA000653: AB_1080551"	"unprognostic (1.47e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (6.56e-6)"	"unprognostic (8.84e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.73e-1)"	12.1	18.5	33.2	12.3	34.0	3.0	7.4	30.8	28.8	9.2	21.3	7.9	5.6	11.9	4.2	4.3	8.7	9.0	36.0	28.1	30.8	8.1	3.8	16.0	7.8	38.7	36.3	13.4	5.7	3.9	13.7	19.9	36.6	6.5	5.2	67.6	5.6	4.5	7.5	4.6	8.2	11.5	37.1	18.3	5.1	13.2	36.1	3.2	6.1	7.0	6.6	8.5	6.6	36.4	1.1	5.6	46.1	13.8	11.6	8.4	2.3	4.0	1.3	3.4	1.4	1.5	3.1	2.1	2.8	3.2	4.2	1.3	7.3	1.5	1.0	25.0	5.3	35.1	3.4	1.5	6.9	1.5	3.5	4.5	0.3	1.3	0.2	10.4	85.0	6.2	1.6	0.4	1.1	7.1	1.3	3.0	4.7	1.4	2.8	1.3	4.6	1.0	0.9	2.6	19.1	14.8	4.6	1.8	2.2	9.1	7.8	7.4	24.2	4.3	9.6	5.2	2.0	2.0	1.1	1.2	6.1	11.2	8.3	0.0	0.8	0.0	0.6	2.0	0.5	0.1	0.3	0.3	1.3	0.3	0.2	0.3	0.0	0.2	2.7	2.4	0.1	0.5	33.2	34.0	30.8	28.8	28.1	30.8	38.7	36.3	36.6	37.1	36.1	36.4	17.3	0.0	2.3	7.2	2.7	0.6	0.0	0.3	0.0	9.4	0.9	2.4	10.9	1.5	0.7	1.8	139.7	0.4	11.1	0.0	0.0	0.9	72.8	0.8	7.7	27.5	6.7	0.0	13.4	0.0	0.3	7.6	1.5	0.6	12.0	18.1	31.8	1.2	14.8	0.0	11.9	0.4	2.0	14.2	9.3	95.3	1.8	23.6	1.8	53.4	7.6	15.2	3.1	21.6	21.8	0.3	0.0	3.0	0.4	0.0	0.0	0.2	0.0	98.8	13.1	5.5	10.0	0.8	2.3	0.4	0.1	0.3	1.8	5.7	0.2	0.1
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383538	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 21.8;MCF7: 18.4;U-2197: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2000000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	55.7	15.5	1.5	5.8	2.3	2.7	31.5	0.8	2.3	48.1	3.0	12.1	3.4	30.3	0.0	34.1	24.6	7.3	30.5	1.1	0.5	56.1	31.8	44.9	2.8	6.3	5.5	40.0	10.3	0.0	12.8	10.4	1.7	17.9	0.0	0.3	15.9	0.0	6.9	38.8	11.2	0.0	1.6	13.0	13.4	16.8	4.6	0.0	26.8	0.0	0.0	26.5	38.9	2.7	4.2	0.0	0.6	0.5	0.2	0.2	12.6	21.8	0.1	0.0	0.0	1.9	5.5	0.0	4.5	0.3	2.6	0.3	0.0	0.0	0.0	13.7	2.2	0.9	15.9	14.9	0.6	0.0	0.4	7.9	0.0	0.3	0.0	3.1	0.0	0.1	3.1	0.8	0.0	18.4	1.0	5.3	2.2	0.4	2.4	1.0	0.0	0.0	0.0	0.1	1.4	9.3	6.5	13.5	0.6	2.2	6.8	2.5	0.0	17.5	12.5	78.4	4.6	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.8	2.3	1.1	0.5	6.3	5.5	1.7	1.6	4.6	2.7	10.0	6.4	13.1	5.5	1.4	9.6	7.8	4.2	9.1	0.5	21.9	10.9	16.2	32.9	6.4	23.9	0.0	5.4	2.8	1.5	7.9	13.1	1.1	12.1	58.7	4.6	0.0	0.0	1.1	2.9	7.2	104.2	16.8	20.5	3.8	4.6	2.9	15.3	3.4	0.0	0.9	2.0	2.0	0.6	21.7	2.8	50.1	2.0	14.2	2.8	0.0	18.3	0.0	0.5	0.3	28.3	1.2	60.9	0.8	6.4	0.2	12.3	2.7	0.7	98.6	12.6	80.9	0.8	4.1	3.7	7.5	10.0	3.5	2.3	0.8	4.9
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VAT1	"FLJ20230, VATI"	ENSG00000108828	"Vesicle amine transport 1"	Q99536	17	43014607-43025123	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 133.2;Hofbauer cells: 146.4;Melanocytes: 122.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 295.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 104.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 104.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 680.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045170	Uncertain					NA	NA		2700000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA045170: AB_10964166"	"unprognostic (2.22e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-2)"	180.4	251.5	53.6	32.1	57.6	86.5	137.5	55.3	67.3	160.8	54.8	97.5	25.7	121.4	65.0	132.6	78.4	85.6	74.7	47.3	129.9	70.5	44.5	111.7	29.0	88.4	132.3	184.8	67.2	54.7	103.7	83.9	173.9	64.9	32.9	7.6	86.3	52.2	29.2	194.3	65.1	94.2	60.5	40.3	56.1	79.2	93.3	63.7	68.3	45.8	33.7	109.5	126.3	77.3	38.9	225.0	53.6	119.0	556.9	435.5	75.5	94.2	282.1	89.7	167.1	139.7	83.2	7.7	128.8	395.8	283.7	58.9	94.1	81.6	82.7	14.4	127.6	36.2	107.3	279.5	357.7	177.6	271.5	234.3	119.2	154.0	71.2	203.8	428.9	230.5	77.3	12.1	227.3	37.2	262.2	76.6	68.1	111.6	106.2	37.3	66.1	19.4	102.2	76.6	50.0	94.6	51.3	29.5	680.8	217.9	82.5	99.4	431.7	199.9	92.5	226.2	22.9	19.4	30.2	14.3	203.1	132.0	31.4	104.0	16.6	24.9	13.1	7.9	15.3	19.9	18.5	13.6	8.4	19.5	16.8	10.4	5.1	11.1	9.2	4.1	13.4	19.0	53.6	57.6	55.3	67.3	47.3	129.9	88.4	132.3	173.9	60.5	93.3	77.3	133.2	22.4	13.9	1.0	17.2	28.4	14.2	17.9	34.1	1.1	29.5	30.2	31.6	17.2	10.7	23.9	4.2	6.5	6.5	9.2	17.6	99.7	27.5	14.2	32.5	71.0	15.1	12.6	2.3	43.4	45.1	91.4	8.2	32.6	77.2	93.8	73.9	15.8	146.4	5.0	2.4	4.1	4.1	40.0	32.4	45.2	51.9	43.9	122.7	6.5	16.1	4.2	3.1	3.5	4.1	49.6	10.4	58.6	19.6	25.5	36.5	60.1	12.6	1.8	13.1	19.4	39.1	12.8	15.5	35.1	33.5	11.1	12.6	31.2	4.7	21.8
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772708-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.1;lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 30.7;dendritic cells: 31.3;granulocytes: 34.9;Hofbauer cells: 50.6;Kupffer cells: 29.4;Macrophages: 33.9;Microglial cells: 30.9;T-cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 100.7;Karpas-707: 114.7;MOLT-4: 115.8;REH: 76.1;THP-1: 88.9;U-266/84: 89.5;U-937: 95.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001864, HPA005925"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA001864: AB_1858722, HPA005925: "	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	6.6	3.8	3.3	36.3	3.3	54.1	2.7	3.6	4.6	2.6	4.5	6.5	5.8	1.8	1.4	3.7	2.4	6.3	1.9	3.3	4.4	2.1	5.0	11.5	46.4	6.2	4.9	1.1	1.3	4.2	1.6	8.7	5.6	2.8	7.1	0.2	6.1	2.3	1.0	1.7	14.1	5.3	5.0	44.9	5.5	1.8	5.7	45.7	2.0	2.1	39.1	13.0	1.7	7.6	1.6	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	12.7	51.0	16.5	0.0	0.0	0.2	0.0	0.0	0.0	22.0	1.8	61.8	0.0	0.0	0.0	60.7	100.7	0.0	0.0	0.0	0.0	0.0	0.0	63.9	2.3	114.7	0.0	9.6	115.8	36.6	0.0	0.0	0.0	76.1	0.0	41.0	2.2	0.0	0.0	0.0	0.0	18.3	0.1	0.0	8.0	88.9	0.2	0.0	1.6	0.1	0.1	69.9	89.5	57.9	0.1	95.3	0.0	1.6	18.3	20.0	22.0	30.3	15.7	14.3	16.1	19.3	16.6	13.6	17.2	15.6	40.6	19.2	39.8	14.4	14.5	18.2	3.3	3.3	3.6	4.6	3.3	4.4	6.2	4.9	5.6	5.0	5.7	7.6	0.5	3.2	3.0	0.0	30.7	1.3	0.8	3.7	0.0	0.5	0.4	0.4	1.1	0.0	6.9	0.0	0.0	0.8	31.3	1.5	0.0	4.2	5.4	5.3	0.3	1.5	1.2	9.9	1.9	0.4	0.7	1.2	1.1	1.1	34.9	0.0	1.8	0.3	50.6	0.0	1.5	1.0	8.2	29.4	19.6	2.2	0.0	33.9	1.8	30.9	18.8	0.0	22.6	0.5	1.2	9.9	6.1	0.0	21.6	0.3	0.0	0.2	11.9	0.0	0.0	0.3	1.2	1.7	1.4	0.3	0.9	1.4	26.5	0.3	2.4	0.6
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 48.3;Inhibitory neurons: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3"	"Group enriched"	"Detected in many"	22	"B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (3.97e-2)"	8.4	26.8	9.3	10.7	8.8	3.0	7.7	7.4	9.8	12.0	10.9	11.8	20.9	9.9	7.2	6.7	12.2	10.8	7.4	11.6	9.9	21.3	46.1	16.8	13.3	11.6	16.0	5.5	38.6	10.8	8.0	13.1	13.2	10.2	9.6	3.0	13.2	8.9	2.0	6.1	22.4	6.9	8.9	13.9	9.5	4.4	9.9	6.2	13.8	2.3	13.3	11.4	7.9	8.4	12.5	21.6	33.3	13.5	9.0	15.1	85.8	24.6	13.5	20.3	12.2	33.0	19.0	3.6	19.6	24.6	26.2	72.8	31.6	53.0	10.4	21.3	7.3	4.2	28.3	37.2	33.4	10.3	1.6	15.0	33.5	17.9	25.3	13.6	22.9	7.3	7.3	6.0	14.2	63.5	0.8	5.1	16.3	54.3	20.5	33.9	28.2	12.1	46.1	22.4	36.9	24.9	64.7	42.7	8.8	21.3	26.0	14.5	18.7	28.6	16.0	28.7	34.5	0.4	0.3	6.8	19.1	8.8	18.0	0.0	0.8	0.0	0.0	2.0	0.0	3.3	0.0	0.0	1.1	2.1	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.5	9.3	8.8	7.4	9.8	11.6	9.9	11.6	16.0	13.2	8.9	9.9	8.4	4.8	0.0	5.4	20.5	11.2	5.1	3.0	10.1	4.0	1.9	6.7	5.6	4.7	21.5	7.5	36.8	0.0	1.3	0.6	27.0	3.9	9.2	2.5	6.9	6.4	6.6	28.2	0.4	8.5	12.5	18.3	5.0	9.7	13.9	0.0	24.6	6.8	48.3	6.2	0.0	40.9	9.8	6.1	5.4	7.2	7.9	7.2	7.7	1.8	8.4	9.3	4.2	2.1	31.2	2.6	24.7	15.6	6.0	3.3	6.3	35.7	13.6	3.3	1.8	13.1	6.4	8.8	0.1	3.8	2.1	2.7	1.0	1.7	12.0	13.5	2.1
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571161-107965180	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 83.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.5;Basal squamous epithelial cells: 163.9;Syncytiotrophoblasts: 246.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 28.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 52.8;RH-30: 61.7;RPTEC TERT1: 86.2;T-47d: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002012	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	3.1	1.7	4.1	10.8	4.4	19.3	34.1	5.9	7.1	6.9	15.4	41.2	9.3	4.5	4.0	34.9	3.7	2.6	1.5	2.2	3.5	83.9	2.4	4.1	10.4	4.2	7.1	0.5	17.4	1.5	1.4	34.3	4.3	4.3	50.9	7.4	7.3	11.5	0.9	49.0	15.2	3.6	1.5	11.2	7.2	5.1	9.2	8.8	9.9	1.2	16.6	12.7	16.1	3.0	0.0	12.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.5	16.9	0.6	0.2	0.0	0.0	4.5	17.4	5.8	10.2	0.0	16.3	6.5	0.0	36.6	0.0	1.1	0.0	0.0	8.5	0.0	13.3	0.2	5.7	34.2	4.2	5.0	0.2	1.2	52.8	61.7	0.4	86.2	29.5	2.8	2.6	16.4	7.2	0.3	1.5	107.2	29.7	1.2	0.6	0.0	0.1	0.6	8.0	3.3	0.5	13.0	26.1	1.2	4.7	0.6	0.7	2.1	0.5	1.1	1.7	0.6	1.0	2.6	2.0	0.1	1.4	1.7	2.1	0.2	1.6	2.6	0.7	4.1	4.4	5.9	7.1	2.2	3.5	4.2	7.1	4.3	1.5	9.2	3.0	7.3	0.0	1.7	263.5	37.0	11.7	10.3	13.3	163.9	15.0	48.5	21.5	2.4	5.7	17.8	51.5	2.1	108.8	91.0	87.3	117.4	7.9	55.7	11.2	1.1	9.6	21.1	11.3	38.2	0.0	25.6	3.1	2.6	5.8	7.6	0.0	10.0	0.2	23.6	0.0	77.7	29.1	4.1	15.7	10.6	40.1	0.3	22.1	3.6	23.4	13.3	3.8	69.0	36.2	2.4	0.1	47.2	0.4	32.7	2.1	25.2	79.6	12.3	28.4	6.6	51.1	1.6	1.3	3.0	108.7	21.0	246.0	30.3	8.8	45.9	4.7
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 8.4"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	1.6	0.0	4.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	0.0	2.8	0.2	8.4	0.1	0.2	0.0	0.0	2.3	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239841	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol		NA	NA		15000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	32.1	32.5	48.6	29.4	50.2	50.5	31.6	54.6	60.5	24.2	43.6	30.1	23.0	25.2	26.6	31.0	23.5	21.1	65.7	49.5	53.7	40.4	31.2	23.3	41.3	52.7	52.8	25.5	19.7	38.2	29.7	30.2	53.4	30.9	33.0	48.2	20.6	25.4	101.5	19.3	24.3	28.9	54.6	24.8	22.6	15.9	51.9	45.8	31.6	121.2	40.4	32.2	19.9	60.1	162.8	57.6	122.1	81.1	49.6	68.0	35.2	78.8	60.7	99.7	155.3	69.1	80.8	207.1	163.6	66.8	154.1	62.4	179.3	74.0	129.5	110.0	123.9	87.6	86.0	54.2	58.9	142.6	65.5	51.0	84.7	84.7	105.6	53.1	93.7	101.0	173.4	119.9	113.6	67.7	134.3	120.9	71.0	149.1	122.1	114.0	97.0	121.4	86.8	73.0	132.0	80.0	54.1	62.7	90.1	83.4	53.8	107.5	55.6	80.5	100.0	138.3	198.0	133.9	209.0	361.3	71.6	173.1	101.0	22.5	23.0	75.8	26.3	25.1	30.2	28.6	30.5	31.7	36.2	23.7	34.5	37.5	26.3	28.2	21.9	29.5	43.2	33.0	48.6	50.2	54.6	60.5	49.5	53.7	52.7	52.8	53.4	54.6	51.9	60.1	40.7	51.3	29.1	12.1	55.1	57.4	81.2	89.9	33.6	54.9	33.2	30.2	80.5	30.0	48.0	38.6	20.9	73.7	60.4	27.9	191.7	65.8	2.5	32.8	41.3	47.3	23.4	128.6	12.7	57.6	101.4	52.6	28.5	28.9	47.5	36.6	30.7	24.9	67.6	32.0	14.2	30.0	75.3	29.5	64.4	4.6	42.0	40.7	46.2	6.5	80.1	78.7	47.4	6.6	21.3	52.7	43.1	39.9	56.8	78.0	29.3	126.3	37.2	46.3	46.0	45.1	52.8	80.7	88.2	37.1	52.6	68.7	60.0	81.6	45.9	63.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 389.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 142.6;Hepatic stellate cells: 94.9;Kupffer cells: 561.9;Proximal tubular cells: 188.4;Theca cells: 186.8"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 164.7;HSkMC: 111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		NA	NA	624000000	1300000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	29.1	43.2	4.0	34.7	3.5	8.3	15.0	5.0	4.5	6.7	6.0	15.0	15.4	9.4	2.4	7.7	9.8	29.5	9.4	2.8	7.6	64.3	43.7	18.1	96.3	6.5	6.2	39.5	13.3	18.4	7.0	43.2	7.0	9.7	23.5	1.5	8.7	5.5	3.1	3.6	14.4	11.0	6.0	389.3	14.4	5.4	11.2	24.6	7.3	6.3	75.9	72.7	5.5	5.9	0.0	0.0	0.8	0.3	0.6	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.1	25.7	0.0	0.0	0.0	0.0	164.7	0.2	0.0	111.0	0.0	29.3	0.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.5	5.0	4.5	2.8	7.6	6.5	6.2	7.0	6.0	11.2	5.9	9.6	0.0	5.6	0.0	1.7	9.9	0.5	0.4	0.0	0.1	0.9	0.6	1.9	0.0	0.2	3.7	0.0	1.3	1.1	0.0	9.8	142.6	0.3	0.7	14.0	40.3	0.0	2.7	0.0	3.2	1.2	60.1	0.0	0.8	1.3	7.5	94.9	3.2	3.6	0.0	0.0	0.0	0.0	561.9	15.9	0.0	17.1	7.9	1.8	6.5	0.0	4.0	0.0	0.0	0.1	2.3	1.1	7.5	0.9	1.3	0.0	188.4	1.5	0.0	0.0	5.5	19.2	0.1	2.3	0.4	7.4	2.7	10.0	186.8	0.1	0.4
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471618-83582303	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 975.7;Granulosa cells: 1131.8;Kupffer cells: 547.3;Macrophages: 605.6;monocytes: 948.1;Oligodendrocyte precursor cells: 1644.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 240.0;myeloid DC: 88.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 88.9;monocytes: 240.0"	"Cell line enhanced"	"Detected in many"		"AF22: 300.5;HSkMC: 199.5;hTERT-RPE1: 959.0;RPTEC TERT1: 381.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	42.0	23.9	18.6	74.9	20.8	32.6	15.6	24.2	23.0	29.4	5.2	11.3	3.8	17.8	1.8	3.8	8.6	30.5	45.0	25.7	27.8	6.5	2.7	34.4	2.3	36.1	19.3	2.1	3.1	2.4	2.1	73.5	31.3	6.8	10.7	0.2	7.6	4.2	3.9	11.2	5.7	48.0	28.9	13.9	7.7	4.8	44.9	2.7	6.6	6.8	1.9	48.3	7.2	42.7	0.2	5.6	300.5	0.1	119.8	81.5	0.1	2.3	6.2	2.1	1.5	3.1	0.2	0.0	45.2	111.5	3.9	0.0	0.4	0.4	1.7	0.1	9.8	2.1	0.0	2.3	5.5	0.1	0.0	199.5	0.1	127.6	1.2	959.0	0.1	0.0	0.0	0.1	64.6	0.0	0.5	0.0	51.1	0.0	10.3	0.0	63.0	0.1	381.0	0.0	3.6	15.5	0.0	0.0	0.2	33.2	0.2	0.5	116.5	90.6	0.5	168.3	179.0	0.0	0.1	0.2	41.8	0.1	16.4	8.3	240.0	0.5	0.5	31.3	0.3	0.2	0.1	0.1	88.9	0.1	0.1	0.0	3.9	0.5	3.5	1.7	0.0	94.0	18.6	20.8	24.2	23.0	25.7	27.8	36.1	19.3	31.3	28.9	44.9	42.7	23.4	19.2	19.8	128.9	5.5	38.6	10.6	14.9	1.2	0.0	1.8	1.9	8.2	44.3	17.5	25.8	0.0	5.9	7.4	0.0	0.0	1.9	3.0	64.4	975.7	29.9	0.0	5.2	1.5	0.7	7.0	348.1	3.6	241.3	12.6	1131.8	16.8	3.6	25.6	0.0	30.7	0.2	0.0	547.3	83.1	2.5	18.6	605.6	44.4	20.6	948.1	0.0	13.4	1644.7	1.5	32.3	1.1	117.8	2.5	2.5	0.0	1.8	16.2	0.0	0.0	11.0	80.6	0.9	1.2	1.1	28.7	11.5	12.7	1.6	0.3	0.9
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA001146: AB_1845558, HPA076561: AB_2732312"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	2.9	4.1	1.7	3.4	2.1	5.1	2.3	2.4	5.3	3.7	3.0	3.3	1.7	3.0	2.6	4.9	2.9	2.3	2.7	2.5	2.0	2.7	3.9	3.1	4.3	2.0	1.9	2.6	2.9	1.9	3.3	1.6	2.0	2.7	1.6	1.5	2.2	1.6	2.3	3.9	3.2	1.5	1.5	4.8	3.6	2.1	2.2	4.7	2.6	1.8	4.4	3.0	3.2	2.5	4.2	4.4	4.0	4.9	2.6	3.1	4.4	4.0	4.4	4.4	3.3	2.8	4.8	12.8	2.7	2.8	1.1	7.9	4.9	7.0	4.4	6.4	3.2	2.5	1.7	2.8	3.6	6.4	3.3	2.0	3.9	4.8	4.9	3.0	5.5	4.6	3.0	5.3	3.3	5.5	13.4	6.7	3.9	6.1	7.2	9.0	7.4	3.4	5.6	6.3	6.7	7.9	5.9	1.6	7.1	3.6	4.0	5.7	1.4	7.2	5.6	2.6	4.5	5.1	11.4	5.0	2.5	5.2	3.5	12.1	2.8	0.0	9.3	4.7	10.9	27.1	9.1	11.5	3.8	21.4	11.2	12.4	0.8	11.8	2.2	5.4	7.8	4.8	1.7	2.1	2.4	5.3	2.5	2.0	2.0	1.9	2.0	1.5	2.2	2.5	11.5	12.8	9.8	7.8	38.0	30.3	17.3	7.7	30.1	6.5	12.8	10.8	3.6	8.6	9.7	7.3	10.4	10.2	25.7	5.6	9.8	5.8	39.4	14.1	9.8	8.3	5.4	9.5	12.6	5.7	8.4	9.3	7.7	17.1	17.7	7.2	6.8	7.7	5.1	1.7	11.0	8.5	12.2	7.5	16.4	10.2	7.5	8.7	10.6	3.7	9.5	3.5	15.5	10.6	17.5	5.3	8.0	4.9	48.2	15.5	7.8	6.7	8.6	8.1	0.0	9.1	9.1	14.4	16.6	24.9	37.4	11.5	22.4	10.2	7.1	17.1
VCX	"VCX-10r, VCX-B1, VCX1, VCX10R"	ENSG00000182583	"Variable charge X-linked"	Q9H320	X	7842262-7844143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 33.4"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 855.2;Spermatogonia: 1008.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;NB-4: 1.7;RPMI-8226: 1.4;THP-1: 1.5;U-138 MG: 1.4;U-266/70: 2.8"									"HPA044996, HPA049357"	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA044996: AB_2679174, HPA049357: AB_2680727"					"unprognostic (1.65e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.73e-1)"			"unprognostic (7.89e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.20e-1)"		"unprognostic (7.18e-3)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	33.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	1.7	0.8	0.3	0.2	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.6	1.5	0.0	1.4	0.3	1.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	83.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	98.1	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	85.5	0.0	0.0	855.2	1008.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
VCX2	VCX-2r	ENSG00000177504	"Variable charge X-linked 2"	Q9H322	X	8169944-8171267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	208	"testis: 28.0"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 306.0;Spermatogonia: 414.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044642, HPA044996, HPA049357"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727"															"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	306.0	414.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCX3A	"VCX-8r, VCX-A, VCX3"	ENSG00000169059	"Variable charge X-linked 3A"	Q9NNX9	X	6533618-6535118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	122	"testis: 56.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 598.9;Spermatogonia: 754.0"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.9;PC-3: 2.5;U-138 MG: 7.4;U-2197: 1.8;U-266/70: 4.6"									"HPA044996, HPA049357"	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA044996: AB_2679174, HPA049357: AB_2680727"					"unprognostic (1.11e-1)"			"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.43e-1)"					"unprognostic (3.29e-2)"		"unprognostic (1.64e-2)"	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	56.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	7.4	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	33.6	6.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	92.1	0.0	0.0	598.9	754.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
VCX3B	VCX-C	ENSG00000205642	"Variable charge X-linked 3B"	Q9H321	X	8464830-8466510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	64	"testis: 32.8"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 902.7;Spermatogonia: 1055.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-138 MG: 18.6"									"HPA044996, HPA049357"	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA044996: AB_2679174, HPA049357: AB_2680727"		"unprognostic (1.60e-1)"		"unprognostic (1.25e-1)"	"unprognostic (1.67e-1)"			"unprognostic (7.51e-2)"		"unprognostic (2.07e-1)"		"unprognostic (4.19e-3)"	"unprognostic (4.41e-2)"		"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.58e-2)"	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.5	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	32.8	0.3	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	18.6	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	75.7	0.1	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.7	0.2	0.0	0.0	0.0	0.0	54.4	8.1	1.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	111.7	0.0	0.1	902.7	1055.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0
VCY	"BPY1, VCY1, VCY1A"	ENSG00000129864	"Variable charge Y-linked"	O14598	Y	13985772-13986513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	131	"testis: 60.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"					"HPA044996: AB_2679174, HPA049357: AB_2680727"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCY1B	BPY1B	ENSG00000129862	"Variable charge Y-linked 1B"	O14598	Y	14056227-14056958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	572	"testis: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-266/70: 2.9"									"HPA044996, HPA049357"	Supported					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"				"HPA044996: AB_2679174, HPA049357: AB_2680727"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971871-134004975	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1045.7;tongue: 812.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005885, HPA030780, CAB072343"	Supported					NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (8.49e-4)"	"prognostic unfavorable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	96.3	129.8	104.8	96.2	113.5	53.9	106.2	112.8	137.4	62.8	149.0	154.1	265.7	54.4	196.9	172.3	61.5	90.3	403.5	116.7	122.3	200.9	206.2	79.3	89.6	113.4	105.1	60.8	99.7	181.8	63.4	104.5	118.3	82.4	166.4	316.0	132.9	72.5	1045.7	113.9	179.1	90.7	101.1	60.2	163.6	37.5	117.3	90.9	68.5	812.0	129.3	108.3	91.0	106.4	364.5	315.8	282.8	295.3	277.5	385.0	398.0	398.1	292.2	386.5	395.2	650.0	282.9	497.4	291.5	418.0	515.1	278.2	403.4	701.2	480.7	296.1	331.7	287.3	308.9	526.0	282.2	266.5	272.9	353.3	368.5	301.1	333.0	385.3	381.2	248.0	260.1	197.8	511.8	404.5	326.3	264.1	198.5	555.2	264.3	296.5	282.6	474.3	608.6	450.0	315.0	177.7	253.7	305.2	416.0	385.9	147.0	257.6	311.6	361.4	241.6	335.9	530.2	262.9	278.3	309.4	537.1	351.9	420.7	24.9	83.2	30.3	54.5	118.4	60.0	58.3	55.6	57.3	140.7	40.5	38.8	43.8	6.9	87.7	105.1	41.1	74.5	72.9	104.8	113.5	112.8	137.4	116.7	122.3	113.4	105.1	118.3	101.1	117.3	106.4	89.9	105.8	63.1	21.2	101.9	204.8	246.6	250.8	128.7	463.6	163.7	98.3	276.0	198.8	133.2	126.9	81.3	372.4	94.9	333.1	729.8	303.4	68.7	140.8	161.1	120.7	104.1	96.7	41.5	302.6	471.4	136.9	225.8	184.6	121.8	163.9	57.1	203.9	332.7	519.9	40.6	202.7	189.2	130.6	243.5	50.3	95.7	165.7	249.1	31.9	315.8	277.0	60.8	24.1	23.8	300.7	227.7	112.1	162.0	353.6	415.8	585.3	121.2	257.2	85.5	132.8	171.4	10.9	32.7	275.5	232.9	325.6	111.0	229.1	326.7	265.1
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043475	Enhanced		Supported	Mitochondria		NA	NA		490000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (4.51e-4)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	138.2	150.3	95.5	93.3	97.4	138.5	116.2	116.2	115.0	165.5	117.1	209.1	151.3	116.6	90.7	322.1	117.4	85.4	420.5	99.0	109.0	177.5	115.9	112.0	83.5	105.7	107.1	132.8	150.6	192.7	85.3	115.6	110.1	108.8	184.4	198.4	151.4	134.0	539.4	171.6	148.4	149.2	105.0	77.7	159.4	104.6	107.1	92.7	111.0	565.9	148.3	163.6	207.1	110.4	304.4	245.0	291.0	370.5	253.3	342.1	305.2	384.9	430.4	412.7	386.6	367.5	281.8	358.6	210.9	324.3	228.6	398.2	539.2	382.2	402.1	196.0	313.5	209.4	191.4	425.2	252.6	402.0	223.4	305.6	441.7	352.8	747.3	578.2	310.0	222.9	359.9	283.7	439.4	222.6	262.6	325.7	250.7	341.2	937.6	308.2	230.0	228.3	408.9	187.5	183.4	216.5	212.4	701.7	467.4	337.8	409.7	177.4	241.4	204.4	279.8	305.7	419.8	226.7	333.1	369.0	296.3	390.4	178.1	168.2	179.0	138.9	106.7	193.1	130.8	154.2	144.3	119.4	220.4	127.9	144.2	134.5	61.5	135.5	238.4	107.3	178.6	221.6	95.5	97.4	116.2	115.0	99.0	109.0	105.7	107.1	110.1	105.0	107.1	110.4	130.3	96.1	54.9	30.3	135.5	381.4	417.8	575.6	280.6	149.6	149.5	159.1	325.1	128.7	246.3	112.2	43.8	315.0	128.0	583.7	669.1	413.3	257.6	172.2	110.9	146.5	149.7	148.5	22.1	345.7	437.6	142.6	158.0	199.9	112.3	197.5	165.9	79.2	266.1	129.5	30.7	305.1	284.8	164.8	220.3	110.8	169.9	180.2	224.1	16.9	264.3	275.5	92.7	23.1	26.0	443.5	497.2	166.3	172.2	386.3	610.9	324.3	119.5	161.1	177.5	170.3	289.0	359.7	149.7	493.3	420.4	396.5	129.6	210.5	355.7	568.1
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405937	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 385.2;skeletal muscle: 914.4;tongue: 942.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 403.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	67.5	76.2	117.3	59.1	119.4	92.1	70.3	116.8	150.6	53.7	115.4	106.9	79.8	63.5	68.6	99.9	85.8	56.0	385.2	121.1	130.8	108.8	92.9	51.9	66.3	122.7	119.3	61.6	64.6	92.4	58.9	63.9	139.2	69.5	106.4	123.1	61.6	81.3	914.4	54.1	73.0	92.8	114.1	67.3	72.1	114.5	118.6	80.1	83.3	942.7	79.3	78.9	59.8	113.8	226.3	225.7	174.5	185.9	146.3	126.6	84.8	180.0	151.1	225.4	205.2	173.4	190.4	235.8	165.0	153.7	196.3	142.5	238.4	194.1	244.7	117.2	196.6	352.9	138.4	250.2	105.2	172.0	190.1	98.6	143.3	171.6	80.9	149.6	279.8	201.3	284.4	158.6	235.7	126.4	373.3	197.1	205.2	285.6	144.5	193.6	322.1	165.3	245.7	198.8	156.8	133.3	112.1	132.8	116.1	126.4	279.9	129.9	149.8	86.6	150.0	217.7	174.0	145.2	264.1	266.9	117.5	238.0	150.9	142.8	165.3	183.4	145.8	167.2	148.7	126.5	155.6	146.5	222.7	96.6	152.7	147.7	82.8	125.8	155.6	163.0	202.5	360.5	117.3	119.4	116.8	150.6	121.1	130.8	122.7	119.3	139.2	114.1	118.6	113.8	78.1	44.8	24.4	50.6	59.8	64.5	81.1	197.8	58.1	85.9	53.0	73.9	321.2	55.8	82.8	66.2	35.5	145.5	91.9	65.7	307.2	116.3	151.1	112.8	56.7	70.5	47.8	186.4	63.2	90.0	112.1	81.5	41.3	47.1	55.2	100.6	68.2	60.4	139.7	138.0	78.9	86.1	177.0	58.5	77.8	146.4	69.3	107.7	72.9	26.2	130.1	72.9	83.4	38.2	34.7	84.9	86.7	97.4	75.9	48.9	125.3	177.5	142.1	94.5	65.7	146.4	123.8	403.7	156.3	82.3	70.8	58.3	79.7	94.2	124.8	70.4
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 349.4;Muller glia cells: 265.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 79.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 398.9;U-87 MG: 628.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000	57000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	155.8	52.7	17.6	36.5	20.3	45.5	92.4	34.2	28.2	45.2	46.8	32.6	50.9	104.0	10.5	61.3	40.9	80.1	208.3	22.8	25.1	116.9	217.3	94.1	9.3	27.0	38.5	25.0	68.1	105.0	22.3	46.2	26.8	120.3	21.4	229.1	32.1	17.8	221.2	44.2	44.6	57.1	19.6	70.1	63.9	5.3	32.0	5.6	270.9	150.9	9.5	122.3	61.7	24.9	76.5	13.4	12.5	71.8	21.0	32.9	84.2	45.6	81.1	29.7	58.4	43.1	9.9	24.9	35.5	27.7	305.4	30.6	34.0	92.0	52.0	27.4	10.4	19.0	17.8	29.2	220.3	20.8	40.4	58.0	178.6	290.6	286.2	398.9	7.7	21.0	35.7	121.7	109.4	31.3	2.3	28.3	7.9	221.2	19.2	2.3	12.0	60.5	114.8	62.9	22.3	46.8	65.6	44.4	162.0	16.1	17.3	75.1	10.4	122.6	32.9	179.2	76.1	68.8	43.6	49.1	628.6	47.9	43.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	20.3	34.2	28.2	22.8	25.1	27.0	38.5	26.8	19.6	32.0	24.9	63.6	349.4	84.7	121.5	9.8	70.5	51.2	76.8	60.3	37.8	67.0	57.1	164.7	77.2	85.7	22.0	31.3	1.3	11.6	92.9	1.9	54.7	0.0	38.4	59.1	29.0	27.4	21.3	12.1	40.8	6.3	69.7	124.4	121.2	112.0	111.7	17.5	116.0	13.9	180.0	17.0	71.8	12.2	16.2	199.0	0.3	1.8	144.1	28.4	10.3	11.3	265.8	0.0	124.1	1.8	86.0	47.1	3.4	15.9	119.4	61.9	20.5	11.4	43.9	0.0	42.1	79.1	1.1	1.9	82.0	78.3	7.9	11.4	17.4	51.0	137.5
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345596-15384413	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 42.7"	"Cell type enriched"	"Detected in some"	12	"Fibroblasts: 39.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 2.8;EFO-21: 1.3;HSkMC: 2.8"	"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6"	"Not detected"	"Not detected"			HPA027342	Uncertain				"Secreted to blood"	NA	NA	592000	450000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	11.4	9.9	1.8	0.7	1.8	0.0	20.3	1.5	2.3	19.2	1.5	5.0	1.2	3.8	4.9	2.7	4.1	2.8	15.5	1.6	2.0	1.7	1.5	42.7	0.4	1.8	1.7	4.4	0.7	2.7	7.0	0.2	2.0	1.5	2.0	0.3	2.3	1.8	17.6	1.2	4.2	3.3	1.3	2.8	5.8	0.6	2.1	0.3	1.5	23.0	1.3	6.0	8.1	2.0	0.0	0.6	0.5	0.9	3.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.3	2.8	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.5	2.3	1.6	2.0	1.8	1.7	2.0	1.3	2.1	2.0	3.1	3.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.8	2.3	1.6	3.6	1.1	2.8	1.9	1.6	1.5	1.5	1.9	1.9	0.4	1.6	0.5	0.5	1.8	1.5	1.5	1.5	1.5	1.7	0.5	3.8	0.5	1.9	1.7	1.5	1.2	0.5	1.4	0.5	1.5	1.3	0.4	0.2	1.3	0.8	0.9	1.2	1.0	1.2	0.9	5.7	0.9	1.0	2.5	0.2	0.8	0.1	0.4	1.4	1.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.6	1.1	1.6	1.5	1.5	1.5	1.9	1.7	1.5	0.9	2.5	1.8	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.2;kidney: 27.0;lung: 29.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.3;renal cancer: 4.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.4	20.2	0.2	0.1	0.3	2.2	1.9	0.8	0.1	3.1	11.1	0.8	0.7	0.3	17.6	0.0	5.4	0.9	0.2	0.7	0.4	27.0	0.5	29.4	0.0	2.7	1.1	0.2	13.1	2.1	17.1	1.3	2.9	1.4	0.8	0.4	2.5	2.8	0.1	1.5	0.1	0.2	0.4	4.0	0.9	2.9	0.4	0.1	2.0	0.1	0.0	0.4	0.3	0.2	7.3	0.8	16.0	0.0	9.2	33.8	0.0	41.9	92.0	12.2	17.7	1.1	6.4	0.0	16.0	45.3	1.9	0.3	0.5	1.0	67.2	0.2	0.0	7.3	0.8	0.0	2.9	0.0	0.1	9.9	0.7	51.9	10.3	96.7	245.1	0.0	2.5	0.0	33.4	0.9	0.0	0.0	6.6	1.9	6.2	0.0	1.2	0.0	6.1	3.6	0.6	0.0	1.3	1.9	17.0	0.2	70.7	0.1	147.2	48.0	1.6	16.8	58.0	0.0	0.0	0.0	38.6	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.8	0.1	0.7	0.4	2.7	1.1	2.9	0.4	0.4	0.2	0.1	266.0	175.9	1.6	0.5	1.8	0.2	0.0	0.0	0.2	4.5	3.7	0.5	22.8	14.3	31.3	2.1	1.8	0.2	1.2	46.9	6.9	64.5	11.1	0.5	0.9	0.0	0.0	2.8	10.1	0.1	0.9	0.0	4.4	0.0	0.8	0.0	0.0	0.2	0.0	3.3	0.4	0.0	0.0	0.3	84.7	1.5	2.3	28.4	0.0	0.7	1.5	0.0	0.0	0.9	1.8	3.2	0.4	0.0	0.3	0.0	28.7	8.1	0.5	0.0	0.1	1.3	0.3	0.9	0.0	0.4	0.0	0.6	0.9	0.8	0.2
VEZF1	"DB1, ZNF161"	ENSG00000136451	"Vascular endothelial zinc finger 1"	Q14119	17	57971547-57988259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027520, HPA048315"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA027520: AB_10602680, HPA048315: AB_2680353"	"unprognostic (7.24e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.14e-5)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.03e-2)"	22.1	29.1	20.8	18.7	33.4	56.6	24.0	26.7	23.9	30.9	26.0	40.7	19.1	37.6	16.0	24.8	37.7	25.0	29.2	20.4	25.9	26.2	16.6	28.5	21.9	32.1	28.6	32.1	25.7	24.8	20.5	26.3	31.0	29.3	23.1	70.5	27.5	27.2	65.7	16.0	24.3	33.0	24.3	23.9	26.0	18.9	27.5	34.9	37.4	44.5	20.2	32.7	24.2	47.3	42.5	48.1	93.8	30.1	22.9	32.4	28.9	35.1	50.9	44.7	41.0	22.9	44.4	20.6	55.3	40.3	41.6	23.7	38.1	40.7	60.3	58.2	23.7	41.7	39.5	25.6	27.1	36.0	33.6	23.0	47.6	29.9	52.1	59.3	42.2	29.5	30.9	28.9	44.2	15.3	58.0	20.0	30.5	38.4	48.7	43.4	68.9	16.9	25.6	40.9	36.6	63.2	32.3	15.3	51.8	39.3	90.3	33.1	40.2	59.7	59.3	37.5	56.1	30.9	26.3	33.9	40.5	30.4	76.3	31.6	15.2	30.1	17.9	19.0	18.0	12.8	13.8	19.3	18.6	14.3	18.0	16.2	25.2	30.7	33.9	17.2	14.3	16.4	20.8	33.4	26.7	23.9	20.4	25.9	32.1	28.6	31.0	24.3	27.5	47.3	44.4	83.3	60.9	29.0	32.2	36.2	39.5	25.8	70.0	73.6	42.6	37.6	111.0	40.0	41.5	25.8	66.7	16.3	49.5	24.9	25.4	36.2	28.9	73.5	41.4	44.6	49.0	23.8	8.1	36.5	19.2	48.6	23.4	64.3	57.0	44.4	34.2	18.3	22.6	33.7	14.5	29.7	24.4	34.9	48.5	36.6	36.1	36.5	42.7	19.7	39.4	44.5	34.0	43.2	81.9	30.9	21.1	27.8	20.2	48.3	21.1	23.8	63.0	65.7	52.6	102.8	60.5	42.1	24.5	36.0	21.0	19.8	34.3	21.8	26.7	35.3
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532215-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 203.9"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6"	"Group enriched"	"Detected in many"	4	"ovarian cancer: 13.7;urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA042403: AB_2677980, HPA064616: AB_2685300"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.4	1.5	1.3	0.6	0.1	0.0	0.0	6.6	0.1	2.1	0.0	0.0	0.0	0.1	1.5	0.0	1.4	203.9	0.0	1.4	0.0	0.0	5.1	6.7	0.0	0.2	0.2	0.0	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.0	1.1	22.7	1.6	0.0	130.7	0.0	0.0	0.1	0.0	0.0	189.5	0.0	0.0	0.0	0.0	18.1	72.7	0.0	0.0	0.0	0.0	5.9	0.0	7.5	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.1	2.1	0.0	0.1	0.0	0.1	0.0	328.6	0.2	0.2	0.0	328.7	0.3	13.2	5.6	0.4	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	4.9	1.8	0.2	0.0	16.6	36.8	0.0	1282.0	0.1	0.0	0.0	2.1	0.0	3.3	0.1	2.7	0.0	0.0	0.0	0.2	582.3	5.8	0.0	2.0	1.3	0.0	0.0	0.0	108.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	0.1	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1788.6	0.0	0.0	0.0	30.5
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991149	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.1;Extravillous trophoblasts: 178.1;Late spermatids: 71.8;Leydig cells: 132.3;Peritubular cells: 149.3;Skeletal myocytes: 65.9;Syncytiotrophoblasts: 80.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9;urothelial cancer: 6.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 518.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054983	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli, Cytosol"		"HPA054983: AB_2682663"	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	21.0	1.5	5.7	3.3	1.8	0.4	7.4	0.5	2.1	5.4	6.8	6.7	1.1	8.0	1.4	3.0	5.4	9.6	4.3	1.9	6.9	1.5	0.6	15.9	2.3	0.9	2.3	14.2	4.0	1.2	0.3	40.1	1.0	11.0	2.2	1.1	1.6	4.1	1.7	4.1	2.2	9.0	0.6	2.0	2.6	3.4	2.7	0.5	3.0	1.5	0.8	9.3	4.0	0.5	8.1	13.1	69.5	0.2	90.5	112.2	1.1	48.6	34.0	40.8	50.8	15.2	3.1	0.0	0.1	76.9	4.6	6.9	4.8	4.6	55.9	28.4	0.1	3.6	4.8	0.3	41.3	0.5	0.2	86.6	7.6	60.1	26.9	21.8	6.1	0.1	0.0	0.1	51.5	0.1	0.5	0.4	1.4	0.1	0.3	0.1	91.7	0.4	0.0	8.3	0.2	0.1	20.8	0.7	0.1	2.4	0.2	0.3	2.8	90.3	13.4	518.3	1.6	0.2	0.2	0.0	16.8	0.0	3.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	5.7	1.8	0.5	2.1	1.9	6.9	0.9	2.3	1.0	0.6	2.7	0.5	2.5	3.2	2.2	0.0	0.0	8.0	11.1	2.1	4.0	0.0	0.9	4.6	1.2	1.5	3.3	11.0	0.0	35.6	0.1	0.0	0.0	13.4	138.1	1.3	31.0	1.7	0.0	0.0	0.4	2.6	178.1	33.4	1.1	1.2	0.0	0.1	2.5	0.0	7.5	0.0	2.0	0.0	2.0	0.0	10.3	71.8	132.3	0.7	3.6	6.5	0.0	17.1	0.0	0.0	1.4	13.2	0.0	149.3	0.0	17.7	0.0	0.1	3.2	0.3	13.1	65.9	21.8	1.1	1.4	1.8	5.3	80.7	0.5	23.1	0.0	4.5
VGLL4	KIAA0121	ENSG00000144560	"Vestigial like family member 4"	Q14135	3	11556069-11771350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038225, HPA038614"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA038225: AB_10674549, HPA038614: AB_2676115"	"unprognostic (1.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.26e-1)"	36.2	44.2	29.3	16.8	28.9	14.7	37.2	21.8	31.2	54.2	73.1	31.6	25.4	50.6	21.3	37.0	45.7	35.8	31.1	33.0	26.1	34.8	15.8	33.0	20.0	30.1	27.2	78.0	25.2	37.2	25.3	25.1	26.1	31.5	17.9	19.8	43.8	22.9	18.9	39.7	25.7	31.1	22.3	21.1	27.0	24.5	30.2	29.6	45.8	12.6	21.9	35.2	46.1	30.2	26.6	17.1	38.8	9.9	55.0	28.5	97.4	16.7	33.0	12.8	14.0	15.2	26.0	33.0	36.1	26.1	25.1	18.1	20.4	29.9	9.2	20.8	32.5	27.1	15.7	22.6	43.2	27.9	23.0	36.0	61.8	16.1	25.4	72.6	51.8	33.1	10.4	5.1	20.1	23.1	27.3	31.0	25.0	37.1	24.7	43.5	25.9	44.3	33.3	39.0	20.6	50.0	16.8	21.7	43.1	29.8	21.3	26.0	27.1	33.1	18.5	22.3	39.0	9.9	28.9	72.7	37.4	44.9	64.0	20.2	3.9	0.8	10.2	2.3	7.0	5.9	6.0	9.0	5.1	3.8	6.9	8.5	2.5	5.6	9.2	4.2	3.3	6.1	29.3	28.9	21.8	31.2	33.0	26.1	30.1	27.2	26.1	22.3	30.2	30.2	76.8	32.1	20.8	92.4	21.3	64.5	61.8	101.8	82.6	43.1	63.1	68.6	4.1	61.5	53.3	44.1	148.0	74.0	22.6	23.8	62.6	73.3	15.6	63.8	44.4	78.4	34.6	29.9	108.9	35.8	80.6	59.5	35.2	67.5	14.5	66.5	69.3	17.2	33.1	74.0	75.5	34.1	105.8	20.2	43.6	16.1	73.3	21.1	44.4	50.6	23.1	95.3	32.0	111.6	60.8	54.5	35.3	90.7	14.7	101.7	36.2	27.1	61.7	55.3	32.9	58.9	59.0	8.7	28.3	78.2	76.1	44.7	26.8	66.0	41.3	77.7
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141778-10153667	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031631, HPA031632, HPA068954"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: "	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	14.0	13.7	11.5	21.1	11.0	27.9	14.7	13.6	12.1	11.8	6.7	14.8	15.7	14.1	9.8	12.3	13.4	11.5	7.9	11.8	14.9	12.6	14.1	11.8	29.6	9.4	9.4	12.6	12.7	11.7	9.0	14.1	9.3	14.0	15.7	8.9	14.5	10.2	11.4	14.2	17.2	12.8	9.6	22.5	16.0	13.4	16.6	23.4	15.8	7.7	29.7	12.5	10.9	12.5	19.5	18.2	39.9	24.6	36.0	27.7	146.5	16.8	24.0	21.1	24.5	21.5	23.7	67.9	22.2	23.0	29.9	16.4	37.2	23.6	25.7	33.0	33.7	52.7	30.5	30.6	34.3	47.3	41.3	28.1	26.3	28.0	35.1	28.4	24.6	42.5	48.3	50.3	21.1	35.0	45.5	40.9	26.7	21.1	23.4	57.3	34.6	34.6	25.5	48.7	15.0	49.4	35.0	18.7	21.0	23.9	37.0	59.1	21.3	20.8	27.7	19.6	26.8	35.7	78.1	105.6	23.2	55.3	19.4	4.6	3.2	2.3	2.6	2.2	1.9	2.5	1.8	2.2	2.0	3.3	1.7	1.8	5.6	3.0	2.0	2.3	1.7	1.2	11.5	11.0	13.6	12.1	11.8	14.9	9.4	9.4	9.3	9.6	16.6	12.5	12.4	12.8	12.5	9.1	38.7	14.7	17.8	14.3	24.5	14.7	10.7	6.1	6.1	20.0	9.6	16.5	18.8	16.8	21.9	10.7	7.9	11.8	9.6	13.1	26.1	14.8	14.4	30.5	15.9	5.1	18.7	12.8	20.9	19.9	5.1	18.4	18.9	14.3	14.9	18.5	14.2	11.3	16.2	27.1	45.8	7.3	14.0	32.3	12.4	7.5	31.9	9.1	28.8	12.1	14.9	10.7	11.7	11.3	33.3	23.8	12.3	9.5	9.7	15.3	6.6	17.4	11.9	15.4	24.0	26.7	20.5	17.2	23.5	21.4	10.2	25.9
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 436.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.6	1.1	0.0	10.3	0.1	0.3	0.8	0.3	0.2	0.7	0.0	175.9	395.0	0.5	0.0	0.9	0.7	28.1	1.0	0.0	0.0	25.9	31.4	0.7	0.3	0.0	0.0	1.1	29.4	0.0	1.4	0.3	0.0	1.0	184.0	0.0	0.6	0.4	0.4	1.1	436.3	8.1	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.1	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750797-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 72.2;lymphoid tissue: 155.5"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 80.6;Melanocytes: 28.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;TIME: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000			"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	2.7	12.2	5.5	155.5	7.9	0.1	1.9	4.9	10.9	1.8	4.6	72.2	16.6	1.2	0.4	4.3	1.5	3.7	4.3	7.3	28.7	2.5	1.1	3.4	0.4	6.9	40.0	0.8	8.3	0.3	0.8	0.6	7.7	2.7	61.4	1.0	0.5	0.5	1.4	0.4	45.8	41.6	4.8	9.7	22.2	1.0	11.9	0.1	2.3	1.7	0.1	1.6	9.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	7.9	4.9	10.9	7.3	28.7	6.9	40.0	7.7	4.8	11.9	5.9	2.5	0.0	0.0	3.3	0.2	0.4	0.0	0.0	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	80.6	0.0	0.0	0.3	0.0	6.5	0.0	0.0	28.4	4.7	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VIPAS39	"C14orf133, hSPE-39, SPE-39, SPE39, VIPAR, VPS16B"	ENSG00000151445	"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog"	Q9H9C1	14	77426675-77457952	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003589, HPA003593"	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003589: AB_10599707, HPA003593: AB_10601879"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (2.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.09e-2)"	12.4	11.8	15.3	9.4	16.0	9.1	12.2	15.4	17.9	12.1	15.6	14.3	10.1	12.1	14.7	13.2	10.8	9.1	14.8	15.7	15.6	11.2	13.6	9.9	12.4	15.2	15.3	18.5	11.9	14.6	13.4	15.5	15.6	11.8	12.7	14.4	10.0	13.7	13.7	13.7	11.1	14.6	15.6	13.2	11.6	15.9	15.9	16.5	11.7	15.0	14.7	13.9	11.6	17.7	10.6	17.8	18.3	26.6	32.5	26.5	18.3	17.5	16.1	20.8	20.2	11.9	24.7	18.4	15.1	14.3	10.8	20.4	17.0	15.5	24.9	15.8	5.8	13.7	10.7	14.7	26.3	8.6	23.2	25.4	24.2	17.8	24.2	27.7	36.3	25.5	10.9	17.4	19.9	25.1	17.7	18.4	16.5	31.0	19.3	17.6	23.0	12.7	20.9	15.3	13.0	15.0	22.7	16.7	20.2	21.7	39.1	18.1	25.9	14.1	12.5	15.5	9.8	14.8	15.1	14.6	15.3	15.9	17.0	1.8	9.4	17.6	5.0	15.6	6.5	4.8	6.5	5.6	10.8	5.6	5.7	5.6	7.8	13.0	20.3	5.5	7.8	6.1	15.3	16.0	15.4	17.9	15.7	15.6	15.2	15.3	15.6	15.6	15.9	17.7	6.0	3.2	1.5	16.0	6.3	3.2	3.0	4.7	2.8	8.5	5.3	5.3	9.0	4.3	3.4	9.2	20.9	20.7	6.3	7.2	7.9	9.3	5.7	4.0	7.4	6.8	5.4	11.2	14.6	6.3	16.6	8.2	5.1	6.2	2.5	12.2	8.2	6.6	13.3	10.1	14.4	5.4	2.0	17.6	3.8	3.8	11.5	8.3	0.0	13.1	17.6	7.4	9.2	15.1	17.2	9.1	9.4	15.4	4.0	2.5	10.7	5.8	3.6	13.3	6.6	5.5	6.8	11.0	9.2	6.3	4.3	19.2	6.3	15.5	7.2	2.8
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 132.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0"	"Group enriched"	"Detected in many"	4	"amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	17.5	2.6	10.1	3.4	12.7	2.3	16.9	13.5	15.2	2.9	5.1	28.0	34.5	1.2	6.6	5.3	1.3	6.0	6.5	13.0	5.5	2.7	32.4	132.1	4.6	5.3	4.8	0.6	2.5	4.2	1.9	2.8	6.3	25.0	27.7	4.2	22.7	8.9	1.2	29.8	30.0	1.3	4.4	5.7	6.1	1.4	4.7	1.9	15.1	4.9	2.4	8.7	5.0	12.1	0.1	2.4	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.4	2.2	60.8	0.2	3.1	0.0	0.0	2.4	0.0	1.6	0.1	0.0	5.2	3.8	1.8	0.0	0.3	0.0	0.5	0.0	3.8	0.2	1.2	0.0	0.7	0.6	0.0	0.0	0.0	5.2	0.0	0.3	3.8	36.2	0.2	0.5	0.0	2.8	0.0	44.0	1.3	0.0	0.0	24.7	0.0	7.1	15.2	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.0	1.8	0.0	0.2	1.5	1.0	0.0	2.4	1.0	2.1	0.0	2.7	0.8	0.0	0.0	1.3	0.0	0.4	0.9	10.1	12.7	13.5	15.2	13.0	5.5	5.3	4.8	6.3	4.4	4.7	12.1	16.0	3.2	6.0	3.3	1.3	7.6	4.5	2.2	22.2	0.2	19.2	21.5	2.6	5.7	2.1	1.8	8.4	0.1	0.4	71.8	0.0	0.3	3.0	0.2	0.1	2.8	4.8	0.0	26.9	0.9	1.0	1.0	16.3	0.6	0.0	0.3	19.6	0.4	0.7	0.0	1.5	48.6	0.0	8.7	4.0	0.6	0.0	5.9	0.0	3.7	8.9	1.4	0.0	3.0	1.7	1.2	96.2	0.0	1.5	6.3	58.6	0.1	1.0	5.4	32.9	0.2	20.8	0.1	0.1	4.1	7.7	0.3	2.9	0.1	24.0	3.9
VIPR2	"VPAC2, VPAC2R"	ENSG00000106018	"Vasoactive intestinal peptide receptor 2"	P41587	7	159028175-159144867	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 20.6;Excitatory neurons: 15.2;Muller glia cells: 38.9;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 45.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	17	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 6.6;HMC-1: 9.0;MOLT-4: 12.9;U-266/70: 40.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 27.1"	"Low region specificity"	"Detected in many"			HPA062707	Approved		Approved	"Focal adhesion sites"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Focal adhesion sites"		"HPA062707: AB_2684842"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.89e-2)"	12.5	0.8	2.2	0.9	1.6	0.4	2.5	0.6	6.9	16.8	1.4	13.8	1.7	6.8	12.2	1.4	4.5	2.5	16.4	2.1	2.0	1.1	0.4	0.6	1.1	2.2	0.8	12.0	17.5	0.9	2.7	5.7	2.6	9.2	1.1	6.5	0.3	20.5	7.4	0.7	4.8	4.2	2.1	0.8	8.6	2.2	1.3	8.2	0.2	5.4	0.4	6.8	11.2	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.2	12.9	0.1	1.0	0.0	0.0	3.2	0.1	0.7	0.0	0.0	2.8	2.3	0.1	0.2	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	40.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	12.3	0.0	0.1	2.2	1.6	0.6	6.9	2.1	2.0	2.2	0.8	2.6	2.1	1.3	2.9	0.8	0.0	0.0	2.9	0.7	0.6	2.9	0.0	1.8	1.7	1.6	1.8	7.5	0.0	0.0	0.0	2.1	0.0	20.6	0.0	0.0	0.0	1.3	0.4	6.9	0.4	0.0	0.0	15.2	6.7	0.0	10.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.3	1.9	10.2	0.5	1.8	1.9	0.0	38.9	4.1	49.8	0.3	0.8	0.0	2.6	2.4	2.0	0.0	0.5	0.0	45.1	0.0	2.9	5.6	3.6	10.2	0.1	0.0	0.0	3.8	0.1	0.0	0.3
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487689-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	12.5	7.8	6.9	11.6	8.5	27.3	17.5	11.5	7.2	13.1	7.1	9.9	8.1	13.7	8.6	9.7	11.4	8.9	9.9	6.1	7.4	10.8	12.5	10.7	14.4	7.1	7.2	16.7	10.3	14.8	6.3	13.2	7.2	10.7	11.7	12.3	9.5	10.3	8.7	9.7	9.1	13.9	7.2	11.4	11.6	16.5	7.3	20.0	13.3	9.3	15.2	10.5	8.0	9.2	40.5	25.2	26.8	14.9	32.4	42.5	17.1	27.5	27.9	29.4	29.9	17.9	33.2	43.6	25.5	36.1	23.0	25.9	36.2	33.5	42.9	38.7	20.0	52.0	19.6	17.6	23.6	25.9	17.9	32.8	13.4	35.4	33.7	30.1	37.5	28.2	54.0	26.6	30.0	23.8	50.7	14.6	17.5	41.4	19.1	29.9	24.4	24.3	19.1	27.6	20.9	28.9	21.6	5.5	23.8	26.3	31.2	20.7	37.3	26.9	15.9	23.1	25.7	20.8	27.8	51.0	26.4	33.7	26.2	14.2	5.0	8.7	6.7	6.4	10.7	6.6	7.4	9.1	5.2	5.0	9.0	7.9	6.0	9.5	13.8	3.3	6.9	5.8	6.9	8.5	11.5	7.2	6.1	7.4	7.1	7.2	7.2	7.2	7.3	9.2	24.2	25.6	21.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	16.9	16.4	0.0	0.0	14.9	7.3	0.0	26.4	20.0	0.0	7.9	14.4	0.0	23.8	32.2	9.8	0.0	0.0	0.0	12.2	23.7	10.6	0.0	22.4	5.1	28.5	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	14.7	0.0	0.0	5.2	0.0	0.0	6.9	8.7	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	16.8	9.9	25.0	0.0	0.0
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 454.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 749.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 638.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	99.4	107.6	56.0	38.4	60.4	55.2	87.0	60.3	73.5	111.0	64.9	97.0	44.2	109.9	87.2	51.8	90.8	58.9	99.1	57.4	59.3	122.7	454.9	77.4	35.8	64.4	59.5	115.1	168.0	51.3	115.7	45.6	63.8	76.3	41.1	23.0	92.4	69.8	34.4	81.1	82.3	84.7	59.9	62.2	88.1	55.6	68.5	35.0	76.3	32.2	32.6	100.6	88.0	64.8	73.6	187.7	57.2	165.4	638.0	389.6	68.2	269.0	229.3	128.9	218.5	79.0	83.3	54.9	141.6	331.6	87.2	66.2	79.4	103.5	139.5	81.9	204.8	52.5	239.9	378.2	103.1	104.1	74.1	225.0	54.2	173.4	146.6	336.8	141.0	78.2	70.3	130.6	253.6	271.1	74.4	205.9	106.8	98.0	175.9	132.7	160.3	286.8	127.7	61.8	119.5	146.9	118.7	84.2	137.8	91.2	138.3	123.9	126.8	171.1	61.5	159.6	101.9	76.1	80.2	50.7	445.8	174.5	90.8	77.0	127.5	196.2	118.1	94.7	116.8	91.7	116.7	119.4	127.6	102.6	102.9	101.4	104.0	84.2	98.2	157.4	143.1	112.8	56.0	60.4	60.3	73.5	57.4	59.3	64.4	59.5	63.8	59.9	68.5	64.8	95.1	57.7	51.0	5.9	30.6	84.6	68.0	157.0	10.8	12.3	93.3	117.3	20.9	141.5	64.3	108.5	8.4	85.7	48.1	34.3	62.6	204.2	6.1	25.8	83.7	89.5	67.1	32.4	8.8	129.4	293.6	132.8	10.7	48.8	55.3	60.3	118.9	749.9	184.1	10.1	7.5	44.2	46.8	80.1	94.3	13.9	158.1	66.9	115.6	5.6	107.4	68.8	51.5	6.6	17.6	103.8	28.2	172.3	29.5	59.5	152.9	204.6	33.4	19.3	59.2	78.4	99.8	30.6	34.2	10.7	112.0	39.5	39.7	82.4	49.0	55.2
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873074-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	54.0	11.1	8.1	11.2	9.0	4.3	23.7	8.3	12.1	12.0	3.7	12.4	11.1	12.3	10.6	12.5	10.0	10.0	12.1	10.1	9.2	10.0	22.9	18.4	8.7	18.1	10.5	17.3	9.7	33.6	6.7	12.0	10.5	12.0	12.5	11.5	10.9	12.4	21.6	12.8	11.6	11.6	8.9	7.4	12.8	9.1	8.5	9.7	13.9	15.3	8.7	11.9	9.6	9.6	46.8	29.5	23.4	29.5	72.6	28.6	42.3	49.5	31.8	29.0	29.1	28.7	44.9	40.4	39.0	35.7	43.9	31.2	33.6	20.1	47.9	25.5	33.1	27.6	25.4	24.7	35.4	38.7	20.3	23.2	25.3	29.5	40.7	22.5	29.2	22.6	59.0	30.0	34.9	18.3	31.8	44.8	56.1	43.8	22.0	34.5	34.0	50.5	28.0	18.5	28.0	39.8	38.3	68.5	21.8	32.8	34.5	29.5	33.3	46.6	32.0	29.5	51.0	26.9	47.1	46.1	28.6	43.0	41.6	2.0	1.1	2.7	1.2	1.1	1.0	1.3	1.5	1.4	1.3	1.1	0.9	0.9	1.3	2.9	2.2	3.5	1.5	0.7	8.1	9.0	8.3	12.1	10.1	9.2	18.1	10.5	10.5	8.9	8.5	9.6	19.5	73.7	41.7	16.6	5.5	24.9	18.6	16.2	9.6	21.8	18.6	15.9	21.5	27.1	24.2	16.5	12.5	12.5	10.0	27.1	5.9	18.1	39.0	13.7	23.8	17.1	13.8	26.1	42.7	24.8	21.2	22.6	19.4	25.3	5.1	24.1	10.8	46.9	16.0	30.3	36.6	26.4	20.3	6.6	10.2	9.1	17.7	12.9	7.2	28.1	10.0	11.6	7.2	26.7	34.6	31.6	8.2	18.4	15.6	36.3	14.4	11.4	11.7	20.2	6.6	24.9	26.4	18.5	7.2	17.9	32.0	8.8	6.6	10.8	20.3	22.6
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621182-2660056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 6.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		Yes	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	15.7	16.3	2.7	2.2	6.4	0.8	8.5	5.3	4.2	10.3	6.4	6.6	0.5	9.6	3.2	19.2	13.8	2.9	43.7	3.2	5.3	10.6	3.1	10.7	0.7	7.7	5.6	77.5	27.4	19.5	6.5	5.9	5.9	6.6	2.0	12.3	11.6	2.0	26.2	5.3	1.9	6.8	4.0	5.5	9.0	6.0	4.9	0.8	11.6	11.7	1.7	12.5	10.4	9.8	0.1	0.8	14.3	0.4	1.5	0.5	22.3	7.0	2.2	1.7	4.3	3.6	0.3	0.0	6.4	2.8	0.6	0.3	3.4	5.6	4.5	9.7	2.4	0.1	1.6	1.8	1.9	9.2	1.7	1.5	3.3	0.7	0.1	7.6	0.7	20.5	0.0	17.4	1.1	0.9	1.1	1.1	9.9	1.5	0.9	0.1	0.4	0.0	6.4	0.4	2.5	2.4	0.6	0.6	10.4	7.5	0.3	33.3	0.3	2.8	4.5	0.1	3.3	14.1	6.1	2.6	14.7	8.2	0.6	0.0	0.0	6.3	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	2.7	6.4	5.3	4.2	3.2	5.3	7.7	5.6	5.9	4.0	4.9	9.8	4.2	16.0	8.8	1.0	0.1	2.7	1.2	18.7	4.6	23.8	4.3	3.9	78.1	1.5	9.7	5.5	104.3	13.2	1.6	9.8	1.9	11.3	5.7	8.6	6.1	3.6	10.9	0.0	8.3	10.3	29.0	17.2	3.1	19.3	0.0	5.7	2.2	2.8	2.3	11.8	10.9	1.4	24.4	1.0	1.1	2.8	7.8	0.6	10.6	2.8	1.0	3.9	0.0	8.0	39.1	8.6	4.3	10.9	0.5	5.1	0.0	8.0	11.9	32.5	0.0	2.7	9.4	8.2	6.4	5.0	2.0	3.4	1.7	15.9	1.3	6.0
VMA21	"MEAX, XMEA"	ENSG00000160131	"Vacuolar ATPase assembly factor VMA21"	Q3ZAQ7	X	151396515-151409364	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010972	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA010972: AB_1853034"	"unprognostic (1.17e-1)"	"prognostic favorable (2.30e-5)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.48e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.76e-1)"	10.4	12.2	16.5	7.6	17.0	22.8	10.6	16.2	17.1	9.6	18.3	6.8	6.3	9.0	14.1	9.3	13.6	6.6	7.5	18.5	23.5	12.8	9.8	8.0	11.4	19.8	20.8	10.5	8.7	11.6	10.9	12.0	20.3	8.6	6.6	15.6	8.1	8.2	7.9	12.5	6.6	7.8	20.1	9.9	7.0	8.3	18.3	10.3	13.3	7.1	12.4	8.5	7.6	19.6	21.5	23.5	26.7	28.3	25.9	24.7	26.2	23.7	25.4	21.4	21.1	17.8	27.5	63.1	75.3	24.2	24.0	19.1	37.5	22.6	33.2	22.2	18.6	27.5	25.9	32.3	34.6	52.4	30.4	25.8	27.4	24.3	34.1	22.8	24.9	27.2	14.9	32.2	40.6	20.4	35.8	51.9	33.3	25.7	24.5	35.9	31.8	40.6	25.5	17.3	9.6	20.3	18.4	24.3	29.0	24.4	14.9	34.1	25.4	34.6	15.6	44.3	38.5	27.1	50.8	91.7	35.2	63.9	35.4	11.9	12.4	7.7	6.5	14.4	8.5	7.7	8.5	8.3	13.6	6.0	11.3	10.5	2.8	12.8	13.1	12.2	9.4	10.6	16.5	17.0	16.2	17.1	18.5	23.5	19.8	20.8	20.3	20.1	18.3	19.6	38.5	22.4	24.4	9.1	46.5	44.9	28.0	35.3	42.7	40.2	35.8	31.1	46.8	30.0	21.0	31.3	18.8	33.2	62.9	21.0	19.6	28.2	50.6	44.1	22.4	34.6	22.1	52.5	16.4	33.0	66.7	28.0	15.8	24.1	24.1	25.7	32.2	38.9	143.7	20.2	19.1	22.5	20.3	150.3	86.6	51.5	18.3	89.8	39.2	5.6	142.9	49.9	53.5	13.0	14.3	47.7	17.6	22.6	50.9	43.8	26.8	33.5	28.6	26.2	52.6	31.7	34.5	27.4	58.8	46.0	51.6	31.9	41.6	37.0	21.8	30.5
VMO1		ENSG00000182853	"Vitelline membrane outer layer 1 homolog"	Q7Z5L0	17	4785285-4786433	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.8;pituitary gland: 27.7"	"Group enriched"	"Detected in many"	4	"Club cells: 923.5;monocytes: 857.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"non-classical monocyte: 111.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 111.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.0;MCF7: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023038	Uncertain				"Secreted to blood"	NA	NA		2900000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA023038: AB_10964632"	"unprognostic (1.30e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.65e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.69e-1)"	5.1	2.5	4.5	7.0	4.5	2.4	2.3	4.7	6.5	3.1	6.7	2.1	4.9	1.6	0.1	1.7	1.6	3.4	2.3	4.5	5.2	5.5	10.4	8.9	2.0	6.1	4.7	1.0	2.3	13.3	27.7	2.3	5.1	3.0	0.8	0.5	5.2	1.6	10.1	2.0	5.6	0.9	5.3	21.8	1.6	0.7	5.1	2.1	1.4	1.5	0.5	4.7	2.5	6.1	0.2	3.0	0.3	1.8	0.3	0.7	0.3	0.6	1.1	0.1	0.3	0.9	1.1	0.1	0.0	0.1	0.2	0.5	0.0	0.4	0.2	2.2	0.4	0.1	0.6	0.8	0.6	0.0	1.3	0.5	0.4	0.1	0.4	0.6	0.0	0.4	0.3	0.4	0.6	3.9	0.0	0.9	0.7	0.7	1.3	0.7	1.5	0.3	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.2	1.2	0.1	0.3	1.2	0.1	0.3	0.2	0.0	0.3	0.0	0.5	0.6	0.9	0.1	0.2	0.0	0.0	9.7	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.1	0.0	0.4	111.9	0.0	0.0	3.7	4.5	4.5	4.7	6.5	4.5	5.2	6.1	4.7	5.1	5.3	5.1	6.1	2.8	3.2	7.7	1.0	2.8	8.5	13.4	217.2	0.6	6.7	2.8	3.7	0.9	1.5	923.5	0.0	0.0	0.4	0.8	1.1	1.9	0.9	8.2	0.4	0.8	5.2	1.2	3.2	0.5	1.5	0.3	2.5	0.0	0.4	14.0	0.3	79.6	3.3	16.2	0.0	0.9	1.0	101.7	59.8	210.9	40.3	0.3	70.8	5.4	1.0	857.9	1.0	0.0	0.0	0.6	1.5	0.3	1.2	0.7	11.2	4.3	2.4	158.4	2.9	13.1	1.3	45.5	0.6	1.5	0.8	7.2	0.3	2.0	0.5	1.3	14.2
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 984.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 3000.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 3000.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	36.7	47.2	23.1	56.2	29.1	22.8	36.6	15.9	32.7	30.3	5.4	58.6	56.0	32.4	23.2	33.0	16.0	59.8	22.0	17.1	23.7	36.6	58.5	29.6	31.4	29.1	24.9	22.9	30.8	38.4	10.4	39.2	27.3	34.0	59.8	30.2	23.5	23.1	19.9	19.5	60.4	33.9	24.5	52.5	47.6	22.3	35.8	22.3	32.5	28.9	20.7	47.9	16.4	38.0	65.8	128.2	43.8	82.2	88.3	54.8	77.3	87.4	87.4	64.3	98.0	85.1	166.1	42.2	143.9	70.6	81.5	79.8	62.4	59.5	80.5	102.7	80.9	55.5	89.2	97.3	89.6	68.5	51.4	77.4	46.7	87.3	76.2	93.2	67.6	41.3	69.8	70.2	68.7	177.9	66.7	21.9	63.0	146.6	75.3	41.8	79.8	101.1	92.5	72.1	36.4	89.1	57.5	62.4	83.8	62.6	124.4	49.0	89.8	81.3	75.0	68.8	83.6	105.4	145.0	66.8	84.4	37.6	92.8	131.6	570.4	76.0	62.8	393.0	69.2	56.6	59.3	65.4	174.3	49.5	53.9	60.5	3000.2	69.0	666.9	59.2	73.9	501.6	23.1	29.1	15.9	32.7	17.1	23.7	29.1	24.9	27.3	24.5	35.8	38.0	164.8	89.8	124.1	35.3	68.6	161.1	984.4	188.9	665.9	36.1	429.1	187.1	27.9	125.8	273.3	275.8	58.4	91.7	71.0	511.1	23.5	223.1	7.2	372.8	197.7	148.2	310.6	29.9	80.1	137.9	123.5	193.6	367.0	708.6	135.4	111.2	48.2	108.4	121.7	28.6	84.6	254.1	168.9	335.2	270.7	11.5	35.8	322.6	129.9	45.0	231.1	50.4	51.5	51.8	141.2	160.7	508.1	35.3	92.5	553.1	361.1	72.6	289.7	51.6	92.1	59.2	293.5	83.6	44.6	672.6	129.7	175.8	127.3	67.5	241.7	629.2
VN1R2	V1RL2	ENSG00000196131	"Vomeronasal 1 receptor 2"	Q8NFZ6	19	53258292-53261837	"G-protein coupled receptors, Predicted membrane proteins"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"Early spermatids: 15.8;Late spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044551	Uncertain					NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"			"HPA044551: AB_2678982"					"unprognostic (9.54e-2)"							"unprognostic (3.17e-1)"			"unprognostic (1.06e-1)"			0.2	0.2	0.2	0.3	0.2	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.4	0.3	0.0	0.1	0.3	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VN1R4	V1RL4	ENSG00000228567	"Vomeronasal 1 receptor 4"	Q7Z5H5	19	53266676-53267723	"G-protein coupled receptors, Predicted membrane proteins"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027018	Uncertain					NA	NA									"HPA027018: AB_10603142"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VPREB1	"CD179A, VpreB"	ENSG00000169575	"V-set pre-B cell surrogate light chain 1"	P12018	22	22244780-22245515	"CD markers, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"bone marrow: 29.8"	"Cell type enhanced"	"Detected in single"		"NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 5.7;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 5.7"	"Group enriched"	"Detected in some"	11	"Daudi: 9.4;MOLT-4: 19.8;RPMI-8226: 5.4"					"Not detected"	"Not detected"			HPA055886	Approved				"Intracellular and membrane"	NA	NA		62000	"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055886: AB_2682956"																		0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.5;intestine: 72.5;lymphoid tissue: 118.5"	"Cell type enriched"	"Detected in some"	12	"B-cells: 287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	709	"memory B-cell: 753.3;naive B-cell: 803.7"	"Lineage enriched"	"Detected in many"	732	"B-cells: 803.7"	"Group enriched"	"Detected in some"	46	"Daudi: 263.3;REH: 309.9;U-698: 85.2"	"Low region specificity"	"Detected in single"							HPA003041	Supported				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	1.7	21.1	2.0	41.3	2.0	25.8	0.4	2.6	3.8	0.3	2.6	3.9	1.7	1.1	51.5	1.2	0.3	2.7	1.1	1.7	2.0	1.6	1.9	0.8	112.4	2.1	2.1	0.1	0.5	0.6	2.5	0.2	2.1	1.6	3.7	2.2	2.5	0.3	1.6	0.6	72.5	0.3	1.9	60.3	6.1	0.6	2.9	7.9	1.7	0.5	118.5	6.2	0.3	1.8	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.6	263.3	0.3	0.2	0.0	0.1	0.5	0.2	0.1	0.6	2.8	0.1	0.0	0.2	0.2	0.3	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.4	0.4	1.1	0.0	1.3	0.5	1.0	0.3	0.3	1.1	309.9	0.5	4.7	0.1	0.1	0.7	1.0	0.3	0.7	3.5	0.2	0.6	0.4	1.2	0.0	0.5	0.9	0.0	1.3	0.3	85.2	0.0	0.5	0.3	0.9	0.7	0.6	0.4	0.3	0.4	753.3	0.4	0.5	0.7	803.7	0.5	0.5	1.0	0.4	0.7	0.6	1.0	17.5	2.0	2.0	2.6	3.8	1.7	2.0	2.1	2.1	2.1	1.9	2.9	1.8	0.1	0.0	0.5	0.3	287.8	0.4	0.8	0.6	0.6	4.5	0.3	0.5	0.9	1.5	0.8	0.0	2.1	0.0	5.4	1.1	1.9	0.1	0.3	0.1	0.8	0.1	5.4	2.7	0.2	0.0	0.0	1.5	1.5	0.3	0.0	0.7	1.1	1.0	0.3	0.0	0.2	0.6	2.0	0.3	0.8	0.2	0.0	1.2	5.4	0.0	0.7	0.8	2.1	0.5	0.1	0.1	0.3	0.0	22.6	0.2	1.5	2.4	0.0	2.1	0.0	0.5	0.4	0.1	0.2	0.4	0.1	0.0	3.5	0.1	0.7	0.3
VPS11	"PEP5, RNF108"	ENSG00000160695	"VPS11 core subunit of CORVET and HOPS complexes"	Q9H270	11	119067818-119081972	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039020	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA039020: AB_10674847"	"unprognostic (6.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (4.07e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-1)"	21.6	25.1	16.7	14.7	16.8	17.6	19.4	16.7	18.6	20.8	15.3	19.6	13.4	23.5	19.0	14.6	20.1	12.8	16.6	17.6	17.8	16.9	11.5	16.8	18.1	17.0	17.6	22.5	18.0	22.4	22.8	17.3	17.3	18.4	13.4	17.6	18.2	16.5	21.7	21.4	17.9	19.5	16.0	21.7	18.5	13.3	17.5	20.1	21.1	21.1	17.2	21.0	17.4	18.4	11.6	11.8	12.8	9.8	27.5	24.2	14.0	15.4	18.4	15.3	16.5	19.9	24.2	16.6	21.5	30.2	27.1	21.0	16.1	20.7	15.1	17.1	8.0	36.6	12.0	19.5	30.8	22.9	21.5	29.6	21.3	23.2	15.9	27.2	24.4	13.9	29.5	28.8	20.2	30.5	19.3	21.6	6.4	21.2	22.5	21.7	21.1	12.6	18.2	24.1	10.2	17.5	19.2	25.3	16.8	13.7	38.3	20.1	24.5	19.1	7.1	6.9	11.5	11.3	11.0	15.6	14.0	27.2	17.0	24.8	16.8	12.8	16.4	13.9	16.8	11.3	13.7	15.2	20.7	11.9	12.9	16.6	3.8	16.5	19.0	8.7	16.5	13.9	16.7	16.8	16.7	18.6	17.6	17.8	17.0	17.6	17.3	16.0	17.5	18.4	9.9	6.4	10.5	8.1	10.2	2.9	4.4	7.0	8.6	10.2	8.1	9.8	7.6	8.6	12.1	9.2	12.5	11.2	16.2	9.7	9.8	8.2	7.8	9.9	10.0	10.7	9.6	6.3	9.6	10.1	7.0	9.7	11.2	9.9	15.2	10.2	13.2	6.0	17.0	5.0	9.9	10.1	6.1	14.8	8.9	3.0	17.1	12.6	7.2	7.5	11.6	9.2	5.2	6.6	14.4	7.2	6.8	15.4	11.5	3.6	9.2	11.0	10.5	15.5	13.1	6.2	10.2	11.3	7.3	6.5	4.8	14.1	12.2	9.4	9.5	3.8
VPS13A	"CHAC, KIAA0986"	ENSG00000197969	"Vacuolar protein sorting 13 homolog A"	Q96RL7	9	77177445-77421537	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021652, HPA021662"	Supported					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA021652: AB_1858759, HPA021662: AB_1858760"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.68e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.69e-3)"	"unprognostic (9.67e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-2)"	5.1	7.6	2.6	7.1	4.8	17.6	7.3	11.2	9.6	4.4	3.6	9.4	16.3	6.0	8.0	7.6	4.7	9.0	9.5	6.0	0.1	9.9	7.4	6.3	8.8	0.5	0.1	3.6	8.8	9.3	6.5	3.6	0.3	6.7	11.4	7.2	8.0	6.6	14.6	15.6	13.8	7.2	0.0	10.6	12.3	16.8	0.2	10.3	8.5	9.8	7.6	6.4	6.2	3.1	21.0	10.4	9.1	7.9	8.5	7.4	13.7	11.4	10.3	9.8	11.1	4.2	9.3	16.4	5.2	10.6	11.9	27.9	13.7	11.3	17.4	15.5	11.0	21.7	21.3	10.3	8.3	28.3	13.9	4.7	16.6	14.5	17.7	17.3	14.1	15.7	14.3	17.4	6.0	9.8	21.7	9.7	10.2	11.9	8.3	15.7	17.4	6.8	14.1	20.2	13.3	13.3	14.3	9.2	6.3	16.6	6.3	6.3	18.6	10.4	11.3	14.4	14.6	9.7	9.6	8.4	10.8	13.2	4.2	3.8	0.2	2.0	1.2	0.1	1.2	0.9	0.9	0.9	0.1	1.2	0.7	0.8	0.2	1.2	0.1	2.2	0.7	0.2	2.6	4.8	11.2	9.6	6.0	0.1	0.5	0.1	0.3	0.0	0.2	3.1	29.7	64.1	46.5	48.3	32.2	33.0	26.6	28.0	27.3	29.1	25.4	22.1	87.2	27.1	41.2	29.5	58.4	15.2	42.3	78.9	3.9	18.2	90.5	33.8	28.2	38.6	87.8	48.4	228.3	18.4	4.8	18.9	86.6	42.6	19.0	32.4	37.5	34.1	8.6	11.8	101.1	47.4	30.5	10.6	14.4	55.0	13.7	13.3	23.2	43.1	11.9	16.4	41.2	72.4	23.0	46.2	42.9	15.8	42.7	31.0	98.5	21.7	38.9	18.2	32.9	33.1	30.5	74.3	64.5	36.6	31.3	8.9	43.2	38.0	39.8	25.7
VPS13C	"FLJ10381, FLJ20136, KIAA1421"	ENSG00000129003	"Vacuolar protein sorting 13 homolog C"	Q709C8	15	61852389-62060473	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 272.2;Oligodendrocytes: 291.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043507	Uncertain		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Microtubules		"HPA043507: AB_10960840"	"unprognostic (1.09e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.58e-3)"	9.3	8.3	6.0	13.3	13.8	10.5	9.6	10.2	8.4	11.7	3.1	8.9	6.8	12.0	7.6	4.1	9.4	9.1	6.7	4.4	6.9	8.9	7.2	10.9	17.7	12.9	8.3	16.9	8.6	12.3	5.5	7.9	15.2	7.9	9.1	18.8	8.0	6.1	7.1	5.7	7.7	9.4	8.3	17.8	12.8	6.1	9.9	14.6	11.5	12.8	15.1	9.1	3.5	24.6	8.2	13.9	5.2	5.5	22.8	20.1	6.1	6.4	25.4	6.2	7.5	5.8	5.3	27.9	7.4	12.5	11.6	9.3	18.8	7.2	5.5	20.1	3.4	28.3	7.9	5.4	11.3	13.7	17.6	14.3	4.8	6.7	13.9	14.0	19.2	28.1	8.9	19.5	9.9	3.5	8.1	5.4	3.4	8.7	3.7	19.0	16.1	7.5	10.5	32.5	7.7	9.4	11.5	6.6	7.0	9.1	7.2	19.9	28.9	14.0	7.8	8.5	8.2	9.8	9.4	16.3	11.1	28.8	6.8	3.7	4.2	2.5	3.3	3.1	2.8	4.9	2.7	2.7	3.0	5.3	3.0	2.5	1.1	2.2	5.4	5.9	2.3	1.2	6.0	13.8	10.2	8.4	4.4	6.9	12.9	8.3	15.2	8.3	9.9	24.6	92.5	67.3	61.6	161.6	108.5	18.6	32.3	33.1	26.7	84.9	41.8	24.5	75.2	25.8	83.2	57.0	146.0	14.8	141.1	16.7	9.8	36.7	6.4	92.9	79.6	57.3	53.0	30.7	182.8	29.6	8.3	56.2	83.1	118.9	89.7	51.8	43.2	22.7	31.3	124.5	272.2	29.9	44.7	71.0	58.1	7.3	50.4	107.2	35.6	148.9	118.5	29.6	84.5	217.1	291.3	26.7	21.0	51.6	83.9	25.2	21.6	12.3	113.1	84.5	32.9	86.5	66.9	20.8	20.4	5.9	23.3	8.2	98.8	88.2	23.9	28.3
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230030-12512047	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	10.9	6.9	14.3	4.4	17.2	5.0	10.3	14.5	17.9	13.7	18.1	12.2	3.8	8.1	8.7	12.6	8.9	5.3	21.9	15.8	14.5	10.5	10.4	8.8	6.4	14.6	16.5	8.9	10.9	13.4	7.7	5.3	14.3	17.4	6.4	14.1	10.8	9.3	18.1	24.7	8.7	6.0	13.4	9.3	11.1	6.1	17.8	6.6	15.5	15.3	6.2	9.6	10.6	16.6	9.3	5.2	5.8	4.4	15.1	11.9	2.7	4.4	7.7	7.4	7.0	3.5	6.4	8.7	5.4	12.6	6.2	8.3	10.1	8.7	10.3	4.7	3.4	7.4	8.1	2.8	6.3	10.8	3.7	10.1	11.9	9.5	9.3	9.2	12.0	8.2	15.5	4.3	6.9	4.3	6.4	4.2	2.3	5.0	6.5	5.5	6.9	2.6	5.3	5.4	2.8	3.8	12.9	9.4	9.0	5.4	8.1	3.6	13.1	4.6	4.7	12.0	3.7	3.8	3.3	13.4	5.2	7.5	7.1	3.2	0.7	0.5	1.1	0.7	1.2	0.9	1.2	0.8	0.6	1.6	1.1	0.9	0.9	0.7	0.5	1.5	0.6	0.3	14.3	17.2	14.5	17.9	15.8	14.5	14.6	16.5	14.3	13.4	17.8	16.6	28.9	19.2	23.4	111.0	19.8	21.7	45.1	23.2	19.9	38.1	18.8	12.8	68.0	14.3	35.7	18.4	73.0	8.4	20.3	24.7	3.9	9.1	83.1	20.6	23.5	23.0	14.4	9.4	181.4	14.4	7.2	19.4	28.1	48.1	12.6	26.3	17.9	21.2	11.5	47.1	149.2	15.1	18.3	17.3	15.5	208.7	23.0	17.5	12.4	79.6	16.7	23.0	17.5	78.4	107.4	17.0	11.2	21.8	11.8	32.0	18.2	9.8	32.0	34.1	46.0	23.4	46.5	18.8	12.3	38.2	31.4	14.8	21.4	20.3	15.5	37.3
VPS16		ENSG00000215305	"VPS16 core subunit of CORVET and HOPS complexes"	Q9H269	20	2840703-2866732	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043229, HPA048661"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043229: AB_2678373, HPA048661: AB_2680484"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (9.30e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.65e-2)"	"prognostic favorable (5.89e-5)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (1.33e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-3)"	18.2	16.0	9.9	18.2	10.1	23.1	17.6	9.7	11.2	21.3	10.6	17.6	16.9	22.1	10.7	16.4	18.3	13.8	12.8	10.4	10.3	14.8	15.9	17.9	17.9	12.0	9.7	19.1	21.9	19.5	16.0	14.0	11.0	17.9	10.9	8.9	19.1	12.7	18.5	21.5	20.8	20.4	9.1	23.5	18.1	11.3	10.6	21.1	22.5	14.7	17.3	17.0	17.8	10.1	27.1	36.7	28.8	27.8	27.5	30.1	16.0	24.0	31.3	27.5	24.8	22.1	25.5	18.3	16.6	27.6	43.9	34.6	25.0	45.5	14.8	30.0	20.7	21.4	15.4	24.4	27.8	21.6	21.3	38.7	21.0	32.6	21.1	18.1	27.5	35.2	30.6	30.2	23.9	28.2	20.4	40.1	27.3	42.7	30.4	26.4	20.8	28.2	26.0	24.8	23.9	39.6	25.7	57.1	26.7	18.7	29.3	26.2	24.0	27.0	24.7	17.6	16.3	40.9	44.4	17.0	12.7	38.6	26.1	24.0	25.8	28.4	35.2	24.6	19.5	12.3	15.4	22.6	32.1	9.1	15.8	20.4	14.5	34.3	29.5	10.6	25.7	25.5	9.9	10.1	9.7	11.2	10.4	10.3	12.0	9.7	11.0	9.1	10.6	10.1	12.7	12.8	15.9	1.3	10.4	6.0	14.5	13.7	8.6	14.4	9.7	7.6	7.5	18.6	11.0	12.9	8.4	14.2	18.7	24.8	9.8	16.1	2.6	8.2	11.9	11.5	5.4	8.6	4.2	13.2	17.8	12.9	16.3	6.9	7.0	11.8	10.0	15.5	23.3	23.5	4.1	13.0	12.2	18.4	8.8	3.3	13.1	15.2	14.2	1.9	22.3	20.8	33.0	3.0	3.5	13.0	11.6	9.4	12.8	5.6	33.2	19.4	11.2	15.0	13.1	8.4	17.9	20.9	16.1	8.0	3.8	14.1	17.4	17.6	13.9	9.2
VPS18	"KIAA1475, PEP3"	ENSG00000104142	"VPS18 core subunit of CORVET and HOPS complexes"	Q9P253	15	40894450-40903975	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040701	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"HPA040701: AB_10794145"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.69e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.61e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.06e-2)"	8.6	11.8	9.2	7.3	9.9	21.3	7.4	12.0	10.3	7.5	8.0	9.7	6.8	11.3	8.7	9.2	8.3	7.7	12.9	9.2	10.8	9.8	10.7	9.0	8.8	11.5	10.3	7.5	5.9	11.2	9.6	6.2	12.9	8.7	4.1	3.8	8.3	8.3	13.0	9.5	9.0	8.2	9.1	11.9	9.6	6.2	11.3	7.5	7.9	9.5	7.2	9.8	6.1	12.1	9.9	23.1	11.1	19.1	35.5	15.1	15.2	20.3	29.4	24.5	29.9	29.5	5.9	5.3	19.0	24.3	31.1	25.7	23.4	23.0	10.3	12.2	15.8	23.5	22.2	17.0	31.3	19.8	30.2	26.2	11.9	24.6	13.6	11.5	26.0	11.8	16.5	13.1	20.9	13.0	13.4	21.8	14.7	10.1	15.7	27.1	12.6	9.9	20.0	52.3	12.8	12.8	14.6	28.4	13.7	13.5	17.7	22.0	25.8	24.8	12.9	25.0	13.4	13.0	20.9	14.4	27.2	21.5	12.5	7.3	10.9	13.1	10.1	7.4	8.3	8.3	5.2	7.8	11.1	5.8	5.4	5.8	12.0	7.8	10.6	4.8	9.8	9.0	9.2	9.9	12.0	10.3	9.2	10.8	11.5	10.3	12.9	9.1	11.3	12.1	3.3	3.2	7.2	2.0	7.5	2.4	2.3	7.7	4.0	9.0	4.2	2.3	6.7	5.7	10.4	7.3	6.2	7.1	11.0	12.0	3.9	16.7	1.1	6.8	3.7	6.9	11.9	1.3	4.0	7.7	4.6	5.0	12.2	8.2	7.0	8.1	7.5	10.8	21.4	6.7	4.1	6.4	10.2	10.9	6.6	1.8	7.2	9.5	8.8	2.8	13.2	6.8	12.3	1.5	3.1	11.5	5.9	9.8	4.0	3.2	10.3	11.4	5.4	7.1	6.6	4.1	4.5	5.8	6.2	8.0	2.0	10.8	6.9	7.5	5.8	5.8
VPS25	"DERP9, EAP20, MGC10540"	ENSG00000131475	"Vacuolar protein sorting 25 homolog"	Q9BRG1	17	42773449-42779599	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004978, HPA021992, HPA052217, HPA057284"	Uncertain		Supported	Vesicles		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004978: AB_426095, HPA021992: , HPA052217: AB_2681765, HPA057284: AB_2683397"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (7.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.76e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	36.6	40.3	32.8	32.5	33.0	44.3	53.3	34.8	36.8	41.6	36.6	61.9	53.8	35.5	65.3	91.4	58.9	33.4	43.5	32.9	33.2	70.1	68.6	31.8	37.8	32.9	32.8	33.2	49.0	72.3	27.6	46.7	33.5	40.2	68.4	31.2	48.7	36.5	51.3	50.5	45.4	42.8	33.5	37.1	50.0	27.4	33.8	51.3	40.9	41.3	57.2	44.8	44.3	34.0	67.2	136.6	101.8	62.1	126.9	86.5	94.5	83.0	117.1	167.5	116.3	117.9	77.0	66.8	135.8	122.0	88.5	68.7	142.2	181.8	107.9	61.2	178.7	50.6	87.0	177.5	131.0	95.7	64.6	118.2	115.4	148.9	158.0	99.1	106.7	79.0	175.6	65.5	102.1	96.5	138.8	105.2	78.9	152.0	95.3	51.1	123.3	108.7	202.6	75.8	86.3	66.7	46.8	60.1	129.6	155.8	138.4	100.2	58.0	105.7	68.4	60.0	90.3	64.0	39.4	97.9	92.7	64.5	79.6	85.1	76.9	106.7	38.8	89.0	39.9	48.8	42.4	46.4	80.3	46.6	42.3	40.7	44.9	78.9	82.7	54.1	43.1	59.6	32.8	33.0	34.8	36.8	32.9	33.2	32.9	32.8	33.5	33.5	33.8	34.0	26.3	25.6	36.3	4.2	25.3	13.9	41.0	88.3	16.5	24.1	44.4	46.6	26.9	51.5	65.7	62.5	14.6	136.1	22.0	74.3	133.1	135.9	2.6	61.8	48.5	35.4	41.0	47.9	3.5	152.4	186.5	40.8	40.8	55.9	29.2	21.5	29.6	46.4	102.3	23.5	3.5	70.5	85.5	34.5	12.7	5.6	27.7	33.0	42.7	0.0	46.7	56.1	44.3	2.5	4.7	134.4	75.7	30.5	40.9	44.4	83.5	93.6	74.9	29.5	32.9	13.5	69.9	42.8	46.7	61.9	22.9	121.6	22.8	69.9	63.4	53.5
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS26B	"MGC10485, Pep8b"	ENSG00000151502	"VPS26, retromer complex component B"	Q4G0F5	11	134224671-134247788	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038172	Uncertain					NA	NA		8800	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038172: AB_10675630"	"unprognostic (1.55e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.05e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.13e-1)"	17.7	21.2	37.8	13.5	40.8	30.4	16.3	33.1	42.4	18.2	28.6	23.5	20.5	20.5	31.5	19.8	20.4	15.3	23.7	42.4	36.4	14.2	29.5	15.8	14.0	31.4	33.1	19.1	25.8	17.5	21.4	13.4	33.3	21.0	17.2	24.7	21.6	18.8	17.1	35.3	21.4	20.5	30.8	18.5	20.1	16.9	35.9	30.2	17.7	16.1	12.8	18.9	16.7	35.4	25.1	27.8	22.8	70.0	50.2	44.2	19.1	26.3	31.5	23.4	17.4	46.4	43.3	15.8	52.0	46.1	27.4	35.8	30.5	43.6	17.5	37.4	21.9	69.5	16.1	30.3	36.6	41.3	42.9	42.1	28.0	22.4	41.3	32.9	41.9	60.1	34.3	27.1	33.3	30.4	89.8	47.0	13.0	78.3	45.1	20.5	18.4	22.5	29.2	39.6	38.0	38.3	30.0	53.9	17.3	24.0	99.8	31.9	34.7	29.5	16.5	37.7	18.8	34.0	20.0	6.4	19.2	64.1	22.3	3.9	3.3	8.3	5.4	4.1	4.8	0.9	4.6	5.8	3.0	0.4	2.9	5.3	4.9	5.5	3.6	3.4	5.1	2.9	37.8	40.8	33.1	42.4	42.4	36.4	31.4	33.1	33.3	30.8	35.9	35.4	14.3	12.8	6.4	14.7	9.4	17.7	12.7	7.1	25.0	30.0	21.9	22.1	29.1	17.2	6.9	20.2	8.4	18.8	36.2	31.4	21.5	8.6	26.5	12.9	16.7	14.0	28.4	24.8	24.8	14.8	27.1	19.2	29.0	11.5	1.3	22.5	14.6	34.7	23.9	30.3	18.8	30.3	10.2	32.7	16.4	67.9	18.0	27.5	12.4	11.2	21.7	23.8	48.4	13.6	19.9	11.2	32.4	30.9	26.8	11.7	63.8	22.7	7.7	22.8	6.6	14.6	19.7	13.4	21.3	24.4	24.0	12.4	26.6	20.0	25.7	12.0
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 26.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 26.4;Hofbauer cells: 32.7;Pancreatic endocrine cells: 33.2;Proximal tubular cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	19.8	24.5	14.8	18.5	16.1	21.4	15.8	16.8	15.8	16.3	15.9	26.6	28.0	14.8	11.4	21.2	13.8	19.6	24.9	14.4	15.6	32.9	29.5	22.1	22.6	16.1	15.9	17.4	22.6	17.7	8.6	21.4	16.6	14.3	26.0	13.6	16.9	15.8	31.5	15.7	26.9	19.9	16.2	20.2	21.2	7.5	16.5	28.1	18.1	37.8	23.6	21.9	14.2	17.6	31.8	13.8	30.2	26.5	55.4	49.4	34.3	29.9	66.2	26.6	40.2	19.2	32.7	22.0	11.7	70.0	63.9	15.0	32.6	32.1	26.1	52.8	23.5	37.6	13.6	18.7	49.1	27.8	24.3	43.5	31.2	31.0	50.4	48.1	51.4	40.5	24.0	46.8	52.5	14.1	47.2	23.7	34.4	48.7	13.8	44.8	14.5	32.5	32.8	23.7	24.4	32.6	20.6	40.9	65.5	39.0	38.4	22.0	41.0	30.6	10.8	33.2	18.5	71.3	78.0	30.3	48.3	47.9	35.2	58.6	48.6	84.9	50.7	60.5	46.8	37.5	43.1	45.4	47.7	29.4	39.8	41.0	50.1	52.9	55.7	19.4	54.9	54.1	14.8	16.1	16.8	15.8	14.4	15.6	16.1	15.9	16.6	16.2	16.5	17.6	18.1	9.6	21.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	14.5	13.3	0.0	0.0	6.8	9.2	0.0	16.0	23.8	0.0	21.5	26.4	0.0	12.5	12.7	8.4	0.0	0.0	0.0	28.0	26.4	5.4	0.0	16.1	8.8	19.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	16.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.1	0.0	0.0	29.7	4.4	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	14.6	8.5	10.1	0.0	0.0
VPS28		ENSG00000160948	"VPS28 subunit of ESCRT-I"	Q9UK41	8	144423601-144428563	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024688, HPA024745"	Supported					NA	NA		63000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA024688: AB_1858766, HPA024745: AB_1858765"	"unprognostic (2.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.93e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.37e-2)"	132.8	137.6	0.1	0.0	0.1	0.0	132.9	0.0	0.3	147.7	0.0	150.5	0.0	133.7	0.0	138.0	127.3	0.1	177.5	0.1	0.2	173.8	162.7	123.1	0.1	0.1	0.2	159.6	146.5	0.0	129.3	0.1	0.5	136.3	0.0	0.7	119.7	0.2	197.7	150.4	140.0	0.0	0.0	144.9	154.1	151.8	0.1	0.0	144.5	1.1	0.0	128.7	135.4	0.2	0.2	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.2	0.5	0.0	0.1	0.2	189.6	112.2	128.6	32.3	126.9	103.2	138.6	180.0	105.9	91.9	139.0	171.2	70.1	131.5	133.9	169.2	60.5	166.4	126.6	387.2	273.9	264.5	208.6	130.4	131.5	149.7	172.7	139.3	20.1	251.1	160.9	142.9	154.9	164.9	185.5	191.5	142.1	141.4	250.7	57.2	25.9	256.8	128.1	178.9	155.9	183.1	198.8	172.1	188.5	22.5	285.8	168.6	144.1	20.1	32.3	287.3	462.2	156.1	112.8	128.9	561.9	526.5	134.6	121.8	157.8	140.0	206.5	232.1	127.2	142.7	133.5	112.7	160.9	275.7	206.0	168.8
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29 retromer complex component"	Q9UBQ0	12	110491083-110502111	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	61.1	62.7	45.6	57.0	47.0	96.2	59.2	46.2	61.8	50.3	47.0	76.4	64.1	52.9	89.5	71.1	50.3	51.1	73.8	48.7	48.3	79.2	77.6	54.9	69.7	47.2	46.3	47.1	56.6	54.8	53.7	47.3	47.4	62.7	79.0	99.6	58.5	71.3	127.3	46.8	65.7	67.1	48.0	76.5	62.8	32.6	46.1	63.2	54.1	100.8	72.0	65.1	50.6	51.1	103.5	98.6	91.9	65.6	100.4	98.7	72.6	94.9	98.1	93.9	84.2	100.0	87.0	94.0	97.1	94.3	87.7	95.5	123.1	88.0	97.0	112.2	98.9	115.4	122.6	83.0	87.4	139.5	97.1	66.0	73.3	79.3	87.4	114.1	166.0	116.6	112.1	85.5	170.0	51.9	110.3	196.4	52.6	90.9	124.8	72.2	93.5	131.8	157.0	149.7	98.1	51.8	107.9	94.0	122.8	78.5	128.6	106.0	94.0	80.6	53.4	112.9	113.0	58.0	87.5	112.1	93.9	130.8	87.8	246.2	262.7	259.4	139.1	356.8	155.3	195.9	175.5	164.9	318.3	158.7	159.8	156.8	178.7	202.9	405.4	214.0	224.8	385.1	45.6	47.0	46.2	61.8	48.7	48.3	47.2	46.3	47.4	48.0	46.1	51.1	138.8	76.9	96.2	21.2	93.7	143.5	172.6	395.9	70.6	39.0	93.4	109.2	282.4	90.1	209.7	101.2	27.1	192.8	116.5	156.3	289.5	231.0	56.8	94.7	79.8	125.0	83.2	147.5	30.2	179.8	187.6	120.2	60.1	104.1	153.9	78.1	94.9	158.7	409.9	42.1	26.7	149.8	248.2	158.0	296.1	82.6	92.2	178.7	177.9	30.9	295.2	107.9	101.0	22.6	30.4	217.9	182.2	105.7	94.8	157.4	142.2	404.7	131.1	111.8	157.8	81.9	212.1	256.4	148.4	108.3	173.0	178.8	111.2	105.8	164.5	187.7
VPS33B	FLJ14848	ENSG00000184056	"VPS33B late endosome and lysosome associated"	Q9H267	15	90998673-91022603	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040415	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040415: AB_10795419"	"unprognostic (7.49e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-2)"	5.7	5.4	5.9	5.1	7.2	2.8	6.1	6.3	7.6	6.6	6.7	6.7	5.8	6.3	7.0	6.8	8.1	4.7	3.8	6.6	7.1	5.9	4.3	5.6	6.9	6.3	6.3	6.8	6.9	8.1	5.3	6.8	6.4	6.6	6.4	5.8	6.7	6.7	4.1	11.0	6.9	6.2	6.3	6.9	7.9	6.1	7.2	5.4	5.5	4.3	6.5	6.1	6.4	7.7	5.6	16.4	3.4	6.0	8.9	15.1	17.7	6.8	12.7	10.7	10.9	7.0	11.0	7.1	9.4	11.9	9.6	10.0	4.7	10.3	5.6	3.8	4.9	7.7	6.6	10.3	10.9	9.6	10.3	17.0	10.7	8.0	9.5	9.3	15.2	8.6	12.6	1.7	7.9	11.9	6.5	6.8	8.3	14.8	5.8	4.9	8.9	8.7	12.2	12.3	5.2	9.6	10.0	7.9	17.5	8.1	8.1	12.6	10.4	7.0	7.8	5.0	5.2	3.6	12.9	2.7	14.7	9.3	6.4	12.5	7.1	12.1	7.7	11.8	8.9	5.6	6.8	6.9	9.5	7.8	7.8	11.0	3.2	7.9	13.4	4.7	5.9	6.4	5.9	7.2	6.3	7.6	6.6	7.1	6.3	6.3	6.4	6.3	7.2	7.7	2.2	0.0	7.3	5.5	5.3	2.2	3.0	3.5	1.8	9.2	2.6	1.8	4.8	2.8	4.4	3.7	2.1	16.8	5.0	6.9	5.9	9.0	3.1	3.0	2.7	4.7	2.4	5.7	11.4	9.4	10.8	2.9	7.7	2.9	8.2	6.7	5.7	4.9	8.0	8.4	11.3	5.1	4.1	6.0	4.1	4.0	3.7	4.5	8.8	3.7	7.7	6.3	3.1	7.5	9.7	9.3	5.0	5.3	4.9	4.1	7.9	4.3	7.9	7.0	6.6	2.7	3.5	11.0	8.2	2.3	2.6	12.3	5.0	3.6	4.3	3.0
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35 retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes		NA	NA		500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Endosomes, Lysosomes"		"HPA040802: AB_2677142"	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	5.4	4.2	2.9	3.0	3.0	9.5	4.6	2.6	3.2	4.2	2.8	4.2	1.9	4.3	1.9	4.7	4.0	1.4	6.1	3.0	2.5	3.7	1.7	4.1	2.9	3.0	2.4	4.7	4.4	5.2	3.3	2.1	3.2	3.0	1.8	4.1	4.5	2.4	4.6	6.1	4.9	1.7	2.1	4.2	4.5	2.7	2.8	3.9	2.7	2.7	1.8	4.5	4.2	3.4	3.2	5.0	4.1	2.8	6.5	7.3	2.1	3.8	5.4	6.4	3.7	4.3	2.7	4.2	2.3	6.5	3.3	3.9	7.5	7.5	9.1	1.6	6.4	3.9	3.8	3.0	5.4	5.2	5.8	5.8	5.5	7.3	4.5	6.3	6.6	6.0	3.1	1.8	6.5	2.9	4.0	5.0	1.4	3.0	6.6	5.4	5.4	5.2	5.2	4.4	1.8	2.1	4.1	3.2	1.8	4.5	1.9	2.6	3.9	1.9	1.9	4.3	2.7	2.3	3.2	4.9	3.4	4.0	1.3	1.8	1.3	1.3	0.7	1.7	0.7	0.8	0.7	0.6	1.5	1.0	1.0	0.7	1.5	0.8	2.3	0.6	1.1	1.1	2.9	3.0	2.6	3.2	3.0	2.5	3.0	2.4	3.2	2.1	2.8	3.4	65.9	51.3	59.4	20.5	84.3	72.5	80.0	98.6	72.8	56.5	77.9	75.9	102.9	57.2	83.4	68.0	60.5	134.5	44.9	65.9	54.8	111.7	111.2	136.4	92.3	63.3	80.8	52.6	43.1	72.5	102.2	70.1	88.7	88.4	72.2	211.1	54.7	40.2	123.4	45.4	42.5	79.7	107.8	108.3	87.9	32.4	77.9	113.6	46.2	30.0	153.0	71.4	45.3	28.6	31.3	101.1	101.9	72.2	41.7	77.0	164.6	103.7	188.9	82.6	46.0	57.5	88.9	207.9	118.0	101.5	87.7	113.1	51.5	95.9	97.6	84.5
VPS35L	"C16orf62, MGC16824"	ENSG00000103544	"VPS35 endosomal protein sorting factor like"	Q7Z3J2	16	19555240-19706793	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042969, HPA053547"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042969: AB_10794920, HPA053547: AB_2682183"	"unprognostic (7.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.31e-8)"	"unprognostic (1.82e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-2)"	19.3	22.7	23.3	15.9	33.5	13.2	17.1	21.8	24.9	21.2	11.7	19.2	13.7	20.1	22.4	16.8	19.2	17.5	17.8	20.7	23.5	22.2	14.4	16.2	14.6	23.3	24.4	23.3	16.5	35.6	20.4	20.2	24.6	15.9	19.4	16.1	12.4	18.9	22.2	13.8	15.3	25.1	20.5	17.2	13.3	31.5	28.0	16.1	22.7	25.2	16.6	18.3	15.6	40.3	22.3	37.5	35.7	28.4	44.2	60.1	5.8	32.5	52.3	33.9	38.9	6.4	37.0	27.1	67.4	51.7	0.2	6.2	27.5	16.7	36.5	1.6	15.7	16.4	32.6	0.6	57.4	25.9	31.6	43.9	24.4	31.7	21.5	48.2	54.4	13.2	22.3	6.2	55.7	15.7	23.0	7.2	24.8	3.9	5.1	19.6	11.7	7.1	38.6	5.2	21.8	22.1	43.7	1.5	18.6	27.2	12.9	22.2	61.0	17.4	16.2	25.7	3.7	23.8	45.2	10.6	33.6	21.1	27.5	26.5	35.3	16.5	18.9	42.0	23.5	14.7	18.0	18.8	42.6	23.5	21.0	18.6	4.2	37.6	37.7	11.5	21.6	28.5	23.3	33.5	21.8	24.9	20.7	23.5	23.3	24.4	24.6	20.5	28.0	40.3	32.4	6.4	16.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.5	9.1	0.0	0.0	8.1	16.5	0.0	29.4	5.0	0.0	29.4	20.4	0.0	8.2	15.8	15.5	0.0	0.0	0.0	17.0	19.5	8.1	0.0	11.1	3.8	18.1	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	1.2	0.0	0.0	21.9	2.9	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	40.2	3.4	21.0	0.0	0.0
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450634	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	17.1	15.1	10.1	16.8	11.5	8.6	26.1	14.0	16.3	20.0	9.6	24.5	27.6	18.7	12.2	23.7	16.8	16.6	24.0	11.8	10.1	25.4	23.6	19.9	19.5	12.4	11.0	17.9	17.9	23.3	11.0	25.0	12.8	21.8	27.5	43.1	25.2	18.3	23.4	51.1	27.7	20.7	9.9	24.1	18.1	4.0	12.1	22.3	22.5	26.2	20.7	18.9	21.3	12.1	7.3	11.8	20.4	13.5	21.1	29.3	17.8	16.7	12.5	16.1	9.6	14.3	22.9	25.5	8.6	23.8	10.6	20.1	16.6	19.7	18.0	19.3	16.0	30.2	18.7	12.8	25.3	40.2	31.4	20.5	37.9	11.2	18.0	18.0	16.6	33.6	22.7	21.8	31.8	9.6	30.4	40.6	19.5	29.0	6.3	31.0	11.9	15.9	28.7	18.9	10.4	22.0	11.9	27.3	25.9	24.0	15.9	67.1	26.3	10.3	12.6	10.3	19.1	16.3	22.0	26.8	10.6	28.4	24.7	15.6	14.6	12.3	12.3	16.3	19.8	15.3	13.5	15.4	15.6	13.0	12.2	13.1	3.6	21.6	22.7	16.3	16.0	13.7	10.1	11.5	14.0	16.3	11.8	10.1	12.4	11.0	12.8	9.9	12.1	12.1	54.2	83.3	51.5	41.1	49.9	42.8	48.9	57.6	62.0	132.2	51.6	72.8	80.8	38.6	47.7	33.1	120.9	60.2	83.4	62.6	68.4	35.4	1.2	28.0	45.9	55.7	49.8	31.1	57.0	29.3	43.0	46.6	36.7	37.0	44.3	44.9	38.2	54.0	43.8	52.2	54.6	64.1	40.7	44.0	29.1	3.7	49.7	47.1	28.4	36.5	60.8	39.8	59.8	44.7	40.7	29.8	63.0	52.3	55.0	65.4	77.4	78.5	33.2	265.8	46.0	52.7	76.1	15.3	25.9	83.5	58.2	38.2	48.2	40.6	58.6	45.4
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A subunit of ESCRT-I"	Q8NEZ2	8	17246931-17302427	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	18.9	19.4	11.9	14.8	15.1	15.4	18.5	28.7	17.5	21.1	5.0	16.8	20.9	19.4	14.3	20.2	13.7	16.8	36.2	10.1	13.6	25.0	27.8	16.2	14.2	11.2	12.5	18.4	17.5	33.8	12.4	29.7	12.1	20.2	17.2	55.0	12.5	23.2	39.4	14.7	17.5	24.4	10.0	12.3	14.5	32.3	12.2	17.5	18.9	31.2	15.2	25.1	15.0	18.4	17.2	27.3	24.0	21.7	51.8	41.5	25.8	60.8	50.2	53.9	45.9	17.6	16.2	14.6	31.6	48.7	50.1	16.7	27.2	26.4	63.8	15.1	7.8	26.5	13.7	20.2	59.7	11.3	25.1	39.7	50.2	50.4	51.5	38.0	38.7	22.7	20.2	36.8	57.7	11.7	32.0	26.9	23.4	38.2	14.2	15.4	26.5	17.6	45.8	23.4	27.1	14.4	23.8	23.9	37.9	47.1	15.6	22.2	33.4	33.1	16.7	47.6	32.0	12.0	25.0	17.2	37.5	19.9	33.8	34.0	17.2	16.5	13.9	13.1	17.1	10.5	13.4	13.6	13.4	10.8	12.0	14.8	17.6	24.5	12.4	11.8	13.3	14.1	11.9	15.1	28.7	17.5	10.1	13.6	11.2	12.5	12.1	10.0	12.2	18.4	31.8	16.0	15.6	19.6	21.2	39.5	32.7	33.1	18.8	26.4	19.3	13.5	40.7	14.3	25.8	7.3	58.4	36.1	20.5	15.8	37.2	29.3	93.2	20.9	29.0	24.6	18.0	26.1	32.4	15.5	59.2	27.0	15.8	28.4	9.5	16.8	24.3	23.1	44.6	21.9	30.7	16.6	30.5	17.5	22.7	39.6	25.7	25.3	21.4	20.6	22.4	25.8	15.5	24.1	34.0	31.2	13.1	25.9	21.5	50.6	27.8	48.8	18.8	60.2	26.3	21.5	36.6	111.6	43.4	22.5	37.8	113.0	22.7	17.1	14.6	52.6
VPS37B	FLJ12750	ENSG00000139722	"VPS37B subunit of ESCRT-I"	Q9H9H4	12	122865330-122896127	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038217, HPA038218"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA038217: AB_10672740, HPA038218: AB_2675898"	"unprognostic (1.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.58e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.44e-2)"	19.9	28.3	24.1	15.7	19.6	46.6	18.7	17.2	26.1	13.8	23.6	29.5	17.8	11.8	5.2	63.4	14.9	18.1	23.5	25.5	16.4	30.6	11.0	28.1	14.5	19.5	17.7	15.3	27.2	10.8	23.5	10.7	16.4	19.5	17.4	9.3	36.2	9.2	10.3	23.0	23.6	7.2	17.9	34.5	37.3	25.4	19.6	10.8	28.3	6.8	16.7	17.1	19.2	21.6	55.2	19.2	52.0	21.0	8.7	15.6	49.6	26.6	24.7	20.5	17.6	21.4	42.1	1.4	19.3	16.8	33.7	35.6	29.1	39.0	15.6	15.1	28.3	106.2	13.3	15.2	19.8	13.9	82.7	18.9	34.3	28.2	24.8	38.5	30.5	65.3	40.6	34.5	27.1	10.4	33.0	40.5	29.3	57.1	52.4	25.3	32.2	17.0	31.8	51.3	31.4	35.4	23.6	25.7	58.8	21.9	45.5	23.2	28.2	20.7	28.3	24.3	48.1	116.5	116.8	0.6	26.3	20.4	123.6	12.1	4.5	10.4	14.2	6.6	10.2	10.3	4.7	8.3	1.7	12.7	4.2	6.0	27.6	8.3	9.0	0.2	4.5	4.7	24.1	19.6	17.2	26.1	25.5	16.4	19.5	17.7	16.4	17.9	19.6	21.6	57.3	54.5	34.3	18.9	159.3	43.2	98.7	66.6	46.1	32.0	30.8	18.8	2.6	25.8	75.0	31.3	68.8	19.9	198.7	123.1	17.6	53.6	40.5	88.1	24.8	37.6	44.3	30.5	26.2	42.7	34.1	16.0	141.2	168.2	90.9	14.1	30.0	13.4	17.6	10.1	16.7	49.5	63.1	19.0	66.3	52.5	8.1	46.7	39.2	19.7	9.5	20.8	62.8	12.1	27.2	71.0	83.6	7.9	168.3	104.4	43.8	5.8	56.6	20.7	6.6	14.1	29.1	14.1	12.5	49.2	44.6	43.6	119.0	30.6	61.3	158.0
VPS37C	FLJ20847	ENSG00000167987	"VPS37C subunit of ESCRT-I"	A5D8V6	11	61130257-61161615	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043348	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA043348: AB_10794658"	"unprognostic (1.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-1)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.37e-7)"	"unprognostic (1.99e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.05e-2)"	14.1	13.8	11.5	13.2	10.9	10.3	14.0	10.0	12.2	14.3	11.9	17.7	17.1	15.9	5.2	22.0	12.5	11.2	15.8	12.6	9.9	16.8	10.7	14.5	8.1	11.9	11.6	14.1	24.1	11.9	20.1	14.1	10.5	20.9	10.5	22.7	23.3	14.6	23.6	22.2	15.5	14.5	9.6	13.3	27.7	15.3	12.0	6.2	12.1	11.8	10.0	18.3	15.9	11.4	33.8	13.1	16.7	16.1	8.0	16.6	37.2	16.4	44.0	23.9	16.2	15.7	15.6	8.8	22.5	22.5	19.7	18.5	15.2	17.3	12.3	19.2	11.4	11.2	9.0	17.8	25.7	9.0	13.7	15.0	26.3	20.6	25.7	14.3	15.8	6.0	29.6	14.6	16.4	41.1	2.0	13.7	20.6	14.7	18.8	3.1	7.2	21.4	18.9	17.2	10.3	25.1	16.4	52.2	28.8	14.0	49.5	22.2	12.1	23.9	17.2	24.4	20.8	6.9	10.0	7.2	21.6	11.1	16.5	0.4	1.4	1.7	0.3	2.6	0.4	0.5	0.2	0.4	1.0	0.5	0.3	0.1	3.8	0.2	2.4	0.1	0.2	0.7	11.5	10.9	10.0	12.2	12.6	9.9	11.9	11.6	10.5	9.6	12.0	11.4	6.3	16.0	6.0	5.9	4.1	12.5	14.3	9.4	10.2	5.8	14.9	9.3	7.5	12.8	10.0	12.9	10.4	30.6	1.2	15.6	11.7	17.4	8.9	5.0	4.0	11.2	16.3	4.2	8.9	19.8	20.9	10.6	13.7	6.8	0.0	5.1	7.1	6.7	17.3	25.2	7.1	18.3	8.2	13.7	11.4	6.5	7.8	13.9	7.2	13.1	12.3	11.5	2.1	4.5	8.3	21.7	11.3	13.5	2.2	17.7	19.0	7.2	12.2	41.7	0.0	6.7	9.2	12.9	16.7	8.4	19.9	35.2	2.9	7.4	10.6	14.5
VPS37D	"MGC35352, WBSCR24"	ENSG00000176428	"VPS37D subunit of ESCRT-I"	Q86XT2	7	73667831-73672112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.0;Collecting duct cells: 11.0;Distal tubular cells: 9.8;Muller glia cells: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040978	Uncertain		Approved	Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA040978: AB_10805833"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (4.19e-2)"	"prognostic favorable (5.80e-9)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.43e-1)"	1.8	1.3	8.4	0.3	8.7	0.2	2.4	7.9	12.1	6.1	3.5	3.1	1.8	3.7	2.8	0.8	3.6	1.4	2.3	8.9	7.9	11.3	9.6	1.0	0.2	7.9	7.3	4.2	4.0	2.7	3.3	0.3	8.0	3.7	0.2	1.6	3.2	2.0	1.3	2.5	1.9	0.7	6.3	0.9	2.1	7.1	8.6	0.3	3.4	0.5	0.1	2.2	2.8	7.0	0.5	2.3	1.8	3.8	1.2	2.4	1.1	1.0	1.5	0.8	1.0	0.2	0.7	0.8	0.9	1.3	2.1	0.3	1.9	0.9	0.2	0.3	2.0	0.0	0.2	2.6	3.2	0.0	1.1	1.9	0.5	1.1	0.3	3.5	0.9	3.2	1.1	0.2	1.1	2.8	0.6	0.0	1.2	0.7	3.3	0.1	0.0	0.1	3.0	0.2	3.7	11.8	0.0	1.6	2.3	0.3	3.8	0.1	1.3	2.2	3.0	1.3	0.8	1.4	0.1	1.1	5.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.7	7.9	12.1	8.9	7.9	7.9	7.3	8.0	6.3	8.6	7.0	2.4	0.0	0.0	1.3	0.2	1.0	0.8	0.3	0.6	13.0	3.4	3.8	1.8	1.5	0.1	11.0	0.0	0.2	0.1	0.2	9.8	4.0	1.1	3.6	3.1	1.1	4.9	0.0	1.6	0.8	0.4	1.6	0.0	5.1	0.0	5.9	1.8	5.3	0.1	0.0	2.7	0.4	2.0	0.0	0.4	0.9	1.8	0.2	5.4	1.0	0.6	13.9	0.0	1.0	0.9	1.8	1.4	2.6	0.3	1.0	2.0	8.3	0.2	5.3	0.0	0.9	2.7	0.6	8.3	0.1	1.1	0.3	0.2	0.9	0.7	0.4
VPS41	HVSP41	ENSG00000006715	"VPS41 subunit of HOPS complex"	P49754	7	38722974-38932394	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.2;Oligodendrocytes: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020080, HPA020299"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020080: AB_1858768, HPA020299: AB_1858769"	"unprognostic (9.20e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.40e-8)"	"unprognostic (1.62e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	23.0	17.5	25.5	20.3	30.6	12.3	22.4	22.2	28.4	25.9	34.0	25.2	17.3	23.9	14.9	24.2	23.5	35.9	25.5	31.2	25.4	30.6	26.4	25.2	25.0	23.1	22.4	31.1	23.4	37.5	15.4	23.0	24.8	23.2	19.7	29.3	13.2	25.0	8.1	16.1	19.1	25.2	25.3	23.4	20.8	15.6	22.5	24.2	30.9	11.4	25.6	23.2	12.5	31.6	31.8	41.7	41.5	44.6	60.6	55.8	21.1	33.3	58.8	26.6	42.5	24.4	46.4	31.0	93.6	42.2	110.8	39.3	61.7	41.3	44.4	41.1	29.7	29.6	24.2	20.6	47.7	37.9	58.6	41.0	33.9	35.7	35.8	46.0	47.4	39.3	46.5	64.7	47.7	28.5	38.4	21.3	45.5	43.3	27.4	41.1	37.9	33.0	48.8	78.0	35.6	62.9	31.8	50.6	31.2	73.6	56.9	45.8	51.5	30.0	29.8	40.5	33.7	65.1	128.3	59.2	64.4	32.7	104.4	26.6	19.5	27.9	15.3	19.4	12.9	16.5	11.6	14.1	23.4	21.5	12.1	13.3	23.2	23.1	27.9	14.0	13.4	13.6	25.5	30.6	22.2	28.4	31.2	25.4	23.1	22.4	24.8	25.3	22.5	31.6	24.6	22.4	34.6	56.2	23.9	15.2	11.4	16.1	15.4	33.2	14.6	13.0	27.3	38.6	17.5	33.1	18.8	17.7	17.6	14.7	21.5	29.6	2.9	19.9	23.5	21.7	24.0	16.6	118.2	13.8	14.0	19.9	16.8	34.2	42.4	36.4	20.3	25.4	28.6	30.3	78.9	14.1	22.4	28.2	20.1	3.5	15.2	30.3	30.2	49.6	45.2	37.4	12.3	82.4	109.2	18.2	14.6	26.4	15.3	10.5	13.8	26.6	22.7	20.6	0.0	18.7	18.8	10.7	11.0	15.6	17.0	25.9	17.2	29.3	14.9	13.3
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.8;Late spermatids: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	19.1	26.8	32.3	12.0	34.6	6.6	17.8	40.2	43.0	20.1	27.7	22.0	12.6	18.7	22.5	16.7	16.1	13.7	38.6	34.0	33.2	21.1	12.5	15.4	13.5	30.6	31.4	14.0	11.1	26.4	19.1	17.3	31.5	18.8	17.2	29.2	14.3	20.1	19.3	16.5	15.3	25.2	31.5	16.2	17.4	11.0	32.9	17.0	19.8	16.6	15.3	18.5	15.9	32.8	31.5	24.3	40.9	27.0	37.1	29.4	19.0	44.7	23.7	45.3	37.4	17.7	26.1	19.3	26.5	37.0	19.9	26.0	42.4	27.0	49.0	38.7	31.1	24.6	33.5	16.8	24.7	17.6	30.2	25.8	24.8	43.5	22.8	29.7	37.1	38.6	34.4	28.3	40.0	53.5	34.7	17.5	28.4	28.7	38.4	23.7	41.9	27.4	31.2	30.0	28.5	59.7	34.9	29.8	46.9	46.2	48.9	45.6	32.6	20.8	25.1	18.7	31.3	21.3	49.4	18.9	30.9	24.4	30.2	23.6	26.6	4.7	16.0	28.0	15.0	15.6	13.6	15.1	25.9	12.8	13.2	13.9	2.5	14.1	19.9	14.6	16.8	18.4	32.3	34.6	40.2	43.0	34.0	33.2	30.6	31.4	31.5	31.5	32.9	32.8	9.4	12.8	14.0	85.8	11.9	7.4	8.2	12.7	13.1	20.9	11.0	10.2	44.0	8.6	11.0	16.5	18.8	20.9	12.5	8.3	7.9	12.3	202.8	9.7	14.2	10.4	7.8	4.6	79.4	7.2	9.5	14.7	12.8	10.1	6.3	24.6	12.1	7.2	19.0	30.3	90.2	8.1	14.2	18.0	8.6	267.9	21.5	13.6	10.6	45.9	19.7	17.9	6.2	92.5	59.5	11.4	11.6	14.7	8.4	6.4	13.6	9.2	11.5	23.8	32.9	7.3	17.1	18.1	15.1	11.6	7.7	14.8	11.2	21.2	9.7	7.9
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	24.2	18.3	10.5	25.5	13.1	52.6	28.8	13.2	17.8	26.8	9.3	42.3	35.1	22.7	19.5	75.4	18.6	23.7	16.2	10.3	14.6	23.8	28.4	23.8	31.2	13.5	15.9	19.3	17.3	27.8	11.5	28.7	14.0	23.4	37.0	7.0	24.7	19.5	11.0	32.3	36.4	21.0	12.6	28.8	32.5	12.1	12.5	31.4	28.5	13.0	39.1	30.2	31.1	15.6	57.1	21.9	22.4	24.5	33.5	47.1	38.9	48.6	45.5	36.4	39.2	15.7	39.4	54.1	31.2	35.7	30.9	119.6	26.8	53.1	47.5	40.6	22.3	27.6	27.8	23.7	48.6	94.5	56.8	43.1	80.3	32.3	56.2	36.5	33.9	31.0	14.3	49.4	52.1	20.2	59.9	29.2	23.2	22.7	32.3	48.8	47.2	52.4	45.6	66.2	38.2	33.6	36.9	35.4	55.3	28.3	34.2	50.5	52.8	55.4	27.3	21.6	32.7	163.6	86.5	69.3	31.9	44.0	42.3	163.6	54.6	125.0	52.2	56.5	49.0	64.8	54.3	54.2	46.2	73.4	48.2	51.1	185.9	68.4	76.5	45.6	66.7	56.6	10.5	13.1	13.2	17.8	10.3	14.6	13.5	15.9	14.0	12.6	12.5	15.6	52.0	115.4	57.4	21.5	62.4	68.8	47.2	66.5	44.9	37.0	54.4	46.0	39.5	47.1	72.4	33.1	22.9	70.0	92.2	142.0	45.0	48.0	113.3	92.2	74.0	44.6	45.5	27.8	27.3	42.1	56.7	51.0	47.4	145.5	59.3	37.7	36.8	55.8	46.4	43.7	29.6	76.8	67.1	58.8	33.0	15.5	49.0	58.0	32.0	18.7	53.4	39.2	76.2	18.6	49.5	91.3	120.7	36.5	42.1	43.1	61.8	57.9	85.1	31.5	59.2	45.6	54.7	30.1	29.4	87.5	83.4	140.4	67.4	56.5	72.6	79.5
VPS50	"CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L"	ENSG00000004766	"VPS50 subunit of EARP/GARPII complex"	Q96JG6	7	93232340-93361123	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026679	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA026679: AB_1846135"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	7.4	9.0	4.2	3.4	4.6	2.6	8.2	5.7	5.3	7.3	4.6	8.9	1.9	8.2	4.2	9.2	6.8	2.7	7.7	4.4	4.0	7.1	6.1	6.1	4.9	4.1	4.0	7.6	7.8	6.0	7.7	4.8	4.2	6.4	5.2	5.1	8.8	3.2	12.0	8.8	8.2	3.5	4.2	9.5	7.8	6.5	3.8	4.3	7.3	4.9	4.8	7.9	7.8	5.0	6.5	2.2	2.6	5.0	8.2	7.9	6.3	5.5	5.0	9.1	6.1	5.5	9.0	5.5	5.1	4.2	13.6	3.6	10.4	7.0	11.3	5.8	4.6	14.6	3.1	2.4	4.9	3.4	4.5	3.8	8.7	9.9	9.5	5.9	11.5	3.9	10.2	8.2	11.3	4.7	5.3	4.6	6.2	8.7	5.9	3.5	6.3	8.1	5.1	2.9	3.7	7.8	4.8	13.5	4.4	7.5	6.3	2.8	5.8	12.4	4.4	16.3	4.5	3.3	8.0	9.1	6.9	6.1	6.8	3.1	3.2	2.1	2.6	3.5	4.6	2.4	2.7	2.7	4.5	2.4	2.0	2.5	1.1	1.4	2.5	2.8	2.9	2.0	4.2	4.6	5.7	5.3	4.4	4.0	4.1	4.0	4.2	4.2	3.8	5.0	10.9	12.8	11.3	0.0	13.5	0.0	3.4	0.0	6.8	14.1	11.7	6.3	0.0	2.8	5.0	5.5	16.7	7.5	11.0	5.5	3.9	6.2	27.9	7.6	10.8	7.9	2.4	10.8	0.0	5.5	11.7	6.4	11.2	8.2	7.6	12.6	9.7	6.1	10.7	10.1	0.0	7.1	0.0	13.7	0.0	14.2	9.0	10.0	0.0	0.0	9.4	10.3	6.2	0.0	0.0	6.9	9.4	7.2	10.2	2.7	6.1	8.3	5.8	14.3	6.6	11.2	6.3	18.1	12.8	7.9	0.0	9.4	8.5	13.9	5.1	2.8
VPS51	"ANG2, ANG3, C11orf2, C11orf3, FFR"	ENSG00000149823	"VPS51 subunit of GARP complex"	Q9UID3	11	65089324-65111862	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039650, HPA061447"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"	Nucleoli	"HPA039650: AB_10673147, HPA061447: AB_2684521"	"unprognostic (2.36e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.41e-9)"	"unprognostic (7.77e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.18e-1)"	48.5	37.8	19.0	34.9	23.1	60.9	46.6	22.0	30.7	45.6	20.4	55.4	52.9	54.4	7.3	42.5	46.1	20.3	45.3	22.5	15.5	33.7	36.2	34.2	48.6	18.5	18.6	83.8	120.3	37.4	28.6	22.2	20.2	38.1	25.1	20.3	65.5	27.7	84.2	71.2	49.7	22.7	14.3	40.9	70.3	28.4	17.2	46.7	39.7	42.9	32.5	45.2	38.1	21.5	71.8	74.5	35.7	44.4	15.5	38.5	72.1	27.5	53.2	52.6	38.8	55.2	88.7	118.0	76.1	51.4	27.3	60.0	37.9	59.3	19.2	69.6	62.1	72.5	72.6	55.1	51.3	77.1	65.0	66.8	39.9	39.0	32.1	41.6	58.4	55.0	73.6	82.9	21.7	95.1	105.8	83.0	59.8	30.7	61.5	67.5	17.5	150.7	36.2	76.2	61.5	87.8	20.7	110.9	71.8	21.0	93.7	39.1	48.1	35.2	32.0	45.4	39.7	115.7	92.2	68.9	39.9	28.0	26.3	10.6	15.0	15.4	17.9	15.8	21.2	22.4	25.2	27.1	22.1	21.2	23.3	20.7	8.0	30.6	16.0	19.1	17.7	18.3	19.0	23.1	22.0	30.7	22.5	15.5	18.5	18.6	20.2	14.3	17.2	21.5	49.8	19.2	47.7	18.9	77.3	49.1	66.3	46.0	58.6	64.7	76.5	67.8	5.8	44.3	27.8	31.3	29.2	78.4	73.7	156.5	62.6	49.2	77.5	25.6	35.0	46.5	95.8	50.5	21.8	120.5	79.4	38.8	45.9	34.4	37.5	47.3	55.3	52.5	45.5	67.3	24.1	110.0	32.6	54.0	30.6	222.4	53.4	36.1	49.8	15.9	71.3	65.9	89.6	21.6	28.0	51.2	144.4	54.5	66.4	45.1	158.7	75.9	16.1	52.5	26.3	49.3	44.4	40.3	31.4	52.3	54.8	115.3	64.0	61.5	170.5	51.0
VPS52	"ARE1, SACM2L"	ENSG00000223501	"VPS52 subunit of GARP complex"	Q8N1B4	6	33250272-33272047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.3;THP-1: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042667, HPA048128"	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"			"HPA042667: AB_2678105, HPA048128: AB_2680278"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.63e-2)"	20.1	28.1	2.4	8.2	3.6	3.8	21.6	2.2	4.8	24.6	5.6	23.6	9.9	23.2	8.3	29.9	20.7	7.3	20.0	2.4	4.0	21.6	24.3	18.2	12.4	4.6	3.0	24.9	25.3	0.0	26.2	3.2	3.9	22.7	6.2	2.9	24.0	2.7	37.8	27.6	25.1	7.0	2.3	27.6	23.7	17.9	3.4	10.4	27.9	23.3	10.0	22.4	24.0	4.0	0.1	6.6	0.4	26.4	9.3	9.2	24.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	18.1	0.0	10.9	20.2	25.3	0.0	0.0	0.0	2.9	0.0	6.6	13.4	11.2	0.0	24.2	0.0	0.0	0.0	17.8	16.4	11.8	10.5	27.1	2.0	0.0	0.1	0.4	0.0	20.8	11.0	16.7	9.9	4.0	27.5	15.0	17.4	0.0	16.3	13.1	45.3	14.4	0.0	0.8	39.1	0.0	13.7	7.0	16.0	22.2	0.0	0.0	18.7	0.0	11.5	0.0	5.7	4.5	4.1	2.8	3.6	2.1	2.4	3.0	4.1	3.7	2.2	3.3	4.0	2.0	4.9	2.9	1.7	4.5	4.2	2.4	3.6	2.2	4.8	2.4	4.0	4.6	3.0	3.9	2.3	3.4	4.0	8.4	12.8	13.0	18.9	8.8	6.6	6.3	9.0	10.8	13.0	12.2	10.4	1.3	10.0	9.3	3.7	2.1	16.7	6.9	17.7	7.9	11.0	7.8	10.0	8.8	8.7	7.2	7.8	10.7	11.8	16.0	7.3	18.3	14.2	1.3	10.7	11.4	19.1	11.4	6.7	11.1	14.5	12.2	14.1	4.6	7.2	6.8	8.5	7.2	15.9	11.4	13.3	2.1	7.5	16.4	9.7	7.7	9.1	14.2	4.3	13.7	8.9	10.6	12.6	13.1	7.0	6.9	25.7	14.2	15.4	8.7	17.6	6.6	8.4	12.5	6.4
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53 subunit of GARP complex"	Q5VIR6	17	508503-721717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	4.3	4.7	7.0	3.0	5.9	20.5	4.6	21.4	10.3	5.2	2.8	4.5	3.7	4.4	3.4	9.0	4.0	3.6	4.3	8.2	3.3	4.0	4.5	5.1	4.9	3.0	3.9	5.3	4.5	6.4	6.0	4.6	4.2	4.6	5.9	8.1	4.7	5.0	7.0	7.1	4.0	6.1	0.9	4.5	5.0	14.6	4.0	4.9	7.6	5.1	5.2	4.1	4.8	9.4	12.9	26.5	7.6	8.3	12.4	9.5	5.5	6.4	9.4	15.8	15.4	12.6	5.8	7.8	5.9	19.9	10.0	10.9	16.5	13.9	23.1	6.7	11.4	5.0	17.2	8.1	6.1	6.6	9.2	11.1	7.8	14.7	9.8	6.4	11.7	9.7	9.1	9.1	14.9	8.9	4.3	5.1	6.2	5.6	6.9	10.5	3.9	5.2	8.0	10.4	7.6	6.1	12.4	4.3	5.4	7.5	6.5	3.5	7.9	6.8	5.4	12.5	7.0	4.3	3.3	4.8	11.5	5.2	8.6	8.1	1.9	4.4	2.4	2.3	1.8	2.1	2.2	1.7	1.1	3.0	2.3	1.9	6.1	1.9	5.6	3.0	1.9	0.9	7.0	5.9	21.4	10.3	8.2	3.3	3.0	3.9	4.2	0.9	4.0	9.4	16.0	12.8	25.9	54.5	19.3	25.5	16.5	11.6	19.9	53.3	19.6	9.3	17.4	14.3	21.5	40.5	70.9	10.5	19.9	24.9	1.9	16.7	270.0	23.9	22.2	18.7	24.6	5.0	109.3	18.3	7.9	18.5	26.5	28.1	24.1	18.2	15.7	17.7	21.4	63.9	103.6	27.4	4.1	20.6	19.4	203.9	18.6	21.0	10.6	39.4	27.5	18.3	37.0	48.2	62.5	25.3	15.5	23.0	20.6	18.7	21.0	10.6	24.3	52.2	6.6	31.1	20.7	46.0	35.3	24.6	38.8	8.9	26.8	17.2	22.0	19.6
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8 subunit of CORVET complex"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	10.9	9.6	18.7	10.0	22.1	23.2	10.6	24.2	24.0	12.7	29.1	11.4	8.3	12.3	16.3	10.1	9.0	11.1	19.6	20.4	23.6	10.6	8.5	10.7	10.5	25.1	21.4	14.3	8.9	15.8	16.3	12.1	26.3	10.9	14.7	16.4	7.9	10.1	28.6	12.9	9.3	12.9	17.1	13.3	13.0	16.9	26.1	11.6	14.9	15.3	10.7	10.4	10.3	36.4	18.0	10.7	15.9	15.9	32.5	28.8	10.6	17.7	18.8	12.3	17.0	13.6	9.0	19.1	29.3	26.9	50.4	20.8	17.3	21.0	23.6	34.8	15.4	20.4	13.0	8.1	20.0	14.3	27.0	20.6	19.4	17.6	17.5	22.6	31.4	17.7	10.9	13.5	22.7	12.8	11.6	8.5	10.5	18.4	10.1	14.1	30.6	15.0	12.2	30.8	16.2	10.6	19.9	20.8	15.6	23.6	33.2	7.5	27.9	18.8	10.5	19.6	15.3	16.5	21.5	25.9	21.6	17.7	15.5	19.0	6.6	22.9	5.0	5.2	4.9	4.4	5.4	5.2	8.1	5.5	8.0	5.4	23.9	5.7	6.6	2.3	4.8	4.3	18.7	22.1	24.2	24.0	20.4	23.6	25.1	21.4	26.3	17.1	26.1	36.4	11.8	12.8	11.5	66.3	17.9	10.5	9.2	8.3	11.4	24.5	8.7	8.3	24.6	11.5	9.7	9.2	18.8	12.8	10.8	17.3	7.9	7.7	22.2	11.0	17.5	12.8	18.0	11.6	154.1	4.6	6.7	14.7	21.9	14.3	2.5	124.3	12.5	7.7	20.2	11.8	132.2	16.6	12.2	19.1	16.7	16.5	10.5	21.2	10.6	89.9	32.0	10.1	32.0	86.5	149.2	6.4	12.7	12.8	14.4	9.4	9.2	8.8	14.4	17.3	6.6	13.0	10.0	94.3	27.8	15.8	16.1	7.7	17.8	11.8	13.2	13.0
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720898	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2;Inhibitory neurons: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 18.0"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 18.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	12.9	26.9	23.8	16.2	26.3	13.2	10.5	15.8	39.2	13.2	16.5	14.6	13.5	11.0	4.4	33.3	12.0	7.4	15.8	25.4	19.3	23.1	30.4	16.1	9.3	25.4	19.5	10.8	12.6	12.5	31.6	5.4	25.7	15.3	3.8	5.7	15.3	6.1	11.6	12.7	17.2	4.9	15.4	29.1	12.8	18.8	21.3	3.5	17.3	5.5	5.1	11.2	15.9	23.6	6.2	9.3	10.2	10.8	10.2	9.9	8.5	11.3	11.7	9.6	4.7	8.0	13.6	6.3	7.1	12.6	5.4	14.1	0.9	6.4	2.7	5.7	15.0	4.5	8.7	10.0	7.7	2.6	10.5	10.9	5.8	11.6	2.7	15.5	6.7	5.8	11.5	3.8	6.5	28.1	4.8	10.0	3.8	4.9	10.4	11.8	8.5	3.8	7.7	9.8	8.4	8.8	14.5	5.3	11.6	3.1	24.0	11.0	10.5	12.4	15.5	10.2	6.9	17.4	5.9	5.4	18.0	6.8	10.6	2.2	0.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.3	0.4	0.4	0.2	18.0	0.2	0.3	0.0	0.2	0.2	23.8	26.3	15.8	39.2	25.4	19.3	25.4	19.5	25.7	15.4	21.3	23.6	3.5	6.4	5.1	30.0	3.6	2.0	2.0	5.4	5.7	13.3	6.5	5.5	8.8	2.8	6.4	9.2	10.4	3.0	6.1	11.6	7.9	4.9	13.5	5.8	6.8	3.1	10.8	1.7	43.2	7.8	2.3	5.3	8.2	9.3	4.5	8.7	9.7	9.6	4.8	8.4	41.9	3.9	2.0	8.5	8.3	21.7	6.2	12.6	3.6	4.7	3.7	6.6	3.1	16.1	17.5	6.2	5.1	6.0	3.9	1.8	13.5	6.1	4.6	12.8	0.0	5.2	5.8	12.3	4.7	7.5	3.8	3.0	4.5	8.6	7.2	2.8
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VRK2		ENSG00000028116	"VRK serine/threonine kinase 2"	Q86Y07	2	57907629-58159920	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 540.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	14.8	13.2	14.9	20.2	26.4	18.8	17.2	15.1	16.2	10.8	9.3	14.0	10.9	15.3	16.7	19.5	13.4	11.9	15.6	12.8	16.0	10.7	16.8	15.9	22.5	23.9	21.1	10.7	19.7	14.7	7.6	14.6	23.0	14.2	16.4	4.8	13.8	11.4	14.3	13.3	11.0	19.4	14.8	18.0	13.7	13.3	18.9	12.7	18.6	15.1	26.0	14.7	12.6	40.6	37.1	24.3	2.7	16.3	16.7	30.6	48.4	32.8	33.3	22.7	22.9	49.8	38.5	44.3	43.0	29.8	37.1	27.4	34.9	36.7	33.7	80.9	23.1	50.9	19.0	35.8	27.8	44.1	29.0	17.7	42.6	36.3	52.8	26.1	64.9	6.2	50.2	28.5	38.2	21.2	0.3	32.9	29.9	56.9	11.6	49.4	12.0	30.6	36.8	30.2	9.4	0.3	52.5	31.2	27.5	26.2	22.0	26.1	37.0	0.5	74.4	20.6	0.6	40.5	33.9	24.0	18.2	52.7	38.4	31.0	24.5	35.3	15.1	32.2	18.4	30.6	14.2	17.7	25.5	31.7	10.6	13.6	9.0	18.7	34.3	26.4	18.5	15.4	14.9	26.4	15.1	16.2	12.8	16.0	23.9	21.1	23.0	14.8	18.9	40.6	17.9	22.4	11.2	1.3	26.4	9.8	12.6	21.8	14.8	1.0	14.0	10.2	21.8	7.2	22.4	18.4	0.0	21.2	13.7	6.5	15.6	27.1	23.0	12.7	10.9	15.8	6.6	39.1	2.7	26.2	21.1	14.0	16.3	12.7	17.7	9.6	8.9	8.4	18.4	0.0	4.7	5.1	30.5	19.1	19.1	8.4	5.9	26.2	10.6	54.4	41.7	5.3	16.5	32.2	540.8	24.8	8.7	6.0	25.7	18.4	2.5	9.5	30.7	4.0	6.6	7.4	14.3	22.0	10.9	19.2	8.4	19.4	16.5	6.8	7.9	16.4
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 2.7"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 50.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0
VSIG1	"GPA34, MGC44287"	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 193.6"	"Cell type enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 333.8"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 12.0;T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 4: Stomach - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.0	0.1	0.1	1.3	0.3	0.5	0.1	0.2	0.3	0.0	0.2	0.2	1.2	0.1	0.3	0.2	0.0	8.4	0.0	0.2	0.2	0.1	0.1	1.0	1.9	0.1	0.1	0.0	0.2	0.0	2.6	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.5	0.0	0.0	0.8	193.6	47.7	0.1	0.8	0.1	0.0	1.6	8.9	0.1	0.1	0.1	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	1.1	0.0	7.4	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.6	2.3	0.2	0.0	0.0	0.3	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	1.0	0.0	3.8	2.8	8.1	3.6	0.0	1.3	12.0	5.8	0.3	0.1	0.1	0.1	12.9	2.6	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	25.6	11.0	1.0	2.4	0.6	0.9	0.7	0.0	0.9	0.2	0.1	0.5	1.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	2.9	6.1	1.1	0.1	1.0	0.0	0.0	4.1	4.6	0.0	0.6	333.8	0.2	2.5	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.4	10.8	0.6	0.7	0.0	0.0	0.3	0.1	1.0	0.0	0.1	32.9	0.0	0.0	1.0	0.6	0.0	0.0	0.9	0.8	0.0	1.1	0.2	1.0	0.6	0.0	0.0	0.1	4.5	0.2	0.1	3.8
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.3;Proximal enterocytes: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA062022: AB_2732675"	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	6.1	11.3	4.5	2.3	5.5	0.8	6.0	5.4	4.6	6.8	4.8	13.3	13.9	4.3	3.1	8.7	4.7	3.8	3.8	3.9	4.5	6.2	5.7	8.4	1.5	6.0	4.9	6.4	7.1	8.1	4.4	8.6	4.9	5.9	15.8	1.9	7.0	5.2	17.0	5.6	24.5	3.2	5.4	3.9	6.5	2.6	5.3	0.9	12.1	10.8	2.1	5.9	6.9	4.8	7.9	11.4	4.8	16.1	19.4	8.8	12.4	13.3	8.5	6.4	5.3	3.3	18.2	1.1	5.3	9.8	12.0	18.9	33.8	3.4	7.6	4.0	5.1	1.8	11.0	5.0	3.9	1.1	2.7	4.0	9.8	4.9	3.1	18.6	14.2	3.8	2.3	0.1	6.1	8.3	0.0	1.1	14.9	22.8	7.5	2.8	13.2	0.0	9.4	25.1	4.1	5.3	13.0	5.4	3.4	10.2	11.9	5.3	16.8	7.4	4.7	9.2	6.8	0.1	0.1	0.1	10.7	5.5	15.0	0.2	0.5	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.6	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.1	4.5	5.5	5.4	4.6	3.9	4.5	6.0	4.9	4.9	5.4	5.3	4.8	23.6	19.2	28.6	14.0	3.3	2.4	13.0	1.8	6.8	9.9	15.1	11.7	11.4	31.5	5.0	29.5	12.5	38.0	2.2	69.3	19.6	26.2	6.1	10.3	13.0	19.1	50.4	9.9	4.7	20.3	41.0	11.9	16.8	13.6	2.5	33.3	21.0	27.5	11.2	5.0	5.1	40.4	2.0	6.7	9.4	9.9	18.0	5.6	3.6	3.7	7.4	18.9	2.1	9.0	3.1	26.7	45.3	14.7	3.1	10.4	106.6	13.7	2.7	7.9	0.0	12.9	8.6	4.0	6.1	12.4	3.1	14.0	4.0	24.7	48.2	15.3
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 20.3;esophagus: 62.3;salivary gland: 23.5;vagina: 22.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1;Melanocytes: 5.4;Sertoli cells: 6.6;Squamous epithelial cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 4.7;OE19: 11.0;T-47d: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.2	0.1	0.1	0.0	0.4	0.1	0.8	0.8	0.5	20.3	0.0	0.1	0.0	0.0	0.0	62.3	0.1	0.3	0.1	0.1	0.7	0.1	0.7	0.1	0.1	0.5	1.0	0.2	0.0	0.0	0.1	0.0	0.8	1.2	0.0	0.0	23.5	0.1	0.1	10.6	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.0	6.3	0.2	22.3	0.7	0.0	0.9	0.0	0.3	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.2	4.7	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.4	1.3	0.0	0.4	0.0	0.1	0.6	11.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	8.4	0.0	0.0	0.0	0.1	0.7	0.0	1.1	0.7	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.5	0.1	0.7	0.5	1.0	0.8	0.1	0.6	0.7	1.2	0.0	0.5	1.3	0.8	0.6	1.1	0.6	1.8	1.6	2.2	1.8	0.9	0.0	0.1	0.0	0.0	0.4	0.2	0.9	0.0	1.1	0.2	0.0	0.3	0.5	1.2	0.0	0.6	0.0	0.9	1.6	1.1	0.2	1.3	1.0	1.4	1.2	4.5	10.1	1.0	0.5	0.0	3.2	0.9	0.7	2.1	2.4	5.4	1.0	1.1	1.4	0.0	0.0	0.9	0.4	1.3	4.1	0.1	1.0	1.6	0.9	0.0	0.6	6.6	1.5	1.2	0.5	2.6	6.1	0.4	0.5	0.4	2.2	0.7	0.7
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747474-124752255	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"stomach 1: 619.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 87.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"OE19: 429.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	6.5	0.8	3.1	7.0	6.4	3.4	9.5	0.8	7.1	29.7	0.2	136.2	6.2	4.9	0.4	26.4	17.5	26.5	5.3	2.8	1.5	6.3	3.0	45.7	0.9	1.7	3.6	1.1	2.0	1.9	1.7	6.0	2.0	58.2	137.8	0.6	31.8	4.3	2.3	1.5	2.8	4.7	1.1	1.6	619.2	0.9	3.1	0.2	43.7	2.5	2.5	84.5	9.3	3.6	0.4	0.1	4.8	3.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	1.5	2.4	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3	16.6	0.0	7.9	0.7	0.5	3.0	0.1	0.0	0.0	0.0	0.3	2.8	0.3	0.3	0.6	0.0	1.6	0.1	0.1	0.6	429.0	3.7	0.4	3.6	0.1	0.1	69.2	0.3	0.9	0.1	4.6	0.0	0.7	0.4	2.4	4.1	1.8	1.1	0.3	0.8	0.3	0.0	0.0	0.6	1.7	0.9	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.4	0.0	0.6	0.4	0.1	0.3	0.2	0.0	0.7	0.9	3.1	6.4	0.8	7.1	2.8	1.5	1.7	3.6	2.0	1.1	3.1	3.6	4.6	125.0	51.6	0.0	1.5	0.8	19.2	25.3	2.8	1.5	31.5	18.4	0.7	82.9	99.3	3.7	0.0	0.0	0.6	514.3	1.9	14.6	0.0	12.1	1.8	5.0	66.8	0.0	0.2	90.9	0.1	0.9	623.4	18.3	1.3	0.1	3.9	0.2	0.1	0.0	0.1	285.6	20.3	0.3	2.7	0.0	1.5	2.4	3.6	1.0	0.0	0.0	0.0	0.0	0.1	260.2	509.9	0.0	0.7	61.6	1.3	0.1	36.7	0.0	0.0	0.3	6.2	0.2	0.7	0.7	0.4	0.0	2.2	0.3	207.0	285.3
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4"	"Cancer enriched"	"Detected in all"	5	"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	31	"dendritic cells: 17.8;monocytes: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		59000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	137.1	68.8	17.9	44.2	18.8	7.8	44.2	17.0	36.6	14.1	21.5	40.9	22.5	15.5	5.3	15.4	66.8	39.6	30.0	18.2	18.3	17.9	51.0	166.0	27.8	25.1	23.6	12.9	14.3	6.8	7.0	139.6	25.8	10.6	31.7	2.2	24.5	9.3	8.2	10.8	43.9	108.3	18.9	69.3	22.9	7.3	37.6	5.4	12.3	12.5	1.8	61.5	11.6	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	18.7	0.1	0.0	11.1	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.5	0.0	0.4	0.1	0.0	5.6	17.9	18.8	17.0	36.6	18.2	18.3	25.1	23.6	25.8	18.9	37.6	26.7	1.3	3.2	16.1	0.0	1.2	2.3	0.3	0.0	0.0	0.0	2.6	0.5	1.8	7.2	3.1	0.0	0.0	5.3	0.3	0.0	0.0	0.1	7.9	0.0	0.0	10.4	0.0	0.0	0.0	0.0	4.9	2.7	0.0	0.0	3.8	0.0	5.0	3.2	989.8	0.0	0.0	0.0	0.0	590.9	111.8	16.6	1.5	328.4	3.6	12.2	1.5	0.5	0.0	0.5	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	4.4	0.0	6.6	0.6	2.0	0.3	0.9	0.5	1.7	12.3	1.5	0.0	0.0	0.2
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 25.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 11.2;Collecting duct cells: 5.5;Gastric mucus-secreting cells: 5.1;Suprabasal keratinocytes: 4.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA023219	Uncertain					NA	NA		650000		"Cluster 61: Skin - Cornification"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.6	0.1	0.5	0.1	0.5	0.0	0.1	2.0	0.3	3.4	1.8	0.1	0.1	0.1	0.0	4.0	1.3	0.1	0.2	0.2	0.0	5.5	0.0	0.5	0.1	1.4	0.8	0.8	0.1	0.0	0.2	0.1	1.4	0.1	0.0	0.0	5.5	0.0	0.1	25.6	0.1	0.0	0.6	0.2	0.1	0.4	0.1	0.4	0.2	0.0	6.5	0.1	3.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	2.0	0.3	0.2	0.0	1.4	0.8	1.4	0.6	0.1	0.4	0.5	0.0	0.0	0.0	0.1	11.2	0.7	0.2	1.2	2.6	0.5	0.4	0.2	1.5	0.3	5.5	0.0	0.2	0.6	0.6	0.0	0.1	0.6	1.7	0.8	0.5	3.6	0.0	0.0	0.0	0.2	0.9	5.1	0.9	0.0	2.3	0.4	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.9	0.2	0.6	0.4	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.8	2.1	0.1	2.2	0.4	0.0	0.9	0.6	0.5	0.0	1.8	4.5	0.1	1.1	1.1	1.1	0.8
VSTM2L	"C20orf102, dJ1118M15.2"	ENSG00000132821	"V-set and transmembrane domain containing 2 like"	Q96N03	20	37903111-37945350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0;heart muscle: 81.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 25.2;Cholangiocytes: 61.5;Club cells: 28.7;Inhibitory neurons: 44.0;Respiratory ciliated cells: 83.0"	"Group enriched"	"Detected in all"	5	"lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 67.2;HDLM-2: 98.8;hTCEpi: 23.4;SH-SY5Y: 22.5;SK-BR-3: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043832	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA043832: AB_10968449"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (8.14e-4)"	0.7	6.1	33.9	0.8	33.8	0.0	0.5	1.3	76.9	12.5	0.0	3.2	1.2	1.7	9.7	1.0	15.5	17.5	81.8	87.0	38.7	1.4	3.0	11.5	0.4	19.1	36.5	0.3	2.6	0.0	17.3	0.8	10.6	9.2	0.4	3.0	7.3	16.2	1.1	1.0	1.2	0.8	41.8	29.6	7.9	4.9	45.9	3.0	1.7	0.0	1.0	0.7	0.6	20.0	0.0	0.8	7.7	0.3	0.3	0.4	0.2	0.9	0.0	0.0	0.0	0.3	67.2	0.0	0.4	0.6	0.3	0.2	0.1	3.2	0.0	98.8	1.9	0.1	0.1	0.0	3.6	0.1	2.5	3.2	23.4	0.1	0.7	2.4	0.0	0.1	0.0	0.0	8.4	0.0	0.1	0.1	0.2	2.3	20.1	0.0	0.0	0.3	0.1	0.0	2.6	22.5	2.7	81.0	0.8	0.0	0.4	0.0	4.6	0.0	0.6	0.2	1.5	0.2	0.1	0.0	0.5	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	33.8	1.3	76.9	87.0	38.7	19.1	36.5	10.6	41.8	45.9	20.0	0.1	6.4	1.8	2.0	0.1	0.4	1.2	10.7	1.8	8.5	1.0	0.0	25.2	61.5	28.7	0.0	8.4	0.6	1.3	0.2	0.0	3.7	0.4	0.1	0.5	0.3	18.6	0.0	17.8	0.2	0.2	1.8	4.1	0.0	0.0	1.5	2.9	1.3	0.0	13.5	44.0	1.2	10.2	0.8	1.5	0.9	5.3	0.9	0.0	1.9	0.0	0.9	0.0	3.0	3.2	7.9	2.6	16.1	0.1	5.3	0.1	1.0	83.0	4.6	0.0	0.0	2.9	0.2	0.8	0.1	0.6	0.1	1.2	3.5	0.2	0.7
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014236-49115522	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	18.7	41.5	7.1	3.2	9.0	0.3	9.8	8.0	6.6	22.3	7.7	7.8	2.5	12.3	7.4	7.8	8.5	10.5	12.3	6.2	7.6	12.3	3.9	10.9	3.5	8.9	9.3	35.2	1.5	26.8	5.1	10.4	9.2	13.5	5.6	2.3	3.4	11.7	5.6	4.9	4.9	11.4	8.6	2.3	5.6	9.4	8.4	6.5	27.8	5.9	4.6	12.0	7.5	9.4	0.0	0.0	3.1	0.1	1.3	0.7	0.1	2.6	4.1	0.9	0.2	0.0	0.1	0.1	0.1	6.1	3.4	0.1	0.2	0.0	0.4	3.2	1.4	0.2	0.1	0.1	0.1	0.1	0.0	4.7	0.0	4.2	0.0	0.0	0.0	0.8	8.6	0.1	0.8	0.1	0.0	0.2	0.6	0.0	0.0	0.0	9.3	5.0	0.0	0.1	0.1	7.9	0.1	0.0	0.0	0.4	0.1	0.3	0.0	10.6	1.2	24.0	0.1	0.0	6.8	0.0	11.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.3	0.1	0.1	0.0	0.0	7.1	9.0	8.0	6.6	6.2	7.6	8.9	9.3	9.2	8.6	8.4	9.4	9.4	3.2	17.5	17.3	1.3	6.5	1.6	0.1	0.6	5.4	1.2	1.1	16.7	0.0	9.4	0.0	2.1	0.4	3.7	0.2	1.9	0.1	88.5	0.8	10.7	6.2	0.0	0.0	11.1	0.0	0.3	29.7	0.0	0.7	12.6	96.9	5.3	5.0	0.7	5.0	7.0	0.0	0.0	2.2	11.1	140.6	9.6	2.9	7.2	4.7	1.0	9.1	2.1	20.1	33.3	0.2	0.1	14.7	0.7	0.8	0.0	9.4	3.8	2.9	59.2	20.6	37.7	1.3	4.4	0.4	4.3	0.4	2.0	44.7	0.0	0.7
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
VSX2	"CHX10, HOX10, RET1"	ENSG00000119614	"Visual system homeobox 2"	P58304	14	74239449-74262738	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"retina: 73.6"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 152.4;Muller glia cells: 86.0"	"Cancer enriched"	"Detected in single"	34	"testis cancer: 2.5"	"Region enhanced"	"Detected in some"		"pons: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"midbrain: 1.3;pons and medulla: 1.7"	"Region enhanced"	"Detected in single"		"pons: 1.7"	HPA003436	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 56: Bipolar cells - Visual perception"			"HPA003436: AB_1078523"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"			"unprognostic (2.79e-1)"	"unprognostic (3.29e-1)"		"unprognostic (3.21e-4)"		"unprognostic (7.77e-2)"				"unprognostic (8.39e-4)"	"unprognostic (3.13e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	73.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.5	1.7	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	152.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	86.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 100.9;fallopian tube: 32.7;pancreas: 30.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA				"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	100.9	0.0	0.0	15.3	0.0	0.0	0.4	4.5	5.0	0.4	32.7	5.0	0.2	0.0	0.0	17.3	1.1	0.7	0.0	0.0	0.0	0.1	30.1	0.0	0.1	0.8	0.0	3.0	0.0	0.0	22.1	7.8	0.2	2.8	0.0	0.1	0.0	0.0	3.6	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
VTI1A	"MVti1, Vti1-rp2"	ENSG00000151532	"Vesicle transport through interaction with t-SNAREs 1A"	Q96AJ9	10	112446998-112818744	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054108	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Vesicles"		"HPA054108: AB_2682382"	"unprognostic (9.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic favorable (7.27e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-1)"	6.6	4.7	3.7	7.0	3.7	13.8	4.7	2.3	4.7	3.5	1.1	6.4	7.2	3.8	4.9	7.3	3.2	4.6	5.8	4.8	2.6	6.8	4.7	5.1	7.7	2.8	3.7	3.1	3.9	7.5	2.6	4.0	3.5	4.7	7.5	4.2	5.2	4.8	7.4	5.9	7.2	5.7	1.8	5.6	5.5	4.5	4.3	8.6	6.3	6.1	9.4	5.2	4.4	4.6	13.5	11.2	10.1	14.1	15.5	13.4	6.1	14.1	17.4	11.0	12.2	12.7	13.6	14.0	5.3	16.0	9.3	15.6	8.8	11.2	14.9	18.0	8.1	11.9	8.1	13.3	11.0	16.8	16.8	10.4	13.9	12.6	25.9	12.4	11.9	14.1	11.3	16.9	14.8	9.5	13.3	12.8	4.4	10.5	6.5	13.9	14.6	6.2	11.5	11.9	4.6	9.0	10.0	8.6	9.5	8.4	7.8	9.3	17.0	8.7	7.4	10.8	15.8	7.4	11.0	15.9	14.2	15.3	8.6	9.2	7.0	9.6	5.4	9.3	5.1	5.5	4.5	4.4	5.2	4.6	4.3	4.4	11.4	5.7	8.7	4.9	7.2	4.6	3.7	3.7	2.3	4.7	4.8	2.6	2.8	3.7	3.5	1.8	4.3	4.6	13.5	12.8	10.3	135.2	33.1	11.2	14.5	8.8	13.6	16.5	7.8	4.6	14.0	7.2	11.6	5.5	43.8	7.6	31.5	17.0	7.9	15.4	42.9	11.4	15.5	13.6	18.5	18.1	244.7	25.0	12.3	12.9	21.9	17.0	19.6	10.2	8.9	8.1	18.8	21.9	199.5	10.7	14.2	17.0	27.0	102.8	6.8	20.9	12.4	195.8	19.0	6.0	25.7	172.4	218.6	29.7	12.2	5.7	23.9	12.6	17.2	9.4	11.7	20.7	0.0	13.5	14.1	11.1	9.2	17.0	16.3	14.4	25.4	9.7	12.1	19.7
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647085-67674820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	53.8	26.9	55.5	20.4	56.8	22.3	39.8	54.4	102.1	22.7	49.8	42.9	28.3	18.4	53.5	44.3	18.5	28.7	60.1	56.6	58.1	53.0	41.6	26.8	23.8	55.1	56.6	21.0	44.0	23.9	17.1	21.3	56.8	22.3	35.2	23.0	30.1	13.6	46.5	31.0	24.1	22.4	56.0	26.5	40.0	30.8	56.3	12.1	34.0	28.2	27.0	33.3	23.4	56.9	111.7	54.8	31.4	18.1	61.9	37.2	45.4	48.1	30.5	23.8	23.7	27.3	38.5	32.9	40.2	54.5	27.5	30.6	36.8	36.6	37.7	34.3	22.6	33.4	32.5	34.8	26.6	20.9	22.9	36.3	39.6	25.6	26.1	60.5	27.2	23.1	22.2	25.4	34.5	131.1	26.6	77.7	20.3	76.6	88.0	31.8	35.6	12.2	35.1	65.0	17.4	35.5	33.8	45.5	71.4	23.7	41.9	58.0	38.5	62.6	93.8	51.4	45.6	23.8	27.8	53.2	52.9	38.9	29.0	88.8	61.5	143.8	49.4	80.4	42.4	49.0	43.1	51.1	59.6	43.0	40.5	50.3	27.2	56.4	70.2	38.6	60.2	58.3	55.5	56.8	54.4	102.1	56.6	58.1	55.1	56.6	56.8	56.0	56.3	56.9	47.6	25.6	35.0	13.1	48.7	42.3	61.4	91.7	33.0	23.2	82.2	65.4	30.5	67.2	64.4	66.2	22.9	107.4	47.5	138.2	217.2	109.1	141.7	58.5	43.2	51.5	46.6	102.7	15.8	131.4	167.9	51.6	40.8	49.5	64.0	43.6	73.9	95.3	131.4	15.2	18.2	96.0	50.8	99.8	49.2	493.5	41.7	80.9	71.2	11.2	121.6	65.4	78.2	13.6	17.1	130.7	119.4	39.9	51.0	120.5	165.4	268.6	55.3	44.8	19.7	36.5	58.2	104.5	57.2	58.2	52.8	125.9	46.8	35.5	91.9	124.6
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6039.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 5507.4"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"CACO-2: 1748.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	6.2	98.9	2.4	2.5	2.7	0.3	0.9	5.4	3.7	1.0	0.4	0.9	4.6	1.4	0.9	0.5	2.2	61.2	53.1	2.5	2.8	3.6	6039.5	1.8	4.3	2.1	5.3	1.9	17.7	0.1	3.0	40.6	2.3	1.2	0.3	47.4	0.6	4.3	0.4	0.8	1.3	2.7	1.5	2.9	5.1	10.0	2.2	0.1	0.8	0.5	0.4	4.2	0.7	2.4	0.0	28.4	0.7	0.4	0.2	0.3	7.3	1.8	0.8	0.9	0.9	1748.9	0.1	1.2	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.2	0.2	1.2	1.1	86.7	2.5	6.1	0.5	0.4	0.0	0.6	0.0	3.9	0.1	0.0	1.6	0.3	0.2	0.7	0.2	0.0	0.8	0.4	0.1	0.4	3.5	0.1	0.3	0.0	1.0	1.4	115.6	8.0	0.2	4.3	0.3	0.0	1.0	0.4	0.3	0.1	0.2	1.0	0.5	1.4	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.4	2.7	5.4	3.7	2.5	2.8	2.1	5.3	2.3	1.5	2.2	2.4	0.1	0.0	1.1	2.0	21.5	0.0	0.0	0.0	0.0	13.0	0.1	0.1	18.1	1162.4	0.0	0.0	77.2	3.7	0.0	0.0	3.9	16.8	0.0	0.0	1.2	7.3	0.0	131.0	0.9	19.7	2.8	48.1	0.0	0.0	0.0	1.8	120.3	5507.4	4.7	38.7	1.0	0.1	0.0	160.3	0.3	0.2	0.0	0.3	0.0	0.0	20.1	6.9	0.0	1.0	0.5	23.5	1.2	1.5	0.0	0.0	0.1	9.5	0.0	38.3	0.0	0.4	1.5	4.2	0.6	0.0	0.0	9.6	9.0	0.7	0.0	0.0
VWA2	"AMACO, CCSP-2, FLJ16213, FLJ45857, NET42"	ENSG00000165816	"Von Willebrand factor A domain containing 2"	Q5GFL6	10	114239254-114294489	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 8.4"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 6.8;Early spermatids: 9.6;Gastric mucus-secreting cells: 5.1;Late spermatids: 15.8;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 5.7;HaCaT: 3.0;SCLC-21H: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037847	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA037847: AB_10670961"	"unprognostic (6.03e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.14e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.22e-1)"	0.5	0.0	2.7	0.4	1.6	0.5	3.1	2.2	1.6	4.0	0.3	1.3	1.6	0.9	1.0	1.2	6.4	0.2	0.0	1.4	1.3	0.5	0.0	3.3	0.2	1.9	1.7	0.1	2.3	0.2	0.3	0.4	1.8	5.4	1.0	0.3	4.5	1.0	0.3	6.4	1.4	0.1	1.7	1.4	8.4	1.1	2.1	3.4	0.8	0.2	0.5	0.7	0.9	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.3	0.0	0.0	3.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.7	1.6	2.2	1.6	1.4	1.3	1.9	1.7	1.8	1.7	2.1	1.5	0.4	0.0	0.0	0.0	0.0	0.3	4.1	2.8	6.8	0.0	1.1	0.3	0.5	0.0	1.7	1.8	0.0	1.3	0.0	0.1	0.0	2.1	9.6	0.7	0.1	0.2	0.0	0.0	4.1	1.6	0.0	0.1	5.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.4	2.0	0.0	0.0	15.8	0.3	0.0	0.0	16.9	0.0	0.0	0.0	2.5	0.1	2.2	0.2	0.0	0.0	2.0	0.6	0.1	0.6	0.0	0.0	0.2	0.1	0.8	0.3	1.1	0.0	0.7	0.0	0.1	0.5	1.3
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.2;choroid plexus: 53.0;fallopian tube: 39.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favorable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	0.3	0.3	9.6	0.0	11.9	0.4	0.3	4.1	13.2	11.0	53.0	0.3	0.1	2.5	0.1	0.1	39.7	0.0	0.8	7.8	6.5	0.5	0.1	8.8	0.1	21.0	28.2	0.5	0.3	0.1	16.6	0.1	13.3	0.4	0.1	0.3	0.1	0.1	0.1	1.9	0.3	0.1	15.1	0.3	0.2	8.2	10.1	0.1	0.5	0.2	0.2	0.1	0.1	10.9	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.9	4.1	13.2	7.8	6.5	21.0	28.2	13.3	15.1	10.1	10.9	0.3	0.0	1.1	25.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	45.6	0.3	0.0	0.0	0.0	33.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	15.2	0.3	0.2	0.0	3.7	0.0	0.0	0.0	4.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	88.0	0.0	0.0	0.0	1.2	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.3;testis: 30.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 467.1;Late spermatids: 995.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.1"	"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.7	0.6	5.0	0.1	0.0	0.2	0.0	0.0	22.3	0.0	0.0	1.3	1.5	0.1	0.0	2.5	0.0	7.0	5.8	0.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	30.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.9	0.7	1.3	1.5	7.0	5.8	3.7	4.8	1.2	2.7	0.3	0.0	1.1	11.8	0.1	0.3	1.7	2.2	0.0	1.0	0.1	0.3	0.9	0.0	12.1	1.8	31.3	0.0	0.0	0.8	0.0	0.0	467.1	53.8	0.6	0.6	1.8	0.0	1.9	0.4	0.2	0.8	4.6	1.6	0.0	0.1	1.1	0.0	0.2	0.0	1.0	2.8	6.1	0.0	0.8	995.9	4.7	0.7	0.0	3.7	0.6	0.7	0.0	1.5	0.7	0.2	2.7	5.7	0.2	0.4	0.2	0.0	124.5	0.5	0.0	0.5	1.0	17.6	6.0	0.0	0.4	0.0	0.1	0.2	1.0	0.8
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115404-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"granulocytes: 563.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 57.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	17.2	24.9	18.7	12.8	16.1	3.1	24.2	12.8	19.4	22.4	14.3	37.9	26.5	13.9	25.3	15.0	15.0	31.1	6.8	16.9	44.0	21.7	6.4	30.8	12.2	21.3	25.6	10.2	20.7	4.4	37.4	10.2	27.9	17.8	43.3	11.9	30.0	19.2	4.3	28.5	36.6	16.0	17.0	8.3	28.2	9.6	47.1	8.0	11.5	12.3	14.6	22.8	12.6	16.2	0.0	0.6	7.6	0.5	7.9	7.4	2.8	1.1	0.6	0.6	0.3	0.4	59.7	0.0	7.2	1.3	10.3	0.4	1.5	13.6	0.0	20.9	0.2	44.1	10.5	1.4	32.1	0.6	19.8	21.8	1.5	1.3	4.4	2.9	39.5	5.8	2.4	7.3	2.4	0.2	0.9	0.7	11.9	0.0	1.5	0.0	26.2	0.3	43.0	0.5	6.7	0.7	1.1	0.4	2.1	17.3	5.4	1.9	1.0	0.2	5.5	0.3	0.0	2.7	2.5	0.0	24.1	0.9	0.4	57.8	7.9	0.9	4.7	5.5	1.1	7.1	5.0	2.7	8.0	3.8	6.3	4.1	0.6	8.1	9.3	4.3	12.7	6.1	18.7	16.1	12.8	19.4	16.9	44.0	21.3	25.6	27.9	17.0	47.1	16.2	5.0	9.6	28.3	4.6	1.3	17.2	14.6	14.9	4.6	3.8	12.6	8.8	2.6	5.7	33.2	33.1	2.1	7.9	2.0	25.0	9.8	27.8	50.6	11.5	4.8	4.3	15.0	3.4	4.0	28.1	2.5	11.4	17.3	7.6	563.0	3.8	3.9	3.2	35.7	32.0	17.1	22.3	30.5	6.6	7.2	6.0	2.8	6.7	5.4	1.9	3.6	14.3	3.1	8.0	2.6	17.7	16.8	0.4	2.5	6.5	50.6	15.1	59.1	1.4	0.0	9.5	5.7	0.7	4.1	4.8	12.5	1.9	9.4	5.9	23.7	13.6
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;choroid plexus: 19.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 1.2"	"Low region specificity"	"Detected in many"							"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.1	0.1	0.0	19.1	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	1.1	2.9	1.3	0.0	0.1	0.1	3.7	6.3	0.0	0.0	1.1	2.9	0.1	5.1	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	3.0	0.0	0.2	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.1	0.1	1.1	2.9	3.7	6.3	5.1	1.5	3.0	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 40.7;brain: 16.4"	"Group enriched"	"Detected in some"	7	"Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9;pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 31.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.9"	"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.0	40.7	7.8	0.0	1.7	0.1	0.0	0.7	16.4	0.5	0.0	0.4	1.8	0.2	0.1	0.0	1.3	0.0	0.0	6.5	0.7	0.2	0.0	0.1	0.0	7.4	0.5	0.4	5.6	1.4	8.3	0.0	5.0	0.5	0.3	0.2	0.6	2.4	0.0	0.0	1.1	0.0	0.0	0.0	2.8	1.0	2.6	0.0	0.3	0.0	0.0	0.1	0.1	2.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.9	0.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.3	0.0	0.0	31.7	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.7	0.7	16.4	6.5	0.7	7.4	0.5	5.0	0.0	2.6	2.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	7.6	0.1	0.1	112.4	0.0	39.2	0.2	0.0	0.0	6.1	0.8	0.0	0.2	1.1	0.0	0.2	3.3	29.2	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	1.7	0.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777328	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 2.9;hypothalamus: 8.2;medulla oblongata: 5.9;pons: 5.5;thalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.0;pons and medulla: 3.9"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		9200	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	0.4	0.3	0.5	0.1	0.3	0.0	0.7	0.1	2.9	0.8	0.0	1.3	1.0	4.6	0.0	0.4	7.2	0.7	5.2	0.8	8.2	5.7	1.4	1.4	0.1	5.9	1.0	0.5	2.6	1.7	21.3	0.0	5.5	0.8	0.4	0.2	1.4	1.3	6.6	0.8	2.3	0.0	0.0	0.5	3.0	0.7	7.5	0.0	1.8	0.0	0.1	0.6	0.7	1.0	0.8	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.1	2.9	0.8	8.2	5.9	1.0	5.5	0.0	7.5	1.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	0.5	1.2	0.5	0.1	0.3	0.8	0.0	0.3	1.8	0.0	0.0	0.2	1.4	1.9	0.6	0.0	1.5	0.1	0.1	4.2	0.0	1.5	0.5	0.0	0.1	8.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.4	0.3	5.0	2.4	1.6	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.5	0.4
VWA8	KIAA0564	ENSG00000102763	"Von Willebrand factor A domain containing 8"	A3KMH1	13	41566835-41961120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.9;Excitatory neurons: 183.9;Inhibitory neurons: 252.6;Oligodendrocyte precursor cells: 151.3;Oligodendrocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039075, HPA045478"	Uncertain		Approved	"Vesicles,Lipid droplets"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Lipid droplets"		"HPA039075: AB_2676334, HPA045478: AB_2679341"	"unprognostic (9.93e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (6.38e-14)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.26e-1)"	8.0	7.8	5.1	3.7	6.8	5.7	8.7	9.5	5.6	9.2	14.3	6.8	7.1	7.2	5.5	5.7	6.4	5.3	13.7	2.9	5.0	17.6	21.6	4.9	4.5	5.5	6.4	6.3	7.3	14.6	3.8	5.0	6.2	6.1	7.5	15.1	7.7	5.8	29.3	4.1	5.4	6.0	4.0	3.7	6.6	4.1	7.9	7.7	7.1	35.1	4.4	6.2	3.8	5.1	5.2	7.6	7.6	10.5	7.0	10.2	7.1	8.2	12.0	7.3	5.8	10.0	8.2	13.8	5.4	7.2	5.9	18.3	7.1	20.0	9.1	15.6	12.3	13.1	7.0	12.7	7.5	17.3	1.7	12.0	12.2	7.0	16.7	9.9	7.4	10.8	12.7	9.6	6.5	7.0	9.8	8.9	11.4	13.6	7.0	0.1	4.8	14.5	19.7	18.8	4.7	10.0	10.2	15.9	11.4	8.3	6.6	13.2	6.6	5.5	5.8	7.1	7.8	9.7	9.9	21.4	6.1	8.2	7.3	0.6	0.4	0.0	1.1	0.4	1.6	0.7	0.6	1.0	0.9	1.0	0.8	1.2	0.2	1.6	0.6	0.5	0.4	0.8	5.1	6.8	9.5	5.6	2.9	5.0	5.5	6.4	6.2	4.0	7.9	5.1	7.5	16.0	2.6	161.9	9.2	4.0	16.5	8.2	9.6	10.7	13.1	5.7	45.5	11.5	10.4	5.5	35.5	7.6	7.3	7.5	1.9	3.7	35.4	10.1	7.6	5.3	3.0	12.0	183.9	1.6	2.1	6.2	15.8	14.4	0.0	5.8	2.2	16.5	3.9	3.3	252.6	7.8	4.1	3.8	4.0	14.2	5.9	11.5	5.4	69.3	4.1	4.9	4.1	151.3	146.1	4.0	9.3	5.3	18.2	16.0	9.4	8.2	6.7	42.6	0.0	7.6	8.9	5.5	4.8	12.5	2.8	2.9	10.4	8.5	9.4	11.9
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773638-49921950	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.9;heart muscle: 5.0;ovary: 4.9"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 361.7;Oligodendrocyte precursor cells: 163.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 8.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055243	Approved				"Secreted to extracellular matrix"	NA	NA		39000		"Cluster 21: Non-specific - Transcription"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055243: AB_2682755"	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.1	0.0	2.5	0.0	2.6	0.0	0.0	8.9	1.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	5.0	0.6	1.6	0.1	0.0	0.1	0.0	0.8	1.9	4.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.1	0.4	0.3	0.1	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.6	8.9	1.7	0.6	1.6	0.8	1.9	0.9	0.3	4.0	0.5	0.0	0.0	0.0	3.3	0.0	0.5	0.1	0.0	10.8	22.6	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	18.4	0.5	0.0	0.0	65.2	0.0	0.0	1.6	0.0	0.4	0.0	47.6	0.0	0.0	0.0	1.7	361.7	0.2	0.0	0.0	1.6	0.0	0.0	0.3	0.0	10.3	0.0	0.9	0.0	163.3	1.7	0.0	7.3	0.0	0.1	0.2	0.1	0.0	0.0	13.5	0.0	0.1	2.7	0.0	0.4	0.7	2.0	0.0	0.3	0.6	0.3	0.2
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing 2 like"	B2RUY7	2	214411054-214578976	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 2.7;retina: 1.4"	"Group enriched"	"Detected in some"	21	"Excitatory neurons: 67.4;Inhibitory neurons: 132.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044815: AB_10962359, HPA059414: AB_2684007"	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.2	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.1	2.1	2.7	2.2	0.8	1.8	1.8	0.2	2.3	1.8	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	132.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	4.5	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295316	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.3;ovary: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2200000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.8	1.1	0.6	0.1	0.9	1.6	1.5	0.3	1.6	2.9	0.0	0.6	0.3	1.3	0.6	0.9	3.5	0.6	0.8	0.7	0.7	0.5	14.3	0.3	0.2	0.5	1.2	7.9	0.3	0.1	0.6	2.4	0.4	1.0	0.4	0.8	0.9	0.5	0.7	0.7	0.4	0.4	0.0	0.4	0.4	1.8	0.5	2.5	0.8	0.4	0.1	0.6	1.2	0.2	0.0	0.1	1.5	0.2	0.2	1.8	0.6	0.2	2.0	0.0	0.3	7.2	0.0	0.5	0.0	0.4	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.8	0.0	26.3	1.2	0.0	0.3	13.4	0.6	0.7	0.0	0.1	2.3	3.3	0.2	0.3	0.3	0.1	5.5	0.0	2.2	0.0	0.0	14.0	0.2	0.0	0.1	0.1	0.6	1.0	0.0	0.1	0.7	2.4	0.9	0.0	0.8	0.3	0.3	0.5	0.2	0.2	0.6	1.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.3	1.6	0.7	0.7	0.5	1.2	0.4	0.0	0.5	0.2	2.1	3.2	1.7	19.2	0.3	1.8	1.8	3.8	3.4	3.6	1.7	0.5	1.0	1.5	2.3	0.0	29.2	1.0	0.5	0.2	0.0	0.1	0.5	2.9	1.0	5.5	1.8	6.1	7.5	0.5	5.0	2.6	0.0	1.8	3.8	6.5	2.5	16.4	1.2	0.0	5.8	0.1	2.0	3.5	2.4	0.8	6.8	2.6	1.8	2.8	2.3	2.3	1.0	2.5	1.4	0.0	0.0	1.9	0.4	1.1	0.1	0.3	5.4	21.1	0.0	0.9	1.1	1.1	3.4	1.3	2.3	4.4	0.9	7.7	0.3	0.7
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.3;salivary gland: 3.3;thyroid gland: 3.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.8;Excitatory neurons: 11.8;Granulosa cells: 5.4;Inhibitory neurons: 11.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 5.0;K-562: 13.0;NTERA-2: 4.8;SCLC-21H: 7.0"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044, HPA036045"	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA026619: AB_2671920, HPA036044: AB_2674916, HPA036045: "	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.0	0.3	0.5	0.1	0.8	2.3	1.6	0.0	0.5	0.1	0.0	0.3	0.1	0.4	4.3	0.1	1.1	0.4	2.0	0.4	0.3	0.2	0.1	0.2	0.1	0.4	0.4	0.0	0.0	0.3	0.4	0.1	0.3	1.1	0.1	0.0	3.3	1.6	0.0	0.4	0.1	0.1	0.5	0.1	0.7	0.2	0.3	0.1	3.1	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.0	1.2	0.0	0.2	2.4	0.0	1.5	0.5	0.7	0.3	2.4	0.1	0.0	0.0	0.9	0.7	1.7	1.6	1.1	2.7	2.4	3.4	5.0	0.0	0.0	1.9	1.5	0.1	0.2	0.0	1.1	2.4	1.0	1.3	13.0	0.0	0.0	1.6	0.0	0.0	4.8	0.0	0.8	0.0	0.0	1.1	0.4	1.2	7.0	1.5	0.0	1.4	0.0	1.7	0.0	0.8	0.1	0.0	0.9	0.0	1.5	2.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.5	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.1	0.1	0.0	1.5	0.3	0.0	0.3	2.1	0.9	2.8	0.0	1.6	1.0	8.8	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	1.2	0.7	0.2	0.2	0.0	3.0	11.8	0.0	0.5	1.1	0.0	1.8	0.0	5.4	0.0	0.0	0.1	0.0	11.6	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.2	0.0	0.0	2.9	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	0.4	0.7	0.1	0.1	0.7	0.4	0.5	1.8
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948877-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Adipocytes: 904.3;Endothelial cells: 737.5;Hepatic stellate cells: 424.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 76.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"HUVEC TERT2: 560.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	NA	NA	28300000000	5600000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	151.9	5.9	40.0	20.2	38.8	0.8	117.3	32.9	31.4	46.0	29.2	32.7	12.8	51.1	10.6	21.9	45.7	30.2	137.8	27.4	32.3	9.7	2.1	106.2	22.8	37.6	37.4	22.0	15.0	27.3	6.3	72.7	41.7	27.4	9.2	2.9	18.1	19.2	57.0	23.5	34.5	44.2	32.2	44.1	25.7	10.8	52.4	7.0	50.8	51.6	9.5	39.7	35.5	37.1	0.0	0.0	0.0	0.0	0.7	0.6	0.5	0.0	0.6	0.2	0.4	0.0	0.3	0.0	1.2	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	560.9	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.3	0.5	0.4	0.0	0.1	10.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	40.0	38.8	32.9	31.4	27.4	32.3	37.6	37.4	41.7	32.2	52.4	37.1	904.3	12.8	25.7	3.6	1.0	6.6	0.6	1.3	4.6	0.0	4.5	4.7	112.2	1.5	1.7	11.0	0.0	1.1	2.6	0.0	0.0	0.5	6.8	2.0	1.6	737.5	0.0	2.7	2.9	0.0	0.9	21.1	0.0	2.1	5.7	0.1	424.4	3.3	0.5	0.0	2.2	0.0	4.1	5.3	3.4	15.5	5.9	2.6	5.4	75.9	0.3	0.7	0.0	1.5	4.2	0.0	0.0	0.7	0.0	1.3	0.0	0.1	1.0	1.7	0.0	12.4	34.7	2.9	5.7	4.7	4.3	1.0	2.0	10.6	0.0	1.7
WAC	"BM-016, FLJ31290, MGC10753, PRO1741, Wwp4"	ENSG00000095787	"WW domain containing adaptor with coiled-coil"	Q9BTA9	10	28532493-28623112	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036528, HPA042609, HPA074604"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.27e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.36e-1)"	53.2	39.9	18.4	30.8	24.3	51.6	48.9	45.2	22.0	49.4	17.9	66.3	27.3	50.3	16.7	45.9	47.1	23.7	44.8	19.6	20.5	38.1	35.9	50.4	31.6	19.2	21.9	53.1	39.5	34.0	36.9	31.6	19.6	40.6	23.2	34.5	44.2	25.6	55.1	50.2	47.4	25.0	19.1	45.6	45.8	37.3	21.8	45.8	43.7	34.0	28.4	54.9	46.7	26.3	72.4	45.2	65.5	51.1	40.7	31.4	59.9	58.2	33.1	60.9	50.5	68.7	73.2	71.8	42.8	46.6	44.6	63.1	51.5	46.8	55.1	92.1	54.0	89.0	40.6	41.2	51.2	39.9	66.7	33.0	57.7	65.6	46.7	38.4	44.4	65.8	76.8	69.9	38.4	60.0	87.8	24.6	41.9	48.1	21.4	71.8	109.3	56.2	29.3	36.1	60.1	56.8	50.7	57.4	78.2	40.6	45.8	56.1	47.9	38.5	64.3	40.1	52.8	40.8	44.4	82.6	47.8	70.5	38.8	13.7	10.7	9.2	10.5	15.0	10.5	12.7	8.7	12.7	11.2	12.3	10.3	9.2	13.0	13.4	14.3	7.3	9.2	8.5	18.4	24.3	45.2	22.0	19.6	20.5	19.2	21.9	19.6	19.1	21.8	26.3	110.8	93.0	75.1	114.6	94.1	176.0	94.6	44.2	105.9	114.5	95.8	78.9	109.6	81.5	52.9	40.5	95.9	59.2	115.7	77.1	31.3	47.0	99.8	92.9	107.4	92.8	69.5	97.8	117.8	47.6	61.5	86.4	58.6	142.4	55.8	94.1	75.3	61.4	53.6	107.7	107.1	86.2	44.7	111.5	154.8	123.6	83.0	107.2	76.5	138.7	92.1	68.4	87.6	142.7	180.9	55.0	68.5	82.8	86.0	128.5	73.2	59.4	45.5	92.4	59.2	113.5	85.1	85.9	59.2	80.5	184.1	99.1	100.4	83.4	71.6	134.5
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WARS2	mtTrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140654	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	7.3	8.8	2.4	4.1	2.4	1.9	9.4	2.4	3.0	6.9	6.5	7.3	7.7	6.3	3.8	6.1	9.4	4.9	7.9	2.3	2.6	9.6	6.1	5.0	4.7	2.4	2.4	8.2	8.9	10.2	3.8	6.3	2.4	5.7	8.0	6.0	5.4	3.5	6.3	5.2	5.1	5.2	2.4	3.0	7.2	4.6	2.3	4.6	6.8	6.5	5.1	6.8	5.6	2.8	12.8	5.0	7.5	7.9	9.6	21.6	7.6	7.0	10.5	7.6	9.1	14.4	5.6	19.0	11.4	12.0	4.2	8.2	13.9	12.6	11.7	9.8	16.6	8.9	12.8	13.9	19.6	14.8	4.8	16.1	9.7	11.1	20.2	10.0	11.7	7.9	14.1	13.4	14.4	15.7	8.9	8.6	9.9	9.8	10.6	6.3	24.9	9.9	20.9	17.5	10.7	6.6	11.3	15.4	16.7	13.1	6.9	11.1	8.8	7.8	9.2	15.2	13.8	6.4	4.6	8.3	9.6	12.1	14.7	0.0	5.0	0.3	3.4	3.6	5.0	4.6	3.6	4.5	6.7	6.2	4.2	4.2	0.2	4.2	2.2	3.2	4.5	3.4	2.4	2.4	2.4	3.0	2.3	2.6	2.4	2.4	2.4	2.4	2.3	2.8	7.2	9.6	12.3	22.5	10.4	9.6	17.6	14.7	14.2	6.7	13.1	11.3	10.6	5.7	11.2	11.0	6.2	16.9	7.0	6.5	17.6	9.8	57.7	15.2	8.6	7.5	6.7	18.9	15.5	11.9	15.3	15.5	17.9	13.8	8.8	9.7	2.2	7.5	9.5	6.7	21.4	10.2	14.2	10.0	6.9	31.8	9.9	8.2	10.6	11.2	13.0	5.0	3.1	12.1	18.2	8.7	6.1	8.2	9.1	13.1	7.5	18.8	14.7	8.2	6.6	12.0	10.1	5.4	6.1	19.8	10.7	20.0	10.2	19.6	15.8	14.4
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"WASP actin nucleation promoting factor"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.4;lymphoid tissue: 83.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 37.4;monocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	10.2	5.2	6.3	52.2	5.8	58.4	4.4	5.9	8.1	3.3	6.3	6.4	8.0	2.8	3.0	3.5	5.6	6.9	3.5	6.0	8.0	4.4	7.2	19.1	54.2	11.1	8.2	1.8	2.4	1.4	2.9	9.0	8.6	4.2	5.0	0.4	4.9	2.8	1.4	2.8	23.0	6.1	8.0	83.0	7.0	1.9	8.6	42.0	3.5	3.4	36.2	10.3	3.0	10.8	0.8	0.2	0.4	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.9	76.5	0.3	0.0	0.3	2.0	0.3	0.2	0.0	44.2	0.4	67.6	0.9	0.0	0.8	34.9	157.0	0.3	0.1	0.1	0.0	0.0	0.0	40.3	0.7	45.7	0.0	7.6	70.8	75.7	0.4	1.1	0.4	61.1	0.3	94.0	0.1	0.0	0.5	0.9	1.0	0.7	0.5	0.2	0.4	68.8	0.5	0.1	0.4	1.2	0.1	83.1	43.6	53.7	0.5	87.4	0.2	3.3	7.6	37.4	4.6	8.4	3.4	3.0	3.5	3.9	5.7	3.3	3.1	3.5	29.2	3.6	9.5	3.1	5.4	4.0	6.3	5.8	5.9	8.1	6.0	8.0	11.1	8.2	8.6	8.0	8.6	10.8	1.5	3.2	14.3	0.7	83.2	2.4	0.2	0.2	2.2	0.2	1.1	1.8	1.1	0.0	0.1	0.0	0.0	0.9	91.7	0.3	1.9	0.4	0.6	0.4	0.4	2.6	1.2	14.1	0.3	0.4	1.1	1.5	5.6	0.3	48.1	0.2	3.9	1.6	111.5	0.0	0.3	0.2	0.0	110.7	54.5	1.1	0.0	118.1	3.6	4.7	88.2	0.2	84.5	0.5	0.0	0.1	0.1	0.0	57.8	0.2	0.1	1.8	1.6	0.2	0.0	1.0	1.3	1.3	1.1	0.8	1.4	1.4	99.3	0.4	0.1	0.2
WASF1	"KIAA0269, SCAR1, WAVE, WAVE1"	ENSG00000112290	"WASP family member 1"	Q92558	6	110099819-110180004	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.8;testis: 78.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Excitatory neurons: 220.2;Late spermatids: 476.1;Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 25.5;basal ganglia: 43.8;cerebral cortex: 82.8;hippocampal formation: 58.8;white matter: 36.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 3.3;naive B-cell: 4.2;plasmacytoid DC: 8.4"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;dendritic cells: 8.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004105, CAB022161"	Approved	Supported				NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB022161: , HPA004105: AB_1080583"	"unprognostic (8.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.82e-8)"	"unprognostic (9.20e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.38e-1)"	9.2	9.1	25.5	3.7	43.8	9.6	7.6	6.1	82.8	10.1	0.0	13.6	2.1	12.3	5.6	12.9	11.6	7.9	3.7	58.8	3.8	7.8	7.6	4.7	3.6	4.3	0.6	22.5	5.3	3.0	13.4	2.8	5.1	5.5	3.6	16.4	6.8	4.5	1.6	6.4	6.3	13.4	1.3	2.4	8.4	78.6	3.7	8.1	3.9	2.4	3.7	6.5	9.0	36.1	10.3	11.1	60.1	48.9	25.4	32.2	6.6	21.9	24.8	18.2	31.5	19.8	9.9	59.9	13.9	34.3	27.1	11.7	94.7	29.2	31.1	0.9	43.1	116.3	22.9	17.8	45.3	6.4	17.2	25.5	41.4	24.9	124.2	26.4	27.7	29.3	42.6	13.6	21.3	8.2	60.7	2.0	54.3	7.9	15.0	56.3	21.9	2.4	29.4	11.8	46.8	73.9	15.6	11.3	14.0	62.0	13.6	30.2	21.1	16.8	17.0	48.1	28.6	0.4	9.4	53.0	18.4	50.5	12.7	0.0	0.6	0.0	0.0	0.2	0.2	3.3	0.2	0.0	0.6	4.2	0.1	0.1	0.1	0.6	0.6	8.4	0.0	0.4	25.5	43.8	6.1	82.8	58.8	3.8	4.3	0.6	5.1	1.3	3.7	36.1	1.5	0.0	0.0	16.0	2.6	14.8	2.1	7.4	22.8	14.4	5.1	4.7	1.7	1.5	2.3	0.0	6.2	3.8	2.8	0.0	1.9	4.8	192.5	2.9	15.3	2.9	12.6	10.3	220.2	0.9	3.1	11.8	3.1	7.0	0.0	57.5	6.4	6.1	1.1	10.1	63.1	2.1	2.0	1.8	4.4	476.1	18.0	1.6	3.6	12.2	0.8	4.4	0.0	67.3	106.5	1.2	2.8	9.4	1.8	3.0	0.2	12.6	0.5	7.1	6.6	2.6	9.8	85.0	38.5	33.5	8.8	1.8	0.7	26.3	1.2	1.9
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WASP family member 2"	Q9Y6W5	1	27404230-27490167	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		84000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	55.2	34.1	37.9	44.1	48.1	59.8	45.8	42.3	36.3	41.3	29.5	49.4	27.5	53.8	21.6	89.8	46.3	31.1	32.9	33.4	39.5	28.4	14.9	45.7	48.1	58.9	49.0	63.5	35.2	31.0	17.0	52.3	53.6	33.1	39.3	9.1	38.3	41.9	18.4	56.7	42.3	51.9	48.2	47.6	40.3	36.8	48.4	54.6	35.5	27.8	52.3	47.8	39.9	50.6	75.4	35.3	80.3	73.4	57.1	74.3	46.5	59.9	55.5	64.7	57.9	30.8	79.2	52.1	56.6	94.4	44.1	58.8	65.5	98.4	77.1	73.3	41.1	113.5	60.5	36.7	76.9	91.9	62.8	68.5	105.1	70.7	130.8	70.0	82.3	56.8	92.3	26.3	89.0	27.1	68.7	42.1	64.9	38.3	53.7	141.8	98.5	53.3	46.3	42.0	39.9	43.8	104.6	46.3	78.3	48.6	38.7	55.1	109.1	53.4	54.8	112.1	47.8	53.6	76.0	67.7	63.0	111.2	61.3	50.0	65.4	54.7	33.3	79.8	27.2	37.8	26.3	23.5	41.7	46.6	26.9	21.2	100.7	24.4	112.7	60.5	28.8	58.6	37.9	48.1	42.3	36.3	33.4	39.5	58.9	49.0	53.6	48.2	48.4	50.6	243.0	67.3	57.5	58.1	112.7	148.1	221.8	245.9	104.2	24.4	143.0	201.9	39.6	75.8	144.1	90.1	14.6	219.2	145.1	147.0	62.6	111.0	51.4	86.6	167.7	194.8	108.5	195.1	19.1	101.7	118.9	157.9	85.1	174.2	58.9	77.7	163.5	48.4	151.2	20.2	12.8	101.9	93.6	250.4	129.2	75.9	165.0	162.7	76.5	93.7	207.6	61.2	142.2	29.1	67.1	164.9	131.8	182.4	74.2	281.7	139.1	50.7	104.4	19.2	138.1	206.1	180.6	120.7	118.1	216.3	194.5	143.5	104.5	79.3	120.3	372.5
WASF3	"KIAA0900, SCAR3, WAVE3"	ENSG00000132970	"WASP family member 3"	Q9UPY6	13	26557683-26688948	"Cancer-related genes, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.0;retina: 56.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.6;Early spermatids: 104.1;Horizontal cells: 82.4;Inhibitory neurons: 127.5;Oligodendrocyte precursor cells: 69.9"	"Cancer enhanced"	"Detected in all"		"glioma: 14.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037086, HPA066228"	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"CAB037086: AB_1080585, HPA066228: "	"unprognostic (1.42e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.19e-2)"	"unprognostic (8.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (8.86e-3)"	"unprognostic (2.93e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.18e-2)"	19.6	15.9	49.6	2.8	52.4	0.3	14.7	60.0	50.0	9.3	2.6	7.4	1.0	9.1	4.9	3.9	11.2	4.0	8.7	48.9	48.1	6.9	6.9	7.4	2.6	40.2	51.1	20.9	5.2	6.7	8.6	0.5	31.3	9.0	3.1	56.4	6.1	9.3	7.8	4.7	3.8	7.6	28.8	5.1	7.2	13.0	50.3	1.6	17.0	5.0	1.7	7.4	7.6	45.2	0.0	0.2	39.4	0.1	82.8	16.4	3.6	17.6	24.7	26.4	11.7	0.0	3.7	15.3	2.1	39.5	10.2	3.6	10.7	11.4	20.7	0.0	9.9	1.0	0.0	15.0	12.3	5.8	11.2	33.7	10.7	5.6	17.1	5.4	35.2	5.0	0.5	0.1	8.3	3.2	0.0	0.2	10.5	0.6	3.8	0.0	21.5	0.1	2.9	7.3	9.2	18.9	8.6	7.4	11.5	8.4	0.0	0.6	20.1	19.3	7.4	10.1	9.1	0.0	0.0	15.1	9.3	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	49.6	52.4	60.0	50.0	48.9	48.1	40.2	51.1	31.3	28.8	50.3	45.2	11.2	25.6	2.0	161.6	0.2	2.2	2.8	1.7	2.8	46.2	4.9	6.5	9.8	4.3	1.9	9.2	33.3	0.1	0.3	0.9	11.7	2.3	104.1	1.3	4.6	8.3	20.4	0.0	49.4	2.7	0.3	15.7	2.0	2.3	14.7	62.8	12.5	8.2	0.3	82.4	127.5	1.3	0.0	1.9	2.7	35.3	14.6	4.3	5.4	30.9	0.7	46.7	1.0	69.9	41.0	2.0	0.0	29.0	0.1	5.1	0.0	3.3	1.2	41.2	6.6	32.0	9.1	7.2	18.7	2.0	1.4	0.0	0.2	5.1	0.5	1.9
WASH6P	"CXYorf1, FAM39A"	ENSG00000182484	"WASP family homolog 6, pseudogene"		X	156020826-156025710	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"granulocytes: 225.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 10.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA002689	Uncertain		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 60: Granulocytes - Receptor signaling"	Vesicles		"HPA002689: AB_1078803"	"unprognostic (2.01e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (4.69e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.86e-3)"	1.0	1.3	1.0	1.7	1.0	3.5	1.0	1.2	1.6	0.5	1.3	1.0	2.6	1.6	2.7	0.4	1.1	0.8	1.2	1.2	1.0	2.3	0.7	1.2	1.8	1.8	1.2	1.7	4.1	0.7		1.2	1.5	1.1	0.7	3.6	0.9	1.2	6.5	3.1	2.2	0.6	0.8	2.9	1.7	2.3	1.6	1.1	1.2	0.6	0.9	0.7		2.5	9.6	1.5	1.6	5.0	0.7	0.0	5.9	2.5	0.4	0.8	1.5	0.4	5.2	3.1	1.7	1.4	4.0	7.3	1.2	2.0	0.7	0.7	1.7	4.7	0.6	1.3	0.0	1.8	3.7	0.2	0.9	1.4	2.0	0.5	1.2	0.9	6.2	4.6	0.0	1.2	7.9	4.1	2.3	4.2	0.9	7.0	3.0	2.0	0.3	0.4	4.2	6.3	3.1	4.7	5.7	1.3	6.6	5.8	3.1	3.5	3.4	3.3	3.9	8.0	9.8	1.8	0.8	3.1	3.9	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.0	0.3	0.2	0.3	0.1	0.2	0.1	0.8	1.1	0.2	0.4	0.3	1.0	1.0	1.2	1.6	1.2	1.0	1.8	1.2	1.5	0.8	1.6	2.5	0.0	35.3	23.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	225.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.3	0.0
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14475-73865	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002689	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	15.7	18.1	13.2	7.1	14.2	16.3	17.6	13.2	15.1	24.5	16.5	19.6	10.2	20.3	21.9	19.2	24.1	9.0	17.9	13.3	13.5	25.9	20.9	17.1	13.4	14.4	13.8	23.0	21.9	5.2	21.2	6.6	14.3	27.0	4.7	15.9	17.6	13.5	22.8	26.1	21.9	15.3	13.4	29.0	18.3	24.1	14.5	8.6	22.1	6.8	6.0	19.7	20.5	14.9	13.5	8.5	5.0	10.3	8.5	5.7	12.4	11.7	11.4	6.9	5.5	8.4	8.3	5.7	6.6	4.8	6.2	16.7	7.4	5.7	2.5	5.9	14.4	5.5	7.0	8.6	4.7	11.3	10.0	4.3	4.2	3.5	4.7	17.3	2.1	5.0	12.6	21.0	2.2	4.0	11.6	9.4	9.2	9.1	10.5	7.9	4.3	7.2	5.1	9.8	5.6	14.9	6.8	14.3	8.6	6.2	8.6	10.5	8.0	9.2	6.7	4.0	10.3	9.4	7.9	4.5	8.6	12.0	8.6	1.2	2.5	2.2	1.9	2.7	1.5	1.3	1.5	1.6	2.3	1.2	1.6	1.3	1.4	2.1	4.0	2.1	1.8	1.5	13.2	14.2	13.2	15.1	13.3	13.5	14.4	13.8	14.3	13.4	14.5	14.9	34.5	22.4	22.5	0.0	10.5	0.0	0.0	0.0	0.0	0.0	29.0	28.3	0.0	0.0	7.4	60.7	0.0	37.4	21.5	0.0	50.9	13.7	0.0	24.7	28.6	7.5	0.0	0.0	0.0	15.8	26.1	10.8	0.0	22.9	16.4	27.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	6.7	0.0	0.0	47.5	8.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	42.8	11.4	14.3	0.0	0.0
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133509	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	25.3	25.9	19.9	22.1	20.7	37.5	24.0	23.4	24.8	24.7	18.3	28.9	25.2	22.5	19.2	20.2	19.7	18.0	58.6	19.9	19.9	22.9	15.5	26.0	28.8	21.1	21.2	26.7	17.7	23.3	21.5	22.9	21.1	20.6	28.9	19.9	21.9	20.0	22.3	25.7	28.9	21.2	18.6	26.6	21.5	12.5	22.6	24.2	23.3	15.6	26.9	23.8	22.1	23.9	26.1	12.5	21.1	24.3	83.2	46.0	16.9	29.8	64.0	43.7	46.6	28.8	37.8	22.5	18.1	44.8	41.3	28.0	31.2	25.3	43.2	22.2	22.0	15.9	25.6	29.7	58.6	28.0	27.2	47.8	31.2	47.6	30.5	46.2	33.1	19.2	26.6	22.2	53.9	19.1	15.5	48.0	17.1	16.7	58.4	23.1	30.1	13.7	30.5	29.3	7.3	22.4	27.8	25.9	40.9	30.9	31.6	19.2	49.4	22.0	18.5	62.7	25.0	23.4	48.3	19.1	48.9	51.4	9.0	1.0	9.1	9.9	9.1	11.6	10.1	5.1	8.0	8.8	7.3	4.9	7.7	6.0	4.1	8.2	6.9	4.6	9.2	7.9	19.9	20.7	23.4	24.8	19.9	19.9	21.1	21.2	21.1	18.6	22.6	23.9	16.2	38.5	28.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	10.6	11.0	0.0	0.0	22.9	14.7	0.0	7.4	10.0	0.0	0.0	16.7	0.0	45.7	19.9	7.9	0.0	0.0	0.0	15.6	6.9	8.9	0.0	20.3	15.2	13.5	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.6	0.0	0.0	11.7	41.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.7	7.8	9.4	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	19.4	15.7	10.9	17.3	11.8	42.5	17.5	14.8	14.9	19.1	13.5	20.3	15.2	16.8	12.4	13.5	14.9	16.5	22.0	11.3	11.4	18.0	15.9	17.7	20.2	12.5	12.2	21.6	11.6	21.4	13.9	13.7	12.7	15.6	22.0	14.2	15.3	14.6	17.1	17.6	19.7	19.0	9.6	19.3	15.0	12.9	14.1	21.2	17.1	9.8	18.7	17.7	14.6	14.0	24.5	25.9	20.7	23.5	52.1	45.8	12.4	28.4	45.8	32.4	30.8	16.0	23.3	20.1	18.8	41.7	30.8	21.6	23.2	13.0	32.6	18.9	19.2	20.9	32.3	12.3	55.0	21.4	24.6	43.4	30.4	35.4	26.1	31.6	33.7	16.5	33.9	15.7	40.1	12.8	14.0	35.9	14.8	14.7	3.9	17.4	30.5	10.5	23.8	38.2	10.0	22.3	32.8	16.1	39.4	21.0	22.1	20.6	58.1	16.8	18.0	44.7	19.1	21.5	36.3	19.6	23.5	49.4	9.2	14.1	17.1	11.7	12.2	17.9	11.8	9.9	10.1	12.7	11.7	9.2	10.0	8.9	16.8	12.5	22.8	8.1	10.4	13.3	10.9	11.8	14.8	14.9	11.3	11.4	12.5	12.2	12.7	9.6	14.1	14.0	16.2	35.3	35.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	11.3	8.8	0.0	0.0	11.8	23.9	0.0	6.8	11.8	0.0	3.9	13.5	0.0	11.3	17.9	6.1	0.0	0.0	0.0	14.0	6.4	7.9	0.0	13.9	30.3	13.7	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	3.8	0.0	0.0	12.8	24.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	7.8	7.0	12.1	0.0	0.0
WASHC3	"CCDC53, CGI-116"	ENSG00000120860	"WASH complex subunit 3"	Q9Y3C0	12	102012840-102062149	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Hofbauer cells: 73.1;Proximal tubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038339	Uncertain		Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA038339: AB_2675966"	"unprognostic (4.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	27.3	32.2	41.3	14.2	41.9	13.2	24.7	42.8	57.2	26.4	38.3	33.7	13.6	27.5	35.7	28.4	18.0	17.7	35.0	42.8	44.9	41.6	41.1	20.6	22.8	44.6	43.9	20.3	17.4	37.8	33.4	20.0	45.2	26.1	20.7	25.3	19.8	34.9	34.5	20.1	20.5	29.3	43.4	22.7	27.3	98.1	43.5	31.2	25.7	42.2	26.2	28.8	23.4	44.2	17.1	23.3	20.1	12.6	75.2	90.9	18.9	23.3	48.0	33.6	37.3	18.8	16.0	18.0	16.4	52.9	34.2	32.1	21.4	57.0	44.5	41.8	12.9	25.3	15.9	29.5	67.0	22.4	13.9	55.9	72.4	42.1	42.2	92.1	46.3	43.5	15.3	19.6	88.4	23.1	23.6	39.9	6.1	32.7	41.0	13.6	30.4	27.2	59.4	27.7	19.6	10.8	32.6	22.9	50.2	36.5	29.1	12.8	25.5	41.5	9.9	24.7	16.3	49.5	32.7	22.7	59.0	15.6	17.8	125.7	41.3	95.3	37.5	66.6	45.4	61.9	56.3	50.7	56.1	49.4	41.2	49.4	18.2	59.9	70.9	54.9	118.5	52.8	41.3	41.9	42.8	57.2	42.8	44.9	44.6	43.9	45.2	43.4	43.5	44.2	55.4	28.9	41.5	0.0	18.5	0.0	0.0	0.0	0.0	0.0	36.4	55.4	0.0	0.0	14.2	33.1	0.0	60.3	28.4	0.0	125.2	47.9	0.0	40.5	49.2	15.0	0.0	0.0	0.0	38.8	48.5	24.8	0.0	27.4	40.4	36.1	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	46.5	0.0	0.0	0.0	0.0	35.5	0.0	0.0	5.4	0.0	0.0	98.9	22.6	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	39.4	18.8	60.9	0.0	0.0
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169130	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	22.4	21.1	9.4	30.9	13.8	23.8	20.8	13.8	12.2	20.7	11.8	16.1	15.3	20.1	19.9	15.1	13.1	22.6	14.3	9.1	13.8	23.5	29.7	20.2	44.0	17.8	13.0	22.8	18.3	20.4	8.5	30.5	18.4	19.2	18.4	15.4	16.1	15.8	12.2	31.2	18.4	19.8	15.2	32.9	17.9	12.1	14.5	18.0	22.1	14.2	39.5	17.6	12.6	22.1	24.0	28.2	24.6	18.2	56.3	56.6	29.5	36.5	41.5	41.7	38.0	20.2	13.5	53.4	19.8	61.0	26.5	21.9	21.5	22.3	33.5	19.2	15.3	11.1	25.6	16.8	38.4	30.9	20.5	45.7	25.7	37.3	30.4	45.1	68.7	18.1	22.1	18.6	45.9	12.1	17.1	32.6	30.1	16.8	23.5	32.7	32.8	16.6	55.6	27.5	15.4	19.0	37.7	26.4	37.9	31.0	19.6	32.9	84.1	49.8	13.6	32.1	23.9	23.3	23.9	42.7	35.4	26.1	51.4	21.3	15.1	9.2	3.0	18.4	4.4	16.2	4.7	4.1	11.9	12.9	4.9	4.7	16.7	8.0	34.2	5.8	3.5	6.9	9.4	13.8	13.8	12.2	9.1	13.8	17.8	13.0	18.4	15.2	14.5	22.1	37.5	35.3	24.3	0.0	25.3	0.0	0.0	0.0	0.0	0.0	16.4	11.0	0.0	0.0	11.8	44.1	0.0	24.1	17.5	0.0	19.6	25.8	0.0	23.8	48.3	18.0	0.0	0.0	0.0	22.1	28.0	14.6	0.0	31.7	26.5	30.7	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	24.2	0.0	0.0	5.2	0.0	0.0	41.8	17.5	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	32.0	8.9	29.1	0.0	0.0
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322"	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	18.1	18.6	10.5	18.5	16.9	21.3	19.6	14.9	13.2	17.2	16.5	18.5	18.1	16.2	15.7	16.6	13.3	17.8	16.1	11.1	12.5	22.9	18.5	17.1	19.6	14.7	13.7	15.6	13.0	24.8	9.5	21.2	14.6	17.4	20.1	11.4	14.3	16.1	15.9	13.6	14.7	20.2	14.0	19.3	16.1	9.5	13.8	21.8	23.3	18.5	21.0	21.1	10.3	24.7	40.0	45.4	24.9	30.6	55.3	58.8	16.3	42.0	63.6	43.0	45.8	17.0	42.1	36.1	29.1	54.1	25.3	30.6	40.2	37.7	56.8	47.5	23.1	48.1	26.5	22.8	53.8	14.8	46.6	58.7	25.1	35.5	31.2	33.2	49.9	30.9	28.3	35.6	53.0	87.6	44.3	11.8	23.7	66.7	46.7	29.8	22.4	36.7	33.2	48.5	13.1	26.3	48.8	109.2	39.5	25.8	47.3	25.5	44.7	23.6	51.9	39.4	37.7	31.7	31.2	31.7	62.4	27.5	33.4	10.4	17.0	12.5	13.5	20.9	14.3	9.5	12.8	13.9	19.7	10.6	10.1	14.3	5.8	17.2	29.3	7.2	16.9	13.0	10.5	16.9	14.9	13.2	11.1	12.5	14.7	13.7	14.6	14.0	13.8	24.7	10.9	3.2	19.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	14.4	9.3	0.0	0.0	5.0	11.0	0.0	13.4	6.9	0.0	5.9	12.2	0.0	9.9	13.5	4.9	0.0	0.0	0.0	17.2	11.0	5.4	0.0	14.8	8.8	11.1	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.9	0.0	0.0	17.2	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	12.3	3.8	9.6	0.0	0.0
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"WASP like actin nucleation promoting factor"	O00401	7	123681943-123749003	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 282.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 138.3;U-2197: 128.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	20.4	24.7	19.2	12.8	22.2	5.6	21.7	13.5	42.4	29.1	13.6	42.4	37.2	27.1	18.3	29.5	18.7	28.4	18.2	43.0	20.4	44.1	46.8	19.9	7.8	18.0	19.1	35.1	29.5	40.0	13.0	34.6	17.4	25.3	37.9	24.9	22.3	24.0	24.7	18.0	41.5	23.6	13.5	17.0	30.1	22.5	20.9	10.3	35.2	28.7	11.0	38.7	22.5	18.4	34.4	24.8	26.7	23.0	41.2	42.4	34.7	23.3	38.7	16.9	21.7	20.5	42.2	3.5	18.1	35.3	36.0	25.1	50.1	25.7	25.9	6.0	19.9	3.0	19.6	22.2	44.7	4.6	2.9	34.2	47.0	25.0	42.2	37.9	29.5	3.6	15.5	6.6	40.6	20.7	6.0	6.1	50.1	36.5	22.4	3.6	21.6	7.7	35.6	138.3	32.9	48.1	32.1	95.0	63.0	41.4	18.6	4.5	33.8	44.9	12.6	128.1	23.2	7.2	2.7	7.5	38.8	3.8	36.7	2.4	1.7	0.8	1.7	1.7	1.4	2.0	1.1	1.0	1.5	1.3	1.4	1.5	0.7	2.5	3.0	1.9	0.6	0.6	19.2	22.2	13.5	42.4	43.0	20.4	18.0	19.1	17.4	13.5	20.9	18.4	71.2	86.6	61.1	36.9	11.5	60.4	48.9	44.4	46.1	32.9	67.6	57.1	69.8	52.9	53.7	53.3	20.9	41.6	12.6	200.2	52.8	52.6	26.2	58.0	53.1	43.9	67.9	5.9	55.9	54.1	52.4	62.6	50.0	68.8	3.8	35.0	56.4	61.9	12.7	26.9	51.2	105.1	40.7	13.8	25.1	9.3	48.1	15.6	30.2	34.7	14.0	60.9	6.2	42.7	48.7	70.6	113.4	64.7	14.0	104.4	108.0	96.0	49.5	32.4	19.7	54.1	75.3	17.2	21.3	54.9	68.3	81.3	13.1	76.0	74.8	282.3
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458400-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	36.9	70.7	141.7	19.6	145.8	31.9	37.7	139.4	171.9	48.2	133.1	46.6	29.1	39.1	44.8	35.7	56.1	36.5	49.9	137.7	136.6	71.2	80.3	33.7	32.2	144.2	141.3	55.6	62.3	73.7	60.8	24.9	138.2	69.9	17.7	24.4	56.4	37.3	31.4	34.9	33.2	19.8	138.1	42.5	58.0	31.8	145.0	44.7	66.9	53.9	20.6	45.7	37.5	139.0	20.6	91.3	56.2	66.7	69.9	54.0	45.7	20.6	40.3	22.4	17.5	47.3	41.9	19.4	39.3	48.9	33.2	28.3	24.8	55.8	19.0	74.3	49.1	27.4	41.4	68.9	47.6	10.3	27.4	76.2	58.9	30.4	42.2	93.8	44.7	51.6	11.5	72.0	54.8	133.8	40.1	25.5	43.3	53.6	46.3	36.4	63.5	33.6	55.9	83.1	35.0	81.3	28.2	49.9	62.5	49.4	65.5	26.9	26.5	53.0	41.9	20.0	23.5	106.7	38.8	22.2	56.2	27.0	48.5	24.1	28.5	19.2	26.5	23.5	22.5	28.4	23.0	25.5	30.2	27.8	31.3	28.0	18.6	34.6	20.1	47.0	39.2	27.1	141.7	145.8	139.4	171.9	137.7	136.6	144.2	141.3	138.2	138.1	145.0	139.0	1.5	3.2	4.2	0.0	14.3	0.9	0.6	2.0	29.0	1.6	3.2	2.2	0.5	0.0	4.2	1.8	2.1	1.4	1.7	3.3	1.9	5.5	2.4	3.1	2.4	3.6	1.8	9.7	0.0	3.9	1.4	7.2	33.1	1.8	1.3	1.1	0.4	0.8	1.7	0.0	0.0	4.7	2.0	2.4	1.0	1.8	2.1	7.1	0.0	0.0	6.0	1.7	2.1	0.0	0.0	5.2	3.1	1.2	57.2	1.2	5.6	3.3	13.1	1.7	0.0	0.5	5.8	0.6	0.2	28.1	1.3	1.8	10.4	0.9	3.7	0.3
WBP11	"BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784582-14803486	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644"	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	22.3	23.4	14.2	22.4	15.3	65.7	20.8	14.3	17.1	17.8	14.3	19.4	16.1	22.4	17.4	19.8	24.1	18.2	31.2	14.6	19.0	20.0	23.1	20.4	27.4	14.5	17.6	24.8	21.0	25.0	13.3	25.1	14.4	21.8	22.2	21.3	21.3	18.0	38.8	23.3	18.8	22.2	13.5	22.9	18.8	39.0	16.8	26.0	24.3	32.9	29.6	21.5	16.8	14.9	52.1	45.3	53.0	102.4	34.7	32.9	95.6	41.8	35.0	62.3	62.3	83.9	63.2	64.1	26.7	38.0	53.0	42.4	82.3	55.3	76.5	114.6	54.5	94.3	48.1	52.0	34.8	89.6	50.1	32.2	43.7	69.8	52.0	33.6	50.2	59.5	61.3	33.7	50.1	50.1	84.0	48.7	171.9	35.4	29.0	70.7	84.3	40.6	45.3	70.8	28.3	57.6	55.8	46.3	44.9	123.8	24.6	58.2	37.8	43.7	66.1	38.9	72.8	29.2	43.8	116.6	45.7	43.6	59.3	12.3	14.0	12.7	18.8	19.4	20.8	18.3	18.1	19.1	13.2	16.9	20.9	19.6	8.7	19.2	20.6	9.6	21.3	13.7	14.2	15.3	14.3	17.1	14.6	19.0	14.5	17.6	14.4	13.5	16.8	14.9	56.8	57.7	61.0	10.1	79.3	54.9	86.9	49.7	41.5	43.7	53.5	40.6	108.6	54.3	60.7	36.8	47.9	57.8	87.2	36.6	43.0	62.5	98.5	70.1	66.8	52.5	39.5	72.6	17.5	59.5	93.3	62.2	32.6	56.7	106.3	41.0	45.0	48.6	46.6	43.7	16.2	37.8	32.6	44.3	42.1	58.4	45.4	56.7	35.6	9.4	104.6	49.6	74.2	13.0	23.0	52.8	22.3	32.7	64.0	64.1	34.0	53.8	78.7	54.1	59.2	79.3	81.3	207.5	140.4	43.5	55.7	75.9	84.8	42.9	42.6	68.1
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743948-102834516	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Microtubules	Nucleoplasm	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	34.9	43.2	21.3	22.3	23.1	5.0	25.8	20.7	20.1	26.4	28.7	27.7	15.2	27.4	18.9	21.1	29.4	25.1	24.1	19.8	22.4	20.8	42.1	24.5	21.4	32.0	23.9	26.5	15.5	41.7	22.9	23.5	23.6	26.9	15.0	5.7	22.6	22.4	54.6	37.5	19.9	26.2	25.9	21.3	25.7	14.2	24.7	33.7	41.1	49.0	18.9	24.5	20.5	22.6	21.0	26.8	14.5	24.5	47.0	37.9	29.5	21.0	56.7	20.5	25.8	18.3	31.9	18.1	27.8	32.5	16.5	22.7	10.7	18.2	15.5	18.3	11.3	36.6	11.6	13.3	30.3	17.8	41.7	41.2	32.0	26.4	20.3	47.0	40.5	21.6	18.1	22.0	35.6	27.5	21.7	19.8	11.0	16.1	12.9	42.9	38.3	11.7	18.2	20.4	3.4	13.9	11.5	11.6	24.1	26.0	47.2	19.5	30.4	19.6	20.1	22.3	19.1	40.6	22.9	13.0	27.7	33.6	8.8	7.8	12.2	16.2	8.7	14.8	7.0	6.5	7.3	8.4	8.7	6.1	6.5	6.9	15.2	12.9	19.4	5.4	8.2	10.6	21.3	23.1	20.7	20.1	19.8	22.4	32.0	23.9	23.6	25.9	24.7	22.6	13.3	22.4	19.0	29.4	12.2	8.2	8.0	17.0	11.4	6.4	25.0	15.4	15.7	12.8	17.8	12.9	0.0	33.9	17.2	26.4	1.9	14.2	2.0	9.7	11.0	20.4	9.1	11.1	24.6	25.3	14.6	29.3	16.8	12.7	38.1	16.4	27.1	56.2	27.7	13.5	26.4	14.6	14.2	46.6	13.1	1.8	13.1	28.8	10.6	40.3	28.9	9.8	29.9	19.1	26.3	24.6	13.7	19.5	9.0	29.9	18.3	8.9	20.5	3.8	19.7	16.6	17.7	4.4	5.8	11.3	11.8	40.0	14.4	8.9	12.2	11.3
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WBP2NL	"FLJ26145, GRAMD7, MGC26816, PAWP"	ENSG00000183066	"WBP2 N-terminal like"	Q6ICG8	22	41998725-42058456	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 17.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 254.5;Late spermatids: 807.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048557	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA048557: AB_2680440"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-4)"	"unprognostic (2.77e-3)"	"unprognostic (6.12e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (9.84e-4)"	"unprognostic (3.31e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.36e-5)"	0.2	0.1	0.6	0.0	0.6	0.0	0.7	0.6	0.9	0.2	0.0	0.2	0.1	0.2	1.2	0.1	0.5	0.2	0.0	0.6	0.6	0.3	0.1	0.3	0.2	1.0	0.7	0.6	0.7	0.4	0.3	0.1	1.0	0.3	0.1	0.7	0.5	0.3	0.1	0.4	0.2	0.1	0.8	0.2	0.3	17.8	0.5	0.1	0.6	0.1	0.1	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.6	0.9	0.6	0.6	1.0	0.7	1.0	0.8	0.5	1.4	0.3	0.0	2.8	50.6	4.3	0.4	2.1	1.0	2.8	16.4	1.8	2.4	0.7	2.8	3.7	0.0	20.9	2.2	0.6	1.7	3.9	0.9	254.5	0.9	1.5	1.3	4.8	0.4	16.0	1.3	1.0	0.9	1.5	1.3	0.0	4.7	2.2	1.5	1.4	10.1	18.6	2.2	4.1	2.8	1.9	807.7	6.5	2.3	1.8	9.4	1.8	2.9	3.1	9.5	16.6	0.9	3.9	5.7	1.5	1.2	3.4	2.0	0.8	23.0	0.0	0.6	0.7	30.6	20.2	1.2	0.9	1.9	1.9	1.6	2.7	1.4
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
WDCP	"C2orf44, FLJ21945, MMAP"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029347-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	2.6	3.7	3.9	3.8	4.1	1.4	4.4	4.7	4.0	3.5	4.6	4.2	2.5	4.2	3.7	3.2	3.2	2.7	3.4	3.8	4.0	3.5	4.1	2.6	6.6	3.9	4.1	5.4	2.6	5.0	2.3	4.2	4.0	3.6	2.9	6.3	2.9	4.5	6.1	2.9	3.3	3.5	3.9	4.2	3.0	4.9	4.3	7.7	3.1	8.7	7.0	3.6	2.7	4.6	12.3	18.8	20.1	14.0	13.6	10.7	7.2	14.6	7.8	15.1	14.1	17.2	5.6	32.0	6.2	7.5	12.6	8.8	28.7	10.0	15.6	19.4	16.4	19.7	8.5	17.8	9.3	18.0	13.0	6.5	7.6	15.6	7.7	7.8	14.3	18.4	27.5	8.7	15.9	5.6	23.8	10.8	24.3	12.2	14.3	25.7	33.8	12.9	7.1	6.1	15.4	21.3	7.2	7.0	9.1	14.0	5.4	7.9	13.9	12.0	13.1	7.2	13.6	14.4	19.2	45.2	7.7	19.0	9.5	0.0	1.8	1.1	5.2	2.7	5.3	3.3	3.3	3.8	3.1	2.9	4.6	5.0	0.4	3.9	2.0	1.1	5.4	3.3	3.9	4.1	4.7	4.0	3.8	4.0	3.9	4.1	4.0	3.9	4.3	4.6	3.1	3.2	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	9.2	0.0	2.9	1.8	0.0	7.9	2.3	0.0	1.5	3.2	1.6	0.0	0.0	0.0	2.0	2.5	1.4	0.0	1.0	0.0	4.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	1.0	4.5	0.0	0.0
WDFY1	"FENS-1, KIAA1435, WDF1, ZFYVE17"	ENSG00000085449	"WD repeat and FYVE domain containing 1"	Q8IWB7	2	223855716-223945357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050603, HPA079597"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA050603: AB_2681188, HPA079597: "	"unprognostic (2.49e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.55e-2)"	18.6	13.2	9.3	18.0	9.5	48.5	14.4	9.3	12.0	20.5	11.2	20.4	15.6	22.6	19.8	14.4	20.5	17.5	11.7	9.2	10.7	14.8	18.0	18.4	23.3	11.0	10.2	20.2	14.1	19.8	8.7	27.4	11.4	16.2	20.1	15.9	13.5	12.8	11.4	13.5	15.9	19.6	9.7	21.2	19.8	10.9	10.5	15.9	22.1	12.6	18.9	17.9	13.7	11.1	27.9	19.3	34.9	27.2	46.4	44.0	43.7	34.7	48.3	37.5	30.4	81.4	25.0	7.7	30.8	60.6	47.3	19.2	18.7	52.3	40.4	15.6	15.8	19.2	31.9	59.2	36.4	15.2	15.8	39.0	37.9	46.3	71.0	62.4	63.9	16.2	34.3	23.4	44.4	26.8	6.5	11.1	34.5	20.7	16.6	25.3	44.8	8.6	28.4	47.7	29.6	15.7	20.7	19.2	90.9	41.6	12.5	38.1	70.9	74.9	25.7	13.5	18.0	28.8	4.6	21.4	36.3	32.9	26.2	4.4	21.5	8.1	13.7	29.0	16.6	14.1	9.7	13.5	14.8	11.7	10.0	9.5	10.3	24.0	25.7	3.0	9.7	17.6	9.3	9.5	9.3	12.0	9.2	10.7	11.0	10.2	11.4	9.7	10.5	11.1	40.0	16.0	9.3	22.5	22.0	12.5	14.5	19.9	17.1	14.0	11.8	7.6	7.7	12.8	24.4	16.5	8.4	22.6	25.5	36.4	9.8	12.9	0.8	23.2	30.7	34.1	10.3	11.2	28.7	17.2	11.2	21.4	29.6	36.5	17.7	12.5	16.8	25.7	17.9	28.6	28.1	15.2	8.2	26.3	17.2	2.4	14.6	24.4	35.6	27.2	25.6	13.9	24.7	33.7	39.8	18.0	24.4	23.7	21.8	16.6	16.0	14.4	29.9	10.9	6.6	13.1	26.7	3.8	8.8	24.4	15.5	19.0	21.1	15.0	21.8	28.7
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669597-84966690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 241.0;Excitatory neurons: 231.0;Inhibitory neurons: 248.7;Microglial cells: 209.9;Oligodendrocyte precursor cells: 262.9;Oligodendrocytes: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"TIME: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: AB_2678135, HPA048572: AB_2680447"	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.64e-5)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	8.6	8.6	14.8	7.6	31.7	14.4	8.7	26.8	22.9	8.5	4.7	5.7	3.6	8.2	6.4	7.4	8.2	8.8	5.7	16.3	15.6	20.1	5.6	7.4	2.6	30.6	30.4	13.6	9.0	16.3	6.5	11.8	28.7	8.6	5.6	26.2	7.2	7.4	5.9	10.8	4.7	8.5	21.7	7.8	5.6	8.1	25.6	3.4	11.7	13.2	2.3	8.7	5.7	44.9	11.9	7.8	14.3	7.9	24.8	19.3	9.0	11.2	11.8	11.5	10.3	9.1	9.6	0.0	11.3	18.8	12.3	5.9	15.4	12.3	14.6	7.9	4.9	7.5	9.0	5.5	9.4	5.9	13.7	14.2	10.9	15.0	15.1	13.9	37.1	6.0	7.5	35.3	21.4	8.5	5.7	1.4	7.4	11.4	4.0	8.4	11.4	1.8	19.6	15.6	16.8	7.8	13.8	15.1	7.5	13.5	7.9	14.4	57.0	15.1	14.9	8.5	14.1	0.1	0.0	0.0	10.2	5.0	16.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1	14.8	31.7	26.8	22.9	16.3	15.6	30.6	30.4	28.7	21.7	25.6	44.9	28.5	19.2	12.9	241.0	1.0	14.7	9.1	12.4	11.4	46.6	13.8	11.3	18.2	20.0	14.7	16.5	35.5	11.8	0.5	6.5	1.9	8.6	6.7	27.1	27.8	20.1	9.1	1.3	231.0	7.3	6.9	19.5	15.3	43.4	0.0	31.0	17.9	8.1	20.5	28.6	248.7	7.8	20.3	43.1	14.1	10.1	18.3	29.9	7.2	209.9	19.7	28.7	0.0	262.9	440.4	10.7	6.5	24.5	0.2	13.6	4.8	18.4	15.5	41.9	26.3	30.0	22.8	11.4	7.3	14.1	16.1	14.5	1.8	15.0	6.7	13.6
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 28.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5"	"Group enriched"	"Detected in many"	7	"B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	1.9	0.7	3.2	12.1	3.4	11.7	1.4	4.2	4.8	1.1	3.2	1.9	1.5	0.8	1.9	1.4	0.7	3.2	0.6	3.2	4.2	0.8	1.3	5.2	28.5	6.0	4.9	0.6	1.0	0.4	0.3	1.2	6.2	0.8	1.9	0.1	1.3	0.6	0.7	2.6	7.4	1.7	5.9	17.3	2.3	3.7	6.3	12.3	0.6	0.4	23.9	3.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	6.5	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	25.0	0.0	0.0	3.0	0.0	0.0	2.8	0.0	14.3	0.0	0.1	11.3	21.2	0.0	0.0	10.2	0.0	1.3	32.5	0.0	1.1	3.2	3.4	4.2	4.8	3.2	4.2	6.0	4.9	6.2	5.9	6.3	9.3	0.2	0.0	1.1	2.0	44.7	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.6	1.8	0.0	0.1	29.9	0.0	1.9	0.0	47.2	0.0	0.1	0.3	0.0	0.4	0.7	0.0	0.2	1.1	0.0	0.0	5.7	0.0	0.0	0.0	13.0	0.0	0.4	0.1	0.0	12.9	30.6	17.7	0.3	24.6	1.8	81.5	16.4	0.0	0.0	1.0	0.5	0.0	0.0	0.4	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	2.9	0.5	0.2	0.3	0.3	1.5	0.0	0.3	0.1
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	0.9	0.9	1.2	0.1	2.8	1.8	2.1	0.6	2.4	1.6	1.3	0.9	0.7	0.2	1.1	1.2	1.3	5.5	0.2	0.2	1.4	0.9	1.5	0.3	2.8	0.2	1.0	4.0	1.8	0.7	0.8	0.6	2.0	1.7	2.6	0.3	1.7	1.6	5.3	0.4	8.0	0.9	0.8	6.7	1.7	1.1	0.9	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	0.9	0.9	0.7	0.2	0.2	0.2	0.2	0.3	0.4	0.9	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDPCP	"BBS15, C2orf86, CPLANE5, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63119559-63827843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	4.7	3.5	11.3	2.5	11.7	8.2	3.2	17.7	15.7	2.5	6.5	1.6	1.8	3.9	4.0	2.0	4.2	2.8	4.9	10.4	6.9	3.6	2.4	2.5	3.3	6.4	5.4	4.6	1.5	2.9	1.9	2.6	8.4	2.6	1.8	12.2	2.2	2.1	5.3	3.4	1.7	3.0	3.2	3.3	3.3	5.1	6.3	3.6	3.5	2.9	2.7	1.8	1.1	18.6	5.2	4.6	3.3	4.0	3.7	4.6	3.0	4.3	2.2	2.8	2.3	3.3	2.6	5.8	3.5	2.9	3.3	3.4	2.3	2.8	3.3	5.7	3.8	6.1	3.5	2.8	2.5	5.0	4.1	2.3	1.9	2.9	1.9	3.7	2.9	6.7	2.3	5.7	2.9	5.3	5.8	5.1	3.9	2.7	1.7	6.2	4.3	5.0	1.9	2.5	5.2	5.2	3.7	4.4	5.3	4.7	3.8	3.9	4.7	4.6	7.2	4.0	3.6	5.3	3.6	10.3	5.2	5.3	5.3	6.6	2.8	1.5	1.9	1.5	3.7	1.8	1.7	2.6	2.3	3.1	2.3	3.6	1.9	3.8	1.3	2.7	1.5	1.1	11.3	11.7	17.7	15.7	10.4	6.9	6.4	5.4	8.4	3.2	6.3	18.6	6.0	169.9	128.0	124.7	8.0	4.1	3.2	4.3	2.8	16.1	4.4	3.2	10.1	7.2	59.6	1.8	22.9	2.5	5.5	0.8	1.9	2.6	46.7	17.9	6.2	14.4	0.0	7.8	261.4	2.2	2.6	13.5	6.6	3.7	65.0	7.4	5.0	1.8	4.0	11.8	240.9	1.3	4.1	3.0	4.4	17.5	4.4	8.4	5.4	103.0	3.8	7.5	6.2	136.2	296.3	1.8	1.6	3.8	5.1	1.5	0.5	4.5	98.8	27.4	0.0	8.6	5.7	16.1	9.5	2.3	3.4	1.9	9.4	4.0	1.1	1.7
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851305-120909524	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	15.2	12.3	5.9	16.9	5.7	6.6	15.3	6.7	5.1	15.4	10.8	15.2	14.2	15.3	10.8	14.8	17.7	15.0	7.8	6.0	7.1	24.4	20.2	15.2	18.6	10.1	6.5	16.0	13.6	38.6	5.3	16.8	10.9	15.6	16.6	15.1	14.4	14.2	3.5	9.7	14.9	16.9	10.3	18.5	16.1	11.5	6.6	17.9	22.5	6.5	20.2	15.7	8.6	14.7	28.5	25.1	24.8	43.4	35.4	42.2	18.0	26.0	52.4	28.3	34.9	14.7	29.1	19.9	13.1	37.5	22.5	26.5	29.1	35.8	35.4	26.5	24.2	20.8	19.9	15.3	33.6	29.6	23.6	36.7	28.5	26.2	42.2	51.7	53.1	14.0	16.9	23.3	30.1	12.1	18.7	12.9	12.8	24.8	16.1	7.7	43.3	17.4	33.7	21.8	12.2	21.8	22.6	24.9	68.8	43.3	18.4	18.7	40.0	18.6	11.6	2.8	25.1	12.9	8.6	24.3	26.4	24.8	9.9	27.4	8.5	3.8	4.5	11.2	3.6	8.5	3.0	4.1	9.7	4.6	3.1	3.3	0.6	5.9	25.3	2.3	4.3	5.2	5.9	5.7	6.7	5.1	6.0	7.1	10.1	6.5	10.9	10.3	6.6	14.7	23.7	6.4	16.4	77.7	42.3	12.0	13.5	15.5	10.8	42.8	16.6	13.6	8.3	27.1	20.1	25.8	98.0	19.3	30.5	24.3	11.7	18.3	3.8	31.7	33.1	24.4	27.1	16.6	57.0	10.5	12.1	21.8	29.6	32.7	9.5	34.2	33.9	33.9	32.2	25.2	54.2	24.5	12.2	43.2	16.5	4.4	43.5	34.9	3.6	30.9	42.4	21.0	20.6	112.1	84.7	25.3	23.4	38.7	25.6	17.9	34.8	19.9	30.1	85.3	19.7	28.9	17.9	25.8	16.3	15.6	14.2	15.2	18.9	41.7	20.6	19.3
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874261-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	2.6	3.6	2.1	2.7	2.3	3.6	3.6	2.3	3.2	2.5	1.4	3.0	4.1	3.2	3.2	3.2	3.1	2.3	4.0	2.2	2.9	5.2	4.2	1.7	3.3	2.5	2.1	3.2	2.2	3.5	1.9	2.7	2.7	2.2	4.0	2.6	1.9	2.3	4.8	3.6	2.9	3.4	1.5	2.1	2.3	3.5	2.8	3.2	3.2	6.0	3.7	4.1	2.3	2.5	5.3	5.8	6.4	12.5	12.3	10.4	11.4	7.6	6.6	10.1	9.8	14.8	7.5	10.2	7.2	6.6	8.5	6.6	18.2	13.3	16.0	4.6	11.1	17.0	9.0	17.7	8.0	22.1	9.9	9.5	9.4	12.0	23.6	6.4	10.8	10.2	26.7	5.9	11.3	6.5	14.8	13.3	14.9	7.3	14.3	11.1	9.7	16.1	11.2	6.5	11.4	9.8	6.5	8.2	9.8	11.0	4.7	14.1	8.3	8.3	6.9	7.4	8.4	8.0	12.8	16.3	8.7	15.3	8.8	1.3	1.6	0.6	1.4	1.7	2.0	1.9	1.3	1.4	2.1	1.9	1.7	1.7	0.6	1.3	1.7	2.4	1.6	1.1	2.1	2.3	2.3	3.2	2.2	2.9	2.5	2.1	2.7	1.5	2.8	2.5	10.1	9.6	16.9	12.1	13.6	20.5	21.4	24.4	13.1	10.2	8.4	9.1	27.9	7.2	19.1	5.5	2.1	25.3	7.9	7.8	15.6	18.0	14.3	14.7	25.3	12.6	5.4	22.1	19.2	10.6	34.9	16.5	9.7	13.3	15.2	15.8	8.2	15.0	18.0	15.2	20.3	10.6	24.4	7.2	6.0	8.9	17.1	9.2	1.8	12.2	13.7	6.4	5.2	10.6	9.9	14.2	6.6	15.4	9.3	17.3	13.9	38.1	15.7	8.3	13.1	20.1	41.9	43.0	32.3	18.2	17.3	21.5	10.7	21.0	19.2	17.0
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	67.2	76.7	84.2	27.7	81.1	34.6	63.8	68.2	95.2	71.6	85.0	71.6	43.8	71.5	73.7	54.6	67.1	33.4	150.3	85.7	70.4	91.9	106.3	60.8	23.4	73.0	70.2	93.1	189.2	36.9	80.1	29.5	70.5	67.5	26.3	28.2	75.7	45.3	105.2	56.9	54.4	37.5	69.4	58.6	76.6	22.9	74.5	18.7	64.8	83.0	19.6	59.5	56.3	78.5	41.6	59.4	29.3	90.8	39.3	57.4	22.4	28.1	50.7	31.9	29.0	35.5	64.8	28.7	26.3	57.8	25.7	35.0	14.6	61.6	11.3	34.2	26.2	19.7	72.2	65.3	89.3	17.1	51.4	54.7	86.4	45.3	82.7	55.6	44.4	16.3	19.8	35.5	44.9	59.4	23.7	29.9	21.2	18.0	46.6	22.4	31.0	52.3	56.7	32.6	33.9	41.9	31.8	65.2	66.9	20.4	41.9	32.6	74.0	33.0	48.8	52.8	27.5	41.0	16.6	11.0	48.9	25.3	46.5	75.5	42.4	24.7	20.9	47.4	16.7	32.7	21.8	19.9	39.1	25.0	17.4	19.6	29.9	33.0	57.2	24.6	27.0	31.1	84.2	81.1	68.2	95.2	85.7	70.4	73.0	70.2	70.5	69.4	74.5	78.5	61.1	44.8	41.7	19.9	22.3	35.1	72.8	69.1	37.5	45.5	39.2	35.8	79.7	68.6	49.9	20.2	54.2	44.2	19.9	75.5	103.7	89.0	6.1	75.9	36.1	54.0	50.4	31.2	7.8	119.2	34.5	50.5	62.2	53.0	30.4	46.2	65.3	50.2	42.6	33.7	6.6	58.3	50.8	35.4	30.6	20.8	51.6	34.9	58.7	15.0	42.1	68.9	22.6	7.1	14.0	96.8	75.0	43.2	28.3	48.3	90.2	140.7	74.3	55.6	46.0	51.2	59.6	11.2	21.0	29.7	29.8	70.7	21.4	56.2	59.8	65.8
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065841-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 11.5;retina: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 183.1;Cone photoreceptor cells: 64.6;Excitatory neurons: 222.8;Inhibitory neurons: 127.6;Oligodendrocyte precursor cells: 125.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 5.6;SCLC-21H: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	0.8	2.9	4.5	0.9	7.9	0.6	1.3	2.9	7.6	1.4	0.0	2.5	0.5	1.8	2.4	0.6	1.9	1.1	0.8	8.5	2.5	2.5	0.3	1.4	0.6	0.0	0.0	1.8	2.2	7.0	11.5	0.1	0.8	0.8	1.1	28.6	0.8	0.8	0.2	0.4	1.2	1.0	0.0	1.1	1.3	1.9	2.3	0.3	4.3	0.3	0.5	1.4	1.0	3.4	0.0	2.5	5.6	0.0	0.1	0.4	0.2	0.1	0.0	0.6	1.9	0.2	0.0	3.7	0.0	0.1	3.0	0.0	2.4	1.4	0.5	0.0	2.0	0.0	0.5	0.0	0.2	2.0	2.8	0.8	0.7	0.1	0.3	0.7	0.0	4.3	0.0	0.3	0.5	1.1	2.4	0.1	1.2	0.0	1.4	0.0	2.5	0.0	0.2	0.0	7.6	4.8	0.0	1.4	3.8	0.7	0.4	0.0	0.0	0.8	1.0	0.0	3.4	2.7	1.8	2.3	4.2	0.0	1.4	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	4.5	7.9	2.9	7.6	8.5	2.5	0.0	0.0	0.8	0.0	2.3	3.4	0.3	0.0	5.8	183.1	2.4	0.1	0.5	0.1	3.4	16.9	0.6	0.9	0.9	1.5	1.3	0.0	64.6	0.0	0.0	0.1	1.9	0.3	1.5	0.5	0.6	0.7	4.8	1.7	222.8	0.6	0.0	2.0	0.0	0.0	3.8	0.1	2.2	0.1	0.2	21.9	127.6	0.1	0.0	0.6	0.6	1.5	0.9	1.3	1.8	23.4	0.6	10.2	0.0	125.2	40.0	0.2	0.0	1.5	0.2	0.4	0.0	11.6	7.7	36.6	0.0	3.0	1.9	2.7	5.2	0.4	0.0	0.0	0.3	1.4	0.1	0.3
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984332-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 162.0;Proximal tubular cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	14.8	21.7	12.3	12.0	12.6	11.3	15.3	12.7	18.3	14.0	11.5	16.4	11.6	14.8	3.3	26.0	13.9	4.9	20.6	12.6	11.6	25.1	31.7	12.7	8.8	13.6	12.1	13.7	18.3	8.3	18.9	10.2	13.1	16.4	4.2	7.1	16.0	9.3	23.7	21.5	14.6	4.1	11.8	18.2	15.8	17.7	13.0	8.4	15.6	8.8	6.7	15.2	15.6	13.4	58.3	55.2	16.7	28.2	15.7	14.4	68.0	25.6	14.3	30.5	22.6	62.8	19.6	68.9	29.8	37.2	3.6	46.6	45.4	53.3	11.8	36.1	75.3	33.3	34.1	79.8	36.7	71.7	30.1	18.5	28.1	18.2	42.5	15.5	28.3	32.7	74.9	25.7	11.4	62.3	53.2	102.9	96.1	39.7	35.8	99.1	39.8	107.0	19.4	35.8	63.7	60.4	24.3	20.0	26.5	11.5	47.5	42.6	28.8	34.3	41.7	67.8	40.7	83.0	74.9	33.7	29.6	44.3	37.0	11.5	77.5	18.9	53.4	84.8	52.8	56.6	53.7	58.0	117.8	69.7	53.2	48.4	3.6	57.1	70.8	74.6	65.2	66.7	12.3	12.6	12.7	18.3	12.6	11.6	13.6	12.1	13.1	11.8	13.0	13.4	20.8	9.6	13.0	10.4	19.5	19.4	28.4	57.9	25.0	28.6	23.1	22.6	13.6	15.7	31.1	31.3	22.9	90.3	14.5	22.4	70.5	73.2	35.6	18.0	17.4	24.6	32.3	20.8	9.8	54.4	162.0	22.3	23.0	18.9	16.5	47.7	23.6	43.0	46.0	26.9	7.9	33.0	44.7	19.2	17.2	38.2	15.5	19.2	16.0	5.6	47.7	32.2	23.7	1.5	6.0	47.8	23.9	16.1	30.0	27.9	28.8	207.8	27.2	24.8	13.1	16.2	31.7	36.5	30.6	29.8	20.3	60.1	18.7	43.7	48.3	24.2
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	6.1	9.1	3.9	4.0	3.6	3.9	6.2	5.0	6.9	7.5	4.1	7.1	4.8	7.9	1.0	7.1	7.5	2.8	7.9	3.8	3.0	7.5	11.2	6.0	4.8	4.2	4.0	9.2	7.2	5.8	9.4	3.2	3.5	8.5	1.1	1.8	6.9	3.0	11.7	8.5	7.1	2.0	3.2	9.2	7.8	14.2	3.9	4.3	8.7	4.1	2.4	7.5	6.6	3.7	6.1	14.0	6.2	8.6	5.9	4.2	10.9	7.5	6.7	9.2	8.0	15.3	8.8	9.4	12.8	3.4	2.3	9.4	6.1	7.4	2.0	15.9	19.0	6.4	19.8	5.8	9.4	7.9	9.6	7.4	4.9	6.6	5.5	4.8	5.0	9.0	12.7	10.3	3.4	22.2	14.0	5.8	9.7	3.1	10.6	20.4	5.1	17.6	3.0	4.2	15.1	6.9	8.5	14.3	8.7	2.8	13.2	7.8	7.3	6.6	6.8	7.4	7.3	21.9	21.5	15.3	4.3	7.8	9.4	4.3	5.1	2.8	6.6	3.0	5.4	4.3	4.2	4.9	5.1	3.7	4.9	4.8	1.2	3.0	7.8	4.1	6.1	5.0	3.9	3.6	5.0	6.9	3.8	3.0	4.2	4.0	3.5	3.2	3.9	3.7	2.9	6.4	6.2	2.3	4.2	1.1	2.6	4.7	4.0	5.1	5.2	4.4	5.0	1.5	5.0	7.3	2.1	7.4	2.9	6.0	7.9	4.9	17.1	12.2	2.9	3.1	10.1	5.2	2.0	5.6	4.4	3.1	6.6	2.9	4.5	6.9	2.5	9.6	5.1	21.9	2.0	7.3	4.1	6.3	1.6	48.0	5.6	3.9	0.0	1.9	4.4	7.3	1.0	2.0	2.4	4.5	2.1	3.0	6.8	3.8	8.0	6.4	19.4	2.6	19.7	2.6	4.2	18.8	8.7	2.1	1.6	7.4	3.4	7.6	5.5	2.0
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.4	10.0	7.6	2.5	7.8	4.1	6.5	8.0	9.5	8.1	8.1	6.7	3.2	7.9	4.2	4.5	6.8	3.0	6.6	7.4	7.5	7.0	8.6	5.8	3.6	7.6	7.6	6.6	12.9	3.5	11.3	3.3	8.5	7.9	2.5	4.5	5.7	3.6	10.7	5.7	4.8	2.7	7.0	5.7	6.5	7.4	7.3	5.6	9.1	4.5	2.3	7.9	5.4	7.8	3.5	6.1	4.2	15.6	6.7	6.2	3.5	6.4	10.2	7.3	7.4	2.9	6.5	5.1	7.9	5.0	2.0	6.2	4.0	7.8	3.8	5.0	2.9	3.4	6.9	4.9	12.2	4.0	3.8	9.3	9.2	5.3	7.9	6.4	5.3	5.9	4.2	7.3	4.8	13.5	6.0	4.4	3.2	4.2	10.7	4.3	5.9	3.6	5.6	2.8	9.8	10.3	5.2	1.9	9.0	4.0	7.2	1.4	9.2	2.8	3.2	10.8	3.7	4.9	2.6	2.5	9.7	3.0	5.4	34.0	16.4	24.6	8.6	14.6	8.7	13.0	11.1	9.1	14.3	8.5	11.7	8.6	8.7	5.6	16.3	11.0	12.0	12.2	7.6	7.8	8.0	9.5	7.4	7.5	7.6	7.6	8.5	7.0	7.3	7.8	7.1	0.0	6.4	12.1	5.1	3.2	4.3	8.6	0.6	8.8	5.5	6.1	2.6	0.0	6.9	3.7	10.4	8.4	6.7	6.3	9.8	12.7	9.2	13.8	6.7	8.8	5.4	11.0	17.8	33.6	4.7	6.2	8.2	8.5	3.8	3.9	5.0	8.7	6.9	5.0	16.9	9.0	14.2	5.6	4.0	6.3	6.8	3.7	5.4	16.9	5.4	14.0	5.2	14.6	19.1	13.3	3.8	11.3	6.3	3.3	7.5	17.9	11.8	16.2	13.1	4.5	7.2	15.6	17.0	2.8	3.0	7.0	5.0	9.2	7.1	3.0
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702067	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Excitatory neurons: 57.2;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	5.1	4.5	2.8	3.1	2.2	2.6	6.7	3.1	3.1	9.5	5.9	6.7	3.4	8.1	4.8	6.3	9.9	3.3	3.5	2.3	2.0	5.0	4.4	4.7	4.1	2.4	2.5	10.9	6.1	3.1	5.1	3.0	2.2	6.8	3.6	2.5	6.2	2.0	4.1	4.7	6.1	2.2	1.7	4.8	5.8	10.5	2.7	3.5	10.0	0.8	3.0	6.4	8.0	2.0	3.8	6.5	17.6	6.4	4.2	8.3	4.4	5.8	1.6	3.5	4.1	6.1	4.8	3.1	3.5	1.8	5.0	8.5	3.1	4.4	5.1	4.0	6.0	6.7	13.4	6.1	2.5	3.3	1.0	4.3	4.1	4.4	3.3	6.5	6.5	7.3	15.6	6.1	4.6	4.9	2.1	12.3	4.6	2.8	3.3	5.0	3.6	5.6	3.3	3.5	7.3	7.5	3.8	3.6	2.1	4.7	4.3	6.1	5.6	4.6	3.7	4.3	5.1	5.8	2.2	7.5	4.2	7.7	4.7	0.0	0.1	0.3	0.3	0.1	0.8	0.3	0.4	0.4	0.1	0.8	1.6	0.2	0.0	0.1	0.1	0.4	0.4	0.3	2.8	2.2	3.1	3.1	2.3	2.0	2.4	2.5	2.2	1.7	2.7	2.0	7.0	9.6	3.9	44.1	6.6	2.2	5.6	6.7	8.0	13.5	8.5	9.0	4.3	7.2	5.4	12.9	6.2	5.2	3.2	3.2	0.0	2.3	28.3	26.9	15.5	7.2	4.2	7.8	57.2	1.5	2.8	7.3	11.2	6.2	3.8	13.7	9.3	4.1	2.2	21.9	52.6	4.7	2.0	2.4	2.5	10.3	8.1	3.4	3.6	38.4	1.4	5.9	4.1	51.3	47.4	2.1	5.7	9.8	4.8	4.3	4.2	2.1	25.7	12.7	0.0	5.2	6.3	21.7	10.7	8.1	1.1	1.9	5.4	6.3	7.0	5.4
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 18.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 69.6;Cone photoreceptor cells: 29.2;Early spermatids: 29.5;Late spermatids: 27.2;Rod photoreceptor cells: 42.0;Spermatocytes: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	1.2	3.4	2.6	0.5	2.9	1.0	2.8	1.9	2.4	1.9	4.8	1.5	1.1	1.5	1.9	1.4	3.9	1.4	5.7	2.3	2.8	3.4	1.6	1.4	0.4	2.5	3.0	2.2	1.8	11.1	2.9	0.6	2.3	2.0	1.3	18.0	3.8	2.0	0.9	1.5	0.6	1.1	2.2	0.4	1.3	4.9	3.1	0.9	3.7	1.0	0.4	1.3	1.1	1.9	3.6	2.6	0.9	1.8	3.1	3.6	0.8	0.8	1.7	0.9	1.1	0.4	2.3	1.3	0.6	1.3	2.5	2.2	0.8	1.7	1.7	2.2	0.2	1.1	1.4	0.4	3.5	0.6	0.1	1.9	2.2	3.6	3.2	2.4	0.7	1.9	3.0	1.2	0.9	2.4	1.1	0.9	0.5	3.4	3.3	1.3	0.7	1.6	2.3	0.7	2.2	1.6	4.2	0.7	2.0	0.7	5.5	0.5	0.4	1.1	1.3	3.1	0.9	2.4	2.5	0.2	1.7	0.8	1.2	1.7	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.9	0.4	0.2	0.2	0.2	0.2	2.6	2.9	1.9	2.4	2.3	2.8	2.5	3.0	2.3	2.2	3.1	1.9	0.9	6.4	8.2	11.1	0.2	5.4	5.3	2.2	3.4	5.5	3.5	2.4	69.6	4.3	8.1	1.8	29.2	0.4	1.5	1.1	5.9	2.0	29.5	12.3	2.9	3.8	0.0	4.4	7.9	0.2	0.3	7.6	0.0	2.3	5.1	3.4	1.4	3.0	0.8	6.7	8.8	1.4	0.0	1.2	2.2	27.2	1.8	1.3	0.0	1.9	0.2	8.2	1.0	2.0	3.2	1.0	0.6	1.5	0.1	2.8	0.2	5.5	24.6	42.0	0.0	6.0	4.1	25.1	8.6	1.7	4.3	0.3	1.1	2.8	2.1	3.3
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701027-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: AB_2679686"	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	20.2	16.1	16.2	18.5	16.9	17.3	20.4	35.0	19.0	24.5	19.8	21.9	14.7	19.9	14.4	20.9	21.6	11.8	20.0	16.2	17.0	19.9	27.9	18.9	22.0	15.0	16.5	27.8	20.1	19.1	23.0	16.8	16.3	22.1	15.1	24.5	19.3	12.9	21.2	26.6	22.2	15.0	14.2	27.8	18.5	20.6	16.6	30.9	24.2	21.3	23.9	19.9	22.9	20.0	40.3	22.3	38.2	31.2	22.3	22.9	39.0	36.0	28.5	37.3	35.2	52.1	30.3	50.5	39.0	24.0	34.4	31.8	43.6	30.5	48.6	46.5	26.0	48.9	28.2	56.6	25.1	59.7	35.1	22.4	31.7	35.9	30.3	26.7	32.4	45.0	41.5	44.4	26.6	25.1	62.3	43.7	46.5	25.9	24.6	43.1	38.6	40.4	21.5	51.6	35.5	27.5	32.3	29.6	26.0	35.7	23.0	34.4	29.8	29.3	42.6	33.0	31.1	42.8	70.5	96.4	23.9	23.4	27.8	35.7	20.6	35.1	24.9	22.7	25.8	30.5	25.2	24.2	27.4	28.3	26.6	25.7	14.1	34.7	25.0	19.7	34.4	18.5	16.2	16.9	35.0	19.0	16.2	17.0	15.0	16.5	16.3	14.2	16.6	20.0	63.0	35.3	45.0	47.3	77.9	110.0	77.3	83.8	51.2	50.7	41.3	41.4	46.5	64.3	51.5	36.8	64.6	80.7	74.7	31.4	46.9	48.1	42.4	38.3	39.8	55.0	39.4	35.9	66.2	44.8	87.9	49.3	40.8	47.4	64.7	49.8	43.2	72.5	49.5	60.6	68.9	36.6	75.3	42.0	82.0	25.2	50.4	50.8	76.5	45.0	69.2	32.2	64.9	73.4	83.5	38.9	37.0	50.4	110.1	51.2	42.3	56.7	35.6	61.3	46.0	48.8	71.3	113.3	81.2	53.7	115.8	110.5	79.2	59.7	43.2	65.5
WDR35	"FAP118, IFT121, IFTA1, KIAA1336, MGC33196"	ENSG00000118965	"WD repeat domain 35"	Q9P2L0	2	19910263-19990105	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044147	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA044147: AB_10970242"	"unprognostic (2.51e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.13e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.71e-1)"	3.6	5.1	4.3	2.7	4.4	2.0	7.8	4.1	4.7	6.6	10.0	4.9	1.7	9.3	7.2	2.9	11.3	3.5	3.3	4.1	5.5	7.9	2.0	4.5	2.7	5.5	5.5	9.6	3.8	14.4	9.0	2.7	5.1	5.5	3.0	12.6	3.0	6.3	2.5	3.4	3.0	6.2	4.9	2.0	3.7	10.6	6.0	4.8	8.8	2.6	2.6	4.4	3.7	5.7	8.3	10.4	9.9	9.5	7.6	7.4	0.5	4.2	7.4	6.0	4.3	3.2	3.6	0.0	1.8	4.7	5.0	2.6	10.6	10.3	9.9	1.6	8.2	8.1	6.6	10.0	6.6	15.8	3.1	9.0	7.2	10.7	15.2	10.8	7.4	3.3	13.1	2.3	6.1	3.0	2.3	11.4	11.9	1.5	10.0	0.0	7.1	3.5	12.8	4.7	18.6	21.9	6.9	4.6	12.3	4.7	4.9	3.4	7.7	6.8	3.3	9.4	12.4	4.7	8.3	0.0	12.7	1.1	6.8	2.9	0.1	0.3	0.5	0.0	0.1	0.4	0.3	0.3	0.2	0.6	0.3	0.4	0.2	0.4	0.0	0.1	0.4	0.2	4.3	4.4	4.1	4.7	4.1	5.5	5.5	5.5	5.1	4.9	6.0	5.7	2.9	3.2	9.0	36.6	5.7	3.3	3.5	5.0	2.2	6.5	5.8	7.2	10.8	11.5	7.2	11.0	2.1	0.2	2.9	0.3	0.0	3.3	1.9	16.1	13.1	3.1	6.0	7.8	30.0	4.0	1.0	9.7	5.1	4.0	9.5	9.4	3.6	2.4	1.3	6.7	21.9	1.5	4.1	0.9	2.8	3.5	10.2	2.0	3.6	18.7	1.1	10.0	2.1	25.1	27.6	6.3	0.7	10.9	2.4	2.0	0.7	5.6	28.6	15.2	6.6	14.6	7.4	28.8	9.0	2.2	2.6	0.3	5.4	9.0	1.5	1.1
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	9.1	6.3	3.5	9.4	3.5	9.9	10.1	4.7	4.5	7.4	4.1	7.0	6.5	9.0	6.6	7.9	6.8	7.2	6.0	3.9	4.1	7.5	14.1	6.3	11.3	3.6	4.0	10.1	6.4	7.3	4.5	7.5	3.8	8.3	8.1	4.7	6.0	7.0	9.1	10.1	6.8	7.5	3.8	8.8	7.3	6.3	3.9	9.1	9.7	7.2	12.0	9.8	6.1	4.2	17.0	14.9	13.7	36.6	24.7	32.2	19.2	14.6	13.9	19.5	27.9	19.1	19.7	53.8	17.0	12.2	22.7	19.2	26.8	33.8	34.8	15.9	15.7	26.6	17.2	19.5	26.3	25.6	38.8	19.2	21.4	34.6	37.5	36.5	20.3	18.4	32.3	18.1	25.8	14.3	31.7	24.9	18.3	16.8	15.6	25.6	29.9	42.4	18.1	19.3	24.3	19.5	18.6	15.2	22.4	15.0	15.2	21.3	19.1	28.1	15.6	20.0	30.5	18.1	14.0	48.6	22.4	37.9	22.2	0.3	2.5	1.0	3.3	3.3	3.8	2.7	3.0	3.7	4.0	2.4	4.3	3.6	0.1	3.3	5.0	2.1	3.8	2.6	3.5	3.5	4.7	4.5	3.9	4.1	3.6	4.0	3.8	3.8	3.9	4.2	17.2	19.2	13.8	15.3	26.0	61.1	15.4	18.3	113.3	9.9	14.5	12.1	15.6	18.6	19.6	16.5	6.2	9.4	15.4	5.3	7.9	9.5	5.1	10.6	26.0	20.4	6.0	20.6	30.5	13.8	9.9	20.7	13.7	16.2	14.0	16.9	12.5	35.1	14.7	11.8	24.8	12.9	16.2	24.1	16.0	4.2	8.7	18.2	21.4	20.6	18.3	5.7	16.5	27.6	22.3	9.9	6.4	11.3	27.5	20.8	5.3	11.3	12.3	8.6	19.7	20.2	17.3	18.5	17.8	42.3	57.8	5.3	18.0	18.1	13.4	11.2
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132384	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	8.4	16.5	10.4	9.3	10.5	22.2	7.8	0.4	18.7	8.1	2.0	8.9	7.3	7.9	8.9	9.1	7.8	6.1	17.6	13.1	2.5	8.7	10.3	10.3	12.5	1.5	1.9	9.7	10.1	9.8	14.6	6.3	2.9	8.1	6.7	14.9	7.6	5.1	18.3	11.5	11.2	6.6	0.0	21.0	10.3	21.2	3.1	10.3	9.5	15.7	9.8	7.0	7.9	9.7	12.4	9.0	11.6	9.4	10.9	15.8	8.2	15.5	8.4	9.5	9.4	11.3	10.4	6.1	9.2	20.3	2.0	11.2	6.1	18.1	8.1	7.4	10.0	14.8	9.6	7.7	7.7	8.8	16.0	19.8	13.6	13.6	4.8	11.3	21.0	12.1	9.1	7.3	15.2	10.9	9.8	6.9	6.4	9.6	4.8	14.9	6.5	10.5	13.2	13.8	5.2	10.1	7.2	13.3	11.9	8.8	12.8	17.9	27.7	7.5	2.5	24.8	12.5	13.4	13.3	8.2	17.4	9.9	5.4	6.0	4.8	3.5	10.0	6.2	8.7	5.5	5.6	7.4	5.2	4.4	6.3	7.3	3.8	11.2	7.1	4.8	5.3	5.2	10.4	10.5	0.4	18.7	13.1	2.5	1.5	1.9	2.9	0.0	3.1	9.7	10.5	3.2	8.1	33.6	14.5	13.4	13.0	7.5	10.2	16.3	8.4	7.2	23.3	5.7	7.9	11.0	12.5	6.2	27.4	8.6	0.0	4.8	184.8	5.7	8.6	13.6	10.7	6.5	65.3	6.1	4.2	9.0	13.3	11.1	12.0	7.3	30.7	7.0	9.0	8.4	59.7	8.1	8.2	18.8	13.7	92.9	12.5	14.8	16.0	43.1	23.7	5.3	86.5	36.7	47.3	9.5	8.3	18.0	9.6	13.6	7.2	4.8	4.9	14.7	6.6	13.0	8.5	11.6	14.3	11.9	12.4	11.4	19.1	10.1	5.9	19.7
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	5.1	4.7	4.0	7.2	3.9	6.7	3.9	3.8	4.8	4.3	3.4	3.8	5.0	5.1	1.9	9.1	4.1	1.8	3.5	3.8	3.4	4.8	6.0	3.8	9.3	4.3	3.9	4.3	5.6	2.9	2.3	4.1	4.4	3.4	3.1	1.6	3.6	2.6	6.7	5.0	4.0	3.3	3.9	5.4	3.6	4.7	4.0	5.3	4.1	3.2	7.3	5.7	5.0	4.5	35.7	48.5	12.9	18.5	6.9	8.2	30.7	20.2	7.3	16.9	10.7	48.9	18.1	58.8	11.5	14.5	24.5	19.3	44.7	25.5	11.8	19.2	42.0	59.7	52.0	41.9	13.3	36.8	14.5	4.7	11.2	22.9	16.4	6.3	22.1	20.9	72.6	22.0	14.8	29.4	38.5	20.9	32.3	26.4	47.0	41.6	7.8	58.4	12.8	21.2	30.4	19.5	21.2	31.1	10.2	4.1	20.4	28.2	16.4	25.9	17.3	12.1	41.0	28.9	21.6	48.1	12.5	57.2	31.1	0.0	3.9	0.2	2.4	6.8	3.6	5.4	3.4	3.1	7.1	4.9	3.4	3.5	0.0	3.6	4.2	3.5	4.4	3.5	4.0	3.9	3.8	4.8	3.8	3.4	4.3	3.9	4.4	3.9	4.0	4.5	3.6	0.0	4.8	5.5	10.3	8.5	12.7	7.3	4.0	4.1	5.3	4.6	2.5	0.0	3.2	0.0	2.1	16.3	5.5	5.9	0.0	7.4	4.8	2.8	5.8	5.2	5.4	8.4	4.8	6.7	25.8	4.7	6.1	3.4	10.2	5.4	3.6	7.0	12.5	3.3	4.5	6.0	4.1	3.5	4.0	3.8	2.8	4.7	7.2	2.8	1.9	3.8	2.1	1.5	5.1	6.9	1.0	3.0	15.3	24.6	3.5	6.8	2.1	4.6	6.6	2.7	6.1	10.4	8.4	7.5	10.9	11.5	3.6	8.2	7.7	10.7
WDR41	FLJ10904	ENSG00000164253	"WD repeat domain 41"	Q9HAD4	5	77425970-77620611	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043124	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA043124: AB_10793990"	"unprognostic (1.81e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.11e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.90e-3)"	16.3	9.4	13.5	13.7	15.1	19.3	15.7	13.3	18.3	13.4	8.5	12.8	8.9	10.9	12.3	19.6	16.6	11.7	17.1	13.8	13.7	12.9	14.8	14.0	15.2	15.0	13.6	7.6	21.0	13.8	6.9	11.4	14.8	11.3	13.1	20.6	12.1	10.9	21.4	12.1	8.8	19.1	12.4	11.8	11.3	27.6	14.0	11.7	22.4	21.0	17.2	14.8	10.8	17.0	17.7	29.8	42.6	62.1	41.9	60.1	32.2	55.5	59.6	26.3	47.5	28.1	28.7	54.1	24.6	53.1	44.4	22.3	31.6	77.8	27.6	65.5	37.1	21.6	32.0	24.7	63.7	46.1	50.0	38.5	96.1	30.1	63.1	28.3	42.0	29.6	21.7	56.8	42.2	39.1	24.7	29.7	15.4	17.8	11.7	58.1	56.1	38.7	27.9	14.8	23.5	29.7	48.2	31.0	47.9	49.9	29.4	57.8	38.2	34.3	28.0	19.1	41.3	51.3	44.8	96.7	48.1	20.7	59.4	25.4	28.5	50.1	11.3	33.8	10.9	19.0	6.5	10.2	51.0	13.3	4.4	8.0	13.7	31.8	38.5	23.2	5.8	16.5	13.5	15.1	13.3	18.3	13.8	13.7	15.0	13.6	14.8	12.4	14.0	17.0	10.2	38.5	12.3	63.3	12.6	12.0	25.2	31.0	14.2	34.8	11.6	12.3	17.3	12.8	16.5	18.4	20.9	8.8	16.4	4.4	37.2	22.7	178.8	17.7	25.6	11.3	6.0	13.5	41.3	20.9	25.5	23.7	9.2	8.3	15.8	11.7	8.9	11.5	26.3	23.5	46.7	8.5	14.2	20.2	29.5	87.5	9.6	23.9	17.8	36.5	16.4	14.9	15.5	56.8	78.9	15.2	7.4	8.2	25.6	26.8	5.0	18.7	17.0	19.2	6.6	12.7	22.3	56.4	44.5	23.9	14.2	6.3	11.4	35.5	10.9	28.0
WDR43	"KIAA0007, NET12, UTP5"	ENSG00000163811	"WD repeat domain 43"	Q15061	2	28894667-28948219	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 383.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044733	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"			"HPA044733: AB_10959613"	"unprognostic (3.39e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.66e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	22.1	11.3	7.3	17.5	8.0	42.3	23.6	11.6	8.4	16.5	9.0	16.6	12.1	15.5	9.0	18.2	14.6	12.1	9.6	7.4	8.8	12.3	23.0	11.1	20.3	7.6	7.9	17.0	22.8	15.6	7.4	17.5	8.8	12.1	16.5	13.3	11.5	12.0	55.6	17.6	11.5	19.1	8.4	14.4	12.8	19.8	8.9	18.5	14.5	15.7	24.2	24.2	11.9	10.4	108.5	90.7	42.9	57.0	37.7	47.4	127.1	69.1	44.7	61.4	44.8	92.6	48.6	138.2	50.1	57.9	77.1	54.4	116.6	103.4	98.1	57.9	81.8	122.4	65.5	135.6	57.1	160.9	56.3	49.3	60.5	97.0	164.0	29.3	58.9	52.5	130.2	52.5	54.4	63.7	127.0	89.6	111.0	74.7	59.3	96.3	130.1	95.1	43.4	111.8	61.6	63.8	40.9	67.6	75.1	40.5	30.4	40.5	53.5	63.5	73.1	50.8	118.8	64.2	95.0	383.1	44.2	101.3	60.8	0.4	11.5	8.7	12.5	13.6	22.7	17.3	15.5	14.0	14.8	16.5	19.5	15.0	2.5	22.0	15.5	12.6	14.0	11.7	7.3	8.0	11.6	8.4	7.4	8.8	7.6	7.9	8.8	8.4	8.9	10.4	40.8	51.3	50.7	17.6	54.1	167.7	93.1	41.2	82.0	29.8	53.1	49.7	36.5	37.1	71.5	25.8	22.9	39.0	35.3	21.8	15.6	55.7	88.7	46.1	75.6	40.5	20.9	36.6	28.6	46.2	44.4	56.5	34.7	82.7	45.5	27.5	20.3	49.6	24.3	21.9	29.0	32.1	26.4	21.6	29.6	125.8	37.6	30.3	33.8	30.9	31.8	17.7	27.8	34.2	26.5	55.2	15.7	29.3	42.8	50.8	15.0	19.6	29.7	42.3	6.6	82.7	46.4	33.6	38.6	67.8	148.0	40.4	38.6	41.4	53.8	58.5
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: AB_2679772"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	8.4	7.3	6.6	8.2	8.9	6.0	6.3	7.9	7.6	8.0	2.5	6.8	8.3	7.8	6.7	11.3	5.8	11.8	8.3	7.1	6.9	6.0	12.8	7.9	9.4	6.0	6.5	7.6	6.7	10.1	5.2	7.2	6.1	7.5	6.2	8.4	5.6	10.5	9.7	5.1	7.7	10.4	5.7	8.1	8.6	9.8	7.2	10.6	6.9	8.9	9.2	10.0	6.9	10.1	16.4	9.4	10.0	5.8	16.7	13.6	5.5	25.2	17.6	17.9	25.2	6.4	18.4	4.6	14.4	18.1	15.1	12.6	19.7	12.0	20.6	18.6	8.8	18.5	23.3	4.2	11.5	11.7	12.4	8.1	12.6	17.0	11.4	18.2	16.1	8.5	14.8	15.8	17.3	8.0	9.2	6.9	18.1	12.3	15.1	7.2	8.6	7.2	14.6	10.3	4.3	6.7	23.9	8.3	7.9	17.7	7.4	8.3	20.5	13.3	5.1	18.2	14.4	5.9	10.0	6.5	11.2	13.7	9.1	8.0	3.2	7.3	5.4	4.9	5.5	3.6	4.4	5.4	5.1	3.2	5.1	5.6	2.0	7.2	5.5	3.7	7.1	4.0	6.6	8.9	7.9	7.6	7.1	6.9	6.0	6.5	6.1	5.7	7.2	10.1	14.3	22.4	15.0	18.3	11.0	14.8	7.2	6.3	9.1	8.9	7.6	6.3	11.4	10.0	6.2	12.9	10.4	2.3	9.9	9.6	1.9	5.2	0.4	10.9	10.8	12.0	1.2	5.0	35.2	5.3	2.2	11.1	14.3	17.8	8.8	9.8	5.7	16.7	8.6	1.7	41.2	5.2	4.1	13.6	17.7	1.3	7.2	17.2	7.2	40.3	10.3	7.5	11.3	35.2	89.6	11.0	5.8	11.3	12.1	10.2	6.2	4.2	9.1	7.0	26.3	9.3	11.1	17.5	17.6	12.3	9.2	1.2	14.7	5.7	4.6	7.4
WDR45	"JM5, NBIA5, WDRX1, WIPI4"	ENSG00000196998	"WD repeat domain 45"	Q9Y484	X	49074433-49101170	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027562	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027562: AB_10610565"	"unprognostic (1.39e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.30e-2)"	"unprognostic (6.66e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.27e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-3)"	58.0	74.7	53.3	22.4	59.1	43.2	54.3	56.1	57.8	54.8	59.4	52.3	27.6	51.5	208.4	38.5	45.7	29.7	79.6	53.6	55.3	61.8	68.5	46.6	25.7	63.8	61.1	49.0	58.6	54.8	43.4	21.9	58.1	48.9	19.6	21.2	50.8	34.4	115.9	48.5	38.2	24.7	57.8	45.0	59.0	10.0	61.0	32.3	52.9	87.5	23.2	45.9	43.0	52.7	36.3	41.9	23.4	23.7	50.1	63.7	45.7	39.0	80.6	30.1	42.1	22.1	51.5	25.1	21.6	77.1	38.6	30.8	35.3	31.6	21.6	27.6	61.0	15.6	79.5	33.5	114.2	12.1	34.5	57.2	54.9	49.4	52.1	47.8	30.7	23.8	33.3	42.8	40.3	40.9	25.6	31.0	23.8	15.9	36.3	20.4	34.8	85.7	53.2	32.8	31.3	46.8	49.2	37.5	120.5	29.9	23.9	43.4	41.8	32.8	29.4	65.6	16.6	66.2	48.9	18.1	60.1	19.5	24.1	125.4	89.0	82.0	54.5	81.6	54.3	49.1	41.0	51.4	67.1	48.4	32.0	36.5	88.9	83.7	97.9	68.0	65.3	72.0	53.3	59.1	56.1	57.8	53.6	55.3	63.8	61.1	58.1	57.8	61.0	52.7	36.5	32.1	34.6	15.0	34.0	46.5	54.2	49.3	36.5	18.8	43.7	41.8	35.8	35.8	42.6	35.0	12.5	30.6	56.5	37.9	56.7	71.3	1.3	22.5	35.0	30.5	28.8	71.8	8.9	98.5	56.8	50.8	43.3	26.1	27.3	27.5	35.0	49.7	42.1	26.9	9.3	32.2	10.2	38.8	44.1	3.8	40.4	47.1	35.6	6.5	74.8	38.7	68.0	4.5	11.0	109.6	44.0	32.4	86.5	67.9	68.5	131.2	23.4	24.0	19.7	42.4	44.5	2.6	5.0	24.8	47.3	62.1	33.4	48.3	28.7	73.4
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289247	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043004, HPA055425"	Uncertain		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA043004: AB_10967417, HPA055425: "	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	19.4	19.0	2.2	14.1	2.4	12.6	18.9	1.8	3.8	21.2	2.5	16.4	13.5	23.6	13.6	19.1	17.4	3.2	12.8	2.7	2.7	15.6	17.1	14.7	10.6	2.2	2.4	17.3	19.2	3.0	19.7	5.5	2.6	16.8	11.2	3.0	18.7	2.7	26.1	23.9	15.6	9.6	2.2	20.4	16.7	14.8	2.5	6.3	16.4	12.6	18.8	19.6	17.8	3.5	0.9	21.1	15.3	61.2	11.4	1.6	56.2	42.3	4.9	0.2	7.0	27.8	15.5	49.4	35.5	22.5	60.2	23.4	3.9	31.0	19.3	31.6	32.2	65.6	20.3	54.0	10.4	56.6	74.2	12.5	5.2	18.4	9.5	15.6	0.0	26.6	37.5	13.8	6.8	23.3	32.1	46.8	45.1	8.5	18.3	47.1	28.1	40.3	9.3	20.7	30.9	40.3	20.4	44.4	46.9	18.3	17.2	37.8	30.9	37.9	42.8	31.6	64.3	56.5	104.3	83.5	16.4	55.9	35.3	12.1	17.3	6.2	24.9	28.7	21.4	16.1	18.2	22.4	27.9	18.9	17.0	21.7	1.2	28.1	33.9	13.7	18.6	20.1	2.2	2.4	1.8	3.8	2.7	2.7	2.2	2.4	2.6	2.2	2.5	3.5	21.0	0.0	11.7	2.9	30.4	43.7	30.8	40.7	28.5	14.4	23.8	20.2	7.2	17.2	25.7	23.9	6.2	44.0	33.9	20.4	11.7	43.5	65.0	19.0	30.9	22.9	13.8	13.7	11.1	43.0	48.7	27.7	20.4	24.3	21.6	35.1	14.6	26.4	28.9	13.5	6.5	21.5	22.4	19.0	24.1	23.3	25.7	22.0	17.8	5.6	29.0	17.9	36.0	2.5	2.8	33.1	15.6	23.0	25.0	38.0	18.2	37.8	14.7	10.1	13.1	35.7	28.3	42.3	37.2	23.6	42.6	38.2	26.1	46.8	31.9	30.0
WDR47	KIAA0893	ENSG00000085433	"WD repeat domain 47"	O94967	1	108970214-109042113	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 93.6;Suprabasal keratinocytes: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027287, HPA027289"	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	"Actin filaments"	Nucleoplasm	"HPA027287: AB_10599416, HPA027289: AB_10601862"	"unprognostic (8.55e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.05e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.39e-3)"	"unprognostic (7.90e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.09e-2)"	7.8	7.1	22.6	5.5	26.6	12.2	6.3	14.1	27.3	8.8	1.5	8.0	3.7	9.3	5.7	14.4	8.5	7.3	8.1	27.7	17.9	7.6	3.5	7.0	5.6	13.4	11.0	7.5	5.9	9.2	5.3	6.5	14.6	7.3	5.3	37.0	5.8	7.0	17.0	22.9	4.5	10.2	10.9	5.7	6.0	22.7	16.7	7.7	6.2	15.3	7.5	7.5	8.9	19.5	15.6	4.7	8.8	10.9	17.0	14.8	4.7	17.4	10.7	11.4	12.7	4.6	2.3	7.0	9.0	16.7	8.4	17.1	12.5	7.6	15.0	13.1	7.0	5.8	9.9	5.3	9.7	9.2	8.3	9.2	12.4	17.9	8.5	13.8	13.7	8.1	3.5	9.5	19.4	9.3	8.9	7.2	3.7	5.0	9.1	12.5	22.3	3.9	19.0	13.3	15.3	14.0	15.2	8.1	12.5	9.4	3.7	9.3	23.5	15.1	7.0	26.7	14.5	6.1	5.4	5.5	17.6	9.0	23.0	18.0	5.4	7.1	3.3	5.7	3.1	2.4	3.1	3.5	5.8	3.4	2.8	2.5	22.0	2.7	5.9	6.3	5.5	2.6	22.6	26.6	14.1	27.3	27.7	17.9	13.4	11.0	14.6	10.9	16.7	19.5	16.5	12.8	6.5	33.3	13.8	93.6	5.1	7.7	62.0	15.3	11.1	12.6	18.9	10.0	8.0	7.3	45.9	2.4	25.1	2.7	5.9	3.5	33.2	20.5	9.3	12.1	3.0	1.7	46.2	0.9	2.1	10.7	8.2	10.4	2.5	5.6	7.1	2.0	4.4	11.8	39.1	1.0	4.1	5.5	28.4	41.4	8.4	13.9	24.9	19.7	6.3	13.2	8.2	15.1	26.5	3.9	0.9	15.1	14.9	2.4	2.4	5.5	18.9	32.3	6.6	13.5	16.5	32.2	28.9	52.1	104.4	4.9	18.9	3.3	2.1	4.1
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39052013-39096671	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	14.1	15.5	20.7	13.3	22.2	35.1	17.7	20.3	25.7	17.7	17.1	14.3	15.1	20.0	14.1	14.0	15.7	13.2	16.2	21.9	22.9	21.4	16.1	13.9	17.6	21.2	21.8	21.1	16.1	22.0	4.4	20.8	21.3	16.0	15.1	17.9	15.4	20.9	11.5	14.1	15.1	16.9	21.6	16.1	14.2	47.9	22.8	26.8	24.8	17.1	19.4	16.8	6.3	24.2	11.6	16.4	32.9	23.6	23.8	27.2	14.4	14.4	20.6	17.6	22.5	11.5	12.7	27.8	10.0	20.2	15.7	13.8	30.3	18.7	20.5	70.3	38.8	26.1	22.8	19.0	10.8	18.8	13.7	18.1	21.2	19.0	21.9	31.9	21.8	20.1	30.7	27.8	16.3	9.9	24.6	20.1	36.3	16.8	19.8	9.6	17.3	24.1	21.9	24.2	24.1	29.0	14.7	29.8	25.4	29.0	15.6	26.7	18.8	15.9	12.0	14.7	16.2	30.2	48.6	22.7	18.5	16.9	15.5	13.3	6.0	7.5	9.2	7.9	9.1	9.4	10.6	10.7	8.7	10.9	10.7	9.3	8.0	15.1	13.0	7.2	12.6	8.9	20.7	22.2	20.3	25.7	21.9	22.9	21.2	21.8	21.3	21.6	22.8	24.2	27.0	16.0	22.0	45.4	26.6	17.6	13.3	9.2	20.5	21.6	18.1	16.6	23.2	7.2	15.5	11.0	16.7	15.9	26.0	14.4	17.6	13.9	77.2	20.2	28.5	20.6	22.1	17.9	35.3	12.4	12.2	18.0	9.7	29.7	24.1	25.5	16.1	13.0	8.6	21.9	37.0	13.7	4.1	11.4	15.9	71.9	18.6	16.2	14.2	26.2	19.8	23.6	13.4	38.7	41.1	12.0	12.9	16.6	20.9	21.9	17.3	13.4	17.8	17.9	26.3	21.9	19.2	104.5	59.9	16.7	21.2	21.5	25.7	23.0	12.3	19.5
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 2.9;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.5"	"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.1	0.1	10.2	0.4	8.2	2.0	0.1	16.6	3.4	0.3	29.3	0.1	2.0	0.4	0.0	0.9	10.0	0.2	2.1	7.0	15.6	0.3	0.0	1.9	0.3	30.1	27.0	0.1	0.3	0.0	0.5	0.0	23.8	0.2	0.1	0.0	0.2	0.0	0.0	0.1	4.6	0.1	31.3	0.4	0.2	0.6	15.5	0.4	0.0	0.2	0.3	0.2	0.2	23.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	10.2	8.2	16.6	3.4	7.0	15.6	30.1	27.0	23.8	31.3	15.5	23.4	0.2	0.0	0.6	79.0	0.1	0.0	0.9	1.7	9.1	0.0	0.1	0.1	1.1	0.0	10.9	0.0	0.0	0.0	1.6	0.1	0.0	0.1	2.4	43.4	0.3	0.2	0.0	1.7	4.5	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	4.1	1.6	2.5	0.8	0.0	1.8	0.0	0.0	4.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	47.7	0.0	6.6	0.3	0.6	0.1	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.8
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 74.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	7.8	7.4	9.4	6.9	10.3	14.7	9.0	10.3	12.1	7.7	9.7	8.1	4.3	8.1	11.0	9.0	7.1	6.3	8.1	9.5	10.0	8.8	10.0	6.9	10.6	9.6	9.7	7.0	5.9	10.0	6.7	6.3	11.2	7.2	7.1	8.9	7.0	6.1	13.0	11.9	7.9	7.4	9.4	10.8	7.2	74.2	9.8	12.1	7.1	12.6	11.9	7.2	7.6	11.3	39.4	8.5	14.6	13.6	15.0	13.2	23.8	20.1	16.2	23.0	21.7	22.8	20.2	18.9	66.4	13.0	21.2	22.3	18.9	18.4	28.8	30.0	16.3	19.4	21.2	14.6	18.5	26.9	14.3	10.7	25.9	20.6	22.2	11.4	18.7	23.6	18.8	34.5	17.7	36.4	22.5	27.5	19.5	25.7	24.4	26.5	25.3	40.5	12.8	13.4	15.0	15.2	15.0	20.8	32.2	19.8	53.0	24.2	17.2	18.9	18.0	21.5	40.6	29.5	63.8	56.6	12.7	34.2	19.4	13.1	5.5	15.7	8.8	4.7	14.1	7.8	12.2	8.5	4.7	7.5	10.2	6.1	4.7	7.4	7.8	6.2	16.5	5.0	9.4	10.3	10.3	12.1	9.5	10.0	9.6	9.7	11.2	9.4	9.8	11.3	3.9	0.0	2.8	6.8	3.8	4.2	3.2	8.1	2.8	3.7	3.4	3.4	5.6	2.8	5.8	3.7	0.0	5.7	3.5	1.7	5.9	5.0	313.9	3.3	3.5	4.7	0.0	7.4	5.5	4.2	6.1	3.9	0.5	2.7	9.5	3.2	3.9	2.5	4.3	3.3	4.8	1.6	10.2	3.8	3.0	118.8	5.0	3.9	5.4	10.3	7.3	4.0	4.1	6.0	7.1	3.7	1.9	3.4	3.7	2.9	1.5	5.0	3.1	2.8	19.7	4.0	5.5	135.6	13.9	3.5	4.7	4.7	6.3	4.1	2.7	2.6
WDR54	FLJ12953	ENSG00000005448	"WD repeat domain 54"	Q9H977	2	74421678-74425755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 70.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043257, HPA053558"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA043257: AB_10795981, HPA053558: AB_2682189"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.85e-2)"	8.2	8.5	11.0	6.5	11.7	6.7	7.7	8.5	11.2	11.8	17.6	6.7	3.2	10.4	5.6	3.4	70.2	8.4	4.3	11.8	14.2	12.1	1.9	10.7	11.6	10.3	12.5	10.8	6.3	30.0	24.4	6.3	11.2	7.4	4.0	28.0	5.2	9.9	1.3	4.9	7.0	7.7	10.8	12.2	7.0	38.0	11.7	18.5	7.8	1.7	11.2	8.6	6.3	9.9	44.9	78.3	37.9	32.5	14.0	25.7	11.8	22.5	45.8	56.8	52.8	6.9	34.4	39.3	22.5	25.1	34.5	37.6	27.8	100.6	49.8	30.3	16.8	19.4	42.4	4.7	14.3	30.6	15.3	11.6	27.6	58.1	30.3	67.5	30.6	61.6	7.7	45.8	32.4	69.8	48.6	32.3	30.3	10.9	29.8	41.2	44.1	84.4	51.3	22.4	66.4	52.1	17.6	15.9	27.0	11.2	25.6	14.7	15.3	29.2	50.9	32.1	50.7	49.2	26.7	10.1	86.5	18.8	21.6	6.6	8.5	0.6	31.1	11.5	31.4	24.2	35.5	33.7	28.6	22.0	25.1	23.8	0.7	29.1	10.1	46.7	36.8	21.6	11.0	11.7	8.5	11.2	11.8	14.2	10.3	12.5	11.2	10.8	11.7	9.9	20.0	3.2	12.8	1.3	23.1	7.0	20.1	64.1	10.2	48.3	9.4	10.9	1.7	20.0	39.4	23.9	83.4	9.8	30.1	1.5	19.6	28.5	77.8	207.0	18.5	25.1	28.9	5.5	5.6	6.0	14.6	14.3	7.1	9.2	12.7	23.8	30.0	1.9	8.6	32.0	4.1	6.0	38.7	6.9	17.4	124.6	17.1	7.4	12.4	0.0	29.8	51.9	26.8	3.0	2.4	13.6	4.4	22.2	17.5	9.4	0.8	28.4	395.9	112.5	0.0	8.4	30.6	147.9	19.3	1.7	4.8	2.9	30.5	37.2	3.8	13.3
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	9.9	9.2	5.2	9.5	5.4	12.9	9.2	6.2	5.6	7.6	6.8	10.6	9.3	7.8	4.3	13.4	7.4	6.1	7.7	5.4	5.8	9.4	12.3	8.8	10.1	6.4	5.6	7.5	11.1	6.1	9.0	7.6	6.0	8.8	10.3	4.0	10.5	5.4	9.1	11.0	11.0	6.4	5.4	12.6	10.5	4.9	5.7	7.8	7.4	6.0	10.6	8.9	7.9	5.9	13.2	18.0	8.5	34.4	12.8	10.1	23.7	12.9	15.5	13.3	15.2	31.1	17.7	12.3	16.8	16.6	24.3	16.1	11.5	22.4	10.2	11.6	9.6	14.1	15.9	12.7	12.2	14.8	25.5	12.2	12.7	18.3	9.6	9.2	14.4	13.7	9.9	9.3	14.9	19.2	14.0	13.3	8.9	18.9	15.2	11.6	12.2	11.6	15.9	19.7	8.3	11.1	17.7	51.3	20.2	10.4	36.3	15.8	13.0	17.5	9.0	20.3	17.6	15.6	12.9	9.6	22.7	19.5	10.6	6.4	10.2	7.8	11.3	16.6	11.7	8.5	10.5	9.8	9.9	7.3	8.3	8.5	9.0	10.3	14.2	7.2	12.6	10.0	5.2	5.4	6.2	5.6	5.4	5.8	6.4	5.6	6.0	5.4	5.7	5.9	17.1	9.6	16.7	5.9	16.9	14.5	10.9	9.1	9.6	13.5	15.5	10.3	5.3	5.7	16.2	18.4	12.5	21.6	28.9	31.9	21.5	20.2	29.3	20.6	13.1	12.9	14.9	13.9	7.2	28.2	42.8	12.6	25.0	13.9	19.7	16.4	12.5	14.9	20.8	23.5	7.0	22.6	8.2	16.1	13.9	9.7	9.6	18.3	8.8	1.0	20.5	5.7	23.7	4.5	6.5	27.2	39.3	7.5	23.0	15.6	24.9	20.8	17.2	8.3	13.1	13.0	14.1	7.9	9.8	15.1	13.4	23.3	21.0	14.2	26.0	16.4
WDR59	FLJ12270	ENSG00000103091	"WD repeat domain 59"	Q6PJI9	16	74871362-75000173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041084, HPA048218"	Approved		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA041084: AB_10793867, HPA048218: AB_2680318"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.16e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.61e-2)"	11.6	19.0	18.2	13.8	22.1	16.1	14.2	18.2	21.3	19.2	15.5	15.3	13.1	16.1	21.1	17.3	14.9	9.7	17.0	17.9	20.0	17.3	35.7	11.1	12.7	19.0	19.3	22.4	16.9	22.6	22.9	14.1	19.8	15.8	14.0	37.9	14.1	11.6	24.8	21.1	16.4	13.2	17.2	15.3	14.2	13.9	20.6	22.3	22.9	17.4	16.0	14.5	17.3	28.5	15.6	23.8	27.1	25.8	20.8	18.7	22.9	9.8	17.0	20.7	23.5	32.3	27.1	21.8	10.6	18.3	19.3	24.6	21.7	23.4	29.3	13.2	23.1	27.9	16.3	52.5	12.6	20.4	32.7	21.8	18.7	25.1	23.7	26.7	21.7	52.5	42.0	10.6	9.9	46.1	31.4	36.4	21.6	34.0	9.7	31.3	11.9	18.3	22.2	13.9	16.5	18.2	28.0	16.2	12.6	28.5	24.5	17.8	19.0	12.9	19.6	14.8	8.5	20.1	29.3	47.2	22.8	14.1	14.3	0.7	0.7	0.7	1.0	0.4	3.4	1.9	1.9	1.5	0.4	1.1	1.2	1.4	0.7	1.0	0.8	0.7	1.0	0.4	18.2	22.1	18.2	21.3	17.9	20.0	19.0	19.3	19.8	17.2	20.6	28.5	9.8	16.0	16.5	77.1	15.0	22.4	20.0	12.7	21.6	38.8	15.0	16.3	17.6	21.5	15.0	22.0	62.6	34.4	9.6	13.1	9.8	13.0	37.4	13.1	14.6	11.8	22.1	21.0	41.5	9.6	16.5	13.6	17.3	20.1	13.3	22.4	17.9	24.6	10.8	20.2	53.8	11.9	12.2	13.2	17.1	79.2	13.4	12.7	8.8	29.0	15.3	11.9	14.4	65.9	88.8	11.9	14.0	11.7	5.9	24.1	17.0	19.6	16.7	55.5	19.7	17.1	9.7	17.7	19.1	16.5	24.2	47.3	15.3	13.8	16.8	23.4
WDR5B	FLJ11287	ENSG00000196981	"WD repeat domain 5B"	Q86VZ2	3	122411846-122416062	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042994	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA042994: AB_10960397"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.45e-3)"	2.6	3.4	2.0	3.6	2.6	1.9	6.2	2.9	2.5	4.1	2.8	2.1	3.4	3.0	9.5	2.1	7.0	2.2	2.9	2.1	2.2	3.9	5.3	2.9	5.6	2.6	2.4	4.7	6.0	3.9	3.7	2.9	2.6	4.4	2.7	7.2	4.8	3.2	1.7	3.5	3.6	2.5	2.3	5.1	4.6	3.7	2.3	4.9	6.8	1.7	5.3	2.4	2.1	3.5	5.3	3.2	4.9	5.6	8.8	7.2	3.0	3.9	5.9	5.4	4.6	2.9	4.6	3.2	5.3	3.7	4.4	7.3	3.9	2.9	7.0	2.0	3.3	4.7	3.8	2.9	5.7	2.6	5.0	4.9	7.9	4.0	9.2	6.2	4.2	5.6	2.1	2.7	4.5	6.3	4.2	4.8	2.4	7.9	5.3	4.0	4.8	2.8	5.1	2.2	5.5	5.9	4.0	2.6	8.1	5.5	7.5	5.6	3.4	4.1	5.1	2.0	2.6	2.3	1.0	6.2	5.5	2.5	5.3	3.0	2.0	1.3	1.2	2.1	1.6	1.3	1.9	1.1	1.0	1.8	2.8	2.1	0.7	1.1	4.3	0.6	2.3	1.2	2.0	2.6	2.9	2.5	2.1	2.2	2.6	2.4	2.6	2.3	2.3	3.5	2.7	3.2	4.8	4.2	2.7	0.5	2.8	4.0	2.8	4.1	5.0	3.9	2.6	5.7	4.0	12.9	6.2	5.6	1.2	0.9	7.9	4.3	14.9	5.8	3.6	3.0	0.0	6.1	1.2	4.0	1.6	3.1	4.1	2.3	0.0	3.3	6.1	4.9	2.5	6.7	1.2	3.8	0.0	4.3	0.6	1.0	4.7	1.8	0.0	0.0	2.1	6.2	9.2	3.5	7.6	2.5	2.0	3.0	1.6	3.7	3.2	6.5	16.3	7.1	0.0	3.2	3.3	11.9	4.9	1.6	2.0	2.9	2.7	2.2	2.5	1.8
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	67.5	148.8	108.7	51.9	106.3	41.8	69.8	104.9	124.5	153.1	120.1	130.1	66.5	122.8	83.1	65.1	129.8	59.7	82.7	105.8	116.3	113.7	97.7	77.8	61.2	105.1	112.8	205.9	136.7	91.0	207.4	46.1	108.1	159.3	50.9	49.4	99.2	74.1	71.4	63.7	105.4	68.1	102.0	112.9	93.3	61.2	120.9	54.7	178.2	37.8	53.5	118.8	90.5	107.2	61.4	82.4	133.7	113.7	87.8	71.1	90.1	89.4	73.1	98.7	79.4	73.9	86.2	98.3	55.5	143.2	75.8	68.1	107.8	125.0	70.0	78.3	71.8	93.1	223.0	98.8	88.8	97.3	40.3	128.5	87.3	91.1	68.4	136.2	73.0	101.8	54.0	102.4	90.6	121.7	113.5	109.8	119.1	55.7	75.9	65.5	57.3	61.8	117.6	179.3	64.9	121.0	66.8	54.1	40.6	96.9	94.8	76.7	98.4	72.7	116.1	71.3	121.1	177.3	82.7	84.3	98.7	122.2	53.4	6.4	11.5	12.8	19.0	15.5	21.1	13.0	13.9	14.4	13.5	12.8	15.8	12.2	3.9	14.6	8.0	17.0	12.6	16.8	108.7	106.3	104.9	124.5	105.8	116.3	105.1	112.8	108.1	102.0	120.9	107.2	16.0	22.4	48.5	67.9	28.0	17.8	24.3	32.0	27.9	26.0	48.1	43.1	3.1	42.9	38.5	47.8	47.9	46.5	21.4	18.4	9.8	30.7	4.3	34.6	32.3	20.8	72.3	16.6	9.3	26.0	21.0	24.1	36.7	39.2	29.1	66.7	26.0	44.7	26.8	37.0	17.5	32.3	28.5	19.2	20.2	7.0	38.2	18.7	12.4	22.5	24.7	39.0	12.3	27.2	23.3	28.0	23.5	28.2	29.9	26.2	30.8	31.3	26.2	46.4	26.3	20.0	21.0	43.0	34.9	15.5	11.4	56.5	25.9	44.7	36.4	19.9
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299703	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	38.8	52.7	34.5	29.6	36.5	61.5	59.9	50.4	63.0	40.8	31.1	39.5	36.2	34.9	115.7	40.1	46.6	28.6	41.0	40.8	40.4	60.8	50.9	34.6	37.4	41.5	41.2	34.6	41.3	55.6	49.9	35.5	40.0	46.0	43.5	49.4	39.5	37.4	45.4	52.1	30.4	41.4	38.2	29.9	33.5	49.0	37.0	48.5	56.8	38.2	46.0	41.4	32.4	61.5	39.3	92.4	74.3	77.4	74.1	61.6	56.1	60.9	68.6	76.6	73.6	87.9	67.9	80.7	72.6	69.8	119.2	78.2	165.8	71.5	58.3	53.9	123.8	66.2	79.9	84.6	62.6	99.2	63.3	52.8	50.5	30.8	24.0	52.7	82.7	80.0	113.1	78.8	92.5	116.6	82.3	81.6	54.3	98.5	76.2	74.7	59.7	89.1	81.3	112.3	103.7	56.2	88.0	90.9	323.7	76.9	56.0	124.2	58.2	53.7	66.0	38.2	103.6	69.3	113.7	113.0	80.5	153.3	112.6	39.0	91.2	33.6	59.6	100.0	65.0	66.4	59.7	62.1	134.2	53.5	62.2	68.6	7.7	72.4	86.0	71.6	72.7	89.1	34.5	36.5	50.4	63.0	40.8	40.4	41.5	41.2	40.0	38.2	37.0	61.5	38.7	35.3	44.7	20.5	26.7	49.1	61.5	105.0	31.9	57.2	44.8	47.2	25.8	28.6	57.5	38.6	47.9	106.1	29.2	23.2	125.2	62.5	32.2	41.5	38.6	42.2	23.4	37.6	34.6	55.6	78.1	51.0	20.4	29.1	47.5	49.1	40.0	47.0	66.1	43.7	36.8	38.0	93.6	37.0	47.2	12.4	50.1	37.0	58.7	12.2	61.1	81.9	42.2	17.1	33.1	41.0	28.5	50.8	36.4	51.6	35.4	132.7	70.1	50.7	6.6	37.8	90.2	122.4	60.2	38.3	58.7	92.4	31.7	59.4	52.4	57.7
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WDR64	FLJ32978	ENSG00000162843	"WD repeat domain 64"	B1ANS9	1	241652278-241802133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 3.1"	"Group enriched"	"Detected in some"	18	"Early spermatids: 158.3;Late spermatids: 149.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046186	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA046186: AB_10960064"	"unprognostic (6.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.56e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	158.3	0.0	0.0	0.2	0.0	0.0	8.3	0.0	1.2	0.1	0.0	0.1	0.0	2.7	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.0	0.0	149.8	1.8	0.2	0.0	2.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.4	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.9	0.7	0.0	0.0	0.8	0.3	0.5	0.0	0.0
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57029811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	5.9	7.6	13.2	5.9	14.2	7.2	4.9	7.0	19.8	4.8	3.1	5.4	4.1	4.8	5.3	4.4	4.2	5.3	5.9	16.2	11.1	5.3	7.4	5.0	7.4	14.6	8.8	4.2	4.2	9.2	8.4	4.7	14.7	7.5	4.9	18.8	4.2	5.7	8.2	4.3	4.3	5.6	7.8	6.2	4.9	4.6	9.6	10.3	9.1	9.6	5.8	5.0	4.5	16.0	4.7	7.7	8.7	4.9	13.5	7.8	2.2	9.2	7.8	7.4	8.8	3.1	2.9	13.0	3.6	8.3	6.3	4.9	8.8	7.2	9.2	15.1	5.4	12.3	5.8	2.8	8.1	18.7	15.0	6.7	5.9	9.9	6.6	6.1	9.3	6.1	6.0	17.5	9.3	4.6	13.0	5.5	3.7	2.4	5.1	5.8	6.7	6.3	5.7	8.4	11.3	5.6	6.5	3.1	4.3	7.4	4.9	5.2	8.3	10.5	5.3	3.2	5.0	17.4	14.2	13.9	8.6	9.3	7.2	4.0	3.0	5.5	3.6	4.4	4.5	2.4	4.0	3.7	3.6	2.2	4.2	3.8	2.6	4.6	5.5	1.7	5.2	2.0	13.2	14.2	7.0	19.8	16.2	11.1	14.6	8.8	14.7	7.8	9.6	16.0	8.7	3.2	4.8	99.6	7.5	2.9	1.9	2.3	2.8	24.5	3.4	2.4	12.5	5.7	6.8	0.0	31.3	2.0	7.7	5.8	3.9	3.2	21.0	4.4	6.0	6.6	8.4	8.2	268.8	3.6	1.2	6.3	7.7	3.9	10.8	9.0	9.3	8.9	5.8	26.9	223.0	2.7	0.0	16.2	2.8	7.0	5.6	11.3	0.0	111.5	8.8	7.1	10.3	146.3	244.7	2.6	2.6	8.2	10.1	2.6	4.5	3.2	5.7	26.3	6.6	10.7	5.8	2.0	1.7	5.8	2.4	0.7	9.9	9.3	4.1	1.6
WDR70	FLJ10233	ENSG00000082068	"WD repeat domain 70"	Q9NW82	5	37379285-37753435	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 177.2;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043064, HPA048149"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA043064: , HPA048149: AB_2680287"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.11e-2)"	9.2	6.2	3.6	7.4	4.4	12.6	10.5	8.2	5.0	9.3	4.7	9.1	7.1	11.5	8.6	8.1	8.9	6.8	7.8	3.4	4.8	7.3	8.0	8.2	10.4	5.1	4.3	10.8	8.4	9.4	4.0	9.5	5.2	8.4	9.3	5.2	7.5	8.8	15.4	8.8	8.2	10.6	3.5	9.5	7.8	8.8	5.0	11.8	8.9	11.1	10.8	8.6	7.9	6.7	17.8	11.5	22.7	28.9	22.8	22.4	31.2	21.6	21.9	26.3	21.6	19.5	17.9	28.7	12.7	21.6	19.8	16.4	19.4	21.7	27.9	27.5	24.5	21.5	34.3	13.9	17.6	37.4	18.5	21.8	15.8	19.9	26.9	19.8	21.5	21.7	27.2	11.5	16.7	12.2	23.8	18.6	15.4	14.7	21.4	27.2	56.1	29.9	13.3	21.0	19.5	18.3	73.6	16.3	16.6	17.0	21.0	23.3	23.8	22.7	21.6	22.2	17.8	15.3	24.1	32.9	15.1	33.3	19.2	8.1	16.5	15.0	9.7	20.7	10.5	13.4	11.2	10.6	17.9	14.8	11.0	10.5	3.7	14.0	19.5	18.4	12.0	8.3	3.6	4.4	8.2	5.0	3.4	4.8	5.1	4.3	5.2	3.5	5.0	6.7	23.7	32.1	29.1	103.2	25.1	9.2	13.7	15.4	12.5	37.2	23.3	17.5	18.6	17.2	14.4	9.2	37.5	27.1	33.6	18.3	19.6	18.3	20.1	16.9	36.4	17.7	13.8	17.7	177.2	20.7	26.7	17.9	15.8	20.1	19.7	22.8	22.5	25.7	18.9	25.2	166.2	21.5	14.2	25.8	6.4	7.0	29.5	21.2	12.4	113.4	31.3	16.4	30.9	153.3	168.6	16.1	17.0	22.6	21.5	6.9	16.1	21.2	20.8	52.2	13.1	20.0	21.7	42.7	25.2	11.9	7.7	22.2	20.2	17.3	22.1	8.7
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 105.7;liver: 33.1;thyroid gland: 57.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.1	7.2	0.0	0.6	2.6	1.4	0.5	0.4	2.6	3.9	0.1	0.0	0.1	105.7	33.1	0.8	0.1	0.1	0.4	0.2	3.5	1.8	0.3	0.1	0.1	0.1	0.8	0.7	18.4	0.6	0.0	2.0	0.9	0.0	0.0	0.1	1.1	0.5	0.1	0.0	57.9	0.0	0.0	1.7	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	3.2	0.1	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	18.3	0.1	0.0	0.1	17.5	10.1	3.5	1.9	0.0	0.0	0.1	0.0	15.2	2.4	0.0	0.1	0.3	0.5	0.0	0.1	7.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	6.4	3.6	0.0	0.5	0.1	1.1	0.0	0.6	0.5	0.0	0.1	0.6	12.8	0.0	22.0	0.0	0.6	0.0	0.2	9.8	3.2	1.2	4.9	1.0	0.1	0.0	0.0	0.4	0.5	2.1	0.2	0.0	13.2	0.0	0.0	0.0	44.3	0.1	3.3	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	93.2	0.1	0.1	0.0	0.0	0.1	1.0	1.6	0.9	0.4	0.1	0.7	0.0	0.3	6.4
WDR73	"FLJ14888, HSPC264"	ENSG00000177082	"WD repeat domain 73"	Q6P4I2	15	84639285-84654343	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039357	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA039357: AB_10673242"	"unprognostic (8.49e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.19e-4)"	"unprognostic (9.21e-4)"	"unprognostic (4.12e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.02e-2)"	2.2	3.6	1.8	2.2	2.1	2.8	3.3	3.0	2.3	3.2	3.1	3.2	2.3	3.4	4.2	2.7	3.3	1.5	2.2	2.3	2.1	3.2	2.3	2.4	2.3	2.0	2.2	3.3	3.1	3.7	3.2	1.6	2.3	3.5	2.7	3.4	2.9	2.4	2.2	3.0	3.1	2.9	1.8	3.3	2.9	1.8	2.1	3.0	3.9	1.8	2.8	2.9	2.8	2.8	2.8	4.6	5.5	2.7	2.7	3.1	2.8	1.4	2.7	2.4	1.8	4.3	4.7	3.2	1.5	4.7	2.5	6.6	6.4	4.3	2.6	1.7	3.4	2.3	5.5	2.5	3.7	3.4	3.2	5.6	4.0	3.9	5.5	4.5	2.2	3.9	3.9	1.8	1.4	4.7	4.0	5.1	4.7	2.9	1.9	4.2	4.1	2.4	3.7	7.0	3.5	5.8	3.6	5.1	5.8	3.0	8.4	6.5	2.4	2.9	3.3	3.1	4.2	3.4	6.0	2.6	5.1	5.7	4.2	0.4	0.3	0.4	0.4	0.4	0.4	0.3	0.2	0.4	0.1	0.6	0.3	0.3	0.8	0.4	0.2	0.3	0.1	0.4	1.8	2.1	3.0	2.3	2.3	2.1	2.0	2.2	2.3	1.8	2.1	2.8	17.0	25.6	32.8	21.9	17.5	5.4	18.9	18.6	12.5	48.4	16.9	20.1	1.1	27.1	25.9	29.5	73.0	33.6	14.4	13.9	23.5	27.6	4.8	32.2	26.3	14.9	18.0	14.3	13.6	14.0	16.1	18.2	16.3	21.8	17.1	38.0	18.9	9.5	13.2	40.4	15.2	13.8	22.4	10.7	5.1	2.3	22.7	9.8	5.4	15.0	17.4	36.8	21.6	13.6	12.2	17.3	11.5	16.1	8.4	17.7	10.1	20.7	70.1	98.5	6.6	27.2	17.7	44.9	18.0	8.7	5.3	25.7	17.1	44.5	15.0	13.9
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 565.6;choroid plexus: 711.0"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.3	21.8	352.4	20.5	274.3	127.1	21.2	485.9	291.6	19.5	711.0	19.6	17.1	20.8	14.6	25.8	22.3	11.4	23.1	251.8	208.5	21.5	28.5	14.9	30.6	220.8	221.4	25.6	30.9	15.1	11.4	18.3	292.3	19.5	16.4	33.7	25.0	13.7	59.3	31.2	17.7	17.0	305.3	30.1	22.0	15.4	244.7	62.3	28.4	25.3	23.9	24.8	18.9	565.6	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	352.4	274.3	485.9	291.6	251.8	208.5	220.8	221.4	292.3	305.3	244.7	565.6	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826980-43868412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.1;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	2.6	1.2	1.0	8.4	1.1	19.1	3.5	4.8	1.7	3.0	0.8	4.8	3.2	3.3	0.9	4.5	1.7	1.9	1.1	0.7	1.1	1.5	2.2	2.4	19.8	1.3	1.1	2.2	3.1	2.7	1.1	3.9	1.3	1.9	6.0	6.3	2.4	2.0	0.8	4.1	3.3	3.9	1.0	3.6	2.9	5.3	1.3	19.5	2.5	1.3	21.3	2.8	2.8	1.2	35.1	17.5	40.7	31.3	4.5	10.7	11.1	57.3	33.9	61.5	76.8	22.1	17.8	51.4	24.8	26.9	31.0	49.4	42.4	20.5	53.1	80.4	25.2	63.3	52.1	7.3	2.5	65.0	27.0	3.4	3.3	33.8	7.7	8.9	19.9	54.7	48.6	86.9	42.6	12.2	63.4	15.4	14.6	11.0	18.1	66.9	70.1	32.4	11.4	35.5	31.3	30.9	36.1	22.5	7.0	12.6	35.0	31.0	9.1	56.3	26.5	63.5	58.9	42.7	114.6	129.1	40.4	56.7	31.5	0.0	0.6	0.3	3.8	0.5	4.1	1.8	4.6	3.4	1.0	2.2	3.8	2.9	0.0	4.8	0.2	1.2	6.6	2.0	1.0	1.1	4.8	1.7	0.7	1.1	1.3	1.1	1.3	1.0	1.3	1.2	4.1	3.2	1.3	2.6	8.2	7.4	3.2	2.4	4.6	3.7	3.7	2.8	1.2	1.5	2.3	1.8	10.4	12.8	6.2	3.5	1.9	2.9	1.7	1.8	3.9	4.8	0.0	35.3	2.5	4.2	13.0	3.9	4.6	3.3	5.7	12.2	2.9	0.9	8.9	1.7	3.3	3.7	0.0	3.5	5.3	0.9	1.8	3.9	3.6	2.8	3.3	8.0	10.3	0.5	1.9	1.1	3.1	2.2	16.1	1.5	1.4	0.9	0.4	16.2	6.6	5.8	5.7	23.5	35.9	7.4	5.8	3.6	11.6	1.5	9.0	1.8
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	16.5	23.5	13.5	18.2	13.6	10.3	14.1	13.0	13.5	14.2	13.3	17.0	14.9	20.1	17.7	27.3	104.9	12.4	29.6	15.1	14.6	19.5	22.7	13.8	28.4	14.1	15.2	12.6	17.5	18.2	14.2	18.5	14.2	17.4	24.1	11.4	19.4	14.7	42.2	13.6	16.3	19.2	13.4	22.5	21.2	14.1	15.1	20.5	13.6	32.9	36.2	24.6	16.7	14.1	70.0	58.6	56.0	46.2	32.5	19.6	76.6	51.8	27.6	76.4	50.1	86.0	25.5	118.8	48.6	44.0	49.1	49.4	101.2	96.9	91.1	46.9	80.0	70.9	67.4	125.2	36.9	71.7	114.6	23.8	68.6	75.4	47.6	20.5	51.7	51.9	96.3	30.1	74.5	86.0	94.0	38.8	109.7	64.5	99.4	92.2	88.2	44.9	68.9	118.7	45.6	33.4	45.5	54.7	42.3	70.6	45.1	50.5	38.7	42.3	86.4	82.6	111.1	25.4	34.1	106.3	54.6	81.1	126.5	17.6	24.6	6.6	27.5	38.2	31.2	53.6	30.0	31.5	54.5	42.3	31.2	29.4	3.6	58.5	35.6	34.1	27.8	27.1	13.5	13.6	13.0	13.5	15.1	14.6	14.1	15.2	14.2	13.4	15.1	14.1	11.1	12.8	11.4	8.1	29.6	20.8	27.9	34.8	10.8	11.5	13.2	11.7	22.2	10.0	17.7	18.4	25.0	56.1	19.4	7.0	25.4	30.6	4.8	42.1	18.2	15.3	15.7	18.1	6.0	13.6	57.0	12.9	26.5	40.9	15.8	21.2	8.2	15.6	47.4	8.4	7.2	14.4	20.3	20.3	8.0	4.1	7.5	18.9	5.4	7.5	16.0	9.7	13.4	7.1	5.8	22.1	7.8	9.1	20.1	28.2	8.8	29.3	34.2	9.2	13.1	10.6	18.3	22.3	24.8	26.1	18.5	45.6	15.3	36.0	22.5	23.5
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	17.7	16.2	4.5	4.6	5.4	4.9	16.9	4.6	6.3	18.2	6.6	11.5	4.8	18.9	2.4	9.9	17.4	1.6	10.9	4.3	4.4	11.9	32.8	13.7	5.6	5.9	5.1	21.4	11.0	2.4	13.1	3.9	5.3	16.0	1.7	0.8	11.0	5.9	18.2	18.4	17.8	5.1	4.7	24.3	11.0	7.5	6.1	6.6	10.5	2.1	4.2	15.4	13.7	6.4	0.7	12.3	1.7	9.1	12.4	7.0	9.2	0.9	0.2	0.6	0.0	1.8	4.4	4.9	6.5	5.4	6.2	12.2	6.3	8.4	0.4	9.5	12.8	0.3	8.8	5.9	22.1	4.1	7.6	17.8	8.8	5.9	4.1	1.9	5.0	3.7	1.0	6.3	7.6	6.8	1.3	7.6	3.9	4.2	9.4	6.4	2.9	6.8	3.7	2.0	2.2	5.0	4.3	3.4	15.4	0.1	6.0	6.1	6.8	4.8	5.4	7.9	6.7	0.5	1.3	3.1	7.7	5.9	2.4	0.0	1.4	2.8	1.1	2.3	1.3	1.3	1.2	1.2	1.8	1.0	0.8	1.1	0.3	2.1	2.3	3.3	1.2	1.1	4.5	5.4	4.6	6.3	4.3	4.4	5.9	5.1	5.3	4.7	6.1	6.4	6.3	12.8	10.3	6.5	4.2	2.5	2.9	4.4	8.6	4.5	4.8	5.3	3.6	4.3	3.8	0.0	4.2	2.5	9.9	6.8	1.9	3.1	0.7	2.1	6.2	5.4	1.2	14.3	5.3	4.5	1.9	8.2	6.6	2.9	4.5	6.2	4.6	27.7	23.8	5.0	5.3	4.6	10.2	22.3	4.5	1.2	16.4	15.3	0.0	9.4	7.5	2.5	9.2	5.0	7.6	4.8	4.8	15.1	5.3	2.9	8.7	20.1	6.4	1.8	19.7	5.9	4.5	0.7	2.0	3.4	1.7	2.3	4.7	5.8	4.4	1.7
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666802-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	"Nucleoplasm,Vesicles,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Centriolar satellite"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (3.12e-4)"	5.2	6.7	7.5	3.4	8.1	5.3	5.2	8.0	9.3	6.0	7.1	7.1	2.6	6.2	2.0	4.2	6.8	2.9	7.2	7.5	7.9	6.9	4.8	4.6	5.0	7.8	7.8	6.5	6.3	5.6	5.7	2.7	7.7	5.9	1.4	2.5	8.1	3.3	4.2	6.5	4.6	1.9	7.5	5.3	6.9	10.0	7.8	6.8	5.8	2.9	3.1	5.7	4.5	8.2	6.8	11.0	6.2	8.1	11.0	4.4	4.9	6.1	5.8	7.3	7.5	13.4	5.7	10.0	8.7	5.6	4.2	7.0	7.3	9.6	1.3	10.2	16.0	8.0	7.6	8.0	9.3	11.3	8.4	8.0	7.6	6.0	4.9	5.1	7.2	21.6	7.2	0.8	3.4	25.6	16.4	9.2	4.8	8.0	18.8	10.9	7.7	9.3	7.1	8.0	12.6	8.6	6.4	9.0	5.3	3.5	5.1	11.2	4.0	8.0	2.4	6.2	6.1	24.7	17.7	4.9	12.7	8.7	4.6	5.6	13.4	5.7	10.2	12.4	12.2	9.7	10.2	10.2	14.0	10.8	9.8	12.8	6.7	21.9	6.4	23.5	12.2	10.8	7.5	8.1	8.0	9.3	7.5	7.9	7.8	7.8	7.7	7.5	7.8	8.2	10.8	0.0	14.4	4.2	13.5	15.4	12.1	15.9	11.4	21.1	10.1	9.8	4.4	17.2	12.0	18.4	12.5	12.4	22.3	9.0	17.6	15.6	17.8	12.2	7.3	12.0	9.6	16.2	7.2	17.5	13.9	9.9	9.2	6.1	14.0	12.4	8.6	9.2	13.2	20.2	7.1	7.8	16.2	11.6	19.2	61.9	15.8	9.6	16.0	1.9	17.8	18.2	24.7	4.5	4.4	13.5	5.8	18.0	11.6	15.4	13.6	33.7	18.4	22.7	19.7	8.1	11.3	25.8	17.6	8.3	16.1	9.0	12.4	10.1	9.6	14.6
WDR83OS	"Asterix, C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668073-12669415	"Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	152.2	219.2	204.0	80.1	213.4	203.3	156.9	213.2	226.5	164.0	199.2	138.5	103.9	146.9	276.1	174.0	223.2	138.0	206.8	198.6	212.5	194.9	189.2	133.3	128.7	209.9	205.9	226.2	210.0	204.7	164.8	119.7	211.1	160.6	151.4	50.2	180.9	135.9	226.7	175.1	128.5	169.6	216.9	146.5	164.7	80.4	210.8	129.8	190.1	234.1	174.2	164.4	144.8	223.7	190.9	204.4	223.1	252.8	338.2	267.0	96.4	135.3	230.3	211.6	181.7	170.0	161.1	86.2	310.0	390.4	143.5	150.9	242.7	255.9	175.2	180.9	333.0	107.4	170.3	259.6	262.1	183.5	148.5	287.1	343.2	208.0	243.7	309.9	265.2	161.2	196.2	196.3	253.5	661.5	136.8	399.3	187.7	254.4	584.9	110.0	117.7	310.1	241.7	217.2	182.3	278.6	155.2	162.4	193.5	148.2	197.6	295.1	156.7	289.8	78.2	317.2	205.8	342.4	428.4	126.5	245.4	313.2	189.0	612.8	502.8	492.3	329.2	469.3	312.0	445.2	308.6	336.5	466.7	394.4	280.0	305.8	485.8	451.4	503.7	319.2	396.0	635.4	204.0	213.4	213.2	226.5	198.6	212.5	209.9	205.9	211.1	216.9	210.8	223.7	198.5	80.1	54.6	11.8	156.8	171.7	193.7	391.7	272.0	42.3	310.7	424.2	129.4	168.7	204.5	342.1	27.1	435.7	153.8	233.0	401.1	255.5	7.9	128.6	184.0	185.7	195.3	126.4	10.5	255.8	333.8	205.2	162.6	162.7	147.9	239.7	183.1	314.3	287.5	50.5	10.6	282.6	301.1	212.5	230.2	22.7	170.6	209.3	297.1	13.1	254.5	264.8	179.2	13.0	39.4	243.4	295.7	144.8	256.0	230.9	398.1	586.3	103.6	55.7	98.6	140.9	187.6	87.3	98.4	353.6	221.3	405.1	172.2	279.8	262.4	241.1
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 8.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.2	0.4	0.4	0.9	0.9	0.9	0.1	0.9	0.8	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.2	0.5	0.9	0.6	0.2	0.3	0.1	0.2	1.2	0.3	0.2	0.7	0.8	0.0	0.2	0.2	0.3	0.3	0.0	1.5	0.8	0.0	0.2	0.7	0.7	0.0	0.2	0.6	0.3	8.9	0.4	0.0	1.0	0.0	0.0	0.2	0.0	0.4	0.5	1.1	0.7	1.3	0.3	0.0	1.0	0.4	0.0	0.1	0.0	0.5	1.1	1.3	0.6	0.0	0.8	0.4	0.0	0.1	0.0	2.8	0.4	1.3	1.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.9	1.4	0.0	1.7	0.5	0.6	0.5	0.4	0.4	1.1	0.4	0.2	0.0	0.6	1.9	1.9	1.3	0.6	0.3	0.9	1.6	1.0	0.7	0.3	1.0	0.6	0.2	1.2	0.9	0.7	0.2	2.1	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.9	0.9	0.8	0.6	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	15.9	0.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 58: T-cells - T-cell receptor"	"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favorable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	4.9	5.8	4.4	7.6	4.9	3.0	8.1	7.0	5.9	6.8	3.3	6.1	5.1	6.9	6.8	5.3	6.4	4.8	4.4	4.5	4.6	8.8	8.8	5.4	11.2	4.5	4.4	8.2	5.9	7.4	3.0	6.6	4.2	5.8	6.8	11.4	4.1	4.5	5.8	6.1	4.0	5.3	3.9	8.6	5.4	5.3	5.1	10.1	9.2	7.3	10.3	6.6	4.4	5.7	35.4	16.2	18.2	10.2	10.7	11.2	27.2	14.0	7.6	14.4	16.2	11.6	17.0	33.7	11.4	4.2	9.7	16.7	22.8	13.2	24.3	21.8	13.1	22.7	10.5	14.4	13.8	29.9	15.5	10.1	17.1	16.0	22.7	8.1	12.8	24.0	19.7	17.8	10.5	19.5	24.0	17.3	17.5	23.9	29.2	18.2	18.3	19.2	15.5	14.6	16.5	12.4	15.0	16.8	11.1	18.1	19.2	16.0	9.2	16.8	16.4	11.0	16.6	10.4	8.8	20.9	7.2	20.9	11.9	0.1	2.8	0.5	8.4	2.7	10.5	8.0	8.8	7.8	4.8	7.3	14.3	12.4	0.6	9.4	4.6	3.1	10.1	5.3	4.4	4.9	7.0	5.9	4.5	4.6	4.5	4.4	4.2	3.9	5.1	5.7	5.6	9.6	6.7	4.9	14.5	9.7	13.9	4.6	8.0	6.7	6.3	5.3	4.8	8.6	7.0	5.5	4.2	9.9	7.0	3.8	13.7	6.8	2.8	3.4	7.7	7.0	3.6	11.6	11.3	5.5	13.6	6.5	2.6	4.1	1.3	7.5	5.3	8.0	6.3	1.7	13.2	5.1	4.1	6.3	4.2	4.6	4.4	5.1	3.6	6.5	5.6	7.0	8.2	8.5	14.5	3.6	2.4	6.4	6.1	11.2	2.7	7.9	3.1	9.3	13.1	6.9	4.9	6.1	11.6	6.3	10.9	7.0	11.2	8.7	5.5	7.3
WDR90	"C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924, POC16"	ENSG00000161996	"WD repeat domain 90"	Q96KV7	16	649311-667833	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 32.3;Respiratory ciliated cells: 57.6;Rod photoreceptor cells: 34.7;Spermatocytes: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA049362, HPA061785"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA049362: AB_2680728, HPA061785: AB_2684606"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.89e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.84e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.48e-2)"	8.1	16.3	8.7	3.4	8.8	11.5	10.9	9.5	12.3	17.0	9.9	11.4	5.9	13.3	3.2	10.5	22.1	3.6	9.7	8.9	8.7	16.4	10.9	10.0	4.0	9.2	9.3	21.5	15.7	4.4	25.9	2.5	8.9	15.1	2.2	4.6	9.5	5.5	4.6	9.9	9.3	2.2	8.5	7.4	11.7	61.2	9.1	5.1	22.2	1.4	2.0	10.0	10.5	9.4	10.2	14.1	7.8	18.8	2.9	1.9	0.5	7.4	2.8	5.4	6.3	18.2	14.0	8.8	5.7	2.3	0.1	22.0	3.8	6.0	1.2	15.0	13.7	2.9	57.2	16.9	0.8	15.7	13.4	3.8	4.7	10.8	2.5	2.0	4.0	13.7	1.0	21.9	2.4	7.4	12.5	15.0	7.6	8.4	4.4	34.7	3.1	14.6	6.0	9.4	14.6	15.3	6.8	13.9	1.6	0.5	28.7	12.9	4.3	13.0	13.1	14.3	9.8	22.0	10.4	9.7	3.8	8.5	8.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	8.7	8.8	9.5	12.3	8.9	8.7	9.2	9.3	8.9	8.5	9.1	9.4	4.5	0.0	9.1	10.4	1.1	3.4	2.8	4.5	3.4	9.4	9.7	10.4	4.9	14.3	6.9	9.2	14.6	2.8	0.7	10.1	0.0	5.4	5.6	32.3	6.5	4.3	1.2	2.5	5.0	3.8	2.6	5.9	12.2	9.9	0.0	15.1	1.8	4.5	2.7	11.8	5.5	6.9	0.0	0.8	2.5	4.0	6.2	2.2	3.6	5.6	0.3	5.6	0.0	1.5	2.6	4.5	3.1	4.5	1.3	2.7	3.0	2.1	57.6	34.7	6.6	8.3	5.1	34.2	20.7	3.0	2.3	2.5	1.5	8.3	10.8	2.0
WDR91	"HSPC049, SORF-1"	ENSG00000105875	"WD repeat domain 91"	A4D1P6	7	135183839-135211534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 32.2;THP-1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024260	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA024260: AB_1844392"	"unprognostic (5.37e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	6.4	5.1	6.9	3.7	7.3	6.0	6.4	7.3	7.8	7.8	17.8	4.3	2.0	5.2	6.7	10.2	9.0	3.2	3.5	8.3	6.5	19.3	7.1	9.7	5.5	7.2	6.9	12.5	18.7	3.4	5.7	7.7	6.7	5.9	2.2	2.6	6.3	6.8	4.7	6.8	5.1	3.3	6.3	8.6	7.6	6.1	7.2	5.2	3.8	2.7	5.2	5.5	7.1	7.2	3.0	1.2	2.8	7.9	5.0	3.8	3.6	3.4	4.0	3.0	3.7	1.3	1.1	2.0	5.1	2.5	4.1	2.3	4.6	11.8	3.4	10.3	3.8	1.9	3.4	4.9	7.3	3.4	1.6	5.3	6.4	2.7	2.3	2.6	4.0	4.9	7.9	3.1	3.0	2.2	6.5	9.1	4.1	2.5	3.1	8.3	4.3	4.8	32.2	1.8	1.7	3.3	4.3	4.0	10.0	2.8	2.2	23.3	1.4	6.8	1.6	4.8	3.2	6.7	2.8	6.3	6.2	6.6	4.9	0.4	3.7	3.4	1.4	1.3	1.5	1.8	1.7	0.9	2.1	1.6	2.6	1.6	2.1	2.5	1.2	0.9	2.4	1.8	6.9	7.3	7.3	7.8	8.3	6.5	7.2	6.9	6.7	6.3	7.2	7.2	4.5	6.4	9.3	14.7	7.1	4.2	3.8	11.8	16.5	6.8	4.8	6.1	2.9	8.6	8.8	7.3	6.2	23.2	6.5	1.1	19.6	9.1	33.4	18.7	6.3	5.2	1.2	4.4	11.4	7.1	5.0	5.0	5.6	25.3	16.5	8.6	6.4	7.7	36.4	3.3	12.5	1.8	2.0	11.6	12.3	54.2	5.9	9.9	3.6	7.5	6.8	3.4	0.0	7.1	10.2	3.9	4.8	15.4	5.0	2.4	1.5	18.5	6.8	3.4	13.1	5.6	5.7	9.1	8.6	7.1	4.0	29.0	5.0	7.6	1.2	1.4
WDR92	"FLJ31741, Monad"	ENSG00000243667	"WD repeat domain 92"	Q96MX6	2	68122936-68157549	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Respiratory ciliated cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035335, HPA035336"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035335: AB_10959456, HPA035336: AB_10964348"	"unprognostic (3.55e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.61e-1)"	"unprognostic (3.56e-3)"	"unprognostic (9.86e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.15e-2)"	6.0	7.0	4.9	6.6	6.4	3.6	8.6	7.6	5.5	5.4	10.4	6.1	6.3	7.4	16.0	7.0	11.1	5.3	9.0	5.0	4.9	5.5	5.2	5.8	9.7	5.7	7.2	6.9	4.3	7.2	4.7	5.7	4.6	8.1	8.0	6.9	6.4	6.8	11.4	10.5	5.3	7.5	5.2	8.2	5.9	8.0	4.7	8.1	8.3	9.1	8.9	5.0	5.1	5.5	15.3	9.4	12.0	12.6	14.5	14.7	10.3	11.6	10.1	12.1	12.8	7.0	12.5	16.5	3.7	10.3	16.5	15.0	13.0	8.8	15.6	11.2	13.8	16.9	13.1	8.0	7.0	18.5	5.2	9.4	11.5	10.0	8.6	12.9	11.7	15.2	11.3	11.1	14.3	7.3	13.2	18.6	12.2	12.8	12.9	15.9	15.3	14.1	12.5	8.6	12.4	10.6	8.6	15.5	9.6	11.8	11.9	12.1	13.6	18.4	7.4	11.6	10.1	7.6	11.6	11.6	17.3	17.6	9.3	0.7	2.3	1.7	3.2	2.5	4.2	5.3	3.4	3.8	2.7	4.9	4.0	5.0	1.0	6.3	1.8	5.1	4.0	2.1	4.9	6.4	7.6	5.5	5.0	4.9	5.7	7.2	4.6	5.2	4.7	5.5	7.8	3.2	10.9	5.9	5.2	3.4	4.7	6.5	2.2	28.7	5.6	5.6	3.1	1.5	11.1	5.5	47.9	13.6	12.2	1.3	1.9	6.7	5.8	26.3	6.8	7.4	0.0	7.0	17.9	6.5	9.2	5.7	1.5	4.3	13.3	9.7	8.2	6.3	7.3	11.8	16.4	3.3	4.1	3.5	1.2	2.8	7.8	3.5	1.8	8.4	7.2	12.0	6.2	14.1	11.6	6.2	2.9	9.4	2.0	3.3	3.7	6.7	40.2	21.9	6.6	9.0	5.9	26.0	15.2	1.8	4.1	5.1	3.6	9.4	6.0	2.1
WDR93	"C1d-87, CFAP297, FAP297"	ENSG00000140527	"WD repeat domain 93"	Q6P2C0	15	89690811-89743638	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.9;testis: 11.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 20.9;Early spermatids: 49.1;Endometrial ciliated cells: 28.1;Late spermatids: 42.4;Respiratory ciliated cells: 47.7;Spermatocytes: 30.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA046196, HPA048112"	Uncertain		Uncertain	"Actin filaments"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"		"HPA046196: AB_2679582, HPA048112: AB_2680267"	"unprognostic (2.56e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.44e-2)"	0.4	0.2	0.6	0.0	0.6	0.4	0.7	1.6	0.6	0.6	3.5	0.1	0.0	0.4	4.9	0.0	8.9	0.2	1.2	0.8	1.0	1.0	0.1	1.0	0.2	2.4	2.9	0.4	0.6	0.5	0.8	0.1	1.1	0.6	0.1	2.8	0.3	0.5	0.3	0.2	0.1	0.0	1.6	0.1	0.1	11.6	0.9	0.1	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.5	0.2	0.7	0.2	1.0	0.1	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.6	1.6	0.6	0.8	1.0	2.4	2.9	1.1	1.6	0.9	1.0	0.1	3.2	0.5	2.9	0.0	0.3	0.7	1.8	0.0	2.7	0.8	0.6	0.5	0.0	4.2	9.2	20.9	0.4	0.1	0.1	3.9	0.8	49.1	28.1	0.6	0.7	0.0	0.0	2.7	0.2	0.3	0.4	0.0	0.8	0.0	0.4	0.4	0.0	0.2	3.3	2.1	0.1	0.0	0.3	0.8	42.4	1.5	0.3	1.8	0.0	0.6	0.6	0.0	0.5	1.0	0.3	1.1	0.7	0.1	0.7	0.0	2.1	47.7	14.8	0.0	0.9	0.6	30.4	5.7	0.0	0.1	0.3	0.6	2.9	0.2	0.4
WDR97	KIAA1875	ENSG00000179698	"WD repeat domain 97"	A6NE52	8	144107726-144118328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.0;Cone photoreceptor cells: 6.2;Gastric mucus-secreting cells: 5.1;Horizontal cells: 5.0;Rod photoreceptor cells: 8.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059409	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA059409: AB_2684005"	"unprognostic (3.95e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.58e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.01e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.11e-6)"	"unprognostic (2.79e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-4)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.8	0.0	1.7	0.0	0.9	0.0	0.2	0.0	0.6	7.0	1.3	1.3	0.0	1.5	0.0	0.0	6.2	0.1	3.1	0.3	1.9	0.7	4.4	2.2	0.4	0.4	0.0	0.4	0.0	0.2	0.0	0.4	5.1	0.7	0.0	0.8	0.7	1.7	0.2	5.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.6	2.6	0.0	0.5	0.6	1.5	0.2	0.7	8.5	0.0	2.1	0.6	3.8	2.2	0.8	0.0	0.0	0.6	0.0	0.7	0.3
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234632-27308636	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	16.5	24.4	25.4	10.5	22.3	14.7	17.5	20.2	25.4	18.9	12.7	24.7	12.9	19.7	7.0	18.0	19.9	10.5	35.9	21.8	20.0	19.9	18.7	16.9	14.4	25.3	21.0	19.0	22.1	47.7	16.9	10.6	24.4	19.3	9.5	33.5	20.1	15.1	63.0	24.8	18.0	12.0	19.4	17.7	23.2	37.6	23.5	19.8	18.4	54.4	12.7	19.8	18.5	21.1	19.8	8.6	13.5	1.3	18.9	15.8	5.6	12.0	20.1	12.7	15.5	2.9	19.3	17.0	14.0	24.0	9.3	10.1	13.0	18.4	11.0	23.2	22.0	17.7	8.9	7.9	17.0	9.0	22.4	15.1	29.6	15.8	14.4	22.9	17.4	5.4	18.2	17.2	13.6	11.1	14.6	21.6	6.3	13.0	18.1	7.3	10.1	18.7	15.2	4.2	19.7	16.9	15.7	6.6	14.4	10.1	9.8	15.5	15.2	10.3	6.2	14.5	5.9	24.7	14.2	8.1	20.8	17.3	12.5	0.1	0.2	2.7	1.4	0.3	0.5	0.6	0.3	0.6	0.7	0.4	0.2	0.6	2.1	0.4	0.2	0.5	0.4	0.5	25.4	22.3	20.2	25.4	21.8	20.0	25.3	21.0	24.4	19.4	23.5	21.1	10.8	9.6	10.7	19.6	13.8	12.9	10.3	8.4	16.5	31.4	18.5	14.5	15.6	14.3	7.6	31.3	54.2	14.2	14.3	17.3	9.8	15.1	29.8	15.3	8.2	10.1	16.7	32.8	22.4	14.1	4.8	10.6	16.3	13.2	1.3	15.4	18.5	16.6	13.0	21.9	21.2	16.9	6.1	21.0	11.3	66.2	17.1	15.8	10.6	19.7	18.9	15.8	28.8	16.6	22.2	16.0	10.1	16.6	12.3	17.2	26.6	19.1	18.4	70.0	6.6	17.1	10.3	30.9	6.6	13.0	17.3	16.4	13.3	14.1	15.0	16.8
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573670-9593457	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	12.7	5.6	1.5	14.1	1.3	23.0	46.1	2.4	2.3	21.5	2.8	18.4	10.6	62.6	24.5	46.3	18.6	49.0	43.0	1.2	2.3	16.8	57.8	11.6	24.8	2.8	4.0	10.9	10.1	17.8	8.4	34.6	3.6	21.2	14.4	4.5	17.4	12.7	10.4	57.1	13.5	35.0	2.2	8.1	17.2	31.5	2.0	23.7	26.6	7.2	30.2	53.0	15.4	1.9	43.1	16.4	69.1	38.8	65.2	29.8	125.9	48.8	44.8	29.3	29.8	33.8	53.3	100.7	18.0	27.6	30.8	48.8	49.0	23.3	41.1	33.3	30.7	43.1	30.1	26.2	7.0	66.6	39.7	12.0	25.3	13.8	53.8	34.9	21.6	43.6	64.0	75.8	55.7	13.2	63.5	39.4	97.6	36.9	18.5	57.6	54.5	24.6	28.1	100.0	25.0	31.8	39.9	48.6	29.2	89.3	27.1	32.9	21.7	51.1	35.2	23.0	42.2	14.4	51.1	140.1	23.3	36.5	41.0	0.0	0.0	6.0	1.7	0.0	0.2	8.0	1.7	3.0	0.1	4.7	0.1	1.3	0.1	1.9	0.0	0.1	7.1	0.6	1.5	1.3	2.4	2.3	1.2	2.3	2.8	4.0	3.6	2.2	2.0	1.9	17.2	51.3	33.9	0.0	36.8	176.4	170.4	38.5	213.9	1.8	168.5	67.2	61.1	65.8	53.5	42.3	0.0	94.8	11.2	54.7	13.7	24.9	25.0	160.1	86.2	18.7	61.1	40.4	0.1	13.6	200.1	39.2	52.5	262.4	7.0	28.5	9.7	85.0	17.0	1.7	0.4	65.6	18.3	2.5	21.9	41.7	11.8	10.0	17.8	1.0	2.4	9.9	8.2	2.0	0.1	24.8	38.5	10.9	17.2	82.7	35.9	8.3	62.6	7.1	6.6	180.7	23.7	61.4	44.4	181.4	191.1	137.2	19.0	11.8	55.5	85.5
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC1	PS20	ENSG00000103175	"WAP four-disulfide core domain 1"	Q9HC57	16	84294846-84329844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 99.8;seminal vesicle: 115.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.1;Fibroblasts: 72.6;Peritubular cells: 257.3;Smooth muscle cells: 95.8;Theca cells: 325.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 29.8;BJ: 20.5;HEL: 18.2;HeLa: 27.6;THP-1: 9.9;U-937: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031411	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA031411: AB_10600921"	"unprognostic (6.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.04e-1)"	8.1	26.9	16.5	10.5	16.5	1.9	4.3	19.1	21.2	21.5	12.9	79.3	8.9	17.3	18.8	24.5	7.9	35.1	4.4	16.1	15.5	16.7	5.5	29.5	0.6	17.0	16.2	3.7	1.0	0.4	5.7	99.8	15.3	69.0	17.4	8.4	6.2	115.1	1.2	3.2	14.6	32.2	14.9	3.5	20.8	12.5	16.3	0.3	4.8	1.6	0.8	54.2	13.5	14.9	0.0	0.0	4.4	29.8	0.0	0.1	0.2	20.5	2.5	0.0	0.0	0.0	0.0	0.0	5.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	27.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.5	0.0	0.4	0.0	0.0	2.3	0.0	0.0	5.3	0.1	0.0	0.5	3.2	0.1	0.1	9.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	16.5	19.1	21.2	16.1	15.5	17.0	16.2	15.3	14.9	16.3	14.9	3.4	3.2	0.5	9.1	0.0	1.8	0.9	0.1	0.0	111.1	2.0	0.9	1.4	0.0	0.1	1.8	0.0	2.1	0.1	0.9	11.7	0.0	27.8	0.6	10.6	3.9	4.2	0.0	4.1	0.0	2.0	72.6	7.7	0.5	0.0	0.2	12.5	0.0	6.6	5.0	0.9	4.7	0.0	0.0	3.0	41.1	15.8	2.3	0.0	2.8	0.0	1.4	0.0	29.1	0.6	0.1	0.6	257.3	0.3	1.3	0.4	1.3	0.7	4.2	0.0	1.0	95.8	5.5	0.9	0.1	0.4	3.8	0.5	325.9	3.1	1.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469753-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 5211.9;salivary gland: 1988.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4507.8;Club cells: 6299.8;Collecting duct cells: 1988.1;Endometrial ciliated cells: 3253.3;Glandular and luminal cells: 4817.5;Respiratory ciliated cells: 2935.3;Urothelial cells: 3783.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 1815.6;ovarian cancer: 1086.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 115.8;CAPAN-2: 210.6;EFO-21: 171.3;HaCaT: 151.9;RPTEC TERT1: 165.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042302	Enhanced				"Secreted in other tissues"	NA	NA		1600000		"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	16.8	1.6	6.7	11.0	14.1	0.0	81.2	6.6	9.3	5211.9	22.3	163.7	9.6	240.0	941.9	54.9	676.7	166.1	6.0	7.2	7.5	909.9	23.6	144.7	0.9	7.7	9.1	10.4	30.5	81.9	152.4	0.7	7.1	221.7	224.9	6.9	1988.3	825.3	2.0	38.2	60.1	28.9	6.9	0.7	44.1	14.9	7.2	12.3	253.8	0.5	8.8	161.2	25.0	7.3	115.8	0.0	0.3	0.4	0.0	0.1	4.7	0.0	0.0	0.0	0.0	4.9	210.6	0.0	171.3	0.0	0.7	151.9	0.0	0.0	0.0	0.8	1.9	0.0	1.2	0.3	0.0	0.2	0.7	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	6.7	0.3	2.7	18.4	0.6	0.0	0.1	0.0	0.0	165.6	1.3	5.0	1.0	10.6	0.0	1.1	2.0	3.1	0.6	0.0	0.3	2.8	0.6	0.5	0.7	0.6	1.6	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	14.1	6.6	9.3	7.2	7.5	7.7	9.1	7.1	6.9	7.2	7.3	2.8	169.9	273.8	2.6	4.2	8.9	1190.9	4507.8	35.3	30.3	340.4	238.5	2.0	94.4	6299.8	1988.1	22.9	1.0	4.3	239.8	221.1	308.2	1.6	3253.3	359.3	21.7	422.7	0.0	4.7	129.2	0.8	23.4	31.6	4817.5	10.1	12.5	3.9	3.3	1.9	0.0	7.6	1764.7	1328.5	0.6	1.1	5.0	36.1	26.8	10.6	1.9	5.7	31.3	0.0	2.0	3.4	179.0	424.6	0.0	0.8	1169.7	1.7	113.9	2935.3	6.1	6.6	1.1	319.1	12.4	11.9	110.2	14.1	0.7	36.8	0.0	318.2	3783.3
WFDC8	"C20orf170, dJ461P17.1, WAP8"	ENSG00000158901	"WAP four-disulfide core domain 8"	Q8IUA0	20	45551153-45579326	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	518	"epididymis: 410.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-87 MG: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042710, HPA071119"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"			"HPA042710: AB_2732501, HPA071119: AB_2732172"				"unprognostic (5.63e-3)"						"unprognostic (1.09e-2)"				"unprognostic (2.34e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.07e-2)"		0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	410.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WASP homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Approved		Supported	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	7.7	4.8	4.3	3.9	4.4	29.7	7.2	6.1	4.7	6.6	8.8	6.8	4.6	5.5	2.8	7.2	6.1	2.9	5.8	4.3	3.9	7.0	8.8	7.8	5.5	4.5	4.3	7.2	7.5	6.1	5.4	4.6	4.3	7.7	4.0	4.0	6.6	3.5	17.7	9.0	7.3	3.3	3.8	8.5	6.2	3.7	4.3	5.1	6.6	7.8	4.7	7.5	6.4	5.8	4.0	4.1	2.5	3.6	7.9	5.5	4.2	5.5	5.5	6.0	5.9	2.6	7.2	8.7	6.7	5.2	5.6	8.8	7.7	4.5	3.9	2.9	4.4	5.0	4.5	3.9	8.0	3.6	5.7	5.4	6.0	2.8	5.9	6.0	4.3	4.1	4.6	11.3	6.0	3.1	3.0	5.2	1.0	5.0	2.4	4.4	5.3	2.5	10.4	16.1	2.3	1.9	8.5	5.5	5.8	5.1	3.7	7.7	6.8	7.9	2.7	5.3	6.3	12.0	7.3	4.2	5.6	4.9	5.0	2.6	0.5	0.5	1.2	0.4	1.0	1.0	1.1	0.8	0.3	1.1	1.0	1.0	1.3	2.3	0.4	0.9	1.0	0.4	4.3	4.4	6.1	4.7	4.3	3.9	4.5	4.3	4.3	3.8	4.3	5.8	36.6	16.0	17.3	18.9	37.1	26.5	42.8	6.6	34.1	16.2	16.7	17.7	15.6	17.2	7.6	20.2	14.6	14.5	47.3	18.1	5.9	8.9	6.9	19.6	13.9	23.2	6.7	31.5	10.1	10.3	16.6	18.7	23.9	29.4	10.8	12.6	19.2	13.8	19.9	23.5	15.9	19.4	6.1	15.8	41.4	5.5	17.4	25.4	19.6	15.0	19.3	17.9	61.8	14.1	23.4	13.0	15.5	23.7	24.1	49.0	16.8	11.2	7.1	18.0	32.9	24.5	19.5	29.8	31.1	29.2	25.1	25.4	36.1	15.5	13.8	75.1
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WIPF2	"WICH, WIRE"	ENSG00000171475	"WAS/WASL interacting protein family member 2"	Q8TF74	17	40219304-40284136	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024000, HPA024001, HPA024467"	Enhanced					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (9.23e-2)"	10.9	7.1	10.4	10.0	9.9	17.4	8.4	11.1	18.8	9.6	2.2	14.3	12.0	10.3	9.3	14.9	9.3	10.0	6.4	11.4	12.0	12.2	7.5	12.7	8.5	8.0	8.3	7.8	10.3	12.4	7.4	12.0	6.2	8.5	13.5	9.4	9.0	10.3	6.9	15.4	13.3	11.8	3.7	11.9	12.8	6.6	10.9	7.8	9.0	6.8	11.3	9.3	10.2	9.1	23.4	36.0	15.3	14.5	15.6	16.4	15.1	20.5	14.1	18.5	19.8	17.7	20.1	13.7	22.8	24.8	23.0	39.4	13.1	15.7	24.3	24.7	15.9	14.8	17.6	21.3	15.9	19.7	16.1	13.2	19.3	19.3	21.8	19.9	18.2	14.6	14.3	12.5	18.0	15.3	19.5	9.9	9.2	17.5	11.1	12.5	18.6	13.6	19.8	38.2	18.8	13.1	37.3	99.2	13.6	26.0	33.5	12.1	26.5	12.5	18.7	24.0	23.8	13.9	23.3	13.9	27.5	10.3	18.9	5.2	2.0	2.4	3.3	1.8	2.7	3.0	1.9	2.0	1.5	2.2	2.2	1.9	7.1	2.6	2.1	2.5	2.4	1.0	10.4	9.9	11.1	18.8	11.4	12.0	8.0	8.3	6.2	3.7	10.9	9.1	28.4	67.3	39.5	71.2	32.5	43.1	33.8	28.7	29.6	38.0	35.7	23.6	11.8	41.5	25.2	46.0	45.9	50.7	29.4	102.5	13.7	29.0	3.9	31.8	27.8	35.5	47.3	17.2	71.8	36.6	31.5	24.5	35.2	54.9	38.1	23.6	43.2	25.3	30.3	42.1	52.7	33.9	26.4	48.3	31.7	3.4	20.2	27.9	16.0	37.5	32.2	20.8	33.0	36.2	36.5	52.0	57.5	25.9	15.9	44.6	60.3	26.4	22.3	17.2	39.5	26.9	23.3	20.6	34.2	54.9	69.0	67.5	31.1	15.9	36.4	70.7
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 41.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.1;Granulosa cells: 149.4;Leydig cells: 50.7;Peritubular cells: 100.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 22.1;cerebral cortex: 49.9;hippocampal formation: 40.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.1;HEK 293: 4.1;K-562: 6.6;NTERA-2: 5.1;RPMI-8226: 11.3;SK-MEL-30: 4.5"	"Region enhanced"	"Detected in all"		"hippocampal formation: 213.9"	"Region enhanced"	"Detected in all"		"hippocampal formation: 156.3"	"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favorable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	8.7	1.0	22.1	0.5	1.1	0.0	49.9	0.4	0.0	0.7	2.9	3.3	19.7	1.2	8.8	1.4	4.0	40.3	4.2	2.5	0.5	0.5	0.7	0.4	2.6	41.7	1.7	1.2	0.9	0.2	0.1	4.4	0.5	3.8	4.0	4.8	25.0	0.9	2.6	4.1	0.5	1.0	5.9	18.8	7.4	0.4	2.0	8.8	0.7	1.4	0.2	8.1	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	18.1	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.1	0.0	0.1	0.0	0.0	5.1	0.0	3.6	0.0	0.0	11.3	0.0	0.0	1.8	1.5	0.1	0.1	4.5	2.4	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.1	0.0	8.7	22.1	0.0	49.9	40.3	4.2	0.4	2.6	0.1	0.5	7.4	8.1	1.5	0.0	0.0	6.2	0.0	2.2	1.5	0.6	1.2	8.2	4.9	4.6	9.3	0.0	1.4	3.7	2.1	0.0	0.3	0.5	3.9	3.8	1.8	5.0	0.4	4.1	1.8	3.0	45.1	3.5	0.1	7.3	11.7	1.2	0.0	149.4	0.4	0.5	4.5	5.0	27.0	0.7	0.0	0.0	1.0	4.8	50.7	1.0	5.4	1.9	0.0	6.2	0.0	2.0	1.9	2.4	1.5	100.4	0.1	1.1	5.5	5.5	5.1	2.9	6.6	7.2	16.0	4.4	9.9	0.9	0.4	0.0	1.0	8.7	2.0	0.4
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190196-5233840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 255.9;Spermatocytes: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	31.1	30.9	38.8	22.9	40.7	47.0	30.8	35.2	41.8	27.3	37.1	33.9	24.7	32.1	26.3	35.8	29.0	23.2	38.0	42.8	38.6	32.2	35.7	26.4	30.2	36.3	39.1	28.2	37.1	38.2	30.6	32.8	38.7	28.7	20.2	19.1	43.5	28.2	41.3	47.1	26.7	26.8	37.0	29.6	33.6	53.8	38.7	36.8	27.4	45.0	29.2	27.1	30.0	39.8	67.5	42.1	40.4	69.4	60.7	63.3	62.0	58.7	66.9	61.2	64.2	41.2	60.9	47.7	43.9	73.8	76.0	48.2	41.2	47.8	47.4	24.9	64.1	32.7	39.7	45.8	59.9	51.8	34.4	66.9	56.4	69.7	38.3	60.9	86.3	64.3	94.2	41.9	56.2	69.9	39.6	90.0	84.3	35.9	61.1	64.3	57.7	79.5	40.4	32.3	50.3	75.4	43.0	72.8	52.4	67.3	44.8	97.2	69.2	38.9	80.9	65.6	44.4	75.0	75.2	54.7	63.4	59.3	58.8	0.4	4.7	13.6	4.4	6.0	2.8	5.7	5.8	8.0	4.2	6.2	7.5	4.7	9.1	2.6	4.2	6.4	9.0	2.2	38.8	40.7	35.2	41.8	42.8	38.6	36.3	39.1	38.7	37.0	38.7	39.8	40.2	38.5	31.5	16.3	51.6	54.9	39.5	13.9	39.3	71.5	49.4	50.5	37.0	42.9	17.6	18.4	62.6	89.4	62.7	42.6	72.4	43.0	195.8	50.0	38.1	37.9	39.5	125.0	19.7	41.8	96.6	43.1	34.7	48.0	31.1	54.8	54.7	60.4	69.1	47.1	19.6	42.6	18.3	61.4	44.8	255.9	42.6	55.9	44.4	20.6	64.5	89.5	44.3	13.6	23.5	55.6	37.0	56.1	67.7	97.7	48.7	80.6	26.4	52.8	52.6	39.7	39.4	233.0	117.3	49.8	71.0	150.8	46.8	44.1	43.0	69.8
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 83.1;skeletal muscle: 62.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	2.0	3.0	14.9	3.3	14.8	0.0	4.9	4.6	39.1	4.7	0.3	36.0	17.9	5.8	4.2	5.7	15.4	1.3	83.1	18.3	7.7	0.8	1.3	0.9	0.5	13.8	6.0	1.1	42.8	2.3	29.6	3.0	8.8	16.7	11.9	28.8	47.3	12.3	62.3	15.8	21.5	4.5	1.9	2.7	14.7	6.6	14.2	7.1	1.8	31.0	1.0	5.5	3.4	10.5	7.4	6.6	4.6	13.2	0.0	0.0	8.8	0.0	0.0	0.1	0.0	2.7	0.2	18.8	2.4	0.0	1.3	0.3	10.4	0.0	0.0	0.0	12.1	0.0	5.8	31.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.2	0.0	0.0	9.8	0.2	0.2	11.5	7.2	0.4	0.0	0.0	15.3	0.0	1.1	37.6	14.8	2.4	10.2	0.9	1.3	1.3	2.2	0.1	0.0	4.8	0.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	14.8	4.6	39.1	18.3	7.7	13.8	6.0	8.8	1.9	14.2	10.5	0.3	0.0	0.0	76.4	0.3	1.3	8.5	3.1	0.0	62.0	19.4	18.7	58.1	31.5	14.1	0.0	160.6	15.5	0.2	34.3	0.0	17.1	1.2	7.7	9.2	1.3	32.4	0.0	128.5	9.1	6.7	2.7	3.6	15.8	0.0	8.6	0.4	0.2	3.4	1.7	98.8	77.3	6.1	1.3	2.2	2.6	0.9	0.1	1.8	29.0	0.6	60.3	0.0	9.0	3.2	3.2	57.0	6.0	0.2	11.1	47.7	1.1	6.6	106.8	13.1	3.5	5.0	0.7	7.7	1.1	5.5	15.6	0.4	0.1	59.0	8.9
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.7;testis: 9.9"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 193.3;Granulosa cells: 199.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.5;AN3-CA: 3.4;HAP1: 5.2;NTERA-2: 9.1;SiHa: 4.5;SuSa: 3.8;U-2 OS: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA077678: AB_2686850"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.2	2.5	1.6	0.1	1.7	0.1	0.6	0.3	1.9	0.6	0.0	0.3	0.2	0.5	11.7	0.2	0.8	0.3	0.7	1.0	4.6	1.0	3.6	0.3	0.1	1.6	4.8	3.0	0.3	0.9	2.4	0.3	2.4	0.9	0.0	3.3	0.3	0.8	0.1	0.3	0.2	0.5	0.6	0.2	0.6	9.9	4.5	0.1	0.6	0.1	0.1	0.5	0.4	1.2	0.0	0.0	4.5	3.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	5.2	0.1	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.2	0.6	0.0	0.9	0.1	1.4	1.3	4.5	0.0	0.5	3.8	0.4	0.0	0.2	0.0	3.9	0.0	1.0	0.0	3.3	0.0	1.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.7	0.3	1.9	1.0	4.6	1.6	4.8	2.4	0.6	4.5	1.2	1.9	0.0	2.3	18.3	0.7	3.7	4.3	0.3	9.1	24.9	5.8	6.9	193.3	2.8	3.2	7.3	14.6	0.2	0.0	0.1	5.9	1.7	6.4	2.0	7.8	8.5	0.0	0.8	14.5	0.0	0.3	6.7	0.0	4.9	6.3	199.5	20.3	48.3	0.1	35.3	29.7	0.0	2.0	0.8	1.5	20.4	15.8	0.6	0.0	3.7	0.0	19.5	0.0	48.2	19.2	0.2	0.0	43.6	0.0	6.0	0.0	3.9	0.2	43.3	6.6	4.8	10.5	43.8	46.3	2.1	1.1	0.1	1.5	9.8	0.0	1.4
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880852-218899581	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 7.0;skin 1: 8.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.2;Basal keratinocytes: 17.1;Basal respiratory cells: 15.5;Basal squamous epithelial cells: 30.1;Bipolar cells: 16.2;dendritic cells: 16.4;Plasma cells: 30.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 50.8;HaCaT: 140.1;HDLM-2: 58.7;RPTEC TERT1: 29.2;U-266/70: 69.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.1"	HPA013898	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.7	0.2	0.7	1.0	1.6	0.5	0.5	0.2	1.3	1.5	0.2	1.6	3.7	0.0	0.4	7.0	1.2	0.3	0.1	1.2	0.5	2.4	0.2	0.7	2.5	0.4	0.6	0.2	0.1	0.0	4.3	3.4	0.5	1.7	1.0	1.4	2.5	1.0	0.0	8.9	2.1	0.0	0.3	2.0	2.5	0.4	0.7	1.1	0.2	0.0	1.9	2.7	2.9	0.7	15.8	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	50.8	2.8	10.4	0.0	3.8	140.1	0.0	0.1	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	10.5	29.2	0.4	0.0	0.4	0.3	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	69.0	1.1	1.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	6.2	1.0	0.0	0.7	1.6	0.2	1.3	1.2	0.5	0.4	0.6	0.5	0.3	0.7	0.7	0.2	0.0	0.0	0.3	12.2	17.1	8.2	15.5	30.1	16.2	0.5	1.3	1.4	0.0	1.1	9.2	2.1	1.2	16.4	0.0	0.0	0.3	1.2	0.3	0.1	0.2	0.0	0.4	1.3	0.0	0.4	1.9	0.5	0.2	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.0	2.0	0.0	1.3	0.1	0.6	1.0	7.2	0.0	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	30.4	2.5	0.0	0.3	0.6	1.5	0.0	0.1	0.8	0.9	0.6	5.2	4.7	0.1	9.8	0.0	0.2	3.2
WNT10B	"SHFM6, WNT-12"	ENSG00000169884	"Wnt family member 10B"	O00744	12	48965340-48971735	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.3;Extravillous trophoblasts: 21.7;Fibroblasts: 4.8;Inhibitory neurons: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 7.3;T-47d: 8.2;U-266/84: 7.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA055048, HPA062539"	Enhanced		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA055048: AB_2682683, HPA062539: AB_2684793"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.73e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.99e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.39e-6)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.25e-1)"	1.5	0.2	13.1	1.5	14.9	1.2	0.6	4.2	17.9	0.8	3.2	1.4	1.4	0.3	1.5	1.4	1.0	0.5	1.5	15.3	7.3	0.4	0.4	1.1	1.7	8.6	7.6	0.2	0.3	0.1	2.4	0.3	8.2	0.8	0.7	0.1	0.9	0.6	0.7	3.4	4.3	0.1	5.1	4.1	1.1	3.3	10.4	1.9	1.0	0.4	1.5	1.3	1.0	9.8	1.9	1.2	0.0	1.7	0.0	0.0	4.6	1.3	2.4	0.5	0.1	3.6	4.0	0.0	0.3	0.2	1.5	2.2	4.8	0.3	0.2	1.1	6.3	2.1	1.7	0.1	0.0	0.7	2.9	0.0	0.4	0.1	2.1	4.1	0.0	1.5	7.3	0.3	0.7	2.4	0.1	2.5	0.0	1.3	2.5	0.0	0.6	2.2	0.0	0.4	0.1	0.0	0.3	0.1	0.6	2.2	8.2	2.7	0.0	2.5	4.9	0.4	0.6	2.6	7.8	0.0	1.0	5.4	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.9	4.2	17.9	15.3	7.3	8.6	7.6	8.2	5.1	10.4	9.8	0.2	0.0	0.0	0.7	0.2	0.4	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.0	7.3	0.0	21.7	4.8	0.0	0.1	0.0	0.0	0.7	0.0	0.3	0.0	4.7	0.2	0.0	0.0	1.2	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	3.0	0.9	1.3	1.4	1.6	0.0	0.0	0.1
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.4"	"Group enriched"	"Detected in some"	5	"Adipocytes: 41.5;Fibroblasts: 23.2;Theca cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 36.2;CACO-2: 12.1;CAPAN-2: 17.8;EFO-21: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050101	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA050101: AB_2681015"	"prognostic favorable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	37.4	20.8	1.7	0.4	3.5	0.9	23.7	4.1	2.2	4.8	14.3	3.6	2.5	2.7	1.3	1.2	6.7	2.1	8.3	3.8	3.5	2.8	8.0	6.3	1.1	7.4	2.7	4.5	9.5	1.2	3.1	4.1	6.9	4.3	1.1	0.3	4.3	1.1	12.3	8.1	3.3	0.6	2.8	3.5	1.4	0.9	2.8	0.9	17.2	7.1	0.2	4.0	3.8	2.1	0.0	0.0	0.0	0.0	2.9	0.2	36.2	0.0	0.0	0.1	0.2	12.1	17.8	0.0	57.0	0.1	0.2	5.5	1.1	0.0	0.0	5.5	2.1	2.9	1.4	2.2	0.0	0.0	0.4	0.1	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	1.4	0.3	0.0	0.4	0.9	0.0	2.9	0.4	0.0	2.1	0.2	0.0	2.5	0.1	1.4	0.0	0.0	2.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.2	1.7	3.5	4.1	2.2	3.8	3.5	7.4	2.7	6.9	2.8	2.8	2.1	41.5	0.0	0.0	0.3	0.5	1.3	0.5	0.0	1.2	0.0	0.9	1.9	4.7	0.0	0.0	0.0	0.0	0.9	2.3	2.2	0.0	0.0	0.0	5.0	2.9	1.8	0.0	0.0	0.2	0.2	3.3	23.2	0.0	1.1	0.0	0.4	0.7	2.5	0.1	0.0	0.5	0.5	0.0	0.3	2.3	0.0	0.0	0.7	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.6	0.7	0.7	0.1	3.8	0.0	0.0	0.0	0.0	1.8	5.7	0.4	0.5	0.1	0.9	1.4	0.9	24.3	1.5	0.1
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117313-22143969	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 42.1;Breast glandular cells: 19.9;Breast myoepithelial cells: 24.3;Endometrial stromal cells: 71.4;Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;SCLC-21H: 10.2;SK-BR-3: 8.6;T-47d: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.8	9.0	2.4	0.4	1.5	0.3	2.2	0.2	2.9	8.9	0.5	2.3	3.2	4.5	8.9	12.1	8.3	2.6	0.1	2.0	2.9	1.1	1.4	1.2	0.1	1.6	1.8	16.8	3.0	0.1	5.6	1.6	1.2	5.5	1.6	0.2	4.1	2.6	3.1	40.8	3.1	1.9	1.1	0.3	4.3	0.6	3.9	1.1	3.4	0.6	1.5	3.1	6.3	1.1	1.3	0.1	2.5	0.1	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.3	8.5	0.0	0.6	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	1.1	0.2	0.3	0.0	0.0	0.0	1.6	10.2	0.0	0.1	8.6	0.6	0.6	3.4	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.5	0.2	2.9	2.0	2.9	1.6	1.8	1.2	1.1	3.9	1.1	0.9	3.2	8.6	0.3	0.7	16.7	4.3	42.1	6.8	0.0	19.9	24.3	0.6	0.0	15.2	0.0	0.0	0.7	0.1	0.9	0.0	2.7	0.1	4.1	71.4	0.6	29.4	0.0	0.2	0.6	0.1	3.1	0.5	1.6	0.0	0.2	0.7	0.5	0.1	0.0	1.9	16.0	4.1	0.0	0.2	0.9	0.0	0.4	5.4	6.5	0.1	0.0	0.0	0.0	0.3	0.9	0.1	3.8	0.6	5.7	0.3	0.0	12.0	0.0	0.0	0.4	2.2	0.0	0.3	2.5	10.4	0.3	0.6	0.0	0.6	4.2
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859805-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 92.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 34.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	3.5	0.6	1.1	0.1	10.0	0.0	3.5	0.3	4.2	4.3	0.5	7.4	0.1	2.4	0.0	1.3	3.2	0.0	3.4	0.9	0.8	1.1	0.3	0.3	0.1	1.0	1.1	3.1	0.8	0.0	2.0	2.0	1.1	3.1	0.0	0.1	1.1	0.1	1.1	2.6	2.8	0.0	0.5	7.2	2.7	3.6	2.5	0.0	1.1	0.0	0.1	1.9	3.7	0.2	0.0	0.0	0.0	1.2	0.0	0.0	34.4	0.0	0.0	0.0	0.0	3.3	0.5	0.0	3.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	5.0	1.7	0.0	0.0	3.7	0.1	4.7	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	10.0	0.3	4.2	0.9	0.8	1.0	1.1	1.1	0.5	2.5	0.2	2.5	0.0	0.0	0.0	1.6	0.5	21.0	1.1	0.6	3.5	1.4	8.5	0.6	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	3.4	0.4	3.1	5.9	0.0	0.0	0.2	0.0	1.6	2.0	0.0	0.1	0.0	0.4	2.5	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.3	4.5	0.0	0.3	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	3.1	5.5	0.0	0.0	0.0	2.0	92.1	0.3	15.5	16.9	0.3	0.2	0.1	0.7	0.2	0.1	0.0	1.3
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.6	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.3	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.4	2.1	0.2	0.0	2.0	0.2	5.1	1.9	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.4	1.3	0.0	1.3	2.5	0.0	0.0	0.0	0.1	0.3	0.1	2.8	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.6	3.1	1.0	3.7	2.4	2.1	5.1	1.9	2.5	3.4	2.5	2.8	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083990-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.8;Inhibitory neurons: 1.5;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA038539	Uncertain				"Secreted to extracellular matrix"	NA	NA					"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463009-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.2"	"Cell type enhanced"	"Detected in single"		"Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;JURKAT: 3.1;RPMI-8226: 1.0;SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036570	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.2	0.1	0.0	0.0	0.2	0.0	0.9	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.0	0.7	1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 14.0;seminal vesicle: 9.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SuSa: 7.4"	"Region enriched"	"Detected in single"	7	"thalamus: 5.8"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	0.3	0.3	0.6	0.0	1.0	0.1	0.3	0.3	0.8	0.1	0.0	0.0	1.7	0.2	1.2	0.1	0.1	0.1	0.5	0.4	0.6	3.2	0.7	0.2	0.1	0.7	1.3	0.0	0.1	14.0	0.0	0.6	0.3	0.1	0.0	0.1	0.0	9.7	0.1	2.4	0.9	0.2	0.5	1.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.3	0.8	0.4	0.6	0.7	1.3	0.3	0.5	2.3	0.5	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	13.8	14.3	12.0	10.7	12.9	23.8	13.4	13.3	16.1	14.2	12.5	14.7	13.9	14.2	7.9	15.7	13.4	9.0	14.2	11.7	11.5	13.6	13.5	13.3	17.6	12.1	12.4	14.0	18.1	10.1	17.5	9.6	12.4	13.6	9.0	8.4	13.5	7.8	16.3	12.9	18.1	8.8	11.9	21.5	16.7	15.9	12.8	14.3	14.6	9.6	14.1	13.9	13.5	14.0	30.5	17.4	17.0	33.1	22.4	14.3	16.8	14.9	14.6	24.8	21.5	27.5	39.4	33.5	27.5	19.0	20.2	22.6	50.0	29.8	12.8	59.3	75.8	19.1	23.7	31.3	24.0	22.5	29.2	13.2	20.7	20.1	25.6	13.8	22.2	39.7	31.8	19.9	18.1	27.2	47.6	33.7	23.5	30.4	36.7	29.3	24.5	17.9	13.1	12.6	43.7	61.1	17.3	23.5	43.1	14.4	23.3	35.9	17.9	19.1	19.1	32.6	21.7	27.0	34.7	68.7	9.8	45.8	8.6	57.3	23.4	70.3	21.7	22.5	21.6	22.2	22.7	21.1	24.3	22.4	19.9	21.0	28.8	24.2	33.3	20.5	27.3	19.3	12.0	12.9	13.3	16.1	11.7	11.5	12.1	12.4	12.4	11.9	12.8	14.0	15.4	3.2	13.4	12.1	18.3	7.0	10.8	22.3	12.0	23.5	8.7	9.4	7.9	10.0	12.9	14.7	35.5	21.3	21.0	15.4	13.7	13.1	12.1	11.3	9.4	11.2	10.3	5.9	9.0	14.2	12.5	12.0	14.3	8.7	4.5	14.8	10.0	7.0	18.3	42.1	7.9	13.8	16.2	11.9	6.8	25.7	12.5	13.5	12.4	9.4	14.8	17.6	15.5	6.0	10.3	16.6	7.8	9.8	16.5	14.2	30.3	9.4	14.2	26.9	6.6	9.8	15.3	38.1	15.8	12.3	6.8	14.5	20.3	15.4	13.0	9.6
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
WRNIP1	"bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP"	ENSG00000124535	"WRN helicase interacting protein 1"	Q96S55	6	2765393-2786952	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	23.7	31.1	45.6	22.6	47.0	49.0	28.8	47.8	46.8	29.2	46.2	29.7	23.6	26.7	37.1	48.3	35.6	24.6	39.5	47.8	46.7	35.7	33.0	30.3	34.7	44.4	44.8	30.1	43.9	46.4	43.1	43.3	43.5	28.5	29.1	45.8	46.1	26.8	44.0	37.2	27.4	23.8	43.6	28.7	29.1	31.5	47.4	43.9	39.0	76.3	34.7	32.1	31.7	45.1	86.8	42.7	42.5	70.1	44.1	37.7	56.5	38.9	54.2	69.8	69.2	67.8	39.4	77.4	103.1	50.4	75.6	65.9	70.2	78.1	67.8	77.9	77.5	80.9	50.3	107.4	50.1	51.4	53.8	38.7	62.7	64.4	69.5	48.5	89.8	71.8	62.8	27.2	51.6	84.5	76.7	92.7	36.5	59.3	52.5	60.3	62.2	78.4	75.3	52.5	127.8	36.5	45.9	46.1	93.7	66.7	59.4	57.1	49.4	52.1	39.4	45.8	95.8	34.8	65.3	59.8	20.4	55.0	72.1	9.4	1.6	2.3	4.0	1.8	1.2	2.3	2.7	2.8	1.3	1.3	3.1	3.0	0.7	2.6	0.9	2.6	4.2	1.4	45.6	47.0	47.8	46.8	47.8	46.7	44.4	44.8	43.5	43.6	47.4	45.1	16.4	19.2	14.6	14.0	12.4	32.5	13.4	20.1	23.9	24.8	22.3	19.4	23.7	24.3	12.3	11.0	8.4	30.4	11.8	29.6	3.9	14.5	45.0	21.9	19.7	20.9	39.7	26.1	23.5	13.5	25.6	15.1	11.7	17.5	9.5	12.7	28.2	25.0	12.4	8.4	20.8	21.2	24.4	16.2	17.9	13.4	22.4	12.4	21.4	23.4	15.0	20.0	10.3	26.2	23.0	18.0	16.3	22.2	10.2	18.5	14.8	13.7	24.1	17.4	6.6	19.9	17.8	22.1	23.9	32.4	32.1	25.4	12.5	20.5	25.0	16.3
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	41.9	22.1	14.1	45.9	35.7	48.7	35.7	22.9	26.9	47.0	5.2	40.7	28.6	49.4	24.6	27.7	45.9	39.6	32.5	14.1	35.9	29.0	15.6	58.3	34.5	38.7	22.7	47.7	29.6	19.0	23.8	75.0	40.6	27.6	30.9	76.0	27.4	32.1	23.0	23.2	33.7	44.8	17.0	69.9	32.7	21.6	33.2	24.8	28.8	16.1	35.2	32.8	39.1	80.0	30.8	21.3	65.3	37.5	40.3	49.7	69.7	26.6	37.9	20.6	39.6	32.0	12.2	30.6	29.6	36.6	26.2	28.4	40.0	19.6	30.9	85.3	33.1	48.7	41.9	32.7	75.7	34.1	69.2	60.2	26.3	30.1	18.4	31.5	83.1	31.7	49.8	28.6	36.9	19.4	44.4	38.4	19.4	17.1	17.3	35.5	35.9	18.5	31.1	24.6	20.9	28.8	27.8	27.3	36.7	77.8	22.1	44.5	46.5	25.3	19.2	34.8	26.4	12.8	34.9	31.2	23.9	26.8	23.4	75.0	41.1	71.5	21.6	70.3	26.1	22.1	18.1	24.2	65.5	25.3	17.0	19.7	37.1	21.4	82.5	21.5	30.2	26.4	14.1	35.7	22.9	26.9	14.1	35.9	38.7	22.7	40.6	17.0	33.2	80.0	300.4	221.2	476.1	189.7	245.4	249.2	185.6	138.4	253.8	91.9	186.7	147.7	67.5	144.4	194.2	239.1	348.2	360.7	183.2	222.7	27.4	124.9	153.0	201.2	187.6	254.9	194.4	148.1	229.5	65.1	217.2	284.6	190.6	301.5	163.5	436.3	316.6	43.3	228.2	82.4	267.8	191.5	162.8	412.6	288.9	26.6	141.4	358.9	197.5	206.1	153.2	170.5	112.3	349.3	658.2	76.7	185.4	122.6	144.9	196.3	178.7	30.7	137.5	381.4	124.9	243.8	221.9	119.6	104.8	202.2	280.3	714.5	183.9	98.5	133.6	148.9
WSB2	"MGC10210, SBA2"	ENSG00000176871	"WD repeat and SOCS box containing 2"	Q9NYS7	12	118032687-118062430	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 163.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052606	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA052606: AB_2681882"	"unprognostic (5.02e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (2.42e-3)"	"unprognostic (4.66e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	33.8	46.8	94.4	29.8	102.1	17.6	20.2	85.2	117.5	19.6	53.2	44.7	35.3	18.7	23.8	53.0	17.9	25.3	55.8	103.0	83.8	35.5	36.6	31.5	24.1	100.3	106.3	13.8	36.7	43.0	36.1	19.2	96.4	26.6	45.3	38.9	20.9	26.4	102.7	23.0	39.0	35.7	95.2	17.7	33.0	18.6	99.4	20.8	46.5	163.3	28.3	45.6	21.1	95.4	49.3	78.2	55.2	93.5	81.1	46.7	39.1	129.3	95.9	138.6	82.8	41.5	66.4	7.1	42.6	168.7	77.4	25.8	46.6	78.6	98.7	90.7	29.6	27.5	36.7	39.0	85.7	16.2	71.5	62.7	77.7	75.0	51.6	148.7	72.3	48.5	83.2	12.5	143.8	73.2	10.3	9.9	32.2	110.7	48.2	29.3	57.5	2.2	81.9	211.5	58.5	87.3	100.1	21.8	69.9	54.7	75.0	37.3	113.7	164.6	68.7	53.1	158.8	21.6	14.6	13.4	148.8	20.3	266.9	9.7	5.0	11.5	4.5	7.5	4.0	0.7	4.4	4.7	3.5	1.8	1.9	3.4	5.4	3.4	5.2	4.1	5.1	1.8	94.4	102.1	85.2	117.5	103.0	83.8	100.3	106.3	96.4	95.2	99.4	95.4	17.1	25.6	15.7	14.7	5.9	16.6	39.4	16.4	5.2	21.0	20.2	10.3	33.7	24.3	14.1	20.2	4.2	10.0	11.8	75.1	21.5	37.4	2.0	19.5	23.6	16.7	72.7	7.4	45.9	85.1	24.3	19.6	23.0	31.5	7.0	13.1	17.2	36.4	34.7	57.2	31.9	40.7	22.4	51.8	18.4	4.7	7.5	23.5	28.4	18.7	34.8	34.1	11.3	18.1	30.7	89.6	44.5	17.3	6.2	53.4	47.7	35.6	7.2	14.1	13.1	21.8	26.0	3.2	5.1	17.8	18.6	17.2	13.1	44.8	25.8	86.9
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 99.6;Oligodendrocyte precursor cells: 110.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 40.0;HUVEC TERT2: 24.7;OE19: 26.4;PC-3: 24.8;RH-30: 50.5;SCLC-21H: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	2.2	2.2	19.7	1.0	21.7	0.0	1.8	29.5	19.8	1.1	6.8	6.8	3.4	1.2	0.2	0.6	1.0	0.9	2.0	18.1	19.1	5.9	0.5	1.4	1.3	29.4	23.8	0.5	1.5	0.9	3.5	4.8	24.9	0.6	3.8	5.7	1.2	0.7	11.4	1.3	4.3	1.3	22.2	13.6	1.3	11.2	22.9	1.1	0.9	3.8	0.9	0.8	0.8	26.7	0.0	5.8	40.0	3.2	0.2	0.0	2.1	4.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	10.0	0.3	0.0	0.0	13.6	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.5	0.0	24.7	0.1	0.0	0.9	1.2	0.8	0.0	0.0	13.3	26.4	24.8	0.0	50.5	1.6	8.4	2.1	15.5	0.0	0.2	0.0	0.0	4.1	0.0	0.3	0.1	0.0	1.4	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	21.7	29.5	19.8	18.1	19.1	29.4	23.8	24.9	22.2	22.9	26.7	7.7	0.0	0.0	11.8	0.1	0.4	0.0	0.0	0.6	24.1	0.2	0.1	3.8	0.0	0.0	1.8	0.0	0.7	0.1	22.4	1.9	0.3	73.4	0.1	0.0	5.9	0.0	0.0	2.7	0.2	0.1	0.2	0.0	0.0	0.0	0.7	10.0	0.4	1.2	1.7	12.5	3.3	0.0	0.8	0.4	99.6	0.6	0.0	1.8	4.7	0.0	9.8	0.0	110.1	20.6	0.2	6.5	0.0	0.0	0.0	21.5	1.4	0.0	3.5	0.0	6.0	0.7	0.4	3.3	0.1	0.6	0.0	0.3	0.1	5.8	0.1
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;thyroid gland: 16.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	8.9	0.1	14.3	0.0	0.8	36.7	13.9	3.5	0.3	3.3	0.3	10.1	2.1	1.0	2.6	0.1	0.4	17.9	4.2	1.0	0.0	0.3	0.1	0.6	2.4	0.3	1.4	0.0	1.4	0.2	2.2	4.2	0.3	11.9	0.3	13.5	0.2	0.8	0.7	6.8	2.7	0.1	1.9	0.2	10.0	0.0	16.8	0.4	0.1	2.5	1.3	7.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.9	14.3	36.7	13.9	17.9	4.2	0.6	2.4	2.2	2.7	10.0	7.2	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	26.5	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	18.4	0.0	0.7	0.0	67.6	5.3	0.0	52.3	1.3	4.5	0.1	0.0	16.3	0.1	0.8	0.0	0.2	0.1	45.8	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.1	0.0	19.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	86.2	63.7	35.3	62.3	35.7	245.1	74.9	40.0	41.3	71.7	41.3	54.6	34.9	64.7	65.1	65.0	64.2	52.2	54.3	35.0	42.5	54.8	50.7	68.6	77.5	38.2	38.3	70.5	63.3	53.2	49.8	61.8	39.4	65.1	55.2	35.6	62.0	44.6	179.7	72.5	61.6	51.5	36.9	67.0	58.5	34.9	40.1	89.7	57.4	67.4	80.7	102.6	65.1	41.2	55.5	51.1	115.8	100.2	136.5	147.7	67.1	86.2	299.4	108.7	145.4	95.7	49.0	126.8	50.8	92.6	238.4	70.4	112.2	94.3	138.1	70.0	71.9	135.0	46.7	144.2	108.4	116.1	75.4	172.0	94.7	120.0	155.0	82.6	81.6	130.7	149.1	114.2	116.0	53.5	170.5	165.0	91.9	88.6	44.2	107.4	74.3	94.4	114.0	62.6	104.5	74.5	158.2	83.5	45.7	77.5	41.3	152.6	72.6	70.0	81.4	100.1	125.0	83.9	109.6	206.5	67.8	120.9	76.8	46.6	24.5	31.0	28.1	31.7	31.7	33.1	33.9	34.3	29.1	27.5	29.9	31.4	42.9	32.1	38.3	24.3	40.2	20.2	35.3	35.7	40.0	41.3	35.0	42.5	38.2	38.3	39.4	36.9	40.1	41.2	131.1	35.3	57.3	31.3	138.1	419.0	198.0	52.9	113.8	30.0	144.2	123.6	58.1	74.4	39.9	60.7	35.5	107.3	138.5	61.2	86.1	128.1	47.1	86.4	125.5	118.8	61.6	59.3	41.5	81.4	126.7	226.9	97.9	171.9	40.0	56.7	58.2	90.5	75.4	37.0	36.6	65.7	24.4	99.7	560.1	50.7	65.3	168.6	243.7	33.7	113.7	49.7	88.6	44.7	57.0	75.8	59.7	50.8	111.5	307.5	49.6	106.5	35.3	36.2	72.3	222.2	124.5	93.8	73.9	113.0	455.3	149.3	138.6	54.7	74.0	150.9
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291645-168472303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 142.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	7.8	0.6	41.8	2.9	43.3	0.1	21.2	41.0	39.7	6.0	50.4	6.4	24.3	2.8	6.8	22.9	17.2	8.7	1.6	40.3	41.3	73.3	38.1	20.2	3.0	56.8	47.0	0.8	28.3	23.5	7.8	10.2	43.6	16.4	6.1	17.8	142.3	11.8	0.0	19.9	20.2	1.1	46.6	0.7	22.9	1.7	54.3	1.3	29.7	0.0	6.9	9.3	10.1	38.6	50.6	56.4	9.2	0.4	0.0	0.0	96.8	3.7	0.9	17.1	15.3	120.2	73.6	0.0	58.6	1.2	47.4	35.0	18.9	46.1	20.1	0.1	18.6	0.0	28.6	29.9	0.9	4.4	0.0	6.0	13.9	32.3	28.5	13.2	0.0	3.0	0.0	7.2	1.3	56.4	0.0	0.1	13.3	60.8	8.2	0.0	0.4	29.1	260.4	68.8	30.7	11.4	66.5	136.4	17.1	11.6	67.8	4.3	0.0	3.0	34.2	0.4	36.9	0.8	0.4	0.2	3.4	0.1	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.8	43.3	41.0	39.7	40.3	41.3	56.8	47.0	43.6	46.6	54.3	38.6	0.3	64.1	72.3	162.2	1.3	11.9	14.7	6.0	1.8	1.4	35.7	25.7	1.8	34.3	42.1	58.8	91.8	11.6	0.6	17.9	13.7	44.9	0.4	81.8	10.8	1.3	7.8	0.0	50.1	40.5	2.3	5.3	15.3	149.2	1.3	5.6	1.1	16.9	1.3	0.0	27.9	7.8	6.1	0.6	1.1	0.1	1.2	4.2	10.6	8.4	1.1	18.1	0.0	17.6	1.9	73.1	10.9	0.7	0.1	38.8	18.9	61.8	36.7	9.1	0.0	0.2	5.6	0.3	5.0	7.3	13.9	18.2	2.1	2.5	12.2	16.5
WWC2	"BOMB, FLJ22029"	ENSG00000151718	"WW and C2 domain containing 2"	Q6AWC2	4	183099257-183320777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Microglial cells: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 84.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044005	Uncertain		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules		"HPA044005: AB_10960552"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (7.16e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (3.27e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.52e-2)"	9.0	5.5	4.7	4.6	5.9	0.6	7.8	5.5	4.4	7.7	10.0	5.0	2.0	8.9	3.3	5.2	6.9	6.9	12.1	4.4	4.4	18.8	19.2	28.2	2.3	7.3	5.8	11.5	12.6	9.7	1.8	14.5	6.3	7.9	2.9	21.3	6.1	8.8	4.2	4.1	2.1	9.9	6.6	6.3	6.8	15.5	5.4	1.0	15.9	5.5	2.2	6.2	3.8	7.7	26.0	10.9	23.1	20.7	16.9	18.8	26.7	34.5	27.1	37.2	26.6	48.2	24.7	0.0	16.9	55.7	13.0	9.2	35.7	14.3	46.9	0.0	11.0	26.3	25.4	24.9	17.5	12.5	27.6	14.3	10.7	24.6	22.9	30.8	25.1	3.7	18.9	1.4	28.6	7.5	0.0	8.3	22.0	0.7	9.3	0.0	21.1	14.0	52.7	6.9	1.5	11.7	84.2	72.7	11.1	36.5	17.6	4.2	37.8	13.8	38.2	8.2	25.1	0.0	0.0	0.3	13.5	5.7	24.7	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	4.7	5.9	5.5	4.4	4.4	4.4	7.3	5.8	6.3	6.6	5.4	7.7	27.8	262.8	65.4	23.2	0.4	24.0	9.3	6.3	8.6	5.4	15.0	11.4	30.0	37.1	24.0	7.3	64.6	15.4	1.4	0.7	27.4	16.3	36.9	26.7	26.6	27.4	1.2	3.6	62.1	14.6	9.8	25.0	9.2	35.4	19.0	39.5	17.2	39.0	10.5	0.0	98.1	0.2	4.1	15.6	7.7	26.9	17.7	9.0	12.4	129.3	7.6	11.7	0.0	52.3	44.0	30.3	0.1	21.1	0.8	29.3	0.0	24.7	11.5	58.6	26.3	34.2	24.2	41.8	19.7	7.7	15.3	6.6	3.2	19.9	0.4	12.2
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015254-10144474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 131.5"					"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Actin filaments"	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	11.2	13.8	13.7	9.6	16.9	5.5	10.9	13.0	11.8	11.2	12.2	15.2	4.0	11.3	19.3	11.3	9.7	9.7	18.6	10.3	11.4	7.3	3.4	21.7	12.6	14.1	15.1	18.1	8.5	7.8	6.5	15.7	13.4	11.3	4.8	1.9	9.3	26.7	8.5	13.5	11.6	8.3	12.4	11.6	10.8	5.4	15.1	7.1	12.2	6.4	9.6	11.0	11.3	16.6	17.2	19.1	22.7	7.5	9.4	13.2	21.6	9.6	16.5	5.7	6.2	2.5	17.5	1.8	0.2	12.8	22.0	8.8	5.3	9.9	4.7	13.0	1.9	3.9	13.1	1.7	20.1	0.0	5.8	8.5	20.4	14.1	14.8	30.0	26.7	3.2	0.3	22.4	13.7	35.2	4.2	1.1	21.4	9.0	6.7	12.5	1.1	7.5	5.5	8.7	2.4	6.4	11.7	14.9	10.2	42.0	131.5	1.4	36.0	16.4	0.5	24.4	10.8	18.2	13.3	6.3	10.0	6.3	24.7	4.0	0.8	0.2	5.8	0.7	4.9	2.0	2.8	4.3	0.4	5.0	2.5	3.0	10.7	2.6	0.7	0.6	1.4	1.8	13.7	16.9	13.0	11.8	10.3	11.4	14.1	15.1	13.4	12.4	15.1	16.6	41.0	22.4	68.4	20.2	15.4	5.6	12.9	8.2	7.4	6.1	22.9	15.9	20.5	5.7	13.0	5.5	6.2	14.3	7.1	7.9	0.0	6.2	0.7	6.3	15.4	26.9	16.1	24.8	29.0	9.5	6.3	15.3	2.6	7.5	3.8	12.7	31.8	5.6	11.6	3.3	21.1	4.2	8.2	19.4	11.8	1.4	12.8	12.2	16.0	12.2	6.8	4.1	10.3	13.0	35.7	9.5	7.4	24.8	10.2	14.8	8.1	2.5	11.5	2.0	19.7	11.9	20.2	0.7	2.5	8.8	13.1	7.9	12.0	15.8	3.6	9.4
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099430-79212667	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	8.6	6.3	18.6	4.0	23.9	4.2	7.4	24.0	20.3	8.6	21.2	5.2	5.3	8.2	10.1	7.7	9.0	7.4	5.2	18.8	22.5	12.7	12.0	5.3	4.6	24.0	22.4	7.6	8.3	12.1	9.8	5.3	25.3	7.7	3.2	6.9	8.5	6.4	3.3	7.1	4.5	5.1	22.0	4.7	6.0	9.3	21.0	9.0	21.8	2.1	6.0	6.7	7.1	30.0	11.1	9.5	9.2	7.7	11.0	5.3	11.1	1.6	3.2	3.7	3.2	7.0	9.6	19.5	8.6	1.5	5.2	10.0	5.1	1.3	2.6	11.0	26.8	6.0	1.9	15.7	7.5	16.7	3.4	5.9	3.8	2.3	2.4	0.9	4.4	25.9	9.2	4.2	2.6	85.7	27.7	21.9	8.6	5.9	5.7	32.2	3.9	19.1	5.3	3.9	17.6	10.0	7.1	11.9	4.0	9.3	12.8	12.0	1.6	2.7	10.4	2.2	6.4	0.0	18.3	41.2	10.4	8.4	4.6	7.0	9.1	2.1	11.4	7.9	13.4	9.3	8.2	9.1	7.7	6.6	8.4	8.3	0.7	9.1	5.8	14.5	13.5	6.0	18.6	23.9	24.0	20.3	18.8	22.5	24.0	22.4	25.3	22.0	21.0	30.0	12.0	6.4	6.9	927.8	9.0	9.2	21.2	8.0	19.4	7.4	12.1	16.1	8.8	17.2	13.3	14.7	4.2	25.7	10.9	4.5	33.2	12.4	43.1	18.2	13.9	9.5	9.6	13.3	270.5	10.3	11.9	12.0	9.2	7.6	12.7	18.7	13.2	18.9	9.2	5.0	540.9	5.1	0.0	5.6	5.7	38.2	14.0	7.7	5.4	471.2	5.9	46.3	9.2	914.9	793.5	4.5	5.9	17.7	18.4	11.5	8.7	28.3	18.7	12.2	6.6	10.3	11.8	19.7	17.9	13.3	6.8	17.4	9.9	12.1	6.8	13.0
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342547-86478420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	33.6	22.1	16.3	25.8	21.5	18.2	40.6	19.6	16.3	23.6	24.3	26.9	26.3	23.0	24.6	33.1	18.5	45.3	50.8	14.3	20.7	40.9	111.7	27.2	39.0	18.3	19.0	24.7	28.0	116.3	9.8	36.9	19.7	33.4	33.1	43.2	25.9	25.6	171.4	40.8	28.1	24.6	18.1	45.7	34.3	29.5	19.5	22.7	32.6	122.2	30.6	33.7	15.8	23.1	59.8	27.1	18.3	13.1	23.0	22.4	16.3	21.0	22.5	16.5	19.5	18.9	35.3	24.9	14.0	36.5	22.9	49.3	26.4	34.1	28.5	31.6	21.0	28.7	24.4	44.7	16.8	11.7	14.0	20.5	42.5	18.2	33.3	25.3	74.1	29.0	14.3	28.7	28.4	29.6	27.7	8.1	11.2	82.6	30.0	18.0	21.4	22.5	37.3	44.5	5.5	12.9	21.2	104.7	23.0	39.8	31.3	10.8	84.4	23.9	28.7	26.3	10.7	33.9	22.0	25.7	29.9	1.6	19.0	6.2	2.1	3.9	5.2	1.9	4.6	2.7	6.4	5.3	1.5	2.4	7.5	4.7	1.3	2.4	2.2	1.9	6.5	2.0	16.3	21.5	19.6	16.3	14.3	20.7	18.3	19.0	19.7	18.1	19.5	23.1	51.2	25.6	22.6	29.0	13.0	35.8	26.9	15.4	26.7	28.8	41.7	23.5	82.7	44.3	19.2	29.5	58.4	28.3	19.5	23.7	43.0	20.5	42.1	22.6	20.1	32.3	23.6	3.0	55.3	37.6	3.3	27.6	35.2	35.5	3.8	18.0	62.4	88.8	55.9	40.4	134.6	25.3	14.2	95.2	28.1	12.7	32.3	43.0	30.2	61.8	18.6	23.3	18.6	60.3	103.8	45.1	16.0	36.5	18.5	45.1	15.8	45.7	17.2	52.6	6.6	18.8	16.6	12.4	21.2	28.8	39.5	23.0	32.0	25.1	19.7	38.3
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3"	"Low region specificity"	"Detected in all"							HPA057302	Approved		Supported	Nucleoplasm,Mitochondria		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria"		"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	31.9	12.8	28.3	29.7	29.8	33.4	24.2	27.7	39.6	42.3	23.8	17.5	26.8	26.5	13.0	17.0	22.5	34.0	30.9	27.5	29.2	23.5	63.6	35.8	29.7	37.5	28.4	52.9	2.9	2.9	14.3	25.9	30.8	24.9	16.8	4.8	47.6	11.2	14.1	18.4	25.4	24.3	31.9	63.4	23.6	9.2	31.5	23.8	18.2	13.5	15.5	17.3	22.1	27.5	5.2	0.3	0.7	1.4	6.7	15.1	0.7	7.1	26.3	81.8	83.8	0.7	7.5	1.3	2.0	10.2	28.9	3.1	0.0	1.3	9.3	11.4	0.3	1.9	0.9	1.0	35.3	1.2	8.0	6.9	0.0	11.3	0.3	0.4	6.9	25.5	0.7	26.1	2.6	0.4	6.3	22.1	0.6	0.2	2.2	11.3	0.4	0.5	0.2	4.9	0.5	0.6	3.6	0.5	14.3	0.6	0.8	30.4	0.7	1.1	0.8	2.3	0.5	3.9	1.4	0.5	2.6	18.4	2.2	17.4	9.6	4.3	7.8	12.7	5.7	3.6	6.0	5.6	8.0	4.6	3.8	4.0	10.6	8.0	12.5	0.8	9.9	5.6	28.3	29.8	27.7	39.6	27.5	29.2	37.5	28.4	30.8	31.9	31.5	27.5	174.2	60.9	29.9	14.0	25.7	5.2	5.7	5.5	13.1	0.5	4.1	10.3	2.7	8.6	30.0	0.0	0.0	0.4	37.1	12.4	0.0	1.3	4.0	18.9	68.4	90.4	1.8	10.7	0.3	1.9	5.1	29.8	27.5	10.4	48.7	44.4	33.5	20.1	15.9	0.0	0.3	9.2	0.0	21.3	11.2	2.6	36.4	54.4	5.4	103.0	44.5	1.1	70.0	1.5	0.6	10.1	2.7	27.4	11.4	2.5	11.4	0.3	24.3	0.4	19.7	27.3	19.0	0.2	0.8	11.8	2.7	0.4	35.1	47.3	9.2	5.6
XAGE2	"CT12.2, GAGED3, XAGE-2, XAGE2B"	ENSG00000155622	"X antigen family member 2"	Q96GT9	X	52369021-52375680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 199.5"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 1027.3;Extravillous trophoblasts: 1890.1;Syncytiotrophoblasts: 1367.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 96.3;SK-BR-3: 22.7;SuSa: 27.9;T-47d: 20.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"								"unprognostic (1.21e-1)"		"unprognostic (9.67e-2)"	"unprognostic (1.49e-1)"				"unprognostic (4.47e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	5.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	199.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	96.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.7	1.2	27.9	20.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.5	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1027.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1890.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	1367.6	0.0	0.0	0.0	0.0
XAGE3	"CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3"	ENSG00000171402	"X antigen family member 3"	Q8WTP9	X	52862525-52868083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	121	"placenta: 382.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"							"unprognostic (6.04e-2)"						"unprognostic (2.30e-1)"		"unprognostic (2.92e-1)"			3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	382.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2223.5	0.0	0.1	0.0	0.2	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.4	1309.1	11.1	0.0	0.3	0.0	0.0	0.0	4.6	191.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	15.1	7.0	0.0	0.0	2678.1	0.0	0.0	0.1	0.0
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"U-2 OS: 22.0"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576605-168582069	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 185.3;T-cells: 213.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"NK-cell: 88.5"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 88.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 4.1;SCLC-21H: 3.3;SuSa: 6.1;U-266/70: 5.0;U-266/84: 1.9"	"Not detected"	"Not detected"							HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	0.5	0.1	0.1	1.0	0.1	3.5	1.0	0.0	0.2	1.0	0.0	0.7	1.0	2.2	0.8	0.2	0.6	1.1	0.5	0.1	0.2	0.5	2.6	1.8	2.3	0.1	0.1	0.2	0.5	0.0	0.1	2.2	0.2	0.4	1.0	0.0	1.5	0.3	0.1	0.1	1.5	0.3	0.1	4.6	1.2	0.2	0.6	4.1	0.3	0.0	1.6	0.9	0.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.3	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.0	1.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.2	0.0	0.2	0.0	1.0	5.9	0.0	0.0	0.3	4.0	0.3	88.5	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.6	0.1	2.3	3.2	5.5	0.0	1.5	4.0	0.5	0.0	2.2	0.0	1.3	1.5	2.0	1.5	0.0	0.0	0.0	1.4	185.3	0.7	0.0	0.0	1.3	2.0	1.9	1.9	0.0	8.4	0.0	0.2	1.2	1.9	8.2	2.9	2.5	0.0	1.4	0.9	0.4	0.0	0.1	0.8	0.0	1.9	10.6	0.0	0.0	3.1	39.2	0.0	0.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	0.3	1.7	0.2	0.2	1.8	4.3	0.8	213.4	0.0	0.4	0.1
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;RT4: 1.1;SuSa: 1.1"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.1	0.8	0.3	3.2	0.3	14.1	0.9	0.3	0.5	1.0	0.4	1.9	3.2	3.6	0.9	0.6	1.8	1.9	0.7	0.3	0.4	0.4	5.6	3.3	5.6	0.5	0.3	0.4	0.6	0.3	0.2	1.4	0.4	0.5	1.5	0.0	1.9	1.0	0.3	0.1	2.0	1.4	0.4	13.4	2.9	0.3	0.6	3.8	0.6	0.5	3.6	2.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.4	47.2	0.2	2.7	0.3	3.6	50.1	0.3	0.1	2.1	37.1	1.9	423.5	0.3	0.1	0.0	17.1	0.3	0.3	0.3	0.5	0.3	0.4	0.5	0.3	0.4	0.4	0.6	0.4	2.9	0.0	1.1	0.0	3.3	2.4	0.0	0.0	1.8	0.0	1.6	1.4	0.8	0.0	0.0	0.0	0.0	0.1	513.6	0.3	0.0	0.1	0.0	2.4	2.0	1.0	0.0	19.2	0.0	0.0	0.0	1.1	8.2	2.2	1.3	0.0	1.4	0.6	0.4	0.0	0.0	0.7	0.0	5.0	4.0	0.0	0.0	3.7	33.8	0.0	0.8	0.0	277.1	0.0	0.0	0.0	1.1	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.9	1.1	0.0	240.6	0.0	0.1	0.1
XCR1	"CCXCR1, GPR5"	ENSG00000173578	"X-C motif chemokine receptor 1"	P46094	3	46017007-46027487	"G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.2"	"Cell type enriched"	"Detected in some"	5	"Langerhans cells: 10.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"myeloid DC: 3.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;Karpas-707: 2.5;RT4: 2.0;U-266/84: 2.2;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013169	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA013169: AB_1846211"	"unprognostic (3.49e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.53e-6)"	"unprognostic (3.89e-6)"	"unprognostic (9.27e-3)"	"unprognostic (4.41e-3)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-1)"	0.9	0.1	0.1	3.8	0.2	3.0	0.6	0.8	0.7	0.7	0.5	1.1	1.7	0.5	4.5	1.9	0.5	3.0	0.5	0.5	0.1	0.3	1.1	1.4	11.2	0.3	0.1	0.9	0.1	0.1	0.0	4.3	0.3	0.6	1.1	0.6	0.2	0.6	0.1	2.7	1.7	1.5	0.0	7.2	1.2	0.4	0.3	8.8	0.5	0.4	4.6	1.6	0.2	0.7	0.0	0.8	0.3	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.7	0.0	0.7	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.4	0.3	0.5	2.5	0.0	0.8	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	2.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.0	0.4	0.9	0.2	0.1	1.2	2.2	0.7	1.7	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.8	0.7	0.5	0.1	0.3	0.1	0.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	10.2	1.5	0.0	2.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 42.2;intestine: 49.5;liver: 68.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		77000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.0	0.0	4.8	0.0	0.1	42.2	0.3	0.0	0.3	0.4	11.1	44.9	0.9	2.3	9.8	0.1	4.5	0.0	0.0	0.0	0.2	68.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.1	1.3	9.5	0.1	3.6	0.1	0.5	1.1	49.5	0.7	0.0	0.0	3.2	0.1	0.0	0.2	0.3	0.0	2.3	2.7	2.0	0.1	2.0	0.4	0.0	0.0	0.0	0.1	0.1	8.2	4.7	1.0	1.4	0.3	2.3	0.1	1.6	0.3	0.8	4.2	0.0	20.0	1.0	1.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	1.8	1.1	31.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.4	1.2	0.2	0.0	1.4	4.5	5.7	5.2	0.0	0.1	0.1	0.3	0.0	1.7	0.0	0.0	0.0	3.8	2.4	0.2	8.9	2.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.4	0.0	0.2	0.5	6.0	5.5	2.8	0.3	262.1	6.5	0.4	2.8	3.6	0.0	0.0	0.3	1.1	143.5	0.0	3.9	0.3	7.9	2.8	0.3	11.9	0.0	0.2	8.2	0.6	0.2	2.0	37.0	0.0	0.0	1.4	46.9	0.0	0.0	0.2	8.4	2.0	1.9	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	48.8	0.0	0.0	2.2	96.8	0.0	1.0	0.7	0.0	0.3	0.7	0.0	0.2	1.2	0.1	0.4	0.7	0.2	22.2	16.9
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913976	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	9.2	7.7	6.5	9.2	7.5	8.3	9.7	6.8	7.0	9.6	12.9	12.4	10.1	8.4	10.0	11.5	7.4	8.6	7.8	5.8	8.2	11.8	12.1	8.5	10.4	7.6	8.1	7.5	8.3	18.4	6.3	8.6	7.3	8.5	10.1	21.4	8.6	7.4	10.3	8.8	10.1	7.4	8.5	10.4	10.2	4.2	8.1	8.9	14.9	11.9	8.6	9.6	6.1	10.3	15.8	13.2	10.2	8.8	11.8	15.0	13.3	16.9	12.4	8.9	7.7	5.9	17.9	14.7	24.3	14.4	17.1	5.6	15.3	10.5	16.3	15.5	8.3	9.9	11.1	9.2	14.9	18.1	19.7	10.4	16.0	14.9	19.0	10.2	12.7	10.8	15.9	16.4	17.6	16.5	10.2	8.8	8.4	15.6	10.3	10.8	11.9	15.6	13.4	22.6	6.8	10.0	22.9	13.0	13.5	9.0	8.0	8.7	15.7	0.5	6.0	27.0	18.9	13.8	14.9	15.8	18.3	12.7	11.5	9.3	1.8	2.6	3.3	1.5	3.0	3.1	2.4	3.6	1.0	4.0	2.7	1.9	5.6	2.4	2.9	2.9	1.8	1.5	6.5	7.5	6.8	7.0	5.8	8.2	7.6	8.1	7.3	8.5	8.1	10.3	50.0	80.1	91.6	26.4	42.1	26.6	36.3	35.0	28.5	72.1	29.7	19.9	44.5	44.3	55.2	53.3	95.9	17.9	41.7	122.9	27.4	36.0	2.7	38.4	44.9	55.0	47.4	23.5	30.0	54.0	30.0	38.4	39.8	50.4	60.7	30.9	64.2	85.8	29.0	75.7	34.9	62.2	26.4	43.6	33.0	4.1	42.6	44.2	8.8	29.0	45.8	45.8	55.6	32.6	41.9	65.4	53.5	51.6	39.5	53.0	59.2	59.8	50.6	133.7	65.7	43.6	34.9	15.2	21.0	30.8	35.5	38.0	40.8	30.0	48.0	68.1
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 682.0;skeletal muscle: 383.4"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 850.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0"	"Not detected"	"Not detected"							"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.1	0.3	0.0	1.2	0.0	0.0	0.2	2.0	0.3	0.0	0.1	0.7	0.0	0.2	0.0	5.6	0.0	1.0	682.0	1.1	0.1	0.1	0.1	1.7	0.0	0.6	0.2	0.1	1.2	0.0	0.5	0.7	0.2	3.4	0.0	0.0	5.1	0.0	383.4	0.5	0.5	0.4	0.2	0.6	0.3	0.0	0.1	0.5	0.2	96.4	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	1.1	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	850.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 202.3;skeletal muscle: 1034.1;tongue: 543.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	202.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.0	0.0	1034.1	1.2	0.1	0.0	0.0	0.5	0.1	3.0	0.0	0.1	0.3	543.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685791-37732130	"Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;intestine: 12.2;stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	53	"basophil: 10.2;eosinophil: 5.8"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.2	2.1	2.5	1.4	2.5	14.2	0.7	2.3	3.0	1.2	0.2	12.2	10.8	0.7	0.5	2.0	3.8	0.9	4.3	3.2	4.9	0.9	0.8	1.0	0.2	1.6	0.9	0.7	4.9	0.7	1.3	0.7	2.0	1.5	11.2	2.1	1.2	0.9	5.4	0.7	10.6	1.8	0.5	0.5	11.5	1.4	2.8	0.2	0.9	5.8	0.5	1.1	0.8	1.4	17.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	14.7	0.3	0.0	0.8	2.7	15.4	0.1	0.0	0.0	4.2	44.4	2.4	0.0	0.0	23.2	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	29.1	10.9	0.1	1.7	0.2	21.1	5.5	0.7	5.6	0.0	0.0	20.2	0.0	1.1	4.1	0.1	0.8	1.4	0.1	0.9	2.1	5.6	0.0	0.0	0.8	0.0	2.4	9.3	16.5	0.0	0.2	12.1	0.1	10.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.5	2.5	2.3	3.0	3.2	4.9	1.6	0.9	2.0	0.5	2.8	1.4	0.0	0.0	1.1	2.6	0.8	0.4	0.4	0.1	1.2	0.7	1.1	0.8	7.9	0.0	0.1	0.0	6.2	0.3	0.1	26.7	0.0	0.0	1.2	4.0	0.1	0.3	6.1	63.5	11.0	3.1	0.1	0.6	17.9	0.9	0.0	0.1	0.0	0.9	0.1	3.3	12.6	10.9	2.0	0.3	0.0	0.4	0.0	0.2	1.8	1.9	0.0	0.0	0.0	4.5	1.2	1.1	9.2	0.7	2.2	0.9	21.5	0.1	1.7	1.4	0.0	0.7	1.3	10.2	6.1	3.8	1.1	0.0	0.3	0.1	14.7	1.5
XKR3	"MGC57211, XTES"	ENSG00000172967	"XK related 3"	Q5GH77	22	16783412-16821699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 8.1"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 230.8"									"HPA003379, HPA035081"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA003379: AB_10602682, HPA035081: AB_2674451"	"unprognostic (4.57e-1)"				"unprognostic (3.37e-1)"								"unprognostic (3.11e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.5	0.0	0.0	15.2	230.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.9	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
XKR7	"C20orf159, dJ310O13.4"	ENSG00000260903	"XK related 7"	Q5GH72	20	31968151-32003387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 8.9;pituitary gland: 4.3;retina: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.1;Early spermatids: 2.1;Excitatory neurons: 4.5;Horizontal cells: 1.7;Inhibitory neurons: 4.8;Late spermatids: 2.1;Rod photoreceptor cells: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 8.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 20.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	HPA040854	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA040854: AB_10795481"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.03e-2)"	"unprognostic (3.74e-7)"	"unprognostic (4.29e-2)"	"unprognostic (9.34e-2)"		"unprognostic (1.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-5)"	"unprognostic (1.99e-1)"	0.0	0.2	1.5	0.0	3.7	0.0	0.0	8.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.3	0.0	4.3	0.0	0.7	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	20.9	4.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.7	8.9	2.5	1.3	0.9	0.8	0.2	0.7	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959588-27968093	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"eosinophil: 202.8;neutrophil: 101.6"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 202.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	5.8	4.4	17.7	8.6	18.0	22.7	6.6	18.7	19.1	6.2	18.5	6.0	7.0	5.7	8.1	5.3	7.7	6.7	8.1	18.3	19.3	6.8	15.3	7.4	8.8	18.9	18.6	9.1	14.0	9.7	4.5	15.2	18.0	6.3	6.1	5.4	10.3	8.0	6.2	5.6	6.0	9.3	17.9	9.4	9.0	6.3	19.1	6.9	6.5	11.7	7.4	7.0	4.7	17.9	10.9	8.6	12.4	13.4	10.5	15.5	13.5	8.8	17.1	19.5	18.7	18.2	7.6	4.1	9.1	21.1	14.5	4.6	19.0	9.5	9.8	15.0	18.2	13.8	5.2	15.4	15.7	6.8	4.7	16.9	18.8	21.8	15.2	19.7	19.3	12.5	21.6	8.9	14.1	10.0	8.5	19.7	40.3	9.1	12.6	15.1	4.0	8.8	15.6	6.3	2.9	4.1	3.8	9.6	6.2	21.7	6.2	16.8	8.0	11.4	10.2	23.9	8.0	13.1	13.6	6.5	29.3	9.2	8.7	20.3	11.9	202.8	15.1	11.9	14.8	7.6	15.7	14.1	13.0	7.1	14.4	13.5	101.6	14.0	10.2	6.3	14.8	11.2	17.7	18.0	18.7	19.1	18.3	19.3	18.9	18.6	18.0	17.9	19.1	17.9	4.4	3.2	1.1	2.6	8.8	1.9	3.8	3.5	1.8	4.5	5.2	3.4	3.3	5.7	4.4	3.7	0.0	62.0	15.5	4.7	3.9	7.8	0.5	1.8	2.9	6.8	1.8	2.1	2.2	11.4	15.8	6.1	5.6	2.4	1.3	5.2	8.6	5.6	14.0	3.3	2.2	6.1	2.0	6.6	3.7	0.9	3.4	8.0	1.8	1.0	21.1	14.0	16.5	3.5	5.5	7.2	2.8	3.8	14.0	5.1	7.2	4.5	1.7	1.3	6.6	5.1	4.0	0.6	7.8	2.2	3.0	22.4	9.1	4.4	5.2	4.1
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669339-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.3;testis: 7.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.0;Inhibitory neurons: 17.9;Oligodendrocytes: 23.0;Spermatocytes: 82.3;Spermatogonia: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.3;hTCEpi: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 45: Intestine - Brush border"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.2	1.1	0.5	0.4	0.5	0.5	0.4	0.0	1.6	0.2	0.0	0.9	2.6	0.2	1.3	0.5	0.1	2.2	0.2	0.5	0.3	0.5	3.3	0.6	0.5	0.6	0.2	0.2	0.3	0.1	0.6	0.4	1.1	0.6	0.5	2.4	0.5	0.0	0.2	0.9	5.3	0.3	0.0	0.5	1.8	7.7	0.3	0.5	0.4	0.3	0.5	1.0	0.2	1.5	2.3	0.1	0.5	0.2	0.0	0.5	0.3	0.9	0.4	0.3	0.9	3.3	0.2	0.3	1.5	0.0	1.1	0.1	0.0	0.5	1.1	0.4	0.3	0.2	0.2	0.2	0.0	0.7	1.2	0.6	6.4	0.1	0.0	0.2	0.0	1.6	0.1	2.3	0.1	0.3	0.4	0.3	1.3	0.1	0.4	0.3	0.6	0.1	0.1	1.7	1.4	0.2	0.4	1.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	0.4	0.3	2.0	0.5	1.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.4	0.2	0.0	0.2	0.6	0.4	0.1	0.2	0.0	0.0	0.8	0.0	0.5	0.5	0.0	1.6	0.5	0.3	0.6	0.2	1.1	0.0	0.3	1.5	0.1	6.4	2.2	14.4	1.1	2.7	3.5	3.9	4.6	2.2	0.7	1.0	0.4	1.5	3.3	0.0	8.4	1.0	0.3	1.4	0.0	1.6	5.3	0.5	0.3	0.6	0.0	0.0	42.0	4.6	0.6	0.8	6.1	0.6	0.0	0.3	0.0	2.3	0.3	1.7	17.9	3.4	0.0	0.3	0.4	4.9	0.9	0.2	0.0	1.9	0.0	1.5	2.1	1.5	23.0	6.0	1.3	0.4	0.8	1.7	11.7	0.5	3.2	5.3	0.0	0.1	0.2	82.3	19.7	0.5	0.9	1.0	1.0	0.1	0.4	2.3
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	15.1	13.4	9.9	9.5	10.3	9.1	13.4	12.0	15.4	13.9	10.8	23.0	15.8	14.0	11.0	14.9	13.1	9.7	9.9	9.7	10.8	18.4	18.8	11.3	14.0	10.2	10.0	13.0	11.8	18.7	9.9	9.7	9.8	14.8	9.9	10.6	12.5	12.7	19.5	12.5	13.1	12.0	9.7	12.5	21.6	5.2	10.7	11.0	23.6	8.6	17.2	15.4	13.5	10.6	35.5	8.2	11.9	14.8	14.3	13.7	8.2	9.4	14.9	16.9	11.4	21.4	28.9	19.9	8.9	10.5	11.3	17.4	9.6	11.4	14.1	13.7	19.2	15.7	17.7	12.0	15.5	18.7	18.2	12.0	12.0	7.9	8.0	11.4	19.1	16.1	22.0	15.2	9.4	11.0	24.4	22.5	8.2	33.5	13.5	24.6	25.4	17.0	27.0	13.7	16.7	16.7	13.4	10.3	12.7	9.0	14.9	11.1	12.0	5.9	14.8	23.4	20.6	26.5	22.7	12.3	14.6	13.2	11.8	12.8	21.6	22.6	25.5	23.0	30.1	34.4	27.9	25.0	23.0	40.5	33.5	29.0	2.6	35.2	29.7	39.8	33.1	19.6	9.9	10.3	12.0	15.4	9.7	10.8	10.2	10.0	9.8	9.7	10.7	10.6	32.4	25.6	37.8	49.0	36.1	17.3	23.3	39.3	31.9	101.4	24.8	31.9	36.2	45.8	39.7	22.0	81.3	32.1	47.2	10.6	121.3	36.3	1.7	22.5	29.1	30.4	22.3	11.1	49.3	38.3	9.7	31.3	22.4	17.2	30.9	28.0	28.2	48.7	36.0	84.1	63.5	24.6	30.5	27.7	20.7	4.0	44.1	24.5	14.2	40.3	49.6	87.0	64.9	74.9	96.0	29.3	19.2	47.4	26.2	18.9	32.1	55.5	28.6	97.5	32.9	38.3	39.4	18.2	17.9	28.5	18.8	14.0	34.9	36.4	24.2	23.5
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	22.9	17.2	14.3	16.4	17.3	10.2	22.9	15.6	14.6	27.2	15.2	20.1	19.0	24.9	17.6	16.1	25.3	16.6	13.1	12.9	17.3	24.8	24.2	20.7	24.5	16.8	17.4	34.6	21.6	24.0	25.8	15.6	17.4	22.9	15.6	15.2	18.5	23.6	21.3	31.9	24.0	17.5	15.2	24.2	17.4	12.4	16.0	21.2	26.7	9.8	21.7	22.9	20.3	18.3	14.3	33.8	36.7	22.6	51.0	35.8	124.8	33.6	88.7	29.9	22.3	11.8	14.7	46.6	14.5	37.5	14.7	15.6	23.6	49.3	23.6	21.5	24.7	24.9	35.7	21.7	45.0	16.8	42.2	50.1	56.4	39.7	77.4	34.2	34.5	19.0	31.2	22.5	32.5	27.2	17.9	16.3	23.5	20.4	21.2	19.3	17.9	33.7	36.2	36.9	8.8	29.9	36.1	27.2	23.5	54.6	29.9	13.8	57.1	11.2	32.1	18.4	15.4	54.5	46.4	25.4	26.5	19.4	41.6	41.4	20.2	26.8	23.2	16.6	22.7	27.1	26.7	23.5	17.9	25.0	28.3	20.8	73.1	24.3	23.3	17.4	24.7	16.9	14.3	17.3	15.6	14.6	12.9	17.3	16.8	17.4	17.4	15.2	16.0	18.3	26.0	60.9	63.2	16.6	39.9	13.8	20.4	25.5	59.2	35.6	19.0	25.9	11.8	31.5	47.7	16.5	39.6	42.5	38.9	13.4	35.2	19.3	2.3	32.2	44.8	29.9	16.3	20.8	18.0	19.2	20.3	29.2	15.3	25.5	47.4	25.0	22.9	40.5	18.2	26.9	22.0	13.9	20.3	23.9	14.9	2.7	30.7	19.6	8.8	15.0	40.1	24.9	54.6	17.1	27.5	19.5	15.0	28.2	29.1	18.9	32.7	66.1	55.0	51.0	26.3	43.3	27.7	28.7	54.9	21.4	11.1	32.0	42.3	26.3	18.1	10.5
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	19.7	19.4	13.2	22.9	13.6	23.3	20.1	13.1	14.8	19.7	17.2	32.2	51.7	19.4	22.7	25.1	22.3	27.5	27.9	15.3	13.4	21.4	18.9	19.2	25.4	13.2	12.7	19.8	62.0	24.5	19.2	26.6	13.1	21.7	40.4	18.7	30.4	15.7	28.4	29.5	61.8	28.2	13.2	19.3	24.4	18.1	13.3	19.5	23.6	22.1	28.4	24.6	19.3	13.7	78.1	33.6	52.3	72.1	83.6	77.4	40.2	42.4	85.5	61.8	66.5	65.4	65.2	110.3	35.9	65.0	31.3	40.5	41.7	52.2	60.4	33.0	40.3	74.0	20.5	27.6	58.2	58.3	59.0	76.9	31.8	67.8	60.1	94.6	103.1	70.0	24.3	34.3	80.1	26.3	41.7	36.0	20.6	58.7	35.7	46.1	105.3	19.8	78.5	24.3	15.9	60.5	36.9	23.1	70.6	56.9	28.3	53.6	53.9	25.3	32.9	40.4	38.1	58.4	30.4	92.8	59.4	80.0	20.3	25.7	26.8	11.3	19.5	42.2	13.4	10.6	12.6	17.5	46.4	8.9	8.7	11.7	2.2	30.5	36.8	36.4	15.5	29.6	13.2	13.6	13.1	14.8	15.3	13.4	13.2	12.7	13.1	13.2	13.3	13.7	13.4	6.4	14.4	24.5	14.6	8.9	13.2	32.9	11.4	20.5	12.1	9.7	17.0	18.6	26.3	3.7	6.2	38.2	33.1	34.5	17.6	37.4	6.4	12.3	16.5	18.2	16.8	14.7	18.9	72.9	29.6	22.7	24.5	13.6	11.4	17.0	15.7	12.1	30.9	26.9	25.3	37.1	18.3	20.5	9.6	5.1	18.3	37.5	8.8	15.9	33.5	27.1	24.7	21.6	27.0	54.4	35.1	29.7	18.1	22.5	63.5	31.1	22.8	19.5	13.1	9.8	14.2	17.5	35.9	18.6	8.7	25.2	19.4	30.0	36.5	27.1
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 232.9;Late spermatids: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	2.7	4.9	6.4	1.3	6.3	1.6	2.6	8.3	7.8	2.9	7.1	2.5	14.6	4.7	5.0	2.8	3.7	4.4	5.3	7.8	6.1	3.7	8.2	2.4	2.5	7.2	6.6	3.8	3.6	2.1	3.7	1.5	6.6	2.8	2.2	4.4	3.4	2.5	5.5	5.5	10.1	2.4	5.6	2.8	2.8	3.7	6.7	5.9	3.2	3.5	1.9	3.7	2.8	9.0	2.7	4.1	2.5	5.5	6.3	4.6	2.1	3.3	2.5	1.7	1.7	3.1	1.6	5.2	1.8	6.5	7.8	7.3	4.7	2.4	2.7	3.5	9.7	3.3	9.7	7.5	3.2	6.0	0.5	4.0	3.9	5.7	3.3	2.7	3.3	3.8	2.9	4.8	4.3	4.1	3.1	3.2	1.5	5.0	8.3	3.9	3.3	3.0	5.9	3.6	2.3	1.9	3.9	4.8	3.3	2.6	6.1	2.7	3.2	3.6	3.4	3.4	2.1	4.7	4.0	7.4	5.6	8.5	2.5	2.8	2.5	2.9	2.1	2.5	1.0	3.7	1.2	1.2	1.9	1.9	2.4	1.9	3.6	0.7	6.9	3.8	1.9	2.8	6.4	6.3	8.3	7.8	7.8	6.1	7.2	6.6	6.6	5.6	6.7	9.0	9.6	6.4	17.6	32.0	12.7	13.3	8.0	15.6	9.6	16.0	12.9	13.2	22.5	15.7	14.0	9.2	18.8	21.7	11.0	6.2	15.6	12.2	232.9	37.5	16.6	11.7	13.8	12.0	22.0	17.1	18.7	13.1	12.2	12.0	14.0	17.8	10.8	36.0	14.7	16.8	24.0	9.5	12.2	12.6	15.7	306.8	19.9	11.9	17.8	18.7	7.8	13.0	9.2	19.6	42.3	10.4	9.5	15.4	11.8	7.8	3.5	25.3	38.5	19.8	32.9	14.0	12.7	65.6	34.2	12.2	16.3	20.0	11.0	19.5	8.7	7.6
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
XPO7	"KIAA0745, RANBP16"	ENSG00000130227	"Exportin 7"	Q9UIA9	8	21919662-22006585	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043727, HPA048153"	Uncertain					NA	NA		53000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043727: AB_2678638, HPA048153: AB_2680289"	"unprognostic (6.30e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (6.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	20.0	21.8	25.1	21.9	27.2	61.9	26.6	24.5	25.7	26.5	24.7	24.7	15.9	30.7	28.5	26.5	30.5	20.3	31.3	27.9	23.2	40.3	19.2	22.5	26.8	19.7	20.7	39.7	21.7	43.4	19.9	31.8	20.3	21.3	28.3	45.0	20.6	24.7	33.2	28.0	17.7	28.6	22.4	23.2	23.6	41.0	24.3	33.4	35.5	40.5	31.2	23.9	21.6	28.4	47.8	83.2	60.7	43.9	49.9	43.3	47.9	46.2	54.3	67.2	60.4	63.6	29.1	78.0	51.5	57.6	61.0	45.5	87.9	66.2	117.8	23.7	44.7	87.5	67.9	46.9	34.0	42.3	63.9	34.0	45.9	67.1	64.0	48.8	65.5	69.1	106.0	61.0	49.9	36.8	105.6	39.4	78.3	81.2	33.0	60.5	78.3	40.9	44.3	98.0	36.7	57.9	43.8	45.3	46.4	61.2	41.2	34.7	42.9	35.0	44.5	50.3	47.0	21.4	25.9	83.0	53.5	50.9	63.1	6.4	3.4	2.6	5.1	4.6	4.3	4.5	4.5	3.9	5.1	3.2	3.4	4.3	1.6	3.4	4.3	1.8	4.9	3.9	25.1	27.2	24.5	25.7	27.9	23.2	19.7	20.7	20.3	22.4	24.3	28.4	14.8	22.4	11.4	37.5	14.6	14.3	6.3	9.0	10.2	31.8	11.8	10.7	38.1	15.7	13.5	18.4	14.6	11.5	12.0	11.2	3.9	10.3	70.5	12.0	12.0	12.4	20.9	169.5	65.8	11.2	13.4	13.1	19.9	11.3	7.6	32.1	13.6	14.1	14.4	50.5	68.8	12.0	8.2	23.9	11.3	39.7	15.5	16.8	10.6	37.5	17.3	15.3	11.3	70.4	70.9	10.7	6.5	17.7	15.7	10.3	7.8	15.3	9.8	23.5	13.1	14.9	13.2	21.6	21.4	16.0	12.1	5.6	9.4	13.2	12.8	8.5
XPR1	"SLC53A1, SYG1, X3"	ENSG00000143324	"Xenotropic and polytropic retrovirus receptor 1"	Q9UBH6	1	180632022-180890279	"Disease related genes, Human disease related genes, Predicted membrane proteins"		"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 100.9;Excitatory neurons: 118.2;Inhibitory neurons: 102.5;Microglial cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016557	Supported					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA016557: AB_2669382"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.44e-2)"	7.7	9.0	6.4	7.3	7.8	6.2	6.6	4.5	8.0	19.3	13.8	9.2	11.0	10.9	7.4	7.2	15.3	8.5	30.3	5.3	10.5	20.3	6.3	10.1	5.9	5.6	8.7	7.3	12.6	20.3	6.1	14.1	7.6	6.5	9.9	10.1	6.1	10.1	5.4	4.2	11.0	9.8	5.5	7.0	4.6	16.7	11.5	8.5	13.6	8.3	6.7	12.4	4.4	4.7	16.1	22.6	54.4	19.1	17.9	24.1	51.5	18.2	24.1	12.1	12.9	32.6	23.2	15.2	42.3	21.1	19.2	42.7	22.0	32.3	17.8	21.4	14.1	19.7	15.0	23.3	20.9	16.6	20.7	20.2	31.3	17.2	35.5	19.7	26.7	20.2	61.3	24.7	28.8	14.7	15.9	7.6	51.4	20.3	4.9	16.6	19.5	20.2	30.8	32.8	34.6	145.7	25.0	22.0	16.0	37.0	19.5	18.8	22.3	15.9	15.3	22.9	23.1	27.3	27.5	29.9	11.5	16.3	26.4	0.9	4.5	2.1	3.1	8.4	2.7	1.6	2.8	2.8	3.8	2.0	2.6	2.7	4.3	2.8	13.4	1.1	3.2	3.2	6.4	7.8	4.5	8.0	5.3	10.5	5.6	8.7	7.6	5.5	11.5	4.7	22.4	9.6	14.4	100.9	11.2	25.6	19.7	22.6	55.8	16.3	11.0	9.1	47.3	15.7	15.0	5.5	27.1	13.7	5.3	20.2	3.9	22.3	19.4	27.1	13.3	21.3	12.0	18.3	118.2	44.6	6.6	10.7	8.2	48.2	7.6	11.6	15.0	11.9	9.8	13.5	102.5	7.0	20.3	21.4	17.7	9.7	4.7	14.8	10.6	102.1	9.7	8.1	12.3	79.9	47.5	23.5	12.4	14.3	13.4	13.5	25.6	24.3	23.0	10.5	6.6	8.9	10.5	15.5	17.5	22.3	17.0	7.7	13.4	10.0	10.4	14.1
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 80.8;Pancreatic endocrine cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 61.6"	"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA006801: AB_1858899, HPA051538: AB_2681526"	"prognostic unfavorable (1.80e-5)"	"unprognostic (3.05e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.91e-2)"	4.4	4.2	2.8	6.0	3.1	4.4	6.1	3.1	3.9	3.1	2.5	5.9	7.6	3.5	3.2	3.8	3.9	5.2	7.9	3.2	3.3	7.2	5.4	4.7	8.5	3.2	3.1	2.3	2.5	2.4	2.1	5.4	3.2	3.9	5.7	2.3	3.4	4.3	2.6	3.3	5.1	3.9	3.3	4.8	4.3	8.8	3.0	10.3	4.3	2.4	9.0	5.5	2.9	3.4	15.1	11.7	14.1	12.5	7.8	11.3	13.2	13.7	11.2	14.8	17.3	10.0	21.8	20.9	10.3	11.0	21.2	12.8	9.4	30.7	24.2	10.0	11.8	11.1	8.3	12.4	5.2	12.5	17.2	7.9	14.3	19.3	10.8	15.6	12.4	13.8	8.2	9.8	17.6	12.1	23.1	16.0	7.9	8.8	17.2	19.0	61.6	20.7	14.1	6.8	9.2	11.8	8.9	6.5	18.4	11.8	13.2	19.5	7.8	8.2	17.6	8.9	19.0	7.8	12.3	26.6	14.8	22.2	13.5	17.6	17.3	12.4	5.9	25.8	6.1	9.3	6.2	6.5	13.6	8.8	8.3	6.8	16.5	15.2	25.4	10.1	7.7	9.1	2.8	3.1	3.1	3.9	3.2	3.3	3.2	3.1	3.2	3.3	3.0	3.4	10.4	16.0	5.5	39.8	13.0	5.4	13.2	28.0	5.2	4.7	5.5	5.0	15.3	8.6	19.2	5.5	0.0	17.4	12.9	7.6	15.6	17.4	10.2	14.8	12.6	8.9	0.0	6.3	16.6	28.4	38.9	11.6	11.2	10.0	10.8	11.9	11.4	5.5	19.1	1.7	18.7	7.8	22.4	20.7	12.1	5.9	7.8	20.5	8.8	30.9	25.1	7.8	14.4	53.3	80.8	65.7	6.7	7.2	11.3	4.4	7.2	26.5	16.9	4.5	0.0	4.6	11.9	33.1	25.3	7.1	4.4	11.9	12.6	8.0	6.2	8.2
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		940000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	79.6	74.0	52.8	102.4	58.4	112.0	114.6	56.0	69.9	96.4	38.1	91.0	82.2	103.3	85.3	96.8	95.8	83.2	77.1	58.1	56.4	100.2	140.6	76.6	127.8	52.4	50.7	104.0	71.7	118.4	61.4	87.1	54.4	84.7	106.6	102.0	71.6	91.3	103.1	91.6	82.3	100.1	59.1	83.9	77.0	69.5	51.0	176.8	129.2	92.7	140.9	131.7	72.7	65.6	234.4	194.9	427.0	230.5	185.5	210.9	256.6	269.9	279.2	307.1	328.5	421.0	225.7	225.6	214.8	239.1	269.2	203.5	425.2	329.5	469.7	215.0	291.0	488.5	282.9	398.0	229.2	437.1	230.0	193.5	172.1	361.2	156.6	218.4	368.0	272.1	314.4	199.7	405.9	225.9	496.7	221.7	498.0	236.0	170.6	429.8	376.7	186.5	331.9	262.6	372.6	314.6	217.8	159.9	201.1	428.5	196.7	325.8	264.2	287.3	241.5	190.6	312.3	240.0	311.4	493.6	223.4	339.5	290.0	253.2	172.7	175.0	153.6	177.1	165.3	121.2	148.1	157.0	168.0	121.6	147.6	149.1	192.7	172.9	217.4	102.1	167.5	330.4	52.8	58.4	56.0	69.9	58.1	56.4	52.4	50.7	54.4	59.1	51.0	65.6	129.0	105.8	126.3	65.6	131.0	113.7	174.0	242.4	90.5	136.7	93.6	87.1	163.0	105.8	190.0	101.2	45.9	210.5	141.6	79.8	97.8	304.3	103.0	147.4	175.4	142.4	133.3	159.4	73.9	235.8	238.8	134.1	74.5	159.1	146.7	140.2	82.8	222.5	157.3	89.2	82.4	90.7	173.0	100.5	85.3	30.0	101.5	130.7	69.4	108.7	310.9	142.0	138.0	93.0	111.4	247.9	70.3	129.4	132.5	137.4	82.8	139.9	160.1	114.0	111.7	142.9	161.3	252.2	179.2	114.7	120.3	165.5	149.7	165.3	112.0	161.2
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 119.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	9.0	6.8	2.9	12.2	4.5	21.2	10.7	11.4	5.5	8.4	6.4	8.2	11.0	9.8	7.8	7.0	6.2	8.0	5.5	3.2	4.0	6.8	16.2	8.6	13.1	3.8	3.2	10.1	8.1	8.8	6.0	10.5	4.2	8.8	9.4	14.6	7.4	6.1	11.7	9.4	12.4	6.6	4.5	12.8	9.0	9.3	3.9	14.4	8.7	9.7	11.3	7.7	8.2	6.8	22.1	3.9	9.6	8.6	11.1	17.0	5.9	9.9	12.9	12.3	15.2	3.6	6.1	8.9	10.3	13.3	10.0	8.6	8.6	5.2	19.2	21.4	6.5	12.7	7.3	3.5	9.6	12.8	12.7	14.0	6.1	8.8	11.7	12.1	11.4	9.7	8.0	20.4	11.7	4.5	11.2	7.6	3.0	3.4	4.4	9.0	119.2	11.4	6.5	10.8	5.7	7.3	17.3	10.4	8.2	5.9	11.9	10.8	16.0	9.0	4.7	10.3	8.7	29.1	14.2	13.7	8.4	7.2	7.9	31.0	5.8	17.2	10.0	5.4	7.1	9.8	7.7	9.1	2.9	7.2	10.1	7.0	21.2	5.9	5.0	8.0	6.2	3.1	2.9	4.5	11.4	5.5	3.2	4.0	3.8	3.2	4.2	4.5	3.9	6.8	66.1	54.5	33.3	74.7	55.9	25.6	33.7	22.7	33.6	33.7	27.2	21.0	26.5	18.6	30.2	46.0	50.1	22.9	80.8	46.5	11.7	16.5	49.9	31.9	50.7	40.6	28.2	43.6	101.6	12.5	7.8	41.8	48.4	29.0	21.5	33.7	33.9	48.0	16.3	26.9	114.2	22.5	14.2	28.9	23.0	19.1	24.8	38.8	14.2	81.5	41.4	21.0	50.4	126.7	120.4	18.6	41.9	29.0	111.7	44.0	43.4	13.2	34.2	53.9	6.6	56.0	39.9	61.8	20.5	27.6	28.3	53.5	69.8	37.1	15.0	43.8
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303331-21389825	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	36.1	36.1	14.7	42.6	17.2	73.3	42.9	18.5	15.8	33.4	21.1	29.9	24.3	37.0	31.3	25.9	33.2	35.8	24.8	13.6	16.5	34.8	42.7	34.4	43.2	16.5	15.5	36.7	32.8	45.2	18.7	37.4	17.0	28.4	32.4	24.8	27.0	33.6	38.2	24.3	24.8	39.4	16.1	36.1	24.9	29.9	16.1	46.8	41.2	26.5	45.8	46.5	23.1	18.3	91.9	106.7	115.1	88.7	84.1	102.7	113.7	82.3	107.1	107.2	124.1	71.8	102.2	89.7	47.8	86.8	146.1	106.0	131.0	138.7	136.6	40.8	66.0	116.0	37.7	136.5	73.9	105.7	96.8	98.0	68.7	118.5	103.1	95.3	93.6	84.5	94.9	74.7	101.0	71.7	156.5	69.6	89.8	88.8	71.1	113.1	195.4	76.9	91.0	95.6	88.9	115.2	96.0	116.6	89.9	88.6	65.5	123.9	87.0	107.0	79.8	24.8	105.4	65.3	90.0	95.0	41.5	48.5	82.5	36.0	68.6	49.2	34.6	54.8	46.4	30.5	37.7	38.1	61.1	30.9	39.8	38.7	69.2	43.9	71.8	26.2	49.2	54.3	14.7	17.2	18.5	15.8	13.6	16.5	16.5	15.5	17.0	16.1	16.1	18.3	118.6	60.9	112.2	29.7	72.4	63.6	90.8	81.2	64.9	44.9	85.0	75.2	58.7	52.9	94.4	40.5	41.7	106.2	99.1	36.6	27.4	123.8	157.6	119.5	128.5	99.9	59.5	62.6	45.7	120.9	96.8	80.1	39.8	113.7	83.5	92.0	41.0	70.4	105.4	50.5	48.9	52.6	67.1	129.6	57.9	26.8	57.8	111.2	60.5	49.6	165.9	55.1	85.5	46.8	67.6	96.1	53.7	55.7	77.1	91.6	45.1	80.6	102.7	49.7	59.2	120.1	108.1	104.1	116.6	65.6	67.2	105.2	83.5	99.4	68.1	89.7
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	1.4	2.3	1.3	1.5	1.0	2.2	3.0	5.4	2.0	1.6	0.0	4.1	5.8	1.9	0.8	1.9	1.1	1.6	0.5	0.9	0.7	11.4	33.4	0.7	1.0	0.9	0.2	2.2	2.5	1.1	0.8	0.9	1.1	1.6	4.6	2.1	5.3	0.9	0.6	1.5	6.4	1.4	0.0	1.0	3.5	1.0	0.9	1.6	0.7	0.5	0.8	1.2	1.3	0.6	3.5	6.4	2.8	6.7	4.2	4.3	6.3	5.9	2.0	4.5	4.4	8.2	3.6	3.7	1.4	7.6	5.4	2.5	8.1	2.5	5.6	5.0	6.2	7.5	5.0	24.1	2.2	10.1	7.7	3.0	5.2	5.8	2.7	1.9	4.7	8.5	18.0	6.2	5.0	2.4	8.3	1.4	3.8	8.9	7.9	4.2	5.5	5.0	0.6	6.3	3.6	3.2	3.7	16.0	12.7	2.4	7.2	6.1	2.6	9.0	7.3	15.6	2.5	3.5	6.6	8.5	5.4	9.1	7.2	1.4	0.9	2.0	0.6	1.6	0.5	0.2	0.5	0.3	1.7	0.3	0.6	0.6	1.9	0.5	1.4	0.6	1.5	0.4	1.3	1.0	5.4	2.0	0.9	0.7	0.9	0.2	1.1	0.0	0.9	0.6	1.0	0.0	1.3	14.0	0.9	0.9	2.1	1.8	6.8	3.2	3.0	3.4	1.1	2.8	1.5	0.0	0.0	4.3	1.7	3.8	1.9	1.0	0.5	0.4	3.5	1.8	0.0	3.4	39.3	3.0	3.8	2.3	8.6	1.0	0.0	1.3	1.1	49.3	4.0	0.0	35.9	5.7	2.0	1.0	3.7	1.0	1.5	2.0	0.0	17.8	1.0	0.4	0.0	17.1	17.7	1.3	5.8	1.9	1.6	1.7	13.0	31.7	1.3	5.1	0.0	2.4	1.4	0.5	2.7	4.1	0.9	1.4	0.8	1.8	5.1	2.1
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470960	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.1;ASC TERT1: 34.0;U-2197: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		150000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	6.4	6.2	6.2	4.9	8.0	7.2	4.5	2.3	6.3	7.8	8.5	8.8	4.3	7.9	1.0	5.1	3.7	2.3	4.2	8.8	3.6	1.0	0.3	3.5	5.1	3.7	4.3	5.3	2.8	0.9	0.6	6.0	4.2	2.7	5.2	8.3	2.5	4.5	1.1	5.0	5.3	5.7	1.6	5.4	3.4	2.3	3.6	4.1	2.2	1.2	4.3	4.3	4.6	4.6	0.0	0.3	8.0	0.1	55.1	34.0	9.6	25.6	12.9	2.7	1.0	0.3	0.6	6.1	0.0	31.3	0.9	0.6	0.0	5.1	4.5	12.1	0.6	8.0	0.0	0.0	0.6	11.5	10.2	12.6	0.7	15.0	2.4	4.6	0.0	0.3	0.0	23.8	2.8	0.8	0.1	12.4	8.5	4.4	0.0	3.5	0.0	1.2	0.0	11.5	2.0	15.2	1.9	7.9	1.4	5.9	1.9	7.2	0.0	24.6	2.9	57.2	0.0	26.4	1.4	11.6	28.9	12.8	22.4	0.3	0.2	0.4	0.2	1.2	0.3	0.1	0.1	0.1	0.4	0.3	0.2	0.1	0.1	0.4	2.0	0.1	0.3	0.2	6.2	8.0	2.3	6.3	8.8	3.6	3.7	4.3	4.2	1.6	3.6	4.6	1.0	3.2	2.5	45.4	9.2	7.9	1.6	0.0	1.2	12.9	3.8	3.7	3.4	0.0	0.7	0.0	98.0	12.7	12.4	9.1	0.0	1.5	0.5	0.5	24.7	2.9	12.6	7.4	172.8	1.6	20.1	12.2	2.6	0.8	2.5	6.4	1.4	0.2	3.5	0.0	72.8	4.3	4.1	9.7	27.6	0.8	12.8	8.5	3.6	29.0	6.1	1.9	11.3	1194.8	63.0	4.0	7.4	50.0	6.2	5.3	6.1	0.2	0.0	4.4	6.6	7.9	5.9	0.3	1.6	4.1	18.5	13.1	7.7	8.1	6.9	6.4
YAE1	"C7orf36, CIAB2, GK003, YAE1D1"	ENSG00000241127	"YAE1 maturation factor of ABCE1"	Q9NRH1	7	39566385-39610320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.2;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 12.0;Fibroblasts: 6.2;Hofbauer cells: 10.0;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019226, HPA031249"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA019226: AB_1845759, HPA031249: AB_2673807"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-3)"	11.2	13.9	14.6	9.7	15.6	2.3	17.4	17.4	20.3	14.7	15.4	18.9	14.4	17.0	21.9	15.2	15.4	11.0	16.4	14.8	15.0	15.3	12.0	11.1	10.0	14.5	14.8	21.0	11.1	21.1	14.4	10.9	14.8	13.5	20.0	18.3	13.4	12.3	13.9	11.0	19.3	15.9	14.9	9.4	14.1	19.8	14.4	11.0	14.9	16.6	9.1	12.4	11.6	16.4	29.3	18.5	35.5	40.2	28.5	28.5	21.3	43.8	33.6	35.4	39.7	14.9	17.1	15.1	19.9	33.4	62.4	27.9	35.2	26.3	33.1	15.4	28.7	13.7	20.9	28.7	26.6	14.6	10.5	26.9	21.0	39.3	42.4	21.1	29.6	13.7	46.8	6.9	29.7	18.5	11.8	29.2	81.0	34.6	21.8	16.5	24.9	17.4	33.0	24.4	48.1	52.3	32.7	46.6	44.1	38.9	41.3	27.6	21.3	17.7	34.3	23.8	35.5	22.1	50.3	34.9	22.1	34.6	56.2	21.6	6.4	8.6	9.9	6.8	11.0	16.1	12.8	15.2	7.1	16.2	22.7	16.6	0.7	10.7	5.1	10.6	15.5	7.9	14.6	15.6	17.4	20.3	14.8	15.0	14.5	14.8	14.8	14.9	14.4	16.4	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	15.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	12.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1187.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	11.5	9.5	9.7	8.1	10.5	10.8	10.0	13.9	12.0	10.3	4.3	8.1	5.9	9.4	8.7	6.9	8.8	8.6	36.6	11.6	10.4	9.5	18.0	8.1	12.5	9.2	9.1	9.0	6.3	7.8	8.6	9.0	10.3	8.2	7.3	14.2	6.6	8.4	29.4	6.3	7.9	10.3	9.9	10.6	6.9	7.3	10.1	13.5	11.1	21.1	10.0	10.0	8.9	12.6	13.5	10.6	15.3	12.1	19.1	16.9	9.9	19.1	17.1	15.5	15.1	14.4	10.7	8.6	14.0	16.6	6.2	11.5	15.0	10.7	21.7	20.5	14.9	18.0	4.6	6.8	11.0	17.6	11.1	12.1	14.9	12.8	25.3	15.7	16.3	8.3	17.2	20.1	20.1	5.6	20.4	21.2	3.9	16.0	14.1	15.0	16.6	13.9	20.1	10.1	11.6	14.6	16.0	18.3	14.8	6.9	12.4	13.0	14.4	13.6	12.1	16.7	9.5	16.6	26.4	31.7	15.0	82.3	6.8	43.2	15.6	28.9	18.2	18.9	18.6	20.6	17.6	20.9	12.5	24.2	13.4	14.5	56.6	27.1	17.2	19.3	26.5	9.7	9.7	10.5	13.9	12.0	11.6	10.4	9.2	9.1	10.3	9.9	10.1	12.6	41.9	22.4	13.4	68.2	41.1	58.1	40.8	31.0	33.0	75.0	45.2	35.1	1187.5	31.5	27.6	20.2	85.5	40.1	71.2	22.7	62.6	32.2	33.6	27.7	43.1	61.7	38.9	36.2	105.5	45.5	22.4	49.7	18.3	37.0	70.5	88.4	50.7	104.7	27.8	144.7	89.4	33.1	46.8	44.7	61.3	15.9	58.1	37.6	42.7	83.4	48.8	94.6	84.5	97.0	57.8	35.3	26.8	76.8	44.6	37.2	29.9	66.0	20.1	99.7	105.2	44.8	63.8	38.0	38.2	30.5	51.1	45.3	58.7	36.2	27.5	32.7
YAP1	YAP65	ENSG00000137693	"Yes1 associated transcriptional regulator"	P46937	11	102110447-102233424	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038884, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	57.2	27.8	19.1	25.9	19.1	0.3	42.7	18.6	17.1	62.5	44.3	41.5	27.2	78.1	45.9	74.7	65.6	49.3	48.1	15.9	22.1	39.3	33.5	45.7	13.0	31.8	30.2	93.1	22.3	37.0	9.9	83.1	21.8	59.2	30.1	12.9	40.6	83.7	48.3	44.2	27.4	100.5	27.3	14.7	31.6	15.0	27.0	13.8	85.9	58.2	22.7	60.9	52.6	20.2	56.9	52.1	141.5	69.6	151.1	143.1	118.7	130.4	147.8	124.2	101.5	130.2	134.9	0.0	105.4	171.6	92.1	98.0	71.0	186.4	130.6	16.8	25.5	0.1	67.3	89.5	115.3	0.1	2.5	115.2	119.4	136.6	220.2	138.4	39.4	6.7	0.0	0.1	142.1	27.2	2.6	0.4	66.8	135.9	49.3	0.1	79.7	0.3	90.9	99.5	0.4	4.7	153.6	57.2	43.5	129.1	103.2	0.8	43.4	175.4	68.8	89.6	55.7	0.1	0.2	0.8	51.0	0.2	130.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	19.1	18.6	17.1	15.9	22.1	31.8	30.2	21.8	27.3	27.0	20.2	28.4	35.3	69.4	145.3	1.5	113.7	47.8	43.5	71.2	0.4	48.1	43.8	39.2	62.9	37.2	92.0	0.0	91.4	0.4	16.2	11.7	27.6	6.7	61.8	53.3	28.9	7.3	0.0	1.5	18.3	20.3	49.0	23.9	85.1	0.0	127.2	26.0	45.2	10.6	0.0	1.6	13.1	14.2	1.6	21.5	4.6	37.9	2.2	44.4	60.0	1.0	27.6	0.0	5.0	0.7	25.2	16.3	40.6	0.1	66.0	27.2	26.1	41.6	1.2	39.5	21.6	62.0	2.5	5.3	59.5	123.2	61.6	2.1	15.9	27.8	65.6
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755897	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	6.1	6.0	4.1	6.5	3.8	7.8	6.6	4.3	4.5	5.9	3.9	5.8	4.8	5.8	5.0	7.1	5.2	4.4	6.2	3.9	3.3	4.8	6.0	4.3	8.1	3.7	3.0	6.1	5.8	6.5	3.7	7.8	4.3	4.6	6.4	4.6	8.1	4.5	7.3	5.4	5.2	5.3	3.1	6.1	5.8	4.6	3.2	7.9	4.6	8.5	8.3	7.4	5.1	4.3	19.8	23.3	13.3	15.8	14.3	16.6	42.0	14.8	15.0	17.9	17.4	58.8	24.6	35.4	23.6	15.0	25.8	24.9	26.7	38.9	20.0	15.5	41.8	23.6	16.4	33.0	20.6	25.3	13.2	15.6	24.4	16.9	30.5	23.0	28.5	18.4	33.7	15.9	19.1	16.1	18.9	30.4	73.5	13.0	28.2	21.0	28.4	21.1	22.9	27.8	20.5	10.0	22.7	19.5	14.7	51.5	36.5	22.7	19.5	16.9	17.7	27.8	25.3	9.4	10.7	37.0	15.7	18.6	14.3	10.2	6.1	3.7	8.4	8.0	8.8	7.3	8.8	8.7	8.5	9.6	9.0	10.5	1.0	11.9	9.6	8.2	8.4	5.1	4.1	3.8	4.3	4.5	3.9	3.3	3.7	3.0	4.3	3.1	3.2	4.3	14.5	6.4	4.4	25.5	16.1	10.1	20.1	27.0	14.2	16.8	11.4	8.4	7.7	1.5	15.1	11.0	20.9	34.7	15.9	5.4	7.9	19.9	6.5	19.7	17.7	10.2	7.2	21.2	22.2	16.5	36.9	12.5	6.6	24.6	7.0	18.9	6.8	5.6	20.1	15.2	31.2	7.3	16.2	9.3	6.0	4.6	10.5	10.4	5.4	18.7	16.0	12.3	16.5	26.7	44.1	14.2	7.6	8.6	9.3	13.9	7.9	11.5	9.0	19.9	13.1	10.5	19.1	6.3	12.8	12.9	8.4	17.9	13.9	24.3	12.8	12.6
YBEY	C21orf57	ENSG00000182362	"YbeY metalloendoribonuclease"	P58557	21	46286342-46297751	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 78.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 376.6;Late spermatids: 276.0;Spermatocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016593, HPA018162"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA016593: AB_1845698, HPA018162: AB_1845699"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.81e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-3)"	12.0	13.0	13.8	5.4	15.1	5.9	13.4	15.5	17.8	12.1	12.9	14.5	11.5	10.0	14.4	9.7	10.1	8.7	15.9	13.3	14.6	14.0	18.3	7.8	11.4	15.0	14.5	12.6	17.1	11.8	11.8	6.0	15.2	12.8	12.1	7.5	13.7	8.1	16.5	16.1	16.1	4.2	14.6	11.0	11.1	78.8	14.4	10.9	9.4	12.8	14.3	8.9	9.2	16.7	24.4	21.1	17.7	21.5	13.2	50.0	17.2	16.4	24.3	15.8	19.2	11.2	4.0	30.7	13.9	17.0	8.4	7.9	7.7	7.5	14.3	29.3	29.9	8.9	13.9	4.4	37.7	10.1	1.0	34.8	31.9	12.5	25.9	20.7	10.5	15.2	21.6	36.0	18.6	20.7	19.9	13.2	51.5	9.3	21.7	41.4	8.4	59.6	32.5	11.2	13.0	22.6	22.3	10.0	46.6	5.8	5.1	8.8	12.8	15.1	5.6	12.2	10.8	44.4	85.2	53.8	27.5	11.1	9.3	27.7	9.1	7.3	13.2	10.4	13.2	32.7	16.3	16.9	10.5	24.9	15.8	18.2	3.2	21.3	12.5	24.1	26.6	10.3	13.8	15.1	15.5	17.8	13.3	14.6	15.0	14.5	15.2	14.6	14.4	16.7	16.9	3.2	7.4	12.1	35.2	46.3	38.4	49.6	45.5	14.4	44.7	46.1	21.6	21.5	23.1	18.4	8.4	17.5	33.3	45.1	64.6	36.4	376.6	31.4	31.2	22.3	32.0	13.7	7.9	77.2	27.9	27.6	28.5	17.9	11.4	20.5	26.4	50.5	25.2	16.8	13.5	55.5	30.5	37.8	45.8	276.0	40.7	24.6	39.2	7.5	27.7	21.3	40.2	11.6	18.4	47.9	58.4	24.5	36.9	28.1	103.4	65.6	20.6	20.8	6.6	21.1	19.5	273.7	31.8	31.2	60.5	9.6	30.2	32.5	55.6	36.8
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682418-42703805	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2038.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 8388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum, Vesicles, Plasma membrane"	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	532.0	254.5	141.7	422.4	155.4	863.9	401.1	153.3	157.7	331.8	154.4	600.2	364.9	406.2	211.3	365.0	337.0	209.8	789.7	140.6	159.4	318.9	309.9	396.3	407.9	175.1	160.2	311.7	266.7	133.8	122.2	242.2	178.8	307.8	378.1	391.8	270.5	219.5	2038.9	295.0	366.1	338.9	152.7	367.1	405.0	783.5	180.8	353.4	282.0	1133.9	382.2	501.5	332.3	173.5	1552.8	761.5	1020.4	1232.7	991.0	908.1	1200.2	971.5	768.9	1116.6	875.8	1034.6	1253.7	1630.6	1157.5	825.2	495.5	870.2	1162.6	1230.5	1103.9	1087.8	1278.0	1596.4	1491.9	1343.8	786.7	2214.4	1320.7	812.6	1092.3	1094.5	1365.7	630.0	950.3	1271.9	1823.0	720.6	1104.0	837.7	2816.5	2464.6	2902.1	755.0	1006.4	1789.6	1972.5	1938.2	1176.7	933.8	1731.6	1298.5	893.7	1294.0	2038.3	1096.8	443.2	5002.2	862.6	945.4	1748.6	1371.1	2209.3	1213.7	1670.6	2004.8	910.4	1750.3	1049.9	15.3	48.4	69.9	42.9	107.1	52.9	69.4	51.8	43.3	77.4	61.2	44.0	45.9	9.0	35.1	124.2	58.6	69.7	34.1	141.7	155.4	153.3	157.7	140.6	159.4	175.1	160.2	178.8	152.7	180.8	173.5	701.7	173.1	230.9	16.3	818.3	1397.7	1265.9	419.7	747.3	247.8	569.7	564.5	1072.3	441.8	355.5	325.5	150.1	753.9	678.4	620.6	1457.6	1013.6	8388.7	363.5	695.5	755.1	587.8	2244.2	16.2	886.6	1998.9	687.6	461.3	427.0	383.1	489.1	483.3	480.1	1708.7	121.1	27.1	930.2	354.0	1656.0	2342.9	3743.4	751.2	1307.6	905.4	19.7	1171.0	463.8	744.6	23.6	32.7	858.2	975.1	806.1	981.0	1935.1	993.3	1169.8	196.2	602.4	466.8	754.8	1083.7	3245.2	425.5	1113.5	1302.5	481.5	635.6	811.4	1257.7	1697.8
YBX2	"Contrin, CSDA3, MSY2"	ENSG00000006047	"Y-box binding protein 2"	Q9Y2T7	17	7288263-7294639	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	77	"testis: 551.1"	"Group enriched"	"Detected in some"	18	"Early spermatids: 346.9;Late spermatids: 427.3;Spermatocytes: 234.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;MCF7: 8.7;SH-SY5Y: 3.2;SK-BR-3: 3.9;T-47d: 12.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB012332, HPA053904, HPA056744"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB012332: AB_776541, HPA053904: AB_2682302, HPA056744: AB_2683223"	"unprognostic (1.76e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (9.80e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.31e-1)"	"unprognostic (2.35e-2)"	3.0	0.1	0.5	0.1	0.6	0.2	3.2	0.4	1.1	2.4	0.1	7.2	1.0	1.3	0.0	2.0	2.3	0.0	1.4	0.9	0.5	1.1	1.9	0.1	0.0	0.9	0.7	0.3	0.3	0.3	0.5	0.0	0.6	1.4	0.3	0.0	1.2	0.8	2.0	1.4	4.0	0.5	0.5	0.1	1.2	551.1	0.9	0.0	1.1	0.1	0.0	1.0	0.9	0.8	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	2.3	0.0	2.4	0.0	0.0	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	8.7	0.3	0.4	1.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	1.3	3.9	0.3	2.0	12.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	1.1	0.9	0.5	0.9	0.7	0.6	0.5	0.9	0.8	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.0	0.2	2.8	3.3	4.4	0.0	0.3	1.8	0.0	0.2	0.5	18.0	0.0	0.1	346.9	0.7	0.1	0.7	4.8	0.0	0.5	0.2	0.4	0.4	0.0	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	8.2	0.0	0.0	0.0	427.3	6.8	0.7	3.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	9.9	6.8	0.0	0.3	10.0	0.4	0.3	0.5	0.0	0.4	1.2	234.3	12.0	1.8	0.9	0.1	0.1	0.1	15.2	1.1
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 4915.7;tongue: 1635.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		NA	NA		230000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	250.4	96.7	17.6	77.5	17.6	151.1	200.2	18.8	25.5	152.1	28.4	249.1	37.5	136.8	47.3	271.0	166.7	65.0	469.9	16.5	22.3	194.1	53.8	209.5	32.9	25.4	22.4	134.6	291.0	18.6	84.1	72.5	23.9	177.1	58.8	82.8	218.1	67.5	4915.7	358.1	99.0	100.9	20.9	79.5	149.7	265.7	22.2	36.7	136.1	1635.6	54.6	225.4	204.8	19.7	117.2	90.3	41.4	136.1	165.7	310.7	307.4	173.4	142.7	138.7	132.0	160.4	259.5	109.3	57.7	130.3	96.5	215.5	173.3	338.1	124.6	1.2	325.2	91.3	123.6	108.4	198.3	171.7	10.4	343.3	452.3	124.2	414.6	148.9	313.6	152.3	123.1	0.4	154.7	112.6	137.8	141.9	435.5	103.7	76.9	76.9	192.6	127.4	192.6	150.0	52.2	0.3	129.1	130.9	174.1	288.0	37.1	133.9	221.3	94.5	282.6	108.4	201.5	0.5	38.1	13.4	133.1	0.2	104.8	0.0	4.2	0.0	0.6	4.2	0.0	1.6	0.0	1.5	3.2	6.5	0.0	1.6	0.8	0.8	2.4	0.1	0.1	1.0	17.6	17.6	18.8	25.5	16.5	22.3	25.4	22.4	23.9	20.9	22.2	19.7	680.9	150.6	164.4	14.0	192.8	764.9	1226.9	212.9	552.7	36.1	288.8	292.7	497.7	105.8	177.8	145.3	89.6	145.7	39.2	94.3	133.1	125.3	1418.1	563.0	402.1	563.1	67.6	1081.5	2.4	143.3	84.3	484.8	119.8	551.3	63.3	291.0	235.6	23.1	97.7	16.8	1.0	139.5	120.1	223.2	494.7	470.2	264.7	292.2	259.7	21.5	83.9	67.2	2.1	4.5	0.1	122.0	76.3	223.8	80.6	1553.4	43.9	240.4	240.4	365.4	124.9	1316.7	643.1	594.6	158.4	638.6	1050.5	125.7	72.5	70.8	157.4	1339.7
YEATS2	"FLJ10201, FLJ12841, FLJ13308, KIAA1197"	ENSG00000163872	"YEATS domain containing 2"	Q9ULM3	3	183697797-183812624	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045891	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA045891: AB_10961271"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.33e-3)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.08e-2)"	7.4	4.8	5.4	8.9	7.4	14.5	7.9	8.1	8.8	8.5	0.0	9.1	5.4	9.0	4.7	8.2	10.3	6.5	6.6	6.4	5.2	6.1	3.4	10.0	12.9	2.4	3.7	15.1	5.4	9.9	8.6	11.2	3.0	8.2	6.8	15.6	8.0	7.3	5.5	8.5	7.0	11.9	1.9	8.9	5.8	8.0	4.2	16.9	9.7	4.8	11.8	8.7	8.4	7.0	38.1	11.3	32.4	14.5	15.5	22.8	35.8	22.1	17.0	32.1	37.5	27.8	13.3	34.7	39.8	19.5	49.9	23.9	31.8	21.2	32.7	28.5	18.8	35.0	12.2	13.7	23.9	26.3	19.4	15.6	16.3	23.1	27.8	32.1	33.1	35.2	14.0	28.3	24.5	10.2	38.3	20.2	29.3	13.8	22.0	53.5	30.5	42.0	12.9	16.6	31.3	22.3	16.4	55.4	29.2	27.1	27.5	17.8	28.2	29.5	21.3	15.1	25.0	26.9	22.6	57.6	22.9	25.8	21.3	0.1	4.6	1.2	1.9	2.0	1.3	1.9	1.7	1.4	1.6	1.3	1.3	1.5	8.5	1.3	7.1	2.1	0.7	1.8	5.4	7.4	8.1	8.8	6.4	5.2	2.4	3.7	3.0	1.9	4.2	7.0	13.8	35.3	2.3	41.4	7.0	2.0	3.3	7.0	8.6	19.5	5.6	7.5	10.1	5.7	5.9	5.5	10.4	4.8	7.4	4.4	0.0	5.7	2.4	10.5	18.3	15.3	8.5	6.3	95.6	4.0	9.7	9.2	7.1	9.8	7.0	42.1	7.5	3.0	7.1	13.5	62.1	6.0	6.1	8.7	6.7	3.3	9.9	10.1	1.8	40.3	6.6	5.8	5.2	71.9	80.0	7.1	3.1	9.4	9.5	5.3	4.7	1.0	11.2	15.8	0.0	10.1	10.4	3.1	12.3	8.7	3.4	2.1	8.8	9.7	4.8	2.8
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 20.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	25.2	13.5	11.9	10.5	12.7	4.1	21.8	12.7	14.3	17.4	11.5	21.8	24.8	16.0	17.9	22.7	13.9	18.9	13.1	11.7	13.7	27.9	50.6	17.2	6.2	13.9	13.2	12.4	26.5	20.0	6.1	41.7	13.5	15.0	22.7	8.3	21.0	11.9	8.3	16.7	23.7	15.9	14.2	27.4	21.3	19.0	14.3	10.5	22.0	14.6	8.8	20.3	11.5	14.1	42.7	20.8	64.3	50.6	37.8	46.5	75.6	27.9	56.2	32.0	43.7	49.9	30.7	0.1	28.8	47.3	41.0	24.3	60.8	49.1	62.3	0.2	20.7	12.6	19.4	35.1	30.6	9.9	21.7	35.7	51.7	48.5	53.6	39.8	109.8	7.0	56.1	18.4	46.1	29.3	6.0	13.0	40.9	26.0	26.4	7.4	50.6	3.6	46.8	49.6	13.1	15.3	57.5	42.9	37.1	42.3	29.7	20.5	95.6	78.4	86.2	59.9	75.8	15.7	8.3	2.6	29.7	13.8	47.6	20.2	0.0	1.0	2.2	0.0	1.5	0.1	0.4	1.2	0.0	0.0	1.0	1.7	0.0	1.1	0.0	0.0	0.1	0.6	11.9	12.7	12.7	14.3	11.7	13.7	13.9	13.2	13.5	14.2	14.3	14.1	120.3	25.6	36.8	18.9	3.3	60.2	46.8	21.4	50.1	6.0	38.1	26.7	18.2	24.3	31.3	29.5	6.2	37.1	52.9	40.3	3.9	29.6	29.4	32.8	35.0	91.0	22.8	12.0	0.4	39.2	26.6	35.4	57.6	43.6	13.9	35.9	39.7	44.9	4.9	3.3	10.3	37.2	14.2	5.4	14.7	11.7	18.3	5.0	24.9	46.9	2.0	16.8	16.5	31.7	30.2	51.0	28.8	12.8	28.9	65.4	33.1	45.6	29.0	8.6	19.7	35.9	23.8	20.3	13.6	53.1	49.7	45.6	27.5	42.4	36.7	66.6
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289145	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014840, HPA076194"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014840: AB_2217189, HPA076194: "	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (8.70e-4)"	49.2	54.7	33.4	28.4	36.0	16.7	47.5	38.5	41.4	42.7	42.4	50.8	56.5	53.5	34.5	50.9	45.7	25.5	57.8	33.5	35.6	50.9	149.5	44.9	22.9	38.9	36.1	42.1	86.0	40.6	74.1	34.5	38.2	47.3	37.7	12.3	51.1	29.6	96.2	43.0	47.4	41.1	38.5	35.9	56.1	36.4	35.6	21.6	49.9	59.3	24.7	45.4	40.6	41.9	80.7	131.3	39.4	72.6	130.0	138.7	73.8	114.4	122.3	95.5	94.3	126.0	95.5	67.9	111.5	161.4	107.8	119.9	60.7	107.9	75.6	77.7	72.0	42.5	93.3	158.7	147.4	59.3	61.5	97.4	144.4	98.6	158.9	76.6	91.3	67.0	80.7	114.8	84.3	199.3	71.3	64.4	40.3	147.4	136.6	54.9	61.2	203.9	81.9	70.9	58.5	57.9	62.5	106.7	103.4	49.6	155.5	43.5	81.0	80.8	69.0	165.3	54.1	78.1	86.0	63.0	125.4	56.2	90.2	19.4	95.6	20.6	71.3	141.4	78.4	95.9	60.6	67.2	116.4	82.4	48.0	55.3	9.4	51.2	140.0	141.6	54.9	99.8	33.4	36.0	38.5	41.4	33.5	35.6	38.9	36.1	38.2	38.5	35.6	41.9	63.4	38.5	48.0	6.2	52.2	36.1	88.1	170.4	38.1	27.1	84.4	92.7	34.5	82.9	115.5	46.0	22.9	114.3	42.6	66.8	64.6	137.9	28.1	42.1	84.8	53.6	87.4	21.0	1.9	149.4	248.5	90.4	55.0	42.8	29.9	38.8	49.2	172.0	105.4	26.9	3.9	140.9	116.0	38.4	44.9	48.6	75.5	45.0	72.9	8.4	40.8	73.7	28.8	10.1	10.4	132.1	93.3	82.4	92.4	195.2	202.2	135.2	101.4	34.0	39.5	60.8	150.0	61.0	56.8	63.3	46.3	154.3	36.5	88.1	107.2	112.1
YIF1B	FinGER8	ENSG00000167645	"Yip1 interacting factor homolog B, membrane trafficking protein"	Q5BJH7	19	38303558-38317273	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039328, HPA055257, HPA062675"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		37000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Golgi apparatus"	"HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830"	"unprognostic (2.51e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.94e-3)"	30.1	30.7	29.3	33.0	32.4	69.1	26.7	37.0	38.3	33.5	29.0	26.6	20.4	24.1	10.9	33.2	25.6	16.5	40.6	30.2	32.6	27.2	58.3	35.7	32.1	36.3	30.9	26.7	27.1	16.9	29.1	23.5	38.6	23.7	16.1	13.6	30.2	12.5	35.0	26.0	24.0	18.1	33.4	47.7	22.0	23.1	34.0	20.9	19.8	26.7	20.9	26.8	25.6	38.5	43.7	108.9	48.3	57.5	68.4	63.5	37.8	103.2	79.0	75.7	110.7	53.5	32.6	75.7	44.4	121.1	81.5	27.4	85.9	54.6	28.7	81.1	43.3	117.0	48.2	56.5	94.8	82.4	132.9	52.3	47.9	78.0	33.8	76.1	71.3	99.4	152.9	205.3	68.5	46.0	87.6	98.9	37.0	74.9	33.7	89.0	58.6	117.9	48.9	40.6	34.8	58.1	34.5	76.7	55.4	37.2	29.9	163.2	68.8	74.6	73.2	108.4	83.9	76.4	122.1	51.8	96.1	150.5	54.6	81.9	155.7	179.0	60.8	119.4	54.4	49.3	57.3	54.8	300.3	42.7	46.7	47.5	42.8	44.0	70.8	127.0	59.0	120.2	29.3	32.4	37.0	38.3	30.2	32.6	36.3	30.9	38.6	33.4	34.0	38.5	27.4	0.0	5.5	5.5	22.8	17.7	19.4	25.8	18.2	12.2	22.6	18.7	4.7	18.6	14.2	22.0	12.5	44.7	17.0	16.0	0.0	39.4	6.3	17.5	18.2	23.9	14.4	33.2	7.3	27.7	52.9	23.8	16.3	18.6	22.9	43.4	37.1	30.5	94.4	11.8	7.4	24.7	32.6	42.3	37.4	8.5	9.0	53.3	35.6	3.7	34.4	20.8	16.5	4.0	12.7	15.5	13.5	9.1	69.4	14.8	8.1	16.1	20.7	15.5	6.6	11.1	40.3	20.6	31.9	30.7	20.0	27.6	18.8	26.2	25.9	19.5
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889798	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	7.1	9.2	5.3	6.2	5.6	5.7	8.5	5.8	15.2	6.7	6.9	7.9	6.9	4.1	7.6	9.0	6.3	5.5	6.6	5.9	6.3	11.1	13.5	7.7	7.1	6.7	5.8	7.0	6.8	7.0	6.2	9.7	6.8	11.3	9.2	7.2	11.7	4.8	14.6	9.4	6.9	6.0	6.2	8.2	8.7	7.2	6.0	8.8	22.1	10.4	10.7	7.7	7.1	6.4	11.0	6.4	10.1	7.1	11.9	13.1	9.0	7.7	12.0	14.0	18.3	7.1	3.3	3.8	12.9	9.2	21.6	13.2	12.9	17.0	14.4	27.4	10.3	8.9	6.4	11.6	15.9	10.0	8.1	13.3	15.8	11.3	13.5	12.0	15.0	13.2	9.6	10.0	14.0	9.2	10.8	14.2	7.7	12.7	10.4	6.6	9.3	15.4	11.5	5.8	4.5	5.6	7.4	13.8	35.4	31.0	21.4	11.1	7.1	5.7	5.8	10.4	6.8	20.1	24.7	7.0	9.3	8.1	5.0	19.1	18.4	20.2	11.8	16.5	11.0	10.4	10.0	12.1	16.6	13.8	9.5	9.2	38.3	11.0	23.3	11.5	24.3	16.5	5.3	5.6	5.8	15.2	5.9	6.3	6.7	5.8	6.8	6.2	6.0	6.4	11.6	6.4	12.6	9.8	9.0	8.5	17.6	19.2	9.6	6.6	20.0	12.4	9.6	24.3	24.0	9.2	0.0	80.0	8.5	14.6	11.7	28.3	30.5	11.4	10.9	10.9	9.6	12.2	9.8	32.6	28.4	9.9	9.7	14.7	9.5	6.3	11.7	20.8	39.7	10.1	8.2	27.5	30.5	19.4	7.7	54.9	5.9	18.9	10.6	11.2	20.2	16.5	21.6	8.5	11.5	32.5	10.8	9.4	28.1	33.2	12.3	17.7	19.7	6.5	0.0	5.6	17.7	22.2	20.9	12.3	10.9	129.6	10.8	17.7	10.8	29.0
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.5	43.5	18.1	15.9	18.7	29.6	34.1	20.5	26.6	41.7	30.7	34.7	31.8	38.1	26.8	51.0	35.2	30.3	31.6	19.4	20.3	45.1	56.1	32.8	16.8	22.4	19.6	39.6	114.3	33.4	108.2	38.9	21.0	40.3	15.8	6.5	105.7	23.6	24.8	33.8	29.9	14.2	18.2	27.7	39.2	76.8	19.4	14.3	47.5	10.3	11.2	32.6	39.6	20.4	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	18.1	18.7	20.5	26.6	19.4	20.3	22.4	19.6	21.0	18.2	19.4	20.4	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277904-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 129.1;choroid plexus: 65.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	7.0	6.2	69.9	5.5	66.9	2.5	8.4	69.6	129.1	6.1	65.6	6.9	5.8	6.9	7.2	5.0	5.0	4.5	7.4	71.7	68.8	7.7	9.2	5.6	5.9	69.3	67.7	6.6	14.8	6.5	5.2	5.9	71.9	6.6	6.2	13.1	7.4	5.6	8.0	7.0	5.8	6.5	66.8	6.9	6.4	4.2	67.3	7.9	10.1	6.0	5.1	5.3	5.1	75.4	8.9	4.4	8.6	7.7	9.8	12.4	4.5	7.5	7.5	7.7	5.0	5.9	6.6	4.7	5.1	8.2	7.4	6.8	9.2	6.6	10.0	7.6	14.3	7.6	9.8	10.7	11.5	10.2	6.2	8.7	12.4	6.9	11.0	10.6	6.6	5.2	10.7	9.6	8.5	5.8	8.0	10.6	7.0	9.6	7.5	5.5	12.7	8.9	8.4	3.8	9.6	9.2	6.4	6.4	11.7	5.5	3.5	8.6	7.4	10.1	4.8	7.1	7.2	14.2	19.1	5.8	15.9	9.7	5.7	14.9	5.4	5.7	4.4	5.1	3.7	4.6	4.4	4.1	4.6	4.0	4.5	4.0	14.9	6.4	5.1	5.4	4.6	4.7	69.9	66.9	69.6	129.1	71.7	68.8	69.3	67.7	71.9	66.8	67.3	75.4	61.4	93.0	69.8	13.1	68.5	51.4	56.9	59.5	50.7	113.8	63.3	28.2	88.0	60.1	58.3	42.3	106.3	68.4	81.3	68.8	33.2	45.3	34.7	39.5	57.9	59.0	57.1	86.9	18.8	39.3	69.9	66.6	28.1	40.1	40.0	56.3	67.8	80.9	48.3	101.0	20.1	70.2	50.8	81.7	60.7	21.0	86.6	58.0	81.8	21.5	85.1	53.1	114.4	22.1	31.8	41.8	66.8	74.9	62.6	78.5	62.7	60.1	62.2	122.2	78.9	71.9	66.2	160.2	59.6	41.1	65.9	192.8	60.7	65.4	46.8	74.7
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158162-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 236.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	22.2	20.4	8.3	17.7	9.8	21.0	24.1	9.8	11.0	24.7	16.3	25.8	30.5	20.2	21.2	28.6	20.3	21.4	18.1	9.5	12.5	25.4	31.7	20.3	18.9	9.7	10.3	20.6	32.0	25.7	17.0	30.2	11.5	18.3	26.0	20.6	26.2	19.2	9.3	17.7	27.3	28.5	10.3	15.5	22.7	20.9	10.3	16.1	22.6	14.5	23.9	24.0	14.3	12.0	43.2	28.2	36.0	28.6	84.4	90.5	32.9	143.6	96.9	63.2	101.5	45.3	44.0	23.5	67.3	156.9	72.5	38.7	34.7	70.5	84.8	32.9	30.2	17.4	44.9	46.7	68.0	39.3	27.7	69.1	64.3	56.8	46.3	108.9	61.0	25.6	18.8	38.5	86.4	22.5	19.4	22.2	23.3	27.5	30.7	20.3	53.4	39.3	39.4	37.7	24.4	30.0	49.7	26.4	66.5	36.2	54.9	25.5	236.7	74.0	35.8	72.5	57.2	34.7	61.8	29.9	70.7	36.9	55.2	48.9	34.5	48.7	47.2	47.4	53.1	37.9	47.1	52.4	41.2	36.4	49.0	46.3	26.0	41.0	44.7	45.0	62.8	40.6	8.3	9.8	9.8	11.0	9.5	12.5	9.7	10.3	11.5	10.3	10.3	12.0	43.5	38.5	27.4	8.5	35.6	29.4	24.5	49.4	26.2	40.6	33.4	29.6	21.8	31.5	35.9	20.2	33.3	56.7	40.5	33.0	31.3	43.7	14.9	31.4	49.8	44.1	14.8	20.0	19.7	68.3	77.1	51.9	33.6	31.2	36.8	34.1	30.4	34.7	36.5	33.7	16.9	50.1	22.4	34.0	24.4	7.3	35.4	28.7	30.2	6.5	38.3	54.9	27.8	13.6	16.2	60.5	35.5	33.8	70.0	23.4	56.0	36.1	50.6	53.8	39.5	31.8	45.4	83.9	56.0	33.4	26.0	67.5	42.0	41.1	27.4	24.5
YIPF6	"FinGER6, MGC21416"	ENSG00000181704	"Yip1 domain family member 6"	Q96EC8	X	68498562-68537282	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003720	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003720: AB_1080626"	"unprognostic (5.07e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.32e-2)"	14.3	14.7	13.9	7.8	15.7	6.6	14.9	15.6	15.4	14.5	15.4	12.5	11.7	13.3	14.5	11.6	13.2	11.1	11.6	12.9	16.0	18.9	21.6	12.4	6.4	15.9	16.5	10.5	14.5	20.6	15.0	18.2	14.9	19.9	14.1	14.3	16.4	14.5	16.9	10.7	11.4	12.9	15.1	8.3	15.3	6.2	15.7	6.7	21.8	16.4	7.4	12.4	8.4	15.5	23.5	22.4	22.6	7.9	28.7	17.8	24.8	18.0	22.5	13.8	17.4	23.5	23.5	0.1	32.6	15.1	22.8	18.2	29.8	12.2	23.2	6.8	20.2	10.4	22.6	19.6	26.4	11.4	14.3	17.6	22.3	20.5	25.4	24.1	13.8	13.4	16.6	22.3	18.8	24.8	6.6	9.7	24.0	34.0	23.3	6.7	27.5	12.3	22.9	25.9	23.5	24.6	30.6	20.9	21.7	20.4	12.9	11.8	18.8	15.4	14.8	49.2	35.0	12.2	15.0	4.6	22.8	17.2	26.1	5.3	4.0	4.7	2.2	4.7	1.5	3.9	2.2	2.0	3.0	2.1	2.2	1.9	10.5	2.9	4.2	3.6	2.6	2.8	13.9	15.7	15.6	15.4	12.9	16.0	15.9	16.5	14.9	15.1	15.7	15.5	42.1	70.5	99.6	25.5	25.6	34.9	62.3	110.0	21.6	54.6	47.4	32.3	33.7	32.9	88.6	57.0	47.9	101.6	19.8	43.8	35.2	47.4	25.9	50.9	35.2	41.7	54.4	80.4	18.8	43.9	111.3	53.1	27.5	47.8	53.7	33.6	42.1	60.2	44.1	45.4	21.9	61.8	93.6	25.9	42.0	63.2	42.6	38.5	35.6	23.4	23.4	63.5	29.9	26.7	34.9	47.3	34.7	47.4	42.7	90.4	42.4	62.4	81.6	52.7	26.3	50.8	44.6	31.5	28.1	31.4	43.3	278.8	29.0	29.6	33.5	89.5
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 84.9;tongue: 27.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Cardiomyocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 4.8;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.0;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA030642	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	0.0	0.1	1.0	0.0	1.0	0.0	0.1	5.4	1.3	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.0	0.8	1.0	1.2	0.1	0.0	0.0	0.1	0.8	1.1	0.2	0.3	0.0	0.2	0.0	1.0	0.3	0.0	0.3	0.3	0.2	84.9	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.9	0.0	0.1	27.9	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	1.0	5.4	1.3	1.0	1.2	0.8	1.1	1.0	0.9	0.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 50.4;testis: 24.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 605.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.3;HEK 293: 12.1"									HPA060789	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA060789: AB_2684366"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	0.4	0.4	22.1	0.4	46.0	0.0	0.3	0.2	38.9	0.4	1.2	0.6	0.1	0.3	2.7	0.3	0.8	0.1	1.8	50.4	15.3	2.2	0.9	0.4	0.4	10.6	5.4	0.7	0.6	0.1	4.3	0.3	6.1	1.9	0.4	0.5	0.2	0.3	0.5	1.3	0.4	0.2	0.8	0.9	0.6	24.3	6.6	0.2	1.0	0.1	0.3	0.6	0.4	9.7	0.2	0.8	1.7	0.7	0.2	0.4	10.3	0.6	0.1	0.4	0.6	0.8	0.6	0.5	1.4	0.1	0.1	1.1	0.2	0.2	0.0	0.1	12.1	0.0	1.8	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.0	0.7	0.8	0.6	0.0	0.9	0.0	0.1	3.3	0.0	2.5	1.9	0.4	0.3	0.0	0.1	0.2	2.8	0.2	0.0	0.3	0.5	1.2	1.4	0.7	0.3	0.8	3.2	0.8	2.7	2.2	0.6	0.2	1.6	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	22.1	46.0	0.2	38.9	50.4	15.3	10.6	5.4	6.1	0.8	6.6	9.7	2.7	9.6	0.5	11.8	2.3	2.0	2.2	1.8	0.6	19.7	3.2	3.2	1.9	1.5	4.4	0.0	10.4	1.6	2.3	6.2	1.9	1.8	136.4	2.6	4.0	2.5	5.4	4.4	22.4	0.6	1.1	2.4	5.6	5.5	1.3	4.0	1.4	1.8	1.1	10.1	29.0	6.7	0.0	0.6	2.0	605.2	3.7	2.0	1.8	5.6	1.4	5.1	3.1	3.5	6.3	0.7	2.6	1.9	0.7	2.4	4.4	0.5	2.3	17.2	6.6	7.5	3.8	16.1	13.2	0.7	4.1	1.8	2.8	0.9	6.0	1.2
YJU2	"CCDC94, FLJ10374"	ENSG00000105248	"YJU2 splicing factor homolog"	Q9BW85	19	4247080-4269088	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.7;Distal tubular cells: 23.5;Ductal cells: 23.5;Exocrine glandular cells: 32.9;Extravillous trophoblasts: 23.3;Pancreatic endocrine cells: 21.9;Syncytiotrophoblasts: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043606, HPA055675"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043606: AB_10963431, HPA055675: AB_2682880"	"unprognostic (1.75e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.32e-4)"	"prognostic favorable (8.04e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.46e-3)"	15.6	17.0	16.9	11.0	19.1	44.3	16.7	18.9	22.3	14.9	14.3	16.2	13.3	18.5	7.6	20.1	15.4	7.3	16.3	16.8	16.6	19.1	20.4	12.5	15.2	20.0	17.6	18.4	23.8	11.8	11.3	10.0	18.2	17.6	7.6	8.0	16.3	8.7	23.4	23.5	17.8	7.1	17.1	20.4	19.4	15.4	18.0	12.6	17.4	13.9	10.7	16.4	14.7	21.4	30.7	29.1	16.0	12.9	9.3	12.3	16.3	12.2	15.3	22.2	24.4	26.2	18.3	35.5	13.5	18.3	19.1	22.8	26.1	28.8	15.4	20.6	25.8	22.9	19.4	31.0	13.7	30.1	30.6	13.1	17.0	19.6	28.8	13.5	18.2	16.9	33.0	40.1	9.3	42.2	31.9	18.7	38.3	13.9	22.0	18.4	13.5	31.6	21.1	29.7	22.9	23.9	10.8	23.3	21.8	9.2	16.8	27.9	20.5	15.7	16.4	31.8	30.5	43.2	33.0	35.2	21.9	31.6	17.1	21.3	19.6	31.0	25.7	25.5	23.2	31.0	24.6	23.8	24.0	33.1	29.0	24.2	12.1	23.4	19.3	25.0	33.4	18.9	16.9	19.1	18.9	22.3	16.8	16.6	20.0	17.6	18.2	17.1	18.0	21.4	11.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	9.4	9.0	0.0	0.0	0.0	9.2	0.0	29.7	10.1	0.0	23.5	23.5	0.0	7.6	7.7	7.0	0.0	0.0	0.0	32.9	23.3	4.4	0.0	11.6	0.0	10.4	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	18.6	0.0	0.0	0.0	0.0	21.9	0.0	0.0	1.7	0.0	0.0	19.6	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	45.7	4.7	11.9	0.0	0.0
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200959-44214294	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	31.6	33.4	52.4	31.7	51.8	36.9	26.4	50.8	52.2	23.5	46.3	34.9	30.5	30.3	38.7	50.1	22.8	19.9	37.8	53.9	57.8	33.7	20.2	27.7	27.6	56.1	62.8	19.5	52.6	34.3	31.7	27.7	60.2	27.2	34.5	16.0	37.6	27.1	49.6	34.3	29.7	35.0	57.2	30.2	40.4	28.4	58.7	38.4	28.8	36.5	34.9	31.2	24.7	56.5	81.9	86.1	71.3	94.8	85.3	72.6	63.1	161.5	130.3	104.5	103.6	93.7	75.9	88.0	71.4	157.7	184.5	94.5	83.1	111.0	140.8	89.4	65.3	53.7	63.1	58.7	105.1	103.4	80.8	66.7	97.6	114.7	123.4	77.5	111.5	75.9	126.2	64.8	125.2	79.4	87.3	106.8	178.8	111.5	120.2	81.9	76.0	68.4	72.2	69.2	94.2	151.6	83.0	126.4	97.8	115.8	100.0	100.4	138.0	112.5	123.9	104.2	199.1	134.5	187.8	130.3	146.2	87.5	219.4	5.6	10.8	18.2	5.3	11.5	7.9	7.1	7.0	9.0	10.0	10.1	5.4	5.4	8.9	5.1	10.6	7.9	7.5	5.5	52.4	51.8	50.8	52.2	53.9	57.8	56.1	62.8	60.2	57.2	58.7	56.5	12.4	12.8	9.4	9.1	16.2	26.0	18.1	14.1	10.2	8.4	21.6	15.4	19.7	7.2	13.7	20.2	10.4	25.3	13.9	45.4	25.4	47.1	25.4	9.4	15.8	19.3	13.8	9.5	7.0	83.0	63.5	18.7	18.8	17.7	1.3	15.1	14.6	15.7	41.2	13.5	6.5	26.6	16.2	19.4	19.3	8.3	9.9	19.5	26.6	1.0	40.2	11.0	23.7	8.0	8.3	79.0	23.3	13.5	38.8	35.8	33.1	23.1	8.7	7.9	0.0	13.1	23.8	18.9	23.0	22.9	25.9	49.3	15.2	11.8	24.0	44.4
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763316-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	13.3	13.0	12.5	10.4	12.8	17.6	13.8	18.1	15.6	18.0	2.8	12.9	7.0	16.1	12.9	12.7	15.9	8.5	11.4	10.9	16.4	10.6	8.5	11.2	13.1	9.5	10.0	22.1	13.1	12.1	15.6	11.2	9.3	14.0	9.2	17.6	15.0	10.3	15.0	15.3	13.4	9.4	4.8	13.4	11.9	18.5	12.3	14.9	16.8	7.4	11.9	14.0	15.0	12.8	28.3	28.9	31.8	7.1	25.2	20.8	18.0	18.3	18.7	18.9	18.9	25.8	19.6	40.9	13.4	20.8	13.7	26.1	28.6	19.6	30.2	24.6	17.3	29.4	19.8	20.0	12.2	22.3	21.9	19.0	13.5	20.9	16.5	23.3	25.3	22.9	24.1	18.9	23.5	29.9	26.4	24.4	20.0	19.2	26.1	40.5	31.8	14.3	16.5	37.2	24.2	23.8	29.4	20.2	8.3	21.8	22.9	17.4	37.0	22.6	28.3	15.6	23.9	23.3	24.8	43.6	19.3	17.3	17.2	0.3	1.4	1.5	1.5	1.6	1.7	1.9	1.3	1.3	1.1	1.9	1.8	1.8	1.0	2.3	1.5	3.4	1.1	1.4	12.5	12.8	18.1	15.6	10.9	16.4	9.5	10.0	9.3	4.8	12.3	12.8	26.8	25.6	34.3	54.2	32.7	19.9	11.2	13.3	27.9	42.0	27.7	25.3	45.9	14.3	25.0	9.2	41.7	19.7	32.4	15.7	1.9	15.7	35.4	26.8	36.0	29.7	20.4	23.5	86.7	15.5	13.5	24.4	23.0	28.6	17.7	54.1	21.8	16.8	19.1	52.2	84.3	18.9	12.2	22.6	12.3	17.7	33.8	19.5	5.4	51.5	28.6	24.6	32.0	68.9	76.5	18.0	13.3	48.5	30.3	18.9	14.0	14.7	33.0	30.8	19.7	35.5	24.8	62.8	49.0	29.2	23.3	15.7	29.3	32.5	21.6	13.2
YME1L1	YME1L	ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110111-27155266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	48.8	52.6	17.7	51.7	18.4	95.1	47.5	23.3	21.7	52.4	36.4	52.2	46.0	50.3	53.3	59.1	43.7	46.0	61.4	17.8	22.7	54.0	65.5	39.8	56.6	18.2	22.1	50.8	52.0	54.5	33.3	61.1	19.9	48.4	52.4	42.0	44.7	44.5	111.4	40.1	46.3	49.2	16.6	46.4	48.8	51.2	19.7	65.9	62.2	97.7	62.5	56.8	35.0	24.4	146.6	105.3	125.5	62.0	118.3	123.9	100.7	143.3	79.7	139.7	157.6	143.3	171.9	152.1	90.8	154.8	100.5	135.6	152.8	122.6	152.9	143.4	89.0	144.4	91.0	98.3	124.6	100.4	114.5	104.7	143.3	123.4	121.6	122.5	146.7	138.8	173.8	150.5	154.4	95.1	189.1	53.7	97.4	119.3	49.4	160.4	199.7	143.0	107.7	68.2	95.6	121.9	138.4	105.2	138.9	102.8	101.5	115.1	146.9	83.4	117.3	140.8	126.7	75.1	121.9	196.1	119.4	178.8	65.8	195.0	146.4	165.4	147.5	128.5	149.4	143.0	142.4	138.8	121.9	149.7	129.3	136.8	204.0	135.6	143.1	222.6	156.7	155.5	17.7	18.4	23.3	21.7	17.8	22.7	18.2	22.1	19.9	16.6	19.7	24.4	105.4	67.3	81.8	40.5	108.3	70.1	96.7	55.6	92.2	53.1	76.8	90.9	103.6	32.9	66.4	29.5	83.4	61.2	121.0	179.4	15.6	52.2	62.3	141.4	152.5	86.1	50.3	63.1	67.0	48.6	74.4	101.1	136.6	224.3	110.8	75.0	58.5	70.0	73.2	50.5	68.1	121.2	32.6	98.9	133.2	27.0	57.8	125.4	56.9	41.2	63.7	63.8	47.4	66.9	75.2	66.8	109.3	43.2	93.8	83.7	156.5	47.3	70.1	65.7	72.3	156.6	94.5	143.4	57.4	92.5	64.9	94.8	122.1	102.2	104.4	75.0
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.6"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 70.9;Glandular and luminal cells: 118.8;Late spermatids: 103.3;Urothelial cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 86.3;K-562: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	3.0	4.5	3.5	4.3	3.8	58.6	5.4	3.7	5.5	5.2	3.9	3.9	4.2	3.7	2.9	24.6	2.6	2.8	4.4	4.0	3.4	4.7	5.4	8.5	4.7	5.5	3.6	2.9	3.2	1.6	2.7	5.7	4.4	3.0	3.9	7.6	6.6	2.7	4.8	15.6	4.8	2.5	3.6	5.7	8.8	3.8	5.0	9.9	5.3	4.1	7.6	4.6	10.9	9.9	11.8	6.1	9.5	5.7	3.3	4.4	18.5	7.6	5.9	5.7	5.7	11.7	11.9	6.1	3.0	4.7	2.7	12.6	0.1	9.3	6.4	4.9	10.3	86.3	27.6	5.6	3.1	11.5	29.2	3.1	7.1	4.6	17.7	6.7	5.0	12.5	61.1	0.0	5.0	0.1	10.1	6.3	9.1	4.9	13.5	5.1	0.4	4.5	5.7	13.0	5.0	11.0	12.5	14.4	16.7	8.4	5.1	8.1	2.4	4.8	12.6	4.0	10.0	9.5	0.6	9.0	5.7	0.0	3.3	1.0	0.3	0.5	0.2	0.3	0.3	0.0	0.3	0.2	0.3	0.1	0.3	0.4	0.7	0.3	0.2	0.1	0.2	0.2	3.5	3.8	3.7	5.5	4.0	3.4	5.5	3.6	4.4	3.6	5.0	9.9	6.8	41.7	12.2	20.5	3.3	31.6	29.4	8.1	21.1	8.0	6.2	3.8	7.0	2.8	10.0	1.8	4.2	2.7	8.2	39.4	1.9	4.1	35.4	50.5	19.0	6.7	8.9	70.9	8.5	10.5	3.2	5.5	36.2	118.8	8.2	6.1	2.9	8.6	2.8	11.8	6.4	5.0	12.2	10.0	12.5	103.3	1.5	8.3	14.2	6.5	5.2	4.9	6.2	6.0	16.4	24.4	67.8	2.2	4.8	38.2	7.8	7.0	21.6	17.9	6.6	3.6	6.0	10.9	4.6	33.9	40.2	1.8	6.9	9.0	7.5	86.5
YPEL1		ENSG00000100027	"Yippee like 1"	O60688	22	21697536-21735794	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 29.9;testis: 77.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 706.3;Late spermatids: 1354.3;Spermatocytes: 394.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.8;JURKAT: 38.0;MOLT-4: 20.4;REH: 22.1;SCLC-21H: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.36e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.82e-3)"	"unprognostic (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.16e-3)"	3.3	2.3	13.2	2.9	29.9	6.4	3.3	8.9	16.6	2.0	8.1	3.3	2.4	4.1	1.6	2.0	2.7	3.1	7.2	17.4	13.3	2.4	2.5	5.5	5.8	4.8	6.2	7.6	3.9	3.3	2.6	1.3	5.6	2.7	1.8	3.7	2.7	1.2	15.7	1.7	2.5	2.4	4.6	8.4	3.4	77.9	14.4	14.6	2.7	6.4	4.5	2.1	1.3	9.4	2.1	0.4	18.8	11.6	1.4	0.6	1.0	0.7	0.2	1.3	1.8	0.0	1.0	3.1	2.4	0.3	1.7	0.2	1.1	0.3	1.1	9.6	3.3	0.2	0.3	0.9	1.1	2.1	2.4	1.3	0.3	0.5	0.2	3.3	3.2	38.0	1.2	10.1	1.8	0.5	20.4	5.0	1.1	0.3	2.9	22.1	4.7	1.2	0.4	0.1	19.2	13.6	2.3	2.2	1.5	3.7	1.1	2.7	1.8	0.3	5.0	0.4	0.7	13.9	7.2	10.7	1.1	2.2	3.1	0.2	0.1	0.1	1.9	0.4	1.5	0.3	0.3	1.8	0.2	0.6	0.1	0.9	0.8	2.4	0.1	1.7	0.8	0.5	13.2	29.9	8.9	16.6	17.4	13.3	4.8	6.2	5.6	4.6	14.4	9.4	6.3	3.2	4.8	13.7	9.1	1.8	2.9	0.5	0.6	6.8	6.4	3.8	4.8	7.2	2.1	3.7	6.2	0.6	62.1	0.6	0.0	7.1	706.3	6.1	3.1	6.4	13.1	10.3	16.7	3.5	0.4	3.6	2.6	3.6	0.0	23.0	10.4	6.7	1.6	6.7	11.6	1.8	0.0	3.2	3.7	1354.3	11.5	4.9	0.0	8.4	2.9	4.7	90.6	9.0	7.6	3.9	0.3	10.9	12.5	3.4	0.2	4.2	2.3	7.5	13.1	8.4	4.3	394.7	12.0	0.5	1.8	1.4	20.6	1.7	2.6	2.4
YPEL2	FKSG4	ENSG00000175155	"Yippee like 2"	Q96QA6	17	59331655-59401729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 489.6;Oligodendrocytes: 237.8;Rod photoreceptor cells: 862.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.2;HSkMC: 20.0;SuSa: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.73e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.04e-1)"	17.4	9.8	12.5	11.0	17.3	28.4	11.9	13.8	19.7	9.1	3.2	11.3	9.6	9.2	10.2	11.5	11.6	15.0	24.7	12.2	15.3	13.5	19.6	12.4	10.6	16.4	13.8	6.9	10.8	13.3	9.2	15.0	15.3	7.6	10.3	83.3	10.6	11.3	31.0	12.0	9.5	16.7	10.5	12.3	9.6	8.5	14.3	7.8	11.5	22.7	9.7	10.4	9.0	30.4	0.2	3.0	3.2	1.9	18.4	17.3	6.5	1.5	6.3	1.5	2.5	1.0	3.4	2.8	15.8	3.5	1.9	0.2	1.5	1.9	2.0	28.2	4.2	0.7	2.1	3.2	3.7	4.3	0.7	20.0	4.2	2.8	3.0	5.9	17.3	3.6	1.1	3.3	1.3	2.5	1.2	5.5	1.2	6.2	0.4	1.3	1.0	5.9	5.5	2.6	2.6	10.4	1.6	1.5	4.5	35.5	2.9	6.2	12.0	1.6	4.8	1.2	0.4	4.6	1.5	0.9	3.6	3.2	2.1	13.5	12.6	7.0	3.4	17.2	2.1	6.2	5.5	4.2	7.1	8.6	10.4	7.3	10.5	13.0	17.5	2.5	10.3	7.6	12.5	17.3	13.8	19.7	12.2	15.3	16.4	13.8	15.3	10.5	14.3	30.4	44.0	22.4	15.5	18.3	20.0	19.8	6.8	7.5	27.9	75.9	59.8	23.6	43.2	44.3	15.8	27.6	196.0	1.3	17.5	32.1	7.9	46.0	2.5	29.5	15.0	64.4	30.5	10.3	40.0	16.2	11.1	40.2	43.3	52.8	4.5	130.8	29.3	31.2	9.2	489.6	35.4	42.9	14.2	58.5	37.4	6.2	19.3	40.6	24.9	37.5	34.4	25.1	12.3	13.6	237.8	15.9	25.2	15.8	8.7	21.5	17.9	27.3	25.5	862.6	39.5	17.6	56.8	2.3	14.0	13.6	26.6	2.2	20.2	75.6	17.4	13.3
YPEL3	MGC10500	ENSG00000090238	"Yippee like 3"	P61236	16	30092314-30096915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 23.2;eosinophil: 31.0;neutrophil: 47.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 47.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 74.1;RPMI-8226: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.64e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	96.3	64.9	97.1	34.4	107.7	51.9	95.4	99.8	193.7	84.1	37.8	96.6	31.7	75.9	15.8	97.7	85.0	23.4	98.5	114.0	70.7	84.5	54.5	101.5	41.4	104.1	82.7	97.9	97.8	35.1	80.3	37.7	105.0	84.7	11.8	25.5	97.3	26.9	190.5	119.6	106.1	14.8	74.8	178.9	76.9	24.4	92.3	39.1	81.6	58.3	31.5	83.2	97.5	120.7	13.5	3.3	8.8	2.9	33.1	32.9	36.6	21.4	13.7	5.1	12.4	1.8	44.9	4.4	74.1	16.2	0.2	7.6	5.1	11.4	2.2	26.6	17.3	5.2	9.6	18.3	24.6	0.0	40.8	54.8	15.6	7.5	2.0	47.0	17.8	0.4	4.4	33.4	7.0	25.7	0.9	4.2	8.1	4.9	2.8	24.4	0.1	102.2	10.3	11.5	18.2	47.7	8.7	10.9	18.7	10.9	15.3	16.3	18.7	1.4	9.0	4.1	0.1	55.9	19.2	7.4	14.7	7.9	4.2	23.2	3.2	31.0	2.4	1.5	2.7	3.3	4.4	3.2	2.0	3.8	4.1	2.3	47.4	5.8	1.3	2.0	4.1	1.4	97.1	107.7	99.8	193.7	114.0	70.7	104.1	82.7	105.0	74.8	92.3	120.7	128.6	41.7	54.4	44.7	119.0	53.8	87.0	26.7	87.6	90.3	105.3	146.3	56.8	80.1	33.7	71.7	54.2	174.7	149.6	43.2	92.0	80.9	25.1	72.9	35.7	72.9	47.4	232.8	67.3	69.0	126.1	69.7	42.3	61.4	23.5	75.0	127.8	22.0	48.1	55.5	71.5	51.9	26.4	107.7	39.9	33.3	98.5	85.3	32.0	36.5	68.7	139.7	134.9	36.7	61.2	144.7	46.9	63.9	162.7	113.2	68.4	91.3	33.8	103.2	59.2	89.4	75.6	6.4	22.7	55.0	77.0	113.6	111.4	51.7	22.5	152.1
YPEL4	FLJ30213	ENSG00000166793	"Yippee like 4"	Q96NS1	11	57645087-57649944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.0;Early spermatids: 29.7;Erythroid cells: 92.4;Langerhans cells: 15.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.2;ASC diff: 2.1;SK-MEL-30: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045621	Uncertain					NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA045621: "	"unprognostic (6.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.34e-6)"	"unprognostic (1.50e-4)"	"unprognostic (9.56e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.92e-1)"	1.6	3.3	9.6	0.3	12.8	7.2	1.9	11.7	23.2	4.8	0.0	1.9	0.4	3.6	0.2	0.6	1.9	1.2	0.8	12.3	10.5	0.7	0.4	1.6	0.2	11.3	6.9	5.4	0.4	0.1	5.4	0.7	11.0	0.8	0.2	3.2	0.7	0.4	0.4	0.9	1.1	1.3	4.3	1.2	0.8	2.4	7.7	0.3	0.8	0.7	0.1	0.8	2.8	16.5	0.2	0.1	3.2	0.2	2.1	1.9	0.4	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.9	0.1	0.3	0.0	1.8	0.0	0.7	0.0	0.2	0.1	0.0	0.7	0.3	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.0	0.0	0.8	0.1	0.1	4.4	1.8	0.3	0.0	0.0	0.1	0.7	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.6	12.8	11.7	23.2	12.3	10.5	11.3	6.9	11.0	4.3	7.7	16.5	0.7	0.0	0.0	1.0	0.9	1.1	0.8	0.1	0.6	34.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.6	29.7	0.6	1.7	1.2	0.0	92.4	13.4	0.0	0.6	4.3	0.5	0.6	3.8	0.1	0.4	0.1	1.0	8.4	15.0	0.0	0.0	1.3	15.7	12.8	1.2	3.3	5.4	1.0	0.1	1.0	0.0	5.5	12.3	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	2.8	0.0	4.4	2.6	0.3	0.1	0.4	1.3	3.3	2.5	0.1	0.0	0.1
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 438.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 548.0;Plasma cells: 545.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	65.2	67.0	61.5	44.9	65.6	438.1	55.2	58.0	81.2	61.3	68.2	70.3	40.5	51.4	84.3	55.6	51.3	64.0	56.7	66.0	64.7	87.4	64.4	61.1	62.7	64.0	57.2	60.3	44.8	101.5	45.6	64.6	63.0	68.8	45.5	77.2	63.3	95.5	54.1	51.9	44.4	65.1	61.8	58.9	49.4	71.4	60.8	77.2	61.8	48.7	62.8	78.1	47.0	61.6	35.9	18.1	42.5	20.9	113.3	109.4	35.0	50.7	152.6	28.5	43.3	16.3	36.7	21.4	32.7	100.7	65.0	19.1	9.9	50.5	40.2	94.1	19.1	11.0	8.0	26.0	98.3	3.7	24.9	114.1	100.7	53.0	67.6	122.5	53.8	13.5	15.5	36.8	77.2	18.5	11.3	26.3	23.9	41.2	22.7	7.0	56.8	20.9	96.4	69.6	16.7	51.1	24.6	24.4	65.2	77.1	27.3	20.5	70.6	77.4	29.5	21.2	14.2	86.5	34.9	28.7	55.1	9.9	31.7	229.3	82.4	190.7	53.3	95.4	54.7	89.9	65.8	64.2	78.0	74.0	62.2	55.8	306.9	56.5	149.5	152.9	95.8	146.6	61.5	65.6	58.0	81.2	66.0	64.7	64.0	57.2	63.0	61.8	60.8	61.6	83.8	83.3	90.5	13.4	398.6	134.0	162.9	184.8	122.3	70.7	142.5	105.5	73.2	47.1	119.3	101.2	47.9	172.8	300.4	104.1	138.9	90.9	253.9	178.0	71.0	74.3	208.9	93.7	30.9	78.8	140.4	84.2	126.9	213.7	81.3	46.4	56.0	43.3	103.3	63.9	25.9	94.5	114.0	132.1	168.7	548.0	57.8	214.9	170.7	15.9	321.0	103.4	50.4	19.6	28.3	110.2	108.6	82.8	545.7	143.3	84.8	137.0	101.4	63.5	52.6	87.4	114.9	133.8	78.0	97.4	142.6	408.0	358.5	53.5	46.8	281.2
YRDC	"FLJ23476, IRIP, SUA5"	ENSG00000196449	"YrdC N6-threonylcarbamoyltransferase domain containing"	Q86U90	1	37802945-37808208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.8;Prostatic glandular cells: 87.8;Urothelial cells: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030147	Approved		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA030147: AB_10603327"	"unprognostic (2.98e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-2)"	12.4	11.1	8.2	9.8	8.2	50.1	11.2	9.5	9.8	6.6	7.9	9.8	8.2	7.5	8.0	16.1	8.0	8.6	7.8	8.2	8.8	10.5	14.1	8.9	10.5	8.3	8.3	7.2	14.1	10.8	10.6	13.3	8.8	8.6	11.9	8.1	9.7	6.0	8.6	16.0	8.6	9.4	7.9	9.2	10.6	16.9	8.8	8.3	9.1	5.7	10.9	16.4	9.7	8.0	25.2	17.6	18.7	23.9	12.7	14.6	53.6	20.3	16.5	31.5	19.9	23.7	23.3	60.3	32.6	20.4	36.1	20.0	35.6	32.8	29.2	36.3	35.1	42.1	21.3	24.9	27.9	55.5	41.7	15.2	48.1	35.0	50.3	20.6	22.5	45.7	66.5	26.4	25.4	17.6	32.7	32.4	70.2	36.3	37.1	32.3	30.1	39.3	26.1	25.2	48.5	49.7	22.0	28.0	72.8	33.2	15.3	24.2	20.9	26.8	28.3	29.6	67.8	53.2	81.2	50.3	23.6	35.4	43.8	8.8	0.6	0.5	0.6	0.6	0.6	0.5	0.9	0.5	0.5	0.8	1.0	1.0	0.7	0.5	0.4	0.9	1.0	0.4	8.2	8.2	9.5	9.8	8.2	8.8	8.3	8.3	8.8	7.9	8.8	8.0	31.3	0.0	9.2	3.9	21.0	50.6	77.8	6.3	29.6	10.8	28.3	25.9	3.6	10.0	5.5	5.5	6.2	24.3	23.6	7.6	23.5	7.7	3.5	16.2	15.7	22.5	15.6	17.2	3.5	9.2	48.5	14.4	10.2	25.4	7.0	13.0	10.8	12.5	12.7	21.9	3.8	10.2	4.1	9.4	19.1	1.8	4.1	15.3	5.4	3.7	6.3	10.9	4.1	3.0	5.0	15.9	7.1	4.1	25.6	87.8	6.1	16.8	4.9	8.8	6.6	12.5	22.0	19.4	37.4	28.6	49.3	40.6	20.2	14.2	11.7	92.7
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513694-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.8;Inhibitory neurons: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	8.4	9.7	5.2	11.3	5.8	9.9	10.1	8.8	6.6	8.9	7.8	8.7	9.3	9.2	8.6	9.4	8.3	8.0	7.6	6.1	5.1	8.5	12.6	7.4	13.8	5.3	5.8	11.0	8.7	15.5	8.7	6.9	5.3	8.1	10.0	18.3	8.9	7.4	11.5	11.3	10.1	7.9	5.1	11.4	9.2	14.8	4.7	10.2	9.2	10.9	12.9	9.8	8.9	7.1	16.0	14.2	18.1	30.7	9.8	12.9	19.7	12.1	13.4	15.2	23.6	10.0	8.8	29.1	8.5	10.2	19.5	15.3	22.0	27.2	19.8	12.6	19.9	15.8	25.8	13.6	14.5	12.8	13.4	10.6	10.3	9.6	17.4	14.3	21.5	13.0	15.8	13.0	13.6	5.3	17.8	9.1	8.4	4.7	9.2	7.4	15.6	22.7	12.7	20.9	14.4	12.0	16.3	11.7	12.7	11.3	16.6	11.4	18.8	23.2	8.1	12.1	16.7	13.3	18.0	18.0	13.3	14.4	10.1	0.0	2.8	2.9	2.8	1.9	3.3	7.3	3.2	3.0	2.4	5.1	3.4	2.9	1.0	4.3	3.3	3.6	2.6	1.2	5.2	5.8	8.8	6.6	6.1	5.1	5.3	5.8	5.3	5.1	4.7	7.1	27.4	28.9	32.8	61.0	39.6	13.3	21.8	14.7	15.9	59.9	17.6	17.7	17.7	14.3	25.3	12.9	83.4	13.7	34.0	12.3	0.0	17.8	47.5	15.5	24.5	24.0	7.2	16.6	129.8	18.6	8.3	22.4	34.1	17.2	12.6	69.0	20.0	25.7	17.3	52.2	146.3	14.2	20.3	30.0	13.2	44.2	19.9	26.8	12.4	95.5	23.9	21.4	16.5	94.5	97.6	18.0	7.8	14.7	20.0	14.4	16.0	17.8	24.9	88.9	26.3	34.0	26.6	93.8	37.8	19.2	14.3	18.1	33.0	33.4	16.7	18.5
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	33.5	33.0	20.0	26.7	21.0	63.9	38.3	22.1	24.8	27.5	29.5	32.0	29.4	27.8	43.6	37.5	27.7	27.0	27.0	21.3	22.5	31.8	42.2	35.6	35.6	20.2	19.6	29.3	27.4	37.1	18.0	34.4	20.6	22.9	33.8	20.2	39.8	23.9	43.9	41.9	26.2	32.9	21.4	32.1	27.6	29.3	21.2	44.1	28.0	33.7	43.8	32.8	26.1	23.1	68.8	46.3	99.6	96.8	75.5	58.1	117.8	66.1	80.7	80.0	80.4	42.8	78.1	117.8	64.4	84.4	47.8	62.2	117.3	105.7	94.0	76.0	91.9	98.7	60.7	78.4	90.0	105.1	74.4	78.5	106.4	86.1	121.1	70.0	99.0	70.0	101.9	55.6	89.7	53.3	112.1	80.8	161.8	61.1	61.1	95.4	74.2	96.8	111.3	95.8	85.7	91.2	68.6	102.1	181.7	82.6	67.8	95.8	69.4	55.4	57.8	52.5	93.5	68.2	47.7	133.3	63.3	81.2	89.9	108.3	78.4	78.7	66.1	91.1	88.3	80.3	72.7	80.3	96.7	59.0	77.9	73.2	26.5	92.4	94.4	62.6	92.3	109.5	20.0	21.0	22.1	24.8	21.3	22.5	20.2	19.6	20.6	21.4	21.2	23.1	70.8	51.3	61.2	13.7	70.8	152.7	104.9	111.0	109.8	45.4	110.2	101.3	52.8	77.2	85.3	44.1	31.3	149.6	79.5	46.4	66.5	102.0	16.3	65.8	78.2	78.5	75.7	52.8	22.5	69.6	108.3	64.5	49.5	76.6	72.3	63.6	77.4	102.3	77.3	58.9	20.4	76.0	105.8	65.4	75.4	19.3	71.1	56.7	37.4	21.5	74.1	66.4	73.2	14.1	23.5	80.7	43.8	75.2	71.0	78.6	42.4	96.0	53.8	45.9	92.1	61.5	83.0	142.2	115.5	95.3	161.7	260.2	69.2	69.5	65.9	118.7
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885702-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212"	Enhanced		Supported	Cytosol		NA	NA		97000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (6.14e-4)"	"prognostic unfavorable (1.91e-6)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	133.1	120.6	214.6	140.0	225.1	111.1	106.8	156.3	275.9	103.7	155.9	160.8	128.4	102.0	83.5	148.3	97.6	97.6	105.0	232.0	221.6	155.6	96.7	126.4	174.3	187.5	175.4	81.2	58.1	123.1	48.3	123.2	187.7	99.9	173.5	114.9	83.8	133.4	85.7	129.9	135.3	142.6	174.1	162.3	123.5	56.8	201.5	139.1	118.1	78.6	210.3	153.5	91.6	195.0	306.5	227.8	179.5	173.2	291.0	255.5	238.9	270.8	263.2	327.7	284.6	479.6	336.9	324.2	272.6	361.9	355.5	315.5	256.1	506.0	388.0	124.1	153.1	242.4	180.8	285.8	192.6	396.8	223.6	201.4	370.4	257.2	328.4	223.6	333.5	196.0	265.6	152.6	340.9	363.2	312.1	325.3	169.7	348.9	341.6	240.3	259.5	251.1	352.3	336.6	189.8	202.6	459.9	485.7	331.1	207.7	354.6	376.3	381.2	504.6	259.7	288.8	281.2	100.4	196.9	292.5	369.9	260.8	263.5	105.5	95.2	90.5	71.3	130.8	74.0	71.2	89.3	87.7	102.8	66.5	70.6	86.2	93.4	72.4	155.4	65.9	113.8	71.9	214.6	225.1	156.3	275.9	232.0	221.6	187.5	175.4	187.7	174.1	201.5	195.0	421.4	253.2	289.0	35.6	292.8	276.7	256.0	270.8	195.2	239.9	229.6	199.3	197.1	200.1	236.5	248.3	50.1	358.6	317.2	532.6	230.9	476.1	17.7	183.0	274.2	351.5	298.1	183.4	93.8	489.8	627.7	246.4	192.7	278.5	227.9	262.8	300.9	155.9	410.3	292.7	64.1	388.4	160.7	394.5	329.9	24.2	188.9	418.7	222.3	51.5	543.5	229.0	295.5	25.6	63.0	654.9	429.9	210.3	301.8	419.0	328.9	364.5	206.4	131.5	230.1	173.3	337.8	51.1	171.3	333.3	325.3	531.3	369.3	394.2	382.4	440.5
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344275-1400222	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008445, CAB016200, CAB021109, CAB047350"	Approved		Supported	Cytosol		NA	NA		83000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	221.9	198.9	251.8	122.8	264.2	121.3	198.7	266.3	272.8	168.8	195.7	161.1	136.8	155.6	192.7	239.1	188.1	103.7	242.3	260.7	275.4	229.3	211.7	176.9	113.7	271.1	246.8	170.8	154.9	236.9	178.8	198.2	267.1	150.0	168.1	220.8	184.8	121.6	656.7	193.3	129.3	137.3	279.2	101.5	136.9	165.4	262.2	211.0	208.5	441.8	164.5	186.9	179.7	302.7	615.3	565.8	700.2	563.4	376.9	454.7	589.8	382.1	481.5	724.5	571.3	907.5	305.5	524.7	411.9	621.9	439.7	463.1	859.2	745.6	798.7	294.2	930.9	334.1	366.2	409.4	483.4	277.1	311.1	421.6	458.6	619.3	897.0	520.6	729.2	458.5	402.8	337.9	719.7	368.5	445.8	264.1	566.6	596.9	332.7	477.3	255.9	380.4	547.7	365.7	354.2	497.2	531.1	240.3	364.3	439.9	442.3	290.9	467.4	411.9	293.8	453.7	731.4	190.5	329.9	346.6	478.4	387.5	585.4	78.6	137.2	41.2	47.3	153.6	57.8	78.1	67.3	55.1	180.3	59.1	55.7	51.2	49.9	64.1	144.8	133.8	99.7	151.0	251.8	264.2	266.3	272.8	260.7	275.4	271.1	246.8	267.1	279.2	262.2	302.7	363.6	298.1	194.4	83.2	161.1	573.9	457.5	468.4	281.7	153.6	313.6	219.1	473.4	265.9	310.9	371.5	50.1	463.2	128.7	300.7	745.4	460.8	258.0	573.6	414.3	352.6	352.6	244.7	73.4	421.4	709.5	319.4	194.7	502.7	211.5	328.1	262.3	309.0	384.9	111.0	72.4	346.3	376.4	260.9	434.9	434.3	280.8	227.5	425.2	60.0	320.5	357.8	55.6	56.8	112.1	464.8	289.8	294.9	279.5	487.9	272.1	707.8	504.6	173.3	243.3	361.2	524.6	508.7	573.3	333.8	586.6	519.5	130.7	287.2	361.1	474.4
YWHAG	"14-3-3γ, 14-3-3GAMMA, PPP1R170"	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326799-76358991	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.4;skeletal muscle: 349.8"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 408.8;Suprabasal keratinocytes: 425.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013274, CAB018389, HPA026918"	Approved	Approved	Approved	Cytosol		NA	NA		66000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	188.1	99.2	165.6	60.6	185.3	27.3	61.0	80.2	337.4	41.1	8.5	48.4	47.8	50.9	20.8	64.5	37.9	54.5	111.4	206.5	206.1	50.8	72.4	47.1	43.2	204.5	120.7	40.7	59.7	50.1	32.6	55.4	192.9	46.1	44.0	87.2	39.9	40.0	349.8	43.7	41.6	66.4	81.5	44.2	38.2	28.9	135.1	40.2	29.7	238.4	48.6	78.8	46.3	199.1	189.0	231.9	200.5	256.7	200.5	114.9	90.5	213.3	105.0	129.6	139.5	147.0	196.7	263.5	71.7	190.8	215.2	171.6	254.3	235.8	180.5	179.9	110.9	250.2	150.0	164.5	182.6	309.0	234.0	127.1	221.0	151.5	310.8	137.3	208.9	140.2	349.9	289.0	195.8	177.6	222.3	227.1	223.0	150.7	160.4	256.3	203.0	291.7	204.5	126.3	107.0	297.1	236.7	299.2	156.0	256.9	208.5	184.2	222.6	250.7	145.7	225.4	290.1	95.1	191.6	399.5	225.5	285.3	273.8	1.5	2.3	0.5	0.8	2.0	1.4	1.3	1.0	1.1	2.4	0.7	0.7	0.9	0.5	0.5	1.8	2.6	0.9	0.9	165.6	185.3	80.2	337.4	206.5	206.1	204.5	120.7	192.9	81.5	135.1	199.1	73.7	32.1	26.4	23.2	51.8	408.8	128.3	87.9	126.9	102.9	107.0	70.1	234.0	40.0	55.1	38.6	12.5	36.5	39.3	49.9	37.2	52.4	91.2	96.0	82.9	92.0	85.4	72.8	99.9	38.2	84.1	97.4	61.2	127.9	67.3	38.7	50.0	93.1	83.5	124.5	78.5	35.7	44.7	90.3	229.0	25.2	46.3	87.8	94.3	40.3	64.2	27.1	20.6	23.1	57.1	71.1	29.9	43.2	56.6	129.8	34.1	61.3	47.2	35.3	32.9	92.5	91.5	13.4	19.0	160.1	425.4	67.2	41.5	46.4	45.1	177.1
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944522-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 501.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025918	Uncertain					NA	NA		42000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB025918: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	104.9	82.7	244.8	87.2	309.8	86.8	76.6	96.2	501.2	54.6	4.6	106.3	64.8	68.7	92.8	60.4	73.1	82.4	78.1	386.6	217.9	77.6	61.4	112.2	68.3	156.7	109.2	53.0	69.6	29.5	64.4	100.0	145.9	57.8	111.1	114.1	59.4	70.9	68.7	65.0	68.9	131.0	74.1	57.9	109.3	16.2	118.1	70.4	62.0	54.8	82.4	89.9	58.3	229.8	344.5	142.4	180.8	91.8	112.7	107.0	97.0	321.9	172.0	208.1	228.6	157.8	124.2	202.8	76.6	329.4	116.6	169.1	208.7	183.7	271.4	177.0	157.7	118.7	108.2	156.8	108.5	391.4	132.8	84.9	113.0	176.9	135.6	137.3	201.3	76.9	171.5	155.6	249.6	148.5	121.0	189.8	185.2	197.1	150.8	173.7	201.2	115.1	216.5	153.1	323.5	104.4	184.2	134.7	124.7	245.9	78.2	119.3	248.4	206.0	190.1	138.2	216.6	80.7	130.5	257.7	137.3	162.0	170.9	11.9	19.8	22.0	7.6	16.8	11.1	12.4	9.4	10.8	22.9	13.0	3.7	4.9	11.6	25.4	18.4	6.2	19.5	14.0	244.8	309.8	96.2	501.2	386.6	217.9	156.7	109.2	145.9	74.1	118.1	229.8	259.0	51.3	21.7	27.1	106.6	334.1	223.5	27.3	125.2	54.8	123.6	79.0	51.2	125.8	26.5	126.9	22.9	171.7	53.0	242.8	232.8	148.0	3.9	180.0	81.1	211.7	75.4	269.8	132.0	160.6	145.4	118.8	139.1	153.0	40.0	33.4	120.3	72.1	245.6	53.8	62.9	125.4	34.6	155.6	269.8	13.7	61.2	397.6	300.6	66.5	102.1	80.1	44.3	22.1	42.0	203.3	115.7	80.9	120.4	240.7	93.4	125.5	52.5	73.7	157.8	55.8	197.1	23.3	35.5	164.1	340.0	34.8	95.2	25.7	116.1	191.8
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583967-9630997	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007925, CAB010286"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		49000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB010286: AB_2218221, HPA007925: AB_1844340"	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	144.6	141.0	190.8	106.1	223.2	178.4	153.6	216.5	239.1	177.0	149.4	161.2	119.4	184.3	141.6	187.3	136.5	122.6	218.7	205.1	229.7	140.0	116.3	119.3	132.0	218.6	203.8	163.2	201.5	131.9	112.9	123.2	212.4	161.1	133.0	143.6	120.2	140.2	53.5	121.5	116.2	177.4	203.9	89.8	127.5	144.6	205.7	148.2	137.6	62.1	141.1	144.4	161.8	280.5	316.1	465.2	412.0	400.3	316.6	434.5	385.7	421.6	412.3	432.5	360.2	352.9	269.3	404.4	214.0	608.5	451.3	288.5	462.8	459.7	553.6	1003.0	374.8	378.8	268.9	379.9	241.1	369.1	219.7	295.8	264.5	473.6	305.9	394.9	493.5	285.6	378.5	236.8	539.3	219.3	658.2	374.4	700.7	351.9	527.5	473.0	533.3	497.4	478.8	276.9	390.1	659.9	384.1	392.2	317.3	343.8	244.4	187.0	453.9	539.6	380.7	473.4	654.4	239.3	351.4	526.6	461.8	378.9	458.8	99.5	102.7	120.5	207.8	137.8	255.6	151.9	192.8	223.5	144.2	147.8	103.6	170.1	31.1	252.0	137.0	73.1	208.4	344.1	190.8	223.2	216.5	239.1	205.1	229.7	218.6	203.8	212.4	203.9	205.7	280.5	186.6	51.3	67.3	26.1	144.0	316.7	366.5	339.0	143.4	201.4	198.4	153.7	82.6	90.1	143.4	136.1	27.1	261.6	189.9	209.9	416.7	371.5	281.9	132.9	175.8	191.0	187.1	179.2	57.3	283.7	615.3	242.0	115.2	131.6	125.0	152.5	84.9	97.9	215.3	572.0	45.1	129.2	270.6	111.9	228.3	360.5	174.0	132.3	295.3	30.0	195.0	229.2	155.5	39.7	186.6	261.2	150.9	250.5	187.9	323.7	135.9	278.8	111.7	105.8	197.2	191.5	312.7	432.2	205.8	252.1	355.3	238.6	217.7	252.9	186.5	457.3
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916523-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005065	Approved					NA	NA		320000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB005065: AB_2218378"	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	379.0	262.9	246.2	374.2	324.1	527.2	251.7	147.4	343.0	269.6	88.3	475.2	327.3	275.6	220.9	892.8	243.9	333.0	187.3	366.2	269.6	224.9	190.9	275.8	429.3	163.3	195.7	227.7	191.5	233.3	109.0	339.2	222.5	265.8	445.9	285.3	244.8	291.2	95.0	399.4	375.4	356.5	170.1	272.8	365.4	226.8	276.9	434.8	289.7	168.9	566.1	501.0	343.2	205.0	1902.4	879.2	1605.4	457.7	396.6	490.9	808.0	877.6	1099.2	1124.6	1098.2	602.4	1149.5	816.5	857.1	1349.3	937.2	785.0	1025.5	1213.5	1630.1	765.1	454.2	779.5	579.0	378.1	524.8	311.5	840.3	475.4	1524.0	936.7	1430.1	923.8	1008.7	584.9	887.8	758.9	920.2	660.6	1357.1	535.4	548.0	2269.0	1026.7	569.7	468.6	544.8	1023.1	963.5	889.7	642.7	669.5	609.8	1365.4	1094.7	896.0	374.6	879.0	554.6	834.3	693.7	798.3	503.6	625.3	994.6	925.8	595.2	2303.2	1340.5	427.5	705.8	559.0	589.1	559.3	484.8	463.3	537.3	497.3	395.9	348.3	441.8	616.5	503.7	726.9	313.4	663.9	1087.2	246.2	324.1	147.4	343.0	366.2	269.6	163.3	195.7	222.5	170.1	276.9	205.0	199.4	250.0	228.9	43.1	637.6	1007.0	438.4	309.3	507.6	120.4	285.9	209.9	87.0	188.8	321.3	263.0	89.6	243.4	491.2	552.7	121.3	405.2	1092.9	359.6	245.6	216.0	265.3	137.3	150.2	421.3	551.6	277.4	448.5	578.8	452.9	122.1	183.1	104.5	276.3	134.6	92.5	525.2	244.1	303.5	641.2	2118.0	125.6	456.9	391.3	56.2	334.9	110.9	407.8	51.3	91.5	771.0	452.7	147.1	457.2	427.2	310.6	160.4	292.0	96.3	131.5	229.4	290.4	170.2	92.6	908.0	1184.7	408.9	596.5	116.5	371.7	794.9
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
YY1AP1	"HCCA2, YAP, YY1AP"	ENSG00000163374	"YY1 associated protein 1"	Q9H869	1	155659443-155689000	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA064249"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"		"HPA006986: AB_1080620, HPA064249: AB_2685226"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (6.81e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.84e-2)"	41.9	36.1	35.4	28.1	38.6	77.2	42.8	51.1	41.6	47.1	20.7	56.6	23.5	41.5	38.6	53.0	44.2	26.7	48.1	33.5	32.7	42.3	38.3	49.3	38.6	32.6	35.2	47.5	37.6	35.4	47.1	32.0	32.4	46.3	35.6	41.3	41.0	37.6	113.8	54.0	39.7	42.6	31.7	47.9	41.8	74.6	38.8	50.4	39.9	73.2	49.8	45.8	45.8	41.3	63.5	32.0	40.3	45.9	44.9	40.4	86.5	39.9	58.0	70.4	59.9	49.3	65.7	50.1	38.4	58.6	35.8	60.5	61.3	55.7	66.2	46.7	30.5	41.6	36.2	31.2	47.5	66.7	54.2	43.0	56.1	53.7	68.5	48.8	44.3	47.5	55.8	69.9	52.2	56.0	68.5	32.4	63.7	86.5	46.4	53.7	34.9	80.4	42.7	45.5	40.3	47.8	52.6	75.0	51.5	72.5	82.3	108.7	36.0	39.4	34.6	41.4	53.5	87.7	62.8	123.2	38.9	43.0	46.4	40.3	27.6	50.3	34.7	27.5	36.8	26.7	29.6	36.4	34.0	20.9	25.5	25.5	29.5	45.0	27.7	15.9	40.1	35.1	35.4	38.6	51.1	41.6	33.5	32.7	32.6	35.2	32.4	31.7	38.8	41.3	18.3	19.2	26.7	28.7	26.0	34.7	30.5	20.2	38.7	24.5	27.4	21.3	23.2	22.8	22.9	12.9	43.8	23.6	24.5	25.7	13.7	17.3	68.0	20.0	21.8	24.5	34.9	42.9	33.8	19.1	27.9	24.7	25.0	25.5	25.3	16.6	15.7	23.1	21.5	16.8	34.8	23.8	12.2	20.8	36.3	81.0	28.0	28.5	19.6	37.5	27.4	20.8	15.5	38.7	48.3	18.4	16.2	25.6	36.9	29.2	22.5	11.7	17.3	24.9	6.6	24.9	22.3	77.6	25.5	38.8	35.7	45.0	26.7	26.6	24.4	33.8
YY2	ZNF631	ENSG00000230797	"YY2 transcription factor"	O15391	X	21855987-21858740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 5.7"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 23.6;Spermatogonia: 57.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001119, HPA030335"	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA001119: AB_1858930, HPA030335: AB_2673434"	"unprognostic (1.90e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-4)"	"unprognostic (4.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	1.2	1.2	0.5	1.1	0.6	0.4	1.0	1.5	0.8	1.2	0.5	0.8	0.4	1.7	1.2	0.9	1.0	0.9	0.7	0.5	0.6	1.0	1.6	0.9	0.7	0.6	0.6	1.7	0.8	0.7	1.3	1.5	0.6	1.2	0.7	0.7	0.9	1.0	0.8	1.2	0.7	1.3	0.5	0.8	0.6	5.7	0.6	0.9	0.9	0.6	0.6	0.8	0.9	0.8	3.2	2.9	1.9	6.2	2.3	1.0	0.2	3.4	2.0	3.8	4.4	2.3	5.1	3.6	1.9	4.5	5.0	1.7	4.2	4.6	6.7	2.6	4.1	1.0	7.5	1.9	4.1	3.9	1.9	1.9	3.4	2.9	4.7	3.0	2.4	1.3	3.8	4.2	6.9	2.2	2.1	4.0	3.6	1.6	3.7	2.0	3.2	5.5	2.1	1.3	1.1	2.7	2.0	1.7	5.7	5.0	3.0	1.3	2.7	7.0	1.4	12.4	4.0	2.8	3.5	2.2	4.6	1.9	5.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.5	0.6	1.5	0.8	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.8	1.8	0.0	2.6	0.0	0.7	0.9	0.9	1.5	0.6	2.7	1.6	1.3	1.0	1.5	0.7	1.8	4.2	2.9	0.4	0.4	0.0	0.9	0.4	1.0	2.1	2.6	1.2	0.4	0.0	0.7	1.4	1.9	0.0	1.0	1.3	4.4	1.4	2.9	2.3	6.7	0.0	0.9	0.0	1.6	0.6	1.4	6.2	1.0	0.0	0.0	3.4	1.5	2.1	0.0	0.0	1.4	0.5	3.8	1.1	1.5	0.7	0.9	0.8	3.3	0.0	2.7	1.4	23.6	57.5	0.7	1.4	2.1	0.8	3.7	0.8	1.1
Z82190.2		ENSG00000285404	"Novel protein, DEPDC5-YWHAH readthrough"		22	31754899-31956243	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA054969, HPA055619"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"			"Cluster 11: Alveolar cells - Smell perception"			"HPA054969: AB_2682655, HPA055619: AB_2682864"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
Z83844.2		ENSG00000285304	"Novel protein"		22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 8.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000757	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA000757: AB_1079951"																		1.0	0.2	0.1	7.3	0.0	8.8	1.0	0.1	1.4	3.1	0.0	5.9	5.6	1.3	0.0	4.0	1.6	1.3	0.5	0.2	0.1	0.0	0.9	3.4	7.4	0.0	0.0	1.0	0.7	2.6		3.7	0.2	0.9	5.0	0.1	2.1	2.3	0.2	1.7	8.1	2.3	0.1	3.9	1.4	0.7	0.2	6.5	0.5	0.0	6.6	4.2		0.4	14.7	2.1	7.7	5.0	2.3	6.5	8.3	4.1	12.9	15.3	15.8	9.8	3.5	8.4	1.4	4.5	5.1	12.2	9.2	22.3	4.7	10.2	7.0	21.3	0.0	10.7	4.2	33.2	25.5	7.8	9.4	17.7	1.6	6.5	0.9	6.1	5.9	7.5	0.7	13.4	1.2	1.9	7.9	23.9	1.6	12.6	4.9	7.7	1.6	4.5	4.4	7.2	1.1	4.9	8.0	5.4	6.4	14.5	1.5	2.0	7.5	1.2	0.0	12.3	4.7	8.8	5.2	21.5	14.8	0.0	0.6	0.0	0.4	0.3	0.3	0.3	0.2	0.5	0.9	0.2	0.6	0.4	0.0	0.5	0.6	0.4	0.6	0.3	0.1	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195113-75209139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	17.7	12.9	15.6	11.8	17.8	20.7	22.2	19.2	22.0	18.8	14.0	26.3	19.0	15.5	24.8	20.0	17.9	15.8	34.3	17.0	12.9	24.2	32.5	16.3	19.3	16.8	13.9	23.9	26.6	24.7	21.5	36.6	18.3	17.1	28.7	30.6	23.8	18.2	44.9	22.0	26.0	15.2	16.5	16.1	21.3	7.0	15.5	23.3	27.8	40.7	20.6	16.6	16.9	16.8	21.7	14.1	14.8	30.4	22.6	29.0	16.3	38.5	44.6	14.8	18.5	8.7	30.0	15.2	6.0	38.3	17.4	28.7	18.5	32.6	10.4	94.6	27.1	34.1	32.7	17.0	16.0	58.0	33.2	32.2	31.9	11.9	27.2	27.5	30.9	35.2	18.6	54.0	28.6	25.5	14.6	28.6	3.8	20.9	31.9	31.0	23.7	50.2	28.9	36.2	27.2	22.4	21.4	21.7	24.5	10.4	21.8	28.4	27.7	28.9	22.0	9.2	12.4	8.8	41.2	10.5	19.1	49.5	23.8	1.7	3.4	8.9	3.2	2.9	2.3	2.1	2.6	2.9	2.3	1.5	1.4	2.2	1.7	1.7	3.8	1.7	3.2	1.8	15.6	17.8	19.2	22.0	17.0	12.9	16.8	13.9	18.3	16.5	15.5	16.8	41.5	35.3	17.9	12.4	7.5	9.7	18.7	13.9	9.6	59.0	15.3	10.8	56.3	20.0	12.5	27.6	6.2	8.4	15.9	24.8	19.6	12.3	0.5	8.5	39.0	24.1	23.4	9.9	16.6	21.1	8.1	26.4	12.8	11.1	7.0	42.6	23.6	25.0	16.4	25.2	14.1	25.1	14.2	20.2	19.1	2.1	36.7	18.3	12.4	12.2	23.9	21.3	13.4	20.6	14.9	15.5	21.9	63.2	6.2	18.5	35.2	19.0	8.1	40.9	19.7	25.5	12.3	0.4	4.9	23.7	11.1	6.7	11.0	73.0	27.2	20.9
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 121.0;MOLT-4: 183.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	3.3	1.3	0.5	28.0	0.6	24.8	1.9	0.5	0.9	1.7	0.7	4.0	5.8	1.4	0.5	2.3	2.2	5.4	1.4	0.5	0.7	2.8	3.9	8.7	57.0	0.8	1.3	0.8	1.0	0.4	1.1	0.9	0.7	2.5	1.5	0.0	2.3	0.8	2.0	2.4	18.5	0.5	0.6	35.5	6.7	2.7	1.2	79.9	3.5	2.8	17.7	4.9	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	121.0	0.0	0.7	0.0	0.0	183.4	0.5	0.1	0.0	0.0	7.2	0.1	9.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	14.1	0.1	0.0	0.0	0.3	0.3	0.5	137.4	0.4	93.2	0.2	71.7	108.3	0.3	1.6	50.8	79.8	2.2	112.2	1.0	0.9	80.1	64.2	0.5	0.6	0.5	0.9	0.5	0.7	0.8	1.3	0.7	0.6	1.2	0.6	0.8	9.6	13.6	0.3	3.9	1.5	0.0	0.0	0.0	0.0	0.8	0.5	3.0	0.0	0.0	0.0	0.0	0.1	101.0	0.2	1.9	0.2	1.0	1.6	0.5	0.8	0.0	8.8	0.2	0.0	0.0	1.8	4.6	0.4	2.5	0.1	2.5	0.7	2.2	0.0	0.2	0.0	0.0	2.8	2.2	0.7	0.0	3.4	1.8	2.8	5.0	0.0	155.5	0.0	0.1	0.0	0.0	0.0	28.0	0.1	0.0	0.5	0.0	0.0	0.0	14.3	0.6	1.3	2.1	0.2	1.4	0.0	105.6	0.1	0.1	0.2
ZAR1L	Z3CXXC7	ENSG00000189167	"Zygote arrest 1 like"	A6NP61	13	32303699-32315363	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Spermatocytes: 2.1;Spermatogonia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041319	Uncertain					NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA041319: AB_10794407"	"unprognostic (4.03e-1)"	"unprognostic (1.79e-1)"		"unprognostic (4.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.33e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.66e-1)"				"unprognostic (8.34e-2)"	"unprognostic (3.73e-1)"		"unprognostic (7.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167239843-167407874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 13.5;choroid plexus: 28.9;fallopian tube: 23.2;testis: 35.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced		Approved	"Golgi apparatus"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.0	0.2	3.7	0.0	2.6	0.0	0.0	0.7	1.5	0.7	28.9	0.0	0.0	0.8	0.1	0.0	23.2	0.0	0.0	2.4	2.7	0.2	0.0	3.5	0.0	13.5	11.1	0.0	0.0	0.3	2.0	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	35.9	3.5	0.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.6	0.7	1.5	2.4	2.7	13.5	11.1	6.6	10.5	3.5	6.1	0.0	0.0	1.1	7.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	423.4	107.4	0.6	0.6	0.0	0.0	80.1	0.0	0.0	0.5	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	23.8	0.0	6.1	0.0	0.0	232.4	1.5	0.4	0.0	1.9	0.0	0.0	0.0	4.5	1.1	0.1	0.0	1.5	0.0	0.1	0.0	0.2	226.2	0.0	0.0	0.0	1.2	37.4	11.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500976	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 91.0"					"Low region specificity"	"Detected in all"			HPA077591	Approved		Approved	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Centrosome"	"Nuclear membrane"	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	20.4	35.8	16.4	11.8	17.7	7.2	16.8	20.0	16.1	16.9	11.3	16.4	18.9	18.0	5.3	12.2	13.0	12.9	32.5	14.4	17.1	13.9	32.5	12.2	12.5	25.1	21.7	13.1	21.4	11.3	10.4	9.9	22.8	15.4	11.5	8.1	16.8	10.5	70.9	22.3	20.4	9.3	21.3	15.5	14.7	7.8	20.9	11.3	12.1	37.4	9.3	13.1	12.9	16.2	11.6	28.3	20.2	22.4	12.6	13.3	91.0	16.1	17.5	9.3	10.7	36.4	10.0	22.8	18.1	21.5	25.5	5.4	19.5	16.7	6.9	27.0	26.0	17.0	23.4	31.3	16.5	10.6	34.1	19.7	12.8	9.8	7.3	13.8	22.1	15.2	21.9	7.3	18.2	8.2	17.7	8.5	49.9	7.4	16.6	14.0	20.0	10.8	15.6	22.2	24.0	23.6	13.7	36.2	25.6	22.6	10.0	22.3	30.7	19.9	10.5	11.0	17.7	8.7	0.1	37.4	8.1	14.8	11.5	2.2	11.8	10.3	10.6	11.7	9.3	8.4	6.1	5.9	13.3	11.2	5.7	4.9	12.5	5.5	9.8	9.7	6.4	11.7	16.4	17.7	20.0	16.1	14.4	17.1	25.1	21.7	22.8	21.3	20.9	16.2	12.9	12.8	11.7	0.0	20.7	15.2	17.6	14.1	29.6	55.5	12.9	12.4	27.8	40.0	9.2	25.8	14.6	15.9	18.7	23.3	11.7	22.8	0.4	23.0	18.2	17.5	15.5	7.6	0.0	23.4	18.0	22.6	8.2	28.5	14.7	37.1	18.5	37.3	18.0	10.1	0.0	19.4	10.2	22.2	24.9	1.3	19.9	19.5	8.8	0.0	23.0	20.5	34.0	0.0	0.0	22.7	17.3	23.0	8.8	19.7	25.5	18.1	15.8	23.5	6.6	23.7	19.2	0.7	2.6	15.8	11.2	38.0	14.4	29.5	23.2	12.9
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087285	"Predicted intracellular proteins, Predicted secreted proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.7;JURKAT: 31.0;MOLT-4: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA055995: AB_2683000"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	10.3	3.3	9.3	1.9	14.2	2.6	8.8	9.4	10.8	6.7	7.5	4.2	3.9	10.2	7.4	2.4	7.0	3.5	4.6	7.8	9.2	10.0	10.7	5.0	1.9	16.0	12.2	7.9	7.6	8.4	3.9	2.4	10.9	5.1	4.3	3.8	6.0	6.6	2.7	2.6	3.3	8.7	9.9	3.6	6.4	1.9	13.5	4.8	11.2	3.8	1.9	3.0	3.7	17.1	5.2	4.2	5.4	29.7	22.1	1.5	0.3	1.7	5.0	2.6	6.9	9.1	2.4	0.0	10.9	3.4	1.1	0.6	2.9	1.8	2.3	1.7	5.8	4.0	9.1	10.4	13.1	5.5	1.5	24.6	6.8	1.3	5.1	4.2	8.3	31.0	0.0	11.0	1.6	5.2	29.4	0.8	3.5	1.4	2.5	12.1	10.3	1.7	12.3	2.0	5.9	12.4	6.1	5.0	8.7	2.1	7.5	3.8	3.3	2.3	4.5	5.1	7.0	8.0	8.2	11.5	3.6	10.4	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.3	14.2	9.4	10.8	7.8	9.2	16.0	12.2	10.9	9.9	13.5	17.1	10.5	0.0	2.8	8.1	1.7	1.3	3.8	0.3	4.0	8.4	13.5	13.6	10.7	12.8	2.0	12.9	12.5	1.5	2.0	3.1	17.6	4.1	3.3	16.5	13.5	11.7	16.2	5.0	3.3	6.0	0.3	9.3	11.7	12.5	1.3	20.2	12.1	31.8	9.6	3.3	8.5	5.3	0.0	13.6	4.9	2.2	17.7	9.0	7.2	5.6	5.1	13.8	3.1	16.1	18.3	2.7	3.4	11.3	1.4	5.6	1.9	17.2	0.1	17.0	0.0	21.4	7.7	1.5	3.4	2.2	1.4	0.3	1.2	25.6	7.1	1.8
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853844-49890080	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA045341: AB_2679295"	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	3.6	2.6	2.3	5.3	2.1	11.0	3.4	5.6	2.3	3.1	1.3	5.7	5.3	3.5	2.7	6.5	3.3	3.5	3.3	2.2	1.6	3.7	4.7	4.2	6.6	2.2	1.9	3.6	5.3	3.0	3.3	3.9	2.1	3.4	4.8	4.7	3.8	2.1	4.5	5.0	5.3	3.2	1.2	5.1	4.5	3.8	2.2	10.9	3.3	3.2	5.5	4.0	3.5	4.0	14.9	13.1	24.5	19.5	7.4	8.1	15.2	8.6	7.1	9.3	8.6	13.5	6.5	29.3	5.9	9.2	9.7	16.7	17.4	11.1	9.9	11.6	21.2	16.8	13.2	12.8	10.7	36.0	23.2	7.6	16.5	10.2	15.4	9.3	12.6	28.0	18.2	13.7	11.1	11.9	30.0	17.1	13.4	12.9	9.1	35.5	22.1	17.8	9.9	14.9	12.9	25.7	8.5	24.9	17.3	15.2	11.8	20.3	14.7	12.7	19.9	7.5	12.3	13.5	9.0	26.5	7.7	15.9	15.2	0.4	0.4	0.7	0.8	0.6	1.6	0.6	0.8	0.9	1.0	0.4	1.0	0.8	0.2	2.9	0.6	1.0	0.6	0.6	2.3	2.1	5.6	2.3	2.2	1.6	2.2	1.9	2.1	1.2	2.2	4.0	4.9	0.0	6.5	11.4	7.2	5.1	5.1	5.0	4.0	7.9	6.3	6.1	7.2	7.2	8.6	5.5	14.6	3.6	23.5	8.7	3.9	9.2	4.8	10.0	10.1	6.6	12.6	12.8	14.7	7.1	6.4	5.1	7.7	10.1	0.0	10.1	5.3	6.9	6.8	13.5	14.7	9.5	4.1	12.6	5.2	4.6	3.1	7.3	0.0	16.9	8.5	2.5	16.5	12.1	16.6	13.3	8.5	4.1	12.5	9.2	3.8	2.9	6.2	9.9	6.6	5.8	7.1	4.8	6.4	6.7	3.8	3.3	17.2	7.4	11.0	6.8
ZBED5	Buster1	ENSG00000236287	"Zinc finger BED-type containing 5"	Q49AG3	11	10812074-10858796	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048472, HPA050994"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA048472: AB_2680408, HPA050994: AB_2681300"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.05e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (5.69e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.87e-4)"	26.4	22.0	16.9	36.6	22.5	34.1	32.7	35.3	20.0	39.4	23.3	33.1	25.6	45.6	35.7	26.4	38.5	25.8	32.5	16.8	18.0	33.1	15.7	31.5	57.1	20.1	18.5	45.1	28.8	35.0	30.5	27.9	21.1	36.3	29.9	50.8	29.6	21.9	33.3	51.4	36.5	28.9	19.5	42.9	28.5	21.3	18.7	49.7	40.1	29.1	45.4	30.7	31.7	32.7	46.8	36.7	63.1	41.2	33.8	52.0	32.7	37.4	38.2	24.8	24.5	27.0	99.6	50.7	27.5	28.0	34.5	56.8	39.8	39.3	33.1	49.8	35.5	13.4	89.3	15.6	27.5	42.3	17.1	36.0	55.3	18.8	41.0	44.3	31.0	25.3	35.0	56.0	36.0	23.6	41.9	46.2	34.1	33.3	47.8	62.8	34.3	27.4	29.2	64.6	30.9	54.4	38.4	49.1	30.6	35.3	46.8	23.1	31.1	53.2	38.4	35.9	26.6	27.9	36.8	39.8	46.0	29.5	41.2	1.1	8.7	8.0	11.0	9.6	14.3	20.6	13.1	14.1	12.2	21.2	17.0	17.2	7.3	17.8	11.6	15.8	12.3	8.5	16.9	22.5	35.3	20.0	16.8	18.0	20.1	18.5	21.1	19.5	18.7	32.7	17.1	57.7	33.0	32.0	44.6	34.7	46.1	25.0	34.7	32.8	15.9	11.8	38.8	20.0	39.4	22.0	29.2	17.1	13.6	12.3	23.5	22.2	6.9	13.9	29.4	22.7	27.6	8.8	18.1	16.2	8.5	27.3	15.3	14.0	8.8	25.8	20.7	6.2	12.1	28.6	22.3	15.6	26.4	15.7	19.8	7.9	27.4	19.3	16.0	16.9	18.1	21.6	14.4	25.6	40.9	18.3	13.1	27.4	26.6	25.3	12.5	14.5	42.7	35.8	19.7	41.2	25.2	43.4	22.2	25.9	35.7	12.4	22.6	18.7	16.7	28.5
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150322639-150332721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 72.3;parathyroid gland: 25.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.2;K-562: 34.5"					"Low region specificity"	"Detected in all"			"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favorable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	1.3	72.3	1.0	5.2	0.8	3.8	2.1	0.6	0.8	3.0	3.1	4.0	3.3	4.3	1.2	3.0	4.1	1.6	1.2	1.1	1.1	5.3	12.1	3.1	6.9	1.1	1.0	6.0	7.2	25.6	5.4	0.8	0.8	3.5	3.1	1.7	2.7	2.1	0.5	3.6	5.0	1.8	0.6	4.9	4.2	1.1	1.2	5.6	4.0	0.2	6.7	2.7	2.1	0.6	8.1	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.3	0.9	10.9	8.4	4.8	4.0	0.1	0.0	3.5	0.0	0.0	0.7	85.2	5.4	6.3	13.3	17.6	2.1	0.0	8.4	1.4	3.9	0.0	0.0	0.3	0.4	16.2	34.5	11.8	0.0	3.3	14.5	2.8	5.3	3.4	0.0	0.0	0.5	10.2	3.2	16.4	15.1	8.4	14.9	3.2	0.5	2.4	1.0	3.6	0.2	0.0	0.0	0.0	0.1	10.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.2	0.8	0.5	0.6	0.9	0.2	0.8	0.8	0.8	0.8	0.7	0.0	0.2	0.6	0.7	1.0	0.8	0.6	0.8	1.1	1.1	1.1	1.0	0.8	0.6	1.2	0.6	0.0	0.0	1.5	0.0	0.6	0.3	0.5	1.0	0.0	1.0	1.2	0.9	0.9	2.8	1.6	1.8	8.4	1.5	2.2	2.2	5.9	2.8	0.0	3.1	0.4	0.9	4.8	0.8	0.0	13.3	0.8	0.6	1.5	3.3	1.3	1.3	0.4	3.7	0.6	0.0	0.0	2.4	4.1	1.2	0.0	0.4	2.8	0.7	0.0	0.0	3.4	1.2	3.1	0.0	0.0	13.4	1.2	1.2	0.2	0.4	1.3	0.9	0.6	0.6	0.0	0.9	0.2	0.4	0.9	0.9	0.1	1.9	1.4	1.1	2.3	0.4
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 12.6;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045445: AB_10959608, HPA055817: AB_2682933"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	2.6	4.6	5.4	1.1	6.9	0.2	3.9	10.7	7.3	7.5	5.3	5.0	1.6	6.1	7.8	2.1	5.4	2.5	4.2	5.0	6.0	4.1	1.8	2.4	1.6	5.6	5.8	10.9	3.1	3.2	9.9	4.6	5.8	4.7	1.9	8.8	5.0	4.8	2.6	2.8	2.0	3.8	6.0	2.4	2.7	4.3	5.6	2.1	5.6	3.1	1.8	4.9	4.3	9.0	5.7	4.4	10.8	9.6	8.5	6.2	4.4	4.8	4.5	5.8	8.8	4.0	4.4	4.7	9.1	1.6	13.7	6.0	6.2	2.8	7.7	4.8	6.2	3.0	6.7	5.2	3.1	1.9	3.6	2.4	5.8	4.3	2.8	5.3	3.0	4.0	2.1	4.4	6.2	2.3	1.8	3.2	2.6	2.3	4.7	2.3	12.5	3.1	2.7	1.6	11.1	3.7	6.4	1.8	5.5	4.3	4.2	2.0	2.1	8.7	5.7	2.7	4.1	4.0	7.2	1.2	6.2	2.9	8.7	0.0	0.7	0.3	0.7	0.5	0.4	0.2	0.6	0.5	0.9	0.1	0.4	0.3	0.0	1.1	1.0	0.8	0.0	0.4	5.4	6.9	10.7	7.3	5.0	6.0	5.6	5.8	5.8	6.0	5.6	9.0	1.4	0.0	0.5	4.2	0.2	0.0	1.0	0.0	1.8	5.7	1.6	1.3	3.3	0.0	0.6	1.8	2.1	4.0	0.1	0.5	1.9	1.4	1.3	2.6	3.0	1.7	0.0	1.7	4.0	0.4	1.6	3.4	1.1	1.3	0.0	7.2	1.1	0.2	1.5	3.3	5.5	0.7	0.0	0.9	0.0	0.4	6.5	0.6	0.0	1.0	1.1	6.1	0.0	4.5	12.6	0.7	0.7	5.7	0.4	0.7	0.4	1.2	5.1	4.1	13.1	2.4	3.2	3.8	5.1	0.8	0.0	1.4	0.3	2.1	0.7	0.3
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 27.2;Spermatocytes: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.1	0.5	0.8	0.1	0.6	0.1	0.9	1.6	0.8	0.8	0.1	0.4	0.2	0.6	3.1	0.2	1.2	0.2	0.3	0.6	0.6	0.8	1.2	0.5	0.1	0.2	0.3	1.6	0.8	0.9	0.7	0.6	0.3	1.4	0.5	1.5	0.7	1.9	0.0	0.2	0.2	0.3	0.1	0.0	0.3	8.7	0.4	0.4	1.7	0.0	0.1	0.2	0.3	0.4	1.1	1.2	1.2	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.7	0.0	0.7	0.0	4.7	0.1	2.4	0.6	0.0	1.3	0.2	0.0	3.0	0.2	0.8	1.1	0.7	0.0	0.0	0.6	4.4	0.1	2.1	0.7	0.0	0.0	8.3	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.6	0.4	0.5	0.0	1.3	1.3	1.2	2.8	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	1.3	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	1.6	0.8	0.6	0.6	0.2	0.3	0.3	0.1	0.4	0.4	0.0	0.0	3.2	0.3	0.2	0.0	0.9	0.0	2.2	1.6	1.5	0.8	1.9	2.8	0.6	0.0	2.1	2.8	0.0	1.0	1.9	1.7	27.2	1.1	0.3	0.3	1.2	0.0	5.2	1.3	1.5	0.3	0.0	1.1	0.0	1.7	0.0	1.9	0.4	0.0	5.7	1.4	0.0	0.0	0.0	5.4	2.5	0.1	0.0	0.0	0.1	1.1	0.0	1.0	0.2	0.4	0.8	0.0	0.0	0.9	0.5	0.6	0.7	1.5	0.0	0.2	0.2	24.9	3.5	1.3	0.0	1.0	0.0	0.2	1.2	0.6
ZBP1	"C20orf183, DAI, dJ718J7.3, DLM-1, DLM1"	ENSG00000124256	"Z-DNA binding protein 1"	Q9H171	20	57603846-57620576	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.7;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 34.0;dendritic cells: 42.7;NK-cells: 53.5;Plasma cells: 189.2;T-cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.1;U-266/70: 16.6;U-266/84: 22.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA041256	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041256: AB_2677380"	"unprognostic (5.78e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.58e-8)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	"unprognostic (9.79e-2)"	2.6	1.4	0.6	18.8	0.7	28.7	3.6	4.6	2.8	2.1	0.1	9.8	13.1	1.9	2.2	2.1	1.0	7.8	1.9	1.5	0.0	1.3	2.1	5.1	23.9	0.6	0.2	1.8	2.0	0.2	0.4	1.3	1.3	1.8	10.8	4.1	6.2	1.6	0.8	3.9	10.6	1.2	0.7	21.8	8.4	2.2	0.4	5.0	2.7	1.3	25.1	8.5	0.8	2.9	0.8	0.6	1.9	3.5	0.6	0.5	1.0	0.6	0.3	0.2	0.9	3.0	1.6	9.3	0.7	0.0	1.1	1.5	0.0	1.1	0.0	0.8	2.0	2.9	5.5	1.4	0.5	2.5	2.2	0.0	0.4	1.1	0.9	1.8	0.4	1.5	1.2	34.1	1.3	4.7	1.5	4.8	2.2	0.5	4.1	1.4	0.2	10.0	0.0	4.3	1.9	2.0	0.3	1.6	1.4	1.3	1.3	1.4	1.6	4.3	1.5	2.8	1.6	16.6	22.8	4.1	1.6	2.8	0.8	1.6	3.8	17.5	18.8	3.9	12.5	16.2	12.6	11.4	4.4	12.1	5.6	7.8	38.0	19.6	2.4	0.2	18.4	7.0	0.6	0.7	4.6	2.8	1.5	0.0	0.6	0.2	1.3	0.7	0.4	2.9	1.2	0.0	0.6	0.0	34.0	0.3	1.0	0.2	0.0	0.0	0.5	0.3	1.0	0.0	0.0	0.0	2.1	0.1	42.7	12.9	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.5	3.1	0.4	3.8	0.0	0.0	0.0	1.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.0	2.1	14.2	0.0	3.1	0.5	53.5	0.0	0.1	1.3	3.4	0.0	189.2	1.8	0.8	0.2	0.0	0.3	0.0	1.5	0.8	0.0	0.0	0.0	0.3	0.0	25.8	0.0	1.0	0.8
ZBTB1	"KIAA0997, ZNF909"	ENSG00000126804	"Zinc finger and BTB domain containing 1"	Q9Y2K1	14	64503712-64533690	"Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050516, HPA054552, HPA075151"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050516: AB_2681153, HPA054552: , HPA075151: "	"unprognostic (4.09e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.11e-3)"	"unprognostic (9.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.27e-2)"	24.0	15.2	14.2	28.9	17.1	83.1	25.8	15.8	16.6	21.1	17.8	21.4	16.9	20.5	26.9	15.9	24.8	21.2	16.9	15.0	14.2	17.9	22.1	22.3	44.1	16.5	15.6	21.5	17.8	20.8	18.0	24.0	16.8	24.2	22.2	20.8	18.5	17.9	22.6	34.7	23.9	19.3	16.3	34.8	21.0	12.4	17.7	38.5	27.9	21.3	35.8	21.9	20.2	19.8	56.2	18.4	40.5	25.4	41.1	49.3	41.5	23.8	35.4	22.0	27.9	17.9	38.7	53.5	23.2	33.8	17.2	38.4	19.9	23.6	30.0	79.7	13.5	26.1	35.9	15.1	25.8	21.9	36.7	63.7	40.6	15.3	22.6	48.3	25.8	33.8	13.1	35.7	41.2	42.5	38.0	22.0	16.9	28.8	27.5	33.7	25.0	20.7	38.3	67.1	28.2	22.6	38.9	29.0	32.7	39.0	27.9	27.9	34.4	36.6	24.7	17.7	16.7	44.6	20.6	59.6	36.9	20.6	24.5	42.5	13.6	23.1	18.8	13.1	21.4	14.8	16.6	20.9	14.6	14.3	16.8	20.8	10.4	19.9	19.1	9.1	25.6	16.4	14.2	17.1	15.8	16.6	15.0	14.2	16.5	15.6	16.8	16.3	17.7	19.8	19.8	16.0	12.7	65.6	56.9	31.7	17.0	29.7	40.9	11.5	14.4	13.7	11.9	8.6	22.3	9.2	12.5	8.0	115.7	9.2	9.8	13.2	83.0	40.0	41.5	24.7	22.1	20.8	40.6	8.6	13.7	26.5	19.9	30.2	28.5	18.8	19.2	8.4	15.2	6.7	58.1	12.1	30.5	23.0	73.5	38.0	15.8	50.5	30.2	58.1	13.8	7.7	22.6	40.2	96.3	16.2	8.3	18.4	48.3	15.2	6.0	6.6	27.8	8.4	6.6	20.4	27.9	2.2	4.5	23.7	24.2	7.8	78.7	23.5	10.9	19.2
ZBTB10	"FLJ12752, RINZF"	ENSG00000205189	"Zinc finger and BTB domain containing 10"	Q96DT7	8	80485619-80526265	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021554, HPA050569"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA021554: AB_1858937, HPA050569: AB_2681179"	"unprognostic (7.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.63e-2)"	7.9	7.9	4.1	4.8	5.2	23.7	8.2	12.1	4.4	8.7	3.9	6.9	2.0	11.2	6.1	3.7	11.8	7.4	7.5	3.3	5.1	10.2	18.5	6.2	5.3	4.9	4.4	12.7	14.0	7.1	3.5	17.8	5.0	14.1	7.8	7.3	7.6	6.3	5.4	1.9	2.2	8.9	4.3	7.0	4.6	11.2	4.7	8.6	10.1	8.0	3.4	5.5	3.3	5.7	0.0	4.2	21.1	10.7	9.1	6.9	28.5	3.9	0.0	3.0	3.0	9.2	3.4	12.7	11.0	5.8	9.2	0.9	16.7	5.3	3.5	0.0	26.8	6.5	2.8	7.3	5.3	2.2	2.9	6.5	4.6	3.7	10.6	2.5	7.7	10.5	5.9	24.2	2.5	6.7	12.6	5.5	5.3	1.3	6.6	14.7	11.1	4.5	8.4	12.5	12.6	14.6	5.2	48.5	14.8	23.6	9.4	9.1	9.9	7.3	13.5	0.1	3.6	7.0	3.7	14.0	2.8	0.0	9.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.0	0.5	0.2	0.9	0.0	0.0	4.1	5.2	12.1	4.4	3.3	5.1	4.9	4.4	5.0	4.3	4.7	5.7	37.1	25.6	17.0	18.9	55.3	28.4	21.1	8.1	44.3	13.4	48.8	39.8	36.1	25.8	11.8	12.9	16.7	38.3	34.1	38.9	3.9	13.1	83.7	82.4	60.6	34.5	60.4	3.0	12.8	6.9	41.0	29.3	40.8	142.6	9.5	37.0	16.8	31.7	13.3	32.0	11.1	43.0	20.3	21.3	79.6	29.7	19.3	32.0	49.8	13.1	11.2	20.8	8.2	19.6	13.4	8.3	14.8	21.1	24.5	82.1	0.4	14.5	19.4	10.6	26.3	46.6	49.5	14.6	10.6	13.6	12.6	105.2	28.4	19.6	34.7	19.6
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677132	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	7.3	7.2	6.1	10.6	7.0	38.0	10.0	11.8	10.3	8.2	5.9	6.7	8.3	9.8	7.2	7.6	6.8	7.4	5.6	6.9	5.9	7.3	9.6	8.2	13.5	5.6	6.0	10.4	9.6	9.9	5.5	9.2	6.2	8.1	7.6	12.4	9.2	6.7	9.1	12.4	7.2	7.1	6.6	13.1	7.8	10.5	6.3	13.7	8.4	10.0	12.7	8.6	6.8	10.0	14.8	16.5	10.7	14.0	16.7	16.3	18.7	14.4	14.2	13.0	14.3	15.0	10.0	18.1	11.4	11.0	11.6	18.0	16.3	16.4	23.3	18.8	11.3	40.1	15.8	14.1	12.8	28.8	14.2	13.1	20.8	12.1	27.8	11.6	13.0	20.6	23.7	21.2	14.1	18.4	25.5	12.8	10.1	15.7	24.0	20.6	16.7	22.1	12.2	17.4	31.0	11.4	18.7	15.0	19.1	6.5	19.1	15.3	14.7	19.6	14.2	8.2	14.5	24.2	21.7	33.4	12.2	18.6	13.9	6.7	3.7	4.2	3.6	4.6	4.7	2.9	3.1	4.0	4.6	3.8	3.5	3.0	2.4	3.0	7.3	2.7	3.8	2.8	6.1	7.0	11.8	10.3	6.9	5.9	5.6	6.0	6.2	6.6	6.3	10.0	19.0	32.1	20.8	12.7	28.2	46.4	20.0	8.4	51.8	14.2	21.4	17.4	12.1	10.0	19.3	1.8	33.3	10.2	40.3	14.0	0.0	6.6	3.2	44.7	50.4	20.1	20.2	12.4	32.7	5.5	7.5	19.4	15.8	70.2	8.8	13.7	13.2	10.3	7.9	21.9	28.2	14.5	14.2	23.0	24.4	3.9	8.4	25.9	19.6	12.2	20.3	12.0	21.6	15.1	27.6	7.6	4.4	14.3	32.6	18.3	8.2	6.2	20.1	22.8	6.6	25.0	19.1	25.5	21.8	50.0	49.0	16.8	34.1	14.3	14.2	24.1
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899613-31902086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	1.8	2.8	0.6	0.0	0.6	0.0	1.9	0.5	0.7	5.7	0.0	2.7	0.0	5.0	0.0	2.7	4.1	0.1	1.7	0.5	0.3	1.9	1.3	1.5	0.0	0.7	0.7	6.4	2.1	0.0	2.2	0.0	0.6	3.2	0.0	0.0	2.4	0.0	2.0	1.5	2.4	0.0	0.6	2.4	2.1	2.3	0.7	0.0	2.5	0.0	0.0	4.2	3.1	1.1	1.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	1.1	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.5	0.2	2.5	0.0	1.2	4.6	0.3	0.2	0.0	0.0	1.1	1.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.1	1.4	3.1	0.6	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.7	0.5	0.3	0.7	0.7	0.6	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.3	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.4	0.0	2.5	0.4	0.0	0.0	0.2	0.5	0.2	0.0	1.0	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	1.7	0.0	0.3	1.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.1	0.1
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB16	"PLZF, ZNF145"	ENSG00000109906	"Zinc finger and BTB domain containing 16"	Q05516	11	114059711-114256765	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 105.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 134.8;Inhibitory neurons: 125.9;NK-cells: 119.4;Skeletal myocytes: 163.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 23.3;MAIT T-cell: 39.4;naive B-cell: 11.0;NK-cell: 10.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;NK-cells: 10.9;T-cells: 39.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 71.5;ASC TERT1: 38.6;HEL: 40.7;HHSteC: 26.6;HSkMC: 26.7;hTCEpi: 30.6;hTERT-HME1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001499, CAB004540"	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB004540: AB_2218941, HPA001499: AB_1079640"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.90e-2)"	55.8	20.8	5.1	3.4	14.9	7.6	32.3	11.7	24.8	25.9	17.7	20.9	0.9	29.6	4.0	28.1	30.9	13.1	28.1	9.9	8.4	10.6	14.5	27.1	8.8	20.1	8.4	51.4	61.7	34.3	6.4	9.6	15.2	15.1	3.3	2.2	13.3	7.0	88.6	28.5	16.3	15.8	4.9	13.2	18.3	4.0	7.1	6.5	29.3	105.8	2.0	29.4	19.7	18.0	0.0	0.0	13.0	0.0	71.5	38.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	40.7	0.0	0.0	26.6	0.9	0.7	26.7	30.6	0.0	25.6	0.0	4.6	5.5	0.1	0.0	0.8	0.0	2.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	4.2	1.2	23.3	1.2	39.4	0.4	1.2	3.5	0.1	11.0	1.3	0.6	0.3	10.9	1.2	0.0	0.4	5.7	5.1	14.9	11.7	24.8	9.9	8.4	20.1	8.4	15.2	4.9	7.1	18.0	95.3	22.4	7.7	59.1	16.3	11.1	81.7	7.7	8.6	32.6	12.6	16.8	35.1	42.9	7.1	9.2	0.0	0.1	51.2	0.7	1.9	1.9	21.1	1.7	41.3	49.5	7.2	18.1	134.8	0.9	0.2	59.8	1.1	3.8	14.5	38.2	65.7	50.9	0.8	0.0	125.9	3.7	8.2	27.0	5.3	27.7	89.8	32.1	7.2	65.6	7.6	20.2	119.4	45.8	43.4	0.3	0.1	92.2	17.7	38.6	28.8	6.6	6.8	1.9	105.2	163.9	75.3	0.4	9.9	1.8	6.8	0.3	27.8	0.2	3.5	9.4
ZBTB17	"MIZ1, pHZ-67, ZNF151, ZNF60"	ENSG00000116809	"Zinc finger and BTB domain containing 17"	Q13105	1	15941869-15976132	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005789	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA005789: AB_1080633"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (2.08e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.04e-4)"	17.1	21.7	21.2	11.9	22.1	28.4	17.3	20.5	24.8	20.3	18.7	19.5	9.1	18.7	3.0	19.8	15.6	7.3	24.2	20.5	20.1	20.2	17.6	20.2	12.8	21.9	21.7	19.9	23.8	6.8	16.8	6.3	20.8	20.6	3.7	6.2	16.3	7.2	27.2	17.6	19.6	5.4	19.4	28.6	20.8	31.8	21.5	10.6	20.7	10.9	7.1	17.6	18.0	23.9	10.7	11.6	13.3	24.7	10.0	6.9	11.1	14.5	16.5	14.5	12.5	11.8	16.3	10.9	12.9	12.7	11.3	11.1	6.6	14.6	4.5	22.6	11.6	17.6	18.6	15.5	13.3	13.0	21.4	9.4	11.7	20.9	12.8	10.8	12.6	22.2	17.4	17.9	10.2	16.0	23.7	26.0	11.8	9.5	16.7	23.8	12.9	11.6	8.9	8.5	16.5	21.9	11.4	11.2	19.8	5.5	11.9	21.0	14.2	16.0	16.9	14.5	11.7	22.5	11.2	11.6	21.1	15.4	22.3	1.3	6.4	6.6	7.5	6.0	5.6	8.6	5.7	8.0	5.5	6.4	5.2	4.7	10.9	9.7	5.1	5.1	6.6	4.6	21.2	22.1	20.5	24.8	20.5	20.1	21.9	21.7	20.8	19.4	21.5	23.9	10.6	9.6	2.7	8.5	15.7	13.9	8.5	8.9	10.8	10.4	8.5	6.1	7.1	10.0	7.5	9.2	6.2	7.8	9.0	14.9	5.9	12.9	29.9	6.2	6.2	10.8	6.6	8.6	6.9	9.8	9.5	7.9	13.7	7.6	8.8	12.9	6.8	6.9	10.0	16.8	7.2	7.5	22.4	9.1	9.4	7.8	12.5	8.8	8.8	6.5	29.3	9.1	9.2	7.1	17.9	11.7	14.2	13.2	9.5	8.2	12.2	7.0	4.3	11.0	13.1	9.0	10.6	34.6	14.8	10.1	10.7	10.7	12.1	8.4	9.1	9.6
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 172.8;skeletal muscle: 85.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.8;Muller glia cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 217.5"	"HPA024656, HPA074019"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA024656: , HPA074019: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favorable (6.78e-6)"	9.8	6.3	36.2	14.9	45.4	28.2	9.0	172.8	57.5	7.4	20.3	9.2	13.2	7.2	18.5	5.8	8.6	7.4	12.2	66.1	13.5	11.9	19.0	10.0	18.2	18.0	18.1	7.2	24.6	6.2	4.9	9.4	24.7	10.1	10.8	42.2	10.6	11.5	85.5	8.3	14.6	6.1	19.0	20.2	11.4	22.3	18.9	41.9	8.4	37.5	15.7	10.0	5.4	29.8	23.7	8.2	31.2	1.2	4.0	4.1	21.7	13.0	9.6	20.5	12.4	6.3	18.7	17.9	1.2	25.2	6.6	2.4	20.1	6.4	25.5	6.4	17.7	3.0	3.1	3.0	6.3	3.8	9.1	3.5	5.3	12.3	7.7	24.7	22.5	19.3	2.3	7.5	24.5	0.3	31.4	15.2	16.1	7.3	3.6	9.1	21.2	5.1	13.1	8.0	45.8	44.6	5.4	0.2	14.8	13.0	0.4	27.2	33.7	10.5	12.9	6.5	28.0	3.2	0.4	7.0	10.6	11.6	21.6	0.1	0.2	1.3	0.1	0.3	0.1	0.6	0.2	0.2	0.3	0.9	0.5	0.3	2.3	0.1	0.6	0.9	0.2	0.1	36.2	45.4	172.8	57.5	66.1	13.5	18.0	18.1	24.7	19.0	18.9	29.8	18.5	9.6	18.5	37.2	16.2	11.2	3.3	5.0	8.0	6.1	32.6	6.1	22.2	8.6	10.0	18.4	12.5	1.5	8.2	10.5	0.0	4.5	3.8	18.2	3.3	15.3	19.3	0.0	51.8	5.1	2.0	3.8	10.7	11.0	6.3	5.1	12.8	44.3	6.1	6.7	19.8	16.1	18.3	25.4	26.7	5.0	2.1	16.1	3.6	15.0	13.9	52.1	2.1	21.6	20.8	8.5	7.9	4.9	2.2	5.2	6.6	12.0	17.4	27.6	13.1	10.9	6.2	9.8	7.7	8.7	19.7	1.0	7.2	1.7	14.8	4.2
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364115-151391559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	8.4	4.8	4.8	8.5	5.1	16.1	8.5	6.0	6.3	6.9	4.5	8.0	7.5	8.5	6.9	5.9	7.7	7.9	6.0	5.2	5.1	6.9	9.4	9.7	14.4	5.4	5.3	13.3	8.3	7.1	3.0	8.7	5.4	6.1	9.0	3.2	7.1	5.9	9.1	6.9	8.2	9.4	5.0	9.3	7.4	6.7	5.2	20.8	29.7	9.7	12.6	11.0	5.4	6.6	15.3	10.9	16.3	12.4	17.1	17.9	17.4	23.6	33.9	29.2	27.7	21.1	12.2	38.9	12.8	23.9	29.5	17.8	26.5	28.7	36.1	17.7	19.7	17.5	12.6	32.2	25.3	47.9	20.8	19.0	16.9	26.8	32.6	16.6	17.4	18.1	32.5	22.2	20.8	34.2	26.1	22.3	19.8	18.8	16.4	24.6	15.4	15.6	22.2	22.7	18.1	12.6	18.6	24.2	18.8	16.3	16.3	28.4	14.4	24.5	26.8	11.3	31.8	29.4	32.9	43.2	10.1	25.7	17.8	18.7	6.5	16.8	11.3	7.1	14.2	6.3	10.2	13.5	7.1	4.5	8.4	10.4	7.3	8.9	12.9	2.9	9.2	7.1	4.8	5.1	6.0	6.3	5.2	5.1	5.4	5.3	5.4	5.0	5.2	6.6	13.3	9.6	4.6	4.6	13.2	15.7	11.4	5.8	42.7	3.0	14.4	7.4	8.8	5.7	9.1	0.0	0.0	5.9	18.0	4.6	13.7	4.8	9.4	18.7	14.2	12.7	9.0	8.2	5.6	2.9	19.6	9.9	6.6	29.5	9.5	4.9	5.7	3.3	7.5	1.7	4.4	6.3	18.3	8.8	17.4	10.5	8.7	10.8	10.6	1.0	4.4	3.1	12.3	5.5	11.1	5.0	2.0	4.1	11.1	14.8	5.8	5.3	7.1	2.3	6.6	6.2	10.8	4.1	6.7	23.8	18.3	12.4	16.3	3.7	7.3	9.6
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314500-115147288	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	4.1	3.9	24.5	1.1	43.8	2.5	3.4	66.5	43.7	3.4	5.7	1.7	0.8	3.6	9.6	1.2	2.4	2.3	3.5	65.9	30.9	5.2	5.4	1.8	1.8	43.8	42.6	6.8	3.4	2.3	1.4	1.0	32.9	5.4	1.4	8.5	3.0	4.9	7.9	2.3	0.8	2.9	29.9	2.5	1.7	15.8	39.4	1.9	5.0	8.9	1.7	1.6	0.7	41.1	1.4	2.7	1.0	2.8	4.2	1.8	0.0	1.3	2.5	0.8	0.6	1.7	0.5	0.4	3.7	3.2	0.8	0.0	4.0	0.6	0.7	0.3	0.1	0.4	1.7	1.3	0.8	0.1	0.0	1.8	0.2	1.4	0.4	2.4	0.8	0.2	0.1	0.6	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.4	0.0	2.9	0.0	0.3	0.7	0.5	0.0	0.9	0.1	0.0	0.3	4.8	1.0	3.5	0.2	1.8	0.9	0.0	0.1	1.7	0.2	1.3	9.7	1.5	6.4	6.8	2.3	4.6	20.4	6.4	6.4	1.9	11.3	8.3	6.8	3.5	5.3	4.6	4.9	3.6	3.5	24.5	43.8	66.5	43.7	65.9	30.9	43.8	42.6	32.9	29.9	39.4	41.1	278.1	160.3	122.6	1998.0	115.4	25.7	38.2	11.3	22.2	123.6	103.7	81.8	48.5	108.7	25.2	294.3	60.5	0.2	56.1	10.3	49.0	231.4	450.3	109.8	628.3	106.4	31.8	20.4	72.3	82.9	0.6	174.5	36.7	170.5	80.6	194.5	56.0	106.0	4.3	80.8	462.3	14.5	40.7	20.4	28.5	111.1	105.6	36.0	32.0	855.4	29.3	127.7	36.0	1908.5	2090.4	107.8	10.5	120.7	58.4	28.0	19.2	198.4	36.4	108.6	85.5	301.2	124.6	6.9	8.7	14.2	18.5	0.5	67.4	140.7	17.2	25.0
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.2"	"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 60.4;U-266/84: 57.0"	"Low region specificity"	"Detected in all"							"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032"	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	8.9	35.6	3.2	6.0	3.6	41.2	8.1	4.6	5.6	7.9	2.2	5.7	4.0	13.7	7.1	6.5	6.6	11.9	4.6	3.9	7.2	6.5	11.2	6.9	5.1	5.3	7.2	8.5	9.4	14.0	4.8	6.9	5.0	7.8	4.9	14.2	4.1	4.2	2.5	8.8	4.7	8.5	2.2	6.5	6.5	12.2	5.3	6.4	9.5	3.1	5.4	9.6	5.1	5.4	12.8	10.0	9.6	10.9	13.3	10.2	9.3	11.6	16.6	10.9	16.5	12.0	6.2	22.5	5.1	11.6	19.6	9.5	14.1	8.2	17.6	11.9	13.9	2.6	10.3	7.3	10.2	8.9	5.2	5.9	17.2	15.2	19.9	4.8	6.2	12.2	15.1	38.0	7.8	18.6	24.0	4.3	9.5	9.3	12.3	10.1	10.7	26.4	4.8	10.1	13.6	7.9	16.1	23.8	11.2	4.8	8.5	4.2	7.0	16.0	8.9	11.3	11.5	60.4	57.0	20.9	21.0	14.5	10.6	0.1	2.4	1.2	1.6	2.8	1.9	2.6	1.8	1.3	2.4	1.9	2.6	1.9	2.3	0.5	3.2	2.1	1.3	1.2	3.2	3.6	4.6	5.6	3.9	7.2	5.3	7.2	5.0	2.2	5.3	5.4	19.0	6.4	41.1	8.1	24.7	60.0	32.9	6.2	26.2	14.5	15.6	15.9	4.9	12.8	12.4	7.3	2.1	6.7	20.8	7.1	11.7	5.4	14.0	20.8	34.8	19.6	4.2	2.1	13.8	5.0	5.5	31.9	10.2	27.1	16.5	6.7	9.3	20.4	6.1	32.0	15.5	10.2	10.2	6.3	24.8	5.3	4.1	14.5	35.6	5.6	7.2	10.1	5.2	4.5	8.1	3.9	6.0	10.5	20.3	24.7	5.4	4.8	13.5	13.6	6.6	36.1	21.0	21.5	14.1	19.3	63.2	9.7	20.8	7.3	5.6	20.9
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483219	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	3.1	2.2	1.5	5.4	2.4	8.9	4.6	2.4	2.4	4.0	1.0	3.5	3.6	3.1	3.2	3.0	2.9	2.5	2.2	1.6	1.9	3.9	2.6	3.9	8.7	1.5	1.2	3.4	3.5	7.4	1.8	3.2	1.6	3.5	3.8	10.1	4.4	3.3	3.2	4.7	3.7	2.8	1.3	5.5	4.1	4.3	1.6	6.9	4.9	2.9	7.3	3.5	2.7	2.9	4.7	4.8	4.3	10.8	6.8	6.9	7.0	5.3	7.3	6.5	7.4	6.7	3.6	20.0	6.7	6.7	7.8	6.0	10.9	8.3	9.8	12.4	10.7	16.2	6.5	5.1	5.0	13.3	8.0	7.0	6.7	6.6	11.4	4.6	5.5	9.3	13.8	11.0	6.8	8.0	19.2	9.0	10.7	4.7	5.3	11.9	6.1	8.3	8.0	8.0	7.3	6.4	6.8	7.1	16.9	5.9	5.0	14.5	5.4	5.3	5.3	4.4	11.5	5.3	4.4	20.2	7.0	10.4	9.0	0.1	0.6	0.9	0.7	0.6	0.4	3.4	1.5	0.9	0.7	2.8	1.9	1.1	0.4	1.3	0.8	1.1	2.9	0.5	1.5	2.4	2.4	2.4	1.6	1.9	1.5	1.2	1.6	1.3	1.6	2.9	8.4	12.8	9.1	2.6	32.8	10.1	11.2	5.3	7.4	21.7	8.6	7.4	3.8	7.2	5.2	3.7	31.3	8.5	16.8	4.5	3.9	6.6	1.4	7.3	14.3	6.6	9.6	12.0	3.3	9.1	9.9	8.6	12.8	10.7	9.5	14.1	3.6	7.3	7.7	10.1	2.8	11.0	6.1	12.5	12.1	1.8	7.2	10.3	8.8	5.6	20.5	10.0	14.4	1.0	5.4	6.4	5.1	6.4	16.8	8.2	7.4	6.4	6.0	65.2	0.0	13.2	7.4	6.2	27.8	9.3	9.7	7.8	17.8	15.0	8.5	7.3
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA054699: AB_2682579"	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	6.6	6.1	6.5	8.3	7.9	7.6	6.1	8.8	8.5	7.3	6.5	7.4	3.6	6.1	8.3	4.1	8.4	5.4	11.0	7.1	6.2	4.8	6.9	6.9	11.1	8.7	7.3	8.0	6.7	6.2	9.0	4.3	8.0	6.7	4.9	11.1	4.7	4.8	11.2	7.7	7.8	5.6	7.3	8.4	5.1	6.4	8.8	12.7	8.8	8.9	11.1	7.6	6.5	11.0	20.2	8.7	5.6	5.4	8.0	10.0	11.2	3.4	6.1	5.5	7.2	4.0	13.8	14.9	3.9	5.7	6.9	18.1	5.7	5.7	6.7	15.6	1.8	3.4	14.1	1.9	9.2	2.3	7.6	12.8	5.5	5.4	10.7	11.7	5.1	14.0	2.1	23.7	6.6	8.7	8.5	3.5	2.9	7.1	8.9	6.5	6.2	6.4	6.3	9.4	5.5	6.0	7.1	5.3	4.5	5.2	6.8	1.8	5.5	7.5	11.2	3.5	5.2	20.9	5.1	6.7	11.1	3.0	5.7	3.8	2.4	1.6	6.5	1.6	8.6	6.6	9.3	6.4	1.7	3.9	10.7	10.8	2.4	7.0	1.4	2.9	8.9	7.5	6.5	7.9	8.8	8.5	7.1	6.2	8.7	7.3	8.0	7.3	8.8	11.0	7.2	6.4	13.0	15.3	25.1	7.9	8.4	13.9	12.5	19.4	7.1	7.6	19.2	8.6	7.8	7.3	18.8	7.1	19.3	2.3	9.8	8.5	47.9	15.6	9.4	8.7	3.5	14.1	23.1	6.6	9.8	10.8	6.1	7.6	6.3	11.9	7.1	10.9	10.8	8.4	28.1	2.6	8.2	11.1	19.1	54.1	13.4	12.6	17.8	15.9	10.5	7.5	27.8	26.7	37.0	7.2	3.7	10.9	19.3	6.3	3.8	7.7	15.4	22.4	0.0	12.5	10.2	11.9	11.8	7.7	8.4	4.0	33.2	8.7	4.6	5.9
ZBTB26	ZNF481	ENSG00000171448	"Zinc finger and BTB domain containing 26"	Q9HCK0	9	122915566-122931512	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.3;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021444	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA021444: AB_1858948"	"unprognostic (5.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.26e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.81e-2)"	3.1	3.1	3.6	4.1	4.2	5.7	6.3	4.9	5.0	6.2	3.2	6.7	3.9	8.0	4.8	3.7	5.5	3.8	3.3	3.3	4.0	4.2	2.6	3.7	5.9	3.9	3.7	9.3	4.6	7.5	4.6	5.6	3.8	6.2	5.0	11.2	4.6	6.0	4.1	3.7	5.4	6.2	3.7	5.8	4.6	9.9	3.8	5.5	7.0	4.1	5.5	5.6	4.7	5.6	3.6	3.7	13.9	6.6	4.1	7.7	5.4	4.0	4.4	4.6	4.3	7.2	5.8	7.1	3.8	4.0	10.7	13.3	6.1	3.0	6.8	7.3	4.8	9.0	12.7	5.3	5.1	8.3	8.8	5.6	8.8	3.9	5.2	8.7	5.1	11.1	8.7	11.1	4.6	6.3	8.6	6.3	5.4	11.9	4.8	7.5	12.8	8.3	4.9	4.8	10.7	9.2	7.3	4.0	5.1	6.7	9.9	3.0	4.6	6.5	6.2	5.5	3.6	8.3	13.9	7.7	4.0	3.4	7.1	1.5	0.6	0.7	0.2	1.4	0.5	0.3	0.6	0.4	0.9	0.7	0.5	0.6	0.6	1.0	0.5	0.4	0.3	0.4	3.6	4.2	4.9	5.0	3.3	4.0	3.9	3.7	3.8	3.7	3.8	5.6	2.0	3.2	1.1	5.9	3.9	0.3	2.0	2.2	4.6	4.0	3.2	2.0	2.3	1.5	2.5	1.8	0.0	2.6	4.1	1.4	5.9	1.4	37.3	1.9	2.8	2.9	6.0	5.7	8.3	0.6	0.8	2.3	1.5	1.5	4.5	5.3	3.3	1.9	1.4	3.3	9.0	1.7	2.0	2.5	1.6	57.7	2.1	1.4	0.0	2.8	2.8	2.5	2.1	8.0	12.2	1.0	2.5	6.0	2.7	2.1	1.5	1.7	4.5	3.1	6.6	1.6	3.2	14.1	5.6	3.0	0.4	2.1	2.6	2.1	2.2	1.8
ZBTB3	FLJ23392	ENSG00000185670	"Zinc finger and BTB domain containing 3"	Q9H5J0	11	62748319-62754184	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035321, HPA035322"	Approved		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA035321: AB_2674569, HPA035322: AB_10610567"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (5.52e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.65e-5)"	"prognostic favorable (9.98e-4)"	"unprognostic (3.37e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.43e-2)"	1.3	1.4	3.2	2.2	4.9	2.3	2.0	3.5	3.9	1.8	1.4	2.4	2.3	1.6	1.9	1.9	4.3	1.0	3.0	2.9	2.6	1.7	1.8	2.8	2.4	4.2	3.7	2.5	2.5	2.2	1.0	2.0	3.9	1.8	2.1	3.1	3.5	2.2	2.8	5.8	2.2	1.8	2.6	2.1	5.0	2.8	3.6	2.8	2.7	3.2	2.6	1.4	1.2	8.1	2.1	3.2	2.6	3.5	4.9	2.4	2.2	2.3	2.4	2.6	2.3	2.1	2.7	3.4	3.3	2.4	1.9	4.6	2.3	2.5	1.2	3.9	3.9	1.8	6.7	2.6	2.4	2.7	3.7	2.7	2.9	2.0	3.0	3.3	2.2	2.7	3.3	3.5	2.6	4.3	3.4	3.1	7.8	1.6	1.6	2.5	2.0	3.3	2.1	2.7	2.4	2.3	2.3	2.9	1.6	3.7	4.3	2.0	2.0	3.9	1.7	2.8	1.3	3.6	2.8	2.9	3.7	1.6	1.5	1.9	7.2	9.4	4.0	5.6	4.8	4.0	4.1	4.9	5.2	3.3	4.6	3.6	2.3	5.0	4.8	1.5	5.9	6.2	3.2	4.9	3.5	3.9	2.9	2.6	4.2	3.7	3.9	2.6	3.6	8.1	1.4	3.2	2.7	0.7	2.1	0.8	1.6	1.3	2.8	2.7	1.6	1.8	3.3	1.5	1.3	0.0	6.2	4.4	0.9	3.2	7.9	3.2	12.8	1.5	2.4	1.7	0.0	0.4	0.5	1.9	2.4	1.9	2.6	1.6	0.0	2.5	1.1	3.0	2.4	0.0	0.5	3.1	4.1	2.2	0.8	7.5	1.5	1.4	0.0	0.0	2.0	1.7	4.1	0.0	2.2	2.1	3.9	3.0	1.0	1.1	2.8	2.7	1.4	4.5	0.0	0.9	1.8	2.9	3.9	1.0	1.1	2.5	1.5	2.1	1.9	1.1
ZBTB32	"FAXF, FAZF, Rog, TZFP, ZNF538"	ENSG00000011590	"Zinc finger and BTB domain containing 32"	Q9Y2Y4	19	35704558-35717038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.0;Early spermatids: 39.6;granulocytes: 17.7;Late spermatids: 73.0;Plasma cells: 25.6;Spermatocytes: 115.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.4"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 10.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;hTEC/SVTERT24-B: 2.0;U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076730	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA076730: AB_2732320"	"unprognostic (2.11e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-5)"	"unprognostic (2.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-8)"	"unprognostic (2.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.94e-3)"	0.1	0.1	0.2	2.0	0.1	0.6	0.0	1.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.3	3.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.1	1.7	0.1	0.0	2.6	0.5	49.0	0.1	0.3	0.1	0.0	1.3	0.5	0.0	0.1	0.7	0.6	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.3	0.0	1.2	1.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.5	0.6	0.0	3.8	0.1	0.3	0.0	0.0	0.0	0.0	2.3	0.6	0.2	0.1	1.4	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.3	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	39.6	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.5	0.0	17.7	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	73.0	1.2	0.3	1.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	1.2	25.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	115.5	0.8	0.0	0.0	0.0	4.1	0.0	0.1	0.0
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	6.4	7.0	6.4	8.5	7.0	19.5	15.4	7.1	9.0	6.8	4.7	6.8	7.7	6.2	9.4	9.9	8.2	7.3	4.9	6.4	9.2	6.4	19.0	8.7	13.2	7.3	8.7	9.7	8.4	13.7	4.8	8.8	8.5	7.4	6.5	5.7	10.4	6.0	5.4	18.8	6.4	4.8	8.4	11.5	8.6	5.7	9.3	16.2	10.2	7.7	12.8	8.0	4.8	9.7	13.6	12.9	19.6	18.1	15.9	17.8	23.4	10.3	13.5	11.7	14.5	9.0	11.7	19.5	18.8	10.4	15.7	20.7	31.9	15.7	15.3	22.0	21.6	20.3	20.3	12.7	11.6	21.2	22.7	12.7	19.9	11.2	17.6	17.1	20.9	18.7	13.5	23.2	14.6	15.6	19.2	14.1	24.3	20.9	15.3	21.9	14.9	32.0	12.5	22.2	35.6	15.2	20.9	21.3	25.3	14.9	11.5	29.6	19.6	9.5	6.9	14.3	18.5	12.7	13.1	24.7	12.6	29.4	11.9	11.5	4.2	5.6	2.9	6.4	5.0	2.4	3.8	3.9	6.2	2.2	4.6	3.4	0.9	4.0	4.2	6.7	3.5	3.6	6.4	7.0	7.1	9.0	6.4	9.2	7.3	8.7	8.5	8.4	9.3	9.7	15.7	16.0	7.0	3.9	7.9	12.7	7.8	5.1	12.5	4.5	11.5	13.1	5.2	8.6	11.9	1.8	0.0	7.7	21.7	5.3	1.9	5.5	0.1	12.9	8.7	8.5	8.4	10.3	3.4	6.7	8.7	7.9	7.1	10.3	0.0	16.0	7.9	16.6	7.6	3.3	4.6	7.0	6.1	12.8	10.3	0.4	4.4	8.2	3.6	3.7	14.6	7.0	14.4	5.0	4.6	6.9	5.7	2.6	5.4	9.5	6.8	4.0	15.3	1.6	6.6	6.9	4.1	5.0	10.0	12.7	13.1	9.3	8.7	11.2	6.0	11.9
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	3.8	2.7	4.9	4.3	6.1	14.7	3.7	7.6	5.3	3.1	2.8	3.5	3.0	3.6	3.1	3.2	3.2	3.9	3.1	4.2	4.8	3.3	2.9	5.3	4.8	5.9	6.2	3.6	3.2	3.7	3.5	6.7	5.6	3.0	2.9	12.7	4.4	2.9	3.3	4.1	3.7	3.1	5.4	5.4	3.8	3.0	6.0	4.8	3.5	4.8	4.6	3.3	3.1	6.8	2.6	3.5	9.9	4.1	7.6	7.6	13.8	3.1	4.6	3.6	4.0	8.3	4.8	5.0	3.3	3.3	3.3	7.9	12.1	3.1	3.6	5.2	5.0	5.7	9.8	4.4	5.3	7.9	9.1	6.7	4.9	4.2	4.8	4.7	4.8	8.6	12.3	3.9	3.4	3.7	5.1	6.6	8.7	4.9	2.6	9.5	11.5	5.2	4.7	3.8	3.1	10.7	4.1	3.6	5.6	8.9	3.6	11.6	5.2	3.3	6.0	4.7	3.4	6.8	8.5	4.2	3.0	6.4	3.2	0.7	0.3	1.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.1	1.4	0.4	0.2	0.3	0.0	0.1	4.9	6.1	7.6	5.3	4.2	4.8	5.9	6.2	5.6	5.4	6.0	6.8	5.6	3.2	4.6	5.2	1.3	5.4	2.5	1.6	2.8	6.8	5.9	3.9	2.2	2.8	3.5	1.8	6.2	3.8	3.8	5.6	1.9	2.4	8.4	2.1	4.0	5.4	1.8	3.0	6.9	1.6	3.1	4.7	4.1	4.8	0.0	3.7	6.8	4.1	7.8	8.4	8.1	4.1	2.0	13.6	8.4	31.8	6.8	7.2	5.4	7.5	8.3	2.1	2.1	7.1	12.4	3.2	5.0	0.7	1.7	4.4	4.0	2.5	2.3	12.7	0.0	4.5	5.6	4.0	2.5	3.8	8.2	3.3	2.2	2.1	2.4	4.7
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 12.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	3.0	1.6	4.6	2.6	7.5	5.7	2.6	6.3	4.6	2.8	2.1	1.9	1.8	2.1	2.3	1.4	2.1	1.6	2.0	4.4	4.6	2.2	2.1	2.7	3.8	8.6	6.3	3.3	2.0	1.8	2.6	2.1	9.2	2.3	1.6	10.8	2.0	1.4	1.8	3.2	2.3	1.8	4.4	3.8	2.3	9.3	6.4	3.2	2.7	2.2	3.0	2.0	2.3	12.7	1.7	2.5	3.8	1.6	2.3	1.8	4.2	1.5	1.1	2.7	1.9	3.2	2.1	4.6	3.1	2.4	1.4	2.1	3.2	1.7	2.2	2.6	2.0	6.4	3.0	1.6	1.3	3.8	3.9	1.7	1.1	4.0	2.6	1.6	1.4	3.2	5.7	3.0	2.8	1.2	2.6	0.9	3.6	1.3	0.6	1.7	3.3	1.5	1.5	4.2	2.8	3.5	2.1	2.9	2.8	4.0	4.2	3.9	2.5	3.5	3.7	1.7	2.4	5.3	4.2	7.3	2.3	2.1	2.1	0.1	0.4	1.4	1.1	0.4	0.4	0.2	0.5	0.7	0.2	0.6	0.2	0.6	2.3	0.9	0.4	0.9	0.4	0.3	4.6	7.5	6.3	4.6	4.4	4.6	8.6	6.3	9.2	4.4	6.4	12.7	8.5	6.4	6.3	2.0	9.7	2.9	3.7	3.6	4.0	27.2	5.7	2.8	9.2	12.8	4.2	11.0	33.3	8.3	11.9	4.6	7.9	3.6	60.2	9.1	8.8	6.8	3.5	5.7	1.6	3.8	3.9	7.4	5.1	7.6	2.5	16.9	11.0	4.7	5.0	18.5	2.1	3.9	0.0	15.4	5.5	67.0	8.7	10.0	10.6	2.8	10.6	10.3	18.6	3.5	5.3	2.8	2.7	13.2	5.7	4.3	4.7	5.4	10.6	60.1	6.6	9.5	10.8	23.2	13.2	3.2	5.8	9.2	9.3	11.6	3.6	3.4
ZBTB39	"KIAA0352, ZNF922"	ENSG00000166860	"Zinc finger and BTB domain containing 39"	O15060	12	56998836-57006546	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 16.7;Early spermatids: 19.9;Horizontal cells: 21.9;Late spermatids: 20.3;Spermatogonia: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RH-30: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016866, HPA020306"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles		"HPA016866: AB_2669470, HPA020306: AB_2670406"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (7.00e-2)"	2.6	1.5	1.7	2.9	2.0	5.8	2.8	2.2	2.0	2.1	0.9	2.5	2.2	3.2	2.5	2.4	3.1	1.8	2.2	1.6	1.8	2.1	3.4	2.7	3.9	1.9	2.0	4.4	2.9	3.3	1.1	3.7	1.9	2.6	2.3	2.9	2.6	3.3	2.5	2.9	2.9	2.8	1.5	4.2	2.6	7.1	2.0	4.2	2.5	2.7	3.6	2.1	1.7	2.3	3.4	5.5	15.3	7.9	3.4	3.6	10.1	3.2	4.1	5.2	3.7	5.7	2.3	10.8	4.2	3.2	3.3	4.5	11.8	5.0	5.0	5.0	8.2	12.1	3.6	4.6	3.2	9.3	9.6	2.8	4.8	4.1	6.6	5.6	6.0	12.2	15.2	9.7	3.8	3.9	13.7	7.8	15.2	3.5	4.6	13.0	46.9	5.2	2.4	6.7	7.5	9.7	4.7	6.0	4.7	14.2	5.1	10.1	4.8	4.3	9.5	2.0	4.1	12.5	8.7	11.5	2.7	5.2	2.7	0.7	0.3	0.0	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.6	0.0	0.7	0.0	0.5	0.1	0.3	1.7	2.0	2.2	2.0	1.6	1.8	1.9	2.0	1.9	1.5	2.0	2.3	2.9	0.0	0.6	3.3	3.5	1.5	2.3	1.6	7.4	11.6	1.7	1.5	3.5	2.8	1.9	0.0	16.7	3.1	3.0	0.9	0.0	1.5	19.9	1.2	3.3	4.3	1.2	2.1	1.8	1.8	1.8	2.3	1.5	1.2	1.3	3.6	8.6	2.5	1.9	21.9	1.8	2.5	2.0	3.0	2.0	20.3	1.8	1.4	1.8	0.0	3.6	1.8	3.1	1.5	2.8	2.5	3.2	5.7	3.2	3.5	1.5	1.4	3.1	7.4	6.6	3.4	2.2	10.1	17.6	3.2	1.6	2.2	2.1	1.9	2.4	1.4
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153682-197201293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: AB_2674355, HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	3.5	4.7	5.0	3.0	4.7	1.3	7.0	6.6	5.8	5.2	2.2	3.2	3.2	4.2	4.7	3.4	3.7	4.3	3.2	4.6	5.8	5.3	4.4	3.4	3.9	5.5	6.1	6.8	4.0	4.8	3.9	3.3	5.6	4.2	3.5	7.0	3.9	3.4	3.6	3.5	2.9	3.2	6.0	4.4	4.3	3.8	5.8	5.2	7.5	4.7	3.3	3.9	2.4	6.9	8.1	4.6	5.8	4.7	9.0	13.6	4.6	4.8	7.8	4.9	4.6	2.9	6.7	3.0	6.8	10.9	3.0	6.5	4.1	4.1	7.7	2.7	2.4	2.4	6.0	2.6	8.0	4.8	2.3	5.6	10.6	5.0	8.6	10.0	3.4	3.4	5.7	3.5	12.8	3.9	3.6	2.7	2.3	5.6	1.6	2.5	8.1	5.4	6.0	4.5	8.3	7.4	8.6	14.9	9.3	4.2	11.4	3.6	5.6	9.7	5.6	7.8	6.3	4.0	2.2	3.2	4.6	1.7	13.8	0.3	0.1	0.1	0.2	0.1	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.4	0.1	0.1	0.2	0.1	5.0	4.7	6.6	5.8	4.6	5.8	5.5	6.1	5.6	6.0	5.8	6.9	11.6	19.2	8.9	21.2	9.4	7.5	6.9	5.8	11.4	13.6	17.5	10.7	14.7	10.0	10.0	16.5	2.1	4.3	10.6	4.2	1.9	6.3	3.2	14.5	18.0	8.2	13.1	1.7	32.1	5.7	4.0	13.3	7.7	11.3	1.3	18.5	6.8	9.2	4.4	25.2	27.9	7.3	2.0	7.3	5.2	4.6	15.5	8.1	12.4	13.1	9.3	28.5	11.3	19.6	41.0	6.8	2.9	12.0	6.3	9.4	4.3	10.4	12.8	9.1	6.6	13.3	12.7	7.0	4.9	10.8	10.1	3.4	7.7	16.0	7.0	6.0
ZBTB42	ZNF925	ENSG00000179627	"Zinc finger and BTB domain containing 42"	B2RXF5	14	104800596-104804712	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9"	"Not detected"	"Not detected"							HPA066961	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066961: AB_2685756"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.99e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (2.30e-9)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-3)"	"unprognostic (5.45e-2)"	2.3	3.5	1.1	1.7	1.1	0.3	3.3	1.0	0.9	1.7	1.5	3.0	3.2	2.2	1.8	4.8	4.5	1.8	4.5	0.9	1.2	4.1	5.5	4.3	1.4	1.8	1.4	1.1	11.5	2.2	1.0	1.1	1.3	6.2	1.8	0.4	6.3	3.3	6.5	2.6	2.9	1.4	1.4	2.2	6.5	2.4	1.2	1.4	4.7	2.6	1.3	2.3	2.2	1.0	1.3	4.4	1.3	5.3	1.0	1.1	5.4	1.9	2.0	3.4	3.0	2.8	5.1	0.4	3.7	1.9	2.3	5.8	1.1	1.8	0.5	19.3	1.3	1.8	2.3	3.3	1.6	0.4	10.3	2.0	2.1	1.4	0.7	2.4	1.5	3.8	3.0	2.9	0.6	33.7	3.6	2.8	0.8	8.9	4.0	5.0	0.3	2.7	2.5	8.6	5.9	2.5	1.5	7.9	3.4	1.2	26.9	2.1	2.4	1.3	3.0	0.3	0.6	3.1	1.8	0.3	4.3	1.8	2.8	0.0	0.1	5.4	0.3	0.0	0.5	0.4	0.4	0.1	0.0	0.4	0.3	0.4	0.0	0.1	0.0	0.4	0.3	0.2	1.1	1.1	1.0	0.9	0.9	1.2	1.8	1.4	1.3	1.4	1.2	1.0	3.1	3.2	11.7	0.3	1.2	0.4	5.0	1.9	1.2	0.3	8.1	3.4	4.4	5.7	8.2	0.0	0.0	1.2	1.1	4.3	3.9	4.2	2.6	2.3	1.2	2.6	5.4	4.4	0.0	13.5	1.9	1.1	3.1	3.9	0.0	2.3	2.5	7.3	1.1	0.0	0.0	6.4	2.0	2.5	0.6	0.9	0.6	0.9	1.8	0.0	0.8	2.8	5.2	0.5	0.0	7.5	3.2	0.4	0.7	6.9	3.4	4.3	3.1	0.4	0.0	1.5	1.6	8.4	3.4	3.4	0.1	0.8	1.8	0.5	4.9	5.1
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	5.3	5.4	4.5	4.7	5.3	60.6	5.9	6.3	6.8	5.0	9.0	4.6	5.2	5.7	4.4	9.5	4.1	5.3	10.6	4.7	4.9	3.9	7.9	8.3	5.6	4.1	5.1	6.1	4.9	9.5	4.6	5.2	4.5	4.4	5.8	9.3	6.0	3.5	32.8	14.4	4.8	5.0	3.5	5.0	7.0	16.2	5.0	5.9	5.3	20.2	6.4	5.1	6.4	6.3	6.3	4.7	8.5	7.8	7.0	9.9	8.7	8.0	8.0	6.3	5.6	11.0	4.3	8.7	3.9	8.4	12.4	18.4	7.5	8.0	7.8	7.6	5.0	6.0	14.6	4.9	9.6	8.6	11.0	12.1	20.2	10.2	25.0	6.0	4.9	7.1	10.6	19.8	9.4	6.8	7.5	5.4	7.8	6.7	8.0	6.3	27.4	7.1	6.8	7.2	7.5	6.9	8.5	8.5	7.8	7.6	7.6	5.4	4.7	7.6	7.1	8.4	7.0	21.0	16.4	3.3	9.4	7.0	6.3	12.0	4.5	3.9	7.0	4.3	6.8	4.2	3.8	4.1	3.7	3.3	4.1	4.8	2.5	6.7	3.5	2.0	6.1	3.3	4.5	5.3	6.3	6.8	4.7	4.9	4.1	5.1	4.5	3.5	5.0	6.3	16.5	35.3	44.7	34.0	23.4	84.9	68.2	37.5	30.7	42.2	36.0	19.9	42.7	27.1	46.1	27.6	108.4	18.2	30.6	80.2	1.9	31.1	91.2	51.7	35.0	25.1	11.4	21.4	44.2	18.5	12.3	27.7	78.5	133.6	31.0	23.7	17.5	25.3	14.7	26.9	40.5	21.6	40.7	21.7	74.1	45.3	17.7	46.4	24.9	12.2	18.3	29.3	21.6	25.6	37.3	43.4	51.5	14.3	27.2	54.9	33.5	7.9	27.7	55.7	13.1	39.4	29.3	49.7	73.1	70.8	117.3	52.0	31.8	22.4	25.6	141.7
ZBTB44	"BTBD15, HSPC063, ZNF851"	ENSG00000196323	"Zinc finger and BTB domain containing 44"	Q8NCP5	11	130226677-130314917	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052589	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA052589: AB_2681874"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (7.60e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.34e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.78e-2)"	13.0	11.2	14.0	10.5	16.4	12.8	15.6	21.3	13.8	12.6	9.1	11.3	8.8	12.0	17.5	11.5	14.6	8.7	11.3	13.2	12.2	25.4	14.1	11.5	15.7	10.4	13.6	15.8	11.4	16.0	8.2	12.6	10.8	10.6	9.8	16.7	14.2	11.6	36.9	14.6	10.9	9.4	11.1	14.3	10.4	36.9	15.0	25.3	13.4	31.4	16.4	12.3	12.0	16.5	14.0	9.1	13.6	12.4	18.9	18.4	14.9	8.3	14.7	7.5	9.4	15.7	42.5	44.0	42.8	14.0	18.4	14.0	19.1	18.0	12.7	37.8	11.6	65.3	10.2	9.7	11.2	34.2	47.2	12.3	19.2	12.8	27.8	15.9	11.5	26.3	18.6	63.8	8.5	11.1	33.4	24.2	12.0	21.1	13.6	21.8	12.1	15.0	21.4	14.2	28.4	12.1	24.4	16.3	6.5	12.9	29.8	26.9	12.8	15.3	13.5	6.9	9.5	12.2	19.4	40.0	4.0	42.4	14.1	0.7	0.7	0.9	2.0	0.8	1.3	1.1	1.2	1.2	0.8	1.3	1.0	1.2	2.0	1.5	0.6	1.6	1.6	0.4	14.0	16.4	21.3	13.8	13.2	12.2	10.4	13.6	10.8	11.1	15.0	16.5	32.6	25.6	39.4	33.0	42.9	72.1	33.9	33.8	46.7	44.4	56.6	41.4	49.3	40.0	28.6	77.3	58.4	34.0	61.6	18.3	19.6	26.6	56.5	47.9	38.7	33.8	19.3	55.2	50.5	20.4	18.6	40.2	16.3	85.3	10.2	56.6	38.6	43.4	14.9	20.2	48.5	26.8	24.4	42.5	29.9	58.3	73.7	30.0	23.2	39.4	33.6	23.2	104.0	64.3	125.7	21.4	16.9	79.0	27.1	51.7	27.7	69.7	30.5	37.6	39.5	64.4	26.5	103.4	61.6	39.8	82.1	26.8	40.2	42.3	33.1	40.9
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035754, HPA075485"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nuclear bodies"	"HPA035754: AB_10603461, HPA075485: "	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	7.9	8.5	6.5	5.1	6.7	4.9	8.6	5.2	11.4	9.9	1.9	10.3	6.1	12.0	1.1	10.1	9.5	3.1	9.1	7.1	4.9	7.7	6.9	6.1	4.2	8.9	6.4	9.3	8.2	4.2	7.1	3.1	8.3	9.5	1.6	2.1	9.0	4.1	10.3	12.7	7.6	2.4	4.5	8.0	8.3	4.9	6.7	3.3	8.3	3.0	2.3	10.5	9.0	7.4	21.3	29.7	7.6	11.7	7.7	6.6	9.6	11.8	4.8	3.0	2.9	5.8	13.4	31.9	15.6	6.6	8.4	13.2	4.2	10.7	1.1	21.4	55.3	17.3	15.1	7.1	4.9	11.1	11.1	6.3	7.4	4.7	3.9	5.6	6.2	32.1	16.0	1.8	4.6	14.2	17.4	11.6	10.6	12.5	26.1	13.8	4.7	19.4	6.2	19.4	23.4	16.7	8.7	22.5	6.1	4.6	33.4	7.6	13.1	12.9	5.6	4.3	11.7	34.8	27.2	15.9	14.7	4.6	8.4	5.8	5.0	10.2	5.7	7.6	6.8	4.4	3.9	5.3	5.3	5.0	4.6	3.4	4.4	5.5	9.1	6.4	3.7	4.7	6.5	6.7	5.2	11.4	7.1	4.9	8.9	6.4	8.3	4.5	6.7	7.4	3.3	9.6	0.5	2.9	5.6	1.7	3.7	5.5	2.2	4.2	4.5	4.6	3.3	1.5	4.0	12.9	0.0	8.9	5.1	6.3	5.9	10.6	0.6	3.4	4.6	5.0	10.3	7.4	1.9	8.9	8.0	3.9	8.6	3.8	0.0	5.6	8.6	4.5	6.6	6.7	2.0	4.6	8.2	6.8	2.4	1.3	5.9	3.7	7.2	0.0	12.3	3.7	7.2	1.5	1.6	8.8	2.6	9.8	3.6	3.8	5.9	5.6	3.8	3.0	13.1	2.5	5.1	5.2	5.9	3.5	2.7	5.6	3.1	4.8	6.0	2.6
ZBTB46	"BTBD4, BZEL, FLJ13502, RINZF, ZNF340"	ENSG00000130584	"Zinc finger and BTB domain containing 46"	Q86UZ6	20	63743668-63832038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.6;Excitatory neurons: 26.0;Hepatic stellate cells: 28.9;Microglial cells: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013997, HPA048051"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013997: AB_1858961, HPA048051: "	"unprognostic (1.11e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.12e-1)"	8.4	5.0	5.1	2.2	4.7	1.2	7.5	13.9	5.5	8.0	4.3	2.5	1.2	7.2	4.5	2.1	7.7	2.5	10.7	4.3	5.5	9.1	4.7	5.8	3.5	4.3	3.5	12.2	3.2	2.2	10.0	4.1	3.9	4.5	0.7	4.1	2.9	2.6	3.7	2.4	3.4	1.8	3.4	16.6	2.7	3.9	5.1	1.3	9.8	3.7	1.2	3.5	3.4	3.0	1.6	0.6	6.9	1.9	0.4	0.8	3.6	0.4	2.7	0.4	0.2	1.8	4.7	0.2	7.2	0.1	1.5	1.2	0.4	0.1	0.4	0.5	1.7	0.3	1.0	3.3	1.8	0.5	1.0	0.4	0.1	0.1	0.0	0.8	0.8	0.2	2.4	0.5	1.5	4.1	0.1	9.7	1.0	1.9	2.4	1.8	2.4	2.9	0.5	1.1	7.2	1.7	0.7	3.9	0.5	3.8	4.0	5.7	0.1	4.1	2.4	1.7	0.6	1.2	3.3	0.4	0.2	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	4.7	13.9	5.5	4.3	5.5	4.3	3.5	3.9	3.4	5.1	3.0	28.6	0.0	1.1	14.4	0.8	0.4	1.3	2.0	1.2	4.7	2.6	2.0	10.8	1.5	2.8	1.8	18.8	4.3	0.6	1.0	0.0	1.6	0.6	1.5	11.2	14.5	1.2	4.0	26.0	0.6	0.9	5.1	0.0	1.6	2.5	0.1	28.9	0.3	3.0	1.7	6.9	0.0	4.1	3.8	14.6	2.3	8.1	4.2	1.8	45.0	1.7	3.9	0.0	12.1	2.0	2.3	0.1	8.6	0.5	2.6	0.2	1.3	1.7	10.1	0.0	2.2	8.0	0.7	1.9	0.3	0.4	3.7	0.5	13.4	0.2	2.0
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653697-42667580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Inhibitory neurons: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;fHDF/TERT166: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	23.2	13.7	74.4	9.3	69.3	2.7	17.9	52.6	65.3	21.5	32.9	29.3	3.9	23.0	4.5	11.5	15.2	11.4	70.3	61.0	54.0	9.4	6.2	14.0	2.7	70.5	63.8	15.3	13.4	9.9	12.3	6.2	58.2	23.5	3.3	6.5	17.4	14.5	112.5	16.4	11.2	14.8	59.9	7.2	18.7	9.1	70.8	2.0	19.4	63.1	1.8	23.7	15.9	81.2	6.7	5.9	3.6	2.4	55.5	20.7	1.2	15.1	12.7	6.5	4.7	1.3	2.7	0.1	6.4	30.9	2.5	1.6	0.9	5.9	1.2	0.0	7.2	3.7	18.9	1.6	17.5	0.1	5.3	23.5	10.4	8.5	7.1	17.0	7.3	0.0	3.9	4.8	12.9	1.7	0.2	0.5	2.1	0.2	3.5	5.0	6.7	1.9	3.4	1.3	4.0	6.7	7.3	1.2	6.0	1.5	8.3	8.6	17.3	14.1	8.2	13.9	6.4	0.2	0.0	0.0	13.1	4.8	4.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	74.4	69.3	52.6	65.3	61.0	54.0	70.5	63.8	58.2	59.9	70.8	81.2	1.8	0.0	1.1	21.9	0.0	4.0	1.5	3.6	3.4	6.4	0.8	0.9	10.5	0.0	1.8	1.8	0.0	0.1	1.6	0.1	0.0	0.7	10.0	0.5	4.5	2.1	0.0	0.0	7.8	1.3	0.2	6.4	4.6	1.2	4.5	2.9	2.2	0.7	1.4	0.0	11.8	0.3	2.0	1.9	4.1	2.5	3.4	2.0	8.8	8.4	0.8	7.7	0.0	9.0	11.5	0.6	1.2	3.0	1.9	2.0	0.0	0.6	1.1	1.9	0.0	7.8	4.4	0.0	0.2	1.3	3.1	0.1	0.4	5.9	0.0	1.1
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6579994-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.1	10.9	6.7	13.3	7.3	14.2	10.8	6.9	8.6	15.4	9.3	10.7	11.8	11.0	11.9	11.9	13.1	11.2	8.5	7.2	7.2	11.5	21.2	11.1	14.1	7.1	7.7	16.5	11.6	13.3	11.9	10.5	7.2	15.5	12.4	6.9	11.5	10.0	10.2	14.1	11.5	10.6	6.5	16.0	12.4	25.5	7.8	16.9	14.2	14.2	15.0	12.0	13.0	8.5	6.5	7.2	12.1	17.8	13.0	10.1	6.1	6.3	7.5	12.2	12.8	8.1	14.8	20.8	11.1	5.7	8.1	12.4	18.3	12.8	9.3	21.6	16.5	17.0	24.1	7.9	15.1	28.0	45.2	10.0	9.5	11.9	18.9	16.1	8.9	16.0	17.5	13.2	9.0	12.0	14.0	20.0	9.2	12.7	12.9	15.5	11.3	23.4	10.6	5.3	23.4	10.7	9.7	22.3	15.1	12.1	12.7	22.2	9.9	8.3	5.3	9.1	8.3	14.7	13.8	33.2	7.7	22.0	5.1	20.0	10.5	42.3	8.3	6.5	8.5	9.1	6.5	8.1	11.5	10.5	8.7	7.8	14.6	10.6	10.7	7.7	5.9	8.4	6.7	7.3	6.9	8.6	7.2	7.2	7.1	7.7	7.2	6.5	7.8	8.5	7.7	3.2	12.3	10.4	13.0	4.7	9.3	13.3	3.4	8.0	7.8	8.0	5.8	11.5	10.0	11.0	6.2	6.1	12.5	15.1	11.7	4.7	61.8	10.1	7.1	6.1	15.5	3.4	7.5	3.6	5.1	6.8	23.4	6.5	26.6	10.1	7.1	15.1	10.8	10.1	6.6	15.5	14.2	7.6	5.4	19.1	8.7	11.2	5.4	4.7	9.2	11.1	9.2	4.0	5.5	3.1	14.6	5.7	6.6	5.6	22.6	12.6	18.3	7.8	19.7	10.5	8.2	34.5	14.8	5.3	5.5	5.1	9.9	13.6	10.0	6.5
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	2.3	1.8	0.8	2.2	0.7	5.1	2.4	1.0	1.6	2.4	1.1	2.1	1.6	2.2	2.4	1.8	1.9	1.9	2.3	0.8	0.8	1.8	1.9	2.4	3.0	0.9	0.7	3.7	2.9	2.1	3.1	2.0	1.2	2.8	1.6	3.4	2.2	2.2	2.9	2.2	1.9	2.3	0.4	3.5	1.7	4.0	1.0	2.0	2.9	2.1	3.0	2.4	2.1	2.3	1.4	2.2	2.7	4.6	3.6	3.7	3.2	1.6	3.2	3.6	2.8	1.9	2.6	4.9	1.7	1.9	4.4	2.3	4.8	2.8	3.7	1.6	1.9	5.7	1.5	2.8	2.8	3.5	2.0	2.4	2.3	3.3	2.1	2.0	3.6	5.2	3.0	2.6	3.4	2.2	6.9	6.7	4.7	2.0	3.0	4.1	3.6	3.1	1.4	2.4	3.3	3.2	3.7	1.4	3.7	3.6	2.0	3.3	3.6	3.2	1.4	2.0	3.7	3.1	3.3	4.3	2.3	2.9	3.2	2.9	2.0	9.8	4.6	2.1	3.8	1.6	2.6	4.5	1.5	2.4	2.9	3.4	4.6	2.8	1.8	0.3	2.6	1.5	0.8	0.7	1.0	1.6	0.8	0.8	0.9	0.7	1.2	0.4	1.0	2.3	3.1	0.0	1.1	3.9	5.3	2.5	1.9	1.8	2.2	2.9	2.2	3.4	1.9	1.5	2.1	1.8	4.2	2.0	5.8	0.8	0.0	1.9	2.7	1.2	2.7	3.1	1.2	3.6	11.5	2.6	1.5	3.1	2.0	1.3	1.3	5.4	3.9	2.2	1.8	1.7	12.5	1.8	2.0	3.1	2.4	0.7	1.5	2.7	3.6	4.7	4.5	1.7	9.2	11.6	10.0	1.1	2.9	2.2	6.6	2.1	1.8	0.9	1.3	8.2	0.0	2.2	2.1	9.7	5.5	1.7	2.6	1.5	6.3	4.6	1.6	1.2
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438102-37465450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	4.9	6.2	4.9	5.6	5.8	13.6	7.4	5.9	5.0	6.3	5.0	6.1	6.3	6.3	7.7	17.8	5.9	5.4	5.5	4.7	5.0	7.4	12.9	7.9	9.0	5.7	5.3	8.4	8.4	7.6	4.7	6.2	5.5	7.2	5.8	9.2	7.8	6.7	5.2	11.9	7.2	5.3	5.0	7.2	7.2	8.8	5.2	9.5	10.3	7.2	12.1	5.6	9.3	7.8	9.3	10.5	26.6	16.6	6.7	4.7	11.4	7.5	5.8	9.0	7.4	7.8	6.7	18.8	7.9	5.6	6.6	11.1	17.5	6.2	6.9	13.9	9.1	6.9	28.7	9.1	6.5	8.6	5.8	4.5	15.5	4.5	9.5	10.2	10.2	14.8	16.6	15.6	6.8	5.9	18.2	6.3	6.8	10.0	5.3	16.3	12.8	7.2	8.7	8.2	12.2	21.9	7.3	11.7	5.8	13.3	18.7	8.3	7.0	6.3	17.3	3.7	7.2	8.3	9.8	16.3	5.8	7.3	6.8	0.1	0.4	0.0	0.6	0.2	0.7	0.9	0.5	0.5	0.8	0.7	0.8	0.9	0.0	0.3	0.0	0.2	0.5	0.3	4.9	5.8	5.9	5.0	4.7	5.0	5.7	5.3	5.5	5.0	5.2	7.8	4.0	16.0	6.5	12.7	5.1	14.3	8.8	5.0	11.4	2.0	8.4	6.6	3.2	7.2	9.3	1.8	6.2	3.9	3.7	6.5	0.0	4.0	2.2	7.3	4.2	5.6	8.4	2.1	8.9	3.2	2.2	4.2	5.1	7.3	1.3	6.6	3.6	8.6	2.4	13.5	9.1	5.2	4.1	1.9	4.8	5.3	4.1	3.4	3.6	10.3	3.7	3.3	1.0	13.6	15.5	4.1	3.7	3.8	4.2	12.6	3.1	3.5	6.0	5.1	0.0	5.4	4.0	7.5	7.9	17.9	18.2	5.7	2.7	4.4	5.1	8.2
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	4.2	4.4	3.4	7.0	3.9	3.2	6.8	5.2	5.8	5.4	2.8	5.3	5.9	6.3	4.0	4.9	5.0	4.0	5.5	3.4	3.6	4.8	4.2	4.5	9.7	3.5	3.6	7.2	4.5	6.6	2.3	4.5	3.8	4.9	4.8	7.3	4.5	4.7	6.7	5.0	5.8	4.7	4.1	6.7	5.5	5.5	3.5	7.3	7.5	7.0	9.2	5.3	2.6	5.3	5.1	5.9	9.3	8.5	9.6	9.2	9.4	8.4	10.3	8.3	7.3	6.1	6.3	8.1	5.1	7.6	7.4	22.8	9.8	10.3	10.3	11.5	7.8	8.6	11.9	5.7	9.5	11.4	14.9	7.6	15.5	7.6	12.5	10.2	7.7	10.1	9.2	9.7	12.1	9.6	11.6	7.7	11.7	15.0	9.9	6.1	25.6	11.4	8.7	8.3	11.7	15.2	13.0	12.6	8.2	9.8	15.8	7.4	7.9	9.0	7.0	9.2	9.8	17.0	21.7	2.2	10.5	7.7	9.3	10.6	1.5	2.3	1.2	1.7	1.7	1.4	1.7	1.2	1.6	1.0	2.4	2.2	2.0	2.5	2.9	0.9	2.0	1.7	3.4	3.9	5.2	5.8	3.4	3.6	3.5	3.6	3.8	4.1	3.5	5.3	5.3	6.4	3.6	3.6	6.8	2.2	3.1	2.9	3.4	8.0	4.1	2.9	3.5	7.2	6.9	1.8	10.4	2.3	7.2	3.5	0.0	2.7	9.1	4.4	7.6	4.4	3.0	2.1	4.6	2.5	1.3	5.4	4.1	3.7	7.6	5.0	6.1	3.1	2.4	6.7	5.1	3.9	4.1	7.6	4.0	4.4	3.1	4.1	1.8	3.7	4.3	8.8	2.1	6.6	6.8	2.9	2.5	7.9	3.7	4.1	2.9	4.2	5.3	10.6	6.6	5.1	5.2	6.0	5.1	4.9	2.7	1.9	5.8	5.0	3.4	3.2
ZBTB7A	"DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A"	ENSG00000178951	"Zinc finger and BTB domain containing 7A"	O95365	19	4043303-4066899	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037214, CAB037285, HPA046387"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 47: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (6.50e-6)"	"unprognostic (7.54e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.34e-6)"	"prognostic favorable (1.79e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.36e-2)"	15.2	13.2	23.0	8.7	23.1	12.8	12.9	12.0	58.3	16.6	1.7	22.5	16.3	20.0	3.3	39.1	15.4	5.8	14.0	29.4	13.7	9.8	15.0	13.7	6.6	19.8	13.7	12.0	9.5	8.9	13.4	4.9	19.0	13.5	6.4	8.1	16.2	7.3	33.7	25.9	17.5	4.8	6.8	13.3	18.9	4.4	25.0	5.7	12.7	10.4	5.6	18.9	21.2	28.1	26.5	13.5	2.1	7.5	16.5	17.2	9.3	19.2	11.0	5.0	5.2	4.9	10.7	12.4	12.4	13.7	6.9	23.1	2.7	8.9	4.3	23.4	13.2	7.1	10.2	6.3	11.7	10.1	25.2	9.5	14.5	6.9	7.1	10.6	5.7	5.5	14.4	10.2	5.7	18.3	13.1	7.6	5.5	11.8	16.9	9.8	6.3	12.4	8.0	11.7	9.8	7.4	11.6	24.8	11.5	1.8	13.9	17.9	18.0	19.2	9.3	26.6	24.4	23.6	10.6	6.9	24.7	10.3	12.3	0.7	0.9	0.3	0.7	1.1	0.5	1.1	0.3	0.5	0.2	0.6	0.3	0.6	1.5	1.2	1.0	0.7	0.3	0.2	23.0	23.1	12.0	58.3	29.4	13.7	19.8	13.7	19.0	6.8	25.0	28.1	76.3	41.7	32.8	27.4	73.1	88.5	69.7	26.5	175.2	104.7	73.5	57.4	26.6	104.4	27.7	42.3	54.2	22.6	93.7	185.8	27.4	20.9	5.5	66.4	63.8	64.5	47.9	118.0	39.0	20.2	10.7	54.1	77.5	67.6	26.6	21.6	72.8	67.9	23.6	159.9	35.5	115.6	8.2	72.9	80.7	7.7	44.1	74.3	37.4	25.3	52.1	32.7	76.2	17.6	34.2	33.1	98.0	49.2	71.6	83.6	68.0	19.9	31.0	72.8	32.9	80.0	60.2	3.8	1.8	181.1	113.9	53.8	74.9	36.5	136.3	113.0
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.2;Proximal enterocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	24.9	35.3	12.9	18.1	15.8	30.0	27.9	15.8	12.9	25.3	11.7	55.4	61.9	16.1	6.4	95.4	17.9	11.0	25.2	11.2	13.6	19.7	48.4	25.0	16.2	18.3	17.5	12.7	29.9	15.6	20.0	9.0	17.3	30.5	18.6	6.5	40.2	12.8	40.6	111.9	71.2	9.9	15.8	31.6	37.7	6.1	17.7	9.0	25.5	17.6	15.2	20.4	44.4	17.9	16.5	29.0	2.5	8.8	12.7	7.2	34.7	11.1	13.1	11.4	13.2	19.5	23.4	7.2	19.5	12.6	9.1	24.5	8.1	15.7	2.4	39.4	9.1	12.0	51.4	13.1	18.6	9.2	31.7	9.4	54.8	15.6	19.3	15.3	9.1	1.1	17.3	32.2	6.7	31.2	0.2	20.7	8.7	26.4	23.8	6.8	1.9	45.6	17.2	16.9	16.1	16.5	21.4	56.5	8.9	10.6	35.2	30.7	7.7	7.4	12.9	14.8	9.5	38.1	25.1	7.6	17.3	30.3	8.6	0.4	1.5	1.3	0.6	1.4	0.2	0.6	0.7	0.3	0.9	0.7	0.6	0.2	2.3	0.7	1.2	0.0	1.0	2.5	12.9	15.8	15.8	12.9	11.2	13.6	18.3	17.5	17.3	15.8	17.7	17.9	6.5	9.6	0.0	11.1	8.5	35.2	9.3	8.8	29.6	13.6	35.2	15.6	2.6	18.6	7.1	5.5	2.1	11.9	6.9	135.2	11.7	13.3	4.3	15.4	6.7	5.6	6.7	6.1	1.0	15.1	14.6	4.9	27.5	21.3	5.7	2.8	6.1	29.9	14.8	16.8	1.1	32.7	14.2	28.7	40.3	8.3	9.0	20.7	16.0	4.7	25.8	5.4	11.3	0.0	8.6	16.8	57.7	7.2	6.8	24.9	158.5	10.0	4.2	10.3	0.0	3.2	5.7	0.5	1.2	51.7	53.6	27.5	11.3	4.4	38.5	24.4
ZBTB8A	"BOZF1, FLJ90065, ZBTB8, ZNF916A"	ENSG00000160062	"Zinc finger and BTB domain containing 8A"	Q96BR9	1	32539427-32605941	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031768, HPA031769, HPA031770"	Approved		Approved	"Nuclear speckles,Focal adhesion sites"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nuclear speckles, Focal adhesion sites"		"HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.45e-5)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.15e-2)"	3.8	2.2	1.5	1.6	1.6	1.2	3.4	3.5	1.6	6.2	1.1	2.9	1.8	6.1	3.2	3.4	3.3	2.7	2.4	1.3	0.9	2.4	2.0	2.8	0.9	1.5	1.2	3.4	2.6	3.6	1.8	2.7	1.5	3.0	3.0	1.5	2.5	4.0	2.8	1.8	2.0	5.1	0.8	1.3	3.1	2.4	1.2	1.3	5.5	6.1	1.5	3.7	3.0	2.5	6.4	1.8	7.2	7.8	5.0	6.7	5.4	6.2	4.9	5.7	5.8	0.8	5.0	5.3	4.2	6.7	2.5	4.9	7.2	5.0	5.0	1.4	4.8	0.2	5.7	2.7	6.5	1.2	0.3	4.5	7.0	4.2	11.0	5.7	6.5	4.5	1.0	3.6	5.8	6.5	3.5	0.6	6.5	3.1	2.5	6.3	10.4	4.1	3.5	6.4	6.0	5.5	8.8	4.3	8.4	3.8	5.7	2.9	6.8	7.6	6.2	10.5	4.6	6.5	3.3	3.9	5.2	1.3	3.2	1.5	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.2	0.3	0.1	0.2	1.0	0.7	0.2	0.5	0.1	0.1	1.5	1.6	3.5	1.6	1.3	0.9	1.5	1.2	1.5	0.8	1.2	2.5	17.0	16.0	13.8	5.9	1.4	4.1	7.8	8.0	5.2	11.7	7.4	5.8	4.1	4.3	5.8	7.3	22.9	3.5	3.8	6.5	1.9	6.9	5.9	7.5	30.0	20.1	4.9	6.1	9.4	5.1	6.7	14.5	9.7	11.8	2.5	11.2	30.4	5.2	1.6	6.7	7.8	5.4	2.0	4.1	7.4	7.2	19.9	2.3	3.6	15.9	1.8	4.0	0.0	21.6	20.6	6.0	4.7	35.3	3.2	10.7	3.3	3.0	3.6	10.8	32.9	23.3	12.9	2.0	6.4	3.8	3.8	1.5	2.3	4.1	8.8	6.4
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	1.9	0.0	0.0	0.0	0.1	1.2	1.9	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.9	1.2	1.9	1.1	0.4	1.8	0.8	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZBTB8OS	ARCH	ENSG00000176261	"Zinc finger and BTB domain containing 8 opposite strand"	Q8IWT0	1	32600172-32650903	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046315	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA046315: AB_2679623"	"unprognostic (3.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (5.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.11e-8)"	"unprognostic (1.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.42e-1)"	21.5	25.5	21.1	28.7	21.0	21.5	20.6	23.7	34.4	17.1	20.4	33.8	32.2	16.3	35.6	27.2	18.3	14.7	32.4	20.9	22.5	28.2	34.5	20.3	36.9	20.9	20.8	12.4	27.4	21.5	27.7	14.9	21.1	21.6	33.3	27.6	22.8	15.9	43.6	17.0	29.1	20.2	20.3	27.1	28.5	16.5	21.9	16.9	18.3	35.5	43.8	21.4	18.2	22.2	56.1	31.8	27.9	47.2	47.7	43.3	38.1	62.1	62.3	48.5	49.0	75.5	60.9	62.0	55.9	45.6	53.5	41.1	48.7	48.5	64.4	83.2	44.8	50.5	67.4	127.0	39.2	73.2	44.9	43.4	52.3	42.7	51.2	30.3	53.6	74.6	50.8	81.6	62.9	44.3	56.2	42.4	86.1	86.5	48.7	44.9	59.8	60.7	58.7	65.7	55.9	43.0	50.1	49.9	83.3	74.8	34.2	59.8	38.4	67.2	40.8	55.0	78.9	123.1	130.8	177.0	48.1	89.6	68.1	37.5	57.7	71.5	46.3	71.0	44.8	73.0	50.5	56.0	41.6	54.0	41.9	45.1	66.3	48.0	78.0	53.6	86.1	37.8	21.1	21.0	23.7	34.4	20.9	22.5	20.9	20.8	21.1	20.3	21.9	22.2	39.4	22.4	53.7	32.0	56.3	17.2	31.2	69.5	18.2	46.9	28.5	34.7	69.3	30.0	53.3	38.6	43.8	49.3	54.5	68.8	90.1	60.5	38.1	42.5	38.1	34.4	37.7	46.1	58.3	52.7	61.8	35.9	35.2	45.3	44.2	24.0	33.2	82.5	72.3	16.8	60.5	53.2	71.2	61.9	19.8	30.5	36.7	47.4	51.6	21.5	82.2	35.7	75.2	35.7	46.8	68.4	71.6	46.3	79.9	32.8	115.9	139.4	42.0	56.5	32.9	27.3	51.7	52.9	30.0	28.1	15.6	65.1	50.3	31.2	49.7	37.8
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZC2HC1A	"C8orf70, CGI-62, FAM164A"	ENSG00000104427	"Zinc finger C2HC-type containing 1A"	Q96GY0	8	78666089-78719765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 44.6"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.1;T-reg: 33.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 42.1;SK-BR-3: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024726	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Actin filaments"	"HPA024726: AB_1846597"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.19e-7)"	"unprognostic (2.96e-1)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.05e-3)"	6.5	5.5	8.4	5.7	9.5	1.6	13.8	11.0	9.9	10.7	1.7	6.2	2.7	19.5	8.4	11.1	19.0	9.7	8.2	9.4	8.4	7.7	2.3	12.6	5.3	9.3	6.9	22.7	3.7	24.0	8.5	6.6	10.1	12.2	7.3	10.9	7.3	9.9	2.4	44.6	4.2	12.1	6.3	5.8	5.5	8.8	7.6	5.1	19.7	6.3	8.4	9.0	8.8	10.9	5.2	6.3	11.6	9.5	24.1	25.2	5.0	14.1	9.4	6.9	8.8	1.7	9.0	8.6	5.8	14.2	14.5	4.2	7.0	7.8	10.1	28.6	4.5	1.0	5.5	5.2	14.3	1.5	2.8	18.2	13.0	5.6	16.8	21.1	9.6	2.9	1.6	42.1	14.6	5.1	1.7	2.5	2.9	0.4	9.9	0.0	14.8	1.8	10.4	11.0	4.5	18.0	11.0	79.2	15.8	10.7	2.0	0.3	7.9	21.4	8.9	9.9	7.1	10.5	11.4	5.8	10.1	0.1	8.3	45.1	6.7	0.2	0.1	7.5	0.0	8.8	6.7	0.4	6.0	6.3	2.0	0.7	0.3	1.2	15.9	0.5	33.3	2.7	8.4	9.5	11.0	9.9	9.4	8.4	9.3	6.9	10.1	6.3	7.6	10.9	21.7	67.3	23.7	71.8	17.0	29.2	38.7	39.9	52.3	26.3	12.3	47.5	15.9	5.7	27.4	18.4	4.2	29.0	1.0	1.8	27.4	18.1	16.3	55.5	38.0	17.5	9.0	1.7	96.4	8.2	29.9	34.5	13.3	25.8	6.3	18.8	21.8	0.8	15.9	47.1	68.3	4.2	16.2	6.0	11.3	5.9	19.3	11.1	16.0	14.0	18.5	39.2	0.0	65.9	52.4	9.4	2.4	36.9	12.5	13.1	0.1	11.8	105.5	25.5	6.6	32.0	33.9	48.6	32.2	26.0	42.3	17.4	6.5	9.4	4.4	14.6
ZC2HC1C	"C14orf140, FAM164C"	ENSG00000119703	"Zinc finger C2HC-type containing 1C"	Q53FD0	14	75064109-75119502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.9;testis: 55.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA050928, HPA065062"	Enhanced		Approved	"Nuclear speckles,Mitochondria"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Mitochondria	"HPA050928: AB_2681277, HPA065062: AB_2732728"	"unprognostic (8.01e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (4.63e-13)"	"unprognostic (4.69e-3)"	"unprognostic (7.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.81e-1)"	1.1	2.5	2.5	0.6	2.7	0.4	1.7	2.8	2.9	1.8	5.1	2.7	3.1	1.3	23.9	1.3	11.0	1.6	5.2	2.4	2.9	5.5	8.4	2.5	0.2	3.1	3.7	0.6	5.1	6.9	6.1	0.8	2.9	1.3	2.4	2.6	2.9	3.4	4.7	1.6	2.4	1.0	2.8	0.8	1.6	55.3	2.9	2.3	7.0	1.5	0.5	1.4	0.6	3.3	3.8	2.8	0.3	3.3	0.2	0.0	1.8	0.3	1.1	1.4	0.8	4.8	6.9	3.3	2.6	0.4	2.6	1.0	0.0	0.0	1.2	3.9	0.3	0.6	1.0	2.3	2.5	0.0	1.8	0.3	0.4	1.6	0.0	1.7	1.1	0.2	5.8	1.0	0.7	0.6	0.4	0.3	0.7	2.4	1.8	0.0	0.2	0.7	4.3	0.3	5.7	1.3	2.4	2.0	1.5	0.6	2.9	0.9	0.7	0.9	0.9	1.0	0.8	4.0	4.9	1.1	1.4	0.4	0.6	0.3	0.0	0.2	0.6	0.0	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.2	0.1	0.2	0.9	0.1	2.5	2.7	2.8	2.9	2.4	2.9	3.1	3.7	2.9	2.8	2.9	3.3	0.8	6.4	9.7	2.0	0.9	1.8	1.9	1.3	4.6	4.5	7.9	5.1	7.0	2.8	6.6	11.0	10.4	2.3	1.6	2.5	3.9	4.6	165.2	21.0	2.1	2.0	5.3	0.4	2.4	1.4	1.1	2.5	1.1	1.9	1.3	1.1	2.9	4.7	1.7	11.8	2.1	2.3	0.0	1.0	0.7	195.1	3.1	1.0	3.6	1.0	0.9	3.0	8.2	0.5	1.0	1.6	0.6	2.6	0.6	2.8	4.2	7.4	32.5	8.5	6.6	5.2	2.0	198.5	5.5	1.9	0.9	5.1	0.9	2.3	3.9	1.3
ZC3H10	"FLJ14451, ZC3HDC10"	ENSG00000135482	"Zinc finger CCCH-type containing 10"	Q96K80	12	56118260-56127514	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039236, HPA062265"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA039236: AB_10795463, HPA062265: AB_2684730"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.31e-5)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-1)"	2.8	3.1	1.9	3.0	2.8	1.4	2.5	3.4	2.4	3.8	1.1	3.6	1.6	3.9	2.2	1.9	3.3	1.7	2.5	1.9	2.1	2.3	2.9	2.4	2.9	2.9	2.5	4.1	3.6	2.5	2.4	2.0	2.7	2.6	1.3	4.0	2.8	2.4	5.0	2.4	2.3	2.0	2.1	3.9	2.4	8.7	2.7	2.9	2.6	3.1	2.2	3.3	2.6	4.0	3.3	5.8	4.6	3.6	5.5	3.7	3.5	3.9	2.6	2.3	1.8	1.6	1.9	3.7	6.3	2.8	1.3	4.4	2.4	1.4	1.5	6.3	6.1	5.5	5.8	1.7	3.4	5.4	3.3	2.4	3.1	2.7	3.1	4.3	3.5	4.2	2.9	6.5	3.1	2.4	5.6	2.1	3.1	1.9	4.7	5.5	5.0	3.4	1.9	1.6	4.4	4.3	2.3	3.4	3.5	3.4	5.6	4.5	5.0	2.2	5.1	4.3	2.9	5.4	3.7	2.0	2.9	2.4	5.4	3.6	5.0	5.9	4.7	6.0	4.9	3.6	3.7	4.1	5.3	3.9	3.7	3.6	3.6	8.0	10.5	2.4	2.0	3.7	1.9	2.8	3.4	2.4	1.9	2.1	2.9	2.5	2.7	2.1	2.7	4.0	4.2	0.0	4.2	1.3	5.6	0.8	2.5	1.3	1.8	9.0	3.2	2.2	3.0	5.7	0.8	7.3	20.9	6.3	5.9	7.1	15.6	5.3	47.6	2.2	4.3	5.1	1.2	5.2	0.6	3.0	2.7	3.3	1.1	2.6	2.5	5.9	6.8	3.0	5.3	13.5	0.9	3.8	2.0	7.4	1.6	9.5	5.3	4.0	3.6	1.0	10.6	9.2	9.2	0.0	1.5	3.3	2.3	5.3	1.6	2.3	6.0	4.7	2.7	17.3	0.0	6.2	5.3	16.2	15.5	1.9	1.7	6.4	3.2	5.1	3.9	1.4
ZC3H11A	"KIAA0663, ZC3HDC11A"	ENSG00000058673	"Zinc finger CCCH-type containing 11A"	O75152	1	203795623-203854999	"Predicted intracellular proteins"	"mRNA transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (8.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.41e-1)"	14.9	15.6	8.3	20.9	12.3	28.8	15.5	11.5	11.7	14.2	13.1	14.7	20.4	18.7	12.8	16.8	16.1	15.2	13.9	8.2	9.6	16.6	16.2	14.5	26.2	9.4	8.9	18.9	15.5	19.8	5.6	17.4	10.0	16.2	17.7	20.2	19.4	13.2	23.4	26.2	22.5	16.6	5.6	23.1	20.4	22.9	9.7	33.4	22.6	23.1	25.5	16.1	6.5	15.5	29.7	23.8	45.2	28.8	28.7	22.9	49.7	33.6	24.0	27.0	30.2	32.7	36.2	37.6	19.9	35.7	22.0	41.0	35.8	19.7	37.2	56.6	25.8	36.3	39.3	16.5	15.4	50.9	62.3	19.1	23.5	29.0	28.2	34.2	25.5	40.4	74.0	51.6	24.0	24.2	56.2	20.3	42.6	20.8	19.4	40.1	52.1	24.7	19.1	50.0	33.1	31.4	33.8	27.5	29.8	51.7	29.5	38.1	39.2	39.2	34.7	33.1	32.3	36.8	37.3	58.5	25.2	29.1	30.7	15.6	3.6	5.5	5.2	3.5	7.2	5.0	4.7	4.8	4.2	3.5	5.9	4.4	7.9	5.1	5.8	2.3	5.0	4.2	8.3	12.3	11.5	11.7	8.2	9.6	9.4	8.9	10.0	5.6	9.7	15.5	2.4	12.8	22.5	105.8	49.2	101.5	61.7	50.6	112.7	46.2	1.1	0.9	54.2	58.6	38.4	0.0	45.9	31.1	18.2	43.6	0.0	0.3	54.7	3.1	2.9	49.9	46.7	67.1	71.9	0.2	27.3	51.5	53.0	3.9	25.3	0.9	54.7	70.0	32.5	84.1	69.0	64.2	28.5	54.6	60.8	14.3	60.3	37.2	48.0	82.4	31.7	40.5	41.2	103.0	169.4	0.6	42.2	67.4	64.1	104.0	52.1	0.3	43.9	49.8	78.9	83.3	42.1	63.6	40.2	84.5	111.5	51.0	41.4	0.5	52.1	114.2
ZC3H11B	ZC3HDC11B	ENSG00000215817	"Zinc finger CCCH-type containing 11B"	A0A1B0GTU1	1	219608010-219613145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.3;Cardiomyocytes: 1.5;Collecting duct cells: 1.8;monocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA026439, HPA028490, HPA028526"	Uncertain		Approved	"Nuclear speckles"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (1.75e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.87e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.4	0.2	0.1	0.0	0.2	0.2	5.1	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.5	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.6	0.8	0.3	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0
ZC3H12A	"FLJ23231, MCPIP1, Regnase-1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474580-37484377	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;RT4: 61.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	28.9	28.0	2.4	17.3	2.3	136.3	15.1	3.6	4.1	9.1	2.7	16.3	14.1	6.6	4.6	45.4	14.3	36.0	12.1	2.5	3.8	15.7	23.3	40.0	13.6	4.1	3.7	6.0	12.4	2.5	9.2	3.7	4.1	29.5	7.9	0.3	22.9	5.2	10.8	51.5	20.1	5.7	3.0	15.5	23.5	5.2	3.7	5.7	6.5	3.2	15.5	39.0	21.4	2.8	7.8	5.5	0.6	3.5	2.7	4.0	6.2	5.5	48.8	3.5	4.5	6.1	17.2	8.7	22.8	5.3	37.8	16.8	2.2	35.4	2.0	17.8	3.2	2.3	20.9	9.7	3.9	4.6	3.5	8.6	17.8	30.0	5.3	7.9	3.9	4.4	4.3	14.1	3.1	9.4	3.5	8.3	4.2	10.4	4.8	5.2	2.2	5.1	8.8	61.2	1.6	1.1	11.0	17.4	1.3	5.3	6.0	5.1	4.1	10.3	5.7	7.7	8.5	11.2	4.5	6.6	23.5	9.7	2.0	1.2	1.4	4.0	3.1	1.4	3.3	3.1	1.3	1.9	1.7	3.9	0.7	1.5	5.6	3.5	1.2	1.5	2.0	1.7	2.4	2.3	3.6	4.1	2.5	3.8	4.1	3.7	4.1	3.0	3.7	2.8	19.1	16.0	36.2	1.6	56.9	195.9	149.8	300.7	242.4	0.4	93.6	69.8	4.2	61.5	117.6	11.0	0.0	3.7	78.1	71.5	0.0	79.5	16.9	67.6	20.8	32.2	63.9	0.4	0.1	73.9	10.0	41.0	66.3	102.2	42.6	5.0	5.3	11.4	9.7	0.0	0.1	77.3	69.2	10.5	232.8	2.7	0.9	71.2	48.0	1.0	14.0	0.9	9.2	0.5	0.9	55.4	73.2	1.2	52.1	127.9	59.5	0.6	58.4	4.5	6.6	52.7	36.1	1.6	1.3	217.6	225.2	11.8	76.6	9.5	62.2	81.9
ZC3H12B	"CXorf32, MCPIP2"	ENSG00000102053	"Zinc finger CCCH-type containing 12B"	Q5HYM0	X	65366638-65507887	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	30	"Astrocytes: 90.4;Excitatory neurons: 232.1;Inhibitory neurons: 219.8;Microglial cells: 128.4;Oligodendrocyte precursor cells: 253.8;Oligodendrocytes: 258.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000836	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"	"Golgi apparatus, Vesicles"	"HPA000836: AB_2217374"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.44e-3)"	"unprognostic (7.86e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.71e-2)"	0.6	0.5	2.4	0.4	2.7	0.2	0.5	2.1	2.7	1.3	0.8	1.3	0.6	1.3	0.5	0.3	1.3	0.6	0.6	2.7	1.6	0.7	0.5	0.5	0.5	1.1	1.4	1.7	0.4	1.6	2.2	0.0	0.9	1.1	0.6	1.9	0.6	1.1	0.2	0.3	0.9	0.9	1.3	0.4	0.8	0.2	2.1	0.9	1.0	0.3	0.3	1.0	0.9	2.3	0.1	0.2	2.1	0.3	0.0	0.0	0.2	0.5	1.1	0.0	0.3	0.2	0.2	0.3	0.1	0.6	0.0	0.3	0.5	0.0	0.0	0.3	1.5	0.7	1.2	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.4	0.0	1.7	0.4	1.7	0.0	0.0	0.9	0.2	0.8	1.2	0.4	1.0	0.1	0.4	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.4	0.7	0.2	0.3	0.4	0.7	1.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.4	2.7	2.1	2.7	2.7	1.6	1.1	1.4	0.9	1.3	2.1	2.3	0.2	6.4	0.5	90.4	1.3	0.0	0.5	0.0	1.2	2.7	0.1	0.6	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.7	0.0	0.2	0.2	0.7	1.3	0.5	4.2	0.0	232.1	0.2	0.2	1.4	0.0	0.1	0.0	0.6	0.7	0.7	0.1	1.7	219.8	1.3	0.0	0.0	0.3	0.2	2.5	0.0	0.0	128.4	0.1	1.0	0.0	253.8	258.0	0.2	0.6	4.1	0.3	0.3	1.0	0.4	0.0	1.5	0.0	2.1	1.1	0.0	0.1	0.1	0.4	0.0	0.4	0.5	1.0	0.1
ZC3H12C	"KIAA1726, MCPIP3"	ENSG00000149289	"Zinc finger CCCH-type containing 12C"	Q9C0D7	11	110093392-110171841	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038836, HPA038837"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane, Golgi apparatus"		"HPA038836: AB_2676229, HPA038837: AB_10675953"	"unprognostic (1.22e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (9.90e-6)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.11e-1)"	4.6	4.2	4.0	2.4	6.7	3.2	2.5	6.5	3.9	4.0	2.7	4.6	1.7	3.7	1.7	3.2	3.2	4.7	4.4	4.2	4.9	3.4	4.0	4.0	1.5	6.8	5.6	6.7	3.5	4.7	3.2	2.6	5.5	3.5	3.7	4.1	2.3	3.3	10.5	5.9	2.6	4.4	4.1	1.8	2.4	3.4	5.4	1.5	8.1	13.2	1.4	5.4	2.1	6.5	6.1	3.6	14.0	0.0	6.4	14.8	2.7	2.3	15.7	4.1	6.8	4.6	5.6	0.1	8.7	7.1	10.3	5.8	2.8	8.5	8.1	23.2	2.0	9.7	4.5	1.7	7.2	0.0	4.4	23.8	8.0	7.2	11.7	8.1	5.8	0.0	0.9	1.3	8.6	0.9	0.0	0.0	2.2	0.1	12.7	0.0	4.9	0.6	4.6	12.4	6.4	11.5	5.6	0.4	10.5	2.7	3.5	3.6	9.8	9.1	4.4	4.8	5.2	0.5	0.0	0.0	5.5	1.7	10.8	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	6.7	6.5	3.9	4.2	4.9	6.8	5.6	5.5	4.1	5.4	6.5	21.1	35.3	8.6	102.2	1.1	47.4	4.8	19.1	7.4	8.8	3.5	5.0	15.5	2.8	9.1	5.5	4.2	1.5	0.2	17.0	0.0	6.1	10.6	8.6	6.7	14.9	8.9	2.1	23.8	3.5	0.5	8.9	5.6	14.1	0.0	5.2	13.6	6.4	10.9	15.2	50.0	8.1	0.0	5.7	39.3	11.8	9.6	9.9	23.2	26.2	3.9	5.6	0.0	52.3	56.1	3.4	15.2	8.2	0.6	21.0	5.7	6.6	8.9	2.7	0.0	9.1	5.7	4.6	0.8	3.2	66.5	0.8	1.1	5.6	8.0	7.8
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485014	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	0.7	0.4	1.0	7.2	0.5	3.6	0.4	0.4	0.9	0.3	0.3	1.5	2.8	0.2	0.2	0.3	0.3	0.6	0.3	0.8	0.9	0.6	0.3	0.8	9.8	1.0	0.5	0.3	0.1	0.0	0.2	0.3	0.8	0.3	1.4	0.5	0.7	0.3	0.4	1.1	4.7	0.5	0.4	5.8	0.8	0.3	0.9	1.1	0.5	0.0	12.6	1.0	0.2	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	8.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	34.3	0.2	0.3	1.2	2.7	0.0	2.8	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	2.5	0.0	0.0	0.0	7.1	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	4.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.9	0.4	2.5	0.1	0.7	0.8	0.1	0.1	0.5	0.2	1.4	1.5	0.7	0.8	1.3	0.9	0.2	0.5	0.3	1.4	0.4	3.5	0.8	1.0	0.5	0.4	0.9	0.8	0.9	1.0	0.5	0.8	0.4	0.9	0.9	1.0	3.2	3.9	1.3	14.6	0.4	0.5	0.0	0.0	0.7	0.3	0.3	1.4	1.5	0.6	0.0	4.2	0.0	3.7	7.7	1.9	0.0	0.4	0.4	0.4	1.3	0.0	0.4	1.2	0.4	0.0	0.7	0.5	0.6	0.0	0.2	1.4	0.3	3.7	0.0	0.7	1.1	0.0	12.4	4.4	0.5	0.0	7.4	1.8	1.0	1.6	0.8	0.0	0.0	0.7	0.3	0.8	0.0	4.6	0.4	7.5	1.6	0.0	1.1	0.0	0.9	0.4	0.2	0.4	0.1	1.4	0.0	17.4	0.0	2.6	0.4
ZC3H13	"DKFZp434D1812, KIAA0853, Xio"	ENSG00000123200	"Zinc finger CCCH-type containing 13"	Q5T200	13	45954465-46052759	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 166.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039340, HPA040140, HPA047806"	Uncertain		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane, Actin filaments"		"HPA039340: AB_2676454, HPA040140: AB_2676858, HPA047806: AB_2680161"	"unprognostic (1.50e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.21e-3)"	15.4	10.1	21.9	13.4	26.9	15.0	15.9	16.9	22.0	14.8	6.7	15.0	9.3	18.5	15.3	10.7	12.0	11.4	11.7	17.4	24.9	12.7	58.6	12.6	15.9	18.4	24.2	17.7	9.4	17.7	9.1	15.5	20.4	15.6	12.3	15.7	12.5	14.3	16.0	13.8	11.7	14.6	17.9	16.4	12.0	11.4	25.2	22.5	17.5	15.8	13.1	12.9	11.0	27.3	16.6	20.9	51.1	19.9	36.0	36.6	21.4	29.9	24.5	24.1	15.9	32.3	28.9	46.4	18.8	31.9	16.6	29.0	32.1	25.0	38.4	41.4	32.5	53.3	21.0	28.2	21.2	68.5	28.3	28.2	20.4	25.5	30.0	22.9	26.6	26.5	29.1	13.8	25.6	21.6	34.8	34.7	46.2	31.7	13.4	34.9	33.1	14.2	19.9	25.4	13.4	30.4	29.6	19.0	166.2	33.6	14.7	32.0	44.7	21.5	19.3	19.6	26.3	13.8	17.2	45.5	24.5	35.9	27.8	15.3	4.6	10.5	7.4	5.7	7.4	5.4	5.2	5.8	4.6	5.1	5.1	4.6	7.7	8.8	6.9	7.9	6.3	3.9	21.9	26.9	16.9	22.0	17.4	24.9	18.4	24.2	20.4	17.9	25.2	27.3	79.1	214.7	186.1	37.5	70.9	40.7	65.6	44.2	34.7	84.6	47.3	63.5	164.0	90.1	89.0	55.2	43.8	88.3	75.8	43.6	27.4	64.5	4.2	67.0	114.7	82.7	55.6	117.6	69.4	48.6	78.6	76.2	29.6	79.8	129.3	64.1	75.7	269.2	63.5	85.8	71.2	42.4	40.7	82.5	31.4	11.8	76.7	66.0	28.4	48.7	90.2	87.1	112.3	55.3	149.5	54.7	38.7	81.6	44.0	60.9	34.4	19.5	83.9	69.2	52.6	120.2	99.4	183.6	106.0	37.7	50.6	80.3	80.8	66.9	49.7	54.5
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562970-88627596	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 173.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1282.6;Late spermatids: 460.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"	"Nucleoli, Nucleoli rim"	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	20.9	21.0	9.5	16.3	10.7	23.6	22.5	26.9	14.9	23.7	38.3	26.9	19.7	25.7	25.1	20.2	27.7	18.7	24.7	10.8	8.1	24.3	43.3	24.2	18.2	5.5	5.1	26.1	37.4	33.2	24.3	23.0	6.8	23.6	31.2	41.1	31.4	23.6	30.2	21.4	21.2	28.2	4.4	15.7	21.6	173.6	9.0	20.0	32.2	25.1	23.6	22.1	19.5	13.1	39.5	75.4	64.7	54.8	50.8	48.6	68.3	58.6	54.2	85.2	74.7	55.3	63.2	55.1	41.9	61.4	46.3	44.4	46.8	55.7	115.9	43.4	34.7	26.7	51.6	42.5	51.2	57.3	34.3	39.2	65.2	68.2	66.9	53.3	56.7	47.2	54.2	21.0	75.8	86.3	52.8	28.1	39.9	60.8	64.1	46.1	83.9	23.1	54.3	68.2	45.6	37.0	75.2	75.4	37.3	54.3	75.3	36.3	39.2	101.3	65.1	43.1	59.2	29.3	30.0	61.7	49.0	27.1	48.0	19.1	20.7	29.4	18.9	25.3	20.4	16.8	18.0	20.8	22.1	15.4	17.2	16.9	3.8	25.9	29.6	12.5	17.2	17.4	9.5	10.7	26.9	14.9	10.8	8.1	5.5	5.1	6.8	4.4	9.0	13.1	25.2	121.8	57.0	38.2	18.1	22.7	24.5	25.2	21.1	61.2	27.0	24.9	22.6	28.6	37.6	20.2	77.2	49.2	25.4	28.4	35.2	25.6	1282.6	53.0	46.6	28.7	31.8	17.1	88.8	23.0	27.4	30.5	20.9	34.3	45.6	51.8	24.3	38.1	20.3	65.6	65.5	31.4	34.6	14.9	16.3	460.1	39.4	19.6	5.4	34.7	20.0	33.6	18.6	64.3	62.9	22.0	16.4	47.4	18.6	26.0	27.4	32.4	53.0	78.9	13.1	46.6	35.4	217.9	81.5	23.0	19.7	40.6	20.1	39.2	32.8	16.3
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486253-186509361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	42.6	47.5	39.2	44.3	42.0	128.8	45.9	43.4	52.5	35.1	38.6	40.8	48.3	39.8	47.0	40.2	26.3	36.5	37.0	42.6	44.5	53.8	67.3	28.4	53.9	42.2	40.9	32.6	47.9	41.2	27.2	48.8	41.7	37.0	46.0	53.0	45.3	32.4	50.3	44.3	46.1	36.9	39.4	38.6	36.8	40.6	41.7	50.2	49.3	44.9	51.4	54.0	29.2	42.4	103.5	68.9	83.3	107.8	93.0	93.4	124.9	112.7	76.7	102.3	91.5	202.9	81.8	140.3	100.2	80.9	130.9	73.6	155.8	137.5	144.0	128.7	118.1	201.9	101.1	221.9	124.9	208.7	118.6	77.2	149.6	111.4	157.2	89.9	111.9	86.0	197.0	106.8	108.4	93.5	133.7	146.5	157.6	135.7	171.8	105.2	113.0	131.6	127.6	124.0	100.3	73.6	71.5	96.4	167.3	124.3	68.1	149.7	95.7	114.7	99.1	70.9	136.4	92.0	167.0	199.8	101.7	145.7	102.3	59.9	47.9	49.1	44.7	61.6	55.8	55.0	54.8	57.4	54.7	42.2	50.5	53.9	28.8	60.4	75.1	48.0	66.6	41.5	39.2	42.0	43.4	52.5	42.6	44.5	42.2	40.9	41.7	39.4	41.7	42.4	107.1	73.7	83.6	26.4	137.0	212.2	169.1	116.6	99.6	75.0	101.9	118.9	95.8	57.2	104.8	115.8	60.5	131.3	116.1	131.4	256.3	112.0	153.1	110.1	125.5	106.4	101.7	98.7	38.0	104.3	167.0	107.4	67.8	127.1	112.2	220.1	62.4	137.0	124.3	57.2	39.8	136.1	87.5	107.4	104.8	307.1	78.6	113.2	64.0	33.7	142.5	82.6	126.7	19.6	32.8	111.6	106.2	87.3	128.0	179.5	164.1	330.2	68.3	130.2	32.9	156.2	127.6	215.6	174.4	116.1	209.1	177.6	117.3	319.6	151.2	163.5
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570403-88631964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	14.1	11.0	10.7	18.7	11.3	25.5	13.6	14.4	14.2	14.3	5.7	16.1	14.9	17.4	4.3	14.5	14.2	8.8	14.3	10.6	11.4	10.9	12.0	13.1	18.4	10.1	9.6	14.1	13.7	12.3	10.1	11.9	9.2	11.5	8.1	9.0	13.6	8.2	22.8	15.3	15.6	10.1	7.5	17.4	14.5	25.3	10.2	19.1	13.1	10.1	12.3	15.3	13.7	12.1	45.3	59.6	42.6	42.8	20.7	17.7	68.3	44.5	24.1	40.8	18.5	58.8	38.3	55.1	36.9	21.1	27.3	53.0	40.3	33.7	25.6	32.5	51.2	36.6	29.2	50.6	26.2	28.5	30.7	16.1	25.2	43.3	20.8	16.9	25.5	37.8	101.4	17.8	20.4	87.4	91.6	50.5	66.7	35.3	35.5	111.0	29.3	40.4	18.5	28.3	44.9	38.7	85.2	23.5	25.2	24.8	53.3	38.1	35.1	43.6	45.2	32.0	45.5	39.5	67.2	130.8	38.6	65.7	47.0	2.3	2.0	2.0	2.5	2.3	2.8	2.3	2.4	2.7	1.9	1.9	2.1	1.7	3.4	3.1	5.4	2.8	3.3	2.1	10.7	11.3	14.4	14.2	10.6	11.4	10.1	9.6	9.2	7.5	10.2	12.1	24.9	28.9	24.2	11.1	29.6	16.8	17.0	11.1	13.1	26.6	13.8	14.4	10.2	20.0	23.9	16.5	35.5	24.1	45.6	30.1	7.9	16.5	76.2	21.9	28.7	21.3	25.0	28.6	12.0	16.6	22.1	18.7	22.4	32.1	20.8	26.6	16.4	12.9	18.2	28.6	11.9	18.5	10.2	20.1	21.1	10.0	21.8	30.5	14.2	12.2	23.9	18.1	46.4	7.1	15.7	17.5	21.7	17.0	35.5	20.5	20.3	8.4	13.1	44.0	6.6	28.8	19.5	41.4	37.5	19.6	22.3	25.2	39.2	25.1	24.7	16.6
ZC3H3	"KIAA0150, ZC3HDC3"	ENSG00000014164	"Zinc finger CCCH-type containing 3"	Q8IXZ2	8	143437659-143541447	"Predicted intracellular proteins"	"mRNA transport, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023658, HPA050577"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA023658: AB_1858973, HPA050577: "	"unprognostic (1.15e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (4.38e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.18e-1)"	16.4	12.7	6.0	5.6	6.1	17.2	14.4	6.3	9.4	11.8	2.7	13.4	11.7	12.3	1.0	14.6	11.3	2.2	11.4	6.6	3.6	25.0	45.9	14.5	5.0	6.3	4.7	12.0	10.5	2.9	8.2	3.6	6.4	12.1	1.5	1.9	11.0	3.5	21.1	16.9	21.5	2.6	3.7	19.1	11.8	19.4	6.2	5.3	14.0	2.9	2.5	12.2	12.0	6.8	11.3	16.1	5.1	12.4	3.1	3.6	13.7	6.4	4.5	8.0	6.5	8.8	10.3	8.0	11.2	5.3	4.3	12.9	4.1	6.6	1.7	16.7	14.2	10.0	10.6	14.2	7.6	5.0	8.9	8.0	6.1	6.6	4.7	3.7	5.9	7.6	17.1	14.5	3.3	29.3	24.1	9.7	9.4	9.2	26.0	13.9	4.1	25.6	5.9	6.8	13.1	8.7	12.4	10.9	7.1	2.6	17.5	9.4	8.2	7.0	21.1	15.4	11.3	13.2	9.4	6.8	9.1	11.6	7.8	6.5	4.6	6.3	3.9	5.5	4.5	3.2	4.6	4.8	3.7	2.7	5.8	4.8	9.1	2.2	3.6	3.2	3.4	5.4	6.0	6.1	6.3	9.4	6.6	3.6	6.3	4.7	6.4	3.7	6.2	6.8	6.9	0.0	2.3	10.7	8.4	7.0	3.4	4.5	5.7	7.3	5.1	3.4	1.4	4.3	3.4	5.5	8.4	7.9	4.0	14.2	1.9	6.5	8.8	5.6	6.1	5.5	10.7	12.8	9.8	7.3	9.4	5.4	20.4	7.2	5.7	28.1	5.0	13.2	8.5	5.0	9.9	11.2	6.1	9.8	6.0	7.9	5.3	10.9	3.6	6.5	6.4	6.1	7.2	4.0	10.5	7.6	2.3	5.7	8.4	4.4	16.7	11.2	3.5	7.5	13.1	4.0	5.8	22.8	14.8	6.3	8.7	12.3	7.2	3.8	9.0	5.5
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113776	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.23e-4)"	8.0	7.7	11.6	8.3	11.6	5.6	8.1	11.9	9.8	9.7	3.3	10.3	6.7	11.5	3.2	11.5	9.1	3.7	8.7	9.6	8.3	8.4	10.4	6.9	9.0	11.5	11.1	10.6	10.8	4.8	9.8	3.8	9.7	9.1	4.0	5.2	8.3	4.7	10.5	10.4	10.3	4.7	9.3	12.5	9.0	11.2	11.2	9.6	9.4	5.3	6.3	9.6	8.8	11.0	14.4	22.2	13.5	19.3	7.4	4.6	13.7	11.3	6.4	10.4	7.0	15.9	15.8	30.3	8.2	7.7	6.4	24.5	5.9	16.1	6.6	18.8	9.6	21.6	13.9	12.2	6.4	20.7	22.1	7.8	4.4	9.6	7.6	5.6	8.6	18.4	21.2	11.2	6.9	25.2	23.6	34.9	20.1	9.7	7.4	36.5	11.6	13.7	8.0	23.2	16.4	23.1	17.3	14.3	8.6	6.5	15.0	16.6	15.2	14.1	13.7	9.1	16.1	14.5	12.7	26.4	11.0	16.6	20.5	2.6	0.9	1.5	2.2	1.6	2.3	2.1	1.9	2.3	1.2	1.9	1.7	1.9	2.7	2.3	1.6	3.0	1.3	0.6	11.6	11.6	11.9	9.8	9.6	8.3	11.5	11.1	9.7	9.3	11.2	11.0	19.4	3.2	13.1	10.7	16.6	22.3	6.2	8.4	6.8	23.8	18.0	10.0	12.8	28.6	11.7	20.2	14.6	6.6	14.7	20.0	9.8	10.8	18.0	13.0	16.0	14.7	19.2	20.0	8.8	11.6	7.4	12.7	9.7	18.2	12.6	17.5	19.2	16.5	12.9	16.8	9.9	18.4	8.2	28.3	20.0	6.8	16.8	18.9	7.2	13.1	23.3	14.3	17.5	12.5	17.6	10.9	14.6	9.8	8.2	9.7	15.1	11.5	12.6	23.8	6.6	16.0	13.8	15.6	9.8	14.7	22.4	8.6	16.1	9.8	17.1	7.5
ZC3H6	"FLJ41410, FLJ45877, KIAA2035, ZC3HDC6"	ENSG00000188177	"Zinc finger CCCH-type containing 6"	P61129	2	112275597-112340063	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036019, HPA036020, HPA076065"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.99e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.45e-2)"	3.9	2.5	3.1	1.8	4.4	1.7	3.3	5.5	4.1	3.2	0.0	3.0	1.4	2.9	3.4	1.8	3.6	1.8	2.9	2.6	3.1	2.1	1.8	2.4	2.9	3.1	3.3	6.1	2.3	3.0	3.4	1.7	3.0	2.4	1.7	9.4	2.8	2.1	5.8	4.4	2.6	1.8	2.9	3.1	2.2	2.9	3.0	3.8	3.7	5.7	2.6	2.9	2.9	5.4	1.1	0.4	2.3	2.2	2.1	4.1	0.7	1.2	1.9	0.7	1.5	0.2	1.4	1.7	0.9	0.7	2.0	0.6	0.7	0.3	1.0	2.0	0.2	0.3	0.5	0.0	1.9	0.4	0.4	1.6	3.3	0.8	5.5	3.4	1.2	2.2	0.4	3.0	1.7	1.0	1.0	0.6	1.5	0.7	0.5	0.6	0.1	1.6	1.0	0.2	1.7	2.3	1.1	0.6	1.2	1.2	0.7	0.6	1.8	1.1	0.1	1.3	0.5	3.1	0.9	1.5	2.2	1.1	3.0	0.5	0.6	0.8	0.9	0.4	1.0	1.3	1.3	1.0	0.6	1.7	1.4	1.2	1.2	0.6	1.3	1.0	1.2	0.4	3.1	4.4	5.5	4.1	2.6	3.1	3.1	3.3	3.0	2.9	3.0	5.4	33.3	38.5	32.0	33.3	24.4	17.3	30.0	12.1	33.0	69.3	31.9	33.4	68.7	20.0	20.6	22.0	54.2	21.1	17.5	7.8	29.4	13.1	16.8	39.3	16.0	27.7	16.2	14.5	46.7	14.8	7.3	31.7	7.7	16.2	26.6	41.2	25.7	16.7	12.4	114.4	62.2	13.5	6.1	19.5	14.2	12.4	46.3	16.2	5.4	29.0	21.1	47.6	30.9	43.7	114.4	16.0	10.4	36.1	12.2	30.7	12.1	22.3	30.6	89.5	32.9	50.8	31.0	75.2	46.4	13.7	18.5	7.9	28.6	26.9	12.9	20.6
ZC3H7B	"DKFZp434K0920, FLJ13787, KIAA1031, RoXaN"	ENSG00000100403	"Zinc finger CCCH-type containing 7B"	Q9UGR2	22	41301525-41360147	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001784, HPA076092"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001784: AB_1080637, HPA076092: "	"unprognostic (1.71e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-1)"	29.5	42.9	37.5	20.2	37.1	16.0	22.9	31.9	43.4	25.6	15.1	25.8	24.3	31.1	13.5	20.3	27.2	17.2	26.1	34.1	38.7	31.4	42.1	26.9	21.4	56.0	35.7	41.3	30.9	44.5	30.5	18.5	58.8	26.0	13.2	17.9	44.9	26.7	24.9	20.0	25.9	20.7	30.2	25.6	24.8	11.6	37.2	25.2	45.9	19.1	15.2	23.5	19.7	36.0	59.0	32.2	42.0	25.6	37.6	33.9	49.1	65.8	69.6	53.8	42.1	35.3	23.8	33.1	79.1	92.0	30.1	39.1	35.7	61.8	27.4	76.0	58.9	29.6	40.2	45.4	50.4	57.4	24.9	42.7	34.6	46.3	56.4	45.7	58.9	25.7	60.4	17.9	46.0	59.1	45.4	29.7	30.3	44.2	24.1	68.7	26.4	37.8	45.9	41.5	27.1	20.3	60.5	36.6	31.5	29.0	24.1	38.1	119.0	52.5	54.4	16.3	40.8	30.8	18.4	33.2	44.0	28.0	46.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.0	37.5	37.1	31.9	43.4	34.1	38.7	56.0	35.7	58.8	30.2	37.2	36.0	15.4	12.8	22.2	14.4	13.1	7.1	12.7	13.4	10.2	22.4	18.2	15.6	10.1	20.0	15.7	22.0	18.8	9.0	11.3	13.5	7.9	14.0	0.9	14.2	25.8	17.9	33.6	7.8	20.1	13.3	9.0	16.4	11.2	16.9	8.2	59.0	19.2	44.0	12.0	42.1	20.6	14.6	26.4	12.9	9.8	3.1	33.2	8.2	12.4	13.1	15.2	9.8	20.6	19.1	17.6	18.8	8.1	29.0	7.4	21.2	23.0	18.5	11.7	22.2	19.7	23.1	18.0	2.0	4.9	8.9	5.8	6.2	11.1	46.9	17.1	14.8
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211529-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA034803: AB_2674338, HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	3.6	3.9	4.7	5.7	4.8	6.2	8.0	6.5	6.2	5.4	3.1	4.6	5.2	4.6	4.4	8.6	5.1	2.6	8.6	5.0	4.7	5.7	5.9	2.9	8.5	4.5	4.1	6.0	9.0	11.2	6.6	3.7	4.5	5.6	6.0	5.9	7.1	3.9	11.0	7.6	4.6	4.4	4.0	6.1	4.4	9.0	4.1	9.1	7.2	11.0	8.6	4.9	6.1	4.8	22.1	10.5	13.2	13.7	7.4	8.0	20.6	6.8	5.8	9.5	7.9	25.3	8.3	45.6	12.4	4.8	13.3	13.1	19.4	13.7	12.5	16.2	9.0	30.3	11.8	12.9	11.7	28.6	13.4	10.0	27.0	18.4	28.4	7.0	7.2	27.3	39.2	12.2	7.5	14.6	31.0	25.7	12.2	23.1	29.2	21.2	22.5	18.8	8.7	9.7	19.8	15.4	12.9	13.7	29.9	11.5	10.9	15.1	9.6	12.3	15.9	8.8	17.4	21.9	27.9	44.4	8.8	23.4	4.9	2.7	2.5	0.8	4.0	2.0	8.4	5.9	4.2	4.3	2.5	6.1	7.1	5.9	1.4	7.2	2.6	4.1	4.7	2.4	4.7	4.8	6.5	6.2	5.0	4.7	4.5	4.1	4.5	4.0	4.1	4.8	15.5	9.6	15.2	17.0	35.6	12.6	18.2	16.6	30.7	50.2	28.7	28.6	35.4	12.8	22.8	7.3	41.7	18.1	38.7	13.4	27.4	15.2	30.9	25.5	28.0	15.4	14.9	19.8	35.8	18.6	16.8	16.4	12.2	15.1	35.4	20.2	13.6	11.3	11.4	38.7	46.2	27.4	22.4	15.7	7.8	40.6	22.1	13.7	1.8	12.2	18.1	16.1	43.3	41.2	27.8	19.5	11.3	20.3	14.3	21.2	12.7	24.3	17.4	53.5	13.1	20.9	16.2	60.9	39.0	34.3	17.8	14.2	31.6	24.4	24.0	12.5
ZC3HAV1	"ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043515-139132122	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		24000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	13.5	12.7	8.7	19.1	8.9	85.9	11.1	8.1	15.2	8.6	12.2	12.9	9.7	8.6	10.3	12.9	9.7	11.4	6.4	8.1	13.6	11.1	11.0	16.1	24.0	12.3	11.5	10.9	7.3	9.2	6.2	9.3	12.3	9.5	13.7	2.5	14.3	9.1	3.2	13.1	13.9	13.8	12.7	21.0	10.4	6.5	14.9	24.0	10.6	5.6	23.8	11.9	8.7	12.4	25.1	29.5	4.1	24.7	37.4	35.9	17.6	27.5	21.2	46.9	47.7	21.6	31.4	21.9	25.2	43.9	40.6	27.6	33.2	32.6	26.3	37.2	12.2	43.8	29.7	26.9	21.8	51.1	38.6	37.0	20.3	53.3	11.8	17.4	35.3	32.1	37.6	23.5	20.1	23.3	41.9	59.0	16.6	18.6	17.6	48.5	14.6	21.0	32.0	31.0	7.5	15.4	43.1	29.2	37.8	9.3	17.4	30.9	45.3	9.9	14.3	27.6	23.1	17.9	20.2	49.9	22.4	47.0	24.0	78.7	19.6	30.8	43.0	26.0	56.0	32.2	61.9	53.1	15.2	35.3	59.0	58.6	52.5	38.7	30.6	17.7	58.8	30.6	8.7	8.9	8.1	15.2	8.1	13.6	12.3	11.5	12.3	12.7	14.9	12.4	150.3	25.6	41.1	8.1	119.4	28.7	21.7	17.5	62.6	2.8	70.8	44.8	6.2	21.5	21.1	53.3	4.2	12.6	194.8	57.0	9.8	20.2	2.8	185.9	77.7	74.5	53.2	64.4	0.8	21.2	23.1	68.1	60.6	359.9	32.3	41.6	49.2	36.1	35.1	0.0	3.0	42.2	8.2	43.9	150.0	1.9	18.6	84.4	39.2	33.7	57.1	13.9	88.6	27.6	1.0	23.8	33.8	26.7	104.2	41.5	28.0	36.4	29.9	1.3	13.1	79.5	53.6	1.0	1.1	61.7	22.3	2.3	222.3	41.3	35.8	28.0
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 5.6;Gastric mucus-secreting cells: 4.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 10.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA020386: AB_2257412, HPA050741: AB_2681224"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	3.1	3.7	2.2	2.6	2.8	1.3	3.4	0.0	2.1	3.3	9.9	2.3	3.2	6.7	2.2	4.3	4.9	3.2	2.6	3.3	3.8	2.8	0.8	2.5	2.5	1.4	1.2	9.3	1.8	2.3	1.6	9.5	0.9	3.9	3.2	0.5	2.6	4.3	1.7	8.7	2.6	5.2	0.6	4.6	2.8	2.0	4.4	2.9	8.3	1.6	3.0	2.7	2.8	1.0	14.9	11.9	8.6	28.8	7.1	10.8	0.4	7.2	3.2	5.3	7.3	19.9	8.4	0.4	10.1	7.8	0.0	10.5	12.1	3.0	16.0	8.8	0.1	19.0	12.6	6.8	5.7	0.1	6.6	8.3	4.6	7.9	3.7	0.3	9.1	9.3	8.3	0.5	10.9	0.1	20.4	11.4	1.5	2.0	7.4	21.1	29.2	0.2	4.9	7.9	5.8	26.1	17.7	2.5	10.6	1.7	10.9	7.7	12.7	9.5	8.5	3.2	0.1	0.5	0.1	0.3	5.3	0.1	9.0	10.2	0.1	0.9	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.9	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.2	2.2	2.8	0.0	2.1	3.3	3.8	1.4	1.2	0.9	0.6	4.4	1.0	2.4	0.0	0.0	1.6	0.1	0.4	0.9	0.2	2.8	0.3	0.8	1.7	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.0	0.2	0.0	1.4	4.4	1.6	0.0	3.8	5.6	0.0	1.6	2.0	4.6	0.8	4.5	3.0	1.1	0.0	0.9	0.0	2.3	0.0	0.0	0.3	0.3	0.0	1.8	0.5	0.0	9.4	0.0	0.6	0.0	5.5	0.2	0.2	0.0	1.5	1.5	0.6	0.0	0.3	0.1	0.0	0.0	0.9	2.3	0.0	0.6	2.9	1.0	0.7	0.2	3.8	0.2	0.5
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.4	11.2	7.3	11.3	4.7	8.4	10.9	11.4	9.1	11.9	9.5	5.4	9.3	8.6	7.4	8.3	5.7	16.5	11.1	12.1	11.8	14.1	6.3	10.6	11.4	11.5	9.3	7.5	11.6	7.5	8.4	11.4	8.3	7.2	5.8	7.1	7.0	32.7	6.3	7.6	11.5	11.4	12.5	8.7	15.6	12.1	10.4	7.4	29.1	10.6	9.1	7.6	11.8	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	11.2	11.3	10.9	11.4	11.1	12.1	11.4	11.5	11.4	11.4	12.1	11.8	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZC4H2	"HCA127, KIAA1166, MCS, MRXS4, WWS"	ENSG00000126970	"Zinc finger C4H2-type containing"	Q9NQZ6	X	64915802-65034713	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Inhibitory neurons: 39.4;Oligodendrocyte precursor cells: 58.3;Oligodendrocytes: 59.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.3;REH: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049584	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Microtubules"		"HPA049584: AB_2680825"	"unprognostic (9.55e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.51e-5)"	"unprognostic (5.34e-2)"	4.5	6.3	7.1	2.5	7.2	2.5	4.1	7.0	8.0	5.9	6.9	9.6	3.9	7.0	4.3	3.4	6.1	3.7	5.7	7.0	7.9	5.4	5.3	3.4	2.8	7.5	7.6	7.2	3.6	11.8	8.6	0.9	7.6	5.3	4.4	5.0	4.3	5.8	1.8	3.8	5.3	7.9	7.2	4.2	6.3	1.0	7.2	8.0	5.4	1.9	2.6	5.3	4.1	7.3	0.0	1.5	23.4	11.0	0.2	0.0	3.7	4.4	9.3	6.3	11.5	2.2	8.8	4.4	2.5	3.9	0.0	0.1	10.4	4.0	6.2	0.0	9.5	7.4	3.3	3.2	1.4	6.8	2.2	4.7	3.3	2.9	6.5	9.5	11.5	25.1	2.4	9.9	7.5	0.0	20.2	0.0	37.3	4.2	10.2	29.8	11.3	0.2	6.5	0.0	0.0	16.8	0.0	0.1	0.9	13.9	2.0	1.3	7.2	3.2	6.7	0.3	0.0	1.8	0.2	14.9	9.9	6.2	0.0	0.0	0.7	0.0	1.7	1.0	3.0	2.6	2.4	2.4	0.9	1.9	3.9	2.4	0.0	2.1	0.2	2.4	1.2	1.4	7.1	7.2	7.0	8.0	7.0	7.9	7.5	7.6	7.6	7.2	7.2	7.3	2.9	3.2	0.0	20.5	6.6	0.6	2.0	1.9	1.8	3.8	1.5	2.2	4.0	4.3	1.8	1.8	4.2	0.1	1.2	1.9	1.9	7.7	0.6	1.7	3.0	4.5	3.6	3.4	37.4	5.7	0.8	4.0	3.6	0.5	2.5	5.2	5.0	4.1	1.1	0.0	39.4	1.9	8.2	0.9	0.0	0.8	7.2	0.8	0.0	22.5	0.5	5.1	2.1	58.3	59.0	4.7	2.2	8.6	1.5	1.0	3.8	5.6	0.6	1.6	13.1	2.8	4.1	0.6	0.5	1.8	0.6	0.0	1.9	4.5	3.3	1.0
ZCCHC10	FLJ20094	ENSG00000155329	"Zinc finger CCHC-type containing 10"	Q8TBK6	5	132996985-133026604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038944	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	Nucleoplasm	"HPA038944: AB_10673601"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.89e-3)"	15.8	14.5	8.5	18.6	8.9	38.1	16.1	11.4	12.5	12.3	10.4	25.8	19.2	14.8	13.9	23.4	12.4	14.0	17.3	8.3	10.5	16.5	21.9	13.1	29.4	8.4	9.7	12.7	15.1	14.1	12.3	19.7	8.7	11.1	22.4	18.9	14.9	10.2	24.8	13.5	18.3	14.2	7.6	16.8	17.7	21.2	9.6	24.1	11.4	24.0	28.4	21.1	14.3	9.6	28.0	29.4	37.7	30.5	18.2	15.9	48.3	29.1	21.1	35.2	40.1	74.2	33.6	75.1	43.5	18.3	28.9	35.3	46.3	35.9	38.5	46.3	62.0	45.0	35.4	54.4	26.4	36.8	50.5	14.0	41.0	21.8	35.5	19.8	35.2	37.6	47.7	41.3	25.9	36.1	62.7	45.1	40.5	29.7	30.5	54.1	43.5	33.8	32.8	40.8	28.7	24.1	46.6	18.2	55.0	50.5	40.9	50.4	37.6	30.7	37.0	20.2	43.5	35.4	60.6	107.9	24.7	69.6	36.7	49.8	65.6	41.6	44.4	61.7	47.0	102.3	54.1	54.0	66.5	122.4	47.4	48.5	34.7	59.9	66.2	58.3	70.2	48.4	8.5	8.9	11.4	12.5	8.3	10.5	8.4	9.7	8.7	7.6	9.6	9.6	47.4	28.9	37.5	11.8	76.2	33.3	37.5	48.9	26.2	28.2	33.3	22.7	55.7	50.1	42.6	12.9	8.4	46.8	43.6	72.1	33.2	38.6	7.3	39.1	28.8	39.9	37.8	40.4	13.6	67.2	56.7	37.2	27.5	30.9	33.0	29.0	39.7	65.2	47.0	28.6	13.8	57.9	67.1	54.4	61.9	6.3	24.5	37.2	35.6	15.0	48.8	24.3	53.5	16.6	14.4	54.5	77.6	29.7	30.6	31.0	47.4	90.5	42.9	27.9	13.1	34.0	33.0	60.3	72.8	31.5	37.8	61.6	45.2	24.1	52.2	50.6
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823824-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 281.2;endometrium 1: 101.5;fallopian tube: 132.2;smooth muscle: 141.6"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 4.6;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Group enriched"	"Detected in all"	5	"hypothalamus: 281.2;thalamus: 156.5"	"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (1.18e-1)"	0.2	7.7	35.8	0.8	24.5	0.0	0.4	19.4	30.0	32.1	0.4	1.2	0.3	101.5	8.7	0.0	132.2	0.4	0.1	22.2	281.2	0.1	0.1	0.5	0.6	26.5	48.1	3.1	0.1	0.0	26.9	0.0	37.8	0.4	0.4	4.2	0.0	0.5	0.0	0.0	0.9	141.6	12.4	0.2	0.9	0.5	156.5	0.6	3.1	0.0	0.7	0.0	6.1	5.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.0	3.9	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.5	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	35.8	24.5	19.4	30.0	22.2	281.2	26.5	48.1	37.8	12.4	156.5	5.5	0.2	0.0	0.0	0.7	0.6	0.0	0.1	0.0	0.6	0.9	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.2	0.2	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	4.6	0.5	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.5	1.4	1.2	5.6	0.1	0.1	0.0	0.7	0.5	0.1	0.0
ZCCHC13	"4930513O09RIK, Cnbp2, ZNF9L"	ENSG00000187969	"Zinc finger CCHC-type containing 13"	Q8WW36	X	74304180-74305034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	229	"testis: 22.9"	"Group enriched"	"Detected in some"	80	"Early spermatids: 247.9;Late spermatids: 541.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003382	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA003382: AB_10967182"															"unprognostic (1.61e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	247.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	541.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZCCHC17	"HSPC251, pNO40, PS1D"	ENSG00000121766	"Zinc finger CCHC-type containing 17"	Q9NP64	1	31296982-31364953	"Predicted intracellular proteins"		Ribonucleoprotein		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053727	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053727: AB_2732581"	"unprognostic (1.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.17e-1)"	22.3	26.9	69.7	16.9	71.0	19.2	29.7	63.0	92.1	21.7	50.1	25.1	12.5	21.3	57.8	21.9	20.6	15.0	51.7	73.8	72.0	31.7	16.9	18.2	21.3	68.7	75.4	19.7	17.8	23.6	26.1	21.3	74.1	21.8	19.9	37.9	19.7	26.4	32.1	23.3	18.5	22.7	69.7	20.6	20.4	48.1	68.1	26.9	21.0	24.2	25.9	23.6	20.8	77.5	42.5	35.4	59.4	38.9	55.5	46.4	34.8	63.7	56.1	71.4	64.5	58.0	38.0	45.3	48.2	48.5	31.3	30.6	67.9	59.9	81.2	29.8	45.4	60.5	53.5	66.4	46.5	56.1	25.1	34.0	60.8	81.7	84.1	50.9	77.6	48.7	64.8	26.8	65.6	35.6	48.8	59.1	105.8	51.8	61.3	46.0	81.4	41.3	78.2	42.2	42.7	26.7	54.7	43.9	205.9	87.9	32.2	34.9	52.7	36.1	38.8	83.1	66.2	26.0	45.1	55.6	49.1	69.4	103.5	87.1	35.8	60.2	41.0	38.5	36.9	39.7	41.1	43.1	35.9	47.7	37.7	45.5	12.2	36.6	38.3	40.7	42.2	52.3	69.7	71.0	63.0	92.1	73.8	72.0	68.7	75.4	74.1	69.7	68.1	77.5	38.1	19.2	23.7	25.5	31.6	31.0	36.4	55.1	20.5	52.8	34.8	43.3	61.6	31.5	37.0	27.6	27.1	87.7	48.7	24.7	72.4	54.3	80.4	37.4	39.8	41.3	24.7	48.0	46.9	52.4	71.8	33.3	13.7	41.9	41.8	50.2	36.4	24.3	54.2	85.8	41.3	28.5	32.6	26.8	30.8	122.7	42.9	50.6	35.6	24.4	56.5	71.5	69.0	39.2	33.2	54.8	35.4	53.8	27.8	54.0	22.3	64.7	29.2	53.8	46.0	35.5	50.5	249.2	177.6	28.7	34.2	83.9	41.8	45.3	29.4	58.6
ZCCHC18	"PNMA7B, SIZN2"	ENSG00000166707	"Zinc finger CCHC-type containing 18"	P0CG32	X	104112131-104115842	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;ovary: 4.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;NK-cells: 9.2;Oligodendrocyte precursor cells: 6.6;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;Karpas-707: 4.6;SH-SY5Y: 3.1"					"Low region specificity"	"Detected in all"			"HPA034940, HPA078516"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA034940: AB_10671098, HPA078516: "	"unprognostic (7.20e-2)"	"unprognostic (7.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.44e-6)"	"unprognostic (4.05e-2)"	"unprognostic (1.02e-6)"	"unprognostic (3.82e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.14e-3)"	0.5	0.8	3.0	1.3	2.9	0.4	0.3	2.9	3.0	1.8	1.1	0.7	0.3	1.5	0.2	0.3	1.3	0.4	0.5	2.7	5.0	0.4	0.1	0.4	2.0	2.2	2.5	4.2	0.9	0.0	1.6	0.1	2.2	0.8	0.3	1.2	0.2	0.6	0.1	0.2	2.0	0.6	2.4	2.2	0.5	1.0	4.9	0.4	0.3	0.1	2.0	0.6	0.7	2.1	0.0	0.1	1.9	1.3	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.1	0.0	2.5	0.0	0.1	0.4	0.0	1.1	0.0	0.1	0.7	0.9	0.4	0.1	0.0	0.2	1.4	0.4	0.1	0.0	0.2	0.0	1.1	0.3	0.1	0.0	4.6	0.1	0.0	0.0	0.0	1.0	0.0	0.3	1.7	0.4	0.0	0.2	0.2	1.3	3.1	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.5	0.1	0.6	0.1	0.0	1.2	0.0	1.4	0.4	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.3	0.5	0.0	0.8	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.1	3.0	2.9	2.9	3.0	2.7	5.0	2.2	2.5	2.2	2.4	4.9	2.1	0.9	0.0	0.6	3.3	4.0	0.1	0.2	0.0	0.0	0.8	0.3	0.3	0.7	0.0	1.3	1.8	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.6	0.9	1.2	4.2	0.8	2.6	0.2	0.0	1.2	0.0	0.3	0.0	1.3	0.7	0.0	0.0	1.7	1.5	0.0	0.0	0.3	0.4	0.3	1.5	0.1	1.8	0.0	0.1	3.4	9.2	6.6	0.3	0.0	0.0	1.2	1.7	0.1	0.0	0.2	1.5	1.0	6.6	0.2	2.4	0.0	0.2	0.1	0.0	0.0	3.6	1.0	0.0	0.1
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523025-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 143.8;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	10.7	5.5	6.2	5.8	6.6	26.5	9.1	9.3	8.2	6.7	6.0	7.1	6.7	6.3	5.9	5.5	7.8	8.6	8.5	5.5	6.9	5.5	23.3	10.2	7.0	7.2	6.8	8.0	6.2	5.8	8.0	8.1	6.7	7.3	5.4	10.0	37.2	5.3	12.2	11.6	7.5	5.8	5.3	9.0	6.4	12.0	6.6	7.6	7.3	7.3	6.3	7.9	6.5	11.5	8.0	6.8	5.8	11.5	17.1	7.3	10.9	4.5	6.7	10.5	10.4	3.7	4.8	22.4	5.8	7.4	8.6	13.2	18.6	9.9	4.3	15.5	8.8	5.9	15.6	25.2	5.9	11.4	8.3	7.2	12.6	6.7	12.3	7.6	19.9	9.9	6.4	7.3	3.5	6.5	7.5	4.8	3.7	5.8	6.7	9.7	6.1	0.1	7.3	8.0	7.2	4.5	7.5	16.8	6.6	10.2	5.9	8.9	8.6	10.3	7.0	4.1	6.5	2.8	5.8	9.4	7.6	4.7	3.9	0.0	0.3	0.8	0.5	0.5	0.4	0.1	0.3	0.4	0.1	0.4	0.6	0.4	1.5	0.2	0.1	0.3	0.4	0.1	6.2	6.6	9.3	8.2	5.5	6.9	7.2	6.8	6.7	5.3	6.6	11.5	23.1	25.6	18.8	28.1	10.8	26.6	16.9	7.5	10.8	33.1	15.2	13.2	18.8	20.0	12.4	16.5	54.2	7.4	33.6	10.2	3.9	6.8	143.8	24.1	12.3	28.8	12.6	8.2	48.5	6.2	10.9	9.7	10.2	27.5	2.5	4.4	17.5	35.4	14.1	43.7	33.9	15.5	2.0	44.4	22.0	158.6	8.1	30.6	7.2	29.0	11.9	7.7	9.2	37.2	51.7	5.1	9.1	7.9	10.7	16.5	8.4	5.3	10.8	19.5	6.6	15.6	15.0	16.3	15.2	15.3	18.5	6.8	22.6	5.6	11.5	12.2
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 148.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 66.0;Hepatic stellate cells: 64.2;Hepatocytes: 59.2;Leydig cells: 68.6;Oligodendrocyte precursor cells: 184.5;Oligodendrocytes: 130.6;Peritubular cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.0;ASC TERT1: 115.1;BJ hTERT+: 91.6;HSkMC: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	40.4	11.9	119.7	13.8	147.7	2.6	32.5	112.0	109.7	42.3	44.8	67.7	6.2	42.8	8.9	14.0	34.1	23.8	35.7	89.4	101.0	8.7	33.1	22.7	7.5	134.9	145.8	26.4	8.4	4.0	9.4	16.1	120.3	32.2	8.9	3.7	12.0	27.2	58.0	13.7	18.2	36.1	119.7	10.9	25.5	8.9	136.8	2.7	18.4	26.5	4.3	43.2	22.9	148.0	3.3	3.1	10.4	9.0	135.0	115.1	2.5	24.6	91.6	14.2	16.5	2.6	0.1	0.1	13.1	49.5	5.0	0.3	1.7	0.6	11.9	6.2	6.5	1.3	7.2	3.1	35.1	3.8	2.0	120.5	1.3	12.8	3.5	42.1	2.9	0.9	4.8	5.3	12.3	1.1	0.1	14.9	2.5	0.6	30.1	0.6	12.3	2.2	1.7	4.0	0.3	12.9	7.7	0.9	31.5	9.7	3.5	7.0	2.0	13.6	12.4	37.4	8.5	9.2	6.5	0.1	27.9	4.9	49.4	0.0	0.6	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.1	0.1	119.7	147.7	112.0	109.7	89.4	101.0	134.9	145.8	120.3	119.7	136.8	148.0	36.2	0.0	2.6	29.0	1.4	7.6	1.4	1.5	1.8	0.1	5.6	5.7	20.2	5.7	1.2	0.0	0.0	0.6	4.5	0.3	0.0	0.8	2.0	2.3	66.0	29.5	0.0	4.4	0.3	0.8	0.9	40.9	5.1	2.6	1.3	4.1	64.2	59.2	10.7	0.0	0.5	0.4	0.0	17.1	14.5	4.8	68.6	7.4	16.0	30.0	5.6	16.7	1.0	184.5	130.6	0.9	0.1	65.5	5.0	2.9	0.0	1.8	1.2	1.1	13.1	38.7	24.0	0.7	1.7	1.4	4.5	1.5	3.6	8.9	0.1	1.3
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312774-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	4.5	3.6	2.8	3.5	3.6	3.8	5.0	3.7	3.5	4.3	3.5	3.9	3.8	5.2	4.0	3.3	4.3	3.3	4.6	2.7	3.0	3.8	3.5	3.6	5.2	3.3	3.1	6.1	3.4	6.0	2.7	3.3	3.4	3.9	4.0	4.8	3.9	3.9	7.4	4.3	4.0	3.7	3.0	4.4	3.4	4.4	3.3	4.8	4.5	5.5	4.5	4.1	3.6	4.3	4.5	2.8	9.1	4.2	6.9	8.8	8.1	11.4	12.1	13.1	15.0	4.4	11.9	7.5	3.1	7.0	12.9	3.5	8.9	8.3	18.2	1.8	4.8	7.0	5.8	7.4	8.8	11.6	4.9	7.0	9.2	12.5	9.8	7.8	6.3	11.4	12.7	3.6	11.3	3.4	12.0	15.2	12.5	7.4	6.0	8.0	13.9	4.6	7.1	4.7	8.4	5.8	4.9	4.1	7.4	8.8	6.0	6.9	5.0	11.0	4.6	7.2	15.7	7.2	9.6	11.0	11.8	11.0	10.8	1.4	1.9	0.6	3.0	2.4	4.4	3.5	3.9	3.8	2.8	3.6	3.7	4.1	1.1	4.4	2.3	2.1	4.3	2.3	2.8	3.6	3.7	3.5	2.7	3.0	3.3	3.1	3.4	3.0	3.3	4.3	5.9	0.0	5.8	12.1	7.6	3.7	4.0	4.3	6.8	3.7	3.0	2.9	6.4	1.5	5.5	0.0	2.1	5.9	4.2	2.1	3.9	3.8	1.5	5.5	5.1	4.6	2.4	2.1	10.7	2.3	4.5	4.8	3.1	3.9	1.3	6.4	2.2	3.1	5.1	3.3	15.5	3.6	6.1	4.4	2.2	0.5	4.1	3.3	3.6	5.6	2.6	5.5	5.2	19.6	23.6	2.9	3.9	5.3	3.7	2.7	5.7	4.5	8.2	5.2	0.0	5.2	5.7	9.0	9.1	4.9	3.4	3.7	5.4	4.0	4.4	2.5
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120574-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 124.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	8.3	7.4	5.8	12.7	5.5	13.7	13.2	18.7	8.8	9.3	5.1	8.2	7.9	11.6	11.3	7.5	9.6	7.9	6.4	5.3	5.4	7.4	8.1	6.5	23.2	5.6	6.2	16.6	11.2	7.1	9.4	7.9	6.6	7.0	10.9	9.9	7.8	7.1	5.9	8.2	8.2	9.5	4.4	10.6	7.7	12.1	7.4	12.9	12.3	6.0	24.8	9.5	7.5	9.2	17.2	9.4	17.5	18.4	17.4	27.0	15.5	17.4	21.3	14.0	19.2	11.8	8.6	54.8	8.1	14.0	15.9	7.2	16.6	17.1	19.9	26.3	8.8	19.1	19.3	10.7	27.3	32.5	17.5	18.6	26.3	14.2	56.7	26.0	16.0	24.4	53.3	21.8	12.7	8.2	24.9	18.2	18.3	20.3	17.3	124.7	11.0	16.2	17.6	7.1	17.5	12.9	12.6	15.3	17.1	16.9	10.2	21.4	12.7	9.9	11.8	14.1	10.3	5.0	13.2	76.4	14.9	20.8	18.7	8.4	7.6	20.6	12.9	9.0	12.8	32.6	14.9	15.0	7.2	48.9	18.6	17.3	15.3	18.4	17.2	13.2	13.4	9.3	5.8	5.5	18.7	8.8	5.3	5.4	5.6	6.2	6.6	4.4	7.4	9.2	27.7	35.3	18.5	126.3	110.3	28.3	29.5	28.2	32.5	15.5	21.7	23.7	10.7	15.7	21.7	5.5	10.4	15.3	32.8	7.7	27.4	16.3	52.2	17.6	37.6	18.7	19.1	38.5	225.6	15.8	25.4	31.0	30.1	24.2	23.5	18.0	16.4	11.6	15.2	11.8	229.6	22.5	40.7	17.9	22.8	20.8	27.1	20.3	16.0	121.8	19.8	18.2	28.8	196.1	250.0	12.8	13.6	19.5	44.7	34.9	17.7	22.5	19.1	24.9	6.6	33.9	25.4	60.1	44.8	29.3	32.7	18.6	42.2	32.4	20.3	26.0
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471599-122501073	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 43.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	10.2	8.2	3.6	8.9	4.0	43.7	9.9	7.5	4.8	10.8	5.5	9.3	9.0	9.8	8.8	9.8	10.2	6.5	6.3	3.4	3.5	7.9	10.3	8.5	10.5	4.2	3.6	11.5	9.4	8.9	8.9	8.1	3.9	7.9	8.1	10.8	9.7	6.6	16.8	11.8	10.4	7.5	3.0	11.0	10.7	12.1	3.9	10.7	10.8	8.7	11.8	8.9	9.6	5.5	14.8	14.4	21.7	21.0	8.4	10.8	25.2	18.0	11.3	21.5	16.1	13.9	13.0	26.6	10.9	7.6	12.5	17.4	23.1	9.8	19.6	20.9	14.0	17.5	21.0	11.5	19.8	30.5	16.9	9.4	15.7	12.9	18.2	19.2	10.9	26.8	24.3	17.0	11.3	8.4	20.7	23.9	18.5	10.0	15.3	24.2	17.8	21.4	10.5	9.3	15.6	17.2	20.5	9.5	23.0	21.1	20.0	20.3	12.2	14.3	15.3	14.2	17.7	18.2	11.6	36.6	7.8	19.6	8.6	5.5	3.4	2.2	3.5	3.6	3.6	4.5	4.1	4.3	2.8	4.0	4.6	3.8	2.9	4.3	4.3	2.9	5.7	2.5	3.6	4.0	7.5	4.8	3.4	3.5	4.2	3.6	3.9	3.0	3.9	5.5	21.6	32.1	22.6	20.5	26.8	20.5	27.2	13.5	27.3	30.5	23.1	21.5	9.4	21.5	27.0	9.2	125.1	17.4	32.6	13.3	1.9	11.8	78.5	30.7	40.6	21.0	19.6	48.2	21.7	9.5	17.6	22.8	26.0	41.4	19.0	22.5	10.4	17.9	12.8	15.2	24.6	15.5	14.2	15.6	20.2	48.1	14.9	22.4	16.0	26.2	23.5	12.4	21.6	27.6	25.3	14.1	12.2	14.7	29.6	21.3	18.8	6.6	20.4	72.7	6.6	33.6	21.0	34.4	17.1	24.0	25.7	32.3	26.2	19.0	17.3	22.9
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301587-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	13.4	12.3	8.7	15.9	8.6	10.8	13.5	9.7	13.4	15.5	9.8	15.2	14.9	15.5	16.3	14.6	12.6	14.3	11.2	8.6	9.2	17.9	33.3	11.2	19.0	8.9	9.0	17.2	11.8	13.0	13.8	19.1	9.0	15.5	14.9	14.0	10.5	11.0	14.9	16.3	18.7	14.6	8.5	13.3	12.9	14.9	9.4	17.7	12.6	11.6	18.2	16.3	13.5	9.1	26.6	18.5	44.5	23.7	37.5	35.3	59.7	39.2	46.3	29.5	40.8	41.0	35.8	24.6	15.8	19.8	51.1	19.4	35.6	35.8	46.9	55.3	33.5	25.4	21.0	48.4	44.2	32.6	20.3	27.6	30.7	25.3	62.7	22.9	25.3	26.5	43.1	23.4	30.8	36.3	54.0	48.7	32.4	14.9	23.7	31.9	57.0	36.4	23.4	26.5	21.6	20.5	31.1	18.4	146.5	32.1	23.0	51.7	17.6	18.5	22.6	33.2	43.4	33.2	36.5	37.7	32.7	46.7	40.3	12.6	10.8	11.3	10.5	14.9	13.2	12.8	14.0	12.8	13.3	11.1	13.3	13.8	10.6	10.8	13.6	15.1	17.4	6.5	8.7	8.6	9.7	13.4	8.6	9.2	8.9	9.0	9.0	8.5	9.4	9.1	15.9	9.6	18.6	10.4	18.2	9.1	12.5	25.8	14.2	18.0	14.5	17.1	12.3	37.1	19.3	31.3	14.6	28.0	17.3	15.0	31.3	22.4	68.4	22.6	31.5	17.9	7.8	12.8	15.0	20.4	53.8	23.9	14.8	18.8	13.3	13.3	29.6	61.7	36.7	26.9	19.3	23.3	16.2	14.2	16.5	19.1	32.6	19.9	3.6	13.1	33.2	22.0	35.0	12.1	14.2	30.2	27.4	29.0	17.6	13.8	44.8	67.1	28.1	28.2	19.7	16.2	18.8	75.6	38.2	14.0	9.2	23.0	19.8	22.3	21.6	12.6
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28348721-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	1.5	1.7	1.8	0.9	1.5	0.8	1.8	1.6	1.9	1.4	0.2	1.4	1.2	2.1	2.1	1.3	1.0	2.0	2.7	1.7	1.1	1.6	1.2	1.3	1.2	0.8	1.0	2.4	1.9	1.5	1.2	1.2	1.0	2.2	1.1	1.6	2.3	1.1	6.2	1.9	0.9	1.0	0.8	1.1	1.8	9.9	1.2	0.6	2.5	4.5	1.0	0.8	0.8	1.6	0.3	0.2	0.8	0.3	1.2	2.8	1.2	1.1	0.8	0.3	0.3	0.2	0.9	0.7	0.5	0.6	0.8	0.4	0.2	0.2	0.3	0.4	0.4	0.3	1.1	0.3	0.6	0.5	0.6	1.2	0.5	0.3	0.5	1.3	0.5	1.5	0.3	1.0	1.5	0.3	0.2	0.6	0.3	0.1	1.1	0.3	0.3	0.6	1.2	0.1	0.3	0.9	0.2	0.4	0.7	0.8	0.4	2.6	1.0	0.8	0.4	0.7	0.6	0.3	0.2	0.3	2.8	0.5	1.0	1.0	0.7	1.1	0.3	0.7	0.2	0.1	0.3	0.2	0.3	0.2	0.5	0.7	1.0	0.2	0.2	0.4	0.3	0.2	1.8	1.5	1.6	1.9	1.7	1.1	0.8	1.0	1.0	0.8	1.2	1.6	1.6	0.0	2.0	35.6	0.4	0.6	2.7	3.7	1.2	3.0	1.6	2.7	13.6	0.0	4.3	0.0	0.0	2.4	0.1	0.4	5.9	0.5	95.0	1.2	1.2	1.0	1.2	0.0	33.7	0.9	1.4	4.3	0.0	0.6	2.5	0.8	1.4	0.5	1.3	3.3	34.9	1.9	8.2	0.6	0.7	17.7	4.7	1.3	0.0	13.1	0.7	3.7	1.0	32.2	31.7	0.6	0.3	4.9	0.3	1.1	0.6	2.6	1.7	2.0	0.0	4.4	4.5	68.7	5.8	1.1	1.6	1.2	0.6	1.3	0.7	1.3
ZDBF2	"FLJ45338, KIAA1571"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	2.3	4.1	1.8	0.9	3.5	0.6	1.6	3.4	1.8	3.0	7.8	2.4	0.4	2.6	1.7	1.1	3.2	1.2	2.3	2.3	3.8	1.4	1.5	1.3	1.1	1.2	1.4	9.5	5.0	1.5	8.0	2.3	1.1	1.8	0.6	5.5	1.7	1.4	2.7	1.1	1.7	1.3	0.4	1.4	2.0	1.7	3.5	0.9	2.0	1.5	0.9	1.7	2.0	0.4	1.4	0.2	4.4	0.8	1.7	1.4	6.9	1.4	1.5	0.7	0.9	0.4	1.2	0.0	0.6	1.5	2.6	0.3	3.0	1.1	1.3	1.4	2.9	0.0	3.4	0.1	2.2	1.3	2.9	1.4	1.9	1.4	2.7	5.1	2.1	1.1	0.2	1.9	2.1	0.2	0.4	0.0	6.2	0.1	1.6	0.0	4.6	0.0	0.8	0.6	2.4	5.6	2.6	0.0	2.5	10.0	0.1	0.0	2.6	0.7	2.3	0.5	1.1	4.1	1.1	0.2	3.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	3.5	3.4	1.8	2.3	3.8	1.2	1.4	1.1	0.4	3.5	0.4	6.9	3.2	3.9	15.7	19.3	4.0	1.9	3.1	7.4	26.9	4.4	3.3	9.2	1.5	4.4	11.0	14.6	5.2	9.7	0.6	0.0	2.8	4.1	1.9	7.5	5.1	7.8	0.8	75.0	2.2	6.9	11.7	4.6	0.6	12.7	44.4	3.3	3.4	0.5	8.4	56.5	1.3	4.1	0.3	4.2	5.1	4.4	2.3	1.8	18.7	0.1	8.7	0.0	26.2	3.1	1.2	0.5	5.3	23.4	3.5	1.0	2.3	10.6	18.1	0.0	19.2	9.2	4.4	9.0	6.0	3.3	9.0	13.5	24.5	0.5	0.8
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394152-67416833	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 84.6;Late spermatids: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.4;ASC TERT1: 11.3;U-138 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	17.7	10.9	3.7	1.8	3.5	0.2	17.9	3.2	5.6	27.1	7.4	14.5	2.3	21.7	3.9	6.8	22.4	6.3	10.8	3.4	4.2	19.3	4.4	12.4	1.4	4.9	6.7	23.6	17.7	7.8	20.4	3.1	4.1	19.5	1.7	0.8	17.0	6.7	10.7	19.1	7.4	3.9	4.7	14.9	10.6	20.3	4.4	0.6	29.4	3.0	0.8	12.8	16.3	2.8	5.2	6.0	1.4	7.3	11.4	11.3	0.0	3.2	9.0	2.6	2.8	0.0	2.6	0.0	1.3	4.2	2.5	3.3	0.4	0.6	0.5	1.6	4.6	0.5	0.1	0.4	5.2	0.2	4.0	6.0	5.3	2.7	0.6	6.0	3.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	2.9	1.8	0.1	0.0	0.0	0.0	3.5	2.9	2.1	7.4	0.5	0.1	6.5	0.4	1.9	1.1	5.8	11.7	2.0	5.6	3.3	1.4	0.3	0.0	7.2	0.1	4.7	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	3.7	3.5	3.2	5.6	3.4	4.2	4.9	6.7	4.1	4.7	4.4	2.8	7.0	0.0	0.0	10.4	0.9	7.1	6.7	1.3	10.8	2.2	7.5	7.0	1.1	10.0	1.4	7.3	4.2	2.0	0.3	5.2	9.8	3.4	29.3	84.6	10.9	5.2	9.0	0.4	5.7	4.0	0.2	13.6	8.6	7.3	0.0	8.5	6.1	2.0	2.0	3.3	5.0	12.9	2.0	16.4	6.8	53.0	14.6	9.3	5.4	2.8	8.2	7.9	1.0	4.0	2.5	2.2	4.9	10.9	0.7	7.2	2.0	6.6	5.5	0.5	0.0	5.1	9.4	12.4	8.6	6.2	7.1	5.7	0.7	10.4	6.8	4.8
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Early spermatids: 17.0;Endometrial ciliated cells: 26.2;Excitatory neurons: 21.4;Inhibitory neurons: 16.4;Oligodendrocytes: 18.3;Respiratory ciliated cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.9	0.9	8.0	0.4	9.9	0.5	2.1	8.3	13.0	2.7	8.0	3.5	6.1	1.1	1.8	3.9	6.5	0.9	9.0	7.4	5.1	4.1	5.2	4.7	0.5	7.9	9.9	1.7	2.8	0.6	12.0	0.8	9.0	2.8	0.8	4.3	2.7	0.9	2.0	3.1	2.9	0.5	2.3	3.3	4.4	10.4	7.1	0.7	2.4	2.2	0.7	2.4	2.2	15.0	0.4	7.4	4.1	0.9	1.3	0.3	5.4	0.3	0.1	0.2	0.1	1.0	0.3	3.1	0.8	0.0	0.9	7.1	2.6	0.0	0.0	9.6	4.9	0.3	3.0	3.9	0.4	4.5	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.5	0.4	2.5	7.3	0.0	2.8	4.6	2.7	4.3	0.2	1.5	4.2	0.8	0.2	0.1	3.5	8.0	11.5	0.8	0.4	0.2	6.9	3.9	0.1	5.6	8.3	0.9	0.3	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	9.9	8.3	13.0	7.4	5.1	7.9	9.9	9.0	2.3	7.1	15.0	0.7	19.2	13.1	8.5	0.0	1.9	0.4	0.6	0.0	3.4	1.6	2.0	7.7	1.5	13.4	0.0	0.0	0.2	0.3	1.2	0.0	0.5	17.0	26.2	3.8	1.5	1.8	0.4	21.4	0.0	0.1	3.6	4.1	4.2	3.8	0.1	1.1	2.7	0.4	6.7	16.4	3.9	0.0	0.0	0.3	9.1	0.6	0.9	0.0	0.0	0.1	0.3	0.0	7.5	18.3	0.2	1.7	0.0	1.4	0.3	6.0	1.3	25.8	2.2	6.6	0.9	1.0	9.5	3.7	0.7	1.6	0.3	1.1	0.1	1.6	0.4
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710355-784729	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	6	"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 23.0;Excitatory neurons: 47.2;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 70.1;Respiratory ciliated cells: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;SCLC-21H: 2.4;THP-1: 3.4"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.7	1.2	15.1	0.2	19.6	0.0	0.8	5.9	19.9	0.5	0.0	2.0	2.7	0.4	0.1	1.5	2.0	0.3	4.5	14.6	9.0	0.7	1.2	2.4	0.0	14.2	8.6	0.6	1.8	0.4	4.5	0.2	14.9	0.5	2.3	4.3	1.7	0.5	3.6	2.2	2.4	0.4	3.3	1.2	2.3	0.7	15.5	0.0	1.1	1.6	0.3	1.0	0.6	29.5	0.0	0.8	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	2.1	0.1	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.4	0.0	0.0	0.7	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	19.6	5.9	19.9	14.6	9.0	14.2	8.6	14.9	3.3	15.5	29.5	0.2	19.2	23.0	17.0	0.0	2.7	1.0	0.1	2.2	7.0	1.1	0.9	8.9	1.5	5.7	3.7	0.0	0.0	0.4	2.0	0.0	0.8	2.5	11.9	0.7	2.8	3.0	0.0	47.2	0.8	0.1	4.7	4.1	3.6	1.3	0.0	0.7	2.3	1.7	10.1	38.3	6.7	0.0	0.6	1.1	0.4	0.9	0.8	0.0	1.9	0.0	0.6	0.0	26.7	70.1	0.1	1.4	0.0	1.7	0.3	7.7	0.5	21.8	0.3	6.6	1.4	2.4	5.0	2.5	2.3	3.1	0.0	1.5	0.5	2.4	2.6
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type palmitoyltransferase 12"	Q96GR4	9	128720870-128724127	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	18.8	23.9	7.8	15.5	7.7	41.3	19.3	7.5	9.9	16.8	8.4	40.5	26.3	12.9	7.1	67.8	12.0	14.1	13.7	7.4	8.8	30.6	52.3	23.3	20.0	9.6	7.8	7.4	67.1	9.8	11.3	16.3	8.4	26.6	13.7	0.5	43.2	12.5	15.6	42.4	36.8	6.3	8.4	31.7	49.2	24.7	10.5	12.4	16.2	4.1	13.7	18.7	30.5	9.7	53.5	127.6	6.0	31.3	17.6	12.1	59.4	32.8	28.8	34.5	22.9	109.6	61.5	37.3	29.6	25.5	62.9	139.8	13.0	65.0	3.8	65.0	31.7	20.1	92.7	49.1	34.7	33.1	87.1	19.9	44.7	29.6	11.0	17.7	25.6	65.6	18.8	93.6	7.1	187.3	45.9	66.2	26.8	118.8	107.6	21.0	21.0	108.4	28.7	43.4	42.1	30.4	46.2	64.1	18.3	9.6	98.9	35.6	27.5	0.1	36.9	25.9	45.8	58.1	106.8	17.3	61.3	38.4	41.4	231.1	122.3	385.6	105.1	123.9	91.2	94.6	95.9	101.5	100.1	111.0	99.2	91.4	269.5	90.5	150.0	244.7	130.9	101.0	7.8	7.7	7.5	9.9	7.4	8.8	9.6	7.8	8.4	8.4	10.5	9.7	10.0	16.0	12.0	1.3	31.8	16.2	43.3	94.0	10.8	1.2	55.5	30.4	14.8	77.2	59.0	46.0	0.0	183.9	39.1	171.0	13.7	106.8	73.2	20.7	11.5	21.1	51.2	51.1	0.6	200.0	224.0	14.2	38.7	52.5	18.4	13.7	35.7	55.3	137.0	0.0	0.5	108.5	67.1	62.2	20.9	30.0	9.6	46.5	42.7	6.5	115.3	18.4	81.4	0.5	2.0	133.8	167.7	7.2	43.3	56.5	186.0	48.5	20.1	2.0	6.6	5.4	16.3	36.0	18.6	55.2	28.1	134.1	34.1	22.0	110.0	77.5
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type palmitoyltransferase 14"	Q8IZN3	6	157381133-157678157	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 161.7;Horizontal cells: 122.8;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 315.2;Oligodendrocytes: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013437, HPA063754"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA013437: , HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	2.9	1.6	7.3	1.8	7.6	2.5	1.6	9.7	6.8	5.3	1.1	2.4	2.8	12.4	0.4	1.7	2.0	2.3	5.2	7.5	5.1	4.6	4.4	3.0	2.4	12.5	9.1	1.4	2.5	5.6	1.6	2.2	10.9	3.5	1.7	1.3	2.1	1.4	2.3	1.4	4.1	6.1	13.5	3.1	3.8	3.3	10.8	0.9	1.7	3.9	2.4	2.4	1.9	22.7	2.6	2.7	0.8	3.8	2.0	1.5	8.7	4.1	3.7	2.8	2.5	3.3	1.9	6.4	1.4	3.3	5.4	1.3	2.2	2.2	2.5	50.9	3.2	12.7	1.0	1.5	2.7	1.7	2.8	1.1	2.3	2.9	1.2	2.4	4.3	2.8	10.4	4.7	1.6	1.7	1.1	4.2	1.6	5.1	3.2	0.2	0.4	3.9	5.8	1.1	6.3	1.9	4.8	3.1	3.5	1.6	0.4	2.0	6.0	4.2	3.1	8.3	5.2	1.1	1.3	0.9	1.5	4.5	4.7	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	7.3	7.6	9.7	6.8	7.5	5.1	12.5	9.1	10.9	13.5	10.8	22.7	23.4	3.2	0.0	45.4	9.8	12.9	2.1	3.0	4.0	25.3	5.8	8.0	18.3	12.8	1.4	7.3	6.2	12.5	11.2	7.4	11.7	7.5	10.7	5.0	16.6	15.1	2.4	4.2	161.7	3.1	2.2	11.4	6.1	9.4	0.0	7.7	22.5	23.1	11.4	122.8	108.1	9.8	6.1	15.5	6.7	5.9	8.1	8.8	10.6	65.6	3.8	5.4	7.2	315.2	221.0	2.7	8.5	10.1	4.5	14.2	6.0	3.8	0.4	6.0	0.0	6.2	8.4	7.2	10.0	1.5	8.4	21.1	6.6	4.6	11.5	2.7
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type palmitoyltransferase 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.2;Inhibitory neurons: 17.7;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.2;K-562: 2.1;LHCN-M2: 2.2;MOLT-4: 2.4;NTERA-2: 2.0;RH-30: 3.1;RPTEC TERT1: 1.7;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003618, HPA064901"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686, HPA064901: "	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	0.8	1.5	1.7	0.3	1.7	0.1	1.6	1.8	1.5	1.6	1.3	1.0	0.2	1.9	1.0	0.8	1.2	0.8	1.7	1.5	2.5	1.5	0.2	1.2	0.3	2.2	2.2	2.5	1.1	1.1	1.1	0.0	2.0	1.1	0.5	1.9	4.5	1.1	0.3	0.7	0.3	1.5	1.8	0.8	0.4	0.6	3.0	0.8	2.0	0.5	0.2	0.7	0.8	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.1	0.0	2.2	0.0	2.4	0.0	2.0	0.0	0.0	0.0	3.1	0.0	1.7	0.0	0.8	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.8	1.5	1.5	2.5	2.2	2.2	2.0	1.8	3.0	2.0	2.9	6.4	3.1	8.5	0.1	4.0	1.6	0.0	3.4	4.2	2.0	1.5	9.5	1.5	1.3	5.5	4.2	0.0	0.3	0.0	0.0	0.7	0.0	0.2	2.9	3.5	1.8	0.4	18.2	0.7	0.0	3.5	0.0	0.3	1.3	2.5	2.2	0.1	0.1	0.0	17.7	0.0	0.0	0.0	4.4	0.2	0.9	0.1	0.0	5.6	0.0	2.2	1.0	17.1	9.1	0.2	0.0	3.8	0.0	0.7	0.0	1.0	0.0	2.3	6.6	5.4	2.5	0.2	0.7	2.2	3.7	0.0	0.5	2.3	0.0	0.6
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type palmitoyltransferase 16"	Q969W1	10	97446170-97457370	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	15.6	14.9	17.8	10.2	18.5	6.8	16.3	20.3	21.9	15.0	16.4	17.1	14.3	16.4	18.5	19.9	12.2	9.9	22.1	18.1	16.5	25.1	30.3	20.8	11.3	17.2	17.8	15.9	22.8	25.5	16.7	21.6	16.4	18.3	17.3	17.4	24.2	12.1	25.8	13.1	14.7	16.6	16.1	14.5	24.1	17.3	18.8	12.6	16.0	27.9	15.1	17.1	15.3	16.7	50.7	57.4	37.9	47.1	58.7	40.4	38.7	54.6	72.1	61.2	58.4	45.7	43.6	44.4	60.1	79.8	53.4	58.0	48.2	76.7	54.2	43.7	56.0	28.5	39.8	44.3	47.4	34.0	39.7	45.7	49.8	71.6	51.3	66.3	63.9	40.4	23.1	32.8	79.0	48.4	51.8	46.0	29.9	45.8	49.5	34.0	38.6	40.9	51.9	23.2	18.4	25.9	33.2	33.7	30.6	37.7	44.6	32.9	39.6	38.2	35.0	25.0	64.7	29.2	53.0	26.9	44.1	51.7	20.7	0.3	11.1	11.1	7.2	11.9	8.1	9.0	12.5	11.5	15.7	10.6	10.0	10.1	0.5	14.5	11.8	12.0	11.1	6.8	17.8	18.5	20.3	21.9	18.1	16.5	17.2	17.8	16.4	16.1	18.8	16.7	6.2	19.2	23.1	3.9	9.0	5.2	18.9	31.8	14.8	15.8	13.6	9.3	10.1	14.3	27.6	12.9	4.2	39.8	10.3	11.5	25.4	35.5	24.8	7.0	13.3	11.3	7.2	11.6	8.2	32.3	67.2	13.7	10.2	10.9	7.0	13.3	7.5	19.5	24.6	13.5	9.2	18.9	28.5	7.3	5.9	7.6	8.7	9.3	3.6	9.4	18.4	14.9	15.5	11.1	8.4	31.5	12.1	3.8	17.1	20.0	18.9	22.2	8.3	13.0	6.6	5.2	12.2	20.1	12.9	13.8	4.3	37.9	7.2	10.9	20.9	19.3
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type palmitoyltransferase 17"	Q8IUH5	12	76764103-76853696	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 17.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	15.6	14.1	18.6	12.1	20.4	23.7	16.1	23.1	25.9	15.8	11.8	13.7	7.5	21.7	12.3	8.0	12.8	10.5	12.5	19.8	18.9	11.0	9.8	10.6	14.8	18.2	18.6	20.1	10.2	12.7	11.0	16.4	18.9	14.1	10.1	31.0	8.1	12.8	11.8	10.2	10.3	14.6	19.2	14.4	8.5	12.8	19.4	14.9	11.8	14.2	11.4	11.7	11.7	27.8	8.2	9.5	30.1	15.4	17.6	18.5	14.6	16.2	13.4	10.5	9.2	7.8	5.8	11.2	9.5	15.9	10.5	7.5	12.1	10.1	16.2	9.5	12.6	16.4	13.1	12.0	11.9	16.5	13.9	17.6	10.3	10.0	14.7	35.2	12.2	15.2	18.0	5.2	13.8	7.6	12.0	21.9	22.1	3.6	11.3	16.1	10.7	12.3	12.0	12.3	11.7	20.1	17.8	6.4	10.7	25.7	14.4	16.3	16.9	14.3	11.0	8.8	9.3	8.1	8.5	11.9	5.4	7.6	15.0	6.2	2.3	5.7	3.6	2.4	2.9	2.5	2.9	2.6	2.8	3.9	3.0	2.5	5.9	2.0	2.5	17.1	1.3	1.5	18.6	20.4	23.1	25.9	19.8	18.9	18.2	18.6	18.9	19.2	19.4	27.8	33.4	32.1	18.3	75.7	20.1	7.1	10.4	9.8	12.5	54.6	9.9	10.7	21.3	12.8	15.5	12.9	39.6	20.3	74.1	5.0	0.0	8.0	11.3	11.8	23.8	24.8	19.2	12.0	102.2	4.7	10.2	21.2	7.1	10.1	41.2	20.7	20.3	10.6	8.8	28.6	95.1	7.5	8.2	12.3	19.4	13.7	20.2	14.9	5.4	54.4	14.9	26.1	18.6	88.4	115.8	6.8	4.5	21.1	13.5	10.2	8.4	5.5	18.0	38.1	0.0	32.3	22.0	17.7	22.6	9.5	5.5	5.6	18.1	19.6	6.2	5.5
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type palmitoyltransferase 18"	Q9NUE0	1	26826688-26857604	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 113.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 48.8"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 48.8"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 132.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040234	Approved		Approved	Microtubules		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	23.4	8.1	26.0	27.4	24.6	113.9	17.0	25.7	29.0	12.9	16.9	14.6	12.9	13.6	4.6	24.3	11.3	14.8	15.0	25.4	30.0	8.8	18.6	16.2	22.1	29.1	28.7	9.6	10.5	8.6	11.7	23.3	33.5	11.4	15.0	19.3	16.9	9.1	10.8	18.5	13.9	18.4	22.2	31.3	12.4	7.4	28.5	14.7	15.3	16.1	20.9	22.7	14.4	25.1	45.3	19.8	31.5	21.8	25.6	17.8	30.9	26.7	31.5	45.9	33.9	18.3	28.4	20.9	16.7	35.5	24.0	31.3	33.8	15.9	39.2	132.6	28.7	20.3	15.3	25.7	22.0	18.1	16.9	15.5	21.3	42.3	27.9	16.5	25.9	31.6	21.4	41.8	18.4	22.1	34.5	14.6	30.4	28.1	18.8	28.3	27.2	22.2	19.2	11.3	14.6	17.7	17.9	13.4	19.3	23.9	12.1	17.6	22.2	31.5	24.2	52.3	31.0	49.7	38.8	18.1	17.9	32.5	21.9	0.0	0.5	10.0	1.6	1.1	1.1	0.4	1.2	1.2	0.8	0.3	0.7	0.8	48.8	1.0	0.8	0.4	2.7	0.5	26.0	24.6	25.7	29.0	25.4	30.0	29.1	28.7	33.5	22.2	28.5	25.1	12.9	9.6	7.9	6.5	7.5	25.6	8.6	4.4	6.8	39.8	8.4	6.6	6.0	10.0	6.8	1.8	27.1	10.6	21.2	27.0	0.0	4.1	3.8	6.1	7.0	9.1	3.0	9.3	10.2	2.8	7.1	7.1	4.6	12.7	1.3	5.9	7.9	12.0	7.3	18.5	10.2	3.9	2.0	8.5	17.0	2.1	6.2	11.0	10.6	5.6	26.6	5.7	12.3	4.0	6.3	8.0	25.6	3.8	8.3	19.3	10.4	2.2	4.6	35.3	0.0	7.1	6.2	3.5	11.4	14.6	36.2	6.2	17.4	8.0	7.0	34.7
ZDHHC2	"DHHC2, ZNF372"	ENSG00000104219	"Zinc finger DHHC-type palmitoyltransferase 2"	Q9UIJ5	8	17156482-17224799	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 77.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023331, HPA023334"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA023331: AB_2671165, HPA023334: "	"unprognostic (8.92e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (5.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.10e-2)"	10.3	24.4	10.3	11.0	8.9	31.7	7.5	43.9	14.8	13.4	13.5	15.3	10.5	7.6	11.8	3.9	13.8	7.0	9.7	8.0	22.4	26.4	6.5	14.3	9.3	17.7	13.6	11.8	30.7	28.9	9.5	6.9	16.6	11.7	11.2	77.8	19.6	12.9	17.9	1.8	10.3	9.5	13.5	10.7	16.3	16.6	26.3	12.7	33.5	37.2	11.7	19.7	4.4	22.0	2.3	12.4	23.7	4.9	20.3	36.0	13.8	41.5	49.9	23.0	27.2	3.9	34.3	26.1	15.9	36.2	57.9	1.5	32.2	20.5	42.5	16.8	16.2	23.2	16.8	5.0	20.3	24.7	2.6	15.3	3.2	28.8	26.1	52.7	38.4	29.8	2.7	66.5	28.1	0.6	18.3	15.2	15.0	18.8	19.1	17.9	23.7	9.5	41.8	26.7	12.7	8.3	17.8	0.0	3.8	34.9	1.0	10.9	32.0	11.6	35.2	26.0	41.7	13.2	53.7	30.1	32.1	22.2	5.3	1.6	1.2	2.6	1.9	1.3	3.3	2.5	2.4	2.3	1.1	2.1	2.1	2.3	0.9	2.2	0.8	2.3	1.3	0.7	10.3	8.9	43.9	14.8	8.0	22.4	17.7	13.6	16.6	13.5	26.3	22.0	20.9	44.8	25.4	34.0	18.8	3.1	15.3	4.1	1.8	54.4	21.1	8.0	15.2	15.7	10.5	51.5	77.2	0.5	27.1	8.7	21.5	22.2	8.3	19.3	6.8	11.6	19.7	22.7	49.8	33.4	1.2	10.4	9.7	25.4	8.2	10.9	10.0	8.0	12.6	11.8	20.1	16.2	6.1	28.6	16.1	11.7	5.0	22.2	23.2	37.5	12.9	40.6	8.2	26.7	61.3	37.0	10.7	3.0	14.0	31.3	6.1	26.1	7.7	90.2	13.1	9.1	7.5	6.6	3.9	3.3	2.7	0.4	17.0	8.7	17.0	36.5
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type palmitoyltransferase 20"	Q5W0Z9	13	21372571-21459370	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	10.9	9.2	15.2	17.6	52.9	30.0	11.5	51.8	23.3	16.2	0.0	16.9	19.3	13.8	9.6	30.2	10.9	17.1	7.9	12.0	27.0	6.7	9.8	17.0	18.0	70.8	40.7	9.7	9.0	8.9	4.4	18.8	60.3	15.1	16.1	5.6	8.5	12.2	4.0	22.1	19.0	15.2	35.1	16.1	39.5	31.7	40.7	22.6	16.4	9.4	19.5	22.9	9.3	95.0	32.9	16.4	27.7	18.1	24.5	26.7	68.3	35.6	36.3	23.3	20.6	33.8	102.5	34.8	19.3	44.7	23.8	52.7	30.5	26.5	44.8	40.0	20.4	61.8	11.7	19.6	14.1	43.3	25.8	24.2	19.4	23.6	16.2	30.0	37.6	45.9	17.3	14.9	35.3	27.2	62.0	17.2	22.9	87.3	18.0	49.8	49.1	12.7	28.9	59.7	25.2	11.4	46.0	28.7	19.3	28.6	27.0	21.8	62.6	25.0	24.0	41.7	27.4	15.6	19.9	37.7	18.2	23.6	73.1	12.6	16.2	3.8	10.1	14.9	9.3	4.6	8.7	8.7	8.4	3.4	8.1	8.4	3.0	11.2	13.8	4.1	10.4	13.5	15.2	52.9	51.8	23.3	12.0	27.0	70.8	40.7	60.3	35.1	40.7	95.0	27.6	51.3	31.5	29.0	19.9	1.0	7.8	1.4	18.2	7.4	21.9	13.7	7.4	14.3	20.7	11.0	8.4	20.7	34.7	35.5	0.0	8.5	91.3	23.4	25.2	25.7	24.0	8.4	69.1	12.2	20.9	13.6	53.0	34.5	14.0	16.1	20.0	20.8	21.7	18.5	80.0	29.1	2.0	92.5	3.2	81.2	15.5	49.0	1.8	46.9	48.4	3.7	30.9	54.8	434.3	22.8	25.5	10.9	18.1	14.5	30.3	6.3	11.7	9.5	19.7	12.7	11.6	10.4	14.1	28.1	1.6	44.6	28.4	9.7	25.1	25.6
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type palmitoyltransferase 21"	Q8IVQ6	9	14611071-14693432	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	3.7	5.7	4.7	4.6	5.8	2.5	6.2	12.7	6.7	6.2	2.2	4.7	6.8	4.9	6.1	8.5	4.5	3.5	5.1	6.0	4.5	4.9	2.6	5.2	6.6	3.4	3.3	5.2	4.7	4.8	6.5	4.2	3.7	5.2	5.2	10.6	4.6	3.7	4.5	8.7	7.2	4.1	3.4	5.5	4.3	4.1	3.5	2.6	6.1	3.4	6.1	4.2	6.7	4.7	7.1	3.6	6.9	4.6	1.1	1.2	5.3	8.9	2.7	3.1	3.5	1.8	3.3	7.0	2.1	6.2	3.9	4.5	4.8	2.9	4.4	14.1	3.7	29.9	8.3	3.5	3.6	5.3	9.5	2.3	6.6	3.6	2.3	5.7	18.4	2.8	2.5	0.8	5.5	3.9	1.2	5.1	4.8	3.0	6.7	0.0	3.3	3.5	9.6	7.8	4.2	11.3	4.1	5.0	2.8	5.3	6.3	8.6	13.2	2.2	3.3	2.2	8.3	2.8	5.6	0.0	4.6	0.3	2.3	0.2	0.1	0.0	0.4	0.3	0.4	2.0	0.4	0.4	0.0	1.4	0.3	0.4	0.0	1.1	0.2	0.5	0.6	0.2	4.7	5.8	12.7	6.7	6.0	4.5	3.4	3.3	3.7	3.4	3.5	4.7	18.0	22.4	24.1	132.9	46.6	9.6	9.3	8.1	13.1	45.1	23.0	14.1	23.2	24.3	18.2	44.1	43.8	8.8	27.7	31.9	5.9	16.0	5.3	18.1	23.5	18.4	15.6	7.2	219.4	17.9	7.1	14.0	26.5	24.6	10.8	36.7	32.9	10.1	11.1	37.0	201.6	14.6	10.2	15.5	8.2	7.7	19.3	11.8	1.8	107.7	17.7	65.7	41.2	268.9	158.2	35.9	14.1	31.2	20.8	12.4	46.7	11.3	12.7	49.4	6.6	19.7	15.3	22.3	26.6	24.4	20.0	7.7	14.4	10.5	13.9	16.1
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type palmitoyltransferase 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 26.7;Excitatory neurons: 72.2;Late spermatids: 41.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 5.4;basal ganglia: 7.3;cerebral cortex: 9.4;hippocampal formation: 7.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.1	1.0	5.4	3.0	7.3	1.2	2.6	0.0	9.4	1.4	13.2	9.4	7.3	1.2	1.5	1.5	2.4	1.6	1.0	7.4	0.0	5.5	4.0	3.2	2.8	0.0	0.0	0.9	4.8	7.4	3.2	0.9	0.0	2.5	11.5	3.6	6.6	1.8	1.2	3.8	6.8	1.3	0.0	2.4	6.2	12.2	0.0	1.2	6.1	0.9	3.8	1.9	1.5	0.8	17.8	4.4	0.5	10.1	1.5	0.3	14.8	6.9	2.1	1.3	2.0	7.1	11.6	8.1	5.9	4.0	11.0	11.4	13.0	1.9	2.2	4.9	6.0	7.5	7.0	4.4	0.5	8.5	6.7	0.3	2.2	0.3	0.8	1.6	1.1	8.5	0.0	4.6	0.2	10.2	7.0	0.5	3.1	18.2	4.9	1.2	5.8	6.8	7.0	8.6	17.6	4.4	5.3	17.5	3.3	3.9	10.5	2.7	0.3	4.8	9.6	1.0	3.1	5.2	7.3	13.2	4.1	5.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	5.4	7.3	0.0	9.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	0.0	1.5	12.1	10.5	3.1	2.0	2.3	0.6	2.1	4.8	4.2	1.4	7.2	2.2	16.5	8.4	0.9	2.7	21.8	0.0	2.1	26.7	13.6	1.6	2.8	13.8	0.4	72.2	1.9	1.6	1.0	9.2	8.5	0.0	3.2	4.2	6.4	0.4	0.0	4.0	12.7	0.0	0.3	2.2	41.0	1.2	1.3	3.6	2.8	1.0	4.2	0.0	2.5	5.4	0.7	8.3	0.0	2.3	3.9	10.9	4.4	8.7	0.9	0.0	1.7	0.7	18.2	2.9	2.1	2.7	0.3	1.3	0.9	12.6	1.7
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546235	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA016619	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	5.2	6.9	5.8	3.3	4.5	5.0	4.7	4.2	5.4	3.6	5.8	3.5	2.8	4.3	5.1	4.3	3.9	2.2	3.6	4.9	5.2	6.2	4.6	4.5	4.3	5.5	5.2	2.7	7.1	6.0	4.7	2.5	4.8	4.5	2.1	2.6	5.0	2.7	2.9	5.1	4.7	1.9	4.4	7.2	4.8	3.7	6.4	3.1	5.9	1.1	3.0	4.0	3.4	4.5	5.2	7.4	2.4	6.5	5.8	4.7	6.2	3.9	3.4	3.1	2.1	6.5	7.7	1.6	11.5	3.3	8.3	11.9	1.9	3.4	2.1	7.6	4.9	2.9	3.7	4.1	5.5	3.4	6.9	5.6	6.2	2.5	3.6	3.7	5.1	13.0	4.2	4.3	4.0	10.4	7.4	8.6	5.3	12.2	7.6	8.8	5.3	9.3	3.9	3.6	3.5	5.6	6.7	6.5	11.6	2.7	9.5	2.4	8.0	7.1	2.4	8.3	3.1	6.9	2.2	2.1	6.2	1.5	8.2	3.0	5.9	1.0	7.3	5.7	6.6	6.4	6.0	8.4	7.2	7.5	3.8	5.9	2.2	8.0	5.0	23.1	6.6	6.1	5.8	4.5	4.2	5.4	4.9	5.2	5.5	5.2	4.8	4.4	6.4	4.5	21.7	12.8	8.3	7.8	21.9	8.0	15.2	26.8	10.8	9.6	21.5	15.2	4.5	22.8	17.3	23.9	10.4	33.0	49.9	29.0	9.8	50.3	13.5	15.1	14.4	23.3	14.4	6.3	7.6	49.4	37.2	15.0	17.9	19.8	8.9	18.5	23.2	14.9	63.9	23.5	7.0	17.8	20.3	42.8	14.8	12.1	7.5	27.9	17.8	5.6	36.4	16.9	46.4	4.0	8.5	42.8	40.6	9.8	15.8	24.9	54.8	35.2	14.7	10.3	19.7	11.2	15.1	29.6	4.1	21.6	8.1	24.1	23.3	18.5	21.8	23.1
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type palmitoyltransferase 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 570.7;Late spermatids: 1564.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	50.1	48.6	23.0	25.7	21.5	82.8	36.3	27.9	22.9	42.2	25.8	70.6	44.1	35.4	24.5	58.0	27.5	32.0	36.3	25.8	21.1	40.3	32.3	41.9	21.9	28.7	25.1	28.9	22.2	46.0	13.4	28.7	29.8	35.6	64.6	16.6	33.3	40.1	43.7	70.0	58.1	36.3	25.8	29.6	55.3	80.8	27.0	26.9	38.6	52.8	33.3	53.6	42.5	25.3	62.5	53.3	41.0	49.1	219.2	100.5	46.8	58.8	80.7	78.3	66.5	61.0	85.1	58.7	31.4	107.9	52.8	80.7	68.4	104.3	74.6	61.7	29.3	55.9	57.9	45.7	50.6	136.3	43.0	92.5	111.6	73.6	67.2	59.8	79.6	63.8	73.8	51.3	78.1	42.9	46.2	73.6	60.7	155.9	96.7	29.9	40.6	47.0	66.7	176.7	14.6	52.8	70.3	70.5	36.4	70.4	57.4	88.2	78.0	55.4	55.2	60.2	66.3	32.2	66.6	59.6	55.2	198.9	39.4	53.7	24.5	32.6	14.6	12.3	13.3	10.7	11.0	16.1	26.8	12.6	10.2	14.4	25.4	14.5	17.5	15.3	17.1	13.6	23.0	21.5	27.9	22.9	25.8	21.1	28.7	25.1	29.8	25.8	27.0	25.3	41.5	41.7	82.1	7.5	17.8	48.2	42.1	40.8	48.9	9.8	24.4	20.8	29.2	24.3	27.1	53.3	6.2	47.7	23.4	105.6	72.4	46.6	570.7	18.8	31.2	34.1	35.9	68.8	15.7	79.0	59.4	26.4	69.3	26.6	19.0	21.5	35.7	29.4	49.5	15.2	15.6	78.2	38.7	34.0	26.7	1564.3	51.9	37.4	24.9	18.7	35.6	25.1	34.0	15.1	11.2	115.8	73.1	44.8	26.2	73.7	112.9	30.1	20.9	10.6	19.7	15.6	31.9	104.5	45.3	70.5	60.2	101.7	25.0	26.1	72.8	128.9
ZDHHC4	"FLJ10479, ZNF374"	ENSG00000136247	"Zinc finger DHHC-type palmitoyltransferase 4"	Q9NPG8	7	6577434-6589374	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA032124: AB_10610699"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (6.82e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.18e-7)"	"unprognostic (8.75e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.94e-4)"	25.9	31.0	17.5	16.2	19.4	18.8	24.3	19.4	18.8	24.4	21.1	38.2	19.1	28.0	34.2	19.5	31.0	23.3	26.5	17.8	21.1	33.6	35.7	21.9	20.6	19.5	20.9	27.6	37.9	33.0	23.9	18.5	20.5	25.3	20.8	19.3	32.2	25.5	54.5	13.5	22.5	24.6	19.1	17.9	32.9	33.8	20.9	18.6	36.8	43.7	19.4	29.2	18.7	19.6	50.7	35.0	11.7	68.8	60.8	41.4	52.4	26.2	6.5	31.2	44.3	44.3	69.7	29.9	40.1	51.3	66.2	44.2	40.8	25.7	33.2	16.8	24.0	31.4	37.8	48.6	47.8	39.8	36.6	45.2	37.6	24.1	0.0	40.8	27.9	51.8	72.4	40.3	43.5	59.2	22.1	39.6	59.4	45.0	28.1	29.4	57.5	40.3	25.9	43.7	26.9	68.7	35.5	11.8	51.7	60.4	43.1	45.8	18.7	40.6	54.9	39.2	39.3	62.1	58.7	66.7	21.6	50.0	56.5	56.3	25.0	44.8	24.1	31.9	24.8	38.8	25.1	27.3	28.1	36.0	31.4	31.1	2.9	28.7	26.5	113.9	24.5	29.3	17.5	19.4	19.4	18.8	17.8	21.1	19.5	20.9	20.5	19.1	20.9	19.6	11.7	38.5	20.1	2.9	23.3	11.3	46.5	63.4	24.5	30.2	42.1	34.7	4.4	57.2	42.4	35.0	10.4	69.0	46.1	12.1	86.1	60.5	3.0	24.1	22.1	14.3	32.4	26.5	4.6	66.4	69.4	26.0	20.9	20.3	10.2	25.9	25.0	47.3	55.3	21.9	5.4	21.2	42.7	36.5	18.2	3.5	18.0	24.8	21.4	2.8	35.3	71.8	28.8	5.0	6.7	54.6	21.4	32.7	34.2	39.5	27.2	71.9	32.5	24.6	13.1	20.9	25.6	70.2	69.7	19.2	9.2	48.8	19.0	40.6	27.5	39.5
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type palmitoyltransferase 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	19.5	19.9	15.2	24.6	16.0	21.8	22.7	16.7	18.9	21.2	20.2	24.5	44.6	24.0	33.2	23.7	19.3	23.2	17.0	15.4	16.1	59.3	29.5	20.0	30.6	15.5	15.7	25.7	21.3	21.4	15.4	25.9	15.6	22.4	29.9	21.3	23.9	20.6	14.9	20.5	45.8	17.8	15.9	24.8	25.9	13.6	16.9	25.0	26.2	18.1	30.6	23.9	20.8	17.9	51.7	39.4	40.3	50.2	38.2	28.8	28.5	49.3	46.7	38.2	45.3	37.7	89.6	28.4	22.1	30.2	43.0	60.0	33.8	31.5	44.3	67.0	41.4	29.4	46.4	47.3	24.7	67.9	49.5	21.9	20.7	41.9	48.9	58.7	48.6	42.0	32.4	46.1	41.7	43.3	38.1	75.6	23.6	57.0	32.1	31.4	51.1	26.6	45.3	28.1	15.0	20.9	25.5	40.1	49.1	31.4	22.4	49.2	34.8	43.7	27.6	29.5	47.3	25.7	31.7	37.5	38.7	118.0	29.0	10.4	17.4	21.6	14.7	16.2	18.9	16.7	16.7	18.5	16.6	14.0	14.1	15.9	11.3	16.0	13.7	13.6	23.9	15.9	15.2	16.0	16.7	18.9	15.4	16.1	15.5	15.7	15.6	15.9	16.9	17.9	21.0	22.4	20.1	11.8	35.9	20.3	31.9	23.2	23.9	11.0	21.9	16.1	14.3	31.5	27.4	35.0	8.4	34.8	25.7	31.3	60.7	35.8	72.4	14.9	15.5	18.7	11.4	26.1	15.0	29.8	46.9	17.9	16.3	23.8	23.5	17.8	19.2	21.2	34.4	15.2	15.7	22.7	10.2	20.2	35.9	17.7	16.1	28.6	12.4	12.2	22.2	21.0	23.7	15.1	14.4	31.2	27.9	19.5	23.7	25.7	66.9	39.7	13.4	15.5	6.6	13.9	18.2	11.7	12.5	27.6	22.3	36.5	33.0	10.9	28.5	47.7
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type palmitoyltransferase 7"	Q9NXF8	16	84974175-85011535	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059054, HPA059642"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"		"HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	33.0	28.1	19.0	24.7	18.8	64.2	26.8	21.4	18.6	40.0	27.1	42.5	27.1	36.8	12.8	27.6	27.7	31.2	31.2	19.1	19.8	35.4	30.0	37.2	26.5	20.1	21.0	27.7	26.9	35.5	19.6	33.4	20.3	32.8	32.4	10.3	24.1	20.0	56.5	31.8	33.5	30.0	19.1	35.4	44.7	14.1	23.5	16.1	25.5	58.4	23.5	37.4	33.1	19.6	63.8	55.0	28.5	34.5	123.1	92.3	38.9	57.4	110.8	88.4	43.7	58.3	72.4	29.1	32.7	93.5	29.0	65.6	37.1	76.1	110.9	16.4	29.7	21.0	22.0	66.5	51.5	40.0	21.2	76.7	85.4	72.5	41.5	56.0	46.1	26.7	68.9	9.7	56.8	75.8	27.0	38.1	44.3	53.2	39.5	33.6	26.2	15.7	86.4	82.5	24.2	29.8	74.3	40.9	36.1	43.0	77.6	24.0	67.9	53.1	39.9	49.8	34.3	33.5	51.0	65.5	50.1	29.1	43.0	7.5	9.7	8.3	2.1	8.2	2.6	1.4	2.0	1.7	6.3	2.2	1.5	2.2	6.4	1.4	7.2	4.3	0.5	3.6	19.0	18.8	21.4	18.6	19.1	19.8	20.1	21.0	20.3	19.1	23.5	19.6	13.3	32.1	25.2	12.1	10.8	13.3	21.5	25.4	17.1	9.2	16.2	13.2	22.5	12.8	17.9	16.5	6.2	18.5	15.7	37.7	1.9	14.1	9.7	15.5	20.1	12.2	12.6	11.6	16.4	15.6	24.9	23.0	28.5	29.1	3.8	14.3	15.0	11.6	28.1	15.2	16.2	29.4	14.2	46.8	26.7	10.9	17.4	36.2	16.0	19.7	42.9	5.9	21.6	13.6	14.7	30.0	33.9	21.1	15.2	26.2	22.1	9.5	32.6	6.7	13.1	13.7	14.9	8.3	13.0	20.1	12.8	16.1	13.4	6.8	34.7	35.3
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type palmitoyltransferase 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	31.6	31.2	13.8	18.6	15.1	10.7	30.4	11.3	26.4	32.6	0.0	22.8	12.1	31.2	7.5	29.3	27.7	13.0	31.6	13.9	7.0	30.4	36.1	31.0	17.1	12.2	10.0	34.6	35.6	14.4	41.3	16.9	9.9	28.1	7.0	7.4	27.6	15.4	23.6	32.2	24.7	13.1	6.6	35.7	26.4	14.9	12.3	13.7	37.3	10.3	11.7	25.3	30.9	12.8	30.0	18.7	29.3	38.7	42.0	25.0	26.3	55.1	37.3	36.6	32.6	9.8	15.2	0.1	22.3	46.0	19.8	40.2	15.5	42.2	18.0	43.2	59.4	14.5	57.2	23.0	34.5	0.0	19.5	43.7	27.9	28.2	23.6	22.5	41.4	21.0	101.4	22.8	33.0	14.7	17.8	39.1	14.9	13.2	29.4	37.8	25.6	10.9	15.6	35.9	46.9	23.7	22.4	10.7	26.6	13.1	0.7	20.4	48.0	82.5	59.8	46.8	25.0	32.6	11.5	11.7	24.2	18.7	24.8	1.3	0.4	0.1	0.8	0.5	0.4	0.2	0.2	0.4	0.1	0.5	0.4	0.5	0.0	0.4	0.2	1.3	0.7	0.2	13.8	15.1	11.3	26.4	13.9	7.0	12.2	10.0	9.9	6.6	12.3	12.8	17.4	3.2	3.1	17.6	3.7	9.1	3.8	3.6	5.7	11.9	8.2	8.1	7.1	4.3	3.5	11.0	14.6	3.6	9.2	4.3	1.9	5.2	0.5	4.3	15.7	11.5	4.2	0.8	16.6	4.5	8.5	9.3	10.2	8.7	5.7	8.7	10.4	9.8	4.9	13.5	9.9	5.9	10.2	5.0	5.0	2.1	10.8	5.7	5.4	9.4	3.7	7.4	1.0	13.0	13.3	7.7	5.4	14.7	2.7	7.6	2.7	2.1	1.5	10.8	6.6	10.5	6.8	1.4	3.8	5.5	9.8	3.4	4.2	8.0	5.0	3.4
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144521057	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 363.7"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 154.0;THP-1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	61.3	45.2	185.6	56.8	258.3	127.5	29.5	138.3	165.5	52.4	3.0	24.5	21.9	29.6	9.6	27.9	20.3	43.9	45.7	132.5	155.4	18.2	23.3	41.2	43.2	238.3	214.5	70.5	5.7	6.7	3.3	62.1	222.8	18.5	29.9	35.5	9.6	22.7	20.8	12.8	25.9	33.3	183.2	69.4	18.0	16.2	249.6	10.6	13.3	18.8	24.2	46.6	24.1	363.7	1.6	2.0	83.4	0.1	98.9	49.7	0.3	35.1	35.1	38.5	37.1	0.0	0.8	6.6	0.1	37.4	10.6	0.4	14.5	0.1	47.6	37.6	11.2	154.0	6.3	0.2	23.0	26.4	113.2	42.1	0.9	48.9	22.9	33.7	29.4	0.0	43.0	4.1	45.2	0.2	0.4	79.9	12.3	0.0	1.9	44.1	63.5	0.2	0.4	0.6	0.7	22.1	4.2	0.2	97.3	27.5	0.2	181.4	45.9	42.9	0.7	87.5	11.0	47.1	0.3	7.5	66.7	78.4	122.6	27.8	47.7	12.2	21.0	42.6	1.9	9.2	2.7	10.7	27.0	9.4	1.9	7.7	15.2	7.3	43.9	21.5	0.6	19.0	185.6	258.3	138.3	165.5	132.5	155.4	238.3	214.5	222.8	183.2	249.6	363.7	32.6	6.4	19.2	121.8	92.4	24.9	1.2	0.6	3.4	158.6	2.2	4.3	71.0	1.5	10.1	5.5	4.2	1.7	426.2	0.1	1.9	0.7	2.2	2.1	84.7	29.2	0.0	127.0	228.2	0.8	2.0	123.0	13.3	2.5	157.5	99.3	79.2	4.6	144.5	662.9	539.3	0.0	0.0	435.0	276.3	7.2	120.5	435.0	103.2	343.8	233.6	69.3	223.5	381.0	1489.6	0.2	1.1	66.5	132.3	1.8	0.0	10.3	4.0	11.9	184.1	185.0	198.7	2.9	11.3	3.4	19.6	4.7	136.7	108.8	0.4	2.2
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	30.3	26.8	15.2	14.8	15.9	28.6	41.8	19.1	21.4	30.8	11.8	27.6	25.8	35.3	26.9	28.3	32.0	24.2	22.2	15.6	17.4	30.7	35.5	24.5	26.8	15.4	15.7	55.7	53.8	32.3	21.7	18.9	16.7	28.1	29.9	21.0	39.9	26.5	21.6	20.7	23.6	32.5	14.0	25.2	30.0	9.2	16.0	31.8	58.1	27.9	29.6	32.1	23.5	16.4	74.1	23.5	31.3	29.4	40.5	86.0	31.0	42.5	57.8	38.3	48.0	26.4	56.8	72.5	49.1	32.5	41.4	47.2	35.9	61.7	57.4	60.1	36.8	41.1	35.1	29.5	78.7	53.9	26.6	70.8	138.4	26.0	239.0	64.6	46.9	70.6	61.1	96.7	38.6	46.0	65.4	35.6	9.6	147.5	70.1	43.8	26.2	32.5	48.1	67.1	30.8	21.6	30.1	19.3	71.6	35.2	62.6	38.7	29.7	27.2	39.4	38.5	60.5	38.2	26.2	45.3	30.9	4.6	21.9	16.8	29.5	8.4	21.8	21.3	36.7	36.4	35.2	28.8	40.8	27.2	46.6	36.1	2.9	37.0	25.8	24.3	44.1	36.0	15.2	15.9	19.1	21.4	15.6	17.4	15.4	15.7	16.7	14.0	16.0	16.4	44.1	25.6	38.3	14.4	47.9	95.8	73.0	73.0	88.2	27.3	49.7	63.6	18.8	41.5	41.4	25.8	4.2	33.8	32.8	10.0	103.7	27.4	3.4	20.1	25.3	42.8	23.4	31.5	49.2	49.4	45.6	36.3	32.1	21.4	34.9	28.9	41.7	22.5	29.1	23.5	45.3	33.6	36.7	47.7	75.0	3.7	39.7	29.1	49.8	20.6	35.2	15.3	23.7	26.7	29.0	33.6	24.4	29.7	44.4	72.2	28.4	80.1	20.9	15.2	32.9	42.6	48.1	18.5	17.3	53.0	78.4	32.7	42.6	49.1	33.3	61.5
ZFAND2A	AIRAP	ENSG00000178381	"Zinc finger AN1-type containing 2A"	Q8N6M9	7	1152071-1160759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019469	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA019469: AB_1859009"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.52e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (5.47e-7)"	"unprognostic (5.44e-3)"	"unprognostic (7.60e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.59e-2)"	27.0	26.0	57.7	10.6	58.9	80.5	24.1	62.8	98.9	18.1	52.7	26.4	17.8	20.7	14.7	21.5	18.8	18.1	18.5	63.0	61.3	30.8	81.1	32.5	15.4	58.7	60.4	20.9	33.8	16.4	22.4	21.1	60.8	23.2	18.1	15.1	19.6	12.1	13.2	20.3	19.9	14.4	60.3	24.3	32.5	26.9	59.3	13.4	27.0	7.9	11.8	25.2	21.7	66.2	44.7	50.6	12.8	29.3	28.6	20.3	20.3	40.1	32.6	40.1	30.6	35.7	35.4	14.5	15.8	33.5	63.3	59.8	10.2	10.6	40.5	11.9	21.1	9.8	22.7	179.8	54.4	29.2	19.3	19.1	34.2	32.9	58.3	28.2	14.0	32.8	56.0	33.0	29.6	69.6	8.3	32.8	51.8	105.8	69.3	25.3	2.4	23.0	16.5	19.0	18.6	19.0	14.3	39.1	50.5	26.7	40.1	58.5	18.2	29.6	23.2	34.3	54.7	40.0	51.2	27.3	29.1	32.5	64.3	71.6	25.8	34.2	31.3	24.7	28.8	32.3	28.1	33.0	18.7	34.5	26.9	23.4	31.8	33.2	25.3	34.6	39.5	30.0	57.7	58.9	62.8	98.9	63.0	61.3	58.7	60.4	60.8	60.3	59.3	66.2	65.4	32.1	17.2	4.2	40.6	22.6	490.1	27.6	46.7	15.6	39.8	34.7	17.9	22.8	17.4	7.3	16.7	18.9	49.1	211.8	23.5	21.6	9.7	46.3	33.4	40.7	126.9	17.2	5.6	39.5	46.6	50.8	54.0	83.8	116.4	9.7	20.3	50.3	40.6	11.8	5.8	207.9	18.3	29.2	119.6	12.6	13.4	121.1	32.0	1.0	31.6	23.7	21.6	2.5	7.4	65.7	310.4	18.0	89.7	255.2	29.3	34.1	13.1	25.6	0.0	16.6	40.5	47.1	39.0	64.8	27.7	65.9	156.4	13.3	123.6	322.2
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 144.0;Proximal enterocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	28.5	26.6	33.2	20.7	34.3	38.2	28.3	34.4	43.7	38.2	27.4	41.6	41.5	29.7	18.1	48.8	28.5	20.0	28.1	33.3	34.0	44.1	64.5	32.3	28.4	37.2	33.3	29.0	40.7	26.8	36.2	17.4	34.3	31.3	25.0	10.8	27.7	17.6	34.3	42.5	45.4	15.9	33.1	45.9	37.4	15.6	34.3	37.9	49.8	15.5	23.3	33.0	35.5	37.5	23.0	14.4	17.2	23.7	17.6	18.5	23.5	22.8	26.3	32.1	31.7	34.8	18.9	16.5	23.0	39.2	26.0	15.5	15.4	28.9	25.5	27.8	25.2	41.8	25.6	30.3	36.3	22.9	45.3	15.3	62.2	31.9	75.0	17.7	21.2	40.0	25.0	38.9	31.9	40.0	37.9	47.9	8.9	31.7	17.5	22.4	8.3	31.6	29.6	17.7	33.7	16.3	10.9	17.3	24.8	19.3	15.4	47.3	22.5	32.2	29.5	37.2	33.3	20.2	6.6	34.1	31.5	44.2	25.6	30.8	34.8	48.6	49.1	46.0	42.5	43.6	44.2	48.0	26.7	53.0	39.9	48.9	58.3	53.5	38.3	33.5	51.6	44.3	33.2	34.3	34.4	43.7	33.3	34.0	37.2	33.3	34.3	33.1	34.3	37.5	30.4	22.4	21.2	17.6	43.5	27.1	26.3	34.0	19.9	14.9	37.1	33.7	12.7	44.3	24.5	20.2	14.6	26.9	52.4	144.0	56.7	44.1	4.9	14.6	17.7	26.4	40.2	15.2	17.8	66.0	24.3	19.6	42.3	20.7	32.4	11.6	23.6	39.4	34.9	8.4	16.1	67.5	36.7	32.4	31.3	7.8	32.0	35.6	35.6	5.6	24.4	21.5	44.3	6.0	15.3	60.3	101.1	29.7	39.5	25.1	170.6	79.5	13.8	17.2	26.3	15.9	28.7	6.2	22.9	27.6	36.1	51.3	46.7	27.8	54.4	28.8
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819727-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 821.8;Late spermatids: 3021.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	44.2	42.3	36.6	31.7	38.0	42.6	36.4	36.8	36.4	42.6	33.2	50.3	39.3	41.2	35.3	37.4	33.4	36.3	51.1	37.0	41.4	47.7	53.3	37.8	28.1	46.2	40.8	32.3	39.0	56.6	33.8	48.8	41.5	35.3	32.1	39.4	32.8	46.1	137.8	33.8	39.5	46.9	39.2	31.6	42.0	113.0	38.2	39.7	52.0	67.3	29.3	49.3	31.2	42.9	59.1	33.8	116.8	82.8	72.4	75.9	42.5	88.6	115.6	87.3	92.8	68.4	33.4	24.6	71.8	106.8	96.2	39.5	48.3	73.4	122.3	102.2	30.6	75.6	17.3	65.3	171.0	29.5	59.4	96.1	93.7	91.7	157.0	101.6	76.8	56.9	37.3	48.1	68.4	50.6	50.2	27.0	33.4	84.5	38.4	52.4	48.4	29.6	79.5	94.0	74.2	63.2	54.6	43.6	151.5	98.1	70.2	61.5	81.5	87.2	66.2	47.5	58.8	47.3	47.7	74.2	32.4	47.1	91.9	0.5	1.7	6.1	1.5	1.7	1.1	1.3	1.1	1.2	0.9	1.9	0.9	1.5	6.0	1.6	1.3	2.9	1.5	0.9	36.6	38.0	36.8	36.4	37.0	41.4	46.2	40.8	41.5	39.2	38.2	42.9	25.4	22.4	11.5	241.0	27.0	27.3	30.9	20.0	52.9	25.8	19.8	19.4	23.0	25.8	11.6	47.8	22.9	35.0	23.2	55.2	74.3	27.3	821.8	25.4	26.6	28.1	16.2	22.5	332.7	29.3	33.1	27.2	31.6	33.2	5.1	33.9	27.5	48.8	33.8	30.3	262.9	30.5	6.1	43.7	44.3	3021.1	38.8	49.2	14.2	283.9	32.9	47.4	34.0	276.0	316.4	38.9	29.1	55.3	28.3	52.3	57.6	38.2	17.2	21.6	32.9	32.9	31.2	63.5	54.1	41.3	30.1	86.1	31.2	21.1	21.5	61.2
ZFAND4	"ANUBL1, FLJ40185"	ENSG00000172671	"Zinc finger AN1-type containing 4"	Q86XD8	10	45615500-45672780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 37.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 414.6;Late spermatids: 689.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"Daudi: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057543, HPA074103"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA057543: AB_2683461, HPA074103: "	"unprognostic (1.57e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.85e-5)"	"unprognostic (3.23e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-3)"	2.2	3.3	1.8	2.0	1.9	2.2	3.0	4.0	2.1	2.6	1.9	2.1	2.1	2.4	1.5	1.6	2.7	1.4	2.5	1.5	2.4	2.1	3.8	2.2	4.9	2.3	2.4	2.4	2.4	1.4	3.0	1.2	2.3	2.6	2.2	2.2	2.3	1.7	2.2	3.2	2.0	1.8	2.1	2.5	1.9	37.4	2.3	3.2	3.4	1.6	4.7	2.1	2.2	2.4	1.0	0.7	1.4	2.1	3.2	2.5	0.0	1.4	2.4	1.3	1.4	0.0	1.0	34.6	1.7	0.9	1.9	0.3	1.1	0.9	1.6	5.6	1.7	1.0	1.1	0.8	2.4	0.0	6.8	2.2	1.7	0.5	1.3	1.0	1.2	4.5	0.9	5.8	1.5	0.1	3.3	0.7	1.4	1.1	0.9	0.5	1.1	0.0	1.1	0.9	2.7	1.8	1.1	1.3	1.1	1.5	2.9	1.9	1.1	0.5	2.5	2.1	1.7	4.6	8.2	0.0	1.0	3.4	0.6	0.3	0.2	0.0	0.4	0.1	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.4	0.0	0.7	0.4	0.1	0.3	0.1	1.8	1.9	4.0	2.1	1.5	2.4	2.3	2.4	2.3	2.1	2.3	2.4	2.5	6.4	3.1	22.5	7.6	0.8	3.3	1.0	5.7	7.9	4.0	2.2	3.9	4.3	0.7	1.8	27.1	0.3	7.1	3.7	1.9	1.1	414.6	6.5	3.4	2.8	1.8	5.7	3.3	1.8	0.4	3.1	4.6	1.8	2.5	3.0	3.3	5.6	2.2	3.3	23.2	2.5	0.0	2.5	1.0	689.8	6.5	2.3	3.6	13.1	2.2	4.1	1.0	47.3	39.7	1.3	0.5	3.0	10.3	3.9	1.6	3.7	8.9	8.7	6.6	4.5	2.2	86.3	13.5	3.2	2.3	0.1	7.0	4.0	2.7	1.9
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351413-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 591.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 450.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	312.2	187.7	99.9	55.3	112.7	145.7	150.0	105.5	136.0	97.6	70.9	88.1	39.4	91.0	115.7	99.8	120.6	87.3	117.7	103.9	107.8	114.9	204.7	108.5	46.9	93.9	113.3	250.4	73.6	69.1	138.8	79.2	105.6	76.8	49.2	50.7	69.8	121.4	591.1	75.4	69.0	94.9	100.5	60.4	95.5	88.5	105.9	52.3	79.2	273.9	59.1	108.9	87.1	110.8	115.9	113.0	138.8	59.4	156.5	77.3	104.3	131.9	178.9	71.1	55.1	14.5	112.6	60.4	81.3	194.5	105.2	122.4	305.1	50.4	103.4	450.1	43.1	53.5	57.7	70.1	120.4	74.7	71.1	99.0	87.6	72.7	79.2	156.3	122.1	60.4	49.8	82.1	82.6	31.3	96.3	38.8	178.9	107.2	74.3	74.1	72.4	70.5	218.4	109.3	101.2	86.4	85.2	91.2	117.2	142.1	42.1	64.3	97.1	57.4	71.7	104.7	90.9	113.9	110.3	38.1	77.2	49.1	146.3	39.0	35.9	37.3	11.2	52.1	12.0	17.0	14.6	14.1	33.6	15.1	13.2	12.2	27.7	19.2	81.6	6.2	11.2	23.9	99.9	112.7	105.5	136.0	103.9	107.8	93.9	113.3	105.6	100.5	105.9	110.8	370.7	176.3	192.1	102.8	125.8	339.2	573.2	130.6	376.7	93.9	267.0	207.1	322.6	92.9	132.6	132.4	75.0	145.1	118.6	213.3	148.7	145.8	91.8	257.1	291.9	195.3	136.7	155.6	45.7	142.6	164.8	270.8	145.2	527.6	109.2	116.1	97.5	308.3	198.0	40.4	38.6	119.8	126.1	290.6	320.1	44.5	118.4	470.1	208.1	31.9	268.8	84.2	53.5	38.7	67.2	185.9	221.3	93.3	149.3	329.9	87.2	127.1	109.2	70.6	85.5	674.9	285.2	148.7	116.4	298.1	291.2	226.3	165.5	102.9	109.4	528.2
ZFAND6	"AWP1, ZA20D3, ZFAND5B"	ENSG00000086666	"Zinc finger AN1-type containing 6"	Q6FIF0	15	80059568-80138393	"Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 496.7;Late spermatids: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034845, HPA052746, HPA077824"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA034845: AB_10671234, HPA052746: , HPA077824: "	"unprognostic (2.04e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.48e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (8.20e-4)"	63.2	70.2	41.3	48.4	43.1	79.9	65.4	54.5	48.8	47.8	48.7	61.5	54.8	58.2	66.2	54.9	54.9	49.8	90.5	42.1	50.1	76.3	123.5	55.7	73.2	50.6	46.4	40.8	42.1	60.6	41.2	50.6	47.7	56.3	61.1	74.2	52.9	50.6	128.5	44.0	53.9	59.8	53.7	60.9	59.6	135.9	44.0	50.9	100.9	109.8	75.5	55.2	43.1	57.2	78.9	161.0	116.9	67.3	118.0	93.4	110.3	91.7	127.2	78.7	107.0	56.6	133.6	87.5	115.7	94.3	76.6	63.1	125.9	92.3	83.8	52.8	107.2	207.1	72.7	78.5	138.2	74.7	131.9	83.3	117.8	87.3	117.7	108.3	120.0	74.4	84.5	66.8	87.3	83.3	59.5	74.0	73.6	70.3	53.4	48.1	102.6	200.8	196.3	129.4	23.9	68.8	79.2	91.0	238.4	144.5	89.1	106.7	111.5	82.1	66.5	53.2	89.8	88.9	189.1	102.6	85.0	127.1	58.6	505.1	90.0	290.1	93.6	118.9	82.5	226.4	84.7	91.2	103.1	174.4	88.2	98.4	216.3	85.0	167.1	89.5	91.2	135.7	41.3	43.1	54.5	48.8	42.1	50.1	50.6	46.4	47.7	53.7	44.0	57.2	60.5	54.5	86.8	76.0	122.5	149.5	141.3	236.1	46.7	40.3	96.2	60.1	92.7	85.8	147.8	75.4	41.7	125.3	101.1	95.9	199.6	103.7	496.7	102.0	57.0	75.0	82.6	97.2	18.1	98.3	130.8	75.0	69.8	135.3	105.1	57.0	72.8	154.6	144.2	32.0	27.7	88.6	203.4	96.1	173.5	598.2	53.1	109.8	124.5	78.7	167.2	101.3	91.6	61.9	73.9	126.5	107.6	62.8	92.7	174.1	64.8	278.8	168.3	89.9	92.1	70.0	98.6	230.6	173.3	62.8	169.3	392.8	87.0	67.6	67.3	183.4
ZFAT	"KIAA1485, ZFAT1, ZNF406"	ENSG00000066827	"Zinc finger and AT-hook domain containing"	Q9P243	8	134477788-134713049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 31.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.5;dendritic cells: 35.6;Early spermatids: 49.3;Late spermatids: 53.0;Syncytiotrophoblasts: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	24	"plasmacytoid DC: 34.5"	"Lineage enriched"	"Detected in many"	24	"dendritic cells: 34.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020989, HPA063592"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"	Nucleoplasm	"HPA020989: AB_2670552, HPA063592: AB_2685051"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-3)"	"unprognostic (5.91e-3)"	"unprognostic (2.45e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.33e-1)"	2.2	1.4	0.8	2.8	0.9	1.2	2.1	0.5	1.4	1.8	1.7	4.7	2.3	2.5	2.0	2.6	2.0	1.2	2.2	1.0	0.9	9.7	1.5	2.2	3.7	1.3	0.6	2.1	2.3	2.7	1.5	31.1	0.8	2.2	1.7	2.7	1.8	2.1	7.5	1.9	2.1	2.6	0.5	2.5	1.9	2.3	0.7	3.2	1.6	4.3	2.9	2.8	1.8	0.7	4.1	6.5	2.3	2.9	4.4	4.3	2.1	4.4	3.8	3.9	4.0	4.5	5.2	4.7	3.8	4.6	2.3	3.2	4.7	5.6	5.1	3.9	6.0	8.7	5.7	3.3	3.4	4.9	4.3	3.5	2.8	4.3	5.7	3.6	4.9	1.7	3.4	8.4	3.4	5.6	5.1	0.8	3.2	4.2	3.9	3.1	3.0	2.0	3.8	6.2	2.8	2.1	4.5	3.4	3.7	2.6	2.8	4.6	5.4	2.3	3.4	3.3	5.0	3.0	4.4	4.5	2.8	3.6	4.9	1.1	0.6	1.4	0.4	0.8	0.4	0.9	0.4	0.7	0.5	1.1	0.6	0.4	1.0	0.1	0.5	34.5	0.3	0.9	0.8	0.9	0.5	1.4	1.0	0.9	1.3	0.6	0.8	0.5	0.7	0.7	3.5	3.2	3.3	14.4	7.0	1.5	1.2	1.0	1.8	5.3	4.0	1.4	2.0	1.5	3.1	1.8	4.2	74.5	35.6	1.5	0.0	2.1	49.3	2.6	5.0	2.8	0.0	0.8	24.4	1.5	17.2	2.7	3.6	3.1	2.5	2.9	0.7	1.4	8.4	1.7	18.9	1.4	0.0	3.8	2.1	53.0	3.4	4.2	8.8	14.0	3.5	2.1	4.1	9.5	12.6	3.3	0.5	2.6	17.0	1.6	1.1	12.2	1.1	6.0	0.0	3.7	2.5	2.9	5.5	1.9	1.7	126.7	3.6	3.2	1.3	1.5
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609599-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	9.6	12.3	4.1	10.1	5.1	18.5	8.1	8.1	6.2	9.5	5.3	10.6	6.2	8.7	10.5	10.4	9.2	7.3	7.8	4.2	6.0	7.9	5.5	12.1	14.5	4.5	4.2	11.0	8.0	7.6	8.0	8.0	4.5	8.3	8.9	13.4	8.1	8.2	7.7	9.1	11.1	6.3	2.9	10.9	10.1	12.4	5.0	13.2	9.0	5.6	12.0	9.8	9.5	6.2	16.1	15.7	12.6	8.6	14.4	26.5	7.6	12.9	18.6	17.8	17.7	15.1	9.2	21.2	7.3	15.0	7.9	19.2	15.3	7.4	23.8	20.8	13.0	21.6	27.6	7.3	8.6	22.0	10.5	15.2	14.6	13.1	6.1	25.4	18.2	17.1	19.6	9.8	17.0	5.0	15.5	8.2	11.5	7.2	9.6	14.0	13.7	15.9	13.5	12.4	8.3	8.3	13.4	8.1	8.0	12.0	21.0	14.4	16.7	12.2	7.4	6.9	6.9	17.3	10.5	15.2	12.6	15.8	7.7	60.5	20.9	27.1	15.0	10.7	12.1	21.7	13.3	10.4	9.3	29.9	13.1	11.2	60.7	11.7	20.3	27.1	11.9	3.5	4.1	5.1	8.1	6.2	4.2	6.0	4.5	4.2	4.5	2.9	5.0	6.2	33.5	35.3	25.5	37.2	50.1	47.9	85.8	20.6	46.7	32.8	28.4	17.1	18.4	7.2	30.5	14.7	22.9	14.6	60.2	35.7	1.9	20.5	97.6	33.2	46.0	35.8	20.9	24.8	56.9	16.9	14.5	40.2	52.0	66.5	48.8	32.7	23.9	12.0	17.5	58.9	58.1	32.1	18.3	17.8	47.0	65.2	32.0	49.7	10.6	55.3	39.3	14.7	37.0	62.4	68.6	28.5	36.4	23.0	54.0	45.1	32.1	8.4	22.9	33.0	26.3	39.9	37.5	51.7	30.8	79.3	40.9	11.5	44.9	29.2	28.7	93.4
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520857-23556192	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;SuSa: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	0.5	0.7	1.8	0.5	6.3	0.1	0.4	11.9	5.3	0.4	0.0	0.7	0.1	0.7	0.4	0.2	2.2	0.4	0.3	3.2	0.0	1.3	0.2	0.5	0.3	1.5	0.1	0.5	0.4	1.7	3.4	0.2	0.2	0.6	0.2	3.1	0.4	1.2	0.7	0.5	0.3	0.6	0.0	0.2	0.4	7.3	0.9	0.2	0.7	0.5	0.2	0.3	0.2	2.3	0.1	3.1	2.4	4.8	1.6	0.2	0.1	0.7	0.2	0.3	1.2	0.3	0.2	0.2	0.3	0.0	0.3	0.1	1.2	0.1	0.5	2.2	0.8	2.5	0.0	0.6	0.2	0.4	1.7	0.3	0.1	0.5	0.1	1.3	0.3	2.1	0.4	0.4	0.1	0.8	0.3	0.3	2.9	0.3	0.7	1.4	0.0	0.0	1.3	1.2	2.7	1.7	0.4	0.6	0.1	3.6	1.0	0.6	0.1	0.0	1.2	0.7	0.3	0.3	1.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	6.3	11.9	5.3	3.2	0.0	1.5	0.1	0.2	0.0	0.9	2.3	0.5	0.0	1.1	22.5	0.7	0.1	0.6	1.1	0.0	9.0	2.2	2.3	2.5	0.0	2.4	1.8	0.0	0.3	0.1	0.6	1.9	2.8	38.9	12.2	0.6	1.1	6.7	0.0	31.0	2.4	0.0	1.4	2.0	2.5	0.0	3.2	0.7	0.2	1.0	8.4	20.0	0.7	2.0	1.0	1.9	19.1	0.6	0.8	0.0	4.7	1.0	2.7	0.0	27.2	20.8	1.2	1.2	0.4	0.1	1.4	0.4	1.4	9.8	3.8	0.0	2.5	1.3	16.5	1.2	0.7	0.0	0.3	0.4	0.2	0.6	0.3
ZFHX3	"ATBF1, C16orf47, FLJ26184, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 501.8"	"Cell type enhanced"	"Detected in all"		"Microglial cells: 285.8;Smooth muscle cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 501.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059353	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA059353: AB_2683987"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	6.0	4.3	5.9	1.9	5.8	0.9	3.6	2.8	501.8	5.2	7.1	6.0	1.5	4.7	4.0	2.0	3.6	4.2	3.5	68.3	12.1	3.2	3.1	4.3	1.2	72.3	13.7	2.8	4.0	9.7	3.9	6.2	49.5	6.9	2.6	4.5	4.0	6.4	9.9	2.6	2.6	4.1	11.3	3.1	3.6	1.8	12.5	1.3	7.4	10.7	0.7	6.8	3.5	56.5	5.0	9.2	14.7	12.3	5.3	6.7	15.1	3.9	4.3	2.5	2.8	10.6	2.9	2.3	5.5	7.5	3.4	3.5	9.4	4.7	3.4	9.3	2.3	0.4	13.1	15.1	4.9	1.6	3.5	2.5	2.8	7.3	6.5	2.3	4.7	1.0	1.1	0.6	6.3	10.9	0.5	3.1	2.4	2.7	1.5	7.0	4.0	0.8	4.0	8.8	10.9	3.9	6.9	2.1	4.8	6.7	3.0	0.7	10.3	6.0	7.0	6.5	4.9	4.7	1.7	1.6	2.9	1.4	4.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	5.9	5.8	2.8	501.8	68.3	12.1	72.3	13.7	49.5	11.3	12.5	56.5	13.6	70.5	26.7	109.7	8.6	17.0	55.6	13.1	37.0	122.0	24.5	20.6	23.7	47.1	34.8	47.8	22.9	47.4	5.2	11.0	5.9	23.0	2.6	94.6	33.1	40.3	26.9	7.4	22.0	23.4	19.4	68.8	25.5	154.6	21.0	20.7	44.6	37.5	67.0	23.5	8.7	23.2	22.4	84.2	142.6	2.8	10.5	72.9	21.4	285.8	40.8	13.9	3.1	83.9	18.5	20.7	22.4	19.9	2.2	77.5	6.9	7.4	29.3	34.1	124.9	153.7	177.3	3.7	16.8	29.5	17.2	62.1	7.7	12.4	31.0	43.8
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681239-76867281	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 358.5;Bipolar cells: 87.2;Oligodendrocyte precursor cells: 234.2;Oligodendrocytes: 222.6;Skeletal myocytes: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 16.8;TIME: 33.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	3.0	3.6	7.5	0.5	12.0	0.0	2.1	0.9	9.3	3.2	0.0	3.2	0.0	0.8	3.2	0.3	0.6	0.9	0.4	6.0	18.9	0.3	2.8	0.1	0.3	11.3	23.3	1.9	0.2	0.2	2.8	0.1	17.7	1.0	0.5	2.2	0.6	5.5	2.8	0.4	0.3	1.1	7.0	0.1	0.8	6.7	15.3	0.6	0.3	3.1	0.0	2.7	2.6	15.0	0.0	2.2	3.8	0.0	7.2	8.7	0.0	3.3	4.6	3.8	3.9	0.0	0.0	0.0	5.8	5.7	1.7	0.4	7.8	1.0	7.6	0.0	10.3	0.1	0.0	0.0	1.9	0.0	0.5	16.8	0.4	9.5	3.0	6.5	0.7	0.0	0.1	0.3	7.0	0.0	0.0	0.0	0.6	0.4	7.1	0.0	6.8	0.0	5.8	0.0	0.0	6.5	0.0	0.8	0.0	0.0	0.9	0.0	33.4	3.7	5.6	10.6	7.4	10.9	1.2	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	12.0	0.9	9.3	6.0	18.9	11.3	23.3	17.7	7.0	15.3	15.0	5.4	0.0	1.5	358.5	0.3	0.5	0.1	1.0	2.2	87.2	2.4	2.2	4.0	42.9	0.3	5.5	2.1	0.1	0.2	0.0	0.0	0.1	70.0	0.0	1.1	2.0	0.0	0.0	13.7	0.0	0.0	37.5	0.0	0.0	0.0	0.1	1.1	30.5	0.4	5.0	12.6	0.2	0.0	0.6	1.8	24.3	13.7	0.7	0.0	29.0	0.0	15.0	0.0	234.2	222.6	0.0	0.0	21.4	0.1	0.3	0.0	0.3	0.3	5.8	0.0	120.6	8.1	12.4	2.3	1.2	1.1	0.0	0.6	10.0	0.0	0.9
ZFP1	"FLJ34243, ZNF475"	ENSG00000184517	"ZFP1 zinc finger protein"	Q6P2D0	16	75148494-75172236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044916, HPA062910"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA044916: AB_2679144, HPA062910: AB_2684902"	"unprognostic (1.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (5.55e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-1)"	4.2	3.3	3.7	1.7	4.4	1.8	3.9	4.4	5.1	4.8	1.7	5.4	1.7	5.7	2.2	2.7	4.8	2.7	3.6	4.6	3.4	3.7	11.1	3.5	3.1	3.3	3.0	5.1	2.1	4.6	3.8	3.0	3.3	2.9	2.0	5.8	2.2	3.1	5.8	2.7	3.0	4.0	3.7	2.5	3.0	4.2	3.7	8.2	4.8	4.3	3.2	4.7	3.6	5.3	3.1	6.6	9.1	8.2	5.1	6.7	3.6	3.7	4.4	8.2	9.8	5.3	2.4	13.1	4.2	3.0	3.2	3.8	8.1	5.6	9.5	7.2	4.9	4.8	2.4	4.0	4.4	4.7	14.8	4.5	5.5	6.1	7.9	8.6	5.4	12.3	5.6	2.7	6.4	11.9	16.4	4.6	2.8	2.6	2.5	15.1	4.0	4.2	3.6	2.8	9.0	7.2	9.0	2.7	3.5	2.3	6.0	3.9	3.7	7.4	7.9	3.4	4.3	11.2	11.5	28.6	3.6	6.7	5.8	1.1	0.7	0.2	1.5	1.2	1.6	1.2	1.1	1.7	0.7	1.6	1.4	1.5	0.0	1.9	0.5	0.3	1.7	0.9	3.7	4.4	4.4	5.1	4.6	3.4	3.3	3.0	3.3	3.7	3.7	5.3	5.4	6.4	4.8	6.8	5.1	5.4	2.5	2.3	5.7	6.9	3.8	3.4	4.2	1.5	2.0	1.8	0.0	2.9	7.6	1.0	1.9	3.6	4.6	2.9	7.5	5.3	7.2	4.6	9.5	2.3	2.7	5.9	0.0	3.9	1.3	5.1	3.9	11.7	2.0	13.5	8.5	0.9	0.0	4.1	2.7	5.2	3.4	1.8	1.8	7.5	3.6	6.8	4.1	7.1	11.7	1.6	1.0	4.1	2.7	2.3	0.8	3.6	2.6	3.8	0.0	5.6	8.2	15.9	8.8	5.0	5.8	4.1	5.5	4.7	1.8	2.4
ZFP14	"KIAA1559, ZNF531"	ENSG00000142065	"ZFP14 zinc finger protein"	Q9HCL3	19	36334453-36379201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.2;Rod photoreceptor cells: 105.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030637	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA030637: AB_10602353"	"unprognostic (1.89e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.75e-5)"	1.8	2.6	4.0	2.5	5.2	1.1	4.1	6.2	4.7	2.9	6.9	2.3	2.8	3.3	5.2	1.6	3.1	1.9	1.7	3.8	5.4	3.2	2.0	1.9	3.7	4.3	4.5	4.2	1.9	4.7	3.8	2.1	4.7	3.0	2.0	9.0	2.2	3.0	1.5	3.2	2.5	2.2	3.7	3.6	2.5	1.1	4.4	3.9	4.4	1.5	3.5	2.4	2.4	8.6	1.5	2.5	5.1	4.7	4.3	2.1	1.2	0.7	2.2	1.4	2.2	1.7	1.2	4.2	1.8	1.0	1.1	0.5	2.1	0.3	1.5	1.6	1.6	3.7	2.5	1.4	1.4	3.0	3.8	0.9	0.9	0.6	0.1	2.6	1.9	4.8	1.1	0.0	2.2	1.0	4.8	1.2	3.8	2.2	1.1	3.8	2.9	1.2	1.5	2.9	2.8	4.2	2.6	0.8	1.5	2.6	1.6	2.4	1.3	1.4	3.2	1.5	0.7	1.1	1.9	2.1	0.2	0.4	2.5	5.6	2.8	4.1	4.1	3.4	4.4	8.1	4.7	5.6	2.8	6.0	6.5	6.6	1.7	4.5	2.9	4.2	4.8	1.3	4.0	5.2	6.2	4.7	3.8	5.4	4.3	4.5	4.7	3.7	4.4	8.6	12.0	0.0	5.3	17.9	25.5	3.2	6.7	4.5	8.0	63.2	8.5	6.1	6.5	20.0	5.9	12.9	52.1	8.2	18.5	8.2	7.9	8.9	2.8	6.5	7.9	11.2	13.2	10.3	32.9	4.5	2.4	9.3	7.7	4.6	13.3	22.1	12.5	4.3	8.6	47.1	39.5	8.3	6.1	8.5	4.6	0.8	15.5	8.8	3.6	17.8	15.6	16.9	44.3	41.2	56.2	4.9	13.0	19.5	4.9	7.0	13.9	12.4	11.3	105.3	32.9	10.4	9.1	7.9	8.3	3.0	2.6	2.5	17.3	15.2	7.7	7.2
ZFP2	"FLJ21628, ZNF751"	ENSG00000198939	"ZFP2 zinc finger protein"	Q6ZN57	5	178895898-178933212	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 15.0;Excitatory neurons: 10.9;Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 2.6;THP-1: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023364	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA023364: AB_2671173"	"unprognostic (2.07e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.79e-3)"	2.4	1.4	4.4	1.3	4.8	0.2	3.1	6.3	5.3	3.3	2.8	3.8	0.9	3.4	2.2	1.2	3.2	1.7	1.5	4.3	4.7	2.9	1.1	1.4	0.7	4.3	5.0	4.8	2.2	2.8	3.2	1.9	4.6	3.2	1.6	6.8	1.3	3.0	2.3	1.8	1.4	2.3	4.3	1.6	1.8	4.7	4.8	1.1	3.4	2.7	0.9	3.1	2.1	6.2	0.0	0.3	1.0	5.5	0.9	0.9	1.4	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.6	0.3	0.0	2.6	0.3	0.1	0.0	1.9	0.0	0.2	0.5	1.6	0.0	0.3	1.8	0.5	0.0	0.3	1.2	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.3	0.1	0.1	0.1	1.3	0.2	0.0	1.5	0.2	0.9	0.7	0.3	0.0	0.1	1.2	0.1	2.4	0.0	0.1	1.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.4	0.9	0.6	0.7	0.0	0.4	0.7	0.2	0.1	0.1	0.0	0.0	0.5	0.2	4.4	4.8	6.3	5.3	4.3	4.7	4.3	5.0	4.6	4.3	4.8	6.2	3.0	3.2	1.1	15.0	0.3	0.1	0.3	0.2	0.0	3.9	1.1	0.9	1.8	1.5	0.8	1.8	0.0	1.7	0.0	0.4	1.9	1.0	0.1	0.5	0.8	1.6	1.2	0.0	10.9	0.2	0.9	0.7	0.0	0.6	0.0	1.8	0.0	0.2	0.3	3.3	15.3	0.3	0.0	0.0	0.7	0.5	1.2	0.0	1.8	2.8	0.0	3.2	0.0	18.1	19.3	0.4	0.1	1.5	0.3	0.1	0.2	1.3	0.2	2.1	0.0	1.3	1.3	2.6	2.7	0.4	0.3	1.5	0.2	1.1	0.3	0.1
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556808	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	4.2	4.2	6.7	2.3	7.0	1.3	4.4	8.0	7.8	5.4	5.0	4.8	1.9	6.4	4.8	2.9	4.6	3.9	4.6	7.7	7.4	4.2	0.9	4.3	2.6	6.9	6.9	10.7	3.5	6.2	6.1	3.8	7.8	4.9	2.2	11.0	3.2	4.6	2.9	3.5	2.7	5.1	6.0	3.8	3.2	7.5	6.8	3.4	5.3	3.9	2.7	4.6	4.3	8.4	0.0	1.7	7.9	2.4	2.6	2.5	4.1	5.2	5.0	4.1	6.7	0.0	1.1	0.0	2.6	6.2	7.9	0.2	3.9	1.7	6.2	0.0	6.7	5.4	0.3	0.0	7.4	0.2	6.0	6.9	2.2	6.2	0.1	8.1	0.8	2.8	1.1	0.1	5.3	0.0	2.7	1.0	3.6	0.0	1.7	4.2	10.3	0.0	5.5	3.4	0.0	7.2	0.0	0.3	1.2	7.2	3.0	5.4	2.0	3.8	4.1	0.4	6.4	0.1	0.2	0.5	0.1	0.1	0.4	0.0	0.1	1.4	0.1	0.1	0.8	0.6	0.8	0.6	0.4	1.1	0.6	0.5	0.1	0.8	0.1	0.5	1.3	0.3	6.7	7.0	8.0	7.8	7.7	7.4	6.9	6.9	7.8	6.0	6.8	8.4	5.1	9.6	3.6	6.2	1.0	5.7	2.8	2.0	4.0	7.6	3.3	2.5	5.6	1.5	2.1	5.5	4.2	0.8	1.2	0.6	7.9	2.7	4.2	2.7	3.5	4.3	2.4	1.7	6.7	0.8	0.8	3.5	1.1	3.6	3.8	3.8	2.2	0.5	0.7	10.1	6.7	0.4	4.1	0.3	3.1	2.0	4.1	1.6	5.4	3.7	1.7	6.0	0.0	6.0	8.1	1.1	1.8	4.9	0.2	3.1	0.1	2.7	2.5	5.9	0.0	6.7	4.6	9.7	5.7	2.1	3.8	0.7	3.0	3.9	0.8	1.8
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078467-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;SH-SY5Y: 6.0;SiHa: 5.5"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	2.6	2.6	2.9	3.9	3.7	0.9	4.7	6.4	4.4	3.3	6.7	4.8	7.1	3.4	3.3	2.7	5.8	2.5	6.8	3.2	3.4	5.2	1.2	3.8	5.3	3.9	3.9	4.9	4.6	9.4	2.1	2.7	3.4	3.9	5.7	8.0	6.0	3.7	6.8	3.5	6.1	3.2	3.2	5.1	4.4	3.1	3.9	5.0	5.8	9.7	6.2	2.8	2.3	3.7	0.0	1.0	0.2	0.0	0.9	0.4	0.0	2.2	0.0	1.7	1.9	4.5	2.0	0.0	3.1	2.2	0.8	4.5	0.0	0.0	0.9	0.0	0.1	0.1	1.9	0.0	3.0	0.0	5.8	1.5	0.0	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	3.2	0.4	0.0	0.6	1.5	2.7	2.7	2.7	6.0	5.5	4.5	2.9	1.0	2.7	4.4	0.0	0.0	0.8	1.5	3.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.8	0.6	1.0	0.9	0.6	0.8	0.6	0.9	0.5	2.1	1.5	1.1	0.0	0.7	0.8	0.3	0.6	0.7	2.9	3.7	6.4	4.4	3.2	3.4	3.9	3.9	3.4	3.2	3.9	3.7	1.8	0.0	4.2	1.6	2.1	0.3	0.4	0.9	1.2	4.1	1.6	1.4	7.8	1.5	2.1	1.8	8.4	1.2	2.4	3.1	0.0	1.7	1.8	3.1	2.7	1.8	0.0	0.8	3.0	1.1	0.4	1.8	4.6	0.8	1.3	2.9	4.2	0.1	1.7	3.3	4.5	2.2	0.0	2.5	0.2	0.5	1.5	1.2	0.0	0.0	0.9	2.8	2.1	4.5	3.1	0.6	1.0	1.2	1.8	0.6	2.6	1.4	11.0	6.0	0.0	3.0	1.5	7.1	3.8	2.3	0.1	0.8	1.6	2.9	2.5	0.5
ZFP30	"KIAA0961, ZNF745"	ENSG00000120784	"ZFP30 zinc finger protein"	Q9Y2G7	19	37613749-37692337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030606	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA030606: AB_10602684"	"unprognostic (1.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.64e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-3)"	2.7	3.7	2.2	2.1	3.4	1.1	4.8	8.5	3.4	3.2	0.8	3.0	2.3	4.5	3.8	3.4	4.1	2.6	2.7	2.3	2.9	3.4	2.3	3.1	4.0	1.7	2.1	5.1	3.6	5.8	1.1	4.4	2.0	4.4	2.9	8.7	2.6	4.3	3.0	5.4	2.0	3.5	2.0	4.1	3.2	7.3	2.4	4.6	6.1	3.9	3.8	2.4	1.1	4.7	9.4	8.1	12.9	18.2	6.8	6.6	3.9	9.5	8.7	7.0	7.6	6.5	1.7	0.0	9.5	8.7	5.7	3.4	12.9	5.0	7.5	14.2	5.0	9.4	10.0	5.0	5.1	1.3	7.0	6.0	7.6	6.1	9.1	5.6	4.1	6.4	7.2	0.0	9.1	4.3	10.3	4.8	2.8	1.2	5.5	4.0	16.8	0.1	4.3	15.3	14.4	15.6	11.1	4.3	3.4	5.1	5.9	2.5	9.0	9.5	32.5	4.6	9.6	4.9	5.5	5.9	0.0	0.1	7.3	2.2	0.5	1.3	1.1	0.6	1.5	0.5	1.4	1.1	0.4	2.1	1.7	1.8	0.3	2.8	0.2	0.9	1.1	1.0	2.2	3.4	8.5	3.4	2.3	2.9	1.7	2.1	2.0	2.0	2.4	4.7	4.6	6.4	1.8	9.8	6.7	0.8	1.2	1.5	2.8	11.4	2.6	2.5	7.3	4.3	2.7	3.7	4.2	2.6	3.0	1.4	1.9	3.4	60.5	3.5	5.5	6.3	4.2	1.7	17.6	2.3	1.6	5.1	4.6	3.6	9.5	7.3	3.6	0.9	2.5	8.4	19.1	3.1	0.0	2.1	1.1	14.3	7.5	2.4	0.0	11.2	1.6	4.8	5.2	20.1	17.5	1.8	0.8	6.4	1.4	1.8	0.6	2.8	3.2	9.2	6.6	5.4	4.6	9.4	5.2	2.9	0.4	0.8	4.0	4.1	2.2	0.7
ZFP36	"G0S24, NUP475, RNF162A, TIS11, TTP"	ENSG00000128016	"ZFP36 ring finger protein"	P26651	19	39406847-39409412	"Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, RNA-mediated gene silencing, Transport"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 154.7;hTCEpi: 179.0;Karpas-707: 167.0;U-266/84: 149.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 151.4"	HPA006009	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA006009: AB_1859030"	"unprognostic (2.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.20e-1)"	"unprognostic (3.61e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.20e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.92e-3)"	1520.5	341.7	46.9	258.1	49.9	745.3	716.3	55.6	74.0	517.1	71.2	582.4	168.3	316.1	17.0	645.5	1276.8	520.0	575.4	42.8	84.3	288.1	462.0	1135.1	175.1	130.5	63.1	480.5	160.6	124.5	311.5	120.9	68.5	342.3	175.6	39.2	329.7	143.6	322.8	828.9	322.5	426.0	78.8	282.1	554.4	49.4	86.3	269.6	510.2	281.6	73.1	523.2	712.5	79.6	27.5	16.5	4.3	1.5	108.8	154.7	7.7	20.8	26.7	11.2	8.7	12.8	28.3	16.8	6.2	32.7	12.1	13.2	1.0	35.0	3.5	21.1	1.6	7.2	12.1	8.0	70.2	7.4	41.6	56.7	179.0	8.0	66.3	14.6	6.6	18.7	10.2	167.0	19.4	21.5	13.2	17.7	1.6	83.4	2.6	18.9	2.3	35.9	14.9	43.6	1.2	4.2	10.1	23.6	6.1	6.3	16.8	39.8	11.4	15.3	6.1	28.2	6.3	116.5	149.7	19.5	15.4	15.1	6.4	121.8	72.2	68.8	38.8	69.9	32.8	47.8	33.4	39.5	69.0	45.5	38.0	37.0	313.6	17.4	95.5	50.9	41.9	44.3	46.9	49.9	55.6	74.0	42.8	84.3	130.5	63.1	68.5	78.8	86.3	79.6	2759.0	419.9	864.0	7.5	686.2	1160.4	1543.0	789.3	2108.6	0.4	819.5	566.2	514.9	351.8	426.9	80.9	4.2	70.3	962.4	628.2	31.3	234.2	6.1	528.1	797.5	1208.6	631.9	109.2	0.4	105.6	95.5	2072.6	881.3	1055.0	690.7	45.7	668.6	206.4	703.1	1.7	0.2	608.3	250.3	669.9	2332.1	17.4	557.7	1189.0	631.5	24.4	125.6	55.0	94.7	0.0	1.6	156.4	907.8	139.5	1540.1	823.3	1060.8	60.2	298.5	7.1	769.2	878.2	1346.7	2.9	5.4	1641.6	1585.6	154.2	1193.0	87.1	366.5	639.9
ZFP36L1	"Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B"	ENSG00000185650	"ZFP36 ring finger protein like 1"	Q07352	14	68787660-68796253	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA transport, Transport"	"Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1973.2;Squamous epithelial cells: 2019.8;Suprabasal keratinocytes: 3223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 2901.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2901.2"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 462.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001301	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA001301: AB_1080644"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.68e-2)"	342.7	107.9	108.1	218.2	108.3	84.0	305.6	118.0	96.1	466.4	91.7	335.1	127.5	423.1	107.7	293.0	303.3	174.9	178.8	98.7	184.1	157.8	260.1	242.7	199.5	207.8	187.5	453.5	225.4	161.7	67.3	315.8	145.0	222.3	104.2	57.5	319.3	201.7	93.1	511.3	151.5	316.0	162.7	178.5	196.9	49.3	142.6	130.1	190.6	89.6	150.4	335.8	467.0	166.8	235.6	211.8	94.7	139.0	234.4	187.2	203.9	96.4	169.6	59.1	72.9	93.9	159.5	58.4	59.5	177.4	85.5	108.4	8.8	313.8	70.0	27.9	13.2	21.5	115.0	68.2	133.8	3.3	24.3	157.6	396.4	69.1	462.1	195.2	119.2	17.1	61.5	113.7	314.4	54.1	9.3	11.1	78.7	105.1	31.7	150.5	127.1	17.8	213.4	155.3	1.0	2.5	113.7	163.4	87.8	131.9	148.3	3.0	254.4	167.3	122.8	139.0	101.0	62.9	32.9	39.9	213.5	1.4	66.9	230.8	240.9	3.9	211.1	244.7	197.2	266.0	168.8	150.3	123.8	461.4	179.3	162.2	2901.2	154.3	176.1	16.2	174.5	257.5	108.1	108.3	118.0	96.1	98.7	184.1	207.8	187.5	145.0	162.7	142.6	166.8	830.2	477.5	415.6	172.7	513.8	1333.5	761.2	830.2	1973.2	4.6	750.7	504.4	84.2	420.4	523.9	364.1	0.0	442.1	276.5	164.4	84.1	575.8	97.0	434.6	479.6	571.0	20.4	87.7	1.5	573.1	476.6	894.3	218.6	656.2	200.8	21.1	292.7	595.6	548.3	0.0	0.7	225.3	215.7	613.9	1272.8	72.2	502.0	670.0	528.3	142.4	499.0	211.9	131.8	63.8	0.9	544.8	138.3	397.2	191.7	657.7	138.4	143.7	314.5	9.2	269.5	562.0	714.4	12.2	13.3	2019.8	3223.6	898.7	405.2	157.1	191.1	817.8
ZFP36L2	"BRF2, ERF2, RNF162C, TIS11D"	ENSG00000152518	"ZFP36 ring finger protein like 2"	P47974	2	43222402-43226606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1727.3;Basal squamous epithelial cells: 2181.9;Plasma cells: 2029.3;Suprabasal keratinocytes: 1549.6;T-cells: 1760.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047428	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA047428: AB_10963428"	"unprognostic (2.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.98e-2)"	187.0	110.8	33.0	150.1	39.9	195.2	175.0	41.0	31.9	141.5	36.9	130.3	113.6	101.7	38.7	103.7	121.1	124.1	97.6	28.5	45.6	64.7	91.4	169.7	171.1	109.1	50.3	187.4	78.7	19.9	37.7	31.7	51.9	123.1	132.5	17.0	92.5	63.8	64.9	219.9	171.2	65.2	58.5	120.7	127.2	19.2	51.5	160.9	180.8	42.1	121.9	93.5	133.7	45.7	36.2	17.4	17.0	9.5	208.0	211.4	6.9	51.7	93.1	21.6	16.4	61.0	16.7	26.0	37.9	59.7	12.0	66.9	18.2	89.9	18.3	46.6	38.0	42.0	6.4	65.1	61.8	92.3	35.0	149.8	143.4	22.1	143.2	32.6	38.9	39.1	42.6	100.1	21.4	192.0	109.4	190.8	26.0	113.2	30.1	81.0	12.7	151.7	36.9	51.5	15.0	37.6	9.8	58.9	32.2	23.2	10.0	150.4	18.6	58.3	25.2	49.7	32.1	84.1	25.1	39.0	19.6	227.7	27.5	18.7	42.5	82.1	46.6	35.3	45.8	18.1	46.1	62.8	51.2	22.7	34.1	33.9	61.6	52.7	28.1	22.0	19.5	30.0	33.0	39.9	41.0	31.9	28.5	45.6	109.1	50.3	51.9	58.5	51.5	45.7	540.1	48.1	67.1	91.1	1144.2	1727.3	1232.0	76.3	2181.9	3.7	455.0	420.5	120.8	420.4	72.4	136.1	0.0	12.2	1167.2	470.8	84.1	37.2	2.4	192.4	241.9	371.7	187.8	340.6	0.4	37.0	22.2	635.9	562.7	292.0	138.5	497.7	185.6	146.8	236.5	0.0	0.6	538.1	26.4	436.2	435.2	12.5	311.9	579.7	302.4	97.4	318.5	214.2	620.0	29.7	13.8	41.1	378.8	259.9	2029.3	590.1	319.2	81.4	48.2	30.5	105.2	631.8	246.5	3.4	27.8	534.9	1549.6	17.0	1760.1	342.5	581.4	238.0
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038377-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	1.6	1.7	2.2	1.3	2.9	0.2	2.8	4.4	2.5	3.0	0.5	1.6	0.8	4.5	1.8	1.2	2.5	1.3	1.5	1.9	2.7	2.3	0.6	1.3	1.2	2.3	2.2	7.1	1.3	2.9	3.8	1.3	2.5	2.5	1.0	6.3	0.9	1.8	1.4	1.2	1.1	2.5	2.5	2.0	1.2	2.2	3.3	1.2	2.9	1.9	1.3	1.8	1.6	4.0	0.6	1.7	7.2	6.0	3.9	7.5	3.7	2.3	3.4	2.5	2.1	0.0	1.7	4.2	1.8	2.4	3.3	1.5	0.0	0.9	3.9	5.2	0.8	0.2	3.5	1.9	2.1	0.0	0.8	2.1	0.7	3.0	5.8	6.1	1.4	0.0	0.4	3.6	5.2	0.0	0.0	0.0	7.4	4.4	0.0	0.0	10.0	0.6	1.9	0.0	6.1	5.8	7.1	1.5	1.4	3.5	6.0	0.0	0.6	5.8	2.5	6.9	3.5	1.4	2.9	0.0	4.5	0.1	3.6	0.1	0.0	0.0	0.9	0.2	0.7	0.9	0.8	0.9	0.3	0.4	0.6	0.9	0.1	0.7	0.0	0.0	2.4	0.3	2.2	2.9	4.4	2.5	1.9	2.7	2.3	2.2	2.5	2.5	3.3	4.0	3.4	0.0	0.5	5.5	2.1	0.3	0.9	1.3	2.2	10.3	1.4	2.8	8.0	0.0	0.5	0.0	6.2	0.8	1.6	0.1	3.9	1.6	1.0	0.6	4.9	3.2	1.2	0.0	9.2	0.9	1.6	3.8	2.6	0.6	5.7	2.5	2.5	1.3	0.5	6.7	15.5	0.6	4.1	0.3	0.3	0.2	2.1	0.8	0.0	3.7	0.5	3.4	3.1	23.6	29.7	0.4	1.3	2.2	1.1	0.5	0.1	3.1	0.4	6.0	6.6	6.4	4.2	5.6	3.2	2.7	0.0	0.1	1.3	2.6	0.3	0.4
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"	Q8N8Y5	8	143246821-143262705	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	2.9	3.5	5.4	2.3	6.6	1.5	2.8	2.8	6.9	3.6	0.0	3.8	3.4	4.2	1.4	2.9	4.1	1.9	3.1	4.9	6.6	3.9	3.4	2.2	2.6	7.8	5.6	5.3	3.5	4.0	5.3	1.1	5.7	3.7	1.5	2.4	4.8	2.6	3.2	4.9	3.6	2.0	2.4	3.2	3.6	6.3	8.2	2.4	4.1	1.8	2.1	3.4	3.0	9.7	6.7	10.5	4.5	6.0	5.1	3.9	5.3	4.0	2.1	7.6	5.2	5.2	5.5	3.7	5.8	5.2	7.7	5.4	4.9	5.2	3.7	5.9	6.0	4.7	5.6	4.1	7.1	1.8	2.8	4.1	7.2	4.9	7.2	5.2	3.6	2.6	10.1	3.5	3.6	12.0	5.0	2.0	6.7	8.2	10.3	2.6	3.7	1.3	3.3	6.0	5.7	7.8	11.2	3.0	5.9	3.8	7.7	3.6	3.8	5.7	10.2	4.5	6.4	5.6	4.6	1.7	5.1	4.5	7.7	0.0	0.1	0.0	0.3	0.2	0.5	0.1	0.2	0.2	0.1	0.2	0.4	0.3	0.0	0.1	0.0	0.9	0.2	0.2	5.4	6.6	2.8	6.9	4.9	6.6	7.8	5.6	5.7	2.4	8.2	9.7	1.6	0.0	2.0	2.9	2.3	1.1	0.7	0.8	0.6	2.5	2.3	1.9	3.2	5.7	1.1	3.7	6.2	0.3	0.8	3.7	1.9	1.9	1.5	1.8	2.3	1.6	3.0	0.8	2.2	0.9	1.1	1.6	2.6	1.2	0.0	2.7	2.5	3.9	1.2	6.7	3.4	2.4	2.0	2.2	0.5	2.6	1.2	1.5	1.8	1.0	0.9	2.5	2.1	1.5	4.4	1.6	4.1	2.2	1.6	0.5	3.4	1.4	3.2	2.0	0.0	1.6	1.9	7.9	3.7	1.8	0.3	0.3	0.9	1.6	3.4	0.4
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.8;Extravillous trophoblasts: 59.3"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	13	"BEWO: 115.5;SuSa: 77.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.0	0.1	0.4	0.2	0.4	0.4	0.1	0.6	0.5	0.0	0.4	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.7	0.4	0.1	0.2	0.1	0.1	0.1	0.7	0.5	0.1	0.1	0.1	0.5	0.2	2.1	0.5	0.2	0.1	0.0	0.2	0.1	0.0	1.0	0.3	0.0	0.1	0.2	0.0	0.0	115.5	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.2	7.5	0.2	0.0	0.4	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.4	0.1	0.1	0.5	0.3	0.0	0.4	0.2	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.1	77.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.4	0.2	0.2	1.6	0.2	0.3	0.5	0.2	0.4	0.5	0.4	0.3	0.1	0.5	0.4	0.4	1.3	0.7	0.2	0.3	0.4	0.1	0.4	0.4	0.6	0.5	0.4	0.1	0.6	0.2	0.4	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	9.4	0.1	0.0	0.0	0.2
ZFP62	"FLJ34231, ZET, ZNF755"	ENSG00000196670	"ZFP62 zinc finger protein"	Q8NB50	5	180847611-180861285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048629	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Actin filaments"		"HPA048629: AB_2680467"	"unprognostic (2.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.11e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.29e-3)"	7.8	7.1	8.1	12.6	8.9	4.5	13.8	12.8	10.5	12.1	7.0	14.2	13.4	13.6	15.0	13.1	15.4	9.6	9.4	7.5	10.3	11.4	6.6	9.5	18.7	8.4	7.5	19.7	11.2	13.7	8.6	9.8	7.9	12.9	17.2	18.3	11.6	11.4	14.2	15.7	13.5	10.4	5.8	13.9	16.0	8.9	7.8	24.9	23.6	14.1	20.2	10.8	11.2	11.0	13.7	10.5	21.2	28.4	14.9	13.5	26.4	13.8	10.4	11.0	15.3	24.9	33.5	34.2	21.7	6.2	12.9	20.0	10.2	24.7	16.6	58.2	19.0	19.3	30.8	8.4	10.2	17.2	11.0	10.6	20.0	11.5	20.8	17.1	10.2	19.6	16.0	18.0	15.2	31.8	25.2	9.5	14.8	12.5	24.6	22.2	22.3	19.3	9.3	24.4	28.1	19.1	20.1	15.3	15.1	15.0	23.0	15.4	14.6	17.0	14.8	8.3	14.0	18.7	23.4	16.8	14.1	22.9	13.5	6.9	2.1	2.6	2.5	2.9	4.8	4.4	3.4	3.6	2.2	4.8	6.1	5.5	1.0	3.4	3.5	2.5	3.7	2.9	8.1	8.9	12.8	10.5	7.5	10.3	8.4	7.5	7.9	5.8	7.8	11.0	10.5	9.6	11.0	5.5	12.2	7.1	8.9	10.8	11.4	8.2	9.4	11.9	11.4	8.6	7.2	0.0	2.1	6.2	6.8	12.9	15.6	9.7	24.3	9.5	5.8	8.3	10.3	12.4	9.1	16.5	6.7	6.7	7.1	7.9	8.8	16.3	9.7	5.0	6.4	1.7	9.3	17.6	8.2	5.9	4.0	28.0	17.1	5.4	5.4	6.5	7.8	11.4	9.2	9.0	10.1	14.9	7.8	11.7	11.8	8.3	15.3	9.8	6.6	13.1	13.1	7.4	8.2	30.0	14.8	7.2	4.7	5.6	9.9	11.0	15.8	8.5
ZFP64	"dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338"	ENSG00000020256	"ZFP64 zinc finger protein"	Q9NTW7	20	52051663-52204308	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035112, HPA058387"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035112: AB_10672859, HPA058387: AB_2683702"	"unprognostic (3.86e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (4.68e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	4.2	4.8	5.8	5.7	5.5	5.3	4.6	5.2	5.5	5.7	3.0	6.3	6.6	5.7	4.2	7.0	6.7	5.3	4.8	5.1	3.4	4.7	5.2	4.5	6.6	4.7	3.4	7.8	5.6	7.2	4.7	4.3	4.6	6.3	5.7	5.0	5.8	5.7	5.4	11.2	5.9	5.5	2.6	5.7	5.9	6.6	4.5	7.3	6.8	4.5	5.3	5.6	6.1	5.6	35.1	19.6	14.7	35.1	7.2	13.0	21.0	11.9	17.3	25.5	21.1	18.8	14.3	15.5	23.2	21.5	21.1	46.2	12.0	26.6	15.6	6.6	37.5	9.3	35.0	20.1	19.9	10.4	6.6	11.3	39.4	13.0	14.8	13.0	17.6	16.4	11.2	19.5	6.4	14.6	14.5	8.9	14.8	19.0	15.1	15.9	7.6	15.6	12.1	13.9	15.2	18.0	23.1	28.6	22.5	12.0	19.2	12.3	11.6	18.0	26.1	19.7	7.7	21.1	20.6	12.6	17.2	10.3	12.2	5.1	3.3	8.1	4.5	1.8	3.3	5.1	3.4	3.6	4.2	3.2	3.8	3.7	1.8	5.3	4.8	4.1	3.3	2.8	5.8	5.5	5.2	5.5	5.1	3.4	4.7	3.4	4.6	2.6	4.5	5.6	4.7	3.2	3.3	7.2	5.4	8.7	4.3	5.4	19.9	5.1	5.1	3.9	4.0	4.3	2.5	0.0	2.1	4.3	6.2	7.5	7.9	8.2	7.4	3.9	4.4	4.2	6.7	5.5	18.0	5.8	8.5	5.9	9.7	3.9	7.0	5.2	9.3	6.1	4.0	1.7	15.5	9.5	8.2	4.1	4.2	9.1	6.5	2.9	3.6	14.0	4.0	2.7	7.2	15.6	18.6	5.4	6.0	7.2	11.6	3.5	5.3	4.9	4.0	4.7	6.6	3.8	5.5	19.7	2.9	11.3	13.4	1.2	5.8	3.9	9.0	2.6
ZFP69	"FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A"	ENSG00000187815	"ZFP69 zinc finger protein"	Q49AA0	1	40477290-40496343	"Predicted intracellular proteins, Transcription factors"	"Lipid metabolism, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"THP-1: 58.2"	"Not detected"	"Not detected"							"HPA027808, HPA054942"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA027808: AB_10601031, HPA054942: AB_2682644"	"unprognostic (1.07e-2)"	"unprognostic (6.00e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (7.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.81e-1)"	2.0	1.3	2.8	2.3	3.1	1.9	2.0	2.6	2.8	2.4	2.0	2.7	1.9	2.4	2.2	2.0	2.3	1.7	1.8	2.5	2.6	2.2	2.0	2.3	2.9	2.9	2.8	2.6	2.4	2.5	1.3	2.2	2.8	2.5	1.9	2.0	1.7	2.3	0.5	2.8	2.4	2.6	2.6	3.1	2.1	3.6	2.8	3.0	2.1	0.8	2.9	2.7	2.1	3.2	5.4	0.0	3.1	4.1	3.8	3.9	5.3	2.9	3.4	4.4	5.0	2.8	4.2	9.6	3.7	4.6	5.7	4.3	6.0	2.5	5.0	8.7	4.1	7.2	5.3	4.8	3.0	0.1	7.4	4.0	6.2	2.9	4.5	1.4	2.6	0.2	4.2	0.1	2.5	2.8	7.5	9.1	5.9	0.5	0.1	4.1	11.0	4.5	2.4	4.0	4.1	6.5	4.9	4.5	8.3	4.8	0.1	58.2	1.1	2.0	4.0	5.6	0.3	0.2	7.6	5.9	3.7	1.5	5.6	0.0	0.1	0.0	0.5	0.1	0.6	0.3	0.4	0.6	0.2	0.2	0.2	0.6	0.0	1.9	0.1	0.0	0.2	0.2	2.8	3.1	2.6	2.8	2.5	2.6	2.9	2.8	2.8	2.6	2.8	3.2	1.5	6.4	0.0	2.3	2.4	1.0	0.4	0.2	4.0	1.4	0.6	0.6	1.5	0.0	0.1	0.0	0.0	1.2	1.8	0.7	1.9	1.5	15.1	0.8	1.4	2.2	0.0	2.1	2.7	1.3	1.8	1.5	1.1	0.6	0.0	2.6	0.7	1.1	1.3	0.0	2.7	0.9	2.0	1.0	1.9	3.5	1.2	1.4	1.8	2.8	2.4	1.5	2.1	6.6	5.4	1.1	0.3	1.9	3.6	0.4	0.3	0.5	0.8	0.9	0.0	1.4	1.4	4.1	4.6	1.5	0.4	0.3	1.9	1.5	1.3	0.3
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Inhibitory neurons: 7.9;Oligodendrocyte precursor cells: 11.1;Spermatogonia: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	0.4	0.5	1.7	1.7	1.4	0.4	0.9	0.0	2.9	0.9	0.0	0.9	0.9	1.4	0.7	0.7	0.5	1.1	0.6	1.3	0.5	0.4	0.8	0.5	1.4	0.2	0.5	0.6	1.0	0.7	0.5	0.4	1.0	0.6	1.0	1.5	0.4	0.6	0.4	0.5	0.6	1.0	0.0	0.8	0.9	1.4	1.0	1.9	0.9	0.3	1.9	1.2	0.3	1.2	3.6	1.5	6.1	14.8	2.2	5.8	1.7	3.5	3.2	1.5	2.9	1.6	2.3	6.9	3.3	3.0	3.0	1.3	3.1	3.0	3.4	6.0	1.3	2.8	3.5	5.2	1.5	0.4	4.4	1.3	4.9	5.4	7.1	1.5	2.1	9.0	7.5	6.9	4.6	2.5	9.4	0.6	8.1	1.3	1.5	5.3	5.9	3.3	3.0	3.5	8.0	8.4	5.6	4.6	2.4	3.4	2.4	8.0	4.6	4.9	10.4	4.6	5.0	10.4	10.6	14.8	6.5	0.9	5.2	0.0	0.1	0.3	0.9	0.7	1.2	0.6	0.6	0.5	0.4	0.6	1.2	1.0	0.0	0.6	0.2	0.1	1.4	0.3	1.7	1.4	0.0	2.9	1.3	0.5	0.2	0.5	1.0	0.0	1.0	1.2	1.1	0.0	0.0	1.3	2.4	0.3	0.6	0.3	0.0	3.4	0.8	0.6	0.7	0.0	0.2	1.8	0.0	0.6	1.0	0.1	0.0	1.2	0.0	0.8	1.6	1.3	0.0	0.4	10.2	0.2	1.4	0.7	1.1	0.5	0.0	3.2	1.1	0.1	1.1	0.0	7.9	0.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	1.0	1.1	0.9	3.1	11.1	1.8	1.1	0.3	0.4	2.4	0.3	0.2	0.2	0.1	2.2	0.0	0.9	1.3	1.8	5.7	0.3	0.1	0.0	1.5	0.9	0.4	0.2
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: AB_2732568, HPA060470: AB_2684290"	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	2.1	2.1	4.5	1.3	4.8	0.7	2.7	6.4	6.8	3.6	3.4	2.7	0.7	3.1	4.2	0.9	3.0	1.9	2.6	4.5	4.7	2.3	0.6	1.5	2.6	3.9	4.3	4.4	1.2	2.7	3.1	2.4	3.9	2.7	1.1	5.1	1.4	1.8	0.8	0.9	1.7	2.2	3.9	2.7	1.3	2.5	4.3	2.9	4.1	1.1	2.6	3.0	2.3	4.8	0.1	2.8	8.6	7.3	2.0	2.8	2.7	2.9	3.2	5.0	6.3	1.3	1.0	7.0	5.5	3.2	4.8	0.3	0.0	0.8	6.1	4.6	4.0	7.2	1.5	1.6	4.9	0.0	5.7	3.8	1.1	3.4	0.9	0.0	2.2	9.8	0.1	0.1	5.3	0.0	12.2	0.1	4.8	0.0	1.2	8.8	5.2	1.5	2.8	3.9	0.4	8.6	0.0	0.6	4.0	6.4	1.7	4.1	0.5	2.1	2.8	4.3	5.6	5.6	3.7	10.0	0.1	0.1	4.6	0.2	0.5	0.7	2.7	0.5	2.6	4.8	2.6	3.0	1.3	4.3	4.0	3.6	0.4	2.5	0.6	1.6	1.7	1.5	4.5	4.8	6.4	6.8	4.5	4.7	3.9	4.3	3.9	3.9	4.3	4.8	3.6	0.0	6.4	7.5	9.0	1.0	2.3	2.4	1.8	20.3	3.7	3.6	4.6	1.5	3.4	5.5	22.9	7.8	3.5	0.1	9.8	6.0	11.2	2.2	4.6	5.9	3.0	1.7	16.4	1.4	5.9	5.5	0.5	1.7	6.3	11.4	3.3	0.6	4.4	33.7	19.0	0.3	6.1	2.6	3.4	2.5	5.9	3.5	5.4	6.5	1.4	7.9	3.1	21.1	22.1	1.1	0.2	7.5	3.2	1.9	0.4	4.8	6.1	11.8	19.7	4.7	5.0	17.5	9.1	0.6	0.6	1.4	5.7	7.6	0.9	1.2
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	7.0	6.3	19.4	7.2	18.6	6.1	11.1	27.0	31.1	11.7	9.9	8.2	2.9	10.8	12.2	5.9	9.5	6.5	8.0	18.2	18.1	8.6	5.4	6.7	9.5	15.2	14.6	12.7	7.4	15.7	13.5	5.8	15.3	9.2	6.2	12.7	6.3	8.8	8.2	9.3	7.3	9.3	11.0	10.5	8.1	9.7	18.2	13.4	8.2	9.0	11.3	7.5	8.0	20.3	10.6	11.4	20.9	19.9	18.1	19.2	9.7	9.7	11.0	13.2	15.2	8.0	7.0	11.5	12.7	12.6	11.1	9.7	12.9	12.5	15.0	10.1	4.7	3.0	2.2	13.4	14.0	0.0	10.3	17.2	20.2	12.1	16.8	23.5	10.7	21.2	5.8	4.1	16.3	18.8	11.6	10.7	7.8	6.3	8.5	21.0	6.5	7.6	9.0	7.2	23.5	17.9	28.1	2.1	10.5	15.4	16.8	14.9	8.4	12.2	7.2	10.4	5.8	8.1	15.9	14.0	4.1	4.0	9.9	7.9	1.5	2.5	5.2	1.6	6.7	4.5	4.9	6.0	2.0	3.3	6.7	5.9	0.3	4.3	1.0	2.3	5.8	2.7	19.4	18.6	27.0	31.1	18.2	18.1	15.2	14.6	15.3	11.0	18.2	20.3	13.1	19.2	8.9	18.6	15.1	3.4	6.4	10.5	14.8	21.1	8.5	9.4	10.5	10.0	9.0	20.2	14.6	3.4	11.8	1.5	7.9	10.2	20.6	9.8	14.4	10.9	16.1	13.2	34.0	6.1	1.7	14.7	5.1	6.5	12.0	30.3	11.0	5.2	6.9	18.5	41.4	4.7	4.1	7.9	5.7	13.2	16.4	8.3	3.6	11.2	6.4	13.0	19.6	31.2	35.5	6.5	3.2	17.7	7.2	5.9	1.3	8.1	24.2	17.3	0.0	12.4	11.0	12.1	19.1	8.6	4.5	1.4	18.7	13.7	4.5	4.0
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein, atypical E3 ubiquitin ligase"	Q96JP5	11	58579063-58621550	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	25.0	22.0	27.8	23.0	32.3	59.2	21.9	28.0	33.4	22.0	16.0	28.9	25.9	22.4	17.6	24.4	19.9	21.5	29.8	22.9	26.9	25.1	30.7	21.3	24.8	26.5	28.8	20.2	22.8	29.8	15.3	20.3	27.1	19.3	33.5	29.8	20.2	22.6	53.2	25.7	29.0	24.4	28.8	24.3	21.1	86.4	28.4	36.7	25.9	45.3	26.2	27.5	20.4	32.8	65.4	36.3	42.0	43.3	39.6	47.5	23.1	52.3	98.3	59.6	50.7	19.9	67.1	77.5	50.6	66.9	59.4	56.7	43.2	56.0	77.9	41.3	24.3	51.2	36.5	21.9	44.9	65.3	80.9	41.8	53.8	83.9	97.3	49.4	60.0	51.5	51.4	71.4	77.7	21.7	56.8	36.1	22.2	37.6	35.4	43.4	71.0	51.8	43.8	60.9	45.1	35.9	67.2	61.0	86.8	22.7	68.2	48.5	67.8	74.8	51.4	114.0	59.3	41.0	32.3	62.9	66.2	36.1	78.1	1.3	1.4	1.0	1.5	1.2	0.8	1.3	0.9	0.9	1.4	1.1	0.9	1.2	1.5	1.0	1.3	2.0	0.8	0.8	27.8	32.3	28.0	33.4	22.9	26.9	26.5	28.8	27.1	28.8	28.4	32.8	24.6	25.6	33.6	0.0	29.1	60.2	26.1	20.6	44.3	31.9	25.4	17.9	45.7	38.6	20.6	18.4	16.7	12.1	31.7	46.2	13.7	23.7	243.7	30.1	33.7	28.8	25.2	46.7	0.0	31.2	11.4	31.3	23.9	40.9	50.6	32.5	27.5	51.3	16.6	35.3	0.0	27.6	12.2	45.3	55.9	179.3	30.7	36.5	23.2	0.0	36.4	21.1	25.7	0.0	0.0	29.5	18.6	27.1	26.2	35.0	34.6	26.7	24.2	22.4	19.7	34.7	27.6	140.9	41.1	53.7	66.5	13.8	24.2	17.9	39.1	43.4
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.8	2.2	2.1	0.5	2.0	3.0	1.1	2.6	1.9	1.7	2.4	0.9	0.3	1.2	2.6	0.2	3.2	0.4	1.1	1.4	2.0	1.2	0.6	2.6	0.4	1.3	1.9	3.8	0.7	4.3	2.6	0.7	1.9	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.5	1.1	0.6	0.7	2.6	0.2	0.7	0.5	0.5	0.3	0.3	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.6	1.9	1.4	2.0	1.3	1.9	1.9	0.5	2.6	1.4	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZFPL1	"D11S750, MCG4"	ENSG00000162300	"Zinc finger protein like 1"	O95159	11	65084210-65088398	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014909, HPA017347"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA014909: AB_1859055, HPA017347: AB_1859056"	"unprognostic (2.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.12e-6)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.63e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.94e-2)"	30.8	32.5	23.0	11.5	25.7	29.3	29.3	24.9	29.8	29.5	22.6	30.4	17.9	31.4	18.7	30.0	27.8	10.0	30.7	22.4	23.9	27.9	32.6	21.4	11.9	25.1	24.5	29.3	32.0	15.6	40.5	12.8	24.0	31.5	9.1	7.6	30.8	16.8	37.8	35.2	28.1	12.7	23.8	25.4	30.4	27.5	25.2	11.0	27.1	20.4	8.3	31.1	26.5	26.3	60.3	41.1	25.4	26.5	22.3	31.5	40.5	26.0	33.8	31.8	25.2	27.5	40.9	19.5	51.2	39.5	31.0	30.8	15.0	34.4	11.1	27.7	25.0	20.0	29.3	54.3	48.0	14.8	27.0	29.7	45.2	24.0	40.6	20.2	31.2	30.4	24.3	29.4	23.9	83.1	25.6	35.8	17.2	19.9	35.7	23.3	14.5	53.7	25.0	27.9	27.6	22.3	21.5	41.8	63.5	12.1	61.7	25.4	30.1	21.2	35.0	47.2	21.4	19.4	21.0	24.0	33.2	14.6	41.2	77.1	19.7	42.2	15.1	21.4	16.3	18.0	14.0	15.9	20.0	20.1	15.3	13.8	27.3	23.8	21.2	19.6	26.1	12.0	23.0	25.7	24.9	29.8	22.4	23.9	25.1	24.5	24.0	23.8	25.2	26.3	22.6	12.8	18.4	6.8	16.1	11.0	29.6	45.0	19.4	20.4	27.4	27.1	4.4	21.5	35.3	12.9	4.2	49.9	19.0	49.6	58.7	39.4	18.6	24.1	17.9	17.9	22.8	14.5	6.4	47.9	47.1	19.4	25.0	29.6	9.5	30.0	16.4	20.7	32.1	23.5	6.1	40.1	32.6	15.7	11.9	47.0	20.5	12.8	17.8	3.7	25.0	39.2	18.6	5.0	23.7	44.0	44.4	20.3	29.5	29.8	55.0	32.6	25.8	19.5	19.7	17.5	27.5	35.7	18.3	24.4	12.5	68.3	13.6	17.0	37.5	36.1
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	2.1	2.5	4.8	1.9	2.4	9.2	1.9	5.7	5.8	2.3	4.2	1.7	12.4	2.2	1.0	1.8	4.0	1.5	4.8	5.8	2.1	3.7	8.6	2.1	2.7	3.5	3.2	2.2	10.4	1.4	5.6	0.8	2.6	3.2	0.8	0.7	2.8	1.3	1.6	3.7	6.8	0.2	1.6	4.9	13.7	5.7	3.3	1.5	4.0	0.3	1.2	2.3	2.0	1.6	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	2.4	5.7	5.8	5.8	2.1	3.5	3.2	2.6	1.6	3.3	1.6	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804539	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.2;ovary: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 115.2;Excitatory neurons: 524.4;Inhibitory neurons: 159.8;Microglial cells: 152.7;Oligodendrocyte precursor cells: 689.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 64.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ hTERT+: 14.2;HHSteC: 9.9;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.9;K-562: 6.0;TIME: 6.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 39.4"	HPA004094	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	12.2	2.8	7.4	1.5	3.1	0.0	4.5	64.2	12.7	6.5	0.0	4.3	0.5	10.7	2.3	4.5	12.3	5.8	10.2	16.4	3.5	1.1	2.7	3.8	2.7	11.9	5.7	33.3	0.7	0.4	1.1	4.2	12.3	0.9	2.1	1.1	1.0	1.9	18.0	1.6	1.9	17.8	0.2	2.9	2.8	4.3	6.3	1.3	6.8	17.2	1.5	7.0	4.9	3.4	0.0	0.0	6.4	0.0	5.4	1.7	0.0	0.5	14.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.7	0.0	1.9	10.9	0.0	6.0	0.0	1.3	0.0	1.4	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	4.3	0.0	6.5	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	3.1	64.2	12.7	16.4	3.5	11.9	5.7	12.3	0.2	6.3	3.4	10.0	0.0	0.6	115.2	0.1	3.6	0.3	0.0	0.6	2.9	0.1	0.3	21.3	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	55.2	0.6	9.8	7.9	0.0	0.0	524.4	0.0	0.1	17.1	1.1	1.5	0.0	24.6	7.1	0.0	0.3	8.4	159.8	0.2	0.0	0.0	1.7	34.0	23.9	0.3	1.8	152.7	0.6	0.1	0.0	689.7	10.0	0.1	0.0	13.5	0.0	0.6	0.0	0.0	0.0	0.7	6.6	22.5	8.1	0.9	2.2	0.1	2.8	0.4	0.2	1.4	0.2	0.4
ZFR	"SPG71, ZFR1"	ENSG00000056097	"Zinc finger RNA binding protein"	Q96KR1	5	32354350-32444740	"Predicted intracellular proteins"		"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016666	Supported		Approved	Nucleoplasm		NA	NA		8100	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016666: AB_1859060"	"unprognostic (7.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	26.6	28.3	32.2	21.8	36.4	30.9	26.8	32.5	37.6	26.6	23.9	22.1	18.5	27.9	21.7	26.0	27.9	23.6	34.4	34.4	32.2	29.5	24.9	19.5	26.7	31.8	32.2	38.4	26.0	31.3	14.2	35.5	32.2	26.2	22.5	36.7	27.7	24.7	42.4	16.1	21.0	27.4	33.0	22.6	21.2	30.2	32.6	31.6	34.1	41.3	26.3	28.7	17.3	36.8	45.1	65.8	75.4	47.2	81.4	59.3	65.8	68.0	57.3	70.5	50.3	65.9	39.0	65.7	43.2	66.8	92.0	34.4	99.0	48.1	98.4	62.4	55.3	80.5	66.9	65.3	71.2	83.7	63.6	56.7	59.1	74.7	135.8	63.9	53.9	31.9	82.0	53.9	73.1	34.0	73.7	35.4	55.5	47.3	48.7	59.2	101.3	36.1	52.7	73.1	41.9	44.2	101.1	58.2	60.8	53.1	36.1	102.0	61.4	69.5	65.0	51.9	57.4	26.7	50.3	72.6	51.4	66.2	86.2	35.3	15.5	19.8	15.6	24.2	18.1	16.6	14.9	16.1	17.3	13.1	14.2	14.3	10.1	22.9	24.9	9.1	15.1	13.2	32.2	36.4	32.5	37.6	34.4	32.2	31.8	32.2	32.2	33.0	32.6	36.8	48.0	51.3	55.4	80.0	55.1	26.0	70.6	47.0	61.5	61.2	39.4	34.9	108.7	34.3	63.7	31.3	22.9	40.1	51.4	28.3	49.0	51.7	53.1	47.7	62.1	51.6	39.5	36.6	109.5	35.9	31.3	66.0	34.1	48.6	76.5	50.4	40.4	35.8	32.7	77.4	98.5	26.1	52.9	35.8	31.3	35.6	53.1	47.3	30.2	74.0	53.9	70.8	52.5	117.6	171.4	44.9	39.6	60.9	52.3	69.8	28.7	45.6	56.3	55.4	39.5	81.2	70.9	118.5	71.8	53.1	24.6	55.5	50.1	65.3	34.1	55.7
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;pituitary gland: 26.1;retina: 10.9;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA043275: , HPA055678: AB_2682883"	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	0.2	2.5	9.6	0.4	9.5	0.2	0.1	0.3	17.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.7	0.1	0.3	7.9	10.9	0.2	0.1	0.3	0.2	3.9	3.0	0.1	0.4	2.5	26.1	0.0	4.0	0.4	0.1	10.9	0.1	0.1	0.1	0.2	0.3	0.0	1.3	0.3	0.3	13.4	8.0	0.0	0.3	0.0	0.2	0.1	0.2	5.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.5	6.9	0.0	0.4	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	1.1	0.0	1.2	0.0	0.7	0.5	0.0	0.2	1.0	0.8	0.2	0.4	0.0	0.0	0.2	0.3	9.6	9.5	0.3	17.0	7.9	10.9	3.9	3.0	4.0	1.3	8.0	5.3	0.2	0.0	1.1	2.9	0.2	1.0	0.5	0.1	0.0	33.7	0.2	1.0	1.6	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.5	25.3	0.7	0.2	0.5	0.0	0.0	39.3	0.2	0.1	0.2	1.1	0.2	1.3	0.3	0.0	0.1	0.1	32.0	42.7	0.2	0.0	0.0	0.4	11.0	0.9	0.2	1.8	1.9	0.1	4.4	1.0	16.1	4.5	0.2	0.0	0.0	0.3	0.4	0.0	0.3	1.5	38.5	0.0	0.6	0.2	29.4	15.9	0.0	0.1	0.0	1.5	0.1	0.0	0.4
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	13.2	6.8	9.8	8.8	13.4	29.5	10.5	21.2	10.8	12.6	8.4	9.9	6.8	15.6	9.7	7.3	12.5	6.9	8.8	7.1	12.9	8.0	10.2	8.6	11.6	10.7	13.4	17.3	9.9	15.4	6.0	13.7	9.4	14.8	6.1	10.3	7.4	11.3	15.1	8.0	8.1	14.5	9.8	12.3	8.0	4.7	12.4	17.3	10.7	12.5	10.0	9.1	11.3	14.3	13.8	17.6	19.3	20.9	23.4	16.4	9.2	12.9	11.9	13.5	14.6	11.4	9.4	15.0	17.1	19.5	31.3	17.5	19.4	23.3	18.1	15.4	26.9	14.4	63.3	6.2	9.8	18.2	24.4	14.3	7.4	27.1	34.1	15.3	17.2	9.4	16.5	16.9	9.7	6.6	14.2	12.5	10.3	6.0	13.7	18.8	15.4	13.9	8.8	21.4	9.6	14.4	37.9	14.5	11.8	11.7	9.6	10.0	18.3	12.6	7.4	18.3	8.9	9.5	13.7	15.3	9.3	7.7	14.4	9.6	6.5	10.2	6.9	7.6	7.2	5.9	6.5	7.1	7.1	9.4	6.5	6.1	11.8	6.8	7.0	4.8	4.1	5.5	9.8	13.4	21.2	10.8	7.1	12.9	10.7	13.4	9.4	9.8	12.4	14.3	35.4	19.2	12.0	38.2	37.7	22.0	18.1	14.5	19.4	19.1	29.6	17.5	16.6	30.0	19.9	7.3	20.9	56.6	60.7	21.0	5.9	14.4	2.0	29.2	48.1	26.2	20.4	16.4	32.4	16.1	13.6	29.2	16.3	30.6	27.9	39.9	24.7	26.6	17.1	15.2	33.6	16.6	4.1	24.3	26.2	5.7	35.8	31.2	30.2	47.8	28.8	15.7	22.6	49.8	52.6	14.8	17.1	35.7	34.1	21.6	14.8	11.5	15.4	22.7	32.9	47.3	36.2	18.2	27.1	15.1	20.9	20.7	34.0	29.8	14.5	20.5
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.7;Late spermatids: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	2.6	1.7	0.6	2.5	0.8	8.0	2.1	3.3	2.1	0.0	1.0	2.3	2.7	0.0	3.0	4.6	0.0	3.1	1.9	0.6	1.0	1.7	4.4	1.7	1.3	0.8	0.9	0.0	2.6	1.9	1.6	3.8	0.9	5.0	5.0	2.3	2.7	4.0	3.4	1.8	4.2	0.0	0.7	2.2	2.5	7.2	0.6	0.0	2.8	7.4	3.7	3.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	9.3	13.6	13.5	11.5	10.7	0.0	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	14.7	15.5	0.0	19.2	0.2	7.6	9.6	0.0	0.0	10.6	9.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	12.8	0.0	8.5	0.0	4.9	0.0	0.0	0.0	8.1	5.2	7.6	17.7	9.8	0.0	0.0	0.0	13.4	6.4	0.0	6.5	11.7	11.3	0.0	0.1	7.3	6.7	0.0	17.5	1.8	0.0	0.0	0.0	2.7	2.2	2.3	1.8	3.1	2.0	2.5	1.3	2.8	2.4	2.7	1.4	1.5	2.9	1.5	2.0	1.6	1.8	0.6	0.8	3.3	2.1	0.6	1.0	0.8	0.9	0.9	0.7	0.6	1.2	0.0	9.6	10.5	7.2	14.7	11.1	10.6	6.8	10.2	12.4	0.0	0.0	7.6	7.2	10.3	1.8	8.4	5.0	8.0	1.0	0.0	4.4	35.7	0.0	0.0	5.8	1.8	11.1	14.1	0.0	2.8	7.8	11.7	0.0	7.0	0.0	10.0	3.7	3.4	13.5	11.3	1.9	2.0	11.3	12.6	88.9	9.9	10.5	3.6	6.5	8.0	12.1	18.6	7.5	6.7	1.3	0.0	10.9	12.2	11.7	1.9	3.3	7.5	8.6	13.1	6.5	5.9	20.3	7.7	12.8	9.5	3.7	12.7	0.1	2.4	12.0
ZFYVE1	"DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1"	ENSG00000165861	"Zinc finger FYVE-type containing 1"	Q9HBF4	14	72969451-73027131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.8;Late spermatids: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002898	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA002898: AB_1080653"	"unprognostic (2.19e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.07e-12)"	"unprognostic (4.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.48e-2)"	11.8	13.5	9.8	5.8	11.3	12.3	9.3	9.8	9.6	8.6	7.4	11.1	9.3	9.1	5.7	13.2	7.2	8.1	9.4	9.4	10.9	12.1	11.2	8.2	7.1	11.3	10.8	9.6	7.7	11.1	6.4	9.4	11.1	7.7	6.6	9.1	8.3	7.1	16.3	13.2	9.1	9.4	10.1	8.2	7.7	16.9	11.2	8.1	12.5	13.7	7.3	9.2	9.3	10.9	8.0	11.3	10.6	10.3	26.9	18.5	7.2	11.5	17.9	12.4	19.5	7.8	6.9	4.2	8.6	14.7	14.6	5.7	7.5	7.1	12.7	16.6	4.2	5.2	5.3	5.5	23.0	1.9	18.7	24.3	18.6	12.2	10.2	18.7	19.7	11.3	4.8	10.8	16.3	9.5	8.3	5.9	5.0	6.4	10.3	11.7	7.4	5.2	11.2	8.3	5.7	9.9	10.4	10.5	12.0	14.6	14.3	7.1	22.0	22.7	9.3	6.4	3.9	15.7	16.9	5.9	12.4	4.2	10.7	2.2	7.0	9.6	6.7	6.3	4.6	3.0	3.4	4.6	6.1	3.0	3.6	4.5	10.9	3.7	5.9	3.5	5.7	5.5	9.8	11.3	9.8	9.6	9.4	10.9	11.3	10.8	11.1	10.1	11.2	10.9	5.6	12.8	5.5	10.1	5.1	6.5	1.8	3.6	8.0	6.2	6.8	4.1	7.8	1.5	3.7	9.2	4.2	3.7	6.8	10.2	1.9	6.4	45.8	6.5	6.3	6.3	7.2	23.1	14.8	5.3	4.4	6.3	7.7	7.0	8.2	9.7	7.1	8.6	5.5	16.8	14.3	7.6	4.1	7.1	3.3	108.9	8.7	7.1	12.4	10.3	6.6	7.6	6.2	13.0	20.6	6.1	9.7	9.1	6.9	3.3	13.1	8.3	3.5	5.4	0.0	5.5	7.6	5.5	3.6	9.0	5.4	9.3	6.4	7.5	4.5	6.2
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80483379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.2;neutrophil: 21.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 80.7"					"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	8.4	8.7	5.1	8.1	12.0	5.2	8.7	5.7	6.4	15.1	4.3	6.4	5.1	12.7	2.5	7.2	7.2	11.2	14.0	4.1	8.2	9.5	10.3	9.1	5.6	7.0	8.5	12.3	6.4	9.0	3.9	13.0	7.6	8.5	6.3	8.6	5.0	6.6	6.1	4.3	6.8	9.9	6.5	9.0	6.6	9.3	8.3	5.0	9.5	8.4	4.5	9.5	4.7	15.5	11.9	13.4	23.4	21.9	14.0	14.3	15.5	17.6	15.2	15.4	20.7	9.9	16.5	7.9	12.5	14.6	16.4	11.9	17.2	14.4	16.9	5.1	10.9	8.6	16.3	11.3	11.6	2.6	6.3	15.4	7.5	12.9	12.4	12.4	18.0	7.3	8.5	12.0	16.8	14.9	5.7	2.5	5.3	6.1	6.5	11.7	48.3	8.4	12.9	22.1	8.8	19.5	25.3	11.6	80.7	14.1	20.2	7.7	16.0	9.2	10.3	14.3	14.6	3.6	7.6	7.8	12.1	8.0	21.0	21.2	4.5	2.5	1.8	2.8	1.0	3.6	0.9	1.6	1.8	3.2	0.7	0.9	21.3	3.0	5.4	3.0	1.0	0.4	5.1	12.0	5.7	6.4	4.1	8.2	7.0	8.5	7.6	6.5	8.3	15.5	49.3	25.6	22.2	127.0	25.8	18.2	14.0	16.4	15.4	94.9	23.4	18.2	52.3	14.3	33.8	31.3	114.7	22.1	28.9	20.3	9.8	16.2	7.4	47.6	85.6	33.1	21.6	7.8	87.7	12.3	11.8	33.7	23.9	37.5	10.1	59.7	35.7	16.8	26.5	80.8	114.0	11.3	2.0	59.8	71.5	7.0	37.9	71.4	19.6	64.6	34.7	26.3	17.5	182.0	620.2	16.4	20.2	44.4	19.0	16.5	16.3	13.6	49.9	75.3	32.9	58.6	43.3	49.0	22.0	15.6	25.4	37.4	17.5	44.7	12.9	20.1
ZFYVE19	"ANCHR, FLJ14840"	ENSG00000166140	"Zinc finger FYVE-type containing 19"	Q96K21	15	40807086-40815084	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040283, HPA041946"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040283: AB_10673369, HPA041946: AB_2677762"	"unprognostic (3.59e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-1)"	8.8	8.9	14.2	7.9	16.5	8.6	10.2	19.6	17.2	11.1	12.5	12.0	12.3	8.9	10.7	15.4	9.1	6.6	11.5	13.5	16.9	10.4	19.3	9.1	10.0	19.8	17.4	10.5	8.3	14.1	9.5	9.0	19.1	12.4	8.1	6.6	13.7	8.1	13.5	11.6	12.5	8.8	16.9	13.7	9.6	8.1	18.0	10.9	8.9	13.5	10.5	10.8	11.4	17.5	10.0	12.3	8.8	13.3	13.9	13.9	13.4	15.0	19.4	19.9	20.7	8.9	23.5	9.2	16.5	14.7	17.5	18.0	12.7	17.4	12.1	28.6	12.4	16.6	21.5	11.2	12.5	12.0	24.1	13.5	18.3	13.0	12.6	18.0	19.6	15.2	12.9	11.9	12.7	10.7	15.2	14.8	5.5	22.4	17.6	18.8	5.1	11.4	12.1	19.7	16.0	9.7	13.7	34.6	4.8	6.7	16.4	19.8	9.6	12.4	13.8	9.2	9.9	10.3	14.3	9.8	11.8	22.9	12.4	9.0	5.8	5.2	5.3	9.4	6.2	5.2	5.5	5.2	6.5	3.7	6.0	5.5	3.1	8.9	6.2	5.5	6.1	4.7	14.2	16.5	19.6	17.2	13.5	16.9	19.8	17.4	19.1	16.9	18.0	17.5	11.4	6.4	5.6	6.2	6.6	6.4	13.3	19.7	8.0	11.1	14.8	12.2	9.3	15.7	18.0	12.9	12.5	74.7	5.7	22.6	19.6	24.4	5.3	12.4	8.0	9.7	3.5	5.2	7.6	17.6	16.8	9.6	12.2	12.5	12.7	12.7	10.4	21.8	22.4	3.3	9.4	15.5	22.4	9.9	6.8	10.9	12.8	9.7	7.2	7.5	14.3	9.8	8.2	7.1	15.7	19.3	20.7	9.4	4.2	9.1	50.3	27.4	17.9	10.7	13.1	7.3	9.6	18.6	19.4	7.9	7.7	55.1	9.3	8.9	15.5	15.1
ZFYVE21	"MGC2550, ZF21"	ENSG00000100711	"Zinc finger FYVE-type containing 21"	Q9BQ24	14	103715730-103733668	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055721	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA055721: AB_2682896"	"unprognostic (1.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.89e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.32e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.11e-3)"	"unprognostic (5.02e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.06e-1)"	57.4	28.9	117.0	14.2	121.0	11.9	54.0	115.6	143.1	69.3	113.2	52.3	18.2	70.8	50.3	68.4	71.8	28.4	51.6	112.8	116.0	37.0	34.7	31.6	16.5	121.3	114.4	56.1	26.7	34.1	32.0	30.1	118.0	41.0	25.7	15.2	61.5	53.3	22.0	73.2	31.0	45.6	123.6	28.1	44.9	35.5	120.0	19.3	50.3	29.9	17.5	65.1	67.8	127.4	27.1	34.1	29.1	26.7	76.9	61.6	48.2	49.8	35.2	41.5	36.2	40.2	34.3	6.0	31.5	53.2	29.9	45.4	25.3	59.4	37.3	11.5	30.9	33.5	23.0	55.3	60.8	8.6	21.4	42.1	61.6	18.4	29.8	37.4	51.0	19.6	13.0	11.4	29.9	165.5	23.3	26.8	13.4	41.3	47.9	12.6	21.6	9.2	81.5	95.5	16.6	11.5	35.2	44.3	26.2	32.2	56.6	22.3	44.7	20.1	16.3	68.4	25.6	12.8	13.8	9.2	22.7	18.7	19.5	28.3	36.2	42.1	20.0	57.6	19.8	18.1	18.7	20.1	23.9	24.7	19.4	18.5	29.6	16.3	47.8	19.4	21.7	24.6	117.0	121.0	115.6	143.1	112.8	116.0	121.3	114.4	118.0	123.6	120.0	127.4	68.0	19.2	23.9	61.7	9.5	45.5	83.5	161.9	59.2	27.8	58.8	68.6	36.0	41.5	83.1	80.9	33.3	115.7	20.9	33.6	121.3	56.4	14.2	25.3	54.7	71.0	19.3	76.2	30.9	54.5	40.0	65.3	12.2	30.3	19.7	22.0	66.4	26.9	55.4	20.2	11.8	34.2	81.4	22.6	29.5	23.0	109.6	28.4	103.2	19.7	32.3	91.6	24.7	11.6	21.8	79.3	51.9	197.1	7.4	87.7	31.5	98.9	47.1	29.6	65.7	57.2	60.7	46.3	78.4	50.9	60.2	101.5	13.4	36.3	32.4	81.9
ZFYVE26	"KIAA0321, SPG15"	ENSG00000072121	"Zinc finger FYVE-type containing 26"	Q68DK2	14	67727374-67816590	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 50.1;Rod photoreceptor cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 4.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055500	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA055500: AB_2682837"	"unprognostic (3.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (6.87e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.29e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.54e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.34e-2)"	5.3	6.4	4.8	5.4	6.3	5.9	5.3	5.8	5.5	5.6	6.8	5.7	4.1	5.7	4.0	5.5	4.5	4.4	5.1	4.5	5.1	4.9	4.4	6.6	7.0	6.4	6.1	6.6	4.9	7.3	5.5	5.9	5.9	4.8	4.7	6.3	4.8	4.6	8.7	7.1	5.8	6.0	5.0	7.3	5.2	2.7	7.8	6.9	5.2	9.6	6.6	5.2	4.8	6.5	12.1	6.9	7.3	7.8	15.2	6.8	10.7	5.8	9.1	13.0	14.9	7.2	7.3	6.7	3.0	7.4	10.8	7.2	10.1	6.9	10.6	6.9	5.6	5.1	8.4	6.7	8.4	3.1	8.3	8.3	9.1	10.1	8.1	6.4	14.6	7.4	7.6	5.3	8.9	9.2	5.1	4.6	3.8	4.8	7.8	4.5	12.1	3.5	5.6	12.2	7.3	4.7	9.0	6.8	8.0	7.1	9.8	4.0	12.9	11.3	9.2	6.9	4.7	4.5	3.3	8.2	9.3	5.6	5.5	0.0	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.0	0.3	0.0	4.8	0.4	0.2	4.8	6.3	5.8	5.5	4.5	5.1	6.4	6.1	5.9	5.0	7.8	6.5	4.4	0.0	9.0	19.9	4.6	2.8	1.8	3.1	6.8	11.6	4.6	3.6	5.8	7.2	4.1	3.7	50.1	2.8	9.6	6.1	0.0	3.9	2.0	4.2	3.7	5.0	3.5	3.8	20.5	2.8	2.4	4.0	5.1	5.2	0.0	6.5	7.1	4.9	9.7	16.8	19.0	3.4	2.0	6.3	6.1	3.1	2.8	8.0	3.6	8.4	7.5	6.9	7.2	16.6	22.1	4.0	6.2	2.2	7.3	2.5	5.0	2.7	4.1	126.3	6.6	7.5	4.0	1.2	1.6	6.9	7.2	4.0	3.8	3.6	3.4	1.9
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	14.4	27.9	33.1	12.9	32.1	23.2	15.8	29.2	35.9	20.6	34.8	25.6	24.8	16.5	22.9	16.5	20.3	12.1	17.8	35.5	33.6	28.3	32.6	17.7	16.1	32.6	31.4	25.9	23.7	19.2	38.3	9.5	33.2	22.0	16.3	28.4	18.9	10.3	12.8	18.2	30.6	8.5	29.1	29.1	19.8	23.0	33.5	12.7	20.4	5.9	13.1	16.8	17.0	32.4	17.7	21.4	12.6	28.1	14.1	9.8	17.2	17.7	18.5	20.3	19.7	19.1	35.9	27.2	19.8	12.8	25.9	38.8	18.4	17.2	10.6	28.3	18.6	12.9	23.1	18.1	18.1	20.9	24.9	16.0	20.4	19.9	15.2	32.4	11.5	22.5	19.6	17.9	15.3	13.8	16.9	39.4	10.3	15.3	16.4	19.2	12.7	13.0	19.5	10.8	10.1	19.7	11.9	9.9	47.2	11.5	21.8	20.5	12.4	10.2	11.9	15.6	34.2	20.6	18.6	14.3	25.3	26.5	11.9	4.8	5.8	9.3	9.6	6.2	8.2	7.1	6.6	7.9	5.4	6.7	7.5	8.3	8.2	6.8	9.2	5.6	9.5	8.3	33.1	32.1	29.2	35.9	35.5	33.6	32.6	31.4	33.2	29.1	33.5	32.4	10.0	3.2	11.4	14.0	22.1	8.2	12.8	11.3	18.8	29.9	11.1	8.9	7.2	14.3	9.7	14.7	58.4	7.4	21.2	33.9	7.9	14.9	5.2	14.3	7.8	11.0	20.3	14.3	33.6	16.0	5.7	10.1	19.4	11.4	14.0	17.3	10.8	10.9	8.2	37.0	35.2	15.6	14.2	8.8	5.7	1.5	9.6	11.0	10.6	16.9	11.2	14.8	15.5	12.5	20.2	13.9	26.1	9.1	13.4	13.8	35.5	8.6	16.6	43.7	19.7	6.7	9.9	8.9	7.6	10.4	5.5	13.5	17.9	10.9	14.7	17.7
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142089-52348671	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.0;Inhibitory neurons: 162.6;Oligodendrocyte precursor cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570"	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	9.3	8.2	13.7	3.3	14.5	1.1	11.2	20.5	16.6	12.4	31.1	8.3	5.7	12.0	7.3	9.1	10.0	6.9	7.2	15.5	13.2	12.9	9.2	9.8	2.2	13.0	13.2	16.3	15.0	25.7	8.9	6.3	14.2	11.1	8.2	13.7	9.2	11.1	25.7	10.7	5.5	11.2	10.9	3.6	7.4	13.8	13.5	5.3	16.9	20.2	3.4	8.9	8.6	13.5	17.9	8.3	11.7	15.1	27.5	25.0	19.2	14.2	18.8	16.5	18.8	9.6	1.4	0.0	8.7	20.0	22.7	6.5	20.8	22.5	25.1	0.1	14.6	5.1	9.3	11.4	18.0	4.5	2.9	16.7	24.9	14.2	31.9	20.1	24.0	11.8	8.0	3.2	22.2	3.9	6.5	3.3	15.4	4.7	14.8	5.7	20.1	1.7	9.4	38.5	9.9	10.2	15.9	13.4	18.4	23.2	6.2	5.9	22.3	16.6	6.7	12.8	8.6	4.5	2.9	2.2	11.8	5.4	6.8	1.3	0.0	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.1	13.7	14.5	20.5	16.6	15.5	13.2	13.0	13.2	14.2	10.9	13.5	13.5	11.5	9.6	5.9	61.7	0.7	5.1	10.0	4.0	10.8	19.9	6.6	5.7	13.6	7.2	9.4	1.8	4.2	5.5	1.1	8.8	7.9	6.4	12.6	6.3	19.1	9.3	17.5	0.0	131.0	7.4	5.3	11.0	23.4	7.9	1.3	16.0	5.0	8.5	0.5	23.5	162.6	8.1	2.0	0.6	1.3	17.3	15.2	0.5	7.2	45.9	0.2	10.0	1.0	80.9	37.5	4.1	7.9	16.6	3.5	7.8	8.2	10.2	2.5	14.3	13.1	20.9	8.3	45.5	46.8	11.7	7.4	2.9	3.8	15.0	6.3	6.4
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778256-29782973	"Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"intestine: 479.5"	"Cell type enriched"	"Detected in some"	10	"Intestinal goblet cells: 20216.0"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.5	0.0	0.0	7.8	0.2	0.1	0.7	0.1	0.1	0.0	0.0	362.9	57.8	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.4	22.2	0.0	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	479.5	0.1	0.0	0.5	0.0	0.1	136.9	12.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	1107.2	0.0	0.0	0.0	0.1	0.0	0.1	145.5	0.0	0.1	11.9	0.0	0.1	0.0	0.2	40.1	0.0	0.4	44.6	0.0	0.0	0.1	20216.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	484.8	0.0	0.0	0.2	1950.6	1.6	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	7.1	0.0	306.7	0.3
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	717	"salivary gland: 63926.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2"	"Not detected"	"Not detected"							"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		690000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	2.5	13.2	0.0	3.9	0.0	4.6	33.1	0.0	0.1	33.0	0.0	13.6	11.5	0.6	1.5	25.3	4.4	34.4	9.0	0.0	0.0	2.6	8.2	3.3	0.3	0.0	0.8	10.3	46.6	30.4	6.0	4.8	0.1	89.1	17.8	0.0	63926.2	7.1	6.1	47.7	9.6	0.4	0.0	4.2	33.2	4.4	0.0	0.2	2.9	0.1	5.9	11.2	16.3	0.0	0.0	1.1	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.3	0.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	9.0	2.8	2.4	1.6	0.0	0.0	0.1	0.2	0.0	1.2	0.1	0.0	0.0	0.2	3.6	0.2	27.1	0.0	0.4	0.1	57.5	5.0	0.0	0.0	8.6	0.2	6.3	0.0	0.0	0.1	24.1	0.0	0.1	22.2	0.0	3.1	0.1	0.5	1.9	0.1	0.0	0.5	0.3	0.3	6.5	0.3	1.7	6.3	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.4	1.2	7.4	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	9.1	194.0	181.6	0.0	0.0	154.9	82.5	0.0	70.1	343.9	1.8	0.0	0.1	2.0	107.1	0.0	5.9	7.7	3.5	1.6	2.8	58.2	0.4	0.0	28.1	3.2	1.8	21.9	13.0	5.7	1.7	0.7	0.1	14.6	0.0	0.0	232.2	140.4	4.6	0.5	5.7	0.0	4.4	83.6	0.0	5.6	0.0	0.0	0.0	0.0	46.4	65.3	0.0	0.0	398.1	12.5	0.0	74.7	0.0	0.0	0.0	19.2	1.4	0.6	9.5	24.0	0.3	2.5	21.3	76.7	357.4
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger GATA like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.5;Hofbauer cells: 12.7;Kupffer cells: 20.0;Macrophages: 12.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 32.8;U-937: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA049855: AB_2680916"	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	1.9	1.5	5.0	1.0	5.2	0.5	2.3	4.6	10.7	4.0	4.3	2.4	1.0	2.5	0.4	1.9	3.3	0.8	1.7	5.3	4.4	7.8	6.4	2.2	1.7	4.2	4.0	5.2	3.3	0.5	8.3	0.9	4.0	6.8	0.2	0.5	2.5	1.0	1.2	2.1	2.6	0.2	3.7	5.0	1.9	5.0	4.4	0.4	9.2	0.4	0.7	2.6	2.7	4.8	0.5	1.2	1.7	0.6	1.1	0.5	4.3	0.9	0.3	0.8	1.8	1.2	0.4	1.9	0.9	0.3	0.8	1.8	1.2	0.4	0.3	1.6	5.5	1.8	2.0	0.7	0.7	0.0	0.5	0.9	2.5	0.8	0.5	0.7	0.2	1.4	1.8	1.3	1.1	2.0	0.2	32.8	2.7	0.4	2.0	1.8	0.8	0.8	0.7	0.8	1.4	1.6	0.4	0.3	1.6	0.4	2.5	0.6	0.6	2.5	2.9	2.4	0.3	6.2	7.9	0.9	0.4	8.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.2	4.6	10.7	5.3	4.4	4.2	4.0	4.0	3.7	4.4	4.8	1.1	0.0	1.8	4.6	0.5	0.9	0.6	1.2	0.0	1.6	2.0	2.4	0.8	0.0	1.2	1.8	0.0	0.5	0.8	0.9	0.0	0.6	0.8	0.9	1.3	1.1	0.0	0.4	9.5	0.0	0.4	0.6	0.0	0.9	0.0	2.7	0.7	1.2	12.7	6.7	6.9	0.7	0.0	20.0	7.9	1.3	0.9	12.6	3.6	2.8	7.8	1.7	0.0	1.5	1.6	0.3	1.5	0.7	0.1	0.9	0.4	0.4	1.5	1.5	0.0	0.5	0.8	2.2	16.3	0.3	0.9	0.1	0.6	0.8	1.6	0.0
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.0;Microglial cells: 17.8;Oligodendrocytes: 27.5;Spermatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	1.0	0.7	0.9	2.0	1.4	7.8	1.3	2.2	1.5	0.9	0.1	1.1	1.2	1.2	0.3	1.0	0.8	0.5	0.7	0.8	0.7	0.5	0.6	0.9	2.5	1.3	0.9	1.1	0.7	0.3	1.3	1.7	1.3	0.9	1.4	4.3	0.9	0.4	1.2	1.4	1.5	0.9	1.0	1.8	0.9	3.6	1.0	5.2	0.8	0.6	2.9	0.7	0.8	2.1	5.0	3.6	12.1	8.6	0.9	1.6	4.7	8.8	3.7	8.7	7.8	6.9	7.3	13.2	2.5	2.7	3.6	4.0	12.7	4.7	10.0	7.3	3.1	8.3	5.8	2.1	0.4	18.5	5.3	0.8	0.6	11.0	3.0	1.2	3.5	13.6	12.0	14.3	6.0	8.2	25.0	6.7	6.3	5.2	4.2	13.8	18.1	4.5	1.5	4.4	5.6	9.5	3.9	5.3	1.7	8.8	2.5	5.4	4.2	10.9	10.6	5.9	7.1	5.5	10.1	17.0	4.9	6.3	6.3	0.0	0.1	0.3	0.2	0.7	0.1	0.3	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.2	0.1	0.7	0.2	0.1	0.9	1.4	2.2	1.5	0.8	0.7	1.3	0.9	1.3	1.0	1.0	2.1	3.3	0.0	1.3	10.4	5.4	0.0	1.3	0.0	0.6	10.4	2.1	1.7	2.4	0.0	3.7	1.8	8.4	3.5	10.4	2.1	0.0	1.0	2.9	1.8	3.5	1.9	1.2	11.1	18.0	0.5	2.7	2.3	4.6	2.8	2.5	12.2	1.1	0.6	1.8	5.0	14.5	1.8	0.0	1.6	0.0	2.8	0.6	4.1	0.0	17.8	1.3	1.6	6.2	17.6	27.5	0.6	1.4	2.2	10.5	0.8	0.7	0.3	0.7	17.6	0.0	3.1	2.7	22.1	15.6	3.6	0.0	0.8	5.0	2.2	2.5	0.9
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.0"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	2.7	2.4	1.4	1.1	1.8	8.5	2.5	2.1	1.8	2.3	1.3	1.8	2.0	1.8	1.8	2.8	2.1	1.1	2.5	1.3	1.4	2.3	2.6	2.9	2.4	1.8	1.7	2.3	1.6	1.1	3.6	1.7	1.6	2.5	2.4	2.9	2.5	1.3	4.1	2.5	1.9	1.6	1.2	3.0	1.8	1.4	1.9	2.2	2.1	1.9	2.7	1.9	2.3	2.3	3.4	4.3	3.1	2.2	1.9	2.1	2.0	1.5	1.5	3.6	2.7	3.5	2.6	2.0	1.3	2.5	2.1	2.2	3.5	1.9	5.4	3.5	7.3	5.9	3.1	4.2	1.9	1.2	3.1	2.8	2.8	2.9	1.8	1.5	4.2	5.9	4.9	2.8	3.2	10.6	5.0	3.9	0.8	6.8	4.7	3.9	2.0	2.8	2.5	3.4	4.8	3.4	3.0	26.0	1.6	1.7	3.9	1.1	0.3	1.5	3.0	2.5	3.4	3.9	5.2	4.3	2.1	3.2	1.1	1.7	2.9	4.8	2.0	4.1	1.9	2.7	2.6	1.8	2.5	2.9	2.1	1.8	1.0	2.7	2.9	2.3	4.9	2.0	1.4	1.8	2.1	1.8	1.3	1.4	1.8	1.7	1.6	1.2	1.9	2.3	2.5	0.0	1.1	4.6	2.0	3.1	5.3	2.5	0.0	0.4	2.2	2.0	1.1	1.5	2.7	3.7	0.0	1.9	5.2	0.9	1.9	1.8	1.4	1.0	1.0	1.7	3.0	0.0	2.0	1.8	2.6	1.8	0.0	0.8	0.0	1.7	2.2	0.8	2.7	10.1	2.8	2.2	4.1	1.3	2.1	1.4	0.9	2.0	1.8	0.0	2.4	0.9	3.1	4.5	4.9	2.2	0.5	1.2	0.7	2.9	1.6	1.3	4.3	1.4	0.0	1.6	1.4	2.7	2.5	0.4	1.4	1.0	1.3	0.8	1.4	7.0
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781655-122974510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 252.1;Microglial cells: 81.5;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 49.3;REH: 53.1;U-698: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.6	11.7	18.5	14.0	25.7	6.8	11.5	19.4	19.5	15.2	10.0	8.8	5.4	14.7	7.0	9.7	15.1	12.3	20.6	18.7	18.6	10.2	15.0	13.8	27.6	23.0	21.4	27.6	17.7	7.7	12.0	6.4	21.8	15.1	6.5	11.7	13.3	9.7	33.8	9.3	12.0	11.5	19.2	15.8	7.9	2.8	21.8	14.2	13.7	21.9	23.2	13.0	10.7	31.3	5.7	2.7	14.9	3.0	7.1	2.2	0.0	3.2	9.9	3.5	4.6	0.6	18.0	49.3	13.0	10.7	2.7	4.7	10.1	6.3	3.8	22.8	7.0	22.3	3.3	17.5	7.9	5.5	7.0	6.4	7.4	3.3	17.2	16.6	4.2	8.9	0.8	16.7	4.2	16.2	5.2	5.1	8.7	2.9	3.7	53.1	8.1	4.1	17.2	13.5	6.6	3.7	12.9	38.8	6.8	9.9	6.6	12.6	6.9	2.8	7.3	3.4	7.0	4.5	0.1	48.4	2.8	4.3	4.7	13.0	1.0	5.5	6.5	1.3	6.8	11.6	4.7	6.3	1.2	10.0	6.8	5.7	5.2	7.0	2.1	5.4	5.2	3.5	18.5	25.7	19.4	19.5	18.7	18.6	23.0	21.4	21.8	19.2	21.8	31.3	6.0	6.4	4.6	252.1	24.8	5.5	5.1	3.4	8.6	1.8	12.0	6.2	11.2	12.8	2.7	9.2	0.0	0.5	19.5	3.5	3.9	10.7	7.7	4.2	9.1	7.1	4.2	1.7	4.4	6.2	0.4	15.4	5.6	11.8	8.2	3.0	5.7	11.5	1.9	5.0	23.5	5.0	8.2	5.5	18.0	2.6	10.5	5.5	10.6	81.5	4.1	12.6	8.2	200.6	176.9	6.2	3.9	19.5	16.6	13.0	4.9	5.2	2.8	0.8	0.0	21.4	9.8	0.6	0.1	8.3	8.8	1.4	16.1	4.2	4.0	10.2
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 616.8"	"Group enriched"	"Detected in some"	4	"Microglial cells: 25.3;Skeletal myocytes: 61.0"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 616.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 174.0;MCF7: 43.9;U-2197: 28.5"	"Region enhanced"	"Detected in all"		"cerebellum: 207.4"	"Region enriched"	"Detected in all"	8	"cerebellum: 638.1"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	3.4	0.7	25.0	0.0	50.7	0.0	0.2	616.8	30.3	0.0	39.0	0.1	0.2	0.0	1.8	0.2	0.0	0.1	0.1	13.6	39.5	0.1	12.8	0.1	0.1	66.8	55.3	0.2	0.1	0.0	2.4	0.0	67.3	0.0	0.1	10.7	0.5	0.0	6.9	2.5	0.8	0.0	23.8	0.0	0.2	0.3	112.1	0.0	0.0	0.8	0.0	0.0	0.0	44.8	0.0	0.0	174.0	0.0	17.9	19.6	9.8	11.4	13.5	12.1	9.9	0.0	0.0	0.0	9.1	0.9	9.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.7	0.0	0.0	3.1	0.0	10.9	43.9	0.0	0.0	0.5	0.9	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	17.9	0.0	28.5	11.0	0.0	0.0	0.0	13.5	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	50.7	616.8	30.3	13.6	39.5	66.8	55.3	67.3	23.8	112.1	44.8	0.2	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	25.3	0.0	4.3	0.0	2.0	9.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	61.0	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566127-137577691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;choroid plexus: 4.0;retina: 2.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.0	0.0	2.9	0.0	3.9	0.1	0.0	13.8	3.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.0	0.0	0.0	0.0	3.5	3.7	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	42.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	24.8	0.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.9	13.8	3.5	1.8	4.5	3.5	3.7	4.0	2.3	4.3	3.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.7	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406809	"Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 68.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 68.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"cerebellum: 67.3"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.6	0.0	1.9	0.0	6.6	0.0	0.0	68.5	4.7	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.7	5.5	0.0	0.3	0.0	0.0	10.6	5.8	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	4.8	0.0	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	16.5	0.0	4.7	1.9	3.5	1.8	0.4	0.2	0.5	0.0	0.0	0.0	2.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	3.9	1.8	0.0	0.0	0.0	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.6	68.5	4.7	1.7	5.5	10.6	5.8	9.0	2.7	10.5	15.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	6.5	0.0	5.5	0.0	0.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.2	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIK1	ZNF762	ENSG00000171649	"Zinc finger protein interacting with K protein 1"	Q3SY52	19	57578456-57593890	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8"	"Low region specificity"	"Detected in all"							HPA059975	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA059975: AB_2684184"	"unprognostic (2.14e-2)"	"unprognostic (9.03e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (5.15e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.50e-1)"	1.9	1.9	2.0	2.6	2.5	4.6	3.2	5.6	2.1	2.9	2.1	2.1	0.6	2.4	4.3	1.3	4.9	1.9	3.1	1.9	2.3	2.2	0.7	2.5	5.9	1.5	1.7	6.0	1.1	6.7	2.6	3.3	1.4	3.2	1.4	6.9	1.7	4.0	1.8	2.1	2.2	2.7	1.7	4.6	1.6	5.2	2.6	7.1	5.6	2.4	6.4	2.0	1.1	2.3	0.1	0.0	22.5	0.1	0.9	0.9	0.0	7.9	7.4	11.3	10.2	0.1	0.2	0.0	5.6	4.0	8.9	0.6	0.0	12.6	16.0	0.0	28.8	4.6	0.1	2.5	2.6	0.1	8.5	4.6	0.0	8.7	0.0	1.0	0.8	1.8	0.2	0.0	3.7	0.0	17.8	2.4	34.3	0.0	2.8	25.6	0.1	5.6	3.2	0.0	16.4	16.5	0.1	0.0	0.7	17.4	0.1	0.3	0.1	10.2	5.2	0.0	9.3	0.2	34.8	8.8	0.1	0.0	10.1	1.8	1.6	8.1	1.8	1.9	3.5	6.8	3.5	2.2	2.6	9.4	6.5	3.2	0.3	4.1	1.7	2.8	4.4	2.6	2.0	2.5	5.6	2.1	1.9	2.3	1.5	1.7	1.4	1.7	2.6	2.3	1.4	0.0	0.0	3.3	4.5	1.0	1.4	1.8	1.2	3.7	1.7	1.4	3.0	5.7	1.9	5.5	0.0	2.0	1.1	0.0	3.9	3.0	2.9	0.3	1.5	1.8	0.0	4.2	2.3	0.2	1.0	1.7	2.0	0.3	3.8	5.4	2.9	0.3	1.9	3.3	1.9	0.1	4.1	0.8	1.8	3.4	2.1	1.2	0.0	1.0	1.0	4.8	0.0	4.0	0.7	0.2	0.1	2.2	2.6	0.7	0.0	0.5	0.9	5.0	6.6	1.5	1.9	1.0	5.6	0.7	0.9	1.2	2.3	1.7	0.1	1.1
ZIM3	ZNF657	ENSG00000141946	"Zinc finger imprinted 3"	Q96PE6	19	57134096-57145202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034575	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA034575: AB_10603463"														"unprognostic (9.06e-2)"	"unprognostic (1.46e-1)"			0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	12.0	18.4	20.2	11.6	29.1	8.7	22.7	17.2	22.1	16.4	7.4	21.5	18.2	15.5	17.1	18.8	21.7	13.9	10.1	14.4	23.8	13.3	52.8	10.9	11.7	21.3	23.2	19.0	26.1	16.5	10.9	11.0	23.4	23.0	23.5	15.8	25.3	10.8	10.4	32.6	16.9	13.7	13.9	13.5	32.6	11.1	24.1	14.2	11.9	8.8	11.9	12.2	17.4	37.5	17.0	12.3	31.8	34.6	32.0	38.7	12.0	18.6	22.5	10.9	11.0	7.4	15.7	19.1	23.0	20.9	19.1	13.7	18.4	16.1	20.6	18.4	11.3	15.5	15.8	19.3	18.0	29.9	17.7	26.1	25.1	14.7	49.0	29.5	24.4	22.2	36.2	16.3	21.7	22.4	28.4	17.6	12.8	31.6	15.2	16.7	16.2	17.3	18.2	26.4	36.8	44.0	28.9	37.4	32.4	17.8	19.1	19.6	36.8	23.7	23.0	27.9	18.9	18.7	35.3	19.5	16.2	20.8	31.7	16.0	4.0	4.1	5.0	3.1	4.9	3.8	3.9	4.9	5.8	4.8	5.3	3.9	4.2	8.8	9.0	3.9	3.5	3.8	20.2	29.1	17.2	22.1	14.4	23.8	21.3	23.2	23.4	13.9	24.1	37.5	45.3	25.6	55.4	57.5	37.0	15.0	45.7	43.4	71.7	93.9	77.6	38.7	42.8	140.2	61.4	46.0	150.1	41.1	40.1	84.8	15.6	55.9	46.5	89.2	90.9	52.2	220.9	24.6	70.1	43.8	15.3	47.9	103.5	68.0	35.4	120.5	44.6	140.8	19.8	89.2	77.7	99.2	77.3	32.7	18.6	18.4	51.3	31.2	40.9	62.8	45.8	61.2	34.0	102.1	272.5	46.6	81.3	53.4	27.1	93.1	70.4	32.4	153.6	70.1	19.7	87.4	43.9	32.8	16.7	62.9	21.5	65.9	32.3	74.0	114.4	62.0
ZKSCAN2	"FLJ23199, ZNF694, ZSCAN34"	ENSG00000155592	"Zinc finger with KRAB and SCAN domains 2"	Q63HK3	16	25236001-25257845	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Cone photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049141	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus"	"HPA049141: AB_2680652"	"unprognostic (2.71e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.28e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.70e-6)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.03e-2)"	1.2	1.3	2.2	0.9	2.0	1.9	1.7	2.0	1.9	2.1	0.7	1.3	0.6	2.3	1.2	0.6	1.7	1.0	1.9	2.1	2.6	1.5	1.6	1.2	1.2	2.0	2.2	3.8	1.1	2.9	1.6	1.6	2.3	1.6	1.0	4.1	1.2	1.7	3.2	0.6	1.0	1.9	1.8	1.1	1.1	4.2	3.0	2.4	2.1	4.6	1.1	1.2	0.9	2.4	2.0	1.9	8.6	5.4	3.4	3.2	3.5	2.1	3.2	3.1	3.0	5.0	1.4	6.5	2.2	2.5	3.4	1.4	5.8	2.8	3.7	3.6	3.9	3.8	3.4	7.7	4.5	3.1	1.9	4.3	3.3	2.9	4.9	3.2	2.4	4.6	7.0	3.1	2.9	2.0	7.7	3.3	4.7	0.7	1.8	9.0	6.3	1.4	2.5	2.8	6.8	6.8	2.6	2.3	2.3	4.1	2.8	5.0	2.4	5.0	3.3	2.0	3.3	4.1	3.6	7.5	1.7	2.5	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.1	2.2	2.0	2.0	1.9	2.1	2.6	2.0	2.2	2.3	1.8	3.0	2.4	1.2	16.0	2.3	4.2	2.4	0.8	2.7	1.3	0.6	7.4	2.0	1.9	3.8	0.0	0.6	1.8	14.6	3.4	1.5	1.1	0.0	1.6	4.4	2.4	3.9	2.1	4.9	0.4	3.3	0.9	2.1	2.5	0.5	2.9	1.3	7.2	0.7	3.2	1.6	6.7	4.9	1.7	2.0	2.4	1.5	2.1	5.0	1.3	1.8	2.8	1.7	4.1	2.1	1.5	4.1	2.2	0.8	3.8	4.1	2.5	1.1	1.4	2.3	8.9	0.0	3.6	1.9	11.4	8.2	1.0	0.6	4.1	1.5	3.9	1.3	1.4
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349947-28369172	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	2.2	2.6	1.5	2.1	1.7	1.1	3.9	3.0	2.3	3.9	2.5	3.4	2.2	3.5	4.5	2.4	3.6	1.9	2.4	1.8	1.6	3.3	2.8	3.1	3.0	1.7	1.6	5.6	2.3	4.7	2.6	4.0	1.8	4.1	3.9	3.8	2.4	4.3	2.5	3.8	2.3	4.7	1.3	3.4	4.1	2.4	1.9	4.3	4.3	2.5	3.9	2.8	2.7	2.6	3.0	1.8	6.9	12.4	6.2	4.3	2.5	2.6	2.8	4.4	5.8	2.4	1.7	4.6	6.0	2.8	4.7	4.1	7.6	3.4	4.4	4.3	3.2	6.1	4.9	3.9	4.3	6.0	1.9	3.8	3.0	4.8	4.1	5.2	7.0	5.8	15.7	2.9	5.3	0.9	3.1	5.9	3.1	1.7	1.8	8.7	5.4	6.7	4.6	2.1	5.5	6.1	4.6	2.4	4.1	8.9	3.5	6.1	4.2	4.6	3.0	3.0	3.4	3.8	6.2	4.2	1.5	7.9	3.2	1.9	1.2	5.1	2.2	2.1	2.3	2.2	1.5	1.7	1.7	2.1	1.4	2.3	1.4	1.6	1.3	2.0	2.2	1.1	1.5	1.7	3.0	2.3	1.8	1.6	1.7	1.6	1.8	1.3	1.9	2.6	1.7	0.0	3.4	4.9	1.2	0.5	0.5	0.8	1.2	1.5	1.9	1.8	2.1	0.0	0.5	3.7	8.4	2.6	0.8	1.0	0.0	1.3	0.6	1.3	2.3	3.0	0.0	3.8	6.6	1.0	1.9	1.7	0.5	1.4	2.5	3.5	3.9	2.3	2.0	0.0	7.2	1.5	4.1	3.8	1.0	2.9	2.8	1.1	0.0	1.9	2.7	2.4	2.1	5.0	4.6	1.6	0.5	1.5	0.7	0.6	1.7	1.9	3.5	2.3	0.0	2.1	1.8	0.9	1.1	1.8	0.3	1.0	2.0	2.7	2.6	0.4
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504662-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	2.7	3.2	4.8	2.9	5.1	3.1	3.4	6.0	5.7	3.1	4.1	3.0	1.6	3.3	3.5	2.3	3.0	2.6	3.2	4.8	4.8	3.2	3.1	2.9	3.4	4.5	4.8	3.6	1.5	3.8	2.9	3.3	5.0	3.3	2.7	5.4	2.0	3.5	4.7	2.4	2.4	4.1	4.3	3.1	2.5	8.4	4.9	6.0	3.7	6.8	3.8	3.1	2.6	5.2	6.6	10.6	12.4	16.5	8.5	6.4	5.3	11.1	10.6	12.7	12.4	7.6	5.9	11.3	9.9	8.3	15.5	5.2	11.1	7.2	12.7	6.5	6.6	7.2	6.9	7.1	8.9	10.8	11.4	5.7	10.2	10.9	16.7	8.1	9.1	9.9	14.8	15.0	13.7	8.5	15.0	11.8	10.9	5.9	8.6	9.4	10.6	9.4	8.1	6.5	8.8	14.0	10.0	9.4	7.4	9.8	5.7	7.5	8.7	16.2	11.7	13.1	9.5	9.6	14.6	16.9	7.5	7.5	14.6	0.8	0.8	2.4	2.0	1.2	1.6	0.7	0.7	1.0	1.6	0.6	1.6	1.6	0.7	1.7	0.8	1.1	1.4	1.0	4.8	5.1	6.0	5.7	4.8	4.8	4.5	4.8	5.0	4.3	4.9	5.2	6.9	6.4	3.2	7.8	5.8	2.7	1.9	2.3	4.6	5.8	4.7	4.4	6.1	0.0	4.8	3.7	14.6	3.8	5.6	4.3	0.0	3.3	6.2	3.8	5.8	6.4	6.0	6.5	8.5	3.5	3.4	3.7	5.6	4.4	5.7	7.5	4.6	4.2	3.4	10.1	8.6	3.0	8.2	3.9	4.0	2.9	4.1	4.9	0.0	9.4	3.5	8.7	2.1	6.0	8.4	4.3	0.8	5.7	4.4	2.4	4.1	2.5	3.0	6.3	6.6	6.5	4.1	18.0	6.6	5.9	2.8	2.6	4.4	5.9	3.3	1.8
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	1.5	2.7	0.8	1.0	0.8	0.3	1.6	1.8	1.0	2.8	1.2	1.9	0.4	2.8	2.3	0.8	2.5	0.9	2.1	0.7	0.8	2.7	2.2	1.3	1.3	0.7	0.7	4.2	3.0	0.8	4.2	0.7	0.6	2.4	0.7	3.0	1.6	1.3	1.0	0.6	1.7	1.4	0.4	2.0	1.7	4.1	0.7	2.2	2.6	0.6	1.2	2.4	1.5	0.9	0.0	0.0	2.6	4.0	0.8	0.3	0.0	1.3	1.1	1.4	1.5	0.0	0.0	0.0	0.4	0.9	0.4	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.9	1.1	2.4	0.0	0.0	1.8	0.9	0.7	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.2	0.0	0.7	0.3	1.9	4.8	0.0	0.1	0.0	2.9	0.0	1.9	0.4	0.8	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	0.3	0.8	0.1	0.2	0.3	0.5	0.6	0.2	0.7	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	0.8	0.8	1.8	1.0	0.7	0.8	0.7	0.7	0.6	0.4	0.7	0.9	0.3	0.0	0.5	5.2	1.4	0.1	0.4	0.9	0.6	6.6	0.9	1.1	4.8	0.0	0.4	1.8	0.0	0.0	3.3	0.2	0.0	2.1	15.4	0.6	1.8	0.9	3.0	1.3	4.3	0.5	0.1	2.1	0.0	0.4	0.0	3.1	0.4	1.4	1.1	3.3	4.7	0.3	0.0	0.3	0.4	17.1	0.9	0.7	0.0	1.0	1.4	3.8	6.2	10.6	6.4	0.9	0.0	2.6	0.4	0.5	0.4	1.3	0.3	4.2	0.0	1.0	1.1	10.8	3.6	0.5	0.4	0.1	1.0	2.9	0.6	0.2
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141883-28159460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	11.0	7.7	4.5	8.1	6.2	14.8	11.5	8.9	7.2	11.2	7.4	11.8	6.6	15.9	13.3	5.6	11.1	7.6	7.6	4.5	5.6	7.7	7.3	9.2	10.5	5.5	5.1	17.6	9.9	12.9	8.4	9.4	6.1	10.3	8.4	17.6	9.0	11.6	8.1	7.9	10.7	10.7	5.0	10.8	9.2	9.1	5.2	13.1	10.6	8.9	10.9	10.2	7.9	9.2	9.0	5.6	26.1	25.4	15.8	14.9	8.2	9.7	18.3	12.6	15.7	6.3	5.3	19.4	15.7	9.4	10.5	7.4	16.7	6.2	17.9	11.2	14.1	17.7	11.7	13.6	14.4	21.8	12.7	15.4	10.4	12.9	19.2	21.5	12.5	16.9	27.9	7.1	12.9	4.4	15.5	18.2	9.5	2.1	6.4	17.0	16.5	15.2	8.6	10.9	19.5	24.7	11.6	5.3	11.9	14.3	5.9	11.7	10.9	18.1	10.5	6.1	13.2	17.3	13.2	15.6	5.1	14.8	9.9	2.2	0.5	0.6	1.0	1.2	1.1	0.5	0.6	0.4	0.4	1.7	1.0	0.8	0.1	1.1	2.1	0.7	0.6	0.6	4.5	6.2	8.9	7.2	4.5	5.6	5.5	5.1	6.1	5.0	5.2	9.2	6.9	3.2	9.3	11.8	9.8	4.8	2.6	3.8	14.8	9.5	8.5	5.1	8.0	7.2	5.0	7.3	6.2	4.2	11.0	2.0	0.0	3.1	3.7	5.9	10.0	8.8	7.2	9.4	11.1	2.9	2.0	9.5	4.6	7.4	5.1	12.7	8.6	10.2	4.1	6.7	12.5	4.6	4.1	11.1	6.8	5.2	9.0	6.0	1.8	15.9	5.9	6.5	4.1	26.7	17.1	3.0	2.4	9.1	9.0	4.3	2.3	3.5	6.1	9.2	0.0	9.9	7.3	11.9	8.6	8.5	2.8	2.3	7.1	7.4	3.7	1.9
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932079	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.4	9.3	11.1	2.8	11.5	6.3	7.5	10.5	15.1	8.0	10.6	7.3	1.8	5.5	21.2	2.4	10.0	2.1	7.9	10.7	10.7	18.3	9.7	5.7	6.6	11.5	10.9	15.2	10.3	4.3	34.8	0.7	11.0	10.7	1.3	9.4	6.7	3.7	2.6	3.0	7.5	1.3	11.1	13.8	5.8	6.7	10.9	3.2	25.0	1.5	2.6	6.0	4.8	12.1	0.2	0.0	1.0	1.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	1.2	1.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.2	0.7	1.9	0.0	8.2	0.6	0.0	0.1	0.1	1.3	0.0	0.1	1.5	0.0	0.1	2.3	0.0	0.4	1.1	0.7	0.0	0.1	1.1	1.4	2.1	2.0	0.6	0.0	0.0	0.1	4.1	0.3	0.0	0.4	2.0	0.6	0.8	0.3	0.5	0.2	0.1	0.4	0.6	0.3	0.4	0.0	0.9	0.4	0.3	0.2	0.1	0.1	0.9	0.2	0.1	11.1	11.5	10.5	15.1	10.7	10.7	11.5	10.9	11.0	11.1	10.9	12.1	18.9	16.0	31.2	190.3	30.2	4.1	7.6	0.2	7.4	38.1	18.2	12.3	25.4	11.5	14.4	14.7	43.8	0.1	16.5	0.6	3.9	5.0	14.9	28.2	3.7	16.8	10.3	6.9	30.7	2.7	0.0	10.3	2.0	21.6	15.8	51.5	13.6	10.6	3.3	16.8	32.8	2.8	0.0	9.7	11.1	9.7	1.8	11.7	7.2	71.2	10.7	25.8	10.3	111.1	112.8	1.5	1.6	1.2	7.4	6.1	2.7	5.7	13.0	57.5	0.0	27.5	9.0	22.4	10.2	3.2	2.8	0.1	16.3	5.4	2.6	4.3
ZMAT2	"FLJ31121, hSNU23, Snu23"	ENSG00000146007	"Zinc finger matrin-type 2"	Q96NC0	5	140698680-140706686	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036518	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036518: AB_10671960"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.38e-3)"	"unprognostic (6.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.84e-2)"	51.5	53.2	65.8	41.6	76.0	73.0	59.2	61.8	85.6	49.3	63.3	52.1	35.2	49.7	53.0	67.1	51.5	34.0	41.2	70.6	68.7	60.7	57.8	41.7	55.2	65.2	69.0	49.1	38.8	78.1	44.9	47.3	66.0	42.2	56.7	46.9	49.4	46.7	81.7	59.9	45.6	48.2	63.3	55.4	48.8	28.9	68.0	69.2	44.1	79.5	69.4	50.2	51.2	69.8	78.2	128.0	81.5	138.5	128.8	85.8	109.5	79.2	84.9	107.0	114.9	195.5	127.7	87.0	126.2	136.7	121.6	72.9	116.7	158.0	136.4	96.2	99.9	70.6	151.0	138.3	82.1	168.5	89.0	100.0	119.1	111.2	128.0	106.6	90.9	138.1	81.0	93.5	100.6	117.2	135.1	115.4	61.4	54.7	79.5	93.0	96.4	96.9	92.5	110.3	96.8	73.0	112.5	109.8	124.5	115.5	151.6	144.6	77.4	92.5	50.8	48.3	123.4	60.0	130.9	97.5	100.7	114.5	73.7	63.7	37.2	59.9	30.7	29.9	38.7	29.6	33.3	32.3	27.0	27.6	30.6	33.6	96.9	29.3	31.9	28.8	34.8	30.2	65.8	76.0	61.8	85.6	70.6	68.7	65.2	69.0	66.0	63.3	68.0	69.8	44.1	51.3	81.3	9.1	63.8	56.7	76.9	70.8	50.1	30.5	52.4	56.8	87.1	72.9	73.6	69.9	6.2	132.5	66.8	81.0	117.4	80.9	10.8	80.8	69.5	60.0	68.8	170.9	12.8	67.4	126.3	54.5	43.8	70.5	82.8	47.3	51.0	92.7	82.6	16.8	9.7	55.7	44.7	95.8	61.1	11.2	56.5	68.9	58.7	10.3	135.4	82.4	95.8	5.5	9.2	70.9	86.9	57.9	55.3	71.6	68.6	168.0	96.8	22.4	52.6	56.4	58.2	60.1	73.5	68.0	63.2	207.6	71.9	38.0	59.2	87.5
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	178960121-179072215	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HSkMC: 76.0;LHCN-M2: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460"	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	5.2	7.9	9.9	5.2	10.9	3.4	5.9	4.4	14.5	5.8	3.4	6.3	3.4	5.2	6.2	6.8	5.8	8.9	6.1	12.1	11.0	6.3	12.6	5.9	7.4	10.5	12.1	4.4	4.1	8.8	4.9	5.6	11.9	5.9	8.5	6.1	4.3	7.7	3.1	6.1	3.4	11.2	9.9	6.9	5.1	4.1	12.5	10.2	7.5	4.4	6.4	6.1	3.7	11.7	5.9	4.0	12.8	8.4	57.4	64.2	28.3	23.1	33.9	3.3	4.3	5.1	3.5	24.2	11.1	36.2	5.1	5.4	4.6	24.6	7.6	20.7	7.0	10.7	7.8	16.2	45.7	11.7	16.0	76.0	45.2	8.1	16.7	51.2	48.5	6.8	5.7	3.3	87.7	5.8	9.3	2.1	5.7	8.3	3.3	10.7	11.1	5.2	19.2	11.3	3.0	12.7	7.1	6.4	7.7	23.8	8.0	4.9	53.2	49.9	19.2	8.3	11.0	3.2	2.9	10.2	29.6	1.7	34.9	2.1	0.7	1.7	1.8	0.6	1.0	0.9	1.3	1.4	0.7	1.8	2.2	1.5	0.8	1.6	1.4	0.8	1.0	0.6	9.9	10.9	4.4	14.5	12.1	11.0	10.5	12.1	11.9	9.9	12.5	11.7	11.2	54.5	105.8	38.2	24.6	39.6	10.6	26.1	34.1	19.5	22.2	22.9	21.0	24.3	53.8	35.0	25.0	10.7	25.1	14.0	7.9	16.1	1.1	12.0	15.7	14.6	20.9	14.5	40.7	20.7	2.9	28.2	19.9	12.2	39.8	19.8	17.2	32.1	18.2	62.2	36.7	9.5	30.5	40.2	16.6	2.2	20.2	24.4	51.6	41.2	49.7	15.5	32.0	87.4	18.9	28.6	11.9	29.0	11.1	17.3	14.0	20.2	45.1	11.1	39.5	25.0	23.8	9.5	13.1	25.2	36.7	4.4	29.8	42.8	10.4	11.1
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.5;retina: 4.4;thyroid gland: 16.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.2	0.1	7.5	0.0	0.1	1.6	15.0	1.4	0.0	0.7	0.0	0.3	0.1	0.0	0.1	0.1	0.4	6.2	2.7	0.3	0.0	0.0	0.1	15.5	4.5	0.4	0.1	0.0	1.8	0.1	15.4	0.6	0.2	4.4	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.1	1.4	11.1	0.3	16.3	0.0	0.1	0.0	0.0	4.1	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.2	7.5	1.6	15.0	6.2	2.7	15.5	4.5	15.4	0.3	11.1	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZMAT5	"SNRNP20, ZC3H19"	ENSG00000100319	"Zinc finger matrin-type 5"	Q9UDW3	22	29730956-29767011	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004858	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004858: AB_1080657"	"unprognostic (2.14e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-3)"	"unprognostic (6.04e-3)"	"unprognostic (5.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.10e-2)"	14.3	26.0	25.8	10.6	26.4	14.2	14.5	26.5	34.9	17.1	25.9	19.6	12.2	18.0	19.8	21.1	20.5	10.0	25.5	25.3	26.0	21.3	26.8	13.7	15.0	27.5	26.5	16.2	20.4	23.0	10.6	8.4	25.5	19.2	7.2	7.8	18.2	16.6	37.1	18.1	14.4	13.8	26.0	19.9	20.1	10.6	27.2	17.8	19.1	24.5	12.2	19.0	15.8	26.8	17.9	22.1	19.3	37.5	23.7	26.2	8.7	19.4	23.9	28.5	34.7	19.4	11.0	12.2	18.9	20.8	22.0	16.5	16.5	19.9	18.6	39.2	36.3	46.9	10.8	36.3	43.8	21.6	14.8	22.7	30.2	36.5	22.2	24.2	30.4	19.0	12.3	25.9	23.8	26.7	31.0	22.5	7.2	34.7	25.9	37.1	34.2	32.6	22.8	10.9	14.8	27.4	18.1	22.4	27.9	10.9	33.7	30.0	19.4	38.8	19.4	26.4	29.2	24.0	20.5	20.4	29.9	25.6	27.9	48.1	84.6	95.3	46.1	94.6	47.3	61.6	47.7	48.6	73.9	60.3	41.8	49.1	69.5	60.8	94.7	57.6	61.0	65.3	25.8	26.4	26.5	34.9	25.3	26.0	27.5	26.5	25.5	26.0	27.2	26.8	17.0	16.0	20.8	6.2	14.6	9.6	21.0	32.0	10.2	12.7	16.2	22.6	1.4	17.2	20.4	14.7	18.8	21.5	11.3	16.4	33.2	35.3	0.9	13.8	14.3	15.2	14.4	8.6	3.7	27.3	18.1	15.9	13.3	10.4	33.7	13.0	15.0	17.1	45.1	5.0	5.1	19.4	24.4	21.4	17.9	3.0	15.8	22.1	12.4	3.7	27.7	26.0	34.0	6.0	6.5	31.7	18.1	21.8	14.9	12.4	27.8	40.0	19.3	21.4	32.9	15.1	40.0	11.0	22.8	14.0	11.8	14.1	18.0	18.2	14.4	18.9
ZMIZ1	"FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10"	ENSG00000108175	"Zinc finger MIZ-type containing 1"	Q9ULJ6	10	79068966-79316519	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 259.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 176.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045144, HPA071156"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045144: AB_10962360, HPA071156: "	"unprognostic (4.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.90e-2)"	"prognostic favorable (3.64e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.34e-2)"	34.0	24.4	24.5	19.2	27.1	26.6	27.7	25.1	30.1	44.7	5.2	28.1	19.2	51.5	18.8	37.5	26.5	25.9	31.8	25.8	27.5	17.2	8.7	26.5	17.5	34.5	36.0	48.5	23.3	19.2	12.5	21.7	29.9	19.5	14.5	14.6	28.4	28.8	34.6	33.7	22.2	26.9	27.2	44.8	27.6	4.5	33.9	16.4	37.3	17.0	18.2	28.4	31.0	23.1	24.0	29.3	54.8	23.6	55.8	16.0	19.1	22.4	40.2	15.6	8.8	8.7	10.8	12.2	17.8	52.8	40.9	33.0	9.2	16.6	8.4	26.5	5.1	43.5	11.1	25.9	39.2	24.3	88.1	21.0	18.2	22.3	15.9	98.4	25.3	10.2	16.9	62.9	13.3	45.4	24.4	37.6	16.2	13.8	44.0	107.5	10.3	12.3	11.6	20.0	56.8	82.8	14.8	176.2	46.8	19.4	56.5	23.4	35.5	58.7	23.5	29.9	29.2	11.5	21.9	0.2	77.0	42.7	11.5	1.3	2.1	1.6	1.2	3.6	0.8	0.5	0.8	0.7	2.6	0.2	0.3	0.6	3.0	3.4	3.0	2.5	1.0	1.2	24.5	27.1	25.1	30.1	25.8	27.5	34.5	36.0	29.9	27.2	33.9	23.1	49.3	38.5	26.0	64.9	14.5	22.8	8.4	14.9	15.4	49.8	27.1	18.0	54.4	20.0	15.8	16.5	0.0	7.1	14.7	39.1	7.9	22.1	47.2	17.9	75.3	49.9	13.8	25.7	23.1	24.1	5.6	36.2	38.7	33.2	50.6	16.8	56.4	9.6	37.9	63.9	16.4	14.5	14.2	34.9	86.0	259.7	28.3	52.4	24.9	46.9	27.2	12.9	4.1	92.5	45.5	19.3	22.5	23.7	14.2	13.0	19.7	8.1	14.7	3.4	19.7	24.7	32.6	1.8	3.2	40.8	23.7	3.6	12.1	14.3	14.8	12.7
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 70.1;Late spermatids: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	20.2	27.4	19.2	23.1	20.5	19.3	21.3	0.0	26.9	22.2	0.0	22.9	20.8	23.6	9.4	25.1	26.1	12.4	27.8	20.4	0.3	30.4	17.4	28.3	22.8	4.1	3.5	25.3	34.3	17.0	36.3	9.3	1.4	26.2	10.2	6.5	29.4	18.2	20.8	29.7	26.9	9.8	0.3	33.5	23.2	31.7	6.4	17.6	39.6	9.1	16.5	23.1	21.8	13.3	33.1	37.4	17.1	33.3	11.4	7.6	18.1	16.6	15.6	13.9	16.7	21.4	50.5	22.6	25.3	17.5	34.7	44.4	10.6	18.9	8.4	53.3	20.1	9.1	36.8	17.0	23.3	13.2	19.2	11.6	11.4	21.9	14.3	12.4	26.3	24.2	27.0	49.7	20.9	31.8	29.3	36.3	32.4	24.8	35.5	36.6	9.4	29.6	16.1	25.0	60.6	40.0	22.3	43.3	9.9	16.0	41.4	20.2	39.4	13.3	28.5	36.2	38.6	71.4	24.4	17.3	25.7	23.0	55.4	0.3	0.6	0.2	0.8	0.8	0.5	1.0	0.4	0.6	0.6	1.8	0.2	0.3	0.2	1.1	0.4	1.5	0.4	0.3	19.2	20.5	0.0	26.9	20.4	0.3	4.1	3.5	1.4	0.3	6.4	13.3	16.9	12.8	16.9	23.5	22.0	10.1	4.3	11.1	10.8	14.1	18.9	18.4	17.5	7.2	14.7	23.9	14.6	8.2	16.5	18.6	1.9	17.5	26.2	19.3	12.7	12.7	19.9	6.9	17.8	15.7	2.3	11.8	34.7	27.8	14.5	22.3	13.6	16.4	11.2	11.8	14.7	19.6	14.2	14.5	70.1	88.8	13.4	19.9	14.2	14.0	24.8	5.4	10.3	8.5	21.0	24.4	14.2	18.0	15.9	9.3	14.2	8.4	19.7	7.5	6.6	12.2	11.7	4.4	4.2	16.8	18.5	7.3	12.9	13.4	21.2	9.8
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258041-40294180	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		50000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	20.5	24.6	16.3	19.9	16.7	5.6	25.5	18.1	22.9	26.2	21.9	28.5	22.2	26.7	27.4	21.7	18.8	25.7	20.6	16.1	18.8	46.0	38.4	21.7	16.8	17.4	17.7	14.3	17.4	53.3	10.2	22.1	18.5	26.3	33.1	10.9	19.6	23.8	16.3	16.3	23.4	32.2	18.7	13.7	21.3	11.0	17.7	15.5	27.5	18.1	23.0	29.4	16.2	18.9	69.3	38.4	35.6	26.1	90.3	71.3	67.0	64.0	60.6	81.7	73.9	35.4	118.8	62.7	41.1	92.1	29.9	71.0	78.4	67.9	97.9	54.4	39.8	59.9	36.0	44.5	45.4	99.3	68.8	45.5	67.4	64.7	28.4	45.4	58.3	27.3	63.0	60.6	80.1	30.2	60.7	28.3	70.0	47.2	42.2	52.2	60.2	77.6	75.2	58.0	38.0	44.6	60.9	155.6	85.9	56.3	55.2	249.1	46.4	68.6	52.5	56.0	78.0	37.1	106.2	49.6	75.6	64.6	79.1	18.9	21.4	14.0	17.6	27.2	22.5	15.0	19.4	19.4	29.4	11.4	16.7	22.9	8.5	29.6	24.3	18.4	24.6	22.7	16.3	16.7	18.1	22.9	16.1	18.8	17.4	17.7	18.5	18.7	17.7	18.9	28.9	38.5	24.1	19.2	20.1	32.0	24.2	41.4	33.0	6.6	35.9	19.0	25.5	54.3	43.0	73.5	0.0	41.4	22.1	44.3	31.3	58.9	3.5	30.7	32.6	31.2	27.6	18.1	16.6	36.9	38.3	36.0	21.9	40.0	21.0	16.6	27.5	64.4	34.0	10.1	13.9	31.0	54.9	33.9	24.5	2.2	28.6	28.6	24.9	11.2	30.5	29.3	19.6	17.6	20.2	44.0	29.3	32.7	31.1	37.7	31.7	42.6	64.2	7.7	0.0	26.8	41.2	7.8	6.4	31.5	27.1	39.0	23.1	28.9	35.6	24.5
ZMYM2	"FIM, MYM, RAMP, ZNF198"	ENSG00000121741	"Zinc finger MYM-type containing 2"	Q9UBW7	13	19958677-20091829	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031765	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum"		"HPA031765: AB_10601927"	"unprognostic (2.96e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.80e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.07e-4)"	14.3	17.3	6.2	12.3	9.2	26.5	17.0	6.3	10.4	17.5	10.1	13.8	14.3	15.0	12.4	16.4	14.6	15.9	18.1	6.6	8.4	17.3	14.5	13.2	14.8	6.1	7.1	16.4	16.8	17.7	8.4	14.7	7.3	19.2	13.8	25.4	14.0	16.8	13.7	12.7	12.2	15.2	3.3	14.3	17.2	49.3	8.5	20.9	24.6	20.6	18.8	17.6	9.8	13.1	14.9	13.1	50.2	22.0	21.0	23.2	23.7	15.4	24.2	19.1	23.4	20.4	29.4	35.5	13.6	21.3	18.5	23.8	38.2	16.3	25.7	14.2	10.5	63.5	19.4	10.5	21.4	54.8	18.5	22.5	30.1	15.2	16.0	30.2	33.5	35.8	24.7	24.8	27.4	21.4	51.8	16.4	46.5	45.4	8.2	58.4	54.7	16.7	14.5	21.2	58.3	56.6	29.1	21.0	27.6	33.3	28.1	37.6	19.5	9.6	14.8	12.0	8.1	19.3	16.3	36.4	8.2	12.3	23.4	0.1	2.7	2.2	2.7	3.0	3.4	2.7	3.6	2.7	3.2	2.0	3.7	3.3	3.8	3.0	2.7	3.3	2.8	1.9	6.2	9.2	6.3	10.4	6.6	8.4	6.1	7.1	7.3	3.3	8.5	13.1	40.1	44.8	39.3	140.7	85.3	55.1	47.1	51.4	55.2	112.8	43.8	34.0	36.8	25.8	58.5	51.5	112.6	13.6	71.2	24.4	5.9	23.8	105.8	45.4	53.1	38.5	55.8	32.8	218.4	17.8	15.3	43.0	49.5	59.1	46.3	61.2	42.1	34.4	21.6	72.3	179.5	28.4	44.7	57.5	101.8	174.6	55.9	53.6	33.8	124.6	40.0	34.9	41.2	225.7	305.6	35.3	41.4	41.0	42.1	51.3	27.4	16.1	51.7	106.6	32.9	45.2	38.3	94.9	54.9	55.1	44.6	11.4	68.0	37.3	29.6	82.6
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 38.8;Theca cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA003211: AB_1080661, HPA075255: AB_2732287"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	10.0	29.2	19.5	8.6	18.9	7.1	10.2	10.7	18.2	17.3	9.5	15.5	7.1	15.9	18.6	9.9	19.2	9.9	9.6	17.8	20.4	13.2	13.6	11.0	12.1	12.8	14.4	37.1	10.8	11.6	18.1	7.9	14.2	15.5	7.8	13.3	11.6	17.1	10.8	11.4	12.0	14.6	13.0	15.5	12.2	20.5	25.9	16.0	15.8	5.7	10.9	13.3	13.3	13.7	15.4	27.9	66.2	35.2	18.8	18.9	16.7	14.0	20.8	29.7	27.8	31.1	22.9	39.0	34.1	25.3	26.8	14.2	57.1	21.2	22.3	13.1	30.6	33.9	25.6	27.9	8.7	31.9	20.3	22.3	12.1	21.6	13.4	52.8	25.2	30.8	39.7	20.9	22.0	25.5	38.6	40.6	65.9	19.0	24.2	47.7	20.3	28.7	22.0	18.6	31.5	21.7	23.8	14.7	13.7	47.8	21.7	20.7	19.5	14.6	26.7	21.5	12.8	18.9	12.1	32.9	17.6	42.9	16.4	6.1	5.2	4.3	4.2	4.8	4.8	7.1	4.8	3.9	4.8	6.6	4.0	4.0	0.3	4.9	4.2	10.1	4.8	4.0	19.5	18.9	10.7	18.2	17.8	20.4	12.8	14.4	14.2	13.0	25.9	13.7	5.6	12.8	11.9	14.7	6.9	3.8	2.7	12.2	6.8	12.9	9.2	10.0	10.6	7.2	15.0	31.3	10.4	8.5	4.7	3.3	1.9	6.7	1.1	12.0	8.5	7.5	4.8	7.6	15.8	8.9	7.0	7.0	6.6	9.4	2.5	38.8	8.9	15.3	9.8	13.5	17.3	9.2	6.1	11.9	6.7	4.0	13.7	6.6	3.6	6.5	11.2	9.5	7.2	7.1	12.3	5.5	8.8	23.3	4.9	1.9	4.5	15.1	12.0	7.7	6.6	5.3	9.9	1.5	4.0	9.3	3.8	4.2	5.2	40.0	7.1	2.0
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268709-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	12.1	11.4	13.3	12.5	14.3	13.6	17.2	23.9	15.2	17.2	12.0	11.8	8.9	16.3	15.5	12.7	14.8	13.5	11.2	11.8	14.9	13.3	12.8	12.1	14.4	12.8	13.3	21.7	13.9	18.1	9.3	17.2	14.0	15.0	11.5	24.6	12.2	13.6	14.9	10.9	9.2	13.7	13.8	14.8	13.7	34.2	14.0	20.9	18.4	15.3	17.0	14.6	9.9	16.0	28.1	22.6	67.7	35.0	19.2	41.4	24.9	32.7	49.1	39.1	50.7	24.6	27.6	52.0	19.6	41.3	19.1	17.8	47.3	24.4	56.2	29.5	27.8	63.5	25.0	21.4	35.5	54.7	28.1	31.3	21.1	38.3	35.9	32.4	44.0	28.5	70.0	14.1	47.9	17.4	47.4	32.0	56.3	15.0	19.9	52.4	43.4	26.1	28.7	37.2	39.1	37.5	39.1	29.4	45.7	42.3	23.2	41.4	53.7	36.4	37.8	16.3	35.9	15.3	29.9	40.0	26.2	41.4	35.7	1.8	3.6	2.7	3.1	5.1	2.9	3.2	2.8	2.7	3.5	2.4	2.7	2.6	0.7	6.6	7.1	7.0	2.4	1.9	13.3	14.3	23.9	15.2	11.8	14.9	12.8	13.3	14.0	13.8	14.0	16.0	33.6	12.8	21.9	94.3	17.4	11.5	16.6	14.4	17.1	30.7	31.8	29.1	32.0	25.8	20.8	27.6	31.3	14.7	20.6	6.6	5.9	22.7	59.8	25.0	45.1	22.8	22.3	22.5	127.9	23.7	12.5	27.0	21.9	33.7	14.5	49.1	18.5	16.1	13.1	23.5	136.5	14.7	14.2	23.1	12.5	91.9	26.4	21.4	5.4	109.6	27.5	22.5	26.8	174.4	132.6	19.9	8.1	23.0	13.9	22.7	5.5	11.8	21.6	33.0	19.7	33.4	29.0	34.4	13.3	13.8	11.4	14.1	13.9	45.5	14.0	22.7
ZMYM5	"MYM, ZNF198L1, ZNF237"	ENSG00000132950	"Zinc finger MYM-type containing 5"	Q9UJ78	13	19823482-19863649	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015544, HPA020879"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA015544: , HPA020879: AB_2670524"	"unprognostic (4.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	7.0	7.8	2.6	7.1	3.6	12.2	7.9	3.5	3.4	6.7	3.9	5.9	6.2	7.6	8.6	7.6	5.4	9.2	5.4	2.2	2.9	6.6	6.9	6.7	10.3	3.9	3.2	6.7	5.4	5.5	4.8	7.1	3.5	8.2	6.2	9.0	5.7	5.5	6.2	7.8	6.6	6.9	2.9	7.5	7.3	23.4	3.3	10.1	8.6	7.7	8.9	7.2	5.8	5.0	8.5	4.4	9.6	7.7	6.5	10.3	3.6	7.8	12.2	12.5	10.3	10.6	16.5	11.8	8.4	11.2	15.5	7.9	7.1	9.3	14.0	9.5	5.7	22.1	7.9	7.4	21.0	15.9	11.4	12.5	11.0	6.8	12.7	12.8	12.7	7.6	9.0	10.0	12.0	21.4	11.9	16.4	5.2	11.0	6.4	13.2	12.3	4.6	10.5	9.4	9.0	8.2	10.1	8.2	27.4	10.2	12.7	13.7	10.6	6.8	5.1	9.2	5.8	15.9	7.7	17.6	6.8	6.9	11.2	16.1	5.4	8.6	8.7	5.2	9.3	9.9	9.9	8.5	5.7	8.6	7.7	8.2	10.7	8.0	7.4	7.8	8.9	4.2	2.6	3.6	3.5	3.4	2.2	2.9	3.9	3.2	3.5	2.9	3.3	5.0	34.1	28.9	17.3	33.0	35.7	24.3	20.8	20.3	43.9	29.7	27.4	26.8	16.2	22.8	18.9	11.0	18.8	17.9	32.4	10.7	7.9	15.5	16.0	24.0	24.0	21.3	27.6	22.3	36.2	10.5	9.6	24.4	19.9	25.4	33.6	19.6	15.0	7.9	11.4	28.6	35.8	11.9	24.4	12.9	24.0	20.8	22.7	23.9	21.4	26.2	17.0	15.2	16.5	30.7	52.9	14.2	16.9	18.4	20.7	16.8	10.7	11.2	10.4	30.3	32.9	27.2	24.7	92.7	51.1	56.5	21.7	8.3	38.3	15.5	11.4	32.9
ZMYM6	"Buster2, MYM, ZBED7, ZNF198L4, ZNF258"	ENSG00000163867	"Zinc finger MYM-type containing 6"	O95789	1	34986165-35031945	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011004, HPA071865"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA011004: AB_1859075, HPA071865: AB_2686464"	"prognostic favorable (1.30e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.11e-6)"	"unprognostic (1.77e-3)"	"unprognostic (4.83e-3)"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.84e-3)"	5.7	7.5	3.2	8.4	4.5	15.2	6.9	5.2	4.6	5.3	3.3	6.2	6.4	7.1	8.5	6.9	4.8	6.4	6.8	3.3	4.0	6.8	4.6	6.4	9.5	3.8	3.7	9.2	5.0	7.6	6.8	4.9	4.4	6.5	7.5	9.2	5.2	5.4	3.5	8.2	7.1	6.6	3.2	10.6	7.3	9.6	4.5	8.2	9.4	4.8	8.6	5.5	4.9	5.4	8.3	4.8	7.9	8.0	9.3	10.8	5.1	7.5	10.7	7.8	8.6	3.4	8.9	11.3	7.2	10.4	5.8	7.7	9.2	7.3	9.8	7.7	5.4	9.6	6.4	4.4	8.1	14.7	11.8	9.9	9.9	9.3	7.2	5.8	9.2	9.5	15.9	12.2	8.3	3.0	6.5	10.0	7.7	4.8	7.6	8.9	10.9	6.5	7.2	6.1	8.4	8.4	8.1	7.8	9.5	8.0	5.2	7.9	9.7	10.0	8.0	11.0	10.6	7.6	13.0	8.5	10.5	13.6	8.9	3.0	5.5	5.7	5.3	4.6	4.6	4.6	3.6	3.0	5.0	5.5	5.2	3.5	3.1	4.0	5.9	7.7	4.3	2.6	3.2	4.5	5.2	4.6	3.3	4.0	3.8	3.7	4.4	3.2	4.5	5.4	9.2	12.8	16.5	30.0	11.1	6.0	5.5	7.2	10.2	12.0	7.8	6.1	15.7	8.6	7.9	16.5	20.9	3.9	13.5	8.9	5.9	5.1	2.0	5.6	7.7	6.9	3.6	3.4	34.4	5.6	3.3	8.0	13.3	7.1	10.1	10.6	5.0	8.8	7.8	13.5	37.9	8.0	6.1	20.6	15.7	1.8	8.4	15.6	1.8	30.9	19.0	8.5	15.5	22.6	41.4	5.8	7.4	11.3	7.0	4.0	7.5	7.3	8.3	20.9	13.1	8.0	12.0	24.7	18.8	9.0	6.5	5.3	8.5	8.6	8.2	5.7
ZMYND19	MIZIP	ENSG00000165724	"Zinc finger MYND-type containing 19"	Q96E35	9	137582081-137590512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 287.8"	"Group enriched"	"Detected in many"	14	"Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020642, HPA050761"	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA020642: AB_1859078, HPA050761: AB_2681228"	"unprognostic (2.30e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.72e-1)"	11.9	16.5	19.6	9.4	19.9	9.1	11.9	18.8	23.9	14.2	18.6	12.4	8.8	11.2	5.0	26.5	11.4	7.2	14.1	20.0	19.5	12.9	21.1	12.0	11.9	18.7	19.2	12.9	16.1	8.0	16.9	8.5	19.7	16.5	5.7	287.8	15.9	7.1	14.2	27.7	12.4	6.8	18.9	15.1	22.2	49.5	19.4	9.5	10.8	8.8	9.4	13.3	16.6	19.8	28.9	44.7	41.8	45.5	22.1	21.3	42.1	38.8	25.8	41.7	31.8	53.1	28.7	51.7	43.6	25.8	40.2	71.7	51.3	38.9	13.2	33.8	49.7	26.9	86.1	41.8	34.4	58.4	33.9	16.8	58.7	38.0	37.1	18.4	22.3	40.5	66.3	22.2	25.6	97.2	68.4	88.7	60.7	86.4	61.9	73.8	36.8	79.6	25.7	24.2	60.1	39.4	37.4	79.4	35.4	18.5	53.7	89.9	21.3	51.1	38.9	76.8	63.8	21.4	54.9	56.8	31.6	44.8	35.9	0.0	0.3	0.3	0.5	1.6	1.2	0.8	0.3	0.2	0.3	0.3	0.5	0.4	0.0	0.1	0.2	0.9	1.0	0.1	19.6	19.9	18.8	23.9	20.0	19.5	18.7	19.2	19.7	18.9	19.4	19.8	6.1	9.6	7.2	3.6	4.0	17.5	5.6	3.2	5.2	23.6	14.9	19.2	6.2	2.8	2.4	1.8	244.0	5.2	6.8	5.3	0.0	3.2	4.5	6.5	12.8	5.6	2.4	6.9	4.1	3.6	6.8	6.3	10.7	8.1	1.3	10.6	3.9	7.6	4.4	11.8	4.0	8.8	6.1	3.2	5.7	4.4	2.8	3.6	5.4	1.9	2.2	31.6	5.2	2.0	2.1	4.2	4.6	3.0	10.9	10.2	1.9	3.1	1.3	680.0	0.0	6.9	6.7	27.8	28.7	4.5	22.9	4.5	4.6	8.5	7.8	7.1
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	13.1	32.7	25.4	10.5	21.3	26.0	14.7	26.2	36.2	11.9	47.8	14.1	11.0	9.8	33.3	16.0	15.9	12.3	12.5	35.5	29.5	18.5	10.9	11.1	12.8	30.5	22.9	13.6	12.3	11.6	25.9	11.8	33.0	11.8	14.5	20.1	14.6	14.6	15.3	19.9	16.2	8.7	9.4	18.3	20.0	14.2	25.2	14.6	11.0	11.0	12.8	14.5	14.9	37.3	27.6	17.2	90.5	36.6	15.2	21.3	59.4	21.7	17.8	22.3	22.8	107.7	26.0	26.5	34.4	16.3	27.1	18.7	39.4	96.0	33.3	11.4	14.9	110.4	6.3	95.9	55.4	11.9	55.9	20.9	43.4	24.8	94.1	40.4	61.0	9.5	90.6	17.7	41.0	32.1	4.4	45.4	85.9	20.3	24.3	55.8	15.0	22.9	30.4	49.6	38.0	14.3	10.3	32.4	44.4	70.3	17.0	22.6	143.6	23.9	16.6	23.3	20.2	12.5	25.2	23.2	80.8	18.3	80.3	34.8	7.4	10.4	8.7	7.5	8.7	15.3	8.8	9.0	4.7	18.3	11.4	11.8	19.8	16.3	6.8	16.5	9.3	4.3	25.4	21.3	26.2	36.2	35.5	29.5	30.5	22.9	33.0	9.4	25.2	37.3	48.2	44.8	78.5	94.0	36.6	8.8	32.2	44.6	15.9	108.1	29.3	20.7	23.7	28.6	74.3	90.1	160.6	23.1	36.2	64.0	15.6	36.5	13.6	111.3	29.8	31.7	56.3	112.9	153.8	28.7	42.0	24.2	41.8	124.4	32.2	44.8	30.7	16.1	21.9	85.8	113.5	49.2	42.7	48.8	12.8	21.9	27.7	31.8	10.6	49.6	25.0	24.4	40.2	89.0	138.7	47.1	42.3	26.7	29.7	23.9	56.8	12.0	82.3	50.0	32.9	33.4	27.5	6.3	29.9	19.2	8.4	66.5	34.2	39.3	32.1	24.2
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 45.5;Excitatory neurons: 46.0;Inhibitory neurons: 48.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	6.7	14.3	4.9	3.7	5.6	8.6	12.3	8.8	7.6	14.4	6.2	10.9	3.7	15.0	23.4	6.0	12.1	10.3	8.3	5.8	8.0	10.9	10.6	7.6	5.9	4.7	6.8	22.4	13.2	17.3	45.3	5.2	5.6	15.1	6.2	13.1	8.0	12.7	4.9	8.8	7.1	8.6	5.4	6.0	10.5	15.3	7.8	7.7	21.2	6.3	5.8	10.7	8.8	7.1	3.8	2.2	10.8	0.0	11.5	4.8	6.5	4.4	3.9	5.3	3.6	3.9	2.4	0.0	6.0	4.4	2.9	1.7	6.8	3.6	3.9	0.0	6.6	8.0	10.5	4.4	3.5	5.0	2.6	5.0	3.3	5.7	6.3	7.9	4.4	6.3	6.0	0.0	6.3	1.2	12.0	10.6	11.1	2.1	4.4	9.9	6.8	5.4	4.2	7.9	10.7	7.0	8.7	1.4	3.7	4.9	6.6	5.0	4.3	3.9	3.6	3.7	3.7	0.2	0.0	12.8	1.2	1.7	3.7	0.9	0.5	1.4	2.9	0.6	3.2	3.1	3.4	4.1	1.4	3.0	6.5	3.3	0.5	6.3	0.4	3.4	0.9	1.8	4.9	5.6	8.8	7.6	5.8	8.0	4.7	6.8	5.6	5.4	7.8	7.1	6.8	0.0	9.0	39.2	39.6	3.8	5.3	3.9	45.5	15.9	9.9	9.4	7.7	4.3	7.1	0.0	31.3	4.5	9.1	1.8	1.9	2.3	24.6	11.9	7.6	5.0	12.6	5.0	46.0	1.4	2.0	15.5	21.4	11.7	10.8	5.0	1.4	4.9	2.5	5.0	48.4	3.9	6.1	3.8	4.6	6.3	2.8	9.0	3.6	21.5	1.5	9.1	2.1	54.3	45.4	1.0	2.1	6.8	16.3	2.6	2.2	2.5	2.7	16.2	0.0	6.3	14.3	20.4	15.4	21.4	3.8	3.8	21.9	6.0	3.3	1.6
ZNF100		ENSG00000197020	"Zinc finger protein 100"	Q8IYN0	19	21722771-21767579	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.7;Late spermatids: 68.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 30.7"									HPA059135	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA059135: AB_2683918"	"unprognostic (2.20e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.94e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (5.47e-4)"	3.0	2.8	0.9	3.0	2.2	5.6	3.5	4.9	1.1	3.1	0.9	2.6	1.0	3.3	3.5	1.8	3.2	1.9	1.8	0.4	1.4	2.0	1.5	2.9	5.4	1.9	1.4	6.0	2.7	1.6	2.0	3.2	2.0	2.9	3.3	2.0	2.5	2.5	3.0	2.0	2.9	2.4	1.2	4.0	2.5	8.3	1.8	6.2	3.0	3.6	4.6	2.8	2.3	3.5	0.3	0.1	10.8	4.2	2.2	2.3	10.0	4.2	3.2	7.2	10.8	3.6	2.6	6.5	7.4	2.3	4.6	2.9	11.0	3.4	13.7	0.0	8.0	7.8	3.4	1.9	1.3	0.0	4.8	2.6	0.5	5.4	0.2	2.0	3.2	15.1	13.6	0.2	5.4	4.0	30.7	8.5	9.8	0.1	5.1	12.4	13.0	4.7	3.6	11.1	6.7	4.9	6.9	0.2	3.6	8.3	4.1	5.6	3.6	3.0	2.2	6.1	5.6	0.2	4.3	13.2	0.0	7.8	3.3	4.8	3.0	3.4	1.0	3.0	1.2	2.8	1.9	1.7	3.4	4.6	3.0	2.4	3.5	2.8	2.1	1.6	2.0	1.2	0.9	2.2	4.9	1.1	0.4	1.4	1.9	1.4	2.0	1.2	1.8	3.5	10.1	3.2	4.5	14.0	10.0	3.1	6.0	2.2	4.6	7.1	7.3	5.2	5.7	2.8	5.5	9.2	2.1	7.6	9.0	4.0	3.9	5.0	77.7	6.2	8.6	6.6	3.0	5.5	11.2	5.8	7.8	6.8	6.6	12.3	10.1	16.3	5.3	1.0	5.5	1.7	12.0	3.8	4.1	10.4	6.1	68.7	11.5	10.3	8.8	13.1	9.8	3.2	8.2	20.6	25.9	6.8	5.8	4.5	7.2	5.7	2.9	2.3	7.4	5.1	26.3	8.2	6.2	21.7	11.3	3.1	2.8	8.8	7.9	15.4	4.6	11.4
ZNF101	"DKFZp570I0164, HZF12"	ENSG00000181896	"Zinc finger protein 101"	Q8IZC7	19	19668796-19683509	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.6"	"Cell type enhanced"	"Detected in many"		"NK-cells: 24.7;T-cells: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 82.5"									"HPA023449, HPA055486"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA023449: AB_2671211, HPA055486: AB_2682831"	"unprognostic (5.05e-2)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.15e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (1.11e-4)"	"unprognostic (3.15e-2)"	"unprognostic (7.02e-2)"	"prognostic favorable (4.37e-4)"	3.2	2.0	2.1	13.1	2.2	13.2	6.2	3.0	3.6	3.2	2.1	4.8	3.2	2.3	2.8	6.9	2.4	2.6	2.2	2.3	1.7	4.1	3.1	3.4	27.6	2.4	2.0	1.8	2.4	2.0	1.9	3.3	2.4	2.3	4.5	4.2	3.1	1.9	1.7	3.7	8.2	2.1	1.7	11.1	4.6	10.6	2.5	25.4	3.1	1.3	24.7	5.6	3.0	3.2	6.0	5.5	6.7	8.7	2.5	4.5	13.3	7.0	3.8	5.3	9.2	6.9	7.8	35.5	7.5	3.7	5.6	5.6	11.8	7.1	10.7	4.7	6.2	11.2	5.1	11.0	2.0	20.9	18.7	3.5	4.0	9.7	7.1	3.2	6.7	25.7	8.1	19.8	6.5	7.2	27.4	6.8	18.8	6.2	8.6	10.3	8.9	16.0	5.5	10.1	3.4	4.1	8.0	5.1	2.5	8.3	7.7	12.0	5.3	7.5	2.9	11.6	7.2	9.5	18.8	82.5	4.4	11.2	7.2	16.4	4.3	7.7	12.8	5.9	23.2	13.8	30.9	20.3	6.4	15.6	43.3	32.3	6.0	11.1	7.4	10.1	61.2	16.0	2.1	2.2	3.0	3.6	2.3	1.7	2.4	2.0	2.4	1.7	2.5	3.2	6.0	12.8	6.8	2.0	18.2	2.5	2.2	4.1	1.2	7.3	5.0	3.8	2.8	1.5	4.3	9.2	6.2	5.6	9.8	5.1	3.9	4.5	12.7	2.9	2.7	6.5	3.0	4.2	3.1	6.6	5.1	2.5	2.6	3.6	6.3	4.0	5.7	3.1	6.8	1.7	3.0	3.7	0.0	9.7	3.5	9.9	2.8	5.7	3.6	1.0	8.8	3.5	24.7	4.0	3.6	5.5	4.6	1.5	13.9	2.9	4.3	2.9	5.8	11.5	0.0	3.3	2.7	13.0	8.6	1.8	2.3	2.1	23.8	2.5	2.7	3.3
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 392.5;tongue: 465.5"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.4	11.2	20.8	14.3	29.8	24.4	17.9	19.0	28.1	18.0	109.2	19.7	10.0	15.9	17.3	18.5	12.7	17.2	175.6	23.3	22.6	16.5	8.7	20.9	17.5	23.6	29.1	15.9	10.3	17.8	10.3	12.9	22.5	20.9	13.9	22.0	12.9	14.7	392.5	11.7	13.3	23.0	20.8	17.1	12.8	14.3	27.4	15.6	13.2	465.5	18.6	14.6	9.1	27.7	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	20.8	29.8	19.0	28.1	23.3	22.6	23.6	29.1	22.5	20.8	27.4	27.7	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF112	"ZFP112, ZNF228"	ENSG00000062370	"Zinc finger protein 112"	Q9UJU3	19	44326555-44367217	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.8;Inhibitory neurons: 9.9;Oligodendrocyte precursor cells: 10.6;Oligodendrocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 17.3"					"Low region specificity"	"Detected in all"			HPA023856	Approved		Approved	Centrosome		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA023856: AB_1859018"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (1.54e-5)"	"unprognostic (1.65e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.57e-3)"	1.7	3.0	4.1	0.8	4.7	0.1	4.3	8.1	4.7	2.3	4.5	3.0	2.6	3.8	3.8	2.6	3.9	2.3	3.4	4.1	4.7	2.8	1.6	2.5	0.9	4.6	4.5	4.4	2.5	4.5	3.4	2.5	4.7	3.8	2.9	5.2	3.0	3.9	1.9	2.8	2.7	2.8	4.7	2.0	3.2	7.5	4.5	1.4	4.1	2.5	1.5	2.3	2.2	6.0	4.4	2.7	7.5	4.4	4.4	3.9	1.8	4.1	6.8	3.8	5.7	1.9	3.1	0.0	2.9	3.5	3.5	3.9	4.5	2.8	6.0	0.0	5.5	5.1	4.6	1.8	3.5	0.0	0.0	4.1	4.9	2.9	6.0	6.5	4.5	0.0	1.9	11.9	4.5	1.0	0.0	0.0	4.1	1.1	1.6	0.0	8.1	2.3	3.6	4.8	3.6	5.8	5.4	1.0	2.9	6.3	2.2	0.0	6.2	6.0	4.5	17.3	3.4	0.0	0.0	0.1	3.6	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	4.1	4.7	8.1	4.7	4.1	4.7	4.6	4.5	4.7	4.7	4.5	6.0	2.8	0.0	0.5	6.2	0.1	0.4	1.1	1.7	0.6	6.9	1.7	1.9	4.4	1.5	1.7	0.0	0.0	1.2	0.0	1.5	1.9	1.7	5.5	1.2	1.8	1.7	1.2	1.3	10.8	1.2	0.7	1.8	0.0	0.9	0.0	6.1	1.8	0.2	0.5	8.4	9.9	1.6	0.0	0.0	0.4	1.0	0.6	0.5	0.0	7.5	0.4	4.3	0.0	10.6	13.4	0.7	0.5	1.5	0.0	0.7	1.3	1.2	2.8	2.5	0.0	2.3	1.5	2.9	2.0	2.1	0.4	0.3	0.1	3.5	1.1	0.3
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270081-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 5.9"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	0.8	0.4	1.8	0.7	1.6	0.8	0.6	2.1	2.1	1.1	0.8	0.3	0.3	1.1	0.7	0.5	0.9	0.5	0.7	1.7	1.8	0.5	0.2	0.7	0.6	1.4	1.8	0.4	0.8	1.6	0.4	1.4	1.2	0.4	0.2	0.6	0.4	0.5	0.5	1.0	0.1	0.2	0.6	0.6	0.1	0.9	1.8	0.2	5.9	0.4	0.6	0.2	0.3	2.3	3.8	5.9	6.9	0.2	0.0	0.0	22.2	0.4	0.0	2.1	2.8	2.2	5.6	0.0	6.4	0.3	2.4	7.4	9.5	0.1	2.5	0.1	0.6	0.3	1.4	27.8	1.5	3.7	0.5	0.4	0.7	1.1	0.0	0.5	0.1	0.4	0.7	0.0	0.2	10.9	0.3	11.6	13.8	10.3	0.9	14.6	0.0	0.0	0.2	2.7	2.7	3.1	3.7	0.1	3.7	4.2	1.4	7.0	0.9	0.5	2.2	1.7	0.6	0.2	0.2	0.0	0.2	1.8	0.5	1.8	0.3	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.7	1.2	0.1	0.1	2.0	0.7	0.2	1.0	0.1	0.1	1.8	1.6	2.1	2.1	1.7	1.8	1.4	1.8	1.2	0.6	1.8	2.3	2.3	3.2	1.8	0.7	0.2	0.4	1.3	0.5	0.0	1.2	0.3	0.4	0.5	0.0	2.6	0.0	0.0	2.1	0.2	0.0	1.9	0.5	2.6	3.3	1.6	1.4	0.0	1.3	0.2	0.6	2.5	0.6	0.0	3.9	0.0	0.9	2.2	0.8	1.8	0.0	0.9	0.0	0.0	0.3	2.0	0.8	1.2	0.6	0.0	0.0	0.2	1.3	0.0	2.0	0.2	0.3	0.0	0.7	0.1	0.9	0.0	0.4	0.8	0.7	0.0	0.9	0.6	0.8	4.4	0.0	0.1	15.3	0.5	0.7	0.1	1.1
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560329-9584504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 68.2;RT4: 72.3"	"Low region specificity"	"Detected in all"							HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: AB_2682651"	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favorable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.75e-5)"	7.0	4.8	5.5	5.2	5.9	14.3	7.2	8.8	6.4	5.3	8.2	5.5	3.6	4.7	5.6	9.3	5.4	4.0	6.1	5.7	6.7	8.0	8.5	7.5	6.2	6.0	5.1	4.6	6.3	8.7	6.7	4.2	6.3	7.1	5.8	7.2	6.7	3.5	4.4	10.8	6.4	4.8	5.3	7.4	5.7	3.6	6.3	6.0	5.6	3.2	6.8	5.3	7.0	9.5	14.9	8.7	10.3	23.7	4.6	5.4	16.4	5.3	5.3	7.3	10.0	17.7	6.6	16.1	13.3	4.6	4.1	13.6	18.8	15.0	9.2	8.4	32.4	43.2	29.2	15.7	6.1	26.0	25.6	7.2	11.2	7.2	16.3	6.1	5.4	17.4	16.9	27.7	5.4	11.8	17.9	68.2	27.1	5.2	13.9	10.9	13.0	11.8	8.0	72.3	19.6	10.2	7.6	10.6	6.2	20.7	7.8	8.2	6.1	21.7	12.0	7.6	12.1	26.6	17.6	18.4	6.0	14.4	9.1	1.6	1.5	0.9	2.1	1.9	2.8	1.5	2.0	1.9	1.6	2.3	2.3	2.6	1.2	3.1	2.0	2.0	2.0	0.9	5.5	5.9	8.8	6.4	5.7	6.7	6.0	5.1	6.3	5.3	6.3	9.5	16.0	6.4	10.5	3.9	14.7	22.6	36.9	15.6	10.8	7.3	12.7	11.7	11.2	5.7	15.7	9.2	12.5	12.3	25.8	5.6	7.9	11.4	1.5	12.3	16.9	11.8	13.7	11.6	6.2	5.3	11.3	11.7	11.7	18.3	15.2	16.7	10.8	9.9	5.3	6.7	5.3	10.2	8.2	10.4	13.8	0.6	6.2	9.7	8.8	1.0	6.9	3.1	12.3	7.5	6.7	11.4	5.6	8.2	12.6	26.2	4.1	5.3	11.0	7.8	6.6	17.0	10.3	11.0	12.5	21.3	31.7	10.5	14.5	11.9	14.6	35.9
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.3;salivary gland: 42.6"	"Group enriched"	"Detected in many"	16	"Early spermatids: 343.2;Late spermatids: 1250.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.03e-4)"	2.4	2.3	0.9	4.1	2.8	6.0	3.5	14.3	5.2	2.6	0.4	7.0	6.3	4.3	3.9	2.0	2.2	3.5	2.0	2.5	4.4	4.6	3.2	4.0	6.1	2.5	2.9	3.2	3.4	1.5	1.0	4.3	1.9	2.9	6.9	4.8	42.6	2.4	1.8	4.3	5.9	3.5	0.5	5.5	4.4	3.9	3.3	6.7	3.7	1.4	6.3	3.3	1.9	6.6	5.8	4.3	12.0	15.8	4.4	2.5	29.9	5.8	3.5	6.0	6.0	6.5	5.1	11.6	6.8	4.7	4.0	6.2	14.4	4.6	8.6	0.7	3.8	10.0	5.6	14.0	4.3	18.5	11.3	3.5	3.7	5.9	5.7	2.9	8.8	13.4	14.6	8.0	7.5	5.1	18.9	11.8	31.1	11.1	9.9	19.9	9.7	8.2	5.7	17.0	18.5	18.9	8.7	6.7	6.0	14.0	4.8	28.8	10.0	4.5	6.8	5.0	10.7	6.8	9.0	16.8	1.9	18.6	9.6	8.1	7.9	9.2	5.8	9.1	8.2	9.3	7.4	7.1	11.2	5.1	9.9	9.8	1.8	9.5	14.5	8.7	6.2	5.5	0.9	2.8	14.3	5.2	2.5	4.4	2.5	2.9	1.9	0.5	3.3	6.6	8.2	16.0	8.9	5.5	14.9	3.6	5.8	10.2	6.2	3.7	4.1	6.5	4.6	7.2	11.2	3.7	4.2	3.6	13.8	8.6	1.9	5.3	343.2	7.2	6.8	8.9	7.8	5.5	13.5	5.0	6.6	4.5	13.3	7.9	11.4	10.7	3.3	0.7	7.9	0.0	47.8	5.1	12.2	26.8	5.3	1250.3	12.2	16.7	7.2	18.7	10.5	2.3	5.2	25.6	12.7	5.0	10.6	12.0	9.3	6.8	7.7	6.2	4.5	5.6	6.6	9.3	5.1	8.8	12.3	3.7	1.6	1.4	10.6	4.7	9.0	5.5
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440153	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.0;Cone photoreceptor cells: 4.2;Early spermatids: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	1.4	2.3	1.8	1.3	1.9	0.3	2.6	4.7	2.7	2.7	4.6	1.7	1.2	1.8	3.5	1.6	3.8	1.3	3.0	1.8	1.9	3.0	0.8	1.8	1.8	1.5	2.3	3.7	1.6	8.9	3.4	1.8	1.6	2.9	1.1	5.0	3.0	3.1	1.9	2.3	1.1	2.1	1.4	2.3	1.5	3.1	1.7	1.6	5.4	1.7	2.2	1.9	1.5	2.7	1.2	1.3	3.4	1.2	3.9	3.3	0.1	2.6	3.2	2.1	2.0	0.1	1.0	3.3	0.2	3.2	2.1	1.3	0.0	3.9	1.5	0.5	5.9	0.6	1.1	0.7	3.4	1.3	2.1	3.5	1.3	3.6	2.3	2.5	2.0	0.5	0.4	0.3	4.1	0.5	0.7	0.1	3.5	0.4	1.2	0.4	0.7	0.9	1.3	1.4	3.0	3.1	1.0	0.9	1.1	3.6	0.2	3.2	2.4	2.1	0.2	0.5	0.5	4.1	0.8	0.0	1.0	0.1	1.4	0.0	0.8	0.8	0.9	1.0	2.2	1.1	1.1	0.5	1.2	1.4	1.7	1.4	0.0	1.2	1.2	1.0	1.1	0.8	1.8	1.9	4.7	2.7	1.8	1.9	1.5	2.3	1.6	1.4	1.7	2.7	0.4	0.0	0.5	1.6	0.6	0.0	0.6	0.5	0.0	1.2	0.4	0.4	4.0	1.5	0.2	0.0	4.2	0.5	0.2	0.1	0.0	0.6	3.7	1.2	1.0	0.8	0.0	1.7	2.0	0.4	0.2	0.7	2.0	0.4	1.3	1.6	0.4	0.9	0.5	3.3	2.3	0.8	0.0	0.3	0.0	0.7	0.6	0.7	0.0	0.0	0.2	1.4	0.0	1.0	2.5	0.1	0.0	0.7	0.5	0.9	0.3	1.5	0.7	1.7	0.0	0.7	0.8	2.5	0.8	0.8	0.3	0.4	0.5	0.8	0.2	0.3
ZNF133	"pHZ-13, pHZ-66, ZNF150"	ENSG00000125846	"Zinc finger protein 133"	P52736	20	18288283-18316996	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.1;Inhibitory neurons: 42.0;Oligodendrocyte precursor cells: 32.6;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001493	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA001493: AB_1080666"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.46e-6)"	"unprognostic (6.01e-3)"	"unprognostic (8.60e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-1)"	12.3	13.1	16.8	4.6	17.1	4.3	14.5	19.0	19.0	17.1	20.5	15.7	5.2	13.3	16.5	14.8	14.1	7.7	11.1	16.9	17.7	18.1	13.0	10.9	5.7	16.1	16.4	17.6	16.0	11.4	21.2	8.7	16.7	18.7	6.8	10.5	12.9	8.8	14.0	16.7	10.3	10.5	15.5	15.5	12.9	10.2	16.9	7.1	17.4	9.8	5.9	14.1	15.1	17.8	10.0	10.8	8.3	12.0	19.9	13.7	17.6	9.2	13.5	11.5	16.6	8.7	11.5	2.6	5.4	10.9	13.2	21.4	8.1	24.1	10.8	2.9	5.6	6.8	9.9	19.4	14.9	5.8	1.0	13.4	16.3	9.6	28.0	15.6	11.2	11.0	8.1	2.8	10.0	10.0	7.2	9.5	6.9	11.9	10.6	6.2	11.4	6.4	11.3	6.8	11.7	11.9	7.1	18.9	13.3	11.5	7.4	15.7	8.0	12.1	5.8	8.6	9.2	9.1	9.8	0.9	3.7	3.9	7.0	1.5	3.1	2.4	5.9	2.2	3.9	3.2	5.0	4.0	3.9	3.4	3.8	4.6	1.0	8.7	3.5	2.1	4.0	2.7	16.8	17.1	19.0	19.0	16.9	17.7	16.1	16.4	16.7	15.5	16.9	17.8	3.7	6.4	9.2	18.6	2.5	2.2	2.7	7.3	3.4	7.5	4.6	7.4	7.9	5.7	5.7	1.8	4.2	5.0	0.8	2.2	3.9	4.5	14.7	5.1	7.7	4.7	1.2	3.2	37.1	2.3	3.2	5.3	5.1	4.5	7.0	7.1	5.3	4.2	4.7	3.3	42.0	4.6	2.0	3.8	0.9	25.0	7.8	2.2	0.0	21.5	1.4	3.1	4.1	32.6	31.8	3.7	1.5	4.5	2.3	3.3	2.5	3.4	5.0	5.0	0.0	4.4	3.6	6.1	2.6	3.0	3.1	2.3	1.9	3.7	3.3	3.0
ZNF134	pHZ-15	ENSG00000213762	"Zinc finger protein 134"	P52741	19	57614233-57624724	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA009064	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009064: AB_1080668"	"unprognostic (3.60e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.88e-1)"	"unprognostic (4.29e-2)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	4.6	5.4	4.9	4.7	5.2	12.5	7.5	8.7	5.3	5.7	4.0	6.5	3.5	5.5	6.0	5.3	6.5	4.5	6.0	4.9	5.5	5.6	4.9	5.8	7.5	3.9	4.0	7.6	3.8	12.0	5.7	7.9	3.7	7.3	4.5	10.6	5.4	8.3	6.3	7.1	4.9	6.0	3.6	7.1	6.0	6.6	5.5	11.1	8.3	7.2	8.5	6.1	4.1	4.7	2.5	6.6	15.5	8.4	6.8	9.1	7.7	6.8	11.1	9.8	4.9	2.2	2.9	5.0	4.7	8.5	7.5	2.1	7.2	12.6	16.8	0.1	33.2	15.8	7.0	6.2	9.9	10.6	11.2	12.3	12.1	7.4	16.7	12.9	6.6	8.2	2.1	5.7	14.8	3.7	21.0	4.4	21.8	1.6	13.6	12.2	22.5	7.9	7.3	21.5	12.4	14.5	11.3	4.9	7.2	17.0	6.9	8.4	8.7	14.7	6.3	3.5	9.0	15.3	21.8	6.9	7.7	1.8	9.9	2.3	4.2	7.4	6.3	3.0	8.3	9.5	6.5	6.7	4.6	8.3	7.5	7.5	3.4	11.9	3.4	3.5	4.4	5.5	4.9	5.2	8.7	5.3	4.9	5.5	3.9	4.0	3.7	3.6	5.5	4.7	6.0	9.6	4.1	1.0	14.4	5.4	12.7	4.4	8.6	8.4	9.8	8.0	11.2	11.5	5.6	3.7	12.5	8.2	11.1	1.2	7.9	7.8	1.7	6.0	7.8	8.3	1.2	13.0	1.0	3.7	4.3	6.2	1.1	7.3	6.3	10.6	9.7	4.1	5.3	8.4	0.9	4.0	6.1	5.1	3.2	1.5	7.2	4.4	3.6	0.0	7.0	11.3	9.2	1.0	1.6	3.8	2.6	14.7	5.0	9.3	2.8	4.6	5.1	11.9	6.6	6.6	8.5	2.2	15.2	6.7	7.7	16.3	8.8	8.0	3.6	13.8
ZNF135	"pHZ-17, ZNF61, ZNF78L1"	ENSG00000176293	"Zinc finger protein 135"	P52742	19	58059239-58086310	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.5;HSkMC: 5.5;MOLT-4: 6.3;NTERA-2: 5.5;T-47d: 7.0"					"Low region specificity"	"Detected in all"			HPA006961	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA006961: AB_1080670"	"unprognostic (4.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.18e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.25e-1)"	3.6	2.5	5.2	2.1	5.1	1.3	6.2	3.8	5.0	6.5	4.3	4.6	1.3	8.7	7.9	2.7	6.2	4.2	3.5	4.4	5.2	6.2	0.8	2.7	2.2	4.7	4.3	11.4	2.3	10.6	8.3	3.9	4.5	6.0	2.0	10.0	2.3	5.2	2.0	4.6	2.1	6.8	3.0	3.9	2.6	6.5	4.9	7.1	8.0	1.8	2.3	4.8	3.8	7.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	3.3	0.0	4.3	0.2	0.0	0.2	0.0	3.6	4.7	2.6	0.2	0.0	0.0	4.7	0.0	5.1	0.0	0.0	0.0	1.9	0.0	5.5	5.5	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	6.3	0.0	5.5	0.0	0.0	0.0	0.0	0.0	2.2	3.8	5.2	0.1	0.0	0.0	0.0	4.8	7.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	2.3	0.0	0.0	0.0	2.6	0.0	0.0	1.9	0.0	0.1	0.0	0.4	0.1	0.1	0.8	1.7	1.7	1.0	0.0	2.6	0.0	2.0	0.1	0.4	5.2	5.1	3.8	5.0	4.4	5.2	4.7	4.3	4.5	3.0	4.9	7.8	2.7	0.0	1.1	5.5	3.2	2.3	2.5	0.8	2.8	11.9	7.9	7.6	5.3	11.5	1.2	9.2	16.7	0.9	0.8	0.1	21.5	6.4	13.3	7.8	5.6	3.3	2.4	1.7	8.1	0.7	0.2	4.1	0.0	3.6	5.1	12.3	4.2	0.3	0.6	15.2	9.3	1.2	2.0	0.3	0.3	11.5	7.8	0.5	1.8	1.9	0.3	8.0	1.0	6.0	13.7	0.6	0.3	6.8	0.0	2.1	0.2	2.5	4.2	14.0	0.0	3.3	5.3	12.7	11.5	1.0	3.1	0.7	1.0	4.6	0.9	1.6
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710472-19733112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	3.0	2.6	3.4	3.3	3.7	8.3	7.3	7.1	4.4	5.6	1.4	3.1	2.2	5.2	5.2	2.7	5.1	2.8	3.8	2.8	3.6	4.7	0.8	2.7	6.8	2.3	3.2	8.7	3.2	7.6	3.3	4.2	2.8	5.4	2.8	4.8	3.8	5.1	2.0	3.6	3.1	3.4	2.3	5.3	4.1	3.5	3.8	4.9	7.8	4.4	6.5	3.6	3.2	5.0	2.8	2.7	4.7	6.1	3.1	3.4	5.6	2.9	4.0	4.2	4.5	2.7	2.1	7.6	4.7	3.0	2.4	2.8	4.9	2.9	5.2	1.9	5.6	3.5	2.0	3.5	3.7	0.1	5.2	3.3	3.0	2.9	2.5	5.5	2.6	3.7	4.2	3.5	4.2	4.7	6.6	4.1	6.1	5.3	8.1	3.4	7.6	3.6	3.0	5.6	4.6	3.3	0.0	3.3	4.7	4.0	4.6	7.3	1.7	3.6	1.0	4.3	3.8	2.7	3.5	6.5	0.2	3.9	2.2	22.4	2.7	9.4	13.3	4.7	21.0	14.9	18.1	16.6	3.8	12.0	24.8	19.9	6.1	10.1	5.8	4.4	12.7	9.1	3.4	3.7	7.1	4.4	2.8	3.6	2.3	3.2	2.8	2.3	3.8	5.0	3.6	0.0	3.7	11.4	8.5	2.4	4.4	1.5	3.4	4.6	3.2	3.4	2.8	0.0	1.4	3.7	0.0	3.4	5.3	0.4	3.9	1.7	0.6	1.5	2.1	3.4	3.0	4.8	9.7	1.3	1.5	3.5	2.6	2.5	1.3	4.7	3.3	0.2	1.8	6.7	12.5	1.4	4.1	0.8	1.4	0.9	1.8	1.8	3.6	11.2	0.3	3.8	4.1	12.5	13.7	0.8	2.5	3.8	2.8	2.2	1.0	3.0	2.9	5.7	6.6	3.2	2.9	3.4	3.0	1.5	1.4	2.2	9.5	2.2	1.3	2.5
ZNF140	pHZ-39	ENSG00000196387	"Zinc finger protein 140"	P52738	12	133080474-133107526	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003655, HPA048332"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003655: , HPA048332: AB_2680362"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.13e-3)"	6.6	8.4	8.5	3.8	7.5	3.0	11.0	8.9	8.5	9.8	7.8	7.0	7.4	11.2	8.4	6.2	10.0	7.9	5.7	6.9	6.7	8.2	8.2	5.7	7.1	6.9	6.5	11.5	9.8	9.4	11.7	6.9	6.7	8.6	5.4	11.1	8.0	7.4	5.5	7.3	6.5	7.2	6.9	6.6	7.2	9.0	7.4	9.1	12.8	4.6	6.5	7.4	7.9	9.0	5.8	6.0	9.3	0.1	7.6	12.7	12.0	7.0	4.5	6.0	6.2	2.9	2.9	3.5	7.9	6.9	7.3	5.2	8.4	5.1	5.0	0.4	11.5	9.4	4.9	5.7	10.8	7.7	13.3	13.4	11.6	6.9	16.2	12.3	7.0	9.0	4.4	4.4	10.5	9.0	13.1	12.0	10.0	3.5	3.3	11.5	1.1	7.7	7.7	12.9	10.8	13.7	11.3	7.5	8.3	5.9	11.8	14.6	11.0	0.2	6.5	5.1	5.2	2.7	0.1	6.8	0.6	7.0	5.8	11.0	7.3	19.1	13.1	11.4	18.9	18.0	15.4	15.8	12.6	15.1	22.3	17.9	11.5	19.2	7.5	7.3	19.4	10.9	8.5	7.5	8.9	8.5	6.9	6.7	6.9	6.5	6.7	6.9	7.4	9.0	11.1	0.0	16.4	7.5	13.5	7.1	12.0	7.9	12.5	7.6	10.9	9.5	7.2	5.7	15.3	0.0	10.4	8.8	7.4	5.4	13.7	9.5	16.0	11.1	10.2	8.1	13.8	4.2	13.4	5.8	7.9	8.9	12.8	10.8	7.6	9.7	7.5	4.4	5.8	6.7	13.8	6.6	16.2	7.2	6.4	5.2	9.0	5.5	8.8	12.2	4.2	7.4	7.2	18.6	15.0	6.8	9.1	8.2	5.5	9.7	5.4	7.4	9.7	7.2	0.0	10.0	8.5	16.5	13.4	8.5	6.0	14.9	11.3	9.9	6.2	10.2
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218633329-218659655	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	6.0	5.7	5.0	5.0	5.5	8.0	6.0	5.5	6.9	6.4	1.2	8.0	2.6	7.5	2.5	6.7	6.7	3.6	7.0	5.5	3.6	6.3	4.5	5.4	5.3	4.5	3.9	6.2	7.5	4.9	8.3	3.2	4.2	6.8	3.1	6.4	6.3	4.3	10.3	7.0	6.5	4.9	2.6	7.3	7.0	4.8	4.7	6.0	6.9	6.6	4.9	7.3	5.8	5.1	6.3	9.7	9.0	10.7	8.5	6.3	8.5	7.1	4.2	9.7	7.4	19.3	5.0	8.3	6.1	6.4	8.1	11.4	17.6	11.7	6.6	12.0	16.5	12.9	20.7	12.3	6.8	16.8	11.8	4.3	11.0	11.5	11.3	5.3	8.2	9.2	17.0	15.7	5.0	13.7	11.7	9.6	11.8	3.9	8.8	17.7	5.1	8.1	7.3	11.3	12.3	9.3	5.3	10.4	4.0	8.5	6.0	6.1	12.2	9.2	9.7	7.8	11.0	10.5	7.1	13.4	5.9	7.9	9.5	0.9	0.7	0.8	1.0	0.1	0.4	0.7	0.6	0.6	0.6	0.3	0.7	0.5	0.4	0.3	0.2	0.8	0.6	0.6	5.0	5.5	5.5	6.9	5.5	3.6	4.5	3.9	4.2	2.6	4.7	5.1	3.5	3.2	0.5	4.9	6.0	5.9	2.0	1.7	5.7	3.5	3.8	3.4	5.3	4.3	2.7	3.7	6.2	2.2	4.0	4.1	0.0	3.2	2.7	2.7	4.3	3.2	0.0	2.1	7.0	3.8	2.2	3.8	6.6	5.2	1.3	5.2	4.2	3.1	3.0	1.7	6.7	3.0	4.1	4.7	3.2	4.8	3.7	4.1	3.6	4.7	3.1	2.3	8.2	3.0	6.7	4.1	3.5	3.8	8.5	2.8	3.4	2.2	1.0	2.7	6.6	3.9	2.9	5.5	5.5	6.6	6.1	1.1	6.3	4.1	4.3	2.3
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238771	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	25.9	21.1	22.6	25.6	30.4	12.5	41.6	26.6	33.9	33.7	20.5	26.8	23.1	37.0	21.9	24.7	28.1	22.4	23.7	21.5	26.4	29.2	32.4	23.4	35.3	28.4	30.7	40.5	22.8	33.4	28.2	32.4	30.9	30.5	31.5	31.2	24.4	26.4	46.3	27.0	21.8	32.6	24.0	27.0	25.2	12.1	27.9	39.6	33.9	46.4	37.5	34.4	23.2	36.2	70.2	96.0	79.8	77.1	57.8	64.5	42.5	60.2	55.4	57.1	56.2	43.5	49.6	67.7	94.6	56.0	37.4	31.8	102.6	70.5	102.3	105.5	57.2	113.0	37.4	52.7	67.4	180.1	74.9	52.8	106.5	55.1	156.0	60.0	71.7	72.6	122.2	72.3	69.4	45.9	84.1	42.2	108.1	122.2	57.7	96.1	80.3	58.2	69.4	67.7	100.7	63.5	74.7	93.0	66.1	81.6	41.5	90.9	55.0	64.0	76.8	50.6	107.1	50.2	63.7	95.2	44.9	88.0	83.1	7.9	11.2	8.7	15.8	13.8	22.7	19.1	18.1	16.0	13.6	17.4	23.2	21.4	2.6	14.9	22.4	6.9	16.8	14.9	22.6	30.4	26.6	33.9	21.5	26.4	28.4	30.7	30.9	24.0	27.9	36.2	21.4	44.8	29.0	21.5	29.7	23.6	30.8	20.5	22.8	10.8	26.7	22.1	45.4	21.5	28.4	20.2	10.4	34.3	26.3	11.6	35.2	27.7	18.3	16.7	35.5	22.8	14.5	25.0	29.2	18.0	48.7	26.9	16.3	23.6	20.8	28.5	20.3	20.8	18.9	11.8	33.4	24.6	14.2	17.8	14.0	20.9	25.1	15.5	10.6	19.7	18.8	9.0	28.8	37.2	121.1	25.0	13.7	19.2	18.6	38.1	9.0	21.2	23.7	10.3	6.6	30.2	29.6	13.0	10.7	24.5	29.8	23.5	29.9	20.0	26.4	29.6
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225669-125375325	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	8.9	7.5	5.6	9.4	8.9	7.9	12.1	12.9	7.8	12.6	0.0	10.8	7.6	13.9	10.2	10.3	12.4	9.5	15.5	4.5	16.4	12.9	11.7	10.3	12.3	4.2	6.5	17.4	9.5	15.8	4.7	9.7	4.2	11.1	11.5	13.1	10.0	11.1	11.1	5.8	8.9	13.7	2.3	11.9	9.8	10.5	14.5	16.9	30.0	12.0	14.4	10.6	6.1	8.3	30.6	19.8	21.1	18.9	18.4	19.7	16.0	27.2	31.5	29.9	28.4	19.1	16.6	24.4	18.5	40.3	24.1	24.4	23.2	20.5	42.4	10.9	8.9	30.1	23.3	9.8	13.6	20.9	29.1	16.1	21.0	28.0	29.4	19.7	20.7	17.7	15.0	20.2	22.3	23.9	26.1	7.7	13.6	20.6	16.8	18.6	23.2	13.9	17.1	33.6	18.2	15.3	36.2	18.2	29.7	11.7	22.7	20.8	26.6	22.6	24.1	28.5	17.5	17.4	21.5	36.6	16.9	13.1	21.3	4.4	15.3	32.0	21.8	14.5	22.5	24.5	19.2	20.9	13.0	22.2	27.9	22.0	51.4	33.2	23.4	11.3	19.6	20.1	5.6	8.9	12.9	7.8	4.5	16.4	4.2	6.5	4.2	2.3	14.5	8.3	54.7	93.0	41.3	92.7	56.7	35.6	26.0	36.2	48.9	68.0	37.0	35.7	75.2	24.3	43.0	33.1	39.6	28.7	53.7	34.7	25.4	37.5	82.0	28.8	54.3	51.6	47.9	32.0	166.7	37.4	24.3	44.5	31.1	38.1	50.6	75.7	37.9	41.0	31.1	75.7	170.3	34.4	26.4	37.1	21.2	135.2	48.1	41.2	17.8	143.4	50.1	45.7	59.8	154.3	151.4	33.7	25.6	59.0	35.8	36.6	28.2	43.9	27.5	39.4	32.9	63.4	60.7	24.4	24.2	32.5	38.4	31.6	52.0	42.0	33.6	35.6
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 11.8;granulocytes: 10.8;Oligodendrocyte precursor cells: 10.6;Rod photoreceptor cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;HSkMC: 2.9;MOLT-4: 4.4;NTERA-2: 2.9;SuSa: 6.1"					"Low region specificity"	"Detected in all"			HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	1.3	2.8	2.4	3.2	2.8	1.2	2.1	6.4	2.8	1.4	4.9	3.6	1.1	0.8	1.5	2.1	0.9	2.0	2.9	2.6	2.8	2.2	0.7	1.6	4.9	1.6	2.2	1.4	1.4	3.6	5.1	3.1	1.2	2.2	1.3	4.6	2.4	3.5	1.6	0.8	2.5	1.4	0.9	4.6	1.2	0.9	3.1	6.1	5.8	1.5	4.4	2.4	0.8	1.5	0.1	0.2	5.2	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.1	0.2	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.8	0.1	1.8	0.3	0.4	2.9	0.0	0.3	0.0	1.8	0.1	0.2	0.2	0.3	1.2	0.1	4.4	0.2	2.9	0.1	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	6.1	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.0	0.8	0.1	2.0	0.2	0.0	0.6	0.4	0.2	0.4	0.1	1.0	0.3	0.3	0.6	0.5	0.0	0.5	0.0	0.2	2.4	2.8	6.4	2.8	2.6	2.8	1.6	2.2	1.2	0.9	3.1	1.5	2.0	0.0	1.9	11.8	7.5	0.4	1.5	0.5	0.6	8.1	1.9	2.2	4.2	1.5	1.0	1.8	8.4	0.2	5.5	0.1	0.0	2.5	0.0	0.5	1.4	2.7	0.0	0.4	7.3	0.2	0.2	1.2	2.0	0.8	10.8	2.2	3.6	0.2	1.6	8.4	7.2	0.0	2.0	0.6	1.7	0.2	0.3	1.2	0.0	1.9	0.7	3.4	4.1	10.6	1.4	0.1	0.0	1.5	2.5	1.3	0.0	0.2	1.3	10.3	0.0	1.5	3.6	0.6	1.1	0.5	0.4	0.3	2.6	0.3	0.0	2.0
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Excitatory neurons: 22.0;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	4.1	5.6	4.1	3.3	4.8	2.9	5.5	7.2	5.1	4.6	4.3	4.0	3.3	4.7	6.1	3.6	3.7	3.6	6.0	4.0	4.7	5.2	6.5	4.4	4.4	4.1	3.9	6.1	3.0	8.2	4.5	4.4	4.3	5.1	4.6	8.6	3.8	4.6	3.2	5.4	4.0	5.8	3.8	6.0	5.2	3.3	4.4	6.6	7.8	3.5	4.3	4.0	2.9	5.5	5.1	4.2	10.4	9.5	5.6	6.5	3.0	4.1	3.9	2.8	4.1	2.8	2.5	0.0	5.1	6.4	4.0	3.9	3.5	8.7	4.7	5.7	8.7	10.8	9.8	3.1	5.8	3.9	6.0	9.2	7.0	5.8	8.5	8.2	6.6	0.2	0.2	0.1	7.8	4.5	4.9	3.9	6.4	2.1	3.7	0.0	11.1	3.8	7.5	16.3	7.0	9.3	10.1	0.6	4.0	9.1	6.7	9.3	5.0	6.3	9.2	4.1	6.0	11.5	9.1	0.0	5.3	0.7	5.9	8.1	2.7	9.8	6.5	2.9	6.3	4.0	4.5	7.0	4.1	5.2	5.5	5.0	2.4	5.5	2.2	2.4	4.2	4.2	4.1	4.8	7.2	5.1	4.0	4.7	4.1	3.9	4.3	3.8	4.4	5.5	2.4	0.0	1.3	23.5	2.7	1.5	1.1	2.2	1.2	3.6	2.4	2.2	0.4	1.5	1.9	0.0	0.0	1.8	1.8	2.3	1.9	1.8	0.5	0.8	1.3	2.6	0.0	0.8	22.0	1.5	0.6	2.0	2.0	1.2	1.3	3.2	2.5	1.5	1.6	6.7	16.1	1.3	2.0	0.8	1.3	0.9	2.8	1.3	1.8	9.4	0.9	4.2	1.0	24.6	24.1	0.9	0.8	5.7	1.0	1.2	1.9	1.9	0.8	3.2	0.0	2.2	2.4	1.3	1.4	1.4	1.3	1.1	2.2	3.0	1.5	1.0
ZNF157	HZF22	ENSG00000147117	"Zinc finger protein 157"	P51786	X	47370578-47414498	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.6;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 2.5;Spermatogonia: 1.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;U-266/84: 2.3"					"Not detected"	"Not detected"			HPA003319	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003319: AB_1080677"	"unprognostic (1.85e-1)"	"unprognostic (3.99e-1)"		"unprognostic (7.24e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-2)"		"unprognostic (7.38e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.59e-4)"	"unprognostic (5.36e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.15e-2)"	"unprognostic (4.92e-2)"	0.1	0.1	0.6	0.1	0.5	0.2	0.1	2.8	0.7	0.3	0.0	0.1	0.0	0.3	1.4	0.1	1.2	0.1	0.0	0.5	0.6	0.3	0.0	0.1	0.5	0.3	0.4	0.4	0.0	0.7	0.9	0.0	0.4	0.2	0.1	1.1	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.3	0.5	0.5	0.5	0.1	0.3	0.1	0.1	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.8	0.4	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.1	0.0	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.0	0.1	0.1	0.8	0.5	0.1	0.0	0.3	0.4	0.0	0.0	0.6	2.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.5	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.5	2.8	0.7	0.5	0.6	0.3	0.4	0.4	0.3	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	2.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.6	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	4.6	3.6	4.6	2.4	4.7	2.6	6.3	4.4	5.0	6.0	5.9	6.5	4.7	6.2	6.9	5.9	7.1	5.7	4.4	4.5	4.4	5.3	3.9	3.7	3.2	4.2	4.2	11.0	7.5	8.6	4.0	3.9	4.3	5.4	4.7	5.1	4.6	5.6	8.3	9.3	4.8	5.5	4.5	3.4	5.0	7.5	4.8	4.4	7.0	8.3	3.9	5.7	6.0	4.6	4.5	3.9	7.7	4.2	6.4	9.0	5.5	4.0	8.9	8.0	7.2	3.1	4.5	7.1	5.2	5.2	4.3	3.5	5.4	8.9	7.2	3.1	4.5	8.2	4.4	4.5	10.7	3.0	4.6	10.9	8.8	5.1	13.2	7.9	4.4	5.3	5.7	4.7	6.4	6.2	6.1	3.0	4.7	6.9	8.8	7.5	4.5	4.5	6.8	6.7	6.4	4.7	8.5	5.1	6.9	5.8	9.5	5.6	4.7	3.6	7.5	4.3	4.5	3.4	3.1	6.4	4.1	4.0	5.8	2.6	3.0	2.2	4.9	2.9	5.6	2.8	3.8	4.5	4.8	4.4	3.8	3.5	0.4	9.2	3.0	2.5	5.8	3.2	4.6	4.7	4.4	5.0	4.5	4.4	4.2	4.2	4.3	4.5	4.8	4.6	3.6	3.2	4.4	4.9	3.4	2.7	6.9	6.8	5.2	11.4	4.3	2.9	3.7	5.7	3.1	9.2	12.5	5.9	7.0	3.2	1.9	7.3	10.3	2.0	3.5	3.7	4.2	3.0	6.8	4.4	3.6	3.8	5.1	3.9	7.0	9.4	5.0	4.5	3.6	6.7	6.3	5.6	6.1	3.5	2.4	3.7	6.2	2.1	1.8	6.5	5.4	6.2	7.2	6.6	7.2	3.6	4.9	6.4	3.2	4.2	10.6	4.8	3.4	25.1	0.0	3.4	4.0	13.6	18.1	4.5	4.5	5.5	5.1	6.6	5.4	5.5
ZNF160	"F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18"	ENSG00000170949	"Zinc finger protein 160"	Q9HCG1	19	53066606-53103436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 67.7;Theca cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 48.6"									HPA023599	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA023599: AB_2218442"	"unprognostic (1.18e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.65e-5)"	"unprognostic (5.20e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.67e-5)"	19.3	29.0	7.3	7.8	10.2	7.4	17.6	12.2	11.6	19.6	4.9	17.4	8.0	18.9	13.7	11.0	17.9	13.9	15.9	6.9	11.9	22.5	13.8	15.0	11.6	9.0	9.5	20.8	12.7	18.1	10.2	13.7	10.3	15.3	10.7	14.2	14.2	13.5	8.4	12.4	12.5	14.1	6.7	33.3	13.7	14.9	9.6	13.5	29.3	9.0	10.4	17.2	15.5	17.1	9.8	8.6	11.6	17.8	19.1	13.4	19.7	10.4	13.9	8.3	13.2	7.4	6.0	11.1	8.8	9.7	11.0	7.0	11.1	10.7	16.4	8.3	13.4	17.2	6.6	4.2	10.5	0.0	11.3	16.7	10.8	8.9	12.5	20.9	9.0	12.9	8.8	0.0	15.8	6.7	14.5	10.6	10.9	2.6	13.7	9.1	12.2	8.6	13.0	48.6	9.8	12.8	0.0	8.2	1.6	37.0	8.8	10.0	17.3	23.0	8.2	6.9	7.7	6.1	27.4	15.9	4.0	4.2	11.1	10.9	3.1	11.4	6.7	4.2	10.0	8.6	6.9	9.2	4.4	9.9	10.4	8.3	6.6	17.6	6.6	4.2	7.9	5.5	7.3	10.2	12.2	11.6	6.9	11.9	9.0	9.5	10.3	6.7	9.6	17.1	46.5	22.4	30.5	23.8	18.5	4.0	10.0	14.7	9.6	23.2	9.4	9.5	20.6	15.7	14.1	9.2	29.2	8.3	16.8	8.0	5.9	8.2	31.0	12.4	21.6	29.8	8.4	9.9	17.1	6.8	9.5	15.4	20.4	16.0	18.3	67.7	34.2	5.0	6.4	47.1	18.8	8.3	8.2	11.3	6.4	10.2	10.8	13.0	1.8	15.9	7.1	13.8	19.6	21.6	29.4	8.1	6.3	14.3	12.7	12.6	11.1	5.9	12.7	19.1	13.1	13.9	18.4	8.3	8.3	8.1	4.0	10.4	18.5	66.0	5.7	13.0
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259298-94301829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.4;Inhibitory neurons: 16.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041769, HPA061185"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Vesicles, Cytosol"	"HPA041769: AB_2677662, HPA061185: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	3.0	2.7	3.8	4.4	4.4	3.2	3.9	4.3	4.8	5.4	3.4	4.3	2.9	3.9	4.2	2.6	4.8	1.7	2.6	3.8	2.4	3.7	2.1	3.2	6.0	3.7	2.6	5.4	3.3	2.3	2.7	2.1	3.8	4.2	5.5	4.2	3.9	2.6	4.6	5.2	5.7	2.8	1.8	6.1	4.1	2.6	3.5	3.8	4.8	1.8	5.1	4.0	4.1	5.7	3.0	2.6	2.8	4.9	1.5	3.4	3.1	1.1	2.0	2.2	2.3	1.8	4.3	7.3	1.4	1.7	2.2	5.8	5.7	2.7	2.9	4.0	6.3	5.1	6.5	3.3	1.8	7.8	5.0	3.0	2.9	1.8	2.8	2.8	2.7	6.8	4.6	2.1	2.8	2.9	3.7	4.4	4.6	6.2	3.2	3.1	2.0	2.3	1.9	2.5	2.9	3.5	1.9	3.5	1.4	2.7	2.2	3.2	3.1	2.0	2.6	2.6	2.2	3.9	1.5	1.4	1.9	5.2	1.9	2.2	3.0	3.2	2.4	3.4	3.1	3.0	2.9	1.7	2.1	4.0	3.0	4.1	2.5	3.3	2.6	2.0	3.1	1.7	3.8	4.4	4.3	4.8	3.8	2.4	3.7	2.6	3.8	1.8	3.5	5.7	2.0	3.2	0.5	10.4	8.0	0.3	2.2	1.3	1.2	4.8	1.0	1.3	1.2	1.5	2.6	1.8	4.2	0.5	3.9	2.5	0.0	1.1	1.0	0.6	1.4	2.3	1.2	3.8	18.4	0.9	0.8	1.8	2.6	0.5	0.0	6.3	2.5	0.8	0.7	5.0	16.7	4.1	0.0	4.4	1.6	1.0	5.9	4.1	0.0	7.5	7.8	2.3	15.5	14.1	19.9	1.2	3.1	3.4	2.6	2.6	4.3	1.0	2.4	4.5	0.0	2.9	1.7	5.2	3.6	0.7	0.4	0.4	4.7	3.7	2.1	2.4
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401215-3409364	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009656, HPA070692"	Approved		Supported	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA009656: AB_1080679, HPA070692: "	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	6.7	7.0	7.8	5.5	8.3	4.0	6.8	8.0	9.1	8.1	7.1	10.4	6.1	9.5	11.5	6.1	10.8	5.6	10.0	7.4	9.0	6.6	6.6	5.4	8.2	8.0	8.1	12.6	5.8	14.1	9.3	5.0	8.3	8.8	7.1	9.9	7.9	10.9	9.9	7.4	6.4	10.3	7.8	7.3	6.8	9.5	8.3	9.5	7.5	10.6	8.4	9.0	6.8	9.4	7.1	11.6	13.1	14.9	15.8	11.3	8.4	6.1	16.2	14.2	12.7	8.8	12.3	23.0	9.3	11.9	12.7	10.1	12.4	11.0	13.1	14.0	11.7	12.2	11.2	11.4	11.3	14.5	13.9	13.3	12.6	11.9	11.9	13.6	11.7	16.8	18.9	10.8	14.7	12.2	14.7	12.4	13.9	10.5	14.2	19.8	14.3	19.3	10.0	3.6	12.0	9.1	12.7	14.1	11.0	12.2	13.7	15.4	9.1	10.4	10.8	8.3	8.5	12.9	14.9	19.5	5.6	9.1	10.1	17.4	6.4	27.0	9.6	7.5	9.1	10.3	10.0	11.0	7.9	8.0	12.0	8.9	7.8	8.5	5.1	4.2	10.2	7.6	7.8	8.3	8.0	9.1	7.4	9.0	8.0	8.1	8.3	7.8	8.3	9.4	4.3	3.2	2.0	4.9	4.1	1.9	1.4	2.6	6.2	6.4	3.3	4.3	5.3	4.3	1.8	0.0	6.2	6.1	5.6	3.0	3.9	5.0	7.1	5.4	4.4	5.2	3.6	5.5	3.4	4.3	3.8	4.7	1.5	2.5	1.3	4.9	2.9	3.5	4.5	3.3	4.3	2.2	8.2	2.5	0.9	4.0	8.7	2.6	3.6	1.0	2.4	7.7	8.2	3.5	10.6	4.0	5.0	9.8	4.6	2.2	4.7	4.7	1.6	8.8	0.0	4.7	4.0	15.1	10.3	4.7	1.8	2.9	4.0	5.8	3.4	0.8
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571283-51592510	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 50.6;RT4: 45.4;TIME: 45.7"					"Low region specificity"	"Detected in all"			"HPA002717, HPA074615"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoli	Cytosol	"HPA002717: AB_1080681, HPA074615: "	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (3.50e-3)"	3.1	3.9	4.6	4.3	5.0	3.5	5.4	11.2	6.2	3.9	6.7	3.9	5.5	5.9	5.2	3.1	4.7	3.1	4.4	3.9	4.8	4.4	3.1	4.9	6.0	4.7	4.4	8.9	3.3	10.0	6.2	8.0	4.5	4.0	3.8	11.3	6.0	4.9	4.6	3.6	4.3	5.1	3.9	6.0	4.5	10.3	5.9	5.2	6.9	3.6	6.1	3.8	3.2	6.7	3.6	6.3	6.2	6.6	6.5	9.0	0.1	8.1	10.3	7.4	8.9	6.4	5.5	6.6	4.6	8.2	4.6	5.9	6.8	5.6	13.2	0.0	10.0	50.6	10.5	2.2	5.7	8.5	31.1	3.5	5.1	15.1	7.3	37.2	12.1	6.3	17.3	6.7	8.1	0.0	9.2	6.3	3.5	4.4	6.4	0.0	8.1	3.2	4.0	45.4	7.9	5.7	7.6	2.5	4.7	5.0	1.8	6.9	45.7	11.3	5.1	2.6	7.9	8.8	17.6	6.8	31.4	5.0	5.8	0.0	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.4	0.4	0.5	0.6	0.5	0.2	0.2	0.1	1.4	0.1	0.2	4.6	5.0	11.2	6.2	3.9	4.8	4.7	4.4	4.5	3.9	5.9	6.7	3.6	6.4	5.4	12.1	3.4	1.1	1.5	1.7	1.8	8.0	2.7	2.5	3.5	1.5	5.3	5.5	2.1	7.9	4.1	1.5	1.9	1.9	11.6	1.4	2.9	3.9	1.8	16.2	11.6	1.6	1.5	3.4	2.6	1.5	14.0	5.5	6.4	2.4	3.2	16.8	12.8	1.3	2.0	5.9	2.1	10.6	3.4	2.4	3.6	10.3	3.1	2.6	5.2	12.5	17.5	6.9	0.6	2.6	1.6	1.8	4.4	2.0	4.4	7.8	0.0	4.3	2.6	6.3	4.3	2.1	1.4	12.0	2.4	3.2	2.0	0.8
ZNF177		ENSG00000188629	"Zinc finger protein 177"	Q13360	19	9363020-9382617	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 7.6;Spermatocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 11.4"					"Low region specificity"	"Detected in all"			HPA003141	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA003141: AB_1859102"	"unprognostic (1.66e-1)"			"unprognostic (2.88e-1)"	"unprognostic (8.86e-3)"			"unprognostic (1.74e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.97e-2)"	3.2	4.9	9.4	0.9	9.3	0.5	3.7	11.2	11.7	7.4	8.5	4.8	0.7	5.6	8.2	1.2	6.5	1.4	4.5	9.5	9.2	8.5	2.7	2.9	1.3	9.3	9.1	8.0	2.2	2.7	7.4	1.9	9.0	5.8	1.7	9.9	2.2	2.9	1.3	2.0	2.6	2.7	8.4	4.1	2.5	10.4	9.2	2.9	5.1	1.5	1.0	3.8	3.4	10.1	0.4	0.6	6.1	3.8	2.8	3.0	2.1	1.1	0.8	1.6	2.3	0.3	0.2	0.4	3.3	0.7	2.1	0.2	1.3	1.1	2.5	1.2	6.0	2.0	0.6	0.5	1.6	2.1	4.2	1.2	2.4	0.9	3.2	4.9	0.8	5.1	0.1	4.1	2.4	0.0	3.4	11.4	1.1	0.1	1.9	2.2	2.0	0.5	1.2	3.1	4.8	1.1	1.8	0.1	0.9	4.6	1.2	4.0	0.7	1.7	1.2	3.5	1.8	0.2	0.0	1.8	0.6	1.7	1.7	0.6	0.0	0.4	0.4	0.1	0.2	0.2	0.0	0.4	0.4	0.0	0.4	0.2	0.3	0.8	0.0	0.2	0.1	0.2	9.4	9.3	11.2	11.7	9.5	9.2	9.3	9.1	9.0	8.4	9.2	10.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	7.6	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997475	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	7.2	5.7	7.9	5.8	8.6	13.7	6.1	7.7	11.2	6.7	7.4	6.0	5.0	5.3	6.3	7.5	5.7	5.5	5.9	7.9	8.3	5.8	12.4	5.1	8.8	8.4	8.0	5.7	6.0	4.3	7.7	4.0	8.8	8.4	6.7	4.9	5.2	5.1	7.3	9.7	6.6	5.8	7.6	10.2	5.3	14.1	8.1	8.5	6.2	4.6	8.0	6.3	6.6	9.8	3.0	6.1	6.4	9.7	11.9	10.5	3.4	4.3	7.5	5.5	5.9	2.9	5.0	10.3	6.3	4.7	4.8	6.1	5.4	6.8	5.9	7.8	4.5	6.1	6.9	4.0	8.4	3.4	7.8	8.7	10.8	4.2	7.6	6.3	8.4	12.0	3.6	4.7	7.6	3.1	11.5	6.9	4.8	10.9	2.8	9.4	6.5	4.6	8.0	3.6	2.5	5.4	7.3	3.6	5.9	37.2	5.1	3.2	6.7	6.5	3.2	2.9	3.3	5.2	4.1	5.1	7.5	7.9	7.8	10.5	5.9	6.9	10.3	5.9	9.6	9.0	9.3	9.7	5.8	7.2	10.0	10.3	19.1	7.7	8.2	8.6	11.1	6.1	7.9	8.6	7.7	11.2	7.9	8.3	8.4	8.0	8.8	7.6	8.1	9.8	2.5	0.0	2.0	10.1	3.8	2.0	1.7	4.2	4.6	2.0	2.0	1.4	1.6	2.8	2.1	1.8	2.1	2.4	3.5	2.5	1.9	3.1	23.0	1.8	2.8	1.9	1.2	5.2	7.4	0.9	2.2	2.7	2.0	1.8	2.5	5.1	2.5	3.7	4.3	1.7	8.4	4.2	6.1	3.8	1.8	27.3	3.4	3.2	1.8	8.4	3.4	2.0	5.2	7.5	9.3	2.1	5.0	3.4	2.3	1.6	3.9	3.1	2.5	1.2	0.0	2.5	2.3	9.6	4.9	5.0	2.3	1.5	4.7	2.8	3.1	1.1
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	2.8	2.8	1.7	2.4	1.8	2.7	4.5	2.3	2.2	3.2	2.4	2.9	2.4	3.5	2.6	2.7	4.1	1.6	2.4	1.8	1.8	2.9	3.3	3.0	3.2	1.8	2.0	4.7	3.3	8.1	2.4	2.7	1.9	5.2	3.4	4.7	2.4	3.0	2.6	3.0	3.0	3.2	1.8	3.2	3.1	2.8	1.8	3.9	4.5	2.2	4.0	2.7	2.8	2.2	7.0	2.0	9.1	6.5	2.1	3.9	5.5	4.0	4.3	6.3	7.4	3.6	0.9	0.6	3.1	5.5	4.5	2.2	5.5	8.0	7.8	8.0	3.3	7.7	1.6	2.7	2.0	11.7	4.8	3.8	3.3	3.8	4.8	5.8	4.4	3.4	3.7	5.6	4.4	1.3	6.2	4.1	6.0	6.5	4.4	3.7	4.9	5.2	6.1	11.4	7.5	6.4	7.1	6.8	3.3	5.8	3.6	9.8	3.5	10.8	4.3	1.4	5.7	1.5	5.7	3.2	2.4	5.0	5.6	2.1	1.1	2.3	1.1	0.6	1.6	1.8	1.7	2.0	1.7	1.7	1.9	1.8	0.3	1.7	1.2	0.4	4.6	1.3	1.7	1.8	2.3	2.2	1.8	1.8	1.8	2.0	1.9	1.8	1.8	2.2	3.4	6.4	1.5	4.2	4.3	2.5	2.2	2.4	4.0	6.7	3.2	2.4	4.5	2.8	4.1	1.8	4.2	5.5	4.2	3.5	7.9	4.2	5.8	3.0	4.7	2.8	4.2	8.2	5.7	4.2	4.0	3.5	4.1	2.9	1.3	5.7	5.3	3.7	3.4	1.7	5.8	4.9	6.1	4.6	1.1	1.3	2.8	2.6	5.4	8.4	5.4	6.0	7.2	6.6	9.0	3.9	5.7	4.5	1.7	2.2	4.3	3.5	4.3	4.4	6.6	4.3	3.5	2.7	4.6	2.5	1.3	3.1	4.0	3.5	4.0	1.7
ZNF181	"HHZ181, MGC44316"	ENSG00000197841	"Zinc finger protein 181"	Q2M3W8	19	34734155-34745378	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043701, HPA062305"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA043701: AB_10960859, HPA062305: AB_2684743"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.34e-2)"	"prognostic favorable (5.45e-4)"	7.5	8.9	10.4	5.9	12.5	3.6	10.4	13.8	13.2	8.8	10.3	9.4	9.7	9.0	6.3	6.5	9.0	7.2	13.8	10.0	11.2	9.2	14.6	8.1	7.8	11.6	11.3	18.2	11.8	13.2	6.8	5.5	11.1	8.5	7.0	17.7	8.0	10.6	22.8	5.1	8.8	8.1	11.2	9.8	7.6	7.1	10.8	8.8	10.5	23.7	9.1	7.8	5.8	14.1	4.4	7.0	8.5	11.2	13.4	10.5	2.7	5.3	9.4	5.7	6.5	5.0	4.6	6.8	14.8	8.2	7.6	4.1	5.9	5.8	4.3	14.5	6.0	12.9	9.1	7.0	15.8	7.6	4.3	8.1	9.2	4.0	7.8	14.4	5.5	15.0	10.6	0.1	11.4	3.0	15.1	5.4	5.4	10.0	5.7	10.3	10.7	8.9	7.5	5.1	5.9	10.8	11.6	3.2	12.4	7.0	6.7	12.1	7.2	14.6	7.3	3.6	5.8	10.2	16.4	5.7	5.8	2.0	7.5	3.0	4.1	6.6	8.3	5.6	8.5	8.8	11.0	11.3	6.0	15.2	17.1	12.3	0.7	10.9	16.1	6.6	7.6	6.3	10.4	12.5	13.8	13.2	10.0	11.2	11.6	11.3	11.1	11.2	10.8	14.1	11.5	16.0	5.3	8.5	5.7	1.7	3.7	4.0	3.4	15.9	6.5	9.0	40.8	2.8	9.4	5.5	4.2	3.6	3.1	5.3	17.6	6.3	3.3	4.6	7.3	8.9	4.2	1.7	6.8	4.9	1.0	11.2	5.6	4.0	2.5	13.1	7.5	8.5	3.8	13.5	7.8	6.5	4.1	5.4	2.0	2.5	9.3	3.3	5.4	2.8	3.0	16.1	15.5	8.0	11.7	2.6	4.6	12.0	2.6	2.7	6.9	8.0	14.5	15.5	0.0	22.3	14.6	18.9	8.9	3.2	0.9	1.1	6.2	13.1	4.4	1.5
ZNF182	"HHZ150, KOX14, Zfp182, ZNF21"	ENSG00000147118	"Zinc finger protein 182"	P17025	X	47974851-48003989	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059574	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059574: AB_2684068"	"unprognostic (1.86e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.88e-3)"	"unprognostic (6.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (1.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.59e-2)"	"prognostic favorable (1.55e-7)"	4.5	4.2	4.3	4.0	4.5	5.0	4.5	6.0	5.8	6.5	4.6	4.8	2.9	4.6	4.6	3.0	5.4	3.2	3.6	4.0	4.4	6.3	5.3	4.5	6.6	4.6	4.3	6.3	6.5	4.4	7.7	3.4	4.7	5.7	3.4	6.7	4.2	3.6	3.0	3.7	5.7	2.9	4.1	8.4	4.6	2.8	4.7	7.6	8.8	3.6	6.2	4.6	4.4	5.3	3.6	4.8	5.8	5.6	3.2	3.6	2.2	4.5	5.3	6.4	7.7	3.7	4.7	9.2	3.2	2.9	6.1	4.3	9.7	2.6	7.7	6.6	5.6	4.6	6.3	4.7	4.0	8.6	7.2	3.2	5.5	5.5	6.5	7.7	3.9	8.9	4.0	6.7	6.0	2.7	6.7	15.2	9.2	2.4	5.4	5.7	11.0	10.2	5.6	2.4	5.4	7.3	7.3	2.3	4.3	12.6	5.9	7.5	3.9	5.1	5.5	7.6	3.8	8.7	7.6	7.1	3.5	7.2	3.4	1.8	1.9	4.2	3.3	1.9	3.8	4.4	3.0	3.1	2.4	2.9	4.6	3.9	4.2	3.0	5.5	1.8	3.2	2.5	4.3	4.5	6.0	5.8	4.0	4.4	4.6	4.3	4.7	4.1	4.7	5.3	3.5	12.8	7.0	6.2	5.8	0.3	1.0	1.3	3.4	6.7	2.3	2.0	4.4	5.7	2.4	1.8	2.1	2.1	4.7	0.6	0.0	2.8	0.2	3.6	4.1	3.5	7.7	7.8	6.6	1.8	1.4	2.5	1.1	2.5	0.0	10.3	4.2	2.5	1.7	1.7	7.4	4.1	2.0	3.7	0.7	0.4	2.5	4.0	3.6	4.7	4.9	3.8	6.2	5.0	8.0	2.7	3.0	1.9	6.0	1.1	0.9	2.1	4.4	2.9	0.0	4.0	4.5	2.8	3.2	1.7	1.1	0.8	3.8	6.5	2.5	1.1
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	2.8	3.1	2.4	4.3	4.6	8.8	5.4	1.2	8.4	6.1	0.0	4.4	3.4	5.4	4.1	3.8	4.5	4.0	2.8	6.4	0.6	7.0	3.6	4.1	6.3	0.4	0.3	6.0	2.7	5.9	4.1	3.0	0.3	4.3	4.5	4.4	3.5	4.3	2.9	5.7	3.6	4.3	0.6	4.6	4.4	8.3	0.3	10.2	5.6	5.0	6.6	4.5	2.9	2.7	6.4	2.0	10.8	19.7	7.6	5.6	3.6	6.2	8.3	7.1	10.9	3.6	3.7	11.7	10.3	4.0	4.8	3.9	9.7	4.0	10.3	11.4	6.0	14.0	7.3	5.1	4.0	16.9	9.7	4.1	6.0	5.2	5.4	8.4	7.8	17.8	10.9	21.1	11.9	3.2	27.3	14.3	6.3	3.5	4.5	35.4	15.2	17.5	4.9	5.9	18.4	8.9	7.0	6.0	9.2	5.3	7.0	14.4	5.3	10.8	7.1	4.9	7.2	9.6	17.4	21.8	2.4	19.4	10.9	2.1	2.7	8.0	7.9	3.7	10.9	7.4	8.3	7.7	4.1	6.9	6.3	7.9	1.4	7.0	2.9	2.5	10.4	3.9	2.4	4.6	1.2	8.4	6.4	0.6	0.4	0.3	0.3	0.6	0.3	2.7	5.4	6.4	8.1	2.0	9.8	4.1	3.8	2.5	6.8	2.5	5.1	5.5	3.5	2.8	6.4	1.8	2.1	4.3	17.5	2.1	7.9	2.7	36.9	7.9	3.7	5.1	7.1	3.4	10.3	3.0	3.0	4.5	2.0	5.0	5.1	7.4	3.9	1.5	2.8	10.1	3.4	5.1	2.0	3.8	3.8	12.6	3.4	3.6	1.8	5.6	3.0	3.3	9.2	4.0	4.2	2.5	2.1	3.8	6.5	4.6	1.6	4.5	6.3	4.8	0.0	5.2	6.8	12.8	5.9	4.3	4.4	2.9	12.5	4.6	4.4	4.5
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 328.7;esophagus: 326.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 32.2;Pancreatic endocrine cells: 72.0;Squamous epithelial cells: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 51.8;monocytes: 27.4"	"Cell line enhanced"	"Detected in many"		"A-431: 124.4;EFO-21: 139.9;HBEC3-KT: 100.0;PC-3: 87.7;TIME: 236.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	5.2	11.6	4.0	5.6	4.2	8.7	12.2	4.8	3.7	69.5	10.9	4.5	1.8	21.8	328.7	326.7	16.4	6.7	1.8	3.2	3.9	11.0	2.1	12.1	4.5	3.5	3.8	6.1	4.3	3.7	8.4	24.9	3.5	24.5	4.2	3.4	44.8	144.1	2.9	53.7	2.6	10.3	4.2	4.5	7.4	3.4	4.3	3.6	21.3	2.9	41.0	11.6	117.5	3.9	124.4	25.9	2.4	1.6	3.0	4.0	5.5	6.0	0.4	14.8	2.2	0.9	36.7	1.6	139.9	9.0	1.4	17.3	3.7	100.0	60.1	1.5	2.4	7.9	9.8	4.1	7.0	0.5	0.6	2.9	70.2	1.6	57.0	14.6	76.5	1.6	0.5	1.1	0.4	29.1	0.5	0.7	1.9	31.4	87.7	0.5	0.4	0.9	7.7	11.5	1.0	8.2	0.2	22.7	3.6	23.3	23.3	2.7	236.2	0.8	50.5	3.0	4.5	1.2	1.0	1.1	1.6	8.9	1.7	51.8	27.4	11.4	1.0	24.4	0.6	0.7	0.7	1.2	7.4	0.6	1.1	0.7	18.5	0.5	21.1	4.9	1.0	20.7	4.0	4.2	4.8	3.7	3.2	3.9	3.5	3.8	3.5	4.2	4.3	3.9	1.1	12.8	2.6	1.3	0.7	9.2	6.2	5.7	4.6	0.5	5.7	7.6	0.9	1.5	9.4	9.2	2.1	3.8	1.7	1.0	0.0	8.6	0.6	14.1	4.2	1.1	0.0	0.0	1.0	3.0	5.0	2.2	2.6	32.2	1.3	3.9	1.4	0.1	9.4	0.0	1.7	2.5	2.0	11.3	4.0	0.3	1.2	9.5	3.6	0.0	14.4	4.0	0.0	1.0	1.4	72.0	0.3	1.2	0.1	7.6	0.3	1.2	6.9	0.3	0.0	0.5	1.9	4.2	5.8	69.7	21.2	0.7	0.8	0.4	2.4	21.3
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 86.0"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Intermediate filaments"		"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	24.2	21.6	15.7	9.4	20.3	4.0	16.2	16.8	24.0	12.5	13.8	10.8	12.3	13.8	86.0	7.4	10.5	23.3	15.4	27.8	15.8	14.6	18.6	9.5	10.7	17.9	15.7	16.0	31.3	14.2	19.7	8.8	17.0	13.9	10.2	12.7	9.8	11.6	16.4	5.9	12.3	13.3	16.4	12.6	12.7	13.7	15.0	11.2	13.3	16.8	15.2	8.4	7.0	27.2	7.4	6.0	19.1	14.0	16.7	11.6	9.1	10.3	15.8	11.9	10.2	12.7	5.7	9.9	6.8	12.5	12.4	14.1	9.6	9.8	10.5	13.1	6.6	10.8	9.6	27.3	12.4	11.5	9.1	14.2	13.3	10.6	16.3	16.3	15.0	11.9	13.0	13.9	17.7	4.1	13.8	4.9	13.8	16.2	6.7	9.7	27.3	7.6	11.4	8.4	19.7	12.4	11.2	7.6	11.4	12.5	6.3	14.3	12.6	11.6	8.4	9.6	8.1	13.1	21.7	4.7	10.0	4.4	12.0	0.5	0.8	1.4	0.7	1.0	0.7	0.9	1.2	1.5	0.7	1.0	1.4	1.2	0.4	1.3	0.8	0.5	0.6	0.6	15.7	20.3	16.8	24.0	27.8	15.8	17.9	15.7	17.0	16.4	15.0	27.2	7.5	9.6	6.4	11.1	9.7	9.8	8.2	4.9	8.0	7.4	8.9	6.5	22.2	25.8	11.9	1.8	4.2	4.6	6.4	6.2	9.8	7.2	3.1	5.2	8.7	9.4	5.4	6.5	29.1	18.0	2.1	9.0	6.1	5.4	9.5	9.8	8.9	9.0	5.5	8.4	17.4	6.3	8.2	14.4	7.6	3.1	11.1	9.6	7.2	11.2	3.9	6.8	6.2	17.1	124.9	7.2	6.7	10.9	4.9	6.2	7.2	14.5	8.2	3.9	13.1	10.6	8.9	7.0	3.6	9.1	6.5	1.9	6.2	7.8	5.9	5.2
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.9;Spermatocytes: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA063685	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA063685: AB_2685090"	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	3.3	3.2	1.7	2.4	3.1	2.6	3.5	2.5	6.0	2.0	3.1	2.4	3.7	3.9	8.3	4.4	8.3	6.5	4.3	4.3	0.6	3.5	2.3	4.3	3.1	0.4	0.1	4.2	6.2	4.3	5.3	1.8	0.0	3.2	2.1	11.3	3.4	2.0	9.7	6.5	3.1	1.5	0.0	2.7	2.9	16.2	1.6	1.1	8.2	1.7	1.4	1.7	0.6	5.7	1.2	1.0	2.9	2.8	1.3	0.9	2.0	1.9	0.9	1.1	1.2	2.1	3.9	1.7	2.1	0.9	2.0	1.4	1.4	1.7	0.4	1.3	1.3	2.3	2.2	3.2	0.8	2.3	1.9	2.1	1.8	1.5	3.2	2.5	0.5	3.0	1.3	2.1	1.4	1.8	1.6	1.5	1.5	0.7	2.5	1.0	2.5	0.6	1.6	2.2	4.0	3.0	3.3	1.1	2.6	1.9	2.2	1.8	1.0	3.3	1.7	2.1	1.8	1.9	1.9	0.4	2.7	1.3	1.8	2.3	0.9	0.8	1.1	0.8	0.3	2.1	1.2	1.1	0.7	2.4	1.5	1.4	1.7	0.9	1.0	1.3	0.5	0.6	1.7	3.1	2.5	6.0	4.3	0.6	0.4	0.1	0.0	0.0	1.6	5.7	1.4	0.0	3.2	3.9	3.7	0.3	2.0	2.1	1.2	3.8	3.1	1.8	1.2	1.5	2.3	1.8	10.4	1.4	2.3	1.8	5.9	4.4	7.3	6.3	1.3	1.6	1.2	3.6	1.7	1.4	0.8	2.1	0.5	1.2	0.0	5.0	2.2	4.1	1.4	10.1	1.6	2.0	2.0	1.0	1.6	4.4	0.6	0.9	0.0	2.8	1.3	3.5	0.0	2.0	2.1	2.2	1.7	1.9	0.8	1.3	3.6	3.3	10.0	25.9	6.6	2.2	2.0	15.3	7.6	0.8	0.6	0.5	1.8	3.4	1.5	1.0
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.24e-4)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.79e-7)"	9.3	10.1	12.1	6.6	12.0	10.8	13.7	13.1	16.0	12.3	11.8	11.1	9.4	8.5	15.6	9.1	8.5	7.1	7.7	12.1	13.7	13.0	13.1	8.7	11.3	13.9	12.5	6.8	13.1	6.2	10.2	6.4	13.7	13.7	12.1	14.1	10.3	6.2	11.8	8.3	12.4	7.5	11.9	16.5	10.3	4.9	12.8	17.1	10.2	9.5	11.0	10.3	9.2	13.4	15.8	18.6	32.0	38.2	9.9	11.8	37.7	16.7	14.1	16.4	22.6	19.4	24.3	26.7	11.1	10.8	24.2	21.1	34.5	20.0	24.6	14.2	28.4	18.3	15.6	19.1	12.5	32.3	28.7	14.7	17.9	13.4	21.7	12.1	21.7	35.0	32.8	17.3	17.9	12.7	37.6	25.1	66.4	18.4	19.1	35.8	20.4	14.2	27.4	38.3	47.8	49.5	18.5	21.2	15.9	27.8	10.7	29.0	17.2	9.1	14.2	11.6	14.0	14.9	25.5	43.8	7.7	23.6	13.8	2.4	11.6	14.7	15.4	13.0	20.0	18.8	19.0	19.5	17.3	17.8	17.9	20.3	1.8	18.7	11.6	14.5	28.4	11.3	12.1	12.0	13.1	16.0	12.1	13.7	13.9	12.5	13.7	11.9	12.8	13.4	13.8	16.0	21.9	15.0	16.6	12.1	16.9	18.6	14.2	15.3	9.7	12.8	18.3	11.5	20.8	7.3	10.4	9.7	17.3	9.0	9.8	25.1	3.3	10.3	18.7	12.7	20.4	12.0	19.8	18.9	10.5	12.0	23.4	13.3	6.3	33.9	8.2	7.5	10.9	18.5	24.3	14.0	14.2	12.3	8.4	0.8	5.9	8.8	7.2	6.5	9.8	17.9	15.5	20.1	27.9	25.3	13.5	5.7	16.9	13.6	10.0	12.5	15.6	13.7	0.0	12.6	12.3	12.3	9.6	12.4	6.8	4.0	15.9	15.2	15.8	17.5
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA054567: AB_2682527"	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	6.2	5.8	2.8	1.9	3.0	1.1	5.7	4.6	3.0	6.3	2.1	7.2	2.1	6.3	2.7	4.5	6.1	2.2	5.4	2.8	3.3	5.6	6.3	4.6	2.4	3.1	3.0	7.4	5.9	3.3	7.4	2.7	2.9	6.0	2.4	5.7	5.2	2.9	11.6	4.8	5.0	2.7	2.7	4.8	5.2	5.7	3.1	3.2	7.6	4.2	2.3	6.9	5.6	3.5	2.6	1.2	10.4	3.4	5.5	6.4	0.4	5.0	6.5	4.3	4.6	2.1	2.3	2.1	3.1	4.0	2.6	1.7	4.8	4.0	4.4	0.4	1.2	9.0	4.0	1.7	5.7	6.8	2.4	6.7	5.2	4.9	7.3	5.6	3.2	2.8	6.1	3.7	6.3	0.6	3.9	4.9	7.2	2.8	3.4	1.5	7.3	2.9	3.9	2.6	4.2	7.3	4.5	2.3	6.0	5.5	6.2	6.8	3.1	4.5	3.6	7.0	4.2	4.9	5.6	1.4	3.5	2.3	4.5	0.4	0.7	0.5	0.7	0.3	0.6	0.5	0.6	0.6	1.0	1.7	0.7	0.4	0.3	1.3	4.7	1.7	0.8	0.3	2.8	3.0	4.6	3.0	2.8	3.3	3.1	3.0	2.9	2.7	3.1	3.5	7.3	16.0	8.7	13.1	3.8	2.5	4.6	4.1	5.7	12.4	4.5	3.9	12.3	1.5	9.7	0.0	8.4	1.1	5.7	7.2	1.9	7.4	16.7	4.6	8.0	5.4	6.1	3.0	13.5	8.9	0.7	6.2	3.6	4.5	3.8	10.9	6.8	7.6	4.6	16.8	17.1	6.5	2.0	5.1	3.4	4.5	5.6	5.1	5.4	12.2	8.5	13.2	7.2	14.6	20.1	6.8	5.2	5.3	5.4	5.0	6.4	4.5	4.6	8.5	6.6	6.6	6.4	11.2	5.7	3.3	3.4	0.4	4.6	13.5	5.1	3.6
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	2.1	2.6	2.3	2.3	2.5	0.7	2.5	2.7	2.9	3.2	2.0	2.4	2.1	2.4	3.2	2.3	2.9	1.5	3.1	2.2	2.2	2.7	1.9	2.4	3.1	2.3	2.3	3.9	2.1	3.8	1.9	2.2	2.4	2.6	1.7	3.0	2.3	3.2	3.4	2.9	1.8	2.6	2.1	2.9	2.5	3.0	2.3	3.2	3.1	3.6	3.2	2.3	1.8	3.0	4.1	3.7	4.5	7.6	6.2	5.1	2.8	4.0	5.7	6.1	7.7	3.9	2.5	2.2	3.0	4.1	4.3	3.0	5.1	3.2	6.1	5.8	4.0	5.8	2.9	4.9	5.1	2.8	3.4	4.4	4.3	5.5	7.8	6.3	5.1	4.6	3.9	1.9	5.9	3.1	4.2	4.1	1.8	3.3	4.9	4.1	7.4	3.3	3.4	2.3	4.0	5.2	4.1	5.7	4.9	3.8	3.6	4.4	4.0	7.0	4.2	5.4	3.6	3.4	3.3	3.0	4.4	3.7	5.2	5.6	3.4	12.9	6.3	4.8	4.4	5.4	4.9	5.5	4.0	5.1	6.3	6.2	2.6	3.5	4.0	3.1	6.2	4.0	2.3	2.5	2.7	2.9	2.2	2.2	2.3	2.3	2.4	2.1	2.3	3.0	2.1	0.0	1.7	3.3	2.0	1.0	0.7	1.1	1.8	3.3	2.3	1.5	2.6	5.7	2.1	1.8	0.0	1.8	2.9	0.8	5.9	1.8	2.7	1.3	2.0	1.9	0.0	1.3	7.7	2.0	1.4	2.1	1.5	1.2	1.3	4.7	2.5	1.6	2.5	1.7	6.2	0.7	0.0	2.5	1.2	0.8	2.1	2.2	0.0	3.7	0.5	4.2	4.1	7.1	5.7	0.9	0.5	3.0	1.4	0.9	1.5	2.8	2.5	2.7	6.6	1.6	2.0	5.5	7.5	0.9	1.1	1.6	1.6	2.8	1.1	0.7
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 42.1;Late spermatids: 66.3;Respiratory ciliated cells: 29.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 22.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 22.9;NK-cells: 6.8"	"Low cell line specificity"	"Detected in many"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	0.8	1.2	0.9	1.6	0.9	2.7	3.0	2.1	1.3	1.3	2.3	2.0	0.7	1.2	3.1	2.0	4.9	1.2	0.8	0.9	0.7	1.8	0.8	1.6	2.1	0.9	1.1	1.8	2.1	1.8	1.2	0.9	0.9	1.3	1.8	1.9	2.2	1.5	0.3	2.4	1.4	1.0	0.8	1.3	2.1	6.1	0.7	1.5	3.4	1.1	1.3	1.5	1.2	1.3	2.4	0.0	3.1	6.8	1.2	2.4	2.4	1.6	3.3	1.7	2.4	0.8	0.9	1.8	1.9	2.2	1.7	1.4	1.6	0.5	2.0	1.7	0.6	0.4	2.4	0.8	0.7	0.0	2.2	1.9	3.3	0.8	1.0	2.0	1.3	3.7	1.0	0.3	3.9	0.9	3.0	2.2	5.4	1.2	1.7	2.0	1.6	1.0	2.1	5.4	1.2	3.2	1.6	1.4	2.9	3.0	2.3	3.0	0.0	4.1	1.3	4.3	1.1	3.4	2.0	2.2	0.4	0.0	1.6	16.3	2.5	6.5	1.4	1.3	1.2	1.6	1.4	1.6	1.3	2.6	1.3	1.1	22.9	6.8	1.9	1.7	3.2	1.2	0.9	0.9	2.1	1.3	0.9	0.7	0.9	1.1	0.9	0.8	0.7	1.3	0.4	0.0	0.0	0.0	1.0	0.1	0.8	2.3	1.8	0.6	1.8	1.1	0.8	1.5	1.5	1.8	2.1	1.0	0.9	1.9	1.9	2.1	42.1	10.3	0.7	0.7	4.2	1.7	0.0	2.4	1.3	0.5	3.6	1.4	2.5	0.8	0.4	2.3	1.7	0.0	0.0	2.1	0.0	0.8	1.0	66.3	0.6	1.0	0.0	0.0	1.4	0.4	1.0	0.0	0.0	2.7	2.1	0.0	1.5	1.7	2.9	2.9	29.7	1.4	0.0	0.4	1.0	10.8	1.7	1.8	0.6	1.1	1.2	0.3	1.7	1.6
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.8;Spermatocytes: 39.0;Spermatogonia: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018981: AB_1859021, HPA059310: AB_2683974"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	3.7	3.0	2.2	5.8	2.3	2.4	4.4	3.1	3.3	3.5	2.2	3.4	4.1	3.8	3.7	3.3	4.3	3.5	3.4	2.4	2.5	3.5	3.9	4.0	7.0	2.5	2.3	4.4	2.2	4.7	2.4	6.3	2.3	3.4	3.6	4.0	2.8	3.4	2.1	3.2	3.2	3.9	2.4	6.1	3.3	17.6	2.4	5.2	3.3	3.6	6.6	4.2	2.9	2.4	7.1	7.3	16.1	11.6	5.9	6.1	19.2	9.1	11.2	12.2	11.2	11.2	5.9	13.6	6.8	7.4	7.2	5.3	13.2	9.8	14.6	12.7	12.2	11.3	9.6	9.5	7.8	19.9	26.0	6.2	8.3	9.0	8.1	7.0	10.8	9.7	12.8	10.3	11.1	6.5	14.0	10.8	25.3	8.8	6.9	16.9	22.0	16.0	7.6	4.0	9.1	13.3	8.6	6.5	7.5	11.0	9.3	21.9	7.4	12.4	11.4	4.5	8.0	25.8	27.1	11.9	3.0	12.3	9.8	32.4	5.3	18.4	10.6	6.8	10.3	7.2	9.4	12.5	6.6	6.9	9.6	10.9	22.1	11.6	6.6	4.2	12.1	7.2	2.2	2.3	3.1	3.3	2.4	2.5	2.5	2.3	2.3	2.4	2.4	2.4	10.7	3.2	3.7	4.2	6.4	3.2	4.5	4.2	1.2	5.4	5.2	5.8	3.9	5.7	5.1	3.7	12.5	7.5	7.4	3.3	3.9	5.0	51.8	3.6	3.2	8.1	6.7	9.1	5.2	4.0	6.7	5.0	0.5	3.1	5.1	5.7	10.4	3.8	7.1	0.0	4.1	3.8	4.1	6.6	5.4	22.6	5.6	6.6	7.2	1.9	6.3	6.7	13.4	5.0	3.4	3.6	6.3	3.0	5.7	4.6	3.7	2.8	3.5	8.1	6.6	7.4	4.5	39.0	44.9	4.3	3.1	5.9	8.5	6.1	3.5	4.0
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.0	10.4	7.0	4.0	6.7	1.9	10.1	18.0	9.9	12.2	4.6	11.4	8.0	13.0	2.0	10.7	11.1	6.2	12.7	6.7	6.1	12.0	14.0	9.2	3.0	7.0	6.8	14.4	16.3	6.8	10.7	5.5	6.7	14.0	3.2	4.0	10.6	5.3	20.4	14.3	7.7	4.5	4.8	7.6	11.9	3.8	6.8	1.6	11.5	6.8	1.6	9.9	10.7	7.7	11.0	14.3	12.2	19.6	4.7	6.2	16.5	9.0	9.3	11.5	14.1	7.6	10.2	0.4	11.4	5.6	7.4	16.5	10.8	9.3	5.5	2.9	22.1	4.5	21.2	9.0	10.6	0.5	2.5	7.0	14.4	11.1	7.5	11.9	13.4	0.2	9.9	8.1	5.8	18.6	0.2	0.5	12.8	7.2	11.3	0.7	15.1	9.9	6.8	6.3	17.1	14.9	9.3	19.9	13.1	6.3	13.9	3.9	7.8	11.5	13.2	11.3	13.0	0.2	8.6	0.5	5.0	0.6	9.8	0.0	0.1	0.4	0.5	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.5	0.0	0.8	0.0	0.0	0.3	0.1	7.0	6.7	18.0	9.9	6.7	6.1	7.0	6.8	6.7	4.8	6.8	7.7	12.7	0.0	0.0	4.6	1.4	5.7	3.8	4.3	8.0	7.8	8.4	9.8	1.5	14.3	2.3	5.5	4.2	9.7	0.3	12.7	5.9	13.1	0.8	7.5	7.8	9.9	10.3	0.8	3.2	13.7	13.8	7.5	10.2	7.3	4.5	20.1	12.1	8.6	8.9	6.7	4.3	14.6	2.0	4.4	4.2	1.5	17.1	3.7	5.4	3.7	4.2	9.6	0.0	3.5	6.7	14.0	7.7	19.5	0.1	3.8	19.5	15.3	1.9	8.4	26.3	9.1	9.8	1.7	2.1	7.5	5.5	4.8	0.4	15.0	13.0	2.1
ZNF207	BuGZ	ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350132-32381885	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	71.8	65.5	36.8	74.0	40.2	239.5	67.8	50.3	45.3	72.0	44.4	68.7	55.1	70.6	72.0	111.1	62.3	58.5	60.5	38.6	37.7	63.2	63.4	72.3	101.0	39.3	37.2	71.7	55.3	72.0	61.3	78.7	40.7	57.2	81.3	61.9	71.6	56.4	84.5	76.3	63.6	77.8	40.7	69.3	63.6	66.3	39.4	103.8	63.0	62.1	128.6	93.2	78.2	48.0	169.9	203.5	215.8	122.4	113.0	121.3	172.6	165.5	231.9	230.1	205.3	195.2	157.3	231.5	124.8	204.6	178.5	170.6	282.1	200.6	258.1	120.0	188.9	237.9	183.8	202.9	118.2	305.0	209.4	141.3	118.3	162.0	89.6	129.4	215.9	115.5	245.9	173.2	223.9	154.6	245.2	142.5	187.1	160.8	114.8	217.5	193.5	217.0	191.5	324.9	150.6	167.7	155.8	113.2	148.1	183.9	204.8	178.7	154.1	129.4	153.4	132.5	227.8	146.7	235.6	369.5	110.6	141.9	204.9	110.5	75.7	78.1	67.6	84.8	70.2	59.7	61.7	62.7	99.8	44.7	50.8	59.1	38.6	83.9	92.5	47.1	86.9	90.6	36.8	40.2	50.3	45.3	38.6	37.7	39.3	37.2	40.7	40.7	39.4	48.0	119.3	80.1	114.7	135.8	131.1	149.4	195.5	120.8	149.1	134.2	108.8	64.1	32.9	65.8	146.1	64.4	225.2	123.3	191.1	118.2	54.8	94.9	62.0	101.9	116.9	110.1	115.9	125.1	171.2	105.7	175.5	101.3	124.9	144.2	75.3	152.8	85.3	58.4	98.7	101.0	163.0	95.2	93.6	98.8	130.2	26.1	107.2	133.1	55.2	123.7	175.8	55.0	168.9	215.7	257.4	146.5	91.2	97.8	144.9	160.3	101.7	57.7	115.0	141.0	124.9	146.3	145.6	136.3	113.5	175.9	148.5	178.7	143.8	90.0	109.9	250.3
ZNF211	"CH2H2-25, ZNF-25"	ENSG00000121417	"Zinc finger protein 211"	Q13398	19	57630395-57644041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011340, HPA049967"	Approved		Approved	"Mitochondria,Rods & Rings"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Rods & Rings"	"HPA011340: AB_2668488, HPA049967: AB_2680973"	"unprognostic (6.47e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.72e-3)"	7.3	11.3	14.1	7.2	13.4	23.7	9.3	14.9	15.9	8.9	19.1	11.2	4.2	8.6	10.1	6.8	10.0	6.2	13.6	13.5	13.5	11.5	6.7	9.1	12.0	12.9	12.6	10.9	6.9	16.7	17.2	10.6	12.5	13.1	8.1	18.5	8.5	11.7	6.3	11.0	11.2	8.2	12.0	17.5	15.2	6.5	13.5	13.5	16.1	7.0	12.7	11.3	7.5	14.4	4.6	3.1	13.5	12.2	7.9	7.5	7.8	6.3	7.9	9.1	5.9	2.5	2.7	4.3	2.6	6.8	5.4	1.0	6.4	9.4	18.9	5.4	15.3	8.6	7.0	5.6	6.5	5.8	8.5	6.8	11.5	6.9	6.2	13.2	6.9	7.8	1.8	5.4	11.5	2.3	12.1	4.5	5.3	5.9	7.0	7.6	10.3	3.8	7.7	17.9	6.1	8.4	7.5	3.5	3.0	14.8	4.1	8.5	3.3	9.1	4.4	3.9	5.3	7.7	10.1	8.9	2.4	4.9	5.3	10.0	5.8	12.4	7.3	5.7	12.4	8.0	9.6	10.8	7.1	10.8	11.6	8.3	7.8	7.5	4.1	1.6	11.6	6.5	14.1	13.4	14.9	15.9	13.5	13.5	12.9	12.6	12.5	12.0	13.5	14.4	5.0	3.2	3.4	10.4	8.2	1.1	1.8	4.4	4.0	4.0	5.0	3.8	4.3	1.5	3.6	1.8	8.4	8.2	7.8	2.1	0.0	4.1	0.8	5.0	4.5	4.8	1.2	12.8	4.1	1.1	5.2	3.0	8.6	2.7	5.7	3.9	4.6	2.0	4.0	0.0	3.9	2.8	6.1	5.7	3.9	1.2	1.2	4.0	1.8	5.6	3.9	4.7	6.2	12.5	7.6	1.3	1.0	2.2	4.1	1.9	5.0	1.4	12.0	7.2	13.1	2.3	4.0	2.4	3.1	1.9	1.7	17.8	8.5	3.1	2.9	3.0
ZNF212	C2H2-150	ENSG00000170260	"Zinc finger protein 212"	Q9UDV6	7	149239651-149255606	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049807, HPA054178"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA049807: AB_2680891, HPA054178: AB_2682406"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.55e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.59e-1)"	5.4	8.3	6.7	4.8	6.9	12.2	6.7	7.2	6.9	9.9	6.7	7.1	9.2	8.1	6.2	14.7	7.4	4.1	5.9	6.4	6.5	7.4	10.2	4.8	8.0	7.1	6.8	9.1	7.9	6.4	6.4	6.2	6.9	8.7	4.8	4.5	8.6	6.2	6.2	10.9	9.7	5.1	6.7	10.7	7.0	12.5	6.8	9.5	7.7	4.7	8.0	6.9	9.6	7.2	10.7	10.4	12.5	15.9	8.7	7.0	13.8	6.3	9.5	11.2	11.2	8.9	13.3	14.0	9.7	6.4	9.0	9.6	9.3	10.4	9.2	10.8	16.7	7.7	8.1	7.5	6.6	12.8	9.2	8.0	11.7	7.7	8.1	7.0	6.7	16.9	14.3	10.5	6.5	15.2	23.2	26.0	16.6	8.4	12.5	15.6	8.6	15.3	7.0	8.9	12.5	20.5	9.7	9.4	9.6	7.5	5.6	13.5	5.7	11.3	3.1	14.5	11.7	24.1	11.3	12.6	14.8	11.5	10.4	0.0	3.5	7.6	5.0	2.9	5.0	4.1	3.7	4.2	4.4	3.9	6.4	5.5	1.9	8.2	3.7	3.9	5.9	2.1	6.7	6.9	7.2	6.9	6.4	6.5	7.1	6.8	6.9	6.7	6.8	7.2	3.7	6.4	3.3	5.9	5.4	9.7	3.1	3.2	4.0	7.3	5.4	4.7	3.0	5.7	2.2	0.0	4.2	9.6	2.9	5.5	3.9	5.9	1.8	5.9	3.5	4.2	6.7	5.2	6.8	4.0	10.0	4.0	2.6	5.7	2.5	7.1	4.2	5.8	4.2	10.1	6.5	5.5	8.2	5.6	2.3	0.8	6.2	2.9	1.8	5.6	6.1	6.0	6.2	6.0	7.7	4.6	1.2	6.0	4.0	3.8	11.1	3.8	4.5	8.3	13.1	4.2	3.1	13.8	22.1	4.4	8.7	15.1	5.4	5.8	5.3	4.0
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142804	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	4.3	6.7	5.0	3.6	4.9	3.9	4.6	5.7	6.2	5.1	0.9	5.7	5.5	6.5	1.7	6.9	5.1	3.2	5.6	4.9	3.3	4.6	2.5	3.5	5.7	7.1	4.6	6.5	7.2	4.9	6.7	2.1	4.7	5.7	1.2	4.3	10.4	3.0	11.5	10.0	6.8	2.3	3.4	4.9	5.7	17.9	5.1	2.5	5.2	1.2	0.9	5.7	5.2	5.4	3.6	11.1	4.9	11.3	4.7	3.8	6.0	6.4	2.6	3.3	3.9	3.6	7.2	4.3	6.2	4.2	4.9	8.4	2.2	7.1	1.3	9.2	8.3	2.4	13.4	7.0	8.8	7.5	7.8	3.7	8.7	4.4	1.8	2.5	2.5	8.2	8.0	9.4	2.2	15.1	7.0	9.1	8.3	3.8	8.4	9.4	5.7	8.1	2.6	2.4	10.0	8.5	9.7	5.7	4.7	3.1	7.5	12.8	6.3	6.8	6.2	7.7	4.5	5.2	5.4	6.4	2.7	9.9	5.3	0.0	0.5	1.3	1.2	0.9	1.1	0.9	1.2	0.8	0.5	1.5	1.5	1.1	1.3	1.6	0.7	1.2	0.7	0.8	5.0	4.9	5.7	6.2	4.9	3.3	7.1	4.6	4.7	3.4	5.1	5.4	4.1	0.0	1.1	3.6	1.9	1.9	1.5	2.1	2.8	5.3	4.8	4.2	4.4	1.5	1.7	0.0	2.1	1.8	3.4	10.2	1.9	4.0	22.7	3.0	3.1	3.4	2.4	2.1	3.2	4.9	2.0	3.9	4.6	4.4	4.5	4.8	4.6	1.4	3.2	8.4	3.5	6.0	0.0	5.1	1.7	58.3	6.5	3.6	0.0	1.0	4.4	5.6	5.2	0.5	4.6	5.2	4.2	7.2	1.3	2.1	14.6	2.5	1.5	5.2	19.7	3.9	4.1	9.5	4.5	4.8	2.0	1.4	2.3	3.5	6.6	1.8
ZNF214		ENSG00000149050	"Zinc finger protein 214"	Q9UL59	11	6997085-7020346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 3.5"									HPA055391	Uncertain		Approved	Nucleoplasm,Midbody		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Midbody	"HPA055391: AB_2682804"	"unprognostic (3.01e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.53e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	0.6	1.0	1.0	0.2	1.2	0.0	2.1	0.8	1.5	2.3	1.8	1.2	0.5	2.3	2.7	0.5	3.9	0.8	0.8	0.9	1.1	2.4	1.2	1.2	0.2	1.8	1.7	4.2	1.0	2.5	1.3	0.1	1.1	2.0	1.1	5.3	0.9	2.1	0.4	0.4	0.6	1.7	1.2	0.2	0.7	3.1	1.0	0.2	3.4	0.5	0.2	1.4	1.3	1.4	0.4	0.8	3.3	0.0	0.6	2.2	0.8	1.3	3.5	1.7	1.9	0.0	2.4	0.1	0.4	0.9	1.1	0.5	0.3	0.9	1.9	0.0	0.9	0.0	0.5	0.2	1.2	0.0	0.1	0.6	2.2	0.0	1.9	2.3	1.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	2.6	1.3	0.1	0.1	1.3	0.5	0.0	0.2	1.1	1.4	3.0	0.0	0.0	0.0	0.0	1.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.5	0.9	1.1	1.8	1.7	1.1	1.2	1.0	1.4	0.5	0.0	1.5	4.6	0.1	0.0	2.0	1.6	0.6	2.5	1.1	1.5	0.9	1.5	2.7	0.0	0.0	0.1	0.0	0.4	1.9	2.1	6.6	6.6	2.0	0.6	2.4	0.0	10.5	0.9	0.4	1.5	0.0	0.9	0.0	1.2	0.0	0.4	0.1	3.3	5.5	1.7	0.0	0.0	0.5	1.0	0.6	0.2	0.0	2.8	0.0	3.0	0.0	4.0	2.9	1.1	0.1	0.4	0.0	0.6	0.8	3.3	10.4	3.6	0.0	0.8	0.9	10.4	3.3	0.9	0.1	0.0	0.2	0.8	0.9	0.4
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 13.7;Inhibitory neurons: 8.5;Plasma cells: 27.5;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-698: 19.8"					"Low region specificity"	"Detected in many"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA047243: , HPA051010: AB_2681308"	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	0.4	0.4	0.4	1.3	0.4	0.7	1.3	0.2	0.5	0.8	0.1	2.0	2.2	0.7	0.6	0.9	0.4	0.5	0.4	0.4	0.5	1.0	0.3	0.5	3.4	0.5	0.4	0.8	2.2	0.0	0.2	0.2	0.4	0.8	2.6	0.4	1.4	0.4	0.2	0.5	1.9	0.5	0.2	1.6	0.8	1.5	0.6	1.2	0.8	0.1	4.2	1.1	0.7	0.3	2.9	1.1	1.8	0.2	1.2	1.7	6.4	7.0	5.7	3.6	6.5	0.2	0.0	10.1	2.1	3.2	4.3	3.1	4.8	6.4	6.3	0.0	7.5	0.0	0.3	0.0	1.2	6.5	0.0	3.2	3.1	0.1	7.0	1.4	5.3	0.1	11.5	3.1	1.3	0.0	0.1	0.0	8.9	0.0	1.6	0.0	0.0	1.3	0.1	5.3	0.0	0.2	0.0	2.4	0.0	4.4	0.1	2.4	2.8	2.0	5.8	2.4	0.0	0.3	0.1	19.8	4.8	0.0	1.9	1.5	0.4	0.1	0.1	0.2	0.0	0.6	0.1	0.3	0.4	0.5	0.3	0.1	0.6	0.2	0.1	0.7	0.2	0.3	0.4	0.4	0.2	0.5	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.3	0.2	0.0	0.0	0.3	2.5	0.4	1.7	1.0	1.8	0.6	0.7	0.3	0.2	0.0	0.9	7.3	6.2	0.4	0.1	0.9	1.9	0.1	0.3	0.8	1.8	0.6	1.2	2.5	13.7	1.8	2.6	1.1	0.0	0.9	1.3	0.6	0.0	0.9	0.4	3.3	8.5	3.5	0.0	0.3	0.0	0.3	0.0	0.8	1.8	3.7	0.0	0.1	0.0	1.5	0.4	0.3	0.8	0.0	27.5	0.6	2.0	1.1	0.4	0.0	0.0	0.2	0.7	5.6	9.1	2.3	0.3	0.0	0.8	2.2	2.2	0.8
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567071-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 129.1;Glandular and luminal cells: 154.8;Squamous epithelial cells: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 148.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051857	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051857: AB_2681641"	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	15.0	4.2	4.0	20.5	3.8	31.1	22.0	4.0	3.8	17.9	9.6	18.1	12.8	11.8	8.3	13.1	11.1	15.1	5.4	3.2	3.9	11.0	14.5	12.2	29.6	6.0	6.0	9.7	10.1	17.3	4.8	19.0	5.4	16.5	17.5	0.8	18.9	8.2	3.4	16.9	13.5	8.9	4.7	29.2	17.9	22.1	5.9	26.0	10.9	6.4	23.7	21.8	11.6	5.0	28.7	33.4	27.5	40.3	25.1	28.5	60.1	31.3	31.8	34.8	17.1	21.5	31.2	27.5	32.9	38.4	44.9	27.5	22.3	33.0	40.1	19.9	6.3	8.9	14.3	37.8	19.5	14.5	36.7	15.6	31.1	18.6	51.4	27.4	20.1	28.2	19.8	126.9	26.4	113.8	50.1	31.9	29.2	16.2	32.8	38.9	23.0	32.3	20.3	62.8	2.8	7.6	29.2	148.2	30.5	34.6	44.3	60.3	14.2	69.7	25.6	36.0	38.9	52.4	62.4	23.0	25.4	16.0	22.8	9.1	6.1	10.9	3.2	7.4	4.1	5.6	3.4	4.1	4.9	4.3	3.8	3.8	23.3	6.8	15.8	5.0	3.6	3.1	4.0	3.8	4.0	3.8	3.2	3.9	6.0	6.0	5.4	4.7	5.9	5.0	18.7	0.0	8.0	7.5	30.6	129.1	40.3	25.3	71.7	0.6	41.7	22.5	8.2	20.0	26.1	18.4	0.0	16.4	43.7	58.5	9.8	27.5	39.1	76.2	34.4	21.6	6.0	24.4	0.5	16.7	17.7	21.7	42.8	154.8	12.0	24.8	14.6	26.8	16.1	0.0	0.5	32.0	22.4	43.6	52.3	25.9	6.8	39.6	21.4	22.5	43.0	1.8	20.6	3.0	3.4	22.2	39.8	5.3	31.7	65.8	13.8	11.0	30.4	0.5	0.0	13.3	22.7	8.0	23.3	118.8	106.8	45.1	40.5	12.3	24.7	87.1
ZNF219		ENSG00000165804	"Zinc finger protein 219"	Q9P2Y4	14	21090077-21104722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030761, HPA056168"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030761: AB_2673598, HPA056168: AB_2683052"	"unprognostic (9.82e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.35e-2)"	44.2	77.1	15.2	7.4	10.7	4.5	35.5	32.0	17.9	33.9	14.3	83.3	22.4	41.6	9.4	49.2	29.6	5.4	42.0	22.0	14.8	20.6	17.1	32.8	2.5	20.7	25.7	30.7	24.7	12.4	23.5	6.5	20.3	38.3	10.3	11.0	28.2	21.7	34.0	45.6	33.1	9.3	13.6	13.1	33.3	11.9	17.8	10.9	32.3	5.9	3.6	44.7	36.1	9.1	8.1	26.6	33.6	49.5	4.5	4.3	48.1	9.8	15.0	4.9	7.7	15.5	17.7	12.0	7.2	3.7	5.4	59.1	10.8	31.4	3.4	24.6	11.5	7.1	42.2	32.7	2.8	1.5	10.9	6.6	25.9	8.0	14.7	6.5	6.0	11.0	6.9	3.5	2.7	22.4	16.2	11.3	47.5	15.3	5.7	33.7	5.6	3.1	3.8	44.0	38.2	34.4	13.5	7.9	7.8	6.7	9.5	4.2	1.2	6.0	26.4	14.7	4.0	6.1	4.2	2.7	3.8	6.0	11.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.4	0.0	0.0	15.2	10.7	32.0	17.9	22.0	14.8	20.7	25.7	20.3	13.6	17.8	9.1	5.6	3.2	10.7	12.7	1.8	14.8	13.3	13.5	11.4	36.6	14.4	19.6	7.6	10.0	4.3	3.7	27.1	9.6	3.4	33.0	1.9	10.3	9.2	2.5	1.9	6.3	7.8	8.2	3.5	11.3	1.0	6.0	5.1	4.6	14.7	35.1	9.3	8.0	7.4	11.8	4.9	17.4	10.2	7.5	11.8	5.6	9.9	5.9	8.8	7.5	0.8	33.0	1.0	13.6	2.5	7.8	10.0	12.4	3.9	12.0	23.6	6.8	4.3	27.4	13.1	9.3	14.7	8.9	8.7	13.5	15.6	12.4	5.2	6.3	26.6	12.7
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000923-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 184.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.3	13.5	19.8	21.9	21.3	25.7	41.1	20.5	26.1	22.8	18.1	21.0	18.9	30.6	23.5	10.9	25.7	17.6	23.9	19.1	21.0	25.2	38.7	23.1	36.1	25.1	20.7	35.8	39.6	13.3	8.6	40.0	21.5	22.8	21.6	19.2	22.7	19.6	21.1	8.4	18.2	23.9	21.4	27.1	22.8	9.0	20.9	70.4	23.9	25.7	35.1	18.1	10.9	22.9	46.7	7.4	63.3	39.3	32.1	23.2	0.5	21.6	44.5	54.7	58.8	25.5	38.6	48.4	33.5	32.5	12.0	7.8	62.1	23.2	77.3	30.3	1.1	50.3	11.3	0.3	68.8	98.5	17.0	41.6	33.3	22.3	0.9	0.5	87.7	127.8	67.8	84.9	43.7	1.4	184.0	148.5	38.0	26.8	12.9	133.8	87.8	69.4	43.0	39.2	60.5	52.7	19.3	38.8	32.3	57.5	8.4	96.7	48.4	39.2	72.2	27.2	73.3	48.0	51.0	46.4	24.4	3.6	42.6	28.2	28.1	37.6	51.7	27.5	62.5	42.2	33.6	53.8	37.8	54.4	45.3	56.6	2.9	70.8	18.3	64.7	21.1	38.1	19.8	21.3	20.5	26.1	19.1	21.0	25.1	20.7	21.5	21.4	20.9	22.9	69.3	28.9	27.4	5.9	45.7	19.2	65.5	34.1	42.1	33.6	51.2	68.6	9.9	68.6	25.2	33.1	10.4	71.7	48.0	7.0	56.7	58.7	6.3	22.1	48.7	72.9	40.0	67.5	5.0	43.3	55.8	49.5	21.4	25.4	33.5	59.1	91.8	58.6	49.3	38.7	7.6	37.2	38.7	28.7	28.4	3.6	44.4	32.7	19.6	4.7	61.4	57.2	89.6	7.5	11.3	35.7	15.1	51.1	31.9	57.9	6.9	54.6	28.4	32.7	32.9	77.1	48.4	40.1	37.1	23.9	13.2	53.2	36.4	58.7	34.7	27.6
ZNF221		ENSG00000159905	"Zinc finger protein 221"	Q9UK13	19	43951223-43967709	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA059435	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA059435: AB_2684016"	"unprognostic (2.06e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	0.9	1.2	1.3	0.6	1.5	0.6	1.2	4.8	1.5	1.0	1.0	0.7	0.5	1.1	0.8	0.8	1.3	0.6	1.2	1.1	1.5	1.1	1.1	1.0	0.7	1.1	1.3	1.9	0.7	2.3	0.9	1.3	1.7	1.5	0.8	3.0	0.7	1.1	0.4	1.2	0.8	1.3	0.8	1.0	0.8	1.1	1.5	1.2	1.8	0.7	0.7	1.0	0.7	3.5	1.4	1.2	3.6	2.8	1.2	2.4	1.0	1.5	2.3	1.3	2.0	1.6	0.5	0.0	0.8	1.5	0.9	0.6	1.4	1.0	2.3	0.0	2.9	3.8	5.1	0.6	1.2	0.4	1.6	3.5	0.9	2.2	0.8	2.7	2.4	0.0	0.2	0.0	1.7	0.1	0.0	0.6	3.3	0.5	1.2	0.1	4.0	0.4	0.8	4.6	2.9	2.5	3.0	0.2	0.3	2.1	1.0	3.5	4.1	1.6	3.6	0.8	1.2	1.9	2.6	0.0	0.5	1.5	1.9	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.2	0.1	0.3	0.6	0.1	0.3	0.1	0.1	1.3	1.5	4.8	1.5	1.1	1.5	1.1	1.3	1.7	0.8	1.5	3.5	1.4	0.0	2.0	1.0	0.2	0.0	0.1	1.1	0.6	2.8	0.5	0.3	0.7	0.0	0.4	0.0	2.1	0.3	0.2	0.1	0.0	0.4	0.3	0.8	1.8	0.8	0.0	1.3	2.7	0.4	0.2	1.4	1.5	0.8	1.3	1.3	0.7	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.3	0.5	1.2	0.2	1.8	0.0	0.0	1.3	1.0	2.5	2.6	0.5	0.0	0.4	0.4	0.1	0.0	0.4	0.3	2.3	0.0	0.9	1.1	0.9	0.7	0.7	0.1	0.3	0.4	1.3	0.1	0.4
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	2.8	4.1	3.7	3.0	3.7	5.3	4.5	6.0	5.3	3.2	3.6	2.5	1.6	2.8	3.9	1.9	2.9	3.4	4.3	3.6	4.5	3.8	2.8	3.2	4.4	4.3	4.5	4.7	3.1	3.7	5.1	3.1	4.4	3.5	2.7	6.8	2.6	3.3	2.3	2.6	2.7	3.2	3.4	4.6	3.1	9.1	4.2	5.8	4.1	2.3	4.3	3.8	2.0	4.9	3.8	4.5	7.4	6.7	5.5	5.5	0.3	4.1	7.3	4.7	7.4	2.1	2.4	1.2	6.1	4.4	5.5	1.3	5.2	3.6	5.9	4.9	4.7	6.4	6.5	3.8	7.0	0.2	5.2	4.2	5.4	3.9	6.5	7.4	4.5	5.2	1.2	2.4	5.9	0.5	4.3	2.4	4.5	1.8	1.7	0.1	7.7	2.1	3.8	12.1	4.0	9.0	6.4	1.2	5.4	6.3	1.6	6.2	3.3	5.1	4.9	2.9	5.0	10.6	9.1	0.1	2.7	0.1	5.8	7.7	2.4	5.0	5.9	1.6	4.8	4.7	5.4	5.7	2.5	5.9	6.2	4.6	4.8	4.9	2.0	2.9	4.2	2.8	3.7	3.7	6.0	5.3	3.6	4.5	4.3	4.5	4.4	3.4	4.2	4.9	2.1	0.0	1.5	1.0	1.9	2.5	1.9	2.3	0.0	5.3	2.1	2.0	1.9	0.0	1.8	5.5	0.0	1.8	3.1	0.8	7.9	2.4	78.5	1.6	1.7	2.4	3.0	4.8	3.7	1.2	1.1	3.0	1.5	2.7	4.5	3.5	3.3	1.1	2.3	6.7	4.2	2.1	6.1	1.3	1.5	6.9	1.8	1.5	1.8	1.0	1.7	6.3	3.1	3.5	3.6	0.8	0.4	2.2	1.5	0.8	1.1	1.3	0.3	2.8	0.0	2.8	3.0	9.9	3.5	0.7	1.7	1.1	3.7	3.5	1.2	1.1
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.4"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	3.2	3.8	2.9	3.5	2.8	2.0	5.5	3.9	3.7	3.6	2.3	4.5	4.0	3.3	5.9	3.0	3.9	3.8	4.9	2.4	3.3	3.9	2.6	3.9	3.6	2.8	2.7	4.0	2.8	4.9	4.1	5.5	3.0	6.5	5.7	4.5	3.6	4.8	2.1	4.9	4.4	3.9	2.5	4.9	4.9	3.2	3.4	2.7	6.3	1.6	4.3	3.9	3.0	3.0	2.8	1.5	5.9	1.4	3.8	4.7	0.1	4.2	4.6	3.7	5.3	2.8	4.6	0.0	3.9	3.3	2.2	2.6	0.0	4.7	3.9	0.1	4.5	5.6	5.0	3.9	2.8	0.3	0.1	4.6	3.7	3.1	3.0	5.2	4.2	0.1	0.2	0.0	4.2	2.2	0.0	2.1	4.4	1.9	2.1	0.0	2.4	1.3	4.5	23.4	3.6	8.5	7.3	0.9	2.9	7.5	4.1	5.2	4.2	3.5	3.3	1.9	1.6	2.7	5.0	0.0	1.5	0.1	3.4	15.0	4.9	7.8	2.4	5.9	3.5	3.2	3.8	1.9	5.4	3.3	7.4	3.2	0.4	6.2	2.7	6.6	3.6	2.4	2.9	2.8	3.9	3.7	2.4	3.3	2.8	2.7	3.0	2.5	3.4	3.0	2.4	0.0	1.1	4.2	1.3	0.0	0.6	0.0	1.2	3.6	1.7	1.4	0.9	2.8	0.0	1.8	2.1	2.1	0.9	2.2	3.9	2.3	3.8	1.4	1.0	1.8	0.0	3.0	6.1	0.5	0.8	1.8	2.0	1.5	0.0	1.8	3.3	0.4	1.7	3.3	5.0	2.8	0.0	2.4	0.0	1.0	1.5	1.3	0.0	1.9	1.7	1.2	3.1	4.5	3.4	1.4	1.5	1.9	0.3	0.6	2.3	1.1	0.7	1.6	0.0	0.7	1.4	1.9	2.1	1.9	0.0	1.0	0.7	1.3	1.7	0.7
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	15.5	15.4	12.5	17.6	14.2	9.6	17.0	15.9	13.9	16.2	16.0	15.0	18.1	17.8	23.1	9.4	16.1	13.8	12.5	12.3	13.3	14.3	15.8	16.3	22.4	13.1	13.2	20.6	14.7	14.1	19.5	14.8	13.7	17.1	21.2	17.8	15.6	15.7	7.5	24.6	22.2	13.3	12.6	27.2	16.0	6.4	13.4	18.3	19.8	5.9	22.6	12.7	13.0	16.7	8.5	13.9	14.7	12.1	14.4	15.0	12.0	10.5	15.6	7.1	16.2	7.0	6.6	10.2	11.3	13.9	5.4	9.5	8.1	9.0	9.4	10.5	16.4	19.7	26.5	7.3	7.6	14.3	22.0	18.6	16.0	8.8	13.1	22.6	13.1	10.1	6.1	12.0	12.0	2.2	12.6	17.2	6.4	4.7	9.5	7.4	15.9	6.3	10.8	26.9	7.5	17.1	14.4	6.2	5.0	14.4	6.1	18.5	13.8	15.7	10.1	7.1	7.4	16.2	16.3	5.8	8.4	11.0	7.4	49.6	9.1	22.0	18.4	6.3	20.3	16.9	15.5	18.7	9.7	17.8	19.5	15.1	6.9	16.7	13.7	8.7	19.5	10.4	12.5	14.2	15.9	13.9	12.3	13.3	13.1	13.2	13.7	12.6	13.4	16.7	16.0	22.4	14.6	16.3	26.2	5.6	7.3	14.7	10.8	26.8	9.1	5.7	4.7	18.6	11.3	25.8	18.8	13.1	30.4	14.5	1.9	8.1	14.5	7.9	9.9	12.2	9.6	12.0	26.2	5.3	8.1	12.4	8.6	8.2	21.0	20.5	16.1	7.6	7.3	26.9	23.4	11.2	20.3	13.9	8.9	4.4	16.1	10.4	5.4	14.0	19.8	11.8	47.4	14.1	29.0	8.6	13.3	13.9	12.1	10.4	29.8	3.3	7.4	22.1	13.1	10.9	9.3	5.4	4.1	6.8	6.8	8.2	27.3	19.9	11.0	9.3
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.37e-5)"	13.5	31.5	14.5	12.2	18.6	11.7	20.5	23.1	20.6	13.4	18.5	14.1	13.8	13.9	25.6	10.6	16.1	16.9	16.5	15.0	18.0	18.5	17.9	12.8	20.2	16.5	16.4	20.1	9.4	21.8	32.9	12.1	18.0	21.2	14.5	31.1	12.4	15.7	10.0	12.7	14.8	12.3	18.0	18.7	16.2	17.2	16.4	20.7	23.8	7.2	15.9	15.1	11.4	26.0	18.6	20.3	22.4	16.5	20.8	33.1	10.1	19.0	42.6	20.9	38.0	14.3	22.5	6.6	23.5	24.5	28.9	10.1	9.9	18.8	25.1	10.6	23.7	26.3	25.8	10.8	18.2	17.1	17.1	37.6	24.3	25.4	50.9	40.2	27.7	19.6	5.6	6.3	40.4	6.1	18.7	7.2	10.9	10.8	15.0	11.2	17.9	13.3	20.5	50.9	16.0	25.5	38.2	13.9	9.1	21.9	22.6	24.6	21.7	19.1	23.4	10.5	22.8	31.0	30.6	19.7	17.4	11.7	20.9	53.8	14.7	10.1	22.1	15.6	25.1	19.8	22.2	21.8	17.9	28.2	25.9	22.9	11.4	26.4	13.6	19.3	26.8	13.4	14.5	18.6	23.1	20.6	15.0	18.0	16.5	16.4	18.0	18.0	16.4	26.0	15.1	16.0	13.8	20.5	19.6	4.0	17.0	48.2	8.6	39.8	14.2	14.7	27.6	14.3	30.9	11.0	27.1	13.5	19.8	13.0	35.2	22.7	20.2	24.4	12.3	17.1	12.1	19.1	13.4	27.7	7.5	15.6	16.3	17.0	11.4	25.2	16.1	24.8	18.0	21.9	14.2	18.5	30.5	16.0	7.4	7.4	19.3	12.1	21.4	9.4	22.9	29.3	36.0	17.1	35.8	26.1	19.3	22.2	7.7	20.4	20.9	47.4	37.1	30.7	6.6	13.6	15.0	15.0	21.8	9.2	5.8	12.9	18.4	36.6	10.6	20.5
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.64e-4)"	6.3	6.9	9.5	5.9	10.3	5.0	8.3	14.0	10.7	7.8	8.8	6.9	5.4	8.0	7.6	6.6	8.0	5.9	5.7	9.2	10.5	6.9	7.4	6.1	10.3	9.7	10.1	11.0	6.6	10.4	8.0	7.7	9.9	8.5	5.8	8.7	5.6	6.9	6.4	6.5	5.8	6.8	9.6	9.5	8.6	7.4	10.1	17.2	8.3	6.4	11.2	7.1	6.5	13.2	9.6	13.4	15.8	19.7	12.6	10.9	7.4	9.2	13.1	8.7	17.0	6.6	7.3	16.8	13.9	8.6	10.4	5.5	18.2	9.7	11.7	21.9	22.8	29.3	14.7	8.2	9.0	25.8	12.4	9.9	10.6	8.6	16.0	14.5	13.1	19.2	2.9	0.4	9.4	5.1	24.3	6.8	25.3	9.8	7.0	14.4	15.9	14.4	9.0	17.2	26.7	27.3	20.6	9.2	7.2	15.2	7.7	13.7	11.3	9.6	15.8	7.4	11.8	37.6	54.5	36.1	6.3	10.6	13.1	17.3	4.8	9.9	10.8	3.5	11.8	12.0	10.2	10.6	5.9	12.2	13.3	11.2	4.2	11.9	3.5	6.2	13.5	5.7	9.5	10.3	14.0	10.7	9.2	10.5	9.7	10.1	9.9	9.6	10.1	13.2	8.0	0.0	1.5	13.7	8.1	3.1	3.8	4.8	3.4	6.0	5.4	4.6	7.0	1.5	6.4	5.5	2.1	5.6	6.3	3.3	3.9	4.2	22.6	4.0	4.6	8.4	2.4	7.8	10.5	4.0	4.5	4.4	3.6	3.7	1.3	8.7	8.9	3.9	4.4	8.4	10.3	4.7	2.0	5.7	3.7	30.0	5.6	3.9	1.8	9.4	5.2	6.3	11.3	17.1	16.8	6.1	3.3	5.7	4.0	6.0	4.2	3.3	4.1	5.4	6.6	5.9	5.5	4.4	8.7	3.3	3.8	2.2	6.9	8.6	3.3	2.9
ZNF229		ENSG00000278318	"Zinc finger protein 229"	Q9UJW7	19	44417519-44448578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.9"									HPA001494	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA001494: AB_1080692"	"unprognostic (2.59e-1)"	"unprognostic (7.41e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.04e-3)"	"prognostic favorable (8.43e-5)"	"unprognostic (3.66e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.34e-1)"	0.5	1.7	1.3	0.1	1.4	0.1	1.0	1.3	1.6	1.0	1.7	0.9	0.7	1.1	1.1	0.7	1.9	0.5	1.4	1.4	1.4	0.8	0.7	0.6	0.3	1.3	1.3	2.3	0.8	2.7	1.3	1.1	1.3	1.2	0.1	4.5	0.7	0.8	0.8	0.3	0.4	0.8	1.2	0.6	0.6	0.7	1.5	1.1	2.0	1.2	0.3	0.8	0.5	1.6	0.0	3.7	2.7	0.0	2.9	2.4	0.0	4.4	1.4	2.1	2.8	0.0	0.6	0.0	1.7	2.5	3.4	1.3	0.0	2.8	1.4	0.0	1.4	0.4	1.2	0.3	5.0	0.0	0.0	3.4	0.0	1.7	6.9	2.9	2.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.4	0.0	1.0	0.0	0.0	1.3	2.1	5.5	0.7	1.0	1.9	0.3	0.0	2.0	0.0	0.0	1.9	1.3	0.1	0.5	0.1	3.1	2.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	1.3	1.4	1.3	1.6	1.4	1.4	1.3	1.3	1.3	1.2	1.5	1.6	1.4	0.0	0.0	5.9	0.4	0.1	0.7	2.0	1.8	5.8	2.1	2.2	3.7	0.0	1.3	0.0	4.2	0.9	0.0	0.2	3.9	1.7	0.7	1.6	1.7	1.3	0.0	2.1	3.1	1.2	0.6	1.0	2.6	1.0	0.0	3.4	1.4	0.2	0.7	1.7	4.5	0.3	0.0	0.6	0.0	0.5	0.9	0.3	0.0	1.0	0.1	4.7	0.0	7.5	2.2	2.0	0.3	1.9	0.0	1.6	0.3	1.6	4.5	6.9	0.0	1.0	1.5	1.8	2.4	1.4	0.0	0.8	0.2	3.4	0.5	0.9
ZNF23	"KOX16, Zfp612, ZNF359, ZNF612"	ENSG00000167377	"Zinc finger protein 23"	P17027	16	71447597-71463095	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 16.0;Respiratory ciliated cells: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023534	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA023534: AB_1859140"	"unprognostic (8.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.04e-2)"	5.5	4.3	8.6	5.3	8.4	4.4	6.2	8.8	9.9	5.8	8.9	5.6	2.8	6.9	8.0	4.2	7.1	3.6	5.1	8.6	8.5	5.6	5.4	5.4	6.2	8.4	8.3	8.2	4.6	5.4	14.3	4.7	8.1	5.3	5.7	16.9	4.3	5.8	6.5	5.8	5.0	6.9	8.2	5.7	4.1	6.9	8.6	4.9	7.5	7.1	6.0	4.2	3.5	9.8	7.8	4.7	12.0	8.8	7.6	6.6	7.8	17.1	15.9	11.7	8.6	6.1	7.6	15.1	4.2	13.1	11.4	4.7	7.9	10.2	13.7	4.0	5.2	6.7	5.0	6.5	9.2	12.3	5.7	10.7	9.0	12.1	18.6	10.9	4.1	7.9	11.1	2.9	12.5	13.0	6.4	6.0	13.4	4.0	3.9	3.3	5.3	4.6	7.7	6.4	9.9	12.8	5.5	3.9	5.3	7.5	5.1	6.4	11.5	21.2	7.2	5.9	10.7	6.5	10.6	19.8	16.0	6.2	13.2	0.8	0.8	0.5	1.9	1.8	1.8	1.3	1.0	2.1	1.1	2.7	2.1	1.5	0.0	2.6	1.0	1.9	1.9	0.9	8.6	8.4	8.8	9.9	8.6	8.5	8.4	8.3	8.1	8.2	8.6	9.8	0.6	6.4	2.3	15.0	2.6	0.3	0.3	0.2	2.8	2.6	0.7	0.6	0.4	0.0	3.2	0.0	6.2	0.2	0.4	0.5	1.9	2.0	0.2	1.0	1.0	1.1	0.0	7.8	10.0	1.0	0.3	0.9	1.5	0.5	2.5	1.3	1.1	0.5	0.4	3.3	11.2	1.0	0.0	0.3	0.3	0.0	0.6	0.5	0.0	6.5	0.4	1.4	2.1	13.0	16.0	1.5	1.4	0.0	1.5	0.3	0.7	0.3	9.2	3.3	0.0	0.7	0.9	1.5	1.4	2.3	0.0	0.0	1.4	0.5	1.5	0.1
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.1;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	1.8	1.2	3.0	1.1	3.5	0.4	1.9	3.4	4.3	2.7	3.1	2.7	1.0	2.4	2.4	1.6	2.3	1.3	2.0	3.1	3.5	2.3	2.1	1.5	1.9	3.6	3.1	3.4	2.8	1.9	1.6	1.5	3.5	2.1	1.3	2.3	1.9	1.3	2.0	1.4	1.8	1.9	3.1	1.9	2.2	2.6	3.5	1.6	2.4	1.8	1.4	1.8	1.8	4.2	5.8	4.3	6.9	7.0	2.4	1.0	3.7	2.8	1.4	2.7	3.7	6.7	1.4	11.5	3.4	1.0	4.0	3.9	4.9	2.8	1.6	4.6	7.4	2.0	10.0	6.0	3.5	0.0	3.4	1.9	3.0	2.9	2.5	1.9	2.0	13.7	10.0	4.1	3.3	2.8	10.1	4.0	13.5	4.9	4.6	8.5	4.4	7.8	2.2	0.8	7.2	4.7	5.4	2.1	4.6	5.2	1.1	2.8	3.2	2.7	4.6	2.1	5.5	5.5	9.3	3.0	6.9	0.3	4.6	1.3	1.9	1.9	4.2	2.0	5.2	12.5	4.7	5.8	3.9	11.4	7.0	6.5	0.1	5.7	1.2	7.4	4.3	3.5	3.0	3.5	3.4	4.3	3.1	3.5	3.6	3.1	3.5	3.1	3.5	4.2	4.2	0.0	2.6	2.0	5.2	4.2	2.9	4.0	5.7	5.7	3.8	6.6	5.6	0.0	3.9	5.5	0.0	3.9	3.5	3.1	3.9	7.0	8.6	5.5	6.8	5.2	1.2	2.1	3.4	4.0	5.0	3.4	1.5	2.2	0.0	4.0	3.6	3.9	6.1	0.0	3.3	2.4	0.0	3.8	1.3	6.9	3.7	2.9	0.0	3.7	1.8	4.2	0.0	3.0	8.1	3.7	7.6	5.3	1.4	4.1	2.6	3.2	6.5	3.9	0.0	4.4	4.4	18.1	21.7	3.3	4.7	2.1	3.2	3.4	3.8	1.8
ZNF233	FLJ38032	ENSG00000159915	"Zinc finger protein 233"	A6NK53	19	44259880-44275317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 40.9;Spermatocytes: 38.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 6.9;U-266/84: 7.6"									HPA020975	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020975: AB_1859145"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.71e-4)"	"unprognostic (1.55e-1)"	0.4	1.1	1.8	1.1	1.9	1.8	1.5	3.4	3.1	0.7	0.4	3.0	0.9	0.4	1.6	0.6	1.3	0.9	3.2	1.5	1.8	1.3	0.5	0.6	1.3	1.2	0.1	0.5	0.8	1.7	3.1	1.3	1.5	2.7	1.3	4.9	0.9	1.0	1.7	1.6	1.0	0.4	0.3	1.3	1.1	14.2	0.9	1.5	1.9	0.6	0.6	0.8	0.4	2.5	0.4	1.8	2.0	1.9	2.2	0.4	0.5	0.7	0.6	0.7	1.2	1.5	2.1	0.6	1.9	0.6	1.1	0.6	0.0	0.5	0.8	0.3	2.4	1.0	2.5	1.7	1.5	0.7	0.8	0.5	0.3	0.5	1.3	2.9	0.9	0.7	0.8	3.8	0.1	0.7	0.6	0.5	2.1	0.4	0.3	1.2	0.2	0.8	0.4	1.2	2.8	4.4	0.7	0.5	1.3	3.7	3.5	1.0	0.3	0.6	0.4	0.4	0.4	6.9	7.6	1.2	3.0	0.5	0.9	1.5	0.3	0.2	0.5	0.3	0.4	0.9	0.4	0.3	0.1	1.3	0.6	0.7	0.7	1.1	0.3	1.3	0.7	0.1	1.8	1.9	3.4	3.1	1.5	1.8	1.2	0.1	1.5	0.3	0.9	2.5	0.5	0.0	0.5	2.6	0.4	0.0	0.2	0.2	0.0	3.7	1.1	0.4	4.6	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.0	0.6	40.9	1.3	0.3	0.9	1.2	0.4	9.0	0.0	0.1	0.6	0.5	0.5	0.0	0.7	0.0	0.0	0.6	0.0	7.9	0.2	2.0	0.0	0.0	8.5	0.6	0.1	0.0	1.0	0.0	1.9	0.0	4.5	5.7	0.1	0.1	0.7	0.0	0.5	0.8	0.0	0.4	4.0	0.0	0.6	0.4	38.6	1.9	0.0	0.0	0.0	0.3	1.1	0.4	0.1
ZNF234	"HZF4, ZNF269"	ENSG00000263002	"Zinc finger protein 234"	Q14588	19	44141554-44160313	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA001664	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA001664: AB_1080694"	"unprognostic (9.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (4.34e-5)"	3.5	4.8	2.1	4.0	2.9	0.7	4.8	3.7	3.0	3.6	3.2	3.6	3.7	3.7	2.7	3.0	3.2	3.3	4.5	2.1	2.6	3.7	3.1	3.2	4.7	2.4	2.5	5.2	2.9	4.7	3.5	4.7	3.1	4.0	3.6	5.3	3.6	3.5	3.3	4.4	4.0	4.2	1.8	5.7	3.9	2.1	2.7	4.8	4.2	2.9	5.1	3.3	3.3	4.5	5.1	3.5	8.4	8.0	9.8	9.9	3.8	6.5	4.7	5.0	8.3	4.4	3.1	0.1	4.3	5.9	4.7	3.8	6.4	4.1	6.0	0.0	7.7	10.1	8.1	5.8	4.6	0.0	6.8	5.7	9.1	5.4	6.2	6.9	5.7	0.0	0.6	0.1	7.6	1.6	6.8	2.4	5.6	3.3	3.3	0.0	9.6	1.6	3.1	9.7	4.7	7.8	4.7	3.8	3.4	8.6	4.3	4.1	5.8	9.3	7.6	1.7	6.0	5.2	4.7	0.1	1.0	0.0	7.6	1.4	2.0	3.1	3.6	2.6	3.0	2.2	2.1	2.5	2.4	3.4	3.9	3.8	0.7	4.4	1.8	1.6	1.2	1.7	2.1	2.9	3.7	3.0	2.1	2.6	2.4	2.5	3.1	1.8	2.7	4.5	5.0	0.0	2.0	6.2	4.7	3.1	2.4	3.1	2.8	4.8	2.8	2.8	8.3	0.0	4.7	1.8	2.1	5.8	4.2	2.2	5.9	4.1	11.0	3.2	4.7	4.5	3.6	9.1	5.6	2.0	2.5	6.6	3.6	2.5	3.8	7.5	6.8	0.9	2.8	5.0	4.1	2.8	2.0	2.7	2.8	6.3	6.8	2.3	1.8	8.4	3.4	2.9	10.3	7.5	14.2	2.3	5.0	5.7	0.9	2.4	3.3	2.2	2.1	5.7	6.6	4.7	4.3	4.0	4.8	2.7	2.8	3.1	4.8	7.9	2.2	2.2
ZNF235	"ANF270, HZF6, ZFP93, ZNF270"	ENSG00000159917	"Zinc finger protein 235"	Q14590	19	44228729-44305046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 8.3;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045582	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045582: AB_10963792"	"unprognostic (2.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.38e-2)"	2.0	1.3	2.6	2.1	2.8	0.7	2.7	2.9	3.5	1.9	2.6	2.5	1.7	2.0	2.1	1.6	2.2	1.6	2.4	3.0	2.5	2.2	1.8	2.2	2.8	2.7	3.1	2.6	1.8	2.7	1.9	2.4	2.8	2.4	2.0	3.1	1.7	2.5	2.6	1.4	2.0	2.3	2.6	2.7	1.5	2.4	2.8	4.5	2.3	3.0	3.3	1.7	1.4	4.0	1.6	2.6	4.7	5.1	3.7	2.2	1.6	1.0	3.1	1.8	2.1	1.6	2.8	2.9	2.5	1.9	2.8	1.5	4.4	2.1	2.2	0.0	5.3	5.8	4.0	2.4	3.0	3.5	3.6	2.1	2.7	2.0	2.4	2.9	2.9	4.9	1.3	0.0	1.8	1.4	5.4	0.7	6.0	2.8	1.5	2.7	4.7	2.4	3.2	4.0	3.6	10.1	2.7	3.2	2.4	4.9	2.4	4.1	3.6	1.8	2.4	0.5	1.1	6.0	6.4	1.9	1.4	1.0	2.8	20.7	3.5	3.5	6.3	3.1	4.2	6.9	4.6	5.3	2.7	10.1	6.8	5.8	1.8	6.2	3.0	8.1	3.7	2.4	2.6	2.8	2.9	3.5	3.0	2.5	2.7	3.1	2.8	2.6	2.8	4.0	3.5	0.0	0.0	6.2	5.6	0.5	0.5	1.5	4.6	1.7	1.5	1.5	2.3	1.5	0.7	0.0	6.2	1.5	2.5	1.3	0.0	1.4	1.5	1.7	1.8	2.4	0.0	5.2	8.3	0.0	0.4	1.4	2.0	1.2	2.5	2.5	1.8	1.4	1.4	1.7	6.7	1.1	0.0	2.2	0.9	0.3	0.6	2.2	1.8	1.0	1.4	1.1	3.1	5.0	9.2	0.6	3.6	3.4	3.2	0.6	2.0	0.9	0.9	1.6	0.0	1.8	2.0	2.3	5.6	1.8	0.6	1.5	4.1	1.3	0.8	0.2
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822557-76972901	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	2.5	2.2	3.2	2.2	5.3	4.9	2.4	9.2	4.4	3.0	0.0	2.8	1.9	3.2	2.8	2.5	2.9	2.0	2.3	3.4	4.3	2.0	2.1	2.1	2.6	2.3	3.5	4.3	2.8	3.1	3.6	2.2	2.6	2.6	1.5	2.4	2.7	2.3	2.5	4.1	2.5	2.1	1.4	2.3	2.8	6.8	3.5	4.1	2.6	3.1	2.4	2.6	2.9	5.7	2.5	2.4	4.7	3.4	3.7	3.4	1.9	1.8	2.6	2.9	2.4	2.3	2.3	3.6	0.9	2.5	3.2	4.6	3.0	2.8	2.5	3.8	3.1	3.4	3.9	2.8	2.1	5.7	3.7	3.4	3.1	2.8	4.4	3.4	3.0	5.5	3.3	2.9	3.1	2.2	6.9	3.2	2.5	0.6	2.6	4.3	4.9	2.4	2.4	3.8	2.6	2.8	3.6	2.2	2.5	2.2	2.5	3.9	3.2	5.3	2.0	1.3	2.9	2.0	3.0	4.4	3.6	3.0	3.9	0.7	2.0	3.9	3.1	1.9	3.0	5.9	2.3	2.1	1.4	4.4	2.6	2.7	2.1	1.9	1.8	2.8	2.7	0.9	3.2	5.3	9.2	4.4	3.4	4.3	2.3	3.5	2.6	1.4	3.5	5.7	9.3	9.6	7.9	39.5	11.9	7.1	8.5	5.4	10.8	15.3	8.0	7.6	9.5	12.8	6.7	7.3	10.4	8.4	12.9	5.6	1.9	5.4	6.9	10.8	12.6	9.3	6.0	12.8	37.7	3.9	7.2	8.8	9.2	10.5	1.3	15.8	10.0	6.8	6.0	25.2	25.3	5.0	6.1	7.2	7.2	6.0	10.5	8.7	7.2	16.9	8.4	9.7	9.2	41.7	39.7	4.7	3.1	7.2	9.1	6.8	5.9	3.0	10.9	15.9	6.6	14.2	10.4	26.7	26.2	8.8	8.4	6.0	12.4	7.8	5.7	6.3
ZNF239	"HOK-2, MOK2"	ENSG00000196793	"Zinc finger protein 239"	Q16600	10	43556344-43574618	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 49.2;Late spermatids: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 2.8;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.4;T-47d: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030843, HPA046679"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA030843: AB_2673632, HPA046679: AB_10960498"	"unprognostic (1.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-7)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.90e-3)"	"unprognostic (4.13e-2)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	2.5	2.3	4.3	1.9	4.3	0.3	5.3	4.1	4.9	3.8	3.1	3.3	1.3	4.4	2.1	1.1	4.3	1.4	1.4	4.1	4.0	6.2	1.5	1.4	2.9	3.8	3.8	3.9	5.0	4.3	4.5	0.9	3.7	5.2	2.7	1.5	1.9	4.5	2.9	0.7	2.0	4.9	3.9	1.5	2.5	8.2	4.2	1.7	3.2	2.7	2.6	4.3	1.7	4.3	0.0	4.3	5.0	4.9	6.8	5.2	0.0	8.9	1.0	10.6	9.3	11.1	9.7	0.0	3.3	4.9	3.9	0.3	0.0	0.5	13.5	0.1	7.2	0.0	8.0	0.0	5.3	0.0	3.2	5.7	0.2	8.3	0.0	3.2	0.4	0.0	14.7	0.0	8.8	4.9	1.4	1.5	24.4	4.8	5.0	0.0	0.0	0.3	8.8	3.9	9.3	12.7	4.0	0.1	0.6	6.9	19.1	6.1	1.1	0.0	10.8	0.3	11.6	1.2	8.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	3.7	2.6	3.5	2.4	0.0	2.8	6.4	3.8	0.0	0.4	0.0	0.0	2.0	1.4	4.3	4.3	4.1	4.9	4.1	4.0	3.8	3.8	3.7	3.9	4.2	4.3	0.5	0.0	0.5	3.6	1.4	0.0	1.7	0.3	4.0	3.1	1.8	2.4	0.7	0.0	1.3	3.7	0.0	0.3	0.2	0.2	1.9	2.0	49.2	0.5	2.2	0.3	0.0	0.4	5.6	0.4	1.2	1.6	1.5	0.7	0.0	2.1	0.4	0.2	0.4	0.0	6.7	0.9	0.0	0.0	0.3	16.4	0.3	0.2	0.0	1.0	0.6	1.3	3.1	7.5	4.3	0.9	0.2	1.5	0.1	0.9	0.0	1.5	0.0	0.5	0.0	1.9	1.6	6.1	8.2	0.4	0.0	0.1	0.8	2.8	1.1	0.2
ZNF24	"KOX17, Zfp191, ZNF191, ZSCAN3"	ENSG00000172466	"Zinc finger protein 24"	P17028	18	35332227-35345482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024062, CAB025642"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB025642: , HPA024062: AB_1859150"	"unprognostic (1.19e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (5.25e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-3)"	19.4	21.9	32.1	22.4	40.0	25.0	35.3	34.9	34.8	21.6	29.7	19.7	20.5	23.8	22.2	17.8	18.2	18.1	20.9	28.7	33.1	23.8	30.9	21.5	28.8	36.4	36.8	26.1	25.8	32.3	12.5	23.4	37.3	25.5	21.4	38.0	23.7	18.3	23.7	15.4	21.4	18.2	33.4	25.6	25.1	19.9	33.4	34.0	33.3	27.6	26.4	19.2	12.6	54.4	19.3	19.1	60.0	31.5	24.9	26.7	16.9	25.9	29.1	31.3	35.7	12.4	15.5	43.7	28.4	21.7	25.0	34.8	44.7	24.3	53.5	40.1	24.3	31.3	40.2	26.7	26.2	66.9	48.6	22.6	41.0	28.0	30.2	36.0	30.2	27.2	48.2	27.6	32.8	22.8	51.3	28.5	31.2	12.8	12.8	38.0	38.8	35.1	31.5	44.0	51.0	43.7	31.6	29.2	54.7	31.0	27.4	50.3	25.7	44.8	20.1	10.8	26.1	69.7	60.6	44.4	25.0	27.0	41.8	30.2	21.0	24.8	24.4	20.3	23.5	30.5	24.1	20.8	19.3	30.2	23.0	21.4	40.9	22.4	30.3	29.7	20.0	15.2	32.1	40.0	34.9	34.8	28.7	33.1	36.4	36.8	37.3	33.4	33.4	54.4	49.0	57.7	63.0	30.0	66.1	32.9	65.9	44.2	29.0	57.2	62.6	55.4	46.9	52.9	60.7	25.8	43.8	41.4	52.7	37.7	27.4	46.4	126.1	47.6	37.6	50.2	55.6	43.1	26.9	41.1	33.6	47.5	29.6	41.1	43.6	40.0	42.8	48.3	35.3	79.1	26.4	39.2	44.7	38.2	25.4	33.8	54.3	38.6	23.2	33.7	43.1	101.3	56.7	33.2	71.7	42.3	37.8	50.0	34.0	67.2	29.8	30.4	59.1	85.5	46.0	50.1	53.9	59.0	51.6	32.7	32.5	70.7	45.6	50.9	32.2	76.5
ZNF248	bA162G10.3	ENSG00000198105	"Zinc finger protein 248"	Q8NDW4	10	37776526-37858106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.0;Excitatory neurons: 145.0;Inhibitory neurons: 135.1;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018237, HPA018287, HPA018455"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869"	"unprognostic (6.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-4)"	"prognostic favorable (1.04e-4)"	"unprognostic (6.37e-3)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.22e-4)"	"prognostic unfavorable (6.71e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.68e-3)"	5.2	7.1	12.8	6.7	12.8	0.8	7.8	21.0	16.7	15.9	7.6	17.6	5.5	15.2	14.1	5.8	12.2	6.6	7.9	12.7	11.7	8.2	6.0	6.2	6.7	10.3	10.9	15.5	6.8	12.3	18.9	6.5	10.7	12.2	8.9	17.1	6.8	16.1	8.5	7.3	7.9	10.8	8.5	7.9	7.7	7.0	12.8	5.5	13.4	9.7	6.5	9.5	9.7	17.5	7.0	5.8	1.2	16.1	11.3	9.4	7.0	7.1	3.6	7.2	7.7	7.2	8.7	9.2	6.1	5.0	5.5	8.7	9.4	5.0	6.2	16.2	10.3	11.5	12.9	8.8	5.6	9.6	7.5	3.8	9.4	3.8	3.1	14.3	6.6	9.9	5.1	6.5	10.7	3.4	9.7	6.2	4.9	4.6	31.1	8.9	16.2	6.6	8.9	3.4	6.7	12.7	6.1	3.3	4.2	9.8	8.8	2.7	6.5	6.5	6.8	5.2	4.3	10.1	11.6	7.7	8.7	12.5	3.2	0.8	1.3	1.2	4.0	0.9	4.5	4.2	3.5	3.5	2.9	5.1	6.0	5.3	0.2	3.4	1.2	2.6	2.0	2.2	12.8	12.8	21.0	16.7	12.7	11.7	10.3	10.9	10.7	8.5	12.8	17.5	7.1	12.8	14.4	110.0	10.0	2.0	7.6	4.4	10.2	47.4	6.7	7.6	24.4	8.6	7.2	5.5	47.9	6.3	7.7	4.0	7.9	4.1	1.0	15.7	15.4	8.3	5.4	7.2	145.0	1.6	3.1	11.1	6.1	24.7	5.1	26.3	5.0	4.1	4.3	42.1	135.1	4.4	0.0	1.6	2.9	1.8	9.9	3.3	1.8	52.5	4.0	16.1	6.2	101.6	106.8	3.8	5.9	12.0	8.2	4.8	4.2	4.4	5.2	36.9	0.0	17.0	14.2	9.0	10.5	5.9	2.7	2.6	6.4	17.1	5.1	4.2
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949573-37976647	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	10.2	10.1	12.3	3.5	12.5	2.6	8.2	12.5	19.1	9.7	4.1	12.3	2.2	9.9	6.1	5.4	9.2	6.1	10.0	12.5	15.9	5.7	3.0	6.4	4.8	11.9	10.9	11.1	5.4	7.6	14.3	4.7	12.4	7.3	4.4	10.6	4.6	8.9	22.3	4.8	5.3	8.9	9.8	6.5	5.8	4.7	14.6	4.6	6.0	21.5	4.3	8.8	7.1	12.6	1.6	3.0	3.3	6.7	12.1	9.2	0.6	3.6	4.9	2.8	4.2	0.5	2.3	3.1	1.0	6.4	1.0	0.4	0.9	1.5	4.5	7.3	1.6	5.0	0.0	1.0	7.7	3.3	3.1	6.5	6.6	3.1	3.6	11.1	4.9	4.0	0.4	2.3	6.9	1.0	1.1	2.6	0.6	0.6	2.2	1.2	3.7	0.6	3.3	0.6	1.2	7.6	1.2	0.2	4.7	1.2	2.9	5.3	7.1	4.3	0.8	7.1	2.2	2.8	1.4	1.3	8.2	6.3	2.9	1.3	1.5	3.4	1.6	2.5	1.7	1.0	1.4	1.3	1.9	1.3	1.8	1.5	0.2	1.0	5.2	0.3	1.2	1.2	12.3	12.5	12.5	19.1	12.5	15.9	11.9	10.9	12.4	9.8	14.6	12.6	10.0	3.2	3.2	17.9	4.8	3.4	2.5	2.5	3.4	17.3	3.8	3.6	23.6	4.3	2.9	7.3	6.2	1.2	3.5	1.0	1.9	2.0	27.9	2.4	7.0	7.6	0.0	2.1	46.7	2.5	0.5	10.6	4.1	2.7	8.2	8.2	10.4	2.9	5.7	16.8	44.6	1.2	4.1	13.2	6.8	41.9	12.2	9.5	3.6	14.0	8.1	13.7	5.2	38.2	36.7	1.8	0.3	16.1	1.5	2.6	1.3	3.1	8.1	7.1	0.0	11.4	10.4	4.4	6.4	2.4	4.0	0.3	5.2	4.8	0.8	1.3
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	4.7	3.9	3.2	3.3	3.2	2.9	5.6	10.5	4.7	9.7	2.3	6.9	4.8	7.4	2.8	6.4	7.6	3.3	4.9	2.4	4.5	7.6	4.0	5.1	3.0	3.0	3.2	9.7	4.9	6.0	7.3	5.5	3.3	7.5	3.6	7.9	6.0	5.2	4.8	10.9	5.2	4.2	1.5	5.5	4.9	4.5	3.3	4.5	10.0	5.8	3.3	6.3	8.6	3.4	5.1	2.9	13.4	11.1	6.8	5.9	4.3	5.6	6.4	9.4	7.7	2.4	3.9	12.0	9.8	6.5	3.8	6.6	5.3	4.8	6.0	3.8	7.8	10.8	14.9	3.5	2.0	1.8	3.6	3.9	6.5	5.6	4.5	7.2	3.9	7.1	8.6	11.5	7.9	6.8	12.6	4.1	4.0	6.0	12.5	14.4	5.9	5.0	7.8	3.7	13.2	10.1	11.8	4.4	5.3	5.3	6.3	6.1	5.1	9.2	8.8	7.3	5.3	5.6	5.1	8.0	4.7	6.2	4.1	3.2	5.1	5.8	10.5	2.7	8.1	10.3	7.7	5.8	6.6	9.7	8.9	7.3	2.9	6.0	3.7	2.6	11.7	4.5	3.2	3.2	10.5	4.7	2.4	4.5	3.0	3.2	3.3	1.5	3.3	3.4	5.8	12.8	3.0	10.7	10.7	5.5	3.2	7.5	10.2	8.4	4.3	6.6	4.3	1.5	3.9	5.5	0.0	2.3	18.6	2.4	3.9	7.5	7.4	5.1	6.0	5.5	4.2	1.7	11.9	1.9	1.3	5.2	2.6	4.9	2.5	6.3	5.0	2.1	1.7	8.4	17.5	1.9	12.2	2.2	8.0	3.0	4.1	3.0	5.4	4.7	2.0	3.3	5.2	11.1	7.8	2.6	1.0	5.3	8.2	3.3	3.7	3.4	5.0	9.9	13.1	4.1	6.1	14.3	8.7	4.4	5.5	1.9	10.9	4.9	3.4	2.3
ZNF251		ENSG00000198169	"Zinc finger protein 251"	Q9BRH9	8	144720907-144756417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.6;Excitatory neurons: 49.1;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018290	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA018290: AB_1859153"	"unprognostic (1.16e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.42e-9)"	"unprognostic (5.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-3)"	16.6	10.4	12.5	6.2	12.3	3.5	16.6	17.4	12.9	21.3	10.4	17.5	6.8	17.5	24.4	9.8	18.1	10.5	23.4	12.7	12.4	15.8	11.4	10.5	12.2	11.8	12.0	20.0	14.5	12.2	22.6	8.8	11.6	17.8	11.4	17.5	12.2	13.5	10.1	13.1	15.7	12.6	10.9	14.9	13.2	14.1	12.9	11.2	28.0	8.6	11.1	16.6	15.5	12.6	9.9	6.0	23.0	10.8	13.5	17.7	8.7	9.9	14.9	11.3	15.8	2.5	11.6	14.6	9.0	12.9	6.3	13.5	6.8	6.1	15.3	4.1	5.0	11.1	25.1	6.8	7.8	4.1	5.9	13.4	9.1	6.9	13.2	22.0	9.2	10.3	7.4	4.1	13.3	4.7	12.3	2.4	6.9	7.3	10.5	12.7	3.3	5.9	7.6	5.5	10.7	13.9	9.5	4.8	11.0	10.4	12.2	9.6	7.4	9.4	14.4	16.4	8.7	4.4	1.3	8.5	10.5	6.0	7.5	0.0	0.3	1.0	0.9	0.5	1.5	1.3	1.4	1.4	0.7	1.0	1.9	1.4	0.0	1.2	0.5	0.7	1.6	0.8	12.5	12.3	17.4	12.9	12.7	12.4	11.8	12.0	11.6	10.9	12.9	12.6	9.3	0.0	5.3	31.6	4.8	2.2	3.8	1.7	5.7	5.5	4.0	4.1	3.9	1.5	8.9	1.8	6.2	2.0	3.1	1.0	5.9	1.6	20.2	4.5	7.1	7.7	1.2	3.8	49.1	1.5	1.4	5.6	6.6	5.0	1.3	6.8	1.8	0.9	1.6	5.0	50.2	2.1	0.0	3.0	3.0	9.5	7.8	2.0	1.8	22.5	2.9	2.8	3.1	37.7	40.7	2.0	1.8	4.5	5.7	3.0	2.0	3.2	5.3	5.9	13.1	5.2	6.1	11.9	10.3	3.9	3.1	1.4	5.0	5.4	1.9	2.0
ZNF256	BMZF-3	ENSG00000152454	"Zinc finger protein 256"	Q9Y2P7	19	57940833-57947706	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8"									HPA055390	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA055390: AB_2682803"	"unprognostic (2.47e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.83e-2)"	"unprognostic (6.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.28e-3)"	3.5	2.5	2.3	2.3	2.6	10.8	5.6	5.6	3.3	2.9	2.4	3.3	2.3	3.5	4.4	2.7	3.9	1.9	6.0	2.5	1.9	3.1	1.8	3.2	4.9	1.6	1.8	5.5	2.1	4.4	2.8	4.6	1.6	3.8	2.9	9.1	3.3	4.0	3.6	7.1	3.5	3.5	1.6	4.6	2.6	4.3	1.7	5.4	3.9	4.2	5.3	3.1	2.8	2.3	3.9	1.3	9.6	9.7	2.0	3.3	8.3	3.3	3.5	5.2	3.5	0.8	2.1	0.0	2.9	4.3	8.0	0.5	2.2	7.4	8.5	0.0	32.8	9.5	0.0	2.6	3.7	0.0	7.4	6.5	2.0	3.8	0.0	5.4	3.2	9.1	0.7	0.0	5.3	0.9	13.2	0.0	11.6	0.4	8.2	4.2	12.0	5.9	3.8	16.8	4.8	6.9	0.0	3.0	2.4	11.8	7.2	3.0	1.3	10.7	6.3	0.0	6.5	4.4	4.7	16.9	0.3	0.0	4.7	1.3	1.0	1.3	3.3	3.4	6.1	4.7	5.6	5.0	4.2	5.6	5.4	6.4	0.5	3.9	3.6	2.0	4.9	2.2	2.3	2.6	5.6	3.3	2.5	1.9	1.6	1.8	1.6	1.6	1.7	2.3	2.4	0.0	0.0	2.0	4.0	2.7	4.8	3.5	2.2	4.5	2.4	1.4	3.2	1.5	1.7	1.8	0.0	3.1	2.2	0.4	3.9	3.5	0.2	1.2	1.1	2.7	1.2	5.2	1.6	0.8	1.7	2.0	1.1	1.3	0.0	2.2	0.7	0.7	1.4	1.7	1.4	0.9	8.2	0.8	1.0	0.3	1.8	0.8	0.0	1.0	1.7	3.8	1.0	3.5	0.6	0.8	0.3	0.4	0.3	2.7	0.8	0.9	3.4	7.2	0.0	2.6	2.1	4.9	8.7	1.6	3.4	2.6	3.1	2.3	1.2	3.7
ZNF26	"FLJ20755, KOX20"	ENSG00000198393	"Zinc finger protein 26"	P17031	12	132986365-133032952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA018329, HPA042406"	Uncertain		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria	"Nuclear bodies"	"HPA018329: AB_1859157, HPA042406: AB_2677982"	"unprognostic (7.31e-3)"	"unprognostic (7.60e-3)"	"unprognostic (7.26e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-12)"	"unprognostic (8.24e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.64e-4)"	0.8	0.7	1.2	0.9	1.2	1.6	0.8	1.9	1.7	1.0	2.2	0.7	0.8	0.9	1.5	0.6	1.2	0.5	0.6	1.4	0.9	0.8	0.6	1.0	0.9	1.2	0.9	0.9	0.8	0.4	0.7	0.5	0.9	0.7	0.6	1.4	0.8	0.5	1.1	1.4	0.8	0.6	0.4	0.9	0.8	1.1	1.4	0.6	0.8	0.2	0.8	0.7	0.8	2.0	1.3	0.3	1.0	2.0	0.4	0.5	3.4	0.9	0.7	0.9	0.5	0.4	1.0	0.9	1.8	0.8	0.6	1.4	0.4	0.4	0.5	1.1	3.1	2.0	1.2	0.4	0.2	2.7	3.2	0.8	0.7	0.6	1.3	0.8	0.4	1.4	1.3	0.3	0.6	1.4	2.5	1.7	2.2	0.4	2.4	3.0	2.6	2.7	0.3	2.5	2.6	4.2	0.8	1.3	1.1	0.5	2.9	2.4	2.4	1.5	1.1	0.7	1.2	0.7	0.1	3.5	0.9	1.6	1.8	5.9	1.2	3.2	4.0	1.4	4.0	2.1	3.4	2.9	1.8	3.8	4.3	3.8	0.9	3.4	1.3	1.5	3.3	2.8	1.2	1.2	1.9	1.7	1.4	0.9	1.2	0.9	0.9	0.4	1.4	2.0	10.7	22.4	16.0	6.5	15.7	0.0	9.0	0.1	7.4	26.6	9.1	6.7	5.2	11.5	8.2	5.5	25.0	6.4	18.9	3.3	3.9	7.5	1.1	8.8	9.5	10.1	8.4	3.8	11.6	5.7	4.2	8.2	9.2	8.4	9.5	20.3	11.4	5.6	5.3	26.9	8.8	7.0	0.0	6.6	0.0	1.5	8.1	7.5	0.0	11.2	6.5	5.6	17.5	9.5	10.3	8.4	4.9	6.0	10.7	8.1	5.9	2.8	3.0	23.2	0.0	19.1	7.4	12.1	10.9	5.3	0.0	4.8	15.8	14.0	7.2	7.8
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510687-36528271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	4.5	5.0	4.9	4.1	5.7	1.7	7.9	5.5	5.8	6.7	4.4	3.9	4.1	7.2	5.2	5.1	5.3	5.4	5.0	4.5	5.5	7.4	5.8	4.9	6.3	5.2	5.5	8.4	3.9	11.7	3.2	6.8	5.3	6.6	4.6	8.9	4.8	4.7	2.4	6.8	4.2	5.2	5.2	5.9	5.5	3.1	5.6	7.6	9.7	4.1	6.7	6.1	3.4	6.9	11.2	11.2	25.1	19.1	7.7	11.5	10.9	9.6	10.1	8.6	11.0	5.1	6.2	7.3	15.2	7.8	6.6	4.1	12.8	5.9	13.2	9.7	5.6	10.8	8.6	5.8	10.7	5.5	8.7	10.6	9.8	8.9	13.7	12.5	11.7	10.7	8.7	7.9	17.4	6.1	20.6	3.6	15.9	7.0	4.8	13.5	15.5	5.5	9.8	19.6	18.1	19.9	21.3	11.4	8.0	15.3	9.5	10.5	10.2	15.0	15.5	8.9	8.7	10.0	20.4	16.7	0.4	5.9	20.7	4.6	1.3	1.4	1.7	1.2	1.8	2.4	2.3	1.4	1.5	2.9	3.1	2.4	0.6	1.9	1.9	1.0	2.2	1.4	4.9	5.7	5.5	5.8	4.5	5.5	5.2	5.5	5.3	5.2	5.6	6.9	10.9	9.6	6.2	9.4	14.1	10.3	8.2	7.2	18.2	7.9	12.3	9.8	8.9	1.5	11.1	0.0	8.4	6.4	8.9	2.7	5.9	8.2	18.0	9.3	12.7	9.7	12.0	10.7	13.2	4.4	7.0	9.3	7.7	9.2	8.2	15.9	10.8	4.0	4.6	21.9	13.4	5.1	12.2	5.7	3.3	4.1	5.9	5.4	1.8	9.4	6.0	7.9	5.2	24.1	27.7	6.6	3.5	8.2	3.7	7.1	3.4	8.3	6.3	7.9	6.6	6.4	9.1	8.0	3.8	16.2	13.1	4.1	10.4	9.2	4.6	11.9
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	20.8	18.3	18.3	16.8	18.1	19.1	24.1	20.4	22.5	20.2	20.3	20.1	14.5	22.9	23.2	15.4	24.5	16.7	15.1	19.1	17.7	20.4	17.6	19.4	22.6	20.1	17.6	29.2	21.5	30.7	23.4	20.4	17.2	21.4	17.0	24.6	20.2	20.2	17.3	24.0	19.3	18.7	16.6	23.2	22.0	18.1	18.2	22.3	20.0	13.7	21.5	19.5	17.5	20.5	19.7	25.1	27.6	40.8	22.7	28.8	36.6	26.1	38.6	30.0	32.2	27.5	30.3	74.2	26.5	33.6	28.6	25.7	38.6	26.4	29.9	41.6	41.3	31.4	35.6	25.6	25.7	48.8	38.5	34.0	53.3	27.6	40.0	33.5	26.2	44.5	37.9	47.4	24.8	25.5	43.9	37.2	55.7	23.2	19.2	70.4	29.8	57.6	20.7	18.4	40.6	43.8	27.9	30.0	30.9	32.5	32.8	57.7	30.1	31.4	30.9	23.3	25.4	50.8	60.8	88.0	12.9	23.6	23.8	1.4	2.5	6.4	3.5	2.4	4.0	2.5	4.2	4.7	3.5	4.4	5.4	3.8	3.0	4.5	3.4	2.9	3.1	1.9	18.3	18.1	20.4	22.5	19.1	17.7	20.1	17.6	17.2	16.6	18.2	20.5	15.9	0.0	11.5	8.8	16.6	17.5	17.1	3.7	16.5	12.5	13.9	12.8	4.6	15.7	5.0	1.8	0.0	11.5	16.1	8.7	7.9	10.2	60.9	10.5	8.8	12.8	13.2	6.3	7.9	10.0	11.1	11.9	11.2	13.5	7.0	14.3	10.0	7.1	9.1	3.3	6.7	12.1	10.2	9.4	14.3	35.1	8.1	9.5	16.0	7.5	8.4	9.8	19.6	8.0	7.8	10.3	6.0	7.9	11.8	16.3	7.5	6.3	5.7	9.0	13.1	17.5	17.3	13.0	11.1	14.3	20.6	11.1	15.0	15.2	12.3	13.6
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412461-9435571	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 74.2"	"Low region specificity"	"Detected in all"							"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	21.0	17.6	8.7	12.7	9.1	17.5	22.8	10.5	10.7	26.3	10.1	22.8	10.2	20.6	53.3	17.5	21.7	9.7	15.3	8.4	8.9	16.3	15.4	21.8	23.8	8.9	8.9	24.2	15.1	15.7	20.1	15.0	9.0	31.5	15.9	12.6	19.0	14.6	11.4	25.1	29.4	14.0	8.8	44.1	19.4	16.7	9.1	27.6	26.3	8.6	27.9	20.0	20.3	9.9	21.5	5.4	13.0	26.6	10.8	15.3	10.3	19.4	18.9	19.1	27.5	10.1	7.1	22.5	12.6	10.7	7.4	6.3	19.3	10.8	22.1	6.8	29.6	27.1	21.8	13.9	9.2	16.9	17.3	16.4	16.0	9.6	14.3	15.5	14.2	25.7	18.0	0.0	16.7	2.1	25.8	74.2	16.6	9.9	16.5	9.6	16.4	16.9	13.6	22.2	13.0	19.5	10.5	11.0	14.0	14.0	8.8	14.2	13.7	16.6	6.9	23.1	11.8	32.1	55.6	28.0	4.5	14.8	11.3	4.0	3.5	4.9	9.6	4.1	6.8	4.8	5.7	7.4	2.9	5.3	7.5	8.1	2.0	11.1	5.4	2.7	7.5	4.8	8.7	9.1	10.5	10.7	8.4	8.9	8.9	8.9	9.0	8.8	9.1	9.9	8.8	0.0	14.3	10.4	15.3	4.0	5.9	5.3	11.4	8.0	9.0	8.8	5.5	4.3	8.7	3.7	12.5	4.8	22.4	7.2	3.9	5.5	0.7	5.0	5.4	7.5	9.5	14.3	12.5	3.7	3.3	6.6	11.2	6.5	12.0	12.9	10.8	3.1	4.8	8.4	12.0	7.1	6.1	11.4	7.2	1.4	6.2	9.1	5.4	14.0	11.3	4.2	20.6	14.1	15.1	4.7	5.2	4.5	10.5	5.6	7.6	1.4	6.6	9.5	6.6	7.2	6.2	5.5	8.7	6.4	4.7	4.7	17.1	6.5	7.4	6.4
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873807-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.1;Macrophages: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	6.3	3.7	3.2	18.6	3.8	27.4	7.3	3.4	11.6	5.5	5.4	6.1	7.1	6.7	3.1	7.1	6.0	10.0	4.4	2.9	4.4	5.0	6.6	9.3	17.9	4.6	4.4	6.2	4.8	4.5	2.3	10.0	4.8	5.2	7.1	2.5	5.3	3.9	6.1	4.0	5.9	5.9	4.2	13.2	6.8	9.8	6.4	11.4	5.9	6.6	18.4	13.6	4.4	5.5	8.8	10.0	8.8	7.0	6.2	7.2	26.9	7.0	11.7	9.6	14.7	17.9	13.7	15.6	12.6	5.7	9.6	11.3	14.4	11.4	18.5	23.6	12.1	15.8	5.6	16.1	5.6	17.0	35.3	10.3	7.7	13.6	9.7	7.0	14.0	11.8	25.9	35.9	13.2	12.2	11.4	11.3	8.2	6.8	5.8	11.4	24.8	13.7	10.9	38.8	2.8	4.3	10.8	9.6	10.3	15.3	5.7	23.6	16.8	9.3	8.5	8.2	12.0	20.1	12.3	15.7	12.3	13.6	5.7	36.6	24.0	33.4	12.4	23.4	18.6	21.2	16.2	12.5	18.8	15.9	12.6	15.2	75.3	16.5	27.5	11.3	20.3	12.3	3.2	3.8	3.4	11.6	2.9	4.4	4.6	4.4	4.8	4.2	6.4	5.5	23.7	9.6	8.0	3.6	37.0	31.9	39.6	15.2	13.1	4.5	12.3	12.2	5.6	8.6	14.0	3.7	0.0	14.1	27.2	5.4	7.9	19.1	23.3	34.8	10.3	33.5	7.7	10.9	7.1	20.0	10.4	17.2	13.7	31.4	60.3	5.4	7.5	2.8	21.5	11.8	3.7	7.0	14.2	25.3	131.1	8.8	5.9	82.2	14.2	15.0	68.5	5.0	22.6	9.5	7.7	49.7	8.0	3.4	19.9	30.1	4.2	12.4	26.2	3.9	0.0	10.8	12.2	20.7	29.6	33.1	25.6	8.3	47.6	5.9	5.6	48.9
ZNF268	HZF3	ENSG00000090612	"Zinc finger protein 268"	Q14587	12	133181409-133214832	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001794	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001794: AB_2666437"	"unprognostic (7.65e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.63e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.53e-3)"	5.6	6.6	2.8	4.0	3.9	3.6	9.5	5.0	3.9	7.4	4.9	5.5	4.4	7.5	7.4	6.5	8.7	4.3	4.4	2.7	3.3	9.3	12.8	5.6	6.2	3.4	3.5	9.7	5.3	13.1	3.9	9.5	3.3	8.1	5.4	12.0	5.6	6.9	2.4	5.1	5.2	5.8	3.2	6.0	7.1	5.8	3.2	7.3	10.7	4.9	7.1	6.3	3.7	4.2	6.9	10.1	21.4	19.0	9.0	11.5	14.6	10.2	10.8	9.3	7.4	10.6	4.6	5.9	15.5	10.3	9.4	6.3	10.5	12.8	11.8	0.2	8.5	14.6	5.3	13.4	9.6	14.1	12.6	16.9	12.6	11.1	17.4	12.5	10.8	5.6	11.2	7.8	15.9	8.2	5.7	6.4	15.8	8.7	0.6	5.7	6.6	7.3	5.3	15.9	15.3	12.9	20.9	7.0	9.1	18.2	17.0	12.0	11.6	10.6	13.2	3.7	9.3	2.8	4.2	12.9	5.9	7.3	11.3	1.9	5.1	6.0	8.2	5.0	5.5	9.6	9.3	10.4	7.6	7.2	14.2	10.2	1.6	10.8	8.6	6.0	5.2	5.0	2.8	3.9	5.0	3.9	2.7	3.3	3.4	3.5	3.3	3.2	3.2	4.2	8.0	19.2	22.3	6.8	10.0	1.8	5.6	5.7	5.2	24.3	10.0	8.4	8.4	12.8	13.6	7.3	20.9	14.9	3.2	2.8	5.9	8.8	15.5	7.1	9.0	9.5	3.6	15.8	8.4	6.4	9.4	9.7	4.6	7.5	2.5	19.1	14.6	11.0	9.8	21.9	10.0	6.9	4.1	6.7	3.0	4.3	10.5	7.7	5.4	10.3	5.5	15.8	8.2	11.6	12.9	7.7	7.6	11.3	5.2	6.3	5.5	11.5	7.1	19.1	6.6	17.4	8.8	14.9	17.3	6.4	2.8	8.6	7.5	12.4	6.9	4.4
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 77.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	12.0	11.5	10.1	9.9	11.1	13.1	13.0	13.5	10.3	11.3	15.2	14.4	8.6	10.2	13.6	14.9	14.5	8.8	18.0	9.6	9.5	16.4	19.2	13.1	14.0	10.8	10.5	21.7	8.7	21.7	14.4	9.4	11.0	12.9	7.5	17.3	10.3	10.7	17.7	15.1	14.8	8.9	10.0	17.3	11.4	14.4	10.7	11.5	18.9	14.6	14.3	12.7	11.8	14.5	18.5	12.3	20.9	8.5	12.9	19.1	20.3	14.3	7.9	15.9	14.1	7.5	13.1	6.2	9.4	9.3	16.9	5.1	10.1	20.3	21.8	12.7	77.1	29.5	12.8	12.1	20.8	20.9	46.1	15.0	25.7	19.6	37.2	16.6	12.8	9.7	22.5	26.8	12.0	12.0	11.5	19.1	20.0	10.6	12.2	26.0	5.3	26.8	11.9	7.4	13.6	6.1	19.6	8.6	16.9	15.7	20.4	39.4	12.5	8.5	12.8	10.0	16.9	12.5	14.1	20.9	3.8	23.3	18.4	23.0	7.3	36.9	13.5	8.0	21.1	20.5	17.7	19.7	10.3	26.3	26.1	18.5	26.1	22.1	13.4	5.0	24.4	13.2	10.1	11.1	13.5	10.3	9.6	9.5	10.8	10.5	11.0	10.0	10.7	14.5	15.2	16.0	19.6	17.6	33.5	10.5	40.1	12.8	8.0	32.6	10.2	8.3	14.5	15.7	14.1	18.4	43.8	11.3	12.7	10.4	1.9	13.5	18.5	8.3	8.1	13.9	6.6	10.8	4.4	5.6	11.7	9.2	13.7	11.9	29.2	11.2	13.2	9.9	7.1	20.2	3.7	9.0	4.1	13.0	15.9	10.7	12.2	11.9	7.2	10.3	10.4	22.3	18.6	16.6	21.0	12.3	17.9	12.0	7.8	26.7	18.0	10.3	12.4	67.0	19.7	14.1	16.6	21.6	14.6	8.8	12.1	16.7	23.7	5.5	8.3	25.5
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334147-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 76.3;Peritubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 57.3"									HPA000566	Approved		Approved	Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	8.5	77.5	10.1	5.1	10.5	3.1	7.6	10.6	9.7	7.9	10.1	5.2	3.9	8.4	17.6	2.8	8.5	7.2	4.4	9.5	11.9	5.5	13.5	4.1	6.3	11.3	10.8	42.6	10.1	32.3	11.0	3.1	11.1	7.2	4.3	5.2	6.5	14.5	4.8	2.4	6.1	7.3	11.7	11.1	6.0	8.5	12.9	6.3	6.9	7.3	8.0	4.7	3.0	12.7	10.2	4.1	8.4	6.1	10.0	9.6	4.1	7.0	11.7	4.4	6.6	4.3	2.1	17.0	14.0	13.3	6.7	1.7	10.1	6.2	6.5	4.1	7.8	5.7	3.8	6.6	13.4	7.0	4.8	11.4	4.5	3.7	7.2	7.2	5.5	9.2	8.5	0.0	8.1	7.4	8.2	5.8	3.7	10.3	7.2	9.6	9.3	6.0	3.3	6.1	4.3	5.8	3.5	0.3	8.4	5.2	1.5	13.0	5.8	6.5	7.8	10.9	9.1	57.3	16.9	32.9	5.9	13.5	4.6	0.3	0.8	0.1	1.6	0.7	1.9	1.9	1.5	1.5	0.7	2.0	2.1	1.8	0.0	1.4	0.7	1.3	2.4	1.0	10.1	10.5	10.6	9.7	9.5	11.9	11.3	10.8	11.1	11.7	12.9	12.7	26.1	0.0	4.6	7.8	10.9	3.3	4.0	3.6	3.4	6.5	6.2	3.9	5.2	10.0	2.3	9.2	12.5	1.4	9.8	2.6	7.9	2.8	1.3	4.5	15.3	6.6	0.0	8.2	3.8	5.0	4.4	10.5	8.6	8.8	2.5	76.3	7.5	28.3	2.5	0.0	4.8	5.8	4.1	6.0	3.5	4.4	14.3	3.5	3.6	2.8	4.5	6.5	6.2	7.5	3.7	3.9	3.2	39.5	28.7	6.1	2.1	8.3	1.6	2.8	13.1	12.8	11.8	3.5	3.7	4.3	2.3	0.8	7.0	21.5	5.3	2.1
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 63.5;NK-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.9	12.5	13.3	11.0	14.2	21.0	10.4	13.5	15.9	12.5	9.3	13.0	10.7	10.0	3.5	19.1	14.5	5.3	10.0	12.4	11.8	13.5	14.3	12.0	16.9	15.2	13.2	16.0	13.6	4.4	14.6	4.8	14.0	13.4	5.7	3.8	11.7	4.2	10.6	17.6	19.6	4.5	11.0	26.8	12.0	9.3	14.4	8.1	12.8	4.6	10.6	10.8	14.4	19.7	6.6	5.5	4.8	11.8	3.7	5.4	7.9	5.2	3.0	4.6	1.7	7.4	7.4	8.4	4.6	5.2	2.1	12.1	6.0	5.6	3.1	5.4	25.8	7.9	12.0	3.1	6.8	7.7	9.7	7.3	7.2	6.2	4.7	4.5	5.9	7.7	13.9	7.8	1.9	9.9	9.1	19.3	3.2	7.1	10.6	14.4	5.5	6.0	5.5	3.9	11.5	10.0	9.4	8.8	6.0	2.8	11.8	11.0	7.6	6.3	9.1	5.2	4.3	24.4	8.5	4.7	6.2	14.5	7.2	3.8	1.2	1.5	6.6	1.1	3.3	1.2	3.7	5.4	0.7	1.7	3.7	4.9	3.1	3.8	1.0	1.2	2.7	2.0	13.3	14.2	13.5	15.9	12.4	11.8	15.2	13.2	14.0	11.0	14.4	19.7	17.1	9.6	13.3	15.7	20.8	11.5	8.3	11.2	14.8	15.8	13.9	11.7	2.6	12.8	10.7	11.0	20.9	4.6	63.5	16.8	1.9	7.6	1.9	11.5	14.7	13.6	7.2	13.5	17.6	6.6	3.9	9.5	15.8	14.4	12.6	14.3	20.0	11.5	9.0	6.7	14.6	14.5	2.0	9.8	9.8	2.3	11.5	19.7	8.8	18.7	13.5	9.7	89.6	25.1	30.6	9.2	13.2	10.5	25.4	12.9	19.8	3.4	10.1	21.6	13.1	12.3	8.7	17.0	9.7	15.5	16.1	4.0	39.0	24.0	15.7	11.0
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206695-112343934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	7.5	6.8	3.9	5.4	4.9	6.1	8.9	4.2	7.2	6.1	3.8	7.1	5.9	6.7	3.1	7.1	6.0	6.4	8.0	4.5	3.7	9.5	11.6	7.0	6.8	4.7	3.8	7.1	11.3	7.1	4.6	4.6	4.6	5.6	6.9	4.5	7.1	4.4	6.5	8.3	5.6	6.0	3.8	5.8	7.8	5.4	4.7	7.9	9.4	3.4	6.3	8.2	7.0	7.1	7.6	4.5	7.5	9.3	10.2	28.1	5.6	7.4	7.9	3.5	6.3	6.8	6.8	12.6	13.3	6.1	7.2	5.0	5.7	7.3	9.4	10.2	3.6	6.6	6.1	5.8	6.3	12.1	5.2	17.1	10.8	8.6	5.7	11.1	10.7	13.2	7.9	13.3	6.4	8.8	15.2	20.6	5.1	6.5	5.0	7.4	8.2	11.4	9.5	5.6	5.3	13.8	9.7	12.0	11.9	8.1	3.4	10.2	14.9	5.4	3.1	12.0	4.8	11.5	14.6	14.8	3.9	11.5	6.6	9.3	4.6	6.4	5.7	8.1	8.5	8.7	8.0	8.2	3.7	9.6	9.6	8.1	6.6	7.4	7.2	5.9	9.4	3.7	3.9	4.9	4.2	7.2	4.5	3.7	4.7	3.8	4.6	3.8	4.7	7.1	13.0	38.5	24.6	77.1	25.7	20.6	18.2	35.7	26.2	10.0	19.0	17.5	12.8	27.1	24.1	5.5	2.1	12.3	19.6	12.4	27.4	25.9	46.4	13.6	15.6	17.9	18.5	11.1	51.9	31.0	18.3	15.7	12.8	16.3	7.6	21.4	16.4	19.2	21.7	32.0	43.4	22.5	34.6	46.9	34.8	8.6	17.1	29.1	12.4	43.1	50.6	6.6	37.0	47.7	70.5	24.6	22.9	25.2	13.2	17.5	27.0	34.5	12.7	12.0	19.7	17.1	23.7	32.8	10.4	19.1	24.3	13.8	25.8	28.1	22.4	21.5
ZNF280B	"5'OY11.1, SUHW2, ZNF279, ZNF632"	ENSG00000275004	"Zinc finger protein 280B"	Q86YH2	22	22484421-22508742	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 135.6;Late spermatids: 99.3;Spermatocytes: 104.2;Spermatogonia: 161.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 20.9;U-2 OS: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059519	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA059519: AB_2684050"	"unprognostic (7.32e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.80e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.34e-2)"	0.1	1.6	2.4	0.6	2.4	0.3	0.2	1.5	3.2	0.4	0.1	0.3	0.2	1.1	1.0	0.2	0.8	0.4	0.5	2.3	4.0	0.2	0.1	0.2	1.0	2.3	2.8	2.1	0.6	1.2	1.3	0.2	2.3	0.9	0.4	3.3	0.2	1.0	0.3	0.3	0.4	0.8	1.6	0.9	0.4	13.4	3.6	0.8	1.9	0.2	0.9	0.2	0.1	2.2	0.0	2.5	3.2	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.0	1.8	1.1	3.2	3.1	0.1	3.0	0.0	2.8	0.3	0.0	0.0	3.8	4.0	0.6	3.6	2.4	2.5	4.4	1.2	0.0	2.7	0.0	0.5	2.7	3.1	20.9	1.4	1.0	0.0	3.0	1.7	2.4	1.5	0.5	3.0	0.0	0.2	0.8	0.0	2.0	2.2	0.0	0.0	1.1	2.6	0.0	1.9	1.0	4.4	9.8	1.0	0.1	1.7	1.9	1.9	3.0	2.1	0.2	12.9	1.6	2.9	2.6	2.5	4.2	2.8	3.2	2.5	1.5	2.8	3.8	4.5	4.1	5.2	5.4	2.4	2.6	1.8	2.4	2.4	1.5	3.2	2.3	4.0	2.3	2.8	2.3	1.6	3.6	2.2	0.1	0.0	0.6	3.9	5.3	0.1	0.6	0.4	0.0	7.1	0.9	1.3	2.6	2.8	0.6	0.0	4.2	0.3	0.8	0.3	0.0	2.8	135.6	3.4	2.4	1.8	3.0	0.4	12.7	3.7	0.3	1.3	1.1	3.9	0.0	11.4	1.4	0.2	3.0	5.0	14.6	0.7	0.0	0.8	1.9	99.3	2.5	2.6	5.4	1.0	1.9	6.9	5.2	7.5	4.2	2.3	0.1	7.2	0.7	0.8	0.0	4.4	0.0	8.0	6.6	2.3	0.5	104.2	161.7	0.0	0.0	0.3	2.3	17.2	1.6	0.1
ZNF280C	"FLJ20095, SUHW3, ZNF633, ZPET"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202707-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.1;Spermatocytes: 27.5;Spermatogonia: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: AB_2681506, HPA055788: AB_2682921"	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	1.6	1.4	0.6	1.7	1.3	2.6	1.6	1.5	1.3	2.9	0.3	1.5	1.3	2.7	5.1	1.4	1.5	1.8	0.9	0.7	1.3	1.1	1.2	1.5	2.3	0.5	0.8	1.8	1.3	1.7	1.6	1.8	0.7	1.5	1.4	1.8	1.2	1.2	1.3	1.6	1.4	1.8	0.5	1.7	1.1	9.4	0.8	2.2	1.6	1.1	2.6	1.6	1.6	1.1	3.3	4.1	10.7	9.6	3.1	4.3	4.0	3.1	4.0	3.2	4.8	2.5	5.2	7.8	12.0	2.2	6.3	3.2	7.5	2.4	5.7	6.9	2.1	3.4	3.2	1.9	2.5	11.1	3.0	3.2	1.1	4.6	4.7	3.2	3.7	5.0	1.7	4.6	3.8	4.2	6.0	4.5	6.2	4.9	3.4	8.2	3.6	3.0	3.4	5.2	5.2	7.1	3.0	1.7	3.4	4.3	1.9	3.7	3.7	3.5	2.9	5.8	8.2	1.9	1.3	4.3	3.3	9.9	3.3	1.0	0.5	0.6	1.0	0.8	1.7	1.4	1.2	1.2	0.7	1.0	0.9	1.3	0.2	1.8	1.1	0.8	1.8	0.4	0.6	1.3	1.5	1.3	0.7	1.3	0.5	0.8	0.7	0.5	0.8	1.1	3.1	3.2	3.6	8.8	6.8	0.9	2.1	1.3	3.4	2.4	2.1	3.2	1.3	0.0	1.4	1.8	2.1	2.0	8.1	1.2	0.0	1.3	0.3	2.9	7.4	2.8	4.8	3.4	13.1	1.8	1.7	2.9	5.1	3.6	0.0	7.4	3.6	2.7	1.6	5.0	11.2	0.9	4.1	3.2	1.0	0.3	3.4	2.4	0.0	9.4	4.3	0.9	0.0	20.1	11.8	1.1	1.8	3.0	3.2	2.1	1.0	2.1	3.2	3.1	6.6	3.8	3.2	27.5	33.8	4.3	1.6	0.8	4.3	5.0	2.3	2.5
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630176-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	11.3	11.4	3.4	8.7	3.9	23.1	15.4	9.0	4.6	18.0	4.8	10.2	7.5	20.1	8.1	8.4	12.4	9.6	9.2	3.6	3.8	10.3	13.2	10.1	10.0	3.1	3.0	23.7	13.7	11.1	4.5	11.5	3.6	10.6	11.5	12.4	10.5	9.9	12.6	6.6	9.5	15.1	4.0	10.3	10.3	7.8	3.5	35.9	11.5	11.6	9.9	10.9	8.5	9.8	13.4	7.4	13.6	20.9	13.3	18.7	9.9	20.2	14.3	8.2	9.3	5.4	13.6	22.7	8.4	14.5	7.9	10.0	6.7	5.3	9.9	11.6	4.1	2.4	12.5	8.2	13.3	20.4	6.6	12.8	7.6	5.6	8.0	20.6	18.3	23.0	11.9	25.7	13.0	9.6	14.4	2.3	0.0	15.6	5.8	4.3	22.2	16.1	10.1	15.4	11.2	20.0	16.9	10.5	6.7	0.7	11.4	19.9	16.2	12.1	18.2	11.3	16.1	13.2	21.6	0.0	13.7	31.0	13.2	7.8	2.6	3.5	2.1	2.2	2.0	3.4	1.9	1.7	3.6	3.2	2.0	2.4	0.4	1.8	2.0	3.6	1.9	1.0	3.4	3.9	9.0	4.6	3.6	3.8	3.1	3.0	3.6	4.0	3.5	9.8	32.4	9.6	18.9	176.6	31.1	11.1	18.3	12.9	42.7	79.8	20.5	20.7	37.9	22.8	14.6	3.7	83.4	23.0	25.5	12.2	7.9	12.0	18.3	14.3	33.0	36.5	32.3	27.5	107.2	14.0	21.5	37.5	26.0	14.2	17.7	37.8	34.2	31.1	36.6	69.0	151.3	25.7	16.2	35.6	18.1	49.5	33.2	22.9	16.0	91.8	27.0	24.9	28.8	200.1	293.3	10.5	10.4	21.1	41.4	21.1	26.8	14.2	12.8	84.5	6.6	47.4	30.8	49.4	33.8	26.8	13.9	13.3	21.4	27.7	22.2	16.3
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	7.7	3.3	6.3	10.7	12.0	33.5	7.9	10.8	9.8	6.9	4.2	4.6	5.4	7.0	3.9	3.2	4.3	10.1	4.2	7.1	7.6	7.1	21.6	7.5	11.3	8.8	8.9	5.7	5.7	5.6	2.6	8.9	8.3	4.7	4.3	10.7	5.5	4.3	5.7	2.7	4.1	9.0	7.0	9.7	5.1	9.6	8.6	12.6	5.1	7.9	11.7	7.9	2.0	20.7	19.9	19.8	27.2	12.5	10.8	14.5	22.2	21.0	33.3	21.0	19.6	19.7	15.7	29.0	11.6	24.2	24.4	13.4	29.6	19.7	24.9	30.6	17.5	23.6	15.6	20.4	11.6	21.3	12.9	14.1	21.9	22.6	24.5	26.2	19.1	15.6	33.9	4.6	21.5	9.8	22.5	13.8	61.1	6.3	17.1	20.6	18.8	17.2	21.7	10.3	9.2	24.4	21.1	13.8	18.6	42.4	27.0	15.4	25.7	38.1	28.2	8.7	22.3	16.8	17.8	37.0	20.2	16.8	20.5	15.2	8.1	30.3	9.9	8.5	9.7	10.7	8.3	10.4	8.0	9.1	13.6	11.9	38.1	8.1	8.3	8.3	10.9	3.4	6.3	12.0	10.8	9.8	7.1	7.6	8.8	8.9	8.3	7.0	8.6	20.7	30.2	64.1	40.3	7.2	35.1	48.2	26.2	24.0	37.5	55.1	46.3	26.9	14.5	28.6	25.9	27.6	29.2	15.4	24.6	13.8	13.7	22.1	2.6	21.6	37.1	38.9	26.8	22.9	16.0	10.5	31.0	21.2	11.2	41.4	6.3	16.3	30.0	76.9	19.6	18.5	19.6	11.4	8.2	52.1	25.8	3.6	9.9	43.5	23.2	15.0	30.6	15.5	26.8	22.6	59.4	17.8	13.3	7.9	31.7	25.4	10.9	20.3	20.5	37.0	13.1	21.1	32.9	50.1	42.4	18.9	22.7	12.3	29.5	14.2	12.9	20.4
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195546-149226238	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.6;Late spermatids: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	10.4	10.1	8.8	6.6	8.2	11.0	11.0	10.3	9.0	15.1	5.7	13.6	9.9	14.3	2.5	15.6	12.4	6.0	12.3	7.9	7.2	10.4	13.1	8.8	6.8	8.3	8.0	14.0	17.0	6.8	9.9	8.0	7.4	18.3	4.0	3.7	12.7	7.0	16.9	17.0	10.8	5.7	6.9	12.6	12.5	5.3	8.0	7.2	11.4	9.1	4.7	14.0	12.1	8.8	20.6	20.3	11.5	27.7	10.0	11.6	17.0	18.4	13.4	15.8	15.7	18.8	21.9	20.7	27.1	11.6	14.0	22.2	13.6	17.6	6.0	31.3	49.1	17.2	13.1	16.0	15.0	22.0	18.8	13.6	23.4	15.2	16.5	11.9	16.7	13.6	33.8	15.6	8.6	24.6	46.4	33.0	37.3	12.0	25.3	29.9	11.2	28.8	8.7	19.6	26.1	25.1	20.3	24.2	16.9	6.1	15.6	21.3	20.9	22.5	5.1	27.2	27.0	22.4	14.4	15.5	18.8	19.0	19.7	0.0	0.5	1.1	0.5	0.5	0.6	0.2	0.7	0.6	0.3	1.7	0.3	0.4	0.5	0.6	0.6	0.7	1.0	0.3	8.8	8.2	10.3	9.0	7.9	7.2	8.3	8.0	7.4	6.9	8.0	8.8	8.2	3.2	4.5	5.2	3.9	7.1	2.7	4.7	5.2	11.4	9.0	8.3	4.8	7.2	3.6	1.8	4.2	11.7	3.8	10.2	0.0	4.9	31.6	7.0	6.2	6.8	13.1	3.0	6.1	4.4	5.4	5.4	4.6	9.3	5.7	13.3	7.5	8.7	6.0	15.2	6.7	11.5	2.0	6.8	2.7	32.6	6.2	4.5	1.8	9.4	4.2	6.9	3.1	6.0	9.3	6.3	11.9	5.7	4.4	4.9	9.9	3.2	2.9	7.7	13.1	7.5	6.3	11.8	1.3	6.0	6.5	5.1	5.3	9.6	10.1	4.4
ZNF285	ZNF285A	ENSG00000267508	"Zinc finger protein 285"	Q96NJ3	19	44382298-44401608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.0"									"HPA046100, HPA049212"	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA046100: AB_2679538, HPA049212: AB_2680677"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.42e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.42e-6)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.55e-3)"	1.1	2.0	4.6	0.9	4.6	0.2	2.5	5.5	5.5	1.6	3.3	2.1	0.8	1.9	1.6	1.0	2.8	1.1	2.4	4.4	4.7	2.1	0.6	0.7	1.3	4.3	4.3	6.3	1.1	2.5	2.0	1.1	4.4	2.0	1.1	5.6	0.9	1.9	1.8	0.8	0.9	1.9	4.2	1.6	1.4	2.9	4.8	1.7	2.8	2.3	1.4	2.0	1.2	5.4	0.1	3.1	3.0	0.0	2.3	2.4	0.1	1.1	1.1	1.5	2.0	0.5	1.9	0.0	1.6	0.7	2.0	1.0	0.0	2.1	2.6	0.0	2.0	4.4	1.2	0.9	3.3	0.6	0.0	1.9	0.0	0.6	6.0	4.4	2.7	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.8	0.8	1.5	0.0	0.0	1.9	1.6	2.5	1.3	2.2	0.1	0.5	0.0	2.9	3.7	1.5	2.6	1.6	1.3	0.8	0.1	1.9	4.2	0.0	1.5	0.0	1.9	1.8	0.1	0.0	0.1	0.2	0.1	1.6	0.3	0.2	0.5	4.0	2.2	2.3	0.0	1.2	0.4	0.4	0.6	0.6	4.6	4.6	5.5	5.5	4.4	4.7	4.3	4.3	4.4	4.2	4.8	5.4	0.7	0.0	0.0	2.9	0.9	0.3	0.5	0.5	0.0	2.4	0.8	0.8	3.7	0.0	0.9	1.8	4.2	0.5	0.2	0.3	0.0	0.9	1.5	1.0	0.6	0.8	1.2	1.7	5.8	0.6	0.5	0.4	0.0	0.7	0.0	3.9	1.8	0.2	0.4	1.7	3.6	0.6	2.0	0.0	0.6	0.2	0.3	0.4	0.0	0.0	0.1	1.1	3.1	4.5	5.9	0.2	0.2	1.2	0.0	0.9	0.8	0.6	0.6	0.9	0.0	1.1	0.5	3.9	3.0	0.0	0.1	0.0	0.4	1.4	1.1	0.4
ZNF287	"ZKSCAN13, ZSCAN45"	ENSG00000141040	"Zinc finger protein 287"	Q9HBT7	17	16546954-16569204	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029290	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA029290: AB_10603465"	"unprognostic (4.74e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.28e-5)"	"unprognostic (5.69e-3)"	"unprognostic (5.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.87e-1)"	2.4	3.3	1.3	2.0	2.1	0.7	3.2	4.2	2.0	3.1	0.4	1.9	0.8	2.7	4.0	1.9	2.8	2.1	4.9	1.6	1.4	2.8	0.3	2.3	2.6	1.0	1.4	4.2	2.1	6.7	3.5	1.5	1.4	3.1	1.9	5.0	1.7	3.6	3.0	3.1	1.5	3.0	1.4	2.5	2.4	2.7	1.4	2.6	3.7	4.4	2.9	2.3	1.6	2.5	3.9	7.0	6.1	6.4	4.0	7.8	1.5	3.2	5.7	6.0	7.5	1.3	2.8	1.7	3.5	5.2	4.1	6.1	3.7	5.7	7.3	2.7	3.1	0.0	0.5	0.0	5.0	0.0	5.6	5.8	3.8	2.6	3.8	5.8	3.7	7.9	0.4	0.0	8.9	3.5	5.5	0.2	1.3	3.3	3.3	0.0	6.8	0.2	3.5	1.9	3.5	5.8	10.2	1.3	4.1	16.5	4.8	0.6	3.0	3.8	2.0	5.0	4.3	3.1	2.4	0.0	5.5	0.0	4.7	0.1	0.6	0.5	8.0	0.7	6.8	10.9	8.6	8.1	2.9	7.7	9.3	9.4	0.1	6.7	3.1	1.8	7.0	4.4	1.3	2.1	4.2	2.0	1.6	1.4	1.0	1.4	1.4	1.4	1.4	2.5	2.3	3.2	1.7	4.6	4.2	0.6	1.5	6.0	2.2	3.7	1.4	1.8	10.0	1.5	4.9	0.0	4.2	0.2	3.3	0.1	5.9	5.2	3.0	1.8	2.3	3.8	2.4	0.4	7.2	9.1	0.7	4.0	2.0	0.9	7.0	3.5	1.8	0.1	1.3	16.8	8.4	0.6	0.0	1.0	0.9	2.9	2.1	1.1	0.0	1.0	1.0	3.8	4.1	8.0	9.2	4.6	0.2	3.4	0.8	0.6	0.1	2.3	7.2	3.7	6.6	2.6	3.1	12.6	5.9	1.7	1.4	0.0	4.3	6.3	0.9	0.7
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87265943	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	6.8	6.3	4.4	7.8	4.6	25.4	9.6	17.8	8.7	8.7	1.8	7.3	7.9	10.3	9.5	6.6	6.2	6.7	6.2	3.9	3.1	6.3	6.4	5.7	10.9	3.2	2.5	13.7	6.9	13.8	8.5	8.8	3.8	8.2	6.8	26.4	8.3	7.2	5.5	8.6	8.8	6.4	2.2	8.0	8.1	6.2	3.7	14.3	9.6	5.6	9.1	7.1	7.3	10.3	8.3	4.7	16.1	14.2	9.0	8.1	16.8	6.4	8.1	7.4	10.1	8.2	5.7	12.8	9.0	8.4	10.4	8.4	10.1	9.6	15.9	29.3	7.6	17.3	6.4	6.8	6.7	14.0	7.6	8.1	9.2	7.3	9.4	11.8	6.9	13.6	12.8	19.1	8.1	4.6	8.1	12.0	8.1	2.9	4.4	16.9	15.9	4.9	6.2	17.8	11.9	16.8	8.0	5.3	6.1	9.2	5.4	16.0	7.8	9.8	6.8	7.2	10.1	17.5	12.3	8.6	10.8	11.8	7.2	60.3	16.9	20.0	15.7	5.4	14.8	46.6	16.8	17.3	8.0	42.8	18.7	16.1	83.6	11.2	5.7	25.0	18.3	8.3	4.4	4.6	17.8	8.7	3.9	3.1	3.2	2.5	3.8	2.2	3.7	10.3	64.2	60.9	72.4	147.2	99.0	66.2	31.2	46.1	70.0	167.7	48.0	47.9	76.8	48.6	51.8	25.8	123.0	27.0	89.9	64.9	9.8	122.3	44.4	119.3	89.6	55.6	47.3	43.5	176.6	38.5	36.6	52.3	66.3	203.1	29.1	135.6	40.0	19.0	26.8	186.7	225.7	52.7	40.7	29.2	53.1	12.4	60.0	46.3	32.0	124.6	53.0	62.5	65.9	210.6	209.8	52.2	49.5	66.2	90.8	49.4	72.5	14.5	50.1	99.4	32.9	84.6	59.5	56.3	34.1	36.7	51.4	211.8	90.8	66.8	44.5	58.5
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076587	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;Basal squamous epithelial cells: 94.4;Plasma cells: 48.2;Squamous epithelial cells: 107.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;SK-BR-3: 15.6;U-698: 28.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	0.6	1.1	1.4	2.2	1.2	5.3	1.7	3.3	1.9	1.3	0.4	2.5	3.0	0.5	0.1	9.2	1.4	0.2	0.4	1.4	1.0	1.5	0.7	1.3	2.8	1.2	1.1	0.7	0.7	0.1	3.3	0.1	1.2	2.4	0.3	0.5	5.1	0.4	0.5	6.0	4.2	0.1	1.1	5.9	2.7	2.3	1.0	0.4	1.2	0.1	1.4	1.5	3.2	0.9	4.6	2.9	0.1	0.6	0.0	0.2	2.5	0.6	0.0	0.3	0.2	4.7	1.6	24.0	2.7	0.1	0.0	8.3	1.2	1.8	0.0	5.2	6.3	7.2	1.4	4.8	1.2	3.9	7.2	0.9	0.9	0.9	0.0	0.1	0.7	0.4	5.2	8.0	0.0	6.5	0.3	6.8	2.7	2.8	6.3	13.5	0.0	14.8	0.5	1.6	4.4	0.4	3.0	15.6	0.1	0.4	3.4	8.1	1.5	0.0	2.4	0.1	0.0	8.6	9.3	28.7	0.2	5.0	0.1	59.7	10.7	17.2	8.3	18.3	9.7	82.6	4.3	9.3	26.0	62.8	1.8	4.7	5.1	45.9	18.5	78.5	4.4	8.7	1.4	1.2	3.3	1.9	1.4	1.0	1.2	1.1	1.2	1.1	1.0	0.9	2.4	0.0	0.6	2.3	53.3	12.1	13.9	1.5	94.4	1.4	20.5	13.3	1.2	0.0	2.6	3.7	4.2	0.4	31.9	18.5	0.0	1.8	0.5	6.1	1.0	2.0	5.3	3.0	0.4	0.9	3.6	1.3	21.9	4.5	8.9	0.5	1.4	0.2	3.5	0.0	0.3	32.1	6.1	2.9	19.1	0.5	0.0	7.6	3.6	0.0	24.9	0.4	12.3	0.0	0.5	1.2	36.1	1.2	48.2	6.4	23.4	0.2	3.9	1.6	0.0	0.8	3.2	1.1	14.2	107.3	10.1	0.8	18.5	0.2	28.9	6.2
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	13.3	11.1	18.5	9.9	21.1	27.1	19.8	20.4	20.6	17.7	20.0	16.9	20.3	21.3	22.2	13.5	36.5	11.9	11.8	18.7	19.0	15.1	18.6	12.3	12.9	21.3	21.0	21.7	16.0	19.2	13.0	11.7	21.4	14.9	18.4	14.9	14.3	15.7	18.3	13.9	21.0	14.2	20.3	13.9	16.6	8.8	19.9	18.6	18.5	19.5	15.5	14.3	13.8	26.1	13.2	14.1	39.1	54.9	18.8	14.5	23.1	16.8	18.5	23.8	20.4	18.4	19.0	19.2	28.8	15.7	19.6	17.2	29.3	18.2	19.8	20.1	23.7	15.5	20.8	26.6	22.4	28.7	13.6	18.5	21.5	16.8	37.3	26.4	21.4	27.6	44.9	29.3	22.0	36.1	67.3	28.9	54.9	24.2	25.7	27.7	31.4	49.0	22.8	25.9	40.9	60.5	20.1	57.2	26.1	37.1	16.5	27.1	17.5	29.5	21.8	22.0	22.0	39.9	47.3	38.1	14.8	24.6	29.3	13.1	10.2	19.5	14.2	9.8	16.6	13.4	11.8	14.7	10.5	15.5	13.6	14.9	3.9	18.6	14.5	11.8	12.7	10.1	18.5	21.1	20.4	20.6	18.7	19.0	21.3	21.0	21.4	20.3	19.9	26.1	13.5	12.8	31.9	8.1	16.9	7.6	10.0	8.1	12.0	18.7	15.1	12.2	10.5	14.3	13.2	3.7	16.7	12.5	12.6	17.0	7.9	19.3	2.7	42.3	16.1	17.4	26.3	26.1	5.8	11.1	7.6	16.4	15.8	13.0	15.2	28.5	14.6	14.5	6.6	18.5	6.2	20.0	10.2	12.6	5.9	1.8	15.2	7.8	3.6	2.8	11.5	16.5	30.9	9.0	20.4	16.1	18.1	15.1	11.6	12.7	32.5	13.5	32.1	19.5	6.6	9.3	12.1	16.2	17.0	9.9	8.9	10.4	11.1	14.0	20.1	8.2
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 15.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.4;Horizontal cells: 13.5;Inhibitory neurons: 13.2;Oligodendrocytes: 15.6;Rod photoreceptor cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	2.1	2.9	5.1	1.4	5.4	0.5	2.6	8.0	6.0	2.5	2.7	2.5	2.0	2.1	1.5	1.8	3.0	1.2	2.6	4.5	4.2	2.9	3.6	2.7	2.6	4.4	4.2	2.4	3.7	3.0	3.3	1.5	4.8	3.3	2.0	15.6	2.3	2.2	2.7	2.6	2.4	2.3	4.2	3.7	2.3	2.5	4.5	1.8	2.1	2.8	2.4	2.2	2.2	5.7	3.4	7.3	3.1	7.8	5.3	3.3	0.1	3.2	2.2	2.9	3.2	5.3	1.1	0.0	4.2	2.2	1.1	2.0	9.0	4.6	3.6	0.0	4.3	2.4	4.2	4.1	2.5	3.3	2.2	2.9	4.0	2.7	3.9	1.1	4.6	6.5	8.0	0.0	4.6	2.5	2.4	1.4	4.3	8.2	3.8	3.1	2.4	0.7	2.2	2.9	4.0	5.8	0.0	0.1	2.9	3.2	3.0	0.8	3.4	6.1	3.2	2.2	4.4	2.1	11.1	0.9	1.2	0.0	3.6	1.8	0.1	0.1	3.1	0.3	3.1	2.2	2.5	1.4	0.9	1.3	4.7	4.9	0.0	4.7	0.0	0.8	2.7	1.3	5.1	5.4	8.0	6.0	4.5	4.2	4.4	4.2	4.8	4.2	4.5	5.7	3.6	0.0	1.1	8.8	1.3	0.4	0.4	0.5	1.8	6.4	1.2	0.9	3.6	0.0	0.4	1.8	6.2	0.1	2.6	0.1	3.9	1.1	0.6	1.0	2.5	3.6	1.2	6.1	15.4	1.3	0.5	1.4	2.0	0.9	5.7	2.4	5.0	1.0	0.8	13.5	13.2	1.2	0.0	1.9	0.3	0.8	2.1	0.5	1.8	3.7	0.3	4.4	6.2	9.0	15.6	1.0	0.7	2.2	1.0	0.5	0.5	1.4	2.5	11.5	0.0	1.4	1.5	2.7	2.6	1.2	0.1	0.0	2.3	2.1	1.5	0.4
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 36.1"					"Low region specificity"	"Detected in all"			"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	3.6	1.0	2.3	2.6	3.2	2.7	4.5	3.8	2.8	6.5	2.3	3.6	2.7	7.4	2.3	5.1	4.4	3.3	3.2	2.3	2.9	7.4	1.2	2.4	3.0	3.0	3.1	10.2	5.5	0.8	2.4	1.5	3.1	5.4	2.7	9.1	2.8	2.3	0.9	4.4	3.8	4.0	2.6	3.9	4.7	6.4	2.9	2.8	6.9	1.5	2.9	4.5	4.9	3.5	2.1	4.7	28.2	0.0	2.4	5.8	0.0	7.1	5.6	6.1	8.7	2.4	3.5	0.0	6.1	5.9	18.3	4.2	0.0	16.2	9.5	0.0	9.3	0.0	36.1	3.9	5.0	0.2	0.1	8.9	5.0	12.7	14.7	8.6	10.4	0.1	0.0	15.1	6.1	0.0	0.0	1.5	27.2	0.0	0.0	0.0	4.1	8.5	4.4	5.3	15.9	26.2	16.7	14.3	9.8	17.1	9.4	0.0	4.6	8.1	3.4	5.9	12.9	0.5	0.2	0.0	0.8	0.1	17.1	0.0	0.1	0.3	0.1	0.4	0.0	0.2	0.2	0.0	0.3	1.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	2.3	3.2	3.8	2.8	2.3	2.9	3.0	3.1	3.1	2.6	2.9	3.5	2.0	0.0	0.5	0.3	1.8	1.5	3.1	2.3	7.4	4.0	2.3	1.7	0.6	1.5	2.7	7.3	0.0	0.7	1.9	0.3	1.9	2.5	3.2	1.8	5.3	2.3	3.0	4.0	0.8	1.6	2.2	3.8	13.3	1.9	0.0	11.5	1.8	0.2	0.5	0.0	1.9	1.4	2.0	1.0	1.2	0.9	2.5	0.8	0.0	5.6	1.5	3.3	3.1	5.5	6.7	1.8	0.1	1.2	0.3	2.0	0.6	1.8	0.8	4.3	6.6	4.1	2.8	7.2	3.7	5.9	2.3	0.8	1.2	2.7	1.8	3.0
ZNF304		ENSG00000131845	"Zinc finger protein 304"	Q9HCX3	19	57351271-57359898	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050531	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear speckles"	Cytosol	"HPA050531: AB_2681160"	"unprognostic (4.44e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (1.52e-7)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.31e-1)"	"unprognostic (9.00e-3)"	4.4	6.3	4.2	3.5	4.4	4.3	6.5	6.7	6.0	4.3	3.5	4.9	2.6	5.0	7.4	5.2	5.2	4.3	6.2	4.8	4.4	4.5	3.5	5.3	5.2	3.0	3.6	6.7	2.5	10.0	5.0	5.5	3.2	5.5	3.1	5.3	4.7	6.2	5.0	6.1	3.8	5.1	3.4	6.8	3.9	4.4	4.3	7.5	7.0	5.3	7.3	4.2	3.0	4.1	6.4	3.1	7.6	9.6	6.2	5.9	4.8	6.4	9.7	7.1	16.0	0.0	3.0	5.3	3.9	7.4	3.7	2.3	4.4	8.4	10.6	1.7	20.5	8.4	8.9	4.5	4.4	4.7	5.1	7.1	11.0	7.0	9.7	7.6	4.5	11.8	2.6	0.0	7.6	1.7	10.0	2.7	5.1	0.0	9.9	6.3	12.3	6.7	5.0	13.7	6.0	6.4	6.7	5.1	4.4	6.9	6.2	6.6	5.2	9.9	5.9	3.1	6.8	8.1	7.7	7.8	6.3	0.1	5.3	2.5	1.3	1.1	1.4	1.0	2.6	2.3	2.4	2.0	1.8	1.8	1.9	2.1	0.1	2.8	2.8	0.9	2.0	1.7	4.2	4.4	6.7	6.0	4.8	4.4	3.0	3.6	3.2	3.4	4.3	4.1	5.0	0.0	0.5	4.2	3.2	6.4	0.8	1.3	4.6	4.9	6.9	5.1	4.4	7.2	4.6	0.0	0.0	1.7	2.9	1.0	1.9	1.7	1.2	3.2	1.8	4.1	0.0	0.0	8.2	1.0	0.8	1.9	1.5	4.0	0.0	5.2	10.4	2.7	1.6	3.3	6.4	1.4	4.1	2.1	2.8	1.1	1.8	1.6	3.6	2.8	0.6	1.4	1.0	3.0	2.8	0.9	0.5	2.2	1.6	1.4	0.8	1.6	6.2	2.2	0.0	2.2	2.8	2.2	4.2	5.4	5.5	1.1	2.1	5.0	1.9	1.2
ZNF311		ENSG00000197935	"Zinc finger protein 311"	Q5JNZ3	6	28994785-29005316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Spermatocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 1.4;K-562: 2.0;SK-MEL-30: 1.1;WM-115: 1.0"					"Low region specificity"	"Detected in many"			HPA050541	Approved					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA050541: AB_2681164"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.14e-1)"	0.5	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.7	0.0	0.7	0.7	0.6	0.9	0.2	0.3	0.1	0.0	1.0	0.7	0.4	0.1	0.0	0.2	1.1	0.6	0.0	0.3	0.0	0.0	1.1	0.2	0.0	0.6	0.1	0.1	0.6	0.5	0.0	0.0	0.6	0.5	2.5	0.0	0.0	1.2	0.0	0.1	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	2.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.3	0.0	0.4	0.6	0.5	1.2	0.7	1.1	1.0	0.4	1.5	0.1	1.8	0.0	0.4	0.0	0.7	1.9	0.8	0.1	1.1	1.0	0.6	0.0	1.3	0.2	0.7	0.3	0.5	0.0	0.5	0.0	1.8	2.5	0.8	0.5	0.0	0.3	1.7	0.0	0.8	0.0	1.3	0.6	0.2	3.6	1.0	0.8	1.4	0.0	0.0	1.8	1.0	1.7	0.0	0.0	0.6	0.6	0.1	0.1	0.8	0.0	0.4	0.6	6.5	2.8	0.6	0.1	0.0	0.1	0.7	1.1	0.3
ZNF317		ENSG00000130803	"Zinc finger protein 317"	Q96PQ6	19	9140397-9163424	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042075, HPA048625"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA042075: AB_10796471, HPA048625: AB_2680464"	"unprognostic (3.81e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.70e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.42e-3)"	15.8	17.5	21.3	10.2	22.0	26.2	14.7	22.4	34.1	15.1	22.3	17.4	11.2	16.4	11.5	17.4	15.5	8.3	16.1	21.4	21.8	22.2	21.1	14.2	14.2	21.4	21.6	16.4	19.6	12.4	15.8	9.1	21.3	17.8	10.4	12.9	13.6	9.6	14.6	22.8	17.9	10.3	21.3	24.7	18.3	6.7	21.9	15.0	14.5	12.7	15.3	17.7	15.1	22.7	17.4	14.6	15.7	21.0	15.7	14.9	13.6	14.3	22.3	19.2	23.2	16.6	9.2	29.5	17.9	15.3	22.8	17.2	25.7	24.7	24.8	24.4	34.5	26.6	13.3	18.4	20.9	27.8	26.0	17.9	32.2	21.9	38.1	16.6	17.0	25.8	24.8	33.6	19.6	14.6	34.8	88.3	29.0	18.4	30.9	24.4	19.8	23.6	17.0	29.4	27.0	18.6	19.9	17.4	22.7	13.7	13.1	28.7	15.1	13.6	12.3	31.2	19.3	42.0	42.8	33.3	13.1	24.2	17.8	19.4	14.8	16.1	13.0	15.5	20.5	20.8	17.3	15.2	15.0	16.4	16.4	17.9	9.0	22.8	13.4	13.6	22.5	14.2	21.3	22.0	22.4	34.1	21.4	21.8	21.4	21.6	21.3	21.3	21.9	22.7	5.7	9.6	13.4	6.8	11.8	7.4	7.1	4.4	6.2	8.3	8.9	6.7	7.3	7.2	9.4	5.5	6.2	5.6	12.6	9.5	3.9	5.3	0.7	8.9	9.0	7.6	7.2	9.1	6.1	6.4	5.2	7.9	12.2	13.1	13.9	8.1	6.4	10.1	8.0	8.4	7.4	8.6	6.1	15.9	6.2	1.4	3.7	10.1	5.4	7.5	8.1	4.6	8.2	10.6	9.3	8.5	4.7	3.8	10.5	9.5	5.8	9.8	9.4	5.3	0.0	5.7	5.4	2.4	1.0	7.0	6.5	10.9	10.3	7.7	9.6	11.7
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.9;Spermatogonia: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.1	6.4	6.4	12.4	5.5	11.4	7.9	11.7	8.8	14.2	1.9	9.3	7.2	11.5	10.6	6.4	9.7	7.0	7.0	6.3	5.3	6.4	8.1	7.5	25.6	3.7	4.6	11.9	8.2	10.8	7.3	8.0	3.6	9.7	8.0	21.2	7.5	8.1	8.5	12.0	9.7	9.0	3.1	14.4	6.3	26.2	4.8	13.3	12.5	6.3	25.0	8.9	10.0	6.9	26.4	6.2	18.0	29.9	15.4	13.7	9.3	11.6	14.3	12.8	11.1	6.6	3.2	41.5	6.4	14.4	15.0	11.4	20.0	9.5	16.6	11.8	10.7	11.4	8.1	10.7	7.7	20.2	9.2	8.8	9.8	10.8	9.6	10.8	10.2	11.3	15.6	19.3	13.8	9.0	6.4	12.8	8.1	42.9	5.9	7.6	17.9	6.4	7.1	5.9	16.6	10.2	8.6	7.2	9.0	13.8	9.1	27.6	10.6	17.9	9.2	12.2	11.4	12.4	10.9	28.2	5.6	15.1	10.2	0.0	0.3	0.0	0.5	0.2	0.1	0.6	0.4	0.3	0.3	2.1	0.3	0.3	0.1	0.3	0.1	0.3	0.5	0.2	6.4	5.5	11.7	8.8	6.3	5.3	3.7	4.6	3.6	3.1	4.8	6.9	7.8	9.6	14.5	10.7	29.9	9.7	4.4	5.6	12.0	18.1	6.5	6.9	9.5	8.6	6.4	9.2	8.4	5.8	6.8	5.2	3.9	5.2	30.7	9.2	13.3	7.8	5.4	8.2	19.9	4.7	4.4	10.4	5.1	6.3	6.3	20.6	11.7	19.4	6.6	25.2	18.9	5.1	6.1	11.1	7.2	16.5	6.2	10.7	3.6	4.7	9.7	9.4	16.5	15.6	17.5	4.2	8.2	9.8	5.1	3.0	11.4	3.9	6.8	11.8	26.3	13.6	8.7	82.9	46.3	9.0	5.1	1.8	8.8	8.9	8.3	2.0
ZNF319	"KIAA1388, Zfp319"	ENSG00000166188	"Zinc finger protein 319"	Q9P2F9	16	57994676-58000672	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052584	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052584: AB_2681873"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.87e-5)"	"unprognostic (8.69e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.80e-2)"	3.8	4.5	4.0	3.6	4.2	11.8	3.6	5.2	4.7	5.1	2.1	5.1	3.1	6.5	2.3	3.0	4.8	1.9	5.2	3.9	4.5	3.6	3.4	3.7	4.1	5.0	4.5	5.8	5.2	6.1	3.8	2.6	4.9	4.0	1.7	2.2	3.8	3.8	5.1	4.2	4.0	3.5	3.7	6.6	3.7	3.8	5.0	3.9	6.4	5.1	2.9	5.8	3.2	4.3	4.5	10.8	6.1	8.7	5.5	6.9	4.8	6.2	6.7	6.6	3.1	5.5	2.9	6.8	10.7	5.2	4.9	4.4	5.4	6.6	4.2	2.9	4.2	3.3	6.4	5.7	10.8	3.9	10.2	8.9	8.1	4.8	11.6	6.2	3.9	5.7	6.2	1.2	5.7	4.3	8.1	5.8	3.7	2.2	10.5	11.5	3.4	7.6	4.1	11.4	4.1	4.4	9.1	4.3	4.3	4.6	1.5	5.8	6.4	5.1	3.1	2.7	4.6	5.6	3.2	6.0	4.0	3.8	5.8	0.0	1.0	3.4	2.1	0.7	1.2	0.5	1.0	1.4	1.1	0.5	0.7	1.1	1.9	0.7	0.6	0.4	0.9	1.4	4.0	4.2	5.2	4.7	3.9	4.5	5.0	4.5	4.9	3.7	5.0	4.3	2.7	3.2	3.4	1.6	1.2	0.9	0.5	2.4	1.2	2.0	1.9	2.4	5.3	5.7	1.6	0.0	0.0	1.6	4.1	1.6	3.9	2.4	0.3	3.2	2.9	2.2	4.9	0.4	0.9	3.0	1.0	2.1	0.0	2.7	1.3	3.3	3.9	2.2	2.3	0.0	1.2	1.5	0.0	7.6	1.0	0.1	3.1	1.8	0.0	1.9	4.3	3.2	10.3	4.0	1.7	2.7	0.5	3.4	1.0	0.8	2.0	1.3	3.7	3.1	0.0	2.4	1.4	2.8	1.1	0.8	1.3	0.3	2.8	3.2	1.2	0.2
ZNF320	"DKFZp686G16228, ZFPL"	ENSG00000182986	"Zinc finger protein 320"	A2RRD8	19	52860851-52897693	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 105.9;U-266/84: 56.1"									"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: AB_2732685"	"unprognostic (3.33e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.47e-4)"	"unprognostic (8.90e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.75e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.61e-3)"	4.9	6.3	4.5	6.6	5.8	5.0	10.4	8.9	5.5	8.9	5.1	9.0	6.9	10.0	9.8	5.1	10.5	7.3	7.2	4.9	4.9	10.7	1.5	5.9	6.7	4.5	3.9	13.4	6.8	12.3	6.5	11.1	4.7	10.3	9.7	13.0	6.3	8.0	7.0	9.1	5.3	7.8	2.5	7.5	7.8	5.3	4.7	6.3	10.8	3.6	6.4	9.5	7.1	7.3	11.2	0.5	16.8	28.1	3.8	6.2	19.8	8.0	7.3	10.5	12.7	6.7	3.8	12.5	10.3	6.9	9.3	3.1	0.1	5.7	7.4	0.1	3.6	12.6	16.6	0.1	7.8	0.8	14.2	10.7	4.8	12.2	2.6	4.8	7.8	5.5	12.9	0.8	7.7	0.0	16.1	9.8	20.4	0.2	9.5	12.0	15.3	14.1	10.2	105.9	13.3	26.4	0.3	7.0	2.9	23.3	10.0	1.3	9.0	4.4	11.0	2.7	12.2	14.1	56.1	9.3	0.3	0.2	9.8	3.2	2.1	1.8	3.2	2.6	2.9	2.2	1.8	2.4	2.5	3.2	3.4	3.5	3.5	7.9	2.4	3.7	2.0	2.5	4.5	5.8	8.9	5.5	4.9	4.9	4.5	3.9	4.7	2.5	4.7	7.3	0.6	3.2	1.7	13.7	2.8	1.9	5.8	3.4	1.2	8.3	0.2	0.1	13.2	14.3	5.9	1.8	10.4	10.5	2.9	9.0	0.0	0.3	6.7	1.9	1.0	4.5	10.7	4.2	10.2	0.0	6.3	5.0	6.1	2.8	1.3	0.6	6.8	0.8	4.3	16.8	10.1	9.0	4.1	3.2	3.9	2.7	4.4	1.6	3.6	3.7	2.4	5.6	9.2	17.6	12.4	0.1	6.3	2.6	0.5	9.4	4.1	0.2	4.4	12.4	0.0	9.2	3.2	5.6	5.8	5.3	4.3	7.7	1.8	0.4	7.3	7.5
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	7.8	12.0	11.0	7.8	11.9	1.3	12.8	12.1	12.4	15.4	10.9	8.8	9.3	15.5	13.3	8.6	11.4	9.8	7.7	10.2	12.0	11.8	9.3	9.9	9.9	11.8	11.5	17.9	8.2	17.7	7.1	11.2	12.4	14.9	10.9	14.3	8.7	13.9	6.6	6.0	8.1	10.5	12.0	11.7	9.1	11.1	11.6	10.1	15.3	12.8	9.7	10.8	7.4	15.0	9.3	6.8	26.2	31.0	17.3	22.5	9.7	12.3	16.1	16.6	20.1	13.3	5.5	11.0	28.5	10.6	20.8	11.5	19.7	7.4	20.8	17.3	18.0	19.5	8.7	13.2	19.5	0.0	17.3	14.1	27.0	10.7	12.3	20.8	14.4	13.5	23.3	11.7	18.3	5.2	14.1	16.9	7.8	8.5	8.4	15.4	18.6	16.0	10.1	14.5	21.3	22.7	14.5	13.6	25.9	12.8	12.5	12.8	14.4	27.8	11.0	11.4	12.4	12.2	25.8	10.8	5.8	2.9	28.4	3.3	8.4	10.8	10.5	7.2	7.6	11.2	5.3	6.9	6.9	9.0	6.1	9.1	8.0	17.8	11.9	7.8	4.5	5.1	11.0	11.9	12.1	12.4	10.2	12.0	11.8	11.5	12.4	12.0	11.6	15.0	24.8	6.4	10.5	3.9	18.0	4.0	17.3	4.8	14.8	32.1	23.9	31.2	5.8	12.8	11.1	9.2	8.4	12.5	16.1	9.9	35.2	17.7	4.1	14.2	32.6	20.1	19.7	7.2	5.3	10.2	11.3	21.9	10.2	15.7	13.3	30.0	18.2	7.6	13.3	47.1	7.0	14.1	8.2	8.9	5.3	3.7	30.1	11.7	8.8	6.5	12.7	26.7	10.3	11.1	10.3	16.1	12.8	26.4	11.8	26.4	10.2	13.3	8.1	13.9	32.9	20.6	22.2	26.0	15.7	12.0	6.5	9.6	9.1	37.7	10.0	24.9
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 54.2"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	3.4	3.9	4.8	3.4	4.9	6.7	3.7	6.3	6.0	4.6	2.8	4.1	4.3	5.0	3.2	5.9	5.2	2.9	3.4	5.1	4.2	3.1	5.7	3.2	3.1	4.7	3.9	5.8	7.0	4.4	6.6	2.9	3.8	4.6	2.2	3.0	4.7	4.2	3.0	6.6	3.9	3.3	2.9	3.9	4.4	4.4	3.4	6.8	4.8	2.6	2.9	4.4	3.8	4.8	7.8	8.9	5.0	10.1	5.3	5.0	7.2	6.3	6.4	5.6	5.0	8.5	4.2	11.2	5.9	4.3	7.6	9.3	6.4	6.6	2.1	10.5	54.2	6.9	6.7	3.6	4.5	12.3	9.2	3.9	8.5	7.1	3.3	5.1	3.7	7.9	11.4	7.1	6.0	6.0	12.5	6.6	5.4	6.4	12.9	13.9	6.5	7.3	3.8	15.5	11.8	9.5	6.5	10.8	3.8	3.6	4.9	10.1	6.4	17.6	3.9	6.4	11.2	10.4	12.0	5.8	9.5	6.7	6.5	2.3	5.3	8.9	10.5	5.9	11.5	5.8	8.0	11.6	3.8	6.2	12.1	9.7	15.6	7.3	4.5	7.0	8.8	4.2	4.8	4.9	6.3	6.0	5.1	4.2	4.7	3.9	3.8	2.9	3.4	4.8	4.8	0.0	1.7	5.2	8.4	9.1	5.5	3.1	2.2	37.0	10.3	7.5	7.5	2.8	3.8	0.0	25.0	4.8	6.9	9.9	0.0	4.9	1.2	6.3	6.3	5.5	7.8	6.5	5.6	4.1	3.8	6.0	6.6	3.6	1.3	11.3	7.5	3.6	2.9	33.7	6.3	7.9	6.1	2.4	3.7	1.6	12.8	3.2	3.6	7.5	4.1	15.8	7.2	4.5	6.7	4.2	12.4	14.7	5.6	8.0	9.0	2.3	5.8	57.2	6.6	11.7	8.5	19.4	15.8	4.8	13.4	6.7	7.6	11.2	6.3	3.8
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451611-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Inhibitory neurons: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in all"		"HEK 293: 38.7"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	2.4	2.2	1.0	2.8	1.1	1.7	2.7	2.3	2.3	3.4	0.4	2.3	1.8	2.9	1.4	3.0	3.0	2.1	1.8	1.3	0.4	2.3	2.4	2.2	2.3	0.8	0.2	3.0	3.6	2.6	3.0	1.4	0.4	2.7	1.8	1.9	2.7	2.4	3.1	3.8	2.3	2.2	0.0	3.4	2.6	3.0	0.3	2.5	2.8	1.7	2.0	3.0	2.6	0.8	5.9	9.6	5.2	8.6	3.6	3.1	3.8	5.2	3.8	4.2	3.0	3.4	2.5	8.0	3.2	3.1	4.3	4.8	6.9	4.8	3.2	8.1	38.7	6.9	8.5	1.3	3.7	11.3	9.8	3.1	4.8	4.7	4.0	2.7	3.0	7.0	10.1	4.7	4.3	3.9	8.4	2.7	2.8	6.9	5.4	7.9	6.8	4.8	2.7	11.4	12.2	7.0	4.9	7.9	1.3	3.5	2.9	3.2	3.5	9.9	2.5	5.3	8.5	10.2	9.9	5.7	3.9	4.8	3.9	0.0	0.6	0.0	0.6	0.3	0.4	0.2	0.3	0.4	0.3	0.5	0.6	0.4	0.7	4.0	0.2	0.3	0.2	0.5	1.0	1.1	2.3	2.3	1.3	0.4	0.8	0.2	0.4	0.0	0.3	0.8	1.8	0.0	0.5	9.1	2.9	0.8	1.0	0.6	1.8	3.1	1.6	1.3	0.9	1.5	2.2	1.8	22.9	0.9	2.4	2.2	0.0	1.8	1.0	1.9	3.1	1.5	0.0	2.1	9.5	1.6	0.9	1.5	1.5	1.2	0.0	1.8	1.4	1.3	0.9	5.0	10.6	1.0	0.0	2.2	0.4	1.8	3.1	1.2	0.0	0.0	2.0	2.0	3.1	7.5	9.5	1.4	0.6	2.6	1.5	1.0	1.2	1.2	2.7	6.6	6.6	2.3	1.6	6.6	4.8	1.2	1.0	0.7	2.0	4.2	1.3	1.0
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995110-90035533	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 52.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 79: Retina - Phototransduction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	11.0	9.5	5.9	5.5	7.2	21.0	11.1	8.9	6.7	13.5	6.8	12.8	8.8	12.5	7.4	15.3	11.0	5.3	10.4	7.1	5.2	12.2	12.8	8.5	6.9	7.3	6.5	17.2	17.0	4.5	10.3	6.2	7.3	9.3	8.5	52.6	13.4	3.9	9.8	10.2	12.6	5.0	6.7	8.0	10.3	6.9	5.8	5.3	10.9	2.4	6.0	9.6	12.4	10.2	9.2	6.9	17.9	7.1	6.1	4.3	16.4	11.1	4.5	6.6	5.0	7.2	8.1	13.3	5.7	5.6	6.3	9.5	10.8	7.2	8.8	5.9	7.2	10.6	14.3	7.0	2.4	12.6	6.1	4.3	4.3	6.8	5.7	8.5	4.6	7.8	11.7	5.8	7.1	4.0	13.3	9.6	11.2	6.1	8.0	11.1	11.1	3.0	6.2	15.5	11.3	10.9	10.1	10.6	5.0	10.2	7.8	4.2	8.0	9.3	7.7	8.3	8.4	7.2	3.8	8.8	2.7	10.1	5.3	1.0	1.1	1.2	0.9	1.4	0.8	0.9	0.8	0.9	0.7	1.5	0.8	1.0	0.8	2.0	1.5	1.7	0.6	0.4	5.9	7.2	8.9	6.7	7.1	5.2	7.3	6.5	7.3	6.7	5.8	10.2	43.0	22.4	50.9	48.0	40.5	65.1	61.5	43.3	37.0	140.8	35.3	39.0	39.2	28.6	43.4	23.9	373.2	46.4	46.7	81.6	19.6	54.2	5.1	45.0	50.3	43.5	70.3	66.9	29.1	54.8	85.3	35.6	35.2	48.9	51.8	68.4	29.6	35.1	26.1	69.0	35.1	47.8	38.7	19.4	38.2	7.3	43.2	34.0	39.2	28.1	40.9	57.0	28.8	58.8	61.3	47.7	70.6	33.8	33.0	53.8	61.0	19.6	44.6	458.4	26.3	45.0	53.6	58.5	35.8	53.2	45.3	49.4	31.6	71.0	50.0	82.0
ZNF329	FLJ12586	ENSG00000181894	"Zinc finger protein 329"	Q86UD4	19	58126248-58155110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044373, HPA077958"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA044373: AB_10966569, HPA077958: "	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"prognostic favorable (8.58e-9)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.52e-1)"	3.9	3.9	4.4	2.7	5.0	6.4	6.0	6.4	6.0	5.1	5.4	4.5	1.6	5.2	5.2	2.9	5.2	2.8	4.5	4.8	4.5	6.0	4.9	3.5	3.9	4.3	4.4	5.5	3.1	9.0	5.3	4.1	4.8	5.0	3.0	8.5	3.4	4.4	1.4	4.4	3.6	4.9	3.6	4.6	3.5	7.7	4.3	5.8	5.7	3.2	4.0	4.7	3.9	5.7	3.6	1.9	8.6	15.3	6.6	6.9	0.1	4.9	10.2	4.8	3.5	1.0	2.8	2.3	2.5	8.8	3.1	1.2	1.3	6.7	5.9	1.8	11.7	7.7	2.5	2.8	6.5	4.6	6.9	7.4	7.1	5.0	10.3	8.1	6.9	5.5	1.8	10.0	7.4	1.0	7.9	2.8	6.5	2.0	6.3	4.4	8.4	2.4	5.6	7.4	5.6	5.4	7.0	0.9	3.9	10.9	8.7	2.5	3.7	13.3	3.6	1.1	0.0	5.7	18.5	5.8	2.8	0.1	7.8	3.1	0.9	4.1	1.4	1.0	2.5	4.1	2.7	2.4	1.2	4.8	4.4	2.6	2.8	3.5	0.7	3.0	1.3	1.4	4.4	5.0	6.4	6.0	4.8	4.5	4.3	4.4	4.8	3.6	4.3	5.7	4.2	3.2	0.5	7.2	5.2	1.7	2.1	1.7	2.8	12.5	3.4	3.2	6.9	7.2	2.8	3.7	6.2	2.2	3.4	0.9	1.9	2.9	2.2	4.6	5.1	4.6	2.4	5.2	14.5	1.6	1.2	3.1	1.5	3.5	2.5	6.2	3.9	3.7	1.5	8.4	13.5	1.6	0.0	2.1	2.1	2.0	2.8	1.7	0.0	4.7	0.5	5.7	5.2	11.6	9.5	0.9	1.3	1.5	1.0	1.9	0.9	2.5	2.0	10.0	0.0	3.9	3.6	7.6	6.7	1.3	1.6	1.5	4.4	4.0	1.3	1.7
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043973: AB_10961277, HPA054680: AB_2682571"	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	6.3	3.8	4.5	3.7	5.0	6.3	5.2	5.9	5.4	6.8	3.5	6.1	1.9	6.4	4.6	2.3	6.7	2.9	3.5	4.5	4.3	3.2	2.2	4.2	3.5	4.8	4.7	7.3	4.3	3.1	3.0	3.4	5.1	4.3	2.5	5.6	3.0	3.6	7.8	3.6	3.7	5.2	4.6	6.8	3.6	3.8	4.9	3.5	3.3	4.1	3.0	5.7	4.7	6.6	1.2	0.8	4.6	6.1	6.6	6.2	1.8	2.7	4.0	2.5	3.6	0.1	0.9	1.8	3.3	3.5	0.6	1.0	1.2	0.9	3.6	4.9	1.3	8.5	1.9	1.8	5.5	3.2	4.6	5.4	3.2	2.1	6.6	3.3	3.6	2.2	1.5	3.9	3.2	0.5	1.7	8.1	1.7	2.8	1.5	3.1	2.6	1.9	2.4	1.4	2.5	5.1	2.6	0.3	4.9	1.8	1.1	5.5	5.8	4.1	1.9	6.9	3.0	1.7	0.9	1.7	4.3	5.8	5.0	8.6	3.4	5.3	3.5	4.5	4.6	2.3	3.0	2.9	4.3	2.2	3.5	3.3	6.4	13.8	4.6	2.7	3.2	2.2	4.5	5.0	5.9	5.4	4.5	4.3	4.8	4.7	5.1	4.6	4.9	6.6	8.8	6.4	8.7	9.1	6.6	3.1	5.4	1.6	6.2	12.7	4.5	5.6	3.7	0.0	2.7	3.7	4.2	3.0	4.7	2.2	1.9	2.7	5.8	2.3	9.0	7.5	2.4	3.4	12.6	3.0	3.0	9.1	3.1	3.1	16.5	12.0	5.0	2.2	5.1	8.4	15.7	1.0	4.1	9.1	6.0	3.7	9.9	8.0	1.8	11.2	9.5	5.5	12.3	13.6	22.9	2.3	2.1	9.1	4.1	4.1	2.0	2.1	3.5	17.4	13.1	10.8	9.8	11.9	7.3	2.6	2.7	1.4	5.5	4.3	2.3	3.5
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.1;Inhibitory neurons: 29.1;Oligodendrocyte precursor cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 19.4;NTERA-2: 10.4;SCLC-21H: 12.9;SuSa: 22.0"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.5	7.9	9.3	0.9	9.8	1.4	6.9	15.1	10.3	7.9	10.2	3.7	2.0	6.7	9.3	2.1	9.5	4.1	2.5	8.2	10.5	6.9	5.5	3.4	1.4	11.6	10.6	15.8	8.9	1.7	16.1	5.1	9.7	12.6	2.3	15.7	6.4	5.8	0.9	2.0	3.6	3.3	9.3	3.2	5.2	7.7	10.7	2.9	12.3	1.7	1.1	5.1	5.5	10.2	0.1	0.0	15.5	0.1	1.0	0.1	19.4	1.4	0.1	1.2	0.1	0.0	4.0	0.0	0.0	0.4	4.8	0.0	0.0	0.3	0.6	0.0	3.3	5.1	0.1	5.7	4.1	0.1	0.0	4.9	0.0	1.3	0.0	0.7	0.1	0.1	3.5	0.0	0.1	0.0	0.0	9.1	10.4	2.6	1.3	0.0	0.0	0.1	4.2	3.9	12.9	7.3	0.0	0.4	0.2	22.0	0.1	4.5	0.0	0.2	6.9	0.1	0.0	1.2	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	9.3	9.8	15.1	10.3	8.2	10.5	11.6	10.6	9.7	9.3	10.7	10.2	1.2	9.6	4.5	43.1	0.2	0.1	3.5	1.1	2.8	11.0	5.6	4.3	1.9	1.5	5.5	3.7	2.1	4.1	0.0	0.4	5.9	4.5	0.6	2.5	6.2	1.7	0.0	2.1	15.7	1.3	3.7	3.9	7.7	1.3	2.5	11.1	2.2	0.9	1.7	10.1	29.1	1.2	0.0	0.0	0.3	1.4	2.8	1.2	0.0	3.7	0.0	7.8	0.0	33.2	7.5	1.7	0.3	1.9	0.2	2.2	0.6	3.4	7.9	12.3	0.0	5.1	2.4	5.7	7.5	1.4	0.0	1.0	0.2	6.5	1.8	1.6
ZNF337	dJ694B14.1	ENSG00000130684	"Zinc finger protein 337"	Q9Y3M9	20	25673195-25696853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Excitatory neurons: 30.4;Inhibitory neurons: 26.8;Oligodendrocyte precursor cells: 26.2;Oligodendrocytes: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044303, HPA064219"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nuclear speckles"	"HPA044303: AB_2678890, HPA064219: AB_2685215"	"unprognostic (2.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.54e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.36e-4)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.82e-3)"	15.8	13.4	21.5	7.4	21.9	10.3	16.1	28.6	25.5	27.4	23.0	26.5	5.9	21.5	16.1	14.8	26.2	6.9	14.4	20.9	20.6	19.2	11.6	16.6	11.2	20.6	20.3	31.2	13.1	10.4	24.4	7.7	20.5	27.4	8.9	25.9	12.7	13.2	12.5	13.1	18.6	11.7	19.2	21.7	14.0	9.3	20.6	15.3	18.8	8.6	9.5	22.4	19.7	25.3	10.0	17.3	14.0	9.9	11.2	14.3	11.9	8.4	7.3	6.3	7.8	3.6	9.1	12.3	7.8	7.8	12.8	16.0	9.3	27.9	8.7	4.4	7.2	7.5	13.9	15.8	9.6	6.9	8.1	13.3	24.1	7.5	22.1	16.7	10.0	15.7	6.8	10.6	12.5	11.4	18.6	13.4	3.7	5.3	12.2	11.8	12.8	6.0	6.6	11.1	11.2	12.0	8.3	13.4	11.1	17.2	7.7	9.4	13.5	14.1	7.2	9.4	11.3	14.9	8.3	4.3	6.7	5.9	11.2	0.0	1.6	3.2	4.6	2.7	5.0	2.3	3.7	4.2	2.7	1.8	5.2	6.1	0.0	3.9	1.5	2.5	2.5	2.6	21.5	21.9	28.6	25.5	20.9	20.6	20.6	20.3	20.5	19.2	20.6	25.3	8.6	6.4	15.4	26.4	4.3	2.0	5.6	3.4	4.6	8.4	4.1	5.2	1.2	2.8	10.8	3.7	2.1	3.8	4.5	1.2	3.9	4.3	1.4	6.7	8.9	5.6	5.4	1.3	30.4	3.1	2.0	5.4	2.0	4.4	5.1	9.8	3.3	3.2	3.3	6.7	26.8	4.2	0.0	3.1	1.1	0.3	7.2	4.3	1.8	25.3	3.1	7.9	11.3	26.2	29.3	2.7	1.0	5.7	1.7	5.4	1.6	1.9	15.5	13.0	0.0	6.3	4.8	8.1	10.2	3.6	2.4	2.3	6.2	5.4	2.6	1.9
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	9.2	12.6	5.8	12.2	7.0	12.2	17.9	17.1	7.6	14.5	9.6	12.2	13.4	15.1	10.9	9.3	14.9	11.8	9.0	5.0	7.8	15.3	16.3	10.1	14.8	9.5	7.1	14.8	16.9	17.1	14.0	11.4	9.9	15.1	15.8	20.6	14.9	14.3	13.9	13.9	13.7	10.3	6.7	14.2	16.7	4.3	6.8	14.0	15.7	15.8	16.2	11.0	10.3	8.4	16.3	9.1	16.2	14.1	7.8	9.8	12.8	7.3	7.1	9.1	10.2	9.7	14.5	31.5	7.7	9.8	5.2	10.6	19.3	12.6	8.5	18.9	22.0	25.2	18.6	13.2	7.9	36.0	20.2	8.6	22.5	6.9	10.1	17.0	7.5	17.7	13.5	16.5	9.3	10.6	15.0	8.2	16.4	8.2	10.5	12.9	11.2	14.8	12.8	15.0	12.6	19.8	11.3	12.3	6.4	11.2	14.8	9.5	7.3	8.0	11.7	9.0	5.8	13.0	17.1	18.5	7.4	19.7	3.7	12.7	3.6	6.1	5.4	5.0	4.7	6.4	4.7	3.6	3.4	6.2	5.8	4.6	15.9	4.7	6.6	6.3	3.6	3.1	5.8	7.0	17.1	7.6	5.0	7.8	9.5	7.1	9.9	6.7	6.8	8.4	28.4	60.9	73.0	39.8	47.5	11.9	33.0	25.6	19.4	38.2	33.4	28.6	70.6	31.5	49.0	27.6	33.3	28.4	43.1	27.1	25.4	34.9	4.6	62.8	19.3	31.6	34.1	30.3	47.4	29.2	20.0	23.5	25.5	37.7	33.6	47.6	21.4	39.6	19.4	30.3	63.9	28.2	18.3	22.8	16.8	6.7	23.9	26.1	10.6	58.1	46.9	21.1	38.1	56.3	81.5	32.0	29.6	24.0	32.1	38.9	22.0	39.3	80.8	31.8	26.3	32.7	22.7	15.3	18.9	18.7	12.8	35.6	34.6	33.2	27.5	38.4
ZNF33B	"KOX2, KOX31, ZNF11B"	ENSG00000196693	"Zinc finger protein 33B"	Q06732	10	42574185-42638570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (3.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.61e-2)"	4.7	9.8	3.9	5.9	4.9	3.1	20.6	9.8	5.1	9.5	9.5	9.1	8.9	11.7	7.6	7.4	18.6	8.6	5.3	4.8	6.6	18.5	10.3	8.9	9.4	4.9	4.0	23.5	34.1	15.2	10.0	7.2	5.1	12.6	10.4	10.4	18.6	10.4	3.9	12.2	9.7	5.2	2.5	10.3	14.3	4.7	5.3	8.0	18.3	4.9	8.9	9.0	9.0	3.7	13.2	3.3	8.5	8.8	3.1	0.4	10.6	8.1	6.2	5.1	7.1	7.3	14.9	19.9	4.8	3.1	7.7	10.9	16.5	5.6	5.7	11.8	12.4	7.9	12.7	11.9	3.6	18.8	6.2	5.1	20.1	3.1	17.0	13.4	4.4	10.8	10.9	14.7	3.1	5.7	7.5	4.5	9.3	6.5	7.7	8.0	8.5	8.5	13.4	17.2	15.3	14.9	5.1	10.5	5.1	7.7	13.4	5.7	5.3	2.6	12.3	4.5	8.6	9.5	15.5	6.1	1.8	13.9	2.4	19.4	7.5	7.1	10.7	6.7	15.1	20.1	15.4	10.8	6.7	15.4	19.5	13.7	2.4	8.3	5.5	11.1	13.4	9.0	3.9	4.9	9.8	5.1	4.8	6.6	4.9	4.0	5.1	2.5	5.3	3.7	10.0	80.1	37.8	14.0	17.7	4.8	18.0	5.5	18.2	15.4	26.0	27.8	31.5	34.3	30.0	20.2	10.4	18.6	13.4	9.7	21.5	27.0	2.4	37.2	6.0	14.1	25.3	17.1	25.6	36.1	16.8	10.0	14.8	14.5	8.2	23.8	16.4	10.8	8.4	10.1	48.2	17.6	4.1	13.6	3.6	3.8	20.5	9.3	7.2	36.5	17.9	10.2	21.6	30.7	14.1	25.8	21.4	11.7	15.2	13.0	21.2	27.0	47.6	9.6	0.0	9.0	8.5	9.0	11.3	11.8	4.0	11.5	17.0	22.6	18.5	12.8
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144772224-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725"	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.3	4.2	8.5	2.8	9.3	3.3	8.6	12.8	10.5	10.4	8.1	10.2	2.2	9.1	4.7	3.8	10.0	3.6	5.8	8.6	9.4	6.0	5.0	5.5	3.9	9.0	9.0	10.8	5.1	6.2	9.7	4.7	9.6	7.5	3.6	12.4	4.5	7.3	6.3	8.1	5.6	6.6	8.4	4.9	5.6	6.4	9.0	5.4	8.2	6.4	3.0	9.1	7.4	10.9	2.1	3.0	5.7	4.7	4.7	4.8	1.4	1.8	4.1	4.6	3.8	0.8	3.3	3.1	3.4	4.9	2.6	2.0	3.4	3.9	3.6	2.9	2.8	6.3	5.4	2.7	4.3	1.8	3.4	4.8	4.4	3.5	7.7	5.0	3.2	2.0	4.2	2.6	4.1	5.0	3.8	2.7	3.9	4.7	3.3	3.3	2.1	4.1	2.6	2.2	5.6	4.0	4.1	3.0	3.1	3.6	3.2	2.3	2.0	4.3	3.9	3.4	3.9	3.4	1.2	3.9	3.1	2.7	5.1	8.2	6.7	12.9	6.6	6.5	5.7	7.2	6.2	7.8	10.2	7.4	4.3	6.5	1.0	6.1	16.3	4.8	5.1	4.8	8.5	9.3	12.8	10.5	8.6	9.4	9.0	9.0	9.6	8.4	9.0	10.9	17.2	6.4	5.1	3.3	5.5	3.7	2.8	3.9	5.2	7.8	4.6	9.1	3.0	1.5	3.9	0.0	0.0	2.7	2.4	1.4	5.9	3.0	10.6	3.2	7.7	7.9	0.0	1.7	4.8	1.3	3.1	6.7	1.1	4.9	5.1	3.8	2.9	2.1	1.8	13.5	6.2	1.7	6.1	1.2	4.5	7.9	7.2	4.1	3.6	2.8	8.2	6.2	2.1	3.0	8.2	1.1	3.2	4.9	2.7	2.0	2.8	2.3	1.1	9.1	6.6	8.5	7.5	16.4	9.9	8.4	4.8	2.3	4.9	4.2	2.3	0.9
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	1.2	0.9	1.0	1.9	1.1	2.4	0.9	0.8	2.2	1.1	0.0	1.5	1.4	1.3	1.0	1.3	1.3	0.9	1.0	1.6	0.2	0.6	0.6	1.1	1.9	0.3	0.1	1.3	1.6	0.9	0.6	1.4	0.4	1.3	1.1	0.7	1.5	1.0	3.3	2.1	1.0	1.2	0.2	1.9	1.4	1.5	0.5	1.8	0.9	3.3	1.2	1.2	1.1	1.3	2.4	6.4	2.2	4.7	2.1	1.7	9.5	2.3	1.2	1.9	1.2	4.6	5.4	3.7	3.8	1.7	2.2	3.7	2.4	4.1	0.8	3.3	2.2	3.6	3.6	3.7	1.2	2.1	4.3	1.4	3.0	1.6	1.0	1.7	2.3	3.4	1.9	1.7	2.0	2.9	1.9	1.6	3.0	3.5	3.1	2.4	1.4	2.1	1.3	5.2	1.9	2.1	6.1	5.6	1.4	1.7	5.0	1.7	2.9	3.4	1.4	2.5	2.2	1.3	1.9	3.4	3.3	1.7	2.4	2.6	1.3	2.9	1.1	1.8	1.0	2.2	0.8	0.7	1.0	1.2	0.5	1.5	2.5	1.3	1.2	0.7	0.6	0.9	1.0	1.1	0.8	2.2	1.6	0.2	0.3	0.1	0.4	0.2	0.5	1.3	1.8	3.2	5.1	5.5	2.9	0.4	1.0	1.5	0.6	2.2	1.9	1.4	2.7	2.8	4.7	1.8	2.1	2.6	0.9	7.0	0.0	1.5	0.6	1.6	1.4	1.4	1.2	0.8	11.3	1.4	3.3	1.6	6.6	2.1	2.5	1.8	1.4	1.0	1.4	1.7	8.0	2.0	2.0	1.6	2.0	0.1	0.6	2.4	0.0	3.7	1.2	0.6	2.1	6.0	7.7	1.7	2.5	0.4	2.6	2.5	4.2	0.4	4.6	2.3	0.0	1.9	1.1	1.6	2.4	1.6	1.0	2.1	1.9	1.5	2.4	2.5
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.0;Inhibitory neurons: 14.2;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA030587: AB_10603246, HPA052438: AB_2681833"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	6.8	4.4	4.3	5.2	3.9	1.9	8.1	6.6	6.8	7.4	3.9	7.5	4.1	8.0	10.3	5.6	6.6	4.3	4.2	4.6	4.8	5.5	4.7	5.2	5.3	3.2	3.4	7.9	4.5	8.7	4.7	6.2	3.5	5.8	5.9	6.2	5.5	6.1	7.9	8.0	4.2	7.7	2.3	5.8	4.9	4.4	4.4	5.6	6.4	8.9	6.2	6.7	6.2	5.8	11.7	14.5	8.7	10.5	10.1	10.0	3.4	8.7	9.3	10.2	10.1	8.2	6.8	18.1	3.6	8.3	10.7	12.4	13.8	15.7	13.0	4.4	7.6	9.9	6.9	18.0	9.2	6.8	4.0	10.3	15.0	13.2	20.6	11.2	10.1	11.5	13.9	7.6	10.0	4.7	13.1	5.8	9.0	10.5	13.8	11.1	12.3	10.1	6.3	5.8	10.7	16.6	10.5	17.1	10.6	7.1	6.1	6.1	7.5	13.6	6.7	10.8	10.1	15.4	28.3	8.1	3.2	8.7	8.7	0.5	2.2	2.7	2.9	2.3	3.5	4.0	3.9	2.4	2.3	4.8	4.0	4.7	1.7	1.3	2.1	3.6	3.4	2.1	4.3	3.9	6.6	6.8	4.6	4.8	3.2	3.4	3.5	2.3	4.4	5.8	2.0	3.2	1.5	6.2	4.0	2.0	1.6	0.9	5.2	4.1	1.8	1.5	1.9	1.5	2.3	1.8	0.0	2.4	2.2	1.6	1.9	2.2	0.9	0.9	3.3	2.2	3.0	0.8	14.0	0.9	1.3	3.6	2.0	1.2	1.3	2.2	1.8	3.6	1.4	8.4	14.2	2.2	4.1	1.3	1.2	0.2	4.1	1.4	1.8	2.8	1.4	2.6	1.0	13.6	8.9	2.5	0.8	3.0	2.3	2.1	1.8	3.4	1.0	2.9	0.0	2.2	3.9	4.2	3.5	4.5	2.3	0.8	1.9	2.0	2.5	1.7
ZNF345	HZF10	ENSG00000251247	"Zinc finger protein 345"	Q14585	19	36850361-36913029	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"Early spermatids: 304.8;Late spermatids: 382.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA025816	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA025816: AB_10602354"	"unprognostic (1.55e-3)"	"unprognostic (9.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.17e-4)"	"unprognostic (6.14e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.87e-5)"	4.5	4.7	1.6	5.1	0.8	5.1	6.4	6.7	3.2	5.8	0.0	5.0	5.3	6.3	6.2	3.8	4.5	4.5	3.3	1.5	4.7	3.6	3.6	4.7	7.3	0.6	0.6	7.2	3.3	5.7	4.2	4.9	1.2	5.2	4.8	6.8	5.2	4.3	2.7	8.2	5.2	4.0	0.3	6.1	4.5	14.8	1.2	6.4	5.5	2.4	5.6	4.5	5.3	2.3	0.3	0.8	9.0	5.1	2.3	2.7	3.1	1.6	2.2	1.4	3.7	0.5	2.4	2.1	4.3	1.3	3.2	2.1	2.1	2.0	2.2	6.2	5.2	3.9	2.1	2.3	1.8	3.3	3.9	5.9	2.6	2.5	0.0	3.8	2.7	6.9	0.9	1.0	2.6	1.6	6.3	4.6	3.4	0.1	1.8	4.8	6.4	3.5	1.1	6.9	6.2	5.9	5.1	0.5	1.5	3.8	2.7	3.2	2.2	3.6	4.6	2.7	1.5	5.9	4.0	4.3	0.2	0.2	5.0	13.0	1.4	5.1	3.6	1.3	3.7	2.1	4.3	3.3	1.3	3.1	6.1	4.8	1.7	3.1	1.4	1.6	4.3	2.5	1.6	0.8	6.7	3.2	1.5	4.7	0.6	0.6	1.2	0.3	1.2	2.3	4.7	9.6	3.9	10.1	5.3	3.6	3.7	3.3	1.8	5.3	5.0	4.7	3.2	1.5	4.6	1.8	0.0	5.0	6.9	1.0	7.9	2.7	304.8	3.8	3.5	4.8	2.4	2.1	7.7	1.0	2.5	3.7	1.1	3.7	3.8	7.8	5.3	2.6	3.4	0.0	8.6	3.0	2.0	1.3	4.0	382.5	6.2	3.4	5.4	5.6	2.2	4.7	11.3	14.1	18.2	1.8	1.0	10.5	3.0	2.2	3.1	3.5	8.6	6.8	6.6	6.6	5.4	18.3	10.8	2.1	3.8	4.7	5.7	4.6	1.8	6.9
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Excitatory neurons: 36.7;Inhibitory neurons: 35.1;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	5.9	8.1	8.5	5.0	8.4	6.4	6.3	13.5	10.0	9.7	6.5	7.6	4.6	8.4	7.7	8.5	8.4	4.6	6.9	8.2	7.7	8.1	7.3	5.3	7.8	5.7	5.8	13.4	8.0	7.2	10.4	5.0	5.3	8.3	5.1	11.1	6.5	7.1	8.1	7.7	6.1	9.0	4.5	8.1	6.2	9.7	8.6	10.1	10.4	6.5	9.5	7.4	7.8	7.2	6.5	11.7	18.7	25.4	9.6	8.7	16.1	11.3	11.5	17.8	19.7	14.8	9.8	17.1	12.5	10.8	15.3	8.5	17.7	18.0	16.9	54.3	14.1	11.1	13.7	13.2	11.5	18.0	10.2	9.7	10.1	16.9	12.3	10.5	20.8	18.4	13.4	10.2	8.2	21.8	25.2	9.6	8.2	8.1	19.0	25.6	12.9	7.8	12.4	7.6	24.0	10.3	13.9	10.3	8.9	9.0	14.5	10.0	11.0	14.4	11.5	10.0	12.3	9.6	10.6	18.5	5.7	16.1	11.8	0.8	4.0	6.6	8.2	4.0	5.3	5.3	5.8	5.4	4.2	8.4	7.2	7.4	4.2	18.3	4.0	3.9	6.4	4.9	8.5	8.4	13.5	10.0	8.2	7.7	5.7	5.8	5.3	4.5	8.6	7.2	5.2	0.0	6.0	31.0	7.1	2.9	2.9	4.3	8.0	11.4	4.3	5.3	4.1	7.2	3.2	5.5	6.2	9.5	3.3	2.6	9.8	6.0	2.4	3.6	7.5	7.7	4.8	15.2	36.7	5.8	5.8	5.9	1.5	3.2	2.5	9.6	4.2	2.9	5.7	8.4	35.1	4.1	8.2	2.9	1.7	5.4	5.0	3.1	3.6	12.2	3.5	7.8	1.0	29.1	20.9	4.0	2.2	6.4	8.6	1.0	4.7	4.1	1.1	6.0	0.0	6.1	5.8	12.9	10.9	5.5	4.8	3.3	6.7	10.1	3.2	1.4
ZNF347	ZNF1111	ENSG00000197937	"Zinc finger protein 347"	Q96SE7	19	53124072-53159075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023448	Uncertain		Approved	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Microtubules		"HPA023448: AB_1859214"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.59e-3)"	4.8	4.7	6.7	5.7	5.3	19.3	5.1	17.5	6.8	4.7	0.8	3.6	2.7	6.2	5.5	3.8	3.9	6.0	4.5	6.0	7.7	3.5	2.0	5.0	5.8	6.9	5.3	6.3	5.3	4.6	2.9	5.0	6.4	4.4	3.7	14.9	4.4	4.8	3.6	6.8	3.1	4.9	1.9	9.5	4.2	3.8	5.8	5.7	6.8	3.6	4.1	3.7	3.5	15.8	0.8	0.8	7.9	13.2	5.0	5.4	7.4	8.6	8.6	10.0	11.8	1.3	2.2	7.6	3.3	7.3	11.2	3.7	0.9	1.5	12.8	1.5	5.8	1.4	5.1	2.4	3.1	1.7	7.7	6.1	0.6	7.4	0.0	3.5	2.5	4.6	6.4	2.3	5.2	0.9	12.9	3.9	9.6	0.4	4.0	3.5	0.3	1.7	4.0	20.1	5.7	5.9	1.3	2.6	3.4	10.1	7.1	3.5	4.2	12.5	8.1	6.8	12.4	1.1	7.1	13.4	2.0	1.4	7.1	3.8	1.1	1.6	1.8	0.9	1.8	1.9	1.5	1.6	1.1	3.0	1.9	1.6	6.8	3.7	1.5	1.9	1.8	0.8	6.7	5.3	17.5	6.8	6.0	7.7	6.9	5.3	6.4	1.9	5.8	15.8	16.2	19.2	12.4	5.9	6.0	2.0	4.9	1.0	3.4	10.5	3.5	4.2	7.3	4.3	6.8	3.7	4.2	3.1	1.5	3.8	1.9	2.9	0.3	5.5	7.8	15.9	1.2	3.0	7.7	4.0	3.7	6.5	4.6	6.1	3.8	11.7	11.7	1.3	2.7	8.4	10.8	2.5	2.0	3.8	2.8	0.8	5.3	3.5	1.8	4.7	3.4	4.0	8.2	8.5	14.9	3.5	1.1	3.8	2.0	4.6	2.9	1.4	18.6	14.3	0.0	11.4	5.9	3.0	5.4	4.2	2.0	3.4	3.9	16.9	2.8	3.0
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648732-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	3.9	2.7	2.2	1.6	2.4	1.9	3.1	2.9	2.5	3.1	1.4	4.1	1.3	4.3	2.8	3.9	2.8	1.7	4.0	2.3	2.4	3.5	2.0	2.8	1.4	2.3	2.5	2.3	2.8	2.0	3.5	1.4	2.4	3.4	1.6	2.5	3.1	2.1	3.8	3.3	2.9	3.2	2.1	3.1	3.2	7.1	2.3	1.3	3.1	2.3	2.4	3.6	3.3	2.9	3.2	2.4	6.2	8.0	4.0	3.2	1.1	3.9	5.4	6.7	6.4	4.3	1.4	2.8	1.7	5.4	2.9	2.2	0.3	5.6	6.9	0.1	2.2	9.3	4.3	0.2	3.6	9.3	6.8	3.3	4.1	6.0	5.3	3.3	5.4	0.0	6.3	2.6	7.4	1.9	0.2	3.0	13.9	2.3	6.7	0.1	6.6	4.9	3.6	9.0	3.4	8.8	4.9	3.0	0.8	5.1	8.0	5.7	5.7	7.1	5.2	3.9	7.8	7.1	11.8	1.6	6.1	4.5	5.6	0.0	1.7	0.7	0.9	1.9	0.6	1.5	0.2	1.0	1.8	1.9	0.4	0.5	0.1	2.3	1.8	0.7	0.1	1.0	2.2	2.4	2.9	2.5	2.3	2.4	2.3	2.5	2.4	2.1	2.3	2.9	6.6	6.4	8.7	6.8	5.3	2.8	3.9	3.0	1.8	4.9	4.8	3.4	3.2	2.8	3.3	1.8	0.0	0.3	3.7	2.8	1.9	8.1	10.2	2.2	4.2	9.3	2.4	3.8	7.5	8.7	0.1	5.8	2.6	3.5	0.0	5.7	5.0	1.5	3.8	6.7	8.5	2.4	10.2	2.8	1.4	6.5	1.2	3.2	1.8	4.7	3.6	4.4	7.2	8.0	11.2	10.3	3.3	4.5	4.0	4.3	2.0	3.8	3.4	6.4	0.0	4.8	5.5	30.7	11.7	3.0	2.8	0.4	2.6	5.7	3.0	3.3
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964340-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favorable (2.54e-4)"	6.6	4.4	5.8	5.4	7.3	26.2	13.8	8.6	6.7	5.5	4.1	6.6	5.4	6.4	8.2	4.7	5.8	5.2	5.1	6.4	6.5	7.0	5.3	6.3	9.7	6.0	5.7	8.3	4.5	9.2	4.8	9.3	6.1	27.5	9.1	9.7	6.4	6.3	4.5	7.5	6.1	5.8	5.8	9.0	7.3	6.3	6.5	9.0	9.8	5.9	9.1	6.2	5.2	7.2	0.8	4.4	5.6	6.8	7.5	6.7	1.1	4.6	6.5	4.8	9.5	0.0	3.5	2.1	3.6	5.5	8.8	5.8	4.9	6.5	6.6	0.0	10.5	8.6	7.5	3.9	6.3	2.2	10.1	9.5	9.9	6.4	6.6	9.4	5.5	3.5	2.3	0.1	5.8	2.8	8.5	10.2	3.7	0.5	6.8	4.0	8.0	6.9	7.6	11.9	4.7	6.3	0.0	6.0	5.0	7.9	9.8	7.7	5.9	5.2	3.7	3.1	4.7	1.6	2.8	2.7	1.0	0.1	5.6	65.3	11.2	26.9	16.2	12.7	16.4	16.8	15.3	15.6	13.6	17.2	17.7	14.2	30.8	21.5	16.2	8.8	13.4	8.1	5.8	7.3	8.6	6.7	6.4	6.5	6.0	5.7	6.1	5.8	6.5	7.2	9.1	0.0	7.3	4.6	13.1	5.9	11.0	11.1	5.7	9.9	6.0	5.3	6.6	2.8	10.7	9.2	12.5	12.2	12.9	5.1	7.9	6.7	13.0	4.5	4.7	8.0	7.3	2.5	4.2	5.3	9.9	7.1	3.6	6.7	12.0	9.7	6.4	3.1	7.8	6.7	4.1	5.9	16.2	9.5	12.0	3.4	11.1	10.8	12.4	6.5	11.6	7.9	23.7	4.0	9.1	6.0	5.7	6.0	7.5	14.5	7.6	3.9	7.8	13.1	0.0	7.2	8.4	10.2	5.7	3.5	7.0	23.1	15.1	6.8	3.8	13.4
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178711512-178730659	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.6"	"Low region specificity"	"Detected in all"							HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	8.3	5.3	7.8	7.7	7.6	9.4	8.3	7.4	9.3	9.5	6.8	12.4	4.3	8.6	7.6	6.9	8.8	5.8	7.7	7.8	6.9	11.7	4.8	8.1	8.4	7.1	7.3	7.6	11.1	8.1	6.5	8.5	7.3	9.7	5.8	8.5	6.3	8.4	7.5	7.5	8.2	8.0	6.7	12.6	7.9	10.5	7.7	8.4	10.8	8.1	8.8	9.9	8.3	7.9	7.6	5.8	12.0	31.9	20.4	16.4	49.6	8.6	11.4	11.7	12.5	8.7	12.5	10.1	11.1	7.9	21.5	14.9	4.5	37.6	17.8	13.7	13.8	3.1	8.0	1.1	15.4	0.0	8.3	12.9	22.9	10.3	20.8	15.1	11.3	13.5	2.5	0.0	17.2	15.4	15.5	10.2	10.5	7.0	15.0	11.6	2.1	6.5	10.9	7.6	13.1	14.3	10.9	12.3	17.0	15.7	10.1	14.9	8.8	13.2	8.6	7.5	7.4	3.3	7.2	6.3	0.5	2.3	16.9	4.5	6.0	15.6	4.9	4.0	6.1	5.4	4.3	5.5	5.4	3.5	4.8	3.6	15.8	6.1	4.1	2.0	4.4	3.6	7.8	7.6	7.4	9.3	7.8	6.9	7.1	7.3	7.3	6.7	7.7	7.9	10.7	12.8	7.4	8.8	7.5	5.0	11.7	14.1	4.0	9.0	8.2	9.3	6.6	4.3	11.3	7.3	14.6	12.8	12.6	3.7	13.7	11.3	18.8	5.9	9.0	9.0	4.8	7.8	18.6	7.6	14.6	9.5	3.6	5.7	6.3	14.3	4.6	1.5	8.9	6.7	10.9	2.7	8.2	7.7	8.2	4.7	6.8	8.2	10.6	10.3	7.6	9.2	16.5	12.5	13.3	7.2	1.4	10.5	3.2	10.7	4.1	17.0	9.5	10.5	6.6	10.1	9.4	36.2	12.0	4.8	5.5	12.2	9.2	10.9	4.3	7.7
ZNF354B	"FLJ25008, KID2"	ENSG00000178338	"Zinc finger protein 354B"	Q96LW1	5	178859953-178888122	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"brain: 142.5;choroid plexus: 99.2"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029056	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA029056: AB_10603006"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.24e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (2.88e-4)"	"unprognostic (6.72e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.15e-3)"	11.6	6.3	50.1	6.0	55.6	4.3	12.0	81.0	142.5	10.8	99.2	10.1	6.3	9.7	5.5	6.4	9.0	5.5	5.7	41.0	33.5	8.4	6.0	7.7	7.8	80.5	33.1	9.3	10.0	6.8	8.1	14.0	58.4	10.0	5.4	11.1	8.1	7.5	4.8	7.5	7.9	6.5	35.6	9.1	8.0	5.2	55.9	6.8	11.6	5.5	6.8	8.4	8.7	72.3	5.2	4.0	7.4	16.9	7.2	6.9	18.9	6.4	5.8	6.1	7.0	5.1	9.1	0.0	6.7	5.7	8.4	10.6	9.4	10.8	7.4	0.0	7.7	6.0	15.6	3.8	6.2	0.1	4.1	6.4	6.4	5.0	7.6	9.3	5.5	8.9	5.0	0.0	6.6	5.8	9.8	13.5	3.9	2.5	5.4	9.1	4.0	5.8	5.3	6.2	8.3	8.6	7.7	6.8	4.9	7.2	6.0	10.4	6.5	10.7	9.6	3.9	4.8	3.7	5.7	0.2	0.7	0.0	5.7	2.0	1.8	0.7	3.1	1.1	2.8	2.6	2.1	1.7	1.6	3.8	2.6	2.7	0.5	1.3	1.2	2.0	2.0	0.9	50.1	55.6	81.0	142.5	41.0	33.5	80.5	33.1	58.4	35.6	55.9	72.3	21.5	9.6	4.8	3.3	4.0	4.6	6.9	2.4	4.6	6.8	5.3	6.5	6.9	4.3	6.2	7.3	8.4	20.4	5.3	1.0	0.0	4.6	1.2	2.8	8.7	10.1	0.0	2.1	6.0	2.3	6.7	8.0	6.1	3.7	0.0	7.7	8.9	2.0	4.9	11.8	5.7	2.4	0.0	3.5	4.9	0.1	5.0	4.4	0.0	4.7	3.2	3.5	12.3	4.0	6.5	2.1	0.8	5.3	2.6	5.8	1.7	2.4	5.2	6.5	0.0	9.8	7.0	10.4	11.1	3.3	5.4	34.6	5.6	7.8	1.8	3.9
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060373-179083977	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.8"	"Low region specificity"	"Detected in all"							"HPA030904, HPA068570"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030904: AB_10603842, HPA068570: "	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	3.2	2.2	2.7	2.4	3.7	0.6	4.0	6.1	2.9	3.6	1.8	3.1	1.2	5.1	1.8	2.0	3.6	2.6	2.8	2.3	2.6	2.1	1.4	2.6	3.4	3.0	3.5	7.0	2.0	3.1	1.2	3.2	3.2	3.5	1.6	6.4	2.1	3.3	2.2	1.9	2.0	3.8	2.9	3.3	2.0	2.2	3.4	4.4	4.7	4.3	3.4	2.5	2.3	4.4	1.0	1.4	11.1	17.8	5.6	9.0	0.0	5.0	4.3	5.4	6.1	0.0	2.2	0.0	5.9	5.4	9.0	3.4	0.0	1.7	10.2	0.0	0.1	0.0	0.5	0.0	5.3	0.0	2.4	6.8	1.6	5.4	0.0	1.7	2.6	0.0	0.1	0.0	6.5	0.6	10.6	0.0	7.7	0.8	0.0	0.0	0.0	0.0	2.0	0.4	6.7	11.2	7.8	0.1	5.2	4.7	4.6	4.2	3.3	0.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.1	0.1	0.5	0.2	0.5	0.3	0.7	0.5	0.2	0.3	0.7	0.6	0.0	0.3	0.6	0.0	0.5	0.3	2.7	3.7	6.1	2.9	2.3	2.6	3.0	3.5	3.2	2.9	3.4	4.4	6.4	3.2	3.1	10.4	2.6	0.9	0.6	1.4	2.8	10.5	1.7	3.0	6.1	4.3	2.3	0.0	0.0	2.2	2.2	0.1	0.0	1.3	0.4	1.3	5.5	4.3	0.0	2.1	8.0	0.9	1.4	5.1	0.5	1.3	1.3	7.4	4.6	0.9	1.7	16.8	2.5	0.5	2.0	1.6	2.2	0.4	3.1	1.7	1.8	4.7	0.6	5.4	1.0	17.6	16.2	0.7	0.1	5.7	0.7	0.6	0.2	0.6	1.3	5.0	6.6	7.0	3.9	2.3	1.3	2.2	0.9	0.5	2.2	4.3	0.7	0.3
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Granulosa cells: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 47: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	70.6	57.4	82.5	12.0	73.1	2.2	58.4	64.8	109.9	75.5	47.5	107.9	29.5	69.8	28.0	31.9	62.1	31.9	109.4	79.3	70.9	52.8	67.0	50.6	10.5	77.8	81.7	88.6	50.5	49.6	60.9	18.3	69.7	78.6	18.3	11.8	51.3	43.8	175.5	38.8	47.9	37.4	68.3	39.6	67.9	12.6	88.4	14.1	59.9	147.0	7.9	88.4	54.3	79.7	32.5	21.4	39.7	63.3	83.2	91.8	33.9	12.0	78.2	53.7	47.0	9.4	22.6	0.0	45.7	64.8	8.5	12.4	16.5	30.8	17.2	0.1	35.0	6.2	24.9	13.3	91.0	0.9	0.3	80.3	57.2	25.4	22.0	80.0	57.1	0.0	16.7	0.0	48.2	16.0	0.1	23.5	40.9	13.4	37.4	35.8	21.2	3.5	28.2	13.8	43.8	87.1	15.1	12.5	43.8	25.5	9.5	16.9	27.1	34.4	24.8	51.6	18.4	41.8	24.8	0.1	31.7	0.0	48.6	1.5	0.5	0.4	0.6	0.5	0.4	0.1	0.1	0.3	0.2	0.7	0.4	0.7	0.0	0.2	0.1	0.4	0.0	0.2	82.5	73.1	64.8	109.9	79.3	70.9	77.8	81.7	69.7	68.3	88.4	79.7	29.5	9.6	11.1	11.8	4.6	7.8	11.8	7.1	2.2	20.8	32.8	37.1	126.5	20.0	5.5	16.5	14.6	3.3	6.5	38.8	5.9	13.0	3.8	9.4	28.2	22.1	36.5	0.8	5.8	16.8	5.1	29.2	8.6	14.2	14.7	178.1	32.5	43.0	10.9	50.5	8.5	27.8	8.2	21.1	10.8	7.7	37.9	13.3	5.4	7.5	3.8	48.8	1.0	8.5	14.9	16.0	21.7	37.2	3.4	11.3	48.3	30.7	3.3	20.7	13.1	22.1	27.6	0.7	1.2	3.2	3.7	3.0	3.6	23.9	24.7	12.8
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256492-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	15.7	12.0	18.4	8.5	17.2	6.7	15.5	17.2	23.1	19.5	8.5	18.9	7.3	22.0	10.2	12.6	16.3	9.1	20.2	16.9	15.6	15.4	8.9	12.6	9.4	18.3	15.4	17.0	13.5	11.9	17.7	11.3	14.3	20.1	5.5	6.3	16.4	13.3	19.7	17.7	11.6	11.7	12.7	16.2	13.7	7.6	18.0	12.2	16.3	11.3	6.7	18.6	15.0	15.8	6.3	10.3	43.7	17.4	11.3	7.9	27.8	8.6	10.3	10.7	11.3	10.6	21.2	3.0	17.1	11.2	3.3	20.6	10.2	5.0	4.5	18.0	7.5	16.1	6.1	13.2	10.1	7.3	12.3	16.9	12.2	4.7	4.1	10.8	14.8	21.2	1.6	5.5	8.3	15.7	23.9	12.9	23.9	3.9	8.4	39.4	10.4	1.5	8.6	10.2	15.4	46.4	24.8	7.8	39.9	18.5	7.7	19.9	21.0	6.5	8.2	15.2	5.6	15.8	15.3	3.4	5.1	6.7	19.4	1.9	1.9	2.6	1.8	1.7	1.3	1.1	1.3	1.6	1.4	2.9	1.2	1.2	1.4	1.7	2.0	3.5	1.1	1.3	18.4	17.2	17.2	23.1	16.9	15.6	18.3	15.4	14.3	12.7	18.0	15.8	15.6	9.6	12.4	13.1	9.2	10.1	4.7	6.2	20.5	12.8	11.0	11.2	25.5	5.7	7.9	11.0	0.0	11.7	16.6	2.6	1.9	6.6	2.5	5.2	12.0	13.9	1.8	3.4	14.3	7.3	5.9	11.8	3.6	7.6	10.1	15.3	18.2	6.9	10.2	8.4	17.7	4.4	6.1	13.9	5.0	8.0	13.7	11.2	8.8	19.7	9.9	9.2	10.3	26.7	14.3	4.3	10.7	21.4	7.5	1.9	7.3	11.4	2.4	4.9	6.6	12.4	16.7	1.2	5.0	11.4	9.5	3.6	10.6	7.7	6.1	2.9
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	Q70YC5	10	62374192-62480288	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;esophagus: 10.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6"	"Group enriched"	"Detected in many"	9	"gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9"	"Group enriched"	"Detected in many"	62	"NK-cells: 6.4;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052446	Supported		Approved	Vesicles,Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centrosome"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.1	1.3	1.0	0.1	2.8	0.0	0.3	1.5	22.7	0.9	0.0	0.0	0.1	0.1	0.2	10.2	0.1	0.3	1.0	8.3	0.0	0.1	0.0	0.7	0.0	0.0	3.2	0.0	0.4	5.6	1.6	0.1	0.0	1.8	0.1	5.1	1.1	2.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.5	8.0	0.5	0.6	0.1	1.4	0.8	1.1	16.6	6.3	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.8	2.6	2.1	0.0	1.0	0.0	0.2	3.1	8.4	22.3	0.0	0.4	3.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.9	6.6	0.9	0.0	0.0	0.0	5.5	2.1	0.7	0.0	0.9	0.0	13.9	0.0	0.2	0.0	0.3	2.8	0.1	1.2	1.1	0.2	0.6	0.0	0.0	0.0	0.0	1.1	6.1	0.0	18.6	0.0	0.0	0.0	12.9	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	2.7	0.0	0.0	0.4	2.7	0.0	6.4	0.0	0.0	5.9	0.8	1.0	2.8	1.5	22.7	8.3	0.0	0.0	3.2	0.0	0.0	8.0	16.6	0.0	0.0	0.0	15.3	0.2	0.5	3.7	0.6	0.0	13.5	0.3	0.3	2.6	1.5	0.1	3.7	2.1	0.0	2.8	0.0	0.0	0.2	0.5	0.3	0.2	0.2	0.0	0.0	112.7	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.1	18.5	23.4	0.0	0.0	0.3	1.1	0.3	0.0	0.4	0.0	6.5	0.0	2.7	0.0	113.6	195.5	0.9	0.0	0.0	1.9	1.2	0.0	0.7	0.1	5.3	0.0	0.8	0.8	0.1	0.7	0.0	0.4	0.0	3.9	0.2	0.0	6.0
ZNF366	FLJ39796	ENSG00000178175	"Zinc finger protein 366"	Q8N895	5	72439903-72507410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cone photoreceptor cells: 31.3;Endothelial cells: 18.3;Langerhans cells: 9.3;Microglial cells: 54.4;monocytes: 14.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"myeloid DC: 10.4"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.3;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023128, HPA023526, HPA074074"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA023128: AB_1859223, HPA023526: AB_1859224, HPA074074: "	"unprognostic (3.49e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.29e-2)"	5.8	0.8	6.1	3.4	5.0	0.1	3.2	4.5	5.6	2.8	2.4	1.4	1.5	3.1	0.7	1.8	2.4	2.3	3.8	4.1	4.6	2.1	1.0	2.6	5.0	5.8	5.5	0.8	0.7	1.1	0.4	8.9	6.0	0.9	1.5	0.5	0.8	1.5	5.0	2.2	1.9	3.9	4.1	6.4	1.4	0.5	7.1	3.1	2.2	5.6	4.0	1.7	1.0	4.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.5	6.1	5.0	4.5	5.6	4.1	4.6	5.8	5.5	6.0	4.1	7.1	4.5	19.0	0.0	0.6	0.0	0.1	0.5	0.4	0.0	0.6	0.4	0.1	0.3	1.6	0.0	0.6	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.4	0.5	0.0	0.3	0.0	0.0	4.6	9.3	0.5	0.3	2.4	0.0	54.4	14.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.7	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.0
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418370	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	1.4	0.6	0.7	3.7	1.3	26.1	1.7	1.4	1.3	1.1	0.2	3.0	2.9	1.1	0.1	2.4	0.7	1.0	2.1	0.7	1.0	3.0	10.8	1.1	4.6	1.5	1.4	1.0	1.4	1.6	0.3	1.9	1.4	1.2	3.3	1.3	0.7	0.4	1.5	3.5	3.0	2.4	0.9	1.3	2.1	6.1	1.3	8.7	1.1	2.7	4.7	1.5	1.2	2.7	25.4	10.3	9.9	8.9	3.8	5.3	13.4	34.6	20.4	16.9	20.0	6.4	17.5	19.2	14.4	16.5	12.6	30.5	11.6	12.6	19.9	21.2	10.0	14.0	19.1	5.3	0.0	19.8	16.5	0.9	0.8	13.7	6.9	3.7	6.3	13.3	13.0	45.4	21.7	16.9	30.4	16.1	6.7	27.9	16.7	15.3	49.9	11.7	4.9	16.8	17.4	12.0	15.3	18.1	10.6	8.0	9.4	17.3	5.7	27.6	15.8	25.6	26.6	17.6	32.0	7.8	16.7	17.0	23.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	1.3	1.4	1.3	0.7	1.0	1.5	1.4	1.4	0.9	1.3	2.7	1.1	0.0	0.0	2.9	3.8	9.9	1.3	0.4	10.8	0.7	2.2	2.3	2.6	0.0	0.9	0.0	0.0	3.2	2.5	2.4	0.0	0.5	0.7	0.6	1.1	2.0	0.0	22.3	5.1	1.2	4.2	1.7	2.6	1.8	0.0	4.7	1.1	3.8	1.9	0.0	5.3	3.6	0.0	2.1	2.6	0.8	0.6	8.3	3.6	2.8	0.1	0.6	1.0	3.0	7.9	0.7	0.5	0.7	9.6	0.6	0.9	2.5	0.0	1.5	6.6	2.0	3.6	10.3	1.7	10.9	6.5	0.8	5.0	0.3	5.6	1.1
ZNF37A	"KOX21, ZNF37"	ENSG00000075407	"Zinc finger protein 37A"	P17032	10	38094334-38150293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003172	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA003172: AB_1080709"	"unprognostic (8.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.09e-2)"	4.9	5.6	5.9	6.2	6.0	3.1	5.7	11.3	7.8	6.3	4.3	5.6	4.8	7.2	5.8	3.7	5.2	4.5	4.3	6.3	8.0	5.8	4.9	4.8	5.9	5.5	5.0	7.5	8.7	9.7	8.6	4.8	5.9	5.7	4.8	16.6	7.6	5.6	3.7	6.3	4.6	5.6	3.6	6.0	5.6	2.4	6.7	5.8	8.1	5.1	6.0	4.4	4.2	8.8	15.8	7.9	7.0	13.2	10.5	10.2	7.6	11.9	4.5	5.4	7.2	6.4	4.5	23.1	3.5	6.6	7.4	6.3	13.2	10.0	8.4	14.9	12.5	23.3	9.7	9.1	9.0	24.7	14.4	7.8	16.4	9.3	7.7	10.8	7.2	10.8	15.4	15.9	11.7	3.7	14.0	3.7	6.1	5.5	13.0	10.0	19.0	4.6	5.7	6.1	5.6	9.6	8.2	6.6	6.7	7.4	12.1	7.6	12.4	10.1	10.9	9.8	11.6	17.8	20.5	8.9	6.7	17.3	6.5	1.3	1.0	1.0	1.5	0.8	2.0	1.5	1.8	1.6	1.0	2.6	2.1	1.8	0.7	2.7	2.3	1.2	1.1	0.7	5.9	6.0	11.3	7.8	6.3	8.0	5.5	5.0	5.9	3.6	6.7	8.8	21.8	25.6	43.6	31.6	26.0	8.2	14.7	11.0	18.8	66.1	14.4	16.4	29.6	15.7	18.8	11.0	54.2	10.2	23.2	7.6	1.9	18.1	3.7	15.0	30.0	26.3	41.9	26.3	46.7	11.8	6.8	27.0	16.3	14.9	40.5	56.9	22.9	10.4	7.1	42.1	57.7	10.4	10.2	11.3	6.4	1.4	28.3	13.8	5.4	40.3	16.6	27.4	30.9	64.3	85.5	11.9	8.3	28.2	34.4	17.0	12.6	7.3	12.6	55.1	13.1	53.5	25.7	22.2	15.2	14.7	6.0	3.8	18.5	48.5	12.5	9.3
ZNF382	"FLJ14686, KS1"	ENSG00000161298	"Zinc finger protein 382"	Q96SR6	19	36604817-36634114	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;retina: 18.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.8;Early spermatids: 23.3;Excitatory neurons: 19.1;Horizontal cells: 50.5;Late spermatids: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049259	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA049259: AB_2680694"	"unprognostic (5.43e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.76e-5)"	"unprognostic (8.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.22e-2)"	1.7	2.8	2.6	1.9	4.2	0.9	1.6	12.1	4.3	1.9	0.1	2.8	0.6	2.3	2.0	1.5	2.7	1.4	4.0	3.7	1.9	1.8	0.7	1.3	2.7	0.2	0.2	2.1	1.3	2.2	5.4	2.3	0.0	1.7	0.8	18.0	1.5	1.4	0.9	0.6	1.6	2.1	0.0	2.9	1.1	3.8	4.3	3.2	2.8	2.6	3.2	1.8	1.0	3.9	0.2	0.1	4.5	6.4	1.8	2.5	1.5	2.0	0.6	5.9	6.0	0.1	0.3	4.0	4.2	2.5	2.5	0.1	5.8	0.1	3.7	11.3	2.6	6.6	0.3	1.6	5.0	0.9	7.6	3.4	0.2	3.3	0.1	5.9	0.7	7.8	0.1	0.2	3.9	0.6	9.3	2.1	2.9	0.0	2.2	0.4	1.9	1.8	1.6	0.1	0.5	8.6	0.3	0.3	3.7	6.5	2.7	0.7	0.1	1.4	0.3	0.3	5.9	9.9	0.8	0.4	0.0	0.1	3.5	2.4	0.5	3.3	5.2	0.6	7.7	9.0	7.7	5.4	2.1	5.3	6.3	7.3	0.9	4.4	0.6	2.2	4.9	2.6	2.6	4.2	12.1	4.3	3.7	1.9	0.2	0.2	0.0	0.0	4.3	3.9	2.4	3.2	0.0	7.5	3.5	0.1	0.9	0.5	2.2	23.8	1.7	2.0	13.2	1.5	1.0	3.7	10.4	2.0	1.3	0.1	5.9	3.2	23.3	3.5	2.3	2.4	0.0	4.8	19.1	0.4	1.0	1.7	0.5	1.9	0.0	6.8	2.5	0.3	2.9	50.5	16.0	0.1	0.0	0.8	0.8	20.5	0.6	1.2	1.8	1.9	0.7	4.3	0.0	8.0	8.5	0.2	0.3	1.2	0.3	0.4	0.0	1.8	2.6	13.7	0.0	2.6	2.7	6.5	3.0	0.5	0.0	0.1	3.5	2.9	0.0	0.3
ZNF383	"FLJ35863, Zfp383"	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	3.6	3.2	2.5	3.4	4.4	3.5	5.1	8.5	3.4	4.1	1.5	3.3	3.5	3.8	3.6	3.6	3.7	2.9	4.9	2.7	3.5	4.4	3.2	3.5	6.1	3.7	3.1	5.8	2.9	4.4	2.8	3.2	3.8	4.1	3.5	5.4	4.0	3.9	7.4	5.4	3.4	3.8	2.0	5.1	3.9	3.9	3.7	5.7	5.3	9.0	6.0	3.4	3.4	7.1	2.9	6.8	4.6	7.1	5.7	5.8	3.1	4.1	5.6	4.0	5.9	3.1	3.6	4.0	5.9	3.9	3.8	3.0	3.6	5.5	5.9	5.4	4.2	5.7	5.2	2.6	6.1	6.9	6.2	7.1	4.6	3.9	7.6	5.1	3.7	5.5	3.2	2.1	5.0	1.4	6.3	3.2	4.2	5.8	1.9	4.4	8.4	3.7	3.6	8.2	5.2	4.1	6.6	3.8	5.7	5.8	4.6	4.1	2.3	5.0	3.5	3.7	4.0	6.5	6.4	7.9	0.7	3.2	4.7	3.7	3.2	5.3	5.8	3.9	8.2	8.0	5.4	7.1	3.3	10.7	8.6	6.9	3.5	4.8	4.9	3.1	6.0	3.9	2.5	4.4	8.5	3.4	2.7	3.5	3.7	3.1	3.8	2.0	3.7	7.1	7.2	3.2	4.4	7.5	10.2	2.7	4.0	3.4	5.7	9.8	3.7	5.2	12.8	7.2	2.5	1.8	14.6	3.8	7.5	3.8	1.9	3.5	8.9	3.6	5.4	5.1	2.4	11.0	7.4	3.6	4.8	5.8	4.6	3.7	5.7	7.8	6.4	2.2	3.8	15.2	8.7	3.8	2.0	6.3	3.5	3.0	6.5	4.5	8.8	4.7	5.5	6.2	10.3	9.5	10.4	2.7	3.6	7.5	3.8	5.1	5.8	3.9	2.5	9.9	13.1	9.9	6.1	5.8	5.2	3.9	3.3	4.9	8.5	6.6	4.8	4.1
ZNF384	"CAGH1A, CIZ, NMP4, NP, TNRC1"	ENSG00000126746	"Zinc finger protein 384"	Q8TF68	12	6666477-6689572	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004051	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004051: AB_1859228"	"unprognostic (1.90e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.13e-2)"	31.4	33.2	21.9	36.2	23.2	59.9	30.7	26.9	26.4	39.8	22.9	35.1	35.1	40.6	25.1	27.9	35.8	26.1	25.9	22.5	23.8	28.9	26.3	28.6	36.0	23.5	22.3	46.3	29.8	34.7	32.6	32.5	22.3	31.9	32.7	30.2	29.9	30.0	36.7	32.1	36.8	37.8	20.8	40.2	30.9	31.7	22.8	46.7	38.4	32.3	37.6	36.7	30.8	25.4	35.4	66.2	79.9	53.7	55.2	38.9	107.1	50.0	46.4	47.3	50.3	73.3	73.6	82.9	18.5	56.4	68.5	46.6	59.8	45.9	53.6	150.8	54.0	94.9	93.0	38.6	38.9	91.2	67.5	43.0	43.6	58.3	90.1	88.9	41.5	57.4	50.6	27.9	52.4	54.8	82.6	58.3	155.0	64.1	28.7	81.0	85.4	32.2	41.9	93.6	24.8	80.4	51.8	68.4	44.1	133.5	18.0	74.5	51.9	51.6	71.4	40.9	59.6	38.5	39.6	149.9	51.0	32.4	60.0	3.7	8.5	15.4	16.4	9.8	13.4	9.7	10.7	13.4	11.5	8.0	10.2	11.6	14.4	17.0	15.3	7.6	14.5	8.3	21.9	23.2	26.9	26.4	22.5	23.8	23.5	22.3	22.3	20.8	22.8	25.4	19.2	0.0	8.7	17.3	12.5	7.9	2.6	4.4	12.0	6.0	11.1	11.9	2.6	10.0	4.7	1.8	10.4	6.7	17.9	16.5	0.0	4.6	4.3	10.2	12.9	10.7	3.6	8.0	10.3	5.0	6.8	8.2	12.8	13.5	5.7	14.7	8.9	8.3	7.0	0.0	10.4	11.8	2.0	16.6	6.0	2.7	8.4	8.6	5.4	6.5	9.9	6.1	7.2	9.0	11.8	6.8	14.4	8.6	11.4	4.8	10.6	4.3	5.6	7.8	0.0	9.3	9.3	7.1	6.5	10.7	9.8	7.3	13.2	9.0	13.4	4.6
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412218-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.0;testis: 15.1"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 1766.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	8	"cerebellum: 44.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.8;hTERT-RPE1: 5.4;LHCN-M2: 5.3;PC-3: 5.3;RPTEC TERT1: 15.1;U-87 MG: 21.1"					"Low region specificity"	"Detected in all"			HPA036190	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	3.8	0.2	2.6	1.4	4.5	0.3	2.2	44.0	5.4	1.8	0.0	0.8	0.3	1.1	0.5	2.0	0.7	2.7	1.8	1.7	2.5	1.4	0.1	0.6	0.8	3.3	4.5	0.6	0.6	0.2	0.1	0.0	3.6	1.3	0.5	7.3	0.7	1.1	1.0	0.7	0.5	1.7	1.5	0.3	0.4	15.1	3.1	0.7	0.5	3.3	1.0	2.7	1.2	5.3	0.0	0.0	0.3	0.0	2.0	4.3	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	5.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	15.1	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.1	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	2.6	4.5	44.0	5.4	1.7	2.5	3.3	4.5	3.6	1.5	3.1	5.3	82.2	12.8	13.4	17.3	1.4	9.7	0.7	6.2	1.8	58.8	1.5	6.3	3.6	1.5	19.2	1.8	8.4	0.3	1.4	0.9	27.4	0.6	174.9	0.2	1.9	89.0	0.0	12.6	267.5	0.7	0.2	20.5	0.0	0.3	5.1	1.8	2.2	5.8	0.4	323.0	1766.6	0.7	0.0	0.0	14.0	274.5	16.8	4.9	12.4	64.6	0.6	114.3	1.0	159.3	12.7	1.4	0.6	13.5	0.3	1.7	2.3	6.6	4.4	31.0	13.1	22.0	20.2	50.4	2.0	0.6	7.7	0.1	1.5	34.3	0.7	1.0
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 52.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 2.1;basal ganglia: 3.1;cerebral cortex: 3.3;hippocampal formation: 2.8;white matter: 2.2"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050886	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA050886: AB_2681262"	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	2.3	2.1	2.1	0.9	3.1	0.3	3.3	0.5	3.3	3.6	0.0	1.6	0.8	3.1	3.1	1.8	3.9	1.3	1.1	2.8	0.0	2.8	0.3	1.9	1.9	0.4	0.0	5.0	2.1	3.7	1.7	1.4	0.1	2.5	1.7	2.1	2.2	3.4	0.6	1.8	1.1	2.4	0.0	2.3	1.6	4.9	0.3	1.4	4.0	0.8	1.7	1.7	1.5	2.2	4.9	0.7	2.9	10.2	1.2	1.6	5.9	1.2	0.9	1.7	3.9	2.7	1.0	0.0	4.3	1.1	3.4	1.6	5.8	4.5	2.7	0.0	3.5	1.8	0.2	0.9	1.9	5.4	2.5	4.9	5.7	0.3	4.5	3.5	0.2	8.1	8.1	0.0	0.3	1.0	6.4	7.6	3.6	0.7	3.2	0.0	0.0	1.3	1.1	1.9	1.1	4.7	0.0	6.7	0.5	4.7	1.1	4.6	0.6	5.5	1.7	0.3	3.7	3.1	8.1	0.0	0.2	0.5	6.0	0.1	0.0	0.0	0.3	0.0	0.7	1.4	0.5	0.2	0.0	1.3	1.0	0.7	0.0	0.3	0.0	0.4	0.1	0.2	2.1	3.1	0.5	3.3	2.8	0.0	0.4	0.0	0.1	0.0	0.3	2.2	1.7	0.0	1.1	2.3	1.2	0.9	0.5	0.7	0.6	2.2	1.8	1.7	1.0	0.0	2.9	1.8	0.0	2.4	0.1	0.1	0.0	1.0	52.5	7.0	2.4	2.0	1.8	1.3	12.1	1.4	1.1	2.4	0.0	1.7	0.0	3.9	1.8	0.0	1.1	3.3	6.7	0.2	2.0	0.0	0.6	4.7	1.8	0.4	0.0	3.7	0.0	4.4	0.0	7.5	1.7	1.2	0.6	2.6	0.3	0.2	0.0	1.3	12.4	0.9	0.0	1.6	1.3	6.5	2.8	1.3	0.3	0.3	0.6	1.9	1.1	0.4
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF395	"DKFZp434K1210, HDBP2, PBF, PRF-1"	ENSG00000186918	"Zinc finger protein 395"	Q9H8N7	8	28345590-28402701	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049382, HPA076275"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA049382: , HPA076275: "	"unprognostic (1.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (9.35e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.42e-2)"	33.0	18.5	21.9	14.4	22.1	37.5	30.5	14.9	20.8	23.1	27.6	25.7	20.9	17.4	13.9	47.6	27.2	14.5	27.2	18.3	17.3	23.4	37.0	19.7	21.3	25.7	18.5	53.6	47.5	17.7	16.4	33.9	19.3	23.7	13.9	27.1	38.8	17.5	16.3	42.9	24.7	9.5	19.4	21.8	26.2	10.9	26.7	18.9	18.6	13.9	25.2	26.3	29.3	20.7	140.0	19.4	17.9	48.7	13.9	19.6	52.6	16.2	28.4	13.2	30.6	31.0	24.0	66.1	56.2	25.7	30.5	29.3	16.1	40.6	25.6	11.0	12.7	16.4	3.8	6.5	14.2	7.3	6.6	34.9	55.3	2.3	34.3	37.5	6.5	21.2	16.9	14.2	18.3	23.7	31.6	21.7	28.1	33.9	22.7	29.3	19.7	22.1	30.6	26.4	48.1	50.9	3.8	10.3	26.5	15.8	18.9	16.3	1.5	26.6	32.9	15.1	6.6	17.4	9.6	42.9	72.8	13.6	21.5	10.0	4.3	11.5	4.6	0.8	4.4	11.4	5.5	5.6	1.6	13.7	7.1	4.8	1.9	3.7	0.7	6.2	2.4	2.2	21.9	22.1	14.9	20.8	18.3	17.3	25.7	18.5	19.3	19.4	26.7	20.7	14.8	32.1	22.7	45.7	24.7	16.8	17.2	33.0	45.5	10.3	19.1	16.0	12.4	12.8	20.5	9.2	14.6	17.1	9.3	18.4	3.9	22.5	0.6	18.0	9.9	15.1	27.2	8.6	15.9	24.1	21.6	15.8	11.2	21.8	11.4	11.9	26.0	32.4	5.8	6.7	10.8	21.7	6.1	16.8	6.0	1.5	24.8	5.6	10.6	17.8	7.1	17.4	7.2	15.6	18.3	23.7	8.5	18.0	9.0	14.8	21.9	7.6	19.1	10.2	26.3	25.8	11.6	1.1	3.2	29.2	11.5	6.3	7.9	4.9	27.2	9.7
ZNF396	"FLJ31213, ZSCAN14"	ENSG00000186496	"Zinc finger protein 396"	Q96N95	18	35366694-35377337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 14.4;Late spermatids: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA006686	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA006686: AB_1080710"	"unprognostic (3.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.72e-2)"	"unprognostic (5.75e-7)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.91e-2)"	1.6	2.6	2.2	1.5	3.1	2.4	3.4	3.8	3.2	3.0	4.9	1.6	1.1	1.6	2.7	1.0	4.9	2.4	0.9	2.1	2.5	3.6	1.5	2.0	1.3	3.0	3.2	1.7	3.0	4.4	3.3	0.7	2.6	2.3	1.8	4.0	3.3	2.1	1.4	1.6	2.2	1.2	2.4	1.5	2.7	5.6	3.0	1.5	5.5	1.0	1.6	1.6	1.0	3.3	0.3	2.2	1.9	2.0	1.3	0.8	1.7	0.4	1.1	0.9	1.8	0.7	1.3	0.1	1.0	1.0	1.2	0.2	1.0	1.0	1.3	0.8	1.3	0.8	1.8	1.7	2.2	0.4	1.4	1.1	1.1	0.5	0.5	3.0	1.5	2.7	0.6	2.4	0.7	2.3	0.6	1.0	0.5	0.6	0.4	0.4	0.0	0.7	2.2	1.8	1.0	3.4	1.4	1.1	2.3	1.6	3.3	1.9	0.1	0.3	0.4	0.8	0.6	4.6	1.8	0.1	1.7	0.1	1.5	8.9	1.4	2.6	1.5	0.8	0.9	0.6	1.1	0.9	1.2	1.3	1.6	1.1	5.8	1.5	1.1	1.6	0.5	0.6	2.2	3.1	3.8	3.2	2.1	2.5	3.0	3.2	2.6	2.4	3.0	3.3	0.6	6.4	5.3	1.6	0.2	0.4	1.0	1.1	0.6	2.7	1.9	1.8	0.8	2.8	2.9	0.0	0.0	0.4	0.5	1.2	0.0	1.8	14.4	7.1	1.9	1.0	0.0	0.4	1.2	2.0	0.3	2.3	1.5	1.4	2.5	0.8	1.1	0.7	0.7	3.3	1.5	1.1	6.1	0.8	1.0	12.0	0.9	1.0	0.0	2.8	1.6	4.5	0.0	3.0	2.6	1.4	1.9	1.2	0.1	0.7	1.1	3.0	19.0	5.9	6.6	2.9	2.2	8.4	1.6	0.8	0.1	0.1	0.8	1.8	0.9	0.8
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	12.9	13.4	17.6	14.4	23.4	5.0	16.1	19.1	20.0	13.5	14.9	12.8	10.6	15.7	12.4	9.8	11.7	10.1	10.5	16.4	20.7	11.3	10.6	10.4	16.2	20.5	20.9	17.8	12.4	14.8	12.0	11.9	20.1	13.9	13.9	25.0	12.4	12.1	11.7	13.6	12.6	11.5	15.4	16.1	13.3	9.9	20.3	13.1	15.7	11.0	15.8	11.9	11.8	34.4	4.2	7.9	18.7	17.1	20.3	17.0	8.9	8.4	8.3	4.1	5.4	3.0	5.7	21.2	7.4	6.7	5.6	11.1	12.2	9.2	5.7	13.5	7.5	0.9	11.7	8.6	6.7	10.3	7.4	7.7	12.1	4.9	14.1	14.6	2.6	16.1	12.7	14.4	10.7	9.1	17.4	7.8	16.1	3.2	3.2	18.2	5.4	15.1	8.4	11.0	20.2	17.4	13.7	7.2	8.2	16.2	12.5	7.6	4.2	13.6	7.6	4.6	3.8	23.2	9.3	11.9	12.0	7.1	13.1	10.1	4.6	8.3	5.7	7.5	4.1	10.6	5.3	4.7	3.3	11.3	7.8	5.4	11.0	4.7	9.4	7.5	3.0	2.2	17.6	23.4	19.1	20.0	16.4	20.7	20.5	20.9	20.1	15.4	20.3	34.4	15.5	35.3	21.0	24.5	35.3	4.1	19.4	8.0	10.2	51.0	11.8	10.4	16.4	15.7	17.3	14.7	35.5	22.6	15.8	14.1	13.7	18.7	66.0	10.8	20.4	17.6	31.0	20.4	17.4	10.9	13.4	18.4	12.8	8.9	11.4	31.7	31.1	12.6	10.8	33.7	19.5	11.5	12.2	20.5	5.4	49.6	18.6	11.8	8.8	23.4	20.3	24.6	15.5	30.2	94.1	10.7	18.3	22.6	6.1	15.8	24.3	11.4	16.4	46.1	32.9	25.3	16.6	29.7	23.4	7.8	4.5	14.6	13.9	22.1	16.1	11.1
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872365-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.5;Oligodendrocytes: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 43.7"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	2.4	3.2	9.2	1.1	10.3	0.6	2.7	9.7	11.3	3.8	8.3	5.8	0.6	2.4	9.6	2.0	6.4	2.4	9.1	8.8	9.3	3.9	2.3	2.1	3.6	9.9	9.7	6.8	2.4	2.5	14.3	2.9	9.9	6.1	1.8	18.0	2.8	2.3	2.6	3.1	2.7	2.0	9.7	5.4	3.2	4.6	10.3	2.3	4.2	1.9	1.6	4.6	2.9	12.0	3.4	0.5	3.4	0.4	8.4	11.8	2.0	4.6	2.2	2.9	4.0	0.3	1.2	0.0	4.7	2.2	0.1	0.4	0.6	2.3	3.9	0.5	3.3	1.2	0.1	1.3	3.0	0.3	0.9	7.1	5.5	2.1	2.0	9.8	2.5	0.0	0.1	0.0	2.7	0.3	0.0	0.1	2.8	0.1	0.7	0.0	1.8	0.7	2.8	2.2	1.8	1.4	1.9	0.8	2.4	6.1	0.1	1.3	1.1	4.1	43.7	3.7	2.7	5.8	8.1	0.0	5.8	0.0	2.4	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.3	0.3	0.0	0.5	0.0	0.2	0.3	0.1	9.2	10.3	9.7	11.3	8.8	9.3	9.9	9.7	9.9	9.7	10.3	12.0	1.3	0.0	3.2	21.5	1.5	0.0	0.7	1.1	0.6	3.6	1.3	1.9	7.0	0.0	0.9	0.0	0.0	1.5	0.3	0.2	0.0	0.7	1.5	1.6	3.2	1.5	2.4	0.4	6.9	0.2	1.1	1.6	0.5	1.1	7.0	2.9	1.1	0.5	0.7	5.0	6.9	0.6	4.1	0.3	0.3	0.3	0.9	0.7	0.0	1.9	0.4	3.8	2.1	3.0	19.4	0.2	0.5	3.4	0.1	0.8	0.7	0.4	1.9	3.3	0.0	0.4	1.3	1.7	3.2	0.4	0.0	1.0	1.5	0.5	0.9	0.5
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	2.4	1.9	2.9	3.1	3.5	5.3	2.9	8.0	2.8	2.7	8.6	2.8	2.2	3.7	1.9	2.5	2.7	2.1	3.2	2.3	2.9	2.4	2.2	2.4	3.3	3.6	3.0	4.8	2.2	3.9	1.5	2.7	4.1	2.8	2.2	2.9	2.4	2.8	3.9	2.3	2.4	3.1	2.9	3.4	2.3	4.0	3.2	5.5	3.6	3.6	3.0	2.4	2.0	4.1	3.9	4.0	4.4	4.1	3.2	4.7	3.2	5.1	4.4	3.7	4.0	1.7	2.2	5.6	1.5	7.1	2.5	4.5	4.2	5.5	5.4	9.3	2.6	7.1	5.5	3.2	2.9	10.9	6.0	4.3	2.4	5.9	5.1	3.5	5.6	3.9	4.1	8.0	5.7	3.1	5.3	1.5	2.6	1.4	3.6	5.4	5.8	4.4	2.6	7.2	4.2	4.0	4.7	2.9	3.6	3.2	3.4	4.6	7.9	8.3	3.5	2.3	4.1	2.8	6.2	5.7	3.0	4.6	5.0	1.6	0.7	0.9	1.0	0.9	1.0	0.8	0.8	0.6	0.3	0.8	0.9	1.1	2.2	1.1	0.6	1.3	0.2	0.4	2.9	3.5	8.0	2.8	2.3	2.9	3.6	3.0	4.1	2.9	3.2	4.1	16.5	6.4	6.3	96.9	10.6	3.2	5.0	3.0	2.8	11.2	6.3	6.0	19.4	2.8	4.9	5.5	6.2	4.2	11.4	6.9	0.0	4.3	4.6	8.6	15.3	10.0	4.2	3.4	111.0	2.9	2.7	7.6	17.3	14.4	1.3	10.2	3.3	5.5	3.2	5.0	100.2	5.7	2.0	5.3	2.8	3.3	5.3	7.6	5.4	113.4	6.1	6.2	8.2	122.6	130.5	4.8	6.0	4.5	11.1	4.4	4.3	2.6	6.2	13.2	6.6	10.8	8.1	9.0	12.8	5.6	4.1	5.2	10.1	12.1	6.0	3.9
ZNF408	FLJ12827	ENSG00000175213	"Zinc finger protein 408"	Q9H9D4	11	46701030-46705912	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017892	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA017892: AB_1859248"	"unprognostic (7.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (3.01e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.99e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-2)"	5.9	5.1	6.2	4.0	6.6	14.5	5.6	6.8	7.8	6.4	4.7	6.6	5.1	7.8	1.6	8.6	5.7	4.0	6.6	5.9	5.8	5.9	12.7	3.9	5.3	6.7	6.4	5.7	6.5	3.2	5.3	3.7	6.1	7.2	2.8	1.2	5.7	4.3	10.3	10.1	6.6	3.4	6.1	7.5	7.4	5.9	6.5	5.4	5.3	6.2	3.3	7.2	5.9	6.8	4.8	11.4	5.2	9.4	6.5	5.7	13.5	6.3	8.8	12.5	9.1	10.3	5.3	7.4	5.7	7.6	9.0	12.2	6.7	12.4	4.4	5.9	13.5	7.1	8.0	12.7	12.2	7.4	9.7	11.2	12.0	6.3	9.0	6.7	6.2	11.1	11.4	6.5	5.2	15.5	9.0	15.1	21.8	15.9	13.8	9.8	7.8	11.7	6.7	12.5	7.3	9.8	12.1	15.0	10.0	4.8	13.1	12.9	7.1	12.2	8.1	10.2	12.4	9.4	8.8	10.9	7.9	8.5	9.9	3.9	7.6	7.8	8.5	8.3	6.6	6.3	8.3	10.2	7.2	7.6	9.2	7.0	7.1	5.8	6.3	5.7	8.1	7.3	6.2	6.6	6.8	7.8	5.9	5.8	6.7	6.4	6.1	6.1	6.5	6.8	4.6	6.4	2.2	1.6	7.5	6.6	5.5	12.0	7.4	5.1	6.4	5.5	5.3	4.3	5.7	1.8	0.0	10.1	8.5	9.6	11.7	7.8	5.6	7.0	7.2	4.8	8.4	11.4	1.4	4.8	7.7	4.5	6.6	14.9	0.0	8.2	5.3	9.2	5.5	3.3	1.6	9.4	2.0	7.1	2.8	3.2	6.2	3.2	10.6	1.9	6.6	7.9	8.2	1.5	2.1	5.9	3.2	6.4	5.2	4.5	9.0	5.8	4.3	3.5	13.1	3.7	7.2	11.2	9.0	7.5	4.1	10.5	4.8	5.7	7.1	6.0
ZNF41	"MGC8941, MRX89"	ENSG00000147124	"Zinc finger protein 41"	P51814	X	47445879-47482946	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.6;Inhibitory neurons: 18.6;Microglial cells: 17.8;Oligodendrocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069102	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA069102: AB_2686086"	"unprognostic (9.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.87e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (3.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	4.2	3.2	3.6	6.2	3.9	1.4	6.3	5.5	5.1	6.1	4.4	6.0	4.2	5.1	3.5	4.5	4.2	4.3	9.8	3.6	3.9	5.2	4.9	5.3	6.3	3.7	3.9	5.1	3.8	8.7	3.4	4.9	3.9	4.9	7.0	9.6	4.4	4.6	19.1	4.7	4.3	5.4	3.0	6.2	5.5	2.2	4.4	7.5	7.0	16.2	7.4	5.3	3.0	4.8	6.3	6.8	5.5	14.0	6.6	7.3	3.8	8.5	7.0	7.2	8.2	3.9	6.7	8.9	4.6	11.2	9.2	9.7	12.5	5.9	9.0	14.3	4.7	2.2	9.4	2.4	4.5	9.0	7.8	5.3	7.3	8.2	10.6	6.5	6.6	7.4	6.5	9.5	9.1	9.4	9.4	4.9	9.3	5.7	10.4	8.7	7.2	9.3	5.5	10.5	7.6	7.7	12.5	9.6	4.8	6.4	10.1	4.9	10.0	7.6	5.9	15.5	6.1	6.9	10.0	9.4	6.5	17.8	8.2	0.8	2.7	2.8	3.5	3.3	4.1	2.5	3.0	3.8	3.6	4.2	3.4	3.2	0.7	3.5	1.7	2.4	2.8	2.3	3.6	3.9	5.5	5.1	3.6	3.9	3.7	3.9	3.9	3.0	4.4	4.8	3.1	3.2	3.9	9.4	3.4	0.6	2.1	1.1	4.0	3.8	1.5	1.1	4.6	0.0	1.3	0.0	0.0	0.3	2.1	2.0	1.9	1.5	0.1	1.4	2.2	2.3	0.0	3.8	12.6	1.4	0.8	3.1	3.6	2.2	1.3	1.7	3.9	1.7	1.1	0.0	18.6	1.4	2.0	1.3	1.0	0.2	0.9	2.7	1.8	17.8	1.0	1.6	2.1	8.5	16.3	1.7	2.5	0.7	5.7	1.5	2.0	0.8	2.0	3.7	0.0	1.6	2.2	1.6	1.7	4.1	0.1	0.8	4.0	2.3	1.7	2.5
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 40.5"	"Low region specificity"	"Detected in all"							HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	14.3	19.6	5.6	5.2	6.3	9.1	15.9	5.0	12.3	22.3	0.5	16.8	7.9	23.2	1.3	18.3	17.2	1.8	16.7	5.7	4.8	17.2	20.9	11.4	6.3	7.1	5.6	22.4	14.9	3.4	21.3	3.7	6.3	23.9	1.1	2.1	15.0	4.4	18.1	21.9	15.6	1.8	3.5	19.3	14.5	20.6	6.6	4.3	22.5	2.7	1.9	17.2	18.0	11.1	9.2	7.8	4.2	6.8	1.1	2.6	9.2	6.9	2.6	4.4	3.9	6.9	4.4	12.5	19.3	2.1	3.2	12.5	1.4	5.6	0.6	11.4	31.0	7.9	7.2	8.3	5.9	7.0	10.3	4.8	4.0	3.6	1.3	2.4	1.9	7.8	10.7	18.0	2.7	11.3	15.7	40.5	12.5	2.4	22.0	18.1	2.2	12.8	3.1	7.5	14.4	22.3	7.5	5.7	6.6	0.8	10.8	8.1	7.1	12.8	6.5	18.7	8.9	26.0	11.8	10.0	10.2	5.8	7.1	1.4	0.5	0.3	0.6	0.4	0.3	0.8	0.9	0.9	0.5	0.8	0.8	0.8	1.6	0.8	0.7	1.2	0.4	0.4	5.6	6.3	5.0	12.3	5.7	4.8	7.1	5.6	6.3	3.5	6.6	11.1	9.7	0.0	1.1	4.2	11.8	11.9	13.5	6.9	26.2	18.3	12.1	14.7	2.1	11.5	2.5	3.7	10.4	28.8	15.8	14.3	15.6	3.9	27.1	5.7	9.2	8.2	22.2	9.2	3.6	5.3	22.8	11.8	17.3	8.0	4.5	15.0	13.2	10.9	13.1	11.8	3.6	14.6	2.0	12.7	7.6	93.4	20.5	11.6	8.8	3.7	8.8	20.4	11.3	4.0	6.5	4.6	16.0	16.1	9.3	9.1	16.2	17.6	1.4	21.9	13.1	11.5	10.0	21.3	38.3	18.0	12.1	31.5	12.8	19.0	13.2	9.8
ZNF415		ENSG00000170954	"Zinc finger protein 415"	Q09FC8	19	53107879-53133077	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 54.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 21.9"									HPA005553	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center, Microtubules"		"HPA005553: AB_1859252"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.84e-2)"	6.7	17.8	14.1	2.0	17.7	0.9	8.5	18.7	18.8	7.5	9.9	7.7	2.0	7.5	13.5	3.4	6.4	5.4	16.7	14.6	16.8	7.0	1.2	4.8	3.2	15.8	15.9	9.5	5.6	11.3	5.3	4.2	16.2	9.7	5.2	10.6	6.2	7.7	4.4	3.9	3.3	7.0	13.2	5.4	5.0	21.6	16.4	4.9	10.8	6.7	2.8	6.4	5.1	27.5	0.2	0.0	4.9	14.2	0.7	0.8	11.3	5.3	8.3	7.6	11.5	9.2	0.3	0.0	2.9	9.2	8.8	0.2	0.0	0.0	7.5	0.0	0.7	0.0	0.5	0.0	2.7	0.0	7.8	8.5	0.1	1.8	0.0	0.8	0.1	0.4	0.3	0.3	4.2	0.7	9.3	0.1	10.3	0.1	0.5	0.0	0.0	0.4	6.3	21.9	3.1	7.6	0.6	0.1	0.0	12.3	7.3	0.4	0.0	3.5	3.4	0.4	6.3	0.2	9.6	6.4	0.4	0.0	11.7	3.6	0.6	3.9	0.3	0.3	0.3	4.1	0.8	0.2	1.2	3.9	1.8	1.6	0.9	3.4	0.5	2.9	0.5	0.6	14.1	17.7	18.7	18.8	14.6	16.8	15.8	15.9	16.2	13.2	16.4	27.5	7.7	0.0	6.2	11.4	2.1	0.5	2.5	0.6	2.8	4.8	4.0	4.7	24.2	1.5	4.4	3.7	2.1	3.5	0.4	1.1	13.7	5.8	108.2	5.0	4.2	6.5	0.0	0.0	9.3	4.7	3.5	4.4	1.5	3.5	0.0	13.3	5.3	0.0	0.7	1.7	13.8	1.9	2.0	0.3	0.9	54.7	1.8	0.5	0.0	2.8	0.6	5.5	7.2	9.5	17.6	2.7	0.3	4.5	0.4	2.5	0.3	0.1	5.4	2.8	0.0	3.0	5.6	17.4	5.0	1.2	0.3	1.9	0.9	17.6	1.3	2.6
ZNF417	MGC34079	ENSG00000173480	"Zinc finger protein 417"	Q8TAU3	19	57900296-57916610	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 57.4"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.34e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-2)"	"unprognostic (8.75e-2)"	"prognostic favorable (3.48e-4)"	7.7	9.7	29.5	9.7	29.9	15.7	21.3	37.9	38.0	18.4	31.9	10.5	9.4	13.4	48.9	8.3	13.0	15.0	11.2	28.9	33.5	11.7	14.9	10.5	19.0	28.7	29.1	12.1	8.4	15.4	10.5	10.0	28.8	15.8	13.4	25.8	12.6	17.4	7.3	29.0	10.7	10.4	25.3	17.8	14.5	9.5	31.3	21.6	21.1	6.3	22.3	9.3	4.9	35.6	7.1	10.8	17.2	11.9	17.0	16.2	14.6	8.8	12.7	8.0	6.7	11.6	4.1	15.1	4.8	12.9	6.1	4.9	10.9	11.9	22.4	2.6	57.4	16.2	26.5	10.7	11.5	15.0	16.7	11.9	11.9	7.9	10.5	14.9	10.3	12.0	5.1	0.9	16.7	6.9	16.3	7.2	9.9	4.9	10.6	12.8	20.7	10.8	8.6	32.1	15.7	10.2	11.6	7.8	3.0	17.7	8.3	12.0	7.1	20.2	8.6	4.6	8.9	16.1	27.8	12.5	8.7	6.0	9.8	5.9	2.0	5.1	2.6	2.4	3.3	2.6	3.0	2.6	1.5	3.6	4.0	3.0	3.3	2.1	1.7	3.3	2.7	1.5	29.5	29.9	37.9	38.0	28.9	33.5	28.7	29.1	28.8	25.3	31.3	35.6	1.5	6.4	1.1	5.5	1.7	0.8	1.2	0.7	1.8	4.0	2.5	1.9	3.0	2.8	4.8	0.0	0.0	1.0	1.5	1.7	0.0	1.2	0.5	1.2	1.2	2.6	6.0	6.1	3.9	1.4	0.8	2.0	2.0	1.6	4.5	2.0	2.9	2.2	1.0	1.7	3.8	2.1	0.0	2.5	1.5	0.1	2.5	1.7	0.0	1.9	1.0	0.9	2.1	2.5	5.7	0.4	0.5	1.5	5.0	1.4	1.5	1.5	2.2	3.9	6.6	1.9	1.7	1.3	2.1	1.0	1.3	0.8	2.0	1.2	1.7	1.6
ZNF418	"FLJ31551, KIAA1956"	ENSG00000196724	"Zinc finger protein 418"	Q8TF45	19	57921882-57935402	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 9.1;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 11.1;SuSa: 7.6;T-47d: 6.9"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.41e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.36e-3)"	2.2	2.8	4.9	2.4	5.7	2.0	5.9	10.3	5.0	3.2	0.2	4.5	1.0	4.1	5.3	2.0	4.7	2.4	8.7	4.5	5.6	4.1	2.3	2.6	5.2	2.6	3.3	6.2	4.5	6.2	5.3	5.7	2.5	4.7	1.5	12.4	3.5	5.6	3.3	9.0	2.5	4.0	1.4	5.1	3.5	4.4	4.9	4.6	6.7	4.9	4.5	3.6	2.9	9.2	0.3	1.3	11.1	3.6	1.7	3.6	1.2	3.4	1.1	2.5	0.2	0.2	1.2	0.4	2.3	1.7	3.3	1.0	0.0	2.8	3.0	0.3	1.0	0.2	0.7	0.1	1.0	0.3	2.3	3.0	0.8	3.1	0.0	0.0	0.5	1.0	0.9	0.8	2.1	0.4	0.6	0.4	5.7	0.1	0.4	0.5	0.8	4.0	2.1	1.4	0.2	0.5	0.1	2.0	0.1	7.6	6.9	1.2	0.0	0.7	0.5	0.4	0.6	1.8	4.7	2.9	0.3	1.3	2.2	1.3	0.5	0.5	0.1	1.3	0.4	3.2	1.1	0.7	1.0	5.5	1.8	0.5	0.6	4.3	0.5	1.8	0.0	0.8	4.9	5.7	10.3	5.0	4.5	5.6	2.6	3.3	2.5	1.4	4.9	9.2	1.7	0.0	0.6	4.2	2.9	0.4	0.8	0.4	0.6	4.3	1.8	1.4	9.1	1.5	1.0	0.0	4.2	1.0	0.8	0.0	1.9	1.2	0.1	1.8	0.9	1.9	0.0	2.5	4.1	0.6	0.6	1.9	1.1	1.1	5.7	2.5	2.5	0.8	0.8	3.3	3.5	0.0	0.0	0.3	0.7	0.9	0.3	0.6	0.0	1.9	0.2	4.3	1.0	4.0	6.3	0.2	1.2	1.5	0.1	1.1	0.0	1.1	5.6	5.9	13.1	0.7	1.3	2.6	5.6	0.7	0.4	0.8	0.7	0.3	0.2	0.8
ZNF419	"ZAPHIR, ZNF419A"	ENSG00000105136	"Zinc finger protein 419"	Q96HQ0	19	57487711-57496098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.9"									"HPA003152, HPA003274"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716, HPA003274: AB_1080714"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.55e-5)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.53e-5)"	6.0	8.7	10.0	4.6	10.1	3.0	6.2	10.7	12.6	4.8	9.9	6.3	3.8	5.3	9.7	4.7	6.2	3.5	8.2	10.0	10.1	8.1	6.6	7.0	7.4	9.4	8.9	7.8	4.6	9.1	13.4	6.1	8.8	8.9	3.6	11.1	6.4	6.3	10.4	7.4	6.2	4.0	8.9	10.6	5.3	5.3	10.2	8.0	10.8	7.8	8.9	5.4	4.6	10.1	5.4	6.0	10.3	10.5	4.7	7.1	8.9	6.4	8.8	5.8	31.9	3.8	3.4	1.8	5.1	4.5	5.2	1.6	4.9	13.3	8.0	0.5	22.4	8.3	9.1	4.2	16.8	6.5	6.0	9.7	19.3	5.8	13.8	12.0	6.4	8.0	0.9	1.3	7.3	0.9	10.9	6.7	6.8	0.7	7.9	10.1	9.9	7.6	6.3	11.5	8.4	9.4	6.5	6.0	6.2	8.8	5.3	9.7	6.6	7.0	7.7	2.5	5.6	15.2	18.0	4.5	5.6	3.5	5.7	4.5	2.7	6.1	5.2	3.3	8.9	14.3	8.9	6.6	4.7	15.8	13.8	7.4	3.2	9.7	2.7	3.4	6.5	4.4	10.0	10.1	10.7	12.6	10.0	10.1	9.4	8.9	8.8	8.9	10.2	10.1	3.1	0.0	5.3	3.6	7.2	4.1	5.7	4.9	2.8	8.1	4.3	5.2	5.3	4.3	5.2	7.3	6.2	5.0	4.2	1.3	0.0	5.8	0.3	2.0	2.1	4.8	1.2	2.5	3.3	1.8	2.4	3.7	0.5	1.7	4.5	7.4	5.7	4.6	3.2	10.1	2.8	1.8	8.2	3.2	1.7	0.5	1.8	1.8	5.4	0.0	4.1	6.8	7.2	3.5	1.9	2.5	2.8	5.7	1.6	9.0	2.0	1.9	1.8	9.5	6.6	2.9	3.3	4.9	10.4	2.1	3.8	8.3	4.8	4.2	1.8	5.6
ZNF420	FLJ32191	ENSG00000197050	"Zinc finger protein 420"	Q8TAQ5	19	37007857-37130368	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059675	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA059675: AB_2684101"	"unprognostic (1.00e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.40e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (7.94e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.63e-2)"	3.0	4.2	4.9	2.5	5.2	1.6	5.6	6.7	6.2	5.0	5.0	3.9	2.5	4.5	3.9	3.0	5.1	2.7	3.3	4.9	5.0	4.2	3.3	2.8	4.2	4.5	4.8	8.0	3.2	6.3	3.4	3.3	5.5	4.2	2.5	7.3	3.4	4.0	5.5	3.4	2.7	4.1	5.0	4.4	3.1	9.8	4.9	5.7	6.6	6.5	4.6	3.4	3.2	5.4	0.0	6.8	6.4	6.7	5.8	3.8	3.2	4.2	4.1	4.7	7.1	1.5	1.4	3.3	8.1	2.9	2.9	1.2	6.6	2.1	5.5	10.8	5.0	7.5	3.6	2.8	6.0	6.3	3.2	4.0	4.5	5.1	3.5	5.4	2.7	5.6	4.1	0.3	5.5	2.3	10.7	2.4	7.4	2.7	4.1	6.1	12.9	6.8	2.7	4.5	8.7	9.7	6.1	2.5	3.4	4.5	4.0	4.9	3.1	5.0	7.7	4.6	4.9	9.9	12.9	8.2	0.0	1.3	4.4	2.1	2.9	6.8	9.9	4.0	10.6	9.8	11.0	10.4	5.6	13.7	11.1	12.3	0.5	12.3	4.3	3.0	14.3	5.9	4.9	5.2	6.7	6.2	4.9	5.0	4.5	4.8	5.5	5.0	4.9	5.4	7.1	12.8	8.6	11.1	11.0	9.9	3.3	4.0	7.4	18.7	7.4	6.3	6.1	4.3	6.6	3.7	0.0	9.2	6.2	2.1	7.9	4.1	31.4	4.6	4.1	6.7	6.0	4.2	32.8	1.3	4.1	7.0	0.5	2.9	12.7	15.3	10.0	4.2	4.2	16.8	24.2	2.8	8.2	3.8	2.3	34.5	9.6	3.5	7.2	26.2	2.8	5.9	12.3	28.1	26.4	1.9	2.9	9.4	5.9	4.2	2.7	5.3	10.7	9.0	26.3	10.5	6.5	15.5	7.4	6.4	8.7	4.0	10.4	6.6	4.3	2.6
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	0.8	1.2	3.1	0.9	3.1	0.6	1.7	3.3	3.2	2.1	2.1	2.1	1.0	2.4	2.1	2.1	2.3	1.0	0.8	3.0	2.7	2.2	1.0	1.0	0.8	2.8	2.8	3.8	1.5	2.3	1.4	0.7	2.8	1.9	0.8	1.4	1.8	2.2	3.8	2.5	0.9	1.7	2.6	1.0	1.6	1.3	2.9	1.6	1.9	1.9	1.2	1.9	1.5	2.8	1.4	1.7	3.6	3.1	5.3	1.5	2.0	2.0	3.4	1.1	1.2	0.4	1.8	1.6	2.8	1.6	1.4	1.9	0.6	1.0	0.4	1.1	1.4	1.9	2.4	0.8	3.0	0.9	0.8	3.1	1.7	1.1	2.0	3.0	0.5	2.4	1.4	1.5	3.7	6.6	2.5	2.9	8.6	2.0	3.3	2.7	1.8	0.9	2.4	1.9	1.6	3.0	1.9	2.4	4.5	2.3	1.6	2.6	0.7	2.3	0.3	2.7	0.5	3.2	2.1	1.2	1.9	0.6	1.9	2.1	0.6	1.4	1.8	0.7	2.3	1.4	1.5	1.2	0.6	1.8	2.1	2.3	1.6	3.2	0.4	2.1	2.0	0.8	3.1	3.1	3.3	3.2	3.0	2.7	2.8	2.8	2.8	2.6	2.9	2.8	0.4	0.0	2.0	5.2	1.9	0.3	0.8	0.7	2.2	3.4	1.8	1.5	1.8	0.0	1.2	3.7	0.0	0.8	0.3	0.5	5.9	1.6	0.9	1.4	2.2	0.6	1.2	3.0	7.5	0.5	0.8	1.5	4.6	1.2	0.0	3.4	0.4	0.6	0.4	6.7	8.5	0.7	2.0	0.0	0.2	0.3	4.4	0.6	0.0	7.5	1.8	4.7	0.0	9.0	10.7	0.6	0.6	5.3	1.3	1.0	0.7	1.1	2.4	1.2	0.0	2.3	1.5	3.5	3.5	2.8	0.3	1.0	1.4	3.0	0.8	0.5
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607224-43619629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"HPA042596: AB_2678070, HPA048072: AB_2680249"	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	26.4	43.4	47.5	17.3	45.6	24.0	26.7	39.3	59.8	38.5	28.9	48.8	17.3	43.4	8.9	22.3	34.7	10.7	45.7	46.9	44.9	44.4	39.2	25.2	17.6	44.7	43.9	43.3	30.7	18.1	55.2	13.5	39.0	41.7	6.3	15.6	28.2	14.0	44.1	18.8	25.0	10.7	40.3	30.9	30.1	57.1	52.2	22.0	37.5	14.3	10.0	34.1	26.7	44.6	38.2	33.8	53.2	79.6	20.8	15.5	21.6	28.6	15.6	23.0	24.5	19.8	25.6	66.3	62.7	26.1	13.8	9.4	21.7	6.1	7.8	54.1	87.2	73.4	34.1	34.7	39.0	57.3	55.8	27.8	12.7	19.9	10.3	23.3	32.5	48.3	76.9	40.1	24.6	42.3	140.0	97.9	30.8	17.9	22.8	135.6	23.3	49.1	27.3	25.4	90.2	102.0	44.2	25.5	66.6	14.2	15.3	79.6	55.2	24.1	66.7	22.7	44.5	43.2	56.8	117.1	34.2	56.9	53.4	1.4	2.1	9.3	6.2	1.4	3.1	4.8	5.5	6.1	2.5	6.2	5.9	2.7	0.8	2.6	2.6	5.6	3.9	1.0	47.5	45.6	39.3	59.8	46.9	44.9	44.7	43.9	39.0	40.3	52.2	44.6	67.8	0.0	3.9	26.1	44.5	32.1	80.3	173.5	55.8	101.7	68.6	74.7	19.7	61.5	76.4	66.2	14.6	142.1	78.8	43.1	148.7	89.1	153.3	81.7	79.1	69.3	162.2	66.0	17.6	79.6	46.7	79.3	38.7	59.4	36.3	214.9	76.4	51.4	104.4	57.2	19.7	62.3	156.6	38.6	60.8	63.5	88.9	42.3	113.8	14.0	45.4	191.7	99.9	18.1	26.7	74.5	52.0	90.7	45.5	41.0	30.0	216.8	48.1	72.5	72.3	59.0	102.9	29.6	173.1	44.2	25.9	55.1	71.3	174.1	52.8	53.7
ZNF43	"HTF6, KOX27, ZNF39L1"	ENSG00000198521	"Zinc finger protein 43"	P17038	19	21804946-21852125	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 52.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 37.8"									HPA050271	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA050271: AB_2681070"	"unprognostic (9.25e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.47e-3)"	"unprognostic (4.45e-3)"	"prognostic favorable (3.16e-5)"	"unprognostic (2.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.43e-3)"	3.9	4.0	1.6	5.5	4.1	10.7	7.8	10.6	3.0	4.9	1.1	4.4	3.6	6.3	4.6	3.6	6.8	4.0	4.5	1.5	5.2	5.0	1.4	4.2	8.4	2.9	1.9	11.2	3.0	6.7	2.6	4.8	3.2	7.2	5.3	6.7	3.5	4.9	3.1	7.3	4.2	4.4	0.8	6.6	4.8	8.7	2.9	10.1	8.7	4.1	6.8	3.6	3.1	7.7	0.4	3.7	25.0	19.8	2.7	5.9	10.4	6.6	2.7	8.3	11.4	0.3	3.8	5.9	7.5	4.2	7.7	0.5	0.3	0.7	13.8	0.8	6.5	0.3	1.6	2.9	1.3	0.2	7.2	5.6	0.9	8.9	0.4	2.1	1.9	21.8	0.4	1.1	6.3	4.3	37.8	9.1	18.0	0.5	5.4	22.0	9.8	6.6	5.4	18.9	16.7	12.6	0.1	0.1	2.2	11.3	9.6	5.1	0.4	0.7	0.8	6.0	7.0	1.5	11.3	10.2	0.3	0.8	0.8	30.7	4.5	6.2	8.8	4.6	8.4	18.8	11.5	9.9	4.6	19.1	18.6	12.7	4.5	9.0	4.0	8.5	8.1	3.9	1.6	4.1	10.6	3.0	1.5	5.2	2.9	1.9	3.2	0.8	2.9	7.7	17.0	12.8	15.1	19.2	14.4	2.0	8.1	1.4	2.8	16.0	10.6	12.2	13.2	8.6	9.9	3.7	10.4	9.4	10.6	3.7	17.6	11.0	36.3	11.6	13.6	16.0	11.4	16.2	9.5	9.4	7.6	12.8	5.1	16.6	16.4	52.0	16.8	0.4	4.8	8.4	14.1	4.2	6.1	4.4	4.4	9.8	14.0	6.6	1.8	18.7	6.5	12.5	20.6	26.7	23.1	7.6	4.0	9.4	7.7	8.8	2.4	7.4	6.6	9.6	6.6	13.8	13.3	21.3	15.7	3.3	2.0	5.9	10.8	41.0	7.1	4.4
ZNF430	FLJ13659	ENSG00000118620	"Zinc finger protein 430"	Q9H8G1	19	21020634-21060050	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059135	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA059135: AB_2683918"	"unprognostic (2.47e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-4)"	"unprognostic (2.03e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.24e-3)"	3.2	3.0	3.0	5.4	4.4	12.0	5.2	7.3	3.5	4.0	0.0	3.1	3.7	4.3	8.5	6.8	3.8	3.5	1.9	1.8	2.7	2.7	1.2	3.8	10.3	3.8	2.7	12.7	4.1	7.9	1.9	3.4	3.8	4.9	4.2	2.9	3.5	3.8	1.5	7.0	3.4	3.5	1.9	6.7	4.9	3.0	3.1	9.8	8.6	2.7	7.8	4.5	4.7	5.9	6.6	1.9	8.0	5.7	6.0	11.2	7.7	6.0	6.4	8.6	8.2	3.7	6.0	10.4	5.7	5.2	5.4	3.7	0.3	6.0	13.0	3.8	7.7	7.3	4.3	3.5	2.9	2.5	14.4	5.9	7.3	5.4	9.9	6.1	6.2	10.8	8.2	12.0	7.8	3.0	17.4	7.8	8.0	3.4	12.8	11.2	10.8	6.0	6.3	9.6	8.9	5.8	1.7	0.8	5.1	7.7	3.5	12.9	4.3	4.6	2.9	8.9	7.4	6.2	7.0	13.1	2.1	7.2	4.6	19.6	4.4	15.9	8.5	5.2	10.4	10.2	10.6	10.1	3.6	13.0	13.9	11.2	10.3	10.4	5.5	6.6	11.4	4.8	3.0	4.4	7.3	3.5	1.8	2.7	3.8	2.7	3.8	1.9	3.1	5.9	16.8	9.6	12.8	16.3	48.2	28.7	23.7	13.2	21.6	33.1	11.4	11.0	4.0	5.7	9.8	18.4	20.9	12.3	50.8	8.3	1.9	11.9	0.8	11.6	17.8	14.4	10.7	16.2	13.8	8.0	10.6	15.1	13.7	33.3	17.7	45.6	16.1	0.8	10.2	23.5	18.6	7.7	12.2	16.9	17.7	1.8	15.2	20.6	3.6	11.2	19.0	8.6	28.8	23.1	31.1	13.9	7.5	11.3	27.9	26.8	7.0	1.9	12.1	19.7	0.0	13.9	14.8	18.4	16.8	33.5	35.5	9.9	40.9	32.8	9.6	50.4
ZNF431	KIAA1969	ENSG00000196705	"Zinc finger protein 431"	Q8TF32	19	21142024-21196053	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Granulosa cells: 132.7;Theca cells: 185.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059135	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA059135: AB_2683918"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.01e-3)"	5.0	10.3	2.5	6.1	3.4	14.6	7.3	7.5	3.4	8.3	0.4	4.0	3.4	5.7	6.9	19.2	4.9	3.1	7.6	2.1	2.8	3.7	1.2	6.7	9.4	2.9	3.8	21.9	7.1	4.9	3.5	5.6	4.3	5.1	5.0	7.1	6.7	3.3	5.2	11.6	4.8	4.6	1.5	6.7	6.4	8.3	2.8	9.6	12.3	5.7	8.3	4.5	11.3	5.9	11.0	3.1	9.7	11.4	2.7	5.4	14.7	5.6	4.9	10.5	10.4	6.0	7.7	13.9	9.6	3.8	4.9	7.2	8.5	6.1	12.8	5.0	10.7	10.6	8.3	3.7	2.6	5.3	10.7	3.9	10.9	6.6	6.3	5.9	8.2	12.3	19.5	8.1	6.3	4.7	16.9	5.9	11.3	4.2	9.2	9.2	12.4	3.9	4.1	12.6	9.3	7.8	14.5	0.1	5.1	15.3	6.0	9.3	5.0	6.6	0.5	9.1	8.2	6.4	12.9	18.1	1.6	9.2	4.5	4.1	3.4	7.1	2.8	3.1	4.1	8.1	4.9	3.8	2.4	8.0	6.0	4.7	5.0	8.6	4.3	5.8	4.1	1.8	2.5	3.4	7.5	3.4	2.1	2.8	2.9	3.8	4.3	1.5	2.8	5.9	17.5	121.8	22.1	7.2	32.0	12.6	15.0	8.0	15.4	32.8	13.6	13.7	17.3	12.8	20.1	23.9	37.5	17.6	34.4	9.0	3.9	12.6	3.7	23.2	30.5	16.5	16.9	19.3	12.5	8.8	18.4	19.9	24.5	52.5	20.3	132.7	17.5	0.6	10.7	15.2	12.5	10.2	12.2	17.9	11.3	5.4	32.6	16.4	3.6	19.7	16.0	11.3	43.3	16.6	24.0	14.0	3.1	21.4	21.2	17.8	5.5	4.5	11.9	30.8	19.7	25.2	23.2	26.7	16.1	26.0	15.5	11.6	27.1	185.6	10.4	31.7
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031378-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 26.9;Rod photoreceptor cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	6.3	13.4	3.2	3.7	3.9	8.0	6.5	5.7	3.7	6.5	8.8	5.5	5.2	7.0	8.7	6.6	6.0	3.5	6.0	3.4	5.5	5.1	4.1	5.6	4.3	3.9	3.7	6.8	18.0	5.6	12.4	4.4	3.9	11.8	4.3	24.6	7.1	4.5	4.1	7.8	5.2	4.3	2.9	4.4	6.4	7.2	4.3	4.0	6.7	4.4	4.1	5.0	6.5	4.8	4.6	3.7	8.2	13.0	5.6	7.2	2.8	5.2	3.9	3.7	5.9	3.2	2.7	3.1	1.6	5.6	4.0	3.4	4.8	4.5	6.4	3.2	11.8	9.5	9.2	6.0	2.6	0.0	8.5	7.3	3.6	5.4	7.9	7.1	4.9	3.7	2.6	14.0	6.8	2.6	9.3	5.2	3.0	2.4	6.3	4.9	9.5	5.4	5.5	22.2	4.8	5.0	8.1	4.4	2.6	5.8	3.9	3.7	7.0	3.1	4.7	3.7	5.5	7.2	10.7	7.5	7.2	0.8	6.1	0.9	1.1	1.3	1.4	1.3	1.0	1.9	0.8	0.8	0.9	1.2	1.5	1.1	1.0	0.6	0.6	0.6	1.2	0.8	3.2	3.9	5.7	3.7	3.4	5.5	3.9	3.7	3.9	2.9	4.3	4.8	6.2	16.0	10.0	8.1	8.0	2.0	3.3	3.4	3.4	9.8	3.8	3.2	6.0	2.8	11.6	9.2	16.7	2.7	6.4	3.7	3.9	3.5	14.7	11.9	6.4	5.7	10.2	2.5	9.4	1.6	5.8	5.8	6.6	9.0	12.6	7.8	3.9	1.3	2.3	26.9	6.7	4.9	4.1	4.1	1.3	12.4	3.7	3.2	3.6	9.4	3.8	7.7	10.3	9.0	6.9	2.1	5.2	4.5	4.0	3.6	2.0	2.7	11.6	30.7	6.6	7.1	6.4	10.0	8.4	2.2	2.3	4.9	6.5	4.2	3.1	3.3
ZNF433	FLJ40981	ENSG00000197647	"Zinc finger protein 433"	Q8N7K0	19	12014732-12035741	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.4;Late spermatids: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073724	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA073724: AB_2686631"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.90e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-3)"	"prognostic favorable (8.33e-15)"	"unprognostic (1.06e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.69e-2)"	4.1	3.8	5.1	2.3	5.2	11.8	7.8	10.9	5.2	5.7	5.3	3.6	2.1	4.9	9.4	6.9	4.7	3.8	5.3	6.1	5.2	14.2	5.3	4.0	3.2	5.2	5.4	5.7	9.2	9.1	4.9	5.1	5.0	6.3	3.6	9.9	7.2	4.7	5.6	9.0	2.5	3.2	4.3	4.6	4.8	27.6	5.1	1.8	9.1	3.9	2.9	4.5	5.3	6.0	5.5	0.4	4.1	11.5	3.9	3.7	6.0	4.8	3.5	5.3	5.6	3.1	1.1	1.7	2.6	4.1	3.6	2.2	0.0	5.3	5.0	0.8	1.4	4.0	1.1	3.4	4.1	3.7	9.0	4.3	4.9	3.7	1.8	3.3	0.0	6.4	1.0	0.8	5.9	2.3	4.9	4.7	1.6	0.1	4.5	2.6	2.8	0.4	7.7	11.3	3.4	2.8	0.0	3.0	2.3	4.4	6.2	5.5	3.4	6.0	2.5	10.3	3.4	8.1	10.6	4.8	1.1	4.2	3.7	6.5	1.1	5.1	1.3	0.9	1.1	1.5	1.2	1.7	4.1	2.6	1.8	2.2	2.0	5.9	1.4	3.9	0.9	1.1	5.1	5.2	10.9	5.2	6.1	5.2	5.2	5.4	5.0	4.3	5.1	6.0	3.8	3.2	2.8	7.5	1.7	1.8	3.4	3.7	1.8	4.9	4.8	4.3	7.2	5.7	4.1	5.5	16.7	10.5	1.7	0.8	7.9	4.2	198.4	7.1	3.8	2.2	0.0	3.6	6.7	3.8	4.5	3.1	3.6	9.5	3.8	3.3	1.4	3.1	6.9	6.7	5.9	0.5	4.1	2.2	1.6	134.4	3.1	1.5	5.4	0.0	0.0	4.7	1.0	10.1	3.7	3.0	1.1	4.1	0.6	2.1	0.0	6.1	6.1	8.1	6.6	1.9	2.9	35.1	5.7	4.5	2.6	3.4	0.9	2.4	0.8	2.5
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369836	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.8;HSkMC: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	10.0	14.8	4.8	2.3	5.2	1.4	9.8	5.5	5.4	9.8	4.5	8.5	3.1	9.9	8.0	16.5	6.9	5.5	8.3	5.5	5.3	4.0	3.7	4.2	2.7	6.3	5.2	15.4	6.9	5.3	4.4	4.2	5.6	9.5	3.1	4.6	14.6	5.1	6.5	12.6	5.6	6.2	5.6	7.0	6.1	7.9	5.4	3.5	9.0	6.2	3.6	10.4	10.2	5.9	3.8	2.4	8.6	4.5	9.1	18.8	4.1	3.4	4.6	4.3	5.0	1.4	3.3	2.6	3.8	4.9	2.8	4.8	15.0	5.7	4.6	3.2	3.3	2.8	5.3	2.2	3.6	1.2	1.9	34.9	8.0	3.6	4.1	7.8	6.2	3.1	3.4	1.8	4.5	1.8	2.9	2.1	0.3	1.7	3.8	3.8	3.6	2.5	3.4	9.5	3.9	4.9	9.6	4.7	3.7	2.9	2.6	1.4	5.0	3.7	2.7	2.9	1.9	2.8	3.6	2.1	2.9	2.3	2.9	0.0	0.7	0.7	0.7	0.8	0.7	0.4	0.5	0.8	1.1	0.5	0.8	0.7	0.5	2.6	0.8	0.1	0.9	0.6	4.8	5.2	5.5	5.4	5.5	5.3	6.3	5.2	5.6	5.6	5.4	5.9	7.8	0.0	0.5	2.6	2.0	5.2	1.6	1.9	22.2	4.1	6.9	5.0	6.4	1.5	1.6	5.5	6.2	3.8	2.6	3.5	0.0	2.9	2.3	5.0	8.5	14.0	3.6	1.7	4.2	4.9	1.8	9.6	2.0	7.8	0.0	9.4	3.3	3.1	2.1	10.1	3.3	4.6	2.0	1.9	3.8	1.5	9.9	2.1	5.4	0.0	4.5	9.3	2.1	2.5	3.1	3.6	5.9	11.7	2.1	3.3	4.0	2.8	2.4	2.4	0.0	4.5	4.5	5.5	6.9	22.1	9.7	2.9	2.4	7.9	3.1	2.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZNF439	DKFZp571K0837	ENSG00000171291	"Zinc finger protein 439"	Q8NDP4	19	11848726-11883750	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.4;U-138 MG: 15.6"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.83e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.29e-2)"	2.6	3.5	3.8	3.5	4.7	4.2	5.7	8.2	5.2	4.2	4.3	5.0	1.1	5.2	5.0	3.2	4.0	2.4	3.5	4.0	4.0	6.3	1.3	5.1	7.3	4.5	4.1	8.1	4.1	16.5	10.1	5.2	5.0	6.2	3.8	14.7	5.3	4.4	0.8	8.0	8.0	2.6	4.0	9.4	3.9	5.7	4.1	10.0	7.3	1.1	7.6	5.6	4.8	6.7	0.1	0.0	4.2	12.2	0.4	0.3	0.0	5.2	1.8	6.2	4.2	3.0	0.2	4.5	2.2	2.9	1.8	0.1	0.0	0.4	7.2	0.0	0.1	4.4	0.0	1.8	1.2	0.0	4.2	1.2	0.3	1.3	0.0	2.7	0.0	4.2	0.8	0.0	0.4	0.4	6.2	15.4	5.1	0.0	1.2	7.3	1.2	0.0	4.6	2.6	7.5	8.0	0.0	0.1	5.6	4.3	3.2	10.0	0.0	15.6	1.4	1.3	3.1	6.0	10.1	10.1	0.2	0.0	4.3	26.1	0.6	5.7	1.7	1.6	2.3	8.9	3.0	1.7	2.8	8.6	5.4	3.1	1.6	2.2	3.5	2.7	1.4	1.9	3.8	4.7	8.2	5.2	4.0	4.0	4.5	4.1	5.0	4.0	4.1	6.7	3.1	3.2	10.4	15.0	23.9	0.5	2.5	1.6	3.4	26.2	3.9	4.6	3.5	11.5	6.8	0.0	52.1	32.8	8.3	9.2	3.9	8.2	4.5	6.5	5.1	4.6	6.1	3.0	19.2	1.8	22.2	3.8	4.1	4.4	29.8	11.2	6.1	0.2	4.2	16.8	8.7	2.3	2.0	1.9	3.1	3.8	4.4	2.7	5.4	14.0	2.4	10.4	25.7	31.7	28.3	3.0	6.0	7.9	4.1	2.1	6.5	2.1	5.8	49.9	13.1	1.8	5.9	21.7	5.8	1.1	1.8	13.5	7.4	2.8	3.1	1.3
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 95.9;Early spermatids: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (9.21e-6)"	6.9	5.7	2.5	2.7	2.7	9.6	6.8	3.8	3.1	7.5	3.8	6.9	3.3	5.4	5.2	6.8	6.3	2.1	5.2	2.5	2.7	12.1	11.0	6.1	4.4	2.8	2.7	9.4	6.8	4.0	7.1	2.7	2.8	7.4	4.9	5.0	5.7	3.1	3.5	7.9	7.4	2.6	2.3	9.4	5.0	9.7	2.8	3.2	6.7	2.4	4.2	7.0	6.9	3.4	3.0	0.9	1.8	4.3	2.1	1.9	9.6	4.2	1.7	6.5	5.9	4.2	1.7	3.0	5.0	3.4	1.9	3.2	3.0	2.6	5.6	0.0	2.7	2.9	4.4	11.3	2.9	0.0	7.4	2.5	3.9	4.1	4.9	2.6	2.6	3.8	1.9	0.6	4.2	3.2	4.6	5.7	1.8	3.0	5.2	3.2	4.7	3.8	3.7	7.1	2.6	2.9	5.4	2.2	1.4	6.2	4.5	4.6	2.8	8.3	2.3	8.3	3.7	6.5	7.5	2.8	0.2	2.7	2.4	11.9	1.7	15.8	7.3	3.2	8.5	4.2	7.9	7.9	1.3	3.4	8.4	8.4	5.6	11.5	3.2	3.2	6.1	3.4	2.5	2.7	3.8	3.1	2.5	2.7	2.8	2.7	2.8	2.3	2.8	3.4	14.6	28.9	19.9	16.6	16.1	9.1	6.6	8.2	8.0	16.1	10.6	8.3	16.9	17.2	13.9	64.4	37.5	17.2	21.5	17.9	95.9	9.9	113.1	21.1	11.6	11.8	15.6	6.5	13.8	9.3	6.8	8.3	6.1	25.1	24.1	14.4	11.0	12.4	8.5	16.8	16.1	12.9	10.2	11.1	8.7	34.1	14.0	10.9	10.6	25.3	8.8	9.8	27.8	17.6	21.7	9.6	13.0	6.0	13.7	6.2	17.1	13.6	24.8	36.7	19.7	11.6	9.8	36.5	24.8	16.4	11.6	8.6	19.2	8.4	12.9	9.6
ZNF440	FLJ37933	ENSG00000171295	"Zinc finger protein 440"	Q8IYI8	19	11814273-11835216	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 44.8;Respiratory ciliated cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"RT4: 25.5"									HPA047845	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.48e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.57e-4)"	"prognostic favorable (1.18e-4)"	"unprognostic (9.81e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.88e-4)"	3.8	3.9	2.8	3.4	2.5	6.9	6.8	6.3	3.6	6.1	7.4	10.0	5.6	4.4	4.8	9.8	14.5	4.3	3.3	5.0	1.8	4.7	3.7	6.9	4.2	3.7	5.3	3.8	5.5	16.4	2.8	9.7	3.1	6.3	11.1	7.1	7.1	4.3	4.3	15.6	7.1	3.5	1.2	4.3	8.6	6.4	2.4	8.0	4.1	2.2	5.2	11.6	7.1	4.8	6.7	0.0	7.3	8.9	5.4	4.8	19.4	4.6	3.8	5.5	4.7	7.0	5.7	3.7	4.4	4.2	2.7	8.2	3.8	8.9	7.6	0.3	2.5	5.2	4.8	5.6	2.7	0.1	11.5	2.7	5.8	3.4	0.9	3.9	3.1	5.0	19.9	0.3	6.4	2.8	4.7	6.9	5.6	2.3	5.8	3.9	9.5	1.6	4.0	25.5	4.2	3.3	7.2	3.0	5.3	7.8	12.9	10.3	3.3	12.5	2.6	9.2	4.1	6.7	5.2	4.9	5.8	3.3	4.6	12.6	1.4	1.9	1.1	0.9	1.4	1.0	1.4	1.3	1.8	1.1	1.0	1.6	2.5	3.0	2.9	1.1	1.8	0.8	2.8	2.5	6.3	3.6	5.0	1.8	3.7	5.3	3.1	1.2	2.4	4.8	3.9	16.0	7.9	7.2	2.5	2.9	7.6	5.2	8.0	5.5	3.4	2.7	3.0	1.5	14.6	9.2	35.5	31.1	5.8	25.1	3.9	3.6	16.7	44.8	3.8	4.2	6.7	2.1	10.4	3.6	20.7	3.1	15.3	11.9	10.8	3.3	4.2	1.7	4.5	6.7	6.7	12.7	2.0	5.0	2.8	5.7	2.8	3.0	3.6	2.8	2.2	2.0	4.1	10.6	5.8	5.8	15.9	1.9	2.5	5.7	20.8	2.1	74.1	13.1	0.0	3.9	4.1	9.7	3.5	9.0	4.8	29.8	4.6	1.1	12.1	9.8
ZNF442	FLJ14356	ENSG00000198342	"Zinc finger protein 442"	Q9H7R0	19	12345944-12365905	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.7;Granulosa cells: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 5.5"									"HPA045738, HPA053407"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane"	Vesicles	"HPA045738: AB_10968057, HPA053407: AB_2682138"	"unprognostic (2.61e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.99e-2)"	1.6	1.0	2.5	1.0	4.3	0.5	1.7	3.4	2.3	1.8	5.7	1.1	0.6	1.9	1.1	0.9	2.1	0.6	1.2	2.0	4.5	2.1	2.0	1.2	1.3	10.0	6.0	4.9	1.7	1.3	0.9	1.0	7.7	1.7	1.3	1.2	0.9	2.1	0.8	1.3	0.8	1.6	3.9	1.7	0.9	1.3	6.1	1.2	2.0	1.5	1.0	1.8	1.5	5.3	0.2	0.0	1.7	2.2	1.0	0.5	0.1	2.3	0.6	2.0	1.6	1.6	0.5	2.0	0.7	1.2	0.8	0.4	1.4	1.1	1.9	0.0	0.2	0.1	3.2	1.5	0.8	0.0	1.9	0.9	1.2	0.8	0.3	0.1	0.2	1.4	2.9	0.2	1.8	1.5	2.4	0.3	1.4	0.3	1.0	0.1	2.5	0.1	0.8	1.3	0.1	0.4	0.0	0.0	0.0	1.9	2.2	1.5	0.0	2.6	1.3	3.3	1.4	2.0	5.5	0.0	0.1	0.0	1.0	0.5	0.3	2.2	0.8	0.5	0.5	2.5	0.5	0.5	0.5	0.4	1.3	0.8	0.6	0.4	0.4	0.5	0.0	0.3	2.5	4.3	3.4	2.3	2.0	4.5	10.0	6.0	7.7	3.9	6.1	5.3	7.7	0.0	2.6	1.0	2.4	0.4	1.1	2.2	1.8	1.6	1.9	1.9	2.8	1.5	0.6	1.8	6.2	0.4	1.6	0.7	1.9	0.9	1.0	0.9	1.6	3.2	1.2	0.4	0.9	0.9	0.4	2.5	0.0	1.2	2.5	7.0	3.6	1.6	1.5	0.0	1.5	0.7	2.0	2.4	0.6	0.5	0.6	1.5	3.6	1.9	1.6	2.2	3.1	0.5	1.3	0.2	0.1	0.4	2.7	0.8	0.3	3.7	1.8	1.7	0.0	4.8	3.9	2.4	2.5	1.2	0.6	0.4	1.3	0.6	0.5	0.6
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429706-12441021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.3"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	1.4	1.7	3.2	1.4	3.3	0.6	4.2	3.6	3.8	2.9	2.5	2.8	2.0	2.7	3.1	2.6	2.6	2.1	1.8	2.9	3.1	3.8	3.2	1.6	1.8	3.2	3.3	2.3	2.6	2.8	1.9	3.2	3.0	3.1	3.3	3.3	2.9	3.2	1.1	3.8	2.2	1.8	3.1	1.6	2.4	1.8	3.4	4.0	2.4	1.7	2.2	2.8	2.8	2.9	3.1	1.4	5.4	4.9	1.6	1.3	7.4	2.2	1.6	3.0	2.8	3.0	0.9	3.7	3.9	1.8	1.2	1.8	3.6	2.3	2.5	0.0	1.8	1.5	1.9	7.0	0.4	3.5	4.1	1.2	1.4	1.5	0.7	2.0	1.7	4.5	2.6	0.0	3.3	3.8	13.3	4.8	4.6	3.1	4.6	1.5	5.7	4.5	3.6	11.6	2.6	4.2	3.7	2.0	0.5	3.0	0.0	4.3	1.2	5.9	2.4	3.2	2.2	2.2	3.6	2.3	0.8	3.5	1.2	2.5	0.6	0.9	1.0	0.3	3.7	2.1	2.2	2.2	1.1	1.7	1.9	1.4	0.4	1.6	0.2	0.6	1.8	1.0	3.2	3.3	3.6	3.8	2.9	3.1	3.2	3.3	3.0	3.1	3.4	2.9	3.5	0.0	0.5	10.7	2.4	1.0	1.5	1.2	2.2	1.2	2.8	2.3	2.3	2.8	1.4	0.0	4.2	7.7	2.6	1.8	1.9	2.7	6.3	2.9	1.2	2.8	3.0	1.7	8.9	1.2	1.2	1.4	1.1	3.4	0.0	3.7	1.4	1.6	1.3	1.7	8.1	2.1	2.0	0.9	1.5	2.7	0.6	1.0	0.0	3.7	0.1	3.0	5.2	8.5	5.0	1.1	2.8	2.2	0.6	0.6	1.7	2.2	2.3	2.2	0.0	1.0	1.7	5.0	6.6	3.0	2.6	1.6	2.1	1.2	2.6	0.7
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 118.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	13.2	23.4	33.8	6.3	31.4	3.2	15.8	28.3	36.3	24.1	31.3	32.5	11.4	24.9	7.7	16.5	26.1	9.3	23.9	30.5	30.2	23.7	64.3	18.1	5.7	38.6	32.4	26.0	46.4	7.8	29.3	4.8	31.4	35.2	4.2	5.7	21.6	19.6	18.6	14.6	19.0	5.9	29.1	17.7	32.0	21.3	32.6	16.0	28.8	7.0	4.4	25.8	17.7	32.1	11.3	21.1	19.0	16.7	8.0	8.1	12.5	14.0	9.2	11.7	12.6	23.1	12.4	19.7	12.2	8.1	5.9	10.3	11.8	9.5	4.9	17.3	118.4	19.6	15.3	42.4	13.0	8.7	17.4	9.5	8.5	9.5	7.3	17.6	10.6	24.1	25.7	8.6	8.3	14.6	28.4	24.4	20.5	22.3	38.2	32.7	12.3	10.7	13.0	10.2	20.4	28.0	7.1	23.2	11.2	10.3	23.2	15.7	14.4	20.8	18.2	4.6	15.6	20.5	18.9	15.1	13.1	11.8	13.9	1.9	1.1	2.4	2.3	0.9	2.5	1.2	4.0	4.0	1.2	2.3	4.0	2.7	0.1	2.2	0.6	2.1	2.9	1.4	33.8	31.4	28.3	36.3	30.5	30.2	38.6	32.4	31.4	29.1	32.6	32.1	12.2	3.2	18.1	26.1	11.0	3.1	17.4	15.3	5.2	17.9	13.9	11.8	13.9	28.6	17.6	11.0	8.4	18.8	5.6	15.6	9.8	26.4	28.6	16.2	8.9	15.1	29.3	6.1	10.0	21.9	9.7	10.0	20.9	9.2	10.2	16.8	18.5	38.9	10.7	20.2	10.0	28.0	20.3	7.2	6.1	39.2	12.2	5.5	16.0	5.6	13.6	17.7	12.3	14.6	19.0	18.3	9.9	12.0	8.6	13.5	18.7	26.9	18.3	13.4	26.3	8.5	12.6	13.6	25.6	3.4	5.3	12.4	11.2	43.4	22.9	11.0
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431705-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	4.2	3.0	2.3	1.8	2.5	1.3	3.9	4.3	2.4	6.0	1.1	4.7	1.4	5.1	2.0	2.7	5.0	1.6	3.6	2.4	2.4	3.3	4.9	4.1	1.9	2.1	2.1	7.0	4.4	2.8	5.0	2.0	2.2	4.4	1.7	4.2	3.6	2.1	4.4	3.7	3.5	2.2	1.7	3.9	3.9	3.1	2.2	3.3	3.8	2.7	2.1	4.1	4.4	2.9	1.9	2.1	6.4	5.1	3.5	3.6	2.9	2.5	2.1	3.7	3.7	3.2	1.6	3.3	1.5	2.6	2.3	1.5	4.4	1.7	4.5	3.6	1.6	6.1	4.7	3.2	2.2	7.8	4.9	2.5	2.1	4.2	2.6	3.1	2.6	4.6	4.8	2.4	3.0	1.2	7.5	5.2	4.4	1.2	1.9	3.3	4.0	1.6	2.0	3.8	3.2	3.9	3.9	2.0	1.0	4.7	3.7	3.4	3.2	5.2	4.6	3.2	3.2	1.9	1.5	2.7	1.9	3.8	3.2	1.0	0.3	0.6	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.3	0.2	1.0	0.5	0.8	0.3	0.1	0.1	2.3	2.5	4.3	2.4	2.4	2.4	2.1	2.1	2.2	1.7	2.2	2.9	11.7	12.8	17.4	19.2	8.4	4.1	4.4	2.9	9.6	36.0	4.8	4.4	11.1	5.7	7.6	11.0	37.5	4.1	15.7	3.8	1.9	5.8	2.5	6.3	14.1	9.7	7.2	10.3	21.7	8.4	1.7	9.0	7.1	6.8	11.4	26.6	13.2	10.1	5.7	28.6	24.3	6.3	2.0	16.4	4.7	2.2	9.3	10.5	0.0	9.4	11.6	10.1	22.6	11.6	19.5	4.9	6.0	9.8	9.5	5.6	4.3	2.8	9.6	28.4	13.1	14.5	10.6	6.7	6.9	5.6	2.6	1.4	9.8	9.3	7.2	3.8
ZNF446	"FLJ20626, ZKSCAN20, ZSCAN52"	ENSG00000083838	"Zinc finger protein 446"	Q9NWS9	19	58474017-58481230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052786, HPA078262"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA052786: , HPA078262: "	"unprognostic (1.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.94e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.94e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	6.0	7.2	8.0	3.4	7.7	3.0	6.8	9.4	8.5	9.7	7.2	8.7	3.3	9.4	4.6	5.9	9.9	3.2	6.6	7.8	8.0	9.4	10.8	4.8	4.0	8.5	7.9	11.5	9.3	7.7	12.5	2.3	7.5	10.9	2.2	3.7	6.2	5.5	6.4	9.1	6.5	3.3	7.2	6.6	7.9	13.2	7.6	4.9	9.5	3.1	2.5	8.7	6.5	8.6	4.4	8.8	6.0	6.2	5.8	10.1	5.6	2.6	7.9	2.4	2.8	4.3	4.1	4.0	3.8	3.8	10.2	6.4	2.6	3.5	0.9	5.9	27.7	4.8	6.7	3.9	8.6	2.6	6.9	9.4	6.3	4.0	4.0	8.7	5.2	7.0	2.9	2.8	3.5	5.2	7.0	3.0	2.2	4.1	5.5	6.1	4.2	5.5	4.8	8.0	7.4	6.8	4.9	7.3	4.5	3.3	5.3	3.6	3.7	11.4	3.8	2.4	5.7	9.6	13.2	2.6	5.7	1.4	4.9	2.9	2.1	2.3	2.8	3.1	1.8	2.3	3.3	1.8	3.0	2.8	2.2	2.9	2.6	1.7	5.2	1.9	2.8	1.9	8.0	7.7	9.4	8.5	7.8	8.0	8.5	7.9	7.5	7.2	7.6	8.6	4.8	3.2	3.2	7.8	4.6	2.0	2.3	7.0	4.0	8.9	7.3	8.3	1.0	14.3	5.6	5.5	8.4	5.6	2.2	8.3	3.9	7.9	5.5	14.4	5.7	4.2	10.7	5.7	7.8	5.1	3.8	4.5	6.1	5.8	8.2	6.7	2.2	3.1	4.5	8.4	9.7	6.6	10.2	3.3	2.3	5.2	7.2	2.4	3.6	3.7	2.1	10.8	7.2	5.5	9.5	4.9	4.8	5.3	3.4	1.9	6.8	6.3	11.8	8.5	0.0	6.8	4.8	40.0	21.1	4.1	3.7	3.4	3.4	8.8	5.3	1.5
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.8;Inhibitory neurons: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	7.3	10.3	2.9	4.4	3.2	1.4	6.1	2.6	4.0	5.6	2.7	5.5	3.2	6.4	5.3	3.6	4.4	5.3	5.3	3.2	3.4	3.8	3.5	5.0	3.9	3.2	2.9	4.5	8.3	5.8	4.2	6.8	3.1	5.6	3.4	4.9	4.8	4.3	5.2	3.6	3.7	4.8	2.8	6.1	4.9	2.8	3.8	2.8	7.0	5.5	3.4	4.5	4.7	3.1	2.7	3.8	7.7	6.3	6.8	13.5	3.7	5.1	3.9	3.2	7.8	1.3	3.6	1.7	6.4	4.0	4.3	3.1	5.4	2.3	5.1	2.3	4.6	2.2	4.3	2.0	5.2	1.8	3.2	5.3	6.6	2.7	7.9	4.5	6.2	4.2	2.2	1.8	9.2	1.5	2.3	2.0	2.7	2.6	4.2	1.9	5.1	2.5	4.7	1.6	1.8	4.5	1.2	3.7	3.8	4.9	2.7	2.0	6.1	7.4	2.7	5.0	4.6	1.4	1.8	1.3	2.9	3.0	4.8	0.7	1.2	1.7	1.2	1.5	2.4	0.7	1.1	1.7	1.1	0.4	1.1	1.1	0.3	2.6	3.3	0.7	1.1	1.0	2.9	3.2	2.6	4.0	3.2	3.4	3.2	2.9	3.1	2.8	3.8	3.1	6.7	0.0	2.2	7.8	2.4	0.9	0.9	1.1	1.2	6.0	2.5	2.5	10.2	1.5	1.3	1.8	0.0	2.5	1.3	0.8	0.0	1.7	0.3	1.2	3.4	6.4	3.0	0.8	15.8	0.6	2.1	3.7	3.1	1.1	1.3	6.4	6.8	0.6	4.2	10.1	12.5	0.8	0.0	3.2	1.9	0.5	5.3	2.4	3.6	8.4	5.0	3.9	0.0	9.5	7.2	1.2	1.4	4.1	1.1	1.1	0.6	0.6	2.2	2.8	0.0	2.4	4.0	2.8	2.3	1.0	2.3	1.2	1.9	11.5	0.6	0.6
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912624-43935282	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA038611: AB_10669544, HPA075124: AB_2686735"	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	4.8	5.5	3.0	5.1	3.7	6.3	7.1	6.3	3.4	6.7	3.7	5.2	5.6	7.1	5.5	4.6	6.5	5.1	4.6	3.1	4.9	5.8	5.8	5.9	7.3	3.7	3.4	9.0	4.0	9.7	5.0	5.3	3.2	6.7	6.1	8.5	4.9	5.8	6.5	5.9	5.3	6.0	3.2	7.3	5.0	3.6	3.8	10.7	7.4	5.8	7.1	5.1	3.9	4.5	9.2	12.1	16.9	15.1	8.0	7.0	5.9	11.7	12.7	12.0	18.2	5.9	3.7	13.3	7.0	7.3	9.2	5.2	12.9	8.5	15.0	11.2	13.7	19.7	10.6	5.3	7.4	19.5	12.8	7.1	8.4	8.8	7.7	11.9	9.7	4.5	6.3	5.2	13.0	4.2	11.6	4.9	19.8	8.6	5.1	9.4	16.8	4.8	7.3	20.1	11.6	19.0	16.4	6.6	5.8	10.8	6.9	12.7	10.1	13.3	19.4	5.6	10.8	21.1	37.1	14.5	5.6	7.5	15.7	3.4	3.7	5.7	5.6	3.4	8.4	5.8	5.4	6.0	4.9	4.1	7.4	5.0	1.1	6.3	4.7	3.2	6.1	4.2	3.0	3.7	6.3	3.4	3.1	4.9	3.7	3.4	3.2	3.2	3.8	4.5	2.9	3.2	1.7	7.5	4.2	1.5	0.8	2.2	3.4	1.8	3.1	2.0	3.3	1.5	3.6	0.0	6.2	2.0	5.1	2.4	0.0	2.3	0.2	2.4	1.9	2.4	2.4	3.4	5.0	1.5	1.1	2.3	3.6	2.6	0.0	3.2	1.8	2.1	2.9	3.3	4.9	3.2	2.0	2.8	1.6	0.6	1.8	2.5	1.8	10.3	2.4	1.6	1.0	8.0	9.0	1.2	0.7	4.9	1.5	1.7	2.6	1.9	4.1	2.4	19.7	2.4	1.9	1.1	2.1	3.9	1.6	1.2	3.7	2.4	2.1	1.5
ZNF454	FLJ37444	ENSG00000178187	"Zinc finger protein 454"	Q8N9F8	5	178941191-178966433	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.0;Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 13.1;Spermatocytes: 24.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;EFO-21: 1.9;HHSteC: 1.4;HSkMC: 1.7;NTERA-2: 1.4;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024556	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA024556: AB_1859283"	"unprognostic (1.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.43e-3)"	"unprognostic (2.78e-1)"	0.8	0.5	0.9	0.2	0.4	0.0	1.0	2.9	0.9	1.3	0.0	0.9	0.3	1.4	0.6	0.4	1.6	0.8	0.8	0.5	1.7	0.9	0.1	0.6	0.1	0.6	0.9	1.9	0.9	0.9	2.4	0.7	0.6	1.4	0.5	2.4	0.7	1.2	0.1	0.5	0.4	1.4	0.1	0.4	0.7	2.0	1.5	0.3	1.2	0.3	0.2	1.1	0.9	1.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	1.9	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	2.9	0.9	0.5	1.7	0.6	0.9	0.6	0.1	1.5	1.0	4.4	3.2	6.4	3.3	0.2	0.1	1.3	0.3	1.2	22.0	1.2	1.4	1.2	1.5	5.0	0.0	16.7	1.2	0.2	0.3	1.9	2.3	8.4	1.1	4.7	4.1	0.0	0.0	5.1	0.5	1.2	2.7	1.1	0.7	1.3	5.1	1.1	0.1	0.3	5.0	5.5	0.1	0.0	0.0	0.4	1.8	4.1	0.5	0.0	1.0	0.0	3.5	0.0	7.1	2.3	0.5	0.0	2.6	0.1	1.5	0.2	0.4	2.9	13.1	0.0	3.3	2.2	24.2	7.2	0.4	0.4	0.8	0.3	4.1	0.3	0.8
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57294069	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.5"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	1.9	4.9	5.1	0.7	7.9	6.0	1.6	7.9	6.2	1.4	3.6	0.9	0.3	1.0	0.8	1.3	1.0	1.0	1.4	3.4	4.6	1.1	1.5	1.3	0.9	7.8	6.8	2.3	1.0	1.3	1.7	1.4	9.2	1.1	0.6	2.6	1.3	1.1	1.5	1.9	0.7	1.1	4.8	1.4	0.9	1.8	5.2	1.0	1.4	1.3	1.0	1.1	1.3	19.7	1.2	1.9	1.5	2.1	1.5	1.3	3.8	0.8	1.2	0.9	2.8	2.4	0.7	1.9	0.9	1.0	0.8	0.8	2.0	1.0	1.6	1.4	3.9	1.8	1.6	1.2	1.7	3.2	2.0	0.7	1.8	2.5	2.8	0.7	0.6	2.0	1.8	13.5	1.1	0.9	1.9	0.5	2.1	1.0	1.8	1.4	2.1	0.9	0.6	2.4	1.9	1.0	2.1	1.1	1.2	1.0	0.9	2.2	0.9	2.8	3.3	0.4	1.7	5.7	2.7	3.1	1.0	1.2	0.9	0.0	0.5	1.0	0.7	1.1	0.8	0.8	0.5	0.4	0.1	2.2	1.2	0.5	1.2	0.8	0.7	0.0	1.1	0.7	5.1	7.9	7.9	6.2	3.4	4.6	7.8	6.8	9.2	4.8	5.2	19.7	7.9	3.2	1.5	3.9	11.6	3.1	3.6	0.7	22.2	4.3	4.1	2.8	5.9	1.5	2.0	0.0	0.0	1.4	6.6	1.3	0.0	1.5	3.4	7.0	9.5	4.9	0.0	11.2	6.2	0.4	2.0	7.3	10.2	13.1	0.0	4.7	7.1	2.0	1.1	8.4	5.9	1.2	4.1	1.9	2.2	0.7	1.8	3.3	1.8	1.9	4.0	2.4	4.1	2.5	13.3	1.7	0.2	1.5	16.3	3.0	0.7	0.8	2.4	3.2	0.0	8.1	8.4	3.6	1.4	21.5	2.4	2.6	7.8	3.6	1.3	4.4
ZNF461	"GIOT-1, MGC33911"	ENSG00000197808	"Zinc finger protein 461"	Q8TAF7	19	36636618-36666853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 23.8;Early spermatids: 43.5;granulocytes: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021139	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA021139: AB_10961418"	"unprognostic (8.37e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.01e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.11e-3)"	2.2	3.6	3.5	2.0	3.4	3.0	3.0	6.2	5.2	2.0	1.7	2.2	0.5	3.3	2.5	2.1	3.0	2.0	2.3	3.5	3.4	2.7	2.0	2.0	3.2	2.3	2.6	4.4	1.3	3.2	3.0	3.4	2.6	2.8	1.9	6.6	1.6	2.2	2.2	3.0	1.9	3.2	2.4	3.5	2.5	3.7	3.5	2.5	4.1	2.1	3.2	2.0	2.0	3.7	2.9	4.7	3.5	4.8	2.6	4.9	2.4	2.9	3.0	4.2	5.8	0.8	1.4	0.4	6.2	3.8	4.2	0.6	2.5	3.0	4.6	5.6	3.4	4.9	0.7	1.9	4.1	3.7	5.5	3.5	5.6	1.5	4.3	5.6	2.6	2.4	0.2	0.5	4.3	2.7	6.1	1.7	2.3	0.4	2.1	0.4	3.6	1.0	1.8	6.3	4.6	6.1	0.3	2.1	3.8	3.5	2.2	1.5	3.2	2.5	3.4	2.1	3.7	7.6	12.2	1.6	0.0	0.8	3.6	0.8	0.5	0.5	1.3	1.1	1.7	1.5	2.1	2.8	1.2	2.0	1.6	1.3	0.1	1.4	0.2	0.5	2.0	0.9	3.5	3.4	6.2	5.2	3.5	3.4	2.3	2.6	2.6	2.4	3.5	3.7	2.3	28.9	23.8	8.1	4.1	3.3	2.0	2.3	4.6	5.4	4.7	2.5	2.2	7.2	12.9	3.7	0.0	2.5	2.6	0.9	1.9	1.7	43.5	4.6	2.9	5.2	3.0	0.8	16.3	0.9	2.9	6.2	1.5	4.6	33.5	3.1	2.9	1.2	1.7	3.3	14.0	1.1	0.0	2.5	3.2	8.3	0.9	3.2	0.0	4.7	0.9	1.6	1.0	9.0	12.4	0.8	0.5	1.9	1.2	2.3	0.8	1.8	9.9	3.6	0.0	4.9	3.9	10.2	4.0	3.1	3.4	2.9	6.1	1.9	1.3	1.8
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863166-107013634	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.9;Oligodendrocyte precursor cells: 486.5;Oligodendrocytes: 152.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	3.4	8.4	10.6	1.9	16.6	0.1	3.8	13.9	14.2	8.0	6.2	4.9	1.0	4.2	1.8	7.8	5.2	2.9	5.8	8.6	16.4	3.9	1.6	3.0	0.8	14.7	16.0	7.4	1.1	6.1	4.1	3.1	17.6	6.8	3.8	8.2	7.7	4.1	13.2	6.7	2.2	6.7	10.0	2.9	1.7	5.9	16.0	2.0	7.2	5.8	1.3	3.9	6.2	15.9	4.8	12.6	22.5	14.0	6.9	4.9	3.2	3.2	4.0	2.8	3.0	14.8	5.7	0.1	8.3	2.9	13.8	7.6	14.9	12.4	3.5	0.1	2.1	0.0	5.3	0.1	2.6	3.4	0.4	4.6	6.0	6.8	18.0	7.4	1.3	6.0	0.0	6.7	7.3	8.2	2.7	0.1	16.0	0.0	10.0	0.0	15.4	0.3	7.8	4.4	10.6	12.3	6.3	0.1	4.7	13.7	11.2	0.1	1.3	3.8	13.2	8.1	9.8	0.0	0.1	0.1	5.8	0.3	13.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.6	16.6	13.9	14.2	8.6	16.4	14.7	16.0	17.6	10.0	16.0	15.9	25.6	22.4	29.1	114.9	0.9	33.6	10.8	10.6	44.9	60.7	21.6	18.7	27.7	25.8	10.3	7.3	31.3	14.4	0.2	14.7	5.9	7.9	63.1	7.6	25.5	23.3	16.8	2.1	18.4	2.6	7.3	14.1	4.1	10.1	17.1	18.7	40.4	0.0	1.8	18.5	91.6	15.5	12.2	0.8	4.2	16.8	14.6	1.3	12.4	15.9	2.0	19.8	0.0	486.5	152.2	7.7	5.3	27.1	0.0	15.1	6.3	17.4	15.2	39.4	26.3	21.5	22.1	1.3	24.7	24.0	11.5	3.1	1.1	22.0	17.5	6.6
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 60.2;Distal tubular cells: 39.2;Hepatic stellate cells: 40.7;Kupffer cells: 56.8;monocytes: 37.1;Muller glia cells: 75.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 22.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 48.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 48.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.8;EFO-21: 13.5;HMC-1: 15.9;MCF7: 12.9;SK-BR-3: 12.7;T-47d: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	13.2	9.5	7.1	3.8	12.8	10.7	8.9	5.7	7.5	10.1	4.8	10.6	1.0	10.5	1.5	5.5	13.8	3.1	10.7	6.9	6.7	25.5	14.6	16.3	3.7	8.5	8.5	8.5	14.8	5.6	14.5	2.0	7.5	7.4	1.4	11.1	9.3	3.8	1.6	9.3	7.9	2.7	7.0	27.6	16.1	1.5	8.0	4.2	16.1	3.0	2.3	7.0	6.9	5.5	0.0	3.4	4.2	28.8	0.1	0.0	0.1	0.1	0.0	0.4	0.1	1.0	8.6	0.2	13.5	0.2	0.1	0.3	2.2	0.1	0.2	0.1	0.4	1.6	0.0	0.0	8.7	0.0	15.9	5.8	1.2	0.0	0.1	10.9	3.0	0.6	2.5	0.7	0.0	12.9	0.5	1.4	0.4	1.3	8.3	2.3	0.1	10.7	2.1	0.0	1.4	1.2	0.0	12.7	0.0	1.4	15.6	1.3	6.3	0.2	4.4	0.0	0.0	0.6	0.0	0.2	0.2	4.9	0.1	0.0	8.9	4.4	0.3	3.7	0.2	0.0	0.4	0.4	5.8	0.0	0.6	0.2	48.6	0.2	1.2	2.9	0.0	2.4	7.1	12.8	5.7	7.5	6.9	6.7	8.5	8.5	7.5	7.0	8.0	5.5	10.3	0.0	0.5	4.2	1.2	3.6	0.6	1.3	0.6	60.2	13.3	6.9	2.0	2.8	4.1	0.0	2.1	0.4	10.6	0.0	39.2	7.7	0.4	2.6	5.0	23.7	3.0	8.0	0.8	2.9	0.2	3.9	2.6	2.1	0.0	0.3	40.7	7.7	22.3	6.7	2.9	0.0	8.2	56.8	19.4	0.3	1.5	23.0	1.8	2.8	37.1	75.3	6.2	0.5	0.2	1.8	0.0	1.9	1.1	0.8	0.0	8.5	1.7	6.5	0.0	0.6	2.8	1.0	2.9	0.7	7.4	0.4	2.8	0.3	0.0	0.5
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567468-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.0"					"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	2.0	3.0	8.2	1.0	8.2	0.4	1.9	9.0	12.2	3.0	5.8	3.8	0.9	2.8	3.0	1.8	2.3	1.5	3.6	8.5	8.5	4.4	3.2	1.8	1.4	8.4	8.6	2.6	2.0	2.3	5.3	1.6	8.6	3.7	1.1	12.3	1.7	2.4	1.3	1.8	2.0	1.9	7.7	2.1	2.3	4.6	8.6	1.9	2.5	1.1	1.7	3.5	2.3	8.7	0.0	1.6	5.4	2.3	2.8	2.6	4.5	2.6	1.2	2.0	3.8	0.3	1.3	0.0	1.6	2.9	3.5	0.1	2.3	1.2	2.4	0.0	11.0	4.8	0.1	0.4	2.7	1.0	5.4	3.2	1.8	2.3	0.6	2.1	1.2	0.2	0.0	0.1	3.0	0.0	1.1	1.8	4.4	0.0	0.6	0.2	3.8	0.9	2.2	3.3	2.0	5.1	0.0	0.4	0.7	3.7	1.8	3.0	1.2	0.2	2.2	1.8	3.5	1.7	2.5	0.2	0.0	3.2	0.9	0.5	0.2	0.9	0.6	0.1	1.2	0.7	0.6	0.3	0.4	0.8	0.8	0.8	0.6	0.7	0.3	0.6	0.4	0.3	8.2	8.2	9.0	12.2	8.5	8.5	8.4	8.6	8.6	7.7	8.6	8.7	3.4	3.2	3.6	10.4	1.1	1.0	1.4	1.0	1.2	8.6	2.1	2.0	7.4	2.8	1.7	0.0	10.4	1.1	0.8	0.7	1.9	2.6	2.1	2.1	3.1	4.2	0.0	2.1	10.1	0.6	0.9	3.1	0.5	1.9	7.0	4.1	3.6	2.4	1.2	11.8	9.6	0.8	0.0	0.6	2.1	1.7	2.1	1.6	1.8	2.8	1.8	4.2	1.0	6.6	11.9	1.2	1.5	3.0	0.4	1.9	2.1	2.7	1.5	7.1	6.6	3.9	2.6	7.4	13.4	1.5	0.6	0.3	1.4	2.5	1.9	0.9
ZNF471	"KIAA1396, Z1971, Zfp78"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507850-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 8.5;hTERT-RPE1: 12.6;SuSa: 9.0"					"Low region specificity"	"Detected in all"			HPA066695	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA066695: AB_2685704"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.7	6.3	13.6	2.4	16.1	2.8	7.1	14.0	14.8	10.3	7.4	8.9	1.8	13.3	15.9	4.8	10.5	6.8	5.7	13.4	16.6	5.3	2.4	5.6	3.0	14.8	13.1	22.4	3.6	10.4	8.4	6.2	13.7	8.2	4.5	28.5	6.0	7.5	4.9	9.5	3.2	7.9	9.9	4.4	4.5	8.5	14.7	2.7	9.8	6.3	2.0	7.0	7.6	25.5	0.4	0.5	4.8	0.6	4.1	4.5	0.5	4.5	1.6	2.1	1.8	0.6	0.6	0.6	3.0	5.0	4.0	0.3	0.6	0.4	2.0	1.0	1.8	3.6	1.3	0.5	4.0	1.0	3.1	8.5	1.6	2.6	0.2	12.6	0.2	0.5	1.1	1.3	2.3	0.5	0.4	0.6	1.1	0.3	1.9	0.4	3.1	0.4	3.5	3.7	0.6	2.9	0.4	0.1	0.2	9.0	0.6	0.7	0.7	7.6	3.2	0.6	3.5	1.0	1.1	0.3	0.6	0.5	0.4	1.5	0.4	0.3	0.6	0.3	0.4	0.4	0.5	0.4	0.2	0.9	0.5	0.7	1.8	1.0	0.4	0.5	0.3	0.1	13.6	16.1	14.0	14.8	13.4	16.6	14.8	13.1	13.7	9.9	14.7	25.5	5.7	19.2	18.4	24.8	0.6	0.6	2.4	1.6	2.2	11.2	4.1	4.6	10.9	2.8	7.8	5.5	6.2	1.0	1.7	0.9	3.9	2.1	10.2	8.2	5.9	6.0	1.2	0.4	15.0	1.0	0.4	4.6	1.5	6.7	2.5	8.4	5.0	0.8	0.5	6.7	14.4	0.9	0.0	0.6	0.3	3.6	5.0	1.9	1.8	5.6	0.6	7.9	2.1	20.1	32.3	0.7	0.2	7.2	0.0	2.5	0.5	1.6	11.9	9.5	6.6	7.9	6.7	9.9	8.2	1.6	0.6	0.8	0.9	3.6	1.2	1.6
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 42.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA004191: AB_2667168, HPA073309: AB_2686594"	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	2.9	4.0	2.9	4.9	4.2	4.6	5.7	7.6	3.6	9.0	3.1	2.8	3.7	4.0	3.6	7.3	3.2	2.9	4.4	5.0	3.5	3.3	3.5	3.5	5.2	5.8	4.4	4.6	4.3	5.4	3.0	4.8	4.7	3.0	6.2	2.4	3.9	4.1	3.7	2.4	4.9	4.7	6.7	3.1	42.4	5.4	4.1	4.5	4.6	4.5	3.2	2.4	6.8	14.4	9.6	14.7	12.4	5.7	6.6	8.3	13.2	7.9	18.4	17.2	18.4	9.5	22.2	5.0	7.7	6.8	10.8	18.4	8.8	23.4	15.6	18.0	22.5	8.8	9.3	6.6	16.3	13.1	6.8	16.1	19.3	25.2	7.6	6.2	13.1	32.1	19.3	9.4	6.2	13.0	7.8	10.4	22.4	15.1	15.8	20.5	9.8	6.1	15.6	12.1	13.9	18.6	10.1	8.9	10.0	9.4	14.7	3.0	25.7	13.1	5.2	13.4	8.9	22.8	18.4	6.1	12.7	21.0	2.0	5.0	2.9	6.3	7.3	6.6	11.7	6.3	7.7	5.0	10.0	7.8	10.0	4.4	2.5	3.4	5.3	3.9	4.2	4.0	4.9	5.7	7.6	4.4	5.0	5.2	5.8	4.8	4.7	5.4	6.8	2.8	0.0	1.7	0.3	4.6	4.6	2.9	1.9	6.8	0.7	2.9	2.8	2.2	0.0	1.7	0.0	0.0	2.3	1.5	2.3	3.9	2.4	88.9	5.6	5.1	3.8	1.8	5.2	3.1	3.2	3.2	3.5	7.7	4.0	0.0	3.8	6.8	1.7	2.2	0.0	3.1	3.7	2.0	1.3	1.7	23.3	3.7	2.0	1.8	1.9	3.2	1.7	2.1	1.5	2.8	3.4	3.0	3.8	4.1	4.1	1.6	1.7	10.4	4.3	13.1	3.5	2.7	64.7	20.5	4.8	4.7	1.9	3.5	3.5	2.4	2.1
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	2.9	5.1	7.1	3.4	7.3	2.0	3.2	7.9	8.2	4.5	3.9	8.0	3.7	7.2	2.5	2.8	5.7	2.5	4.4	7.5	6.6	4.2	4.2	3.5	4.5	5.7	6.0	3.2	5.6	6.4	5.1	2.0	5.8	4.6	2.4	3.8	4.2	4.4	5.3	4.2	4.1	4.5	5.3	4.2	4.9	2.4	6.7	8.1	3.5	3.7	3.0	5.5	2.8	7.1	7.7	13.4	32.0	25.2	4.3	3.0	9.8	5.7	9.7	12.1	11.2	6.7	10.0	16.2	10.7	5.3	3.4	6.6	15.7	8.9	6.8	12.0	20.2	7.2	6.9	10.2	5.9	9.6	9.1	2.6	11.0	10.0	6.6	11.4	10.9	14.3	12.6	7.2	5.3	28.1	20.8	11.9	26.4	6.0	5.4	47.7	7.4	20.0	7.4	6.6	25.1	31.6	2.5	16.7	2.5	8.4	11.2	8.9	5.1	7.0	8.1	6.3	6.5	8.6	10.9	14.8	4.0	5.8	1.7	0.0	0.0	0.4	0.9	0.0	0.6	0.3	0.4	0.5	0.1	0.3	0.5	0.6	0.0	0.9	0.0	0.4	0.5	0.1	7.1	7.3	7.9	8.2	7.5	6.6	5.7	6.0	5.8	5.3	6.7	7.1	4.0	3.2	2.2	4.6	6.1	3.1	2.5	1.7	4.0	11.7	4.8	5.1	5.4	14.3	3.9	3.7	8.4	3.7	6.7	4.8	1.9	10.4	0.2	3.7	2.8	5.4	9.6	5.2	4.9	7.4	2.2	2.8	1.5	3.7	17.2	7.5	4.2	3.1	2.7	16.8	5.5	4.0	2.0	1.6	2.6	0.3	2.8	1.7	1.8	2.8	6.9	6.6	3.1	1.0	4.0	7.2	5.4	6.8	2.0	4.3	3.5	4.1	1.0	7.3	0.0	3.0	5.5	3.5	3.3	1.8	5.3	0.3	5.0	3.7	6.1	1.7
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297169-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042218	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	7.6	7.3	4.8	10.4	5.9	9.5	6.6	7.7	6.9	7.5	5.3	10.4	9.8	6.0	3.3	6.5	5.6	4.5	11.1	4.8	6.0	8.7	8.6	6.2	12.6	6.0	5.1	6.9	4.5	7.4	5.9	5.7	6.0	6.2	10.1	10.4	7.2	5.2	10.8	5.5	8.2	6.0	4.2	9.8	9.1	3.3	5.9	15.2	7.2	14.9	15.5	11.1	5.4	8.3	7.2	28.4	18.2	21.2	21.1	19.7	14.1	18.3	26.7	12.8	14.9	12.9	10.0	36.0	11.2	15.1	23.4	15.3	19.9	18.5	18.5	0.3	33.1	37.0	15.2	12.5	20.3	52.7	29.0	18.1	23.4	17.8	20.7	26.7	18.8	31.0	27.0	12.0	29.0	11.7	48.3	10.5	13.7	23.7	22.8	24.5	19.5	30.0	18.8	51.0	17.2	15.0	26.6	18.9	7.4	37.3	15.7	38.1	32.4	12.7	15.8	7.3	28.6	28.4	56.9	74.3	5.7	28.2	23.1	10.1	9.6	11.2	12.6	9.4	14.5	19.7	12.8	15.1	11.9	19.1	12.0	16.3	3.6	17.8	11.4	19.3	15.9	7.8	4.8	5.9	7.7	6.9	4.8	6.0	6.0	5.1	6.0	4.2	5.9	8.3	13.1	35.3	11.8	8.5	20.1	5.5	15.3	22.1	5.7	4.7	6.7	6.1	43.0	8.6	18.2	3.7	2.1	8.7	17.8	11.7	17.6	18.6	2.5	12.7	11.9	17.0	12.6	14.9	1.7	27.6	16.8	11.1	9.7	14.1	12.6	15.4	14.3	15.4	17.6	6.7	4.7	18.0	20.3	15.8	14.3	2.4	9.0	12.3	7.2	6.5	19.0	6.1	26.8	9.5	10.2	36.3	11.8	8.2	9.2	25.4	13.5	24.2	16.8	7.4	0.0	10.6	12.0	1.9	6.1	10.5	8.4	14.8	19.7	12.1	16.1	22.6
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92844182-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.7;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	2.0	2.2	1.9	2.0	2.7	4.1	2.2	9.7	3.3	2.5	0.0	1.6	1.2	2.4	1.7	1.3	2.1	1.6	1.6	1.8	3.4	2.4	1.9	2.0	2.4	2.8	2.8	3.1	1.3	3.6	2.1	2.8	3.1	2.3	1.8	5.3	1.5	2.0	1.1	1.3	1.5	2.1	2.7	2.9	2.1	1.7	3.5	2.6	3.1	2.3	2.8	2.1	1.8	4.0	3.1	3.6	4.7	3.0	2.4	3.0	0.0	2.4	3.8	4.2	4.4	1.2	2.2	2.5	2.1	1.9	2.9	5.0	3.5	3.7	4.4	4.2	1.5	2.2	3.1	2.4	3.7	1.9	3.7	3.3	2.7	4.7	4.9	3.2	3.9	2.8	2.4	10.6	4.5	2.9	2.7	0.8	4.0	3.4	1.7	2.2	5.8	1.9	2.3	3.4	3.2	3.0	4.3	1.2	2.4	3.5	0.2	1.5	3.7	3.7	3.7	2.0	1.8	3.9	2.1	1.5	2.4	1.5	3.1	0.6	1.2	2.8	2.4	1.8	3.1	1.8	2.6	2.1	1.1	2.6	3.4	3.2	0.7	2.4	1.6	1.3	2.2	1.5	1.9	2.7	9.7	3.3	1.8	3.4	2.8	2.8	3.1	2.7	3.5	4.0	6.2	0.0	1.5	9.8	13.2	0.1	0.7	1.1	6.8	5.0	1.6	0.9	2.2	0.0	4.7	1.8	0.0	1.2	6.3	0.9	1.9	1.3	0.7	1.3	4.4	4.9	0.0	3.4	17.7	0.4	1.2	4.3	5.6	1.3	2.5	3.6	0.7	0.6	0.8	5.0	22.6	1.4	4.1	0.6	0.4	0.9	0.6	2.7	0.0	12.2	1.2	3.1	5.2	27.2	19.1	0.7	1.6	1.5	5.8	0.6	0.9	1.5	4.1	3.8	0.0	3.7	4.8	0.8	0.7	3.9	0.1	0.7	9.3	3.3	0.7	0.6
ZNF485		ENSG00000198298	"Zinc finger protein 485"	Q8NCK3	10	43606419-43617904	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.9;Spermatocytes: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA059356	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA059356: AB_2683988"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.46e-6)"	"unprognostic (8.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.41e-2)"	1.4	1.7	2.1	2.2	2.6	0.7	3.7	2.2	2.8	1.7	1.6	2.1	1.7	2.3	1.7	1.9	2.7	1.0	1.3	2.0	2.8	2.1	1.8	1.3	3.3	2.5	2.6	3.9	4.1	1.5	1.0	1.0	2.6	2.6	2.0	1.8	1.8	1.8	3.1	3.9	1.6	1.5	2.0	2.2	2.4	4.0	2.5	2.1	1.9	2.5	3.4	1.7	1.6	3.4	3.3	2.4	1.9	7.1	3.7	4.3	0.1	3.6	1.0	4.0	5.6	6.8	5.1	11.1	3.7	1.4	1.6	3.3	4.2	3.5	6.5	4.9	3.3	0.1	3.0	3.1	2.8	1.8	5.2	3.1	5.8	2.5	4.7	1.8	1.6	1.9	10.4	0.2	7.9	5.4	5.8	5.4	9.7	5.2	3.0	3.1	1.3	2.6	3.6	3.1	7.0	5.5	1.7	5.9	2.2	2.9	9.7	3.8	2.2	2.9	4.3	4.4	5.8	7.3	8.5	2.2	0.6	2.7	2.8	0.1	1.9	0.9	4.3	3.8	6.7	6.0	5.5	4.8	2.6	4.8	9.2	5.7	0.3	13.8	1.3	1.5	4.8	3.3	2.1	2.6	2.2	2.8	2.0	2.8	2.5	2.6	2.6	2.0	2.5	3.4	1.2	0.0	1.1	0.3	2.4	0.6	1.8	1.7	2.8	1.7	2.0	2.3	2.6	1.5	1.8	0.0	0.0	0.9	1.5	0.7	3.9	2.0	8.9	0.6	2.2	1.0	0.0	2.5	2.1	2.0	0.9	1.3	0.5	0.6	0.0	2.5	1.4	1.3	1.5	1.7	2.7	1.9	0.0	0.6	0.4	4.6	0.6	1.1	0.0	1.0	1.0	0.6	2.1	2.0	3.4	1.7	2.1	1.2	0.6	1.6	0.2	1.6	0.2	0.6	0.0	2.4	1.1	19.9	4.7	2.6	0.6	0.3	2.1	2.6	2.4	0.9
ZNF490	KIAA1198	ENSG00000188033	"Zinc finger protein 490"	Q9ULM2	19	12576100-12640098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA005576	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA005576: AB_10602689"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.79e-2)"	0.7	1.0	2.0	1.3	1.9	1.7	1.4	2.1	2.4	1.3	0.3	1.2	1.2	1.0	2.0	0.8	1.5	1.1	0.9	1.6	2.1	1.3	1.8	1.3	2.0	1.0	0.8	1.8	1.5	1.9	0.5	1.1	1.0	1.4	1.3	2.1	1.1	1.3	0.9	1.8	0.9	0.9	0.2	2.4	1.2	1.4	1.7	2.2	2.3	1.0	2.4	1.0	0.5	2.2	0.7	0.6	1.2	3.3	3.5	2.3	1.0	0.9	1.6	1.2	1.5	1.1	1.0	1.2	2.0	1.2	0.8	0.9	1.7	1.4	1.6	1.6	1.0	1.5	1.4	1.4	1.9	2.9	3.6	1.8	1.6	1.0	2.2	1.7	1.1	1.4	1.1	1.4	1.6	1.5	2.0	2.2	1.8	0.6	1.8	1.5	1.8	2.1	1.4	1.8	2.2	1.5	1.9	1.2	1.5	1.8	1.7	1.7	1.6	3.0	0.8	2.2	1.0	4.3	3.3	1.5	1.6	1.9	2.0	5.0	1.5	2.3	2.7	2.1	2.5	2.2	1.7	2.6	1.3	2.8	1.5	2.6	1.4	3.8	2.6	3.8	2.3	1.0	2.0	1.9	2.1	2.4	1.6	2.1	1.0	0.8	1.0	0.2	1.7	2.2	1.7	0.0	1.1	7.2	7.4	0.5	0.3	1.2	2.8	1.4	1.8	1.8	1.2	1.5	1.7	0.0	0.0	0.3	2.7	0.9	1.9	0.2	3.9	1.6	3.0	1.5	0.0	3.8	10.2	0.2	0.2	2.4	13.7	2.3	5.7	1.5	0.0	1.0	0.4	0.0	9.3	0.1	0.0	1.6	1.8	1.6	0.6	2.4	3.6	6.5	0.3	0.5	1.0	4.0	10.0	0.2	0.1	0.0	14.8	0.3	0.9	0.3	0.8	0.8	6.6	0.8	2.2	0.9	1.0	4.9	0.3	0.8	6.0	1.1	0.5	0.2
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Respiratory ciliated cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.2"									HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Cell Junctions"	"HPA047872: AB_2680196"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.7	1.4	2.3	1.8	3.3	1.6	1.8	6.4	3.2	2.6	3.7	1.0	1.3	2.3	1.9	2.1	5.7	1.2	1.4	2.7	0.9	3.5	3.1	1.8	2.5	1.6	1.7	2.5	2.5	1.4	4.5	0.9	0.9	2.4	0.8	1.8	2.7	1.1	0.7	2.7	1.2	0.4	0.8	2.3	1.6	1.6	1.6	0.5	3.7	0.0	0.4	0.9	1.7	3.9	2.0	6.8	6.0	5.8	0.2	0.1	7.9	3.7	0.0	0.0	0.0	0.5	2.2	4.0	1.9	0.0	3.3	0.9	0.7	0.4	0.0	4.2	20.2	3.6	2.2	1.2	0.3	1.5	9.2	0.5	0.9	0.1	0.7	6.6	0.0	9.8	3.1	0.6	0.1	7.1	5.1	5.1	3.7	1.7	2.1	12.6	4.4	2.1	0.6	1.6	4.6	6.6	2.0	5.9	3.3	3.0	8.1	4.1	0.6	6.6	3.4	0.6	1.2	8.7	11.1	3.5	1.8	4.1	3.6	1.3	1.1	0.3	0.8	0.4	0.9	1.3	1.0	1.0	1.0	1.5	0.9	1.7	0.3	0.8	0.3	1.8	1.2	0.7	2.3	3.3	6.4	3.2	2.7	0.9	1.6	1.7	0.9	0.8	1.6	3.9	0.3	6.4	0.5	3.9	0.9	0.3	0.4	1.0	1.2	1.4	2.1	1.3	0.7	0.0	1.0	0.0	0.0	2.0	0.1	0.5	1.9	1.4	1.7	3.6	0.6	0.6	0.0	1.3	3.1	0.2	0.5	0.5	1.5	1.2	0.0	1.9	0.0	1.9	0.5	0.0	3.0	1.4	0.0	0.0	0.4	0.9	0.0	0.2	0.0	1.9	0.1	1.3	0.0	3.0	3.5	0.3	1.2	0.0	0.7	0.3	0.4	0.7	5.2	1.6	0.0	0.4	0.4	0.3	1.7	0.8	0.3	0.3	0.5	0.3	1.2	0.1
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: AB_2683565"	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	4.1	3.2	1.7	2.5	1.9	2.2	4.1	4.4	3.1	5.4	1.8	4.7	2.8	6.0	1.6	3.2	4.9	1.9	3.0	2.4	1.1	3.0	2.7	3.1	3.1	2.3	1.7	6.6	3.6	2.6	4.0	2.2	1.1	4.8	1.7	1.7	4.2	2.6	3.3	4.5	3.5	1.5	0.5	4.7	3.6	3.8	1.4	2.4	4.6	1.4	2.2	4.8	4.4	3.0	1.8	7.2	2.3	6.2	2.7	2.4	10.7	5.2	5.7	6.4	4.3	3.2	3.4	3.8	4.4	2.8	2.3	4.0	4.5	2.7	4.6	2.8	7.4	3.1	10.8	4.4	3.8	2.3	3.3	2.9	6.5	2.9	5.3	6.2	3.6	4.8	4.7	5.9	2.5	4.0	4.7	4.0	3.0	1.4	2.6	8.1	5.6	7.6	2.1	2.0	8.7	5.7	4.5	6.6	2.0	1.6	4.3	3.6	4.1	6.0	4.4	6.7	2.5	5.6	4.1	3.4	1.8	1.9	3.8	1.3	1.0	1.5	1.5	1.0	1.2	2.1	0.9	1.1	0.5	1.9	1.5	1.9	1.1	1.2	0.7	2.6	1.7	1.0	1.7	1.9	4.4	3.1	2.4	1.1	2.3	1.7	1.1	0.5	1.4	3.0	4.8	12.8	2.7	5.5	5.8	2.4	3.2	3.6	1.8	19.1	3.7	3.0	5.3	5.7	3.0	7.3	25.0	6.8	10.1	4.6	1.9	4.6	8.9	5.1	6.4	5.5	8.4	5.7	8.8	3.1	4.4	5.9	4.6	2.9	7.0	12.0	12.1	4.1	3.3	18.5	6.3	6.8	4.1	4.8	3.8	1.8	11.5	3.4	1.8	3.7	8.4	11.1	6.2	6.0	5.9	3.5	2.3	11.3	4.3	5.2	7.3	3.3	6.6	20.8	0.0	8.0	4.8	13.2	8.8	1.7	2.3	4.5	5.0	9.8	5.5	1.8
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 3.5"									HPA044161	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA044161: AB_2678841"	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	1.6	0.5	1.0	0.7	1.2	0.1	1.8	1.4	1.1	1.4	0.3	1.9	0.4	2.0	0.5	0.9	1.6	0.6	1.2	0.9	1.0	1.4	0.4	0.9	0.8	1.0	1.1	2.1	1.4	0.5	0.8	1.2	1.0	1.7	0.8	2.0	1.1	1.4	1.2	1.1	1.0	1.3	1.1	1.1	1.1	1.9	1.1	0.8	1.3	1.2	0.9	1.6	1.2	1.0	0.0	0.0	1.1	0.0	2.0	3.5	0.4	1.3	1.2	1.4	1.6	0.5	0.5	1.0	0.0	0.6	1.0	0.4	0.0	0.5	1.3	0.0	0.7	0.0	0.1	1.0	2.8	0.0	0.0	2.0	1.3	1.6	0.1	0.4	0.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	2.6	0.6	0.0	0.7	0.0	0.5	1.1	0.7	1.4	0.9	0.8	0.8	0.5	2.1	0.0	0.1	0.5	0.0	1.2	1.3	1.0	2.2	1.6	0.0	0.0	0.0	1.7	0.5	0.2	0.9	0.7	0.2	0.9	0.8	0.6	0.7	0.3	1.0	0.9	0.6	0.3	0.8	0.3	0.3	0.7	0.3	1.0	1.2	1.4	1.1	0.9	1.0	1.0	1.1	1.0	1.1	1.1	1.0	3.5	0.0	0.5	3.6	2.4	0.9	1.5	1.5	2.8	3.5	2.0	1.8	3.5	1.5	1.8	3.7	2.1	1.9	0.9	0.5	0.0	2.9	1.1	1.3	2.5	2.3	1.2	3.4	1.3	1.9	2.0	3.2	3.1	1.1	0.0	3.1	2.2	1.0	1.6	10.1	3.3	1.0	2.0	1.3	0.8	1.9	1.5	0.9	0.0	1.0	1.5	9.0	5.2	3.5	3.9	1.9	0.4	1.5	3.1	0.9	0.7	1.1	0.9	4.0	6.6	3.1	3.8	7.0	11.3	1.8	1.6	0.3	1.8	2.5	1.3	0.8
ZNF502	"FLJ12515, FLJ14855"	ENSG00000196653	"Zinc finger protein 502"	Q8TBZ5	3	44712643-44723831	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 16.2;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024761, HPA029557"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA024761: AB_10599830, HPA029557: AB_10601448"	"unprognostic (1.80e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (1.88e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.06e-4)"	3.0	3.1	1.5	0.9	1.8	0.8	3.5	2.7	1.7	4.2	1.2	3.9	0.8	4.6	1.3	2.6	4.1	0.9	2.8	1.6	1.8	4.2	2.1	1.9	1.2	1.6	1.7	5.3	4.0	1.3	4.2	1.8	1.5	4.9	1.5	5.2	3.2	2.2	3.2	3.6	2.6	1.9	1.5	3.4	3.1	5.0	1.8	1.4	3.8	2.3	1.1	3.9	3.4	1.5	0.0	0.7	1.9	0.0	2.1	3.0	0.0	1.6	0.4	1.9	1.1	0.1	0.9	0.0	0.5	1.5	2.0	1.0	0.0	2.4	1.6	0.0	0.9	0.0	0.0	0.0	2.3	0.0	0.9	2.4	0.9	2.2	0.0	0.5	1.4	0.0	0.0	0.0	1.9	0.0	0.0	0.5	3.1	0.5	0.0	0.0	1.2	0.0	2.2	2.4	2.0	2.5	0.9	1.6	0.0	2.2	0.0	0.0	1.8	0.0	1.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.4	0.6	0.3	1.0	0.8	1.0	0.8	0.5	1.2	1.5	1.2	0.0	1.2	0.3	0.3	0.2	0.3	1.5	1.8	2.7	1.7	1.6	1.8	1.6	1.7	1.5	1.5	1.8	1.5	4.0	6.4	5.1	3.3	3.9	1.7	3.3	3.2	4.0	12.0	2.4	3.6	4.5	2.8	4.4	3.7	14.6	2.5	3.3	1.4	0.0	3.2	3.1	1.0	3.4	5.4	4.9	1.7	3.0	3.0	1.3	3.2	1.5	1.5	2.5	5.6	4.2	1.6	1.1	10.1	5.9	1.6	4.1	0.8	0.7	2.9	4.7	1.0	0.0	3.7	2.1	11.5	2.1	3.0	2.6	2.7	1.1	6.8	0.5	3.4	2.0	1.6	3.1	16.2	0.0	4.6	2.8	14.1	17.8	2.6	2.6	1.5	1.9	4.3	3.0	1.9
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401764	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	14.5	39.9	6.1	3.1	10.1	2.0	9.2	3.8	5.2	34.5	1.0	17.7	8.1	44.1	10.3	20.1	23.8	2.4	9.0	7.4	5.5	25.6	7.1	14.2	1.5	12.0	9.2	46.3	25.4	4.6	4.8	3.3	7.6	17.5	1.8	1.4	9.5	17.6	3.6	5.3	8.5	7.7	10.0	8.0	16.3	2.4	8.1	1.1	7.8	2.1	1.0	13.8	18.2	6.5	5.2	4.9	1.1	6.3	10.6	7.1	1.6	4.6	2.8	1.9	1.7	7.5	20.4	0.0	13.4	4.6	1.1	9.4	0.7	4.9	1.4	0.0	115.1	0.0	12.4	24.8	8.5	6.1	12.9	19.1	4.8	3.5	2.0	16.6	0.5	0.5	0.1	0.2	2.6	2.7	0.2	18.8	0.1	3.8	149.2	0.0	5.6	0.1	2.8	4.1	4.1	5.2	8.5	0.6	27.1	1.0	1.0	4.2	3.9	14.6	16.3	30.7	13.0	0.0	0.0	0.0	44.9	27.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.1	3.8	5.2	7.4	5.5	12.0	9.2	7.6	10.0	8.1	6.5	27.2	38.5	11.6	2.3	1.7	27.1	35.6	15.0	255.0	23.7	7.7	42.3	20.4	10.0	10.1	40.5	20.9	0.5	2.1	0.8	58.7	45.9	0.1	53.2	72.2	41.0	3.6	5.3	12.6	34.7	0.3	60.1	18.3	48.1	6.3	2.7	44.6	10.3	13.5	6.7	3.2	6.7	10.2	27.4	30.5	2.0	59.7	30.7	24.9	13.1	8.2	7.7	0.0	4.0	0.7	33.2	1.5	49.2	3.9	19.7	13.4	32.5	1.7	26.3	39.5	10.2	78.1	0.2	6.0	189.3	13.9	0.3	4.0	24.5	9.7	14.3
ZNF507	"KIAA1084, Zfp507"	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: AB_2680864"	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	5.1	4.2	4.3	4.6	5.7	6.8	6.8	6.4	5.6	5.9	3.4	4.9	5.7	6.8	4.3	5.1	5.9	4.3	5.6	4.4	4.8	4.7	6.3	4.4	6.7	4.7	5.3	9.5	5.3	6.2	3.7	7.0	5.0	5.9	5.3	8.1	6.4	4.7	9.2	4.7	5.9	6.0	4.8	5.2	5.2	13.1	4.7	8.6	10.7	8.7	5.8	4.3	4.1	7.3	10.0	16.2	13.5	8.2	9.3	14.6	11.4	8.5	8.1	7.3	8.1	9.8	7.6	15.1	10.5	7.8	8.3	5.9	19.4	10.5	14.8	10.6	15.3	14.8	8.7	7.7	11.0	12.8	8.0	9.5	8.9	9.0	15.4	8.6	10.9	11.9	21.0	10.7	8.6	5.8	13.5	5.2	14.9	15.0	5.8	14.0	16.1	6.4	5.5	9.9	11.9	10.5	11.2	7.8	10.2	10.7	5.9	9.5	10.4	12.6	13.3	8.0	11.9	10.4	12.9	14.1	8.7	9.3	11.5	0.2	0.0	0.5	1.0	0.0	1.1	0.7	0.8	0.8	0.0	1.0	1.1	0.9	0.5	0.6	0.0	0.1	0.6	0.4	4.3	5.7	6.4	5.6	4.4	4.8	4.7	5.3	5.0	4.8	4.7	7.3	13.3	9.6	17.7	22.5	13.2	2.8	8.8	5.3	13.6	22.2	9.3	7.6	16.1	5.7	9.0	0.0	14.6	10.9	7.7	7.6	1.9	5.6	22.1	10.0	22.7	11.0	9.0	12.4	31.3	5.5	5.3	11.9	12.2	11.4	3.8	17.1	13.6	12.1	3.7	58.9	36.0	11.5	4.1	0.3	1.8	11.0	9.3	0.8	1.8	16.9	0.4	17.2	10.3	31.2	46.6	4.9	8.0	7.2	6.4	12.0	15.6	4.2	16.1	23.5	0.0	16.1	13.9	25.8	18.9	10.9	2.7	8.8	11.3	12.6	11.2	7.6
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96754553-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	3.6	3.8	4.8	3.3	4.7	2.3	4.8	8.3	6.1	5.2	2.4	3.9	2.6	4.7	3.5	2.7	4.0	2.7	3.6	4.9	5.2	3.8	3.8	3.3	4.3	3.6	4.2	5.7	5.1	5.0	4.6	3.1	3.7	4.3	3.3	11.7	3.3	4.3	4.3	3.4	2.9	4.1	4.0	4.2	3.4	3.3	5.2	5.5	4.7	4.8	4.7	3.7	3.2	5.2	4.2	4.3	8.1	7.2	6.7	6.3	4.0	3.7	6.5	6.1	6.4	3.7	2.7	5.7	2.2	3.7	5.8	8.7	3.2	3.3	5.8	6.5	3.7	6.0	7.0	2.5	3.5	3.5	5.2	4.3	5.8	4.5	6.9	6.5	5.3	8.2	6.8	4.5	7.8	3.9	9.3	5.2	6.6	5.9	3.6	5.6	14.4	2.4	4.3	3.2	9.9	7.8	7.0	3.9	3.8	5.4	3.1	6.2	4.1	4.4	4.5	5.6	5.9	8.8	9.8	3.5	2.7	2.0	4.6	0.4	0.2	0.6	0.7	0.3	1.2	0.9	1.2	0.9	0.2	1.0	1.3	0.9	0.1	1.4	0.8	0.3	0.8	0.4	4.8	4.7	8.3	6.1	4.9	5.2	3.6	4.2	3.7	4.0	5.2	5.2	5.5	3.2	3.2	13.4	4.5	1.7	1.6	1.7	0.6	11.0	2.6	2.5	5.1	1.5	2.9	3.7	2.1	2.2	3.2	1.4	1.9	2.2	5.7	3.5	6.3	4.2	1.2	4.0	21.5	2.6	1.4	5.7	2.0	4.0	1.3	5.7	3.6	1.3	2.0	16.8	22.7	2.1	2.0	2.5	0.5	6.9	5.9	2.2	5.4	10.3	2.0	4.5	8.2	18.1	20.5	1.8	2.8	4.1	3.1	2.0	1.0	1.9	3.2	6.5	6.6	4.6	3.3	3.6	5.6	1.8	1.4	0.8	4.6	4.3	1.5	1.1
ZNF511	"MGC30006, Zfp511"	ENSG00000198546	"Zinc finger protein 511"	Q8NB15	10	133308914-133313162	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035360	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931"	"unprognostic (3.35e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.52e-2)"	12.7	11.6	15.9	8.7	16.2	17.1	11.3	15.5	17.2	15.8	17.5	19.7	16.1	15.7	10.7	10.8	15.4	9.4	21.2	15.4	15.4	10.4	21.3	11.4	12.6	16.7	15.9	20.4	15.5	14.7	12.7	8.7	15.7	16.1	12.8	5.8	16.7	10.7	49.1	7.9	13.2	11.1	16.4	12.5	12.5	9.6	16.8	11.4	10.9	31.9	9.7	13.6	12.5	16.5	54.1	54.0	30.3	43.8	25.6	21.6	32.6	25.2	39.3	53.3	44.4	88.0	50.9	48.2	24.4	29.5	33.9	48.8	41.9	36.0	23.2	38.8	92.1	29.1	22.1	53.4	21.0	57.5	52.1	22.0	19.2	43.7	26.5	30.6	24.3	22.7	40.0	22.4	18.6	71.2	27.5	76.1	37.3	50.2	74.6	37.1	37.1	12.4	28.3	18.6	16.9	37.0	16.8	30.0	38.2	18.7	23.2	33.1	23.3	23.1	35.4	26.5	68.5	31.3	36.4	66.1	37.5	26.8	12.9	40.2	61.1	68.6	45.4	52.6	35.6	66.6	37.0	46.6	61.0	51.8	41.6	40.8	8.5	41.0	51.1	65.9	36.2	47.3	15.9	16.2	15.5	17.2	15.4	15.4	16.7	15.9	15.7	16.4	16.8	16.5	16.3	16.0	14.5	7.5	33.6	29.6	45.6	40.7	39.3	19.5	37.3	52.6	23.6	25.8	21.9	22.0	8.4	61.2	36.7	33.3	70.5	39.5	29.5	18.5	22.4	20.9	53.4	40.2	10.7	41.2	62.9	34.0	20.4	15.2	78.1	40.6	20.3	54.4	47.4	21.9	7.6	128.8	22.4	33.9	38.0	8.8	41.7	39.9	16.0	5.6	64.3	27.4	41.2	3.5	12.3	38.6	44.0	30.5	40.4	43.0	60.8	72.1	23.2	23.6	26.3	27.3	34.5	58.1	48.0	36.3	35.9	28.2	33.0	38.6	65.9	41.5
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	13	"intestine: 9.2;kidney: 8.4;liver: 30.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;RPMI-8226: 1.0"									"HPA035360, HPA038713, HPA052451"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		0.2	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.2	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.4	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	9.2	0.0	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF512	KIAA1805	ENSG00000243943	"Zinc finger protein 512"	Q96ME7	2	27582969-27623217	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031430	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031430: AB_10603844"	"prognostic favorable (9.79e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.75e-3)"	"prognostic favorable (5.08e-9)"	"unprognostic (6.08e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (1.10e-2)"	"unprognostic (8.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-2)"	"unprognostic (5.60e-3)"	11.3	13.1	8.8	10.7	9.4	6.1	16.6	9.1	12.6	19.5	8.1	16.5	7.8	25.0	14.9	8.3	21.4	10.9	13.1	9.1	12.5	12.4	7.0	13.8	16.9	8.6	10.3	34.3	7.7	20.1	13.6	13.0	9.1	18.1	12.0	26.4	11.1	19.2	7.4	7.2	12.9	16.9	8.7	17.0	11.0	13.2	11.5	27.0	20.5	10.5	17.5	16.4	13.0	11.1	26.2	22.8	46.2	20.6	22.4	25.2	0.0	12.7	17.9	23.6	27.7	17.7	16.2	22.8	14.0	14.6	19.6	8.7	41.3	12.0	25.0	21.2	33.0	47.9	18.4	27.0	17.3	31.4	20.8	23.2	12.9	18.4	5.3	18.9	37.9	39.3	42.0	16.2	35.0	3.3	3.3	24.0	32.1	17.2	0.0	52.2	65.0	19.8	16.8	7.2	45.0	44.8	12.0	7.6	36.0	21.9	9.3	17.8	31.5	8.3	20.0	8.6	16.8	16.2	12.1	38.9	12.5	38.4	17.3	24.5	5.5	9.8	10.2	6.7	14.1	12.4	12.9	15.0	8.2	11.1	17.1	14.6	1.7	22.1	5.5	5.9	9.8	10.8	8.8	9.4	9.1	12.6	9.1	12.5	8.6	10.3	9.1	8.7	11.5	11.1	8.9	9.6	14.2	16.6	10.0	3.8	10.4	4.3	6.8	22.8	8.1	7.6	15.6	7.2	7.8	18.4	16.7	1.6	9.7	2.2	9.8	6.8	11.9	5.2	12.7	11.5	9.0	14.7	22.5	1.9	1.1	11.6	8.2	5.2	6.3	25.5	11.7	4.4	5.3	18.5	28.9	6.3	6.1	7.2	7.1	5.7	14.9	6.2	1.8	23.4	8.9	17.0	9.2	25.1	27.2	4.6	3.3	17.3	9.0	5.8	2.3	4.2	8.9	15.7	19.7	14.6	13.4	8.3	9.0	6.6	3.0	1.2	10.3	13.6	5.0	6.9
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956704-63969930	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.4;Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006688, HPA008731"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006688: AB_10963053, HPA008731: "	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	8.6	11.4	8.4	5.5	8.4	5.9	10.4	4.8	11.4	12.9	0.9	10.9	4.4	13.8	2.8	17.2	12.2	5.9	9.6	8.8	7.0	12.4	21.3	8.4	6.2	5.1	5.5	14.2	15.0	9.1	20.8	7.9	4.5	13.0	1.4	4.5	12.6	7.7	12.1	14.4	7.2	5.9	2.9	10.3	10.3	10.2	6.3	8.3	19.7	5.2	4.1	11.4	10.9	5.8	10.2	16.8	18.6	19.8	8.1	5.9	17.0	14.4	11.2	42.3	13.8	33.1	16.8	6.6	34.5	12.6	7.8	12.8	14.1	21.4	10.1	11.0	20.3	16.4	26.4	31.9	12.9	8.9	18.9	12.5	17.3	14.7	8.4	11.1	13.3	29.4	23.1	9.9	8.5	24.3	43.6	19.2	12.9	12.9	21.8	19.8	1.7	20.1	7.6	16.9	27.2	15.8	11.9	19.4	9.8	8.8	40.9	21.4	18.8	40.4	6.2	10.3	12.6	23.6	12.1	18.3	14.5	0.1	17.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.4	8.4	4.8	11.4	8.8	7.0	5.1	5.5	4.5	2.9	6.3	5.8	6.7	3.2	5.6	1.6	3.1	5.4	3.5	5.3	4.6	22.4	10.3	9.5	2.9	5.7	6.5	1.8	22.9	7.8	6.1	0.1	1.9	3.7	0.1	5.2	12.0	5.8	6.0	3.4	1.1	6.1	2.9	6.7	3.6	9.6	0.0	14.0	8.6	19.4	3.9	13.5	1.4	0.8	8.2	1.9	2.5	1.3	6.5	1.7	5.4	1.0	2.3	7.3	4.1	1.5	0.6	3.2	0.2	6.8	5.2	3.5	2.2	5.7	2.6	10.6	0.0	8.7	5.6	6.5	4.1	11.1	7.0	5.1	3.6	14.3	1.2	2.8
ZNF513	"FLJ32203, RP58, Zfp513"	ENSG00000163795	"Zinc finger protein 513"	Q8N8E2	2	27377235-27380790	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	DNA-binding	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051493	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"			"HPA051493: AB_2681505"	"unprognostic (1.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (6.21e-5)"	"unprognostic (2.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.18e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	16.2	23.7	15.7	12.7	15.0	12.1	16.7	17.5	19.2	16.6	12.6	22.5	18.7	18.2	5.7	23.8	16.7	9.3	14.3	15.2	14.2	27.3	38.5	18.2	11.1	15.5	15.4	13.4	20.5	10.1	30.2	6.6	14.4	25.8	7.8	4.8	18.7	10.6	11.4	19.5	23.6	7.1	14.1	27.2	24.2	36.1	16.6	8.7	23.5	5.4	6.5	19.4	17.2	15.1	10.3	12.4	15.7	16.0	10.3	8.6	20.6	13.1	15.1	9.6	8.3	10.2	7.6	3.5	11.6	9.4	10.1	9.1	6.7	11.8	2.8	13.0	11.0	9.9	8.9	7.7	18.3	3.4	26.6	14.7	13.0	9.5	11.5	6.3	11.4	13.8	6.2	2.1	9.2	3.9	6.4	16.6	23.7	9.9	8.0	8.2	11.7	6.6	13.5	17.8	9.7	50.8	6.4	7.4	12.9	8.5	5.5	9.8	10.9	6.7	4.4	5.5	3.9	30.1	19.9	6.6	9.3	8.0	13.5	1.2	0.5	1.0	0.4	1.0	0.0	0.0	0.4	0.1	0.7	0.1	0.4	0.2	0.8	0.0	0.5	0.7	0.0	0.3	15.7	15.0	17.5	19.2	15.2	14.2	15.5	15.4	14.4	14.1	16.6	15.1	7.2	3.2	7.5	4.9	2.5	9.2	6.0	5.7	10.2	7.9	10.3	6.9	0.4	10.0	4.3	5.5	4.2	5.6	4.0	14.8	0.0	6.2	44.1	9.0	8.9	7.7	8.4	4.4	4.5	10.2	4.7	4.9	22.4	11.5	0.0	6.9	2.5	10.8	6.0	5.0	5.1	10.6	6.1	2.9	4.6	10.5	4.1	5.3	5.4	1.9	5.9	11.7	2.1	3.0	3.7	9.0	13.5	3.4	4.8	11.0	9.2	5.2	4.7	6.5	6.6	5.6	6.2	9.3	10.3	12.2	13.4	16.1	4.5	10.8	9.4	13.6
ZNF514	FLJ14457	ENSG00000144026	"Zinc finger protein 514"	Q96K75	2	95145000-95165413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028974	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA028974: AB_10603845"	"unprognostic (8.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-2)"	9.3	9.3	13.5	5.9	13.5	2.5	13.2	14.5	14.4	18.3	12.6	14.1	10.2	15.7	26.8	7.8	14.5	5.9	9.6	13.9	13.1	14.2	6.6	9.0	8.7	13.5	12.7	23.3	10.2	12.7	17.2	8.1	14.3	14.8	9.9	29.9	11.7	11.3	14.4	15.0	9.8	10.5	10.9	10.1	10.8	11.2	13.8	10.1	17.9	13.3	8.2	11.4	13.0	15.9	16.7	5.5	16.0	11.5	11.1	15.0	12.2	6.6	7.2	11.0	11.2	9.3	6.5	2.8	3.3	7.1	16.8	10.7	8.6	6.3	12.2	5.5	11.1	3.2	8.8	7.6	4.6	1.9	8.3	8.9	18.9	6.9	4.7	16.4	5.1	9.5	9.3	3.4	8.9	8.2	5.0	10.3	5.3	5.4	6.0	8.5	5.8	6.1	7.1	6.6	14.8	11.2	7.1	3.5	7.6	21.6	6.3	6.4	5.9	7.9	9.9	2.7	5.6	8.5	6.9	4.9	8.2	3.7	5.2	12.7	4.3	8.4	3.9	2.3	4.7	6.8	5.1	3.7	4.2	7.0	8.5	7.0	1.4	6.1	2.6	3.5	6.2	4.2	13.5	13.5	14.5	14.4	13.9	13.1	13.5	12.7	14.3	10.9	13.8	15.9	8.0	9.6	7.9	20.2	4.6	5.6	9.9	8.0	2.2	13.9	9.4	11.9	14.0	12.8	6.7	0.0	18.8	6.3	4.9	6.3	27.4	6.6	44.1	7.1	7.9	8.0	9.6	7.0	22.8	5.2	3.5	7.2	4.6	5.3	1.3	27.9	7.1	9.4	8.3	15.2	22.3	10.6	10.2	5.1	2.2	43.2	10.5	5.4	7.2	13.1	5.9	12.9	8.2	15.1	34.3	4.9	5.1	7.5	3.1	10.0	10.3	18.2	10.3	31.5	6.6	7.9	8.0	20.6	12.5	3.8	6.3	3.7	4.7	8.2	8.7	10.7
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76357682-76495242	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Early spermatids: 77.4;Endometrial stromal cells: 78.9;Langerhans cells: 69.7;Oligodendrocyte precursor cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	5.8	7.6	19.6	4.5	18.5	24.5	6.4	9.4	11.2	32.2	2.3	8.4	6.2	32.2	8.5	9.0	23.6	5.1	5.3	18.1	21.9	4.6	6.2	7.6	3.0	16.8	18.2	22.8	6.8	9.5	11.3	3.0	10.8	9.7	2.6	16.2	6.4	17.3	14.2	10.1	6.2	11.8	10.7	6.8	6.3	34.4	18.8	4.4	6.4	5.9	2.8	10.3	15.3	6.8	2.4	2.7	18.8	25.0	5.3	8.0	2.4	14.6	12.1	3.1	5.7	5.5	8.9	12.7	3.0	15.5	7.7	5.2	10.4	14.0	2.0	0.0	8.0	1.2	0.0	11.7	13.2	8.5	8.3	15.4	5.9	6.3	6.7	4.2	3.5	5.2	0.0	0.0	3.0	5.2	0.2	14.4	9.5	1.5	0.7	5.7	1.9	6.6	4.7	11.1	18.9	11.3	0.2	0.0	15.3	7.3	3.1	33.2	2.3	7.1	12.4	0.2	1.5	0.1	0.4	9.9	4.2	5.8	18.6	2.5	1.8	2.9	0.0	1.2	0.4	0.0	0.1	0.0	1.2	0.3	0.4	0.2	10.2	0.7	1.4	0.8	0.0	0.4	19.6	18.5	9.4	11.2	18.1	21.9	16.8	18.2	10.8	10.7	18.8	6.8	9.6	9.6	10.1	75.1	5.0	19.5	17.9	12.7	9.1	15.0	8.6	8.1	8.5	5.7	8.8	1.8	31.3	0.3	6.1	4.2	3.9	5.8	77.4	33.1	78.9	9.8	12.6	3.0	19.8	2.9	0.4	15.6	4.6	47.7	1.3	10.4	7.9	11.4	8.4	3.3	37.3	5.2	6.1	20.0	69.7	43.5	30.4	14.2	12.4	30.0	20.9	8.4	9.2	73.9	0.7	5.5	4.5	35.0	0.6	11.8	7.4	5.4	15.3	30.3	13.1	16.1	15.5	3.7	33.1	7.0	20.2	0.5	2.8	21.5	4.5	20.8
ZNF518B	KIAA1729	ENSG00000178163	"Zinc finger protein 518B"	Q9C0D4	4	10439880-10457426	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031215, HPA031216"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031215: AB_10600200, HPA031216: AB_10601449"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	6.3	4.4	4.7	6.4	5.2	3.9	7.0	7.8	4.7	3.7	4.9	3.9	3.7	4.9	3.6	4.2	2.9	4.3	6.4	5.6	6.4	3.3	2.2	4.3	6.7	2.5	4.0	7.8	1.5	3.7	2.9	7.0	3.6	6.9	2.9	7.0	7.4	7.1	6.0	3.7	5.0	5.6	3.9	6.7	3.5	9.0	7.7	8.6	7.9	8.7	8.7	4.2	3.7	4.0	8.2	5.5	20.8	6.1	2.7	3.9	0.1	9.1	2.3	5.7	6.6	0.0	0.0	0.1	9.2	13.7	16.1	0.2	4.8	10.4	12.6	0.0	8.8	26.2	0.0	0.0	11.9	0.0	11.2	11.7	6.0	9.0	0.0	11.6	19.6	19.3	28.9	0.0	4.7	0.0	18.2	0.6	20.4	4.1	12.5	15.5	8.6	3.0	0.3	11.2	15.5	4.6	4.3	0.0	2.8	16.6	3.4	7.0	14.9	0.0	18.7	0.1	8.8	10.7	8.5	15.1	1.1	1.4	1.1	2.2	2.0	9.6	2.1	1.9	2.6	7.9	3.3	2.4	3.5	3.5	3.4	3.2	4.9	5.0	4.7	1.2	2.6	1.7	4.7	5.2	7.8	4.7	5.6	6.4	2.5	4.0	3.6	3.9	7.7	4.0	15.7	3.2	6.3	4.2	12.1	15.9	22.8	8.0	8.6	9.6	5.7	5.1	26.3	4.3	9.5	0.0	10.4	8.9	3.7	3.6	3.9	2.5	13.1	5.0	9.2	13.1	1.2	4.6	12.1	4.0	9.3	11.9	4.6	10.2	16.5	22.5	12.8	1.8	9.2	11.8	10.6	3.5	14.2	10.2	8.0	20.8	16.1	7.3	1.8	7.5	6.5	6.1	6.2	4.5	3.5	1.6	3.3	21.4	5.3	20.0	6.2	1.3	6.7	10.3	0.0	6.7	8.6	13.7	11.2	6.8	14.2	9.2	8.1	19.7	4.3	19.5
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.3;Inhibitory neurons: 64.3;Oligodendrocyte precursor cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 5.5;SCLC-21H: 6.6"									HPA028982	Uncertain		Approved	Nucleoli		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	0.9	0.5	0.3	0.3	0.3	0.3	0.9	1.3	1.0	2.4	0.0	2.4	0.1	1.9	0.3	1.7	1.5	0.4	0.8	0.3	0.2	0.3	0.4	0.5	0.6	0.2	0.2	2.0	0.6	0.2	0.8	0.2	0.3	1.2	0.5	0.4	0.8	0.4	0.4	0.9	1.0	0.7	0.2	0.9	0.7	0.8	0.2	0.6	0.9	0.3	0.4	1.6	1.7	0.4	0.6	0.0	2.3	2.2	0.0	0.5	0.9	0.4	0.3	1.7	1.6	0.7	0.6	1.2	0.8	0.2	0.5	0.6	2.3	0.3	2.5	1.0	1.4	2.7	1.3	0.4	0.0	5.5	0.8	0.1	0.6	1.2	0.3	0.3	0.2	1.9	0.9	1.8	0.7	0.3	3.7	0.8	0.9	1.2	0.7	3.3	2.9	1.6	0.3	0.4	6.6	1.2	1.2	0.1	0.8	1.8	0.4	0.8	0.2	2.7	2.5	1.1	0.9	0.3	0.6	1.3	0.7	1.8	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	1.3	1.0	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.4	4.6	6.4	9.5	17.6	7.6	2.0	2.4	2.5	11.4	15.0	2.8	3.8	4.9	1.5	1.3	0.0	2.1	3.2	3.3	0.6	1.9	2.5	1.1	0.6	11.2	3.2	1.2	8.0	83.3	2.0	4.2	7.6	3.1	1.1	3.8	18.2	2.9	0.7	1.7	3.3	64.3	1.9	4.1	3.1	1.9	1.8	6.5	2.3	1.8	23.4	1.6	5.9	6.2	30.2	15.9	1.0	0.4	9.1	6.0	1.2	0.3	0.7	2.0	7.4	0.0	8.4	4.2	10.7	12.2	18.3	1.3	0.8	6.4	3.6	2.4	1.4
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061924-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 221.7;Oligodendrocytes: 104.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 95.9"	"Group enriched"	"Detected in some"	6	"basophil: 11.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"AF22: 67.6;fHDF/TERT166: 32.7;HUVEC TERT2: 46.9;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"HPA023056, HPA023849"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	13.4	11.9	8.8	3.1	10.5	2.3	11.4	95.9	9.5	10.8	29.9	4.7	1.7	15.3	4.3	3.9	9.0	10.6	9.1	6.0	14.7	3.2	1.2	6.3	3.8	17.4	14.3	20.5	1.2	1.1	7.6	8.6	21.2	2.6	3.6	5.7	9.0	3.0	3.7	6.1	4.4	13.6	12.4	21.0	2.7	3.6	10.8	4.3	6.8	6.0	2.8	5.8	6.8	13.5	0.1	0.0	67.6	0.1	10.6	18.4	0.2	10.0	14.3	3.4	2.1	0.0	0.1	0.0	0.0	32.7	0.0	0.3	0.0	0.0	2.8	0.0	4.0	14.0	0.6	0.5	1.9	0.0	20.2	23.0	0.0	0.3	0.0	0.0	46.9	16.4	0.3	0.1	6.0	0.0	9.2	0.0	4.7	0.0	0.0	0.0	15.2	1.1	0.0	0.0	8.7	5.5	0.8	0.0	0.0	6.1	0.0	38.9	26.9	26.5	2.0	8.0	1.5	0.1	0.0	0.3	10.0	0.0	22.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.1	8.8	10.5	95.9	9.5	6.0	14.7	17.4	14.3	21.2	12.4	10.8	13.5	19.0	0.0	3.0	170.1	0.3	3.7	0.1	0.0	1.2	42.4	8.0	10.9	11.9	0.0	0.6	0.0	2.1	0.1	1.7	0.0	0.0	0.0	2.1	0.5	3.3	28.6	1.2	13.9	16.5	0.0	0.0	21.4	0.0	0.2	13.3	4.7	20.3	0.0	0.1	15.2	22.7	0.1	0.0	0.6	5.5	3.3	9.9	0.9	14.2	53.4	0.1	0.7	0.0	221.7	104.6	0.0	0.0	7.9	0.1	0.2	0.0	4.0	1.5	3.0	0.0	13.7	6.0	0.1	6.1	0.8	4.4	0.1	0.8	17.2	0.0	0.2
ZNF524	MGC23143	ENSG00000171443	"Zinc finger protein 524"	Q96C55	19	55600022-55603138	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050981	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA050981: AB_2681298"	"unprognostic (6.69e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.59e-2)"	"prognostic favorable (4.98e-8)"	22.5	19.4	14.0	7.7	14.4	9.9	22.2	14.0	18.9	18.8	13.1	22.5	14.9	18.2	3.4	26.7	17.6	6.1	23.5	12.2	12.2	20.9	28.6	18.0	9.6	15.9	14.4	16.4	67.9	7.2	18.5	4.4	14.7	21.8	3.8	1.7	24.6	5.4	45.5	37.2	19.4	2.7	14.0	27.7	34.5	6.9	13.9	6.1	20.4	10.9	3.7	19.9	19.6	16.2	12.1	11.3	1.7	7.5	5.3	10.6	12.4	7.4	4.3	4.6	4.7	3.4	13.1	6.1	4.4	4.0	2.6	9.2	1.1	5.6	0.6	18.9	29.2	7.5	6.7	5.9	12.3	4.7	9.2	8.7	13.4	3.8	3.9	4.7	8.8	7.3	7.4	11.4	2.6	6.7	4.7	10.1	2.0	11.1	13.3	6.2	3.9	18.5	5.9	6.4	8.0	5.4	7.6	10.1	8.6	1.2	4.8	15.3	7.9	4.0	6.9	7.6	9.5	5.2	6.9	2.8	10.3	12.0	5.3	15.0	23.9	20.1	13.4	21.2	12.4	11.9	13.7	12.9	18.6	14.4	16.0	8.9	14.6	12.4	14.1	5.6	22.1	15.2	14.0	14.4	14.0	18.9	12.2	12.2	15.9	14.4	14.7	14.0	13.9	16.2	38.5	6.4	14.1	1.6	19.4	25.2	17.2	25.5	23.9	8.5	36.3	42.4	10.1	20.0	16.1	7.3	6.2	22.0	17.8	73.0	17.6	25.0	2.4	16.9	13.4	27.1	23.4	9.4	1.8	53.6	19.5	14.8	34.7	14.5	10.2	12.0	40.4	22.9	38.1	6.7	1.7	62.9	6.1	75.8	27.8	7.5	18.0	37.7	30.2	4.7	46.6	10.1	34.0	1.5	5.8	33.4	56.9	21.8	14.5	18.2	96.1	38.1	8.8	8.4	19.7	14.4	17.6	1.1	6.1	30.9	35.7	25.6	23.4	18.5	46.1	20.5
ZNF526	"KIAA1951, MGC4267"	ENSG00000167625	"Zinc finger protein 526"	Q8TF50	19	42220312-42228201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 33.3;granulocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023070, HPA056609"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA023070: AB_2671057, HPA056609: AB_2683189"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.84e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.30e-1)"	3.4	2.5	2.1	2.8	2.3	3.8	3.1	4.3	2.6	3.9	2.0	3.3	3.3	3.6	2.3	3.1	3.5	1.9	2.8	2.0	2.1	2.3	2.8	2.6	4.0	2.4	2.2	4.5	3.5	3.9	3.0	3.0	2.3	3.3	2.1	2.0	4.6	3.3	5.1	5.2	3.1	2.4	1.6	3.6	3.1	3.5	2.4	4.2	2.8	4.0	3.6	3.5	3.4	3.4	7.8	24.8	7.1	6.4	8.0	7.7	6.2	8.9	8.2	9.2	10.1	13.0	5.5	12.6	6.3	9.5	4.2	5.7	7.7	9.7	5.7	7.5	9.2	12.6	12.0	12.5	7.5	8.1	7.8	7.6	7.7	9.2	9.6	5.7	5.8	6.7	12.3	7.8	5.9	10.8	8.2	5.2	4.7	6.8	8.7	9.4	8.7	5.7	4.2	14.0	7.3	6.4	10.2	10.1	7.2	5.4	4.1	14.4	7.8	11.3	7.7	4.8	11.2	9.3	5.9	8.5	7.5	7.8	9.5	1.8	3.6	1.4	4.5	3.6	6.9	4.7	3.5	4.1	2.8	4.4	4.2	5.3	0.7	3.4	5.3	4.2	3.9	3.3	2.1	2.3	4.3	2.6	2.0	2.1	2.4	2.2	2.3	1.6	2.4	3.4	3.0	22.4	33.3	2.0	6.9	5.5	4.4	2.8	4.0	7.4	3.1	2.4	3.2	0.0	17.1	3.7	14.6	8.0	3.2	5.7	3.9	4.1	5.8	1.7	4.0	7.1	13.8	9.5	1.4	3.0	8.3	7.4	4.6	2.3	25.2	4.9	3.6	2.6	4.6	6.7	1.5	4.2	2.0	6.8	1.8	6.3	7.2	7.0	0.0	1.9	5.8	4.1	11.3	1.0	1.4	2.9	2.8	3.0	6.1	4.6	7.8	2.8	9.2	9.6	0.0	5.7	3.6	9.9	10.1	1.9	5.1	10.3	6.7	3.7	5.7	2.6
ZNF527	KIAA1829	ENSG00000189164	"Zinc finger protein 527"	Q8NB42	19	37371061-37393066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037740, HPA037741"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Golgi apparatus"	"HPA037740: AB_10672284, HPA037741: AB_2675642"	"unprognostic (4.36e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.26e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.05e-4)"	"unprognostic (8.34e-3)"	"unprognostic (8.92e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.17e-4)"	2.0	2.1	1.9	1.3	1.8	2.5	2.0	2.1	2.4	2.8	1.6	2.5	0.8	2.2	1.7	1.5	2.2	1.3	2.3	1.7	2.1	2.2	1.7	1.5	2.1	1.9	1.6	3.3	1.7	2.7	2.3	1.2	2.0	2.3	1.5	3.2	1.9	1.7	2.3	1.7	1.7	1.9	1.5	1.9	1.7	2.4	1.9	2.5	2.5	3.0	1.5	2.3	2.3	2.3	2.3	2.3	2.1	2.8	1.6	3.3	0.8	2.2	2.2	1.9	2.6	2.1	0.6	2.1	2.6	2.1	1.4	0.9	3.1	1.9	2.5	4.9	1.4	1.7	2.8	0.2	2.3	4.1	2.5	2.6	2.7	2.1	3.6	2.3	2.0	3.4	0.9	1.5	2.4	0.8	2.7	2.2	1.6	2.6	1.0	3.4	2.6	1.7	1.7	2.3	4.1	1.8	3.4	1.0	1.5	1.8	2.3	3.6	3.6	2.0	2.7	2.5	2.4	4.0	5.4	6.4	0.1	3.1	1.7	2.2	1.0	3.4	3.3	1.4	2.9	3.5	2.1	3.0	1.3	2.8	3.0	3.7	1.0	2.4	0.9	1.5	2.3	2.3	1.9	1.8	2.1	2.4	1.7	2.1	1.9	1.6	2.0	1.5	1.9	2.3	2.6	9.6	4.8	5.2	2.5	2.7	1.9	3.3	3.4	6.1	2.4	1.8	8.7	1.5	3.5	0.0	12.5	2.3	5.8	1.2	3.9	1.9	1.3	2.0	2.9	3.0	1.2	2.5	5.8	1.5	1.3	3.5	1.1	2.4	1.3	4.5	2.2	1.9	1.7	6.7	6.9	1.9	4.1	0.8	1.3	0.8	2.5	2.0	0.0	2.8	1.7	3.8	6.2	6.6	7.0	0.5	0.6	1.5	1.8	1.9	1.4	2.4	4.0	10.2	0.0	4.1	3.7	5.3	2.7	2.0	1.6	2.1	4.6	3.3	1.9	1.3
ZNF529	KIAA1615	ENSG00000186020	"Zinc finger protein 529"	Q6P280	19	36534774-36605276	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.6;Horizontal cells: 75.7;Inhibitory neurons: 45.7;Oligodendrocytes: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031311	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031311: AB_10604158"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.84e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.39e-5)"	5.7	5.8	8.1	5.1	11.5	10.1	6.0	9.6	10.4	6.2	6.5	5.1	3.1	6.9	5.5	3.3	8.0	3.8	7.3	7.1	9.8	5.9	4.4	5.8	7.4	8.9	9.5	8.9	3.6	6.0	5.7	4.8	9.8	5.1	3.0	20.1	4.2	3.4	5.4	6.6	5.1	4.5	9.0	6.0	3.9	9.2	9.1	6.3	5.7	5.5	6.4	4.7	5.2	14.9	4.0	8.1	11.5	12.3	5.4	6.6	4.5	6.1	3.3	3.4	8.6	4.1	3.1	10.7	7.7	4.9	4.4	1.5	8.7	3.9	6.2	14.4	9.7	13.1	7.6	3.0	6.4	9.9	7.9	8.0	5.0	4.6	6.7	5.8	2.9	8.1	5.5	0.7	7.1	1.1	10.0	3.4	7.5	0.2	3.3	2.9	6.9	4.9	3.0	10.6	5.1	10.4	8.5	2.7	2.6	4.4	3.5	6.0	7.0	7.4	5.3	6.1	7.6	13.2	8.5	9.0	0.2	3.3	5.7	4.7	1.1	1.5	2.3	0.6	3.1	2.9	2.5	2.4	1.2	2.2	2.8	2.2	0.5	2.1	0.7	1.4	3.1	1.2	8.1	11.5	9.6	10.4	7.1	9.8	8.9	9.5	9.8	9.0	9.1	14.9	10.0	3.2	3.3	23.8	14.1	9.8	5.3	2.9	10.2	19.0	12.3	8.1	14.7	5.7	5.7	7.3	25.0	3.6	11.0	1.4	5.9	3.5	4.5	10.1	8.0	10.0	3.0	14.1	46.6	1.6	2.8	7.9	5.1	9.9	2.5	15.2	7.9	6.9	4.0	75.7	45.7	3.5	4.1	5.1	8.4	2.3	6.5	4.3	5.4	19.7	3.1	7.8	6.2	36.2	61.5	2.2	2.5	6.8	7.2	7.0	1.4	4.5	8.8	22.4	0.0	9.1	7.5	18.0	10.3	8.2	9.1	3.3	11.2	9.9	2.8	6.5
ZNF530	KIAA1508	ENSG00000183647	"Zinc finger protein 530"	Q6P9A1	19	57599885-57612722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 8.6;Muller glia cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HEK 293: 75.0;U-266/84: 58.8"									HPA045868	Uncertain		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA045868: AB_2679478"	"unprognostic (1.57e-1)"	"unprognostic (3.02e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-1)"	1.5	1.4	4.5	1.2	4.2	3.2	1.6	6.8	5.4	0.7	5.6	1.1	1.0	1.0	1.9	0.9	0.7	0.7	4.0	4.6	4.2	1.1	0.8	0.9	2.0	4.3	3.7	0.9	1.5	0.8	0.7	1.2	4.0	1.4	0.8	2.6	1.2	1.4	6.3	2.2	1.0	0.7	3.8	2.2	1.8	1.2	4.0	2.3	1.0	2.7	2.3	1.0	0.7	4.8	6.7	5.8	4.3	3.7	0.3	1.9	6.8	4.1	1.7	6.8	3.8	4.1	1.0	0.8	3.3	1.5	4.1	2.2	3.6	3.0	7.2	0.2	75.0	13.4	11.6	2.6	0.5	4.9	6.1	1.3	1.7	6.4	1.8	1.9	1.5	4.7	1.7	3.0	2.3	2.6	7.0	3.8	6.4	0.5	14.2	0.9	13.6	6.3	1.3	11.3	4.9	4.5	4.8	1.2	1.4	3.8	3.1	7.6	2.0	8.5	5.3	1.9	8.5	14.6	58.8	9.3	5.2	5.2	6.0	1.0	1.5	1.0	3.0	0.9	2.2	3.5	2.0	3.1	1.8	2.5	2.7	2.2	1.7	3.1	1.1	1.7	2.9	1.6	4.5	4.2	6.8	5.4	4.6	4.2	4.3	3.7	4.0	3.8	4.0	4.8	2.7	6.4	1.5	1.6	2.3	1.8	0.7	1.7	1.8	3.3	1.8	1.0	8.6	1.5	0.9	0.0	0.0	2.0	3.1	0.6	1.9	1.9	0.3	0.9	0.8	2.7	0.0	4.0	1.4	2.9	1.5	1.4	1.1	0.8	2.5	2.2	2.9	0.7	2.0	0.0	1.0	0.2	2.0	0.8	2.0	0.3	0.9	0.6	5.4	0.0	1.5	9.1	2.1	0.5	0.9	1.4	1.7	1.5	2.5	1.3	0.9	0.8	0.7	4.2	6.6	1.5	1.7	2.1	2.9	1.6	1.7	1.4	2.3	1.1	1.0	0.9
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	24.0	12.5	33.5	15.7	53.1	1.4	17.9	73.9	39.8	30.3	12.4	25.9	7.2	65.1	20.1	22.3	26.2	24.5	36.0	34.3	45.0	14.1	4.2	19.9	14.2	55.2	44.2	52.8	6.8	16.3	15.7	26.4	56.6	48.0	13.3	25.7	15.8	34.1	61.1	16.5	12.0	41.4	33.8	17.0	12.8	24.2	46.1	11.9	24.7	49.8	17.4	23.0	21.3	84.8	21.3	30.0	118.8	63.4	18.5	42.2	5.8	37.6	35.2	26.0	23.4	10.2	23.0	26.5	28.3	47.2	12.9	34.1	1.0	29.7	26.7	19.5	25.0	0.0	51.8	0.6	24.5	0.2	0.2	33.1	54.5	27.2	49.5	34.4	28.8	0.0	0.3	31.9	30.8	0.0	0.2	0.3	63.0	1.0	19.9	0.6	31.6	4.2	18.1	2.8	27.1	70.3	24.2	2.6	40.8	78.8	30.3	17.3	22.0	70.7	50.1	0.5	30.7	0.4	21.7	7.3	24.0	0.0	55.2	0.0	0.3	0.0	0.4	1.1	0.1	3.7	0.2	0.2	0.7	1.6	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.4	33.5	53.1	73.9	39.8	34.3	45.0	55.2	44.2	56.6	33.8	46.1	84.8	16.6	12.8	12.2	90.1	13.2	10.6	12.5	8.0	12.0	28.8	9.3	8.8	17.0	5.7	10.1	1.8	27.1	2.0	1.4	0.3	0.0	4.9	4.9	8.3	48.3	24.2	4.2	0.0	86.9	0.5	2.7	17.9	3.1	10.0	0.0	15.8	14.6	0.1	4.4	35.3	90.9	0.2	4.1	9.1	14.3	3.5	11.5	9.2	8.8	53.4	5.2	22.1	0.0	130.2	178.2	6.0	1.4	18.0	8.6	33.5	0.0	1.6	8.8	9.7	13.1	15.5	24.2	5.5	17.2	8.9	9.2	3.4	4.3	5.0	0.3	11.9
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Excitatory neurons: 47.7;Inhibitory neurons: 56.5;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 27.7;Rod photoreceptor cells: 22.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0"									HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	1.6	4.9	10.5	2.3	10.2	0.6	3.1	14.4	11.2	5.0	6.8	4.4	2.1	3.3	4.8	1.6	3.9	1.8	5.3	9.4	12.3	5.0	2.2	2.6	3.8	8.2	8.9	8.5	2.5	5.3	14.7	1.1	8.6	5.5	1.8	25.8	3.5	4.6	2.0	3.2	4.2	1.8	7.9	4.7	3.2	2.9	11.4	2.1	7.9	1.6	3.4	3.6	3.4	9.1	0.1	0.0	1.1	1.3	3.0	1.8	0.1	0.4	0.4	0.5	0.9	0.1	0.0	0.5	0.1	1.1	0.3	0.4	0.8	0.4	0.4	1.7	1.2	0.4	0.8	0.0	0.8	0.5	0.9	0.9	1.1	0.3	0.0	0.2	0.0	2.4	0.2	0.0	0.7	0.0	0.8	0.3	0.4	0.1	0.2	0.7	0.7	0.4	0.2	0.1	1.2	1.4	0.4	0.1	0.1	0.8	0.6	0.5	0.0	0.4	1.4	0.5	0.4	1.6	1.0	1.3	0.0	0.2	0.2	0.0	0.0	0.8	2.7	0.0	2.6	1.9	2.7	3.0	0.1	2.2	4.4	4.8	0.1	2.4	0.0	0.2	3.1	1.2	10.5	10.2	14.4	11.2	9.4	12.3	8.2	8.9	8.6	7.9	11.4	9.1	2.3	3.2	2.6	15.3	6.3	1.7	1.3	0.8	3.4	23.3	2.4	2.2	10.4	0.0	1.7	1.8	6.2	0.3	3.3	0.2	7.9	0.3	18.6	1.1	1.0	2.2	0.0	0.0	47.7	0.4	0.4	2.8	1.5	0.6	3.8	1.7	2.2	1.1	0.8	18.5	56.5	0.3	0.0	0.8	1.0	5.5	2.5	1.0	3.6	11.2	0.5	5.5	8.2	23.1	27.7	0.2	1.1	5.7	2.5	0.4	2.3	2.7	0.4	22.3	6.6	3.1	2.9	5.7	3.3	1.8	1.3	0.1	3.9	1.2	0.3	0.2
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 21.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.0	3.1	0.3	0.1	0.3	0.1	0.6	0.2	0.8	0.1	0.0	0.8	0.1	0.3	0.0	0.0	0.2	0.2	0.9	0.5	0.0	0.7	0.1	0.1	0.2	0.4	0.1	2.3	0.1	0.1	0.6	0.3	0.4	0.1	0.1	0.5	0.1	0.1	0.5	0.4	0.3	0.2	0.0	0.5	0.1	21.9	0.2	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.5	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.8	0.5	0.0	0.4	0.1	0.4	0.0	0.2	0.2	4.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.5	0.3	1.8	0.0	0.0	1.8	2.1	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.1	1.6	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.3	0.0	2.0	6.1	0.4	0.0	0.0	1.5	0.1	0.0	0.0	0.0	12.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.5	19.1	0.0	0.8	0.0	0.0	0.1	37.3	11.7	0.0	0.1	0.0	0.4	0.5	0.0	0.0
ZNF544	AF020591	ENSG00000198131	"Zinc finger protein 544"	Q6NX49	19	58228594-58277495	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 164.2"					"Low region specificity"	"Detected in all"			HPA002732	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA002732: AB_1080735"	"unprognostic (5.28e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (3.61e-3)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (4.94e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.49e-1)"	8.2	10.4	13.0	6.9	14.3	9.9	15.7	24.7	14.0	13.4	24.2	10.3	5.4	11.7	38.7	11.2	25.3	10.1	18.7	15.2	12.5	11.7	9.7	9.0	14.0	13.3	14.2	15.4	13.3	26.2	12.9	12.7	11.5	12.2	10.5	22.8	10.8	11.6	3.7	14.6	7.9	13.1	12.9	10.2	12.0	24.8	13.0	19.3	21.1	8.5	15.8	10.1	8.4	13.3	49.6	18.2	12.8	13.5	12.8	23.1	29.7	23.3	9.9	42.0	29.5	14.4	19.5	65.8	11.1	27.0	0.0	16.1	15.2	50.1	59.4	29.7	164.2	49.3	38.6	6.9	35.7	30.2	36.1	15.7	71.9	28.7	76.2	41.4	36.6	0.4	28.0	0.0	24.0	15.6	64.0	19.3	29.5	10.0	8.9	21.3	13.8	50.7	26.9	73.3	68.8	0.1	26.6	13.1	8.9	21.7	19.4	18.8	32.0	7.0	25.5	7.5	24.9	56.2	118.2	0.2	0.0	0.1	18.7	4.4	2.3	15.4	8.0	4.6	7.5	11.7	7.0	10.2	5.9	13.4	8.6	11.9	2.9	17.2	1.0	9.7	6.4	5.8	13.0	14.3	24.7	14.0	15.2	12.5	13.3	14.2	11.5	12.9	13.0	13.3	9.8	6.4	11.3	15.0	14.3	5.9	11.8	11.9	8.6	25.2	12.6	13.0	12.3	17.2	17.7	7.3	45.9	15.7	9.6	3.9	19.6	7.7	43.7	17.6	8.0	9.5	11.5	21.5	21.5	4.5	10.4	5.8	9.7	9.0	10.8	18.9	11.0	9.3	13.6	21.9	23.5	7.9	10.2	4.1	3.3	62.7	5.6	5.0	8.8	9.4	2.9	18.6	20.6	26.7	8.8	9.4	1.9	3.8	15.2	12.9	7.0	12.4	16.3	34.4	19.7	7.4	8.1	55.9	28.0	13.1	7.7	11.8	12.4	11.1	8.6	11.7
ZNF547	FLJ31100	ENSG00000152433	"Zinc finger protein 547"	Q8IVP9	19	57363477-57379565	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Excitatory neurons: 13.0;Inhibitory neurons: 13.2;Ionocytes: 8.2;Oligodendrocyte precursor cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.2"									HPA056001	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA056001: AB_2683005"	"unprognostic (9.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.23e-3)"	"unprognostic (4.39e-5)"	"unprognostic (7.16e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.62e-4)"	1.6	3.6	4.6	1.6	4.6	0.9	2.5	8.4	5.1	1.2	4.3	2.0	0.9	1.3	3.4	2.0	1.8	1.7	2.9	4.3	4.6	3.2	1.8	1.5	2.5	4.0	4.4	2.0	2.1	2.4	4.8	2.4	4.1	2.9	1.6	5.2	2.0	2.5	2.4	4.1	1.9	1.3	3.9	4.4	1.5	3.2	4.5	2.4	3.2	1.4	3.5	1.4	1.1	4.7	1.0	1.2	3.3	4.3	3.9	1.7	1.5	2.5	3.1	2.3	5.8	1.2	0.6	2.8	1.5	1.3	1.1	0.7	2.0	1.0	3.5	0.6	9.2	1.9	4.7	2.3	1.1	1.7	4.0	1.8	4.3	1.3	2.9	4.7	1.3	3.0	0.4	0.1	4.0	0.1	3.0	1.1	1.5	0.1	2.6	1.3	3.7	0.7	1.8	4.5	3.0	2.3	1.6	0.4	1.3	2.7	1.7	2.6	3.9	4.2	1.2	1.5	2.2	1.9	1.0	1.6	1.8	1.1	2.1	2.6	1.7	1.2	1.1	2.5	2.5	4.8	1.7	1.7	1.9	3.2	2.3	1.8	1.2	2.7	1.4	2.4	0.9	1.4	4.6	4.6	8.4	5.1	4.3	4.6	4.0	4.4	4.1	3.9	4.5	4.7	1.4	0.0	0.0	10.7	2.6	0.6	0.9	1.9	0.6	1.6	1.3	2.3	2.3	0.0	2.0	1.8	6.2	1.7	2.3	0.1	1.9	0.8	3.3	0.6	0.5	1.8	0.0	5.3	13.0	0.2	0.3	0.8	0.5	0.5	7.0	1.5	0.7	0.6	1.2	0.0	13.2	0.3	8.2	0.8	0.0	0.5	0.0	0.5	0.0	2.8	0.1	1.3	3.1	8.5	4.8	0.5	0.3	1.2	0.3	0.8	0.2	0.4	1.9	1.4	0.0	0.5	1.1	3.8	3.4	1.6	0.6	3.0	1.2	1.3	0.4	0.5
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 55.6"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	13.8	6.8	5.2	16.9	5.4	26.3	12.3	11.6	11.2	8.2	6.6	10.0	6.8	10.8	6.9	8.1	10.2	11.3	11.1	7.2	5.5	6.5	6.8	12.0	23.8	4.8	5.0	11.8	6.9	8.6	7.1	8.4	4.5	7.8	8.2	12.6	7.1	7.1	7.6	10.3	14.6	11.6	3.6	18.9	7.2	6.5	5.3	13.4	11.8	5.5	17.9	8.4	7.7	7.2	7.5	6.8	12.1	8.7	5.7	6.2	2.5	5.4	8.0	8.4	14.0	1.7	20.5	7.4	3.4	4.3	5.6	3.3	5.1	5.9	7.6	3.5	17.4	7.7	55.6	8.8	4.1	8.1	16.3	7.2	8.5	8.0	11.7	8.1	4.2	15.1	0.5	0.1	7.6	2.0	12.8	3.1	3.4	0.2	7.6	15.6	13.3	10.1	4.4	12.7	7.5	9.1	6.6	3.5	4.0	10.2	7.6	6.1	6.9	10.0	9.7	3.3	9.8	18.7	13.1	10.3	6.9	4.5	10.1	1.3	1.5	2.6	4.0	1.7	5.6	3.9	3.7	5.2	3.1	8.4	5.5	5.8	1.4	5.1	2.2	2.6	7.0	2.6	5.2	5.4	11.6	11.2	7.2	5.5	4.8	5.0	4.5	3.6	5.3	7.2	10.2	3.2	6.7	4.6	9.5	6.6	4.9	4.3	4.6	5.0	9.1	7.1	5.7	7.2	4.0	7.3	6.2	4.4	8.9	1.9	3.9	4.4	12.7	5.3	4.4	9.1	6.0	1.7	3.0	2.4	2.9	5.9	2.0	4.5	9.5	7.6	11.0	8.4	4.2	1.7	3.9	3.8	4.1	4.8	2.9	5.1	5.6	4.3	0.0	1.9	3.2	6.3	8.2	4.0	4.6	2.5	1.1	4.1	8.8	3.5	3.3	2.7	5.8	9.4	0.0	7.7	7.8	11.7	7.1	4.5	5.7	4.4	9.4	4.2	2.3	2.2
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Rod photoreceptor cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.2"	"Group enriched"	"Detected in all"	4	"B-cells: 4.5;NK-cells: 11.2;T-cells: 4.6"	"Low cell line specificity"	"Detected in many"											HPA039511	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	2.5	3.3	4.3	3.4	4.3	3.6	4.3	9.9	4.1	2.9	3.3	3.3	1.9	3.3	3.9	2.0	4.1	2.7	3.5	4.6	3.6	3.9	1.3	3.3	5.0	2.9	2.8	5.6	2.4	5.5	4.9	3.7	2.7	4.2	2.3	11.8	3.0	3.3	3.0	3.9	3.3	3.2	2.0	5.6	2.9	4.0	3.6	5.9	4.7	2.4	5.3	3.3	2.4	4.5	1.5	2.0	7.9	6.6	2.4	1.9	1.9	3.8	4.5	3.6	17.5	2.1	1.4	2.2	2.6	3.5	4.5	0.9	2.5	5.5	5.9	0.2	14.7	10.2	1.9	3.1	3.3	8.6	7.0	3.4	4.2	3.7	5.1	5.2	2.3	5.7	0.1	0.3	6.6	0.9	9.8	3.6	6.8	0.2	5.3	6.8	6.6	4.7	1.4	3.9	3.3	5.7	0.1	0.5	4.4	6.6	4.5	6.7	1.9	6.9	4.7	0.3	5.5	3.7	11.6	7.0	1.1	2.9	6.4	0.6	0.8	1.5	2.4	0.7	3.2	2.2	3.3	3.8	1.5	4.5	4.6	3.0	0.5	11.2	1.2	1.4	2.2	1.9	4.3	4.3	9.9	4.1	4.6	3.6	2.9	2.8	2.7	2.0	3.6	4.5	2.2	0.0	2.8	5.9	7.0	1.7	1.7	1.3	0.6	7.5	2.2	1.7	3.2	4.3	0.8	1.8	14.6	1.6	5.6	0.4	3.9	1.4	0.6	2.2	2.3	3.6	3.6	5.7	9.8	0.7	0.8	2.2	1.1	1.9	6.3	6.1	3.9	0.6	1.5	8.4	7.9	0.5	0.0	3.2	0.4	0.4	3.1	2.3	5.4	6.5	1.5	3.9	7.2	8.0	4.1	0.7	1.8	2.2	1.3	1.8	0.7	0.8	5.8	14.8	6.6	2.6	2.3	1.2	4.7	0.6	1.6	1.1	4.0	2.3	0.9	1.2
ZNF550	MGC41917	ENSG00000251369	"Zinc finger protein 550"	Q7Z398	19	57535257-57559863	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA003251	Uncertain		Approved	Vesicles,Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Microtubules	"HPA003251: AB_1080736"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.52e-1)"	2.8	3.7	1.8	5.1	2.0	5.2	6.0	5.8	2.7	5.5	3.2	2.8	2.2	4.6	3.9	3.1	4.6	3.1	5.6	1.7	2.9	2.9	3.0	3.4	6.7	1.5	1.8	9.1	2.4	7.8	2.5	6.5	2.3	6.0	2.9	7.3	4.2	4.4	2.2	4.0	3.6	3.3	1.1	7.7	3.5	2.8	1.7	7.4	4.8	3.3	5.4	3.6	1.3	2.9	4.3	3.0	8.4	8.0	2.8	6.9	0.0	5.7	4.8	5.0	2.1	3.7	3.9	1.2	3.9	4.2	4.0	3.6	4.4	5.0	6.3	0.1	23.2	11.5	10.9	4.9	4.1	10.1	4.3	5.8	3.0	3.9	11.2	6.9	4.2	10.6	1.8	0.1	5.4	1.0	15.5	4.4	9.2	1.3	5.8	12.3	8.7	12.1	2.7	7.6	7.8	11.0	7.2	4.8	3.5	5.9	5.5	6.6	4.8	6.9	4.2	2.6	5.6	24.0	24.0	10.0	2.8	5.8	6.1	0.4	1.4	2.0	3.6	1.9	4.5	1.8	4.5	2.5	2.0	2.6	5.8	3.4	0.4	5.2	0.6	0.7	4.5	2.3	1.8	2.0	5.8	2.7	1.7	2.9	1.5	1.8	2.3	1.1	1.7	2.9	4.5	0.0	1.1	4.2	8.9	5.1	3.9	2.6	5.7	4.5	4.7	3.6	7.2	2.8	3.4	0.0	6.2	4.2	4.9	0.5	1.9	2.8	1.0	3.4	4.7	5.8	3.6	5.0	4.8	1.2	4.4	3.9	0.5	2.9	5.1	8.3	5.0	3.2	2.3	11.8	5.3	2.8	4.1	1.9	2.2	0.6	4.7	1.4	3.6	2.8	2.5	3.0	12.3	4.0	3.7	2.2	0.8	0.7	3.4	6.7	1.2	0.9	6.5	5.1	0.0	3.3	4.4	3.2	5.0	4.4	6.8	5.2	6.2	4.4	2.7	4.3
ZNF552	FLJ21603	ENSG00000178935	"Zinc finger protein 552"	Q9H707	19	57803841-57814913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"breast cancer: 23.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in all"		"BEWO: 30.3;RT4: 42.5;T-47d: 69.6"					"Low region specificity"	"Detected in all"			"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"prognostic favorable (4.57e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.03e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.36e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-3)"	3.0	2.3	3.0	4.7	3.1	8.1	26.0	14.9	6.5	9.8	9.3	9.4	7.1	5.0	5.4	5.5	5.6	8.7	2.9	3.4	3.0	7.1	4.7	6.0	5.3	2.8	2.0	4.2	4.2	6.0	2.5	6.5	2.3	12.4	12.1	4.0	17.5	6.9	4.9	9.7	7.3	3.0	0.5	6.0	13.9	3.0	3.5	5.0	4.1	2.7	5.5	14.7	5.8	3.4	5.6	3.2	3.7	5.9	3.0	1.5	30.3	2.0	2.4	4.5	2.5	9.6	8.8	7.6	3.8	3.6	1.0	4.8	7.6	5.0	5.4	3.4	15.1	2.6	8.4	7.1	7.1	8.5	3.4	3.3	10.9	3.1	3.2	2.8	6.0	8.0	5.5	2.5	3.0	5.0	3.7	2.5	5.2	6.9	7.3	7.6	4.7	8.0	13.4	42.5	4.9	3.5	10.2	22.6	5.1	10.4	69.6	3.5	4.5	3.8	4.2	2.5	3.5	11.0	8.1	6.1	3.1	6.4	2.2	2.1	3.3	7.4	2.7	3.3	2.5	3.7	3.4	4.3	1.7	3.7	4.5	3.8	25.3	2.4	1.4	2.3	3.0	2.4	3.0	3.1	14.9	6.5	3.4	3.0	2.8	2.0	2.3	0.5	3.5	3.4	2.9	12.8	3.1	4.2	7.8	2.5	14.8	9.7	8.0	6.2	19.4	9.8	3.1	18.6	15.0	20.2	2.1	22.1	5.3	9.4	25.4	6.9	5.7	20.2	4.9	3.7	8.4	6.1	7.7	1.8	5.2	3.8	19.4	15.0	8.8	14.2	7.1	4.2	5.2	3.3	8.1	14.5	14.2	2.4	3.1	1.5	2.8	3.6	1.8	1.9	3.1	2.3	2.1	4.5	5.1	3.1	13.4	2.2	4.8	8.3	15.6	4.8	20.5	12.7	6.6	2.9	3.5	3.8	4.6	7.0	2.7	21.3	7.1	5.4	9.3	14.2
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819868-2836735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	2.0	2.0	2.9	0.6	2.8	0.5	2.5	2.7	4.0	3.0	1.5	2.6	1.3	2.6	1.2	2.5	2.3	0.6	3.3	2.7	2.8	2.9	3.1	1.4	0.6	2.9	2.4	3.7	3.1	1.5	2.9	1.1	2.9	2.7	0.8	2.5	2.7	0.9	5.2	3.5	2.3	0.6	1.8	1.9	2.5	2.5	3.5	0.9	2.6	2.1	0.7	2.7	2.6	2.4	1.2	0.2	0.9	1.3	0.7	0.9	1.3	0.7	0.6	1.0	0.7	0.1	0.3	1.5	0.6	0.4	1.1	0.7	0.2	0.7	0.8	0.0	0.5	0.5	0.8	0.4	0.6	0.2	0.5	0.7	1.0	0.4	0.7	0.9	0.3	1.1	1.1	0.8	0.5	0.6	1.1	0.3	0.7	0.2	0.1	1.3	0.6	0.3	0.5	1.1	1.5	1.8	0.5	0.3	1.1	0.9	0.4	0.8	0.2	0.4	0.4	0.6	0.4	2.3	2.8	0.4	0.6	0.7	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.0	0.6	0.3	0.1	0.1	0.2	0.2	0.9	0.1	0.2	2.9	2.8	2.7	4.0	2.7	2.8	2.9	2.4	2.9	1.8	3.5	2.4	2.2	12.8	12.5	2.9	3.5	1.3	2.8	1.0	4.0	4.9	2.3	2.2	4.6	1.5	4.6	0.0	8.4	2.8	1.5	3.4	3.9	2.6	0.8	2.1	1.9	3.1	3.6	3.4	4.0	1.4	1.3	3.4	1.5	2.7	0.0	4.4	3.3	2.9	1.5	3.3	4.8	2.0	2.0	2.4	2.5	0.7	3.1	1.6	0.0	1.0	1.4	4.7	5.2	3.5	2.7	1.7	1.0	2.6	3.3	3.3	5.9	3.0	5.5	4.9	0.0	3.8	2.3	7.0	12.2	2.7	1.4	8.8	2.7	3.7	2.2	2.1
ZNF555	MGC26707	ENSG00000186300	"Zinc finger protein 555"	Q8NEP9	19	2841437-2860471	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.6;Late spermatids: 62.6;Spermatocytes: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053956, HPA055430"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA053956: AB_2682321, HPA055430: AB_2682814"	"unprognostic (9.64e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.11e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.06e-7)"	"unprognostic (2.44e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.66e-2)"	2.3	1.9	1.3	1.5	2.0	2.8	4.0	3.1	2.4	3.0	1.0	2.5	1.4	3.7	3.0	3.3	3.2	1.3	3.0	1.4	1.7	3.0	2.3	2.2	2.4	2.4	1.8	5.9	2.7	3.3	1.9	3.9	2.3	2.9	1.8	5.5	2.3	3.4	2.7	2.0	1.7	2.2	1.7	2.8	2.2	5.7	1.9	2.5	4.0	4.7	3.0	2.7	2.4	2.9	2.5	1.2	5.7	4.9	4.6	7.6	2.9	2.2	6.0	5.6	5.6	3.1	2.0	3.1	1.8	3.9	4.3	2.0	4.9	3.1	5.2	0.0	2.3	2.3	1.5	4.0	5.5	0.0	4.0	5.0	4.7	3.0	7.4	6.2	5.6	4.0	5.0	1.7	6.4	0.9	1.9	2.4	3.4	1.5	2.9	4.1	6.0	1.3	6.7	2.5	1.3	4.5	3.2	3.4	5.6	6.6	2.5	4.2	3.8	3.2	1.8	4.7	3.0	1.0	4.7	0.0	3.3	6.4	3.1	5.2	4.7	8.0	3.2	5.6	4.7	3.0	3.6	4.4	6.9	2.1	3.2	2.6	0.5	2.6	9.6	9.6	4.0	3.3	1.3	2.0	3.1	2.4	1.4	1.7	2.4	1.8	2.3	1.7	1.9	2.9	2.4	0.0	1.1	13.1	2.0	0.6	1.7	1.4	1.8	13.2	2.8	2.5	5.7	1.5	1.0	1.8	18.8	1.9	2.6	0.4	3.9	2.8	81.6	2.4	4.1	2.2	1.2	3.4	8.9	2.0	1.2	3.2	1.5	3.3	0.0	6.2	3.9	0.9	2.1	11.8	11.7	1.3	0.0	1.9	3.8	62.6	5.9	2.7	0.0	1.9	2.9	6.8	1.0	8.5	11.5	1.8	1.5	3.8	5.8	1.7	0.5	2.3	2.3	13.0	0.0	4.7	2.5	27.2	11.3	1.6	1.7	1.6	1.8	4.3	1.0	1.1
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069703-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"		"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	1.5	1.9	1.2	1.8	1.5	3.9	1.9	3.1	1.7	1.6	1.5	1.5	1.1	1.7	1.6	1.7	1.9	1.3	1.2	1.3	1.0	1.8	2.2	1.4	2.6	1.4	1.1	2.4	1.8	1.7	1.5	1.5	1.5	1.5	1.4	1.9	1.4	1.4	1.4	2.0	1.7	1.6	0.9	2.3	1.8	2.1	1.4	2.4	2.1	1.0	2.5	1.6	1.5	3.1	2.1	2.2	2.3	5.0	3.1	2.1	1.9	2.1	2.2	2.3	2.8	2.8	1.3	4.4	3.6	2.3	1.8	2.9	4.0	2.3	2.3	4.0	2.6	5.6	4.7	1.5	2.1	6.0	5.9	3.0	2.3	2.4	3.7	2.3	2.0	3.8	2.2	6.7	3.1	3.0	5.0	2.1	2.2	2.0	3.0	3.6	3.6	2.4	1.7	4.9	2.7	3.2	3.1	2.4	2.3	2.0	1.9	3.1	3.9	2.2	1.7	5.0	2.3	6.8	5.8	3.9	2.4	3.1	2.0	5.6	3.1	3.8	4.6	2.9	4.7	4.1	5.0	4.0	3.1	5.4	5.8	4.9	3.5	5.9	2.7	5.7	4.3	1.7	1.2	1.5	3.1	1.7	1.3	1.0	1.4	1.1	1.5	0.9	1.4	3.1	5.5	3.2	4.4	5.2	8.3	1.5	6.9	2.7	2.2	9.4	6.1	5.8	5.4	7.2	6.1	7.3	0.0	5.9	5.8	5.4	15.6	6.2	0.9	3.4	8.9	6.9	5.4	6.1	9.2	6.2	4.2	5.6	4.6	4.6	8.2	9.4	8.6	3.8	6.1	16.8	8.9	5.8	2.0	9.8	2.9	0.5	4.4	6.0	0.0	5.6	9.0	6.1	14.4	3.5	8.8	6.1	6.2	5.7	5.9	6.8	6.1	8.1	4.3	6.8	0.0	7.8	6.7	23.2	19.9	3.6	1.3	5.7	7.7	6.7	5.5	6.9
ZNF558	FLJ30932	ENSG00000167785	"Zinc finger protein 558"	Q96NG5	19	8806170-8832314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003151	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA003151: AB_1859344"	"unprognostic (2.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.89e-3)"	"prognostic unfavorable (1.23e-6)"	"unprognostic (2.28e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (9.30e-5)"	9.3	10.1	7.8	6.5	8.0	4.6	9.5	8.6	9.3	15.0	8.3	11.2	6.0	13.6	9.4	7.9	14.7	5.4	6.6	7.6	8.1	11.4	11.0	8.3	7.3	8.3	8.2	15.1	11.5	10.3	8.5	5.5	8.1	11.5	8.0	14.5	8.3	8.7	6.9	10.1	9.2	10.3	8.0	9.7	9.5	6.2	8.3	7.9	12.2	6.6	8.0	9.9	10.7	8.6	8.1	2.8	12.8	17.6	11.8	13.2	10.9	5.6	8.5	8.2	12.8	4.1	4.9	4.0	14.5	6.4	10.0	7.2	10.9	0.8	11.5	9.6	0.5	0.3	5.0	2.1	9.4	5.9	9.3	12.7	18.5	5.2	0.0	20.0	0.0	12.3	8.6	15.4	10.8	3.3	5.4	31.4	8.0	3.0	4.0	2.8	10.1	3.5	15.2	8.9	2.7	12.7	6.5	3.7	11.5	15.0	7.9	8.5	0.1	10.4	5.9	16.5	6.7	7.0	6.4	8.8	2.4	5.8	3.5	0.4	0.6	0.3	1.0	0.6	0.8	0.3	0.7	1.1	0.7	1.0	1.2	1.5	0.7	2.0	0.5	1.0	0.5	0.5	7.8	8.0	8.6	9.3	7.6	8.1	8.3	8.2	8.1	8.0	8.3	8.6	3.8	9.6	5.6	8.1	3.2	3.6	2.9	3.1	9.1	4.8	5.5	5.5	3.6	2.8	5.5	3.7	8.4	4.0	3.9	3.6	1.9	4.5	9.6	4.5	9.3	4.0	1.2	4.0	4.0	3.3	3.7	4.6	11.2	5.0	3.8	5.1	2.9	5.3	2.9	8.4	3.3	3.3	0.0	4.7	1.3	5.2	2.1	2.9	0.0	3.7	2.4	5.9	5.2	5.5	7.9	4.2	2.7	2.6	1.8	3.3	2.8	1.9	3.6	8.6	0.0	5.2	4.8	4.1	3.9	5.4	2.7	1.5	3.9	2.8	3.9	1.5
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	14.8	14.2	12.5	9.2	13.7	4.0	16.8	19.7	14.0	23.5	17.8	16.7	6.4	22.4	21.5	7.4	23.1	9.9	19.7	12.4	12.9	19.1	11.1	12.4	16.0	12.7	12.3	32.7	10.6	22.2	25.9	12.1	12.4	20.5	11.0	20.4	12.3	12.9	4.7	10.7	14.8	19.1	11.8	22.1	12.9	16.3	13.7	22.7	19.7	10.6	13.1	17.0	15.6	19.4	15.4	8.3	15.6	19.3	9.2	8.3	4.2	9.3	18.6	13.3	11.4	3.8	1.8	12.4	10.8	13.7	18.4	5.4	9.5	8.8	16.9	19.9	13.5	16.2	14.0	5.7	16.0	15.0	18.3	17.3	15.6	14.7	18.7	11.4	11.3	18.8	12.7	42.8	8.7	0.0	20.4	46.8	25.4	2.6	13.4	10.0	18.8	16.7	8.1	21.5	17.8	14.7	17.9	2.9	22.6	22.9	12.7	11.5	9.6	24.6	5.6	20.1	14.2	3.5	0.1	12.6	4.6	9.4	16.0	40.7	4.8	11.4	12.1	4.7	16.4	17.4	13.0	13.3	7.7	17.0	21.0	17.2	2.7	20.9	6.5	6.4	12.6	9.0	12.5	13.7	19.7	14.0	12.4	12.9	12.7	12.3	12.4	11.8	13.7	19.4	9.8	3.2	3.3	0.0	12.9	3.8	6.7	6.2	5.7	30.2	7.0	7.1	8.8	10.0	5.1	3.7	27.1	7.0	12.4	2.2	1.9	7.3	9.1	6.1	8.3	11.0	3.0	3.0	0.0	3.2	5.3	9.8	1.5	3.8	2.5	17.8	12.8	2.7	4.9	26.9	0.0	4.0	2.0	7.0	3.7	2.9	12.8	4.7	3.6	0.0	7.7	17.3	29.9	0.0	0.0	3.2	3.0	13.5	1.8	4.6	2.2	3.4	5.7	27.2	6.6	14.1	10.1	27.0	40.4	2.9	3.0	2.9	10.0	8.5	4.1	2.8
ZNF559-ZNF177		ENSG00000270011	"ZNF559-ZNF177 readthrough"		19	9324174-9382617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"retina: 6.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 25.5;Excitatory neurons: 14.8;Inhibitory neurons: 13.6;Microglial cells: 11.2;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 28.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 3.8"									HPA003141	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA003141: AB_1859102"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.20e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.17e-5)"	0.7	1.7	2.8	0.5	2.7	0.2	1.6	4.3	3.0	1.2	2.7	0.9	0.0	1.8	3.4	0.2	1.7	0.6	1.8	2.7	2.6	1.1	0.2	0.6	0.6	2.0	2.5	3.3	0.3	1.1	1.3	1.3	2.1	1.4	0.4	6.7	0.6	0.9	0.4	0.9	0.4	0.9	2.2	0.7	0.5	4.2	2.6	1.0	1.6	0.4	0.3	0.7	0.7	3.9	0.2	0.3	1.3	2.2	0.2	0.5	0.1	0.5	0.2	0.3	0.4	0.0	0.0	0.7	3.3	0.3	0.9	0.0	0.2	0.0	0.5	3.8	2.5	1.4	0.2	0.0	0.2	0.3	0.4	0.3	0.1	0.6	0.8	3.1	0.1	1.5	0.5	1.5	1.2	0.0	1.2	1.9	1.7	0.0	1.3	1.8	1.2	0.1	0.5	0.7	1.7	1.2	0.4	0.0	0.6	1.7	0.1	0.2	0.2	1.5	0.2	3.3	1.4	0.1	0.0	0.2	0.2	0.5	1.3	0.8	0.0	0.2	0.3	0.0	0.5	0.6	0.1	0.5	0.2	0.2	0.2	0.4	0.0	1.1	0.0	0.2	0.0	0.0	2.8	2.7	4.3	3.0	2.7	2.6	2.0	2.5	2.1	2.2	2.6	3.9	0.0	0.0	0.0	25.5	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.1	0.3	0.0	0.0	14.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	11.2	0.0	0.4	0.0	28.1	28.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.1	4.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
ZNF561	MGC45408	ENSG00000171469	"Zinc finger protein 561"	Q8N587	19	9604680-9621236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (6.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.63e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (9.21e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.27e-3)"	"unprognostic (2.85e-3)"	8.9	8.8	4.6	8.4	5.5	10.2	17.2	7.2	7.6	13.5	5.3	10.3	8.0	17.9	12.0	16.3	18.5	12.9	9.8	5.7	5.6	12.5	11.2	11.2	10.8	6.2	5.8	20.1	10.4	13.6	7.6	10.5	6.2	17.4	12.8	7.3	9.7	17.6	9.1	14.3	8.5	26.0	4.9	9.7	10.6	6.3	5.8	14.5	15.4	14.6	12.5	18.6	12.1	6.1	14.4	5.7	31.8	24.3	26.2	30.9	28.0	18.9	25.2	23.2	26.1	10.7	6.1	13.2	13.5	19.1	13.3	8.2	21.6	36.1	24.2	18.5	23.3	16.9	12.2	18.9	15.7	20.9	16.0	20.5	55.4	17.4	22.4	36.3	29.7	9.6	19.3	17.4	29.0	6.9	9.4	23.3	25.6	12.3	18.1	11.1	15.8	13.5	20.3	51.7	19.7	19.6	0.4	10.9	14.7	30.1	14.6	14.6	9.3	24.8	8.8	17.2	17.9	20.2	30.2	17.7	12.2	5.6	16.8	4.0	5.1	5.8	4.9	5.1	6.2	2.8	3.9	4.4	4.1	3.9	5.4	4.0	3.4	1.7	2.7	3.6	4.0	3.4	4.6	5.5	7.2	7.6	5.7	5.6	6.2	5.8	6.2	4.9	5.8	6.1	8.2	0.0	7.0	5.9	7.9	13.8	25.2	31.9	16.5	9.4	11.5	16.5	9.8	11.5	17.9	14.7	6.2	8.0	11.0	7.3	3.9	11.1	6.9	11.1	12.1	8.9	11.4	11.6	10.0	6.5	8.5	7.7	12.2	9.0	7.6	25.5	10.8	8.2	10.9	10.1	10.5	7.7	16.2	12.8	5.8	9.7	11.5	8.3	3.6	6.5	12.2	6.3	17.5	17.6	12.0	8.6	6.8	13.2	6.2	10.9	9.8	8.5	30.3	11.9	6.6	9.1	10.4	8.2	10.6	23.6	22.4	6.4	10.2	16.2	7.7	25.9
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641807-9675100	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	5.9	4.6	6.1	6.4	6.7	7.5	11.6	12.6	6.3	6.1	5.2	8.3	5.0	7.9	4.3	14.0	5.4	6.4	5.6	4.5	6.3	5.5	6.9	5.7	5.9	5.9	5.3	6.1	6.0	5.8	4.7	6.2	5.6	6.3	7.5	5.7	6.7	6.4	3.0	6.0	5.3	8.0	5.5	7.2	5.8	3.5	6.7	5.4	5.9	5.2	7.4	9.0	7.1	10.2	12.7	10.5	15.2	29.0	7.9	7.3	0.7	13.6	9.4	14.1	15.4	8.2	7.2	12.9	13.1	10.4	11.4	10.1	19.7	15.2	17.5	14.4	12.1	46.3	10.9	8.2	9.2	16.6	33.1	12.9	10.5	17.5	28.1	7.8	15.4	10.3	22.8	22.0	14.0	6.2	16.7	4.1	19.8	8.9	6.8	6.5	17.5	6.3	6.6	34.8	16.0	10.0	20.1	7.7	9.3	12.0	11.3	13.6	13.5	24.9	9.7	11.4	17.7	17.7	45.3	21.1	3.5	1.1	13.2	3.3	2.7	3.1	2.4	3.9	3.6	3.1	2.1	1.7	3.5	2.3	2.4	3.0	1.2	3.0	4.5	2.1	2.3	1.3	6.1	6.7	12.6	6.3	4.5	6.3	5.9	5.3	5.6	5.5	6.7	10.2	14.7	9.6	18.5	8.5	11.3	6.4	40.0	11.6	12.0	30.6	23.9	14.4	9.4	30.0	17.7	25.8	73.0	14.9	11.9	32.2	19.6	19.6	7.5	20.1	17.6	18.1	23.9	23.8	19.4	8.6	18.5	12.7	19.4	29.7	12.7	22.1	23.2	13.6	11.9	28.6	18.0	16.9	12.2	31.5	8.9	12.2	12.2	16.7	7.2	18.7	21.3	12.4	20.6	24.6	22.2	24.7	20.9	13.5	6.1	45.1	9.6	9.1	15.6	31.2	0.0	17.4	12.8	13.5	11.4	14.6	10.1	19.4	11.9	13.7	18.1	67.1
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.2;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.0"									HPA042136	Uncertain		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	2.5	2.8	1.9	2.0	1.9	1.1	3.8	3.1	1.9	3.3	1.6	2.1	1.4	2.1	2.2	2.4	3.1	1.5	3.9	1.9	1.2	3.8	10.0	1.9	2.8	1.7	1.4	3.5	2.1	2.5	2.2	1.1	1.8	4.9	2.1	2.7	2.7	2.6	1.9	3.9	2.2	2.0	0.9	2.6	1.8	14.5	1.8	3.0	5.5	3.0	3.0	2.7	3.2	2.7	2.0	0.2	0.7	2.7	2.8	1.8	0.2	2.3	4.5	2.8	4.1	2.6	0.7	4.6	2.4	2.9	3.1	1.6	2.4	5.4	2.5	0.1	0.4	0.6	0.5	9.0	2.2	0.4	2.8	3.0	3.7	2.8	1.9	2.1	0.1	2.5	0.9	1.0	2.5	1.3	2.5	0.9	1.1	1.0	2.0	0.1	2.0	0.1	3.0	2.7	0.7	1.3	0.3	0.5	0.3	3.1	2.2	0.2	0.3	4.4	0.8	5.1	1.4	4.4	3.8	0.3	0.8	0.4	1.6	0.8	1.1	0.7	2.7	1.2	1.6	3.2	4.6	2.5	1.4	4.2	8.9	5.2	0.8	1.5	1.4	1.4	3.9	2.2	1.9	1.9	3.1	1.9	1.9	1.2	1.7	1.4	1.8	0.9	1.8	2.7	3.2	3.2	1.7	2.3	4.6	1.3	2.0	3.0	4.6	8.4	2.4	3.4	5.5	5.7	2.1	1.8	0.0	0.3	2.6	1.1	1.9	4.7	200.4	3.6	2.3	3.7	0.0	19.4	4.2	4.9	0.2	2.6	2.0	2.0	0.0	9.5	3.3	8.3	2.2	5.0	2.6	2.4	2.0	1.9	0.4	32.3	7.8	1.7	5.4	3.7	1.8	13.9	8.2	3.5	2.7	2.6	4.5	5.7	1.5	2.0	2.6	7.8	4.9	3.4	13.1	3.1	3.3	15.8	6.3	2.8	2.0	0.1	4.7	3.3	2.5	0.9
ZNF564	MGC26914	ENSG00000249709	"Zinc finger protein 564"	Q8TBZ8	19	12525373-12551542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043998	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA043998: AB_10969446"	"unprognostic (3.85e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.26e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.26e-5)"	"unprognostic (5.77e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.83e-2)"	4.7	3.5	4.2	3.7	5.4	4.4	7.4	11.8	6.2	5.5	3.0	7.4	6.3	6.7	6.1	3.0	6.5	3.4	5.1	5.0	3.6	7.7	5.7	4.3	6.9	5.5	4.2	6.0	3.7	7.6	3.1	5.0	5.2	6.3	7.3	7.1	4.8	6.0	6.2	5.3	7.1	4.3	3.5	6.9	6.7	3.0	4.4	7.5	7.9	8.0	7.5	5.3	4.2	9.2	4.3	1.2	4.9	6.2	7.4	5.5	6.0	4.3	6.0	5.3	7.0	3.2	2.7	5.3	5.8	3.9	3.2	4.9	2.5	4.1	5.6	4.3	4.1	3.7	3.9	6.7	5.4	6.6	6.8	5.5	10.3	2.5	6.3	5.5	4.5	5.5	7.8	2.2	6.6	5.7	5.4	3.9	5.0	4.8	5.5	3.2	5.4	4.4	5.9	6.9	3.4	3.0	5.2	2.9	6.2	7.2	4.5	11.4	4.6	8.0	2.5	5.0	3.3	7.6	9.2	4.2	2.4	4.4	3.4	15.2	7.3	18.6	11.9	10.1	11.0	14.7	10.2	10.9	9.4	11.1	11.5	10.6	13.7	11.3	13.1	7.3	9.3	7.1	4.2	5.4	11.8	6.2	5.0	3.6	5.5	4.2	5.2	3.5	4.4	9.2	1.8	0.0	1.5	6.5	6.9	0.0	0.9	0.8	2.8	2.1	1.0	1.1	0.5	5.7	1.5	0.0	4.2	1.3	3.6	1.5	3.9	1.2	0.1	2.0	1.7	1.8	0.0	4.0	8.4	0.7	0.9	1.5	7.7	1.6	0.0	4.9	2.5	1.1	1.1	0.0	8.6	1.0	0.0	1.6	0.4	0.3	0.6	1.4	1.8	13.1	2.0	2.4	5.2	11.1	8.8	1.6	1.0	0.7	5.9	1.7	2.0	0.8	6.3	4.4	0.0	2.2	1.3	1.2	2.3	1.1	0.0	1.2	4.0	1.4	0.9	1.5
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182276-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Late spermatids: 16.1;Oligodendrocytes: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	2.9	2.6	4.6	2.0	7.0	3.7	3.4	5.7	5.8	2.8	2.5	2.5	2.1	3.2	3.0	2.4	3.1	2.2	2.3	4.9	5.5	2.5	3.0	2.2	2.3	6.9	6.3	5.0	2.5	2.9	2.7	2.2	6.4	3.1	2.7	3.5	3.7	2.5	4.2	3.1	2.0	2.9	4.4	2.2	3.0	6.8	5.6	2.2	3.1	4.6	2.8	2.7	2.5	12.1	2.7	4.1	4.7	3.2	7.2	4.9	1.3	2.8	4.5	3.3	5.6	2.2	2.4	2.2	3.4	3.6	1.5	1.6	2.4	2.0	5.3	3.7	0.9	3.8	3.6	3.2	3.0	2.7	2.5	5.4	5.8	2.1	5.5	3.5	3.9	2.5	2.6	2.6	4.0	3.6	3.2	0.7	1.8	6.4	1.8	2.5	2.8	2.0	3.3	3.8	3.5	3.7	2.3	2.5	2.6	2.9	1.6	2.7	3.3	4.3	2.6	3.4	3.9	0.8	1.3	1.4	4.4	2.1	2.2	16.3	2.7	4.3	2.7	2.7	3.0	2.1	3.2	2.7	3.1	2.0	3.6	2.7	1.2	3.1	3.3	1.6	1.8	1.9	4.6	7.0	5.7	5.8	4.9	5.5	6.9	6.3	6.4	4.4	5.6	12.1	3.3	3.2	1.1	5.9	1.6	2.2	7.1	2.3	4.6	4.2	2.0	1.8	2.9	0.0	1.0	1.8	6.2	1.4	1.9	1.1	0.0	2.5	23.3	2.6	3.8	3.4	1.2	0.0	10.2	2.9	2.1	3.8	7.1	3.9	0.0	3.7	2.9	1.1	1.6	1.7	12.4	0.9	2.0	2.7	0.6	16.1	5.3	1.6	0.0	5.6	1.7	2.9	6.2	5.5	21.2	2.6	0.4	2.6	1.5	5.2	1.6	1.6	3.2	4.6	6.6	7.7	3.3	10.8	8.1	2.7	1.4	2.1	2.8	2.5	1.8	4.3
ZNF566	"FLJ14779, MGC12515"	ENSG00000186017	"Zinc finger protein 566"	Q969W8	19	36445119-36489902	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023456	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023456: AB_2221143"	"unprognostic (1.68e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.89e-3)"	"unprognostic (5.71e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.19e-4)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.47e-3)"	4.1	5.0	5.0	3.6	5.0	3.2	4.2	7.9	6.6	4.5	4.5	4.7	3.2	4.6	4.4	2.8	5.0	2.9	4.7	4.5	5.0	3.9	5.7	3.7	4.2	4.6	4.7	6.3	3.9	4.7	5.0	2.6	4.9	4.0	2.6	5.5	3.0	3.1	4.7	3.8	4.0	4.1	4.5	4.4	3.7	2.4	5.1	3.4	4.7	6.0	4.3	4.2	3.6	5.9	3.7	9.1	10.3	11.5	7.6	7.6	7.1	7.3	6.2	9.0	9.5	3.8	1.5	7.3	7.7	4.6	4.0	2.6	9.5	2.5	10.1	11.7	7.1	7.3	6.2	3.2	5.4	7.9	8.5	6.6	3.8	4.8	7.3	4.2	3.5	7.5	10.8	0.1	6.3	6.0	10.3	3.8	12.5	6.7	4.0	6.7	8.2	4.9	2.7	7.3	9.7	14.4	8.9	4.9	7.0	4.9	4.4	10.7	3.7	7.8	10.8	3.2	7.0	2.8	8.4	10.0	0.3	5.0	10.5	6.5	1.1	1.6	3.9	1.2	6.5	6.5	5.0	4.9	2.3	5.3	6.0	6.1	1.0	4.0	1.3	1.6	5.6	2.5	5.0	5.0	7.9	6.6	4.5	5.0	4.6	4.7	4.9	4.5	5.1	5.9	7.6	9.6	7.7	14.0	9.3	3.3	4.2	4.4	7.4	22.3	4.5	3.0	10.2	4.3	7.4	5.5	35.5	6.7	8.4	1.6	11.7	4.5	4.1	4.2	8.1	8.1	3.0	8.0	24.0	2.5	3.2	10.5	3.1	4.0	2.5	10.6	10.0	4.3	4.4	32.0	26.9	4.5	6.1	3.2	3.9	0.6	8.4	3.5	10.6	11.2	2.5	8.6	8.2	14.1	20.7	2.3	4.7	14.7	5.2	5.1	2.8	6.8	4.0	22.2	19.7	12.2	9.6	11.4	5.7	5.7	3.3	1.9	9.3	9.6	4.9	2.8
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.7;Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	3.3	3.7	2.7	2.9	2.7	3.4	5.8	5.1	4.1	4.1	3.3	3.4	2.3	5.1	4.2	3.1	3.9	3.2	3.1	2.8	3.0	3.3	4.8	3.4	4.7	2.1	2.6	4.6	2.6	5.5	4.8	5.6	2.3	5.2	2.8	4.9	3.6	5.0	2.3	3.3	3.0	4.5	2.5	4.5	3.3	9.5	3.2	6.6	4.8	3.1	4.9	4.2	3.5	3.0	7.1	5.5	9.8	8.7	5.5	5.4	9.3	5.1	7.8	5.7	9.1	3.1	2.5	4.4	6.0	4.6	4.2	1.8	9.1	5.3	7.7	8.8	4.7	8.4	6.0	3.0	5.0	10.8	6.2	8.4	6.2	5.4	10.5	7.4	6.7	8.9	3.3	2.3	6.9	4.5	13.9	4.1	9.4	4.8	4.3	6.8	13.5	6.4	3.8	10.7	7.3	7.8	9.5	4.7	4.9	10.9	5.9	7.2	4.2	7.5	7.6	3.8	5.8	8.8	7.8	14.9	0.0	4.3	6.7	5.0	1.8	5.8	5.7	1.5	4.8	5.7	6.2	5.4	3.2	7.0	6.0	6.1	0.9	6.8	1.6	2.2	5.5	2.5	2.7	2.7	5.1	4.1	2.8	3.0	2.1	2.6	2.3	2.5	3.2	3.0	15.5	6.4	6.9	4.6	15.3	11.7	12.5	7.4	7.4	9.0	13.4	14.7	5.8	5.7	8.8	9.2	10.4	15.3	13.3	3.8	3.9	8.6	86.7	13.4	7.8	9.9	4.2	11.6	12.8	5.1	13.5	7.7	8.2	11.1	17.2	11.7	12.8	6.5	7.5	11.8	11.2	4.6	4.1	5.1	3.7	153.0	9.9	4.7	7.2	11.2	6.7	8.1	14.4	8.5	11.9	4.4	6.2	15.1	5.9	13.1	3.7	6.7	4.8	6.1	6.6	11.5	10.1	42.2	13.4	6.1	17.6	27.5	13.2	12.2	4.4	13.3
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024541: , HPA052061: AB_2681713"	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	4.1	6.5	5.5	3.6	5.4	3.7	5.6	12.4	6.4	6.3	7.3	4.5	2.4	7.3	4.9	3.4	5.9	3.4	5.2	5.4	8.4	4.5	3.3	4.2	4.1	5.9	6.9	9.3	4.4	8.3	5.3	5.2	5.8	4.9	2.9	11.8	4.8	5.4	5.5	4.1	3.2	5.9	3.9	6.1	4.3	6.0	6.9	4.8	7.7	5.7	4.5	4.4	4.1	9.9	0.2	5.0	8.4	2.5	7.8	8.8	2.6	7.4	7.4	6.0	8.1	0.6	2.9	0.3	8.3	9.3	4.3	1.4	0.1	4.3	6.3	1.1	6.5	2.8	0.9	1.0	10.1	0.4	6.5	10.7	5.1	6.1	0.2	7.3	2.9	3.7	0.3	0.8	9.2	0.2	1.6	1.3	6.9	0.0	0.3	0.7	6.7	2.6	5.7	11.0	8.2	10.7	0.3	0.2	6.2	8.3	6.7	1.1	4.7	3.5	11.9	6.1	4.8	9.0	13.1	6.0	0.2	0.2	12.5	19.6	1.7	6.4	7.1	1.3	6.3	9.0	6.8	5.9	2.9	6.9	8.4	6.4	1.4	7.4	2.1	2.7	6.4	3.0	5.5	5.4	12.4	6.4	5.4	8.4	5.9	6.9	5.8	3.9	6.9	9.9	7.7	3.2	7.0	12.7	7.5	5.1	3.4	4.5	2.8	18.9	5.7	6.5	6.6	10.0	3.1	9.2	14.6	5.0	6.3	0.5	3.9	7.1	28.9	5.1	7.1	7.4	0.0	1.3	22.4	3.7	4.1	7.8	2.6	3.8	16.5	13.9	6.4	1.4	3.5	40.4	22.6	1.4	14.2	2.5	3.4	19.5	6.5	3.5	1.8	10.3	3.5	9.4	12.3	25.6	25.7	2.8	0.3	9.8	3.4	3.9	0.7	5.1	5.2	17.0	6.6	13.6	6.6	18.1	12.6	3.4	4.1	2.9	7.9	7.2	1.0	2.6
ZNF569	"FLJ32053, ZAP1, Zfp74"	ENSG00000196437	"Zinc finger protein 569"	Q5MCW4	19	37411155-37469275	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.7;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052994	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA052994: AB_2682007"	"unprognostic (1.40e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.00e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.41e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	3.3	4.1	4.0	2.8	4.1	4.6	3.5	7.2	4.5	3.3	4.0	2.2	1.7	3.8	4.7	2.2	3.3	2.3	4.3	3.3	5.9	3.5	3.3	2.5	4.0	3.6	4.8	5.6	1.8	4.5	3.3	3.0	4.2	2.9	1.8	13.7	2.3	2.8	4.4	3.2	1.8	3.4	3.6	3.4	2.3	10.9	5.8	5.1	5.6	4.7	3.2	2.2	1.8	6.5	3.3	6.2	7.6	12.2	6.0	5.5	3.7	5.9	3.4	6.1	6.5	2.3	1.5	4.0	8.4	4.5	6.0	1.2	8.4	2.0	6.6	9.0	5.1	10.3	1.8	3.8	3.6	1.9	4.0	3.8	1.4	6.3	0.2	6.3	5.2	11.7	3.3	0.8	8.7	2.0	12.0	4.1	8.0	0.2	4.4	8.1	9.6	4.1	4.4	3.3	6.4	9.8	0.2	1.3	3.4	7.1	5.3	8.1	5.3	4.9	10.1	3.9	9.6	10.2	18.6	15.0	0.2	4.2	7.8	3.7	1.8	5.9	6.4	2.6	5.5	4.6	5.7	6.1	2.2	5.4	8.0	6.5	1.8	4.8	3.3	2.4	6.1	2.4	4.0	4.1	7.2	4.5	3.3	5.9	3.6	4.8	4.2	3.6	5.8	6.5	5.1	0.0	1.7	14.0	7.8	1.7	1.7	2.0	2.8	16.1	3.5	4.2	16.3	0.0	5.2	1.8	31.3	3.2	8.1	0.5	1.9	1.5	137.7	5.1	3.9	6.5	0.0	2.1	14.5	2.0	4.0	4.0	1.5	2.3	2.5	5.3	5.3	2.5	2.9	3.3	17.4	0.4	0.0	3.8	3.9	41.8	4.7	4.0	0.0	8.4	3.0	9.3	8.2	20.6	23.4	1.6	0.4	7.5	2.4	0.9	1.0	4.7	5.3	30.2	0.0	6.9	6.3	32.3	13.1	3.4	2.0	0.8	9.1	4.2	0.7	0.9
ZNF570	FLJ30791	ENSG00000171827	"Zinc finger protein 570"	Q96NI8	19	37467585-37488652	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Horizontal cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028881	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA028881: AB_10603938"	"unprognostic (2.93e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (4.06e-5)"	"unprognostic (5.30e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.20e-3)"	2.1	2.4	2.4	1.7	2.9	2.2	2.9	3.3	3.0	2.1	1.8	1.6	1.9	2.5	2.1	2.3	2.0	2.2	2.5	2.5	3.0	2.8	1.8	2.0	2.7	2.8	3.0	3.4	1.6	4.0	1.8	2.1	2.7	2.9	1.2	3.1	2.3	2.1	2.0	1.8	1.5	2.3	2.7	2.4	2.1	6.0	2.7	2.4	3.2	2.8	2.4	1.9	1.3	3.4	1.5	2.0	2.7	8.3	3.6	4.4	1.3	2.9	1.5	2.7	3.6	0.0	0.6	0.3	3.9	2.1	1.6	0.3	2.4	1.8	3.2	1.6	1.7	2.0	0.2	0.9	2.5	0.1	4.2	3.8	1.7	1.8	0.0	2.5	2.6	3.2	0.3	0.1	2.9	0.5	4.8	1.5	1.7	0.1	0.8	0.8	2.8	1.6	2.2	2.3	2.5	5.2	0.0	0.0	1.0	3.3	1.6	2.2	1.4	1.1	2.1	1.8	2.1	4.4	4.2	2.1	0.0	0.2	2.2	0.7	0.7	0.9	1.3	1.3	1.0	1.6	2.1	0.9	0.7	1.4	1.7	1.8	1.4	1.8	0.5	0.7	1.3	0.9	2.4	2.9	3.3	3.0	2.5	3.0	2.8	3.0	2.7	2.7	2.7	3.4	7.9	6.4	0.5	1.6	5.5	1.7	1.7	0.7	4.6	6.4	5.7	6.0	13.7	5.7	2.8	1.8	10.4	2.6	11.4	1.3	9.8	5.5	56.0	6.5	6.6	7.4	6.0	3.0	2.1	3.8	6.7	6.7	1.1	3.9	6.3	5.7	8.2	2.2	3.3	32.0	2.0	1.7	0.0	2.5	0.7	9.0	5.0	3.5	5.4	0.0	2.5	5.4	8.2	2.5	2.9	2.9	1.1	9.8	2.6	1.8	1.6	3.6	3.4	7.2	0.0	6.7	7.6	11.0	6.6	4.8	0.4	1.4	7.9	4.4	2.1	1.1
ZNF572	FLJ38002	ENSG00000180938	"Zinc finger protein 572"	Q7Z3I7	8	124973295-124979389	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.1"					"Low region specificity"	"Detected in all"			HPA066838	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA066838: AB_2685734"	"unprognostic (8.65e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.37e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.17e-2)"	0.6	0.3	0.9	1.0	1.3	0.1	1.8	1.0	1.2	1.1	0.7	1.0	0.9	1.4	2.2	0.5	1.5	0.7	0.9	0.8	1.0	1.7	0.9	0.7	1.9	1.4	1.1	2.3	1.0	0.6	0.4	1.5	1.1	1.4	1.3	1.9	1.3	1.5	0.2	0.8	0.9	0.8	1.1	1.5	1.4	3.6	1.1	1.9	1.8	0.2	1.9	1.1	0.8	1.6	1.0	0.5	1.1	0.0	1.5	1.7	0.0	0.3	0.1	1.3	0.7	1.4	0.7	2.5	1.6	0.4	0.2	1.9	0.6	0.0	1.1	0.0	0.5	0.0	0.7	1.7	1.2	0.0	1.2	1.3	1.6	1.3	0.0	0.3	0.8	0.0	1.5	0.0	1.7	4.1	0.0	0.0	0.0	2.4	0.0	1.6	2.8	0.3	0.7	0.7	2.5	2.4	1.5	2.4	2.6	2.1	1.0	1.6	0.5	1.5	1.7	0.4	0.0	0.0	1.4	1.1	0.3	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.4	0.6	0.2	0.1	0.1	0.6	0.8	0.5	0.0	0.7	0.2	0.0	0.0	0.1	0.9	1.3	1.0	1.2	0.8	1.0	1.4	1.1	1.1	1.1	1.1	1.6	0.2	0.0	0.0	3.9	0.8	0.1	0.2	0.0	0.0	1.0	0.3	0.4	0.6	0.0	0.6	0.0	0.0	0.9	0.2	0.2	1.9	0.3	0.5	0.9	0.5	0.4	0.0	0.4	1.3	0.2	0.3	0.4	0.0	0.3	0.0	1.6	0.4	0.3	0.4	0.0	2.5	0.1	0.0	0.3	0.0	0.4	0.0	0.2	0.0	2.8	0.6	2.3	1.0	2.5	2.7	0.0	0.1	1.2	0.0	0.1	0.1	1.0	0.9	0.6	0.0	0.1	0.2	2.4	2.8	0.3	0.0	0.3	0.3	0.5	0.6	0.1
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	1.6	1.7	0.5	1.1	1.2	2.1	2.0	4.0	1.4	1.0	0.2	0.9	1.3	1.9	2.7	0.7	1.2	1.7	0.9	0.6	2.6	1.3	0.7	1.4	1.2	0.7	0.6	2.1	1.3	1.4	0.8	1.5	0.9	1.3	1.2	2.7	0.8	0.9	0.9	2.1	1.0	0.9	0.2	1.7	2.0	1.3	0.6	1.1	2.5	0.7	1.6	0.7	0.8	2.4	0.5	1.8	1.4	1.3	0.7	1.5	0.6	1.2	1.3	0.4	1.0	1.8	1.2	1.8	1.1	1.0	0.5	1.1	1.4	1.9	1.7	0.4	1.2	2.0	2.8	0.9	0.6	1.7	1.6	1.4	0.6	2.5	1.0	0.9	1.3	1.0	0.8	0.8	0.3	0.7	1.4	1.0	2.0	0.5	0.2	1.4	2.8	0.6	0.0	1.3	1.8	1.6	2.2	0.6	0.2	0.9	1.7	1.5	0.5	1.6	1.5	1.4	1.9	2.1	2.8	2.6	0.3	0.2	1.3	2.1	0.4	1.6	1.9	0.6	1.5	1.5	1.6	2.1	0.9	2.8	2.6	2.0	0.2	1.7	1.3	1.5	1.0	0.5	0.5	1.2	4.0	1.4	0.6	2.6	0.7	0.6	0.9	0.2	0.6	2.4	3.1	0.0	3.9	7.2	7.4	1.8	2.6	2.1	1.8	15.7	2.1	2.4	11.8	2.8	1.9	3.7	12.5	4.0	7.1	0.8	1.9	2.5	37.9	1.4	3.8	4.7	1.2	3.4	22.2	0.7	3.2	4.0	1.1	1.3	0.0	7.6	5.0	1.4	4.0	16.8	28.1	1.3	0.0	1.3	2.5	16.8	8.7	2.2	3.6	12.2	3.2	7.3	7.2	21.1	22.9	1.3	1.6	6.4	1.8	1.9	2.6	2.9	2.4	12.0	0.0	5.2	3.8	7.7	7.6	2.8	2.6	1.6	5.7	3.6	2.1	1.2
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	8.1	5.4	6.8	4.6	6.1	11.1	7.9	9.5	7.7	8.4	4.3	9.5	6.7	10.3	2.7	9.6	8.8	5.1	6.8	6.2	6.2	5.5	5.4	5.6	6.5	6.9	5.8	9.6	7.9	6.1	6.5	5.0	5.8	7.5	2.8	4.1	8.1	6.7	9.3	12.8	7.5	3.7	5.6	8.4	7.2	27.1	6.3	6.3	6.0	6.4	4.2	8.2	7.5	6.3	15.0	41.1	9.0	11.4	8.1	8.0	9.7	11.0	9.6	14.2	13.6	16.2	10.1	21.4	9.7	9.1	7.5	8.9	10.4	14.1	5.6	11.4	17.6	20.5	10.1	14.0	8.6	12.6	13.5	9.5	13.9	13.2	11.1	8.7	7.9	11.8	17.1	13.3	10.1	31.2	15.2	10.9	16.1	13.5	16.2	20.7	8.6	9.3	7.4	19.7	14.9	12.8	11.3	24.0	7.3	6.2	11.0	20.5	9.5	19.2	14.9	5.8	16.4	14.3	9.3	15.7	10.6	11.9	11.0	12.3	10.5	16.7	16.2	7.8	17.6	17.3	12.1	17.8	12.5	12.8	12.6	11.9	13.3	10.9	11.2	11.1	10.3	12.9	6.8	6.1	9.5	7.7	6.2	6.2	6.9	5.8	5.8	5.6	6.3	6.3	6.0	0.0	3.3	1.3	11.3	29.3	15.1	6.1	40.9	7.5	11.0	7.6	4.3	4.3	6.0	1.8	2.1	7.9	6.3	5.8	1.9	6.9	25.3	6.1	5.7	7.6	3.5	8.6	1.4	5.1	6.7	6.6	7.7	5.7	12.7	5.4	6.8	3.1	5.1	3.3	1.7	7.6	6.1	2.5	11.0	15.7	5.6	3.0	8.8	1.0	7.5	3.9	4.1	1.5	0.9	4.3	8.5	8.6	8.1	10.6	6.4	4.3	5.2	9.8	6.6	8.8	8.0	35.5	20.5	22.1	22.7	4.8	10.6	3.8	7.9	9.6
ZNF575	FLJ32567	ENSG00000176472	"Zinc finger protein 575"	Q86XF7	19	43525497-43536130	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 18.9;Paneth cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051865	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA051865: AB_2681643"	"unprognostic (1.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.53e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.87e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.75e-1)"	2.8	1.6	1.5	1.1	2.2	0.6	2.1	2.5	4.4	3.0	0.0	4.5	1.6	2.9	1.0	1.6	2.3	0.7	2.3	2.1	0.0	2.1	2.1	1.6	1.1	0.9	0.2	3.1	1.5	0.5	3.2	0.4	0.9	2.1	2.0	0.6	1.7	1.0	4.6	2.0	2.2	0.8	0.0	2.1	1.5	0.8	1.1	1.1	2.1	0.5	0.6	2.2	2.3	1.5	1.9	1.7	0.4	0.5	2.4	2.0	0.1	1.2	0.8	0.4	0.6	0.4	0.7	0.4	0.8	0.9	0.2	1.0	0.0	0.2	0.2	2.7	0.3	1.4	0.7	0.3	0.5	0.6	1.7	1.2	0.7	0.6	0.1	1.3	0.3	2.6	0.5	2.6	0.7	1.3	7.7	0.2	0.1	1.3	0.8	4.1	0.0	1.0	0.4	1.1	0.3	0.6	0.9	1.2	1.3	0.3	0.3	0.7	1.3	2.3	1.5	0.5	0.9	1.3	2.2	1.2	1.4	1.7	2.4	0.0	0.4	0.3	1.4	0.2	0.5	0.7	1.3	1.4	0.6	1.8	2.1	1.5	0.4	3.3	0.2	0.9	1.4	0.7	1.5	2.2	2.5	4.4	2.1	0.0	0.9	0.2	0.9	0.0	1.1	1.5	1.5	6.4	1.1	1.6	1.3	0.1	0.6	1.2	1.8	1.2	1.1	1.9	2.0	0.0	0.9	0.0	4.2	1.3	1.9	18.9	3.9	0.4	0.1	0.5	1.6	1.8	1.2	1.3	0.9	0.6	0.9	3.5	1.1	1.1	0.0	1.5	2.5	2.3	1.6	0.0	1.1	2.3	0.0	2.7	1.0	0.4	2.5	1.8	1.8	0.0	0.8	0.8	4.1	0.0	1.3	0.2	8.7	3.4	2.6	0.3	2.0	2.5	0.2	0.1	0.0	2.0	2.6	0.1	1.1	2.6	1.7	0.3	3.1	0.7	2.7	0.5
ZNF576	MGC2508	ENSG00000124444	"Zinc finger protein 576"	Q9H609	19	43596392-43601157	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050064	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050064: AB_2681003"	"unprognostic (1.28e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.60e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.34e-3)"	10.3	13.9	10.3	7.1	11.2	3.4	10.5	12.5	12.5	10.7	6.0	12.4	9.4	11.4	4.8	11.1	9.8	7.9	11.7	10.1	9.8	12.0	18.7	6.8	8.4	11.3	11.5	11.8	9.4	8.7	15.0	5.1	11.3	15.1	4.8	5.3	10.7	6.8	14.0	9.0	9.7	5.5	9.9	9.3	10.2	13.6	12.1	7.6	9.1	10.7	5.2	11.9	10.1	11.2	21.9	24.9	9.1	11.6	11.7	10.5	8.1	17.8	11.6	17.5	19.4	12.2	16.2	14.3	19.7	13.4	10.2	8.6	13.0	12.6	4.7	15.6	22.3	10.5	16.7	15.4	9.9	14.2	18.8	9.1	15.4	15.3	6.0	8.7	12.6	12.3	13.3	18.0	13.2	21.4	20.0	6.3	6.4	18.0	21.0	16.7	8.0	14.1	10.5	19.2	16.7	10.5	11.7	23.3	9.3	6.5	11.0	16.2	13.2	23.3	13.1	10.5	26.5	9.4	11.4	10.0	20.1	16.4	20.6	10.5	15.2	16.2	17.2	15.4	15.5	28.2	17.2	14.6	15.9	18.6	18.5	14.6	8.5	19.3	15.6	25.4	18.9	11.5	10.3	11.2	12.5	12.5	10.1	9.8	11.3	11.5	11.3	9.9	12.1	11.2	12.7	6.4	7.3	1.3	11.3	10.6	8.7	17.1	11.4	23.2	15.1	20.1	13.1	10.0	12.7	14.7	31.3	13.7	11.0	16.8	21.5	18.9	34.2	8.6	12.5	13.5	11.4	8.6	3.4	18.9	20.3	13.4	6.6	7.9	9.5	42.0	14.6	20.3	15.4	23.5	3.1	11.9	6.1	6.3	9.2	96.2	13.4	6.6	19.6	0.0	11.1	24.8	12.3	4.0	3.7	19.3	13.0	15.4	9.6	18.0	30.6	32.4	10.7	33.4	6.6	11.3	11.3	28.4	19.4	11.8	12.4	5.7	8.7	14.7	16.0	10.9
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	9.4	7.2	11.9	5.4	15.0	4.2	12.2	14.2	13.2	14.3	8.0	14.5	4.6	11.7	7.1	6.8	12.7	8.0	12.2	11.5	16.1	13.6	6.8	7.9	5.5	14.0	12.3	27.1	8.8	14.9	8.4	9.3	13.3	18.4	6.6	16.9	12.0	11.3	7.2	20.6	9.0	7.2	10.2	12.7	8.9	18.8	13.5	7.7	18.7	9.1	5.7	11.1	9.3	21.0	1.6	0.1	7.8	9.5	13.1	14.1	0.0	9.3	3.4	3.5	7.1	1.0	1.3	1.6	0.9	4.3	5.2	2.5	3.1	1.9	1.9	0.0	9.0	15.6	0.2	1.4	10.2	3.4	5.1	11.1	5.8	5.2	1.5	10.9	1.8	0.0	3.5	0.1	4.5	0.0	9.7	4.4	9.0	0.0	0.2	4.2	3.9	2.9	5.8	3.4	3.2	1.6	2.3	1.1	8.0	7.9	1.6	3.7	1.2	6.4	8.8	1.8	3.4	6.3	0.0	2.0	1.7	0.6	10.6	4.4	1.6	3.7	0.9	2.5	2.7	7.2	1.8	2.2	1.8	3.5	2.2	1.4	0.6	3.3	2.0	2.0	0.9	1.1	11.9	15.0	14.2	13.2	11.5	16.1	14.0	12.3	13.3	10.2	13.5	21.0	8.8	0.0	2.6	14.4	4.0	4.5	3.7	4.0	2.2	12.2	8.1	7.9	8.5	4.3	3.0	18.4	10.4	7.2	4.8	2.7	39.2	4.3	56.3	7.2	7.4	6.6	3.0	2.1	20.1	1.1	5.4	6.3	4.1	5.6	5.1	9.8	7.1	1.8	5.7	6.7	19.3	4.7	2.0	2.2	3.7	60.6	8.1	6.7	0.0	9.4	4.0	15.2	1.0	26.2	50.1	1.2	1.9	12.8	0.9	5.9	5.1	4.9	3.0	9.9	0.0	6.9	7.6	12.3	14.0	4.2	5.3	4.5	2.5	4.2	4.4	3.0
ZNF579	FLJ35453	ENSG00000218891	"Zinc finger protein 579"	Q8NAF0	19	55576774-55580848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEK 293: 43.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062812	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA062812: AB_2684873"	"unprognostic (1.76e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (5.27e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.08e-3)"	11.5	9.1	8.7	3.3	7.8	4.5	9.3	17.1	10.0	10.0	5.3	11.6	4.5	14.7	6.8	6.7	12.7	7.9	14.3	8.5	9.2	18.4	11.8	10.1	4.7	12.3	11.1	13.5	15.3	3.3	12.6	2.5	10.6	12.0	2.6	6.7	8.4	4.5	33.4	6.6	8.8	4.1	7.5	8.8	20.9	3.7	9.3	3.0	16.7	13.4	2.1	9.9	6.5	9.5	7.9	15.9	8.6	8.8	13.1	9.6	11.0	15.3	4.2	8.4	8.5	5.4	9.3	13.1	6.1	8.9	2.7	7.6	5.2	8.3	8.8	2.6	43.9	8.3	32.5	10.1	13.2	4.9	6.5	24.0	8.9	6.4	6.7	18.8	4.7	4.6	16.6	4.2	17.0	10.4	7.3	6.7	7.8	4.3	24.6	12.4	7.8	5.5	11.4	14.9	10.4	14.6	10.2	7.6	7.8	16.7	4.0	7.0	10.9	11.0	10.6	3.4	9.7	11.6	10.3	7.2	5.6	7.8	5.7	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	8.7	7.8	17.1	10.0	8.5	9.2	12.3	11.1	10.6	7.5	9.3	9.5	10.3	3.2	6.7	4.2	4.7	3.3	7.9	1.7	6.2	13.3	8.9	8.0	5.2	18.6	1.5	5.5	12.5	0.7	4.5	4.3	3.9	6.0	0.0	8.6	7.6	6.8	11.4	2.5	2.7	4.8	0.6	5.3	15.3	9.8	4.5	17.2	13.6	7.2	5.1	15.2	3.4	7.1	0.0	5.7	2.8	0.5	8.4	3.8	3.6	3.7	1.8	15.9	3.1	2.5	3.6	6.6	2.0	12.4	2.5	9.4	2.1	11.1	3.0	8.9	13.1	4.7	9.2	0.9	0.9	3.7	3.3	0.4	3.5	13.6	6.1	9.3
ZNF580		ENSG00000213015	"Zinc finger protein 580"	Q9UK33	19	55635016-55643470	"Predicted intracellular proteins, Transcription factors"	"Chemotaxis, Inflammatory response, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 279.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054058	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA054058: AB_2682360"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.46e-3)"	32.0	46.1	53.1	18.2	49.4	12.9	33.9	47.6	62.0	48.3	47.7	55.3	13.1	59.0	24.0	25.9	48.0	5.4	35.9	52.0	54.4	53.2	17.8	33.4	17.5	53.6	50.8	56.6	43.7	26.5	68.6	8.5	48.5	60.0	9.8	12.4	35.8	20.6	19.3	31.1	39.6	18.1	44.3	44.6	42.0	17.6	48.9	14.5	65.6	5.5	14.3	49.2	33.8	46.6	17.6	31.2	27.0	17.6	29.2	16.4	11.3	24.5	25.6	33.3	39.9	5.5	15.6	13.1	6.6	31.2	7.3	15.1	18.2	19.3	25.1	43.4	279.2	23.6	32.7	14.6	38.6	11.1	53.7	35.4	20.5	15.9	29.6	43.8	23.1	29.9	26.1	32.1	27.8	5.1	50.5	15.9	14.4	10.9	43.0	51.1	10.4	53.1	38.0	19.2	30.2	39.3	15.2	15.0	22.4	14.6	13.3	11.4	30.5	18.0	29.4	13.3	13.2	72.3	22.8	29.7	9.9	17.0	17.9	4.6	3.4	11.5	1.1	5.1	1.2	8.4	2.6	2.5	3.7	12.3	3.1	2.7	5.9	3.1	9.9	4.0	2.2	1.7	53.1	49.4	47.6	62.0	52.0	54.4	53.6	50.8	48.5	44.3	48.9	46.6	41.4	9.6	9.7	18.3	39.7	18.6	44.0	32.6	57.5	33.4	51.0	61.2	10.0	37.1	16.3	57.0	4.2	25.3	36.5	25.1	76.3	47.0	3.5	16.1	46.2	36.6	67.4	21.0	9.9	56.0	20.2	36.6	31.6	16.1	19.1	42.8	48.2	11.9	25.9	20.2	10.8	27.2	18.3	31.4	31.1	8.7	59.4	29.2	39.2	11.2	39.1	44.2	28.8	11.6	13.5	45.7	30.9	70.7	49.7	37.6	49.2	78.2	7.6	22.8	39.5	28.5	48.6	11.3	12.9	49.2	16.9	19.0	22.7	70.5	29.8	35.8
ZNF581	"FLJ22550, HSPC189"	ENSG00000171425	"Zinc finger protein 581"	Q9P0T4	19	55635459-55645623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 143.9"					"Low region specificity"	"Detected in all"			HPA059657	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"			"HPA059657: AB_2684098"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.35e-1)"	18.7	20.0	11.8	10.3	11.9	16.7	16.9	12.3	14.2	24.2	12.0	21.9	9.3	19.0	9.4	23.1	18.9	7.0	12.2	11.5	11.5	16.3	13.0	14.7	15.6	12.4	11.7	34.5	34.5	7.1	12.0	6.7	11.9	16.1	5.8	4.3	16.5	7.3	20.7	26.8	19.7	6.7	11.9	27.3	20.7	10.6	12.2	12.9	15.3	8.1	18.2	18.6	19.4	12.1	16.6	24.9	15.6	14.8	22.1	53.8	23.6	10.4	28.0	19.3	21.8	18.9	20.9	75.2	11.5	15.5	10.0	15.3	27.1	35.6	10.8	12.7	143.9	22.2	17.8	30.4	34.0	20.6	15.5	69.4	38.8	12.3	24.1	64.4	25.9	30.6	33.8	9.2	16.8	13.6	34.0	26.1	21.3	17.2	58.8	33.2	16.9	37.3	33.5	23.5	30.7	30.0	10.8	26.6	36.4	14.5	13.0	20.7	24.5	23.5	20.5	5.8	18.8	31.6	21.9	36.0	16.4	15.2	11.6	32.6	42.0	27.7	20.1	50.9	22.3	81.1	29.9	21.9	41.9	84.0	34.9	33.8	21.4	22.4	35.9	24.9	40.4	26.3	11.8	11.9	12.3	14.2	11.5	11.5	12.4	11.7	11.9	11.9	12.2	12.1	12.4	16.0	7.0	3.3	50.7	71.0	20.4	32.7	55.8	6.2	35.5	30.1	5.8	20.0	15.8	7.3	0.0	24.5	20.3	16.7	7.9	22.2	1.5	12.9	20.8	21.3	19.7	14.7	1.3	30.7	31.2	19.1	10.2	15.1	21.6	31.0	30.0	7.1	34.6	3.3	1.4	23.0	20.3	84.1	64.8	3.7	31.4	29.5	33.8	0.0	46.5	6.1	9.2	1.0	2.0	29.4	21.6	15.1	21.5	24.8	53.8	24.8	9.2	5.8	6.6	10.4	15.4	8.6	21.1	37.1	77.0	25.9	24.6	29.3	28.9	21.2
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	2.3	4.5	5.8	2.2	6.8	1.6	3.3	7.5	8.6	3.2	6.2	3.1	1.1	4.1	6.9	2.5	3.1	3.3	4.4	5.8	7.0	4.0	2.5	2.7	4.8	6.5	6.2	5.1	2.1	3.8	5.0	2.9	6.3	4.3	1.3	10.5	2.1	2.7	1.8	3.0	2.0	2.3	6.2	4.1	1.9	5.1	6.2	2.6	7.4	1.6	1.9	3.0	2.1	7.3	0.0	1.3	6.9	1.4	1.6	1.7	0.0	2.9	3.0	1.8	1.4	0.0	0.4	0.0	1.8	1.6	4.0	0.0	0.9	0.4	1.3	0.0	28.3	7.0	0.0	0.5	2.9	1.8	5.4	6.1	1.5	1.1	0.0	1.8	1.1	0.7	1.6	0.0	1.1	0.0	4.1	4.5	3.9	0.1	0.0	1.9	2.3	2.5	1.5	3.9	0.0	4.5	0.0	0.9	0.0	5.1	3.1	3.8	1.2	3.6	7.4	0.9	3.9	6.0	7.0	4.4	0.2	0.4	2.1	2.9	1.4	4.2	2.8	2.3	4.2	4.3	3.4	2.8	2.3	3.2	2.4	3.1	0.4	7.6	1.7	2.3	1.1	1.9	5.8	6.8	7.5	8.6	5.8	7.0	6.5	6.2	6.3	6.2	6.2	7.3	4.9	0.0	0.0	4.2	4.0	1.3	2.4	2.3	1.2	4.4	2.5	2.8	3.5	1.5	2.1	7.3	2.1	2.7	2.9	0.2	13.7	2.5	1.0	2.8	1.7	4.6	0.0	0.4	4.5	0.6	0.7	2.6	1.1	1.9	8.2	3.2	4.6	2.4	2.8	1.7	4.9	0.5	6.1	1.0	2.0	0.9	2.1	2.3	3.6	0.0	1.6	13.2	5.2	7.1	9.2	1.4	0.3	4.1	0.1	4.2	0.7	4.9	2.2	5.5	13.1	3.5	2.8	2.8	7.9	0.9	1.0	3.6	2.7	4.5	0.6	2.3
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.5;Late spermatids: 43.0;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	Cytosol	"HPA023805: AB_2671318, HPA023957: AB_2671383"	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	3.2	2.4	3.9	1.7	4.0	1.0	1.9	5.6	4.2	2.2	1.3	2.1	1.3	2.6	2.2	1.5	2.4	2.3	2.1	3.7	4.9	2.8	2.6	2.8	1.8	4.0	3.9	4.6	2.6	4.0	2.7	2.0	3.8	2.4	1.4	4.0	0.9	1.9	2.1	0.8	1.3	2.6	4.2	2.4	1.6	7.4	3.9	2.7	3.4	3.3	1.8	2.1	1.3	4.3	0.0	2.1	4.9	0.0	3.4	2.7	0.0	6.2	6.2	2.8	2.3	0.3	0.7	4.7	3.0	5.7	5.1	0.3	2.0	1.9	3.0	2.2	10.8	6.2	0.0	1.1	3.9	5.2	5.4	3.8	3.0	4.0	2.0	4.1	2.8	4.8	2.3	1.7	9.3	0.0	6.5	1.7	1.2	0.0	2.0	3.2	9.3	3.5	2.2	4.5	2.8	4.2	0.0	0.6	1.6	2.5	3.1	6.6	1.9	14.5	4.0	2.8	12.4	6.2	12.3	7.4	0.3	1.4	5.2	9.7	1.5	3.3	3.1	2.2	4.6	4.5	2.5	2.9	1.7	3.5	4.6	2.8	0.6	6.1	3.7	2.4	3.6	1.9	3.9	4.0	5.6	4.2	3.7	4.9	4.0	3.9	3.8	4.2	3.9	4.3	7.7	3.2	1.5	4.6	7.9	1.8	3.2	2.8	0.6	17.5	3.5	1.8	5.3	0.0	1.9	1.8	6.2	1.8	4.9	0.6	9.8	5.7	60.5	2.1	6.2	6.6	0.0	9.1	14.6	2.7	0.5	6.5	1.1	2.9	10.8	10.5	7.5	2.4	3.9	10.1	12.1	1.6	0.0	3.3	4.3	43.0	6.8	3.3	3.6	4.7	3.8	12.2	16.5	15.1	12.0	2.5	1.8	13.5	1.6	3.0	1.2	5.2	1.7	15.1	6.6	13.8	7.1	30.6	17.2	0.6	1.7	1.1	6.8	6.9	1.4	2.4
ZNF584	FLJ39899	ENSG00000171574	"Zinc finger protein 584"	Q8IVC4	19	58401504-58418327	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 49.8"					"Low region specificity"	"Detected in all"			"HPA043408, HPA048075"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA043408: AB_2678466, HPA048075: AB_2680251"	"unprognostic (6.06e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.76e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.36e-2)"	5.7	6.7	4.6	2.9	4.5	1.8	5.0	5.4	5.5	5.6	6.0	6.6	3.5	6.9	3.8	5.8	6.8	2.3	8.9	5.1	4.3	5.3	6.6	4.3	2.5	5.3	4.6	6.1	4.9	8.4	6.7	2.7	4.6	5.0	2.6	5.1	4.7	5.7	9.8	9.0	3.5	5.1	4.0	3.3	5.6	4.7	4.5	3.2	4.7	10.9	3.4	6.1	5.0	4.1	11.7	16.7	11.2	14.7	10.8	10.7	4.5	8.9	15.8	5.4	6.7	2.7	3.5	5.8	7.0	14.7	14.2	6.5	12.1	14.6	6.1	7.5	49.8	15.7	9.6	3.5	18.3	17.3	4.3	11.1	10.4	16.5	22.8	11.9	10.9	9.5	15.8	5.4	8.9	8.3	14.4	5.4	2.8	7.6	23.2	10.4	8.4	9.0	7.6	13.7	9.0	9.5	19.5	5.6	7.4	2.9	3.7	8.6	7.0	21.2	6.5	8.9	14.3	5.0	9.5	1.3	15.2	6.0	7.1	0.0	2.2	0.8	3.2	2.1	5.2	2.1	4.3	4.5	3.4	3.3	2.3	3.6	0.7	3.2	3.5	2.9	5.1	2.7	4.6	4.5	5.4	5.5	5.1	4.3	5.3	4.6	4.6	4.0	4.5	4.1	4.2	3.2	3.9	1.0	2.3	11.2	3.2	5.6	6.2	4.1	4.8	4.3	12.8	5.7	2.1	9.2	4.2	1.0	5.9	1.6	13.7	5.6	9.6	8.1	6.1	4.6	6.7	9.5	2.0	5.1	1.5	5.6	3.6	1.8	2.5	5.5	6.8	4.7	2.6	3.3	2.2	2.3	4.1	2.4	3.3	7.8	5.3	2.1	1.8	0.0	1.3	6.1	2.1	0.5	1.6	4.9	2.8	6.4	2.6	4.2	2.1	5.5	10.2	9.2	6.6	4.4	6.3	8.1	3.7	4.3	15.9	0.4	4.0	12.3	3.2	2.0
ZNF586	FLJ20070	ENSG00000083828	"Zinc finger protein 586"	Q9NXT0	19	57769655-57819939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 18.9"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA030306, HPA060782"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli fibrillar center"	Vesicles	"HPA030306: AB_2673423, HPA060782: AB_2684362"	"prognostic favorable (9.83e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.36e-4)"	5.2	4.3	3.6	6.3	4.0	25.4	6.9	18.9	4.1	6.1	5.9	5.6	5.9	5.9	5.0	6.6	5.9	4.9	6.0	3.6	4.6	5.3	4.8	5.8	11.8	2.4	2.2	9.0	6.5	4.2	4.8	6.9	2.0	8.4	5.9	9.3	8.9	4.1	9.7	8.3	6.5	5.8	0.3	10.4	7.2	5.0	3.0	13.4	6.2	7.2	9.8	6.5	7.2	4.3	7.2	6.0	8.6	9.6	4.1	3.7	14.4	5.0	5.3	7.0	3.8	2.8	7.2	16.1	0.4	4.6	6.6	4.7	1.6	7.2	13.1	2.4	30.9	12.2	15.1	1.6	7.5	12.0	10.4	6.4	7.5	5.2	7.6	7.9	8.5	15.6	8.0	0.7	8.3	1.7	12.3	8.2	12.8	4.8	17.3	11.9	3.2	20.2	8.3	17.8	11.9	5.9	2.3	7.4	5.8	7.4	7.1	7.6	4.6	9.2	5.1	0.3	8.8	15.4	23.0	17.1	5.0	1.3	6.6	8.0	9.6	31.5	8.4	8.0	8.2	7.0	10.8	8.9	8.9	9.7	13.3	12.2	29.5	10.1	5.4	6.6	15.1	7.3	3.6	4.0	18.9	4.1	3.6	4.6	2.4	2.2	2.0	0.3	3.0	4.3	3.9	0.0	1.5	3.6	13.6	12.1	7.9	6.6	9.6	3.6	4.9	4.2	4.8	0.0	3.3	3.7	0.0	7.1	8.5	2.1	9.8	3.4	0.9	4.3	2.8	4.5	3.0	4.4	4.0	2.0	6.9	3.4	2.6	5.7	3.8	8.6	5.0	3.5	5.5	6.7	4.7	4.0	8.2	8.2	6.8	1.1	0.9	5.6	3.6	1.9	7.1	3.1	6.2	3.0	3.4	2.1	1.7	2.6	9.2	3.6	4.4	5.9	2.2	5.2	6.6	2.6	3.8	10.4	8.7	7.0	11.4	10.0	9.2	4.5	4.0	8.5
ZNF587	"FLJ14710, FLJ20813, UBF-fl, ZF6"	ENSG00000198466	"Zinc finger protein 587"	Q96SQ5	19	57849859-57865117	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RT4: 41.5"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (1.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-3)"	5.0	5.1	3.9	6.4	3.6	6.8	10.1	4.5	5.3	6.4	5.9	8.5	8.2	5.9	5.6	6.1	6.0	3.7	6.0	3.7	3.8	6.5	6.2	6.2	5.4	2.9	2.9	7.1	9.1	4.9	11.5	8.0	2.9	9.6	13.1	11.4	12.1	6.5	4.5	5.9	7.9	5.5	2.1	6.1	8.9	4.4	3.3	5.4	7.7	4.1	6.8	6.2	7.3	4.7	8.6	7.8	7.0	5.7	7.5	10.9	10.5	7.5	9.5	11.2	9.8	11.2	5.7	5.7	3.9	5.9	4.4	5.1	10.1	11.1	20.8	5.3	21.5	11.1	28.6	8.0	4.3	11.1	10.6	10.8	5.1	11.0	10.4	8.6	12.1	7.8	14.1	7.5	8.4	3.6	6.7	4.1	2.1	2.2	7.1	5.3	6.6	3.8	6.7	41.5	11.1	5.2	8.7	7.9	2.7	9.2	6.8	6.3	5.7	8.3	5.1	2.1	10.7	12.0	9.8	6.0	3.8	4.7	5.0	1.4	0.5	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.5	0.7	0.4	0.7	1.2	0.5	0.4	0.4	0.7	0.3	3.9	3.6	4.5	5.3	3.7	3.8	2.9	2.9	2.9	2.1	3.3	4.7	6.9	3.2	6.8	13.1	8.4	9.2	13.6	7.3	1.8	20.0	10.4	5.8	7.1	30.0	9.6	7.3	31.3	10.8	7.4	12.2	11.7	9.1	9.5	16.9	10.0	7.8	23.4	3.8	19.9	3.7	9.8	7.3	19.4	22.6	12.7	18.3	12.5	9.4	6.5	20.2	19.3	18.2	4.1	7.1	5.5	1.3	4.7	7.0	0.0	10.3	7.2	7.6	7.2	17.6	14.1	7.6	15.9	9.1	8.7	13.4	14.8	8.5	13.3	24.7	0.0	9.2	6.3	4.2	6.7	5.4	6.7	10.1	8.7	9.5	15.5	15.4
ZNF587B		ENSG00000269343	"Zinc finger protein 587B"	E7ETH6	19	57819721-57846238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 36.2"									"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.13e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.70e-2)"	3.6	3.1	1.2	3.4	1.6	9.4	5.3	4.0	1.1	2.5	3.4	4.0	5.7	3.2	2.5	3.8	3.2	2.6	3.1	1.3	0.8	4.0	6.6	3.8	4.8	0.7	0.7	3.3	5.6	3.0	3.0	3.0	0.4	4.0	4.4	2.0	6.0	2.3	9.9	6.9	5.6	2.2	0.1	6.4	4.7	5.3	1.3	2.8	4.0	2.0	5.0	3.7	2.9	0.8	5.6	16.3	6.0	13.0	1.5	1.7	7.0	4.5	3.5	4.4	3.0	9.6	8.9	11.9	2.4	6.1	2.4	4.7	5.9	14.1	10.5	2.0	13.8	8.8	15.3	10.1	5.2	15.4	8.3	5.0	2.7	6.8	7.1	1.2	3.7	8.5	10.3	5.5	2.8	6.2	7.2	2.6	15.7	5.2	7.2	5.9	6.5	5.6	5.3	36.2	3.7	6.2	5.0	6.6	4.3	9.4	9.1	5.5	5.1	6.0	6.9	1.4	6.6	7.7	6.6	9.1	4.9	4.5	6.7	2.0	1.8	0.8	1.1	1.6	1.2	1.2	1.2	1.3	1.1	1.2	1.6	1.5	3.0	1.1	0.9	1.2	1.0	1.8	1.2	1.6	4.0	1.1	1.3	0.8	0.7	0.7	0.4	0.1	1.3	0.8	1.7	6.4	1.5	6.5	3.4	3.2	3.4	2.4	1.2	4.2	2.2	0.6	2.7	4.3	5.4	0.0	0.0	3.5	3.9	1.3	1.9	3.9	4.6	3.1	2.2	2.8	4.2	1.3	11.6	2.0	3.3	2.8	3.1	3.3	0.0	5.8	5.7	3.4	1.4	3.3	12.2	3.7	4.1	2.2	1.0	0.9	0.6	1.9	1.8	4.7	1.8	0.8	2.1	11.1	4.6	2.1	1.4	0.7	2.2	2.9	1.4	3.3	3.2	3.6	6.6	2.3	2.5	4.2	5.8	1.3	3.8	2.5	2.2	4.4	2.4	3.1
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 44.1;NTERA-2: 71.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	7.2	8.5	9.6	6.7	9.7	5.8	6.9	14.9	11.2	11.2	2.3	8.3	3.8	7.6	20.1	10.2	8.8	4.6	6.2	11.0	9.3	7.1	3.7	10.1	12.3	7.9	7.9	13.6	6.5	5.9	7.8	3.0	7.7	18.3	6.6	14.8	6.6	15.7	6.1	9.8	16.1	6.0	7.2	24.1	7.9	6.6	8.9	8.1	16.6	4.2	12.2	8.5	10.7	10.2	4.5	3.2	12.7	10.8	15.8	8.7	16.1	4.6	3.5	5.2	6.9	6.8	6.0	17.8	3.3	4.7	4.0	3.9	44.1	11.2	4.2	11.5	10.5	22.5	14.9	5.4	2.9	5.4	5.6	2.8	7.5	6.4	4.3	5.7	9.0	13.7	15.4	4.5	2.8	4.5	6.8	4.1	71.1	4.3	6.6	3.3	4.6	6.8	4.0	4.4	4.9	9.1	3.4	3.7	13.7	18.8	6.0	8.0	14.0	3.0	5.8	7.2	3.5	8.9	12.0	14.6	4.0	12.6	9.3	1.2	2.2	1.6	2.8	2.0	3.5	3.1	3.4	3.8	2.3	1.9	3.8	3.8	1.2	1.2	2.8	10.9	3.1	1.9	9.6	9.7	14.9	11.2	11.0	9.3	7.9	7.9	7.7	7.2	8.9	10.2	2.0	0.0	5.4	4.2	5.5	1.1	1.4	0.9	3.4	15.3	2.4	1.5	4.1	0.0	2.8	9.2	20.9	2.2	13.7	1.3	3.9	1.4	1.5	7.3	3.5	2.7	1.8	2.1	9.8	1.0	1.2	4.3	1.5	11.7	0.0	3.9	2.5	1.0	3.3	1.7	11.5	2.5	0.0	5.5	3.0	2.0	2.1	7.3	1.8	3.7	3.7	5.3	1.0	9.5	11.0	1.0	1.7	4.5	5.3	1.5	1.4	1.6	2.4	13.1	6.6	4.1	3.0	1.4	3.1	2.9	1.3	0.0	4.4	7.0	2.5	0.9
ZNF592	"CAMOS, KIAA0211, SCAR5"	ENSG00000166716	"Zinc finger protein 592"	Q92610	15	84748592-84806445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020332, HPA021600"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA020332: AB_1859365, HPA021600: AB_1859364"	"unprognostic (2.83e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.04e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.62e-1)"	9.7	8.7	9.4	6.7	10.0	11.1	9.6	10.4	9.4	9.7	7.4	9.4	7.9	9.1	7.9	7.4	9.8	4.9	9.6	9.8	9.0	8.7	10.9	9.0	9.5	11.5	10.1	11.8	10.9	9.1	7.9	5.9	10.2	8.7	7.1	7.5	7.5	6.5	18.2	10.1	10.7	6.8	9.3	11.2	8.1	8.0	10.2	11.4	8.8	14.5	9.4	8.5	8.3	10.6	7.7	12.8	11.6	6.5	12.7	8.5	12.8	5.3	7.5	8.6	6.8	12.2	8.9	11.1	6.7	11.9	7.4	13.9	18.0	7.6	6.0	9.0	10.8	12.9	12.9	11.0	7.8	10.6	9.9	9.4	10.6	6.7	11.0	10.2	7.6	7.7	13.0	6.8	9.1	12.0	7.2	13.0	10.6	7.3	5.0	10.3	10.4	9.8	9.2	15.4	10.5	11.4	12.1	10.7	9.0	16.1	6.0	22.3	10.8	12.7	7.4	7.1	10.2	7.8	9.0	11.8	8.0	15.5	7.5	0.0	1.2	0.9	1.2	1.4	0.4	1.5	0.7	1.2	1.3	1.4	1.0	0.9	2.6	1.0	1.3	1.0	0.8	0.8	9.4	10.0	10.4	9.4	9.8	9.0	11.5	10.1	10.2	9.3	10.2	10.6	9.2	9.6	10.5	23.8	15.2	8.4	4.2	8.2	6.2	9.0	14.3	8.8	5.3	8.6	7.5	3.7	8.4	5.6	9.6	18.8	0.0	8.4	7.8	24.7	10.8	9.8	7.8	12.0	21.7	8.1	8.9	8.7	13.7	40.3	3.8	10.2	10.4	16.7	11.3	3.3	20.7	10.8	4.1	21.1	9.8	11.8	4.7	14.6	7.2	28.1	14.9	3.7	11.3	10.1	29.9	9.8	11.1	9.8	16.9	5.6	16.2	6.3	8.4	8.5	6.6	13.1	9.2	13.2	12.4	8.9	7.1	4.8	11.6	8.1	11.4	5.1
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169908-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	35.8	31.8	20.0	12.6	21.0	20.3	30.7	21.4	25.6	18.1	20.6	23.6	13.0	22.7	6.6	32.5	23.0	6.1	37.9	20.3	23.0	40.2	63.9	21.8	10.1	21.1	22.3	32.1	61.5	16.4	25.7	9.3	22.7	31.3	6.2	2.5	24.3	7.6	101.3	32.4	21.1	7.0	20.6	28.2	39.0	16.3	20.8	4.6	28.0	21.9	8.3	25.5	20.7	21.5	76.0	41.3	13.1	48.4	13.3	17.3	72.2	32.8	16.5	37.3	36.3	62.8	44.4	87.2	58.9	21.0	29.7	48.3	47.2	43.5	13.5	53.1	150.6	59.6	33.6	98.3	56.6	82.5	50.0	31.4	41.8	41.8	43.7	15.5	32.3	20.6	91.4	32.7	23.1	58.1	34.1	154.7	53.0	72.7	143.0	42.0	23.6	89.8	27.7	32.8	35.7	39.4	39.8	98.4	132.1	10.7	41.0	46.3	33.6	35.7	42.0	75.8	62.4	64.1	71.3	97.2	42.2	171.1	46.9	0.5	41.3	0.6	35.6	69.1	33.0	64.2	48.7	34.9	57.5	63.3	36.1	34.6	1.9	44.6	70.9	70.4	58.4	39.3	20.0	21.0	21.4	25.6	20.3	23.0	21.1	22.3	22.7	20.6	20.8	21.5	38.9	12.8	57.9	2.6	56.8	171.3	180.9	67.7	128.1	18.0	116.1	142.0	6.0	88.6	50.6	60.7	2.1	114.5	29.8	86.1	103.7	102.2	6.7	70.7	62.6	45.1	109.8	26.5	2.5	147.0	158.5	49.7	75.4	83.4	50.9	62.2	40.7	201.5	79.4	3.3	3.2	156.7	36.7	59.9	52.3	14.3	32.3	37.3	49.8	0.0	47.2	20.9	21.6	2.0	2.1	130.8	61.6	23.3	94.9	197.2	71.7	218.0	27.8	16.7	13.1	65.1	57.7	39.0	52.2	111.6	168.4	222.6	28.8	68.0	128.4	185.3
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179535-5191868	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	1.8	3.3	2.8	4.2	3.9	0.7	4.9	6.0	3.8	4.4	4.5	3.9	1.6	5.1	4.2	1.9	4.4	2.2	2.9	3.0	2.7	4.2	2.2	2.2	6.2	3.8	2.8	10.7	3.3	5.4	6.2	3.2	3.1	5.1	2.7	11.7	3.8	4.3	4.0	2.1	4.0	3.0	2.0	5.1	2.9	4.5	3.4	5.1	5.6	2.9	5.9	3.6	2.9	6.8	5.8	2.5	10.5	8.3	1.6	1.8	8.9	3.8	1.9	6.6	6.2	7.3	2.1	13.1	5.9	3.0	4.9	6.2	6.8	0.2	8.3	7.0	6.9	4.2	10.2	3.7	2.4	0.0	4.0	1.4	1.1	4.0	0.0	1.7	0.7	7.5	1.7	3.2	2.2	5.7	3.6	1.8	4.9	0.9	3.5	7.6	8.9	1.7	1.9	1.5	6.2	8.4	2.8	1.5	5.8	4.6	3.4	3.1	0.1	0.1	3.7	3.4	2.7	2.0	4.5	3.0	0.6	0.0	4.1	0.2	0.4	0.5	1.4	0.5	1.0	1.6	1.5	1.4	0.4	2.5	2.3	1.6	0.2	1.3	0.5	2.2	2.4	0.6	2.8	3.9	6.0	3.8	3.0	2.7	3.8	2.8	3.1	2.0	3.4	6.8	1.8	6.4	3.9	14.0	3.6	1.1	1.3	0.4	1.2	9.5	2.5	2.2	5.5	4.3	2.8	5.5	6.2	1.4	1.3	0.7	7.9	1.6	0.8	0.8	3.1	2.1	1.2	2.5	17.8	1.1	0.7	2.7	1.5	0.8	3.8	9.9	3.9	0.7	1.1	15.2	15.7	1.5	0.0	1.4	0.6	4.3	3.4	1.2	0.0	8.4	1.5	7.7	3.1	14.6	20.3	0.7	1.5	2.6	0.8	0.9	0.6	1.0	5.0	9.2	0.0	3.3	2.4	2.5	4.1	0.9	0.3	0.3	1.8	5.2	1.3	0.5
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.1;Late spermatids: 20.4;Oligodendrocytes: 20.7;Spermatocytes: 63.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4"					"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	2.6	3.5	4.2	2.0	4.5	1.8	5.2	8.3	5.0	3.8	4.6	2.7	2.7	7.1	7.0	2.3	4.1	2.1	3.4	4.0	5.5	4.2	3.0	3.1	3.8	4.4	4.1	5.0	3.4	4.9	4.6	3.6	4.3	3.9	3.2	18.7	2.3	4.0	2.9	4.5	2.6	3.2	3.2	5.0	3.7	15.5	5.1	3.4	5.7	1.8	2.8	2.7	2.5	6.8	1.6	1.1	4.5	11.4	2.1	2.3	3.6	3.6	1.5	1.3	2.4	1.1	2.0	1.6	1.3	2.7	1.9	3.3	1.2	2.6	1.7	1.2	1.9	3.3	3.3	1.3	2.4	1.4	1.8	4.8	0.4	1.5	2.4	2.2	1.0	5.7	2.4	5.4	7.8	5.6	4.0	1.8	2.4	3.0	1.1	1.6	1.0	2.7	4.4	2.7	2.7	6.7	2.3	1.2	1.8	2.3	3.6	4.1	2.6	3.3	0.9	0.3	1.8	1.7	5.1	2.2	4.1	1.4	2.4	4.6	1.5	2.3	2.4	1.2	3.1	3.2	2.5	2.2	1.7	3.6	2.9	3.4	1.4	1.5	2.9	2.3	2.9	1.3	4.2	4.5	8.3	5.0	4.0	5.5	4.4	4.1	4.3	3.2	5.1	6.8	2.3	3.2	2.7	10.1	2.2	0.4	0.7	2.6	2.2	8.3	1.3	1.8	2.9	1.5	2.4	1.8	2.1	2.1	0.8	1.6	3.9	2.1	60.1	1.5	2.7	2.5	0.0	1.7	14.1	1.7	1.4	2.1	5.1	1.3	5.1	2.9	2.2	0.9	1.1	11.8	15.7	1.5	4.1	0.8	0.3	20.4	4.1	0.9	0.0	9.4	0.5	5.4	1.0	15.6	20.7	1.3	0.5	1.2	2.9	0.7	1.6	1.9	3.8	9.0	0.0	2.6	1.8	63.7	4.5	3.1	0.4	1.5	1.8	2.9	1.5	0.5
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432414-3443504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	1.6	1.9	1.1	1.5	1.1	1.9	1.7	1.0	1.3	1.4	0.8	1.1	1.2	1.5	2.1	1.1	1.4	1.9	1.3	1.0	1.5	1.3	1.7	2.4	2.1	0.9	1.1	2.0	1.6	1.4	1.3	2.3	1.0	1.4	1.0	2.3	1.1	1.2	0.7	1.3	1.3	1.2	1.0	1.8	1.2	3.9	1.4	1.5	2.0	1.1	1.8	1.6	0.9	1.2	0.0	1.2	1.5	3.7	1.1	1.7	5.9	1.8	2.2	1.7	2.1	0.0	2.3	3.1	1.7	2.0	1.3	1.0	3.5	1.6	2.2	1.9	1.4	5.3	3.6	2.2	1.6	3.2	3.1	2.2	2.5	1.9	2.1	1.7	4.7	1.6	1.1	2.0	2.0	1.0	2.3	3.3	5.0	1.4	0.0	1.4	4.5	2.1	1.4	4.9	2.0	2.8	3.5	1.8	1.4	4.1	1.5	4.7	3.1	2.8	1.4	0.0	1.7	2.6	2.9	0.4	0.0	1.8	1.7	3.1	0.8	8.8	0.9	1.7	1.5	0.9	0.7	0.8	0.8	0.7	1.2	0.9	0.2	0.7	0.8	0.4	1.2	0.6	1.1	1.1	1.0	1.3	1.0	1.5	0.9	1.1	1.0	1.0	1.4	1.2	8.3	25.6	2.6	0.0	4.3	0.1	1.8	0.3	2.8	2.1	4.3	3.8	1.9	1.5	5.2	1.8	0.0	1.2	3.6	1.4	0.0	1.1	8.1	3.8	2.1	4.2	2.4	0.4	2.9	1.0	1.8	2.6	1.5	4.5	3.8	3.0	2.5	1.4	1.2	0.0	1.9	2.1	0.0	1.0	0.7	4.1	1.2	2.7	0.0	4.7	3.0	1.8	0.0	1.0	2.0	1.8	1.0	2.2	2.1	2.4	0.7	1.3	0.9	3.1	6.6	2.7	2.6	5.3	8.0	1.9	0.4	1.5	3.3	1.1	2.4	2.3
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598, E3 ubiquitin ligase"		16	1997654-2009821	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA041760: AB_10792490, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	15.0	10.1	2.3	6.8	2.2	11.8	13.9	2.3	5.3	15.4	0.9	14.7	7.0	15.4	0.0	19.4	13.1	2.6	11.6	2.5	2.1	13.1	21.0	15.3	5.5	2.9	2.4	12.4	32.3	2.2	16.3	5.0	2.3	16.2	1.4	0.4	18.7	4.4	26.7	30.0	14.8	2.1	1.7	18.6	14.9	17.6	2.6	5.1	10.8	3.8	2.9	15.8	15.3	2.0	22.8	30.1	7.0	17.5	4.9	6.6	22.0	17.3	7.4	10.5	8.3	31.9	12.4	23.4	20.0	6.7	7.7	27.0	9.3	17.3	1.7	31.2	69.9	18.6	33.5	18.3	22.3	29.3	20.0	7.9	23.2	16.6	18.9	1.1	11.6	27.2	41.3	31.5	4.0	40.5	25.2	45.0	21.6	8.9	35.4	62.4	14.2	52.9	4.0	8.7	33.5	28.9	17.4	20.4	28.3	1.3	14.5	46.6	20.6	23.0	27.6	21.0	32.4	39.2	36.3	29.6	9.7	27.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	2.3	2.2	2.3	5.3	2.5	2.1	2.9	2.4	2.3	1.7	2.6	2.0	11.7	6.4	11.5	6.2	7.5	29.7	12.9	9.0	10.2	12.8	13.9	12.4	1.0	10.0	8.8	1.8	16.7	9.1	11.1	21.2	0.0	8.1	5.6	10.1	11.6	12.7	11.4	10.8	5.4	26.5	12.8	10.5	36.2	13.7	12.7	11.9	6.8	20.1	9.5	16.8	5.3	36.2	12.2	8.4	10.3	9.7	13.4	8.8	1.8	5.6	8.2	7.8	9.2	1.0	6.7	19.6	9.5	8.2	9.3	23.9	13.5	3.3	12.7	10.7	0.0	11.2	9.1	9.0	11.9	14.0	34.8	9.3	9.8	13.1	20.8	19.7
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758073-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	4.4	5.9	5.8	2.3	6.7	1.2	5.6	6.8	6.0	8.1	8.1	6.3	2.5	7.6	11.9	3.9	8.6	2.4	4.7	5.5	6.4	9.5	4.7	4.7	3.3	6.4	6.6	7.4	4.8	9.8	11.0	3.1	6.3	9.5	2.8	4.7	5.9	4.8	3.6	4.4	4.3	3.6	6.2	5.0	4.8	14.0	6.6	4.2	11.1	5.0	2.7	6.0	6.1	7.3	4.8	2.4	4.6	3.4	5.2	6.9	2.6	1.7	4.5	4.1	4.7	2.0	3.1	0.5	4.3	3.1	3.8	2.3	3.4	2.3	4.9	0.5	4.2	3.6	4.9	5.7	4.1	0.8	3.5	6.5	3.1	1.9	2.0	6.7	4.7	8.3	6.2	0.4	6.0	1.9	9.1	3.8	2.0	6.5	0.1	4.6	4.5	3.0	5.1	1.1	5.8	8.4	5.6	1.0	3.2	3.0	2.8	0.4	2.6	3.2	4.4	3.0	1.9	5.1	5.6	0.4	2.5	0.1	3.8	1.9	0.6	3.5	3.4	1.4	2.3	1.0	3.5	1.9	1.0	2.2	3.5	3.2	0.3	3.5	3.2	2.2	2.8	1.6	5.8	6.7	6.8	6.0	5.5	6.4	6.4	6.6	6.3	6.2	6.6	7.3	5.8	0.0	3.7	5.2	2.5	3.1	7.6	5.5	6.8	4.2	10.2	11.2	4.4	1.5	8.3	18.4	2.1	7.9	5.2	1.1	33.2	4.6	81.4	25.4	6.4	5.3	1.2	3.8	0.7	2.3	4.5	8.3	1.5	4.1	0.0	6.6	5.0	4.0	3.8	0.0	3.5	3.3	4.1	1.0	1.9	30.8	10.2	1.2	5.4	0.0	0.9	14.4	4.1	9.5	8.1	3.1	0.9	4.9	4.8	5.5	2.9	15.3	22.7	2.7	6.6	5.7	5.7	26.2	7.5	4.8	1.6	1.9	3.9	7.2	3.2	6.0
ZNF605		ENSG00000196458	"Zinc finger protein 605"	Q86T29	12	132918306-132956306	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA061970, HPA062655"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA061970: AB_2684649, HPA062655: AB_2684820"	"unprognostic (2.38e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.16e-6)"	"unprognostic (3.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.53e-2)"	"unprognostic (9.06e-3)"	2.9	4.1	5.7	2.5	5.7	1.4	5.2	7.3	6.8	4.6	6.6	5.1	2.8	4.3	5.4	3.5	4.6	2.7	4.4	5.6	4.7	4.7	4.3	2.9	3.2	5.4	5.0	5.4	3.9	6.2	6.7	3.3	5.5	5.2	2.8	8.4	4.5	3.8	4.2	5.0	4.2	3.2	4.3	3.9	4.0	2.1	5.4	4.0	6.9	5.2	2.9	4.4	4.2	6.4	4.8	3.8	9.7	9.2	5.2	10.7	7.2	6.5	3.7	2.9	2.1	0.6	0.6	2.0	3.4	5.6	3.6	2.6	4.2	1.6	3.6	1.6	7.2	9.2	3.4	3.0	3.9	3.9	9.7	6.8	7.0	2.0	4.4	9.0	2.2	4.7	1.4	0.1	7.4	1.3	5.1	5.4	7.5	1.3	5.2	4.7	6.3	1.4	5.0	8.1	6.2	7.1	2.9	1.7	4.5	5.7	10.6	11.1	4.4	3.6	5.8	5.4	2.6	0.0	0.0	1.6	0.1	3.2	2.2	0.4	0.2	0.2	0.2	0.1	0.1	0.5	0.2	0.3	0.1	0.3	0.5	0.3	0.3	0.3	0.1	0.2	0.0	0.1	5.7	5.7	7.3	6.8	5.6	4.7	5.4	5.0	5.5	4.3	5.4	6.4	8.4	19.2	33.5	21.9	9.3	3.4	8.1	3.3	18.8	33.6	10.5	11.2	22.5	15.7	25.1	9.2	29.2	7.5	5.0	7.3	9.8	7.2	2.2	8.1	15.0	12.7	6.1	7.6	24.9	3.3	3.6	12.6	15.3	7.1	10.1	20.2	13.6	4.9	3.9	40.4	25.2	10.1	6.1	7.3	2.7	2.5	15.8	6.1	0.0	11.2	8.9	16.4	13.4	28.1	15.8	7.5	4.5	13.5	5.8	9.5	5.8	5.2	13.7	35.2	13.1	16.2	11.5	6.8	7.9	9.4	4.5	5.6	10.8	23.0	7.1	6.2
ZNF606	"FLJ14260, KIAA1852, ZNF328"	ENSG00000166704	"Zinc finger protein 606"	Q8WXB4	19	57977053-58003349	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041712, HPA043584"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041712: AB_10960410, HPA043584: AB_2678565"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (4.75e-6)"	4.4	5.3	7.3	5.0	9.2	4.0	8.0	10.5	8.1	8.3	11.8	5.7	5.6	8.1	8.9	5.0	10.0	3.5	5.7	6.8	7.2	9.7	5.7	5.3	8.1	8.4	9.1	10.4	6.4	9.3	11.3	4.3	8.2	8.9	4.5	10.0	7.9	6.0	3.9	7.2	8.4	3.5	8.1	9.0	6.7	7.6	7.8	8.5	13.3	2.8	6.6	6.3	6.0	12.1	1.7	3.1	13.1	10.9	3.9	5.4	9.4	4.0	1.4	3.9	2.4	4.1	4.7	2.7	3.1	2.7	4.2	4.0	1.7	3.9	5.2	0.0	23.5	6.6	1.3	3.7	3.0	0.0	5.1	6.4	1.9	3.4	1.9	6.1	2.8	7.7	3.4	0.1	5.0	1.6	9.0	1.5	7.9	2.1	5.8	9.9	4.8	4.0	4.2	8.2	12.1	8.0	7.2	0.2	3.0	6.3	6.3	6.3	3.3	3.1	4.4	1.1	1.3	7.8	9.1	1.9	0.2	0.7	4.1	10.2	2.3	6.5	2.2	2.0	3.2	6.5	3.6	2.7	2.1	7.4	6.4	3.7	6.2	5.5	2.3	6.5	2.6	1.8	7.3	9.2	10.5	8.1	6.8	7.2	8.4	9.1	8.2	8.1	7.8	12.1	4.3	6.4	7.8	9.1	9.6	1.0	3.5	2.5	5.2	15.4	3.5	2.9	10.8	2.8	5.6	12.9	25.0	3.2	6.2	1.7	3.9	4.0	2.8	8.6	4.6	5.9	0.0	9.0	8.4	1.6	1.1	3.9	6.1	2.2	5.1	14.4	5.3	2.6	2.0	11.8	9.8	2.4	4.1	0.8	3.0	1.2	8.1	2.5	0.0	7.5	2.2	8.6	10.3	10.1	12.9	2.2	2.4	3.4	3.0	4.1	4.2	2.2	22.6	29.2	6.6	2.9	4.6	12.3	12.7	3.1	2.0	3.4	4.4	6.8	2.2	3.2
ZNF607	"FLJ14802, MGC13071"	ENSG00000198182	"Zinc finger protein 607"	Q96SK3	19	37696371-37719761	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 26.7;Smooth muscle cells: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA049465, HPA055018"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA049465: AB_2680778, HPA055018: AB_2682674"	"unprognostic (6.70e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.86e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.23e-5)"	1.8	2.9	4.6	1.5	5.4	0.5	3.3	5.5	4.8	3.3	4.2	3.1	1.7	3.4	3.3	3.1	4.6	1.8	2.9	4.1	4.6	3.3	0.8	2.1	2.7	6.4	4.6	5.1	2.8	5.3	5.5	2.7	4.9	3.3	2.0	5.0	2.3	2.5	2.0	3.5	2.7	2.3	4.7	3.1	2.4	9.0	5.1	2.8	4.0	2.0	3.3	3.0	3.1	6.5	5.1	5.3	8.0	8.4	4.3	4.9	5.6	3.7	3.6	3.3	5.9	8.0	2.8	7.1	5.2	3.9	4.4	2.4	7.9	2.8	5.0	3.7	8.1	3.5	4.6	4.4	3.5	0.1	2.1	3.2	5.3	4.1	3.8	4.8	1.7	4.7	7.3	0.0	3.7	4.4	7.1	3.9	9.4	3.6	2.1	3.2	12.3	1.9	3.5	6.6	2.3	7.0	0.2	2.1	0.6	5.8	5.7	0.6	0.4	2.4	1.7	2.9	4.2	6.9	8.0	9.8	0.0	0.0	3.2	0.0	0.2	1.6	1.3	0.2	0.9	3.0	2.2	2.8	0.8	2.0	1.9	2.3	0.0	2.4	0.3	1.6	0.8	0.8	4.6	5.4	5.5	4.8	4.1	4.6	6.4	4.6	4.9	4.7	5.1	6.5	1.3	3.2	0.5	4.9	3.0	1.3	0.8	1.5	2.8	2.7	2.1	2.5	4.1	2.8	1.9	1.8	2.1	2.5	1.1	1.2	0.0	1.7	33.0	3.2	1.5	1.3	0.0	0.4	5.5	1.2	2.3	1.6	2.6	1.6	0.0	3.2	1.8	0.2	1.4	1.7	7.1	1.9	0.0	0.6	0.4	26.7	0.9	0.7	3.6	1.0	0.6	1.2	2.1	3.0	10.6	0.7	0.5	1.9	0.6	1.2	1.0	1.2	7.2	1.5	0.0	1.1	13.9	5.4	5.2	2.9	1.1	0.8	1.4	1.6	1.5	0.9
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 105.4;Inhibitory neurons: 141.2;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5;naive B-cell: 1.6"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 61.0;AN3-CA: 39.2;REH: 110.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	6.1	9.9	10.4	4.2	14.0	1.4	6.7	12.1	10.4	7.4	4.1	5.6	11.1	4.8	2.7	3.5	9.1	6.9	9.0	11.7	12.8	5.3	2.7	10.7	8.0	14.7	12.4	6.3	8.4	3.7	4.4	3.1	12.4	5.6	7.2	23.6	5.7	4.5	6.4	3.3	6.6	4.2	9.2	2.8	6.7	9.4	12.4	4.8	9.2	3.2	8.0	3.1	4.4	17.1	0.2	1.1	61.0	39.2	8.9	14.5	0.0	0.0	1.6	0.3	3.6	6.6	18.6	20.8	20.2	0.0	9.8	0.8	4.2	3.9	0.3	0.0	9.9	0.0	0.1	0.3	13.7	0.0	1.9	14.6	11.0	1.9	1.7	9.1	13.2	0.1	2.0	0.4	3.3	0.1	0.0	0.0	25.9	0.5	0.8	110.6	5.4	0.1	8.7	0.9	9.2	32.0	0.0	0.7	14.1	34.5	3.5	1.8	3.5	12.3	22.9	0.3	3.9	9.7	10.2	36.9	3.1	0.6	17.7	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	10.4	14.0	12.1	10.4	11.7	12.8	14.7	12.4	12.4	9.2	12.4	17.1	25.2	32.1	35.3	105.4	7.4	1.3	10.4	5.5	31.3	35.8	8.6	7.7	20.1	18.6	36.2	14.7	39.6	0.8	1.5	13.0	3.9	16.7	16.9	30.6	3.0	23.4	40.0	1.3	17.0	8.7	3.8	9.9	11.7	16.8	0.0	7.3	11.4	2.0	0.8	42.1	141.2	6.1	4.1	0.3	2.2	8.8	2.1	1.3	7.2	28.1	2.1	31.2	0.0	219.2	209.9	6.2	7.3	1.5	3.7	3.5	8.1	8.4	13.2	36.7	0.0	13.2	7.7	19.2	7.2	11.8	0.9	0.4	1.5	19.1	9.8	2.5
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	9.5	8.3	11.3	8.3	10.1	5.5	8.5	13.0	9.6	11.3	8.8	12.0	8.7	12.0	4.5	7.8	11.9	7.2	8.1	11.2	12.6	6.7	7.1	10.9	8.7	10.6	10.4	20.5	7.2	14.1	8.4	11.9	7.4	10.3	7.8	20.5	9.7	9.5	7.2	9.6	8.7	11.1	8.3	9.8	8.2	22.0	10.1	18.0	9.0	9.9	8.3	11.3	10.8	12.1	11.1	27.6	29.1	11.2	11.0	13.8	9.9	14.2	18.8	17.5	17.5	17.1	17.2	19.0	11.7	16.9	23.9	23.2	43.1	19.6	18.2	22.2	9.2	34.7	16.0	8.4	20.2	20.2	22.3	14.1	17.6	18.3	35.8	25.3	32.8	15.9	55.6	12.0	14.5	10.1	15.7	8.5	22.1	14.8	7.7	14.3	26.5	10.0	12.7	19.7	23.6	18.0	19.5	21.9	13.1	27.7	10.9	14.0	33.0	16.2	25.8	8.4	17.9	13.3	16.1	16.6	10.1	21.6	13.4	1.3	0.4	0.6	0.5	0.1	0.3	0.2	0.3	0.4	0.1	0.2	0.8	0.8	0.5	1.1	0.2	0.5	0.2	0.2	11.3	10.1	13.0	9.6	11.2	12.6	10.6	10.4	7.4	8.3	10.1	12.1	14.6	12.8	25.4	123.4	8.8	18.0	16.2	10.5	8.0	35.8	12.6	11.8	20.1	24.3	20.3	18.4	141.8	19.1	13.9	12.2	3.9	13.8	22.6	42.2	21.9	18.4	18.6	11.1	142.1	14.6	14.7	13.6	13.7	16.1	10.1	19.4	18.9	14.6	10.0	45.4	116.5	11.9	4.1	30.5	18.3	12.7	18.0	16.4	14.2	139.6	19.1	17.3	19.6	108.6	208.0	13.2	13.5	13.9	10.5	22.9	9.9	3.9	33.8	54.9	19.7	14.4	16.9	48.3	17.0	9.3	17.3	31.2	17.0	20.8	11.2	20.1
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336243-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.0"									"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055771: AB_2682914, HPA078134: AB_2732372"	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	1.2	2.7	4.9	0.8	5.5	0.3	3.2	5.6	7.4	3.8	4.6	1.7	0.7	2.9	6.7	1.1	4.3	2.6	2.6	4.9	5.9	3.6	0.4	1.9	1.5	5.3	6.2	8.2	1.4	4.0	2.4	2.7	5.9	4.5	1.5	6.2	1.2	2.6	1.1	0.7	0.9	2.5	5.0	2.4	1.5	12.1	5.5	3.1	4.6	1.5	1.1	1.8	1.2	5.9	0.1	0.0	5.0	4.2	3.5	2.8	4.2	1.5	3.5	0.9	3.0	0.0	0.3	0.4	3.1	0.7	6.6	0.1	0.0	0.0	2.1	0.1	2.3	0.1	0.3	0.2	5.1	0.0	1.0	3.8	0.1	0.9	0.2	2.5	3.0	2.8	0.2	0.1	5.0	1.0	2.9	0.8	5.7	0.0	0.3	1.9	3.9	0.5	2.3	3.7	6.4	3.9	0.0	0.3	1.6	7.4	3.0	2.3	2.3	0.2	1.5	0.0	2.0	0.1	11.0	0.0	0.0	0.1	2.0	1.7	0.2	0.5	1.1	0.0	1.7	1.0	0.9	0.8	0.5	1.1	1.6	0.7	0.4	1.2	0.0	0.6	1.3	0.7	4.9	5.5	5.6	7.4	4.9	5.9	5.3	6.2	5.9	5.0	5.5	5.9	0.9	0.0	0.5	4.2	0.5	0.0	0.6	0.5	1.2	3.1	1.3	1.8	3.1	2.8	2.1	3.7	4.2	1.3	0.3	0.2	5.9	1.9	35.6	3.0	1.0	1.5	0.0	1.7	3.8	0.0	1.6	1.2	0.5	1.7	2.5	4.4	0.7	0.0	0.6	0.0	5.5	0.3	0.0	0.3	0.0	10.0	0.9	0.2	1.8	0.0	0.0	4.3	0.0	5.5	7.5	0.2	0.1	1.2	0.1	0.7	0.3	0.8	2.3	2.5	6.6	0.4	1.2	5.7	3.6	0.1	0.3	0.7	0.6	1.6	0.5	0.5
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 19.4"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favorable (1.92e-6)"	3.2	3.2	3.4	2.6	3.8	1.4	7.0	4.6	4.2	3.1	3.2	5.2	2.2	3.5	3.8	3.4	3.2	2.8	3.5	3.5	5.1	4.9	2.9	3.8	4.2	4.0	4.2	3.8	2.5	6.0	3.2	6.6	3.9	19.4	5.0	7.2	2.9	4.0	2.7	3.6	2.9	4.1	3.5	4.3	2.8	2.8	4.0	5.6	4.3	3.5	4.2	3.6	2.8	4.2	2.9	3.8	6.2	6.3	5.5	5.7	1.5	5.0	7.8	6.4	8.1	1.3	3.5	2.7	2.6	6.1	5.8	3.2	6.3	6.1	6.9	0.1	8.2	5.4	2.8	3.7	5.5	0.3	7.2	4.6	7.1	6.2	5.0	7.7	7.1	6.2	2.5	0.0	6.6	0.5	8.9	4.1	4.5	1.3	5.9	4.7	7.0	2.8	6.5	9.9	4.2	4.0	8.0	5.8	4.6	9.8	6.3	6.4	4.6	2.7	5.3	2.2	5.3	5.5	0.0	4.9	0.1	0.0	8.5	5.7	5.2	10.5	7.1	5.3	6.5	6.0	7.4	8.3	7.0	9.0	7.6	9.9	5.4	7.7	9.4	3.5	7.7	5.4	3.4	3.8	4.6	4.2	3.5	5.1	4.0	4.2	3.9	3.5	4.0	4.2	2.0	3.2	2.6	2.0	0.9	0.5	0.6	0.8	0.6	2.4	1.6	1.0	4.6	1.5	2.7	3.7	0.0	6.1	1.5	1.9	3.9	2.5	2.3	1.2	1.2	3.0	1.2	0.0	2.4	2.2	1.7	1.2	1.5	1.6	1.3	4.9	3.3	1.5	3.2	0.0	2.0	3.7	6.1	1.6	1.5	1.2	1.2	1.2	0.0	4.7	3.0	2.3	3.1	4.5	4.6	1.8	2.1	1.5	0.5	1.6	1.0	1.4	0.5	4.0	0.0	1.6	1.5	1.9	2.1	1.5	0.6	7.1	1.4	2.3	2.1	0.7
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Late spermatids: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	4.1	3.6	4.0	3.3	4.6	6.3	5.6	8.2	5.3	4.2	2.4	3.0	2.5	5.3	3.9	3.4	4.2	3.3	4.0	3.7	4.8	3.8	2.3	3.5	4.3	4.5	4.6	7.5	1.8	5.0	3.3	6.9	4.3	8.9	3.0	8.7	3.0	4.7	4.0	4.3	2.9	4.9	4.1	4.5	3.2	6.9	5.2	5.9	8.0	5.0	4.4	3.9	2.1	6.4	4.8	3.5	8.8	11.5	6.2	6.9	1.1	6.4	4.5	5.8	7.0	4.4	2.7	12.1	3.4	5.5	5.4	2.0	13.3	8.5	8.6	3.2	18.8	18.2	6.6	9.0	5.1	3.8	8.8	5.4	4.6	5.9	8.2	5.8	6.9	10.5	9.9	2.6	7.9	1.9	16.0	7.6	10.2	0.7	6.3	10.5	17.0	10.0	6.0	12.0	11.6	7.1	3.8	4.7	3.9	10.8	6.3	9.6	7.1	5.7	7.9	3.2	7.6	5.2	8.7	18.3	5.5	5.2	7.6	2.3	2.4	1.6	3.2	3.2	3.9	3.0	2.9	3.1	3.0	2.8	4.1	2.6	1.7	5.7	2.8	1.7	3.2	1.8	4.0	4.6	8.2	5.3	3.7	4.8	4.5	4.6	4.3	4.1	5.2	6.4	5.2	0.0	2.2	3.6	4.8	3.2	5.3	2.4	4.6	6.8	4.2	4.2	5.8	4.3	4.9	5.5	4.2	6.1	6.5	1.7	0.0	2.9	47.9	2.8	6.1	5.8	5.4	7.4	6.6	0.9	7.1	3.7	5.6	3.7	7.0	5.0	8.2	1.6	2.3	16.8	6.7	2.4	2.0	4.1	2.3	34.9	4.1	3.2	1.8	4.7	2.2	5.1	10.3	6.0	9.2	1.4	0.7	7.2	5.4	4.6	1.8	2.0	0.9	5.6	0.0	7.1	5.7	2.2	5.0	4.4	2.7	14.4	4.1	2.7	2.2	5.1
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"prostate cancer: 11.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA052422	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria	Nucleoli	"HPA052422: AB_2681825"	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.98e-4)"	5.2	3.7	4.1	2.9	6.5	5.7	6.6	9.4	5.6	4.9	3.4	4.8	3.5	7.8	4.7	4.2	6.4	5.0	5.9	4.5	6.0	6.0	3.9	5.1	4.4	3.7	4.6	10.2	3.8	10.1	4.6	5.6	3.7	17.5	3.6	9.8	5.5	6.3	3.7	4.7	3.1	6.5	1.8	5.3	4.1	3.7	4.6	4.7	7.6	6.8	4.3	4.2	3.5	8.6	1.5	6.2	5.8	12.4	11.2	8.1	4.7	4.5	6.9	6.4	5.7	1.2	1.7	2.2	2.4	5.0	3.9	1.5	4.7	3.1	5.2	0.3	10.0	7.5	5.6	4.3	8.6	0.0	4.1	6.8	3.7	10.2	10.2	10.6	3.0	2.7	0.0	0.0	4.3	0.5	0.0	3.8	6.1	0.2	9.6	4.7	10.2	4.0	3.9	10.3	5.4	4.7	5.4	4.7	3.2	6.3	7.1	3.4	5.9	5.4	6.2	3.3	3.3	4.3	12.3	2.8	3.0	0.0	8.7	5.8	2.2	4.2	2.5	3.2	5.3	2.8	4.5	3.6	3.3	2.9	4.3	3.1	2.5	8.2	2.0	2.0	4.2	2.9	4.1	6.5	9.4	5.6	4.5	6.0	3.7	4.6	3.7	1.8	4.6	8.6	5.1	6.4	7.2	7.5	4.5	2.8	2.1	1.0	1.8	6.4	4.4	3.4	6.9	5.7	1.4	3.7	6.2	4.1	5.9	2.4	3.9	2.2	2.6	2.3	4.4	3.5	9.0	2.1	10.2	1.2	2.9	5.3	2.0	2.4	0.0	6.2	4.2	2.1	3.0	3.3	7.8	2.7	2.0	3.5	3.6	1.0	2.5	4.1	7.2	5.6	3.8	3.2	7.2	8.0	12.0	1.2	3.9	4.1	3.4	4.3	2.2	3.1	3.1	7.0	6.6	5.2	6.7	3.8	2.2	2.6	4.0	5.1	3.9	2.8	2.8	2.0
ZNF616	MGC45556	ENSG00000204611	"Zinc finger protein 616"	Q08AN1	19	52113091-52139938	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA062639, HPA071539"	Approved		Approved	Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Centrosome		"HPA062639: AB_2684815, HPA071539: AB_2686414"	"unprognostic (5.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.32e-3)"	5.4	11.6	3.6	4.1	3.8	2.4	6.2	8.3	4.1	6.1	3.1	4.9	4.1	6.8	5.7	4.2	6.8	4.4	3.8	3.4	4.5	6.0	5.9	5.2	5.4	2.9	3.3	10.9	5.5	7.7	2.6	6.8	3.2	6.9	5.6	9.5	4.6	5.1	4.1	5.7	4.3	5.9	1.7	5.9	5.4	4.0	3.4	7.2	7.8	4.9	5.3	3.7	3.7	4.6	5.4	4.9	13.8	11.4	16.0	14.8	0.2	6.9	7.9	6.0	9.4	5.9	4.4	7.2	4.7	6.5	3.2	3.4	12.4	7.8	9.7	5.3	20.0	13.6	14.0	12.3	10.4	12.9	8.3	10.5	10.6	5.9	19.3	11.0	8.3	8.8	15.4	3.8	10.2	4.0	11.7	7.0	15.1	4.2	12.4	11.1	20.3	10.9	4.6	14.5	16.2	9.3	12.3	4.9	3.8	12.3	7.6	4.3	8.2	5.3	6.4	6.2	7.5	6.9	11.1	10.4	4.8	7.9	10.9	3.8	2.9	3.4	4.9	1.7	4.4	3.2	4.5	3.9	3.0	3.4	4.0	3.6	3.9	13.2	10.5	3.7	3.2	2.1	3.6	3.8	8.3	4.1	3.4	4.5	2.9	3.3	3.2	1.7	3.4	4.6	2.4	6.4	3.2	1.6	2.5	4.1	3.9	1.4	5.2	3.6	3.0	2.2	3.1	7.2	1.8	7.3	4.2	3.2	3.0	3.6	5.9	3.5	0.0	2.8	4.3	2.7	1.2	1.7	3.1	1.8	4.3	4.2	4.1	2.0	0.0	4.0	2.9	2.6	3.2	6.7	3.0	4.0	2.0	1.9	3.2	0.6	6.5	2.7	1.8	5.6	3.1	3.6	8.2	6.0	5.6	2.0	1.5	2.6	1.5	3.2	3.6	3.1	3.7	8.1	0.0	2.4	3.6	4.5	4.2	2.7	2.6	1.9	2.9	2.7	2.9	4.5
ZNF618	"KIAA1952, NEDD10"	ENSG00000157657	"Zinc finger protein 618"	Q5T7W0	9	113876282-114056591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.0;REH: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023116, HPA061732"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023116: AB_10964204, HPA061732: AB_2684596"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.22e-7)"	"unprognostic (4.57e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.51e-2)"	3.3	4.6	2.5	2.1	2.4	2.7	3.7	4.5	2.3	5.8	4.5	1.8	2.2	6.4	2.9	2.3	5.4	4.0	2.0	1.8	3.1	7.3	5.5	3.5	1.2	3.4	2.9	9.6	5.5	6.9	3.9	2.1	2.9	3.0	1.6	1.9	3.4	2.8	2.3	2.2	1.6	4.5	2.1	3.9	4.2	2.5	3.7	3.5	5.4	1.8	1.1	2.0	2.6	2.1	7.4	22.5	33.0	14.4	7.8	9.1	1.6	4.8	7.9	9.5	8.4	0.2	5.2	4.1	4.5	8.4	2.7	0.2	16.6	8.3	3.7	0.1	6.6	0.0	1.7	0.1	5.8	4.4	7.4	8.8	3.3	10.1	2.2	8.6	24.2	0.5	0.0	0.0	4.3	12.1	0.2	5.6	16.4	0.6	4.9	31.8	19.2	0.1	10.2	8.1	10.2	24.2	13.7	8.7	8.7	9.4	0.7	8.9	19.8	12.6	9.9	7.1	5.9	0.0	0.0	0.0	0.9	6.6	9.0	1.6	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.3	1.4	0.5	0.2	0.2	0.0	1.1	0.3	1.7	0.0	0.4	2.5	2.4	4.5	2.3	1.8	3.1	3.4	2.9	2.9	2.1	3.7	2.1	9.1	3.2	13.2	4.9	2.1	2.0	4.8	3.7	12.0	14.9	12.6	17.1	2.7	24.3	4.2	11.0	4.2	0.2	3.1	0.5	7.9	16.0	7.6	7.4	22.8	10.0	2.4	7.6	14.6	8.2	0.1	12.7	10.7	12.2	21.0	26.9	11.0	10.9	3.4	58.9	30.6	2.1	2.0	5.4	8.5	4.8	15.2	7.2	0.0	38.4	12.1	10.1	4.1	24.1	8.7	9.7	1.9	15.4	0.4	1.8	0.1	10.8	2.3	1.6	26.3	10.1	19.2	0.4	11.4	3.6	3.7	0.3	2.0	40.0	2.8	1.9
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40491053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	1.7	1.6	2.3	2.0	3.5	3.1	2.9	3.0	2.8	2.0	2.5	2.0	2.3	2.0	2.1	1.4	2.5	1.3	1.8	2.2	2.6	2.2	2.4	2.0	2.4	3.0	3.0	2.6	2.5	3.1	1.2	2.0	3.0	2.1	2.6	4.1	2.7	2.2	2.5	2.4	2.0	2.3	2.2	2.9	2.4	1.1	3.0	1.5	3.0	2.2	2.9	1.7	1.5	4.6	1.9	2.5	2.9	2.8	4.5	4.3	1.3	2.7	3.1	4.5	3.9	0.9	2.6	0.2	1.4	2.2	2.2	2.1	3.2	5.0	4.8	3.6	1.1	6.1	2.2	1.4	4.6	4.2	5.0	3.4	3.9	4.7	6.6	3.9	3.8	0.2	3.9	2.9	2.9	2.3	0.1	2.1	1.6	2.2	2.8	1.2	3.0	3.3	2.1	4.2	2.1	2.2	2.4	4.1	2.0	2.9	3.4	2.7	3.6	3.3	2.7	2.0	2.8	1.6	2.2	0.2	2.1	2.6	3.7	0.8	0.7	1.1	0.7	0.9	0.7	0.7	0.6	0.8	1.0	0.8	0.6	0.9	0.8	1.3	1.0	0.6	1.2	0.7	2.3	3.5	3.0	2.8	2.2	2.6	3.0	3.0	3.0	2.2	3.0	4.6	1.5	0.0	1.1	1.0	2.3	0.3	0.8	0.6	1.2	3.6	1.0	1.0	1.3	0.0	0.3	3.7	2.1	1.4	1.0	0.7	0.0	1.4	0.1	1.4	1.6	1.6	0.0	2.1	0.5	1.5	0.9	1.2	1.5	1.1	0.0	2.4	1.8	0.9	1.1	0.0	1.0	1.3	0.0	1.6	0.4	0.0	1.2	1.2	0.0	2.8	1.6	2.5	2.1	1.0	2.3	0.6	0.2	0.4	1.7	0.5	1.6	1.3	1.0	3.6	0.0	2.0	1.1	1.2	1.4	1.7	0.1	0.4	1.5	2.5	0.8	0.6
ZNF620	MGC50836	ENSG00000177842	"Zinc finger protein 620"	Q6ZNG0	3	40477131-40518736	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA031452, HPA059383"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Centrosome		"HPA031452: AB_10603939, HPA059383: AB_2732636"	"unprognostic (1.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.21e-5)"	"unprognostic (1.28e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.19e-4)"	1.4	1.9	2.1	1.0	3.3	3.2	2.0	4.6	2.4	1.3	2.8	1.8	1.7	1.3	1.6	1.1	1.9	1.1	1.7	1.7	2.4	2.4	1.4	2.2	1.3	2.6	2.6	1.5	2.5	2.7	2.5	2.3	2.4	1.8	2.1	4.3	1.0	1.9	2.6	0.7	1.5	1.6	2.2	1.8	2.7	1.1	2.7	1.6	3.4	2.3	1.0	1.4	0.9	3.5	2.4	3.1	8.8	3.3	0.7	0.9	3.6	0.6	1.0	3.8	6.0	9.0	5.2	0.0	2.7	0.5	3.5	0.6	13.3	1.3	3.1	8.0	10.4	6.6	9.8	4.9	1.5	2.4	1.0	0.6	0.9	2.6	1.2	1.0	3.0	0.1	3.5	0.8	0.5	4.5	0.5	2.0	10.4	5.0	2.0	3.6	3.5	1.2	3.9	8.7	10.4	8.0	0.7	6.3	4.2	7.9	8.1	2.4	2.0	0.4	5.8	0.8	2.9	1.3	2.3	0.1	1.4	1.2	1.5	7.7	0.5	1.0	2.1	0.9	2.4	0.4	0.8	2.0	0.5	1.6	1.6	2.2	0.6	3.0	0.3	1.2	3.5	0.9	2.1	3.3	4.6	2.4	1.7	2.4	2.6	2.6	2.4	2.2	2.7	3.5	5.4	6.4	4.1	2.6	1.7	0.5	3.4	1.6	0.6	10.5	3.3	2.9	2.1	4.3	3.2	0.0	4.2	8.5	3.6	2.3	5.9	6.1	0.1	4.3	2.0	5.4	9.0	8.6	1.6	2.9	1.8	2.1	3.1	9.2	7.0	7.8	5.0	2.1	1.4	3.3	2.2	4.2	8.2	1.9	1.2	0.7	0.3	1.6	0.0	0.0	11.0	9.0	7.2	3.0	6.2	2.2	4.8	0.4	0.5	2.8	2.3	3.5	2.1	11.6	0.0	4.5	4.6	7.8	6.7	0.8	0.1	1.9	2.7	5.0	4.3	1.4
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Golgi apparatus"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	19.5	13.5	20.3	13.8	21.4	36.0	18.4	17.2	21.8	16.7	14.4	21.5	16.9	17.8	17.2	17.9	15.3	12.1	56.9	18.1	19.6	14.6	22.0	16.6	17.8	18.7	20.7	15.6	54.3	15.6	15.1	16.9	20.3	15.5	20.7	10.8	18.3	12.7	41.7	25.6	20.3	12.5	19.1	15.5	22.4	20.5	19.4	16.0	15.5	25.2	15.7	17.5	17.0	22.1	25.7	55.2	16.9	35.2	40.4	34.3	61.4	45.2	33.9	36.0	45.6	66.0	23.2	30.0	59.6	36.0	48.4	33.3	27.5	35.3	28.9	40.6	37.3	27.4	92.8	47.7	58.1	53.8	31.5	53.3	43.7	33.6	31.5	28.0	25.6	17.6	37.6	28.9	40.1	43.2	28.4	52.3	30.0	24.2	53.8	22.1	20.6	25.8	33.6	38.0	23.4	26.2	63.1	46.8	78.2	29.4	26.0	41.1	35.3	40.0	30.5	39.3	29.1	41.3	39.7	41.9	34.9	45.8	28.5	89.3	65.6	88.6	73.8	71.3	77.8	85.4	73.7	82.0	73.3	81.9	84.2	70.3	87.9	67.9	79.6	59.2	85.0	82.6	20.3	21.4	17.2	21.8	18.1	19.6	18.7	20.7	20.3	19.1	19.4	22.1	14.8	22.4	24.2	2.9	33.2	60.7	43.1	48.6	34.1	22.8	19.8	16.4	73.8	24.3	34.4	14.7	10.4	64.0	39.5	77.5	27.4	55.2	111.5	35.0	36.8	22.3	98.7	20.0	7.6	66.7	57.2	34.1	31.1	71.3	52.0	13.3	15.0	25.1	50.0	16.8	7.9	60.6	48.8	19.3	35.1	62.8	18.0	29.7	33.8	4.7	43.3	22.6	37.0	6.6	9.0	51.2	127.1	19.9	26.6	28.3	84.5	39.2	29.7	19.3	19.7	31.7	46.9	63.2	37.8	21.8	43.2	40.6	41.6	20.5	55.5	33.5
ZNF623	KIAA0628	ENSG00000183309	"Zinc finger protein 623"	O75123	8	143636019-143656418	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"PC-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044372	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044372: AB_10966790"	"unprognostic (1.06e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.03e-2)"	5.8	5.0	2.5	1.8	2.3	0.6	5.5	1.8	3.0	7.4	1.2	7.4	2.3	7.0	1.7	6.2	6.6	1.5	6.0	2.6	2.7	5.2	5.7	5.2	2.3	2.2	2.1	8.5	5.4	2.8	5.9	1.8	2.5	5.9	2.0	1.7	6.0	1.3	7.2	7.8	6.4	2.1	1.5	6.8	5.4	7.2	2.7	2.1	5.2	1.8	1.9	7.6	6.5	2.3	3.0	6.9	2.6	2.5	4.1	8.0	2.5	2.9	3.8	4.7	3.3	2.4	2.5	1.8	3.6	6.5	3.2	1.9	3.0	1.9	3.7	5.1	2.3	7.5	7.3	2.2	3.2	1.7	2.1	3.3	3.8	2.0	8.7	5.1	3.3	4.9	6.1	3.3	3.4	6.6	5.8	2.4	3.4	3.7	18.3	4.0	2.3	2.8	2.6	4.0	6.4	6.2	11.9	2.4	4.0	2.6	5.4	5.2	1.5	4.4	1.5	1.8	2.4	1.9	2.3	2.8	3.2	2.8	3.6	1.1	0.2	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.4	0.2	0.5	0.5	0.4	0.2	2.5	2.3	1.8	3.0	2.6	2.7	2.2	2.1	2.5	1.5	2.7	2.3	4.6	6.4	3.9	3.9	5.8	1.7	3.1	1.6	7.4	5.9	4.4	4.2	10.3	7.2	1.5	7.3	6.2	5.9	4.7	5.8	3.9	5.9	5.4	3.0	8.1	5.8	5.4	9.9	7.5	3.8	6.0	5.6	4.6	5.0	1.3	9.2	7.1	6.6	5.8	15.2	5.3	5.3	2.0	6.6	2.4	4.5	8.4	4.6	3.6	4.7	8.3	7.2	7.2	5.5	5.4	4.4	2.3	13.9	2.8	4.5	5.4	3.9	1.3	7.0	19.7	8.2	5.1	10.8	13.9	6.2	2.6	4.8	5.8	5.8	5.2	1.7
ZNF624	KIAA1349	ENSG00000197566	"Zinc finger protein 624"	Q9P2J8	17	16620734-16653856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.1"					"Low region specificity"	"Detected in all"			"HPA023157, HPA023244"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA023157: AB_2671094, HPA023244: AB_2671117"	"unprognostic (2.47e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-1)"	1.6	0.7	1.3	1.5	2.2	1.1	1.8	1.4	2.5	2.3	0.3	1.7	1.3	2.5	1.2	1.3	2.0	1.2	1.5	1.2	1.8	1.8	0.8	2.0	2.4	2.5	1.9	3.6	0.8	2.5	0.4	3.0	2.1	1.0	1.8	2.6	0.9	1.5	0.4	1.5	1.4	2.0	1.8	3.5	1.9	4.8	2.5	3.1	2.3	0.9	2.1	1.4	0.9	4.1	1.1	1.8	5.3	1.8	2.6	3.1	1.4	1.8	3.1	3.4	3.1	0.9	1.0	2.7	1.5	2.4	1.1	1.5	1.5	1.9	3.7	2.9	1.8	3.0	0.9	0.8	2.5	2.1	2.9	3.5	4.4	1.9	3.8	1.8	3.1	3.4	1.9	0.7	4.5	1.6	5.2	0.8	0.9	3.8	0.8	5.5	9.0	0.8	2.3	2.2	1.6	3.2	2.0	1.5	2.1	12.1	1.2	0.9	4.4	3.2	1.2	1.2	1.3	1.2	0.9	0.0	1.5	0.0	2.7	1.0	1.0	2.0	1.7	3.3	2.5	1.6	2.0	2.0	1.9	2.9	2.2	1.3	0.2	2.8	1.5	0.5	1.5	1.1	1.3	2.2	1.4	2.5	1.2	1.8	2.5	1.9	2.1	1.8	2.5	4.1	4.2	0.0	0.0	5.9	2.9	0.5	0.4	1.1	0.6	5.1	1.4	1.0	2.6	1.5	2.2	0.0	2.1	1.3	2.4	1.9	3.9	1.3	11.2	1.3	4.1	3.0	0.0	1.7	5.6	1.0	1.5	2.7	1.5	1.4	3.8	4.1	4.6	0.3	2.6	8.4	9.6	1.3	0.0	4.6	1.6	2.1	1.5	2.3	0.0	8.4	1.2	2.8	2.1	16.6	21.1	1.5	0.8	2.6	0.6	0.5	0.8	2.0	3.6	3.2	0.0	2.4	4.1	12.0	8.4	0.9	0.9	1.5	2.3	4.6	0.9	1.1
ZNF626		ENSG00000188171	"Zinc finger protein 626"	Q68DY1	19	20619939-20661596	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.8"									HPA045631	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA045631: AB_2679397"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.31e-1)"	7.4	8.9	3.0	5.4	4.7	3.8	16.1	4.8	4.5	8.4	4.8	3.7	1.6	11.2	7.8	6.3	12.2	9.3	10.0	3.0	3.8	11.0	5.7	5.2	12.2	2.5	3.4	25.9	7.2	21.4	3.6	7.3	2.7	11.0	3.2	7.5	7.0	9.7	4.6	9.3	2.4	9.4	3.1	7.0	8.0	5.0	3.8	8.6	23.7	5.9	9.7	14.8	4.1	5.8	0.1	0.0	5.9	0.4	6.8	8.7	0.3	6.5	0.6	9.1	7.9	0.1	0.1	0.5	3.0	8.3	10.7	1.1	0.0	0.2	11.6	0.1	0.2	0.0	0.2	2.3	12.1	0.1	0.0	16.6	2.6	5.5	2.8	0.1	4.3	0.1	4.1	0.6	9.6	0.1	0.4	1.1	12.0	0.0	2.9	5.7	4.1	2.1	8.4	6.4	1.6	10.6	0.1	0.7	6.0	10.6	13.7	0.1	0.1	4.2	0.2	16.4	0.5	9.0	19.8	8.6	0.1	0.1	0.5	0.9	1.1	6.3	7.2	1.1	6.8	8.4	7.6	8.2	3.2	10.5	7.0	6.3	11.2	9.8	4.8	4.2	3.8	3.8	3.0	4.7	4.8	4.5	3.0	3.8	2.5	3.4	2.7	3.1	3.8	5.8	14.0	3.2	8.2	26.4	18.5	9.4	13.7	4.2	10.2	11.1	18.2	18.8	9.8	12.8	6.7	27.6	10.4	17.5	11.1	1.4	31.3	8.7	1.3	19.3	15.0	11.6	2.4	1.7	29.3	9.5	24.9	13.9	6.1	20.8	7.0	19.7	17.2	7.4	11.0	13.5	27.6	1.3	6.1	4.7	9.8	1.7	18.6	5.1	5.4	15.9	2.9	16.2	19.6	37.7	43.0	9.1	0.4	15.4	3.9	17.2	0.1	30.8	12.3	9.5	13.1	11.4	11.9	10.1	16.2	6.1	12.6	43.4	12.3	39.8	0.8	15.5
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619161	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	5.6	4.1	5.7	4.3	5.9	7.6	11.1	7.4	6.8	8.3	6.0	5.9	5.7	10.6	8.7	4.6	12.2	5.0	5.2	5.6	5.9	9.6	7.1	6.1	6.8	6.1	6.0	13.1	7.5	8.9	5.8	6.3	5.9	8.0	6.8	8.3	5.9	6.5	4.0	5.5	5.0	6.2	6.2	6.6	6.0	8.0	6.3	9.3	13.1	5.6	5.6	6.4	5.6	7.9	6.0	5.2	15.0	18.8	6.7	6.9	8.5	8.4	10.0	9.5	9.5	3.9	4.0	4.6	8.4	6.6	4.8	5.1	6.0	8.2	10.5	8.3	2.8	12.8	2.8	7.6	12.5	6.9	6.9	8.4	11.6	6.2	14.3	14.5	10.6	10.9	11.9	6.0	12.5	12.3	11.3	6.9	11.3	4.0	10.4	12.6	11.3	6.3	10.8	9.2	20.8	15.5	11.5	6.1	12.6	12.7	11.1	19.6	9.2	10.0	4.8	6.2	5.9	8.6	9.0	4.8	4.6	11.3	8.4	14.2	4.5	7.4	4.6	4.9	5.3	9.0	5.6	5.8	7.2	5.8	7.4	6.7	2.4	7.3	4.8	2.7	3.2	4.2	5.7	5.9	7.4	6.8	5.6	5.9	6.1	6.0	5.9	6.2	6.3	7.9	2.9	12.8	5.9	6.2	11.2	1.3	3.4	4.0	6.2	4.5	6.2	5.8	15.0	7.2	3.1	9.2	4.2	5.2	5.4	3.7	17.6	5.4	7.9	7.0	4.9	4.3	5.3	8.0	4.5	2.6	4.3	4.3	10.2	3.7	1.3	6.1	6.1	6.1	3.2	6.7	4.8	3.2	10.2	4.4	4.4	4.0	5.3	3.1	0.0	3.7	3.2	4.9	3.1	6.6	7.3	4.1	3.1	5.3	6.7	4.9	3.5	7.3	11.6	5.8	0.0	3.1	4.7	15.5	4.4	3.6	2.7	4.7	4.8	3.1	4.3	3.3
ZNF628	"ZEC, Zfp628"	ENSG00000197483	"Zinc finger protein 628"	Q5EBL2	19	55476617-55484487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 35.4;Late spermatids: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044451	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044451: AB_10962507"	"unprognostic (8.70e-2)"	"unprognostic (5.08e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.88e-3)"	4.8	4.6	1.1	1.6	0.8	3.1	5.0	0.5	1.9	4.8	0.1	6.3	2.2	6.5	0.4	5.0	5.1	0.4	4.9	1.4	0.2	4.2	4.7	4.5	1.1	0.8	0.3	5.2	4.8	0.7	5.4	0.7	0.2	5.2	0.3	0.2	4.9	1.0	13.8	8.2	4.7	0.7	0.0	5.3	4.9	23.1	0.5	0.7	4.8	0.7	0.3	5.2	4.5	0.7	7.0	4.3	1.0	2.9	0.5	1.2	7.9	4.7	0.9	1.6	1.3	2.7	3.0	6.4	4.4	0.9	1.3	4.0	0.5	2.6	0.2	6.6	16.7	4.5	4.1	2.4	1.8	3.6	11.3	1.0	1.8	1.2	0.7	0.8	1.2	3.8	6.8	3.5	0.6	4.5	5.0	2.5	4.4	2.1	8.7	9.5	1.4	6.3	1.4	4.3	5.1	5.6	3.6	4.0	6.1	0.3	4.0	5.5	2.7	3.0	4.3	2.9	4.9	7.9	7.4	4.8	3.8	2.6	2.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.1	0.8	0.5	1.9	1.4	0.2	0.8	0.3	0.2	0.0	0.5	0.7	3.0	0.0	1.1	0.7	8.3	5.0	7.6	2.5	12.0	4.7	5.9	2.7	2.2	5.7	1.8	3.7	4.2	3.2	3.7	9.4	9.8	2.6	35.4	6.5	3.5	3.9	7.2	6.1	0.7	3.6	3.5	2.8	5.1	9.1	13.4	3.9	3.6	3.3	3.1	5.0	0.7	5.7	2.0	3.8	3.1	119.7	5.6	4.2	3.6	0.0	2.5	4.4	5.2	1.0	0.7	4.9	4.1	4.5	5.7	4.1	4.5	3.3	2.0	2.6	13.1	4.6	3.4	8.9	5.5	6.4	4.5	5.5	5.8	3.6	6.7	5.2
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778456-30787205	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	5.6	9.0	5.6	3.0	6.0	4.1	5.7	7.1	5.9	6.5	4.3	6.8	5.5	8.0	4.3	5.1	6.6	3.6	12.6	5.9	6.1	7.8	4.3	5.3	1.9	6.2	6.7	6.8	5.9	15.0	6.6	3.6	5.6	6.3	4.5	7.8	6.5	6.0	9.7	8.6	5.3	6.8	5.0	4.0	7.3	4.1	7.0	3.9	5.9	9.6	2.3	6.5	5.1	5.5	9.8	15.8	23.9	18.5	11.5	10.6	3.6	10.8	15.6	16.6	14.0	9.7	8.8	1.8	10.2	17.6	5.2	11.4	11.7	14.3	11.0	0.4	17.6	13.6	14.0	10.2	12.3	4.8	8.0	17.7	10.5	10.3	8.6	13.0	8.9	0.8	20.2	0.4	14.6	20.8	7.2	6.3	12.6	4.7	6.4	24.3	18.4	0.8	13.9	15.9	22.6	25.3	10.5	19.4	2.6	7.8	14.6	17.4	10.8	15.5	10.1	10.6	8.3	0.3	0.1	0.5	10.2	11.9	5.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.1	0.6	0.0	0.1	5.6	6.0	7.1	5.9	5.9	6.1	6.2	6.7	5.6	5.0	7.0	5.5	4.9	19.2	9.4	5.9	2.6	1.9	3.4	4.3	5.7	16.7	4.2	3.4	28.3	4.3	6.5	9.2	4.2	1.3	1.6	5.4	1.9	8.7	1.7	5.1	9.5	8.0	11.5	4.6	2.4	8.0	0.6	5.3	7.1	5.3	2.5	10.7	8.2	4.7	4.4	16.8	3.7	7.9	6.1	5.2	3.0	4.7	9.3	2.6	1.8	1.0	7.7	13.4	1.0	4.5	3.4	10.9	5.0	4.5	3.0	4.8	5.1	4.3	5.9	12.4	0.0	6.7	5.6	4.6	1.5	3.8	1.8	0.5	1.4	8.3	9.0	3.8
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 5.3"					"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	1.9	2.2	3.8	1.5	4.0	0.9	2.8	5.0	4.8	3.6	4.1	2.5	1.8	2.6	2.8	2.1	2.6	2.5	2.7	3.6	3.8	2.4	1.4	2.1	1.8	4.0	4.1	4.7	3.2	4.2	2.6	1.6	4.2	3.8	2.5	3.7	2.3	2.8	1.0	1.9	1.8	2.4	3.8	2.3	2.9	0.7	4.2	0.9	3.7	1.2	1.5	3.0	2.7	4.6	1.0	0.7	0.2	0.0	0.1	0.0	0.0	1.4	0.5	1.1	0.6	2.3	4.0	0.1	0.8	1.4	1.6	1.8	0.0	0.8	0.9	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.0	4.0	2.3	0.0	2.6	0.7	0.0	0.0	4.2	2.5	4.3	0.0	0.0	1.5	3.5	1.2	0.5	1.0	0.0	1.7	2.2	2.3	1.8	5.3	3.7	1.4	3.2	4.3	0.9	1.3	0.0	1.8	1.8	0.0	0.0	3.7	0.0	0.0	0.1	3.3	2.3	0.8	2.0	0.8	0.3	0.9	1.0	0.7	0.7	1.5	0.6	0.9	1.0	0.9	0.7	0.3	0.4	0.5	0.9	3.8	4.0	5.0	4.8	3.6	3.8	4.0	4.1	4.2	3.8	4.2	4.6	0.8	0.0	0.0	2.6	1.4	0.1	1.0	0.8	3.4	2.5	1.6	1.3	1.6	0.0	0.8	1.8	0.0	0.1	0.4	0.9	1.9	1.4	0.0	1.2	1.9	1.2	4.2	0.8	2.2	1.1	0.9	1.4	1.1	1.3	0.0	4.0	1.8	0.3	0.9	0.0	2.6	1.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.0	1.3	0.7	0.0	5.0	3.2	1.0	0.6	0.4	1.0	0.9	1.1	0.7	0.5	1.0	6.6	1.4	1.4	0.2	0.4	1.7	0.3	0.3	1.1	4.0	1.0	0.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179323031-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049023: AB_2680603, HPA052163: AB_2681747"	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	20.8	19.5	16.5	18.0	17.5	59.2	28.0	22.1	19.3	27.6	15.0	26.6	17.4	31.5	25.6	20.9	26.0	19.8	27.4	16.4	16.6	25.1	23.9	21.9	26.6	16.4	16.8	32.7	24.6	38.6	18.2	22.5	15.9	26.3	22.1	40.0	24.5	27.0	27.3	16.9	18.6	31.0	16.8	23.7	20.6	19.1	17.3	26.6	41.4	30.3	24.6	21.5	18.3	18.0	81.3	18.7	35.5	43.9	31.7	38.4	35.2	37.8	56.4	61.0	54.8	31.7	31.3	94.2	56.4	46.6	74.1	30.1	55.2	50.5	76.0	86.7	43.1	96.1	26.8	31.8	55.0	76.1	34.5	31.1	51.9	31.3	72.5	45.7	42.1	61.3	59.4	48.6	48.6	41.2	79.5	33.7	59.9	56.9	43.5	75.4	37.1	112.1	37.8	32.4	65.3	39.9	37.9	41.1	49.2	29.8	104.9	59.4	34.5	41.3	43.7	33.1	98.7	19.7	19.0	174.2	30.3	58.5	28.9	2.5	1.1	1.2	1.6	0.7	1.5	1.8	2.6	2.6	0.9	2.0	2.2	2.2	0.7	2.2	0.5	0.3	2.4	0.8	16.5	17.5	22.1	19.3	16.4	16.6	16.4	16.8	15.9	16.8	17.3	18.0	16.9	19.2	11.7	9.4	24.2	20.9	34.0	7.0	32.5	21.5	21.6	13.2	19.4	10.0	8.8	14.7	54.2	14.7	18.3	8.6	33.2	12.2	29.8	21.6	22.4	19.4	18.7	29.0	8.7	10.0	11.3	21.8	11.2	30.3	10.1	18.5	18.5	17.0	9.9	16.8	10.6	15.6	6.1	13.2	17.2	8.8	24.5	13.8	14.2	4.7	13.5	19.6	13.4	8.5	9.6	11.5	9.4	24.0	27.5	36.1	11.2	22.2	7.2	44.9	26.3	27.1	22.7	29.9	21.3	29.9	17.5	3.4	23.2	19.8	12.2	24.9
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favorable (3.91e-4)"	"prognostic favorable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	9.0	22.9	8.3	10.7	9.0	6.9	7.8	8.9	9.5	11.3	4.2	8.2	9.4	14.1	10.1	6.6	10.7	9.9	9.1	7.6	9.5	9.2	9.9	10.9	12.5	10.0	10.1	19.6	12.1	14.1	9.8	14.8	9.8	8.8	8.0	16.9	7.4	9.2	16.6	6.2	7.5	13.3	9.1	12.6	9.3	11.9	10.9	14.7	14.7	17.3	12.9	10.7	7.1	9.5	3.2	5.4	8.3	13.9	8.0	2.2	6.1	8.1	5.5	4.3	2.8	9.1	9.1	6.2	11.4	7.3	8.1	5.3	3.1	5.3	1.4	14.2	5.2	10.2	9.9	2.6	7.4	11.0	14.2	3.5	7.9	2.9	6.7	6.9	3.8	7.9	10.4	6.1	3.9	4.1	5.1	4.7	1.8	3.4	2.3	3.4	8.0	5.0	7.0	16.6	3.4	5.2	9.4	4.0	5.9	7.2	10.2	11.2	1.5	4.7	7.5	4.6	3.9	6.6	6.5	4.8	2.8	12.8	4.7	1.6	2.9	7.2	2.7	2.7	1.6	0.4	1.5	2.5	3.1	0.6	1.4	2.6	6.5	4.5	4.0	1.3	0.7	2.4	8.3	9.0	8.9	9.5	7.6	9.5	10.0	10.1	9.8	9.1	10.9	9.5	8.4	6.4	16.1	19.2	9.9	3.1	13.5	4.4	14.2	14.7	7.9	5.6	9.1	11.5	5.7	7.3	10.4	1.4	12.7	4.3	7.9	8.8	2.2	3.8	8.7	9.2	5.4	7.4	16.8	10.4	0.9	12.8	4.6	5.0	3.8	33.0	15.7	8.6	7.6	18.5	38.7	1.7	0.0	18.3	13.5	2.7	15.5	12.3	0.0	15.0	15.3	16.9	27.8	10.1	4.7	7.2	1.3	24.0	3.7	5.9	4.8	5.1	5.0	18.4	19.7	9.3	17.9	5.2	6.0	6.2	2.3	0.5	11.8	45.3	2.7	5.2
ZNF644	"BM-005, KIAA1221, MGC60165, MGC70410"	ENSG00000122482	"Zinc finger protein 644"	Q9H582	1	90915298-91022272	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057795	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA057795: AB_2683529"	"unprognostic (8.20e-2)"	"unprognostic (5.86e-3)"	"prognostic favorable (4.27e-4)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (3.19e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-1)"	12.4	9.8	17.4	11.7	23.4	17.3	17.1	24.5	22.3	15.7	13.3	13.3	8.5	17.2	11.4	10.3	10.9	10.2	10.0	15.3	18.0	11.0	19.8	10.3	15.9	19.0	20.8	14.7	9.6	12.6	7.9	13.2	19.4	11.6	13.4	11.2	15.4	10.4	14.5	10.4	10.5	12.2	18.8	13.2	10.5	13.1	18.6	19.7	18.7	17.4	15.3	13.5	12.1	28.4	24.1	11.2	32.0	17.1	14.9	17.1	19.4	21.0	21.1	22.1	24.1	15.4	8.3	29.0	23.2	15.6	29.3	19.1	31.6	23.7	33.4	21.5	19.8	38.3	21.8	21.1	20.6	34.6	11.9	16.3	27.0	22.4	30.1	20.8	23.8	21.6	26.8	32.0	23.6	9.5	27.9	30.0	30.3	12.5	22.7	28.7	52.3	16.6	23.5	21.5	25.8	20.6	24.5	19.1	55.2	21.7	12.4	33.7	19.0	24.5	21.3	20.4	31.9	24.5	17.8	39.7	10.3	25.8	12.9	5.4	3.5	4.0	4.6	3.6	5.3	6.8	5.0	5.3	4.4	5.2	6.4	5.5	1.1	9.9	3.8	5.4	4.4	2.6	17.4	23.4	24.5	22.3	15.3	18.0	19.0	20.8	19.4	18.8	18.6	28.4	72.6	70.5	30.0	98.9	85.9	54.2	98.9	45.0	48.3	37.3	49.8	45.0	51.2	28.6	47.0	11.0	25.0	25.6	85.2	34.3	31.3	31.1	11.4	87.3	68.7	44.9	55.0	30.9	96.0	22.6	19.6	51.8	43.8	107.9	43.2	51.9	27.1	26.1	22.5	55.5	106.2	30.4	36.7	29.2	38.6	13.3	46.6	49.7	35.6	124.6	30.7	40.2	38.1	144.3	262.3	29.6	29.2	34.6	79.6	58.8	22.2	29.2	41.7	36.8	52.6	83.5	67.4	51.5	49.2	39.8	47.5	12.0	72.9	44.5	34.0	75.2
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.8;Spermatocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	5.6	4.1	4.4	6.7	4.9	9.2	5.0	6.9	5.9	5.8	1.6	5.0	6.4	6.5	2.5	5.2	5.5	3.5	4.8	3.7	2.9	4.9	4.3	4.7	7.1	6.2	4.7	6.2	5.6	4.4	5.0	4.0	4.9	5.4	2.8	1.6	6.2	4.0	7.9	8.0	6.4	3.2	3.5	8.0	5.5	25.7	5.8	8.6	5.1	3.7	5.1	5.4	4.9	6.3	7.8	15.8	10.2	8.0	7.1	5.5	13.7	8.3	8.8	9.8	9.0	11.6	7.1	15.0	13.0	7.1	6.5	10.2	8.5	9.2	3.7	17.2	8.1	11.1	15.6	9.7	7.4	14.4	16.7	7.1	8.1	10.6	6.0	7.6	5.9	12.5	18.2	8.5	7.5	12.2	16.0	9.9	13.8	3.5	8.1	25.5	20.2	15.3	3.1	7.3	14.7	14.9	9.5	10.0	4.9	4.4	8.4	12.5	12.1	12.3	7.0	8.2	7.8	14.2	14.1	14.9	11.2	15.5	9.8	9.8	4.5	13.2	5.1	4.2	2.6	3.9	2.4	2.1	4.6	4.4	2.7	3.0	25.1	4.8	2.8	6.6	2.6	2.1	4.4	4.9	6.9	5.9	3.7	2.9	6.2	4.7	4.9	3.5	5.8	6.3	4.7	3.2	1.3	3.6	4.2	3.3	1.0	2.6	2.8	3.6	3.4	3.4	1.7	1.5	2.2	1.8	4.2	1.9	6.6	6.6	1.9	4.1	24.8	3.0	3.7	3.4	6.0	2.1	2.2	3.5	2.1	2.5	5.6	4.9	1.3	5.1	1.8	1.9	4.9	1.7	2.1	3.4	4.1	4.7	2.8	6.6	2.8	6.4	0.0	7.5	3.7	3.6	4.1	2.0	3.1	4.4	7.6	4.5	2.3	2.4	5.8	2.2	2.7	1.1	0.0	3.5	2.3	16.2	7.0	2.9	4.0	2.5	4.9	2.8	3.7	1.9
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Early spermatids: 1.2;Melanocytes: 1.8;Spermatogonia: 1.3;Theca cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	78	"HMC-1: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053897	Uncertain					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.8	0.4	0.4	0.5	0.1	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0
ZNF649	FLJ12644	ENSG00000198093	"Zinc finger protein 649"	Q9BS31	19	51889235-51905040	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 29.1"					"Low region specificity"	"Detected in all"			HPA026541	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026541: AB_1859390"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-2)"	5.7	4.7	5.6	5.2	6.0	6.5	10.1	9.1	7.8	5.4	1.2	5.6	4.1	8.6	7.0	6.5	7.2	5.6	6.5	5.6	9.2	6.3	4.6	5.6	7.9	7.8	5.2	9.9	6.0	9.5	3.3	8.9	6.1	21.2	6.0	12.8	4.9	7.1	4.0	8.1	4.3	7.6	4.1	6.5	5.5	7.9	6.5	7.9	8.2	6.9	6.4	6.8	3.8	13.8	4.1	0.6	18.3	13.4	7.1	5.7	0.8	7.7	5.4	7.8	7.2	3.5	3.2	3.9	1.8	5.9	5.4	5.6	9.4	7.4	7.3	1.8	22.5	18.4	1.7	4.3	5.5	5.9	8.2	7.1	5.1	9.9	3.3	6.0	4.7	1.0	4.4	0.2	6.6	1.2	16.1	8.2	29.1	0.1	1.7	9.5	10.1	6.6	7.3	15.2	8.2	8.4	9.4	4.8	6.1	10.0	5.9	8.1	3.6	7.0	6.7	2.7	9.5	5.2	0.7	4.9	2.6	1.6	15.3	3.1	4.4	7.7	6.0	4.6	11.6	4.8	7.2	6.7	5.6	9.1	7.4	5.5	1.6	7.7	4.3	4.5	10.1	4.2	5.6	6.0	9.1	7.8	5.6	9.2	7.8	5.2	6.1	4.1	6.5	13.8	5.1	0.0	3.2	0.3	5.9	6.5	10.6	4.2	1.8	8.0	5.4	6.5	5.5	10.0	3.0	3.7	0.0	6.2	4.1	2.5	13.7	5.3	1.2	2.7	6.1	5.6	3.0	6.9	2.0	2.4	7.1	6.1	5.6	3.5	12.0	7.3	5.3	2.9	4.1	15.2	2.2	3.7	0.0	3.5	3.3	1.5	5.3	3.4	5.4	1.9	1.9	6.8	7.2	4.0	6.1	3.5	1.0	9.1	2.4	7.2	1.2	3.8	0.5	6.2	6.6	7.2	5.7	4.4	3.3	4.9	8.1	7.0	3.4	4.1	2.6	8.4
ZNF652	KIAA0924	ENSG00000198740	"Zinc finger protein 652"	Q9Y2D9	17	49289206-49362473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044408	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044408: AB_2678932"	"unprognostic (1.33e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.30e-2)"	2.1	2.3	4.6	2.8	11.4	3.7	9.6	6.7	4.7	3.2	1.5	2.8	2.6	2.1	2.0	2.0	2.1	2.2	1.6	3.6	6.2	2.5	4.0	2.8	2.9	10.7	8.2	2.8	2.4	3.6	1.0	2.6	11.4	3.3	2.9	4.5	4.4	2.4	10.5	6.6	2.1	2.7	5.2	4.6	3.4	3.7	7.9	3.4	3.6	2.5	3.0	2.1	1.1	18.0	4.3	2.9	3.2	4.1	4.3	2.3	4.3	1.6	2.6	1.8	2.1	6.8	2.7	9.7	5.0	3.3	1.4	3.0	2.9	3.1	2.9	3.3	2.6	3.5	5.0	4.7	1.6	2.9	5.3	3.2	2.8	1.6	2.9	1.8	2.2	4.8	2.7	8.1	1.8	6.0	4.3	1.6	3.2	2.5	2.1	3.4	6.6	4.6	2.4	5.7	5.9	4.0	2.8	3.9	4.2	4.8	7.1	4.1	3.6	5.9	4.4	2.6	2.6	10.3	7.6	6.3	3.2	2.6	2.2	7.7	3.0	3.2	2.6	2.6	3.5	1.9	1.9	2.0	2.1	2.6	1.8	1.9	5.9	2.1	3.4	1.9	0.9	2.5	4.6	11.4	6.7	4.7	3.6	6.2	10.7	8.2	11.4	5.2	7.9	18.0	28.8	19.2	19.8	37.5	38.6	16.4	14.2	7.8	18.8	56.5	63.7	50.2	16.6	21.5	15.2	29.5	64.6	24.0	60.6	22.7	13.7	18.6	19.2	56.6	45.1	24.3	12.1	22.3	49.2	19.6	18.2	24.4	16.8	59.1	5.1	24.0	29.6	41.6	12.8	43.7	70.9	20.4	14.2	41.6	32.4	17.3	48.4	25.1	26.6	65.6	37.0	30.1	45.3	76.9	152.6	18.4	18.5	44.4	21.9	24.6	17.9	12.4	21.3	47.1	0.0	30.0	22.8	60.4	29.9	15.6	24.3	13.4	33.7	27.7	24.0	12.6
ZNF653	Zip67	ENSG00000161914	"Zinc finger protein 653"	Q96CK0	19	11483427-11505839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.1;Late spermatids: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023631, HPA023635"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023631: AB_2671269, HPA023635: AB_10603940"	"unprognostic (1.21e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (8.37e-4)"	"prognostic favorable (4.15e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (8.74e-4)"	4.5	8.1	12.9	4.4	13.4	3.7	5.3	20.5	16.9	5.9	11.6	6.8	3.3	5.9	1.7	5.4	6.4	4.1	5.6	14.8	14.3	9.5	8.5	4.8	4.3	12.1	12.3	6.4	8.3	5.4	8.8	3.4	12.2	8.5	2.1	3.5	5.5	3.1	7.6	7.7	6.5	3.8	10.8	5.8	7.5	25.3	12.9	6.2	8.9	3.7	2.6	6.3	5.9	13.6	11.7	9.5	7.1	6.4	1.9	1.4	5.2	4.3	3.7	6.2	5.6	6.5	5.0	8.0	5.4	4.8	6.5	5.2	5.5	4.3	3.1	8.6	7.2	5.2	6.4	7.7	2.0	6.9	8.8	4.2	5.5	5.8	4.7	5.9	4.7	7.0	7.5	11.8	3.5	16.3	9.5	15.6	7.8	6.5	7.7	8.3	4.7	10.5	6.8	9.6	8.3	12.2	2.9	5.0	5.8	3.1	4.8	4.4	6.0	8.8	5.9	10.1	10.6	15.6	24.9	6.1	7.8	9.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	12.9	13.4	20.5	16.9	14.8	14.3	12.1	12.3	12.2	10.8	12.9	13.6	2.5	0.0	0.0	2.6	2.7	3.2	4.0	0.8	1.2	4.4	3.1	3.0	1.8	1.5	0.5	1.8	6.2	1.4	2.5	5.2	0.0	4.5	15.1	4.9	1.7	1.9	4.8	6.1	3.8	5.2	1.3	1.6	2.6	3.1	4.5	3.0	3.6	3.6	0.9	1.7	3.5	4.1	0.0	1.6	0.5	26.7	1.8	1.1	0.0	2.8	3.9	4.9	0.0	2.0	1.5	4.5	0.8	2.2	1.0	2.5	2.0	2.7	1.1	4.1	0.0	2.6	3.1	9.1	4.7	1.3	2.7	1.6	1.5	2.6	3.3	2.2
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"		3	88059255-88144660	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	5.0	3.7	2.6	4.1	2.7	8.1	5.5	4.9	3.3	5.1	1.8	4.4	4.5	4.6	4.7	5.6	3.4	4.8	3.4	2.4	3.2	4.8	7.0	4.5	6.1	2.8	3.1	6.4	4.1	4.3	1.2	5.0	3.3	5.5	4.2	11.7	4.6	4.1	3.0	6.5	4.8	4.1	3.2	4.9	4.7	6.0	2.7	7.6	5.9	4.9	5.7	5.1	2.3	3.9	7.2	3.0	5.0	6.9	9.9	8.6	4.6	9.3	8.4	6.1	8.4	4.4	4.3	11.3	6.2	7.4	4.4	4.7	5.3	8.6	11.8	7.0	3.0	7.0	3.9	3.2	7.5	8.0	7.6	8.4	7.4	6.7	7.8	12.1	8.1	6.6	4.9	9.0	13.6	5.3	8.0	6.5	2.7	5.7	4.8	5.7	3.4	5.4	5.4	9.0	3.7	3.3	6.8	5.2	17.0	6.0	7.3	5.7	9.5	13.6	8.7	51.8	6.6	10.1	7.6	7.9	10.8	7.5	8.6	9.7	1.2	1.8	1.7	1.2	2.0	1.1	1.8	2.4	1.5	1.7	2.2	1.5	1.7	4.0	1.0	0.7	1.4	1.0	2.6	2.7	4.9	3.3	2.4	3.2	2.8	3.1	3.3	3.2	2.7	3.9	18.2	9.6	13.1	10.1	12.8	22.4	10.1	7.9	9.1	14.0	17.4	10.2	11.8	5.7	10.8	5.5	12.5	4.8	14.5	11.9	1.9	7.6	1.4	9.4	16.0	12.4	5.3	5.2	11.7	5.3	4.2	11.7	5.1	12.2	15.8	14.5	8.9	14.0	6.3	16.8	11.3	7.1	10.2	12.3	19.5	1.5	7.5	14.8	8.8	7.5	10.9	9.9	9.2	9.0	13.3	8.4	8.2	12.4	9.2	12.0	9.0	6.0	10.7	14.3	6.6	13.9	11.5	12.1	10.4	11.4	18.6	8.2	14.0	9.0	7.8	14.4
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	11.6	11.9	7.0	14.3	6.2	8.9	12.8	8.3	7.8	13.2	5.9	15.5	15.9	10.1	11.0	26.9	11.5	10.2	8.4	6.3	6.1	13.8	14.9	15.3	19.7	5.0	5.5	13.9	21.1	14.4	8.2	12.5	6.4	11.4	11.8	8.5	16.7	11.3	12.7	18.4	13.8	11.7	5.1	14.2	18.0	7.4	6.3	22.6	11.8	13.5	17.3	18.8	14.9	9.6	40.5	35.9	16.5	23.9	15.8	25.4	12.4	24.0	45.8	40.7	37.8	20.1	37.0	31.8	0.4	33.2	52.0	25.2	18.0	29.6	40.6	34.5	23.6	18.9	16.0	27.8	24.1	38.1	35.9	21.1	32.8	35.8	50.6	21.4	17.3	26.4	54.4	39.7	24.4	0.1	53.9	36.6	21.1	0.1	0.0	19.9	14.0	52.9	25.9	42.8	17.4	37.6	25.1	0.7	27.2	24.0	12.2	20.2	13.3	24.3	60.2	43.4	43.6	47.3	72.7	63.4	23.5	18.2	39.9	147.8	43.2	74.4	47.8	47.2	45.1	32.7	44.1	55.7	40.3	31.3	35.0	43.8	50.3	37.0	55.2	23.3	61.3	55.4	7.0	6.2	8.3	7.8	6.3	6.1	5.0	5.5	6.4	5.1	6.3	9.6	19.5	96.1	82.8	51.2	53.2	44.7	46.5	36.5	42.1	48.8	34.4	25.1	36.1	31.5	44.3	23.9	41.7	31.6	76.3	46.3	33.2	31.6	12.8	25.8	33.9	20.4	41.5	12.8	53.4	36.2	42.7	32.7	37.2	33.0	18.9	70.8	19.2	24.6	37.4	50.5	57.4	40.4	18.3	63.4	31.6	9.7	25.4	56.0	23.2	44.0	59.2	24.9	106.1	61.3	75.3	48.2	55.2	25.2	55.4	44.5	48.1	41.1	26.0	45.8	13.1	39.9	31.7	39.0	29.8	55.6	48.9	73.6	62.5	30.0	28.1	64.0
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	11	"neutrophil: 28.0"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	2.6	2.7	2.4	2.0	2.8	2.0	5.4	4.7	3.0	3.6	2.9	2.5	2.1	3.6	2.7	3.5	4.0	1.8	4.4	2.7	2.8	3.7	2.4	3.0	2.7	1.4	1.8	6.3	3.3	5.0	2.4	1.8	1.4	4.0	2.6	5.4	4.1	3.4	5.0	8.1	1.8	2.8	0.9	3.5	2.7	3.5	3.2	2.8	4.5	4.4	3.1	2.5	2.0	2.3	2.3	3.9	3.7	7.0	3.7	4.4	2.8	1.8	3.3	2.4	2.7	0.3	1.7	5.3	1.9	1.7	2.6	6.1	3.0	3.5	2.6	0.2	1.9	0.8	3.5	0.8	4.1	3.3	1.8	3.5	7.8	2.4	3.4	5.0	4.8	3.4	1.1	1.0	3.1	1.3	2.7	1.7	3.1	1.6	6.6	0.2	5.9	1.9	2.6	5.9	5.4	3.2	2.8	1.5	2.7	3.9	2.2	8.4	1.1	3.1	4.0	2.8	2.2	0.6	3.2	1.3	1.4	1.2	3.3	0.8	0.7	2.3	0.9	0.6	0.1	0.8	1.3	1.1	0.3	1.6	1.8	1.0	28.0	2.4	0.6	0.6	0.7	0.2	2.4	2.8	4.7	3.0	2.7	2.8	1.4	1.8	1.4	0.9	3.2	2.3	3.9	3.2	3.2	3.3	2.7	0.9	1.3	1.9	9.6	7.3	2.6	3.8	3.5	2.8	2.4	0.0	0.0	2.7	0.3	0.8	15.6	1.4	0.8	2.3	2.8	2.7	0.0	0.4	6.5	0.7	1.1	2.2	1.5	1.3	1.3	5.8	1.4	2.3	1.8	10.1	7.8	1.8	2.0	2.4	0.3	1.2	3.1	0.8	0.0	1.9	0.2	5.1	0.0	4.0	4.5	0.8	0.3	5.3	2.0	0.9	1.3	4.6	7.5	4.3	0.0	3.9	2.0	3.2	2.9	5.4	2.0	1.0	1.3	3.5	1.4	1.8
ZNF660	FLJ36870	ENSG00000144792	"Zinc finger protein 660"	Q6AZW8	3	44578223-44599694	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.9;Muller glia cells: 28.1;Rod photoreceptor cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;HEL: 3.4;NTERA-2: 5.2;RH-30: 3.4;SuSa: 2.8"					"Low region specificity"	"Detected in all"			HPA029705	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoli fibrillar center, Cytosol"		"HPA029705: AB_10602592"	"unprognostic (5.43e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.87e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	1.1	0.8	0.7	0.4	0.6	0.8	0.9	2.3	0.7	2.2	0.1	1.4	0.1	2.1	0.6	0.3	1.8	0.7	1.0	0.6	0.9	1.1	0.3	0.9	0.9	0.9	0.8	3.4	0.8	0.7	2.4	0.7	0.8	1.6	0.3	4.6	0.6	0.9	0.4	0.3	0.9	0.9	0.6	1.0	0.8	1.7	0.9	0.8	1.5	0.4	0.6	1.3	1.2	0.8	0.0	0.0	3.4	0.8	0.0	0.0	0.5	0.4	0.8	0.5	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	1.1	0.0	0.6	0.0	0.0	3.4	0.3	0.5	0.8	0.0	0.0	1.3	0.0	1.2	0.0	0.1	0.8	0.0	0.0	0.1	1.8	0.0	0.0	2.0	5.2	0.0	0.0	0.0	3.4	0.0	0.1	0.1	0.8	2.2	0.0	0.0	0.0	2.8	0.0	1.3	0.2	0.9	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.7	0.6	2.3	0.7	0.6	0.9	0.9	0.8	0.8	0.6	0.9	0.8	3.2	0.0	6.0	11.8	1.4	0.1	1.1	0.5	0.0	27.9	1.0	1.0	2.2	4.3	3.2	0.0	6.2	0.0	2.3	0.2	0.0	1.2	10.3	1.9	7.8	4.0	4.2	3.0	7.6	0.5	0.0	4.4	0.5	1.1	6.3	12.4	3.6	0.2	2.0	11.8	11.5	0.3	0.0	1.0	0.5	2.0	5.0	1.3	0.0	11.2	2.9	28.1	6.2	15.6	13.7	0.5	0.0	3.4	0.3	0.8	0.0	0.2	1.0	25.6	0.0	7.9	5.1	7.7	3.9	0.1	0.0	0.0	0.7	7.0	0.4	0.3
ZNF662	FLJ45880	ENSG00000182983	"Zinc finger protein 662"	Q6ZS27	3	42906142-42919334	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;SH-SY5Y: 3.2;THP-1: 3.3;U-2 OS: 4.6"					"Low region specificity"	"Detected in all"			"HPA039116, HPA040377"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"HPA039116: AB_2676355, HPA040377: AB_2676949"	"unprognostic (2.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.80e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.39e-3)"	"unprognostic (7.18e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-2)"	5.9	4.8	3.5	1.4	3.9	0.9	7.3	6.8	6.5	11.3	5.2	7.3	2.0	9.2	4.5	5.8	8.2	2.6	5.1	3.4	3.6	6.9	5.1	4.3	1.6	3.6	3.3	14.2	10.7	1.3	7.2	2.0	3.6	10.4	3.4	11.1	8.3	4.0	3.5	10.9	4.4	4.1	3.0	4.7	6.2	7.4	3.4	1.1	8.2	2.8	1.5	7.9	8.1	5.2	0.1	0.0	0.2	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.5	2.4	1.4	0.2	1.7	1.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.5	0.5	0.0	0.9	0.1	0.4	2.3	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.3	2.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.7	0.1	1.7	3.2	0.0	1.1	0.0	0.6	0.0	3.3	0.1	0.8	4.6	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.1	0.4	0.3	1.3	1.3	0.4	0.5	0.1	0.4	0.2	0.2	3.5	3.9	6.8	6.5	3.4	3.6	3.6	3.3	3.6	3.0	3.4	5.2	4.2	12.8	4.6	7.2	0.2	2.4	2.5	0.2	2.2	6.5	4.4	3.9	2.9	4.3	3.9	1.8	6.2	1.9	0.2	1.4	1.9	1.8	2.0	1.3	5.6	3.4	5.4	1.3	4.3	3.2	2.4	4.6	12.2	2.3	0.0	9.7	3.6	3.4	0.1	6.7	6.5	2.4	2.0	0.8	2.6	4.4	11.5	0.8	5.4	6.5	0.0	4.1	0.0	16.1	8.0	2.9	1.2	4.5	0.1	1.9	0.4	1.7	1.3	10.9	13.1	6.0	3.3	18.5	11.0	0.9	1.8	2.9	0.4	2.2	4.0	2.1
ZNF665	"FLJ14345, ZFP160L"	ENSG00000197497	"Zinc finger protein 665"	Q9H7R5	19	53159213-53193386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA023437	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane"		"HPA023437: AB_2671205"	"unprognostic (8.01e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.81e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (9.27e-2)"	0.7	0.6	0.6	0.6	0.8	0.8	1.3	2.2	1.0	1.1	0.3	0.7	0.3	1.4	1.3	0.6	1.8	0.8	0.5	0.5	0.7	0.6	0.2	1.0	1.4	0.7	0.8	3.3	0.5	1.5	0.4	0.7	0.7	1.2	0.6	0.9	0.8	0.9	0.3	1.0	0.4	1.0	0.4	1.1	0.6	0.9	0.4	1.5	1.6	0.2	0.6	0.8	0.7	2.0	0.7	0.1	0.6	2.1	0.6	1.1	1.4	1.4	0.9	1.4	2.0	0.2	0.6	1.2	1.2	1.0	1.0	0.2	0.4	0.1	2.4	0.0	0.0	0.0	0.4	0.0	1.3	0.2	0.6	1.2	0.0	1.3	0.0	0.5	0.1	0.0	0.2	0.3	0.0	0.2	3.0	0.9	1.1	0.0	0.3	0.0	0.0	0.4	0.3	3.0	0.3	1.2	0.1	0.2	0.1	1.4	0.9	0.5	0.4	1.0	1.3	0.9	0.6	0.2	2.7	3.0	0.1	0.7	1.3	0.8	0.2	0.5	0.3	0.1	0.4	1.2	0.4	0.9	0.4	2.1	0.8	0.8	0.6	2.0	0.6	0.7	0.3	0.2	0.6	0.8	2.2	1.0	0.5	0.7	0.7	0.8	0.7	0.4	0.4	2.0	3.0	19.2	8.4	4.9	4.9	1.1	2.5	0.4	0.6	6.0	1.7	2.2	0.9	4.3	4.0	5.5	0.0	2.4	1.2	0.5	3.9	1.2	2.2	2.8	2.9	4.2	2.4	2.5	3.2	0.7	2.5	4.9	0.0	3.7	5.1	8.0	1.8	0.3	1.3	11.8	4.0	0.5	0.0	0.8	1.1	1.7	2.1	1.9	1.8	4.7	2.5	6.4	5.2	3.5	4.5	0.6	0.3	3.0	0.4	2.9	0.3	0.8	4.6	4.0	0.0	4.4	2.5	2.7	6.7	0.9	0.6	0.8	3.9	4.9	1.0	2.1
ZNF667	FLJ14011	ENSG00000198046	"Zinc finger protein 667"	Q5HYK9	19	56439325-56478065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 24.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.6;Excitatory neurons: 29.2;Horizontal cells: 32.0;Rod photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.3;hTERT-RPE1: 17.5;U-138 MG: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030731, HPA046673"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA030731: AB_2673584, HPA046673: AB_2679746"	"unprognostic (6.10e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.55e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.34e-3)"	"unprognostic (3.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.55e-2)"	2.3	5.4	11.0	1.2	12.1	5.2	4.9	6.7	11.9	4.7	5.2	3.5	1.1	4.6	7.9	1.6	4.9	3.1	3.3	13.7	11.3	5.0	1.1	1.4	1.9	6.6	7.6	7.5	2.4	5.2	24.2	2.2	7.6	4.7	0.5	9.4	3.2	2.9	1.6	2.6	1.3	3.7	5.7	1.8	1.6	4.3	9.5	2.6	8.9	1.7	1.3	3.8	2.8	9.2	0.1	0.2	10.4	0.1	0.0	0.0	0.2	4.6	3.4	3.9	3.1	0.2	0.1	0.6	6.0	1.6	6.0	0.1	0.0	0.1	6.0	0.0	2.3	12.3	0.1	0.2	3.0	7.3	5.4	6.6	0.1	0.8	0.0	17.5	0.0	0.4	0.1	0.2	3.1	0.2	0.1	0.2	7.6	0.1	2.0	0.1	3.9	8.6	3.9	0.6	0.3	5.9	0.2	0.1	0.0	9.2	2.8	0.0	0.0	14.7	4.0	0.2	7.9	0.2	6.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.2	0.2	0.2	3.0	0.8	1.9	0.2	2.7	0.0	1.1	0.1	0.4	11.0	12.1	6.7	11.9	13.7	11.3	6.6	7.6	7.6	5.7	9.5	9.2	4.3	0.0	0.0	10.4	2.9	3.3	6.8	0.5	6.2	30.6	6.0	9.4	6.4	1.5	2.9	5.5	25.0	0.3	1.8	0.1	0.0	3.6	3.0	10.3	8.9	4.0	1.2	3.0	29.2	0.2	0.0	7.4	0.0	5.6	9.5	18.1	2.9	0.2	0.2	32.0	24.4	0.1	0.0	0.0	1.2	2.5	5.3	0.8	3.6	6.5	0.1	8.4	1.0	22.6	23.9	0.4	0.1	7.2	0.5	8.1	0.0	1.4	3.7	29.2	0.0	11.7	5.0	13.6	14.0	1.0	4.1	0.1	1.1	16.7	0.3	2.6
ZNF668	FLJ13479	ENSG00000167394	"Zinc finger protein 668"	Q96K58	16	31060843-31074240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043048	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA043048: AB_10962503"	"unprognostic (2.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.73e-5)"	"unprognostic (4.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (1.72e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.25e-2)"	5.6	6.6	4.4	3.4	4.1	7.9	4.7	4.7	6.6	5.5	1.7	5.6	4.4	6.9	0.7	6.4	4.6	2.3	5.7	4.5	3.2	4.4	4.8	4.4	2.6	5.1	3.6	3.8	3.9	2.3	4.9	3.6	4.8	6.3	1.3	0.8	4.6	2.4	6.1	7.3	4.8	3.4	3.2	6.0	4.8	7.5	4.0	3.0	4.1	1.7	1.6	6.2	5.2	4.0	5.2	17.2	3.8	9.4	3.9	4.1	13.0	14.6	10.3	7.1	5.9	8.0	7.0	8.3	11.2	8.4	4.5	9.2	2.6	7.8	1.8	10.6	11.1	5.1	11.4	12.8	4.8	8.2	12.3	5.1	3.2	12.1	2.4	2.3	5.1	8.9	9.7	4.9	12.8	17.2	17.3	17.2	13.6	3.6	14.4	22.4	28.5	12.0	3.7	11.2	13.3	15.7	9.3	12.5	4.7	1.5	9.6	11.5	8.9	17.5	7.2	13.4	6.2	8.4	15.1	12.1	11.7	8.3	11.4	8.7	4.2	7.9	11.1	3.9	7.3	4.3	3.2	6.7	6.2	3.0	3.4	4.4	1.5	7.8	3.4	3.3	3.5	5.1	4.4	4.1	4.7	6.6	4.5	3.2	5.1	3.6	4.8	3.2	4.0	4.0	3.4	0.0	3.6	3.6	4.6	8.4	2.4	5.3	7.4	3.5	4.5	3.7	0.6	4.3	3.8	0.0	0.0	6.5	5.9	6.3	7.9	8.9	44.7	3.8	4.7	4.3	4.8	4.6	3.7	4.8	11.4	6.4	4.1	8.1	4.5	4.7	3.6	2.8	6.8	11.8	3.7	3.7	4.1	3.8	7.1	15.3	6.2	9.3	3.6	2.8	5.5	5.1	12.3	1.0	4.2	7.5	4.9	15.1	4.5	4.0	7.5	5.8	1.7	2.1	0.0	9.0	5.5	5.9	12.8	8.8	8.8	7.0	7.4	5.0	4.6	2.2
ZNF669	FLJ12606	ENSG00000188295	"Zinc finger protein 669"	Q96BR6	1	247099962-247104372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044043	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA044043: AB_10964039"	"unprognostic (1.88e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.59e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.81e-2)"	3.4	1.8	2.0	2.6	1.7	11.7	5.5	4.8	2.2	3.8	1.5	3.7	2.9	4.7	3.2	2.5	4.0	3.0	2.5	1.6	1.7	3.8	2.1	3.4	5.5	1.7	1.5	4.6	4.3	4.3	1.6	2.8	1.9	3.1	3.6	5.1	2.9	3.2	2.0	2.8	2.4	3.7	1.1	4.0	3.3	4.7	2.0	8.8	5.0	3.7	5.6	2.7	1.6	3.3	4.2	2.9	9.4	10.9	5.4	4.8	9.6	6.1	6.2	8.1	8.3	7.1	4.3	5.9	8.9	4.2	5.8	5.3	9.2	7.2	9.0	3.1	2.2	0.4	6.4	5.2	4.3	5.7	6.9	4.5	7.4	6.6	4.8	3.9	4.9	15.1	10.4	4.1	8.6	3.7	14.6	5.7	22.1	8.7	5.9	11.6	9.1	4.3	6.0	12.0	10.1	17.9	7.8	4.1	3.1	10.5	8.0	20.3	5.6	5.7	6.4	5.3	11.4	10.2	20.1	12.0	1.5	2.9	5.8	10.7	2.4	8.9	4.4	1.6	5.8	6.4	5.2	4.2	3.1	5.1	5.9	5.8	5.8	4.3	2.4	4.2	6.2	2.9	2.0	1.7	4.8	2.2	1.6	1.7	1.7	1.5	1.9	1.1	2.0	3.3	10.2	3.2	8.3	1.6	17.5	9.7	6.2	4.8	7.4	27.1	5.1	5.6	1.6	12.8	4.5	1.8	12.5	3.6	11.3	2.3	7.9	5.1	11.5	9.0	7.2	8.3	7.8	8.6	3.0	7.7	4.9	5.4	3.6	11.5	15.2	9.7	8.6	2.5	4.8	16.8	3.3	2.6	2.0	6.0	19.8	7.4	7.2	7.3	12.4	3.7	4.7	9.9	18.6	3.0	2.4	8.1	1.2	3.8	8.1	3.3	2.8	3.6	7.5	31.1	0.0	5.9	6.2	10.4	9.5	5.1	8.5	2.3	10.5	9.7	2.5	4.1
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247034637-247078811	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	2.2	1.5	0.8	1.1	0.9	0.5	2.3	2.8	1.2	1.5	0.3	1.5	1.0	2.3	0.6	1.2	1.6	1.3	1.1	0.9	0.8	1.7	1.7	1.5	1.5	0.5	0.8	2.1	1.8	1.6	1.0	0.7	0.5	1.3	1.3	2.1	1.5	1.1	1.0	1.5	1.5	1.7	0.5	1.4	2.0	2.3	0.9	1.9	1.4	1.4	1.7	1.7	1.5	0.8	2.7	1.7	5.7	6.9	1.3	1.9	12.0	3.1	2.0	3.7	3.6	2.4	2.5	4.5	6.2	1.9	2.2	2.1	6.3	2.4	6.8	3.1	0.7	4.1	1.4	3.4	1.1	4.6	2.6	1.2	2.5	2.3	4.9	0.6	2.4	3.8	5.4	1.9	3.9	1.1	5.7	2.4	9.8	5.5	3.6	5.7	7.5	3.9	2.2	5.7	6.7	5.4	4.5	1.8	2.6	3.0	1.9	9.3	1.7	2.5	2.4	1.8	3.6	3.8	6.8	8.0	0.9	3.4	3.0	0.0	0.6	0.5	1.2	0.7	0.6	2.1	1.1	1.3	1.3	1.5	1.8	1.3	0.3	1.0	0.4	0.7	0.9	0.6	0.8	0.9	2.8	1.2	0.9	0.8	0.5	0.8	0.5	0.5	0.9	0.8	4.2	3.2	1.7	0.0	2.5	24.2	9.3	6.1	3.4	4.1	5.0	4.8	0.9	4.3	5.1	5.5	0.0	2.3	2.7	0.4	5.9	5.2	8.9	11.9	2.6	5.2	0.0	3.8	0.0	2.9	8.3	6.3	1.5	13.4	0.0	2.0	5.7	2.9	2.5	6.7	0.0	1.8	8.2	1.6	10.2	2.0	1.8	1.5	7.2	0.0	2.0	3.0	1.0	0.0	0.0	3.5	1.8	1.5	0.9	5.2	1.0	3.6	4.7	1.5	0.0	9.3	4.0	3.2	4.0	2.3	11.2	0.8	1.4	2.2	1.8	3.6
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1"					"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favorable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	2.9	6.8	6.8	3.7	7.1	4.4	4.3	11.0	7.7	3.4	7.1	6.5	1.8	2.5	5.3	2.0	4.5	2.8	6.8	6.6	7.7	6.0	2.8	4.0	7.9	6.7	7.1	3.3	3.4	9.4	9.7	4.0	6.8	5.8	2.3	8.3	3.8	5.8	7.7	2.2	6.4	2.7	7.3	13.5	2.7	6.4	7.8	13.7	8.3	6.9	8.5	4.8	2.0	7.4	0.1	0.2	2.2	0.0	0.4	0.1	0.0	2.5	1.4	4.8	1.7	0.3	0.4	5.2	0.8	3.6	1.5	0.1	1.9	2.1	5.6	5.7	3.6	0.1	0.8	0.0	4.2	0.0	7.3	6.2	1.5	3.0	1.7	5.6	0.7	5.4	0.8	2.5	4.4	0.1	10.1	0.1	3.2	0.0	5.1	3.9	6.8	3.2	1.8	0.2	0.2	0.0	0.0	0.1	3.5	5.4	1.4	7.3	0.0	0.5	2.6	0.0	1.9	4.5	0.1	2.8	0.5	1.2	1.6	19.4	10.5	19.3	8.0	9.5	21.4	22.7	17.0	14.1	14.9	30.4	24.2	19.7	7.3	20.9	15.1	13.7	18.9	15.0	6.8	7.1	11.0	7.7	6.6	7.7	6.7	7.1	6.8	7.3	7.8	7.4	1.1	0.0	0.6	5.9	5.2	0.6	0.7	0.9	0.0	5.8	1.3	1.0	5.4	4.3	1.2	3.7	0.0	2.3	2.0	0.0	1.9	3.7	0.2	0.8	0.4	1.7	0.0	3.4	3.4	0.0	1.1	0.7	0.0	0.7	2.5	2.9	1.1	1.2	3.8	6.7	4.1	0.2	6.1	2.7	0.8	0.7	0.0	2.3	1.8	2.8	1.9	8.4	6.2	4.0	2.8	0.3	0.1	0.4	3.8	0.5	0.9	1.6	0.9	7.8	0.0	0.2	1.6	7.0	5.0	0.4	0.4	0.8	4.1	0.6	0.5	0.1
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	13.4	14.8	13.4	11.7	14.8	13.5	13.1	17.9	14.1	13.3	14.6	16.1	11.3	14.3	7.7	19.1	14.9	7.8	30.2	12.8	13.4	22.3	26.1	17.0	14.8	17.2	14.8	11.1	18.0	16.2	17.1	9.3	14.8	24.0	8.4	10.7	17.6	8.2	49.5	17.9	16.8	8.1	14.0	19.8	16.9	16.0	14.9	15.8	20.2	35.7	14.0	16.8	13.7	15.8	19.4	21.5	17.2	19.5	9.4	6.6	33.0	17.8	9.7	12.7	13.6	11.8	19.7	22.0	18.1	11.7	9.6	18.8	9.4	13.3	8.0	32.5	5.3	33.7	20.0	16.0	12.0	14.6	24.4	7.4	10.7	16.6	11.5	10.2	11.7	15.2	41.5	17.6	8.8	13.8	26.8	14.5	20.0	22.3	36.5	49.1	16.3	17.4	12.9	15.6	25.5	22.2	16.0	24.0	15.9	10.2	13.8	30.1	10.0	17.5	10.5	11.6	37.3	52.8	22.2	13.2	16.0	25.1	14.5	9.2	16.3	11.9	8.8	15.9	7.2	11.9	6.3	8.8	24.3	15.0	6.7	6.3	9.2	12.7	15.4	13.6	7.8	14.0	13.4	14.8	17.9	14.1	12.8	13.4	17.2	14.8	14.8	14.0	14.9	15.8	10.7	3.2	15.2	5.9	22.3	13.0	28.2	10.1	6.8	22.0	12.8	9.8	20.2	14.3	8.1	16.5	12.5	32.0	22.0	19.5	21.5	18.3	7.8	9.5	5.7	12.0	18.0	17.0	2.2	10.7	19.9	10.0	10.2	8.9	28.0	12.5	7.5	17.2	16.8	10.1	4.0	17.6	8.2	16.4	16.9	14.6	5.6	20.6	12.4	1.9	17.8	19.5	20.6	2.5	5.2	14.6	19.7	5.7	9.6	21.1	26.5	15.8	9.0	30.5	6.6	17.5	11.7	32.4	23.4	5.5	14.6	71.3	13.5	10.6	16.9	22.5
ZNF674	"MRX92, ZNF673B"	ENSG00000251192	"Zinc finger protein 674"	Q2M3X9	X	46497727-46545457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 13.5;Inhibitory neurons: 11.4;Oligodendrocytes: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA031026, HPA065295"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA031026: AB_10602690, HPA065295: AB_2685456"	"unprognostic (6.11e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.41e-5)"	"unprognostic (2.74e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-4)"	"unprognostic (8.45e-4)"	1.0	1.2	1.7	1.1	1.9	1.0	1.4	3.0	2.0	1.4	1.1	1.2	1.1	1.6	1.6	0.9	1.0	1.2	1.3	1.7	1.9	1.4	2.2	1.0	1.5	1.6	1.4	1.7	2.0	1.4	1.3	1.2	2.0	2.0	1.3	3.9	1.1	1.3	1.4	1.3	1.1	1.7	1.3	1.4	0.9	0.9	1.7	1.5	1.7	1.1	1.2	1.1	1.2	2.5	1.7	2.2	2.1	2.7	1.9	1.9	2.1	1.8	2.5	2.3	2.4	1.4	1.4	1.9	1.1	3.1	4.1	1.6	2.9	2.2	2.6	1.6	1.8	0.8	2.5	1.2	2.5	2.1	3.3	1.8	3.4	1.7	5.6	2.4	1.7	3.2	1.0	2.8	2.1	1.1	2.1	0.9	3.4	0.5	2.1	1.0	3.6	2.2	1.5	0.7	0.8	1.8	2.7	0.9	5.7	5.9	2.3	1.5	1.6	2.9	3.3	1.8	1.7	3.3	3.2	0.8	1.2	1.0	3.0	0.9	0.6	0.9	0.5	1.1	0.5	0.7	0.7	0.4	0.6	0.3	0.5	0.6	1.7	0.5	0.2	0.7	0.6	0.6	1.7	1.9	3.0	2.0	1.7	1.9	1.6	1.4	2.0	1.3	1.7	2.5	2.7	9.6	1.8	5.2	1.3	1.9	3.1	0.5	1.2	6.6	1.1	1.3	4.4	0.0	2.9	1.8	0.0	0.8	2.3	1.5	0.0	0.9	0.0	1.5	2.2	3.4	0.0	0.8	9.3	0.5	0.7	2.0	3.1	1.9	2.5	1.9	3.6	2.1	1.0	13.5	11.4	1.0	0.0	1.9	2.2	0.5	0.3	1.4	0.0	5.6	2.0	2.5	2.1	9.5	12.3	1.3	1.4	1.9	2.3	2.6	1.1	0.9	2.7	5.8	0.0	3.2	1.5	1.3	4.2	1.1	1.7	0.4	1.9	1.2	0.9	2.2
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 602.9;Late spermatids: 408.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 30.4;SuSa: 25.5"									HPA023106	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	6.4	4.7	5.6	5.9	5.6	11.0	9.9	5.3	7.0	4.7	6.9	3.5	10.2	4.3	5.6	11.1	7.4	11.4	4.8	4.8	6.5	2.8	6.3	6.5	5.2	4.6	16.1	5.3	9.7	4.8	9.1	4.9	10.2	4.0	11.7	7.9	7.0	5.3	9.1	3.4	9.3	4.9	8.9	5.4	44.8	4.8	9.3	11.9	7.0	6.2	7.9	5.7	7.9	0.4	0.4	17.5	0.6	5.9	9.0	3.2	11.8	8.8	11.9	10.6	0.0	0.6	0.1	8.5	10.3	15.0	1.1	0.1	9.1	3.5	0.3	6.2	0.5	1.0	0.3	14.6	0.2	11.7	15.7	0.1	11.4	0.2	0.4	5.3	0.2	0.2	0.6	8.1	0.4	10.2	0.2	30.4	0.1	4.0	0.2	0.0	0.2	3.3	4.7	0.3	16.7	0.3	4.4	0.2	25.5	0.6	0.5	3.4	18.6	0.4	0.3	7.8	0.4	0.1	0.4	0.3	0.5	0.1	18.3	2.8	9.0	6.6	3.9	9.4	15.7	9.4	7.2	8.4	23.3	19.8	13.0	3.0	15.7	2.6	20.0	6.6	5.1	4.7	5.9	9.9	5.3	4.8	4.8	5.2	4.6	4.9	4.9	4.8	7.9	27.6	25.6	2.8	9.8	10.0	11.5	25.9	15.7	5.7	24.4	14.2	20.4	19.3	11.5	14.8	20.2	14.6	12.6	7.1	0.7	35.2	15.0	602.9	8.2	12.5	24.3	0.0	12.2	4.0	6.9	21.9	20.6	3.1	11.1	14.0	19.9	31.1	0.3	7.7	28.6	4.7	2.8	12.2	7.2	12.1	408.1	27.4	7.2	14.2	5.6	7.2	21.1	12.3	20.6	10.8	7.5	0.7	17.3	1.8	36.2	1.4	3.3	7.4	18.6	19.7	19.2	22.0	45.3	38.7	7.0	14.6	11.8	8.2	19.7	2.4	27.8
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli, Mitochondria, Cytosol"		"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	2.5	3.1	2.2	3.0	3.3	3.4	3.7	3.6	2.8	3.6	1.1	2.9	2.3	3.8	2.4	2.1	3.1	3.1	1.9	2.3	4.3	2.6	2.2	3.2	4.4	3.1	2.8	4.0	3.3	2.3	1.5	4.2	2.8	4.0	4.1	5.7	2.7	2.4	1.5	1.4	2.1	2.4	2.3	3.6	3.3	3.9	3.4	4.4	5.4	2.7	4.0	2.1	2.3	5.6	2.5	4.0	13.6	15.5	1.6	3.7	8.3	3.3	3.2	4.8	4.9	3.3	2.9	9.7	8.3	1.5	2.5	4.6	8.3	2.2	7.6	4.2	15.8	4.5	2.9	2.0	3.0	8.0	12.0	3.3	3.8	2.8	6.0	3.5	4.5	10.9	12.4	15.1	5.2	2.0	11.3	2.8	12.1	3.6	6.3	8.4	8.9	3.9	3.4	7.7	5.8	11.2	4.8	5.6	2.3	6.6	7.9	9.2	3.3	5.9	5.5	5.2	6.6	4.8	11.8	10.5	2.3	1.4	6.2	5.4	0.6	0.8	1.3	0.1	1.6	3.7	1.3	0.8	1.2	2.6	1.2	1.7	0.1	1.4	0.4	1.8	1.7	0.8	2.2	3.3	3.6	2.8	2.3	4.3	3.1	2.8	2.8	2.3	3.4	5.6	10.9	3.2	7.3	21.2	7.8	2.3	4.0	2.9	2.2	12.2	5.5	2.9	4.2	4.3	4.5	3.7	4.2	2.1	8.2	6.8	1.9	4.0	0.9	4.6	6.0	6.5	9.6	10.3	11.7	5.2	2.4	6.5	7.1	4.8	3.8	9.4	5.3	3.0	1.8	1.7	17.2	4.8	4.1	3.1	3.7	0.6	7.5	3.3	0.0	17.8	3.3	4.7	5.2	38.2	44.7	3.3	7.3	2.6	5.8	5.4	1.3	1.4	5.5	7.3	0.0	12.3	4.9	7.6	10.5	3.1	0.6	1.4	5.8	4.2	3.8	3.8
ZNF682	BC39498_3	ENSG00000197124	"Zinc finger protein 682"	O95780	19	19997058-20039505	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 22.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 14.4;AN3-CA: 21.8"									HPA055998	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA055998: AB_2683002"	"unprognostic (8.96e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.77e-3)"	"unprognostic (4.06e-7)"	"unprognostic (2.07e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.51e-4)"	2.0	2.5	4.0	2.4	4.5	2.1	3.4	4.5	7.2	2.7	1.9	2.4	1.5	2.4	3.5	3.3	3.0	2.2	6.2	4.5	5.2	5.1	4.1	3.7	3.9	4.3	4.4	2.0	3.0	3.0	4.1	3.0	4.4	4.8	2.5	3.2	1.8	4.0	3.4	6.5	2.9	1.3	3.6	4.0	3.0	3.3	4.1	3.1	8.0	1.6	4.5	3.5	3.1	6.0	0.0	0.0	14.4	21.8	1.1	1.5	0.6	3.1	1.4	5.1	8.1	2.5	3.1	0.1	5.2	4.4	1.5	2.6	5.9	0.5	5.7	0.0	6.3	0.0	0.1	1.6	2.0	0.0	5.1	2.1	1.7	2.8	0.0	0.8	0.0	5.7	0.0	0.1	3.9	4.3	8.7	1.3	7.9	0.0	1.9	5.3	7.5	0.1	2.7	9.7	7.9	8.5	0.0	2.8	0.0	7.8	5.4	2.9	0.0	7.5	1.2	12.7	5.4	0.0	9.0	1.4	0.0	0.0	2.4	7.1	0.4	0.9	2.5	0.5	1.8	4.1	3.7	2.0	1.5	2.7	4.0	4.1	1.5	1.4	0.7	1.3	4.2	1.3	4.0	4.5	4.5	7.2	4.5	5.2	4.3	4.4	4.4	3.6	4.1	6.0	5.2	9.6	15.1	7.2	7.0	3.4	2.1	0.6	5.2	5.4	4.6	5.2	10.3	4.3	4.6	3.7	0.0	6.8	8.2	2.7	5.9	4.0	1.8	1.8	2.9	4.4	1.2	4.4	9.8	7.5	6.8	3.5	2.6	3.0	2.5	5.9	5.0	3.0	2.9	3.3	10.1	2.8	0.0	3.5	2.7	0.9	1.8	2.3	1.8	6.5	0.6	4.0	5.2	6.6	22.2	4.8	1.2	4.5	3.1	1.5	1.7	3.8	1.5	2.3	0.0	3.1	3.4	4.3	4.2	3.7	3.4	2.5	6.9	9.2	2.1	2.5
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 473.7;Late spermatids: 482.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Group enriched"	"Detected in some"	8	"NB-4: 2.2;OE19: 4.8"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"	0.2	0.4	0.3	0.6	0.6	1.9	0.8	0.3	0.3	0.9	0.1	0.3	0.3	0.6	0.1	0.7	1.7	1.7	0.8	0.8	0.3	0.3	0.6	4.7	1.9	1.1	0.3	1.0	0.3	0.2	0.3	0.4	0.5	0.9	0.5	0.0	10.1	0.8	0.1	0.5	0.6	0.3	0.5	2.2	3.4	81.9	0.5	2.9	1.1	0.0	0.4	0.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.1	172.4	0.1	0.4	0.2	35.4	113.1	0.0	0.0	13.4	63.2	0.9	11.8	3.8	0.3	1.1	24.2	0.3	0.6	0.3	0.3	0.8	0.3	1.1	0.3	0.5	0.5	0.5	0.6	0.9	3.2	0.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	473.7	0.2	0.5	0.8	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	482.4	1.8	1.8	0.0	0.0	0.3	0.0	6.2	0.0	0.1	0.0	0.0	1.2	1.7	0.1	0.0	0.2	0.7	0.0	0.0	0.4	0.7	3.3	2.2	0.2	0.0	0.0	39.8	0.0	0.0	0.0
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531573-40548167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	2.4	3.7	1.7	2.2	2.6	6.4	3.0	2.0	3.3	1.7	2.2	2.8	2.3	2.4	2.8	1.7	1.7	2.4	7.7	1.5	1.8	6.9	12.4	2.5	3.3	2.3	2.2	2.6	2.6	3.3	1.2	1.5	2.6	1.8	3.4	2.1	2.5	1.4	3.3	2.9	1.9	2.3	1.4	3.1	3.2	3.2	2.3	3.4	3.8	2.8	2.7	1.7	1.4	3.9	2.9	0.9	3.6	4.8	3.2	4.8	2.1	2.6	2.5	3.2	5.4	1.7	3.7	5.0	2.1	1.7	2.1	3.5	3.6	2.7	4.9	4.4	6.3	5.4	3.2	4.9	1.7	5.7	5.7	3.0	1.0	3.8	1.5	1.8	4.6	4.0	2.9	6.9	4.5	0.9	8.6	6.6	8.8	1.3	2.8	4.1	10.3	3.6	4.7	2.5	2.5	4.4	4.7	4.5	5.2	4.7	2.0	36.0	2.8	2.9	6.3	3.1	5.1	5.8	4.8	5.9	2.6	5.9	4.8	4.1	1.9	1.0	3.0	4.1	1.6	3.5	2.0	1.7	1.2	1.5	1.3	2.6	1.0	1.9	2.2	1.9	2.6	1.3	1.7	2.6	2.0	3.3	1.5	1.8	2.3	2.2	2.6	1.4	2.3	3.9	4.9	6.4	3.2	10.4	6.8	2.3	1.6	2.2	4.6	3.4	2.0	2.8	13.0	5.7	2.9	7.3	0.0	1.2	7.2	3.2	17.6	5.7	6.5	1.6	3.2	5.0	1.2	4.2	7.8	14.7	2.5	4.2	1.5	1.8	2.5	4.6	4.2	15.8	4.8	3.3	7.9	2.2	4.1	4.2	2.3	3.7	2.5	4.2	8.8	5.6	6.3	4.3	4.1	12.5	16.1	6.4	2.0	3.0	3.2	1.0	1.1	17.3	4.3	2.6	0.0	5.8	4.8	8.7	4.6	1.7	1.3	0.0	5.9	5.3	3.2	1.5
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292176	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.5;monocytes: 4.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	8.5	10.9	9.0	8.2	9.9	31.2	8.7	12.6	10.2	9.9	6.9	10.7	8.6	10.5	5.5	11.0	9.7	7.0	8.9	8.5	8.4	10.2	9.7	8.6	10.1	10.5	9.6	11.7	16.0	14.1	13.0	7.1	9.5	11.3	5.7	9.4	12.0	8.6	10.9	12.3	11.3	6.1	8.9	14.4	10.8	14.5	9.7	9.3	10.8	6.9	7.5	10.4	8.7	10.5	14.8	21.5	20.4	12.6	11.3	9.5	26.3	7.6	12.9	13.8	13.1	18.1	19.6	12.6	18.7	12.3	14.7	22.3	18.1	15.2	6.1	17.3	18.3	11.9	18.8	20.1	12.1	14.3	16.7	14.7	15.3	11.6	12.1	12.3	9.4	13.4	19.5	22.6	7.8	44.8	19.2	16.8	27.6	19.8	16.5	16.9	16.1	22.8	11.6	22.1	18.5	27.7	20.8	24.6	19.7	19.2	32.2	30.1	9.2	11.0	12.1	13.9	11.6	26.2	24.1	31.3	14.0	9.4	14.2	0.5	1.8	13.5	0.5	2.3	0.5	1.0	0.5	0.4	0.9	1.1	0.7	0.8	8.8	0.4	4.5	0.8	0.4	1.2	9.0	9.9	12.6	10.2	8.5	8.4	10.5	9.6	9.5	8.9	9.7	10.5	4.3	3.2	4.6	3.6	5.8	4.7	2.8	4.9	5.7	6.7	6.0	5.5	1.4	10.0	3.5	1.8	10.4	6.7	3.8	9.3	3.9	5.5	3.1	4.3	3.7	4.4	2.4	3.0	1.6	6.0	5.3	4.2	7.7	5.3	0.0	8.5	2.9	4.5	5.3	8.4	1.9	5.6	8.2	5.2	4.1	2.8	6.2	5.8	0.0	2.8	6.0	5.2	5.2	3.0	1.7	7.3	3.5	7.2	5.8	4.7	10.2	4.1	3.4	10.8	13.1	4.4	3.9	6.9	6.8	4.3	3.4	9.4	4.3	6.5	7.3	5.1
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569672-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 180.3;Late spermatids: 576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	8.7	8.4	17.6	9.8	17.5	11.4	5.1	20.5	19.1	6.7	16.4	9.7	14.6	7.8	5.6	5.6	10.4	4.2	7.0	16.5	15.8	8.2	8.3	7.5	9.5	17.5	16.9	9.1	12.3	9.7	8.4	3.3	17.2	7.5	6.4	5.6	10.1	6.9	25.6	9.0	11.6	5.8	16.2	12.0	10.1	13.6	18.1	8.2	5.1	9.7	5.4	6.6	5.7	20.2	10.4	9.5	7.3	8.1	13.3	5.2	3.1	6.7	8.2	5.0	4.0	2.5	15.1	6.2	12.8	6.9	6.0	8.6	2.2	3.6	4.7	16.7	6.4	3.8	3.7	2.7	6.3	4.3	17.9	8.7	8.2	5.3	6.0	7.7	4.7	7.7	3.9	12.0	5.3	13.5	14.9	9.9	3.3	8.6	4.9	13.3	3.8	9.2	8.2	3.2	12.1	13.2	2.4	14.1	15.3	2.0	15.6	7.8	5.4	5.5	4.0	5.2	4.7	20.5	13.2	5.7	12.2	4.3	9.7	12.0	4.6	11.0	6.2	4.2	5.4	6.5	6.6	6.8	4.2	7.6	5.7	5.0	5.3	20.4	6.5	7.4	11.2	3.3	17.6	17.5	20.5	19.1	16.5	15.8	17.5	16.9	17.2	16.2	18.1	20.2	16.3	6.4	3.1	5.9	22.8	6.4	10.5	12.6	16.5	19.8	20.3	22.7	11.2	22.8	10.2	16.5	18.8	7.5	26.0	38.6	49.0	24.8	180.3	25.4	9.5	14.0	20.4	11.2	5.1	31.2	9.6	15.6	17.9	9.0	5.1	12.1	20.7	22.6	24.4	21.9	5.1	27.7	12.2	33.1	12.0	576.6	19.9	17.4	17.8	1.9	28.3	31.2	30.9	9.0	10.3	21.8	37.2	19.9	16.7	10.1	59.2	54.1	38.4	27.4	6.6	17.2	20.2	34.5	8.5	11.2	7.1	4.7	23.2	15.1	23.6	8.5
ZNF689	"FLJ90415, TIPUH1"	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	3.5	3.5	3.4	3.5	3.5	6.6	10.2	3.4	3.7	4.3	2.4	4.5	4.8	5.4	2.7	2.3	4.1	2.9	3.7	3.3	3.4	3.2	4.3	3.5	4.1	3.4	3.3	5.4	4.8	7.1	3.5	3.2	3.1	3.6	3.1	2.8	3.4	4.7	5.1	2.6	4.3	4.1	3.3	4.7	3.8	19.5	3.4	5.9	3.9	5.5	4.0	4.2	3.0	3.6	4.6	8.1	11.1	11.6	4.7	4.6	5.5	5.6	8.2	9.0	8.7	9.5	3.5	13.2	8.6	5.0	6.5	3.5	14.0	6.1	7.1	10.9	23.6	11.2	7.1	14.7	5.0	11.1	8.2	4.4	5.7	6.2	6.1	4.9	6.4	12.0	13.4	7.4	5.8	6.9	20.6	10.4	12.6	3.6	8.2	25.7	10.7	11.9	3.8	4.5	13.8	8.4	4.1	7.4	6.4	5.5	7.7	9.6	5.0	11.6	4.9	5.6	7.8	13.6	16.8	15.7	4.2	12.0	11.5	0.1	6.2	2.5	5.1	9.3	3.7	3.8	4.2	5.2	8.9	2.9	3.6	3.5	0.4	8.8	10.3	3.2	4.5	4.4	3.4	3.5	3.4	3.7	3.3	3.4	3.4	3.3	3.1	3.3	3.4	3.6	10.5	3.2	2.0	1.3	8.4	1.7	4.9	2.6	1.8	10.0	25.4	20.7	4.7	11.5	1.2	1.8	6.2	4.3	10.2	5.9	0.0	6.2	53.0	2.3	5.7	8.6	6.0	6.1	2.4	6.9	3.2	6.3	3.6	3.3	14.0	8.0	8.6	6.9	5.1	10.1	2.7	6.5	6.1	8.6	4.3	52.0	8.1	6.6	0.0	3.7	6.9	5.8	8.2	2.0	3.0	5.2	4.8	10.5	6.6	5.5	7.9	4.3	1.5	6.1	0.0	11.5	5.8	87.7	8.9	2.1	1.0	0.8	8.8	6.6	6.6	3.0
ZNF69	Cos5	ENSG00000198429	"Zinc finger protein 69"	Q9UC07	19	11887782-11914329	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Late spermatids: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.8"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.08e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.83e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.93e-2)"	2.6	5.0	2.0	2.7	1.8	2.6	3.3	2.1	2.1	5.1	8.2	7.8	2.2	2.7	2.5	0.9	5.5	4.4	2.6	2.4	2.1	9.4	8.8	3.2	2.2	3.1	2.8	6.9	7.5	14.6	2.0	2.4	2.8	4.8	8.0	1.4	4.1	2.2	1.0	1.3	3.5	1.2	1.3	2.2	9.0	4.8	2.0	3.6	3.3	0.9	1.9	3.8	2.1	2.1	5.6	0.1	13.8	8.0	1.5	0.1	4.8	8.2	5.7	4.4	5.5	3.7	2.2	3.5	4.7	4.7	3.5	0.1	0.1	3.1	4.6	0.1	0.1	1.6	0.2	8.0	1.1	0.0	3.3	2.2	0.0	1.6	0.2	2.1	0.1	4.9	0.0	0.2	9.2	0.1	4.3	0.8	8.6	0.5	0.0	0.1	3.1	0.1	10.4	3.9	1.3	3.9	0.0	0.2	1.8	6.6	7.3	2.3	0.4	3.6	2.4	3.7	4.6	3.7	3.6	0.1	0.1	0.0	11.3	12.6	1.5	1.1	1.7	1.5	1.7	0.8	1.2	0.7	1.7	0.5	3.2	3.3	0.7	2.5	0.9	1.2	1.0	1.5	2.0	1.8	2.1	2.1	2.4	2.1	3.1	2.8	2.8	1.3	2.0	2.1	1.4	3.2	10.9	11.8	0.6	0.3	1.3	2.5	1.2	0.7	2.6	2.3	2.4	18.6	4.9	5.5	0.0	3.6	1.1	2.9	3.9	6.8	8.8	6.5	2.4	2.6	0.0	10.7	11.4	3.5	3.2	1.6	13.3	2.4	7.6	8.3	5.0	11.9	2.8	0.0	5.6	5.7	0.0	3.1	1.2	24.2	2.5	2.6	5.4	8.4	0.9	0.9	0.0	14.6	6.0	10.1	3.7	1.9	1.6	1.2	2.0	11.3	3.9	0.2	13.1	0.9	1.8	4.3	4.3	0.5	0.1	1.9	1.4	2.1	4.9	2.8
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	5.9	9.8	11.0	8.8	11.9	2.3	11.2	11.4	14.4	11.1	11.7	9.7	6.5	9.9	15.1	6.1	9.9	6.1	9.1	10.6	11.7	11.6	18.2	7.3	13.0	12.3	11.5	13.0	8.9	13.6	9.2	9.3	12.1	10.5	7.2	11.3	9.8	11.0	8.0	9.5	7.5	9.5	11.1	12.1	7.7	6.7	12.3	15.5	12.1	9.9	12.7	9.0	7.0	12.6	6.6	9.1	18.1	15.0	16.0	12.2	2.3	7.7	9.3	12.4	12.3	6.5	9.5	16.2	11.8	7.3	6.2	11.5	17.6	10.3	10.6	29.3	17.8	17.0	27.2	11.7	11.9	6.6	3.5	10.6	12.3	15.6	12.7	15.1	12.8	15.8	16.8	6.9	12.3	5.3	19.8	8.7	27.1	7.2	6.8	13.2	22.8	11.2	11.6	6.2	13.0	12.9	7.9	14.2	13.3	26.9	7.8	22.2	6.7	12.3	12.8	7.0	8.6	16.5	14.0	4.7	8.6	7.8	10.6	24.5	12.7	19.2	12.9	11.5	17.0	17.2	17.4	17.8	12.7	23.4	16.8	16.6	6.9	21.3	12.4	14.1	23.1	14.8	11.0	11.9	11.4	14.4	10.6	11.7	12.3	11.5	12.1	11.1	12.3	12.6	3.6	6.4	2.7	2.6	4.1	1.8	2.7	4.1	2.8	2.5	4.5	5.6	6.5	10.0	2.7	5.5	4.2	6.5	1.4	1.4	7.9	5.5	6.8	1.2	3.3	5.1	3.0	3.0	2.0	3.8	5.3	4.3	3.1	1.2	5.1	5.3	5.0	7.6	6.8	1.7	2.3	2.8	6.1	4.1	1.2	3.2	7.2	3.0	1.8	3.7	3.1	6.4	5.2	5.0	4.1	2.3	3.2	7.2	2.3	3.2	3.5	9.6	3.2	4.2	0.0	2.3	3.2	10.4	7.4	3.1	0.9	3.3	3.3	5.3	2.4	1.2
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	13.0	16.5	35.1	4.7	36.3	7.5	16.3	36.3	48.5	26.6	34.1	20.1	5.1	17.1	8.2	23.2	25.3	4.9	18.0	35.0	34.7	27.0	21.7	12.5	6.2	36.5	35.5	27.6	28.2	7.4	29.1	4.2	37.7	34.9	3.6	8.5	17.8	5.3	17.7	18.7	16.6	3.8	34.1	23.5	19.7	38.9	35.7	7.0	24.7	4.7	4.4	21.3	20.8	36.8	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	35.1	36.3	36.3	48.5	35.0	34.7	36.5	35.5	37.7	34.1	35.7	36.8	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 3.2;Extravillous trophoblasts: 4.7;Spermatocytes: 3.5;Spermatogonia: 2.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.0	0.0	0.2	0.1	0.2	0.8	0.3	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.2	7.1	0.8	4.2	10.7	0.1	0.1	11.1	2.4	0.1	3.2	4.3	7.3	0.4	5.6	4.4	1.2	2.8	2.2	12.2	0.6	3.7	0.0	4.0	3.8	1.5	4.5	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.3	7.3	5.2	0.0	3.4	2.7	8.2	4.1	7.8	6.8	4.3	4.5	9.7	0.0	0.8	3.8	3.7	6.5	3.4	2.8	1.2	4.0	3.0	5.2	0.6	0.5	6.0	3.2	0.0	0.7	2.2	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.8	1.1	0.5	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.3	0.9	0.9	0.5	0.3	0.0	2.1	0.0	0.0	4.7	0.4	1.5	1.4	0.0	2.0	0.4	0.2	1.4	0.0	0.0	2.1	0.0	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	3.5	2.8	2.0	0.1	1.1	0.0	0.3	1.7	0.2
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143299952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	4.0	3.3	3.9	3.3	3.7	3.5	3.2	5.9	6.1	3.4	0.0	3.3	6.0	4.5	2.5	2.6	3.4	2.1	2.8	4.2	2.5	3.3	4.6	2.8	3.8	5.6	3.0	4.7	5.0	4.3	3.2	2.7	5.0	3.1	1.9	3.6	5.7	2.3	3.9	6.6	3.7	2.3	0.9	4.0	3.3	3.5	3.4	2.1	3.7	2.4	3.0	3.7	2.8	4.9	8.2	7.4	7.8	8.8	3.2	2.5	14.9	6.3	2.4	4.4	2.7	4.3	6.3	0.7	8.2	2.5	2.5	5.8	8.5	3.8	4.5	9.1	17.9	10.8	8.8	6.7	3.4	4.5	13.5	2.4	6.1	3.0	6.8	3.3	2.2	6.4	22.2	5.3	3.1	17.3	4.6	8.8	10.2	9.7	17.1	9.8	4.4	8.1	3.0	6.3	11.6	16.1	9.3	6.7	8.2	5.3	10.3	8.1	4.5	6.2	13.4	5.5	10.9	9.7	7.3	10.0	4.2	9.2	7.5	1.2	2.0	1.7	2.9	1.1	3.0	2.4	2.1	3.1	2.1	3.2	3.9	3.5	1.2	3.5	2.0	3.8	0.7	1.9	3.9	3.7	5.9	6.1	4.2	2.5	5.6	3.0	5.0	0.9	3.4	4.9	2.2	0.0	0.0	3.6	3.0	2.9	2.3	0.6	0.0	5.3	1.5	1.3	2.8	2.8	0.3	3.7	6.2	1.7	1.8	2.1	3.9	2.4	1.2	0.8	2.3	2.5	0.0	1.3	3.4	2.0	1.8	1.9	2.0	1.0	0.0	2.9	2.2	2.2	1.2	3.3	3.9	1.0	2.0	0.9	0.7	2.4	4.1	0.7	1.8	1.0	0.9	1.8	6.2	4.5	3.1	1.5	0.3	1.2	2.3	1.7	2.7	1.9	0.3	4.5	6.6	1.7	2.2	3.0	5.7	1.1	2.0	0.4	2.5	2.7	2.0	0.6
ZNF697	MGC45731	ENSG00000143067	"Zinc finger protein 697"	Q5TEC3	1	119619377-119648266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.0;Syncytiotrophoblasts: 19.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 14.4"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3;cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.8;WM-115: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049933	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA049933: AB_2680958"	"unprognostic (2.57e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.20e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.36e-1)"	4.1	2.9	0.9	1.4	3.3	1.0	3.4	0.0	3.2	1.5	0.0	1.3	1.7	2.2	2.3	0.8	1.4	1.5	4.3	1.5	0.0	7.5	3.1	4.4	0.6	0.0	0.0	2.0	2.8	4.9	2.8	6.9	0.0	4.2	1.4	0.9	5.4	1.0	2.1	1.6	1.5	1.2	0.0	1.4	1.8	3.1	0.2	0.5	3.2	1.9	0.4	2.0	1.0	0.0	2.0	1.0	4.9	1.6	6.4	7.0	6.6	8.8	12.2	5.1	4.6	3.1	0.4	0.0	2.9	4.9	4.0	2.2	3.8	8.7	11.9	0.0	3.8	3.3	2.0	5.9	12.2	2.2	2.2	11.9	2.4	11.4	24.2	5.6	10.1	2.8	3.0	0.4	2.3	1.5	0.0	1.6	26.1	1.8	2.9	0.0	11.8	0.2	2.4	4.5	1.1	6.8	2.0	2.1	42.8	15.4	1.0	3.1	23.4	8.4	10.7	6.0	15.4	1.2	2.0	0.0	11.9	2.3	42.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.3	0.0	3.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.5	1.3	0.1	2.2	1.5	2.5	0.6	0.8	1.7	0.6	8.8	1.5	1.9	1.8	0.0	7.9	0.0	0.7	3.9	1.8	1.6	1.1	2.6	3.5	2.4	0.0	17.0	0.9	2.3	4.3	1.5	1.8	0.0	5.5	3.3	4.2	2.6	0.0	6.9	2.1	4.1	3.7	12.0	3.6	4.7	3.1	5.4	4.7	2.7	1.1	0.0	8.0	0.6	2.1	3.3	6.4	0.0	3.7	1.8	6.4	0.4	0.9	6.6	0.5	5.4	1.3	1.5	0.4	1.8	19.8	0.1	5.3	1.8	0.9
ZNF699	"FLJ38144, hang"	ENSG00000196110	"Zinc finger protein 699"	Q32M78	19	9291140-9309838	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 12.4;hTERT-HME1: 12.3;U-138 MG: 14.1"									HPA058287	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA058287: AB_2683669"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.10e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.07e-1)"	1.5	1.4	1.2	1.7	1.1	2.1	2.2	2.6	1.2	2.2	1.1	1.2	1.5	2.7	2.0	1.4	1.7	1.6	1.4	1.3	1.4	1.6	1.0	1.9	2.5	1.2	1.1	3.7	1.2	3.0	0.8	1.4	1.1	1.9	1.4	3.3	1.2	1.7	0.7	1.7	1.1	1.9	0.9	2.2	1.5	0.9	1.6	2.6	2.3	1.4	2.4	1.3	0.9	1.5	2.0	0.8	3.0	3.2	1.9	2.5	1.5	2.5	3.2	6.3	6.5	0.8	0.7	1.6	1.3	3.4	2.0	1.0	2.0	7.8	12.4	2.0	0.8	2.0	1.3	0.5	2.1	0.5	2.4	3.3	2.1	6.7	12.3	3.2	1.5	3.7	1.2	3.6	8.8	0.6	2.6	2.7	0.9	0.1	2.2	1.2	8.2	0.4	1.1	3.1	1.5	1.4	6.1	0.3	2.7	1.9	1.0	1.2	1.5	14.1	11.2	1.8	6.5	1.1	0.3	2.6	1.4	1.5	3.3	0.7	0.3	1.9	1.0	0.5	0.8	1.0	0.9	0.8	0.6	0.7	1.3	0.8	0.8	0.6	0.8	0.3	0.5	0.5	1.2	1.1	2.6	1.2	1.3	1.4	1.2	1.1	1.1	0.9	1.6	1.5	5.0	3.2	0.5	2.0	8.3	2.0	6.2	2.3	6.8	8.3	2.2	3.3	1.6	1.5	6.4	1.8	8.4	0.6	13.6	1.2	0.0	1.0	0.1	1.1	5.0	3.4	1.2	1.3	4.4	1.0	1.2	3.9	2.6	2.8	1.3	3.4	3.9	0.7	1.2	5.0	4.3	0.2	8.2	1.9	2.9	0.4	2.1	4.1	3.6	5.6	3.7	5.1	15.5	6.0	3.8	1.6	1.5	4.1	6.1	3.2	2.4	0.8	0.4	13.5	0.0	3.8	4.7	3.7	2.3	3.2	2.4	1.0	12.2	1.9	0.7	4.1
ZNF7	"HF.16, KOX4"	ENSG00000147789	"Zinc finger protein 7"	P17097	8	144827464-144847509	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059090	Approved		Approved	Mitochondria		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA059090: AB_2683901"	"unprognostic (1.11e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.46e-8)"	"unprognostic (1.15e-1)"	"unprognostic (5.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (6.53e-2)"	18.4	14.1	10.4	10.7	11.0	14.4	18.3	18.6	12.8	20.2	10.7	18.2	10.4	18.0	15.2	14.8	17.5	10.5	14.3	10.5	9.8	18.3	15.5	14.5	15.0	11.6	10.8	19.4	17.4	15.3	16.8	14.3	11.1	20.5	12.7	13.9	16.4	13.6	26.6	21.1	17.2	12.7	9.0	21.7	15.2	17.0	11.2	15.9	19.3	17.5	15.6	18.3	17.2	13.4	16.7	22.2	21.4	21.1	17.9	27.2	19.6	17.4	22.0	23.1	19.7	11.4	20.9	23.1	19.9	19.0	12.6	14.2	19.5	25.4	25.1	15.4	16.2	41.3	30.6	13.3	20.7	12.1	18.5	26.1	30.3	18.1	44.2	22.4	14.5	19.2	41.9	16.1	26.0	27.3	33.0	13.1	21.8	22.0	26.6	22.6	19.0	18.4	16.1	22.6	21.0	25.6	38.1	21.6	21.3	20.4	26.1	19.1	16.4	17.3	30.9	13.2	16.9	13.0	9.9	25.0	18.0	15.4	21.7	34.3	10.7	10.9	13.5	10.0	16.9	18.1	15.4	12.0	12.2	17.4	20.1	13.8	10.4	16.6	19.2	9.6	16.3	9.2	10.4	11.0	18.6	12.8	10.5	9.8	11.6	10.8	11.1	9.0	11.2	13.4	11.9	19.2	11.6	6.2	16.4	7.0	18.2	12.7	8.6	34.2	9.1	8.0	11.4	7.2	11.3	3.7	29.2	17.3	16.6	6.6	5.9	14.1	18.4	6.3	10.4	10.6	9.6	15.6	11.3	11.2	12.9	14.7	10.2	7.7	3.8	16.7	15.0	8.2	9.1	28.6	10.7	9.1	6.1	9.0	11.1	4.9	17.7	10.2	8.8	3.7	12.9	20.0	22.6	10.6	11.4	13.7	5.6	15.8	7.8	18.6	12.4	7.1	9.2	30.1	6.6	19.3	10.4	44.1	26.7	9.1	9.2	19.4	16.9	19.8	10.2	13.8
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738682-23751112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	1.4	1.2	1.0	1.3	1.4	1.6	1.3	2.8	1.1	1.9	2.2	1.4	0.8	1.9	2.3	0.8	1.9	1.1	1.6	0.9	1.0	1.0	0.7	1.2	1.4	2.0	1.4	3.9	1.8	2.1	1.6	1.2	1.1	1.5	1.2	3.0	2.0	1.5	2.6	1.1	1.2	1.6	0.8	1.4	1.3	1.2	1.6	1.2	1.8	2.1	1.6	1.4	1.3	2.5	1.2	1.5	2.9	3.0	4.2	2.0	0.9	1.1	2.2	2.5	3.5	1.5	0.8	1.7	0.7	2.4	1.6	1.3	2.0	1.5	3.1	1.1	1.8	3.3	3.0	1.3	2.5	3.0	2.7	2.0	0.9	3.3	2.7	3.2	2.0	1.3	1.2	2.4	1.8	1.6	1.7	1.4	0.7	1.1	0.6	7.2	2.8	0.4	0.9	1.6	1.6	2.0	1.6	2.0	1.2	2.0	1.0	1.4	2.6	2.7	3.4	1.8	1.2	2.4	0.4	1.5	2.4	1.3	2.4	1.5	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.3	0.8	0.5	0.2	0.4	0.1	0.1	1.0	1.4	2.8	1.1	0.9	1.0	2.0	1.4	1.1	0.8	1.6	2.5	1.2	0.0	2.8	0.7	1.0	0.4	1.1	0.0	1.2	3.8	1.1	1.4	2.6	2.8	1.8	3.7	10.4	0.4	2.1	0.3	0.0	1.1	1.4	1.6	3.9	1.7	1.2	0.8	0.8	1.1	0.6	3.2	0.5	1.0	1.3	3.8	4.2	0.5	0.8	6.7	1.2	0.6	0.0	1.6	0.6	3.3	6.2	1.0	0.0	0.0	0.8	2.1	0.0	0.0	1.6	0.4	0.0	4.1	1.5	0.7	0.8	0.9	3.6	4.0	6.6	5.4	2.7	2.7	2.5	1.0	0.0	0.3	1.2	2.8	0.7	0.9
ZNF700	DKFZp434I1610	ENSG00000196757	"Zinc finger protein 700"	Q9H0M5	19	11925068-11950773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA047845	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (8.63e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (9.02e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (8.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.53e-5)"	12.1	12.2	4.2	6.5	4.3	17.0	12.4	5.8	5.3	12.7	4.9	15.1	6.1	9.3	8.6	13.7	10.3	4.7	7.7	4.1	4.2	19.4	21.0	13.9	10.4	4.4	4.5	13.9	19.1	7.9	11.2	5.0	4.6	13.8	10.8	9.6	12.2	4.6	5.2	16.6	18.0	4.7	4.2	23.4	14.1	11.3	4.5	8.4	12.3	3.1	11.2	11.6	13.8	4.9	8.0	0.4	8.4	8.7	5.2	5.7	8.5	8.4	7.2	7.4	9.7	6.6	3.9	10.6	7.2	5.4	5.0	6.2	6.9	6.1	10.2	6.0	3.6	11.0	8.2	5.9	4.4	15.6	15.5	4.7	7.1	6.3	7.1	5.0	4.7	6.9	12.4	23.0	10.8	6.5	8.7	14.3	8.6	4.8	7.7	7.3	11.1	8.2	10.5	9.2	4.9	5.9	7.6	5.0	10.1	7.6	8.7	17.7	6.8	18.9	4.9	13.0	9.8	15.9	9.0	10.9	5.0	12.7	6.3	4.8	2.3	4.7	3.2	2.5	3.7	3.2	2.6	4.0	3.2	1.9	2.5	3.2	3.7	3.2	4.4	2.1	3.4	1.9	4.2	4.3	5.8	5.3	4.1	4.2	4.4	4.5	4.6	4.2	4.5	4.9	5.4	9.6	14.1	12.1	7.6	3.1	1.7	2.2	3.4	2.3	5.0	3.9	4.1	8.6	7.4	1.8	2.1	5.2	7.4	9.4	1.9	5.8	0.6	2.2	2.9	5.1	3.0	3.8	15.0	4.5	4.6	2.7	8.2	2.6	16.4	6.5	6.1	7.3	4.5	0.0	13.4	7.7	6.1	7.8	5.0	1.5	4.4	6.8	5.4	30.0	3.9	2.4	9.2	13.0	17.9	5.3	9.7	1.9	3.0	1.9	5.5	2.1	3.7	4.8	0.0	2.6	5.5	11.5	6.8	3.0	1.7	3.7	6.5	3.0	9.1	1.4
ZNF701	FLJ10891	ENSG00000167562	"Zinc finger protein 701"	Q9NV72	19	52555457-52587174	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 28.6"									HPA005532	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centriolar satellite"	"HPA005532: AB_1080746"	"unprognostic (1.21e-1)"	"unprognostic (4.98e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.46e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.17e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.89e-5)"	5.1	4.1	3.9	6.4	5.6	10.1	7.9	6.7	4.5	5.7	7.4	5.6	5.0	5.7	7.2	4.3	6.2	5.0	5.7	4.8	4.2	6.3	2.7	5.7	8.0	5.3	4.4	6.2	4.7	6.2	4.4	7.6	6.0	6.5	6.7	6.3	5.8	4.7	5.7	7.3	6.4	4.7	3.2	7.3	6.4	6.1	4.9	9.3	9.4	5.7	7.1	5.5	5.7	8.3	2.3	0.3	5.0	8.9	5.5	6.5	9.2	5.9	5.8	7.8	8.1	4.6	5.5	11.0	3.3	4.6	7.6	3.5	2.3	6.3	8.3	0.4	6.6	3.0	9.3	1.1	5.6	0.4	14.1	6.8	5.0	6.0	10.1	4.0	7.4	5.8	15.0	1.4	7.2	1.8	11.3	5.2	4.8	2.9	8.0	11.8	6.6	4.6	6.2	28.6	4.9	5.4	3.9	10.1	3.1	10.1	12.9	6.2	7.3	6.2	3.1	3.0	10.7	1.1	7.1	14.4	0.2	12.4	10.1	21.6	9.0	18.1	9.3	9.8	7.9	9.2	7.3	8.2	6.7	9.0	8.5	9.1	23.0	14.2	7.7	6.6	9.1	7.0	3.9	5.6	6.7	4.5	4.8	4.2	5.3	4.4	6.0	3.2	4.9	8.3	7.2	0.0	6.1	4.6	11.1	2.2	6.7	6.0	0.6	5.4	6.3	7.6	4.8	4.3	7.7	14.7	14.6	13.5	13.8	8.9	3.9	6.8	2.3	9.2	7.8	7.3	2.4	5.2	2.1	3.9	9.7	5.5	5.6	9.7	2.5	13.6	6.4	0.6	5.3	3.3	2.4	6.2	8.2	5.5	8.2	1.2	6.2	6.8	3.6	3.7	9.9	3.8	15.5	3.5	5.9	5.5	8.8	3.8	3.0	8.2	13.1	3.7	9.7	6.0	0.0	3.7	7.0	3.8	10.8	3.0	3.7	23.5	9.9	7.2	3.8	11.7
ZNF703	"FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1"	ENSG00000183779	"Zinc finger protein 703"	Q9H7S9	8	37695782-37700019	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.3;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	12	"monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 156.8;OE19: 61.2;SK-MEL-30: 60.0;T-47d: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023930, CAB068249"	Supported					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB068249: AB_2665667, HPA023930: AB_1859425"	"unprognostic (4.64e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (5.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.23e-1)"	24.6	14.4	16.6	7.6	15.0	1.9	27.4	10.7	16.9	39.9	9.8	46.9	15.1	27.8	12.7	18.2	33.2	6.2	18.8	14.2	10.3	8.1	4.2	10.7	4.1	21.8	17.9	19.6	8.7	1.9	5.9	12.1	16.4	21.7	12.6	0.4	18.3	8.7	108.4	57.4	25.9	11.6	15.0	18.9	22.8	2.9	14.7	2.8	10.6	33.3	2.9	36.8	28.7	10.7	3.2	6.6	0.8	5.2	15.1	7.9	5.2	29.1	13.6	8.8	7.4	27.2	36.0	0.0	7.2	18.4	4.0	17.2	3.0	4.4	6.8	0.8	156.8	0.0	9.5	17.5	14.9	0.0	3.0	26.6	8.2	9.1	3.7	19.0	7.8	0.3	0.4	0.0	14.1	27.4	0.1	0.8	2.6	61.2	11.6	2.7	4.7	3.7	2.7	14.2	2.9	0.2	5.4	4.6	60.0	6.2	52.6	3.1	23.1	10.3	23.7	16.1	12.3	1.9	0.1	0.2	9.1	3.2	6.7	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	16.6	15.0	10.7	16.9	14.2	10.3	21.8	17.9	16.4	15.0	14.7	10.7	11.9	6.4	0.0	14.7	15.3	48.2	13.2	28.9	103.0	3.7	39.3	27.8	9.1	2.8	14.5	5.5	0.0	41.4	7.7	52.0	3.9	7.1	0.4	30.8	37.0	9.5	79.6	0.0	1.5	2.5	37.2	36.0	14.8	20.3	0.0	5.8	2.5	2.2	36.2	0.0	2.8	95.4	10.2	23.6	31.9	0.7	31.4	31.2	33.8	11.2	7.9	9.3	0.0	0.0	0.6	3.7	56.9	15.8	1.9	9.7	35.4	2.8	7.7	0.9	52.6	54.9	66.4	0.0	0.6	99.7	74.6	434.1	6.0	6.1	92.6	10.7
ZNF704	"FLJ16218, Gig1"	ENSG00000164684	"Zinc finger protein 704"	Q6ZNC4	8	80628451-80874781	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 170.8;Oligodendrocyte precursor cells: 299.6;Oligodendrocytes: 342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 72.8;RH-30: 46.0;SH-SY5Y: 58.4;SK-BR-3: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024285, HPA024302"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA024285: AB_2219847, HPA024302: AB_1859427"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.90e-2)"	9.9	5.3	14.6	1.8	18.3	0.7	8.5	27.5	12.0	18.7	0.0	7.3	2.8	16.9	7.2	3.0	13.3	6.3	12.2	12.0	9.7	9.2	3.7	7.5	1.4	14.4	14.4	19.8	20.0	13.8	2.2	5.1	12.8	10.2	6.1	2.5	14.9	8.3	6.5	5.0	4.7	7.2	10.7	3.2	5.2	4.4	14.3	6.9	6.0	7.9	1.1	6.4	7.6	29.9	0.0	2.6	11.5	0.1	0.0	0.0	15.7	0.1	0.0	0.1	0.0	1.3	1.9	0.1	4.5	0.0	0.9	72.8	1.1	2.0	0.0	0.0	12.1	4.3	5.7	9.8	0.0	0.8	0.3	0.4	0.1	0.0	0.3	0.1	4.7	0.6	0.0	0.4	0.1	7.6	11.2	0.2	1.0	6.3	1.1	7.7	46.0	0.2	0.0	25.4	14.5	58.4	2.3	72.2	21.3	3.8	11.6	1.6	0.2	0.0	11.8	0.2	2.5	0.1	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.6	18.3	27.5	12.0	12.0	9.7	14.4	14.4	12.8	10.7	14.3	29.9	31.6	51.3	25.9	63.0	0.4	18.5	25.5	4.8	16.5	21.3	28.6	23.4	35.0	21.5	16.5	25.8	0.0	8.8	1.1	20.7	5.9	21.6	20.0	25.5	52.6	21.9	13.8	3.8	112.8	24.5	6.5	40.1	10.7	35.9	27.8	28.7	30.0	10.6	3.2	20.2	170.8	24.7	8.2	5.7	15.7	46.8	32.9	3.6	32.0	56.2	0.0	17.0	0.0	299.6	342.4	9.4	26.5	25.6	0.2	34.7	17.9	18.1	12.8	3.1	13.1	45.1	29.5	1.8	4.2	5.4	5.1	2.9	3.4	60.3	26.2	36.2
ZNF707		ENSG00000181135	"Zinc finger protein 707"	Q96C28	8	143684452-143713898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 19.7;NK-cells: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA044991	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA044991: AB_10961134"	"unprognostic (5.12e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.73e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.08e-2)"	3.3	3.3	1.0	1.8	1.1	1.7	3.4	0.7	1.3	4.0	1.3	3.5	1.5	3.8	1.8	3.7	3.3	1.3	3.0	0.9	0.9	4.9	3.4	3.9	2.6	1.0	0.9	2.9	4.2	1.7	3.7	1.1	0.9	4.1	0.8	0.9	3.8	1.1	1.8	5.9	4.2	1.0	0.7	8.0	3.5	7.4	1.1	2.1	4.5	1.4	1.8	3.6	3.5	1.3	1.7	2.2	2.4	2.6	2.4	2.2	2.4	2.5	1.7	2.7	1.3	1.5	2.4	1.6	2.7	1.6	1.2	2.1	2.5	2.9	1.7	3.3	0.9	4.3	5.7	2.3	1.6	1.1	2.0	2.3	3.3	3.6	2.2	2.3	2.4	2.0	2.0	1.6	0.7	3.6	4.5	1.3	0.1	1.8	3.8	3.0	1.5	1.6	1.4	1.5	1.8	2.1	3.3	2.3	3.0	1.6	3.0	2.3	3.8	1.6	5.5	2.0	3.8	3.3	1.4	0.7	2.3	2.4	1.2	0.3	0.2	0.4	0.5	0.1	0.4	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.3	0.9	0.1	0.3	0.4	0.2	1.0	1.1	0.7	1.3	0.9	0.9	1.0	0.9	0.9	0.7	1.1	1.3	2.4	0.0	1.5	2.9	3.6	2.8	2.7	2.4	5.2	2.7	2.2	1.8	1.9	0.0	2.0	3.7	0.0	2.1	5.6	2.8	3.9	1.9	19.7	1.4	1.8	1.5	0.0	0.4	1.9	1.3	2.5	1.6	2.0	2.5	1.3	3.6	3.3	1.1	1.9	1.7	1.2	1.8	0.0	3.5	4.3	5.3	1.2	2.4	0.0	1.9	5.2	0.6	12.3	1.0	1.2	1.7	2.1	2.2	4.3	2.2	1.9	0.9	1.6	3.4	6.6	1.0	1.5	4.3	3.1	2.3	3.1	2.6	4.8	2.6	1.6	2.2
ZNF709	FLJ38281	ENSG00000242852	"Zinc finger protein 709"	Q8N972	19	12461184-12513854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 15.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.8;Excitatory neurons: 14.5;Inhibitory neurons: 14.8;Late spermatids: 35.7;Oligodendrocyte precursor cells: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA045573, HPA053153"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA045573: AB_2679370, HPA053153: AB_2682060"	"unprognostic (2.27e-1)"	"unprognostic (7.40e-4)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.58e-4)"	"unprognostic (6.76e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-5)"	1.0	0.9	1.8	0.8	2.0	0.5	1.6	2.7	2.5	1.6	1.5	0.9	0.0	1.4	1.6	0.6	2.1	0.6	1.0	2.1	2.4	1.6	0.4	0.8	0.8	3.2	2.2	2.7	1.2	2.3	1.6	1.0	1.7	1.7	0.5	3.1	1.1	1.3	0.9	0.8	0.8	1.1	1.8	1.3	0.8	15.3	2.9	2.1	2.9	1.0	1.2	0.9	1.2	1.6	1.1	0.0	3.6	4.4	0.6	1.0	0.6	1.1	1.3	1.2	1.3	1.0	0.1	1.1	0.7	1.2	0.3	0.8	2.0	0.8	1.4	0.3	0.5	1.0	0.7	0.7	1.4	0.2	1.6	0.5	0.3	0.7	0.0	1.7	0.8	1.4	0.6	0.1	1.5	2.1	2.6	1.3	1.3	0.4	1.1	1.3	3.5	3.5	1.2	1.8	1.6	2.3	0.0	0.1	0.5	1.6	0.8	0.6	0.0	1.8	0.4	0.8	0.8	2.0	3.0	1.6	0.0	0.0	0.9	2.7	0.1	0.0	0.9	0.0	1.4	0.9	1.5	0.9	0.4	0.9	2.0	1.4	0.0	2.5	0.6	0.6	0.9	0.4	1.8	2.0	2.7	2.5	2.1	2.4	3.2	2.2	1.7	1.8	2.9	1.6	0.7	0.0	0.5	8.5	1.3	0.4	0.2	0.3	0.0	0.8	0.8	0.4	0.5	0.0	0.8	1.8	0.0	0.4	0.5	0.4	0.0	0.4	39.8	1.5	0.6	0.6	0.0	0.8	14.5	0.4	0.3	0.4	0.5	0.5	0.0	2.3	1.4	0.4	0.5	0.0	14.8	0.5	0.0	1.3	0.4	35.7	0.9	0.5	0.0	7.5	0.1	1.5	0.0	17.6	8.2	0.3	0.1	0.7	0.6	0.4	0.1	1.2	1.0	2.3	6.6	0.6	1.0	6.8	3.3	0.6	0.6	0.3	0.5	0.4	0.3	0.2
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595300-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.6"									HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	3.3	2.1	3.1	2.0	2.9	1.1	3.1	2.4	4.8	3.3	0.0	3.9	1.3	4.3	1.3	2.5	3.1	1.9	3.9	4.9	2.0	2.4	0.9	2.4	3.0	1.9	2.5	3.6	2.5	2.4	2.9	2.1	1.7	3.1	1.1	3.3	2.5	2.7	3.5	2.8	2.2	2.5	1.0	2.7	2.5	3.2	2.0	3.2	2.3	2.7	1.5	3.5	2.7	2.3	3.1	7.9	9.1	8.7	3.1	3.3	5.7	3.2	3.9	3.6	4.0	1.5	1.4	3.3	3.2	3.5	3.3	1.1	2.0	3.5	2.1	0.0	20.6	5.4	0.9	3.0	3.7	6.4	4.3	4.7	3.4	3.1	2.6	4.0	4.6	7.2	2.3	0.0	3.4	0.0	12.5	2.3	9.0	0.0	7.9	4.8	6.9	3.0	2.1	5.8	9.0	10.5	2.9	4.5	4.4	3.7	3.4	6.3	5.3	10.5	5.1	2.6	6.4	2.2	3.0	5.0	3.0	3.8	3.1	2.9	1.7	3.5	4.3	1.4	4.5	3.2	3.3	3.6	2.8	3.5	3.4	3.6	0.6	6.1	2.6	2.3	3.7	2.6	3.1	2.9	2.4	4.8	4.9	2.0	1.9	2.5	1.7	1.0	2.0	2.3	8.9	3.2	1.7	3.9	4.5	2.9	2.8	3.8	2.8	9.3	4.8	4.3	3.9	4.3	2.0	7.3	4.2	4.9	5.5	0.6	3.9	10.1	2.7	2.5	3.5	9.8	2.4	2.5	7.4	4.9	6.8	4.6	1.5	2.1	0.0	7.8	3.6	1.0	5.7	11.8	6.6	2.1	4.1	2.4	5.2	3.6	6.2	3.5	3.6	1.9	4.2	3.4	12.3	5.0	4.8	6.3	1.9	5.7	1.4	2.4	1.0	5.8	0.9	8.1	0.0	5.1	6.3	7.4	10.7	2.3	4.3	1.5	5.5	5.5	2.3	1.4
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001324-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 44.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"					"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	3.6	4.3	12.0	14.7	13.0	8.7	5.4	6.4	11.2	6.3	3.1	8.3	9.1	5.3	5.0	17.1	5.2	7.0	10.0	6.9	8.8	5.7	5.3	9.8	10.0	12.2	13.6	4.8	44.2	3.3	4.5	5.7	12.9	7.5	6.9	1.2	9.6	4.3	33.4	12.6	8.0	3.4	10.4	14.2	10.2	1.7	12.4	5.6	6.2	1.5	6.5	7.7	9.2	11.5	9.2	10.7	20.1	7.6	2.7	4.0	10.5	9.4	8.8	6.8	8.6	7.7	8.3	9.3	4.3	9.1	6.4	6.2	5.1	13.5	3.8	6.0	9.4	17.1	4.6	13.1	5.5	5.0	25.6	6.6	7.2	14.6	7.9	3.2	11.8	10.0	5.8	6.2	2.6	23.7	11.1	13.9	15.8	11.3	6.9	13.5	4.5	10.2	2.7	11.4	18.3	12.3	12.5	44.8	6.4	5.2	9.6	17.2	17.1	13.9	6.8	4.2	7.4	5.0	2.7	9.0	10.6	14.6	7.4	0.0	1.6	1.2	0.2	3.5	0.2	0.1	0.1	0.2	1.2	0.1	0.4	0.4	1.9	0.2	5.7	1.4	0.5	0.7	12.0	13.0	6.4	11.2	6.9	8.8	12.2	13.6	12.9	10.4	12.4	11.5	1.7	3.2	8.2	38.8	2.7	5.4	4.7	2.8	1.8	1.4	7.1	3.6	12.1	4.3	6.3	11.0	2.1	2.3	6.8	7.7	0.0	3.6	0.8	4.0	4.1	4.3	4.8	2.5	10.2	6.1	3.0	3.1	7.1	6.2	1.3	2.1	5.7	1.6	11.6	3.3	12.0	8.1	0.0	15.8	33.5	5.5	2.5	15.7	1.8	149.9	13.3	1.4	2.1	22.1	36.4	10.1	11.5	3.0	3.8	8.5	2.3	0.8	3.6	0.9	6.6	1.6	3.0	0.3	2.5	4.3	7.5	2.3	2.5	2.0	6.5	13.7
ZNF711	"CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85243991-85273362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 37.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	15.1	6.3	1.6	8.0	7.2	5.7	6.7	7.9	5.8	1.7	3.6	3.1	9.2	2.8	2.6	4.6	4.1	3.8	7.7	7.6	5.1	0.5	1.8	2.4	5.7	6.3	9.4	4.9	1.4	10.9	7.7	5.2	4.0	1.7	5.7	4.1	2.6	1.6	12.2	4.6	3.3	6.5	5.0	2.7	37.3	7.5	16.3	4.9	1.5	2.5	3.0	3.2	5.5	0.0	3.3	34.4	27.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	7.5	3.0	0.1	1.2	0.5	5.5	0.7	50.3	0.0	0.0	0.0	46.0	16.5	0.9	1.9	1.3	0.0	0.4	3.2	0.3	0.0	6.3	0.0	0.3	15.6	5.1	30.7	6.1	1.7	28.4	0.0	16.7	3.1	0.7	0.0	41.9	0.0	0.0	2.5	10.0	25.8	0.1	0.9	0.0	20.0	4.6	4.5	0.1	0.0	11.1	0.1	0.0	11.4	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	8.0	6.7	7.9	7.7	7.6	5.7	6.3	5.2	6.5	7.5	5.5	1.8	3.2	1.1	14.0	3.6	12.0	7.6	2.7	18.2	9.0	18.1	17.4	6.6	1.5	1.8	1.8	0.0	0.3	1.0	0.3	5.9	2.1	2.7	2.9	18.8	4.2	18.5	5.9	19.0	0.5	0.1	8.1	1.1	4.2	0.0	15.2	3.6	0.1	0.3	3.3	21.3	2.3	2.0	0.6	3.2	5.7	3.1	0.9	5.4	11.2	0.1	7.8	0.0	38.2	12.0	0.6	1.9	3.8	2.2	3.0	0.9	2.7	1.2	1.4	0.0	8.7	8.1	13.0	23.6	10.9	9.1	0.3	0.9	12.6	2.6	2.9
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887456-55942530	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.6;Excitatory neurons: 16.2;Late spermatids: 16.2;Oligodendrocytes: 25.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;eosinophil: 2.3;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli		"HPA059425: AB_2684013, HPA062887: AB_2684894"	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	0.6	0.9	1.2	0.6	1.2	1.6	1.2	1.6	1.6	0.9	0.3	0.7	1.1	1.7	1.0	0.6	1.9	0.8	0.7	1.1	1.1	1.0	0.6	0.8	0.6	1.7	1.3	1.7	1.2	0.6	1.8	0.7	1.7	1.2	0.5	2.4	0.9	0.8	1.7	1.1	0.7	1.0	0.7	0.9	1.4	3.8	1.5	1.5	1.3	0.7	0.6	0.4	0.4	4.2	1.0	0.4	3.5	3.5	0.3	0.7	1.3	0.4	0.3	0.6	0.6	0.3	1.3	1.5	1.4	0.3	1.1	0.3	0.8	0.3	0.4	0.9	1.5	0.4	1.5	1.1	0.7	2.0	1.1	0.8	0.6	0.3	0.5	0.8	0.8	2.1	1.1	0.8	0.5	0.7	2.3	1.4	2.6	1.2	0.7	1.6	1.0	0.2	1.7	1.8	3.8	5.2	1.8	0.6	0.7	1.7	1.6	1.4	0.7	0.6	1.9	0.4	0.6	0.9	1.2	0.7	0.4	1.1	3.2	2.1	0.4	2.3	0.2	0.4	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.3	3.6	0.4	0.4	0.4	0.1	0.1	1.2	1.2	1.6	1.6	1.1	1.1	1.7	1.3	1.7	0.7	1.5	4.2	1.8	0.0	3.7	11.4	1.2	1.3	3.8	2.6	0.6	3.0	1.6	0.8	1.8	7.2	3.3	0.0	10.4	1.1	0.8	1.3	0.0	1.2	18.6	6.5	2.5	2.2	0.0	3.0	16.2	1.4	1.0	1.6	1.1	2.4	1.3	6.9	1.1	0.3	0.4	8.4	13.3	1.6	4.1	1.3	3.1	16.2	0.6	1.3	0.0	3.7	0.7	6.0	0.0	11.6	25.6	1.6	0.3	2.6	0.1	2.1	0.4	0.5	8.2	2.9	6.6	3.9	2.2	7.0	7.7	0.9	1.8	2.1	1.3	1.2	0.9	2.3
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75678660-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 47.7"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	5.1	5.7	7.6	3.3	9.6	2.8	7.3	7.7	9.5	5.7	4.4	5.1	5.7	5.9	15.4	5.4	7.2	4.5	5.9	7.2	8.1	9.9	7.9	4.6	4.8	9.0	8.5	7.9	8.9	8.3	9.3	5.0	9.2	6.7	6.6	7.8	7.2	4.7	4.2	9.9	5.2	4.2	8.5	7.1	7.4	8.2	8.7	4.7	9.3	4.4	7.1	5.8	5.4	12.3	11.4	5.8	5.2	3.6	6.1	8.5	3.9	3.5	5.2	5.1	5.9	9.4	9.8	5.2	4.6	6.0	5.0	6.3	6.8	4.5	4.2	0.5	7.0	8.6	9.4	0.9	15.9	0.5	8.6	10.4	4.8	12.8	17.4	4.3	0.7	0.5	47.7	11.6	5.7	1.8	0.6	17.1	5.2	8.9	6.3	7.7	4.5	27.0	7.6	3.8	4.2	17.4	3.5	6.6	14.6	5.1	16.8	4.6	1.6	9.3	10.9	6.4	1.4	12.0	19.9	5.2	4.7	1.3	6.0	1.3	2.6	5.1	2.1	3.8	1.2	5.1	3.3	2.0	2.7	6.1	6.3	3.7	0.7	3.0	3.8	4.1	1.1	2.0	7.6	9.6	7.7	9.5	7.2	8.1	9.0	8.5	9.2	8.5	8.7	12.3	6.6	3.2	3.1	28.1	6.0	3.2	4.2	3.4	5.2	8.5	9.1	8.3	5.6	8.6	4.2	7.3	2.1	5.2	5.8	2.2	11.7	4.6	5.0	3.4	4.8	5.1	5.3	7.4	21.7	4.4	1.8	5.7	4.6	2.6	8.9	11.4	7.9	8.2	7.3	10.1	27.2	7.0	4.1	5.7	4.1	2.1	2.5	4.5	1.8	16.9	5.0	5.2	5.2	25.6	35.4	3.9	2.0	3.0	0.7	5.1	6.3	17.5	6.3	8.1	0.0	5.1	5.3	11.1	8.6	7.0	4.4	3.4	3.1	7.9	5.0	3.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	6.0	6.9	5.9	6.8	5.7	6.5	7.2	10.8	6.4	5.1	5.9	7.3	4.1	6.2	9.4	7.8	7.0	5.9	4.6	5.7	6.3	8.7	6.7	6.1	11.0	6.8	7.3	4.4	7.2	7.2	7.3	9.2	7.7	7.9	7.9	6.1	5.8	7.0	6.3	10.0	5.3	6.1	6.6	8.2	8.3	8.2	6.5	7.4	7.7	4.4	10.8	6.2	5.7	6.3	15.1	10.5	12.6	10.7	10.9	16.5	12.4	15.9	10.1	7.6	10.1	7.9	15.8	7.3	27.2	5.3	11.2	10.2	12.7	6.2	11.3	32.7	6.6	4.1	5.7	21.8	16.4	8.8	21.6	11.1	16.7	5.3	7.3	15.1	14.3	17.4	13.8	9.4	8.3	24.5	8.9	11.6	12.5	10.4	8.2	17.0	5.7	11.5	8.5	9.4	5.6	8.6	15.9	6.8	15.4	19.9	13.5	17.3	9.5	5.5	4.3	11.1	4.9	15.5	18.3	21.0	4.9	13.3	8.8	21.2	6.7	33.7	18.6	7.6	14.3	19.9	13.0	17.2	7.4	20.3	12.2	15.1	8.8	20.2	8.5	12.9	18.1	6.8	5.9	5.7	10.8	6.4	5.7	6.3	6.8	7.3	7.7	6.6	6.5	6.3	19.4	16.0	21.0	25.8	19.8	9.1	16.9	23.4	6.8	25.6	15.0	18.4	12.2	5.7	19.4	5.5	6.2	35.4	24.5	10.3	23.5	16.9	7.3	20.6	19.2	21.5	17.4	9.9	32.0	13.5	12.3	16.4	15.3	20.1	21.5	25.8	15.7	10.6	16.8	23.5	28.7	13.5	22.4	9.5	14.5	4.1	13.4	13.0	10.6	24.4	14.5	18.1	40.2	40.2	31.0	19.0	10.8	18.4	13.9	28.4	7.2	15.7	19.5	9.8	32.9	21.3	15.3	28.2	19.3	9.4	11.5	71.0	20.9	25.7	10.6	24.3
ZNF727	ZNF727P	ENSG00000214652	"Zinc finger protein 727"	A8MUV8	7	64045434-64085339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Excitatory neurons: 13.3;Inhibitory neurons: 7.7;Microglial cells: 9.4;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 27.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"T-47d: 7.2"									"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.73e-4)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-2)"	"unprognostic (8.61e-2)"	1.2	0.7	2.0	0.3	2.4	0.1	2.4	2.9	1.9	1.5	0.0	0.7	0.3	1.9	2.7	0.6	1.6	0.6	0.7	2.2	2.1	1.1	0.1	0.8	0.5	2.1	2.3	3.3	0.8	1.1	1.0	0.0	2.0	2.0	0.6	3.6	1.0	1.1	0.6	1.4	0.3	1.2	1.4	0.7	0.6	1.9	3.4	0.4	3.1	0.9	0.3	0.7	0.9	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.9	7.2	0.0	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.0	2.4	2.9	1.9	2.2	2.1	2.1	2.3	2.0	1.4	3.4	2.7	1.3	0.0	0.0	7.2	0.1	0.0	0.3	0.0	0.6	2.2	0.5	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.2	2.1	0.4	2.1	0.6	0.0	0.0	13.3	0.0	0.0	0.9	0.0	0.2	0.0	1.5	0.0	0.1	0.0	1.7	7.7	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	9.4	0.0	0.4	0.0	34.2	27.0	0.2	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.5	0.0	1.3	0.9	0.6	1.7	0.7	0.0	0.0	0.0	1.6	0.0	0.0
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64356634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.9;Inhibitory neurons: 45.8;Late spermatids: 70.1;Oligodendrocyte precursor cells: 42.7;Rod photoreceptor cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favorable (8.65e-4)"	3.0	2.0	1.8	2.8	2.2	7.7	3.6	1.6	3.0	3.6	0.5	2.4	1.2	2.9	2.6	2.1	3.3	1.7	2.1	1.9	1.2	3.1	1.4	3.0	4.2	0.7	0.9	5.0	3.0	1.7	2.9	1.7	0.7	2.7	1.8	12.4	3.1	1.4	1.6	4.7	3.6	1.7	0.3	3.9	2.5	7.5	1.8	4.1	3.9	2.6	4.1	2.5	3.0	2.3	0.5	0.2	4.6	15.9	1.5	2.4	4.6	2.3	0.1	3.5	5.3	1.2	2.5	12.7	3.7	2.1	4.0	1.9	3.4	0.8	5.6	0.3	3.3	5.4	1.5	0.2	1.7	2.4	7.1	2.1	1.0	3.7	0.0	1.5	0.4	7.1	6.5	2.9	4.1	3.1	8.3	12.7	8.5	0.1	1.1	6.8	7.8	6.0	4.1	7.3	5.1	7.2	6.0	4.1	1.5	8.4	9.6	9.1	0.3	5.2	3.6	1.3	3.2	3.1	5.0	15.2	0.1	2.6	0.1	0.4	0.5	1.1	0.4	0.6	0.3	1.8	0.6	0.4	0.7	1.4	0.6	0.5	0.2	0.1	0.6	1.2	0.4	0.3	1.8	2.2	1.6	3.0	1.9	1.2	0.7	0.9	0.7	0.3	1.8	2.3	7.0	6.4	5.4	28.7	27.1	3.8	2.4	3.5	10.2	12.8	8.6	5.3	3.6	8.6	5.6	5.5	12.5	3.6	8.0	2.2	5.9	4.0	48.9	8.6	7.1	5.9	1.2	18.3	40.7	2.2	3.0	5.2	4.6	13.3	0.0	15.2	6.1	2.7	3.7	8.4	45.8	5.6	6.1	8.1	7.1	70.1	2.5	8.9	3.6	19.7	4.4	7.4	1.0	42.7	41.2	2.1	2.5	3.0	5.4	2.6	1.4	3.9	4.5	43.6	0.0	4.2	5.6	8.2	7.5	9.9	4.0	2.7	9.1	9.6	3.8	2.1
ZNF738		ENSG00000172687	"Zinc finger protein 738"	Q8NE65	19	21358930-21379302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 38.6;Sertoli cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 49.5;NTERA-2: 51.6"									HPA059135	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA059135: AB_2683918"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.27e-3)"	"prognostic favorable (2.27e-4)"	"unprognostic (2.10e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.39e-5)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.20e-2)"	3.4	2.7	4.7	3.6	6.8	13.3	3.7	7.0	7.0	4.8	3.5	3.0	3.2	5.8	4.1	3.7	3.9	2.9	2.7	4.6	5.3	3.6	0.7	3.3	6.9	6.5	6.2	9.3	2.8	2.3	2.6	7.0	6.2	3.8	4.1	5.5	3.7	3.1	1.6	3.5	3.5	4.1	5.3	4.1	3.3	5.0	6.2	6.9	3.9	1.4	6.6	3.5	4.0	9.0	3.2	1.7	49.5	18.7	5.9	4.7	33.2	11.8	4.8	23.1	23.7	3.8	14.7	10.6	12.1	4.5	13.8	8.5	17.8	5.8	31.4	14.0	13.2	7.9	3.6	3.1	3.3	0.2	2.8	4.2	3.4	13.2	7.1	8.0	10.2	29.0	0.1	0.4	14.2	3.3	41.4	14.4	51.6	0.0	8.5	42.4	19.3	6.4	5.9	7.6	22.0	10.9	4.1	0.2	6.4	34.7	5.3	30.5	6.4	2.6	2.8	14.3	10.7	1.1	17.7	28.4	0.2	0.2	5.0	5.6	3.4	4.7	2.0	3.8	1.8	4.0	2.5	2.5	3.0	4.4	2.4	2.4	5.2	4.5	4.8	3.0	4.3	1.7	4.7	6.8	7.0	7.0	4.6	5.3	6.5	6.2	6.2	5.3	6.2	9.0	5.3	9.6	1.1	5.2	8.9	3.4	6.2	7.8	4.0	10.4	7.1	6.7	1.6	4.3	4.6	14.7	14.6	24.2	8.7	1.4	7.9	6.1	2.3	5.3	7.6	7.9	4.2	10.1	5.7	7.6	24.3	8.4	4.6	5.2	2.5	38.6	5.7	0.1	11.1	0.0	8.8	2.5	6.1	10.6	5.1	2.2	5.3	8.1	5.4	5.6	2.0	4.2	6.2	13.6	23.7	6.5	0.6	4.1	6.3	3.8	1.4	1.5	3.5	15.1	32.9	3.7	8.5	17.2	20.0	7.7	1.8	15.6	5.5	19.7	4.8	5.7
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 47.9"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	1.7	2.4	5.0	1.2	5.1	0.6	2.1	4.4	5.2	4.5	3.9	4.3	1.3	4.7	1.9	3.2	3.1	0.8	2.3	5.1	5.2	2.8	2.4	1.9	1.5	4.8	4.8	4.4	4.2	2.7	5.4	1.5	4.8	3.6	1.4	1.7	2.9	3.0	4.7	2.9	2.2	2.4	4.4	2.6	3.1	1.3	5.2	2.5	2.5	2.4	1.1	3.9	3.0	5.2	4.3	4.1	10.4	15.8	2.9	2.8	8.2	4.0	2.9	4.8	4.5	5.7	2.0	0.1	5.6	3.2	1.6	5.2	7.8	5.1	2.7	2.8	17.8	4.9	2.0	8.1	4.8	10.7	5.1	3.1	8.6	3.7	4.2	3.6	4.8	9.3	47.9	0.1	3.4	7.1	10.2	6.6	11.6	8.9	7.2	14.0	6.1	1.6	3.1	4.6	22.8	14.1	4.4	7.9	9.3	5.2	3.6	5.1	3.4	4.6	9.5	5.8	3.0	5.2	6.2	0.1	1.1	6.1	4.0	0.0	1.2	0.9	2.0	1.0	1.6	1.1	1.5	2.4	1.9	1.0	1.8	1.7	0.0	3.8	0.7	1.3	1.4	1.9	5.0	5.1	4.4	5.2	5.1	5.2	4.8	4.8	4.8	4.4	5.2	5.2	1.4	3.2	2.0	3.6	2.1	1.5	1.9	1.6	2.8	5.1	3.6	3.0	3.1	2.8	2.5	0.0	2.1	3.1	3.8	0.9	3.9	3.8	0.5	2.3	3.7	1.7	4.2	2.1	8.5	2.4	4.6	3.5	3.1	2.0	0.0	5.6	2.5	1.7	2.2	3.3	8.8	2.3	2.0	0.6	0.3	0.3	7.2	1.0	0.0	2.8	1.6	2.6	3.1	6.0	6.6	2.5	1.0	4.9	0.9	4.0	1.5	1.7	0.6	2.1	6.6	2.7	3.2	4.3	3.0	1.8	1.0	1.1	2.7	4.4	2.8	1.1
ZNF740	Zfp740	ENSG00000139651	"Zinc finger protein 740"	Q8NDX6	12	53180704-53195142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035691	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035691: AB_10669777"	"unprognostic (2.31e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.19e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (4.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-2)"	5.6	5.6	6.9	6.1	7.3	3.1	6.0	8.0	6.8	6.7	6.8	6.2	4.8	6.6	6.4	6.4	6.8	3.2	4.3	6.4	6.9	6.4	5.8	5.0	8.8	7.2	7.2	7.6	6.6	7.9	4.3	4.1	7.1	6.2	5.1	5.6	6.3	6.5	4.8	6.0	8.4	5.3	6.8	10.1	5.5	3.1	7.1	11.7	6.9	6.0	9.3	5.3	5.0	7.3	5.7	7.5	13.0	8.4	12.9	9.5	4.8	5.8	10.9	9.2	8.0	6.4	8.8	13.0	8.5	6.7	4.5	9.0	9.5	6.9	9.3	9.9	10.1	14.5	10.5	5.7	9.4	13.3	8.7	12.1	13.5	7.3	11.0	15.2	7.6	13.4	9.7	26.1	4.8	6.5	10.6	7.2	6.4	5.3	8.8	10.6	10.0	21.5	5.2	7.8	10.0	11.1	9.9	8.2	9.8	6.1	11.9	13.6	6.8	4.8	6.6	5.5	4.3	12.4	5.7	7.0	7.4	7.4	6.1	1.1	0.2	0.4	0.4	0.1	0.3	0.5	0.4	0.6	0.2	0.5	0.5	0.5	0.0	1.3	0.1	0.4	0.6	0.2	6.9	7.3	8.0	6.8	6.4	6.9	7.2	7.2	7.1	6.8	7.1	7.3	5.2	3.2	9.3	4.6	7.7	6.1	2.3	2.8	5.2	8.5	5.1	4.7	6.3	5.7	2.8	1.8	6.2	3.3	7.1	5.0	1.9	4.2	1.3	6.8	8.8	5.7	8.4	1.7	6.0	4.6	2.0	5.1	2.0	5.1	7.6	8.1	6.1	5.3	3.3	5.0	6.1	5.5	2.0	6.6	3.1	1.5	6.2	4.4	1.8	5.6	5.9	5.7	10.3	10.1	6.7	4.9	6.4	6.0	8.5	4.5	5.1	4.5	5.5	7.5	19.7	6.7	7.0	2.5	3.3	5.6	4.5	2.5	6.6	7.0	6.2	3.5
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	7.9	8.1	8.2	6.4	7.8	21.5	7.4	8.2	9.6	8.9	4.6	8.2	4.1	8.9	3.6	7.0	8.5	4.1	6.5	10.0	7.7	7.0	9.5	8.5	7.1	9.7	6.8	7.9	7.9	6.0	10.6	5.7	9.3	8.5	3.0	4.8	6.8	3.9	6.4	8.4	7.8	4.3	5.8	15.8	7.4	16.2	7.9	7.4	7.5	4.1	4.5	8.6	7.4	6.9	9.4	14.7	7.6	21.0	8.5	7.3	11.6	9.4	7.6	7.3	6.3	9.4	6.9	13.4	13.3	8.2	10.7	10.1	10.0	10.6	4.4	17.0	14.0	6.5	7.7	13.2	10.3	12.7	16.7	8.1	12.7	6.0	6.6	6.6	7.7	10.8	20.2	10.0	9.4	14.3	29.1	17.2	18.9	5.8	10.1	19.1	7.1	11.8	7.1	11.1	10.8	14.9	12.4	13.5	8.9	4.5	6.3	15.6	10.9	9.2	3.3	16.0	13.9	18.5	9.4	10.7	12.1	10.1	16.6	2.0	0.7	0.8	0.4	0.4	0.4	0.2	0.6	1.0	0.4	0.3	0.7	0.5	6.9	0.4	0.4	0.6	1.1	0.3	8.2	7.8	8.2	9.6	10.0	7.7	9.7	6.8	9.3	5.8	7.9	6.9	6.4	0.0	7.2	8.8	7.6	3.6	5.2	2.6	4.6	15.4	5.4	4.2	7.1	4.3	4.1	11.0	4.2	7.0	11.0	4.3	0.0	3.5	10.9	4.3	8.8	5.7	6.0	17.2	13.8	2.4	6.9	6.6	9.7	4.4	6.3	6.2	5.0	7.4	8.3	26.9	12.8	4.3	4.1	14.2	4.0	16.0	6.2	7.7	3.6	7.5	9.1	7.6	8.2	6.0	8.2	4.1	3.1	6.8	4.9	6.6	2.3	4.2	4.3	11.1	0.0	8.0	5.5	18.3	9.7	6.0	3.4	8.8	8.4	10.1	3.9	5.3
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: AB_2686097"	"unprognostic (3.82e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	6.7	7.4	7.1	4.0	7.4	2.7	6.8	7.7	7.3	7.6	5.8	8.8	4.1	8.4	3.3	5.4	7.8	3.0	8.8	6.8	6.4	7.1	10.8	5.2	4.4	7.5	7.3	7.3	6.2	7.6	6.9	2.5	7.4	7.6	3.8	4.6	5.6	6.1	9.7	6.2	7.1	4.1	6.4	7.4	7.2	6.2	7.3	5.3	7.0	6.2	3.9	8.2	5.8	7.9	4.6	4.4	1.3	7.1	5.5	4.8	7.1	3.7	5.6	5.3	5.1	2.6	5.8	9.9	2.5	4.4	0.7	6.7	3.3	4.7	2.3	11.9	7.3	8.6	4.7	4.1	6.0	4.0	11.8	5.5	5.9	4.3	6.6	3.5	3.5	12.3	2.4	8.2	3.7	5.0	18.1	5.5	8.4	2.4	2.9	21.3	0.5	9.2	4.7	2.3	9.8	8.6	5.6	3.7	4.2	3.3	7.2	7.9	2.8	6.7	3.0	5.3	0.1	15.7	11.8	5.5	1.4	6.1	8.1	7.7	3.1	4.4	2.7	1.7	3.1	4.6	3.1	3.1	3.9	5.3	5.2	4.0	1.7	4.4	1.5	5.1	2.4	3.0	7.1	7.4	7.7	7.3	6.8	6.4	7.5	7.3	7.4	6.4	7.3	7.9	5.7	3.2	6.3	1.3	5.8	1.5	3.4	4.8	4.6	8.7	6.1	5.7	6.0	5.7	3.1	0.0	4.2	2.6	8.3	4.4	7.9	6.2	2.6	4.9	5.4	6.2	7.3	8.6	1.9	5.8	2.3	5.8	2.6	3.9	3.8	8.6	6.8	8.7	7.0	6.7	2.0	4.4	0.0	8.8	1.6	1.2	5.9	4.3	0.0	0.0	10.4	7.1	7.2	3.5	2.8	5.2	12.6	9.8	3.6	3.9	9.7	7.6	5.8	7.5	13.1	6.9	5.4	13.1	4.2	4.2	1.1	1.2	4.0	5.7	5.0	2.1
ZNF749	FLJ16360	ENSG00000186230	"Zinc finger protein 749"	O43361	19	57435325-57447101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 27.9;Excitatory neurons: 24.2;Inhibitory neurons: 21.1;Melanocytes: 23.2;Oligodendrocyte precursor cells: 18.1;Squamous epithelial cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 24.0"									"HPA042082, HPA042091, HPA056001"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear membrane"		"HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005"	"unprognostic (2.54e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.05e-5)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-1)"	1.3	1.2	1.6	1.8	1.4	1.4	1.7	3.6	1.5	1.1	1.0	1.0	1.5	1.3	0.9	1.4	1.6	0.9	1.0	1.6	1.2	1.1	1.6	1.0	1.8	0.8	1.1	1.7	1.1	1.5	1.1	1.3	1.1	1.2	0.9	4.0	1.5	0.9	1.3	2.2	1.2	1.1	0.3	1.6	1.2	1.3	1.2	1.9	1.3	0.4	1.6	1.3	1.3	1.7	2.8	6.2	5.5	5.9	1.3	1.3	2.3	1.6	1.1	2.6	4.6	2.5	2.0	5.4	1.5	1.6	1.9	2.1	4.9	4.2	3.8	2.3	24.0	4.6	6.5	3.0	1.9	5.6	3.0	1.9	4.6	3.1	7.7	2.5	1.3	5.6	4.7	6.4	2.0	1.3	6.6	2.4	5.6	1.8	8.8	6.9	7.8	4.2	1.4	6.5	5.7	4.7	3.2	2.0	1.5	4.2	2.9	1.8	1.5	5.0	3.7	1.7	4.8	5.0	6.8	5.8	2.8	2.4	3.2	0.2	0.4	0.1	0.6	0.9	0.9	0.9	1.1	0.8	1.1	0.8	1.2	0.8	0.2	0.6	0.4	0.5	0.8	0.8	1.6	1.4	3.6	1.5	1.6	1.2	0.8	1.1	1.1	0.3	1.2	1.7	1.1	3.2	1.1	7.2	6.7	2.4	1.3	2.9	27.9	1.2	4.0	2.9	0.5	7.2	3.2	0.0	0.0	0.9	2.3	0.4	3.9	1.1	1.0	7.1	1.4	2.3	3.0	8.8	24.2	0.4	0.6	2.5	10.7	3.5	0.0	1.2	1.1	4.0	0.8	3.3	21.1	1.7	2.0	0.8	1.6	0.1	0.6	1.9	23.2	5.6	0.7	0.2	0.0	18.1	10.6	0.8	0.3	0.0	11.6	0.9	3.8	8.1	3.4	0.8	6.6	1.8	2.0	1.2	1.8	35.9	3.1	0.8	4.3	0.3	1.1	1.1
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829434-82840022	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 96.1;skin 1: 139.0;vagina: 51.7"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 33.3;Squamous epithelial cells: 156.8;Suprabasal keratinocytes: 41.1;Syncytiotrophoblasts: 68.1;Urothelial cells: 51.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 20.5;head and neck cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.3;hTCEpi: 7.2;MCF7: 5.4;SK-BR-3: 14.0"	"Not detected"	"Not detected"							"HPA021573, HPA023012"	Enhanced					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.5	0.1	0.8	0.0	1.2	0.1	5.1	0.5	0.9	25.0	0.0	0.1	0.1	0.2	4.1	96.1	0.6	0.2	0.6	0.6	0.2	0.4	0.1	2.0	0.0	1.0	0.3	0.1	0.2	2.2	2.9	3.9	1.0	3.3	0.0	0.0	33.6	2.7	12.0	139.0	0.1	0.0	0.2	0.1	0.2	0.4	0.6	5.1	3.5	0.0	14.7	4.9	51.7	2.3	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	1.2	1.0	0.0	14.0	0.0	1.7	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.5	0.9	0.6	0.2	1.0	0.3	1.0	0.2	0.6	2.3	0.6	0.0	8.2	0.0	0.0	5.2	14.3	19.6	9.1	0.0	7.4	5.0	0.4	0.0	21.2	0.0	0.0	23.1	0.0	0.0	0.0	0.0	2.4	27.1	3.3	0.9	0.0	0.0	0.4	0.0	1.9	0.3	0.0	33.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	10.2	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	7.6	0.0	0.1	14.2	0.0	0.0	0.1	1.5	0.0	0.2	156.8	41.1	68.1	0.2	0.0	0.0	51.3
ZNF75A	FLJ31529	ENSG00000162086	"Zinc finger protein 75a"	Q96N20	16	3305406-3318852	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001665	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA001665: AB_1080751"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.79e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.97e-3)"	5.4	7.3	8.3	8.5	8.6	7.7	10.1	11.0	11.6	8.3	9.3	6.9	6.7	8.6	16.7	5.4	11.5	5.6	8.3	8.4	8.4	9.4	9.1	7.7	13.4	8.8	8.0	14.5	7.9	15.4	8.1	8.1	8.9	11.3	10.0	16.9	6.9	7.7	7.8	9.9	7.7	7.1	8.0	11.0	7.8	11.0	8.8	12.4	10.7	7.4	12.3	5.6	4.9	9.7	7.4	8.8	18.5	8.4	9.3	9.6	17.6	10.6	5.4	9.6	11.4	0.0	10.0	12.3	7.9	8.2	13.0	5.0	10.2	6.1	15.8	4.8	12.6	23.5	10.4	0.9	6.2	16.4	21.3	9.7	8.7	9.0	8.9	10.4	8.1	9.9	15.0	18.8	14.3	9.9	26.3	9.5	30.1	7.4	8.1	49.4	10.0	14.5	10.9	11.7	16.5	11.8	16.3	6.9	9.0	23.1	22.5	19.2	9.9	6.3	17.8	7.0	10.0	13.2	10.9	31.1	2.4	17.2	11.9	29.5	11.7	29.3	22.2	11.9	27.4	33.7	26.1	23.8	9.5	44.1	39.4	29.0	8.8	34.5	17.3	25.8	23.5	6.4	8.3	8.6	11.0	11.6	8.4	8.4	8.8	8.0	8.9	8.0	8.8	9.7	14.5	22.4	14.0	22.5	40.5	4.1	30.6	17.5	6.8	40.4	12.0	9.1	13.3	14.3	15.9	16.5	33.3	19.4	23.8	10.7	5.9	22.0	3.5	8.6	16.7	15.7	6.0	12.4	20.4	10.2	9.4	12.4	13.3	8.4	13.9	27.0	16.8	11.5	10.7	48.8	18.0	10.8	12.2	11.7	5.4	3.6	23.3	12.5	8.8	14.0	19.8	26.8	58.7	27.6	28.7	13.7	8.5	26.7	12.7	24.1	28.6	7.8	12.9	66.5	26.3	19.7	15.4	53.0	48.3	8.3	3.4	15.7	27.1	16.0	13.5	14.5
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 202.9;Late spermatids: 378.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	6.3	14.5	4.8	5.6	4.9	6.9	6.3	4.7	5.3	7.1	5.6	6.7	4.8	6.2	7.5	5.2	7.0	4.7	5.5	4.6	5.6	8.4	11.0	6.7	8.4	5.2	4.9	6.8	9.8	7.1	6.9	5.0	5.4	10.2	5.5	6.7	6.4	5.9	5.1	6.8	8.2	4.9	4.9	13.9	7.5	2.2	5.2	8.6	9.3	3.9	7.2	6.0	5.8	5.3	3.3	4.3	4.6	7.4	7.7	9.3	7.0	5.5	7.5	4.4	9.4	2.6	4.1	3.5	7.9	4.7	8.5	4.5	15.2	2.5	4.2	3.3	4.0	2.4	8.6	3.5	3.3	4.1	6.6	4.6	5.9	2.7	3.4	5.5	4.6	4.4	2.1	5.4	3.9	8.0	5.0	7.5	2.2	6.7	5.8	4.7	4.6	3.1	5.0	4.5	1.5	5.2	3.1	5.2	0.9	4.9	1.8	5.9	4.8	4.2	1.0	7.1	5.3	2.7	4.1	2.5	2.6	4.5	2.7	2.7	1.0	2.0	2.3	0.8	2.1	1.4	2.5	2.7	0.9	1.6	3.1	2.8	1.1	2.8	0.8	0.8	3.4	1.5	4.8	4.9	4.7	5.3	4.6	5.6	5.2	4.9	5.4	4.9	5.2	5.3	6.4	6.4	12.9	23.5	7.5	1.8	1.3	1.4	2.8	4.9	3.9	2.0	4.7	1.5	5.0	0.0	6.2	2.4	8.4	3.7	1.9	2.0	202.9	9.2	4.8	7.1	1.8	0.8	18.5	4.0	1.5	4.2	6.1	4.9	6.3	4.9	5.7	5.3	2.4	5.0	21.8	5.0	6.1	2.9	1.6	378.3	6.5	3.8	0.0	28.1	3.9	4.1	6.2	18.6	21.4	3.1	2.8	3.4	5.0	2.3	3.3	3.7	5.1	5.1	0.0	3.4	3.5	7.6	3.1	3.4	1.4	1.8	7.1	10.2	3.6	2.3
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	15.7	33.0	17.9	11.7	18.3	10.0	18.2	17.5	18.6	22.4	20.7	21.2	12.6	17.4	18.5	15.5	20.9	9.9	30.3	17.4	17.7	27.5	25.6	17.7	17.5	18.8	18.2	30.9	23.4	21.5	45.2	11.0	18.2	27.8	10.4	22.9	21.3	14.5	54.7	13.1	23.1	10.7	17.2	33.7	20.3	24.7	18.6	15.3	39.1	31.7	14.6	20.2	18.0	18.3	10.7	9.6	20.7	23.0	8.6	13.2	14.8	9.0	15.1	14.9	11.9	7.3	14.0	23.1	13.1	13.5	14.2	5.9	17.5	13.6	8.6	34.5	26.7	22.2	15.7	11.6	17.1	11.2	12.6	16.2	8.5	17.2	16.0	9.1	13.7	23.1	16.6	23.7	13.7	23.5	19.1	13.1	10.2	8.5	9.2	18.1	10.7	21.4	13.5	14.7	32.5	11.9	11.0	13.9	27.3	6.8	20.8	36.1	10.6	10.4	8.9	7.2	13.2	23.8	17.8	21.6	9.0	17.4	28.0	5.2	7.2	6.3	16.8	9.5	13.2	10.9	12.1	12.0	8.2	10.4	12.6	13.2	2.2	10.8	10.9	4.1	10.3	10.3	17.9	18.3	17.5	18.6	17.4	17.7	18.8	18.2	18.2	17.2	18.6	18.3	9.6	16.0	9.6	16.3	19.3	5.7	8.3	10.2	15.9	28.5	14.0	10.2	20.3	8.6	9.7	9.2	50.1	23.7	11.6	13.4	21.5	12.5	20.6	9.2	7.7	10.5	12.1	6.9	19.7	15.5	12.4	10.0	7.7	10.1	12.7	19.5	10.0	8.7	11.3	30.3	22.0	13.9	8.2	7.2	6.9	13.4	11.1	7.6	5.4	21.5	6.1	15.3	16.5	24.1	23.9	7.6	13.1	6.0	16.1	6.8	12.1	12.5	9.2	31.2	19.7	8.8	10.2	21.9	10.4	8.7	6.3	22.7	12.6	14.8	10.1	7.9
ZNF763	ZNF440L	ENSG00000197054	"Zinc finger protein 763"	Q0D2J5	19	11965037-11980617	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.2"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (4.09e-3)"	"unprognostic (6.15e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.07e-6)"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.89e-3)"	3.8	3.1	2.5	2.2	2.9	1.9	4.3	3.1	3.0	3.2	2.1	3.4	2.3	3.5	2.9	1.9	3.6	1.7	4.0	2.2	2.3	5.9	2.4	2.9	3.6	2.7	2.5	6.0	4.5	4.8	2.8	3.1	2.8	3.6	3.0	6.9	3.3	2.3	2.0	2.8	4.4	2.2	2.2	5.3	3.5	4.7	2.5	4.3	4.9	1.5	3.4	3.5	2.8	3.9	0.2	0.0	1.7	1.8	1.0	0.3	5.2	1.6	1.0	1.2	0.9	0.5	0.3	1.5	1.2	1.2	0.4	0.5	0.0	0.7	0.4	0.3	0.0	0.7	0.1	0.1	0.2	0.9	1.8	2.5	1.1	0.3	0.1	0.4	0.2	2.4	0.3	0.6	0.8	0.1	2.0	0.5	0.5	0.1	0.2	0.1	0.0	0.6	2.4	1.6	0.3	0.5	0.1	0.1	0.3	3.0	3.1	0.7	0.2	1.7	0.1	1.3	0.3	2.3	3.3	0.5	0.4	0.4	0.3	8.5	1.4	4.4	2.2	1.9	1.7	2.2	2.0	3.1	2.5	7.6	2.2	2.6	7.4	3.8	4.1	1.9	1.2	1.6	2.5	2.9	3.1	3.0	2.2	2.3	2.7	2.5	2.8	2.2	2.5	3.9	1.1	3.2	4.8	6.2	2.1	0.1	0.4	0.4	2.2	2.5	1.1	0.6	1.1	0.0	2.7	0.0	10.4	5.7	2.1	0.6	1.9	0.9	5.3	0.7	0.6	0.7	1.2	0.0	4.9	0.4	1.7	1.4	1.1	0.7	1.3	4.3	0.4	0.7	1.4	0.0	4.0	1.9	0.0	1.9	0.2	0.8	1.5	1.2	0.0	7.5	1.1	3.3	3.1	4.0	6.0	0.5	0.5	1.9	0.1	0.3	2.1	1.6	1.9	6.6	0.0	0.9	0.8	4.0	1.6	0.6	0.0	1.8	0.9	1.3	0.9	0.2
ZNF764	MGC13138	ENSG00000169951	"Zinc finger protein 764"	Q96H86	16	30553764-30558374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003203	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003203: AB_1080753"	"unprognostic (9.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.47e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.62e-2)"	"unprognostic (9.75e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.64e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.05e-1)"	3.5	4.4	2.4	3.1	2.3	4.1	3.6	4.4	2.6	5.0	1.2	4.9	4.8	4.9	1.1	3.5	4.7	2.2	6.6	2.4	2.4	4.2	5.9	3.1	4.5	2.3	2.0	5.6	4.4	3.3	5.0	2.1	2.3	4.8	2.9	2.9	3.5	2.3	3.9	3.5	4.8	1.8	1.5	5.2	6.8	5.8	2.3	3.5	3.5	2.3	2.8	3.7	3.7	2.7	2.9	3.6	6.8	6.6	2.9	2.8	4.1	3.7	2.9	3.5	2.6	2.7	2.8	5.3	4.3	2.1	2.1	4.1	3.6	2.4	2.7	6.0	9.7	3.6	4.5	5.1	3.4	3.4	5.5	2.2	2.9	2.9	3.8	4.6	3.2	12.8	6.8	6.0	3.1	6.6	9.6	5.5	4.0	1.8	4.7	13.0	2.8	7.2	2.8	1.5	13.0	10.1	2.5	5.8	3.6	4.1	5.0	6.2	2.9	4.8	2.6	2.7	3.7	8.1	6.0	4.5	3.4	4.8	6.7	2.3	1.4	4.4	2.9	1.7	3.9	1.8	3.0	3.7	1.8	2.4	3.1	3.0	1.4	7.2	1.8	2.0	2.1	1.8	2.4	2.3	4.4	2.6	2.4	2.4	2.3	2.0	2.3	1.5	2.3	2.7	3.9	0.0	3.2	2.9	5.0	1.7	2.7	1.9	2.8	5.4	3.9	2.8	5.2	7.2	3.1	1.8	0.0	2.6	5.0	4.4	0.0	3.4	0.6	5.3	4.6	3.8	2.4	3.0	1.7	3.0	2.1	2.8	5.6	3.6	1.3	4.6	4.2	2.5	3.7	1.7	1.9	4.2	0.0	3.5	1.2	0.8	3.4	3.2	0.0	0.0	4.2	3.3	6.2	2.5	2.0	3.8	10.4	2.6	3.3	2.6	4.7	2.9	6.3	5.7	6.6	2.6	3.8	10.5	4.3	3.5	0.4	1.0	6.0	2.7	4.4	1.9
ZNF766		ENSG00000196214	"Zinc finger protein 766"	Q5HY98	19	52269587-52296046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.6;Late spermatids: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044882, HPA063496"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA044882: AB_10965173, HPA063496: AB_2685024"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.45e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-3)"	7.6	5.8	5.1	8.5	5.3	16.2	12.5	7.2	5.4	9.5	5.7	9.2	6.2	9.7	7.4	7.2	9.6	6.4	7.0	4.7	6.2	7.9	5.5	8.7	12.6	6.4	5.8	14.6	5.6	9.3	6.1	6.4	6.1	9.4	8.3	5.6	8.3	7.2	6.9	8.7	7.0	6.8	4.4	11.2	8.4	23.8	5.2	14.1	14.0	7.2	11.3	8.1	6.3	7.8	11.8	18.8	13.8	16.0	13.5	19.4	10.2	11.2	11.0	7.2	14.2	5.0	9.2	19.4	10.4	11.9	11.1	11.5	13.0	11.1	12.7	15.1	17.6	20.2	11.0	5.7	7.9	22.7	13.3	15.3	15.8	8.3	19.5	14.0	11.3	25.4	13.7	10.7	12.7	8.0	29.9	9.5	15.6	16.9	20.8	20.7	23.8	17.3	9.2	34.2	17.0	14.1	17.3	13.4	9.7	20.9	15.9	14.2	13.8	6.7	9.5	5.7	11.9	18.6	56.9	29.4	6.4	11.6	13.2	51.4	14.8	30.1	26.1	21.3	36.3	32.7	27.8	29.8	15.1	29.2	43.7	34.6	15.4	31.7	22.9	10.6	32.3	20.9	5.1	5.3	7.2	5.4	4.7	6.2	6.4	5.8	6.1	4.4	5.2	7.8	12.0	22.4	8.7	3.9	17.7	5.5	17.0	13.1	5.2	15.1	8.6	12.2	20.2	14.3	12.7	14.7	4.2	13.3	11.4	4.4	15.6	18.7	83.6	8.9	16.1	12.8	9.1	17.9	8.4	10.3	10.7	12.6	4.1	9.3	10.1	21.1	11.7	5.9	6.5	15.2	10.0	10.5	18.3	8.2	6.4	53.2	11.5	7.6	3.6	7.5	16.5	11.2	21.6	8.5	11.7	11.3	11.2	10.5	5.8	19.2	4.7	8.9	9.7	10.5	0.0	15.7	10.6	13.7	30.8	4.5	7.7	11.9	15.7	12.7	7.5	18.2
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524004-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	22.3	23.2	31.4	9.9	32.9	13.3	22.6	30.6	35.0	28.7	28.3	42.6	29.8	30.8	9.9	22.8	27.5	10.1	49.3	27.8	27.7	34.8	38.5	19.0	7.3	32.3	31.9	28.9	25.7	30.2	27.2	11.3	30.3	30.3	17.0	13.7	25.6	21.1	93.8	28.2	31.1	13.4	28.5	22.1	30.9	39.3	33.0	6.0	23.7	53.1	7.4	34.9	23.0	29.9	27.1	33.3	37.0	36.1	17.6	20.3	29.1	20.2	22.5	32.7	28.4	21.3	36.8	17.1	30.1	14.2	26.3	35.4	24.8	24.1	19.4	38.5	52.6	40.0	24.0	30.0	44.1	26.8	121.3	17.9	52.5	25.1	32.4	30.2	21.9	6.7	47.4	28.0	17.1	74.9	10.0	64.7	34.8	22.0	27.1	50.7	24.7	42.5	23.9	14.0	43.6	48.4	11.5	59.9	77.3	15.9	59.3	66.5	14.9	34.2	25.9	19.4	22.8	41.3	32.4	21.1	28.5	41.4	35.2	0.0	0.4	1.0	0.0	0.6	0.1	1.1	0.1	0.0	0.6	0.4	0.1	0.0	0.5	0.6	0.1	0.5	0.0	0.2	31.4	32.9	30.6	35.0	27.8	27.7	32.3	31.9	30.3	28.5	33.0	29.9	9.7	9.6	1.9	8.8	4.1	5.5	6.7	9.5	6.8	13.3	15.4	12.6	7.6	14.3	5.5	16.5	2.1	7.2	2.0	50.4	11.7	12.2	18.4	10.9	9.9	9.2	18.0	3.8	2.6	16.2	8.0	6.5	10.7	13.3	3.8	15.5	14.6	17.9	12.7	21.9	3.4	29.1	8.2	8.1	7.7	7.4	10.8	6.1	5.4	4.7	6.8	16.5	0.0	4.0	4.5	11.6	38.2	13.2	2.2	7.9	38.9	17.0	7.4	12.7	6.6	11.8	10.5	15.2	5.1	10.0	5.7	3.6	2.1	14.1	31.3	5.3
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	2.7	2.7	2.3	1.2	2.3	2.2	4.6	4.6	2.6	3.5	2.0	2.5	1.4	3.0	2.8	3.1	2.9	1.4	2.6	2.1	2.2	3.4	2.7	2.8	2.5	2.2	2.2	3.4	3.0	3.3	3.1	2.9	2.3	2.8	2.1	4.0	2.6	2.1	2.6	3.2	2.1	2.9	2.1	2.6	3.2	3.6	2.2	3.4	3.0	4.1	3.4	2.6	2.9	2.7	4.3	2.1	9.4	5.5	1.9	2.5	4.2	2.5	3.8	5.0	5.9	6.5	1.7	4.8	2.1	2.8	2.7	3.4	6.1	4.1	8.3	0.7	4.7	5.9	3.4	7.3	4.8	0.2	4.6	3.9	5.6	3.9	5.7	6.2	7.0	9.2	7.7	0.0	3.4	4.7	7.2	4.2	2.1	3.7	2.8	8.1	7.3	3.3	4.1	6.5	3.8	7.2	3.9	3.6	4.6	4.5	3.5	10.0	3.5	2.1	2.7	6.0	4.7	4.8	4.9	2.2	5.4	0.1	3.9	0.0	1.6	0.8	3.0	1.7	3.5	3.7	3.1	3.2	2.2	3.5	2.3	3.4	0.1	2.4	1.8	1.7	1.6	1.9	2.3	2.3	4.6	2.6	2.1	2.2	2.2	2.2	2.3	2.1	2.2	2.7	4.2	3.2	3.9	3.6	2.2	11.6	4.7	3.3	14.2	2.8	4.6	5.3	2.2	1.5	3.4	1.8	2.1	3.6	5.7	1.9	0.0	2.1	2.1	3.3	3.6	3.7	7.2	1.3	2.9	1.8	3.0	2.9	4.6	4.0	2.5	4.0	4.2	2.2	1.7	0.0	3.2	2.5	2.0	1.6	2.8	0.3	2.8	1.7	1.8	0.0	0.7	3.3	4.1	1.0	2.6	2.4	1.9	1.5	2.0	2.8	1.5	1.4	2.0	5.6	0.0	2.5	2.3	9.7	8.1	6.8	10.9	6.2	3.3	5.4	3.4	1.8
ZNF770	"FLJ20582, PRO1914"	ENSG00000198146	"Zinc finger protein 770"	Q6IQ21	15	34978341-34988287	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024518	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA024518: AB_1859449"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.10e-3)"	12.7	12.9	12.2	12.7	16.7	8.9	18.6	16.9	16.3	13.2	12.2	9.7	12.2	15.1	44.9	28.9	17.7	9.0	14.8	14.1	11.4	21.6	29.4	9.8	17.6	9.5	12.3	17.8	10.7	22.2	5.4	22.5	10.0	13.2	9.9	19.7	15.0	12.0	18.6	35.3	11.6	10.7	11.3	15.4	11.7	13.6	12.4	16.6	44.2	19.8	21.9	12.2	12.8	11.5	18.9	23.1	31.8	40.5	25.1	23.9	17.9	22.0	21.0	21.1	23.1	20.5	12.7	18.0	29.6	21.8	20.8	44.7	37.9	30.1	29.5	23.1	16.1	41.9	33.2	23.5	50.7	44.1	26.7	16.3	74.1	19.0	52.8	28.0	24.7	13.4	48.0	26.5	29.0	11.1	30.6	21.9	26.2	29.2	23.6	35.1	29.9	24.8	28.2	34.4	45.3	26.1	32.9	37.3	19.9	25.4	26.8	26.3	21.6	37.1	15.6	21.1	21.3	16.6	28.2	28.7	30.6	32.2	27.5	2.1	3.8	1.3	3.9	3.2	5.5	4.9	4.1	3.4	3.2	4.9	6.0	4.9	4.5	4.2	3.6	3.3	4.8	2.6	12.2	16.7	16.9	16.3	14.1	11.4	9.5	12.3	10.0	11.3	12.4	11.5	20.5	16.0	29.3	26.8	40.3	64.6	40.1	25.4	39.9	25.6	27.5	25.8	13.4	20.0	28.8	33.1	22.9	17.5	32.8	9.8	31.3	21.1	15.8	29.2	30.5	24.9	27.1	13.5	21.6	24.0	14.2	24.2	20.9	26.3	22.1	26.6	27.5	68.1	13.9	25.2	24.8	24.4	14.2	22.9	18.8	8.7	25.4	18.6	39.2	12.2	38.9	29.4	32.0	22.1	19.8	25.3	11.1	23.0	19.8	42.1	12.1	54.3	19.8	21.1	0.0	32.3	18.3	63.8	52.5	64.1	91.1	19.8	26.4	33.3	23.5	39.8
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407414-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6;REH: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	4.6	7.2	9.4	1.5	9.9	1.2	4.8	8.6	15.7	7.8	1.9	10.6	1.3	13.3	2.0	4.4	9.9	1.4	6.9	10.7	8.7	7.8	13.2	3.2	0.9	8.4	6.8	10.8	4.9	2.9	8.1	0.5	6.6	9.5	1.4	1.8	4.0	3.7	12.6	3.8	4.7	2.9	4.7	2.5	6.2	3.7	8.4	1.0	5.2	1.5	1.1	10.2	5.4	8.9	4.5	5.2	6.7	5.6	9.3	4.0	5.2	6.3	3.1	3.9	4.1	2.1	2.2	5.2	10.4	3.1	4.8	3.2	6.9	2.8	4.0	1.9	35.6	4.4	3.6	6.8	4.8	2.3	4.9	6.0	2.2	4.9	3.0	4.2	4.0	5.4	10.9	3.1	3.3	8.1	5.4	7.0	5.3	2.7	3.9	23.7	5.1	3.4	2.3	1.8	10.6	6.7	3.4	3.1	4.8	3.4	3.8	2.6	3.8	6.7	8.0	3.9	4.6	4.6	5.4	2.8	4.5	4.9	4.4	0.8	0.7	0.5	1.8	1.4	2.6	1.4	2.2	2.2	1.7	3.3	3.1	2.0	1.0	1.2	0.3	2.3	2.6	1.6	9.4	9.9	8.6	15.7	10.7	8.7	8.4	6.8	6.6	4.7	8.4	8.9	5.4	3.2	0.5	6.2	3.7	5.1	11.5	1.8	22.2	12.0	9.1	15.7	7.1	20.0	1.5	5.5	10.4	5.5	7.2	7.8	33.2	6.2	1.6	4.5	12.3	7.6	4.2	4.4	8.6	4.4	3.3	12.4	5.6	9.0	1.3	12.6	13.2	19.1	3.5	11.8	9.4	10.0	0.0	1.6	2.4	2.2	25.1	3.2	5.4	5.6	1.3	15.9	2.1	5.5	5.4	2.5	5.1	29.7	4.4	15.5	8.6	29.4	0.7	8.0	13.1	15.2	12.0	1.2	1.8	8.5	6.7	3.6	5.1	9.5	10.0	4.3
ZNF772	DKFZp686I1569	ENSG00000197128	"Zinc finger protein 772"	Q68DY9	19	57466663-57477570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 26.4"					"Low region specificity"	"Detected in all"			HPA031312	Uncertain		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA031312: AB_10603941"	"unprognostic (2.30e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (7.99e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-2)"	1.8	3.8	2.8	1.7	3.2	1.5	4.8	12.9	3.6	2.9	5.6	1.6	1.7	2.3	5.5	2.4	5.3	2.6	6.9	2.5	3.8	4.1	2.6	2.9	3.4	2.0	2.9	6.2	2.9	11.0	4.5	4.4	1.1	4.5	1.6	14.0	4.1	4.1	5.6	4.3	1.9	2.0	1.4	4.8	2.5	3.7	2.5	6.1	9.1	7.9	4.1	1.9	1.4	3.5	2.9	1.9	11.7	4.9	3.0	6.3	4.8	5.1	6.0	7.8	26.4	0.8	2.6	0.3	3.7	4.4	3.4	0.4	2.5	6.4	9.5	0.0	18.5	9.6	1.1	3.1	4.0	1.2	9.7	4.8	3.0	5.5	10.2	7.1	5.7	3.8	2.9	1.8	7.4	2.1	1.4	2.5	7.4	0.7	5.2	2.6	14.4	9.6	3.7	7.5	12.1	7.5	0.2	2.6	3.7	7.9	7.6	6.2	2.7	7.1	4.6	1.6	5.1	11.5	22.2	3.4	1.5	0.2	7.3	0.2	1.2	1.1	0.3	0.8	1.3	2.1	1.0	0.4	1.5	3.7	1.9	1.0	0.6	1.6	0.9	0.8	0.2	1.0	2.8	3.2	12.9	3.6	2.5	3.8	2.0	2.9	1.1	1.4	2.5	3.5	1.5	6.4	2.6	6.5	2.7	0.6	0.5	0.9	0.6	7.0	2.2	1.5	5.3	2.8	1.6	16.5	6.2	2.3	0.4	1.0	0.0	2.0	0.0	1.0	0.8	2.6	2.4	1.7	4.3	0.4	0.9	1.3	1.1	1.2	2.5	3.8	4.2	3.3	2.6	6.7	4.2	1.4	4.1	4.1	0.5	1.2	0.6	1.6	0.0	1.0	1.2	5.4	1.0	7.5	4.5	0.7	0.5	2.2	0.8	1.2	1.0	2.1	1.7	8.8	0.0	1.1	1.9	0.6	1.3	2.3	1.1	1.8	0.7	1.9	1.5	0.8
ZNF773	"MGC4728, ZNF419B"	ENSG00000152439	"Zinc finger protein 773"	Q6PK81	19	57499915-57518404	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003152	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716"	"unprognostic (6.53e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.50e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.71e-3)"	4.0	4.4	4.6	3.1	4.1	6.6	6.0	6.7	5.1	2.9	3.2	3.6	4.5	3.3	5.6	2.8	4.3	2.8	3.3	4.2	4.8	4.1	2.4	3.8	4.8	4.0	4.1	6.0	2.4	6.9	4.4	4.5	3.5	4.8	3.6	5.1	3.8	3.8	4.5	5.2	3.5	3.8	2.5	5.7	3.6	4.4	3.9	5.3	6.1	3.2	5.5	3.2	2.7	5.0	2.3	4.3	7.0	9.7	4.9	6.4	0.4	7.1	10.0	6.1	24.8	4.3	3.6	4.5	3.7	4.3	4.6	1.8	3.6	7.6	9.0	0.2	22.8	8.0	0.6	2.7	8.9	5.9	6.2	14.0	9.9	4.5	15.8	7.8	4.4	8.2	0.3	0.8	7.8	0.6	11.3	4.3	7.7	1.2	12.8	6.4	11.6	6.9	4.3	8.7	7.4	9.4	1.3	3.2	6.9	6.6	5.4	10.7	3.7	9.5	4.3	2.5	7.5	10.9	12.7	7.3	3.8	5.7	8.3	30.4	6.4	10.7	10.6	5.0	17.7	15.3	13.2	11.7	8.8	19.2	21.4	17.2	2.8	13.0	4.4	9.3	10.1	7.9	4.6	4.1	6.7	5.1	4.2	4.8	4.0	4.1	3.5	2.5	3.9	5.0	3.2	0.0	2.6	2.9	6.6	1.0	2.7	1.8	1.8	5.2	2.0	2.0	1.3	2.8	3.9	0.0	6.2	3.0	2.3	0.0	3.9	2.4	0.6	1.3	1.7	3.4	0.0	2.1	6.2	0.7	0.9	2.0	1.5	1.0	1.3	3.9	3.6	0.9	0.9	6.7	5.1	0.9	4.1	1.6	1.2	0.3	1.2	1.5	1.8	0.0	1.7	4.2	3.1	3.5	3.6	1.1	1.7	3.8	2.1	2.3	1.0	0.8	0.8	7.5	13.1	2.3	2.6	4.5	7.7	2.0	0.6	2.9	5.3	4.8	0.9	2.3
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352284-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.0"									"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	0.7	2.7	2.3	1.2	4.2	1.0	3.4	4.3	3.6	2.6	0.0	4.6	2.2	2.8	4.1	1.4	3.0	2.9	2.8	1.9	2.6	1.4	1.1	1.1	0.7	0.7	1.0	1.1	3.9	3.1	3.0	0.7	0.8	2.4	7.1	4.0	3.9	5.7	6.2	3.1	2.0	1.8	0.0	0.6	2.6	2.2	2.7	1.5	2.7	7.2	0.9	1.9	1.6	3.3	1.7	0.7	2.1	2.4	0.9	0.5	5.0	1.0	1.7	1.3	1.6	2.7	2.0	0.6	2.0	1.3	3.7	2.5	2.2	3.7	1.3	1.2	4.2	1.8	9.0	1.3	1.6	1.0	1.3	0.5	4.4	1.9	1.8	3.6	2.3	3.4	2.0	0.8	2.1	1.6	1.4	0.9	0.6	4.5	2.5	1.3	1.8	0.5	2.6	4.6	4.8	2.0	2.0	3.1	0.8	2.4	2.1	0.2	1.1	1.4	1.3	1.1	2.2	5.2	3.8	0.4	2.3	2.8	0.7	1.4	0.3	0.7	0.2	0.1	0.1	0.2	0.2	0.3	0.6	0.4	0.2	0.2	1.2	0.7	0.2	0.3	0.1	0.1	2.3	4.2	4.3	3.6	1.9	2.6	0.7	1.0	0.8	0.0	2.7	3.3	0.6	6.4	3.2	0.3	0.7	0.8	2.5	1.0	2.2	6.4	2.4	2.4	4.9	0.0	1.1	0.0	0.0	1.7	0.2	6.8	1.9	2.8	15.4	1.7	2.3	1.0	2.4	0.0	2.5	2.0	1.1	0.9	4.1	3.2	0.0	45.3	0.0	1.5	0.8	8.4	2.3	3.3	0.0	0.3	0.7	11.0	0.3	0.8	0.0	0.0	0.2	2.0	0.0	1.5	1.1	1.7	5.5	2.2	0.7	1.4	1.9	1.1	0.7	5.3	0.0	1.7	1.9	11.8	4.5	1.3	0.3	1.4	0.5	0.3	5.5	2.0
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746815-57758148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	4.4	6.5	4.5	5.2	5.5	17.2	9.1	10.6	6.3	6.6	5.4	6.4	6.4	5.0	21.6	5.0	7.0	4.0	7.2	5.4	4.9	7.7	6.8	6.3	8.3	4.4	3.8	8.3	4.7	10.8	8.3	7.7	4.7	8.5	6.7	20.7	7.8	7.7	9.1	6.4	5.9	4.2	3.7	8.2	7.6	6.6	4.4	12.6	9.3	10.3	8.2	5.5	5.3	8.2	6.2	5.3	16.7	11.2	2.6	8.2	7.2	5.0	8.3	8.7	5.6	3.2	6.8	7.2	4.4	4.6	4.6	4.1	8.8	8.7	13.8	6.5	32.1	9.8	12.6	3.7	6.2	5.5	7.5	9.5	7.1	5.8	6.2	9.2	6.7	11.6	6.6	5.0	11.2	2.9	18.2	4.9	9.7	2.8	11.0	11.6	12.7	8.3	6.4	20.0	18.7	13.7	9.3	7.7	5.5	9.0	7.9	7.7	6.2	9.2	4.9	0.8	7.6	13.8	16.8	12.1	5.5	5.1	7.7	6.6	1.8	8.9	1.1	1.3	2.7	2.4	1.9	2.4	1.7	3.7	2.8	2.2	4.6	5.6	1.7	1.9	1.8	1.6	4.5	5.5	10.6	6.3	5.4	4.9	4.4	3.8	4.7	3.7	4.4	8.2	3.3	3.2	4.1	7.2	7.1	2.7	4.1	3.9	1.8	8.7	7.7	5.3	12.3	11.5	3.2	9.2	2.1	3.1	2.5	3.9	5.9	3.3	1.4	8.3	3.7	6.5	8.4	8.6	7.1	1.3	2.3	2.8	4.1	6.9	3.8	6.9	10.4	8.1	3.5	11.8	7.7	4.1	6.1	6.0	1.8	0.6	1.2	3.6	0.0	6.5	3.1	12.0	5.2	8.0	9.1	2.5	2.1	4.9	3.9	4.1	3.9	2.8	6.0	7.5	0.0	2.6	3.9	2.9	4.8	3.1	1.7	2.9	3.3	2.9	3.2	5.5
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461062	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	7.5	6.6	5.9	4.4	5.4	7.9	7.7	5.8	7.0	8.7	2.3	9.0	4.5	10.4	3.3	6.2	8.4	3.6	7.1	6.0	6.3	6.2	7.3	5.3	5.1	5.9	5.3	10.0	7.5	6.4	8.5	4.9	5.1	8.9	3.3	3.4	7.5	5.2	13.9	11.7	6.3	5.2	4.7	6.7	7.3	6.7	5.9	5.7	7.3	7.0	3.9	9.0	7.9	5.5	14.9	18.0	11.9	17.3	8.7	7.0	15.3	9.4	9.9	12.5	10.8	11.3	9.3	9.4	18.5	10.7	7.7	9.7	11.7	14.3	6.8	15.3	17.8	9.2	5.0	11.4	14.7	13.2	12.9	8.3	16.1	10.1	14.6	6.6	6.8	12.4	30.2	0.0	7.2	19.2	27.9	18.0	14.5	6.6	10.5	22.7	6.1	19.8	7.7	11.4	12.9	18.1	16.2	16.5	15.7	4.3	7.8	21.7	10.7	10.4	4.1	20.8	15.5	8.6	8.2	4.4	7.8	9.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	5.4	5.8	7.0	6.0	6.3	5.9	5.3	5.1	4.7	5.9	5.5	4.0	0.0	1.7	5.9	3.8	1.1	1.4	0.3	2.8	6.5	3.9	5.5	2.9	2.8	0.1	1.8	6.2	2.0	4.2	3.1	0.0	1.2	2.6	2.9	4.8	2.9	1.8	6.6	6.9	1.0	3.8	2.8	2.0	4.5	0.0	8.2	2.9	5.7	1.6	1.7	6.7	3.1	0.0	2.2	1.3	3.8	2.8	2.0	0.0	4.7	0.2	5.5	2.1	3.0	3.5	1.1	3.1	3.4	1.6	2.4	1.4	1.6	0.8	5.5	0.0	5.2	3.7	1.5	4.6	2.5	1.8	3.8	3.5	6.6	2.8	1.0
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear bodies"	Nucleoplasm	"HPA052057: AB_2681710, HPA057151: AB_2683352"	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	2.1	2.2	2.3	1.9	2.5	1.6	2.5	3.7	2.8	2.1	2.4	2.3	1.1	2.2	1.7	2.0	2.1	1.5	2.3	2.4	2.0	3.2	2.1	2.1	1.8	2.4	2.8	2.1	5.0	8.1	2.5	1.4	4.5	2.3	1.9	3.9	2.5	2.9	3.8	3.2	1.7	2.6	2.0	2.3	2.4	5.2	2.7	2.0	3.1	4.3	2.6	2.1	1.7	2.8	4.2	2.3	6.8	5.6	4.2	3.5	8.4	3.3	5.2	4.7	2.8	6.7	2.8	2.2	6.4	4.2	2.5	4.0	9.4	4.6	7.9	0.8	8.4	5.8	4.6	3.2	2.4	1.7	3.2	3.0	3.3	6.2	4.6	3.0	4.2	3.7	6.5	1.1	4.1	10.5	3.5	2.4	9.9	3.4	3.9	9.7	15.6	0.6	2.4	3.8	14.0	10.1	8.2	4.1	2.6	6.2	10.8	3.2	4.4	5.3	3.7	3.5	4.0	4.0	6.0	4.6	7.3	3.3	3.3	10.9	1.2	3.1	3.0	1.9	1.7	0.9	1.5	1.4	1.5	1.2	1.1	1.9	0.3	1.4	2.1	0.5	1.8	1.4	2.3	2.5	3.7	2.8	2.4	2.0	2.4	2.8	4.5	2.0	2.7	2.8	2.9	12.8	4.4	3.6	2.2	1.7	2.8	1.8	9.1	8.6	4.5	4.6	5.1	2.8	2.8	5.5	14.6	2.4	8.4	1.3	0.0	3.3	16.4	4.2	4.6	4.7	3.0	6.1	6.3	5.6	2.2	3.1	5.6	7.7	0.0	5.2	4.6	5.5	2.5	21.9	5.7	2.9	2.0	5.0	0.7	35.3	2.5	6.2	1.8	1.0	4.3	4.3	11.3	2.0	5.9	3.2	1.8	3.0	9.6	5.4	3.4	3.5	0.5	10.5	13.1	11.7	3.4	15.1	12.7	8.2	1.6	2.3	4.7	3.0	2.0	3.3
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 48.9;Hepatocytes: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	2.4	3.1	1.5	3.2	1.6	1.4	2.5	2.8	2.1	2.6	1.9	2.6	1.9	2.6	3.5	3.6	2.5	2.2	2.2	1.5	1.3	2.6	4.3	2.4	4.2	1.2	1.1	2.7	3.9	3.7	2.8	2.4	1.3	2.7	1.9	3.7	3.5	3.0	1.5	2.7	3.4	1.5	0.6	4.2	3.0	1.8	1.2	2.7	3.7	1.8	4.0	2.6	2.9	1.8	3.4	6.4	4.1	3.8	3.6	3.3	2.9	3.9	3.1	3.1	4.8	4.2	2.3	3.1	2.5	1.9	3.1	2.8	2.6	2.2	3.5	5.3	3.6	4.8	5.5	4.0	3.2	5.0	3.8	3.4	2.4	3.2	2.6	4.2	3.3	3.3	5.5	5.0	2.7	2.0	2.0	1.6	3.3	3.3	2.0	1.6	7.2	1.8	2.6	7.0	2.5	4.8	5.8	2.2	2.5	3.6	2.7	6.0	2.5	3.8	5.1	3.5	3.2	4.9	4.6	3.0	2.4	3.4	2.6	1.4	2.4	4.0	1.6	2.3	2.3	1.8	1.8	1.5	2.1	1.4	2.5	2.1	2.1	1.6	3.8	1.6	2.1	1.1	1.5	1.6	2.8	2.1	1.5	1.3	1.2	1.1	1.3	0.6	1.2	1.8	8.5	9.6	10.2	6.2	8.1	3.8	4.5	15.2	6.2	5.8	9.4	5.7	4.0	8.6	11.6	9.2	2.1	5.9	7.0	7.0	9.8	14.5	25.0	4.1	5.5	8.4	3.5	3.4	7.8	48.9	8.5	6.0	2.0	4.5	16.5	4.2	12.8	37.7	15.0	5.0	5.7	7.4	4.1	25.4	11.5	3.6	4.4	11.4	12.4	9.4	12.0	3.9	17.5	4.0	6.5	32.6	7.1	5.3	5.8	3.2	14.1	21.7	13.5	7.3	6.6	4.4	5.1	9.8	4.0	5.2	2.6	5.9	11.8	5.7	7.6	3.4
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056231	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Excitatory neurons: 56.5;Inhibitory neurons: 59.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	2.3	2.9	0.8	1.8	1.8	1.0	2.7	4.6	1.9	4.1	2.8	4.2	1.1	3.7	3.6	2.1	4.1	1.4	5.2	1.1	1.1	2.8	2.9	2.5	3.2	0.6	0.3	6.3	2.8	2.6	7.8	2.0	1.1	4.0	2.3	14.1	3.4	2.8	3.1	1.7	3.2	2.4	0.5	3.3	3.0	2.4	1.2	3.3	5.8	2.1	3.1	3.9	3.4	2.4	2.0	2.5	5.0	2.4	2.0	1.1	0.0	2.6	1.7	2.8	3.8	5.0	1.5	5.7	2.3	2.4	2.1	1.3	3.2	1.4	2.9	4.6	1.6	4.5	6.2	2.9	1.6	6.1	3.1	2.5	0.6	3.9	1.7	2.2	2.1	2.5	4.7	7.4	2.3	0.5	1.8	0.7	4.0	1.7	2.5	3.1	8.7	1.7	1.2	12.2	3.9	5.0	4.7	1.4	1.2	2.7	1.7	2.3	4.1	1.7	6.4	4.3	3.6	5.6	7.8	3.9	2.3	2.6	1.7	0.0	1.3	0.6	1.1	1.2	1.1	1.0	1.3	1.3	1.0	1.6	1.9	1.7	0.1	1.1	0.8	2.5	0.9	0.6	0.8	1.8	4.6	1.9	1.1	1.1	0.6	0.3	1.1	0.5	1.2	2.4	5.3	9.6	9.6	53.8	11.2	1.9	2.7	4.9	1.2	25.6	3.8	5.2	13.1	7.2	7.9	9.2	33.3	1.8	13.0	2.5	3.9	5.6	8.9	2.7	7.0	6.2	10.3	4.6	56.5	10.0	1.5	5.6	5.1	2.7	7.6	8.1	10.0	5.0	3.7	10.1	59.6	4.2	12.2	5.8	5.8	1.8	3.7	4.7	5.4	38.4	7.6	6.2	4.1	56.3	78.0	6.8	4.2	3.0	4.5	1.7	3.5	3.4	4.8	34.7	6.6	5.5	5.3	2.4	2.8	2.8	3.0	0.7	8.0	3.4	4.4	2.0
ZNF781	FLJ37549	ENSG00000196381	"Zinc finger protein 781"	Q8N8C0	19	37667751-37692315	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.1;Late spermatids: 65.7;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 2.3;HSkMC: 2.1;SH-SY5Y: 2.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"							HPA062512	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA062512: AB_2684788"	"unprognostic (3.01e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	1.5	1.6	3.1	0.5	3.5	0.0	1.0	5.7	3.2	2.3	2.4	2.5	0.3	2.2	1.3	0.5	2.0	0.7	1.8	2.8	3.0	1.3	0.3	1.0	1.0	2.6	3.0	3.1	0.5	1.1	3.9	1.4	2.5	1.6	0.8	3.8	0.5	1.4	0.3	0.5	1.2	2.5	2.1	2.1	1.0	1.3	3.1	0.5	1.9	0.5	0.7	1.8	1.2	3.1	0.0	0.0	0.9	2.3	2.3	0.5	0.5	0.8	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	2.1	0.0	0.6	0.0	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.6	0.0	0.3	0.6	0.0	2.2	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.5	0.7	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.0	0.2	0.2	3.1	3.5	5.7	3.2	2.8	3.0	2.6	3.0	2.5	2.1	3.1	3.1	10.4	0.0	0.6	13.7	2.8	0.5	0.5	0.5	1.2	6.3	2.0	1.0	14.9	2.8	0.1	0.0	20.9	7.5	2.5	0.0	0.0	0.8	71.1	0.4	2.6	5.5	7.8	0.8	18.0	0.0	3.1	4.7	0.5	0.1	3.8	5.3	10.4	0.1	3.9	3.3	22.2	0.0	2.0	1.6	0.4	65.7	4.7	0.5	1.8	3.7	0.1	5.3	11.3	42.3	19.9	0.1	0.0	6.8	0.5	0.2	0.0	0.5	0.5	8.5	13.1	1.5	6.4	17.4	5.1	0.1	0.0	1.4	2.2	2.4	0.0	0.2
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816269-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"Astrocytes: 96.3;Excitatory neurons: 105.1;Inhibitory neurons: 126.8;Microglial cells: 70.3;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 166.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	1.6	1.6	2.1	2.3	1.3	1.3	3.0	9.3	3.0	2.4	0.1	2.0	2.3	2.9	3.5	1.6	2.4	1.8	1.1	1.5	1.0	2.6	1.7	1.4	2.6	0.9	0.7	3.3	4.6	3.2	1.8	2.0	1.4	3.0	2.8	9.0	2.2	2.3	2.2	3.9	2.8	2.1	0.1	2.2	2.7	6.1	1.5	3.2	3.2	2.0	3.0	1.6	1.9	3.4	2.1	1.7	4.2	5.9	1.0	1.0	2.5	1.8	1.5	2.4	1.8	1.8	3.3	3.7	2.3	1.4	3.5	3.6	2.9	1.1	2.8	4.2	1.7	3.2	3.8	1.8	1.4	5.3	3.2	0.6	2.5	2.6	1.6	1.9	1.3	5.7	4.8	5.0	2.0	3.6	4.7	2.4	3.0	3.4	2.7	5.4	4.9	1.3	2.2	1.1	3.8	2.7	2.5	1.6	1.8	2.7	2.8	2.5	2.0	3.5	2.6	3.8	2.1	4.9	3.5	2.2	2.2	2.0	2.7	0.0	0.2	0.0	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	2.1	1.3	9.3	3.0	1.5	1.0	0.9	0.7	1.4	0.1	1.5	3.4	3.4	0.0	4.1	96.3	3.3	1.9	1.4	0.6	4.0	5.9	2.3	2.2	1.6	1.5	0.3	1.8	8.4	0.9	5.1	1.7	0.0	1.4	7.5	2.9	3.9	3.6	0.0	7.4	105.1	1.7	0.4	2.3	2.0	5.2	5.7	6.0	3.6	1.1	1.2	3.3	126.8	1.9	0.0	0.6	0.7	9.2	1.8	1.7	0.0	70.3	4.0	1.7	1.0	117.1	166.0	1.0	0.3	3.0	4.6	1.9	2.4	1.8	1.2	7.6	0.0	5.0	3.1	10.6	2.3	2.1	1.0	0.7	2.9	3.3	1.1	2.0
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.11e-4)"	7.1	5.4	6.6	5.3	6.5	3.0	7.4	6.6	7.4	10.8	5.0	7.7	4.0	8.9	3.6	6.0	10.1	3.0	5.4	6.2	6.6	9.9	3.4	6.2	7.3	7.1	6.6	11.7	7.1	2.9	7.1	2.9	6.7	9.4	3.8	2.9	5.8	4.0	6.4	7.0	9.2	4.5	6.1	12.8	6.6	6.6	6.8	4.0	8.3	3.3	6.4	8.1	7.8	8.0	3.5	3.5	5.7	4.1	3.7	6.9	5.3	2.1	1.1	5.0	2.2	5.6	6.5	11.9	5.5	3.5	1.1	2.3	4.0	4.3	2.2	3.3	3.5	7.6	8.7	1.1	8.5	5.1	9.2	7.4	8.7	4.5	5.5	3.1	3.4	4.2	6.2	6.0	4.2	7.6	7.6	7.8	12.8	8.1	4.7	1.6	0.5	10.6	5.6	5.8	4.5	9.5	8.5	4.0	6.0	3.0	4.4	10.1	5.0	4.0	0.9	2.1	4.9	9.1	6.2	0.1	5.6	1.8	8.7	0.1	0.4	0.1	1.0	0.7	0.8	0.7	0.6	0.6	0.4	1.3	0.8	0.7	0.1	0.5	1.7	0.9	0.4	0.4	6.6	6.5	6.6	7.4	6.2	6.6	7.1	6.6	6.7	6.1	6.8	8.0	6.7	3.2	2.7	5.5	6.1	2.5	2.5	4.6	1.8	13.3	7.5	7.6	2.2	7.2	3.2	0.0	10.4	3.0	6.1	3.4	3.9	2.1	5.3	3.2	7.9	4.3	3.6	1.7	5.7	2.7	2.0	7.0	7.1	6.2	0.0	6.4	5.0	6.6	4.2	6.7	6.3	4.7	4.1	7.9	4.6	5.0	8.7	3.9	5.4	11.2	5.2	3.8	8.2	4.0	8.5	3.0	1.6	5.7	3.9	4.0	3.0	1.1	5.5	8.8	13.1	7.4	5.0	16.3	6.9	3.6	3.0	1.1	5.0	6.9	4.3	2.4
ZNF784	MGC75238	ENSG00000179922	"Zinc finger protein 784"	Q8NCA9	19	55620741-55624566	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059676	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA059676: AB_2684102"	"unprognostic (4.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.02e-4)"	4.5	8.5	3.0	3.0	2.9	6.2	5.3	4.3	3.9	8.6	2.2	12.8	8.3	10.7	3.8	7.2	9.2	2.7	13.9	2.8	2.2	7.8	11.5	4.8	3.5	3.6	2.7	11.8	11.3	4.2	7.7	2.6	2.5	11.2	3.3	4.4	6.7	3.7	42.8	6.7	10.2	3.6	2.3	9.1	8.9	5.4	2.9	2.0	7.4	16.0	2.8	10.6	6.6	3.6	4.6	6.4	5.8	3.1	2.2	2.9	5.5	4.7	2.9	2.6	3.5	3.2	5.0	5.5	4.0	3.3	2.0	2.5	1.7	4.1	1.8	3.0	16.7	5.1	5.1	4.1	4.4	4.2	5.3	4.0	4.4	2.2	2.8	4.2	1.7	7.7	6.1	5.5	4.0	4.4	3.3	4.8	5.7	3.5	13.7	6.2	3.9	6.2	4.8	11.5	6.5	8.7	7.7	3.6	2.2	3.8	3.9	7.4	5.4	3.0	2.9	1.9	3.9	6.3	2.8	3.2	4.6	3.1	2.6	0.0	0.4	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.3	0.3	0.2	0.0	0.1	3.0	2.9	4.3	3.9	2.8	2.2	3.6	2.7	2.5	2.3	2.9	3.6	1.9	0.0	7.4	1.6	3.4	0.9	4.7	1.5	2.8	4.7	2.2	3.2	12.3	8.6	1.9	0.0	2.1	5.5	1.3	10.9	3.9	4.0	2.1	2.7	2.5	2.3	5.4	4.4	0.5	4.1	2.4	3.2	1.5	3.2	2.5	5.5	3.9	6.8	3.5	8.4	0.6	6.2	6.1	3.5	1.0	0.1	4.1	2.4	0.0	1.0	4.5	4.2	0.0	1.5	1.1	4.5	7.4	2.6	2.3	2.1	11.2	5.2	2.2	11.0	13.1	2.9	2.7	0.6	2.3	1.8	1.3	10.1	2.0	7.7	5.5	3.7
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069641-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.8;Horizontal cells: 18.5;Inhibitory neurons: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	2.0	2.2	2.9	2.8	2.6	1.5	2.6	3.9	4.3	3.5	1.1	3.1	2.0	3.3	2.4	3.8	3.1	2.0	2.0	2.8	2.6	2.9	3.1	1.9	3.8	1.6	1.7	3.2	2.6	2.3	3.8	1.6	1.5	3.7	1.4	1.9	3.0	2.2	2.0	5.6	3.1	1.9	0.9	3.9	2.3	1.6	2.8	3.5	2.9	2.3	2.8	3.3	3.5	2.8	4.5	8.1	6.1	10.4	3.7	1.5	8.7	2.7	2.8	2.9	2.3	4.3	4.0	6.3	6.3	1.9	5.1	5.0	3.8	3.6	1.9	6.9	5.9	3.2	5.1	5.4	3.1	6.3	4.1	2.2	4.0	3.6	2.6	3.0	2.7	4.5	5.6	3.5	2.7	13.9	10.7	10.5	11.4	4.1	6.0	7.7	3.0	4.1	2.4	6.1	7.3	11.5	6.6	6.1	5.0	3.8	3.9	3.0	3.6	3.4	2.0	6.0	3.9	12.7	10.0	3.5	5.7	3.9	3.8	1.8	3.4	2.9	10.4	4.7	8.8	6.4	7.5	9.4	4.3	5.9	9.7	8.3	1.1	8.5	4.0	3.7	5.0	5.0	2.9	2.6	3.9	4.3	2.8	2.6	1.6	1.7	1.5	0.9	2.8	2.8	2.4	0.0	1.1	3.6	3.5	2.7	2.6	4.2	2.8	10.1	2.3	1.3	2.7	1.5	1.6	3.7	2.1	2.4	5.9	2.0	3.9	4.1	0.4	0.9	2.1	3.1	4.8	0.8	18.8	1.5	2.5	2.6	6.6	1.1	4.5	4.5	1.8	2.4	2.2	18.5	15.8	1.6	2.0	1.9	2.6	0.4	3.1	2.1	0.0	3.7	3.6	2.8	13.4	7.1	5.4	1.8	3.3	4.1	2.9	1.4	1.7	2.5	2.3	6.0	0.0	3.3	2.5	4.9	8.3	2.3	1.7	1.9	6.0	1.8	2.7	1.7
ZNF787		ENSG00000142409	"Zinc finger protein 787"	Q6DD87	19	56087366-56121295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 110.5;Endometrial ciliated cells: 87.6;Rod photoreceptor cells: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035140	Supported		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Mitochondria"	"HPA035140: AB_10602358"	"unprognostic (1.97e-2)"	"unprognostic (5.86e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-3)"	18.3	24.4	13.4	10.2	13.9	27.0	16.6	12.7	15.4	18.2	11.1	24.0	15.7	19.9	3.9	20.8	22.3	3.0	26.9	12.1	11.4	17.6	43.9	17.9	7.3	15.2	13.1	16.1	34.1	5.9	15.9	4.4	12.6	21.2	4.7	7.6	19.0	7.7	42.2	18.0	19.9	4.0	11.9	27.7	23.2	16.1	15.4	5.6	16.5	9.7	4.4	20.8	16.6	13.8	29.2	28.1	9.0	18.9	2.5	5.6	23.3	14.7	5.7	9.8	11.1	16.7	17.6	20.7	1.0	6.2	8.8	22.7	5.7	11.9	4.4	27.5	102.6	32.9	14.6	25.6	14.1	31.8	27.8	7.4	11.6	8.2	14.2	6.1	7.4	11.6	39.9	22.5	5.8	18.2	19.8	40.0	28.4	26.7	52.3	24.6	13.1	26.7	10.2	19.1	34.2	33.3	15.6	30.2	29.4	5.0	18.6	44.5	16.0	36.8	26.6	15.7	41.2	47.4	37.4	20.3	21.4	21.0	17.6	0.6	0.8	1.1	0.4	0.6	0.6	1.0	0.3	0.3	0.8	1.4	0.5	0.2	1.8	0.5	0.6	2.2	0.5	0.3	13.4	13.9	12.7	15.4	12.1	11.4	15.2	13.1	12.6	11.9	15.4	13.8	29.5	12.8	2.7	5.5	11.2	6.1	11.5	5.0	7.4	52.1	19.2	16.9	12.0	11.5	5.5	11.0	110.5	3.3	20.0	29.7	1.9	6.6	2.0	87.6	17.2	16.2	9.1	4.0	5.1	16.7	4.6	10.1	8.6	48.2	5.7	23.2	11.7	33.4	8.9	35.3	4.2	19.8	8.2	11.0	7.8	3.4	5.0	16.4	1.8	6.5	8.9	44.5	7.2	4.5	6.1	13.1	19.5	4.5	7.1	11.3	12.8	5.8	4.0	71.3	6.6	16.0	13.0	3.8	12.1	4.8	7.2	1.9	9.2	55.8	20.6	12.4
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472890-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	5.2	5.7	8.2	4.7	8.3	7.6	5.5	11.0	9.9	7.7	8.1	8.7	8.5	6.1	7.2	5.0	7.1	2.6	4.6	8.3	8.7	9.8	8.8	4.9	6.2	8.4	8.7	7.9	7.6	3.3	11.8	2.6	8.8	16.4	7.3	11.7	6.1	4.3	5.7	7.3	9.8	3.7	8.0	10.7	6.1	13.4	8.5	4.5	8.4	2.9	5.8	5.1	5.2	9.2	12.0	3.8	6.1	11.0	1.9	1.8	8.4	5.8	2.2	3.7	7.9	6.0	7.7	8.6	4.8	2.7	3.7	5.0	3.2	3.3	5.0	4.0	6.0	6.6	10.3	11.8	3.1	4.3	14.5	2.1	2.8	7.2	3.5	2.2	3.9	11.1	10.2	7.7	3.3	11.6	5.7	12.0	6.1	5.7	5.6	7.0	6.2	9.4	4.9	3.4	5.9	6.6	4.2	11.8	7.3	3.4	3.0	7.5	6.1	6.4	8.0	9.9	5.9	5.0	7.6	11.9	10.8	8.2	6.9	2.0	1.5	1.5	2.3	1.0	2.7	2.3	3.0	2.6	5.2	3.6	6.0	3.7	0.3	4.2	1.3	13.5	5.1	1.8	8.2	8.3	11.0	9.9	8.3	8.7	8.4	8.7	8.8	8.0	8.5	9.2	8.2	0.0	6.3	11.8	9.5	5.5	4.2	4.0	4.6	18.3	6.3	6.7	2.4	1.5	4.6	1.8	14.6	4.4	14.0	6.3	1.9	3.8	33.9	5.2	4.8	7.2	5.4	8.6	10.4	5.4	3.2	4.7	9.2	5.6	3.8	11.8	1.8	3.5	6.9	6.7	12.7	6.3	4.1	3.1	6.5	8.4	3.4	4.6	7.2	10.3	3.8	12.0	5.2	12.5	10.6	4.3	5.4	4.5	6.1	2.7	5.2	4.6	4.9	14.7	0.0	6.5	4.8	20.8	4.8	6.7	5.3	2.2	6.9	8.5	6.6	3.4
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	2.6	3.6	2.1	3.3	2.7	3.4	3.6	5.6	2.5	3.1	2.6	3.6	2.6	3.5	4.4	2.9	4.0	2.0	3.2	2.0	2.7	2.9	3.3	2.9	4.1	2.8	2.3	3.8	2.9	4.9	2.6	3.0	2.2	3.5	3.5	3.1	3.4	3.4	4.7	3.6	2.8	3.7	1.6	3.7	3.0	6.2	2.4	5.5	3.8	5.2	4.7	4.3	2.2	2.9	2.5	5.0	6.5	3.9	7.1	4.2	18.2	6.1	7.4	7.2	8.2	5.3	2.3	5.4	2.4	4.6	9.5	7.7	4.9	7.5	5.7	5.4	3.2	3.7	8.4	6.0	8.4	8.9	5.7	4.2	8.3	8.9	7.2	4.6	7.5	6.1	6.4	7.9	6.9	5.5	7.0	3.3	5.2	6.2	6.4	5.7	9.0	7.7	3.1	3.6	7.4	5.0	11.7	5.9	3.5	5.6	7.9	5.0	5.3	4.6	4.2	4.6	4.8	10.5	24.1	6.8	5.9	2.7	7.8	2.2	3.3	5.1	6.0	4.1	6.7	5.1	3.9	7.6	4.7	5.8	5.2	5.7	4.5	7.2	2.8	4.9	5.5	3.6	2.1	2.7	5.6	2.5	2.0	2.7	2.8	2.3	2.2	1.6	2.4	2.9	0.8	0.0	0.5	2.6	2.4	1.5	1.2	0.8	1.8	0.8	1.0	0.9	2.5	2.8	1.7	0.0	0.0	2.0	0.9	0.9	1.9	2.0	4.5	0.4	1.9	1.1	0.0	4.8	3.1	0.6	0.6	1.2	2.6	0.5	0.0	1.1	1.1	1.2	2.1	1.7	3.2	0.5	0.0	0.8	1.2	4.7	0.6	0.6	0.0	1.0	0.1	0.9	2.1	4.0	2.9	0.5	0.3	1.9	3.0	0.7	0.9	1.0	0.7	1.2	0.0	0.4	1.3	5.8	1.6	2.3	1.0	2.6	1.5	1.3	1.1	0.9
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA056134: AB_2683049, HPA060288: AB_2797260"	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	3.6	4.9	4.0	3.8	5.8	2.2	4.3	9.9	5.4	4.2	5.1	3.1	3.9	3.4	3.0	4.5	3.2	5.0	5.5	3.9	6.8	6.0	8.7	3.7	5.4	7.2	5.6	4.5	4.5	5.8	3.0	3.7	6.4	4.0	2.6	8.1	3.1	3.4	5.0	9.7	3.8	3.4	3.6	4.8	4.9	11.3	5.4	4.3	8.0	5.0	3.4	3.6	3.0	7.2	0.0	0.8	6.7	12.2	4.6	4.8	4.3	4.8	6.4	3.8	6.8	0.0	1.5	1.5	9.4	3.5	4.6	1.8	5.4	4.3	3.4	11.4	4.8	8.1	0.7	1.9	3.9	3.6	5.8	6.2	3.6	3.2	0.0	4.4	6.5	6.1	0.3	0.1	8.5	3.8	9.4	2.9	4.6	0.0	0.9	1.6	5.6	6.2	4.1	9.0	8.4	7.6	4.5	0.1	2.6	7.6	5.5	6.7	7.2	5.2	4.0	4.7	6.4	9.5	14.5	5.6	0.0	0.2	4.2	4.5	2.6	5.1	3.9	4.3	4.1	6.8	5.6	5.6	4.8	7.8	5.8	4.9	0.7	4.8	1.6	4.0	4.9	2.3	4.0	5.8	9.9	5.4	3.9	6.8	7.2	5.6	6.4	3.6	5.4	7.2	5.0	3.2	1.1	14.7	7.5	1.8	3.4	8.3	5.2	24.9	3.7	3.0	4.0	7.2	4.3	7.3	31.3	6.9	8.7	4.3	5.9	5.3	109.1	3.8	5.3	7.9	2.4	10.1	12.4	5.1	3.5	4.5	4.1	4.8	4.5	10.6	5.7	5.6	4.3	11.8	14.6	3.5	10.2	4.6	4.0	33.7	8.4	2.3	3.6	16.9	5.0	10.1	24.7	21.1	17.9	4.6	2.4	4.9	1.5	3.5	6.3	10.6	4.3	28.2	0.0	4.9	5.1	6.9	2.9	3.3	4.1	5.9	7.4	8.7	3.1	6.8
ZNF791	FLJ90396	ENSG00000173875	"Zinc finger protein 791"	Q3KP31	19	12610918-12633840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021537	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021537: AB_2670741"	"unprognostic (1.95e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.86e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.39e-5)"	8.3	5.9	4.9	7.4	5.7	13.3	9.3	11.6	6.1	8.6	6.7	7.2	5.7	8.2	7.6	6.9	7.8	5.1	6.3	4.7	6.4	6.3	6.7	8.6	8.6	6.0	6.2	10.2	7.2	9.6	7.3	6.5	5.8	7.2	6.4	13.6	7.3	6.7	6.9	8.6	7.8	5.7	4.8	7.8	6.7	2.7	5.4	5.2	12.1	8.2	10.1	8.2	8.1	8.3	7.2	4.0	7.6	7.7	8.6	11.3	6.4	9.7	10.1	5.8	8.3	5.0	4.5	1.6	9.1	9.8	3.8	6.7	7.1	8.7	10.6	4.8	7.7	7.6	10.0	6.9	6.9	9.7	6.7	9.9	9.6	8.5	11.4	10.4	7.3	4.4	8.6	11.2	7.2	10.9	6.2	3.5	8.2	4.3	11.9	4.4	13.0	6.2	5.9	14.3	8.5	10.3	7.9	6.6	8.5	8.9	6.5	8.1	7.5	13.2	5.3	11.8	7.3	15.6	22.8	5.0	8.9	6.8	8.3	9.9	2.6	4.7	5.5	1.9	5.5	6.2	4.8	5.6	2.4	8.6	5.4	6.6	4.6	9.2	3.5	8.3	4.2	2.2	4.9	5.7	11.6	6.1	4.7	6.4	6.0	6.2	5.8	4.8	5.4	8.3	34.2	12.8	28.2	4.9	56.1	29.2	31.2	18.1	35.9	75.5	28.3	25.7	21.8	27.1	22.6	18.4	98.0	30.5	56.7	29.0	19.6	23.8	5.5	35.6	29.3	41.2	37.1	16.8	9.1	17.6	19.4	31.6	15.8	34.2	9.5	58.7	48.9	26.5	14.0	35.3	9.4	26.3	16.2	21.8	33.5	3.9	39.1	24.9	14.2	1.0	19.8	36.2	49.4	3.0	10.9	26.3	15.4	39.1	69.5	37.6	33.0	13.3	27.9	98.0	39.5	34.8	34.6	13.4	12.7	22.1	27.7	39.1	41.5	33.2	24.1	36.8
ZNF792	FLJ38451	ENSG00000180884	"Zinc finger protein 792"	Q3KQV3	19	34956354-34964229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2"					"Low region specificity"	"Detected in many"			"HPA035157, HPA035158"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA035157: AB_2674497, HPA035158: AB_10603010"	"unprognostic (1.31e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (2.72e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.77e-3)"	3.8	1.3	1.1	2.2	1.6	1.3	3.6	3.6	1.3	2.4	1.1	1.9	2.1	2.2	1.9	1.0	2.6	1.7	2.0	0.9	1.2	1.6	1.3	4.1	3.8	1.2	1.4	2.3	1.8	2.8	1.1	3.4	1.2	1.8	2.3	2.5	2.2	2.2	1.2	1.5	2.4	2.6	0.9	3.6	2.5	0.9	1.3	4.0	1.9	2.1	2.8	2.3	1.4	0.9	1.1	3.8	1.8	2.7	1.8	1.4	0.0	1.1	2.0	1.3	1.6	1.5	1.8	1.6	3.4	1.5	0.6	0.7	2.6	2.0	2.0	4.6	0.6	12.8	1.1	2.9	1.3	1.1	16.1	1.6	0.6	1.1	0.5	2.3	11.0	1.1	3.4	0.0	2.2	0.9	4.5	1.1	1.3	9.7	0.8	2.9	0.0	0.2	1.0	3.5	0.9	10.2	1.0	1.0	1.3	1.6	1.2	3.4	4.5	1.9	2.4	0.8	1.2	0.3	1.0	0.9	2.1	0.2	0.9	5.4	0.5	4.1	1.9	0.4	2.3	1.3	3.0	2.7	0.7	0.9	3.3	2.8	0.1	3.0	0.3	0.1	3.2	1.7	1.1	1.6	3.6	1.3	0.9	1.2	1.2	1.4	1.2	0.9	1.3	0.9	7.0	0.0	1.1	0.7	2.1	0.5	0.1	0.6	0.6	0.8	1.2	0.9	2.0	0.0	0.2	0.0	2.1	0.1	2.9	0.7	0.0	1.8	0.2	0.7	0.7	7.5	1.8	3.4	0.3	2.6	0.4	1.0	2.0	0.8	1.3	1.4	6.4	0.6	1.5	0.0	0.6	1.7	0.0	3.5	1.4	0.4	1.5	1.6	0.0	1.0	1.6	0.5	2.1	2.5	0.3	2.7	1.0	0.0	1.6	0.2	0.5	0.5	0.2	1.8	0.0	0.9	0.6	0.0	1.5	0.4	0.4	0.1	3.0	0.7	1.4	0.1
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7"					"Low region specificity"	"Detected in all"			HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	1.8	4.4	6.1	2.4	5.7	1.2	3.6	10.0	5.9	4.9	4.3	3.7	1.8	5.3	3.8	3.3	4.6	2.5	4.2	5.5	5.5	5.3	0.8	2.1	3.7	4.4	4.4	8.1	2.5	6.0	9.2	2.7	4.2	4.6	3.3	14.7	2.8	3.2	2.4	6.4	2.5	3.3	3.2	3.6	3.0	9.0	5.3	2.8	6.5	2.3	2.8	3.7	4.5	6.0	0.1	0.2	4.5	11.6	0.9	0.9	0.3	3.7	0.2	0.7	0.4	0.2	1.5	3.4	5.6	1.9	1.0	0.5	0.3	2.9	0.3	0.8	4.2	0.4	0.4	0.3	2.4	0.2	2.9	3.5	2.2	0.7	0.1	0.3	0.1	0.4	0.1	0.5	0.5	3.2	0.4	0.4	7.3	0.0	0.2	0.1	0.1	0.8	3.3	10.0	3.4	6.8	0.1	0.1	0.0	8.2	6.7	0.3	0.4	0.1	1.8	0.2	3.5	18.4	12.7	0.2	0.0	0.2	0.6	4.0	0.6	0.5	0.6	0.2	0.9	0.9	1.1	1.0	0.4	1.4	0.7	0.9	1.6	1.6	0.2	0.9	1.0	0.7	6.1	5.7	10.0	5.9	5.5	5.5	4.4	4.4	4.2	3.2	5.3	6.0	6.5	3.2	5.8	24.2	4.0	3.3	3.8	2.6	6.2	29.1	5.0	5.8	9.7	7.2	5.0	12.9	31.3	5.5	2.9	1.7	3.9	3.6	39.6	5.0	8.7	7.0	9.0	2.1	14.9	1.5	4.1	4.6	1.1	3.9	2.5	21.5	6.4	0.5	0.9	48.8	16.3	2.9	0.0	0.3	3.4	11.2	5.0	0.9	0.0	2.8	1.5	13.6	8.2	19.6	16.7	2.0	1.0	10.1	1.1	2.8	1.0	2.7	5.7	33.6	0.0	8.7	5.3	6.0	6.9	4.0	3.3	1.9	4.0	12.7	3.7	1.9
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	2.9	3.0	2.4	1.5	2.5	1.6	3.8	3.5	2.6	3.4	2.3	2.5	2.1	2.9	2.0	1.8	3.9	2.1	2.0	2.5	2.3	3.4	3.8	2.9	2.6	2.7	2.4	4.4	2.2	2.4	1.1	4.7	2.5	2.6	2.6	1.6	2.2	2.2	1.8	2.4	2.5	2.4	2.4	2.9	2.0	2.7	2.8	3.1	2.0	2.3	2.3	2.7	2.6	2.9	3.0	2.4	3.0	7.2	1.6	1.5	6.0	1.6	2.2	3.9	3.7	4.6	1.2	3.8	2.8	1.9	1.9	2.1	2.4	2.8	3.7	0.0	2.2	3.0	2.0	7.5	0.5	2.3	5.3	1.8	1.7	2.8	2.2	1.2	1.9	3.6	3.1	0.0	2.5	4.2	4.8	3.3	1.6	3.9	6.1	0.5	4.5	3.9	4.0	7.2	1.9	2.2	2.9	0.7	0.9	2.2	3.2	4.2	1.8	4.0	2.3	4.8	1.8	2.6	4.4	3.0	0.4	2.4	1.7	3.1	2.6	2.9	3.9	2.6	4.5	4.7	3.6	5.7	2.1	4.4	3.4	2.7	2.5	2.8	1.6	2.7	4.5	2.3	2.4	2.5	3.5	2.6	2.5	2.3	2.7	2.4	2.5	2.4	2.8	2.9	7.5	6.4	1.5	5.2	3.8	2.4	3.1	1.4	4.6	1.8	5.6	4.3	5.4	1.5	2.0	3.7	0.0	15.2	3.0	3.2	5.9	4.6	8.6	8.0	2.4	7.3	4.2	0.8	5.4	1.3	2.9	2.9	2.6	8.5	3.8	2.9	3.3	1.4	4.4	0.0	4.0	5.7	6.1	1.2	2.6	2.3	2.5	2.2	0.0	10.3	2.1	1.3	6.2	8.0	4.7	2.5	2.3	1.2	2.0	2.1	3.6	2.9	4.7	3.1	13.1	2.8	4.6	4.5	5.6	4.0	1.4	4.5	3.7	1.9	4.0	2.6
ZNF8	"HF.18, Zfp128"	ENSG00000278129	"Zinc finger protein 8"	P17098	19	58278955-58302791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034797, HPA034798"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA034797: AB_10696364, HPA034798: AB_10602785"	"unprognostic (1.41e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.56e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.28e-2)"	1.5	1.8	2.3	1.1	1.8	3.6	1.6	4.6	3.2	1.5	1.0	1.7	1.1	1.8	1.5	1.6	1.7	1.1	2.2	2.8	1.5	1.9	1.1	2.1	1.4	1.7	1.7	1.8	1.6	2.0	2.3	1.5	1.7	1.6	1.1	4.0	1.7	1.3	0.9	2.5	1.7	1.4	0.9	1.8	1.6	1.4	2.1	2.1	1.8	1.4	1.3	1.6	1.6	2.8	1.8	2.6	3.7	6.9	2.3	1.9	3.1	0.9	1.4	0.9	1.0	2.8	1.3	2.3	1.1	1.5	0.8	1.6	2.7	3.0	1.2	1.8	11.4	4.5	6.0	2.5	2.1	1.5	3.5	3.7	1.8	1.6	3.1	2.7	1.7	3.7	2.4	0.9	1.9	2.1	3.5	2.0	3.3	1.3	1.8	3.9	3.5	1.6	1.8	6.3	6.5	3.5	2.8	1.9	0.9	2.8	1.9	2.8	2.5	6.9	1.7	1.0	1.9	3.4	2.9	3.0	1.1	0.0	1.8	1.4	0.7	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.4	0.5	0.3	0.4	1.3	0.5	0.3	0.3	0.2	0.7	2.3	1.8	4.6	3.2	2.8	1.5	1.7	1.7	1.7	0.9	2.1	2.8	4.2	0.0	4.1	2.3	2.3	0.0	2.9	0.0	2.8	11.0	2.5	2.3	3.1	0.0	1.8	5.5	12.5	2.1	1.2	1.4	3.9	4.0	4.0	4.7	5.3	4.5	5.4	10.3	4.2	2.3	1.6	2.8	4.1	3.9	1.3	5.9	6.8	1.7	2.5	11.8	4.3	2.1	0.0	1.9	0.0	0.9	4.1	2.4	0.0	1.9	3.0	3.5	2.1	3.0	3.3	3.1	0.5	1.9	1.7	4.4	1.0	2.5	2.2	10.2	6.6	6.6	2.6	8.0	3.4	2.8	0.0	2.6	3.4	5.1	1.9	2.8
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 3.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.2;granulocytes: 1.3;NK-cells: 2.1;Plasma cells: 1.4;T-cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Not detected"	"Not detected"											HPA065484	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"		"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"	0.1	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.7	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.7	0.0	0.4	0.0	5.2	0.1	0.1	0.0
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	10.7	7.2	5.7	11.6	7.3	74.6	12.0	20.2	5.0	8.4	1.4	10.8	10.4	9.6	7.9	12.5	7.8	11.3	6.0	2.9	4.4	8.2	14.7	10.2	16.6	5.4	6.3	10.3	12.5	11.3	3.5	9.2	5.9	9.3	10.1	9.9	8.2	7.7	5.7	10.6	10.7	9.5	5.9	13.2	11.4	20.6	6.3	13.2	11.0	7.2	14.3	10.5	5.5	7.9	16.0	8.4	9.5	16.5	13.5	17.3	9.2	14.9	17.5	15.1	14.6	7.8	15.0	27.1	9.0	14.6	16.3	11.1	15.7	15.6	20.9	23.9	9.5	17.7	8.5	7.1	16.9	24.2	32.3	15.4	14.9	16.2	22.0	12.5	16.5	16.3	22.3	27.0	16.9	12.4	26.5	17.2	7.9	14.5	10.8	16.7	13.3	18.0	11.0	19.8	13.6	13.9	14.8	58.7	19.8	12.9	7.0	16.3	18.0	25.0	8.0	17.2	18.1	31.7	15.2	39.0	18.8	21.5	21.8	22.1	8.7	13.6	16.1	8.0	16.3	15.4	11.8	16.5	9.0	17.3	19.2	21.0	7.5	25.0	9.0	15.3	18.6	8.0	5.7	7.3	20.2	5.0	2.9	4.4	5.4	6.3	5.9	5.9	6.3	7.9	49.0	38.5	23.5	27.7	65.1	44.7	51.7	14.7	52.3	29.0	28.3	20.6	16.8	11.5	20.1	12.9	22.9	12.0	70.5	30.2	11.7	24.1	44.8	22.2	30.8	37.2	16.2	52.0	46.4	19.2	14.0	32.0	40.2	26.3	29.2	26.3	26.7	17.5	14.4	77.4	35.5	29.3	8.2	25.3	34.1	11.3	27.1	41.7	28.4	45.9	37.9	17.5	79.3	41.7	71.8	24.5	22.0	31.6	57.8	48.3	26.8	13.3	18.3	27.9	26.3	54.9	30.1	111.9	39.9	44.4	47.9	22.0	65.5	30.1	25.5	68.5
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598529-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 3.8"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 267.9;Inhibitory neurons: 676.0;Oligodendrocyte precursor cells: 186.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.3;RH-30: 17.7;THP-1: 13.9;U-698: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.0	0.2	1.6	1.0	4.7	0.6	0.0	4.7	5.0	0.1	0.0	0.2	0.5	0.0	0.0	0.1	0.0	1.1	0.0	3.3	3.5	0.6	0.1	0.3	0.9	2.1	0.8	0.2	0.0	0.0	0.0	0.1	1.6	1.2	0.3	3.8	0.1	1.3	0.0	0.0	1.2	0.1	0.5	0.6	0.4	0.2	1.8	0.0	1.4	0.0	1.0	0.4	0.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	6.3	2.1	1.9	0.0	0.0	28.3	0.0	0.0	2.6	0.0	0.4	0.0	4.6	0.2	0.0	7.4	1.0	0.1	10.0	7.1	0.0	3.1	0.0	0.0	1.6	3.2	4.9	0.0	0.0	1.2	0.0	0.0	0.0	6.8	0.0	0.0	4.8	0.0	17.7	1.1	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.1	0.0	13.9	0.0	6.8	0.1	0.2	2.8	3.1	0.0	20.5	7.7	2.0	2.2	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.7	4.7	5.0	3.3	3.5	2.1	0.8	1.6	0.5	1.8	0.6	0.1	0.0	0.6	13.4	9.2	0.0	0.0	0.0	0.0	38.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	2.2	0.6	0.0	5.5	267.9	0.0	0.0	2.2	0.0	0.3	0.0	0.9	0.0	0.2	2.9	3.3	676.0	1.1	0.0	1.6	3.7	0.6	0.3	5.4	0.0	6.5	3.5	1.0	0.0	186.5	5.4	0.0	0.0	0.0	21.5	0.0	1.5	0.1	0.0	2.9	6.6	0.1	0.7	5.3	1.2	0.0	0.0	0.0	0.5	1.1	2.7	0.1
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759700-89338528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;thyroid gland: 3.9"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 608.6;Inhibitory neurons: 266.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.2	0.9	0.1	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.5	0.2	0.7	0.2	0.9	0.4	0.0	0.8	0.5	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	608.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	266.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	1.8	29.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	1.2	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0
ZNF805		ENSG00000204524	"Zinc finger protein 805"	Q5CZA5	19	57240632-57262728	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA046330, HPA058895"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046330: , HPA058895: AB_2683846"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.64e-1)"	1.5	1.9	2.6	1.5	3.0	6.7	2.0	2.6	2.5	1.6	3.3	1.3	1.0	1.7	1.6	1.1	1.4	1.2	1.5	2.1	2.7	1.3	1.9	1.6	1.5	3.1	3.1	2.1	1.3	2.2	1.3	1.8	2.7	1.3	1.6	2.7	1.4	1.5	1.8	2.0	1.1	1.8	2.5	2.1	1.5	2.2	3.2	1.6	1.7	2.1	2.0	1.3	1.1	3.7	1.3	1.8	2.1	3.0	3.9	2.7	2.6	1.2	2.6	2.1	4.2	1.9	1.1	2.5	0.9	2.9	1.4	0.8	2.1	2.3	3.5	1.3	5.3	2.6	1.8	2.2	3.0	2.5	2.3	3.1	2.6	2.7	4.7	1.9	1.9	2.7	0.9	3.5	1.7	0.9	2.9	1.3	1.6	1.2	2.1	1.3	3.9	2.1	1.6	3.9	1.7	1.9	3.2	1.9	2.1	2.5	1.2	2.5	2.2	3.3	2.1	1.3	1.6	3.2	2.4	2.4	2.0	1.3	1.6	1.0	0.8	2.4	1.6	0.4	1.8	1.5	1.3	2.0	0.8	0.7	1.3	1.4	0.9	2.8	0.6	0.8	1.6	0.9	2.6	3.0	2.6	2.5	2.1	2.7	3.1	3.1	2.7	2.5	3.2	3.7	4.1	3.2	0.5	7.2	2.3	1.7	2.2	1.3	2.8	6.3	2.1	2.2	2.0	0.0	0.7	1.8	8.4	1.1	3.5	0.7	1.9	1.6	5.3	2.8	4.2	2.3	1.2	3.2	7.4	1.1	1.6	2.9	2.0	2.7	4.5	2.6	2.9	0.6	0.9	3.3	7.1	1.1	0.0	0.8	0.4	0.8	1.2	1.9	0.0	10.3	0.0	2.5	2.1	7.5	9.7	1.4	0.2	0.7	3.9	2.1	0.9	0.8	1.6	5.4	0.0	4.4	3.7	7.8	2.8	1.8	1.1	2.3	2.7	5.1	0.7	2.4
ZNF81	"HFZ20, MRX45"	ENSG00000197779	"Zinc finger protein 81"	P51508	X	47836902-48002561	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 17.7;Inhibitory neurons: 19.3;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 16.5"					"Low region specificity"	"Detected in all"			HPA001689	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001689: AB_2666416"	"unprognostic (1.61e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.82e-4)"	"unprognostic (5.20e-2)"	"unprognostic (4.85e-3)"	"unprognostic (6.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-2)"	1.7	1.9	3.0	2.5	3.9	3.2	1.8	2.7	3.4	2.3	1.8	2.4	1.5	2.6	2.3	2.2	1.6	1.7	3.6	2.6	4.3	2.6	1.5	1.9	2.3	3.4	2.5	2.1	1.8	3.5	2.3	2.0	2.9	1.8	2.9	4.3	1.5	1.6	1.8	3.5	1.7	2.3	2.2	2.8	1.8	1.1	3.5	2.9	2.9	1.0	2.9	2.1	2.0	4.5	2.1	8.0	4.3	3.7	4.4	4.6	2.2	3.2	2.3	3.2	2.7	3.6	2.2	4.4	1.9	2.4	4.5	3.1	6.2	3.0	2.8	6.2	5.7	5.8	5.9	0.8	2.8	7.2	4.5	2.9	2.6	5.0	3.5	2.8	2.9	3.9	6.0	3.2	3.6	3.9	4.9	2.0	5.0	1.8	3.0	3.3	5.9	3.1	1.5	2.6	4.1	6.4	8.1	1.5	2.2	4.7	3.4	2.1	7.1	2.8	5.2	5.4	2.4	4.4	16.5	3.6	4.3	5.1	2.7	1.4	1.5	3.0	1.2	1.8	0.4	0.5	1.0	0.9	1.6	0.8	1.1	0.5	1.8	2.7	1.3	1.0	0.8	1.1	3.0	3.9	2.7	3.4	2.6	4.3	3.4	2.5	2.9	2.2	3.5	4.5	1.7	0.0	2.6	22.5	1.8	1.3	1.9	2.0	1.8	3.0	1.7	1.4	4.3	4.3	1.4	5.5	8.4	1.1	1.8	3.0	1.9	1.2	0.2	1.4	3.1	3.6	3.6	0.0	17.7	1.0	1.5	2.0	1.5	1.6	0.0	4.8	2.5	1.8	1.5	1.7	19.3	1.8	4.1	1.3	2.1	0.7	0.6	3.4	5.4	13.1	1.6	2.0	2.1	22.1	37.0	1.4	3.7	1.9	2.6	2.0	2.0	2.3	3.4	2.9	0.0	2.9	2.9	0.8	1.1	1.6	3.7	1.1	2.1	4.9	2.2	2.3
ZNF813	FLJ16542	ENSG00000198346	"Zinc finger protein 813"	Q6ZN06	19	53467733-53496255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 18.1"									HPA056406	Uncertain		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA056406: AB_2683119"	"unprognostic (1.20e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.56e-2)"	1.2	1.1	0.9	1.5	1.3	1.4	2.2	1.1	1.1	1.1	1.4	1.8	1.8	1.3	3.9	1.2	1.8	1.4	0.7	1.0	1.2	1.3	0.7	1.4	2.2	1.4	1.4	1.8	1.3	2.4	0.6	3.6	1.3	4.9	1.7	0.6	1.2	1.1	0.4	2.0	1.7	1.0	1.0	1.9	1.9	1.6	1.3	2.2	1.9	0.5	2.1	1.4	1.2	1.8	0.9	0.8	2.6	4.3	2.2	2.6	6.0	2.4	2.4	1.6	2.3	4.6	2.7	6.9	2.3	2.3	3.0	1.4	6.3	2.7	3.0	0.0	9.9	6.9	1.8	5.2	1.1	0.0	7.1	2.2	2.2	1.8	1.3	0.9	1.4	4.9	3.8	0.1	2.6	1.3	9.2	3.8	3.3	0.8	2.4	5.6	5.7	3.4	1.5	18.1	1.1	2.5	0.0	4.5	1.6	5.6	1.8	3.4	2.3	0.9	3.1	0.1	2.3	3.6	5.5	7.5	0.0	0.0	4.7	1.8	1.1	0.8	1.7	1.6	1.7	1.6	1.6	1.9	1.2	2.4	3.0	2.3	0.5	3.6	3.0	1.1	1.3	1.4	0.9	1.3	1.1	1.1	1.0	1.2	1.4	1.4	1.3	1.0	1.3	1.8	3.4	6.4	1.8	0.3	4.4	1.8	3.1	1.4	4.6	0.7	1.9	1.8	1.9	5.7	2.6	0.0	0.0	5.0	4.3	2.5	1.9	2.2	1.7	2.6	3.2	4.0	0.0	3.4	0.3	1.2	10.1	4.1	3.6	2.6	0.0	7.0	13.6	1.2	2.8	3.3	1.0	3.2	2.0	3.0	1.7	0.9	2.5	2.6	3.6	1.0	3.7	1.1	3.1	2.0	2.8	1.5	3.4	2.2	1.5	5.0	1.2	0.8	2.0	0.6	0.0	4.0	3.4	0.9	4.1	2.2	1.6	8.9	2.8	2.6	3.9	2.3
ZNF814		ENSG00000204514	"Zinc finger protein 814"	B7Z6K7	19	57848731-57889074	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 32.5;U-266/84: 33.4"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (3.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.78e-4)"	"unprognostic (5.05e-3)"	"unprognostic (2.41e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.54e-5)"	6.4	14.5	9.2	4.5	7.8	10.4	8.1	24.8	8.3	5.5	7.3	7.6	6.6	5.2	6.9	5.2	8.5	4.5	12.9	9.2	5.2	14.5	13.4	6.3	8.7	6.3	5.2	7.4	7.2	9.7	14.2	4.9	5.7	12.6	4.8	13.8	8.7	5.5	10.0	9.5	9.2	4.0	1.2	13.0	5.4	11.2	6.6	9.5	14.7	5.7	8.1	6.3	5.4	7.1	1.6	4.0	11.6	16.6	1.2	1.1	3.0	4.1	2.7	4.4	0.6	2.0	1.6	8.9	2.7	3.8	4.5	1.3	0.7	8.8	5.4	1.6	7.9	6.6	7.0	2.4	4.8	7.8	8.2	7.3	7.9	1.6	1.7	7.8	1.1	3.6	1.8	3.6	7.3	1.7	25.2	3.6	32.5	0.9	5.1	3.1	1.3	15.6	3.8	6.2	4.7	11.8	1.4	3.2	6.1	23.5	8.0	2.5	2.5	10.3	3.5	2.4	2.2	10.1	33.4	22.5	2.6	4.3	12.9	4.6	8.2	9.7	5.4	9.7	14.0	37.4	14.2	11.7	11.9	38.7	22.4	18.5	5.4	24.8	6.0	27.9	4.2	7.4	9.2	7.8	24.8	8.3	9.2	5.2	6.3	5.2	5.7	1.2	6.6	7.1	6.2	0.0	1.5	4.6	15.6	6.8	10.5	7.3	4.0	22.7	11.5	9.8	12.9	21.5	10.1	12.9	47.9	13.2	10.8	5.0	17.6	8.0	46.5	13.9	6.6	7.6	4.9	5.9	10.9	1.4	18.6	5.5	6.1	20.4	16.5	12.6	14.6	15.3	13.0	20.2	12.3	8.7	14.2	2.8	7.9	19.5	4.1	6.5	10.6	4.7	5.9	9.4	13.4	7.5	10.1	1.7	17.8	7.2	5.9	8.4	10.5	44.0	8.4	35.9	19.7	5.7	6.6	14.1	10.9	3.5	13.1	11.6	9.2	8.9	22.1	12.6
ZNF816	ZNF816A	ENSG00000180257	"Zinc finger protein 816"	Q0VGE8	19	52949379-52962911	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 52.6"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (1.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (6.21e-2)"	"unprognostic (5.45e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-2)"	2.8	3.2	2.5	4.6	2.9	3.3	7.9	6.7	3.5	9.5	3.7	9.1	4.8	5.8	8.4	4.3	11.7	5.3	4.6	2.2	2.8	6.0	2.7	5.5	7.7	2.9	2.5	8.4	5.7	6.0	2.9	6.6	3.3	12.5	10.1	5.9	4.6	6.9	1.8	5.2	4.9	4.6	2.3	6.8	10.0	4.4	2.8	9.6	7.2	3.0	8.8	8.2	4.5	3.1	6.5	0.2	5.8	14.5	10.2	11.6	17.0	5.4	5.5	6.8	10.1	4.7	4.1	17.8	11.2	4.8	10.5	3.9	8.5	6.3	6.6	8.9	17.1	8.3	7.0	7.7	3.5	0.0	12.3	5.5	7.8	4.3	7.9	8.0	5.8	8.1	13.4	0.6	8.7	5.3	14.4	9.6	6.8	3.8	8.0	7.9	12.2	8.6	10.7	52.6	4.4	8.1	0.2	9.1	3.6	11.3	5.7	9.6	5.0	5.0	4.9	3.4	6.1	6.0	18.4	16.1	0.6	8.8	6.0	15.2	8.6	17.3	14.4	7.5	19.5	11.3	13.5	14.3	10.0	11.6	18.5	14.5	3.9	21.3	9.6	9.3	13.9	8.9	2.5	2.9	6.7	3.5	2.2	2.8	2.9	2.5	3.3	2.3	2.8	3.1	2.0	3.2	1.5	0.0	2.8	0.9	2.8	4.3	2.2	1.6	1.4	1.3	2.2	2.8	7.0	1.8	6.2	4.9	2.5	1.8	7.9	3.8	3.3	4.8	1.8	2.1	0.0	7.8	0.0	1.6	3.7	1.7	2.0	3.7	7.6	3.8	1.4	0.7	2.4	0.0	0.0	3.2	4.1	1.0	1.7	2.3	1.5	1.8	5.4	0.0	3.7	1.0	8.2	0.0	0.0	2.0	2.5	1.2	1.9	1.4	1.6	0.9	4.8	0.9	0.0	1.3	1.8	1.5	5.0	1.6	1.6	3.6	3.3	2.3	3.3	4.1
ZNF816-ZNF321P	ZNF816-ZNF321	ENSG00000221874	"ZNF816-ZNF321P readthrough"		19	52928475-52962823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 9.8;Syncytiotrophoblasts: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RT4: 9.0"									HPA051271	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA051271: AB_2681415"												"unprognostic (4.18e-2)"						0.2	0.1	0.0	0.3	0.0	0.4	0.8	0.0	0.2	0.7	0.0	0.9	0.0	0.5	0.0	0.2	0.8	0.3	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.5	0.3	0.2	0.2	0.8	0.0	1.7	1.5	0.0	0.4	0.7	0.0	0.2	0.2	0.0	0.0	0.3	1.0	0.1	0.0	0.2	0.2	0.0	0.4	0.6	0.4	0.0	0.3	0.0	0.8	0.2	0.5	0.1	0.5	0.0	0.3	0.5	0.5	0.0	0.3	0.9	0.3	0.4	0.8	0.1	0.8	0.1	0.0	0.5	1.1	0.4	0.1	1.1	0.6	0.0	0.2	0.5	0.0	0.8	0.0	0.3	0.4	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.1	0.0	0.2	9.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.6	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.8	0.0	3.8	0.0	3.4	0.0	1.5	2.4	0.6	4.3	0.0	0.0	0.0	9.8	1.2	4.4	3.9	3.6	1.9	7.3	1.9	1.0	0.0	3.0	0.7	3.6	5.7	1.1	6.6	7.4	4.5	1.5	1.4	0.3	3.7	0.0	0.3	3.6	0.0	1.6	0.0	1.1	0.3	1.8	0.0	1.0	2.9	0.0	4.1	1.0	0.6	3.5	2.5	0.7	1.0	2.7	1.9	1.1	0.0	0.0	0.0	1.3	1.1	1.3	1.6	2.0	0.0	11.2	1.6	1.0	3.0	5.9
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 143.0;Spermatocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 13.4;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.2;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.1	2.8	5.4	1.5	5.7	2.5	3.3	9.8	6.0	6.0	2.9	2.8	1.4	4.4	7.5	2.6	3.1	2.6	2.8	5.7	6.7	4.0	1.8	2.9	4.4	5.2	5.0	4.9	2.3	4.1	8.9	1.7	5.3	4.2	3.4	9.3	3.3	3.3	3.6	5.3	4.3	1.9	4.7	3.9	2.5	21.2	5.8	3.3	4.2	4.1	5.4	2.0	4.2	4.8	1.1	0.9	13.2	6.4	2.6	3.3	2.2	1.4	3.0	2.9	4.6	1.9	0.8	2.5	2.3	2.6	3.2	1.9	4.4	2.0	3.5	3.9	5.0	0.5	0.8	0.8	1.6	0.9	2.8	2.9	3.2	2.0	1.2	5.0	2.3	0.6	1.7	1.8	3.2	3.3	1.5	0.9	5.2	3.9	0.6	6.0	2.8	4.5	3.3	0.4	13.2	6.3	1.8	1.1	1.5	5.6	4.5	3.0	4.5	3.1	3.2	1.1	0.9	4.4	2.4	10.2	1.0	2.5	3.0	0.0	0.5	0.4	2.0	0.0	1.8	9.5	2.1	1.5	0.9	13.4	1.3	0.5	0.4	1.0	0.5	0.0	5.6	0.8	5.4	5.7	9.8	6.0	5.7	6.7	5.2	5.0	5.3	4.7	5.8	4.8	7.4	0.0	4.2	13.7	28.7	8.0	8.7	7.2	23.3	41.8	15.2	12.4	1.2	11.5	4.9	16.5	45.9	5.8	11.8	23.5	21.5	9.7	143.0	8.5	11.5	8.4	23.4	6.1	28.3	4.8	5.2	7.7	29.0	14.8	9.5	13.5	12.5	1.8	7.9	32.0	30.4	11.3	6.1	10.6	13.4	57.4	12.5	10.3	3.6	8.4	3.7	25.8	9.2	22.1	13.7	6.2	16.7	12.4	22.6	8.0	42.8	10.8	4.7	51.6	13.1	6.3	9.2	79.4	20.8	16.1	7.5	6.2	15.4	6.3	7.7	4.3
ZNF827		ENSG00000151612	"Zinc finger protein 827"	Q17R98	4	145757627-145938823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 96.3;Excitatory neurons: 77.5;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021166	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA021166: AB_2670608"	"unprognostic (2.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.88e-2)"	2.9	7.1	2.4	3.2	5.5	2.2	4.5	9.1	4.3	5.7	0.0	6.4	5.2	8.1	2.9	2.2	6.1	3.7	4.8	3.0	2.4	4.7	0.6	2.7	3.8	2.3	2.2	7.4	3.0	7.0	8.3	1.3	1.0	15.8	3.9	1.3	10.7	4.8	7.9	2.8	6.4	6.0	0.8	4.0	3.8	3.5	2.2	7.3	7.7	5.3	4.4	6.5	3.8	4.0	4.4	3.5	12.8	7.3	5.2	5.4	0.0	7.7	7.6	5.7	4.2	1.3	10.5	0.6	2.0	12.9	4.4	2.2	6.9	4.9	4.6	7.3	2.5	3.9	4.8	3.7	4.1	3.1	0.0	8.1	4.3	4.6	11.7	10.9	9.2	2.1	0.4	5.6	4.8	0.0	3.0	0.0	5.1	0.0	7.5	10.6	6.0	1.9	5.1	4.7	10.5	9.0	6.0	9.4	13.3	5.6	5.5	0.1	17.8	13.9	10.9	1.0	8.1	4.6	0.1	3.4	4.7	11.7	49.2	2.9	0.0	0.0	1.8	0.0	0.9	1.6	0.9	1.8	0.0	1.2	0.9	1.7	0.0	1.9	0.0	1.5	0.0	0.6	2.4	5.5	9.1	4.3	3.0	2.4	2.3	2.2	1.0	0.8	2.2	4.0	7.3	12.8	19.8	96.3	12.3	6.4	8.3	16.2	22.8	12.7	19.2	19.2	22.4	2.8	16.9	23.9	10.4	2.3	10.3	14.9	3.9	12.1	17.1	11.9	10.8	8.7	25.8	5.9	77.5	7.1	0.5	7.8	14.3	14.6	2.5	17.4	8.2	1.3	1.3	18.5	64.3	18.6	10.2	1.2	0.8	7.8	9.0	1.2	1.8	8.4	0.7	4.7	8.2	174.9	96.6	14.2	9.5	17.0	13.7	30.7	20.1	12.3	19.3	1.5	6.6	20.6	7.1	2.1	5.0	5.8	4.8	1.4	9.4	18.7	19.5	11.6
ZNF83	"FLJ11015, HPF1, ZNF816B"	ENSG00000167766	"Zinc finger protein 83"	P51522	19	52594060-52690496	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA025970	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA025970: AB_1859463"	"unprognostic (6.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (9.20e-4)"	"prognostic favorable (9.06e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (6.92e-6)"	42.7	54.4	35.4	24.7	49.8	30.1	45.6	53.3	47.7	82.9	35.5	55.6	14.9	50.8	92.0	28.7	88.2	28.2	36.5	33.9	40.8	99.3	13.1	42.8	36.2	43.7	38.0	100.8	36.5	26.1	77.3	30.0	44.8	81.2	24.2	67.4	33.3	40.5	9.8	30.8	40.4	29.3	36.8	48.9	34.2	22.1	40.2	19.1	71.5	8.9	29.6	50.2	61.0	51.0	19.6	1.0	27.0	19.6	23.7	47.4	15.0	29.9	20.4	17.6	23.7	7.2	16.5	20.2	14.9	20.3	13.0	8.6	16.3	20.1	24.5	2.7	18.4	16.5	18.9	9.3	19.5	12.3	23.1	38.4	24.2	14.7	73.0	61.8	19.9	22.6	19.3	15.7	29.2	13.2	17.4	20.5	7.4	3.4	18.3	17.3	23.2	13.5	45.0	39.1	15.2	12.5	19.2	18.6	7.7	42.9	19.8	12.7	27.0	17.7	10.7	8.5	31.1	1.4	18.3	27.5	1.0	12.8	14.2	4.1	3.0	7.5	5.7	3.2	6.1	5.7	7.0	7.5	3.6	9.3	6.0	6.7	2.7	10.9	4.7	2.5	3.8	3.2	35.4	49.8	53.3	47.7	33.9	40.8	43.7	38.0	44.8	36.8	40.2	51.0	28.1	35.3	20.0	53.8	20.3	10.3	52.9	23.6	11.4	25.2	23.1	20.7	15.4	12.8	38.1	40.5	35.5	48.4	22.6	10.6	19.6	21.2	24.5	35.2	30.7	28.9	10.8	14.1	26.9	6.9	20.8	32.9	16.3	47.4	37.2	130.5	23.2	1.1	13.5	48.8	57.2	11.3	18.3	5.7	15.8	17.3	42.6	12.0	30.2	46.9	14.6	16.6	37.0	56.8	80.0	10.7	18.5	34.6	9.9	90.8	8.2	23.9	34.9	38.3	6.6	43.3	21.4	15.4	15.8	6.4	9.7	64.0	26.0	62.5	8.8	116.2
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961540-34963777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	8.0	7.0	5.9	9.5	6.3	11.1	8.4	7.9	7.2	7.9	6.3	8.3	8.6	9.4	6.8	8.7	8.9	6.8	7.0	5.9	6.1	9.0	10.4	6.5	13.9	5.9	6.0	12.8	8.2	8.0	5.5	7.8	6.1	8.1	6.4	6.3	7.8	6.7	8.0	8.5	10.6	6.5	5.8	14.7	8.9	10.1	6.1	13.7	9.0	8.5	11.8	9.4	7.5	7.4	7.9	15.2	13.5	12.5	14.1	10.9	9.3	9.5	9.6	12.2	12.0	11.5	10.5	14.3	8.5	9.3	12.7	18.2	14.5	8.6	13.7	8.7	19.7	16.9	15.5	14.5	14.3	25.4	23.2	10.7	19.9	10.2	19.7	12.3	11.1	17.4	24.6	20.5	11.1	6.1	23.2	28.5	8.9	10.6	7.4	15.4	18.3	19.1	11.3	10.6	15.9	13.6	9.3	5.7	15.4	12.9	13.2	27.5	11.7	12.8	9.4	9.5	16.7	22.6	18.5	19.1	11.0	13.4	11.7	30.8	12.3	40.7	16.2	12.1	16.2	13.1	17.3	18.0	13.5	13.0	26.2	20.9	11.6	15.8	8.7	14.4	16.9	12.3	5.9	6.3	7.9	7.2	5.9	6.1	5.9	6.0	6.1	5.8	6.1	7.4	27.6	38.5	21.3	4.2	35.3	24.0	45.3	26.7	25.0	19.9	23.3	18.7	8.3	17.2	30.9	12.9	14.6	24.5	45.8	25.7	35.2	19.0	7.1	14.1	27.3	23.6	18.5	20.2	5.1	13.1	16.7	23.2	23.0	17.3	17.1	20.4	15.4	10.6	14.4	10.1	4.8	21.1	22.4	11.5	16.7	3.8	26.8	15.8	21.4	6.5	18.3	20.4	51.5	4.5	11.6	13.4	25.3	27.4	21.3	27.7	26.5	22.4	15.4	31.8	26.3	27.2	22.6	44.8	46.4	18.6	24.2	26.7	36.3	22.6	28.2	34.3
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Group enriched"	"Detected in some"	6	"Daudi: 4.0;HMC-1: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.3	0.1	2.2	2.3	1.6	0.9	0.3	0.0	2.7	0.1	0.0	0.3	0.2	0.1	0.2	0.2	0.2	0.5	0.0	3.4	0.3	0.1	0.2	0.6	6.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.1	1.9	0.0	0.0	2.6	0.6	0.2	0.9	1.5	0.3	0.0	3.8	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	1.4	0.2	1.0	1.5	0.0	0.1	0.8	1.0	0.1	1.2	0.0	0.0	2.1	0.4	2.2	1.6	0.0	2.7	3.4	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.6	0.7	4.8	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	1.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	19.5	0.0	0.0	0.1	0.5	0.1	2.5	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	17.5	0.5	0.9	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0
ZNF835	BC37295_3	ENSG00000127903	"Zinc finger protein 835"	Q9Y2P0	19	56661980-56671783	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Cone photoreceptor cells: 8.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;EFO-21: 2.0;HEL: 1.7;NTERA-2: 4.8;SH-SY5Y: 2.4;U-266/84: 4.1"									HPA051136	Uncertain		Approved	Microtubules		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Microtubules		"HPA051136: AB_2681357"	"unprognostic (3.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.58e-5)"	"unprognostic (6.65e-2)"	"unprognostic (5.35e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.72e-4)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.21e-2)"	1.5	1.4	2.4	1.1	2.6	0.3	1.0	4.2	3.5	1.8	0.5	2.4	0.3	2.1	0.8	0.9	1.9	0.5	2.2	2.5	1.9	1.3	0.2	0.8	1.2	2.2	2.0	4.2	0.9	2.3	1.5	0.6	2.1	1.2	0.2	1.5	1.8	1.4	2.2	0.3	0.8	0.9	1.5	1.7	0.8	0.4	2.2	0.3	1.6	1.3	1.0	1.8	1.0	3.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	1.8	0.3	0.3	0.3	0.2	0.7	1.7	1.3	0.8	0.5	2.1	2.2	1.5	0.5	1.6	0.3	1.5	0.7	0.8	2.4	2.6	4.2	3.5	2.5	1.9	2.2	2.0	2.1	1.5	2.2	3.0	1.5	3.2	0.0	2.0	1.1	0.0	0.1	0.0	0.0	5.3	0.5	0.6	3.1	0.0	0.6	0.0	8.4	1.1	0.6	0.0	0.0	0.4	0.0	0.2	1.6	1.2	0.0	0.8	1.7	0.5	0.4	1.7	0.0	0.1	0.0	3.6	1.8	0.1	0.3	16.8	2.3	0.0	0.0	0.3	0.5	0.0	2.1	0.6	0.0	0.0	0.8	3.5	4.1	3.0	2.4	0.1	0.0	3.4	0.2	0.1	0.0	0.8	0.0	3.1	0.0	0.5	1.1	0.0	0.6	0.0	0.1	0.3	0.2	1.7	0.0	0.1
ZNF837		ENSG00000152475	"Zinc finger protein 837"	Q96EG3	19	58367618-58381030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.3"									HPA042833	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA042833: AB_10806373"	"unprognostic (2.61e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.07e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (2.35e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.07e-2)"	1.2	2.5	0.8	0.4	0.8	0.1	1.7	0.6	0.8	2.3	1.8	1.7	0.9	2.4	0.0	2.4	3.1	0.1	0.6	0.7	0.8	3.2	4.9	1.0	0.4	2.1	2.3	2.8	3.0	0.5	2.9	0.1	1.1	2.8	0.1	0.9	2.4	0.3	0.3	3.1	1.9	0.1	1.5	2.2	2.0	2.1	0.9	0.5	4.1	0.0	0.2	1.5	1.8	1.3	1.5	0.7	0.9	1.0	0.1	0.3	1.6	1.4	0.3	0.0	0.1	0.3	1.5	1.8	1.2	0.0	0.6	0.4	0.1	0.0	0.0	0.9	9.3	0.8	0.2	0.1	0.3	0.6	0.5	0.5	0.3	0.1	0.1	0.3	0.1	2.3	1.1	0.5	0.1	2.0	4.2	1.7	2.4	0.6	2.4	3.6	0.4	1.8	0.2	1.1	2.8	3.6	1.1	0.9	1.7	0.1	1.1	0.8	0.4	2.1	0.1	0.6	0.5	2.2	1.8	1.6	1.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.8	0.6	0.8	0.7	0.8	2.1	2.3	1.1	1.5	0.9	1.3	1.1	3.2	1.8	0.0	3.2	0.9	1.2	2.2	6.2	2.6	2.9	3.2	1.4	1.5	1.7	3.7	0.0	1.7	0.4	2.3	7.9	4.3	4.3	2.3	1.8	1.4	1.2	0.8	1.1	5.2	1.2	1.6	2.6	2.0	0.0	4.8	1.8	4.0	1.0	1.7	1.0	3.2	4.1	0.8	0.3	0.6	1.8	0.8	3.6	0.0	3.0	2.2	4.1	2.5	1.1	2.9	2.4	1.2	0.3	2.5	3.0	6.8	0.6	0.6	0.0	2.1	1.8	2.5	5.8	2.6	1.7	2.2	2.0	4.7	2.8	1.1
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	7.6	9.3	9.7	6.8	8.9	11.5	13.7	6.2	9.5	9.2	7.9	7.8	7.1	8.1	9.3	7.2	17.0	6.8	8.7	8.9	11.0	11.3	14.6	6.1	10.8	8.7	8.6	10.9	12.1	10.8	9.2	5.6	8.1	9.0	8.1	8.0	10.5	9.5	18.5	19.4	9.8	5.2	6.7	15.1	8.0	31.3	9.3	12.2	11.2	12.1	8.8	7.0	6.0	8.7	13.5	12.1	15.4	27.8	7.0	11.8	26.2	10.3	8.4	12.6	10.3	4.6	11.2	13.8	8.3	7.0	5.2	13.0	10.0	25.9	9.7	18.6	19.1	9.6	12.7	7.7	6.3	9.1	8.1	9.5	18.9	24.4	22.6	19.1	17.0	19.3	21.0	17.6	17.9	25.1	13.9	14.6	20.6	7.3	12.0	29.7	9.4	8.8	11.2	10.9	8.2	25.7	8.5	10.7	9.6	14.5	24.5	14.7	6.7	8.1	7.3	11.3	9.3	17.3	13.5	16.2	6.3	10.7	13.6	0.0	0.2	0.7	0.6	0.6	0.7	0.5	0.4	0.4	0.3	0.4	0.7	0.6	1.0	0.1	0.1	0.6	0.6	0.1	9.7	8.9	6.2	9.5	8.9	11.0	8.7	8.6	8.1	6.7	9.3	8.7	4.6	0.0	10.0	12.1	4.1	3.1	2.6	2.2	2.8	7.6	6.7	7.1	1.9	7.2	3.7	11.0	8.4	6.3	6.5	3.3	11.7	2.9	27.4	6.1	4.3	3.5	1.2	7.4	7.9	2.8	3.1	4.0	5.6	4.5	3.8	10.6	4.6	4.7	3.1	3.3	7.8	5.7	4.1	2.2	1.5	3.8	5.0	3.5	3.6	3.7	1.9	6.9	1.0	5.0	8.2	2.8	1.6	4.1	4.5	2.5	5.3	7.0	7.9	9.6	0.0	3.6	3.3	19.9	11.6	3.7	2.6	5.6	4.5	5.7	5.4	1.5
ZNF84	HPF2	ENSG00000198040	"Zinc finger protein 84"	P51523	12	133037292-133063304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028860	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA028860: AB_10604102"	"unprognostic (2.39e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.30e-3)"	11.1	11.1	14.6	8.9	16.2	9.3	16.6	18.3	30.2	15.7	16.6	13.9	7.5	18.0	23.0	8.6	15.8	11.3	11.2	14.7	15.3	16.6	13.1	10.5	13.7	13.8	14.9	20.8	12.7	13.5	23.1	11.6	15.4	17.0	12.0	24.7	11.9	12.2	10.3	12.3	11.6	13.3	13.8	13.6	11.3	14.0	14.9	14.9	18.2	11.7	14.4	13.5	12.2	22.4	18.4	14.3	38.0	25.0	16.1	25.3	33.1	16.5	14.2	12.0	11.5	8.7	5.5	22.0	14.4	14.3	14.6	8.2	15.4	13.4	18.7	6.2	26.0	32.8	18.2	12.4	19.8	35.8	14.0	17.9	16.1	18.3	19.7	38.9	18.9	15.4	16.8	10.8	30.8	10.8	24.8	33.6	51.5	6.9	11.7	34.4	17.7	15.2	16.8	39.5	31.7	34.5	31.8	9.6	13.9	21.3	31.5	21.0	23.2	13.6	15.2	12.8	11.7	5.2	0.0	50.2	7.9	27.8	17.8	1.5	3.5	4.4	8.1	5.2	12.2	9.5	9.0	10.4	5.9	7.9	11.9	9.8	0.8	10.1	3.8	7.4	5.4	5.0	14.6	16.2	18.3	30.2	14.7	15.3	13.8	14.9	15.4	13.8	14.9	22.4	16.6	9.6	9.6	27.4	21.8	3.1	13.4	2.7	17.6	18.6	14.0	14.4	24.1	10.0	8.1	16.5	6.2	10.3	11.7	3.2	3.9	13.4	14.9	15.5	15.4	16.1	9.6	20.8	33.7	7.1	5.6	16.3	7.1	9.6	13.9	23.2	15.7	8.6	10.5	20.2	36.2	9.6	0.0	7.3	2.4	15.2	13.4	8.6	1.8	14.0	5.1	14.6	17.5	45.2	47.5	9.7	9.1	15.1	9.1	12.9	5.4	11.2	17.6	17.3	13.1	16.9	14.3	13.1	24.2	11.5	2.7	6.4	14.2	12.0	7.5	9.3
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNF844	FLJ14959	ENSG00000223547	"Zinc finger protein 844"	Q08AG5	19	12064731-12081565	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.7"									HPA046982	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046982: AB_10964399"	"unprognostic (2.07e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.92e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.74e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.63e-2)"	3.4	2.0	3.1	1.8	4.4	3.8	4.6	7.5	3.3	3.9	4.3	4.0	1.8	3.9	3.8	2.9	4.9	1.5	5.3	3.2	3.2	7.0	2.9	2.6	2.0	4.0	3.7	8.5	3.3	7.4	3.2	2.5	3.5	3.7	2.9	11.9	5.1	3.4	3.4	3.6	2.6	2.8	3.2	2.8	3.0	3.7	3.8	1.6	7.7	4.6	1.8	4.2	3.5	6.8	0.0	0.1	1.3	3.4	2.5	1.5	1.3	1.8	0.3	1.6	0.9	3.4	0.6	2.0	2.2	1.7	1.4	1.0	0.0	0.3	1.2	0.1	0.1	4.2	0.3	0.8	2.2	0.2	3.0	1.9	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.1	1.6	0.8	1.8	0.0	0.1	0.2	4.5	0.5	0.9	0.1	1.4	1.0	0.0	1.5	0.6	2.4	3.6	0.1	0.1	0.6	1.5	1.9	1.9	3.8	11.7	0.2	0.1	0.2	0.3	3.2	0.5	1.2	0.4	0.8	0.2	0.6	0.2	0.2	0.2	0.6	0.4	0.4	1.9	0.7	0.4	0.2	0.1	0.3	3.1	4.4	7.5	3.3	3.2	3.2	4.0	3.7	3.5	3.2	3.8	6.8	20.0	16.0	11.5	4.2	16.0	2.4	5.6	2.2	10.8	19.2	16.2	16.3	31.5	14.3	11.1	3.7	33.3	4.1	6.8	14.0	5.9	3.9	2.8	9.9	15.5	10.2	14.4	2.1	1.7	3.3	3.4	13.4	17.3	13.5	19.6	11.6	7.5	4.2	6.4	25.2	0.6	8.4	2.0	6.2	4.0	2.8	3.7	9.7	7.2	3.7	3.3	12.5	7.2	7.1	3.6	1.4	7.6	6.8	6.4	6.9	5.9	7.4	7.7	60.6	0.0	31.5	12.6	19.2	8.7	14.0	3.3	5.2	5.8	3.1	6.9	5.4
ZNF846		ENSG00000196605	"Zinc finger protein 846"	Q147U1	19	9751993-9793180	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 242.1;Late spermatids: 91.0;Spermatocytes: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA034617, HPA034618"	Approved		Approved	"Actin filaments"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"		"HPA034617: AB_10603942, HPA034618: AB_2674249"	"unprognostic (1.36e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (5.25e-8)"	"unprognostic (2.57e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.05e-3)"	7.9	6.6	9.3	6.2	8.9	4.5	7.0	6.5	9.1	8.5	6.6	8.2	4.2	11.1	9.6	9.2	8.5	9.7	8.2	7.2	8.0	5.0	4.6	6.9	8.1	9.5	10.2	12.9	3.9	7.3	5.5	6.3	8.5	11.8	7.2	7.4	7.1	18.7	5.4	8.0	5.3	10.6	9.2	6.4	6.6	14.0	8.9	8.0	7.3	5.7	6.3	13.1	8.9	10.3	3.8	0.8	11.6	2.8	12.8	16.4	2.6	5.8	4.0	4.1	8.2	2.1	3.1	1.5	2.3	6.9	4.8	1.4	0.8	4.5	4.5	3.4	2.5	8.6	0.3	3.1	4.6	0.8	8.9	16.9	5.9	3.1	2.4	9.4	3.4	4.6	1.5	0.0	4.4	1.5	3.1	7.2	1.7	3.1	4.8	4.5	0.9	0.4	5.2	14.6	1.8	3.5	3.1	0.3	4.4	4.0	1.9	6.0	1.8	3.3	2.4	2.8	0.5	6.5	7.3	8.3	0.4	1.1	2.9	1.1	2.1	1.3	1.7	1.7	3.5	4.2	2.6	4.3	6.9	5.2	2.0	4.2	0.8	2.2	1.2	4.5	3.3	1.6	9.3	8.9	6.5	9.1	7.2	8.0	9.5	10.2	8.5	9.2	8.9	10.3	4.4	9.6	5.4	18.3	4.7	7.9	15.0	14.5	20.5	1.7	7.3	10.0	6.8	5.7	11.9	0.0	2.1	1.6	5.5	5.4	9.8	6.5	242.1	6.4	7.7	5.1	1.2	4.8	25.8	4.9	2.1	7.8	5.1	4.5	5.1	7.8	5.7	5.4	7.5	0.0	13.7	4.9	6.1	13.9	9.1	91.0	6.8	10.2	7.2	41.2	9.2	3.2	1.0	14.6	14.6	7.0	3.9	9.1	3.7	7.3	3.1	6.1	12.5	2.4	6.6	3.7	8.2	177.1	8.6	8.0	8.8	1.2	5.2	7.8	4.1	16.4
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 128.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044760	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favorable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	2.7	4.9	0.9	2.0	0.9	5.0	5.2	3.4	1.1	2.6	0.3	1.9	0.4	2.4	1.6	2.8	2.4	1.6	1.8	0.9	0.9	2.5	0.9	1.8	5.8	1.1	1.1	6.6	8.1	2.1	1.4	3.6	1.1	2.4	2.6	1.1	2.9	1.6	0.7	2.9	2.2	2.3	0.7	3.6	5.6	11.5	1.0	5.4	7.8	0.3	6.0	2.2	2.7	1.4	0.9	0.6	12.6	12.5	3.5	3.2	9.0	8.1	3.6	12.5	12.7	0.1	4.9	13.8	9.1	3.4	5.6	1.1	0.2	7.9	13.2	0.5	6.4	2.1	0.9	0.9	0.9	0.1	3.1	1.6	2.3	5.8	6.9	2.6	3.6	12.5	0.2	4.2	6.6	1.8	20.9	7.5	11.0	0.0	11.4	9.9	17.6	6.9	4.0	5.3	10.3	5.4	0.2	0.3	2.6	10.7	5.2	9.7	3.0	7.2	1.3	15.7	10.4	5.4	15.3	13.2	0.2	0.0	5.1	0.4	0.7	2.8	1.8	2.3	1.5	5.4	2.2	1.3	1.7	3.6	2.6	2.1	2.1	5.3	1.3	2.0	2.8	1.4	0.9	0.9	3.4	1.1	0.9	0.9	1.1	1.1	1.1	0.7	1.0	1.4	5.4	3.2	1.7	2.0	8.5	0.8	2.2	1.5	1.8	4.7	4.5	4.4	3.4	1.5	2.0	5.5	0.0	9.9	8.5	1.0	1.9	6.9	128.4	2.4	4.1	8.3	0.0	9.0	3.4	6.1	14.2	5.0	3.6	3.9	12.0	10.3	5.7	0.3	8.8	3.3	4.8	2.6	4.1	1.9	3.3	24.1	3.1	4.3	5.4	6.5	5.0	3.7	5.2	9.0	5.3	3.5	2.1	3.8	3.8	2.4	0.1	3.9	2.6	2.0	19.7	2.5	5.3	23.2	13.6	3.1	1.4	7.5	4.7	6.5	1.3	3.3
ZNF850	ZNF850P	ENSG00000267041	"Zinc finger protein 850"	A8MQ14	19	36714383-36772825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.2;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029299	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029299: AB_2672987"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.37e-3)"	0.8	0.6	0.7	1.0	0.6	5.1	0.9	2.4	1.0	0.7	0.9	0.7	0.6	0.7	0.3	1.0	0.7	0.8	1.6	1.5	0.7	0.6	0.9	0.7	1.5	0.9	0.7	1.2	0.6	1.0	0.5	3.1	0.8	0.9	1.0	1.0	0.7	0.7	0.4	1.2	0.6	0.8	0.3	1.1	0.7	2.6	0.7	0.7	0.7	0.5	0.8	0.5	0.5	1.4	0.3	1.7	3.7	6.0	0.8	0.2	7.0	2.2	1.3	1.5	1.8	1.3	0.4	1.2	5.1	0.4	7.6	1.1	2.6	0.5	2.7	0.8	2.3	15.2	0.3	1.2	1.0	1.8	8.6	1.0	0.1	2.3	0.0	0.5	1.3	1.8	4.4	0.8	3.6	0.8	2.7	1.7	11.9	0.6	1.0	1.7	7.8	1.1	0.7	7.5	2.4	3.8	3.5	0.2	0.5	5.0	1.5	3.3	2.9	3.6	5.9	2.1	3.7	1.4	2.7	3.2	0.0	0.9	5.6	1.8	1.2	0.9	1.3	1.3	1.7	2.7	1.6	1.1	1.1	1.7	1.8	2.0	1.9	1.3	1.5	1.2	1.2	2.2	0.7	0.6	2.4	1.0	1.5	0.7	0.9	0.7	0.8	0.3	0.7	1.4	2.4	0.0	0.0	0.7	1.7	2.2	1.3	0.5	1.8	1.1	1.9	1.5	5.1	1.5	0.2	3.7	0.0	4.4	1.3	0.3	0.0	1.0	8.0	1.6	1.5	2.9	0.0	5.7	1.3	0.7	5.4	3.0	0.5	2.4	0.0	3.6	7.1	2.1	1.3	5.0	1.0	3.5	2.0	2.2	2.1	3.3	1.2	0.8	3.6	1.9	0.5	1.2	2.1	3.0	3.7	0.6	0.4	0.4	0.7	0.8	0.1	0.7	0.2	0.5	0.0	2.5	1.6	5.9	5.7	1.1	3.4	2.9	1.1	1.7	0.8	0.9
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44494847-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA048312, HPA071850"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA048312: AB_2680352, HPA071850: AB_2686458"	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	1.3	1.4	0.7	2.5	0.6	1.6	2.1	3.4	0.9	2.0	3.6	1.9	1.7	2.2	1.7	0.9	1.6	1.3	0.5	0.8	1.1	1.7	1.7	1.8	2.5	0.9	0.7	2.5	2.1	2.9	0.8	2.3	1.1	2.6	3.1	0.9	3.7	2.1	0.5	2.5	2.0	1.9	0.3	2.7	3.0	1.3	1.2	2.9	1.7	0.9	3.2	1.1	0.8	0.7	1.0	1.4	3.9	6.6	0.8	2.3	2.4	1.0	1.3	2.1	3.1	2.1	1.1	3.2	0.7	0.8	0.9	0.8	4.3	1.1	2.8	2.8	1.5	3.1	6.5	1.9	1.2	3.3	5.7	0.8	1.9	2.7	1.1	2.2	1.7	3.3	3.7	1.4	2.5	0.2	3.0	3.8	2.4	1.2	0.8	1.5	4.3	1.9	1.6	3.2	3.0	2.5	2.2	0.9	0.7	6.6	2.2	3.5	2.8	2.6	2.5	1.4	1.0	2.4	1.9	1.9	1.1	2.6	1.7	0.0	0.4	0.7	0.2	0.5	0.3	1.1	0.5	0.3	0.2	0.9	0.5	0.7	0.6	0.4	0.2	1.4	0.2	0.1	0.7	0.6	3.4	0.9	0.8	1.1	0.9	0.7	1.1	0.3	1.2	0.7	2.0	0.0	5.4	5.9	2.3	3.3	0.8	0.9	1.2	2.1	1.5	1.5	1.8	2.8	1.4	0.0	2.1	0.8	5.1	0.8	3.9	1.9	0.3	2.6	1.6	2.0	0.0	3.2	5.7	1.4	0.9	1.4	1.1	1.5	1.3	1.8	2.2	1.4	0.7	1.7	6.8	0.9	2.0	0.3	1.0	0.4	0.6	1.4	1.8	1.9	1.4	2.8	3.1	9.0	9.2	1.5	0.1	1.2	6.8	1.1	1.0	1.0	4.2	1.6	0.0	2.4	1.6	2.0	1.6	0.5	1.8	0.3	2.3	1.6	0.8	0.9
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615610-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	4.1	2.8	24.8	2.3	24.7	0.6	4.5	20.4	24.0	9.6	11.8	12.9	1.1	11.3	4.4	4.3	9.2	4.5	10.5	23.7	23.7	4.9	0.5	3.7	2.9	27.8	27.9	12.0	7.0	5.5	6.6	2.8	25.1	7.8	1.7	5.1	5.4	8.6	27.1	3.1	4.4	6.6	25.6	3.5	4.9	2.6	24.8	3.3	7.9	20.2	2.0	10.1	4.9	21.0	0.0	1.6	4.7	20.1	0.2	0.0	0.2	0.4	0.0	2.1	0.4	3.6	0.8	0.0	7.8	0.0	0.7	0.0	7.2	0.2	2.0	0.0	2.6	0.6	0.0	3.8	2.8	0.0	0.1	0.7	0.6	0.2	0.1	2.0	0.0	1.6	3.2	0.1	1.3	0.1	0.5	2.7	7.5	0.0	0.0	2.3	7.8	0.1	1.5	7.6	6.3	29.5	0.0	0.3	1.2	3.9	1.1	4.3	0.0	1.5	19.5	0.0	1.9	0.4	0.1	0.1	0.0	0.0	7.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	24.8	24.7	20.4	24.0	23.7	23.7	27.8	27.9	25.1	25.6	24.8	21.0	4.3	0.0	0.0	2.0	1.0	0.5	1.5	0.2	1.2	13.2	3.2	4.4	10.4	0.0	0.6	7.3	6.2	0.0	2.0	0.1	0.0	0.6	1.6	7.5	4.3	3.2	1.8	0.4	1.5	0.7	0.0	4.4	0.5	2.3	0.0	15.1	2.5	0.0	0.1	5.0	2.7	0.0	0.0	0.0	0.9	2.4	5.3	0.2	3.6	1.9	0.1	13.2	1.0	2.0	2.8	0.4	0.1	8.6	1.3	3.3	0.0	0.2	2.3	10.4	13.1	6.4	5.4	0.5	0.5	0.4	0.3	0.3	1.8	6.9	0.1	0.7
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981750-31991723	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 14.0;Extravillous trophoblasts: 3.8;Respiratory ciliated cells: 4.3;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 7.0;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	56	"B-cells: 7.0"	"Cell line enriched"	"Detected in many"	4	"BEWO: 44.8"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	0.3	0.2	0.2	1.4	0.2	0.1	1.4	0.0	0.2	1.5	0.5	0.6	0.2	0.9	2.3	1.7	1.0	0.6	0.2	0.4	0.3	1.0	0.0	0.7	3.1	0.1	0.6	0.6	0.1	0.0	1.4	1.3	0.3	2.8	0.8	0.7	1.4	1.2	0.1	1.2	1.2	0.7	0.0	1.6	0.6	1.0	0.3	0.4	0.9	0.2	4.2	1.1	0.8	0.1	3.0	0.9	0.0	2.3	0.0	0.1	44.8	0.2	0.1	0.2	0.3	3.0	3.5	3.3	3.3	0.0	1.4	2.8	1.0	4.5	0.3	0.0	0.4	0.0	4.4	1.5	0.0	0.0	0.0	0.2	2.0	0.3	8.6	0.3	0.8	0.0	0.0	0.0	0.4	2.6	0.0	0.0	1.2	8.1	4.7	0.0	0.0	0.1	10.2	1.2	0.2	0.0	0.6	5.3	0.0	2.1	4.0	0.0	1.7	0.3	3.5	0.0	0.3	0.0	0.0	5.2	0.4	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.3	0.1	0.6	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	14.0	0.9	0.5	0.7	0.6	0.6	1.9	0.8	0.6	0.0	3.1	0.0	0.0	1.7	0.1	0.2	0.0	0.1	0.1	1.2	0.7	1.1	3.5	0.0	1.6	0.5	3.8	0.7	1.5	1.6	0.0	0.0	0.4	0.0	0.3	0.0	1.7	0.5	2.0	0.0	0.5	0.3	0.6	0.3	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.3	0.2	0.4	0.7	0.8	0.5	1.2	4.3	0.0	0.0	0.2	0.7	0.1	0.2	2.4	0.3	4.2	0.4	0.0	0.5	0.6
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838375-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Excitatory neurons: 44.0;Inhibitory neurons: 45.2;Microglial cells: 31.9;Oligodendrocyte precursor cells: 46.3;Oligodendrocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (8.66e-4)"	5.6	7.0	8.1	6.8	8.6	5.6	7.7	8.9	8.4	8.9	13.0	8.6	4.4	7.5	11.7	6.1	9.6	7.2	6.2	7.7	8.4	9.2	7.6	6.4	9.5	8.5	7.6	9.7	11.4	10.9	10.4	3.8	8.2	9.0	6.9	9.9	11.7	7.9	6.5	16.7	8.7	6.5	7.0	10.1	7.8	4.2	8.6	12.3	13.6	6.2	9.2	7.4	6.3	10.8	3.3	3.5	7.8	12.3	8.8	9.5	0.2	6.7	6.8	2.2	3.6	0.4	8.6	1.5	8.6	7.7	3.0	2.2	2.3	3.3	1.6	5.0	3.4	1.5	2.9	0.0	7.9	2.4	1.4	10.7	11.8	2.2	3.4	9.7	5.3	9.1	1.7	6.1	4.0	8.5	2.8	6.2	2.6	6.3	3.5	5.1	1.0	9.2	6.2	2.0	3.1	10.3	5.8	4.2	5.8	3.7	3.2	2.9	9.6	5.5	0.2	12.7	2.5	9.4	5.5	1.5	9.5	6.3	6.4	0.0	1.1	0.7	3.2	2.0	0.8	1.8	1.1	1.6	1.4	0.5	1.3	1.2	0.1	0.8	0.7	1.4	0.9	1.0	8.1	8.6	8.9	8.4	7.7	8.4	8.5	7.6	8.2	7.0	8.6	10.8	2.6	0.0	1.5	51.2	6.4	0.8	0.6	1.8	13.6	5.7	4.4	4.1	4.0	2.8	2.9	7.3	12.5	1.1	1.5	1.6	1.9	1.9	1.3	2.9	2.6	3.2	1.8	3.4	44.0	1.4	0.3	6.0	5.6	3.4	4.5	5.2	1.8	3.0	1.0	10.1	45.2	2.0	2.0	1.0	0.4	1.5	1.5	3.2	0.0	31.9	1.5	2.7	0.0	46.3	58.4	1.3	1.9	2.2	3.3	1.6	2.2	0.9	3.2	6.0	0.0	3.7	2.6	1.3	2.3	7.7	1.3	2.6	9.3	2.7	2.2	0.7
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605647-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 34.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoli	Nucleoplasm	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	8.9	7.8	5.4	2.9	4.8	4.2	8.4	5.7	6.4	10.4	0.2	12.9	3.7	12.4	0.9	7.4	10.1	0.7	15.5	5.2	2.1	8.5	8.1	8.6	2.4	5.5	4.2	11.0	9.9	3.7	10.5	1.6	3.8	11.5	1.0	1.6	8.5	2.1	34.9	11.4	9.4	1.3	2.1	13.0	9.3	4.1	5.2	3.0	10.6	6.2	1.3	10.7	8.1	5.2	7.4	5.9	2.5	4.1	2.7	2.1	6.9	5.2	2.9	2.8	2.7	1.9	4.7	8.5	5.8	3.8	1.4	6.1	1.6	3.2	1.1	8.5	19.4	4.9	3.8	2.6	4.3	5.7	9.3	3.1	4.9	3.4	2.0	2.5	1.9	5.2	9.6	5.7	1.8	3.5	8.9	6.1	5.7	4.3	10.3	13.8	4.0	5.4	3.3	5.0	6.0	9.7	7.2	4.3	4.6	1.3	3.4	8.8	5.6	4.2	10.1	3.9	6.6	11.9	11.0	4.4	5.2	4.3	6.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	4.8	5.7	6.4	5.2	2.1	5.5	4.2	3.8	2.1	5.2	5.2	7.2	0.0	0.0	3.9	6.3	4.1	1.3	3.1	8.0	5.3	5.4	3.7	20.5	4.3	1.3	14.7	0.0	2.6	3.4	8.3	5.9	3.7	2.3	3.0	3.5	5.4	6.0	3.0	3.2	4.5	3.2	5.2	8.6	3.6	0.0	6.9	7.1	6.7	4.7	10.1	3.0	5.6	4.1	5.3	5.8	5.2	5.3	5.1	5.4	1.0	4.0	4.5	3.1	4.0	2.7	6.1	1.8	10.1	4.5	1.4	5.8	4.0	1.6	3.3	6.6	4.3	6.4	1.3	1.2	4.5	4.3	2.6	5.7	5.6	6.1	1.1
ZNF875	HKR1	ENSG00000181666	"Zinc finger protein 875"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 141.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Cardiomyocytes: 19.8;Cytotrophoblasts: 11.0;Extravillous trophoblasts: 5.7;Hofbauer cells: 7.3;Syncytiotrophoblasts: 9.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	18.9	37.4	29.0	10.8	26.2	14.8	25.9	36.8	30.9	24.1	46.5	22.6	8.3	20.4	23.9	17.4	23.9	14.4	31.9	28.0	30.3	34.0	18.3	18.7	16.7	25.4	26.5	28.1	20.0	31.8	36.5	18.3	26.4	39.4	14.0	141.0	27.1	19.2	21.3	28.4	19.4	17.4	19.3	27.9	21.1	30.4	28.7	19.2	37.9	18.1	18.9	21.7	22.0	30.2	7.8	19.7	24.9	32.3	18.0	15.1	17.2	13.2	20.0	23.7	25.8	10.0	9.1	27.8	31.4	14.0	11.1	6.6	16.5	17.7	24.9	14.5	28.4	9.8	26.9	10.4	23.3	8.6	23.9	23.4	21.5	16.4	35.4	23.8	14.8	19.9	1.9	1.6	17.6	16.0	20.0	17.7	51.0	13.9	11.3	13.7	10.7	10.9	21.2	31.9	32.1	42.5	13.1	16.7	16.9	36.2	24.1	17.4	13.6	18.8	13.1	14.2	21.0	34.9	40.4	29.8	2.2	10.7	21.3	12.8	4.5	7.4	7.6	5.8	14.9	11.1	10.6	11.5	6.9	12.6	14.3	12.0	4.1	11.4	4.0	8.4	13.9	6.8	29.0	26.2	36.8	30.9	28.0	30.3	25.4	26.5	26.4	19.3	28.7	30.2	5.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	11.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.9	0.4	0.0	0.0	0.0
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.3	0.1	0.2	0.0	1.3	0.2	0.7	0.4	0.4	0.1	0.3	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.1	0.1	1.1	0.2	0.4	0.2	0.2	0.2	0.5	0.5	0.1	0.2	0.7	0.2	0.3	0.2	0.4	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.3	0.3	1.0	0.3	0.2	0.3	0.1	0.1	0.3	0.2	0.0	1.5	0.0	0.8	3.2	0.0	0.0	2.0	0.5	0.2	0.6	0.8	1.3	0.2	0.7	0.7	0.2	0.9	0.4	0.3	0.5	0.5	0.0	0.5	0.9	0.0	1.7	0.0	0.6	1.6	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	1.6	0.9	1.8	0.0	0.2	1.2	1.6	0.0	1.1	1.2	0.8	0.1	0.0	0.0	0.1	1.7	1.7	2.1	0.0	0.9	0.7	0.7	0.9	0.6	2.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.0	0.8	0.0	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.3	0.1	0.2	0.2	0.4	0.0	0.0	0.2	0.2	0.9	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.4	1.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0
ZNF879	DKFZp686E2433	ENSG00000234284	"Zinc finger protein 879"	B4DU55	5	179023804-179035064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 12.5;Spermatocytes: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068608	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068608: AB_2686010"	"unprognostic (3.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.04e-2)"	"unprognostic (5.69e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.17e-3)"	2.3	1.5	2.7	2.1	3.8	0.8	2.7	4.0	3.4	2.3	2.9	2.2	1.2	2.7	2.2	2.0	2.3	1.6	2.7	2.7	2.9	2.3	1.4	2.0	3.0	3.5	3.3	3.9	1.7	2.5	2.6	2.8	3.1	2.6	1.2	7.1	2.2	3.2	2.2	3.5	1.9	2.3	3.1	3.2	1.7	6.2	2.8	3.4	3.8	3.1	3.5	1.9	1.8	4.6	0.0	3.6	3.2	9.9	3.0	2.3	10.5	1.8	2.6	4.2	5.2	3.3	1.8	2.7	2.5	1.7	4.9	1.5	0.0	2.0	3.4	0.0	0.3	0.0	2.3	0.6	4.8	0.0	4.9	2.3	1.9	2.3	1.2	1.9	1.5	2.6	0.5	0.0	3.5	1.8	3.1	1.0	3.5	1.3	0.9	2.8	1.1	0.3	3.1	2.9	1.3	3.3	3.4	0.5	4.6	4.8	4.8	3.0	1.5	1.9	3.5	2.2	0.4	0.0	0.0	4.1	0.0	0.0	2.6	14.0	3.8	3.9	4.9	3.4	4.9	4.1	4.3	4.0	3.5	4.0	6.6	5.1	0.1	5.4	3.3	2.4	6.0	3.0	2.7	3.8	4.0	3.4	2.7	2.9	3.5	3.3	3.1	3.1	2.8	4.6	1.8	6.4	1.1	2.9	3.1	0.5	1.7	1.3	0.0	8.7	1.2	0.6	2.2	5.7	1.1	5.5	12.5	3.6	5.6	0.7	5.9	1.7	6.0	0.6	1.2	2.5	1.2	0.4	1.7	0.8	2.0	2.5	2.0	0.8	2.5	4.0	1.8	0.9	2.2	10.1	1.8	0.3	2.0	1.6	1.9	3.4	1.5	1.2	0.0	1.0	1.4	3.1	8.2	2.5	2.4	0.8	0.1	2.2	1.0	1.7	1.4	1.6	1.5	5.6	6.6	4.6	2.4	13.3	9.8	0.6	1.1	4.2	2.2	2.2	0.7	1.1
ZNF891		ENSG00000214029	"Zinc finger protein 891"	A8MT65	12	133104779-133130274	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 31.4;Early spermatids: 70.4;Horizontal cells: 40.4;Rod photoreceptor cells: 32.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA040301	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA040301: AB_10795380"	"unprognostic (3.05e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.72e-1)"	"unprognostic (7.51e-3)"	"unprognostic (5.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.07e-3)"	"unprognostic (6.68e-2)"	0.9	1.7	1.4	1.0	1.6	1.3	2.0	3.8	1.7	1.3	1.1	0.9	0.8	2.1	1.4	1.2	1.3	0.9	0.8	1.6	1.1	1.2	0.8	0.9	1.3	1.4	1.3	2.3	0.9	1.3	1.4	1.0	1.2	1.1	1.1	4.7	1.1	1.1	1.0	1.7	0.9	1.5	1.0	1.2	1.0	4.2	1.4	1.3	1.8	1.4	1.3	0.8	0.9	2.8	1.1	1.4	4.1	0.1	1.4	1.9	3.5	0.8	1.2	2.2	1.7	0.9	0.6	0.1	1.1	1.2	2.6	1.6	3.0	1.8	1.6	0.0	2.3	3.7	3.7	1.2	1.4	2.3	1.9	1.4	0.9	2.0	2.0	2.0	1.4	3.0	2.4	0.3	2.2	0.8	3.4	2.6	3.5	2.2	2.0	3.4	3.8	2.4	1.0	2.2	3.5	1.5	3.0	0.6	1.0	3.0	2.9	1.3	0.8	2.0	2.4	1.5	1.5	0.2	0.1	3.4	0.5	0.9	1.5	0.5	0.3	0.6	0.9	0.3	0.7	1.1	0.7	0.9	0.3	1.3	1.3	1.3	0.4	1.0	0.3	0.6	0.9	0.4	1.4	1.6	3.8	1.7	1.6	1.1	1.4	1.3	1.2	1.0	1.4	2.8	6.4	3.2	5.3	2.0	14.3	1.8	5.9	2.3	2.8	31.4	3.2	3.9	5.7	5.7	6.7	11.0	29.2	3.4	5.2	1.1	0.0	3.9	70.4	6.6	11.9	5.9	6.7	4.0	2.8	1.9	2.3	6.2	3.6	5.6	1.3	16.7	6.8	2.0	2.0	40.4	3.4	2.4	0.0	2.8	0.8	10.0	5.3	4.3	1.8	1.9	2.7	10.6	10.3	3.5	3.6	1.8	2.1	6.0	2.7	3.7	2.4	2.2	9.5	32.4	19.7	11.2	8.4	14.2	14.1	3.0	1.7	2.3	6.5	8.9	3.2	2.4
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	0.3	0.2	0.1	0.6	0.3	0.6	0.5	1.0	0.2	0.8	0.2	0.5	0.2	0.9	0.6	0.4	0.8	0.3	0.3	0.1	0.2	0.5	0.1	0.7	1.2	0.3	0.2	1.5	0.9	1.8	0.3	1.2	0.3	0.6	0.7	0.0	0.3	1.4	0.2	1.1	0.6	0.6	0.1	0.5	0.8	0.6	0.3	0.8	1.9	0.0	0.8	1.0	0.7	0.4	0.0	0.0	3.7	9.5	0.0	0.0	0.0	0.9	0.3	3.3	4.0	3.2	2.3	1.3	1.7	0.6	2.5	1.1	0.0	0.5	5.7	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	7.9	17.0	0.0	0.0	0.0	3.1	0.4	2.3	3.3	0.0	3.9	0.0	1.4	0.2	10.5	1.8	0.0	0.0	1.0	0.0	7.0	3.7	0.0	1.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	2.2	6.4	8.4	1.0	31.7	217.1	112.5	32.7	2.8	0.6	7.8	6.6	1.9	50.1	16.7	7.3	2.1	87.5	25.1	4.8	17.6	2.3	8.2	1.9	4.9	28.8	8.5	26.7	0.5	2.0	99.1	27.6	1.5	4.5	1.3	9.3	54.3	57.1	47.8	0.0	0.7	16.9	14.2	107.1	329.2	24.2	60.9	14.9	124.5	5.6	34.6	2.2	44.3	1.5	2.9	1.2	12.3	34.6	1.8	87.8	8.4	14.0	8.6	2.5	19.7	45.2	451.1	8.6	16.7	1.9	280.3	81.5	40.1	16.0	19.0	66.4
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 132.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	17.1	9.4	9.7	14.3	10.7	28.7	12.4	9.1	9.8	10.1	12.1	11.2	11.0	11.3	9.0	8.1	10.7	14.1	13.2	8.9	9.4	11.8	9.6	18.8	14.2	14.0	11.0	9.9	9.2	13.0	8.5	12.3	10.8	9.7	10.5	8.7	10.3	9.6	15.5	11.8	12.4	13.6	13.3	19.1	11.4	13.4	11.9	13.1	13.8	14.5	13.4	16.5	9.0	11.3	16.3	24.9	5.8	8.2	31.4	24.5	9.8	21.6	50.9	132.7	54.9	28.4	13.2	13.5	27.3	43.5	37.6	30.7	10.8	29.3	45.1	12.8	3.6	16.0	18.1	12.5	27.2	13.0	18.7	26.3	26.9	29.7	22.0	24.3	20.3	8.0	12.4	16.2	33.6	6.8	14.2	8.7	5.6	14.0	20.7	8.9	19.6	3.8	21.8	22.1	5.9	4.3	31.6	61.1	22.4	7.1	15.7	10.8	50.9	64.8	18.3	23.8	21.1	10.7	4.0	7.2	26.0	8.7	14.6	19.3	12.3	20.1	13.5	15.2	12.0	9.4	13.6	13.1	9.1	7.1	12.9	10.0	51.9	9.9	27.1	5.2	11.0	11.5	9.7	10.7	9.1	9.8	8.9	9.4	14.0	11.0	10.8	13.3	11.9	11.3	36.5	41.7	27.2	10.4	25.8	27.8	21.2	14.4	19.4	15.7	13.7	11.2	14.4	10.0	24.8	20.2	10.4	6.1	18.7	28.0	0.0	23.9	37.4	15.9	17.9	38.1	13.1	10.7	12.5	22.7	7.0	28.0	28.5	18.6	27.3	8.1	29.3	13.4	15.1	11.8	11.7	14.2	16.2	26.4	38.0	21.1	22.7	34.2	19.6	15.0	30.2	29.5	17.5	7.1	9.9	32.3	21.8	27.1	9.3	32.8	18.7	6.7	42.8	15.1	0.0	27.8	29.9	42.0	16.3	16.2	21.7	11.4	31.4	10.2	10.4	35.7
ZNHIT1	"CG1I, H_DJ0747G18.14, ZNFN4A1"	ENSG00000106400	"Zinc finger HIT-type containing 1"	O43257	7	101218165-101224190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 905.3;Proximal tubular cells: 889.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019043	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA019043: AB_1859481"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.24e-3)"	67.1	58.3	142.9	34.3	149.3	59.5	53.7	153.0	173.5	51.9	149.9	65.4	66.8	38.4	54.1	45.4	60.8	46.5	67.6	141.2	146.9	82.3	199.3	38.1	48.5	152.3	148.5	32.5	62.3	77.8	45.0	44.1	149.5	49.1	43.2	21.0	73.6	52.8	90.8	46.3	58.0	39.8	148.5	48.7	62.8	20.7	148.6	55.8	49.2	70.0	38.8	44.8	39.1	158.1	100.1	92.5	61.8	128.6	114.4	147.4	63.0	113.8	112.8	111.2	111.2	97.6	120.9	70.1	154.6	132.7	87.8	80.2	56.5	159.8	49.1	76.7	221.5	37.8	83.0	116.6	142.7	75.4	82.9	137.8	190.5	97.6	49.8	94.0	166.4	102.4	121.4	126.8	99.9	280.8	145.0	411.2	121.8	151.5	239.7	73.5	47.7	222.1	154.4	46.6	79.6	176.0	79.8	166.2	197.7	70.5	44.6	99.8	121.8	109.0	94.0	190.6	91.0	95.8	136.8	95.3	101.7	142.5	138.7	231.5	214.5	220.2	121.3	202.7	126.5	130.9	133.6	124.4	186.6	142.4	107.9	114.7	181.3	121.4	205.5	202.3	195.2	234.5	142.9	149.3	153.0	173.5	141.2	146.9	152.3	148.5	149.5	148.5	148.6	158.1	203.1	93.0	81.8	6.8	85.3	100.7	121.1	214.6	76.2	30.8	146.0	163.3	77.6	183.0	139.4	191.3	16.7	204.4	115.8	358.1	361.9	200.5	30.5	177.2	153.2	158.5	241.4	195.5	4.6	254.5	199.9	124.7	121.3	169.9	78.6	110.4	174.9	905.3	205.9	11.8	5.0	315.6	166.8	205.4	133.7	59.9	135.2	126.3	129.9	5.6	222.1	89.9	176.1	5.0	17.3	271.4	389.9	124.8	119.4	89.4	432.8	889.4	139.4	37.4	151.2	71.7	150.1	70.6	42.0	109.1	116.5	163.5	104.5	153.8	287.1	138.8
ZNHIT2	"C11orf5, FON"	ENSG00000174276	"Zinc finger HIT-type containing 2"	Q9UHR6	11	65116403-65117701	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 67.5"	"Group enriched"	"Detected in many"	8	"Early spermatids: 356.7;Late spermatids: 720.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058066	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA058066: AB_2683593"	"unprognostic (1.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.53e-2)"	8.1	25.3	4.5	2.1	4.7	3.4	9.1	5.0	6.3	8.0	10.2	8.5	3.3	10.3	0.9	10.6	12.9	0.8	9.6	4.9	4.8	10.5	15.7	6.6	2.0	5.6	5.4	8.1	14.6	2.3	16.3	1.2	4.9	10.5	0.5	0.8	9.3	2.4	14.2	12.8	7.7	0.8	4.9	9.5	10.4	67.5	4.6	1.4	11.2	1.1	1.0	8.2	6.5	5.3	17.4	13.0	1.9	5.5	1.5	2.6	13.1	6.6	2.6	4.5	2.8	6.2	8.9	5.5	13.4	1.4	4.4	18.4	0.9	5.0	0.5	12.4	17.7	5.5	10.5	5.4	4.6	12.4	8.9	3.1	6.7	3.0	2.5	2.0	2.8	5.1	14.5	4.8	2.0	18.1	10.2	19.5	14.9	3.9	25.4	8.4	2.5	35.7	3.3	4.5	16.2	15.5	6.7	11.0	18.6	0.6	17.0	10.6	6.3	5.1	6.8	10.1	7.1	20.9	15.5	3.5	8.3	4.2	5.9	11.7	20.5	11.5	25.1	15.2	25.1	19.0	19.6	23.5	18.7	27.3	20.6	23.1	3.4	16.8	10.1	26.3	11.3	17.4	4.5	4.7	5.0	6.3	4.9	4.8	5.6	5.4	4.9	4.9	4.6	5.3	4.2	16.0	9.3	0.7	9.5	11.1	14.6	16.0	6.8	13.6	11.4	11.4	3.0	10.0	13.0	12.9	6.2	12.5	11.6	13.9	31.3	22.4	356.7	36.0	5.6	6.1	13.8	6.9	1.2	18.9	9.8	7.3	9.7	7.6	2.5	2.7	7.5	17.1	10.6	11.8	1.3	11.0	20.3	5.7	5.2	720.1	14.9	5.5	7.2	1.9	10.7	13.5	23.7	1.5	1.5	17.7	15.9	12.0	11.0	12.5	13.6	40.5	41.7	15.8	19.7	6.3	12.1	61.2	26.0	8.1	8.7	11.4	9.0	14.4	14.8	11.1
ZNHIT3	"Hit1, TRIP3"	ENSG00000273611	"Zinc finger HIT-type containing 3"	Q15649	17	36486629-36499310	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060019, HPA078211"	Approved		Approved	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA060019: AB_2684188, HPA078211: "	"unprognostic (5.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.03e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.19e-2)"	27.4	32.4	33.4	17.6	34.9	31.2	32.7	33.6	43.1	26.2	31.3	30.9	24.1	24.6	39.9	30.4	24.0	20.1	27.2	33.9	35.1	35.1	35.9	19.4	39.1	33.5	34.0	31.1	33.1	27.4	24.0	21.0	33.9	26.3	30.5	19.5	26.3	20.0	58.0	30.9	24.1	18.9	35.2	25.5	28.2	50.4	33.4	29.4	28.7	32.4	39.7	30.0	26.5	35.6	39.6	39.0	70.4	55.1	38.6	49.4	38.8	35.8	56.0	53.6	55.2	6.9	55.7	67.3	38.8	18.0	66.8	37.1	25.7	30.8	66.5	35.3	25.7	27.2	41.1	54.3	28.2	73.0	37.7	34.4	69.0	22.1	53.6	60.3	37.1	79.6	48.5	39.8	58.3	36.0	98.3	92.5	50.1	38.0	38.0	33.0	71.2	56.1	67.7	35.2	57.6	42.7	42.7	26.3	73.0	59.5	76.3	72.7	36.4	25.2	42.6	50.9	54.3	41.3	57.6	68.8	54.6	44.3	50.5	15.7	14.5	10.3	15.5	11.3	32.4	22.6	27.1	21.5	20.0	21.6	33.9	27.6	7.9	23.8	26.5	20.0	27.2	17.2	33.4	34.9	33.6	43.1	33.9	35.1	33.5	34.0	33.9	35.2	33.4	35.6	29.0	25.6	27.0	7.5	48.3	46.4	34.1	99.9	38.1	25.4	51.2	75.2	11.8	30.0	47.5	33.1	12.5	93.2	58.1	24.4	88.0	61.1	222.2	37.9	29.9	32.3	43.5	33.9	10.9	51.2	98.5	30.9	21.4	32.3	34.2	48.5	25.4	30.4	67.4	15.2	12.7	33.8	42.7	49.4	36.7	79.1	37.0	34.6	53.4	10.3	66.6	42.5	47.4	12.1	14.7	60.9	36.8	44.4	32.4	47.3	50.6	88.1	33.8	28.3	46.0	36.6	37.5	179.1	71.2	37.2	43.8	77.2	58.3	55.9	44.6	34.0
ZNHIT6	"BCD1, C1orf181, FLJ20729, NY-BR-75"	ENSG00000117174	"Zinc finger HIT-type containing 6"	Q9NWK9	1	85649417-85708433	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018132	Uncertain		Approved	"Nuclear speckles,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles, Vesicles"		"HPA018132: AB_1848789"	"unprognostic (1.37e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.08e-6)"	"unprognostic (1.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.37e-2)"	10.3	6.6	7.2	5.2	8.2	5.2	10.1	6.8	7.7	14.6	5.3	9.7	2.9	11.0	4.4	11.8	9.6	3.6	7.7	6.8	7.9	9.0	6.7	6.9	6.4	7.7	7.4	10.4	7.2	4.2	7.5	4.7	7.6	8.9	4.2	3.3	9.5	4.4	7.8	11.1	7.9	5.5	8.1	8.1	6.9	6.1	7.6	5.5	8.5	3.9	6.0	11.6	11.3	9.1	13.5	9.1	8.9	8.1	19.2	17.4	11.3	17.0	16.3	11.5	11.0	9.2	6.8	10.4	19.7	10.4	24.7	11.2	15.9	10.9	18.6	14.3	13.7	21.6	10.3	10.7	16.2	35.4	8.3	17.2	10.0	15.3	13.4	11.4	13.7	16.4	20.2	13.3	17.6	5.1	20.9	9.2	13.5	11.0	16.5	16.6	19.7	12.0	18.7	25.2	8.6	5.6	13.3	20.3	19.3	9.3	9.0	8.9	15.6	14.8	10.0	12.5	24.7	8.5	9.3	28.2	3.4	22.0	13.1	0.6	0.7	0.1	1.8	0.7	2.0	1.9	1.6	2.0	1.2	2.4	2.0	2.0	0.1	1.8	0.7	2.1	1.8	0.8	7.2	8.2	6.8	7.7	6.8	7.9	7.7	7.4	7.6	8.1	7.6	9.1	22.0	16.0	22.5	22.5	20.3	16.2	14.4	12.5	13.1	31.8	10.6	9.9	17.6	11.5	38.0	31.3	33.3	9.0	21.0	25.6	3.9	11.9	4.2	15.5	47.4	20.9	9.5	8.4	40.4	8.8	13.7	22.2	6.1	16.1	27.8	22.4	14.3	10.6	7.5	15.2	30.0	20.9	16.2	13.5	7.4	3.8	13.4	9.1	7.2	22.5	11.0	17.6	27.8	34.2	45.3	12.2	11.6	12.8	11.1	11.1	15.5	6.3	18.0	38.8	19.7	22.4	20.7	35.8	21.6	14.0	16.3	2.7	20.1	25.8	20.5	10.8
ZNRD2	"p27, SSSCA1"	ENSG00000173465	"Zinc ribbon domain containing 2"	O60232	11	65570460-65573942	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 44.9;Cytotrophoblasts: 81.1;Extravillous trophoblasts: 84.5;Hofbauer cells: 57.9;Syncytiotrophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039789, HPA064670"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA039789: AB_2676680, HPA064670: AB_2732718"	"unprognostic (9.32e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.34e-2)"	39.1	46.0	16.3	32.8	20.2	48.2	38.9	14.0	28.5	38.4	9.1	50.7	22.5	45.9	8.8	41.5	42.5	20.2	50.5	21.7	14.4	45.4	47.6	38.7	32.8	16.1	16.5	38.8	61.8	19.9	31.2	23.3	14.8	41.9	9.1	7.2	45.2	20.7	104.0	42.4	30.9	16.1	9.9	41.4	41.2	50.6	14.7	25.7	35.9	37.0	16.4	43.1	35.7	18.7	79.4	61.5	39.2	72.0	23.5	20.1	61.0	55.0	31.2	50.8	35.5	59.1	79.9	75.3	93.4	30.8	37.0	68.9	29.5	59.2	18.1	54.7	45.8	67.7	61.0	48.0	32.8	81.6	53.8	31.5	40.2	39.4	40.2	39.2	40.6	68.0	79.8	97.0	28.8	110.0	100.1	72.1	63.9	28.2	104.7	77.4	29.0	142.1	30.3	40.2	78.2	81.3	33.4	82.3	79.8	15.9	111.4	41.3	47.3	92.1	50.5	111.1	69.0	69.0	102.8	66.1	74.3	57.1	83.5	15.4	62.8	27.1	56.5	55.5	59.1	103.5	57.2	57.4	51.5	89.5	66.1	57.7	20.1	85.4	37.5	85.9	69.8	50.7	16.3	20.2	14.0	28.5	21.7	14.4	16.1	16.5	14.8	9.9	14.7	18.7	16.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	81.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	84.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	57.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	79.9	2.3	0.0	0.0	0.0
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999024-75110994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.4;T-reg: 2.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.4;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"HMC-1: 176.9;MOLT-4: 134.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	18.7	16.5	21.1	9.6	22.3	6.7	17.8	9.1	22.8	25.3	19.0	30.6	9.6	22.5	9.5	65.9	18.0	7.5	21.0	23.4	24.5	14.7	17.6	24.1	7.7	19.6	22.5	17.4	11.5	11.8	13.4	11.2	18.6	13.7	12.1	7.4	16.9	7.0	81.2	25.0	15.3	11.4	13.4	4.5	21.0	37.4	30.7	53.2	29.3	30.6	13.3	22.5	26.4	17.5	10.9	15.7	26.7	27.5	27.7	21.4	91.2	13.0	18.3	17.5	17.1	25.4	33.2	2.9	9.9	28.3	16.8	25.5	13.0	17.8	13.9	26.7	7.5	56.7	4.8	47.0	22.0	27.5	176.9	19.5	14.7	18.4	14.9	30.8	29.0	68.3	27.8	8.8	13.7	104.5	134.6	100.6	37.1	31.4	16.7	59.0	10.0	17.4	25.1	30.5	35.4	37.7	20.7	27.0	8.3	21.7	71.6	25.8	19.9	12.0	21.0	21.5	7.9	50.5	55.1	31.6	15.8	30.2	12.6	2.4	0.5	0.4	0.0	0.5	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.5	0.0	2.4	0.1	21.1	22.3	9.1	22.8	23.4	24.5	19.6	22.5	18.6	13.4	30.7	17.5	34.8	9.6	14.4	16.6	1.8	15.9	16.0	11.2	4.6	12.6	24.3	22.4	16.4	18.6	14.0	3.7	52.1	6.4	2.3	25.5	0.0	8.9	25.9	30.7	15.1	30.2	19.8	30.5	45.2	12.7	10.1	15.1	18.3	28.0	36.8	23.7	12.8	14.4	10.4	3.3	42.4	14.0	14.2	7.3	10.9	16.3	6.8	7.3	14.2	33.7	7.6	15.0	0.0	33.7	29.5	20.0	12.1	4.1	1.8	17.2	9.6	6.2	15.1	6.5	0.0	12.4	14.7	13.6	18.7	21.0	19.6	4.5	13.3	16.7	12.7	29.6
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284597-30367689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.4	6.5	4.8	11.5	5.3	13.0	9.6	5.5	4.2	5.1	14.5	18.9	13.2	8.4	10.7	10.4	4.4	9.4	5.1	4.3	4.0	22.0	21.5	7.4	15.3	7.4	6.6	3.7	10.3	9.1	5.0	9.3	6.0	5.7	16.2	4.7	9.2	5.3	5.7	10.0	15.2	9.5	7.5	10.8	15.0	24.0	7.9	8.9	11.7	6.2	13.2	11.2	4.2	8.4	13.2	4.7	3.8	3.4	4.4	3.0	19.8	4.9	5.1	5.4	7.2	2.4	21.5	13.8	12.6	4.1	14.0	12.5	12.7	8.5	5.7	13.4	11.5	8.6	9.7	6.4	2.3	6.7	15.6	4.6	14.0	3.7	9.1	5.6	4.6	10.5	10.7	26.6	5.9	5.1	13.6	17.5	8.9	13.2	5.9	11.7	8.2	23.8	16.4	28.0	13.0	12.3	9.9	41.2	8.5	22.2	11.1	26.5	5.1	5.2	8.9	5.0	10.5	44.9	41.5	18.1	5.7	14.3	7.8	0.2	0.3	0.4	0.3	0.3	0.5	0.4	0.4	0.5	0.3	0.2	0.2	0.4	0.5	0.3	0.4	2.2	1.0	0.2	4.8	5.3	5.5	4.2	4.3	4.0	7.4	6.6	6.0	7.5	7.9	8.4	11.3	9.6	8.4	19.9	13.9	15.9	7.4	4.8	8.6	11.3	26.5	10.4	3.6	14.3	5.0	16.5	41.7	10.1	40.8	60.0	7.9	4.9	5.2	32.7	7.6	6.6	31.3	6.1	54.4	10.3	11.4	5.1	14.3	43.7	3.8	4.7	8.2	41.6	10.7	1.7	32.3	14.0	0.0	23.3	16.2	10.1	2.8	23.1	12.4	119.9	13.1	5.1	4.1	41.7	39.7	7.4	19.5	2.2	11.5	8.5	22.6	32.3	5.8	5.8	6.6	7.7	9.8	18.3	7.0	7.9	18.9	11.5	17.6	7.6	23.4	14.3
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883572-29057488	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Astrocytes: 504.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	2.8	7.1	11.3	1.3	11.2	0.3	2.6	8.1	13.8	4.4	1.0	3.9	3.0	5.1	13.4	3.4	4.8	2.1	2.6	12.1	5.5	8.2	6.6	4.3	0.5	13.2	9.2	5.9	3.3	8.7	2.7	5.0	4.2	7.2	3.4	1.1	7.5	7.7	3.8	5.3	2.7	4.6	5.1	1.2	4.4	5.0	13.6	1.3	4.1	1.9	0.6	3.2	3.3	6.2	5.8	13.7	12.5	3.5	2.3	2.6	23.7	3.5	1.7	2.7	2.6	20.8	3.2	0.1	5.4	1.8	4.9	9.8	8.7	5.5	3.3	7.8	8.9	2.3	2.5	46.1	2.0	6.9	2.3	2.7	5.0	4.3	4.3	2.3	2.4	4.1	5.0	3.2	3.9	5.6	0.2	3.5	4.6	7.3	5.4	6.9	8.2	5.3	11.6	8.5	20.6	7.6	6.2	6.1	3.5	3.8	4.1	3.1	2.3	10.3	8.8	8.2	5.8	4.3	6.3	8.1	4.4	3.9	5.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	11.3	11.2	8.1	13.8	12.1	5.5	13.2	9.2	4.2	5.1	13.6	6.2	4.2	12.8	23.6	504.1	0.3	12.6	5.2	4.9	15.9	3.7	5.7	9.5	7.5	8.6	5.3	12.9	0.0	28.1	0.5	2.1	1.9	5.0	12.7	8.0	8.0	5.8	8.4	4.0	62.9	2.5	2.5	5.8	5.6	15.5	0.0	5.4	2.2	17.6	3.5	1.7	37.4	9.4	0.0	1.0	3.1	15.0	10.8	0.8	0.0	82.4	0.0	6.0	0.0	54.8	34.4	3.7	2.1	12.8	0.6	9.6	2.4	11.6	4.9	3.9	0.0	16.0	6.6	4.6	3.2	7.8	7.5	7.7	0.7	14.5	12.9	2.8
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 4.8"	"Cell type enriched"	"Detected in single"	15	"Proximal enterocytes: 7.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"cerebellum: 4.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	37	"HDLM-2: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011296	Enhanced				"Secreted in female reproductive system"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
ZP3	"ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC"	ENSG00000188372	"Zona pellucida glycoprotein 3"	P21754	7	76397518-76442071	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 78.4;Early spermatids: 45.6;Late spermatids: 89.7;Spermatocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 35.2;hTCEpi: 37.8;Karpas-707: 52.0;MCF7: 71.6;OE19: 30.2"					"Not detected"	"Not detected"			"HPA054061, HPA071198"	Supported				"Secreted in female reproductive system"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA054061: AB_2682363, HPA071198: "	"unprognostic (6.48e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.13e-1)"	1.0	2.9	1.1	0.7	1.9	2.2	3.1	1.3	1.7	1.1	1.9	2.4	1.9	0.8	2.2	4.2	4.0	0.6	0.3	1.0	1.1	1.0	0.8	0.5	0.8	1.2	1.0	2.8	4.1	0.6	1.2	0.6	1.3	1.4	2.6	0.5	1.5	0.7	1.4	4.1	1.1	1.1	1.0	1.8	1.1	1.3	1.2	0.5	0.8	0.4	0.9	0.7	2.4	1.3	17.6	35.2	0.2	18.4	0.9	1.0	0.9	1.2	2.8	0.3	3.3	1.3	15.2	0.1	0.6	4.6	0.5	4.3	3.8	1.2	0.3	9.5	8.5	2.8	10.5	0.1	8.0	0.7	5.2	1.5	37.8	3.9	1.1	0.1	0.7	9.1	4.0	52.0	0.0	71.6	1.6	9.1	3.8	30.2	10.0	0.1	1.5	3.9	1.6	0.2	7.6	0.0	4.6	23.9	0.6	0.4	15.6	3.0	2.2	0.1	1.8	0.1	0.1	15.4	13.4	0.1	1.5	20.2	3.2	0.6	9.4	0.1	0.1	4.0	0.4	2.4	1.1	0.5	9.6	1.1	4.5	3.2	0.8	0.2	4.5	2.0	0.1	3.1	1.1	1.9	1.3	1.7	1.0	1.1	1.2	1.0	1.3	1.0	1.2	1.3	2.6	3.2	3.6	1.3	2.9	8.5	5.8	78.4	9.6	1.5	9.3	12.6	0.8	4.3	21.1	1.8	0.0	5.8	2.7	5.3	0.0	2.9	45.6	1.6	1.4	2.8	4.2	3.0	3.3	4.3	3.6	1.9	1.1	3.0	0.0	5.0	2.9	0.8	7.0	1.7	2.7	4.7	6.1	7.2	4.6	89.7	4.4	5.7	3.6	2.8	5.4	4.4	0.0	1.5	1.7	3.3	8.6	5.7	4.2	5.5	0.6	3.7	20.4	2.0	6.6	3.1	2.5	34.9	12.4	9.0	9.9	9.3	2.2	2.7	7.6	17.1
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"BJ hTERT+: 3.2"					"Not detected"	"Not detected"			HPA008547	Supported				"Secreted in female reproductive system"	NA	NA					"Cluster 10: BJ & FHDF - ECM organization"				"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZPBP	"SP38, ZPBP1"	ENSG00000042813	"Zona pellucida binding protein"	Q9BS86	7	49850421-50121329	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 143.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 973.0;Spermatocytes: 691.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058673	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA058673: AB_2683794"	"unprognostic (1.16e-1)"							"unprognostic (6.46e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.15e-7)"		"unprognostic (9.49e-2)"	"unprognostic (2.34e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	15.0	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	973.0	0.1	0.1	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	22.9	0.0	0.0	0.0	0.0	116.0	11.1	0.4	0.0	1.9	0.0	1.9	0.0	9.0	0.5	0.1	0.0	7.9	0.0	0.2	0.0	0.5	0.6	20.2	6.6	0.0	0.0	691.6	17.1	0.0	0.3	0.0	0.0	0.2	0.0	0.2
ZPBP2	"MGC41930, ZPBPL"	ENSG00000186075	"Zona pellucida binding protein 2"	Q6X784	17	39868202-39877896	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	100	"testis: 95.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 273.9;Spermatocytes: 598.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;U-698: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027997, HPA053070"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA027997: AB_1859488, HPA053070: AB_2682033"		"unprognostic (2.14e-2)"						"unprognostic (3.38e-1)"				"unprognostic (1.62e-1)"		"unprognostic (2.87e-1)"	"unprognostic (5.39e-1)"		"unprognostic (2.54e-3)"	0.1	0.1	0.4	0.3	0.2	0.3	0.2	0.7	0.6	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.2	0.1	0.7	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.6	0.1	0.1	0.4	0.3	0.1	0.0	0.0	0.3	0.2	95.3	0.3	0.1	0.1	0.1	0.9	0.1	0.0	0.6	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	1.3	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.3	0.6	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.2	0.4	1.0	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.4	0.1	4.9	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.6	0.3	0.5	0.2	0.1	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	273.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	598.2	19.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ZPR1	ZNF259	ENSG00000109917	"ZPR1 zinc finger"	O75312	11	116773799-116788039	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.5;Late spermatids: 418.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022596, HPA030979"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB022596: , HPA030979: AB_2673684"	"unprognostic (2.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.01e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.66e-2)"	21.2	12.3	12.2	14.3	12.7	35.2	16.5	10.9	13.4	13.4	8.3	13.9	10.6	14.0	13.0	16.5	13.5	11.6	14.3	13.7	13.6	16.3	24.5	14.4	15.6	12.4	12.2	15.2	21.1	9.6	11.8	12.8	12.6	13.3	12.6	5.6	12.3	12.3	28.4	15.3	14.2	15.6	13.6	14.1	16.1	27.3	14.0	13.9	14.1	14.3	18.7	20.3	13.6	14.2	23.3	33.3	19.4	36.9	29.0	30.1	25.7	39.0	30.6	34.4	36.6	84.0	41.1	53.2	67.4	39.1	61.9	31.0	53.9	35.7	48.5	34.7	26.5	112.6	18.1	45.6	57.4	51.4	45.2	28.7	49.3	65.6	105.6	23.0	38.7	33.8	54.4	35.3	50.7	28.9	42.3	64.0	35.5	63.9	49.7	32.9	29.6	58.9	33.1	40.0	25.3	43.7	32.0	42.2	28.1	33.1	28.5	34.9	33.3	44.3	22.0	26.2	55.6	24.6	19.8	64.3	24.2	89.9	43.5	12.7	20.7	16.5	15.9	22.2	18.5	28.1	21.6	20.5	22.5	22.6	21.2	19.3	3.0	24.5	18.5	16.2	23.7	20.3	12.2	12.7	10.9	13.4	13.7	13.6	12.4	12.2	12.6	13.6	14.0	14.2	23.8	9.6	15.9	0.7	37.0	0.0	66.3	0.0	32.5	8.8	21.6	20.1	11.7	20.0	9.9	20.2	0.0	34.5	36.3	13.6	45.0	45.8	228.5	18.9	20.1	22.0	23.4	14.7	1.1	40.2	58.0	21.3	18.8	24.2	28.0	29.9	13.9	19.9	36.3	5.0	1.4	19.2	0.0	19.5	0.0	418.8	19.0	25.1	0.0	1.9	36.6	7.9	26.8	1.0	2.4	62.5	20.3	12.4	29.4	83.1	42.5	28.8	2.9	6.2	6.6	29.3	23.3	75.2	33.2	30.4	0.0	45.8	34.3	27.1	25.4	84.2
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	13.9	21.1	17.9	6.6	18.7	22.5	13.1	26.7	21.8	14.4	18.8	13.8	5.1	14.4	12.4	10.5	10.8	9.7	18.4	18.1	17.8	10.9	24.8	10.6	8.2	17.7	17.8	19.3	8.8	16.8	8.7	10.6	17.8	11.2	8.8	17.5	9.0	13.6	52.9	15.0	7.7	15.2	18.0	8.7	8.3	19.7	18.3	13.6	10.1	46.4	10.7	10.3	11.7	19.4	15.1	8.6	17.8	13.1	27.1	22.7	7.5	14.5	39.6	27.1	31.3	12.8	11.7	15.7	10.6	18.4	8.8	10.7	22.8	10.7	36.2	16.8	11.3	9.0	9.7	13.8	57.6	13.6	6.6	25.2	30.8	19.9	42.2	37.7	17.3	14.2	1.3	12.7	14.8	12.1	16.2	11.9	6.5	8.2	9.1	13.7	12.7	7.2	12.0	10.9	9.1	15.2	12.3	9.4	16.4	16.7	10.4	11.5	12.9	11.5	11.8	9.7	18.3	13.4	12.5	18.1	13.1	9.5	5.8	0.9	0.4	1.2	0.8	0.1	0.6	0.9	0.9	0.7	0.3	1.3	1.5	1.2	1.7	1.3	0.2	0.5	0.9	0.3	17.9	18.7	26.7	21.8	18.1	17.8	17.7	17.8	17.8	18.0	18.3	19.4	28.6	19.2	25.3	61.7	17.9	24.6	22.8	10.7	22.2	36.9	29.0	21.2	22.9	15.7	17.3	18.4	50.1	12.3	26.3	16.2	0.0	13.1	80.2	29.4	38.6	21.7	26.8	25.7	58.2	11.6	9.8	21.4	14.3	38.5	26.0	34.3	14.6	43.8	12.5	37.0	58.5	19.0	4.1	16.7	22.4	30.3	23.9	24.3	16.0	52.5	13.2	24.2	19.6	56.3	76.0	19.3	11.5	23.0	21.0	31.4	11.9	10.5	19.2	26.0	13.1	34.6	27.6	28.8	19.1	20.5	27.8	27.5	21.4	23.7	13.1	31.1
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081289	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	41.0	39.4	29.7	45.3	31.1	60.0	52.6	36.9	47.0	45.0	36.8	40.8	35.5	70.7	67.6	29.3	45.4	29.6	42.7	30.7	29.1	35.3	30.2	40.4	62.5	32.0	27.7	56.7	33.8	33.2	64.5	36.3	31.6	44.2	42.9	62.1	39.5	38.0	58.9	43.4	37.9	50.1	29.3	42.6	35.6	50.4	30.3	47.6	48.5	38.9	49.3	37.9	35.2	38.8	86.8	31.1	122.3	73.0	46.5	79.8	71.0	103.2	55.6	89.2	113.2	58.7	55.5	177.6	89.0	64.2	82.7	53.5	111.1	63.9	133.4	127.5	79.9	154.5	127.3	50.0	70.8	171.5	62.7	61.7	80.3	86.1	73.5	98.1	76.3	90.3	165.1	93.6	69.6	29.3	145.0	58.4	128.7	52.9	59.6	159.8	92.3	108.4	60.5	72.6	93.8	58.3	88.7	58.8	91.4	63.7	74.7	76.8	102.5	65.9	62.1	51.9	103.8	75.7	100.6	193.8	96.4	160.3	94.6	99.1	33.4	32.1	44.5	32.3	51.2	68.8	47.5	44.0	26.8	63.1	61.2	48.7	30.7	48.2	33.8	73.4	49.6	31.2	29.7	31.1	36.9	47.0	30.7	29.1	32.0	27.7	31.6	29.3	30.3	38.8	86.9	99.3	154.5	83.6	109.8	50.6	94.4	66.1	59.7	166.5	61.4	66.5	99.9	50.1	68.4	49.7	129.3	55.1	136.9	85.8	49.0	60.2	190.3	79.9	123.5	63.5	73.0	87.1	135.3	68.2	50.4	92.6	62.7	85.7	87.4	132.8	50.7	41.8	45.4	213.7	114.7	64.5	54.9	34.5	39.7	46.2	185.4	55.7	48.0	73.1	74.8	116.6	139.0	90.5	131.9	69.2	76.5	115.5	127.5	54.8	41.2	41.1	76.5	202.2	118.3	88.1	99.2	218.7	113.0	55.3	46.5	63.5	89.6	96.4	55.1	68.5
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034025-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.8;pituitary gland: 15.9;testis: 8.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 11.7;Early spermatids: 28.2;Endometrial ciliated cells: 21.8;Late spermatids: 19.6;Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HMC-1: 2.1;NTERA-2: 2.1;T-47d: 3.1"									HPA007938	Uncertain		Approved	Nucleoli		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.1	0.9	3.7	0.0	2.7	0.1	0.9	4.1	4.6	1.2	1.4	0.3	0.0	0.6	6.1	0.1	2.1	0.2	0.5	3.6	7.8	2.6	0.1	0.5	0.0	4.0	5.3	0.6	1.0	2.6	15.9	0.2	3.1	2.4	0.0	2.3	0.4	0.8	0.0	0.2	0.1	0.1	2.1	0.2	0.1	8.7	5.1	0.6	5.9	0.0	0.0	0.5	0.3	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.7	4.1	4.6	3.6	7.8	4.0	5.3	3.1	2.1	5.1	1.6	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.2	0.0	3.4	1.8	2.2	1.1	1.5	0.2	1.8	2.1	0.0	0.0	0.0	11.7	1.7	28.2	21.8	3.1	0.5	0.0	0.0	3.8	0.0	0.0	0.8	0.0	1.7	0.0	3.2	0.4	0.0	0.1	3.3	5.4	0.0	0.0	0.0	0.0	19.6	0.9	0.1	1.8	2.8	0.0	8.1	0.0	4.0	1.8	0.3	0.0	0.0	0.0	0.9	0.0	0.2	4.3	2.6	0.0	0.0	0.6	13.7	2.7	0.0	0.0	0.0	0.1	6.7	0.0	0.5
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124609-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 69.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	3.2	3.9	5.3	5.5	6.4	3.2	7.0	7.7	7.6	3.9	5.2	7.1	8.6	3.9	7.1	3.6	4.1	4.0	3.0	5.6	6.6	5.4	4.4	4.9	8.3	6.4	5.9	2.5	4.9	6.9	3.2	2.2	6.4	4.7	9.0	7.2	6.6	5.8	3.2	6.9	8.4	4.7	5.5	7.4	7.0	2.2	6.1	8.0	4.6	2.7	9.1	4.2	2.7	9.1	0.1	8.8	11.1	8.2	3.0	0.7	9.1	3.0	6.4	7.8	8.4	6.1	5.7	8.8	8.0	2.8	5.4	6.8	7.8	4.4	7.4	12.8	10.8	9.1	7.4	8.7	4.8	6.8	7.4	1.0	7.3	6.6	3.6	8.3	14.7	0.2	1.3	7.3	2.1	10.0	0.0	10.7	2.3	7.4	5.3	10.9	8.4	12.2	9.3	12.6	15.0	16.5	1.5	9.2	10.9	7.2	12.2	3.2	4.6	2.9	6.7	4.4	7.9	3.7	12.5	2.4	1.3	3.4	1.6	69.0	8.6	10.2	13.8	11.8	17.7	19.3	12.0	10.6	9.0	14.6	14.5	11.8	15.6	17.7	11.6	19.6	14.7	8.6	5.3	6.4	7.7	7.6	5.6	6.6	6.4	5.9	6.4	5.5	6.1	9.1	5.6	6.4	2.6	0.3	5.6	1.8	0.8	4.9	1.2	3.8	5.2	5.6	1.6	10.0	7.5	7.3	4.2	2.2	12.6	4.7	5.9	12.8	3.3	4.2	0.8	4.0	1.8	8.2	1.4	12.6	1.2	1.4	4.6	3.3	2.5	4.8	4.2	2.0	2.1	1.7	1.1	6.0	14.2	3.8	1.3	1.5	0.6	4.3	1.8	1.0	6.1	5.6	11.3	3.5	3.7	9.6	6.1	3.4	4.2	1.3	10.3	8.3	7.7	6.6	0.0	1.7	3.7	1.7	6.3	2.7	1.3	1.8	6.1	2.2	7.0	1.1
ZSCAN18	"FLJ12895, ZNF447"	ENSG00000121413	"Zinc finger and SCAN domain containing 18"	Q8TBC5	19	58083838-58118427	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 128.4;SCLC-21H: 59.3;U-266/84: 46.6"	"Low region specificity"	"Detected in all"							HPA024318	Supported		Approved	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA024318: AB_1859494"	"unprognostic (1.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (3.68e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.04e-2)"	29.5	31.2	74.2	8.3	74.5	5.8	32.8	56.3	74.7	53.0	61.8	60.0	9.9	63.1	20.8	21.3	66.3	14.9	55.7	71.6	78.0	56.1	14.4	28.8	9.4	71.9	70.0	63.5	22.9	27.9	82.8	14.9	68.8	46.3	6.2	36.9	23.8	28.9	23.7	29.0	28.9	18.8	63.2	28.1	32.4	42.5	79.8	10.3	60.8	13.2	6.7	49.5	34.6	67.3	0.2	1.7	14.4	35.2	1.7	1.9	32.4	9.5	0.2	12.8	2.3	0.0	8.7	3.8	18.8	13.6	14.4	0.2	1.2	7.7	12.4	0.1	128.4	0.4	0.1	0.2	25.7	0.0	25.8	23.1	0.4	9.5	0.0	17.1	0.9	9.3	0.2	1.4	18.1	0.0	18.9	7.2	22.6	0.0	0.0	21.8	0.0	1.5	11.8	29.1	59.3	13.8	0.0	0.5	0.1	12.5	39.5	0.0	0.0	0.6	15.0	15.4	0.1	15.2	46.6	0.1	0.0	0.2	10.5	1.0	0.2	1.3	0.1	0.1	0.8	0.6	0.6	0.6	0.3	1.4	0.9	0.8	1.4	0.8	0.2	0.8	0.0	0.3	74.2	74.5	56.3	74.7	71.6	78.0	71.9	70.0	68.8	63.2	79.8	67.3	30.6	16.0	26.9	31.0	24.9	12.1	51.2	6.7	7.4	77.5	22.5	25.0	44.3	25.8	26.2	42.3	33.3	45.9	10.1	3.7	15.6	25.1	52.3	46.9	26.8	33.2	26.5	3.4	29.5	5.8	8.6	28.5	11.7	24.0	23.5	39.8	33.5	4.1	9.0	112.7	26.4	14.7	10.2	3.2	6.4	75.9	40.0	6.0	10.6	13.1	6.0	73.0	25.7	21.6	40.7	5.9	13.1	58.6	3.6	38.4	7.3	11.1	36.7	110.5	19.7	32.6	30.1	30.0	27.9	6.5	12.1	65.7	15.8	39.3	10.5	32.6
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.0;Proximal tubular cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	7.6	5.8	3.0	4.2	3.9	8.7	7.2	4.8	3.6	6.7	2.3	4.5	3.1	6.4	2.3	2.3	4.0	3.5	6.0	3.2	4.1	7.5	8.8	3.0	4.1	3.2	3.3	6.0	16.6	4.1	4.1	2.1	3.8	5.2	2.9	6.2	6.8	3.0	8.2	2.6	4.4	3.3	2.8	5.9	8.1	11.8	3.7	10.1	4.1	3.1	3.1	4.6	3.5	4.8	2.2	13.4	9.0	14.6	5.7	3.5	8.5	2.5	6.2	5.3	6.4	10.4	5.2	4.9	6.9	3.5	9.8	5.6	6.9	5.0	4.6	10.4	13.0	6.2	8.4	22.0	4.9	3.9	4.4	5.6	4.9	7.0	6.6	7.0	15.5	24.0	8.4	3.9	5.6	6.7	16.8	9.6	16.9	4.5	7.9	16.8	5.6	9.2	5.3	16.7	13.5	23.1	7.6	4.1	11.7	14.5	9.1	9.8	10.8	6.3	12.4	3.2	3.3	6.3	9.5	16.8	4.3	8.7	3.7	6.4	5.8	5.0	5.7	6.4	2.8	3.9	5.2	4.3	6.6	3.5	3.8	4.3	3.1	5.6	8.4	5.9	7.8	3.9	3.0	3.9	4.8	3.6	3.2	4.1	3.2	3.3	3.8	2.8	3.7	4.8	9.1	0.0	2.0	1.6	3.9	0.9	1.2	2.6	2.2	3.1	3.5	3.2	2.5	4.3	1.7	7.3	2.1	1.6	2.5	1.3	5.9	6.9	18.0	5.7	3.3	3.0	3.0	3.0	1.6	8.6	5.1	2.3	4.6	6.9	1.3	8.0	1.1	7.5	3.6	0.0	1.6	3.2	4.1	2.8	2.3	12.3	0.9	2.9	1.8	1.0	5.5	2.3	2.1	4.0	2.5	9.9	4.2	1.5	11.1	2.6	1.9	22.6	1.8	3.1	6.6	2.3	3.9	7.1	8.2	0.9	0.4	1.4	3.7	3.6	2.6	1.5
ZSCAN20	"KOX29, ZNF31, ZNF360"	ENSG00000121903	"Zinc finger and SCAN domain containing 20"	P17040	1	33472645-33496507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017933	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA017933: AB_1859028"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.28e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.77e-6)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.74e-2)"	0.8	0.8	1.4	0.7	1.7	0.2	1.3	2.3	1.4	1.2	1.6	1.1	2.7	1.4	0.9	0.9	1.2	0.7	1.9	1.1	1.2	1.1	0.5	0.9	0.6	1.7	1.6	2.3	0.9	2.5	0.9	1.2	1.9	1.2	1.3	1.5	1.0	1.5	1.1	0.8	1.2	1.5	1.1	0.9	1.2	1.7	1.8	1.2	1.3	2.0	1.0	1.0	0.7	2.4	2.4	1.7	4.0	2.7	3.1	3.1	2.6	2.9	2.9	3.8	3.1	1.8	3.0	1.7	1.5	3.0	2.2	2.9	3.3	1.5	3.9	0.0	3.7	3.6	4.2	1.5	2.9	2.0	1.2	2.2	2.7	4.0	3.3	3.5	3.0	2.9	2.4	2.2	3.4	0.8	1.6	1.2	3.3	2.2	1.0	1.7	4.6	0.7	2.1	2.0	1.5	2.3	2.2	2.4	3.2	5.2	1.6	2.2	2.7	3.3	2.3	3.1	4.2	2.9	2.0	0.8	3.5	0.6	2.2	0.0	0.5	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.1	0.2	0.2	0.2	0.2	0.1	1.4	1.7	2.3	1.4	1.1	1.2	1.7	1.6	1.9	1.1	1.8	2.4	0.8	0.0	1.3	1.3	0.2	0.0	0.6	0.7	1.8	1.8	0.5	0.4	2.2	2.8	0.4	0.0	4.2	0.9	0.1	1.0	0.0	0.8	15.9	0.4	1.2	0.9	1.2	2.7	2.6	0.2	0.8	1.7	2.6	0.4	1.3	2.8	1.8	0.4	0.6	0.0	2.7	0.7	0.0	1.2	0.0	2.6	1.2	0.3	0.0	4.7	2.0	1.0	1.0	4.0	3.7	0.9	1.6	1.9	0.4	0.5	0.4	0.5	0.9	1.9	0.0	1.4	1.2	3.2	1.5	1.0	0.0	0.3	0.8	0.9	0.4	0.5
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065040	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	7.8	7.8	10.6	4.5	12.3	6.1	8.0	12.6	11.7	10.3	10.2	11.2	4.6	9.8	9.2	5.7	10.6	6.0	7.6	10.5	10.7	9.6	13.1	6.2	6.2	11.4	11.6	9.9	10.0	7.0	7.6	8.0	11.3	10.8	5.3	9.3	10.3	7.2	14.1	7.0	6.9	7.8	10.6	7.4	9.0	12.2	12.0	7.1	8.3	12.9	4.9	9.4	7.4	14.1	5.9	9.8	16.0	18.7	14.8	9.5	13.1	6.7	10.3	13.0	13.0	7.8	6.7	6.4	8.2	7.9	22.1	5.3	14.5	9.7	12.9	8.5	11.9	5.8	8.6	7.3	16.0	8.4	2.3	11.3	16.8	12.7	21.1	10.8	10.5	13.0	14.0	5.4	9.7	15.1	14.0	13.8	19.9	8.2	7.3	9.5	12.8	7.8	10.8	9.2	8.2	20.9	9.2	19.4	12.9	22.6	7.8	7.0	4.6	11.8	14.6	10.4	9.4	10.7	10.6	14.1	5.5	5.3	16.1	12.9	6.0	12.9	9.9	5.8	10.8	6.6	6.0	9.0	6.3	6.5	6.6	7.5	0.8	10.7	3.9	5.9	7.4	4.9	10.6	12.3	12.6	11.7	10.5	10.7	11.4	11.6	11.3	10.6	12.0	14.1	5.1	3.2	5.1	5.5	4.3	1.5	3.4	4.1	5.2	6.0	3.5	3.6	1.6	2.8	4.4	3.7	2.1	16.6	10.6	2.9	7.9	7.1	2.7	4.0	7.7	4.7	1.8	11.0	3.7	4.0	6.5	5.4	2.6	3.8	2.5	8.0	3.6	5.2	5.2	10.1	4.1	2.5	8.2	2.5	2.1	0.7	5.9	2.9	3.6	7.5	3.0	16.5	3.1	7.1	7.5	4.4	5.0	9.8	3.4	4.0	3.2	11.9	2.5	5.9	0.0	7.7	6.7	14.1	19.7	2.9	3.8	17.6	2.9	8.0	2.8	1.7
ZSCAN22	"HKR2, ZNF50"	ENSG00000182318	"Zinc finger and SCAN domain containing 22"	P10073	19	58326994-58342332	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 14.7"	"Low region specificity"	"Detected in all"							HPA006471	Uncertain		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA006471: AB_2221026"	"unprognostic (5.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.00e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.07e-1)"	1.2	1.5	1.4	1.3	1.7	0.7	1.1	2.9	1.6	1.7	1.0	1.5	1.2	1.5	0.8	1.8	1.3	0.7	1.2	1.3	1.4	1.3	2.4	1.1	1.2	1.4	1.2	1.5	1.4	1.6	2.6	1.2	1.4	1.4	0.9	0.8	1.2	1.0	1.1	2.3	1.3	1.2	0.8	1.4	1.4	1.2	1.2	1.1	1.3	1.0	1.4	1.5	1.5	2.8	2.4	4.2	2.3	3.5	2.6	1.6	2.4	2.0	1.0	1.2	1.1	2.3	1.7	1.9	1.3	1.6	1.5	1.8	3.3	2.2	1.3	3.0	14.7	4.1	4.2	2.1	2.1	3.3	4.2	1.8	2.2	2.6	2.7	2.2	1.8	1.9	4.1	3.6	2.1	1.9	1.6	1.5	2.0	3.0	4.8	2.2	3.6	3.3	1.2	3.1	3.6	2.6	3.0	4.0	2.0	1.8	1.9	2.3	1.8	6.5	1.9	1.6	3.5	3.6	5.3	1.4	2.6	2.2	2.3	0.0	0.8	1.0	2.0	0.7	1.3	0.8	1.1	1.6	1.1	1.0	0.9	1.0	0.2	1.2	0.9	0.5	0.9	1.0	1.4	1.7	2.9	1.6	1.3	1.4	1.4	1.2	1.4	0.8	1.2	2.8	1.1	0.0	4.1	1.6	1.5	1.8	0.6	1.0	0.0	0.7	1.3	0.9	0.6	1.5	1.6	1.8	0.0	0.9	0.8	0.4	1.9	0.9	0.3	1.1	1.2	0.9	0.0	1.7	2.1	0.6	0.9	1.1	1.1	1.6	0.0	1.1	0.0	1.3	0.5	1.7	2.1	0.5	0.0	0.8	0.8	0.0	2.1	2.3	1.8	0.0	1.3	0.5	0.0	1.0	2.2	1.1	1.6	0.4	1.1	0.9	0.8	0.6	1.1	0.7	0.0	1.7	0.8	4.3	1.9	1.1	3.7	0.7	1.2	0.9	1.0	0.4
ZSCAN23	"dJ29K1.3.1, ZNF390, ZNF453"	ENSG00000187987	"Zinc finger and SCAN domain containing 23"	Q3MJ62	6	28431930-28443502	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 13.7;Excitatory neurons: 20.2;Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;SCLC-21H: 1.8"					"Low region specificity"	"Detected in all"			"HPA035959, HPA035960"	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035959: AB_10696647, HPA035960: AB_2674889"	"unprognostic (6.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.32e-3)"	0.1	0.3	0.2	0.1	0.3	0.0	0.7	0.8	0.2	0.4	0.3	0.2	0.1	0.8	1.2	0.1	0.4	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.1	1.1	0.3	0.7	0.3	0.3	0.1	0.8	0.3	1.3	0.6	0.6	0.0	0.1	0.2	0.4	0.0	0.3	0.1	0.5	0.1	0.2	0.8	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.5	0.0	0.7	1.4	0.2	0.4	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.6	0.4	0.5	0.0	1.0	0.0	0.0	0.1	0.2	0.4	0.0	0.5	0.3	0.3	0.5	0.8	0.1	0.2	0.6	0.0	0.3	0.0	0.0	0.4	0.7	0.0	0.3	0.3	0.4	0.0	0.2	0.5	1.8	1.1	0.0	0.4	0.0	1.1	0.0	0.1	0.0	1.0	0.8	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.0	13.7	0.2	0.0	0.2	0.2	1.2	2.1	0.2	0.1	0.4	0.0	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.2	4.8	0.3	0.8	0.3	1.8	0.0	20.2	0.6	0.1	0.3	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	24.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.6	0.0	0.6	0.0	17.6	10.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.7	1.9	0.6	0.1	0.0	0.1	0.1	1.1	0.1	0.0
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 34.6;Excitatory neurons: 48.1;Inhibitory neurons: 44.9;Microglial cells: 32.8;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	4.2	4.0	2.8	4.8	2.7	6.4	5.0	3.3	3.1	4.9	3.1	4.4	3.3	5.1	2.3	4.7	5.1	3.3	3.0	2.6	2.5	3.9	3.3	3.8	6.0	2.8	2.3	7.7	4.5	5.7	3.1	4.1	2.5	4.7	3.6	2.7	4.5	5.4	4.5	6.1	4.1	4.8	2.2	5.1	3.9	5.3	2.8	9.5	4.6	3.9	5.3	4.3	4.3	3.1	7.6	3.5	10.0	11.5	4.3	3.3	9.8	8.2	6.9	9.3	9.6	9.3	6.1	10.6	9.3	6.9	8.5	9.7	11.0	9.5	11.5	6.1	9.4	7.1	5.8	8.1	7.4	16.6	6.3	5.2	11.7	7.4	7.7	3.7	6.0	11.7	20.4	8.3	6.6	8.4	24.0	23.4	18.4	4.2	8.3	10.0	10.3	11.4	4.0	10.3	6.8	16.8	10.8	16.2	11.7	11.8	4.5	11.2	4.3	14.4	11.6	8.3	14.0	7.4	12.8	18.2	7.8	10.2	21.6	3.5	2.4	3.2	4.3	2.6	5.3	1.9	3.0	4.2	1.9	1.6	5.0	5.1	2.9	2.8	2.4	1.6	4.7	3.3	2.8	2.7	3.3	3.1	2.6	2.5	2.8	2.3	2.5	2.2	2.8	3.1	3.9	0.0	6.2	34.6	4.6	3.4	1.8	2.6	2.8	4.9	4.0	4.4	4.2	2.8	1.5	1.8	8.4	4.3	5.1	5.2	1.9	2.9	5.2	2.3	4.6	3.9	2.4	5.5	48.1	2.8	3.4	3.3	3.6	3.5	5.1	4.5	4.2	3.6	3.6	5.0	44.9	4.4	6.1	6.0	1.4	2.7	3.7	2.0	1.8	32.8	3.9	2.3	4.1	47.7	44.4	2.1	3.1	6.0	5.5	3.0	3.7	2.4	2.5	4.7	6.6	4.0	3.9	10.0	7.6	4.0	2.3	1.9	6.2	4.7	3.7	1.7
ZSCAN29	"FLJ35867, Zfp690, ZNF690"	ENSG00000140265	"Zinc finger and SCAN domain containing 29"	Q8IWY8	15	43358172-43371025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007241, HPA011109"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments"	"HPA007241: AB_10600420, HPA011109: AB_10611525"	"unprognostic (3.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.43e-2)"	6.3	5.6	7.9	8.6	10.1	5.6	6.8	8.1	7.4	7.2	8.1	7.6	8.8	8.9	5.2	7.2	6.4	6.0	5.5	6.6	7.4	5.7	6.9	6.9	10.7	9.3	9.7	7.4	11.4	7.7	5.5	8.1	8.9	6.8	7.6	13.6	8.5	6.5	9.7	5.8	9.9	6.4	7.7	9.0	8.8	17.3	8.5	10.7	7.2	8.5	10.4	6.6	6.0	10.3	11.7	12.5	28.9	17.9	10.0	10.5	15.6	9.0	13.9	15.6	16.2	19.7	8.1	11.4	14.7	11.1	12.6	33.7	21.5	11.0	13.9	29.6	11.8	25.1	20.5	15.5	11.1	17.3	21.2	9.3	19.0	10.6	14.9	11.0	8.0	17.3	23.7	13.5	12.7	7.4	16.7	14.2	14.5	17.1	9.6	25.7	16.1	14.0	9.1	13.9	20.6	22.2	13.9	22.5	10.4	14.5	15.8	26.6	9.1	18.3	14.4	14.0	16.4	25.8	38.4	21.6	10.7	16.9	14.1	0.4	0.3	3.1	0.4	0.4	0.3	0.8	0.4	0.3	0.4	0.5	0.2	0.6	0.7	1.0	0.3	0.3	0.8	0.3	7.9	10.1	8.1	7.4	6.6	7.4	9.3	9.7	8.9	7.7	8.5	10.3	3.5	6.4	7.9	6.8	5.8	3.6	2.6	3.7	4.6	10.8	4.8	4.8	7.8	4.3	7.8	7.3	27.1	5.1	7.1	11.0	0.0	5.4	81.7	5.0	8.2	4.9	6.1	1.3	6.4	7.1	4.4	5.8	9.7	7.8	0.0	6.5	3.9	7.2	5.8	13.5	5.2	8.1	4.1	10.6	3.7	20.7	6.8	4.8	5.4	9.4	6.7	5.5	10.3	10.1	10.2	8.7	5.0	6.0	3.3	3.9	7.7	2.6	5.2	18.0	0.0	4.9	3.8	12.0	6.7	4.4	3.1	3.8	4.2	2.8	7.0	2.4
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.2	14.1	12.1	7.9	14.4	7.5	10.1	26.1	16.2	12.3	9.3	11.2	8.6	10.7	10.9	7.1	11.7	7.3	17.5	11.0	15.8	12.1	8.4	9.2	11.0	12.9	9.6	11.1	10.7	13.1	16.7	8.1	12.6	11.3	6.8	28.0	9.3	7.0	16.9	9.9	11.2	7.6	7.7	12.9	9.3	10.0	14.5	11.1	14.6	8.7	7.9	9.7	9.1	26.9	6.2	1.7	13.4	18.2	9.1	17.8	9.3	11.9	15.9	6.7	13.1	5.1	7.6	11.3	7.7	12.5	11.5	4.1	6.5	12.4	18.0	11.5	3.7	7.1	8.9	3.6	9.3	5.9	6.8	11.6	9.6	17.9	15.5	17.5	13.2	15.7	12.1	12.8	18.0	2.8	9.1	10.5	8.9	1.8	5.7	13.6	4.6	8.4	10.4	4.2	19.4	9.9	11.7	3.7	4.8	14.1	5.8	8.3	15.5	24.6	5.2	3.8	4.6	23.4	10.7	10.0	18.4	6.8	13.9	1.4	0.6	2.3	2.1	0.8	1.3	2.5	2.0	1.2	1.1	3.3	2.3	2.6	2.3	2.0	1.0	2.6	2.0	1.2	12.1	14.4	26.1	16.2	11.0	15.8	12.9	9.6	12.6	7.7	14.5	26.9	8.4	9.6	8.7	22.2	7.5	1.8	2.0	3.2	13.6	30.5	4.8	5.5	15.5	10.0	9.1	1.8	20.9	3.3	6.4	3.4	5.9	5.2	9.3	7.0	11.9	10.7	7.2	7.8	21.8	3.4	1.5	6.0	7.7	6.5	8.8	18.8	10.0	5.2	2.6	20.2	18.4	4.0	2.0	4.7	1.7	9.0	5.9	3.3	0.0	23.4	2.3	12.2	7.2	26.2	52.1	3.1	4.0	7.9	3.3	2.0	5.9	4.5	6.2	19.3	0.0	10.3	6.3	13.5	5.3	4.2	1.0	1.8	5.3	15.4	3.1	1.6
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.5;Late spermatids: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.3	3.4	10.5	2.5	12.9	4.7	13.0	24.1	18.3	8.1	4.4	9.9	4.1	19.2	9.5	11.3	7.9	18.7	7.9	15.5	8.7	6.2	5.6	10.7	2.5	14.0	10.8	19.7	7.2	4.4	6.2	3.0	14.6	8.3	6.1	8.2	6.4	9.3	9.6	13.4	4.4	12.6	11.7	2.7	16.9	20.9	12.7	4.6	13.5	8.0	4.1	5.7	6.3	21.2	2.0	2.7	4.1	19.1	0.7	0.9	6.0	0.9	1.2	0.9	0.8	2.5	29.5	0.5	40.1	1.4	5.9	6.2	2.1	1.8	0.6	3.6	1.7	6.5	16.0	4.5	1.7	14.0	8.3	0.7	16.2	1.1	1.7	1.9	28.0	5.4	7.7	4.9	4.3	2.9	2.4	3.4	1.3	1.4	12.1	6.2	3.7	3.7	2.8	2.5	13.6	3.7	26.3	16.6	3.9	3.0	8.4	4.7	31.0	6.1	47.6	1.2	2.2	2.1	3.3	0.5	0.7	6.7	1.4	17.6	0.3	0.6	1.3	0.2	1.2	1.2	1.1	1.0	0.3	1.0	0.8	1.2	0.2	1.3	0.3	1.8	0.2	0.3	10.5	12.9	24.1	18.3	15.5	8.7	14.0	10.8	14.6	11.7	12.7	21.2	7.0	28.9	3.3	15.7	0.5	0.8	2.4	7.5	14.8	8.9	3.3	2.8	7.6	2.8	11.6	3.7	0.0	1.9	1.8	4.9	7.9	2.9	138.5	6.6	1.5	7.4	6.0	0.8	27.9	8.1	0.9	4.1	10.2	5.8	2.5	2.2	1.8	4.8	0.7	1.7	11.7	2.5	16.2	0.8	1.2	65.0	3.7	0.7	1.8	4.7	0.7	7.2	1.0	4.0	18.5	4.8	2.6	5.3	2.0	1.4	1.2	8.1	3.9	5.9	6.6	2.7	3.4	11.2	4.5	6.8	2.3	0.8	1.1	2.3	3.3	1.5
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	4.8	5.9	8.9	5.6	9.4	3.6	5.9	8.6	10.9	6.2	10.0	6.6	7.8	6.0	4.4	4.9	6.9	5.0	5.3	8.6	10.1	5.9	5.5	6.0	8.6	9.6	9.6	8.2	7.4	7.6	8.4	5.4	9.5	6.5	5.7	11.6	4.9	7.0	4.6	6.1	5.4	5.5	8.8	6.9	5.9	7.4	9.6	10.1	7.2	3.3	9.1	6.1	5.2	11.4	6.0	10.1	12.7	15.3	10.1	10.0	9.5	7.1	12.6	10.3	9.9	5.2	8.8	19.4	7.5	10.6	6.8	6.4	10.6	10.6	12.0	13.0	7.6	16.7	9.1	7.1	12.7	11.9	12.1	10.0	17.1	10.2	17.3	11.2	10.6	21.3	16.5	7.5	13.5	7.5	16.4	8.1	13.8	10.6	5.1	16.0	13.1	18.6	8.9	6.4	11.2	8.6	14.4	8.8	7.8	8.1	10.1	14.7	12.8	8.9	8.4	7.3	8.6	12.4	14.8	25.1	2.5	9.4	13.6	4.1	5.4	7.3	9.7	4.2	8.3	8.3	6.7	6.2	4.9	6.7	9.3	9.0	6.0	15.0	13.1	5.0	9.5	6.2	8.9	9.4	8.6	10.9	8.6	10.1	9.6	9.6	9.5	8.8	9.6	11.4	3.9	19.2	5.3	3.3	5.1	2.3	2.2	1.7	1.8	4.6	3.0	3.4	0.9	5.7	6.2	1.8	8.4	4.9	3.6	2.7	11.7	5.6	1.6	3.5	3.8	3.9	0.0	6.1	4.8	6.2	2.7	2.8	1.5	2.2	5.1	4.6	2.5	3.4	3.0	8.4	4.4	3.3	2.0	5.1	1.8	1.4	4.4	5.1	1.8	9.4	6.2	6.0	9.2	8.0	7.7	5.8	3.2	5.3	3.6	3.9	3.1	3.7	1.7	4.2	0.0	4.1	2.9	15.9	15.9	2.9	2.8	2.6	5.6	6.5	3.1	1.5
ZSCAN4	"FLJ35105, ZNF494"	ENSG00000180532	"Zinc finger and SCAN domain containing 4"	Q8NAM6	19	57668935-57679152	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 2.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Microglial cells: 1.0;Syncytiotrophoblasts: 1.6"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006491	Uncertain					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA006491: AB_10603385"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"		"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.75e-1)"		"unprognostic (4.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.73e-1)"	0.2	0.0	0.3	0.0	0.3	0.3	0.1	1.0	0.5	0.5	0.1	0.1	0.1	0.0	0.4	0.1	0.4	0.1	0.3	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.2	0.5	0.6	0.2	0.9	0.1	0.0	0.0	0.2	2.8	0.4	0.2	0.2	0.3	0.2	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.5	0.2	0.2	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3
ZSCAN5A	"MGC4161, ZNF495, ZSCAN5"	ENSG00000131848	"Zinc finger and SCAN domain containing 5A"	Q9BUG6	19	56219670-56368383	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 128.5;Late spermatids: 88.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (1.72e-1)"	"unprognostic (3.19e-3)"	"unprognostic (8.22e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.67e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (3.99e-3)"	3.1	3.2	3.5	3.6	4.0	2.5	2.8	3.3	3.4	3.4	5.3	3.8	3.9	3.7	2.0	3.0	7.1	2.6	4.1	3.6	3.6	3.6	2.6	3.1	2.8	3.7	4.0	3.5	2.6	3.8	3.3	2.0	3.8	3.0	4.5	2.3	3.2	2.4	4.1	4.3	3.4	3.9	3.3	2.8	2.6	25.1	3.6	4.5	3.2	3.5	3.4	3.7	3.2	3.4	5.9	5.0	7.1	8.6	5.7	3.6	10.4	3.4	7.2	10.3	6.1	10.1	3.4	10.6	2.7	6.0	6.1	7.0	9.2	7.3	9.2	3.0	19.4	13.0	3.4	10.2	4.5	14.5	14.0	2.8	11.0	10.1	4.6	2.1	7.5	8.2	5.3	4.7	3.2	7.2	3.5	8.0	12.8	5.2	13.1	5.5	10.7	6.1	4.3	10.9	6.9	6.9	9.1	6.9	3.6	4.0	3.0	13.2	4.1	8.9	8.9	4.7	11.4	7.7	21.1	7.2	11.5	14.2	3.5	3.7	6.5	4.4	4.2	7.2	6.4	3.3	4.4	3.2	7.5	1.9	5.7	3.0	0.5	1.3	4.5	9.3	1.2	3.7	3.5	4.0	3.3	3.4	3.6	3.6	3.7	4.0	3.8	3.3	3.6	3.4	3.3	0.0	4.2	2.3	5.3	4.8	5.8	6.0	6.2	4.9	6.4	5.0	17.4	0.0	5.0	0.0	8.4	3.0	5.6	4.3	11.7	5.0	128.5	10.5	3.4	4.1	7.8	5.5	0.6	5.1	3.5	5.5	5.1	4.9	2.5	2.8	4.6	6.8	6.5	3.3	0.3	4.0	8.2	7.3	3.0	88.5	2.5	5.2	0.0	0.0	3.0	7.8	2.1	0.5	0.3	4.4	1.0	2.6	4.0	4.5	4.5	6.0	12.4	10.8	0.0	6.5	3.3	14.7	16.5	4.2	3.7	7.0	3.4	3.3	5.2	3.3
ZSCAN5B	"ZNF371, ZNF495B"	ENSG00000197213	"Zinc finger and SCAN domain containing 5B"	A6NJL1	19	56189570-56197920	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.3"	"Cell type enriched"	"Detected in single"	8	"Spermatogonia: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043123, HPA046836, HPA059494, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: "	"unprognostic (4.73e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN5C	"ZNF495C, ZSCAN5CP"	ENSG00000204532	"Zinc finger and SCAN domain containing 5C"	A6NGD5	19	56202273-56209200	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA							"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (3.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.53e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	3.0	4.1	2.7	3.7	2.6	6.0	3.5	4.6	2.9	3.1	2.7	4.1	4.6	3.4	3.5	3.5	4.2	3.2	4.9	2.7	2.5	3.6	1.9	3.3	5.0	2.6	2.7	5.8	4.2	4.9	1.1	4.0	2.5	4.1	3.5	8.2	4.9	3.4	15.9	6.5	4.4	3.5	1.9	4.6	4.3	3.8	2.9	3.9	4.5	5.1	4.9	3.4	1.4	3.1	7.2	8.6	6.4	7.8	11.2	6.3	6.5	4.8	5.9	10.2	9.3	19.5	8.4	8.4	13.9	6.7	11.2	17.0	10.1	12.9	7.7	3.4	6.1	10.7	11.5	14.0	6.8	9.2	10.9	9.2	10.6	8.6	8.2	7.8	7.9	7.3	9.8	6.7	6.0	20.8	10.0	7.9	3.6	8.1	9.7	7.8	9.1	6.0	6.7	10.1	8.6	5.5	16.2	24.0	5.8	5.7	14.6	7.2	7.0	11.5	7.3	6.4	7.0	6.6	5.0	8.2	9.2	6.8	6.0	2.4	1.4	3.6	0.5	1.8	0.3	2.4	1.7	0.7	0.7	2.2	2.3	2.1	1.6	0.6	1.8	2.2	1.4	0.8	2.7	2.6	4.6	2.9	2.7	2.5	2.6	2.7	2.5	1.9	2.9	3.1	0.8	3.2	2.7	0.7	1.4	1.1	2.4	2.4	2.2	3.0	0.8	0.5	5.7	4.3	1.2	0.0	0.0	2.9	0.3	4.2	3.9	2.4	0.6	1.1	1.7	1.7	2.4	4.4	0.8	3.8	2.8	1.9	4.1	1.5	3.8	2.5	2.5	2.1	1.7	6.7	0.9	2.8	2.0	1.4	1.9	0.7	3.4	0.7	0.0	0.0	1.8	1.6	1.0	0.0	0.8	3.3	3.7	1.5	0.5	1.6	2.4	1.2	0.4	3.8	0.0	2.0	1.8	1.0	2.0	1.4	1.6	2.3	1.8	3.6	3.0	2.0
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857614-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.6;Inhibitory neurons: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: AB_2682887, HPA060508: AB_2684297"	"prognostic unfavorable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	1.3	2.9	2.3	2.0	2.2	0.7	1.8	2.8	2.5	1.8	1.4	2.3	2.4	1.9	2.8	1.8	2.1	1.5	2.0	2.1	2.3	1.8	2.3	1.9	3.4	2.0	2.1	2.7	1.5	2.2	1.9	1.7	2.1	1.9	2.3	3.3	1.8	1.6	1.4	2.2	2.4	1.7	2.0	3.2	1.8	3.2	2.2	3.5	1.9	2.4	3.9	1.6	1.4	2.1	1.7	1.4	4.1	2.4	4.9	3.5	2.4	2.6	3.1	4.7	4.6	5.9	2.6	5.3	8.8	2.2	2.3	2.8	5.9	2.8	3.5	3.3	2.5	5.1	2.6	3.8	5.9	2.9	6.7	3.2	3.1	3.6	2.2	5.0	4.1	4.6	4.8	2.5	3.6	8.5	4.0	5.8	1.6	3.9	5.6	3.9	3.8	4.0	1.3	1.0	5.4	2.7	4.2	4.8	3.3	3.1	2.3	7.6	4.1	4.7	1.5	1.8	1.6	5.4	3.0	3.4	4.0	3.4	1.5	1.0	1.1	1.6	1.3	1.5	2.8	2.1	1.5	2.0	1.9	1.8	1.4	1.9	0.8	1.7	4.8	1.1	2.4	1.1	2.3	2.2	2.8	2.5	2.1	2.3	2.0	2.1	2.1	2.0	2.2	2.1	1.6	3.2	1.1	4.6	4.1	0.4	0.3	0.7	0.6	4.4	1.1	1.0	1.3	0.0	0.5	1.8	0.0	1.3	1.4	2.8	0.0	1.2	0.5	0.6	1.2	1.8	2.4	0.8	7.6	1.4	0.6	1.4	1.5	1.0	0.0	5.2	2.2	0.8	1.0	0.0	9.2	1.1	0.0	1.3	1.4	0.7	0.3	1.1	0.0	6.5	0.6	2.8	0.0	7.1	7.0	0.6	0.3	1.2	2.6	0.2	2.0	1.2	0.5	4.3	0.0	1.3	1.2	2.4	4.3	1.3	0.3	0.8	3.1	4.7	0.9	0.4
ZSWIM4	FLJ12221	ENSG00000132003	"Zinc finger SWIM-type containing 4"	Q9H7M6	19	13795460-13832230	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.6"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 34.2;Urothelial cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042084	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA042084: AB_10795392"	"unprognostic (3.29e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.25e-3)"	"unprognostic (6.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (3.47e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.63e-2)"	3.3	5.3	0.8	2.0	0.8	1.0	4.9	0.9	1.9	5.6	1.4	2.8	1.1	4.2	0.2	16.6	3.3	1.4	4.1	0.8	1.2	6.2	1.9	7.1	1.2	1.5	1.2	3.6	3.9	1.0	4.7	1.6	1.3	5.0	0.3	1.1	14.8	0.8	2.9	8.5	3.0	0.9	0.8	4.1	3.5	1.4	1.4	1.4	5.8	0.8	1.3	3.2	7.6	0.9	4.3	2.4	4.7	2.4	0.6	0.5	4.5	1.8	3.9	1.6	1.7	0.9	2.3	1.5	2.8	1.5	2.5	1.7	0.8	1.6	1.1	5.4	1.5	0.2	3.0	0.5	3.8	0.4	1.2	2.5	0.4	1.8	0.7	3.9	3.8	3.6	1.4	3.2	0.5	2.3	2.4	3.4	5.5	0.8	2.4	5.3	4.4	2.5	2.2	2.0	1.3	9.1	3.1	7.6	3.3	2.7	1.1	2.8	4.5	4.7	1.7	1.4	6.2	3.9	2.5	1.0	3.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.9	1.9	0.8	1.2	1.5	1.2	1.3	0.8	1.4	0.9	5.5	3.2	2.0	4.9	2.4	5.4	17.1	8.6	2.8	5.4	11.9	6.9	3.3	8.6	7.4	3.7	8.4	4.2	2.0	3.3	0.0	13.1	0.2	11.1	5.0	10.4	10.7	1.7	5.8	23.1	3.4	6.0	4.1	23.0	0.0	3.7	4.6	1.8	4.6	6.7	7.0	3.0	2.0	7.0	11.9	0.4	1.2	5.6	3.6	5.6	3.8	2.4	0.0	6.0	1.8	23.8	2.3	1.2	1.5	14.3	3.9	3.2	12.6	3.7	0.0	34.2	6.4	0.3	0.9	4.9	7.0	6.0	6.8	0.7	3.9	26.8
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 96.9;Excitatory neurons: 84.3;Granulosa cells: 36.3;Inhibitory neurons: 133.8;Microglial cells: 54.4;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.2;Hep G2: 6.1;SCLC-21H: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.0	12.1	2.8	0.9	3.4	0.2	1.7	5.4	3.1	2.2	0.9	4.1	4.4	3.0	2.4	1.3	2.4	1.1	1.5	2.6	3.3	2.9	0.6	2.1	1.1	3.0	3.2	8.0	2.9	6.0	6.0	0.9	2.9	3.1	4.9	8.5	2.9	2.3	1.2	1.5	6.8	3.0	2.2	1.6	1.9	3.0	3.5	0.7	4.1	1.1	0.9	2.6	1.3	2.5	0.4	1.3	3.1	5.2	0.4	0.1	0.7	0.1	4.2	0.8	0.6	0.4	0.5	0.3	0.1	0.1	2.3	0.1	2.2	0.0	0.9	2.2	3.9	0.2	4.6	6.1	0.0	0.6	0.6	0.1	0.1	0.2	0.0	0.4	0.9	1.0	0.2	0.2	0.1	1.8	0.4	0.2	2.8	3.7	1.5	1.4	0.1	0.2	0.0	1.0	7.2	3.7	2.0	0.7	0.3	0.9	1.5	0.1	0.2	0.7	0.4	0.2	0.8	1.4	0.2	0.1	2.8	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.8	3.4	5.4	3.1	2.6	3.3	3.0	3.2	2.9	2.2	3.5	2.5	0.3	0.0	3.1	96.9	0.4	0.5	0.5	0.1	1.2	9.3	1.5	1.4	1.4	2.8	1.3	0.0	10.4	0.1	0.2	5.7	1.9	0.3	1.2	0.4	0.7	1.9	6.7	0.0	84.3	1.3	0.0	1.0	1.5	0.7	0.0	36.3	1.8	0.3	0.1	8.4	133.8	3.9	0.0	0.0	0.3	1.5	0.3	0.2	0.0	54.4	0.6	1.8	0.0	144.8	106.1	0.8	3.7	1.5	0.2	0.5	6.1	1.8	0.7	4.9	0.0	1.1	1.1	1.3	2.3	0.5	0.9	0.1	0.9	0.7	4.4	0.3
ZSWIM6	KIAA1577	ENSG00000130449	"Zinc finger SWIM-type containing 6"	Q9HCJ5	5	61332258-61546172	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 500.1;Microglial cells: 365.4;Oligodendrocyte precursor cells: 765.6;Oligodendrocytes: 740.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035938	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA035938: AB_10672077"	"unprognostic (2.22e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.99e-1)"	8.1	5.4	11.0	8.9	17.0	3.8	5.8	13.0	14.3	6.6	4.1	9.6	6.0	5.0	5.5	8.8	6.3	9.5	4.8	11.0	12.0	5.1	7.8	13.4	5.7	15.7	13.6	7.2	7.7	5.8	6.4	7.8	14.9	8.3	10.7	8.3	6.9	6.4	3.4	5.3	7.5	6.2	12.4	7.0	10.0	7.4	14.2	6.9	6.5	2.5	5.0	7.6	8.4	26.5	6.0	7.8	35.4	2.5	7.5	13.6	3.0	7.9	7.1	8.6	13.2	3.1	9.4	1.5	6.7	9.9	13.7	5.1	7.9	9.6	12.0	25.0	7.4	2.9	16.3	1.7	9.9	1.9	4.1	9.9	7.0	20.2	17.2	11.8	21.3	3.3	0.9	29.3	35.4	4.3	1.6	3.8	5.4	1.8	5.8	11.8	10.3	44.4	14.1	7.7	7.2	11.3	18.7	1.1	7.3	13.7	3.1	7.7	29.8	7.1	9.2	9.9	11.4	5.1	0.8	3.2	11.0	2.3	15.4	0.9	1.1	0.5	0.0	0.9	0.3	0.2	0.1	0.1	0.5	0.3	0.1	0.1	1.6	0.4	1.3	1.3	0.1	0.2	11.0	17.0	13.0	14.3	11.0	12.0	15.7	13.6	14.9	12.4	14.2	26.5	24.5	25.6	12.6	500.1	13.3	47.4	80.2	12.0	42.1	6.9	25.8	20.4	12.2	25.8	27.1	11.0	10.4	0.4	29.5	38.4	1.9	12.0	12.7	47.4	37.4	23.6	14.2	1.7	223.4	12.9	0.5	22.7	28.1	86.1	14.5	9.6	27.8	8.0	25.9	8.4	167.7	25.8	14.2	59.3	49.0	8.5	5.6	53.3	16.0	365.4	34.0	15.6	2.1	765.6	740.4	19.2	30.2	6.4	14.3	40.6	9.4	4.9	28.8	5.1	6.6	19.5	22.7	18.9	18.8	32.2	39.9	1.4	15.7	27.1	19.8	58.3
ZSWIM7	SWS1	ENSG00000214941	"Zinc finger SWIM-type containing 7"	Q19AV6	17	15976560-15999717	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054681	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA054681: AB_2682572"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (1.70e-1)"	12.5	18.0	6.9	6.0	7.2	4.3	12.6	6.8	10.4	11.8	6.2	12.9	7.3	11.7	4.8	8.5	10.9	4.4	18.2	7.3	7.8	14.5	13.8	10.1	7.2	7.4	7.1	15.7	12.6	6.6	16.2	5.4	7.5	10.8	4.6	5.6	9.3	4.7	32.7	10.9	10.1	5.4	6.8	13.9	10.2	5.8	7.7	4.6	11.7	10.2	3.7	10.4	10.4	7.5	17.2	24.5	12.4	30.1	5.1	4.8	15.1	11.3	4.4	11.7	8.6	4.6	4.9	8.1	9.8	12.2	3.5	5.5	4.1	8.9	5.5	8.7	14.1	9.3	11.5	9.7	12.1	7.5	15.1	11.7	15.4	6.4	11.0	1.7	15.1	21.2	5.9	4.5	6.1	23.2	26.2	17.4	8.1	25.0	14.4	16.2	31.7	13.1	10.6	9.0	4.4	18.9	17.5	17.4	12.4	33.2	12.5	1.8	21.5	18.9	6.4	4.9	9.9	2.3	6.3	9.8	16.2	9.3	16.3	28.0	27.2	12.0	13.6	27.5	14.6	26.8	15.9	13.1	42.0	24.6	18.8	18.0	1.6	18.0	19.8	25.9	12.6	19.7	6.9	7.2	6.8	10.4	7.3	7.8	7.4	7.1	7.5	6.8	7.7	7.5	42.4	35.3	54.5	16.6	35.7	25.6	33.7	50.0	37.0	38.4	56.0	65.0	65.0	67.2	32.7	40.5	62.6	99.9	39.2	35.0	86.1	56.5	13.6	32.9	40.0	33.9	50.8	24.0	16.1	52.0	58.9	29.5	21.9	27.6	55.2	52.3	37.5	55.2	49.7	18.5	13.4	37.1	59.0	55.4	37.8	14.4	45.4	53.0	55.2	15.0	46.9	60.1	53.5	14.6	21.9	50.6	35.7	39.9	24.5	37.0	50.0	134.5	35.8	56.9	26.3	33.9	30.6	87.1	74.1	28.8	27.6	72.8	29.1	71.2	36.3	28.8
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785606-73801797	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favorable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	60.4	97.0	86.7	19.7	88.1	42.8	59.3	85.1	110.5	77.1	88.3	77.7	27.2	63.8	43.4	105.6	62.5	24.9	65.1	87.5	85.5	97.3	143.6	68.9	25.1	87.9	86.4	69.8	64.4	35.4	145.0	24.8	87.1	91.1	17.8	27.5	70.9	28.4	62.2	88.9	70.1	28.1	83.7	109.8	68.1	96.4	87.8	25.1	87.6	22.4	21.6	74.5	77.1	90.4	14.0	23.3	28.4	46.9	65.6	31.2	16.3	17.5	48.1	24.3	29.1	20.7	11.3	7.9	12.3	28.6	23.6	20.6	10.1	19.9	12.2	12.6	21.3	11.2	26.1	27.7	49.2	7.7	41.4	51.4	36.2	30.2	35.0	66.0	28.5	16.4	16.0	14.9	28.3	21.2	11.7	22.8	8.4	11.2	72.8	13.9	13.5	4.7	34.9	29.6	6.8	30.9	14.5	42.1	25.9	24.5	28.5	15.8	29.6	26.7	16.0	12.2	18.1	37.6	21.6	5.1	29.5	11.3	14.1	2.4	2.2	1.9	3.0	1.5	1.7	1.8	1.3	1.3	1.8	1.2	0.6	1.9	4.9	1.1	2.5	3.8	1.8	1.0	86.7	88.1	85.1	110.5	87.5	85.5	87.9	86.4	87.1	83.7	87.8	90.4	17.2	3.2	11.5	49.6	7.2	12.4	7.4	15.1	11.4	32.8	20.2	17.7	1.4	20.0	12.8	20.2	68.8	13.4	27.2	21.7	1.9	13.7	5.5	14.0	19.0	17.1	20.4	11.4	34.0	14.8	8.4	13.2	24.5	22.2	0.0	18.8	29.6	35.0	19.0	35.3	30.2	18.3	14.2	24.2	15.7	2.2	22.1	17.1	16.0	21.5	19.2	19.6	15.5	26.7	36.5	17.5	19.5	24.0	8.2	17.7	41.3	11.7	15.4	45.3	13.1	21.1	18.3	35.8	15.9	14.9	14.2	28.7	13.9	19.3	12.1	17.9
ZSWIM9	"C19orf68, LOC374920"	ENSG00000185453	"Zinc finger SWIM-type containing 9"	Q86XI8	19	48170680-48197620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 6.1;Granulosa cells: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061028	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA061028: AB_2684419"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.03e-1)"	3.8	2.4	17.0	2.2	15.6	2.4	3.2	10.1	14.4	5.3	7.4	6.9	2.2	6.1	0.8	4.1	4.9	1.2	5.3	13.6	13.3	2.9	2.6	3.0	2.5	18.2	14.8	5.6	4.6	2.6	3.6	1.7	13.3	4.2	1.3	1.6	3.5	2.5	9.1	5.4	4.0	2.2	12.5	3.6	3.9	4.0	13.8	1.9	4.3	2.8	1.4	6.1	4.7	14.2	9.5	10.4	6.1	4.5	3.9	2.2	5.5	7.2	3.8	3.3	3.8	1.7	3.0	7.6	3.4	3.3	4.1	7.8	2.0	4.4	3.6	11.5	7.6	4.8	7.0	4.4	4.2	4.4	3.9	2.3	3.5	4.8	5.7	5.9	3.4	6.0	1.2	4.0	2.1	5.1	4.8	18.5	3.8	8.9	6.6	8.9	5.5	2.1	2.3	7.7	4.2	5.2	10.0	3.1	5.0	3.7	4.3	6.6	8.6	3.9	7.1	3.3	7.9	6.5	7.0	4.5	2.3	6.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	15.6	10.1	14.4	13.6	13.3	18.2	14.8	13.3	12.5	13.8	14.2	6.1	3.2	3.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	5.5	0.0	0.0	0.6	3.7	0.0	5.6	2.2	0.0	3.9	4.1	0.0	3.2	5.6	2.4	0.0	0.0	0.0	5.8	2.8	2.4	0.0	5.5	2.5	11.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.7	0.0	0.0	2.4	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.7	1.7	5.8	0.0	0.0
ZUP1	"C6orf113, dJ412I7.3, ZUFSP"	ENSG00000153975	"Zinc finger containing ubiquitin peptidase 1"	Q96AP4	6	116635618-116668794	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	4.4	4.5	4.2	6.2	4.7	13.5	5.6	7.2	6.3	4.0	3.0	5.1	10.5	3.6	4.1	5.6	3.1	5.5	2.7	4.3	4.6	4.6	4.3	5.0	8.7	4.4	4.4	2.5	5.7	4.2	3.9	5.3	4.6	5.0	5.7	6.0	3.8	4.0	3.1	5.5	7.1	4.1	4.5	6.0	4.7	6.1	4.7	7.5	4.6	3.3	8.7	6.1	4.1	5.9	6.6	6.3	13.9	26.2	7.9	10.3	10.4	14.0	13.3	13.5	16.3	11.5	7.3	23.3	11.6	8.9	15.2	10.3	15.8	10.1	17.9	14.0	18.1	18.0	9.5	20.0	12.3	21.1	21.3	9.2	15.7	11.0	18.7	10.0	12.5	17.4	32.1	11.6	17.9	10.7	10.2	16.0	10.3	9.9	6.8	13.9	12.1	9.6	15.0	6.6	12.1	14.0	10.0	8.3	8.6	11.8	4.9	15.9	10.7	8.6	5.8	5.3	11.9	10.7	14.9	24.0	7.7	12.8	12.8	19.5	7.5	7.6	7.0	8.9	8.2	9.5	7.9	8.1	10.1	10.4	8.6	6.4	2.9	8.3	11.0	6.9	11.7	6.5	4.2	4.7	7.2	6.3	4.3	4.6	4.4	4.4	4.6	4.5	4.7	5.9	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	5.3	5.2	0.0	0.0	0.0	1.8	0.0	10.4	12.8	0.0	9.8	9.7	0.0	7.4	8.7	2.2	0.0	0.0	0.0	8.0	8.3	2.2	0.0	8.4	0.0	10.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	12.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	9.3	4.4	6.0	0.0	0.0
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773735	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	6.9	6.0	3.5	8.1	4.1	9.2	10.9	5.0	4.8	8.1	3.7	8.3	7.2	7.6	7.3	9.6	6.1	5.9	5.6	3.8	3.8	8.8	13.0	6.4	9.4	4.2	4.7	6.9	9.1	7.2	5.1	7.7	4.6	7.9	10.0	6.8	8.3	7.3	13.4	13.7	7.1	8.7	3.8	7.0	7.3	13.5	4.2	12.1	6.7	12.0	12.0	8.5	7.5	5.7	25.0	14.4	30.2	22.1	18.4	20.0	17.4	26.1	21.4	32.2	32.5	38.1	46.1	29.0	34.5	25.8	28.1	34.2	36.7	31.6	46.0	19.1	15.1	30.9	12.0	23.5	20.6	31.7	18.8	16.5	20.8	34.1	27.4	14.2	33.5	31.7	36.3	11.8	33.8	12.2	29.3	20.9	21.7	29.8	29.0	27.0	34.4	32.7	21.2	22.2	13.3	15.7	29.1	24.2	11.8	24.2	44.9	17.4	21.1	28.8	44.2	14.4	28.8	6.1	10.6	30.6	9.9	38.1	33.0	8.5	7.4	7.4	6.3	10.4	8.5	5.9	5.9	5.6	9.5	5.1	5.4	6.8	1.9	6.2	9.2	3.0	5.6	5.6	3.5	4.1	5.0	4.8	3.8	3.8	4.2	4.7	4.6	3.8	4.2	5.7	5.6	0.0	4.8	11.1	5.8	12.1	7.6	7.5	8.0	2.9	5.9	5.0	6.8	7.2	7.3	0.0	0.0	9.2	3.9	3.9	9.8	10.1	10.7	7.7	7.1	6.9	3.6	10.7	12.5	11.8	10.0	6.5	8.2	12.7	3.8	7.8	3.9	8.1	9.2	3.3	11.1	4.6	4.1	6.0	5.4	7.3	5.0	6.1	3.6	10.3	8.0	7.6	3.1	12.1	18.7	8.4	3.8	5.7	10.4	5.6	5.3	7.2	4.8	4.9	19.7	7.0	7.0	44.4	17.5	9.4	12.5	10.5	5.9	6.9	6.4	5.8
ZXDA	ZNF896	ENSG00000198205	"Zinc finger X-linked duplicated A"	P98168	X	57905430-57910458	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.53e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.85e-3)"	"unprognostic (6.50e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-2)"	2.2	2.0	1.7	1.7	2.6	2.9	2.5	4.4	2.0	2.5	0.1	1.7	1.4	2.8	2.1	1.4	3.1	1.9	2.1	1.6	1.8	2.1	1.8	1.9	2.9	2.3	2.0	4.5	2.4	2.7	1.1	1.0	2.3	2.8	1.5	1.8	1.7	2.4	3.1	1.6	1.4	2.1	1.9	3.2	2.5	0.9	2.1	2.2	3.0	3.0	2.5	1.7	1.2	3.9	1.8	1.6	0.5	2.0	2.1	2.9	1.2	1.1	2.0	1.3	1.5	0.3	1.3	4.2	2.5	2.7	1.5	1.7	1.9	2.2	1.3	3.0	3.0	0.5	1.4	0.0	3.1	0.0	0.2	2.4	4.6	2.0	4.3	2.5	2.5	2.4	0.6	0.1	3.0	1.5	1.9	1.0	2.1	0.3	1.3	2.0	1.5	1.1	1.4	1.6	0.2	1.7	2.3	1.6	1.8	2.6	2.1	1.5	1.7	2.2	4.7	0.6	1.1	0.0	0.0	2.2	1.6	1.8	1.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.7	2.6	4.4	2.0	1.6	1.8	2.3	2.0	2.3	1.9	2.1	3.9	4.1	0.0	0.5	1.0	5.6	9.3	4.2	1.5	8.0	2.8	1.6	1.4	2.3	2.8	1.4	1.8	4.2	0.9	1.7	0.6	0.0	1.6	0.0	1.5	1.6	3.3	1.2	0.0	2.6	0.8	0.7	2.8	3.6	1.9	1.3	1.5	0.7	0.7	1.1	3.3	3.7	1.4	2.0	1.9	2.9	0.0	2.5	1.3	3.6	3.7	0.7	1.9	0.0	2.5	5.8	0.9	0.8	1.2	4.7	2.2	0.5	1.6	1.2	2.4	0.0	2.9	2.4	0.0	0.4	1.4	6.5	0.8	3.2	1.4	1.1	2.8
ZXDB	ZNF905	ENSG00000198455	"Zinc finger X-linked duplicated B"	P98169	X	57592011-57597477	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 31.7;Suprabasal keratinocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 34.8"									HPA043789	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.87e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.61e-3)"	"unprognostic (4.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.87e-3)"	3.6	3.1	3.7	3.4	3.6	8.2	4.8	4.6	4.0	4.5	2.8	3.6	2.8	5.2	3.1	3.3	5.5	4.2	3.6	3.5	4.2	3.6	14.5	3.4	4.8	3.9	3.9	5.8	6.0	6.1	2.3	2.6	4.1	4.9	3.7	3.3	3.3	4.3	4.2	4.7	3.4	5.7	3.8	4.1	4.1	1.5	3.6	3.3	5.3	4.8	4.5	4.3	2.7	4.2	5.5	6.4	4.1	5.5	6.8	6.7	5.6	3.9	4.8	3.1	3.2	2.7	4.0	4.8	5.6	7.0	4.9	6.1	11.9	20.5	6.0	11.7	6.4	2.6	8.3	7.3	8.8	4.5	2.9	5.9	34.8	8.0	21.4	6.8	9.4	5.2	3.0	5.0	8.4	3.9	4.0	3.7	16.5	2.2	8.0	5.0	14.9	2.7	4.2	8.7	3.5	6.5	7.7	5.6	6.1	9.2	5.8	4.9	8.3	6.7	12.9	5.8	3.9	0.0	2.1	6.4	4.8	3.9	3.1	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.2	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.1	3.7	3.6	4.6	4.0	3.5	4.2	3.9	3.9	4.1	3.8	3.6	4.2	4.6	6.4	2.6	1.0	6.4	31.7	11.4	3.7	12.5	3.5	10.6	4.8	6.1	8.6	3.5	1.8	0.0	2.4	7.3	2.8	3.9	2.9	0.0	9.8	6.1	5.6	0.0	4.0	2.8	3.7	1.6	6.0	7.1	14.5	0.0	4.4	3.9	12.0	1.1	6.7	3.7	7.8	0.0	2.2	8.1	0.2	5.0	2.7	7.2	1.9	1.4	1.0	2.1	4.0	3.6	4.0	1.7	5.7	7.3	17.1	2.2	2.9	3.5	3.5	0.0	7.1	4.6	0.2	0.2	9.7	38.1	2.9	4.8	1.8	4.6	16.1
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.9;testis: 3.8;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in some"		"Prostatic glandular cells: 2.5;Spermatocytes: 3.5;Spermatogonia: 7.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.5;hTEC/SVTERT24-B: 10.4;K-562: 10.7;SiHa: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.3	0.1	0.1	0.5	0.8	0.2	0.2	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.3	2.9	1.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.3	2.3	0.0	0.7	0.1	0.4	0.4	0.0	2.0	0.3	0.0	0.0	0.0	4.5	1.2	1.4	5.8	4.7	0.1	0.0	0.0	3.0	1.8	0.0	0.1	3.8	0.1	6.8	0.3	7.5	0.0	12.5	0.0	2.7	0.0	0.9	0.0	0.3	10.4	0.0	0.3	1.3	0.0	10.7	5.6	0.2	5.6	0.0	5.6	1.4	0.0	1.0	0.0	1.2	4.9	3.5	0.2	1.4	2.1	10.8	0.4	0.0	4.3	6.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	4.9	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	0.5	1.6	0.5	0.7	0.0	0.1	0.0	0.0	1.1	0.3	0.4	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.5	0.0	0.1	0.4	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.0	0.9	2.5	0.0	1.3	0.2	1.3	0.0	0.6	0.3	3.5	7.9	1.5	0.1	0.3	0.1	0.0	0.1	0.3
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143030	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		1100000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	10.2	10.6	6.4	10.1	6.7	20.8	9.7	7.4	7.3	8.4	18.3	19.2	15.5	9.9	5.7	11.1	9.1	6.4	11.0	7.1	6.0	7.6	9.0	11.3	10.1	8.0	6.9	10.1	14.2	12.1	11.2	6.0	7.8	10.1	14.6	11.2	9.1	7.4	22.2	12.1	27.5	8.8	5.8	14.2	12.0	8.0	8.5	15.1	10.7	13.3	9.7	10.9	8.1	7.5	13.1	20.1	7.1	9.7	17.4	9.8	8.5	11.1	13.9	12.7	12.3	10.0	4.5	12.4	7.3	15.0	8.4	14.6	14.4	7.6	12.9	14.5	15.0	12.0	16.4	6.5	11.8	10.2	22.6	12.6	10.0	12.5	14.7	6.6	16.6	12.3	8.8	12.2	8.0	8.9	12.7	6.0	4.3	12.5	7.6	14.0	8.6	5.4	7.1	13.2	5.6	8.2	12.6	7.7	10.8	7.0	7.6	7.7	19.7	11.1	5.6	14.1	14.7	5.4	3.0	6.3	11.1	8.9	10.5	0.7	0.6	0.6	0.8	0.9	1.0	0.4	0.5	0.5	0.5	0.3	0.3	0.6	1.0	0.2	1.0	0.4	0.4	0.4	6.4	6.7	7.4	7.3	7.1	6.0	8.0	6.9	7.8	5.8	8.5	7.5	19.3	57.7	54.8	39.8	23.5	7.1	5.4	6.6	13.1	30.6	12.6	10.3	22.8	18.6	30.0	9.2	98.0	8.3	23.7	93.4	0.0	7.3	48.9	18.8	17.4	19.2	13.2	12.4	50.3	11.2	6.4	21.6	46.4	25.6	26.5	21.8	23.2	15.2	11.9	40.4	55.3	38.5	12.2	30.5	10.6	26.8	14.9	29.0	12.4	22.5	20.4	15.8	19.6	35.2	53.6	14.9	34.3	9.8	27.8	9.5	115.2	4.8	22.7	50.3	6.6	23.7	15.2	12.0	11.8	16.4	10.1	8.9	31.1	18.0	28.6	9.3
ZZZ3	"ATAC1, DKFZP564I052"	ENSG00000036549	"Zinc finger ZZ-type containing 3"	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	8.9	12.2	6.3	10.2	10.8	9.7	17.1	5.6	6.9	13.0	2.6	9.6	9.0	13.0	9.2	9.8	11.2	8.6	11.1	5.3	7.5	14.5	16.7	8.2	12.8	5.7	7.2	16.9	9.7	13.9	6.0	10.5	8.0	11.9	9.5	11.3	10.4	12.2	8.7	10.8	8.1	12.0	7.1	9.8	10.4	6.5	7.9	14.3	19.8	10.2	12.4	10.4	6.5	16.0	27.9	12.4	22.4	17.9	21.3	30.3	26.0	32.6	27.9	27.7	31.3	15.5	12.9	34.8	29.3	27.2	32.3	24.3	29.3	22.2	44.4	25.9	26.9	41.1	26.9	19.8	33.2	45.5	12.0	26.0	34.2	31.0	63.4	30.1	31.2	24.2	41.4	24.0	27.3	13.1	22.0	13.7	35.1	15.9	29.5	25.9	40.3	17.1	22.5	26.1	30.0	26.5	19.2	23.0	60.6	16.4	13.0	25.7	24.9	23.7	29.9	40.2	44.6	20.3	30.8	36.7	27.2	39.2	19.3	0.1	4.3	5.3	6.1	4.5	9.6	7.3	7.6	7.7	7.4	9.0	9.5	8.6	0.8	7.8	5.0	4.9	10.4	5.1	6.3	10.8	5.6	6.9	5.3	7.5	5.7	7.2	8.0	7.1	7.9	16.0	11.3	0.0	0.0	73.8	22.2	17.2	13.6	10.9	27.9	18.1	0.0	0.0	0.0	15.7	5.6	0.0	8.4	13.3	14.3	6.9	0.0	0.0	5.1	0.0	0.0	10.5	19.8	17.4	102.1	0.0	12.3	11.0	16.3	0.0	0.0	0.0	15.0	15.1	14.1	16.8	100.7	14.1	6.1	13.2	11.8	3.9	16.8	8.2	12.4	77.8	7.5	16.1	17.5	141.8	280.3	0.0	14.0	19.5	14.9	18.7	10.1	0.0	4.2	19.7	6.6	29.6	11.4	7.8	9.7	28.1	19.6	8.5	14.2	0.0	14.2	14.2